data_2k1e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.2 -29.99 71.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.041 1.336 . . . . 0.0 109.323 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -91.94 -2.46 56.76 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 121.267 -0.896 . . . . 0.0 111.712 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.21 -36.46 19.44 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 119.599 1.09 . . . . 0.0 108.965 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -67.71 -35.01 78.01 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.894 -1.129 . . . . 0.0 110.305 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -75.43 -34.38 60.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 121.769 -0.582 . . . . 0.0 109.651 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.04 82.45 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.798 0.839 . . . . 0.0 109.715 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -60.49 -38.37 84.08 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.662 1.185 . . . . 0.0 111.417 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -56.3 -42.5 77.65 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.569 1.148 . . . . 0.0 110.612 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.06 -32.29 73.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.632 -0.668 . . . . 0.0 111.061 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.11 -27.68 67.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.625 -0.672 . . . . 0.0 111.853 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.35 -39.26 81.92 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 109.158 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.47 -36.17 82.88 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.488 0.715 . . . . 0.0 110.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -38.89 92.91 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.607 0.717 . . . . 0.0 111.057 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -69.08 -21.01 64.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.364 1.066 . . . . 0.0 111.883 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -72.51 -40.72 66.62 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -64.46 -38.88 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.845 0.858 . . . . 0.0 108.709 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.92 -43.26 86.15 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.556 1.142 . . . . 0.0 111.859 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.82 -53.86 53.39 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.321 1.058 . . . . 0.0 110.251 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -73.06 -28.96 62.62 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.265 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.06 89.19 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 124.925 1.29 . . . . 0.0 110.428 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m -56.96 -37.82 72.11 Favored 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.498 1.119 . . . . 0.0 112.042 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -75.59 -51.68 12.32 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.387 0.675 . . . . 0.0 110.854 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.3 -38.22 88.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 120.989 -1.069 . . . . 0.0 109.498 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.96 75.25 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.353 1.461 . . . . 0.0 112.505 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.38 -33.05 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 O-C-N 121.375 -0.828 . . . . 0.0 111.415 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.34 -44.82 50.73 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.8 84.95 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.577 1.551 . . . . 0.0 108.721 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -79.59 -44.26 21.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -77.11 93.88 3.96 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 119.372 -2.08 . . . . 0.0 110.537 -172.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.87 -17.85 3.41 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.98 151.4 54.6 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.025 0.912 . . . . 0.0 109.196 -176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.84 137.07 13.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.839 2.36 . . . . 0.0 110.731 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 -4.61 83.64 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 118.784 0.72 . . . . 0.0 111.306 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.88 146.76 54.06 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.492 1.117 . . . . 0.0 111.662 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.66 -11.1 1.59 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.519 1.128 . . . . 0.0 111.138 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.11 -66.32 0.73 Allowed 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.088 -1.007 . . . . 0.0 111.152 -172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 40' ' ' SER 0.495 44.9 pt 58.28 -100.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 174.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 39' ' ' ILE . 24.7 m -54.11 143.23 22.97 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -56.05 -57.45 22.12 Favored Pre-proline 0 C--N 1.356 0.859 0 C-N-CA 125.866 1.666 . . . . 0.0 114.991 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.22 -5.58 17.16 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.258 2.913 . . . . 0.0 111.207 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -107.98 1.97 22.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.17 -45.21 9.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.79 -32.15 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 124.237 1.015 . . . . 0.0 110.781 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.86 -10.54 59.71 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.122 -0.986 . . . . 0.0 112.143 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -90.14 -22.95 21.49 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -89.32 54.7 3.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 120.151 -1.593 . . . . 0.0 109.36 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.21 -73.72 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.44 -31.72 65.7 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.506 1.922 . . . . 0.0 108.638 -169.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -52.64 -37.67 58.9 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.091 1.357 . . . . 0.0 111.627 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -16.48 58.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 119.664 -1.898 . . . . 0.0 111.919 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t -108.55 38.48 2.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.388 4.6 p 62.74 -110.31 0.34 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.597 2.359 . . . . 0.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t 70.51 -70.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.891 1.676 . . . . 0.0 110.116 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.5 -24.3 29.14 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -78.27 55.92 1.61 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 109.787 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.76 -13.65 66.43 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 120.369 -1.457 . . . . 0.0 110.358 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 t0 76.09 14.37 2.54 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 127.583 2.353 . . . . 0.0 108.751 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -148.79 -178.3 6.27 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.26 139.76 21.69 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.59 175.93 8.35 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.992 3.128 . . . . 0.0 107.766 161.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.314 2.6 p -113.43 -88.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-N 120.832 1.651 . . . . 0.0 112.046 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -157.64 -40.45 0.07 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.496 -2.003 . . . . 0.0 107.21 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.91 -23.5 31.16 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 123.121 0.568 . . . . 0.0 110.795 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.8 -35.95 71.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.492 1.517 . . . . 0.0 108.043 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.04 96.35 2.08 Favored Glycine 0 CA--C 1.47 -2.74 1 N-CA-C 97.992 -6.043 . . . . 0.0 97.992 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.409 HH12 ' HB2' ' D' ' 59' ' ' ASP . 16.3 ttm180 -62.64 -17.21 59.94 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 118.726 1.263 . . . . 0.0 110.072 -174.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -44.06 -29.63 0.63 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.561 2.744 . . . . 0.0 113.813 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.93 -40.99 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 124.593 1.157 . . . . 0.0 109.137 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 -49.05 12.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.196 -0.94 . . . . 0.0 108.617 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -47.85 -50.32 26.63 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.703 2.001 . . . . 0.0 111.721 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.1 -27.31 61.63 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.662 -0.649 . . . . 0.0 111.562 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.97 -44.15 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.9 mtm -63.19 -44.23 95.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.135 0.574 . . . . 0.0 110.539 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -65.84 -32.54 74.12 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.342 -0.849 . . . . 0.0 111.473 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.06 79.2 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.355 -0.841 . . . . 0.0 110.403 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.43 -41.34 96.46 Favored Glycine 0 CA--C 1.487 -1.695 0 C-N-CA 123.969 0.795 . . . . 0.0 111.145 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.71 -46.95 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 C-N-CA 124.078 0.951 . . . . 0.0 108.722 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.13 -39.4 94.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 120.734 -1.229 . . . . 0.0 112.302 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.85 -55.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.71 0.804 . . . . 0.0 109.361 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.39 -18.65 61.13 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.579 -0.7 . . . . 0.0 111.667 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.35 23.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.073 -1.017 . . . . 0.0 109.861 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.81 -37.27 87.05 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.935 -1.103 . . . . 0.0 110.585 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.33 -7.62 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 O-C-N 121.188 -0.945 . . . . 0.0 112.246 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -57.97 -23.95 55.98 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 124.706 1.202 . . . . 0.0 110.72 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.75 72.96 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.182 -1.574 . . . . 0.0 112.457 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.77 -39.98 56.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 120.998 -1.064 . . . . 0.0 108.612 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.59 -35.05 78.26 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.689 0.757 . . . . 0.0 110.425 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.74 68.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.672 -1.268 . . . . 0.0 112.343 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 t -84.57 5.12 29.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.709 -1.245 . . . . 0.0 109.709 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.72 -48.39 59.69 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 118.786 0.721 . . . . 0.0 109.693 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -67.98 -27.94 67.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.723 -1.235 . . . . 0.0 111.551 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -29.1 46.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 125.085 1.354 . . . . 0.0 109.115 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -59.96 -18.51 45.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.243 1.817 . . . . 0.0 111.847 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -61.81 -36.68 81.83 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.974 1.31 . . . . 0.0 109.676 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 CA--C 1.499 -1.015 0 O-C-N 120.683 -1.261 . . . . 0.0 109.815 -169.151 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.926 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.417 ' CD2' ' HG3' ' B' ' 5' ' ' GLU . 36.8 p-80 -56.16 -30.07 61.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.425 2.29 . . . . 0.0 114.348 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' B' ' 4' ' ' HIS . 8.3 mt-10 -74.62 -21.2 59.59 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -79.38 -42.57 25.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.59 -31.25 66.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.038 0.447 . . . . 0.0 110.473 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.53 -43.31 93.48 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.754 0.822 . . . . 0.0 111.558 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -72.83 -30.57 64.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.773 0.797 . . . . 0.0 110.351 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -66.45 -34.4 77.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.742 0.817 . . . . 0.0 110.214 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.94 79.28 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -63.29 -36.62 84.27 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.494 -0.753 . . . . 0.0 111.0 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.99 -33.95 76.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.916 0.886 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -62.81 -41.83 99.47 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 121.246 -0.909 . . . . 0.0 109.32 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.64 -39.65 94.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.795 -0.566 . . . . 0.0 110.939 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.97 -38.05 84.58 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.368 0.667 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -62.57 -45.2 94.01 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.339 0.656 . . . . 0.0 109.568 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.53 -38.72 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 123.756 0.823 . . . . 0.0 109.72 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.91 -45.92 85.75 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.824 0.85 . . . . 0.0 111.261 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.58 -37.63 77.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.592 1.157 . . . . 0.0 110.712 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.48 -35.59 63.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.72 -0.613 . . . . 0.0 109.898 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.73 -36.79 85.02 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.142 0.977 . . . . 0.0 111.068 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -28.94 69.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.727 1.149 . . . . 0.0 112.949 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.05 -53.71 10.42 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -58.18 -48.11 81.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 125.073 1.349 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.56 -43.87 84.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.644 1.178 . . . . 0.0 112.224 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 -48.69 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 -20.35 49.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -50.67 43.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 108.504 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.83 -21.66 63.36 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 mmm-85 -70.68 90.57 0.77 Allowed 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 120.149 -1.595 . . . . 0.0 110.694 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.87 -21.45 3.01 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 107.519 -2.233 . . . . 0.0 107.519 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.44 152.26 66.91 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 117.761 0.78 . . . . 0.0 110.771 -172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.57 128.32 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.87 2.38 . . . . 0.0 110.667 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.38 -63.05 0.28 Allowed Glycine 0 CA--C 1.471 -2.688 1 N-CA-C 103.036 -4.026 . . . . 0.0 103.036 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.422 ' H ' HG22 ' B' ' 63' ' ' VAL . . . 45.41 -94.53 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 128.643 2.777 . . . . 0.0 111.503 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 83.75 -29.09 0.09 Allowed 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 127.165 2.186 . . . . 0.0 109.042 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.92 122.5 39.96 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 pt -154.44 170.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 76.61 139.83 0.07 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.017 1.727 . . . . 0.0 111.673 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -47.3 23.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.585 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -70.48 -21.6 29.91 Favored 'Trans proline' 0 CA--C 1.502 -1.089 0 CA-C-N 124.512 2.647 . . . . 0.0 112.952 -168.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.38 6.52 24.43 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 119.945 1.248 . . . . 0.0 110.37 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.67 -38.85 67.48 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.631 0.729 . . . . 0.0 109.25 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -65.09 -33.24 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 123.414 0.686 . . . . 0.0 109.773 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -41.63 84.02 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.971 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.19 0.995 . . . . 0.0 109.177 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -58.02 -41.42 83.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.976 1.31 . . . . 0.0 111.165 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.79 -51.88 67.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 O-C-N 121.49 -0.756 . . . . 0.0 111.114 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . 0.285 6.6 pt-20 -76.37 -12.1 60.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.028 -1.045 . . . . 0.0 112.538 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 90.0 m -68.33 -42.94 78.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.6 67.38 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.323 -1.486 . . . . 0.0 112.287 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -76.58 -18.86 58.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.851 -0.531 . . . . 0.0 111.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.311 13.9 p 68.6 10.31 7.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.616 2.366 . . . . 0.0 111.307 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.23 -53.72 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.14 -46.65 3.67 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 120.838 -1.164 . . . . 0.0 110.554 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 76.91 -67.08 0.22 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 128.187 2.595 . . . . 0.0 109.002 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.69 27.79 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.03 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.36 178.22 7.45 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -156.23 154.62 27.7 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.91 174.5 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.073 2.515 . . . . 0.0 111.465 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.422 HG22 ' H ' ' B' ' 36' ' ' ALA . 2.4 t -95.83 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.914 0.885 . . . . 0.0 111.165 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -128.62 -32.08 2.18 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.448 1.899 . . . . 0.0 107.657 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -92.58 -6.2 50.01 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.769 0.827 . . . . 0.0 108.801 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -35.4 59.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.62 64.44 0.67 Allowed Glycine 0 CA--C 1.468 -2.897 0 N-CA-C 103.12 -3.992 . . . . 0.0 103.12 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -31.79 -16.82 0.0 OUTLIER 'General case' 0 C--N 1.369 1.45 1 C-N-CA 132.816 4.446 . . . . 0.0 117.7 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.46 -15.41 2.69 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.275 -1.516 . . . . 0.0 113.428 158.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.25 -54.6 32.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.171 1.388 . . . . 0.0 107.973 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.1 -46.0 75.55 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.463 -0.773 . . . . 0.0 110.31 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -49.73 -43.12 47.52 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 126.084 1.754 . . . . 0.0 111.393 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.38 -50.02 73.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.442 1.097 . . . . 0.0 110.913 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.84 -43.44 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.597 0.759 . . . . 0.0 109.624 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtm -63.14 -48.8 76.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.373 1.069 . . . . 0.0 110.134 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -71.61 -27.25 62.99 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.289 -0.882 . . . . 0.0 110.813 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.78 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.872 -1.142 . . . . 0.0 109.824 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.82 61.42 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -58.71 -45.56 90.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 C-N-CA 124.035 0.934 . . . . 0.0 110.52 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.55 -27.97 68.83 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.516 -1.365 . . . . 0.0 112.569 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.75 -46.71 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 120.368 -1.458 . . . . 0.0 108.247 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -65.95 -21.57 66.43 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.934 0.894 . . . . 0.0 110.956 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -42.78 16.43 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.619 1.167 . . . . 0.0 110.732 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.8 -40.4 83.96 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.208 1.403 . . . . 0.0 111.031 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 29.2 m -63.33 -8.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 123.836 0.855 . . . . 0.0 112.393 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.7 m -64.72 -12.58 48.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.678 -1.264 . . . . 0.0 110.535 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.96 65.98 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.828 -1.795 . . . . 0.0 112.098 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.51 -37.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.951 -1.093 . . . . 0.0 109.108 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.02 -36.59 64.46 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.417 -0.802 . . . . 0.0 111.267 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.33 -12.82 60.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.847 -1.158 . . . . 0.0 111.187 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -96.88 1.44 50.55 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.945 -1.097 . . . . 0.0 108.974 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.3 -37.3 66.26 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 120.305 1.411 . . . . 0.0 109.017 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -66.74 -30.01 70.13 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 120.289 -1.507 . . . . 0.0 111.406 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.6 -22.95 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.091 1.357 . . . . 0.0 109.6 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.92 -25.31 65.03 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.07 -1.019 . . . . 0.0 111.519 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -8.51 54.04 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.526 -1.359 . . . . 0.0 112.36 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 CA--C 1.496 -1.098 0 O-C-N 120.298 -1.501 . . . . 0.0 107.625 173.859 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 . . . . . 0 CA--C 1.501 -0.906 0 CA-C-O 122.88 1.324 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -19.99 63.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.691 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.15 -38.67 20.37 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -62.78 -32.2 73.32 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.503 -1.373 . . . . 0.0 112.182 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -64.48 -36.09 83.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.07 0.948 . . . . 0.0 110.936 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -44.73 62.04 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.173 -0.954 . . . . 0.0 109.519 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -66.83 -33.36 75.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.487 0.66 . . . . 0.0 111.345 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.97 -37.51 79.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.672 1.989 . . . . 0.0 111.113 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.01 -38.86 66.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.948 0.899 . . . . 0.0 110.291 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.05 -40.82 90.75 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.084 -1.01 . . . . 0.0 110.962 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.61 -18.03 62.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.298 -0.876 . . . . 0.0 111.728 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -73.83 -38.39 64.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.94 -38.11 89.89 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.249 0.62 . . . . 0.0 110.544 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.26 -24.94 68.09 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.604 -0.685 . . . . 0.0 112.449 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -80.12 -23.75 40.98 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.373 1.469 . . . . 0.0 109.55 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.17 -35.52 20.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 124.46 1.104 . . . . 0.0 108.034 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -60.55 -33.94 73.41 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.88 0.872 . . . . 0.0 111.462 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -60.62 -50.14 74.71 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.663 1.185 . . . . 0.0 110.225 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.38 -41.0 96.93 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 121.573 -0.704 . . . . 0.0 109.995 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.25 87.18 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.536 1.135 . . . . 0.0 110.389 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 83.5 p -62.72 -33.41 75.06 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.63 0.728 . . . . 0.0 112.116 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -80.15 -54.31 5.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.57 -30.79 67.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.772 0.829 . . . . 0.0 109.467 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.95 76.1 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 125.052 1.341 . . . . 0.0 112.736 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.23 -34.21 57.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 O-C-N 120.896 -1.128 . . . . 0.0 110.615 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.61 -40.63 73.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.852 -1.155 . . . . 0.0 109.389 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.6 1.09 Allowed 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.398 1.479 . . . . 0.0 109.53 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.34 -31.4 0.05 Allowed 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 123.694 0.621 . . . . 0.0 109.446 171.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -70.4 81.65 0.56 Allowed 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.224 -1.547 . . . . 0.0 111.915 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.66 -4.24 1.43 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.6 148.1 68.88 Favored Pre-proline 0 N--CA 1.442 -0.867 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -169.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -78.01 81.83 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.141 2.56 . . . . 0.0 113.182 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.68 34.11 3.15 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 146.18 13.89 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 126.813 2.045 . . . . 0.0 112.402 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.46 -46.07 1.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 125.169 1.388 . . . . 0.0 108.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.1 115.81 18.11 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 122.111 0.958 . . . . 0.0 108.603 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.8 163.21 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t 75.28 131.39 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.882 1.273 . . . . 0.0 112.377 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -67.29 -45.82 49.84 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 116.333 -1.794 . . . . 0.0 111.929 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.23 -10.54 27.4 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 CA-C-N 125.208 2.896 . . . . 0.0 113.904 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.361 0.7 OUTLIER -103.66 -19.43 14.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 121.372 1.896 . . . . 0.0 110.408 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.24 73.92 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.086 0.954 . . . . 0.0 112.214 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tp -66.05 -29.97 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.482 -0.762 . . . . 0.0 110.846 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -34.7 55.04 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -58.71 -41.99 87.59 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 122.385 1.088 . . . . 0.0 109.743 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -10.54 55.24 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.761 -1.212 . . . . 0.0 114.006 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.29 -47.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.5 57.56 4.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.607 1.563 . . . . 0.0 110.722 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -160.66 -51.21 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.64 -6.33 51.61 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.398 -1.439 . . . . 0.0 111.373 -170.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -80.52 -7.44 59.2 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.075 2.15 . . . . 0.0 110.459 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.309 34.2 p 76.93 17.76 1.63 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.689 2.396 . . . . 0.0 110.44 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.71 111.55 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.54 0.83 Allowed Glycine 0 CA--C 1.481 -2.075 1 N-CA-C 101.805 -4.518 . . . . 0.0 101.805 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.18 -33.06 38.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.92 -116.49 1.33 Allowed Glycine 0 CA--C 1.479 -2.187 0 N-CA-C 103.269 -3.932 . . . . 0.0 103.269 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.302 43.7 t0 64.13 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.348 0.52 0 C-N-CA 126.686 1.994 . . . . 0.0 109.825 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -128.75 158.96 37.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -161.05 147.0 11.16 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.01 163.62 22.9 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 122.795 2.33 . . . . 0.0 109.65 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.259 8.2 t -98.88 -105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -168.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -134.72 -60.04 0.79 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.371 -2.081 . . . . 0.0 108.827 -162.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -78.26 -6.35 54.72 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.377 1.471 . . . . 0.0 108.881 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.35 -20.77 46.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 C-N-CA 131.827 4.051 . . . . 0.0 108.028 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.69 84.36 0.84 Allowed Glycine 0 CA--C 1.482 -1.982 1 N-CA-C 101.473 -4.651 . . . . 0.0 101.473 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -23.52 24.66 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 110.92 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -57.65 -10.34 1.53 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.83 -41.21 87.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 120.059 1.3 . . . . 0.0 110.297 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.62 -51.09 21.09 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 120.991 -1.068 . . . . 0.0 109.163 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -46.05 -51.34 13.88 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 127.213 2.205 . . . . 0.0 112.966 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.98 -28.14 61.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.594 0.758 . . . . 0.0 110.714 -171.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 68.1 t -74.1 -46.08 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 79.2 mtm -59.98 -42.75 94.86 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.36 0.664 . . . . 0.0 111.231 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -65.37 -27.27 68.45 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 121.706 -0.621 . . . . 0.0 111.649 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.73 71.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.196 -0.94 . . . . 0.0 110.681 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.83 -35.83 61.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.57 -46.57 96.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 108.672 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.0 -50.33 73.76 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.73 -52.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 124.979 1.312 . . . . 0.0 110.379 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.29 -0.7 42.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.247 -0.908 . . . . 0.0 111.337 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.12 -37.58 14.12 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 120.733 -1.23 . . . . 0.0 108.295 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.48 -34.83 76.13 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 125.215 1.406 . . . . 0.0 111.344 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.88 -9.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 C-N-CA 124.079 0.952 . . . . 0.0 113.069 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -59.57 -24.19 63.53 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 125.52 1.528 . . . . 0.0 111.396 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.01 -23.56 66.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.771 -1.206 . . . . 0.0 111.562 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.43 -42.93 13.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.86 -41.59 91.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.44 1.096 . . . . 0.0 112.806 -171.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.75 -5.82 40.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.869 -1.144 . . . . 0.0 111.769 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.14 -8.48 25.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.35 -39.64 74.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.504 1.047 . . . . 0.0 109.305 -167.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -80.31 -15.02 57.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.195 -1.565 . . . . 0.0 113.04 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.16 -27.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.608 -1.308 . . . . 0.0 107.562 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 35.3 ttm105 -55.83 -23.4 30.28 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 126.405 1.882 . . . . 0.0 111.937 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -59.54 -32.67 70.54 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.421 -1.424 . . . . 0.0 111.732 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--N 1.355 0.822 0 O-C-N 121.005 -1.059 . . . . 0.0 108.487 -175.37 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 CA-C-O 121.851 0.834 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.98 -26.0 68.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.463 -1.398 . . . . 0.0 111.56 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.18 -24.86 60.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.259 -0.9 . . . . 0.0 111.308 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -30.2 38.58 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -67.42 -44.77 77.94 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.57 -0.706 . . . . 0.0 110.31 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.49 -38.36 74.34 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.769 -0.582 . . . . 0.0 110.384 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.85 -48.08 80.58 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.939 0.896 . . . . 0.0 111.588 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.02 -35.34 79.7 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.519 -0.738 . . . . 0.0 110.487 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.58 -31.81 73.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.837 0.855 . . . . 0.0 110.496 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.27 97.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.401 -0.812 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -29.69 70.76 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.522 0.677 . . . . 0.0 111.552 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.2 -28.85 66.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 121.251 -0.906 . . . . 0.0 110.42 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -82.47 -23.71 34.58 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.749 -1.219 . . . . 0.0 109.9 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.48 -42.97 99.6 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 120.637 -1.289 . . . . 0.0 110.5 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -59.36 -35.59 74.17 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.435 1.094 . . . . 0.0 112.162 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -66.83 -44.9 79.88 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.611 1.164 . . . . 0.0 108.926 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.24 -38.04 81.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 C-N-CA 124.259 1.023 . . . . 0.0 109.416 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.47 -44.87 81.01 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.642 0.777 . . . . 0.0 112.076 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.89 -43.69 71.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.025 0.53 . . . . 0.0 110.701 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.34 -47.21 80.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.59 1.186 . . . . 0.0 109.825 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.0 -28.68 64.61 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.017 -1.052 . . . . 0.0 111.876 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -74.42 -31.08 62.18 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 119.582 1.083 . . . . 0.0 110.769 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -62.05 -48.02 82.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -63.55 -50.68 68.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.208 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.06 70.06 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 125.291 1.437 . . . . 0.0 113.236 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.44 -35.34 61.59 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 120.947 -1.096 . . . . 0.0 110.59 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -81.78 -22.73 37.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.411 -1.431 . . . . 0.0 110.096 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -52.58 14.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 127.093 2.157 . . . . 0.0 107.778 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.84 -35.73 79.12 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.451 1.12 . . . . 0.0 110.967 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.84 103.51 2.64 Favored 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 120.184 -1.572 . . . . 0.0 111.586 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.41 -25.21 3.65 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 106.231 -2.747 . . . . 0.0 106.231 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 148.27 74.94 Favored Pre-proline 0 N--CA 1.439 -0.999 0 O-C-N 121.675 -0.897 . . . . 0.0 110.228 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 134.88 17.77 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.253 1.969 . . . . 0.0 110.131 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 26.63 61.26 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 137.28 51.26 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.287 1.835 . . . . 0.0 111.416 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.08 -47.08 2.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tt -85.93 71.27 10.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.728 1.251 . . . . 0.0 110.142 -172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -96.61 -6.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 O-C-N 120.159 -1.588 . . . . 0.0 111.205 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.2 p -95.96 141.98 28.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.097 -1.002 . . . . 0.0 110.862 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -89.73 -61.11 0.22 Allowed Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.318 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.25 -5.92 17.26 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 CA-C-N 125.797 3.106 . . . . 0.0 110.818 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.29 -18.56 21.51 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.076 1.751 . . . . 0.0 107.492 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.21 72.32 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 111.083 -168.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.26 -35.34 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 124.115 0.966 . . . . 0.0 110.515 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -36.15 74.23 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -67.95 -41.06 83.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.399 1.095 . . . . 0.0 109.393 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.8 t -60.62 -41.17 94.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.961 -1.087 . . . . 0.0 110.339 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.51 -53.35 31.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 125.432 1.493 . . . . 0.0 110.6 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -76.1 -15.35 60.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.684 -0.635 . . . . 0.0 111.62 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 73.8 m -76.41 -36.82 57.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.45 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.234 -0.916 . . . . 0.0 111.574 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.438 ' HG1' HG23 ' D' ' 55' ' ' VAL . 17.5 p -87.59 13.15 10.84 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.781 -0.575 . . . . 0.0 110.736 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p 52.56 49.02 21.3 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.296 1.839 . . . . 0.0 114.0 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.438 HG23 ' HG1' ' D' ' 53' ' ' THR . 0.7 OUTLIER -127.11 -55.05 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -177.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.87 -44.31 3.22 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 120.52 -1.363 . . . . 0.0 110.014 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.38 -75.72 0.07 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 127.111 2.164 . . . . 0.0 108.29 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.29 37.4 0.02 OUTLIER Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.409 ' HB2' HH12 ' A' ' 68' ' ' ARG . 5.2 t70 -87.0 -66.06 0.95 Allowed 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -130.52 -160.81 1.07 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -165.54 150.19 7.73 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.57 161.67 12.6 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.967 3.111 . . . . 0.0 108.707 168.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -154.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-N 119.893 1.224 . . . . 0.0 108.116 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -91.13 -50.07 6.05 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 119.672 -1.893 . . . . 0.0 108.687 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -77.34 -3.23 38.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.076 1.751 . . . . 0.0 110.847 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -29.8 69.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.59 80.23 1.19 Allowed Glycine 0 CA--C 1.468 -2.891 1 N-CA-C 99.1 -5.6 . . . . 0.0 99.1 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -63.16 -1.68 1.09 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.544 1.537 . . . . 0.0 112.613 -166.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -69.46 -13.3 62.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.602 1.161 . . . . 0.0 112.394 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -53.08 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.28 73.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.313 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -63.62 -34.57 78.12 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.718 0.807 . . . . 0.0 111.893 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.7 -37.08 85.99 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.967 -1.083 . . . . 0.0 111.206 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.22 -39.22 82.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 O-C-N 121.067 -1.021 . . . . 0.0 109.893 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 64.5 mtt -62.01 -50.37 72.33 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.67 0.788 . . . . 0.0 110.024 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.71 -30.64 70.93 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.496 -0.752 . . . . 0.0 110.641 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.13 96.12 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.066 -1.021 . . . . 0.0 110.469 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.09 -44.68 95.43 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 124.349 0.976 . . . . 0.0 111.428 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.64 -47.47 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 O-C-N 121.891 -0.77 . . . . 0.0 109.552 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -69.75 -32.82 71.56 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.927 -1.108 . . . . 0.0 113.306 -173.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.41 -42.48 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 110.109 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.14 -36.81 64.18 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 121.634 -0.666 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.28 -23.12 62.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.872 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.55 -32.63 72.7 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.856 -1.778 . . . . 0.0 109.797 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.48 -18.77 21.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 124.792 1.237 . . . . 0.0 110.276 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -60.05 -14.29 15.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 120.809 -1.182 . . . . 0.0 111.663 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.0 2.75 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.37 -1.456 . . . . 0.0 111.24 167.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.7 98.5 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.947 1.299 . . . . 0.0 109.517 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.12 -41.89 89.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 111.915 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.9 -11.45 60.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.978 -1.076 . . . . 0.0 110.356 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -74.72 -26.83 60.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 120.805 -1.184 . . . . 0.0 108.384 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.268 0.6 OUTLIER -80.14 -4.7 54.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 120.317 -1.489 . . . . 0.0 112.818 -160.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -81.78 -29.79 32.6 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 120.674 -1.266 . . . . 0.0 109.337 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.56 -28.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.49 1.116 . . . . 0.0 109.288 -172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -62.72 -12.38 23.45 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.272 -0.893 . . . . 0.0 111.691 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -68.96 -16.55 63.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.434 -0.791 . . . . 0.0 112.37 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 . . . . . 0 C--N 1.353 0.721 0 O-C-N 120.683 -1.261 . . . . 0.0 109.304 175.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.45 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 59.26 -80.6 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.692 2.397 . . . . 0.0 111.379 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -9.59 49.75 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.82 -42.1 91.03 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.337 -0.852 . . . . 0.0 109.18 164.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -71.73 -33.06 68.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 O-C-N 120.569 -1.332 . . . . 0.0 110.437 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.47 -38.5 87.46 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.01 93.5 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.502 1.121 . . . . 0.0 111.44 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -63.78 -36.35 83.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.476 1.51 . . . . 0.0 111.216 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -75.02 -23.87 58.25 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 121.361 0.6 . . . . 0.0 110.038 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.65 86.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.448 -2.033 . . . . 0.0 111.1 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -61.31 -37.47 83.37 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.896 0.855 . . . . 0.0 110.978 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.68 -32.86 74.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.47 1.908 . . . . 0.0 110.214 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -78.15 -32.1 50.11 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 120.895 -1.128 . . . . 0.0 109.083 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.27 -43.76 98.35 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.966 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -59.76 -35.89 75.53 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.309 0.644 . . . . 0.0 112.1 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -32.71 73.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.833 0.853 . . . . 0.0 110.908 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.57 -40.08 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.44 -37.26 86.9 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.488 -0.758 . . . . 0.0 110.917 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.19 -39.58 82.45 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.903 -1.123 . . . . 0.0 111.306 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -69.49 -37.84 77.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.715 0.806 . . . . 0.0 109.762 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.83 89.51 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 125.887 1.675 . . . . 0.0 110.746 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m -63.89 -31.68 72.94 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.968 0.907 . . . . 0.0 111.93 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -75.2 -49.56 19.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.387 -0.821 . . . . 0.0 108.826 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -73.98 -22.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.316 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.42 4.58 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 125.202 1.401 . . . . 0.0 108.553 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.6 t -64.01 -28.78 45.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 O-C-N 119.811 -1.805 . . . . 0.0 111.18 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.36 -35.09 77.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.801 -1.187 . . . . 0.0 110.757 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.73 -59.27 2.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.595 1.558 . . . . 0.0 107.804 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.12 -30.67 62.44 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.287 1.835 . . . . 0.0 112.581 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -77.89 87.12 4.09 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.316 -2.115 . . . . 0.0 110.586 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.0 -21.87 1.13 Allowed Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.39 157.9 35.51 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 118.57 1.185 . . . . 0.0 110.598 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -85.97 131.96 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.391 2.061 . . . . 0.0 111.552 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.0 60.34 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.26 137.45 58.26 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.741 1.216 . . . . 0.0 110.853 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.16 -55.97 2.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.594 0.757 . . . . 0.0 109.727 -173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.33 91.25 8.43 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.196 0.998 . . . . 0.0 109.369 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.04 50.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.322 -1.486 . . . . 0.0 109.279 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.97 148.03 23.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.996 -1.69 . . . . 0.0 109.415 170.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -69.97 -45.58 22.87 Favored Pre-proline 0 C--N 1.353 0.726 0 CA-C-O 116.184 -1.865 . . . . 0.0 112.555 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.33 -19.08 33.87 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 125.545 3.016 . . . . 0.0 113.366 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -103.89 -3.91 24.17 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 120.118 1.326 . . . . 0.0 109.91 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.57 85.7 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.347 1.07 . . . . 0.0 110.41 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.57 -22.08 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 C-N-CA 124.702 1.201 . . . . 0.0 111.081 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.03 -26.54 26.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.603 -0.685 . . . . 0.0 109.457 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -68.96 -45.15 71.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.9 m -59.28 -12.29 5.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.444 1.098 . . . . 0.0 113.776 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -71.25 -58.22 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 123.999 0.92 . . . . 0.0 108.726 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 92.2 mt-10 -83.57 75.59 10.02 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.416 -0.802 . . . . 0.0 109.434 -172.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -170.37 -45.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.35 81.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 124.358 1.063 . . . . 0.0 111.97 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 p -96.24 18.37 13.85 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 124.006 0.922 . . . . 0.0 110.652 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.65 62.92 2.21 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 127.104 2.161 . . . . 0.0 115.07 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.77 165.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 1 N-CA-C 95.267 -5.827 . . . . 0.0 95.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.65 120.74 0.97 Allowed Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 99.06 -5.616 . . . . 0.0 99.06 170.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -84.8 -17.66 37.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 119.06 1.43 . . . . 0.0 109.071 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.36 21.01 4.93 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 121.129 -0.982 . . . . 0.0 112.886 171.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.27 -39.83 22.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.031 -1.276 . . . . 0.0 112.805 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -147.86 153.05 38.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -162.96 145.14 8.03 Favored Pre-proline 0 C--N 1.354 0.776 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.08 178.77 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 2.965 . . . . 0.0 111.793 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.275 9.4 p -119.54 -129.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 125.416 1.486 . . . . 0.0 108.412 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -99.45 -57.87 2.06 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 119.493 -2.005 . . . . 0.0 112.069 -160.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -75.41 -9.82 58.91 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 119.182 0.901 . . . . 0.0 109.835 -171.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -71.65 -13.62 61.81 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.672 1.989 . . . . 0.0 108.89 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.5 85.26 0.87 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 100.847 -4.901 . . . . 0.0 100.847 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -56.13 -20.92 19.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.327 1.061 . . . . 0.0 112.22 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.31 -15.74 17.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 118.283 -0.865 . . . . 0.0 113.066 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.01 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.007 1.73 . . . . 0.0 109.325 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.13 -52.75 21.18 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 121.064 -1.023 . . . . 0.0 109.132 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.98 -36.65 79.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.51 -34.88 78.75 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.71 -40.79 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.208 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 53.0 mtt -60.73 -48.38 82.06 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.11 0.964 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' D' ' 12' ' ' GLU . 8.7 tmtt? -66.08 -33.6 76.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 110.519 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.32 89.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.77 -0.581 . . . . 0.0 110.402 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -45.83 94.86 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 124.047 0.832 . . . . 0.0 111.124 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.84 -47.75 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 124.591 1.156 . . . . 0.0 109.702 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -67.82 -31.58 71.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.784 -1.197 . . . . 0.0 112.254 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 t -66.18 -53.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 O-C-N 121.59 -0.694 . . . . 0.0 109.16 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.24 -19.2 62.39 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 121.403 -0.81 . . . . 0.0 111.358 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.18 40.37 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 120.721 -1.237 . . . . 0.0 109.998 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.44 -43.72 84.14 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.101 1.361 . . . . 0.0 110.474 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 m -68.82 -6.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -59.71 -21.48 60.68 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.491 1.041 . . . . 0.0 110.495 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.89 73.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.794 -1.191 . . . . 0.0 112.433 171.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.88 -37.6 55.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.888 0.875 . . . . 0.0 108.849 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.13 -0.357 . . . . 0.0 111.154 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.15 80.21 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.562 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -7.27 58.4 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 120.889 -1.132 . . . . 0.0 111.878 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -30.69 66.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.59 1.087 . . . . 0.0 109.557 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.85 -27.56 60.31 Favored 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 120.596 -1.315 . . . . 0.0 112.019 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.32 -22.62 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.415 1.086 . . . . 0.0 108.664 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -63.46 -21.61 66.41 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.61 -1.306 . . . . 0.0 111.615 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -71.46 -8.56 54.64 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.469 -1.394 . . . . 0.0 112.094 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.44 -0.958 0 O-C-N 120.811 -1.18 . . . . 0.0 110.011 175.009 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 61.2 t0 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.42 -26.65 58.53 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.383 1.073 . . . . 0.0 110.326 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -68.11 -32.82 73.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.725 1.61 . . . . 0.0 111.471 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.6 -40.0 80.64 Favored 'General case' 0 CA--C 1.503 -0.848 0 O-C-N 121.881 -0.512 . . . . 0.0 110.071 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.84 -37.87 79.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.08 70.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -67.26 -35.14 78.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.786 -0.571 . . . . 0.0 110.927 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -78.66 -15.22 58.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.96 -1.088 . . . . 0.0 110.771 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.17 72.18 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.564 -1.335 . . . . 0.0 108.917 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -30.45 70.01 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.714 0.805 . . . . 0.0 111.593 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.01 -36.06 81.31 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.738 0.815 . . . . 0.0 110.147 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.59 -33.08 73.44 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 123.441 0.696 . . . . 0.0 109.321 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -63.54 -40.19 96.36 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 121.396 -0.815 . . . . 0.0 110.331 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.72 -41.13 66.69 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 124.32 1.048 . . . . 0.0 111.16 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.57 -41.41 98.39 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.291 0.636 . . . . 0.0 110.875 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.58 -44.39 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 121.727 -0.608 . . . . 0.0 109.416 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tp -53.8 -52.31 60.71 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 128.018 2.527 . . . . 0.0 110.149 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.68 -34.48 64.89 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 121.382 -0.824 . . . . 0.0 110.038 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -68.05 -29.24 68.17 Favored 'General case' 0 C--N 1.355 0.848 0 CA-C-N 120.241 1.382 . . . . 0.0 109.872 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.06 66.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.906 0.882 . . . . 0.0 112.398 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 90.0 p -68.94 -42.72 76.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 O-C-N 121.114 -0.991 . . . . 0.0 110.43 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -38.05 84.87 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.04 -36.44 72.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.259 -0.901 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.61 29.42 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.927 1.291 . . . . 0.0 110.382 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.33 -33.11 52.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 123.954 0.902 . . . . 0.0 111.677 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -83.89 -16.78 43.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.958 0.903 . . . . 0.0 109.647 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.59 70.37 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.186 0.994 . . . . 0.0 109.754 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -65.14 -27.11 68.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 121.806 -0.559 . . . . 0.0 111.822 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.87 83.72 4.97 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.8 -23.74 2.77 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.69 138.67 20.75 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.892 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -82.14 105.72 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.86 2.373 . . . . 0.0 112.916 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.54 47.38 0.15 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.56 137.24 57.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.884 0.873 . . . . 0.0 111.685 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.0 -45.57 0.14 Allowed 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.137 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.38 -63.72 1.0 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.991 0.917 . . . . 0.0 108.807 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . 0.369 40.2 pt 53.8 -127.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 126.173 1.789 . . . . 0.0 112.93 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -13.01 134.85 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 132.236 4.215 . . . . 0.0 121.332 -167.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -65.21 -55.5 25.74 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 116.645 -1.645 . . . . 0.0 115.173 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.03 -5.0 15.87 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 125.076 2.848 . . . . 0.0 110.559 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.8 -42.13 12.78 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.205 1.802 . . . . 0.0 106.834 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -33.69 72.98 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.368 1.467 . . . . 0.0 112.496 -170.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.9 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 121.724 -0.61 . . . . 0.0 110.629 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -29.55 54.42 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.727 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.42 -48.3 61.4 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -60.43 -33.43 72.52 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.773 -1.205 . . . . 0.0 112.952 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.94 -24.81 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.889 1.276 . . . . 0.0 112.537 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.24 -17.93 53.84 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.013 -1.679 . . . . 0.0 109.932 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.429 ' C ' ' H ' ' B' ' 53' ' ' THR . 9.3 t -116.94 -166.17 1.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.71 -21.28 0.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 127.131 2.172 . . . . 0.0 110.846 -167.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.429 ' H ' ' C ' ' B' ' 51' ' ' THR . 2.8 p -93.51 -1.43 55.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.568 2.347 . . . . 0.0 110.759 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.274 0.0 OUTLIER 62.7 61.76 1.16 Allowed 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.308 1.443 . . . . 0.0 110.895 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.91 -69.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.69 72.75 1.0 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -39.91 86.6 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 122.229 -0.571 . . . . 0.0 110.092 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.0 47.47 1.59 Allowed Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.25 -55.59 8.9 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -110.77 165.03 12.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -108.86 127.74 26.78 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.35 170.83 14.34 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.788 2.325 . . . . 0.0 109.66 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.518 HG12 ' H ' ' B' ' 64' ' ' THR . 1.2 t -92.86 -166.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.518 ' H ' HG12 ' B' ' 63' ' ' VAL . 32.7 m -101.09 -63.71 1.11 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.994 0.918 . . . . 0.0 109.132 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -54.61 -28.64 47.98 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -168.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -146.42 -164.36 1.96 Allowed 'General case' 0 N--CA 1.436 -1.17 1 N-CA-C 97.994 -4.817 . . . . 0.0 97.994 160.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.82 -75.34 1.1 Allowed Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 104.334 -3.506 . . . . 0.0 104.334 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' A' ' 50' ' ' GLU . 17.1 ttt180 -69.53 -38.63 77.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.953 0.883 . . . . 0.0 109.996 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.13 -17.3 60.95 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.122 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.03 -45.82 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 O-C-N 119.664 -1.897 . . . . 0.0 106.1 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -35.32 64.48 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 126.182 1.793 . . . . 0.0 112.401 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -50.43 -51.95 42.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 126.586 1.954 . . . . 0.0 111.245 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.25 -37.93 88.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.912 0.885 . . . . 0.0 109.508 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.07 -41.63 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 121.727 -0.608 . . . . 0.0 110.575 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.7 mtm -63.15 -54.58 35.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 122.982 0.513 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -69.59 -27.48 65.14 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 121.554 -0.716 . . . . 0.0 111.084 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.73 -45.09 91.47 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 120.457 -1.402 . . . . 0.0 110.228 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.68 76.66 Favored Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 124.148 0.88 . . . . 0.0 111.318 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.5 -49.17 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 C-N-CA 124.842 1.257 . . . . 0.0 109.705 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.31 -21.68 62.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 120.919 -1.113 . . . . 0.0 111.628 -171.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.98 -54.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.44 -31.21 70.36 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.184 -0.947 . . . . 0.0 111.824 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.9 -22.29 61.52 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.656 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.69 -35.45 75.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 120.069 -1.645 . . . . 0.0 108.291 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.71 -17.05 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 125.051 1.34 . . . . 0.0 110.217 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -63.85 -13.39 44.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.938 -1.101 . . . . 0.0 110.937 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.84 68.7 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 110.76 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.69 85.59 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.563 1.145 . . . . 0.0 110.692 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.86 -40.8 79.13 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.217 0.607 . . . . 0.0 109.8 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.65 -22.54 63.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.445 -0.784 . . . . 0.0 110.417 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -75.18 -26.57 59.16 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.048 -1.033 . . . . 0.0 109.027 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.488 -1.383 . . . . 0.0 111.513 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -70.81 -28.5 64.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.288 -1.508 . . . . 0.0 112.012 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.55 -29.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 C-N-CA 125.28 1.432 . . . . 0.0 108.529 -173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -60.58 -28.79 68.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.508 1.523 . . . . 0.0 110.316 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -60.49 -26.16 66.61 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.289 -0.882 . . . . 0.0 111.936 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.442 -0.84 0 O-C-N 120.711 -1.243 . . . . 0.0 110.79 -176.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 CA--C 1.502 -0.9 0 CA-C-O 121.32 0.581 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -65.58 -26.12 67.71 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.435 -0.79 . . . . 0.0 112.151 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -77.75 -37.1 49.9 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -171.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.47 -42.41 99.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 110.569 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -70.45 -33.98 71.91 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.667 -0.645 . . . . 0.0 111.001 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.86 96.79 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -76.38 -20.42 57.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.124 -0.985 . . . . 0.0 112.141 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -70.61 -37.43 73.84 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.214 -0.929 . . . . 0.0 108.767 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.24 81.31 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.554 -0.717 . . . . 0.0 111.054 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' D' ' 76' ' ' LYS . 76.7 mt-10 -63.24 -36.98 85.46 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -64.52 -41.9 96.11 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 122.282 1.039 . . . . 0.0 108.655 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.15 -32.33 73.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.325 1.45 . . . . 0.0 109.711 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.48 -45.47 87.21 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.671 0.789 . . . . 0.0 110.682 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.81 -23.44 62.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.97 -1.081 . . . . 0.0 111.742 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -65.69 -46.63 78.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.75 . . . . 0.0 110.075 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.15 -25.98 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 121.068 -1.02 . . . . 0.0 110.758 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.66 -41.38 96.14 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.385 -0.822 . . . . 0.0 111.119 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.4 -33.39 67.12 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.955 0.902 . . . . 0.0 111.531 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -67.62 -45.8 74.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.032 0.933 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.98 62.52 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.072 1.349 . . . . 0.0 110.97 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p -67.16 -39.41 86.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 119.433 1.015 . . . . 0.0 110.275 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -44.22 93.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.604 1.162 . . . . 0.0 108.427 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -67.6 -39.31 84.77 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.563 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.75 87.7 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.676 1.19 . . . . 0.0 111.878 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.93 -31.16 49.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 O-C-N 120.87 -1.144 . . . . 0.0 110.029 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.25 -19.21 43.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.763 0.825 . . . . 0.0 110.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.22 14.43 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.736 1.614 . . . . 0.0 107.024 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -80.29 -0.86 38.38 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.98 0.895 . . . . 0.0 110.869 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -74.42 81.88 1.92 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.816 1.647 . . . . 0.0 110.084 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.1 19.68 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 139.13 54.3 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 121.322 -1.105 . . . . 0.0 108.113 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -79.22 136.28 12.67 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.355 2.036 . . . . 0.0 110.437 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 4.16 89.34 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 119.529 1.059 . . . . 0.0 111.971 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 129.11 20.17 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 126.896 2.078 . . . . 0.0 114.107 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.34 -38.02 11.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.992 0.901 . . . . 0.0 108.682 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.3 tp -89.27 125.35 35.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 pt -144.45 -22.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -80.22 150.42 30.1 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.726 -0.609 . . . . 0.0 111.894 -171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.46 -64.52 0.3 Allowed Pre-proline 0 C--N 1.35 0.62 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.198 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.86 -26.89 21.89 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 125.691 3.068 . . . . 0.0 109.936 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 -14.89 61.2 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.538 0.735 . . . . 0.0 109.723 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.39 85.15 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.147 -0.971 . . . . 0.0 110.439 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -72.65 -22.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 121.736 -0.603 . . . . 0.0 110.488 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -72.52 -31.08 65.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -74.87 -37.21 62.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.485 -1.385 . . . . 0.0 108.647 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -76.13 64.38 1.96 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.916 1.287 . . . . 0.0 108.594 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -144.95 -67.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.76 -23.29 66.69 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.689 1.196 . . . . 0.0 112.561 -167.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m -68.06 -37.28 81.1 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.567 1.547 . . . . 0.0 110.629 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.24 -24.42 51.18 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.549 -0.719 . . . . 0.0 110.138 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 6.9 p -90.98 9.33 31.09 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.778 -0.576 . . . . 0.0 109.796 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 48.63 60.73 3.48 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 126.823 2.049 . . . . 0.0 113.684 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.1 -87.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.91 76.38 1.3 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -73.85 -20.48 60.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.415 -1.05 . . . . 0.0 111.411 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.16 32.66 3.68 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.64 -53.42 22.63 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -147.0 169.02 20.08 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -148.14 148.92 30.99 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.92 163.11 18.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.125 3.217 . . . . 0.0 109.195 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.44 -102.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 120.437 1.471 . . . . 0.0 111.869 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -154.06 -30.73 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.622 -1.299 . . . . 0.0 109.61 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -101.26 11.74 38.77 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 120.2 -1.562 . . . . 0.0 108.786 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -44.01 88.04 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.74 86.28 1.62 Allowed Glycine 0 N--CA 1.416 -2.67 1 N-CA-C 98.033 -6.027 . . . . 0.0 98.033 -167.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -56.22 -20.04 16.45 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 125.642 1.577 . . . . 0.0 112.278 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -46.02 -28.22 1.12 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 126.677 1.991 . . . . 0.0 113.05 164.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.27 -43.94 95.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.849 -1.157 . . . . 0.0 109.682 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.48 62.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.344 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -51.2 -47.17 62.32 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.099 2.16 . . . . 0.0 111.116 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.37 -41.34 98.8 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.251 1.02 . . . . 0.0 111.329 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -41.41 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 C-N-CA 123.644 0.778 . . . . 0.0 109.635 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 37.6 mtt -58.99 -52.49 65.54 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.903 0.881 . . . . 0.0 110.299 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.58 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.09 82.87 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.412 -0.805 . . . . 0.0 111.403 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.86 -43.51 93.73 Favored Glycine 0 CA--C 1.494 -1.257 0 C-N-CA 124.202 0.906 . . . . 0.0 111.342 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.87 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 O-C-N 121.735 -0.862 . . . . 0.0 109.159 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.18 -47.6 84.72 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.492 -0.755 . . . . 0.0 111.956 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.49 -40.71 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.799 -0.563 . . . . 0.0 111.471 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.97 -38.48 61.66 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.678 0.672 . . . . 0.0 109.745 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.23 82.83 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.54 -36.42 69.24 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.4 -18.38 11.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.915 1.286 . . . . 0.0 111.043 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.6 m -59.23 -23.95 62.75 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.68 -1.887 . . . . 0.0 111.984 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.46 68.06 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.357 -1.465 . . . . 0.0 111.197 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.24 -52.35 7.84 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.33 -34.65 78.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.217 1.007 . . . . 0.0 113.537 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.76 -14.68 62.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.837 -1.164 . . . . 0.0 110.985 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 81.0 p -85.06 -11.16 55.94 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.55 -1.344 . . . . 0.0 110.855 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -17.55 61.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 119.243 0.929 . . . . 0.0 111.065 -169.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -82.24 -34.66 28.74 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.387 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 26.4 t -65.51 -35.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.463 1.505 . . . . 0.0 109.103 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -42.5 -34.89 0.92 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 128.21 2.604 . . . . 0.0 112.976 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -63.71 -27.05 68.94 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.056 -1.028 . . . . 0.0 111.836 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.44 -0.936 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -177.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.883 0 CA-C-O 122.613 1.197 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -74.05 -52.52 12.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.639 2.375 . . . . 0.0 108.513 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -58.89 -29.53 67.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 126.1 1.76 . . . . 0.0 112.686 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.1 -39.75 82.77 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.681 -0.637 . . . . 0.0 109.69 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -68.5 -36.21 78.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.71 -40.55 84.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.28 95.79 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.622 0.769 . . . . 0.0 111.919 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.33 -40.24 74.28 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 123.301 0.641 . . . . 0.0 110.566 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -61.69 -41.21 97.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.489 0.716 . . . . 0.0 110.28 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.21 70.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.117 0.967 . . . . 0.0 111.877 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 26.8 mt-10 -65.27 -37.14 86.28 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.669 -0.645 . . . . 0.0 111.655 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.81 -31.42 64.82 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -67.52 -35.25 78.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.703 0.801 . . . . 0.0 109.764 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.25 -38.41 90.95 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 111.645 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.43 -36.65 76.3 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.883 0.873 . . . . 0.0 110.756 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.46 -44.84 77.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.184 0.994 . . . . 0.0 110.058 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.02 -47.34 90.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.23 -38.36 85.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.923 -0.485 . . . . 0.0 110.455 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.58 -32.19 65.81 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.489 1.04 . . . . 0.0 113.343 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -69.18 -39.73 78.54 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 119.698 -1.877 . . . . 0.0 108.397 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -32.95 74.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -50.46 -52.08 41.29 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 125.769 1.627 . . . . 0.0 111.648 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -65.98 -34.71 78.73 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -84.48 -15.14 47.03 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.243 0.617 . . . . 0.0 110.972 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -44.61 65.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.513 1.125 . . . . 0.0 109.834 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.25 -40.39 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 122.371 1.081 . . . . 0.0 109.423 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.39 -29.81 68.6 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.954 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.92 92.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 125.189 1.396 . . . . 0.0 110.372 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -77.92 -6.32 53.96 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -76.41 90.62 3.25 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 119.9 -1.75 . . . . 0.0 107.188 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.94 -28.83 1.41 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.75 150.31 47.93 Favored Pre-proline 0 N--CA 1.443 -0.79 0 O-C-N 121.397 -1.061 . . . . 0.0 111.133 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.54 97.06 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.792 2.328 . . . . 0.0 112.723 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.35 -41.69 1.31 Allowed Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.23 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.526 2.331 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 72.81 -66.49 0.31 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.7 1.6 . . . . 0.0 112.401 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 49.4 tp -83.37 64.25 7.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.06 112.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 45.4 t -177.57 -141.72 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.9 -63.83 0.01 OUTLIER Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -72.53 -13.94 27.57 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 CA-C-N 125.541 3.015 . . . . 0.0 112.344 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -86.88 -11.06 51.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.04 85.51 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.596 0.758 . . . . 0.0 110.009 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.65 -41.97 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 109.522 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -38.91 83.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.204 -0.935 . . . . 0.0 109.865 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -66.07 -37.66 86.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.519 0.728 . . . . 0.0 110.499 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -36.53 71.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.077 -1.014 . . . . 0.0 109.808 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -54.65 -56.96 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 126.17 1.788 . . . . 0.0 109.578 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -71.66 -17.31 62.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 112.024 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -82.49 -37.01 25.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.691 -1.256 . . . . 0.0 109.237 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.93 73.36 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.422 -0.799 . . . . 0.0 110.739 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -95.44 11.91 31.2 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.683 0.793 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p 55.29 38.63 30.64 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.32 1.848 . . . . 0.0 112.035 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.02 -68.29 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.46 95.69 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.98 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -61.21 -32.73 72.5 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.542 1.163 . . . . 0.0 111.288 -169.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.35 39.31 0.15 Allowed Glycine 0 CA--C 1.48 -2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 165.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -90.91 -59.11 2.26 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 mtm-85 -138.07 164.85 28.08 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 158.01 36.57 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 -175.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 168.99 19.84 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.253 2.635 . . . . 0.0 109.829 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.57 -93.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.214 0.461 . . . . 0.0 110.292 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -137.73 -81.57 0.35 Allowed 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 129.0 38.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 61.25 -61.87 0.08 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 126.808 2.043 . . . . 0.0 115.566 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . -34.54 -49.63 0.71 Allowed Glycine 0 CA--C 1.488 -1.64 0 C-N-CA 128.917 3.151 . . . . 0.0 114.524 -170.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.221 0.608 . . . . 0.0 112.094 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -71.15 -32.68 69.24 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.609 0.764 . . . . 0.0 109.231 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.41 -51.45 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.09 89.28 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.606 1.162 . . . . 0.0 113.121 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -53.6 -42.32 67.55 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.22 2.208 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -67.55 -39.08 84.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.647 -0.658 . . . . 0.0 110.445 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.64 -48.08 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 O-C-N 121.622 -0.674 . . . . 0.0 110.059 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 21.1 ptp -65.82 -37.15 85.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.549 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . 0.519 ' HZ1' ' CD ' ' C' ' 12' ' ' GLU . 74.2 tttt -64.88 -41.34 95.71 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 121.467 -0.771 . . . . 0.0 110.678 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.154 0.582 . . . . 0.0 110.569 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.06 -46.21 93.89 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 123.633 0.635 . . . . 0.0 112.265 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.84 -43.64 92.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 124.026 0.931 . . . . 0.0 109.983 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -63.9 -41.5 97.68 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.01 -47.13 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 C-N-CA 124.204 1.002 . . . . 0.0 110.679 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -73.3 -10.79 60.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.407 -0.808 . . . . 0.0 111.186 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.81 14.11 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.82 0.848 . . . . 0.0 109.606 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.45 -33.05 74.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.419 1.887 . . . . 0.0 111.041 -174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.93 -7.64 2.11 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 112.724 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 40.3 m -62.01 -20.94 64.44 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.8 63.34 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.248 -1.532 . . . . 0.0 111.401 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.51 -53.72 4.82 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.236 1.014 . . . . 0.0 108.706 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.86 -36.96 70.64 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 124.486 1.114 . . . . 0.0 112.918 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 -22.54 61.49 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.008 -1.058 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 81.7 p -78.37 -17.56 56.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.325 -1.484 . . . . 0.0 109.813 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -69.98 -34.76 73.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.7 0.762 . . . . 0.0 109.453 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.96 -30.4 65.26 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.485 -1.385 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.76 -26.38 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 C-N-CA 124.284 1.033 . . . . 0.0 109.299 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -57.9 -14.92 7.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.83 1.252 . . . . 0.0 113.59 172.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -68.9 -38.56 79.68 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.394 1.092 . . . . 0.0 108.672 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -176.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -170.97 -64.22 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.528 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 45.9 p-80 -61.88 -22.33 65.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.126 1.37 . . . . 0.0 113.449 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 18.4 mp0 -75.73 -22.04 56.94 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.546 -1.346 . . . . 0.0 110.224 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -66.77 -41.92 86.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -60.56 -47.51 85.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.43 96.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 111.545 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -61.23 -45.54 94.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 124.587 1.155 . . . . 0.0 109.493 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -61.57 -36.17 79.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.752 1.221 . . . . 0.0 110.179 -175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.41 72.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -66.95 -30.4 70.53 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.822 -1.174 . . . . 0.0 111.515 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.2 -26.04 55.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.312 -0.868 . . . . 0.0 109.872 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.41 -37.98 74.54 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.81 0.844 . . . . 0.0 109.371 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.36 -40.25 95.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.307 0.575 . . . . 0.0 110.917 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -63.53 -26.36 68.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.3 0.64 . . . . 0.0 112.058 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.83 -41.7 87.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.178 0.991 . . . . 0.0 109.333 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -39.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.524 1.129 . . . . 0.0 108.974 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.88 -42.29 84.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.299 1.04 . . . . 0.0 111.995 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.55 -23.45 58.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.107 0.963 . . . . 0.0 111.309 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.76 -32.27 19.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.789 -1.194 . . . . 0.0 108.348 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.21 73.68 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.525 1.53 . . . . 0.0 111.155 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.8 p -68.11 -39.68 82.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 118.716 0.689 . . . . 0.0 110.115 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -64.1 -49.1 73.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -63.94 -38.44 91.1 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.58 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 119.987 1.267 . . . . 0.0 111.431 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.14 -42.43 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.09 -19.58 59.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.152 -1.592 . . . . 0.0 112.002 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.5 -49.2 27.85 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.555 1.142 . . . . 0.0 108.443 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -58.52 -47.05 85.44 Favored 'General case' 0 CA--C 1.476 -1.9 0 C-N-CA 124.344 1.058 . . . . 0.0 110.646 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -63.45 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.17 0.988 . . . . 0.0 111.995 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.28 2.58 5.92 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.29 128.56 38.08 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 118.731 1.265 . . . . 0.0 108.771 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.44 146.01 17.04 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.402 2.068 . . . . 0.0 109.499 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.6 -18.88 47.71 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 118.972 0.805 . . . . 0.0 112.311 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.05 164.4 26.67 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.261 1.425 . . . . 0.0 112.888 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.04 2.44 3.63 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.18 0.592 . . . . 0.0 111.999 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 52.93 1.89 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 120.31 -1.494 . . . . 0.0 111.408 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -84.4 164.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.02 -1.675 . . . . 0.0 109.766 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.9 t 81.29 129.59 0.05 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.939 1.696 . . . . 0.0 110.686 166.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -67.39 -47.65 47.83 Favored Pre-proline 0 C--N 1.358 0.936 0 CA-C-O 116.213 -1.851 . . . . 0.0 112.152 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.26 -11.59 30.45 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 125.482 2.993 . . . . 0.0 111.892 -175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.63 -48.09 9.21 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.342 1.457 . . . . 0.0 107.248 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.29 74.05 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 125.103 1.361 . . . . 0.0 112.533 -174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.63 -30.39 48.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 O-C-N 121.685 -0.635 . . . . 0.0 111.145 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -33.34 55.68 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.777 -1.202 . . . . 0.0 108.967 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.0 -34.38 78.29 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.328 0.651 . . . . 0.0 110.297 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -56.3 -38.45 71.27 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 120.788 -1.195 . . . . 0.0 111.769 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.67 60.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -158.29 -36.37 0.07 Allowed 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -67.57 -33.78 75.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.825 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.27 -21.94 65.68 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.613 -1.305 . . . . 0.0 112.791 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.23 4.22 52.84 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.281 0.632 . . . . 0.0 109.97 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 p 48.46 47.31 20.29 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 127.139 2.176 . . . . 0.0 112.184 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.496 HG21 ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -100.37 -69.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.496 ' H ' HG21 ' A' ' 55' ' ' VAL . . . 85.63 72.87 1.29 Allowed Glycine 0 CA--C 1.492 -1.396 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -19.08 52.83 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.76 5.25 Favored Glycine 0 CA--C 1.486 -1.755 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -71.49 -46.09 60.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -132.01 165.2 24.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -140.09 130.8 14.08 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 100.804 -3.776 . . . . 0.0 100.804 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -86.11 176.22 5.26 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.721 2.947 . . . . 0.0 109.168 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.13 -142.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-O 123.103 1.43 . . . . 0.0 107.744 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 p -92.14 -43.63 9.25 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 119.657 -1.902 . . . . 0.0 111.094 -165.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.85 -29.56 70.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 127.799 2.44 . . . . 0.0 110.218 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.73 -24.65 67.63 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.71 2.004 . . . . 0.0 109.975 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.85 88.81 0.57 Allowed Glycine 0 CA--C 1.476 -2.366 1 N-CA-C 101.052 -4.819 . . . . 0.0 101.052 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.47 -17.81 2.26 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-O 123.291 1.519 . . . . 0.0 113.096 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -63.26 -14.68 52.18 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 125.071 1.348 . . . . 0.0 112.378 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.73 -45.01 99.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 CA-C-N 119.77 1.168 . . . . 0.0 108.592 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.72 67.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.837 -0.539 . . . . 0.0 110.046 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -48.84 -46.26 41.92 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.631 1.572 . . . . 0.0 110.908 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.73 -38.81 92.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.396 1.078 . . . . 0.0 111.725 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.97 -42.0 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 121.352 -0.842 . . . . 0.0 108.928 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.3 mtm -61.81 -46.07 91.11 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.103 0.561 . . . . 0.0 111.093 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -63.72 -38.66 91.93 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.812 -0.555 . . . . 0.0 110.953 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.19 90.91 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.937 0.495 . . . . 0.0 110.911 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.05 92.46 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 124.225 0.917 . . . . 0.0 111.104 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.91 -46.81 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.448 1.099 . . . . 0.0 109.14 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.33 -37.84 84.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 121.069 -1.02 . . . . 0.0 111.993 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.49 -56.65 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 109.598 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.1 -41.51 98.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.362 0.665 . . . . 0.0 110.835 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.7 -34.63 78.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.75 0.82 . . . . 0.0 111.113 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -66.64 -30.85 71.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.472 -1.392 . . . . 0.0 111.063 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.73 -12.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 110.829 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -58.35 -22.8 54.82 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.597 -1.939 . . . . 0.0 112.652 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.23 -24.99 61.12 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.893 -1.129 . . . . 0.0 111.685 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.83 -40.58 9.26 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.871 1.268 . . . . 0.0 110.969 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.7 -39.8 91.6 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.818 0.818 . . . . 0.0 111.126 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -28.05 62.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.008 -1.057 . . . . 0.0 110.984 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -71.89 -10.52 59.89 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.223 -1.548 . . . . 0.0 111.563 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.77 -38.51 86.72 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 122.235 1.016 . . . . 0.0 109.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -81.4 -11.83 59.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 119.355 -2.09 . . . . 0.0 112.967 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.36 -27.48 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.4 -27.36 47.22 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.56 1.544 . . . . 0.0 113.053 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -64.76 -21.32 66.74 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-O 122.038 0.923 . . . . 0.0 111.825 -172.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.433 -1.278 0 C-N-CA 125.77 1.628 . . . . 0.0 108.223 -178.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.517 ' CE1' ' OE2' ' B' ' 5' ' ' GLU . 13.0 p-80 -61.69 -26.65 68.16 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 128.741 2.816 . . . . 0.0 112.039 -174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.517 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 8.9 mt-10 -75.04 -28.57 60.49 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.674 1.19 . . . . 0.0 110.348 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.88 -35.87 64.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.092 -1.005 . . . . 0.0 109.898 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.489 ' CD ' ' HZ1' ' B' ' 10' ' ' LYS . 2.1 tp10 -68.99 -31.18 69.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 122.011 0.91 . . . . 0.0 109.418 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.02 86.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.815 0.846 . . . . 0.0 110.67 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -71.96 -36.44 69.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.893 -0.505 . . . . 0.0 110.092 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.489 ' HZ1' ' CD ' ' B' ' 7' ' ' GLU . 26.9 ttpt -58.15 -35.99 72.35 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.415 1.486 . . . . 0.0 110.991 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.89 89.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.488 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.36 -36.62 83.36 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 120.928 -1.108 . . . . 0.0 110.658 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -66.5 -36.68 83.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.666 -0.646 . . . . 0.0 110.222 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -63.44 -42.92 98.69 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.785 1.234 . . . . 0.0 109.528 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.62 -37.21 72.91 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-O 121.804 0.811 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.8 -21.35 62.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.164 -0.96 . . . . 0.0 112.029 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -78.19 -30.28 48.91 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.15 -0.969 . . . . 0.0 108.883 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.32 -32.4 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 120.455 -1.403 . . . . 0.0 109.214 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.94 -36.55 77.29 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.217 -0.927 . . . . 0.0 111.949 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.27 -46.53 83.27 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.663 1.185 . . . . 0.0 109.782 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -70.61 -41.03 72.8 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 108.225 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 126.812 2.045 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 -49.96 75.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.145 1.378 . . . . 0.0 109.924 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -67.21 -46.42 73.93 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -61.69 -44.98 95.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.55 -53.15 52.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.72 -37.0 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -92.79 -1.05 57.12 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.887 -1.133 . . . . 0.0 110.895 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.72 -46.96 8.59 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.25 -24.47 59.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.954 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -74.48 108.83 7.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.198 -1.563 . . . . 0.0 111.242 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.96 -21.83 5.21 Favored Glycine 0 CA--C 1.495 -1.181 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.03 152.87 53.95 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.022 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.53 146.54 19.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.628 2.219 . . . . 0.0 110.492 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 34.87 89.47 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 124.092 0.853 . . . . 0.0 111.303 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 134.16 45.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.066 0.947 . . . . 0.0 109.474 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.34 -39.53 1.87 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.358 . . . . 0.0 109.87 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 tp -68.46 -33.29 73.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.956 . . . . 0.0 110.574 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 tt -41.47 76.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 1 C-N-CA 131.979 4.112 . . . . 0.0 116.94 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.84 136.11 7.81 Favored 'General case' 0 CA--C 1.494 -1.185 0 O-C-N 119.24 -2.162 . . . . 0.0 105.409 166.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -64.68 -54.21 38.08 Favored Pre-proline 0 C--N 1.349 0.559 0 CA-C-O 116.849 -1.548 . . . . 0.0 111.728 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.7 -16.87 23.56 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.007 2.824 . . . . 0.0 110.695 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -94.39 -22.9 18.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.62 76.43 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.092 1.357 . . . . 0.0 108.73 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.41 -27.55 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.197 0.522 . . . . 0.0 110.992 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.07 55.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -76.18 -33.58 59.31 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 123.37 0.668 . . . . 0.0 109.573 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -54.42 -29.77 50.32 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.955 -1.091 . . . . 0.0 112.042 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.01 -40.45 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 124.926 1.291 . . . . 0.0 110.356 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.95 -20.78 66.32 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.841 1.657 . . . . 0.0 112.139 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.07 -38.7 6.84 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -164.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -29.05 65.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.774 -1.204 . . . . 0.0 111.766 -170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -86.91 1.01 54.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.704 -0.623 . . . . 0.0 110.329 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.8 p 55.03 50.72 14.8 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 125.968 1.707 . . . . 0.0 110.984 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -103.44 -59.34 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.64 48.04 64.71 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 120.857 -1.152 . . . . 0.0 112.331 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -29.26 69.86 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.443 1.116 . . . . 0.0 112.393 -168.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.97 29.11 2.26 Favored Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.5 -63.94 0.96 Allowed 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.044 -0.68 . . . . 0.0 110.182 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -138.86 163.33 32.55 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -134.92 148.67 67.91 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.05 165.65 21.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 123.55 2.834 . . . . 0.0 110.421 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.91 -154.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -95.15 -54.52 3.4 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.546 1.138 . . . . 0.0 108.746 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.4 -4.7 46.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.576 1.551 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.17 -28.77 68.39 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.852 1.31 . . . . 0.0 107.817 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.38 87.5 1.02 Allowed Glycine 0 CA--C 1.479 -2.159 1 N-CA-C 101.074 -4.811 . . . . 0.0 101.074 -170.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -59.96 -12.0 6.93 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.235 1.518 . . . . 0.0 111.5 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -54.95 -17.93 4.35 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.469 1.908 . . . . 0.0 113.029 164.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -52.85 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 O-C-N 120.493 -1.38 . . . . 0.0 107.315 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.51 92.07 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.471 0.708 . . . . 0.0 110.633 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -49.76 -46.55 50.73 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.955 1.702 . . . . 0.0 111.235 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -62.95 -40.19 96.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.289 1.036 . . . . 0.0 111.301 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.62 -41.44 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.0 mtm -62.64 -45.67 91.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.383 0.673 . . . . 0.0 110.029 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.38 -36.35 83.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 121.502 -0.749 . . . . 0.0 111.364 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.89 89.08 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.48 0.712 . . . . 0.0 110.669 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.16 -45.15 92.6 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.59 -42.78 89.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 C-N-CA 124.109 0.964 . . . . 0.0 109.706 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -60.42 -42.78 96.74 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.078 -1.014 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 t -64.81 -52.35 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.389 1.076 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.63 -13.63 61.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 121.597 -0.689 . . . . 0.0 111.528 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.34 -36.87 14.4 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.327 -0.858 . . . . 0.0 109.88 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.1 -33.19 74.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.038 1.335 . . . . 0.0 110.41 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.06 -10.32 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 121.491 -0.756 . . . . 0.0 112.3 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -58.66 -18.89 34.5 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.871 1.669 . . . . 0.0 110.618 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.62 -65.07 0.63 Allowed 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.709 -1.245 . . . . 0.0 109.673 165.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.472 ' HA ' ' HD2' ' B' ' 4' ' ' HIS . . . -68.67 -42.03 78.45 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 120.775 -1.203 . . . . 0.0 111.3 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.5 -33.93 76.1 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.357 0.663 . . . . 0.0 111.195 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.03 -23.86 33.05 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.436 -1.415 . . . . 0.0 110.784 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.5 m -69.04 -21.81 64.08 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.293 -1.505 . . . . 0.0 108.392 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.28 -39.96 84.59 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.184 -0.947 . . . . 0.0 110.843 -164.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -65.73 -23.99 66.87 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.441 -0.787 . . . . 0.0 112.774 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -79.04 -20.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -68.01 -16.23 63.95 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.496 -1.377 . . . . 0.0 110.377 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -67.38 -2.0 5.57 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.824 -0.548 . . . . 0.0 112.422 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 C--N 1.36 1.032 0 O-C-N 120.917 -1.114 . . . . 0.0 110.085 163.687 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 123.067 1.413 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.461 ' CD2' HG23 ' C' ' 91' ' ' THR . 34.2 p80 -174.07 -50.24 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -69.07 -39.32 79.16 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.976 1.31 . . . . 0.0 110.518 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -54.7 -51.85 64.26 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.762 2.025 . . . . 0.0 110.733 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -75.05 -30.28 60.97 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.34 93.7 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.929 -1.107 . . . . 0.0 111.256 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -71.04 -36.67 72.43 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.609 -0.682 . . . . 0.0 110.886 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.1 -38.03 89.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.86 0.864 . . . . 0.0 110.548 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.3 86.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.499 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.41 -40.32 86.31 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.251 0.62 . . . . 0.0 110.813 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -70.34 -22.83 62.76 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.537 -0.727 . . . . 0.0 111.937 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.26 -32.2 58.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.113 -0.992 . . . . 0.0 108.683 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.48 -40.22 95.27 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.622 -0.674 . . . . 0.0 110.443 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -58.44 -38.31 77.23 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 112.048 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -66.66 -42.26 86.91 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.96 -40.34 85.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 124.39 1.076 . . . . 0.0 109.515 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.24 -42.65 77.69 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 124.124 0.969 . . . . 0.0 112.571 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.22 -42.84 75.17 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.413 -0.804 . . . . 0.0 110.058 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.45 -36.02 73.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.52 0.728 . . . . 0.0 109.607 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.39 83.67 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 126.191 1.796 . . . . 0.0 111.35 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 24.1 m -64.8 -39.24 93.26 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.495 0.718 . . . . 0.0 110.761 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -71.28 -44.4 65.29 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -68.35 -45.66 72.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.543 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.32 94.41 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 120.041 1.292 . . . . 0.0 111.532 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.51 -41.09 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 121.564 -0.71 . . . . 0.0 109.934 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.47 -22.78 43.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.342 -0.849 . . . . 0.0 110.146 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.3 71.78 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 125.026 1.33 . . . . 0.0 109.147 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.22 -23.81 62.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.256 0.622 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -71.07 87.61 0.77 Allowed 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.61 1.85 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.35 141.72 57.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 117.511 0.655 . . . . 0.0 111.483 -168.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 134.45 7.51 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 122.149 1.899 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.79 19.84 60.79 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.69 140.19 56.77 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 109.971 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.6 -42.82 3.39 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -83.72 17.37 2.31 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.4 1.88 . . . . 0.0 110.523 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -75.48 76.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.054 1.407 . . . . 0.0 110.183 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.8 m -143.3 -123.38 0.09 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . 0.28 1.5 t80 173.56 -58.12 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.91 0 C-N-CA 128.755 2.822 . . . . 0.0 106.557 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.04 -18.21 31.22 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 CA-C-N 126.451 3.34 . . . . 0.0 112.838 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.483 ' CG ' HH12 ' C' ' 60' ' ' ARG . 31.3 p30 -106.1 14.97 27.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 119.398 0.999 . . . . 0.0 109.007 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.06 -35.87 66.78 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.937 -1.102 . . . . 0.0 108.761 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.28 -29.32 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 123.57 0.748 . . . . 0.0 110.162 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -64.32 -45.83 86.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.895 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -69.41 -37.1 77.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.971 0.908 . . . . 0.0 108.919 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -56.26 -44.02 79.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.27 1.028 . . . . 0.0 111.538 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -68.94 -38.98 79.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 O-C-N 120.739 -1.226 . . . . 0.0 111.73 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.17 -30.01 68.14 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 120.138 1.335 . . . . 0.0 110.861 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -61.23 -43.72 98.42 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.645 1.178 . . . . 0.0 109.866 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.42 65.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.945 -1.097 . . . . 0.0 112.26 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -87.26 4.19 43.66 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.419 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.2 p 57.63 29.32 17.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.426 1.49 . . . . 0.0 112.655 169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -85.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 176.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.1 86.12 0.74 Allowed Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -73.44 -22.25 60.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.001 -1.294 . . . . 0.0 109.343 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 35.57 2.86 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.73 -47.74 51.78 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.483 HH12 ' CG ' ' C' ' 43' ' ' ASP . 69.6 mtt180 -140.98 173.44 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.39 148.85 21.61 Favored Pre-proline 0 N--CA 1.435 -1.217 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.54 171.26 12.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.888 3.059 . . . . 0.0 109.14 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.6 -109.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 119.392 0.996 . . . . 0.0 112.271 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 45.0 m -150.22 -40.53 0.13 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -82.78 -6.35 59.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.447 0.699 . . . . 0.0 110.007 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -31.84 66.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.23 56.47 0.93 Allowed Glycine 0 CA--C 1.472 -2.595 0 N-CA-C 104.564 -3.414 . . . . 0.0 104.564 167.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -22.22 -21.28 0.0 OUTLIER 'General case' 0 C--N 1.366 1.325 1 C-N-CA 134.048 4.939 . . . . 0.0 118.947 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -19.16 5.74 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 119.625 -1.922 . . . . 0.0 112.751 159.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.84 -45.67 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 119.549 1.068 . . . . 0.0 109.577 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -47.71 58.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.504 -0.747 . . . . 0.0 109.205 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.61 -47.95 58.07 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 124.757 1.223 . . . . 0.0 110.771 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -67.35 -33.87 76.15 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.94 -0.475 . . . . 0.0 111.716 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.02 -44.22 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 121.33 -0.856 . . . . 0.0 109.01 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 67.0 mtm -63.5 -46.8 84.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.25 1.02 . . . . 0.0 110.027 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -64.5 -40.7 96.14 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.51 0.724 . . . . 0.0 110.814 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.27 84.03 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.456 0.702 . . . . 0.0 111.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.2 -48.15 77.74 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -58.43 -46.41 89.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 124.532 1.133 . . . . 0.0 109.842 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -59.55 -45.14 92.66 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.909 0.884 . . . . 0.0 111.19 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.91 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.568 1.147 . . . . 0.0 109.966 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -66.39 -37.46 85.3 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.636 -0.665 . . . . 0.0 110.815 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.16 73.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.754 0.822 . . . . 0.0 110.596 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.46 -34.03 73.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.892 1.277 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.88 -12.05 3.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 125.433 1.493 . . . . 0.0 111.43 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -59.38 -25.66 64.45 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 112.449 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 -23.92 66.96 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-O 122.601 1.191 . . . . 0.0 111.618 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.73 -30.39 20.36 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.531 -1.355 . . . . 0.0 109.791 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.82 -49.86 13.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.888 0.851 . . . . 0.0 110.698 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.42 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.954 -1.091 . . . . 0.0 112.34 -170.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.461 HG23 ' CD2' ' C' ' 4' ' ' HIS . 13.0 t -72.86 -12.57 61.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 120.325 -1.485 . . . . 0.0 110.239 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -88.34 3.16 50.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.531 1.059 . . . . 0.0 110.531 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -34.65 18.69 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 160.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.01 -29.74 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 O-C-N 121.059 -1.025 . . . . 0.0 110.434 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -61.24 -14.21 24.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -64.92 -32.27 73.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.101 -0.999 . . . . 0.0 110.689 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 . . . . . 0 C--N 1.356 0.856 0 CA-C-N 119.269 0.941 . . . . 0.0 108.782 -178.657 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.84 -59.55 2.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 131.118 3.767 . . . . 0.0 108.466 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.507 ' CD2' HG22 ' D' ' 91' ' ' THR . 24.5 p80 -60.1 -33.14 71.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.79 2.836 . . . . 0.0 112.011 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.05 -36.19 81.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.09 0.956 . . . . 0.0 109.862 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtp-105 -71.07 -38.35 72.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.423 -0.798 . . . . 0.0 110.511 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.22 -26.25 61.07 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.81 79.52 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.757 -1.214 . . . . 0.0 110.801 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -68.34 -29.38 68.1 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.216 -0.928 . . . . 0.0 111.708 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -64.1 -42.62 96.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 109.691 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.77 88.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.721 0.808 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.31 -38.38 83.5 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.787 -0.57 . . . . 0.0 111.717 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.97 -36.72 78.2 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.43 -26.77 67.38 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.316 -0.865 . . . . 0.0 110.799 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.21 -36.47 77.3 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 120.944 -1.097 . . . . 0.0 111.06 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -64.16 -31.91 73.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.196 0.999 . . . . 0.0 110.865 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.04 1.336 . . . . 0.0 110.109 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.6 -33.45 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.98 -40.65 89.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.685 0.794 . . . . 0.0 110.91 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.3 -43.2 78.19 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.176 0.591 . . . . 0.0 111.192 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.18 -38.99 86.33 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.95 75.55 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 124.607 1.163 . . . . 0.0 111.438 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -60.05 -46.74 88.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.163 0.892 . . . . 0.0 111.364 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -68.86 -51.72 37.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.927 1.691 . . . . 0.0 108.207 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -68.88 -43.83 74.51 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.942 0.897 . . . . 0.0 110.309 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.24 75.14 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 119.555 1.07 . . . . 0.0 110.72 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.55 -36.14 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.746 0.784 . . . . 0.0 109.314 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.49 -22.8 54.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 121.429 -0.794 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.64 -36.65 83.5 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 126.271 1.828 . . . . 0.0 110.486 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.72 -16.03 60.21 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.412 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -85.63 85.12 7.43 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.281 -1.512 . . . . 0.0 107.636 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.92 -33.66 0.56 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 105.117 -3.193 . . . . 0.0 105.117 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.37 149.16 57.47 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 124.225 1.01 . . . . 0.0 111.565 -171.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.82 97.89 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.888 2.392 . . . . 0.0 113.528 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.32 47.74 0.45 Allowed Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.61 0.23 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.572 1.149 . . . . 0.0 113.494 -169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.98 -59.34 1.93 Allowed 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 109.64 -169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.456 HD11 ' CD2' ' D' ' 47' ' ' TRP . 3.4 tt -84.55 63.07 7.67 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.7 tt -96.23 -6.08 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.116 -1.615 . . . . 0.0 109.082 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -88.57 120.98 30.47 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.672 0.789 . . . . 0.0 111.687 -171.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -74.4 -59.14 1.68 Allowed Pre-proline 0 C--N 1.353 0.73 0 CA-C-O 116.05 -1.929 . . . . 0.0 112.506 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.45 -14.13 30.69 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 CA-C-N 125.941 3.157 . . . . 0.0 110.906 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.31 -11.7 42.68 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 124.196 0.998 . . . . 0.0 109.471 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.2 67.32 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 120.872 -1.143 . . . . 0.0 110.384 -170.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -16.24 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.061 1.41 . . . . 0.0 109.225 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -76.64 -51.85 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 119.794 -1.816 . . . . 0.0 106.566 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.456 ' CD2' HD11 ' D' ' 38' ' ' LEU . 74.4 t90 -55.44 -46.12 76.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.117 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -64.82 -16.91 63.73 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.17 -50.97 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.07 65.64 9.19 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -159.55 -52.64 0.06 Allowed 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -18.45 64.94 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.43 -0.794 . . . . 0.0 112.042 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -87.06 -3.6 59.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.116 1.766 . . . . 0.0 111.057 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 56.15 38.4 29.82 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 125.544 1.538 . . . . 0.0 111.149 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.61 -37.58 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 121.771 -0.581 . . . . 0.0 110.905 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.34 -81.61 0.29 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.08 142.03 52.7 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.75 34.55 0.68 Allowed Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.21 -59.86 0.5 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.288 2.235 . . . . 0.0 109.011 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -97.28 156.24 16.52 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -142.55 148.26 46.14 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -80.36 167.77 19.02 Favored 'Trans proline' 0 CA--C 1.503 -1.057 0 C-N-CA 122.59 2.193 . . . . 0.0 110.266 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.513 HG13 ' H ' ' D' ' 64' ' ' THR . 4.1 t -97.56 -150.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 174.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.513 ' H ' HG13 ' D' ' 63' ' ' VAL . 4.6 p -91.23 -60.09 1.99 Allowed 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.755 -1.84 . . . . 0.0 112.541 -162.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -75.07 129.73 38.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 58.08 -104.78 0.23 Allowed 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.35 -82.19 0.0 OUTLIER Glycine 0 C--N 1.357 1.705 0 C-N-CA 130.006 3.669 . . . . 0.0 112.579 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -72.13 -32.53 67.02 Favored 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 126.074 1.75 . . . . 0.0 112.025 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.5 -24.11 65.54 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.155 1.343 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -78.8 -50.58 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.9 -39.7 71.98 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 111.919 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.88 -48.89 21.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 128.497 2.719 . . . . 0.0 112.055 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.69 -38.35 76.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.428 0.691 . . . . 0.0 110.132 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.12 -45.03 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 C-N-CA 124.181 0.993 . . . . 0.0 109.39 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -61.7 -45.64 93.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.298 1.039 . . . . 0.0 110.867 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.21 -41.59 93.36 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 110.857 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -36.72 84.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.388 0.675 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.64 64.12 Favored Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 123.979 0.799 . . . . 0.0 111.297 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.62 -46.36 90.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 124.203 1.001 . . . . 0.0 109.768 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -61.87 -30.52 70.92 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.421 1.088 . . . . 0.0 113.046 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 t -74.31 -50.43 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.56 -44.15 97.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.453 0.701 . . . . 0.0 109.999 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.33 -23.32 63.77 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.929 0.891 . . . . 0.0 111.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.89 -30.63 68.12 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.147 -1.595 . . . . 0.0 109.355 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -61.83 -13.42 9.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.411 1.084 . . . . 0.0 110.385 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.5 m -58.89 -20.68 53.64 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 119.537 -1.977 . . . . 0.0 112.596 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.37 68.5 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.983 -1.698 . . . . 0.0 111.445 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.15 -35.97 19.82 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.14 0.976 . . . . 0.0 109.643 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 mt -73.16 -44.75 59.5 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.426 0.631 . . . . 0.0 112.197 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.19 70.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.835 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.507 HG22 ' CD2' ' D' ' 4' ' ' HIS . 9.0 t -73.31 -6.48 46.38 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.067 -1.021 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.82 -14.62 58.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.692 1.133 . . . . 0.0 110.739 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -33.1 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 119.842 1.201 . . . . 0.0 108.726 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.97 -29.12 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.294 1.038 . . . . 0.0 109.594 -174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -68.39 -12.08 60.6 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.335 -0.853 . . . . 0.0 111.793 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -61.62 -37.12 82.79 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.265 1.031 . . . . 0.0 110.146 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 N--CA 1.442 -0.829 0 O-C-N 119.862 -1.774 . . . . 0.0 109.572 -175.268 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.11 -71.97 0.4 Allowed 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.1 -23.96 67.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -75.82 -26.42 57.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 109.624 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -64.89 -44.99 87.85 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.32 1.048 . . . . 0.0 108.445 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.21 -40.54 90.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.033 1.333 . . . . 0.0 109.781 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.54 91.72 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 110.844 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.51 -28.14 64.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.62 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -68.49 -34.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.9 90.35 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.343 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.82 -31.9 73.0 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.394 -0.816 . . . . 0.0 111.975 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.93 -41.45 97.63 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.96 0.904 . . . . 0.0 109.392 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -65.74 -34.33 77.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.499 1.119 . . . . 0.0 109.63 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.28 -44.91 94.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.738 0.815 . . . . 0.0 111.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -62.77 -38.21 89.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.238 0.542 . . . . 0.0 111.082 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.18 -37.66 88.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.926 0.89 . . . . 0.0 110.363 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.98 -41.62 84.75 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 C-N-CA 124.127 0.971 . . . . 0.0 108.885 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.2 -45.01 79.98 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.941 0.896 . . . . 0.0 111.802 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -75.2 -24.74 57.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.945 0.898 . . . . 0.0 111.285 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -81.0 -37.93 28.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.63 76.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.459 1.504 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -66.76 -39.7 87.98 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 119.394 0.997 . . . . 0.0 109.79 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.14 -48.45 70.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.733 -0.604 . . . . 0.0 110.174 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -60.81 -48.44 81.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 121.399 -0.813 . . . . 0.0 110.381 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.81 80.15 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.272 1.429 . . . . 0.0 111.903 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.3 -43.45 98.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 O-C-N 121.281 -0.887 . . . . 0.0 110.356 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.36 -29.3 57.14 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.352 -0.843 . . . . 0.0 110.46 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.0 71.76 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.479 1.512 . . . . 0.0 108.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 3.3 tp10 -69.9 -28.63 65.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.064 1.345 . . . . 0.0 110.819 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -67.03 107.3 2.22 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.341 -1.474 . . . . 0.0 110.746 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.62 -13.24 32.74 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.15 150.9 72.15 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 118.264 1.032 . . . . 0.0 109.483 -171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 36' ' ' ALA . 57.5 Cg_endo -78.03 148.67 24.93 Favored 'Trans proline' 0 CA--C 1.505 -0.938 0 C-N-CA 122.827 2.351 . . . . 0.0 108.871 175.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.63 -25.92 5.52 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 119.855 1.207 . . . . 0.0 111.645 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -38.31 135.6 0.73 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 131.282 3.833 . . . . 0.0 115.565 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.48 -29.23 1.22 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.113 0.965 . . . . 0.0 110.532 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.01 51.87 1.85 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.094 1.757 . . . . 0.0 110.984 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 tt -108.67 73.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 119.131 -2.23 . . . . 0.0 109.924 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 t -174.7 137.31 0.46 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -66.8 -53.14 29.07 Favored Pre-proline 0 C--N 1.351 0.647 0 CA-C-O 115.611 -2.138 . . . . 0.0 112.652 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -69.78 -20.57 34.59 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 125.568 3.024 . . . . 0.0 113.126 -170.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.278 0.6 OUTLIER -103.04 -12.27 17.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 119.541 1.064 . . . . 0.0 110.34 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.89 -31.53 63.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 120.546 -1.346 . . . . 0.0 110.867 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tp -67.26 -32.47 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -33.95 68.32 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.534 -1.353 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -67.04 -38.62 86.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.657 1.218 . . . . 0.0 108.981 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -60.0 -43.53 95.13 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.56 1.144 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.61 -49.85 79.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 124.275 1.03 . . . . 0.0 110.415 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.61 -17.03 62.3 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.683 -0.636 . . . . 0.0 111.605 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m -80.14 -38.59 31.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.672 -0.642 . . . . 0.0 109.697 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.8 67.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.844 -1.16 . . . . 0.0 111.528 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -86.19 6.82 27.62 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.9 0.48 . . . . 0.0 110.121 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p 50.08 54.13 11.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.587 1.955 . . . . 0.0 112.584 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 56' ' ' GLY . 8.2 p -116.99 -77.42 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.459 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 73.05 85.06 0.23 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -74.39 -14.82 60.92 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.664 -1.492 . . . . 0.0 111.061 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 32.08 3.88 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.5 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 49.0 t0 -73.28 -48.97 30.27 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.5 ' HE ' ' CG ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -136.85 169.83 17.1 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.32 146.56 33.56 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.89 -172.61 1.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 124.61 3.54 . . . . 0.0 109.432 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.509 HG23 ' H ' ' A' ' 64' ' ' THR 0.253 13.3 p -129.02 -146.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 63' ' ' VAL . 18.9 m -100.63 -49.97 4.03 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.562 1.545 . . . . 0.0 107.946 -172.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -79.4 -12.27 59.91 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.452 0.701 . . . . 0.0 111.179 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -63.78 -30.36 71.47 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 122.931 1.348 . . . . 0.0 107.649 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.55 81.14 1.49 Allowed Glycine 0 CA--C 1.469 -2.794 1 N-CA-C 99.601 -5.4 . . . . 0.0 99.601 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.456 HH22 ' CG ' ' D' ' 59' ' ' ASP . 12.0 ttm180 -59.18 -8.04 1.42 Allowed 'General case' 0 C--N 1.362 1.144 0 CA-C-O 123.238 1.494 . . . . 0.0 112.929 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -60.17 -15.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 120.144 -1.597 . . . . 0.0 113.171 164.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.91 -50.53 74.64 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-N 120.688 1.585 . . . . 0.0 107.367 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.86 -47.21 83.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.311 0.644 . . . . 0.0 111.798 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.89 -45.86 71.22 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.096 1.358 . . . . 0.0 110.728 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -33.6 75.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.909 0.884 . . . . 0.0 111.539 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.43 -49.31 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.4 ptp -65.68 -38.31 88.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 122.01 -0.431 . . . . 0.0 110.332 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -65.14 -38.05 89.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.484 -0.76 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.59 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.315 0.646 . . . . 0.0 110.702 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -44.56 97.55 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.405 1.002 . . . . 0.0 110.71 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.93 -44.17 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 121.894 -0.768 . . . . 0.0 109.294 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.36 -47.43 85.9 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.068 -1.02 . . . . 0.0 112.02 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.83 -39.2 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 O-C-N 121.719 -0.613 . . . . 0.0 111.202 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.69 -39.04 64.67 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.687 0.676 . . . . 0.0 109.387 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.29 73.86 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 121.455 -0.778 . . . . 0.0 111.172 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.77 -36.22 76.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.296 1.438 . . . . 0.0 111.267 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.84 -12.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 125.202 1.401 . . . . 0.0 111.198 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -58.99 -21.52 59.05 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.762 -1.836 . . . . 0.0 111.58 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.92 -26.51 68.84 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 120.815 -1.178 . . . . 0.0 112.15 172.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.54 -47.65 11.1 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.19 -40.58 94.45 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.079 0.951 . . . . 0.0 113.342 -170.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -16.5 63.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.102 -0.999 . . . . 0.0 111.616 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.6 p -87.59 -12.51 45.45 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.89 -1.131 . . . . 0.0 110.641 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -76.26 -17.48 59.45 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -166.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HA ' ' CE1' ' B' ' 4' ' ' HIS . 4.5 p90 -81.36 -31.64 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.962 -1.086 . . . . 0.0 110.379 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -71.54 -22.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 125.904 1.682 . . . . 0.0 109.025 -169.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -53.85 -24.04 14.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.362 1.465 . . . . 0.0 112.585 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -65.91 -16.16 63.61 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 120.221 -1.55 . . . . 0.0 112.029 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.35 0.628 0 CA-C-O 122.018 0.913 . . . . 0.0 109.494 176.802 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 120.683 0.277 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.521 ' CE1' ' HA ' ' A' ' 93' ' ' PHE . 31.8 m170 -76.32 -21.45 56.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.897 -1.127 . . . . 0.0 110.98 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -81.59 -48.08 12.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -64.14 -40.22 95.69 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.405 -0.809 . . . . 0.0 112.198 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.46 -27.46 60.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.43 71.71 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.432 -0.792 . . . . 0.0 109.844 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.38 -37.55 86.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.759 0.824 . . . . 0.0 111.075 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -64.43 -37.16 86.55 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.409 0.683 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -29.46 70.8 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.477 -0.764 . . . . 0.0 111.208 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -67.33 -30.12 69.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.109 -0.994 . . . . 0.0 111.528 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.4 -28.45 61.09 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.79 -1.194 . . . . 0.0 110.141 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.38 -42.76 95.98 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.227 1.011 . . . . 0.0 109.138 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.6 -40.53 97.22 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.459 -0.776 . . . . 0.0 110.749 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -67.44 -27.31 66.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -69.5 -43.88 72.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.485 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.11 -35.31 74.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 123.921 0.889 . . . . 0.0 109.34 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.9 mt -53.82 -53.95 45.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 123.938 0.895 . . . . 0.0 109.73 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -66.89 -32.86 74.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.782 -0.574 . . . . 0.0 111.944 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.18 -51.7 50.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.843 0.83 . . . . 0.0 109.535 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.53 83.43 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.991 0.916 . . . . 0.0 111.388 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -63.57 -40.14 96.2 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 123.61 0.764 . . . . 0.0 110.852 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -63.93 -40.39 96.35 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -68.73 -40.65 79.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.384 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.69 67.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.911 1.684 . . . . 0.0 113.086 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.87 -25.49 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.801 0.81 . . . . 0.0 111.721 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.17 -36.2 13.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.04 -50.67 63.38 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.698 1.999 . . . . 0.0 110.187 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.18 56.46 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.375 -0.828 . . . . 0.0 109.98 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -138.61 101.85 4.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.04 -2.1 38.18 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.16 64.74 Favored Pre-proline 0 N--CA 1.442 -0.844 0 O-C-N 121.586 -0.95 . . . . 0.0 109.658 -172.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.45 113.07 2.56 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.366 2.71 . . . . 0.0 112.423 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.0 23.86 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.31 163.15 17.86 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.56 -25.9 0.27 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.33 52.0 2.26 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.65 1.214 . . . . 0.0 108.718 -172.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 43.8 pt -80.06 27.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 124.932 1.293 . . . . 0.0 111.1 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -122.34 142.5 50.44 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.89 -1.131 . . . . 0.0 109.429 -168.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.73 -62.02 0.23 Allowed Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-O 116.937 -1.506 . . . . 0.0 110.198 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.14 -12.55 23.44 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 CA-C-N 125.496 2.998 . . . . 0.0 111.659 -172.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -87.72 -8.85 55.53 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.26 99.43 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 121.687 -0.633 . . . . 0.0 110.016 -173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.54 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.028 0.531 . . . . 0.0 110.338 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -20.47 55.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 120.713 -1.242 . . . . 0.0 111.877 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -75.85 -53.48 8.39 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 m -54.82 -33.1 61.19 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.7 t -56.75 -48.76 80.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 124.281 1.032 . . . . 0.0 110.584 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.63 -16.43 55.82 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 119.798 1.181 . . . . 0.0 111.795 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -65.71 -42.17 91.44 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 109.318 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -29.14 68.77 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 123.353 0.661 . . . . 0.0 111.416 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.0 p -87.17 -0.75 57.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 16.6 p 54.44 33.89 19.7 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.759 1.624 . . . . 0.0 110.806 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.89 -60.76 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 103.255 -2.868 . . . . 0.0 103.255 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 50.13 64.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.03 -41.3 91.12 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 118.095 0.948 . . . . 0.0 108.628 -171.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.68 -111.05 0.46 Allowed Glycine 0 CA--C 1.471 -2.713 0 N-CA-C 103.398 -3.881 . . . . 0.0 103.398 172.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.8 t0 76.5 -72.55 0.1 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.184 0.993 . . . . 0.0 109.741 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.62 167.42 19.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.64 128.31 13.52 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -88.07 161.38 7.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.027 2.485 . . . . 0.0 109.708 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.348 14.6 p -96.71 -126.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -119.87 -38.86 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.864 1.666 . . . . 0.0 109.266 -170.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -93.04 5.45 51.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.718 0.807 . . . . 0.0 109.976 -168.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.11 38.11 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.63 73.87 1.27 Allowed Glycine 0 CA--C 1.469 -2.832 1 N-CA-C 101.444 -4.662 . . . . 0.0 101.444 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -48.26 -8.02 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 130.293 3.437 . . . . 0.0 114.738 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -48.22 -26.34 1.91 Allowed 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 127.015 2.126 . . . . 0.0 112.804 154.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.95 -48.18 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 125.022 1.329 . . . . 0.0 108.826 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.26 60.64 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 109.886 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -49.76 -46.65 50.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 127.856 2.462 . . . . 0.0 109.961 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -61.67 -43.9 97.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.086 0.954 . . . . 0.0 111.019 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.25 -43.84 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -61.39 -51.76 67.44 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.05 0.54 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -66.39 -35.57 80.66 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.822 -0.549 . . . . 0.0 110.094 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.3 93.64 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.608 -0.683 . . . . 0.0 110.836 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.53 -48.79 79.26 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.98 -48.11 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.808 1.243 . . . . 0.0 109.943 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.28 -33.79 76.81 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.638 -1.289 . . . . 0.0 111.947 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.82 -49.51 68.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.553 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -66.82 -22.78 66.0 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.381 0.672 . . . . 0.0 111.135 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.12 -39.42 25.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.33 -34.36 76.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.676 1.191 . . . . 0.0 111.312 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 m -66.25 -7.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 121.442 -0.786 . . . . 0.0 112.124 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 72.2 m -59.19 -22.03 60.36 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.128 1.371 . . . . 0.0 111.085 171.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.19 68.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 118.852 -2.405 . . . . 0.0 112.382 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.99 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.5 -35.72 72.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.232 1.413 . . . . 0.0 112.45 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.434 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . . . -71.38 -16.94 62.43 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 121.005 -1.06 . . . . 0.0 112.011 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -76.53 -24.51 53.65 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.7 -9.14 59.3 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.813 -1.179 . . . . 0.0 110.327 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' B' ' 90' ' ' ALA . 3.1 m-30 -73.82 -34.43 64.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.55 1.14 . . . . 0.0 108.423 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.29 -31.76 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 125.101 1.36 . . . . 0.0 108.457 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -62.99 -5.11 2.63 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.214 -0.929 . . . . 0.0 112.829 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -64.78 -23.29 67.2 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 0.5 OUTLIER -45.91 -33.97 3.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 128.507 2.723 . . . . 0.0 112.441 166.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.43 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 7.0 pt-20 -79.61 -28.2 41.02 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -71.57 -40.31 70.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -70.14 -35.41 74.04 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.674 0.75 . . . . 0.0 109.117 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.54 83.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.511 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.27 -35.55 75.8 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.795 1.638 . . . . 0.0 111.373 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -66.4 -42.44 87.84 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.962 1.305 . . . . 0.0 109.43 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 110.877 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.63 -39.87 68.39 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.683 1.193 . . . . 0.0 111.418 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -71.38 -36.48 71.43 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.501 1.12 . . . . 0.0 110.105 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.69 -39.1 87.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.542 1.137 . . . . 0.0 109.875 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.15 -40.49 97.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.012 -1.055 . . . . 0.0 111.369 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -65.58 -40.14 92.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.67 1.188 . . . . 0.0 111.74 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -73.48 -29.29 62.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.767 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.79 -34.95 70.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.125 -0.984 . . . . 0.0 109.599 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.41 -37.72 78.77 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.077 -1.014 . . . . 0.0 111.684 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -64.08 -46.23 85.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.235 -0.915 . . . . 0.0 109.958 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.26 -37.52 85.67 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.353 -0.842 . . . . 0.0 110.316 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.36 74.25 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.792 1.237 . . . . 0.0 111.671 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -63.31 -42.55 99.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.149 0.5 . . . . 0.0 110.967 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.62 -50.45 62.94 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.54 1.536 . . . . 0.0 107.829 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.89 -41.17 87.64 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.128 -0.357 . . . . 0.0 110.821 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.24 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 123.573 0.749 . . . . 0.0 110.499 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.81 72.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 O-C-N 120.431 -1.418 . . . . 0.0 110.551 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -70.39 -32.11 69.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.16 1.384 . . . . 0.0 109.409 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.56 -49.52 76.31 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.978 1.311 . . . . 0.0 110.808 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -74.92 -17.68 60.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 121.769 -0.582 . . . . 0.0 111.354 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -94.55 79.46 3.82 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.128 -1.608 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.74 -29.75 0.83 Allowed Glycine 0 CA--C 1.491 -1.444 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.93 155.19 36.73 Favored Pre-proline 0 N--CA 1.443 -0.788 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.43 161.5 31.48 Favored 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.236 1.957 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.88 6.24 76.29 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 123.932 0.777 . . . . 0.0 111.751 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 122.36 6.34 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 126.087 1.755 . . . . 0.0 114.228 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 -24.5 0.86 Allowed 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -76.04 -87.32 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 mt 64.8 161.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.778 0 C-N-CA 125.411 1.484 . . . . 0.0 109.466 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.9 t 81.88 115.23 0.06 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.659 1.583 . . . . 0.0 112.118 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -68.73 -52.19 18.98 Favored Pre-proline 0 C--N 1.349 0.568 0 CA-C-O 115.973 -1.965 . . . . 0.0 112.408 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.85 -7.49 20.1 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 126.094 3.212 . . . . 0.0 111.542 -170.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -93.51 -33.3 13.83 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.79 74.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.677 1.191 . . . . 0.0 111.699 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 tt -60.76 -29.04 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 124.63 1.172 . . . . 0.0 111.493 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -23.28 29.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.286 -0.884 . . . . 0.0 109.606 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -78.94 -37.57 39.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 12.5 p -77.79 55.59 1.4 Allowed 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 121.427 -0.795 . . . . 0.0 110.115 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -131.43 -68.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.45 -19.24 64.56 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -67.58 -35.86 79.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.183 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.12 56.91 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 120.774 -1.204 . . . . 0.0 110.325 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -93.33 15.74 14.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.22 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.266 10.2 t 49.69 55.24 9.69 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 112.803 168.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.6 m -143.3 -164.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 N-CA-C 98.336 -4.69 . . . . 0.0 98.336 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.32 106.22 0.19 Allowed Glycine 0 CA--C 1.467 -2.909 1 N-CA-C 100.057 -5.217 . . . . 0.0 100.057 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -87.39 -6.91 58.26 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -167.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.94 42.0 2.02 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.72 -51.1 12.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -144.78 -177.27 5.43 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.99 138.66 13.42 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.81 169.34 15.05 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.54 2.827 . . . . 0.0 110.078 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -101.86 -175.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-O 122.605 1.193 . . . . 0.0 111.897 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -87.62 -61.48 1.71 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 124.562 1.145 . . . . 0.0 110.375 -166.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -59.44 -37.64 78.63 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.514 0.726 . . . . 0.0 111.514 -169.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.69 -76.29 0.57 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.048 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -23.72 -51.07 0.03 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 129.473 3.416 . . . . 0.0 117.305 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -58.76 -47.34 85.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.01 1.724 . . . . 0.0 112.736 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -75.58 -27.82 58.7 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.114 . . . . 0.0 108.803 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.05 -52.57 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.83 95.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.076 1.35 . . . . 0.0 111.464 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -34.01 72.7 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 119.18 0.9 . . . . 0.0 111.584 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.78 -42.56 94.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.277 1.031 . . . . 0.0 109.984 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.34 -44.34 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.252 1.021 . . . . 0.0 109.59 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mtp -57.03 -48.79 77.65 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.374 1.069 . . . . 0.0 110.078 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -62.32 -31.9 72.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.303 1.841 . . . . 0.0 111.97 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.99 71.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.627 0.771 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.33 -42.16 75.65 Favored Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.65 -42.73 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 109.797 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -53.77 -56.33 18.45 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 110.544 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.45 -49.82 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 C-N-CA 125.358 1.463 . . . . 0.0 109.516 -171.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.87 -24.01 62.42 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.716 -0.615 . . . . 0.0 111.098 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.52 47.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.961 -1.087 . . . . 0.0 110.144 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.96 -37.31 81.94 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 111.661 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.56 -1.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.623 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -58.5 -24.03 59.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.178 1.791 . . . . 0.0 113.784 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.18 84.78 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 119.14 -2.225 . . . . 0.0 112.216 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -66.27 -42.08 88.98 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.2 -43.73 66.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.172 0.51 . . . . 0.0 111.093 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.71 -41.59 26.42 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 120.357 -1.464 . . . . 0.0 112.667 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 34.1 p -69.07 -7.01 31.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.619 -1.3 . . . . 0.0 111.41 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -74.23 -5.46 42.11 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.835 -0.541 . . . . 0.0 110.41 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -35.56 71.66 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 120.043 -1.661 . . . . 0.0 111.02 167.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.39 -17.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.42 1.488 . . . . 0.0 108.934 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.69 -29.81 40.61 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.512 1.525 . . . . 0.0 111.966 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -60.48 -39.82 89.03 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.71 1.204 . . . . 0.0 110.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.436 -1.157 0 O-C-N 121.422 -0.799 . . . . 0.0 109.58 -177.074 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.21 -39.82 94.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.796 1.638 . . . . 0.0 111.407 -169.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.461 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 19.6 p80 -78.54 -20.68 50.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.403 -0.811 . . . . 0.0 111.232 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.461 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 18.3 mt-10 -89.86 -21.69 22.42 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.096 -1.003 . . . . 0.0 108.561 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.55 -43.71 96.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.121 1.768 . . . . 0.0 109.784 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.47 -32.16 71.96 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 109.362 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.38 -35.46 73.52 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.206 1.003 . . . . 0.0 111.321 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.53 -31.75 72.99 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.469 -0.769 . . . . 0.0 111.439 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.73 -33.66 74.44 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.795 -0.566 . . . . 0.0 110.836 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.682 0.793 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.48 -39.4 88.73 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.872 0.869 . . . . 0.0 110.262 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -46.02 91.35 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 121.287 -0.883 . . . . 0.0 109.846 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.6 -41.68 81.71 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.825 2.05 . . . . 0.0 109.942 -175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.89 -40.79 96.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.068 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.23 -27.69 67.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.513 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -69.57 -42.79 74.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.27 -0.893 . . . . 0.0 110.342 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 m -72.59 -26.37 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 121.657 -0.652 . . . . 0.0 110.941 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.56 -41.27 96.42 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.307 -0.871 . . . . 0.0 111.096 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.46 -30.38 59.92 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 124.073 0.949 . . . . 0.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.93 -39.25 72.79 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 119.787 -1.821 . . . . 0.0 109.507 173.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.11 85.58 Favored 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.013 1.325 . . . . 0.0 110.85 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.1 p -67.19 -37.15 83.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 119.202 0.91 . . . . 0.0 111.196 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.13 -52.7 31.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.506 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -71.07 -25.12 62.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.076 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.82 -53.64 47.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.396 1.078 . . . . 0.0 110.016 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.74 -38.61 83.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -77.05 -6.59 53.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.332 -1.48 . . . . 0.0 112.421 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.48 -52.32 5.42 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -48.48 -50.58 31.01 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 129.034 2.934 . . . . 0.0 114.382 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -74.07 85.68 1.83 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.731 0.777 . . . . 0.0 110.413 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.34 -18.36 1.7 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.63 140.03 31.56 Favored Pre-proline 0 N--CA 1.445 -0.705 0 O-C-N 121.128 -1.219 . . . . 0.0 111.15 -170.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.39 132.82 6.06 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.77 2.314 . . . . 0.0 111.232 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.57 27.85 37.64 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.9 157.4 5.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.43 2.292 . . . . 0.0 111.9 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.02 -36.04 0.83 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.132 1.373 . . . . 0.0 110.072 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.45 81.5 1.48 Allowed 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.927 1.346 . . . . 0.0 112.865 -164.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 35.0 pt -93.79 -8.67 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 118.871 2.915 . . . . 0.0 118.871 -166.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.7 m -121.32 141.2 51.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 123.656 2.935 . . . . 0.0 110.708 -164.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -59.21 -47.77 97.66 Favored Pre-proline 0 C--N 1.353 0.757 0 CA-C-O 116.172 -1.871 . . . . 0.0 112.909 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -72.62 -5.59 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 CA-C-N 125.374 2.955 . . . . 0.0 112.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -30.76 12.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.6 76.4 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.294 1.037 . . . . 0.0 111.931 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.9 tt -72.06 -27.39 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 110.022 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.01 -35.75 49.52 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 108.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -63.6 -44.85 92.78 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.957 0.903 . . . . 0.0 110.578 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.5 p -65.74 -27.16 68.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 120.609 -1.307 . . . . 0.0 111.175 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.51 -20.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 111.452 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.9 -16.14 57.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.17 -1.581 . . . . 0.0 110.177 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 7.1 m -99.8 -177.45 3.56 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 102.038 -3.319 . . . . 0.0 102.038 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 76.4 -30.14 0.18 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.793 1.637 . . . . 0.0 111.263 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.8 p -90.96 -10.92 40.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.65 1.58 . . . . 0.0 111.397 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p 58.45 30.83 20.23 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.359 1.463 . . . . 0.0 111.223 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.92 -87.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 101.446 -3.539 . . . . 0.0 101.446 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.32 73.33 1.19 Allowed Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -44.62 93.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.65 0.78 . . . . 0.0 111.099 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.3 -62.7 0.27 Allowed Glycine 0 CA--C 1.477 -2.331 0 C-N-CA 117.36 -2.352 . . . . 0.0 112.6 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.456 ' CG ' HH22 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -10.33 -67.24 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 128.948 2.899 . . . . 0.0 117.747 -162.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.94 155.13 43.58 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 104.424 -2.435 . . . . 0.0 104.424 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.43 152.22 19.52 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.66 158.37 19.0 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.085 2.524 . . . . 0.0 111.518 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.48 HG21 ' H ' ' D' ' 64' ' ' THR . 8.5 p -101.99 -151.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.48 ' H ' HG21 ' D' ' 63' ' ' VAL . 2.2 m -76.65 -50.11 14.55 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.547 1.939 . . . . 0.0 111.157 -171.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -77.59 -14.51 59.63 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.457 1.503 . . . . 0.0 110.498 -162.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.62 -20.18 62.76 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.165 0.983 . . . . 0.0 109.658 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.72 89.38 0.84 Allowed Glycine 0 CA--C 1.478 -2.265 1 N-CA-C 98.691 -5.764 . . . . 0.0 98.691 -170.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -65.06 -11.36 38.58 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.056 1.928 . . . . 0.0 110.02 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -57.28 -14.84 4.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.324 1.05 . . . . 0.0 113.597 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.88 -43.32 97.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.487 1.494 . . . . 0.0 109.116 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.98 -43.08 75.63 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -44.93 82.33 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.596 1.158 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.76 -45.51 93.61 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.402 0.681 . . . . 0.0 111.364 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.8 -39.73 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.634 0.774 . . . . 0.0 109.32 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.7 ttm -62.9 -48.14 80.27 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.384 1.074 . . . . 0.0 110.303 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -63.57 -42.18 98.34 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 109.846 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.3 80.7 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 111.439 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.79 -36.67 93.66 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.211 0.91 . . . . 0.0 112.249 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -68.66 -42.85 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 121.311 -1.111 . . . . 0.0 108.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.95 -43.08 99.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 121.432 -0.793 . . . . 0.0 111.604 -175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.69 -40.78 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 O-C-N 121.79 -0.569 . . . . 0.0 111.355 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.29 -21.09 56.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.75 25.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.166 -0.959 . . . . 0.0 110.367 174.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.1 -42.54 90.74 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 125.837 1.655 . . . . 0.0 109.877 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.71 -4.26 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.564 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -62.2 -19.79 63.49 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.856 -1.152 . . . . 0.0 110.427 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.07 77.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.341 -1.475 . . . . 0.0 111.841 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.35 -33.07 49.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 120.926 -1.109 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.01 -31.49 68.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.125 0.488 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.87 70.47 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.834 -1.166 . . . . 0.0 111.257 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -9.94 59.03 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.876 -1.14 . . . . 0.0 111.922 173.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.45 -40.17 70.5 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 119.644 1.111 . . . . 0.0 109.359 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -68.46 -29.64 68.33 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.959 -1.088 . . . . 0.0 111.239 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.83 -21.92 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.914 1.286 . . . . 0.0 108.97 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -62.18 -12.55 20.6 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.438 1.095 . . . . 0.0 111.485 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.79 -24.94 67.96 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.404 1.082 . . . . 0.0 112.229 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -176.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 122.639 1.209 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -105.68 -42.17 5.25 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -71.17 -31.36 67.58 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.207 -0.933 . . . . 0.0 111.623 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.55 -40.79 61.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.601 0.715 . . . . 0.0 110.193 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -68.47 -31.64 71.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.48 -0.763 . . . . 0.0 110.359 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -81.0 -30.92 34.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.018 -0.426 . . . . 0.0 110.243 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.6 76.04 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.931 -1.106 . . . . 0.0 110.197 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -57.1 -35.63 69.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.573 1.949 . . . . 0.0 111.691 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -64.42 -39.18 93.34 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.563 1.145 . . . . 0.0 109.84 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.93 80.52 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.693 -0.629 . . . . 0.0 110.156 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.41 -33.67 74.09 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.621 0.769 . . . . 0.0 111.449 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.83 -42.56 94.85 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 109.89 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.55 -36.89 81.88 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.874 0.87 . . . . 0.0 109.459 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -56.87 -44.72 82.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.121 0.569 . . . . 0.0 111.264 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -63.14 -38.14 90.01 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.104 0.962 . . . . 0.0 111.606 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.19 -39.12 92.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.887 1.275 . . . . 0.0 109.83 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.93 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.715 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.1 mt -59.74 -43.95 93.99 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.32 -0.862 . . . . 0.0 111.185 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -74.53 -22.33 59.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.234 1.014 . . . . 0.0 111.798 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.91 -41.04 21.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 120.573 -1.329 . . . . 0.0 108.385 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.6 76.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.716 1.207 . . . . 0.0 111.412 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 p -66.85 -38.35 86.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.454 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -61.37 -47.91 83.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.235 1.414 . . . . 0.0 107.812 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -65.63 -47.06 76.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 122.662 0.385 . . . . 0.0 110.572 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.48 90.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.03 1.332 . . . . 0.0 112.058 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.86 -34.66 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.434 -0.791 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.23 -24.79 27.68 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 120.271 -1.518 . . . . 0.0 110.357 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.85 -53.66 6.57 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.83 -34.88 69.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 119.073 0.851 . . . . 0.0 110.98 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -74.65 108.88 7.69 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 119.569 -1.957 . . . . 0.0 110.455 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.66 -33.12 2.8 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.57 144.53 83.65 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.309 -170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.64 138.7 21.85 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 C-N-CA 122.799 2.333 . . . . 0.0 109.833 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.45 -0.07 89.31 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.16 146.8 54.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.054 0.942 . . . . 0.0 111.543 -171.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.55 -42.45 3.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.78 131.11 34.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 pt -149.45 173.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.3 m 66.64 132.94 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.526 1.931 . . . . 0.0 114.163 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.32 -46.82 38.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 115.77 -2.062 . . . . 0.0 112.309 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.5 -11.65 30.2 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 CA-C-N 126.056 3.199 . . . . 0.0 112.293 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.15 -47.63 7.95 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.59 75.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 126.166 1.786 . . . . 0.0 112.37 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.73 -28.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 121.359 0.599 . . . . 0.0 111.115 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -22.29 32.19 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.235 -0.916 . . . . 0.0 109.69 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -78.14 -33.84 50.2 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.76 61.26 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.123 -0.985 . . . . 0.0 110.862 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -138.84 -76.1 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -67.71 -14.88 63.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 112.031 -169.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -64.88 -36.56 84.76 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 126.331 1.852 . . . . 0.0 108.582 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.23 60.28 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.207 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -88.99 13.41 12.96 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 p 56.79 51.1 11.35 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.514 1.526 . . . . 0.0 113.065 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.19 -104.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.22 71.46 0.73 Allowed Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -66.75 -18.98 65.65 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.587 -0.949 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.51 22.23 6.18 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' CG ' HH22 ' B' ' 68' ' ' ARG . 0.4 OUTLIER -63.85 -56.21 17.12 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.995 0.898 . . . . 0.0 110.131 174.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -147.47 161.68 40.58 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.97 146.94 18.44 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.9 176.53 9.9 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 124.481 3.454 . . . . 0.0 110.341 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 t -112.5 -102.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 120.053 1.297 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -139.53 -41.53 0.45 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -88.07 -19.19 27.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.577 0.751 . . . . 0.0 111.146 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.02 -34.56 77.83 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 108.036 170.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.57 79.52 1.44 Allowed Glycine 0 CA--C 1.471 -2.659 1 N-CA-C 100.297 -5.121 . . . . 0.0 100.297 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.438 HH22 ' CG ' ' D' ' 59' ' ' ASP . 49.5 ttm-85 -39.07 -28.15 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 128.806 2.842 . . . . 0.0 114.512 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -53.27 -15.74 1.05 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.53 -46.82 92.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 125.216 1.407 . . . . 0.0 109.399 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.163 0.985 . . . . 0.0 108.899 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.37 -43.24 33.48 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.595 1.558 . . . . 0.0 111.667 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -62.58 -38.17 89.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.13 0.572 . . . . 0.0 111.437 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.71 -38.63 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -59.95 -44.62 94.27 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.046 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -63.17 -34.3 77.32 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.493 -0.754 . . . . 0.0 110.961 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.92 85.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.753 0.706 . . . . 0.0 111.291 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.29 50.97 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.04 -38.89 62.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 124.562 1.145 . . . . 0.0 108.897 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -70.35 -49.28 50.93 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.815 -1.178 . . . . 0.0 111.177 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.89 -45.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 O-C-N 121.33 -0.856 . . . . 0.0 110.199 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -73.48 -29.69 62.68 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 121.447 -0.783 . . . . 0.0 110.2 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.0 62.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 120.665 -1.272 . . . . 0.0 110.314 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.93 -35.4 80.56 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.935 -1.103 . . . . 0.0 110.769 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.92 -9.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.161 1.385 . . . . 0.0 111.26 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 m -59.34 -23.01 62.15 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 118.986 -2.321 . . . . 0.0 111.931 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.33 61.26 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.551 -1.343 . . . . 0.0 112.36 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.37 -41.94 9.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.512 1.525 . . . . 0.0 109.577 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -41.76 63.2 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.637 -1.289 . . . . 0.0 111.582 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.19 -5.43 41.85 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 121.037 -1.039 . . . . 0.0 111.12 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -97.54 -5.42 35.8 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.701 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.26 18.2 m-20 -80.13 -16.86 54.04 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 121.094 1.77 . . . . 0.0 111.268 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.49 -29.55 37.37 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.837 -1.164 . . . . 0.0 109.602 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.41 -30.87 50.45 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 124.429 1.092 . . . . 0.0 109.248 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -53.5 -26.44 20.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.001 1.32 . . . . 0.0 112.916 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -62.59 -34.75 77.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.524 1.13 . . . . 0.0 110.689 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 O-C-N 121.919 -0.488 . . . . 0.0 110.132 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.504 -0.789 0 CA-C-O 121.812 0.815 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -62.81 -23.63 67.35 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.588 1.955 . . . . 0.0 112.709 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -81.83 -41.58 20.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -70.08 -35.18 74.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.379 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.8 -39.66 85.75 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.494 0.718 . . . . 0.0 110.304 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.61 91.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.408 0.683 . . . . 0.0 111.495 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -68.31 -38.55 81.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 121.594 -0.691 . . . . 0.0 110.219 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.85 -36.27 80.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.46 0.648 . . . . 0.0 110.892 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.14 83.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.839 0.856 . . . . 0.0 111.193 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.27 -32.39 73.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.508 -0.745 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.23 -35.83 71.62 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.165 -0.959 . . . . 0.0 109.597 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.81 -30.21 69.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 120.641 -1.287 . . . . 0.0 110.325 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -61.16 -43.68 98.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 122.978 0.511 . . . . 0.0 111.186 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.33 -35.15 79.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.344 0.658 . . . . 0.0 110.892 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -67.61 -39.11 84.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.274 0.63 . . . . 0.0 110.668 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.76 -39.87 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.797 0.839 . . . . 0.0 109.302 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.22 -43.45 87.73 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.179 0.899 . . . . 0.0 111.969 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.35 -37.39 80.44 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.59 1.156 . . . . 0.0 110.501 -177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.22 -46.06 52.57 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.681 1.229 . . . . 0.0 108.788 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.31 64.57 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 125.043 1.337 . . . . 0.0 112.236 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.8 p -73.32 -31.57 64.08 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.341 -0.849 . . . . 0.0 110.006 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -40.96 71.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.028 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.5 75.22 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.796 1.239 . . . . 0.0 112.742 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.04 -29.96 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 O-C-N 120.912 -1.117 . . . . 0.0 111.381 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.96 -20.57 28.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.153 0.501 . . . . 0.0 110.52 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.34 94.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.412 1.885 . . . . 0.0 109.462 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -69.39 -106.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.571 0.7 . . . . 0.0 111.58 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 58.17 9.66 1.04 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.48 34.63 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.72 149.14 38.64 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -77.14 113.09 3.53 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.486 2.124 . . . . 0.0 110.693 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -65.37 0.28 Allowed Glycine 0 CA--C 1.484 -1.901 0 N-CA-C 103.109 -3.996 . . . . 0.0 103.109 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 75.23 162.47 0.25 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 127.65 2.38 . . . . 0.0 108.424 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.98 -72.61 0.08 Allowed 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.595 -0.691 . . . . 0.0 110.265 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.34 80.5 1.59 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 tt -122.99 93.99 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.5 m -156.07 -150.73 0.3 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -167.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.05 -58.36 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 116.445 -1.741 . . . . 0.0 106.447 169.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.51 -29.03 20.89 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.803 3.108 . . . . 0.0 112.434 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.52 9.12 39.8 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 123.809 0.843 . . . . 0.0 110.148 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.05 -41.22 82.35 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.679 -1.263 . . . . 0.0 109.675 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -73.45 -24.86 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 O-C-N 121.559 -0.713 . . . . 0.0 110.034 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -58.27 -55.66 32.18 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 125.687 1.595 . . . . 0.0 110.195 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -71.09 -34.82 71.51 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -55.84 -43.41 77.0 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.526 1.13 . . . . 0.0 110.954 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.7 t -55.19 -51.15 58.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 124.414 1.086 . . . . 0.0 111.061 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.42 -22.16 55.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.31 -0.869 . . . . 0.0 111.693 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -65.07 -40.96 95.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.183 0.993 . . . . 0.0 109.093 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.17 65.5 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 121.235 -0.916 . . . . 0.0 112.175 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -89.04 5.49 44.14 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.872 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 56.09 28.97 13.75 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.665 1.186 . . . . 0.0 111.463 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.17 -56.66 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.55 62.39 5.84 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.4 -27.5 66.27 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 123.14 1.448 . . . . 0.0 108.115 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.47 43.96 1.4 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 107.446 -2.261 . . . . 0.0 107.446 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.55 -50.97 9.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -133.87 172.57 12.61 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -146.25 149.88 39.54 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.77 166.75 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.524 2.816 . . . . 0.0 109.36 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.24 -144.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 7.3 p -107.12 -59.75 1.77 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.213 1.405 . . . . 0.0 107.781 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.84 -16.28 48.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 130.185 3.394 . . . . 0.0 111.99 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -67.63 -22.71 65.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 124.137 1.923 . . . . 0.0 108.482 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.82 67.92 1.41 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 101.557 -4.617 . . . . 0.0 101.557 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.456 HH22 ' CG ' ' A' ' 59' ' ' ASP . 47.3 ttt85 -37.76 -20.71 0.01 OUTLIER 'General case' 0 C--N 1.362 1.124 0 C-N-CA 131.62 3.968 . . . . 0.0 115.461 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -54.69 -14.62 1.42 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.75 1.62 . . . . 0.0 114.499 162.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.98 -44.11 92.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.134 0 CA-C-N 121.709 2.05 . . . . 0.0 107.305 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.54 86.37 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.575 -0.703 . . . . 0.0 110.193 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.42 -45.31 80.77 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 123.762 0.825 . . . . 0.0 110.872 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -55.19 -46.76 75.87 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.627 1.971 . . . . 0.0 111.56 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.5 t -72.35 -44.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 C-N-CA 123.256 0.623 . . . . 0.0 109.494 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 72.9 mtm -58.89 -49.18 78.74 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.895 0.878 . . . . 0.0 110.293 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.77 -40.2 94.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.071 0.548 . . . . 0.0 110.783 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.98 76.27 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.116 0.566 . . . . 0.0 111.418 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -44.02 91.78 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 124.259 0.933 . . . . 0.0 111.172 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.96 -42.07 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.796 -0.826 . . . . 0.0 108.954 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.36 -50.85 71.65 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.174 -0.954 . . . . 0.0 111.995 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.3 -41.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 O-C-N 121.829 -0.544 . . . . 0.0 110.577 -173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -75.75 -27.97 58.31 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.588 -0.695 . . . . 0.0 110.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.6 -34.5 69.94 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.008 -1.057 . . . . 0.0 109.584 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.37 -34.0 76.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.296 1.038 . . . . 0.0 110.86 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.44 -21.9 19.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 124.847 1.259 . . . . 0.0 110.691 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 2.5 m -62.23 -16.33 52.7 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.574 -1.329 . . . . 0.0 111.531 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.41 -35.31 80.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.3 -2.125 . . . . 0.0 111.17 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.34 -33.75 61.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.83 -25.03 40.94 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.141 0.577 . . . . 0.0 111.569 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.35 -27.96 64.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 120.036 -1.665 . . . . 0.0 109.268 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -9.01 55.28 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.025 -1.047 . . . . 0.0 112.314 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -72.45 -23.09 61.01 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.397 -1.44 . . . . 0.0 110.728 -172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -75.23 -28.27 59.83 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.41 -0.806 . . . . 0.0 110.404 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.96 -40.15 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 124.131 0.972 . . . . 0.0 108.64 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -60.5 -23.56 64.63 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.352 -0.842 . . . . 0.0 112.663 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -52.67 -46.51 67.26 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.852 1.261 . . . . 0.0 109.983 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 N--CA 1.439 -0.977 0 O-C-N 121.807 -0.558 . . . . 0.0 110.466 -173.042 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 123.003 1.382 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.446 ' CG ' ' HA ' ' C' ' 88' ' ' ALA . 0.1 OUTLIER -59.09 -29.35 67.29 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.038 1.335 . . . . 0.0 113.733 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -80.64 -43.71 20.03 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -65.83 -41.55 91.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 123.832 0.853 . . . . 0.0 110.796 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -65.48 -35.67 81.57 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.259 0.624 . . . . 0.0 110.718 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.79 94.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.75 -31.72 66.97 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.952 -0.467 . . . . 0.0 111.676 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.0 -36.37 84.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.94 0.896 . . . . 0.0 110.001 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.59 72.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.29 -40.36 85.9 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 111.069 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.65 -25.43 59.19 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.167 1.387 . . . . 0.0 110.533 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.74 -36.74 67.8 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.305 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -63.72 -44.78 92.59 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -65.44 -24.49 67.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.458 -0.776 . . . . 0.0 112.488 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -60.31 -43.81 95.99 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.532 1.133 . . . . 0.0 109.911 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.14 -40.74 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.263 1.025 . . . . 0.0 109.057 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -40.16 95.24 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.721 0.809 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.56 -21.86 38.19 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.0 111.969 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.41 -47.57 17.3 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.33 60.17 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 124.149 0.979 . . . . 0.0 112.592 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.3 p -67.76 -40.36 84.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.034 1.288 . . . . 0.0 109.089 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -68.52 -44.61 74.26 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.45 -42.72 88.01 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.237 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.58 65.0 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.905 1.282 . . . . 0.0 111.48 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 m -72.3 -27.9 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 O-C-N 121.171 -0.956 . . . . 0.0 111.694 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.89 -37.67 67.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.44 -50.34 16.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 126.277 1.831 . . . . 0.0 109.614 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.58 -34.82 78.74 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.967 0.907 . . . . 0.0 111.266 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -66.49 122.83 18.44 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 119.48 -2.013 . . . . 0.0 109.379 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.26 7.04 59.69 Favored Glycine 0 CA--C 1.496 -1.12 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.83 147.43 34.74 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -77.49 131.74 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.976 2.45 . . . . 0.0 110.792 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 0.1 82.16 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.55 26.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.39 1.476 . . . . 0.0 109.825 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.88 -28.25 8.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 14.1 tp -98.74 83.25 2.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.612 -1.305 . . . . 0.0 108.271 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.2 pt -127.3 64.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -154.03 125.17 7.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -60.43 -47.49 96.22 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-O 115.944 -1.979 . . . . 0.0 113.754 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -71.7 -26.54 19.32 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 CA-C-N 126.04 3.193 . . . . 0.0 110.908 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -85.65 -8.81 58.0 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.97 79.68 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.105 -0.997 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.82 -33.32 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.95 -26.96 49.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.56 -1.337 . . . . 0.0 111.174 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -70.87 -46.43 62.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -66.25 -20.79 66.21 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.313 -0.867 . . . . 0.0 112.941 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.54 -51.47 72.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 124.457 1.103 . . . . 0.0 110.337 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.26 -27.45 61.58 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 118.803 0.728 . . . . 0.0 110.333 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -69.88 -37.9 76.19 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.94 -29.27 68.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.187 -0.945 . . . . 0.0 111.587 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -88.62 4.67 46.21 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.145 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.384 12.7 p 79.34 -63.62 0.26 Allowed 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 127.762 2.425 . . . . 0.0 107.889 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -1.19 -77.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.023 1 C-N-CA 131.964 4.106 . . . . 0.0 113.064 -177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.57 68.96 1.48 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -63.59 -29.35 70.61 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 121.584 -0.95 . . . . 0.0 111.941 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 42.7 0.88 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -65.24 -46.29 81.2 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -138.95 -152.51 0.42 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -165.99 146.29 5.46 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 100.598 -3.852 . . . . 0.0 100.598 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.83 -174.65 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 124.72 3.613 . . . . 0.0 108.791 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.35 -171.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -75.31 -41.86 55.98 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 126.394 1.877 . . . . 0.0 110.389 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.23 -24.42 59.32 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.833 0.853 . . . . 0.0 109.619 -167.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -59.49 -45.91 90.33 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.45 78.03 0.73 Allowed Glycine 0 CA--C 1.465 -3.089 1 N-CA-C 97.44 -6.264 . . . . 0.0 97.44 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -47.51 -17.71 0.1 Allowed 'General case' 0 C--N 1.37 1.499 0 C-N-CA 127.984 2.513 . . . . 0.0 114.629 -166.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -51.18 -16.03 0.44 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 127.637 2.375 . . . . 0.0 113.689 165.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . 0.267 30.0 t -72.04 -39.67 66.36 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 CA-C-N 123.504 2.865 . . . . 0.0 109.2 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.89 95.97 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 110.757 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.34 -43.82 97.93 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.066 0.946 . . . . 0.0 111.066 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -59.58 -51.05 71.51 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 125.077 1.351 . . . . 0.0 111.17 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.08 -43.19 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 26.8 ttp -60.1 -50.32 74.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.266 1.026 . . . . 0.0 110.561 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -65.57 -39.55 91.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.691 -0.631 . . . . 0.0 110.181 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.65 91.73 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.067 0.547 . . . . 0.0 111.059 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.04 -48.22 82.12 Favored Glycine 0 CA--C 1.494 -1.237 0 C-N-CA 123.74 0.686 . . . . 0.0 112.013 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.22 -45.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 124.03 0.932 . . . . 0.0 109.365 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.2 -42.79 95.84 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.27 1.028 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.88 -50.1 78.98 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 110.914 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.27 -35.01 78.63 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 121.363 -0.836 . . . . 0.0 111.167 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.66 -36.95 79.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.128 0.571 . . . . 0.0 110.405 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.01 -25.18 68.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.186 1.394 . . . . 0.0 111.968 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.44 -16.9 8.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 125.155 1.382 . . . . 0.0 110.745 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.8 t -66.16 -11.73 51.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 119.707 -1.87 . . . . 0.0 111.936 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.39 -19.91 63.9 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 110.902 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.446 ' HA ' ' CG ' ' C' ' 4' ' ' HIS . . . -89.78 -61.27 1.73 Allowed 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 125.329 1.452 . . . . 0.0 107.722 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.3 mt -68.48 -28.39 66.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -165.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.31 -12.0 60.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 120.626 -1.296 . . . . 0.0 110.632 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -15.07 55.89 Favored 'General case' 0 CA--C 1.492 -1.257 0 O-C-N 120.365 -1.46 . . . . 0.0 107.905 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.307 63.7 m-20 -93.38 10.57 31.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.222 -155.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -100.12 -19.1 16.63 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 121.515 -0.741 . . . . 0.0 109.793 159.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.9 -25.85 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.487 -1.383 . . . . 0.0 107.339 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -72.22 -3.21 22.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.868 -1.145 . . . . 0.0 112.365 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -61.65 -25.53 67.44 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.435 -1.416 . . . . 0.0 109.9 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 . . . . . 0 N--CA 1.436 -1.143 0 C-N-CA 124.419 1.088 . . . . 0.0 109.311 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -168.3 -89.77 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 -162.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.466 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 5.3 p80 -59.26 -22.65 61.47 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.557 2.743 . . . . 0.0 114.371 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.466 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 44.1 mp0 -67.68 -27.76 67.11 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -69.84 -37.92 76.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -79.36 -34.18 42.26 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.72 95.7 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.424 -0.798 . . . . 0.0 111.355 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.23 67.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.873 -0.517 . . . . 0.0 110.184 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.45 -35.2 79.65 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 124.213 1.005 . . . . 0.0 110.627 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.29 69.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 111.463 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -62.18 -41.07 97.99 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.157 -0.964 . . . . 0.0 110.983 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 -27.46 68.92 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 111.756 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -73.69 -35.32 65.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.0 -41.73 95.12 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.802 -1.187 . . . . 0.0 110.458 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -59.92 -31.35 69.75 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.788 1.235 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -66.67 -47.63 71.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.911 1.284 . . . . 0.0 108.941 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.68 -30.44 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.26 -47.58 83.12 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.06 -48.64 73.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 124.657 1.183 . . . . 0.0 109.246 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -66.03 -34.98 79.33 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.506 1.122 . . . . 0.0 110.575 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.27 43.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.534 -1.354 . . . . 0.0 111.295 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -64.31 -43.77 93.66 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.534 -0.729 . . . . 0.0 109.969 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -69.76 -30.18 67.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -66.49 -50.95 61.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -45.54 78.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.895 1.278 . . . . 0.0 112.248 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.88 -28.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.065 -1.022 . . . . 0.0 111.151 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.29 -33.3 22.16 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.545 -1.347 . . . . 0.0 108.674 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.26 74.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.834 2.054 . . . . 0.0 109.408 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -36.51 84.12 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.52 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp85 -78.38 89.07 4.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.239 1.019 . . . . 0.0 111.653 -165.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.42 -12.74 4.32 Favored Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.69 53.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 124.776 1.23 . . . . 0.0 108.493 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.22 141.99 13.19 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 123.108 2.146 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.19 77.33 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 170.87 9.46 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.3 92.32 1.86 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.05 58.46 0.07 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.013 0.911 . . . . 0.0 109.057 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 28.0 pt -95.23 -179.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 O-C-N 119.908 -1.745 . . . . 0.0 108.801 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.8 134.74 0.02 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.411 2.685 . . . . 0.0 114.044 172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -65.97 -46.11 64.1 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 119.715 -1.865 . . . . 0.0 110.484 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -73.45 -11.75 24.67 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 124.185 2.53 . . . . 0.0 113.971 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . 0.251 1.5 m-20 -90.64 -44.6 9.42 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -31.51 72.78 Favored 'General case' 0 CA--C 1.494 -1.205 0 O-C-N 121.178 -0.951 . . . . 0.0 112.238 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.17 -31.98 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 121.892 -0.505 . . . . 0.0 110.698 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -36.51 76.06 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 120.528 -1.357 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.456 ' CD1' ' HB2' ' D' ' 60' ' ' ARG . 65.7 t90 -70.55 -35.11 72.94 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.377 -0.827 . . . . 0.0 110.024 174.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -61.69 -42.06 98.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.178 0.991 . . . . 0.0 109.413 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.37 -53.54 42.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 125.159 1.384 . . . . 0.0 110.196 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.79 -45.89 70.86 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.435 1.494 . . . . 0.0 111.782 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.9 m -66.9 -38.13 85.67 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.071 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.35 73.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.461 -0.775 . . . . 0.0 111.36 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -86.22 5.07 35.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 118.98 -0.534 . . . . 0.0 112.273 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 62.7 p 55.98 46.04 22.66 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.658 1.183 . . . . 0.0 112.982 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.425 HG21 ' H ' ' D' ' 56' ' ' GLY . 0.3 OUTLIER -112.03 -93.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.425 ' H ' HG21 ' D' ' 55' ' ' VAL . . . 101.89 64.68 0.75 Allowed Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -28.57 68.01 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -172.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 129.01 2.27 5.63 Favored Glycine 0 CA--C 1.488 -1.654 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.438 ' CG ' HH22 ' A' ' 68' ' ' ARG . 1.7 m-20 -64.79 -41.79 95.54 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' D' ' 47' ' ' TRP . 50.5 mmt-85 -134.56 143.72 47.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 102.634 -3.099 . . . . 0.0 102.634 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -128.41 130.61 23.53 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.61 170.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 108.841 172.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -128.96 -167.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -76.8 -36.21 57.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 120.606 -1.309 . . . . 0.0 109.125 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -72.4 -24.06 61.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.059 1.344 . . . . 0.0 112.369 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.11 -24.44 51.74 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 123.108 1.432 . . . . 0.0 107.249 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 60.72 1.17 Allowed Glycine 0 CA--C 1.463 -3.209 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -31.88 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 1 C-N-CA 131.963 4.105 . . . . 0.0 116.927 -171.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.06 1.34 2.81 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 120.375 -1.453 . . . . 0.0 113.309 167.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -51.55 57.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.36 67.88 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.605 1.162 . . . . 0.0 110.965 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -52.44 -40.13 61.86 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.033 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -67.64 -33.75 75.59 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.61 -38.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 120.788 -1.195 . . . . 0.0 109.463 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -60.52 -39.61 88.45 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.761 -0.587 . . . . 0.0 110.902 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -57.52 -47.37 82.14 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.738 0.815 . . . . 0.0 110.76 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.06 97.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.875 0.47 . . . . 0.0 110.993 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.09 -50.57 50.95 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.15 -48.29 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.35 1.06 . . . . 0.0 109.385 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.29 -36.86 84.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.88 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.99 -51.83 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 119.388 0.995 . . . . 0.0 109.658 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.87 -21.84 63.3 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.448 -0.783 . . . . 0.0 111.114 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.02 -33.63 20.99 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.89 -39.19 88.31 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 124.529 1.132 . . . . 0.0 110.233 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.94 -7.99 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 121.519 -0.738 . . . . 0.0 112.321 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -60.86 -18.06 53.84 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-N 119.205 0.911 . . . . 0.0 110.229 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 119.704 -1.873 . . . . 0.0 112.372 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.79 71.69 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.06 -25.83 58.93 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.878 0.371 . . . . 0.0 110.9 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.19 -49.71 33.31 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 120.578 -1.326 . . . . 0.0 109.816 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -71.26 1.8 5.6 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.987 -1.07 . . . . 0.0 111.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.34 -24.09 63.86 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.957 -1.09 . . . . 0.0 108.56 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -67.3 -16.52 64.32 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 119.913 -1.742 . . . . 0.0 112.5 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 5.1 m -73.61 -21.64 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 O-C-N 119.652 -1.905 . . . . 0.0 110.561 -173.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -74.6 3.76 7.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.746 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -80.12 -35.77 36.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -176.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 62.96 12.04 5.56 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.938 2.095 . . . . 0.0 112.113 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -154.68 -36.35 0.09 Allowed 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 120.84 -1.163 . . . . 0.0 111.0 -164.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.6 -45.76 71.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -62.26 -37.76 86.67 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.386 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.47 -37.62 56.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.99 0.916 . . . . 0.0 109.289 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.57 89.45 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.948 0.899 . . . . 0.0 111.434 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -75.79 -16.75 60.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.315 -0.866 . . . . 0.0 111.583 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -76.6 -36.89 57.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.2 80.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.655 1.182 . . . . 0.0 111.19 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -55.83 -42.45 75.74 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 123.719 0.807 . . . . 0.0 111.7 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.9 -28.82 67.03 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.27 1.028 . . . . 0.0 110.601 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -41.59 87.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 tp -64.83 -39.43 93.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 122.632 0.373 . . . . 0.0 111.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -54.52 -46.09 73.48 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.206 0.602 . . . . 0.0 111.847 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -74.44 -32.26 62.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.88 -1.137 . . . . 0.0 111.855 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.65 -42.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.781 -1.2 . . . . 0.0 109.706 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.47 -30.42 69.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.923 -1.11 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -65.04 -41.64 95.01 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.607 -1.308 . . . . 0.0 111.033 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -62.29 -47.05 86.02 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.16 0.981 . . . . 0.0 109.268 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -27.89 69.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.76 0.824 . . . . 0.0 112.39 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.7 m -63.18 -33.33 75.24 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.366 1.067 . . . . 0.0 111.379 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -72.56 -36.37 68.21 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.22 -47.55 67.56 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -47.17 79.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.992 1.717 . . . . 0.0 112.672 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.6 -30.33 46.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 O-C-N 120.748 -1.22 . . . . 0.0 110.789 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.06 -41.74 41.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.677 -1.264 . . . . 0.0 108.515 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.51 38.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 128.005 2.522 . . . . 0.0 108.634 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -63.82 -50.71 67.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.509 1.124 . . . . 0.0 111.134 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.0 ttp85 -81.55 101.58 10.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 119.681 -1.887 . . . . 0.0 111.266 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -27.18 2.16 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 104.593 -3.403 . . . . 0.0 104.593 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 151.13 62.79 Favored Pre-proline 0 N--CA 1.439 -1.025 0 C-N-CA 124.016 0.927 . . . . 0.0 111.932 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -77.62 105.5 2.04 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.878 2.386 . . . . 0.0 112.12 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.67 11.62 11.28 Favored Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.91 132.3 5.34 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 127.442 2.297 . . . . 0.0 115.276 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.06 -61.69 1.65 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.279 1.032 . . . . 0.0 111.166 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.79 106.85 18.35 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-O 122.257 1.027 . . . . 0.0 112.798 -171.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.431 ' H ' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -111.41 169.58 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 O-C-N 120.266 -1.521 . . . . 0.0 108.586 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 m 71.81 146.01 0.07 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.771 2.428 . . . . 0.0 113.141 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -72.69 -51.58 6.8 Favored Pre-proline 0 C--N 1.349 0.583 0 CA-C-O 115.925 -1.988 . . . . 0.0 111.886 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.14 -11.02 26.71 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 125.338 2.942 . . . . 0.0 111.992 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.2 -34.7 11.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.1 96.04 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.037 -1.04 . . . . 0.0 110.771 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.88 -33.4 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 122.753 0.421 . . . . 0.0 111.562 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -28.79 65.45 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.152 -1.592 . . . . 0.0 110.763 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -76.93 -40.55 46.77 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 107.962 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -63.87 -30.81 71.86 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 121.026 -1.046 . . . . 0.0 112.61 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.23 -36.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-N 118.723 0.692 . . . . 0.0 110.155 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -63.19 -61.1 2.6 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -50.33 -36.99 34.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.176 1.79 . . . . 0.0 113.25 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.38 97.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.707 1.203 . . . . 0.0 111.71 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -91.51 4.68 51.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.283 30.1 p 66.86 -136.54 0.14 Allowed 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 127.304 2.242 . . . . 0.0 108.244 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 t 69.19 -79.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.64 87.45 0.47 Allowed Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -72.01 -33.31 67.97 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.399 -1.059 . . . . 0.0 108.263 -170.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.57 16.55 1.65 Allowed Glycine 0 CA--C 1.489 -1.575 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -58.93 -56.36 23.25 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 117.838 0.819 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 166.34 24.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 174.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.8 142.7 19.21 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 102.314 -3.217 . . . . 0.0 102.314 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 96.5 Cg_endo -84.06 162.53 13.6 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.02 2.48 . . . . 0.0 110.132 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.77 176.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 122.288 1.042 . . . . 0.0 108.965 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.514 ' HA ' ' CE2' ' D' ' 46' ' ' TRP . 0.2 OUTLIER -61.67 -47.8 83.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 127.59 2.356 . . . . 0.0 114.219 -166.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -81.48 1.09 34.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 118.967 -2.333 . . . . 0.0 110.246 -170.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -61.24 -32.43 72.23 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-O 123.372 1.558 . . . . 0.0 107.797 175.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.0 85.78 0.96 Allowed Glycine 0 CA--C 1.471 -2.714 1 N-CA-C 100.995 -4.842 . . . . 0.0 100.995 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.6 ' HB2' ' CE2' ' D' ' 46' ' ' TRP . 1.7 ttp85 -58.62 -9.0 1.44 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 118.24 1.02 . . . . 0.0 113.202 -169.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -45.96 -35.9 5.07 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.207 1.403 . . . . 0.0 112.659 160.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.36 -59.5 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.12 77.21 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.503 0.721 . . . . 0.0 112.436 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.16 -39.08 71.78 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.595 2.358 . . . . 0.0 111.57 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -70.13 -31.03 68.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 t -71.65 -41.76 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 O-C-N 121.512 -0.742 . . . . 0.0 109.073 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 59.9 mtt -56.28 -49.52 74.01 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.604 1.162 . . . . 0.0 110.433 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -66.76 -37.24 84.23 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.15 -0.969 . . . . 0.0 110.647 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.56 87.34 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.152 -0.968 . . . . 0.0 111.015 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.08 -38.94 63.51 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -70.88 -35.77 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 O-C-N 121.289 -1.124 . . . . 0.0 109.348 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.87 -38.15 89.7 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 120.429 -1.419 . . . . 0.0 112.285 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.51 -39.11 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -78.17 -30.43 49.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.477 0.58 . . . . 0.0 109.922 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.89 89.08 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 123.575 0.75 . . . . 0.0 110.494 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.91 -30.31 71.3 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.849 1.26 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.48 -11.99 7.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 C-N-CA 125.327 1.451 . . . . 0.0 110.614 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.8 t -53.55 -25.74 18.33 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 119.728 -1.857 . . . . 0.0 112.621 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -18.98 63.82 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.094 -1.004 . . . . 0.0 109.716 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.85 -50.8 7.23 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.47 -48.42 69.94 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.428 1.091 . . . . 0.0 113.423 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.18 -12.6 60.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -84.7 -27.25 27.15 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -32.97 74.6 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.557 -1.339 . . . . 0.0 110.991 -159.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -62.38 -30.64 71.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.32 -0.862 . . . . 0.0 112.837 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.78 -24.37 35.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.237 1.415 . . . . 0.0 108.819 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -59.35 -24.14 63.12 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.31 -0.869 . . . . 0.0 112.471 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -64.87 -28.55 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.972 -1.08 . . . . 0.0 110.395 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 . . . . . 0 C--N 1.354 0.794 0 CA-C-N 119.253 0.933 . . . . 0.0 109.805 -179.243 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.5 -0.967 0 CA-C-O 122.859 1.314 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -73.33 -19.53 61.0 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.264 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -82.33 -32.53 29.33 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.49 -25.44 61.41 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.623 -0.673 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.27 -49.85 72.46 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.568 1.147 . . . . 0.0 108.879 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.56 87.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.03 1.332 . . . . 0.0 110.838 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.23 -37.95 87.36 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.924 0.89 . . . . 0.0 110.75 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -69.46 -25.94 64.34 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.42 -1.425 . . . . 0.0 110.702 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.91 71.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 120.701 -1.249 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.439 ' CD ' ' HZ1' ' C' ' 76' ' ' LYS . 5.1 mm-40 -59.0 -37.61 77.26 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.742 1.217 . . . . 0.0 111.553 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.29 -30.78 71.27 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.587 1.555 . . . . 0.0 110.11 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -70.64 -42.67 70.53 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.536 1.134 . . . . 0.0 108.57 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.21 -38.61 91.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 123.865 0.866 . . . . 0.0 111.364 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -63.77 -29.72 70.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.446 -0.784 . . . . 0.0 111.789 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -75.58 -30.28 59.59 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.858 -1.151 . . . . 0.0 110.637 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.11 -38.9 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.87 -44.95 78.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 124.069 0.948 . . . . 0.0 111.784 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.85 -48.88 67.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.337 0.655 . . . . 0.0 110.31 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.14 -24.2 60.56 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.936 -1.102 . . . . 0.0 110.898 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 -26.03 62.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 120.981 -1.075 . . . . 0.0 111.532 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -63.75 -46.8 83.66 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.64 -45.31 87.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.667 1.187 . . . . 0.0 109.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -60.55 -59.11 5.92 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.446 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.02 89.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 111.804 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.79 -35.71 61.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.72 -1.238 . . . . 0.0 110.317 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.16 -39.17 55.53 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.047 -1.033 . . . . 0.0 109.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.59 70.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 127.072 2.149 . . . . 0.0 109.461 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.58 61.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.816 -0.552 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -72.83 95.94 2.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.693 -1.879 . . . . 0.0 111.379 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.18 -11.95 3.3 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.63 152.65 47.32 Favored Pre-proline 0 N--CA 1.442 -0.845 0 O-C-N 121.254 -1.144 . . . . 0.0 109.496 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.64 152.75 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.022 2.481 . . . . 0.0 109.576 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -78.14 1.8 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.509 -3.437 . . . . 0.0 104.509 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.13 138.71 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 129.226 3.01 . . . . 0.0 111.247 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.73 -39.85 1.95 Allowed 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 120.278 -1.514 . . . . 0.0 108.289 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -100.18 137.24 38.88 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.79 0.805 . . . . 0.0 109.575 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.6 pt -147.02 175.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 100.497 -3.89 . . . . 0.0 100.497 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m 72.77 129.88 0.04 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 112.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -67.77 -48.71 41.13 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 116.818 -1.563 . . . . 0.0 110.102 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.66 -13.08 29.66 Favored 'Trans proline' 0 CA--C 1.509 -0.751 0 CA-C-N 124.987 2.817 . . . . 0.0 113.004 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.24 -25.83 17.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.988 1.267 . . . . 0.0 107.649 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.66 81.48 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.359 -0.838 . . . . 0.0 111.162 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.04 -34.12 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 121.444 -0.785 . . . . 0.0 110.301 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -36.35 72.08 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.801 -1.187 . . . . 0.0 110.327 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -64.49 -44.26 91.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.44 1.496 . . . . 0.0 109.368 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -57.74 -39.36 77.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.867 1.667 . . . . 0.0 111.3 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -53.84 -51.98 39.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 124.716 1.206 . . . . 0.0 111.271 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -71.9 -22.08 61.55 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.762 0.71 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.0 m -74.07 -40.71 62.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.017 0.927 . . . . 0.0 108.757 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -28.83 63.49 Favored 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 121.142 -0.974 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.4 p -84.64 3.83 35.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.568 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 53.82 51.58 14.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.822 1.649 . . . . 0.0 111.062 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -117.81 -111.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.105 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.21 76.39 1.22 Allowed Glycine 0 CA--C 1.483 -1.924 0 N-CA-C 104.804 -3.318 . . . . 0.0 104.804 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -74.49 -16.59 60.84 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.868 -1.371 . . . . 0.0 109.745 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.75 52.85 0.53 Allowed Glycine 0 CA--C 1.481 -2.092 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.15 -59.12 2.9 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -144.02 174.93 10.42 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -142.28 129.35 11.19 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.82 165.87 27.89 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 124.116 3.211 . . . . 0.0 110.318 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.449 HG21 ' H ' ' B' ' 64' ' ' THR . 3.8 p -101.61 -167.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 122.752 1.263 . . . . 0.0 109.234 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.449 ' H ' HG21 ' B' ' 63' ' ' VAL . 3.1 p -86.89 -39.68 15.58 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.872 -1.767 . . . . 0.0 109.245 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.62 -9.12 59.8 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.011 1.725 . . . . 0.0 110.884 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.39 -23.79 61.95 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-O 124.297 1.998 . . . . 0.0 107.18 169.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.54 75.72 1.27 Allowed Glycine 0 CA--C 1.468 -2.873 1 N-CA-C 101.978 -4.449 . . . . 0.0 101.978 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -47.61 -12.2 0.03 OUTLIER 'General case' 0 C--N 1.373 1.587 0 C-N-CA 129.96 3.304 . . . . 0.0 113.729 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -50.63 -19.62 0.97 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.458 1.903 . . . . 0.0 113.627 158.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.93 -54.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 CA-C-N 122.089 2.222 . . . . 0.0 107.342 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.54 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.324 0.583 . . . . 0.0 110.733 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.89 -42.66 80.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.269 1.428 . . . . 0.0 111.996 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.96 -40.96 95.79 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.392 1.077 . . . . 0.0 110.1 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.09 -46.92 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 C-N-CA 123.536 0.734 . . . . 0.0 109.578 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 46.1 mtp -59.23 -48.77 80.37 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.18 0.992 . . . . 0.0 110.285 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -61.99 -41.02 97.58 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.167 0.987 . . . . 0.0 110.771 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.59 91.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 123.01 0.524 . . . . 0.0 111.122 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.64 -49.57 63.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.37 -44.66 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 124.192 0.997 . . . . 0.0 109.316 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.68 -38.35 90.71 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.788 -1.195 . . . . 0.0 111.754 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.48 -53.03 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.207 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.2 -11.63 60.58 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.336 0.655 . . . . 0.0 112.118 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.99 -21.13 15.13 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 123.755 0.822 . . . . 0.0 109.657 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.94 -28.13 64.27 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 119.632 -1.918 . . . . 0.0 108.976 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.16 -14.94 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.943 0.897 . . . . 0.0 111.996 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 66.8 m -58.95 -12.44 4.55 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 125.936 1.694 . . . . 0.0 111.674 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.82 -26.05 68.55 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.538 -1.976 . . . . 0.0 112.388 167.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.01 -30.81 27.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 119.856 -1.778 . . . . 0.0 108.742 175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.26 31.42 0.65 Allowed 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 126.04 1.736 . . . . 0.0 109.29 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.6 -1.98 1.11 Allowed 'General case' 0 N--CA 1.433 -1.316 0 O-C-N 120.59 -1.318 . . . . 0.0 108.26 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -116.85 16.94 15.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -83.2 -48.52 10.41 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.354 2.262 . . . . 0.0 107.188 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -65.2 -20.41 66.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.481 1.113 . . . . 0.0 111.648 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.55 -28.53 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 124.657 1.183 . . . . 0.0 109.375 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -65.65 -21.72 66.58 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 124.51 1.124 . . . . 0.0 111.916 -172.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -19.18 63.33 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.828 -1.17 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.127 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . 0.28 38.1 m-20 . . . . . 0 CA--C 1.501 -0.911 0 CA-C-O 122.845 1.307 . . . . 0.0 113.328 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -161.68 -45.61 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.48 -47.69 83.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.879 2.072 . . . . 0.0 110.263 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -80.73 -6.63 58.72 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.645 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.84 -47.36 11.95 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.65 93.85 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.044 0.938 . . . . 0.0 110.632 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -57.11 -38.28 73.18 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.815 1.246 . . . . 0.0 111.751 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -72.92 -28.11 62.26 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.167 -0.958 . . . . 0.0 110.446 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.27 -40.29 77.9 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.056 0.542 . . . . 0.0 109.695 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.11 -40.33 93.36 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.515 0.726 . . . . 0.0 110.947 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.36 -38.8 81.33 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.74 0.816 . . . . 0.0 111.442 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.29 -40.09 93.39 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.116 1.366 . . . . 0.0 109.519 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.49 -38.65 91.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.555 -0.716 . . . . 0.0 111.055 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.44 -31.8 72.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.382 -0.824 . . . . 0.0 112.149 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -67.73 -39.65 84.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.05 0.94 . . . . 0.0 109.368 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.54 -32.61 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 124.286 1.034 . . . . 0.0 109.035 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.3 -44.95 88.78 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.016 0.825 . . . . 0.0 111.176 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.54 -38.27 80.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.398 0.679 . . . . 0.0 110.242 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.56 -44.42 86.79 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 121.186 -0.946 . . . . 0.0 109.077 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.18 72.91 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.807 1.643 . . . . 0.0 111.41 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -59.42 -47.6 84.84 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.006 0.922 . . . . 0.0 111.553 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -45.69 69.76 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 125.149 1.38 . . . . 0.0 108.221 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.64 -36.07 78.12 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.893 0.477 . . . . 0.0 111.01 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.73 -44.42 61.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 123.825 0.85 . . . . 0.0 110.73 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.57 -32.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 121.471 -0.768 . . . . 0.0 110.018 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -84.66 -12.85 53.09 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.108 -0.995 . . . . 0.0 111.382 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.4 78.73 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -81.33 -10.12 59.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.764 0.792 . . . . 0.0 111.535 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -78.97 81.96 5.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 119.921 -1.737 . . . . 0.0 108.3 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.09 0.51 4.22 Favored Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.21 42.89 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.37 112.51 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.533 2.155 . . . . 0.0 113.388 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.26 -46.27 0.67 Allowed Glycine 0 CA--C 1.482 -1.999 1 N-CA-C 101.949 -4.461 . . . . 0.0 101.949 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 73.16 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.626 1.97 . . . . 0.0 108.419 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.6 -71.39 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 112.573 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 tt -100.68 120.35 39.94 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.48 13.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 28.3 t -109.67 130.49 55.51 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.72 -56.36 9.74 Favored Pre-proline 0 C--N 1.349 0.572 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.026 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.02 -12.07 25.73 Favored 'Trans proline' 0 CA--C 1.511 -0.669 0 CA-C-N 124.988 2.817 . . . . 0.0 111.386 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.83 -20.34 21.58 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 119.366 0.985 . . . . 0.0 108.7 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.49 -36.25 83.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.338 -0.851 . . . . 0.0 109.95 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -72.35 -25.92 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.876 1.27 . . . . 0.0 110.557 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 -42.27 37.02 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.525 -1.359 . . . . 0.0 107.812 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -70.07 -32.47 70.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.657 0.783 . . . . 0.0 110.684 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 54.6 p -68.67 -27.52 66.06 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.249 -1.532 . . . . 0.0 111.311 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.03 -53.57 47.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 CA-C-N 119.14 0.882 . . . . 0.0 109.601 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.96 -10.94 59.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.812 -0.555 . . . . 0.0 112.005 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -81.12 -33.32 33.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.172 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -35.55 75.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.775 -1.203 . . . . 0.0 111.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.46 0.73 48.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 122.039 -0.413 . . . . 0.0 110.596 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.9 p 65.42 20.18 11.72 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 126.085 1.754 . . . . 0.0 111.493 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.79 -55.89 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.39 44.31 97.81 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 121.629 -0.669 . . . . 0.0 112.125 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.84 -40.65 73.13 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.616 1.567 . . . . 0.0 110.518 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.59 -122.79 1.12 Allowed Glycine 0 CA--C 1.48 -2.14 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.322 4.4 t0 62.62 -85.29 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 127.072 2.149 . . . . 0.0 108.947 -168.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -119.67 169.07 10.42 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.34 148.72 21.48 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.92 176.58 7.49 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.033 2.488 . . . . 0.0 108.695 171.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.458 HG13 ' H ' ' C' ' 64' ' ' THR 0.285 9.9 p -101.2 -121.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 170.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.458 ' H ' HG13 ' C' ' 63' ' ' VAL . 12.6 m -107.34 -82.67 0.55 Allowed 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 120.283 -1.511 . . . . 0.0 107.174 -171.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.05 122.41 12.98 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.101 1.36 . . . . 0.0 109.406 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . 0.28 6.6 tt0 76.33 -68.63 0.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.301 -1.333 . . . . 0.0 112.637 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -37.15 -49.07 1.54 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 128.216 2.817 . . . . 0.0 114.646 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -75.31 -38.46 60.26 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.798 1.239 . . . . 0.0 112.094 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -76.48 -29.74 56.99 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.84 -44.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 O-C-N 119.766 -1.834 . . . . 0.0 109.08 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.14 99.37 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 111.205 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -48.82 -44.85 39.69 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.692 1.997 . . . . 0.0 112.194 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -63.94 -40.1 95.66 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.69 -39.23 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 124.342 1.057 . . . . 0.0 109.263 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.42 -45.86 87.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . 0.439 ' HZ1' ' CD ' ' B' ' 12' ' ' GLU . 23.2 ttmm -63.28 -39.34 94.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.696 0.799 . . . . 0.0 110.931 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.48 71.61 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.914 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.65 -49.87 7.63 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.13 -46.29 84.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 110.167 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.62 -31.83 73.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.421 -0.799 . . . . 0.0 112.572 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.59 -51.59 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -66.17 -33.98 77.01 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 122.878 0.471 . . . . 0.0 110.975 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.56 83.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.53 1.132 . . . . 0.0 110.517 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.72 -22.16 66.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.772 1.229 . . . . 0.0 112.935 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -59.59 -19.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 124.892 1.277 . . . . 0.0 110.401 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -57.77 -20.42 34.95 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 112.631 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.0 51.15 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.311 -1.493 . . . . 0.0 112.422 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.09 -31.57 11.7 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.792 1.237 . . . . 0.0 110.644 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 35.1 mt -82.62 -41.43 19.47 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.428 -0.795 . . . . 0.0 109.956 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.84 72.75 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.5 1.12 . . . . 0.0 109.62 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -16.79 64.13 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.522 -1.361 . . . . 0.0 112.098 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.36 -24.42 59.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.497 1.044 . . . . 0.0 110.518 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -37.97 61.3 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 120.705 -1.247 . . . . 0.0 109.705 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.25 -27.85 42.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 125.32 1.448 . . . . 0.0 110.191 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -59.72 -22.52 62.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.342 1.057 . . . . 0.0 113.027 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . 0.3 18.3 ptt85 -69.46 -28.59 66.23 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 121.254 1.843 . . . . 0.0 111.506 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 C--N 1.351 0.669 0 O-C-N 119.621 -1.924 . . . . 0.0 110.345 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -55.85 -46.28 78.23 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.087 2.155 . . . . 0.0 110.466 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CD2' ' CB ' ' D' ' 87' ' ' ALA 0.252 1.4 m80 -81.15 -16.34 53.25 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -169.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.06 -30.82 31.17 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.418 1.008 . . . . 0.0 109.166 169.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -63.42 -46.1 87.94 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.54 -31.17 66.74 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.97 -0.457 . . . . 0.0 110.4 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.21 70.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 121.353 -0.842 . . . . 0.0 110.744 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -69.84 -29.95 67.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.835 -0.54 . . . . 0.0 111.574 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.27 -40.62 91.0 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.713 0.805 . . . . 0.0 110.232 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.46 84.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.591 0.756 . . . . 0.0 111.445 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.19 -37.88 81.56 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 121.459 -0.775 . . . . 0.0 110.912 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -70.96 -26.53 63.2 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.981 -1.075 . . . . 0.0 111.337 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -76.15 -34.19 59.38 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.23 -39.53 93.12 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.33 0.652 . . . . 0.0 111.164 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.02 -35.19 74.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.615 0.766 . . . . 0.0 111.916 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -67.11 -39.25 86.64 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.691 -0.631 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.65 -39.85 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.075 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . 0.527 HD22 ' H ' ' D' ' 49' ' ' VAL . 87.3 mt -64.84 -37.5 87.84 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.136 0.974 . . . . 0.0 112.478 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -67.84 -32.69 73.38 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.61 0.719 . . . . 0.0 111.577 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.79 -36.4 28.48 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.417 -0.802 . . . . 0.0 108.949 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.35 84.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 125.455 1.502 . . . . 0.0 111.992 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -66.77 -40.95 88.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.597 0.713 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -69.09 -39.47 78.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 109.175 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -73.59 -40.33 63.96 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.855 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.21 80.89 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.092 1.357 . . . . 0.0 112.642 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.96 -38.05 81.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 O-C-N 120.832 -1.168 . . . . 0.0 111.647 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.91 -23.17 36.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.964 -1.085 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.24 -52.81 20.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.641 1.976 . . . . 0.0 107.774 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.02 -33.44 70.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.582 1.182 . . . . 0.0 111.946 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -68.93 104.77 2.17 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.63 -1.919 . . . . 0.0 112.14 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.06 -33.92 1.98 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 104.824 -3.311 . . . . 0.0 104.824 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.41 150.64 73.95 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 123.771 0.828 . . . . 0.0 110.412 -173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.46 145.63 23.81 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.064 1.842 . . . . 0.0 109.301 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.11 17.57 74.07 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 118.563 0.619 . . . . 0.0 112.125 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.49 128.41 22.79 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.891 1.676 . . . . 0.0 113.573 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.44 -39.46 1.02 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.993 1.317 . . . . 0.0 109.709 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.39 15.3 1.28 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.84 1.656 . . . . 0.0 111.609 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tp -98.63 121.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 119.6 -1.937 . . . . 0.0 108.257 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.8 p -172.82 -105.06 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.81 -65.21 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.006 0 C-N-CA 128.111 2.565 . . . . 0.0 106.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 -18.98 28.24 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 124.837 2.763 . . . . 0.0 110.804 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.62 -22.56 26.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.87 -33.64 62.11 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 120.941 -1.099 . . . . 0.0 111.468 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.67 -20.79 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.607 1.194 . . . . 0.0 108.747 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.6 ' CE2' ' HB2' ' A' ' 68' ' ' ARG . 24.9 t90 -77.55 -40.43 42.51 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.336 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -60.14 -44.14 95.19 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.19 1.396 . . . . 0.0 109.925 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 82.3 p -74.97 -169.76 0.97 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.999 0.904 . . . . 0.0 108.982 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . 0.527 ' H ' HD22 ' D' ' 19' ' ' LEU 0.352 2.1 t 71.58 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.955 2.102 . . . . 0.0 110.683 -170.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -28.63 70.13 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.618 1.099 . . . . 0.0 110.415 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -29.87 69.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.037 0.935 . . . . 0.0 111.126 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.75 49.42 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.809 -1.182 . . . . 0.0 109.844 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -83.74 3.63 32.43 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.442 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 71.2 p 54.61 59.59 4.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.252 2.221 . . . . 0.0 111.871 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -109.06 -89.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.45 60.45 1.45 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -9.95 59.24 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 121.674 -0.898 . . . . 0.0 111.498 -170.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.37 35.35 3.63 Favored Glycine 0 CA--C 1.486 -1.763 0 O-C-N 120.467 -1.395 . . . . 0.0 110.81 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.02 -65.23 0.8 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -138.01 153.76 49.37 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 102.957 -2.979 . . . . 0.0 102.957 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.69 144.22 48.05 Favored Pre-proline 0 N--CA 1.44 -0.937 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.01 165.9 25.62 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.249 2.632 . . . . 0.0 109.546 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.517 HG12 ' H ' ' D' ' 64' ' ' THR . 2.8 t -103.69 -153.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.517 ' H ' HG12 ' D' ' 63' ' ' VAL . 0.2 OUTLIER -93.14 -54.29 3.78 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 119.619 -1.926 . . . . 0.0 109.279 -161.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.03 3.65 33.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 109.245 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -25.91 62.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.85 55.54 1.4 Allowed Glycine 0 CA--C 1.466 -3.012 0 N-CA-C 104.575 -3.41 . . . . 0.0 104.575 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -21.42 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.376 1.733 1 C-N-CA 133.878 4.871 . . . . 0.0 116.825 -174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -52.47 -16.21 0.84 Allowed 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 125.601 1.56 . . . . 0.0 113.256 162.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.05 -47.39 88.09 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 122.246 2.294 . . . . 0.0 108.449 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.94 -47.84 73.35 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.099 0.56 . . . . 0.0 110.63 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.03 -38.95 80.5 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 111.704 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -67.79 -29.33 68.49 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.561 -1.337 . . . . 0.0 111.44 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.71 -42.13 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 121.307 -0.87 . . . . 0.0 108.672 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.54 -49.71 76.44 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.717 1.207 . . . . 0.0 109.829 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -65.32 -37.77 88.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.015 -0.428 . . . . 0.0 111.298 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.94 92.38 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -50.39 61.49 Favored Glycine 0 CA--C 1.49 -1.478 0 C-N-CA 124.129 0.871 . . . . 0.0 111.067 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -57.83 -48.29 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.387 1.075 . . . . 0.0 109.598 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.05 -32.05 73.57 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 t -65.62 -55.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-N 119.371 0.987 . . . . 0.0 109.388 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.63 -38.6 84.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.324 0.583 . . . . 0.0 110.375 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.53 63.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.346 -0.847 . . . . 0.0 111.047 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.06 -30.9 71.5 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.182 -1.574 . . . . 0.0 110.118 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 -12.47 7.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.804 1.242 . . . . 0.0 110.68 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -52.79 -22.82 5.78 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.448 -1.408 . . . . 0.0 111.621 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.427 ' CB ' ' CD2' ' D' ' 4' ' ' HIS . . . -73.54 -19.26 60.95 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 119.466 -2.021 . . . . 0.0 114.423 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.32 -41.8 15.19 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.91 -40.98 90.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 112.525 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.83 64.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.201 -0.937 . . . . 0.0 111.871 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -92.14 -1.0 57.42 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 120.777 -1.202 . . . . 0.0 108.462 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -74.58 -30.22 61.63 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 119.253 0.933 . . . . 0.0 109.753 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -80.83 -31.8 35.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 120.597 -1.314 . . . . 0.0 111.524 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -23.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 125.163 1.385 . . . . 0.0 109.294 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -50.16 -35.35 25.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 125.606 1.563 . . . . 0.0 113.256 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -71.24 -16.57 62.5 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.315 -0.866 . . . . 0.0 110.87 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.825 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -151.85 -82.49 0.09 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -0.28 31.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 121.068 -1.02 . . . . 0.0 113.324 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -30.06 68.26 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.334 1.454 . . . . 0.0 108.248 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -66.88 -37.9 85.29 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.606 0.763 . . . . 0.0 109.05 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.7 -28.55 36.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.38 76.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.421 0.629 . . . . 0.0 111.16 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -75.32 -23.49 57.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.568 -0.707 . . . . 0.0 111.043 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.84 -36.03 77.68 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.588 -0.695 . . . . 0.0 109.51 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.84 71.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.976 -1.078 . . . . 0.0 111.471 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.83 -23.22 65.14 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.417 -0.802 . . . . 0.0 111.97 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.47 -43.09 67.24 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 120.658 -1.276 . . . . 0.0 109.242 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.48 -39.14 92.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.653 1.181 . . . . 0.0 108.645 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.24 -43.29 92.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.003 0.521 . . . . 0.0 111.562 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.17 -30.9 71.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.812 0.845 . . . . 0.0 111.905 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -69.43 -39.8 77.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.49 -0.756 . . . . 0.0 109.646 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.8 -38.79 82.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 O-C-N 121.29 -0.881 . . . . 0.0 109.202 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -58.77 -42.68 89.53 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.788 0.835 . . . . 0.0 111.618 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.82 -28.53 62.61 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.33 1.052 . . . . 0.0 111.737 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -73.73 -46.12 47.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.745 -1.222 . . . . 0.0 107.798 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -27.95 68.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.761 1.225 . . . . 0.0 112.221 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 p -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.654 1.116 . . . . 0.0 110.791 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.32 -43.62 77.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.58 -44.72 95.61 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.02 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 126.212 1.805 . . . . 0.0 112.42 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.2 m -64.66 -34.94 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 119.955 1.252 . . . . 0.0 112.131 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -78.18 -35.48 48.64 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 125.256 1.423 . . . . 0.0 108.38 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -51.2 10.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 124.662 1.185 . . . . 0.0 108.505 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.03 -40.66 87.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.085 0.945 . . . . 0.0 110.267 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -77.23 104.82 7.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 119.802 -1.811 . . . . 0.0 111.349 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -21.89 2.36 Favored Glycine 0 CA--C 1.49 -1.489 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.23 89.0 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 123.4 0.68 . . . . 0.0 110.702 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.68 126.05 11.69 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.971 2.448 . . . . 0.0 110.105 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -67.81 3.26 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 106.069 -2.812 . . . . 0.0 106.069 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.7 -172.98 0.18 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 126.516 1.926 . . . . 0.0 108.55 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.81 -40.41 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.969 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.33 -68.47 0.64 Allowed 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt 32.02 37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 128.326 2.65 . . . . 0.0 114.934 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -148.72 133.6 18.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -79.67 -52.14 1.12 Allowed Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-O 116.01 -1.947 . . . . 0.0 110.8 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.71 -13.42 29.66 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 CA-C-N 126.145 3.23 . . . . 0.0 111.73 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.57 -27.79 29.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.487 1.515 . . . . 0.0 108.559 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.46 -33.72 76.6 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.778 0.831 . . . . 0.0 111.785 -167.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -73.56 -24.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 123.836 0.855 . . . . 0.0 110.376 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.85 -32.45 21.71 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 120.744 -1.222 . . . . 0.0 108.766 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -70.23 -35.57 73.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.554 1.169 . . . . 0.0 108.974 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -81.27 62.47 5.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 120.674 -1.266 . . . . 0.0 108.907 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.87 -68.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -46.88 -32.99 4.15 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 130.107 3.363 . . . . 0.0 114.231 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -69.21 -37.61 78.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.879 1.672 . . . . 0.0 109.851 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.43 58.17 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 120.177 -1.577 . . . . 0.0 109.724 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -79.59 -11.09 59.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.416 1.487 . . . . 0.0 109.319 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 54.11 62.88 2.38 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.848 2.059 . . . . 0.0 112.144 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.49 -84.17 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.58 -84.66 0.36 Allowed Glycine 0 CA--C 1.482 -2.0 1 N-CA-C 101.902 -4.479 . . . . 0.0 101.902 -173.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.431 ' CZ ' ' HA2' ' B' ' 56' ' ' GLY . 0.1 OUTLIER 65.13 -69.87 0.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 127.046 2.138 . . . . 0.0 111.448 179.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.32 53.15 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.722 0 O-C-N 120.529 -1.357 . . . . 0.0 115.507 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.12 -64.87 0.89 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.241 2.02 . . . . 0.0 108.113 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.82 179.05 6.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -157.72 152.82 21.51 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.47 172.22 13.8 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.782 2.988 . . . . 0.0 109.409 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 t -115.92 -100.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 119.463 1.029 . . . . 0.0 108.535 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -140.77 -44.0 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.12 -16.21 41.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.406 -0.809 . . . . 0.0 111.793 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -61.06 -35.95 78.31 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.928 1.291 . . . . 0.0 108.11 171.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 97.81 2.02 Favored Glycine 0 N--CA 1.418 -2.53 1 N-CA-C 97.548 -6.221 . . . . 0.0 97.548 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -62.08 -16.62 53.53 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 119.239 1.519 . . . . 0.0 110.112 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.46 -10.14 4.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 125.196 1.398 . . . . 0.0 112.97 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.55 -46.35 75.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 120.748 -1.22 . . . . 0.0 108.165 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.11 74.28 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -49.22 -45.15 44.04 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.529 1.532 . . . . 0.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -58.69 -47.71 83.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.759 1.224 . . . . 0.0 111.232 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.5 -42.31 72.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 O-C-N 121.749 -0.594 . . . . 0.0 109.574 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.59 -48.18 82.1 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.111 0.964 . . . . 0.0 110.105 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.52 -36.22 78.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.295 -0.878 . . . . 0.0 110.862 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.85 98.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.709 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.91 92.75 Favored Glycine 0 CA--C 1.491 -1.427 0 C-N-CA 124.244 0.926 . . . . 0.0 111.135 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.83 -45.39 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.127 0.971 . . . . 0.0 109.562 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -64.78 -33.7 76.6 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.587 -1.32 . . . . 0.0 111.6 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.8 -53.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 124.098 0.959 . . . . 0.0 109.692 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -71.36 -20.91 62.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.832 0.825 . . . . 0.0 111.395 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 -33.54 31.0 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.084 -1.635 . . . . 0.0 110.082 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.16 -39.8 91.49 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.501 1.12 . . . . 0.0 110.622 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.3 m -66.88 -6.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 O-C-N 121.65 -0.656 . . . . 0.0 112.522 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.4 m -53.69 -25.69 19.4 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 125.66 1.584 . . . . 0.0 110.427 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.14 -43.27 74.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.56 -1.337 . . . . 0.0 112.764 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -42.33 58.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.39 1.076 . . . . 0.0 109.257 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.29 -34.3 77.1 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.156 0.503 . . . . 0.0 110.68 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.41 75.88 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.824 -1.173 . . . . 0.0 111.751 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -13.1 60.0 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.757 -1.214 . . . . 0.0 111.954 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.86 -35.93 81.16 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.615 1.197 . . . . 0.0 109.106 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -73.89 -35.53 64.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 119.794 -1.816 . . . . 0.0 112.068 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.92 -25.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 125.929 1.692 . . . . 0.0 109.229 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -56.47 -24.91 49.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.775 1.63 . . . . 0.0 112.71 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.71 -16.95 59.37 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.015 -1.053 . . . . 0.0 111.132 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--N 1.357 0.896 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.144 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.503 -0.857 0 CA-C-O 121.604 0.716 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -59.97 -31.95 70.36 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.849 1.26 . . . . 0.0 113.382 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -71.56 -34.03 69.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.038 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -70.69 -35.7 72.92 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 120.968 -1.082 . . . . 0.0 110.397 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.56 -35.32 67.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 -46.48 81.15 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.015 0.926 . . . . 0.0 111.334 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -66.53 -34.28 77.55 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.541 -0.725 . . . . 0.0 110.467 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.91 -41.3 99.4 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 109.996 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.87 80.72 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.652 0.781 . . . . 0.0 111.228 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.55 -31.88 73.29 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.478 -0.764 . . . . 0.0 111.957 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -70.75 -32.87 70.18 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.038 -1.038 . . . . 0.0 109.425 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.82 -34.25 77.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.88 -1.138 . . . . 0.0 109.395 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.23 -38.14 87.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.447 0.699 . . . . 0.0 110.24 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -58.42 -36.48 73.66 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 124.221 1.008 . . . . 0.0 111.766 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.23 -44.77 87.17 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.867 0.867 . . . . 0.0 110.057 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 -20.05 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 121.438 -0.789 . . . . 0.0 110.698 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.76 -48.76 79.23 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 119.564 1.074 . . . . 0.0 109.874 172.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.29 -40.5 90.07 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.06 -1.025 . . . . 0.0 110.347 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -63.55 -40.05 95.98 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.735 0.814 . . . . 0.0 111.277 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.63 98.58 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.204 1.401 . . . . 0.0 109.575 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -57.38 -35.28 69.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.187 1.395 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.71 -51.84 9.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.563 -0.711 . . . . 0.0 109.925 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -63.89 -28.61 69.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.58 -1.325 . . . . 0.0 110.796 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.75 94.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.408 1.083 . . . . 0.0 112.244 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.59 -14.69 13.77 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-O 122.35 1.071 . . . . 0.0 110.395 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -87.17 -38.61 16.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.726 -2.484 . . . . 0.0 107.862 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.22 65.79 6.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.014 1.726 . . . . 0.0 108.692 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -31.54 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.13 30.47 0.0 OUTLIER 'General case' 0 C--N 1.355 0.821 0 C-N-CA 130.527 3.531 . . . . 0.0 117.549 -168.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.84 36.66 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.12 156.69 35.74 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 119.062 1.431 . . . . 0.0 108.947 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -85.14 117.41 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.711 2.274 . . . . 0.0 112.517 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 31.35 26.34 Favored Glycine 0 CA--C 1.494 -1.269 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.84 137.87 47.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.034 0.933 . . . . 0.0 109.272 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.04 -37.99 8.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 123.529 0.732 . . . . 0.0 109.924 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.04 140.56 29.53 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 pt -156.35 37.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 CA-C-N 118.971 0.805 . . . . 0.0 109.164 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -137.59 -117.87 0.15 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 118.255 -2.778 . . . . 0.0 112.101 -158.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.68 -68.95 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.755 0 C-N-CA 128.487 2.715 . . . . 0.0 103.951 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.61 -20.05 27.32 Favored 'Trans proline' 0 CA--C 1.513 -0.55 0 CA-C-N 125.654 3.055 . . . . 0.0 111.419 -173.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.88 -25.31 61.88 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.649 1.18 . . . . 0.0 109.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.23 -36.51 79.62 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 123.542 0.737 . . . . 0.0 110.284 -167.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.89 -29.15 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.899 -0.501 . . . . 0.0 110.686 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -42.18 76.48 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.881 -1.137 . . . . 0.0 108.735 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -59.16 -48.01 83.21 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 110.09 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.5 m -57.89 -36.41 72.38 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.422 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.2 -53.69 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 123.762 0.825 . . . . 0.0 109.253 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.48 -20.88 63.73 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.279 1.038 . . . . 0.0 111.757 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -74.64 -39.77 61.89 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 120.664 -1.272 . . . . 0.0 109.253 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.29 66.91 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 120.712 -1.242 . . . . 0.0 111.933 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -1.18 56.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.646 0.778 . . . . 0.0 110.124 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 42.9 p 65.64 16.14 10.36 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.44 1.896 . . . . 0.0 111.92 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.98 -58.45 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . 62.2 56.36 22.57 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 174.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.408 ' CE2' ' HA2' ' C' ' 56' ' ' GLY . 6.2 t80 -57.43 -41.85 81.25 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.736 1.214 . . . . 0.0 110.422 -168.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.69 8.63 0.58 Allowed Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.13 -55.57 5.93 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 118.959 1.38 . . . . 0.0 111.734 -170.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.97 155.86 49.2 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -160.3 137.59 6.88 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -82.21 159.22 17.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 122.687 1.995 . . . . 0.0 112.119 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.263 34.9 m -106.33 -154.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 122.663 1.22 . . . . 0.0 111.32 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -73.41 -54.82 7.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.257 1.823 . . . . 0.0 111.434 -165.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -69.39 -16.84 63.6 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.154 1.782 . . . . 0.0 109.376 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -81.97 -18.5 43.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.53 93.34 0.65 Allowed Glycine 0 CA--C 1.483 -1.917 1 N-CA-C 102.129 -4.388 . . . . 0.0 102.129 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -53.72 -28.66 35.33 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 119.162 1.481 . . . . 0.0 110.709 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -58.16 -11.95 3.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.18 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 120.988 1.722 . . . . 0.0 109.756 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.57 -57.94 3.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -53.39 -38.89 63.82 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.089 1.356 . . . . 0.0 112.93 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -76.76 -24.56 52.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.953 -1.092 . . . . 0.0 111.104 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.16 -43.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.03 -49.95 75.96 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.236 1.014 . . . . 0.0 110.647 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -72.8 -15.72 61.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.877 -1.139 . . . . 0.0 112.162 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.18 65.5 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 120.051 -1.656 . . . . 0.0 108.626 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.05 -46.97 89.87 Favored Glycine 0 CA--C 1.492 -1.347 0 C-N-CA 124.676 1.131 . . . . 0.0 111.217 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.15 -48.5 65.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 C-N-CA 124.869 1.268 . . . . 0.0 110.421 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.35 -22.55 63.73 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 120.914 -1.116 . . . . 0.0 112.523 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.84 -53.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -62.83 -41.19 99.22 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.896 0.878 . . . . 0.0 110.439 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -30.53 71.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.766 0.826 . . . . 0.0 111.381 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.85 -30.36 67.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.965 -1.085 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.5 -14.87 11.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 120.843 -1.16 . . . . 0.0 110.324 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -61.28 -20.91 63.43 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.341 -2.099 . . . . 0.0 112.241 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.35 -17.39 62.54 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 120.47 -1.394 . . . . 0.0 111.593 172.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.5 -46.87 6.8 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 124.87 1.268 . . . . 0.0 108.605 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 55.0 mt -61.2 -38.49 86.75 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.294 -0.879 . . . . 0.0 112.414 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.87 0.13 19.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.038 -1.039 . . . . 0.0 111.212 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.1 p -97.94 -14.27 20.72 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 120.835 -1.166 . . . . 0.0 109.716 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.33 -18.86 60.64 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 119.557 1.071 . . . . 0.0 111.054 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -91.24 -16.76 27.11 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 120.658 -1.276 . . . . 0.0 112.295 170.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.43 -27.09 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -53.69 -22.35 8.85 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 126.028 1.731 . . . . 0.0 114.572 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -66.66 -28.0 68.12 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.585 -0.697 . . . . 0.0 110.063 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.441 -0.901 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.138 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 CA--C 1.486 -1.494 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.479 ' HE1' ' OE2' ' C' ' 5' ' ' GLU . 18.6 p80 -48.87 -35.83 15.64 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.497 1.919 . . . . 0.0 114.691 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.479 ' OE2' ' HE1' ' C' ' 4' ' ' HIS . 14.0 mt-10 -80.15 -33.57 38.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.316 -1.49 . . . . 0.0 110.567 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -73.31 -31.12 63.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.676 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.87 -49.81 69.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.148 2.179 . . . . 0.0 108.798 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.9 87.82 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.807 1.243 . . . . 0.0 112.067 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -60.17 -36.71 78.19 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.189 0.996 . . . . 0.0 111.174 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -74.66 -19.98 60.06 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.116 -0.99 . . . . 0.0 111.705 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.99 90.56 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.573 -0.704 . . . . 0.0 109.185 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -63.24 -39.0 93.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.682 1.193 . . . . 0.0 111.344 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.24 -39.83 71.43 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.762 0.825 . . . . 0.0 109.827 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.37 -31.21 71.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.405 1.082 . . . . 0.0 110.148 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.01 -47.96 73.98 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 125.505 1.522 . . . . 0.0 110.414 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.03 -35.56 80.89 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.519 0.727 . . . . 0.0 110.374 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -67.3 -49.33 64.68 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 111.308 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.9 -40.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 121.806 -0.558 . . . . 0.0 110.322 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.73 -35.06 72.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 O-C-N 122.02 -0.425 . . . . 0.0 109.99 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.82 -38.2 76.48 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 119.264 0.938 . . . . 0.0 111.465 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -20.62 46.25 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.103 -0.998 . . . . 0.0 108.399 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.04 46.75 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.958 -1.089 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m -52.48 -46.41 66.56 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 125.384 1.474 . . . . 0.0 111.528 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.72 -43.31 98.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 126.383 1.873 . . . . 0.0 108.859 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -71.48 -41.78 68.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 117.344 -1.312 . . . . 0.0 109.231 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.42 -51.8 67.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.874 1.215 . . . . 0.0 110.998 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.61 -37.23 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 O-C-N 121.617 -0.677 . . . . 0.0 110.538 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -75.39 -28.04 59.3 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.248 -1.533 . . . . 0.0 110.166 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.11 68.41 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.245 1.418 . . . . 0.0 109.335 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -2.15 58.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.5 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -67.34 95.66 0.45 Allowed 'General case' 0 C--N 1.357 0.897 0 O-C-N 120.981 -1.074 . . . . 0.0 109.653 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.76 6.05 30.84 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.96 152.6 68.9 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 118.586 1.193 . . . . 0.0 108.841 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.52 137.51 14.7 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.115 1.877 . . . . 0.0 110.217 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.15 70.58 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.54 155.21 19.08 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.455 1.902 . . . . 0.0 111.236 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.76 -22.59 0.87 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.675 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.29 37.34 2.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.655 1.982 . . . . 0.0 108.511 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.03 -15.77 20.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 50.8 m -89.68 124.89 35.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 121.163 -0.96 . . . . 0.0 112.47 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -67.21 -61.05 5.1 Favored Pre-proline 0 C--N 1.348 0.522 0 C-N-CA 127.059 2.143 . . . . 0.0 113.221 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -14.03 24.66 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 CA-C-N 125.679 3.064 . . . . 0.0 110.874 -172.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.36 -16.4 49.29 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 124.357 1.063 . . . . 0.0 108.73 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.03 74.22 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 123.469 0.708 . . . . 0.0 111.224 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.63 -31.99 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 123.753 0.821 . . . . 0.0 110.542 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.74 -34.39 69.49 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 119.758 -1.839 . . . . 0.0 109.282 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -72.33 -43.64 63.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -68.91 -28.0 66.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.779 -1.201 . . . . 0.0 112.051 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.8 t -56.52 -54.63 26.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 124.064 0.946 . . . . 0.0 109.967 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.68 -21.63 51.79 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.703 -0.623 . . . . 0.0 111.431 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -67.8 -39.22 84.04 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.126 0.97 . . . . 0.0 110.038 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.78 -22.93 62.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.889 -1.132 . . . . 0.0 111.631 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -91.92 4.02 53.89 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.607 -0.683 . . . . 0.0 110.199 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 56.9 p 49.38 41.77 21.14 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.859 2.064 . . . . 0.0 111.453 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.3 -66.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . 0.408 ' HA2' ' CE2' ' B' ' 57' ' ' TYR . . . 74.14 52.02 8.23 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 174.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -14.44 61.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.652 -0.911 . . . . 0.0 110.907 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.99 29.89 3.88 Favored Glycine 0 CA--C 1.49 -1.478 0 O-C-N 121.019 -1.051 . . . . 0.0 110.917 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -70.95 -59.77 2.6 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -138.87 173.36 11.65 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -143.96 144.81 27.89 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.74 164.36 14.0 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.543 2.829 . . . . 0.0 110.03 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.8 -162.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -91.17 -47.77 7.33 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.775 1.63 . . . . 0.0 107.548 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.13 2.19 18.8 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.556 1.542 . . . . 0.0 111.864 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.81 -27.31 63.78 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.296 1.998 . . . . 0.0 106.354 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.95 82.89 0.97 Allowed Glycine 0 CA--C 1.471 -2.673 1 N-CA-C 100.451 -5.06 . . . . 0.0 100.451 -170.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -57.79 -7.69 0.77 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.513 1.525 . . . . 0.0 112.768 -170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.74 -13.17 53.87 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 119.918 -1.739 . . . . 0.0 113.193 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.7 -58.39 5.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 120.821 1.646 . . . . 0.0 106.689 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.43 68.53 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.201 1.0 . . . . 0.0 112.627 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -62.44 -34.22 76.36 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.423 1.089 . . . . 0.0 111.654 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.56 -33.89 76.98 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.132 -1.605 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.25 -43.29 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 O-C-N 121.731 -0.605 . . . . 0.0 109.47 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.12 -49.79 76.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.458 1.103 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -66.29 -35.59 80.78 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.474 -0.766 . . . . 0.0 111.293 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.91 79.09 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.502 -0.749 . . . . 0.0 110.668 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.38 -45.66 77.25 Favored Glycine 0 CA--C 1.495 -1.178 0 C-N-CA 124.144 0.878 . . . . 0.0 111.584 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -44.94 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.312 1.045 . . . . 0.0 109.449 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -65.84 -24.82 66.97 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.118 -0.989 . . . . 0.0 112.288 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.37 -53.38 32.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 120.439 1.472 . . . . 0.0 109.418 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -71.81 -21.9 61.64 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.474 0.654 . . . . 0.0 111.211 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.79 -35.31 26.6 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.361 -0.837 . . . . 0.0 110.949 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.61 -35.28 77.11 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 119.939 -1.726 . . . . 0.0 110.78 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.33 -9.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 121.145 -0.972 . . . . 0.0 112.258 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 20.0 m -65.42 -9.69 27.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.647 1.179 . . . . 0.0 111.804 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.99 -58.21 9.17 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.441 -1.412 . . . . 0.0 110.532 166.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.1 86.84 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.978 -1.076 . . . . 0.0 110.692 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.25 -40.64 86.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.043 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -12.46 60.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 121.092 -1.005 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 7.3 m -82.21 -23.69 35.3 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.77 -35.39 79.99 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 120.903 -1.123 . . . . 0.0 110.504 -159.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -66.34 -26.52 67.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.795 -0.566 . . . . 0.0 112.196 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.32 -27.33 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 124.455 1.102 . . . . 0.0 108.228 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -59.73 -14.41 14.22 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.164 -0.96 . . . . 0.0 112.423 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.986 -1.071 . . . . 0.0 111.018 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -174.376 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -162.96 -92.31 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -168.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 1.9 p80 -63.97 -18.07 63.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.493 1.517 . . . . 0.0 113.343 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 35.3 mp0 -69.92 -34.16 73.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 120.652 -1.28 . . . . 0.0 109.582 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -73.47 -38.76 65.33 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.036 -1.04 . . . . 0.0 108.633 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.95 -42.51 99.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.64 87.59 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.6 1.16 . . . . 0.0 112.119 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.15 -42.36 94.74 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.261 0.625 . . . . 0.0 111.181 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.79 -38.2 90.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.177 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.81 89.62 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.41 -0.806 . . . . 0.0 111.014 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.83 -36.94 84.86 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.453 -0.78 . . . . 0.0 111.027 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.61 -29.99 70.65 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.548 1.139 . . . . 0.0 110.748 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -74.97 -38.44 61.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.561 1.144 . . . . 0.0 108.259 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.95 -45.73 93.54 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.571 0.748 . . . . 0.0 110.666 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -58.2 -31.42 67.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 112.67 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -69.78 -41.1 75.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.424 0.69 . . . . 0.0 109.677 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.39 -35.45 74.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 124.061 0.944 . . . . 0.0 109.175 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.38 -37.8 84.73 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 121.238 -0.914 . . . . 0.0 111.708 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -82.79 -16.89 46.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.514 0.726 . . . . 0.0 111.278 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -77.64 -46.34 22.36 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 168.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.37 74.38 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 126.327 1.851 . . . . 0.0 111.374 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -62.52 -44.35 96.57 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.388 0.675 . . . . 0.0 110.772 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -67.99 -50.09 57.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -61.47 -42.46 98.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.793 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.06 99.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.217 1.407 . . . . 0.0 111.673 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.8 -45.16 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 O-C-N 121.025 -1.047 . . . . 0.0 109.448 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -70.23 -27.82 64.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.317 -0.864 . . . . 0.0 110.703 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -57.03 4.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.421 1.889 . . . . 0.0 108.782 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.53 -32.44 74.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.095 0.958 . . . . 0.0 111.776 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -66.84 104.32 1.32 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.135 -1.603 . . . . 0.0 110.559 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.98 -28.29 3.7 Favored Glycine 0 CA--C 1.489 -1.556 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.52 145.01 70.89 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 123.351 0.661 . . . . 0.0 110.75 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -78.78 138.37 14.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.192 1.928 . . . . 0.0 110.231 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.06 80.91 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.439 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.84 147.95 36.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.813 1.245 . . . . 0.0 111.698 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.53 -37.7 2.48 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 tp -106.93 93.98 4.86 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.124 -0.985 . . . . 0.0 108.883 -173.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -135.58 57.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 120.229 -1.545 . . . . 0.0 109.047 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 30.9 t -150.31 135.03 17.5 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -68.82 -43.09 26.65 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 115.625 -2.131 . . . . 0.0 111.256 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -68.53 -28.18 32.19 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-N 126.106 3.216 . . . . 0.0 111.966 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.83 -17.65 31.06 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 118.957 0.799 . . . . 0.0 108.949 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.68 86.82 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 124.677 1.191 . . . . 0.0 112.039 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.54 -14.87 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 123.579 0.751 . . . . 0.0 110.305 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 -33.19 18.35 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 120.881 -1.137 . . . . 0.0 107.944 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -73.3 -40.02 64.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 15.0 p -76.18 59.05 1.31 Allowed 'General case' 0 C--N 1.358 0.943 0 O-C-N 121.234 -0.916 . . . . 0.0 111.419 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 72.0 t -133.48 -65.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 -21.41 65.26 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.505 0.722 . . . . 0.0 111.784 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -69.69 -28.91 66.25 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 121.507 -0.745 . . . . 0.0 110.394 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.17 -26.47 42.69 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.161 -0.962 . . . . 0.0 109.655 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 15.3 p -91.89 3.35 55.39 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.578 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 12.7 p 54.04 25.88 5.93 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.427 1.891 . . . . 0.0 113.095 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -86.22 -53.0 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.85 73.07 0.82 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -23.77 53.56 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.621 -1.517 . . . . 0.0 109.852 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.57 35.71 1.85 Allowed Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -155.2 176.37 12.65 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -149.2 145.92 20.29 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -80.3 165.78 20.84 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 CA-C-N 121.944 1.73 . . . . 0.0 110.527 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.29 -146.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.538 0 CA-C-N 119.218 0.917 . . . . 0.0 109.959 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -91.59 -54.09 4.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.273 -1.517 . . . . 0.0 109.849 -163.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -89.34 16.73 6.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.439 0.696 . . . . 0.0 109.608 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -30.29 62.6 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 163.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.34 83.48 1.18 Allowed Glycine 0 CA--C 1.476 -2.385 1 N-CA-C 99.583 -5.407 . . . . 0.0 99.583 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' D' ' 68' ' ' ARG . 20.1 ttm-85 -52.44 -18.57 1.71 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.056 1.742 . . . . 0.0 112.003 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -53.97 -28.22 36.2 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.504 2.322 . . . . 0.0 113.26 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.57 -53.2 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.391 0.677 . . . . 0.0 111.88 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.3 -46.65 55.53 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 126.233 1.813 . . . . 0.0 110.721 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.84 -38.06 89.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.493 0.717 . . . . 0.0 110.8 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.77 -39.05 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 123.446 0.698 . . . . 0.0 109.125 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -57.81 -52.91 63.53 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.984 1.314 . . . . 0.0 110.253 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.8 -38.0 89.47 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.033 0.533 . . . . 0.0 110.659 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.16 79.03 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.661 0.784 . . . . 0.0 111.58 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.81 -45.77 80.78 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.57 -48.97 85.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 C-N-CA 124.268 1.027 . . . . 0.0 108.932 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -57.03 -42.29 80.17 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.208 1.403 . . . . 0.0 112.503 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -65.56 -55.48 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 124.744 1.218 . . . . 0.0 109.248 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -67.26 -34.84 78.27 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.748 -0.595 . . . . 0.0 110.617 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.38 78.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.463 1.105 . . . . 0.0 111.135 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.65 -38.2 90.2 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 124.536 1.135 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.1 -14.5 7.75 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 125.128 1.371 . . . . 0.0 111.279 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 6.3 m -61.81 -20.59 63.79 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 119.376 -2.078 . . . . 0.0 111.696 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.66 66.73 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.684 -1.26 . . . . 0.0 111.336 171.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.91 -49.75 11.45 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.33 -32.25 73.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.736 0.814 . . . . 0.0 112.741 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.99 63.64 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.26 -1.525 . . . . 0.0 111.121 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -82.45 -11.02 58.8 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.701 -1.249 . . . . 0.0 111.225 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -32.55 74.17 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 119.454 1.024 . . . . 0.0 111.206 -171.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -77.17 -32.99 56.55 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.969 -1.082 . . . . 0.0 111.173 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.71 -26.64 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 125.884 1.674 . . . . 0.0 108.973 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -66.55 -5.73 12.47 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 112.331 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -69.16 -18.41 63.93 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 119.81 1.187 . . . . 0.0 110.997 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 -178.167 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.048 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -41.68 -57.87 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 128.786 2.835 . . . . 0.0 112.446 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -77.97 -19.21 54.94 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 125.082 1.353 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.93 -38.47 57.61 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -60.96 -35.31 76.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 123.816 0.846 . . . . 0.0 111.622 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -59.96 -41.93 92.98 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.737 2.015 . . . . 0.0 110.175 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -41.75 74.4 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.593 0.757 . . . . 0.0 110.263 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.39 -32.56 72.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.799 0.84 . . . . 0.0 111.408 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -71.94 -32.67 67.55 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.363 1.065 . . . . 0.0 110.527 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.123 0.569 . . . . 0.0 110.213 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -55.64 -42.84 75.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.709 1.204 . . . . 0.0 111.795 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -76.7 -29.89 56.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.777 -0.577 . . . . 0.0 109.578 -174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.22 -31.21 69.63 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.477 -0.764 . . . . 0.0 109.975 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.18 -43.1 92.15 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 121.725 -0.609 . . . . 0.0 111.326 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -62.46 -29.43 70.51 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.187 -0.946 . . . . 0.0 112.209 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.37 -31.62 67.53 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.654 -0.654 . . . . 0.0 110.267 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.65 -41.55 90.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.187 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.92 -42.81 85.57 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.914 0.886 . . . . 0.0 110.305 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.31 -42.7 99.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.378 -0.826 . . . . 0.0 111.699 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.16 -38.63 69.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.65 79.46 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 124.914 1.286 . . . . 0.0 111.639 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -66.56 -32.96 74.63 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 124.146 0.978 . . . . 0.0 111.124 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -70.75 -47.1 61.44 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 121.568 -0.708 . . . . 0.0 109.747 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -60.14 -50.39 73.88 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.129 0.972 . . . . 0.0 109.35 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.81 88.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.646 1.579 . . . . 0.0 112.554 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.88 -48.14 89.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.191 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.33 -29.02 61.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.41 -0.806 . . . . 0.0 111.216 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.16 91.53 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.079 1.352 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.43 -20.0 60.2 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.544 -0.722 . . . . 0.0 112.021 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -75.09 87.13 2.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 120.194 -1.566 . . . . 0.0 110.577 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.88 3.11 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.61 140.58 59.57 Favored Pre-proline 0 N--CA 1.442 -0.825 0 O-C-N 121.703 -0.881 . . . . 0.0 110.046 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.15 135.43 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.495 2.13 . . . . 0.0 110.245 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.86 24.75 68.71 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.67 144.59 56.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.085 0.954 . . . . 0.0 110.103 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.08 -34.47 2.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.79 131.66 36.99 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 pt -151.23 169.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 100.649 -3.834 . . . . 0.0 100.649 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t 76.89 134.07 0.06 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.963 1.705 . . . . 0.0 111.082 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -66.01 -49.48 56.9 Favored Pre-proline 0 C--N 1.352 0.701 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.072 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -70.21 -14.46 34.68 Favored 'Trans proline' 0 CA--C 1.514 -0.513 0 CA-C-N 125.308 2.932 . . . . 0.0 112.584 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.23 -43.14 12.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.97 77.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.235 1.014 . . . . 0.0 112.215 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.14 -16.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-O 121.714 0.769 . . . . 0.0 111.397 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -31.76 17.31 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 120.757 -1.214 . . . . 0.0 108.162 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.33 -40.02 94.97 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 120.795 -1.19 . . . . 0.0 110.244 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -67.05 -17.3 64.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.948 -1.095 . . . . 0.0 111.669 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.5 -51.09 67.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.682 1.193 . . . . 0.0 109.315 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.61 -7.41 50.08 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 124.07 0.948 . . . . 0.0 111.167 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.6 m -94.13 -45.11 7.69 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 120.36 -1.462 . . . . 0.0 107.058 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.01 70.15 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.308 -0.87 . . . . 0.0 112.325 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -91.77 3.83 54.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.272 67.8 p 59.53 -142.46 0.6 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.447 1.899 . . . . 0.0 107.334 -167.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t 75.63 -90.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.94 94.28 0.25 Allowed Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -80.07 -20.8 44.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.305 -1.703 . . . . 0.0 109.711 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.73 25.29 4.31 Favored Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.58 -48.19 34.74 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.277 1.539 . . . . 0.0 110.055 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.36 152.88 51.12 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.464 ' CD1' ' HD2' ' A' ' 62' ' ' PRO . 17.6 t80 -145.17 137.71 13.55 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 46.5 Cg_endo -80.97 168.17 17.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.908 2.405 . . . . 0.0 110.951 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -88.91 -111.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -134.83 -39.42 0.78 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 122.224 1.011 . . . . 0.0 109.225 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -79.28 -22.58 44.46 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.601 -1.312 . . . . 0.0 109.627 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -62.08 -32.03 72.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.075 1.75 . . . . 0.0 108.386 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.42 65.18 0.93 Allowed Glycine 0 CA--C 1.465 -3.081 1 N-CA-C 102.483 -4.247 . . . . 0.0 102.483 168.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -26.33 -26.39 0.0 OUTLIER 'General case' 0 C--N 1.363 1.185 1 C-N-CA 132.65 4.38 . . . . 0.0 116.851 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -49.34 -20.47 0.67 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.06 -42.92 94.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 124.954 1.301 . . . . 0.0 109.693 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -48.51 31.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.12 -50.82 19.46 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 126.463 1.905 . . . . 0.0 111.303 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.27 -35.53 81.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.427 0.632 . . . . 0.0 110.692 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.1 t -73.22 -37.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.41 -0.806 . . . . 0.0 109.14 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.5 mtt -61.83 -46.36 89.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 123.632 0.773 . . . . 0.0 109.656 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.48 -33.27 75.31 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.078 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.18 97.04 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 121.746 -0.596 . . . . 0.0 110.656 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.06 -46.93 77.5 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.35 -45.49 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 109.602 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.87 -36.38 83.72 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.855 -1.153 . . . . 0.0 110.681 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.03 -52.07 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 119.959 1.254 . . . . 0.0 110.563 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -70.47 -22.76 62.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.809 -0.557 . . . . 0.0 111.126 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.54 -32.94 23.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.382 -0.824 . . . . 0.0 110.546 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.43 -24.25 67.14 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.496 -1.377 . . . . 0.0 111.207 -172.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.17 -11.26 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.484 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.0 m -45.24 -29.68 1.04 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 127.826 2.45 . . . . 0.0 112.058 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.72 -39.77 52.64 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.406 1.482 . . . . 0.0 113.889 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 -36.12 6.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.94 1.296 . . . . 0.0 109.307 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.31 -41.57 66.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.736 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.21 -32.19 49.81 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 119.813 -1.805 . . . . 0.0 111.229 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -73.86 -0.36 15.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.529 -1.357 . . . . 0.0 110.003 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.24 -26.56 64.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 121.245 -0.909 . . . . 0.0 109.414 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -72.83 -33.4 66.15 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.454 -1.404 . . . . 0.0 110.634 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.17 -21.91 27.11 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.223 1.409 . . . . 0.0 109.171 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.39 -29.47 48.83 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 125.399 1.48 . . . . 0.0 112.247 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -65.57 -36.56 84.14 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.541 0.686 . . . . 0.0 110.479 -174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -170.757 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 122.065 0.936 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.54 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 3.5 p-80 -83.77 -23.64 31.44 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.58 -0.7 . . . . 0.0 110.601 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.16 -38.06 21.13 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -63.19 -47.61 81.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.225 1.41 . . . . 0.0 110.954 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -26.44 65.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.371 -0.83 . . . . 0.0 111.256 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.91 -35.44 74.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.319 -0.863 . . . . 0.0 110.657 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -64.74 -45.87 84.64 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.999 0.92 . . . . 0.0 109.231 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -64.34 -31.94 73.35 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.112 0.565 . . . . 0.0 111.534 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.93 81.62 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.755 0.822 . . . . 0.0 110.685 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' C' ' 76' ' ' LYS . 0.2 OUTLIER -68.44 -39.5 81.5 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.074 -178.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.53 -43.04 84.04 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 125.748 1.619 . . . . 0.0 110.484 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.37 -38.92 91.42 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.138 1.375 . . . . 0.0 110.079 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.3 -41.56 89.29 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 123.908 0.883 . . . . 0.0 111.391 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -63.91 -29.58 70.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.866 1.266 . . . . 0.0 110.73 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -76.08 -30.33 58.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.246 1.019 . . . . 0.0 110.217 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -70.35 -35.67 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 31.2 mt -61.76 -42.32 98.83 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.809 -0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -60.75 -45.54 93.9 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.086 0.857 . . . . 0.0 110.519 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -68.93 -40.18 79.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.874 0.845 . . . . 0.0 110.486 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -31.11 71.29 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.264 1.426 . . . . 0.0 111.256 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -66.0 -44.25 85.34 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.085 0.954 . . . . 0.0 110.199 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -61.03 -49.68 76.4 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.025 1.33 . . . . 0.0 107.785 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.83 -41.96 99.54 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.388 0.675 . . . . 0.0 111.232 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.21 91.38 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 124.892 1.277 . . . . 0.0 111.965 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.45 -40.97 73.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.17 -10.67 59.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.291 -1.506 . . . . 0.0 111.704 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' B' ' 67' ' ' GLY . . . -70.58 -21.25 62.7 Favored 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.907 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.97 -1.99 41.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.27 79.36 2.8 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.2 -41.6 0.71 Allowed Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.81 154.93 70.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 O-C-N 122.185 -0.597 . . . . 0.0 111.457 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.1 151.27 23.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.014 2.476 . . . . 0.0 110.41 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.61 41.23 65.54 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 136.64 57.92 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.376 1.071 . . . . 0.0 112.205 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.11 -57.28 2.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.62 97.95 10.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.094 0.95 . . . . 0.0 108.455 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.49 12.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -105.08 129.99 53.37 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -78.93 -57.81 0.75 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 127.257 2.223 . . . . 0.0 108.692 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.45 -13.89 25.13 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.344 2.944 . . . . 0.0 111.69 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -93.35 -10.34 35.65 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.397 0.998 . . . . 0.0 108.417 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.64 83.73 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.61 -1.306 . . . . 0.0 110.512 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.92 -9.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 124.454 1.102 . . . . 0.0 110.562 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.85 -41.08 16.37 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 120.14 -1.6 . . . . 0.0 107.28 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -68.87 -32.83 72.76 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.538 -0.727 . . . . 0.0 110.815 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 7.0 p -66.41 -17.41 64.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.978 -1.076 . . . . 0.0 111.586 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.76 -17.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.924 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -97.72 10.82 39.07 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.488 -1.383 . . . . 0.0 109.177 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -123.26 -173.75 2.79 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.45 -3.537 . . . . 0.0 101.45 173.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 77.24 -42.27 0.4 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 126.1 1.76 . . . . 0.0 111.095 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.0 p -81.19 2.75 26.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 126.22 1.808 . . . . 0.0 111.692 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p 52.07 59.3 4.63 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.826 2.051 . . . . 0.0 111.595 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.41 -77.01 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.08 66.49 1.96 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -72.45 -46.04 56.81 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.64 -105.48 0.24 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.327 5.2 t70 56.92 -72.63 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 128.271 2.628 . . . . 0.0 112.232 -163.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -163.59 1.35 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -173.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -153.24 153.49 29.52 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.6 168.41 9.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.331 3.354 . . . . 0.0 112.847 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 m -83.14 177.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.55 1.14 . . . . 0.0 112.442 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -83.21 -69.44 0.63 Allowed 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 125.475 1.51 . . . . 0.0 111.337 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.99 -37.5 64.07 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 124.611 1.165 . . . . 0.0 112.907 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -121.16 -107.62 0.36 Allowed 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 167.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' B' ' 29' ' ' ALA . . . 40.13 -73.55 0.0 OUTLIER Glycine 0 C--N 1.358 1.785 0 C-N-CA 129.748 3.547 . . . . 0.0 116.165 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.39 -37.86 87.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.363 2.665 . . . . 0.0 111.488 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.838 0.827 . . . . 0.0 109.275 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.05 -46.42 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.58 84.49 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.408 1.483 . . . . 0.0 111.603 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.67 -47.22 29.55 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.049 1.739 . . . . 0.0 110.938 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.72 -36.59 84.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.119 1.368 . . . . 0.0 110.283 -176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.33 -42.01 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.679 -0.638 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -60.59 -46.74 89.09 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -63.13 -38.3 90.62 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 122.121 -0.362 . . . . 0.0 111.158 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.02 80.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.159 0.584 . . . . 0.0 111.301 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.13 91.65 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 124.483 1.039 . . . . 0.0 111.214 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.08 -42.52 90.17 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 123.853 0.861 . . . . 0.0 108.707 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.81 -51.19 65.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 120.94 -1.1 . . . . 0.0 112.275 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.88 -41.32 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 112.144 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -74.15 -38.51 63.7 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.25 -32.18 71.22 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.69 -31.88 62.8 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.759 1.223 . . . . 0.0 111.406 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.9 -12.05 8.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.666 1.186 . . . . 0.0 111.099 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 16.2 m -64.4 -24.82 67.77 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 118.897 -2.377 . . . . 0.0 110.761 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.58 -20.35 65.99 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.154 -1.591 . . . . 0.0 111.318 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.54 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -90.27 -40.71 11.99 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.38 1.072 . . . . 0.0 108.913 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.96 -31.75 51.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 122.785 0.434 . . . . 0.0 111.545 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.29 -23.02 66.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.122 -0.986 . . . . 0.0 111.374 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . 0.343 0.6 OUTLIER -83.36 -10.72 58.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.916 -1.115 . . . . 0.0 109.47 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.275 46.1 m-20 -82.46 -2.68 54.02 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.458 -1.401 . . . . 0.0 111.801 -172.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.19 -35.88 15.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.27 -1.519 . . . . 0.0 108.538 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 t -66.84 -25.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 125.074 1.349 . . . . 0.0 110.224 -169.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -63.58 -8.92 11.02 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.422 -0.799 . . . . 0.0 112.844 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -66.34 -32.85 74.49 Favored 'General case' 0 C--N 1.359 1.004 0 O-C-N 120.851 -1.156 . . . . 0.0 110.068 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -172.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 CA--C 1.492 -1.258 0 CA-C-O 121.913 0.863 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.497 ' CE1' HG23 ' C' ' 91' ' ' THR . 4.5 p80 -67.07 -27.83 67.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.56 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.61 -42.88 57.83 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -65.75 -37.71 87.12 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.827 -1.171 . . . . 0.0 110.826 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.87 -31.44 72.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.379 1.072 . . . . 0.0 110.987 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.84 -47.68 71.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.729 0.812 . . . . 0.0 110.203 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.357 -0.839 . . . . 0.0 111.615 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -65.44 -39.63 92.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.873 1.269 . . . . 0.0 109.311 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.4 82.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.896 0.878 . . . . 0.0 110.681 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -55.53 -42.76 75.03 Favored 'General case' 0 C--N 1.36 1.03 0 CA-C-O 121.667 0.746 . . . . 0.0 110.829 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -60.93 -39.38 89.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.139 1.376 . . . . 0.0 110.363 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.98 -34.2 76.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.149 0.979 . . . . 0.0 109.505 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.47 -40.33 89.29 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.819 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.31 -28.02 68.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.558 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -66.04 -39.77 90.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.977 0.911 . . . . 0.0 110.181 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.7 -35.15 74.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 124.247 1.019 . . . . 0.0 109.198 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.57 -35.67 80.22 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 121.29 -0.881 . . . . 0.0 111.898 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.8 -32.62 59.94 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.137 0.575 . . . . 0.0 110.337 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 -42.06 59.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.12 -0.987 . . . . 0.0 108.767 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -36.01 78.24 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.758 1.623 . . . . 0.0 111.895 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -69.4 -36.63 76.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.909 -0.494 . . . . 0.0 110.299 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -67.58 -38.03 83.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -66.19 -55.24 17.24 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.0 68.69 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.739 1.215 . . . . 0.0 111.984 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.68 -43.92 96.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 O-C-N 119.962 -1.712 . . . . 0.0 111.985 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.79 -34.99 20.99 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 121.211 -0.931 . . . . 0.0 109.274 -171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.37 -50.77 58.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.552 1.941 . . . . 0.0 109.546 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.04 -24.1 62.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.236 -0.915 . . . . 0.0 111.637 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.95 95.19 6.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.455 -1.403 . . . . 0.0 111.918 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.46 -7.57 4.98 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.71 148.02 37.53 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 123.577 0.751 . . . . 0.0 109.788 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -77.69 103.46 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.895 2.397 . . . . 0.0 113.051 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 -52.44 0.72 Allowed Glycine 0 CA--C 1.477 -2.324 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.719 2.008 . . . . 0.0 110.901 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.34 -91.62 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.92 127.14 31.62 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.27 131.18 1.84 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 169.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.86 -49.03 60.83 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.038 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.0 -5.52 17.13 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 CA-C-N 124.777 2.742 . . . . 0.0 111.955 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -99.88 -29.27 12.68 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.67 76.32 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 111.939 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.71 -36.89 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 123.418 0.687 . . . . 0.0 110.222 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -30.22 60.59 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.474 -1.391 . . . . 0.0 109.92 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -72.85 -32.05 65.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.984 0.897 . . . . 0.0 109.124 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -67.04 -42.24 85.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.279 -0.888 . . . . 0.0 110.358 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -67.66 -23.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 C-N-CA 124.155 0.982 . . . . 0.0 112.87 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.4 -13.72 51.4 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 120.07 -1.644 . . . . 0.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -104.61 -175.02 2.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . 79.47 -33.63 0.14 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 126.952 2.101 . . . . 0.0 110.672 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.1 p -89.73 3.78 51.69 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 125.956 1.703 . . . . 0.0 111.949 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.278 41.5 p 52.43 63.87 2.07 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.503 1.921 . . . . 0.0 111.917 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.21 -107.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 1 N-CA-C 98.546 -4.613 . . . . 0.0 98.546 173.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.3 87.48 1.09 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 106.651 -2.58 . . . . 0.0 106.651 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -69.2 -45.63 69.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.357 1.075 . . . . 0.0 109.118 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.44 48.48 0.28 Allowed Glycine 0 CA--C 1.485 -1.797 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.492 ' CG ' HH22 ' D' ' 68' ' ' ARG . 34.8 t70 -73.48 -45.35 54.59 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -132.96 -154.2 0.6 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.83 142.86 2.04 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 100.829 -3.767 . . . . 0.0 100.829 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.07 179.8 3.53 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 123.664 2.344 . . . . 0.0 107.49 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.432 ' H ' ' CG ' ' C' ' 66' ' ' GLU . 2.7 t -100.6 -121.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.405 1.482 . . . . 0.0 110.118 -168.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 73.4 m -136.48 -38.8 0.66 Allowed 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.692 -1.255 . . . . 0.0 108.584 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -86.17 -6.11 59.06 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.979 -1.076 . . . . 0.0 109.834 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.432 ' CG ' ' H ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -63.98 -36.83 85.24 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 123.216 1.484 . . . . 0.0 107.373 175.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.94 62.41 0.85 Allowed Glycine 0 CA--C 1.464 -3.111 1 N-CA-C 100.643 -4.983 . . . . 0.0 100.643 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -26.86 -25.2 0.0 OUTLIER 'General case' 0 C--N 1.36 1.04 1 C-N-CA 132.989 4.516 . . . . 0.0 117.778 -175.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -52.87 -15.44 0.75 Allowed 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 161.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.23 -44.39 87.84 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 O-C-N 120.153 -1.592 . . . . 0.0 109.294 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.59 66.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 123.142 0.577 . . . . 0.0 109.681 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . 0.258 1.1 pp20? -65.38 -33.72 76.63 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 121.799 -0.563 . . . . 0.0 111.836 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.31 -36.99 79.18 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 121.55 0.691 . . . . 0.0 110.624 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.3 t -72.77 -37.82 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.507 -0.745 . . . . 0.0 109.477 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 50.8 mtt -64.42 -47.91 77.34 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 123.856 0.863 . . . . 0.0 109.55 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' B' ' 12' ' ' GLU . 33.9 ttmt -61.83 -40.58 95.79 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.425 0.69 . . . . 0.0 110.747 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.05 94.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.546 0.738 . . . . 0.0 110.872 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.64 78.09 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.28 -49.54 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 124.195 0.998 . . . . 0.0 108.943 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.83 -39.19 87.56 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 118.531 0.605 . . . . 0.0 111.474 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.32 -54.85 28.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 119.331 0.969 . . . . 0.0 110.4 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.58 -14.02 60.03 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 111.737 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.94 -37.62 22.07 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.623 -1.298 . . . . 0.0 108.035 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.97 -33.63 72.2 Favored 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 124.996 1.318 . . . . 0.0 111.738 -175.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -64.56 -5.31 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 O-C-N 121.335 -0.853 . . . . 0.0 112.663 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 26.3 m -59.2 -18.52 37.32 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.742 1.217 . . . . 0.0 111.167 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.62 68.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.847 -1.783 . . . . 0.0 113.104 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.58 -43.46 13.47 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.0 -38.86 92.6 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.079 0.942 . . . . 0.0 111.318 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.29 -20.32 62.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.982 -1.073 . . . . 0.0 111.833 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.497 HG23 ' CE1' ' C' ' 4' ' ' HIS . 9.7 t -99.52 7.71 45.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.4 -45.34 60.14 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.833 1.197 . . . . 0.0 107.978 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -63.09 -34.62 77.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.48 -0.762 . . . . 0.0 111.556 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.03 -23.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.007 1.723 . . . . 0.0 110.033 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -65.48 -16.16 63.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.1 -1.0 . . . . 0.0 111.435 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -64.19 -25.2 67.97 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.32 -0.862 . . . . 0.0 111.833 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 . . . . . 0 C--N 1.356 0.864 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.782 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.16 -45.63 84.16 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 123.199 1.476 . . . . 0.0 109.657 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 17.2 p-80 -69.93 -17.48 63.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.079 1.352 . . . . 0.0 111.917 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -77.11 -40.12 46.99 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -55.55 -50.59 69.61 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.195 1.398 . . . . 0.0 110.485 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.88 -37.9 87.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.938 0.895 . . . . 0.0 109.667 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.55 95.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.553 0.741 . . . . 0.0 111.643 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -68.33 -36.7 79.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.669 -0.644 . . . . 0.0 110.774 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -68.12 -35.09 77.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.705 -0.622 . . . . 0.0 111.039 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.14 98.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.363 1.065 . . . . 0.0 111.104 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -66.76 -35.44 80.11 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.323 -0.86 . . . . 0.0 111.636 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -72.42 -34.12 67.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.676 -1.265 . . . . 0.0 111.161 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -64.84 -35.19 80.31 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.831 1.252 . . . . 0.0 108.844 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -63.22 -39.15 93.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.454 -0.779 . . . . 0.0 111.11 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.13 -21.58 63.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.615 -1.303 . . . . 0.0 112.035 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.4 -36.11 71.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.626 0.727 . . . . 0.0 110.464 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.35 -26.25 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 O-C-N 119.854 -1.779 . . . . 0.0 110.358 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.28 -46.13 90.16 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 121.957 0.884 . . . . 0.0 110.864 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.1 -39.15 86.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.52 -1.363 . . . . 0.0 110.177 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.87 96.02 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.361 1.065 . . . . 0.0 110.798 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.69 76.43 Favored 'General case' 0 CA--C 1.496 -1.123 0 O-C-N 121.301 -0.874 . . . . 0.0 111.469 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -65.06 -44.1 90.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 110.496 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.86 -53.32 48.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 125.124 1.37 . . . . 0.0 109.547 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -65.69 -37.98 87.95 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.308 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.91 83.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 124.37 1.068 . . . . 0.0 111.747 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.14 -50.05 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-N 118.509 0.595 . . . . 0.0 109.857 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -72.43 -31.59 65.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.447 -0.783 . . . . 0.0 110.732 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.49 67.83 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.955 0.902 . . . . 0.0 109.326 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.9 -40.61 96.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 125.482 1.513 . . . . 0.0 110.219 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.76 91.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.928 1.291 . . . . 0.0 112.387 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.65 -5.84 7.5 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.07 59.15 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 118.677 1.238 . . . . 0.0 111.76 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -80.82 137.54 11.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.585 2.19 . . . . 0.0 110.692 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.46 78.15 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 165.2 24.4 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.921 1.289 . . . . 0.0 111.292 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.9 32.51 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 121.808 -0.557 . . . . 0.0 110.472 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -145.14 74.43 1.4 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 120.792 -1.192 . . . . 0.0 107.912 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.67 165.19 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 O-C-N 120.948 -1.095 . . . . 0.0 108.197 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t 81.39 131.37 0.05 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.64 1.576 . . . . 0.0 112.201 165.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -62.69 -42.51 79.16 Favored Pre-proline 0 C--N 1.349 0.581 0 CA-C-O 116.864 -1.541 . . . . 0.0 113.328 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -69.06 -24.56 32.76 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 CA-C-N 124.158 2.521 . . . . 0.0 112.404 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 -32.94 19.98 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 124.745 1.218 . . . . 0.0 107.96 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.07 73.45 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.44 -32.95 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 121.729 -0.607 . . . . 0.0 110.118 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -36.18 76.87 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -65.44 -37.6 87.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.848 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -64.56 -44.42 90.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.464 -0.772 . . . . 0.0 109.491 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.86 64.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.705 0 CA-C-O 121.767 0.794 . . . . 0.0 110.856 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -162.42 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -68.48 -36.65 79.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.099 -1.001 . . . . 0.0 110.964 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.05 65.31 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.281 -0.887 . . . . 0.0 111.681 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -93.79 15.21 17.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 33.0 p 47.34 54.47 9.5 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 126.066 1.746 . . . . 0.0 113.06 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.515 HG11 ' H ' ' D' ' 56' ' ' GLY . 1.0 OUTLIER -121.12 -82.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 178.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.515 ' H ' HG11 ' D' ' 55' ' ' VAL . . . 77.78 64.61 2.02 Favored Glycine 0 CA--C 1.491 -1.426 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.82 -27.86 64.19 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.231 1.015 . . . . 0.0 109.899 -165.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.66 31.14 0.16 Allowed Glycine 0 CA--C 1.486 -1.779 0 O-C-N 120.728 -1.232 . . . . 0.0 110.776 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -81.71 -76.06 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 118.751 1.275 . . . . 0.0 110.837 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -128.54 159.42 35.56 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.31 149.23 18.29 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -73.94 149.89 42.83 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.361 2.707 . . . . 0.0 111.534 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.454 HG12 ' HG1' ' D' ' 64' ' ' THR . 14.7 t -86.38 -93.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 124.116 0.966 . . . . 0.0 111.03 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.454 ' HG1' HG12 ' D' ' 63' ' ' VAL . 28.8 m -140.04 -52.58 0.51 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.734 -1.229 . . . . 0.0 108.468 -166.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.73 -16.77 46.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.674 1.189 . . . . 0.0 109.587 -168.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 1.4 pm0 -73.74 -7.27 51.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.09 88.49 0.4 Allowed Glycine 0 CA--C 1.477 -2.303 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.492 HH22 ' CG ' ' C' ' 59' ' ' ASP . 24.9 ttm180 -60.78 -19.77 60.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.39 -1.653 . . . . 0.0 111.235 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -54.57 -16.62 2.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.685 1.194 . . . . 0.0 113.403 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.01 -39.23 84.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 119.992 -1.692 . . . . 0.0 109.229 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -39.84 70.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.115 -0.991 . . . . 0.0 109.922 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -38.01 79.36 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-O 121.876 0.846 . . . . 0.0 110.53 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -29.93 66.56 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.62 -0.675 . . . . 0.0 111.601 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.67 -46.4 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 121.053 -1.029 . . . . 0.0 108.718 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.23 -39.82 89.83 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 122.003 -0.436 . . . . 0.0 110.124 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.56 -47.19 87.29 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.083 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.29 72.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 122.951 0.5 . . . . 0.0 111.275 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -44.22 89.31 Favored Glycine 0 CA--C 1.496 -1.143 0 O-C-N 121.506 -0.746 . . . . 0.0 111.638 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.56 -46.5 95.46 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 124.357 1.063 . . . . 0.0 108.79 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.43 -46.33 69.78 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.075 1.35 . . . . 0.0 111.24 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.21 -57.35 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 C-N-CA 124.929 1.292 . . . . 0.0 110.522 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -66.78 -35.98 81.34 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.42 -0.8 . . . . 0.0 110.467 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.39 95.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.998 0.919 . . . . 0.0 110.863 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.87 -39.9 95.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.71 -15.82 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.422 1.489 . . . . 0.0 111.137 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -59.24 -13.9 9.2 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.623 1.169 . . . . 0.0 111.544 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.27 -48.44 78.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 119.905 -1.747 . . . . 0.0 112.395 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.516 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -68.51 -35.72 77.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 O-C-N 121.348 -0.845 . . . . 0.0 110.156 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.06 -32.65 63.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.42 0.688 . . . . 0.0 110.055 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.43 75.8 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.077 -1.639 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -14.48 62.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.782 -1.199 . . . . 0.0 113.128 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.21 -32.68 74.47 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 120.576 1.535 . . . . 0.0 111.032 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -77.69 -28.64 51.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.064 -1.023 . . . . 0.0 111.421 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -68.86 -24.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 125.291 1.436 . . . . 0.0 108.347 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -59.48 -12.05 5.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.501 1.52 . . . . 0.0 113.797 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -72.88 -33.13 65.86 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 121.169 -0.957 . . . . 0.0 111.569 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.438 -1.074 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.069 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.56 -68.17 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -42.65 86.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.047 2.539 . . . . 0.0 112.08 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 2.3 pm0 -71.0 -26.24 63.04 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.661 0.785 . . . . 0.0 110.585 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.5 -37.04 77.02 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -71.32 -35.05 71.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.309 0.576 . . . . 0.0 109.863 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.0 95.95 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 121.411 -0.805 . . . . 0.0 111.362 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -71.77 -28.81 63.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 121.385 -0.822 . . . . 0.0 111.535 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -69.92 -37.52 75.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.898 -1.126 . . . . 0.0 109.361 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.73 97.36 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.98 0.912 . . . . 0.0 111.363 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -63.0 -36.68 84.37 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.44 -0.787 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.11 -35.36 69.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.028 -1.045 . . . . 0.0 110.792 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.29 -32.82 74.57 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.26 -42.31 98.41 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.924 -1.11 . . . . 0.0 111.61 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -64.31 -28.31 69.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.677 1.191 . . . . 0.0 111.212 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -69.59 -33.76 73.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.899 1.28 . . . . 0.0 110.452 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -71.62 -29.58 35.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.99 -1.068 . . . . 0.0 108.641 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.21 -29.8 66.74 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.01 -1.056 . . . . 0.0 111.223 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -71.31 -33.6 69.83 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.47 1.508 . . . . 0.0 110.329 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -72.44 -45.47 59.45 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 120.388 -1.445 . . . . 0.0 108.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.02 84.87 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 126.233 1.813 . . . . 0.0 111.483 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -67.6 -38.26 83.72 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 122.655 0.382 . . . . 0.0 110.269 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.959 0.904 . . . . 0.0 109.575 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -67.11 -55.0 16.14 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -41.25 73.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 125.688 1.595 . . . . 0.0 113.015 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.16 -37.1 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 O-C-N 120.735 -1.228 . . . . 0.0 112.582 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.67 -34.2 30.87 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.6 -53.72 37.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.543 1.537 . . . . 0.0 109.219 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.38 12.16 5.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.927 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -71.81 94.87 1.45 Allowed 'General case' 0 C--N 1.351 0.664 0 O-C-N 119.672 -1.892 . . . . 0.0 109.626 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.62 61.86 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 150.13 51.7 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -76.33 145.03 26.66 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 122.836 2.358 . . . . 0.0 108.807 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.25 5.22 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 118.956 0.798 . . . . 0.0 112.575 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 151.79 39.5 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 126.361 1.865 . . . . 0.0 110.039 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.75 6.75 0.54 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.075 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.03 -58.13 3.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.9 pt 34.97 29.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 119.228 3.047 . . . . 0.0 119.228 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -162.98 156.61 19.98 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 119.941 -1.724 . . . . 0.0 106.874 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.88 -44.78 0.61 Allowed Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.671 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.26 -17.6 16.76 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 CA-C-N 125.962 3.165 . . . . 0.0 111.413 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.0 -14.77 24.05 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.478 1.111 . . . . 0.0 109.047 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.43 98.53 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.934 0.873 . . . . 0.0 111.766 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.41 -11.68 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.57 0.7 . . . . 0.0 109.769 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.13 -41.58 15.56 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.08 -27.95 60.13 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.714 -0.617 . . . . 0.0 111.02 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.6 p -66.97 -20.27 65.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.518 -1.364 . . . . 0.0 111.924 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.47 -18.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.291 1.037 . . . . 0.0 109.844 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -73.19 -42.05 63.13 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 120.367 -1.458 . . . . 0.0 108.337 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.3 t -85.32 -167.76 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 78.98 -31.16 0.14 Allowed 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 127.179 2.192 . . . . 0.0 111.115 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 p -66.27 -24.53 66.58 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 129.834 3.254 . . . . 0.0 110.191 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.358 28.7 p 64.29 37.49 8.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 129.696 3.198 . . . . 0.0 109.712 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.85 147.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 167.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.51 130.82 5.82 Favored Glycine 0 CA--C 1.474 -2.529 1 N-CA-C 95.085 -7.206 . . . . 0.0 95.085 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -87.51 -36.5 17.59 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.38 47.65 0.25 Allowed Glycine 0 CA--C 1.479 -2.186 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 168.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.99 -55.78 6.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.53 1.165 . . . . 0.0 108.448 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -112.81 171.19 7.68 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -140.12 110.88 7.16 Favored Pre-proline 0 N--CA 1.445 -0.715 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.07 175.49 11.09 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.451 2.768 . . . . 0.0 109.835 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -143.13 176.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -63.48 -36.61 84.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 113.106 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.25 -27.94 61.86 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.77 0.828 . . . . 0.0 110.026 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -66.58 -30.43 70.73 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 123.577 1.656 . . . . 0.0 106.829 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 75.78 1.3 Allowed Glycine 0 CA--C 1.463 -3.174 1 N-CA-C 99.53 -5.428 . . . . 0.0 99.53 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -46.12 -13.77 0.02 OUTLIER 'General case' 0 C--N 1.367 1.342 0 C-N-CA 128.742 2.817 . . . . 0.0 114.22 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -54.19 -18.3 3.69 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 126.992 2.117 . . . . 0.0 114.131 162.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.88 -52.9 24.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-N 120.892 1.678 . . . . 0.0 107.442 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.43 80.32 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 118.386 0.539 . . . . 0.0 111.658 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.48 -47.15 66.69 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 126.614 1.966 . . . . 0.0 111.449 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -62.68 -41.57 99.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.469 -0.769 . . . . 0.0 109.556 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.2 -36.17 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.09 0.556 . . . . 0.0 110.012 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.3 mtt -58.59 -53.12 61.9 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.296 0.638 . . . . 0.0 109.921 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' D' ' 12' ' ' GLU . 63.6 tttp -62.94 -40.11 96.64 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 122.931 0.492 . . . . 0.0 110.336 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.54 79.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.684 0.793 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.74 -45.17 59.69 Favored Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 124.75 1.166 . . . . 0.0 111.144 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -57.66 -45.83 86.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.237 1.015 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -57.31 -43.75 83.52 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.599 0.76 . . . . 0.0 110.562 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.92 -52.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 124.429 1.091 . . . . 0.0 109.451 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.15 -39.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 121.903 -0.498 . . . . 0.0 110.632 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.46 94.33 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 110.776 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.05 -33.38 75.3 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 124.771 1.228 . . . . 0.0 111.616 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.5 -18.08 13.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.806 1.242 . . . . 0.0 110.707 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -58.75 -22.99 59.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.05 -1.656 . . . . 0.0 112.134 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.17 -24.09 66.98 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.295 -1.503 . . . . 0.0 111.859 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.79 -43.08 11.51 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.008 0.923 . . . . 0.0 108.561 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.9 -39.58 94.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 122.006 0.907 . . . . 0.0 111.552 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -24.74 63.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.607 0.763 . . . . 0.0 112.294 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.9 t -90.72 -2.81 57.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.5 -41.49 72.57 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 120.534 1.516 . . . . 0.0 108.93 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -70.45 -22.2 62.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.732 -1.23 . . . . 0.0 112.978 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.66 -24.98 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.301 1.04 . . . . 0.0 108.783 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -59.0 -19.4 43.15 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 125.626 1.57 . . . . 0.0 113.309 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -72.83 -28.17 62.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.862 -1.149 . . . . 0.0 109.234 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 CA--C 1.502 -0.904 0 O-C-N 120.944 -1.098 . . . . 0.0 108.634 -179.125 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 CA--C 1.497 -1.084 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.41 ' CG ' ' HA ' ' B' ' 88' ' ' ALA . 10.9 p80 -55.45 -23.18 24.0 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -68.52 -28.38 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.278 -0.889 . . . . 0.0 109.246 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.42 -23.31 40.43 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.17 -0.956 . . . . 0.0 110.966 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -83.05 -41.5 18.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.22 76.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 112.024 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -61.75 -49.12 77.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.589 1.155 . . . . 0.0 109.784 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -64.56 -35.86 82.35 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.698 0.799 . . . . 0.0 110.551 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -44.74 94.69 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -63.55 -43.25 97.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.256 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 123.33 0.652 . . . . 0.0 110.062 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . 0.295 4.1 tt0 -77.13 -11.89 59.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.213 -0.929 . . . . 0.0 112.127 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -70.22 -35.04 73.6 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -60.35 -35.66 76.18 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.845 0.858 . . . . 0.0 110.736 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.7 -39.88 95.41 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.726 1.21 . . . . 0.0 109.923 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.05 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 O-C-N 121.379 -0.826 . . . . 0.0 109.526 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.56 -40.19 96.04 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.903 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.47 -44.29 78.94 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.117 -0.989 . . . . 0.0 109.532 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.87 -39.15 90.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.758 1.223 . . . . 0.0 110.477 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.27 77.22 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 126.025 1.73 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -66.43 -44.1 83.81 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.3 1.04 . . . . 0.0 110.197 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -65.44 -53.72 38.83 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.49 1.116 . . . . 0.0 108.68 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -57.39 -48.6 78.65 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.699 1.199 . . . . 0.0 110.698 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 -41.86 65.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 125.057 1.343 . . . . 0.0 111.666 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.22 -47.08 82.6 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.797 -1.189 . . . . 0.0 107.949 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.34 -1.89 38.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.06 -1.025 . . . . 0.0 110.918 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.76 61.23 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 109.594 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -80.06 -110.93 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 71.18 -33.34 0.27 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.754 2.022 . . . . 0.0 113.515 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.15 41.05 0.38 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.07 153.86 39.03 Favored Pre-proline 0 C--N 1.35 0.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.75 123.21 3.21 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 C-N-CA 123.265 2.643 . . . . 0.0 111.43 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 23.0 53.05 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.94 33.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 126.851 2.061 . . . . 0.0 111.157 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -37.63 0.22 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.873 0.469 . . . . 0.0 110.528 -172.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.98 60.32 4.76 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-O 124.011 1.862 . . . . 0.0 107.865 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.72 -14.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 O-C-N 120.051 -1.656 . . . . 0.0 112.255 -168.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -99.2 132.41 44.53 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.061 -1.649 . . . . 0.0 112.399 -167.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.36 -54.41 11.4 Favored Pre-proline 0 C--N 1.351 0.644 0 CA-C-O 116.619 -1.658 . . . . 0.0 109.606 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.89 -13.07 24.14 Favored 'Trans proline' 0 CA--C 1.508 -0.815 0 CA-C-N 125.552 3.018 . . . . 0.0 111.297 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.51 -10.83 26.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.62 95.07 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.97 -28.72 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 123.989 0.916 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -37.87 62.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.117 0.967 . . . . 0.0 108.793 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -66.69 -43.17 85.11 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.779 0.831 . . . . 0.0 109.475 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 42.0 m -53.53 -30.4 41.47 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.988 1.315 . . . . 0.0 113.572 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.34 -34.87 51.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.435 1.094 . . . . 0.0 110.715 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -77.81 -36.46 50.25 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.842 -1.161 . . . . 0.0 113.174 -171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -77.26 -37.32 53.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -166.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.11 -26.8 64.14 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.522 -0.736 . . . . 0.0 112.071 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.403 ' HG1' HG22 ' B' ' 55' ' ' VAL . 3.3 p -89.23 7.43 35.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p 55.08 64.07 1.91 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.62 1.568 . . . . 0.0 111.778 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' HG1' ' B' ' 53' ' ' THR . 22.3 t -122.71 -106.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 76.55 1.28 Allowed Glycine 0 CA--C 1.484 -1.866 0 N-CA-C 104.634 -3.387 . . . . 0.0 104.634 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -35.78 58.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.65 -0.912 . . . . 0.0 108.911 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 39.45 0.73 Allowed Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.401 ' HB2' HH12 ' C' ' 68' ' ' ARG . 6.5 t70 -77.72 -51.23 10.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 118.554 1.177 . . . . 0.0 108.69 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.32 160.16 38.78 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -130.79 114.45 16.62 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.62 173.08 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.582 2.854 . . . . 0.0 109.349 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.25 -112.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.021 0.929 . . . . 0.0 110.735 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.0 m -136.33 -41.16 0.64 Allowed 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.658 -1.276 . . . . 0.0 108.627 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -81.72 -2.67 51.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.202 -0.936 . . . . 0.0 109.277 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -29.52 43.42 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.01 69.66 1.26 Allowed Glycine 0 CA--C 1.47 -2.77 0 N-CA-C 103.795 -3.722 . . . . 0.0 103.795 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -36.03 -18.49 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.444 3.498 . . . . 0.0 116.869 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -53.12 -17.57 1.66 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 119.988 -1.695 . . . . 0.0 113.132 158.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.13 -46.29 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 119.56 -1.962 . . . . 0.0 108.756 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.61 -48.73 63.37 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.59 -47.05 77.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.38 1.072 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -69.85 -37.82 76.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.307 -0.871 . . . . 0.0 112.356 -173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.35 -43.73 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ttp -62.14 -51.03 69.5 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.298 1.039 . . . . 0.0 110.537 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.31 -30.96 70.95 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.631 0.772 . . . . 0.0 110.044 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.5 73.88 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.331 -0.856 . . . . 0.0 111.12 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.19 85.95 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 mt -60.61 -45.29 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 C-N-CA 124.307 1.043 . . . . 0.0 109.562 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -29.27 70.35 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.111 -0.993 . . . . 0.0 112.078 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.08 -54.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -62.52 -42.19 99.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.728 0.811 . . . . 0.0 110.69 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.11 79.25 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.079 1.352 . . . . 0.0 111.158 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tt -66.77 -34.18 77.27 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.109 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.07 -10.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 124.451 1.101 . . . . 0.0 110.236 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 8.4 m -60.7 -22.98 64.51 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 119.303 -2.123 . . . . 0.0 111.49 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.65 69.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.327 -1.483 . . . . 0.0 111.811 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' B' ' 4' ' ' HIS . . . -80.27 -45.63 17.6 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.12 -37.8 88.65 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 124.5 1.12 . . . . 0.0 111.795 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.61 65.75 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.598 -0.688 . . . . 0.0 112.202 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 -6.58 52.35 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.603 -1.311 . . . . 0.0 109.291 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.299 0.2 OUTLIER -79.12 -12.38 60.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 120.402 1.455 . . . . 0.0 110.616 -167.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.44 -31.75 54.08 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 168.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.53 -22.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.895 1.278 . . . . 0.0 108.672 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -55.62 -24.79 35.4 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.951 1.7 . . . . 0.0 112.18 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -64.19 -22.02 66.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 120.828 -1.17 . . . . 0.0 110.894 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.5 -0.96 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 -178.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.505 -0.774 0 CA-C-O 122.452 1.12 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.548 ' HE1' ' OD1' ' C' ' 92' ' ' ASP . 0.6 OUTLIER -176.09 -37.97 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.89 2.076 . . . . 0.0 105.486 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.17 -35.82 74.24 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.131 0.967 . . . . 0.0 110.325 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -58.27 -36.04 72.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.473 1.909 . . . . 0.0 111.389 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.94 -42.42 39.35 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.196 1.398 . . . . 0.0 108.513 -176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.44 85.62 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.302 1.041 . . . . 0.0 110.889 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.27 -37.53 87.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.391 1.476 . . . . 0.0 110.697 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -67.57 -36.03 80.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.009 0.924 . . . . 0.0 109.154 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.92 97.39 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.998 0.919 . . . . 0.0 111.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.66 -27.84 68.66 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 121.235 -0.915 . . . . 0.0 112.435 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.31 -35.73 81.89 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.671 -1.268 . . . . 0.0 109.542 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.74 -44.51 93.76 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.48 -44.05 92.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.034 0.534 . . . . 0.0 110.88 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.35 -40.13 74.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.769 0.827 . . . . 0.0 112.339 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -73.69 -28.53 61.79 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 120.872 -1.142 . . . . 0.0 111.044 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.05 -37.26 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.01 -49.09 69.65 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.085 0.954 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.71 -45.96 91.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.852 0.751 . . . . 0.0 111.672 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -42.71 82.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.715 -0.615 . . . . 0.0 109.99 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.43 84.3 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.963 1.305 . . . . 0.0 111.651 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -62.86 -50.27 71.6 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.977 1.311 . . . . 0.0 109.593 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -67.2 -40.37 86.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -62.0 -48.88 78.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.384 1.074 . . . . 0.0 110.724 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.34 72.66 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 111.824 -173.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.79 -42.39 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 O-C-N 122.204 -0.31 . . . . 0.0 110.396 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.17 -23.63 60.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 120.365 -1.459 . . . . 0.0 112.148 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.55 69.7 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.361 1.464 . . . . 0.0 107.983 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.92 -28.21 63.33 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.739 0.78 . . . . 0.0 111.001 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.34 95.87 1.07 Allowed 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.618 -1.301 . . . . 0.0 110.378 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.0 -11.56 6.54 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.76 142.83 26.12 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 118.272 1.036 . . . . 0.0 109.061 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.54 129.72 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.407 2.071 . . . . 0.0 112.064 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.88 45.01 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 141.69 31.25 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.494 2.318 . . . . 0.0 112.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.89 -45.21 2.59 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.78 65.88 5.92 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 123.018 1.39 . . . . 0.0 109.449 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -96.79 -10.87 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 O-C-N 119.851 -1.781 . . . . 0.0 111.447 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.3 m -98.71 127.23 44.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.514 -0.741 . . . . 0.0 109.668 -169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.84 -52.19 65.87 Favored Pre-proline 0 N--CA 1.445 -0.712 0 C-N-CA 126.148 1.779 . . . . 0.0 112.187 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.75 -8.41 20.31 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 CA-C-N 125.086 2.852 . . . . 0.0 111.624 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.79 -25.97 20.82 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.55 76.16 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.624 0.77 . . . . 0.0 111.348 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.2 -25.23 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 124.609 1.163 . . . . 0.0 110.411 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -79.57 -44.68 20.62 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 119.737 -1.852 . . . . 0.0 107.164 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.03 -37.5 87.43 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.176 0.991 . . . . 0.0 110.547 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -67.59 -35.34 78.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.025 -1.672 . . . . 0.0 111.519 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.26 -51.99 66.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.293 1.037 . . . . 0.0 109.554 -178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.75 -30.81 65.99 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.487 -0.758 . . . . 0.0 110.727 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 80.5 m -62.82 -36.35 82.89 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.955 -1.09 . . . . 0.0 110.783 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -16.05 63.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 120.632 -1.292 . . . . 0.0 113.036 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -89.34 -3.99 58.26 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.458 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.314 11.3 p 68.41 2.09 3.19 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 127.343 2.257 . . . . 0.0 112.66 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.81 -53.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.38 1.472 . . . . 0.0 107.418 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.34 -62.02 4.68 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 74.4 -44.95 0.57 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.798 2.839 . . . . 0.0 109.914 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.57 40.0 0.55 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 107.157 -2.377 . . . . 0.0 107.157 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.55 -55.73 9.33 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.503 1.151 . . . . 0.0 108.275 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -149.25 168.34 23.56 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -134.88 126.71 17.98 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -165.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . 0.409 ' HB2' ' HG2' ' C' ' 66' ' ' GLU . 89.5 Cg_endo -80.52 172.19 13.78 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 123.368 2.712 . . . . 0.0 109.71 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -93.37 -106.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.306 1.042 . . . . 0.0 113.641 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 18.7 m -155.86 -38.44 0.08 Allowed 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 119.013 -2.304 . . . . 0.0 106.411 -171.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -91.52 10.26 28.59 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 120.851 -1.156 . . . . 0.0 109.084 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' C' ' 62' ' ' PRO . 0.0 OUTLIER -71.68 -42.16 67.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.56 91.38 1.91 Allowed Glycine 0 N--CA 1.418 -2.537 1 N-CA-C 96.662 -6.575 . . . . 0.0 96.662 -170.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' B' ' 59' ' ' ASP . 24.9 ttm180 -65.87 -11.52 47.4 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.04 1.92 . . . . 0.0 110.388 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -46.14 -23.87 0.38 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.456 1.902 . . . . 0.0 113.971 159.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.84 -41.61 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 119.99 -1.694 . . . . 0.0 109.385 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.98 61.76 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -49.8 -49.19 49.6 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 126.236 1.814 . . . . 0.0 111.55 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -44.51 90.05 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.188 0.995 . . . . 0.0 111.813 -173.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.28 -37.92 60.17 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.415 -0.803 . . . . 0.0 109.252 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 73.7 mtm -66.36 -44.77 82.25 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 123.359 0.664 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -59.01 -43.1 91.49 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 123.846 0.858 . . . . 0.0 110.631 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.13 96.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.022 0.529 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.85 91.89 Favored Glycine 0 CA--C 1.493 -1.333 0 C-N-CA 123.905 0.764 . . . . 0.0 111.546 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.25 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 109.017 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.25 -37.97 86.76 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.634 -0.666 . . . . 0.0 111.674 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.57 -53.56 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 119.298 0.953 . . . . 0.0 110.054 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.07 -34.23 76.04 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 122.857 0.463 . . . . 0.0 110.71 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.12 65.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.915 -1.115 . . . . 0.0 110.489 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.03 -32.1 73.38 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 120.647 -1.283 . . . . 0.0 111.481 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.93 -1.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 120.99 -1.069 . . . . 0.0 112.271 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -58.65 -18.06 27.51 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 111.181 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.0 68.44 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.563 -1.336 . . . . 0.0 112.123 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.87 -44.62 16.61 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.317 -0.864 . . . . 0.0 108.857 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.4 -40.62 95.07 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.331 1.053 . . . . 0.0 111.633 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.25 99.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.471 0.708 . . . . 0.0 111.312 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -17.78 64.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 120.924 -1.11 . . . . 0.0 113.303 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . 0.548 ' OD1' ' HE1' ' C' ' 4' ' ' HIS . 1.3 m-20 -74.7 -20.07 60.0 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 119.907 1.231 . . . . 0.0 111.028 -167.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -82.41 -31.83 29.39 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.035 -1.04 . . . . 0.0 110.519 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.04 -19.96 26.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.371 1.468 . . . . 0.0 109.382 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -65.17 -15.51 62.51 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 120.319 -1.488 . . . . 0.0 111.543 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -72.36 -14.01 61.62 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.129 -1.607 . . . . 0.0 111.48 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--N 1.355 0.819 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -170.368 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . 0.308 3.3 m-20 67.9 -35.08 0.26 Allowed 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 131.358 3.863 . . . . 0.0 111.807 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -68.57 -22.54 64.47 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.856 -1.153 . . . . 0.0 112.528 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.89 -45.77 92.3 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 122.191 0.996 . . . . 0.0 108.845 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -67.1 -38.53 85.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 124.409 1.084 . . . . 0.0 110.142 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.14 -35.39 69.07 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.956 -0.465 . . . . 0.0 109.893 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.68 86.69 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 121.693 -0.63 . . . . 0.0 110.104 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -60.97 -39.71 90.61 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.625 1.57 . . . . 0.0 111.473 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.09 -30.31 62.29 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.358 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.76 79.2 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.822 -1.174 . . . . 0.0 110.982 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 52.2 mt-10 -64.02 -35.92 82.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.596 -0.69 . . . . 0.0 111.966 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.76 -42.82 81.16 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.766 1.226 . . . . 0.0 108.334 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . 0.441 ' CD ' ' HZ2' ' D' ' 17' ' ' LYS . 45.7 tp10 -55.83 -45.13 78.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 125.576 1.55 . . . . 0.0 109.839 -176.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.78 -36.83 79.96 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.542 -0.724 . . . . 0.0 112.348 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -65.01 -34.91 79.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.65 0.78 . . . . 0.0 109.988 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.441 ' HZ2' ' CD ' ' D' ' 14' ' ' GLU . 14.2 pttt -75.59 -29.3 59.23 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 120.839 -1.163 . . . . 0.0 110.513 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.05 -47.82 52.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.27 -31.84 73.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.512 -0.742 . . . . 0.0 110.445 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -67.39 -43.51 81.15 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.797 -1.189 . . . . 0.0 111.064 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.48 -39.93 95.75 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.82 -1.175 . . . . 0.0 110.456 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.26 -25.6 68.13 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.31 -0.868 . . . . 0.0 112.343 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -66.09 -42.59 89.14 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.389 1.076 . . . . 0.0 111.021 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -66.54 -34.83 78.78 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.471 1.109 . . . . 0.0 108.461 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -74.41 -50.49 18.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 118.273 -0.87 . . . . 0.0 108.722 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.11 -41.8 75.81 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 126.83 2.052 . . . . 0.0 113.166 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.82 -31.12 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 O-C-N 120.722 -1.236 . . . . 0.0 110.896 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 -34.11 22.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.69 47.2 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 0.0 109.373 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.37 -36.5 71.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 120.997 0.427 . . . . 0.0 111.191 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.02 106.53 1.63 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 120.024 -1.673 . . . . 0.0 111.568 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.41 -25.13 4.32 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.94 153.81 75.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 123.657 0.783 . . . . 0.0 110.979 -170.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -80.43 135.78 10.78 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.312 2.008 . . . . 0.0 109.988 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.64 14.07 74.14 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.0 135.0 56.28 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.01 1.724 . . . . 0.0 111.725 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.82 -31.08 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.984 1.314 . . . . 0.0 109.047 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' D' ' 60' ' ' ARG . 4.6 tt -86.72 121.97 29.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.246 1.418 . . . . 0.0 109.103 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 pt -148.88 175.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 73.3 m 67.13 122.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.212 2.205 . . . . 0.0 113.662 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.9 -50.5 87.65 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 116.815 -1.564 . . . . 0.0 113.189 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.61 -11.93 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 124.459 2.628 . . . . 0.0 111.525 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.56 -37.85 14.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.6 83.59 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.939 1.696 . . . . 0.0 112.207 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -64.8 -31.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.47 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.69 -18.25 41.58 Favored 'General case' 0 N--CA 1.437 -1.108 0 O-C-N 120.674 -1.266 . . . . 0.0 110.878 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -72.01 -43.47 65.0 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -66.03 -26.11 67.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 121.33 -0.856 . . . . 0.0 113.202 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.4 -36.18 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 C-N-CA 124.403 1.081 . . . . 0.0 111.351 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.61 -5.9 57.87 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.649 -1.282 . . . . 0.0 110.133 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.7 m -96.95 177.72 5.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 80.96 -41.12 0.16 Allowed 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.328 1.451 . . . . 0.0 110.208 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.6 p -85.33 3.54 39.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.982 1.713 . . . . 0.0 111.939 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p 59.24 53.68 5.23 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 126.095 1.758 . . . . 0.0 112.314 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.28 -99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.13 106.22 0.5 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 106.78 -2.528 . . . . 0.0 106.78 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -86.88 -15.64 38.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.747 -1.443 . . . . 0.0 109.233 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.84 28.6 5.27 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -65.57 -56.21 13.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' D' ' 38' ' ' LEU . 88.5 mtt-85 -137.2 156.97 47.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -128.49 149.92 73.04 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 101.206 -3.628 . . . . 0.0 101.206 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.26 152.06 3.72 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 123.313 2.676 . . . . 0.0 110.057 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 p -109.32 -179.59 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 122.328 1.061 . . . . 0.0 109.09 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -62.63 -49.13 76.39 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.18 2.192 . . . . 0.0 113.913 -167.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -83.64 -0.0 48.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.744 1.218 . . . . 0.0 110.019 -167.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -28.19 67.41 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 123.745 1.736 . . . . 0.0 106.674 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 75.17 1.27 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 99.973 -5.251 . . . . 0.0 99.973 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.26 8.4 mtm180 -55.18 -2.35 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 126.104 1.762 . . . . 0.0 114.92 -169.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.82 -0.77 4.5 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.828 1.251 . . . . 0.0 112.984 160.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.23 -59.82 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.81 -56.24 17.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 114.647 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . 0.302 1.5 pp20? -68.38 -26.63 65.67 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.313 -0.867 . . . . 0.0 111.551 -172.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -67.54 -31.08 70.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.613 -0.679 . . . . 0.0 110.777 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.15 -45.27 86.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.1 mtp -64.99 -46.54 81.0 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.662 0.785 . . . . 0.0 110.056 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -63.76 -37.89 89.06 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.222 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.57 91.62 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.396 0.617 . . . . 0.0 110.939 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.59 -41.52 89.69 Favored Glycine 0 CA--C 1.489 -1.588 0 O-C-N 121.615 -0.678 . . . . 0.0 112.469 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.47 -47.35 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.919 0.888 . . . . 0.0 109.709 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.27 -26.14 61.87 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.101 -0.999 . . . . 0.0 111.934 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 t -64.64 -50.91 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.82 -2.87 32.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.527 -0.733 . . . . 0.0 111.397 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -30.94 13.01 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.067 0.947 . . . . 0.0 109.491 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.84 -33.97 75.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.617 -1.302 . . . . 0.0 109.83 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -62.69 -12.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.183 0.993 . . . . 0.0 111.899 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 21.3 m -68.26 -14.87 63.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 120.337 -1.477 . . . . 0.0 111.73 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -16.39 64.19 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 120.007 -1.683 . . . . 0.0 111.31 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.82 -49.33 7.18 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 62.9 mt -60.39 -35.54 75.98 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.652 1.181 . . . . 0.0 112.085 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 120.924 -1.11 . . . . 0.0 112.435 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -4.45 55.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 120.777 -1.202 . . . . 0.0 108.415 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.9 -32.17 67.14 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 119.382 0.992 . . . . 0.0 109.454 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -75.84 -28.59 58.29 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.379 -1.45 . . . . 0.0 111.079 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 t -70.55 -17.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 108.74 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -59.1 -22.21 60.47 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 125.656 1.582 . . . . 0.0 111.606 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -60.66 -33.0 72.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 123.013 1.387 . . . . 0.0 110.242 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 103.25 -2.871 . . . . 0.0 103.25 -161.129 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.826 0 CA-C-O 121.822 0.82 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 4' ' ' HIS . 13.5 p30 -157.03 -74.17 0.09 Allowed 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -171.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 23.4 p-80 -58.4 -35.59 72.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 129.456 3.102 . . . . 0.0 112.313 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.477 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 7.7 mt-10 -68.21 -32.66 73.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.113 0.965 . . . . 0.0 111.498 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -65.61 -40.0 92.15 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.72 -31.89 68.9 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.74 0.816 . . . . 0.0 109.636 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.58 -43.05 70.21 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.544 0.738 . . . . 0.0 109.981 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -68.27 -35.98 78.7 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.914 -0.491 . . . . 0.0 110.305 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.71 -40.12 78.8 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.689 1.196 . . . . 0.0 110.889 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.45 94.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.729 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -64.67 -28.0 69.31 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.427 -0.796 . . . . 0.0 111.608 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.72 -35.94 72.97 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.789 -1.194 . . . . 0.0 110.246 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -68.15 -38.48 82.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.28 -38.71 84.43 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.309 -0.869 . . . . 0.0 111.747 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -71.18 -27.05 63.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 121.403 -0.811 . . . . 0.0 111.458 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -72.17 -39.14 68.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.443 -0.786 . . . . 0.0 109.488 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.2 -34.57 64.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.568 1.147 . . . . 0.0 109.792 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.95 -48.04 82.93 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.926 -1.109 . . . . 0.0 111.342 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.49 -42.51 87.33 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.808 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.28 -49.18 78.64 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 110.072 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.69 88.24 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 125.732 1.613 . . . . 0.0 111.243 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -43.47 98.81 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.588 0.755 . . . . 0.0 111.103 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -66.08 -40.73 91.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 124.398 1.079 . . . . 0.0 108.916 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -76.27 -44.66 36.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.699 -0.626 . . . . 0.0 111.18 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.6 95.54 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.665 1.586 . . . . 0.0 111.09 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.82 -38.05 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 122.189 -0.319 . . . . 0.0 110.212 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.283 89.0 mt-10 -67.98 -40.03 83.19 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.022 -1.049 . . . . 0.0 109.352 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.02 -47.3 85.38 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.76 1.624 . . . . 0.0 109.613 -171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.15 -8.62 59.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 121.666 -0.646 . . . . 0.0 111.929 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -76.17 80.95 2.98 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.081 -1.637 . . . . 0.0 110.141 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.65 -13.74 5.84 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.89 150.08 97.71 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 118.124 0.962 . . . . 0.0 109.903 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -75.55 147.76 32.35 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 121.984 1.79 . . . . 0.0 108.525 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 4.21 64.86 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 120.192 1.36 . . . . 0.0 113.957 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 159.44 27.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.755 0.822 . . . . 0.0 111.736 -171.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.96 -32.32 0.8 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.137 0.975 . . . . 0.0 109.78 -171.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.12 40.73 0.72 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 123.828 1.775 . . . . 0.0 109.392 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.66 72.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 O-C-N 119.158 -2.214 . . . . 0.0 105.388 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -158.06 -120.37 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 116.553 -1.689 . . . . 0.0 107.041 -168.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.6 t80 178.23 -64.28 0.0 OUTLIER Pre-proline 0 C--N 1.359 1.0 0 CA-C-N 121.052 1.751 . . . . 0.0 110.355 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -75.14 -8.46 19.92 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 CA-C-N 125.515 3.005 . . . . 0.0 111.887 -167.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -10.18 28.33 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 129.662 3.185 . . . . 0.0 107.136 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -48.7 51.31 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.13 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.3 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -17.51 60.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.498 -1.376 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -86.29 -39.21 16.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.23 -38.3 76.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.745 -1.222 . . . . 0.0 111.726 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.57 -25.85 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.695 1.198 . . . . 0.0 110.824 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.99 -23.03 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.976 -1.078 . . . . 0.0 110.809 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -107.47 -22.85 12.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 -165.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.2 64.17 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.372 -1.455 . . . . 0.0 111.999 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.95 2.35 51.86 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.919 1.288 . . . . 0.0 110.578 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.252 9.6 p 56.67 63.09 2.05 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.34 1.856 . . . . 0.0 111.261 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 56' ' ' GLY . 2.6 t -145.79 -164.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -177.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.481 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 156.67 101.72 0.19 Allowed Glycine 0 CA--C 1.475 -2.459 1 N-CA-C 100.191 -5.164 . . . . 0.0 100.191 -177.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.89 -26.87 29.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.3 33.57 1.6 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.482 ' CG ' HH22 ' B' ' 68' ' ' ARG . 30.8 t70 -83.67 -26.46 29.84 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.434 -1.039 . . . . 0.0 109.418 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -179.58 4.69 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -158.7 114.99 1.67 Allowed Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.71 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.697 2.932 . . . . 0.0 109.417 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.36 -120.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.909 0.883 . . . . 0.0 110.372 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -141.67 -36.28 0.43 Allowed 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -89.41 9.97 24.31 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 120.881 -1.137 . . . . 0.0 108.187 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -43.92 63.21 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.44 90.92 2.03 Favored Glycine 0 N--CA 1.417 -2.594 1 N-CA-C 96.397 -6.681 . . . . 0.0 96.397 -172.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -64.36 -12.03 38.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 119.364 1.582 . . . . 0.0 111.081 -172.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -46.95 -28.97 1.8 Allowed 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.002 0.921 . . . . 0.0 113.215 162.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.8 t -66.92 -39.4 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 0.0 110.133 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.48 -50.46 18.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 120.951 -1.093 . . . . 0.0 108.42 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -50.81 -44.5 59.05 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.612 1.565 . . . . 0.0 111.998 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -65.64 -36.02 82.48 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.416 0.686 . . . . 0.0 110.148 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.38 -42.59 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.9 mtt -59.79 -50.89 72.03 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.243 1.017 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -64.55 -38.27 90.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.149 0.98 . . . . 0.0 110.83 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.08 96.55 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.188 0.595 . . . . 0.0 110.518 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.69 -48.72 79.21 Favored Glycine 0 CA--C 1.49 -1.522 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.36 -47.48 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.387 1.075 . . . . 0.0 109.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.72 -39.92 95.48 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 120.929 -1.107 . . . . 0.0 111.397 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 t -64.22 -52.89 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.738 0.815 . . . . 0.0 109.851 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.26 -41.22 94.45 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 110.499 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.13 -30.9 71.48 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 123.565 0.746 . . . . 0.0 111.019 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.57 -30.38 69.99 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.059 -1.026 . . . . 0.0 110.852 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.3 t -59.87 -18.44 15.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 124.375 1.07 . . . . 0.0 110.582 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 m -56.42 -27.71 57.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.248 1.419 . . . . 0.0 112.739 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.04 -28.28 64.36 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.485 1.114 . . . . 0.0 111.376 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 -45.92 9.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.088 0.955 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.7 mt -49.62 -46.71 49.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.476 1.91 . . . . 0.0 113.434 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.82 42.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.756 -1.215 . . . . 0.0 111.222 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.8 p -64.11 -6.14 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.381 1.072 . . . . 0.0 113.259 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.36 -74.79 0.14 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.31 0.93 57.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.439 -1.413 . . . . 0.0 112.347 -168.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.68 -29.52 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 O-C-N 119.761 -1.837 . . . . 0.0 108.761 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -59.5 -18.08 37.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.001 1.32 . . . . 0.0 113.2 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -52.22 -35.46 49.47 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.28 1.432 . . . . 0.0 111.593 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -175.437 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 CA--C 1.506 -0.736 0 CA-C-O 123.15 1.453 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -72.02 -28.92 63.69 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.159 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.62 -43.05 23.61 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.32 -37.47 87.4 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.962 -0.461 . . . . 0.0 110.32 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.35 -34.83 65.83 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.979 0.418 . . . . 0.0 110.036 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.28 78.59 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 123.674 0.79 . . . . 0.0 110.287 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -77.97 -11.98 59.95 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.633 -0.667 . . . . 0.0 111.452 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' B' ' 13' ' ' GLU . 44.1 tptt -77.77 -29.34 50.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 121.394 -0.816 . . . . 0.0 109.349 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.62 87.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.41 -23.48 63.71 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.693 0.797 . . . . 0.0 111.905 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' B' ' 10' ' ' LYS . 37.1 tt0 -72.28 -44.66 62.44 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.931 -1.106 . . . . 0.0 108.161 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.81 -33.75 76.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.693 1.197 . . . . 0.0 109.818 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.02 -45.58 82.99 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 111.913 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.13 -38.89 90.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.286 1.034 . . . . 0.0 109.916 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -63.48 -41.21 98.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.011 0.924 . . . . 0.0 111.382 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.52 -48.41 47.2 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 124.175 0.99 . . . . 0.0 110.372 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.71 -35.22 80.36 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -65.51 -39.03 91.36 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.795 -1.191 . . . . 0.0 110.929 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.79 -37.62 86.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.437 -1.415 . . . . 0.0 109.217 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.62 66.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 123.387 0.675 . . . . 0.0 111.841 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.5 p -66.93 -39.01 87.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 118.767 0.712 . . . . 0.0 110.694 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.34 -46.03 81.88 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.45 -43.14 99.53 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.621 1.169 . . . . 0.0 108.936 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.99 84.64 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.147 1.379 . . . . 0.0 113.279 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.88 -47.78 91.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-O 121.88 0.847 . . . . 0.0 109.502 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -79.96 -20.79 44.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 O-C-N 121.663 -0.648 . . . . 0.0 110.673 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -51.43 22.74 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 125.9 1.68 . . . . 0.0 109.664 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 -18.37 55.35 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.834 -0.542 . . . . 0.0 111.869 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.51 87.67 1.2 Allowed 'General case' 0 C--N 1.353 0.754 0 O-C-N 119.973 -1.704 . . . . 0.0 110.107 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.31 -11.46 3.27 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.4 143.77 32.92 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 118.398 1.099 . . . . 0.0 111.69 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.18 125.19 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.359 2.706 . . . . 0.0 111.636 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 23.28 68.0 Favored Glycine 0 CA--C 1.495 -1.206 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 167.11 21.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.157 1.383 . . . . 0.0 109.524 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.58 -39.51 1.28 Allowed 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.222 0.609 . . . . 0.0 109.615 -166.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -94.78 130.57 41.28 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.6 pt -140.56 6.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 O-C-N 120.81 -1.182 . . . . 0.0 111.124 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.9 138.51 26.99 Favored 'General case' 0 CA--C 1.499 -0.99 0 O-C-N 119.944 -1.723 . . . . 0.0 109.502 -161.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -52.98 65.83 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 126.234 1.813 . . . . 0.0 113.347 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.19 -15.28 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 123.732 2.369 . . . . 0.0 111.827 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.86 -40.39 14.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.16 86.19 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 124.891 1.277 . . . . 0.0 111.886 -170.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.42 -38.73 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 122.749 0.419 . . . . 0.0 110.338 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -38.5 72.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.658 -0.651 . . . . 0.0 110.172 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.49 -43.0 99.88 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-O 122.157 0.979 . . . . 0.0 109.796 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 55.9 m -63.58 -30.61 71.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.517 -1.364 . . . . 0.0 113.006 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.36 -53.8 43.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 123.687 0.795 . . . . 0.0 109.622 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.91 -18.18 60.45 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 121.35 -0.844 . . . . 0.0 111.89 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -69.49 -36.81 76.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.454 0.702 . . . . 0.0 109.19 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.49 71.3 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.147 0.979 . . . . 0.0 111.664 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -82.97 3.4 30.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.358 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p 55.49 53.17 10.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.889 1.676 . . . . 0.0 112.574 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.71 -69.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.91 80.19 0.25 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -62.61 -43.29 99.19 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.463 1.125 . . . . 0.0 108.499 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.48 -120.67 0.99 Allowed Glycine 0 CA--C 1.48 -2.127 1 N-CA-C 102.043 -4.423 . . . . 0.0 102.043 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.341 0.2 OUTLIER 66.08 -64.05 0.22 Allowed 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 127.241 2.216 . . . . 0.0 114.594 -177.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -132.88 166.71 21.69 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -160.19 135.97 6.05 Favored Pre-proline 0 N--CA 1.436 -1.145 0 CA-C-O 117.391 -1.29 . . . . 0.0 107.536 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.45 151.04 15.23 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.967 2.445 . . . . 0.0 110.801 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.77 -119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 124.524 1.13 . . . . 0.0 109.145 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 13.4 p -113.93 -43.93 3.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.285 -1.51 . . . . 0.0 111.813 -166.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -83.03 -23.63 33.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.745 1.618 . . . . 0.0 108.041 -163.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.23 -14.62 63.12 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.592 1.957 . . . . 0.0 110.169 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.65 87.85 0.39 Allowed Glycine 0 CA--C 1.481 -2.087 1 N-CA-C 103.055 -4.018 . . . . 0.0 103.055 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.482 HH22 ' CG ' ' A' ' 59' ' ' ASP . 36.9 ttm180 -58.27 -21.21 47.73 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.59 -1.535 . . . . 0.0 111.872 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -55.86 -15.75 3.71 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.43 -43.73 97.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 O-C-N 120.722 -1.236 . . . . 0.0 108.729 172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.04 -43.68 67.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.403 0.681 . . . . 0.0 109.601 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.13 -39.85 69.89 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.819 1.648 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -40.52 95.78 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.035 1.334 . . . . 0.0 110.703 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.93 -43.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.8 mtt -57.84 -49.92 75.05 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.096 0.958 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.17 90.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.668 -0.645 . . . . 0.0 111.157 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.5 98.78 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.877 1.227 . . . . 0.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.59 -43.38 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 121.641 -0.917 . . . . 0.0 108.927 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.24 -31.95 70.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.914 -1.116 . . . . 0.0 113.262 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.96 -41.06 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 120.058 1.299 . . . . 0.0 110.607 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.14 -38.58 75.53 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.617 0.644 . . . . 0.0 109.428 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.83 69.86 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.103 -0.998 . . . . 0.0 111.363 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.01 -15.46 63.48 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.546 -1.347 . . . . 0.0 111.207 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -5.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.5 -1.375 . . . . 0.0 110.157 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 14.8 t -49.58 -26.01 3.21 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 119.602 -1.936 . . . . 0.0 113.048 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.63 -36.49 71.9 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.975 1.31 . . . . 0.0 110.893 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.45 23.97 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.305 1.042 . . . . 0.0 108.46 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.44 -42.15 96.16 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 120.788 -1.195 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.84 -1.61 23.04 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.897 -1.127 . . . . 0.0 111.731 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 44.4 p -85.72 -42.1 14.54 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.92 -25.23 52.68 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.789 0.804 . . . . 0.0 110.666 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.96 -50.04 37.54 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 126.736 2.015 . . . . 0.0 111.693 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.61 -30.4 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.749 1.22 . . . . 0.0 109.418 -171.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -58.67 -12.28 4.02 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.371 1.068 . . . . 0.0 112.964 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -54.98 -33.92 62.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.394 -0.816 . . . . 0.0 111.126 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -175.046 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.507 -0.68 0 CA-C-O 121.759 0.79 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -79.85 -19.96 47.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.1 0.96 . . . . 0.0 112.165 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -30.76 62.85 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -61.63 -39.8 92.59 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.078 0.951 . . . . 0.0 110.827 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -32.17 73.49 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.346 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.1 70.15 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 123.482 0.713 . . . . 0.0 110.975 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.15 -33.34 73.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -63.35 -34.3 77.41 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.031 1.733 . . . . 0.0 110.28 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.94 -37.35 81.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.7 -15.56 62.21 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.975 -1.078 . . . . 0.0 111.873 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -69.95 -42.81 72.72 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.48 -1.388 . . . . 0.0 109.034 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.0 -35.78 81.82 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.32 0.648 . . . . 0.0 110.803 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -42.91 88.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.54 -35.14 78.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.331 -0.856 . . . . 0.0 111.706 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -60.16 -46.5 89.47 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.089 1.356 . . . . 0.0 110.058 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.7 -39.07 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.195 0.998 . . . . 0.0 109.819 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.81 -45.32 82.34 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.299 0.954 . . . . 0.0 111.925 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.77 -38.08 79.79 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 122.971 0.508 . . . . 0.0 110.851 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -74.33 -39.89 62.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.78 -1.2 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.17 74.58 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 124.883 1.273 . . . . 0.0 112.339 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -70.74 -36.99 73.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.217 0.917 . . . . 0.0 110.473 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -66.73 -41.28 88.16 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -65.5 -46.9 77.88 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.31 -49.02 65.03 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.87 1.668 . . . . 0.0 112.576 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.42 -34.27 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 O-C-N 121.795 -0.566 . . . . 0.0 112.17 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -87.91 -24.15 23.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.539 0.685 . . . . 0.0 109.394 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.84 37.22 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.54 -8.68 53.24 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 122.058 0.932 . . . . 0.0 112.316 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.52 107.57 13.44 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 119.647 -1.908 . . . . 0.0 108.125 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.03 15.8 40.71 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.18 21.72 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.79 107.64 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.432 2.088 . . . . 0.0 113.179 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.23 27.36 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.14 145.09 22.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.337 1.855 . . . . 0.0 112.911 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.0 -16.08 5.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.344 1.058 . . . . 0.0 110.785 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.59 -79.84 0.3 Allowed 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 121.221 -0.924 . . . . 0.0 108.595 -168.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . 0.359 12.7 pt 38.94 -128.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 126.779 2.032 . . . . 0.0 111.048 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.4 -135.58 0.82 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.913 1.688 . . . . 0.0 109.752 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -173.03 -68.12 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-O 116.653 -1.642 . . . . 0.0 106.758 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.73 -17.84 22.67 Favored 'Trans proline' 0 CA--C 1.51 -0.685 0 CA-C-N 125.321 2.936 . . . . 0.0 111.197 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.44 -23.75 65.56 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.269 1.427 . . . . 0.0 109.947 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.42 99.31 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 112.259 -167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -69.3 -33.71 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.18 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 121.543 -0.723 . . . . 0.0 110.19 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -63.16 -45.4 92.01 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.84 0.456 . . . . 0.0 110.508 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 62.0 m -58.94 -36.09 74.21 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.678 -0.639 . . . . 0.0 112.062 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.32 -45.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 C-N-CA 123.89 0.876 . . . . 0.0 110.191 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -73.84 3.24 6.91 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 122.1 0.952 . . . . 0.0 112.785 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -104.71 -36.3 7.49 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.702 -1.249 . . . . 0.0 108.856 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.68 61.39 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.426 -1.421 . . . . 0.0 111.768 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.8 p -87.69 -3.01 58.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.728 1.211 . . . . 0.0 109.983 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.254 6.9 p 55.62 36.35 27.02 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.522 1.929 . . . . 0.0 112.77 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -91.19 -19.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 O-C-N 121.61 -0.681 . . . . 0.0 111.474 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.48 -60.14 1.55 Allowed Glycine 0 CA--C 1.493 -1.334 0 O-C-N 120.59 -1.319 . . . . 0.0 112.412 168.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -75.71 73.09 2.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.875 1.321 . . . . 0.0 113.62 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.09 10.15 75.77 Favored Glycine 0 CA--C 1.492 -1.399 0 O-C-N 118.512 -2.618 . . . . 0.0 114.552 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t0 71.7 -4.73 1.83 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 126.095 1.758 . . . . 0.0 111.562 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -136.53 163.25 30.96 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -136.0 148.32 64.38 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.13 171.19 15.47 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.812 3.008 . . . . 0.0 108.488 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 t -115.21 -95.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 120.655 1.57 . . . . 0.0 110.282 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -140.48 -49.97 0.45 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -85.13 -16.35 40.77 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 123.646 0.778 . . . . 0.0 110.085 -165.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -33.21 74.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 108.33 171.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.35 95.32 1.81 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 98.229 -5.948 . . . . 0.0 98.229 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -61.92 -16.22 49.2 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 118.836 1.318 . . . . 0.0 110.62 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -59.81 -11.21 4.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.22 -39.88 86.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.084 -1.635 . . . . 0.0 108.99 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -45.18 69.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.82 -44.57 66.79 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.789 1.636 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -63.85 -36.0 82.48 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 112.34 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -71.84 -43.85 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 121.062 -1.024 . . . . 0.0 108.801 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.78 -42.51 97.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.606 0.762 . . . . 0.0 110.486 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.69 -47.15 83.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.621 1.168 . . . . 0.0 110.294 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.9 98.14 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.233 0.613 . . . . 0.0 110.509 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.13 77.92 Favored Glycine 0 CA--C 1.496 -1.119 0 C-N-CA 123.75 0.69 . . . . 0.0 111.832 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.75 -49.33 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 125.066 1.346 . . . . 0.0 108.675 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.42 -45.12 94.54 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 111.044 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.2 -52.87 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 C-N-CA 124.258 1.023 . . . . 0.0 110.367 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -72.27 -21.92 61.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.222 -0.924 . . . . 0.0 111.18 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.43 -37.88 36.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.115 -0.991 . . . . 0.0 110.111 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.23 -41.72 84.72 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.421 1.488 . . . . 0.0 110.609 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -69.04 -2.93 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -62.49 -12.57 22.98 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.361 1.065 . . . . 0.0 110.394 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.21 -57.3 12.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.122 -1.611 . . . . 0.0 111.841 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.4 77.6 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 126.07 1.748 . . . . 0.0 109.807 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.43 -33.37 75.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.35 40.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.007 -1.058 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . 0.334 0.1 OUTLIER -70.36 -2.39 13.49 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.517 -1.23 . . . . 0.0 110.617 -176.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.281 0.6 OUTLIER -76.25 1.65 15.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 122.148 2.249 . . . . 0.0 111.531 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.24 -24.03 61.32 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 119.673 -1.892 . . . . 0.0 111.05 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.78 -12.95 14.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 O-C-N 120.112 -1.617 . . . . 0.0 110.275 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -79.64 -3.97 49.58 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.893 1.277 . . . . 0.0 109.388 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -77.77 -27.37 50.27 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.009 -1.682 . . . . 0.0 108.489 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -169.778 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.327 0.584 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' D' ' 4' ' ' HIS . 6.6 t70 -170.14 -104.38 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 -166.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.435 ' H ' ' CG ' ' D' ' 3' ' ' ASP . 10.3 p-80 -53.11 -22.54 6.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.989 3.316 . . . . 0.0 114.366 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.64 -28.56 67.82 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 125.385 1.474 . . . . 0.0 110.447 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -68.28 -43.3 78.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.923 0.889 . . . . 0.0 109.742 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.07 -31.34 62.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.503 -0.748 . . . . 0.0 109.588 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.95 91.44 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.871 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -66.12 -38.4 88.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.56 -42.99 99.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 109.904 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.32 84.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.74 0.816 . . . . 0.0 111.566 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.74 -38.16 77.8 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.564 0.745 . . . . 0.0 110.807 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.6 -30.14 65.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.303 -0.873 . . . . 0.0 110.406 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.76 -32.97 73.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.5 -43.2 97.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.357 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -56.05 -33.55 65.08 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.394 1.078 . . . . 0.0 111.745 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -71.19 -23.63 62.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.143 1.377 . . . . 0.0 111.174 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.68 -42.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.48 -40.23 74.57 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 124.939 1.296 . . . . 0.0 111.261 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -54.3 -51.68 63.85 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.273 1.029 . . . . 0.0 111.728 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.58 -38.37 67.92 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.65 0.78 . . . . 0.0 109.254 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.33 77.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.727 1.611 . . . . 0.0 111.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -64.46 -40.06 94.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.629 1.172 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -68.7 -46.62 68.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.49 -49.07 75.03 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.326 -0.859 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.08 -46.57 87.95 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 126.086 1.755 . . . . 0.0 111.836 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.34 -37.32 78.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 118.42 0.554 . . . . 0.0 110.139 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.34 -33.62 61.13 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.944 -1.098 . . . . 0.0 109.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.8 -55.51 14.55 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.249 1.82 . . . . 0.0 109.195 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.09 -32.9 74.38 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.019 0.928 . . . . 0.0 111.135 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -74.18 101.6 4.01 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 120.339 -1.476 . . . . 0.0 110.892 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.05 -22.49 4.79 Favored Glycine 0 CA--C 1.489 -1.541 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.8 142.96 66.1 Favored Pre-proline 0 N--CA 1.443 -0.801 0 O-C-N 121.547 -0.972 . . . . 0.0 109.653 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.94 140.38 12.64 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 122.781 2.321 . . . . 0.0 109.703 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.04 -8.84 71.67 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 119.132 0.878 . . . . 0.0 110.956 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.89 150.65 27.96 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 126.71 2.004 . . . . 0.0 111.287 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.93 -28.89 1.52 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.035 0.534 . . . . 0.0 110.572 -170.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.7 91.4 8.63 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 120.278 -1.514 . . . . 0.0 107.067 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 tt -122.49 53.13 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 O-C-N 120.848 -1.158 . . . . 0.0 108.117 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 26.4 t -153.97 142.0 20.28 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 119.489 -2.007 . . . . 0.0 106.948 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -80.64 -49.7 1.11 Allowed Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 115.807 -2.044 . . . . 0.0 109.929 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -69.18 -15.24 39.1 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 CA-C-N 126.036 3.192 . . . . 0.0 111.723 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.06 -13.53 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.22 80.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.03 -1.044 . . . . 0.0 109.044 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -67.9 -29.33 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 123.132 0.573 . . . . 0.0 110.909 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -47.48 63.85 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -67.23 -32.99 74.4 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.301 -0.875 . . . . 0.0 111.015 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -57.71 -24.85 58.93 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.618 -1.301 . . . . 0.0 112.523 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -40.65 15.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.709 -1.245 . . . . 0.0 110.228 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.38 -27.38 62.26 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 127.502 2.321 . . . . 0.0 110.835 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -99.31 -37.25 9.33 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 120.06 -1.65 . . . . 0.0 109.865 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.82 -14.12 61.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.394 -1.441 . . . . 0.0 112.262 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -99.0 2.07 46.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.257 63.5 p 56.31 28.96 14.18 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.343 2.257 . . . . 0.0 111.856 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.89 -52.88 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.88 63.43 4.79 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.816 -0.436 . . . . 0.0 113.626 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.39 -16.74 63.58 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 118.879 1.34 . . . . 0.0 110.092 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.24 36.8 4.28 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.25 -54.43 12.73 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.65 169.01 14.96 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.06 130.17 10.0 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 100.366 -3.939 . . . . 0.0 100.366 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.35 177.57 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.253 2.635 . . . . 0.0 107.841 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.38 -119.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 C-N-CA 123.696 0.798 . . . . 0.0 110.949 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -132.63 -38.68 1.01 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.88 -14.62 53.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.791 1.636 . . . . 0.0 108.81 -168.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -33.51 68.84 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.18 63.44 0.81 Allowed Glycine 0 CA--C 1.464 -3.127 1 N-CA-C 102.69 -4.164 . . . . 0.0 102.69 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -30.95 -18.76 0.0 OUTLIER 'General case' 0 C--N 1.361 1.077 1 C-N-CA 132.647 4.379 . . . . 0.0 117.466 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.33 -19.08 7.74 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 119.931 -1.73 . . . . 0.0 113.436 160.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.38 -44.18 98.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 124.451 1.1 . . . . 0.0 108.946 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.72 -55.08 7.3 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -40.08 -58.19 1.5 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.833 2.053 . . . . 0.0 112.326 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.14 -34.23 72.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.421 -169.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -74.23 -42.18 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 52.4 mtm -61.66 -49.72 75.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.524 0.73 . . . . 0.0 110.418 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.92 -27.47 66.66 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.514 -0.741 . . . . 0.0 111.185 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.35 81.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.677 -0.639 . . . . 0.0 110.811 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.69 89.57 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.91 -47.12 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.24 1.016 . . . . 0.0 109.907 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -69.26 -30.6 68.76 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.113 -0.992 . . . . 0.0 112.112 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.27 -52.1 60.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 C-N-CA 123.709 0.804 . . . . 0.0 109.265 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -69.1 -32.12 71.31 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.744 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.28 77.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.376 -0.827 . . . . 0.0 111.243 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -65.68 -36.14 82.8 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.651 1.18 . . . . 0.0 110.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.92 -19.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.405 1.482 . . . . 0.0 110.497 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -59.88 -20.48 57.47 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.791 -1.193 . . . . 0.0 112.714 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.93 74.8 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.228 -2.17 . . . . 0.0 111.539 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.96 53.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.005 0.922 . . . . 0.0 110.178 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.5 -27.93 18.88 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.864 1.316 . . . . 0.0 108.717 175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.77 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 119.836 -1.79 . . . . 0.0 110.757 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -68.28 -12.23 60.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.992 -1.068 . . . . 0.0 109.487 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.09 -20.78 59.32 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.024 -1.047 . . . . 0.0 111.37 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.02 -31.64 72.9 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.153 0.981 . . . . 0.0 108.976 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 t -90.63 -38.3 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 108.37 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -55.96 -35.76 67.05 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.724 1.61 . . . . 0.0 112.238 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -64.51 -20.36 66.16 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.029 -1.045 . . . . 0.0 112.407 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.445 -0.718 0 O-C-N 119.957 -1.714 . . . . 0.0 110.278 172.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -52.34 62.6 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.404 1.881 . . . . 0.0 109.908 -167.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 42.7 p-80 -76.53 -15.13 59.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.774 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.66 -32.8 35.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -63.86 -44.66 92.45 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.12 0.968 . . . . 0.0 110.0 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.59 -33.76 76.65 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.87 -0.519 . . . . 0.0 111.579 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.98 80.97 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.374 -0.829 . . . . 0.0 110.754 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -67.57 -39.22 84.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.757 -0.589 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.95 -35.88 82.14 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.5 0.72 . . . . 0.0 110.854 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.84 92.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.163 0.985 . . . . 0.0 110.554 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.36 -47.42 81.69 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.839 0.828 . . . . 0.0 110.782 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -70.71 -32.23 69.37 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.725 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -35.79 76.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.749 1.219 . . . . 0.0 109.032 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 tp -67.84 -41.71 82.54 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 121.618 -0.676 . . . . 0.0 111.191 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -66.33 -27.47 67.92 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.564 -0.71 . . . . 0.0 111.731 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -67.71 -39.69 84.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.73 1.212 . . . . 0.0 110.137 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.14 -37.83 77.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.997 0.919 . . . . 0.0 109.101 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.0 mt -56.92 -41.81 78.85 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.124 0.97 . . . . 0.0 112.182 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.54 -46.14 84.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.142 -0.974 . . . . 0.0 110.059 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -67.07 -33.44 75.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.918 -1.114 . . . . 0.0 111.54 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.16 -36.37 79.63 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.004 1.321 . . . . 0.0 110.617 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -63.83 -45.11 91.04 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 123.739 0.815 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -67.76 -49.29 63.28 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.565 0.698 . . . . 0.0 110.668 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -67.29 -34.41 77.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.64 0.776 . . . . 0.0 110.842 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.8 -49.09 61.45 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.297 1.039 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.29 -45.86 89.11 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-O 122.417 1.103 . . . . 0.0 110.189 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -86.87 2.07 50.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.525 -0.734 . . . . 0.0 111.302 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.87 27.6 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.23 -42.49 75.61 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 125.048 1.339 . . . . 0.0 108.911 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -69.58 85.93 0.45 Allowed 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.339 -0.851 . . . . 0.0 111.572 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.14 2.26 Favored Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.02 151.07 37.39 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 117.817 0.808 . . . . 0.0 109.24 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.01 131.84 8.13 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.17 1.914 . . . . 0.0 110.79 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.73 16.74 23.27 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.81 134.81 48.05 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 125.898 1.679 . . . . 0.0 114.177 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.03 -58.93 1.36 Allowed 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.466 1.107 . . . . 0.0 110.543 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.26 93.82 9.63 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 122.553 1.168 . . . . 0.0 112.067 -166.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.61 62.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 O-C-N 119.515 -1.991 . . . . 0.0 111.279 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -152.06 118.34 5.59 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 119.904 -1.747 . . . . 0.0 108.52 169.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.9 -48.93 96.55 Favored Pre-proline 0 C--N 1.359 0.993 0 CA-C-O 116.373 -1.775 . . . . 0.0 112.433 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.36 -8.96 23.58 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 CA-C-N 125.551 3.018 . . . . 0.0 112.947 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -101.78 -24.03 14.11 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.05 98.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 124.035 0.934 . . . . 0.0 110.058 -171.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.75 -32.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 124.567 1.147 . . . . 0.0 111.73 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -42.04 61.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 O-C-N 121.388 -0.82 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -67.33 -35.02 78.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -55.98 -34.46 65.75 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.819 -1.176 . . . . 0.0 112.013 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.31 -49.22 84.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.414 ' CD ' ' HH ' ' B' ' 61' ' ' TYR . 16.5 mt-10 -60.15 -38.03 81.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.819 1.648 . . . . 0.0 111.324 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -65.15 -45.56 84.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.554 1.942 . . . . 0.0 109.435 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.46 64.95 Favored 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 121.143 -0.973 . . . . 0.0 111.266 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 p -84.26 1.85 42.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.734 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.365 18.3 p 75.85 -41.04 0.42 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 128.339 2.655 . . . . 0.0 111.289 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -39.58 -54.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 128.183 2.593 . . . . 0.0 114.277 -169.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.89 65.93 3.03 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -67.16 -9.42 39.84 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.784 1.234 . . . . 0.0 113.464 -167.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 28.06 6.89 Favored Glycine 0 CA--C 1.488 -1.651 0 O-C-N 120.973 -1.079 . . . . 0.0 110.436 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' CG ' HH22 ' B' ' 68' ' ' ARG . 32.1 t70 -74.61 -47.64 31.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.367 -1.078 . . . . 0.0 109.05 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -123.7 160.45 27.2 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -136.57 147.25 58.98 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.98 167.1 12.79 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.617 2.211 . . . . 0.0 110.577 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.79 178.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 125.874 1.67 . . . . 0.0 108.823 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -74.56 -83.89 0.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.779 1.632 . . . . 0.0 109.85 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -57.81 -55.08 39.54 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 120.084 1.311 . . . . 0.0 113.958 -161.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -89.87 -56.95 3.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.705 -0.622 . . . . 0.0 111.721 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.23 -35.17 49.2 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 125.438 1.494 . . . . 0.0 113.81 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -68.39 -38.32 81.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 118.072 0.936 . . . . 0.0 110.775 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -69.75 -39.7 76.56 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 123.654 0.782 . . . . 0.0 109.888 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.71 -46.64 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.29 86.42 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 124.673 1.189 . . . . 0.0 110.41 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -48.53 -51.93 25.13 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 126.675 1.99 . . . . 0.0 110.375 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -71.1 -42.52 69.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.296 -0.877 . . . . 0.0 111.958 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.74 -42.98 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 124.022 0.929 . . . . 0.0 109.748 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.23 -47.87 82.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 124.758 1.223 . . . . 0.0 109.71 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -60.48 -35.59 76.27 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.504 0.722 . . . . 0.0 110.44 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.21 72.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.705 -0.622 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.53 -41.29 90.43 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.65 -46.79 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 124.33 1.052 . . . . 0.0 108.726 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -62.63 -32.72 73.81 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.8 -0.563 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.15 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 123.914 0.886 . . . . 0.0 110.567 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -62.56 -37.42 86.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.736 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.13 63.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.784 -0.572 . . . . 0.0 111.954 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -73.61 -26.21 60.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.099 -1.625 . . . . 0.0 110.309 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.82 -15.46 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.093 1.357 . . . . 0.0 110.348 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 m -54.08 -24.31 16.96 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 126.207 1.803 . . . . 0.0 112.849 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.49 64.03 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 120.179 -1.576 . . . . 0.0 112.264 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -92.62 -48.35 6.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.555 1.142 . . . . 0.0 108.746 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.47 -39.91 92.53 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 112.598 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.81 61.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -97.28 11.14 37.52 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 120.805 -1.184 . . . . 0.0 108.824 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -79.36 -29.67 42.28 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.396 -1.44 . . . . 0.0 109.048 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -78.7 -24.71 44.85 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.723 -1.236 . . . . 0.0 110.691 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.76 -32.57 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 123.586 0.754 . . . . 0.0 109.698 -171.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -63.35 -16.58 60.85 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.759 1.224 . . . . 0.0 111.884 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.34 -31.76 67.76 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.289 1.036 . . . . 0.0 110.562 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -177.279 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 . . . . . 0 CA--C 1.483 -1.624 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.528 ' CE1' ' HG3' ' B' ' 5' ' ' GLU . 12.5 p80 -50.46 -35.34 28.49 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 125.501 1.521 . . . . 0.0 114.743 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.528 ' HG3' ' CE1' ' B' ' 4' ' ' HIS . 4.9 mt-10 -67.59 -33.25 74.63 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.36 1.064 . . . . 0.0 110.78 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -81.03 -20.31 41.97 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.613 -0.679 . . . . 0.0 109.764 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -27.06 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -46.06 84.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.833 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.97 -28.59 62.49 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.446 -0.784 . . . . 0.0 111.007 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.9 -40.08 95.66 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.985 0.914 . . . . 0.0 109.8 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.62 76.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.049 0.939 . . . . 0.0 111.401 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -65.28 -39.5 92.65 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.9 -47.35 80.93 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.502 -0.748 . . . . 0.0 110.255 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -25.15 62.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.539 -0.726 . . . . 0.0 111.278 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -63.55 -39.73 95.16 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 120.831 -1.168 . . . . 0.0 111.334 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -62.05 -38.93 90.6 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.446 -0.784 . . . . 0.0 110.06 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.58 84.75 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.093 0.957 . . . . 0.0 110.27 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.44 -47.94 89.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.551 -0.718 . . . . 0.0 110.31 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.43 -36.29 80.94 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.673 -0.642 . . . . 0.0 110.486 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -62.75 -42.04 99.49 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.116 -1.615 . . . . 0.0 110.104 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -66.49 -36.79 83.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.848 0.832 . . . . 0.0 109.698 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.98 73.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.752 0.821 . . . . 0.0 111.552 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -60.93 -38.02 84.32 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.506 1.123 . . . . 0.0 111.98 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -69.03 -41.64 77.44 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.311 -0.868 . . . . 0.0 109.094 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -70.13 -26.37 63.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 121.822 -0.549 . . . . 0.0 110.933 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.07 95.72 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.303 1.041 . . . . 0.0 111.217 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.31 42.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 124.255 1.979 . . . . 0.0 108.474 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -147.19 -42.24 0.18 Allowed 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 100.875 -3.75 . . . . 0.0 100.875 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 56.52 0.46 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.689 1.996 . . . . 0.0 110.216 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? 179.68 -27.49 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 125.921 1.688 . . . . 0.0 108.289 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.43 71.73 6.02 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.495 -0.753 . . . . 0.0 109.985 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.22 -34.47 0.84 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 159.24 57.8 Favored Pre-proline 0 CA--C 1.51 -0.586 0 O-C-N 120.681 -1.482 . . . . 0.0 112.817 -173.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.17 152.26 24.01 Favored 'Trans proline' 0 CA--C 1.501 -1.163 0 C-N-CA 122.062 1.842 . . . . 0.0 109.848 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.13 42.34 84.42 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.63 -60.18 2.94 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.859 0.864 . . . . 0.0 109.716 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 65.43 -9.32 0.24 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.557 1.543 . . . . 0.0 113.597 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -123.52 31.64 5.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.732 1.613 . . . . 0.0 107.804 -165.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 45.0 pt -70.45 38.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.425 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -161.72 142.68 10.92 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 119.571 -1.956 . . . . 0.0 109.583 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.81 -57.29 1.55 Allowed Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 126.899 2.079 . . . . 0.0 110.978 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.66 -11.84 26.34 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 CA-C-N 126.076 3.206 . . . . 0.0 111.228 -169.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.71 -7.13 44.53 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 125.67 1.588 . . . . 0.0 107.954 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.09 66.86 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 123.983 0.913 . . . . 0.0 109.06 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -82.21 14.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.348 1.071 . . . . 0.0 109.86 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.0 -58.53 2.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 167.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -54.49 -41.62 69.79 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.705 1.602 . . . . 0.0 111.804 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -65.24 -21.81 66.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 120.794 -1.191 . . . . 0.0 113.723 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.25 -53.82 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -47.33 -50.63 21.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 126.682 1.993 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -71.99 -30.16 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.772 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.23 60.65 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.223 -0.923 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -83.57 -1.18 53.22 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 122.963 0.505 . . . . 0.0 111.092 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.278 3.4 p 53.89 56.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.323 1.849 . . . . 0.0 112.505 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.0 t -120.54 -72.71 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.05 60.91 1.89 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -19.11 10.38 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.98 27.48 16.28 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.303 -1.498 . . . . 0.0 109.703 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -70.28 -63.67 1.04 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.031 2.133 . . . . 0.0 107.553 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -138.85 170.32 16.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.414 ' HH ' ' CD ' ' A' ' 50' ' ' GLU . 8.3 t80 -173.05 138.41 0.82 Allowed Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-O 115.696 -2.097 . . . . 0.0 105.356 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.92 179.38 6.04 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.069 2.513 . . . . 0.0 111.595 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.19 175.34 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -48.81 -50.39 34.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 129.25 3.02 . . . . 0.0 113.215 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.6 -11.88 61.21 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.905 1.282 . . . . 0.0 109.593 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -104.33 5.37 34.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 O-C-N 121.894 -0.504 . . . . 0.0 111.368 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.35 84.07 0.38 Allowed Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 104.543 -3.423 . . . . 0.0 104.543 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.414 HH22 ' CG ' ' A' ' 59' ' ' ASP . 24.7 ttm180 -59.76 -20.37 56.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.535 -1.568 . . . . 0.0 111.125 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -54.84 -13.48 1.08 Allowed 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.828 1.651 . . . . 0.0 113.082 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.98 -40.99 84.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 120.651 -1.281 . . . . 0.0 110.087 169.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.18 -50.17 29.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -48.79 -44.15 38.73 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.989 1.715 . . . . 0.0 111.038 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -48.1 79.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.142 1.377 . . . . 0.0 111.269 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.25 -43.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.53 -46.14 89.72 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.645 1.178 . . . . 0.0 110.413 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.54 -43.03 99.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.29 97.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 122.599 0.36 . . . . 0.0 110.963 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.58 -47.0 93.13 Favored Glycine 0 CA--C 1.495 -1.179 0 C-N-CA 124.358 0.98 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.38 -50.53 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 124.301 1.04 . . . . 0.0 109.054 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -63.28 -33.53 75.71 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 121.802 -0.561 . . . . 0.0 111.782 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.52 -59.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 C-N-CA 124.125 0.97 . . . . 0.0 110.48 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -64.79 -35.62 81.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 121.384 -0.823 . . . . 0.0 110.151 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.62 88.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 111.266 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.45 -35.62 81.52 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.4 1.08 . . . . 0.0 110.533 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.72 -16.11 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.796 1.238 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -59.79 -18.65 45.17 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 120.494 -1.379 . . . . 0.0 111.608 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.53 75.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 119.565 -1.96 . . . . 0.0 112.456 171.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.35 -38.73 55.44 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 121.182 -0.949 . . . . 0.0 109.29 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -32.69 69.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.73 67.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 120.389 -1.444 . . . . 0.0 111.685 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -90.63 3.3 54.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 120.706 -1.246 . . . . 0.0 109.014 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -75.34 -33.75 61.13 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 122.118 0.961 . . . . 0.0 108.72 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -68.55 -32.06 71.73 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.403 -1.435 . . . . 0.0 111.944 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 -22.75 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.912 1.285 . . . . 0.0 109.116 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -59.61 -26.32 65.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.329 1.052 . . . . 0.0 112.07 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -67.97 -24.27 65.14 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 120.242 1.383 . . . . 0.0 111.836 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 C--N 1.354 0.77 0 O-C-N 121.046 -1.033 . . . . 0.0 108.776 177.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.682 0 CA-C-O 122.938 1.352 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.567 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 48.8 p-80 -72.56 -18.01 61.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.958 1.303 . . . . 0.0 112.88 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -75.99 -41.04 52.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -72.51 -31.97 65.78 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.949 -1.094 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -75.1 -27.21 59.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.369 -0.832 . . . . 0.0 110.032 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -45.82 78.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.161 0.984 . . . . 0.0 110.579 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -62.25 -40.69 97.02 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.475 1.11 . . . . 0.0 110.763 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -60.12 -36.08 76.69 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 124.541 1.136 . . . . 0.0 110.839 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.87 76.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.56 0.744 . . . . 0.0 111.384 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.13 -34.65 78.9 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.184 -0.948 . . . . 0.0 111.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -72.69 -31.9 65.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 110.117 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.85 -33.56 74.02 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.4 1.48 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.93 -42.61 94.54 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.649 0.779 . . . . 0.0 110.663 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -61.9 -36.63 81.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.428 -0.795 . . . . 0.0 111.55 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.65 -43.49 97.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.85 0.86 . . . . 0.0 111.277 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.96 -23.89 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 121.119 -0.988 . . . . 0.0 110.692 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.86 -38.92 80.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 123.789 0.836 . . . . 0.0 110.509 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -65.47 -38.5 89.97 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.568 1.147 . . . . 0.0 110.452 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.02 -38.03 61.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.683 -1.261 . . . . 0.0 109.155 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -37.97 76.34 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 125.107 1.363 . . . . 0.0 111.493 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -43.21 81.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 118.906 0.775 . . . . 0.0 110.358 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.69 -50.6 62.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -59.58 -45.91 90.47 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 124.021 0.928 . . . . 0.0 109.524 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -42.69 99.89 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.968 0.907 . . . . 0.0 111.897 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.52 -33.16 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 O-C-N 120.973 -1.079 . . . . 0.0 110.326 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.64 -33.34 64.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.464 -0.772 . . . . 0.0 109.338 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.55 79.38 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 126.789 2.036 . . . . 0.0 109.725 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -74.44 -12.65 60.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.47 0.652 . . . . 0.0 112.12 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -79.63 77.19 6.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 120.487 -1.383 . . . . 0.0 110.327 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.82 -11.12 1.66 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.67 147.41 46.25 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 117.847 0.824 . . . . 0.0 110.773 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.32 121.73 3.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.843 2.362 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.87 29.91 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.95 124.34 20.51 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.075 1.75 . . . . 0.0 112.74 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.94 -21.47 6.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.033 0.533 . . . . 0.0 110.638 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -36.64 80.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.648 1.179 . . . . 0.0 110.524 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tp -47.56 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 128.994 2.918 . . . . 0.0 112.067 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -168.3 103.8 0.45 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -60.77 -36.64 37.14 Favored Pre-proline 0 C--N 1.35 0.612 0 CA-C-O 115.315 -2.279 . . . . 0.0 113.101 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.93 -48.79 0.62 Allowed 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 126.757 3.449 . . . . 0.0 110.473 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -6.51 47.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.986 1.314 . . . . 0.0 111.246 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.62 80.63 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 125.636 1.574 . . . . 0.0 110.876 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.96 -24.84 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.55 -44.66 77.72 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.895 -1.128 . . . . 0.0 108.61 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.7 -41.26 99.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.636 -0.665 . . . . 0.0 110.833 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -57.93 -46.12 85.5 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.092 -1.005 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -80.25 74.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 122.206 1.003 . . . . 0.0 108.851 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -165.14 -40.62 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -31.55 71.08 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.968 0.907 . . . . 0.0 110.485 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -24.12 64.81 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.441 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.46 6.61 48.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 123.279 0.632 . . . . 0.0 109.55 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 55.92 52.28 10.88 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 126.125 1.77 . . . . 0.0 112.418 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.3 -156.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.37 103.95 0.33 Allowed Glycine 0 CA--C 1.475 -2.467 1 N-CA-C 99.133 -5.587 . . . . 0.0 99.133 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.96 -28.28 62.32 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 118.101 0.951 . . . . 0.0 110.214 -172.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.0 46.04 0.84 Allowed Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -75.44 -51.75 12.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -137.69 172.48 12.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.35 125.17 5.92 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 101.843 -3.391 . . . . 0.0 101.843 -168.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.85 168.68 21.87 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 123.83 3.02 . . . . 0.0 110.757 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.29 -90.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.011 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 12.7 m -165.01 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.624 -1.922 . . . . 0.0 106.732 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -73.74 -18.8 60.94 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.815 1.246 . . . . 0.0 108.979 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -62.07 -36.48 81.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 125.043 1.337 . . . . 0.0 109.576 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.22 -15.62 1.49 Allowed Glycine 0 CA--C 1.481 -2.087 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 172.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.481 ' H ' ' CD ' ' C' ' 66' ' ' GLU 0.352 3.5 ptp85 63.18 -48.63 0.22 Allowed 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 131.481 3.912 . . . . 0.0 111.734 -170.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.25 12.71 2.2 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.51 -49.42 59.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -49.12 65.59 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 122.897 0.479 . . . . 0.0 110.008 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.92 -42.92 69.3 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.067 0.947 . . . . 0.0 111.433 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -67.37 -32.27 73.07 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 111.224 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.74 -42.29 61.91 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.36 -47.39 85.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 110.502 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.22 -40.67 94.86 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.271 1.029 . . . . 0.0 110.914 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.73 85.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.466 0.707 . . . . 0.0 111.18 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.68 -44.27 92.79 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 124.036 0.827 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.7 -43.23 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.689 0.795 . . . . 0.0 109.116 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.09 -52.99 63.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 123.504 0.722 . . . . 0.0 111.608 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.82 -41.57 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 121.952 -0.468 . . . . 0.0 111.028 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -75.38 -25.23 57.49 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.559 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.77 -33.68 34.76 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.67 -1.269 . . . . 0.0 109.773 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.2 -41.59 75.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.789 1.636 . . . . 0.0 110.873 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.42 -8.03 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.489 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 13.0 m -62.98 -17.43 62.1 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.998 -1.064 . . . . 0.0 109.842 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.05 75.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.185 -1.572 . . . . 0.0 112.337 169.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.72 -52.64 10.02 Favored 'General case' 0 CA--C 1.492 -1.283 0 O-C-N 120.694 -1.254 . . . . 0.0 107.887 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.76 -29.05 70.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.03 0.443 . . . . 0.0 111.938 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.57 -20.72 64.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.587 -1.321 . . . . 0.0 111.074 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -80.95 -10.96 59.65 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.638 -1.289 . . . . 0.0 110.506 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.26 1.8 m-20 -79.39 -12.97 59.9 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 119.869 1.213 . . . . 0.0 110.817 -167.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.49 -19.97 41.15 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.329 -1.482 . . . . 0.0 109.928 167.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.13 -38.4 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 124.718 1.207 . . . . 0.0 108.077 -172.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -50.79 -31.3 16.51 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 125.816 1.646 . . . . 0.0 113.239 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -60.33 -32.18 71.0 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -172.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.215 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.59 -29.83 69.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.073 -1.017 . . . . 0.0 111.076 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -68.38 -22.53 64.64 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.051 -1.031 . . . . 0.0 111.908 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.82 -36.02 23.8 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -62.35 -40.81 97.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.125 0.97 . . . . 0.0 110.488 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.62 -38.44 90.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.483 1.113 . . . . 0.0 110.437 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.74 75.35 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.109 0.964 . . . . 0.0 111.207 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -65.15 -41.49 94.69 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.754 -0.591 . . . . 0.0 110.449 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -64.93 -31.75 73.14 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 122.81 0.444 . . . . 0.0 111.76 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.12 81.52 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.897 -0.502 . . . . 0.0 110.35 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.51 -50.65 72.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.97 0.508 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.56 -34.34 75.42 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.805 0.842 . . . . 0.0 111.462 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . 0.435 ' CD ' ' HZ1' ' D' ' 17' ' ' LYS . 2.9 tp10 -73.97 -32.02 63.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.032 -1.042 . . . . 0.0 110.503 -176.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.43 -38.18 90.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.722 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -75.41 -9.03 58.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.961 -1.087 . . . . 0.0 112.525 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.435 ' HZ1' ' CD ' ' D' ' 14' ' ' GLU . 5.5 tmmm? -82.9 -38.97 22.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.07 -38.16 81.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.227 -0.921 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.8 mt -51.94 -42.95 63.23 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.798 1.239 . . . . 0.0 112.518 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -68.32 -42.93 78.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.785 0.834 . . . . 0.0 110.48 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.21 -38.51 68.98 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.22 73.23 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 125.154 1.381 . . . . 0.0 111.955 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -57.55 -47.96 80.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.069 1.414 . . . . 0.0 110.697 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -73.39 -43.15 61.16 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.723 1.209 . . . . 0.0 108.514 -171.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -73.39 -29.66 62.75 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.723 0.809 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.79 79.15 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.035 0.934 . . . . 0.0 111.492 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.95 -43.59 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-O 122.424 1.106 . . . . 0.0 109.846 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -62.55 -32.97 74.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.48 1.512 . . . . 0.0 109.594 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -50.43 71.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 126.099 1.76 . . . . 0.0 110.643 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 111.3 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -80.73 68.24 6.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.414 -1.429 . . . . 0.0 110.987 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.14 -30.43 0.48 Allowed Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.73 150.08 81.35 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.345 1.058 . . . . 0.0 111.778 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -84.27 145.22 10.77 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 122.808 2.339 . . . . 0.0 109.861 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 33.41 55.59 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 147.25 47.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.315 1.046 . . . . 0.0 110.95 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.53 -52.93 1.59 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.98 97.74 10.92 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -137.84 114.05 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -179.6 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -174.86 -65.41 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 116.218 -1.848 . . . . 0.0 106.112 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.84 -16.81 29.44 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 CA-C-N 125.386 2.959 . . . . 0.0 112.637 -166.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -95.03 -8.43 36.79 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.948 1.299 . . . . 0.0 109.639 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.26 62.92 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.757 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.99 -33.58 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.029 0.931 . . . . 0.0 109.626 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -27.38 59.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 119.577 -1.952 . . . . 0.0 110.335 -174.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -69.03 -42.36 76.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.0 p -69.28 -32.26 71.31 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.193 -1.567 . . . . 0.0 110.866 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.81 -46.59 83.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 125.334 1.453 . . . . 0.0 110.936 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -80.61 -2.14 45.21 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 118.757 0.708 . . . . 0.0 112.013 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -101.22 -40.65 7.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 -22.92 66.31 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.765 -1.21 . . . . 0.0 111.685 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -91.83 2.8 56.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 125.026 1.33 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 25.6 p 52.03 70.42 0.56 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.343 1.857 . . . . 0.0 112.785 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.529 HG11 ' H ' ' D' ' 56' ' ' GLY . 1.2 p -129.24 -80.01 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 104.184 -2.525 . . . . 0.0 104.184 169.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.529 ' H ' HG11 ' D' ' 55' ' ' VAL . . . 80.63 80.36 0.85 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -171.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -74.55 -16.15 60.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.028 -1.278 . . . . 0.0 110.983 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.23 5.76 Favored Glycine 0 CA--C 1.492 -1.378 0 O-C-N 121.393 -0.817 . . . . 0.0 111.103 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -70.12 -59.07 3.12 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -137.97 162.64 33.56 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -158.24 154.68 24.39 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.12 177.77 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.483 2.789 . . . . 0.0 109.878 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . 0.264 5.6 p -115.01 -118.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 174.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -104.93 -85.62 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.189 -1.569 . . . . 0.0 108.988 -170.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.88 128.77 37.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.576 1.15 . . . . 0.0 109.086 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . 0.3 51.7 mt-10 62.2 -111.26 0.4 Allowed 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 115.441 -2.219 . . . . 0.0 106.972 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.51 -80.88 0.0 OUTLIER Glycine 0 C--N 1.353 1.49 0 C-N-CA 129.772 3.558 . . . . 0.0 113.786 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -58.92 -41.97 88.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 127.381 2.272 . . . . 0.0 113.196 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.35 -18.1 62.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.473 1.109 . . . . 0.0 109.464 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.63 -45.11 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.22 -50.91 69.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.666 1.187 . . . . 0.0 113.104 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.86 -35.46 70.99 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.875 0.87 . . . . 0.0 111.62 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -67.96 -45.51 74.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.248 1.019 . . . . 0.0 109.034 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.53 -43.62 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.932 0.893 . . . . 0.0 109.522 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.9 -43.64 98.26 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.387 0.675 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.08 -37.8 83.99 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.234 0.614 . . . . 0.0 111.097 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.11 85.9 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.147 0.579 . . . . 0.0 111.237 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.44 -46.52 55.62 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.81 -47.49 85.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 109.628 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -66.97 -26.69 66.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.13 -0.981 . . . . 0.0 112.372 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.28 -45.18 71.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.748 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.59 -35.2 80.24 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.078 0.942 . . . . 0.0 110.062 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -32.62 67.06 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.391 -0.818 . . . . 0.0 111.332 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.04 -43.92 94.09 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 124.628 1.171 . . . . 0.0 109.727 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -69.96 -4.83 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.375 -0.828 . . . . 0.0 112.061 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -57.49 -24.85 58.22 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.186 1.394 . . . . 0.0 110.344 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.84 78.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 119.847 -1.783 . . . . 0.0 112.163 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.84 -42.87 69.6 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -28.34 63.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.768 0.827 . . . . 0.0 110.858 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.32 76.48 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 119.982 -1.699 . . . . 0.0 109.442 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -11.53 52.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.87 -1.144 . . . . 0.0 112.593 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.37 -26.53 61.94 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.831 1.65 . . . . 0.0 111.595 -170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -79.06 -24.14 43.75 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.212 0.915 . . . . 0.0 110.062 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.97 -36.53 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.414 1.085 . . . . 0.0 108.701 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -55.5 -32.94 63.29 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 126.421 1.888 . . . . 0.0 110.83 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -61.7 -23.58 66.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.296 1.038 . . . . 0.0 111.74 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 . . . . . 0 C--N 1.358 0.968 0 O-C-N 121.797 -0.565 . . . . 0.0 109.934 -174.077 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.59 -43.23 97.6 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.033 1.733 . . . . 0.0 110.604 -171.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -47.09 72.07 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.634 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -38.29 89.06 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 122.578 0.351 . . . . 0.0 110.101 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -64.23 -46.27 84.57 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.682 -0.637 . . . . 0.0 110.871 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 121.796 -0.565 . . . . 0.0 111.04 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.47 85.61 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 110.805 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.8 -36.1 77.84 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.11 -38.07 85.03 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.904 1.282 . . . . 0.0 109.974 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.44 -37.22 86.76 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 111.711 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.38 -29.17 70.24 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.86 -1.15 . . . . 0.0 111.607 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -68.08 -31.94 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -71.9 -29.29 64.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.0 -37.22 83.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.985 -1.072 . . . . 0.0 110.204 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.19 -26.78 66.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.889 -1.132 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -63.85 -50.12 70.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 123.884 0.873 . . . . 0.0 109.605 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.42 -23.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 121.627 -0.671 . . . . 0.0 110.334 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.6 -50.18 74.56 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.364 0.984 . . . . 0.0 109.711 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -64.09 -42.79 96.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.807 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.05 -44.31 76.7 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.938 -0.476 . . . . 0.0 109.921 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.07 -37.45 85.04 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.144 -0.972 . . . . 0.0 112.026 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 -43.89 86.79 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.941 0.896 . . . . 0.0 110.738 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HZ3' ' CD ' ' A' ' 28' ' ' GLU . 14.9 tmtt? -65.21 -43.54 91.22 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.684 1.194 . . . . 0.0 107.973 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -64.52 -49.02 72.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.35 1.06 . . . . 0.0 110.839 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.09 92.97 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.526 1.53 . . . . 0.0 111.216 -173.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.7 -37.78 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 121.465 -0.772 . . . . 0.0 110.344 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' CD ' ' HZ3' ' A' ' 24' ' ' LYS . 55.6 mt-10 -69.72 -38.48 76.91 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.747 -1.221 . . . . 0.0 110.466 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.15 -47.87 66.87 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 126.144 1.777 . . . . 0.0 109.501 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.15 -38.97 79.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.385 1.074 . . . . 0.0 110.977 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -69.74 99.14 1.3 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 119.99 -1.694 . . . . 0.0 113.073 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.81 -3.27 19.54 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.29 148.87 37.42 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 118.193 0.997 . . . . 0.0 108.446 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -80.26 145.59 17.15 Favored 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.418 2.079 . . . . 0.0 109.967 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.31 -8.83 69.35 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 119.239 0.927 . . . . 0.0 111.374 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.01 53.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.92 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.06 -29.25 4.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.31 58.17 4.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.994 1.378 . . . . 0.0 107.959 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -87.5 42.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 O-C-N 119.852 -1.78 . . . . 0.0 111.276 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.477 ' HG ' ' CG ' ' A' ' 43' ' ' ASP . 1.6 p -135.29 -117.0 0.18 Allowed 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.745 -1.222 . . . . 0.0 109.672 -167.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 t80 171.7 -66.65 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.904 0 CA-C-O 116.315 -1.802 . . . . 0.0 108.766 -172.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -4.64 15.7 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 CA-C-N 125.175 2.884 . . . . 0.0 111.796 -164.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.477 ' CG ' ' HG ' ' A' ' 40' ' ' SER . 3.4 p-10 -103.99 -10.15 18.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 127.157 2.183 . . . . 0.0 109.1 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.85 63.89 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.231 -0.918 . . . . 0.0 110.31 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.79 -38.17 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.91 0.862 . . . . 0.0 110.479 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.32 -31.45 26.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -55.77 -40.87 73.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.297 1.039 . . . . 0.0 110.854 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -62.37 -29.36 70.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.698 0.799 . . . . 0.0 112.596 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.78 -36.07 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 120.846 -1.159 . . . . 0.0 108.52 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -65.69 -17.39 64.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.448 1.099 . . . . 0.0 112.166 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 t -109.31 -31.35 7.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.59 -1.319 . . . . 0.0 108.554 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.05 65.57 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.31 -1.494 . . . . 0.0 112.569 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 p -97.9 3.41 49.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.268 12.2 p 55.53 26.71 9.36 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 128.739 2.816 . . . . 0.0 112.569 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.02 -54.48 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 55.87 11.42 Favored Glycine 0 CA--C 1.485 -1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.85 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.89 -17.25 61.36 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.805 0.812 . . . . 0.0 111.96 -173.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.6 40.36 6.82 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.98 -46.61 70.84 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.59 -168.15 1.69 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.04 108.43 5.0 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.11 175.41 10.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.417 2.745 . . . . 0.0 109.281 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.0 p -140.14 -176.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 65.7 m -66.7 -45.25 79.36 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.714 -1.866 . . . . 0.0 112.158 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -80.0 -6.77 58.18 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 119.206 0.912 . . . . 0.0 111.156 -170.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.56 -32.68 74.18 Favored 'General case' 0 C--N 1.359 0.986 0 CA-C-O 123.888 1.804 . . . . 0.0 106.259 168.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.26 65.82 1.02 Allowed Glycine 0 CA--C 1.463 -3.168 1 N-CA-C 102.22 -4.352 . . . . 0.0 102.22 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -27.09 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.374 1.665 1 C-N-CA 131.95 4.1 . . . . 0.0 115.472 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -50.72 -12.23 0.1 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 164.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.73 -49.64 49.85 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 123.023 2.647 . . . . 0.0 106.942 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.03 -43.39 98.96 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.871 0.868 . . . . 0.0 110.426 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -65.23 -43.69 90.62 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.705 0.402 . . . . 0.0 111.386 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.68 -41.0 96.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 121.184 -0.948 . . . . 0.0 110.767 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.47 -34.44 35.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.889 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 55.9 ttm -62.72 -52.21 64.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.15 -32.49 70.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.426 -0.796 . . . . 0.0 110.481 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.3 -35.08 77.92 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.835 -0.541 . . . . 0.0 110.907 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.78 96.62 Favored Glycine 0 CA--C 1.492 -1.377 0 C-N-CA 123.646 0.641 . . . . 0.0 111.743 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.14 -47.04 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 124.264 1.026 . . . . 0.0 109.016 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.79 -30.21 68.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.139 -0.976 . . . . 0.0 111.572 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.65 -55.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.618 0.767 . . . . 0.0 109.461 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.37 -33.6 74.56 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 121.464 -0.772 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.72 72.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.153 -0.967 . . . . 0.0 110.529 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.74 -29.06 70.03 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 120.6 -1.312 . . . . 0.0 111.108 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.68 -11.7 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.489 1.515 . . . . 0.0 111.121 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.3 m -51.42 -29.39 15.74 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 119.428 -2.045 . . . . 0.0 112.581 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.14 62.88 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.407 -1.433 . . . . 0.0 112.065 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.2 -56.4 3.29 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 125.695 1.598 . . . . 0.0 108.686 172.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.09 -39.64 75.42 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.994 0.918 . . . . 0.0 112.816 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.9 -14.99 60.27 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.048 -1.033 . . . . 0.0 111.372 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.36 -9.52 47.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 120.683 -1.26 . . . . 0.0 107.702 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -37.52 73.81 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.415 -0.803 . . . . 0.0 109.618 -172.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -71.38 -24.9 62.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.987 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.5 t -70.52 -24.48 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 108.4 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -65.23 -15.7 62.75 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.081 -1.012 . . . . 0.0 111.735 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -55.91 -40.74 73.51 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 124.027 0.931 . . . . 0.0 110.438 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . 0.297 11.3 pt-20 . . . . . 0 CA--C 1.501 -0.928 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.32 -172.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p30 . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -61.36 -20.17 62.69 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.82 -34.37 62.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.048 -1.033 . . . . 0.0 108.537 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -69.1 -25.61 64.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.69 -0.631 . . . . 0.0 111.008 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -69.78 -44.16 70.7 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.87 87.95 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.261 1.424 . . . . 0.0 111.677 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -56.31 -38.7 71.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.771 1.629 . . . . 0.0 111.161 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -79.34 -13.77 59.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.391 -0.818 . . . . 0.0 111.396 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.55 -36.33 63.12 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -62.99 -43.18 99.5 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.78 0.8 . . . . 0.0 110.395 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.86 -43.43 98.81 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.26 1.424 . . . . 0.0 109.932 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.39 -39.93 77.13 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.931 1.692 . . . . 0.0 110.369 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.71 -41.11 98.14 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 123.381 0.672 . . . . 0.0 111.026 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -59.48 -35.63 74.47 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.426 1.091 . . . . 0.0 110.801 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.33 -34.94 79.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.638 1.175 . . . . 0.0 110.595 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.6 -39.67 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.93 -34.49 78.09 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -72.01 -30.71 65.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 111.864 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -81.89 -37.09 27.41 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.599 -1.313 . . . . 0.0 108.892 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.46 92.87 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.494 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 21.5 p -60.62 -38.7 85.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.492 0.717 . . . . 0.0 111.878 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -75.42 -53.84 8.03 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -62.4 -26.52 68.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.874 0.87 . . . . 0.0 111.186 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -43.85 72.14 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.837 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.16 -12.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.603 1.192 . . . . 0.0 109.153 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.52 21.5 17.35 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.842 -1.786 . . . . 0.0 107.119 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.7 5.02 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' B' ' 31' ' ' ARG 0.286 0.6 OUTLIER -76.98 -80.42 0.1 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.129 -170.54 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.57 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 9.8 mmm180 59.72 -27.73 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 129.611 3.164 . . . . 0.0 116.584 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.45 37.66 0.23 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.19 156.35 79.15 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.968 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.83 123.14 8.74 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.249 2.633 . . . . 0.0 109.899 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.95 -58.41 3.25 Favored Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.3 174.1 0.16 Allowed 'General case' 0 C--N 1.35 0.598 0 C-N-CA 127.539 2.335 . . . . 0.0 109.515 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -174.92 -53.2 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.76 -1.212 . . . . 0.0 108.93 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.22 138.34 31.57 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 pt -163.18 177.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t 71.97 102.85 0.07 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.751 2.02 . . . . 0.0 110.662 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -49.67 -53.43 41.59 Favored Pre-proline 0 C--N 1.35 0.627 0 CA-C-O 116.782 -1.58 . . . . 0.0 113.264 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.86 -11.68 25.85 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 124.709 2.718 . . . . 0.0 111.921 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -95.52 -27.96 15.12 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.77 72.13 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.442 1.497 . . . . 0.0 111.491 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.08 -30.37 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 121.506 -0.746 . . . . 0.0 111.206 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.03 -20.9 40.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.659 -1.275 . . . . 0.0 109.912 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -65.32 -47.2 77.36 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -57.85 -30.91 66.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.88 -27.95 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.73 0.812 . . . . 0.0 111.296 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -88.36 -3.55 58.82 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.269 -1.519 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -113.18 -175.75 2.74 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 81.11 -50.21 0.28 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.351 1.86 . . . . 0.0 109.391 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -88.12 32.27 0.76 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.204 1.401 . . . . 0.0 111.532 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 42.07 61.7 1.87 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.318 2.247 . . . . 0.0 114.313 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.62 -93.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.97 87.74 0.9 Allowed Glycine 0 CA--C 1.495 -1.2 0 N-CA-C 104.976 -3.25 . . . . 0.0 104.976 -171.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -77.73 -18.8 56.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.813 -1.404 . . . . 0.0 108.712 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 45.53 1.8 Allowed Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.95 -59.55 2.73 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.82 162.04 36.5 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -144.9 148.89 40.68 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.52 160.64 19.53 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 123.381 2.721 . . . . 0.0 108.622 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.23 -99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-N 121.02 1.736 . . . . 0.0 110.424 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -141.57 -48.31 0.39 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 120.13 1.332 . . . . 0.0 111.299 -167.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -27.57 64.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 125.522 1.529 . . . . 0.0 108.196 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.47 -25.44 16.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.067 2.147 . . . . 0.0 111.963 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.32 93.86 1.31 Allowed Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 98.736 -5.746 . . . . 0.0 98.736 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -63.49 -11.6 25.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.69 -1.477 . . . . 0.0 111.9 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -61.58 -17.3 54.47 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.999 0.92 . . . . 0.0 112.328 168.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.78 -33.44 59.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.811 -1.181 . . . . 0.0 109.379 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.99 7.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 120.467 -1.395 . . . . 0.0 108.007 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -48.09 -52.43 20.37 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 125.916 1.687 . . . . 0.0 110.29 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -69.36 -29.57 67.39 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.983 -0.448 . . . . 0.0 111.234 -170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.8 t -75.41 -44.01 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 O-C-N 120.824 -1.172 . . . . 0.0 108.673 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.0 mtm -64.75 -45.68 85.4 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -75.39 -21.7 58.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.378 -0.826 . . . . 0.0 111.15 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.24 -31.11 70.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.889 -1.132 . . . . 0.0 110.486 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.26 -39.23 95.9 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.6 mt -61.84 -38.44 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.09 0.956 . . . . 0.0 108.946 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.97 -54.79 24.93 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.623 -1.298 . . . . 0.0 112.065 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 m -66.74 -45.38 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 123.119 0.568 . . . . 0.0 110.513 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.97 -33.29 63.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.04 -28.88 67.77 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.958 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -65.55 -36.79 84.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 120.925 -1.11 . . . . 0.0 109.984 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.1 -17.97 20.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 125.135 1.374 . . . . 0.0 110.766 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -54.49 -24.41 20.32 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.701 1.2 . . . . 0.0 111.895 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.66 86.93 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.233 -1.542 . . . . 0.0 112.472 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.1 -45.17 70.91 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.66 1.184 . . . . 0.0 108.683 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.86 -37.36 85.97 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.621 0.724 . . . . 0.0 110.353 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.21 76.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.901 -1.124 . . . . 0.0 111.387 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.7 t -78.51 -0.38 29.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 120.607 -1.308 . . . . 0.0 110.27 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -33.89 65.43 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 119.25 0.932 . . . . 0.0 109.758 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -71.11 -31.07 67.3 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.767 -1.208 . . . . 0.0 110.508 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.07 -24.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.89 1.276 . . . . 0.0 109.455 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -58.52 -21.74 53.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.213 1.005 . . . . 0.0 112.38 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.88 -23.01 67.1 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.63 -1.294 . . . . 0.0 111.049 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 C--N 1.357 0.899 0 O-C-N 121.074 -1.016 . . . . 0.0 110.013 179.674 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.383 0 CA-C-O 122.759 1.266 . . . . 0.0 114.126 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.548 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 36.6 p-80 -58.35 -25.43 61.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.512 2.325 . . . . 0.0 115.413 -174.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -75.31 -27.15 59.18 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.338 -1.476 . . . . 0.0 110.435 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.47 -36.4 71.17 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.2 -0.937 . . . . 0.0 109.603 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.28 -38.44 65.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.93 0.892 . . . . 0.0 109.29 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.31 93.57 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.235 1.014 . . . . 0.0 111.858 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -27.75 60.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.397 -0.815 . . . . 0.0 110.578 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.69 -33.0 66.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.9 84.72 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -58.8 -35.13 72.34 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.552 0.741 . . . . 0.0 112.128 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.33 -24.08 61.25 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.345 -0.847 . . . . 0.0 111.384 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -73.77 -35.96 65.04 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.82 -42.46 99.05 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.303 -0.873 . . . . 0.0 110.928 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -57.83 -38.07 74.97 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.346 1.058 . . . . 0.0 111.97 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.81 81.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.567 1.147 . . . . 0.0 109.892 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.67 -37.7 79.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 O-C-N 121.15 -0.969 . . . . 0.0 108.748 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.33 -36.48 73.46 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.742 0.817 . . . . 0.0 112.226 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -63.42 -51.91 63.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.703 1.201 . . . . 0.0 109.169 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -63.77 -40.43 96.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.494 0.664 . . . . 0.0 110.216 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -32.27 73.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.386 1.474 . . . . 0.0 112.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -68.94 -34.87 76.06 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.387 -0.821 . . . . 0.0 110.378 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -70.89 -37.59 73.01 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.22 -51.54 63.2 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 -17.55 63.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -82.66 -36.07 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 O-C-N 120.327 -1.483 . . . . 0.0 108.402 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -78.33 -41.8 32.53 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.81 90.23 7.83 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 143.99 2.09 0.0 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.987 3.715 . . . . 0.0 110.085 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -91.05 41.36 1.06 Allowed 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.594 -1.941 . . . . 0.0 112.408 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.31 44.67 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.389 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.75 157.42 33.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.21 98.64 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.658 2.239 . . . . 0.0 112.647 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 9.36 36.79 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 143.6 15.83 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.604 1.562 . . . . 0.0 112.591 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.88 -32.4 3.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 124.639 1.176 . . . . 0.0 108.807 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.563 ' HG ' ' HE ' ' C' ' 60' ' ' ARG . 2.4 tt -89.49 50.6 1.94 Allowed 'General case' 0 C--N 1.35 0.603 0 CA-C-O 122.898 1.332 . . . . 0.0 108.144 -174.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.53 53.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 O-C-N 119.915 -1.741 . . . . 0.0 110.083 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -125.87 -151.17 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.89 -1.131 . . . . 0.0 108.401 -167.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -171.32 -64.12 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -69.6 -32.11 19.89 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.214 2.898 . . . . 0.0 112.386 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.488 ' CG ' HH22 ' C' ' 60' ' ' ARG . 8.3 p-10 -95.32 15.71 18.66 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.504 1.047 . . . . 0.0 109.88 -178.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -32.9 73.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.636 -1.29 . . . . 0.0 110.009 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -73.2 -22.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 O-C-N 121.562 -0.711 . . . . 0.0 109.84 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.24 -43.1 58.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.84 -37.24 86.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.75 1.22 . . . . 0.0 109.651 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -58.74 -35.22 72.37 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.73 1.212 . . . . 0.0 111.262 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.54 -52.72 56.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.007 0.923 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.36 -24.98 60.4 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 121.834 -0.541 . . . . 0.0 110.922 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -63.87 -42.77 97.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.002 1.321 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.38 73.9 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.34 -0.85 . . . . 0.0 112.05 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -3.02 45.54 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.158 -0.964 . . . . 0.0 111.405 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.255 3.1 p 59.8 21.71 10.57 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 127.479 2.312 . . . . 0.0 111.578 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.66 -48.05 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.53 74.53 0.35 Allowed Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -69.13 -24.96 64.16 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.217 -1.167 . . . . 0.0 110.867 -170.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.31 10.27 9.75 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.7 -61.4 2.38 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 126.737 2.015 . . . . 0.0 109.509 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.563 ' HE ' ' HG ' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -145.6 174.14 11.44 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 171.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -167.53 154.37 7.86 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.14 170.63 8.22 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.005 2.47 . . . . 0.0 110.73 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.87 -146.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -76.83 -60.52 2.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 126.172 1.789 . . . . 0.0 109.914 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.91 -16.74 61.09 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.897 0.856 . . . . 0.0 110.264 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.35 -16.42 60.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.608 -0.682 . . . . 0.0 109.352 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.77 88.76 0.64 Allowed Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 101.252 -4.739 . . . . 0.0 101.252 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -64.47 -13.03 49.77 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.426 -1.632 . . . . 0.0 110.846 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -60.77 -14.07 19.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.165 0.986 . . . . 0.0 113.172 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.09 -37.4 79.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 O-C-N 120.833 -1.167 . . . . 0.0 109.584 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.83 57.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.085 -1.009 . . . . 0.0 108.953 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.69 -48.77 49.45 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.045 1.738 . . . . 0.0 112.235 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -67.69 -32.06 72.44 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 120.47 -1.394 . . . . 0.0 112.056 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.77 -37.62 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.057 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 69.5 mtm -63.07 -45.89 90.0 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.538 0.735 . . . . 0.0 110.807 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -62.9 -35.61 80.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.718 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.3 77.93 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 118.271 0.487 . . . . 0.0 111.815 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.18 -53.32 22.69 Favored Glycine 0 CA--C 1.49 -1.482 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.76 -44.59 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.195 0.998 . . . . 0.0 109.382 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -65.39 -40.0 92.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.441 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.58 -50.1 69.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -66.9 -37.39 84.29 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.655 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.82 -32.89 74.67 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.104 0.962 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.19 -35.72 77.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 124.874 1.27 . . . . 0.0 110.963 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.69 -13.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 125.408 1.483 . . . . 0.0 111.118 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.8 m -62.04 -18.1 59.52 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.654 -1.904 . . . . 0.0 111.986 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.71 -17.33 62.87 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.571 -1.331 . . . . 0.0 111.594 170.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.548 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -83.45 -54.46 4.95 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.74 -28.44 66.82 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -165.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.76 -14.18 60.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.61 -1.931 . . . . 0.0 111.029 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -73.78 -17.14 61.13 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 119.94 -1.725 . . . . 0.0 109.828 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -30.13 70.43 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.245 0.618 . . . . 0.0 111.064 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -75.42 -23.89 57.04 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.027 -1.046 . . . . 0.0 110.911 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.67 -27.24 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 123.914 0.885 . . . . 0.0 108.675 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -67.49 -10.83 55.3 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.698 -0.626 . . . . 0.0 112.538 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -67.24 -36.65 82.09 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 120.782 -1.199 . . . . 0.0 109.074 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.436 -1.125 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -176.175 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.417 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.433 -1.277 0 CA-C-O 121.394 0.616 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.25 -64.86 0.46 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 129.017 2.927 . . . . 0.0 112.688 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.417 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 39.3 p-80 -62.91 -25.6 68.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 112.996 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -79.61 -39.67 31.08 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -64.07 -44.65 91.75 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.592 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.54 -37.21 86.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 110.563 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.84 72.6 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.092 -1.005 . . . . 0.0 110.215 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.32 -28.31 67.04 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.424 0.69 . . . . 0.0 110.646 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.97 -41.81 75.33 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 125.697 1.599 . . . . 0.0 110.964 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.15 86.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.286 0.634 . . . . 0.0 111.5 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.91 -26.03 65.79 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.069 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -71.43 -33.2 69.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.9 -1.125 . . . . 0.0 109.969 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -65.42 -40.04 92.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 123.905 0.882 . . . . 0.0 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.88 -42.61 89.91 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.09 0.556 . . . . 0.0 111.527 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.3 -36.98 79.14 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 112.28 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -68.87 -39.79 79.64 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 110.003 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.06 -40.41 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.15 -53.1 60.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.951 0.796 . . . . 0.0 110.554 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -59.72 -50.02 75.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.869 0.868 . . . . 0.0 111.166 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -73.67 -29.05 62.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.857 -1.152 . . . . 0.0 111.513 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.88 63.94 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -58.51 -45.08 89.54 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.377 1.071 . . . . 0.0 110.565 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -60.9 -49.91 75.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -64.16 -31.82 73.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 123.923 0.889 . . . . 0.0 111.599 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.33 68.77 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.346 0.975 . . . . 0.0 110.693 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -88.01 -32.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 O-C-N 121.393 -0.817 . . . . 0.0 111.793 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -75.29 -23.87 57.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.227 -1.545 . . . . 0.0 111.413 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.0 37.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.72 -86.54 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 mtm-85 -17.32 90.45 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 129.121 2.968 . . . . 0.0 115.361 -151.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -30.79 2.0 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 107.021 -2.432 . . . . 0.0 107.021 -171.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.62 141.24 25.57 Favored Pre-proline 0 C--N 1.353 0.727 0 C-N-CA 125.728 1.611 . . . . 0.0 114.396 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.07 92.83 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.698 2.266 . . . . 0.0 113.345 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.68 -43.55 1.48 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 103.667 -3.773 . . . . 0.0 103.667 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.68 -179.17 0.17 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.551 1.94 . . . . 0.0 109.894 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.7 -41.79 0.05 Allowed 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.75 -14.75 13.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.05 1.34 . . . . 0.0 112.39 -167.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 pt -43.2 105.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -174.91 -143.53 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.6 -58.8 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.09 0 C-N-CA 126.641 1.977 . . . . 0.0 107.553 173.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.6 -20.71 26.53 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 126.064 3.201 . . . . 0.0 112.334 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.68 6.11 42.87 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 118.632 0.651 . . . . 0.0 110.241 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.0 -50.69 67.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.394 -0.817 . . . . 0.0 109.758 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.6 -7.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.013 0.911 . . . . 0.0 110.625 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 -28.24 15.92 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -83.74 -28.51 28.18 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.4 1.0 . . . . 0.0 108.947 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.8 t -78.17 62.69 2.94 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.484 -1.385 . . . . 0.0 108.717 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 84.4 t -137.87 -77.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.99 -5.61 54.29 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.003 -1.061 . . . . 0.0 111.606 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -82.04 -17.16 47.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 121.076 -1.015 . . . . 0.0 108.493 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.09 -32.77 56.88 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.898 -1.126 . . . . 0.0 109.158 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -91.36 16.86 9.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.193 0.597 . . . . 0.0 110.336 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p 55.1 52.45 11.7 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.143 1.777 . . . . 0.0 114.373 170.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -127.11 -61.87 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 87.65 -51.32 4.11 Favored Glycine 0 CA--C 1.496 -1.13 0 O-C-N 119.997 -1.689 . . . . 0.0 109.785 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 74.89 -24.76 0.21 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 128.151 2.58 . . . . 0.0 110.615 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 111.25 23.87 5.61 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.02 -65.91 0.64 Allowed 'General case' 0 C--N 1.36 1.063 0 CA-C-N 118.905 1.352 . . . . 0.0 110.056 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -126.81 161.72 27.55 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.57 89.06 7.61 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 117.858 -1.067 . . . . 0.0 109.168 -170.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.17 158.85 56.14 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.823 2.349 . . . . 0.0 111.875 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.453 HG21 ' H ' ' D' ' 64' ' ' THR . 3.6 p -111.8 -162.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 120.161 1.346 . . . . 0.0 110.788 -174.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.453 ' H ' HG21 ' D' ' 63' ' ' VAL . 1.3 p -70.09 -49.73 47.97 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 128.968 2.907 . . . . 0.0 111.258 -174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -69.65 -30.63 68.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.003 0.921 . . . . 0.0 110.942 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 8.4 pt-20 -79.49 -1.27 36.77 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.83 82.44 0.21 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 104.131 -3.588 . . . . 0.0 104.131 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -50.87 -22.09 2.03 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 120.642 2.221 . . . . 0.0 111.75 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -43.8 -23.08 0.07 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.412 1.885 . . . . 0.0 115.42 161.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.37 -43.91 97.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.588 1.54 . . . . 0.0 108.778 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.54 87.29 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.026 0.53 . . . . 0.0 110.22 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -57.56 -41.91 81.96 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.722 1.209 . . . . 0.0 110.466 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -62.23 -40.36 95.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.347 1.059 . . . . 0.0 111.429 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.06 -42.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -60.98 -46.43 90.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.526 0.73 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -66.84 -36.12 81.61 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 121.438 -0.789 . . . . 0.0 111.523 -175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -44.75 93.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 121.764 -0.585 . . . . 0.0 110.047 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.04 -47.81 89.21 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 124.465 1.031 . . . . 0.0 112.537 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.17 -49.39 81.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.63 1.172 . . . . 0.0 109.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.36 -31.46 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.477 -0.764 . . . . 0.0 111.429 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.4 -53.0 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 118.862 0.756 . . . . 0.0 110.136 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.53 -32.29 72.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.811 -0.555 . . . . 0.0 110.957 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.54 -39.86 92.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.694 1.198 . . . . 0.0 110.802 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.77 -22.42 12.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 124.766 1.226 . . . . 0.0 110.982 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -60.87 -12.21 10.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.0 95.16 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 118.784 -2.447 . . . . 0.0 112.27 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.88 72.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 36.9 mt -80.36 -28.51 38.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.722 0.772 . . . . 0.0 110.876 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.94 -26.32 59.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 120.326 -1.484 . . . . 0.0 110.025 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -78.65 -2.78 40.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.773 -1.204 . . . . 0.0 109.949 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.251 11.8 m-20 -78.68 -16.83 56.83 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 120.68 1.582 . . . . 0.0 111.663 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -80.68 -11.89 59.56 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.227 -1.546 . . . . 0.0 109.846 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.75 -32.85 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -61.7 -19.29 62.2 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.804 1.642 . . . . 0.0 111.872 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -65.18 -22.16 66.86 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.445 1.098 . . . . 0.0 111.439 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.433 -1.281 0 C-N-CA 126.359 1.864 . . . . 0.0 106.16 -170.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 73.13 -58.27 0.61 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.958 2.103 . . . . 0.0 111.11 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 2' ' ' ALA . 28.9 p80 -61.99 -30.51 70.99 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.962 1.705 . . . . 0.0 111.098 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -67.06 -45.13 78.33 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.67 1.188 . . . . 0.0 108.46 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.04 -44.53 96.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.98 0.912 . . . . 0.0 109.687 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -66.23 -32.97 74.71 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.443 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.38 88.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 121.569 -0.707 . . . . 0.0 110.454 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -69.91 -31.13 68.76 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.614 0.721 . . . . 0.0 110.967 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -66.7 -38.52 86.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.907 0.883 . . . . 0.0 110.088 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.04 77.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.772 0.829 . . . . 0.0 111.075 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.45 -37.11 84.63 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.79 0.836 . . . . 0.0 111.559 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -65.87 -43.42 88.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.78 -32.73 73.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 110.224 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.7 -39.95 91.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.375 0.67 . . . . 0.0 111.525 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -64.64 -32.93 74.81 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.592 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -64.82 -39.76 94.1 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.71 0.804 . . . . 0.0 109.915 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.03 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 O-C-N 120.704 -1.248 . . . . 0.0 109.479 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.2 mt -60.99 -37.41 82.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.292 -0.88 . . . . 0.0 111.573 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.99 -45.48 73.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.933 0.893 . . . . 0.0 109.16 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -63.0 -43.64 98.22 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.969 -0.457 . . . . 0.0 109.814 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.31 74.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.873 1.669 . . . . 0.0 111.554 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -65.96 -37.38 85.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 122.153 -0.342 . . . . 0.0 110.964 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -73.09 -45.59 56.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -61.47 -46.28 90.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.07 53.16 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.027 1.331 . . . . 0.0 111.271 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.99 -39.39 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.767 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -81.96 -15.03 55.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.267 -1.521 . . . . 0.0 111.383 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.65 7.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.84 -33.15 74.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.251 1.021 . . . . 0.0 111.465 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -72.31 108.48 5.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 119.541 -1.974 . . . . 0.0 110.356 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.07 -18.83 7.4 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.43 143.82 42.24 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 117.519 0.66 . . . . 0.0 111.0 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.63 116.12 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.575 2.183 . . . . 0.0 111.983 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.3 45.18 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.95 -67.37 0.27 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 127.616 2.366 . . . . 0.0 109.845 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 90.22 -31.1 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 126.754 2.022 . . . . 0.0 108.733 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -89.46 124.92 34.93 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.3 pt -137.63 -3.97 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.986 -1.071 . . . . 0.0 112.483 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -117.99 152.86 34.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 120.097 1.317 . . . . 0.0 109.942 -164.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -83.03 -55.69 0.5 Allowed Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.02 -17.92 28.03 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 CA-C-N 125.404 2.966 . . . . 0.0 111.706 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.64 -21.05 25.52 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.39 70.53 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 120.997 -1.064 . . . . 0.0 110.541 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.68 -28.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.541 -0.725 . . . . 0.0 109.553 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.37 68.71 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 119.752 -1.843 . . . . 0.0 109.927 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -62.79 -47.63 82.63 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.165 0.986 . . . . 0.0 109.815 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -68.73 -28.44 66.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.291 -1.505 . . . . 0.0 111.698 -172.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.4 t -56.83 -54.31 31.11 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 124.153 0.981 . . . . 0.0 109.974 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -20.26 61.29 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.787 -0.57 . . . . 0.0 111.116 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.6 m -75.14 -40.36 59.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.37 1.068 . . . . 0.0 109.218 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -26.55 63.07 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 120.86 -1.15 . . . . 0.0 111.359 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 p -83.37 -1.18 52.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.916 -0.49 . . . . 0.0 110.12 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 p 55.3 39.76 31.38 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 126.386 1.874 . . . . 0.0 111.538 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -104.23 -75.12 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.42 91.77 0.12 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -28.24 57.86 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.834 -1.392 . . . . 0.0 109.734 -172.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.33 3.64 5.63 Favored Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -56.6 -50.94 70.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.5 1.52 . . . . 0.0 113.29 -179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 59' ' ' ASP . 21.7 mtm-85 -142.06 158.62 43.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.33 148.06 20.51 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 102.934 -2.987 . . . . 0.0 102.934 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -90.79 171.09 3.41 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.901 2.4 . . . . 0.0 110.707 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.01 -154.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.686 0 CA-C-O 122.61 1.195 . . . . 0.0 110.291 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -83.51 -52.89 6.11 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.029 -1.669 . . . . 0.0 110.89 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -63.65 -32.2 73.6 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.798 2.439 . . . . 0.0 111.657 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -28.04 69.57 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 123.309 1.528 . . . . 0.0 108.1 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 65.74 1.22 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 103.097 -4.001 . . . . 0.0 103.097 174.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -27.78 -26.79 0.0 OUTLIER 'General case' 0 C--N 1.376 1.742 1 C-N-CA 131.715 4.006 . . . . 0.0 116.043 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -55.02 -12.77 0.92 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.366 2.666 . . . . 0.0 113.201 167.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 -52.13 34.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.11 99.68 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.555 -0.716 . . . . 0.0 111.347 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -50.6 -47.46 58.14 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.364 1.466 . . . . 0.0 111.379 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.66 -40.91 96.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.58 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.84 -43.77 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.205 1.002 . . . . 0.0 109.375 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.04 -49.1 78.98 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 124.391 1.076 . . . . 0.0 110.111 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -64.38 -35.04 79.6 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.631 -0.668 . . . . 0.0 110.897 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.38 80.6 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.147 0.579 . . . . 0.0 111.262 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.05 -43.65 80.71 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.54 -43.66 97.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 124.279 1.032 . . . . 0.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -60.41 -39.96 89.25 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.393 -0.817 . . . . 0.0 111.271 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.06 -54.28 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.103 0.961 . . . . 0.0 109.537 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -61.67 -40.08 93.67 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.421 0.689 . . . . 0.0 111.302 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.36 80.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.914 0.885 . . . . 0.0 110.981 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.58 -35.24 79.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.529 1.132 . . . . 0.0 110.804 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.12 -16.79 7.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 125.301 1.44 . . . . 0.0 111.206 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.0 m -56.6 -24.35 47.16 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.12 -1.612 . . . . 0.0 112.48 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.18 -23.78 62.52 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.842 -1.161 . . . . 0.0 112.439 172.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.59 -3.88 21.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.623 1.169 . . . . 0.0 111.587 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.5 mt -96.67 -42.98 7.76 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.45 64.64 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.343 -0.848 . . . . 0.0 111.067 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -71.32 -20.48 62.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 120.632 -1.292 . . . . 0.0 111.161 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.265 25.5 m-20 -86.8 -8.95 56.88 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.249 -162.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -81.96 -32.36 30.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.442 165.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.67 -32.67 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.789 1.236 . . . . 0.0 109.075 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -53.22 -24.67 11.65 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.583 1.553 . . . . 0.0 112.543 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -54.26 -39.33 66.76 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.596 1.559 . . . . 0.0 110.774 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 N--CA 1.444 -0.753 0 O-C-N 121.591 -0.693 . . . . 0.0 111.643 -175.481 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 121.871 0.844 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 35.1 p-80 -63.9 -21.48 66.48 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.501 1.52 . . . . 0.0 111.769 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -35.09 76.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.666 1.187 . . . . 0.0 109.044 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -68.69 -31.68 70.94 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.407 -0.808 . . . . 0.0 110.894 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.07 -27.9 63.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.297 0.57 . . . . 0.0 110.075 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.35 -35.62 78.01 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.305 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.73 -28.72 61.85 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.436 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.69 -38.34 90.66 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.393 -0.817 . . . . 0.0 109.817 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.45 89.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.956 0.903 . . . . 0.0 110.99 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.45 -37.91 89.18 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 121.302 -0.874 . . . . 0.0 111.335 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -65.62 -41.25 92.9 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.386 -0.821 . . . . 0.0 109.713 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.39 -37.23 74.88 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.765 1.226 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -63.67 -42.67 98.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.26 -29.07 68.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.543 -0.723 . . . . 0.0 111.423 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -66.47 -46.89 74.85 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.804 1.242 . . . . 0.0 109.851 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -76.01 -19.33 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 121.534 -0.729 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.75 -43.3 99.16 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 119.533 1.06 . . . . 0.0 110.323 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.54 -39.18 77.63 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -68.87 -31.93 71.23 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.199 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.32 -32.36 73.93 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.752 1.221 . . . . 0.0 110.636 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.0 t -62.2 -48.23 80.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.429 1.092 . . . . 0.0 109.269 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -60.98 -53.39 57.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 108.793 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -65.15 -38.44 90.58 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.33 -54.05 43.06 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.676 1.126 . . . . 0.0 110.984 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.24 -36.59 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.814 -0.554 . . . . 0.0 110.082 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.51 -31.88 57.94 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.18 -0.95 . . . . 0.0 110.33 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.5 -41.87 37.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 O-C-N 121.911 -0.493 . . . . 0.0 110.011 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.31 -28.23 69.17 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 121.87 0.843 . . . . 0.0 111.954 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -72.28 107.53 4.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 119.73 -1.856 . . . . 0.0 110.621 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.02 -24.13 4.56 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 106.594 -2.602 . . . . 0.0 106.594 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 147.22 84.37 Favored Pre-proline 0 N--CA 1.444 -0.759 0 O-C-N 121.94 -0.741 . . . . 0.0 111.444 -171.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.92 145.62 22.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.441 2.094 . . . . 0.0 109.689 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.95 -67.55 3.69 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.04 157.45 0.11 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.936 2.894 . . . . 0.0 109.946 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.27 -43.82 0.37 Allowed 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 120.922 -1.111 . . . . 0.0 108.907 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 12.7 tp -121.64 111.43 17.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.8 80.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 120.336 -1.478 . . . . 0.0 108.649 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -159.11 158.86 33.74 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.81 -61.58 0.24 Allowed Pre-proline 0 C--N 1.347 0.5 0 CA-C-O 116.971 -1.49 . . . . 0.0 109.204 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.5 -9.53 24.22 Favored 'Trans proline' 0 CA--C 1.511 -0.646 0 CA-C-N 124.835 2.763 . . . . 0.0 112.121 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.08 -22.22 16.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -40.33 82.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 121.452 -0.78 . . . . 0.0 109.25 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -66.16 -27.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 122.737 0.415 . . . . 0.0 110.937 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -73.14 -43.17 61.97 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.465 -0.772 . . . . 0.0 109.09 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.47 -31.93 73.24 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 125.071 1.349 . . . . 0.0 110.036 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 m -63.06 -36.47 83.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 119.08 -2.262 . . . . 0.0 112.45 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 t -64.87 -45.51 94.66 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 121.534 -0.729 . . . . 0.0 110.54 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -65.42 -33.83 76.86 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 122.008 0.909 . . . . 0.0 110.302 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 87.4 m -67.56 -41.3 84.45 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.285 -0.884 . . . . 0.0 109.85 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.75 61.78 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.173 -0.954 . . . . 0.0 112.189 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -97.29 0.86 48.79 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.263 18.7 p 62.21 31.37 17.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.863 1.665 . . . . 0.0 113.775 173.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 78.87 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.93 120.08 5.83 Favored Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 103.584 -3.806 . . . . 0.0 103.584 173.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -86.08 -84.95 0.16 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -168.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.95 37.6 0.31 Allowed Glycine 0 CA--C 1.479 -2.205 0 N-CA-C 106.292 -2.723 . . . . 0.0 106.292 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.1 -62.1 1.56 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -143.22 170.61 15.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -156.76 153.58 24.75 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.96 173.83 8.84 Favored 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 124.25 3.3 . . . . 0.0 109.692 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.34 -99.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 119.695 1.134 . . . . 0.0 112.505 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.7 m -150.46 -40.07 0.13 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.029 1.732 . . . . 0.0 109.106 -172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -88.45 -20.5 25.11 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.283 -0.886 . . . . 0.0 110.645 -169.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 66' ' ' GLU . 0.5 OUTLIER -59.53 -35.08 73.51 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 126.303 1.841 . . . . 0.0 108.315 171.058 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.38 90.02 1.88 Allowed Glycine 0 CA--C 1.467 -2.927 1 N-CA-C 97.802 -6.119 . . . . 0.0 97.802 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -56.42 -18.99 12.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.261 1.825 . . . . 0.0 111.382 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -54.72 -22.65 14.63 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 127.104 2.162 . . . . 0.0 113.135 168.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.26 -43.62 98.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.806 -1.184 . . . . 0.0 108.841 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.76 67.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.742 -0.599 . . . . 0.0 109.485 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -52.87 -45.04 67.26 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.482 1.513 . . . . 0.0 110.818 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.57 -39.82 85.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.001 0.92 . . . . 0.0 111.364 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.96 -41.22 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 109.086 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.5 mtt -60.43 -47.54 85.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.81 0.844 . . . . 0.0 110.049 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.927 -0.483 . . . . 0.0 111.134 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.37 90.76 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.766 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.23 -46.17 88.38 Favored Glycine 0 CA--C 1.495 -1.198 0 C-N-CA 124.061 0.839 . . . . 0.0 111.153 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.89 -46.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 C-N-CA 124.443 1.097 . . . . 0.0 109.182 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -62.76 -51.48 66.96 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.315 -0.866 . . . . 0.0 112.327 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.24 -40.84 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 O-C-N 121.76 -0.587 . . . . 0.0 111.081 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -74.22 -38.57 63.52 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.96 74.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.54 -0.725 . . . . 0.0 111.016 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.28 -30.57 71.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.756 1.222 . . . . 0.0 111.068 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.93 -14.91 15.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.879 1.272 . . . . 0.0 110.397 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 20.6 m -55.86 -23.46 30.96 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.6 -1.313 . . . . 0.0 110.894 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.45 74.92 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 119.251 -2.156 . . . . 0.0 112.446 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.61 -45.15 17.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 120.903 -1.123 . . . . 0.0 108.047 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.9 -27.7 63.99 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.877 0.871 . . . . 0.0 111.336 -173.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.06 -17.07 62.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 120.689 -1.257 . . . . 0.0 111.192 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -76.72 -13.92 59.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 120.559 -1.338 . . . . 0.0 111.128 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.259 7.4 t70 -75.71 -18.23 59.67 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 120.231 1.378 . . . . 0.0 111.218 -167.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.43 -36.13 60.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 119.895 -1.753 . . . . 0.0 110.234 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.35 -28.82 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 126.029 1.731 . . . . 0.0 109.437 -171.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -44.21 -36.75 2.83 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 126.835 2.054 . . . . 0.0 112.013 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -58.33 -33.12 69.15 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 123.917 0.887 . . . . 0.0 111.753 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 N--CA 1.44 -0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 107.971 -173.181 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.495 -1.173 0 CA-C-O 120.811 0.338 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -61.29 -28.34 69.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.93 -37.57 64.55 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 120.137 1.335 . . . . 0.0 107.837 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -73.84 -38.31 64.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -68.43 -35.19 77.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.969 -0.457 . . . . 0.0 110.345 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.56 90.07 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.8 0.84 . . . . 0.0 110.796 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.64 -38.22 83.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.832 -0.542 . . . . 0.0 110.556 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.89 -40.42 92.98 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.72 0.808 . . . . 0.0 110.328 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.15 75.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.588 0.755 . . . . 0.0 111.588 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -38.49 86.41 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.791 -0.568 . . . . 0.0 111.403 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.71 -30.67 69.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 122.219 1.009 . . . . 0.0 109.846 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.29 -33.56 71.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.803 0.841 . . . . 0.0 109.213 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.35 -43.87 93.22 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.42 0.688 . . . . 0.0 110.649 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -52.36 -41.04 62.73 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.906 1.282 . . . . 0.0 111.771 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -24.17 61.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.845 0.858 . . . . 0.0 111.199 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -78.42 -36.55 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.73 -41.85 91.82 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.815 1.246 . . . . 0.0 111.14 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -74.36 -14.95 60.95 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.58 -36.15 19.05 Favored 'General case' 0 CA--C 1.493 -1.232 0 O-C-N 120.672 -1.268 . . . . 0.0 108.023 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.49 72.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.033 0.933 . . . . 0.0 111.152 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -68.95 -36.84 78.39 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.992 0.815 . . . . 0.0 110.432 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -71.15 -43.8 66.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.93 -49.88 76.15 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.591 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.8 86.65 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.432 1.093 . . . . 0.0 112.017 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -37.07 74.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.283 -1.511 . . . . 0.0 110.187 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -73.85 -31.92 63.41 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 120.751 -1.218 . . . . 0.0 109.279 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.24 15.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 126.06 1.744 . . . . 0.0 109.053 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.64 -25.96 64.18 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.143 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.61 104.91 2.5 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 119.481 -2.012 . . . . 0.0 110.59 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.47 -5.76 21.09 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 144.31 28.87 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.68 139.6 11.27 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.367 2.045 . . . . 0.0 110.277 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.65 81.46 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.58 116.01 4.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 125.74 1.616 . . . . 0.0 106.906 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.74 -33.55 15.7 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.72 127.84 36.45 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 pt -144.88 168.8 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 101.222 -3.622 . . . . 0.0 101.222 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m 74.8 131.2 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.407 1.883 . . . . 0.0 113.402 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -58.64 -49.09 95.35 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 116.194 -1.86 . . . . 0.0 112.527 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.53 -27.94 38.78 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.297 2.928 . . . . 0.0 113.491 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.339 4.8 p-10 -98.7 -1.64 40.15 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 120.739 1.609 . . . . 0.0 111.035 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.17 74.69 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 120.713 -1.242 . . . . 0.0 110.878 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.66 -16.71 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 O-C-N 121.091 -1.006 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.08 -41.48 28.63 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.887 -1.133 . . . . 0.0 108.304 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.7 -33.29 75.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.858 0.837 . . . . 0.0 109.977 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -77.29 53.85 1.05 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 120.935 -1.103 . . . . 0.0 111.144 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -141.69 -54.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -34.25 71.13 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.741 1.216 . . . . 0.0 112.422 -172.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -72.68 -33.29 66.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 125.313 1.445 . . . . 0.0 109.898 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.1 -31.09 58.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.411 -1.431 . . . . 0.0 110.309 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -85.01 -1.74 57.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.171 0.588 . . . . 0.0 110.727 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p 51.13 68.01 0.86 Allowed 'General case' 0 C--N 1.352 0.709 0 C-N-CA 127.695 2.398 . . . . 0.0 112.099 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.12 -75.87 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.65 -78.94 0.63 Allowed Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -173.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 83.28 -49.62 0.15 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 127.746 2.419 . . . . 0.0 106.434 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.24 42.49 0.25 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -70.24 -54.12 14.12 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -139.4 -169.57 2.71 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.09 137.71 11.49 Favored Pre-proline 0 N--CA 1.438 -1.067 1 N-CA-C 100.153 -4.017 . . . . 0.0 100.153 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.07 163.0 0.26 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 CA-C-N 123.695 2.355 . . . . 0.0 109.389 166.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.19 -177.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-O 123.24 1.495 . . . . 0.0 111.558 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -68.64 -34.82 76.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 119.085 -2.259 . . . . 0.0 111.211 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -78.68 -23.64 45.53 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 -170.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -34.76 78.37 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' C' ' 69' ' ' LYS . . . 101.34 67.32 0.81 Allowed Glycine 0 CA--C 1.461 -3.327 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 171.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . 0.272 6.4 ttm180 -54.24 1.54 0.02 OUTLIER 'General case' 0 C--N 1.373 1.617 0 C-N-CA 127.582 2.353 . . . . 0.0 116.539 -166.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' C' ' 67' ' ' GLY . 1.2 mmmp? -54.54 -24.17 19.67 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 127.1 2.16 . . . . 0.0 111.48 155.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.24 -50.25 69.76 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 CA-C-N 120.639 1.563 . . . . 0.0 108.439 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.8 75.42 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.901 0.88 . . . . 0.0 110.869 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . 0.43 ' CD ' ' HZ1' ' C' ' 69' ' ' LYS . 17.9 tt0 -51.87 -44.17 63.59 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.782 1.633 . . . . 0.0 112.081 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -62.4 -35.4 79.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.071 1.348 . . . . 0.0 110.899 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.43 -40.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 O-C-N 121.61 -0.681 . . . . 0.0 109.358 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -59.65 -46.79 87.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.853 1.261 . . . . 0.0 110.115 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.67 -41.08 98.89 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.966 -0.459 . . . . 0.0 110.707 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.98 89.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.883 0.473 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.78 87.87 Favored Glycine 0 CA--C 1.494 -1.232 0 C-N-CA 123.744 0.687 . . . . 0.0 111.534 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.66 -44.27 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 123.983 0.913 . . . . 0.0 109.648 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.91 -33.63 76.48 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.397 -0.815 . . . . 0.0 111.911 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.78 -53.68 28.91 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 123.642 0.777 . . . . 0.0 109.581 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -67.11 -36.13 81.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.53 87.58 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.342 0.657 . . . . 0.0 110.644 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.67 -35.39 74.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.213 1.405 . . . . 0.0 111.775 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.63 -16.46 10.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 C-N-CA 125.255 1.422 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -62.72 -13.26 30.46 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 119.602 -1.936 . . . . 0.0 112.166 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.85 67.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.923 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.2 -55.69 4.57 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.01 -38.63 86.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.403 1.481 . . . . 0.0 113.304 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.68 61.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.558 -1.339 . . . . 0.0 110.852 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 68.7 p -88.78 -12.37 42.26 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 120.82 -1.175 . . . . 0.0 110.616 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.37 -28.45 67.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.229 0.922 . . . . 0.0 110.537 -167.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -77.08 -33.44 57.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.93 -33.06 56.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 125.366 1.466 . . . . 0.0 108.685 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -52.51 -24.17 7.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.636 1.974 . . . . 0.0 113.956 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -58.01 -32.98 68.45 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 119.756 1.162 . . . . 0.0 112.111 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.438 -1.048 0 O-C-N 121.144 -0.973 . . . . 0.0 111.04 -178.486 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.74 -35.65 81.76 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 121.722 -0.612 . . . . 0.0 111.326 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.446 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 7.3 p80 -73.32 -23.93 60.31 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 121.013 -1.055 . . . . 0.0 111.42 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.446 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 0.1 OUTLIER -83.16 -27.95 29.71 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -63.78 -42.32 97.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.361 1.065 . . . . 0.0 110.361 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.7 -38.74 84.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.839 0.828 . . . . 0.0 109.148 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.26 89.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.39 1.076 . . . . 0.0 111.413 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -69.84 -28.76 65.96 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.529 -0.732 . . . . 0.0 110.766 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.75 69.67 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.337 0.655 . . . . 0.0 111.738 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.97 -36.13 82.49 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.44 -0.787 . . . . 0.0 111.365 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.07 -27.11 60.75 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.927 -1.108 . . . . 0.0 110.647 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.72 -27.5 65.03 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.475 -0.765 . . . . 0.0 110.463 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 tp -71.79 -39.19 70.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.342 -0.848 . . . . 0.0 109.996 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -62.42 -31.92 72.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 123.424 0.69 . . . . 0.0 111.519 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.03 -45.5 92.6 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.504 1.122 . . . . 0.0 110.224 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -67.8 -35.67 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 123.917 0.887 . . . . 0.0 109.244 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.27 -53.69 54.71 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.288 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -68.68 -40.89 79.87 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.451 -0.78 . . . . 0.0 110.777 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.93 -47.33 83.72 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 109.837 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.56 60.93 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 121.009 -1.057 . . . . 0.0 111.771 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -66.04 -40.33 90.89 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 109.742 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -71.23 -25.57 62.55 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.34 1.456 . . . . 0.0 110.084 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -79.22 -55.5 5.05 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.4 -43.87 79.72 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 126.228 1.811 . . . . 0.0 112.531 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -31.8 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -83.96 -34.45 24.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.12 -50.45 54.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 127.009 2.124 . . . . 0.0 109.92 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.88 -41.84 99.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.999 1.32 . . . . 0.0 110.231 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -62.2 121.77 13.95 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 119.722 -1.861 . . . . 0.0 110.233 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.19 -12.44 48.48 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.22 56.66 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 118.144 0.972 . . . . 0.0 110.504 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.85 141.81 19.49 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.894 1.73 . . . . 0.0 109.775 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.81 75.51 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.57 139.28 58.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 111.666 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.91 -29.39 2.33 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 124.5 1.12 . . . . 0.0 110.185 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 30.0 tp -81.4 -106.77 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . 0.285 35.5 mt 71.97 173.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 -172.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 39.0 t 73.17 124.36 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.225 1.488 . . . . 0.0 110.511 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -66.66 -50.11 47.13 Favored Pre-proline 0 C--N 1.348 0.503 0 O-C-N 119.802 -1.811 . . . . 0.0 110.778 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -71.67 -11.71 28.23 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 125.074 2.848 . . . . 0.0 112.227 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.92 -45.3 12.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.61 72.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.048 0.939 . . . . 0.0 112.394 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -82.81 1.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.723 0.773 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -43.27 7.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 119.693 -1.879 . . . . 0.0 106.202 171.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -57.79 -32.57 67.67 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.346 1.858 . . . . 0.0 111.967 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 p -68.9 -34.6 75.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.026 -2.296 . . . . 0.0 110.321 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 t -87.93 63.43 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 0.0 108.795 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -175.87 -31.43 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 50.2 m -62.51 -39.28 93.03 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.346 1.458 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.62 65.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.135 -0.978 . . . . 0.0 112.176 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.97 4.38 45.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 122.68 0.392 . . . . 0.0 110.177 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.26 1.0 OUTLIER 64.67 10.63 6.11 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.04 1.736 . . . . 0.0 112.927 174.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.65 -65.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 -63.82 4.22 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.55 -60.57 0.53 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.301 2.24 . . . . 0.0 109.692 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.47 -95.07 0.1 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . 0.286 10.7 t70 43.62 -101.73 0.04 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.178 2.191 . . . . 0.0 113.79 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 170.05 15.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -124.94 150.62 66.84 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.82 165.72 19.72 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.142 2.561 . . . . 0.0 109.427 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.44 -162.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 122.913 1.34 . . . . 0.0 107.837 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -86.58 -52.18 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 125.639 1.576 . . . . 0.0 109.059 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.54 -23.41 64.52 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 128.83 2.852 . . . . 0.0 110.345 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.99 -26.42 66.02 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 123.888 1.804 . . . . 0.0 108.398 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.8 67.6 1.31 Allowed Glycine 0 CA--C 1.462 -3.239 1 N-CA-C 99.483 -5.447 . . . . 0.0 99.483 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -34.22 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.36 1.028 1 C-N-CA 132.134 4.174 . . . . 0.0 114.765 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -55.75 -15.27 2.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 127.387 2.275 . . . . 0.0 113.273 165.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -72.29 -54.9 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.28 85.48 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.014 0.926 . . . . 0.0 112.14 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.13 -45.29 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.808 2.043 . . . . 0.0 112.108 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.59 -29.65 64.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 121.832 -0.542 . . . . 0.0 110.94 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -72.68 -47.22 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -70.88 -41.39 71.42 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.092 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -64.02 -41.83 97.32 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 121.272 -0.892 . . . . 0.0 110.736 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.07 79.23 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.604 -0.685 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.7 -45.54 96.06 Favored Glycine 0 CA--C 1.494 -1.278 0 C-N-CA 123.827 0.727 . . . . 0.0 111.654 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 86.7 mt -58.67 -47.06 90.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 124.273 1.029 . . . . 0.0 109.409 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -63.72 -34.78 78.63 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.383 -0.823 . . . . 0.0 112.125 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.93 -50.07 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.604 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.72 -21.25 64.41 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.599 -0.688 . . . . 0.0 111.142 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.11 -37.7 25.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.35 -37.2 84.74 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.975 1.31 . . . . 0.0 110.652 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.32 -2.73 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.335 -0.853 . . . . 0.0 112.39 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 24.9 m -63.09 -16.84 61.29 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.818 -1.176 . . . . 0.0 110.856 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.91 -38.05 81.19 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.863 -1.773 . . . . 0.0 111.908 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.24 63.37 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 120.555 -1.341 . . . . 0.0 108.423 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.57 -37.8 87.58 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.807 1.243 . . . . 0.0 111.532 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -21.37 63.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.419 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -85.23 -16.19 41.04 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.48 -38.48 84.44 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.765 -1.209 . . . . 0.0 110.112 -170.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -70.59 -29.51 65.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.291 -1.505 . . . . 0.0 111.043 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.26 -20.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 109.502 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -50.74 -37.45 41.89 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.888 1.675 . . . . 0.0 110.233 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -56.77 -36.22 69.56 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.987 1.315 . . . . 0.0 111.197 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -171.02 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.272 0 CA-C-O 123.547 1.641 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -57.1 2.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -57.04 -24.16 51.77 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 128.079 2.552 . . . . 0.0 114.941 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.88 -28.58 61.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.509 -1.369 . . . . 0.0 110.07 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.87 -32.44 65.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.003 -1.06 . . . . 0.0 110.187 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -71.57 -38.23 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.212 1.005 . . . . 0.0 109.183 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.33 86.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.821 0.848 . . . . 0.0 111.158 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -73.32 -22.28 60.36 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.085 -1.009 . . . . 0.0 111.788 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -73.05 -23.84 60.63 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.129 -0.982 . . . . 0.0 109.879 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.43 77.85 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.9 -1.125 . . . . 0.0 109.98 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.8 -30.26 71.37 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.574 -0.704 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 120.891 -1.13 . . . . 0.0 111.176 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -68.79 -31.2 70.04 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.618 0.767 . . . . 0.0 109.074 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.07 -40.48 94.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.649 0.737 . . . . 0.0 110.635 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -70.06 -25.27 63.46 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.16 -0.962 . . . . 0.0 111.419 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -71.2 -46.68 60.73 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -70.94 -25.2 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 121.604 -0.685 . . . . 0.0 110.132 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.55 -55.17 38.52 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 118.963 0.802 . . . . 0.0 110.471 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.38 -31.47 67.34 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.624 -0.673 . . . . 0.0 110.986 -174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.23 -48.31 70.99 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.916 -1.115 . . . . 0.0 109.627 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.14 63.39 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 123.989 0.915 . . . . 0.0 112.144 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.4 m -65.65 -39.74 91.74 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.639 -0.663 . . . . 0.0 110.156 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -69.36 -43.45 73.58 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.44 -53.12 61.85 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.499 0.72 . . . . 0.0 110.61 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.47 98.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.08 1.352 . . . . 0.0 112.648 -172.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -71.2 -35.25 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.945 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -77.0 -25.2 52.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 120.934 -1.104 . . . . 0.0 109.576 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.68 96.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.984 1.713 . . . . 0.0 109.495 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.4 -17.62 64.26 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.706 1.202 . . . . 0.0 113.133 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -78.23 80.43 4.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.24 -1.537 . . . . 0.0 110.369 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.09 2.76 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.33 143.8 37.23 Favored Pre-proline 0 N--CA 1.444 -0.757 0 O-C-N 120.926 -1.338 . . . . 0.0 110.525 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.71 128.42 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.985 2.456 . . . . 0.0 112.333 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 34.04 45.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.36 147.69 47.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.579 1.151 . . . . 0.0 110.624 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -44.43 0.93 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.217 0.607 . . . . 0.0 109.784 -170.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -87.08 46.48 1.38 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-O 123.13 1.443 . . . . 0.0 108.803 -171.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.04 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 119.4 -2.063 . . . . 0.0 108.94 -171.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 m -141.66 -122.01 0.1 Allowed 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -173.13 -71.51 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -20.89 25.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 125.512 3.004 . . . . 0.0 111.341 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.59 -33.17 64.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.443 1.497 . . . . 0.0 109.92 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.776 0.83 . . . . 0.0 109.703 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.96 -34.9 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 122.065 -0.397 . . . . 0.0 110.082 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 109.674 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -64.46 -35.12 79.88 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.512 1.148 . . . . 0.0 110.276 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -65.04 -42.35 94.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.722 -1.236 . . . . 0.0 109.684 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -56.62 -54.37 29.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.212 1.405 . . . . 0.0 110.031 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -69.46 -26.45 64.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.614 0.366 . . . . 0.0 111.455 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.6 m -69.34 -39.43 78.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.431 1.092 . . . . 0.0 109.707 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.37 -30.01 70.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.549 -1.344 . . . . 0.0 111.658 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.457 ' HG1' HG21 ' A' ' 55' ' ' VAL . 1.2 p -87.67 3.49 47.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.716 -0.615 . . . . 0.0 110.651 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p 59.85 36.93 21.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.012 1.725 . . . . 0.0 112.324 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 ' HG1' ' A' ' 53' ' ' THR . 24.7 t -82.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 -85.63 0.55 Allowed Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 105.951 -2.859 . . . . 0.0 105.951 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 69.86 -65.18 0.32 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.872 2.469 . . . . 0.0 110.674 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.65 54.68 0.59 Allowed Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.09 -44.23 15.38 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -138.04 168.54 19.51 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.59 128.18 17.92 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.29 172.78 13.27 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.265 3.31 . . . . 0.0 109.543 169.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.91 -137.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 p -124.04 -27.69 3.85 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.025 1.33 . . . . 0.0 110.723 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.12 6.05 50.13 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -36.12 63.84 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.46 -11.44 0.55 Allowed Glycine 0 CA--C 1.477 -2.321 0 CA-C-O 117.096 -1.947 . . . . 0.0 108.968 171.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 67.14 -56.45 0.44 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 130.232 3.413 . . . . 0.0 109.33 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -84.81 20.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.029 1.331 . . . . 0.0 111.061 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.0 -49.39 44.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.7 74.92 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.179 0.592 . . . . 0.0 109.41 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.44 -41.78 69.81 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.226 1.41 . . . . 0.0 111.696 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.87 -49.28 76.85 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.846 -0.533 . . . . 0.0 110.775 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.96 -38.41 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 O-C-N 121.744 -0.597 . . . . 0.0 109.44 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.0 tpp -55.73 -53.74 52.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.572 1.549 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -66.22 -40.8 90.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.112 0.965 . . . . 0.0 109.935 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.11 82.84 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.827 0.851 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -46.37 91.66 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.98 -30.76 47.85 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 O-C-N 121.658 -0.907 . . . . 0.0 109.582 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.98 -46.44 81.44 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.661 -1.9 . . . . 0.0 109.866 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 t -63.44 -52.81 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 124.477 1.111 . . . . 0.0 109.782 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -74.41 -8.11 55.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.647 -0.658 . . . . 0.0 112.049 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.89 -32.65 15.94 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.817 -1.177 . . . . 0.0 110.103 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.33 -36.85 85.31 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.781 -1.199 . . . . 0.0 110.096 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -63.44 -12.53 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.0 m -65.16 -15.93 62.96 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.853 1.261 . . . . 0.0 111.173 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.11 71.6 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 111.213 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 -31.86 38.39 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 120.507 -1.371 . . . . 0.0 109.427 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.29 -39.46 39.83 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.411 0.624 . . . . 0.0 111.231 -173.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.97 64.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.198 -0.938 . . . . 0.0 111.734 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -96.6 -0.18 49.03 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.606 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -77.92 -22.84 49.03 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.556 1.525 . . . . 0.0 109.751 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -73.59 -33.02 64.42 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 119.511 -1.993 . . . . 0.0 110.467 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.41 -24.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 124.945 1.298 . . . . 0.0 109.102 -170.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -62.11 -19.06 62.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.428 1.891 . . . . 0.0 110.706 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -65.33 -31.35 72.44 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 120.99 -1.069 . . . . 0.0 110.674 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.444 -0.746 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 -172.33 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 120.957 -1.089 . . . . 0.0 110.4 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -67.27 -19.53 65.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -75.23 -46.68 32.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 124.853 1.261 . . . . 0.0 108.487 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.399 1.08 . . . . 0.0 109.657 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.2 90.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.856 0.862 . . . . 0.0 111.568 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -69.15 -34.15 74.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.69 0.757 . . . . 0.0 111.028 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.084 -1.01 . . . . 0.0 111.224 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.45 -46.38 73.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.895 0.878 . . . . 0.0 109.199 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.91 -38.41 88.28 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.647 1.213 . . . . 0.0 111.625 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.1 -24.07 60.59 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.953 1.301 . . . . 0.0 110.322 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.1 -41.48 61.6 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 120.259 -1.525 . . . . 0.0 107.847 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -55.79 -46.76 77.9 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.658 1.183 . . . . 0.0 111.552 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -54.87 -37.73 66.62 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.091 0.957 . . . . 0.0 112.236 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -73.86 -32.44 63.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.86 -0.525 . . . . 0.0 110.512 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.3 -35.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.298 -0.876 . . . . 0.0 108.766 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.53 -37.41 87.22 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.065 -1.022 . . . . 0.0 111.279 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.11 -38.83 69.22 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.813 0.845 . . . . 0.0 110.745 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -73.62 -43.65 59.06 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.112 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.43 62.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 121.141 -0.974 . . . . 0.0 111.963 -175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -71.96 -37.46 69.94 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.204 0.911 . . . . 0.0 110.345 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -43.33 99.07 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 125.323 1.449 . . . . 0.0 108.433 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -66.13 -45.96 79.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.629 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.07 77.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.047 1.339 . . . . 0.0 112.746 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.2 -44.45 97.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 121.817 -0.552 . . . . 0.0 109.832 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.69 -28.29 62.6 Favored 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 120.872 -1.143 . . . . 0.0 111.629 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.32 80.31 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.644 1.578 . . . . 0.0 109.24 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -20.11 51.92 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.286 0.565 . . . . 0.0 110.842 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -70.95 72.63 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 125.055 1.342 . . . . 0.0 113.086 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.28 -18.3 1.04 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.82 147.07 61.31 Favored Pre-proline 0 N--CA 1.444 -0.735 0 O-C-N 121.7 -0.882 . . . . 0.0 110.375 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -82.66 129.66 5.71 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.54 2.16 . . . . 0.0 111.405 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 27.43 42.46 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.64 139.17 32.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.268 2.227 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.25 -32.36 2.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.398 0.679 . . . . 0.0 109.226 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -99.44 118.82 36.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.41 -154.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.6 t 75.1 -149.53 0.03 OUTLIER 'General case' 0 C--N 1.358 0.961 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -145.64 -56.18 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 116.309 -1.805 . . . . 0.0 106.295 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.33 -29.26 38.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 125.028 2.831 . . . . 0.0 110.734 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.17 -42.93 93.2 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.068 0.947 . . . . 0.0 110.183 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.28 95.2 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 111.121 -172.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 tt -76.2 -27.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 121.027 0.441 . . . . 0.0 110.843 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -33.62 61.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.385 -1.447 . . . . 0.0 109.696 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -67.76 -34.19 76.31 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.864 0.866 . . . . 0.0 111.413 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.7 p -69.05 -20.76 64.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 119.727 -1.858 . . . . 0.0 111.35 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 -47.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.011 0.924 . . . . 0.0 109.5 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.58 -27.22 65.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.672 1.225 . . . . 0.0 110.933 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -73.98 -32.19 63.33 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.845 -1.16 . . . . 0.0 109.721 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.44 70.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.356 -0.84 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.9 p -93.58 10.89 30.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.446 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p 52.79 26.71 4.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.701 2.001 . . . . 0.0 112.721 174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.11 -41.92 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -61.51 4.62 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 62.94 -85.54 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 128.446 2.698 . . . . 0.0 108.481 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.19 40.97 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.456 ' CG ' HH22 ' C' ' 68' ' ' ARG . 26.4 t70 -71.14 -62.57 1.35 Allowed 'General case' 0 C--N 1.358 0.943 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -141.1 170.81 15.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -131.38 146.13 60.64 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -94.06 158.58 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.043 2.495 . . . . 0.0 108.217 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -79.21 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 42.0 m -156.2 -36.67 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 O-C-N 119.047 -2.283 . . . . 0.0 106.927 -170.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -95.61 11.24 33.92 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.367 -0.833 . . . . 0.0 108.918 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.04 -33.41 61.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 168.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 88.73 1.24 Allowed Glycine 0 N--CA 1.418 -2.566 1 N-CA-C 98.403 -5.879 . . . . 0.0 98.403 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -63.53 -11.77 26.94 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 119.439 1.619 . . . . 0.0 110.935 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -46.55 -26.24 0.85 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.494 2.318 . . . . 0.0 113.821 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -68.56 -40.99 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.698 1.199 . . . . 0.0 108.734 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.49 -45.49 68.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -51.92 -41.66 62.18 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 126.441 1.897 . . . . 0.0 111.758 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.47 -42.56 92.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.914 1.286 . . . . 0.0 111.064 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.13 -38.38 70.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.422 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 42.4 mtt -62.79 -47.85 81.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.862 0.865 . . . . 0.0 110.177 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -61.26 -40.28 93.47 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.609 -0.682 . . . . 0.0 110.772 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.6 -34.8 77.75 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 122.758 0.423 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.97 -52.07 9.61 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.09 -47.01 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 124.39 1.076 . . . . 0.0 109.947 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.9 -38.27 90.4 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.051 -1.03 . . . . 0.0 111.565 -176.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.97 -38.4 49.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 O-C-N 120.642 -1.286 . . . . 0.0 110.906 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.52 -19.85 62.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.787 -0.571 . . . . 0.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.84 -38.19 13.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.655 0.782 . . . . 0.0 110.396 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.85 -35.91 71.58 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.008 1.723 . . . . 0.0 111.408 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.67 -6.98 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.751 0.82 . . . . 0.0 112.606 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -55.04 -24.34 24.34 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.364 1.466 . . . . 0.0 110.414 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.26 74.06 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.357 -1.464 . . . . 0.0 113.155 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.68 -33.16 23.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.868 -1.145 . . . . 0.0 108.33 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 72.4 mt -78.91 -28.4 43.94 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.928 0.891 . . . . 0.0 112.066 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -10.64 59.53 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.058 -1.651 . . . . 0.0 111.337 172.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.44 -36.59 74.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.097 1.317 . . . . 0.0 110.664 -169.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -75.21 -20.71 59.12 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.417 -1.427 . . . . 0.0 112.148 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.55 -33.09 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.234 -1.541 . . . . 0.0 107.596 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -60.88 -19.88 60.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.604 1.561 . . . . 0.0 112.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -55.81 -25.25 40.63 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.557 1.143 . . . . 0.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.439 -0.976 0 O-C-N 120.59 -1.319 . . . . 0.0 111.162 -177.403 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -16.46 53.91 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.243 -1.535 . . . . 0.0 109.651 -167.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -65.8 -36.5 83.68 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.204 1.802 . . . . 0.0 111.161 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -81.87 -33.67 30.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -35.42 74.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.461 0.304 . . . . 0.0 110.544 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.85 96.7 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.824 0.85 . . . . 0.0 111.384 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -71.59 -34.61 70.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.075 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -66.04 -36.6 83.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.535 1.134 . . . . 0.0 109.574 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.41 91.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 124.517 1.127 . . . . 0.0 111.445 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -59.63 -38.6 81.79 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.802 0.811 . . . . 0.0 111.287 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -74.04 -27.56 60.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.583 0.753 . . . . 0.0 110.183 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -66.77 -38.21 86.13 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.147 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.86 -38.1 89.51 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.289 -0.882 . . . . 0.0 111.402 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -55.22 -38.68 68.75 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 111.876 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -70.82 -38.91 73.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.171 1.388 . . . . 0.0 109.352 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.9 -28.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 123.872 0.869 . . . . 0.0 108.998 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.09 -39.7 95.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.905 -1.122 . . . . 0.0 111.435 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.24 -46.41 87.03 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.284 -0.885 . . . . 0.0 109.927 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.33 -52.08 67.11 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-O 121.22 0.533 . . . . 0.0 109.615 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.44 -34.74 74.42 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 126.014 1.726 . . . . 0.0 111.454 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.9 m -63.36 -46.59 85.84 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.812 0.845 . . . . 0.0 110.799 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.45 -40.75 73.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.88 -39.81 95.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.821 0.848 . . . . 0.0 110.913 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -47.38 80.91 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.17 1.388 . . . . 0.0 111.466 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.01 -15.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.4 1.095 . . . . 0.0 110.102 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -101.23 -5.1 25.99 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 119.979 -1.701 . . . . 0.0 108.599 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.42 -18.85 18.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 124.808 1.243 . . . . 0.0 110.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.81 -30.89 69.54 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 121.028 -1.045 . . . . 0.0 108.553 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.44 113.96 4.0 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.32 1.848 . . . . 0.0 108.587 -169.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.02 -5.62 72.3 Favored Glycine 0 CA--C 1.498 -0.999 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.09 148.44 34.4 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.57 125.14 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.353 2.035 . . . . 0.0 111.1 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 45.48 3.08 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.83 24.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.897 -0.766 . . . . 0.0 112.195 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.01 -36.6 1.17 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.663 0.744 . . . . 0.0 110.063 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -85.85 37.42 0.71 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 108.675 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.08 -22.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.224 2.21 . . . . 0.0 109.519 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -79.93 121.09 25.01 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.738 0.78 . . . . 0.0 109.252 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.84 -55.93 15.64 Favored Pre-proline 0 C--N 1.351 0.631 0 C-N-CA 126.885 2.074 . . . . 0.0 111.369 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.13 -11.96 23.34 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 CA-C-N 125.769 3.096 . . . . 0.0 111.339 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.33 -26.28 28.6 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 124.827 1.251 . . . . 0.0 108.747 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.47 91.32 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.091 0.956 . . . . 0.0 110.706 -167.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.4 -33.43 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.045 0.938 . . . . 0.0 111.267 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -32.51 48.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.909 -1.119 . . . . 0.0 109.964 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.474 ' CD2' HD12 ' C' ' 38' ' ' LEU . 50.0 t90 -67.04 -37.53 84.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.404 -0.81 . . . . 0.0 110.259 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -60.25 -25.11 65.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.239 -0.913 . . . . 0.0 112.735 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.14 -51.41 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 123.694 0.798 . . . . 0.0 109.437 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.76 40.52 0.9 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.62 1.168 . . . . 0.0 111.181 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 17.6 m -141.68 -56.92 0.47 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.75 73.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.353 -0.842 . . . . 0.0 112.923 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 16.5 p -95.01 23.69 5.42 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p 51.24 78.49 0.11 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.619 1.968 . . . . 0.0 111.871 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 t -122.23 -92.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.6 45.67 9.37 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 111.064 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -43.14 92.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.53 1.157 . . . . 0.0 110.375 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.52 -139.92 7.47 Favored Glycine 0 CA--C 1.483 -1.945 1 N-CA-C 101.645 -4.582 . . . . 0.0 101.645 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.3 34.5 t0 65.2 -71.83 0.08 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 127.27 2.228 . . . . 0.0 111.327 -173.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -124.54 158.9 31.84 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.66 154.13 55.58 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 166.8 27.09 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.203 2.602 . . . . 0.0 110.504 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.2 164.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -62.71 -69.19 0.27 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.337 1.455 . . . . 0.0 114.367 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.75 -72.88 0.06 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.651 1.18 . . . . 0.0 111.484 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -94.58 -39.79 10.18 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.155 -0.965 . . . . 0.0 113.317 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.92 -39.46 25.5 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 120.41 1.459 . . . . 0.0 113.938 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.456 HH22 ' CG ' ' B' ' 59' ' ' ASP . 99.3 mtt180 -74.14 -36.87 64.17 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 117.629 0.714 . . . . 0.0 112.26 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -74.29 -30.07 61.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 121.379 -0.826 . . . . 0.0 110.127 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.0 -40.84 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 O-C-N 121.168 -0.957 . . . . 0.0 109.662 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.36 92.9 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -58.13 -36.01 72.34 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 125.729 1.612 . . . . 0.0 111.395 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -66.04 -52.15 51.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.204 1.001 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 p -73.19 -27.27 23.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 121.576 -0.703 . . . . 0.0 109.636 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 19.5 tpp -58.54 -48.24 81.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 110.335 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -66.21 -36.75 83.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.993 -0.442 . . . . 0.0 110.518 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.26 78.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.366 0.666 . . . . 0.0 111.425 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.45 -40.94 78.85 Favored Glycine 0 CA--C 1.494 -1.266 0 O-C-N 121.664 -0.647 . . . . 0.0 111.546 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 81.2 mt -63.16 -46.57 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -57.26 -47.68 80.8 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.197 0.999 . . . . 0.0 110.774 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.99 -55.04 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.459 1.104 . . . . 0.0 111.086 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -71.61 -33.45 69.0 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 118.551 0.614 . . . . 0.0 110.695 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.33 -30.24 65.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.781 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.75 -12.79 60.82 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.138 -0.976 . . . . 0.0 111.589 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.19 -10.99 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 119.988 -1.695 . . . . 0.0 110.51 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -49.39 -27.24 3.87 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.383 1.873 . . . . 0.0 112.717 170.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.7 -27.16 48.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.499 1.12 . . . . 0.0 112.824 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.67 -51.66 2.79 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 112.063 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.15 -2.25 54.99 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.461 -1.399 . . . . 0.0 109.433 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.25 -11.85 45.39 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -33.8 76.49 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.7 -1.25 . . . . 0.0 109.91 -166.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.51 -12.68 60.54 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.055 -1.028 . . . . 0.0 112.608 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.48 -32.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -69.14 -8.24 43.6 Favored 'General case' 0 C--N 1.359 1.021 0 O-C-N 121.026 -1.046 . . . . 0.0 111.483 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 48.3 ttp85 -64.73 -29.97 70.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -175.55 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.45 -36.38 78.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 122.388 1.089 . . . . 0.0 110.763 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -71.02 -17.61 62.62 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.09 -1.006 . . . . 0.0 112.061 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -86.92 -38.95 16.22 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -66.82 -37.59 84.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.077 0.951 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -68.23 -36.88 80.19 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.618 -0.676 . . . . 0.0 110.34 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.62 75.4 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.035 0.934 . . . . 0.0 110.188 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -65.06 -35.99 82.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.204 1.402 . . . . 0.0 111.205 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -69.01 -30.42 68.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.849 -1.157 . . . . 0.0 110.742 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.33 75.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.063 -1.023 . . . . 0.0 110.649 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.94 -38.41 90.93 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.737 0.815 . . . . 0.0 110.516 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.58 1.152 . . . . 0.0 110.219 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.65 -41.68 98.19 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.878 0.871 . . . . 0.0 109.086 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 tp -62.97 -37.52 87.43 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.436 0.694 . . . . 0.0 111.503 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.57 -31.48 72.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.223 -0.923 . . . . 0.0 112.285 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -71.39 -35.46 71.05 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.35 -38.89 83.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 109.307 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.8 -42.39 84.14 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.24 1.019 . . . . 0.0 111.323 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.27 -44.11 65.89 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.957 0.903 . . . . 0.0 109.282 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -66.21 -39.05 89.34 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.04 72.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.191 1.396 . . . . 0.0 112.165 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.49 -43.34 73.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.493 0.717 . . . . 0.0 109.807 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -43.86 75.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.778 1.231 . . . . 0.0 108.677 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -63.91 -48.4 76.74 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.699 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.44 70.06 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 119.769 1.168 . . . . 0.0 110.818 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.74 -39.74 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.67 -30.03 59.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.779 -1.826 . . . . 0.0 110.758 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.34 35.27 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.067 0.947 . . . . 0.0 109.752 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -22.56 60.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.507 -0.746 . . . . 0.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -68.9 98.6 0.95 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.028 0.918 . . . . 0.0 111.619 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.24 -4.41 12.42 Favored Glycine 0 CA--C 1.494 -1.251 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.75 146.36 46.25 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 121.629 -0.924 . . . . 0.0 109.088 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -80.5 131.7 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.952 1.768 . . . . 0.0 111.42 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.44 2.91 69.81 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.52 136.65 57.59 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.006 1.722 . . . . 0.0 112.42 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.63 4.31 1.93 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.35 -38.16 20.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.3 tt -5.93 88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 1 C-N-CA 133.248 4.619 . . . . 0.0 114.387 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 33.1 p -162.96 -131.3 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.79 -65.5 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 127.925 2.49 . . . . 0.0 106.051 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.93 -14.03 26.47 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 CA-C-N 125.649 3.053 . . . . 0.0 111.687 -171.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -100.74 -11.36 19.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.66 64.93 Favored 'General case' 0 CA--C 1.504 -0.826 0 O-C-N 120.776 -1.203 . . . . 0.0 109.854 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.25 -7.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 125.178 1.391 . . . . 0.0 109.675 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -81.84 -49.56 10.22 Favored 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 119.423 -2.048 . . . . 0.0 106.081 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -53.24 -41.68 65.66 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.791 1.636 . . . . 0.0 111.115 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.4 p -69.51 -28.84 66.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.696 -1.877 . . . . 0.0 111.683 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.46 -45.66 81.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 C-N-CA 123.699 0.799 . . . . 0.0 109.284 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.9 -9.35 57.57 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.445 -0.784 . . . . 0.0 112.006 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 72.4 m -86.14 -48.45 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 120.697 -1.252 . . . . 0.0 111.082 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.18 62.51 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.662 -1.274 . . . . 0.0 112.007 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -87.8 0.86 55.21 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.879 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 55.18 67.97 0.94 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.875 2.07 . . . . 0.0 110.904 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.83 -98.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.58 102.24 0.46 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 106.58 -2.608 . . . . 0.0 106.58 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -75.73 -33.68 60.3 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.65 39.7 2.32 Favored Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.96 -50.27 30.39 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -130.87 160.95 32.94 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.53 151.78 36.88 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 167.71 26.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.059 2.506 . . . . 0.0 111.275 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.74 -148.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -107.07 -60.35 1.69 Allowed 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.039 1.736 . . . . 0.0 107.573 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -80.13 0.61 31.42 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.352 1.461 . . . . 0.0 111.179 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -64.84 -30.13 71.12 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.845 1.307 . . . . 0.0 108.773 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.26 83.57 1.37 Allowed Glycine 0 CA--C 1.473 -2.557 1 N-CA-C 99.277 -5.529 . . . . 0.0 99.277 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttt85 -60.95 -11.24 7.39 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 122.876 1.322 . . . . 0.0 111.44 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -61.51 -12.92 17.16 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.452 1.101 . . . . 0.0 113.302 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.43 -52.59 58.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.33 97.58 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 123.168 0.587 . . . . 0.0 110.535 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.11 -50.11 38.77 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.946 1.699 . . . . 0.0 111.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.65 -40.08 95.94 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.646 0.779 . . . . 0.0 110.879 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.66 -43.39 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 123.704 0.801 . . . . 0.0 109.579 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.7 mtm -66.91 -42.83 84.77 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 121.806 -0.559 . . . . 0.0 110.621 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -65.58 -35.0 79.55 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.844 -0.535 . . . . 0.0 110.517 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.25 99.13 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.524 0.729 . . . . 0.0 110.494 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.03 81.33 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.1 -46.72 88.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 109.804 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.12 -42.01 94.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.299 -0.876 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.98 -46.94 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.24 -0.913 . . . . 0.0 110.4 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -71.12 -9.0 57.32 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.392 -0.817 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.32 -39.76 8.25 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.199 1.0 . . . . 0.0 109.84 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -52.1 -34.93 46.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 127.133 2.173 . . . . 0.0 110.697 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.45 -8.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 124.372 1.069 . . . . 0.0 113.833 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -68.85 -14.28 62.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 120.113 -1.617 . . . . 0.0 111.832 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.16 -27.56 65.77 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.748 -1.22 . . . . 0.0 111.494 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.88 -37.04 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.458 1.103 . . . . 0.0 109.554 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.32 -37.72 66.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.564 -0.71 . . . . 0.0 112.231 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.73 -21.19 63.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.57 -1.331 . . . . 0.0 111.008 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 10.9 t -96.32 11.19 35.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.842 -1.162 . . . . 0.0 108.765 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.3 -33.65 25.91 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -71.67 -32.68 68.14 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.191 -1.568 . . . . 0.0 112.865 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.8 -11.34 14.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 121.461 -0.774 . . . . 0.0 111.275 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -60.99 -19.73 61.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.033 1.333 . . . . 0.0 112.132 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -6.67 58.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.457 1.026 . . . . 0.0 110.81 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.34 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -132.89 -78.1 0.49 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.411 ' HE1' ' OE2' ' A' ' 5' ' ' GLU . 1.8 p80 -71.52 -15.83 62.31 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 123.572 0.749 . . . . 0.0 111.69 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.411 ' OE2' ' HE1' ' A' ' 4' ' ' HIS . 52.5 mp0 -63.88 -36.9 85.45 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.977 1.711 . . . . 0.0 110.137 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -77.15 -24.11 51.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.455 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -74.27 -41.65 60.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.673 1.189 . . . . 0.0 108.185 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.32 96.87 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.17 -34.07 77.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.732 1.213 . . . . 0.0 111.387 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -71.4 -39.14 71.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.371 -0.831 . . . . 0.0 108.904 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.85 78.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.532 0.733 . . . . 0.0 111.648 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -65.3 -28.35 69.26 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.05 -1.031 . . . . 0.0 111.808 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -73.81 -31.96 63.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.794 0.837 . . . . 0.0 110.06 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.04 -38.94 92.52 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 121.469 -0.769 . . . . 0.0 110.743 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.26 -41.67 84.77 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.532 0.733 . . . . 0.0 111.992 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.735 1.214 . . . . 0.0 109.633 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.31 -40.53 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.053 0.941 . . . . 0.0 109.486 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.2 mt -58.74 -40.76 84.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.083 0.953 . . . . 0.0 111.906 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.25 -41.6 73.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.63 1.572 . . . . 0.0 110.066 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -67.32 -52.32 41.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.521 1.529 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.56 -29.88 63.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.484 1.114 . . . . 0.0 111.977 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -63.05 -41.69 99.55 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 119.129 0.877 . . . . 0.0 110.178 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.82 -43.55 71.8 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.872 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -67.34 -18.96 65.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 120.709 -1.244 . . . . 0.0 111.033 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.86 70.57 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.45 0.7 . . . . 0.0 110.289 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.15 -33.15 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.775 0.798 . . . . 0.0 111.768 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -28.92 61.66 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.87 68.1 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.349 1.059 . . . . 0.0 111.263 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.24 -5.95 53.46 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.462 1.105 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -105.64 71.87 0.94 Allowed 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.647 -1.908 . . . . 0.0 108.508 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.45 -42.32 0.33 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.74 157.94 38.86 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 123.206 0.603 . . . . 0.0 109.665 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -80.9 153.07 19.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.221 1.948 . . . . 0.0 111.121 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.33 15.93 31.18 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.207 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 131.46 50.6 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -166.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.65 -46.99 0.24 Allowed 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.554 0.741 . . . . 0.0 110.009 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.82 62.08 6.73 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 123.01 1.386 . . . . 0.0 107.902 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.9 pt -91.46 -1.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.805 -1.81 . . . . 0.0 109.5 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -89.43 127.85 35.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.469 -0.77 . . . . 0.0 110.997 -174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -79.44 -54.64 0.95 Allowed Pre-proline 0 C--N 1.347 0.457 0 CA-C-O 116.196 -1.859 . . . . 0.0 112.73 -172.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -73.54 -12.02 24.59 Favored 'Trans proline' 0 CA--C 1.511 -0.658 0 CA-C-N 126.718 3.435 . . . . 0.0 111.813 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.12 -13.17 48.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.38 89.86 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.298 1.039 . . . . 0.0 111.59 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.92 -33.66 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.643 0.735 . . . . 0.0 109.535 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -24.76 57.74 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 119.92 -1.737 . . . . 0.0 109.572 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -69.52 -46.55 66.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.418 1.087 . . . . 0.0 108.396 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.4 p -67.35 -29.81 69.45 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.822 -1.173 . . . . 0.0 111.819 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -51.94 -50.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 124.447 1.099 . . . . 0.0 110.633 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.01 -0.3 43.64 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.488 -0.757 . . . . 0.0 111.792 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.3 m -91.62 -39.92 11.61 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 121.546 -0.721 . . . . 0.0 109.296 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.83 62.52 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 120.503 -1.373 . . . . 0.0 111.357 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 p -89.35 9.29 26.67 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.473 0.709 . . . . 0.0 110.152 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 51.17 50.03 19.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.422 1.889 . . . . 0.0 112.973 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.68 -77.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.82 95.12 0.11 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.07 -69.91 0.58 Allowed 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.666 -1.49 . . . . 0.0 109.958 -170.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.8 41.57 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.75 -52.74 7.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -134.44 -175.06 3.75 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -143.06 135.78 13.63 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 101.994 -3.336 . . . . 0.0 101.994 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.8 166.2 10.14 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.026 2.484 . . . . 0.0 110.236 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.509 HG23 ' H ' ' A' ' 67' ' ' GLY . 17.5 m -69.41 166.07 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.603 1.192 . . . . 0.0 110.94 173.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 m -78.53 -67.77 0.71 Allowed 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.345 -0.847 . . . . 0.0 109.173 -174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -50.36 -63.5 1.1 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.586 1.555 . . . . 0.0 112.115 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.69 -67.05 0.87 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.324 -0.86 . . . . 0.0 111.412 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.509 ' H ' HG23 ' A' ' 63' ' ' VAL . . . -30.76 -46.22 0.13 Allowed Glycine 0 C--N 1.349 1.293 0 C-N-CA 129.212 3.291 . . . . 0.0 116.114 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -68.19 -51.9 40.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.105 0.952 . . . . 0.0 112.483 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.7 -25.64 68.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 119.419 1.009 . . . . 0.0 110.803 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.88 -50.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.18 85.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.062 1.345 . . . . 0.0 112.129 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -51.63 -39.19 57.61 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.893 1.677 . . . . 0.0 110.846 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -29.58 64.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.08 -43.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.8 mtt -58.62 -52.32 66.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.414 1.485 . . . . 0.0 109.917 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -66.04 -36.95 84.63 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.614 -0.679 . . . . 0.0 110.652 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.41 87.77 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.168 -0.958 . . . . 0.0 111.313 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.86 -48.11 75.44 Favored Glycine 0 CA--C 1.492 -1.349 0 C-N-CA 124.646 1.117 . . . . 0.0 110.903 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -43.76 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.113 0.965 . . . . 0.0 109.257 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -61.43 -39.18 89.86 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 120.438 -1.414 . . . . 0.0 111.97 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.16 -54.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 124.41 1.084 . . . . 0.0 108.928 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.47 -40.87 93.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.82 -0.55 . . . . 0.0 110.913 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -27.15 65.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.394 -0.816 . . . . 0.0 111.522 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.82 -35.67 81.86 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.887 -1.133 . . . . 0.0 110.031 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.8 t -59.65 -14.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 125.524 1.53 . . . . 0.0 111.262 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -55.82 -23.31 29.67 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 120.066 -1.646 . . . . 0.0 111.989 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.9 -31.45 69.82 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 120.82 -1.175 . . . . 0.0 112.33 172.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 -45.44 14.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.688 -1.257 . . . . 0.0 107.789 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -62.77 -40.29 96.82 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.182 0.993 . . . . 0.0 113.297 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.36 -11.3 60.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.129 -0.982 . . . . 0.0 111.519 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 m -82.6 -22.66 34.73 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.022 -1.049 . . . . 0.0 108.384 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -71.08 -24.5 62.33 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 120.698 -1.252 . . . . 0.0 112.86 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -81.03 -25.33 37.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.85 -1.156 . . . . 0.0 111.879 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.78 -28.03 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -70.14 -5.42 26.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 112.05 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -66.57 -31.04 71.49 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.913 -1.117 . . . . 0.0 109.319 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -170.015 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.498 -1.034 0 CA-C-O 121.94 0.876 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -72.8 -32.26 65.42 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.92 -33.95 66.3 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.734 0.814 . . . . 0.0 109.026 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -58.29 -45.28 88.25 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.324 1.05 . . . . 0.0 110.582 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.22 -45.84 79.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.82 1.248 . . . . 0.0 109.051 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.5 92.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 111.567 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.84 -37.1 76.06 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.643 0.777 . . . . 0.0 109.617 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.02 -33.38 75.6 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.784 -1.198 . . . . 0.0 110.251 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.74 75.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.329 -0.857 . . . . 0.0 111.373 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.43 -31.99 73.43 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.844 0.858 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -67.99 -41.22 82.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 121.562 -0.711 . . . . 0.0 109.781 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -66.21 -28.46 68.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.593 -0.692 . . . . 0.0 111.277 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 118.42 0.554 . . . . 0.0 110.738 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -62.32 -36.11 81.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 110.683 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.37 -37.79 86.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.754 0.821 . . . . 0.0 110.741 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.43 -40.19 88.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 121.071 -1.018 . . . . 0.0 109.036 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.93 -42.96 85.92 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 123.634 0.774 . . . . 0.0 111.359 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.77 -46.17 83.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.015 1.326 . . . . 0.0 109.949 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -68.48 -41.95 79.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 122.046 -0.409 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -29.64 69.79 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.726 1.21 . . . . 0.0 111.601 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -61.58 -43.23 99.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.145 0.978 . . . . 0.0 109.491 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -38.57 81.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.486 1.114 . . . . 0.0 108.822 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.22 -54.01 40.28 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.108 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.03 75.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.005 1.322 . . . . 0.0 112.915 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.15 -28.18 39.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 120.683 -1.26 . . . . 0.0 113.041 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.63 -34.76 18.37 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -49.46 67.7 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.697 1.599 . . . . 0.0 110.268 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.36 -26.85 66.68 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 112.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 119.614 -1.929 . . . . 0.0 110.801 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.05 -15.14 6.53 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.63 145.33 41.58 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 118.071 0.935 . . . . 0.0 109.801 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.78 135.53 11.46 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 110.136 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 14.41 76.91 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.38 145.49 55.97 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.12 0.968 . . . . 0.0 110.605 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.89 -37.98 0.9 Allowed 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 108.943 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 tp -88.84 129.98 35.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -150.26 -179.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 t 76.23 127.21 0.04 OUTLIER 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.226 1.41 . . . . 0.0 109.502 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -65.13 -46.53 73.1 Favored Pre-proline 0 C--N 1.35 0.623 0 CA-C-O 116.921 -1.514 . . . . 0.0 111.611 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 -10.54 25.15 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 124.953 2.805 . . . . 0.0 112.608 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.02 -39.13 15.93 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.47 84.11 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 123.416 0.686 . . . . 0.0 112.581 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -68.79 -29.19 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 O-C-N 122.03 -0.419 . . . . 0.0 110.08 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -38.22 70.41 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.755 -1.216 . . . . 0.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.09 -38.29 82.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.679 0.752 . . . . 0.0 109.368 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -59.27 -47.77 84.11 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.013 1.325 . . . . 0.0 110.191 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -54.51 -52.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 125.486 1.514 . . . . 0.0 111.099 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.96 -24.46 63.34 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 121.349 -0.844 . . . . 0.0 111.836 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -76.03 -33.59 59.64 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 123.897 0.879 . . . . 0.0 109.393 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.23 -24.61 65.84 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.964 -1.085 . . . . 0.0 111.693 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -92.92 10.41 31.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.542 0.737 . . . . 0.0 111.499 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 p 51.23 53.86 12.18 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 125.675 1.59 . . . . 0.0 112.838 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.56 -87.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.92 74.61 1.2 Allowed Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.53 -21.64 60.33 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 120.781 -1.423 . . . . 0.0 109.756 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.62 40.84 1.82 Allowed Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.26 -29.51 26.39 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 120.884 -1.362 . . . . 0.0 111.25 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -144.41 166.89 23.84 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -143.03 115.14 5.94 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.67 161.16 16.6 Favored 'Trans proline' 0 CA--C 1.512 -0.617 0 C-N-CA 122.527 2.151 . . . . 0.0 110.15 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.424 HG11 ' H ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -106.05 -159.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.742 1.258 . . . . 0.0 110.769 -173.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.424 ' H ' HG11 ' B' ' 63' ' ' VAL . 1.9 m -86.7 -36.22 18.83 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 119.734 -1.853 . . . . 0.0 110.612 -165.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.63 -15.87 41.07 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.486 1.114 . . . . 0.0 109.499 -167.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -28.77 69.91 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 123.478 1.609 . . . . 0.0 107.417 172.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.17 82.39 1.25 Allowed Glycine 0 CA--C 1.464 -3.152 1 N-CA-C 99.974 -5.25 . . . . 0.0 99.974 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm105 -66.97 3.93 0.98 Allowed 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.643 1.222 . . . . 0.0 112.999 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.14 -12.9 56.02 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 120.987 -1.071 . . . . 0.0 111.895 160.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -50.18 79.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.63 92.79 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.01 0.924 . . . . 0.0 111.701 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -53.95 -42.04 68.43 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.157 1.383 . . . . 0.0 110.623 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -63.76 -40.45 96.74 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.755 -0.591 . . . . 0.0 110.851 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.42 -49.02 80.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.018 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -69.92 -40.86 75.3 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 121.949 -0.469 . . . . 0.0 110.516 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -64.65 -41.59 96.02 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.324 -0.86 . . . . 0.0 109.725 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.94 85.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 122.028 -0.42 . . . . 0.0 111.388 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.34 -47.65 77.4 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.76 -45.18 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.778 1.231 . . . . 0.0 109.006 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.61 -44.21 80.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.112 -0.993 . . . . 0.0 111.357 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.86 -52.49 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.071 0.949 . . . . 0.0 109.599 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -72.19 -18.19 61.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.924 0.489 . . . . 0.0 111.492 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.78 -31.54 16.48 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.08 -31.85 73.19 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 120.38 -1.45 . . . . 0.0 110.018 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.48 -11.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 123.378 0.671 . . . . 0.0 112.098 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 22.8 m -60.35 -15.79 29.06 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.95 1.3 . . . . 0.0 111.426 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.53 -50.55 69.69 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.215 166.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.37 92.63 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 124.609 1.164 . . . . 0.0 110.272 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.03 -39.97 95.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 120.873 -1.142 . . . . 0.0 111.071 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 -15.74 60.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.677 -0.639 . . . . 0.0 110.701 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.4 m -83.25 -32.94 26.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 121.0 -1.062 . . . . 0.0 108.167 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.08 -11.45 59.99 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 111.801 -156.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -72.77 -31.93 65.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 121.387 -0.821 . . . . 0.0 110.299 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 t -74.08 -24.32 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.475 1.51 . . . . 0.0 109.047 -170.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -51.36 -31.91 23.85 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 124.851 1.26 . . . . 0.0 110.184 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -53.93 -31.8 51.5 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.98 1.312 . . . . 0.0 112.56 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 . . . . . 0 N--CA 1.444 -0.75 0 O-C-N 120.806 -1.184 . . . . 0.0 111.283 -174.903 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 . . . . . 0 CA--C 1.494 -1.193 0 CA-C-O 122.189 0.995 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.493 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 5.1 p-80 -67.3 -29.57 69.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.477 -0.764 . . . . 0.0 110.928 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.05 -37.6 46.42 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -57.32 -43.81 83.65 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.693 0.797 . . . . 0.0 111.941 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.57 -24.42 53.53 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.624 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.1 93.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.917 -1.114 . . . . 0.0 110.209 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -65.05 -37.11 86.5 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.659 -0.651 . . . . 0.0 111.225 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -62.44 -35.65 79.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.791 1.236 . . . . 0.0 110.261 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.96 82.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.783 0.833 . . . . 0.0 111.482 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -60.97 -37.79 83.65 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -63.38 -39.48 94.63 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.913 0.885 . . . . 0.0 110.018 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -67.69 -35.9 79.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.005 0.922 . . . . 0.0 109.469 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.7 tp -65.4 -37.76 87.95 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.229 1.014 . . . . 0.0 110.624 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.74 -21.67 61.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.879 -1.138 . . . . 0.0 111.635 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -69.81 -47.2 63.71 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.554 0.742 . . . . 0.0 109.624 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.45 -25.63 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.381 -0.824 . . . . 0.0 110.43 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.84 -40.66 98.14 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.405 0.682 . . . . 0.0 111.059 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.91 -47.11 86.41 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.392 0.997 . . . . 0.0 110.229 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -58.86 -55.11 39.38 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.33 83.24 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 125.964 1.706 . . . . 0.0 112.014 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 60.7 m -54.57 -51.2 65.99 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 124.367 1.067 . . . . 0.0 110.066 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -82.63 -35.66 26.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 121.905 -0.497 . . . . 0.0 110.566 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -63.57 -35.12 79.44 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.815 -1.178 . . . . 0.0 109.986 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.53 72.62 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.404 1.081 . . . . 0.0 111.887 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -34.92 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.688 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.42 -18.98 25.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.181 -0.949 . . . . 0.0 108.638 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -28.24 60.99 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.46 -0.775 . . . . 0.0 111.04 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -33.97 57.22 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -70.65 89.73 0.74 Allowed 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 125.972 1.709 . . . . 0.0 110.591 -167.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.24 2.03 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.61 155.11 56.54 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 153.94 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.119 1.879 . . . . 0.0 109.383 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.91 30.63 57.32 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -36.0 141.44 0.1 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 129.057 2.943 . . . . 0.0 113.493 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -115.51 0.17 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -164.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 153.49 36.9 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 19.0 pt -136.23 -158.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -62.21 -169.8 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.508 2.723 . . . . 0.0 111.482 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 81.38 -178.23 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.54 9.24 1.94 Allowed 'Trans proline' 0 CA--C 1.517 -0.35 0 CA-C-N 125.645 3.052 . . . . 0.0 112.262 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.68 -35.81 60.26 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.169 0.988 . . . . 0.0 109.061 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.33 -47.56 72.36 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 125.503 1.521 . . . . 0.0 112.727 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tt -74.92 -26.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.142 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -39.57 82.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.056 -1.028 . . . . 0.0 110.093 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -71.57 -35.45 70.58 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 118.661 0.664 . . . . 0.0 110.191 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -59.59 -39.21 83.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.823 -1.173 . . . . 0.0 110.048 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.04 68.43 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.019 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.455 ' HB3' HH12 ' D' ' 68' ' ' ARG . 21.4 pt-20 -164.05 -39.48 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -66.28 -41.03 90.41 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.104 0.962 . . . . 0.0 110.653 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -24.0 63.69 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 120.929 -1.107 . . . . 0.0 112.358 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.96 -1.2 57.39 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 121.448 -0.783 . . . . 0.0 109.483 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.8 p 52.25 49.43 20.56 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.302 1.841 . . . . 0.0 112.307 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.42 82.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.54 98.33 1.99 Allowed Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -79.28 -21.36 46.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.309 1.052 . . . . 0.0 108.307 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.91 39.76 1.14 Allowed Glycine 0 CA--C 1.483 -1.951 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.43 ' HB2' HH21 ' D' ' 68' ' ' ARG . 40.7 t0 -84.74 -50.34 7.69 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -131.92 -155.82 0.71 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 107.509 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.99 153.37 15.44 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 101.692 -3.447 . . . . 0.0 101.692 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -89.71 -177.36 1.41 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 123.392 2.728 . . . . 0.0 108.73 169.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.39 -167.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 119.81 1.186 . . . . 0.0 108.813 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.46 -56.46 2.18 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.158 0.983 . . . . 0.0 109.806 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.65 -41.33 77.02 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.258 -0.902 . . . . 0.0 112.313 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.52 -138.45 0.19 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 100.686 -3.82 . . . . 0.0 100.686 162.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.21 -73.35 1.09 Allowed Glycine 0 CA--C 1.492 -1.381 0 CA-C-N 120.454 1.479 . . . . 0.0 109.447 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -32.42 68.09 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.343 1.457 . . . . 0.0 110.295 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -69.97 -33.45 72.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.8 t -73.42 -47.49 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.89 76.6 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.453 1.501 . . . . 0.0 112.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -48.07 -47.05 34.18 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 126.979 2.112 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.7 -33.13 75.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.012 1.325 . . . . 0.0 110.735 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.65 -42.25 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.347 1.059 . . . . 0.0 109.416 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -60.18 -45.12 94.22 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.691 -0.63 . . . . 0.0 109.943 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -55.01 -50.09 69.89 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.316 1.446 . . . . 0.0 110.98 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -32.17 72.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.473 1.109 . . . . 0.0 110.835 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.72 -47.96 18.78 Favored Glycine 0 CA--C 1.491 -1.435 0 O-C-N 121.779 -0.576 . . . . 0.0 111.784 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.7 -41.14 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 122.068 -0.666 . . . . 0.0 110.084 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.68 -29.81 68.35 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 120.505 -1.372 . . . . 0.0 112.089 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.36 -49.17 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -73.49 -12.71 60.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.52 -0.737 . . . . 0.0 111.201 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.85 -53.94 7.24 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -50.88 -42.14 58.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.452 2.301 . . . . 0.0 112.939 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 m -60.51 -19.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 112.248 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 4.9 m -69.29 -13.39 62.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.919 -1.113 . . . . 0.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.92 68.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.805 -1.81 . . . . 0.0 111.075 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.493 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -74.76 -47.16 32.6 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.725 -1.234 . . . . 0.0 108.661 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.44 -31.18 66.91 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.13 0.972 . . . . 0.0 110.777 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.799 -1.188 . . . . 0.0 111.562 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 10.3 t -94.31 1.39 55.93 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.838 -1.163 . . . . 0.0 108.865 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -26.8 58.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 120.341 1.428 . . . . 0.0 110.055 -176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -69.9 -38.9 76.46 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.716 -1.24 . . . . 0.0 109.521 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.09 -25.0 37.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 125.533 1.533 . . . . 0.0 110.643 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -57.08 -24.6 55.12 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.114 1.366 . . . . 0.0 112.678 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -58.31 -31.82 67.88 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 121.138 -0.976 . . . . 0.0 111.628 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 N--CA 1.439 -1.019 0 O-C-N 121.756 -0.59 . . . . 0.0 109.821 -172.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -173.71 -120.8 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.056 1 N-CA-C 99.641 -4.207 . . . . 0.0 99.641 -157.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.587 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 28.4 p-80 -53.17 -21.58 5.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 129.052 2.941 . . . . 0.0 114.521 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.8 -31.72 71.09 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.857 0.863 . . . . 0.0 111.007 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -68.67 -43.22 76.62 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.946 -1.096 . . . . 0.0 109.951 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.5 -32.05 69.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.86 -46.56 90.09 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.562 0.745 . . . . 0.0 111.457 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.62 -31.98 73.02 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 121.645 -0.659 . . . . 0.0 111.778 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -69.78 -35.65 75.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.479 -0.763 . . . . 0.0 109.438 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.91 82.27 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.941 -1.099 . . . . 0.0 111.353 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.8 -20.79 62.54 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.784 -1.198 . . . . 0.0 112.064 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.16 -39.28 63.36 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.031 1.332 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -64.38 -34.83 79.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.254 1.822 . . . . 0.0 110.257 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.94 -41.29 91.51 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 121.895 -0.503 . . . . 0.0 110.311 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.44 -32.75 74.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.308 0.643 . . . . 0.0 110.924 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -64.65 -42.68 95.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.237 1.415 . . . . 0.0 110.904 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.0 -25.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 O-C-N 121.079 -1.013 . . . . 0.0 110.568 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -60.57 -47.98 83.79 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-N 119.361 0.982 . . . . 0.0 109.771 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -61.61 -46.52 89.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.556 0.742 . . . . 0.0 111.137 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -74.39 -34.74 63.4 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.442 -0.786 . . . . 0.0 109.402 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.84 73.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 120.314 -1.491 . . . . 0.0 111.923 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -61.9 -41.75 98.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.413 1.085 . . . . 0.0 110.926 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -69.14 -38.16 78.67 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.56 -53.89 44.63 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.733 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -47.74 74.27 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.181 1.392 . . . . 0.0 112.549 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.468 HG21 HH21 ' D' ' 31' ' ' ARG . 11.2 p -71.13 -26.29 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 120.527 -1.358 . . . . 0.0 111.523 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -89.96 -28.09 19.37 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 109.02 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.92 -55.68 7.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.17 2.588 . . . . 0.0 108.797 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.41 -26.1 68.3 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.95 1.3 . . . . 0.0 111.527 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . 0.468 HH21 HG21 ' D' ' 27' ' ' VAL . 6.8 tpp180 -69.01 104.85 2.22 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 120.035 -1.666 . . . . 0.0 109.876 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.04 -7.8 29.2 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.0 140.26 29.08 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.26 134.46 5.89 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.308 2.005 . . . . 0.0 110.634 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.86 0.46 66.33 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.16 115.48 6.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.976 1.71 . . . . 0.0 108.518 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.49 -26.89 13.96 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.23 104.18 16.14 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -148.14 70.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 120.218 -1.551 . . . . 0.0 109.333 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -167.61 157.61 10.59 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -77.18 -50.99 2.11 Favored Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 115.774 -2.06 . . . . 0.0 110.84 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.01 -15.96 36.35 Favored 'Trans proline' 0 CA--C 1.512 -0.575 0 CA-C-N 126.063 3.201 . . . . 0.0 111.396 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -82.26 -36.61 26.94 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.43 90.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.034 0.933 . . . . 0.0 111.999 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tp -72.85 -21.45 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.503 1.144 . . . . 0.0 109.906 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -40.1 25.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 120.266 -1.521 . . . . 0.0 109.311 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -65.0 -35.99 82.98 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.931 1.292 . . . . 0.0 110.64 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -86.27 62.14 7.25 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 120.29 -1.506 . . . . 0.0 109.51 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.84 -61.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -30.17 69.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.236 0.925 . . . . 0.0 110.62 -167.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -57.12 -35.31 69.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 125.617 1.567 . . . . 0.0 111.077 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.15 -25.26 55.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 119.869 -1.769 . . . . 0.0 110.697 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.67 -0.75 39.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.443 1.497 . . . . 0.0 108.404 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.265 4.1 p 60.72 47.95 7.59 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.007 2.123 . . . . 0.0 111.437 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.2 152.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 99.035 -4.432 . . . . 0.0 99.035 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.6 110.08 0.51 Allowed Glycine 0 CA--C 1.472 -2.645 1 N-CA-C 99.61 -5.396 . . . . 0.0 99.61 176.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -37.78 64.1 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 45.83 0.21 Allowed Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 168.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.9 -48.95 50.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 117.3 0.55 . . . . 0.0 110.463 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -137.7 177.45 7.86 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -149.05 140.65 14.45 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.95 -175.36 2.63 Favored 'Trans proline' 0 CA--C 1.516 -0.382 0 C-N-CA 124.627 3.552 . . . . 0.0 110.311 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.78 -157.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.8 p -77.46 -49.93 13.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 127.618 2.367 . . . . 0.0 109.368 -171.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -85.67 -13.95 46.98 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.846 1.258 . . . . 0.0 111.193 -162.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -22.15 62.75 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.443 1.592 . . . . 0.0 107.484 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.27 54.03 2.51 Favored Glycine 0 CA--C 1.464 -3.104 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.455 HH12 ' HB3' ' C' ' 50' ' ' GLU . 62.0 ttt-85 -20.53 -28.13 0.0 OUTLIER 'General case' 0 C--N 1.368 1.386 1 C-N-CA 134.509 5.124 . . . . 0.0 117.392 -175.349 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -61.98 2.04 0.25 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.584 1.954 . . . . 0.0 113.263 166.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -70.96 -47.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 168.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.687 0.795 . . . . 0.0 110.516 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.57 -44.52 69.4 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 124.658 1.183 . . . . 0.0 111.036 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -61.52 -44.5 96.95 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.61 -44.91 82.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 121.76 -0.588 . . . . 0.0 109.774 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.6 mtm -61.92 -47.69 83.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.84 -31.63 68.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.076 -1.015 . . . . 0.0 111.355 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.28 81.32 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.154 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.63 96.62 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 123.551 0.596 . . . . 0.0 111.748 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -57.9 -49.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.789 0 C-N-CA 124.22 1.008 . . . . 0.0 109.599 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.94 -45.34 71.21 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.019 1.328 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.77 -57.0 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 124.695 1.198 . . . . 0.0 109.384 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -68.17 -34.74 76.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 121.64 -0.663 . . . . 0.0 110.669 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.73 78.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 110.637 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.94 -36.09 82.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.866 -1.146 . . . . 0.0 110.474 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.58 -10.86 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.042 1.337 . . . . 0.0 110.947 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -58.65 -21.12 53.19 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.665 -1.897 . . . . 0.0 111.015 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.33 68.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 120.314 -1.491 . . . . 0.0 112.525 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.587 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.11 -47.86 22.86 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.22 -32.62 74.15 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.883 0.849 . . . . 0.0 112.022 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.93 -11.84 60.97 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.323 -1.486 . . . . 0.0 111.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 62.6 p -82.93 -19.06 37.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 120.391 -1.443 . . . . 0.0 109.748 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.05 -34.19 77.16 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.987 0.812 . . . . 0.0 111.14 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -77.88 -18.1 56.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.626 -1.296 . . . . 0.0 111.479 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -81.45 -30.08 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -57.13 -23.53 47.82 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 124.909 1.284 . . . . 0.0 111.213 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -59.86 -25.95 65.46 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.242 1.017 . . . . 0.0 112.178 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.437 -1.104 0 O-C-N 120.83 -1.169 . . . . 0.0 110.509 179.607 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.063 0 CA-C-O 121.846 0.831 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 4' ' ' HIS . 6.9 p-10 -66.24 -43.35 86.83 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.961 1.704 . . . . 0.0 108.815 -175.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' OD2' ' A' ' 3' ' ' ASP . 57.0 m170 -69.7 -31.07 68.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.355 -0.841 . . . . 0.0 111.75 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.39 -43.58 60.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -66.09 -44.59 83.97 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.081 0.952 . . . . 0.0 110.243 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -66.57 -36.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.901 0.858 . . . . 0.0 110.771 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.84 -43.49 79.41 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 121.162 -0.961 . . . . 0.0 110.367 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -69.83 -31.22 68.97 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.1 0.56 . . . . 0.0 110.348 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -59.45 -40.84 88.14 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.743 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.73 -33.84 75.67 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.715 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.47 -34.24 77.32 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.571 -0.706 . . . . 0.0 111.504 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -60.78 -45.99 92.22 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.133 0.973 . . . . 0.0 109.854 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.53 -34.33 77.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.265 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.78 -35.23 77.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.385 -0.822 . . . . 0.0 111.1 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.13 -36.03 66.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 121.508 -0.745 . . . . 0.0 110.537 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.74 -45.56 93.8 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.498 1.119 . . . . 0.0 110.987 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.04 -20.19 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 O-C-N 121.254 -0.904 . . . . 0.0 111.238 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.29 -41.66 96.77 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 119.435 1.016 . . . . 0.0 110.194 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.68 -26.52 59.9 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.378 1.071 . . . . 0.0 110.328 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -79.52 -41.41 27.4 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.483 -1.386 . . . . 0.0 108.51 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.55 69.93 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.102 1.361 . . . . 0.0 111.903 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.1 p -66.24 -50.54 63.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 119.224 0.92 . . . . 0.0 109.563 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 28' ' ' GLU . 4.8 tmtm? -63.31 -47.15 83.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.363 1.865 . . . . 0.0 109.044 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.5 -32.61 71.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.313 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.21 50.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 119.942 1.247 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.19 -38.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 121.759 0.79 . . . . 0.0 109.58 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 24' ' ' LYS . 39.9 tt0 -71.24 -33.74 70.13 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.966 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.19 94.59 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.504 1.122 . . . . 0.0 111.169 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 37' ' ' ALA . 6.3 pt-20 -82.93 -14.0 54.97 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.933 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -74.11 73.84 1.74 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.055 0.931 . . . . 0.0 111.049 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.73 23.92 0.69 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.274 -1.931 . . . . 0.0 108.274 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.49 142.58 43.45 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -77.86 121.63 5.52 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.936 2.424 . . . . 0.0 110.662 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.23 22.9 6.28 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.58 149.77 20.66 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 126.119 1.768 . . . . 0.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' H ' ' CD ' ' A' ' 30' ' ' GLU . . . -137.77 -65.81 0.51 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.244 0.618 . . . . 0.0 111.706 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.56 55.91 3.38 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.591 1.186 . . . . 0.0 108.703 -171.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 tt -72.96 -13.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 125.979 1.712 . . . . 0.0 111.016 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.3 m -90.9 126.92 36.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.95 -51.21 80.98 Favored Pre-proline 0 C--N 1.349 0.558 0 CA-C-O 116.219 -1.848 . . . . 0.0 113.939 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.64 -8.83 23.13 Favored 'Trans proline' 0 CA--C 1.514 -0.482 0 CA-C-N 126.003 3.18 . . . . 0.0 111.932 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.68 -35.38 14.22 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.579 1.152 . . . . 0.0 108.136 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.29 88.14 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.618 1.567 . . . . 0.0 110.651 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.33 -29.78 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.784 -0.573 . . . . 0.0 111.941 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -27.39 56.91 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.937 -1.102 . . . . 0.0 109.75 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -72.18 -38.85 69.01 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -55.41 -35.38 65.3 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.67 -0.644 . . . . 0.0 111.964 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.42 -39.09 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 110.261 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -80.28 -15.96 55.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.378 -0.826 . . . . 0.0 112.268 -168.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -97.2 -31.06 12.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 110.267 -173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -23.04 62.39 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.04 -1.038 . . . . 0.0 111.701 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -84.35 -2.75 57.59 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.424 1.09 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 53.27 65.37 1.54 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 126.067 1.747 . . . . 0.0 112.18 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.47 -84.41 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.75 76.85 1.27 Allowed Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.95 -49.14 16.19 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.1 -122.56 1.18 Allowed Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 104.053 -3.619 . . . . 0.0 104.053 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.513 ' CB ' HH12 ' B' ' 68' ' ' ARG 0.287 8.8 t0 62.95 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.428 1.891 . . . . 0.0 111.211 -169.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.79 -176.95 3.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -156.13 147.12 16.46 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.24 177.55 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.268 2.646 . . . . 0.0 110.199 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.81 170.57 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.27 1.428 . . . . 0.0 107.92 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -62.31 1.69 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.122 2.169 . . . . 0.0 112.47 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.7 -40.9 80.56 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.093 0.957 . . . . 0.0 112.451 -165.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.96 -108.75 0.34 Allowed 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.53 -83.01 0.0 OUTLIER Glycine 0 C--N 1.358 1.79 0 C-N-CA 128.239 2.828 . . . . 0.0 114.53 171.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.453 HH12 ' CD ' ' D' ' 50' ' ' GLU . 57.5 ttm-85 -54.79 -44.16 73.49 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.046 2.538 . . . . 0.0 112.439 174.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.98 -30.05 63.51 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.214 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.82 -45.1 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.49 78.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.837 2.055 . . . . 0.0 112.041 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -51.7 -44.44 63.17 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 109.736 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -72.33 -30.27 64.59 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.15 -47.89 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.62 -37.28 82.27 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.97 -38.11 87.3 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.505 -0.747 . . . . 0.0 111.08 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.45 -28.21 69.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.655 0.782 . . . . 0.0 111.385 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.52 -42.59 11.38 Favored Glycine 0 CA--C 1.49 -1.484 0 C-N-CA 124.709 1.147 . . . . 0.0 110.722 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.7 -47.84 81.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.678 1.191 . . . . 0.0 109.198 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -69.16 -25.71 64.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.317 -0.865 . . . . 0.0 111.916 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.47 -51.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.178 -0.951 . . . . 0.0 108.526 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.25 -26.03 66.37 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.48 -0.762 . . . . 0.0 111.231 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.57 48.59 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.023 0.929 . . . . 0.0 110.506 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.75 -39.12 87.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 124.803 1.241 . . . . 0.0 111.246 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.72 -6.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 121.366 -0.834 . . . . 0.0 112.679 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -60.31 -20.29 58.63 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.815 1.246 . . . . 0.0 110.682 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.11 78.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.345 -1.472 . . . . 0.0 112.688 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.18 -45.38 60.61 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.39 -37.63 88.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.562 0.745 . . . . 0.0 110.99 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.41 97.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.867 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -15.99 41.03 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.68 -1.263 . . . . 0.0 113.191 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.96 -17.1 60.6 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 111.853 -172.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -77.94 -24.71 48.12 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.239 -1.538 . . . . 0.0 110.734 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.72 -39.57 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -61.86 -20.89 64.18 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.18 1.392 . . . . 0.0 112.414 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttp85 -58.81 -22.35 58.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 125.005 1.322 . . . . 0.0 111.896 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 . . . . . 0 C--N 1.353 0.739 0 O-C-N 120.07 -1.644 . . . . 0.0 111.5 177.004 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.389 0 CA-C-O 122.184 0.992 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.468 ' CE1' ' OE1' ' B' ' 5' ' ' GLU . 7.7 p80 -59.91 -28.6 67.73 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.451 1.1 . . . . 0.0 112.413 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.468 ' OE1' ' CE1' ' B' ' 4' ' ' HIS . 9.3 tp10 -80.5 -34.61 35.59 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -167.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -71.34 -37.2 71.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.169 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -60.7 -43.07 98.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.931 1.692 . . . . 0.0 110.076 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.8 -45.42 82.42 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.351 1.06 . . . . 0.0 110.994 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.04 -37.43 87.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.436 1.094 . . . . 0.0 110.996 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.51 -33.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.382 1.473 . . . . 0.0 110.917 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.72 -37.93 79.84 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.663 -1.273 . . . . 0.0 110.072 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.17 -30.45 71.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.65 -38.39 90.12 Favored 'General case' 0 C--N 1.357 0.906 0 O-C-N 121.223 -0.923 . . . . 0.0 110.865 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -67.74 -36.25 80.22 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 121.627 -0.67 . . . . 0.0 109.795 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -61.61 -40.55 95.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.628 -0.67 . . . . 0.0 110.669 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.21 -27.24 67.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.361 -0.837 . . . . 0.0 111.989 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.63 -39.64 73.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.79 -38.9 83.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 124.426 1.09 . . . . 0.0 109.421 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -42.11 76.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.236 1.014 . . . . 0.0 112.301 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.86 -43.88 67.54 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.46 -33.17 73.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.101 -1.0 . . . . 0.0 111.394 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.73 -32.69 72.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.049 1.339 . . . . 0.0 110.993 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.0 p -66.83 -41.98 86.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -64.63 -45.37 87.13 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.98 1.312 . . . . 0.0 108.646 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -60.82 -58.16 9.63 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 109.807 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.72 79.9 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.824 1.249 . . . . 0.0 112.858 -172.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.57 -49.57 81.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 CA-C-N 118.814 0.734 . . . . 0.0 109.495 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -76.27 -25.11 54.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.504 0.669 . . . . 0.0 109.644 -170.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 125.544 1.538 . . . . 0.0 110.159 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.18 -12.66 60.13 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.025 -1.047 . . . . 0.0 113.128 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.83 77.68 1.6 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.557 -1.339 . . . . 0.0 110.986 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.04 -19.62 1.58 Allowed Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.41 140.95 45.2 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 121.248 -1.148 . . . . 0.0 109.911 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.62 151.25 25.15 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 122.11 1.873 . . . . 0.0 109.131 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 16.37 79.07 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 119.179 0.899 . . . . 0.0 112.19 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.53 142.93 57.72 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.355 1.862 . . . . 0.0 110.61 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.72 -25.12 0.32 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.324 0.583 . . . . 0.0 110.702 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.25 -38.14 66.09 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.535 1.534 . . . . 0.0 108.512 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -37.85 115.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 130.169 3.388 . . . . 0.0 111.854 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 47.1 t -177.88 -152.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 99.975 -4.083 . . . . 0.0 99.975 -168.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.26 -56.62 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -69.73 -31.3 20.93 Favored 'Trans proline' 0 CA--C 1.503 -1.034 0 CA-C-N 124.416 2.613 . . . . 0.0 111.404 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -107.77 14.51 25.44 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 119.757 1.162 . . . . 0.0 110.148 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.22 -35.37 73.84 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.404 -0.81 . . . . 0.0 109.336 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -28.2 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 123.814 0.845 . . . . 0.0 109.764 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -34.03 76.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.255 -1.528 . . . . 0.0 110.896 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -68.5 -42.76 78.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.685 0.794 . . . . 0.0 109.581 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.6 p -68.38 -28.37 67.05 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.395 -1.441 . . . . 0.0 111.376 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.08 -53.94 24.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 124.568 1.147 . . . . 0.0 110.737 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -73.82 -21.05 60.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.358 -0.838 . . . . 0.0 111.98 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.0 m -72.22 -39.56 68.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.46 67.48 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.371 -0.831 . . . . 0.0 111.727 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 4.37 44.82 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.943 -0.473 . . . . 0.0 110.918 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 24.2 p 55.67 56.58 6.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.273 1.429 . . . . 0.0 112.547 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 55.1 t -121.27 -93.29 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 101.972 -3.344 . . . . 0.0 101.972 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.03 82.98 1.1 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -174.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -73.9 -24.7 59.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.425 -1.044 . . . . 0.0 111.562 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.42 38.58 0.91 Allowed Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -82.32 -60.89 2.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.47 153.99 43.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.7 146.85 36.89 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 161.87 17.28 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.868 2.378 . . . . 0.0 108.797 164.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.18 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 119.465 1.029 . . . . 0.0 108.539 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -114.74 -36.63 4.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.68 1.229 . . . . 0.0 109.054 -172.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.95 -3.63 57.14 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 121.361 -0.837 . . . . 0.0 109.385 -166.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -26.26 60.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 77.11 1.32 Allowed Glycine 0 CA--C 1.471 -2.705 1 N-CA-C 101.445 -4.662 . . . . 0.0 101.445 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.513 HH12 ' CB ' ' A' ' 59' ' ' ASP . 21.0 ttm180 -53.52 -7.9 0.12 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 128.401 2.68 . . . . 0.0 114.263 -170.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -53.14 -19.98 3.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 120.716 -1.24 . . . . 0.0 113.276 157.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.17 -52.04 63.75 Favored 'Isoleucine or valine' 0 C--N 1.363 1.16 0 CA-C-N 120.464 1.484 . . . . 0.0 107.644 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.78 77.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.681 -0.637 . . . . 0.0 109.642 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.06 -46.98 75.42 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.232 1.013 . . . . 0.0 110.553 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.96 -44.04 91.41 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 124.899 1.28 . . . . 0.0 111.094 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.1 -44.16 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.367 0.667 . . . . 0.0 109.969 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.0 mtm -63.16 -46.54 86.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.346 0.593 . . . . 0.0 109.823 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -61.31 -41.51 97.12 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.063 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.13 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.765 0.826 . . . . 0.0 111.033 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.46 -48.17 76.44 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.87 -43.35 91.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 C-N-CA 124.47 1.108 . . . . 0.0 110.206 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.25 -40.9 94.63 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.118 -0.989 . . . . 0.0 111.684 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.9 -47.63 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.26 -11.15 60.76 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 121.562 -0.711 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.76 -42.3 12.7 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.835 -1.166 . . . . 0.0 109.144 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.53 -36.69 74.25 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 126.112 1.765 . . . . 0.0 111.04 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.64 -7.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 112.498 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.6 m -63.65 -16.86 62.1 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.314 -1.492 . . . . 0.0 110.985 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.45 -19.34 63.4 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.52 -1.987 . . . . 0.0 111.751 169.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.08 -54.48 4.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.124 1.37 . . . . 0.0 108.705 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.69 -36.34 70.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.468 -0.77 . . . . 0.0 112.533 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.14 -17.2 61.41 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 119.834 -1.791 . . . . 0.0 110.2 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -87.41 -2.27 58.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.729 -1.232 . . . . 0.0 109.36 175.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.02 -31.45 67.94 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 120.674 1.579 . . . . 0.0 111.302 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -72.94 -25.71 61.13 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.84 -1.163 . . . . 0.0 111.22 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.64 -32.5 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -63.37 -26.1 68.6 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.294 1.038 . . . . 0.0 111.552 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -50.57 -39.77 50.42 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.283 1.433 . . . . 0.0 111.438 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 CA--C 1.507 -0.689 0 O-C-N 120.926 -1.109 . . . . 0.0 112.128 -179.496 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 CA--C 1.505 -0.752 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -52.39 -29.8 25.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.365 1.466 . . . . 0.0 113.769 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.82 -25.96 56.8 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.943 -1.098 . . . . 0.0 111.326 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.94 -38.72 69.77 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.186 -0.946 . . . . 0.0 108.524 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.62 -27.95 66.48 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.28 0.562 . . . . 0.0 109.852 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.79 75.97 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.253 -0.905 . . . . 0.0 111.193 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -74.53 -29.5 61.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 120.872 -1.143 . . . . 0.0 111.08 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -64.17 -28.79 70.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 111.286 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.36 65.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.893 -1.13 . . . . 0.0 110.438 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.43 -32.35 73.67 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 120.898 -1.126 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.6 -29.31 66.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.793 -1.192 . . . . 0.0 110.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' C' ' 17' ' ' LYS . 7.8 tp10 -68.67 -37.49 79.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.324 1.449 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 27.4 tp -56.86 -48.89 77.05 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 126.073 1.749 . . . . 0.0 110.026 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.03 -39.79 79.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.673 1.589 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' C' ' 14' ' ' GLU . 28.3 ttpt -74.12 -46.7 40.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.338 1.455 . . . . 0.0 110.742 -172.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.98 -36.23 72.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.101 -0.999 . . . . 0.0 111.111 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.19 -28.04 57.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -49.59 74.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -63.19 -43.41 98.28 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.44 1.114 . . . . 0.0 109.197 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.16 63.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.637 -0.665 . . . . 0.0 112.518 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 m -69.13 -47.73 64.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 124.075 0.95 . . . . 0.0 109.702 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -66.24 -43.79 85.58 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.43 -20.61 64.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.461 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -45.09 73.69 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 119.975 1.261 . . . . 0.0 110.451 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.04 -44.29 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.91 -45.02 94.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.801 1.64 . . . . 0.0 110.258 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.18 86.45 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 124.869 1.267 . . . . 0.0 111.174 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -32.45 58.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 121.959 -0.463 . . . . 0.0 109.9 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.6 90.49 1.03 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.443 1.097 . . . . 0.0 109.637 -174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.75 -27.41 2.82 Favored Glycine 0 CA--C 1.491 -1.463 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.57 156.07 40.06 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -76.77 154.08 34.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.23 1.953 . . . . 0.0 110.734 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.41 49.73 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.16 136.41 15.12 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.636 1.974 . . . . 0.0 113.536 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.7 -30.42 0.19 Allowed 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.185 0.994 . . . . 0.0 111.007 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -102.88 148.08 26.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -168.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -156.47 179.43 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m 65.32 109.36 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.572 1.549 . . . . 0.0 114.258 161.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -57.59 -37.89 61.53 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 116.227 -1.844 . . . . 0.0 114.757 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.6 -21.77 14.44 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 CA-C-N 125.628 3.046 . . . . 0.0 112.666 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -82.84 -25.45 32.62 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.72 71.86 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.96 1.704 . . . . 0.0 112.507 -172.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -67.13 -25.16 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 123.338 0.655 . . . . 0.0 111.114 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -21.01 56.25 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 120.822 -1.174 . . . . 0.0 110.867 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -80.62 -40.16 26.14 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.372 1.082 . . . . 0.0 108.126 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m -70.61 -31.42 68.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 O-C-N 120.328 -1.483 . . . . 0.0 112.634 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -62.62 -51.05 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.68 -15.76 61.69 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.08 1.352 . . . . 0.0 112.291 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 50.3 m -82.3 -36.73 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.066 -1.021 . . . . 0.0 108.525 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -27.74 61.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.37 -0.831 . . . . 0.0 110.451 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -93.0 6.91 46.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.452 0.701 . . . . 0.0 110.211 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.259 7.9 p 54.2 55.02 8.71 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 126.855 2.062 . . . . 0.0 114.317 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.87 -75.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.96 -64.06 3.09 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 t80 78.68 -47.6 0.43 Allowed 'General case' 0 C--N 1.351 0.668 0 C-N-CA 127.369 2.267 . . . . 0.0 109.437 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.05 13.72 0.42 Allowed Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -57.57 4.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.658 -0.907 . . . . 0.0 111.144 -173.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 26.0 mtm-85 -138.13 154.95 49.17 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -134.27 150.41 73.97 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.23 166.82 20.21 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 109.556 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.1 -179.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p -82.54 -79.85 0.18 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -32.47 -61.68 0.26 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.596 2.758 . . . . 0.0 110.912 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.77 -59.41 1.8 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -41.02 -41.45 2.67 Favored Glycine 0 CA--C 1.488 -1.639 0 C-N-CA 127.47 2.462 . . . . 0.0 114.819 -169.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -76.36 -30.68 57.68 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.292 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -35.35 71.59 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 121.528 1.967 . . . . 0.0 108.888 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.93 -51.38 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.79 98.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 125.094 1.358 . . . . 0.0 112.551 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.98 -46.89 52.95 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 127.328 2.251 . . . . 0.0 109.457 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -66.59 -36.39 82.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.75 -44.46 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.6 mtt -59.5 -46.26 89.32 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.679 0.791 . . . . 0.0 110.664 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -61.94 -43.61 98.48 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.48 84.12 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.226 0.61 . . . . 0.0 110.931 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.19 86.64 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 123.821 0.724 . . . . 0.0 111.833 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.99 -43.11 97.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.938 0.895 . . . . 0.0 109.527 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.77 -33.36 73.94 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.342 -0.848 . . . . 0.0 111.94 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.21 -53.59 35.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 123.689 0.796 . . . . 0.0 109.558 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -66.09 -38.79 89.14 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.85 -30.47 71.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.423 0.689 . . . . 0.0 111.842 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.68 -36.86 81.48 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 121.026 -1.046 . . . . 0.0 110.443 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.64 -20.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.932 1.293 . . . . 0.0 110.416 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 2.9 m -55.76 -22.79 25.94 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.927 1.291 . . . . 0.0 112.185 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.66 70.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.662 -1.899 . . . . 0.0 112.826 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.0 -16.68 35.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 123.961 0.904 . . . . 0.0 110.381 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.4 -35.6 17.03 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.33 62.07 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.611 -1.306 . . . . 0.0 111.179 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -73.26 -19.22 61.11 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 120.44 -1.412 . . . . 0.0 110.787 171.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . 0.442 ' CG ' ' HE ' ' C' ' 95' ' ' ARG . 4.6 m-20 -83.7 -11.37 57.28 Favored 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 120.935 -1.103 . . . . 0.0 111.136 -157.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -84.58 -21.3 30.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.109 -0.994 . . . . 0.0 110.336 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.84 -35.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . 0.442 ' HE ' ' CG ' ' C' ' 92' ' ' ASP . 61.7 mtt-85 -55.35 -19.46 8.92 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.036 1.334 . . . . 0.0 113.217 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -57.46 -28.87 63.73 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.296 -0.877 . . . . 0.0 110.947 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 N--CA 1.436 -1.17 0 O-C-N 121.319 -0.863 . . . . 0.0 110.805 -176.772 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 74.48 -67.69 0.24 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.866 2.066 . . . . 0.0 110.645 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 5.7 p80 -70.83 -28.93 64.98 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 126.662 1.985 . . . . 0.0 111.857 -175.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 2.2 mp0 -69.32 -23.46 63.79 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 120.967 -1.083 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.07 -42.78 88.94 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.453 -0.779 . . . . 0.0 109.908 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.76 -39.64 80.17 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.63 93.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.536 0.735 . . . . 0.0 111.17 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.34 -39.52 85.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.469 0.708 . . . . 0.0 110.389 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -64.06 -35.61 81.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.005 0.922 . . . . 0.0 110.808 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.03 79.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.388 1.075 . . . . 0.0 111.122 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -65.26 -34.69 78.96 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 120.901 -1.125 . . . . 0.0 111.17 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.96 -33.67 74.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 121.595 -0.69 . . . . 0.0 110.867 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -61.68 -41.94 98.24 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.194 1.398 . . . . 0.0 109.297 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.61 -38.84 91.76 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.051 -1.031 . . . . 0.0 111.417 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -69.12 -22.65 63.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.157 -0.964 . . . . 0.0 112.405 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.48 -39.96 36.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.25 -38.33 80.8 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 124.379 1.071 . . . . 0.0 109.544 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.79 -45.9 63.99 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.556 1.142 . . . . 0.0 112.056 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -71.41 -41.14 69.94 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 122.776 0.431 . . . . 0.0 110.585 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -62.68 -43.37 98.99 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.38 68.69 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.875 1.67 . . . . 0.0 112.17 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -67.08 -37.95 84.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 110.163 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -35.21 63.85 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -64.66 -50.06 68.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.57 0.748 . . . . 0.0 109.185 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.39 69.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.678 1.191 . . . . 0.0 113.507 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.23 -28.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 O-C-N 120.187 -1.57 . . . . 0.0 109.888 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -75.75 -49.17 18.97 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.797 -1.19 . . . . 0.0 108.304 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.27 78.62 6.49 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' D' ' 66' ' ' GLU . 0.9 OUTLIER -159.82 -55.05 0.06 Allowed 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.889 1.368 . . . . 0.0 108.051 163.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -79.42 103.54 9.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 119.406 -2.058 . . . . 0.0 110.303 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.38 -49.59 0.26 Allowed Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 105.181 -3.168 . . . . 0.0 105.181 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 161.69 70.05 Favored Pre-proline 0 CA--C 1.504 -0.807 0 C-N-CA 123.446 0.698 . . . . 0.0 112.759 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -78.65 113.78 3.36 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.589 2.193 . . . . 0.0 110.766 172.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.33 2.25 13.55 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.129 -0.817 . . . . 0.0 111.202 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.03 145.09 21.42 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.858 1.263 . . . . 0.0 113.172 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.16 -48.56 1.33 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.626 1.171 . . . . 0.0 111.128 -167.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.78 133.81 34.51 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 pt -148.11 17.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.11 138.65 33.66 Favored 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 120.484 -1.385 . . . . 0.0 108.228 -170.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.58 -49.39 8.57 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.982 -1.961 . . . . 0.0 111.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.27 -8.04 21.35 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 CA-C-N 125.865 3.13 . . . . 0.0 111.101 -173.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -98.82 -25.63 14.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.09 80.5 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.532 1.133 . . . . 0.0 111.086 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.37 -35.53 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 121.977 -0.452 . . . . 0.0 110.445 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -28.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.487 -1.383 . . . . 0.0 110.429 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -63.79 -42.93 97.63 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.417 1.103 . . . . 0.0 108.457 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -58.33 -37.47 75.21 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.307 1.443 . . . . 0.0 111.388 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.53 -49.77 71.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 124.328 1.051 . . . . 0.0 110.591 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.453 ' CD ' HH12 ' A' ' 68' ' ' ARG . 8.0 pt-20 -75.36 -23.85 57.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.849 0.833 . . . . 0.0 110.863 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 64.3 m -70.31 -39.33 74.87 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.72 67.12 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.098 -1.001 . . . . 0.0 111.942 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -88.65 5.82 41.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 119.149 -0.453 . . . . 0.0 110.077 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 51.48 29.7 5.6 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 127.614 2.366 . . . . 0.0 112.437 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.07 -47.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.31 51.48 58.54 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -71.11 -33.23 69.94 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.978 0.894 . . . . 0.0 109.361 -166.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 155.68 -123.47 1.34 Allowed Glycine 0 CA--C 1.476 -2.36 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 75.13 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.345 1.458 . . . . 0.0 108.016 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -145.37 171.58 14.41 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -164.36 148.21 7.97 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -91.67 155.06 3.5 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 C-N-CA 122.468 2.112 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -155.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.937 0.875 . . . . 0.0 110.424 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -53.84 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.382 -1.449 . . . . 0.0 112.26 -164.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' D' ' 67' ' ' GLY . 8.9 tt0 -79.86 -7.78 58.91 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.784 1.233 . . . . 0.0 109.621 -165.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' D' ' 30' ' ' GLU . 40.2 mm-40 -95.98 41.26 1.11 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' D' ' 65' ' ' GLU . . . 15.16 81.56 0.01 OUTLIER Glycine 0 CA--C 1.462 -3.253 1 C-N-CA 133.139 5.162 . . . . 0.0 110.434 -170.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -53.37 -13.8 0.63 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.599 1.96 . . . . 0.0 113.457 -164.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.05 -6.01 0.32 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 160.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.12 -49.15 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 O-C-N 120.274 -1.517 . . . . 0.0 107.713 167.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.23 82.06 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -48.67 -46.28 40.06 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.604 1.161 . . . . 0.0 113.324 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.27 -37.43 83.44 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.107 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.34 -44.97 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 58.2 mtm -63.05 -48.34 79.13 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.21 1.004 . . . . 0.0 110.62 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.39 -38.27 88.98 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.531 -0.731 . . . . 0.0 110.505 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.698 -0.626 . . . . 0.0 111.911 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.17 -46.98 66.97 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.74 -44.89 94.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 C-N-CA 124.559 1.144 . . . . 0.0 109.663 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.78 -47.56 84.3 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 111.388 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.16 -49.99 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 124.284 1.034 . . . . 0.0 109.768 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -71.75 -16.23 62.2 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.903 -0.498 . . . . 0.0 111.482 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.27 -35.55 16.08 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.256 -0.903 . . . . 0.0 109.859 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.52 -31.48 72.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.584 1.554 . . . . 0.0 110.927 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.08 -3.02 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.696 0 O-C-N 121.326 -0.858 . . . . 0.0 112.609 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 88.0 m -58.35 -22.85 54.91 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.476 1.51 . . . . 0.0 111.571 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.88 66.33 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.198 -1.564 . . . . 0.0 111.935 172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.69 -49.06 6.68 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.09 -39.9 91.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.726 -1.234 . . . . 0.0 113.657 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.85 61.81 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.945 -1.097 . . . . 0.0 110.892 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 80.8 p -85.31 -14.47 46.43 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.568 -1.333 . . . . 0.0 110.566 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.39 -16.2 61.34 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.14 -1.6 . . . . 0.0 111.067 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -80.31 -31.36 38.15 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.651 -1.281 . . . . 0.0 111.874 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.19 -11.74 14.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 CA-C-O 121.562 0.696 . . . . 0.0 110.168 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -61.41 -17.26 53.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.788 0.835 . . . . 0.0 110.848 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . 0.444 ' HB3' ' HE2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER -60.58 -22.21 63.46 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.586 1.085 . . . . 0.0 112.021 176.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 N--CA 1.441 -0.883 0 C-N-CA 123.682 0.793 . . . . 0.0 109.474 -178.344 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.865 0 CA-C-O 121.61 0.719 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 14.8 t0 -136.42 129.47 31.24 Favored 'General case' 0 CA--C 1.477 -1.857 1 N-CA-C 96.573 -5.343 . . . . 0.0 96.573 153.116 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' OE1' ' A' ' 5' ' ' GLU 0.299 22.4 p80 144.07 -60.88 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 128.5 2.72 . . . . 0.0 107.251 -177.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.52 ' OE1' ' CE1' ' A' ' 4' ' ' HIS . 2.8 pt-20 -76.34 -28.15 56.75 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 120.745 -1.222 . . . . 0.0 110.803 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -64.02 -37.54 87.79 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.06 -1.025 . . . . 0.0 111.167 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -73.48 -34.21 65.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.085 1.354 . . . . 0.0 108.27 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.96 90.34 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.953 1.301 . . . . 0.0 110.587 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -61.8 -42.16 98.66 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 110.082 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -64.03 -34.3 77.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.911 0.862 . . . . 0.0 110.947 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.48 70.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.003 -1.061 . . . . 0.0 110.987 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.02 -32.8 74.7 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.191 -0.943 . . . . 0.0 111.038 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.89 -34.81 74.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.744 -1.223 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.54 -36.54 82.93 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.46 -48.77 76.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.594 1.158 . . . . 0.0 110.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -71.49 -27.07 62.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.733 -1.229 . . . . 0.0 112.283 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -67.09 -44.34 80.26 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.211 1.404 . . . . 0.0 109.805 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.48 -29.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.946 -1.096 . . . . 0.0 110.249 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.75 -38.87 89.57 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 123.799 0.839 . . . . 0.0 111.168 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.93 -31.55 63.11 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.197 0.999 . . . . 0.0 110.826 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -77.88 -39.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.03 78.79 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.274 1.029 . . . . 0.0 111.715 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -65.83 -32.69 74.36 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.862 -0.524 . . . . 0.0 110.587 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -62.55 -47.43 83.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.395 0.678 . . . . 0.0 109.576 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -64.96 -38.04 89.66 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 110.115 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.23 75.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.149 0.98 . . . . 0.0 112.555 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.8 t -72.71 -43.19 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 121.089 -1.007 . . . . 0.0 109.175 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.0 -37.87 81.98 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.65 -1.282 . . . . 0.0 110.104 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 64.74 6.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.919 1.688 . . . . 0.0 108.219 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -164.74 -53.86 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.91 89.53 0.01 OUTLIER 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.119 1.768 . . . . 0.0 112.269 -170.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.58 10.12 25.74 Favored Glycine 0 CA--C 1.498 -0.995 0 O-C-N 121.035 -1.041 . . . . 0.0 111.792 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.71 133.46 25.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.722 1.261 . . . . 0.0 107.945 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.39 130.0 8.83 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.696 2.264 . . . . 0.0 110.645 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.76 74.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 160.38 16.39 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.9 9.17 Favored 'General case' 0 N--CA 1.427 -1.595 1 N-CA-C 99.04 -4.43 . . . . 0.0 99.04 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt 82.63 87.99 0.04 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 tt -138.57 142.83 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.71 138.73 0.06 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.324 1.849 . . . . 0.0 112.73 169.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -51.65 -53.48 50.01 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 126.033 1.733 . . . . 0.0 114.37 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.77 -6.94 18.83 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 CA-C-N 124.366 2.595 . . . . 0.0 112.316 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.48 -48.08 4.9 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.6 77.77 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 125.382 1.473 . . . . 0.0 112.441 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -66.42 -31.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.509 -0.744 . . . . 0.0 110.452 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -23.16 36.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.394 -0.816 . . . . 0.0 109.916 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -72.37 -38.56 68.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -75.92 65.84 2.06 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.551 1.54 . . . . 0.0 108.318 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.69 -71.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.577 ' CD ' HH22 ' B' ' 68' ' ' ARG . 20.0 pt-20 -69.37 -24.4 63.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.869 0.842 . . . . 0.0 111.946 -165.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -66.93 -35.37 79.84 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 124.837 1.255 . . . . 0.0 107.988 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.84 -23.64 52.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 120.358 -1.464 . . . . 0.0 110.695 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -87.31 9.93 18.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.282 5.4 t 48.08 48.29 18.41 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 127.723 2.409 . . . . 0.0 112.569 172.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.99 -99.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 171.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.88 67.01 0.57 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 103.142 -3.983 . . . . 0.0 103.142 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -68.12 -30.55 69.73 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 122.134 0.969 . . . . 0.0 108.466 -174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.62 49.07 0.53 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.582 ' CG ' HH21 ' B' ' 68' ' ' ARG 0.479 4.6 p-10 -80.48 -28.96 37.41 Favored 'General case' 0 C--N 1.362 1.11 0 CA-C-N 119.063 1.431 . . . . 0.0 110.372 170.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -147.03 -179.84 7.1 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -146.05 137.54 12.97 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -84.49 -177.12 2.8 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 C-N-CA 124.422 3.415 . . . . 0.0 108.863 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' H ' ' CG ' ' A' ' 66' ' ' GLU 0.308 7.8 p -112.1 -128.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.657 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 -37.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.443 1.897 . . . . 0.0 107.183 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -84.22 -2.19 56.47 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.77 0.828 . . . . 0.0 109.78 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -73.86 -35.51 64.75 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.81 60.29 0.66 Allowed Glycine 0 CA--C 1.466 -3.017 1 N-CA-C 102.772 -4.131 . . . . 0.0 102.772 168.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -13.84 -30.75 0.0 OUTLIER 'General case' 0 C--N 1.364 1.214 1 C-N-CA 135.489 5.515 . . . . 0.0 117.738 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -53.36 -22.31 7.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 126.737 2.015 . . . . 0.0 112.626 163.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.3 -51.35 65.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.52 -1.363 . . . . 0.0 108.439 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.79 -45.09 68.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.376 0.67 . . . . 0.0 110.341 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.81 -37.09 75.6 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 110.841 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -58.18 -39.65 79.46 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 121.4 -0.812 . . . . 0.0 110.601 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.51 -36.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mmt -57.9 -57.49 12.58 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.397 1.079 . . . . 0.0 109.741 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.95 -28.06 67.98 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 121.345 -0.847 . . . . 0.0 111.057 -175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.92 -22.74 65.94 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.588 -0.695 . . . . 0.0 110.883 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.93 -36.78 10.85 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.25 -42.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 125.359 1.464 . . . . 0.0 110.426 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.76 -37.27 84.29 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.438 -0.789 . . . . 0.0 110.91 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.36 -57.99 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 124.535 1.134 . . . . 0.0 109.979 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.01 -13.7 62.6 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.709 -0.619 . . . . 0.0 110.691 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.62 -46.97 16.23 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 121.112 -0.992 . . . . 0.0 110.091 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.47 -36.9 79.39 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.065 1.346 . . . . 0.0 111.64 -172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.0 m -62.71 -9.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.408 -0.807 . . . . 0.0 112.602 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -62.91 -18.58 63.22 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.121 1.369 . . . . 0.0 110.941 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.82 -24.28 66.78 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.682 -1.261 . . . . 0.0 111.636 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.47 -46.52 10.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 108.197 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.43 -41.55 98.79 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.17 0.988 . . . . 0.0 112.902 -171.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.04 -9.96 59.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.13 -0.981 . . . . 0.0 111.466 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.6 p -83.78 -16.18 45.64 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 120.768 -1.208 . . . . 0.0 110.323 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.73 -24.77 58.77 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.628 -163.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -74.65 -32.02 62.12 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.644 -1.285 . . . . 0.0 110.995 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 t -69.43 -32.87 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 125.399 1.48 . . . . 0.0 108.423 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -61.84 -11.63 13.64 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.398 1.479 . . . . 0.0 112.442 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -68.34 -22.34 64.69 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 120.001 -1.687 . . . . 0.0 110.595 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--N 1.353 0.749 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.459 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 CA--C 1.507 -0.683 0 CA-C-O 123.537 1.637 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.25 -21.05 63.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.191 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -85.66 -39.11 17.63 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -70.84 -31.25 67.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.478 -0.764 . . . . 0.0 110.864 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.11 -47.64 79.24 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.0 70.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.294 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.14 -35.91 80.72 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.218 1.007 . . . . 0.0 110.208 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.25 -28.12 64.99 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -39.35 93.37 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.09 -47.79 76.0 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.404 -0.81 . . . . 0.0 110.548 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -52.88 -51.97 59.16 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.312 1.845 . . . . 0.0 110.222 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -76.03 -12.59 60.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.443 -0.786 . . . . 0.0 112.045 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.733 -1.229 . . . . 0.0 108.12 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.77 -14.05 60.66 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.54 -1.35 . . . . 0.0 111.193 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.93 -51.65 21.03 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.15 -23.75 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.859 -0.526 . . . . 0.0 111.393 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.14 -39.71 83.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.369 -0.832 . . . . 0.0 112.076 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.74 -24.34 38.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.293 0.568 . . . . 0.0 110.583 -174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.33 -42.15 46.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.82 82.15 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 126.309 1.844 . . . . 0.0 111.584 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -65.99 -44.97 83.29 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 122.111 -0.368 . . . . 0.0 110.324 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.11 -48.16 77.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.248 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -68.31 -25.55 65.19 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.098 -175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -43.9 58.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 109.673 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 73.7 t -60.43 -45.72 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.241 -0.912 . . . . 0.0 110.127 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.59 17.96 15.2 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 121.638 -0.664 . . . . 0.0 111.099 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.448 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -75.69 -48.52 21.66 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 170.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -27.53 58.78 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 126.396 1.878 . . . . 0.0 115.082 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -73.77 75.88 1.58 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.61 0.764 . . . . 0.0 109.393 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.59 -43.23 0.77 Allowed Glycine 0 CA--C 1.488 -1.618 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.41 152.12 60.35 Favored Pre-proline 0 N--CA 1.445 -0.713 0 O-C-N 121.486 -1.008 . . . . 0.0 111.263 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.05 153.5 11.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.136 1.891 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.17 41.61 10.13 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 132.44 52.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 -42.06 0.17 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.358 0.263 . . . . 0.0 110.683 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -6.61 54.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.896 1.678 . . . . 0.0 110.739 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.14 84.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 O-C-N 120.634 -1.291 . . . . 0.0 111.929 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.1 112.05 0.74 Allowed 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -53.37 -47.7 95.26 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.404 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -71.47 -20.14 27.7 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-N 124.962 2.808 . . . . 0.0 113.011 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.73 0.63 17.47 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 119.941 1.246 . . . . 0.0 109.922 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.44 -34.72 76.46 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.189 -0.944 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.99 -35.75 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.287 1.035 . . . . 0.0 109.614 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.63 -38.83 67.6 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.466 -1.396 . . . . 0.0 108.815 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -65.18 -44.86 87.11 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 123.356 0.662 . . . . 0.0 110.152 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -66.96 -29.43 69.28 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.953 -1.092 . . . . 0.0 110.851 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 23.3 t -58.35 -43.25 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.453 1.101 . . . . 0.0 111.117 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -82.45 -15.0 54.16 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.794 1.179 . . . . 0.0 112.298 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.48 -36.14 29.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.756 -1.215 . . . . 0.0 107.804 -174.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.37 -23.39 61.12 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.882 -1.136 . . . . 0.0 112.066 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.96 -6.28 59.0 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.188 0.995 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 14.6 p 55.7 54.48 8.22 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.863 1.665 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.89 -91.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 1 N-CA-C 100.031 -4.062 . . . . 0.0 100.031 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.52 76.72 1.34 Allowed Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.65 -18.23 51.93 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.49 -1.006 . . . . 0.0 108.605 -171.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.3 48.93 0.68 Allowed Glycine 0 CA--C 1.484 -1.877 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 168.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.61 -54.34 9.37 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -131.33 -136.62 0.2 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.191 0.596 . . . . 0.0 109.594 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -171.91 121.57 0.47 Allowed Pre-proline 0 N--CA 1.444 -0.726 1 N-CA-C 100.029 -4.063 . . . . 0.0 100.029 -168.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.85 158.15 13.82 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 124.59 2.675 . . . . 0.0 109.791 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 m -76.11 169.92 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.635 1.207 . . . . 0.0 111.819 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -59.63 2.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.38 1.072 . . . . 0.0 110.793 -169.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.31 -17.26 64.7 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 -168.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -130.56 -108.05 0.27 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.448 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 25.94 -70.87 0.0 OUTLIER Glycine 0 CA--C 1.486 -1.758 1 C-N-CA 132.442 4.83 . . . . 0.0 116.204 170.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.582 HH21 ' CG ' ' A' ' 59' ' ' ASP . 52.7 ttm-85 -61.78 -42.92 99.61 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 126.083 1.753 . . . . 0.0 112.575 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -67.79 -34.5 76.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 120.251 1.387 . . . . 0.0 109.589 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.99 -47.75 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.2 90.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.876 1.671 . . . . 0.0 110.9 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -50.91 -46.1 60.55 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 127.648 2.379 . . . . 0.0 110.482 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -66.73 -37.46 84.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -74.51 -45.76 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.223 1.009 . . . . 0.0 109.372 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 71.7 mtm -61.06 -45.01 96.48 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.629 1.172 . . . . 0.0 109.759 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -64.8 -32.49 74.2 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.909 -0.495 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.512 -0.743 . . . . 0.0 110.329 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -40.59 97.02 Favored Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 124.186 0.898 . . . . 0.0 111.732 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.63 -51.0 77.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 C-N-CA 124.086 0.954 . . . . 0.0 108.456 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -65.41 -27.4 68.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.541 -0.724 . . . . 0.0 111.724 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.87 -58.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 124.391 1.076 . . . . 0.0 110.333 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -65.28 -25.41 67.63 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 121.539 0.685 . . . . 0.0 110.148 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.21 -41.97 32.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 121.367 -0.833 . . . . 0.0 111.268 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.16 -36.93 85.26 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.522 -1.361 . . . . 0.0 110.682 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.79 -3.45 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 O-C-N 121.563 -0.711 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 56.5 m -56.6 -22.77 36.17 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.992 1.317 . . . . 0.0 109.985 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.05 72.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.329 -1.482 . . . . 0.0 112.503 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.01 -35.42 61.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 120.954 -1.091 . . . . 0.0 109.191 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.5 -32.49 62.54 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 122.967 0.507 . . . . 0.0 110.67 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.844 -1.16 . . . . 0.0 111.115 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -11.21 60.62 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.066 -1.021 . . . . 0.0 113.22 174.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.7 -47.61 80.46 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 120.208 1.367 . . . . 0.0 109.839 -171.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -71.54 -27.16 62.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.941 -1.099 . . . . 0.0 111.736 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.01 -17.75 22.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.982 1.313 . . . . 0.0 109.455 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -70.37 -17.73 63.05 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.082 -1.636 . . . . 0.0 111.707 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -66.41 -13.48 60.77 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 120.496 -1.377 . . . . 0.0 110.478 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 . . . . . 0 CA--C 1.497 -1.064 0 C-N-CA 126.195 1.798 . . . . 0.0 109.876 176.482 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.498 -1.036 0 CA-C-O 121.639 0.733 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' C' ' 5' ' ' GLU . 40.5 p-80 -65.82 -30.33 70.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.803 -0.561 . . . . 0.0 112.004 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' C' ' 4' ' ' HIS . 7.2 mt-10 -77.36 -40.72 42.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.04 -44.46 96.66 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.521 -0.737 . . . . 0.0 109.986 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -33.98 75.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.025 0.441 . . . . 0.0 110.685 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.73 90.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.669 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -68.64 -34.39 75.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 121.674 -0.641 . . . . 0.0 110.62 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -66.56 -35.39 80.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.219 1.408 . . . . 0.0 110.73 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.42 87.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.351 -0.843 . . . . 0.0 111.069 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -63.76 -33.89 76.67 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.978 0.894 . . . . 0.0 111.5 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -68.33 -30.84 69.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.103 1.361 . . . . 0.0 110.518 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -69.22 -37.01 77.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.777 -1.202 . . . . 0.0 108.987 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.5 -44.43 97.09 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.222 1.009 . . . . 0.0 110.838 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.61 -39.6 70.99 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.254 1.021 . . . . 0.0 112.376 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.2 71.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.274 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.61 -40.66 88.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.73 -42.68 84.36 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.319 1.048 . . . . 0.0 111.095 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.7 -39.96 94.54 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -88.31 -12.54 43.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.949 -1.094 . . . . 0.0 109.983 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.51 -37.51 42.91 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.783 -1.198 . . . . 0.0 109.286 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -37.65 84.97 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.232 0.613 . . . . 0.0 110.311 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -44.26 81.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.285 1.434 . . . . 0.0 109.218 172.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -69.14 -48.77 61.48 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.652 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.98 80.91 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.302 1.041 . . . . 0.0 112.924 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.27 -23.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 O-C-N 121.294 -0.879 . . . . 0.0 110.839 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.85 -4.26 47.36 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 119.854 -1.779 . . . . 0.0 109.016 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.63 -48.62 12.39 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -173.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.85 -110.67 0.13 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . 0.305 11.5 mtm-85 43.23 71.57 0.23 Allowed 'General case' 0 C--N 1.358 0.945 0 C-N-CA 126.32 1.848 . . . . 0.0 112.942 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.14 36.97 2.05 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.83 153.7 42.22 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.19 121.34 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.996 2.464 . . . . 0.0 110.041 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.19 25.78 39.03 Favored Glycine 0 CA--C 1.496 -1.107 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.69 151.65 46.4 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.116 1.366 . . . . 0.0 109.575 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.25 -34.9 0.52 Allowed 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.255 0.622 . . . . 0.0 109.759 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.4 tp -94.75 55.06 1.84 Allowed 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.87 19.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 124.646 1.178 . . . . 0.0 110.28 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.5 t -129.42 125.61 36.91 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.14 -53.05 20.47 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-O 115.85 -2.024 . . . . 0.0 112.109 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.54 -16.2 34.27 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 CA-C-N 126.252 3.269 . . . . 0.0 111.109 -173.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.01 -20.62 44.96 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.8 79.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.159 -0.963 . . . . 0.0 111.63 -167.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.06 -21.86 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.628 0.728 . . . . 0.0 110.632 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -25.34 21.91 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.875 0.87 . . . . 0.0 109.147 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -67.48 -46.67 72.28 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 170.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -77.37 64.25 2.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.734 -0.604 . . . . 0.0 110.037 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 66.2 t -136.1 -71.07 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.38 -15.1 62.36 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-O 121.95 0.881 . . . . 0.0 112.598 -164.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.7 t -73.03 -32.37 65.06 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 124.719 1.207 . . . . 0.0 109.102 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.39 58.71 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 121.08 -1.012 . . . . 0.0 110.55 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -92.23 7.46 42.56 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.05 0.54 . . . . 0.0 110.128 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 51.2 p 49.68 42.33 23.21 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.482 1.913 . . . . 0.0 113.772 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.64 -56.24 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.77 3.06 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.23 -45.85 62.38 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -172.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.68 52.25 0.23 Allowed Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.66 -36.42 73.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.863 -0.786 . . . . 0.0 111.493 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -126.79 -163.71 1.27 Allowed 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -148.43 112.2 3.73 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 168.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.57 -173.61 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.769 2.979 . . . . 0.0 108.779 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.268 7.4 p -128.39 -128.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -121.35 -37.16 2.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.279 1.432 . . . . 0.0 108.035 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.71 -12.2 58.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.869 1.268 . . . . 0.0 110.371 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -32.94 68.23 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.09 64.83 0.84 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 102.348 -4.301 . . . . 0.0 102.348 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -14.21 -38.6 0.0 OUTLIER 'General case' 0 C--N 1.366 1.284 1 C-N-CA 132.491 4.316 . . . . 0.0 116.434 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.49 -26.88 0.24 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.637 1.575 . . . . 0.0 113.791 165.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.46 -42.78 92.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.409 -1.432 . . . . 0.0 110.833 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.2 31.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -60.27 -31.19 69.99 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 123.681 0.792 . . . . 0.0 113.026 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -69.23 -32.45 71.7 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.407 -1.433 . . . . 0.0 110.545 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.92 62.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -57.2 -52.29 65.9 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.706 1.202 . . . . 0.0 110.381 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.83 -42.84 99.52 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 122.015 -0.428 . . . . 0.0 110.88 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.01 -33.92 75.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.688 0.395 . . . . 0.0 111.549 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -45.49 86.41 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 123.837 0.732 . . . . 0.0 111.329 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.34 -45.82 93.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.35 1.06 . . . . 0.0 109.352 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.94 -38.46 85.93 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.519 -0.738 . . . . 0.0 112.31 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.15 -53.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 109.198 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -66.73 -38.91 87.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.919 -0.488 . . . . 0.0 111.041 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.36 73.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 110.997 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.04 -30.93 71.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.314 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.88 -18.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 124.911 1.284 . . . . 0.0 110.775 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -56.53 -20.64 21.53 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 112.424 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.04 72.06 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.136 -1.602 . . . . 0.0 111.898 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.08 -50.66 10.03 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.732 -1.23 . . . . 0.0 108.233 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 44.1 mt -59.63 -39.28 83.8 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.802 1.241 . . . . 0.0 112.27 -173.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.13 60.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.039 -1.038 . . . . 0.0 111.396 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 27.0 m -85.65 -18.01 34.45 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.7 -25.03 61.09 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.126 -1.609 . . . . 0.0 111.643 -164.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -77.55 -20.65 53.79 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.669 -1.27 . . . . 0.0 111.176 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.27 -24.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -172.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.03 -36.56 60.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.03 1.332 . . . . 0.0 111.846 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -54.84 -40.22 69.4 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 125.057 1.343 . . . . 0.0 110.955 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 . . . . . 0 N--CA 1.44 -0.973 0 C-N-CA 123.793 0.837 . . . . 0.0 110.206 -176.828 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.74 -66.63 0.31 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 130.042 3.337 . . . . 0.0 112.017 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 46.8 p-80 -65.05 -27.62 68.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.333 1.853 . . . . 0.0 112.763 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.76 -31.41 61.77 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.237 -0.914 . . . . 0.0 108.928 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.93 -41.15 91.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.995 0.918 . . . . 0.0 109.282 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.79 -41.87 95.48 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.81 1.244 . . . . 0.0 109.159 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.68 98.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.059 0.944 . . . . 0.0 111.48 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -70.54 -29.81 66.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.556 -0.715 . . . . 0.0 111.832 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -63.95 -34.24 77.52 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.129 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.41 94.05 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.634 0.774 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.67 -36.25 83.22 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -71.12 -24.86 62.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.053 -1.03 . . . . 0.0 111.325 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.2 -35.02 73.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.982 0.913 . . . . 0.0 109.185 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 tp -64.66 -40.51 95.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.365 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -60.21 -28.36 67.93 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.023 0.929 . . . . 0.0 112.334 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -70.25 -42.98 71.49 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.35 -29.81 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 123.992 0.917 . . . . 0.0 109.745 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.44 -44.04 97.37 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.283 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -77.54 -31.58 53.41 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.111 1.364 . . . . 0.0 110.988 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -65.14 -53.68 41.38 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.915 1.34 . . . . 0.0 108.962 171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.49 -24.5 60.19 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 124.642 1.177 . . . . 0.0 111.524 -167.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 12.0 p -64.43 -46.33 83.66 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.254 1.026 . . . . 0.0 109.247 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.77 -46.36 88.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.343 1.857 . . . . 0.0 108.586 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.32 -47.9 77.66 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.326 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.63 84.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.411 1.084 . . . . 0.0 110.763 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.978 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.77 -34.35 34.3 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.5 91.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.75 1.62 . . . . 0.0 109.364 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.22 -26.54 65.76 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.358 1.063 . . . . 0.0 111.889 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -74.12 112.62 10.44 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.64 -1.913 . . . . 0.0 107.836 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.5 -22.97 8.63 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.98 64.73 Favored Pre-proline 0 N--CA 1.443 -0.806 0 O-C-N 121.735 -0.862 . . . . 0.0 110.927 -176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -84.09 128.02 4.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.104 2.536 . . . . 0.0 111.864 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.78 46.88 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.43 135.0 50.75 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 127.668 2.387 . . . . 0.0 112.388 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.22 -31.17 1.13 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 123.795 0.838 . . . . 0.0 109.846 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.08 49.83 1.87 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 107.737 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.87 -164.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER 80.88 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 116.51 -1.71 . . . . 0.0 106.966 178.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -157.54 -62.8 0.02 OUTLIER Pre-proline 0 C--N 1.35 0.624 0 CA-C-O 116.135 -1.888 . . . . 0.0 109.037 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.48 -14.37 25.04 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 CA-C-N 125.709 3.075 . . . . 0.0 111.084 -169.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -34.18 29.53 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.284 2.634 . . . . 0.0 107.867 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.85 69.49 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.129 0.972 . . . . 0.0 111.62 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 tt -70.6 -33.01 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.341 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -19.29 59.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.316 -1.49 . . . . 0.0 109.984 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -70.03 -53.71 16.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 p -65.1 -19.11 65.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.08 -44.53 99.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 124.097 0.959 . . . . 0.0 111.159 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.2 -32.35 49.94 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.602 1.092 . . . . 0.0 108.494 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -81.36 63.36 5.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.903 0.881 . . . . 0.0 111.055 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.71 -52.14 0.07 Allowed 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 20.8 p -95.53 46.18 1.1 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.954 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 11.9 p 42.86 65.94 0.86 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.919 1.688 . . . . 0.0 113.641 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.01 -108.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.15 48.36 1.9 Allowed Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 105.813 -2.915 . . . . 0.0 105.813 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -11.98 59.88 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.913 -0.757 . . . . 0.0 111.327 -166.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.16 40.55 3.98 Favored Glycine 0 CA--C 1.495 -1.207 0 O-C-N 120.288 -1.507 . . . . 0.0 110.001 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.0 -56.73 6.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.856 1.263 . . . . 0.0 108.773 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -144.34 167.76 21.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.32 122.91 18.37 Favored Pre-proline 0 CA--C 1.499 -0.985 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.05 169.96 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.374 2.049 . . . . 0.0 108.716 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.99 -106.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-N 119.07 0.85 . . . . 0.0 112.864 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -155.79 -39.46 0.08 Allowed 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -170.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -77.54 -11.7 59.88 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.622 1.969 . . . . 0.0 109.894 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.17 60.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.26 90.5 1.81 Allowed Glycine 0 N--CA 1.418 -2.524 1 N-CA-C 98.029 -6.028 . . . . 0.0 98.029 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -56.49 -18.86 12.87 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 119.664 1.732 . . . . 0.0 110.694 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -49.95 -21.82 1.33 Allowed 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.574 1.55 . . . . 0.0 114.384 165.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.06 -46.22 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 O-C-N 120.562 -1.336 . . . . 0.0 108.809 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -43.06 93.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.249 0.62 . . . . 0.0 109.476 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.51 -44.33 69.01 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.444 1.498 . . . . 0.0 111.102 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -57.85 -47.73 81.83 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.352 1.061 . . . . 0.0 111.362 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -45.14 85.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-O 121.535 0.683 . . . . 0.0 109.531 -172.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.46 -43.49 85.38 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.129 0.572 . . . . 0.0 110.807 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.64 -34.67 78.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 121.504 -0.748 . . . . 0.0 110.28 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.65 88.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.797 -0.564 . . . . 0.0 110.684 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.33 96.16 Favored Glycine 0 CA--C 1.495 -1.17 0 C-N-CA 124.058 0.837 . . . . 0.0 112.053 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.48 -46.91 92.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 124.413 1.085 . . . . 0.0 109.69 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.22 -36.96 85.79 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.204 -0.935 . . . . 0.0 112.23 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.47 -51.15 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.908 0.883 . . . . 0.0 109.822 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.48 -4.8 50.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.515 -0.741 . . . . 0.0 111.444 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.17 -40.55 12.15 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.353 -0.842 . . . . 0.0 108.991 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -57.05 -39.93 75.83 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 126.495 1.918 . . . . 0.0 111.082 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.9 m -62.95 -6.82 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.28 1.032 . . . . 0.0 112.92 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.2 m -62.17 -17.72 58.84 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.617 -1.302 . . . . 0.0 110.641 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.9 69.62 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.305 -1.497 . . . . 0.0 111.846 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -82.16 -45.82 14.63 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.046 -1.034 . . . . 0.0 108.519 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -62.79 -34.05 76.46 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.804 0.812 . . . . 0.0 111.915 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.44 66.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.977 -1.077 . . . . 0.0 111.941 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.5 t -92.45 0.48 57.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.062 -1.024 . . . . 0.0 108.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.69 -34.52 62.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.69 0.757 . . . . 0.0 109.157 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -73.65 -34.87 65.15 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.786 -1.197 . . . . 0.0 110.764 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.66 -25.85 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 125.582 1.553 . . . . 0.0 109.376 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -47.73 -38.58 15.63 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 125.876 1.67 . . . . 0.0 111.357 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -61.18 -14.05 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.354 0.799 0 O-C-N 121.398 -0.814 . . . . 0.0 109.885 170.589 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.393 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 4' ' ' HIS 0.279 33.9 t70 -176.74 -116.79 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -137.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.472 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 30.9 p80 -44.38 -35.36 2.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 130.611 3.564 . . . . 0.0 114.919 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.81 -31.35 72.5 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.679 0.792 . . . . 0.0 111.624 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -71.44 -32.06 67.9 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -78.46 -34.86 47.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.7 79.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.012 0.925 . . . . 0.0 110.487 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -66.0 -35.73 81.37 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 123.992 0.917 . . . . 0.0 111.378 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -62.83 -41.34 99.28 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.313 -0.867 . . . . 0.0 109.818 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.12 71.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.458 0.703 . . . . 0.0 111.579 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -62.94 -30.54 71.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.524 -0.735 . . . . 0.0 111.319 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.43 -33.69 67.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.62 -42.86 97.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 110.254 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.68 -42.15 95.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 123.094 0.558 . . . . 0.0 111.03 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.85 -37.63 79.8 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -67.04 -33.87 76.47 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 121.558 -0.714 . . . . 0.0 111.322 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.35 -30.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.265 -0.897 . . . . 0.0 109.048 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.52 -37.52 81.42 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.948 -1.095 . . . . 0.0 111.72 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.02 -44.56 72.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.643 1.177 . . . . 0.0 110.327 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.43 -39.4 92.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 121.322 -0.861 . . . . 0.0 109.567 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.58 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.792 1.237 . . . . 0.0 111.337 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 p -66.65 -43.12 85.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.689 0.677 . . . . 0.0 109.818 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.39 -54.9 37.67 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.062 0.945 . . . . 0.0 110.548 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -71.62 -31.34 66.77 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.865 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.99 71.84 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 119.142 0.883 . . . . 0.0 110.194 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.68 -38.72 83.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-O 121.856 0.836 . . . . 0.0 110.035 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.03 -33.97 72.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.474 -0.766 . . . . 0.0 110.286 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.9 84.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.433 1.111 . . . . 0.0 111.794 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -36.7 85.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 126.809 2.043 . . . . 0.0 111.207 176.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.72 77.87 9.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.508 1.147 . . . . 0.0 109.493 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.28 -35.55 0.71 Allowed Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 106.239 -2.744 . . . . 0.0 106.239 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.36 156.67 62.62 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 122.305 -0.527 . . . . 0.0 110.221 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.15 152.19 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.053 1.835 . . . . 0.0 110.033 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.32 56.59 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.24 26.38 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.046 1.338 . . . . 0.0 114.145 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -58.27 0.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.599 1.159 . . . . 0.0 111.944 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.8 tp -82.2 76.1 9.1 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.892 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.02 75.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 O-C-N 120.484 -1.385 . . . . 0.0 108.439 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -158.03 120.41 3.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.07 -54.01 60.66 Favored Pre-proline 0 C--N 1.352 0.716 0 CA-C-O 116.355 -1.784 . . . . 0.0 112.518 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.47 -3.91 14.6 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 CA-C-N 125.277 2.92 . . . . 0.0 112.044 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -105.4 -33.12 8.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.47 -24.41 61.99 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 120.459 -1.401 . . . . 0.0 112.081 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.68 -23.7 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.771 0.796 . . . . 0.0 110.005 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -39.91 51.34 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.542 -1.349 . . . . 0.0 108.173 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.2 t90 -64.94 -46.83 79.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 123.81 0.844 . . . . 0.0 108.851 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -64.32 -27.1 68.8 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.71 -54.12 37.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 C-N-CA 123.794 0.838 . . . . 0.0 109.011 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.59 -27.24 62.05 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.675 -0.641 . . . . 0.0 111.177 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -62.22 -40.42 96.06 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.962 0.905 . . . . 0.0 110.769 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.52 74.05 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 121.427 -0.796 . . . . 0.0 111.815 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.53 1.05 39.74 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.937 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p 56.54 21.44 5.69 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.335 1.854 . . . . 0.0 112.474 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.35 -58.72 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.7 72.51 0.63 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.74 -22.19 62.44 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.136 0.97 . . . . 0.0 109.962 -166.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.23 26.06 3.88 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.418 ' CG ' HH12 ' B' ' 68' ' ' ARG . 19.0 t70 -65.5 -53.74 38.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.966 1.306 . . . . 0.0 110.335 177.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.43 164.73 28.6 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.82 137.19 30.24 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.53 169.17 12.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.621 2.214 . . . . 0.0 110.41 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -71.13 176.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.759 1.266 . . . . 0.0 111.743 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 m -96.96 -51.24 4.32 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.711 1.205 . . . . 0.0 109.959 -172.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.57 -42.9 89.02 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 111.237 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -130.85 -137.1 0.21 Allowed 'General case' 0 CA--C 1.492 -1.27 1 N-CA-C 100.184 -4.006 . . . . 0.0 100.184 165.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.46 -77.98 1.18 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.496 HH22 ' CG ' ' D' ' 59' ' ' ASP . 6.5 ttm180 -63.08 -40.81 98.75 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.585 1.954 . . . . 0.0 110.492 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -75.17 -19.26 59.93 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.734 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.01 -50.12 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.6 74.0 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.745 1.618 . . . . 0.0 111.588 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -42.13 -51.96 4.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 127.654 2.382 . . . . 0.0 112.32 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.62 -35.28 75.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.299 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.04 -46.35 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.454 1.102 . . . . 0.0 109.126 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.69 -45.38 94.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.001 1.321 . . . . 0.0 109.717 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -59.73 -37.69 79.65 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.545 0.738 . . . . 0.0 111.947 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.67 89.38 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.587 -0.696 . . . . 0.0 110.543 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.3 -46.85 85.15 Favored Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.8 -47.45 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 109.188 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.9 -42.75 99.89 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.127 -0.983 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.9 t -63.6 -52.13 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.264 0.938 . . . . 0.0 110.142 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.92 -28.94 67.92 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.063 0.545 . . . . 0.0 111.077 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.13 -34.32 32.58 Favored 'General case' 0 CA--C 1.505 -0.75 0 O-C-N 120.932 -1.105 . . . . 0.0 110.606 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.45 -32.68 74.19 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.39 -1.444 . . . . 0.0 110.865 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -65.6 -5.15 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 121.56 -0.713 . . . . 0.0 112.41 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -55.35 -20.88 13.0 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.596 1.559 . . . . 0.0 111.566 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.56 -21.07 65.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 120.422 -1.424 . . . . 0.0 113.046 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.27 -39.16 14.63 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 124.821 1.248 . . . . 0.0 108.727 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.58 -45.53 91.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.883 1.273 . . . . 0.0 110.013 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.33 60.21 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.409 ' CG2' ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER -79.91 -15.98 56.23 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 119.781 -1.825 . . . . 0.0 107.653 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.413 55.1 m-20 -98.55 14.67 27.53 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.606 -160.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -89.62 -30.86 17.85 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 153.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.65 -24.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.402 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -56.19 -23.79 37.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.597 1.159 . . . . 0.0 111.99 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -64.52 -19.7 65.76 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.182 -1.574 . . . . 0.0 112.061 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 C--N 1.355 0.846 0 O-C-N 121.226 -0.921 . . . . 0.0 110.322 178.084 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 122.642 1.21 . . . . 0.0 108.363 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.424 ' HE1' ' OE2' ' B' ' 5' ' ' GLU . 18.6 p80 -60.2 -31.75 70.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.819 2.048 . . . . 0.0 113.735 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.424 ' OE2' ' HE1' ' B' ' 4' ' ' HIS . 6.6 mt-10 -74.66 -35.64 62.82 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.047 -1.033 . . . . 0.0 110.959 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -73.95 -36.52 64.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.794 -0.566 . . . . 0.0 110.491 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.82 -37.8 82.42 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.96 90.35 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.908 0.883 . . . . 0.0 111.112 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.13 -35.2 78.02 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.099 0.96 . . . . 0.0 110.913 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -65.13 -38.22 89.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.283 1.033 . . . . 0.0 110.545 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.18 80.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.429 1.092 . . . . 0.0 110.782 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.51 -36.26 83.63 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.474 -0.766 . . . . 0.0 111.042 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -75.61 -25.13 56.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.023 -1.048 . . . . 0.0 111.354 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.434 ' CD ' ' HZ2' ' B' ' 17' ' ' LYS . 29.1 tp10 -67.58 -38.33 83.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.57 -46.18 89.66 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.423 0.689 . . . . 0.0 110.886 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -57.23 -41.02 78.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.339 1.456 . . . . 0.0 111.367 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.434 ' HZ2' ' CD ' ' B' ' 14' ' ' GLU . 20.7 ttpt -66.38 -37.37 85.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.356 1.063 . . . . 0.0 110.761 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.25 -38.34 81.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 O-C-N 120.938 -1.101 . . . . 0.0 108.643 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.47 -44.09 89.16 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 123.736 0.815 . . . . 0.0 110.526 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.68 -48.7 74.63 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 110.592 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -75.57 -36.79 60.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.783 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.16 -29.05 69.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.357 1.063 . . . . 0.0 111.87 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -62.24 -42.3 99.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.758 1.223 . . . . 0.0 110.443 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -67.77 -48.11 67.28 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 125.363 1.465 . . . . 0.0 107.37 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -58.07 -47.48 83.04 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 124.626 1.17 . . . . 0.0 111.299 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.87 78.81 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.979 0.912 . . . . 0.0 111.366 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.95 -44.17 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 -29.26 65.05 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 119.817 1.189 . . . . 0.0 110.947 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.8 -42.67 60.63 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 125.092 1.357 . . . . 0.0 109.611 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -74.98 -21.0 59.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.618 0.723 . . . . 0.0 111.022 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -74.67 89.47 2.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 120.276 -1.515 . . . . 0.0 110.636 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.78 -4.01 11.78 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.92 150.95 56.83 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 118.065 0.933 . . . . 0.0 109.082 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -82.26 132.58 7.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.937 2.425 . . . . 0.0 110.723 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 5.19 88.07 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.47 146.02 55.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 123.671 0.789 . . . . 0.0 111.497 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.43 -47.48 4.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 124.906 1.282 . . . . 0.0 108.078 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -90.47 66.07 6.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 122.807 1.289 . . . . 0.0 108.836 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -101.03 26.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 O-C-N 120.344 -1.472 . . . . 0.0 108.485 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 11.6 p -91.05 -114.86 0.08 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 t80 162.2 -70.99 0.0 OUTLIER Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 126.757 2.023 . . . . 0.0 106.296 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.92 -12.03 19.8 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-N 125.112 2.862 . . . . 0.0 111.868 -163.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.0 6.31 36.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.296 1.038 . . . . 0.0 109.059 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.96 74.68 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.368 -0.832 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.63 -30.35 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.075 0.95 . . . . 0.0 111.574 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -85.61 -18.47 33.18 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.343 -0.848 . . . . 0.0 109.962 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -80.72 -41.05 24.24 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.88 60.53 0.96 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 111.452 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.43 -64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.86 -19.06 64.99 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -167.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -72.62 -30.76 64.6 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.123 0.969 . . . . 0.0 108.947 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.59 62.17 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.502 -1.374 . . . . 0.0 110.381 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -93.52 14.84 17.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.685 0.794 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 67.5 p 55.4 51.72 12.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.751 1.62 . . . . 0.0 113.728 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.87 -145.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.047 1 N-CA-C 99.473 -4.269 . . . . 0.0 99.473 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.9 90.31 0.13 Allowed Glycine 0 CA--C 1.481 -2.047 1 N-CA-C 99.058 -5.617 . . . . 0.0 99.058 -171.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -81.58 -17.57 47.85 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.447 -1.031 . . . . 0.0 108.673 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.41 44.22 1.49 Allowed Glycine 0 CA--C 1.486 -1.764 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -72.28 -63.72 1.09 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -102.06 -169.24 1.65 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -155.35 100.9 2.25 Favored Pre-proline 0 N--CA 1.443 -0.805 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.81 153.34 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.698 2.265 . . . . 0.0 110.255 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.51 -124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -135.2 -11.14 2.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.036 -1.04 . . . . 0.0 109.046 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -112.54 2.67 16.37 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 125.64 1.576 . . . . 0.0 107.433 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.27 43.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.06 91.26 1.54 Allowed Glycine 0 N--CA 1.418 -2.564 1 N-CA-C 98.14 -5.984 . . . . 0.0 98.14 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.418 HH12 ' CG ' ' A' ' 59' ' ' ASP . 37.6 ttm180 -68.74 -3.98 14.21 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.073 1.937 . . . . 0.0 110.648 -174.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.168 1.787 . . . . 0.0 111.638 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -47.89 84.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 124.994 1.317 . . . . 0.0 109.4 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.41 77.44 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -55.18 -41.56 72.07 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.711 1.605 . . . . 0.0 111.114 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -65.38 -35.39 80.83 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.428 -0.795 . . . . 0.0 111.578 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.17 -41.78 44.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 9.2 tpp -53.59 -54.94 30.29 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 126.249 1.819 . . . . 0.0 109.96 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -68.81 -36.11 77.82 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.162 0.985 . . . . 0.0 110.499 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.67 87.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.594 -0.691 . . . . 0.0 110.939 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.95 96.96 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 124.455 1.026 . . . . 0.0 111.322 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 72.3 mt -60.36 -42.95 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 109.114 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -73.09 -31.31 64.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.061 -1.025 . . . . 0.0 113.262 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.43 -43.44 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.256 -0.902 . . . . 0.0 109.702 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.81 -36.56 78.39 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 118.686 0.675 . . . . 0.0 110.073 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.46 92.39 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.896 0.878 . . . . 0.0 110.944 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.28 -31.97 73.38 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.579 -1.326 . . . . 0.0 111.651 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.77 -25.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 124.194 0.998 . . . . 0.0 109.762 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -68.33 -3.11 9.93 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 121.142 -0.974 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.52 82.65 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.679 -2.513 . . . . 0.0 110.84 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.53 59.72 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 39.4 mt -110.02 27.22 9.82 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.25 -9.33 8.62 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.414 HG22 ' CD2' ' B' ' 4' ' ' HIS . 10.0 t -100.36 3.36 43.21 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -71.71 -45.41 61.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.517 1.127 . . . . 0.0 109.197 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.59 -26.36 68.65 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.8 -1.187 . . . . 0.0 112.386 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.2 -29.16 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 123.984 0.914 . . . . 0.0 109.993 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -26.06 64.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 120.423 -1.423 . . . . 0.0 109.53 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -70.62 -19.45 62.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.796 -0.565 . . . . 0.0 111.696 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--N 1.347 0.497 0 O-C-N 120.03 -1.669 . . . . 0.0 109.565 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 123.754 1.74 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -60.38 -36.07 77.2 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 130.312 3.445 . . . . 0.0 110.424 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -75.38 -36.41 60.9 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -33.87 76.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.701 0.801 . . . . 0.0 111.202 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -45.9 64.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.779 0.832 . . . . 0.0 108.877 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.65 98.89 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.163 0.985 . . . . 0.0 111.552 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -71.33 -26.23 62.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.105 1.362 . . . . 0.0 110.702 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.39 -37.93 63.26 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.99 95.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.233 -0.917 . . . . 0.0 111.235 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.98 -34.58 78.77 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.413 -0.805 . . . . 0.0 111.094 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -62.98 -33.48 75.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.606 1.162 . . . . 0.0 110.457 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.98 -42.56 84.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 109.146 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.6 tp -62.04 -37.11 83.72 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.16 0.984 . . . . 0.0 110.968 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.64 -27.67 69.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -34.91 63.31 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.518 -1.364 . . . . 0.0 109.289 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.75 -36.51 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.03 -41.04 77.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 123.877 0.871 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -72.07 -35.51 69.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.851 0.86 . . . . 0.0 111.2 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.92 -46.74 56.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.731 1.253 . . . . 0.0 107.992 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.79 64.35 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 125.787 1.635 . . . . 0.0 111.432 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' C' ' 45' ' ' ILE . 1.4 p -74.21 -36.6 63.97 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.296 -0.877 . . . . 0.0 110.014 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.521 ' HZ3' ' CD ' ' C' ' 28' ' ' GLU . 14.5 tmtt? -64.94 -47.66 76.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -64.3 -35.61 81.42 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.338 0.655 . . . . 0.0 111.004 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.04 60.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.35 1.06 . . . . 0.0 110.943 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.16 -36.07 73.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 CA-C-O 122.08 0.943 . . . . 0.0 110.069 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.521 ' CD ' ' HZ3' ' C' ' 24' ' ' LYS . 37.6 tt0 -69.13 -36.16 77.18 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.056 -1.028 . . . . 0.0 110.298 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.8 67.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.635 1.574 . . . . 0.0 111.706 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -75.63 -17.6 59.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 121.451 -0.781 . . . . 0.0 110.72 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -85.58 75.48 10.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.363 -1.46 . . . . 0.0 110.152 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.37 -42.3 0.44 Allowed Glycine 0 CA--C 1.478 -2.237 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 151.11 66.02 Favored Pre-proline 0 N--CA 1.437 -1.093 0 O-C-N 122.36 -0.494 . . . . 0.0 110.806 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.72 147.73 24.99 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.868 1.712 . . . . 0.0 110.214 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 28.87 35.25 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.509 -0.606 . . . . 0.0 112.17 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.08 132.66 54.16 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 112.703 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.8 -37.21 0.6 Allowed 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.175 0.99 . . . . 0.0 109.539 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.71 35.67 0.78 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.749 1.22 . . . . 0.0 107.906 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 tt -77.41 4.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 123.673 1.702 . . . . 0.0 108.651 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -71.68 125.8 28.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.03 2.132 . . . . 0.0 110.373 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -87.71 -55.85 0.33 Allowed Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.908 -1.52 . . . . 0.0 111.225 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.42 -24.52 16.32 Favored 'Trans proline' 0 CA--C 1.501 -1.172 0 CA-C-N 125.075 2.848 . . . . 0.0 111.228 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.0 -7.2 58.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.89 79.45 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.043 -1.035 . . . . 0.0 111.126 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' C' ' 23' ' ' SER . 20.3 tt -69.17 -29.34 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.485 -0.759 . . . . 0.0 110.186 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -36.71 74.57 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 121.017 -1.052 . . . . 0.0 111.318 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -71.4 -33.32 69.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.632 0.729 . . . . 0.0 109.639 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -59.93 -41.56 92.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.95 -55.03 18.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.174 1.39 . . . . 0.0 110.753 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.89 -13.22 60.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.593 -0.692 . . . . 0.0 112.196 -173.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -79.47 -39.47 32.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.964 0.906 . . . . 0.0 109.252 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -24.02 64.88 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 120.88 -1.137 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p -92.81 2.43 56.76 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.477 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p 50.03 36.98 13.07 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.119 1.768 . . . . 0.0 111.269 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.6 -59.13 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 61.17 6.85 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -43.49 60.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -170.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.93 -114.26 0.59 Allowed Glycine 0 CA--C 1.482 -1.983 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.305 27.2 t70 62.17 -71.38 0.05 OUTLIER 'General case' 0 C--N 1.351 0.672 0 C-N-CA 127.199 2.2 . . . . 0.0 111.185 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -117.19 -163.98 0.96 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -155.53 148.08 17.8 Favored Pre-proline 0 N--CA 1.433 -1.301 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -90.24 159.55 4.67 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.197 1.932 . . . . 0.0 109.684 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.421 ' H ' HG22 ' C' ' 63' ' ' VAL . 16.1 m -82.94 -175.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.91 1.684 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 -79.64 0.2 Allowed 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.461 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -39.7 -43.8 1.43 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.174 2.189 . . . . 0.0 113.31 -165.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -113.92 -91.18 0.51 Allowed 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 8.04 -69.04 0.0 OUTLIER Glycine 0 C--N 1.36 1.863 1 C-N-CA 131.584 4.421 . . . . 0.0 117.267 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -66.61 -41.23 88.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.475 1.51 . . . . 0.0 113.033 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -80.42 -20.2 44.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.098 -1.001 . . . . 0.0 109.031 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.93 -46.41 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 172.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.78 76.67 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 126.116 1.766 . . . . 0.0 111.576 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.51 -53.54 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.495 2.318 . . . . 0.0 111.074 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.24 -39.91 89.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.188 1.395 . . . . 0.0 110.551 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.98 -45.42 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.55 1.14 . . . . 0.0 109.315 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.0 mtm -59.67 -46.81 87.94 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 109.888 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -60.09 -38.68 83.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 111.302 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.58 82.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.609 0.764 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.99 -46.54 58.96 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.99 -45.62 92.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.556 0 C-N-CA 124.388 1.075 . . . . 0.0 109.536 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -61.7 -42.43 98.94 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.445 -0.784 . . . . 0.0 111.692 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.68 -49.88 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 123.956 0.902 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -67.96 -35.02 77.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.925 -0.484 . . . . 0.0 110.648 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.06 -28.46 61.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.055 -1.028 . . . . 0.0 110.715 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.08 -18.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 120.503 -1.373 . . . . 0.0 111.384 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.66 1.5 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 120.144 -1.598 . . . . 0.0 111.22 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 31.4 m -62.9 -20.53 65.26 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.104 -1.623 . . . . 0.0 111.31 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.89 44.82 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 124.785 1.234 . . . . 0.0 112.159 169.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.23 -40.21 13.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.529 1.532 . . . . 0.0 110.269 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.65 -46.08 48.79 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.141 0.577 . . . . 0.0 111.297 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.3 -28.16 66.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.603 -0.685 . . . . 0.0 110.815 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -85.59 -14.49 45.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.067 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.363 16.5 t70 -74.29 -30.08 61.93 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-N 121.776 2.08 . . . . 0.0 110.767 -168.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -70.49 -26.13 63.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 119.693 -1.879 . . . . 0.0 112.413 174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.84 -22.47 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 124.521 1.129 . . . . 0.0 108.559 -174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -63.26 -17.42 62.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.331 1.053 . . . . 0.0 111.463 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -71.36 -22.35 61.91 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 120.818 -1.176 . . . . 0.0 112.321 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--N 1.354 0.778 0 O-C-N 121.48 -0.762 . . . . 0.0 109.565 -178.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -52.08 -29.93 23.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.531 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 3.5 p-80 -59.56 -33.63 71.67 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.531 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 9.3 mt-10 -79.27 -42.09 26.63 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 23.7 ttp85 -60.87 -38.77 86.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 110.279 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.7 -32.07 71.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.302 -0.873 . . . . 0.0 111.668 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.31 84.06 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.435 0.636 . . . . 0.0 109.597 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -66.83 -37.6 84.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.38 -0.825 . . . . 0.0 110.382 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -69.24 -23.68 63.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.288 -0.882 . . . . 0.0 111.346 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.74 86.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.608 -1.308 . . . . 0.0 111.079 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.12 -31.0 72.04 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.78 -1.2 . . . . 0.0 111.877 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.98 -34.87 79.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.049 1.34 . . . . 0.0 109.3 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -67.91 -41.05 83.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.792 1.237 . . . . 0.0 108.785 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.01 -45.33 95.24 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.689 0.796 . . . . 0.0 110.29 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.946 0.794 . . . . 0.0 112.164 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -74.1 -13.49 60.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.096 -1.003 . . . . 0.0 113.405 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.27 -46.51 12.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -53.06 -49.25 66.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 128.126 2.57 . . . . 0.0 110.459 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -78.11 -17.04 57.42 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.533 -1.354 . . . . 0.0 111.0 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -76.98 -31.9 56.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.44 82.81 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 124.767 1.227 . . . . 0.0 111.544 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -59.4 -42.7 92.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.75 1.22 . . . . 0.0 112.168 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -69.59 -37.99 77.15 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.827 0.851 . . . . 0.0 109.005 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -70.51 -51.01 31.86 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.433 0.693 . . . . 0.0 110.09 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.47 92.2 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 126.18 1.792 . . . . 0.0 112.304 -171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.46 -35.7 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -75.45 -36.13 60.78 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.05 99.13 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.902 2.081 . . . . 0.0 110.201 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -88.48 -21.88 23.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -70.0 84.95 0.51 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 120.444 -1.41 . . . . 0.0 109.787 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.49 -2.2 4.14 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.23 157.55 82.86 Favored Pre-proline 0 N--CA 1.446 -0.644 0 O-C-N 121.138 -1.213 . . . . 0.0 112.55 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.63 131.29 11.29 Favored 'Trans proline' 0 CA--C 1.508 -0.798 0 C-N-CA 123.585 2.856 . . . . 0.0 110.643 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.76 -59.39 4.57 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.37 166.9 0.11 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.729 2.812 . . . . 0.0 110.327 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.05 -53.93 0.13 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.293 -1.744 . . . . 0.0 106.293 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 34.0 tp -99.68 134.83 42.0 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -149.88 167.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m 73.61 131.8 0.04 OUTLIER 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.278 1.831 . . . . 0.0 112.918 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -58.08 -51.65 80.25 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.448 -1.739 . . . . 0.0 113.183 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.53 -13.16 24.99 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 CA-C-N 124.306 2.574 . . . . 0.0 111.967 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 -46.84 9.08 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.16 73.78 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.333 1.453 . . . . 0.0 111.716 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -65.98 -31.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 121.686 -0.634 . . . . 0.0 111.178 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -31.97 47.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 120.727 -1.233 . . . . 0.0 109.854 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -61.92 -40.44 95.5 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.388 1.089 . . . . 0.0 109.443 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -64.5 -35.84 82.26 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 119.898 -1.751 . . . . 0.0 112.169 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.98 -53.35 49.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.007 0.923 . . . . 0.0 109.468 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.422 ' CD ' HH11 ' A' ' 68' ' ' ARG . 14.0 pt-20 -69.03 -24.71 64.23 Favored 'General case' 0 C--N 1.351 0.63 0 C-N-CA 123.275 0.63 . . . . 0.0 111.662 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -76.05 -38.54 57.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.337 -0.852 . . . . 0.0 108.74 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.53 -28.19 65.81 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.981 -1.074 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 10.4 p -93.81 9.63 36.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 123.162 0.585 . . . . 0.0 110.335 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 18.3 p 58.68 43.47 18.75 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.901 1.68 . . . . 0.0 114.702 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.68 -69.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 86.59 -55.66 4.69 Favored Glycine 0 N--CA 1.435 -1.385 0 O-C-N 120.564 -1.335 . . . . 0.0 111.908 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.1 -30.92 0.21 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.5 1.92 . . . . 0.0 113.296 173.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 108.83 26.26 5.36 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.496 ' CG ' HH22 ' A' ' 68' ' ' ARG . 30.0 t70 -68.8 -67.99 0.43 Allowed 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.683 0.793 . . . . 0.0 109.023 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 157.64 46.05 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 102.666 -3.086 . . . . 0.0 102.666 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.9 122.26 4.98 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.78 178.06 6.87 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 C-N-CA 123.022 2.481 . . . . 0.0 110.67 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.417 HG21 ' H ' ' D' ' 64' ' ' THR . 9.8 p -113.27 -177.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 122.895 1.331 . . . . 0.0 111.27 -170.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.417 ' H ' HG21 ' D' ' 63' ' ' VAL . 7.1 m -52.41 -40.65 62.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.733 2.813 . . . . 0.0 113.048 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.63 -11.72 59.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.424 1.09 . . . . 0.0 110.696 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' D' ' 68' ' ' ARG . 0.4 OUTLIER -68.64 -33.27 73.71 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 170.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 131.93 -26.57 3.78 Favored Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.407 ' H ' ' CD ' ' D' ' 66' ' ' GLU 0.348 9.4 ttt85 57.19 -35.92 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.031 1 C-N-CA 132.458 4.303 . . . . 0.0 113.702 -168.339 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' D' ' 67' ' ' GLY . 9.7 tptm -69.81 -9.28 54.1 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 126.243 1.817 . . . . 0.0 109.957 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 t -72.74 -37.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -53.86 37.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -46.94 -55.17 8.54 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 125.862 1.665 . . . . 0.0 112.947 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -70.02 -25.49 63.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.889 -0.507 . . . . 0.0 111.732 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.39 -45.9 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 8.5 mtp -56.5 -45.89 80.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.064 1.346 . . . . 0.0 110.252 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -59.41 -38.03 79.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.635 1.174 . . . . 0.0 112.101 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -36.99 84.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.998 -0.439 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.55 -43.77 85.05 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 123.731 0.681 . . . . 0.0 111.444 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.78 -47.97 89.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 C-N-CA 124.308 1.043 . . . . 0.0 109.419 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -63.75 -43.43 96.46 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 123.848 0.859 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -61.93 -49.8 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 O-C-N 120.86 -1.15 . . . . 0.0 110.592 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.11 0.56 27.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.84 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.25 -40.34 10.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.37 -39.14 72.43 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 126.681 1.992 . . . . 0.0 111.276 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 m -59.1 -15.54 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.106 1.362 . . . . 0.0 112.988 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -70.4 -5.23 26.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.918 1.287 . . . . 0.0 110.12 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.01 70.78 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 119.985 -1.697 . . . . 0.0 109.797 166.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' D' ' 4' ' ' HIS . . . -66.13 -41.62 90.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.827 -1.17 . . . . 0.0 110.476 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.44 -37.96 80.73 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.086 0.554 . . . . 0.0 111.165 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.03 -17.46 60.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.005 -1.06 . . . . 0.0 110.409 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -73.07 -27.84 61.97 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.56 70.47 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.279 -0.888 . . . . 0.0 111.284 -159.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -68.49 -30.12 68.89 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.676 -1.265 . . . . 0.0 111.563 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 12.4 t -74.82 -25.72 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 123.857 0.863 . . . . 0.0 109.063 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.8 mtp-105 -63.55 -25.92 68.46 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 120.992 -1.068 . . . . 0.0 110.931 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.4 -20.88 64.91 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.751 -0.593 . . . . 0.0 111.081 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 . . . . . 0 N--CA 1.436 -1.126 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -177.676 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.56 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.3 51.9 m-20 74.21 -41.7 0.49 Allowed 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.799 2.039 . . . . 0.0 111.009 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -43.98 83.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.483 1.113 . . . . 0.0 112.643 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.259 1.8 pm0 -72.71 -15.25 61.69 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.333 -2.105 . . . . 0.0 112.959 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -74.43 -42.86 58.44 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 120.432 -1.417 . . . . 0.0 108.521 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.63 -39.29 83.82 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.828 2.051 . . . . 0.0 109.212 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.11 92.4 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.856 1.263 . . . . 0.0 112.279 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.63 -26.22 60.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.394 -0.816 . . . . 0.0 111.169 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -65.7 -40.41 92.27 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.936 -1.103 . . . . 0.0 108.861 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.22 77.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.81 0.844 . . . . 0.0 112.09 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -34.83 76.04 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.495 -0.753 . . . . 0.0 111.735 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -68.87 -27.06 65.47 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 120.617 -1.302 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -64.8 -35.17 80.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.025 1.33 . . . . 0.0 109.375 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.96 -43.94 81.84 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.843 0.857 . . . . 0.0 110.141 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.61 -34.16 72.4 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 124.301 1.04 . . . . 0.0 111.912 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -66.91 -41.98 86.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.621 1.169 . . . . 0.0 110.185 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.13 -42.13 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.5 mt -55.32 -42.92 74.38 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.406 1.082 . . . . 0.0 112.397 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -69.71 -38.63 77.02 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.797 1.239 . . . . 0.0 110.873 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.39 -42.51 65.13 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 120.52 -1.362 . . . . 0.0 108.589 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.66 72.51 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.735 1.614 . . . . 0.0 112.351 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -69.66 -35.03 74.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -35.15 68.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.415 1.086 . . . . 0.0 109.277 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -69.24 -55.38 10.71 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 124.534 1.134 . . . . 0.0 108.595 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.02 84.1 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.483 1.513 . . . . 0.0 111.658 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -37.09 78.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.214 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.11 -35.09 64.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.148 -1.595 . . . . 0.0 110.013 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.2 -49.75 63.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.095 1.758 . . . . 0.0 108.342 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.64 -38.12 80.25 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.655 1.182 . . . . 0.0 111.409 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -71.34 109.27 5.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 119.289 -2.132 . . . . 0.0 110.971 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -9.6 16.83 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.79 152.11 48.41 Favored Pre-proline 0 C--N 1.352 0.683 0 CA-C-N 118.391 1.095 . . . . 0.0 109.713 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.82 144.21 24.27 Favored 'Trans proline' 0 CA--C 1.502 -1.09 0 C-N-CA 122.751 2.301 . . . . 0.0 109.481 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.66 78.99 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.73 115.85 2.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 125.966 1.707 . . . . 0.0 109.975 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.98 -43.56 8.48 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.8 tp -90.51 65.31 6.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.928 1.347 . . . . 0.0 110.04 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.93 -0.76 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 119.851 -1.78 . . . . 0.0 112.304 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.5 m -109.44 123.35 49.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.147 -0.971 . . . . 0.0 111.247 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.13 -58.65 11.88 Favored Pre-proline 0 C--N 1.351 0.641 0 C-N-CA 125.83 1.652 . . . . 0.0 111.234 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.12 -6.45 17.99 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.078 2.849 . . . . 0.0 111.13 -171.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -100.59 -3.06 31.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.36 -32.9 69.05 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 119.737 -1.852 . . . . 0.0 109.15 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.59 -30.0 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.826 0.851 . . . . 0.0 109.684 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.95 -47.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 125.919 1.687 . . . . 0.0 110.054 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.69 -41.93 87.29 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.954 1.702 . . . . 0.0 108.554 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -56.21 -45.74 79.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 111.679 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.22 -46.22 94.04 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 121.269 -0.894 . . . . 0.0 111.444 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.03 -13.92 59.7 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 118.894 -1.122 . . . . 0.0 112.537 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -69.69 -36.4 75.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.136 -0.978 . . . . 0.0 108.555 171.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.0 63.2 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.297 -1.502 . . . . 0.0 112.186 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.424 ' HG1' HG13 ' A' ' 55' ' ' VAL . 22.4 p -95.42 15.09 20.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.443 0.565 . . . . 0.0 109.686 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p 53.35 29.2 8.33 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 126.932 2.093 . . . . 0.0 113.499 166.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.424 HG13 ' HG1' ' A' ' 53' ' ' THR . 2.3 p -101.31 -74.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -172.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.06 80.65 0.86 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -10.5 59.48 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.992 -1.299 . . . . 0.0 111.4 -170.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.23 18.4 13.53 Favored Glycine 0 CA--C 1.491 -1.443 0 O-C-N 121.061 -1.024 . . . . 0.0 111.79 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -73.16 -46.3 51.62 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 118.533 1.167 . . . . 0.0 109.312 177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.01 164.26 27.72 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.28 146.69 28.66 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 102.019 -3.326 . . . . 0.0 102.019 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.96 -165.36 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.29 3.327 . . . . 0.0 109.858 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 64' ' ' THR . 13.8 p -139.0 -147.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 63' ' ' VAL . 89.6 m -102.49 -48.19 4.23 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.017 1.327 . . . . 0.0 108.282 -170.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -78.97 -17.08 56.05 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.435 0.694 . . . . 0.0 110.47 -169.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.32 -34.3 75.02 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 123.354 1.55 . . . . 0.0 107.477 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.38 79.2 1.43 Allowed Glycine 0 CA--C 1.462 -3.229 1 N-CA-C 98.594 -5.802 . . . . 0.0 98.594 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.475 HH12 ' CG ' ' D' ' 59' ' ' ASP . 19.8 ttt85 -50.61 -18.16 0.64 Allowed 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.358 1.863 . . . . 0.0 113.731 -171.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -38.78 -31.31 0.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 127.318 2.247 . . . . 0.0 114.697 159.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.06 -43.56 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 119.01 0.823 . . . . 0.0 108.877 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.46 64.38 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.594 -0.691 . . . . 0.0 109.646 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.76 -47.11 51.11 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.402 1.481 . . . . 0.0 112.177 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -68.27 -37.22 80.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.466 0.707 . . . . 0.0 111.033 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.45 -43.47 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.68 -44.27 97.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.2 1.0 . . . . 0.0 110.441 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -66.38 -33.69 76.29 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.204 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.5 74.08 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.347 -0.845 . . . . 0.0 110.928 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.2 86.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.05 -41.47 83.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.855 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -65.92 -43.79 87.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.391 -1.443 . . . . 0.0 113.73 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.2 -45.82 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 118.274 0.488 . . . . 0.0 109.811 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.91 -39.14 72.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.93 81.97 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 121.535 -0.728 . . . . 0.0 111.198 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.43 -31.98 73.37 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 111.736 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.29 -19.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.957 1.303 . . . . 0.0 110.051 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -62.41 -18.1 60.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.914 -1.116 . . . . 0.0 112.394 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.1 -55.49 34.31 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.48 -1.388 . . . . 0.0 110.244 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.46 87.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.93 -42.48 90.04 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.386 -0.821 . . . . 0.0 110.879 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.38 -14.04 60.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.959 -1.088 . . . . 0.0 110.643 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 m -77.06 -21.98 53.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.837 -1.164 . . . . 0.0 108.786 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.16 -42.95 82.04 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 122.012 0.91 . . . . 0.0 111.311 -165.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -70.76 -18.26 62.77 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.727 -1.233 . . . . 0.0 113.364 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -75.12 -20.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -75.67 -11.87 60.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 120.982 -1.074 . . . . 0.0 110.244 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -77.55 -17.42 57.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.865 -1.147 . . . . 0.0 110.926 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.717 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 CA--C 1.504 -0.805 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -58.02 -30.51 66.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.93 -28.97 58.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.812 0.845 . . . . 0.0 110.499 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -72.0 -39.72 69.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -32.72 74.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.62 0.724 . . . . 0.0 110.481 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.98 -46.45 81.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.773 0.829 . . . . 0.0 111.127 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -72.6 -34.63 67.52 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.654 0.74 . . . . 0.0 110.729 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.03 -35.09 79.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.492 1.917 . . . . 0.0 110.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.76 75.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 111.585 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' C' ' 76' ' ' LYS . 0.7 OUTLIER -63.65 -32.19 73.59 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.165 0.986 . . . . 0.0 110.998 177.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.04 -36.32 72.31 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 120.649 -1.282 . . . . 0.0 108.913 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -66.28 -35.73 81.16 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.028 0.931 . . . . 0.0 109.295 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -60.4 -42.26 95.55 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.484 -0.76 . . . . 0.0 111.287 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -59.28 -35.52 73.89 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 123.933 0.893 . . . . 0.0 111.584 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -70.55 -34.98 72.84 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 110.209 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.22 -41.31 86.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 124.516 1.126 . . . . 0.0 108.335 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 48.0 mt -56.42 -44.63 80.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.447 1.099 . . . . 0.0 111.547 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.61 -31.61 71.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.183 0.993 . . . . 0.0 111.488 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.99 -33.33 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.317 -1.489 . . . . 0.0 108.744 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.56 -31.29 71.91 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.917 1.287 . . . . 0.0 111.509 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 59.1 p -66.22 -39.9 89.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 119.026 0.83 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.34 93.39 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.084 1.754 . . . . 0.0 108.64 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.22 -57.96 5.19 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 117.671 -1.157 . . . . 0.0 108.25 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.52 -48.32 57.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 126.171 1.788 . . . . 0.0 112.855 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.12 -39.63 84.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.77 -1.206 . . . . 0.0 111.357 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.1 -25.67 31.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.117 -0.989 . . . . 0.0 109.464 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 126.465 1.906 . . . . 0.0 108.516 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.06 -34.18 77.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.14 0.976 . . . . 0.0 111.73 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -68.15 109.13 3.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.34 -2.1 . . . . 0.0 111.433 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -10.89 16.31 Favored Glycine 0 CA--C 1.496 -1.104 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.72 147.08 40.52 Favored Pre-proline 0 N--CA 1.442 -0.84 0 O-C-N 121.802 -0.822 . . . . 0.0 109.439 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.51 137.81 11.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.49 2.127 . . . . 0.0 110.067 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.28 81.85 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.1 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.23 104.01 0.22 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.19 1.396 . . . . 0.0 109.56 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.72 -28.63 21.65 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.79 132.71 37.91 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -148.36 170.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 81.47 124.77 0.04 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.741 1.616 . . . . 0.0 109.003 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -66.04 -52.45 39.82 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.602 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.97 -3.48 13.84 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 125.226 2.902 . . . . 0.0 112.314 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -110.61 -10.78 14.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.45 75.88 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.25 -0.906 . . . . 0.0 108.846 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -60.24 -26.15 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 125.765 1.626 . . . . 0.0 111.205 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.731 -1.23 . . . . 0.0 109.569 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -79.26 -35.76 40.96 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.8 p -77.31 57.82 1.54 Allowed 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 122.113 -0.367 . . . . 0.0 110.579 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.35 -53.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.77 -26.88 68.55 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 119.328 0.967 . . . . 0.0 111.977 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -67.06 -34.39 77.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.55 1.14 . . . . 0.0 109.439 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.5 62.67 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.449 -1.407 . . . . 0.0 111.013 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -93.39 11.92 26.66 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.688 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.7 p 48.89 55.5 9.13 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.267 1.427 . . . . 0.0 113.17 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' H ' ' B' ' 56' ' ' GLY . 0.2 OUTLIER -121.95 -87.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.403 ' H ' HG22 ' B' ' 55' ' ' VAL . . . 87.15 73.66 1.28 Allowed Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 -19.42 62.12 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.344 -1.092 . . . . 0.0 110.429 -173.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.1 37.99 1.3 Allowed Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -93.2 -30.89 14.98 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 118.125 0.963 . . . . 0.0 110.066 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -140.3 176.55 8.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -155.02 149.66 20.01 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 102.295 -3.224 . . . . 0.0 102.295 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -85.04 -178.21 3.09 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 124.74 3.626 . . . . 0.0 109.949 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.418 HG12 ' H ' ' B' ' 64' ' ' THR . 0.8 OUTLIER -133.76 -153.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.036 0.922 . . . . 0.0 108.799 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.418 ' H ' HG12 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -90.97 -46.78 7.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.03 -1.669 . . . . 0.0 110.676 -169.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -30.67 67.24 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 109.796 -170.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -26.37 68.48 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 123.128 1.442 . . . . 0.0 108.592 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.91 67.67 1.3 Allowed Glycine 0 CA--C 1.461 -3.329 1 N-CA-C 102.534 -4.226 . . . . 0.0 102.534 174.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -40.11 -15.32 0.01 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.578 3.551 . . . . 0.0 116.097 -173.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -55.27 -17.84 5.24 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 120.507 -1.371 . . . . 0.0 113.622 160.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.97 -53.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 CA-C-N 121.07 1.759 . . . . 0.0 107.718 173.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.79 91.08 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.272 0.629 . . . . 0.0 111.061 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.1 -38.44 70.73 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.621 1.168 . . . . 0.0 111.66 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.84 -37.47 84.55 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 124.071 0.948 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.53 -42.53 72.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -61.16 -48.92 79.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.094 0.958 . . . . 0.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.16 -38.43 88.06 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.81 92.57 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.056 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.28 -46.07 91.76 Favored Glycine 0 CA--C 1.494 -1.257 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -46.64 87.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.666 1.186 . . . . 0.0 109.338 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.15 -45.82 86.73 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.173 -0.954 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.68 -51.13 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 124.167 0.987 . . . . 0.0 109.963 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -72.83 -19.46 61.31 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.631 -0.668 . . . . 0.0 111.257 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.5 -27.62 19.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.885 0.874 . . . . 0.0 110.283 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.08 -39.18 85.17 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 126.207 1.803 . . . . 0.0 109.47 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.2 -13.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.823 0.849 . . . . 0.0 111.912 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.8 m -61.68 -16.38 48.32 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.624 1.169 . . . . 0.0 110.852 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.58 -51.0 64.4 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.509 1.123 . . . . 0.0 110.629 165.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.16 75.72 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.71 1.604 . . . . 0.0 110.451 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.02 -42.61 97.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.73 -18.96 61.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.872 -0.518 . . . . 0.0 110.687 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.6 m -80.51 -36.61 33.03 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 121.276 -0.89 . . . . 0.0 108.998 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.34 -8.46 58.45 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.904 -1.123 . . . . 0.0 111.791 -157.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -75.4 -36.77 60.79 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 165.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 t -71.12 -22.28 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 109.978 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -47.92 -31.57 5.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.694 1.998 . . . . 0.0 111.666 171.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -62.11 -30.7 71.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.686 1.194 . . . . 0.0 112.129 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 CA--C 1.505 -0.786 0 O-C-N 120.785 -1.197 . . . . 0.0 109.541 -175.613 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 122.779 1.276 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -66.97 -21.99 65.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 125.791 1.636 . . . . 0.0 111.97 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -77.34 -32.65 55.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -72.87 -32.27 65.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.668 0.747 . . . . 0.0 109.95 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.3 -41.56 93.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.642 1.177 . . . . 0.0 109.512 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.08 78.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.357 1.063 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -57.01 -38.25 72.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.282 1.833 . . . . 0.0 111.243 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -64.73 -33.26 75.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.495 1.118 . . . . 0.0 110.815 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.61 68.2 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.037 -1.039 . . . . 0.0 110.287 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.453 -0.78 . . . . 0.0 112.017 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -27.89 63.76 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.889 -1.132 . . . . 0.0 110.473 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.74 -33.29 73.67 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.994 0.918 . . . . 0.0 109.128 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.41 -36.95 84.12 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.941 -1.099 . . . . 0.0 110.687 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.08 -27.65 67.54 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.264 -0.898 . . . . 0.0 111.083 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.61 -45.67 64.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.684 1.194 . . . . 0.0 110.068 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.31 -24.14 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 O-C-N 121.534 -0.729 . . . . 0.0 110.819 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.13 -37.66 80.73 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.417 -0.802 . . . . 0.0 111.408 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -74.34 -24.29 59.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.617 0.767 . . . . 0.0 111.241 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -87.89 -30.87 19.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.812 -1.18 . . . . 0.0 107.848 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.98 88.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.655 1.182 . . . . 0.0 111.362 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.0 p -65.2 -38.94 92.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.29 0.636 . . . . 0.0 111.173 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -71.08 -48.88 49.98 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.576 -0.703 . . . . 0.0 110.064 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -72.21 -23.16 61.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 121.262 -0.899 . . . . 0.0 110.931 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.92 -48.45 76.54 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.819 0.736 . . . . 0.0 110.885 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.72 -19.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.03 -176.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -80.2 -25.82 39.48 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.157 -1.59 . . . . 0.0 109.531 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.05 73.49 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.67 1.188 . . . . 0.0 108.874 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' C' ' 38' ' ' LEU . 16.8 mt-10 -85.63 -141.09 0.09 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 122.884 1.326 . . . . 0.0 111.115 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 59.86 52.23 5.51 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 126.763 2.025 . . . . 0.0 111.316 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.37 34.35 0.2 Allowed Glycine 0 CA--C 1.487 -1.696 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.45 155.42 78.67 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.78 152.39 11.44 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.324 2.016 . . . . 0.0 109.498 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 -41.03 2.77 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.974 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -3.02 123.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.808 1 C-N-CA 132.486 4.314 . . . . 0.0 117.292 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.48 -38.38 3.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.566 1.146 . . . . 0.0 110.048 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.456 ' H ' ' CD ' ' C' ' 30' ' ' GLU . 5.2 tt -100.98 66.23 1.14 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.033 2.533 . . . . 0.0 109.436 -169.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.45 33.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 119.463 -2.023 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.2 m -134.0 143.62 48.23 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -80.99 -53.14 0.81 Allowed Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.471 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -20.32 24.2 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 CA-C-N 126.404 3.323 . . . . 0.0 110.643 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.9 -13.04 49.07 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 -35.79 81.65 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.186 -0.946 . . . . 0.0 110.928 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.61 -29.08 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.441 0.639 . . . . 0.0 110.278 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -28.75 61.29 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 119.83 -1.794 . . . . 0.0 110.22 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 31.8 t90 -69.66 -40.99 76.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.841 -0.537 . . . . 0.0 109.68 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -69.58 -14.71 62.98 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.83 -49.9 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 120.884 -1.135 . . . . 0.0 110.504 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -76.04 0.45 18.6 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.036 -1.04 . . . . 0.0 112.247 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.27 -38.69 6.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.122 -0.987 . . . . 0.0 109.096 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.73 61.05 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 120.771 -1.206 . . . . 0.0 111.535 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 5.3 p -90.61 1.31 56.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 110.647 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.297 15.5 p 62.65 30.72 16.95 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.46 2.304 . . . . 0.0 112.751 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.18 -59.33 2.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.92 63.26 3.74 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.858 -1.151 . . . . 0.0 112.493 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -23.14 66.86 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.642 0.777 . . . . 0.0 113.006 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 23.51 10.1 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -50.33 18.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -142.52 163.86 31.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -163.12 142.05 6.58 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.98 161.95 20.79 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.044 2.496 . . . . 0.0 110.86 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.533 HG11 ' H ' ' C' ' 64' ' ' THR . 1.1 t -107.02 -162.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 123.118 1.437 . . . . 0.0 109.157 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.533 ' H ' HG11 ' C' ' 63' ' ' VAL . 2.1 m -66.29 -55.5 15.76 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 127.601 2.361 . . . . 0.0 111.553 -167.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -74.12 -16.43 61.01 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.533 1.159 . . . . 0.0 109.27 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -78.08 -23.35 48.02 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 125.514 1.526 . . . . 0.0 107.803 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.89 86.12 0.94 Allowed Glycine 0 CA--C 1.478 -2.276 1 N-CA-C 102.04 -4.424 . . . . 0.0 102.04 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -43.14 -34.81 1.17 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.446 1.898 . . . . 0.0 111.482 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -43.44 -26.87 0.23 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.037 2.135 . . . . 0.0 113.721 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.92 -37.72 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.986 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.09 9.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.33 -47.04 69.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.481 2.312 . . . . 0.0 112.136 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 -37.22 71.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.552 -0.718 . . . . 0.0 110.492 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.33 -42.64 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 58.9 ttm -59.1 -45.19 91.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.602 1.161 . . . . 0.0 110.615 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' B' ' 12' ' ' GLU . 33.2 ttmt -64.65 -31.75 73.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.861 0.464 . . . . 0.0 111.477 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.94 70.17 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.734 -0.604 . . . . 0.0 111.055 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.47 -39.93 86.83 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.28 -46.69 94.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 124.354 1.062 . . . . 0.0 108.947 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -61.24 -39.51 90.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.547 0.739 . . . . 0.0 112.173 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 t -64.06 -52.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.333 1.053 . . . . 0.0 109.575 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.32 -18.67 61.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.7 -0.625 . . . . 0.0 111.297 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.51 8.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.227 -0.92 . . . . 0.0 109.197 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -51.95 -42.01 62.53 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 126.793 2.037 . . . . 0.0 112.832 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 26.5 m -64.56 -11.38 10.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.481 -0.762 . . . . 0.0 112.515 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.7 m -67.95 -15.36 63.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.701 -1.25 . . . . 0.0 110.831 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.49 65.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.437 -1.414 . . . . 0.0 111.448 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.87 -46.37 13.09 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.78 -1.2 . . . . 0.0 107.963 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -65.05 -32.47 74.21 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.222 1.009 . . . . 0.0 112.34 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.32 -11.68 60.58 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 120.839 -1.163 . . . . 0.0 111.874 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 51.3 p -82.01 -19.48 40.37 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.074 -1.641 . . . . 0.0 109.171 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.27 -16.16 59.86 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.675 -0.641 . . . . 0.0 112.026 -165.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -91.16 -23.69 20.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.874 0.845 . . . . 0.0 110.743 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.02 -29.21 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 O-C-N 120.135 -1.603 . . . . 0.0 108.297 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -62.44 -7.56 4.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.495 1.118 . . . . 0.0 112.961 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -75.51 -26.71 58.34 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.284 -1.51 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -176.401 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.099 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.03 -43.59 98.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -18.58 63.74 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.201 -0.937 . . . . 0.0 112.385 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -76.58 -44.07 36.11 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -68.06 -36.42 79.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.427 0.632 . . . . 0.0 109.564 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.07 -51.04 67.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.158 2.583 . . . . 0.0 110.016 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.37 81.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.655 1.182 . . . . 0.0 111.901 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -40.67 84.67 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.208 -0.933 . . . . 0.0 110.186 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -68.69 -27.16 65.71 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 121.192 -0.943 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.22 70.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.473 -1.392 . . . . 0.0 111.87 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -67.02 -25.35 66.24 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.568 -0.707 . . . . 0.0 112.032 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.94 -35.76 64.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 109.08 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.61 -17.17 56.46 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.647 -0.658 . . . . 0.0 109.489 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.78 -44.64 73.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.225 -0.922 . . . . 0.0 109.187 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.88 -41.05 67.14 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 111.169 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -53.45 -47.79 69.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.324 1.85 . . . . 0.0 112.123 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -87.83 -33.02 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.005 -1.06 . . . . 0.0 111.123 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.55 -49.95 74.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 127.863 2.465 . . . . 0.0 109.859 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.12 -42.87 72.06 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.27 -31.24 72.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.653 -0.654 . . . . 0.0 112.012 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.72 71.73 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.469 0.708 . . . . 0.0 111.278 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 92.3 p -67.15 -41.0 86.76 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.99 -27.68 61.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 109.723 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -79.61 -51.34 9.4 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.21 97.46 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 111.731 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.49 -29.42 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 119.413 -2.054 . . . . 0.0 112.106 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -89.05 -27.34 20.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -57.09 6.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.935 1.694 . . . . 0.0 108.358 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.43 -7.9 46.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.359 0.663 . . . . 0.0 112.53 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.12 99.55 1.5 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 120.075 -1.641 . . . . 0.0 109.263 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 4.19 35.1 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.5 138.53 26.78 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 118.649 1.224 . . . . 0.0 108.689 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.52 139.49 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.491 2.128 . . . . 0.0 110.178 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.1 16.5 80.65 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.14 147.21 53.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.343 0.657 . . . . 0.0 110.74 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 -35.99 5.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -89.07 136.58 32.94 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 pt -165.89 172.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.6 m 67.65 129.07 0.02 OUTLIER 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.973 2.509 . . . . 0.0 114.285 167.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -61.78 -57.72 22.59 Favored Pre-proline 0 C--N 1.351 0.659 0 CA-C-O 116.976 -1.487 . . . . 0.0 113.397 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.48 -12.13 22.62 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 124.482 2.637 . . . . 0.0 110.653 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.79 -38.83 20.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -36.71 81.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.733 1.213 . . . . 0.0 112.016 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.29 -30.39 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.656 -0.653 . . . . 0.0 110.55 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 -19.5 56.93 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.08 -1.013 . . . . 0.0 110.764 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -91.25 -30.33 16.68 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.94 -37.56 87.86 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.501 -1.375 . . . . 0.0 110.489 -173.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.21 -25.96 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 123.357 0.663 . . . . 0.0 112.091 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.52 -45.81 21.05 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.242 1.017 . . . . 0.0 110.485 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -77.19 -24.52 51.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 120.784 -1.198 . . . . 0.0 109.581 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.38 -29.69 62.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.196 0.598 . . . . 0.0 110.051 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 25.6 p -92.15 -2.46 56.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 118.283 0.492 . . . . 0.0 110.72 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 55.3 p 54.39 59.41 4.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.095 2.158 . . . . 0.0 112.976 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.436 HG23 ' H ' ' D' ' 56' ' ' GLY . 27.4 m -102.98 -75.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.436 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 91.04 54.3 2.05 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -19.53 63.94 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 122.093 0.949 . . . . 0.0 111.87 -170.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.2 11.1 22.82 Favored Glycine 0 CA--C 1.49 -1.481 0 O-C-N 120.325 -1.484 . . . . 0.0 111.421 168.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -68.84 -52.14 33.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.926 -0.749 . . . . 0.0 110.924 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -139.57 163.25 33.07 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.42 151.26 26.9 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -171.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.05 -179.98 5.95 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 124.346 3.364 . . . . 0.0 109.469 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . 0.324 3.7 p -123.13 -89.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 CA-C-N 120.705 1.593 . . . . 0.0 111.869 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 53.5 m -152.32 -50.31 0.11 Allowed 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 119.376 -2.077 . . . . 0.0 107.019 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.44 -5.66 59.22 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.731 1.212 . . . . 0.0 110.878 -168.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.1 -34.39 77.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.64 -1.287 . . . . 0.0 107.588 165.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.25 88.52 1.32 Allowed Glycine 0 N--CA 1.419 -2.488 1 N-CA-C 98.784 -5.726 . . . . 0.0 98.784 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 26.5 ttm-85 -55.6 -19.81 11.5 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 125.768 1.627 . . . . 0.0 111.076 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -58.27 -17.1 16.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.1 -47.88 76.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 120.064 1.302 . . . . 0.0 108.424 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.1 78.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -53.37 -44.13 68.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.536 1.534 . . . . 0.0 112.328 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -60.38 -47.58 85.44 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.039 0.936 . . . . 0.0 110.51 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.01 -34.28 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 43.3 mtt -56.74 -50.89 70.9 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.838 0.828 . . . . 0.0 110.437 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -68.81 -29.83 68.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.876 -0.515 . . . . 0.0 110.42 -171.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.32 71.7 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.953 -0.467 . . . . 0.0 110.303 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.05 -46.32 94.28 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 123.927 0.775 . . . . 0.0 111.733 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.6 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.9 0.88 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.56 -30.8 71.18 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.957 -1.089 . . . . 0.0 112.521 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 21.0 t -65.87 -53.77 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 109.121 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.5 -35.2 77.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 121.704 -0.623 . . . . 0.0 110.429 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.0 74.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.392 -0.818 . . . . 0.0 111.256 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.46 -28.56 69.31 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.608 -1.307 . . . . 0.0 110.929 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.5 -7.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.045 1.338 . . . . 0.0 110.944 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.8 m -58.84 -21.23 56.33 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 118.937 -2.352 . . . . 0.0 112.315 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.09 -29.15 67.14 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.762 -1.211 . . . . 0.0 110.881 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 -46.54 14.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.988 -1.695 . . . . 0.0 109.163 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.6 -47.58 72.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -167.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.42 -9.84 58.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.112 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -77.72 -38.33 47.43 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 120.447 -1.408 . . . . 0.0 108.148 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.27 55.2 m-20 -83.07 8.64 12.33 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.376 -1.452 . . . . 0.0 112.591 -155.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -96.93 -38.06 9.96 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 117.573 -1.203 . . . . 0.0 111.514 161.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.18 -20.46 27.57 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-N 120.789 1.631 . . . . 0.0 111.113 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -54.08 -22.93 12.06 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.642 1.177 . . . . 0.0 112.308 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.08 -21.73 9.21 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.715 1.606 . . . . 0.0 113.008 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -176.35 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.101 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.0 -62.55 0.71 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.037 2.535 . . . . 0.0 112.631 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -64.61 -23.41 67.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 113.974 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -82.78 -44.41 15.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.7 -40.84 98.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.335 1.054 . . . . 0.0 110.401 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.41 -29.72 67.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.357 0.598 . . . . 0.0 110.658 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.44 86.65 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.271 -0.893 . . . . 0.0 110.479 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -63.17 -43.62 97.74 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.577 -0.702 . . . . 0.0 110.5 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.7 -42.36 75.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.084 1.754 . . . . 0.0 110.419 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.32 93.01 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.441 1.096 . . . . 0.0 110.702 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -63.95 -36.52 84.22 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -74.61 -25.91 59.55 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.798 -1.189 . . . . 0.0 111.875 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.52 -35.95 63.18 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.77 -42.51 79.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.417 1.087 . . . . 0.0 111.874 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.0 -34.19 69.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.129 1.372 . . . . 0.0 112.203 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -74.85 -35.17 62.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.621 -0.674 . . . . 0.0 109.392 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.98 -33.76 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.47 -42.69 92.6 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.459 -0.775 . . . . 0.0 112.0 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.65 -42.61 74.01 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 122.098 -0.376 . . . . 0.0 110.493 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.89 -40.65 87.82 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.703 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.19 79.39 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 125.043 1.337 . . . . 0.0 111.479 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -52.56 -47.02 67.05 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 126.016 1.726 . . . . 0.0 109.938 175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -65.39 -46.2 80.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.265 1.026 . . . . 0.0 109.985 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.99 -43.18 88.53 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 123.885 0.874 . . . . 0.0 110.563 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.67 71.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.694 1.198 . . . . 0.0 111.527 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.28 -51.79 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 120.765 -1.209 . . . . 0.0 109.912 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.46 -28.86 63.19 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.722 -0.612 . . . . 0.0 111.092 -166.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.0 81.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.608 0.763 . . . . 0.0 110.311 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.73 -88.93 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 122.545 0.338 . . . . 0.0 111.51 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 20.09 67.59 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 128.302 2.641 . . . . 0.0 116.69 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.29 -23.45 4.31 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 133.63 90.76 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -174.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.62 125.39 4.94 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.35 2.033 . . . . 0.0 111.71 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.7 54.06 Favored Glycine 0 CA--C 1.485 -1.805 0 CA-C-O 117.906 -1.497 . . . . 0.0 109.828 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -32.1 -65.21 0.15 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 114.345 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 73.39 -15.54 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.769 1.627 . . . . 0.0 111.297 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.2 118.23 36.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 pt -143.72 0.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.843 -0.536 . . . . 0.0 111.235 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.9 m -128.24 130.62 48.21 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.372 -1.455 . . . . 0.0 109.449 -165.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -57.22 -50.31 88.89 Favored Pre-proline 0 C--N 1.351 0.64 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.783 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.38 -11.98 24.93 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 125.301 2.929 . . . . 0.0 111.881 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.79 -25.09 16.19 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.19 -35.11 78.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.656 0.783 . . . . 0.0 111.432 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -69.91 -33.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -31.84 61.04 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.333 -0.854 . . . . 0.0 109.739 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -65.33 -45.18 85.27 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.523 1.129 . . . . 0.0 108.919 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -34.33 68.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.243 1.417 . . . . 0.0 111.419 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.89 -52.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 124.254 1.022 . . . . 0.0 110.719 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.21 -22.84 60.36 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 121.537 -0.727 . . . . 0.0 110.961 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.7 m -73.34 -39.49 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.22 64.95 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.264 -0.898 . . . . 0.0 111.546 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 p -88.23 12.12 14.69 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.371 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 p 48.96 61.33 3.17 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.949 1.7 . . . . 0.0 112.717 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.402 HG11 ' H ' ' A' ' 56' ' ' GLY . 2.4 p -128.48 -77.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' H ' HG11 ' A' ' 55' ' ' VAL . . . 82.88 75.04 1.18 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -69.17 -34.19 74.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.985 -1.303 . . . . 0.0 110.787 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.13 38.61 0.25 Allowed Glycine 0 CA--C 1.487 -1.714 0 N-CA-C 107.926 -2.069 . . . . 0.0 107.926 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.85 -48.2 22.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -135.3 178.89 6.68 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -149.16 93.89 4.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.131 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.18 166.23 30.54 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.572 2.181 . . . . 0.0 110.842 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.89 177.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 123.002 1.382 . . . . 0.0 107.908 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -65.19 -25.01 67.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.853 2.461 . . . . 0.0 112.585 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -75.51 -36.23 60.59 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.304 1.042 . . . . 0.0 109.056 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -53.21 58.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.91 66.67 0.37 Allowed Glycine 0 CA--C 1.461 -3.334 1 N-CA-C 100.797 -4.921 . . . . 0.0 100.797 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.5 ttm-85 -23.18 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.382 2.017 1 C-N-CA 132.258 4.223 . . . . 0.0 115.921 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -54.79 -6.82 0.13 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 116.622 -1.656 . . . . 0.0 115.389 167.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.265 54.8 t -76.01 -46.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.365 1.26 0 CA-C-N 123.771 2.987 . . . . 0.0 107.809 167.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.7 67.75 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.435 1.016 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.64 -34.61 73.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.474 1.11 . . . . 0.0 112.258 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.74 -40.36 84.16 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 120.728 -1.232 . . . . 0.0 110.365 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.38 -43.14 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.3 mtt -59.23 -45.83 90.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 110.147 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.85 -40.44 92.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.929 0.892 . . . . 0.0 111.683 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 81.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.788 0.835 . . . . 0.0 111.071 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.88 -46.22 90.13 Favored Glycine 0 C--N 1.35 1.326 0 C-N-CA 124.678 1.132 . . . . 0.0 110.446 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.04 -41.17 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.894 0.877 . . . . 0.0 109.376 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -59.7 -52.03 67.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.202 -0.936 . . . . 0.0 111.625 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.55 -41.69 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 121.959 -0.463 . . . . 0.0 110.527 -172.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.8 -39.46 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.025 0.53 . . . . 0.0 109.688 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 121.42 -0.8 . . . . 0.0 110.919 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.16 -24.85 64.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 121.021 -1.05 . . . . 0.0 111.538 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.92 -15.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 O-C-N 121.012 -1.055 . . . . 0.0 110.697 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.9 m -53.57 -25.38 16.97 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.023 -1.673 . . . . 0.0 113.067 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.0 66.68 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.509 -1.369 . . . . 0.0 111.294 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.96 -52.75 5.52 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 108.738 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.1 mt -59.34 -40.25 85.74 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.303 1.041 . . . . 0.0 112.958 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.5 -19.37 62.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 121.073 -1.017 . . . . 0.0 111.228 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.2 p -72.26 -22.32 61.24 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.221 -1.549 . . . . 0.0 110.283 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.86 -5.67 55.92 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.924 -1.11 . . . . 0.0 112.128 -167.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.78 -22.72 19.17 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.867 -1.77 . . . . 0.0 109.347 168.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -76.84 -37.72 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 107.983 -170.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -57.9 -18.44 22.98 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.413 1.485 . . . . 0.0 112.479 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -64.97 -32.72 74.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.758 -1.214 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 C--N 1.353 0.72 0 O-C-N 121.038 -1.039 . . . . 0.0 108.917 179.843 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.488 -1.429 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -4.27 58.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.881 -1.137 . . . . 0.0 112.159 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -29.75 56.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.787 1.235 . . . . 0.0 108.37 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -70.85 -33.78 70.98 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.931 -1.106 . . . . 0.0 110.432 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.87 -38.81 92.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 122.174 0.988 . . . . 0.0 109.236 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 -38.51 88.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.541 0.737 . . . . 0.0 111.711 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.13 -41.04 86.82 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.698 -0.626 . . . . 0.0 110.362 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -62.56 -30.96 71.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.625 1.17 . . . . 0.0 111.139 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.414 -0.804 . . . . 0.0 111.354 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -67.58 -33.78 75.71 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.459 -0.776 . . . . 0.0 109.639 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.38 -35.56 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.517 1.127 . . . . 0.0 111.04 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.32 -40.44 95.92 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.78 0.832 . . . . 0.0 109.156 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.728 -0.607 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -58.4 -38.95 78.4 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.094 0.958 . . . . 0.0 112.006 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -62.78 -44.65 95.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.228 1.011 . . . . 0.0 109.452 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.5 -33.39 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.046 0.938 . . . . 0.0 110.062 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.92 -36.37 82.09 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.52 -1.362 . . . . 0.0 111.205 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -72.01 -35.17 69.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.514 -0.741 . . . . 0.0 110.435 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.723 -1.236 . . . . 0.0 109.189 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.7 74.32 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 126.251 1.82 . . . . 0.0 111.69 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.44 -36.11 63.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -43.16 85.64 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.814 0.846 . . . . 0.0 109.18 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.96 -51.73 44.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.816 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.37 96.98 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 124.066 0.946 . . . . 0.0 111.482 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -67.57 -44.78 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.112 -0.992 . . . . 0.0 109.501 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -50.59 31.74 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 110.289 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.64 -29.06 67.47 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.451 -0.78 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -67.06 100.47 0.76 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.352 -1.468 . . . . 0.0 111.413 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.31 -30.18 3.35 Favored Glycine 0 CA--C 1.488 -1.655 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.08 60.21 Favored Pre-proline 0 N--CA 1.443 -0.781 0 C-N-CA 123.588 0.755 . . . . 0.0 110.478 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.72 148.31 12.42 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 C-N-CA 122.553 2.169 . . . . 0.0 109.449 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.58 -17.18 45.93 Favored Glycine 0 CA--C 1.489 -1.538 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.19 114.36 2.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.002 2.521 . . . . 0.0 107.835 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.78 -18.46 14.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -84.29 -8.67 58.95 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.725 0.81 . . . . 0.0 108.901 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 tt -54.02 69.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 128.809 2.844 . . . . 0.0 114.981 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -140.66 -122.01 0.11 Allowed 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 119.476 -2.015 . . . . 0.0 107.373 -165.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -179.21 -67.45 0.0 OUTLIER Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.9 -29.09 18.95 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 125.201 2.893 . . . . 0.0 111.491 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -91.17 0.85 57.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.407 1.083 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.58 64.32 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.246 -0.909 . . . . 0.0 108.712 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -72.52 -20.46 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 123.084 0.554 . . . . 0.0 110.478 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -66.32 -47.55 73.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -67.06 -44.04 81.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.879 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.3 m -56.02 -33.55 65.01 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.0 -41.52 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.93 -40.73 94.33 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -57.1 -37.51 72.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.653 1.181 . . . . 0.0 111.608 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.18 -22.42 63.91 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 123.089 0.556 . . . . 0.0 112.119 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.0 p -84.67 -14.57 48.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.291 19.9 p 76.19 0.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.569 2.348 . . . . 0.0 111.18 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.65 -50.1 77.29 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 C-N-CA 123.465 0.706 . . . . 0.0 109.424 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.93 47.1 92.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.273 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -45.63 -32.31 2.3 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.72 12.46 5.0 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.95 -54.98 16.61 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.628 -0.925 . . . . 0.0 111.108 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -121.78 156.12 33.85 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.83 139.52 34.83 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 102.08 -3.304 . . . . 0.0 102.08 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.11 -173.26 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.145 3.23 . . . . 0.0 108.873 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.525 HG23 ' H ' ' B' ' 64' ' ' THR . 12.9 p -137.23 -158.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.525 ' H ' HG23 ' B' ' 63' ' ' VAL . 53.2 m -92.92 -39.18 11.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 109.672 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.35 -23.59 59.05 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.386 -0.821 . . . . 0.0 110.612 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -29.33 70.59 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 123.732 1.73 . . . . 0.0 108.254 173.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.86 67.21 1.18 Allowed Glycine 0 CA--C 1.461 -3.321 1 N-CA-C 102.335 -4.306 . . . . 0.0 102.335 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -29.61 -24.43 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 133.034 4.534 . . . . 0.0 115.342 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -62.82 0.68 0.49 Allowed 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 125.961 1.704 . . . . 0.0 114.03 165.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.24 -56.11 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.125 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 165.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.21 -43.6 78.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.228 1.411 . . . . 0.0 111.487 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.04 -46.4 61.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.484 1.914 . . . . 0.0 110.805 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.18 -40.13 86.52 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.353 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.23 -49.0 79.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 119.19 0.905 . . . . 0.0 110.055 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.3 ptp -68.08 -41.45 81.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.936 -0.478 . . . . 0.0 110.338 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -69.37 -32.85 72.15 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.08 89.77 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 123.292 0.637 . . . . 0.0 110.457 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.41 -49.69 63.94 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.42 -51.25 66.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 109.841 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.77 -7.11 56.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.519 -1.363 . . . . 0.0 112.954 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -83.86 -54.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -60.66 -29.79 69.5 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.73 0.812 . . . . 0.0 110.155 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.09 -19.74 36.21 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.418 0.687 . . . . 0.0 112.58 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.74 -37.32 59.45 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 119.153 -2.217 . . . . 0.0 107.747 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.07 -5.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 121.383 -0.823 . . . . 0.0 111.544 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.1 m -55.96 -20.54 16.67 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 110.593 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.94 95.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 119.859 -1.776 . . . . 0.0 113.032 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.25 70.55 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 124.516 1.127 . . . . 0.0 108.042 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.54 -27.61 61.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.53 75.48 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.775 -1.828 . . . . 0.0 110.594 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -12.32 28.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.006 -1.059 . . . . 0.0 112.577 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.38 -15.66 61.85 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 119.789 1.177 . . . . 0.0 111.12 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -76.14 -26.64 56.51 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.336 -1.477 . . . . 0.0 111.067 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.93 -34.0 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.135 0.974 . . . . 0.0 108.504 -171.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -61.59 -20.01 62.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.501 1.12 . . . . 0.0 112.348 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -64.66 -32.93 74.82 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.77 0.828 . . . . 0.0 110.813 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.354 0.776 0 O-C-N 120.479 -1.388 . . . . 0.0 109.938 178.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 N--CA 1.429 -1.498 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -58.86 -28.96 66.59 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 127.082 2.153 . . . . 0.0 113.492 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.86 -32.86 72.84 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.848 1.259 . . . . 0.0 109.92 -168.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -65.35 -43.67 90.11 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.533 1.133 . . . . 0.0 109.992 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -72.11 -37.06 69.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.986 0.914 . . . . 0.0 108.915 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.16 95.89 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -71.3 -35.36 71.26 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.899 0.88 . . . . 0.0 110.317 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.3 88.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.085 0.954 . . . . 0.0 111.833 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.8 -33.83 76.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.42 -0.8 . . . . 0.0 111.623 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.01 -35.2 74.19 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.658 0.742 . . . . 0.0 109.601 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -69.62 -29.71 67.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.534 0.734 . . . . 0.0 110.24 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.94 -40.84 95.64 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.77 -34.96 75.27 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.55 -0.719 . . . . 0.0 110.775 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -64.48 -40.72 96.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.505 1.122 . . . . 0.0 111.23 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.4 -31.36 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.618 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.49 -50.23 74.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 126.223 1.809 . . . . 0.0 109.543 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -72.69 -23.93 60.94 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.88 -1.137 . . . . 0.0 110.601 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -72.36 -37.15 68.88 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 -31.58 72.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.156 0.982 . . . . 0.0 112.178 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -58.21 -45.23 88.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.894 1.331 . . . . 0.0 111.578 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -70.63 -47.16 61.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.181 1.792 . . . . 0.0 107.506 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -65.28 -31.0 71.92 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 124.452 1.101 . . . . 0.0 112.674 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.69 68.61 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.93 1.292 . . . . 0.0 110.391 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.43 -36.86 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.399 0.68 . . . . 0.0 110.348 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.72 -38.95 89.81 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.466 -0.772 . . . . 0.0 109.701 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.41 71.54 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.175 1.79 . . . . 0.0 111.562 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -67.32 -24.33 65.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 125.178 1.391 . . . . 0.0 112.307 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -91.91 115.95 28.5 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.79 -48.26 0.98 Allowed Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.88 150.52 38.72 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.322 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.81 162.89 18.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.821 1.681 . . . . 0.0 110.263 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 30.76 12.8 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.11 137.14 56.11 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 117.995 0.898 . . . . 0.0 111.94 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.62 -41.96 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 123.828 0.851 . . . . 0.0 110.024 -170.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.85 -27.04 57.67 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.866 1.266 . . . . 0.0 108.412 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 tp -37.22 106.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 127.911 2.484 . . . . 0.0 113.343 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t -172.03 -131.39 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.3 -70.42 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.731 0 CA-C-O 116.914 -1.517 . . . . 0.0 107.038 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.21 -11.55 19.32 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 CA-C-N 125.004 2.823 . . . . 0.0 111.925 -163.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.57 1.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.341 2.657 . . . . 0.0 107.725 -175.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.28 -34.38 70.61 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.065 0.936 . . . . 0.0 110.214 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.01 -19.5 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 125.334 1.454 . . . . 0.0 109.994 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -50.85 28.77 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.599 -1.938 . . . . 0.0 107.511 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -63.32 -34.25 77.29 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 121.957 0.884 . . . . 0.0 111.399 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -73.06 -31.16 64.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.587 -1.945 . . . . 0.0 110.907 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.95 -53.39 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 123.922 0.889 . . . . 0.0 108.677 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' C' ' 56' ' ' GLY . 20.3 pt-20 -64.37 -30.91 71.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.014 0.526 . . . . 0.0 111.773 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 79.5 m -70.83 -48.37 54.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.814 0.846 . . . . 0.0 110.754 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -27.52 64.38 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.792 -1.193 . . . . 0.0 111.232 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -85.37 -4.26 59.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.927 -0.483 . . . . 0.0 111.124 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p 55.23 64.2 1.86 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 125.495 1.518 . . . . 0.0 112.059 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.86 -87.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 101.592 -3.485 . . . . 0.0 101.592 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' C' ' 50' ' ' GLU . . . 87.21 80.73 1.21 Allowed Glycine 0 CA--C 1.494 -1.254 0 N-CA-C 104.722 -3.351 . . . . 0.0 104.722 -172.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.34 -30.37 57.61 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.97 35.22 3.77 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.99 -38.44 57.39 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -135.07 157.34 47.19 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -129.41 138.11 32.42 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.37 168.04 22.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.515 2.143 . . . . 0.0 109.307 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.1 m -63.74 175.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 122.242 1.02 . . . . 0.0 111.688 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -83.36 -88.06 0.1 Allowed 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 120.958 -1.089 . . . . 0.0 108.323 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -34.17 -58.03 0.47 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.954 2.502 . . . . 0.0 116.589 -169.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -82.67 -98.93 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.68 -86.52 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.378 0 C-N-CA 126.395 1.95 . . . . 0.0 113.496 160.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -58.11 -42.43 85.72 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.301 1.44 . . . . 0.0 112.157 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -58.87 -27.08 64.84 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 118.902 -2.374 . . . . 0.0 112.283 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.18 -55.25 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.5 77.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.001 1.721 . . . . 0.0 112.713 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.0 -43.06 73.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 128.428 2.691 . . . . 0.0 108.555 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -68.2 -43.71 77.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 123.894 0.878 . . . . 0.0 110.188 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.51 -48.88 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 124.32 1.048 . . . . 0.0 110.16 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 23.2 ptp -66.56 -34.47 77.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.557 -0.715 . . . . 0.0 110.333 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -68.7 -30.53 69.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.308 -0.87 . . . . 0.0 110.744 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.11 86.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.909 -0.494 . . . . 0.0 110.206 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.42 92.0 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 123.823 0.725 . . . . 0.0 111.338 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -54.7 -47.46 73.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 125.378 1.471 . . . . 0.0 110.527 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -70.25 -28.41 65.21 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.769 -0.582 . . . . 0.0 112.027 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.58 -48.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 121.008 -1.057 . . . . 0.0 109.509 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -67.14 -25.85 66.38 Favored 'General case' 0 CA--C 1.509 -0.609 0 O-C-N 121.495 -0.753 . . . . 0.0 110.927 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.39 -36.89 57.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.79 -41.83 97.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 124.676 1.19 . . . . 0.0 110.516 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.04 -9.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 O-C-N 121.113 -0.992 . . . . 0.0 111.673 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -19.46 64.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 110.078 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.86 -32.94 74.88 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.434 1.093 . . . . 0.0 111.771 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.4 63.12 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.446 1.098 . . . . 0.0 109.914 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 -32.68 26.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.56 63.64 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.003 -1.061 . . . . 0.0 111.161 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 8.7 p -75.66 -10.82 59.77 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 120.035 -1.665 . . . . 0.0 110.823 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.337 46.5 m-20 -90.9 -0.77 57.82 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.582 -1.647 . . . . 0.0 109.511 -158.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -89.01 -10.37 47.85 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.906 161.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -96.13 -51.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.49 -17.87 24.5 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.396 2.279 . . . . 0.0 111.983 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -68.01 -12.57 61.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.655 -1.278 . . . . 0.0 112.255 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 . . . . . 0 C--N 1.353 0.756 0 O-C-N 119.956 -1.715 . . . . 0.0 108.097 175.345 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -28.91 70.38 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.117 -0.989 . . . . 0.0 112.703 -169.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.472 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 21.2 p80 -63.02 -33.19 74.89 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.202 -0.936 . . . . 0.0 112.44 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.472 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 10.8 mt-10 -80.44 -31.99 37.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.876 -1.14 . . . . 0.0 108.812 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.16 -35.96 74.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.902 -1.124 . . . . 0.0 110.725 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.25 -38.99 93.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.947 1.699 . . . . 0.0 110.154 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.21 92.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.153 0.981 . . . . 0.0 111.896 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -65.34 -32.94 74.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.522 1.129 . . . . 0.0 111.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -68.79 -36.16 77.93 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.742 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.63 94.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.485 0.714 . . . . 0.0 110.752 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.19 -44.14 87.91 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.416 1.086 . . . . 0.0 111.525 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -68.34 -44.1 76.06 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.266 1.026 . . . . 0.0 109.148 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -68.41 -31.57 71.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.584 -0.698 . . . . 0.0 110.409 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.43 -44.03 92.99 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.509 0.723 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.0 -30.83 71.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -65.91 -41.04 91.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.732 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.67 -38.28 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 C-N-CA 123.965 0.906 . . . . 0.0 108.897 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 37.3 mt -60.37 -48.44 81.73 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.204 1.002 . . . . 0.0 110.279 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -67.45 -36.49 81.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.565 -0.709 . . . . 0.0 111.736 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.63 -47.48 78.4 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.66 -41.52 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.367 1.467 . . . . 0.0 110.997 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 58.4 m -52.21 -49.45 63.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 126.064 1.746 . . . . 0.0 112.134 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -61.94 -50.89 70.34 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -62.66 -42.9 99.87 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 117.676 -1.154 . . . . 0.0 110.12 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.34 -47.69 62.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.822 2.049 . . . . 0.0 111.519 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.9 -41.62 76.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.776 -1.202 . . . . 0.0 111.372 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.53 -16.12 37.92 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.128 0.971 . . . . 0.0 109.982 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.12 -56.74 3.89 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.798 1.639 . . . . 0.0 106.73 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.94 -33.65 76.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.999 -0.438 . . . . 0.0 110.418 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -71.3 111.9 7.0 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.942 -1.098 . . . . 0.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.88 -32.18 4.69 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.31 73.5 Favored Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 123.521 0.728 . . . . 0.0 110.025 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.73 110.18 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.073 1.848 . . . . 0.0 113.255 -171.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.39 42.88 2.87 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.719 -2.952 . . . . 0.0 105.719 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.01 163.71 24.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.686 1.194 . . . . 0.0 109.301 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.67 -59.59 0.76 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.67 130.76 34.67 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -150.29 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -142.1 125.74 16.88 Favored 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 119.784 -1.822 . . . . 0.0 109.362 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.04 -48.9 95.79 Favored Pre-proline 0 C--N 1.353 0.735 0 CA-C-O 116.473 -1.727 . . . . 0.0 112.282 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.36 -8.17 22.2 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 CA-C-N 125.33 2.939 . . . . 0.0 112.345 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -101.27 -19.59 15.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.27 75.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 121.043 -1.036 . . . . 0.0 111.519 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -65.92 -28.88 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.612 1.165 . . . . 0.0 110.092 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -86.19 -26.18 25.25 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.483 -0.761 . . . . 0.0 109.788 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -79.17 -34.42 43.15 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.8 m -79.06 51.07 1.1 Allowed 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.721 -0.612 . . . . 0.0 110.669 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.21 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.33 -22.92 55.04 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.416 1.486 . . . . 0.0 113.713 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 5.1 t -72.15 -35.82 69.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.666 -1.271 . . . . 0.0 109.795 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.29 42.39 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.035 -1.041 . . . . 0.0 109.613 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.22 -2.03 54.56 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.861 0.865 . . . . 0.0 109.615 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p 58.93 40.8 22.09 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 127.062 2.145 . . . . 0.0 112.733 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.41 65.69 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.25 99.78 0.74 Allowed Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -35.05 40.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.08 39.99 0.17 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.0 -51.38 16.12 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 118.827 1.314 . . . . 0.0 109.249 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 173.27 11.65 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -137.16 127.93 16.16 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.08 -179.44 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.185 3.257 . . . . 0.0 109.481 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.498 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 6.8 t -112.26 -97.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 124.087 0.955 . . . . 0.0 110.076 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -165.67 -46.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -71.96 -10.22 59.47 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.498 ' CG ' ' H ' ' D' ' 63' ' ' VAL . 0.9 OUTLIER -60.84 -33.11 72.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.502 1.121 . . . . 0.0 109.996 172.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 149.25 -33.02 1.13 Allowed Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.391 -3.483 . . . . 0.0 104.391 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.401 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 37.6 ttm180 74.09 -50.74 0.69 Allowed 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 130.071 3.348 . . . . 0.0 107.578 -171.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' D' ' 67' ' ' GLY . 71.1 mmtt -71.76 12.11 0.42 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.672 2.789 . . . . 0.0 110.884 174.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.89 -61.03 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -49.18 69.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 123.168 0.587 . . . . 0.0 111.031 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.02 -40.24 66.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.935 0.894 . . . . 0.0 111.418 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.8 -37.03 73.26 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 121.708 -0.62 . . . . 0.0 111.348 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.36 -41.95 57.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.146 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 10.3 mtp -56.37 -51.66 67.49 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.826 1.251 . . . . 0.0 110.587 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.75 -40.66 97.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.388 0.675 . . . . 0.0 110.768 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.04 87.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.763 0.825 . . . . 0.0 110.985 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.63 -49.44 64.35 Favored Glycine 0 CA--C 1.496 -1.119 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.62 -49.44 80.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 124.186 0.995 . . . . 0.0 110.339 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . 0.273 11.9 pt-20 -77.95 -9.61 59.18 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 120.202 -1.561 . . . . 0.0 112.664 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.69 -47.17 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -67.47 -20.78 65.52 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 121.462 -0.774 . . . . 0.0 111.137 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.6 -14.78 29.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.659 0.742 . . . . 0.0 111.717 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.18 -38.56 56.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 119.876 -1.765 . . . . 0.0 107.651 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 6.6 m -66.96 -6.39 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.646 0.778 . . . . 0.0 111.458 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.1 m -63.11 -17.77 62.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.375 1.47 . . . . 0.0 111.487 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.56 62.41 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 120.053 -1.655 . . . . 0.0 111.759 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.32 6.32 17.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 125.166 1.386 . . . . 0.0 111.087 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 92.5 mt -113.47 -39.29 4.13 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.28 -13.16 61.44 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.779 -1.2 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -70.7 -19.17 62.79 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 120.956 -1.09 . . . . 0.0 110.879 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.19 7.47 46.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 119.699 1.136 . . . . 0.0 110.6 -160.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -91.99 -20.5 21.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 158.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.9 -40.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -57.75 -38.24 75.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 126.711 2.005 . . . . 0.0 111.163 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.13 -8.64 55.78 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.386 0.674 . . . . 0.0 112.732 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.174 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 122.317 1.056 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.73 151.57 34.07 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.2 -29.99 71.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.041 1.336 . . . . 0.0 109.323 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -91.94 -2.46 56.76 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 121.267 -0.896 . . . . 0.0 111.712 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.21 -36.46 19.44 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 119.599 1.09 . . . . 0.0 108.965 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -67.71 -35.01 78.01 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.894 -1.129 . . . . 0.0 110.305 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -75.43 -34.38 60.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 121.769 -0.582 . . . . 0.0 109.651 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.04 82.45 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.798 0.839 . . . . 0.0 109.715 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -60.49 -38.37 84.08 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.662 1.185 . . . . 0.0 111.417 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -56.3 -42.5 77.65 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.569 1.148 . . . . 0.0 110.612 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.06 -32.29 73.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.632 -0.668 . . . . 0.0 111.061 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.11 -27.68 67.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.625 -0.672 . . . . 0.0 111.853 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.35 -39.26 81.92 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 109.158 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.47 -36.17 82.88 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.488 0.715 . . . . 0.0 110.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -38.89 92.91 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.607 0.717 . . . . 0.0 111.057 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -69.08 -21.01 64.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.364 1.066 . . . . 0.0 111.883 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -72.51 -40.72 66.62 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -64.46 -38.88 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.845 0.858 . . . . 0.0 108.709 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.92 -43.26 86.15 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.556 1.142 . . . . 0.0 111.859 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.82 -53.86 53.39 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.321 1.058 . . . . 0.0 110.251 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -73.06 -28.96 62.62 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.265 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.06 89.19 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 124.925 1.29 . . . . 0.0 110.428 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m -56.96 -37.82 72.11 Favored 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.498 1.119 . . . . 0.0 112.042 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -75.59 -51.68 12.32 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.387 0.675 . . . . 0.0 110.854 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.3 -38.22 88.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 120.989 -1.069 . . . . 0.0 109.498 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.96 75.25 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.353 1.461 . . . . 0.0 112.505 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.38 -33.05 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 O-C-N 121.375 -0.828 . . . . 0.0 111.415 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.34 -44.82 50.73 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.8 84.95 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.577 1.551 . . . . 0.0 108.721 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -79.59 -44.26 21.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -77.11 93.88 3.96 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 119.372 -2.08 . . . . 0.0 110.537 -172.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.87 -17.85 3.41 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.98 151.4 54.6 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.025 0.912 . . . . 0.0 109.196 -176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.84 137.07 13.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.839 2.36 . . . . 0.0 110.731 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 -4.61 83.64 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 118.784 0.72 . . . . 0.0 111.306 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.88 146.76 54.06 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.492 1.117 . . . . 0.0 111.662 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.66 -11.1 1.59 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.519 1.128 . . . . 0.0 111.138 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.11 -66.32 0.73 Allowed 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.088 -1.007 . . . . 0.0 111.152 -172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 40' ' ' SER 0.495 44.9 pt 58.28 -100.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 174.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 39' ' ' ILE . 24.7 m -54.11 143.23 22.97 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -56.05 -57.45 22.12 Favored Pre-proline 0 C--N 1.356 0.859 0 C-N-CA 125.866 1.666 . . . . 0.0 114.991 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.22 -5.58 17.16 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.258 2.913 . . . . 0.0 111.207 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -107.98 1.97 22.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.17 -45.21 9.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.79 -32.15 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 124.237 1.015 . . . . 0.0 110.781 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.86 -10.54 59.71 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.122 -0.986 . . . . 0.0 112.143 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -90.14 -22.95 21.49 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -89.32 54.7 3.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 120.151 -1.593 . . . . 0.0 109.36 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.21 -73.72 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.44 -31.72 65.7 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.506 1.922 . . . . 0.0 108.638 -169.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -52.64 -37.67 58.9 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.091 1.357 . . . . 0.0 111.627 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -16.48 58.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 119.664 -1.898 . . . . 0.0 111.919 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t -108.55 38.48 2.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.388 4.6 p 62.74 -110.31 0.34 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.597 2.359 . . . . 0.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t 70.51 -70.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.891 1.676 . . . . 0.0 110.116 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.5 -24.3 29.14 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -78.27 55.92 1.61 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 109.787 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.76 -13.65 66.43 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 120.369 -1.457 . . . . 0.0 110.358 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 t0 76.09 14.37 2.54 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 127.583 2.353 . . . . 0.0 108.751 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -148.79 -178.3 6.27 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.26 139.76 21.69 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.59 175.93 8.35 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.992 3.128 . . . . 0.0 107.766 161.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.314 2.6 p -113.43 -88.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-N 120.832 1.651 . . . . 0.0 112.046 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -157.64 -40.45 0.07 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.496 -2.003 . . . . 0.0 107.21 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.91 -23.5 31.16 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 123.121 0.568 . . . . 0.0 110.795 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.8 -35.95 71.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.492 1.517 . . . . 0.0 108.043 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.04 96.35 2.08 Favored Glycine 0 CA--C 1.47 -2.74 1 N-CA-C 97.992 -6.043 . . . . 0.0 97.992 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.409 HH12 ' HB2' ' D' ' 59' ' ' ASP . 16.3 ttm180 -62.64 -17.21 59.94 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 118.726 1.263 . . . . 0.0 110.072 -174.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -44.06 -29.63 0.63 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.561 2.744 . . . . 0.0 113.813 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.93 -40.99 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 124.593 1.157 . . . . 0.0 109.137 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 -49.05 12.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.196 -0.94 . . . . 0.0 108.617 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -47.85 -50.32 26.63 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.703 2.001 . . . . 0.0 111.721 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.1 -27.31 61.63 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.662 -0.649 . . . . 0.0 111.562 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.97 -44.15 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.9 mtm -63.19 -44.23 95.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.135 0.574 . . . . 0.0 110.539 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -65.84 -32.54 74.12 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.342 -0.849 . . . . 0.0 111.473 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.06 79.2 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.355 -0.841 . . . . 0.0 110.403 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.43 -41.34 96.46 Favored Glycine 0 CA--C 1.487 -1.695 0 C-N-CA 123.969 0.795 . . . . 0.0 111.145 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.71 -46.95 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 C-N-CA 124.078 0.951 . . . . 0.0 108.722 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.13 -39.4 94.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 120.734 -1.229 . . . . 0.0 112.302 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.85 -55.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.71 0.804 . . . . 0.0 109.361 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.39 -18.65 61.13 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.579 -0.7 . . . . 0.0 111.667 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.35 23.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.073 -1.017 . . . . 0.0 109.861 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.81 -37.27 87.05 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.935 -1.103 . . . . 0.0 110.585 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.33 -7.62 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 O-C-N 121.188 -0.945 . . . . 0.0 112.246 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -57.97 -23.95 55.98 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 124.706 1.202 . . . . 0.0 110.72 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.75 72.96 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.182 -1.574 . . . . 0.0 112.457 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.77 -39.98 56.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 120.998 -1.064 . . . . 0.0 108.612 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.59 -35.05 78.26 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.689 0.757 . . . . 0.0 110.425 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.74 68.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.672 -1.268 . . . . 0.0 112.343 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 t -84.57 5.12 29.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.709 -1.245 . . . . 0.0 109.709 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.72 -48.39 59.69 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 118.786 0.721 . . . . 0.0 109.693 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -67.98 -27.94 67.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.723 -1.235 . . . . 0.0 111.551 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -29.1 46.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 125.085 1.354 . . . . 0.0 109.115 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -59.96 -18.51 45.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.243 1.817 . . . . 0.0 111.847 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -61.81 -36.68 81.83 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.974 1.31 . . . . 0.0 109.676 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -78.14 -18.56 55.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 120.683 -1.261 . . . . 0.0 109.815 -169.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -78.53 -37.42 43.0 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.763 1.225 . . . . 0.0 107.92 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.27 -42.9 99.74 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.747 2.019 . . . . 0.0 109.71 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.29 -10.12 58.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -114.55 -12.85 12.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.56 30.29 64.5 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 110.447 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -170.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.67 -159.24 0.21 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.303 1.441 . . . . 0.0 112.424 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -67.33 0.64 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.417 ' CD2' ' HG3' ' B' ' 5' ' ' GLU . 36.8 p-80 -56.16 -30.07 61.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.425 2.29 . . . . 0.0 114.348 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' B' ' 4' ' ' HIS . 8.3 mt-10 -74.62 -21.2 59.59 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -79.38 -42.57 25.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.59 -31.25 66.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.038 0.447 . . . . 0.0 110.473 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.53 -43.31 93.48 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.754 0.822 . . . . 0.0 111.558 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -72.83 -30.57 64.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.773 0.797 . . . . 0.0 110.351 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -66.45 -34.4 77.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.742 0.817 . . . . 0.0 110.214 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.94 79.28 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -63.29 -36.62 84.27 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.494 -0.753 . . . . 0.0 111.0 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.99 -33.95 76.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.916 0.886 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -62.81 -41.83 99.47 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 121.246 -0.909 . . . . 0.0 109.32 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.64 -39.65 94.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.795 -0.566 . . . . 0.0 110.939 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.97 -38.05 84.58 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.368 0.667 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -62.57 -45.2 94.01 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.339 0.656 . . . . 0.0 109.568 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.53 -38.72 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 123.756 0.823 . . . . 0.0 109.72 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.91 -45.92 85.75 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.824 0.85 . . . . 0.0 111.261 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.58 -37.63 77.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.592 1.157 . . . . 0.0 110.712 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.48 -35.59 63.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.72 -0.613 . . . . 0.0 109.898 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.73 -36.79 85.02 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.142 0.977 . . . . 0.0 111.068 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -28.94 69.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.727 1.149 . . . . 0.0 112.949 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.05 -53.71 10.42 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -58.18 -48.11 81.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 125.073 1.349 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.56 -43.87 84.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.644 1.178 . . . . 0.0 112.224 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 -48.69 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 -20.35 49.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -50.67 43.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 108.504 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.83 -21.66 63.36 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 mmm-85 -70.68 90.57 0.77 Allowed 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 120.149 -1.595 . . . . 0.0 110.694 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.87 -21.45 3.01 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 107.519 -2.233 . . . . 0.0 107.519 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.44 152.26 66.91 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 117.761 0.78 . . . . 0.0 110.771 -172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.57 128.32 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.87 2.38 . . . . 0.0 110.667 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.38 -63.05 0.28 Allowed Glycine 0 CA--C 1.471 -2.688 1 N-CA-C 103.036 -4.026 . . . . 0.0 103.036 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.422 ' H ' HG22 ' B' ' 63' ' ' VAL . . . 45.41 -94.53 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 128.643 2.777 . . . . 0.0 111.503 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 83.75 -29.09 0.09 Allowed 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 127.165 2.186 . . . . 0.0 109.042 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.92 122.5 39.96 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 pt -154.44 170.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 76.61 139.83 0.07 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.017 1.727 . . . . 0.0 111.673 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -47.3 23.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.585 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -70.48 -21.6 29.91 Favored 'Trans proline' 0 CA--C 1.502 -1.089 0 CA-C-N 124.512 2.647 . . . . 0.0 112.952 -168.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.38 6.52 24.43 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 119.945 1.248 . . . . 0.0 110.37 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.67 -38.85 67.48 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.631 0.729 . . . . 0.0 109.25 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -65.09 -33.24 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 123.414 0.686 . . . . 0.0 109.773 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -41.63 84.02 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.971 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.19 0.995 . . . . 0.0 109.177 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -58.02 -41.42 83.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.976 1.31 . . . . 0.0 111.165 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.79 -51.88 67.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 O-C-N 121.49 -0.756 . . . . 0.0 111.114 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . 0.285 6.6 pt-20 -76.37 -12.1 60.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.028 -1.045 . . . . 0.0 112.538 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 90.0 m -68.33 -42.94 78.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.6 67.38 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.323 -1.486 . . . . 0.0 112.287 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -76.58 -18.86 58.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.851 -0.531 . . . . 0.0 111.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.311 13.9 p 68.6 10.31 7.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.616 2.366 . . . . 0.0 111.307 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.23 -53.72 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.14 -46.65 3.67 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 120.838 -1.164 . . . . 0.0 110.554 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 76.91 -67.08 0.22 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 128.187 2.595 . . . . 0.0 109.002 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.69 27.79 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.03 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.36 178.22 7.45 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -156.23 154.62 27.7 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.91 174.5 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.073 2.515 . . . . 0.0 111.465 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.422 HG22 ' H ' ' B' ' 36' ' ' ALA . 2.4 t -95.83 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.914 0.885 . . . . 0.0 111.165 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -128.62 -32.08 2.18 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.448 1.899 . . . . 0.0 107.657 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -92.58 -6.2 50.01 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.769 0.827 . . . . 0.0 108.801 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -35.4 59.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.62 64.44 0.67 Allowed Glycine 0 CA--C 1.468 -2.897 0 N-CA-C 103.12 -3.992 . . . . 0.0 103.12 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -31.79 -16.82 0.0 OUTLIER 'General case' 0 C--N 1.369 1.45 1 C-N-CA 132.816 4.446 . . . . 0.0 117.7 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.46 -15.41 2.69 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.275 -1.516 . . . . 0.0 113.428 158.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.25 -54.6 32.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.171 1.388 . . . . 0.0 107.973 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.1 -46.0 75.55 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.463 -0.773 . . . . 0.0 110.31 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -49.73 -43.12 47.52 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 126.084 1.754 . . . . 0.0 111.393 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.38 -50.02 73.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.442 1.097 . . . . 0.0 110.913 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.84 -43.44 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.597 0.759 . . . . 0.0 109.624 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtm -63.14 -48.8 76.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.373 1.069 . . . . 0.0 110.134 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -71.61 -27.25 62.99 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.289 -0.882 . . . . 0.0 110.813 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.78 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.872 -1.142 . . . . 0.0 109.824 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.82 61.42 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -58.71 -45.56 90.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 C-N-CA 124.035 0.934 . . . . 0.0 110.52 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.55 -27.97 68.83 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.516 -1.365 . . . . 0.0 112.569 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.75 -46.71 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 120.368 -1.458 . . . . 0.0 108.247 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -65.95 -21.57 66.43 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.934 0.894 . . . . 0.0 110.956 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -42.78 16.43 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.619 1.167 . . . . 0.0 110.732 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.8 -40.4 83.96 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.208 1.403 . . . . 0.0 111.031 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 29.2 m -63.33 -8.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 123.836 0.855 . . . . 0.0 112.393 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.7 m -64.72 -12.58 48.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.678 -1.264 . . . . 0.0 110.535 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.96 65.98 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.828 -1.795 . . . . 0.0 112.098 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.51 -37.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.951 -1.093 . . . . 0.0 109.108 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.02 -36.59 64.46 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.417 -0.802 . . . . 0.0 111.267 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.33 -12.82 60.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.847 -1.158 . . . . 0.0 111.187 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -96.88 1.44 50.55 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.945 -1.097 . . . . 0.0 108.974 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.3 -37.3 66.26 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 120.305 1.411 . . . . 0.0 109.017 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -66.74 -30.01 70.13 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 120.289 -1.507 . . . . 0.0 111.406 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.6 -22.95 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.091 1.357 . . . . 0.0 109.6 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.92 -25.31 65.03 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.07 -1.019 . . . . 0.0 111.519 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -8.51 54.04 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.526 -1.359 . . . . 0.0 112.36 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -83.41 -43.63 15.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 120.298 -1.501 . . . . 0.0 107.625 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.67 -43.97 97.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.905 1.282 . . . . 0.0 109.661 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.0 -10.45 59.43 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.598 -0.689 . . . . 0.0 112.329 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -79.02 -35.88 42.04 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.764 -1.21 . . . . 0.0 108.156 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -79.24 -35.63 41.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.03 12.26 62.17 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.662 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.96 176.15 6.36 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -57.56 -52.4 65.57 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 125.497 1.519 . . . . 0.0 109.4 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -19.99 63.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.691 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.15 -38.67 20.37 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -62.78 -32.2 73.32 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.503 -1.373 . . . . 0.0 112.182 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -64.48 -36.09 83.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.07 0.948 . . . . 0.0 110.936 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -44.73 62.04 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.173 -0.954 . . . . 0.0 109.519 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -66.83 -33.36 75.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.487 0.66 . . . . 0.0 111.345 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.97 -37.51 79.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.672 1.989 . . . . 0.0 111.113 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.01 -38.86 66.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.948 0.899 . . . . 0.0 110.291 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.05 -40.82 90.75 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.084 -1.01 . . . . 0.0 110.962 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.61 -18.03 62.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.298 -0.876 . . . . 0.0 111.728 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -73.83 -38.39 64.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.94 -38.11 89.89 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.249 0.62 . . . . 0.0 110.544 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.26 -24.94 68.09 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.604 -0.685 . . . . 0.0 112.449 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -80.12 -23.75 40.98 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.373 1.469 . . . . 0.0 109.55 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.17 -35.52 20.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 124.46 1.104 . . . . 0.0 108.034 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -60.55 -33.94 73.41 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.88 0.872 . . . . 0.0 111.462 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -60.62 -50.14 74.71 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.663 1.185 . . . . 0.0 110.225 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.38 -41.0 96.93 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 121.573 -0.704 . . . . 0.0 109.995 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.25 87.18 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.536 1.135 . . . . 0.0 110.389 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 83.5 p -62.72 -33.41 75.06 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.63 0.728 . . . . 0.0 112.116 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -80.15 -54.31 5.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.57 -30.79 67.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.772 0.829 . . . . 0.0 109.467 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.95 76.1 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 125.052 1.341 . . . . 0.0 112.736 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.23 -34.21 57.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 O-C-N 120.896 -1.128 . . . . 0.0 110.615 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.61 -40.63 73.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.852 -1.155 . . . . 0.0 109.389 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.6 1.09 Allowed 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.398 1.479 . . . . 0.0 109.53 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.34 -31.4 0.05 Allowed 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 123.694 0.621 . . . . 0.0 109.446 171.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -70.4 81.65 0.56 Allowed 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.224 -1.547 . . . . 0.0 111.915 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.66 -4.24 1.43 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.6 148.1 68.88 Favored Pre-proline 0 N--CA 1.442 -0.867 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -169.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -78.01 81.83 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.141 2.56 . . . . 0.0 113.182 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.68 34.11 3.15 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 146.18 13.89 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 126.813 2.045 . . . . 0.0 112.402 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.46 -46.07 1.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 125.169 1.388 . . . . 0.0 108.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.1 115.81 18.11 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 122.111 0.958 . . . . 0.0 108.603 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.8 163.21 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t 75.28 131.39 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.882 1.273 . . . . 0.0 112.377 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -67.29 -45.82 49.84 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 116.333 -1.794 . . . . 0.0 111.929 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.23 -10.54 27.4 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 CA-C-N 125.208 2.896 . . . . 0.0 113.904 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.361 0.7 OUTLIER -103.66 -19.43 14.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 121.372 1.896 . . . . 0.0 110.408 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.24 73.92 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.086 0.954 . . . . 0.0 112.214 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tp -66.05 -29.97 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.482 -0.762 . . . . 0.0 110.846 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -34.7 55.04 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -58.71 -41.99 87.59 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 122.385 1.088 . . . . 0.0 109.743 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -10.54 55.24 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.761 -1.212 . . . . 0.0 114.006 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.29 -47.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.5 57.56 4.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.607 1.563 . . . . 0.0 110.722 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -160.66 -51.21 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.64 -6.33 51.61 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.398 -1.439 . . . . 0.0 111.373 -170.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -80.52 -7.44 59.2 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.075 2.15 . . . . 0.0 110.459 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.309 34.2 p 76.93 17.76 1.63 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.689 2.396 . . . . 0.0 110.44 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.71 111.55 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.54 0.83 Allowed Glycine 0 CA--C 1.481 -2.075 1 N-CA-C 101.805 -4.518 . . . . 0.0 101.805 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.18 -33.06 38.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.92 -116.49 1.33 Allowed Glycine 0 CA--C 1.479 -2.187 0 N-CA-C 103.269 -3.932 . . . . 0.0 103.269 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.302 43.7 t0 64.13 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.348 0.52 0 C-N-CA 126.686 1.994 . . . . 0.0 109.825 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -128.75 158.96 37.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -161.05 147.0 11.16 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.01 163.62 22.9 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 122.795 2.33 . . . . 0.0 109.65 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.259 8.2 t -98.88 -105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -168.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -134.72 -60.04 0.79 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.371 -2.081 . . . . 0.0 108.827 -162.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -78.26 -6.35 54.72 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.377 1.471 . . . . 0.0 108.881 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.35 -20.77 46.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 C-N-CA 131.827 4.051 . . . . 0.0 108.028 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.69 84.36 0.84 Allowed Glycine 0 CA--C 1.482 -1.982 1 N-CA-C 101.473 -4.651 . . . . 0.0 101.473 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -23.52 24.66 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 110.92 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -57.65 -10.34 1.53 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.83 -41.21 87.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 120.059 1.3 . . . . 0.0 110.297 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.62 -51.09 21.09 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 120.991 -1.068 . . . . 0.0 109.163 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -46.05 -51.34 13.88 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 127.213 2.205 . . . . 0.0 112.966 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.98 -28.14 61.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.594 0.758 . . . . 0.0 110.714 -171.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 68.1 t -74.1 -46.08 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 79.2 mtm -59.98 -42.75 94.86 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.36 0.664 . . . . 0.0 111.231 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -65.37 -27.27 68.45 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 121.706 -0.621 . . . . 0.0 111.649 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.73 71.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.196 -0.94 . . . . 0.0 110.681 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.83 -35.83 61.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.57 -46.57 96.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 108.672 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.0 -50.33 73.76 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.73 -52.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 124.979 1.312 . . . . 0.0 110.379 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.29 -0.7 42.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.247 -0.908 . . . . 0.0 111.337 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.12 -37.58 14.12 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 120.733 -1.23 . . . . 0.0 108.295 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.48 -34.83 76.13 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 125.215 1.406 . . . . 0.0 111.344 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.88 -9.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 C-N-CA 124.079 0.952 . . . . 0.0 113.069 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -59.57 -24.19 63.53 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 125.52 1.528 . . . . 0.0 111.396 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.01 -23.56 66.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.771 -1.206 . . . . 0.0 111.562 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.43 -42.93 13.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.86 -41.59 91.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.44 1.096 . . . . 0.0 112.806 -171.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.75 -5.82 40.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.869 -1.144 . . . . 0.0 111.769 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.14 -8.48 25.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.35 -39.64 74.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.504 1.047 . . . . 0.0 109.305 -167.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -80.31 -15.02 57.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.195 -1.565 . . . . 0.0 113.04 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.16 -27.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.608 -1.308 . . . . 0.0 107.562 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 35.3 ttm105 -55.83 -23.4 30.28 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 126.405 1.882 . . . . 0.0 111.937 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -59.54 -32.67 70.54 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.421 -1.424 . . . . 0.0 111.732 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.69 -23.44 45.6 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.005 -1.059 . . . . 0.0 108.487 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -75.25 -46.84 31.18 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.04 -36.11 76.59 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.729 1.612 . . . . 0.0 111.01 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.86 -44.17 39.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.723 2.009 . . . . 0.0 113.314 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -103.4 -25.03 13.43 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.768 -0.583 . . . . 0.0 110.45 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.32 45.6 5.82 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 106.658 -2.577 . . . . 0.0 106.658 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 CA--C 1.506 -0.731 0 O-C-N 121.178 -1.189 . . . . 0.0 109.552 -178.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.434 -1.252 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.33 101.92 0.04 OUTLIER 'General case' 0 C--N 1.351 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 111.175 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.98 -26.0 68.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.463 -1.398 . . . . 0.0 111.56 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.18 -24.86 60.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.259 -0.9 . . . . 0.0 111.308 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -30.2 38.58 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -67.42 -44.77 77.94 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.57 -0.706 . . . . 0.0 110.31 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.49 -38.36 74.34 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.769 -0.582 . . . . 0.0 110.384 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.85 -48.08 80.58 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.939 0.896 . . . . 0.0 111.588 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.02 -35.34 79.7 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.519 -0.738 . . . . 0.0 110.487 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.58 -31.81 73.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.837 0.855 . . . . 0.0 110.496 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.27 97.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.401 -0.812 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -29.69 70.76 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.522 0.677 . . . . 0.0 111.552 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.2 -28.85 66.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 121.251 -0.906 . . . . 0.0 110.42 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -82.47 -23.71 34.58 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.749 -1.219 . . . . 0.0 109.9 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.48 -42.97 99.6 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 120.637 -1.289 . . . . 0.0 110.5 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -59.36 -35.59 74.17 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.435 1.094 . . . . 0.0 112.162 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -66.83 -44.9 79.88 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.611 1.164 . . . . 0.0 108.926 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.24 -38.04 81.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 C-N-CA 124.259 1.023 . . . . 0.0 109.416 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.47 -44.87 81.01 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.642 0.777 . . . . 0.0 112.076 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.89 -43.69 71.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.025 0.53 . . . . 0.0 110.701 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.34 -47.21 80.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.59 1.186 . . . . 0.0 109.825 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.0 -28.68 64.61 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.017 -1.052 . . . . 0.0 111.876 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -74.42 -31.08 62.18 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 119.582 1.083 . . . . 0.0 110.769 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -62.05 -48.02 82.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -63.55 -50.68 68.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.208 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.06 70.06 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 125.291 1.437 . . . . 0.0 113.236 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.44 -35.34 61.59 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 120.947 -1.096 . . . . 0.0 110.59 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -81.78 -22.73 37.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.411 -1.431 . . . . 0.0 110.096 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -52.58 14.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 127.093 2.157 . . . . 0.0 107.778 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.84 -35.73 79.12 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.451 1.12 . . . . 0.0 110.967 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.84 103.51 2.64 Favored 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 120.184 -1.572 . . . . 0.0 111.586 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.41 -25.21 3.65 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 106.231 -2.747 . . . . 0.0 106.231 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 148.27 74.94 Favored Pre-proline 0 N--CA 1.439 -0.999 0 O-C-N 121.675 -0.897 . . . . 0.0 110.228 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 134.88 17.77 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.253 1.969 . . . . 0.0 110.131 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 26.63 61.26 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 137.28 51.26 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.287 1.835 . . . . 0.0 111.416 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.08 -47.08 2.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tt -85.93 71.27 10.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.728 1.251 . . . . 0.0 110.142 -172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -96.61 -6.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 O-C-N 120.159 -1.588 . . . . 0.0 111.205 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.2 p -95.96 141.98 28.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.097 -1.002 . . . . 0.0 110.862 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -89.73 -61.11 0.22 Allowed Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.318 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.25 -5.92 17.26 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 CA-C-N 125.797 3.106 . . . . 0.0 110.818 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.29 -18.56 21.51 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.076 1.751 . . . . 0.0 107.492 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.21 72.32 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 111.083 -168.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.26 -35.34 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 124.115 0.966 . . . . 0.0 110.515 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -36.15 74.23 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -67.95 -41.06 83.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.399 1.095 . . . . 0.0 109.393 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.8 t -60.62 -41.17 94.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.961 -1.087 . . . . 0.0 110.339 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.51 -53.35 31.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 125.432 1.493 . . . . 0.0 110.6 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -76.1 -15.35 60.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.684 -0.635 . . . . 0.0 111.62 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 73.8 m -76.41 -36.82 57.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.45 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.234 -0.916 . . . . 0.0 111.574 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.438 ' HG1' HG23 ' D' ' 55' ' ' VAL . 17.5 p -87.59 13.15 10.84 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.781 -0.575 . . . . 0.0 110.736 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p 52.56 49.02 21.3 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.296 1.839 . . . . 0.0 114.0 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.438 HG23 ' HG1' ' D' ' 53' ' ' THR . 0.7 OUTLIER -127.11 -55.05 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -177.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.87 -44.31 3.22 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 120.52 -1.363 . . . . 0.0 110.014 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.38 -75.72 0.07 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 127.111 2.164 . . . . 0.0 108.29 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.29 37.4 0.02 OUTLIER Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.409 ' HB2' HH12 ' A' ' 68' ' ' ARG . 5.2 t70 -87.0 -66.06 0.95 Allowed 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -130.52 -160.81 1.07 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -165.54 150.19 7.73 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.57 161.67 12.6 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.967 3.111 . . . . 0.0 108.707 168.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -154.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-N 119.893 1.224 . . . . 0.0 108.116 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -91.13 -50.07 6.05 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 119.672 -1.893 . . . . 0.0 108.687 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -77.34 -3.23 38.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.076 1.751 . . . . 0.0 110.847 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -29.8 69.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.59 80.23 1.19 Allowed Glycine 0 CA--C 1.468 -2.891 1 N-CA-C 99.1 -5.6 . . . . 0.0 99.1 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -63.16 -1.68 1.09 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.544 1.537 . . . . 0.0 112.613 -166.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -69.46 -13.3 62.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.602 1.161 . . . . 0.0 112.394 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -53.08 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.28 73.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.313 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -63.62 -34.57 78.12 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.718 0.807 . . . . 0.0 111.893 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.7 -37.08 85.99 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.967 -1.083 . . . . 0.0 111.206 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.22 -39.22 82.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 O-C-N 121.067 -1.021 . . . . 0.0 109.893 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 64.5 mtt -62.01 -50.37 72.33 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.67 0.788 . . . . 0.0 110.024 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.71 -30.64 70.93 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.496 -0.752 . . . . 0.0 110.641 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.13 96.12 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.066 -1.021 . . . . 0.0 110.469 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.09 -44.68 95.43 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 124.349 0.976 . . . . 0.0 111.428 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.64 -47.47 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 O-C-N 121.891 -0.77 . . . . 0.0 109.552 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -69.75 -32.82 71.56 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.927 -1.108 . . . . 0.0 113.306 -173.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.41 -42.48 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 110.109 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.14 -36.81 64.18 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 121.634 -0.666 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.28 -23.12 62.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.872 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.55 -32.63 72.7 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.856 -1.778 . . . . 0.0 109.797 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.48 -18.77 21.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 124.792 1.237 . . . . 0.0 110.276 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -60.05 -14.29 15.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 120.809 -1.182 . . . . 0.0 111.663 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.0 2.75 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.37 -1.456 . . . . 0.0 111.24 167.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.7 98.5 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.947 1.299 . . . . 0.0 109.517 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.12 -41.89 89.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 111.915 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.9 -11.45 60.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.978 -1.076 . . . . 0.0 110.356 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -74.72 -26.83 60.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 120.805 -1.184 . . . . 0.0 108.384 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.268 0.6 OUTLIER -80.14 -4.7 54.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 120.317 -1.489 . . . . 0.0 112.818 -160.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -81.78 -29.79 32.6 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 120.674 -1.266 . . . . 0.0 109.337 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.56 -28.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.49 1.116 . . . . 0.0 109.288 -172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -62.72 -12.38 23.45 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.272 -0.893 . . . . 0.0 111.691 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -68.96 -16.55 63.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.434 -0.791 . . . . 0.0 112.37 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -71.32 -45.54 62.75 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.683 -1.261 . . . . 0.0 109.304 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.31 -35.17 80.19 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.736 0.815 . . . . 0.0 110.193 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -60.12 -47.28 86.55 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.893 1.677 . . . . 0.0 110.06 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -63.14 -37.84 88.8 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.818 1.647 . . . . 0.0 110.195 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -75.31 -26.44 58.67 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.348 1.459 . . . . 0.0 110.292 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.11 3.68 79.02 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 124.161 0.886 . . . . 0.0 110.947 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 -177.826 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.19 37.29 0.05 OUTLIER 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 59.26 -80.6 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.692 2.397 . . . . 0.0 111.379 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -9.59 49.75 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.82 -42.1 91.03 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.337 -0.852 . . . . 0.0 109.18 164.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -71.73 -33.06 68.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 O-C-N 120.569 -1.332 . . . . 0.0 110.437 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.47 -38.5 87.46 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.01 93.5 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.502 1.121 . . . . 0.0 111.44 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -63.78 -36.35 83.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.476 1.51 . . . . 0.0 111.216 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -75.02 -23.87 58.25 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 121.361 0.6 . . . . 0.0 110.038 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.65 86.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.448 -2.033 . . . . 0.0 111.1 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -61.31 -37.47 83.37 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.896 0.855 . . . . 0.0 110.978 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.68 -32.86 74.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.47 1.908 . . . . 0.0 110.214 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -78.15 -32.1 50.11 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 120.895 -1.128 . . . . 0.0 109.083 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.27 -43.76 98.35 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.966 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -59.76 -35.89 75.53 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.309 0.644 . . . . 0.0 112.1 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -32.71 73.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.833 0.853 . . . . 0.0 110.908 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.57 -40.08 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.44 -37.26 86.9 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.488 -0.758 . . . . 0.0 110.917 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.19 -39.58 82.45 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.903 -1.123 . . . . 0.0 111.306 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -69.49 -37.84 77.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.715 0.806 . . . . 0.0 109.762 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.83 89.51 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 125.887 1.675 . . . . 0.0 110.746 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m -63.89 -31.68 72.94 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.968 0.907 . . . . 0.0 111.93 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -75.2 -49.56 19.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.387 -0.821 . . . . 0.0 108.826 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -73.98 -22.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.316 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.42 4.58 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 125.202 1.401 . . . . 0.0 108.553 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.6 t -64.01 -28.78 45.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 O-C-N 119.811 -1.805 . . . . 0.0 111.18 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.36 -35.09 77.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.801 -1.187 . . . . 0.0 110.757 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.73 -59.27 2.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.595 1.558 . . . . 0.0 107.804 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.12 -30.67 62.44 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.287 1.835 . . . . 0.0 112.581 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -77.89 87.12 4.09 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.316 -2.115 . . . . 0.0 110.586 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.0 -21.87 1.13 Allowed Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.39 157.9 35.51 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 118.57 1.185 . . . . 0.0 110.598 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -85.97 131.96 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.391 2.061 . . . . 0.0 111.552 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.0 60.34 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.26 137.45 58.26 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.741 1.216 . . . . 0.0 110.853 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.16 -55.97 2.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.594 0.757 . . . . 0.0 109.727 -173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.33 91.25 8.43 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.196 0.998 . . . . 0.0 109.369 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.04 50.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.322 -1.486 . . . . 0.0 109.279 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.97 148.03 23.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.996 -1.69 . . . . 0.0 109.415 170.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -69.97 -45.58 22.87 Favored Pre-proline 0 C--N 1.353 0.726 0 CA-C-O 116.184 -1.865 . . . . 0.0 112.555 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.33 -19.08 33.87 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 125.545 3.016 . . . . 0.0 113.366 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -103.89 -3.91 24.17 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 120.118 1.326 . . . . 0.0 109.91 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.57 85.7 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.347 1.07 . . . . 0.0 110.41 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.57 -22.08 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 C-N-CA 124.702 1.201 . . . . 0.0 111.081 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.03 -26.54 26.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.603 -0.685 . . . . 0.0 109.457 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -68.96 -45.15 71.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.9 m -59.28 -12.29 5.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.444 1.098 . . . . 0.0 113.776 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -71.25 -58.22 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 123.999 0.92 . . . . 0.0 108.726 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 92.2 mt-10 -83.57 75.59 10.02 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.416 -0.802 . . . . 0.0 109.434 -172.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -170.37 -45.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.35 81.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 124.358 1.063 . . . . 0.0 111.97 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 p -96.24 18.37 13.85 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 124.006 0.922 . . . . 0.0 110.652 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.65 62.92 2.21 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 127.104 2.161 . . . . 0.0 115.07 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.77 165.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 1 N-CA-C 95.267 -5.827 . . . . 0.0 95.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.65 120.74 0.97 Allowed Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 99.06 -5.616 . . . . 0.0 99.06 170.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -84.8 -17.66 37.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 119.06 1.43 . . . . 0.0 109.071 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.36 21.01 4.93 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 121.129 -0.982 . . . . 0.0 112.886 171.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.27 -39.83 22.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.031 -1.276 . . . . 0.0 112.805 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -147.86 153.05 38.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -162.96 145.14 8.03 Favored Pre-proline 0 C--N 1.354 0.776 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.08 178.77 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 2.965 . . . . 0.0 111.793 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.275 9.4 p -119.54 -129.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 125.416 1.486 . . . . 0.0 108.412 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -99.45 -57.87 2.06 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 119.493 -2.005 . . . . 0.0 112.069 -160.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -75.41 -9.82 58.91 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 119.182 0.901 . . . . 0.0 109.835 -171.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -71.65 -13.62 61.81 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.672 1.989 . . . . 0.0 108.89 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.5 85.26 0.87 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 100.847 -4.901 . . . . 0.0 100.847 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -56.13 -20.92 19.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.327 1.061 . . . . 0.0 112.22 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.31 -15.74 17.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 118.283 -0.865 . . . . 0.0 113.066 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.01 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.007 1.73 . . . . 0.0 109.325 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.13 -52.75 21.18 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 121.064 -1.023 . . . . 0.0 109.132 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.98 -36.65 79.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.51 -34.88 78.75 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.71 -40.79 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.208 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 53.0 mtt -60.73 -48.38 82.06 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.11 0.964 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' D' ' 12' ' ' GLU . 8.7 tmtt? -66.08 -33.6 76.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 110.519 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.32 89.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.77 -0.581 . . . . 0.0 110.402 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -45.83 94.86 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 124.047 0.832 . . . . 0.0 111.124 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.84 -47.75 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 124.591 1.156 . . . . 0.0 109.702 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -67.82 -31.58 71.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.784 -1.197 . . . . 0.0 112.254 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 t -66.18 -53.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 O-C-N 121.59 -0.694 . . . . 0.0 109.16 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.24 -19.2 62.39 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 121.403 -0.81 . . . . 0.0 111.358 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.18 40.37 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 120.721 -1.237 . . . . 0.0 109.998 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.44 -43.72 84.14 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.101 1.361 . . . . 0.0 110.474 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 m -68.82 -6.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -59.71 -21.48 60.68 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.491 1.041 . . . . 0.0 110.495 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.89 73.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.794 -1.191 . . . . 0.0 112.433 171.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.88 -37.6 55.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.888 0.875 . . . . 0.0 108.849 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.13 -0.357 . . . . 0.0 111.154 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.15 80.21 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.562 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -7.27 58.4 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 120.889 -1.132 . . . . 0.0 111.878 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -30.69 66.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.59 1.087 . . . . 0.0 109.557 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.85 -27.56 60.31 Favored 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 120.596 -1.315 . . . . 0.0 112.019 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.32 -22.62 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.415 1.086 . . . . 0.0 108.664 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -63.46 -21.61 66.41 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.61 -1.306 . . . . 0.0 111.615 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -71.46 -8.56 54.64 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.469 -1.394 . . . . 0.0 112.094 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.89 -20.07 53.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 120.811 -1.18 . . . . 0.0 110.011 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -106.27 -177.67 3.43 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 69.28 -65.15 0.31 Allowed 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.036 1.734 . . . . 0.0 112.413 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -65.87 -43.99 86.7 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 127.308 2.243 . . . . 0.0 108.182 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -115.57 129.0 56.37 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.37 -8.9 57.26 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 178.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . 0.483 . . 11.5 -103.43 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.414 3.086 . . . . 0.0 117.834 -158.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -154.45 -58.79 0.11 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -158.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.42 -26.65 58.53 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.383 1.073 . . . . 0.0 110.326 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -68.11 -32.82 73.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.725 1.61 . . . . 0.0 111.471 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.6 -40.0 80.64 Favored 'General case' 0 CA--C 1.503 -0.848 0 O-C-N 121.881 -0.512 . . . . 0.0 110.071 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.84 -37.87 79.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.08 70.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -67.26 -35.14 78.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.786 -0.571 . . . . 0.0 110.927 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -78.66 -15.22 58.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.96 -1.088 . . . . 0.0 110.771 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.17 72.18 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.564 -1.335 . . . . 0.0 108.917 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -30.45 70.01 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.714 0.805 . . . . 0.0 111.593 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.01 -36.06 81.31 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.738 0.815 . . . . 0.0 110.147 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.59 -33.08 73.44 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 123.441 0.696 . . . . 0.0 109.321 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -63.54 -40.19 96.36 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 121.396 -0.815 . . . . 0.0 110.331 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.72 -41.13 66.69 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 124.32 1.048 . . . . 0.0 111.16 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.57 -41.41 98.39 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.291 0.636 . . . . 0.0 110.875 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.58 -44.39 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 121.727 -0.608 . . . . 0.0 109.416 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tp -53.8 -52.31 60.71 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 128.018 2.527 . . . . 0.0 110.149 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.68 -34.48 64.89 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 121.382 -0.824 . . . . 0.0 110.038 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -68.05 -29.24 68.17 Favored 'General case' 0 C--N 1.355 0.848 0 CA-C-N 120.241 1.382 . . . . 0.0 109.872 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.06 66.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.906 0.882 . . . . 0.0 112.398 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 90.0 p -68.94 -42.72 76.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 O-C-N 121.114 -0.991 . . . . 0.0 110.43 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -38.05 84.87 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.04 -36.44 72.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.259 -0.901 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.61 29.42 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.927 1.291 . . . . 0.0 110.382 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.33 -33.11 52.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 123.954 0.902 . . . . 0.0 111.677 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -83.89 -16.78 43.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.958 0.903 . . . . 0.0 109.647 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.59 70.37 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.186 0.994 . . . . 0.0 109.754 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -65.14 -27.11 68.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 121.806 -0.559 . . . . 0.0 111.822 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.87 83.72 4.97 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.8 -23.74 2.77 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.69 138.67 20.75 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.892 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -82.14 105.72 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.86 2.373 . . . . 0.0 112.916 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.54 47.38 0.15 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.56 137.24 57.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.884 0.873 . . . . 0.0 111.685 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.0 -45.57 0.14 Allowed 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.137 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.38 -63.72 1.0 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.991 0.917 . . . . 0.0 108.807 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . 0.369 40.2 pt 53.8 -127.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 126.173 1.789 . . . . 0.0 112.93 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -13.01 134.85 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 132.236 4.215 . . . . 0.0 121.332 -167.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -65.21 -55.5 25.74 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 116.645 -1.645 . . . . 0.0 115.173 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.03 -5.0 15.87 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 125.076 2.848 . . . . 0.0 110.559 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.8 -42.13 12.78 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.205 1.802 . . . . 0.0 106.834 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -33.69 72.98 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.368 1.467 . . . . 0.0 112.496 -170.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.9 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 121.724 -0.61 . . . . 0.0 110.629 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -29.55 54.42 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.727 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.42 -48.3 61.4 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -60.43 -33.43 72.52 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.773 -1.205 . . . . 0.0 112.952 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.94 -24.81 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.889 1.276 . . . . 0.0 112.537 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.24 -17.93 53.84 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.013 -1.679 . . . . 0.0 109.932 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.429 ' C ' ' H ' ' B' ' 53' ' ' THR . 9.3 t -116.94 -166.17 1.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.71 -21.28 0.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 127.131 2.172 . . . . 0.0 110.846 -167.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.429 ' H ' ' C ' ' B' ' 51' ' ' THR . 2.8 p -93.51 -1.43 55.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.568 2.347 . . . . 0.0 110.759 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.274 0.0 OUTLIER 62.7 61.76 1.16 Allowed 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.308 1.443 . . . . 0.0 110.895 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.91 -69.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.69 72.75 1.0 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -39.91 86.6 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 122.229 -0.571 . . . . 0.0 110.092 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.0 47.47 1.59 Allowed Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.25 -55.59 8.9 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -110.77 165.03 12.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -108.86 127.74 26.78 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.35 170.83 14.34 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.788 2.325 . . . . 0.0 109.66 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.518 HG12 ' H ' ' B' ' 64' ' ' THR . 1.2 t -92.86 -166.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.518 ' H ' HG12 ' B' ' 63' ' ' VAL . 32.7 m -101.09 -63.71 1.11 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.994 0.918 . . . . 0.0 109.132 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -54.61 -28.64 47.98 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -168.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -146.42 -164.36 1.96 Allowed 'General case' 0 N--CA 1.436 -1.17 1 N-CA-C 97.994 -4.817 . . . . 0.0 97.994 160.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.82 -75.34 1.1 Allowed Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 104.334 -3.506 . . . . 0.0 104.334 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' A' ' 50' ' ' GLU . 17.1 ttt180 -69.53 -38.63 77.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.953 0.883 . . . . 0.0 109.996 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.13 -17.3 60.95 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.122 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.03 -45.82 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 O-C-N 119.664 -1.897 . . . . 0.0 106.1 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -35.32 64.48 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 126.182 1.793 . . . . 0.0 112.401 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -50.43 -51.95 42.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 126.586 1.954 . . . . 0.0 111.245 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.25 -37.93 88.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.912 0.885 . . . . 0.0 109.508 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.07 -41.63 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 121.727 -0.608 . . . . 0.0 110.575 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.7 mtm -63.15 -54.58 35.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 122.982 0.513 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -69.59 -27.48 65.14 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 121.554 -0.716 . . . . 0.0 111.084 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.73 -45.09 91.47 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 120.457 -1.402 . . . . 0.0 110.228 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.68 76.66 Favored Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 124.148 0.88 . . . . 0.0 111.318 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.5 -49.17 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 C-N-CA 124.842 1.257 . . . . 0.0 109.705 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.31 -21.68 62.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 120.919 -1.113 . . . . 0.0 111.628 -171.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.98 -54.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.44 -31.21 70.36 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.184 -0.947 . . . . 0.0 111.824 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.9 -22.29 61.52 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.656 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.69 -35.45 75.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 120.069 -1.645 . . . . 0.0 108.291 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.71 -17.05 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 125.051 1.34 . . . . 0.0 110.217 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -63.85 -13.39 44.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.938 -1.101 . . . . 0.0 110.937 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.84 68.7 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 110.76 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.69 85.59 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.563 1.145 . . . . 0.0 110.692 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.86 -40.8 79.13 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.217 0.607 . . . . 0.0 109.8 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.65 -22.54 63.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.445 -0.784 . . . . 0.0 110.417 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -75.18 -26.57 59.16 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.048 -1.033 . . . . 0.0 109.027 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.488 -1.383 . . . . 0.0 111.513 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -70.81 -28.5 64.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.288 -1.508 . . . . 0.0 112.012 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.55 -29.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 C-N-CA 125.28 1.432 . . . . 0.0 108.529 -173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -60.58 -28.79 68.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.508 1.523 . . . . 0.0 110.316 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -60.49 -26.16 66.61 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.289 -0.882 . . . . 0.0 111.936 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' B' ' 101' ' ' ARG . 12.1 mm-40 -69.08 -27.03 65.25 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.711 -1.243 . . . . 0.0 110.79 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -80.02 -19.95 46.51 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.907 0.483 . . . . 0.0 110.268 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -76.46 -45.51 30.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -61.06 -46.05 92.27 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.689 1.996 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' B' ' 97' ' ' GLU . 76.9 mtm180 -120.03 123.82 44.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.03 -38.94 3.03 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.0 m170 . . . . . 0 CA--C 1.502 -0.892 0 C-N-CA 123.922 0.889 . . . . 0.0 109.743 -173.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 102.456 -3.165 . . . . 0.0 102.456 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.75 156.46 16.32 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.81 -37.14 83.96 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.015 -1.053 . . . . 0.0 109.771 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -65.58 -26.12 67.71 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.435 -0.79 . . . . 0.0 112.151 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -77.75 -37.1 49.9 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -171.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.47 -42.41 99.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 110.569 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -70.45 -33.98 71.91 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.667 -0.645 . . . . 0.0 111.001 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.86 96.79 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -76.38 -20.42 57.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.124 -0.985 . . . . 0.0 112.141 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -70.61 -37.43 73.84 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.214 -0.929 . . . . 0.0 108.767 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.24 81.31 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.554 -0.717 . . . . 0.0 111.054 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' D' ' 76' ' ' LYS . 76.7 mt-10 -63.24 -36.98 85.46 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -64.52 -41.9 96.11 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 122.282 1.039 . . . . 0.0 108.655 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.15 -32.33 73.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.325 1.45 . . . . 0.0 109.711 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.48 -45.47 87.21 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.671 0.789 . . . . 0.0 110.682 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.81 -23.44 62.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.97 -1.081 . . . . 0.0 111.742 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -65.69 -46.63 78.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.75 . . . . 0.0 110.075 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.15 -25.98 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 121.068 -1.02 . . . . 0.0 110.758 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.66 -41.38 96.14 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.385 -0.822 . . . . 0.0 111.119 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.4 -33.39 67.12 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.955 0.902 . . . . 0.0 111.531 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -67.62 -45.8 74.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.032 0.933 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.98 62.52 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.072 1.349 . . . . 0.0 110.97 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p -67.16 -39.41 86.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 119.433 1.015 . . . . 0.0 110.275 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -44.22 93.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.604 1.162 . . . . 0.0 108.427 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -67.6 -39.31 84.77 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.563 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.75 87.7 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.676 1.19 . . . . 0.0 111.878 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.93 -31.16 49.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 O-C-N 120.87 -1.144 . . . . 0.0 110.029 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.25 -19.21 43.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.763 0.825 . . . . 0.0 110.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.22 14.43 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.736 1.614 . . . . 0.0 107.024 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -80.29 -0.86 38.38 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.98 0.895 . . . . 0.0 110.869 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -74.42 81.88 1.92 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.816 1.647 . . . . 0.0 110.084 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.1 19.68 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 139.13 54.3 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 121.322 -1.105 . . . . 0.0 108.113 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -79.22 136.28 12.67 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.355 2.036 . . . . 0.0 110.437 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 4.16 89.34 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 119.529 1.059 . . . . 0.0 111.971 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 129.11 20.17 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 126.896 2.078 . . . . 0.0 114.107 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.34 -38.02 11.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.992 0.901 . . . . 0.0 108.682 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.3 tp -89.27 125.35 35.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 pt -144.45 -22.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -80.22 150.42 30.1 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.726 -0.609 . . . . 0.0 111.894 -171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.46 -64.52 0.3 Allowed Pre-proline 0 C--N 1.35 0.62 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.198 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.86 -26.89 21.89 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 125.691 3.068 . . . . 0.0 109.936 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 -14.89 61.2 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.538 0.735 . . . . 0.0 109.723 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.39 85.15 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.147 -0.971 . . . . 0.0 110.439 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -72.65 -22.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 121.736 -0.603 . . . . 0.0 110.488 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -72.52 -31.08 65.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -74.87 -37.21 62.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.485 -1.385 . . . . 0.0 108.647 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -76.13 64.38 1.96 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.916 1.287 . . . . 0.0 108.594 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -144.95 -67.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.76 -23.29 66.69 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.689 1.196 . . . . 0.0 112.561 -167.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m -68.06 -37.28 81.1 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.567 1.547 . . . . 0.0 110.629 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.24 -24.42 51.18 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.549 -0.719 . . . . 0.0 110.138 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 6.9 p -90.98 9.33 31.09 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.778 -0.576 . . . . 0.0 109.796 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 48.63 60.73 3.48 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 126.823 2.049 . . . . 0.0 113.684 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.1 -87.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.91 76.38 1.3 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -73.85 -20.48 60.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.415 -1.05 . . . . 0.0 111.411 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.16 32.66 3.68 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.64 -53.42 22.63 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -147.0 169.02 20.08 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -148.14 148.92 30.99 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.92 163.11 18.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.125 3.217 . . . . 0.0 109.195 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.44 -102.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 120.437 1.471 . . . . 0.0 111.869 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -154.06 -30.73 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.622 -1.299 . . . . 0.0 109.61 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -101.26 11.74 38.77 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 120.2 -1.562 . . . . 0.0 108.786 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -44.01 88.04 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.74 86.28 1.62 Allowed Glycine 0 N--CA 1.416 -2.67 1 N-CA-C 98.033 -6.027 . . . . 0.0 98.033 -167.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -56.22 -20.04 16.45 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 125.642 1.577 . . . . 0.0 112.278 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -46.02 -28.22 1.12 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 126.677 1.991 . . . . 0.0 113.05 164.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.27 -43.94 95.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.849 -1.157 . . . . 0.0 109.682 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.48 62.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.344 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -51.2 -47.17 62.32 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.099 2.16 . . . . 0.0 111.116 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.37 -41.34 98.8 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.251 1.02 . . . . 0.0 111.329 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -41.41 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 C-N-CA 123.644 0.778 . . . . 0.0 109.635 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 37.6 mtt -58.99 -52.49 65.54 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.903 0.881 . . . . 0.0 110.299 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.58 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.09 82.87 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.412 -0.805 . . . . 0.0 111.403 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.86 -43.51 93.73 Favored Glycine 0 CA--C 1.494 -1.257 0 C-N-CA 124.202 0.906 . . . . 0.0 111.342 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.87 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 O-C-N 121.735 -0.862 . . . . 0.0 109.159 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.18 -47.6 84.72 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.492 -0.755 . . . . 0.0 111.956 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.49 -40.71 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.799 -0.563 . . . . 0.0 111.471 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.97 -38.48 61.66 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.678 0.672 . . . . 0.0 109.745 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.23 82.83 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.54 -36.42 69.24 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.4 -18.38 11.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.915 1.286 . . . . 0.0 111.043 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.6 m -59.23 -23.95 62.75 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.68 -1.887 . . . . 0.0 111.984 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.46 68.06 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.357 -1.465 . . . . 0.0 111.197 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.24 -52.35 7.84 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.33 -34.65 78.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.217 1.007 . . . . 0.0 113.537 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.76 -14.68 62.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.837 -1.164 . . . . 0.0 110.985 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 81.0 p -85.06 -11.16 55.94 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.55 -1.344 . . . . 0.0 110.855 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -17.55 61.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 119.243 0.929 . . . . 0.0 111.065 -169.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -82.24 -34.66 28.74 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.387 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 26.4 t -65.51 -35.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.463 1.505 . . . . 0.0 109.103 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -42.5 -34.89 0.92 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 128.21 2.604 . . . . 0.0 112.976 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -63.71 -27.05 68.94 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.056 -1.028 . . . . 0.0 111.836 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.51 -39.03 77.82 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.03 -36.01 61.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.627 -0.671 . . . . 0.0 109.852 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -69.6 -15.74 63.26 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.407 -0.808 . . . . 0.0 112.11 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -67.0 -31.47 72.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.43 -0.793 . . . . 0.0 110.616 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -74.63 -39.79 61.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.073 -1.017 . . . . 0.0 108.644 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.89 10.23 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 177.775 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.438 -1.075 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.68 140.48 49.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.613 1.197 . . . . 0.0 111.352 -166.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -74.05 -52.52 12.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.639 2.375 . . . . 0.0 108.513 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -58.89 -29.53 67.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 126.1 1.76 . . . . 0.0 112.686 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.1 -39.75 82.77 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.681 -0.637 . . . . 0.0 109.69 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -68.5 -36.21 78.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.71 -40.55 84.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.28 95.79 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.622 0.769 . . . . 0.0 111.919 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.33 -40.24 74.28 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 123.301 0.641 . . . . 0.0 110.566 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -61.69 -41.21 97.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.489 0.716 . . . . 0.0 110.28 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.21 70.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.117 0.967 . . . . 0.0 111.877 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 26.8 mt-10 -65.27 -37.14 86.28 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.669 -0.645 . . . . 0.0 111.655 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.81 -31.42 64.82 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -67.52 -35.25 78.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.703 0.801 . . . . 0.0 109.764 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.25 -38.41 90.95 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 111.645 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.43 -36.65 76.3 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.883 0.873 . . . . 0.0 110.756 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.46 -44.84 77.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.184 0.994 . . . . 0.0 110.058 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.02 -47.34 90.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.23 -38.36 85.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.923 -0.485 . . . . 0.0 110.455 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.58 -32.19 65.81 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.489 1.04 . . . . 0.0 113.343 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -69.18 -39.73 78.54 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 119.698 -1.877 . . . . 0.0 108.397 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -32.95 74.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -50.46 -52.08 41.29 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 125.769 1.627 . . . . 0.0 111.648 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -65.98 -34.71 78.73 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -84.48 -15.14 47.03 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.243 0.617 . . . . 0.0 110.972 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -44.61 65.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.513 1.125 . . . . 0.0 109.834 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.25 -40.39 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 122.371 1.081 . . . . 0.0 109.423 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.39 -29.81 68.6 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.954 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.92 92.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 125.189 1.396 . . . . 0.0 110.372 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -77.92 -6.32 53.96 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -76.41 90.62 3.25 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 119.9 -1.75 . . . . 0.0 107.188 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.94 -28.83 1.41 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.75 150.31 47.93 Favored Pre-proline 0 N--CA 1.443 -0.79 0 O-C-N 121.397 -1.061 . . . . 0.0 111.133 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.54 97.06 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.792 2.328 . . . . 0.0 112.723 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.35 -41.69 1.31 Allowed Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.23 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.526 2.331 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 72.81 -66.49 0.31 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.7 1.6 . . . . 0.0 112.401 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 49.4 tp -83.37 64.25 7.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.06 112.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 45.4 t -177.57 -141.72 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.9 -63.83 0.01 OUTLIER Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -72.53 -13.94 27.57 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 CA-C-N 125.541 3.015 . . . . 0.0 112.344 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -86.88 -11.06 51.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.04 85.51 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.596 0.758 . . . . 0.0 110.009 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.65 -41.97 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 109.522 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -38.91 83.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.204 -0.935 . . . . 0.0 109.865 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -66.07 -37.66 86.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.519 0.728 . . . . 0.0 110.499 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -36.53 71.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.077 -1.014 . . . . 0.0 109.808 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -54.65 -56.96 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 126.17 1.788 . . . . 0.0 109.578 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -71.66 -17.31 62.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 112.024 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -82.49 -37.01 25.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.691 -1.256 . . . . 0.0 109.237 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.93 73.36 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.422 -0.799 . . . . 0.0 110.739 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -95.44 11.91 31.2 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.683 0.793 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p 55.29 38.63 30.64 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.32 1.848 . . . . 0.0 112.035 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.02 -68.29 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.46 95.69 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.98 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -61.21 -32.73 72.5 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.542 1.163 . . . . 0.0 111.288 -169.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.35 39.31 0.15 Allowed Glycine 0 CA--C 1.48 -2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 165.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -90.91 -59.11 2.26 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 mtm-85 -138.07 164.85 28.08 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 158.01 36.57 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 -175.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 168.99 19.84 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.253 2.635 . . . . 0.0 109.829 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.57 -93.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.214 0.461 . . . . 0.0 110.292 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -137.73 -81.57 0.35 Allowed 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 129.0 38.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 61.25 -61.87 0.08 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 126.808 2.043 . . . . 0.0 115.566 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . -34.54 -49.63 0.71 Allowed Glycine 0 CA--C 1.488 -1.64 0 C-N-CA 128.917 3.151 . . . . 0.0 114.524 -170.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.221 0.608 . . . . 0.0 112.094 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -71.15 -32.68 69.24 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.609 0.764 . . . . 0.0 109.231 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.41 -51.45 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.09 89.28 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.606 1.162 . . . . 0.0 113.121 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -53.6 -42.32 67.55 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.22 2.208 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -67.55 -39.08 84.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.647 -0.658 . . . . 0.0 110.445 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.64 -48.08 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 O-C-N 121.622 -0.674 . . . . 0.0 110.059 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 21.1 ptp -65.82 -37.15 85.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.549 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . 0.519 ' HZ1' ' CD ' ' C' ' 12' ' ' GLU . 74.2 tttt -64.88 -41.34 95.71 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 121.467 -0.771 . . . . 0.0 110.678 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.154 0.582 . . . . 0.0 110.569 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.06 -46.21 93.89 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 123.633 0.635 . . . . 0.0 112.265 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.84 -43.64 92.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 124.026 0.931 . . . . 0.0 109.983 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -63.9 -41.5 97.68 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.01 -47.13 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 C-N-CA 124.204 1.002 . . . . 0.0 110.679 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -73.3 -10.79 60.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.407 -0.808 . . . . 0.0 111.186 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.81 14.11 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.82 0.848 . . . . 0.0 109.606 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.45 -33.05 74.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.419 1.887 . . . . 0.0 111.041 -174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.93 -7.64 2.11 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 112.724 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 40.3 m -62.01 -20.94 64.44 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.8 63.34 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.248 -1.532 . . . . 0.0 111.401 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.51 -53.72 4.82 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.236 1.014 . . . . 0.0 108.706 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.86 -36.96 70.64 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 124.486 1.114 . . . . 0.0 112.918 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 -22.54 61.49 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.008 -1.058 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 81.7 p -78.37 -17.56 56.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.325 -1.484 . . . . 0.0 109.813 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -69.98 -34.76 73.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.7 0.762 . . . . 0.0 109.453 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.96 -30.4 65.26 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.485 -1.385 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.76 -26.38 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 C-N-CA 124.284 1.033 . . . . 0.0 109.299 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -57.9 -14.92 7.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.83 1.252 . . . . 0.0 113.59 172.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -68.9 -38.56 79.68 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.394 1.092 . . . . 0.0 108.672 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -82.71 167.48 18.16 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 73.15 -51.03 0.71 Allowed 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.937 1.295 . . . . 0.0 111.169 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.68 -42.09 95.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 120.417 -1.427 . . . . 0.0 110.603 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -74.36 -16.96 60.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.374 -0.829 . . . . 0.0 112.129 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -128.85 82.89 2.11 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -170.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.49 -31.03 2.92 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.224 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.36 -70.94 0.67 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -170.97 -64.22 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.528 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 45.9 p-80 -61.88 -22.33 65.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.126 1.37 . . . . 0.0 113.449 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 18.4 mp0 -75.73 -22.04 56.94 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.546 -1.346 . . . . 0.0 110.224 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -66.77 -41.92 86.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -60.56 -47.51 85.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.43 96.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 111.545 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -61.23 -45.54 94.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 124.587 1.155 . . . . 0.0 109.493 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -61.57 -36.17 79.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.752 1.221 . . . . 0.0 110.179 -175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.41 72.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -66.95 -30.4 70.53 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.822 -1.174 . . . . 0.0 111.515 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.2 -26.04 55.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.312 -0.868 . . . . 0.0 109.872 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.41 -37.98 74.54 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.81 0.844 . . . . 0.0 109.371 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.36 -40.25 95.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.307 0.575 . . . . 0.0 110.917 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -63.53 -26.36 68.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.3 0.64 . . . . 0.0 112.058 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.83 -41.7 87.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.178 0.991 . . . . 0.0 109.333 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -39.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.524 1.129 . . . . 0.0 108.974 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.88 -42.29 84.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.299 1.04 . . . . 0.0 111.995 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.55 -23.45 58.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.107 0.963 . . . . 0.0 111.309 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.76 -32.27 19.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.789 -1.194 . . . . 0.0 108.348 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.21 73.68 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.525 1.53 . . . . 0.0 111.155 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.8 p -68.11 -39.68 82.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 118.716 0.689 . . . . 0.0 110.115 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -64.1 -49.1 73.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -63.94 -38.44 91.1 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.58 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 119.987 1.267 . . . . 0.0 111.431 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.14 -42.43 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.09 -19.58 59.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.152 -1.592 . . . . 0.0 112.002 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.5 -49.2 27.85 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.555 1.142 . . . . 0.0 108.443 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -58.52 -47.05 85.44 Favored 'General case' 0 CA--C 1.476 -1.9 0 C-N-CA 124.344 1.058 . . . . 0.0 110.646 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -63.45 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.17 0.988 . . . . 0.0 111.995 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.28 2.58 5.92 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.29 128.56 38.08 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 118.731 1.265 . . . . 0.0 108.771 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.44 146.01 17.04 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.402 2.068 . . . . 0.0 109.499 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.6 -18.88 47.71 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 118.972 0.805 . . . . 0.0 112.311 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.05 164.4 26.67 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.261 1.425 . . . . 0.0 112.888 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.04 2.44 3.63 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.18 0.592 . . . . 0.0 111.999 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 52.93 1.89 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 120.31 -1.494 . . . . 0.0 111.408 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -84.4 164.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.02 -1.675 . . . . 0.0 109.766 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.9 t 81.29 129.59 0.05 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.939 1.696 . . . . 0.0 110.686 166.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -67.39 -47.65 47.83 Favored Pre-proline 0 C--N 1.358 0.936 0 CA-C-O 116.213 -1.851 . . . . 0.0 112.152 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.26 -11.59 30.45 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 125.482 2.993 . . . . 0.0 111.892 -175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.63 -48.09 9.21 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.342 1.457 . . . . 0.0 107.248 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.29 74.05 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 125.103 1.361 . . . . 0.0 112.533 -174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.63 -30.39 48.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 O-C-N 121.685 -0.635 . . . . 0.0 111.145 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -33.34 55.68 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.777 -1.202 . . . . 0.0 108.967 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.0 -34.38 78.29 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.328 0.651 . . . . 0.0 110.297 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -56.3 -38.45 71.27 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 120.788 -1.195 . . . . 0.0 111.769 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.67 60.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -158.29 -36.37 0.07 Allowed 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -67.57 -33.78 75.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.825 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.27 -21.94 65.68 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.613 -1.305 . . . . 0.0 112.791 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.23 4.22 52.84 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.281 0.632 . . . . 0.0 109.97 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 p 48.46 47.31 20.29 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 127.139 2.176 . . . . 0.0 112.184 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.496 HG21 ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -100.37 -69.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.496 ' H ' HG21 ' A' ' 55' ' ' VAL . . . 85.63 72.87 1.29 Allowed Glycine 0 CA--C 1.492 -1.396 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -19.08 52.83 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.76 5.25 Favored Glycine 0 CA--C 1.486 -1.755 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -71.49 -46.09 60.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -132.01 165.2 24.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -140.09 130.8 14.08 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 100.804 -3.776 . . . . 0.0 100.804 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -86.11 176.22 5.26 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.721 2.947 . . . . 0.0 109.168 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.13 -142.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-O 123.103 1.43 . . . . 0.0 107.744 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 p -92.14 -43.63 9.25 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 119.657 -1.902 . . . . 0.0 111.094 -165.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.85 -29.56 70.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 127.799 2.44 . . . . 0.0 110.218 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.73 -24.65 67.63 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.71 2.004 . . . . 0.0 109.975 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.85 88.81 0.57 Allowed Glycine 0 CA--C 1.476 -2.366 1 N-CA-C 101.052 -4.819 . . . . 0.0 101.052 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.47 -17.81 2.26 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-O 123.291 1.519 . . . . 0.0 113.096 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -63.26 -14.68 52.18 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 125.071 1.348 . . . . 0.0 112.378 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.73 -45.01 99.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 CA-C-N 119.77 1.168 . . . . 0.0 108.592 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.72 67.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.837 -0.539 . . . . 0.0 110.046 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -48.84 -46.26 41.92 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.631 1.572 . . . . 0.0 110.908 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.73 -38.81 92.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.396 1.078 . . . . 0.0 111.725 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.97 -42.0 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 121.352 -0.842 . . . . 0.0 108.928 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.3 mtm -61.81 -46.07 91.11 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.103 0.561 . . . . 0.0 111.093 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -63.72 -38.66 91.93 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.812 -0.555 . . . . 0.0 110.953 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.19 90.91 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.937 0.495 . . . . 0.0 110.911 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.05 92.46 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 124.225 0.917 . . . . 0.0 111.104 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.91 -46.81 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.448 1.099 . . . . 0.0 109.14 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.33 -37.84 84.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 121.069 -1.02 . . . . 0.0 111.993 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.49 -56.65 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 109.598 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.1 -41.51 98.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.362 0.665 . . . . 0.0 110.835 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.7 -34.63 78.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.75 0.82 . . . . 0.0 111.113 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -66.64 -30.85 71.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.472 -1.392 . . . . 0.0 111.063 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.73 -12.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 110.829 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -58.35 -22.8 54.82 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.597 -1.939 . . . . 0.0 112.652 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.23 -24.99 61.12 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.893 -1.129 . . . . 0.0 111.685 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.83 -40.58 9.26 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.871 1.268 . . . . 0.0 110.969 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.7 -39.8 91.6 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.818 0.818 . . . . 0.0 111.126 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -28.05 62.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.008 -1.057 . . . . 0.0 110.984 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -71.89 -10.52 59.89 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.223 -1.548 . . . . 0.0 111.563 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.77 -38.51 86.72 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 122.235 1.016 . . . . 0.0 109.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -81.4 -11.83 59.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 119.355 -2.09 . . . . 0.0 112.967 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.36 -27.48 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.4 -27.36 47.22 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.56 1.544 . . . . 0.0 113.053 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -64.76 -21.32 66.74 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-O 122.038 0.923 . . . . 0.0 111.825 -172.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.2 -34.47 28.95 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 125.77 1.628 . . . . 0.0 108.223 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -91.26 -162.67 0.94 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 61.59 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.356 0.852 0 C-N-CA 127.209 2.203 . . . . 0.0 111.632 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -62.7 -39.06 92.81 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.977 2.511 . . . . 0.0 110.271 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -90.87 -1.46 57.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.858 -0.526 . . . . 0.0 109.902 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.11 70.08 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 124.97 1.271 . . . . 0.0 113.911 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.0 m80 . . . . . 0 CA--C 1.493 -1.236 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 -170.15 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 -112.63 0.03 OUTLIER 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -115.65 -69.98 0.82 Allowed 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.807 1.243 . . . . 0.0 108.102 -173.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.517 ' CE1' ' OE2' ' B' ' 5' ' ' GLU . 13.0 p-80 -61.69 -26.65 68.16 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 128.741 2.816 . . . . 0.0 112.039 -174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.517 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 8.9 mt-10 -75.04 -28.57 60.49 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.674 1.19 . . . . 0.0 110.348 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.88 -35.87 64.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.092 -1.005 . . . . 0.0 109.898 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.489 ' CD ' ' HZ1' ' B' ' 10' ' ' LYS . 2.1 tp10 -68.99 -31.18 69.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 122.011 0.91 . . . . 0.0 109.418 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.02 86.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.815 0.846 . . . . 0.0 110.67 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -71.96 -36.44 69.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.893 -0.505 . . . . 0.0 110.092 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.489 ' HZ1' ' CD ' ' B' ' 7' ' ' GLU . 26.9 ttpt -58.15 -35.99 72.35 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.415 1.486 . . . . 0.0 110.991 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.89 89.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.488 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.36 -36.62 83.36 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 120.928 -1.108 . . . . 0.0 110.658 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -66.5 -36.68 83.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.666 -0.646 . . . . 0.0 110.222 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -63.44 -42.92 98.69 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.785 1.234 . . . . 0.0 109.528 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.62 -37.21 72.91 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-O 121.804 0.811 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.8 -21.35 62.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.164 -0.96 . . . . 0.0 112.029 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -78.19 -30.28 48.91 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.15 -0.969 . . . . 0.0 108.883 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.32 -32.4 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 120.455 -1.403 . . . . 0.0 109.214 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.94 -36.55 77.29 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.217 -0.927 . . . . 0.0 111.949 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.27 -46.53 83.27 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.663 1.185 . . . . 0.0 109.782 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -70.61 -41.03 72.8 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 108.225 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 126.812 2.045 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 -49.96 75.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.145 1.378 . . . . 0.0 109.924 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -67.21 -46.42 73.93 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -61.69 -44.98 95.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.55 -53.15 52.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.72 -37.0 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -92.79 -1.05 57.12 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.887 -1.133 . . . . 0.0 110.895 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.72 -46.96 8.59 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.25 -24.47 59.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.954 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -74.48 108.83 7.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.198 -1.563 . . . . 0.0 111.242 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.96 -21.83 5.21 Favored Glycine 0 CA--C 1.495 -1.181 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.03 152.87 53.95 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.022 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.53 146.54 19.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.628 2.219 . . . . 0.0 110.492 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 34.87 89.47 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 124.092 0.853 . . . . 0.0 111.303 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 134.16 45.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.066 0.947 . . . . 0.0 109.474 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.34 -39.53 1.87 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.358 . . . . 0.0 109.87 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 tp -68.46 -33.29 73.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.956 . . . . 0.0 110.574 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 tt -41.47 76.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 1 C-N-CA 131.979 4.112 . . . . 0.0 116.94 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.84 136.11 7.81 Favored 'General case' 0 CA--C 1.494 -1.185 0 O-C-N 119.24 -2.162 . . . . 0.0 105.409 166.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -64.68 -54.21 38.08 Favored Pre-proline 0 C--N 1.349 0.559 0 CA-C-O 116.849 -1.548 . . . . 0.0 111.728 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.7 -16.87 23.56 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.007 2.824 . . . . 0.0 110.695 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -94.39 -22.9 18.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.62 76.43 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.092 1.357 . . . . 0.0 108.73 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.41 -27.55 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.197 0.522 . . . . 0.0 110.992 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.07 55.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -76.18 -33.58 59.31 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 123.37 0.668 . . . . 0.0 109.573 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -54.42 -29.77 50.32 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.955 -1.091 . . . . 0.0 112.042 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.01 -40.45 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 124.926 1.291 . . . . 0.0 110.356 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.95 -20.78 66.32 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.841 1.657 . . . . 0.0 112.139 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.07 -38.7 6.84 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -164.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -29.05 65.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.774 -1.204 . . . . 0.0 111.766 -170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -86.91 1.01 54.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.704 -0.623 . . . . 0.0 110.329 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.8 p 55.03 50.72 14.8 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 125.968 1.707 . . . . 0.0 110.984 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -103.44 -59.34 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.64 48.04 64.71 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 120.857 -1.152 . . . . 0.0 112.331 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -29.26 69.86 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.443 1.116 . . . . 0.0 112.393 -168.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.97 29.11 2.26 Favored Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.5 -63.94 0.96 Allowed 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.044 -0.68 . . . . 0.0 110.182 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -138.86 163.33 32.55 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -134.92 148.67 67.91 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.05 165.65 21.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 123.55 2.834 . . . . 0.0 110.421 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.91 -154.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -95.15 -54.52 3.4 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.546 1.138 . . . . 0.0 108.746 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.4 -4.7 46.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.576 1.551 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.17 -28.77 68.39 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.852 1.31 . . . . 0.0 107.817 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.38 87.5 1.02 Allowed Glycine 0 CA--C 1.479 -2.159 1 N-CA-C 101.074 -4.811 . . . . 0.0 101.074 -170.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -59.96 -12.0 6.93 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.235 1.518 . . . . 0.0 111.5 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -54.95 -17.93 4.35 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.469 1.908 . . . . 0.0 113.029 164.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -52.85 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 O-C-N 120.493 -1.38 . . . . 0.0 107.315 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.51 92.07 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.471 0.708 . . . . 0.0 110.633 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -49.76 -46.55 50.73 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.955 1.702 . . . . 0.0 111.235 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -62.95 -40.19 96.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.289 1.036 . . . . 0.0 111.301 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.62 -41.44 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.0 mtm -62.64 -45.67 91.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.383 0.673 . . . . 0.0 110.029 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.38 -36.35 83.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 121.502 -0.749 . . . . 0.0 111.364 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.89 89.08 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.48 0.712 . . . . 0.0 110.669 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.16 -45.15 92.6 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.59 -42.78 89.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 C-N-CA 124.109 0.964 . . . . 0.0 109.706 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -60.42 -42.78 96.74 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.078 -1.014 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 t -64.81 -52.35 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.389 1.076 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.63 -13.63 61.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 121.597 -0.689 . . . . 0.0 111.528 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.34 -36.87 14.4 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.327 -0.858 . . . . 0.0 109.88 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.1 -33.19 74.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.038 1.335 . . . . 0.0 110.41 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.06 -10.32 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 121.491 -0.756 . . . . 0.0 112.3 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -58.66 -18.89 34.5 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.871 1.669 . . . . 0.0 110.618 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.62 -65.07 0.63 Allowed 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.709 -1.245 . . . . 0.0 109.673 165.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.472 ' HA ' ' HD2' ' B' ' 4' ' ' HIS . . . -68.67 -42.03 78.45 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 120.775 -1.203 . . . . 0.0 111.3 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.5 -33.93 76.1 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.357 0.663 . . . . 0.0 111.195 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.03 -23.86 33.05 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.436 -1.415 . . . . 0.0 110.784 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.5 m -69.04 -21.81 64.08 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.293 -1.505 . . . . 0.0 108.392 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.28 -39.96 84.59 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.184 -0.947 . . . . 0.0 110.843 -164.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -65.73 -23.99 66.87 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.441 -0.787 . . . . 0.0 112.774 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -79.04 -20.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -68.01 -16.23 63.95 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.496 -1.377 . . . . 0.0 110.377 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -67.38 -2.0 5.57 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.824 -0.548 . . . . 0.0 112.422 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -55.36 -50.15 70.44 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 120.917 -1.114 . . . . 0.0 110.085 163.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.8 -34.89 51.92 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -172.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.13 -33.44 75.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.42 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -65.09 -42.0 94.46 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.207 -0.933 . . . . 0.0 110.998 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -83.92 -26.61 29.18 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 121.692 -0.63 . . . . 0.0 109.982 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.75 15.12 66.24 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 175.253 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.42 58.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 46.01 50.86 11.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 128.912 2.885 . . . . 0.0 110.178 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.461 ' CD2' HG23 ' C' ' 91' ' ' THR . 34.2 p80 -174.07 -50.24 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -69.07 -39.32 79.16 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.976 1.31 . . . . 0.0 110.518 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -54.7 -51.85 64.26 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.762 2.025 . . . . 0.0 110.733 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -75.05 -30.28 60.97 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.34 93.7 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.929 -1.107 . . . . 0.0 111.256 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -71.04 -36.67 72.43 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.609 -0.682 . . . . 0.0 110.886 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.1 -38.03 89.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.86 0.864 . . . . 0.0 110.548 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.3 86.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.499 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.41 -40.32 86.31 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.251 0.62 . . . . 0.0 110.813 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -70.34 -22.83 62.76 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.537 -0.727 . . . . 0.0 111.937 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.26 -32.2 58.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.113 -0.992 . . . . 0.0 108.683 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.48 -40.22 95.27 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.622 -0.674 . . . . 0.0 110.443 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -58.44 -38.31 77.23 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 112.048 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -66.66 -42.26 86.91 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.96 -40.34 85.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 124.39 1.076 . . . . 0.0 109.515 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.24 -42.65 77.69 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 124.124 0.969 . . . . 0.0 112.571 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.22 -42.84 75.17 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.413 -0.804 . . . . 0.0 110.058 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.45 -36.02 73.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.52 0.728 . . . . 0.0 109.607 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.39 83.67 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 126.191 1.796 . . . . 0.0 111.35 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 24.1 m -64.8 -39.24 93.26 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.495 0.718 . . . . 0.0 110.761 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -71.28 -44.4 65.29 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -68.35 -45.66 72.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.543 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.32 94.41 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 120.041 1.292 . . . . 0.0 111.532 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.51 -41.09 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 121.564 -0.71 . . . . 0.0 109.934 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.47 -22.78 43.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.342 -0.849 . . . . 0.0 110.146 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.3 71.78 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 125.026 1.33 . . . . 0.0 109.147 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.22 -23.81 62.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.256 0.622 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -71.07 87.61 0.77 Allowed 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.61 1.85 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.35 141.72 57.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 117.511 0.655 . . . . 0.0 111.483 -168.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 134.45 7.51 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 122.149 1.899 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.79 19.84 60.79 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.69 140.19 56.77 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 109.971 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.6 -42.82 3.39 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -83.72 17.37 2.31 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.4 1.88 . . . . 0.0 110.523 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -75.48 76.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.054 1.407 . . . . 0.0 110.183 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.8 m -143.3 -123.38 0.09 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . 0.28 1.5 t80 173.56 -58.12 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.91 0 C-N-CA 128.755 2.822 . . . . 0.0 106.557 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.04 -18.21 31.22 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 CA-C-N 126.451 3.34 . . . . 0.0 112.838 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.483 ' CG ' HH12 ' C' ' 60' ' ' ARG . 31.3 p30 -106.1 14.97 27.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 119.398 0.999 . . . . 0.0 109.007 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.06 -35.87 66.78 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.937 -1.102 . . . . 0.0 108.761 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.28 -29.32 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 123.57 0.748 . . . . 0.0 110.162 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -64.32 -45.83 86.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.895 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -69.41 -37.1 77.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.971 0.908 . . . . 0.0 108.919 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -56.26 -44.02 79.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.27 1.028 . . . . 0.0 111.538 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -68.94 -38.98 79.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 O-C-N 120.739 -1.226 . . . . 0.0 111.73 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.17 -30.01 68.14 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 120.138 1.335 . . . . 0.0 110.861 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -61.23 -43.72 98.42 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.645 1.178 . . . . 0.0 109.866 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.42 65.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.945 -1.097 . . . . 0.0 112.26 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -87.26 4.19 43.66 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.419 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.2 p 57.63 29.32 17.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.426 1.49 . . . . 0.0 112.655 169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -85.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 176.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.1 86.12 0.74 Allowed Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -73.44 -22.25 60.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.001 -1.294 . . . . 0.0 109.343 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 35.57 2.86 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.73 -47.74 51.78 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.483 HH12 ' CG ' ' C' ' 43' ' ' ASP . 69.6 mtt180 -140.98 173.44 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.39 148.85 21.61 Favored Pre-proline 0 N--CA 1.435 -1.217 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.54 171.26 12.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.888 3.059 . . . . 0.0 109.14 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.6 -109.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 119.392 0.996 . . . . 0.0 112.271 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 45.0 m -150.22 -40.53 0.13 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -82.78 -6.35 59.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.447 0.699 . . . . 0.0 110.007 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -31.84 66.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.23 56.47 0.93 Allowed Glycine 0 CA--C 1.472 -2.595 0 N-CA-C 104.564 -3.414 . . . . 0.0 104.564 167.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -22.22 -21.28 0.0 OUTLIER 'General case' 0 C--N 1.366 1.325 1 C-N-CA 134.048 4.939 . . . . 0.0 118.947 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -19.16 5.74 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 119.625 -1.922 . . . . 0.0 112.751 159.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.84 -45.67 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 119.549 1.068 . . . . 0.0 109.577 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -47.71 58.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.504 -0.747 . . . . 0.0 109.205 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.61 -47.95 58.07 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 124.757 1.223 . . . . 0.0 110.771 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -67.35 -33.87 76.15 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.94 -0.475 . . . . 0.0 111.716 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.02 -44.22 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 121.33 -0.856 . . . . 0.0 109.01 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 67.0 mtm -63.5 -46.8 84.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.25 1.02 . . . . 0.0 110.027 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -64.5 -40.7 96.14 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.51 0.724 . . . . 0.0 110.814 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.27 84.03 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.456 0.702 . . . . 0.0 111.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.2 -48.15 77.74 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -58.43 -46.41 89.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 124.532 1.133 . . . . 0.0 109.842 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -59.55 -45.14 92.66 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.909 0.884 . . . . 0.0 111.19 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.91 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.568 1.147 . . . . 0.0 109.966 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -66.39 -37.46 85.3 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.636 -0.665 . . . . 0.0 110.815 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.16 73.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.754 0.822 . . . . 0.0 110.596 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.46 -34.03 73.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.892 1.277 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.88 -12.05 3.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 125.433 1.493 . . . . 0.0 111.43 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -59.38 -25.66 64.45 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 112.449 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 -23.92 66.96 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-O 122.601 1.191 . . . . 0.0 111.618 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.73 -30.39 20.36 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.531 -1.355 . . . . 0.0 109.791 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.82 -49.86 13.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.888 0.851 . . . . 0.0 110.698 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.42 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.954 -1.091 . . . . 0.0 112.34 -170.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.461 HG23 ' CD2' ' C' ' 4' ' ' HIS . 13.0 t -72.86 -12.57 61.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 120.325 -1.485 . . . . 0.0 110.239 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -88.34 3.16 50.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.531 1.059 . . . . 0.0 110.531 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -34.65 18.69 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 160.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.01 -29.74 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 O-C-N 121.059 -1.025 . . . . 0.0 110.434 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -61.24 -14.21 24.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -64.92 -32.27 73.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.101 -0.999 . . . . 0.0 110.689 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -73.23 -34.88 66.13 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.269 0.941 . . . . 0.0 108.782 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.02 -46.89 82.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 109.606 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -70.84 -38.66 73.22 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.855 -0.528 . . . . 0.0 110.749 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -57.31 -41.88 80.72 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.721 1.208 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -73.51 -29.02 62.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.759 -0.588 . . . . 0.0 111.014 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.23 50.07 Favored Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 . . . . . 0 CA--C 1.493 -1.25 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.029 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 170.63 18.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.84 -59.55 2.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 131.118 3.767 . . . . 0.0 108.466 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.507 ' CD2' HG22 ' D' ' 91' ' ' THR . 24.5 p80 -60.1 -33.14 71.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.79 2.836 . . . . 0.0 112.011 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.05 -36.19 81.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.09 0.956 . . . . 0.0 109.862 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtp-105 -71.07 -38.35 72.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.423 -0.798 . . . . 0.0 110.511 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.22 -26.25 61.07 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.81 79.52 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.757 -1.214 . . . . 0.0 110.801 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -68.34 -29.38 68.1 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.216 -0.928 . . . . 0.0 111.708 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -64.1 -42.62 96.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 109.691 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.77 88.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.721 0.808 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.31 -38.38 83.5 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.787 -0.57 . . . . 0.0 111.717 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.97 -36.72 78.2 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.43 -26.77 67.38 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.316 -0.865 . . . . 0.0 110.799 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.21 -36.47 77.3 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 120.944 -1.097 . . . . 0.0 111.06 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -64.16 -31.91 73.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.196 0.999 . . . . 0.0 110.865 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.04 1.336 . . . . 0.0 110.109 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.6 -33.45 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.98 -40.65 89.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.685 0.794 . . . . 0.0 110.91 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.3 -43.2 78.19 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.176 0.591 . . . . 0.0 111.192 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.18 -38.99 86.33 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.95 75.55 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 124.607 1.163 . . . . 0.0 111.438 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -60.05 -46.74 88.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.163 0.892 . . . . 0.0 111.364 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -68.86 -51.72 37.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.927 1.691 . . . . 0.0 108.207 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -68.88 -43.83 74.51 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.942 0.897 . . . . 0.0 110.309 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.24 75.14 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 119.555 1.07 . . . . 0.0 110.72 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.55 -36.14 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.746 0.784 . . . . 0.0 109.314 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.49 -22.8 54.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 121.429 -0.794 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.64 -36.65 83.5 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 126.271 1.828 . . . . 0.0 110.486 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.72 -16.03 60.21 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.412 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -85.63 85.12 7.43 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.281 -1.512 . . . . 0.0 107.636 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.92 -33.66 0.56 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 105.117 -3.193 . . . . 0.0 105.117 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.37 149.16 57.47 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 124.225 1.01 . . . . 0.0 111.565 -171.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.82 97.89 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.888 2.392 . . . . 0.0 113.528 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.32 47.74 0.45 Allowed Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.61 0.23 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.572 1.149 . . . . 0.0 113.494 -169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.98 -59.34 1.93 Allowed 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 109.64 -169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.456 HD11 ' CD2' ' D' ' 47' ' ' TRP . 3.4 tt -84.55 63.07 7.67 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.7 tt -96.23 -6.08 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.116 -1.615 . . . . 0.0 109.082 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -88.57 120.98 30.47 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.672 0.789 . . . . 0.0 111.687 -171.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -74.4 -59.14 1.68 Allowed Pre-proline 0 C--N 1.353 0.73 0 CA-C-O 116.05 -1.929 . . . . 0.0 112.506 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.45 -14.13 30.69 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 CA-C-N 125.941 3.157 . . . . 0.0 110.906 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.31 -11.7 42.68 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 124.196 0.998 . . . . 0.0 109.471 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.2 67.32 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 120.872 -1.143 . . . . 0.0 110.384 -170.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -16.24 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.061 1.41 . . . . 0.0 109.225 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -76.64 -51.85 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 119.794 -1.816 . . . . 0.0 106.566 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.456 ' CD2' HD11 ' D' ' 38' ' ' LEU . 74.4 t90 -55.44 -46.12 76.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.117 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -64.82 -16.91 63.73 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.17 -50.97 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.07 65.64 9.19 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -159.55 -52.64 0.06 Allowed 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -18.45 64.94 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.43 -0.794 . . . . 0.0 112.042 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -87.06 -3.6 59.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.116 1.766 . . . . 0.0 111.057 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 56.15 38.4 29.82 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 125.544 1.538 . . . . 0.0 111.149 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.61 -37.58 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 121.771 -0.581 . . . . 0.0 110.905 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.34 -81.61 0.29 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.08 142.03 52.7 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.75 34.55 0.68 Allowed Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.21 -59.86 0.5 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.288 2.235 . . . . 0.0 109.011 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -97.28 156.24 16.52 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -142.55 148.26 46.14 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -80.36 167.77 19.02 Favored 'Trans proline' 0 CA--C 1.503 -1.057 0 C-N-CA 122.59 2.193 . . . . 0.0 110.266 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.513 HG13 ' H ' ' D' ' 64' ' ' THR . 4.1 t -97.56 -150.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 174.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.513 ' H ' HG13 ' D' ' 63' ' ' VAL . 4.6 p -91.23 -60.09 1.99 Allowed 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.755 -1.84 . . . . 0.0 112.541 -162.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -75.07 129.73 38.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 58.08 -104.78 0.23 Allowed 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.35 -82.19 0.0 OUTLIER Glycine 0 C--N 1.357 1.705 0 C-N-CA 130.006 3.669 . . . . 0.0 112.579 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -72.13 -32.53 67.02 Favored 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 126.074 1.75 . . . . 0.0 112.025 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.5 -24.11 65.54 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.155 1.343 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -78.8 -50.58 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.9 -39.7 71.98 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 111.919 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.88 -48.89 21.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 128.497 2.719 . . . . 0.0 112.055 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.69 -38.35 76.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.428 0.691 . . . . 0.0 110.132 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.12 -45.03 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 C-N-CA 124.181 0.993 . . . . 0.0 109.39 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -61.7 -45.64 93.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.298 1.039 . . . . 0.0 110.867 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.21 -41.59 93.36 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 110.857 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -36.72 84.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.388 0.675 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.64 64.12 Favored Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 123.979 0.799 . . . . 0.0 111.297 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.62 -46.36 90.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 124.203 1.001 . . . . 0.0 109.768 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -61.87 -30.52 70.92 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.421 1.088 . . . . 0.0 113.046 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 t -74.31 -50.43 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.56 -44.15 97.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.453 0.701 . . . . 0.0 109.999 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.33 -23.32 63.77 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.929 0.891 . . . . 0.0 111.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.89 -30.63 68.12 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.147 -1.595 . . . . 0.0 109.355 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -61.83 -13.42 9.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.411 1.084 . . . . 0.0 110.385 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.5 m -58.89 -20.68 53.64 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 119.537 -1.977 . . . . 0.0 112.596 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.37 68.5 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.983 -1.698 . . . . 0.0 111.445 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.15 -35.97 19.82 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.14 0.976 . . . . 0.0 109.643 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 mt -73.16 -44.75 59.5 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.426 0.631 . . . . 0.0 112.197 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.19 70.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.835 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.507 HG22 ' CD2' ' D' ' 4' ' ' HIS . 9.0 t -73.31 -6.48 46.38 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.067 -1.021 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.82 -14.62 58.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.692 1.133 . . . . 0.0 110.739 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -33.1 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 119.842 1.201 . . . . 0.0 108.726 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.97 -29.12 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.294 1.038 . . . . 0.0 109.594 -174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -68.39 -12.08 60.6 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.335 -0.853 . . . . 0.0 111.793 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -61.62 -37.12 82.79 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.265 1.031 . . . . 0.0 110.146 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.03 -27.29 48.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 119.862 -1.774 . . . . 0.0 109.572 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -83.31 -29.4 28.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.617 -0.677 . . . . 0.0 109.624 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.56 -44.36 76.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.888 2.075 . . . . 0.0 109.494 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -58.79 -25.7 63.36 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 124.909 1.284 . . . . 0.0 112.658 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -72.05 -49.03 39.98 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.81 -8.78 54.78 Favored Glycine 0 CA--C 1.493 -1.294 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 m80 . . . . . 0 CA--C 1.505 -0.753 0 C-N-CA 125.849 1.659 . . . . 0.0 108.331 -173.025 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 121.701 0.763 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.37 -93.21 0.1 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.11 -71.97 0.4 Allowed 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.1 -23.96 67.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -75.82 -26.42 57.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 109.624 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -64.89 -44.99 87.85 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.32 1.048 . . . . 0.0 108.445 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.21 -40.54 90.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.033 1.333 . . . . 0.0 109.781 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.54 91.72 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 110.844 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.51 -28.14 64.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.62 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -68.49 -34.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.9 90.35 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.343 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.82 -31.9 73.0 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.394 -0.816 . . . . 0.0 111.975 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.93 -41.45 97.63 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.96 0.904 . . . . 0.0 109.392 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -65.74 -34.33 77.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.499 1.119 . . . . 0.0 109.63 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.28 -44.91 94.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.738 0.815 . . . . 0.0 111.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -62.77 -38.21 89.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.238 0.542 . . . . 0.0 111.082 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.18 -37.66 88.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.926 0.89 . . . . 0.0 110.363 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.98 -41.62 84.75 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 C-N-CA 124.127 0.971 . . . . 0.0 108.885 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.2 -45.01 79.98 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.941 0.896 . . . . 0.0 111.802 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -75.2 -24.74 57.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.945 0.898 . . . . 0.0 111.285 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -81.0 -37.93 28.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.63 76.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.459 1.504 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -66.76 -39.7 87.98 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 119.394 0.997 . . . . 0.0 109.79 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.14 -48.45 70.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.733 -0.604 . . . . 0.0 110.174 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -60.81 -48.44 81.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 121.399 -0.813 . . . . 0.0 110.381 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.81 80.15 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.272 1.429 . . . . 0.0 111.903 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.3 -43.45 98.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 O-C-N 121.281 -0.887 . . . . 0.0 110.356 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.36 -29.3 57.14 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.352 -0.843 . . . . 0.0 110.46 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.0 71.76 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.479 1.512 . . . . 0.0 108.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 3.3 tp10 -69.9 -28.63 65.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.064 1.345 . . . . 0.0 110.819 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -67.03 107.3 2.22 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.341 -1.474 . . . . 0.0 110.746 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.62 -13.24 32.74 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.15 150.9 72.15 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 118.264 1.032 . . . . 0.0 109.483 -171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 36' ' ' ALA . 57.5 Cg_endo -78.03 148.67 24.93 Favored 'Trans proline' 0 CA--C 1.505 -0.938 0 C-N-CA 122.827 2.351 . . . . 0.0 108.871 175.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.63 -25.92 5.52 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 119.855 1.207 . . . . 0.0 111.645 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -38.31 135.6 0.73 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 131.282 3.833 . . . . 0.0 115.565 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.48 -29.23 1.22 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.113 0.965 . . . . 0.0 110.532 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.01 51.87 1.85 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.094 1.757 . . . . 0.0 110.984 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 tt -108.67 73.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 119.131 -2.23 . . . . 0.0 109.924 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 t -174.7 137.31 0.46 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -66.8 -53.14 29.07 Favored Pre-proline 0 C--N 1.351 0.647 0 CA-C-O 115.611 -2.138 . . . . 0.0 112.652 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -69.78 -20.57 34.59 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 125.568 3.024 . . . . 0.0 113.126 -170.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.278 0.6 OUTLIER -103.04 -12.27 17.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 119.541 1.064 . . . . 0.0 110.34 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.89 -31.53 63.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 120.546 -1.346 . . . . 0.0 110.867 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tp -67.26 -32.47 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -33.95 68.32 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.534 -1.353 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -67.04 -38.62 86.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.657 1.218 . . . . 0.0 108.981 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -60.0 -43.53 95.13 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.56 1.144 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.61 -49.85 79.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 124.275 1.03 . . . . 0.0 110.415 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.61 -17.03 62.3 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.683 -0.636 . . . . 0.0 111.605 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m -80.14 -38.59 31.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.672 -0.642 . . . . 0.0 109.697 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.8 67.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.844 -1.16 . . . . 0.0 111.528 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -86.19 6.82 27.62 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.9 0.48 . . . . 0.0 110.121 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p 50.08 54.13 11.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.587 1.955 . . . . 0.0 112.584 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 56' ' ' GLY . 8.2 p -116.99 -77.42 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.459 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 73.05 85.06 0.23 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -74.39 -14.82 60.92 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.664 -1.492 . . . . 0.0 111.061 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 32.08 3.88 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.5 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 49.0 t0 -73.28 -48.97 30.27 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.5 ' HE ' ' CG ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -136.85 169.83 17.1 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.32 146.56 33.56 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.89 -172.61 1.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 124.61 3.54 . . . . 0.0 109.432 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.509 HG23 ' H ' ' A' ' 64' ' ' THR 0.253 13.3 p -129.02 -146.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 63' ' ' VAL . 18.9 m -100.63 -49.97 4.03 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.562 1.545 . . . . 0.0 107.946 -172.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -79.4 -12.27 59.91 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.452 0.701 . . . . 0.0 111.179 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -63.78 -30.36 71.47 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 122.931 1.348 . . . . 0.0 107.649 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.55 81.14 1.49 Allowed Glycine 0 CA--C 1.469 -2.794 1 N-CA-C 99.601 -5.4 . . . . 0.0 99.601 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.456 HH22 ' CG ' ' D' ' 59' ' ' ASP . 12.0 ttm180 -59.18 -8.04 1.42 Allowed 'General case' 0 C--N 1.362 1.144 0 CA-C-O 123.238 1.494 . . . . 0.0 112.929 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -60.17 -15.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 120.144 -1.597 . . . . 0.0 113.171 164.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.91 -50.53 74.64 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-N 120.688 1.585 . . . . 0.0 107.367 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.86 -47.21 83.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.311 0.644 . . . . 0.0 111.798 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.89 -45.86 71.22 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.096 1.358 . . . . 0.0 110.728 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -33.6 75.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.909 0.884 . . . . 0.0 111.539 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.43 -49.31 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.4 ptp -65.68 -38.31 88.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 122.01 -0.431 . . . . 0.0 110.332 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -65.14 -38.05 89.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.484 -0.76 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.59 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.315 0.646 . . . . 0.0 110.702 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -44.56 97.55 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.405 1.002 . . . . 0.0 110.71 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.93 -44.17 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 121.894 -0.768 . . . . 0.0 109.294 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.36 -47.43 85.9 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.068 -1.02 . . . . 0.0 112.02 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.83 -39.2 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 O-C-N 121.719 -0.613 . . . . 0.0 111.202 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.69 -39.04 64.67 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.687 0.676 . . . . 0.0 109.387 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.29 73.86 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 121.455 -0.778 . . . . 0.0 111.172 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.77 -36.22 76.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.296 1.438 . . . . 0.0 111.267 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.84 -12.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 125.202 1.401 . . . . 0.0 111.198 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -58.99 -21.52 59.05 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.762 -1.836 . . . . 0.0 111.58 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.92 -26.51 68.84 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 120.815 -1.178 . . . . 0.0 112.15 172.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.54 -47.65 11.1 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.19 -40.58 94.45 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.079 0.951 . . . . 0.0 113.342 -170.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -16.5 63.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.102 -0.999 . . . . 0.0 111.616 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.6 p -87.59 -12.51 45.45 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.89 -1.131 . . . . 0.0 110.641 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -76.26 -17.48 59.45 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -166.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HA ' ' CE1' ' B' ' 4' ' ' HIS . 4.5 p90 -81.36 -31.64 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.962 -1.086 . . . . 0.0 110.379 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -71.54 -22.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 125.904 1.682 . . . . 0.0 109.025 -169.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -53.85 -24.04 14.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.362 1.465 . . . . 0.0 112.585 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -65.91 -16.16 63.61 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 120.221 -1.55 . . . . 0.0 112.029 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -68.03 -30.6 69.87 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.018 0.913 . . . . 0.0 109.494 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.59 -48.03 50.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -64.85 -35.56 81.52 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 125.644 1.578 . . . . 0.0 110.984 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.98 -43.62 86.65 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.39 1.476 . . . . 0.0 111.216 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -97.71 -20.42 17.61 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.978 0.911 . . . . 0.0 110.128 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.32 61.67 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -171.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 t60 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.21 162.18 33.27 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.118 0.961 . . . . 0.0 109.008 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -70.43 -26.0 63.47 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.404 -171.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.521 ' CE1' ' HA ' ' A' ' 93' ' ' PHE . 31.8 m170 -76.32 -21.45 56.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.897 -1.127 . . . . 0.0 110.98 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -81.59 -48.08 12.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -64.14 -40.22 95.69 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.405 -0.809 . . . . 0.0 112.198 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.46 -27.46 60.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.43 71.71 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.432 -0.792 . . . . 0.0 109.844 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.38 -37.55 86.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.759 0.824 . . . . 0.0 111.075 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -64.43 -37.16 86.55 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.409 0.683 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -29.46 70.8 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.477 -0.764 . . . . 0.0 111.208 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -67.33 -30.12 69.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.109 -0.994 . . . . 0.0 111.528 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.4 -28.45 61.09 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.79 -1.194 . . . . 0.0 110.141 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.38 -42.76 95.98 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.227 1.011 . . . . 0.0 109.138 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.6 -40.53 97.22 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.459 -0.776 . . . . 0.0 110.749 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -67.44 -27.31 66.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -69.5 -43.88 72.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.485 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.11 -35.31 74.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 123.921 0.889 . . . . 0.0 109.34 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.9 mt -53.82 -53.95 45.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 123.938 0.895 . . . . 0.0 109.73 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -66.89 -32.86 74.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.782 -0.574 . . . . 0.0 111.944 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.18 -51.7 50.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.843 0.83 . . . . 0.0 109.535 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.53 83.43 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.991 0.916 . . . . 0.0 111.388 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -63.57 -40.14 96.2 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 123.61 0.764 . . . . 0.0 110.852 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -63.93 -40.39 96.35 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -68.73 -40.65 79.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.384 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.69 67.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.911 1.684 . . . . 0.0 113.086 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.87 -25.49 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.801 0.81 . . . . 0.0 111.721 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.17 -36.2 13.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.04 -50.67 63.38 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.698 1.999 . . . . 0.0 110.187 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.18 56.46 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.375 -0.828 . . . . 0.0 109.98 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -138.61 101.85 4.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.04 -2.1 38.18 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.16 64.74 Favored Pre-proline 0 N--CA 1.442 -0.844 0 O-C-N 121.586 -0.95 . . . . 0.0 109.658 -172.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.45 113.07 2.56 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.366 2.71 . . . . 0.0 112.423 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.0 23.86 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.31 163.15 17.86 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.56 -25.9 0.27 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.33 52.0 2.26 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.65 1.214 . . . . 0.0 108.718 -172.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 43.8 pt -80.06 27.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 124.932 1.293 . . . . 0.0 111.1 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -122.34 142.5 50.44 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.89 -1.131 . . . . 0.0 109.429 -168.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.73 -62.02 0.23 Allowed Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-O 116.937 -1.506 . . . . 0.0 110.198 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.14 -12.55 23.44 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 CA-C-N 125.496 2.998 . . . . 0.0 111.659 -172.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -87.72 -8.85 55.53 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.26 99.43 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 121.687 -0.633 . . . . 0.0 110.016 -173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.54 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.028 0.531 . . . . 0.0 110.338 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -20.47 55.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 120.713 -1.242 . . . . 0.0 111.877 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -75.85 -53.48 8.39 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 m -54.82 -33.1 61.19 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.7 t -56.75 -48.76 80.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 124.281 1.032 . . . . 0.0 110.584 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.63 -16.43 55.82 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 119.798 1.181 . . . . 0.0 111.795 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -65.71 -42.17 91.44 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 109.318 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -29.14 68.77 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 123.353 0.661 . . . . 0.0 111.416 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.0 p -87.17 -0.75 57.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 16.6 p 54.44 33.89 19.7 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.759 1.624 . . . . 0.0 110.806 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.89 -60.76 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 103.255 -2.868 . . . . 0.0 103.255 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 50.13 64.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.03 -41.3 91.12 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 118.095 0.948 . . . . 0.0 108.628 -171.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.68 -111.05 0.46 Allowed Glycine 0 CA--C 1.471 -2.713 0 N-CA-C 103.398 -3.881 . . . . 0.0 103.398 172.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.8 t0 76.5 -72.55 0.1 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.184 0.993 . . . . 0.0 109.741 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.62 167.42 19.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.64 128.31 13.52 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -88.07 161.38 7.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.027 2.485 . . . . 0.0 109.708 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.348 14.6 p -96.71 -126.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -119.87 -38.86 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.864 1.666 . . . . 0.0 109.266 -170.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -93.04 5.45 51.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.718 0.807 . . . . 0.0 109.976 -168.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.11 38.11 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.63 73.87 1.27 Allowed Glycine 0 CA--C 1.469 -2.832 1 N-CA-C 101.444 -4.662 . . . . 0.0 101.444 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -48.26 -8.02 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 130.293 3.437 . . . . 0.0 114.738 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -48.22 -26.34 1.91 Allowed 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 127.015 2.126 . . . . 0.0 112.804 154.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.95 -48.18 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 125.022 1.329 . . . . 0.0 108.826 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.26 60.64 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 109.886 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -49.76 -46.65 50.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 127.856 2.462 . . . . 0.0 109.961 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -61.67 -43.9 97.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.086 0.954 . . . . 0.0 111.019 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.25 -43.84 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -61.39 -51.76 67.44 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.05 0.54 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -66.39 -35.57 80.66 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.822 -0.549 . . . . 0.0 110.094 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.3 93.64 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.608 -0.683 . . . . 0.0 110.836 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.53 -48.79 79.26 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.98 -48.11 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.808 1.243 . . . . 0.0 109.943 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.28 -33.79 76.81 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.638 -1.289 . . . . 0.0 111.947 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.82 -49.51 68.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.553 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -66.82 -22.78 66.0 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.381 0.672 . . . . 0.0 111.135 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.12 -39.42 25.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.33 -34.36 76.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.676 1.191 . . . . 0.0 111.312 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 m -66.25 -7.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 121.442 -0.786 . . . . 0.0 112.124 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 72.2 m -59.19 -22.03 60.36 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.128 1.371 . . . . 0.0 111.085 171.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.19 68.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 118.852 -2.405 . . . . 0.0 112.382 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.99 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.5 -35.72 72.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.232 1.413 . . . . 0.0 112.45 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.434 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . . . -71.38 -16.94 62.43 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 121.005 -1.06 . . . . 0.0 112.011 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -76.53 -24.51 53.65 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.7 -9.14 59.3 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.813 -1.179 . . . . 0.0 110.327 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' B' ' 90' ' ' ALA . 3.1 m-30 -73.82 -34.43 64.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.55 1.14 . . . . 0.0 108.423 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.29 -31.76 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 125.101 1.36 . . . . 0.0 108.457 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -62.99 -5.11 2.63 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.214 -0.929 . . . . 0.0 112.829 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -64.78 -23.29 67.2 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.6 -33.67 41.4 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -86.68 177.0 7.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 64.93 -63.63 0.18 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.817 2.047 . . . . 0.0 112.96 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -70.78 -36.24 72.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.665 1.586 . . . . 0.0 109.441 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -116.76 143.66 45.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 102.077 -3.305 . . . . 0.0 102.077 168.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.09 -27.15 5.67 Favored Glycine 0 CA--C 1.495 -1.162 0 O-C-N 121.271 -0.893 . . . . 0.0 113.374 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . 0.261 2.3 m-70 . . . . . 0 CA--C 1.502 -0.879 0 C-N-CA 124.515 1.126 . . . . 0.0 110.961 -171.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 73.58 -55.49 0.67 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.282 1.833 . . . . 0.0 110.479 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 78.27 -43.19 0.36 Allowed 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 128.613 2.765 . . . . 0.0 109.274 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 0.5 OUTLIER -45.91 -33.97 3.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 128.507 2.723 . . . . 0.0 112.441 166.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.43 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 7.0 pt-20 -79.61 -28.2 41.02 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -71.57 -40.31 70.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -70.14 -35.41 74.04 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.674 0.75 . . . . 0.0 109.117 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.54 83.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.511 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.27 -35.55 75.8 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.795 1.638 . . . . 0.0 111.373 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -66.4 -42.44 87.84 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.962 1.305 . . . . 0.0 109.43 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 110.877 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.63 -39.87 68.39 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.683 1.193 . . . . 0.0 111.418 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -71.38 -36.48 71.43 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.501 1.12 . . . . 0.0 110.105 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.69 -39.1 87.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.542 1.137 . . . . 0.0 109.875 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.15 -40.49 97.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.012 -1.055 . . . . 0.0 111.369 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -65.58 -40.14 92.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.67 1.188 . . . . 0.0 111.74 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -73.48 -29.29 62.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.767 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.79 -34.95 70.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.125 -0.984 . . . . 0.0 109.599 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.41 -37.72 78.77 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.077 -1.014 . . . . 0.0 111.684 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -64.08 -46.23 85.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.235 -0.915 . . . . 0.0 109.958 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.26 -37.52 85.67 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.353 -0.842 . . . . 0.0 110.316 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.36 74.25 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.792 1.237 . . . . 0.0 111.671 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -63.31 -42.55 99.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.149 0.5 . . . . 0.0 110.967 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.62 -50.45 62.94 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.54 1.536 . . . . 0.0 107.829 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.89 -41.17 87.64 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.128 -0.357 . . . . 0.0 110.821 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.24 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 123.573 0.749 . . . . 0.0 110.499 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.81 72.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 O-C-N 120.431 -1.418 . . . . 0.0 110.551 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -70.39 -32.11 69.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.16 1.384 . . . . 0.0 109.409 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.56 -49.52 76.31 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.978 1.311 . . . . 0.0 110.808 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -74.92 -17.68 60.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 121.769 -0.582 . . . . 0.0 111.354 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -94.55 79.46 3.82 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.128 -1.608 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.74 -29.75 0.83 Allowed Glycine 0 CA--C 1.491 -1.444 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.93 155.19 36.73 Favored Pre-proline 0 N--CA 1.443 -0.788 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.43 161.5 31.48 Favored 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.236 1.957 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.88 6.24 76.29 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 123.932 0.777 . . . . 0.0 111.751 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 122.36 6.34 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 126.087 1.755 . . . . 0.0 114.228 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 -24.5 0.86 Allowed 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -76.04 -87.32 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 mt 64.8 161.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.778 0 C-N-CA 125.411 1.484 . . . . 0.0 109.466 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.9 t 81.88 115.23 0.06 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.659 1.583 . . . . 0.0 112.118 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -68.73 -52.19 18.98 Favored Pre-proline 0 C--N 1.349 0.568 0 CA-C-O 115.973 -1.965 . . . . 0.0 112.408 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.85 -7.49 20.1 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 126.094 3.212 . . . . 0.0 111.542 -170.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -93.51 -33.3 13.83 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.79 74.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.677 1.191 . . . . 0.0 111.699 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 tt -60.76 -29.04 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 124.63 1.172 . . . . 0.0 111.493 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -23.28 29.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.286 -0.884 . . . . 0.0 109.606 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -78.94 -37.57 39.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 12.5 p -77.79 55.59 1.4 Allowed 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 121.427 -0.795 . . . . 0.0 110.115 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -131.43 -68.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.45 -19.24 64.56 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -67.58 -35.86 79.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.183 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.12 56.91 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 120.774 -1.204 . . . . 0.0 110.325 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -93.33 15.74 14.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.22 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.266 10.2 t 49.69 55.24 9.69 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 112.803 168.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.6 m -143.3 -164.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 N-CA-C 98.336 -4.69 . . . . 0.0 98.336 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.32 106.22 0.19 Allowed Glycine 0 CA--C 1.467 -2.909 1 N-CA-C 100.057 -5.217 . . . . 0.0 100.057 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -87.39 -6.91 58.26 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -167.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.94 42.0 2.02 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.72 -51.1 12.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -144.78 -177.27 5.43 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.99 138.66 13.42 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.81 169.34 15.05 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.54 2.827 . . . . 0.0 110.078 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -101.86 -175.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-O 122.605 1.193 . . . . 0.0 111.897 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -87.62 -61.48 1.71 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 124.562 1.145 . . . . 0.0 110.375 -166.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -59.44 -37.64 78.63 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.514 0.726 . . . . 0.0 111.514 -169.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.69 -76.29 0.57 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.048 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -23.72 -51.07 0.03 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 129.473 3.416 . . . . 0.0 117.305 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -58.76 -47.34 85.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.01 1.724 . . . . 0.0 112.736 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -75.58 -27.82 58.7 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.114 . . . . 0.0 108.803 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.05 -52.57 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.83 95.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.076 1.35 . . . . 0.0 111.464 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -34.01 72.7 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 119.18 0.9 . . . . 0.0 111.584 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.78 -42.56 94.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.277 1.031 . . . . 0.0 109.984 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.34 -44.34 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.252 1.021 . . . . 0.0 109.59 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mtp -57.03 -48.79 77.65 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.374 1.069 . . . . 0.0 110.078 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -62.32 -31.9 72.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.303 1.841 . . . . 0.0 111.97 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.99 71.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.627 0.771 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.33 -42.16 75.65 Favored Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.65 -42.73 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 109.797 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -53.77 -56.33 18.45 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 110.544 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.45 -49.82 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 C-N-CA 125.358 1.463 . . . . 0.0 109.516 -171.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.87 -24.01 62.42 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.716 -0.615 . . . . 0.0 111.098 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.52 47.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.961 -1.087 . . . . 0.0 110.144 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.96 -37.31 81.94 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 111.661 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.56 -1.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.623 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -58.5 -24.03 59.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.178 1.791 . . . . 0.0 113.784 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.18 84.78 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 119.14 -2.225 . . . . 0.0 112.216 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -66.27 -42.08 88.98 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.2 -43.73 66.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.172 0.51 . . . . 0.0 111.093 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.71 -41.59 26.42 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 120.357 -1.464 . . . . 0.0 112.667 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 34.1 p -69.07 -7.01 31.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.619 -1.3 . . . . 0.0 111.41 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -74.23 -5.46 42.11 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.835 -0.541 . . . . 0.0 110.41 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -35.56 71.66 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 120.043 -1.661 . . . . 0.0 111.02 167.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.39 -17.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.42 1.488 . . . . 0.0 108.934 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.69 -29.81 40.61 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.512 1.525 . . . . 0.0 111.966 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -60.48 -39.82 89.03 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.71 1.204 . . . . 0.0 110.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.04 -32.86 73.51 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 121.422 -0.799 . . . . 0.0 109.58 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -97.93 0.94 47.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 120.993 0.425 . . . . 0.0 111.1 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -74.97 -31.71 61.52 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.426 -1.421 . . . . 0.0 108.638 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -78.5 -17.52 56.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.866 -0.521 . . . . 0.0 110.939 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -79.53 -37.94 35.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.53 25.76 41.59 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 CA--C 1.486 -1.491 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 171.412 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.431 -1.385 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 164.18 24.52 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.259 1.424 . . . . 0.0 109.356 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.21 -39.82 94.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.796 1.638 . . . . 0.0 111.407 -169.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.461 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 19.6 p80 -78.54 -20.68 50.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.403 -0.811 . . . . 0.0 111.232 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.461 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 18.3 mt-10 -89.86 -21.69 22.42 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.096 -1.003 . . . . 0.0 108.561 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.55 -43.71 96.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.121 1.768 . . . . 0.0 109.784 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.47 -32.16 71.96 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 109.362 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.38 -35.46 73.52 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.206 1.003 . . . . 0.0 111.321 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.53 -31.75 72.99 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.469 -0.769 . . . . 0.0 111.439 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.73 -33.66 74.44 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.795 -0.566 . . . . 0.0 110.836 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.682 0.793 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.48 -39.4 88.73 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.872 0.869 . . . . 0.0 110.262 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -46.02 91.35 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 121.287 -0.883 . . . . 0.0 109.846 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.6 -41.68 81.71 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.825 2.05 . . . . 0.0 109.942 -175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.89 -40.79 96.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.068 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.23 -27.69 67.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.513 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -69.57 -42.79 74.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.27 -0.893 . . . . 0.0 110.342 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 m -72.59 -26.37 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 121.657 -0.652 . . . . 0.0 110.941 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.56 -41.27 96.42 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.307 -0.871 . . . . 0.0 111.096 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.46 -30.38 59.92 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 124.073 0.949 . . . . 0.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.93 -39.25 72.79 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 119.787 -1.821 . . . . 0.0 109.507 173.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.11 85.58 Favored 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.013 1.325 . . . . 0.0 110.85 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.1 p -67.19 -37.15 83.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 119.202 0.91 . . . . 0.0 111.196 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.13 -52.7 31.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.506 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -71.07 -25.12 62.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.076 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.82 -53.64 47.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.396 1.078 . . . . 0.0 110.016 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.74 -38.61 83.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -77.05 -6.59 53.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.332 -1.48 . . . . 0.0 112.421 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.48 -52.32 5.42 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -48.48 -50.58 31.01 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 129.034 2.934 . . . . 0.0 114.382 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -74.07 85.68 1.83 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.731 0.777 . . . . 0.0 110.413 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.34 -18.36 1.7 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.63 140.03 31.56 Favored Pre-proline 0 N--CA 1.445 -0.705 0 O-C-N 121.128 -1.219 . . . . 0.0 111.15 -170.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.39 132.82 6.06 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.77 2.314 . . . . 0.0 111.232 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.57 27.85 37.64 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.9 157.4 5.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.43 2.292 . . . . 0.0 111.9 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.02 -36.04 0.83 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.132 1.373 . . . . 0.0 110.072 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.45 81.5 1.48 Allowed 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.927 1.346 . . . . 0.0 112.865 -164.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 35.0 pt -93.79 -8.67 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 118.871 2.915 . . . . 0.0 118.871 -166.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.7 m -121.32 141.2 51.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 123.656 2.935 . . . . 0.0 110.708 -164.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -59.21 -47.77 97.66 Favored Pre-proline 0 C--N 1.353 0.757 0 CA-C-O 116.172 -1.871 . . . . 0.0 112.909 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -72.62 -5.59 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 CA-C-N 125.374 2.955 . . . . 0.0 112.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -30.76 12.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.6 76.4 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.294 1.037 . . . . 0.0 111.931 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.9 tt -72.06 -27.39 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 110.022 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.01 -35.75 49.52 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 108.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -63.6 -44.85 92.78 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.957 0.903 . . . . 0.0 110.578 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.5 p -65.74 -27.16 68.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 120.609 -1.307 . . . . 0.0 111.175 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.51 -20.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 111.452 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.9 -16.14 57.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.17 -1.581 . . . . 0.0 110.177 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 7.1 m -99.8 -177.45 3.56 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 102.038 -3.319 . . . . 0.0 102.038 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 76.4 -30.14 0.18 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.793 1.637 . . . . 0.0 111.263 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.8 p -90.96 -10.92 40.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.65 1.58 . . . . 0.0 111.397 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p 58.45 30.83 20.23 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.359 1.463 . . . . 0.0 111.223 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.92 -87.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 101.446 -3.539 . . . . 0.0 101.446 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.32 73.33 1.19 Allowed Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -44.62 93.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.65 0.78 . . . . 0.0 111.099 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.3 -62.7 0.27 Allowed Glycine 0 CA--C 1.477 -2.331 0 C-N-CA 117.36 -2.352 . . . . 0.0 112.6 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.456 ' CG ' HH22 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -10.33 -67.24 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 128.948 2.899 . . . . 0.0 117.747 -162.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.94 155.13 43.58 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 104.424 -2.435 . . . . 0.0 104.424 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.43 152.22 19.52 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.66 158.37 19.0 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.085 2.524 . . . . 0.0 111.518 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.48 HG21 ' H ' ' D' ' 64' ' ' THR . 8.5 p -101.99 -151.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.48 ' H ' HG21 ' D' ' 63' ' ' VAL . 2.2 m -76.65 -50.11 14.55 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.547 1.939 . . . . 0.0 111.157 -171.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -77.59 -14.51 59.63 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.457 1.503 . . . . 0.0 110.498 -162.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.62 -20.18 62.76 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.165 0.983 . . . . 0.0 109.658 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.72 89.38 0.84 Allowed Glycine 0 CA--C 1.478 -2.265 1 N-CA-C 98.691 -5.764 . . . . 0.0 98.691 -170.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -65.06 -11.36 38.58 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.056 1.928 . . . . 0.0 110.02 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -57.28 -14.84 4.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.324 1.05 . . . . 0.0 113.597 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.88 -43.32 97.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.487 1.494 . . . . 0.0 109.116 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.98 -43.08 75.63 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -44.93 82.33 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.596 1.158 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.76 -45.51 93.61 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.402 0.681 . . . . 0.0 111.364 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.8 -39.73 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.634 0.774 . . . . 0.0 109.32 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.7 ttm -62.9 -48.14 80.27 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.384 1.074 . . . . 0.0 110.303 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -63.57 -42.18 98.34 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 109.846 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.3 80.7 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 111.439 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.79 -36.67 93.66 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.211 0.91 . . . . 0.0 112.249 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -68.66 -42.85 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 121.311 -1.111 . . . . 0.0 108.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.95 -43.08 99.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 121.432 -0.793 . . . . 0.0 111.604 -175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.69 -40.78 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 O-C-N 121.79 -0.569 . . . . 0.0 111.355 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.29 -21.09 56.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.75 25.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.166 -0.959 . . . . 0.0 110.367 174.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.1 -42.54 90.74 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 125.837 1.655 . . . . 0.0 109.877 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.71 -4.26 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.564 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -62.2 -19.79 63.49 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.856 -1.152 . . . . 0.0 110.427 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.07 77.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.341 -1.475 . . . . 0.0 111.841 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.35 -33.07 49.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 120.926 -1.109 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.01 -31.49 68.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.125 0.488 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.87 70.47 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.834 -1.166 . . . . 0.0 111.257 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -9.94 59.03 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.876 -1.14 . . . . 0.0 111.922 173.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.45 -40.17 70.5 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 119.644 1.111 . . . . 0.0 109.359 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -68.46 -29.64 68.33 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.959 -1.088 . . . . 0.0 111.239 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.83 -21.92 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.914 1.286 . . . . 0.0 108.97 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -62.18 -12.55 20.6 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.438 1.095 . . . . 0.0 111.485 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.79 -24.94 67.96 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.404 1.082 . . . . 0.0 112.229 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.73 166.99 21.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 64.8 -70.88 0.08 Allowed 'General case' 0 C--N 1.351 0.665 0 C-N-CA 125.93 1.692 . . . . 0.0 111.634 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.69 -53.31 59.48 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.933 1.693 . . . . 0.0 109.513 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -70.75 -29.63 65.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.891 -1.131 . . . . 0.0 111.093 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.86 91.34 2.96 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.28 35.4 2.7 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 . . . . . 0 C--N 1.354 0.78 0 C-N-CA 124.591 1.156 . . . . 0.0 112.546 -178.229 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.425 -1.696 1 N-CA-C 100.062 -4.051 . . . . 0.0 100.062 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.95 -176.73 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.057 2.143 . . . . 0.0 112.28 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -105.68 -42.17 5.25 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -71.17 -31.36 67.58 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.207 -0.933 . . . . 0.0 111.623 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.55 -40.79 61.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.601 0.715 . . . . 0.0 110.193 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -68.47 -31.64 71.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.48 -0.763 . . . . 0.0 110.359 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -81.0 -30.92 34.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.018 -0.426 . . . . 0.0 110.243 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.6 76.04 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.931 -1.106 . . . . 0.0 110.197 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -57.1 -35.63 69.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.573 1.949 . . . . 0.0 111.691 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -64.42 -39.18 93.34 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.563 1.145 . . . . 0.0 109.84 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.93 80.52 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.693 -0.629 . . . . 0.0 110.156 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.41 -33.67 74.09 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.621 0.769 . . . . 0.0 111.449 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.83 -42.56 94.85 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 109.89 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.55 -36.89 81.88 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.874 0.87 . . . . 0.0 109.459 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -56.87 -44.72 82.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.121 0.569 . . . . 0.0 111.264 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -63.14 -38.14 90.01 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.104 0.962 . . . . 0.0 111.606 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.19 -39.12 92.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.887 1.275 . . . . 0.0 109.83 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.93 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.715 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.1 mt -59.74 -43.95 93.99 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.32 -0.862 . . . . 0.0 111.185 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -74.53 -22.33 59.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.234 1.014 . . . . 0.0 111.798 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.91 -41.04 21.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 120.573 -1.329 . . . . 0.0 108.385 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.6 76.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.716 1.207 . . . . 0.0 111.412 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 p -66.85 -38.35 86.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.454 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -61.37 -47.91 83.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.235 1.414 . . . . 0.0 107.812 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -65.63 -47.06 76.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 122.662 0.385 . . . . 0.0 110.572 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.48 90.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.03 1.332 . . . . 0.0 112.058 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.86 -34.66 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.434 -0.791 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.23 -24.79 27.68 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 120.271 -1.518 . . . . 0.0 110.357 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.85 -53.66 6.57 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.83 -34.88 69.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 119.073 0.851 . . . . 0.0 110.98 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -74.65 108.88 7.69 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 119.569 -1.957 . . . . 0.0 110.455 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.66 -33.12 2.8 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.57 144.53 83.65 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.309 -170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.64 138.7 21.85 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 C-N-CA 122.799 2.333 . . . . 0.0 109.833 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.45 -0.07 89.31 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.16 146.8 54.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.054 0.942 . . . . 0.0 111.543 -171.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.55 -42.45 3.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.78 131.11 34.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 pt -149.45 173.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.3 m 66.64 132.94 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.526 1.931 . . . . 0.0 114.163 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.32 -46.82 38.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 115.77 -2.062 . . . . 0.0 112.309 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.5 -11.65 30.2 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 CA-C-N 126.056 3.199 . . . . 0.0 112.293 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.15 -47.63 7.95 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.59 75.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 126.166 1.786 . . . . 0.0 112.37 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.73 -28.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 121.359 0.599 . . . . 0.0 111.115 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -22.29 32.19 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.235 -0.916 . . . . 0.0 109.69 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -78.14 -33.84 50.2 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.76 61.26 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.123 -0.985 . . . . 0.0 110.862 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -138.84 -76.1 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -67.71 -14.88 63.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 112.031 -169.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -64.88 -36.56 84.76 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 126.331 1.852 . . . . 0.0 108.582 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.23 60.28 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.207 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -88.99 13.41 12.96 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 p 56.79 51.1 11.35 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.514 1.526 . . . . 0.0 113.065 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.19 -104.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.22 71.46 0.73 Allowed Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -66.75 -18.98 65.65 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.587 -0.949 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.51 22.23 6.18 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' CG ' HH22 ' B' ' 68' ' ' ARG . 0.4 OUTLIER -63.85 -56.21 17.12 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.995 0.898 . . . . 0.0 110.131 174.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -147.47 161.68 40.58 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.97 146.94 18.44 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.9 176.53 9.9 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 124.481 3.454 . . . . 0.0 110.341 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 t -112.5 -102.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 120.053 1.297 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -139.53 -41.53 0.45 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -88.07 -19.19 27.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.577 0.751 . . . . 0.0 111.146 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.02 -34.56 77.83 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 108.036 170.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.57 79.52 1.44 Allowed Glycine 0 CA--C 1.471 -2.659 1 N-CA-C 100.297 -5.121 . . . . 0.0 100.297 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.438 HH22 ' CG ' ' D' ' 59' ' ' ASP . 49.5 ttm-85 -39.07 -28.15 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 128.806 2.842 . . . . 0.0 114.512 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -53.27 -15.74 1.05 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.53 -46.82 92.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 125.216 1.407 . . . . 0.0 109.399 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.163 0.985 . . . . 0.0 108.899 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.37 -43.24 33.48 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.595 1.558 . . . . 0.0 111.667 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -62.58 -38.17 89.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.13 0.572 . . . . 0.0 111.437 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.71 -38.63 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -59.95 -44.62 94.27 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.046 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -63.17 -34.3 77.32 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.493 -0.754 . . . . 0.0 110.961 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.92 85.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.753 0.706 . . . . 0.0 111.291 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.29 50.97 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.04 -38.89 62.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 124.562 1.145 . . . . 0.0 108.897 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -70.35 -49.28 50.93 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.815 -1.178 . . . . 0.0 111.177 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.89 -45.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 O-C-N 121.33 -0.856 . . . . 0.0 110.199 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -73.48 -29.69 62.68 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 121.447 -0.783 . . . . 0.0 110.2 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.0 62.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 120.665 -1.272 . . . . 0.0 110.314 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.93 -35.4 80.56 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.935 -1.103 . . . . 0.0 110.769 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.92 -9.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.161 1.385 . . . . 0.0 111.26 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 m -59.34 -23.01 62.15 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 118.986 -2.321 . . . . 0.0 111.931 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.33 61.26 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.551 -1.343 . . . . 0.0 112.36 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.37 -41.94 9.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.512 1.525 . . . . 0.0 109.577 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -41.76 63.2 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.637 -1.289 . . . . 0.0 111.582 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.19 -5.43 41.85 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 121.037 -1.039 . . . . 0.0 111.12 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -97.54 -5.42 35.8 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.701 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.26 18.2 m-20 -80.13 -16.86 54.04 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 121.094 1.77 . . . . 0.0 111.268 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.49 -29.55 37.37 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.837 -1.164 . . . . 0.0 109.602 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.41 -30.87 50.45 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 124.429 1.092 . . . . 0.0 109.248 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -53.5 -26.44 20.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.001 1.32 . . . . 0.0 112.916 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -62.59 -34.75 77.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.524 1.13 . . . . 0.0 110.689 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.02 -3.18 58.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 121.919 -0.488 . . . . 0.0 110.132 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.61 -174.91 2.61 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 66.52 -64.13 0.23 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.064 2.146 . . . . 0.0 112.432 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -50.83 -51.57 49.76 Favored 'General case' 0 N--CA 1.432 -1.361 1 C-N-CA 131.908 4.083 . . . . 0.0 110.457 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -92.22 -0.06 57.43 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.473 0.709 . . . . 0.0 110.543 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.59 28.51 72.18 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 121.819 -0.551 . . . . 0.0 111.765 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.9 t60 . . . . . 0 CA--C 1.505 -0.754 0 O-C-N 121.619 -0.93 . . . . 0.0 109.419 -174.833 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p . . . . . 0 N--CA 1.432 -1.375 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.69 169.02 10.63 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -47.45 -65.7 0.52 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 127.443 2.297 . . . . 0.0 111.598 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -62.81 -23.63 67.35 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.588 1.955 . . . . 0.0 112.709 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -81.83 -41.58 20.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -70.08 -35.18 74.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.379 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.8 -39.66 85.75 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.494 0.718 . . . . 0.0 110.304 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.61 91.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.408 0.683 . . . . 0.0 111.495 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -68.31 -38.55 81.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 121.594 -0.691 . . . . 0.0 110.219 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.85 -36.27 80.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.46 0.648 . . . . 0.0 110.892 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.14 83.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.839 0.856 . . . . 0.0 111.193 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.27 -32.39 73.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.508 -0.745 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.23 -35.83 71.62 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.165 -0.959 . . . . 0.0 109.597 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.81 -30.21 69.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 120.641 -1.287 . . . . 0.0 110.325 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -61.16 -43.68 98.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 122.978 0.511 . . . . 0.0 111.186 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.33 -35.15 79.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.344 0.658 . . . . 0.0 110.892 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -67.61 -39.11 84.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.274 0.63 . . . . 0.0 110.668 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.76 -39.87 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.797 0.839 . . . . 0.0 109.302 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.22 -43.45 87.73 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.179 0.899 . . . . 0.0 111.969 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.35 -37.39 80.44 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.59 1.156 . . . . 0.0 110.501 -177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.22 -46.06 52.57 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.681 1.229 . . . . 0.0 108.788 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.31 64.57 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 125.043 1.337 . . . . 0.0 112.236 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.8 p -73.32 -31.57 64.08 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.341 -0.849 . . . . 0.0 110.006 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -40.96 71.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.028 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.5 75.22 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.796 1.239 . . . . 0.0 112.742 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.04 -29.96 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 O-C-N 120.912 -1.117 . . . . 0.0 111.381 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.96 -20.57 28.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.153 0.501 . . . . 0.0 110.52 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.34 94.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.412 1.885 . . . . 0.0 109.462 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -69.39 -106.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.571 0.7 . . . . 0.0 111.58 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 58.17 9.66 1.04 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.48 34.63 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.72 149.14 38.64 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -77.14 113.09 3.53 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.486 2.124 . . . . 0.0 110.693 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -65.37 0.28 Allowed Glycine 0 CA--C 1.484 -1.901 0 N-CA-C 103.109 -3.996 . . . . 0.0 103.109 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 75.23 162.47 0.25 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 127.65 2.38 . . . . 0.0 108.424 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.98 -72.61 0.08 Allowed 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.595 -0.691 . . . . 0.0 110.265 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.34 80.5 1.59 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 tt -122.99 93.99 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.5 m -156.07 -150.73 0.3 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -167.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.05 -58.36 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 116.445 -1.741 . . . . 0.0 106.447 169.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.51 -29.03 20.89 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.803 3.108 . . . . 0.0 112.434 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.52 9.12 39.8 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 123.809 0.843 . . . . 0.0 110.148 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.05 -41.22 82.35 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.679 -1.263 . . . . 0.0 109.675 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -73.45 -24.86 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 O-C-N 121.559 -0.713 . . . . 0.0 110.034 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -58.27 -55.66 32.18 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 125.687 1.595 . . . . 0.0 110.195 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -71.09 -34.82 71.51 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -55.84 -43.41 77.0 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.526 1.13 . . . . 0.0 110.954 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.7 t -55.19 -51.15 58.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 124.414 1.086 . . . . 0.0 111.061 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.42 -22.16 55.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.31 -0.869 . . . . 0.0 111.693 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -65.07 -40.96 95.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.183 0.993 . . . . 0.0 109.093 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.17 65.5 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 121.235 -0.916 . . . . 0.0 112.175 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -89.04 5.49 44.14 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.872 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 56.09 28.97 13.75 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.665 1.186 . . . . 0.0 111.463 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.17 -56.66 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.55 62.39 5.84 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.4 -27.5 66.27 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 123.14 1.448 . . . . 0.0 108.115 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.47 43.96 1.4 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 107.446 -2.261 . . . . 0.0 107.446 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.55 -50.97 9.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -133.87 172.57 12.61 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -146.25 149.88 39.54 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.77 166.75 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.524 2.816 . . . . 0.0 109.36 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.24 -144.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 7.3 p -107.12 -59.75 1.77 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.213 1.405 . . . . 0.0 107.781 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.84 -16.28 48.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 130.185 3.394 . . . . 0.0 111.99 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -67.63 -22.71 65.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 124.137 1.923 . . . . 0.0 108.482 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.82 67.92 1.41 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 101.557 -4.617 . . . . 0.0 101.557 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.456 HH22 ' CG ' ' A' ' 59' ' ' ASP . 47.3 ttt85 -37.76 -20.71 0.01 OUTLIER 'General case' 0 C--N 1.362 1.124 0 C-N-CA 131.62 3.968 . . . . 0.0 115.461 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -54.69 -14.62 1.42 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.75 1.62 . . . . 0.0 114.499 162.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.98 -44.11 92.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.134 0 CA-C-N 121.709 2.05 . . . . 0.0 107.305 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.54 86.37 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.575 -0.703 . . . . 0.0 110.193 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.42 -45.31 80.77 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 123.762 0.825 . . . . 0.0 110.872 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -55.19 -46.76 75.87 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.627 1.971 . . . . 0.0 111.56 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.5 t -72.35 -44.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 C-N-CA 123.256 0.623 . . . . 0.0 109.494 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 72.9 mtm -58.89 -49.18 78.74 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.895 0.878 . . . . 0.0 110.293 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.77 -40.2 94.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.071 0.548 . . . . 0.0 110.783 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.98 76.27 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.116 0.566 . . . . 0.0 111.418 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -44.02 91.78 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 124.259 0.933 . . . . 0.0 111.172 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.96 -42.07 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.796 -0.826 . . . . 0.0 108.954 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.36 -50.85 71.65 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.174 -0.954 . . . . 0.0 111.995 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.3 -41.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 O-C-N 121.829 -0.544 . . . . 0.0 110.577 -173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -75.75 -27.97 58.31 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.588 -0.695 . . . . 0.0 110.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.6 -34.5 69.94 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.008 -1.057 . . . . 0.0 109.584 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.37 -34.0 76.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.296 1.038 . . . . 0.0 110.86 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.44 -21.9 19.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 124.847 1.259 . . . . 0.0 110.691 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 2.5 m -62.23 -16.33 52.7 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.574 -1.329 . . . . 0.0 111.531 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.41 -35.31 80.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.3 -2.125 . . . . 0.0 111.17 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.34 -33.75 61.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.83 -25.03 40.94 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.141 0.577 . . . . 0.0 111.569 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.35 -27.96 64.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 120.036 -1.665 . . . . 0.0 109.268 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -9.01 55.28 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.025 -1.047 . . . . 0.0 112.314 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -72.45 -23.09 61.01 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.397 -1.44 . . . . 0.0 110.728 -172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -75.23 -28.27 59.83 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.41 -0.806 . . . . 0.0 110.404 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.96 -40.15 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 124.131 0.972 . . . . 0.0 108.64 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -60.5 -23.56 64.63 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.352 -0.842 . . . . 0.0 112.663 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -52.67 -46.51 67.26 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.852 1.261 . . . . 0.0 109.983 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -77.98 -27.2 49.07 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.807 -0.558 . . . . 0.0 110.466 -173.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.25 -36.15 76.86 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.227 0.611 . . . . 0.0 110.305 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.09 -45.35 67.14 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -53.47 -42.09 66.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 112.839 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -122.96 106.52 10.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 -48.91 0.93 Allowed Glycine 0 CA--C 1.486 -1.726 0 N-CA-C 105.907 -2.877 . . . . 0.0 105.907 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 CA--C 1.502 -0.896 0 C-N-CA 126.191 1.796 . . . . 0.0 112.318 -172.187 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.433 -1.297 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.1 27.58 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.61 -46.93 77.28 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 123.003 1.382 . . . . 0.0 109.52 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.446 ' CG ' ' HA ' ' C' ' 88' ' ' ALA . 0.1 OUTLIER -59.09 -29.35 67.29 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.038 1.335 . . . . 0.0 113.733 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -80.64 -43.71 20.03 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -65.83 -41.55 91.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 123.832 0.853 . . . . 0.0 110.796 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -65.48 -35.67 81.57 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.259 0.624 . . . . 0.0 110.718 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.79 94.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.75 -31.72 66.97 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.952 -0.467 . . . . 0.0 111.676 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.0 -36.37 84.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.94 0.896 . . . . 0.0 110.001 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.59 72.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.29 -40.36 85.9 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 111.069 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.65 -25.43 59.19 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.167 1.387 . . . . 0.0 110.533 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.74 -36.74 67.8 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.305 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -63.72 -44.78 92.59 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -65.44 -24.49 67.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.458 -0.776 . . . . 0.0 112.488 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -60.31 -43.81 95.99 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.532 1.133 . . . . 0.0 109.911 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.14 -40.74 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.263 1.025 . . . . 0.0 109.057 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -40.16 95.24 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.721 0.809 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.56 -21.86 38.19 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.0 111.969 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.41 -47.57 17.3 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.33 60.17 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 124.149 0.979 . . . . 0.0 112.592 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.3 p -67.76 -40.36 84.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.034 1.288 . . . . 0.0 109.089 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -68.52 -44.61 74.26 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.45 -42.72 88.01 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.237 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.58 65.0 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.905 1.282 . . . . 0.0 111.48 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 m -72.3 -27.9 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 O-C-N 121.171 -0.956 . . . . 0.0 111.694 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.89 -37.67 67.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.44 -50.34 16.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 126.277 1.831 . . . . 0.0 109.614 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.58 -34.82 78.74 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.967 0.907 . . . . 0.0 111.266 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -66.49 122.83 18.44 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 119.48 -2.013 . . . . 0.0 109.379 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.26 7.04 59.69 Favored Glycine 0 CA--C 1.496 -1.12 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.83 147.43 34.74 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -77.49 131.74 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.976 2.45 . . . . 0.0 110.792 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 0.1 82.16 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.55 26.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.39 1.476 . . . . 0.0 109.825 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.88 -28.25 8.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 14.1 tp -98.74 83.25 2.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.612 -1.305 . . . . 0.0 108.271 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.2 pt -127.3 64.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -154.03 125.17 7.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -60.43 -47.49 96.22 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-O 115.944 -1.979 . . . . 0.0 113.754 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -71.7 -26.54 19.32 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 CA-C-N 126.04 3.193 . . . . 0.0 110.908 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -85.65 -8.81 58.0 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.97 79.68 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.105 -0.997 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.82 -33.32 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.95 -26.96 49.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.56 -1.337 . . . . 0.0 111.174 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -70.87 -46.43 62.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -66.25 -20.79 66.21 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.313 -0.867 . . . . 0.0 112.941 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.54 -51.47 72.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 124.457 1.103 . . . . 0.0 110.337 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.26 -27.45 61.58 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 118.803 0.728 . . . . 0.0 110.333 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -69.88 -37.9 76.19 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.94 -29.27 68.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.187 -0.945 . . . . 0.0 111.587 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -88.62 4.67 46.21 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.145 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.384 12.7 p 79.34 -63.62 0.26 Allowed 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 127.762 2.425 . . . . 0.0 107.889 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -1.19 -77.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.023 1 C-N-CA 131.964 4.106 . . . . 0.0 113.064 -177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.57 68.96 1.48 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -63.59 -29.35 70.61 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 121.584 -0.95 . . . . 0.0 111.941 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 42.7 0.88 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -65.24 -46.29 81.2 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -138.95 -152.51 0.42 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -165.99 146.29 5.46 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 100.598 -3.852 . . . . 0.0 100.598 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.83 -174.65 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 124.72 3.613 . . . . 0.0 108.791 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.35 -171.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -75.31 -41.86 55.98 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 126.394 1.877 . . . . 0.0 110.389 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.23 -24.42 59.32 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.833 0.853 . . . . 0.0 109.619 -167.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -59.49 -45.91 90.33 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.45 78.03 0.73 Allowed Glycine 0 CA--C 1.465 -3.089 1 N-CA-C 97.44 -6.264 . . . . 0.0 97.44 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -47.51 -17.71 0.1 Allowed 'General case' 0 C--N 1.37 1.499 0 C-N-CA 127.984 2.513 . . . . 0.0 114.629 -166.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -51.18 -16.03 0.44 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 127.637 2.375 . . . . 0.0 113.689 165.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . 0.267 30.0 t -72.04 -39.67 66.36 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 CA-C-N 123.504 2.865 . . . . 0.0 109.2 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.89 95.97 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 110.757 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.34 -43.82 97.93 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.066 0.946 . . . . 0.0 111.066 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -59.58 -51.05 71.51 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 125.077 1.351 . . . . 0.0 111.17 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.08 -43.19 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 26.8 ttp -60.1 -50.32 74.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.266 1.026 . . . . 0.0 110.561 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -65.57 -39.55 91.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.691 -0.631 . . . . 0.0 110.181 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.65 91.73 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.067 0.547 . . . . 0.0 111.059 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.04 -48.22 82.12 Favored Glycine 0 CA--C 1.494 -1.237 0 C-N-CA 123.74 0.686 . . . . 0.0 112.013 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.22 -45.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 124.03 0.932 . . . . 0.0 109.365 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.2 -42.79 95.84 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.27 1.028 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.88 -50.1 78.98 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 110.914 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.27 -35.01 78.63 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 121.363 -0.836 . . . . 0.0 111.167 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.66 -36.95 79.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.128 0.571 . . . . 0.0 110.405 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.01 -25.18 68.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.186 1.394 . . . . 0.0 111.968 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.44 -16.9 8.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 125.155 1.382 . . . . 0.0 110.745 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.8 t -66.16 -11.73 51.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 119.707 -1.87 . . . . 0.0 111.936 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.39 -19.91 63.9 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 110.902 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.446 ' HA ' ' CG ' ' C' ' 4' ' ' HIS . . . -89.78 -61.27 1.73 Allowed 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 125.329 1.452 . . . . 0.0 107.722 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.3 mt -68.48 -28.39 66.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -165.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.31 -12.0 60.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 120.626 -1.296 . . . . 0.0 110.632 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -15.07 55.89 Favored 'General case' 0 CA--C 1.492 -1.257 0 O-C-N 120.365 -1.46 . . . . 0.0 107.905 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.307 63.7 m-20 -93.38 10.57 31.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.222 -155.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -100.12 -19.1 16.63 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 121.515 -0.741 . . . . 0.0 109.793 159.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.9 -25.85 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.487 -1.383 . . . . 0.0 107.339 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -72.22 -3.21 22.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.868 -1.145 . . . . 0.0 112.365 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -61.65 -25.53 67.44 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.435 -1.416 . . . . 0.0 109.9 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.25 -32.75 61.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 124.419 1.088 . . . . 0.0 109.311 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -76.09 -35.38 59.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.357 1.863 . . . . 0.0 108.28 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -77.1 -41.69 41.08 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.235 -0.915 . . . . 0.0 112.114 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -89.54 -12.93 38.49 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.074 -1.016 . . . . 0.0 110.91 -172.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -126.53 112.06 15.11 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.81 -10.69 34.86 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 . . . . . 0 CA--C 1.495 -1.135 0 O-C-N 121.085 -1.244 . . . . 0.0 107.731 -177.686 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.432 -1.357 0 N-CA-C 102.602 -3.11 . . . . 0.0 102.602 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.47 -61.02 1.77 Allowed 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -168.3 -89.77 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 -162.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.466 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 5.3 p80 -59.26 -22.65 61.47 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.557 2.743 . . . . 0.0 114.371 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.466 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 44.1 mp0 -67.68 -27.76 67.11 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -69.84 -37.92 76.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -79.36 -34.18 42.26 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.72 95.7 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.424 -0.798 . . . . 0.0 111.355 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.23 67.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.873 -0.517 . . . . 0.0 110.184 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.45 -35.2 79.65 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 124.213 1.005 . . . . 0.0 110.627 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.29 69.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 111.463 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -62.18 -41.07 97.99 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.157 -0.964 . . . . 0.0 110.983 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 -27.46 68.92 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 111.756 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -73.69 -35.32 65.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.0 -41.73 95.12 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.802 -1.187 . . . . 0.0 110.458 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -59.92 -31.35 69.75 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.788 1.235 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -66.67 -47.63 71.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.911 1.284 . . . . 0.0 108.941 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.68 -30.44 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.26 -47.58 83.12 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.06 -48.64 73.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 124.657 1.183 . . . . 0.0 109.246 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -66.03 -34.98 79.33 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.506 1.122 . . . . 0.0 110.575 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.27 43.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.534 -1.354 . . . . 0.0 111.295 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -64.31 -43.77 93.66 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.534 -0.729 . . . . 0.0 109.969 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -69.76 -30.18 67.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -66.49 -50.95 61.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -45.54 78.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.895 1.278 . . . . 0.0 112.248 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.88 -28.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.065 -1.022 . . . . 0.0 111.151 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.29 -33.3 22.16 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.545 -1.347 . . . . 0.0 108.674 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.26 74.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.834 2.054 . . . . 0.0 109.408 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -36.51 84.12 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.52 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp85 -78.38 89.07 4.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.239 1.019 . . . . 0.0 111.653 -165.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.42 -12.74 4.32 Favored Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.69 53.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 124.776 1.23 . . . . 0.0 108.493 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.22 141.99 13.19 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 123.108 2.146 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.19 77.33 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 170.87 9.46 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.3 92.32 1.86 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.05 58.46 0.07 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.013 0.911 . . . . 0.0 109.057 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 28.0 pt -95.23 -179.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 O-C-N 119.908 -1.745 . . . . 0.0 108.801 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.8 134.74 0.02 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.411 2.685 . . . . 0.0 114.044 172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -65.97 -46.11 64.1 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 119.715 -1.865 . . . . 0.0 110.484 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -73.45 -11.75 24.67 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 124.185 2.53 . . . . 0.0 113.971 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . 0.251 1.5 m-20 -90.64 -44.6 9.42 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -31.51 72.78 Favored 'General case' 0 CA--C 1.494 -1.205 0 O-C-N 121.178 -0.951 . . . . 0.0 112.238 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.17 -31.98 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 121.892 -0.505 . . . . 0.0 110.698 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -36.51 76.06 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 120.528 -1.357 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.456 ' CD1' ' HB2' ' D' ' 60' ' ' ARG . 65.7 t90 -70.55 -35.11 72.94 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.377 -0.827 . . . . 0.0 110.024 174.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -61.69 -42.06 98.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.178 0.991 . . . . 0.0 109.413 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.37 -53.54 42.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 125.159 1.384 . . . . 0.0 110.196 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.79 -45.89 70.86 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.435 1.494 . . . . 0.0 111.782 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.9 m -66.9 -38.13 85.67 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.071 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.35 73.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.461 -0.775 . . . . 0.0 111.36 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -86.22 5.07 35.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 118.98 -0.534 . . . . 0.0 112.273 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 62.7 p 55.98 46.04 22.66 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.658 1.183 . . . . 0.0 112.982 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.425 HG21 ' H ' ' D' ' 56' ' ' GLY . 0.3 OUTLIER -112.03 -93.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.425 ' H ' HG21 ' D' ' 55' ' ' VAL . . . 101.89 64.68 0.75 Allowed Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -28.57 68.01 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -172.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 129.01 2.27 5.63 Favored Glycine 0 CA--C 1.488 -1.654 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.438 ' CG ' HH22 ' A' ' 68' ' ' ARG . 1.7 m-20 -64.79 -41.79 95.54 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' D' ' 47' ' ' TRP . 50.5 mmt-85 -134.56 143.72 47.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 102.634 -3.099 . . . . 0.0 102.634 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -128.41 130.61 23.53 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.61 170.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 108.841 172.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -128.96 -167.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -76.8 -36.21 57.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 120.606 -1.309 . . . . 0.0 109.125 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -72.4 -24.06 61.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.059 1.344 . . . . 0.0 112.369 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.11 -24.44 51.74 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 123.108 1.432 . . . . 0.0 107.249 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 60.72 1.17 Allowed Glycine 0 CA--C 1.463 -3.209 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -31.88 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 1 C-N-CA 131.963 4.105 . . . . 0.0 116.927 -171.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.06 1.34 2.81 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 120.375 -1.453 . . . . 0.0 113.309 167.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -51.55 57.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.36 67.88 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.605 1.162 . . . . 0.0 110.965 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -52.44 -40.13 61.86 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.033 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -67.64 -33.75 75.59 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.61 -38.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 120.788 -1.195 . . . . 0.0 109.463 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -60.52 -39.61 88.45 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.761 -0.587 . . . . 0.0 110.902 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -57.52 -47.37 82.14 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.738 0.815 . . . . 0.0 110.76 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.06 97.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.875 0.47 . . . . 0.0 110.993 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.09 -50.57 50.95 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.15 -48.29 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.35 1.06 . . . . 0.0 109.385 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.29 -36.86 84.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.88 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.99 -51.83 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 119.388 0.995 . . . . 0.0 109.658 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.87 -21.84 63.3 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.448 -0.783 . . . . 0.0 111.114 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.02 -33.63 20.99 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.89 -39.19 88.31 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 124.529 1.132 . . . . 0.0 110.233 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.94 -7.99 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 121.519 -0.738 . . . . 0.0 112.321 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -60.86 -18.06 53.84 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-N 119.205 0.911 . . . . 0.0 110.229 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 119.704 -1.873 . . . . 0.0 112.372 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.79 71.69 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.06 -25.83 58.93 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.878 0.371 . . . . 0.0 110.9 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.19 -49.71 33.31 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 120.578 -1.326 . . . . 0.0 109.816 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -71.26 1.8 5.6 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.987 -1.07 . . . . 0.0 111.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.34 -24.09 63.86 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.957 -1.09 . . . . 0.0 108.56 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -67.3 -16.52 64.32 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 119.913 -1.742 . . . . 0.0 112.5 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 5.1 m -73.61 -21.64 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 O-C-N 119.652 -1.905 . . . . 0.0 110.561 -173.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -74.6 3.76 7.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.746 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -80.12 -35.77 36.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -92.29 -48.84 6.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -86.25 174.04 9.36 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 68.82 -66.48 0.24 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.682 1.993 . . . . 0.0 110.285 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -54.74 -53.76 50.86 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 129.395 3.078 . . . . 0.0 109.228 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -115.09 134.87 54.8 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.69 -31.29 6.6 Favored Glycine 0 CA--C 1.494 -1.273 0 O-C-N 121.54 -0.725 . . . . 0.0 111.349 172.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 35.2 p80 . . . . . 0 CA--C 1.502 -0.872 0 C-N-CA 125.072 1.349 . . . . 0.0 112.719 -172.037 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.17 23.12 1.08 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.745 2.418 . . . . 0.0 113.544 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 62.96 12.04 5.56 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.938 2.095 . . . . 0.0 112.113 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -154.68 -36.35 0.09 Allowed 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 120.84 -1.163 . . . . 0.0 111.0 -164.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.6 -45.76 71.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -62.26 -37.76 86.67 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.386 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.47 -37.62 56.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.99 0.916 . . . . 0.0 109.289 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.57 89.45 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.948 0.899 . . . . 0.0 111.434 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -75.79 -16.75 60.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.315 -0.866 . . . . 0.0 111.583 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -76.6 -36.89 57.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.2 80.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.655 1.182 . . . . 0.0 111.19 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -55.83 -42.45 75.74 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 123.719 0.807 . . . . 0.0 111.7 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.9 -28.82 67.03 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.27 1.028 . . . . 0.0 110.601 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -41.59 87.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 tp -64.83 -39.43 93.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 122.632 0.373 . . . . 0.0 111.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -54.52 -46.09 73.48 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.206 0.602 . . . . 0.0 111.847 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -74.44 -32.26 62.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.88 -1.137 . . . . 0.0 111.855 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.65 -42.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.781 -1.2 . . . . 0.0 109.706 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.47 -30.42 69.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.923 -1.11 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -65.04 -41.64 95.01 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.607 -1.308 . . . . 0.0 111.033 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -62.29 -47.05 86.02 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.16 0.981 . . . . 0.0 109.268 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -27.89 69.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.76 0.824 . . . . 0.0 112.39 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.7 m -63.18 -33.33 75.24 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.366 1.067 . . . . 0.0 111.379 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -72.56 -36.37 68.21 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.22 -47.55 67.56 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -47.17 79.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.992 1.717 . . . . 0.0 112.672 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.6 -30.33 46.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 O-C-N 120.748 -1.22 . . . . 0.0 110.789 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.06 -41.74 41.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.677 -1.264 . . . . 0.0 108.515 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.51 38.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 128.005 2.522 . . . . 0.0 108.634 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -63.82 -50.71 67.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.509 1.124 . . . . 0.0 111.134 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.0 ttp85 -81.55 101.58 10.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 119.681 -1.887 . . . . 0.0 111.266 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -27.18 2.16 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 104.593 -3.403 . . . . 0.0 104.593 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 151.13 62.79 Favored Pre-proline 0 N--CA 1.439 -1.025 0 C-N-CA 124.016 0.927 . . . . 0.0 111.932 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -77.62 105.5 2.04 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.878 2.386 . . . . 0.0 112.12 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.67 11.62 11.28 Favored Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.91 132.3 5.34 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 127.442 2.297 . . . . 0.0 115.276 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.06 -61.69 1.65 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.279 1.032 . . . . 0.0 111.166 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.79 106.85 18.35 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-O 122.257 1.027 . . . . 0.0 112.798 -171.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 ' H ' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -111.41 169.58 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 O-C-N 120.266 -1.521 . . . . 0.0 108.586 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 m 71.81 146.01 0.07 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.771 2.428 . . . . 0.0 113.141 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -72.69 -51.58 6.8 Favored Pre-proline 0 C--N 1.349 0.583 0 CA-C-O 115.925 -1.988 . . . . 0.0 111.886 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.14 -11.02 26.71 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 125.338 2.942 . . . . 0.0 111.992 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.2 -34.7 11.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.1 96.04 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.037 -1.04 . . . . 0.0 110.771 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.88 -33.4 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 122.753 0.421 . . . . 0.0 111.562 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -28.79 65.45 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.152 -1.592 . . . . 0.0 110.763 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -76.93 -40.55 46.77 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 107.962 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -63.87 -30.81 71.86 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 121.026 -1.046 . . . . 0.0 112.61 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.23 -36.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-N 118.723 0.692 . . . . 0.0 110.155 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -63.19 -61.1 2.6 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -50.33 -36.99 34.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.176 1.79 . . . . 0.0 113.25 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.38 97.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.707 1.203 . . . . 0.0 111.71 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -91.51 4.68 51.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.283 30.1 p 66.86 -136.54 0.14 Allowed 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 127.304 2.242 . . . . 0.0 108.244 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 t 69.19 -79.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.64 87.45 0.47 Allowed Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -72.01 -33.31 67.97 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.399 -1.059 . . . . 0.0 108.263 -170.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.57 16.55 1.65 Allowed Glycine 0 CA--C 1.489 -1.575 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -58.93 -56.36 23.25 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 117.838 0.819 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 166.34 24.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 174.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.8 142.7 19.21 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 102.314 -3.217 . . . . 0.0 102.314 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 96.5 Cg_endo -84.06 162.53 13.6 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.02 2.48 . . . . 0.0 110.132 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.77 176.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 122.288 1.042 . . . . 0.0 108.965 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.514 ' HA ' ' CE2' ' D' ' 46' ' ' TRP . 0.2 OUTLIER -61.67 -47.8 83.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 127.59 2.356 . . . . 0.0 114.219 -166.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -81.48 1.09 34.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 118.967 -2.333 . . . . 0.0 110.246 -170.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -61.24 -32.43 72.23 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-O 123.372 1.558 . . . . 0.0 107.797 175.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.0 85.78 0.96 Allowed Glycine 0 CA--C 1.471 -2.714 1 N-CA-C 100.995 -4.842 . . . . 0.0 100.995 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.6 ' HB2' ' CE2' ' D' ' 46' ' ' TRP . 1.7 ttp85 -58.62 -9.0 1.44 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 118.24 1.02 . . . . 0.0 113.202 -169.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -45.96 -35.9 5.07 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.207 1.403 . . . . 0.0 112.659 160.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.36 -59.5 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.12 77.21 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.503 0.721 . . . . 0.0 112.436 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.16 -39.08 71.78 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.595 2.358 . . . . 0.0 111.57 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -70.13 -31.03 68.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 t -71.65 -41.76 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 O-C-N 121.512 -0.742 . . . . 0.0 109.073 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 59.9 mtt -56.28 -49.52 74.01 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.604 1.162 . . . . 0.0 110.433 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -66.76 -37.24 84.23 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.15 -0.969 . . . . 0.0 110.647 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.56 87.34 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.152 -0.968 . . . . 0.0 111.015 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.08 -38.94 63.51 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -70.88 -35.77 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 O-C-N 121.289 -1.124 . . . . 0.0 109.348 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.87 -38.15 89.7 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 120.429 -1.419 . . . . 0.0 112.285 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.51 -39.11 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -78.17 -30.43 49.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.477 0.58 . . . . 0.0 109.922 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.89 89.08 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 123.575 0.75 . . . . 0.0 110.494 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.91 -30.31 71.3 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.849 1.26 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.48 -11.99 7.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 C-N-CA 125.327 1.451 . . . . 0.0 110.614 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.8 t -53.55 -25.74 18.33 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 119.728 -1.857 . . . . 0.0 112.621 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -18.98 63.82 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.094 -1.004 . . . . 0.0 109.716 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.85 -50.8 7.23 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.47 -48.42 69.94 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.428 1.091 . . . . 0.0 113.423 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.18 -12.6 60.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -84.7 -27.25 27.15 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -32.97 74.6 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.557 -1.339 . . . . 0.0 110.991 -159.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -62.38 -30.64 71.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.32 -0.862 . . . . 0.0 112.837 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.78 -24.37 35.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.237 1.415 . . . . 0.0 108.819 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -59.35 -24.14 63.12 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.31 -0.869 . . . . 0.0 112.471 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -64.87 -28.55 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.972 -1.08 . . . . 0.0 110.395 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.51 -24.34 58.98 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 119.253 0.933 . . . . 0.0 109.805 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.4 -42.3 54.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.195 -0.941 . . . . 0.0 108.922 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -72.05 -30.51 65.22 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.663 -0.648 . . . . 0.0 110.726 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -66.98 -31.37 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.865 -1.147 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -72.59 -41.34 65.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.143 -0.973 . . . . 0.0 108.686 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.94 27.01 27.46 Favored Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.963 . . . . 0.0 111.266 -179.477 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.401 ' H ' ' HG3' ' B' ' 5' ' ' GLU . . . -81.51 175.44 10.52 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.367 0.603 . . . . 0.0 109.773 -174.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.92 -52.63 31.68 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 127.696 2.398 . . . . 0.0 111.709 -172.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -73.33 -19.53 61.0 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.264 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' B' ' 2' ' ' ALA . 3.1 mm-40 -82.33 -32.53 29.33 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.49 -25.44 61.41 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.623 -0.673 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.27 -49.85 72.46 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.568 1.147 . . . . 0.0 108.879 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.56 87.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.03 1.332 . . . . 0.0 110.838 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.23 -37.95 87.36 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.924 0.89 . . . . 0.0 110.75 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -69.46 -25.94 64.34 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.42 -1.425 . . . . 0.0 110.702 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.91 71.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 120.701 -1.249 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.439 ' CD ' ' HZ1' ' C' ' 76' ' ' LYS . 5.1 mm-40 -59.0 -37.61 77.26 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.742 1.217 . . . . 0.0 111.553 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.29 -30.78 71.27 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.587 1.555 . . . . 0.0 110.11 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -70.64 -42.67 70.53 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.536 1.134 . . . . 0.0 108.57 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.21 -38.61 91.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 123.865 0.866 . . . . 0.0 111.364 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -63.77 -29.72 70.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.446 -0.784 . . . . 0.0 111.789 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -75.58 -30.28 59.59 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.858 -1.151 . . . . 0.0 110.637 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.11 -38.9 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.87 -44.95 78.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 124.069 0.948 . . . . 0.0 111.784 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.85 -48.88 67.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.337 0.655 . . . . 0.0 110.31 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.14 -24.2 60.56 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.936 -1.102 . . . . 0.0 110.898 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 -26.03 62.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 120.981 -1.075 . . . . 0.0 111.532 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -63.75 -46.8 83.66 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.64 -45.31 87.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.667 1.187 . . . . 0.0 109.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -60.55 -59.11 5.92 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.446 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.02 89.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 111.804 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.79 -35.71 61.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.72 -1.238 . . . . 0.0 110.317 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.16 -39.17 55.53 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.047 -1.033 . . . . 0.0 109.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.59 70.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 127.072 2.149 . . . . 0.0 109.461 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.58 61.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.816 -0.552 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -72.83 95.94 2.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.693 -1.879 . . . . 0.0 111.379 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.18 -11.95 3.3 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.63 152.65 47.32 Favored Pre-proline 0 N--CA 1.442 -0.845 0 O-C-N 121.254 -1.144 . . . . 0.0 109.496 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.64 152.75 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.022 2.481 . . . . 0.0 109.576 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -78.14 1.8 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.509 -3.437 . . . . 0.0 104.509 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.13 138.71 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 129.226 3.01 . . . . 0.0 111.247 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.73 -39.85 1.95 Allowed 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 120.278 -1.514 . . . . 0.0 108.289 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -100.18 137.24 38.88 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.79 0.805 . . . . 0.0 109.575 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.6 pt -147.02 175.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 100.497 -3.89 . . . . 0.0 100.497 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m 72.77 129.88 0.04 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 112.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -67.77 -48.71 41.13 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 116.818 -1.563 . . . . 0.0 110.102 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.66 -13.08 29.66 Favored 'Trans proline' 0 CA--C 1.509 -0.751 0 CA-C-N 124.987 2.817 . . . . 0.0 113.004 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.24 -25.83 17.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.988 1.267 . . . . 0.0 107.649 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.66 81.48 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.359 -0.838 . . . . 0.0 111.162 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.04 -34.12 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 121.444 -0.785 . . . . 0.0 110.301 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -36.35 72.08 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.801 -1.187 . . . . 0.0 110.327 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -64.49 -44.26 91.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.44 1.496 . . . . 0.0 109.368 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -57.74 -39.36 77.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.867 1.667 . . . . 0.0 111.3 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -53.84 -51.98 39.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 124.716 1.206 . . . . 0.0 111.271 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -71.9 -22.08 61.55 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.762 0.71 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.0 m -74.07 -40.71 62.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.017 0.927 . . . . 0.0 108.757 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -28.83 63.49 Favored 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 121.142 -0.974 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.4 p -84.64 3.83 35.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.568 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 53.82 51.58 14.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.822 1.649 . . . . 0.0 111.062 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -117.81 -111.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.105 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.21 76.39 1.22 Allowed Glycine 0 CA--C 1.483 -1.924 0 N-CA-C 104.804 -3.318 . . . . 0.0 104.804 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -74.49 -16.59 60.84 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.868 -1.371 . . . . 0.0 109.745 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.75 52.85 0.53 Allowed Glycine 0 CA--C 1.481 -2.092 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.15 -59.12 2.9 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -144.02 174.93 10.42 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -142.28 129.35 11.19 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.82 165.87 27.89 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 124.116 3.211 . . . . 0.0 110.318 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.449 HG21 ' H ' ' B' ' 64' ' ' THR . 3.8 p -101.61 -167.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 122.752 1.263 . . . . 0.0 109.234 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.449 ' H ' HG21 ' B' ' 63' ' ' VAL . 3.1 p -86.89 -39.68 15.58 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.872 -1.767 . . . . 0.0 109.245 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.62 -9.12 59.8 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.011 1.725 . . . . 0.0 110.884 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.39 -23.79 61.95 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-O 124.297 1.998 . . . . 0.0 107.18 169.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.54 75.72 1.27 Allowed Glycine 0 CA--C 1.468 -2.873 1 N-CA-C 101.978 -4.449 . . . . 0.0 101.978 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -47.61 -12.2 0.03 OUTLIER 'General case' 0 C--N 1.373 1.587 0 C-N-CA 129.96 3.304 . . . . 0.0 113.729 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -50.63 -19.62 0.97 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.458 1.903 . . . . 0.0 113.627 158.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.93 -54.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 CA-C-N 122.089 2.222 . . . . 0.0 107.342 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.54 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.324 0.583 . . . . 0.0 110.733 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.89 -42.66 80.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.269 1.428 . . . . 0.0 111.996 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.96 -40.96 95.79 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.392 1.077 . . . . 0.0 110.1 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.09 -46.92 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 C-N-CA 123.536 0.734 . . . . 0.0 109.578 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 46.1 mtp -59.23 -48.77 80.37 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.18 0.992 . . . . 0.0 110.285 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -61.99 -41.02 97.58 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.167 0.987 . . . . 0.0 110.771 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.59 91.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 123.01 0.524 . . . . 0.0 111.122 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.64 -49.57 63.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.37 -44.66 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 124.192 0.997 . . . . 0.0 109.316 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.68 -38.35 90.71 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.788 -1.195 . . . . 0.0 111.754 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.48 -53.03 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.207 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.2 -11.63 60.58 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.336 0.655 . . . . 0.0 112.118 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.99 -21.13 15.13 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 123.755 0.822 . . . . 0.0 109.657 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.94 -28.13 64.27 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 119.632 -1.918 . . . . 0.0 108.976 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.16 -14.94 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.943 0.897 . . . . 0.0 111.996 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 66.8 m -58.95 -12.44 4.55 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 125.936 1.694 . . . . 0.0 111.674 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.82 -26.05 68.55 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.538 -1.976 . . . . 0.0 112.388 167.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.01 -30.81 27.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 119.856 -1.778 . . . . 0.0 108.742 175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.26 31.42 0.65 Allowed 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 126.04 1.736 . . . . 0.0 109.29 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.6 -1.98 1.11 Allowed 'General case' 0 N--CA 1.433 -1.316 0 O-C-N 120.59 -1.318 . . . . 0.0 108.26 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -116.85 16.94 15.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -83.2 -48.52 10.41 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.354 2.262 . . . . 0.0 107.188 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -65.2 -20.41 66.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.481 1.113 . . . . 0.0 111.648 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.55 -28.53 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 124.657 1.183 . . . . 0.0 109.375 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -65.65 -21.72 66.58 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 124.51 1.124 . . . . 0.0 111.916 -172.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -19.18 63.33 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.828 -1.17 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -96.26 179.58 4.99 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.311 7.6 mt-10 70.21 -59.26 0.52 Allowed 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.355 1.462 . . . . 0.0 112.058 -172.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -30.71 70.16 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.935 1.294 . . . . 0.0 109.762 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.91 -33.35 61.98 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 126.568 1.947 . . . . 0.0 112.796 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -110.35 -0.8 17.47 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 108.651 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.2 11.46 85.03 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 121.402 -0.811 . . . . 0.0 112.363 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 CA--C 1.504 -0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 110.865 -171.289 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.15 -7.53 0.95 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.304 2.242 . . . . 0.0 113.69 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . 0.28 38.1 m-20 19.17 68.35 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.911 1 C-N-CA 132.657 4.383 . . . . 0.0 113.328 -173.68 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -161.68 -45.61 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.48 -47.69 83.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.879 2.072 . . . . 0.0 110.263 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -80.73 -6.63 58.72 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.645 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.84 -47.36 11.95 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.65 93.85 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.044 0.938 . . . . 0.0 110.632 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -57.11 -38.28 73.18 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.815 1.246 . . . . 0.0 111.751 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -72.92 -28.11 62.26 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.167 -0.958 . . . . 0.0 110.446 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.27 -40.29 77.9 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.056 0.542 . . . . 0.0 109.695 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.11 -40.33 93.36 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.515 0.726 . . . . 0.0 110.947 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.36 -38.8 81.33 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.74 0.816 . . . . 0.0 111.442 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.29 -40.09 93.39 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.116 1.366 . . . . 0.0 109.519 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.49 -38.65 91.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.555 -0.716 . . . . 0.0 111.055 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.44 -31.8 72.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.382 -0.824 . . . . 0.0 112.149 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -67.73 -39.65 84.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.05 0.94 . . . . 0.0 109.368 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.54 -32.61 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 124.286 1.034 . . . . 0.0 109.035 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.3 -44.95 88.78 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.016 0.825 . . . . 0.0 111.176 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.54 -38.27 80.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.398 0.679 . . . . 0.0 110.242 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.56 -44.42 86.79 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 121.186 -0.946 . . . . 0.0 109.077 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.18 72.91 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.807 1.643 . . . . 0.0 111.41 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -59.42 -47.6 84.84 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.006 0.922 . . . . 0.0 111.553 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -45.69 69.76 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 125.149 1.38 . . . . 0.0 108.221 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.64 -36.07 78.12 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.893 0.477 . . . . 0.0 111.01 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.73 -44.42 61.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 123.825 0.85 . . . . 0.0 110.73 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.57 -32.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 121.471 -0.768 . . . . 0.0 110.018 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -84.66 -12.85 53.09 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.108 -0.995 . . . . 0.0 111.382 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.4 78.73 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -81.33 -10.12 59.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.764 0.792 . . . . 0.0 111.535 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -78.97 81.96 5.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 119.921 -1.737 . . . . 0.0 108.3 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.09 0.51 4.22 Favored Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.21 42.89 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.37 112.51 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.533 2.155 . . . . 0.0 113.388 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.26 -46.27 0.67 Allowed Glycine 0 CA--C 1.482 -1.999 1 N-CA-C 101.949 -4.461 . . . . 0.0 101.949 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 73.16 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.626 1.97 . . . . 0.0 108.419 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.6 -71.39 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 112.573 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 tt -100.68 120.35 39.94 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.48 13.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 28.3 t -109.67 130.49 55.51 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.72 -56.36 9.74 Favored Pre-proline 0 C--N 1.349 0.572 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.026 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.02 -12.07 25.73 Favored 'Trans proline' 0 CA--C 1.511 -0.669 0 CA-C-N 124.988 2.817 . . . . 0.0 111.386 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.83 -20.34 21.58 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 119.366 0.985 . . . . 0.0 108.7 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.49 -36.25 83.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.338 -0.851 . . . . 0.0 109.95 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -72.35 -25.92 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.876 1.27 . . . . 0.0 110.557 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 -42.27 37.02 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.525 -1.359 . . . . 0.0 107.812 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -70.07 -32.47 70.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.657 0.783 . . . . 0.0 110.684 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 54.6 p -68.67 -27.52 66.06 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.249 -1.532 . . . . 0.0 111.311 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.03 -53.57 47.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 CA-C-N 119.14 0.882 . . . . 0.0 109.601 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.96 -10.94 59.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.812 -0.555 . . . . 0.0 112.005 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -81.12 -33.32 33.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.172 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -35.55 75.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.775 -1.203 . . . . 0.0 111.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.46 0.73 48.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 122.039 -0.413 . . . . 0.0 110.596 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.9 p 65.42 20.18 11.72 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 126.085 1.754 . . . . 0.0 111.493 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.79 -55.89 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.39 44.31 97.81 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 121.629 -0.669 . . . . 0.0 112.125 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.84 -40.65 73.13 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.616 1.567 . . . . 0.0 110.518 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.59 -122.79 1.12 Allowed Glycine 0 CA--C 1.48 -2.14 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.322 4.4 t0 62.62 -85.29 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 127.072 2.149 . . . . 0.0 108.947 -168.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -119.67 169.07 10.42 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.34 148.72 21.48 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.92 176.58 7.49 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.033 2.488 . . . . 0.0 108.695 171.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.458 HG13 ' H ' ' C' ' 64' ' ' THR 0.285 9.9 p -101.2 -121.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 170.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.458 ' H ' HG13 ' C' ' 63' ' ' VAL . 12.6 m -107.34 -82.67 0.55 Allowed 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 120.283 -1.511 . . . . 0.0 107.174 -171.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.05 122.41 12.98 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.101 1.36 . . . . 0.0 109.406 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . 0.28 6.6 tt0 76.33 -68.63 0.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.301 -1.333 . . . . 0.0 112.637 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -37.15 -49.07 1.54 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 128.216 2.817 . . . . 0.0 114.646 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -75.31 -38.46 60.26 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.798 1.239 . . . . 0.0 112.094 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -76.48 -29.74 56.99 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.84 -44.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 O-C-N 119.766 -1.834 . . . . 0.0 109.08 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.14 99.37 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 111.205 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -48.82 -44.85 39.69 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.692 1.997 . . . . 0.0 112.194 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -63.94 -40.1 95.66 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.69 -39.23 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 124.342 1.057 . . . . 0.0 109.263 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.42 -45.86 87.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . 0.439 ' HZ1' ' CD ' ' B' ' 12' ' ' GLU . 23.2 ttmm -63.28 -39.34 94.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.696 0.799 . . . . 0.0 110.931 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.48 71.61 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.914 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.65 -49.87 7.63 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.13 -46.29 84.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 110.167 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.62 -31.83 73.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.421 -0.799 . . . . 0.0 112.572 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.59 -51.59 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -66.17 -33.98 77.01 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 122.878 0.471 . . . . 0.0 110.975 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.56 83.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.53 1.132 . . . . 0.0 110.517 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.72 -22.16 66.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.772 1.229 . . . . 0.0 112.935 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -59.59 -19.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 124.892 1.277 . . . . 0.0 110.401 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -57.77 -20.42 34.95 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 112.631 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.0 51.15 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.311 -1.493 . . . . 0.0 112.422 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.09 -31.57 11.7 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.792 1.237 . . . . 0.0 110.644 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 35.1 mt -82.62 -41.43 19.47 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.428 -0.795 . . . . 0.0 109.956 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.84 72.75 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.5 1.12 . . . . 0.0 109.62 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -16.79 64.13 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.522 -1.361 . . . . 0.0 112.098 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.36 -24.42 59.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.497 1.044 . . . . 0.0 110.518 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -37.97 61.3 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 120.705 -1.247 . . . . 0.0 109.705 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.25 -27.85 42.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 125.32 1.448 . . . . 0.0 110.191 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -59.72 -22.52 62.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.342 1.057 . . . . 0.0 113.027 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . 0.3 18.3 ptt85 -69.46 -28.59 66.23 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 121.254 1.843 . . . . 0.0 111.506 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.8 -13.45 59.8 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 119.621 -1.924 . . . . 0.0 110.345 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.441 ' OE1' ' HE1' ' C' ' 103' ' ' HIS . 87.4 mt-10 -87.76 -36.72 17.16 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.269 -0.895 . . . . 0.0 108.924 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -51.97 -42.73 63.13 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 128.008 2.523 . . . . 0.0 109.545 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -45.66 -37.66 5.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.368 2.667 . . . . 0.0 114.289 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -90.62 -12.91 35.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.329 -0.857 . . . . 0.0 110.459 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.08 82.38 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 123.85 0.738 . . . . 0.0 111.74 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.441 ' HE1' ' OE1' ' C' ' 98' ' ' GLU . 83.9 m-70 . . . . . 0 CA--C 1.504 -0.795 0 C-N-CA 124.527 1.131 . . . . 0.0 111.202 -172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 144.98 33.96 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -55.85 -46.28 78.23 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.087 2.155 . . . . 0.0 110.466 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CD2' ' CB ' ' D' ' 87' ' ' ALA 0.252 1.4 m80 -81.15 -16.34 53.25 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -169.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.06 -30.82 31.17 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.418 1.008 . . . . 0.0 109.166 169.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -63.42 -46.1 87.94 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.54 -31.17 66.74 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.97 -0.457 . . . . 0.0 110.4 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.21 70.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 121.353 -0.842 . . . . 0.0 110.744 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -69.84 -29.95 67.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.835 -0.54 . . . . 0.0 111.574 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.27 -40.62 91.0 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.713 0.805 . . . . 0.0 110.232 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.46 84.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.591 0.756 . . . . 0.0 111.445 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.19 -37.88 81.56 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 121.459 -0.775 . . . . 0.0 110.912 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -70.96 -26.53 63.2 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.981 -1.075 . . . . 0.0 111.337 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -76.15 -34.19 59.38 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.23 -39.53 93.12 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.33 0.652 . . . . 0.0 111.164 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.02 -35.19 74.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.615 0.766 . . . . 0.0 111.916 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -67.11 -39.25 86.64 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.691 -0.631 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.65 -39.85 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.075 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . 0.527 HD22 ' H ' ' D' ' 49' ' ' VAL . 87.3 mt -64.84 -37.5 87.84 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.136 0.974 . . . . 0.0 112.478 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -67.84 -32.69 73.38 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.61 0.719 . . . . 0.0 111.577 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.79 -36.4 28.48 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.417 -0.802 . . . . 0.0 108.949 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.35 84.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 125.455 1.502 . . . . 0.0 111.992 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -66.77 -40.95 88.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.597 0.713 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -69.09 -39.47 78.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 109.175 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -73.59 -40.33 63.96 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.855 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.21 80.89 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.092 1.357 . . . . 0.0 112.642 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.96 -38.05 81.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 O-C-N 120.832 -1.168 . . . . 0.0 111.647 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.91 -23.17 36.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.964 -1.085 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.24 -52.81 20.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.641 1.976 . . . . 0.0 107.774 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.02 -33.44 70.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.582 1.182 . . . . 0.0 111.946 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -68.93 104.77 2.17 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.63 -1.919 . . . . 0.0 112.14 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.06 -33.92 1.98 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 104.824 -3.311 . . . . 0.0 104.824 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.41 150.64 73.95 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 123.771 0.828 . . . . 0.0 110.412 -173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.46 145.63 23.81 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.064 1.842 . . . . 0.0 109.301 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.11 17.57 74.07 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 118.563 0.619 . . . . 0.0 112.125 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.49 128.41 22.79 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.891 1.676 . . . . 0.0 113.573 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.44 -39.46 1.02 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.993 1.317 . . . . 0.0 109.709 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.39 15.3 1.28 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.84 1.656 . . . . 0.0 111.609 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tp -98.63 121.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 119.6 -1.937 . . . . 0.0 108.257 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.8 p -172.82 -105.06 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.81 -65.21 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.006 0 C-N-CA 128.111 2.565 . . . . 0.0 106.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 -18.98 28.24 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 124.837 2.763 . . . . 0.0 110.804 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.62 -22.56 26.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.87 -33.64 62.11 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 120.941 -1.099 . . . . 0.0 111.468 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.67 -20.79 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.607 1.194 . . . . 0.0 108.747 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.6 ' CE2' ' HB2' ' A' ' 68' ' ' ARG . 24.9 t90 -77.55 -40.43 42.51 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.336 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -60.14 -44.14 95.19 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.19 1.396 . . . . 0.0 109.925 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 82.3 p -74.97 -169.76 0.97 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.999 0.904 . . . . 0.0 108.982 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . 0.527 ' H ' HD22 ' D' ' 19' ' ' LEU 0.352 2.1 t 71.58 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.955 2.102 . . . . 0.0 110.683 -170.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -28.63 70.13 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.618 1.099 . . . . 0.0 110.415 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -29.87 69.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.037 0.935 . . . . 0.0 111.126 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.75 49.42 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.809 -1.182 . . . . 0.0 109.844 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -83.74 3.63 32.43 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.442 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 71.2 p 54.61 59.59 4.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.252 2.221 . . . . 0.0 111.871 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -109.06 -89.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.45 60.45 1.45 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -9.95 59.24 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 121.674 -0.898 . . . . 0.0 111.498 -170.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.37 35.35 3.63 Favored Glycine 0 CA--C 1.486 -1.763 0 O-C-N 120.467 -1.395 . . . . 0.0 110.81 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.02 -65.23 0.8 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -138.01 153.76 49.37 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 102.957 -2.979 . . . . 0.0 102.957 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.69 144.22 48.05 Favored Pre-proline 0 N--CA 1.44 -0.937 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.01 165.9 25.62 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.249 2.632 . . . . 0.0 109.546 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.517 HG12 ' H ' ' D' ' 64' ' ' THR . 2.8 t -103.69 -153.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.517 ' H ' HG12 ' D' ' 63' ' ' VAL . 0.2 OUTLIER -93.14 -54.29 3.78 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 119.619 -1.926 . . . . 0.0 109.279 -161.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.03 3.65 33.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 109.245 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -25.91 62.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.85 55.54 1.4 Allowed Glycine 0 CA--C 1.466 -3.012 0 N-CA-C 104.575 -3.41 . . . . 0.0 104.575 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -21.42 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.376 1.733 1 C-N-CA 133.878 4.871 . . . . 0.0 116.825 -174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -52.47 -16.21 0.84 Allowed 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 125.601 1.56 . . . . 0.0 113.256 162.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.05 -47.39 88.09 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 122.246 2.294 . . . . 0.0 108.449 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.94 -47.84 73.35 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.099 0.56 . . . . 0.0 110.63 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.03 -38.95 80.5 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 111.704 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -67.79 -29.33 68.49 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.561 -1.337 . . . . 0.0 111.44 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.71 -42.13 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 121.307 -0.87 . . . . 0.0 108.672 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.54 -49.71 76.44 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.717 1.207 . . . . 0.0 109.829 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -65.32 -37.77 88.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.015 -0.428 . . . . 0.0 111.298 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.94 92.38 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -50.39 61.49 Favored Glycine 0 CA--C 1.49 -1.478 0 C-N-CA 124.129 0.871 . . . . 0.0 111.067 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -57.83 -48.29 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.387 1.075 . . . . 0.0 109.598 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.05 -32.05 73.57 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 t -65.62 -55.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-N 119.371 0.987 . . . . 0.0 109.388 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.63 -38.6 84.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.324 0.583 . . . . 0.0 110.375 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.53 63.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.346 -0.847 . . . . 0.0 111.047 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.06 -30.9 71.5 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.182 -1.574 . . . . 0.0 110.118 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 -12.47 7.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.804 1.242 . . . . 0.0 110.68 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -52.79 -22.82 5.78 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.448 -1.408 . . . . 0.0 111.621 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.427 ' CB ' ' CD2' ' D' ' 4' ' ' HIS . . . -73.54 -19.26 60.95 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 119.466 -2.021 . . . . 0.0 114.423 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.32 -41.8 15.19 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.91 -40.98 90.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 112.525 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.83 64.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.201 -0.937 . . . . 0.0 111.871 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -92.14 -1.0 57.42 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 120.777 -1.202 . . . . 0.0 108.462 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -74.58 -30.22 61.63 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 119.253 0.933 . . . . 0.0 109.753 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -80.83 -31.8 35.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 120.597 -1.314 . . . . 0.0 111.524 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -23.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 125.163 1.385 . . . . 0.0 109.294 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -50.16 -35.35 25.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 125.606 1.563 . . . . 0.0 113.256 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -71.24 -16.57 62.5 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.315 -0.866 . . . . 0.0 110.87 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -77.45 -43.88 30.91 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.38 -45.29 76.69 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.517 -0.74 . . . . 0.0 111.454 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.4 -9.91 59.19 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.281 -0.887 . . . . 0.0 111.5 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 18.8 ttp-105 -70.25 -31.09 68.32 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -78.92 -23.6 44.59 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.163 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.07 17.15 59.78 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 . . . . . 0 C--N 1.357 0.905 0 C-N-CA 125.916 1.686 . . . . 0.0 112.409 -178.182 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -72.08 0.23 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 123.225 0.61 . . . . 0.0 109.407 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -151.85 -82.49 0.09 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -0.28 31.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 121.068 -1.02 . . . . 0.0 113.324 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -30.06 68.26 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.334 1.454 . . . . 0.0 108.248 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -66.88 -37.9 85.29 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.606 0.763 . . . . 0.0 109.05 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.7 -28.55 36.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.38 76.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.421 0.629 . . . . 0.0 111.16 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -75.32 -23.49 57.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.568 -0.707 . . . . 0.0 111.043 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.84 -36.03 77.68 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.588 -0.695 . . . . 0.0 109.51 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.84 71.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.976 -1.078 . . . . 0.0 111.471 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.83 -23.22 65.14 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.417 -0.802 . . . . 0.0 111.97 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.47 -43.09 67.24 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 120.658 -1.276 . . . . 0.0 109.242 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.48 -39.14 92.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.653 1.181 . . . . 0.0 108.645 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.24 -43.29 92.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.003 0.521 . . . . 0.0 111.562 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.17 -30.9 71.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.812 0.845 . . . . 0.0 111.905 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -69.43 -39.8 77.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.49 -0.756 . . . . 0.0 109.646 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.8 -38.79 82.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 O-C-N 121.29 -0.881 . . . . 0.0 109.202 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -58.77 -42.68 89.53 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.788 0.835 . . . . 0.0 111.618 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.82 -28.53 62.61 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.33 1.052 . . . . 0.0 111.737 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -73.73 -46.12 47.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.745 -1.222 . . . . 0.0 107.798 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -27.95 68.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.761 1.225 . . . . 0.0 112.221 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 p -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.654 1.116 . . . . 0.0 110.791 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.32 -43.62 77.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.58 -44.72 95.61 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.02 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 126.212 1.805 . . . . 0.0 112.42 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.2 m -64.66 -34.94 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 119.955 1.252 . . . . 0.0 112.131 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -78.18 -35.48 48.64 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 125.256 1.423 . . . . 0.0 108.38 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -51.2 10.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 124.662 1.185 . . . . 0.0 108.505 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.03 -40.66 87.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.085 0.945 . . . . 0.0 110.267 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -77.23 104.82 7.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 119.802 -1.811 . . . . 0.0 111.349 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -21.89 2.36 Favored Glycine 0 CA--C 1.49 -1.489 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.23 89.0 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 123.4 0.68 . . . . 0.0 110.702 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.68 126.05 11.69 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.971 2.448 . . . . 0.0 110.105 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -67.81 3.26 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 106.069 -2.812 . . . . 0.0 106.069 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.7 -172.98 0.18 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 126.516 1.926 . . . . 0.0 108.55 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.81 -40.41 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.969 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.33 -68.47 0.64 Allowed 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt 32.02 37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 128.326 2.65 . . . . 0.0 114.934 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -148.72 133.6 18.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -79.67 -52.14 1.12 Allowed Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-O 116.01 -1.947 . . . . 0.0 110.8 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.71 -13.42 29.66 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 CA-C-N 126.145 3.23 . . . . 0.0 111.73 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.57 -27.79 29.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.487 1.515 . . . . 0.0 108.559 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.46 -33.72 76.6 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.778 0.831 . . . . 0.0 111.785 -167.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -73.56 -24.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 123.836 0.855 . . . . 0.0 110.376 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.85 -32.45 21.71 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 120.744 -1.222 . . . . 0.0 108.766 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -70.23 -35.57 73.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.554 1.169 . . . . 0.0 108.974 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -81.27 62.47 5.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 120.674 -1.266 . . . . 0.0 108.907 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.87 -68.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -46.88 -32.99 4.15 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 130.107 3.363 . . . . 0.0 114.231 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -69.21 -37.61 78.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.879 1.672 . . . . 0.0 109.851 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.43 58.17 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 120.177 -1.577 . . . . 0.0 109.724 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -79.59 -11.09 59.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.416 1.487 . . . . 0.0 109.319 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 54.11 62.88 2.38 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.848 2.059 . . . . 0.0 112.144 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.49 -84.17 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.58 -84.66 0.36 Allowed Glycine 0 CA--C 1.482 -2.0 1 N-CA-C 101.902 -4.479 . . . . 0.0 101.902 -173.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.431 ' CZ ' ' HA2' ' B' ' 56' ' ' GLY . 0.1 OUTLIER 65.13 -69.87 0.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 127.046 2.138 . . . . 0.0 111.448 179.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.32 53.15 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.722 0 O-C-N 120.529 -1.357 . . . . 0.0 115.507 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.12 -64.87 0.89 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.241 2.02 . . . . 0.0 108.113 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.82 179.05 6.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -157.72 152.82 21.51 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.47 172.22 13.8 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.782 2.988 . . . . 0.0 109.409 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 t -115.92 -100.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 119.463 1.029 . . . . 0.0 108.535 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -140.77 -44.0 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.12 -16.21 41.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.406 -0.809 . . . . 0.0 111.793 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -61.06 -35.95 78.31 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.928 1.291 . . . . 0.0 108.11 171.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 97.81 2.02 Favored Glycine 0 N--CA 1.418 -2.53 1 N-CA-C 97.548 -6.221 . . . . 0.0 97.548 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -62.08 -16.62 53.53 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 119.239 1.519 . . . . 0.0 110.112 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.46 -10.14 4.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 125.196 1.398 . . . . 0.0 112.97 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.55 -46.35 75.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 120.748 -1.22 . . . . 0.0 108.165 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.11 74.28 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -49.22 -45.15 44.04 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.529 1.532 . . . . 0.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -58.69 -47.71 83.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.759 1.224 . . . . 0.0 111.232 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.5 -42.31 72.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 O-C-N 121.749 -0.594 . . . . 0.0 109.574 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.59 -48.18 82.1 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.111 0.964 . . . . 0.0 110.105 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.52 -36.22 78.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.295 -0.878 . . . . 0.0 110.862 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.85 98.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.709 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.91 92.75 Favored Glycine 0 CA--C 1.491 -1.427 0 C-N-CA 124.244 0.926 . . . . 0.0 111.135 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.83 -45.39 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.127 0.971 . . . . 0.0 109.562 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -64.78 -33.7 76.6 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.587 -1.32 . . . . 0.0 111.6 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.8 -53.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 124.098 0.959 . . . . 0.0 109.692 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -71.36 -20.91 62.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.832 0.825 . . . . 0.0 111.395 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 -33.54 31.0 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.084 -1.635 . . . . 0.0 110.082 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.16 -39.8 91.49 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.501 1.12 . . . . 0.0 110.622 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.3 m -66.88 -6.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 O-C-N 121.65 -0.656 . . . . 0.0 112.522 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.4 m -53.69 -25.69 19.4 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 125.66 1.584 . . . . 0.0 110.427 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.14 -43.27 74.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.56 -1.337 . . . . 0.0 112.764 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -42.33 58.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.39 1.076 . . . . 0.0 109.257 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.29 -34.3 77.1 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.156 0.503 . . . . 0.0 110.68 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.41 75.88 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.824 -1.173 . . . . 0.0 111.751 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -13.1 60.0 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.757 -1.214 . . . . 0.0 111.954 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.86 -35.93 81.16 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.615 1.197 . . . . 0.0 109.106 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -73.89 -35.53 64.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 119.794 -1.816 . . . . 0.0 112.068 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.92 -25.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 125.929 1.692 . . . . 0.0 109.229 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -56.47 -24.91 49.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.775 1.63 . . . . 0.0 112.71 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.71 -16.95 59.37 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.015 -1.053 . . . . 0.0 111.132 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -72.2 -30.55 65.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.02 -41.32 91.1 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 123.31 0.644 . . . . 0.0 110.296 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.01 -30.82 71.87 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 111.339 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -65.89 -38.68 89.39 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.76 0.824 . . . . 0.0 110.363 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -96.02 -7.07 37.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.126 0.571 . . . . 0.0 110.596 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.18 24.99 60.32 Favored Glycine 0 C--N 1.347 1.142 0 C-N-CA 124.707 1.146 . . . . 0.0 111.744 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t60 . . . . . 0 C--N 1.351 0.648 0 C-N-CA 126.508 1.923 . . . . 0.0 111.416 -168.868 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.98 175.57 10.88 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.72 -63.94 0.8 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 129.811 3.245 . . . . 0.0 111.589 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -59.97 -31.95 70.36 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.849 1.26 . . . . 0.0 113.382 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -71.56 -34.03 69.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.038 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -70.69 -35.7 72.92 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 120.968 -1.082 . . . . 0.0 110.397 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.56 -35.32 67.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 -46.48 81.15 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.015 0.926 . . . . 0.0 111.334 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -66.53 -34.28 77.55 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.541 -0.725 . . . . 0.0 110.467 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.91 -41.3 99.4 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 109.996 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.87 80.72 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.652 0.781 . . . . 0.0 111.228 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.55 -31.88 73.29 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.478 -0.764 . . . . 0.0 111.957 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -70.75 -32.87 70.18 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.038 -1.038 . . . . 0.0 109.425 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.82 -34.25 77.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.88 -1.138 . . . . 0.0 109.395 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.23 -38.14 87.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.447 0.699 . . . . 0.0 110.24 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -58.42 -36.48 73.66 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 124.221 1.008 . . . . 0.0 111.766 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.23 -44.77 87.17 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.867 0.867 . . . . 0.0 110.057 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 -20.05 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 121.438 -0.789 . . . . 0.0 110.698 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.76 -48.76 79.23 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 119.564 1.074 . . . . 0.0 109.874 172.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.29 -40.5 90.07 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.06 -1.025 . . . . 0.0 110.347 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -63.55 -40.05 95.98 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.735 0.814 . . . . 0.0 111.277 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.63 98.58 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.204 1.401 . . . . 0.0 109.575 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -57.38 -35.28 69.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.187 1.395 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.71 -51.84 9.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.563 -0.711 . . . . 0.0 109.925 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -63.89 -28.61 69.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.58 -1.325 . . . . 0.0 110.796 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.75 94.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.408 1.083 . . . . 0.0 112.244 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.59 -14.69 13.77 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-O 122.35 1.071 . . . . 0.0 110.395 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -87.17 -38.61 16.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.726 -2.484 . . . . 0.0 107.862 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.22 65.79 6.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.014 1.726 . . . . 0.0 108.692 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -31.54 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.13 30.47 0.0 OUTLIER 'General case' 0 C--N 1.355 0.821 0 C-N-CA 130.527 3.531 . . . . 0.0 117.549 -168.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.84 36.66 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.12 156.69 35.74 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 119.062 1.431 . . . . 0.0 108.947 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -85.14 117.41 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.711 2.274 . . . . 0.0 112.517 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 31.35 26.34 Favored Glycine 0 CA--C 1.494 -1.269 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.84 137.87 47.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.034 0.933 . . . . 0.0 109.272 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.04 -37.99 8.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 123.529 0.732 . . . . 0.0 109.924 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.04 140.56 29.53 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 pt -156.35 37.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 CA-C-N 118.971 0.805 . . . . 0.0 109.164 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -137.59 -117.87 0.15 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 118.255 -2.778 . . . . 0.0 112.101 -158.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.68 -68.95 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.755 0 C-N-CA 128.487 2.715 . . . . 0.0 103.951 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.61 -20.05 27.32 Favored 'Trans proline' 0 CA--C 1.513 -0.55 0 CA-C-N 125.654 3.055 . . . . 0.0 111.419 -173.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.88 -25.31 61.88 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.649 1.18 . . . . 0.0 109.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.23 -36.51 79.62 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 123.542 0.737 . . . . 0.0 110.284 -167.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.89 -29.15 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.899 -0.501 . . . . 0.0 110.686 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -42.18 76.48 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.881 -1.137 . . . . 0.0 108.735 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -59.16 -48.01 83.21 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 110.09 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.5 m -57.89 -36.41 72.38 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.422 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.2 -53.69 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 123.762 0.825 . . . . 0.0 109.253 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.48 -20.88 63.73 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.279 1.038 . . . . 0.0 111.757 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -74.64 -39.77 61.89 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 120.664 -1.272 . . . . 0.0 109.253 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.29 66.91 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 120.712 -1.242 . . . . 0.0 111.933 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -1.18 56.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.646 0.778 . . . . 0.0 110.124 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 42.9 p 65.64 16.14 10.36 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.44 1.896 . . . . 0.0 111.92 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.98 -58.45 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . 62.2 56.36 22.57 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 174.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.408 ' CE2' ' HA2' ' C' ' 56' ' ' GLY . 6.2 t80 -57.43 -41.85 81.25 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.736 1.214 . . . . 0.0 110.422 -168.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.69 8.63 0.58 Allowed Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.13 -55.57 5.93 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 118.959 1.38 . . . . 0.0 111.734 -170.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.97 155.86 49.2 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -160.3 137.59 6.88 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -82.21 159.22 17.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 122.687 1.995 . . . . 0.0 112.119 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.263 34.9 m -106.33 -154.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 122.663 1.22 . . . . 0.0 111.32 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -73.41 -54.82 7.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.257 1.823 . . . . 0.0 111.434 -165.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -69.39 -16.84 63.6 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.154 1.782 . . . . 0.0 109.376 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -81.97 -18.5 43.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.53 93.34 0.65 Allowed Glycine 0 CA--C 1.483 -1.917 1 N-CA-C 102.129 -4.388 . . . . 0.0 102.129 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -53.72 -28.66 35.33 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 119.162 1.481 . . . . 0.0 110.709 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -58.16 -11.95 3.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.18 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 120.988 1.722 . . . . 0.0 109.756 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.57 -57.94 3.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -53.39 -38.89 63.82 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.089 1.356 . . . . 0.0 112.93 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -76.76 -24.56 52.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.953 -1.092 . . . . 0.0 111.104 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.16 -43.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.03 -49.95 75.96 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.236 1.014 . . . . 0.0 110.647 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -72.8 -15.72 61.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.877 -1.139 . . . . 0.0 112.162 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.18 65.5 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 120.051 -1.656 . . . . 0.0 108.626 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.05 -46.97 89.87 Favored Glycine 0 CA--C 1.492 -1.347 0 C-N-CA 124.676 1.131 . . . . 0.0 111.217 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.15 -48.5 65.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 C-N-CA 124.869 1.268 . . . . 0.0 110.421 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.35 -22.55 63.73 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 120.914 -1.116 . . . . 0.0 112.523 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.84 -53.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -62.83 -41.19 99.22 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.896 0.878 . . . . 0.0 110.439 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -30.53 71.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.766 0.826 . . . . 0.0 111.381 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.85 -30.36 67.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.965 -1.085 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.5 -14.87 11.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 120.843 -1.16 . . . . 0.0 110.324 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -61.28 -20.91 63.43 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.341 -2.099 . . . . 0.0 112.241 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.35 -17.39 62.54 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 120.47 -1.394 . . . . 0.0 111.593 172.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.5 -46.87 6.8 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 124.87 1.268 . . . . 0.0 108.605 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 55.0 mt -61.2 -38.49 86.75 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.294 -0.879 . . . . 0.0 112.414 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.87 0.13 19.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.038 -1.039 . . . . 0.0 111.212 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.1 p -97.94 -14.27 20.72 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 120.835 -1.166 . . . . 0.0 109.716 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.33 -18.86 60.64 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 119.557 1.071 . . . . 0.0 111.054 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -91.24 -16.76 27.11 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 120.658 -1.276 . . . . 0.0 112.295 170.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.43 -27.09 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -53.69 -22.35 8.85 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 126.028 1.731 . . . . 0.0 114.572 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -66.66 -28.0 68.12 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.585 -0.697 . . . . 0.0 110.063 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.14 172.19 9.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.275 46.6 mt-10 69.88 -50.2 0.63 Allowed 'General case' 0 C--N 1.35 0.589 0 C-N-CA 126.444 1.898 . . . . 0.0 112.426 -173.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -71.53 -45.2 63.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 120.154 -1.592 . . . . 0.0 108.534 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -77.04 -31.08 55.96 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.82 -0.55 . . . . 0.0 111.986 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 36.9 ttp-105 -117.12 108.71 16.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.54 -52.59 0.76 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 105.272 -3.131 . . . . 0.0 105.272 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 CA--C 1.501 -0.934 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -170.173 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 122.772 1.272 . . . . 0.0 107.58 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.58 142.27 18.83 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -89.14 -53.41 4.59 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.479 ' HE1' ' OE2' ' C' ' 5' ' ' GLU . 18.6 p80 -48.87 -35.83 15.64 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.497 1.919 . . . . 0.0 114.691 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.479 ' OE2' ' HE1' ' C' ' 4' ' ' HIS . 14.0 mt-10 -80.15 -33.57 38.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.316 -1.49 . . . . 0.0 110.567 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -73.31 -31.12 63.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.676 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.87 -49.81 69.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.148 2.179 . . . . 0.0 108.798 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.9 87.82 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.807 1.243 . . . . 0.0 112.067 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -60.17 -36.71 78.19 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.189 0.996 . . . . 0.0 111.174 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -74.66 -19.98 60.06 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.116 -0.99 . . . . 0.0 111.705 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.99 90.56 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.573 -0.704 . . . . 0.0 109.185 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -63.24 -39.0 93.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.682 1.193 . . . . 0.0 111.344 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.24 -39.83 71.43 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.762 0.825 . . . . 0.0 109.827 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.37 -31.21 71.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.405 1.082 . . . . 0.0 110.148 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.01 -47.96 73.98 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 125.505 1.522 . . . . 0.0 110.414 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.03 -35.56 80.89 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.519 0.727 . . . . 0.0 110.374 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -67.3 -49.33 64.68 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 111.308 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.9 -40.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 121.806 -0.558 . . . . 0.0 110.322 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.73 -35.06 72.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 O-C-N 122.02 -0.425 . . . . 0.0 109.99 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.82 -38.2 76.48 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 119.264 0.938 . . . . 0.0 111.465 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -20.62 46.25 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.103 -0.998 . . . . 0.0 108.399 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.04 46.75 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.958 -1.089 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m -52.48 -46.41 66.56 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 125.384 1.474 . . . . 0.0 111.528 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.72 -43.31 98.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 126.383 1.873 . . . . 0.0 108.859 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -71.48 -41.78 68.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 117.344 -1.312 . . . . 0.0 109.231 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.42 -51.8 67.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.874 1.215 . . . . 0.0 110.998 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.61 -37.23 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 O-C-N 121.617 -0.677 . . . . 0.0 110.538 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -75.39 -28.04 59.3 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.248 -1.533 . . . . 0.0 110.166 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.11 68.41 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.245 1.418 . . . . 0.0 109.335 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -2.15 58.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.5 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -67.34 95.66 0.45 Allowed 'General case' 0 C--N 1.357 0.897 0 O-C-N 120.981 -1.074 . . . . 0.0 109.653 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.76 6.05 30.84 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.96 152.6 68.9 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 118.586 1.193 . . . . 0.0 108.841 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.52 137.51 14.7 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.115 1.877 . . . . 0.0 110.217 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.15 70.58 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.54 155.21 19.08 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.455 1.902 . . . . 0.0 111.236 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.76 -22.59 0.87 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.675 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.29 37.34 2.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.655 1.982 . . . . 0.0 108.511 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.03 -15.77 20.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 50.8 m -89.68 124.89 35.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 121.163 -0.96 . . . . 0.0 112.47 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -67.21 -61.05 5.1 Favored Pre-proline 0 C--N 1.348 0.522 0 C-N-CA 127.059 2.143 . . . . 0.0 113.221 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -14.03 24.66 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 CA-C-N 125.679 3.064 . . . . 0.0 110.874 -172.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.36 -16.4 49.29 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 124.357 1.063 . . . . 0.0 108.73 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.03 74.22 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 123.469 0.708 . . . . 0.0 111.224 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.63 -31.99 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 123.753 0.821 . . . . 0.0 110.542 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.74 -34.39 69.49 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 119.758 -1.839 . . . . 0.0 109.282 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -72.33 -43.64 63.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -68.91 -28.0 66.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.779 -1.201 . . . . 0.0 112.051 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.8 t -56.52 -54.63 26.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 124.064 0.946 . . . . 0.0 109.967 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.68 -21.63 51.79 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.703 -0.623 . . . . 0.0 111.431 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -67.8 -39.22 84.04 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.126 0.97 . . . . 0.0 110.038 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.78 -22.93 62.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.889 -1.132 . . . . 0.0 111.631 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -91.92 4.02 53.89 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.607 -0.683 . . . . 0.0 110.199 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 56.9 p 49.38 41.77 21.14 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.859 2.064 . . . . 0.0 111.453 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.3 -66.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . 0.408 ' HA2' ' CE2' ' B' ' 57' ' ' TYR . . . 74.14 52.02 8.23 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 174.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -14.44 61.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.652 -0.911 . . . . 0.0 110.907 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.99 29.89 3.88 Favored Glycine 0 CA--C 1.49 -1.478 0 O-C-N 121.019 -1.051 . . . . 0.0 110.917 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -70.95 -59.77 2.6 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -138.87 173.36 11.65 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -143.96 144.81 27.89 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.74 164.36 14.0 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.543 2.829 . . . . 0.0 110.03 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.8 -162.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -91.17 -47.77 7.33 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.775 1.63 . . . . 0.0 107.548 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.13 2.19 18.8 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.556 1.542 . . . . 0.0 111.864 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.81 -27.31 63.78 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.296 1.998 . . . . 0.0 106.354 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.95 82.89 0.97 Allowed Glycine 0 CA--C 1.471 -2.673 1 N-CA-C 100.451 -5.06 . . . . 0.0 100.451 -170.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -57.79 -7.69 0.77 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.513 1.525 . . . . 0.0 112.768 -170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.74 -13.17 53.87 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 119.918 -1.739 . . . . 0.0 113.193 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.7 -58.39 5.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 120.821 1.646 . . . . 0.0 106.689 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.43 68.53 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.201 1.0 . . . . 0.0 112.627 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -62.44 -34.22 76.36 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.423 1.089 . . . . 0.0 111.654 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.56 -33.89 76.98 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.132 -1.605 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.25 -43.29 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 O-C-N 121.731 -0.605 . . . . 0.0 109.47 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.12 -49.79 76.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.458 1.103 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -66.29 -35.59 80.78 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.474 -0.766 . . . . 0.0 111.293 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.91 79.09 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.502 -0.749 . . . . 0.0 110.668 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.38 -45.66 77.25 Favored Glycine 0 CA--C 1.495 -1.178 0 C-N-CA 124.144 0.878 . . . . 0.0 111.584 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -44.94 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.312 1.045 . . . . 0.0 109.449 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -65.84 -24.82 66.97 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.118 -0.989 . . . . 0.0 112.288 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.37 -53.38 32.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 120.439 1.472 . . . . 0.0 109.418 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -71.81 -21.9 61.64 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.474 0.654 . . . . 0.0 111.211 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.79 -35.31 26.6 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.361 -0.837 . . . . 0.0 110.949 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.61 -35.28 77.11 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 119.939 -1.726 . . . . 0.0 110.78 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.33 -9.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 121.145 -0.972 . . . . 0.0 112.258 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 20.0 m -65.42 -9.69 27.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.647 1.179 . . . . 0.0 111.804 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.99 -58.21 9.17 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.441 -1.412 . . . . 0.0 110.532 166.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.1 86.84 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.978 -1.076 . . . . 0.0 110.692 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.25 -40.64 86.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.043 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -12.46 60.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 121.092 -1.005 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 7.3 m -82.21 -23.69 35.3 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.77 -35.39 79.99 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 120.903 -1.123 . . . . 0.0 110.504 -159.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -66.34 -26.52 67.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.795 -0.566 . . . . 0.0 112.196 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.32 -27.33 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 124.455 1.102 . . . . 0.0 108.228 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -59.73 -14.41 14.22 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.164 -0.96 . . . . 0.0 112.423 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.986 -1.071 . . . . 0.0 111.018 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -74.04 138.42 44.03 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.258 29.7 mt-10 71.28 -55.91 0.64 Allowed 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.049 1.34 . . . . 0.0 112.565 -173.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.6 -32.74 74.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.013 1.279 . . . . 0.0 112.827 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -81.38 -16.44 52.22 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.326 0.967 . . . . 0.0 110.962 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -82.47 -39.0 23.13 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.109 -1.619 . . . . 0.0 107.325 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.81 25.13 11.97 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.5 t60 . . . . . 0 C--N 1.352 0.714 0 C-N-CA 124.925 1.29 . . . . 0.0 111.56 -173.158 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 102.783 -3.043 . . . . 0.0 102.783 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.31 -66.57 0.91 Allowed 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -162.96 -92.31 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -168.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 1.9 p80 -63.97 -18.07 63.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.493 1.517 . . . . 0.0 113.343 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 35.3 mp0 -69.92 -34.16 73.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 120.652 -1.28 . . . . 0.0 109.582 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -73.47 -38.76 65.33 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.036 -1.04 . . . . 0.0 108.633 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.95 -42.51 99.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.64 87.59 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.6 1.16 . . . . 0.0 112.119 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.15 -42.36 94.74 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.261 0.625 . . . . 0.0 111.181 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.79 -38.2 90.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.177 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.81 89.62 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.41 -0.806 . . . . 0.0 111.014 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.83 -36.94 84.86 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.453 -0.78 . . . . 0.0 111.027 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.61 -29.99 70.65 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.548 1.139 . . . . 0.0 110.748 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -74.97 -38.44 61.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.561 1.144 . . . . 0.0 108.259 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.95 -45.73 93.54 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.571 0.748 . . . . 0.0 110.666 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -58.2 -31.42 67.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 112.67 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -69.78 -41.1 75.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.424 0.69 . . . . 0.0 109.677 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.39 -35.45 74.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 124.061 0.944 . . . . 0.0 109.175 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.38 -37.8 84.73 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 121.238 -0.914 . . . . 0.0 111.708 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -82.79 -16.89 46.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.514 0.726 . . . . 0.0 111.278 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -77.64 -46.34 22.36 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 168.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.37 74.38 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 126.327 1.851 . . . . 0.0 111.374 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -62.52 -44.35 96.57 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.388 0.675 . . . . 0.0 110.772 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -67.99 -50.09 57.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -61.47 -42.46 98.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.793 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.06 99.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.217 1.407 . . . . 0.0 111.673 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.8 -45.16 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 O-C-N 121.025 -1.047 . . . . 0.0 109.448 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -70.23 -27.82 64.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.317 -0.864 . . . . 0.0 110.703 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -57.03 4.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.421 1.889 . . . . 0.0 108.782 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.53 -32.44 74.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.095 0.958 . . . . 0.0 111.776 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -66.84 104.32 1.32 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.135 -1.603 . . . . 0.0 110.559 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.98 -28.29 3.7 Favored Glycine 0 CA--C 1.489 -1.556 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.52 145.01 70.89 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 123.351 0.661 . . . . 0.0 110.75 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -78.78 138.37 14.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.192 1.928 . . . . 0.0 110.231 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.06 80.91 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.439 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.84 147.95 36.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.813 1.245 . . . . 0.0 111.698 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.53 -37.7 2.48 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 tp -106.93 93.98 4.86 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.124 -0.985 . . . . 0.0 108.883 -173.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -135.58 57.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 120.229 -1.545 . . . . 0.0 109.047 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 30.9 t -150.31 135.03 17.5 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -68.82 -43.09 26.65 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 115.625 -2.131 . . . . 0.0 111.256 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -68.53 -28.18 32.19 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-N 126.106 3.216 . . . . 0.0 111.966 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.83 -17.65 31.06 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 118.957 0.799 . . . . 0.0 108.949 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.68 86.82 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 124.677 1.191 . . . . 0.0 112.039 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.54 -14.87 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 123.579 0.751 . . . . 0.0 110.305 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 -33.19 18.35 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 120.881 -1.137 . . . . 0.0 107.944 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -73.3 -40.02 64.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 15.0 p -76.18 59.05 1.31 Allowed 'General case' 0 C--N 1.358 0.943 0 O-C-N 121.234 -0.916 . . . . 0.0 111.419 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 72.0 t -133.48 -65.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 -21.41 65.26 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.505 0.722 . . . . 0.0 111.784 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -69.69 -28.91 66.25 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 121.507 -0.745 . . . . 0.0 110.394 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.17 -26.47 42.69 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.161 -0.962 . . . . 0.0 109.655 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 15.3 p -91.89 3.35 55.39 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.578 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 12.7 p 54.04 25.88 5.93 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.427 1.891 . . . . 0.0 113.095 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -86.22 -53.0 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.85 73.07 0.82 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -23.77 53.56 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.621 -1.517 . . . . 0.0 109.852 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.57 35.71 1.85 Allowed Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -155.2 176.37 12.65 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -149.2 145.92 20.29 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -80.3 165.78 20.84 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 CA-C-N 121.944 1.73 . . . . 0.0 110.527 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.29 -146.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.538 0 CA-C-N 119.218 0.917 . . . . 0.0 109.959 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -91.59 -54.09 4.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.273 -1.517 . . . . 0.0 109.849 -163.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -89.34 16.73 6.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.439 0.696 . . . . 0.0 109.608 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -30.29 62.6 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 163.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.34 83.48 1.18 Allowed Glycine 0 CA--C 1.476 -2.385 1 N-CA-C 99.583 -5.407 . . . . 0.0 99.583 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' D' ' 68' ' ' ARG . 20.1 ttm-85 -52.44 -18.57 1.71 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.056 1.742 . . . . 0.0 112.003 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -53.97 -28.22 36.2 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.504 2.322 . . . . 0.0 113.26 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.57 -53.2 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.391 0.677 . . . . 0.0 111.88 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.3 -46.65 55.53 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 126.233 1.813 . . . . 0.0 110.721 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.84 -38.06 89.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.493 0.717 . . . . 0.0 110.8 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.77 -39.05 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 123.446 0.698 . . . . 0.0 109.125 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -57.81 -52.91 63.53 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.984 1.314 . . . . 0.0 110.253 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.8 -38.0 89.47 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.033 0.533 . . . . 0.0 110.659 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.16 79.03 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.661 0.784 . . . . 0.0 111.58 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.81 -45.77 80.78 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.57 -48.97 85.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 C-N-CA 124.268 1.027 . . . . 0.0 108.932 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -57.03 -42.29 80.17 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.208 1.403 . . . . 0.0 112.503 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -65.56 -55.48 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 124.744 1.218 . . . . 0.0 109.248 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -67.26 -34.84 78.27 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.748 -0.595 . . . . 0.0 110.617 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.38 78.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.463 1.105 . . . . 0.0 111.135 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.65 -38.2 90.2 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 124.536 1.135 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.1 -14.5 7.75 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 125.128 1.371 . . . . 0.0 111.279 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 6.3 m -61.81 -20.59 63.79 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 119.376 -2.078 . . . . 0.0 111.696 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.66 66.73 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.684 -1.26 . . . . 0.0 111.336 171.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.91 -49.75 11.45 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.33 -32.25 73.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.736 0.814 . . . . 0.0 112.741 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.99 63.64 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.26 -1.525 . . . . 0.0 111.121 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -82.45 -11.02 58.8 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.701 -1.249 . . . . 0.0 111.225 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -32.55 74.17 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 119.454 1.024 . . . . 0.0 111.206 -171.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -77.17 -32.99 56.55 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.969 -1.082 . . . . 0.0 111.173 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.71 -26.64 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 125.884 1.674 . . . . 0.0 108.973 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -66.55 -5.73 12.47 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 112.331 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -69.16 -18.41 63.93 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 119.81 1.187 . . . . 0.0 110.997 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.73 159.76 23.1 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 61.73 -78.48 0.03 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.729 2.012 . . . . 0.0 111.881 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -55.14 -37.59 67.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.032 2.533 . . . . 0.0 110.15 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -61.29 -27.91 68.81 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.485 -0.759 . . . . 0.0 112.255 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -82.05 -22.74 36.22 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.328 -0.857 . . . . 0.0 109.291 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.34 3.97 89.9 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 121.463 -0.773 . . . . 0.0 112.072 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 8.1 t60 . . . . . 0 N--CA 1.442 -0.834 0 C-N-CA 125.989 1.715 . . . . 0.0 111.301 -169.805 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.95 169.76 9.41 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -41.68 -57.87 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 128.786 2.835 . . . . 0.0 112.446 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -77.97 -19.21 54.94 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 125.082 1.353 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.93 -38.47 57.61 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -60.96 -35.31 76.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 123.816 0.846 . . . . 0.0 111.622 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -59.96 -41.93 92.98 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.737 2.015 . . . . 0.0 110.175 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -41.75 74.4 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.593 0.757 . . . . 0.0 110.263 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.39 -32.56 72.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.799 0.84 . . . . 0.0 111.408 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -71.94 -32.67 67.55 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.363 1.065 . . . . 0.0 110.527 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.123 0.569 . . . . 0.0 110.213 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -55.64 -42.84 75.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.709 1.204 . . . . 0.0 111.795 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -76.7 -29.89 56.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.777 -0.577 . . . . 0.0 109.578 -174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.22 -31.21 69.63 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.477 -0.764 . . . . 0.0 109.975 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.18 -43.1 92.15 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 121.725 -0.609 . . . . 0.0 111.326 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -62.46 -29.43 70.51 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.187 -0.946 . . . . 0.0 112.209 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.37 -31.62 67.53 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.654 -0.654 . . . . 0.0 110.267 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.65 -41.55 90.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.187 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.92 -42.81 85.57 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.914 0.886 . . . . 0.0 110.305 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.31 -42.7 99.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.378 -0.826 . . . . 0.0 111.699 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.16 -38.63 69.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.65 79.46 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 124.914 1.286 . . . . 0.0 111.639 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -66.56 -32.96 74.63 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 124.146 0.978 . . . . 0.0 111.124 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -70.75 -47.1 61.44 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 121.568 -0.708 . . . . 0.0 109.747 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -60.14 -50.39 73.88 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.129 0.972 . . . . 0.0 109.35 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.81 88.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.646 1.579 . . . . 0.0 112.554 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.88 -48.14 89.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.191 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.33 -29.02 61.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.41 -0.806 . . . . 0.0 111.216 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.16 91.53 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.079 1.352 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.43 -20.0 60.2 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.544 -0.722 . . . . 0.0 112.021 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -75.09 87.13 2.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 120.194 -1.566 . . . . 0.0 110.577 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.88 3.11 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.61 140.58 59.57 Favored Pre-proline 0 N--CA 1.442 -0.825 0 O-C-N 121.703 -0.881 . . . . 0.0 110.046 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.15 135.43 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.495 2.13 . . . . 0.0 110.245 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.86 24.75 68.71 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.67 144.59 56.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.085 0.954 . . . . 0.0 110.103 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.08 -34.47 2.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.79 131.66 36.99 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 pt -151.23 169.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 100.649 -3.834 . . . . 0.0 100.649 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t 76.89 134.07 0.06 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.963 1.705 . . . . 0.0 111.082 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -66.01 -49.48 56.9 Favored Pre-proline 0 C--N 1.352 0.701 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.072 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -70.21 -14.46 34.68 Favored 'Trans proline' 0 CA--C 1.514 -0.513 0 CA-C-N 125.308 2.932 . . . . 0.0 112.584 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.23 -43.14 12.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.97 77.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.235 1.014 . . . . 0.0 112.215 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.14 -16.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-O 121.714 0.769 . . . . 0.0 111.397 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -31.76 17.31 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 120.757 -1.214 . . . . 0.0 108.162 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.33 -40.02 94.97 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 120.795 -1.19 . . . . 0.0 110.244 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -67.05 -17.3 64.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.948 -1.095 . . . . 0.0 111.669 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.5 -51.09 67.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.682 1.193 . . . . 0.0 109.315 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.61 -7.41 50.08 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 124.07 0.948 . . . . 0.0 111.167 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.6 m -94.13 -45.11 7.69 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 120.36 -1.462 . . . . 0.0 107.058 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.01 70.15 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.308 -0.87 . . . . 0.0 112.325 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -91.77 3.83 54.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.272 67.8 p 59.53 -142.46 0.6 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.447 1.899 . . . . 0.0 107.334 -167.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t 75.63 -90.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.94 94.28 0.25 Allowed Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -80.07 -20.8 44.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.305 -1.703 . . . . 0.0 109.711 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.73 25.29 4.31 Favored Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.58 -48.19 34.74 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.277 1.539 . . . . 0.0 110.055 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.36 152.88 51.12 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.464 ' CD1' ' HD2' ' A' ' 62' ' ' PRO . 17.6 t80 -145.17 137.71 13.55 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 46.5 Cg_endo -80.97 168.17 17.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.908 2.405 . . . . 0.0 110.951 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -88.91 -111.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -134.83 -39.42 0.78 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 122.224 1.011 . . . . 0.0 109.225 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -79.28 -22.58 44.46 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.601 -1.312 . . . . 0.0 109.627 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -62.08 -32.03 72.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.075 1.75 . . . . 0.0 108.386 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.42 65.18 0.93 Allowed Glycine 0 CA--C 1.465 -3.081 1 N-CA-C 102.483 -4.247 . . . . 0.0 102.483 168.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -26.33 -26.39 0.0 OUTLIER 'General case' 0 C--N 1.363 1.185 1 C-N-CA 132.65 4.38 . . . . 0.0 116.851 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -49.34 -20.47 0.67 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.06 -42.92 94.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 124.954 1.301 . . . . 0.0 109.693 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -48.51 31.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.12 -50.82 19.46 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 126.463 1.905 . . . . 0.0 111.303 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.27 -35.53 81.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.427 0.632 . . . . 0.0 110.692 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.1 t -73.22 -37.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.41 -0.806 . . . . 0.0 109.14 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.5 mtt -61.83 -46.36 89.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 123.632 0.773 . . . . 0.0 109.656 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.48 -33.27 75.31 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.078 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.18 97.04 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 121.746 -0.596 . . . . 0.0 110.656 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.06 -46.93 77.5 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.35 -45.49 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 109.602 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.87 -36.38 83.72 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.855 -1.153 . . . . 0.0 110.681 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.03 -52.07 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 119.959 1.254 . . . . 0.0 110.563 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -70.47 -22.76 62.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.809 -0.557 . . . . 0.0 111.126 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.54 -32.94 23.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.382 -0.824 . . . . 0.0 110.546 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.43 -24.25 67.14 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.496 -1.377 . . . . 0.0 111.207 -172.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.17 -11.26 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.484 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.0 m -45.24 -29.68 1.04 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 127.826 2.45 . . . . 0.0 112.058 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.72 -39.77 52.64 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.406 1.482 . . . . 0.0 113.889 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 -36.12 6.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.94 1.296 . . . . 0.0 109.307 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.31 -41.57 66.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.736 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.21 -32.19 49.81 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 119.813 -1.805 . . . . 0.0 111.229 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -73.86 -0.36 15.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.529 -1.357 . . . . 0.0 110.003 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.24 -26.56 64.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 121.245 -0.909 . . . . 0.0 109.414 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -72.83 -33.4 66.15 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.454 -1.404 . . . . 0.0 110.634 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.17 -21.91 27.11 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.223 1.409 . . . . 0.0 109.171 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.39 -29.47 48.83 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 125.399 1.48 . . . . 0.0 112.247 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -65.57 -36.56 84.14 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.541 0.686 . . . . 0.0 110.479 -174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.18 154.01 18.95 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -170.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.292 40.1 mm-40 71.03 -51.59 0.69 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.446 1.898 . . . . 0.0 112.036 -168.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.05 -46.59 71.97 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.645 1.978 . . . . 0.0 109.871 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.53 -24.54 67.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.322 -0.861 . . . . 0.0 112.936 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -80.91 -20.17 42.7 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.45 -0.781 . . . . 0.0 110.094 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.96 34.66 61.83 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.9 m170 . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.65 170.68 15.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.03 -34.77 78.29 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 124.588 1.155 . . . . 0.0 112.242 -167.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.54 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 3.5 p-80 -83.77 -23.64 31.44 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.58 -0.7 . . . . 0.0 110.601 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.16 -38.06 21.13 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -63.19 -47.61 81.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.225 1.41 . . . . 0.0 110.954 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -26.44 65.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.371 -0.83 . . . . 0.0 111.256 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.91 -35.44 74.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.319 -0.863 . . . . 0.0 110.657 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -64.74 -45.87 84.64 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.999 0.92 . . . . 0.0 109.231 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -64.34 -31.94 73.35 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.112 0.565 . . . . 0.0 111.534 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.93 81.62 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.755 0.822 . . . . 0.0 110.685 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' C' ' 76' ' ' LYS . 0.2 OUTLIER -68.44 -39.5 81.5 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.074 -178.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.53 -43.04 84.04 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 125.748 1.619 . . . . 0.0 110.484 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.37 -38.92 91.42 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.138 1.375 . . . . 0.0 110.079 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.3 -41.56 89.29 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 123.908 0.883 . . . . 0.0 111.391 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -63.91 -29.58 70.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.866 1.266 . . . . 0.0 110.73 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -76.08 -30.33 58.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.246 1.019 . . . . 0.0 110.217 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -70.35 -35.67 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 31.2 mt -61.76 -42.32 98.83 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.809 -0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -60.75 -45.54 93.9 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.086 0.857 . . . . 0.0 110.519 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -68.93 -40.18 79.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.874 0.845 . . . . 0.0 110.486 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -31.11 71.29 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.264 1.426 . . . . 0.0 111.256 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -66.0 -44.25 85.34 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.085 0.954 . . . . 0.0 110.199 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -61.03 -49.68 76.4 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.025 1.33 . . . . 0.0 107.785 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.83 -41.96 99.54 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.388 0.675 . . . . 0.0 111.232 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.21 91.38 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 124.892 1.277 . . . . 0.0 111.965 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.45 -40.97 73.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.17 -10.67 59.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.291 -1.506 . . . . 0.0 111.704 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' B' ' 67' ' ' GLY . . . -70.58 -21.25 62.7 Favored 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.907 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.97 -1.99 41.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.27 79.36 2.8 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.2 -41.6 0.71 Allowed Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.81 154.93 70.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 O-C-N 122.185 -0.597 . . . . 0.0 111.457 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.1 151.27 23.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.014 2.476 . . . . 0.0 110.41 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.61 41.23 65.54 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 136.64 57.92 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.376 1.071 . . . . 0.0 112.205 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.11 -57.28 2.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.62 97.95 10.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.094 0.95 . . . . 0.0 108.455 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.49 12.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -105.08 129.99 53.37 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -78.93 -57.81 0.75 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 127.257 2.223 . . . . 0.0 108.692 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.45 -13.89 25.13 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.344 2.944 . . . . 0.0 111.69 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -93.35 -10.34 35.65 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.397 0.998 . . . . 0.0 108.417 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.64 83.73 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.61 -1.306 . . . . 0.0 110.512 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.92 -9.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 124.454 1.102 . . . . 0.0 110.562 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.85 -41.08 16.37 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 120.14 -1.6 . . . . 0.0 107.28 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -68.87 -32.83 72.76 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.538 -0.727 . . . . 0.0 110.815 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 7.0 p -66.41 -17.41 64.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.978 -1.076 . . . . 0.0 111.586 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.76 -17.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.924 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -97.72 10.82 39.07 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.488 -1.383 . . . . 0.0 109.177 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -123.26 -173.75 2.79 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.45 -3.537 . . . . 0.0 101.45 173.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 77.24 -42.27 0.4 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 126.1 1.76 . . . . 0.0 111.095 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.0 p -81.19 2.75 26.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 126.22 1.808 . . . . 0.0 111.692 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p 52.07 59.3 4.63 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.826 2.051 . . . . 0.0 111.595 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.41 -77.01 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.08 66.49 1.96 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -72.45 -46.04 56.81 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.64 -105.48 0.24 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.327 5.2 t70 56.92 -72.63 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 128.271 2.628 . . . . 0.0 112.232 -163.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -163.59 1.35 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -173.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -153.24 153.49 29.52 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.6 168.41 9.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.331 3.354 . . . . 0.0 112.847 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 m -83.14 177.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.55 1.14 . . . . 0.0 112.442 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -83.21 -69.44 0.63 Allowed 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 125.475 1.51 . . . . 0.0 111.337 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.99 -37.5 64.07 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 124.611 1.165 . . . . 0.0 112.907 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -121.16 -107.62 0.36 Allowed 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 167.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' B' ' 29' ' ' ALA . . . 40.13 -73.55 0.0 OUTLIER Glycine 0 C--N 1.358 1.785 0 C-N-CA 129.748 3.547 . . . . 0.0 116.165 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.39 -37.86 87.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.363 2.665 . . . . 0.0 111.488 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.838 0.827 . . . . 0.0 109.275 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.05 -46.42 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.58 84.49 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.408 1.483 . . . . 0.0 111.603 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.67 -47.22 29.55 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.049 1.739 . . . . 0.0 110.938 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.72 -36.59 84.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.119 1.368 . . . . 0.0 110.283 -176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.33 -42.01 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.679 -0.638 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -60.59 -46.74 89.09 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -63.13 -38.3 90.62 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 122.121 -0.362 . . . . 0.0 111.158 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.02 80.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.159 0.584 . . . . 0.0 111.301 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.13 91.65 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 124.483 1.039 . . . . 0.0 111.214 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.08 -42.52 90.17 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 123.853 0.861 . . . . 0.0 108.707 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.81 -51.19 65.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 120.94 -1.1 . . . . 0.0 112.275 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.88 -41.32 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 112.144 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -74.15 -38.51 63.7 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.25 -32.18 71.22 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.69 -31.88 62.8 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.759 1.223 . . . . 0.0 111.406 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.9 -12.05 8.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.666 1.186 . . . . 0.0 111.099 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 16.2 m -64.4 -24.82 67.77 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 118.897 -2.377 . . . . 0.0 110.761 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.58 -20.35 65.99 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.154 -1.591 . . . . 0.0 111.318 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.54 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -90.27 -40.71 11.99 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.38 1.072 . . . . 0.0 108.913 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.96 -31.75 51.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 122.785 0.434 . . . . 0.0 111.545 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.29 -23.02 66.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.122 -0.986 . . . . 0.0 111.374 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . 0.343 0.6 OUTLIER -83.36 -10.72 58.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.916 -1.115 . . . . 0.0 109.47 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.275 46.1 m-20 -82.46 -2.68 54.02 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.458 -1.401 . . . . 0.0 111.801 -172.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.19 -35.88 15.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.27 -1.519 . . . . 0.0 108.538 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 t -66.84 -25.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 125.074 1.349 . . . . 0.0 110.224 -169.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -63.58 -8.92 11.02 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.422 -0.799 . . . . 0.0 112.844 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -66.34 -32.85 74.49 Favored 'General case' 0 C--N 1.359 1.004 0 O-C-N 120.851 -1.156 . . . . 0.0 110.068 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -87.88 159.09 18.52 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -172.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 74.59 -59.98 0.53 Allowed 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.326 1.85 . . . . 0.0 110.514 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -59.59 -29.22 67.82 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.11 2.164 . . . . 0.0 109.857 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -62.6 -38.87 91.85 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.576 -0.703 . . . . 0.0 111.465 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -78.6 -27.18 45.55 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.712 -1.243 . . . . 0.0 108.553 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.21 33.94 27.65 Favored Glycine 0 CA--C 1.491 -1.466 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--N 1.357 0.929 0 C-N-CA 123.712 0.805 . . . . 0.0 111.955 176.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 102.118 -3.29 . . . . 0.0 102.118 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.13 158.32 15.51 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.28 -46.86 85.29 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.428 1.091 . . . . 0.0 110.671 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.497 ' CE1' HG23 ' C' ' 91' ' ' THR . 4.5 p80 -67.07 -27.83 67.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.56 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.61 -42.88 57.83 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -65.75 -37.71 87.12 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.827 -1.171 . . . . 0.0 110.826 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.87 -31.44 72.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.379 1.072 . . . . 0.0 110.987 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.84 -47.68 71.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.729 0.812 . . . . 0.0 110.203 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.357 -0.839 . . . . 0.0 111.615 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -65.44 -39.63 92.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.873 1.269 . . . . 0.0 109.311 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.4 82.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.896 0.878 . . . . 0.0 110.681 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -55.53 -42.76 75.03 Favored 'General case' 0 C--N 1.36 1.03 0 CA-C-O 121.667 0.746 . . . . 0.0 110.829 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -60.93 -39.38 89.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.139 1.376 . . . . 0.0 110.363 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.98 -34.2 76.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.149 0.979 . . . . 0.0 109.505 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.47 -40.33 89.29 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.819 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.31 -28.02 68.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.558 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -66.04 -39.77 90.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.977 0.911 . . . . 0.0 110.181 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.7 -35.15 74.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 124.247 1.019 . . . . 0.0 109.198 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.57 -35.67 80.22 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 121.29 -0.881 . . . . 0.0 111.898 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.8 -32.62 59.94 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.137 0.575 . . . . 0.0 110.337 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 -42.06 59.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.12 -0.987 . . . . 0.0 108.767 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -36.01 78.24 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.758 1.623 . . . . 0.0 111.895 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -69.4 -36.63 76.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.909 -0.494 . . . . 0.0 110.299 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -67.58 -38.03 83.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -66.19 -55.24 17.24 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.0 68.69 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.739 1.215 . . . . 0.0 111.984 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.68 -43.92 96.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 O-C-N 119.962 -1.712 . . . . 0.0 111.985 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.79 -34.99 20.99 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 121.211 -0.931 . . . . 0.0 109.274 -171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.37 -50.77 58.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.552 1.941 . . . . 0.0 109.546 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.04 -24.1 62.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.236 -0.915 . . . . 0.0 111.637 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.95 95.19 6.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.455 -1.403 . . . . 0.0 111.918 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.46 -7.57 4.98 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.71 148.02 37.53 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 123.577 0.751 . . . . 0.0 109.788 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -77.69 103.46 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.895 2.397 . . . . 0.0 113.051 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 -52.44 0.72 Allowed Glycine 0 CA--C 1.477 -2.324 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.719 2.008 . . . . 0.0 110.901 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.34 -91.62 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.92 127.14 31.62 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.27 131.18 1.84 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 169.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.86 -49.03 60.83 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.038 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.0 -5.52 17.13 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 CA-C-N 124.777 2.742 . . . . 0.0 111.955 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -99.88 -29.27 12.68 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.67 76.32 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 111.939 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.71 -36.89 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 123.418 0.687 . . . . 0.0 110.222 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -30.22 60.59 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.474 -1.391 . . . . 0.0 109.92 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -72.85 -32.05 65.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.984 0.897 . . . . 0.0 109.124 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -67.04 -42.24 85.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.279 -0.888 . . . . 0.0 110.358 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -67.66 -23.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 C-N-CA 124.155 0.982 . . . . 0.0 112.87 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.4 -13.72 51.4 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 120.07 -1.644 . . . . 0.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -104.61 -175.02 2.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . 79.47 -33.63 0.14 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 126.952 2.101 . . . . 0.0 110.672 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.1 p -89.73 3.78 51.69 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 125.956 1.703 . . . . 0.0 111.949 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.278 41.5 p 52.43 63.87 2.07 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.503 1.921 . . . . 0.0 111.917 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.21 -107.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 1 N-CA-C 98.546 -4.613 . . . . 0.0 98.546 173.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.3 87.48 1.09 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 106.651 -2.58 . . . . 0.0 106.651 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -69.2 -45.63 69.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.357 1.075 . . . . 0.0 109.118 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.44 48.48 0.28 Allowed Glycine 0 CA--C 1.485 -1.797 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.492 ' CG ' HH22 ' D' ' 68' ' ' ARG . 34.8 t70 -73.48 -45.35 54.59 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -132.96 -154.2 0.6 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.83 142.86 2.04 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 100.829 -3.767 . . . . 0.0 100.829 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.07 179.8 3.53 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 123.664 2.344 . . . . 0.0 107.49 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.432 ' H ' ' CG ' ' C' ' 66' ' ' GLU . 2.7 t -100.6 -121.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.405 1.482 . . . . 0.0 110.118 -168.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 73.4 m -136.48 -38.8 0.66 Allowed 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.692 -1.255 . . . . 0.0 108.584 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -86.17 -6.11 59.06 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.979 -1.076 . . . . 0.0 109.834 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.432 ' CG ' ' H ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -63.98 -36.83 85.24 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 123.216 1.484 . . . . 0.0 107.373 175.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.94 62.41 0.85 Allowed Glycine 0 CA--C 1.464 -3.111 1 N-CA-C 100.643 -4.983 . . . . 0.0 100.643 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -26.86 -25.2 0.0 OUTLIER 'General case' 0 C--N 1.36 1.04 1 C-N-CA 132.989 4.516 . . . . 0.0 117.778 -175.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -52.87 -15.44 0.75 Allowed 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 161.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.23 -44.39 87.84 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 O-C-N 120.153 -1.592 . . . . 0.0 109.294 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.59 66.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 123.142 0.577 . . . . 0.0 109.681 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . 0.258 1.1 pp20? -65.38 -33.72 76.63 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 121.799 -0.563 . . . . 0.0 111.836 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.31 -36.99 79.18 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 121.55 0.691 . . . . 0.0 110.624 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.3 t -72.77 -37.82 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.507 -0.745 . . . . 0.0 109.477 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 50.8 mtt -64.42 -47.91 77.34 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 123.856 0.863 . . . . 0.0 109.55 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' B' ' 12' ' ' GLU . 33.9 ttmt -61.83 -40.58 95.79 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.425 0.69 . . . . 0.0 110.747 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.05 94.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.546 0.738 . . . . 0.0 110.872 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.64 78.09 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.28 -49.54 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 124.195 0.998 . . . . 0.0 108.943 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.83 -39.19 87.56 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 118.531 0.605 . . . . 0.0 111.474 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.32 -54.85 28.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 119.331 0.969 . . . . 0.0 110.4 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.58 -14.02 60.03 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 111.737 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.94 -37.62 22.07 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.623 -1.298 . . . . 0.0 108.035 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.97 -33.63 72.2 Favored 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 124.996 1.318 . . . . 0.0 111.738 -175.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -64.56 -5.31 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 O-C-N 121.335 -0.853 . . . . 0.0 112.663 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 26.3 m -59.2 -18.52 37.32 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.742 1.217 . . . . 0.0 111.167 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.62 68.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.847 -1.783 . . . . 0.0 113.104 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.58 -43.46 13.47 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.0 -38.86 92.6 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.079 0.942 . . . . 0.0 111.318 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.29 -20.32 62.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.982 -1.073 . . . . 0.0 111.833 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.497 HG23 ' CE1' ' C' ' 4' ' ' HIS . 9.7 t -99.52 7.71 45.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.4 -45.34 60.14 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.833 1.197 . . . . 0.0 107.978 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -63.09 -34.62 77.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.48 -0.762 . . . . 0.0 111.556 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.03 -23.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.007 1.723 . . . . 0.0 110.033 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -65.48 -16.16 63.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.1 -1.0 . . . . 0.0 111.435 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -64.19 -25.2 67.97 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.32 -0.862 . . . . 0.0 111.833 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.89 -33.16 62.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -76.1 -43.2 44.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 121.314 -0.867 . . . . 0.0 109.289 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -63.76 -26.28 68.57 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.262 1.425 . . . . 0.0 110.356 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.78 -44.79 74.03 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 125.424 1.49 . . . . 0.0 110.845 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -97.18 -26.14 15.05 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.58 35.23 33.07 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 42.6 t60 . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 -179.071 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.76 152.9 21.5 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.16 -45.63 84.16 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 123.199 1.476 . . . . 0.0 109.657 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 17.2 p-80 -69.93 -17.48 63.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.079 1.352 . . . . 0.0 111.917 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -77.11 -40.12 46.99 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -55.55 -50.59 69.61 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.195 1.398 . . . . 0.0 110.485 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.88 -37.9 87.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.938 0.895 . . . . 0.0 109.667 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.55 95.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.553 0.741 . . . . 0.0 111.643 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -68.33 -36.7 79.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.669 -0.644 . . . . 0.0 110.774 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -68.12 -35.09 77.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.705 -0.622 . . . . 0.0 111.039 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.14 98.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.363 1.065 . . . . 0.0 111.104 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -66.76 -35.44 80.11 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.323 -0.86 . . . . 0.0 111.636 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -72.42 -34.12 67.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.676 -1.265 . . . . 0.0 111.161 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -64.84 -35.19 80.31 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.831 1.252 . . . . 0.0 108.844 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -63.22 -39.15 93.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.454 -0.779 . . . . 0.0 111.11 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.13 -21.58 63.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.615 -1.303 . . . . 0.0 112.035 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.4 -36.11 71.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.626 0.727 . . . . 0.0 110.464 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.35 -26.25 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 O-C-N 119.854 -1.779 . . . . 0.0 110.358 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.28 -46.13 90.16 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 121.957 0.884 . . . . 0.0 110.864 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.1 -39.15 86.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.52 -1.363 . . . . 0.0 110.177 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.87 96.02 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.361 1.065 . . . . 0.0 110.798 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.69 76.43 Favored 'General case' 0 CA--C 1.496 -1.123 0 O-C-N 121.301 -0.874 . . . . 0.0 111.469 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -65.06 -44.1 90.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 110.496 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.86 -53.32 48.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 125.124 1.37 . . . . 0.0 109.547 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -65.69 -37.98 87.95 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.308 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.91 83.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 124.37 1.068 . . . . 0.0 111.747 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.14 -50.05 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-N 118.509 0.595 . . . . 0.0 109.857 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -72.43 -31.59 65.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.447 -0.783 . . . . 0.0 110.732 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.49 67.83 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.955 0.902 . . . . 0.0 109.326 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.9 -40.61 96.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 125.482 1.513 . . . . 0.0 110.219 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.76 91.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.928 1.291 . . . . 0.0 112.387 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.65 -5.84 7.5 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.07 59.15 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 118.677 1.238 . . . . 0.0 111.76 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -80.82 137.54 11.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.585 2.19 . . . . 0.0 110.692 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.46 78.15 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 165.2 24.4 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.921 1.289 . . . . 0.0 111.292 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.9 32.51 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 121.808 -0.557 . . . . 0.0 110.472 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -145.14 74.43 1.4 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 120.792 -1.192 . . . . 0.0 107.912 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.67 165.19 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 O-C-N 120.948 -1.095 . . . . 0.0 108.197 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t 81.39 131.37 0.05 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.64 1.576 . . . . 0.0 112.201 165.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -62.69 -42.51 79.16 Favored Pre-proline 0 C--N 1.349 0.581 0 CA-C-O 116.864 -1.541 . . . . 0.0 113.328 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -69.06 -24.56 32.76 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 CA-C-N 124.158 2.521 . . . . 0.0 112.404 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 -32.94 19.98 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 124.745 1.218 . . . . 0.0 107.96 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.07 73.45 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.44 -32.95 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 121.729 -0.607 . . . . 0.0 110.118 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -36.18 76.87 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -65.44 -37.6 87.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.848 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -64.56 -44.42 90.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.464 -0.772 . . . . 0.0 109.491 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.86 64.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.705 0 CA-C-O 121.767 0.794 . . . . 0.0 110.856 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -162.42 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -68.48 -36.65 79.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.099 -1.001 . . . . 0.0 110.964 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.05 65.31 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.281 -0.887 . . . . 0.0 111.681 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -93.79 15.21 17.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 33.0 p 47.34 54.47 9.5 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 126.066 1.746 . . . . 0.0 113.06 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.515 HG11 ' H ' ' D' ' 56' ' ' GLY . 1.0 OUTLIER -121.12 -82.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 178.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.515 ' H ' HG11 ' D' ' 55' ' ' VAL . . . 77.78 64.61 2.02 Favored Glycine 0 CA--C 1.491 -1.426 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.82 -27.86 64.19 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.231 1.015 . . . . 0.0 109.899 -165.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.66 31.14 0.16 Allowed Glycine 0 CA--C 1.486 -1.779 0 O-C-N 120.728 -1.232 . . . . 0.0 110.776 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -81.71 -76.06 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 118.751 1.275 . . . . 0.0 110.837 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -128.54 159.42 35.56 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.31 149.23 18.29 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -73.94 149.89 42.83 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.361 2.707 . . . . 0.0 111.534 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.454 HG12 ' HG1' ' D' ' 64' ' ' THR . 14.7 t -86.38 -93.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 124.116 0.966 . . . . 0.0 111.03 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.454 ' HG1' HG12 ' D' ' 63' ' ' VAL . 28.8 m -140.04 -52.58 0.51 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.734 -1.229 . . . . 0.0 108.468 -166.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.73 -16.77 46.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.674 1.189 . . . . 0.0 109.587 -168.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 1.4 pm0 -73.74 -7.27 51.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.09 88.49 0.4 Allowed Glycine 0 CA--C 1.477 -2.303 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.492 HH22 ' CG ' ' C' ' 59' ' ' ASP . 24.9 ttm180 -60.78 -19.77 60.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.39 -1.653 . . . . 0.0 111.235 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -54.57 -16.62 2.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.685 1.194 . . . . 0.0 113.403 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.01 -39.23 84.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 119.992 -1.692 . . . . 0.0 109.229 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -39.84 70.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.115 -0.991 . . . . 0.0 109.922 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -38.01 79.36 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-O 121.876 0.846 . . . . 0.0 110.53 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -29.93 66.56 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.62 -0.675 . . . . 0.0 111.601 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.67 -46.4 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 121.053 -1.029 . . . . 0.0 108.718 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.23 -39.82 89.83 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 122.003 -0.436 . . . . 0.0 110.124 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.56 -47.19 87.29 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.083 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.29 72.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 122.951 0.5 . . . . 0.0 111.275 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -44.22 89.31 Favored Glycine 0 CA--C 1.496 -1.143 0 O-C-N 121.506 -0.746 . . . . 0.0 111.638 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.56 -46.5 95.46 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 124.357 1.063 . . . . 0.0 108.79 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.43 -46.33 69.78 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.075 1.35 . . . . 0.0 111.24 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.21 -57.35 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 C-N-CA 124.929 1.292 . . . . 0.0 110.522 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -66.78 -35.98 81.34 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.42 -0.8 . . . . 0.0 110.467 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.39 95.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.998 0.919 . . . . 0.0 110.863 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.87 -39.9 95.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.71 -15.82 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.422 1.489 . . . . 0.0 111.137 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -59.24 -13.9 9.2 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.623 1.169 . . . . 0.0 111.544 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.27 -48.44 78.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 119.905 -1.747 . . . . 0.0 112.395 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.516 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -68.51 -35.72 77.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 O-C-N 121.348 -0.845 . . . . 0.0 110.156 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.06 -32.65 63.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.42 0.688 . . . . 0.0 110.055 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.43 75.8 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.077 -1.639 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -14.48 62.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.782 -1.199 . . . . 0.0 113.128 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.21 -32.68 74.47 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 120.576 1.535 . . . . 0.0 111.032 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -77.69 -28.64 51.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.064 -1.023 . . . . 0.0 111.421 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -68.86 -24.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 125.291 1.436 . . . . 0.0 108.347 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -59.48 -12.05 5.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.501 1.52 . . . . 0.0 113.797 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -72.88 -33.13 65.86 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 121.169 -0.957 . . . . 0.0 111.569 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -80.8 174.37 11.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.28 7.3 mp0 71.04 -59.64 0.54 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.309 1.843 . . . . 0.0 111.25 -171.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.06 -52.74 64.44 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.552 1.941 . . . . 0.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -67.8 -25.73 65.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.028 0.918 . . . . 0.0 111.656 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -76.3 -25.66 55.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.5 39.08 36.32 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 m170 . . . . . 0 CA--C 1.504 -0.8 0 O-C-N 121.528 -0.983 . . . . 0.0 108.76 178.008 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.425 -1.699 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.24 -62.53 1.48 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.735 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.56 -68.17 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -42.65 86.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.047 2.539 . . . . 0.0 112.08 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 2.3 pm0 -71.0 -26.24 63.04 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.661 0.785 . . . . 0.0 110.585 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.5 -37.04 77.02 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -71.32 -35.05 71.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.309 0.576 . . . . 0.0 109.863 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.0 95.95 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 121.411 -0.805 . . . . 0.0 111.362 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -71.77 -28.81 63.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 121.385 -0.822 . . . . 0.0 111.535 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -69.92 -37.52 75.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.898 -1.126 . . . . 0.0 109.361 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.73 97.36 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.98 0.912 . . . . 0.0 111.363 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -63.0 -36.68 84.37 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.44 -0.787 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.11 -35.36 69.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.028 -1.045 . . . . 0.0 110.792 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.29 -32.82 74.57 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.26 -42.31 98.41 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.924 -1.11 . . . . 0.0 111.61 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -64.31 -28.31 69.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.677 1.191 . . . . 0.0 111.212 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -69.59 -33.76 73.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.899 1.28 . . . . 0.0 110.452 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -71.62 -29.58 35.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.99 -1.068 . . . . 0.0 108.641 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.21 -29.8 66.74 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.01 -1.056 . . . . 0.0 111.223 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -71.31 -33.6 69.83 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.47 1.508 . . . . 0.0 110.329 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -72.44 -45.47 59.45 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 120.388 -1.445 . . . . 0.0 108.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.02 84.87 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 126.233 1.813 . . . . 0.0 111.483 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -67.6 -38.26 83.72 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 122.655 0.382 . . . . 0.0 110.269 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.959 0.904 . . . . 0.0 109.575 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -67.11 -55.0 16.14 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -41.25 73.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 125.688 1.595 . . . . 0.0 113.015 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.16 -37.1 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 O-C-N 120.735 -1.228 . . . . 0.0 112.582 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.67 -34.2 30.87 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.6 -53.72 37.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.543 1.537 . . . . 0.0 109.219 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.38 12.16 5.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.927 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -71.81 94.87 1.45 Allowed 'General case' 0 C--N 1.351 0.664 0 O-C-N 119.672 -1.892 . . . . 0.0 109.626 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.62 61.86 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 150.13 51.7 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -76.33 145.03 26.66 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 122.836 2.358 . . . . 0.0 108.807 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.25 5.22 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 118.956 0.798 . . . . 0.0 112.575 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 151.79 39.5 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 126.361 1.865 . . . . 0.0 110.039 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.75 6.75 0.54 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.075 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.03 -58.13 3.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.9 pt 34.97 29.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 119.228 3.047 . . . . 0.0 119.228 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -162.98 156.61 19.98 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 119.941 -1.724 . . . . 0.0 106.874 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.88 -44.78 0.61 Allowed Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.671 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.26 -17.6 16.76 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 CA-C-N 125.962 3.165 . . . . 0.0 111.413 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.0 -14.77 24.05 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.478 1.111 . . . . 0.0 109.047 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.43 98.53 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.934 0.873 . . . . 0.0 111.766 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.41 -11.68 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.57 0.7 . . . . 0.0 109.769 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.13 -41.58 15.56 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.08 -27.95 60.13 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.714 -0.617 . . . . 0.0 111.02 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.6 p -66.97 -20.27 65.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.518 -1.364 . . . . 0.0 111.924 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.47 -18.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.291 1.037 . . . . 0.0 109.844 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -73.19 -42.05 63.13 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 120.367 -1.458 . . . . 0.0 108.337 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.3 t -85.32 -167.76 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 78.98 -31.16 0.14 Allowed 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 127.179 2.192 . . . . 0.0 111.115 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 p -66.27 -24.53 66.58 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 129.834 3.254 . . . . 0.0 110.191 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.358 28.7 p 64.29 37.49 8.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 129.696 3.198 . . . . 0.0 109.712 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.85 147.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 167.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.51 130.82 5.82 Favored Glycine 0 CA--C 1.474 -2.529 1 N-CA-C 95.085 -7.206 . . . . 0.0 95.085 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -87.51 -36.5 17.59 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.38 47.65 0.25 Allowed Glycine 0 CA--C 1.479 -2.186 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 168.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.99 -55.78 6.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.53 1.165 . . . . 0.0 108.448 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -112.81 171.19 7.68 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -140.12 110.88 7.16 Favored Pre-proline 0 N--CA 1.445 -0.715 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.07 175.49 11.09 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.451 2.768 . . . . 0.0 109.835 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -143.13 176.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -63.48 -36.61 84.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 113.106 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.25 -27.94 61.86 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.77 0.828 . . . . 0.0 110.026 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -66.58 -30.43 70.73 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 123.577 1.656 . . . . 0.0 106.829 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 75.78 1.3 Allowed Glycine 0 CA--C 1.463 -3.174 1 N-CA-C 99.53 -5.428 . . . . 0.0 99.53 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -46.12 -13.77 0.02 OUTLIER 'General case' 0 C--N 1.367 1.342 0 C-N-CA 128.742 2.817 . . . . 0.0 114.22 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -54.19 -18.3 3.69 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 126.992 2.117 . . . . 0.0 114.131 162.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.88 -52.9 24.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-N 120.892 1.678 . . . . 0.0 107.442 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.43 80.32 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 118.386 0.539 . . . . 0.0 111.658 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.48 -47.15 66.69 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 126.614 1.966 . . . . 0.0 111.449 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -62.68 -41.57 99.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.469 -0.769 . . . . 0.0 109.556 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.2 -36.17 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.09 0.556 . . . . 0.0 110.012 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.3 mtt -58.59 -53.12 61.9 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.296 0.638 . . . . 0.0 109.921 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' D' ' 12' ' ' GLU . 63.6 tttp -62.94 -40.11 96.64 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 122.931 0.492 . . . . 0.0 110.336 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.54 79.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.684 0.793 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.74 -45.17 59.69 Favored Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 124.75 1.166 . . . . 0.0 111.144 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -57.66 -45.83 86.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.237 1.015 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -57.31 -43.75 83.52 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.599 0.76 . . . . 0.0 110.562 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.92 -52.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 124.429 1.091 . . . . 0.0 109.451 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.15 -39.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 121.903 -0.498 . . . . 0.0 110.632 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.46 94.33 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 110.776 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.05 -33.38 75.3 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 124.771 1.228 . . . . 0.0 111.616 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.5 -18.08 13.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.806 1.242 . . . . 0.0 110.707 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -58.75 -22.99 59.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.05 -1.656 . . . . 0.0 112.134 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.17 -24.09 66.98 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.295 -1.503 . . . . 0.0 111.859 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.79 -43.08 11.51 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.008 0.923 . . . . 0.0 108.561 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.9 -39.58 94.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 122.006 0.907 . . . . 0.0 111.552 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -24.74 63.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.607 0.763 . . . . 0.0 112.294 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.9 t -90.72 -2.81 57.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.5 -41.49 72.57 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 120.534 1.516 . . . . 0.0 108.93 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -70.45 -22.2 62.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.732 -1.23 . . . . 0.0 112.978 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.66 -24.98 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.301 1.04 . . . . 0.0 108.783 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -59.0 -19.4 43.15 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 125.626 1.57 . . . . 0.0 113.309 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -72.83 -28.17 62.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.862 -1.149 . . . . 0.0 109.234 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -108.07 -60.36 1.73 Allowed 'General case' 0 CA--C 1.502 -0.904 0 O-C-N 120.944 -1.098 . . . . 0.0 108.634 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -77.29 157.61 30.65 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.412 ' OE1' ' HE1' ' A' ' 103' ' ' HIS . 1.6 tp10 77.41 -41.55 0.37 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.155 1.382 . . . . 0.0 111.736 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -52.29 -56.05 17.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 110.548 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -86.35 -0.41 55.83 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.491 -0.756 . . . . 0.0 111.049 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.91 -12.67 61.22 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 121.244 -0.91 . . . . 0.0 112.255 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.412 ' HE1' ' OE1' ' A' ' 99' ' ' GLU . 48.9 m80 . . . . . 0 CA--C 1.507 -0.702 0 C-N-CA 125.88 1.672 . . . . 0.0 107.096 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.429 -1.513 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.96 -144.77 0.47 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 111.058 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -144.7 -66.51 0.33 Allowed 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.41 ' CG ' ' HA ' ' B' ' 88' ' ' ALA . 10.9 p80 -55.45 -23.18 24.0 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -68.52 -28.38 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.278 -0.889 . . . . 0.0 109.246 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.42 -23.31 40.43 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.17 -0.956 . . . . 0.0 110.966 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -83.05 -41.5 18.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.22 76.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 112.024 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -61.75 -49.12 77.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.589 1.155 . . . . 0.0 109.784 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -64.56 -35.86 82.35 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.698 0.799 . . . . 0.0 110.551 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -44.74 94.69 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -63.55 -43.25 97.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.256 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 123.33 0.652 . . . . 0.0 110.062 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . 0.295 4.1 tt0 -77.13 -11.89 59.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.213 -0.929 . . . . 0.0 112.127 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -70.22 -35.04 73.6 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -60.35 -35.66 76.18 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.845 0.858 . . . . 0.0 110.736 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.7 -39.88 95.41 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.726 1.21 . . . . 0.0 109.923 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.05 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 O-C-N 121.379 -0.826 . . . . 0.0 109.526 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.56 -40.19 96.04 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.903 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.47 -44.29 78.94 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.117 -0.989 . . . . 0.0 109.532 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.87 -39.15 90.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.758 1.223 . . . . 0.0 110.477 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.27 77.22 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 126.025 1.73 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -66.43 -44.1 83.81 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.3 1.04 . . . . 0.0 110.197 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -65.44 -53.72 38.83 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.49 1.116 . . . . 0.0 108.68 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -57.39 -48.6 78.65 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.699 1.199 . . . . 0.0 110.698 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 -41.86 65.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 125.057 1.343 . . . . 0.0 111.666 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.22 -47.08 82.6 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.797 -1.189 . . . . 0.0 107.949 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.34 -1.89 38.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.06 -1.025 . . . . 0.0 110.918 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.76 61.23 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 109.594 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -80.06 -110.93 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 71.18 -33.34 0.27 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.754 2.022 . . . . 0.0 113.515 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.15 41.05 0.38 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.07 153.86 39.03 Favored Pre-proline 0 C--N 1.35 0.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.75 123.21 3.21 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 C-N-CA 123.265 2.643 . . . . 0.0 111.43 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 23.0 53.05 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.94 33.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 126.851 2.061 . . . . 0.0 111.157 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -37.63 0.22 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.873 0.469 . . . . 0.0 110.528 -172.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.98 60.32 4.76 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-O 124.011 1.862 . . . . 0.0 107.865 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.72 -14.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 O-C-N 120.051 -1.656 . . . . 0.0 112.255 -168.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -99.2 132.41 44.53 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.061 -1.649 . . . . 0.0 112.399 -167.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.36 -54.41 11.4 Favored Pre-proline 0 C--N 1.351 0.644 0 CA-C-O 116.619 -1.658 . . . . 0.0 109.606 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.89 -13.07 24.14 Favored 'Trans proline' 0 CA--C 1.508 -0.815 0 CA-C-N 125.552 3.018 . . . . 0.0 111.297 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.51 -10.83 26.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.62 95.07 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.97 -28.72 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 123.989 0.916 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -37.87 62.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.117 0.967 . . . . 0.0 108.793 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -66.69 -43.17 85.11 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.779 0.831 . . . . 0.0 109.475 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 42.0 m -53.53 -30.4 41.47 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.988 1.315 . . . . 0.0 113.572 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.34 -34.87 51.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.435 1.094 . . . . 0.0 110.715 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -77.81 -36.46 50.25 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.842 -1.161 . . . . 0.0 113.174 -171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -77.26 -37.32 53.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -166.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.11 -26.8 64.14 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.522 -0.736 . . . . 0.0 112.071 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.403 ' HG1' HG22 ' B' ' 55' ' ' VAL . 3.3 p -89.23 7.43 35.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p 55.08 64.07 1.91 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.62 1.568 . . . . 0.0 111.778 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' HG1' ' B' ' 53' ' ' THR . 22.3 t -122.71 -106.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 76.55 1.28 Allowed Glycine 0 CA--C 1.484 -1.866 0 N-CA-C 104.634 -3.387 . . . . 0.0 104.634 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -35.78 58.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.65 -0.912 . . . . 0.0 108.911 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 39.45 0.73 Allowed Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.401 ' HB2' HH12 ' C' ' 68' ' ' ARG . 6.5 t70 -77.72 -51.23 10.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 118.554 1.177 . . . . 0.0 108.69 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.32 160.16 38.78 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -130.79 114.45 16.62 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.62 173.08 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.582 2.854 . . . . 0.0 109.349 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.25 -112.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.021 0.929 . . . . 0.0 110.735 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.0 m -136.33 -41.16 0.64 Allowed 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.658 -1.276 . . . . 0.0 108.627 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -81.72 -2.67 51.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.202 -0.936 . . . . 0.0 109.277 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -29.52 43.42 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.01 69.66 1.26 Allowed Glycine 0 CA--C 1.47 -2.77 0 N-CA-C 103.795 -3.722 . . . . 0.0 103.795 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -36.03 -18.49 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.444 3.498 . . . . 0.0 116.869 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -53.12 -17.57 1.66 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 119.988 -1.695 . . . . 0.0 113.132 158.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.13 -46.29 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 119.56 -1.962 . . . . 0.0 108.756 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.61 -48.73 63.37 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.59 -47.05 77.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.38 1.072 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -69.85 -37.82 76.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.307 -0.871 . . . . 0.0 112.356 -173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.35 -43.73 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ttp -62.14 -51.03 69.5 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.298 1.039 . . . . 0.0 110.537 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.31 -30.96 70.95 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.631 0.772 . . . . 0.0 110.044 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.5 73.88 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.331 -0.856 . . . . 0.0 111.12 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.19 85.95 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 mt -60.61 -45.29 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 C-N-CA 124.307 1.043 . . . . 0.0 109.562 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -29.27 70.35 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.111 -0.993 . . . . 0.0 112.078 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.08 -54.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -62.52 -42.19 99.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.728 0.811 . . . . 0.0 110.69 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.11 79.25 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.079 1.352 . . . . 0.0 111.158 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tt -66.77 -34.18 77.27 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.109 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.07 -10.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 124.451 1.101 . . . . 0.0 110.236 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 8.4 m -60.7 -22.98 64.51 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 119.303 -2.123 . . . . 0.0 111.49 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.65 69.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.327 -1.483 . . . . 0.0 111.811 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' B' ' 4' ' ' HIS . . . -80.27 -45.63 17.6 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.12 -37.8 88.65 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 124.5 1.12 . . . . 0.0 111.795 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.61 65.75 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.598 -0.688 . . . . 0.0 112.202 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 -6.58 52.35 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.603 -1.311 . . . . 0.0 109.291 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.299 0.2 OUTLIER -79.12 -12.38 60.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 120.402 1.455 . . . . 0.0 110.616 -167.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.44 -31.75 54.08 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 168.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.53 -22.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.895 1.278 . . . . 0.0 108.672 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -55.62 -24.79 35.4 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.951 1.7 . . . . 0.0 112.18 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -64.19 -22.02 66.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 120.828 -1.17 . . . . 0.0 110.894 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.05 -37.01 72.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -62.47 -54.7 36.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.07 -31.94 61.55 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -62.34 -40.11 95.3 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -94.97 -20.74 19.12 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.1 0.952 . . . . 0.0 109.461 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.18 17.71 57.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 . . . . . 0 CA--C 1.495 -1.162 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 174.617 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.34 119.23 4.55 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 93.103 -6.629 . . . . 0.0 93.103 165.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.22 93.65 0.07 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 119.837 1.198 . . . . 0.0 109.906 -169.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.548 ' HE1' ' OD1' ' C' ' 92' ' ' ASP . 0.6 OUTLIER -176.09 -37.97 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.89 2.076 . . . . 0.0 105.486 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.17 -35.82 74.24 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.131 0.967 . . . . 0.0 110.325 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -58.27 -36.04 72.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.473 1.909 . . . . 0.0 111.389 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.94 -42.42 39.35 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.196 1.398 . . . . 0.0 108.513 -176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.44 85.62 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.302 1.041 . . . . 0.0 110.889 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.27 -37.53 87.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.391 1.476 . . . . 0.0 110.697 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -67.57 -36.03 80.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.009 0.924 . . . . 0.0 109.154 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.92 97.39 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.998 0.919 . . . . 0.0 111.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.66 -27.84 68.66 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 121.235 -0.915 . . . . 0.0 112.435 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.31 -35.73 81.89 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.671 -1.268 . . . . 0.0 109.542 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.74 -44.51 93.76 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.48 -44.05 92.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.034 0.534 . . . . 0.0 110.88 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.35 -40.13 74.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.769 0.827 . . . . 0.0 112.339 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -73.69 -28.53 61.79 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 120.872 -1.142 . . . . 0.0 111.044 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.05 -37.26 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.01 -49.09 69.65 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.085 0.954 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.71 -45.96 91.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.852 0.751 . . . . 0.0 111.672 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -42.71 82.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.715 -0.615 . . . . 0.0 109.99 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.43 84.3 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.963 1.305 . . . . 0.0 111.651 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -62.86 -50.27 71.6 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.977 1.311 . . . . 0.0 109.593 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -67.2 -40.37 86.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -62.0 -48.88 78.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.384 1.074 . . . . 0.0 110.724 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.34 72.66 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 111.824 -173.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.79 -42.39 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 O-C-N 122.204 -0.31 . . . . 0.0 110.396 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.17 -23.63 60.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 120.365 -1.459 . . . . 0.0 112.148 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.55 69.7 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.361 1.464 . . . . 0.0 107.983 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.92 -28.21 63.33 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.739 0.78 . . . . 0.0 111.001 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.34 95.87 1.07 Allowed 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.618 -1.301 . . . . 0.0 110.378 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.0 -11.56 6.54 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.76 142.83 26.12 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 118.272 1.036 . . . . 0.0 109.061 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.54 129.72 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.407 2.071 . . . . 0.0 112.064 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.88 45.01 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 141.69 31.25 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.494 2.318 . . . . 0.0 112.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.89 -45.21 2.59 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.78 65.88 5.92 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 123.018 1.39 . . . . 0.0 109.449 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -96.79 -10.87 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 O-C-N 119.851 -1.781 . . . . 0.0 111.447 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.3 m -98.71 127.23 44.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.514 -0.741 . . . . 0.0 109.668 -169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.84 -52.19 65.87 Favored Pre-proline 0 N--CA 1.445 -0.712 0 C-N-CA 126.148 1.779 . . . . 0.0 112.187 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.75 -8.41 20.31 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 CA-C-N 125.086 2.852 . . . . 0.0 111.624 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.79 -25.97 20.82 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.55 76.16 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.624 0.77 . . . . 0.0 111.348 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.2 -25.23 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 124.609 1.163 . . . . 0.0 110.411 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -79.57 -44.68 20.62 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 119.737 -1.852 . . . . 0.0 107.164 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.03 -37.5 87.43 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.176 0.991 . . . . 0.0 110.547 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -67.59 -35.34 78.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.025 -1.672 . . . . 0.0 111.519 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.26 -51.99 66.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.293 1.037 . . . . 0.0 109.554 -178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.75 -30.81 65.99 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.487 -0.758 . . . . 0.0 110.727 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 80.5 m -62.82 -36.35 82.89 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.955 -1.09 . . . . 0.0 110.783 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -16.05 63.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 120.632 -1.292 . . . . 0.0 113.036 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -89.34 -3.99 58.26 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.458 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.314 11.3 p 68.41 2.09 3.19 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 127.343 2.257 . . . . 0.0 112.66 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.81 -53.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.38 1.472 . . . . 0.0 107.418 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.34 -62.02 4.68 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 74.4 -44.95 0.57 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.798 2.839 . . . . 0.0 109.914 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.57 40.0 0.55 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 107.157 -2.377 . . . . 0.0 107.157 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.55 -55.73 9.33 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.503 1.151 . . . . 0.0 108.275 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -149.25 168.34 23.56 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -134.88 126.71 17.98 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -165.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . 0.409 ' HB2' ' HG2' ' C' ' 66' ' ' GLU . 89.5 Cg_endo -80.52 172.19 13.78 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 123.368 2.712 . . . . 0.0 109.71 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -93.37 -106.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.306 1.042 . . . . 0.0 113.641 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 18.7 m -155.86 -38.44 0.08 Allowed 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 119.013 -2.304 . . . . 0.0 106.411 -171.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -91.52 10.26 28.59 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 120.851 -1.156 . . . . 0.0 109.084 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' C' ' 62' ' ' PRO . 0.0 OUTLIER -71.68 -42.16 67.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.56 91.38 1.91 Allowed Glycine 0 N--CA 1.418 -2.537 1 N-CA-C 96.662 -6.575 . . . . 0.0 96.662 -170.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' B' ' 59' ' ' ASP . 24.9 ttm180 -65.87 -11.52 47.4 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.04 1.92 . . . . 0.0 110.388 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -46.14 -23.87 0.38 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.456 1.902 . . . . 0.0 113.971 159.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.84 -41.61 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 119.99 -1.694 . . . . 0.0 109.385 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.98 61.76 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -49.8 -49.19 49.6 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 126.236 1.814 . . . . 0.0 111.55 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -44.51 90.05 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.188 0.995 . . . . 0.0 111.813 -173.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.28 -37.92 60.17 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.415 -0.803 . . . . 0.0 109.252 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 73.7 mtm -66.36 -44.77 82.25 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 123.359 0.664 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -59.01 -43.1 91.49 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 123.846 0.858 . . . . 0.0 110.631 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.13 96.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.022 0.529 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.85 91.89 Favored Glycine 0 CA--C 1.493 -1.333 0 C-N-CA 123.905 0.764 . . . . 0.0 111.546 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.25 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 109.017 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.25 -37.97 86.76 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.634 -0.666 . . . . 0.0 111.674 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.57 -53.56 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 119.298 0.953 . . . . 0.0 110.054 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.07 -34.23 76.04 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 122.857 0.463 . . . . 0.0 110.71 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.12 65.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.915 -1.115 . . . . 0.0 110.489 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.03 -32.1 73.38 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 120.647 -1.283 . . . . 0.0 111.481 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.93 -1.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 120.99 -1.069 . . . . 0.0 112.271 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -58.65 -18.06 27.51 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 111.181 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.0 68.44 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.563 -1.336 . . . . 0.0 112.123 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.87 -44.62 16.61 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.317 -0.864 . . . . 0.0 108.857 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.4 -40.62 95.07 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.331 1.053 . . . . 0.0 111.633 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.25 99.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.471 0.708 . . . . 0.0 111.312 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -17.78 64.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 120.924 -1.11 . . . . 0.0 113.303 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . 0.548 ' OD1' ' HE1' ' C' ' 4' ' ' HIS . 1.3 m-20 -74.7 -20.07 60.0 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 119.907 1.231 . . . . 0.0 111.028 -167.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -82.41 -31.83 29.39 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.035 -1.04 . . . . 0.0 110.519 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.04 -19.96 26.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.371 1.468 . . . . 0.0 109.382 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -65.17 -15.51 62.51 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 120.319 -1.488 . . . . 0.0 111.543 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -72.36 -14.01 61.62 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.129 -1.607 . . . . 0.0 111.48 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -63.65 -41.25 98.25 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.59 -34.64 65.18 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 123.98 0.912 . . . . 0.0 110.118 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -74.43 -11.31 60.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.036 0.934 . . . . 0.0 112.79 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -68.86 -31.02 69.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.928 -1.107 . . . . 0.0 110.234 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -112.72 -4.26 14.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.245 -0.91 . . . . 0.0 109.426 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.04 32.75 83.42 Favored Glycine 0 CA--C 1.498 -1.03 0 O-C-N 121.25 -0.907 . . . . 0.0 111.338 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.41 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.433 -1.322 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.23 -46.73 0.57 Allowed 'General case' 0 C--N 1.355 0.809 0 C-N-CA 127.207 2.203 . . . . 0.0 114.32 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . 0.308 3.3 m-20 67.9 -35.08 0.26 Allowed 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 131.358 3.863 . . . . 0.0 111.807 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -68.57 -22.54 64.47 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.856 -1.153 . . . . 0.0 112.528 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.89 -45.77 92.3 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 122.191 0.996 . . . . 0.0 108.845 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -67.1 -38.53 85.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 124.409 1.084 . . . . 0.0 110.142 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.14 -35.39 69.07 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.956 -0.465 . . . . 0.0 109.893 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.68 86.69 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 121.693 -0.63 . . . . 0.0 110.104 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -60.97 -39.71 90.61 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.625 1.57 . . . . 0.0 111.473 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.09 -30.31 62.29 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.358 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.76 79.2 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.822 -1.174 . . . . 0.0 110.982 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 52.2 mt-10 -64.02 -35.92 82.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.596 -0.69 . . . . 0.0 111.966 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.76 -42.82 81.16 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.766 1.226 . . . . 0.0 108.334 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . 0.441 ' CD ' ' HZ2' ' D' ' 17' ' ' LYS . 45.7 tp10 -55.83 -45.13 78.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 125.576 1.55 . . . . 0.0 109.839 -176.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.78 -36.83 79.96 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.542 -0.724 . . . . 0.0 112.348 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -65.01 -34.91 79.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.65 0.78 . . . . 0.0 109.988 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.441 ' HZ2' ' CD ' ' D' ' 14' ' ' GLU . 14.2 pttt -75.59 -29.3 59.23 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 120.839 -1.163 . . . . 0.0 110.513 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.05 -47.82 52.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.27 -31.84 73.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.512 -0.742 . . . . 0.0 110.445 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -67.39 -43.51 81.15 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.797 -1.189 . . . . 0.0 111.064 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.48 -39.93 95.75 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.82 -1.175 . . . . 0.0 110.456 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.26 -25.6 68.13 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.31 -0.868 . . . . 0.0 112.343 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -66.09 -42.59 89.14 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.389 1.076 . . . . 0.0 111.021 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -66.54 -34.83 78.78 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.471 1.109 . . . . 0.0 108.461 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -74.41 -50.49 18.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 118.273 -0.87 . . . . 0.0 108.722 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.11 -41.8 75.81 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 126.83 2.052 . . . . 0.0 113.166 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.82 -31.12 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 O-C-N 120.722 -1.236 . . . . 0.0 110.896 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 -34.11 22.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.69 47.2 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 0.0 109.373 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.37 -36.5 71.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 120.997 0.427 . . . . 0.0 111.191 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.02 106.53 1.63 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 120.024 -1.673 . . . . 0.0 111.568 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.41 -25.13 4.32 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.94 153.81 75.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 123.657 0.783 . . . . 0.0 110.979 -170.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -80.43 135.78 10.78 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.312 2.008 . . . . 0.0 109.988 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.64 14.07 74.14 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.0 135.0 56.28 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.01 1.724 . . . . 0.0 111.725 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.82 -31.08 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.984 1.314 . . . . 0.0 109.047 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' D' ' 60' ' ' ARG . 4.6 tt -86.72 121.97 29.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.246 1.418 . . . . 0.0 109.103 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 pt -148.88 175.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 73.3 m 67.13 122.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.212 2.205 . . . . 0.0 113.662 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.9 -50.5 87.65 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 116.815 -1.564 . . . . 0.0 113.189 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.61 -11.93 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 124.459 2.628 . . . . 0.0 111.525 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.56 -37.85 14.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.6 83.59 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.939 1.696 . . . . 0.0 112.207 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -64.8 -31.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.47 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.69 -18.25 41.58 Favored 'General case' 0 N--CA 1.437 -1.108 0 O-C-N 120.674 -1.266 . . . . 0.0 110.878 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -72.01 -43.47 65.0 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -66.03 -26.11 67.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 121.33 -0.856 . . . . 0.0 113.202 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.4 -36.18 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 C-N-CA 124.403 1.081 . . . . 0.0 111.351 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.61 -5.9 57.87 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.649 -1.282 . . . . 0.0 110.133 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.7 m -96.95 177.72 5.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 80.96 -41.12 0.16 Allowed 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.328 1.451 . . . . 0.0 110.208 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.6 p -85.33 3.54 39.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.982 1.713 . . . . 0.0 111.939 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p 59.24 53.68 5.23 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 126.095 1.758 . . . . 0.0 112.314 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.28 -99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.13 106.22 0.5 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 106.78 -2.528 . . . . 0.0 106.78 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -86.88 -15.64 38.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.747 -1.443 . . . . 0.0 109.233 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.84 28.6 5.27 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -65.57 -56.21 13.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' D' ' 38' ' ' LEU . 88.5 mtt-85 -137.2 156.97 47.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -128.49 149.92 73.04 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 101.206 -3.628 . . . . 0.0 101.206 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.26 152.06 3.72 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 123.313 2.676 . . . . 0.0 110.057 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 p -109.32 -179.59 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 122.328 1.061 . . . . 0.0 109.09 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -62.63 -49.13 76.39 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.18 2.192 . . . . 0.0 113.913 -167.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -83.64 -0.0 48.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.744 1.218 . . . . 0.0 110.019 -167.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -28.19 67.41 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 123.745 1.736 . . . . 0.0 106.674 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 75.17 1.27 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 99.973 -5.251 . . . . 0.0 99.973 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.26 8.4 mtm180 -55.18 -2.35 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 126.104 1.762 . . . . 0.0 114.92 -169.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.82 -0.77 4.5 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.828 1.251 . . . . 0.0 112.984 160.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.23 -59.82 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.81 -56.24 17.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 114.647 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . 0.302 1.5 pp20? -68.38 -26.63 65.67 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.313 -0.867 . . . . 0.0 111.551 -172.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -67.54 -31.08 70.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.613 -0.679 . . . . 0.0 110.777 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.15 -45.27 86.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.1 mtp -64.99 -46.54 81.0 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.662 0.785 . . . . 0.0 110.056 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -63.76 -37.89 89.06 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.222 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.57 91.62 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.396 0.617 . . . . 0.0 110.939 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.59 -41.52 89.69 Favored Glycine 0 CA--C 1.489 -1.588 0 O-C-N 121.615 -0.678 . . . . 0.0 112.469 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.47 -47.35 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.919 0.888 . . . . 0.0 109.709 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.27 -26.14 61.87 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.101 -0.999 . . . . 0.0 111.934 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 t -64.64 -50.91 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.82 -2.87 32.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.527 -0.733 . . . . 0.0 111.397 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -30.94 13.01 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.067 0.947 . . . . 0.0 109.491 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.84 -33.97 75.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.617 -1.302 . . . . 0.0 109.83 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -62.69 -12.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.183 0.993 . . . . 0.0 111.899 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 21.3 m -68.26 -14.87 63.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 120.337 -1.477 . . . . 0.0 111.73 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -16.39 64.19 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 120.007 -1.683 . . . . 0.0 111.31 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.82 -49.33 7.18 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 62.9 mt -60.39 -35.54 75.98 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.652 1.181 . . . . 0.0 112.085 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 120.924 -1.11 . . . . 0.0 112.435 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -4.45 55.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 120.777 -1.202 . . . . 0.0 108.415 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.9 -32.17 67.14 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 119.382 0.992 . . . . 0.0 109.454 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -75.84 -28.59 58.29 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.379 -1.45 . . . . 0.0 111.079 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 t -70.55 -17.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 108.74 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -59.1 -22.21 60.47 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 125.656 1.582 . . . . 0.0 111.606 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -60.66 -33.0 72.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 123.013 1.387 . . . . 0.0 110.242 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -96.54 154.54 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 103.25 -2.871 . . . . 0.0 103.25 -161.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.29 32.1 mt-10 76.23 -47.97 0.56 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.423 1.489 . . . . 0.0 110.546 -171.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -63.29 -35.95 82.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.277 1.431 . . . . 0.0 112.149 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -71.07 -23.35 62.11 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.888 -0.507 . . . . 0.0 111.94 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -85.26 -23.94 27.98 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.177 -0.952 . . . . 0.0 108.52 172.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.22 32.72 25.02 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.701 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.64 -79.08 0.06 Allowed 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.822 0.82 . . . . 0.0 109.103 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 4' ' ' HIS . 13.5 p30 -157.03 -74.17 0.09 Allowed 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -171.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 23.4 p-80 -58.4 -35.59 72.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 129.456 3.102 . . . . 0.0 112.313 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.477 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 7.7 mt-10 -68.21 -32.66 73.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.113 0.965 . . . . 0.0 111.498 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -65.61 -40.0 92.15 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.72 -31.89 68.9 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.74 0.816 . . . . 0.0 109.636 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.58 -43.05 70.21 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.544 0.738 . . . . 0.0 109.981 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -68.27 -35.98 78.7 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.914 -0.491 . . . . 0.0 110.305 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.71 -40.12 78.8 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.689 1.196 . . . . 0.0 110.889 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.45 94.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.729 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -64.67 -28.0 69.31 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.427 -0.796 . . . . 0.0 111.608 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.72 -35.94 72.97 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.789 -1.194 . . . . 0.0 110.246 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -68.15 -38.48 82.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.28 -38.71 84.43 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.309 -0.869 . . . . 0.0 111.747 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -71.18 -27.05 63.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 121.403 -0.811 . . . . 0.0 111.458 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -72.17 -39.14 68.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.443 -0.786 . . . . 0.0 109.488 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.2 -34.57 64.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.568 1.147 . . . . 0.0 109.792 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.95 -48.04 82.93 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.926 -1.109 . . . . 0.0 111.342 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.49 -42.51 87.33 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.808 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.28 -49.18 78.64 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 110.072 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.69 88.24 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 125.732 1.613 . . . . 0.0 111.243 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -43.47 98.81 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.588 0.755 . . . . 0.0 111.103 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -66.08 -40.73 91.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 124.398 1.079 . . . . 0.0 108.916 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -76.27 -44.66 36.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.699 -0.626 . . . . 0.0 111.18 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.6 95.54 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.665 1.586 . . . . 0.0 111.09 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.82 -38.05 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 122.189 -0.319 . . . . 0.0 110.212 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.283 89.0 mt-10 -67.98 -40.03 83.19 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.022 -1.049 . . . . 0.0 109.352 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.02 -47.3 85.38 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.76 1.624 . . . . 0.0 109.613 -171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.15 -8.62 59.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 121.666 -0.646 . . . . 0.0 111.929 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -76.17 80.95 2.98 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.081 -1.637 . . . . 0.0 110.141 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.65 -13.74 5.84 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.89 150.08 97.71 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 118.124 0.962 . . . . 0.0 109.903 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -75.55 147.76 32.35 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 121.984 1.79 . . . . 0.0 108.525 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 4.21 64.86 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 120.192 1.36 . . . . 0.0 113.957 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 159.44 27.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.755 0.822 . . . . 0.0 111.736 -171.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.96 -32.32 0.8 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.137 0.975 . . . . 0.0 109.78 -171.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.12 40.73 0.72 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 123.828 1.775 . . . . 0.0 109.392 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.66 72.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 O-C-N 119.158 -2.214 . . . . 0.0 105.388 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -158.06 -120.37 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 116.553 -1.689 . . . . 0.0 107.041 -168.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.6 t80 178.23 -64.28 0.0 OUTLIER Pre-proline 0 C--N 1.359 1.0 0 CA-C-N 121.052 1.751 . . . . 0.0 110.355 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -75.14 -8.46 19.92 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 CA-C-N 125.515 3.005 . . . . 0.0 111.887 -167.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -10.18 28.33 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 129.662 3.185 . . . . 0.0 107.136 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -48.7 51.31 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.13 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.3 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -17.51 60.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.498 -1.376 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -86.29 -39.21 16.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.23 -38.3 76.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.745 -1.222 . . . . 0.0 111.726 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.57 -25.85 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.695 1.198 . . . . 0.0 110.824 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.99 -23.03 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.976 -1.078 . . . . 0.0 110.809 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -107.47 -22.85 12.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 -165.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.2 64.17 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.372 -1.455 . . . . 0.0 111.999 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.95 2.35 51.86 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.919 1.288 . . . . 0.0 110.578 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.252 9.6 p 56.67 63.09 2.05 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.34 1.856 . . . . 0.0 111.261 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 56' ' ' GLY . 2.6 t -145.79 -164.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -177.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.481 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 156.67 101.72 0.19 Allowed Glycine 0 CA--C 1.475 -2.459 1 N-CA-C 100.191 -5.164 . . . . 0.0 100.191 -177.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.89 -26.87 29.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.3 33.57 1.6 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.482 ' CG ' HH22 ' B' ' 68' ' ' ARG . 30.8 t70 -83.67 -26.46 29.84 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.434 -1.039 . . . . 0.0 109.418 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -179.58 4.69 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -158.7 114.99 1.67 Allowed Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.71 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.697 2.932 . . . . 0.0 109.417 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.36 -120.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.909 0.883 . . . . 0.0 110.372 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -141.67 -36.28 0.43 Allowed 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -89.41 9.97 24.31 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 120.881 -1.137 . . . . 0.0 108.187 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -43.92 63.21 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.44 90.92 2.03 Favored Glycine 0 N--CA 1.417 -2.594 1 N-CA-C 96.397 -6.681 . . . . 0.0 96.397 -172.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -64.36 -12.03 38.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 119.364 1.582 . . . . 0.0 111.081 -172.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -46.95 -28.97 1.8 Allowed 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.002 0.921 . . . . 0.0 113.215 162.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.8 t -66.92 -39.4 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 0.0 110.133 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.48 -50.46 18.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 120.951 -1.093 . . . . 0.0 108.42 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -50.81 -44.5 59.05 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.612 1.565 . . . . 0.0 111.998 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -65.64 -36.02 82.48 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.416 0.686 . . . . 0.0 110.148 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.38 -42.59 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.9 mtt -59.79 -50.89 72.03 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.243 1.017 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -64.55 -38.27 90.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.149 0.98 . . . . 0.0 110.83 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.08 96.55 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.188 0.595 . . . . 0.0 110.518 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.69 -48.72 79.21 Favored Glycine 0 CA--C 1.49 -1.522 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.36 -47.48 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.387 1.075 . . . . 0.0 109.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.72 -39.92 95.48 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 120.929 -1.107 . . . . 0.0 111.397 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 t -64.22 -52.89 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.738 0.815 . . . . 0.0 109.851 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.26 -41.22 94.45 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 110.499 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.13 -30.9 71.48 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 123.565 0.746 . . . . 0.0 111.019 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.57 -30.38 69.99 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.059 -1.026 . . . . 0.0 110.852 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.3 t -59.87 -18.44 15.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 124.375 1.07 . . . . 0.0 110.582 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 m -56.42 -27.71 57.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.248 1.419 . . . . 0.0 112.739 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.04 -28.28 64.36 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.485 1.114 . . . . 0.0 111.376 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 -45.92 9.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.088 0.955 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.7 mt -49.62 -46.71 49.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.476 1.91 . . . . 0.0 113.434 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.82 42.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.756 -1.215 . . . . 0.0 111.222 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.8 p -64.11 -6.14 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.381 1.072 . . . . 0.0 113.259 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.36 -74.79 0.14 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.31 0.93 57.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.439 -1.413 . . . . 0.0 112.347 -168.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.68 -29.52 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 O-C-N 119.761 -1.837 . . . . 0.0 108.761 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -59.5 -18.08 37.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.001 1.32 . . . . 0.0 113.2 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -52.22 -35.46 49.47 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.28 1.432 . . . . 0.0 111.593 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.505 ' CD ' HH21 ' A' ' 100' ' ' ARG . 7.5 tp10 -75.0 -49.76 18.78 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.57 -26.18 63.42 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.575 -0.703 . . . . 0.0 110.919 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -73.77 -27.41 61.14 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 119.816 -1.802 . . . . 0.0 111.412 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.505 HH21 ' CD ' ' A' ' 97' ' ' GLU . 50.5 ttp180 -74.81 -46.01 39.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -131.03 87.79 2.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -172.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.37 -53.7 0.51 Allowed Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 106.445 -2.662 . . . . 0.0 106.445 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . 0.316 14.1 p80 . . . . . 0 CA--C 1.502 -0.872 0 C-N-CA 128.389 2.675 . . . . 0.0 114.274 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.68 169.11 8.76 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.48 -39.55 88.05 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 123.15 1.453 . . . . 0.0 110.405 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -72.02 -28.92 63.69 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.159 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.62 -43.05 23.61 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.32 -37.47 87.4 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.962 -0.461 . . . . 0.0 110.32 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.35 -34.83 65.83 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.979 0.418 . . . . 0.0 110.036 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.28 78.59 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 123.674 0.79 . . . . 0.0 110.287 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -77.97 -11.98 59.95 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.633 -0.667 . . . . 0.0 111.452 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' B' ' 13' ' ' GLU . 44.1 tptt -77.77 -29.34 50.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 121.394 -0.816 . . . . 0.0 109.349 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.62 87.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.41 -23.48 63.71 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.693 0.797 . . . . 0.0 111.905 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' B' ' 10' ' ' LYS . 37.1 tt0 -72.28 -44.66 62.44 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.931 -1.106 . . . . 0.0 108.161 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.81 -33.75 76.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.693 1.197 . . . . 0.0 109.818 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.02 -45.58 82.99 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 111.913 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.13 -38.89 90.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.286 1.034 . . . . 0.0 109.916 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -63.48 -41.21 98.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.011 0.924 . . . . 0.0 111.382 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.52 -48.41 47.2 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 124.175 0.99 . . . . 0.0 110.372 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.71 -35.22 80.36 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -65.51 -39.03 91.36 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.795 -1.191 . . . . 0.0 110.929 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.79 -37.62 86.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.437 -1.415 . . . . 0.0 109.217 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.62 66.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 123.387 0.675 . . . . 0.0 111.841 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.5 p -66.93 -39.01 87.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 118.767 0.712 . . . . 0.0 110.694 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.34 -46.03 81.88 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.45 -43.14 99.53 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.621 1.169 . . . . 0.0 108.936 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.99 84.64 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.147 1.379 . . . . 0.0 113.279 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.88 -47.78 91.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-O 121.88 0.847 . . . . 0.0 109.502 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -79.96 -20.79 44.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 O-C-N 121.663 -0.648 . . . . 0.0 110.673 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -51.43 22.74 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 125.9 1.68 . . . . 0.0 109.664 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 -18.37 55.35 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.834 -0.542 . . . . 0.0 111.869 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.51 87.67 1.2 Allowed 'General case' 0 C--N 1.353 0.754 0 O-C-N 119.973 -1.704 . . . . 0.0 110.107 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.31 -11.46 3.27 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.4 143.77 32.92 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 118.398 1.099 . . . . 0.0 111.69 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.18 125.19 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.359 2.706 . . . . 0.0 111.636 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 23.28 68.0 Favored Glycine 0 CA--C 1.495 -1.206 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 167.11 21.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.157 1.383 . . . . 0.0 109.524 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.58 -39.51 1.28 Allowed 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.222 0.609 . . . . 0.0 109.615 -166.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -94.78 130.57 41.28 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.6 pt -140.56 6.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 O-C-N 120.81 -1.182 . . . . 0.0 111.124 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.9 138.51 26.99 Favored 'General case' 0 CA--C 1.499 -0.99 0 O-C-N 119.944 -1.723 . . . . 0.0 109.502 -161.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -52.98 65.83 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 126.234 1.813 . . . . 0.0 113.347 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.19 -15.28 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 123.732 2.369 . . . . 0.0 111.827 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.86 -40.39 14.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.16 86.19 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 124.891 1.277 . . . . 0.0 111.886 -170.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.42 -38.73 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 122.749 0.419 . . . . 0.0 110.338 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -38.5 72.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.658 -0.651 . . . . 0.0 110.172 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.49 -43.0 99.88 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-O 122.157 0.979 . . . . 0.0 109.796 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 55.9 m -63.58 -30.61 71.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.517 -1.364 . . . . 0.0 113.006 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.36 -53.8 43.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 123.687 0.795 . . . . 0.0 109.622 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.91 -18.18 60.45 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 121.35 -0.844 . . . . 0.0 111.89 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -69.49 -36.81 76.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.454 0.702 . . . . 0.0 109.19 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.49 71.3 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.147 0.979 . . . . 0.0 111.664 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -82.97 3.4 30.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.358 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p 55.49 53.17 10.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.889 1.676 . . . . 0.0 112.574 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.71 -69.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.91 80.19 0.25 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -62.61 -43.29 99.19 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.463 1.125 . . . . 0.0 108.499 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.48 -120.67 0.99 Allowed Glycine 0 CA--C 1.48 -2.127 1 N-CA-C 102.043 -4.423 . . . . 0.0 102.043 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.341 0.2 OUTLIER 66.08 -64.05 0.22 Allowed 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 127.241 2.216 . . . . 0.0 114.594 -177.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -132.88 166.71 21.69 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -160.19 135.97 6.05 Favored Pre-proline 0 N--CA 1.436 -1.145 0 CA-C-O 117.391 -1.29 . . . . 0.0 107.536 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.45 151.04 15.23 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.967 2.445 . . . . 0.0 110.801 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.77 -119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 124.524 1.13 . . . . 0.0 109.145 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 13.4 p -113.93 -43.93 3.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.285 -1.51 . . . . 0.0 111.813 -166.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -83.03 -23.63 33.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.745 1.618 . . . . 0.0 108.041 -163.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.23 -14.62 63.12 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.592 1.957 . . . . 0.0 110.169 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.65 87.85 0.39 Allowed Glycine 0 CA--C 1.481 -2.087 1 N-CA-C 103.055 -4.018 . . . . 0.0 103.055 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.482 HH22 ' CG ' ' A' ' 59' ' ' ASP . 36.9 ttm180 -58.27 -21.21 47.73 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.59 -1.535 . . . . 0.0 111.872 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -55.86 -15.75 3.71 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.43 -43.73 97.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 O-C-N 120.722 -1.236 . . . . 0.0 108.729 172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.04 -43.68 67.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.403 0.681 . . . . 0.0 109.601 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.13 -39.85 69.89 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.819 1.648 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -40.52 95.78 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.035 1.334 . . . . 0.0 110.703 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.93 -43.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.8 mtt -57.84 -49.92 75.05 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.096 0.958 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.17 90.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.668 -0.645 . . . . 0.0 111.157 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.5 98.78 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.877 1.227 . . . . 0.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.59 -43.38 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 121.641 -0.917 . . . . 0.0 108.927 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.24 -31.95 70.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.914 -1.116 . . . . 0.0 113.262 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.96 -41.06 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 120.058 1.299 . . . . 0.0 110.607 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.14 -38.58 75.53 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.617 0.644 . . . . 0.0 109.428 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.83 69.86 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.103 -0.998 . . . . 0.0 111.363 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.01 -15.46 63.48 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.546 -1.347 . . . . 0.0 111.207 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -5.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.5 -1.375 . . . . 0.0 110.157 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 14.8 t -49.58 -26.01 3.21 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 119.602 -1.936 . . . . 0.0 113.048 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.63 -36.49 71.9 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.975 1.31 . . . . 0.0 110.893 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.45 23.97 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.305 1.042 . . . . 0.0 108.46 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.44 -42.15 96.16 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 120.788 -1.195 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.84 -1.61 23.04 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.897 -1.127 . . . . 0.0 111.731 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 44.4 p -85.72 -42.1 14.54 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.92 -25.23 52.68 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.789 0.804 . . . . 0.0 110.666 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.96 -50.04 37.54 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 126.736 2.015 . . . . 0.0 111.693 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.61 -30.4 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.749 1.22 . . . . 0.0 109.418 -171.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -58.67 -12.28 4.02 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.371 1.068 . . . . 0.0 112.964 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -54.98 -33.92 62.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.394 -0.816 . . . . 0.0 111.126 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.51 176.24 6.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.264 20.0 mt-10 69.8 -44.46 0.56 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 126.367 1.867 . . . . 0.0 111.786 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -76.1 -50.96 13.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 112.453 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 -78.3 5.96 9.3 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 119.965 1.257 . . . . 0.0 113.507 -172.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -87.88 -28.11 21.77 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 164.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.35 40.65 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 56.1 t60 . . . . . 0 CA--C 1.509 -0.604 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 -176.081 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.81 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.736 2.015 . . . . 0.0 114.399 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -33.21 73.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 119.946 -1.721 . . . . 0.0 109.377 -174.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -79.85 -19.96 47.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.1 0.96 . . . . 0.0 112.165 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -30.76 62.85 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -61.63 -39.8 92.59 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.078 0.951 . . . . 0.0 110.827 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -32.17 73.49 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.346 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.1 70.15 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 123.482 0.713 . . . . 0.0 110.975 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.15 -33.34 73.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -63.35 -34.3 77.41 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.031 1.733 . . . . 0.0 110.28 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.94 -37.35 81.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.7 -15.56 62.21 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.975 -1.078 . . . . 0.0 111.873 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -69.95 -42.81 72.72 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.48 -1.388 . . . . 0.0 109.034 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.0 -35.78 81.82 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.32 0.648 . . . . 0.0 110.803 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -42.91 88.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.54 -35.14 78.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.331 -0.856 . . . . 0.0 111.706 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -60.16 -46.5 89.47 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.089 1.356 . . . . 0.0 110.058 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.7 -39.07 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.195 0.998 . . . . 0.0 109.819 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.81 -45.32 82.34 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.299 0.954 . . . . 0.0 111.925 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.77 -38.08 79.79 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 122.971 0.508 . . . . 0.0 110.851 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -74.33 -39.89 62.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.78 -1.2 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.17 74.58 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 124.883 1.273 . . . . 0.0 112.339 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -70.74 -36.99 73.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.217 0.917 . . . . 0.0 110.473 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -66.73 -41.28 88.16 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -65.5 -46.9 77.88 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.31 -49.02 65.03 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.87 1.668 . . . . 0.0 112.576 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.42 -34.27 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 O-C-N 121.795 -0.566 . . . . 0.0 112.17 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -87.91 -24.15 23.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.539 0.685 . . . . 0.0 109.394 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.84 37.22 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.54 -8.68 53.24 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 122.058 0.932 . . . . 0.0 112.316 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.52 107.57 13.44 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 119.647 -1.908 . . . . 0.0 108.125 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.03 15.8 40.71 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.18 21.72 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.79 107.64 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.432 2.088 . . . . 0.0 113.179 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.23 27.36 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.14 145.09 22.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.337 1.855 . . . . 0.0 112.911 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.0 -16.08 5.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.344 1.058 . . . . 0.0 110.785 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.59 -79.84 0.3 Allowed 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 121.221 -0.924 . . . . 0.0 108.595 -168.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . 0.359 12.7 pt 38.94 -128.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 126.779 2.032 . . . . 0.0 111.048 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.4 -135.58 0.82 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.913 1.688 . . . . 0.0 109.752 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -173.03 -68.12 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-O 116.653 -1.642 . . . . 0.0 106.758 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.73 -17.84 22.67 Favored 'Trans proline' 0 CA--C 1.51 -0.685 0 CA-C-N 125.321 2.936 . . . . 0.0 111.197 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.44 -23.75 65.56 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.269 1.427 . . . . 0.0 109.947 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.42 99.31 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 112.259 -167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -69.3 -33.71 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.18 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 121.543 -0.723 . . . . 0.0 110.19 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -63.16 -45.4 92.01 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.84 0.456 . . . . 0.0 110.508 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 62.0 m -58.94 -36.09 74.21 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.678 -0.639 . . . . 0.0 112.062 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.32 -45.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 C-N-CA 123.89 0.876 . . . . 0.0 110.191 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -73.84 3.24 6.91 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 122.1 0.952 . . . . 0.0 112.785 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -104.71 -36.3 7.49 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.702 -1.249 . . . . 0.0 108.856 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.68 61.39 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.426 -1.421 . . . . 0.0 111.768 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.8 p -87.69 -3.01 58.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.728 1.211 . . . . 0.0 109.983 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.254 6.9 p 55.62 36.35 27.02 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.522 1.929 . . . . 0.0 112.77 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -91.19 -19.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 O-C-N 121.61 -0.681 . . . . 0.0 111.474 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.48 -60.14 1.55 Allowed Glycine 0 CA--C 1.493 -1.334 0 O-C-N 120.59 -1.319 . . . . 0.0 112.412 168.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -75.71 73.09 2.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.875 1.321 . . . . 0.0 113.62 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.09 10.15 75.77 Favored Glycine 0 CA--C 1.492 -1.399 0 O-C-N 118.512 -2.618 . . . . 0.0 114.552 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t0 71.7 -4.73 1.83 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 126.095 1.758 . . . . 0.0 111.562 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -136.53 163.25 30.96 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -136.0 148.32 64.38 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.13 171.19 15.47 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.812 3.008 . . . . 0.0 108.488 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 t -115.21 -95.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 120.655 1.57 . . . . 0.0 110.282 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -140.48 -49.97 0.45 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -85.13 -16.35 40.77 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 123.646 0.778 . . . . 0.0 110.085 -165.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -33.21 74.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 108.33 171.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.35 95.32 1.81 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 98.229 -5.948 . . . . 0.0 98.229 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -61.92 -16.22 49.2 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 118.836 1.318 . . . . 0.0 110.62 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -59.81 -11.21 4.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.22 -39.88 86.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.084 -1.635 . . . . 0.0 108.99 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -45.18 69.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.82 -44.57 66.79 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.789 1.636 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -63.85 -36.0 82.48 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 112.34 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -71.84 -43.85 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 121.062 -1.024 . . . . 0.0 108.801 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.78 -42.51 97.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.606 0.762 . . . . 0.0 110.486 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.69 -47.15 83.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.621 1.168 . . . . 0.0 110.294 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.9 98.14 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.233 0.613 . . . . 0.0 110.509 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.13 77.92 Favored Glycine 0 CA--C 1.496 -1.119 0 C-N-CA 123.75 0.69 . . . . 0.0 111.832 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.75 -49.33 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 125.066 1.346 . . . . 0.0 108.675 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.42 -45.12 94.54 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 111.044 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.2 -52.87 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 C-N-CA 124.258 1.023 . . . . 0.0 110.367 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -72.27 -21.92 61.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.222 -0.924 . . . . 0.0 111.18 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.43 -37.88 36.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.115 -0.991 . . . . 0.0 110.111 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.23 -41.72 84.72 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.421 1.488 . . . . 0.0 110.609 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -69.04 -2.93 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -62.49 -12.57 22.98 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.361 1.065 . . . . 0.0 110.394 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.21 -57.3 12.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.122 -1.611 . . . . 0.0 111.841 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.4 77.6 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 126.07 1.748 . . . . 0.0 109.807 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.43 -33.37 75.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.35 40.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.007 -1.058 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . 0.334 0.1 OUTLIER -70.36 -2.39 13.49 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.517 -1.23 . . . . 0.0 110.617 -176.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.281 0.6 OUTLIER -76.25 1.65 15.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 122.148 2.249 . . . . 0.0 111.531 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.24 -24.03 61.32 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 119.673 -1.892 . . . . 0.0 111.05 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.78 -12.95 14.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 O-C-N 120.112 -1.617 . . . . 0.0 110.275 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -79.64 -3.97 49.58 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.893 1.277 . . . . 0.0 109.388 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -77.77 -27.37 50.27 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.009 -1.682 . . . . 0.0 108.489 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -103.16 159.73 15.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -169.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.312 10.3 mt-10 73.9 -46.25 0.62 Allowed 'General case' 0 C--N 1.35 0.62 0 C-N-CA 126.171 1.789 . . . . 0.0 111.098 -168.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -68.22 -32.55 72.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 125.739 1.616 . . . . 0.0 114.971 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -64.8 -19.02 65.6 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.974 -1.079 . . . . 0.0 113.867 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -90.12 -21.92 22.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.095 -1.003 . . . . 0.0 109.499 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.17 32.32 56.2 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 124.016 0.817 . . . . 0.0 111.42 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 . . . . . 0 CA--C 1.487 -1.469 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.522 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.03 80.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.378 0.671 . . . . 0.0 111.314 -169.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' D' ' 4' ' ' HIS . 6.6 t70 -170.14 -104.38 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 -166.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.435 ' H ' ' CG ' ' D' ' 3' ' ' ASP . 10.3 p-80 -53.11 -22.54 6.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.989 3.316 . . . . 0.0 114.366 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.64 -28.56 67.82 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 125.385 1.474 . . . . 0.0 110.447 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -68.28 -43.3 78.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.923 0.889 . . . . 0.0 109.742 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.07 -31.34 62.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.503 -0.748 . . . . 0.0 109.588 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.95 91.44 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.871 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -66.12 -38.4 88.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.56 -42.99 99.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 109.904 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.32 84.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.74 0.816 . . . . 0.0 111.566 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.74 -38.16 77.8 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.564 0.745 . . . . 0.0 110.807 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.6 -30.14 65.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.303 -0.873 . . . . 0.0 110.406 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.76 -32.97 73.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.5 -43.2 97.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.357 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -56.05 -33.55 65.08 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.394 1.078 . . . . 0.0 111.745 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -71.19 -23.63 62.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.143 1.377 . . . . 0.0 111.174 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.68 -42.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.48 -40.23 74.57 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 124.939 1.296 . . . . 0.0 111.261 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -54.3 -51.68 63.85 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.273 1.029 . . . . 0.0 111.728 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.58 -38.37 67.92 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.65 0.78 . . . . 0.0 109.254 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.33 77.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.727 1.611 . . . . 0.0 111.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -64.46 -40.06 94.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.629 1.172 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -68.7 -46.62 68.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.49 -49.07 75.03 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.326 -0.859 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.08 -46.57 87.95 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 126.086 1.755 . . . . 0.0 111.836 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.34 -37.32 78.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 118.42 0.554 . . . . 0.0 110.139 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.34 -33.62 61.13 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.944 -1.098 . . . . 0.0 109.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.8 -55.51 14.55 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.249 1.82 . . . . 0.0 109.195 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.09 -32.9 74.38 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.019 0.928 . . . . 0.0 111.135 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -74.18 101.6 4.01 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 120.339 -1.476 . . . . 0.0 110.892 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.05 -22.49 4.79 Favored Glycine 0 CA--C 1.489 -1.541 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.8 142.96 66.1 Favored Pre-proline 0 N--CA 1.443 -0.801 0 O-C-N 121.547 -0.972 . . . . 0.0 109.653 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.94 140.38 12.64 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 122.781 2.321 . . . . 0.0 109.703 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.04 -8.84 71.67 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 119.132 0.878 . . . . 0.0 110.956 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.89 150.65 27.96 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 126.71 2.004 . . . . 0.0 111.287 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.93 -28.89 1.52 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.035 0.534 . . . . 0.0 110.572 -170.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.7 91.4 8.63 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 120.278 -1.514 . . . . 0.0 107.067 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 tt -122.49 53.13 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 O-C-N 120.848 -1.158 . . . . 0.0 108.117 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 26.4 t -153.97 142.0 20.28 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 119.489 -2.007 . . . . 0.0 106.948 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -80.64 -49.7 1.11 Allowed Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 115.807 -2.044 . . . . 0.0 109.929 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -69.18 -15.24 39.1 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 CA-C-N 126.036 3.192 . . . . 0.0 111.723 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.06 -13.53 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.22 80.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.03 -1.044 . . . . 0.0 109.044 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -67.9 -29.33 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 123.132 0.573 . . . . 0.0 110.909 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -47.48 63.85 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -67.23 -32.99 74.4 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.301 -0.875 . . . . 0.0 111.015 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -57.71 -24.85 58.93 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.618 -1.301 . . . . 0.0 112.523 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -40.65 15.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.709 -1.245 . . . . 0.0 110.228 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.38 -27.38 62.26 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 127.502 2.321 . . . . 0.0 110.835 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -99.31 -37.25 9.33 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 120.06 -1.65 . . . . 0.0 109.865 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.82 -14.12 61.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.394 -1.441 . . . . 0.0 112.262 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -99.0 2.07 46.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.257 63.5 p 56.31 28.96 14.18 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.343 2.257 . . . . 0.0 111.856 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.89 -52.88 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.88 63.43 4.79 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.816 -0.436 . . . . 0.0 113.626 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.39 -16.74 63.58 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 118.879 1.34 . . . . 0.0 110.092 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.24 36.8 4.28 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.25 -54.43 12.73 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.65 169.01 14.96 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.06 130.17 10.0 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 100.366 -3.939 . . . . 0.0 100.366 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.35 177.57 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.253 2.635 . . . . 0.0 107.841 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.38 -119.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 C-N-CA 123.696 0.798 . . . . 0.0 110.949 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -132.63 -38.68 1.01 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.88 -14.62 53.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.791 1.636 . . . . 0.0 108.81 -168.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -33.51 68.84 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.18 63.44 0.81 Allowed Glycine 0 CA--C 1.464 -3.127 1 N-CA-C 102.69 -4.164 . . . . 0.0 102.69 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -30.95 -18.76 0.0 OUTLIER 'General case' 0 C--N 1.361 1.077 1 C-N-CA 132.647 4.379 . . . . 0.0 117.466 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.33 -19.08 7.74 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 119.931 -1.73 . . . . 0.0 113.436 160.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.38 -44.18 98.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 124.451 1.1 . . . . 0.0 108.946 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.72 -55.08 7.3 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -40.08 -58.19 1.5 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.833 2.053 . . . . 0.0 112.326 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.14 -34.23 72.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.421 -169.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -74.23 -42.18 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 52.4 mtm -61.66 -49.72 75.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.524 0.73 . . . . 0.0 110.418 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.92 -27.47 66.66 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.514 -0.741 . . . . 0.0 111.185 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.35 81.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.677 -0.639 . . . . 0.0 110.811 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.69 89.57 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.91 -47.12 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.24 1.016 . . . . 0.0 109.907 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -69.26 -30.6 68.76 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.113 -0.992 . . . . 0.0 112.112 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.27 -52.1 60.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 C-N-CA 123.709 0.804 . . . . 0.0 109.265 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -69.1 -32.12 71.31 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.744 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.28 77.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.376 -0.827 . . . . 0.0 111.243 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -65.68 -36.14 82.8 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.651 1.18 . . . . 0.0 110.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.92 -19.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.405 1.482 . . . . 0.0 110.497 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -59.88 -20.48 57.47 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.791 -1.193 . . . . 0.0 112.714 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.93 74.8 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.228 -2.17 . . . . 0.0 111.539 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.96 53.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.005 0.922 . . . . 0.0 110.178 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.5 -27.93 18.88 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.864 1.316 . . . . 0.0 108.717 175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.77 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 119.836 -1.79 . . . . 0.0 110.757 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -68.28 -12.23 60.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.992 -1.068 . . . . 0.0 109.487 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.09 -20.78 59.32 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.024 -1.047 . . . . 0.0 111.37 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.02 -31.64 72.9 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.153 0.981 . . . . 0.0 108.976 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 t -90.63 -38.3 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 108.37 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -55.96 -35.76 67.05 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.724 1.61 . . . . 0.0 112.238 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -64.51 -20.36 66.16 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.029 -1.045 . . . . 0.0 112.407 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.17 -33.16 50.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 119.957 -1.714 . . . . 0.0 110.278 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -66.93 -34.22 77.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 119.017 0.826 . . . . 0.0 109.701 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.37 -41.28 75.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.799 1.639 . . . . 0.0 110.911 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -63.22 -41.16 99.08 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.547 0.739 . . . . 0.0 111.368 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -70.6 -31.34 68.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.751 0.821 . . . . 0.0 108.819 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.71 13.82 56.19 Favored Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 25.3 t60 . . . . . 0 C--N 1.353 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 112.328 -178.71 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.432 -1.345 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.47 174.49 8.13 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -52.34 62.6 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.404 1.881 . . . . 0.0 109.908 -167.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 42.7 p-80 -76.53 -15.13 59.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.774 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.66 -32.8 35.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -63.86 -44.66 92.45 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.12 0.968 . . . . 0.0 110.0 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.59 -33.76 76.65 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.87 -0.519 . . . . 0.0 111.579 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.98 80.97 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.374 -0.829 . . . . 0.0 110.754 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -67.57 -39.22 84.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.757 -0.589 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.95 -35.88 82.14 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.5 0.72 . . . . 0.0 110.854 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.84 92.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.163 0.985 . . . . 0.0 110.554 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.36 -47.42 81.69 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.839 0.828 . . . . 0.0 110.782 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -70.71 -32.23 69.37 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.725 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -35.79 76.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.749 1.219 . . . . 0.0 109.032 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 tp -67.84 -41.71 82.54 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 121.618 -0.676 . . . . 0.0 111.191 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -66.33 -27.47 67.92 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.564 -0.71 . . . . 0.0 111.731 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -67.71 -39.69 84.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.73 1.212 . . . . 0.0 110.137 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.14 -37.83 77.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.997 0.919 . . . . 0.0 109.101 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.0 mt -56.92 -41.81 78.85 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.124 0.97 . . . . 0.0 112.182 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.54 -46.14 84.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.142 -0.974 . . . . 0.0 110.059 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -67.07 -33.44 75.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.918 -1.114 . . . . 0.0 111.54 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.16 -36.37 79.63 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.004 1.321 . . . . 0.0 110.617 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -63.83 -45.11 91.04 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 123.739 0.815 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -67.76 -49.29 63.28 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.565 0.698 . . . . 0.0 110.668 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -67.29 -34.41 77.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.64 0.776 . . . . 0.0 110.842 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.8 -49.09 61.45 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.297 1.039 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.29 -45.86 89.11 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-O 122.417 1.103 . . . . 0.0 110.189 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -86.87 2.07 50.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.525 -0.734 . . . . 0.0 111.302 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.87 27.6 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.23 -42.49 75.61 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 125.048 1.339 . . . . 0.0 108.911 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -69.58 85.93 0.45 Allowed 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.339 -0.851 . . . . 0.0 111.572 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.14 2.26 Favored Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.02 151.07 37.39 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 117.817 0.808 . . . . 0.0 109.24 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.01 131.84 8.13 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.17 1.914 . . . . 0.0 110.79 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.73 16.74 23.27 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.81 134.81 48.05 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 125.898 1.679 . . . . 0.0 114.177 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.03 -58.93 1.36 Allowed 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.466 1.107 . . . . 0.0 110.543 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.26 93.82 9.63 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 122.553 1.168 . . . . 0.0 112.067 -166.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.61 62.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 O-C-N 119.515 -1.991 . . . . 0.0 111.279 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -152.06 118.34 5.59 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 119.904 -1.747 . . . . 0.0 108.52 169.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.9 -48.93 96.55 Favored Pre-proline 0 C--N 1.359 0.993 0 CA-C-O 116.373 -1.775 . . . . 0.0 112.433 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.36 -8.96 23.58 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 CA-C-N 125.551 3.018 . . . . 0.0 112.947 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -101.78 -24.03 14.11 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.05 98.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 124.035 0.934 . . . . 0.0 110.058 -171.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.75 -32.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 124.567 1.147 . . . . 0.0 111.73 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -42.04 61.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 O-C-N 121.388 -0.82 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -67.33 -35.02 78.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -55.98 -34.46 65.75 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.819 -1.176 . . . . 0.0 112.013 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.31 -49.22 84.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' CD ' ' HH ' ' B' ' 61' ' ' TYR . 16.5 mt-10 -60.15 -38.03 81.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.819 1.648 . . . . 0.0 111.324 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -65.15 -45.56 84.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.554 1.942 . . . . 0.0 109.435 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.46 64.95 Favored 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 121.143 -0.973 . . . . 0.0 111.266 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 p -84.26 1.85 42.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.734 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.365 18.3 p 75.85 -41.04 0.42 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 128.339 2.655 . . . . 0.0 111.289 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -39.58 -54.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 128.183 2.593 . . . . 0.0 114.277 -169.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.89 65.93 3.03 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -67.16 -9.42 39.84 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.784 1.234 . . . . 0.0 113.464 -167.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 28.06 6.89 Favored Glycine 0 CA--C 1.488 -1.651 0 O-C-N 120.973 -1.079 . . . . 0.0 110.436 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' CG ' HH22 ' B' ' 68' ' ' ARG . 32.1 t70 -74.61 -47.64 31.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.367 -1.078 . . . . 0.0 109.05 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -123.7 160.45 27.2 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -136.57 147.25 58.98 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.98 167.1 12.79 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.617 2.211 . . . . 0.0 110.577 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.79 178.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 125.874 1.67 . . . . 0.0 108.823 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -74.56 -83.89 0.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.779 1.632 . . . . 0.0 109.85 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -57.81 -55.08 39.54 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 120.084 1.311 . . . . 0.0 113.958 -161.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -89.87 -56.95 3.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.705 -0.622 . . . . 0.0 111.721 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.23 -35.17 49.2 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 125.438 1.494 . . . . 0.0 113.81 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -68.39 -38.32 81.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 118.072 0.936 . . . . 0.0 110.775 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -69.75 -39.7 76.56 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 123.654 0.782 . . . . 0.0 109.888 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.71 -46.64 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.29 86.42 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 124.673 1.189 . . . . 0.0 110.41 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -48.53 -51.93 25.13 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 126.675 1.99 . . . . 0.0 110.375 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -71.1 -42.52 69.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.296 -0.877 . . . . 0.0 111.958 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.74 -42.98 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 124.022 0.929 . . . . 0.0 109.748 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.23 -47.87 82.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 124.758 1.223 . . . . 0.0 109.71 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -60.48 -35.59 76.27 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.504 0.722 . . . . 0.0 110.44 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.21 72.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.705 -0.622 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.53 -41.29 90.43 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.65 -46.79 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 124.33 1.052 . . . . 0.0 108.726 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -62.63 -32.72 73.81 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.8 -0.563 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.15 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 123.914 0.886 . . . . 0.0 110.567 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -62.56 -37.42 86.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.736 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.13 63.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.784 -0.572 . . . . 0.0 111.954 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -73.61 -26.21 60.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.099 -1.625 . . . . 0.0 110.309 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.82 -15.46 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.093 1.357 . . . . 0.0 110.348 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 m -54.08 -24.31 16.96 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 126.207 1.803 . . . . 0.0 112.849 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.49 64.03 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 120.179 -1.576 . . . . 0.0 112.264 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -92.62 -48.35 6.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.555 1.142 . . . . 0.0 108.746 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.47 -39.91 92.53 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 112.598 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.81 61.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -97.28 11.14 37.52 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 120.805 -1.184 . . . . 0.0 108.824 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -79.36 -29.67 42.28 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.396 -1.44 . . . . 0.0 109.048 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -78.7 -24.71 44.85 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.723 -1.236 . . . . 0.0 110.691 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.76 -32.57 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 123.586 0.754 . . . . 0.0 109.698 -171.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -63.35 -16.58 60.85 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.759 1.224 . . . . 0.0 111.884 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.34 -31.76 67.76 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.289 1.036 . . . . 0.0 110.562 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -93.68 157.97 15.91 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 73.08 -47.47 0.67 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.189 1.796 . . . . 0.0 110.851 -173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.61 -42.96 99.61 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.738 -1.226 . . . . 0.0 110.934 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 mtp-105 -81.51 -10.47 59.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.883 -1.136 . . . . 0.0 111.156 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -133.6 73.3 1.5 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.905 0.882 . . . . 0.0 109.103 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.55 -27.53 2.6 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 176.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 -161.58 0.26 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.272 1.429 . . . . 0.0 110.671 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -139.41 -59.81 0.57 Allowed 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.528 ' CE1' ' HG3' ' B' ' 5' ' ' GLU . 12.5 p80 -50.46 -35.34 28.49 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 125.501 1.521 . . . . 0.0 114.743 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.528 ' HG3' ' CE1' ' B' ' 4' ' ' HIS . 4.9 mt-10 -67.59 -33.25 74.63 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.36 1.064 . . . . 0.0 110.78 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -81.03 -20.31 41.97 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.613 -0.679 . . . . 0.0 109.764 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -27.06 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -46.06 84.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.833 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.97 -28.59 62.49 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.446 -0.784 . . . . 0.0 111.007 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.9 -40.08 95.66 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.985 0.914 . . . . 0.0 109.8 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.62 76.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.049 0.939 . . . . 0.0 111.401 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -65.28 -39.5 92.65 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.9 -47.35 80.93 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.502 -0.748 . . . . 0.0 110.255 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -25.15 62.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.539 -0.726 . . . . 0.0 111.278 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -63.55 -39.73 95.16 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 120.831 -1.168 . . . . 0.0 111.334 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -62.05 -38.93 90.6 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.446 -0.784 . . . . 0.0 110.06 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.58 84.75 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.093 0.957 . . . . 0.0 110.27 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.44 -47.94 89.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.551 -0.718 . . . . 0.0 110.31 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.43 -36.29 80.94 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.673 -0.642 . . . . 0.0 110.486 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -62.75 -42.04 99.49 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.116 -1.615 . . . . 0.0 110.104 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -66.49 -36.79 83.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.848 0.832 . . . . 0.0 109.698 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.98 73.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.752 0.821 . . . . 0.0 111.552 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -60.93 -38.02 84.32 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.506 1.123 . . . . 0.0 111.98 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -69.03 -41.64 77.44 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.311 -0.868 . . . . 0.0 109.094 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -70.13 -26.37 63.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 121.822 -0.549 . . . . 0.0 110.933 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.07 95.72 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.303 1.041 . . . . 0.0 111.217 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.31 42.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 124.255 1.979 . . . . 0.0 108.474 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -147.19 -42.24 0.18 Allowed 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 100.875 -3.75 . . . . 0.0 100.875 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 56.52 0.46 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.689 1.996 . . . . 0.0 110.216 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? 179.68 -27.49 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 125.921 1.688 . . . . 0.0 108.289 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.43 71.73 6.02 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.495 -0.753 . . . . 0.0 109.985 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.22 -34.47 0.84 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 159.24 57.8 Favored Pre-proline 0 CA--C 1.51 -0.586 0 O-C-N 120.681 -1.482 . . . . 0.0 112.817 -173.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.17 152.26 24.01 Favored 'Trans proline' 0 CA--C 1.501 -1.163 0 C-N-CA 122.062 1.842 . . . . 0.0 109.848 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.13 42.34 84.42 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.63 -60.18 2.94 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.859 0.864 . . . . 0.0 109.716 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 65.43 -9.32 0.24 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.557 1.543 . . . . 0.0 113.597 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -123.52 31.64 5.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.732 1.613 . . . . 0.0 107.804 -165.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 45.0 pt -70.45 38.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.425 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -161.72 142.68 10.92 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 119.571 -1.956 . . . . 0.0 109.583 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.81 -57.29 1.55 Allowed Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 126.899 2.079 . . . . 0.0 110.978 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.66 -11.84 26.34 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 CA-C-N 126.076 3.206 . . . . 0.0 111.228 -169.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.71 -7.13 44.53 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 125.67 1.588 . . . . 0.0 107.954 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.09 66.86 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 123.983 0.913 . . . . 0.0 109.06 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -82.21 14.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.348 1.071 . . . . 0.0 109.86 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.0 -58.53 2.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 167.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -54.49 -41.62 69.79 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.705 1.602 . . . . 0.0 111.804 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -65.24 -21.81 66.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 120.794 -1.191 . . . . 0.0 113.723 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.25 -53.82 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -47.33 -50.63 21.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 126.682 1.993 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -71.99 -30.16 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.772 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.23 60.65 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.223 -0.923 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -83.57 -1.18 53.22 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 122.963 0.505 . . . . 0.0 111.092 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.278 3.4 p 53.89 56.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.323 1.849 . . . . 0.0 112.505 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.0 t -120.54 -72.71 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.05 60.91 1.89 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -19.11 10.38 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.98 27.48 16.28 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.303 -1.498 . . . . 0.0 109.703 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -70.28 -63.67 1.04 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.031 2.133 . . . . 0.0 107.553 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -138.85 170.32 16.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.414 ' HH ' ' CD ' ' A' ' 50' ' ' GLU . 8.3 t80 -173.05 138.41 0.82 Allowed Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-O 115.696 -2.097 . . . . 0.0 105.356 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.92 179.38 6.04 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.069 2.513 . . . . 0.0 111.595 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.19 175.34 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -48.81 -50.39 34.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 129.25 3.02 . . . . 0.0 113.215 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.6 -11.88 61.21 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.905 1.282 . . . . 0.0 109.593 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -104.33 5.37 34.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 O-C-N 121.894 -0.504 . . . . 0.0 111.368 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.35 84.07 0.38 Allowed Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 104.543 -3.423 . . . . 0.0 104.543 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.414 HH22 ' CG ' ' A' ' 59' ' ' ASP . 24.7 ttm180 -59.76 -20.37 56.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.535 -1.568 . . . . 0.0 111.125 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -54.84 -13.48 1.08 Allowed 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.828 1.651 . . . . 0.0 113.082 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.98 -40.99 84.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 120.651 -1.281 . . . . 0.0 110.087 169.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.18 -50.17 29.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -48.79 -44.15 38.73 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.989 1.715 . . . . 0.0 111.038 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -48.1 79.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.142 1.377 . . . . 0.0 111.269 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.25 -43.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.53 -46.14 89.72 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.645 1.178 . . . . 0.0 110.413 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.54 -43.03 99.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.29 97.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 122.599 0.36 . . . . 0.0 110.963 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.58 -47.0 93.13 Favored Glycine 0 CA--C 1.495 -1.179 0 C-N-CA 124.358 0.98 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.38 -50.53 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 124.301 1.04 . . . . 0.0 109.054 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -63.28 -33.53 75.71 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 121.802 -0.561 . . . . 0.0 111.782 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.52 -59.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 C-N-CA 124.125 0.97 . . . . 0.0 110.48 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -64.79 -35.62 81.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 121.384 -0.823 . . . . 0.0 110.151 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.62 88.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 111.266 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.45 -35.62 81.52 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.4 1.08 . . . . 0.0 110.533 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.72 -16.11 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.796 1.238 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -59.79 -18.65 45.17 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 120.494 -1.379 . . . . 0.0 111.608 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.53 75.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 119.565 -1.96 . . . . 0.0 112.456 171.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.35 -38.73 55.44 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 121.182 -0.949 . . . . 0.0 109.29 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -32.69 69.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.73 67.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 120.389 -1.444 . . . . 0.0 111.685 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -90.63 3.3 54.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 120.706 -1.246 . . . . 0.0 109.014 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -75.34 -33.75 61.13 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 122.118 0.961 . . . . 0.0 108.72 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -68.55 -32.06 71.73 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.403 -1.435 . . . . 0.0 111.944 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 -22.75 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.912 1.285 . . . . 0.0 109.116 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -59.61 -26.32 65.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.329 1.052 . . . . 0.0 112.07 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -67.97 -24.27 65.14 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 120.242 1.383 . . . . 0.0 111.836 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -71.72 -39.54 70.07 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.046 -1.033 . . . . 0.0 108.776 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.63 -43.48 69.15 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.272 0.629 . . . . 0.0 109.793 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -58.24 -43.34 87.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 126.97 2.108 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -59.49 -44.17 93.15 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 111.333 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -92.12 -14.77 28.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.355 -0.841 . . . . 0.0 111.251 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.96 21.89 70.07 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.508 -0.644 0 C-N-CA 124.626 1.17 . . . . 0.0 111.898 -179.759 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.428 -1.562 0 N-CA-C 100.559 -3.867 . . . . 0.0 100.559 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.78 179.24 7.09 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -171.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.95 -68.82 0.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 129.623 3.169 . . . . 0.0 111.234 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.567 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 48.8 p-80 -72.56 -18.01 61.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.958 1.303 . . . . 0.0 112.88 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -75.99 -41.04 52.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -72.51 -31.97 65.78 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.949 -1.094 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -75.1 -27.21 59.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.369 -0.832 . . . . 0.0 110.032 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -45.82 78.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.161 0.984 . . . . 0.0 110.579 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -62.25 -40.69 97.02 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.475 1.11 . . . . 0.0 110.763 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -60.12 -36.08 76.69 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 124.541 1.136 . . . . 0.0 110.839 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.87 76.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.56 0.744 . . . . 0.0 111.384 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.13 -34.65 78.9 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.184 -0.948 . . . . 0.0 111.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -72.69 -31.9 65.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 110.117 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.85 -33.56 74.02 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.4 1.48 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.93 -42.61 94.54 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.649 0.779 . . . . 0.0 110.663 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -61.9 -36.63 81.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.428 -0.795 . . . . 0.0 111.55 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.65 -43.49 97.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.85 0.86 . . . . 0.0 111.277 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.96 -23.89 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 121.119 -0.988 . . . . 0.0 110.692 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.86 -38.92 80.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 123.789 0.836 . . . . 0.0 110.509 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -65.47 -38.5 89.97 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.568 1.147 . . . . 0.0 110.452 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.02 -38.03 61.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.683 -1.261 . . . . 0.0 109.155 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -37.97 76.34 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 125.107 1.363 . . . . 0.0 111.493 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -43.21 81.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 118.906 0.775 . . . . 0.0 110.358 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.69 -50.6 62.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -59.58 -45.91 90.47 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 124.021 0.928 . . . . 0.0 109.524 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -42.69 99.89 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.968 0.907 . . . . 0.0 111.897 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.52 -33.16 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 O-C-N 120.973 -1.079 . . . . 0.0 110.326 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.64 -33.34 64.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.464 -0.772 . . . . 0.0 109.338 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.55 79.38 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 126.789 2.036 . . . . 0.0 109.725 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -74.44 -12.65 60.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.47 0.652 . . . . 0.0 112.12 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -79.63 77.19 6.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 120.487 -1.383 . . . . 0.0 110.327 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.82 -11.12 1.66 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.67 147.41 46.25 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 117.847 0.824 . . . . 0.0 110.773 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.32 121.73 3.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.843 2.362 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.87 29.91 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.95 124.34 20.51 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.075 1.75 . . . . 0.0 112.74 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.94 -21.47 6.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.033 0.533 . . . . 0.0 110.638 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -36.64 80.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.648 1.179 . . . . 0.0 110.524 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tp -47.56 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 128.994 2.918 . . . . 0.0 112.067 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -168.3 103.8 0.45 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -60.77 -36.64 37.14 Favored Pre-proline 0 C--N 1.35 0.612 0 CA-C-O 115.315 -2.279 . . . . 0.0 113.101 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.93 -48.79 0.62 Allowed 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 126.757 3.449 . . . . 0.0 110.473 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -6.51 47.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.986 1.314 . . . . 0.0 111.246 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.62 80.63 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 125.636 1.574 . . . . 0.0 110.876 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.96 -24.84 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.55 -44.66 77.72 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.895 -1.128 . . . . 0.0 108.61 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.7 -41.26 99.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.636 -0.665 . . . . 0.0 110.833 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -57.93 -46.12 85.5 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.092 -1.005 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -80.25 74.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 122.206 1.003 . . . . 0.0 108.851 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -165.14 -40.62 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -31.55 71.08 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.968 0.907 . . . . 0.0 110.485 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -24.12 64.81 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.441 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.46 6.61 48.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 123.279 0.632 . . . . 0.0 109.55 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 55.92 52.28 10.88 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 126.125 1.77 . . . . 0.0 112.418 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.3 -156.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.37 103.95 0.33 Allowed Glycine 0 CA--C 1.475 -2.467 1 N-CA-C 99.133 -5.587 . . . . 0.0 99.133 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.96 -28.28 62.32 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 118.101 0.951 . . . . 0.0 110.214 -172.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.0 46.04 0.84 Allowed Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -75.44 -51.75 12.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -137.69 172.48 12.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.35 125.17 5.92 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 101.843 -3.391 . . . . 0.0 101.843 -168.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.85 168.68 21.87 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 123.83 3.02 . . . . 0.0 110.757 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.29 -90.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.011 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 12.7 m -165.01 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.624 -1.922 . . . . 0.0 106.732 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -73.74 -18.8 60.94 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.815 1.246 . . . . 0.0 108.979 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -62.07 -36.48 81.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 125.043 1.337 . . . . 0.0 109.576 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.22 -15.62 1.49 Allowed Glycine 0 CA--C 1.481 -2.087 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 172.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.481 ' H ' ' CD ' ' C' ' 66' ' ' GLU 0.352 3.5 ptp85 63.18 -48.63 0.22 Allowed 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 131.481 3.912 . . . . 0.0 111.734 -170.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.25 12.71 2.2 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.51 -49.42 59.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -49.12 65.59 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 122.897 0.479 . . . . 0.0 110.008 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.92 -42.92 69.3 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.067 0.947 . . . . 0.0 111.433 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -67.37 -32.27 73.07 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 111.224 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.74 -42.29 61.91 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.36 -47.39 85.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 110.502 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.22 -40.67 94.86 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.271 1.029 . . . . 0.0 110.914 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.73 85.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.466 0.707 . . . . 0.0 111.18 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.68 -44.27 92.79 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 124.036 0.827 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.7 -43.23 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.689 0.795 . . . . 0.0 109.116 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.09 -52.99 63.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 123.504 0.722 . . . . 0.0 111.608 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.82 -41.57 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 121.952 -0.468 . . . . 0.0 111.028 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -75.38 -25.23 57.49 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.559 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.77 -33.68 34.76 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.67 -1.269 . . . . 0.0 109.773 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.2 -41.59 75.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.789 1.636 . . . . 0.0 110.873 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.42 -8.03 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.489 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 13.0 m -62.98 -17.43 62.1 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.998 -1.064 . . . . 0.0 109.842 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.05 75.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.185 -1.572 . . . . 0.0 112.337 169.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.72 -52.64 10.02 Favored 'General case' 0 CA--C 1.492 -1.283 0 O-C-N 120.694 -1.254 . . . . 0.0 107.887 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.76 -29.05 70.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.03 0.443 . . . . 0.0 111.938 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.57 -20.72 64.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.587 -1.321 . . . . 0.0 111.074 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -80.95 -10.96 59.65 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.638 -1.289 . . . . 0.0 110.506 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.26 1.8 m-20 -79.39 -12.97 59.9 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 119.869 1.213 . . . . 0.0 110.817 -167.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.49 -19.97 41.15 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.329 -1.482 . . . . 0.0 109.928 167.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.13 -38.4 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 124.718 1.207 . . . . 0.0 108.077 -172.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -50.79 -31.3 16.51 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 125.816 1.646 . . . . 0.0 113.239 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -60.33 -32.18 71.0 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -87.22 147.5 25.54 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.278 23.9 mm-40 73.68 -41.56 0.49 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.845 2.058 . . . . 0.0 112.514 -171.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -70.89 -40.92 71.93 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 119.673 -1.892 . . . . 0.0 109.309 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -63.09 -36.64 84.27 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.481 -0.762 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -139.09 109.1 6.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.62 38.32 4.49 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 . . . . . 0 C--N 1.354 0.778 0 O-C-N 121.49 -1.006 . . . . 0.0 109.901 179.002 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.428 -1.549 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.38 141.58 35.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.59 -29.83 69.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.073 -1.017 . . . . 0.0 111.076 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -68.38 -22.53 64.64 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.051 -1.031 . . . . 0.0 111.908 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.82 -36.02 23.8 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -62.35 -40.81 97.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.125 0.97 . . . . 0.0 110.488 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.62 -38.44 90.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.483 1.113 . . . . 0.0 110.437 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.74 75.35 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.109 0.964 . . . . 0.0 111.207 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -65.15 -41.49 94.69 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.754 -0.591 . . . . 0.0 110.449 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -64.93 -31.75 73.14 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 122.81 0.444 . . . . 0.0 111.76 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.12 81.52 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.897 -0.502 . . . . 0.0 110.35 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.51 -50.65 72.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.97 0.508 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.56 -34.34 75.42 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.805 0.842 . . . . 0.0 111.462 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . 0.435 ' CD ' ' HZ1' ' D' ' 17' ' ' LYS . 2.9 tp10 -73.97 -32.02 63.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.032 -1.042 . . . . 0.0 110.503 -176.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.43 -38.18 90.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.722 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -75.41 -9.03 58.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.961 -1.087 . . . . 0.0 112.525 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.435 ' HZ1' ' CD ' ' D' ' 14' ' ' GLU . 5.5 tmmm? -82.9 -38.97 22.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.07 -38.16 81.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.227 -0.921 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.8 mt -51.94 -42.95 63.23 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.798 1.239 . . . . 0.0 112.518 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -68.32 -42.93 78.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.785 0.834 . . . . 0.0 110.48 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.21 -38.51 68.98 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.22 73.23 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 125.154 1.381 . . . . 0.0 111.955 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -57.55 -47.96 80.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.069 1.414 . . . . 0.0 110.697 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -73.39 -43.15 61.16 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.723 1.209 . . . . 0.0 108.514 -171.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -73.39 -29.66 62.75 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.723 0.809 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.79 79.15 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.035 0.934 . . . . 0.0 111.492 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.95 -43.59 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-O 122.424 1.106 . . . . 0.0 109.846 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -62.55 -32.97 74.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.48 1.512 . . . . 0.0 109.594 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -50.43 71.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 126.099 1.76 . . . . 0.0 110.643 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 111.3 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -80.73 68.24 6.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.414 -1.429 . . . . 0.0 110.987 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.14 -30.43 0.48 Allowed Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.73 150.08 81.35 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.345 1.058 . . . . 0.0 111.778 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -84.27 145.22 10.77 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 122.808 2.339 . . . . 0.0 109.861 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 33.41 55.59 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 147.25 47.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.315 1.046 . . . . 0.0 110.95 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.53 -52.93 1.59 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.98 97.74 10.92 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -137.84 114.05 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -179.6 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -174.86 -65.41 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 116.218 -1.848 . . . . 0.0 106.112 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.84 -16.81 29.44 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 CA-C-N 125.386 2.959 . . . . 0.0 112.637 -166.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -95.03 -8.43 36.79 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.948 1.299 . . . . 0.0 109.639 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.26 62.92 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.757 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.99 -33.58 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.029 0.931 . . . . 0.0 109.626 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -27.38 59.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 119.577 -1.952 . . . . 0.0 110.335 -174.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -69.03 -42.36 76.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.0 p -69.28 -32.26 71.31 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.193 -1.567 . . . . 0.0 110.866 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.81 -46.59 83.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 125.334 1.453 . . . . 0.0 110.936 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -80.61 -2.14 45.21 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 118.757 0.708 . . . . 0.0 112.013 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -101.22 -40.65 7.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 -22.92 66.31 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.765 -1.21 . . . . 0.0 111.685 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -91.83 2.8 56.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 125.026 1.33 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 25.6 p 52.03 70.42 0.56 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.343 1.857 . . . . 0.0 112.785 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.529 HG11 ' H ' ' D' ' 56' ' ' GLY . 1.2 p -129.24 -80.01 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 104.184 -2.525 . . . . 0.0 104.184 169.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.529 ' H ' HG11 ' D' ' 55' ' ' VAL . . . 80.63 80.36 0.85 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -171.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -74.55 -16.15 60.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.028 -1.278 . . . . 0.0 110.983 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.23 5.76 Favored Glycine 0 CA--C 1.492 -1.378 0 O-C-N 121.393 -0.817 . . . . 0.0 111.103 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -70.12 -59.07 3.12 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -137.97 162.64 33.56 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -158.24 154.68 24.39 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.12 177.77 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.483 2.789 . . . . 0.0 109.878 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . 0.264 5.6 p -115.01 -118.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 174.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -104.93 -85.62 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.189 -1.569 . . . . 0.0 108.988 -170.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.88 128.77 37.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.576 1.15 . . . . 0.0 109.086 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . 0.3 51.7 mt-10 62.2 -111.26 0.4 Allowed 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 115.441 -2.219 . . . . 0.0 106.972 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.51 -80.88 0.0 OUTLIER Glycine 0 C--N 1.353 1.49 0 C-N-CA 129.772 3.558 . . . . 0.0 113.786 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -58.92 -41.97 88.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 127.381 2.272 . . . . 0.0 113.196 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.35 -18.1 62.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.473 1.109 . . . . 0.0 109.464 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.63 -45.11 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.22 -50.91 69.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.666 1.187 . . . . 0.0 113.104 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.86 -35.46 70.99 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.875 0.87 . . . . 0.0 111.62 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -67.96 -45.51 74.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.248 1.019 . . . . 0.0 109.034 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.53 -43.62 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.932 0.893 . . . . 0.0 109.522 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.9 -43.64 98.26 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.387 0.675 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.08 -37.8 83.99 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.234 0.614 . . . . 0.0 111.097 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.11 85.9 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.147 0.579 . . . . 0.0 111.237 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.44 -46.52 55.62 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.81 -47.49 85.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 109.628 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -66.97 -26.69 66.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.13 -0.981 . . . . 0.0 112.372 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.28 -45.18 71.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.748 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.59 -35.2 80.24 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.078 0.942 . . . . 0.0 110.062 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -32.62 67.06 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.391 -0.818 . . . . 0.0 111.332 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.04 -43.92 94.09 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 124.628 1.171 . . . . 0.0 109.727 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -69.96 -4.83 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.375 -0.828 . . . . 0.0 112.061 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -57.49 -24.85 58.22 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.186 1.394 . . . . 0.0 110.344 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.84 78.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 119.847 -1.783 . . . . 0.0 112.163 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.84 -42.87 69.6 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -28.34 63.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.768 0.827 . . . . 0.0 110.858 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.32 76.48 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 119.982 -1.699 . . . . 0.0 109.442 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -11.53 52.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.87 -1.144 . . . . 0.0 112.593 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.37 -26.53 61.94 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.831 1.65 . . . . 0.0 111.595 -170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -79.06 -24.14 43.75 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.212 0.915 . . . . 0.0 110.062 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.97 -36.53 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.414 1.085 . . . . 0.0 108.701 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -55.5 -32.94 63.29 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 126.421 1.888 . . . . 0.0 110.83 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -61.7 -23.58 66.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.296 1.038 . . . . 0.0 111.74 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.45 -21.05 64.66 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.797 -0.565 . . . . 0.0 109.934 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.93 -39.77 15.43 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.52 -33.75 74.67 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.643 -0.661 . . . . 0.0 111.008 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 55.6 ptt85 -70.24 -19.83 63.11 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.297 -0.877 . . . . 0.0 111.975 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -78.31 -28.31 47.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.323 -0.861 . . . . 0.0 109.469 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.17 13.98 75.68 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 121.618 -0.676 . . . . 0.0 111.671 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.228 0 N-CA-C 102.178 -3.267 . . . . 0.0 102.178 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.17 168.53 27.01 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.59 -43.23 97.6 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.033 1.733 . . . . 0.0 110.604 -171.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -47.09 72.07 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.634 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -38.29 89.06 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 122.578 0.351 . . . . 0.0 110.101 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -64.23 -46.27 84.57 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.682 -0.637 . . . . 0.0 110.871 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 121.796 -0.565 . . . . 0.0 111.04 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.47 85.61 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 110.805 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.8 -36.1 77.84 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.11 -38.07 85.03 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.904 1.282 . . . . 0.0 109.974 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.44 -37.22 86.76 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 111.711 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.38 -29.17 70.24 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.86 -1.15 . . . . 0.0 111.607 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -68.08 -31.94 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -71.9 -29.29 64.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.0 -37.22 83.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.985 -1.072 . . . . 0.0 110.204 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.19 -26.78 66.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.889 -1.132 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -63.85 -50.12 70.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 123.884 0.873 . . . . 0.0 109.605 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.42 -23.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 121.627 -0.671 . . . . 0.0 110.334 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.6 -50.18 74.56 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.364 0.984 . . . . 0.0 109.711 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -64.09 -42.79 96.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.807 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.05 -44.31 76.7 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.938 -0.476 . . . . 0.0 109.921 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.07 -37.45 85.04 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.144 -0.972 . . . . 0.0 112.026 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 -43.89 86.79 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.941 0.896 . . . . 0.0 110.738 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HZ3' ' CD ' ' A' ' 28' ' ' GLU . 14.9 tmtt? -65.21 -43.54 91.22 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.684 1.194 . . . . 0.0 107.973 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -64.52 -49.02 72.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.35 1.06 . . . . 0.0 110.839 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.09 92.97 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.526 1.53 . . . . 0.0 111.216 -173.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.7 -37.78 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 121.465 -0.772 . . . . 0.0 110.344 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' CD ' ' HZ3' ' A' ' 24' ' ' LYS . 55.6 mt-10 -69.72 -38.48 76.91 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.747 -1.221 . . . . 0.0 110.466 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.15 -47.87 66.87 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 126.144 1.777 . . . . 0.0 109.501 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.15 -38.97 79.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.385 1.074 . . . . 0.0 110.977 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -69.74 99.14 1.3 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 119.99 -1.694 . . . . 0.0 113.073 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.81 -3.27 19.54 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.29 148.87 37.42 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 118.193 0.997 . . . . 0.0 108.446 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -80.26 145.59 17.15 Favored 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.418 2.079 . . . . 0.0 109.967 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.31 -8.83 69.35 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 119.239 0.927 . . . . 0.0 111.374 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.01 53.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.92 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.06 -29.25 4.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.31 58.17 4.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.994 1.378 . . . . 0.0 107.959 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -87.5 42.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 O-C-N 119.852 -1.78 . . . . 0.0 111.276 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.477 ' HG ' ' CG ' ' A' ' 43' ' ' ASP . 1.6 p -135.29 -117.0 0.18 Allowed 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.745 -1.222 . . . . 0.0 109.672 -167.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 t80 171.7 -66.65 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.904 0 CA-C-O 116.315 -1.802 . . . . 0.0 108.766 -172.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -4.64 15.7 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 CA-C-N 125.175 2.884 . . . . 0.0 111.796 -164.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.477 ' CG ' ' HG ' ' A' ' 40' ' ' SER . 3.4 p-10 -103.99 -10.15 18.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 127.157 2.183 . . . . 0.0 109.1 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.85 63.89 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.231 -0.918 . . . . 0.0 110.31 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.79 -38.17 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.91 0.862 . . . . 0.0 110.479 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.32 -31.45 26.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -55.77 -40.87 73.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.297 1.039 . . . . 0.0 110.854 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -62.37 -29.36 70.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.698 0.799 . . . . 0.0 112.596 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.78 -36.07 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 120.846 -1.159 . . . . 0.0 108.52 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -65.69 -17.39 64.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.448 1.099 . . . . 0.0 112.166 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 t -109.31 -31.35 7.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.59 -1.319 . . . . 0.0 108.554 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.05 65.57 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.31 -1.494 . . . . 0.0 112.569 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 p -97.9 3.41 49.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.268 12.2 p 55.53 26.71 9.36 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 128.739 2.816 . . . . 0.0 112.569 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.02 -54.48 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 55.87 11.42 Favored Glycine 0 CA--C 1.485 -1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.85 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.89 -17.25 61.36 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.805 0.812 . . . . 0.0 111.96 -173.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.6 40.36 6.82 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.98 -46.61 70.84 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.59 -168.15 1.69 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.04 108.43 5.0 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.11 175.41 10.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.417 2.745 . . . . 0.0 109.281 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.0 p -140.14 -176.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 65.7 m -66.7 -45.25 79.36 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.714 -1.866 . . . . 0.0 112.158 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -80.0 -6.77 58.18 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 119.206 0.912 . . . . 0.0 111.156 -170.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.56 -32.68 74.18 Favored 'General case' 0 C--N 1.359 0.986 0 CA-C-O 123.888 1.804 . . . . 0.0 106.259 168.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.26 65.82 1.02 Allowed Glycine 0 CA--C 1.463 -3.168 1 N-CA-C 102.22 -4.352 . . . . 0.0 102.22 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -27.09 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.374 1.665 1 C-N-CA 131.95 4.1 . . . . 0.0 115.472 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -50.72 -12.23 0.1 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 164.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.73 -49.64 49.85 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 123.023 2.647 . . . . 0.0 106.942 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.03 -43.39 98.96 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.871 0.868 . . . . 0.0 110.426 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -65.23 -43.69 90.62 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.705 0.402 . . . . 0.0 111.386 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.68 -41.0 96.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 121.184 -0.948 . . . . 0.0 110.767 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.47 -34.44 35.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.889 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 55.9 ttm -62.72 -52.21 64.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.15 -32.49 70.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.426 -0.796 . . . . 0.0 110.481 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.3 -35.08 77.92 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.835 -0.541 . . . . 0.0 110.907 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.78 96.62 Favored Glycine 0 CA--C 1.492 -1.377 0 C-N-CA 123.646 0.641 . . . . 0.0 111.743 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.14 -47.04 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 124.264 1.026 . . . . 0.0 109.016 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.79 -30.21 68.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.139 -0.976 . . . . 0.0 111.572 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.65 -55.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.618 0.767 . . . . 0.0 109.461 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.37 -33.6 74.56 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 121.464 -0.772 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.72 72.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.153 -0.967 . . . . 0.0 110.529 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.74 -29.06 70.03 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 120.6 -1.312 . . . . 0.0 111.108 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.68 -11.7 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.489 1.515 . . . . 0.0 111.121 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.3 m -51.42 -29.39 15.74 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 119.428 -2.045 . . . . 0.0 112.581 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.14 62.88 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.407 -1.433 . . . . 0.0 112.065 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.2 -56.4 3.29 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 125.695 1.598 . . . . 0.0 108.686 172.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.09 -39.64 75.42 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.994 0.918 . . . . 0.0 112.816 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.9 -14.99 60.27 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.048 -1.033 . . . . 0.0 111.372 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.36 -9.52 47.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 120.683 -1.26 . . . . 0.0 107.702 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -37.52 73.81 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.415 -0.803 . . . . 0.0 109.618 -172.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -71.38 -24.9 62.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.987 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.5 t -70.52 -24.48 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 108.4 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -65.23 -15.7 62.75 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.081 -1.012 . . . . 0.0 111.735 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -55.91 -40.74 73.51 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 124.027 0.931 . . . . 0.0 110.438 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . 0.297 11.3 pt-20 -76.2 -19.28 58.54 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.32 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.58 -45.69 64.89 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -42.58 98.94 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.427 1.091 . . . . 0.0 109.937 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -52.65 -43.46 65.48 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 127.345 2.258 . . . . 0.0 112.818 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -106.41 2.7 26.64 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.603 -0.686 . . . . 0.0 111.469 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.62 19.24 68.9 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 120.888 -1.133 . . . . 0.0 112.759 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.564 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.49 163.18 20.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 120.91 -1.119 . . . . 0.0 108.165 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -69.88 -45.2 68.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 120.262 -1.524 . . . . 0.0 109.736 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -61.36 -20.17 62.69 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.82 -34.37 62.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.048 -1.033 . . . . 0.0 108.537 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -69.1 -25.61 64.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.69 -0.631 . . . . 0.0 111.008 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -69.78 -44.16 70.7 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.87 87.95 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.261 1.424 . . . . 0.0 111.677 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -56.31 -38.7 71.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.771 1.629 . . . . 0.0 111.161 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -79.34 -13.77 59.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.391 -0.818 . . . . 0.0 111.396 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.55 -36.33 63.12 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -62.99 -43.18 99.5 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.78 0.8 . . . . 0.0 110.395 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.86 -43.43 98.81 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.26 1.424 . . . . 0.0 109.932 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.39 -39.93 77.13 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.931 1.692 . . . . 0.0 110.369 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.71 -41.11 98.14 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 123.381 0.672 . . . . 0.0 111.026 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -59.48 -35.63 74.47 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.426 1.091 . . . . 0.0 110.801 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.33 -34.94 79.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.638 1.175 . . . . 0.0 110.595 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.6 -39.67 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.93 -34.49 78.09 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -72.01 -30.71 65.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 111.864 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -81.89 -37.09 27.41 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.599 -1.313 . . . . 0.0 108.892 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.46 92.87 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.494 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 21.5 p -60.62 -38.7 85.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.492 0.717 . . . . 0.0 111.878 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -75.42 -53.84 8.03 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -62.4 -26.52 68.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.874 0.87 . . . . 0.0 111.186 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -43.85 72.14 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.837 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.16 -12.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.603 1.192 . . . . 0.0 109.153 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.52 21.5 17.35 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.842 -1.786 . . . . 0.0 107.119 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.7 5.02 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' B' ' 31' ' ' ARG 0.286 0.6 OUTLIER -76.98 -80.42 0.1 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.129 -170.54 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.57 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 9.8 mmm180 59.72 -27.73 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 129.611 3.164 . . . . 0.0 116.584 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.45 37.66 0.23 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.19 156.35 79.15 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.968 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.83 123.14 8.74 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.249 2.633 . . . . 0.0 109.899 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.95 -58.41 3.25 Favored Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.3 174.1 0.16 Allowed 'General case' 0 C--N 1.35 0.598 0 C-N-CA 127.539 2.335 . . . . 0.0 109.515 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -174.92 -53.2 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.76 -1.212 . . . . 0.0 108.93 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.22 138.34 31.57 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 pt -163.18 177.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t 71.97 102.85 0.07 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.751 2.02 . . . . 0.0 110.662 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -49.67 -53.43 41.59 Favored Pre-proline 0 C--N 1.35 0.627 0 CA-C-O 116.782 -1.58 . . . . 0.0 113.264 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.86 -11.68 25.85 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 124.709 2.718 . . . . 0.0 111.921 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -95.52 -27.96 15.12 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.77 72.13 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.442 1.497 . . . . 0.0 111.491 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.08 -30.37 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 121.506 -0.746 . . . . 0.0 111.206 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.03 -20.9 40.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.659 -1.275 . . . . 0.0 109.912 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -65.32 -47.2 77.36 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -57.85 -30.91 66.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.88 -27.95 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.73 0.812 . . . . 0.0 111.296 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -88.36 -3.55 58.82 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.269 -1.519 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -113.18 -175.75 2.74 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 81.11 -50.21 0.28 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.351 1.86 . . . . 0.0 109.391 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -88.12 32.27 0.76 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.204 1.401 . . . . 0.0 111.532 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 42.07 61.7 1.87 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.318 2.247 . . . . 0.0 114.313 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.62 -93.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.97 87.74 0.9 Allowed Glycine 0 CA--C 1.495 -1.2 0 N-CA-C 104.976 -3.25 . . . . 0.0 104.976 -171.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -77.73 -18.8 56.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.813 -1.404 . . . . 0.0 108.712 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 45.53 1.8 Allowed Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.95 -59.55 2.73 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.82 162.04 36.5 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -144.9 148.89 40.68 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.52 160.64 19.53 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 123.381 2.721 . . . . 0.0 108.622 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.23 -99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-N 121.02 1.736 . . . . 0.0 110.424 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -141.57 -48.31 0.39 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 120.13 1.332 . . . . 0.0 111.299 -167.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -27.57 64.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 125.522 1.529 . . . . 0.0 108.196 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.47 -25.44 16.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.067 2.147 . . . . 0.0 111.963 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.32 93.86 1.31 Allowed Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 98.736 -5.746 . . . . 0.0 98.736 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -63.49 -11.6 25.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.69 -1.477 . . . . 0.0 111.9 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -61.58 -17.3 54.47 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.999 0.92 . . . . 0.0 112.328 168.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.78 -33.44 59.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.811 -1.181 . . . . 0.0 109.379 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.99 7.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 120.467 -1.395 . . . . 0.0 108.007 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -48.09 -52.43 20.37 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 125.916 1.687 . . . . 0.0 110.29 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -69.36 -29.57 67.39 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.983 -0.448 . . . . 0.0 111.234 -170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.8 t -75.41 -44.01 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 O-C-N 120.824 -1.172 . . . . 0.0 108.673 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.0 mtm -64.75 -45.68 85.4 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -75.39 -21.7 58.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.378 -0.826 . . . . 0.0 111.15 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.24 -31.11 70.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.889 -1.132 . . . . 0.0 110.486 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.26 -39.23 95.9 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.6 mt -61.84 -38.44 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.09 0.956 . . . . 0.0 108.946 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.97 -54.79 24.93 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.623 -1.298 . . . . 0.0 112.065 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 m -66.74 -45.38 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 123.119 0.568 . . . . 0.0 110.513 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.97 -33.29 63.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.04 -28.88 67.77 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.958 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -65.55 -36.79 84.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 120.925 -1.11 . . . . 0.0 109.984 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.1 -17.97 20.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 125.135 1.374 . . . . 0.0 110.766 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -54.49 -24.41 20.32 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.701 1.2 . . . . 0.0 111.895 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.66 86.93 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.233 -1.542 . . . . 0.0 112.472 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.1 -45.17 70.91 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.66 1.184 . . . . 0.0 108.683 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.86 -37.36 85.97 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.621 0.724 . . . . 0.0 110.353 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.21 76.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.901 -1.124 . . . . 0.0 111.387 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.7 t -78.51 -0.38 29.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 120.607 -1.308 . . . . 0.0 110.27 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -33.89 65.43 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 119.25 0.932 . . . . 0.0 109.758 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -71.11 -31.07 67.3 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.767 -1.208 . . . . 0.0 110.508 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.07 -24.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.89 1.276 . . . . 0.0 109.455 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -58.52 -21.74 53.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.213 1.005 . . . . 0.0 112.38 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.88 -23.01 67.1 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.63 -1.294 . . . . 0.0 111.049 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.25 -21.49 62.1 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.074 -1.016 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -66.53 -49.5 66.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -16.14 54.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.748 -0.595 . . . . 0.0 112.224 -175.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -66.13 -44.58 83.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.867 0.867 . . . . 0.0 109.391 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -87.57 -20.98 25.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.91 -0.494 . . . . 0.0 110.774 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.17 39.91 25.85 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 62.3 t60 . . . . . 0 N--CA 1.438 -1.06 0 C-N-CA 125.004 1.321 . . . . 0.0 108.373 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.05 86.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 172.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.18 -65.89 0.04 OUTLIER 'General case' 0 C--N 1.346 0.42 0 C-N-CA 130.043 3.337 . . . . 0.0 114.126 163.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.548 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 36.6 p-80 -58.35 -25.43 61.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.512 2.325 . . . . 0.0 115.413 -174.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -75.31 -27.15 59.18 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.338 -1.476 . . . . 0.0 110.435 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.47 -36.4 71.17 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.2 -0.937 . . . . 0.0 109.603 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.28 -38.44 65.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.93 0.892 . . . . 0.0 109.29 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.31 93.57 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.235 1.014 . . . . 0.0 111.858 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -27.75 60.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.397 -0.815 . . . . 0.0 110.578 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.69 -33.0 66.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.9 84.72 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -58.8 -35.13 72.34 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.552 0.741 . . . . 0.0 112.128 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.33 -24.08 61.25 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.345 -0.847 . . . . 0.0 111.384 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -73.77 -35.96 65.04 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.82 -42.46 99.05 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.303 -0.873 . . . . 0.0 110.928 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -57.83 -38.07 74.97 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.346 1.058 . . . . 0.0 111.97 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.81 81.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.567 1.147 . . . . 0.0 109.892 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.67 -37.7 79.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 O-C-N 121.15 -0.969 . . . . 0.0 108.748 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.33 -36.48 73.46 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.742 0.817 . . . . 0.0 112.226 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -63.42 -51.91 63.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.703 1.201 . . . . 0.0 109.169 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -63.77 -40.43 96.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.494 0.664 . . . . 0.0 110.216 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -32.27 73.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.386 1.474 . . . . 0.0 112.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -68.94 -34.87 76.06 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.387 -0.821 . . . . 0.0 110.378 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -70.89 -37.59 73.01 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.22 -51.54 63.2 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 -17.55 63.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -82.66 -36.07 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 O-C-N 120.327 -1.483 . . . . 0.0 108.402 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -78.33 -41.8 32.53 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.81 90.23 7.83 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 143.99 2.09 0.0 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.987 3.715 . . . . 0.0 110.085 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -91.05 41.36 1.06 Allowed 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.594 -1.941 . . . . 0.0 112.408 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.31 44.67 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.389 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.75 157.42 33.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.21 98.64 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.658 2.239 . . . . 0.0 112.647 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 9.36 36.79 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 143.6 15.83 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.604 1.562 . . . . 0.0 112.591 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.88 -32.4 3.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 124.639 1.176 . . . . 0.0 108.807 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.563 ' HG ' ' HE ' ' C' ' 60' ' ' ARG . 2.4 tt -89.49 50.6 1.94 Allowed 'General case' 0 C--N 1.35 0.603 0 CA-C-O 122.898 1.332 . . . . 0.0 108.144 -174.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.53 53.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 O-C-N 119.915 -1.741 . . . . 0.0 110.083 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -125.87 -151.17 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.89 -1.131 . . . . 0.0 108.401 -167.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -171.32 -64.12 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -69.6 -32.11 19.89 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.214 2.898 . . . . 0.0 112.386 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.488 ' CG ' HH22 ' C' ' 60' ' ' ARG . 8.3 p-10 -95.32 15.71 18.66 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.504 1.047 . . . . 0.0 109.88 -178.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -32.9 73.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.636 -1.29 . . . . 0.0 110.009 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -73.2 -22.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 O-C-N 121.562 -0.711 . . . . 0.0 109.84 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.24 -43.1 58.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.84 -37.24 86.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.75 1.22 . . . . 0.0 109.651 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -58.74 -35.22 72.37 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.73 1.212 . . . . 0.0 111.262 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.54 -52.72 56.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.007 0.923 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.36 -24.98 60.4 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 121.834 -0.541 . . . . 0.0 110.922 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -63.87 -42.77 97.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.002 1.321 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.38 73.9 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.34 -0.85 . . . . 0.0 112.05 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -3.02 45.54 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.158 -0.964 . . . . 0.0 111.405 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.255 3.1 p 59.8 21.71 10.57 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 127.479 2.312 . . . . 0.0 111.578 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.66 -48.05 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.53 74.53 0.35 Allowed Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -69.13 -24.96 64.16 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.217 -1.167 . . . . 0.0 110.867 -170.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.31 10.27 9.75 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.7 -61.4 2.38 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 126.737 2.015 . . . . 0.0 109.509 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.563 ' HE ' ' HG ' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -145.6 174.14 11.44 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 171.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -167.53 154.37 7.86 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.14 170.63 8.22 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.005 2.47 . . . . 0.0 110.73 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.87 -146.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -76.83 -60.52 2.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 126.172 1.789 . . . . 0.0 109.914 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.91 -16.74 61.09 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.897 0.856 . . . . 0.0 110.264 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.35 -16.42 60.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.608 -0.682 . . . . 0.0 109.352 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.77 88.76 0.64 Allowed Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 101.252 -4.739 . . . . 0.0 101.252 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -64.47 -13.03 49.77 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.426 -1.632 . . . . 0.0 110.846 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -60.77 -14.07 19.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.165 0.986 . . . . 0.0 113.172 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.09 -37.4 79.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 O-C-N 120.833 -1.167 . . . . 0.0 109.584 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.83 57.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.085 -1.009 . . . . 0.0 108.953 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.69 -48.77 49.45 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.045 1.738 . . . . 0.0 112.235 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -67.69 -32.06 72.44 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 120.47 -1.394 . . . . 0.0 112.056 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.77 -37.62 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.057 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 69.5 mtm -63.07 -45.89 90.0 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.538 0.735 . . . . 0.0 110.807 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -62.9 -35.61 80.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.718 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.3 77.93 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 118.271 0.487 . . . . 0.0 111.815 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.18 -53.32 22.69 Favored Glycine 0 CA--C 1.49 -1.482 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.76 -44.59 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.195 0.998 . . . . 0.0 109.382 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -65.39 -40.0 92.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.441 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.58 -50.1 69.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -66.9 -37.39 84.29 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.655 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.82 -32.89 74.67 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.104 0.962 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.19 -35.72 77.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 124.874 1.27 . . . . 0.0 110.963 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.69 -13.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 125.408 1.483 . . . . 0.0 111.118 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.8 m -62.04 -18.1 59.52 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.654 -1.904 . . . . 0.0 111.986 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.71 -17.33 62.87 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.571 -1.331 . . . . 0.0 111.594 170.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.548 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -83.45 -54.46 4.95 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.74 -28.44 66.82 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -165.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.76 -14.18 60.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.61 -1.931 . . . . 0.0 111.029 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -73.78 -17.14 61.13 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 119.94 -1.725 . . . . 0.0 109.828 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -30.13 70.43 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.245 0.618 . . . . 0.0 111.064 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -75.42 -23.89 57.04 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.027 -1.046 . . . . 0.0 110.911 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.67 -27.24 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 123.914 0.885 . . . . 0.0 108.675 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -67.49 -10.83 55.3 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.698 -0.626 . . . . 0.0 112.538 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -67.24 -36.65 82.09 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 120.782 -1.199 . . . . 0.0 109.074 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.35 166.41 12.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 71.38 -58.53 0.57 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.132 1.773 . . . . 0.0 111.313 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.95 -39.24 93.19 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.418 -1.427 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -76.98 -30.88 56.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.973 -0.455 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -127.48 92.18 3.45 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.35 -28.27 2.8 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 CA--C 1.496 -1.127 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -172.859 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 N--CA 1.427 -1.609 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.417 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -85.37 170.86 12.32 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.394 0.616 . . . . 0.0 109.347 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.25 -64.86 0.46 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 129.017 2.927 . . . . 0.0 112.688 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.417 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 39.3 p-80 -62.91 -25.6 68.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 112.996 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -79.61 -39.67 31.08 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -64.07 -44.65 91.75 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.592 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.54 -37.21 86.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 110.563 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.84 72.6 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.092 -1.005 . . . . 0.0 110.215 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.32 -28.31 67.04 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.424 0.69 . . . . 0.0 110.646 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.97 -41.81 75.33 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 125.697 1.599 . . . . 0.0 110.964 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.15 86.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.286 0.634 . . . . 0.0 111.5 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.91 -26.03 65.79 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.069 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -71.43 -33.2 69.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.9 -1.125 . . . . 0.0 109.969 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -65.42 -40.04 92.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 123.905 0.882 . . . . 0.0 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.88 -42.61 89.91 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.09 0.556 . . . . 0.0 111.527 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.3 -36.98 79.14 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 112.28 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -68.87 -39.79 79.64 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 110.003 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.06 -40.41 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.15 -53.1 60.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.951 0.796 . . . . 0.0 110.554 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -59.72 -50.02 75.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.869 0.868 . . . . 0.0 111.166 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -73.67 -29.05 62.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.857 -1.152 . . . . 0.0 111.513 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.88 63.94 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -58.51 -45.08 89.54 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.377 1.071 . . . . 0.0 110.565 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -60.9 -49.91 75.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -64.16 -31.82 73.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 123.923 0.889 . . . . 0.0 111.599 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.33 68.77 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.346 0.975 . . . . 0.0 110.693 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -88.01 -32.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 O-C-N 121.393 -0.817 . . . . 0.0 111.793 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -75.29 -23.87 57.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.227 -1.545 . . . . 0.0 111.413 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.0 37.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.72 -86.54 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 mtm-85 -17.32 90.45 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 129.121 2.968 . . . . 0.0 115.361 -151.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -30.79 2.0 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 107.021 -2.432 . . . . 0.0 107.021 -171.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.62 141.24 25.57 Favored Pre-proline 0 C--N 1.353 0.727 0 C-N-CA 125.728 1.611 . . . . 0.0 114.396 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.07 92.83 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.698 2.266 . . . . 0.0 113.345 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.68 -43.55 1.48 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 103.667 -3.773 . . . . 0.0 103.667 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.68 -179.17 0.17 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.551 1.94 . . . . 0.0 109.894 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.7 -41.79 0.05 Allowed 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.75 -14.75 13.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.05 1.34 . . . . 0.0 112.39 -167.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 pt -43.2 105.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -174.91 -143.53 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.6 -58.8 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.09 0 C-N-CA 126.641 1.977 . . . . 0.0 107.553 173.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.6 -20.71 26.53 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 126.064 3.201 . . . . 0.0 112.334 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.68 6.11 42.87 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 118.632 0.651 . . . . 0.0 110.241 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.0 -50.69 67.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.394 -0.817 . . . . 0.0 109.758 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.6 -7.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.013 0.911 . . . . 0.0 110.625 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 -28.24 15.92 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -83.74 -28.51 28.18 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.4 1.0 . . . . 0.0 108.947 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.8 t -78.17 62.69 2.94 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.484 -1.385 . . . . 0.0 108.717 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 84.4 t -137.87 -77.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.99 -5.61 54.29 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.003 -1.061 . . . . 0.0 111.606 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -82.04 -17.16 47.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 121.076 -1.015 . . . . 0.0 108.493 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.09 -32.77 56.88 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.898 -1.126 . . . . 0.0 109.158 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -91.36 16.86 9.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.193 0.597 . . . . 0.0 110.336 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p 55.1 52.45 11.7 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.143 1.777 . . . . 0.0 114.373 170.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -127.11 -61.87 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 87.65 -51.32 4.11 Favored Glycine 0 CA--C 1.496 -1.13 0 O-C-N 119.997 -1.689 . . . . 0.0 109.785 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 74.89 -24.76 0.21 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 128.151 2.58 . . . . 0.0 110.615 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 111.25 23.87 5.61 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.02 -65.91 0.64 Allowed 'General case' 0 C--N 1.36 1.063 0 CA-C-N 118.905 1.352 . . . . 0.0 110.056 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -126.81 161.72 27.55 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.57 89.06 7.61 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 117.858 -1.067 . . . . 0.0 109.168 -170.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.17 158.85 56.14 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.823 2.349 . . . . 0.0 111.875 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.453 HG21 ' H ' ' D' ' 64' ' ' THR . 3.6 p -111.8 -162.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 120.161 1.346 . . . . 0.0 110.788 -174.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.453 ' H ' HG21 ' D' ' 63' ' ' VAL . 1.3 p -70.09 -49.73 47.97 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 128.968 2.907 . . . . 0.0 111.258 -174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -69.65 -30.63 68.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.003 0.921 . . . . 0.0 110.942 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 8.4 pt-20 -79.49 -1.27 36.77 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.83 82.44 0.21 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 104.131 -3.588 . . . . 0.0 104.131 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -50.87 -22.09 2.03 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 120.642 2.221 . . . . 0.0 111.75 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -43.8 -23.08 0.07 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.412 1.885 . . . . 0.0 115.42 161.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.37 -43.91 97.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.588 1.54 . . . . 0.0 108.778 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.54 87.29 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.026 0.53 . . . . 0.0 110.22 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -57.56 -41.91 81.96 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.722 1.209 . . . . 0.0 110.466 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -62.23 -40.36 95.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.347 1.059 . . . . 0.0 111.429 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.06 -42.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -60.98 -46.43 90.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.526 0.73 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -66.84 -36.12 81.61 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 121.438 -0.789 . . . . 0.0 111.523 -175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -44.75 93.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 121.764 -0.585 . . . . 0.0 110.047 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.04 -47.81 89.21 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 124.465 1.031 . . . . 0.0 112.537 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.17 -49.39 81.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.63 1.172 . . . . 0.0 109.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.36 -31.46 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.477 -0.764 . . . . 0.0 111.429 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.4 -53.0 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 118.862 0.756 . . . . 0.0 110.136 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.53 -32.29 72.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.811 -0.555 . . . . 0.0 110.957 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.54 -39.86 92.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.694 1.198 . . . . 0.0 110.802 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.77 -22.42 12.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 124.766 1.226 . . . . 0.0 110.982 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -60.87 -12.21 10.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.0 95.16 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 118.784 -2.447 . . . . 0.0 112.27 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.88 72.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 36.9 mt -80.36 -28.51 38.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.722 0.772 . . . . 0.0 110.876 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.94 -26.32 59.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 120.326 -1.484 . . . . 0.0 110.025 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -78.65 -2.78 40.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.773 -1.204 . . . . 0.0 109.949 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.251 11.8 m-20 -78.68 -16.83 56.83 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 120.68 1.582 . . . . 0.0 111.663 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -80.68 -11.89 59.56 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.227 -1.546 . . . . 0.0 109.846 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.75 -32.85 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -61.7 -19.29 62.2 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.804 1.642 . . . . 0.0 111.872 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -65.18 -22.16 66.86 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.445 1.098 . . . . 0.0 111.439 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.33 132.15 40.77 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 126.359 1.864 . . . . 0.0 106.16 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.284 4.3 mt-10 71.88 -32.3 0.24 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.307 1.843 . . . . 0.0 112.61 -170.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.4 -46.69 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.833 1.253 . . . . 0.0 111.741 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . 0.25 37.7 ptt85 -74.6 0.12 16.01 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 120.507 -1.371 . . . . 0.0 112.742 -172.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -69.8 -36.7 75.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.252 -0.905 . . . . 0.0 108.784 167.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.92 27.86 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 CA--C 1.501 -0.914 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.427 -1.618 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 4' ' ' HIS . . . -77.93 -43.66 29.25 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 73.13 -58.27 0.61 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.958 2.103 . . . . 0.0 111.11 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 2' ' ' ALA . 28.9 p80 -61.99 -30.51 70.99 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.962 1.705 . . . . 0.0 111.098 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -67.06 -45.13 78.33 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.67 1.188 . . . . 0.0 108.46 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.04 -44.53 96.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.98 0.912 . . . . 0.0 109.687 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -66.23 -32.97 74.71 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.443 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.38 88.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 121.569 -0.707 . . . . 0.0 110.454 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -69.91 -31.13 68.76 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.614 0.721 . . . . 0.0 110.967 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -66.7 -38.52 86.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.907 0.883 . . . . 0.0 110.088 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.04 77.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.772 0.829 . . . . 0.0 111.075 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.45 -37.11 84.63 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.79 0.836 . . . . 0.0 111.559 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -65.87 -43.42 88.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.78 -32.73 73.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 110.224 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.7 -39.95 91.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.375 0.67 . . . . 0.0 111.525 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -64.64 -32.93 74.81 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.592 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -64.82 -39.76 94.1 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.71 0.804 . . . . 0.0 109.915 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.03 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 O-C-N 120.704 -1.248 . . . . 0.0 109.479 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.2 mt -60.99 -37.41 82.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.292 -0.88 . . . . 0.0 111.573 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.99 -45.48 73.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.933 0.893 . . . . 0.0 109.16 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -63.0 -43.64 98.22 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.969 -0.457 . . . . 0.0 109.814 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.31 74.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.873 1.669 . . . . 0.0 111.554 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -65.96 -37.38 85.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 122.153 -0.342 . . . . 0.0 110.964 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -73.09 -45.59 56.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -61.47 -46.28 90.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.07 53.16 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.027 1.331 . . . . 0.0 111.271 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.99 -39.39 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.767 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -81.96 -15.03 55.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.267 -1.521 . . . . 0.0 111.383 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.65 7.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.84 -33.15 74.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.251 1.021 . . . . 0.0 111.465 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -72.31 108.48 5.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 119.541 -1.974 . . . . 0.0 110.356 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.07 -18.83 7.4 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.43 143.82 42.24 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 117.519 0.66 . . . . 0.0 111.0 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.63 116.12 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.575 2.183 . . . . 0.0 111.983 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.3 45.18 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.95 -67.37 0.27 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 127.616 2.366 . . . . 0.0 109.845 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 90.22 -31.1 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 126.754 2.022 . . . . 0.0 108.733 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -89.46 124.92 34.93 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.3 pt -137.63 -3.97 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.986 -1.071 . . . . 0.0 112.483 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -117.99 152.86 34.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 120.097 1.317 . . . . 0.0 109.942 -164.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -83.03 -55.69 0.5 Allowed Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.02 -17.92 28.03 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 CA-C-N 125.404 2.966 . . . . 0.0 111.706 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.64 -21.05 25.52 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.39 70.53 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 120.997 -1.064 . . . . 0.0 110.541 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.68 -28.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.541 -0.725 . . . . 0.0 109.553 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.37 68.71 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 119.752 -1.843 . . . . 0.0 109.927 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -62.79 -47.63 82.63 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.165 0.986 . . . . 0.0 109.815 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -68.73 -28.44 66.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.291 -1.505 . . . . 0.0 111.698 -172.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.4 t -56.83 -54.31 31.11 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 124.153 0.981 . . . . 0.0 109.974 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -20.26 61.29 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.787 -0.57 . . . . 0.0 111.116 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.6 m -75.14 -40.36 59.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.37 1.068 . . . . 0.0 109.218 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -26.55 63.07 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 120.86 -1.15 . . . . 0.0 111.359 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 p -83.37 -1.18 52.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.916 -0.49 . . . . 0.0 110.12 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 p 55.3 39.76 31.38 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 126.386 1.874 . . . . 0.0 111.538 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -104.23 -75.12 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.42 91.77 0.12 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -28.24 57.86 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.834 -1.392 . . . . 0.0 109.734 -172.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.33 3.64 5.63 Favored Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -56.6 -50.94 70.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.5 1.52 . . . . 0.0 113.29 -179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 59' ' ' ASP . 21.7 mtm-85 -142.06 158.62 43.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.33 148.06 20.51 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 102.934 -2.987 . . . . 0.0 102.934 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -90.79 171.09 3.41 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.901 2.4 . . . . 0.0 110.707 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.01 -154.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.686 0 CA-C-O 122.61 1.195 . . . . 0.0 110.291 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -83.51 -52.89 6.11 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.029 -1.669 . . . . 0.0 110.89 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -63.65 -32.2 73.6 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.798 2.439 . . . . 0.0 111.657 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -28.04 69.57 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 123.309 1.528 . . . . 0.0 108.1 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 65.74 1.22 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 103.097 -4.001 . . . . 0.0 103.097 174.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -27.78 -26.79 0.0 OUTLIER 'General case' 0 C--N 1.376 1.742 1 C-N-CA 131.715 4.006 . . . . 0.0 116.043 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -55.02 -12.77 0.92 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.366 2.666 . . . . 0.0 113.201 167.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 -52.13 34.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.11 99.68 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.555 -0.716 . . . . 0.0 111.347 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -50.6 -47.46 58.14 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.364 1.466 . . . . 0.0 111.379 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.66 -40.91 96.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.58 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.84 -43.77 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.205 1.002 . . . . 0.0 109.375 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.04 -49.1 78.98 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 124.391 1.076 . . . . 0.0 110.111 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -64.38 -35.04 79.6 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.631 -0.668 . . . . 0.0 110.897 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.38 80.6 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.147 0.579 . . . . 0.0 111.262 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.05 -43.65 80.71 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.54 -43.66 97.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 124.279 1.032 . . . . 0.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -60.41 -39.96 89.25 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.393 -0.817 . . . . 0.0 111.271 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.06 -54.28 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.103 0.961 . . . . 0.0 109.537 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -61.67 -40.08 93.67 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.421 0.689 . . . . 0.0 111.302 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.36 80.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.914 0.885 . . . . 0.0 110.981 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.58 -35.24 79.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.529 1.132 . . . . 0.0 110.804 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.12 -16.79 7.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 125.301 1.44 . . . . 0.0 111.206 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.0 m -56.6 -24.35 47.16 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.12 -1.612 . . . . 0.0 112.48 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.18 -23.78 62.52 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.842 -1.161 . . . . 0.0 112.439 172.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.59 -3.88 21.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.623 1.169 . . . . 0.0 111.587 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.5 mt -96.67 -42.98 7.76 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.45 64.64 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.343 -0.848 . . . . 0.0 111.067 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -71.32 -20.48 62.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 120.632 -1.292 . . . . 0.0 111.161 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.265 25.5 m-20 -86.8 -8.95 56.88 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.249 -162.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -81.96 -32.36 30.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.442 165.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.67 -32.67 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.789 1.236 . . . . 0.0 109.075 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -53.22 -24.67 11.65 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.583 1.553 . . . . 0.0 112.543 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -54.26 -39.33 66.76 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.596 1.559 . . . . 0.0 110.774 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -69.83 -27.46 64.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.591 -0.693 . . . . 0.0 111.643 -175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -86.14 -34.36 20.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -68.63 -25.2 64.71 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.636 -1.29 . . . . 0.0 111.865 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -67.29 -26.51 66.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 121.262 -0.899 . . . . 0.0 111.26 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -83.32 -31.29 26.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.552 -0.717 . . . . 0.0 109.457 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.62 69.97 Favored Glycine 0 CA--C 1.496 -1.112 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.1 m80 . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -170.079 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.74 44.35 2.91 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 118.443 0.565 . . . . 0.0 111.521 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.84 -67.38 0.23 Allowed 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 128.794 2.838 . . . . 0.0 110.678 173.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 35.1 p-80 -63.9 -21.48 66.48 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.501 1.52 . . . . 0.0 111.769 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -35.09 76.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.666 1.187 . . . . 0.0 109.044 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -68.69 -31.68 70.94 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.407 -0.808 . . . . 0.0 110.894 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.07 -27.9 63.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.297 0.57 . . . . 0.0 110.075 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.35 -35.62 78.01 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.305 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.73 -28.72 61.85 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.436 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.69 -38.34 90.66 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.393 -0.817 . . . . 0.0 109.817 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.45 89.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.956 0.903 . . . . 0.0 110.99 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.45 -37.91 89.18 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 121.302 -0.874 . . . . 0.0 111.335 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -65.62 -41.25 92.9 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.386 -0.821 . . . . 0.0 109.713 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.39 -37.23 74.88 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.765 1.226 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -63.67 -42.67 98.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.26 -29.07 68.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.543 -0.723 . . . . 0.0 111.423 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -66.47 -46.89 74.85 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.804 1.242 . . . . 0.0 109.851 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -76.01 -19.33 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 121.534 -0.729 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.75 -43.3 99.16 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 119.533 1.06 . . . . 0.0 110.323 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.54 -39.18 77.63 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -68.87 -31.93 71.23 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.199 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.32 -32.36 73.93 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.752 1.221 . . . . 0.0 110.636 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.0 t -62.2 -48.23 80.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.429 1.092 . . . . 0.0 109.269 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -60.98 -53.39 57.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 108.793 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -65.15 -38.44 90.58 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.33 -54.05 43.06 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.676 1.126 . . . . 0.0 110.984 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.24 -36.59 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.814 -0.554 . . . . 0.0 110.082 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.51 -31.88 57.94 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.18 -0.95 . . . . 0.0 110.33 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.5 -41.87 37.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 O-C-N 121.911 -0.493 . . . . 0.0 110.011 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.31 -28.23 69.17 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 121.87 0.843 . . . . 0.0 111.954 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -72.28 107.53 4.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 119.73 -1.856 . . . . 0.0 110.621 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.02 -24.13 4.56 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 106.594 -2.602 . . . . 0.0 106.594 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 147.22 84.37 Favored Pre-proline 0 N--CA 1.444 -0.759 0 O-C-N 121.94 -0.741 . . . . 0.0 111.444 -171.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.92 145.62 22.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.441 2.094 . . . . 0.0 109.689 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.95 -67.55 3.69 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.04 157.45 0.11 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.936 2.894 . . . . 0.0 109.946 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.27 -43.82 0.37 Allowed 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 120.922 -1.111 . . . . 0.0 108.907 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 12.7 tp -121.64 111.43 17.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.8 80.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 120.336 -1.478 . . . . 0.0 108.649 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -159.11 158.86 33.74 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.81 -61.58 0.24 Allowed Pre-proline 0 C--N 1.347 0.5 0 CA-C-O 116.971 -1.49 . . . . 0.0 109.204 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.5 -9.53 24.22 Favored 'Trans proline' 0 CA--C 1.511 -0.646 0 CA-C-N 124.835 2.763 . . . . 0.0 112.121 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.08 -22.22 16.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -40.33 82.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 121.452 -0.78 . . . . 0.0 109.25 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -66.16 -27.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 122.737 0.415 . . . . 0.0 110.937 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -73.14 -43.17 61.97 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.465 -0.772 . . . . 0.0 109.09 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.47 -31.93 73.24 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 125.071 1.349 . . . . 0.0 110.036 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 m -63.06 -36.47 83.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 119.08 -2.262 . . . . 0.0 112.45 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 t -64.87 -45.51 94.66 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 121.534 -0.729 . . . . 0.0 110.54 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -65.42 -33.83 76.86 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 122.008 0.909 . . . . 0.0 110.302 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 87.4 m -67.56 -41.3 84.45 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.285 -0.884 . . . . 0.0 109.85 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.75 61.78 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.173 -0.954 . . . . 0.0 112.189 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -97.29 0.86 48.79 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.263 18.7 p 62.21 31.37 17.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.863 1.665 . . . . 0.0 113.775 173.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 78.87 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.93 120.08 5.83 Favored Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 103.584 -3.806 . . . . 0.0 103.584 173.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -86.08 -84.95 0.16 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -168.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.95 37.6 0.31 Allowed Glycine 0 CA--C 1.479 -2.205 0 N-CA-C 106.292 -2.723 . . . . 0.0 106.292 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.1 -62.1 1.56 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -143.22 170.61 15.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -156.76 153.58 24.75 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.96 173.83 8.84 Favored 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 124.25 3.3 . . . . 0.0 109.692 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.34 -99.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 119.695 1.134 . . . . 0.0 112.505 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.7 m -150.46 -40.07 0.13 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.029 1.732 . . . . 0.0 109.106 -172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -88.45 -20.5 25.11 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.283 -0.886 . . . . 0.0 110.645 -169.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 66' ' ' GLU . 0.5 OUTLIER -59.53 -35.08 73.51 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 126.303 1.841 . . . . 0.0 108.315 171.058 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.38 90.02 1.88 Allowed Glycine 0 CA--C 1.467 -2.927 1 N-CA-C 97.802 -6.119 . . . . 0.0 97.802 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -56.42 -18.99 12.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.261 1.825 . . . . 0.0 111.382 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -54.72 -22.65 14.63 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 127.104 2.162 . . . . 0.0 113.135 168.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.26 -43.62 98.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.806 -1.184 . . . . 0.0 108.841 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.76 67.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.742 -0.599 . . . . 0.0 109.485 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -52.87 -45.04 67.26 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.482 1.513 . . . . 0.0 110.818 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.57 -39.82 85.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.001 0.92 . . . . 0.0 111.364 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.96 -41.22 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 109.086 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.5 mtt -60.43 -47.54 85.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.81 0.844 . . . . 0.0 110.049 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.927 -0.483 . . . . 0.0 111.134 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.37 90.76 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.766 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.23 -46.17 88.38 Favored Glycine 0 CA--C 1.495 -1.198 0 C-N-CA 124.061 0.839 . . . . 0.0 111.153 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.89 -46.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 C-N-CA 124.443 1.097 . . . . 0.0 109.182 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -62.76 -51.48 66.96 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.315 -0.866 . . . . 0.0 112.327 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.24 -40.84 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 O-C-N 121.76 -0.587 . . . . 0.0 111.081 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -74.22 -38.57 63.52 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.96 74.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.54 -0.725 . . . . 0.0 111.016 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.28 -30.57 71.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.756 1.222 . . . . 0.0 111.068 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.93 -14.91 15.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.879 1.272 . . . . 0.0 110.397 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 20.6 m -55.86 -23.46 30.96 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.6 -1.313 . . . . 0.0 110.894 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.45 74.92 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 119.251 -2.156 . . . . 0.0 112.446 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.61 -45.15 17.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 120.903 -1.123 . . . . 0.0 108.047 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.9 -27.7 63.99 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.877 0.871 . . . . 0.0 111.336 -173.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.06 -17.07 62.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 120.689 -1.257 . . . . 0.0 111.192 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -76.72 -13.92 59.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 120.559 -1.338 . . . . 0.0 111.128 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.259 7.4 t70 -75.71 -18.23 59.67 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 120.231 1.378 . . . . 0.0 111.218 -167.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.43 -36.13 60.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 119.895 -1.753 . . . . 0.0 110.234 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.35 -28.82 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 126.029 1.731 . . . . 0.0 109.437 -171.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -44.21 -36.75 2.83 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 126.835 2.054 . . . . 0.0 112.013 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -58.33 -33.12 69.15 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 123.917 0.887 . . . . 0.0 111.753 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -70.23 -36.25 74.39 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 107.971 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.32 -24.51 46.55 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.666 1.587 . . . . 0.0 110.84 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -81.54 -33.8 31.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.603 -0.686 . . . . 0.0 110.258 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -77.81 -48.12 17.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 86.4 mtt85 -92.65 112.21 24.08 Favored 'General case' 0 CA--C 1.498 -1.031 0 O-C-N 121.105 -0.997 . . . . 0.0 109.187 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.96 -2.61 55.49 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 -175.373 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -26.9 113.94 0.06 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.475 3.11 . . . . 0.0 116.625 -163.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.42 -34.03 77.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 125.677 1.591 . . . . 0.0 110.281 -165.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -61.29 -28.34 69.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.93 -37.57 64.55 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 120.137 1.335 . . . . 0.0 107.837 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -73.84 -38.31 64.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -68.43 -35.19 77.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.969 -0.457 . . . . 0.0 110.345 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.56 90.07 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.8 0.84 . . . . 0.0 110.796 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.64 -38.22 83.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.832 -0.542 . . . . 0.0 110.556 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.89 -40.42 92.98 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.72 0.808 . . . . 0.0 110.328 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.15 75.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.588 0.755 . . . . 0.0 111.588 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -38.49 86.41 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.791 -0.568 . . . . 0.0 111.403 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.71 -30.67 69.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 122.219 1.009 . . . . 0.0 109.846 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.29 -33.56 71.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.803 0.841 . . . . 0.0 109.213 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.35 -43.87 93.22 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.42 0.688 . . . . 0.0 110.649 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -52.36 -41.04 62.73 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.906 1.282 . . . . 0.0 111.771 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -24.17 61.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.845 0.858 . . . . 0.0 111.199 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -78.42 -36.55 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.73 -41.85 91.82 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.815 1.246 . . . . 0.0 111.14 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -74.36 -14.95 60.95 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.58 -36.15 19.05 Favored 'General case' 0 CA--C 1.493 -1.232 0 O-C-N 120.672 -1.268 . . . . 0.0 108.023 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.49 72.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.033 0.933 . . . . 0.0 111.152 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -68.95 -36.84 78.39 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.992 0.815 . . . . 0.0 110.432 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -71.15 -43.8 66.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.93 -49.88 76.15 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.591 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.8 86.65 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.432 1.093 . . . . 0.0 112.017 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -37.07 74.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.283 -1.511 . . . . 0.0 110.187 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -73.85 -31.92 63.41 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 120.751 -1.218 . . . . 0.0 109.279 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.24 15.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 126.06 1.744 . . . . 0.0 109.053 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.64 -25.96 64.18 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.143 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.61 104.91 2.5 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 119.481 -2.012 . . . . 0.0 110.59 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.47 -5.76 21.09 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 144.31 28.87 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.68 139.6 11.27 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.367 2.045 . . . . 0.0 110.277 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.65 81.46 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.58 116.01 4.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 125.74 1.616 . . . . 0.0 106.906 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.74 -33.55 15.7 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.72 127.84 36.45 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 pt -144.88 168.8 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 101.222 -3.622 . . . . 0.0 101.222 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m 74.8 131.2 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.407 1.883 . . . . 0.0 113.402 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -58.64 -49.09 95.35 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 116.194 -1.86 . . . . 0.0 112.527 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.53 -27.94 38.78 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.297 2.928 . . . . 0.0 113.491 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.339 4.8 p-10 -98.7 -1.64 40.15 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 120.739 1.609 . . . . 0.0 111.035 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.17 74.69 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 120.713 -1.242 . . . . 0.0 110.878 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.66 -16.71 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 O-C-N 121.091 -1.006 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.08 -41.48 28.63 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.887 -1.133 . . . . 0.0 108.304 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.7 -33.29 75.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.858 0.837 . . . . 0.0 109.977 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -77.29 53.85 1.05 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 120.935 -1.103 . . . . 0.0 111.144 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -141.69 -54.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -34.25 71.13 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.741 1.216 . . . . 0.0 112.422 -172.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -72.68 -33.29 66.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 125.313 1.445 . . . . 0.0 109.898 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.1 -31.09 58.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.411 -1.431 . . . . 0.0 110.309 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -85.01 -1.74 57.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.171 0.588 . . . . 0.0 110.727 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p 51.13 68.01 0.86 Allowed 'General case' 0 C--N 1.352 0.709 0 C-N-CA 127.695 2.398 . . . . 0.0 112.099 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.12 -75.87 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.65 -78.94 0.63 Allowed Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -173.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 83.28 -49.62 0.15 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 127.746 2.419 . . . . 0.0 106.434 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.24 42.49 0.25 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -70.24 -54.12 14.12 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -139.4 -169.57 2.71 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.09 137.71 11.49 Favored Pre-proline 0 N--CA 1.438 -1.067 1 N-CA-C 100.153 -4.017 . . . . 0.0 100.153 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.07 163.0 0.26 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 CA-C-N 123.695 2.355 . . . . 0.0 109.389 166.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.19 -177.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-O 123.24 1.495 . . . . 0.0 111.558 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -68.64 -34.82 76.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 119.085 -2.259 . . . . 0.0 111.211 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -78.68 -23.64 45.53 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 -170.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -34.76 78.37 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' C' ' 69' ' ' LYS . . . 101.34 67.32 0.81 Allowed Glycine 0 CA--C 1.461 -3.327 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 171.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . 0.272 6.4 ttm180 -54.24 1.54 0.02 OUTLIER 'General case' 0 C--N 1.373 1.617 0 C-N-CA 127.582 2.353 . . . . 0.0 116.539 -166.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' C' ' 67' ' ' GLY . 1.2 mmmp? -54.54 -24.17 19.67 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 127.1 2.16 . . . . 0.0 111.48 155.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.24 -50.25 69.76 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 CA-C-N 120.639 1.563 . . . . 0.0 108.439 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.8 75.42 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.901 0.88 . . . . 0.0 110.869 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . 0.43 ' CD ' ' HZ1' ' C' ' 69' ' ' LYS . 17.9 tt0 -51.87 -44.17 63.59 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.782 1.633 . . . . 0.0 112.081 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -62.4 -35.4 79.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.071 1.348 . . . . 0.0 110.899 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.43 -40.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 O-C-N 121.61 -0.681 . . . . 0.0 109.358 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -59.65 -46.79 87.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.853 1.261 . . . . 0.0 110.115 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.67 -41.08 98.89 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.966 -0.459 . . . . 0.0 110.707 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.98 89.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.883 0.473 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.78 87.87 Favored Glycine 0 CA--C 1.494 -1.232 0 C-N-CA 123.744 0.687 . . . . 0.0 111.534 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.66 -44.27 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 123.983 0.913 . . . . 0.0 109.648 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.91 -33.63 76.48 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.397 -0.815 . . . . 0.0 111.911 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.78 -53.68 28.91 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 123.642 0.777 . . . . 0.0 109.581 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -67.11 -36.13 81.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.53 87.58 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.342 0.657 . . . . 0.0 110.644 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.67 -35.39 74.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.213 1.405 . . . . 0.0 111.775 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.63 -16.46 10.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 C-N-CA 125.255 1.422 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -62.72 -13.26 30.46 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 119.602 -1.936 . . . . 0.0 112.166 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.85 67.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.923 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.2 -55.69 4.57 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.01 -38.63 86.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.403 1.481 . . . . 0.0 113.304 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.68 61.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.558 -1.339 . . . . 0.0 110.852 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 68.7 p -88.78 -12.37 42.26 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 120.82 -1.175 . . . . 0.0 110.616 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.37 -28.45 67.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.229 0.922 . . . . 0.0 110.537 -167.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -77.08 -33.44 57.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.93 -33.06 56.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 125.366 1.466 . . . . 0.0 108.685 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -52.51 -24.17 7.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.636 1.974 . . . . 0.0 113.956 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -58.01 -32.98 68.45 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 119.756 1.162 . . . . 0.0 112.111 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.99 -13.79 43.51 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.144 -0.973 . . . . 0.0 111.04 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -89.5 -19.33 25.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.298 0.499 . . . . 0.0 109.849 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -77.04 -54.66 6.26 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.593 -0.692 . . . . 0.0 111.573 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -58.83 -27.75 65.38 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -83.73 -18.62 37.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.817 -0.552 . . . . 0.0 111.299 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.6 44.85 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.501 -0.912 0 O-C-N 121.39 -1.065 . . . . 0.0 108.288 177.63 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.9 165.49 17.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.74 -35.65 81.76 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 121.722 -0.612 . . . . 0.0 111.326 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.446 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 7.3 p80 -73.32 -23.93 60.31 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 121.013 -1.055 . . . . 0.0 111.42 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.446 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 0.1 OUTLIER -83.16 -27.95 29.71 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -63.78 -42.32 97.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.361 1.065 . . . . 0.0 110.361 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.7 -38.74 84.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.839 0.828 . . . . 0.0 109.148 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.26 89.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.39 1.076 . . . . 0.0 111.413 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -69.84 -28.76 65.96 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.529 -0.732 . . . . 0.0 110.766 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.75 69.67 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.337 0.655 . . . . 0.0 111.738 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.97 -36.13 82.49 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.44 -0.787 . . . . 0.0 111.365 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.07 -27.11 60.75 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.927 -1.108 . . . . 0.0 110.647 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.72 -27.5 65.03 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.475 -0.765 . . . . 0.0 110.463 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 tp -71.79 -39.19 70.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.342 -0.848 . . . . 0.0 109.996 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -62.42 -31.92 72.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 123.424 0.69 . . . . 0.0 111.519 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.03 -45.5 92.6 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.504 1.122 . . . . 0.0 110.224 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -67.8 -35.67 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 123.917 0.887 . . . . 0.0 109.244 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.27 -53.69 54.71 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.288 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -68.68 -40.89 79.87 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.451 -0.78 . . . . 0.0 110.777 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.93 -47.33 83.72 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 109.837 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.56 60.93 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 121.009 -1.057 . . . . 0.0 111.771 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -66.04 -40.33 90.89 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 109.742 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -71.23 -25.57 62.55 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.34 1.456 . . . . 0.0 110.084 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -79.22 -55.5 5.05 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.4 -43.87 79.72 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 126.228 1.811 . . . . 0.0 112.531 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -31.8 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -83.96 -34.45 24.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.12 -50.45 54.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 127.009 2.124 . . . . 0.0 109.92 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.88 -41.84 99.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.999 1.32 . . . . 0.0 110.231 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -62.2 121.77 13.95 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 119.722 -1.861 . . . . 0.0 110.233 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.19 -12.44 48.48 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.22 56.66 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 118.144 0.972 . . . . 0.0 110.504 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.85 141.81 19.49 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.894 1.73 . . . . 0.0 109.775 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.81 75.51 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.57 139.28 58.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 111.666 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.91 -29.39 2.33 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 124.5 1.12 . . . . 0.0 110.185 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 30.0 tp -81.4 -106.77 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . 0.285 35.5 mt 71.97 173.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 -172.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 39.0 t 73.17 124.36 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.225 1.488 . . . . 0.0 110.511 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -66.66 -50.11 47.13 Favored Pre-proline 0 C--N 1.348 0.503 0 O-C-N 119.802 -1.811 . . . . 0.0 110.778 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -71.67 -11.71 28.23 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 125.074 2.848 . . . . 0.0 112.227 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.92 -45.3 12.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.61 72.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.048 0.939 . . . . 0.0 112.394 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -82.81 1.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.723 0.773 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -43.27 7.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 119.693 -1.879 . . . . 0.0 106.202 171.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -57.79 -32.57 67.67 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.346 1.858 . . . . 0.0 111.967 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 p -68.9 -34.6 75.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.026 -2.296 . . . . 0.0 110.321 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 t -87.93 63.43 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 0.0 108.795 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -175.87 -31.43 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 50.2 m -62.51 -39.28 93.03 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.346 1.458 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.62 65.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.135 -0.978 . . . . 0.0 112.176 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.97 4.38 45.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 122.68 0.392 . . . . 0.0 110.177 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.26 1.0 OUTLIER 64.67 10.63 6.11 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.04 1.736 . . . . 0.0 112.927 174.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.65 -65.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 -63.82 4.22 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.55 -60.57 0.53 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.301 2.24 . . . . 0.0 109.692 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.47 -95.07 0.1 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . 0.286 10.7 t70 43.62 -101.73 0.04 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.178 2.191 . . . . 0.0 113.79 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 170.05 15.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -124.94 150.62 66.84 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.82 165.72 19.72 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.142 2.561 . . . . 0.0 109.427 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.44 -162.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 122.913 1.34 . . . . 0.0 107.837 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -86.58 -52.18 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 125.639 1.576 . . . . 0.0 109.059 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.54 -23.41 64.52 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 128.83 2.852 . . . . 0.0 110.345 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.99 -26.42 66.02 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 123.888 1.804 . . . . 0.0 108.398 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.8 67.6 1.31 Allowed Glycine 0 CA--C 1.462 -3.239 1 N-CA-C 99.483 -5.447 . . . . 0.0 99.483 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -34.22 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.36 1.028 1 C-N-CA 132.134 4.174 . . . . 0.0 114.765 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -55.75 -15.27 2.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 127.387 2.275 . . . . 0.0 113.273 165.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -72.29 -54.9 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.28 85.48 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.014 0.926 . . . . 0.0 112.14 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.13 -45.29 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.808 2.043 . . . . 0.0 112.108 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.59 -29.65 64.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 121.832 -0.542 . . . . 0.0 110.94 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -72.68 -47.22 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -70.88 -41.39 71.42 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.092 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -64.02 -41.83 97.32 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 121.272 -0.892 . . . . 0.0 110.736 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.07 79.23 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.604 -0.685 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.7 -45.54 96.06 Favored Glycine 0 CA--C 1.494 -1.278 0 C-N-CA 123.827 0.727 . . . . 0.0 111.654 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 86.7 mt -58.67 -47.06 90.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 124.273 1.029 . . . . 0.0 109.409 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -63.72 -34.78 78.63 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.383 -0.823 . . . . 0.0 112.125 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.93 -50.07 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.604 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.72 -21.25 64.41 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.599 -0.688 . . . . 0.0 111.142 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.11 -37.7 25.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.35 -37.2 84.74 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.975 1.31 . . . . 0.0 110.652 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.32 -2.73 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.335 -0.853 . . . . 0.0 112.39 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 24.9 m -63.09 -16.84 61.29 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.818 -1.176 . . . . 0.0 110.856 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.91 -38.05 81.19 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.863 -1.773 . . . . 0.0 111.908 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.24 63.37 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 120.555 -1.341 . . . . 0.0 108.423 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.57 -37.8 87.58 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.807 1.243 . . . . 0.0 111.532 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -21.37 63.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.419 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -85.23 -16.19 41.04 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.48 -38.48 84.44 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.765 -1.209 . . . . 0.0 110.112 -170.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -70.59 -29.51 65.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.291 -1.505 . . . . 0.0 111.043 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.26 -20.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 109.502 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -50.74 -37.45 41.89 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.888 1.675 . . . . 0.0 110.233 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -56.77 -36.22 69.56 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.987 1.315 . . . . 0.0 111.197 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.77 -36.32 43.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -171.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.24 -39.77 78.28 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.905 -0.497 . . . . 0.0 110.49 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -65.9 -43.45 88.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.406 1.082 . . . . 0.0 109.741 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.46 -40.76 96.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.246 1.018 . . . . 0.0 111.14 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -73.96 -39.89 63.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.403 -0.811 . . . . 0.0 110.001 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.85 25.48 22.44 Favored Glycine 0 CA--C 1.496 -1.149 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 66.2 m80 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 125.965 1.706 . . . . 0.0 112.831 -179.168 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.01 163.78 0.27 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 126.73 2.012 . . . . 0.0 111.707 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -57.1 2.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -57.04 -24.16 51.77 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 128.079 2.552 . . . . 0.0 114.941 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.88 -28.58 61.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.509 -1.369 . . . . 0.0 110.07 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.87 -32.44 65.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.003 -1.06 . . . . 0.0 110.187 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -71.57 -38.23 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.212 1.005 . . . . 0.0 109.183 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.33 86.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.821 0.848 . . . . 0.0 111.158 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -73.32 -22.28 60.36 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.085 -1.009 . . . . 0.0 111.788 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -73.05 -23.84 60.63 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.129 -0.982 . . . . 0.0 109.879 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.43 77.85 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.9 -1.125 . . . . 0.0 109.98 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.8 -30.26 71.37 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.574 -0.704 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 120.891 -1.13 . . . . 0.0 111.176 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -68.79 -31.2 70.04 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.618 0.767 . . . . 0.0 109.074 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.07 -40.48 94.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.649 0.737 . . . . 0.0 110.635 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -70.06 -25.27 63.46 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.16 -0.962 . . . . 0.0 111.419 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -71.2 -46.68 60.73 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -70.94 -25.2 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 121.604 -0.685 . . . . 0.0 110.132 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.55 -55.17 38.52 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 118.963 0.802 . . . . 0.0 110.471 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.38 -31.47 67.34 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.624 -0.673 . . . . 0.0 110.986 -174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.23 -48.31 70.99 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.916 -1.115 . . . . 0.0 109.627 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.14 63.39 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 123.989 0.915 . . . . 0.0 112.144 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.4 m -65.65 -39.74 91.74 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.639 -0.663 . . . . 0.0 110.156 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -69.36 -43.45 73.58 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.44 -53.12 61.85 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.499 0.72 . . . . 0.0 110.61 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.47 98.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.08 1.352 . . . . 0.0 112.648 -172.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -71.2 -35.25 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.945 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -77.0 -25.2 52.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 120.934 -1.104 . . . . 0.0 109.576 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.68 96.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.984 1.713 . . . . 0.0 109.495 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.4 -17.62 64.26 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.706 1.202 . . . . 0.0 113.133 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -78.23 80.43 4.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.24 -1.537 . . . . 0.0 110.369 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.09 2.76 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.33 143.8 37.23 Favored Pre-proline 0 N--CA 1.444 -0.757 0 O-C-N 120.926 -1.338 . . . . 0.0 110.525 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.71 128.42 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.985 2.456 . . . . 0.0 112.333 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 34.04 45.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.36 147.69 47.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.579 1.151 . . . . 0.0 110.624 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -44.43 0.93 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.217 0.607 . . . . 0.0 109.784 -170.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -87.08 46.48 1.38 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-O 123.13 1.443 . . . . 0.0 108.803 -171.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.04 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 119.4 -2.063 . . . . 0.0 108.94 -171.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 m -141.66 -122.01 0.1 Allowed 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -173.13 -71.51 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -20.89 25.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 125.512 3.004 . . . . 0.0 111.341 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.59 -33.17 64.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.443 1.497 . . . . 0.0 109.92 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.776 0.83 . . . . 0.0 109.703 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.96 -34.9 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 122.065 -0.397 . . . . 0.0 110.082 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 109.674 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -64.46 -35.12 79.88 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.512 1.148 . . . . 0.0 110.276 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -65.04 -42.35 94.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.722 -1.236 . . . . 0.0 109.684 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -56.62 -54.37 29.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.212 1.405 . . . . 0.0 110.031 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -69.46 -26.45 64.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.614 0.366 . . . . 0.0 111.455 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.6 m -69.34 -39.43 78.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.431 1.092 . . . . 0.0 109.707 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.37 -30.01 70.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.549 -1.344 . . . . 0.0 111.658 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.457 ' HG1' HG21 ' A' ' 55' ' ' VAL . 1.2 p -87.67 3.49 47.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.716 -0.615 . . . . 0.0 110.651 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p 59.85 36.93 21.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.012 1.725 . . . . 0.0 112.324 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 ' HG1' ' A' ' 53' ' ' THR . 24.7 t -82.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 -85.63 0.55 Allowed Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 105.951 -2.859 . . . . 0.0 105.951 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 69.86 -65.18 0.32 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.872 2.469 . . . . 0.0 110.674 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.65 54.68 0.59 Allowed Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.09 -44.23 15.38 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -138.04 168.54 19.51 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.59 128.18 17.92 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.29 172.78 13.27 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.265 3.31 . . . . 0.0 109.543 169.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.91 -137.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 p -124.04 -27.69 3.85 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.025 1.33 . . . . 0.0 110.723 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.12 6.05 50.13 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -36.12 63.84 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.46 -11.44 0.55 Allowed Glycine 0 CA--C 1.477 -2.321 0 CA-C-O 117.096 -1.947 . . . . 0.0 108.968 171.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 67.14 -56.45 0.44 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 130.232 3.413 . . . . 0.0 109.33 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -84.81 20.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.029 1.331 . . . . 0.0 111.061 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.0 -49.39 44.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.7 74.92 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.179 0.592 . . . . 0.0 109.41 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.44 -41.78 69.81 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.226 1.41 . . . . 0.0 111.696 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.87 -49.28 76.85 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.846 -0.533 . . . . 0.0 110.775 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.96 -38.41 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 O-C-N 121.744 -0.597 . . . . 0.0 109.44 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.0 tpp -55.73 -53.74 52.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.572 1.549 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -66.22 -40.8 90.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.112 0.965 . . . . 0.0 109.935 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.11 82.84 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.827 0.851 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -46.37 91.66 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.98 -30.76 47.85 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 O-C-N 121.658 -0.907 . . . . 0.0 109.582 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.98 -46.44 81.44 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.661 -1.9 . . . . 0.0 109.866 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 t -63.44 -52.81 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 124.477 1.111 . . . . 0.0 109.782 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -74.41 -8.11 55.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.647 -0.658 . . . . 0.0 112.049 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.89 -32.65 15.94 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.817 -1.177 . . . . 0.0 110.103 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.33 -36.85 85.31 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.781 -1.199 . . . . 0.0 110.096 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -63.44 -12.53 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.0 m -65.16 -15.93 62.96 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.853 1.261 . . . . 0.0 111.173 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.11 71.6 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 111.213 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 -31.86 38.39 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 120.507 -1.371 . . . . 0.0 109.427 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.29 -39.46 39.83 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.411 0.624 . . . . 0.0 111.231 -173.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.97 64.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.198 -0.938 . . . . 0.0 111.734 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -96.6 -0.18 49.03 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.606 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -77.92 -22.84 49.03 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.556 1.525 . . . . 0.0 109.751 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -73.59 -33.02 64.42 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 119.511 -1.993 . . . . 0.0 110.467 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.41 -24.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 124.945 1.298 . . . . 0.0 109.102 -170.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -62.11 -19.06 62.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.428 1.891 . . . . 0.0 110.706 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -65.33 -31.35 72.44 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 120.99 -1.069 . . . . 0.0 110.674 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -72.18 -27.33 62.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 -172.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.43 -49.86 65.31 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.64 -44.26 96.73 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.498 1.519 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.4 -45.16 84.83 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 127.707 2.403 . . . . 0.0 110.533 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -84.96 -27.57 26.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.678 -0.639 . . . . 0.0 109.843 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.39 38.25 33.98 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 t60 . . . . . 0 N--CA 1.445 -0.7 0 C-N-CA 126.074 1.75 . . . . 0.0 114.587 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.416 -2.137 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.98 4.74 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.67 -94.55 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 120.957 -1.089 . . . . 0.0 110.4 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -67.27 -19.53 65.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -75.23 -46.68 32.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 124.853 1.261 . . . . 0.0 108.487 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.399 1.08 . . . . 0.0 109.657 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.2 90.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.856 0.862 . . . . 0.0 111.568 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -69.15 -34.15 74.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.69 0.757 . . . . 0.0 111.028 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.084 -1.01 . . . . 0.0 111.224 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.45 -46.38 73.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.895 0.878 . . . . 0.0 109.199 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.91 -38.41 88.28 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.647 1.213 . . . . 0.0 111.625 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.1 -24.07 60.59 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.953 1.301 . . . . 0.0 110.322 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.1 -41.48 61.6 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 120.259 -1.525 . . . . 0.0 107.847 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -55.79 -46.76 77.9 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.658 1.183 . . . . 0.0 111.552 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -54.87 -37.73 66.62 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.091 0.957 . . . . 0.0 112.236 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -73.86 -32.44 63.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.86 -0.525 . . . . 0.0 110.512 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.3 -35.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.298 -0.876 . . . . 0.0 108.766 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.53 -37.41 87.22 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.065 -1.022 . . . . 0.0 111.279 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.11 -38.83 69.22 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.813 0.845 . . . . 0.0 110.745 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -73.62 -43.65 59.06 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.112 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.43 62.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 121.141 -0.974 . . . . 0.0 111.963 -175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -71.96 -37.46 69.94 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.204 0.911 . . . . 0.0 110.345 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -43.33 99.07 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 125.323 1.449 . . . . 0.0 108.433 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -66.13 -45.96 79.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.629 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.07 77.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.047 1.339 . . . . 0.0 112.746 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.2 -44.45 97.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 121.817 -0.552 . . . . 0.0 109.832 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.69 -28.29 62.6 Favored 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 120.872 -1.143 . . . . 0.0 111.629 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.32 80.31 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.644 1.578 . . . . 0.0 109.24 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -20.11 51.92 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.286 0.565 . . . . 0.0 110.842 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -70.95 72.63 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 125.055 1.342 . . . . 0.0 113.086 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.28 -18.3 1.04 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.82 147.07 61.31 Favored Pre-proline 0 N--CA 1.444 -0.735 0 O-C-N 121.7 -0.882 . . . . 0.0 110.375 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -82.66 129.66 5.71 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.54 2.16 . . . . 0.0 111.405 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 27.43 42.46 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.64 139.17 32.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.268 2.227 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.25 -32.36 2.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.398 0.679 . . . . 0.0 109.226 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -99.44 118.82 36.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.41 -154.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.6 t 75.1 -149.53 0.03 OUTLIER 'General case' 0 C--N 1.358 0.961 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -145.64 -56.18 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 116.309 -1.805 . . . . 0.0 106.295 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.33 -29.26 38.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 125.028 2.831 . . . . 0.0 110.734 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.17 -42.93 93.2 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.068 0.947 . . . . 0.0 110.183 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.28 95.2 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 111.121 -172.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 tt -76.2 -27.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 121.027 0.441 . . . . 0.0 110.843 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -33.62 61.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.385 -1.447 . . . . 0.0 109.696 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -67.76 -34.19 76.31 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.864 0.866 . . . . 0.0 111.413 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.7 p -69.05 -20.76 64.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 119.727 -1.858 . . . . 0.0 111.35 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 -47.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.011 0.924 . . . . 0.0 109.5 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.58 -27.22 65.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.672 1.225 . . . . 0.0 110.933 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -73.98 -32.19 63.33 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.845 -1.16 . . . . 0.0 109.721 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.44 70.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.356 -0.84 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.9 p -93.58 10.89 30.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.446 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p 52.79 26.71 4.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.701 2.001 . . . . 0.0 112.721 174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.11 -41.92 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -61.51 4.62 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 62.94 -85.54 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 128.446 2.698 . . . . 0.0 108.481 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.19 40.97 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.456 ' CG ' HH22 ' C' ' 68' ' ' ARG . 26.4 t70 -71.14 -62.57 1.35 Allowed 'General case' 0 C--N 1.358 0.943 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -141.1 170.81 15.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -131.38 146.13 60.64 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -94.06 158.58 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.043 2.495 . . . . 0.0 108.217 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -79.21 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 42.0 m -156.2 -36.67 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 O-C-N 119.047 -2.283 . . . . 0.0 106.927 -170.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -95.61 11.24 33.92 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.367 -0.833 . . . . 0.0 108.918 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.04 -33.41 61.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 168.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 88.73 1.24 Allowed Glycine 0 N--CA 1.418 -2.566 1 N-CA-C 98.403 -5.879 . . . . 0.0 98.403 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -63.53 -11.77 26.94 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 119.439 1.619 . . . . 0.0 110.935 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -46.55 -26.24 0.85 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.494 2.318 . . . . 0.0 113.821 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -68.56 -40.99 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.698 1.199 . . . . 0.0 108.734 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.49 -45.49 68.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -51.92 -41.66 62.18 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 126.441 1.897 . . . . 0.0 111.758 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.47 -42.56 92.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.914 1.286 . . . . 0.0 111.064 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.13 -38.38 70.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.422 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 42.4 mtt -62.79 -47.85 81.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.862 0.865 . . . . 0.0 110.177 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -61.26 -40.28 93.47 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.609 -0.682 . . . . 0.0 110.772 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.6 -34.8 77.75 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 122.758 0.423 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.97 -52.07 9.61 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.09 -47.01 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 124.39 1.076 . . . . 0.0 109.947 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.9 -38.27 90.4 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.051 -1.03 . . . . 0.0 111.565 -176.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.97 -38.4 49.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 O-C-N 120.642 -1.286 . . . . 0.0 110.906 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.52 -19.85 62.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.787 -0.571 . . . . 0.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.84 -38.19 13.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.655 0.782 . . . . 0.0 110.396 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.85 -35.91 71.58 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.008 1.723 . . . . 0.0 111.408 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.67 -6.98 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.751 0.82 . . . . 0.0 112.606 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -55.04 -24.34 24.34 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.364 1.466 . . . . 0.0 110.414 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.26 74.06 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.357 -1.464 . . . . 0.0 113.155 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.68 -33.16 23.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.868 -1.145 . . . . 0.0 108.33 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 72.4 mt -78.91 -28.4 43.94 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.928 0.891 . . . . 0.0 112.066 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -10.64 59.53 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.058 -1.651 . . . . 0.0 111.337 172.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.44 -36.59 74.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.097 1.317 . . . . 0.0 110.664 -169.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -75.21 -20.71 59.12 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.417 -1.427 . . . . 0.0 112.148 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.55 -33.09 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.234 -1.541 . . . . 0.0 107.596 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -60.88 -19.88 60.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.604 1.561 . . . . 0.0 112.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -55.81 -25.25 40.63 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.557 1.143 . . . . 0.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.95 -27.34 54.78 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.59 -1.319 . . . . 0.0 111.162 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.46 -39.67 45.79 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -57.24 -46.4 83.02 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 127.483 2.313 . . . . 0.0 109.552 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -65.43 -28.82 69.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.228 0.611 . . . . 0.0 112.622 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -87.37 -21.88 25.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.16 -0.962 . . . . 0.0 108.822 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.72 41.25 64.42 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.765 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.7 -84.46 0.11 Allowed 'General case' 0 C--N 1.355 0.846 0 CA-C-N 118.458 0.572 . . . . 0.0 109.503 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -136.43 -72.61 0.45 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -16.46 53.91 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.243 -1.535 . . . . 0.0 109.651 -167.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -65.8 -36.5 83.68 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.204 1.802 . . . . 0.0 111.161 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -81.87 -33.67 30.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -35.42 74.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.461 0.304 . . . . 0.0 110.544 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.85 96.7 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.824 0.85 . . . . 0.0 111.384 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -71.59 -34.61 70.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.075 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -66.04 -36.6 83.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.535 1.134 . . . . 0.0 109.574 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.41 91.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 124.517 1.127 . . . . 0.0 111.445 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -59.63 -38.6 81.79 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.802 0.811 . . . . 0.0 111.287 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -74.04 -27.56 60.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.583 0.753 . . . . 0.0 110.183 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -66.77 -38.21 86.13 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.147 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.86 -38.1 89.51 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.289 -0.882 . . . . 0.0 111.402 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -55.22 -38.68 68.75 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 111.876 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -70.82 -38.91 73.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.171 1.388 . . . . 0.0 109.352 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.9 -28.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 123.872 0.869 . . . . 0.0 108.998 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.09 -39.7 95.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.905 -1.122 . . . . 0.0 111.435 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.24 -46.41 87.03 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.284 -0.885 . . . . 0.0 109.927 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.33 -52.08 67.11 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-O 121.22 0.533 . . . . 0.0 109.615 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.44 -34.74 74.42 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 126.014 1.726 . . . . 0.0 111.454 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.9 m -63.36 -46.59 85.84 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.812 0.845 . . . . 0.0 110.799 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.45 -40.75 73.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.88 -39.81 95.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.821 0.848 . . . . 0.0 110.913 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -47.38 80.91 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.17 1.388 . . . . 0.0 111.466 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.01 -15.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.4 1.095 . . . . 0.0 110.102 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -101.23 -5.1 25.99 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 119.979 -1.701 . . . . 0.0 108.599 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.42 -18.85 18.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 124.808 1.243 . . . . 0.0 110.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.81 -30.89 69.54 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 121.028 -1.045 . . . . 0.0 108.553 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.44 113.96 4.0 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.32 1.848 . . . . 0.0 108.587 -169.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.02 -5.62 72.3 Favored Glycine 0 CA--C 1.498 -0.999 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.09 148.44 34.4 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.57 125.14 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.353 2.035 . . . . 0.0 111.1 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 45.48 3.08 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.83 24.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.897 -0.766 . . . . 0.0 112.195 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.01 -36.6 1.17 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.663 0.744 . . . . 0.0 110.063 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -85.85 37.42 0.71 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 108.675 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.08 -22.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.224 2.21 . . . . 0.0 109.519 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -79.93 121.09 25.01 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.738 0.78 . . . . 0.0 109.252 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.84 -55.93 15.64 Favored Pre-proline 0 C--N 1.351 0.631 0 C-N-CA 126.885 2.074 . . . . 0.0 111.369 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.13 -11.96 23.34 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 CA-C-N 125.769 3.096 . . . . 0.0 111.339 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.33 -26.28 28.6 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 124.827 1.251 . . . . 0.0 108.747 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.47 91.32 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.091 0.956 . . . . 0.0 110.706 -167.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.4 -33.43 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.045 0.938 . . . . 0.0 111.267 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -32.51 48.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.909 -1.119 . . . . 0.0 109.964 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.474 ' CD2' HD12 ' C' ' 38' ' ' LEU . 50.0 t90 -67.04 -37.53 84.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.404 -0.81 . . . . 0.0 110.259 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -60.25 -25.11 65.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.239 -0.913 . . . . 0.0 112.735 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.14 -51.41 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 123.694 0.798 . . . . 0.0 109.437 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.76 40.52 0.9 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.62 1.168 . . . . 0.0 111.181 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 17.6 m -141.68 -56.92 0.47 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.75 73.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.353 -0.842 . . . . 0.0 112.923 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 16.5 p -95.01 23.69 5.42 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p 51.24 78.49 0.11 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.619 1.968 . . . . 0.0 111.871 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 t -122.23 -92.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.6 45.67 9.37 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 111.064 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -43.14 92.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.53 1.157 . . . . 0.0 110.375 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.52 -139.92 7.47 Favored Glycine 0 CA--C 1.483 -1.945 1 N-CA-C 101.645 -4.582 . . . . 0.0 101.645 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.3 34.5 t0 65.2 -71.83 0.08 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 127.27 2.228 . . . . 0.0 111.327 -173.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -124.54 158.9 31.84 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.66 154.13 55.58 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 166.8 27.09 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.203 2.602 . . . . 0.0 110.504 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.2 164.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -62.71 -69.19 0.27 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.337 1.455 . . . . 0.0 114.367 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.75 -72.88 0.06 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.651 1.18 . . . . 0.0 111.484 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -94.58 -39.79 10.18 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.155 -0.965 . . . . 0.0 113.317 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.92 -39.46 25.5 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 120.41 1.459 . . . . 0.0 113.938 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.456 HH22 ' CG ' ' B' ' 59' ' ' ASP . 99.3 mtt180 -74.14 -36.87 64.17 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 117.629 0.714 . . . . 0.0 112.26 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -74.29 -30.07 61.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 121.379 -0.826 . . . . 0.0 110.127 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.0 -40.84 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 O-C-N 121.168 -0.957 . . . . 0.0 109.662 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.36 92.9 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -58.13 -36.01 72.34 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 125.729 1.612 . . . . 0.0 111.395 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -66.04 -52.15 51.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.204 1.001 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 p -73.19 -27.27 23.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 121.576 -0.703 . . . . 0.0 109.636 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 19.5 tpp -58.54 -48.24 81.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 110.335 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -66.21 -36.75 83.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.993 -0.442 . . . . 0.0 110.518 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.26 78.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.366 0.666 . . . . 0.0 111.425 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.45 -40.94 78.85 Favored Glycine 0 CA--C 1.494 -1.266 0 O-C-N 121.664 -0.647 . . . . 0.0 111.546 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 81.2 mt -63.16 -46.57 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -57.26 -47.68 80.8 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.197 0.999 . . . . 0.0 110.774 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.99 -55.04 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.459 1.104 . . . . 0.0 111.086 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -71.61 -33.45 69.0 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 118.551 0.614 . . . . 0.0 110.695 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.33 -30.24 65.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.781 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.75 -12.79 60.82 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.138 -0.976 . . . . 0.0 111.589 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.19 -10.99 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 119.988 -1.695 . . . . 0.0 110.51 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -49.39 -27.24 3.87 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.383 1.873 . . . . 0.0 112.717 170.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.7 -27.16 48.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.499 1.12 . . . . 0.0 112.824 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.67 -51.66 2.79 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 112.063 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.15 -2.25 54.99 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.461 -1.399 . . . . 0.0 109.433 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.25 -11.85 45.39 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -33.8 76.49 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.7 -1.25 . . . . 0.0 109.91 -166.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.51 -12.68 60.54 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.055 -1.028 . . . . 0.0 112.608 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.48 -32.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -69.14 -8.24 43.6 Favored 'General case' 0 C--N 1.359 1.021 0 O-C-N 121.026 -1.046 . . . . 0.0 111.483 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 48.3 ttp85 -64.73 -29.97 70.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -96.04 156.36 16.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.289 37.3 mt-10 69.91 -60.38 0.48 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.283 1.833 . . . . 0.0 112.6 -167.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.03 -17.46 62.25 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 119.123 0.874 . . . . 0.0 110.771 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -53.2 -38.48 62.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 126.391 1.877 . . . . 0.0 112.91 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -82.69 -47.56 11.88 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.09 57.0 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 CA--C 1.501 -0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 110.107 -177.734 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.48 154.73 24.96 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.45 -36.38 78.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 122.388 1.089 . . . . 0.0 110.763 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -71.02 -17.61 62.62 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.09 -1.006 . . . . 0.0 112.061 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -86.92 -38.95 16.22 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -66.82 -37.59 84.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.077 0.951 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -68.23 -36.88 80.19 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.618 -0.676 . . . . 0.0 110.34 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.62 75.4 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.035 0.934 . . . . 0.0 110.188 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -65.06 -35.99 82.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.204 1.402 . . . . 0.0 111.205 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -69.01 -30.42 68.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.849 -1.157 . . . . 0.0 110.742 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.33 75.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.063 -1.023 . . . . 0.0 110.649 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.94 -38.41 90.93 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.737 0.815 . . . . 0.0 110.516 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.58 1.152 . . . . 0.0 110.219 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.65 -41.68 98.19 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.878 0.871 . . . . 0.0 109.086 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 tp -62.97 -37.52 87.43 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.436 0.694 . . . . 0.0 111.503 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.57 -31.48 72.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.223 -0.923 . . . . 0.0 112.285 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -71.39 -35.46 71.05 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.35 -38.89 83.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 109.307 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.8 -42.39 84.14 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.24 1.019 . . . . 0.0 111.323 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.27 -44.11 65.89 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.957 0.903 . . . . 0.0 109.282 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -66.21 -39.05 89.34 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.04 72.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.191 1.396 . . . . 0.0 112.165 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.49 -43.34 73.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.493 0.717 . . . . 0.0 109.807 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -43.86 75.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.778 1.231 . . . . 0.0 108.677 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -63.91 -48.4 76.74 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.699 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.44 70.06 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 119.769 1.168 . . . . 0.0 110.818 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.74 -39.74 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.67 -30.03 59.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.779 -1.826 . . . . 0.0 110.758 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.34 35.27 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.067 0.947 . . . . 0.0 109.752 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -22.56 60.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.507 -0.746 . . . . 0.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -68.9 98.6 0.95 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.028 0.918 . . . . 0.0 111.619 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.24 -4.41 12.42 Favored Glycine 0 CA--C 1.494 -1.251 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.75 146.36 46.25 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 121.629 -0.924 . . . . 0.0 109.088 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -80.5 131.7 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.952 1.768 . . . . 0.0 111.42 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.44 2.91 69.81 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.52 136.65 57.59 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.006 1.722 . . . . 0.0 112.42 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.63 4.31 1.93 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.35 -38.16 20.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.3 tt -5.93 88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 1 C-N-CA 133.248 4.619 . . . . 0.0 114.387 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 33.1 p -162.96 -131.3 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.79 -65.5 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 127.925 2.49 . . . . 0.0 106.051 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.93 -14.03 26.47 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 CA-C-N 125.649 3.053 . . . . 0.0 111.687 -171.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -100.74 -11.36 19.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.66 64.93 Favored 'General case' 0 CA--C 1.504 -0.826 0 O-C-N 120.776 -1.203 . . . . 0.0 109.854 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.25 -7.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 125.178 1.391 . . . . 0.0 109.675 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -81.84 -49.56 10.22 Favored 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 119.423 -2.048 . . . . 0.0 106.081 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -53.24 -41.68 65.66 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.791 1.636 . . . . 0.0 111.115 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.4 p -69.51 -28.84 66.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.696 -1.877 . . . . 0.0 111.683 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.46 -45.66 81.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 C-N-CA 123.699 0.799 . . . . 0.0 109.284 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.9 -9.35 57.57 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.445 -0.784 . . . . 0.0 112.006 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 72.4 m -86.14 -48.45 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 120.697 -1.252 . . . . 0.0 111.082 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.18 62.51 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.662 -1.274 . . . . 0.0 112.007 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -87.8 0.86 55.21 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.879 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 55.18 67.97 0.94 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.875 2.07 . . . . 0.0 110.904 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.83 -98.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.58 102.24 0.46 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 106.58 -2.608 . . . . 0.0 106.58 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -75.73 -33.68 60.3 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.65 39.7 2.32 Favored Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.96 -50.27 30.39 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -130.87 160.95 32.94 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.53 151.78 36.88 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 167.71 26.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.059 2.506 . . . . 0.0 111.275 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.74 -148.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -107.07 -60.35 1.69 Allowed 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.039 1.736 . . . . 0.0 107.573 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -80.13 0.61 31.42 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.352 1.461 . . . . 0.0 111.179 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -64.84 -30.13 71.12 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.845 1.307 . . . . 0.0 108.773 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.26 83.57 1.37 Allowed Glycine 0 CA--C 1.473 -2.557 1 N-CA-C 99.277 -5.529 . . . . 0.0 99.277 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttt85 -60.95 -11.24 7.39 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 122.876 1.322 . . . . 0.0 111.44 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -61.51 -12.92 17.16 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.452 1.101 . . . . 0.0 113.302 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.43 -52.59 58.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.33 97.58 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 123.168 0.587 . . . . 0.0 110.535 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.11 -50.11 38.77 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.946 1.699 . . . . 0.0 111.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.65 -40.08 95.94 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.646 0.779 . . . . 0.0 110.879 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.66 -43.39 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 123.704 0.801 . . . . 0.0 109.579 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.7 mtm -66.91 -42.83 84.77 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 121.806 -0.559 . . . . 0.0 110.621 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -65.58 -35.0 79.55 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.844 -0.535 . . . . 0.0 110.517 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.25 99.13 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.524 0.729 . . . . 0.0 110.494 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.03 81.33 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.1 -46.72 88.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 109.804 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.12 -42.01 94.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.299 -0.876 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.98 -46.94 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.24 -0.913 . . . . 0.0 110.4 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -71.12 -9.0 57.32 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.392 -0.817 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.32 -39.76 8.25 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.199 1.0 . . . . 0.0 109.84 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -52.1 -34.93 46.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 127.133 2.173 . . . . 0.0 110.697 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.45 -8.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 124.372 1.069 . . . . 0.0 113.833 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -68.85 -14.28 62.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 120.113 -1.617 . . . . 0.0 111.832 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.16 -27.56 65.77 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.748 -1.22 . . . . 0.0 111.494 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.88 -37.04 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.458 1.103 . . . . 0.0 109.554 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.32 -37.72 66.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.564 -0.71 . . . . 0.0 112.231 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.73 -21.19 63.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.57 -1.331 . . . . 0.0 111.008 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 10.9 t -96.32 11.19 35.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.842 -1.162 . . . . 0.0 108.765 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.3 -33.65 25.91 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -71.67 -32.68 68.14 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.191 -1.568 . . . . 0.0 112.865 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.8 -11.34 14.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 121.461 -0.774 . . . . 0.0 111.275 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -60.99 -19.73 61.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.033 1.333 . . . . 0.0 112.132 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -6.67 58.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.457 1.026 . . . . 0.0 110.81 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -85.02 153.22 22.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 72.32 -50.07 0.7 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.114 1.765 . . . . 0.0 111.436 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -61.49 -32.86 72.89 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.72 2.008 . . . . 0.0 110.708 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -58.13 -23.9 56.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.284 1.434 . . . . 0.0 113.356 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -92.92 -10.12 37.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.163 -0.96 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.09 74.17 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.364 0.983 . . . . 0.0 113.426 172.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 31.7 m80 . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.36 -94.63 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -132.89 -78.1 0.49 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.411 ' HE1' ' OE2' ' A' ' 5' ' ' GLU . 1.8 p80 -71.52 -15.83 62.31 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 123.572 0.749 . . . . 0.0 111.69 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' OE2' ' HE1' ' A' ' 4' ' ' HIS . 52.5 mp0 -63.88 -36.9 85.45 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.977 1.711 . . . . 0.0 110.137 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -77.15 -24.11 51.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.455 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -74.27 -41.65 60.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.673 1.189 . . . . 0.0 108.185 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.32 96.87 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.17 -34.07 77.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.732 1.213 . . . . 0.0 111.387 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -71.4 -39.14 71.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.371 -0.831 . . . . 0.0 108.904 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.85 78.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.532 0.733 . . . . 0.0 111.648 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -65.3 -28.35 69.26 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.05 -1.031 . . . . 0.0 111.808 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -73.81 -31.96 63.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.794 0.837 . . . . 0.0 110.06 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.04 -38.94 92.52 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 121.469 -0.769 . . . . 0.0 110.743 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.26 -41.67 84.77 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.532 0.733 . . . . 0.0 111.992 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.735 1.214 . . . . 0.0 109.633 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.31 -40.53 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.053 0.941 . . . . 0.0 109.486 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.2 mt -58.74 -40.76 84.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.083 0.953 . . . . 0.0 111.906 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.25 -41.6 73.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.63 1.572 . . . . 0.0 110.066 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -67.32 -52.32 41.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.521 1.529 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.56 -29.88 63.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.484 1.114 . . . . 0.0 111.977 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -63.05 -41.69 99.55 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 119.129 0.877 . . . . 0.0 110.178 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.82 -43.55 71.8 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.872 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -67.34 -18.96 65.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 120.709 -1.244 . . . . 0.0 111.033 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.86 70.57 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.45 0.7 . . . . 0.0 110.289 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.15 -33.15 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.775 0.798 . . . . 0.0 111.768 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -28.92 61.66 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.87 68.1 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.349 1.059 . . . . 0.0 111.263 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.24 -5.95 53.46 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.462 1.105 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -105.64 71.87 0.94 Allowed 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.647 -1.908 . . . . 0.0 108.508 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.45 -42.32 0.33 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.74 157.94 38.86 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 123.206 0.603 . . . . 0.0 109.665 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -80.9 153.07 19.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.221 1.948 . . . . 0.0 111.121 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.33 15.93 31.18 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.207 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 131.46 50.6 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -166.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.65 -46.99 0.24 Allowed 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.554 0.741 . . . . 0.0 110.009 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.82 62.08 6.73 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 123.01 1.386 . . . . 0.0 107.902 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.9 pt -91.46 -1.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.805 -1.81 . . . . 0.0 109.5 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -89.43 127.85 35.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.469 -0.77 . . . . 0.0 110.997 -174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -79.44 -54.64 0.95 Allowed Pre-proline 0 C--N 1.347 0.457 0 CA-C-O 116.196 -1.859 . . . . 0.0 112.73 -172.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -73.54 -12.02 24.59 Favored 'Trans proline' 0 CA--C 1.511 -0.658 0 CA-C-N 126.718 3.435 . . . . 0.0 111.813 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.12 -13.17 48.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.38 89.86 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.298 1.039 . . . . 0.0 111.59 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.92 -33.66 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.643 0.735 . . . . 0.0 109.535 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -24.76 57.74 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 119.92 -1.737 . . . . 0.0 109.572 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -69.52 -46.55 66.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.418 1.087 . . . . 0.0 108.396 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.4 p -67.35 -29.81 69.45 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.822 -1.173 . . . . 0.0 111.819 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -51.94 -50.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 124.447 1.099 . . . . 0.0 110.633 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.01 -0.3 43.64 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.488 -0.757 . . . . 0.0 111.792 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.3 m -91.62 -39.92 11.61 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 121.546 -0.721 . . . . 0.0 109.296 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.83 62.52 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 120.503 -1.373 . . . . 0.0 111.357 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 p -89.35 9.29 26.67 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.473 0.709 . . . . 0.0 110.152 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 51.17 50.03 19.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.422 1.889 . . . . 0.0 112.973 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.68 -77.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.82 95.12 0.11 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.07 -69.91 0.58 Allowed 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.666 -1.49 . . . . 0.0 109.958 -170.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.8 41.57 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.75 -52.74 7.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -134.44 -175.06 3.75 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -143.06 135.78 13.63 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 101.994 -3.336 . . . . 0.0 101.994 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.8 166.2 10.14 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.026 2.484 . . . . 0.0 110.236 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.509 HG23 ' H ' ' A' ' 67' ' ' GLY . 17.5 m -69.41 166.07 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.603 1.192 . . . . 0.0 110.94 173.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 m -78.53 -67.77 0.71 Allowed 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.345 -0.847 . . . . 0.0 109.173 -174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -50.36 -63.5 1.1 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.586 1.555 . . . . 0.0 112.115 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.69 -67.05 0.87 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.324 -0.86 . . . . 0.0 111.412 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.509 ' H ' HG23 ' A' ' 63' ' ' VAL . . . -30.76 -46.22 0.13 Allowed Glycine 0 C--N 1.349 1.293 0 C-N-CA 129.212 3.291 . . . . 0.0 116.114 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -68.19 -51.9 40.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.105 0.952 . . . . 0.0 112.483 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.7 -25.64 68.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 119.419 1.009 . . . . 0.0 110.803 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.88 -50.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.18 85.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.062 1.345 . . . . 0.0 112.129 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -51.63 -39.19 57.61 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.893 1.677 . . . . 0.0 110.846 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -29.58 64.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.08 -43.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.8 mtt -58.62 -52.32 66.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.414 1.485 . . . . 0.0 109.917 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -66.04 -36.95 84.63 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.614 -0.679 . . . . 0.0 110.652 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.41 87.77 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.168 -0.958 . . . . 0.0 111.313 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.86 -48.11 75.44 Favored Glycine 0 CA--C 1.492 -1.349 0 C-N-CA 124.646 1.117 . . . . 0.0 110.903 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -43.76 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.113 0.965 . . . . 0.0 109.257 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -61.43 -39.18 89.86 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 120.438 -1.414 . . . . 0.0 111.97 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.16 -54.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 124.41 1.084 . . . . 0.0 108.928 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.47 -40.87 93.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.82 -0.55 . . . . 0.0 110.913 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -27.15 65.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.394 -0.816 . . . . 0.0 111.522 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.82 -35.67 81.86 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.887 -1.133 . . . . 0.0 110.031 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.8 t -59.65 -14.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 125.524 1.53 . . . . 0.0 111.262 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -55.82 -23.31 29.67 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 120.066 -1.646 . . . . 0.0 111.989 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.9 -31.45 69.82 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 120.82 -1.175 . . . . 0.0 112.33 172.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 -45.44 14.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.688 -1.257 . . . . 0.0 107.789 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -62.77 -40.29 96.82 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.182 0.993 . . . . 0.0 113.297 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.36 -11.3 60.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.129 -0.982 . . . . 0.0 111.519 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 m -82.6 -22.66 34.73 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.022 -1.049 . . . . 0.0 108.384 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -71.08 -24.5 62.33 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 120.698 -1.252 . . . . 0.0 112.86 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -81.03 -25.33 37.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.85 -1.156 . . . . 0.0 111.879 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.78 -28.03 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -70.14 -5.42 26.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 112.05 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -66.57 -31.04 71.49 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.913 -1.117 . . . . 0.0 109.319 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -96.1 173.98 7.14 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -170.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.252 33.1 mt-10 74.08 -65.0 0.37 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 126.301 1.84 . . . . 0.0 109.44 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.02 -8.31 48.11 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.627 1.171 . . . . 0.0 111.872 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -71.82 -35.53 69.95 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.315 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -93.91 -26.68 16.77 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.22 -6.46 68.77 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 175.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.88 161.32 39.61 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.133 0.968 . . . . 0.0 108.752 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.25 -29.85 68.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 126.693 1.997 . . . . 0.0 111.439 -170.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -72.8 -32.26 65.42 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.92 -33.95 66.3 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.734 0.814 . . . . 0.0 109.026 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -58.29 -45.28 88.25 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.324 1.05 . . . . 0.0 110.582 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.22 -45.84 79.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.82 1.248 . . . . 0.0 109.051 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.5 92.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 111.567 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.84 -37.1 76.06 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.643 0.777 . . . . 0.0 109.617 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.02 -33.38 75.6 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.784 -1.198 . . . . 0.0 110.251 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.74 75.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.329 -0.857 . . . . 0.0 111.373 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.43 -31.99 73.43 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.844 0.858 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -67.99 -41.22 82.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 121.562 -0.711 . . . . 0.0 109.781 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -66.21 -28.46 68.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.593 -0.692 . . . . 0.0 111.277 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 118.42 0.554 . . . . 0.0 110.738 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -62.32 -36.11 81.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 110.683 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.37 -37.79 86.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.754 0.821 . . . . 0.0 110.741 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.43 -40.19 88.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 121.071 -1.018 . . . . 0.0 109.036 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.93 -42.96 85.92 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 123.634 0.774 . . . . 0.0 111.359 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.77 -46.17 83.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.015 1.326 . . . . 0.0 109.949 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -68.48 -41.95 79.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 122.046 -0.409 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -29.64 69.79 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.726 1.21 . . . . 0.0 111.601 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -61.58 -43.23 99.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.145 0.978 . . . . 0.0 109.491 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -38.57 81.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.486 1.114 . . . . 0.0 108.822 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.22 -54.01 40.28 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.108 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.03 75.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.005 1.322 . . . . 0.0 112.915 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.15 -28.18 39.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 120.683 -1.26 . . . . 0.0 113.041 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.63 -34.76 18.37 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -49.46 67.7 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.697 1.599 . . . . 0.0 110.268 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.36 -26.85 66.68 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 112.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 119.614 -1.929 . . . . 0.0 110.801 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.05 -15.14 6.53 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.63 145.33 41.58 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 118.071 0.935 . . . . 0.0 109.801 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.78 135.53 11.46 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 110.136 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 14.41 76.91 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.38 145.49 55.97 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.12 0.968 . . . . 0.0 110.605 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.89 -37.98 0.9 Allowed 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 108.943 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 tp -88.84 129.98 35.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -150.26 -179.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 t 76.23 127.21 0.04 OUTLIER 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.226 1.41 . . . . 0.0 109.502 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -65.13 -46.53 73.1 Favored Pre-proline 0 C--N 1.35 0.623 0 CA-C-O 116.921 -1.514 . . . . 0.0 111.611 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 -10.54 25.15 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 124.953 2.805 . . . . 0.0 112.608 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.02 -39.13 15.93 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.47 84.11 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 123.416 0.686 . . . . 0.0 112.581 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -68.79 -29.19 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 O-C-N 122.03 -0.419 . . . . 0.0 110.08 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -38.22 70.41 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.755 -1.216 . . . . 0.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.09 -38.29 82.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.679 0.752 . . . . 0.0 109.368 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -59.27 -47.77 84.11 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.013 1.325 . . . . 0.0 110.191 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -54.51 -52.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 125.486 1.514 . . . . 0.0 111.099 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.96 -24.46 63.34 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 121.349 -0.844 . . . . 0.0 111.836 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -76.03 -33.59 59.64 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 123.897 0.879 . . . . 0.0 109.393 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.23 -24.61 65.84 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.964 -1.085 . . . . 0.0 111.693 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -92.92 10.41 31.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.542 0.737 . . . . 0.0 111.499 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 p 51.23 53.86 12.18 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 125.675 1.59 . . . . 0.0 112.838 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.56 -87.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.92 74.61 1.2 Allowed Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.53 -21.64 60.33 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 120.781 -1.423 . . . . 0.0 109.756 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.62 40.84 1.82 Allowed Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.26 -29.51 26.39 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 120.884 -1.362 . . . . 0.0 111.25 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -144.41 166.89 23.84 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -143.03 115.14 5.94 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.67 161.16 16.6 Favored 'Trans proline' 0 CA--C 1.512 -0.617 0 C-N-CA 122.527 2.151 . . . . 0.0 110.15 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.424 HG11 ' H ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -106.05 -159.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.742 1.258 . . . . 0.0 110.769 -173.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.424 ' H ' HG11 ' B' ' 63' ' ' VAL . 1.9 m -86.7 -36.22 18.83 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 119.734 -1.853 . . . . 0.0 110.612 -165.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.63 -15.87 41.07 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.486 1.114 . . . . 0.0 109.499 -167.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -28.77 69.91 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 123.478 1.609 . . . . 0.0 107.417 172.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.17 82.39 1.25 Allowed Glycine 0 CA--C 1.464 -3.152 1 N-CA-C 99.974 -5.25 . . . . 0.0 99.974 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm105 -66.97 3.93 0.98 Allowed 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.643 1.222 . . . . 0.0 112.999 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.14 -12.9 56.02 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 120.987 -1.071 . . . . 0.0 111.895 160.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -50.18 79.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.63 92.79 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.01 0.924 . . . . 0.0 111.701 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -53.95 -42.04 68.43 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.157 1.383 . . . . 0.0 110.623 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -63.76 -40.45 96.74 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.755 -0.591 . . . . 0.0 110.851 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.42 -49.02 80.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.018 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -69.92 -40.86 75.3 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 121.949 -0.469 . . . . 0.0 110.516 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -64.65 -41.59 96.02 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.324 -0.86 . . . . 0.0 109.725 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.94 85.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 122.028 -0.42 . . . . 0.0 111.388 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.34 -47.65 77.4 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.76 -45.18 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.778 1.231 . . . . 0.0 109.006 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.61 -44.21 80.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.112 -0.993 . . . . 0.0 111.357 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.86 -52.49 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.071 0.949 . . . . 0.0 109.599 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -72.19 -18.19 61.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.924 0.489 . . . . 0.0 111.492 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.78 -31.54 16.48 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.08 -31.85 73.19 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 120.38 -1.45 . . . . 0.0 110.018 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.48 -11.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 123.378 0.671 . . . . 0.0 112.098 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 22.8 m -60.35 -15.79 29.06 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.95 1.3 . . . . 0.0 111.426 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.53 -50.55 69.69 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.215 166.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.37 92.63 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 124.609 1.164 . . . . 0.0 110.272 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.03 -39.97 95.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 120.873 -1.142 . . . . 0.0 111.071 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 -15.74 60.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.677 -0.639 . . . . 0.0 110.701 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.4 m -83.25 -32.94 26.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 121.0 -1.062 . . . . 0.0 108.167 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.08 -11.45 59.99 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 111.801 -156.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -72.77 -31.93 65.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 121.387 -0.821 . . . . 0.0 110.299 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 t -74.08 -24.32 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.475 1.51 . . . . 0.0 109.047 -170.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -51.36 -31.91 23.85 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 124.851 1.26 . . . . 0.0 110.184 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -53.93 -31.8 51.5 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.98 1.312 . . . . 0.0 112.56 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -78.24 -19.56 53.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 120.806 -1.184 . . . . 0.0 111.283 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.92 -55.15 3.74 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 165.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -68.43 -34.32 75.78 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.226 2.21 . . . . 0.0 114.853 -163.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 27.4 ttm105 -57.31 -38.65 74.34 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 120.369 1.44 . . . . 0.0 110.969 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -103.85 3.48 33.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.966 0.907 . . . . 0.0 108.813 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.6 12.68 64.54 Favored Glycine 0 C--N 1.347 1.175 0 C-N-CA 124.981 1.277 . . . . 0.0 112.524 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 CA--C 1.496 -1.132 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.112 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.428 -1.548 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.6 128.0 46.12 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.974 0.892 . . . . 0.0 110.438 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -75.15 -26.9 59.47 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.189 0.995 . . . . 0.0 109.242 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.493 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 5.1 p-80 -67.3 -29.57 69.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.477 -0.764 . . . . 0.0 110.928 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.05 -37.6 46.42 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -57.32 -43.81 83.65 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.693 0.797 . . . . 0.0 111.941 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.57 -24.42 53.53 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.624 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.1 93.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.917 -1.114 . . . . 0.0 110.209 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -65.05 -37.11 86.5 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.659 -0.651 . . . . 0.0 111.225 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -62.44 -35.65 79.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.791 1.236 . . . . 0.0 110.261 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.96 82.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.783 0.833 . . . . 0.0 111.482 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -60.97 -37.79 83.65 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -63.38 -39.48 94.63 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.913 0.885 . . . . 0.0 110.018 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -67.69 -35.9 79.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.005 0.922 . . . . 0.0 109.469 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.7 tp -65.4 -37.76 87.95 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.229 1.014 . . . . 0.0 110.624 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.74 -21.67 61.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.879 -1.138 . . . . 0.0 111.635 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -69.81 -47.2 63.71 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.554 0.742 . . . . 0.0 109.624 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.45 -25.63 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.381 -0.824 . . . . 0.0 110.43 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.84 -40.66 98.14 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.405 0.682 . . . . 0.0 111.059 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.91 -47.11 86.41 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.392 0.997 . . . . 0.0 110.229 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -58.86 -55.11 39.38 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.33 83.24 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 125.964 1.706 . . . . 0.0 112.014 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 60.7 m -54.57 -51.2 65.99 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 124.367 1.067 . . . . 0.0 110.066 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -82.63 -35.66 26.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 121.905 -0.497 . . . . 0.0 110.566 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -63.57 -35.12 79.44 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.815 -1.178 . . . . 0.0 109.986 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.53 72.62 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.404 1.081 . . . . 0.0 111.887 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -34.92 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.688 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.42 -18.98 25.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.181 -0.949 . . . . 0.0 108.638 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -28.24 60.99 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.46 -0.775 . . . . 0.0 111.04 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -33.97 57.22 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -70.65 89.73 0.74 Allowed 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 125.972 1.709 . . . . 0.0 110.591 -167.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.24 2.03 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.61 155.11 56.54 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 153.94 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.119 1.879 . . . . 0.0 109.383 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.91 30.63 57.32 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -36.0 141.44 0.1 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 129.057 2.943 . . . . 0.0 113.493 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -115.51 0.17 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -164.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 153.49 36.9 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 19.0 pt -136.23 -158.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -62.21 -169.8 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.508 2.723 . . . . 0.0 111.482 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 81.38 -178.23 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.54 9.24 1.94 Allowed 'Trans proline' 0 CA--C 1.517 -0.35 0 CA-C-N 125.645 3.052 . . . . 0.0 112.262 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.68 -35.81 60.26 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.169 0.988 . . . . 0.0 109.061 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.33 -47.56 72.36 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 125.503 1.521 . . . . 0.0 112.727 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tt -74.92 -26.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.142 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -39.57 82.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.056 -1.028 . . . . 0.0 110.093 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -71.57 -35.45 70.58 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 118.661 0.664 . . . . 0.0 110.191 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -59.59 -39.21 83.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.823 -1.173 . . . . 0.0 110.048 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.04 68.43 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.019 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.455 ' HB3' HH12 ' D' ' 68' ' ' ARG . 21.4 pt-20 -164.05 -39.48 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -66.28 -41.03 90.41 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.104 0.962 . . . . 0.0 110.653 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -24.0 63.69 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 120.929 -1.107 . . . . 0.0 112.358 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.96 -1.2 57.39 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 121.448 -0.783 . . . . 0.0 109.483 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.8 p 52.25 49.43 20.56 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.302 1.841 . . . . 0.0 112.307 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.42 82.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.54 98.33 1.99 Allowed Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -79.28 -21.36 46.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.309 1.052 . . . . 0.0 108.307 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.91 39.76 1.14 Allowed Glycine 0 CA--C 1.483 -1.951 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.43 ' HB2' HH21 ' D' ' 68' ' ' ARG . 40.7 t0 -84.74 -50.34 7.69 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -131.92 -155.82 0.71 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 107.509 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.99 153.37 15.44 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 101.692 -3.447 . . . . 0.0 101.692 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -89.71 -177.36 1.41 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 123.392 2.728 . . . . 0.0 108.73 169.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.39 -167.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 119.81 1.186 . . . . 0.0 108.813 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.46 -56.46 2.18 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.158 0.983 . . . . 0.0 109.806 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.65 -41.33 77.02 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.258 -0.902 . . . . 0.0 112.313 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.52 -138.45 0.19 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 100.686 -3.82 . . . . 0.0 100.686 162.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.21 -73.35 1.09 Allowed Glycine 0 CA--C 1.492 -1.381 0 CA-C-N 120.454 1.479 . . . . 0.0 109.447 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -32.42 68.09 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.343 1.457 . . . . 0.0 110.295 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -69.97 -33.45 72.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.8 t -73.42 -47.49 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.89 76.6 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.453 1.501 . . . . 0.0 112.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -48.07 -47.05 34.18 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 126.979 2.112 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.7 -33.13 75.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.012 1.325 . . . . 0.0 110.735 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.65 -42.25 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.347 1.059 . . . . 0.0 109.416 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -60.18 -45.12 94.22 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.691 -0.63 . . . . 0.0 109.943 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -55.01 -50.09 69.89 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.316 1.446 . . . . 0.0 110.98 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -32.17 72.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.473 1.109 . . . . 0.0 110.835 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.72 -47.96 18.78 Favored Glycine 0 CA--C 1.491 -1.435 0 O-C-N 121.779 -0.576 . . . . 0.0 111.784 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.7 -41.14 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 122.068 -0.666 . . . . 0.0 110.084 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.68 -29.81 68.35 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 120.505 -1.372 . . . . 0.0 112.089 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.36 -49.17 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -73.49 -12.71 60.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.52 -0.737 . . . . 0.0 111.201 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.85 -53.94 7.24 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -50.88 -42.14 58.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.452 2.301 . . . . 0.0 112.939 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 m -60.51 -19.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 112.248 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 4.9 m -69.29 -13.39 62.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.919 -1.113 . . . . 0.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.92 68.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.805 -1.81 . . . . 0.0 111.075 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.493 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -74.76 -47.16 32.6 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.725 -1.234 . . . . 0.0 108.661 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.44 -31.18 66.91 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.13 0.972 . . . . 0.0 110.777 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.799 -1.188 . . . . 0.0 111.562 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 10.3 t -94.31 1.39 55.93 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.838 -1.163 . . . . 0.0 108.865 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -26.8 58.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 120.341 1.428 . . . . 0.0 110.055 -176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -69.9 -38.9 76.46 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.716 -1.24 . . . . 0.0 109.521 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.09 -25.0 37.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 125.533 1.533 . . . . 0.0 110.643 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -57.08 -24.6 55.12 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.114 1.366 . . . . 0.0 112.678 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -58.31 -31.82 67.88 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 121.138 -0.976 . . . . 0.0 111.628 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -77.33 -15.28 59.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.756 -0.59 . . . . 0.0 109.821 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -85.86 -42.88 13.73 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.76 -37.32 86.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -74.98 -14.96 60.68 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.73 -1.231 . . . . 0.0 112.428 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -89.39 -25.15 21.7 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.021 -1.049 . . . . 0.0 108.956 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.24 32.23 48.91 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 73.4 m80 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -178.524 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.35 68.92 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 122.607 0.363 . . . . 0.0 111.911 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -173.71 -120.8 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.056 1 N-CA-C 99.641 -4.207 . . . . 0.0 99.641 -157.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.587 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 28.4 p-80 -53.17 -21.58 5.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 129.052 2.941 . . . . 0.0 114.521 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.8 -31.72 71.09 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.857 0.863 . . . . 0.0 111.007 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -68.67 -43.22 76.62 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.946 -1.096 . . . . 0.0 109.951 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.5 -32.05 69.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.86 -46.56 90.09 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.562 0.745 . . . . 0.0 111.457 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.62 -31.98 73.02 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 121.645 -0.659 . . . . 0.0 111.778 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -69.78 -35.65 75.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.479 -0.763 . . . . 0.0 109.438 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.91 82.27 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.941 -1.099 . . . . 0.0 111.353 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.8 -20.79 62.54 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.784 -1.198 . . . . 0.0 112.064 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.16 -39.28 63.36 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.031 1.332 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -64.38 -34.83 79.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.254 1.822 . . . . 0.0 110.257 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.94 -41.29 91.51 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 121.895 -0.503 . . . . 0.0 110.311 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.44 -32.75 74.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.308 0.643 . . . . 0.0 110.924 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -64.65 -42.68 95.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.237 1.415 . . . . 0.0 110.904 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.0 -25.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 O-C-N 121.079 -1.013 . . . . 0.0 110.568 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -60.57 -47.98 83.79 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-N 119.361 0.982 . . . . 0.0 109.771 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -61.61 -46.52 89.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.556 0.742 . . . . 0.0 111.137 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -74.39 -34.74 63.4 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.442 -0.786 . . . . 0.0 109.402 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.84 73.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 120.314 -1.491 . . . . 0.0 111.923 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -61.9 -41.75 98.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.413 1.085 . . . . 0.0 110.926 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -69.14 -38.16 78.67 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.56 -53.89 44.63 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.733 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -47.74 74.27 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.181 1.392 . . . . 0.0 112.549 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.468 HG21 HH21 ' D' ' 31' ' ' ARG . 11.2 p -71.13 -26.29 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 120.527 -1.358 . . . . 0.0 111.523 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -89.96 -28.09 19.37 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 109.02 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.92 -55.68 7.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.17 2.588 . . . . 0.0 108.797 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.41 -26.1 68.3 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.95 1.3 . . . . 0.0 111.527 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . 0.468 HH21 HG21 ' D' ' 27' ' ' VAL . 6.8 tpp180 -69.01 104.85 2.22 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 120.035 -1.666 . . . . 0.0 109.876 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.04 -7.8 29.2 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.0 140.26 29.08 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.26 134.46 5.89 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.308 2.005 . . . . 0.0 110.634 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.86 0.46 66.33 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.16 115.48 6.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.976 1.71 . . . . 0.0 108.518 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.49 -26.89 13.96 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.23 104.18 16.14 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -148.14 70.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 120.218 -1.551 . . . . 0.0 109.333 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -167.61 157.61 10.59 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -77.18 -50.99 2.11 Favored Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 115.774 -2.06 . . . . 0.0 110.84 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.01 -15.96 36.35 Favored 'Trans proline' 0 CA--C 1.512 -0.575 0 CA-C-N 126.063 3.201 . . . . 0.0 111.396 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -82.26 -36.61 26.94 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.43 90.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.034 0.933 . . . . 0.0 111.999 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tp -72.85 -21.45 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.503 1.144 . . . . 0.0 109.906 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -40.1 25.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 120.266 -1.521 . . . . 0.0 109.311 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -65.0 -35.99 82.98 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.931 1.292 . . . . 0.0 110.64 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -86.27 62.14 7.25 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 120.29 -1.506 . . . . 0.0 109.51 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.84 -61.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -30.17 69.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.236 0.925 . . . . 0.0 110.62 -167.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -57.12 -35.31 69.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 125.617 1.567 . . . . 0.0 111.077 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.15 -25.26 55.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 119.869 -1.769 . . . . 0.0 110.697 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.67 -0.75 39.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.443 1.497 . . . . 0.0 108.404 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.265 4.1 p 60.72 47.95 7.59 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.007 2.123 . . . . 0.0 111.437 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.2 152.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 99.035 -4.432 . . . . 0.0 99.035 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.6 110.08 0.51 Allowed Glycine 0 CA--C 1.472 -2.645 1 N-CA-C 99.61 -5.396 . . . . 0.0 99.61 176.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -37.78 64.1 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 45.83 0.21 Allowed Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 168.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.9 -48.95 50.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 117.3 0.55 . . . . 0.0 110.463 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -137.7 177.45 7.86 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -149.05 140.65 14.45 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.95 -175.36 2.63 Favored 'Trans proline' 0 CA--C 1.516 -0.382 0 C-N-CA 124.627 3.552 . . . . 0.0 110.311 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.78 -157.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.8 p -77.46 -49.93 13.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 127.618 2.367 . . . . 0.0 109.368 -171.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -85.67 -13.95 46.98 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.846 1.258 . . . . 0.0 111.193 -162.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -22.15 62.75 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.443 1.592 . . . . 0.0 107.484 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.27 54.03 2.51 Favored Glycine 0 CA--C 1.464 -3.104 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.455 HH12 ' HB3' ' C' ' 50' ' ' GLU . 62.0 ttt-85 -20.53 -28.13 0.0 OUTLIER 'General case' 0 C--N 1.368 1.386 1 C-N-CA 134.509 5.124 . . . . 0.0 117.392 -175.349 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -61.98 2.04 0.25 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.584 1.954 . . . . 0.0 113.263 166.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -70.96 -47.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 168.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.687 0.795 . . . . 0.0 110.516 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.57 -44.52 69.4 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 124.658 1.183 . . . . 0.0 111.036 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -61.52 -44.5 96.95 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.61 -44.91 82.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 121.76 -0.588 . . . . 0.0 109.774 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.6 mtm -61.92 -47.69 83.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.84 -31.63 68.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.076 -1.015 . . . . 0.0 111.355 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.28 81.32 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.154 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.63 96.62 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 123.551 0.596 . . . . 0.0 111.748 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -57.9 -49.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.789 0 C-N-CA 124.22 1.008 . . . . 0.0 109.599 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.94 -45.34 71.21 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.019 1.328 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.77 -57.0 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 124.695 1.198 . . . . 0.0 109.384 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -68.17 -34.74 76.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 121.64 -0.663 . . . . 0.0 110.669 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.73 78.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 110.637 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.94 -36.09 82.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.866 -1.146 . . . . 0.0 110.474 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.58 -10.86 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.042 1.337 . . . . 0.0 110.947 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -58.65 -21.12 53.19 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.665 -1.897 . . . . 0.0 111.015 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.33 68.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 120.314 -1.491 . . . . 0.0 112.525 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.587 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.11 -47.86 22.86 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.22 -32.62 74.15 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.883 0.849 . . . . 0.0 112.022 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.93 -11.84 60.97 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.323 -1.486 . . . . 0.0 111.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 62.6 p -82.93 -19.06 37.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 120.391 -1.443 . . . . 0.0 109.748 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.05 -34.19 77.16 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.987 0.812 . . . . 0.0 111.14 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -77.88 -18.1 56.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.626 -1.296 . . . . 0.0 111.479 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -81.45 -30.08 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -57.13 -23.53 47.82 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 124.909 1.284 . . . . 0.0 111.213 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -59.86 -25.95 65.46 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.242 1.017 . . . . 0.0 112.178 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -75.14 -22.06 58.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 120.83 -1.169 . . . . 0.0 110.509 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -88.65 -26.24 21.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.373 -0.829 . . . . 0.0 109.793 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.25 -43.9 96.72 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.452 -0.78 . . . . 0.0 110.1 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -70.16 -19.14 63.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.872 -0.518 . . . . 0.0 112.356 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -73.38 -47.56 41.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.44 41.78 5.04 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 106.749 -2.541 . . . . 0.0 106.749 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 t60 . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 159.87 25.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 120.82 -1.175 . . . . 0.0 108.896 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 4' ' ' HIS . 6.9 p-10 -66.24 -43.35 86.83 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.961 1.704 . . . . 0.0 108.815 -175.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' OD2' ' A' ' 3' ' ' ASP . 57.0 m170 -69.7 -31.07 68.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.355 -0.841 . . . . 0.0 111.75 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.39 -43.58 60.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -66.09 -44.59 83.97 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.081 0.952 . . . . 0.0 110.243 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -66.57 -36.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.901 0.858 . . . . 0.0 110.771 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.84 -43.49 79.41 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 121.162 -0.961 . . . . 0.0 110.367 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -69.83 -31.22 68.97 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.1 0.56 . . . . 0.0 110.348 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -59.45 -40.84 88.14 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.743 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.73 -33.84 75.67 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.715 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.47 -34.24 77.32 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.571 -0.706 . . . . 0.0 111.504 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -60.78 -45.99 92.22 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.133 0.973 . . . . 0.0 109.854 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.53 -34.33 77.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.265 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.78 -35.23 77.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.385 -0.822 . . . . 0.0 111.1 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.13 -36.03 66.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 121.508 -0.745 . . . . 0.0 110.537 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.74 -45.56 93.8 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.498 1.119 . . . . 0.0 110.987 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.04 -20.19 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 O-C-N 121.254 -0.904 . . . . 0.0 111.238 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.29 -41.66 96.77 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 119.435 1.016 . . . . 0.0 110.194 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.68 -26.52 59.9 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.378 1.071 . . . . 0.0 110.328 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -79.52 -41.41 27.4 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.483 -1.386 . . . . 0.0 108.51 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.55 69.93 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.102 1.361 . . . . 0.0 111.903 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.1 p -66.24 -50.54 63.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 119.224 0.92 . . . . 0.0 109.563 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 28' ' ' GLU . 4.8 tmtm? -63.31 -47.15 83.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.363 1.865 . . . . 0.0 109.044 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.5 -32.61 71.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.313 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.21 50.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 119.942 1.247 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.19 -38.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 121.759 0.79 . . . . 0.0 109.58 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 24' ' ' LYS . 39.9 tt0 -71.24 -33.74 70.13 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.966 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.19 94.59 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.504 1.122 . . . . 0.0 111.169 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 37' ' ' ALA . 6.3 pt-20 -82.93 -14.0 54.97 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.933 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -74.11 73.84 1.74 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.055 0.931 . . . . 0.0 111.049 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.73 23.92 0.69 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.274 -1.931 . . . . 0.0 108.274 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.49 142.58 43.45 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -77.86 121.63 5.52 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.936 2.424 . . . . 0.0 110.662 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.23 22.9 6.28 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.58 149.77 20.66 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 126.119 1.768 . . . . 0.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' H ' ' CD ' ' A' ' 30' ' ' GLU . . . -137.77 -65.81 0.51 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.244 0.618 . . . . 0.0 111.706 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.56 55.91 3.38 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.591 1.186 . . . . 0.0 108.703 -171.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 tt -72.96 -13.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 125.979 1.712 . . . . 0.0 111.016 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.3 m -90.9 126.92 36.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.95 -51.21 80.98 Favored Pre-proline 0 C--N 1.349 0.558 0 CA-C-O 116.219 -1.848 . . . . 0.0 113.939 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.64 -8.83 23.13 Favored 'Trans proline' 0 CA--C 1.514 -0.482 0 CA-C-N 126.003 3.18 . . . . 0.0 111.932 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.68 -35.38 14.22 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.579 1.152 . . . . 0.0 108.136 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.29 88.14 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.618 1.567 . . . . 0.0 110.651 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.33 -29.78 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.784 -0.573 . . . . 0.0 111.941 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -27.39 56.91 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.937 -1.102 . . . . 0.0 109.75 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -72.18 -38.85 69.01 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -55.41 -35.38 65.3 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.67 -0.644 . . . . 0.0 111.964 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.42 -39.09 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 110.261 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -80.28 -15.96 55.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.378 -0.826 . . . . 0.0 112.268 -168.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -97.2 -31.06 12.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 110.267 -173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -23.04 62.39 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.04 -1.038 . . . . 0.0 111.701 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -84.35 -2.75 57.59 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.424 1.09 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 53.27 65.37 1.54 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 126.067 1.747 . . . . 0.0 112.18 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.47 -84.41 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.75 76.85 1.27 Allowed Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.95 -49.14 16.19 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.1 -122.56 1.18 Allowed Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 104.053 -3.619 . . . . 0.0 104.053 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.513 ' CB ' HH12 ' B' ' 68' ' ' ARG 0.287 8.8 t0 62.95 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.428 1.891 . . . . 0.0 111.211 -169.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.79 -176.95 3.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -156.13 147.12 16.46 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.24 177.55 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.268 2.646 . . . . 0.0 110.199 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.81 170.57 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.27 1.428 . . . . 0.0 107.92 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -62.31 1.69 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.122 2.169 . . . . 0.0 112.47 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.7 -40.9 80.56 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.093 0.957 . . . . 0.0 112.451 -165.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.96 -108.75 0.34 Allowed 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.53 -83.01 0.0 OUTLIER Glycine 0 C--N 1.358 1.79 0 C-N-CA 128.239 2.828 . . . . 0.0 114.53 171.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.453 HH12 ' CD ' ' D' ' 50' ' ' GLU . 57.5 ttm-85 -54.79 -44.16 73.49 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.046 2.538 . . . . 0.0 112.439 174.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.98 -30.05 63.51 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.214 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.82 -45.1 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.49 78.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.837 2.055 . . . . 0.0 112.041 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -51.7 -44.44 63.17 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 109.736 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -72.33 -30.27 64.59 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.15 -47.89 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.62 -37.28 82.27 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.97 -38.11 87.3 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.505 -0.747 . . . . 0.0 111.08 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.45 -28.21 69.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.655 0.782 . . . . 0.0 111.385 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.52 -42.59 11.38 Favored Glycine 0 CA--C 1.49 -1.484 0 C-N-CA 124.709 1.147 . . . . 0.0 110.722 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.7 -47.84 81.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.678 1.191 . . . . 0.0 109.198 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -69.16 -25.71 64.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.317 -0.865 . . . . 0.0 111.916 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.47 -51.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.178 -0.951 . . . . 0.0 108.526 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.25 -26.03 66.37 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.48 -0.762 . . . . 0.0 111.231 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.57 48.59 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.023 0.929 . . . . 0.0 110.506 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.75 -39.12 87.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 124.803 1.241 . . . . 0.0 111.246 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.72 -6.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 121.366 -0.834 . . . . 0.0 112.679 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -60.31 -20.29 58.63 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.815 1.246 . . . . 0.0 110.682 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.11 78.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.345 -1.472 . . . . 0.0 112.688 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.18 -45.38 60.61 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.39 -37.63 88.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.562 0.745 . . . . 0.0 110.99 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.41 97.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.867 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -15.99 41.03 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.68 -1.263 . . . . 0.0 113.191 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.96 -17.1 60.6 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 111.853 -172.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -77.94 -24.71 48.12 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.239 -1.538 . . . . 0.0 110.734 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.72 -39.57 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -61.86 -20.89 64.18 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.18 1.392 . . . . 0.0 112.414 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttp85 -58.81 -22.35 58.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 125.005 1.322 . . . . 0.0 111.896 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -67.14 -29.0 68.6 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.07 -1.644 . . . . 0.0 111.5 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -73.3 -36.37 66.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.303 -0.873 . . . . 0.0 109.621 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -68.56 -29.17 67.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.124 1.37 . . . . 0.0 110.095 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -73.54 -33.69 64.84 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.028 1.331 . . . . 0.0 110.434 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -75.96 -36.22 59.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.532 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.67 38.05 8.35 Favored Glycine 0 CA--C 1.493 -1.307 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.582 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.44 135.16 34.95 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -30.38 71.47 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.184 0.992 . . . . 0.0 111.175 -174.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.468 ' CE1' ' OE1' ' B' ' 5' ' ' GLU . 7.7 p80 -59.91 -28.6 67.73 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.451 1.1 . . . . 0.0 112.413 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.468 ' OE1' ' CE1' ' B' ' 4' ' ' HIS . 9.3 tp10 -80.5 -34.61 35.59 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -167.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -71.34 -37.2 71.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.169 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -60.7 -43.07 98.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.931 1.692 . . . . 0.0 110.076 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.8 -45.42 82.42 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.351 1.06 . . . . 0.0 110.994 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.04 -37.43 87.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.436 1.094 . . . . 0.0 110.996 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.51 -33.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.382 1.473 . . . . 0.0 110.917 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.72 -37.93 79.84 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.663 -1.273 . . . . 0.0 110.072 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.17 -30.45 71.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.65 -38.39 90.12 Favored 'General case' 0 C--N 1.357 0.906 0 O-C-N 121.223 -0.923 . . . . 0.0 110.865 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -67.74 -36.25 80.22 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 121.627 -0.67 . . . . 0.0 109.795 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -61.61 -40.55 95.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.628 -0.67 . . . . 0.0 110.669 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.21 -27.24 67.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.361 -0.837 . . . . 0.0 111.989 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.63 -39.64 73.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.79 -38.9 83.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 124.426 1.09 . . . . 0.0 109.421 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -42.11 76.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.236 1.014 . . . . 0.0 112.301 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.86 -43.88 67.54 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.46 -33.17 73.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.101 -1.0 . . . . 0.0 111.394 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.73 -32.69 72.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.049 1.339 . . . . 0.0 110.993 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.0 p -66.83 -41.98 86.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -64.63 -45.37 87.13 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.98 1.312 . . . . 0.0 108.646 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -60.82 -58.16 9.63 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 109.807 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.72 79.9 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.824 1.249 . . . . 0.0 112.858 -172.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.57 -49.57 81.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 CA-C-N 118.814 0.734 . . . . 0.0 109.495 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -76.27 -25.11 54.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.504 0.669 . . . . 0.0 109.644 -170.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 125.544 1.538 . . . . 0.0 110.159 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.18 -12.66 60.13 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.025 -1.047 . . . . 0.0 113.128 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.83 77.68 1.6 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.557 -1.339 . . . . 0.0 110.986 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.04 -19.62 1.58 Allowed Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.41 140.95 45.2 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 121.248 -1.148 . . . . 0.0 109.911 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.62 151.25 25.15 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 122.11 1.873 . . . . 0.0 109.131 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 16.37 79.07 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 119.179 0.899 . . . . 0.0 112.19 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.53 142.93 57.72 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.355 1.862 . . . . 0.0 110.61 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.72 -25.12 0.32 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.324 0.583 . . . . 0.0 110.702 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.25 -38.14 66.09 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.535 1.534 . . . . 0.0 108.512 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -37.85 115.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 130.169 3.388 . . . . 0.0 111.854 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 47.1 t -177.88 -152.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 99.975 -4.083 . . . . 0.0 99.975 -168.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.26 -56.62 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -69.73 -31.3 20.93 Favored 'Trans proline' 0 CA--C 1.503 -1.034 0 CA-C-N 124.416 2.613 . . . . 0.0 111.404 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -107.77 14.51 25.44 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 119.757 1.162 . . . . 0.0 110.148 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.22 -35.37 73.84 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.404 -0.81 . . . . 0.0 109.336 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -28.2 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 123.814 0.845 . . . . 0.0 109.764 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -34.03 76.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.255 -1.528 . . . . 0.0 110.896 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -68.5 -42.76 78.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.685 0.794 . . . . 0.0 109.581 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.6 p -68.38 -28.37 67.05 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.395 -1.441 . . . . 0.0 111.376 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.08 -53.94 24.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 124.568 1.147 . . . . 0.0 110.737 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -73.82 -21.05 60.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.358 -0.838 . . . . 0.0 111.98 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.0 m -72.22 -39.56 68.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.46 67.48 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.371 -0.831 . . . . 0.0 111.727 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 4.37 44.82 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.943 -0.473 . . . . 0.0 110.918 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 24.2 p 55.67 56.58 6.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.273 1.429 . . . . 0.0 112.547 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 55.1 t -121.27 -93.29 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 101.972 -3.344 . . . . 0.0 101.972 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.03 82.98 1.1 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -174.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -73.9 -24.7 59.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.425 -1.044 . . . . 0.0 111.562 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.42 38.58 0.91 Allowed Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -82.32 -60.89 2.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.47 153.99 43.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.7 146.85 36.89 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 161.87 17.28 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.868 2.378 . . . . 0.0 108.797 164.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.18 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 119.465 1.029 . . . . 0.0 108.539 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -114.74 -36.63 4.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.68 1.229 . . . . 0.0 109.054 -172.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.95 -3.63 57.14 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 121.361 -0.837 . . . . 0.0 109.385 -166.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -26.26 60.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 77.11 1.32 Allowed Glycine 0 CA--C 1.471 -2.705 1 N-CA-C 101.445 -4.662 . . . . 0.0 101.445 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.513 HH12 ' CB ' ' A' ' 59' ' ' ASP . 21.0 ttm180 -53.52 -7.9 0.12 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 128.401 2.68 . . . . 0.0 114.263 -170.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -53.14 -19.98 3.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 120.716 -1.24 . . . . 0.0 113.276 157.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.17 -52.04 63.75 Favored 'Isoleucine or valine' 0 C--N 1.363 1.16 0 CA-C-N 120.464 1.484 . . . . 0.0 107.644 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.78 77.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.681 -0.637 . . . . 0.0 109.642 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.06 -46.98 75.42 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.232 1.013 . . . . 0.0 110.553 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.96 -44.04 91.41 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 124.899 1.28 . . . . 0.0 111.094 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.1 -44.16 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.367 0.667 . . . . 0.0 109.969 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.0 mtm -63.16 -46.54 86.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.346 0.593 . . . . 0.0 109.823 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -61.31 -41.51 97.12 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.063 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.13 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.765 0.826 . . . . 0.0 111.033 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.46 -48.17 76.44 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.87 -43.35 91.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 C-N-CA 124.47 1.108 . . . . 0.0 110.206 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.25 -40.9 94.63 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.118 -0.989 . . . . 0.0 111.684 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.9 -47.63 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.26 -11.15 60.76 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 121.562 -0.711 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.76 -42.3 12.7 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.835 -1.166 . . . . 0.0 109.144 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.53 -36.69 74.25 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 126.112 1.765 . . . . 0.0 111.04 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.64 -7.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 112.498 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.6 m -63.65 -16.86 62.1 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.314 -1.492 . . . . 0.0 110.985 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.45 -19.34 63.4 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.52 -1.987 . . . . 0.0 111.751 169.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.08 -54.48 4.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.124 1.37 . . . . 0.0 108.705 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.69 -36.34 70.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.468 -0.77 . . . . 0.0 112.533 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.14 -17.2 61.41 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 119.834 -1.791 . . . . 0.0 110.2 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -87.41 -2.27 58.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.729 -1.232 . . . . 0.0 109.36 175.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.02 -31.45 67.94 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 120.674 1.579 . . . . 0.0 111.302 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -72.94 -25.71 61.13 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.84 -1.163 . . . . 0.0 111.22 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.64 -32.5 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -63.37 -26.1 68.6 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.294 1.038 . . . . 0.0 111.552 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -50.57 -39.77 50.42 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.283 1.433 . . . . 0.0 111.438 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.38 -34.37 77.14 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 120.926 -1.109 . . . . 0.0 112.128 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.64 -35.81 57.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.82 -31.71 73.07 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.607 1.163 . . . . 0.0 111.199 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -63.67 -34.08 77.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.2 1.4 . . . . 0.0 111.579 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.2 -14.41 33.52 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.638 -0.664 . . . . 0.0 109.384 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.0 14.64 66.64 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 CA--C 1.508 -0.67 0 C-N-CA 124.644 1.178 . . . . 0.0 113.002 -179.292 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' C' ' 4' ' ' HIS . . . -85.7 106.63 17.11 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 171.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 24.13 -78.8 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 130.528 3.531 . . . . 0.0 116.046 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' C' ' 2' ' ' ALA . 2.1 p80 -52.39 -29.8 25.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.365 1.466 . . . . 0.0 113.769 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.82 -25.96 56.8 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.943 -1.098 . . . . 0.0 111.326 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.94 -38.72 69.77 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.186 -0.946 . . . . 0.0 108.524 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.62 -27.95 66.48 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.28 0.562 . . . . 0.0 109.852 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.79 75.97 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.253 -0.905 . . . . 0.0 111.193 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -74.53 -29.5 61.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 120.872 -1.143 . . . . 0.0 111.08 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -64.17 -28.79 70.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 111.286 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.36 65.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.893 -1.13 . . . . 0.0 110.438 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.43 -32.35 73.67 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 120.898 -1.126 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.6 -29.31 66.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.793 -1.192 . . . . 0.0 110.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' C' ' 17' ' ' LYS . 7.8 tp10 -68.67 -37.49 79.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.324 1.449 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 27.4 tp -56.86 -48.89 77.05 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 126.073 1.749 . . . . 0.0 110.026 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.03 -39.79 79.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.673 1.589 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' C' ' 14' ' ' GLU . 28.3 ttpt -74.12 -46.7 40.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.338 1.455 . . . . 0.0 110.742 -172.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.98 -36.23 72.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.101 -0.999 . . . . 0.0 111.111 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.19 -28.04 57.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -49.59 74.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -63.19 -43.41 98.28 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.44 1.114 . . . . 0.0 109.197 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.16 63.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.637 -0.665 . . . . 0.0 112.518 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 m -69.13 -47.73 64.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 124.075 0.95 . . . . 0.0 109.702 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -66.24 -43.79 85.58 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.43 -20.61 64.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.461 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -45.09 73.69 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 119.975 1.261 . . . . 0.0 110.451 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.04 -44.29 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.91 -45.02 94.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.801 1.64 . . . . 0.0 110.258 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.18 86.45 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 124.869 1.267 . . . . 0.0 111.174 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -32.45 58.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 121.959 -0.463 . . . . 0.0 109.9 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.6 90.49 1.03 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.443 1.097 . . . . 0.0 109.637 -174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.75 -27.41 2.82 Favored Glycine 0 CA--C 1.491 -1.463 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.57 156.07 40.06 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -76.77 154.08 34.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.23 1.953 . . . . 0.0 110.734 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.41 49.73 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.16 136.41 15.12 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.636 1.974 . . . . 0.0 113.536 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.7 -30.42 0.19 Allowed 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.185 0.994 . . . . 0.0 111.007 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -102.88 148.08 26.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -168.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -156.47 179.43 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m 65.32 109.36 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.572 1.549 . . . . 0.0 114.258 161.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -57.59 -37.89 61.53 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 116.227 -1.844 . . . . 0.0 114.757 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.6 -21.77 14.44 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 CA-C-N 125.628 3.046 . . . . 0.0 112.666 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -82.84 -25.45 32.62 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.72 71.86 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.96 1.704 . . . . 0.0 112.507 -172.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -67.13 -25.16 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 123.338 0.655 . . . . 0.0 111.114 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -21.01 56.25 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 120.822 -1.174 . . . . 0.0 110.867 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -80.62 -40.16 26.14 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.372 1.082 . . . . 0.0 108.126 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m -70.61 -31.42 68.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 O-C-N 120.328 -1.483 . . . . 0.0 112.634 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -62.62 -51.05 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.68 -15.76 61.69 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.08 1.352 . . . . 0.0 112.291 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 50.3 m -82.3 -36.73 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.066 -1.021 . . . . 0.0 108.525 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -27.74 61.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.37 -0.831 . . . . 0.0 110.451 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -93.0 6.91 46.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.452 0.701 . . . . 0.0 110.211 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.259 7.9 p 54.2 55.02 8.71 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 126.855 2.062 . . . . 0.0 114.317 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.87 -75.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.96 -64.06 3.09 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 t80 78.68 -47.6 0.43 Allowed 'General case' 0 C--N 1.351 0.668 0 C-N-CA 127.369 2.267 . . . . 0.0 109.437 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.05 13.72 0.42 Allowed Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -57.57 4.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.658 -0.907 . . . . 0.0 111.144 -173.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 26.0 mtm-85 -138.13 154.95 49.17 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -134.27 150.41 73.97 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.23 166.82 20.21 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 109.556 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.1 -179.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p -82.54 -79.85 0.18 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -32.47 -61.68 0.26 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.596 2.758 . . . . 0.0 110.912 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.77 -59.41 1.8 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -41.02 -41.45 2.67 Favored Glycine 0 CA--C 1.488 -1.639 0 C-N-CA 127.47 2.462 . . . . 0.0 114.819 -169.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -76.36 -30.68 57.68 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.292 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -35.35 71.59 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 121.528 1.967 . . . . 0.0 108.888 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.93 -51.38 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.79 98.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 125.094 1.358 . . . . 0.0 112.551 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.98 -46.89 52.95 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 127.328 2.251 . . . . 0.0 109.457 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -66.59 -36.39 82.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.75 -44.46 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.6 mtt -59.5 -46.26 89.32 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.679 0.791 . . . . 0.0 110.664 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -61.94 -43.61 98.48 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.48 84.12 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.226 0.61 . . . . 0.0 110.931 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.19 86.64 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 123.821 0.724 . . . . 0.0 111.833 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.99 -43.11 97.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.938 0.895 . . . . 0.0 109.527 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.77 -33.36 73.94 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.342 -0.848 . . . . 0.0 111.94 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.21 -53.59 35.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 123.689 0.796 . . . . 0.0 109.558 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -66.09 -38.79 89.14 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.85 -30.47 71.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.423 0.689 . . . . 0.0 111.842 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.68 -36.86 81.48 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 121.026 -1.046 . . . . 0.0 110.443 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.64 -20.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.932 1.293 . . . . 0.0 110.416 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 2.9 m -55.76 -22.79 25.94 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.927 1.291 . . . . 0.0 112.185 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.66 70.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.662 -1.899 . . . . 0.0 112.826 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.0 -16.68 35.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 123.961 0.904 . . . . 0.0 110.381 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.4 -35.6 17.03 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.33 62.07 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.611 -1.306 . . . . 0.0 111.179 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -73.26 -19.22 61.11 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 120.44 -1.412 . . . . 0.0 110.787 171.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . 0.442 ' CG ' ' HE ' ' C' ' 95' ' ' ARG . 4.6 m-20 -83.7 -11.37 57.28 Favored 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 120.935 -1.103 . . . . 0.0 111.136 -157.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -84.58 -21.3 30.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.109 -0.994 . . . . 0.0 110.336 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.84 -35.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.442 ' HE ' ' CG ' ' C' ' 92' ' ' ASP . 61.7 mtt-85 -55.35 -19.46 8.92 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.036 1.334 . . . . 0.0 113.217 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -57.46 -28.87 63.73 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.296 -0.877 . . . . 0.0 110.947 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -75.65 -23.41 56.3 Favored 'General case' 0 N--CA 1.436 -1.17 0 O-C-N 121.319 -0.863 . . . . 0.0 110.805 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -83.78 -31.81 25.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -68.13 -41.9 81.0 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.067 -1.646 . . . . 0.0 110.233 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -67.94 -38.73 83.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.679 1.192 . . . . 0.0 110.967 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -131.7 108.62 9.61 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.1 41.41 4.32 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 . . . . . 0 CA--C 1.502 -0.874 0 O-C-N 121.223 -1.163 . . . . 0.0 109.358 178.505 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.76 57.67 4.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 74.48 -67.69 0.24 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.866 2.066 . . . . 0.0 110.645 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 5.7 p80 -70.83 -28.93 64.98 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 126.662 1.985 . . . . 0.0 111.857 -175.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 2.2 mp0 -69.32 -23.46 63.79 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 120.967 -1.083 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.07 -42.78 88.94 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.453 -0.779 . . . . 0.0 109.908 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.76 -39.64 80.17 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.63 93.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.536 0.735 . . . . 0.0 111.17 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.34 -39.52 85.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.469 0.708 . . . . 0.0 110.389 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -64.06 -35.61 81.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.005 0.922 . . . . 0.0 110.808 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.03 79.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.388 1.075 . . . . 0.0 111.122 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -65.26 -34.69 78.96 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 120.901 -1.125 . . . . 0.0 111.17 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.96 -33.67 74.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 121.595 -0.69 . . . . 0.0 110.867 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -61.68 -41.94 98.24 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.194 1.398 . . . . 0.0 109.297 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.61 -38.84 91.76 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.051 -1.031 . . . . 0.0 111.417 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -69.12 -22.65 63.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.157 -0.964 . . . . 0.0 112.405 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.48 -39.96 36.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.25 -38.33 80.8 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 124.379 1.071 . . . . 0.0 109.544 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.79 -45.9 63.99 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.556 1.142 . . . . 0.0 112.056 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -71.41 -41.14 69.94 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 122.776 0.431 . . . . 0.0 110.585 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -62.68 -43.37 98.99 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.38 68.69 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.875 1.67 . . . . 0.0 112.17 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -67.08 -37.95 84.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 110.163 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -35.21 63.85 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -64.66 -50.06 68.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.57 0.748 . . . . 0.0 109.185 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.39 69.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.678 1.191 . . . . 0.0 113.507 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.23 -28.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 O-C-N 120.187 -1.57 . . . . 0.0 109.888 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -75.75 -49.17 18.97 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.797 -1.19 . . . . 0.0 108.304 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.27 78.62 6.49 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' D' ' 66' ' ' GLU . 0.9 OUTLIER -159.82 -55.05 0.06 Allowed 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.889 1.368 . . . . 0.0 108.051 163.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -79.42 103.54 9.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 119.406 -2.058 . . . . 0.0 110.303 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.38 -49.59 0.26 Allowed Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 105.181 -3.168 . . . . 0.0 105.181 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 161.69 70.05 Favored Pre-proline 0 CA--C 1.504 -0.807 0 C-N-CA 123.446 0.698 . . . . 0.0 112.759 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -78.65 113.78 3.36 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.589 2.193 . . . . 0.0 110.766 172.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.33 2.25 13.55 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.129 -0.817 . . . . 0.0 111.202 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.03 145.09 21.42 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.858 1.263 . . . . 0.0 113.172 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.16 -48.56 1.33 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.626 1.171 . . . . 0.0 111.128 -167.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.78 133.81 34.51 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 pt -148.11 17.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.11 138.65 33.66 Favored 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 120.484 -1.385 . . . . 0.0 108.228 -170.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.58 -49.39 8.57 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.982 -1.961 . . . . 0.0 111.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.27 -8.04 21.35 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 CA-C-N 125.865 3.13 . . . . 0.0 111.101 -173.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -98.82 -25.63 14.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.09 80.5 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.532 1.133 . . . . 0.0 111.086 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.37 -35.53 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 121.977 -0.452 . . . . 0.0 110.445 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -28.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.487 -1.383 . . . . 0.0 110.429 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -63.79 -42.93 97.63 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.417 1.103 . . . . 0.0 108.457 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -58.33 -37.47 75.21 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.307 1.443 . . . . 0.0 111.388 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.53 -49.77 71.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 124.328 1.051 . . . . 0.0 110.591 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.453 ' CD ' HH12 ' A' ' 68' ' ' ARG . 8.0 pt-20 -75.36 -23.85 57.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.849 0.833 . . . . 0.0 110.863 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 64.3 m -70.31 -39.33 74.87 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.72 67.12 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.098 -1.001 . . . . 0.0 111.942 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -88.65 5.82 41.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 119.149 -0.453 . . . . 0.0 110.077 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 51.48 29.7 5.6 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 127.614 2.366 . . . . 0.0 112.437 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.07 -47.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.31 51.48 58.54 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -71.11 -33.23 69.94 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.978 0.894 . . . . 0.0 109.361 -166.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 155.68 -123.47 1.34 Allowed Glycine 0 CA--C 1.476 -2.36 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 75.13 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.345 1.458 . . . . 0.0 108.016 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -145.37 171.58 14.41 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -164.36 148.21 7.97 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -91.67 155.06 3.5 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 C-N-CA 122.468 2.112 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -155.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.937 0.875 . . . . 0.0 110.424 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -53.84 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.382 -1.449 . . . . 0.0 112.26 -164.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' D' ' 67' ' ' GLY . 8.9 tt0 -79.86 -7.78 58.91 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.784 1.233 . . . . 0.0 109.621 -165.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' D' ' 30' ' ' GLU . 40.2 mm-40 -95.98 41.26 1.11 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' D' ' 65' ' ' GLU . . . 15.16 81.56 0.01 OUTLIER Glycine 0 CA--C 1.462 -3.253 1 C-N-CA 133.139 5.162 . . . . 0.0 110.434 -170.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -53.37 -13.8 0.63 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.599 1.96 . . . . 0.0 113.457 -164.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.05 -6.01 0.32 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 160.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.12 -49.15 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 O-C-N 120.274 -1.517 . . . . 0.0 107.713 167.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.23 82.06 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -48.67 -46.28 40.06 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.604 1.161 . . . . 0.0 113.324 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.27 -37.43 83.44 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.107 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.34 -44.97 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 58.2 mtm -63.05 -48.34 79.13 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.21 1.004 . . . . 0.0 110.62 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.39 -38.27 88.98 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.531 -0.731 . . . . 0.0 110.505 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.698 -0.626 . . . . 0.0 111.911 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.17 -46.98 66.97 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.74 -44.89 94.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 C-N-CA 124.559 1.144 . . . . 0.0 109.663 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.78 -47.56 84.3 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 111.388 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.16 -49.99 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 124.284 1.034 . . . . 0.0 109.768 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -71.75 -16.23 62.2 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.903 -0.498 . . . . 0.0 111.482 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.27 -35.55 16.08 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.256 -0.903 . . . . 0.0 109.859 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.52 -31.48 72.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.584 1.554 . . . . 0.0 110.927 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.08 -3.02 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.696 0 O-C-N 121.326 -0.858 . . . . 0.0 112.609 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 88.0 m -58.35 -22.85 54.91 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.476 1.51 . . . . 0.0 111.571 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.88 66.33 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.198 -1.564 . . . . 0.0 111.935 172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.69 -49.06 6.68 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.09 -39.9 91.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.726 -1.234 . . . . 0.0 113.657 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.85 61.81 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.945 -1.097 . . . . 0.0 110.892 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 80.8 p -85.31 -14.47 46.43 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.568 -1.333 . . . . 0.0 110.566 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.39 -16.2 61.34 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.14 -1.6 . . . . 0.0 111.067 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -80.31 -31.36 38.15 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.651 -1.281 . . . . 0.0 111.874 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.19 -11.74 14.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 CA-C-O 121.562 0.696 . . . . 0.0 110.168 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -61.41 -17.26 53.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.788 0.835 . . . . 0.0 110.848 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . 0.444 ' HB3' ' HE2' ' A' ' 4' ' ' HIS . 0.4 OUTLIER -60.58 -22.21 63.46 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.586 1.085 . . . . 0.0 112.021 176.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.66 -47.84 51.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.682 0.793 . . . . 0.0 109.474 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.14 -35.98 30.84 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.465 -0.772 . . . . 0.0 109.54 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.1 -4.72 37.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.282 -0.886 . . . . 0.0 112.057 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -67.82 -40.71 83.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.269 -0.894 . . . . 0.0 109.523 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -91.94 -14.7 29.11 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.514 -0.741 . . . . 0.0 109.19 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.24 62.56 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 m170 . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 179.032 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.76 -161.57 0.23 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.51 2.324 . . . . 0.0 110.558 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 14.8 t0 -136.42 129.47 31.24 Favored 'General case' 0 CA--C 1.477 -1.857 1 N-CA-C 96.573 -5.343 . . . . 0.0 96.573 153.116 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' OE1' ' A' ' 5' ' ' GLU 0.299 22.4 p80 144.07 -60.88 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 128.5 2.72 . . . . 0.0 107.251 -177.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' OE1' ' CE1' ' A' ' 4' ' ' HIS . 2.8 pt-20 -76.34 -28.15 56.75 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 120.745 -1.222 . . . . 0.0 110.803 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -64.02 -37.54 87.79 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.06 -1.025 . . . . 0.0 111.167 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -73.48 -34.21 65.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.085 1.354 . . . . 0.0 108.27 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.96 90.34 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.953 1.301 . . . . 0.0 110.587 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -61.8 -42.16 98.66 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 110.082 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -64.03 -34.3 77.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.911 0.862 . . . . 0.0 110.947 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.48 70.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.003 -1.061 . . . . 0.0 110.987 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.02 -32.8 74.7 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.191 -0.943 . . . . 0.0 111.038 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.89 -34.81 74.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.744 -1.223 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.54 -36.54 82.93 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.46 -48.77 76.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.594 1.158 . . . . 0.0 110.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -71.49 -27.07 62.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.733 -1.229 . . . . 0.0 112.283 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -67.09 -44.34 80.26 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.211 1.404 . . . . 0.0 109.805 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.48 -29.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.946 -1.096 . . . . 0.0 110.249 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.75 -38.87 89.57 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 123.799 0.839 . . . . 0.0 111.168 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.93 -31.55 63.11 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.197 0.999 . . . . 0.0 110.826 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -77.88 -39.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.03 78.79 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.274 1.029 . . . . 0.0 111.715 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -65.83 -32.69 74.36 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.862 -0.524 . . . . 0.0 110.587 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -62.55 -47.43 83.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.395 0.678 . . . . 0.0 109.576 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -64.96 -38.04 89.66 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 110.115 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.23 75.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.149 0.98 . . . . 0.0 112.555 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.8 t -72.71 -43.19 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 121.089 -1.007 . . . . 0.0 109.175 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.0 -37.87 81.98 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.65 -1.282 . . . . 0.0 110.104 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 64.74 6.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.919 1.688 . . . . 0.0 108.219 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -164.74 -53.86 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.91 89.53 0.01 OUTLIER 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.119 1.768 . . . . 0.0 112.269 -170.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.58 10.12 25.74 Favored Glycine 0 CA--C 1.498 -0.995 0 O-C-N 121.035 -1.041 . . . . 0.0 111.792 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.71 133.46 25.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.722 1.261 . . . . 0.0 107.945 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.39 130.0 8.83 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.696 2.264 . . . . 0.0 110.645 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.76 74.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 160.38 16.39 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.9 9.17 Favored 'General case' 0 N--CA 1.427 -1.595 1 N-CA-C 99.04 -4.43 . . . . 0.0 99.04 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt 82.63 87.99 0.04 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 tt -138.57 142.83 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.71 138.73 0.06 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.324 1.849 . . . . 0.0 112.73 169.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -51.65 -53.48 50.01 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 126.033 1.733 . . . . 0.0 114.37 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.77 -6.94 18.83 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 CA-C-N 124.366 2.595 . . . . 0.0 112.316 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.48 -48.08 4.9 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.6 77.77 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 125.382 1.473 . . . . 0.0 112.441 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -66.42 -31.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.509 -0.744 . . . . 0.0 110.452 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -23.16 36.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.394 -0.816 . . . . 0.0 109.916 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -72.37 -38.56 68.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -75.92 65.84 2.06 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.551 1.54 . . . . 0.0 108.318 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.69 -71.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.577 ' CD ' HH22 ' B' ' 68' ' ' ARG . 20.0 pt-20 -69.37 -24.4 63.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.869 0.842 . . . . 0.0 111.946 -165.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -66.93 -35.37 79.84 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 124.837 1.255 . . . . 0.0 107.988 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.84 -23.64 52.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 120.358 -1.464 . . . . 0.0 110.695 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -87.31 9.93 18.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.282 5.4 t 48.08 48.29 18.41 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 127.723 2.409 . . . . 0.0 112.569 172.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.99 -99.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 171.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.88 67.01 0.57 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 103.142 -3.983 . . . . 0.0 103.142 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -68.12 -30.55 69.73 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 122.134 0.969 . . . . 0.0 108.466 -174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.62 49.07 0.53 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.582 ' CG ' HH21 ' B' ' 68' ' ' ARG 0.479 4.6 p-10 -80.48 -28.96 37.41 Favored 'General case' 0 C--N 1.362 1.11 0 CA-C-N 119.063 1.431 . . . . 0.0 110.372 170.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -147.03 -179.84 7.1 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -146.05 137.54 12.97 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -84.49 -177.12 2.8 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 C-N-CA 124.422 3.415 . . . . 0.0 108.863 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' H ' ' CG ' ' A' ' 66' ' ' GLU 0.308 7.8 p -112.1 -128.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.657 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 -37.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.443 1.897 . . . . 0.0 107.183 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -84.22 -2.19 56.47 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.77 0.828 . . . . 0.0 109.78 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -73.86 -35.51 64.75 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.81 60.29 0.66 Allowed Glycine 0 CA--C 1.466 -3.017 1 N-CA-C 102.772 -4.131 . . . . 0.0 102.772 168.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -13.84 -30.75 0.0 OUTLIER 'General case' 0 C--N 1.364 1.214 1 C-N-CA 135.489 5.515 . . . . 0.0 117.738 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -53.36 -22.31 7.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 126.737 2.015 . . . . 0.0 112.626 163.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.3 -51.35 65.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.52 -1.363 . . . . 0.0 108.439 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.79 -45.09 68.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.376 0.67 . . . . 0.0 110.341 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.81 -37.09 75.6 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 110.841 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -58.18 -39.65 79.46 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 121.4 -0.812 . . . . 0.0 110.601 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.51 -36.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mmt -57.9 -57.49 12.58 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.397 1.079 . . . . 0.0 109.741 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.95 -28.06 67.98 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 121.345 -0.847 . . . . 0.0 111.057 -175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.92 -22.74 65.94 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.588 -0.695 . . . . 0.0 110.883 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.93 -36.78 10.85 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.25 -42.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 125.359 1.464 . . . . 0.0 110.426 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.76 -37.27 84.29 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.438 -0.789 . . . . 0.0 110.91 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.36 -57.99 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 124.535 1.134 . . . . 0.0 109.979 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.01 -13.7 62.6 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.709 -0.619 . . . . 0.0 110.691 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.62 -46.97 16.23 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 121.112 -0.992 . . . . 0.0 110.091 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.47 -36.9 79.39 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.065 1.346 . . . . 0.0 111.64 -172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.0 m -62.71 -9.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.408 -0.807 . . . . 0.0 112.602 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -62.91 -18.58 63.22 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.121 1.369 . . . . 0.0 110.941 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.82 -24.28 66.78 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.682 -1.261 . . . . 0.0 111.636 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.47 -46.52 10.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 108.197 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.43 -41.55 98.79 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.17 0.988 . . . . 0.0 112.902 -171.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.04 -9.96 59.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.13 -0.981 . . . . 0.0 111.466 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.6 p -83.78 -16.18 45.64 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 120.768 -1.208 . . . . 0.0 110.323 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.73 -24.77 58.77 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.628 -163.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -74.65 -32.02 62.12 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.644 -1.285 . . . . 0.0 110.995 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 t -69.43 -32.87 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 125.399 1.48 . . . . 0.0 108.423 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -61.84 -11.63 13.64 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.398 1.479 . . . . 0.0 112.442 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -68.34 -22.34 64.69 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 120.001 -1.687 . . . . 0.0 110.595 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.33 -44.6 74.96 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -61.4 -52.36 64.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.913 1.685 . . . . 0.0 109.605 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.53 -41.66 92.85 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.851 -0.53 . . . . 0.0 110.068 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -66.26 -33.74 76.43 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.951 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -77.32 -27.67 52.94 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.4 28.4 52.66 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.4 m80 . . . . . 0 CA--C 1.492 -1.287 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 -175.514 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.434 -1.254 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.34 173.24 11.73 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.313 -0.867 . . . . 0.0 108.923 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -53.66 -53.08 57.06 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 123.537 1.637 . . . . 0.0 109.678 -171.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.25 -21.05 63.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.191 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -85.66 -39.11 17.63 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -70.84 -31.25 67.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.478 -0.764 . . . . 0.0 110.864 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.11 -47.64 79.24 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.0 70.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.294 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.14 -35.91 80.72 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.218 1.007 . . . . 0.0 110.208 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.25 -28.12 64.99 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -39.35 93.37 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.09 -47.79 76.0 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.404 -0.81 . . . . 0.0 110.548 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -52.88 -51.97 59.16 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.312 1.845 . . . . 0.0 110.222 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -76.03 -12.59 60.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.443 -0.786 . . . . 0.0 112.045 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.733 -1.229 . . . . 0.0 108.12 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.77 -14.05 60.66 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.54 -1.35 . . . . 0.0 111.193 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.93 -51.65 21.03 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.15 -23.75 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.859 -0.526 . . . . 0.0 111.393 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.14 -39.71 83.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.369 -0.832 . . . . 0.0 112.076 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.74 -24.34 38.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.293 0.568 . . . . 0.0 110.583 -174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.33 -42.15 46.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.82 82.15 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 126.309 1.844 . . . . 0.0 111.584 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -65.99 -44.97 83.29 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 122.111 -0.368 . . . . 0.0 110.324 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.11 -48.16 77.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.248 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -68.31 -25.55 65.19 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.098 -175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -43.9 58.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 109.673 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 73.7 t -60.43 -45.72 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.241 -0.912 . . . . 0.0 110.127 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.59 17.96 15.2 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 121.638 -0.664 . . . . 0.0 111.099 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.448 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -75.69 -48.52 21.66 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 170.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -27.53 58.78 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 126.396 1.878 . . . . 0.0 115.082 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -73.77 75.88 1.58 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.61 0.764 . . . . 0.0 109.393 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.59 -43.23 0.77 Allowed Glycine 0 CA--C 1.488 -1.618 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.41 152.12 60.35 Favored Pre-proline 0 N--CA 1.445 -0.713 0 O-C-N 121.486 -1.008 . . . . 0.0 111.263 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.05 153.5 11.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.136 1.891 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.17 41.61 10.13 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 132.44 52.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 -42.06 0.17 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.358 0.263 . . . . 0.0 110.683 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -6.61 54.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.896 1.678 . . . . 0.0 110.739 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.14 84.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 O-C-N 120.634 -1.291 . . . . 0.0 111.929 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.1 112.05 0.74 Allowed 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -53.37 -47.7 95.26 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.404 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -71.47 -20.14 27.7 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-N 124.962 2.808 . . . . 0.0 113.011 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.73 0.63 17.47 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 119.941 1.246 . . . . 0.0 109.922 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.44 -34.72 76.46 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.189 -0.944 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.99 -35.75 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.287 1.035 . . . . 0.0 109.614 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.63 -38.83 67.6 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.466 -1.396 . . . . 0.0 108.815 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -65.18 -44.86 87.11 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 123.356 0.662 . . . . 0.0 110.152 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -66.96 -29.43 69.28 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.953 -1.092 . . . . 0.0 110.851 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 23.3 t -58.35 -43.25 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.453 1.101 . . . . 0.0 111.117 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -82.45 -15.0 54.16 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.794 1.179 . . . . 0.0 112.298 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.48 -36.14 29.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.756 -1.215 . . . . 0.0 107.804 -174.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.37 -23.39 61.12 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.882 -1.136 . . . . 0.0 112.066 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.96 -6.28 59.0 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.188 0.995 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 14.6 p 55.7 54.48 8.22 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.863 1.665 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.89 -91.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 1 N-CA-C 100.031 -4.062 . . . . 0.0 100.031 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.52 76.72 1.34 Allowed Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.65 -18.23 51.93 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.49 -1.006 . . . . 0.0 108.605 -171.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.3 48.93 0.68 Allowed Glycine 0 CA--C 1.484 -1.877 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 168.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.61 -54.34 9.37 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -131.33 -136.62 0.2 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.191 0.596 . . . . 0.0 109.594 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -171.91 121.57 0.47 Allowed Pre-proline 0 N--CA 1.444 -0.726 1 N-CA-C 100.029 -4.063 . . . . 0.0 100.029 -168.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.85 158.15 13.82 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 124.59 2.675 . . . . 0.0 109.791 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 m -76.11 169.92 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.635 1.207 . . . . 0.0 111.819 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -59.63 2.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.38 1.072 . . . . 0.0 110.793 -169.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.31 -17.26 64.7 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 -168.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -130.56 -108.05 0.27 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.448 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 25.94 -70.87 0.0 OUTLIER Glycine 0 CA--C 1.486 -1.758 1 C-N-CA 132.442 4.83 . . . . 0.0 116.204 170.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.582 HH21 ' CG ' ' A' ' 59' ' ' ASP . 52.7 ttm-85 -61.78 -42.92 99.61 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 126.083 1.753 . . . . 0.0 112.575 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -67.79 -34.5 76.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 120.251 1.387 . . . . 0.0 109.589 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.99 -47.75 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.2 90.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.876 1.671 . . . . 0.0 110.9 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -50.91 -46.1 60.55 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 127.648 2.379 . . . . 0.0 110.482 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -66.73 -37.46 84.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -74.51 -45.76 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.223 1.009 . . . . 0.0 109.372 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 71.7 mtm -61.06 -45.01 96.48 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.629 1.172 . . . . 0.0 109.759 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -64.8 -32.49 74.2 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.909 -0.495 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.512 -0.743 . . . . 0.0 110.329 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -40.59 97.02 Favored Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 124.186 0.898 . . . . 0.0 111.732 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.63 -51.0 77.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 C-N-CA 124.086 0.954 . . . . 0.0 108.456 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -65.41 -27.4 68.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.541 -0.724 . . . . 0.0 111.724 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.87 -58.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 124.391 1.076 . . . . 0.0 110.333 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -65.28 -25.41 67.63 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 121.539 0.685 . . . . 0.0 110.148 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.21 -41.97 32.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 121.367 -0.833 . . . . 0.0 111.268 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.16 -36.93 85.26 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.522 -1.361 . . . . 0.0 110.682 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.79 -3.45 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 O-C-N 121.563 -0.711 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 56.5 m -56.6 -22.77 36.17 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.992 1.317 . . . . 0.0 109.985 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.05 72.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.329 -1.482 . . . . 0.0 112.503 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.01 -35.42 61.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 120.954 -1.091 . . . . 0.0 109.191 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.5 -32.49 62.54 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 122.967 0.507 . . . . 0.0 110.67 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.844 -1.16 . . . . 0.0 111.115 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -11.21 60.62 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.066 -1.021 . . . . 0.0 113.22 174.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.7 -47.61 80.46 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 120.208 1.367 . . . . 0.0 109.839 -171.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -71.54 -27.16 62.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.941 -1.099 . . . . 0.0 111.736 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.01 -17.75 22.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.982 1.313 . . . . 0.0 109.455 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -70.37 -17.73 63.05 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.082 -1.636 . . . . 0.0 111.707 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -66.41 -13.48 60.77 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 120.496 -1.377 . . . . 0.0 110.478 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -58.1 -47.29 83.69 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 126.195 1.798 . . . . 0.0 109.876 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -60.75 -49.82 75.95 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.63 1.172 . . . . 0.0 109.565 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -0.64 57.69 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.816 -171.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 26.9 ttp-105 -79.98 -40.9 27.0 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.41 -34.37 58.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.712 0.767 . . . . 0.0 109.117 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.28 13.82 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.0 p80 . . . . . 0 CA--C 1.508 -0.642 0 C-N-CA 127.544 2.338 . . . . 0.0 115.572 -174.426 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.53 172.55 18.34 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -48.75 80.25 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 124.765 1.226 . . . . 0.0 109.826 -172.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' C' ' 5' ' ' GLU . 40.5 p-80 -65.82 -30.33 70.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.803 -0.561 . . . . 0.0 112.004 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' C' ' 4' ' ' HIS . 7.2 mt-10 -77.36 -40.72 42.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.04 -44.46 96.66 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.521 -0.737 . . . . 0.0 109.986 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -33.98 75.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.025 0.441 . . . . 0.0 110.685 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.73 90.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.669 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -68.64 -34.39 75.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 121.674 -0.641 . . . . 0.0 110.62 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -66.56 -35.39 80.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.219 1.408 . . . . 0.0 110.73 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.42 87.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.351 -0.843 . . . . 0.0 111.069 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -63.76 -33.89 76.67 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.978 0.894 . . . . 0.0 111.5 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -68.33 -30.84 69.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.103 1.361 . . . . 0.0 110.518 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -69.22 -37.01 77.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.777 -1.202 . . . . 0.0 108.987 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.5 -44.43 97.09 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.222 1.009 . . . . 0.0 110.838 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.61 -39.6 70.99 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.254 1.021 . . . . 0.0 112.376 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.2 71.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.274 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.61 -40.66 88.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.73 -42.68 84.36 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.319 1.048 . . . . 0.0 111.095 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.7 -39.96 94.54 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -88.31 -12.54 43.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.949 -1.094 . . . . 0.0 109.983 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.51 -37.51 42.91 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.783 -1.198 . . . . 0.0 109.286 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -37.65 84.97 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.232 0.613 . . . . 0.0 110.311 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -44.26 81.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.285 1.434 . . . . 0.0 109.218 172.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -69.14 -48.77 61.48 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.652 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.98 80.91 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.302 1.041 . . . . 0.0 112.924 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.27 -23.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 O-C-N 121.294 -0.879 . . . . 0.0 110.839 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.85 -4.26 47.36 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 119.854 -1.779 . . . . 0.0 109.016 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.63 -48.62 12.39 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -173.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.85 -110.67 0.13 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . 0.305 11.5 mtm-85 43.23 71.57 0.23 Allowed 'General case' 0 C--N 1.358 0.945 0 C-N-CA 126.32 1.848 . . . . 0.0 112.942 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.14 36.97 2.05 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.83 153.7 42.22 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.19 121.34 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.996 2.464 . . . . 0.0 110.041 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.19 25.78 39.03 Favored Glycine 0 CA--C 1.496 -1.107 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.69 151.65 46.4 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.116 1.366 . . . . 0.0 109.575 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.25 -34.9 0.52 Allowed 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.255 0.622 . . . . 0.0 109.759 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.4 tp -94.75 55.06 1.84 Allowed 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.87 19.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 124.646 1.178 . . . . 0.0 110.28 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.5 t -129.42 125.61 36.91 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.14 -53.05 20.47 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-O 115.85 -2.024 . . . . 0.0 112.109 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.54 -16.2 34.27 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 CA-C-N 126.252 3.269 . . . . 0.0 111.109 -173.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.01 -20.62 44.96 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.8 79.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.159 -0.963 . . . . 0.0 111.63 -167.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.06 -21.86 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.628 0.728 . . . . 0.0 110.632 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -25.34 21.91 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.875 0.87 . . . . 0.0 109.147 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -67.48 -46.67 72.28 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 170.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -77.37 64.25 2.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.734 -0.604 . . . . 0.0 110.037 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 66.2 t -136.1 -71.07 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.38 -15.1 62.36 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-O 121.95 0.881 . . . . 0.0 112.598 -164.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.7 t -73.03 -32.37 65.06 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 124.719 1.207 . . . . 0.0 109.102 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.39 58.71 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 121.08 -1.012 . . . . 0.0 110.55 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -92.23 7.46 42.56 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.05 0.54 . . . . 0.0 110.128 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 51.2 p 49.68 42.33 23.21 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.482 1.913 . . . . 0.0 113.772 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.64 -56.24 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.77 3.06 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.23 -45.85 62.38 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -172.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.68 52.25 0.23 Allowed Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.66 -36.42 73.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.863 -0.786 . . . . 0.0 111.493 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -126.79 -163.71 1.27 Allowed 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -148.43 112.2 3.73 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 168.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.57 -173.61 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.769 2.979 . . . . 0.0 108.779 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.268 7.4 p -128.39 -128.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -121.35 -37.16 2.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.279 1.432 . . . . 0.0 108.035 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.71 -12.2 58.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.869 1.268 . . . . 0.0 110.371 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -32.94 68.23 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.09 64.83 0.84 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 102.348 -4.301 . . . . 0.0 102.348 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -14.21 -38.6 0.0 OUTLIER 'General case' 0 C--N 1.366 1.284 1 C-N-CA 132.491 4.316 . . . . 0.0 116.434 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.49 -26.88 0.24 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.637 1.575 . . . . 0.0 113.791 165.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.46 -42.78 92.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.409 -1.432 . . . . 0.0 110.833 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.2 31.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -60.27 -31.19 69.99 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 123.681 0.792 . . . . 0.0 113.026 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -69.23 -32.45 71.7 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.407 -1.433 . . . . 0.0 110.545 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.92 62.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -57.2 -52.29 65.9 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.706 1.202 . . . . 0.0 110.381 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.83 -42.84 99.52 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 122.015 -0.428 . . . . 0.0 110.88 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.01 -33.92 75.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.688 0.395 . . . . 0.0 111.549 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -45.49 86.41 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 123.837 0.732 . . . . 0.0 111.329 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.34 -45.82 93.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.35 1.06 . . . . 0.0 109.352 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.94 -38.46 85.93 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.519 -0.738 . . . . 0.0 112.31 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.15 -53.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 109.198 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -66.73 -38.91 87.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.919 -0.488 . . . . 0.0 111.041 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.36 73.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 110.997 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.04 -30.93 71.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.314 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.88 -18.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 124.911 1.284 . . . . 0.0 110.775 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -56.53 -20.64 21.53 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 112.424 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.04 72.06 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.136 -1.602 . . . . 0.0 111.898 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.08 -50.66 10.03 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.732 -1.23 . . . . 0.0 108.233 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 44.1 mt -59.63 -39.28 83.8 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.802 1.241 . . . . 0.0 112.27 -173.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.13 60.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.039 -1.038 . . . . 0.0 111.396 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 27.0 m -85.65 -18.01 34.45 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.7 -25.03 61.09 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.126 -1.609 . . . . 0.0 111.643 -164.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -77.55 -20.65 53.79 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.669 -1.27 . . . . 0.0 111.176 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.27 -24.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -172.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.03 -36.56 60.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.03 1.332 . . . . 0.0 111.846 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -54.84 -40.22 69.4 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 125.057 1.343 . . . . 0.0 110.955 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.83 -33.07 74.81 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.793 0.837 . . . . 0.0 110.206 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -79.79 -37.73 34.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.65 -20.98 60.42 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.147 -0.971 . . . . 0.0 112.451 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -67.5 -38.77 84.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.463 1.505 . . . . 0.0 110.131 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -80.91 -26.27 36.9 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.733 -0.604 . . . . 0.0 110.261 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.63 70.38 Favored Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 79.6 m80 . . . . . 0 CA--C 1.494 -1.2 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -175.073 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.17 175.21 8.17 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.74 -66.63 0.31 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 130.042 3.337 . . . . 0.0 112.017 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 46.8 p-80 -65.05 -27.62 68.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.333 1.853 . . . . 0.0 112.763 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.76 -31.41 61.77 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.237 -0.914 . . . . 0.0 108.928 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.93 -41.15 91.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.995 0.918 . . . . 0.0 109.282 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.79 -41.87 95.48 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.81 1.244 . . . . 0.0 109.159 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.68 98.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.059 0.944 . . . . 0.0 111.48 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -70.54 -29.81 66.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.556 -0.715 . . . . 0.0 111.832 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -63.95 -34.24 77.52 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.129 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.41 94.05 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.634 0.774 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.67 -36.25 83.22 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -71.12 -24.86 62.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.053 -1.03 . . . . 0.0 111.325 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.2 -35.02 73.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.982 0.913 . . . . 0.0 109.185 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 tp -64.66 -40.51 95.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.365 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -60.21 -28.36 67.93 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.023 0.929 . . . . 0.0 112.334 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -70.25 -42.98 71.49 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.35 -29.81 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 123.992 0.917 . . . . 0.0 109.745 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.44 -44.04 97.37 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.283 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -77.54 -31.58 53.41 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.111 1.364 . . . . 0.0 110.988 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -65.14 -53.68 41.38 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.915 1.34 . . . . 0.0 108.962 171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.49 -24.5 60.19 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 124.642 1.177 . . . . 0.0 111.524 -167.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 12.0 p -64.43 -46.33 83.66 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.254 1.026 . . . . 0.0 109.247 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.77 -46.36 88.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.343 1.857 . . . . 0.0 108.586 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.32 -47.9 77.66 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.326 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.63 84.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.411 1.084 . . . . 0.0 110.763 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.978 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.77 -34.35 34.3 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.5 91.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.75 1.62 . . . . 0.0 109.364 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.22 -26.54 65.76 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.358 1.063 . . . . 0.0 111.889 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -74.12 112.62 10.44 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.64 -1.913 . . . . 0.0 107.836 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.5 -22.97 8.63 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.98 64.73 Favored Pre-proline 0 N--CA 1.443 -0.806 0 O-C-N 121.735 -0.862 . . . . 0.0 110.927 -176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -84.09 128.02 4.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.104 2.536 . . . . 0.0 111.864 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.78 46.88 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.43 135.0 50.75 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 127.668 2.387 . . . . 0.0 112.388 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.22 -31.17 1.13 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 123.795 0.838 . . . . 0.0 109.846 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.08 49.83 1.87 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 107.737 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.87 -164.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER 80.88 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 116.51 -1.71 . . . . 0.0 106.966 178.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -157.54 -62.8 0.02 OUTLIER Pre-proline 0 C--N 1.35 0.624 0 CA-C-O 116.135 -1.888 . . . . 0.0 109.037 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.48 -14.37 25.04 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 CA-C-N 125.709 3.075 . . . . 0.0 111.084 -169.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -34.18 29.53 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.284 2.634 . . . . 0.0 107.867 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.85 69.49 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.129 0.972 . . . . 0.0 111.62 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 tt -70.6 -33.01 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.341 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -19.29 59.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.316 -1.49 . . . . 0.0 109.984 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -70.03 -53.71 16.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 p -65.1 -19.11 65.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.08 -44.53 99.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 124.097 0.959 . . . . 0.0 111.159 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.2 -32.35 49.94 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.602 1.092 . . . . 0.0 108.494 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -81.36 63.36 5.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.903 0.881 . . . . 0.0 111.055 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.71 -52.14 0.07 Allowed 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 20.8 p -95.53 46.18 1.1 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.954 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 11.9 p 42.86 65.94 0.86 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.919 1.688 . . . . 0.0 113.641 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.01 -108.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.15 48.36 1.9 Allowed Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 105.813 -2.915 . . . . 0.0 105.813 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -11.98 59.88 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.913 -0.757 . . . . 0.0 111.327 -166.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.16 40.55 3.98 Favored Glycine 0 CA--C 1.495 -1.207 0 O-C-N 120.288 -1.507 . . . . 0.0 110.001 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.0 -56.73 6.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.856 1.263 . . . . 0.0 108.773 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -144.34 167.76 21.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.32 122.91 18.37 Favored Pre-proline 0 CA--C 1.499 -0.985 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.05 169.96 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.374 2.049 . . . . 0.0 108.716 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.99 -106.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-N 119.07 0.85 . . . . 0.0 112.864 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -155.79 -39.46 0.08 Allowed 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -170.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -77.54 -11.7 59.88 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.622 1.969 . . . . 0.0 109.894 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.17 60.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.26 90.5 1.81 Allowed Glycine 0 N--CA 1.418 -2.524 1 N-CA-C 98.029 -6.028 . . . . 0.0 98.029 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -56.49 -18.86 12.87 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 119.664 1.732 . . . . 0.0 110.694 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -49.95 -21.82 1.33 Allowed 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.574 1.55 . . . . 0.0 114.384 165.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.06 -46.22 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 O-C-N 120.562 -1.336 . . . . 0.0 108.809 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -43.06 93.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.249 0.62 . . . . 0.0 109.476 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.51 -44.33 69.01 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.444 1.498 . . . . 0.0 111.102 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -57.85 -47.73 81.83 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.352 1.061 . . . . 0.0 111.362 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -45.14 85.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-O 121.535 0.683 . . . . 0.0 109.531 -172.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.46 -43.49 85.38 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.129 0.572 . . . . 0.0 110.807 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.64 -34.67 78.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 121.504 -0.748 . . . . 0.0 110.28 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.65 88.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.797 -0.564 . . . . 0.0 110.684 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.33 96.16 Favored Glycine 0 CA--C 1.495 -1.17 0 C-N-CA 124.058 0.837 . . . . 0.0 112.053 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.48 -46.91 92.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 124.413 1.085 . . . . 0.0 109.69 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.22 -36.96 85.79 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.204 -0.935 . . . . 0.0 112.23 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.47 -51.15 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.908 0.883 . . . . 0.0 109.822 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.48 -4.8 50.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.515 -0.741 . . . . 0.0 111.444 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.17 -40.55 12.15 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.353 -0.842 . . . . 0.0 108.991 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -57.05 -39.93 75.83 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 126.495 1.918 . . . . 0.0 111.082 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.9 m -62.95 -6.82 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.28 1.032 . . . . 0.0 112.92 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.2 m -62.17 -17.72 58.84 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.617 -1.302 . . . . 0.0 110.641 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.9 69.62 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.305 -1.497 . . . . 0.0 111.846 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -82.16 -45.82 14.63 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.046 -1.034 . . . . 0.0 108.519 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -62.79 -34.05 76.46 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.804 0.812 . . . . 0.0 111.915 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.44 66.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.977 -1.077 . . . . 0.0 111.941 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.5 t -92.45 0.48 57.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.062 -1.024 . . . . 0.0 108.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.69 -34.52 62.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.69 0.757 . . . . 0.0 109.157 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -73.65 -34.87 65.15 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.786 -1.197 . . . . 0.0 110.764 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.66 -25.85 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 125.582 1.553 . . . . 0.0 109.376 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -47.73 -38.58 15.63 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 125.876 1.67 . . . . 0.0 111.357 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -61.18 -14.05 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -58.35 -37.05 74.4 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.398 -0.814 . . . . 0.0 109.885 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -67.98 -53.0 29.38 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.922 1.289 . . . . 0.0 108.966 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -64.89 -33.01 74.99 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 123.954 0.902 . . . . 0.0 112.355 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -69.08 -41.44 77.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.76 -1.213 . . . . 0.0 110.123 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -73.65 -37.84 65.19 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.49 -0.757 . . . . 0.0 109.589 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.6 12.65 50.15 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 CA--C 1.491 -1.296 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 177.182 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 -56.67 3.62 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.135 -175.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 4' ' ' HIS 0.279 33.9 t70 -176.74 -116.79 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -137.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.472 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 30.9 p80 -44.38 -35.36 2.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 130.611 3.564 . . . . 0.0 114.919 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.81 -31.35 72.5 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.679 0.792 . . . . 0.0 111.624 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -71.44 -32.06 67.9 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -78.46 -34.86 47.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.7 79.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.012 0.925 . . . . 0.0 110.487 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -66.0 -35.73 81.37 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 123.992 0.917 . . . . 0.0 111.378 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -62.83 -41.34 99.28 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.313 -0.867 . . . . 0.0 109.818 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.12 71.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.458 0.703 . . . . 0.0 111.579 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -62.94 -30.54 71.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.524 -0.735 . . . . 0.0 111.319 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.43 -33.69 67.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.62 -42.86 97.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 110.254 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.68 -42.15 95.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 123.094 0.558 . . . . 0.0 111.03 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.85 -37.63 79.8 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -67.04 -33.87 76.47 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 121.558 -0.714 . . . . 0.0 111.322 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.35 -30.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.265 -0.897 . . . . 0.0 109.048 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.52 -37.52 81.42 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.948 -1.095 . . . . 0.0 111.72 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.02 -44.56 72.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.643 1.177 . . . . 0.0 110.327 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.43 -39.4 92.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 121.322 -0.861 . . . . 0.0 109.567 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.58 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.792 1.237 . . . . 0.0 111.337 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 p -66.65 -43.12 85.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.689 0.677 . . . . 0.0 109.818 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.39 -54.9 37.67 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.062 0.945 . . . . 0.0 110.548 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -71.62 -31.34 66.77 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.865 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.99 71.84 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 119.142 0.883 . . . . 0.0 110.194 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.68 -38.72 83.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-O 121.856 0.836 . . . . 0.0 110.035 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.03 -33.97 72.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.474 -0.766 . . . . 0.0 110.286 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.9 84.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.433 1.111 . . . . 0.0 111.794 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -36.7 85.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 126.809 2.043 . . . . 0.0 111.207 176.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.72 77.87 9.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.508 1.147 . . . . 0.0 109.493 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.28 -35.55 0.71 Allowed Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 106.239 -2.744 . . . . 0.0 106.239 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.36 156.67 62.62 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 122.305 -0.527 . . . . 0.0 110.221 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.15 152.19 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.053 1.835 . . . . 0.0 110.033 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.32 56.59 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.24 26.38 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.046 1.338 . . . . 0.0 114.145 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -58.27 0.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.599 1.159 . . . . 0.0 111.944 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.8 tp -82.2 76.1 9.1 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.892 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.02 75.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 O-C-N 120.484 -1.385 . . . . 0.0 108.439 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -158.03 120.41 3.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.07 -54.01 60.66 Favored Pre-proline 0 C--N 1.352 0.716 0 CA-C-O 116.355 -1.784 . . . . 0.0 112.518 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.47 -3.91 14.6 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 CA-C-N 125.277 2.92 . . . . 0.0 112.044 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -105.4 -33.12 8.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.47 -24.41 61.99 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 120.459 -1.401 . . . . 0.0 112.081 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.68 -23.7 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.771 0.796 . . . . 0.0 110.005 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -39.91 51.34 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.542 -1.349 . . . . 0.0 108.173 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.2 t90 -64.94 -46.83 79.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 123.81 0.844 . . . . 0.0 108.851 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -64.32 -27.1 68.8 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.71 -54.12 37.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 C-N-CA 123.794 0.838 . . . . 0.0 109.011 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.59 -27.24 62.05 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.675 -0.641 . . . . 0.0 111.177 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -62.22 -40.42 96.06 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.962 0.905 . . . . 0.0 110.769 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.52 74.05 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 121.427 -0.796 . . . . 0.0 111.815 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.53 1.05 39.74 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.937 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p 56.54 21.44 5.69 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.335 1.854 . . . . 0.0 112.474 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.35 -58.72 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.7 72.51 0.63 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.74 -22.19 62.44 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.136 0.97 . . . . 0.0 109.962 -166.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.23 26.06 3.88 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' CG ' HH12 ' B' ' 68' ' ' ARG . 19.0 t70 -65.5 -53.74 38.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.966 1.306 . . . . 0.0 110.335 177.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.43 164.73 28.6 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.82 137.19 30.24 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.53 169.17 12.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.621 2.214 . . . . 0.0 110.41 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -71.13 176.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.759 1.266 . . . . 0.0 111.743 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 m -96.96 -51.24 4.32 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.711 1.205 . . . . 0.0 109.959 -172.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.57 -42.9 89.02 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 111.237 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -130.85 -137.1 0.21 Allowed 'General case' 0 CA--C 1.492 -1.27 1 N-CA-C 100.184 -4.006 . . . . 0.0 100.184 165.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.46 -77.98 1.18 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.496 HH22 ' CG ' ' D' ' 59' ' ' ASP . 6.5 ttm180 -63.08 -40.81 98.75 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.585 1.954 . . . . 0.0 110.492 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -75.17 -19.26 59.93 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.734 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.01 -50.12 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.6 74.0 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.745 1.618 . . . . 0.0 111.588 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -42.13 -51.96 4.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 127.654 2.382 . . . . 0.0 112.32 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.62 -35.28 75.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.299 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.04 -46.35 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.454 1.102 . . . . 0.0 109.126 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.69 -45.38 94.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.001 1.321 . . . . 0.0 109.717 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -59.73 -37.69 79.65 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.545 0.738 . . . . 0.0 111.947 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.67 89.38 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.587 -0.696 . . . . 0.0 110.543 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.3 -46.85 85.15 Favored Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.8 -47.45 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 109.188 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.9 -42.75 99.89 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.127 -0.983 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.9 t -63.6 -52.13 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.264 0.938 . . . . 0.0 110.142 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.92 -28.94 67.92 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.063 0.545 . . . . 0.0 111.077 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.13 -34.32 32.58 Favored 'General case' 0 CA--C 1.505 -0.75 0 O-C-N 120.932 -1.105 . . . . 0.0 110.606 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.45 -32.68 74.19 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.39 -1.444 . . . . 0.0 110.865 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -65.6 -5.15 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 121.56 -0.713 . . . . 0.0 112.41 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -55.35 -20.88 13.0 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.596 1.559 . . . . 0.0 111.566 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.56 -21.07 65.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 120.422 -1.424 . . . . 0.0 113.046 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.27 -39.16 14.63 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 124.821 1.248 . . . . 0.0 108.727 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.58 -45.53 91.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.883 1.273 . . . . 0.0 110.013 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.33 60.21 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.409 ' CG2' ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER -79.91 -15.98 56.23 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 119.781 -1.825 . . . . 0.0 107.653 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.413 55.1 m-20 -98.55 14.67 27.53 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.606 -160.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -89.62 -30.86 17.85 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 153.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.65 -24.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.402 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -56.19 -23.79 37.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.597 1.159 . . . . 0.0 111.99 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -64.52 -19.7 65.76 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.182 -1.574 . . . . 0.0 112.061 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -71.43 -25.14 62.2 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.226 -0.921 . . . . 0.0 110.322 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.41 -42.87 34.6 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -61.01 -31.03 70.65 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.17 0.988 . . . . 0.0 111.355 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -66.74 -25.92 66.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.587 -0.696 . . . . 0.0 111.42 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -82.2 -36.82 26.9 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.29 19.24 46.58 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 . . . . . 0 CA--C 1.501 -0.94 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.682 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.32 -177.45 4.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.714 -1.241 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -62.5 1.82 Allowed 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.713 2.005 . . . . 0.0 108.363 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.424 ' HE1' ' OE2' ' B' ' 5' ' ' GLU . 18.6 p80 -60.2 -31.75 70.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.819 2.048 . . . . 0.0 113.735 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.424 ' OE2' ' HE1' ' B' ' 4' ' ' HIS . 6.6 mt-10 -74.66 -35.64 62.82 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.047 -1.033 . . . . 0.0 110.959 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -73.95 -36.52 64.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.794 -0.566 . . . . 0.0 110.491 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.82 -37.8 82.42 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.96 90.35 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.908 0.883 . . . . 0.0 111.112 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.13 -35.2 78.02 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.099 0.96 . . . . 0.0 110.913 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -65.13 -38.22 89.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.283 1.033 . . . . 0.0 110.545 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.18 80.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.429 1.092 . . . . 0.0 110.782 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.51 -36.26 83.63 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.474 -0.766 . . . . 0.0 111.042 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -75.61 -25.13 56.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.023 -1.048 . . . . 0.0 111.354 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.434 ' CD ' ' HZ2' ' B' ' 17' ' ' LYS . 29.1 tp10 -67.58 -38.33 83.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.57 -46.18 89.66 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.423 0.689 . . . . 0.0 110.886 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -57.23 -41.02 78.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.339 1.456 . . . . 0.0 111.367 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.434 ' HZ2' ' CD ' ' B' ' 14' ' ' GLU . 20.7 ttpt -66.38 -37.37 85.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.356 1.063 . . . . 0.0 110.761 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.25 -38.34 81.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 O-C-N 120.938 -1.101 . . . . 0.0 108.643 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.47 -44.09 89.16 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 123.736 0.815 . . . . 0.0 110.526 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.68 -48.7 74.63 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 110.592 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -75.57 -36.79 60.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.783 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.16 -29.05 69.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.357 1.063 . . . . 0.0 111.87 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -62.24 -42.3 99.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.758 1.223 . . . . 0.0 110.443 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -67.77 -48.11 67.28 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 125.363 1.465 . . . . 0.0 107.37 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -58.07 -47.48 83.04 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 124.626 1.17 . . . . 0.0 111.299 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.87 78.81 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.979 0.912 . . . . 0.0 111.366 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.95 -44.17 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 -29.26 65.05 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 119.817 1.189 . . . . 0.0 110.947 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.8 -42.67 60.63 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 125.092 1.357 . . . . 0.0 109.611 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -74.98 -21.0 59.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.618 0.723 . . . . 0.0 111.022 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -74.67 89.47 2.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 120.276 -1.515 . . . . 0.0 110.636 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.78 -4.01 11.78 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.92 150.95 56.83 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 118.065 0.933 . . . . 0.0 109.082 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -82.26 132.58 7.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.937 2.425 . . . . 0.0 110.723 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 5.19 88.07 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.47 146.02 55.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 123.671 0.789 . . . . 0.0 111.497 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.43 -47.48 4.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 124.906 1.282 . . . . 0.0 108.078 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -90.47 66.07 6.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 122.807 1.289 . . . . 0.0 108.836 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -101.03 26.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 O-C-N 120.344 -1.472 . . . . 0.0 108.485 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 11.6 p -91.05 -114.86 0.08 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 t80 162.2 -70.99 0.0 OUTLIER Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 126.757 2.023 . . . . 0.0 106.296 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.92 -12.03 19.8 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-N 125.112 2.862 . . . . 0.0 111.868 -163.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.0 6.31 36.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.296 1.038 . . . . 0.0 109.059 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.96 74.68 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.368 -0.832 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.63 -30.35 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.075 0.95 . . . . 0.0 111.574 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -85.61 -18.47 33.18 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.343 -0.848 . . . . 0.0 109.962 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -80.72 -41.05 24.24 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.88 60.53 0.96 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 111.452 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.43 -64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.86 -19.06 64.99 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -167.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -72.62 -30.76 64.6 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.123 0.969 . . . . 0.0 108.947 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.59 62.17 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.502 -1.374 . . . . 0.0 110.381 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -93.52 14.84 17.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.685 0.794 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 67.5 p 55.4 51.72 12.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.751 1.62 . . . . 0.0 113.728 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.87 -145.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.047 1 N-CA-C 99.473 -4.269 . . . . 0.0 99.473 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.9 90.31 0.13 Allowed Glycine 0 CA--C 1.481 -2.047 1 N-CA-C 99.058 -5.617 . . . . 0.0 99.058 -171.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -81.58 -17.57 47.85 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.447 -1.031 . . . . 0.0 108.673 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.41 44.22 1.49 Allowed Glycine 0 CA--C 1.486 -1.764 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -72.28 -63.72 1.09 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -102.06 -169.24 1.65 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -155.35 100.9 2.25 Favored Pre-proline 0 N--CA 1.443 -0.805 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.81 153.34 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.698 2.265 . . . . 0.0 110.255 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.51 -124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -135.2 -11.14 2.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.036 -1.04 . . . . 0.0 109.046 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -112.54 2.67 16.37 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 125.64 1.576 . . . . 0.0 107.433 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.27 43.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.06 91.26 1.54 Allowed Glycine 0 N--CA 1.418 -2.564 1 N-CA-C 98.14 -5.984 . . . . 0.0 98.14 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.418 HH12 ' CG ' ' A' ' 59' ' ' ASP . 37.6 ttm180 -68.74 -3.98 14.21 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.073 1.937 . . . . 0.0 110.648 -174.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.168 1.787 . . . . 0.0 111.638 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -47.89 84.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 124.994 1.317 . . . . 0.0 109.4 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.41 77.44 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -55.18 -41.56 72.07 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.711 1.605 . . . . 0.0 111.114 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -65.38 -35.39 80.83 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.428 -0.795 . . . . 0.0 111.578 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.17 -41.78 44.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 9.2 tpp -53.59 -54.94 30.29 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 126.249 1.819 . . . . 0.0 109.96 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -68.81 -36.11 77.82 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.162 0.985 . . . . 0.0 110.499 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.67 87.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.594 -0.691 . . . . 0.0 110.939 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.95 96.96 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 124.455 1.026 . . . . 0.0 111.322 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 72.3 mt -60.36 -42.95 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 109.114 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -73.09 -31.31 64.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.061 -1.025 . . . . 0.0 113.262 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.43 -43.44 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.256 -0.902 . . . . 0.0 109.702 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.81 -36.56 78.39 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 118.686 0.675 . . . . 0.0 110.073 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.46 92.39 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.896 0.878 . . . . 0.0 110.944 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.28 -31.97 73.38 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.579 -1.326 . . . . 0.0 111.651 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.77 -25.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 124.194 0.998 . . . . 0.0 109.762 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -68.33 -3.11 9.93 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 121.142 -0.974 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.52 82.65 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.679 -2.513 . . . . 0.0 110.84 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.53 59.72 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 39.4 mt -110.02 27.22 9.82 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.25 -9.33 8.62 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.414 HG22 ' CD2' ' B' ' 4' ' ' HIS . 10.0 t -100.36 3.36 43.21 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -71.71 -45.41 61.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.517 1.127 . . . . 0.0 109.197 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.59 -26.36 68.65 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.8 -1.187 . . . . 0.0 112.386 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.2 -29.16 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 123.984 0.914 . . . . 0.0 109.993 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -26.06 64.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 120.423 -1.423 . . . . 0.0 109.53 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -70.62 -19.45 62.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.796 -0.565 . . . . 0.0 111.696 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -70.77 -45.28 65.02 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.03 -1.669 . . . . 0.0 109.565 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -92.17 4.41 53.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.259 0.623 . . . . 0.0 110.553 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -80.41 -55.85 4.6 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 167.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -62.53 -51.3 67.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.997 0.903 . . . . 0.0 112.004 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -94.0 116.46 28.9 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.65 -28.04 6.34 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.904 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.63 20.27 0.49 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.086 2.555 . . . . 0.0 115.344 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 63.81 -73.3 0.05 OUTLIER 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.415 2.686 . . . . 0.0 110.061 -175.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -60.38 -36.07 77.2 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 130.312 3.445 . . . . 0.0 110.424 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -75.38 -36.41 60.9 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -33.87 76.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.701 0.801 . . . . 0.0 111.202 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -45.9 64.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.779 0.832 . . . . 0.0 108.877 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.65 98.89 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.163 0.985 . . . . 0.0 111.552 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -71.33 -26.23 62.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.105 1.362 . . . . 0.0 110.702 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.39 -37.93 63.26 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.99 95.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.233 -0.917 . . . . 0.0 111.235 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.98 -34.58 78.77 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.413 -0.805 . . . . 0.0 111.094 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -62.98 -33.48 75.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.606 1.162 . . . . 0.0 110.457 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.98 -42.56 84.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 109.146 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.6 tp -62.04 -37.11 83.72 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.16 0.984 . . . . 0.0 110.968 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.64 -27.67 69.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -34.91 63.31 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.518 -1.364 . . . . 0.0 109.289 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.75 -36.51 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.03 -41.04 77.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 123.877 0.871 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -72.07 -35.51 69.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.851 0.86 . . . . 0.0 111.2 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.92 -46.74 56.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.731 1.253 . . . . 0.0 107.992 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.79 64.35 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 125.787 1.635 . . . . 0.0 111.432 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' C' ' 45' ' ' ILE . 1.4 p -74.21 -36.6 63.97 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.296 -0.877 . . . . 0.0 110.014 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.521 ' HZ3' ' CD ' ' C' ' 28' ' ' GLU . 14.5 tmtt? -64.94 -47.66 76.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -64.3 -35.61 81.42 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.338 0.655 . . . . 0.0 111.004 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.04 60.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.35 1.06 . . . . 0.0 110.943 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.16 -36.07 73.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 CA-C-O 122.08 0.943 . . . . 0.0 110.069 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.521 ' CD ' ' HZ3' ' C' ' 24' ' ' LYS . 37.6 tt0 -69.13 -36.16 77.18 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.056 -1.028 . . . . 0.0 110.298 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.8 67.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.635 1.574 . . . . 0.0 111.706 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -75.63 -17.6 59.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 121.451 -0.781 . . . . 0.0 110.72 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -85.58 75.48 10.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.363 -1.46 . . . . 0.0 110.152 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.37 -42.3 0.44 Allowed Glycine 0 CA--C 1.478 -2.237 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 151.11 66.02 Favored Pre-proline 0 N--CA 1.437 -1.093 0 O-C-N 122.36 -0.494 . . . . 0.0 110.806 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.72 147.73 24.99 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.868 1.712 . . . . 0.0 110.214 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 28.87 35.25 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.509 -0.606 . . . . 0.0 112.17 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.08 132.66 54.16 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 112.703 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.8 -37.21 0.6 Allowed 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.175 0.99 . . . . 0.0 109.539 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.71 35.67 0.78 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.749 1.22 . . . . 0.0 107.906 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 tt -77.41 4.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 123.673 1.702 . . . . 0.0 108.651 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -71.68 125.8 28.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.03 2.132 . . . . 0.0 110.373 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -87.71 -55.85 0.33 Allowed Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.908 -1.52 . . . . 0.0 111.225 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.42 -24.52 16.32 Favored 'Trans proline' 0 CA--C 1.501 -1.172 0 CA-C-N 125.075 2.848 . . . . 0.0 111.228 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.0 -7.2 58.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.89 79.45 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.043 -1.035 . . . . 0.0 111.126 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' C' ' 23' ' ' SER . 20.3 tt -69.17 -29.34 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.485 -0.759 . . . . 0.0 110.186 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -36.71 74.57 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 121.017 -1.052 . . . . 0.0 111.318 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -71.4 -33.32 69.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.632 0.729 . . . . 0.0 109.639 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -59.93 -41.56 92.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.95 -55.03 18.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.174 1.39 . . . . 0.0 110.753 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.89 -13.22 60.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.593 -0.692 . . . . 0.0 112.196 -173.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -79.47 -39.47 32.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.964 0.906 . . . . 0.0 109.252 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -24.02 64.88 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 120.88 -1.137 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p -92.81 2.43 56.76 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.477 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p 50.03 36.98 13.07 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.119 1.768 . . . . 0.0 111.269 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.6 -59.13 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 61.17 6.85 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -43.49 60.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -170.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.93 -114.26 0.59 Allowed Glycine 0 CA--C 1.482 -1.983 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.305 27.2 t70 62.17 -71.38 0.05 OUTLIER 'General case' 0 C--N 1.351 0.672 0 C-N-CA 127.199 2.2 . . . . 0.0 111.185 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -117.19 -163.98 0.96 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -155.53 148.08 17.8 Favored Pre-proline 0 N--CA 1.433 -1.301 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -90.24 159.55 4.67 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.197 1.932 . . . . 0.0 109.684 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.421 ' H ' HG22 ' C' ' 63' ' ' VAL . 16.1 m -82.94 -175.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.91 1.684 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 -79.64 0.2 Allowed 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.461 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -39.7 -43.8 1.43 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.174 2.189 . . . . 0.0 113.31 -165.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -113.92 -91.18 0.51 Allowed 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 8.04 -69.04 0.0 OUTLIER Glycine 0 C--N 1.36 1.863 1 C-N-CA 131.584 4.421 . . . . 0.0 117.267 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -66.61 -41.23 88.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.475 1.51 . . . . 0.0 113.033 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -80.42 -20.2 44.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.098 -1.001 . . . . 0.0 109.031 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.93 -46.41 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 172.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.78 76.67 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 126.116 1.766 . . . . 0.0 111.576 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.51 -53.54 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.495 2.318 . . . . 0.0 111.074 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.24 -39.91 89.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.188 1.395 . . . . 0.0 110.551 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.98 -45.42 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.55 1.14 . . . . 0.0 109.315 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.0 mtm -59.67 -46.81 87.94 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 109.888 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -60.09 -38.68 83.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 111.302 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.58 82.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.609 0.764 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.99 -46.54 58.96 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.99 -45.62 92.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.556 0 C-N-CA 124.388 1.075 . . . . 0.0 109.536 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -61.7 -42.43 98.94 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.445 -0.784 . . . . 0.0 111.692 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.68 -49.88 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 123.956 0.902 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -67.96 -35.02 77.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.925 -0.484 . . . . 0.0 110.648 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.06 -28.46 61.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.055 -1.028 . . . . 0.0 110.715 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.08 -18.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 120.503 -1.373 . . . . 0.0 111.384 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.66 1.5 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 120.144 -1.598 . . . . 0.0 111.22 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 31.4 m -62.9 -20.53 65.26 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.104 -1.623 . . . . 0.0 111.31 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.89 44.82 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 124.785 1.234 . . . . 0.0 112.159 169.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.23 -40.21 13.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.529 1.532 . . . . 0.0 110.269 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.65 -46.08 48.79 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.141 0.577 . . . . 0.0 111.297 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.3 -28.16 66.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.603 -0.685 . . . . 0.0 110.815 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -85.59 -14.49 45.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.067 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.363 16.5 t70 -74.29 -30.08 61.93 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-N 121.776 2.08 . . . . 0.0 110.767 -168.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -70.49 -26.13 63.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 119.693 -1.879 . . . . 0.0 112.413 174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.84 -22.47 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 124.521 1.129 . . . . 0.0 108.559 -174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -63.26 -17.42 62.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.331 1.053 . . . . 0.0 111.463 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -71.36 -22.35 61.91 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 120.818 -1.176 . . . . 0.0 112.321 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -92.08 -15.79 27.29 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.48 -0.762 . . . . 0.0 109.565 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -102.76 -172.64 2.16 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.16 -64.45 0.33 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.243 1.817 . . . . 0.0 111.695 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 30.6 ttp85 -59.91 -33.45 71.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 129.796 3.238 . . . . 0.0 110.994 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -42.33 92.01 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.278 1.031 . . . . 0.0 111.023 174.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.59 56.89 5.27 Favored Glycine 0 CA--C 1.493 -1.319 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -172.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 177.397 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.97 66.35 1.07 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.388 1.475 . . . . 0.0 113.207 172.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -52.08 -29.93 23.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.531 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 3.5 p-80 -59.56 -33.63 71.67 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.531 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 9.3 mt-10 -79.27 -42.09 26.63 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 23.7 ttp85 -60.87 -38.77 86.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 110.279 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.7 -32.07 71.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.302 -0.873 . . . . 0.0 111.668 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.31 84.06 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.435 0.636 . . . . 0.0 109.597 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -66.83 -37.6 84.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.38 -0.825 . . . . 0.0 110.382 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -69.24 -23.68 63.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.288 -0.882 . . . . 0.0 111.346 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.74 86.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.608 -1.308 . . . . 0.0 111.079 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.12 -31.0 72.04 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.78 -1.2 . . . . 0.0 111.877 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.98 -34.87 79.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.049 1.34 . . . . 0.0 109.3 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -67.91 -41.05 83.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.792 1.237 . . . . 0.0 108.785 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.01 -45.33 95.24 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.689 0.796 . . . . 0.0 110.29 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.946 0.794 . . . . 0.0 112.164 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -74.1 -13.49 60.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.096 -1.003 . . . . 0.0 113.405 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.27 -46.51 12.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -53.06 -49.25 66.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 128.126 2.57 . . . . 0.0 110.459 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -78.11 -17.04 57.42 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.533 -1.354 . . . . 0.0 111.0 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -76.98 -31.9 56.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.44 82.81 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 124.767 1.227 . . . . 0.0 111.544 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -59.4 -42.7 92.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.75 1.22 . . . . 0.0 112.168 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -69.59 -37.99 77.15 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.827 0.851 . . . . 0.0 109.005 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -70.51 -51.01 31.86 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.433 0.693 . . . . 0.0 110.09 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.47 92.2 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 126.18 1.792 . . . . 0.0 112.304 -171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.46 -35.7 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -75.45 -36.13 60.78 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.05 99.13 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.902 2.081 . . . . 0.0 110.201 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -88.48 -21.88 23.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -70.0 84.95 0.51 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 120.444 -1.41 . . . . 0.0 109.787 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.49 -2.2 4.14 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.23 157.55 82.86 Favored Pre-proline 0 N--CA 1.446 -0.644 0 O-C-N 121.138 -1.213 . . . . 0.0 112.55 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.63 131.29 11.29 Favored 'Trans proline' 0 CA--C 1.508 -0.798 0 C-N-CA 123.585 2.856 . . . . 0.0 110.643 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.76 -59.39 4.57 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.37 166.9 0.11 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.729 2.812 . . . . 0.0 110.327 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.05 -53.93 0.13 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.293 -1.744 . . . . 0.0 106.293 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 34.0 tp -99.68 134.83 42.0 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -149.88 167.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m 73.61 131.8 0.04 OUTLIER 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.278 1.831 . . . . 0.0 112.918 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -58.08 -51.65 80.25 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.448 -1.739 . . . . 0.0 113.183 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.53 -13.16 24.99 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 CA-C-N 124.306 2.574 . . . . 0.0 111.967 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 -46.84 9.08 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.16 73.78 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.333 1.453 . . . . 0.0 111.716 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -65.98 -31.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 121.686 -0.634 . . . . 0.0 111.178 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -31.97 47.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 120.727 -1.233 . . . . 0.0 109.854 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -61.92 -40.44 95.5 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.388 1.089 . . . . 0.0 109.443 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -64.5 -35.84 82.26 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 119.898 -1.751 . . . . 0.0 112.169 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.98 -53.35 49.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.007 0.923 . . . . 0.0 109.468 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.422 ' CD ' HH11 ' A' ' 68' ' ' ARG . 14.0 pt-20 -69.03 -24.71 64.23 Favored 'General case' 0 C--N 1.351 0.63 0 C-N-CA 123.275 0.63 . . . . 0.0 111.662 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -76.05 -38.54 57.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.337 -0.852 . . . . 0.0 108.74 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.53 -28.19 65.81 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.981 -1.074 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 10.4 p -93.81 9.63 36.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 123.162 0.585 . . . . 0.0 110.335 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 18.3 p 58.68 43.47 18.75 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.901 1.68 . . . . 0.0 114.702 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.68 -69.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 86.59 -55.66 4.69 Favored Glycine 0 N--CA 1.435 -1.385 0 O-C-N 120.564 -1.335 . . . . 0.0 111.908 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.1 -30.92 0.21 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.5 1.92 . . . . 0.0 113.296 173.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 108.83 26.26 5.36 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.496 ' CG ' HH22 ' A' ' 68' ' ' ARG . 30.0 t70 -68.8 -67.99 0.43 Allowed 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.683 0.793 . . . . 0.0 109.023 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 157.64 46.05 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 102.666 -3.086 . . . . 0.0 102.666 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.9 122.26 4.98 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.78 178.06 6.87 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 C-N-CA 123.022 2.481 . . . . 0.0 110.67 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.417 HG21 ' H ' ' D' ' 64' ' ' THR . 9.8 p -113.27 -177.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 122.895 1.331 . . . . 0.0 111.27 -170.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.417 ' H ' HG21 ' D' ' 63' ' ' VAL . 7.1 m -52.41 -40.65 62.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.733 2.813 . . . . 0.0 113.048 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.63 -11.72 59.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.424 1.09 . . . . 0.0 110.696 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' D' ' 68' ' ' ARG . 0.4 OUTLIER -68.64 -33.27 73.71 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 170.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 131.93 -26.57 3.78 Favored Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.407 ' H ' ' CD ' ' D' ' 66' ' ' GLU 0.348 9.4 ttt85 57.19 -35.92 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.031 1 C-N-CA 132.458 4.303 . . . . 0.0 113.702 -168.339 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' D' ' 67' ' ' GLY . 9.7 tptm -69.81 -9.28 54.1 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 126.243 1.817 . . . . 0.0 109.957 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 t -72.74 -37.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -53.86 37.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -46.94 -55.17 8.54 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 125.862 1.665 . . . . 0.0 112.947 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -70.02 -25.49 63.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.889 -0.507 . . . . 0.0 111.732 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.39 -45.9 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 8.5 mtp -56.5 -45.89 80.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.064 1.346 . . . . 0.0 110.252 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -59.41 -38.03 79.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.635 1.174 . . . . 0.0 112.101 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -36.99 84.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.998 -0.439 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.55 -43.77 85.05 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 123.731 0.681 . . . . 0.0 111.444 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.78 -47.97 89.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 C-N-CA 124.308 1.043 . . . . 0.0 109.419 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -63.75 -43.43 96.46 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 123.848 0.859 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -61.93 -49.8 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 O-C-N 120.86 -1.15 . . . . 0.0 110.592 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.11 0.56 27.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.84 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.25 -40.34 10.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.37 -39.14 72.43 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 126.681 1.992 . . . . 0.0 111.276 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 m -59.1 -15.54 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.106 1.362 . . . . 0.0 112.988 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -70.4 -5.23 26.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.918 1.287 . . . . 0.0 110.12 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.01 70.78 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 119.985 -1.697 . . . . 0.0 109.797 166.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' D' ' 4' ' ' HIS . . . -66.13 -41.62 90.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.827 -1.17 . . . . 0.0 110.476 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.44 -37.96 80.73 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.086 0.554 . . . . 0.0 111.165 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.03 -17.46 60.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.005 -1.06 . . . . 0.0 110.409 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -73.07 -27.84 61.97 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.56 70.47 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.279 -0.888 . . . . 0.0 111.284 -159.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -68.49 -30.12 68.89 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.676 -1.265 . . . . 0.0 111.563 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 12.4 t -74.82 -25.72 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 123.857 0.863 . . . . 0.0 109.063 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.8 mtp-105 -63.55 -25.92 68.46 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 120.992 -1.068 . . . . 0.0 110.931 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.4 -20.88 64.91 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.751 -0.593 . . . . 0.0 111.081 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.5 -14.16 61.59 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -110.53 -36.72 5.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -62.87 -32.0 73.16 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.042 -1.036 . . . . 0.0 112.602 -174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -83.51 -6.68 59.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.519 -0.738 . . . . 0.0 112.123 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -102.34 -40.8 6.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.76 0.58 32.24 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 72.6 t60 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 177.612 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.11 -70.74 0.25 Allowed 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.3 51.9 m-20 74.21 -41.7 0.49 Allowed 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.799 2.039 . . . . 0.0 111.009 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -43.98 83.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.483 1.113 . . . . 0.0 112.643 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.259 1.8 pm0 -72.71 -15.25 61.69 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.333 -2.105 . . . . 0.0 112.959 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -74.43 -42.86 58.44 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 120.432 -1.417 . . . . 0.0 108.521 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.63 -39.29 83.82 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.828 2.051 . . . . 0.0 109.212 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.11 92.4 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.856 1.263 . . . . 0.0 112.279 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.63 -26.22 60.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.394 -0.816 . . . . 0.0 111.169 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -65.7 -40.41 92.27 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.936 -1.103 . . . . 0.0 108.861 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.22 77.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.81 0.844 . . . . 0.0 112.09 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -34.83 76.04 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.495 -0.753 . . . . 0.0 111.735 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -68.87 -27.06 65.47 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 120.617 -1.302 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -64.8 -35.17 80.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.025 1.33 . . . . 0.0 109.375 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.96 -43.94 81.84 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.843 0.857 . . . . 0.0 110.141 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.61 -34.16 72.4 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 124.301 1.04 . . . . 0.0 111.912 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -66.91 -41.98 86.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.621 1.169 . . . . 0.0 110.185 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.13 -42.13 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.5 mt -55.32 -42.92 74.38 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.406 1.082 . . . . 0.0 112.397 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -69.71 -38.63 77.02 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.797 1.239 . . . . 0.0 110.873 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.39 -42.51 65.13 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 120.52 -1.362 . . . . 0.0 108.589 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.66 72.51 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.735 1.614 . . . . 0.0 112.351 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -69.66 -35.03 74.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -35.15 68.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.415 1.086 . . . . 0.0 109.277 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -69.24 -55.38 10.71 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 124.534 1.134 . . . . 0.0 108.595 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.02 84.1 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.483 1.513 . . . . 0.0 111.658 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -37.09 78.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.214 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.11 -35.09 64.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.148 -1.595 . . . . 0.0 110.013 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.2 -49.75 63.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.095 1.758 . . . . 0.0 108.342 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.64 -38.12 80.25 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.655 1.182 . . . . 0.0 111.409 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -71.34 109.27 5.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 119.289 -2.132 . . . . 0.0 110.971 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -9.6 16.83 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.79 152.11 48.41 Favored Pre-proline 0 C--N 1.352 0.683 0 CA-C-N 118.391 1.095 . . . . 0.0 109.713 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.82 144.21 24.27 Favored 'Trans proline' 0 CA--C 1.502 -1.09 0 C-N-CA 122.751 2.301 . . . . 0.0 109.481 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.66 78.99 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.73 115.85 2.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 125.966 1.707 . . . . 0.0 109.975 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.98 -43.56 8.48 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.8 tp -90.51 65.31 6.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.928 1.347 . . . . 0.0 110.04 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.93 -0.76 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 119.851 -1.78 . . . . 0.0 112.304 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.5 m -109.44 123.35 49.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.147 -0.971 . . . . 0.0 111.247 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.13 -58.65 11.88 Favored Pre-proline 0 C--N 1.351 0.641 0 C-N-CA 125.83 1.652 . . . . 0.0 111.234 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.12 -6.45 17.99 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.078 2.849 . . . . 0.0 111.13 -171.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -100.59 -3.06 31.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.36 -32.9 69.05 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 119.737 -1.852 . . . . 0.0 109.15 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.59 -30.0 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.826 0.851 . . . . 0.0 109.684 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.95 -47.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 125.919 1.687 . . . . 0.0 110.054 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.69 -41.93 87.29 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.954 1.702 . . . . 0.0 108.554 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -56.21 -45.74 79.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 111.679 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.22 -46.22 94.04 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 121.269 -0.894 . . . . 0.0 111.444 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.03 -13.92 59.7 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 118.894 -1.122 . . . . 0.0 112.537 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -69.69 -36.4 75.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.136 -0.978 . . . . 0.0 108.555 171.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.0 63.2 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.297 -1.502 . . . . 0.0 112.186 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.424 ' HG1' HG13 ' A' ' 55' ' ' VAL . 22.4 p -95.42 15.09 20.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.443 0.565 . . . . 0.0 109.686 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p 53.35 29.2 8.33 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 126.932 2.093 . . . . 0.0 113.499 166.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.424 HG13 ' HG1' ' A' ' 53' ' ' THR . 2.3 p -101.31 -74.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -172.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.06 80.65 0.86 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -10.5 59.48 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.992 -1.299 . . . . 0.0 111.4 -170.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.23 18.4 13.53 Favored Glycine 0 CA--C 1.491 -1.443 0 O-C-N 121.061 -1.024 . . . . 0.0 111.79 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -73.16 -46.3 51.62 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 118.533 1.167 . . . . 0.0 109.312 177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.01 164.26 27.72 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.28 146.69 28.66 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 102.019 -3.326 . . . . 0.0 102.019 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.96 -165.36 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.29 3.327 . . . . 0.0 109.858 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 64' ' ' THR . 13.8 p -139.0 -147.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 63' ' ' VAL . 89.6 m -102.49 -48.19 4.23 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.017 1.327 . . . . 0.0 108.282 -170.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -78.97 -17.08 56.05 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.435 0.694 . . . . 0.0 110.47 -169.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.32 -34.3 75.02 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 123.354 1.55 . . . . 0.0 107.477 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.38 79.2 1.43 Allowed Glycine 0 CA--C 1.462 -3.229 1 N-CA-C 98.594 -5.802 . . . . 0.0 98.594 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.475 HH12 ' CG ' ' D' ' 59' ' ' ASP . 19.8 ttt85 -50.61 -18.16 0.64 Allowed 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.358 1.863 . . . . 0.0 113.731 -171.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -38.78 -31.31 0.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 127.318 2.247 . . . . 0.0 114.697 159.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.06 -43.56 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 119.01 0.823 . . . . 0.0 108.877 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.46 64.38 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.594 -0.691 . . . . 0.0 109.646 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.76 -47.11 51.11 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.402 1.481 . . . . 0.0 112.177 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -68.27 -37.22 80.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.466 0.707 . . . . 0.0 111.033 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.45 -43.47 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.68 -44.27 97.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.2 1.0 . . . . 0.0 110.441 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -66.38 -33.69 76.29 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.204 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.5 74.08 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.347 -0.845 . . . . 0.0 110.928 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.2 86.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.05 -41.47 83.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.855 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -65.92 -43.79 87.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.391 -1.443 . . . . 0.0 113.73 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.2 -45.82 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 118.274 0.488 . . . . 0.0 109.811 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.91 -39.14 72.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.93 81.97 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 121.535 -0.728 . . . . 0.0 111.198 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.43 -31.98 73.37 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 111.736 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.29 -19.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.957 1.303 . . . . 0.0 110.051 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -62.41 -18.1 60.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.914 -1.116 . . . . 0.0 112.394 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.1 -55.49 34.31 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.48 -1.388 . . . . 0.0 110.244 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.46 87.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.93 -42.48 90.04 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.386 -0.821 . . . . 0.0 110.879 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.38 -14.04 60.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.959 -1.088 . . . . 0.0 110.643 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 m -77.06 -21.98 53.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.837 -1.164 . . . . 0.0 108.786 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.16 -42.95 82.04 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 122.012 0.91 . . . . 0.0 111.311 -165.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -70.76 -18.26 62.77 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.727 -1.233 . . . . 0.0 113.364 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -75.12 -20.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -75.67 -11.87 60.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 120.982 -1.074 . . . . 0.0 110.244 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -77.55 -17.42 57.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.865 -1.147 . . . . 0.0 110.926 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -96.35 159.89 14.71 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 73.12 -39.35 0.44 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.261 1.824 . . . . 0.0 110.934 -164.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.11 -44.32 91.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 127.119 2.168 . . . . 0.0 112.021 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -63.9 -31.26 72.38 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.848 0.833 . . . . 0.0 112.152 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -88.1 -19.46 27.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.151 0.98 . . . . 0.0 108.999 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.59 73.61 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -177.705 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.426 -1.646 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.94 -134.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -98.5 -62.37 1.25 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -58.02 -30.51 66.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.93 -28.97 58.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.812 0.845 . . . . 0.0 110.499 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -72.0 -39.72 69.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -32.72 74.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.62 0.724 . . . . 0.0 110.481 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.98 -46.45 81.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.773 0.829 . . . . 0.0 111.127 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -72.6 -34.63 67.52 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.654 0.74 . . . . 0.0 110.729 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.03 -35.09 79.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.492 1.917 . . . . 0.0 110.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.76 75.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 111.585 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' C' ' 76' ' ' LYS . 0.7 OUTLIER -63.65 -32.19 73.59 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.165 0.986 . . . . 0.0 110.998 177.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.04 -36.32 72.31 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 120.649 -1.282 . . . . 0.0 108.913 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -66.28 -35.73 81.16 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.028 0.931 . . . . 0.0 109.295 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -60.4 -42.26 95.55 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.484 -0.76 . . . . 0.0 111.287 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -59.28 -35.52 73.89 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 123.933 0.893 . . . . 0.0 111.584 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -70.55 -34.98 72.84 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 110.209 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.22 -41.31 86.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 124.516 1.126 . . . . 0.0 108.335 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 48.0 mt -56.42 -44.63 80.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.447 1.099 . . . . 0.0 111.547 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.61 -31.61 71.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.183 0.993 . . . . 0.0 111.488 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.99 -33.33 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.317 -1.489 . . . . 0.0 108.744 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.56 -31.29 71.91 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.917 1.287 . . . . 0.0 111.509 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 59.1 p -66.22 -39.9 89.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 119.026 0.83 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.34 93.39 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.084 1.754 . . . . 0.0 108.64 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.22 -57.96 5.19 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 117.671 -1.157 . . . . 0.0 108.25 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.52 -48.32 57.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 126.171 1.788 . . . . 0.0 112.855 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.12 -39.63 84.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.77 -1.206 . . . . 0.0 111.357 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.1 -25.67 31.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.117 -0.989 . . . . 0.0 109.464 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 126.465 1.906 . . . . 0.0 108.516 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.06 -34.18 77.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.14 0.976 . . . . 0.0 111.73 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -68.15 109.13 3.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.34 -2.1 . . . . 0.0 111.433 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -10.89 16.31 Favored Glycine 0 CA--C 1.496 -1.104 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.72 147.08 40.52 Favored Pre-proline 0 N--CA 1.442 -0.84 0 O-C-N 121.802 -0.822 . . . . 0.0 109.439 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.51 137.81 11.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.49 2.127 . . . . 0.0 110.067 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.28 81.85 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.1 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.23 104.01 0.22 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.19 1.396 . . . . 0.0 109.56 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.72 -28.63 21.65 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.79 132.71 37.91 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -148.36 170.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 81.47 124.77 0.04 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.741 1.616 . . . . 0.0 109.003 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -66.04 -52.45 39.82 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.602 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.97 -3.48 13.84 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 125.226 2.902 . . . . 0.0 112.314 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -110.61 -10.78 14.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.45 75.88 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.25 -0.906 . . . . 0.0 108.846 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -60.24 -26.15 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 125.765 1.626 . . . . 0.0 111.205 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.731 -1.23 . . . . 0.0 109.569 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -79.26 -35.76 40.96 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.8 p -77.31 57.82 1.54 Allowed 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 122.113 -0.367 . . . . 0.0 110.579 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.35 -53.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.77 -26.88 68.55 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 119.328 0.967 . . . . 0.0 111.977 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -67.06 -34.39 77.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.55 1.14 . . . . 0.0 109.439 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.5 62.67 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.449 -1.407 . . . . 0.0 111.013 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -93.39 11.92 26.66 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.688 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.7 p 48.89 55.5 9.13 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.267 1.427 . . . . 0.0 113.17 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' H ' ' B' ' 56' ' ' GLY . 0.2 OUTLIER -121.95 -87.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.403 ' H ' HG22 ' B' ' 55' ' ' VAL . . . 87.15 73.66 1.28 Allowed Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 -19.42 62.12 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.344 -1.092 . . . . 0.0 110.429 -173.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.1 37.99 1.3 Allowed Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -93.2 -30.89 14.98 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 118.125 0.963 . . . . 0.0 110.066 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -140.3 176.55 8.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -155.02 149.66 20.01 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 102.295 -3.224 . . . . 0.0 102.295 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -85.04 -178.21 3.09 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 124.74 3.626 . . . . 0.0 109.949 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.418 HG12 ' H ' ' B' ' 64' ' ' THR . 0.8 OUTLIER -133.76 -153.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.036 0.922 . . . . 0.0 108.799 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.418 ' H ' HG12 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -90.97 -46.78 7.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.03 -1.669 . . . . 0.0 110.676 -169.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -30.67 67.24 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 109.796 -170.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -26.37 68.48 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 123.128 1.442 . . . . 0.0 108.592 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.91 67.67 1.3 Allowed Glycine 0 CA--C 1.461 -3.329 1 N-CA-C 102.534 -4.226 . . . . 0.0 102.534 174.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -40.11 -15.32 0.01 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.578 3.551 . . . . 0.0 116.097 -173.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -55.27 -17.84 5.24 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 120.507 -1.371 . . . . 0.0 113.622 160.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.97 -53.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 CA-C-N 121.07 1.759 . . . . 0.0 107.718 173.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.79 91.08 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.272 0.629 . . . . 0.0 111.061 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.1 -38.44 70.73 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.621 1.168 . . . . 0.0 111.66 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.84 -37.47 84.55 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 124.071 0.948 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.53 -42.53 72.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -61.16 -48.92 79.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.094 0.958 . . . . 0.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.16 -38.43 88.06 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.81 92.57 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.056 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.28 -46.07 91.76 Favored Glycine 0 CA--C 1.494 -1.257 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -46.64 87.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.666 1.186 . . . . 0.0 109.338 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.15 -45.82 86.73 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.173 -0.954 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.68 -51.13 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 124.167 0.987 . . . . 0.0 109.963 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -72.83 -19.46 61.31 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.631 -0.668 . . . . 0.0 111.257 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.5 -27.62 19.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.885 0.874 . . . . 0.0 110.283 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.08 -39.18 85.17 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 126.207 1.803 . . . . 0.0 109.47 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.2 -13.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.823 0.849 . . . . 0.0 111.912 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.8 m -61.68 -16.38 48.32 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.624 1.169 . . . . 0.0 110.852 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.58 -51.0 64.4 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.509 1.123 . . . . 0.0 110.629 165.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.16 75.72 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.71 1.604 . . . . 0.0 110.451 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.02 -42.61 97.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.73 -18.96 61.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.872 -0.518 . . . . 0.0 110.687 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.6 m -80.51 -36.61 33.03 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 121.276 -0.89 . . . . 0.0 108.998 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.34 -8.46 58.45 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.904 -1.123 . . . . 0.0 111.791 -157.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -75.4 -36.77 60.79 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 165.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 t -71.12 -22.28 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 109.978 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -47.92 -31.57 5.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.694 1.998 . . . . 0.0 111.666 171.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -62.11 -30.7 71.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.686 1.194 . . . . 0.0 112.129 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.31 -27.41 63.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 120.785 -1.197 . . . . 0.0 109.541 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.38 -37.21 80.19 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.999 -1.063 . . . . 0.0 110.241 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -70.52 -23.35 62.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -66.55 -35.65 80.75 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.015 -1.053 . . . . 0.0 109.944 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -89.88 -7.72 53.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 121.594 -0.692 . . . . 0.0 109.519 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.37 90.17 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 121.477 -0.764 . . . . 0.0 111.494 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.769 178.888 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.98 166.04 32.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -65.45 -55.85 15.68 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 129.378 3.071 . . . . 0.0 108.26 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -66.97 -21.99 65.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 125.791 1.636 . . . . 0.0 111.97 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -77.34 -32.65 55.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -72.87 -32.27 65.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.668 0.747 . . . . 0.0 109.95 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.3 -41.56 93.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.642 1.177 . . . . 0.0 109.512 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.08 78.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.357 1.063 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -57.01 -38.25 72.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.282 1.833 . . . . 0.0 111.243 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -64.73 -33.26 75.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.495 1.118 . . . . 0.0 110.815 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.61 68.2 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.037 -1.039 . . . . 0.0 110.287 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.453 -0.78 . . . . 0.0 112.017 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -27.89 63.76 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.889 -1.132 . . . . 0.0 110.473 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.74 -33.29 73.67 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.994 0.918 . . . . 0.0 109.128 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.41 -36.95 84.12 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.941 -1.099 . . . . 0.0 110.687 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.08 -27.65 67.54 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.264 -0.898 . . . . 0.0 111.083 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.61 -45.67 64.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.684 1.194 . . . . 0.0 110.068 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.31 -24.14 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 O-C-N 121.534 -0.729 . . . . 0.0 110.819 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.13 -37.66 80.73 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.417 -0.802 . . . . 0.0 111.408 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -74.34 -24.29 59.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.617 0.767 . . . . 0.0 111.241 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -87.89 -30.87 19.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.812 -1.18 . . . . 0.0 107.848 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.98 88.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.655 1.182 . . . . 0.0 111.362 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.0 p -65.2 -38.94 92.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.29 0.636 . . . . 0.0 111.173 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -71.08 -48.88 49.98 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.576 -0.703 . . . . 0.0 110.064 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -72.21 -23.16 61.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 121.262 -0.899 . . . . 0.0 110.931 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.92 -48.45 76.54 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.819 0.736 . . . . 0.0 110.885 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.72 -19.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.03 -176.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -80.2 -25.82 39.48 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.157 -1.59 . . . . 0.0 109.531 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.05 73.49 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.67 1.188 . . . . 0.0 108.874 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' C' ' 38' ' ' LEU . 16.8 mt-10 -85.63 -141.09 0.09 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 122.884 1.326 . . . . 0.0 111.115 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 59.86 52.23 5.51 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 126.763 2.025 . . . . 0.0 111.316 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.37 34.35 0.2 Allowed Glycine 0 CA--C 1.487 -1.696 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.45 155.42 78.67 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.78 152.39 11.44 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.324 2.016 . . . . 0.0 109.498 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 -41.03 2.77 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.974 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -3.02 123.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.808 1 C-N-CA 132.486 4.314 . . . . 0.0 117.292 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.48 -38.38 3.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.566 1.146 . . . . 0.0 110.048 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.456 ' H ' ' CD ' ' C' ' 30' ' ' GLU . 5.2 tt -100.98 66.23 1.14 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.033 2.533 . . . . 0.0 109.436 -169.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.45 33.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 119.463 -2.023 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.2 m -134.0 143.62 48.23 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -80.99 -53.14 0.81 Allowed Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.471 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -20.32 24.2 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 CA-C-N 126.404 3.323 . . . . 0.0 110.643 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.9 -13.04 49.07 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 -35.79 81.65 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.186 -0.946 . . . . 0.0 110.928 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.61 -29.08 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.441 0.639 . . . . 0.0 110.278 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -28.75 61.29 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 119.83 -1.794 . . . . 0.0 110.22 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 31.8 t90 -69.66 -40.99 76.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.841 -0.537 . . . . 0.0 109.68 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -69.58 -14.71 62.98 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.83 -49.9 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 120.884 -1.135 . . . . 0.0 110.504 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -76.04 0.45 18.6 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.036 -1.04 . . . . 0.0 112.247 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.27 -38.69 6.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.122 -0.987 . . . . 0.0 109.096 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.73 61.05 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 120.771 -1.206 . . . . 0.0 111.535 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 5.3 p -90.61 1.31 56.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 110.647 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.297 15.5 p 62.65 30.72 16.95 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.46 2.304 . . . . 0.0 112.751 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.18 -59.33 2.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.92 63.26 3.74 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.858 -1.151 . . . . 0.0 112.493 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -23.14 66.86 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.642 0.777 . . . . 0.0 113.006 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 23.51 10.1 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -50.33 18.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -142.52 163.86 31.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -163.12 142.05 6.58 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.98 161.95 20.79 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.044 2.496 . . . . 0.0 110.86 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.533 HG11 ' H ' ' C' ' 64' ' ' THR . 1.1 t -107.02 -162.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 123.118 1.437 . . . . 0.0 109.157 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.533 ' H ' HG11 ' C' ' 63' ' ' VAL . 2.1 m -66.29 -55.5 15.76 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 127.601 2.361 . . . . 0.0 111.553 -167.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -74.12 -16.43 61.01 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.533 1.159 . . . . 0.0 109.27 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -78.08 -23.35 48.02 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 125.514 1.526 . . . . 0.0 107.803 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.89 86.12 0.94 Allowed Glycine 0 CA--C 1.478 -2.276 1 N-CA-C 102.04 -4.424 . . . . 0.0 102.04 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -43.14 -34.81 1.17 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.446 1.898 . . . . 0.0 111.482 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -43.44 -26.87 0.23 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.037 2.135 . . . . 0.0 113.721 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.92 -37.72 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.986 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.09 9.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.33 -47.04 69.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.481 2.312 . . . . 0.0 112.136 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 -37.22 71.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.552 -0.718 . . . . 0.0 110.492 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.33 -42.64 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 58.9 ttm -59.1 -45.19 91.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.602 1.161 . . . . 0.0 110.615 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' B' ' 12' ' ' GLU . 33.2 ttmt -64.65 -31.75 73.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.861 0.464 . . . . 0.0 111.477 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.94 70.17 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.734 -0.604 . . . . 0.0 111.055 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.47 -39.93 86.83 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.28 -46.69 94.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 124.354 1.062 . . . . 0.0 108.947 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -61.24 -39.51 90.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.547 0.739 . . . . 0.0 112.173 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 t -64.06 -52.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.333 1.053 . . . . 0.0 109.575 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.32 -18.67 61.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.7 -0.625 . . . . 0.0 111.297 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.51 8.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.227 -0.92 . . . . 0.0 109.197 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -51.95 -42.01 62.53 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 126.793 2.037 . . . . 0.0 112.832 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 26.5 m -64.56 -11.38 10.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.481 -0.762 . . . . 0.0 112.515 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.7 m -67.95 -15.36 63.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.701 -1.25 . . . . 0.0 110.831 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.49 65.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.437 -1.414 . . . . 0.0 111.448 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.87 -46.37 13.09 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.78 -1.2 . . . . 0.0 107.963 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -65.05 -32.47 74.21 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.222 1.009 . . . . 0.0 112.34 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.32 -11.68 60.58 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 120.839 -1.163 . . . . 0.0 111.874 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 51.3 p -82.01 -19.48 40.37 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.074 -1.641 . . . . 0.0 109.171 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.27 -16.16 59.86 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.675 -0.641 . . . . 0.0 112.026 -165.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -91.16 -23.69 20.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.874 0.845 . . . . 0.0 110.743 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.02 -29.21 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 O-C-N 120.135 -1.603 . . . . 0.0 108.297 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -62.44 -7.56 4.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.495 1.118 . . . . 0.0 112.961 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -75.51 -26.71 58.34 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.284 -1.51 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 160.4 14.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.465 ' CD ' ' HD1' ' C' ' 103' ' ' HIS 0.499 8.9 pt-20 61.68 -37.14 0.11 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.788 2.435 . . . . 0.0 115.31 -167.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -63.02 -49.48 74.46 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 121.122 1.783 . . . . 0.0 110.368 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 13.0 ttp85 -77.38 -12.94 60.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.333 0.587 . . . . 0.0 111.411 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.61 -29.12 16.3 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.393 -0.817 . . . . 0.0 109.659 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.94 50.47 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 124.276 0.941 . . . . 0.0 111.153 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.465 ' HD1' ' CD ' ' C' ' 98' ' ' GLU . 28.1 t60 . . . . . 0 C--N 1.35 0.615 0 C-N-CA 124.936 1.294 . . . . 0.0 111.507 -174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.57 150.63 21.66 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.03 -43.59 98.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -18.58 63.74 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.201 -0.937 . . . . 0.0 112.385 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -76.58 -44.07 36.11 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -68.06 -36.42 79.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.427 0.632 . . . . 0.0 109.564 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.07 -51.04 67.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.158 2.583 . . . . 0.0 110.016 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.37 81.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.655 1.182 . . . . 0.0 111.901 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -40.67 84.67 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.208 -0.933 . . . . 0.0 110.186 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -68.69 -27.16 65.71 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 121.192 -0.943 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.22 70.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.473 -1.392 . . . . 0.0 111.87 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -67.02 -25.35 66.24 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.568 -0.707 . . . . 0.0 112.032 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.94 -35.76 64.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 109.08 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.61 -17.17 56.46 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.647 -0.658 . . . . 0.0 109.489 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.78 -44.64 73.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.225 -0.922 . . . . 0.0 109.187 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.88 -41.05 67.14 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 111.169 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -53.45 -47.79 69.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.324 1.85 . . . . 0.0 112.123 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -87.83 -33.02 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.005 -1.06 . . . . 0.0 111.123 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.55 -49.95 74.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 127.863 2.465 . . . . 0.0 109.859 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.12 -42.87 72.06 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.27 -31.24 72.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.653 -0.654 . . . . 0.0 112.012 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.72 71.73 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.469 0.708 . . . . 0.0 111.278 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 92.3 p -67.15 -41.0 86.76 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.99 -27.68 61.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 109.723 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -79.61 -51.34 9.4 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.21 97.46 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 111.731 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.49 -29.42 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 119.413 -2.054 . . . . 0.0 112.106 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -89.05 -27.34 20.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -57.09 6.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.935 1.694 . . . . 0.0 108.358 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.43 -7.9 46.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.359 0.663 . . . . 0.0 112.53 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.12 99.55 1.5 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 120.075 -1.641 . . . . 0.0 109.263 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 4.19 35.1 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.5 138.53 26.78 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 118.649 1.224 . . . . 0.0 108.689 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.52 139.49 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.491 2.128 . . . . 0.0 110.178 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.1 16.5 80.65 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.14 147.21 53.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.343 0.657 . . . . 0.0 110.74 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 -35.99 5.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -89.07 136.58 32.94 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 pt -165.89 172.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.6 m 67.65 129.07 0.02 OUTLIER 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.973 2.509 . . . . 0.0 114.285 167.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -61.78 -57.72 22.59 Favored Pre-proline 0 C--N 1.351 0.659 0 CA-C-O 116.976 -1.487 . . . . 0.0 113.397 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.48 -12.13 22.62 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 124.482 2.637 . . . . 0.0 110.653 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.79 -38.83 20.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -36.71 81.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.733 1.213 . . . . 0.0 112.016 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.29 -30.39 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.656 -0.653 . . . . 0.0 110.55 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 -19.5 56.93 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.08 -1.013 . . . . 0.0 110.764 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -91.25 -30.33 16.68 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.94 -37.56 87.86 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.501 -1.375 . . . . 0.0 110.489 -173.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.21 -25.96 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 123.357 0.663 . . . . 0.0 112.091 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.52 -45.81 21.05 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.242 1.017 . . . . 0.0 110.485 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -77.19 -24.52 51.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 120.784 -1.198 . . . . 0.0 109.581 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.38 -29.69 62.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.196 0.598 . . . . 0.0 110.051 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 25.6 p -92.15 -2.46 56.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 118.283 0.492 . . . . 0.0 110.72 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 55.3 p 54.39 59.41 4.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.095 2.158 . . . . 0.0 112.976 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.436 HG23 ' H ' ' D' ' 56' ' ' GLY . 27.4 m -102.98 -75.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.436 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 91.04 54.3 2.05 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -19.53 63.94 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 122.093 0.949 . . . . 0.0 111.87 -170.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.2 11.1 22.82 Favored Glycine 0 CA--C 1.49 -1.481 0 O-C-N 120.325 -1.484 . . . . 0.0 111.421 168.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -68.84 -52.14 33.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.926 -0.749 . . . . 0.0 110.924 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -139.57 163.25 33.07 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.42 151.26 26.9 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -171.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.05 -179.98 5.95 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 124.346 3.364 . . . . 0.0 109.469 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . 0.324 3.7 p -123.13 -89.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 CA-C-N 120.705 1.593 . . . . 0.0 111.869 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 53.5 m -152.32 -50.31 0.11 Allowed 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 119.376 -2.077 . . . . 0.0 107.019 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.44 -5.66 59.22 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.731 1.212 . . . . 0.0 110.878 -168.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.1 -34.39 77.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.64 -1.287 . . . . 0.0 107.588 165.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.25 88.52 1.32 Allowed Glycine 0 N--CA 1.419 -2.488 1 N-CA-C 98.784 -5.726 . . . . 0.0 98.784 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 26.5 ttm-85 -55.6 -19.81 11.5 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 125.768 1.627 . . . . 0.0 111.076 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -58.27 -17.1 16.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.1 -47.88 76.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 120.064 1.302 . . . . 0.0 108.424 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.1 78.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -53.37 -44.13 68.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.536 1.534 . . . . 0.0 112.328 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -60.38 -47.58 85.44 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.039 0.936 . . . . 0.0 110.51 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.01 -34.28 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 43.3 mtt -56.74 -50.89 70.9 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.838 0.828 . . . . 0.0 110.437 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -68.81 -29.83 68.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.876 -0.515 . . . . 0.0 110.42 -171.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.32 71.7 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.953 -0.467 . . . . 0.0 110.303 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.05 -46.32 94.28 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 123.927 0.775 . . . . 0.0 111.733 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.6 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.9 0.88 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.56 -30.8 71.18 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.957 -1.089 . . . . 0.0 112.521 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 21.0 t -65.87 -53.77 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 109.121 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.5 -35.2 77.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 121.704 -0.623 . . . . 0.0 110.429 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.0 74.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.392 -0.818 . . . . 0.0 111.256 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.46 -28.56 69.31 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.608 -1.307 . . . . 0.0 110.929 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.5 -7.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.045 1.338 . . . . 0.0 110.944 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.8 m -58.84 -21.23 56.33 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 118.937 -2.352 . . . . 0.0 112.315 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.09 -29.15 67.14 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.762 -1.211 . . . . 0.0 110.881 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 -46.54 14.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.988 -1.695 . . . . 0.0 109.163 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.6 -47.58 72.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -167.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.42 -9.84 58.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.112 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -77.72 -38.33 47.43 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 120.447 -1.408 . . . . 0.0 108.148 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.27 55.2 m-20 -83.07 8.64 12.33 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.376 -1.452 . . . . 0.0 112.591 -155.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -96.93 -38.06 9.96 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 117.573 -1.203 . . . . 0.0 111.514 161.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.18 -20.46 27.57 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-N 120.789 1.631 . . . . 0.0 111.113 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -54.08 -22.93 12.06 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.642 1.177 . . . . 0.0 112.308 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.08 -21.73 9.21 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.715 1.606 . . . . 0.0 113.008 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -76.89 -49.18 16.27 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -98.47 -160.36 0.8 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.65 -60.57 0.27 Allowed 'General case' 0 C--N 1.355 0.817 0 C-N-CA 127.506 2.323 . . . . 0.0 110.975 -169.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -59.47 -36.32 75.77 Favored 'General case' 0 N--CA 1.433 -1.317 1 C-N-CA 132.563 4.345 . . . . 0.0 111.181 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -79.15 -21.5 46.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.311 -0.868 . . . . 0.0 110.705 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.83 15.55 61.18 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 121.715 -0.616 . . . . 0.0 112.057 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 CA--C 1.501 -0.919 0 O-C-N 120.568 -1.548 . . . . 0.0 108.544 178.734 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.03 165.16 18.81 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.704 -0.623 . . . . 0.0 109.49 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.0 -62.55 0.71 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.037 2.535 . . . . 0.0 112.631 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -64.61 -23.41 67.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 113.974 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -82.78 -44.41 15.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.7 -40.84 98.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.335 1.054 . . . . 0.0 110.401 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.41 -29.72 67.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.357 0.598 . . . . 0.0 110.658 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.44 86.65 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.271 -0.893 . . . . 0.0 110.479 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -63.17 -43.62 97.74 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.577 -0.702 . . . . 0.0 110.5 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.7 -42.36 75.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.084 1.754 . . . . 0.0 110.419 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.32 93.01 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.441 1.096 . . . . 0.0 110.702 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -63.95 -36.52 84.22 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -74.61 -25.91 59.55 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.798 -1.189 . . . . 0.0 111.875 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.52 -35.95 63.18 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.77 -42.51 79.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.417 1.087 . . . . 0.0 111.874 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.0 -34.19 69.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.129 1.372 . . . . 0.0 112.203 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -74.85 -35.17 62.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.621 -0.674 . . . . 0.0 109.392 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.98 -33.76 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.47 -42.69 92.6 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.459 -0.775 . . . . 0.0 112.0 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.65 -42.61 74.01 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 122.098 -0.376 . . . . 0.0 110.493 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.89 -40.65 87.82 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.703 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.19 79.39 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 125.043 1.337 . . . . 0.0 111.479 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -52.56 -47.02 67.05 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 126.016 1.726 . . . . 0.0 109.938 175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -65.39 -46.2 80.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.265 1.026 . . . . 0.0 109.985 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.99 -43.18 88.53 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 123.885 0.874 . . . . 0.0 110.563 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.67 71.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.694 1.198 . . . . 0.0 111.527 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.28 -51.79 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 120.765 -1.209 . . . . 0.0 109.912 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.46 -28.86 63.19 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.722 -0.612 . . . . 0.0 111.092 -166.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.0 81.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.608 0.763 . . . . 0.0 110.311 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.73 -88.93 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 122.545 0.338 . . . . 0.0 111.51 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 20.09 67.59 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 128.302 2.641 . . . . 0.0 116.69 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.29 -23.45 4.31 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 133.63 90.76 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -174.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.62 125.39 4.94 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.35 2.033 . . . . 0.0 111.71 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.7 54.06 Favored Glycine 0 CA--C 1.485 -1.805 0 CA-C-O 117.906 -1.497 . . . . 0.0 109.828 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -32.1 -65.21 0.15 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 114.345 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 73.39 -15.54 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.769 1.627 . . . . 0.0 111.297 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.2 118.23 36.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 pt -143.72 0.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.843 -0.536 . . . . 0.0 111.235 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.9 m -128.24 130.62 48.21 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.372 -1.455 . . . . 0.0 109.449 -165.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -57.22 -50.31 88.89 Favored Pre-proline 0 C--N 1.351 0.64 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.783 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.38 -11.98 24.93 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 125.301 2.929 . . . . 0.0 111.881 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.79 -25.09 16.19 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.19 -35.11 78.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.656 0.783 . . . . 0.0 111.432 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -69.91 -33.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -31.84 61.04 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.333 -0.854 . . . . 0.0 109.739 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -65.33 -45.18 85.27 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.523 1.129 . . . . 0.0 108.919 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -34.33 68.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.243 1.417 . . . . 0.0 111.419 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.89 -52.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 124.254 1.022 . . . . 0.0 110.719 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.21 -22.84 60.36 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 121.537 -0.727 . . . . 0.0 110.961 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.7 m -73.34 -39.49 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.22 64.95 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.264 -0.898 . . . . 0.0 111.546 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 p -88.23 12.12 14.69 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.371 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 p 48.96 61.33 3.17 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.949 1.7 . . . . 0.0 112.717 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG11 ' H ' ' A' ' 56' ' ' GLY . 2.4 p -128.48 -77.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' H ' HG11 ' A' ' 55' ' ' VAL . . . 82.88 75.04 1.18 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -69.17 -34.19 74.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.985 -1.303 . . . . 0.0 110.787 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.13 38.61 0.25 Allowed Glycine 0 CA--C 1.487 -1.714 0 N-CA-C 107.926 -2.069 . . . . 0.0 107.926 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.85 -48.2 22.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -135.3 178.89 6.68 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -149.16 93.89 4.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.131 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.18 166.23 30.54 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.572 2.181 . . . . 0.0 110.842 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.89 177.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 123.002 1.382 . . . . 0.0 107.908 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -65.19 -25.01 67.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.853 2.461 . . . . 0.0 112.585 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -75.51 -36.23 60.59 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.304 1.042 . . . . 0.0 109.056 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -53.21 58.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.91 66.67 0.37 Allowed Glycine 0 CA--C 1.461 -3.334 1 N-CA-C 100.797 -4.921 . . . . 0.0 100.797 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.5 ttm-85 -23.18 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.382 2.017 1 C-N-CA 132.258 4.223 . . . . 0.0 115.921 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -54.79 -6.82 0.13 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 116.622 -1.656 . . . . 0.0 115.389 167.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.265 54.8 t -76.01 -46.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.365 1.26 0 CA-C-N 123.771 2.987 . . . . 0.0 107.809 167.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.7 67.75 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.435 1.016 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.64 -34.61 73.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.474 1.11 . . . . 0.0 112.258 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.74 -40.36 84.16 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 120.728 -1.232 . . . . 0.0 110.365 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.38 -43.14 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.3 mtt -59.23 -45.83 90.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 110.147 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.85 -40.44 92.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.929 0.892 . . . . 0.0 111.683 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 81.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.788 0.835 . . . . 0.0 111.071 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.88 -46.22 90.13 Favored Glycine 0 C--N 1.35 1.326 0 C-N-CA 124.678 1.132 . . . . 0.0 110.446 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.04 -41.17 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.894 0.877 . . . . 0.0 109.376 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -59.7 -52.03 67.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.202 -0.936 . . . . 0.0 111.625 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.55 -41.69 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 121.959 -0.463 . . . . 0.0 110.527 -172.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.8 -39.46 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.025 0.53 . . . . 0.0 109.688 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 121.42 -0.8 . . . . 0.0 110.919 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.16 -24.85 64.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 121.021 -1.05 . . . . 0.0 111.538 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.92 -15.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 O-C-N 121.012 -1.055 . . . . 0.0 110.697 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.9 m -53.57 -25.38 16.97 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.023 -1.673 . . . . 0.0 113.067 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.0 66.68 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.509 -1.369 . . . . 0.0 111.294 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.96 -52.75 5.52 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 108.738 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.1 mt -59.34 -40.25 85.74 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.303 1.041 . . . . 0.0 112.958 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.5 -19.37 62.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 121.073 -1.017 . . . . 0.0 111.228 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.2 p -72.26 -22.32 61.24 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.221 -1.549 . . . . 0.0 110.283 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.86 -5.67 55.92 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.924 -1.11 . . . . 0.0 112.128 -167.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.78 -22.72 19.17 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.867 -1.77 . . . . 0.0 109.347 168.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -76.84 -37.72 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 107.983 -170.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -57.9 -18.44 22.98 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.413 1.485 . . . . 0.0 112.479 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -64.97 -32.72 74.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.758 -1.214 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.43 -32.2 66.13 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.038 -1.039 . . . . 0.0 108.917 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.13 -48.3 68.5 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.42 -37.1 84.51 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.518 1.127 . . . . 0.0 110.585 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -61.19 -33.76 73.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.893 1.277 . . . . 0.0 112.115 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -80.61 -24.31 39.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.424 -1.423 . . . . 0.0 110.141 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.53 63.81 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 61.6 t60 . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.146 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . 0.392 . . 21.78 -122.94 0.01 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 129.135 2.974 . . . . 0.0 115.688 -169.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.88 -55.94 0.42 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -165.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -4.27 58.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.881 -1.137 . . . . 0.0 112.159 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -29.75 56.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.787 1.235 . . . . 0.0 108.37 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -70.85 -33.78 70.98 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.931 -1.106 . . . . 0.0 110.432 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.87 -38.81 92.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 122.174 0.988 . . . . 0.0 109.236 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 -38.51 88.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.541 0.737 . . . . 0.0 111.711 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.13 -41.04 86.82 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.698 -0.626 . . . . 0.0 110.362 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -62.56 -30.96 71.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.625 1.17 . . . . 0.0 111.139 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.414 -0.804 . . . . 0.0 111.354 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -67.58 -33.78 75.71 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.459 -0.776 . . . . 0.0 109.639 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.38 -35.56 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.517 1.127 . . . . 0.0 111.04 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.32 -40.44 95.92 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.78 0.832 . . . . 0.0 109.156 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.728 -0.607 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -58.4 -38.95 78.4 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.094 0.958 . . . . 0.0 112.006 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -62.78 -44.65 95.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.228 1.011 . . . . 0.0 109.452 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.5 -33.39 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.046 0.938 . . . . 0.0 110.062 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.92 -36.37 82.09 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.52 -1.362 . . . . 0.0 111.205 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -72.01 -35.17 69.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.514 -0.741 . . . . 0.0 110.435 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.723 -1.236 . . . . 0.0 109.189 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.7 74.32 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 126.251 1.82 . . . . 0.0 111.69 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.44 -36.11 63.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -43.16 85.64 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.814 0.846 . . . . 0.0 109.18 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.96 -51.73 44.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.816 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.37 96.98 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 124.066 0.946 . . . . 0.0 111.482 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -67.57 -44.78 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.112 -0.992 . . . . 0.0 109.501 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -50.59 31.74 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 110.289 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.64 -29.06 67.47 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.451 -0.78 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -67.06 100.47 0.76 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.352 -1.468 . . . . 0.0 111.413 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.31 -30.18 3.35 Favored Glycine 0 CA--C 1.488 -1.655 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.08 60.21 Favored Pre-proline 0 N--CA 1.443 -0.781 0 C-N-CA 123.588 0.755 . . . . 0.0 110.478 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.72 148.31 12.42 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 C-N-CA 122.553 2.169 . . . . 0.0 109.449 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.58 -17.18 45.93 Favored Glycine 0 CA--C 1.489 -1.538 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.19 114.36 2.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.002 2.521 . . . . 0.0 107.835 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.78 -18.46 14.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -84.29 -8.67 58.95 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.725 0.81 . . . . 0.0 108.901 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 tt -54.02 69.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 128.809 2.844 . . . . 0.0 114.981 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -140.66 -122.01 0.11 Allowed 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 119.476 -2.015 . . . . 0.0 107.373 -165.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -179.21 -67.45 0.0 OUTLIER Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.9 -29.09 18.95 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 125.201 2.893 . . . . 0.0 111.491 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -91.17 0.85 57.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.407 1.083 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.58 64.32 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.246 -0.909 . . . . 0.0 108.712 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -72.52 -20.46 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 123.084 0.554 . . . . 0.0 110.478 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -66.32 -47.55 73.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -67.06 -44.04 81.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.879 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.3 m -56.02 -33.55 65.01 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.0 -41.52 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.93 -40.73 94.33 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -57.1 -37.51 72.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.653 1.181 . . . . 0.0 111.608 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.18 -22.42 63.91 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 123.089 0.556 . . . . 0.0 112.119 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.0 p -84.67 -14.57 48.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.291 19.9 p 76.19 0.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.569 2.348 . . . . 0.0 111.18 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.65 -50.1 77.29 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 C-N-CA 123.465 0.706 . . . . 0.0 109.424 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.93 47.1 92.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.273 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -45.63 -32.31 2.3 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.72 12.46 5.0 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.95 -54.98 16.61 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.628 -0.925 . . . . 0.0 111.108 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -121.78 156.12 33.85 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.83 139.52 34.83 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 102.08 -3.304 . . . . 0.0 102.08 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.11 -173.26 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.145 3.23 . . . . 0.0 108.873 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.525 HG23 ' H ' ' B' ' 64' ' ' THR . 12.9 p -137.23 -158.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.525 ' H ' HG23 ' B' ' 63' ' ' VAL . 53.2 m -92.92 -39.18 11.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 109.672 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.35 -23.59 59.05 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.386 -0.821 . . . . 0.0 110.612 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -29.33 70.59 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 123.732 1.73 . . . . 0.0 108.254 173.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.86 67.21 1.18 Allowed Glycine 0 CA--C 1.461 -3.321 1 N-CA-C 102.335 -4.306 . . . . 0.0 102.335 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -29.61 -24.43 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 133.034 4.534 . . . . 0.0 115.342 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -62.82 0.68 0.49 Allowed 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 125.961 1.704 . . . . 0.0 114.03 165.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.24 -56.11 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.125 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 165.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.21 -43.6 78.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.228 1.411 . . . . 0.0 111.487 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.04 -46.4 61.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.484 1.914 . . . . 0.0 110.805 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.18 -40.13 86.52 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.353 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.23 -49.0 79.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 119.19 0.905 . . . . 0.0 110.055 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.3 ptp -68.08 -41.45 81.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.936 -0.478 . . . . 0.0 110.338 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -69.37 -32.85 72.15 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.08 89.77 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 123.292 0.637 . . . . 0.0 110.457 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.41 -49.69 63.94 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.42 -51.25 66.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 109.841 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.77 -7.11 56.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.519 -1.363 . . . . 0.0 112.954 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -83.86 -54.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -60.66 -29.79 69.5 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.73 0.812 . . . . 0.0 110.155 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.09 -19.74 36.21 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.418 0.687 . . . . 0.0 112.58 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.74 -37.32 59.45 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 119.153 -2.217 . . . . 0.0 107.747 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.07 -5.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 121.383 -0.823 . . . . 0.0 111.544 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.1 m -55.96 -20.54 16.67 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 110.593 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.94 95.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 119.859 -1.776 . . . . 0.0 113.032 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.25 70.55 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 124.516 1.127 . . . . 0.0 108.042 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.54 -27.61 61.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.53 75.48 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.775 -1.828 . . . . 0.0 110.594 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -12.32 28.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.006 -1.059 . . . . 0.0 112.577 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.38 -15.66 61.85 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 119.789 1.177 . . . . 0.0 111.12 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -76.14 -26.64 56.51 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.336 -1.477 . . . . 0.0 111.067 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.93 -34.0 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.135 0.974 . . . . 0.0 108.504 -171.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -61.59 -20.01 62.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.501 1.12 . . . . 0.0 112.348 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -64.66 -32.93 74.82 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.77 0.828 . . . . 0.0 110.813 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -71.94 -32.45 67.34 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.479 -1.388 . . . . 0.0 109.938 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.62 -42.55 86.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.11 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.446 ' OE2' ' HE1' ' B' ' 103' ' ' HIS . 61.6 mm-40 -76.11 -9.63 58.78 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -69.83 -27.6 65.0 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 120.987 -1.071 . . . . 0.0 109.82 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -79.03 -31.92 44.78 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.57 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.57 -11.49 64.86 Favored Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.446 ' HE1' ' OE2' ' B' ' 99' ' ' GLU . 80.9 m80 . . . . . 0 CA--C 1.508 -0.645 0 C-N-CA 125.321 1.448 . . . . 0.0 108.739 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.23 -100.47 0.06 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 127.841 2.456 . . . . 0.0 111.585 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -171.49 -62.92 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -58.86 -28.96 66.59 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 127.082 2.153 . . . . 0.0 113.492 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.86 -32.86 72.84 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.848 1.259 . . . . 0.0 109.92 -168.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -65.35 -43.67 90.11 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.533 1.133 . . . . 0.0 109.992 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -72.11 -37.06 69.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.986 0.914 . . . . 0.0 108.915 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.16 95.89 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -71.3 -35.36 71.26 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.899 0.88 . . . . 0.0 110.317 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.3 88.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.085 0.954 . . . . 0.0 111.833 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.8 -33.83 76.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.42 -0.8 . . . . 0.0 111.623 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.01 -35.2 74.19 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.658 0.742 . . . . 0.0 109.601 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -69.62 -29.71 67.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.534 0.734 . . . . 0.0 110.24 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.94 -40.84 95.64 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.77 -34.96 75.27 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.55 -0.719 . . . . 0.0 110.775 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -64.48 -40.72 96.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.505 1.122 . . . . 0.0 111.23 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.4 -31.36 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.618 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.49 -50.23 74.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 126.223 1.809 . . . . 0.0 109.543 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -72.69 -23.93 60.94 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.88 -1.137 . . . . 0.0 110.601 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -72.36 -37.15 68.88 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 -31.58 72.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.156 0.982 . . . . 0.0 112.178 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -58.21 -45.23 88.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.894 1.331 . . . . 0.0 111.578 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -70.63 -47.16 61.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.181 1.792 . . . . 0.0 107.506 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -65.28 -31.0 71.92 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 124.452 1.101 . . . . 0.0 112.674 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.69 68.61 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.93 1.292 . . . . 0.0 110.391 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.43 -36.86 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.399 0.68 . . . . 0.0 110.348 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.72 -38.95 89.81 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.466 -0.772 . . . . 0.0 109.701 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.41 71.54 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.175 1.79 . . . . 0.0 111.562 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -67.32 -24.33 65.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 125.178 1.391 . . . . 0.0 112.307 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -91.91 115.95 28.5 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.79 -48.26 0.98 Allowed Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.88 150.52 38.72 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.322 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.81 162.89 18.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.821 1.681 . . . . 0.0 110.263 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 30.76 12.8 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.11 137.14 56.11 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 117.995 0.898 . . . . 0.0 111.94 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.62 -41.96 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 123.828 0.851 . . . . 0.0 110.024 -170.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.85 -27.04 57.67 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.866 1.266 . . . . 0.0 108.412 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 tp -37.22 106.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 127.911 2.484 . . . . 0.0 113.343 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t -172.03 -131.39 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.3 -70.42 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.731 0 CA-C-O 116.914 -1.517 . . . . 0.0 107.038 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.21 -11.55 19.32 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 CA-C-N 125.004 2.823 . . . . 0.0 111.925 -163.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.57 1.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.341 2.657 . . . . 0.0 107.725 -175.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.28 -34.38 70.61 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.065 0.936 . . . . 0.0 110.214 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.01 -19.5 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 125.334 1.454 . . . . 0.0 109.994 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -50.85 28.77 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.599 -1.938 . . . . 0.0 107.511 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -63.32 -34.25 77.29 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 121.957 0.884 . . . . 0.0 111.399 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -73.06 -31.16 64.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.587 -1.945 . . . . 0.0 110.907 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.95 -53.39 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 123.922 0.889 . . . . 0.0 108.677 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' C' ' 56' ' ' GLY . 20.3 pt-20 -64.37 -30.91 71.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.014 0.526 . . . . 0.0 111.773 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 79.5 m -70.83 -48.37 54.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.814 0.846 . . . . 0.0 110.754 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -27.52 64.38 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.792 -1.193 . . . . 0.0 111.232 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -85.37 -4.26 59.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.927 -0.483 . . . . 0.0 111.124 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p 55.23 64.2 1.86 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 125.495 1.518 . . . . 0.0 112.059 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.86 -87.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 101.592 -3.485 . . . . 0.0 101.592 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' C' ' 50' ' ' GLU . . . 87.21 80.73 1.21 Allowed Glycine 0 CA--C 1.494 -1.254 0 N-CA-C 104.722 -3.351 . . . . 0.0 104.722 -172.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.34 -30.37 57.61 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.97 35.22 3.77 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.99 -38.44 57.39 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -135.07 157.34 47.19 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -129.41 138.11 32.42 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.37 168.04 22.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.515 2.143 . . . . 0.0 109.307 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.1 m -63.74 175.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 122.242 1.02 . . . . 0.0 111.688 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -83.36 -88.06 0.1 Allowed 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 120.958 -1.089 . . . . 0.0 108.323 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -34.17 -58.03 0.47 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.954 2.502 . . . . 0.0 116.589 -169.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -82.67 -98.93 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.68 -86.52 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.378 0 C-N-CA 126.395 1.95 . . . . 0.0 113.496 160.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -58.11 -42.43 85.72 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.301 1.44 . . . . 0.0 112.157 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -58.87 -27.08 64.84 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 118.902 -2.374 . . . . 0.0 112.283 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.18 -55.25 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.5 77.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.001 1.721 . . . . 0.0 112.713 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.0 -43.06 73.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 128.428 2.691 . . . . 0.0 108.555 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -68.2 -43.71 77.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 123.894 0.878 . . . . 0.0 110.188 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.51 -48.88 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 124.32 1.048 . . . . 0.0 110.16 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 23.2 ptp -66.56 -34.47 77.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.557 -0.715 . . . . 0.0 110.333 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -68.7 -30.53 69.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.308 -0.87 . . . . 0.0 110.744 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.11 86.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.909 -0.494 . . . . 0.0 110.206 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.42 92.0 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 123.823 0.725 . . . . 0.0 111.338 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -54.7 -47.46 73.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 125.378 1.471 . . . . 0.0 110.527 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -70.25 -28.41 65.21 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.769 -0.582 . . . . 0.0 112.027 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.58 -48.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 121.008 -1.057 . . . . 0.0 109.509 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -67.14 -25.85 66.38 Favored 'General case' 0 CA--C 1.509 -0.609 0 O-C-N 121.495 -0.753 . . . . 0.0 110.927 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.39 -36.89 57.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.79 -41.83 97.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 124.676 1.19 . . . . 0.0 110.516 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.04 -9.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 O-C-N 121.113 -0.992 . . . . 0.0 111.673 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -19.46 64.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 110.078 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.86 -32.94 74.88 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.434 1.093 . . . . 0.0 111.771 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.4 63.12 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.446 1.098 . . . . 0.0 109.914 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 -32.68 26.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.56 63.64 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.003 -1.061 . . . . 0.0 111.161 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 8.7 p -75.66 -10.82 59.77 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 120.035 -1.665 . . . . 0.0 110.823 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.337 46.5 m-20 -90.9 -0.77 57.82 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.582 -1.647 . . . . 0.0 109.511 -158.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -89.01 -10.37 47.85 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.906 161.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -96.13 -51.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.49 -17.87 24.5 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.396 2.279 . . . . 0.0 111.983 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -68.01 -12.57 61.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.655 -1.278 . . . . 0.0 112.255 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -63.41 145.95 54.55 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 119.956 -1.715 . . . . 0.0 108.097 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 69.01 -63.93 0.35 Allowed 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.204 1.402 . . . . 0.0 111.915 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -63.04 -19.07 64.02 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.05 1.74 . . . . 0.0 111.563 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.8 -33.04 74.37 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.87 -1.144 . . . . 0.0 111.5 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -66.94 -40.28 87.51 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.467 -0.771 . . . . 0.0 109.512 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.83 44.66 19.11 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 CA--C 1.492 -1.26 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 177.049 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.15 80.88 0.06 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.789 2.435 . . . . 0.0 114.006 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -28.91 70.38 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.117 -0.989 . . . . 0.0 112.703 -169.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.472 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 21.2 p80 -63.02 -33.19 74.89 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.202 -0.936 . . . . 0.0 112.44 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.472 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 10.8 mt-10 -80.44 -31.99 37.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.876 -1.14 . . . . 0.0 108.812 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.16 -35.96 74.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.902 -1.124 . . . . 0.0 110.725 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.25 -38.99 93.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.947 1.699 . . . . 0.0 110.154 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.21 92.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.153 0.981 . . . . 0.0 111.896 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -65.34 -32.94 74.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.522 1.129 . . . . 0.0 111.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -68.79 -36.16 77.93 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.742 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.63 94.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.485 0.714 . . . . 0.0 110.752 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.19 -44.14 87.91 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.416 1.086 . . . . 0.0 111.525 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -68.34 -44.1 76.06 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.266 1.026 . . . . 0.0 109.148 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -68.41 -31.57 71.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.584 -0.698 . . . . 0.0 110.409 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.43 -44.03 92.99 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.509 0.723 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.0 -30.83 71.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -65.91 -41.04 91.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.732 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.67 -38.28 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 C-N-CA 123.965 0.906 . . . . 0.0 108.897 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 37.3 mt -60.37 -48.44 81.73 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.204 1.002 . . . . 0.0 110.279 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -67.45 -36.49 81.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.565 -0.709 . . . . 0.0 111.736 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.63 -47.48 78.4 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.66 -41.52 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.367 1.467 . . . . 0.0 110.997 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 58.4 m -52.21 -49.45 63.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 126.064 1.746 . . . . 0.0 112.134 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -61.94 -50.89 70.34 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -62.66 -42.9 99.87 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 117.676 -1.154 . . . . 0.0 110.12 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.34 -47.69 62.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.822 2.049 . . . . 0.0 111.519 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.9 -41.62 76.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.776 -1.202 . . . . 0.0 111.372 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.53 -16.12 37.92 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.128 0.971 . . . . 0.0 109.982 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.12 -56.74 3.89 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.798 1.639 . . . . 0.0 106.73 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.94 -33.65 76.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.999 -0.438 . . . . 0.0 110.418 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -71.3 111.9 7.0 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.942 -1.098 . . . . 0.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.88 -32.18 4.69 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.31 73.5 Favored Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 123.521 0.728 . . . . 0.0 110.025 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.73 110.18 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.073 1.848 . . . . 0.0 113.255 -171.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.39 42.88 2.87 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.719 -2.952 . . . . 0.0 105.719 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.01 163.71 24.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.686 1.194 . . . . 0.0 109.301 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.67 -59.59 0.76 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.67 130.76 34.67 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -150.29 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -142.1 125.74 16.88 Favored 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 119.784 -1.822 . . . . 0.0 109.362 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.04 -48.9 95.79 Favored Pre-proline 0 C--N 1.353 0.735 0 CA-C-O 116.473 -1.727 . . . . 0.0 112.282 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.36 -8.17 22.2 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 CA-C-N 125.33 2.939 . . . . 0.0 112.345 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -101.27 -19.59 15.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.27 75.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 121.043 -1.036 . . . . 0.0 111.519 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -65.92 -28.88 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.612 1.165 . . . . 0.0 110.092 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -86.19 -26.18 25.25 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.483 -0.761 . . . . 0.0 109.788 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -79.17 -34.42 43.15 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.8 m -79.06 51.07 1.1 Allowed 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.721 -0.612 . . . . 0.0 110.669 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.21 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.33 -22.92 55.04 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.416 1.486 . . . . 0.0 113.713 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 5.1 t -72.15 -35.82 69.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.666 -1.271 . . . . 0.0 109.795 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.29 42.39 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.035 -1.041 . . . . 0.0 109.613 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.22 -2.03 54.56 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.861 0.865 . . . . 0.0 109.615 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p 58.93 40.8 22.09 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 127.062 2.145 . . . . 0.0 112.733 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.41 65.69 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.25 99.78 0.74 Allowed Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -35.05 40.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.08 39.99 0.17 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.0 -51.38 16.12 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 118.827 1.314 . . . . 0.0 109.249 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 173.27 11.65 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -137.16 127.93 16.16 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.08 -179.44 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.185 3.257 . . . . 0.0 109.481 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.498 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 6.8 t -112.26 -97.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 124.087 0.955 . . . . 0.0 110.076 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -165.67 -46.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -71.96 -10.22 59.47 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.498 ' CG ' ' H ' ' D' ' 63' ' ' VAL . 0.9 OUTLIER -60.84 -33.11 72.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.502 1.121 . . . . 0.0 109.996 172.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 149.25 -33.02 1.13 Allowed Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.391 -3.483 . . . . 0.0 104.391 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.401 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 37.6 ttm180 74.09 -50.74 0.69 Allowed 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 130.071 3.348 . . . . 0.0 107.578 -171.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' D' ' 67' ' ' GLY . 71.1 mmtt -71.76 12.11 0.42 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.672 2.789 . . . . 0.0 110.884 174.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.89 -61.03 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -49.18 69.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 123.168 0.587 . . . . 0.0 111.031 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.02 -40.24 66.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.935 0.894 . . . . 0.0 111.418 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.8 -37.03 73.26 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 121.708 -0.62 . . . . 0.0 111.348 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.36 -41.95 57.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.146 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 10.3 mtp -56.37 -51.66 67.49 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.826 1.251 . . . . 0.0 110.587 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.75 -40.66 97.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.388 0.675 . . . . 0.0 110.768 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.04 87.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.763 0.825 . . . . 0.0 110.985 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.63 -49.44 64.35 Favored Glycine 0 CA--C 1.496 -1.119 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.62 -49.44 80.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 124.186 0.995 . . . . 0.0 110.339 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . 0.273 11.9 pt-20 -77.95 -9.61 59.18 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 120.202 -1.561 . . . . 0.0 112.664 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.69 -47.17 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -67.47 -20.78 65.52 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 121.462 -0.774 . . . . 0.0 111.137 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.6 -14.78 29.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.659 0.742 . . . . 0.0 111.717 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.18 -38.56 56.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 119.876 -1.765 . . . . 0.0 107.651 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 6.6 m -66.96 -6.39 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.646 0.778 . . . . 0.0 111.458 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.1 m -63.11 -17.77 62.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.375 1.47 . . . . 0.0 111.487 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.56 62.41 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 120.053 -1.655 . . . . 0.0 111.759 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.32 6.32 17.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 125.166 1.386 . . . . 0.0 111.087 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 92.5 mt -113.47 -39.29 4.13 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.28 -13.16 61.44 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.779 -1.2 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -70.7 -19.17 62.79 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 120.956 -1.09 . . . . 0.0 110.879 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.19 7.47 46.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 119.699 1.136 . . . . 0.0 110.6 -160.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -91.99 -20.5 21.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 158.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.9 -40.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -57.75 -38.24 75.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 126.711 2.005 . . . . 0.0 111.163 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.13 -8.64 55.78 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.386 0.674 . . . . 0.0 112.732 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -105.07 148.67 26.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.268 48.9 mt-10 71.58 -55.96 0.65 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 126.705 2.002 . . . . 0.0 111.813 -174.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.65 -22.18 66.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.354 1.062 . . . . 0.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -68.75 -17.69 64.09 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.641 -1.287 . . . . 0.0 113.202 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -92.49 -10.29 38.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.63 66.64 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 . . . . . 0 CA--C 1.493 -1.243 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 -175.042 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.2 -29.99 71.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.041 1.336 . . . . 0.0 109.323 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -91.94 -2.46 56.76 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 121.267 -0.896 . . . . 0.0 111.712 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.21 -36.46 19.44 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 119.599 1.09 . . . . 0.0 108.965 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -67.71 -35.01 78.01 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.894 -1.129 . . . . 0.0 110.305 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -75.43 -34.38 60.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 121.769 -0.582 . . . . 0.0 109.651 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.04 82.45 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.798 0.839 . . . . 0.0 109.715 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -60.49 -38.37 84.08 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.662 1.185 . . . . 0.0 111.417 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -56.3 -42.5 77.65 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.569 1.148 . . . . 0.0 110.612 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.06 -32.29 73.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.632 -0.668 . . . . 0.0 111.061 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.11 -27.68 67.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.625 -0.672 . . . . 0.0 111.853 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.35 -39.26 81.92 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 109.158 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.47 -36.17 82.88 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.488 0.715 . . . . 0.0 110.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -38.89 92.91 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.607 0.717 . . . . 0.0 111.057 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -69.08 -21.01 64.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.364 1.066 . . . . 0.0 111.883 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -72.51 -40.72 66.62 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -64.46 -38.88 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.845 0.858 . . . . 0.0 108.709 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.92 -43.26 86.15 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.556 1.142 . . . . 0.0 111.859 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.82 -53.86 53.39 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.321 1.058 . . . . 0.0 110.251 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -73.06 -28.96 62.62 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.265 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.06 89.19 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 124.925 1.29 . . . . 0.0 110.428 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m -56.96 -37.82 72.11 Favored 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.498 1.119 . . . . 0.0 112.042 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -75.59 -51.68 12.32 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.387 0.675 . . . . 0.0 110.854 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.3 -38.22 88.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 120.989 -1.069 . . . . 0.0 109.498 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.96 75.25 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.353 1.461 . . . . 0.0 112.505 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.38 -33.05 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 O-C-N 121.375 -0.828 . . . . 0.0 111.415 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.34 -44.82 50.73 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -66.88 -42.8 84.95 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.577 1.551 . . . . 0.0 108.721 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -79.59 -44.26 21.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -77.11 93.88 3.96 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 119.372 -2.08 . . . . 0.0 110.537 -172.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.87 -17.85 3.41 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.98 151.4 54.6 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.025 0.912 . . . . 0.0 109.196 -176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.84 137.07 13.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.839 2.36 . . . . 0.0 110.731 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 -4.61 83.64 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 118.784 0.72 . . . . 0.0 111.306 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.88 146.76 54.06 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.492 1.117 . . . . 0.0 111.662 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.66 -11.1 1.59 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.519 1.128 . . . . 0.0 111.138 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.11 -66.32 0.73 Allowed 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.088 -1.007 . . . . 0.0 111.152 -172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 40' ' ' SER 0.495 44.9 pt 58.28 -100.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 174.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 39' ' ' ILE . 24.7 m -54.11 143.23 22.97 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -56.05 -57.45 22.12 Favored Pre-proline 0 C--N 1.356 0.859 0 C-N-CA 125.866 1.666 . . . . 0.0 114.991 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.22 -5.58 17.16 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.258 2.913 . . . . 0.0 111.207 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -107.98 1.97 22.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.17 -45.21 9.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.79 -32.15 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 124.237 1.015 . . . . 0.0 110.781 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.86 -10.54 59.71 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.122 -0.986 . . . . 0.0 112.143 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -90.14 -22.95 21.49 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -89.32 54.7 3.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 120.151 -1.593 . . . . 0.0 109.36 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.21 -73.72 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.44 -31.72 65.7 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.506 1.922 . . . . 0.0 108.638 -169.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -52.64 -37.67 58.9 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.091 1.357 . . . . 0.0 111.627 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -16.48 58.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 119.664 -1.898 . . . . 0.0 111.919 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t -108.55 38.48 2.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.388 4.6 p 62.74 -110.31 0.34 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.597 2.359 . . . . 0.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t 70.51 -70.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.891 1.676 . . . . 0.0 110.116 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.5 -24.3 29.14 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -78.27 55.92 1.61 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 109.787 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.76 -13.65 66.43 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 120.369 -1.457 . . . . 0.0 110.358 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 t0 76.09 14.37 2.54 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 127.583 2.353 . . . . 0.0 108.751 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -148.79 -178.3 6.27 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.26 139.76 21.69 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.59 175.93 8.35 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.992 3.128 . . . . 0.0 107.766 161.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.314 2.6 p -113.43 -88.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-N 120.832 1.651 . . . . 0.0 112.046 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -157.64 -40.45 0.07 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.496 -2.003 . . . . 0.0 107.21 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.91 -23.5 31.16 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 123.121 0.568 . . . . 0.0 110.795 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 1.2 pm0 -57.8 -35.95 71.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.492 1.517 . . . . 0.0 108.043 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.04 96.35 2.08 Favored Glycine 0 CA--C 1.47 -2.74 1 N-CA-C 97.992 -6.043 . . . . 0.0 97.992 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -62.64 -17.21 59.94 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 118.726 1.263 . . . . 0.0 110.072 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -44.06 -29.63 0.63 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.561 2.744 . . . . 0.0 113.813 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.93 -40.99 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 124.593 1.157 . . . . 0.0 109.137 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 -49.05 12.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.196 -0.94 . . . . 0.0 108.617 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -47.85 -50.32 26.63 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.703 2.001 . . . . 0.0 111.721 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.1 -27.31 61.63 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.662 -0.649 . . . . 0.0 111.562 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.97 -44.15 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.9 mtm -63.19 -44.23 95.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.135 0.574 . . . . 0.0 110.539 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -65.84 -32.54 74.12 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.342 -0.849 . . . . 0.0 111.473 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.06 79.2 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.355 -0.841 . . . . 0.0 110.403 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.43 -41.34 96.46 Favored Glycine 0 CA--C 1.487 -1.695 0 C-N-CA 123.969 0.795 . . . . 0.0 111.145 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.71 -46.95 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 C-N-CA 124.078 0.951 . . . . 0.0 108.722 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.13 -39.4 94.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 120.734 -1.229 . . . . 0.0 112.302 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.85 -55.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.71 0.804 . . . . 0.0 109.361 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.39 -18.65 61.13 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.579 -0.7 . . . . 0.0 111.667 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.35 23.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.073 -1.017 . . . . 0.0 109.861 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.81 -37.27 87.05 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.935 -1.103 . . . . 0.0 110.585 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.33 -7.62 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 O-C-N 121.188 -0.945 . . . . 0.0 112.246 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -57.97 -23.95 55.98 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 124.706 1.202 . . . . 0.0 110.72 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.75 72.96 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.182 -1.574 . . . . 0.0 112.457 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.77 -39.98 56.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 120.998 -1.064 . . . . 0.0 108.612 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.59 -35.05 78.26 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.689 0.757 . . . . 0.0 110.425 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.74 68.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.672 -1.268 . . . . 0.0 112.343 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 t -84.57 5.12 29.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.709 -1.245 . . . . 0.0 109.709 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.72 -48.39 59.69 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 118.786 0.721 . . . . 0.0 109.693 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -67.98 -27.94 67.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.723 -1.235 . . . . 0.0 111.551 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -29.1 46.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 125.085 1.354 . . . . 0.0 109.115 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -59.96 -18.51 45.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.243 1.817 . . . . 0.0 111.847 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -61.81 -36.68 81.83 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.974 1.31 . . . . 0.0 109.676 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 CA--C 1.499 -1.015 0 O-C-N 120.683 -1.261 . . . . 0.0 109.815 -169.151 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.926 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' B' ' 5' ' ' GLU . 36.8 p-80 -56.16 -30.07 61.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.425 2.29 . . . . 0.0 114.348 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' CD2' ' B' ' 4' ' ' HIS . 8.3 mt-10 -74.62 -21.2 59.59 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -79.38 -42.57 25.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.59 -31.25 66.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.038 0.447 . . . . 0.0 110.473 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.53 -43.31 93.48 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.754 0.822 . . . . 0.0 111.558 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -72.83 -30.57 64.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.773 0.797 . . . . 0.0 110.351 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -66.45 -34.4 77.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.742 0.817 . . . . 0.0 110.214 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.94 79.28 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -63.29 -36.62 84.27 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.494 -0.753 . . . . 0.0 111.0 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.99 -33.95 76.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.916 0.886 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -62.81 -41.83 99.47 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 121.246 -0.909 . . . . 0.0 109.32 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.64 -39.65 94.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.795 -0.566 . . . . 0.0 110.939 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.97 -38.05 84.58 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.368 0.667 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -62.57 -45.2 94.01 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.339 0.656 . . . . 0.0 109.568 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.53 -38.72 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 123.756 0.823 . . . . 0.0 109.72 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.91 -45.92 85.75 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.824 0.85 . . . . 0.0 111.261 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.58 -37.63 77.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.592 1.157 . . . . 0.0 110.712 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.48 -35.59 63.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.72 -0.613 . . . . 0.0 109.898 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.73 -36.79 85.02 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.142 0.977 . . . . 0.0 111.068 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -28.94 69.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.727 1.149 . . . . 0.0 112.949 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.05 -53.71 10.42 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -58.18 -48.11 81.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 125.073 1.349 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.56 -43.87 84.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.644 1.178 . . . . 0.0 112.224 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 -48.69 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 -20.35 49.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -50.67 43.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 108.504 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.83 -21.66 63.36 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 mmm-85 -70.68 90.57 0.77 Allowed 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 120.149 -1.595 . . . . 0.0 110.694 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.87 -21.45 3.01 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 107.519 -2.233 . . . . 0.0 107.519 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.44 152.26 66.91 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 117.761 0.78 . . . . 0.0 110.771 -172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.57 128.32 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.87 2.38 . . . . 0.0 110.667 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.38 -63.05 0.28 Allowed Glycine 0 CA--C 1.471 -2.688 1 N-CA-C 103.036 -4.026 . . . . 0.0 103.036 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.416 ' H ' HG21 ' B' ' 63' ' ' VAL . . . 45.41 -94.53 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 128.643 2.777 . . . . 0.0 111.503 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 83.75 -29.09 0.09 Allowed 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 127.165 2.186 . . . . 0.0 109.042 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.92 122.5 39.96 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 pt -154.44 170.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 76.61 139.83 0.07 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.017 1.727 . . . . 0.0 111.673 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -47.3 23.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.585 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -70.48 -21.6 29.91 Favored 'Trans proline' 0 CA--C 1.502 -1.089 0 CA-C-N 124.512 2.647 . . . . 0.0 112.952 -168.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.38 6.52 24.43 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 119.945 1.248 . . . . 0.0 110.37 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.67 -38.85 67.48 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.631 0.729 . . . . 0.0 109.25 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -65.09 -33.24 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 123.414 0.686 . . . . 0.0 109.773 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -41.63 84.02 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.971 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.19 0.995 . . . . 0.0 109.177 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -58.02 -41.42 83.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.976 1.31 . . . . 0.0 111.165 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.79 -51.88 67.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 O-C-N 121.49 -0.756 . . . . 0.0 111.114 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . 0.285 6.6 pt-20 -76.37 -12.1 60.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.028 -1.045 . . . . 0.0 112.538 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 90.0 m -68.33 -42.94 78.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.6 67.38 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.323 -1.486 . . . . 0.0 112.287 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -76.58 -18.86 58.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.851 -0.531 . . . . 0.0 111.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.311 13.9 p 68.6 10.31 7.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.616 2.366 . . . . 0.0 111.307 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.23 -53.72 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.14 -46.65 3.67 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 120.838 -1.164 . . . . 0.0 110.554 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 76.91 -67.08 0.22 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 128.187 2.595 . . . . 0.0 109.002 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.69 27.79 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.03 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.36 178.22 7.45 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -156.23 154.62 27.7 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.91 174.5 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.073 2.515 . . . . 0.0 111.465 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.416 HG21 ' H ' ' B' ' 36' ' ' ALA . 2.4 t -95.83 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.914 0.885 . . . . 0.0 111.165 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -128.62 -32.08 2.18 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.448 1.899 . . . . 0.0 107.657 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -92.58 -6.2 50.01 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.769 0.827 . . . . 0.0 108.801 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -35.4 59.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.62 64.44 0.67 Allowed Glycine 0 CA--C 1.468 -2.897 0 N-CA-C 103.12 -3.992 . . . . 0.0 103.12 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -31.79 -16.82 0.0 OUTLIER 'General case' 0 C--N 1.369 1.45 1 C-N-CA 132.816 4.446 . . . . 0.0 117.7 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.46 -15.41 2.69 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.275 -1.516 . . . . 0.0 113.428 158.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.25 -54.6 32.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.171 1.388 . . . . 0.0 107.973 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.1 -46.0 75.55 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.463 -0.773 . . . . 0.0 110.31 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -49.73 -43.12 47.52 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 126.084 1.754 . . . . 0.0 111.393 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.38 -50.02 73.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.442 1.097 . . . . 0.0 110.913 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.84 -43.44 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.597 0.759 . . . . 0.0 109.624 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtm -63.14 -48.8 76.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.373 1.069 . . . . 0.0 110.134 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -71.61 -27.25 62.99 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.289 -0.882 . . . . 0.0 110.813 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.78 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.872 -1.142 . . . . 0.0 109.824 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.82 61.42 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -58.71 -45.56 90.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 C-N-CA 124.035 0.934 . . . . 0.0 110.52 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.55 -27.97 68.83 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.516 -1.365 . . . . 0.0 112.569 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.75 -46.71 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 120.368 -1.458 . . . . 0.0 108.247 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -65.95 -21.57 66.43 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.934 0.894 . . . . 0.0 110.956 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -42.78 16.43 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.619 1.167 . . . . 0.0 110.732 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.8 -40.4 83.96 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.208 1.403 . . . . 0.0 111.031 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 29.2 m -63.33 -8.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 123.836 0.855 . . . . 0.0 112.393 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.7 m -64.72 -12.58 48.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.678 -1.264 . . . . 0.0 110.535 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.96 65.98 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.828 -1.795 . . . . 0.0 112.098 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.51 -37.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.951 -1.093 . . . . 0.0 109.108 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.02 -36.59 64.46 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.417 -0.802 . . . . 0.0 111.267 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.33 -12.82 60.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.847 -1.158 . . . . 0.0 111.187 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -96.88 1.44 50.55 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.945 -1.097 . . . . 0.0 108.974 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.3 -37.3 66.26 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 120.305 1.411 . . . . 0.0 109.017 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -66.74 -30.01 70.13 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 120.289 -1.507 . . . . 0.0 111.406 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.6 -22.95 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.091 1.357 . . . . 0.0 109.6 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.92 -25.31 65.03 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.07 -1.019 . . . . 0.0 111.519 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -8.51 54.04 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.526 -1.359 . . . . 0.0 112.36 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 CA--C 1.496 -1.098 0 O-C-N 120.298 -1.501 . . . . 0.0 107.625 173.859 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 . . . . . 0 CA--C 1.501 -0.906 0 CA-C-O 122.88 1.324 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -19.99 63.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.691 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.15 -38.67 20.37 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -62.78 -32.2 73.32 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.503 -1.373 . . . . 0.0 112.182 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -64.48 -36.09 83.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.07 0.948 . . . . 0.0 110.936 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -44.73 62.04 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.173 -0.954 . . . . 0.0 109.519 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -66.83 -33.36 75.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.487 0.66 . . . . 0.0 111.345 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.97 -37.51 79.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.672 1.989 . . . . 0.0 111.113 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.01 -38.86 66.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.948 0.899 . . . . 0.0 110.291 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.05 -40.82 90.75 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.084 -1.01 . . . . 0.0 110.962 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.61 -18.03 62.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.298 -0.876 . . . . 0.0 111.728 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -73.83 -38.39 64.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.94 -38.11 89.89 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.249 0.62 . . . . 0.0 110.544 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.26 -24.94 68.09 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.604 -0.685 . . . . 0.0 112.449 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -80.12 -23.75 40.98 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.373 1.469 . . . . 0.0 109.55 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.17 -35.52 20.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 124.46 1.104 . . . . 0.0 108.034 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -60.55 -33.94 73.41 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.88 0.872 . . . . 0.0 111.462 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -60.62 -50.14 74.71 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.663 1.185 . . . . 0.0 110.225 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.38 -41.0 96.93 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 121.573 -0.704 . . . . 0.0 109.995 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.25 87.18 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.536 1.135 . . . . 0.0 110.389 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 83.5 p -62.72 -33.41 75.06 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.63 0.728 . . . . 0.0 112.116 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -80.15 -54.31 5.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.57 -30.79 67.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.772 0.829 . . . . 0.0 109.467 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.95 76.1 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 125.052 1.341 . . . . 0.0 112.736 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.23 -34.21 57.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 O-C-N 120.896 -1.128 . . . . 0.0 110.615 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.61 -40.63 73.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.852 -1.155 . . . . 0.0 109.389 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.6 1.09 Allowed 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.398 1.479 . . . . 0.0 109.53 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.34 -31.4 0.05 Allowed 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 123.694 0.621 . . . . 0.0 109.446 171.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -70.4 81.65 0.56 Allowed 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.224 -1.547 . . . . 0.0 111.915 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.66 -4.24 1.43 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.6 148.1 68.88 Favored Pre-proline 0 N--CA 1.442 -0.867 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -169.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -78.01 81.83 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.141 2.56 . . . . 0.0 113.182 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.68 34.11 3.15 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 146.18 13.89 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 126.813 2.045 . . . . 0.0 112.402 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.46 -46.07 1.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 125.169 1.388 . . . . 0.0 108.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.1 115.81 18.11 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 122.111 0.958 . . . . 0.0 108.603 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.8 163.21 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t 75.28 131.39 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.882 1.273 . . . . 0.0 112.377 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -67.29 -45.82 49.84 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 116.333 -1.794 . . . . 0.0 111.929 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.23 -10.54 27.4 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 CA-C-N 125.208 2.896 . . . . 0.0 113.904 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.361 0.7 OUTLIER -103.66 -19.43 14.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 121.372 1.896 . . . . 0.0 110.408 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.24 73.92 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.086 0.954 . . . . 0.0 112.214 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tp -66.05 -29.97 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.482 -0.762 . . . . 0.0 110.846 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -34.7 55.04 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -58.71 -41.99 87.59 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 122.385 1.088 . . . . 0.0 109.743 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -10.54 55.24 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.761 -1.212 . . . . 0.0 114.006 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.29 -47.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.5 57.56 4.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.607 1.563 . . . . 0.0 110.722 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -160.66 -51.21 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.64 -6.33 51.61 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.398 -1.439 . . . . 0.0 111.373 -170.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -80.52 -7.44 59.2 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.075 2.15 . . . . 0.0 110.459 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.309 34.2 p 76.93 17.76 1.63 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.689 2.396 . . . . 0.0 110.44 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.71 111.55 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.54 0.83 Allowed Glycine 0 CA--C 1.481 -2.075 1 N-CA-C 101.805 -4.518 . . . . 0.0 101.805 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.18 -33.06 38.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.92 -116.49 1.33 Allowed Glycine 0 CA--C 1.479 -2.187 0 N-CA-C 103.269 -3.932 . . . . 0.0 103.269 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.302 43.7 t0 64.13 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.348 0.52 0 C-N-CA 126.686 1.994 . . . . 0.0 109.825 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -128.75 158.96 37.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -161.05 147.0 11.16 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.01 163.62 22.9 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 122.795 2.33 . . . . 0.0 109.65 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.259 8.2 t -98.88 -105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -168.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -134.72 -60.04 0.79 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.371 -2.081 . . . . 0.0 108.827 -162.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -78.26 -6.35 54.72 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.377 1.471 . . . . 0.0 108.881 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.35 -20.77 46.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 C-N-CA 131.827 4.051 . . . . 0.0 108.028 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.69 84.36 0.84 Allowed Glycine 0 CA--C 1.482 -1.982 1 N-CA-C 101.473 -4.651 . . . . 0.0 101.473 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -23.52 24.66 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 110.92 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -57.65 -10.34 1.53 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.83 -41.21 87.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 120.059 1.3 . . . . 0.0 110.297 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.62 -51.09 21.09 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 120.991 -1.068 . . . . 0.0 109.163 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -46.05 -51.34 13.88 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 127.213 2.205 . . . . 0.0 112.966 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.98 -28.14 61.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.594 0.758 . . . . 0.0 110.714 -171.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 68.1 t -74.1 -46.08 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 79.2 mtm -59.98 -42.75 94.86 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.36 0.664 . . . . 0.0 111.231 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -65.37 -27.27 68.45 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 121.706 -0.621 . . . . 0.0 111.649 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.73 71.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.196 -0.94 . . . . 0.0 110.681 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.83 -35.83 61.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.57 -46.57 96.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 108.672 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.0 -50.33 73.76 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.73 -52.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 124.979 1.312 . . . . 0.0 110.379 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.29 -0.7 42.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.247 -0.908 . . . . 0.0 111.337 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.12 -37.58 14.12 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 120.733 -1.23 . . . . 0.0 108.295 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.48 -34.83 76.13 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 125.215 1.406 . . . . 0.0 111.344 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.88 -9.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 C-N-CA 124.079 0.952 . . . . 0.0 113.069 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -59.57 -24.19 63.53 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 125.52 1.528 . . . . 0.0 111.396 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.01 -23.56 66.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.771 -1.206 . . . . 0.0 111.562 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.43 -42.93 13.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.86 -41.59 91.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.44 1.096 . . . . 0.0 112.806 -171.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.75 -5.82 40.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.869 -1.144 . . . . 0.0 111.769 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.14 -8.48 25.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.35 -39.64 74.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.504 1.047 . . . . 0.0 109.305 -167.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -80.31 -15.02 57.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.195 -1.565 . . . . 0.0 113.04 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.16 -27.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.608 -1.308 . . . . 0.0 107.562 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 35.3 ttm105 -55.83 -23.4 30.28 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 126.405 1.882 . . . . 0.0 111.937 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -59.54 -32.67 70.54 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.421 -1.424 . . . . 0.0 111.732 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--N 1.355 0.822 0 O-C-N 121.005 -1.059 . . . . 0.0 108.487 -175.37 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 CA-C-O 121.851 0.834 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.98 -26.0 68.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.463 -1.398 . . . . 0.0 111.56 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.18 -24.86 60.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.259 -0.9 . . . . 0.0 111.308 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -30.2 38.58 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -67.42 -44.77 77.94 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.57 -0.706 . . . . 0.0 110.31 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.49 -38.36 74.34 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.769 -0.582 . . . . 0.0 110.384 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.85 -48.08 80.58 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.939 0.896 . . . . 0.0 111.588 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.02 -35.34 79.7 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.519 -0.738 . . . . 0.0 110.487 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.58 -31.81 73.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.837 0.855 . . . . 0.0 110.496 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.27 97.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.401 -0.812 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -29.69 70.76 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.522 0.677 . . . . 0.0 111.552 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.2 -28.85 66.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 121.251 -0.906 . . . . 0.0 110.42 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -82.47 -23.71 34.58 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.749 -1.219 . . . . 0.0 109.9 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.48 -42.97 99.6 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 120.637 -1.289 . . . . 0.0 110.5 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -59.36 -35.59 74.17 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.435 1.094 . . . . 0.0 112.162 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -66.83 -44.9 79.88 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.611 1.164 . . . . 0.0 108.926 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.24 -38.04 81.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 C-N-CA 124.259 1.023 . . . . 0.0 109.416 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.47 -44.87 81.01 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.642 0.777 . . . . 0.0 112.076 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.89 -43.69 71.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.025 0.53 . . . . 0.0 110.701 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.34 -47.21 80.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.59 1.186 . . . . 0.0 109.825 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.0 -28.68 64.61 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.017 -1.052 . . . . 0.0 111.876 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -74.42 -31.08 62.18 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 119.582 1.083 . . . . 0.0 110.769 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -62.05 -48.02 82.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -63.55 -50.68 68.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.208 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.06 70.06 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 125.291 1.437 . . . . 0.0 113.236 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.44 -35.34 61.59 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 120.947 -1.096 . . . . 0.0 110.59 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -81.78 -22.73 37.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.411 -1.431 . . . . 0.0 110.096 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -52.58 14.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 127.093 2.157 . . . . 0.0 107.778 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.84 -35.73 79.12 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.451 1.12 . . . . 0.0 110.967 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.84 103.51 2.64 Favored 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 120.184 -1.572 . . . . 0.0 111.586 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.41 -25.21 3.65 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 106.231 -2.747 . . . . 0.0 106.231 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 148.27 74.94 Favored Pre-proline 0 N--CA 1.439 -0.999 0 O-C-N 121.675 -0.897 . . . . 0.0 110.228 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 134.88 17.77 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.253 1.969 . . . . 0.0 110.131 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 26.63 61.26 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 137.28 51.26 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.287 1.835 . . . . 0.0 111.416 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.08 -47.08 2.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tt -85.93 71.27 10.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.728 1.251 . . . . 0.0 110.142 -172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -96.61 -6.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 O-C-N 120.159 -1.588 . . . . 0.0 111.205 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.2 p -95.96 141.98 28.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.097 -1.002 . . . . 0.0 110.862 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -89.73 -61.11 0.22 Allowed Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.318 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.25 -5.92 17.26 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 CA-C-N 125.797 3.106 . . . . 0.0 110.818 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.29 -18.56 21.51 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.076 1.751 . . . . 0.0 107.492 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.21 72.32 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 111.083 -168.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.26 -35.34 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 124.115 0.966 . . . . 0.0 110.515 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -36.15 74.23 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -67.95 -41.06 83.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.399 1.095 . . . . 0.0 109.393 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.8 t -60.62 -41.17 94.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.961 -1.087 . . . . 0.0 110.339 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.51 -53.35 31.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 125.432 1.493 . . . . 0.0 110.6 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -76.1 -15.35 60.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.684 -0.635 . . . . 0.0 111.62 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 73.8 m -76.41 -36.82 57.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.45 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.234 -0.916 . . . . 0.0 111.574 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.5 p -87.59 13.15 10.84 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.781 -0.575 . . . . 0.0 110.736 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p 52.56 49.02 21.3 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.296 1.839 . . . . 0.0 114.0 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.11 -55.05 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.87 -44.31 3.22 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 120.52 -1.363 . . . . 0.0 110.014 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.38 -75.72 0.07 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 127.111 2.164 . . . . 0.0 108.29 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.29 37.4 0.02 OUTLIER Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.0 -66.06 0.95 Allowed 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -130.52 -160.81 1.07 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -165.54 150.19 7.73 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.57 161.67 12.6 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.967 3.111 . . . . 0.0 108.707 168.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -154.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-N 119.893 1.224 . . . . 0.0 108.116 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -91.13 -50.07 6.05 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 119.672 -1.893 . . . . 0.0 108.687 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -77.34 -3.23 38.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.076 1.751 . . . . 0.0 110.847 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -29.8 69.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.59 80.23 1.19 Allowed Glycine 0 CA--C 1.468 -2.891 1 N-CA-C 99.1 -5.6 . . . . 0.0 99.1 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -63.16 -1.68 1.09 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.544 1.537 . . . . 0.0 112.613 -166.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -69.46 -13.3 62.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.602 1.161 . . . . 0.0 112.394 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -53.08 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.28 73.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.313 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -63.62 -34.57 78.12 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.718 0.807 . . . . 0.0 111.893 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.7 -37.08 85.99 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.967 -1.083 . . . . 0.0 111.206 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.22 -39.22 82.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 O-C-N 121.067 -1.021 . . . . 0.0 109.893 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 64.5 mtt -62.01 -50.37 72.33 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.67 0.788 . . . . 0.0 110.024 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.71 -30.64 70.93 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.496 -0.752 . . . . 0.0 110.641 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.13 96.12 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.066 -1.021 . . . . 0.0 110.469 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.09 -44.68 95.43 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 124.349 0.976 . . . . 0.0 111.428 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.64 -47.47 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 O-C-N 121.891 -0.77 . . . . 0.0 109.552 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -69.75 -32.82 71.56 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.927 -1.108 . . . . 0.0 113.306 -173.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.41 -42.48 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 110.109 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.14 -36.81 64.18 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 121.634 -0.666 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.28 -23.12 62.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.872 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.55 -32.63 72.7 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.856 -1.778 . . . . 0.0 109.797 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.48 -18.77 21.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 124.792 1.237 . . . . 0.0 110.276 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -60.05 -14.29 15.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 120.809 -1.182 . . . . 0.0 111.663 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.0 2.75 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.37 -1.456 . . . . 0.0 111.24 167.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.7 98.5 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.947 1.299 . . . . 0.0 109.517 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.12 -41.89 89.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 111.915 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.9 -11.45 60.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.978 -1.076 . . . . 0.0 110.356 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -74.72 -26.83 60.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 120.805 -1.184 . . . . 0.0 108.384 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.268 0.6 OUTLIER -80.14 -4.7 54.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 120.317 -1.489 . . . . 0.0 112.818 -160.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -81.78 -29.79 32.6 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 120.674 -1.266 . . . . 0.0 109.337 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.56 -28.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.49 1.116 . . . . 0.0 109.288 -172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -62.72 -12.38 23.45 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.272 -0.893 . . . . 0.0 111.691 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -68.96 -16.55 63.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.434 -0.791 . . . . 0.0 112.37 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 . . . . . 0 C--N 1.353 0.721 0 O-C-N 120.683 -1.261 . . . . 0.0 109.304 175.921 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.45 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 59.26 -80.6 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.692 2.397 . . . . 0.0 111.379 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -9.59 49.75 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.82 -42.1 91.03 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.337 -0.852 . . . . 0.0 109.18 164.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -71.73 -33.06 68.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 O-C-N 120.569 -1.332 . . . . 0.0 110.437 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.47 -38.5 87.46 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.01 93.5 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.502 1.121 . . . . 0.0 111.44 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -63.78 -36.35 83.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.476 1.51 . . . . 0.0 111.216 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -75.02 -23.87 58.25 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 121.361 0.6 . . . . 0.0 110.038 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.65 86.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.448 -2.033 . . . . 0.0 111.1 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -61.31 -37.47 83.37 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.896 0.855 . . . . 0.0 110.978 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.68 -32.86 74.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.47 1.908 . . . . 0.0 110.214 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -78.15 -32.1 50.11 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 120.895 -1.128 . . . . 0.0 109.083 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.27 -43.76 98.35 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.966 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -59.76 -35.89 75.53 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.309 0.644 . . . . 0.0 112.1 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -32.71 73.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.833 0.853 . . . . 0.0 110.908 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.57 -40.08 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.44 -37.26 86.9 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.488 -0.758 . . . . 0.0 110.917 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.19 -39.58 82.45 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.903 -1.123 . . . . 0.0 111.306 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -69.49 -37.84 77.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.715 0.806 . . . . 0.0 109.762 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.83 89.51 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 125.887 1.675 . . . . 0.0 110.746 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m -63.89 -31.68 72.94 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.968 0.907 . . . . 0.0 111.93 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -75.2 -49.56 19.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.387 -0.821 . . . . 0.0 108.826 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -73.98 -22.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.316 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.42 4.58 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 125.202 1.401 . . . . 0.0 108.553 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.6 t -64.01 -28.78 45.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 O-C-N 119.811 -1.805 . . . . 0.0 111.18 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.36 -35.09 77.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.801 -1.187 . . . . 0.0 110.757 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.73 -59.27 2.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.595 1.558 . . . . 0.0 107.804 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.12 -30.67 62.44 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.287 1.835 . . . . 0.0 112.581 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -77.89 87.12 4.09 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.316 -2.115 . . . . 0.0 110.586 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.0 -21.87 1.13 Allowed Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.39 157.9 35.51 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 118.57 1.185 . . . . 0.0 110.598 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -85.97 131.96 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.391 2.061 . . . . 0.0 111.552 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.0 60.34 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.26 137.45 58.26 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.741 1.216 . . . . 0.0 110.853 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.16 -55.97 2.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.594 0.757 . . . . 0.0 109.727 -173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.33 91.25 8.43 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.196 0.998 . . . . 0.0 109.369 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.04 50.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.322 -1.486 . . . . 0.0 109.279 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.97 148.03 23.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.996 -1.69 . . . . 0.0 109.415 170.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -69.97 -45.58 22.87 Favored Pre-proline 0 C--N 1.353 0.726 0 CA-C-O 116.184 -1.865 . . . . 0.0 112.555 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.33 -19.08 33.87 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 125.545 3.016 . . . . 0.0 113.366 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -103.89 -3.91 24.17 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 120.118 1.326 . . . . 0.0 109.91 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.57 85.7 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.347 1.07 . . . . 0.0 110.41 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 45' ' ' ILE . 14.0 tt -68.57 -22.08 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 C-N-CA 124.702 1.201 . . . . 0.0 111.081 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.03 -26.54 26.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.603 -0.685 . . . . 0.0 109.457 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -68.96 -45.15 71.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.9 m -59.28 -12.29 5.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.444 1.098 . . . . 0.0 113.776 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -71.25 -58.22 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 123.999 0.92 . . . . 0.0 108.726 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' B' ' 68' ' ' ARG . 92.2 mt-10 -83.57 75.59 10.02 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.416 -0.802 . . . . 0.0 109.434 -172.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -170.37 -45.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.35 81.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 124.358 1.063 . . . . 0.0 111.97 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 p -96.24 18.37 13.85 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 124.006 0.922 . . . . 0.0 110.652 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.65 62.92 2.21 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 127.104 2.161 . . . . 0.0 115.07 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.77 165.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 1 N-CA-C 95.267 -5.827 . . . . 0.0 95.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' D' ' 57' ' ' TYR . . . -160.65 120.74 0.97 Allowed Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 99.06 -5.616 . . . . 0.0 99.06 170.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -84.8 -17.66 37.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 119.06 1.43 . . . . 0.0 109.071 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.36 21.01 4.93 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 121.129 -0.982 . . . . 0.0 112.886 171.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.27 -39.83 22.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.031 -1.276 . . . . 0.0 112.805 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -147.86 153.05 38.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -162.96 145.14 8.03 Favored Pre-proline 0 C--N 1.354 0.776 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.08 178.77 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 2.965 . . . . 0.0 111.793 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 ' H ' ' A' ' 64' ' ' THR 0.275 9.4 p -119.54 -129.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 125.416 1.486 . . . . 0.0 108.412 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.422 ' H ' HG13 ' A' ' 63' ' ' VAL . 21.1 m -99.45 -57.87 2.06 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 119.493 -2.005 . . . . 0.0 112.069 -160.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -75.41 -9.82 58.91 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 119.182 0.901 . . . . 0.0 109.835 -171.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -71.65 -13.62 61.81 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.672 1.989 . . . . 0.0 108.89 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.5 85.26 0.87 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 100.847 -4.901 . . . . 0.0 100.847 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -56.13 -20.92 19.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.327 1.061 . . . . 0.0 112.22 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.31 -15.74 17.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 118.283 -0.865 . . . . 0.0 113.066 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.01 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.007 1.73 . . . . 0.0 109.325 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.13 -52.75 21.18 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 121.064 -1.023 . . . . 0.0 109.132 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.98 -36.65 79.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.51 -34.88 78.75 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.71 -40.79 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.208 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 53.0 mtt -60.73 -48.38 82.06 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.11 0.964 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -66.08 -33.6 76.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 110.519 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.32 89.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.77 -0.581 . . . . 0.0 110.402 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -45.83 94.86 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 124.047 0.832 . . . . 0.0 111.124 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.84 -47.75 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 124.591 1.156 . . . . 0.0 109.702 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -67.82 -31.58 71.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.784 -1.197 . . . . 0.0 112.254 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 t -66.18 -53.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 O-C-N 121.59 -0.694 . . . . 0.0 109.16 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.24 -19.2 62.39 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 121.403 -0.81 . . . . 0.0 111.358 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.18 40.37 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 120.721 -1.237 . . . . 0.0 109.998 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.44 -43.72 84.14 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.101 1.361 . . . . 0.0 110.474 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 m -68.82 -6.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -59.71 -21.48 60.68 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.491 1.041 . . . . 0.0 110.495 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.89 73.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.794 -1.191 . . . . 0.0 112.433 171.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.88 -37.6 55.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.888 0.875 . . . . 0.0 108.849 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.13 -0.357 . . . . 0.0 111.154 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.15 80.21 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.562 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -7.27 58.4 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 120.889 -1.132 . . . . 0.0 111.878 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -30.69 66.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.59 1.087 . . . . 0.0 109.557 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.85 -27.56 60.31 Favored 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 120.596 -1.315 . . . . 0.0 112.019 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.32 -22.62 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.415 1.086 . . . . 0.0 108.664 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -63.46 -21.61 66.41 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.61 -1.306 . . . . 0.0 111.615 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -71.46 -8.56 54.64 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.469 -1.394 . . . . 0.0 112.094 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.44 -0.958 0 O-C-N 120.811 -1.18 . . . . 0.0 110.011 175.009 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 61.2 t0 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.42 -26.65 58.53 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.383 1.073 . . . . 0.0 110.326 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -68.11 -32.82 73.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.725 1.61 . . . . 0.0 111.471 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.6 -40.0 80.64 Favored 'General case' 0 CA--C 1.503 -0.848 0 O-C-N 121.881 -0.512 . . . . 0.0 110.071 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.84 -37.87 79.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.08 70.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -67.26 -35.14 78.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.786 -0.571 . . . . 0.0 110.927 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -78.66 -15.22 58.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.96 -1.088 . . . . 0.0 110.771 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.17 72.18 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.564 -1.335 . . . . 0.0 108.917 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -30.45 70.01 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.714 0.805 . . . . 0.0 111.593 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.01 -36.06 81.31 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.738 0.815 . . . . 0.0 110.147 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.59 -33.08 73.44 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 123.441 0.696 . . . . 0.0 109.321 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -63.54 -40.19 96.36 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 121.396 -0.815 . . . . 0.0 110.331 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.72 -41.13 66.69 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 124.32 1.048 . . . . 0.0 111.16 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.57 -41.41 98.39 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.291 0.636 . . . . 0.0 110.875 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.58 -44.39 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 121.727 -0.608 . . . . 0.0 109.416 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tp -53.8 -52.31 60.71 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 128.018 2.527 . . . . 0.0 110.149 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.68 -34.48 64.89 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 121.382 -0.824 . . . . 0.0 110.038 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -68.05 -29.24 68.17 Favored 'General case' 0 C--N 1.355 0.848 0 CA-C-N 120.241 1.382 . . . . 0.0 109.872 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.06 66.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.906 0.882 . . . . 0.0 112.398 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 90.0 p -68.94 -42.72 76.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 O-C-N 121.114 -0.991 . . . . 0.0 110.43 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -38.05 84.87 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.04 -36.44 72.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.259 -0.901 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.61 29.42 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.927 1.291 . . . . 0.0 110.382 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.33 -33.11 52.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 123.954 0.902 . . . . 0.0 111.677 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -83.89 -16.78 43.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.958 0.903 . . . . 0.0 109.647 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.59 70.37 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.186 0.994 . . . . 0.0 109.754 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -65.14 -27.11 68.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 121.806 -0.559 . . . . 0.0 111.822 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.87 83.72 4.97 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.8 -23.74 2.77 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.69 138.67 20.75 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.892 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -82.14 105.72 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.86 2.373 . . . . 0.0 112.916 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.54 47.38 0.15 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.56 137.24 57.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.884 0.873 . . . . 0.0 111.685 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.0 -45.57 0.14 Allowed 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.137 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.38 -63.72 1.0 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.991 0.917 . . . . 0.0 108.807 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . 0.369 40.2 pt 53.8 -127.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 126.173 1.789 . . . . 0.0 112.93 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -13.01 134.85 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 132.236 4.215 . . . . 0.0 121.332 -167.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -65.21 -55.5 25.74 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 116.645 -1.645 . . . . 0.0 115.173 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.03 -5.0 15.87 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 125.076 2.848 . . . . 0.0 110.559 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.8 -42.13 12.78 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.205 1.802 . . . . 0.0 106.834 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -33.69 72.98 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.368 1.467 . . . . 0.0 112.496 -170.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.9 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 121.724 -0.61 . . . . 0.0 110.629 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -29.55 54.42 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.727 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.42 -48.3 61.4 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -60.43 -33.43 72.52 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.773 -1.205 . . . . 0.0 112.952 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.94 -24.81 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.889 1.276 . . . . 0.0 112.537 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.24 -17.93 53.84 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.013 -1.679 . . . . 0.0 109.932 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.447 ' C ' ' H ' ' B' ' 53' ' ' THR . 9.3 t -116.94 -166.17 1.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.71 -21.28 0.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 127.131 2.172 . . . . 0.0 110.846 -167.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.447 ' H ' ' C ' ' B' ' 51' ' ' THR . 2.8 p -93.51 -1.43 55.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.568 2.347 . . . . 0.0 110.759 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.274 0.0 OUTLIER 62.7 61.76 1.16 Allowed 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.308 1.443 . . . . 0.0 110.895 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.437 HG13 ' H ' ' B' ' 56' ' ' GLY . 7.6 p -137.91 -69.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.437 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 74.69 72.75 1.0 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -39.91 86.6 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 122.229 -0.571 . . . . 0.0 110.092 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.0 47.47 1.59 Allowed Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.25 -55.59 8.9 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -110.77 165.03 12.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -108.86 127.74 26.78 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.35 170.83 14.34 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.788 2.325 . . . . 0.0 109.66 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 64' ' ' THR . 1.2 t -92.86 -166.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.594 ' H ' HG12 ' B' ' 63' ' ' VAL . 32.7 m -101.09 -63.71 1.11 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.994 0.918 . . . . 0.0 109.132 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -54.61 -28.64 47.98 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -168.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -146.42 -164.36 1.96 Allowed 'General case' 0 N--CA 1.436 -1.17 1 N-CA-C 97.994 -4.817 . . . . 0.0 97.994 160.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.82 -75.34 1.1 Allowed Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 104.334 -3.506 . . . . 0.0 104.334 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 50' ' ' GLU . 17.1 ttt180 -69.53 -38.63 77.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.953 0.883 . . . . 0.0 109.996 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.13 -17.3 60.95 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.122 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.03 -45.82 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 O-C-N 119.664 -1.897 . . . . 0.0 106.1 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -35.32 64.48 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 126.182 1.793 . . . . 0.0 112.401 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -50.43 -51.95 42.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 126.586 1.954 . . . . 0.0 111.245 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.25 -37.93 88.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.912 0.885 . . . . 0.0 109.508 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.07 -41.63 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 121.727 -0.608 . . . . 0.0 110.575 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.7 mtm -63.15 -54.58 35.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 122.982 0.513 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -69.59 -27.48 65.14 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 121.554 -0.716 . . . . 0.0 111.084 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.73 -45.09 91.47 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 120.457 -1.402 . . . . 0.0 110.228 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.68 76.66 Favored Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 124.148 0.88 . . . . 0.0 111.318 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.5 -49.17 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 C-N-CA 124.842 1.257 . . . . 0.0 109.705 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.31 -21.68 62.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 120.919 -1.113 . . . . 0.0 111.628 -171.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.98 -54.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.44 -31.21 70.36 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.184 -0.947 . . . . 0.0 111.824 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.9 -22.29 61.52 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.656 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.69 -35.45 75.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 120.069 -1.645 . . . . 0.0 108.291 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.71 -17.05 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 125.051 1.34 . . . . 0.0 110.217 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -63.85 -13.39 44.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.938 -1.101 . . . . 0.0 110.937 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.84 68.7 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 110.76 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.69 85.59 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.563 1.145 . . . . 0.0 110.692 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.86 -40.8 79.13 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.217 0.607 . . . . 0.0 109.8 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.65 -22.54 63.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.445 -0.784 . . . . 0.0 110.417 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -75.18 -26.57 59.16 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.048 -1.033 . . . . 0.0 109.027 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.488 -1.383 . . . . 0.0 111.513 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -70.81 -28.5 64.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.288 -1.508 . . . . 0.0 112.012 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.55 -29.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 C-N-CA 125.28 1.432 . . . . 0.0 108.529 -173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -60.58 -28.79 68.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.508 1.523 . . . . 0.0 110.316 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -60.49 -26.16 66.61 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.289 -0.882 . . . . 0.0 111.936 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.442 -0.84 0 O-C-N 120.711 -1.243 . . . . 0.0 110.79 -176.664 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 CA--C 1.502 -0.9 0 CA-C-O 121.32 0.581 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -65.58 -26.12 67.71 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.435 -0.79 . . . . 0.0 112.151 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -77.75 -37.1 49.9 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -171.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.47 -42.41 99.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 110.569 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -70.45 -33.98 71.91 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.667 -0.645 . . . . 0.0 111.001 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.86 96.79 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -76.38 -20.42 57.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.124 -0.985 . . . . 0.0 112.141 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -70.61 -37.43 73.84 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.214 -0.929 . . . . 0.0 108.767 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.24 81.31 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.554 -0.717 . . . . 0.0 111.054 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -63.24 -36.98 85.46 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -64.52 -41.9 96.11 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 122.282 1.039 . . . . 0.0 108.655 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.15 -32.33 73.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.325 1.45 . . . . 0.0 109.711 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.48 -45.47 87.21 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.671 0.789 . . . . 0.0 110.682 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.81 -23.44 62.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.97 -1.081 . . . . 0.0 111.742 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -65.69 -46.63 78.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.75 . . . . 0.0 110.075 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.15 -25.98 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 121.068 -1.02 . . . . 0.0 110.758 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' C' ' 52' ' ' ALA . 81.8 mt -64.66 -41.38 96.14 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.385 -0.822 . . . . 0.0 111.119 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.4 -33.39 67.12 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.955 0.902 . . . . 0.0 111.531 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -67.62 -45.8 74.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.032 0.933 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.98 62.52 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.072 1.349 . . . . 0.0 110.97 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p -67.16 -39.41 86.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 119.433 1.015 . . . . 0.0 110.275 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -44.22 93.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.604 1.162 . . . . 0.0 108.427 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -67.6 -39.31 84.77 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.563 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.75 87.7 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.676 1.19 . . . . 0.0 111.878 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.93 -31.16 49.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 O-C-N 120.87 -1.144 . . . . 0.0 110.029 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.25 -19.21 43.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.763 0.825 . . . . 0.0 110.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.22 14.43 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.736 1.614 . . . . 0.0 107.024 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -80.29 -0.86 38.38 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.98 0.895 . . . . 0.0 110.869 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -74.42 81.88 1.92 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.816 1.647 . . . . 0.0 110.084 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.1 19.68 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 139.13 54.3 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 121.322 -1.105 . . . . 0.0 108.113 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.447 ' O ' HG11 ' C' ' 63' ' ' VAL . 50.8 Cg_endo -79.22 136.28 12.67 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.355 2.036 . . . . 0.0 110.437 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 4.16 89.34 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 119.529 1.059 . . . . 0.0 111.971 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 129.11 20.17 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 126.896 2.078 . . . . 0.0 114.107 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.34 -38.02 11.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.992 0.901 . . . . 0.0 108.682 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.3 tp -89.27 125.35 35.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 pt -144.45 -22.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -80.22 150.42 30.1 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.726 -0.609 . . . . 0.0 111.894 -171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.46 -64.52 0.3 Allowed Pre-proline 0 C--N 1.35 0.62 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.198 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.86 -26.89 21.89 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 125.691 3.068 . . . . 0.0 109.936 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 -14.89 61.2 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.538 0.735 . . . . 0.0 109.723 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.39 85.15 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.147 -0.971 . . . . 0.0 110.439 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -72.65 -22.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 121.736 -0.603 . . . . 0.0 110.488 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -72.52 -31.08 65.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -74.87 -37.21 62.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.485 -1.385 . . . . 0.0 108.647 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -76.13 64.38 1.96 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.916 1.287 . . . . 0.0 108.594 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -144.95 -67.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.76 -23.29 66.69 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.689 1.196 . . . . 0.0 112.561 -167.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m -68.06 -37.28 81.1 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.567 1.547 . . . . 0.0 110.629 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -77.24 -24.42 51.18 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.549 -0.719 . . . . 0.0 110.138 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 6.9 p -90.98 9.33 31.09 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.778 -0.576 . . . . 0.0 109.796 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 48.63 60.73 3.48 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 126.823 2.049 . . . . 0.0 113.684 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.1 -87.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.91 76.38 1.3 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -73.85 -20.48 60.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.415 -1.05 . . . . 0.0 111.411 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.16 32.66 3.68 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.64 -53.42 22.63 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -147.0 169.02 20.08 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -148.14 148.92 30.99 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.92 163.11 18.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.125 3.217 . . . . 0.0 109.195 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.447 HG11 ' O ' ' C' ' 34' ' ' PRO . 18.8 t -95.44 -102.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 120.437 1.471 . . . . 0.0 111.869 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -154.06 -30.73 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.622 -1.299 . . . . 0.0 109.61 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -101.26 11.74 38.77 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 120.2 -1.562 . . . . 0.0 108.786 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -44.01 88.04 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.74 86.28 1.62 Allowed Glycine 0 N--CA 1.416 -2.67 1 N-CA-C 98.033 -6.027 . . . . 0.0 98.033 -167.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -56.22 -20.04 16.45 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 125.642 1.577 . . . . 0.0 112.278 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -46.02 -28.22 1.12 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 126.677 1.991 . . . . 0.0 113.05 164.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.27 -43.94 95.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.849 -1.157 . . . . 0.0 109.682 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.48 62.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.344 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -51.2 -47.17 62.32 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.099 2.16 . . . . 0.0 111.116 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.37 -41.34 98.8 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.251 1.02 . . . . 0.0 111.329 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -41.41 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 C-N-CA 123.644 0.778 . . . . 0.0 109.635 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 37.6 mtt -58.99 -52.49 65.54 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.903 0.881 . . . . 0.0 110.299 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.58 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.09 82.87 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.412 -0.805 . . . . 0.0 111.403 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.86 -43.51 93.73 Favored Glycine 0 CA--C 1.494 -1.257 0 C-N-CA 124.202 0.906 . . . . 0.0 111.342 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.87 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 O-C-N 121.735 -0.862 . . . . 0.0 109.159 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.18 -47.6 84.72 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.492 -0.755 . . . . 0.0 111.956 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.49 -40.71 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.799 -0.563 . . . . 0.0 111.471 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.97 -38.48 61.66 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.678 0.672 . . . . 0.0 109.745 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.23 82.83 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.54 -36.42 69.24 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.4 -18.38 11.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.915 1.286 . . . . 0.0 111.043 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.6 m -59.23 -23.95 62.75 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.68 -1.887 . . . . 0.0 111.984 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.46 68.06 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.357 -1.465 . . . . 0.0 111.197 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.24 -52.35 7.84 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.33 -34.65 78.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.217 1.007 . . . . 0.0 113.537 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.76 -14.68 62.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.837 -1.164 . . . . 0.0 110.985 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 81.0 p -85.06 -11.16 55.94 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.55 -1.344 . . . . 0.0 110.855 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -17.55 61.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 119.243 0.929 . . . . 0.0 111.065 -169.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -82.24 -34.66 28.74 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.387 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 26.4 t -65.51 -35.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.463 1.505 . . . . 0.0 109.103 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -42.5 -34.89 0.92 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 128.21 2.604 . . . . 0.0 112.976 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -63.71 -27.05 68.94 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.056 -1.028 . . . . 0.0 111.836 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.44 -0.936 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -177.881 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.883 0 CA-C-O 122.613 1.197 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -74.05 -52.52 12.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.639 2.375 . . . . 0.0 108.513 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -58.89 -29.53 67.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 126.1 1.76 . . . . 0.0 112.686 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.1 -39.75 82.77 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.681 -0.637 . . . . 0.0 109.69 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -68.5 -36.21 78.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.71 -40.55 84.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.28 95.79 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.622 0.769 . . . . 0.0 111.919 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.33 -40.24 74.28 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 123.301 0.641 . . . . 0.0 110.566 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -61.69 -41.21 97.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.489 0.716 . . . . 0.0 110.28 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.21 70.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.117 0.967 . . . . 0.0 111.877 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.27 -37.14 86.28 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.669 -0.645 . . . . 0.0 111.655 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.81 -31.42 64.82 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -67.52 -35.25 78.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.703 0.801 . . . . 0.0 109.764 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.25 -38.41 90.95 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 111.645 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.43 -36.65 76.3 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.883 0.873 . . . . 0.0 110.756 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.46 -44.84 77.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.184 0.994 . . . . 0.0 110.058 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.02 -47.34 90.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.23 -38.36 85.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.923 -0.485 . . . . 0.0 110.455 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.58 -32.19 65.81 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.489 1.04 . . . . 0.0 113.343 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -69.18 -39.73 78.54 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 119.698 -1.877 . . . . 0.0 108.397 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -32.95 74.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -50.46 -52.08 41.29 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 125.769 1.627 . . . . 0.0 111.648 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -65.98 -34.71 78.73 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -84.48 -15.14 47.03 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.243 0.617 . . . . 0.0 110.972 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -44.61 65.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.513 1.125 . . . . 0.0 109.834 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.25 -40.39 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 122.371 1.081 . . . . 0.0 109.423 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.39 -29.81 68.6 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.954 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.92 92.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 125.189 1.396 . . . . 0.0 110.372 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -77.92 -6.32 53.96 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -76.41 90.62 3.25 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 119.9 -1.75 . . . . 0.0 107.188 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.94 -28.83 1.41 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.75 150.31 47.93 Favored Pre-proline 0 N--CA 1.443 -0.79 0 O-C-N 121.397 -1.061 . . . . 0.0 111.133 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.54 97.06 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.792 2.328 . . . . 0.0 112.723 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.35 -41.69 1.31 Allowed Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.23 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.526 2.331 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 72.81 -66.49 0.31 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.7 1.6 . . . . 0.0 112.401 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 49.4 tp -83.37 64.25 7.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.06 112.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 45.4 t -177.57 -141.72 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.9 -63.83 0.01 OUTLIER Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -72.53 -13.94 27.57 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 CA-C-N 125.541 3.015 . . . . 0.0 112.344 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -86.88 -11.06 51.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.04 85.51 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.596 0.758 . . . . 0.0 110.009 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.65 -41.97 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 109.522 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -38.91 83.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.204 -0.935 . . . . 0.0 109.865 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.427 ' HB2' ' HE ' ' D' ' 60' ' ' ARG . 70.4 t90 -66.07 -37.66 86.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.519 0.728 . . . . 0.0 110.499 172.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -36.53 71.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.077 -1.014 . . . . 0.0 109.808 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -54.65 -56.96 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 126.17 1.788 . . . . 0.0 109.578 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -71.66 -17.31 62.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 112.024 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -82.49 -37.01 25.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.691 -1.256 . . . . 0.0 109.237 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.93 73.36 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.422 -0.799 . . . . 0.0 110.739 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -95.44 11.91 31.2 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.683 0.793 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.508 HG22 ' HB2' ' D' ' 75' ' ' MET . 16.5 p 55.29 38.63 30.64 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.32 1.848 . . . . 0.0 112.035 169.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.02 -68.29 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.46 95.69 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.98 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 2.4 t80 -61.21 -32.73 72.5 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.542 1.163 . . . . 0.0 111.288 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.35 39.31 0.15 Allowed Glycine 0 CA--C 1.48 -2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 165.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -90.91 -59.11 2.26 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' D' ' 47' ' ' TRP . 15.8 mtm-85 -138.07 164.85 28.08 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 158.01 36.57 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 -175.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 168.99 19.84 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.253 2.635 . . . . 0.0 109.829 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.57 -93.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.214 0.461 . . . . 0.0 110.292 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -137.73 -81.57 0.35 Allowed 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 129.0 38.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 61.25 -61.87 0.08 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 126.808 2.043 . . . . 0.0 115.566 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . -34.54 -49.63 0.71 Allowed Glycine 0 CA--C 1.488 -1.64 0 C-N-CA 128.917 3.151 . . . . 0.0 114.524 -170.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.221 0.608 . . . . 0.0 112.094 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -71.15 -32.68 69.24 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.609 0.764 . . . . 0.0 109.231 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.41 -51.45 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.09 89.28 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.606 1.162 . . . . 0.0 113.121 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -53.6 -42.32 67.55 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.22 2.208 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -67.55 -39.08 84.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.647 -0.658 . . . . 0.0 110.445 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.64 -48.08 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 O-C-N 121.622 -0.674 . . . . 0.0 110.059 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.508 ' HB2' HG22 ' D' ' 54' ' ' THR . 21.1 ptp -65.82 -37.15 85.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.549 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -64.88 -41.34 95.71 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 121.467 -0.771 . . . . 0.0 110.678 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.154 0.582 . . . . 0.0 110.569 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.06 -46.21 93.89 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 123.633 0.635 . . . . 0.0 112.265 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.84 -43.64 92.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 124.026 0.931 . . . . 0.0 109.983 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -63.9 -41.5 97.68 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.01 -47.13 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 C-N-CA 124.204 1.002 . . . . 0.0 110.679 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -73.3 -10.79 60.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.407 -0.808 . . . . 0.0 111.186 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.81 14.11 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.82 0.848 . . . . 0.0 109.606 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.45 -33.05 74.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.419 1.887 . . . . 0.0 111.041 -174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.93 -7.64 2.11 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 112.724 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 40.3 m -62.01 -20.94 64.44 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.8 63.34 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.248 -1.532 . . . . 0.0 111.401 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.51 -53.72 4.82 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.236 1.014 . . . . 0.0 108.706 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.86 -36.96 70.64 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 124.486 1.114 . . . . 0.0 112.918 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 -22.54 61.49 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.008 -1.058 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 81.7 p -78.37 -17.56 56.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.325 -1.484 . . . . 0.0 109.813 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -69.98 -34.76 73.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.7 0.762 . . . . 0.0 109.453 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.96 -30.4 65.26 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.485 -1.385 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.76 -26.38 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 C-N-CA 124.284 1.033 . . . . 0.0 109.299 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -57.9 -14.92 7.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.83 1.252 . . . . 0.0 113.59 172.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -68.9 -38.56 79.68 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.394 1.092 . . . . 0.0 108.672 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -176.842 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -170.97 -64.22 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -61.88 -22.33 65.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.126 1.37 . . . . 0.0 113.449 -173.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -75.73 -22.04 56.94 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.546 -1.346 . . . . 0.0 110.224 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -66.77 -41.92 86.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -60.56 -47.51 85.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.43 96.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 111.545 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -61.23 -45.54 94.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 124.587 1.155 . . . . 0.0 109.493 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -61.57 -36.17 79.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.752 1.221 . . . . 0.0 110.179 -175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.41 72.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -66.95 -30.4 70.53 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.822 -1.174 . . . . 0.0 111.515 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.2 -26.04 55.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.312 -0.868 . . . . 0.0 109.872 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.41 -37.98 74.54 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.81 0.844 . . . . 0.0 109.371 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.36 -40.25 95.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.307 0.575 . . . . 0.0 110.917 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -63.53 -26.36 68.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.3 0.64 . . . . 0.0 112.058 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.83 -41.7 87.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.178 0.991 . . . . 0.0 109.333 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -39.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.524 1.129 . . . . 0.0 108.974 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.88 -42.29 84.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.299 1.04 . . . . 0.0 111.995 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.55 -23.45 58.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.107 0.963 . . . . 0.0 111.309 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.76 -32.27 19.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.789 -1.194 . . . . 0.0 108.348 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.21 73.68 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.525 1.53 . . . . 0.0 111.155 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.8 p -68.11 -39.68 82.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 118.716 0.689 . . . . 0.0 110.115 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -64.1 -49.1 73.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -63.94 -38.44 91.1 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.58 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 119.987 1.267 . . . . 0.0 111.431 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.14 -42.43 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.09 -19.58 59.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.152 -1.592 . . . . 0.0 112.002 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.5 -49.2 27.85 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.555 1.142 . . . . 0.0 108.443 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -58.52 -47.05 85.44 Favored 'General case' 0 CA--C 1.476 -1.9 0 C-N-CA 124.344 1.058 . . . . 0.0 110.646 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -63.45 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.17 0.988 . . . . 0.0 111.995 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.28 2.58 5.92 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.29 128.56 38.08 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 118.731 1.265 . . . . 0.0 108.771 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.44 146.01 17.04 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.402 2.068 . . . . 0.0 109.499 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.6 -18.88 47.71 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 118.972 0.805 . . . . 0.0 112.311 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.05 164.4 26.67 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.261 1.425 . . . . 0.0 112.888 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.04 2.44 3.63 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.18 0.592 . . . . 0.0 111.999 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 52.93 1.89 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 120.31 -1.494 . . . . 0.0 111.408 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -84.4 164.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.02 -1.675 . . . . 0.0 109.766 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.9 t 81.29 129.59 0.05 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.939 1.696 . . . . 0.0 110.686 166.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -67.39 -47.65 47.83 Favored Pre-proline 0 C--N 1.358 0.936 0 CA-C-O 116.213 -1.851 . . . . 0.0 112.152 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.26 -11.59 30.45 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 125.482 2.993 . . . . 0.0 111.892 -175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.63 -48.09 9.21 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.342 1.457 . . . . 0.0 107.248 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.29 74.05 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 125.103 1.361 . . . . 0.0 112.533 -174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.63 -30.39 48.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 O-C-N 121.685 -0.635 . . . . 0.0 111.145 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -33.34 55.68 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.777 -1.202 . . . . 0.0 108.967 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.0 -34.38 78.29 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.328 0.651 . . . . 0.0 110.297 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -56.3 -38.45 71.27 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 120.788 -1.195 . . . . 0.0 111.769 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.67 60.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -158.29 -36.37 0.07 Allowed 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 51' ' ' THR . 1.8 t -67.57 -33.78 75.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.825 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.27 -21.94 65.68 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.613 -1.305 . . . . 0.0 112.791 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.23 4.22 52.84 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.281 0.632 . . . . 0.0 109.97 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 p 48.46 47.31 20.29 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 127.139 2.176 . . . . 0.0 112.184 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -100.37 -69.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 85.63 72.87 1.29 Allowed Glycine 0 CA--C 1.492 -1.396 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -19.08 52.83 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.76 5.25 Favored Glycine 0 CA--C 1.486 -1.755 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -71.49 -46.09 60.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -132.01 165.2 24.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -140.09 130.8 14.08 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 100.804 -3.776 . . . . 0.0 100.804 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -86.11 176.22 5.26 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.721 2.947 . . . . 0.0 109.168 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.13 -142.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-O 123.103 1.43 . . . . 0.0 107.744 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 p -92.14 -43.63 9.25 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 119.657 -1.902 . . . . 0.0 111.094 -165.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.85 -29.56 70.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 127.799 2.44 . . . . 0.0 110.218 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.73 -24.65 67.63 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.71 2.004 . . . . 0.0 109.975 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.85 88.81 0.57 Allowed Glycine 0 CA--C 1.476 -2.366 1 N-CA-C 101.052 -4.819 . . . . 0.0 101.052 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.47 -17.81 2.26 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-O 123.291 1.519 . . . . 0.0 113.096 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -63.26 -14.68 52.18 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 125.071 1.348 . . . . 0.0 112.378 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.73 -45.01 99.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 CA-C-N 119.77 1.168 . . . . 0.0 108.592 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.72 67.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.837 -0.539 . . . . 0.0 110.046 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -48.84 -46.26 41.92 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.631 1.572 . . . . 0.0 110.908 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.73 -38.81 92.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.396 1.078 . . . . 0.0 111.725 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.97 -42.0 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 121.352 -0.842 . . . . 0.0 108.928 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.3 mtm -61.81 -46.07 91.11 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.103 0.561 . . . . 0.0 111.093 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -63.72 -38.66 91.93 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.812 -0.555 . . . . 0.0 110.953 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.19 90.91 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.937 0.495 . . . . 0.0 110.911 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.05 92.46 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 124.225 0.917 . . . . 0.0 111.104 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.91 -46.81 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.448 1.099 . . . . 0.0 109.14 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.33 -37.84 84.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 121.069 -1.02 . . . . 0.0 111.993 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.49 -56.65 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 109.598 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.1 -41.51 98.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.362 0.665 . . . . 0.0 110.835 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.7 -34.63 78.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.75 0.82 . . . . 0.0 111.113 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -66.64 -30.85 71.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.472 -1.392 . . . . 0.0 111.063 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.73 -12.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 110.829 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -58.35 -22.8 54.82 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.597 -1.939 . . . . 0.0 112.652 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.23 -24.99 61.12 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.893 -1.129 . . . . 0.0 111.685 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.83 -40.58 9.26 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.871 1.268 . . . . 0.0 110.969 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.7 -39.8 91.6 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.818 0.818 . . . . 0.0 111.126 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -28.05 62.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.008 -1.057 . . . . 0.0 110.984 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -71.89 -10.52 59.89 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.223 -1.548 . . . . 0.0 111.563 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.77 -38.51 86.72 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 122.235 1.016 . . . . 0.0 109.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -81.4 -11.83 59.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 119.355 -2.09 . . . . 0.0 112.967 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.36 -27.48 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.4 -27.36 47.22 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.56 1.544 . . . . 0.0 113.053 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -64.76 -21.32 66.74 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-O 122.038 0.923 . . . . 0.0 111.825 -172.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.433 -1.278 0 C-N-CA 125.77 1.628 . . . . 0.0 108.223 -178.96 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.521 ' HD2' ' HA ' ' B' ' 88' ' ' ALA . 13.0 p-80 -61.69 -26.65 68.16 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 128.741 2.816 . . . . 0.0 112.039 -174.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.517 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 8.9 mt-10 -75.04 -28.57 60.49 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.674 1.19 . . . . 0.0 110.348 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.88 -35.87 64.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.092 -1.005 . . . . 0.0 109.898 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.99 -31.18 69.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 122.011 0.91 . . . . 0.0 109.418 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.02 86.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.815 0.846 . . . . 0.0 110.67 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -71.96 -36.44 69.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.893 -0.505 . . . . 0.0 110.092 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -58.15 -35.99 72.35 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.415 1.486 . . . . 0.0 110.991 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.89 89.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.488 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.36 -36.62 83.36 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 120.928 -1.108 . . . . 0.0 110.658 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -66.5 -36.68 83.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.666 -0.646 . . . . 0.0 110.222 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -63.44 -42.92 98.69 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.785 1.234 . . . . 0.0 109.528 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.62 -37.21 72.91 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-O 121.804 0.811 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.8 -21.35 62.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.164 -0.96 . . . . 0.0 112.029 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -78.19 -30.28 48.91 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.15 -0.969 . . . . 0.0 108.883 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.32 -32.4 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 120.455 -1.403 . . . . 0.0 109.214 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.94 -36.55 77.29 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.217 -0.927 . . . . 0.0 111.949 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.27 -46.53 83.27 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.663 1.185 . . . . 0.0 109.782 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -70.61 -41.03 72.8 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 108.225 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 126.812 2.045 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 -49.96 75.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.145 1.378 . . . . 0.0 109.924 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -67.21 -46.42 73.93 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -61.69 -44.98 95.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.55 -53.15 52.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.72 -37.0 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -92.79 -1.05 57.12 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.887 -1.133 . . . . 0.0 110.895 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.72 -46.96 8.59 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.25 -24.47 59.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.954 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -74.48 108.83 7.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.198 -1.563 . . . . 0.0 111.242 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.96 -21.83 5.21 Favored Glycine 0 CA--C 1.495 -1.181 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.03 152.87 53.95 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.022 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.53 146.54 19.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.628 2.219 . . . . 0.0 110.492 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 34.87 89.47 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 124.092 0.853 . . . . 0.0 111.303 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 134.16 45.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.066 0.947 . . . . 0.0 109.474 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.34 -39.53 1.87 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.358 . . . . 0.0 109.87 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 tp -68.46 -33.29 73.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.956 . . . . 0.0 110.574 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 tt -41.47 76.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 1 C-N-CA 131.979 4.112 . . . . 0.0 116.94 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.84 136.11 7.81 Favored 'General case' 0 CA--C 1.494 -1.185 0 O-C-N 119.24 -2.162 . . . . 0.0 105.409 166.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -64.68 -54.21 38.08 Favored Pre-proline 0 C--N 1.349 0.559 0 CA-C-O 116.849 -1.548 . . . . 0.0 111.728 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.7 -16.87 23.56 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.007 2.824 . . . . 0.0 110.695 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -94.39 -22.9 18.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.62 76.43 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.092 1.357 . . . . 0.0 108.73 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.41 -27.55 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.197 0.522 . . . . 0.0 110.992 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.07 55.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -76.18 -33.58 59.31 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 123.37 0.668 . . . . 0.0 109.573 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -54.42 -29.77 50.32 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.955 -1.091 . . . . 0.0 112.042 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.01 -40.45 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 124.926 1.291 . . . . 0.0 110.356 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.95 -20.78 66.32 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.841 1.657 . . . . 0.0 112.139 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.07 -38.7 6.84 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -164.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -29.05 65.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.774 -1.204 . . . . 0.0 111.766 -170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -86.91 1.01 54.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.704 -0.623 . . . . 0.0 110.329 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.8 p 55.03 50.72 14.8 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 125.968 1.707 . . . . 0.0 110.984 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -103.44 -59.34 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.64 48.04 64.71 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 120.857 -1.152 . . . . 0.0 112.331 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -29.26 69.86 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.443 1.116 . . . . 0.0 112.393 -168.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.97 29.11 2.26 Favored Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.5 -63.94 0.96 Allowed 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.044 -0.68 . . . . 0.0 110.182 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -138.86 163.33 32.55 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -134.92 148.67 67.91 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.05 165.65 21.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 123.55 2.834 . . . . 0.0 110.421 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.91 -154.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -95.15 -54.52 3.4 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.546 1.138 . . . . 0.0 108.746 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.4 -4.7 46.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.576 1.551 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.17 -28.77 68.39 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.852 1.31 . . . . 0.0 107.817 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.38 87.5 1.02 Allowed Glycine 0 CA--C 1.479 -2.159 1 N-CA-C 101.074 -4.811 . . . . 0.0 101.074 -170.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -59.96 -12.0 6.93 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.235 1.518 . . . . 0.0 111.5 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -54.95 -17.93 4.35 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.469 1.908 . . . . 0.0 113.029 164.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -52.85 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 O-C-N 120.493 -1.38 . . . . 0.0 107.315 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.51 92.07 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.471 0.708 . . . . 0.0 110.633 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -49.76 -46.55 50.73 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.955 1.702 . . . . 0.0 111.235 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -62.95 -40.19 96.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.289 1.036 . . . . 0.0 111.301 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.62 -41.44 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.0 mtm -62.64 -45.67 91.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.383 0.673 . . . . 0.0 110.029 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.38 -36.35 83.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 121.502 -0.749 . . . . 0.0 111.364 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.89 89.08 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.48 0.712 . . . . 0.0 110.669 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.16 -45.15 92.6 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.59 -42.78 89.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 C-N-CA 124.109 0.964 . . . . 0.0 109.706 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -60.42 -42.78 96.74 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.078 -1.014 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 t -64.81 -52.35 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.389 1.076 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.63 -13.63 61.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 121.597 -0.689 . . . . 0.0 111.528 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.34 -36.87 14.4 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.327 -0.858 . . . . 0.0 109.88 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.1 -33.19 74.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.038 1.335 . . . . 0.0 110.41 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.06 -10.32 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 121.491 -0.756 . . . . 0.0 112.3 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -58.66 -18.89 34.5 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.871 1.669 . . . . 0.0 110.618 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.62 -65.07 0.63 Allowed 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.709 -1.245 . . . . 0.0 109.673 165.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' B' ' 4' ' ' HIS . . . -68.67 -42.03 78.45 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 120.775 -1.203 . . . . 0.0 111.3 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.5 -33.93 76.1 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.357 0.663 . . . . 0.0 111.195 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.03 -23.86 33.05 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.436 -1.415 . . . . 0.0 110.784 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.5 m -69.04 -21.81 64.08 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.293 -1.505 . . . . 0.0 108.392 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.28 -39.96 84.59 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.184 -0.947 . . . . 0.0 110.843 -164.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.48 ' CE1' HG21 ' C' ' 94' ' ' VAL . 10.0 p90 -65.73 -23.99 66.87 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.441 -0.787 . . . . 0.0 112.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -79.04 -20.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -68.01 -16.23 63.95 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.496 -1.377 . . . . 0.0 110.377 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -67.38 -2.0 5.57 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.824 -0.548 . . . . 0.0 112.422 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 C--N 1.36 1.032 0 O-C-N 120.917 -1.114 . . . . 0.0 110.085 163.687 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 123.067 1.413 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.445 ' CD2' HG21 ' C' ' 91' ' ' THR . 34.2 p80 -174.07 -50.24 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -69.07 -39.32 79.16 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.976 1.31 . . . . 0.0 110.518 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -54.7 -51.85 64.26 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.762 2.025 . . . . 0.0 110.733 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -75.05 -30.28 60.97 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.34 93.7 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.929 -1.107 . . . . 0.0 111.256 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -71.04 -36.67 72.43 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.609 -0.682 . . . . 0.0 110.886 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.1 -38.03 89.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.86 0.864 . . . . 0.0 110.548 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.3 86.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.499 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.41 -40.32 86.31 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.251 0.62 . . . . 0.0 110.813 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -70.34 -22.83 62.76 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.537 -0.727 . . . . 0.0 111.937 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.26 -32.2 58.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.113 -0.992 . . . . 0.0 108.683 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.48 -40.22 95.27 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.622 -0.674 . . . . 0.0 110.443 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -58.44 -38.31 77.23 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 112.048 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -66.66 -42.26 86.91 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.96 -40.34 85.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 124.39 1.076 . . . . 0.0 109.515 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.24 -42.65 77.69 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 124.124 0.969 . . . . 0.0 112.571 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.22 -42.84 75.17 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.413 -0.804 . . . . 0.0 110.058 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.45 -36.02 73.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.52 0.728 . . . . 0.0 109.607 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.39 83.67 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 126.191 1.796 . . . . 0.0 111.35 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 24.1 m -64.8 -39.24 93.26 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.495 0.718 . . . . 0.0 110.761 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -71.28 -44.4 65.29 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -68.35 -45.66 72.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.543 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.32 94.41 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 120.041 1.292 . . . . 0.0 111.532 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.51 -41.09 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 121.564 -0.71 . . . . 0.0 109.934 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.47 -22.78 43.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.342 -0.849 . . . . 0.0 110.146 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.3 71.78 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 125.026 1.33 . . . . 0.0 109.147 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.22 -23.81 62.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.256 0.622 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -71.07 87.61 0.77 Allowed 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.61 1.85 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.35 141.72 57.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 117.511 0.655 . . . . 0.0 111.483 -168.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 134.45 7.51 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 122.149 1.899 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.79 19.84 60.79 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.69 140.19 56.77 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 109.971 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.6 -42.82 3.39 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.417 HD21 ' CG ' ' C' ' 47' ' ' TRP . 2.0 mt -83.72 17.37 2.31 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.4 1.88 . . . . 0.0 110.523 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -75.48 76.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.054 1.407 . . . . 0.0 110.183 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.8 m -143.3 -123.38 0.09 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . 0.28 1.5 t80 173.56 -58.12 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.91 0 C-N-CA 128.755 2.822 . . . . 0.0 106.557 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.04 -18.21 31.22 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 CA-C-N 126.451 3.34 . . . . 0.0 112.838 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.426 ' CG ' HH12 ' C' ' 60' ' ' ARG . 31.3 p30 -106.1 14.97 27.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 119.398 0.999 . . . . 0.0 109.007 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.06 -35.87 66.78 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.937 -1.102 . . . . 0.0 108.761 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.404 ' O ' HG23 ' C' ' 49' ' ' VAL . 20.1 tt -67.28 -29.32 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 123.57 0.748 . . . . 0.0 110.162 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -64.32 -45.83 86.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.895 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CG ' HD21 ' C' ' 38' ' ' LEU . 76.0 t90 -69.41 -37.1 77.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.971 0.908 . . . . 0.0 108.919 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -56.26 -44.02 79.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.27 1.028 . . . . 0.0 111.538 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 45' ' ' ILE . 3.3 t -68.94 -38.98 79.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 O-C-N 120.739 -1.226 . . . . 0.0 111.73 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.17 -30.01 68.14 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 120.138 1.335 . . . . 0.0 110.861 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -61.23 -43.72 98.42 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.645 1.178 . . . . 0.0 109.866 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.42 65.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.945 -1.097 . . . . 0.0 112.26 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -87.26 4.19 43.66 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.419 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.2 p 57.63 29.32 17.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.426 1.49 . . . . 0.0 112.655 169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.411 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -94.5 -85.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.411 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 82.1 86.12 0.74 Allowed Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -73.44 -22.25 60.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.001 -1.294 . . . . 0.0 109.343 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 35.57 2.86 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.73 -47.74 51.78 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' C' ' 43' ' ' ASP . 69.6 mtt180 -140.98 173.44 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.39 148.85 21.61 Favored Pre-proline 0 N--CA 1.435 -1.217 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.54 171.26 12.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.888 3.059 . . . . 0.0 109.14 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.6 -109.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 119.392 0.996 . . . . 0.0 112.271 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 45.0 m -150.22 -40.53 0.13 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -82.78 -6.35 59.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.447 0.699 . . . . 0.0 110.007 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -31.84 66.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.23 56.47 0.93 Allowed Glycine 0 CA--C 1.472 -2.595 0 N-CA-C 104.564 -3.414 . . . . 0.0 104.564 167.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -22.22 -21.28 0.0 OUTLIER 'General case' 0 C--N 1.366 1.325 1 C-N-CA 134.048 4.939 . . . . 0.0 118.947 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -19.16 5.74 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 119.625 -1.922 . . . . 0.0 112.751 159.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.84 -45.67 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 119.549 1.068 . . . . 0.0 109.577 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -47.71 58.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.504 -0.747 . . . . 0.0 109.205 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.61 -47.95 58.07 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 124.757 1.223 . . . . 0.0 110.771 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -67.35 -33.87 76.15 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.94 -0.475 . . . . 0.0 111.716 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.02 -44.22 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 121.33 -0.856 . . . . 0.0 109.01 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 67.0 mtm -63.5 -46.8 84.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.25 1.02 . . . . 0.0 110.027 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -64.5 -40.7 96.14 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.51 0.724 . . . . 0.0 110.814 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.27 84.03 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.456 0.702 . . . . 0.0 111.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.2 -48.15 77.74 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -58.43 -46.41 89.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 124.532 1.133 . . . . 0.0 109.842 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -59.55 -45.14 92.66 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.909 0.884 . . . . 0.0 111.19 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.91 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.568 1.147 . . . . 0.0 109.966 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -66.39 -37.46 85.3 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.636 -0.665 . . . . 0.0 110.815 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.16 73.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.754 0.822 . . . . 0.0 110.596 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.46 -34.03 73.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.892 1.277 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.88 -12.05 3.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 125.433 1.493 . . . . 0.0 111.43 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -59.38 -25.66 64.45 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 112.449 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 -23.92 66.96 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-O 122.601 1.191 . . . . 0.0 111.618 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.73 -30.39 20.36 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.531 -1.355 . . . . 0.0 109.791 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.82 -49.86 13.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.888 0.851 . . . . 0.0 110.698 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.42 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.954 -1.091 . . . . 0.0 112.34 -170.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.445 HG21 ' CD2' ' C' ' 4' ' ' HIS . 13.0 t -72.86 -12.57 61.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 120.325 -1.485 . . . . 0.0 110.239 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -88.34 3.16 50.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.531 1.059 . . . . 0.0 110.531 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -34.65 18.69 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 160.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' B' ' 93' ' ' PHE . 38.7 t -72.01 -29.74 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 O-C-N 121.059 -1.025 . . . . 0.0 110.434 -171.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -61.24 -14.21 24.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -64.92 -32.27 73.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.101 -0.999 . . . . 0.0 110.689 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 . . . . . 0 C--N 1.356 0.856 0 CA-C-N 119.269 0.941 . . . . 0.0 108.782 -178.657 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.84 -59.55 2.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 131.118 3.767 . . . . 0.0 108.466 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 17.2 p-80 -60.1 -33.14 71.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.79 2.836 . . . . 0.0 112.011 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.05 -36.19 81.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.09 0.956 . . . . 0.0 109.862 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtp-105 -71.07 -38.35 72.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.423 -0.798 . . . . 0.0 110.511 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.22 -26.25 61.07 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.81 79.52 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.757 -1.214 . . . . 0.0 110.801 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -68.34 -29.38 68.1 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.216 -0.928 . . . . 0.0 111.708 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -64.1 -42.62 96.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 109.691 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.77 88.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.721 0.808 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.31 -38.38 83.5 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.787 -0.57 . . . . 0.0 111.717 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.97 -36.72 78.2 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.43 -26.77 67.38 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.316 -0.865 . . . . 0.0 110.799 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.21 -36.47 77.3 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 120.944 -1.097 . . . . 0.0 111.06 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -64.16 -31.91 73.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.196 0.999 . . . . 0.0 110.865 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.04 1.336 . . . . 0.0 110.109 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.6 -33.45 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.98 -40.65 89.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.685 0.794 . . . . 0.0 110.91 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.3 -43.2 78.19 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.176 0.591 . . . . 0.0 111.192 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.18 -38.99 86.33 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.95 75.55 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 124.607 1.163 . . . . 0.0 111.438 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -60.05 -46.74 88.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.163 0.892 . . . . 0.0 111.364 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -68.86 -51.72 37.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.927 1.691 . . . . 0.0 108.207 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -68.88 -43.83 74.51 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.942 0.897 . . . . 0.0 110.309 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.24 75.14 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 119.555 1.07 . . . . 0.0 110.72 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.55 -36.14 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.746 0.784 . . . . 0.0 109.314 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.49 -22.8 54.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 121.429 -0.794 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.64 -36.65 83.5 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 126.271 1.828 . . . . 0.0 110.486 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' D' ' 36' ' ' ALA . 0.6 OUTLIER -75.72 -16.03 60.21 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.412 -174.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -85.63 85.12 7.43 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.281 -1.512 . . . . 0.0 107.636 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.92 -33.66 0.56 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 105.117 -3.193 . . . . 0.0 105.117 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.37 149.16 57.47 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 124.225 1.01 . . . . 0.0 111.565 -171.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.82 97.89 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.888 2.392 . . . . 0.0 113.528 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.32 47.74 0.45 Allowed Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' D' ' 30' ' ' GLU . . . -54.8 106.61 0.23 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.572 1.149 . . . . 0.0 113.494 -169.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.98 -59.34 1.93 Allowed 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 109.64 -169.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' D' ' 47' ' ' TRP . 3.4 tt -84.55 63.07 7.67 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.7 tt -96.23 -6.08 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.116 -1.615 . . . . 0.0 109.082 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -88.57 120.98 30.47 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.672 0.789 . . . . 0.0 111.687 -171.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -74.4 -59.14 1.68 Allowed Pre-proline 0 C--N 1.353 0.73 0 CA-C-O 116.05 -1.929 . . . . 0.0 112.506 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.45 -14.13 30.69 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 CA-C-N 125.941 3.157 . . . . 0.0 110.906 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.31 -11.7 42.68 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 124.196 0.998 . . . . 0.0 109.471 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.2 67.32 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 120.872 -1.143 . . . . 0.0 110.384 -170.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -16.24 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.061 1.41 . . . . 0.0 109.225 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -76.64 -51.85 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 119.794 -1.816 . . . . 0.0 106.566 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.449 ' CD2' HD11 ' D' ' 38' ' ' LEU . 74.4 t90 -55.44 -46.12 76.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.117 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -64.82 -16.91 63.73 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.17 -50.97 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.07 65.64 9.19 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -159.55 -52.64 0.06 Allowed 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -18.45 64.94 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.43 -0.794 . . . . 0.0 112.042 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -87.06 -3.6 59.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.116 1.766 . . . . 0.0 111.057 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 56.15 38.4 29.82 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 125.544 1.538 . . . . 0.0 111.149 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.61 -37.58 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 121.771 -0.581 . . . . 0.0 110.905 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.34 -81.61 0.29 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.08 142.03 52.7 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.75 34.55 0.68 Allowed Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.21 -59.86 0.5 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.288 2.235 . . . . 0.0 109.011 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -97.28 156.24 16.52 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -142.55 148.26 46.14 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -80.36 167.77 19.02 Favored 'Trans proline' 0 CA--C 1.503 -1.057 0 C-N-CA 122.59 2.193 . . . . 0.0 110.266 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' D' ' 64' ' ' THR . 4.1 t -97.56 -150.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 174.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' D' ' 63' ' ' VAL . 4.6 p -91.23 -60.09 1.99 Allowed 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.755 -1.84 . . . . 0.0 112.541 -162.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -75.07 129.73 38.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 58.08 -104.78 0.23 Allowed 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.54 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 42.35 -82.19 0.0 OUTLIER Glycine 0 C--N 1.357 1.705 0 C-N-CA 130.006 3.669 . . . . 0.0 112.579 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -72.13 -32.53 67.02 Favored 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 126.074 1.75 . . . . 0.0 112.025 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.5 -24.11 65.54 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.155 1.343 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -78.8 -50.58 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.9 -39.7 71.98 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 111.919 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.88 -48.89 21.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 128.497 2.719 . . . . 0.0 112.055 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.69 -38.35 76.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.428 0.691 . . . . 0.0 110.132 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.12 -45.03 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 C-N-CA 124.181 0.993 . . . . 0.0 109.39 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -61.7 -45.64 93.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.298 1.039 . . . . 0.0 110.867 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.21 -41.59 93.36 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 110.857 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -36.72 84.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.388 0.675 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.64 64.12 Favored Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 123.979 0.799 . . . . 0.0 111.297 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.62 -46.36 90.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 124.203 1.001 . . . . 0.0 109.768 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -61.87 -30.52 70.92 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.421 1.088 . . . . 0.0 113.046 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 t -74.31 -50.43 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.56 -44.15 97.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.453 0.701 . . . . 0.0 109.999 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.33 -23.32 63.77 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.929 0.891 . . . . 0.0 111.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.89 -30.63 68.12 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.147 -1.595 . . . . 0.0 109.355 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -61.83 -13.42 9.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.411 1.084 . . . . 0.0 110.385 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.5 m -58.89 -20.68 53.64 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 119.537 -1.977 . . . . 0.0 112.596 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.37 68.5 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.983 -1.698 . . . . 0.0 111.445 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -86.15 -35.97 19.82 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.14 0.976 . . . . 0.0 109.643 175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 mt -73.16 -44.75 59.5 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.426 0.631 . . . . 0.0 112.197 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.19 70.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.835 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -73.31 -6.48 46.38 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.067 -1.021 . . . . 0.0 110.607 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.82 -14.62 58.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.692 1.133 . . . . 0.0 110.739 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -33.1 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 119.842 1.201 . . . . 0.0 108.726 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.97 -29.12 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.294 1.038 . . . . 0.0 109.594 -174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -68.39 -12.08 60.6 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.335 -0.853 . . . . 0.0 111.793 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -61.62 -37.12 82.79 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.265 1.031 . . . . 0.0 110.146 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 N--CA 1.442 -0.829 0 O-C-N 119.862 -1.774 . . . . 0.0 109.572 -175.268 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.11 -71.97 0.4 Allowed 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.1 -23.96 67.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -75.82 -26.42 57.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 109.624 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -64.89 -44.99 87.85 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.32 1.048 . . . . 0.0 108.445 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.21 -40.54 90.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.033 1.333 . . . . 0.0 109.781 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.54 91.72 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 110.844 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.51 -28.14 64.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.62 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -68.49 -34.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.9 90.35 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.343 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.82 -31.9 73.0 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.394 -0.816 . . . . 0.0 111.975 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.93 -41.45 97.63 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.96 0.904 . . . . 0.0 109.392 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -65.74 -34.33 77.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.499 1.119 . . . . 0.0 109.63 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.28 -44.91 94.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.738 0.815 . . . . 0.0 111.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -62.77 -38.21 89.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.238 0.542 . . . . 0.0 111.082 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.18 -37.66 88.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.926 0.89 . . . . 0.0 110.363 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.98 -41.62 84.75 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 C-N-CA 124.127 0.971 . . . . 0.0 108.885 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.2 -45.01 79.98 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.941 0.896 . . . . 0.0 111.802 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -75.2 -24.74 57.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.945 0.898 . . . . 0.0 111.285 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -81.0 -37.93 28.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.63 76.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.459 1.504 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -66.76 -39.7 87.98 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 119.394 0.997 . . . . 0.0 109.79 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.14 -48.45 70.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.733 -0.604 . . . . 0.0 110.174 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -60.81 -48.44 81.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 121.399 -0.813 . . . . 0.0 110.381 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.81 80.15 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.272 1.429 . . . . 0.0 111.903 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.3 -43.45 98.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 O-C-N 121.281 -0.887 . . . . 0.0 110.356 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.36 -29.3 57.14 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.352 -0.843 . . . . 0.0 110.46 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.0 71.76 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.479 1.512 . . . . 0.0 108.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.578 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.3 tp10 -69.9 -28.63 65.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.064 1.345 . . . . 0.0 110.819 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -67.03 107.3 2.22 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.341 -1.474 . . . . 0.0 110.746 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.62 -13.24 32.74 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.15 150.9 72.15 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 118.264 1.032 . . . . 0.0 109.483 -171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 36' ' ' ALA . 57.5 Cg_endo -78.03 148.67 24.93 Favored 'Trans proline' 0 CA--C 1.505 -0.938 0 C-N-CA 122.827 2.351 . . . . 0.0 108.871 175.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.63 -25.92 5.52 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 119.855 1.207 . . . . 0.0 111.645 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.31 135.6 0.73 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 131.282 3.833 . . . . 0.0 115.565 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.48 -29.23 1.22 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.113 0.965 . . . . 0.0 110.532 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.01 51.87 1.85 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.094 1.757 . . . . 0.0 110.984 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 tt -108.67 73.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 119.131 -2.23 . . . . 0.0 109.924 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 t -174.7 137.31 0.46 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -66.8 -53.14 29.07 Favored Pre-proline 0 C--N 1.351 0.647 0 CA-C-O 115.611 -2.138 . . . . 0.0 112.652 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -69.78 -20.57 34.59 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 125.568 3.024 . . . . 0.0 113.126 -170.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.278 0.6 OUTLIER -103.04 -12.27 17.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 119.541 1.064 . . . . 0.0 110.34 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.89 -31.53 63.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 120.546 -1.346 . . . . 0.0 110.867 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tp -67.26 -32.47 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -33.95 68.32 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.534 -1.353 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -67.04 -38.62 86.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.657 1.218 . . . . 0.0 108.981 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -60.0 -43.53 95.13 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.56 1.144 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.61 -49.85 79.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 124.275 1.03 . . . . 0.0 110.415 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.61 -17.03 62.3 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.683 -0.636 . . . . 0.0 111.605 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m -80.14 -38.59 31.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.672 -0.642 . . . . 0.0 109.697 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.8 67.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.844 -1.16 . . . . 0.0 111.528 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -86.19 6.82 27.62 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.9 0.48 . . . . 0.0 110.121 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p 50.08 54.13 11.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.587 1.955 . . . . 0.0 112.584 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 56' ' ' GLY . 8.2 p -116.99 -77.42 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.558 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.05 85.06 0.23 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -74.39 -14.82 60.92 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.664 -1.492 . . . . 0.0 111.061 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 32.08 3.88 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 49.0 t0 -73.28 -48.97 30.27 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -136.85 169.83 17.1 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.32 146.56 33.56 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.89 -172.61 1.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 124.61 3.54 . . . . 0.0 109.432 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 64' ' ' THR 0.253 13.3 p -129.02 -146.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 63' ' ' VAL . 18.9 m -100.63 -49.97 4.03 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.562 1.545 . . . . 0.0 107.946 -172.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -79.4 -12.27 59.91 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.452 0.701 . . . . 0.0 111.179 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -63.78 -30.36 71.47 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 122.931 1.348 . . . . 0.0 107.649 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.55 81.14 1.49 Allowed Glycine 0 CA--C 1.469 -2.794 1 N-CA-C 99.601 -5.4 . . . . 0.0 99.601 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -59.18 -8.04 1.42 Allowed 'General case' 0 C--N 1.362 1.144 0 CA-C-O 123.238 1.494 . . . . 0.0 112.929 -168.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -60.17 -15.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 120.144 -1.597 . . . . 0.0 113.171 164.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.91 -50.53 74.64 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-N 120.688 1.585 . . . . 0.0 107.367 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.86 -47.21 83.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.311 0.644 . . . . 0.0 111.798 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.89 -45.86 71.22 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.096 1.358 . . . . 0.0 110.728 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -33.6 75.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.909 0.884 . . . . 0.0 111.539 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.43 -49.31 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.4 ptp -65.68 -38.31 88.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 122.01 -0.431 . . . . 0.0 110.332 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -65.14 -38.05 89.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.484 -0.76 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.59 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.315 0.646 . . . . 0.0 110.702 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -44.56 97.55 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.405 1.002 . . . . 0.0 110.71 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.93 -44.17 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 121.894 -0.768 . . . . 0.0 109.294 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.36 -47.43 85.9 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.068 -1.02 . . . . 0.0 112.02 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.83 -39.2 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 O-C-N 121.719 -0.613 . . . . 0.0 111.202 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.69 -39.04 64.67 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.687 0.676 . . . . 0.0 109.387 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.29 73.86 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 121.455 -0.778 . . . . 0.0 111.172 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.77 -36.22 76.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.296 1.438 . . . . 0.0 111.267 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.84 -12.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 125.202 1.401 . . . . 0.0 111.198 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -58.99 -21.52 59.05 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.762 -1.836 . . . . 0.0 111.58 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.92 -26.51 68.84 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 120.815 -1.178 . . . . 0.0 112.15 172.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.54 -47.65 11.1 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.19 -40.58 94.45 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.079 0.951 . . . . 0.0 113.342 -170.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -16.5 63.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.102 -0.999 . . . . 0.0 111.616 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.6 p -87.59 -12.51 45.45 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.89 -1.131 . . . . 0.0 110.641 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -76.26 -17.48 59.45 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -166.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -81.36 -31.64 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.962 -1.086 . . . . 0.0 110.379 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -71.54 -22.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 125.904 1.682 . . . . 0.0 109.025 -169.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -53.85 -24.04 14.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.362 1.465 . . . . 0.0 112.585 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -65.91 -16.16 63.61 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 120.221 -1.55 . . . . 0.0 112.029 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.35 0.628 0 CA-C-O 122.018 0.913 . . . . 0.0 109.494 176.802 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 120.683 0.277 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.32 -21.45 56.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.897 -1.127 . . . . 0.0 110.98 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -81.59 -48.08 12.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -64.14 -40.22 95.69 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.405 -0.809 . . . . 0.0 112.198 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.46 -27.46 60.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.43 71.71 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.432 -0.792 . . . . 0.0 109.844 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.38 -37.55 86.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.759 0.824 . . . . 0.0 111.075 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -64.43 -37.16 86.55 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.409 0.683 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -29.46 70.8 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.477 -0.764 . . . . 0.0 111.208 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -67.33 -30.12 69.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.109 -0.994 . . . . 0.0 111.528 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.4 -28.45 61.09 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.79 -1.194 . . . . 0.0 110.141 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.38 -42.76 95.98 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.227 1.011 . . . . 0.0 109.138 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.6 -40.53 97.22 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.459 -0.776 . . . . 0.0 110.749 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -67.44 -27.31 66.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -69.5 -43.88 72.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.485 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.11 -35.31 74.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 123.921 0.889 . . . . 0.0 109.34 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.9 mt -53.82 -53.95 45.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 123.938 0.895 . . . . 0.0 109.73 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -66.89 -32.86 74.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.782 -0.574 . . . . 0.0 111.944 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.18 -51.7 50.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.843 0.83 . . . . 0.0 109.535 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.53 83.43 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.991 0.916 . . . . 0.0 111.388 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -63.57 -40.14 96.2 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 123.61 0.764 . . . . 0.0 110.852 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -63.93 -40.39 96.35 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -68.73 -40.65 79.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.384 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.69 67.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.911 1.684 . . . . 0.0 113.086 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.87 -25.49 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.801 0.81 . . . . 0.0 111.721 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.17 -36.2 13.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.04 -50.67 63.38 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.698 1.999 . . . . 0.0 110.187 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.18 56.46 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.375 -0.828 . . . . 0.0 109.98 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -138.61 101.85 4.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.04 -2.1 38.18 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.16 64.74 Favored Pre-proline 0 N--CA 1.442 -0.844 0 O-C-N 121.586 -0.95 . . . . 0.0 109.658 -172.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.45 113.07 2.56 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.366 2.71 . . . . 0.0 112.423 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.0 23.86 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.31 163.15 17.86 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.56 -25.9 0.27 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.33 52.0 2.26 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.65 1.214 . . . . 0.0 108.718 -172.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 43.8 pt -80.06 27.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 124.932 1.293 . . . . 0.0 111.1 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -122.34 142.5 50.44 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.89 -1.131 . . . . 0.0 109.429 -168.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.73 -62.02 0.23 Allowed Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-O 116.937 -1.506 . . . . 0.0 110.198 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.14 -12.55 23.44 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 CA-C-N 125.496 2.998 . . . . 0.0 111.659 -172.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -87.72 -8.85 55.53 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.26 99.43 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 121.687 -0.633 . . . . 0.0 110.016 -173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.54 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.028 0.531 . . . . 0.0 110.338 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -20.47 55.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 120.713 -1.242 . . . . 0.0 111.877 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -75.85 -53.48 8.39 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 m -54.82 -33.1 61.19 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.7 t -56.75 -48.76 80.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 124.281 1.032 . . . . 0.0 110.584 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.63 -16.43 55.82 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 119.798 1.181 . . . . 0.0 111.795 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -65.71 -42.17 91.44 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 109.318 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -29.14 68.77 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 123.353 0.661 . . . . 0.0 111.416 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.0 p -87.17 -0.75 57.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 16.6 p 54.44 33.89 19.7 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.759 1.624 . . . . 0.0 110.806 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.89 -60.76 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 103.255 -2.868 . . . . 0.0 103.255 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 50.13 64.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.03 -41.3 91.12 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 118.095 0.948 . . . . 0.0 108.628 -171.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.68 -111.05 0.46 Allowed Glycine 0 CA--C 1.471 -2.713 0 N-CA-C 103.398 -3.881 . . . . 0.0 103.398 172.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.8 t0 76.5 -72.55 0.1 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.184 0.993 . . . . 0.0 109.741 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.62 167.42 19.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.64 128.31 13.52 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -88.07 161.38 7.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.027 2.485 . . . . 0.0 109.708 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.452 HG13 ' H ' ' B' ' 64' ' ' THR 0.348 14.6 p -96.71 -126.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.452 ' H ' HG13 ' B' ' 63' ' ' VAL . 3.1 m -119.87 -38.86 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.864 1.666 . . . . 0.0 109.266 -170.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -93.04 5.45 51.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.718 0.807 . . . . 0.0 109.976 -168.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.11 38.11 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.63 73.87 1.27 Allowed Glycine 0 CA--C 1.469 -2.832 1 N-CA-C 101.444 -4.662 . . . . 0.0 101.444 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -48.26 -8.02 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 130.293 3.437 . . . . 0.0 114.738 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' B' ' 72' ' ' GLU . 61.4 mttt -48.22 -26.34 1.91 Allowed 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 127.015 2.126 . . . . 0.0 112.804 154.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.95 -48.18 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 125.022 1.329 . . . . 0.0 108.826 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.26 60.64 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 109.886 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.456 ' HB3' ' HA ' ' B' ' 69' ' ' LYS . 14.7 tt0 -49.76 -46.65 50.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 127.856 2.462 . . . . 0.0 109.961 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -61.67 -43.9 97.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.086 0.954 . . . . 0.0 111.019 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.25 -43.84 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -61.39 -51.76 67.44 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.05 0.54 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -66.39 -35.57 80.66 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.822 -0.549 . . . . 0.0 110.094 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.3 93.64 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.608 -0.683 . . . . 0.0 110.836 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.53 -48.79 79.26 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.98 -48.11 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.808 1.243 . . . . 0.0 109.943 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.28 -33.79 76.81 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.638 -1.289 . . . . 0.0 111.947 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.82 -49.51 68.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.553 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -66.82 -22.78 66.0 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.381 0.672 . . . . 0.0 111.135 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.12 -39.42 25.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.33 -34.36 76.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.676 1.191 . . . . 0.0 111.312 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 m -66.25 -7.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 121.442 -0.786 . . . . 0.0 112.124 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 72.2 m -59.19 -22.03 60.36 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.128 1.371 . . . . 0.0 111.085 171.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.19 68.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 118.852 -2.405 . . . . 0.0 112.382 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.99 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.5 -35.72 72.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.232 1.413 . . . . 0.0 112.45 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . . . -71.38 -16.94 62.43 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 121.005 -1.06 . . . . 0.0 112.011 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -76.53 -24.51 53.65 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.7 -9.14 59.3 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.813 -1.179 . . . . 0.0 110.327 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' B' ' 90' ' ' ALA . 3.1 m-30 -73.82 -34.43 64.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.55 1.14 . . . . 0.0 108.423 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.29 -31.76 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 125.101 1.36 . . . . 0.0 108.457 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -62.99 -5.11 2.63 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.214 -0.929 . . . . 0.0 112.829 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -64.78 -23.29 67.2 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.744 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 0.5 OUTLIER -45.91 -33.97 3.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 128.507 2.723 . . . . 0.0 112.441 166.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.43 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 7.0 pt-20 -79.61 -28.2 41.02 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -71.57 -40.31 70.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -70.14 -35.41 74.04 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.674 0.75 . . . . 0.0 109.117 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.54 83.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.511 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.27 -35.55 75.8 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.795 1.638 . . . . 0.0 111.373 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -66.4 -42.44 87.84 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.962 1.305 . . . . 0.0 109.43 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 110.877 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.63 -39.87 68.39 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.683 1.193 . . . . 0.0 111.418 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -71.38 -36.48 71.43 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.501 1.12 . . . . 0.0 110.105 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.69 -39.1 87.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.542 1.137 . . . . 0.0 109.875 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.15 -40.49 97.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.012 -1.055 . . . . 0.0 111.369 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -65.58 -40.14 92.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.67 1.188 . . . . 0.0 111.74 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -73.48 -29.29 62.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.767 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.79 -34.95 70.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.125 -0.984 . . . . 0.0 109.599 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.41 -37.72 78.77 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.077 -1.014 . . . . 0.0 111.684 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -64.08 -46.23 85.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.235 -0.915 . . . . 0.0 109.958 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.26 -37.52 85.67 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.353 -0.842 . . . . 0.0 110.316 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.36 74.25 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.792 1.237 . . . . 0.0 111.671 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -63.31 -42.55 99.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.149 0.5 . . . . 0.0 110.967 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.62 -50.45 62.94 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.54 1.536 . . . . 0.0 107.829 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.89 -41.17 87.64 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.128 -0.357 . . . . 0.0 110.821 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.24 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 123.573 0.749 . . . . 0.0 110.499 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.81 72.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 O-C-N 120.431 -1.418 . . . . 0.0 110.551 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -70.39 -32.11 69.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.16 1.384 . . . . 0.0 109.409 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.56 -49.52 76.31 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.978 1.311 . . . . 0.0 110.808 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' C' ' 38' ' ' LEU . 6.2 mp0 -74.92 -17.68 60.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 121.769 -0.582 . . . . 0.0 111.354 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -94.55 79.46 3.82 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.128 -1.608 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.74 -29.75 0.83 Allowed Glycine 0 CA--C 1.491 -1.444 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.93 155.19 36.73 Favored Pre-proline 0 N--CA 1.443 -0.788 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.43 161.5 31.48 Favored 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.236 1.957 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.88 6.24 76.29 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 123.932 0.777 . . . . 0.0 111.751 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 122.36 6.34 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 126.087 1.755 . . . . 0.0 114.228 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 -24.5 0.86 Allowed 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' C' ' 30' ' ' GLU . 3.6 tt -76.04 -87.32 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 mt 64.8 161.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.778 0 C-N-CA 125.411 1.484 . . . . 0.0 109.466 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.9 t 81.88 115.23 0.06 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.659 1.583 . . . . 0.0 112.118 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -68.73 -52.19 18.98 Favored Pre-proline 0 C--N 1.349 0.568 0 CA-C-O 115.973 -1.965 . . . . 0.0 112.408 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.85 -7.49 20.1 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 126.094 3.212 . . . . 0.0 111.542 -170.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -93.51 -33.3 13.83 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.79 74.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.677 1.191 . . . . 0.0 111.699 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 tt -60.76 -29.04 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 124.63 1.172 . . . . 0.0 111.493 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -23.28 29.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.286 -0.884 . . . . 0.0 109.606 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -78.94 -37.57 39.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 12.5 p -77.79 55.59 1.4 Allowed 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 121.427 -0.795 . . . . 0.0 110.115 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -131.43 -68.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.45 -19.24 64.56 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -67.58 -35.86 79.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.183 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.12 56.91 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 120.774 -1.204 . . . . 0.0 110.325 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -93.33 15.74 14.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.22 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.266 10.2 t 49.69 55.24 9.69 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 112.803 168.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.6 m -143.3 -164.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 N-CA-C 98.336 -4.69 . . . . 0.0 98.336 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.32 106.22 0.19 Allowed Glycine 0 CA--C 1.467 -2.909 1 N-CA-C 100.057 -5.217 . . . . 0.0 100.057 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.418 ' CE1' ' HA3' ' D' ' 56' ' ' GLY . 6.2 m-30 -87.39 -6.91 58.26 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -167.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.94 42.0 2.02 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.72 -51.1 12.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -144.78 -177.27 5.43 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.99 138.66 13.42 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.81 169.34 15.05 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.54 2.827 . . . . 0.0 110.078 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -101.86 -175.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-O 122.605 1.193 . . . . 0.0 111.897 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -87.62 -61.48 1.71 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 124.562 1.145 . . . . 0.0 110.375 -166.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -59.44 -37.64 78.63 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.514 0.726 . . . . 0.0 111.514 -169.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.69 -76.29 0.57 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.048 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -23.72 -51.07 0.03 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 129.473 3.416 . . . . 0.0 117.305 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -58.76 -47.34 85.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.01 1.724 . . . . 0.0 112.736 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -75.58 -27.82 58.7 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.114 . . . . 0.0 108.803 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.05 -52.57 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.83 95.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.076 1.35 . . . . 0.0 111.464 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -34.01 72.7 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 119.18 0.9 . . . . 0.0 111.584 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.78 -42.56 94.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.277 1.031 . . . . 0.0 109.984 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.34 -44.34 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.252 1.021 . . . . 0.0 109.59 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mtp -57.03 -48.79 77.65 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.374 1.069 . . . . 0.0 110.078 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -62.32 -31.9 72.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.303 1.841 . . . . 0.0 111.97 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.99 71.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.627 0.771 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.33 -42.16 75.65 Favored Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.65 -42.73 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 109.797 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -53.77 -56.33 18.45 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 110.544 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.45 -49.82 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 C-N-CA 125.358 1.463 . . . . 0.0 109.516 -171.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.87 -24.01 62.42 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.716 -0.615 . . . . 0.0 111.098 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.52 47.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.961 -1.087 . . . . 0.0 110.144 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.96 -37.31 81.94 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 111.661 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.56 -1.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.623 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -58.5 -24.03 59.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.178 1.791 . . . . 0.0 113.784 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.18 84.78 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 119.14 -2.225 . . . . 0.0 112.216 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -66.27 -42.08 88.98 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.2 -43.73 66.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.172 0.51 . . . . 0.0 111.093 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.71 -41.59 26.42 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 120.357 -1.464 . . . . 0.0 112.667 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 34.1 p -69.07 -7.01 31.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.619 -1.3 . . . . 0.0 111.41 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -74.23 -5.46 42.11 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.835 -0.541 . . . . 0.0 110.41 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -35.56 71.66 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 120.043 -1.661 . . . . 0.0 111.02 167.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.39 -17.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.42 1.488 . . . . 0.0 108.934 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.69 -29.81 40.61 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.512 1.525 . . . . 0.0 111.966 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -60.48 -39.82 89.03 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.71 1.204 . . . . 0.0 110.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.436 -1.157 0 O-C-N 121.422 -0.799 . . . . 0.0 109.58 -177.074 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.21 -39.82 94.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.796 1.638 . . . . 0.0 111.407 -169.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.419 ' CD2' ' HG3' ' D' ' 5' ' ' GLU . 24.1 p-80 -78.54 -20.68 50.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.403 -0.811 . . . . 0.0 111.232 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' D' ' 4' ' ' HIS . 18.3 mt-10 -89.86 -21.69 22.42 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.096 -1.003 . . . . 0.0 108.561 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.55 -43.71 96.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.121 1.768 . . . . 0.0 109.784 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.47 -32.16 71.96 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 109.362 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.38 -35.46 73.52 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.206 1.003 . . . . 0.0 111.321 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.53 -31.75 72.99 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.469 -0.769 . . . . 0.0 111.439 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.73 -33.66 74.44 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.795 -0.566 . . . . 0.0 110.836 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.682 0.793 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.48 -39.4 88.73 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.872 0.869 . . . . 0.0 110.262 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -46.02 91.35 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 121.287 -0.883 . . . . 0.0 109.846 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.6 -41.68 81.71 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.825 2.05 . . . . 0.0 109.942 -175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.89 -40.79 96.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.068 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.23 -27.69 67.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.513 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -69.57 -42.79 74.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.27 -0.893 . . . . 0.0 110.342 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 m -72.59 -26.37 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 121.657 -0.652 . . . . 0.0 110.941 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.56 -41.27 96.42 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.307 -0.871 . . . . 0.0 111.096 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.46 -30.38 59.92 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 124.073 0.949 . . . . 0.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.93 -39.25 72.79 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 119.787 -1.821 . . . . 0.0 109.507 173.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.11 85.58 Favored 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.013 1.325 . . . . 0.0 110.85 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.1 p -67.19 -37.15 83.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 119.202 0.91 . . . . 0.0 111.196 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.13 -52.7 31.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.506 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -71.07 -25.12 62.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.076 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.82 -53.64 47.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.396 1.078 . . . . 0.0 110.016 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.74 -38.61 83.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -77.05 -6.59 53.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.332 -1.48 . . . . 0.0 112.421 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.48 -52.32 5.42 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -48.48 -50.58 31.01 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 129.034 2.934 . . . . 0.0 114.382 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -74.07 85.68 1.83 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.731 0.777 . . . . 0.0 110.413 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.34 -18.36 1.7 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.63 140.03 31.56 Favored Pre-proline 0 N--CA 1.445 -0.705 0 O-C-N 121.128 -1.219 . . . . 0.0 111.15 -170.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.39 132.82 6.06 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.77 2.314 . . . . 0.0 111.232 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.57 27.85 37.64 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.9 157.4 5.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.43 2.292 . . . . 0.0 111.9 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.02 -36.04 0.83 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.132 1.373 . . . . 0.0 110.072 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.45 81.5 1.48 Allowed 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.927 1.346 . . . . 0.0 112.865 -164.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 35.0 pt -93.79 -8.67 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 118.871 2.915 . . . . 0.0 118.871 -166.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.7 m -121.32 141.2 51.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 123.656 2.935 . . . . 0.0 110.708 -164.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -59.21 -47.77 97.66 Favored Pre-proline 0 C--N 1.353 0.757 0 CA-C-O 116.172 -1.871 . . . . 0.0 112.909 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -72.62 -5.59 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 CA-C-N 125.374 2.955 . . . . 0.0 112.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -30.76 12.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.6 76.4 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.294 1.037 . . . . 0.0 111.931 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.9 tt -72.06 -27.39 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 110.022 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.01 -35.75 49.52 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 108.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -63.6 -44.85 92.78 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.957 0.903 . . . . 0.0 110.578 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.5 p -65.74 -27.16 68.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 120.609 -1.307 . . . . 0.0 111.175 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.51 -20.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 111.452 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.9 -16.14 57.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.17 -1.581 . . . . 0.0 110.177 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.48 HG22 ' H ' ' D' ' 52' ' ' ALA . 7.1 m -99.8 -177.45 3.56 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 102.038 -3.319 . . . . 0.0 102.038 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.48 ' H ' HG22 ' D' ' 51' ' ' THR . . . 76.4 -30.14 0.18 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.793 1.637 . . . . 0.0 111.263 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.8 p -90.96 -10.92 40.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.65 1.58 . . . . 0.0 111.397 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p 58.45 30.83 20.23 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.359 1.463 . . . . 0.0 111.223 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.92 -87.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 101.446 -3.539 . . . . 0.0 101.446 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' C' ' 57' ' ' TYR . . . 81.32 73.33 1.19 Allowed Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -44.62 93.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.65 0.78 . . . . 0.0 111.099 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.3 -62.7 0.27 Allowed Glycine 0 CA--C 1.477 -2.331 0 C-N-CA 117.36 -2.352 . . . . 0.0 112.6 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -10.33 -67.24 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 128.948 2.899 . . . . 0.0 117.747 -162.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.94 155.13 43.58 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 104.424 -2.435 . . . . 0.0 104.424 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.43 152.22 19.52 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.66 158.37 19.0 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.085 2.524 . . . . 0.0 111.518 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.457 HG22 ' H ' ' D' ' 64' ' ' THR . 8.5 p -101.99 -151.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.457 ' H ' HG22 ' D' ' 63' ' ' VAL . 2.2 m -76.65 -50.11 14.55 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.547 1.939 . . . . 0.0 111.157 -171.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -77.59 -14.51 59.63 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.457 1.503 . . . . 0.0 110.498 -162.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.62 -20.18 62.76 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.165 0.983 . . . . 0.0 109.658 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.72 89.38 0.84 Allowed Glycine 0 CA--C 1.478 -2.265 1 N-CA-C 98.691 -5.764 . . . . 0.0 98.691 -170.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -65.06 -11.36 38.58 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.056 1.928 . . . . 0.0 110.02 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -57.28 -14.84 4.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.324 1.05 . . . . 0.0 113.597 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.88 -43.32 97.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.487 1.494 . . . . 0.0 109.116 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.98 -43.08 75.63 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -44.93 82.33 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.596 1.158 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.76 -45.51 93.61 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.402 0.681 . . . . 0.0 111.364 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.8 -39.73 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.634 0.774 . . . . 0.0 109.32 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.7 ttm -62.9 -48.14 80.27 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.384 1.074 . . . . 0.0 110.303 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -63.57 -42.18 98.34 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 109.846 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.3 80.7 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 111.439 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.79 -36.67 93.66 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.211 0.91 . . . . 0.0 112.249 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -68.66 -42.85 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 121.311 -1.111 . . . . 0.0 108.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.95 -43.08 99.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 121.432 -0.793 . . . . 0.0 111.604 -175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.69 -40.78 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 O-C-N 121.79 -0.569 . . . . 0.0 111.355 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.29 -21.09 56.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.75 25.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.166 -0.959 . . . . 0.0 110.367 174.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.1 -42.54 90.74 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 125.837 1.655 . . . . 0.0 109.877 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.71 -4.26 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.564 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -62.2 -19.79 63.49 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.856 -1.152 . . . . 0.0 110.427 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.07 77.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.341 -1.475 . . . . 0.0 111.841 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.35 -33.07 49.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 120.926 -1.109 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.01 -31.49 68.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.125 0.488 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.87 70.47 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.834 -1.166 . . . . 0.0 111.257 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -9.94 59.03 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.876 -1.14 . . . . 0.0 111.922 173.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.45 -40.17 70.5 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 119.644 1.111 . . . . 0.0 109.359 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -68.46 -29.64 68.33 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.959 -1.088 . . . . 0.0 111.239 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.83 -21.92 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.914 1.286 . . . . 0.0 108.97 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -62.18 -12.55 20.6 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.438 1.095 . . . . 0.0 111.485 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.79 -24.94 67.96 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.404 1.082 . . . . 0.0 112.229 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -176.957 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 122.639 1.209 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -105.68 -42.17 5.25 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -71.17 -31.36 67.58 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.207 -0.933 . . . . 0.0 111.623 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.55 -40.79 61.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.601 0.715 . . . . 0.0 110.193 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -68.47 -31.64 71.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.48 -0.763 . . . . 0.0 110.359 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -81.0 -30.92 34.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.018 -0.426 . . . . 0.0 110.243 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.6 76.04 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.931 -1.106 . . . . 0.0 110.197 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -57.1 -35.63 69.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.573 1.949 . . . . 0.0 111.691 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -64.42 -39.18 93.34 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.563 1.145 . . . . 0.0 109.84 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.93 80.52 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.693 -0.629 . . . . 0.0 110.156 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.41 -33.67 74.09 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.621 0.769 . . . . 0.0 111.449 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.83 -42.56 94.85 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 109.89 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.55 -36.89 81.88 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.874 0.87 . . . . 0.0 109.459 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -56.87 -44.72 82.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.121 0.569 . . . . 0.0 111.264 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -63.14 -38.14 90.01 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.104 0.962 . . . . 0.0 111.606 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.19 -39.12 92.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.887 1.275 . . . . 0.0 109.83 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.93 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.715 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.1 mt -59.74 -43.95 93.99 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.32 -0.862 . . . . 0.0 111.185 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -74.53 -22.33 59.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.234 1.014 . . . . 0.0 111.798 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.91 -41.04 21.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 120.573 -1.329 . . . . 0.0 108.385 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.6 76.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.716 1.207 . . . . 0.0 111.412 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 p -66.85 -38.35 86.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.454 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -61.37 -47.91 83.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.235 1.414 . . . . 0.0 107.812 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -65.63 -47.06 76.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 122.662 0.385 . . . . 0.0 110.572 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.48 90.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.03 1.332 . . . . 0.0 112.058 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.86 -34.66 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.434 -0.791 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.23 -24.79 27.68 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 120.271 -1.518 . . . . 0.0 110.357 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -79.85 -53.66 6.57 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.83 -34.88 69.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 119.073 0.851 . . . . 0.0 110.98 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -74.65 108.88 7.69 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 119.569 -1.957 . . . . 0.0 110.455 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.66 -33.12 2.8 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.57 144.53 83.65 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.309 -170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.64 138.7 21.85 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 C-N-CA 122.799 2.333 . . . . 0.0 109.833 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.45 -0.07 89.31 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.16 146.8 54.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.054 0.942 . . . . 0.0 111.543 -171.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.55 -42.45 3.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.78 131.11 34.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 pt -149.45 173.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.3 m 66.64 132.94 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.526 1.931 . . . . 0.0 114.163 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.32 -46.82 38.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 115.77 -2.062 . . . . 0.0 112.309 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.5 -11.65 30.2 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 CA-C-N 126.056 3.199 . . . . 0.0 112.293 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.15 -47.63 7.95 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.59 75.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 126.166 1.786 . . . . 0.0 112.37 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.73 -28.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 121.359 0.599 . . . . 0.0 111.115 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -22.29 32.19 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.235 -0.916 . . . . 0.0 109.69 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -78.14 -33.84 50.2 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.76 61.26 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.123 -0.985 . . . . 0.0 110.862 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -138.84 -76.1 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -67.71 -14.88 63.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 112.031 -169.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -64.88 -36.56 84.76 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 126.331 1.852 . . . . 0.0 108.582 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.23 60.28 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.207 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -88.99 13.41 12.96 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 p 56.79 51.1 11.35 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.514 1.526 . . . . 0.0 113.065 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 ' SD ' ' B' ' 75' ' ' MET . 21.3 t -116.19 -104.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.22 71.46 0.73 Allowed Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -66.75 -18.98 65.65 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.587 -0.949 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.51 22.23 6.18 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -56.21 17.12 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.995 0.898 . . . . 0.0 110.131 174.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -147.47 161.68 40.58 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.97 146.94 18.44 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.9 176.53 9.9 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 124.481 3.454 . . . . 0.0 110.341 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 t -112.5 -102.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 120.053 1.297 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -139.53 -41.53 0.45 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -88.07 -19.19 27.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.577 0.751 . . . . 0.0 111.146 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -63.02 -34.56 77.83 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 108.036 170.324 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.57 79.52 1.44 Allowed Glycine 0 CA--C 1.471 -2.659 1 N-CA-C 100.297 -5.121 . . . . 0.0 100.297 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.447 HH22 ' CG ' ' D' ' 59' ' ' ASP . 49.5 ttm-85 -39.07 -28.15 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 128.806 2.842 . . . . 0.0 114.512 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -53.27 -15.74 1.05 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.53 -46.82 92.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 125.216 1.407 . . . . 0.0 109.399 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.163 0.985 . . . . 0.0 108.899 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.37 -43.24 33.48 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.595 1.558 . . . . 0.0 111.667 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -62.58 -38.17 89.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.13 0.572 . . . . 0.0 111.437 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.71 -38.63 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -176.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -59.95 -44.62 94.27 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.046 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -63.17 -34.3 77.32 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.493 -0.754 . . . . 0.0 110.961 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.92 85.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.753 0.706 . . . . 0.0 111.291 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.29 50.97 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.04 -38.89 62.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 124.562 1.145 . . . . 0.0 108.897 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -70.35 -49.28 50.93 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.815 -1.178 . . . . 0.0 111.177 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.89 -45.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 O-C-N 121.33 -0.856 . . . . 0.0 110.199 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -73.48 -29.69 62.68 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 121.447 -0.783 . . . . 0.0 110.2 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.0 62.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 120.665 -1.272 . . . . 0.0 110.314 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.93 -35.4 80.56 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.935 -1.103 . . . . 0.0 110.769 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.92 -9.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.161 1.385 . . . . 0.0 111.26 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 m -59.34 -23.01 62.15 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 118.986 -2.321 . . . . 0.0 111.931 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.33 61.26 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.551 -1.343 . . . . 0.0 112.36 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.37 -41.94 9.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.512 1.525 . . . . 0.0 109.577 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -41.76 63.2 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.637 -1.289 . . . . 0.0 111.582 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.19 -5.43 41.85 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 121.037 -1.039 . . . . 0.0 111.12 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -97.54 -5.42 35.8 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.701 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.26 18.2 m-20 -80.13 -16.86 54.04 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 121.094 1.77 . . . . 0.0 111.268 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.49 -29.55 37.37 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.837 -1.164 . . . . 0.0 109.602 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.41 -30.87 50.45 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 124.429 1.092 . . . . 0.0 109.248 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -53.5 -26.44 20.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.001 1.32 . . . . 0.0 112.916 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -62.59 -34.75 77.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.524 1.13 . . . . 0.0 110.689 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 O-C-N 121.919 -0.488 . . . . 0.0 110.132 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.504 -0.789 0 CA-C-O 121.812 0.815 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -62.81 -23.63 67.35 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.588 1.955 . . . . 0.0 112.709 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -81.83 -41.58 20.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -70.08 -35.18 74.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.379 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.8 -39.66 85.75 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.494 0.718 . . . . 0.0 110.304 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.61 91.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.408 0.683 . . . . 0.0 111.495 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -68.31 -38.55 81.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 121.594 -0.691 . . . . 0.0 110.219 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.85 -36.27 80.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.46 0.648 . . . . 0.0 110.892 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.14 83.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.839 0.856 . . . . 0.0 111.193 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.27 -32.39 73.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.508 -0.745 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.23 -35.83 71.62 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.165 -0.959 . . . . 0.0 109.597 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.81 -30.21 69.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 120.641 -1.287 . . . . 0.0 110.325 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -61.16 -43.68 98.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 122.978 0.511 . . . . 0.0 111.186 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.33 -35.15 79.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.344 0.658 . . . . 0.0 110.892 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -67.61 -39.11 84.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.274 0.63 . . . . 0.0 110.668 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.76 -39.87 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.797 0.839 . . . . 0.0 109.302 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.22 -43.45 87.73 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.179 0.899 . . . . 0.0 111.969 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.35 -37.39 80.44 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.59 1.156 . . . . 0.0 110.501 -177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.22 -46.06 52.57 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.681 1.229 . . . . 0.0 108.788 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.31 64.57 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 125.043 1.337 . . . . 0.0 112.236 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.8 p -73.32 -31.57 64.08 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.341 -0.849 . . . . 0.0 110.006 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -40.96 71.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.028 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.5 75.22 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.796 1.239 . . . . 0.0 112.742 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.04 -29.96 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 O-C-N 120.912 -1.117 . . . . 0.0 111.381 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.96 -20.57 28.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.153 0.501 . . . . 0.0 110.52 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.34 94.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.412 1.885 . . . . 0.0 109.462 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -69.39 -106.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.571 0.7 . . . . 0.0 111.58 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 58.17 9.66 1.04 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.48 34.63 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.72 149.14 38.64 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -77.14 113.09 3.53 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.486 2.124 . . . . 0.0 110.693 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -65.37 0.28 Allowed Glycine 0 CA--C 1.484 -1.901 0 N-CA-C 103.109 -3.996 . . . . 0.0 103.109 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 75.23 162.47 0.25 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 127.65 2.38 . . . . 0.0 108.424 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.98 -72.61 0.08 Allowed 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.595 -0.691 . . . . 0.0 110.265 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.34 80.5 1.59 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 tt -122.99 93.99 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.5 m -156.07 -150.73 0.3 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -167.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.05 -58.36 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 116.445 -1.741 . . . . 0.0 106.447 169.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.51 -29.03 20.89 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.803 3.108 . . . . 0.0 112.434 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.52 9.12 39.8 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 123.809 0.843 . . . . 0.0 110.148 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.05 -41.22 82.35 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.679 -1.263 . . . . 0.0 109.675 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -73.45 -24.86 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 O-C-N 121.559 -0.713 . . . . 0.0 110.034 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -58.27 -55.66 32.18 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 125.687 1.595 . . . . 0.0 110.195 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -71.09 -34.82 71.51 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -55.84 -43.41 77.0 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.526 1.13 . . . . 0.0 110.954 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.7 t -55.19 -51.15 58.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 124.414 1.086 . . . . 0.0 111.061 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.42 -22.16 55.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.31 -0.869 . . . . 0.0 111.693 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -65.07 -40.96 95.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.183 0.993 . . . . 0.0 109.093 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.17 65.5 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 121.235 -0.916 . . . . 0.0 112.175 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -89.04 5.49 44.14 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.872 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 56.09 28.97 13.75 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.665 1.186 . . . . 0.0 111.463 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.17 -56.66 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.55 62.39 5.84 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.4 -27.5 66.27 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 123.14 1.448 . . . . 0.0 108.115 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.47 43.96 1.4 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 107.446 -2.261 . . . . 0.0 107.446 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.55 -50.97 9.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -133.87 172.57 12.61 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -146.25 149.88 39.54 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.77 166.75 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.524 2.816 . . . . 0.0 109.36 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.24 -144.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 7.3 p -107.12 -59.75 1.77 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.213 1.405 . . . . 0.0 107.781 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.84 -16.28 48.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 130.185 3.394 . . . . 0.0 111.99 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -67.63 -22.71 65.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 124.137 1.923 . . . . 0.0 108.482 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.82 67.92 1.41 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 101.557 -4.617 . . . . 0.0 101.557 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -37.76 -20.71 0.01 OUTLIER 'General case' 0 C--N 1.362 1.124 0 C-N-CA 131.62 3.968 . . . . 0.0 115.461 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -54.69 -14.62 1.42 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.75 1.62 . . . . 0.0 114.499 162.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.98 -44.11 92.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.134 0 CA-C-N 121.709 2.05 . . . . 0.0 107.305 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.54 86.37 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.575 -0.703 . . . . 0.0 110.193 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.42 -45.31 80.77 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 123.762 0.825 . . . . 0.0 110.872 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -55.19 -46.76 75.87 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.627 1.971 . . . . 0.0 111.56 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.5 t -72.35 -44.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 C-N-CA 123.256 0.623 . . . . 0.0 109.494 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 55' ' ' VAL . 72.9 mtm -58.89 -49.18 78.74 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.895 0.878 . . . . 0.0 110.293 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.77 -40.2 94.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.071 0.548 . . . . 0.0 110.783 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.98 76.27 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.116 0.566 . . . . 0.0 111.418 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -44.02 91.78 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 124.259 0.933 . . . . 0.0 111.172 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.96 -42.07 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.796 -0.826 . . . . 0.0 108.954 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.36 -50.85 71.65 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.174 -0.954 . . . . 0.0 111.995 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.3 -41.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 O-C-N 121.829 -0.544 . . . . 0.0 110.577 -173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -75.75 -27.97 58.31 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.588 -0.695 . . . . 0.0 110.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.6 -34.5 69.94 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.008 -1.057 . . . . 0.0 109.584 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.37 -34.0 76.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.296 1.038 . . . . 0.0 110.86 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.44 -21.9 19.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 124.847 1.259 . . . . 0.0 110.691 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 2.5 m -62.23 -16.33 52.7 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.574 -1.329 . . . . 0.0 111.531 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.41 -35.31 80.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.3 -2.125 . . . . 0.0 111.17 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.34 -33.75 61.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.83 -25.03 40.94 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.141 0.577 . . . . 0.0 111.569 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.35 -27.96 64.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 120.036 -1.665 . . . . 0.0 109.268 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -9.01 55.28 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.025 -1.047 . . . . 0.0 112.314 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -72.45 -23.09 61.01 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.397 -1.44 . . . . 0.0 110.728 -172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' C' ' 91' ' ' THR . 19.0 p90 -75.23 -28.27 59.83 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.41 -0.806 . . . . 0.0 110.404 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.96 -40.15 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 124.131 0.972 . . . . 0.0 108.64 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -60.5 -23.56 64.63 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.352 -0.842 . . . . 0.0 112.663 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -52.67 -46.51 67.26 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.852 1.261 . . . . 0.0 109.983 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 N--CA 1.439 -0.977 0 O-C-N 121.807 -0.558 . . . . 0.0 110.466 -173.042 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 123.003 1.382 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.491 ' CG ' ' HA ' ' C' ' 88' ' ' ALA . 0.1 OUTLIER -59.09 -29.35 67.29 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.038 1.335 . . . . 0.0 113.733 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -80.64 -43.71 20.03 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -171.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -65.83 -41.55 91.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 123.832 0.853 . . . . 0.0 110.796 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -65.48 -35.67 81.57 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.259 0.624 . . . . 0.0 110.718 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.79 94.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.75 -31.72 66.97 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.952 -0.467 . . . . 0.0 111.676 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.0 -36.37 84.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.94 0.896 . . . . 0.0 110.001 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.59 72.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.29 -40.36 85.9 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 111.069 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.65 -25.43 59.19 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.167 1.387 . . . . 0.0 110.533 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.74 -36.74 67.8 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.305 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -63.72 -44.78 92.59 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -65.44 -24.49 67.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.458 -0.776 . . . . 0.0 112.488 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -60.31 -43.81 95.99 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.532 1.133 . . . . 0.0 109.911 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.14 -40.74 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.263 1.025 . . . . 0.0 109.057 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -40.16 95.24 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.721 0.809 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.56 -21.86 38.19 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.0 111.969 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.41 -47.57 17.3 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.33 60.17 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 124.149 0.979 . . . . 0.0 112.592 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.3 p -67.76 -40.36 84.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.034 1.288 . . . . 0.0 109.089 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -68.52 -44.61 74.26 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.45 -42.72 88.01 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.237 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.58 65.0 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.905 1.282 . . . . 0.0 111.48 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 m -72.3 -27.9 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 O-C-N 121.171 -0.956 . . . . 0.0 111.694 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.89 -37.67 67.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.44 -50.34 16.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 126.277 1.831 . . . . 0.0 109.614 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.58 -34.82 78.74 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.967 0.907 . . . . 0.0 111.266 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -66.49 122.83 18.44 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 119.48 -2.013 . . . . 0.0 109.379 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.26 7.04 59.69 Favored Glycine 0 CA--C 1.496 -1.12 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.83 147.43 34.74 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -77.49 131.74 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.976 2.45 . . . . 0.0 110.792 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 0.1 82.16 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.55 26.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.39 1.476 . . . . 0.0 109.825 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.88 -28.25 8.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 14.1 tp -98.74 83.25 2.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.612 -1.305 . . . . 0.0 108.271 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.2 pt -127.3 64.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -154.03 125.17 7.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -60.43 -47.49 96.22 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-O 115.944 -1.979 . . . . 0.0 113.754 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -71.7 -26.54 19.32 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 CA-C-N 126.04 3.193 . . . . 0.0 110.908 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -85.65 -8.81 58.0 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.97 79.68 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.105 -0.997 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.82 -33.32 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.95 -26.96 49.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.56 -1.337 . . . . 0.0 111.174 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -70.87 -46.43 62.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -66.25 -20.79 66.21 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.313 -0.867 . . . . 0.0 112.941 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.54 -51.47 72.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 124.457 1.103 . . . . 0.0 110.337 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.26 -27.45 61.58 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 118.803 0.728 . . . . 0.0 110.333 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -69.88 -37.9 76.19 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.94 -29.27 68.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.187 -0.945 . . . . 0.0 111.587 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -88.62 4.67 46.21 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.145 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.384 12.7 p 79.34 -63.62 0.26 Allowed 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 127.762 2.425 . . . . 0.0 107.889 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -1.19 -77.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.023 1 C-N-CA 131.964 4.106 . . . . 0.0 113.064 -177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.57 68.96 1.48 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -63.59 -29.35 70.61 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 121.584 -0.95 . . . . 0.0 111.941 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 42.7 0.88 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -65.24 -46.29 81.2 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -138.95 -152.51 0.42 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -165.99 146.29 5.46 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 100.598 -3.852 . . . . 0.0 100.598 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.83 -174.65 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 124.72 3.613 . . . . 0.0 108.791 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.646 HG22 ' H ' ' C' ' 64' ' ' THR . 13.8 p -135.35 -171.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.646 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.6 m -75.31 -41.86 55.98 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 126.394 1.877 . . . . 0.0 110.389 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.23 -24.42 59.32 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.833 0.853 . . . . 0.0 109.619 -167.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -59.49 -45.91 90.33 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.45 78.03 0.73 Allowed Glycine 0 CA--C 1.465 -3.089 1 N-CA-C 97.44 -6.264 . . . . 0.0 97.44 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -47.51 -17.71 0.1 Allowed 'General case' 0 C--N 1.37 1.499 0 C-N-CA 127.984 2.513 . . . . 0.0 114.629 -166.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -51.18 -16.03 0.44 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 127.637 2.375 . . . . 0.0 113.689 165.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . 0.267 30.0 t -72.04 -39.67 66.36 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 CA-C-N 123.504 2.865 . . . . 0.0 109.2 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.89 95.97 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 110.757 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.34 -43.82 97.93 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.066 0.946 . . . . 0.0 111.066 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -59.58 -51.05 71.51 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 125.077 1.351 . . . . 0.0 111.17 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.08 -43.19 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 26.8 ttp -60.1 -50.32 74.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.266 1.026 . . . . 0.0 110.561 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -65.57 -39.55 91.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.691 -0.631 . . . . 0.0 110.181 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.65 91.73 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.067 0.547 . . . . 0.0 111.059 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.04 -48.22 82.12 Favored Glycine 0 CA--C 1.494 -1.237 0 C-N-CA 123.74 0.686 . . . . 0.0 112.013 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.22 -45.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 124.03 0.932 . . . . 0.0 109.365 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.2 -42.79 95.84 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.27 1.028 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.88 -50.1 78.98 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 110.914 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.27 -35.01 78.63 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 121.363 -0.836 . . . . 0.0 111.167 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.66 -36.95 79.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.128 0.571 . . . . 0.0 110.405 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.01 -25.18 68.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.186 1.394 . . . . 0.0 111.968 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.44 -16.9 8.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 125.155 1.382 . . . . 0.0 110.745 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.8 t -66.16 -11.73 51.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 119.707 -1.87 . . . . 0.0 111.936 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.39 -19.91 63.9 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 110.902 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' C' ' 4' ' ' HIS . . . -89.78 -61.27 1.73 Allowed 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 125.329 1.452 . . . . 0.0 107.722 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.3 mt -68.48 -28.39 66.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -165.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.31 -12.0 60.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 120.626 -1.296 . . . . 0.0 110.632 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -81.58 -15.07 55.89 Favored 'General case' 0 CA--C 1.492 -1.257 0 O-C-N 120.365 -1.46 . . . . 0.0 107.905 175.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.307 63.7 m-20 -93.38 10.57 31.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.222 -155.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -100.12 -19.1 16.63 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 121.515 -0.741 . . . . 0.0 109.793 159.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.9 -25.85 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.487 -1.383 . . . . 0.0 107.339 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -72.22 -3.21 22.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.868 -1.145 . . . . 0.0 112.365 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -61.65 -25.53 67.44 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.435 -1.416 . . . . 0.0 109.9 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 . . . . . 0 N--CA 1.436 -1.143 0 C-N-CA 124.419 1.088 . . . . 0.0 109.311 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -168.3 -89.77 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 -162.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -59.26 -22.65 61.47 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.557 2.743 . . . . 0.0 114.371 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -67.68 -27.76 67.11 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -69.84 -37.92 76.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -79.36 -34.18 42.26 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.72 95.7 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.424 -0.798 . . . . 0.0 111.355 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.23 67.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.873 -0.517 . . . . 0.0 110.184 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.45 -35.2 79.65 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 124.213 1.005 . . . . 0.0 110.627 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.29 69.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 111.463 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -62.18 -41.07 97.99 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.157 -0.964 . . . . 0.0 110.983 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 -27.46 68.92 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 111.756 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -73.69 -35.32 65.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.0 -41.73 95.12 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.802 -1.187 . . . . 0.0 110.458 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -59.92 -31.35 69.75 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.788 1.235 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -66.67 -47.63 71.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.911 1.284 . . . . 0.0 108.941 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.68 -30.44 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.26 -47.58 83.12 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.06 -48.64 73.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 124.657 1.183 . . . . 0.0 109.246 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -66.03 -34.98 79.33 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.506 1.122 . . . . 0.0 110.575 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.27 43.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.534 -1.354 . . . . 0.0 111.295 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -64.31 -43.77 93.66 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.534 -0.729 . . . . 0.0 109.969 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -69.76 -30.18 67.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -66.49 -50.95 61.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -45.54 78.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.895 1.278 . . . . 0.0 112.248 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.88 -28.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.065 -1.022 . . . . 0.0 111.151 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.29 -33.3 22.16 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.545 -1.347 . . . . 0.0 108.674 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.26 74.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.834 2.054 . . . . 0.0 109.408 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -36.51 84.12 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.52 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp85 -78.38 89.07 4.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.239 1.019 . . . . 0.0 111.653 -165.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.42 -12.74 4.32 Favored Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.69 53.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 124.776 1.23 . . . . 0.0 108.493 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.22 141.99 13.19 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 123.108 2.146 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.19 77.33 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 170.87 9.46 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.3 92.32 1.86 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.05 58.46 0.07 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.013 0.911 . . . . 0.0 109.057 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 28.0 pt -95.23 -179.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 O-C-N 119.908 -1.745 . . . . 0.0 108.801 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.8 134.74 0.02 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.411 2.685 . . . . 0.0 114.044 172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -65.97 -46.11 64.1 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 119.715 -1.865 . . . . 0.0 110.484 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -73.45 -11.75 24.67 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 124.185 2.53 . . . . 0.0 113.971 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . 0.251 1.5 m-20 -90.64 -44.6 9.42 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -31.51 72.78 Favored 'General case' 0 CA--C 1.494 -1.205 0 O-C-N 121.178 -0.951 . . . . 0.0 112.238 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.17 -31.98 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 121.892 -0.505 . . . . 0.0 110.698 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -36.51 76.06 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 120.528 -1.357 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' D' ' 60' ' ' ARG . 65.7 t90 -70.55 -35.11 72.94 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.377 -0.827 . . . . 0.0 110.024 174.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -61.69 -42.06 98.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.178 0.991 . . . . 0.0 109.413 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.37 -53.54 42.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 125.159 1.384 . . . . 0.0 110.196 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.79 -45.89 70.86 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.435 1.494 . . . . 0.0 111.782 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.9 m -66.9 -38.13 85.67 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.071 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.35 73.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.461 -0.775 . . . . 0.0 111.36 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -86.22 5.07 35.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 118.98 -0.534 . . . . 0.0 112.273 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 62.7 p 55.98 46.04 22.66 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.658 1.183 . . . . 0.0 112.982 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.527 HG23 ' H ' ' D' ' 56' ' ' GLY . 0.3 OUTLIER -112.03 -93.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.527 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 101.89 64.68 0.75 Allowed Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -28.57 68.01 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -172.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 129.01 2.27 5.63 Favored Glycine 0 CA--C 1.488 -1.654 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.447 ' CG ' HH22 ' A' ' 68' ' ' ARG . 1.7 m-20 -64.79 -41.79 95.54 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.446 ' HB2' ' CD1' ' D' ' 47' ' ' TRP . 50.5 mmt-85 -134.56 143.72 47.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 102.634 -3.099 . . . . 0.0 102.634 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -128.41 130.61 23.53 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.61 170.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 108.841 172.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -128.96 -167.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -76.8 -36.21 57.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 120.606 -1.309 . . . . 0.0 109.125 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -72.4 -24.06 61.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.059 1.344 . . . . 0.0 112.369 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.11 -24.44 51.74 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 123.108 1.432 . . . . 0.0 107.249 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 60.72 1.17 Allowed Glycine 0 CA--C 1.463 -3.209 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -31.88 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 1 C-N-CA 131.963 4.105 . . . . 0.0 116.927 -171.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.06 1.34 2.81 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 120.375 -1.453 . . . . 0.0 113.309 167.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -51.55 57.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.36 67.88 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.605 1.162 . . . . 0.0 110.965 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -52.44 -40.13 61.86 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.033 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -67.64 -33.75 75.59 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.61 -38.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 120.788 -1.195 . . . . 0.0 109.463 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -60.52 -39.61 88.45 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.761 -0.587 . . . . 0.0 110.902 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -57.52 -47.37 82.14 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.738 0.815 . . . . 0.0 110.76 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.06 97.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.875 0.47 . . . . 0.0 110.993 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.09 -50.57 50.95 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.15 -48.29 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.35 1.06 . . . . 0.0 109.385 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.29 -36.86 84.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.88 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.99 -51.83 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 119.388 0.995 . . . . 0.0 109.658 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.87 -21.84 63.3 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.448 -0.783 . . . . 0.0 111.114 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.02 -33.63 20.99 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.89 -39.19 88.31 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 124.529 1.132 . . . . 0.0 110.233 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.94 -7.99 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 121.519 -0.738 . . . . 0.0 112.321 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -60.86 -18.06 53.84 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-N 119.205 0.911 . . . . 0.0 110.229 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 119.704 -1.873 . . . . 0.0 112.372 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.79 71.69 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.06 -25.83 58.93 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.878 0.371 . . . . 0.0 110.9 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.19 -49.71 33.31 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 120.578 -1.326 . . . . 0.0 109.816 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -71.26 1.8 5.6 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.987 -1.07 . . . . 0.0 111.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.34 -24.09 63.86 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.957 -1.09 . . . . 0.0 108.56 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -67.3 -16.52 64.32 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 119.913 -1.742 . . . . 0.0 112.5 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 5.1 m -73.61 -21.64 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 O-C-N 119.652 -1.905 . . . . 0.0 110.561 -173.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -74.6 3.76 7.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.746 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -80.12 -35.77 36.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -176.598 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 62.96 12.04 5.56 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.938 2.095 . . . . 0.0 112.113 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -154.68 -36.35 0.09 Allowed 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 120.84 -1.163 . . . . 0.0 111.0 -164.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.6 -45.76 71.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -62.26 -37.76 86.67 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.386 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.47 -37.62 56.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.99 0.916 . . . . 0.0 109.289 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.57 89.45 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.948 0.899 . . . . 0.0 111.434 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -75.79 -16.75 60.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.315 -0.866 . . . . 0.0 111.583 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -76.6 -36.89 57.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.2 80.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.655 1.182 . . . . 0.0 111.19 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -55.83 -42.45 75.74 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 123.719 0.807 . . . . 0.0 111.7 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.9 -28.82 67.03 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.27 1.028 . . . . 0.0 110.601 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -41.59 87.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 81' ' ' VAL . 24.9 tp -64.83 -39.43 93.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 122.632 0.373 . . . . 0.0 111.36 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -54.52 -46.09 73.48 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.206 0.602 . . . . 0.0 111.847 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -74.44 -32.26 62.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.88 -1.137 . . . . 0.0 111.855 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.65 -42.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.781 -1.2 . . . . 0.0 109.706 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.47 -30.42 69.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.923 -1.11 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -65.04 -41.64 95.01 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.607 -1.308 . . . . 0.0 111.033 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -62.29 -47.05 86.02 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.16 0.981 . . . . 0.0 109.268 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -27.89 69.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.76 0.824 . . . . 0.0 112.39 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.7 m -63.18 -33.33 75.24 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.366 1.067 . . . . 0.0 111.379 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -72.56 -36.37 68.21 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.22 -47.55 67.56 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -47.17 79.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.992 1.717 . . . . 0.0 112.672 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.6 -30.33 46.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 O-C-N 120.748 -1.22 . . . . 0.0 110.789 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.06 -41.74 41.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.677 -1.264 . . . . 0.0 108.515 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.51 38.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 128.005 2.522 . . . . 0.0 108.634 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -63.82 -50.71 67.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.509 1.124 . . . . 0.0 111.134 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.0 ttp85 -81.55 101.58 10.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 119.681 -1.887 . . . . 0.0 111.266 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -27.18 2.16 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 104.593 -3.403 . . . . 0.0 104.593 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 151.13 62.79 Favored Pre-proline 0 N--CA 1.439 -1.025 0 C-N-CA 124.016 0.927 . . . . 0.0 111.932 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -77.62 105.5 2.04 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.878 2.386 . . . . 0.0 112.12 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.67 11.62 11.28 Favored Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.91 132.3 5.34 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 127.442 2.297 . . . . 0.0 115.276 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.06 -61.69 1.65 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.279 1.032 . . . . 0.0 111.166 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.79 106.85 18.35 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-O 122.257 1.027 . . . . 0.0 112.798 -171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -111.41 169.58 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 O-C-N 120.266 -1.521 . . . . 0.0 108.586 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 m 71.81 146.01 0.07 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.771 2.428 . . . . 0.0 113.141 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -72.69 -51.58 6.8 Favored Pre-proline 0 C--N 1.349 0.583 0 CA-C-O 115.925 -1.988 . . . . 0.0 111.886 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.14 -11.02 26.71 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 125.338 2.942 . . . . 0.0 111.992 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.2 -34.7 11.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.1 96.04 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.037 -1.04 . . . . 0.0 110.771 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.88 -33.4 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 122.753 0.421 . . . . 0.0 111.562 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -28.79 65.45 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.152 -1.592 . . . . 0.0 110.763 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -76.93 -40.55 46.77 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 107.962 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -63.87 -30.81 71.86 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 121.026 -1.046 . . . . 0.0 112.61 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.23 -36.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-N 118.723 0.692 . . . . 0.0 110.155 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -63.19 -61.1 2.6 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -50.33 -36.99 34.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.176 1.79 . . . . 0.0 113.25 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.38 97.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.707 1.203 . . . . 0.0 111.71 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -91.51 4.68 51.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.283 30.1 p 66.86 -136.54 0.14 Allowed 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 127.304 2.242 . . . . 0.0 108.244 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 t 69.19 -79.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.64 87.45 0.47 Allowed Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -72.01 -33.31 67.97 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.399 -1.059 . . . . 0.0 108.263 -170.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.57 16.55 1.65 Allowed Glycine 0 CA--C 1.489 -1.575 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -58.93 -56.36 23.25 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 117.838 0.819 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 166.34 24.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 174.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.8 142.7 19.21 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 102.314 -3.217 . . . . 0.0 102.314 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -84.06 162.53 13.6 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.02 2.48 . . . . 0.0 110.132 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 64' ' ' THR . 1.7 p -104.77 176.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 122.288 1.042 . . . . 0.0 108.965 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.551 ' HA ' ' CE2' ' D' ' 46' ' ' TRP . 0.2 OUTLIER -61.67 -47.8 83.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 127.59 2.356 . . . . 0.0 114.219 -166.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -81.48 1.09 34.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 118.967 -2.333 . . . . 0.0 110.246 -170.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -32.43 72.23 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-O 123.372 1.558 . . . . 0.0 107.797 175.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.0 85.78 0.96 Allowed Glycine 0 CA--C 1.471 -2.714 1 N-CA-C 100.995 -4.842 . . . . 0.0 100.995 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.59 ' HB2' ' CE2' ' D' ' 46' ' ' TRP . 1.7 ttp85 -58.62 -9.0 1.44 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 118.24 1.02 . . . . 0.0 113.202 -169.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -45.96 -35.9 5.07 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.207 1.403 . . . . 0.0 112.659 160.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.36 -59.5 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.12 77.21 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.503 0.721 . . . . 0.0 112.436 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.16 -39.08 71.78 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.595 2.358 . . . . 0.0 111.57 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -70.13 -31.03 68.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 t -71.65 -41.76 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 O-C-N 121.512 -0.742 . . . . 0.0 109.073 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 59.9 mtt -56.28 -49.52 74.01 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.604 1.162 . . . . 0.0 110.433 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -66.76 -37.24 84.23 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.15 -0.969 . . . . 0.0 110.647 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.56 87.34 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.152 -0.968 . . . . 0.0 111.015 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -71.08 -38.94 63.51 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -70.88 -35.77 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 O-C-N 121.289 -1.124 . . . . 0.0 109.348 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.87 -38.15 89.7 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 120.429 -1.419 . . . . 0.0 112.285 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 15' ' ' LEU . 30.7 m -68.51 -39.11 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -78.17 -30.43 49.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.477 0.58 . . . . 0.0 109.922 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.89 89.08 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 123.575 0.75 . . . . 0.0 110.494 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.91 -30.31 71.3 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.849 1.26 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.48 -11.99 7.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 C-N-CA 125.327 1.451 . . . . 0.0 110.614 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.681 HG21 ' HB3' ' D' ' 89' ' ' LEU . 6.8 t -53.55 -25.74 18.33 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 119.728 -1.857 . . . . 0.0 112.621 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -18.98 63.82 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.094 -1.004 . . . . 0.0 109.716 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.85 -50.8 7.23 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.47 -48.42 69.94 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.428 1.091 . . . . 0.0 113.423 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.18 -12.6 60.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -84.7 -27.25 27.15 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -32.97 74.6 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.557 -1.339 . . . . 0.0 110.991 -159.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -62.38 -30.64 71.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.32 -0.862 . . . . 0.0 112.837 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.78 -24.37 35.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.237 1.415 . . . . 0.0 108.819 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -59.35 -24.14 63.12 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.31 -0.869 . . . . 0.0 112.471 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -64.87 -28.55 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.972 -1.08 . . . . 0.0 110.395 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 . . . . . 0 C--N 1.354 0.794 0 CA-C-N 119.253 0.933 . . . . 0.0 109.805 -179.243 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.5 -0.967 0 CA-C-O 122.859 1.314 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -73.33 -19.53 61.0 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.264 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -82.33 -32.53 29.33 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.49 -25.44 61.41 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.623 -0.673 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.27 -49.85 72.46 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.568 1.147 . . . . 0.0 108.879 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.56 87.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.03 1.332 . . . . 0.0 110.838 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.23 -37.95 87.36 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.924 0.89 . . . . 0.0 110.75 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -69.46 -25.94 64.34 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.42 -1.425 . . . . 0.0 110.702 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.91 71.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 120.701 -1.249 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.0 -37.61 77.26 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.742 1.217 . . . . 0.0 111.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.29 -30.78 71.27 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.587 1.555 . . . . 0.0 110.11 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -70.64 -42.67 70.53 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.536 1.134 . . . . 0.0 108.57 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.21 -38.61 91.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 123.865 0.866 . . . . 0.0 111.364 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -63.77 -29.72 70.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.446 -0.784 . . . . 0.0 111.789 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -75.58 -30.28 59.59 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.858 -1.151 . . . . 0.0 110.637 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.11 -38.9 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.87 -44.95 78.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 124.069 0.948 . . . . 0.0 111.784 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.85 -48.88 67.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.337 0.655 . . . . 0.0 110.31 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.14 -24.2 60.56 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.936 -1.102 . . . . 0.0 110.898 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 -26.03 62.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 120.981 -1.075 . . . . 0.0 111.532 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -63.75 -46.8 83.66 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.64 -45.31 87.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.667 1.187 . . . . 0.0 109.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -60.55 -59.11 5.92 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.446 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.02 89.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 111.804 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.79 -35.71 61.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.72 -1.238 . . . . 0.0 110.317 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.16 -39.17 55.53 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.047 -1.033 . . . . 0.0 109.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.59 70.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 127.072 2.149 . . . . 0.0 109.461 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.58 61.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.816 -0.552 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -72.83 95.94 2.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.693 -1.879 . . . . 0.0 111.379 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.18 -11.95 3.3 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.63 152.65 47.32 Favored Pre-proline 0 N--CA 1.442 -0.845 0 O-C-N 121.254 -1.144 . . . . 0.0 109.496 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.64 152.75 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.022 2.481 . . . . 0.0 109.576 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -78.14 1.8 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.509 -3.437 . . . . 0.0 104.509 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.13 138.71 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 129.226 3.01 . . . . 0.0 111.247 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.73 -39.85 1.95 Allowed 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 120.278 -1.514 . . . . 0.0 108.289 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -100.18 137.24 38.88 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.79 0.805 . . . . 0.0 109.575 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.6 pt -147.02 175.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 100.497 -3.89 . . . . 0.0 100.497 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m 72.77 129.88 0.04 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 112.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -67.77 -48.71 41.13 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 116.818 -1.563 . . . . 0.0 110.102 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.66 -13.08 29.66 Favored 'Trans proline' 0 CA--C 1.509 -0.751 0 CA-C-N 124.987 2.817 . . . . 0.0 113.004 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.24 -25.83 17.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.988 1.267 . . . . 0.0 107.649 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.66 81.48 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.359 -0.838 . . . . 0.0 111.162 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.04 -34.12 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 121.444 -0.785 . . . . 0.0 110.301 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -36.35 72.08 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.801 -1.187 . . . . 0.0 110.327 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -64.49 -44.26 91.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.44 1.496 . . . . 0.0 109.368 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -57.74 -39.36 77.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.867 1.667 . . . . 0.0 111.3 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -53.84 -51.98 39.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 124.716 1.206 . . . . 0.0 111.271 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -71.9 -22.08 61.55 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.762 0.71 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.0 m -74.07 -40.71 62.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.017 0.927 . . . . 0.0 108.757 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -28.83 63.49 Favored 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 121.142 -0.974 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.4 p -84.64 3.83 35.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.568 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 53.82 51.58 14.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.822 1.649 . . . . 0.0 111.062 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -117.81 -111.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.105 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.21 76.39 1.22 Allowed Glycine 0 CA--C 1.483 -1.924 0 N-CA-C 104.804 -3.318 . . . . 0.0 104.804 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -74.49 -16.59 60.84 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.868 -1.371 . . . . 0.0 109.745 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.75 52.85 0.53 Allowed Glycine 0 CA--C 1.481 -2.092 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.15 -59.12 2.9 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -144.02 174.93 10.42 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -142.28 129.35 11.19 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.82 165.87 27.89 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 124.116 3.211 . . . . 0.0 110.318 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.526 HG22 ' H ' ' B' ' 64' ' ' THR . 3.8 p -101.61 -167.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 122.752 1.263 . . . . 0.0 109.234 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.526 ' H ' HG22 ' B' ' 63' ' ' VAL . 3.1 p -86.89 -39.68 15.58 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.872 -1.767 . . . . 0.0 109.245 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.62 -9.12 59.8 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.011 1.725 . . . . 0.0 110.884 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.39 -23.79 61.95 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-O 124.297 1.998 . . . . 0.0 107.18 169.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.54 75.72 1.27 Allowed Glycine 0 CA--C 1.468 -2.873 1 N-CA-C 101.978 -4.449 . . . . 0.0 101.978 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -47.61 -12.2 0.03 OUTLIER 'General case' 0 C--N 1.373 1.587 0 C-N-CA 129.96 3.304 . . . . 0.0 113.729 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -50.63 -19.62 0.97 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.458 1.903 . . . . 0.0 113.627 158.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.93 -54.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 CA-C-N 122.089 2.222 . . . . 0.0 107.342 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.54 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.324 0.583 . . . . 0.0 110.733 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.89 -42.66 80.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.269 1.428 . . . . 0.0 111.996 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.96 -40.96 95.79 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.392 1.077 . . . . 0.0 110.1 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.09 -46.92 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 C-N-CA 123.536 0.734 . . . . 0.0 109.578 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 46.1 mtp -59.23 -48.77 80.37 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.18 0.992 . . . . 0.0 110.285 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -61.99 -41.02 97.58 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.167 0.987 . . . . 0.0 110.771 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.59 91.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 123.01 0.524 . . . . 0.0 111.122 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.64 -49.57 63.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.37 -44.66 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 124.192 0.997 . . . . 0.0 109.316 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.68 -38.35 90.71 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.788 -1.195 . . . . 0.0 111.754 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.48 -53.03 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.207 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.2 -11.63 60.58 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.336 0.655 . . . . 0.0 112.118 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.99 -21.13 15.13 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 123.755 0.822 . . . . 0.0 109.657 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.94 -28.13 64.27 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 119.632 -1.918 . . . . 0.0 108.976 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.16 -14.94 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.943 0.897 . . . . 0.0 111.996 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 66.8 m -58.95 -12.44 4.55 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 125.936 1.694 . . . . 0.0 111.674 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.82 -26.05 68.55 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.538 -1.976 . . . . 0.0 112.388 167.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.01 -30.81 27.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 119.856 -1.778 . . . . 0.0 108.742 175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.26 31.42 0.65 Allowed 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 126.04 1.736 . . . . 0.0 109.29 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.6 -1.98 1.11 Allowed 'General case' 0 N--CA 1.433 -1.316 0 O-C-N 120.59 -1.318 . . . . 0.0 108.26 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -116.85 16.94 15.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -83.2 -48.52 10.41 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.354 2.262 . . . . 0.0 107.188 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -65.2 -20.41 66.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.481 1.113 . . . . 0.0 111.648 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.55 -28.53 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 124.657 1.183 . . . . 0.0 109.375 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -65.65 -21.72 66.58 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 124.51 1.124 . . . . 0.0 111.916 -172.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -19.18 63.33 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.828 -1.17 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.127 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . 0.28 38.1 m-20 . . . . . 0 CA--C 1.501 -0.911 0 CA-C-O 122.845 1.307 . . . . 0.0 113.328 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -161.68 -45.61 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.48 -47.69 83.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.879 2.072 . . . . 0.0 110.263 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -80.73 -6.63 58.72 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.645 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.84 -47.36 11.95 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.65 93.85 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.044 0.938 . . . . 0.0 110.632 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -57.11 -38.28 73.18 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.815 1.246 . . . . 0.0 111.751 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -72.92 -28.11 62.26 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.167 -0.958 . . . . 0.0 110.446 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.27 -40.29 77.9 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.056 0.542 . . . . 0.0 109.695 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.11 -40.33 93.36 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.515 0.726 . . . . 0.0 110.947 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.36 -38.8 81.33 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.74 0.816 . . . . 0.0 111.442 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.29 -40.09 93.39 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.116 1.366 . . . . 0.0 109.519 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.49 -38.65 91.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.555 -0.716 . . . . 0.0 111.055 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.44 -31.8 72.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.382 -0.824 . . . . 0.0 112.149 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -67.73 -39.65 84.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.05 0.94 . . . . 0.0 109.368 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.54 -32.61 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 124.286 1.034 . . . . 0.0 109.035 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.3 -44.95 88.78 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.016 0.825 . . . . 0.0 111.176 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.54 -38.27 80.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.398 0.679 . . . . 0.0 110.242 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.56 -44.42 86.79 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 121.186 -0.946 . . . . 0.0 109.077 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.18 72.91 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.807 1.643 . . . . 0.0 111.41 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -59.42 -47.6 84.84 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.006 0.922 . . . . 0.0 111.553 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -45.69 69.76 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 125.149 1.38 . . . . 0.0 108.221 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.64 -36.07 78.12 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.893 0.477 . . . . 0.0 111.01 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.73 -44.42 61.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 123.825 0.85 . . . . 0.0 110.73 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.57 -32.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 121.471 -0.768 . . . . 0.0 110.018 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -84.66 -12.85 53.09 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.108 -0.995 . . . . 0.0 111.382 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.4 78.73 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.494 ' OE1' HG12 ' C' ' 63' ' ' VAL . 80.6 mm-40 -81.33 -10.12 59.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.764 0.792 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -78.97 81.96 5.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 119.921 -1.737 . . . . 0.0 108.3 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.09 0.51 4.22 Favored Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.21 42.89 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.37 112.51 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.533 2.155 . . . . 0.0 113.388 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.26 -46.27 0.67 Allowed Glycine 0 CA--C 1.482 -1.999 1 N-CA-C 101.949 -4.461 . . . . 0.0 101.949 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 73.16 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.626 1.97 . . . . 0.0 108.419 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.6 -71.39 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 112.573 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 tt -100.68 120.35 39.94 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.48 13.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 28.3 t -109.67 130.49 55.51 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.72 -56.36 9.74 Favored Pre-proline 0 C--N 1.349 0.572 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.026 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.02 -12.07 25.73 Favored 'Trans proline' 0 CA--C 1.511 -0.669 0 CA-C-N 124.988 2.817 . . . . 0.0 111.386 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.83 -20.34 21.58 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 119.366 0.985 . . . . 0.0 108.7 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.49 -36.25 83.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.338 -0.851 . . . . 0.0 109.95 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -72.35 -25.92 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.876 1.27 . . . . 0.0 110.557 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 -42.27 37.02 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.525 -1.359 . . . . 0.0 107.812 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -70.07 -32.47 70.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.657 0.783 . . . . 0.0 110.684 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 54.6 p -68.67 -27.52 66.06 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.249 -1.532 . . . . 0.0 111.311 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.03 -53.57 47.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 CA-C-N 119.14 0.882 . . . . 0.0 109.601 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.96 -10.94 59.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.812 -0.555 . . . . 0.0 112.005 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -81.12 -33.32 33.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.172 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -35.55 75.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.775 -1.203 . . . . 0.0 111.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.46 0.73 48.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 122.039 -0.413 . . . . 0.0 110.596 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.9 p 65.42 20.18 11.72 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 126.085 1.754 . . . . 0.0 111.493 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.79 -55.89 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.39 44.31 97.81 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 121.629 -0.669 . . . . 0.0 112.125 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 1.5 t80 -55.84 -40.65 73.13 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.616 1.567 . . . . 0.0 110.518 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.59 -122.79 1.12 Allowed Glycine 0 CA--C 1.48 -2.14 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.322 4.4 t0 62.62 -85.29 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 127.072 2.149 . . . . 0.0 108.947 -168.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -119.67 169.07 10.42 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.34 148.72 21.48 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.92 176.58 7.49 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.033 2.488 . . . . 0.0 108.695 171.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.755 HG13 ' H ' ' C' ' 64' ' ' THR 0.285 9.9 p -101.2 -121.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 170.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.755 ' H ' HG13 ' C' ' 63' ' ' VAL . 12.6 m -107.34 -82.67 0.55 Allowed 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 120.283 -1.511 . . . . 0.0 107.174 -171.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.05 122.41 12.98 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.101 1.36 . . . . 0.0 109.406 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . 0.28 6.6 tt0 76.33 -68.63 0.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.301 -1.333 . . . . 0.0 112.637 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -37.15 -49.07 1.54 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 128.216 2.817 . . . . 0.0 114.646 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -75.31 -38.46 60.26 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.798 1.239 . . . . 0.0 112.094 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -76.48 -29.74 56.99 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.84 -44.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 O-C-N 119.766 -1.834 . . . . 0.0 109.08 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.14 99.37 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 111.205 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -48.82 -44.85 39.69 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.692 1.997 . . . . 0.0 112.194 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -63.94 -40.1 95.66 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.69 -39.23 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 124.342 1.057 . . . . 0.0 109.263 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.42 -45.86 87.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.28 -39.34 94.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.696 0.799 . . . . 0.0 110.931 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.48 71.61 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.914 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.65 -49.87 7.63 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.13 -46.29 84.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 110.167 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.62 -31.83 73.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.421 -0.799 . . . . 0.0 112.572 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.59 -51.59 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -66.17 -33.98 77.01 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 122.878 0.471 . . . . 0.0 110.975 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.56 83.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.53 1.132 . . . . 0.0 110.517 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.72 -22.16 66.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.772 1.229 . . . . 0.0 112.935 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -59.59 -19.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 124.892 1.277 . . . . 0.0 110.401 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -57.77 -20.42 34.95 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 112.631 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.0 51.15 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.311 -1.493 . . . . 0.0 112.422 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.09 -31.57 11.7 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.792 1.237 . . . . 0.0 110.644 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 35.1 mt -82.62 -41.43 19.47 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.428 -0.795 . . . . 0.0 109.956 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.84 72.75 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.5 1.12 . . . . 0.0 109.62 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -16.79 64.13 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.522 -1.361 . . . . 0.0 112.098 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 26.4 t70 -74.36 -24.42 59.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.497 1.044 . . . . 0.0 110.518 -168.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -37.97 61.3 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 120.705 -1.247 . . . . 0.0 109.705 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.25 -27.85 42.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 125.32 1.448 . . . . 0.0 110.191 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -59.72 -22.52 62.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.342 1.057 . . . . 0.0 113.027 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . 0.3 18.3 ptt85 -69.46 -28.59 66.23 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 121.254 1.843 . . . . 0.0 111.506 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 C--N 1.351 0.669 0 O-C-N 119.621 -1.924 . . . . 0.0 110.345 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -55.85 -46.28 78.23 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.087 2.155 . . . . 0.0 110.466 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CD2' ' HB1' ' D' ' 87' ' ' ALA 0.252 1.4 m80 -81.15 -16.34 53.25 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -169.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.06 -30.82 31.17 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.418 1.008 . . . . 0.0 109.166 169.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -63.42 -46.1 87.94 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.54 -31.17 66.74 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.97 -0.457 . . . . 0.0 110.4 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.21 70.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 121.353 -0.842 . . . . 0.0 110.744 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -69.84 -29.95 67.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.835 -0.54 . . . . 0.0 111.574 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.27 -40.62 91.0 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.713 0.805 . . . . 0.0 110.232 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.46 84.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.591 0.756 . . . . 0.0 111.445 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.19 -37.88 81.56 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 121.459 -0.775 . . . . 0.0 110.912 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -70.96 -26.53 63.2 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.981 -1.075 . . . . 0.0 111.337 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -76.15 -34.19 59.38 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.23 -39.53 93.12 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.33 0.652 . . . . 0.0 111.164 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.02 -35.19 74.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.615 0.766 . . . . 0.0 111.916 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -67.11 -39.25 86.64 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.691 -0.631 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.65 -39.85 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.075 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.738 HD22 ' H ' ' D' ' 49' ' ' VAL . 87.3 mt -64.84 -37.5 87.84 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.136 0.974 . . . . 0.0 112.478 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -67.84 -32.69 73.38 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.61 0.719 . . . . 0.0 111.577 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.79 -36.4 28.48 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.417 -0.802 . . . . 0.0 108.949 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.35 84.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 125.455 1.502 . . . . 0.0 111.992 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -66.77 -40.95 88.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.597 0.713 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -69.09 -39.47 78.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 109.175 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -73.59 -40.33 63.96 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.855 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.21 80.89 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.092 1.357 . . . . 0.0 112.642 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.96 -38.05 81.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 O-C-N 120.832 -1.168 . . . . 0.0 111.647 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.91 -23.17 36.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.964 -1.085 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.24 -52.81 20.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.641 1.976 . . . . 0.0 107.774 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.02 -33.44 70.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.582 1.182 . . . . 0.0 111.946 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -68.93 104.77 2.17 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.63 -1.919 . . . . 0.0 112.14 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.06 -33.92 1.98 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 104.824 -3.311 . . . . 0.0 104.824 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.41 150.64 73.95 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 123.771 0.828 . . . . 0.0 110.412 -173.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.46 145.63 23.81 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.064 1.842 . . . . 0.0 109.301 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.11 17.57 74.07 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 118.563 0.619 . . . . 0.0 112.125 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.49 128.41 22.79 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.891 1.676 . . . . 0.0 113.573 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.44 -39.46 1.02 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.993 1.317 . . . . 0.0 109.709 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.39 15.3 1.28 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.84 1.656 . . . . 0.0 111.609 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tp -98.63 121.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 119.6 -1.937 . . . . 0.0 108.257 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.8 p -172.82 -105.06 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.81 -65.21 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.006 0 C-N-CA 128.111 2.565 . . . . 0.0 106.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 -18.98 28.24 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 124.837 2.763 . . . . 0.0 110.804 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.62 -22.56 26.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.87 -33.64 62.11 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 120.941 -1.099 . . . . 0.0 111.468 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.67 -20.79 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.607 1.194 . . . . 0.0 108.747 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.59 ' CE2' ' HB2' ' A' ' 68' ' ' ARG . 24.9 t90 -77.55 -40.43 42.51 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.336 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -60.14 -44.14 95.19 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.19 1.396 . . . . 0.0 109.925 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 82.3 p -74.97 -169.76 0.97 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.999 0.904 . . . . 0.0 108.982 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.738 ' H ' HD22 ' D' ' 19' ' ' LEU 0.352 2.1 t 71.58 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.955 2.102 . . . . 0.0 110.683 -170.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -28.63 70.13 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.618 1.099 . . . . 0.0 110.415 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -29.87 69.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.037 0.935 . . . . 0.0 111.126 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -77.94 -27.75 49.42 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.809 -1.182 . . . . 0.0 109.844 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -83.74 3.63 32.43 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.442 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 71.2 p 54.61 59.59 4.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.252 2.221 . . . . 0.0 111.871 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -109.06 -89.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 89.45 60.45 1.45 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -9.95 59.24 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 121.674 -0.898 . . . . 0.0 111.498 -170.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.37 35.35 3.63 Favored Glycine 0 CA--C 1.486 -1.763 0 O-C-N 120.467 -1.395 . . . . 0.0 110.81 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.02 -65.23 0.8 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -138.01 153.76 49.37 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 102.957 -2.979 . . . . 0.0 102.957 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.69 144.22 48.05 Favored Pre-proline 0 N--CA 1.44 -0.937 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.01 165.9 25.62 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.249 2.632 . . . . 0.0 109.546 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.546 HG12 ' H ' ' D' ' 64' ' ' THR . 2.8 t -103.69 -153.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.546 ' H ' HG12 ' D' ' 63' ' ' VAL . 0.2 OUTLIER -93.14 -54.29 3.78 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 119.619 -1.926 . . . . 0.0 109.279 -161.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.03 3.65 33.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 109.245 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -25.91 62.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.85 55.54 1.4 Allowed Glycine 0 CA--C 1.466 -3.012 0 N-CA-C 104.575 -3.41 . . . . 0.0 104.575 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -21.42 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.376 1.733 1 C-N-CA 133.878 4.871 . . . . 0.0 116.825 -174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -52.47 -16.21 0.84 Allowed 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 125.601 1.56 . . . . 0.0 113.256 162.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.05 -47.39 88.09 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 122.246 2.294 . . . . 0.0 108.449 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.94 -47.84 73.35 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.099 0.56 . . . . 0.0 110.63 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.03 -38.95 80.5 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 111.704 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -67.79 -29.33 68.49 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.561 -1.337 . . . . 0.0 111.44 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.71 -42.13 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 121.307 -0.87 . . . . 0.0 108.672 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.54 -49.71 76.44 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.717 1.207 . . . . 0.0 109.829 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -65.32 -37.77 88.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.015 -0.428 . . . . 0.0 111.298 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.94 92.38 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -50.39 61.49 Favored Glycine 0 CA--C 1.49 -1.478 0 C-N-CA 124.129 0.871 . . . . 0.0 111.067 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -57.83 -48.29 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.387 1.075 . . . . 0.0 109.598 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.05 -32.05 73.57 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 t -65.62 -55.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-N 119.371 0.987 . . . . 0.0 109.388 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.63 -38.6 84.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.324 0.583 . . . . 0.0 110.375 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.53 63.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.346 -0.847 . . . . 0.0 111.047 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.06 -30.9 71.5 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.182 -1.574 . . . . 0.0 110.118 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 -12.47 7.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.804 1.242 . . . . 0.0 110.68 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -52.79 -22.82 5.78 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.448 -1.408 . . . . 0.0 111.621 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' D' ' 4' ' ' HIS . . . -73.54 -19.26 60.95 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 119.466 -2.021 . . . . 0.0 114.423 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.32 -41.8 15.19 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.681 ' HB3' HG21 ' A' ' 86' ' ' THR . 39.8 mt -59.91 -40.98 90.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 112.525 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.83 64.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.201 -0.937 . . . . 0.0 111.871 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -92.14 -1.0 57.42 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 120.777 -1.202 . . . . 0.0 108.462 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -74.58 -30.22 61.63 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 119.253 0.933 . . . . 0.0 109.753 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -80.83 -31.8 35.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 120.597 -1.314 . . . . 0.0 111.524 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -23.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 125.163 1.385 . . . . 0.0 109.294 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -50.16 -35.35 25.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 125.606 1.563 . . . . 0.0 113.256 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -71.24 -16.57 62.5 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.315 -0.866 . . . . 0.0 110.87 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.825 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -151.85 -82.49 0.09 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -0.28 31.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 121.068 -1.02 . . . . 0.0 113.324 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -30.06 68.26 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.334 1.454 . . . . 0.0 108.248 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -66.88 -37.9 85.29 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.606 0.763 . . . . 0.0 109.05 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.7 -28.55 36.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.38 76.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.421 0.629 . . . . 0.0 111.16 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -75.32 -23.49 57.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.568 -0.707 . . . . 0.0 111.043 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.84 -36.03 77.68 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.588 -0.695 . . . . 0.0 109.51 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.84 71.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.976 -1.078 . . . . 0.0 111.471 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.83 -23.22 65.14 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.417 -0.802 . . . . 0.0 111.97 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.47 -43.09 67.24 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 120.658 -1.276 . . . . 0.0 109.242 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.48 -39.14 92.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.653 1.181 . . . . 0.0 108.645 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.24 -43.29 92.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.003 0.521 . . . . 0.0 111.562 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.17 -30.9 71.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.812 0.845 . . . . 0.0 111.905 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -69.43 -39.8 77.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.49 -0.756 . . . . 0.0 109.646 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.8 -38.79 82.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 O-C-N 121.29 -0.881 . . . . 0.0 109.202 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -58.77 -42.68 89.53 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.788 0.835 . . . . 0.0 111.618 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.82 -28.53 62.61 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.33 1.052 . . . . 0.0 111.737 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -73.73 -46.12 47.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.745 -1.222 . . . . 0.0 107.798 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -27.95 68.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.761 1.225 . . . . 0.0 112.221 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 p -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.654 1.116 . . . . 0.0 110.791 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.32 -43.62 77.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.58 -44.72 95.61 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.02 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 126.212 1.805 . . . . 0.0 112.42 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 41' ' ' TYR . 26.2 m -64.66 -34.94 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 119.955 1.252 . . . . 0.0 112.131 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -78.18 -35.48 48.64 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 125.256 1.423 . . . . 0.0 108.38 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -77.67 -51.2 10.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 124.662 1.185 . . . . 0.0 108.505 -175.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.03 -40.66 87.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.085 0.945 . . . . 0.0 110.267 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -77.23 104.82 7.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 119.802 -1.811 . . . . 0.0 111.349 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -21.89 2.36 Favored Glycine 0 CA--C 1.49 -1.489 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.23 89.0 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 123.4 0.68 . . . . 0.0 110.702 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.68 126.05 11.69 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.971 2.448 . . . . 0.0 110.105 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -67.81 3.26 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 106.069 -2.812 . . . . 0.0 106.069 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.7 -172.98 0.18 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 126.516 1.926 . . . . 0.0 108.55 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.81 -40.41 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.969 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.33 -68.47 0.64 Allowed 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt 32.02 37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 128.326 2.65 . . . . 0.0 114.934 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -148.72 133.6 18.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' HG11 ' A' ' 27' ' ' VAL . 73.8 t80 -79.67 -52.14 1.12 Allowed Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-O 116.01 -1.947 . . . . 0.0 110.8 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.71 -13.42 29.66 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 CA-C-N 126.145 3.23 . . . . 0.0 111.73 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.57 -27.79 29.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.487 1.515 . . . . 0.0 108.559 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.46 -33.72 76.6 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.778 0.831 . . . . 0.0 111.785 -167.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -73.56 -24.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 123.836 0.855 . . . . 0.0 110.376 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.85 -32.45 21.71 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 120.744 -1.222 . . . . 0.0 108.766 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -70.23 -35.57 73.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.554 1.169 . . . . 0.0 108.974 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -81.27 62.47 5.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 120.674 -1.266 . . . . 0.0 108.907 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.87 -68.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -46.88 -32.99 4.15 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 130.107 3.363 . . . . 0.0 114.231 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -69.21 -37.61 78.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.879 1.672 . . . . 0.0 109.851 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.43 58.17 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 120.177 -1.577 . . . . 0.0 109.724 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -79.59 -11.09 59.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.416 1.487 . . . . 0.0 109.319 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 54.11 62.88 2.38 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.848 2.059 . . . . 0.0 112.144 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.49 -84.17 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.58 -84.66 0.36 Allowed Glycine 0 CA--C 1.482 -2.0 1 N-CA-C 101.902 -4.479 . . . . 0.0 101.902 -173.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CZ ' ' HA2' ' B' ' 56' ' ' GLY . 0.1 OUTLIER 65.13 -69.87 0.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 127.046 2.138 . . . . 0.0 111.448 179.022 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.32 53.15 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.722 0 O-C-N 120.529 -1.357 . . . . 0.0 115.507 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.12 -64.87 0.89 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.241 2.02 . . . . 0.0 108.113 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.82 179.05 6.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -157.72 152.82 21.51 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.47 172.22 13.8 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.782 2.988 . . . . 0.0 109.409 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 t -115.92 -100.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 119.463 1.029 . . . . 0.0 108.535 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -140.77 -44.0 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.12 -16.21 41.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.406 -0.809 . . . . 0.0 111.793 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -61.06 -35.95 78.31 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.928 1.291 . . . . 0.0 108.11 171.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 97.81 2.02 Favored Glycine 0 N--CA 1.418 -2.53 1 N-CA-C 97.548 -6.221 . . . . 0.0 97.548 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -62.08 -16.62 53.53 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 119.239 1.519 . . . . 0.0 110.112 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.46 -10.14 4.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 125.196 1.398 . . . . 0.0 112.97 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.55 -46.35 75.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 120.748 -1.22 . . . . 0.0 108.165 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.11 74.28 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -49.22 -45.15 44.04 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.529 1.532 . . . . 0.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -58.69 -47.71 83.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.759 1.224 . . . . 0.0 111.232 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.5 -42.31 72.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 O-C-N 121.749 -0.594 . . . . 0.0 109.574 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.444 ' SD ' HG11 ' D' ' 55' ' ' VAL . 48.9 mtm -61.59 -48.18 82.1 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.111 0.964 . . . . 0.0 110.105 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.52 -36.22 78.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.295 -0.878 . . . . 0.0 110.862 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.85 98.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.709 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.91 92.75 Favored Glycine 0 CA--C 1.491 -1.427 0 C-N-CA 124.244 0.926 . . . . 0.0 111.135 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.83 -45.39 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.127 0.971 . . . . 0.0 109.562 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -64.78 -33.7 76.6 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.587 -1.32 . . . . 0.0 111.6 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.8 -53.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 124.098 0.959 . . . . 0.0 109.692 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -71.36 -20.91 62.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.832 0.825 . . . . 0.0 111.395 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 -33.54 31.0 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.084 -1.635 . . . . 0.0 110.082 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.16 -39.8 91.49 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.501 1.12 . . . . 0.0 110.622 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.3 m -66.88 -6.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 O-C-N 121.65 -0.656 . . . . 0.0 112.522 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.4 m -53.69 -25.69 19.4 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 125.66 1.584 . . . . 0.0 110.427 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.14 -43.27 74.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.56 -1.337 . . . . 0.0 112.764 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -42.33 58.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.39 1.076 . . . . 0.0 109.257 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.29 -34.3 77.1 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.156 0.503 . . . . 0.0 110.68 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.41 75.88 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.824 -1.173 . . . . 0.0 111.751 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -13.1 60.0 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.757 -1.214 . . . . 0.0 111.954 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.86 -35.93 81.16 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.615 1.197 . . . . 0.0 109.106 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -73.89 -35.53 64.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 119.794 -1.816 . . . . 0.0 112.068 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.92 -25.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 125.929 1.692 . . . . 0.0 109.229 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -56.47 -24.91 49.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.775 1.63 . . . . 0.0 112.71 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.71 -16.95 59.37 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.015 -1.053 . . . . 0.0 111.132 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--N 1.357 0.896 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.144 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.503 -0.857 0 CA-C-O 121.604 0.716 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -59.97 -31.95 70.36 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.849 1.26 . . . . 0.0 113.382 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -71.56 -34.03 69.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.038 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -70.69 -35.7 72.92 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 120.968 -1.082 . . . . 0.0 110.397 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.56 -35.32 67.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 -46.48 81.15 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.015 0.926 . . . . 0.0 111.334 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -66.53 -34.28 77.55 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.541 -0.725 . . . . 0.0 110.467 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.91 -41.3 99.4 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 109.996 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.87 80.72 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.652 0.781 . . . . 0.0 111.228 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.55 -31.88 73.29 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.478 -0.764 . . . . 0.0 111.957 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -70.75 -32.87 70.18 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.038 -1.038 . . . . 0.0 109.425 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.82 -34.25 77.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.88 -1.138 . . . . 0.0 109.395 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.23 -38.14 87.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.447 0.699 . . . . 0.0 110.24 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -58.42 -36.48 73.66 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 124.221 1.008 . . . . 0.0 111.766 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.23 -44.77 87.17 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.867 0.867 . . . . 0.0 110.057 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 -20.05 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 121.438 -0.789 . . . . 0.0 110.698 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.76 -48.76 79.23 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 119.564 1.074 . . . . 0.0 109.874 172.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.29 -40.5 90.07 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.06 -1.025 . . . . 0.0 110.347 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -63.55 -40.05 95.98 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.735 0.814 . . . . 0.0 111.277 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.63 98.58 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.204 1.401 . . . . 0.0 109.575 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -57.38 -35.28 69.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.187 1.395 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.71 -51.84 9.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.563 -0.711 . . . . 0.0 109.925 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -63.89 -28.61 69.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.58 -1.325 . . . . 0.0 110.796 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.75 94.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.408 1.083 . . . . 0.0 112.244 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.59 -14.69 13.77 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-O 122.35 1.071 . . . . 0.0 110.395 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -87.17 -38.61 16.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.726 -2.484 . . . . 0.0 107.862 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.22 65.79 6.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.014 1.726 . . . . 0.0 108.692 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -31.54 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.13 30.47 0.0 OUTLIER 'General case' 0 C--N 1.355 0.821 0 C-N-CA 130.527 3.531 . . . . 0.0 117.549 -168.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.84 36.66 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.12 156.69 35.74 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 119.062 1.431 . . . . 0.0 108.947 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -85.14 117.41 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.711 2.274 . . . . 0.0 112.517 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 31.35 26.34 Favored Glycine 0 CA--C 1.494 -1.269 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.84 137.87 47.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.034 0.933 . . . . 0.0 109.272 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.04 -37.99 8.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 123.529 0.732 . . . . 0.0 109.924 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.04 140.56 29.53 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 pt -156.35 37.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 CA-C-N 118.971 0.805 . . . . 0.0 109.164 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -137.59 -117.87 0.15 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 118.255 -2.778 . . . . 0.0 112.101 -158.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.68 -68.95 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.755 0 C-N-CA 128.487 2.715 . . . . 0.0 103.951 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.61 -20.05 27.32 Favored 'Trans proline' 0 CA--C 1.513 -0.55 0 CA-C-N 125.654 3.055 . . . . 0.0 111.419 -173.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.88 -25.31 61.88 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.649 1.18 . . . . 0.0 109.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.23 -36.51 79.62 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 123.542 0.737 . . . . 0.0 110.284 -167.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.89 -29.15 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.899 -0.501 . . . . 0.0 110.686 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -42.18 76.48 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.881 -1.137 . . . . 0.0 108.735 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -59.16 -48.01 83.21 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 110.09 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.5 m -57.89 -36.41 72.38 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.422 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.2 -53.69 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 123.762 0.825 . . . . 0.0 109.253 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.48 -20.88 63.73 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.279 1.038 . . . . 0.0 111.757 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -74.64 -39.77 61.89 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 120.664 -1.272 . . . . 0.0 109.253 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.29 66.91 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 120.712 -1.242 . . . . 0.0 111.933 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -1.18 56.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.646 0.778 . . . . 0.0 110.124 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 42.9 p 65.64 16.14 10.36 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.44 1.896 . . . . 0.0 111.92 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.98 -58.45 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . 62.2 56.36 22.57 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 174.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' HA2' ' C' ' 56' ' ' GLY . 6.2 t80 -57.43 -41.85 81.25 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.736 1.214 . . . . 0.0 110.422 -168.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.69 8.63 0.58 Allowed Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.13 -55.57 5.93 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 118.959 1.38 . . . . 0.0 111.734 -170.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.97 155.86 49.2 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -160.3 137.59 6.88 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.428 ' HA ' ' OE1' ' B' ' 66' ' ' GLU . 34.8 Cg_endo -82.21 159.22 17.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 122.687 1.995 . . . . 0.0 112.119 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.263 34.9 m -106.33 -154.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 122.663 1.22 . . . . 0.0 111.32 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -73.41 -54.82 7.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.257 1.823 . . . . 0.0 111.434 -165.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -69.39 -16.84 63.6 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.154 1.782 . . . . 0.0 109.376 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' B' ' 62' ' ' PRO . 94.8 mt-10 -81.97 -18.5 43.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.53 93.34 0.65 Allowed Glycine 0 CA--C 1.483 -1.917 1 N-CA-C 102.129 -4.388 . . . . 0.0 102.129 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -53.72 -28.66 35.33 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 119.162 1.481 . . . . 0.0 110.709 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -58.16 -11.95 3.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.18 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 120.988 1.722 . . . . 0.0 109.756 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.57 -57.94 3.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -53.39 -38.89 63.82 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.089 1.356 . . . . 0.0 112.93 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -76.76 -24.56 52.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.953 -1.092 . . . . 0.0 111.104 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.16 -43.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.03 -49.95 75.96 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.236 1.014 . . . . 0.0 110.647 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -72.8 -15.72 61.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.877 -1.139 . . . . 0.0 112.162 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.18 65.5 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 120.051 -1.656 . . . . 0.0 108.626 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.05 -46.97 89.87 Favored Glycine 0 CA--C 1.492 -1.347 0 C-N-CA 124.676 1.131 . . . . 0.0 111.217 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.15 -48.5 65.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 C-N-CA 124.869 1.268 . . . . 0.0 110.421 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.35 -22.55 63.73 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 120.914 -1.116 . . . . 0.0 112.523 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.84 -53.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -62.83 -41.19 99.22 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.896 0.878 . . . . 0.0 110.439 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -30.53 71.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.766 0.826 . . . . 0.0 111.381 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.85 -30.36 67.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.965 -1.085 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.5 -14.87 11.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 120.843 -1.16 . . . . 0.0 110.324 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -61.28 -20.91 63.43 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.341 -2.099 . . . . 0.0 112.241 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.35 -17.39 62.54 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 120.47 -1.394 . . . . 0.0 111.593 172.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.5 -46.87 6.8 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 124.87 1.268 . . . . 0.0 108.605 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 55.0 mt -61.2 -38.49 86.75 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.294 -0.879 . . . . 0.0 112.414 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.87 0.13 19.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.038 -1.039 . . . . 0.0 111.212 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.1 p -97.94 -14.27 20.72 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 120.835 -1.166 . . . . 0.0 109.716 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.33 -18.86 60.64 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 119.557 1.071 . . . . 0.0 111.054 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -91.24 -16.76 27.11 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 120.658 -1.276 . . . . 0.0 112.295 170.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.43 -27.09 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -53.69 -22.35 8.85 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 126.028 1.731 . . . . 0.0 114.572 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -66.66 -28.0 68.12 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.585 -0.697 . . . . 0.0 110.063 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.441 -0.901 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.138 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 CA--C 1.486 -1.494 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -48.87 -35.83 15.64 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.497 1.919 . . . . 0.0 114.691 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -80.15 -33.57 38.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.316 -1.49 . . . . 0.0 110.567 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -73.31 -31.12 63.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.676 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.87 -49.81 69.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.148 2.179 . . . . 0.0 108.798 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.9 87.82 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.807 1.243 . . . . 0.0 112.067 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -60.17 -36.71 78.19 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.189 0.996 . . . . 0.0 111.174 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -74.66 -19.98 60.06 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.116 -0.99 . . . . 0.0 111.705 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.99 90.56 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.573 -0.704 . . . . 0.0 109.185 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -63.24 -39.0 93.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.682 1.193 . . . . 0.0 111.344 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.24 -39.83 71.43 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.762 0.825 . . . . 0.0 109.827 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.37 -31.21 71.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.405 1.082 . . . . 0.0 110.148 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.01 -47.96 73.98 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 125.505 1.522 . . . . 0.0 110.414 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.03 -35.56 80.89 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.519 0.727 . . . . 0.0 110.374 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -67.3 -49.33 64.68 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 111.308 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.9 -40.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 121.806 -0.558 . . . . 0.0 110.322 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.73 -35.06 72.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 O-C-N 122.02 -0.425 . . . . 0.0 109.99 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.82 -38.2 76.48 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 119.264 0.938 . . . . 0.0 111.465 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -20.62 46.25 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.103 -0.998 . . . . 0.0 108.399 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.04 46.75 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.958 -1.089 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m -52.48 -46.41 66.56 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 125.384 1.474 . . . . 0.0 111.528 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.72 -43.31 98.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 126.383 1.873 . . . . 0.0 108.859 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -71.48 -41.78 68.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 117.344 -1.312 . . . . 0.0 109.231 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.42 -51.8 67.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.874 1.215 . . . . 0.0 110.998 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.61 -37.23 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 O-C-N 121.617 -0.677 . . . . 0.0 110.538 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -75.39 -28.04 59.3 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.248 -1.533 . . . . 0.0 110.166 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.11 68.41 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.245 1.418 . . . . 0.0 109.335 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -2.15 58.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.5 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -67.34 95.66 0.45 Allowed 'General case' 0 C--N 1.357 0.897 0 O-C-N 120.981 -1.074 . . . . 0.0 109.653 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.76 6.05 30.84 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.96 152.6 68.9 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 118.586 1.193 . . . . 0.0 108.841 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.52 137.51 14.7 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.115 1.877 . . . . 0.0 110.217 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.15 70.58 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.54 155.21 19.08 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.455 1.902 . . . . 0.0 111.236 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.76 -22.59 0.87 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.675 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.29 37.34 2.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.655 1.982 . . . . 0.0 108.511 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.03 -15.77 20.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 50.8 m -89.68 124.89 35.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 121.163 -0.96 . . . . 0.0 112.47 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -67.21 -61.05 5.1 Favored Pre-proline 0 C--N 1.348 0.522 0 C-N-CA 127.059 2.143 . . . . 0.0 113.221 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -14.03 24.66 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 CA-C-N 125.679 3.064 . . . . 0.0 110.874 -172.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.36 -16.4 49.29 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 124.357 1.063 . . . . 0.0 108.73 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.03 74.22 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 123.469 0.708 . . . . 0.0 111.224 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.63 -31.99 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 123.753 0.821 . . . . 0.0 110.542 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.74 -34.39 69.49 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 119.758 -1.839 . . . . 0.0 109.282 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -72.33 -43.64 63.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -68.91 -28.0 66.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.779 -1.201 . . . . 0.0 112.051 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.8 t -56.52 -54.63 26.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 124.064 0.946 . . . . 0.0 109.967 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.68 -21.63 51.79 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.703 -0.623 . . . . 0.0 111.431 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -67.8 -39.22 84.04 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.126 0.97 . . . . 0.0 110.038 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.78 -22.93 62.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.889 -1.132 . . . . 0.0 111.631 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -91.92 4.02 53.89 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.607 -0.683 . . . . 0.0 110.199 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 56.9 p 49.38 41.77 21.14 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.859 2.064 . . . . 0.0 111.453 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.3 -66.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' B' ' 57' ' ' TYR . . . 74.14 52.02 8.23 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 174.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.409 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 0.1 OUTLIER -73.86 -14.44 61.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.652 -0.911 . . . . 0.0 110.907 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.99 29.89 3.88 Favored Glycine 0 CA--C 1.49 -1.478 0 O-C-N 121.019 -1.051 . . . . 0.0 110.917 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -70.95 -59.77 2.6 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -138.87 173.36 11.65 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -143.96 144.81 27.89 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.74 164.36 14.0 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.543 2.829 . . . . 0.0 110.03 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.8 -162.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -91.17 -47.77 7.33 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.775 1.63 . . . . 0.0 107.548 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.13 2.19 18.8 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.556 1.542 . . . . 0.0 111.864 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.81 -27.31 63.78 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.296 1.998 . . . . 0.0 106.354 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.95 82.89 0.97 Allowed Glycine 0 CA--C 1.471 -2.673 1 N-CA-C 100.451 -5.06 . . . . 0.0 100.451 -170.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -57.79 -7.69 0.77 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.513 1.525 . . . . 0.0 112.768 -170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.74 -13.17 53.87 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 119.918 -1.739 . . . . 0.0 113.193 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.7 -58.39 5.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 120.821 1.646 . . . . 0.0 106.689 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.43 68.53 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.201 1.0 . . . . 0.0 112.627 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -62.44 -34.22 76.36 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.423 1.089 . . . . 0.0 111.654 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.56 -33.89 76.98 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.132 -1.605 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.25 -43.29 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 O-C-N 121.731 -0.605 . . . . 0.0 109.47 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.12 -49.79 76.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.458 1.103 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -66.29 -35.59 80.78 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.474 -0.766 . . . . 0.0 111.293 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.91 79.09 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.502 -0.749 . . . . 0.0 110.668 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.38 -45.66 77.25 Favored Glycine 0 CA--C 1.495 -1.178 0 C-N-CA 124.144 0.878 . . . . 0.0 111.584 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -44.94 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.312 1.045 . . . . 0.0 109.449 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -65.84 -24.82 66.97 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.118 -0.989 . . . . 0.0 112.288 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.37 -53.38 32.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 120.439 1.472 . . . . 0.0 109.418 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -71.81 -21.9 61.64 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.474 0.654 . . . . 0.0 111.211 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.79 -35.31 26.6 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.361 -0.837 . . . . 0.0 110.949 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.61 -35.28 77.11 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 119.939 -1.726 . . . . 0.0 110.78 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.33 -9.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 121.145 -0.972 . . . . 0.0 112.258 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 20.0 m -65.42 -9.69 27.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.647 1.179 . . . . 0.0 111.804 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.99 -58.21 9.17 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.441 -1.412 . . . . 0.0 110.532 166.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.1 86.84 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.978 -1.076 . . . . 0.0 110.692 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.25 -40.64 86.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.043 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -12.46 60.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 121.092 -1.005 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 7.3 m -82.21 -23.69 35.3 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.77 -35.39 79.99 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 120.903 -1.123 . . . . 0.0 110.504 -159.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -66.34 -26.52 67.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.795 -0.566 . . . . 0.0 112.196 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.32 -27.33 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 124.455 1.102 . . . . 0.0 108.228 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -59.73 -14.41 14.22 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.164 -0.96 . . . . 0.0 112.423 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.986 -1.071 . . . . 0.0 111.018 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -174.376 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -162.96 -92.31 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -168.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 1.9 p80 -63.97 -18.07 63.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.493 1.517 . . . . 0.0 113.343 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 35.3 mp0 -69.92 -34.16 73.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 120.652 -1.28 . . . . 0.0 109.582 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -73.47 -38.76 65.33 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.036 -1.04 . . . . 0.0 108.633 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.95 -42.51 99.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.64 87.59 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.6 1.16 . . . . 0.0 112.119 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.15 -42.36 94.74 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.261 0.625 . . . . 0.0 111.181 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.79 -38.2 90.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.177 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.81 89.62 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.41 -0.806 . . . . 0.0 111.014 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.83 -36.94 84.86 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.453 -0.78 . . . . 0.0 111.027 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.61 -29.99 70.65 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.548 1.139 . . . . 0.0 110.748 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -74.97 -38.44 61.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.561 1.144 . . . . 0.0 108.259 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.95 -45.73 93.54 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.571 0.748 . . . . 0.0 110.666 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -58.2 -31.42 67.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 112.67 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -69.78 -41.1 75.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.424 0.69 . . . . 0.0 109.677 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.39 -35.45 74.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 124.061 0.944 . . . . 0.0 109.175 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.38 -37.8 84.73 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 121.238 -0.914 . . . . 0.0 111.708 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -82.79 -16.89 46.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.514 0.726 . . . . 0.0 111.278 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -77.64 -46.34 22.36 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 168.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.37 74.38 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 126.327 1.851 . . . . 0.0 111.374 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -62.52 -44.35 96.57 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.388 0.675 . . . . 0.0 110.772 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -67.99 -50.09 57.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -61.47 -42.46 98.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.793 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.06 99.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.217 1.407 . . . . 0.0 111.673 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.8 -45.16 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 O-C-N 121.025 -1.047 . . . . 0.0 109.448 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -70.23 -27.82 64.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.317 -0.864 . . . . 0.0 110.703 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -57.03 4.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.421 1.889 . . . . 0.0 108.782 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.53 -32.44 74.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.095 0.958 . . . . 0.0 111.776 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -66.84 104.32 1.32 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.135 -1.603 . . . . 0.0 110.559 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.98 -28.29 3.7 Favored Glycine 0 CA--C 1.489 -1.556 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.52 145.01 70.89 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 123.351 0.661 . . . . 0.0 110.75 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -78.78 138.37 14.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.192 1.928 . . . . 0.0 110.231 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.06 80.91 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.439 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.84 147.95 36.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.813 1.245 . . . . 0.0 111.698 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.53 -37.7 2.48 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 tp -106.93 93.98 4.86 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.124 -0.985 . . . . 0.0 108.883 -173.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -135.58 57.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 120.229 -1.545 . . . . 0.0 109.047 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 30.9 t -150.31 135.03 17.5 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -68.82 -43.09 26.65 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 115.625 -2.131 . . . . 0.0 111.256 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -68.53 -28.18 32.19 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-N 126.106 3.216 . . . . 0.0 111.966 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.83 -17.65 31.06 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 118.957 0.799 . . . . 0.0 108.949 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.68 86.82 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 124.677 1.191 . . . . 0.0 112.039 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.54 -14.87 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 123.579 0.751 . . . . 0.0 110.305 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 -33.19 18.35 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 120.881 -1.137 . . . . 0.0 107.944 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -73.3 -40.02 64.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 15.0 p -76.18 59.05 1.31 Allowed 'General case' 0 C--N 1.358 0.943 0 O-C-N 121.234 -0.916 . . . . 0.0 111.419 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 72.0 t -133.48 -65.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 -21.41 65.26 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.505 0.722 . . . . 0.0 111.784 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -69.69 -28.91 66.25 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 121.507 -0.745 . . . . 0.0 110.394 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.17 -26.47 42.69 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.161 -0.962 . . . . 0.0 109.655 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 15.3 p -91.89 3.35 55.39 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.578 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 12.7 p 54.04 25.88 5.93 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.427 1.891 . . . . 0.0 113.095 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.444 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.8 p -86.22 -53.0 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.409 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 70.85 73.07 0.82 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -23.77 53.56 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.621 -1.517 . . . . 0.0 109.852 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.57 35.71 1.85 Allowed Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -155.2 176.37 12.65 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -149.2 145.92 20.29 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -80.3 165.78 20.84 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 CA-C-N 121.944 1.73 . . . . 0.0 110.527 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.29 -146.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.538 0 CA-C-N 119.218 0.917 . . . . 0.0 109.959 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -91.59 -54.09 4.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.273 -1.517 . . . . 0.0 109.849 -163.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -89.34 16.73 6.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.439 0.696 . . . . 0.0 109.608 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -30.29 62.6 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 163.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.34 83.48 1.18 Allowed Glycine 0 CA--C 1.476 -2.385 1 N-CA-C 99.583 -5.407 . . . . 0.0 99.583 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.58 HH11 ' HG3' ' D' ' 68' ' ' ARG . 20.1 ttm-85 -52.44 -18.57 1.71 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.056 1.742 . . . . 0.0 112.003 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -53.97 -28.22 36.2 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.504 2.322 . . . . 0.0 113.26 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.57 -53.2 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.391 0.677 . . . . 0.0 111.88 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.3 -46.65 55.53 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 126.233 1.813 . . . . 0.0 110.721 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.84 -38.06 89.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.493 0.717 . . . . 0.0 110.8 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.77 -39.05 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 123.446 0.698 . . . . 0.0 109.125 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -57.81 -52.91 63.53 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.984 1.314 . . . . 0.0 110.253 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.8 -38.0 89.47 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.033 0.533 . . . . 0.0 110.659 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.16 79.03 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.661 0.784 . . . . 0.0 111.58 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.81 -45.77 80.78 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.57 -48.97 85.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 C-N-CA 124.268 1.027 . . . . 0.0 108.932 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -57.03 -42.29 80.17 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.208 1.403 . . . . 0.0 112.503 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -65.56 -55.48 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 124.744 1.218 . . . . 0.0 109.248 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -67.26 -34.84 78.27 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.748 -0.595 . . . . 0.0 110.617 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.38 78.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.463 1.105 . . . . 0.0 111.135 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.65 -38.2 90.2 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 124.536 1.135 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.1 -14.5 7.75 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 125.128 1.371 . . . . 0.0 111.279 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 6.3 m -61.81 -20.59 63.79 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 119.376 -2.078 . . . . 0.0 111.696 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.66 66.73 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.684 -1.26 . . . . 0.0 111.336 171.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.91 -49.75 11.45 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.33 -32.25 73.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.736 0.814 . . . . 0.0 112.741 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.99 63.64 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.26 -1.525 . . . . 0.0 111.121 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -82.45 -11.02 58.8 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.701 -1.249 . . . . 0.0 111.225 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -32.55 74.17 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 119.454 1.024 . . . . 0.0 111.206 -171.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -77.17 -32.99 56.55 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.969 -1.082 . . . . 0.0 111.173 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.71 -26.64 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 125.884 1.674 . . . . 0.0 108.973 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -66.55 -5.73 12.47 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 112.331 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -69.16 -18.41 63.93 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 119.81 1.187 . . . . 0.0 110.997 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 -178.167 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.048 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -41.68 -57.87 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 128.786 2.835 . . . . 0.0 112.446 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.572 ' HB3' HH12 ' D' ' 96' ' ' ARG . 51.7 p-80 -77.97 -19.21 54.94 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 125.082 1.353 . . . . 0.0 112.674 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.93 -38.47 57.61 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -60.96 -35.31 76.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 123.816 0.846 . . . . 0.0 111.622 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -59.96 -41.93 92.98 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.737 2.015 . . . . 0.0 110.175 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -41.75 74.4 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.593 0.757 . . . . 0.0 110.263 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.39 -32.56 72.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.799 0.84 . . . . 0.0 111.408 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -71.94 -32.67 67.55 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.363 1.065 . . . . 0.0 110.527 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.123 0.569 . . . . 0.0 110.213 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -55.64 -42.84 75.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.709 1.204 . . . . 0.0 111.795 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -76.7 -29.89 56.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.777 -0.577 . . . . 0.0 109.578 -174.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.22 -31.21 69.63 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.477 -0.764 . . . . 0.0 109.975 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.18 -43.1 92.15 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 121.725 -0.609 . . . . 0.0 111.326 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -62.46 -29.43 70.51 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.187 -0.946 . . . . 0.0 112.209 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.37 -31.62 67.53 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.654 -0.654 . . . . 0.0 110.267 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.65 -41.55 90.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.187 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.92 -42.81 85.57 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.914 0.886 . . . . 0.0 110.305 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.31 -42.7 99.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.378 -0.826 . . . . 0.0 111.699 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.16 -38.63 69.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.65 79.46 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 124.914 1.286 . . . . 0.0 111.639 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -66.56 -32.96 74.63 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 124.146 0.978 . . . . 0.0 111.124 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -70.75 -47.1 61.44 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 121.568 -0.708 . . . . 0.0 109.747 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -60.14 -50.39 73.88 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.129 0.972 . . . . 0.0 109.35 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.81 88.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.646 1.579 . . . . 0.0 112.554 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.88 -48.14 89.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.191 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.33 -29.02 61.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.41 -0.806 . . . . 0.0 111.216 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.16 91.53 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.079 1.352 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.43 -20.0 60.2 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.544 -0.722 . . . . 0.0 112.021 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -75.09 87.13 2.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 120.194 -1.566 . . . . 0.0 110.577 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.88 3.11 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.61 140.58 59.57 Favored Pre-proline 0 N--CA 1.442 -0.825 0 O-C-N 121.703 -0.881 . . . . 0.0 110.046 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.15 135.43 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.495 2.13 . . . . 0.0 110.245 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.86 24.75 68.71 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.67 144.59 56.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.085 0.954 . . . . 0.0 110.103 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.08 -34.47 2.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.79 131.66 36.99 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 pt -151.23 169.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 100.649 -3.834 . . . . 0.0 100.649 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t 76.89 134.07 0.06 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.963 1.705 . . . . 0.0 111.082 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -66.01 -49.48 56.9 Favored Pre-proline 0 C--N 1.352 0.701 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.072 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -70.21 -14.46 34.68 Favored 'Trans proline' 0 CA--C 1.514 -0.513 0 CA-C-N 125.308 2.932 . . . . 0.0 112.584 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.23 -43.14 12.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.97 77.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.235 1.014 . . . . 0.0 112.215 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.14 -16.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-O 121.714 0.769 . . . . 0.0 111.397 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -31.76 17.31 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 120.757 -1.214 . . . . 0.0 108.162 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.33 -40.02 94.97 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 120.795 -1.19 . . . . 0.0 110.244 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -67.05 -17.3 64.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.948 -1.095 . . . . 0.0 111.669 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.5 -51.09 67.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.682 1.193 . . . . 0.0 109.315 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.61 -7.41 50.08 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 124.07 0.948 . . . . 0.0 111.167 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.6 m -94.13 -45.11 7.69 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 120.36 -1.462 . . . . 0.0 107.058 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.01 70.15 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.308 -0.87 . . . . 0.0 112.325 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -91.77 3.83 54.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.272 67.8 p 59.53 -142.46 0.6 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.447 1.899 . . . . 0.0 107.334 -167.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t 75.63 -90.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.94 94.28 0.25 Allowed Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -80.07 -20.8 44.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.305 -1.703 . . . . 0.0 109.711 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.73 25.29 4.31 Favored Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.58 -48.19 34.74 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.277 1.539 . . . . 0.0 110.055 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.36 152.88 51.12 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.457 ' CD1' ' HD2' ' A' ' 62' ' ' PRO . 17.6 t80 -145.17 137.71 13.55 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 46.5 Cg_endo -80.97 168.17 17.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.908 2.405 . . . . 0.0 110.951 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -88.91 -111.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -134.83 -39.42 0.78 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 122.224 1.011 . . . . 0.0 109.225 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -79.28 -22.58 44.46 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.601 -1.312 . . . . 0.0 109.627 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -62.08 -32.03 72.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.075 1.75 . . . . 0.0 108.386 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.42 65.18 0.93 Allowed Glycine 0 CA--C 1.465 -3.081 1 N-CA-C 102.483 -4.247 . . . . 0.0 102.483 168.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -26.33 -26.39 0.0 OUTLIER 'General case' 0 C--N 1.363 1.185 1 C-N-CA 132.65 4.38 . . . . 0.0 116.851 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -49.34 -20.47 0.67 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.06 -42.92 94.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 124.954 1.301 . . . . 0.0 109.693 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -48.51 31.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.12 -50.82 19.46 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 126.463 1.905 . . . . 0.0 111.303 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.27 -35.53 81.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.427 0.632 . . . . 0.0 110.692 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.1 t -73.22 -37.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.41 -0.806 . . . . 0.0 109.14 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.5 mtt -61.83 -46.36 89.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 123.632 0.773 . . . . 0.0 109.656 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.48 -33.27 75.31 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.078 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.18 97.04 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 121.746 -0.596 . . . . 0.0 110.656 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.06 -46.93 77.5 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.35 -45.49 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 109.602 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.87 -36.38 83.72 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.855 -1.153 . . . . 0.0 110.681 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.03 -52.07 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 119.959 1.254 . . . . 0.0 110.563 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -70.47 -22.76 62.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.809 -0.557 . . . . 0.0 111.126 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.54 -32.94 23.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.382 -0.824 . . . . 0.0 110.546 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.43 -24.25 67.14 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.496 -1.377 . . . . 0.0 111.207 -172.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.17 -11.26 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.484 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.402 HG23 ' HB2' ' A' ' 90' ' ' ALA . 56.0 m -45.24 -29.68 1.04 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 127.826 2.45 . . . . 0.0 112.058 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.72 -39.77 52.64 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.406 1.482 . . . . 0.0 113.889 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 -36.12 6.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.94 1.296 . . . . 0.0 109.307 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.31 -41.57 66.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.736 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -78.21 -32.19 49.81 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 119.813 -1.805 . . . . 0.0 111.229 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -73.86 -0.36 15.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.529 -1.357 . . . . 0.0 110.003 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.24 -26.56 64.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 121.245 -0.909 . . . . 0.0 109.414 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -72.83 -33.4 66.15 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.454 -1.404 . . . . 0.0 110.634 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.17 -21.91 27.11 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.223 1.409 . . . . 0.0 109.171 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.39 -29.47 48.83 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 125.399 1.48 . . . . 0.0 112.247 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -65.57 -36.56 84.14 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.541 0.686 . . . . 0.0 110.479 -174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -170.757 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 122.065 0.936 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -83.77 -23.64 31.44 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.58 -0.7 . . . . 0.0 110.601 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.16 -38.06 21.13 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -63.19 -47.61 81.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.225 1.41 . . . . 0.0 110.954 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -26.44 65.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.371 -0.83 . . . . 0.0 111.256 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.91 -35.44 74.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.319 -0.863 . . . . 0.0 110.657 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -64.74 -45.87 84.64 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.999 0.92 . . . . 0.0 109.231 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -64.34 -31.94 73.35 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.112 0.565 . . . . 0.0 111.534 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.93 81.62 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.755 0.822 . . . . 0.0 110.685 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -39.5 81.5 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.074 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.53 -43.04 84.04 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 125.748 1.619 . . . . 0.0 110.484 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.37 -38.92 91.42 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.138 1.375 . . . . 0.0 110.079 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.441 ' HB2' HG21 ' B' ' 81' ' ' VAL . 21.3 tp -59.3 -41.56 89.29 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 123.908 0.883 . . . . 0.0 111.391 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -63.91 -29.58 70.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.866 1.266 . . . . 0.0 110.73 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -76.08 -30.33 58.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.246 1.019 . . . . 0.0 110.217 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -70.35 -35.67 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 31.2 mt -61.76 -42.32 98.83 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.809 -0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -60.75 -45.54 93.9 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.086 0.857 . . . . 0.0 110.519 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -68.93 -40.18 79.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.874 0.845 . . . . 0.0 110.486 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -31.11 71.29 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.264 1.426 . . . . 0.0 111.256 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -66.0 -44.25 85.34 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.085 0.954 . . . . 0.0 110.199 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -61.03 -49.68 76.4 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.025 1.33 . . . . 0.0 107.785 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.83 -41.96 99.54 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.388 0.675 . . . . 0.0 111.232 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.21 91.38 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 124.892 1.277 . . . . 0.0 111.965 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.45 -40.97 73.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.17 -10.67 59.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.291 -1.506 . . . . 0.0 111.704 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.485 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -70.58 -21.25 62.7 Favored 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.907 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.97 -1.99 41.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.27 79.36 2.8 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.2 -41.6 0.71 Allowed Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.81 154.93 70.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 O-C-N 122.185 -0.597 . . . . 0.0 111.457 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.1 151.27 23.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.014 2.476 . . . . 0.0 110.41 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.61 41.23 65.54 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 173.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 136.64 57.92 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.376 1.071 . . . . 0.0 112.205 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.11 -57.28 2.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.62 97.95 10.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.094 0.95 . . . . 0.0 108.455 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.49 12.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -105.08 129.99 53.37 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -78.93 -57.81 0.75 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 127.257 2.223 . . . . 0.0 108.692 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.45 -13.89 25.13 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.344 2.944 . . . . 0.0 111.69 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -93.35 -10.34 35.65 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.397 0.998 . . . . 0.0 108.417 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.64 83.73 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.61 -1.306 . . . . 0.0 110.512 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.92 -9.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 124.454 1.102 . . . . 0.0 110.562 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.85 -41.08 16.37 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 120.14 -1.6 . . . . 0.0 107.28 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -68.87 -32.83 72.76 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.538 -0.727 . . . . 0.0 110.815 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 7.0 p -66.41 -17.41 64.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.978 -1.076 . . . . 0.0 111.586 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.76 -17.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.924 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -97.72 10.82 39.07 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.488 -1.383 . . . . 0.0 109.177 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -123.26 -173.75 2.79 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.45 -3.537 . . . . 0.0 101.45 173.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 77.24 -42.27 0.4 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 126.1 1.76 . . . . 0.0 111.095 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.0 p -81.19 2.75 26.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 126.22 1.808 . . . . 0.0 111.692 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p 52.07 59.3 4.63 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.826 2.051 . . . . 0.0 111.595 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.41 -77.01 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.08 66.49 1.96 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -72.45 -46.04 56.81 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.64 -105.48 0.24 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.327 5.2 t70 56.92 -72.63 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 128.271 2.628 . . . . 0.0 112.232 -163.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -163.59 1.35 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -173.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -153.24 153.49 29.52 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.6 168.41 9.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.331 3.354 . . . . 0.0 112.847 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 m -83.14 177.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.55 1.14 . . . . 0.0 112.442 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -83.21 -69.44 0.63 Allowed 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 125.475 1.51 . . . . 0.0 111.337 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.99 -37.5 64.07 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 124.611 1.165 . . . . 0.0 112.907 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -121.16 -107.62 0.36 Allowed 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 167.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.485 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 40.13 -73.55 0.0 OUTLIER Glycine 0 C--N 1.358 1.785 0 C-N-CA 129.748 3.547 . . . . 0.0 116.165 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.39 -37.86 87.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.363 2.665 . . . . 0.0 111.488 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.838 0.827 . . . . 0.0 109.275 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.05 -46.42 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.58 84.49 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.408 1.483 . . . . 0.0 111.603 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.67 -47.22 29.55 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.049 1.739 . . . . 0.0 110.938 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.72 -36.59 84.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.119 1.368 . . . . 0.0 110.283 -176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.33 -42.01 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.679 -0.638 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -60.59 -46.74 89.09 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -63.13 -38.3 90.62 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 122.121 -0.362 . . . . 0.0 111.158 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.02 80.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.159 0.584 . . . . 0.0 111.301 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.13 91.65 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 124.483 1.039 . . . . 0.0 111.214 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.08 -42.52 90.17 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 123.853 0.861 . . . . 0.0 108.707 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.81 -51.19 65.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 120.94 -1.1 . . . . 0.0 112.275 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' B' ' 15' ' ' LEU . 27.7 m -72.88 -41.32 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 112.144 -171.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -74.15 -38.51 63.7 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.25 -32.18 71.22 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.69 -31.88 62.8 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.759 1.223 . . . . 0.0 111.406 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.9 -12.05 8.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.666 1.186 . . . . 0.0 111.099 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 16.2 m -64.4 -24.82 67.77 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 118.897 -2.377 . . . . 0.0 110.761 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.58 -20.35 65.99 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.154 -1.591 . . . . 0.0 111.318 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.27 -40.71 11.99 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.38 1.072 . . . . 0.0 108.913 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.96 -31.75 51.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 122.785 0.434 . . . . 0.0 111.545 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.29 -23.02 66.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.122 -0.986 . . . . 0.0 111.374 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . 0.343 0.6 OUTLIER -83.36 -10.72 58.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.916 -1.115 . . . . 0.0 109.47 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.275 46.1 m-20 -82.46 -2.68 54.02 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.458 -1.401 . . . . 0.0 111.801 -172.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.19 -35.88 15.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.27 -1.519 . . . . 0.0 108.538 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 t -66.84 -25.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 125.074 1.349 . . . . 0.0 110.224 -169.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -63.58 -8.92 11.02 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.422 -0.799 . . . . 0.0 112.844 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -66.34 -32.85 74.49 Favored 'General case' 0 C--N 1.359 1.004 0 O-C-N 120.851 -1.156 . . . . 0.0 110.068 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -172.905 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 CA--C 1.492 -1.258 0 CA-C-O 121.913 0.863 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CE1' HG21 ' C' ' 91' ' ' THR . 4.5 p80 -67.07 -27.83 67.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.56 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.61 -42.88 57.83 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -65.75 -37.71 87.12 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.827 -1.171 . . . . 0.0 110.826 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.87 -31.44 72.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.379 1.072 . . . . 0.0 110.987 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.84 -47.68 71.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.729 0.812 . . . . 0.0 110.203 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.357 -0.839 . . . . 0.0 111.615 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -65.44 -39.63 92.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.873 1.269 . . . . 0.0 109.311 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.4 82.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.896 0.878 . . . . 0.0 110.681 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -55.53 -42.76 75.03 Favored 'General case' 0 C--N 1.36 1.03 0 CA-C-O 121.667 0.746 . . . . 0.0 110.829 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -60.93 -39.38 89.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.139 1.376 . . . . 0.0 110.363 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.98 -34.2 76.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.149 0.979 . . . . 0.0 109.505 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.47 -40.33 89.29 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.819 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.31 -28.02 68.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.558 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -66.04 -39.77 90.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.977 0.911 . . . . 0.0 110.181 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.7 -35.15 74.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 124.247 1.019 . . . . 0.0 109.198 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.57 -35.67 80.22 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 121.29 -0.881 . . . . 0.0 111.898 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.8 -32.62 59.94 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.137 0.575 . . . . 0.0 110.337 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 -42.06 59.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.12 -0.987 . . . . 0.0 108.767 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -36.01 78.24 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.758 1.623 . . . . 0.0 111.895 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -69.4 -36.63 76.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.909 -0.494 . . . . 0.0 110.299 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -67.58 -38.03 83.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -66.19 -55.24 17.24 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.0 68.69 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.739 1.215 . . . . 0.0 111.984 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.68 -43.92 96.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 O-C-N 119.962 -1.712 . . . . 0.0 111.985 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.79 -34.99 20.99 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 121.211 -0.931 . . . . 0.0 109.274 -171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.37 -50.77 58.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.552 1.941 . . . . 0.0 109.546 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.04 -24.1 62.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.236 -0.915 . . . . 0.0 111.637 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.95 95.19 6.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.455 -1.403 . . . . 0.0 111.918 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.46 -7.57 4.98 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.71 148.02 37.53 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 123.577 0.751 . . . . 0.0 109.788 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -77.69 103.46 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.895 2.397 . . . . 0.0 113.051 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 -52.44 0.72 Allowed Glycine 0 CA--C 1.477 -2.324 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.719 2.008 . . . . 0.0 110.901 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.34 -91.62 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.92 127.14 31.62 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.27 131.18 1.84 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 169.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.86 -49.03 60.83 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.038 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.0 -5.52 17.13 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 CA-C-N 124.777 2.742 . . . . 0.0 111.955 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -99.88 -29.27 12.68 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.67 76.32 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 111.939 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.71 -36.89 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 123.418 0.687 . . . . 0.0 110.222 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -30.22 60.59 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.474 -1.391 . . . . 0.0 109.92 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -72.85 -32.05 65.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.984 0.897 . . . . 0.0 109.124 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -67.04 -42.24 85.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.279 -0.888 . . . . 0.0 110.358 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -67.66 -23.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 C-N-CA 124.155 0.982 . . . . 0.0 112.87 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.4 -13.72 51.4 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 120.07 -1.644 . . . . 0.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -104.61 -175.02 2.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . 79.47 -33.63 0.14 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 126.952 2.101 . . . . 0.0 110.672 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.1 p -89.73 3.78 51.69 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 125.956 1.703 . . . . 0.0 111.949 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.278 41.5 p 52.43 63.87 2.07 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.503 1.921 . . . . 0.0 111.917 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.21 -107.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 1 N-CA-C 98.546 -4.613 . . . . 0.0 98.546 173.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.3 87.48 1.09 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 106.651 -2.58 . . . . 0.0 106.651 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -69.2 -45.63 69.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.357 1.075 . . . . 0.0 109.118 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.44 48.48 0.28 Allowed Glycine 0 CA--C 1.485 -1.797 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.414 ' CG ' HH22 ' D' ' 68' ' ' ARG . 34.8 t70 -73.48 -45.35 54.59 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -132.96 -154.2 0.6 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.83 142.86 2.04 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 100.829 -3.767 . . . . 0.0 100.829 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.07 179.8 3.53 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 123.664 2.344 . . . . 0.0 107.49 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.487 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.7 t -100.6 -121.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.405 1.482 . . . . 0.0 110.118 -168.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 73.4 m -136.48 -38.8 0.66 Allowed 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.692 -1.255 . . . . 0.0 108.584 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -86.17 -6.11 59.06 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.979 -1.076 . . . . 0.0 109.834 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -63.98 -36.83 85.24 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 123.216 1.484 . . . . 0.0 107.373 175.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.94 62.41 0.85 Allowed Glycine 0 CA--C 1.464 -3.111 1 N-CA-C 100.643 -4.983 . . . . 0.0 100.643 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -26.86 -25.2 0.0 OUTLIER 'General case' 0 C--N 1.36 1.04 1 C-N-CA 132.989 4.516 . . . . 0.0 117.778 -175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -52.87 -15.44 0.75 Allowed 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 161.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.23 -44.39 87.84 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 O-C-N 120.153 -1.592 . . . . 0.0 109.294 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.59 66.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 123.142 0.577 . . . . 0.0 109.681 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . 0.258 1.1 pp20? -65.38 -33.72 76.63 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 121.799 -0.563 . . . . 0.0 111.836 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.31 -36.99 79.18 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 121.55 0.691 . . . . 0.0 110.624 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.3 t -72.77 -37.82 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.507 -0.745 . . . . 0.0 109.477 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 50.8 mtt -64.42 -47.91 77.34 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 123.856 0.863 . . . . 0.0 109.55 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -61.83 -40.58 95.79 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.425 0.69 . . . . 0.0 110.747 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.05 94.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.546 0.738 . . . . 0.0 110.872 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.64 78.09 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.28 -49.54 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 124.195 0.998 . . . . 0.0 108.943 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.83 -39.19 87.56 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 118.531 0.605 . . . . 0.0 111.474 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.32 -54.85 28.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 119.331 0.969 . . . . 0.0 110.4 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.58 -14.02 60.03 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 111.737 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.94 -37.62 22.07 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.623 -1.298 . . . . 0.0 108.035 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.97 -33.63 72.2 Favored 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 124.996 1.318 . . . . 0.0 111.738 -175.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -64.56 -5.31 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 O-C-N 121.335 -0.853 . . . . 0.0 112.663 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 26.3 m -59.2 -18.52 37.32 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.742 1.217 . . . . 0.0 111.167 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.62 68.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.847 -1.783 . . . . 0.0 113.104 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.58 -43.46 13.47 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.0 -38.86 92.6 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.079 0.942 . . . . 0.0 111.318 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.29 -20.32 62.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.982 -1.073 . . . . 0.0 111.833 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.515 HG21 ' CE1' ' C' ' 4' ' ' HIS . 9.7 t -99.52 7.71 45.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.4 -45.34 60.14 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.833 1.197 . . . . 0.0 107.978 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -63.09 -34.62 77.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.48 -0.762 . . . . 0.0 111.556 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.03 -23.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.007 1.723 . . . . 0.0 110.033 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -65.48 -16.16 63.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.1 -1.0 . . . . 0.0 111.435 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -64.19 -25.2 67.97 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.32 -0.862 . . . . 0.0 111.833 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 . . . . . 0 C--N 1.356 0.864 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.782 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' D' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.16 -45.63 84.16 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 123.199 1.476 . . . . 0.0 109.657 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -69.93 -17.48 63.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.079 1.352 . . . . 0.0 111.917 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' D' ' 2' ' ' ALA . 56.0 tt0 -77.11 -40.12 46.99 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -173.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -55.55 -50.59 69.61 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.195 1.398 . . . . 0.0 110.485 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.88 -37.9 87.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.938 0.895 . . . . 0.0 109.667 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.55 95.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.553 0.741 . . . . 0.0 111.643 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -68.33 -36.7 79.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.669 -0.644 . . . . 0.0 110.774 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -68.12 -35.09 77.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.705 -0.622 . . . . 0.0 111.039 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.14 98.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.363 1.065 . . . . 0.0 111.104 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -66.76 -35.44 80.11 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.323 -0.86 . . . . 0.0 111.636 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -72.42 -34.12 67.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.676 -1.265 . . . . 0.0 111.161 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -64.84 -35.19 80.31 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.831 1.252 . . . . 0.0 108.844 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -63.22 -39.15 93.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.454 -0.779 . . . . 0.0 111.11 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.13 -21.58 63.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.615 -1.303 . . . . 0.0 112.035 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.4 -36.11 71.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.626 0.727 . . . . 0.0 110.464 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.35 -26.25 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 O-C-N 119.854 -1.779 . . . . 0.0 110.358 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.28 -46.13 90.16 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 121.957 0.884 . . . . 0.0 110.864 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.1 -39.15 86.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.52 -1.363 . . . . 0.0 110.177 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.87 96.02 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.361 1.065 . . . . 0.0 110.798 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.69 76.43 Favored 'General case' 0 CA--C 1.496 -1.123 0 O-C-N 121.301 -0.874 . . . . 0.0 111.469 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -65.06 -44.1 90.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 110.496 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.86 -53.32 48.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 125.124 1.37 . . . . 0.0 109.547 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -65.69 -37.98 87.95 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.308 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.91 83.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 124.37 1.068 . . . . 0.0 111.747 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.14 -50.05 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-N 118.509 0.595 . . . . 0.0 109.857 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -72.43 -31.59 65.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.447 -0.783 . . . . 0.0 110.732 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.49 67.83 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.955 0.902 . . . . 0.0 109.326 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.9 -40.61 96.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 125.482 1.513 . . . . 0.0 110.219 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.76 91.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.928 1.291 . . . . 0.0 112.387 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.65 -5.84 7.5 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.07 59.15 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 118.677 1.238 . . . . 0.0 111.76 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -80.82 137.54 11.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.585 2.19 . . . . 0.0 110.692 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.46 78.15 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 165.2 24.4 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.921 1.289 . . . . 0.0 111.292 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.9 32.51 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 121.808 -0.557 . . . . 0.0 110.472 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -145.14 74.43 1.4 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 120.792 -1.192 . . . . 0.0 107.912 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.67 165.19 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 O-C-N 120.948 -1.095 . . . . 0.0 108.197 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t 81.39 131.37 0.05 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.64 1.576 . . . . 0.0 112.201 165.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -62.69 -42.51 79.16 Favored Pre-proline 0 C--N 1.349 0.581 0 CA-C-O 116.864 -1.541 . . . . 0.0 113.328 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -69.06 -24.56 32.76 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 CA-C-N 124.158 2.521 . . . . 0.0 112.404 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 -32.94 19.98 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 124.745 1.218 . . . . 0.0 107.96 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.07 73.45 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.44 -32.95 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 121.729 -0.607 . . . . 0.0 110.118 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -36.18 76.87 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -65.44 -37.6 87.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.848 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -64.56 -44.42 90.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.464 -0.772 . . . . 0.0 109.491 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.86 64.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.705 0 CA-C-O 121.767 0.794 . . . . 0.0 110.856 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -162.42 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -68.48 -36.65 79.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.099 -1.001 . . . . 0.0 110.964 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.05 65.31 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.281 -0.887 . . . . 0.0 111.681 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -93.79 15.21 17.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 33.0 p 47.34 54.47 9.5 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 126.066 1.746 . . . . 0.0 113.06 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.554 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.0 OUTLIER -121.12 -82.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 178.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.554 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 77.78 64.61 2.02 Favored Glycine 0 CA--C 1.491 -1.426 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.82 -27.86 64.19 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.231 1.015 . . . . 0.0 109.899 -165.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.66 31.14 0.16 Allowed Glycine 0 CA--C 1.486 -1.779 0 O-C-N 120.728 -1.232 . . . . 0.0 110.776 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -81.71 -76.06 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 118.751 1.275 . . . . 0.0 110.837 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -128.54 159.42 35.56 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.31 149.23 18.29 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' PRO . . . . . 0.443 ' CB ' ' HG3' ' D' ' 66' ' ' GLU . 20.6 Cg_endo -73.94 149.89 42.83 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.361 2.707 . . . . 0.0 111.534 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.495 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 14.7 t -86.38 -93.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 124.116 0.966 . . . . 0.0 111.03 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -140.04 -52.58 0.51 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.734 -1.229 . . . . 0.0 108.468 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.73 -16.77 46.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.674 1.189 . . . . 0.0 109.587 -168.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 1.4 pm0 -73.74 -7.27 51.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.09 88.49 0.4 Allowed Glycine 0 CA--C 1.477 -2.303 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.414 HH22 ' CG ' ' C' ' 59' ' ' ASP . 24.9 ttm180 -60.78 -19.77 60.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.39 -1.653 . . . . 0.0 111.235 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -54.57 -16.62 2.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.685 1.194 . . . . 0.0 113.403 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.01 -39.23 84.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 119.992 -1.692 . . . . 0.0 109.229 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -39.84 70.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.115 -0.991 . . . . 0.0 109.922 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -38.01 79.36 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-O 121.876 0.846 . . . . 0.0 110.53 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -29.93 66.56 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.62 -0.675 . . . . 0.0 111.601 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.67 -46.4 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 121.053 -1.029 . . . . 0.0 108.718 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.23 -39.82 89.83 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 122.003 -0.436 . . . . 0.0 110.124 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.56 -47.19 87.29 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.083 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.29 72.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 122.951 0.5 . . . . 0.0 111.275 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -44.22 89.31 Favored Glycine 0 CA--C 1.496 -1.143 0 O-C-N 121.506 -0.746 . . . . 0.0 111.638 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.56 -46.5 95.46 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 124.357 1.063 . . . . 0.0 108.79 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.43 -46.33 69.78 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.075 1.35 . . . . 0.0 111.24 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.21 -57.35 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 C-N-CA 124.929 1.292 . . . . 0.0 110.522 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -66.78 -35.98 81.34 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.42 -0.8 . . . . 0.0 110.467 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.39 95.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.998 0.919 . . . . 0.0 110.863 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.87 -39.9 95.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.71 -15.82 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.422 1.489 . . . . 0.0 111.137 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -59.24 -13.9 9.2 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.623 1.169 . . . . 0.0 111.544 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.27 -48.44 78.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 119.905 -1.747 . . . . 0.0 112.395 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.51 -35.72 77.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 O-C-N 121.348 -0.845 . . . . 0.0 110.156 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.06 -32.65 63.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.42 0.688 . . . . 0.0 110.055 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.43 75.8 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.077 -1.639 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -14.48 62.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.782 -1.199 . . . . 0.0 113.128 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.21 -32.68 74.47 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 120.576 1.535 . . . . 0.0 111.032 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -77.69 -28.64 51.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.064 -1.023 . . . . 0.0 111.421 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -68.86 -24.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 125.291 1.436 . . . . 0.0 108.347 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -59.48 -12.05 5.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.501 1.52 . . . . 0.0 113.797 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 4' ' ' HIS . 1.1 ptp180 -72.88 -33.13 65.86 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 121.169 -0.957 . . . . 0.0 111.569 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.438 -1.074 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.069 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.56 -68.17 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -42.65 86.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.047 2.539 . . . . 0.0 112.08 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 2.3 pm0 -71.0 -26.24 63.04 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.661 0.785 . . . . 0.0 110.585 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.5 -37.04 77.02 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -71.32 -35.05 71.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.309 0.576 . . . . 0.0 109.863 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.0 95.95 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 121.411 -0.805 . . . . 0.0 111.362 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -71.77 -28.81 63.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 121.385 -0.822 . . . . 0.0 111.535 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -69.92 -37.52 75.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.898 -1.126 . . . . 0.0 109.361 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.73 97.36 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.98 0.912 . . . . 0.0 111.363 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -63.0 -36.68 84.37 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.44 -0.787 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.11 -35.36 69.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.028 -1.045 . . . . 0.0 110.792 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.29 -32.82 74.57 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.26 -42.31 98.41 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.924 -1.11 . . . . 0.0 111.61 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -64.31 -28.31 69.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.677 1.191 . . . . 0.0 111.212 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -69.59 -33.76 73.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.899 1.28 . . . . 0.0 110.452 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -71.62 -29.58 35.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.99 -1.068 . . . . 0.0 108.641 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.21 -29.8 66.74 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.01 -1.056 . . . . 0.0 111.223 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -71.31 -33.6 69.83 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.47 1.508 . . . . 0.0 110.329 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -72.44 -45.47 59.45 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 120.388 -1.445 . . . . 0.0 108.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.02 84.87 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 126.233 1.813 . . . . 0.0 111.483 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -67.6 -38.26 83.72 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 122.655 0.382 . . . . 0.0 110.269 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.959 0.904 . . . . 0.0 109.575 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -67.11 -55.0 16.14 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -41.25 73.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 125.688 1.595 . . . . 0.0 113.015 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.16 -37.1 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 O-C-N 120.735 -1.228 . . . . 0.0 112.582 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.67 -34.2 30.87 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.6 -53.72 37.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.543 1.537 . . . . 0.0 109.219 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.38 12.16 5.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.927 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -71.81 94.87 1.45 Allowed 'General case' 0 C--N 1.351 0.664 0 O-C-N 119.672 -1.892 . . . . 0.0 109.626 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.62 61.86 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 150.13 51.7 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -76.33 145.03 26.66 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 122.836 2.358 . . . . 0.0 108.807 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.25 5.22 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 118.956 0.798 . . . . 0.0 112.575 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 151.79 39.5 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 126.361 1.865 . . . . 0.0 110.039 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.75 6.75 0.54 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.075 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.03 -58.13 3.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.9 pt 34.97 29.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 119.228 3.047 . . . . 0.0 119.228 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -162.98 156.61 19.98 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 119.941 -1.724 . . . . 0.0 106.874 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.88 -44.78 0.61 Allowed Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.671 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.26 -17.6 16.76 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 CA-C-N 125.962 3.165 . . . . 0.0 111.413 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.0 -14.77 24.05 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.478 1.111 . . . . 0.0 109.047 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.43 98.53 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.934 0.873 . . . . 0.0 111.766 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.41 -11.68 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.57 0.7 . . . . 0.0 109.769 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.13 -41.58 15.56 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.08 -27.95 60.13 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.714 -0.617 . . . . 0.0 111.02 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.6 p -66.97 -20.27 65.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.518 -1.364 . . . . 0.0 111.924 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.47 -18.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.291 1.037 . . . . 0.0 109.844 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -73.19 -42.05 63.13 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 120.367 -1.458 . . . . 0.0 108.337 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.3 t -85.32 -167.76 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 78.98 -31.16 0.14 Allowed 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 127.179 2.192 . . . . 0.0 111.115 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 p -66.27 -24.53 66.58 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 129.834 3.254 . . . . 0.0 110.191 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.358 28.7 p 64.29 37.49 8.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 129.696 3.198 . . . . 0.0 109.712 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.85 147.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 167.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.51 130.82 5.82 Favored Glycine 0 CA--C 1.474 -2.529 1 N-CA-C 95.085 -7.206 . . . . 0.0 95.085 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.493 ' CE2' ' HA2' ' B' ' 56' ' ' GLY . 7.2 t80 -87.51 -36.5 17.59 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.38 47.65 0.25 Allowed Glycine 0 CA--C 1.479 -2.186 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 168.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.99 -55.78 6.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.53 1.165 . . . . 0.0 108.448 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -112.81 171.19 7.68 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -140.12 110.88 7.16 Favored Pre-proline 0 N--CA 1.445 -0.715 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.07 175.49 11.09 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.451 2.768 . . . . 0.0 109.835 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 64' ' ' THR . 13.2 p -143.13 176.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -173.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 63' ' ' VAL . 3.3 m -63.48 -36.61 84.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 113.106 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.25 -27.94 61.86 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.77 0.828 . . . . 0.0 110.026 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -66.58 -30.43 70.73 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 123.577 1.656 . . . . 0.0 106.829 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 75.78 1.3 Allowed Glycine 0 CA--C 1.463 -3.174 1 N-CA-C 99.53 -5.428 . . . . 0.0 99.53 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -46.12 -13.77 0.02 OUTLIER 'General case' 0 C--N 1.367 1.342 0 C-N-CA 128.742 2.817 . . . . 0.0 114.22 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 72' ' ' GLU . 13.8 mtpp -54.19 -18.3 3.69 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 126.992 2.117 . . . . 0.0 114.131 162.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.88 -52.9 24.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-N 120.892 1.678 . . . . 0.0 107.442 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.43 80.32 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 118.386 0.539 . . . . 0.0 111.658 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 28.4 tt0 -52.48 -47.15 66.69 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 126.614 1.966 . . . . 0.0 111.449 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -62.68 -41.57 99.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.469 -0.769 . . . . 0.0 109.556 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.2 -36.17 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.09 0.556 . . . . 0.0 110.012 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.3 mtt -58.59 -53.12 61.9 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.296 0.638 . . . . 0.0 109.921 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.94 -40.11 96.64 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 122.931 0.492 . . . . 0.0 110.336 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.54 79.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.684 0.793 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.74 -45.17 59.69 Favored Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 124.75 1.166 . . . . 0.0 111.144 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -57.66 -45.83 86.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.237 1.015 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -57.31 -43.75 83.52 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.599 0.76 . . . . 0.0 110.562 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.92 -52.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 124.429 1.091 . . . . 0.0 109.451 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.15 -39.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 121.903 -0.498 . . . . 0.0 110.632 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.46 94.33 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 110.776 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.05 -33.38 75.3 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 124.771 1.228 . . . . 0.0 111.616 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.5 -18.08 13.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.806 1.242 . . . . 0.0 110.707 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -58.75 -22.99 59.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.05 -1.656 . . . . 0.0 112.134 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.17 -24.09 66.98 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.295 -1.503 . . . . 0.0 111.859 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.79 -43.08 11.51 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.008 0.923 . . . . 0.0 108.561 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.9 -39.58 94.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 122.006 0.907 . . . . 0.0 111.552 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -24.74 63.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.607 0.763 . . . . 0.0 112.294 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.9 t -90.72 -2.81 57.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.5 -41.49 72.57 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 120.534 1.516 . . . . 0.0 108.93 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' B' ' 91' ' ' THR . 7.2 p90 -70.45 -22.2 62.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.732 -1.23 . . . . 0.0 112.978 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.66 -24.98 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.301 1.04 . . . . 0.0 108.783 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -59.0 -19.4 43.15 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 125.626 1.57 . . . . 0.0 113.309 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -72.83 -28.17 62.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.862 -1.149 . . . . 0.0 109.234 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 CA--C 1.502 -0.904 0 O-C-N 120.944 -1.098 . . . . 0.0 108.634 -179.125 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 CA--C 1.497 -1.084 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 88' ' ' ALA . 10.9 p80 -55.45 -23.18 24.0 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -68.52 -28.38 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.278 -0.889 . . . . 0.0 109.246 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.42 -23.31 40.43 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.17 -0.956 . . . . 0.0 110.966 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -83.05 -41.5 18.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.22 76.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 112.024 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -61.75 -49.12 77.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.589 1.155 . . . . 0.0 109.784 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -64.56 -35.86 82.35 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.698 0.799 . . . . 0.0 110.551 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -44.74 94.69 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -63.55 -43.25 97.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.256 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 123.33 0.652 . . . . 0.0 110.062 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . 0.295 4.1 tt0 -77.13 -11.89 59.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.213 -0.929 . . . . 0.0 112.127 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -70.22 -35.04 73.6 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -60.35 -35.66 76.18 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.845 0.858 . . . . 0.0 110.736 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.7 -39.88 95.41 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.726 1.21 . . . . 0.0 109.923 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.05 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 O-C-N 121.379 -0.826 . . . . 0.0 109.526 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.56 -40.19 96.04 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.903 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.47 -44.29 78.94 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.117 -0.989 . . . . 0.0 109.532 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.87 -39.15 90.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.758 1.223 . . . . 0.0 110.477 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.27 77.22 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 126.025 1.73 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -66.43 -44.1 83.81 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.3 1.04 . . . . 0.0 110.197 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -65.44 -53.72 38.83 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.49 1.116 . . . . 0.0 108.68 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -57.39 -48.6 78.65 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.699 1.199 . . . . 0.0 110.698 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 -41.86 65.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 125.057 1.343 . . . . 0.0 111.666 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.22 -47.08 82.6 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.797 -1.189 . . . . 0.0 107.949 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.34 -1.89 38.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.06 -1.025 . . . . 0.0 110.918 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.505 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -69.91 -47.76 61.23 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 109.594 176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -80.06 -110.93 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 71.18 -33.34 0.27 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.754 2.022 . . . . 0.0 113.515 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.15 41.05 0.38 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.07 153.86 39.03 Favored Pre-proline 0 C--N 1.35 0.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.75 123.21 3.21 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 C-N-CA 123.265 2.643 . . . . 0.0 111.43 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 23.0 53.05 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.94 33.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 126.851 2.061 . . . . 0.0 111.157 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -37.63 0.22 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.873 0.469 . . . . 0.0 110.528 -172.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.98 60.32 4.76 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-O 124.011 1.862 . . . . 0.0 107.865 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.72 -14.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 O-C-N 120.051 -1.656 . . . . 0.0 112.255 -168.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -99.2 132.41 44.53 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.061 -1.649 . . . . 0.0 112.399 -167.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.36 -54.41 11.4 Favored Pre-proline 0 C--N 1.351 0.644 0 CA-C-O 116.619 -1.658 . . . . 0.0 109.606 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.89 -13.07 24.14 Favored 'Trans proline' 0 CA--C 1.508 -0.815 0 CA-C-N 125.552 3.018 . . . . 0.0 111.297 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.51 -10.83 26.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.62 95.07 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.97 -28.72 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 123.989 0.916 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -37.87 62.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.117 0.967 . . . . 0.0 108.793 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -66.69 -43.17 85.11 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.779 0.831 . . . . 0.0 109.475 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 42.0 m -53.53 -30.4 41.47 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.988 1.315 . . . . 0.0 113.572 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.34 -34.87 51.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.435 1.094 . . . . 0.0 110.715 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -77.81 -36.46 50.25 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.842 -1.161 . . . . 0.0 113.174 -171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -77.26 -37.32 53.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -166.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.11 -26.8 64.14 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.522 -0.736 . . . . 0.0 112.071 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -89.23 7.43 35.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p 55.08 64.07 1.91 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.62 1.568 . . . . 0.0 111.778 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.71 -106.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 57' ' ' TYR . . . 98.4 76.55 1.28 Allowed Glycine 0 CA--C 1.484 -1.866 0 N-CA-C 104.634 -3.387 . . . . 0.0 104.634 -174.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -35.78 58.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.65 -0.912 . . . . 0.0 108.911 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 39.45 0.73 Allowed Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.42 ' HB2' HH12 ' C' ' 68' ' ' ARG . 6.5 t70 -77.72 -51.23 10.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 118.554 1.177 . . . . 0.0 108.69 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.32 160.16 38.78 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -130.79 114.45 16.62 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.62 173.08 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.582 2.854 . . . . 0.0 109.349 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.25 -112.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.021 0.929 . . . . 0.0 110.735 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.0 m -136.33 -41.16 0.64 Allowed 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.658 -1.276 . . . . 0.0 108.627 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -81.72 -2.67 51.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.202 -0.936 . . . . 0.0 109.277 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -79.08 -29.52 43.42 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.33 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.01 69.66 1.26 Allowed Glycine 0 CA--C 1.47 -2.77 0 N-CA-C 103.795 -3.722 . . . . 0.0 103.795 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -36.03 -18.49 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.444 3.498 . . . . 0.0 116.869 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -53.12 -17.57 1.66 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 119.988 -1.695 . . . . 0.0 113.132 158.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.13 -46.29 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 119.56 -1.962 . . . . 0.0 108.756 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.61 -48.73 63.37 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.59 -47.05 77.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.38 1.072 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -69.85 -37.82 76.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.307 -0.871 . . . . 0.0 112.356 -173.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.35 -43.73 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ttp -62.14 -51.03 69.5 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.298 1.039 . . . . 0.0 110.537 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.31 -30.96 70.95 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.631 0.772 . . . . 0.0 110.044 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.5 73.88 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.331 -0.856 . . . . 0.0 111.12 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.19 85.95 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 mt -60.61 -45.29 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 C-N-CA 124.307 1.043 . . . . 0.0 109.562 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -29.27 70.35 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.111 -0.993 . . . . 0.0 112.078 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.08 -54.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -62.52 -42.19 99.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.728 0.811 . . . . 0.0 110.69 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.11 79.25 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.079 1.352 . . . . 0.0 111.158 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tt -66.77 -34.18 77.27 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.109 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.07 -10.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 124.451 1.101 . . . . 0.0 110.236 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 8.4 m -60.7 -22.98 64.51 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 119.303 -2.123 . . . . 0.0 111.49 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.65 69.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.327 -1.483 . . . . 0.0 111.811 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.469 ' HA ' ' CG ' ' B' ' 4' ' ' HIS . . . -80.27 -45.63 17.6 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.12 -37.8 88.65 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 124.5 1.12 . . . . 0.0 111.795 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.61 65.75 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.598 -0.688 . . . . 0.0 112.202 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -91.5 -6.58 52.35 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.603 -1.311 . . . . 0.0 109.291 176.024 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.299 0.2 OUTLIER -79.12 -12.38 60.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 120.402 1.455 . . . . 0.0 110.616 -167.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.44 -31.75 54.08 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 168.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.53 -22.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.895 1.278 . . . . 0.0 108.672 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -55.62 -24.79 35.4 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.951 1.7 . . . . 0.0 112.18 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -64.19 -22.02 66.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 120.828 -1.17 . . . . 0.0 110.894 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.5 -0.96 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 -178.891 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.505 -0.774 0 CA-C-O 122.452 1.12 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.553 ' HE1' ' OD1' ' C' ' 92' ' ' ASP . 0.6 OUTLIER -176.09 -37.97 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.89 2.076 . . . . 0.0 105.486 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.17 -35.82 74.24 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.131 0.967 . . . . 0.0 110.325 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -58.27 -36.04 72.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.473 1.909 . . . . 0.0 111.389 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.94 -42.42 39.35 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.196 1.398 . . . . 0.0 108.513 -176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.44 85.62 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.302 1.041 . . . . 0.0 110.889 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.27 -37.53 87.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.391 1.476 . . . . 0.0 110.697 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -67.57 -36.03 80.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.009 0.924 . . . . 0.0 109.154 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.92 97.39 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.998 0.919 . . . . 0.0 111.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.66 -27.84 68.66 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 121.235 -0.915 . . . . 0.0 112.435 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.31 -35.73 81.89 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.671 -1.268 . . . . 0.0 109.542 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.74 -44.51 93.76 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.48 -44.05 92.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.034 0.534 . . . . 0.0 110.88 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.35 -40.13 74.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.769 0.827 . . . . 0.0 112.339 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -73.69 -28.53 61.79 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 120.872 -1.142 . . . . 0.0 111.044 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.05 -37.26 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.01 -49.09 69.65 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.085 0.954 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.71 -45.96 91.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.852 0.751 . . . . 0.0 111.672 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -42.71 82.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.715 -0.615 . . . . 0.0 109.99 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.43 84.3 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.963 1.305 . . . . 0.0 111.651 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -62.86 -50.27 71.6 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.977 1.311 . . . . 0.0 109.593 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -67.2 -40.37 86.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -62.0 -48.88 78.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.384 1.074 . . . . 0.0 110.724 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.34 72.66 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 111.824 -173.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.79 -42.39 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 O-C-N 122.204 -0.31 . . . . 0.0 110.396 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.17 -23.63 60.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 120.365 -1.459 . . . . 0.0 112.148 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.55 69.7 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.361 1.464 . . . . 0.0 107.983 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.92 -28.21 63.33 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.739 0.78 . . . . 0.0 111.001 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.34 95.87 1.07 Allowed 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.618 -1.301 . . . . 0.0 110.378 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.0 -11.56 6.54 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.76 142.83 26.12 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 118.272 1.036 . . . . 0.0 109.061 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.54 129.72 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.407 2.071 . . . . 0.0 112.064 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.88 45.01 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 141.69 31.25 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.494 2.318 . . . . 0.0 112.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.89 -45.21 2.59 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.78 65.88 5.92 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 123.018 1.39 . . . . 0.0 109.449 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -96.79 -10.87 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 O-C-N 119.851 -1.781 . . . . 0.0 111.447 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.3 m -98.71 127.23 44.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.514 -0.741 . . . . 0.0 109.668 -169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.84 -52.19 65.87 Favored Pre-proline 0 N--CA 1.445 -0.712 0 C-N-CA 126.148 1.779 . . . . 0.0 112.187 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.75 -8.41 20.31 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 CA-C-N 125.086 2.852 . . . . 0.0 111.624 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.79 -25.97 20.82 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.55 76.16 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.624 0.77 . . . . 0.0 111.348 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.2 -25.23 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 124.609 1.163 . . . . 0.0 110.411 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -79.57 -44.68 20.62 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 119.737 -1.852 . . . . 0.0 107.164 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.03 -37.5 87.43 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.176 0.991 . . . . 0.0 110.547 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -67.59 -35.34 78.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.025 -1.672 . . . . 0.0 111.519 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.26 -51.99 66.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.293 1.037 . . . . 0.0 109.554 -178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.75 -30.81 65.99 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.487 -0.758 . . . . 0.0 110.727 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 80.5 m -62.82 -36.35 82.89 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.955 -1.09 . . . . 0.0 110.783 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -16.05 63.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 120.632 -1.292 . . . . 0.0 113.036 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -89.34 -3.99 58.26 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.458 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.314 11.3 p 68.41 2.09 3.19 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 127.343 2.257 . . . . 0.0 112.66 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.81 -53.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.38 1.472 . . . . 0.0 107.418 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.34 -62.02 4.68 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 74.4 -44.95 0.57 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.798 2.839 . . . . 0.0 109.914 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.57 40.0 0.55 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 107.157 -2.377 . . . . 0.0 107.157 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.55 -55.73 9.33 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.503 1.151 . . . . 0.0 108.275 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -149.25 168.34 23.56 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -134.88 126.71 17.98 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -165.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.52 172.19 13.78 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 123.368 2.712 . . . . 0.0 109.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -93.37 -106.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.306 1.042 . . . . 0.0 113.641 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 18.7 m -155.86 -38.44 0.08 Allowed 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 119.013 -2.304 . . . . 0.0 106.411 -171.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -91.52 10.26 28.59 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 120.851 -1.156 . . . . 0.0 109.084 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -42.16 67.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.56 91.38 1.91 Allowed Glycine 0 N--CA 1.418 -2.537 1 N-CA-C 96.662 -6.575 . . . . 0.0 96.662 -170.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.42 HH12 ' HB2' ' B' ' 59' ' ' ASP . 24.9 ttm180 -65.87 -11.52 47.4 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.04 1.92 . . . . 0.0 110.388 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -46.14 -23.87 0.38 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.456 1.902 . . . . 0.0 113.971 159.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.84 -41.61 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 119.99 -1.694 . . . . 0.0 109.385 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.98 61.76 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -49.8 -49.19 49.6 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 126.236 1.814 . . . . 0.0 111.55 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -44.51 90.05 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.188 0.995 . . . . 0.0 111.813 -173.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.28 -37.92 60.17 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.415 -0.803 . . . . 0.0 109.252 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 73.7 mtm -66.36 -44.77 82.25 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 123.359 0.664 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -59.01 -43.1 91.49 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 123.846 0.858 . . . . 0.0 110.631 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.13 96.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.022 0.529 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.85 91.89 Favored Glycine 0 CA--C 1.493 -1.333 0 C-N-CA 123.905 0.764 . . . . 0.0 111.546 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.25 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 109.017 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.25 -37.97 86.76 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.634 -0.666 . . . . 0.0 111.674 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.57 -53.56 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 119.298 0.953 . . . . 0.0 110.054 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.07 -34.23 76.04 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 122.857 0.463 . . . . 0.0 110.71 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.12 65.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.915 -1.115 . . . . 0.0 110.489 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.03 -32.1 73.38 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 120.647 -1.283 . . . . 0.0 111.481 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.93 -1.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 120.99 -1.069 . . . . 0.0 112.271 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -58.65 -18.06 27.51 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 111.181 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.0 68.44 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.563 -1.336 . . . . 0.0 112.123 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.87 -44.62 16.61 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.317 -0.864 . . . . 0.0 108.857 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.4 -40.62 95.07 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.331 1.053 . . . . 0.0 111.633 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.25 99.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.471 0.708 . . . . 0.0 111.312 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -17.78 64.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 120.924 -1.11 . . . . 0.0 113.303 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.553 ' OD1' ' HE1' ' C' ' 4' ' ' HIS . 1.3 m-20 -74.7 -20.07 60.0 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 119.907 1.231 . . . . 0.0 111.028 -167.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -82.41 -31.83 29.39 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.035 -1.04 . . . . 0.0 110.519 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.04 -19.96 26.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.371 1.468 . . . . 0.0 109.382 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -65.17 -15.51 62.51 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 120.319 -1.488 . . . . 0.0 111.543 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -72.36 -14.01 61.62 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.129 -1.607 . . . . 0.0 111.48 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--N 1.355 0.819 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -170.368 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . 0.308 3.3 m-20 67.9 -35.08 0.26 Allowed 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 131.358 3.863 . . . . 0.0 111.807 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -68.57 -22.54 64.47 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.856 -1.153 . . . . 0.0 112.528 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.89 -45.77 92.3 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 122.191 0.996 . . . . 0.0 108.845 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -67.1 -38.53 85.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 124.409 1.084 . . . . 0.0 110.142 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.14 -35.39 69.07 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.956 -0.465 . . . . 0.0 109.893 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.68 86.69 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 121.693 -0.63 . . . . 0.0 110.104 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -60.97 -39.71 90.61 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.625 1.57 . . . . 0.0 111.473 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.09 -30.31 62.29 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.358 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.76 79.2 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.822 -1.174 . . . . 0.0 110.982 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.02 -35.92 82.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.596 -0.69 . . . . 0.0 111.966 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.76 -42.82 81.16 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.766 1.226 . . . . 0.0 108.334 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -55.83 -45.13 78.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 125.576 1.55 . . . . 0.0 109.839 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.78 -36.83 79.96 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.542 -0.724 . . . . 0.0 112.348 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -65.01 -34.91 79.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.65 0.78 . . . . 0.0 109.988 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -75.59 -29.3 59.23 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 120.839 -1.163 . . . . 0.0 110.513 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.05 -47.82 52.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.27 -31.84 73.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.512 -0.742 . . . . 0.0 110.445 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -67.39 -43.51 81.15 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.797 -1.189 . . . . 0.0 111.064 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.48 -39.93 95.75 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.82 -1.175 . . . . 0.0 110.456 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.26 -25.6 68.13 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.31 -0.868 . . . . 0.0 112.343 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -66.09 -42.59 89.14 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.389 1.076 . . . . 0.0 111.021 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -66.54 -34.83 78.78 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.471 1.109 . . . . 0.0 108.461 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -74.41 -50.49 18.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 118.273 -0.87 . . . . 0.0 108.722 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.11 -41.8 75.81 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 126.83 2.052 . . . . 0.0 113.166 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.82 -31.12 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 O-C-N 120.722 -1.236 . . . . 0.0 110.896 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 -34.11 22.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.69 47.2 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 0.0 109.373 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.37 -36.5 71.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 120.997 0.427 . . . . 0.0 111.191 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.02 106.53 1.63 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 120.024 -1.673 . . . . 0.0 111.568 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.41 -25.13 4.32 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.94 153.81 75.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 123.657 0.783 . . . . 0.0 110.979 -170.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -80.43 135.78 10.78 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.312 2.008 . . . . 0.0 109.988 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.64 14.07 74.14 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.0 135.0 56.28 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.01 1.724 . . . . 0.0 111.725 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.82 -31.08 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.984 1.314 . . . . 0.0 109.047 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' D' ' 60' ' ' ARG . 4.6 tt -86.72 121.97 29.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.246 1.418 . . . . 0.0 109.103 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 pt -148.88 175.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 73.3 m 67.13 122.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.212 2.205 . . . . 0.0 113.662 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.9 -50.5 87.65 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 116.815 -1.564 . . . . 0.0 113.189 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.61 -11.93 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 124.459 2.628 . . . . 0.0 111.525 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.56 -37.85 14.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.6 83.59 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.939 1.696 . . . . 0.0 112.207 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -64.8 -31.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.47 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.69 -18.25 41.58 Favored 'General case' 0 N--CA 1.437 -1.108 0 O-C-N 120.674 -1.266 . . . . 0.0 110.878 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -72.01 -43.47 65.0 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -66.03 -26.11 67.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 121.33 -0.856 . . . . 0.0 113.202 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.4 -36.18 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 C-N-CA 124.403 1.081 . . . . 0.0 111.351 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.61 -5.9 57.87 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.649 -1.282 . . . . 0.0 110.133 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.43 HG22 ' H ' ' D' ' 52' ' ' ALA . 23.7 m -96.95 177.72 5.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 174.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.43 ' H ' HG22 ' D' ' 51' ' ' THR . . . 80.96 -41.12 0.16 Allowed 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.328 1.451 . . . . 0.0 110.208 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.6 p -85.33 3.54 39.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.982 1.713 . . . . 0.0 111.939 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p 59.24 53.68 5.23 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 126.095 1.758 . . . . 0.0 112.314 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.28 -99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.13 106.22 0.5 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 106.78 -2.528 . . . . 0.0 106.78 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -86.88 -15.64 38.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.747 -1.443 . . . . 0.0 109.233 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.84 28.6 5.27 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -65.57 -56.21 13.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' D' ' 38' ' ' LEU . 88.5 mtt-85 -137.2 156.97 47.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -128.49 149.92 73.04 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 101.206 -3.628 . . . . 0.0 101.206 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.26 152.06 3.72 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 123.313 2.676 . . . . 0.0 110.057 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.486 HG22 ' H ' ' D' ' 64' ' ' THR . 3.1 p -109.32 -179.59 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 122.328 1.061 . . . . 0.0 109.09 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.486 ' H ' HG22 ' D' ' 63' ' ' VAL . 4.9 m -62.63 -49.13 76.39 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.18 2.192 . . . . 0.0 113.913 -167.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -83.64 -0.0 48.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.744 1.218 . . . . 0.0 110.019 -167.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -28.19 67.41 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 123.745 1.736 . . . . 0.0 106.674 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 75.17 1.27 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 99.973 -5.251 . . . . 0.0 99.973 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.26 8.4 mtm180 -55.18 -2.35 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 126.104 1.762 . . . . 0.0 114.92 -169.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HG3' ' D' ' 72' ' ' GLU . 94.1 mttt -67.82 -0.77 4.5 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.828 1.251 . . . . 0.0 112.984 160.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.23 -59.82 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.81 -56.24 17.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 114.647 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' D' ' 69' ' ' LYS 0.302 1.5 pp20? -68.38 -26.63 65.67 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.313 -0.867 . . . . 0.0 111.551 -172.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -67.54 -31.08 70.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.613 -0.679 . . . . 0.0 110.777 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.15 -45.27 86.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.1 mtp -64.99 -46.54 81.0 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.662 0.785 . . . . 0.0 110.056 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -63.76 -37.89 89.06 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.222 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.57 91.62 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.396 0.617 . . . . 0.0 110.939 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.59 -41.52 89.69 Favored Glycine 0 CA--C 1.489 -1.588 0 O-C-N 121.615 -0.678 . . . . 0.0 112.469 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.47 -47.35 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.919 0.888 . . . . 0.0 109.709 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.27 -26.14 61.87 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.101 -0.999 . . . . 0.0 111.934 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 t -64.64 -50.91 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.82 -2.87 32.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.527 -0.733 . . . . 0.0 111.397 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -30.94 13.01 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.067 0.947 . . . . 0.0 109.491 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.84 -33.97 75.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.617 -1.302 . . . . 0.0 109.83 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -62.69 -12.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.183 0.993 . . . . 0.0 111.899 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 21.3 m -68.26 -14.87 63.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 120.337 -1.477 . . . . 0.0 111.73 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -16.39 64.19 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 120.007 -1.683 . . . . 0.0 111.31 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.82 -49.33 7.18 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 62.9 mt -60.39 -35.54 75.98 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.652 1.181 . . . . 0.0 112.085 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 120.924 -1.11 . . . . 0.0 112.435 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -4.45 55.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 120.777 -1.202 . . . . 0.0 108.415 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.9 -32.17 67.14 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 119.382 0.992 . . . . 0.0 109.454 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -75.84 -28.59 58.29 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.379 -1.45 . . . . 0.0 111.079 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 t -70.55 -17.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 108.74 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -59.1 -22.21 60.47 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 125.656 1.582 . . . . 0.0 111.606 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -60.66 -33.0 72.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 123.013 1.387 . . . . 0.0 110.242 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 103.25 -2.871 . . . . 0.0 103.25 -161.129 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.826 0 CA-C-O 121.822 0.82 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -157.03 -74.17 0.09 Allowed 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 23.4 p-80 -58.4 -35.59 72.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 129.456 3.102 . . . . 0.0 112.313 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.477 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 7.7 mt-10 -68.21 -32.66 73.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.113 0.965 . . . . 0.0 111.498 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -65.61 -40.0 92.15 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.72 -31.89 68.9 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.74 0.816 . . . . 0.0 109.636 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.58 -43.05 70.21 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.544 0.738 . . . . 0.0 109.981 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -68.27 -35.98 78.7 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.914 -0.491 . . . . 0.0 110.305 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.71 -40.12 78.8 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.689 1.196 . . . . 0.0 110.889 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.45 94.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.729 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -64.67 -28.0 69.31 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.427 -0.796 . . . . 0.0 111.608 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.72 -35.94 72.97 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.789 -1.194 . . . . 0.0 110.246 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -68.15 -38.48 82.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.28 -38.71 84.43 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.309 -0.869 . . . . 0.0 111.747 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -71.18 -27.05 63.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 121.403 -0.811 . . . . 0.0 111.458 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -72.17 -39.14 68.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.443 -0.786 . . . . 0.0 109.488 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.2 -34.57 64.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.568 1.147 . . . . 0.0 109.792 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.95 -48.04 82.93 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.926 -1.109 . . . . 0.0 111.342 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.49 -42.51 87.33 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.808 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.28 -49.18 78.64 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 110.072 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.69 88.24 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 125.732 1.613 . . . . 0.0 111.243 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -43.47 98.81 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.588 0.755 . . . . 0.0 111.103 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -66.08 -40.73 91.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 124.398 1.079 . . . . 0.0 108.916 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -76.27 -44.66 36.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.699 -0.626 . . . . 0.0 111.18 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.6 95.54 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.665 1.586 . . . . 0.0 111.09 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.82 -38.05 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 122.189 -0.319 . . . . 0.0 110.212 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.283 89.0 mt-10 -67.98 -40.03 83.19 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.022 -1.049 . . . . 0.0 109.352 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.02 -47.3 85.38 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.76 1.624 . . . . 0.0 109.613 -171.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.15 -8.62 59.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 121.666 -0.646 . . . . 0.0 111.929 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HD2' HG23 ' A' ' 39' ' ' ILE . 34.9 tpt85 -76.17 80.95 2.98 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.081 -1.637 . . . . 0.0 110.141 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.65 -13.74 5.84 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.89 150.08 97.71 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 118.124 0.962 . . . . 0.0 109.903 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' O ' HG11 ' A' ' 63' ' ' VAL . 37.3 Cg_endo -75.55 147.76 32.35 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 121.984 1.79 . . . . 0.0 108.525 -177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 4.21 64.86 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 120.192 1.36 . . . . 0.0 113.957 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 159.44 27.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.755 0.822 . . . . 0.0 111.736 -171.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.96 -32.32 0.8 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.137 0.975 . . . . 0.0 109.78 -171.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.12 40.73 0.72 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 123.828 1.775 . . . . 0.0 109.392 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG23 ' HD2' ' A' ' 31' ' ' ARG . 7.9 mt -86.66 72.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 O-C-N 119.158 -2.214 . . . . 0.0 105.388 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -158.06 -120.37 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 116.553 -1.689 . . . . 0.0 107.041 -168.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.6 t80 178.23 -64.28 0.0 OUTLIER Pre-proline 0 C--N 1.359 1.0 0 CA-C-N 121.052 1.751 . . . . 0.0 110.355 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -75.14 -8.46 19.92 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 CA-C-N 125.515 3.005 . . . . 0.0 111.887 -167.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -10.18 28.33 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 129.662 3.185 . . . . 0.0 107.136 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -48.7 51.31 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.13 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.3 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -17.51 60.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.498 -1.376 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -86.29 -39.21 16.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.23 -38.3 76.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.745 -1.222 . . . . 0.0 111.726 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.57 -25.85 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.695 1.198 . . . . 0.0 110.824 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.99 -23.03 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.976 -1.078 . . . . 0.0 110.809 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -107.47 -22.85 12.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 -165.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.2 64.17 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.372 -1.455 . . . . 0.0 111.999 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.95 2.35 51.86 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.919 1.288 . . . . 0.0 110.578 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.252 9.6 p 56.67 63.09 2.05 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.34 1.856 . . . . 0.0 111.261 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 56' ' ' GLY . 2.6 t -145.79 -164.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -177.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 156.67 101.72 0.19 Allowed Glycine 0 CA--C 1.475 -2.459 1 N-CA-C 100.191 -5.164 . . . . 0.0 100.191 -177.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.89 -26.87 29.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.3 33.57 1.6 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' CG ' HH22 ' B' ' 68' ' ' ARG . 30.8 t70 -83.67 -26.46 29.84 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.434 -1.039 . . . . 0.0 109.418 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -179.58 4.69 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -158.7 114.99 1.67 Allowed Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.71 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.697 2.932 . . . . 0.0 109.417 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 34' ' ' PRO . 3.5 t -106.36 -120.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.909 0.883 . . . . 0.0 110.372 -173.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -141.67 -36.28 0.43 Allowed 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -89.41 9.97 24.31 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 120.881 -1.137 . . . . 0.0 108.187 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -43.92 63.21 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.44 90.92 2.03 Favored Glycine 0 N--CA 1.417 -2.594 1 N-CA-C 96.397 -6.681 . . . . 0.0 96.397 -172.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.407 HH12 ' HB2' ' D' ' 59' ' ' ASP . 22.6 ttm180 -64.36 -12.03 38.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 119.364 1.582 . . . . 0.0 111.081 -172.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -46.95 -28.97 1.8 Allowed 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.002 0.921 . . . . 0.0 113.215 162.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.8 t -66.92 -39.4 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 0.0 110.133 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.48 -50.46 18.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 120.951 -1.093 . . . . 0.0 108.42 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -50.81 -44.5 59.05 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.612 1.565 . . . . 0.0 111.998 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -65.64 -36.02 82.48 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.416 0.686 . . . . 0.0 110.148 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.38 -42.59 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.9 mtt -59.79 -50.89 72.03 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.243 1.017 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -64.55 -38.27 90.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.149 0.98 . . . . 0.0 110.83 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.08 96.55 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.188 0.595 . . . . 0.0 110.518 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.69 -48.72 79.21 Favored Glycine 0 CA--C 1.49 -1.522 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.36 -47.48 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.387 1.075 . . . . 0.0 109.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.72 -39.92 95.48 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 120.929 -1.107 . . . . 0.0 111.397 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 t -64.22 -52.89 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.738 0.815 . . . . 0.0 109.851 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.26 -41.22 94.45 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 110.499 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.13 -30.9 71.48 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 123.565 0.746 . . . . 0.0 111.019 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.57 -30.38 69.99 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.059 -1.026 . . . . 0.0 110.852 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.3 t -59.87 -18.44 15.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 124.375 1.07 . . . . 0.0 110.582 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 m -56.42 -27.71 57.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.248 1.419 . . . . 0.0 112.739 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.04 -28.28 64.36 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.485 1.114 . . . . 0.0 111.376 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 4' ' ' HIS . . . -89.05 -45.92 9.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.088 0.955 . . . . 0.0 109.495 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.7 mt -49.62 -46.71 49.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.476 1.91 . . . . 0.0 113.434 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.82 42.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.756 -1.215 . . . . 0.0 111.222 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.8 p -64.11 -6.14 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.381 1.072 . . . . 0.0 113.259 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.36 -74.79 0.14 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.31 0.93 57.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.439 -1.413 . . . . 0.0 112.347 -168.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.68 -29.52 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 O-C-N 119.761 -1.837 . . . . 0.0 108.761 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -59.5 -18.08 37.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.001 1.32 . . . . 0.0 113.2 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -52.22 -35.46 49.47 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.28 1.432 . . . . 0.0 111.593 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -175.437 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 CA--C 1.506 -0.736 0 CA-C-O 123.15 1.453 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' B' ' 91' ' ' THR . 24.7 p80 -72.02 -28.92 63.69 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.159 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.62 -43.05 23.61 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.32 -37.47 87.4 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.962 -0.461 . . . . 0.0 110.32 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.35 -34.83 65.83 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.979 0.418 . . . . 0.0 110.036 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.28 78.59 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 123.674 0.79 . . . . 0.0 110.287 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -77.97 -11.98 59.95 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.633 -0.667 . . . . 0.0 111.452 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -77.77 -29.34 50.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 121.394 -0.816 . . . . 0.0 109.349 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.62 87.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.41 -23.48 63.71 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.693 0.797 . . . . 0.0 111.905 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -72.28 -44.66 62.44 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.931 -1.106 . . . . 0.0 108.161 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.81 -33.75 76.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.693 1.197 . . . . 0.0 109.818 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.02 -45.58 82.99 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 111.913 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.13 -38.89 90.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.286 1.034 . . . . 0.0 109.916 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -63.48 -41.21 98.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.011 0.924 . . . . 0.0 111.382 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.52 -48.41 47.2 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 124.175 0.99 . . . . 0.0 110.372 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.71 -35.22 80.36 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -65.51 -39.03 91.36 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.795 -1.191 . . . . 0.0 110.929 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.79 -37.62 86.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.437 -1.415 . . . . 0.0 109.217 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.62 66.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 123.387 0.675 . . . . 0.0 111.841 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.5 p -66.93 -39.01 87.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 118.767 0.712 . . . . 0.0 110.694 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.34 -46.03 81.88 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.45 -43.14 99.53 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.621 1.169 . . . . 0.0 108.936 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.99 84.64 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.147 1.379 . . . . 0.0 113.279 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.88 -47.78 91.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-O 121.88 0.847 . . . . 0.0 109.502 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -79.96 -20.79 44.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 O-C-N 121.663 -0.648 . . . . 0.0 110.673 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -51.43 22.74 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 125.9 1.68 . . . . 0.0 109.664 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 -18.37 55.35 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.834 -0.542 . . . . 0.0 111.869 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.51 87.67 1.2 Allowed 'General case' 0 C--N 1.353 0.754 0 O-C-N 119.973 -1.704 . . . . 0.0 110.107 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.31 -11.46 3.27 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' B' ' 36' ' ' ALA . . . -88.4 143.77 32.92 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 118.398 1.099 . . . . 0.0 111.69 -170.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.18 125.19 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.359 2.706 . . . . 0.0 111.636 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 23.28 68.0 Favored Glycine 0 CA--C 1.495 -1.206 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' B' ' 33' ' ' ALA . . . -78.19 167.11 21.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.157 1.383 . . . . 0.0 109.524 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.58 -39.51 1.28 Allowed 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.222 0.609 . . . . 0.0 109.615 -166.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -94.78 130.57 41.28 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.6 pt -140.56 6.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 O-C-N 120.81 -1.182 . . . . 0.0 111.124 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.9 138.51 26.99 Favored 'General case' 0 CA--C 1.499 -0.99 0 O-C-N 119.944 -1.723 . . . . 0.0 109.502 -161.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -52.98 65.83 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 126.234 1.813 . . . . 0.0 113.347 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.19 -15.28 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 123.732 2.369 . . . . 0.0 111.827 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.86 -40.39 14.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.16 86.19 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 124.891 1.277 . . . . 0.0 111.886 -170.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.42 -38.73 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 122.749 0.419 . . . . 0.0 110.338 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -38.5 72.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.658 -0.651 . . . . 0.0 110.172 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.49 -43.0 99.88 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-O 122.157 0.979 . . . . 0.0 109.796 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 55.9 m -63.58 -30.61 71.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.517 -1.364 . . . . 0.0 113.006 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.36 -53.8 43.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 123.687 0.795 . . . . 0.0 109.622 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.91 -18.18 60.45 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 121.35 -0.844 . . . . 0.0 111.89 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -69.49 -36.81 76.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.454 0.702 . . . . 0.0 109.19 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.49 71.3 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.147 0.979 . . . . 0.0 111.664 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -82.97 3.4 30.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.358 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p 55.49 53.17 10.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.889 1.676 . . . . 0.0 112.574 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.71 -69.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.91 80.19 0.25 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -62.61 -43.29 99.19 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.463 1.125 . . . . 0.0 108.499 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.48 -120.67 0.99 Allowed Glycine 0 CA--C 1.48 -2.127 1 N-CA-C 102.043 -4.423 . . . . 0.0 102.043 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.341 0.2 OUTLIER 66.08 -64.05 0.22 Allowed 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 127.241 2.216 . . . . 0.0 114.594 -177.051 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -132.88 166.71 21.69 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -160.19 135.97 6.05 Favored Pre-proline 0 N--CA 1.436 -1.145 0 CA-C-O 117.391 -1.29 . . . . 0.0 107.536 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.45 151.04 15.23 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.967 2.445 . . . . 0.0 110.801 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' B' ' 66' ' ' GLU . 2.8 t -92.77 -119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 124.524 1.13 . . . . 0.0 109.145 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 13.4 p -113.93 -43.93 3.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.285 -1.51 . . . . 0.0 111.813 -166.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -83.03 -23.63 33.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.745 1.618 . . . . 0.0 108.041 -163.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' B' ' 63' ' ' VAL . 1.2 pm0 -68.23 -14.62 63.12 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.592 1.957 . . . . 0.0 110.169 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.65 87.85 0.39 Allowed Glycine 0 CA--C 1.481 -2.087 1 N-CA-C 103.055 -4.018 . . . . 0.0 103.055 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.502 HH22 ' CG ' ' A' ' 59' ' ' ASP . 36.9 ttm180 -58.27 -21.21 47.73 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.59 -1.535 . . . . 0.0 111.872 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -55.86 -15.75 3.71 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.43 -43.73 97.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 O-C-N 120.722 -1.236 . . . . 0.0 108.729 172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.04 -43.68 67.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.403 0.681 . . . . 0.0 109.601 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.13 -39.85 69.89 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.819 1.648 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -64.52 -40.52 95.78 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.035 1.334 . . . . 0.0 110.703 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.93 -43.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.8 mtt -57.84 -49.92 75.05 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.096 0.958 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.17 90.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.668 -0.645 . . . . 0.0 111.157 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.5 98.78 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.877 1.227 . . . . 0.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.59 -43.38 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 121.641 -0.917 . . . . 0.0 108.927 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.24 -31.95 70.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.914 -1.116 . . . . 0.0 113.262 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.96 -41.06 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 120.058 1.299 . . . . 0.0 110.607 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.14 -38.58 75.53 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.617 0.644 . . . . 0.0 109.428 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.83 69.86 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.103 -0.998 . . . . 0.0 111.363 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.01 -15.46 63.48 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.546 -1.347 . . . . 0.0 111.207 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -5.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.5 -1.375 . . . . 0.0 110.157 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 14.8 t -49.58 -26.01 3.21 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 119.602 -1.936 . . . . 0.0 113.048 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.63 -36.49 71.9 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.975 1.31 . . . . 0.0 110.893 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.45 23.97 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.305 1.042 . . . . 0.0 108.46 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.44 -42.15 96.16 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 120.788 -1.195 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.84 -1.61 23.04 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.897 -1.127 . . . . 0.0 111.731 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.412 HG21 ' CD2' ' B' ' 4' ' ' HIS . 44.4 p -85.72 -42.1 14.54 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.92 -25.23 52.68 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.789 0.804 . . . . 0.0 110.666 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.96 -50.04 37.54 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 126.736 2.015 . . . . 0.0 111.693 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.61 -30.4 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.749 1.22 . . . . 0.0 109.418 -171.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -58.67 -12.28 4.02 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.371 1.068 . . . . 0.0 112.964 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -54.98 -33.92 62.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.394 -0.816 . . . . 0.0 111.126 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -175.046 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.507 -0.68 0 CA-C-O 121.759 0.79 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -79.85 -19.96 47.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.1 0.96 . . . . 0.0 112.165 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -30.76 62.85 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -61.63 -39.8 92.59 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.078 0.951 . . . . 0.0 110.827 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -32.17 73.49 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.346 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' C' ' 85' ' ' VAL . . . -71.69 -35.1 70.15 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 123.482 0.713 . . . . 0.0 110.975 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.15 -33.34 73.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -63.35 -34.3 77.41 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.031 1.733 . . . . 0.0 110.28 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.94 -37.35 81.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.7 -15.56 62.21 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.975 -1.078 . . . . 0.0 111.873 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -69.95 -42.81 72.72 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.48 -1.388 . . . . 0.0 109.034 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.0 -35.78 81.82 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.32 0.648 . . . . 0.0 110.803 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -42.91 88.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.54 -35.14 78.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.331 -0.856 . . . . 0.0 111.706 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -60.16 -46.5 89.47 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.089 1.356 . . . . 0.0 110.058 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.7 -39.07 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.195 0.998 . . . . 0.0 109.819 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.81 -45.32 82.34 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.299 0.954 . . . . 0.0 111.925 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.77 -38.08 79.79 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 122.971 0.508 . . . . 0.0 110.851 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -74.33 -39.89 62.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.78 -1.2 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.17 74.58 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 124.883 1.273 . . . . 0.0 112.339 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -70.74 -36.99 73.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.217 0.917 . . . . 0.0 110.473 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -66.73 -41.28 88.16 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -65.5 -46.9 77.88 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.31 -49.02 65.03 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.87 1.668 . . . . 0.0 112.576 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 27.1 m -67.42 -34.27 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 O-C-N 121.795 -0.566 . . . . 0.0 112.17 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -87.91 -24.15 23.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.539 0.685 . . . . 0.0 109.394 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 66' ' ' GLU . . . -73.6 -47.84 37.22 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.54 -8.68 53.24 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 122.058 0.932 . . . . 0.0 112.316 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.52 107.57 13.44 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 119.647 -1.908 . . . . 0.0 108.125 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.03 15.8 40.71 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.18 21.72 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.79 107.64 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.432 2.088 . . . . 0.0 113.179 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.23 27.36 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.14 145.09 22.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.337 1.855 . . . . 0.0 112.911 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.0 -16.08 5.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.344 1.058 . . . . 0.0 110.785 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.59 -79.84 0.3 Allowed 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 121.221 -0.924 . . . . 0.0 108.595 -168.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . 0.359 12.7 pt 38.94 -128.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 126.779 2.032 . . . . 0.0 111.048 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.4 -135.58 0.82 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.913 1.688 . . . . 0.0 109.752 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -173.03 -68.12 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-O 116.653 -1.642 . . . . 0.0 106.758 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.73 -17.84 22.67 Favored 'Trans proline' 0 CA--C 1.51 -0.685 0 CA-C-N 125.321 2.936 . . . . 0.0 111.197 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.44 -23.75 65.56 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.269 1.427 . . . . 0.0 109.947 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -63.2 -42.42 99.31 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 112.259 -167.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -69.3 -33.71 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.18 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 121.543 -0.723 . . . . 0.0 110.19 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -63.16 -45.4 92.01 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.84 0.456 . . . . 0.0 110.508 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 62.0 m -58.94 -36.09 74.21 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.678 -0.639 . . . . 0.0 112.062 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.32 -45.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 C-N-CA 123.89 0.876 . . . . 0.0 110.191 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -73.84 3.24 6.91 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 122.1 0.952 . . . . 0.0 112.785 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -104.71 -36.3 7.49 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.702 -1.249 . . . . 0.0 108.856 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.68 61.39 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.426 -1.421 . . . . 0.0 111.768 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.8 p -87.69 -3.01 58.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.728 1.211 . . . . 0.0 109.983 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.254 6.9 p 55.62 36.35 27.02 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.522 1.929 . . . . 0.0 112.77 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -91.19 -19.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 O-C-N 121.61 -0.681 . . . . 0.0 111.474 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.48 -60.14 1.55 Allowed Glycine 0 CA--C 1.493 -1.334 0 O-C-N 120.59 -1.319 . . . . 0.0 112.412 168.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -75.71 73.09 2.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.875 1.321 . . . . 0.0 113.62 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.09 10.15 75.77 Favored Glycine 0 CA--C 1.492 -1.399 0 O-C-N 118.512 -2.618 . . . . 0.0 114.552 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t0 71.7 -4.73 1.83 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 126.095 1.758 . . . . 0.0 111.562 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -136.53 163.25 30.96 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -136.0 148.32 64.38 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.13 171.19 15.47 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.812 3.008 . . . . 0.0 108.488 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 t -115.21 -95.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 120.655 1.57 . . . . 0.0 110.282 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -140.48 -49.97 0.45 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -85.13 -16.35 40.77 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 123.646 0.778 . . . . 0.0 110.085 -165.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HB1' ' C' ' 29' ' ' ALA . 0.9 OUTLIER -62.16 -33.21 74.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 108.33 171.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.35 95.32 1.81 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 98.229 -5.948 . . . . 0.0 98.229 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -61.92 -16.22 49.2 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 118.836 1.318 . . . . 0.0 110.62 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -59.81 -11.21 4.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.22 -39.88 86.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.084 -1.635 . . . . 0.0 108.99 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -45.18 69.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.82 -44.57 66.79 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.789 1.636 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -63.85 -36.0 82.48 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 112.34 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -71.84 -43.85 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 121.062 -1.024 . . . . 0.0 108.801 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.78 -42.51 97.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.606 0.762 . . . . 0.0 110.486 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.69 -47.15 83.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.621 1.168 . . . . 0.0 110.294 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.9 98.14 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.233 0.613 . . . . 0.0 110.509 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.13 77.92 Favored Glycine 0 CA--C 1.496 -1.119 0 C-N-CA 123.75 0.69 . . . . 0.0 111.832 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.75 -49.33 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 125.066 1.346 . . . . 0.0 108.675 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.42 -45.12 94.54 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 111.044 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.2 -52.87 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 C-N-CA 124.258 1.023 . . . . 0.0 110.367 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -72.27 -21.92 61.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.222 -0.924 . . . . 0.0 111.18 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.43 -37.88 36.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.115 -0.991 . . . . 0.0 110.111 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.23 -41.72 84.72 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.421 1.488 . . . . 0.0 110.609 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' C' ' 8' ' ' ALA . 17.1 m -69.04 -2.93 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -62.49 -12.57 22.98 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.361 1.065 . . . . 0.0 110.394 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.21 -57.3 12.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.122 -1.611 . . . . 0.0 111.841 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.4 77.6 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 126.07 1.748 . . . . 0.0 109.807 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.43 -33.37 75.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.35 40.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.007 -1.058 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.437 ' O ' HG22 ' C' ' 94' ' ' VAL 0.334 0.1 OUTLIER -70.36 -2.39 13.49 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.517 -1.23 . . . . 0.0 110.617 -176.93 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.281 0.6 OUTLIER -76.25 1.65 15.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 122.148 2.249 . . . . 0.0 111.531 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.24 -24.03 61.32 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 119.673 -1.892 . . . . 0.0 111.05 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.437 HG22 ' O ' ' C' ' 91' ' ' THR . 4.2 m -75.78 -12.95 14.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 O-C-N 120.112 -1.617 . . . . 0.0 110.275 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -79.64 -3.97 49.58 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.893 1.277 . . . . 0.0 109.388 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -77.77 -27.37 50.27 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.009 -1.682 . . . . 0.0 108.489 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -169.778 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.327 0.584 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -170.14 -104.38 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 -166.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -53.11 -22.54 6.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.989 3.316 . . . . 0.0 114.366 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.64 -28.56 67.82 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 125.385 1.474 . . . . 0.0 110.447 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -68.28 -43.3 78.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.923 0.889 . . . . 0.0 109.742 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.07 -31.34 62.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.503 -0.748 . . . . 0.0 109.588 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.95 91.44 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.871 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -66.12 -38.4 88.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.56 -42.99 99.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 109.904 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.32 84.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.74 0.816 . . . . 0.0 111.566 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.74 -38.16 77.8 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.564 0.745 . . . . 0.0 110.807 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.6 -30.14 65.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.303 -0.873 . . . . 0.0 110.406 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.76 -32.97 73.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.5 -43.2 97.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.357 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -56.05 -33.55 65.08 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.394 1.078 . . . . 0.0 111.745 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -71.19 -23.63 62.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.143 1.377 . . . . 0.0 111.174 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.68 -42.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.48 -40.23 74.57 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 124.939 1.296 . . . . 0.0 111.261 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -54.3 -51.68 63.85 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.273 1.029 . . . . 0.0 111.728 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.58 -38.37 67.92 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.65 0.78 . . . . 0.0 109.254 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.33 77.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.727 1.611 . . . . 0.0 111.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -64.46 -40.06 94.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.629 1.172 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -68.7 -46.62 68.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.49 -49.07 75.03 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.326 -0.859 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.08 -46.57 87.95 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 126.086 1.755 . . . . 0.0 111.836 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.34 -37.32 78.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 118.42 0.554 . . . . 0.0 110.139 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.34 -33.62 61.13 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.944 -1.098 . . . . 0.0 109.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.8 -55.51 14.55 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.249 1.82 . . . . 0.0 109.195 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.09 -32.9 74.38 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.019 0.928 . . . . 0.0 111.135 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -74.18 101.6 4.01 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 120.339 -1.476 . . . . 0.0 110.892 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.05 -22.49 4.79 Favored Glycine 0 CA--C 1.489 -1.541 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.8 142.96 66.1 Favored Pre-proline 0 N--CA 1.443 -0.801 0 O-C-N 121.547 -0.972 . . . . 0.0 109.653 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.94 140.38 12.64 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 122.781 2.321 . . . . 0.0 109.703 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.04 -8.84 71.67 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 119.132 0.878 . . . . 0.0 110.956 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.89 150.65 27.96 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 126.71 2.004 . . . . 0.0 111.287 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.93 -28.89 1.52 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.035 0.534 . . . . 0.0 110.572 -170.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.7 91.4 8.63 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 120.278 -1.514 . . . . 0.0 107.067 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 tt -122.49 53.13 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 O-C-N 120.848 -1.158 . . . . 0.0 108.117 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 26.4 t -153.97 142.0 20.28 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 119.489 -2.007 . . . . 0.0 106.948 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -80.64 -49.7 1.11 Allowed Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 115.807 -2.044 . . . . 0.0 109.929 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -69.18 -15.24 39.1 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 CA-C-N 126.036 3.192 . . . . 0.0 111.723 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.06 -13.53 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.22 80.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.03 -1.044 . . . . 0.0 109.044 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -67.9 -29.33 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 123.132 0.573 . . . . 0.0 110.909 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -47.48 63.85 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -67.23 -32.99 74.4 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.301 -0.875 . . . . 0.0 111.015 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -57.71 -24.85 58.93 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.618 -1.301 . . . . 0.0 112.523 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -40.65 15.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.709 -1.245 . . . . 0.0 110.228 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.38 -27.38 62.26 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 127.502 2.321 . . . . 0.0 110.835 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -99.31 -37.25 9.33 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 120.06 -1.65 . . . . 0.0 109.865 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.82 -14.12 61.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.394 -1.441 . . . . 0.0 112.262 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -99.0 2.07 46.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.257 63.5 p 56.31 28.96 14.18 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.343 2.257 . . . . 0.0 111.856 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.89 -52.88 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.88 63.43 4.79 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.816 -0.436 . . . . 0.0 113.626 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.39 -16.74 63.58 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 118.879 1.34 . . . . 0.0 110.092 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.24 36.8 4.28 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.407 ' HB2' HH12 ' A' ' 68' ' ' ARG . 11.6 t70 -70.25 -54.43 12.73 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.65 169.01 14.96 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.06 130.17 10.0 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 100.366 -3.939 . . . . 0.0 100.366 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.35 177.57 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.253 2.635 . . . . 0.0 107.841 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.38 -119.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 C-N-CA 123.696 0.798 . . . . 0.0 110.949 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -132.63 -38.68 1.01 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.88 -14.62 53.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.791 1.636 . . . . 0.0 108.81 -168.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -33.51 68.84 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.18 63.44 0.81 Allowed Glycine 0 CA--C 1.464 -3.127 1 N-CA-C 102.69 -4.164 . . . . 0.0 102.69 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -30.95 -18.76 0.0 OUTLIER 'General case' 0 C--N 1.361 1.077 1 C-N-CA 132.647 4.379 . . . . 0.0 117.466 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.33 -19.08 7.74 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 119.931 -1.73 . . . . 0.0 113.436 160.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.38 -44.18 98.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 124.451 1.1 . . . . 0.0 108.946 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.72 -55.08 7.3 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -40.08 -58.19 1.5 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.833 2.053 . . . . 0.0 112.326 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.14 -34.23 72.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.421 -169.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -74.23 -42.18 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 52.4 mtm -61.66 -49.72 75.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.524 0.73 . . . . 0.0 110.418 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.92 -27.47 66.66 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.514 -0.741 . . . . 0.0 111.185 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.35 81.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.677 -0.639 . . . . 0.0 110.811 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.69 89.57 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.91 -47.12 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.24 1.016 . . . . 0.0 109.907 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -69.26 -30.6 68.76 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.113 -0.992 . . . . 0.0 112.112 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.27 -52.1 60.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 C-N-CA 123.709 0.804 . . . . 0.0 109.265 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -69.1 -32.12 71.31 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.744 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.28 77.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.376 -0.827 . . . . 0.0 111.243 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -65.68 -36.14 82.8 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.651 1.18 . . . . 0.0 110.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.92 -19.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.405 1.482 . . . . 0.0 110.497 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -59.88 -20.48 57.47 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.791 -1.193 . . . . 0.0 112.714 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.93 74.8 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.228 -2.17 . . . . 0.0 111.539 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.96 53.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.005 0.922 . . . . 0.0 110.178 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.5 -27.93 18.88 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.864 1.316 . . . . 0.0 108.717 175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.77 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 119.836 -1.79 . . . . 0.0 110.757 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -68.28 -12.23 60.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.992 -1.068 . . . . 0.0 109.487 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.09 -20.78 59.32 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.024 -1.047 . . . . 0.0 111.37 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.02 -31.64 72.9 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.153 0.981 . . . . 0.0 108.976 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 t -90.63 -38.3 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 108.37 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -55.96 -35.76 67.05 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.724 1.61 . . . . 0.0 112.238 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -64.51 -20.36 66.16 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.029 -1.045 . . . . 0.0 112.407 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.445 -0.718 0 O-C-N 119.957 -1.714 . . . . 0.0 110.278 172.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -52.34 62.6 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.404 1.881 . . . . 0.0 109.908 -167.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.605 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 42.7 p-80 -76.53 -15.13 59.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.774 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.66 -32.8 35.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -63.86 -44.66 92.45 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.12 0.968 . . . . 0.0 110.0 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.59 -33.76 76.65 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.87 -0.519 . . . . 0.0 111.579 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.98 80.97 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.374 -0.829 . . . . 0.0 110.754 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -67.57 -39.22 84.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.757 -0.589 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.95 -35.88 82.14 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.5 0.72 . . . . 0.0 110.854 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.84 92.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.163 0.985 . . . . 0.0 110.554 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.36 -47.42 81.69 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.839 0.828 . . . . 0.0 110.782 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -70.71 -32.23 69.37 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.725 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -35.79 76.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.749 1.219 . . . . 0.0 109.032 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 tp -67.84 -41.71 82.54 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 121.618 -0.676 . . . . 0.0 111.191 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -66.33 -27.47 67.92 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.564 -0.71 . . . . 0.0 111.731 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -67.71 -39.69 84.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.73 1.212 . . . . 0.0 110.137 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.14 -37.83 77.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.997 0.919 . . . . 0.0 109.101 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.0 mt -56.92 -41.81 78.85 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.124 0.97 . . . . 0.0 112.182 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.54 -46.14 84.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.142 -0.974 . . . . 0.0 110.059 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -67.07 -33.44 75.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.918 -1.114 . . . . 0.0 111.54 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.16 -36.37 79.63 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.004 1.321 . . . . 0.0 110.617 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -63.83 -45.11 91.04 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 123.739 0.815 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -67.76 -49.29 63.28 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.565 0.698 . . . . 0.0 110.668 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -67.29 -34.41 77.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.64 0.776 . . . . 0.0 110.842 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.8 -49.09 61.45 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.297 1.039 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.29 -45.86 89.11 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-O 122.417 1.103 . . . . 0.0 110.189 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -86.87 2.07 50.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.525 -0.734 . . . . 0.0 111.302 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.87 27.6 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.23 -42.49 75.61 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 125.048 1.339 . . . . 0.0 108.911 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -69.58 85.93 0.45 Allowed 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.339 -0.851 . . . . 0.0 111.572 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.14 2.26 Favored Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.02 151.07 37.39 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 117.817 0.808 . . . . 0.0 109.24 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.01 131.84 8.13 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.17 1.914 . . . . 0.0 110.79 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.73 16.74 23.27 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.81 134.81 48.05 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 125.898 1.679 . . . . 0.0 114.177 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.03 -58.93 1.36 Allowed 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.466 1.107 . . . . 0.0 110.543 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.26 93.82 9.63 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 122.553 1.168 . . . . 0.0 112.067 -166.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.61 62.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 O-C-N 119.515 -1.991 . . . . 0.0 111.279 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -152.06 118.34 5.59 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 119.904 -1.747 . . . . 0.0 108.52 169.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.9 -48.93 96.55 Favored Pre-proline 0 C--N 1.359 0.993 0 CA-C-O 116.373 -1.775 . . . . 0.0 112.433 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.36 -8.96 23.58 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 CA-C-N 125.551 3.018 . . . . 0.0 112.947 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -101.78 -24.03 14.11 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.05 98.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 124.035 0.934 . . . . 0.0 110.058 -171.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.75 -32.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 124.567 1.147 . . . . 0.0 111.73 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -42.04 61.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 O-C-N 121.388 -0.82 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -67.33 -35.02 78.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -55.98 -34.46 65.75 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.819 -1.176 . . . . 0.0 112.013 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.31 -49.22 84.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -60.15 -38.03 81.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.819 1.648 . . . . 0.0 111.324 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -65.15 -45.56 84.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.554 1.942 . . . . 0.0 109.435 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.46 64.95 Favored 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 121.143 -0.973 . . . . 0.0 111.266 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 p -84.26 1.85 42.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.734 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.365 18.3 p 75.85 -41.04 0.42 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 128.339 2.655 . . . . 0.0 111.289 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.8 t -39.58 -54.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 128.183 2.593 . . . . 0.0 114.277 -169.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.89 65.93 3.03 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -67.16 -9.42 39.84 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.784 1.234 . . . . 0.0 113.464 -167.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 28.06 6.89 Favored Glycine 0 CA--C 1.488 -1.651 0 O-C-N 120.973 -1.079 . . . . 0.0 110.436 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.61 -47.64 31.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.367 -1.078 . . . . 0.0 109.05 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -123.7 160.45 27.2 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -136.57 147.25 58.98 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.98 167.1 12.79 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.617 2.211 . . . . 0.0 110.577 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 64' ' ' THR . 9.8 p -76.79 178.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 125.874 1.67 . . . . 0.0 108.823 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.588 ' H ' HG22 ' A' ' 63' ' ' VAL . 11.4 m -74.56 -83.89 0.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.779 1.632 . . . . 0.0 109.85 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -57.81 -55.08 39.54 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 120.084 1.311 . . . . 0.0 113.958 -161.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -89.87 -56.95 3.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.705 -0.622 . . . . 0.0 111.721 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.402 ' H ' ' CG1' ' A' ' 63' ' ' VAL . . . -53.23 -35.17 49.2 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 125.438 1.494 . . . . 0.0 113.81 -169.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -68.39 -38.32 81.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 118.072 0.936 . . . . 0.0 110.775 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -69.75 -39.7 76.56 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 123.654 0.782 . . . . 0.0 109.888 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.71 -46.64 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.29 86.42 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 124.673 1.189 . . . . 0.0 110.41 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -48.53 -51.93 25.13 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 126.675 1.99 . . . . 0.0 110.375 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -71.1 -42.52 69.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.296 -0.877 . . . . 0.0 111.958 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.74 -42.98 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 124.022 0.929 . . . . 0.0 109.748 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.23 -47.87 82.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 124.758 1.223 . . . . 0.0 109.71 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -60.48 -35.59 76.27 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.504 0.722 . . . . 0.0 110.44 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.21 72.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.705 -0.622 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.53 -41.29 90.43 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.65 -46.79 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 124.33 1.052 . . . . 0.0 108.726 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -62.63 -32.72 73.81 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.8 -0.563 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.15 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 123.914 0.886 . . . . 0.0 110.567 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -62.56 -37.42 86.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.736 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.13 63.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.784 -0.572 . . . . 0.0 111.954 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -73.61 -26.21 60.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.099 -1.625 . . . . 0.0 110.309 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.82 -15.46 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.093 1.357 . . . . 0.0 110.348 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 m -54.08 -24.31 16.96 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 126.207 1.803 . . . . 0.0 112.849 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.49 64.03 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 120.179 -1.576 . . . . 0.0 112.264 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -92.62 -48.35 6.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.555 1.142 . . . . 0.0 108.746 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.47 -39.91 92.53 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 112.598 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.81 61.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -97.28 11.14 37.52 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 120.805 -1.184 . . . . 0.0 108.824 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -79.36 -29.67 42.28 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.396 -1.44 . . . . 0.0 109.048 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -78.7 -24.71 44.85 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.723 -1.236 . . . . 0.0 110.691 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.76 -32.57 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 123.586 0.754 . . . . 0.0 109.698 -171.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -63.35 -16.58 60.85 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.759 1.224 . . . . 0.0 111.884 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 96' ' ' ARG . 21.6 ttp85 -71.34 -31.76 67.76 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.289 1.036 . . . . 0.0 110.562 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -177.279 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 . . . . . 0 CA--C 1.483 -1.624 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' HG3' ' B' ' 5' ' ' GLU . 12.5 p80 -50.46 -35.34 28.49 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 125.501 1.521 . . . . 0.0 114.743 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' B' ' 4' ' ' HIS . 4.9 mt-10 -67.59 -33.25 74.63 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.36 1.064 . . . . 0.0 110.78 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -81.03 -20.31 41.97 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.613 -0.679 . . . . 0.0 109.764 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -27.06 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -46.06 84.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.833 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.97 -28.59 62.49 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.446 -0.784 . . . . 0.0 111.007 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.9 -40.08 95.66 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.985 0.914 . . . . 0.0 109.8 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.62 76.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.049 0.939 . . . . 0.0 111.401 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -65.28 -39.5 92.65 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.9 -47.35 80.93 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.502 -0.748 . . . . 0.0 110.255 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' B' ' 14' ' ' GLU . 0.8 OUTLIER -70.66 -25.15 62.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.539 -0.726 . . . . 0.0 111.278 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -63.55 -39.73 95.16 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 120.831 -1.168 . . . . 0.0 111.334 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -62.05 -38.93 90.6 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.446 -0.784 . . . . 0.0 110.06 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.58 84.75 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.093 0.957 . . . . 0.0 110.27 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.44 -47.94 89.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.551 -0.718 . . . . 0.0 110.31 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.43 -36.29 80.94 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.673 -0.642 . . . . 0.0 110.486 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -62.75 -42.04 99.49 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.116 -1.615 . . . . 0.0 110.104 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -66.49 -36.79 83.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.848 0.832 . . . . 0.0 109.698 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.98 73.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.752 0.821 . . . . 0.0 111.552 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -60.93 -38.02 84.32 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.506 1.123 . . . . 0.0 111.98 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -69.03 -41.64 77.44 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.311 -0.868 . . . . 0.0 109.094 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -70.13 -26.37 63.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 121.822 -0.549 . . . . 0.0 110.933 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.07 95.72 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.303 1.041 . . . . 0.0 111.217 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.31 42.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 124.255 1.979 . . . . 0.0 108.474 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -147.19 -42.24 0.18 Allowed 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 100.875 -3.75 . . . . 0.0 100.875 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 56.52 0.46 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.689 1.996 . . . . 0.0 110.216 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 1.8 pp20? 179.68 -27.49 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 125.921 1.688 . . . . 0.0 108.289 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.43 71.73 6.02 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.495 -0.753 . . . . 0.0 109.985 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.22 -34.47 0.84 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 159.24 57.8 Favored Pre-proline 0 CA--C 1.51 -0.586 0 O-C-N 120.681 -1.482 . . . . 0.0 112.817 -173.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.17 152.26 24.01 Favored 'Trans proline' 0 CA--C 1.501 -1.163 0 C-N-CA 122.062 1.842 . . . . 0.0 109.848 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.13 42.34 84.42 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -66.63 -60.18 2.94 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.859 0.864 . . . . 0.0 109.716 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 65.43 -9.32 0.24 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.557 1.543 . . . . 0.0 113.597 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -123.52 31.64 5.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.732 1.613 . . . . 0.0 107.804 -165.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 45.0 pt -70.45 38.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.425 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -161.72 142.68 10.92 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 119.571 -1.956 . . . . 0.0 109.583 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.81 -57.29 1.55 Allowed Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 126.899 2.079 . . . . 0.0 110.978 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.66 -11.84 26.34 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 CA-C-N 126.076 3.206 . . . . 0.0 111.228 -169.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.71 -7.13 44.53 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 125.67 1.588 . . . . 0.0 107.954 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.09 66.86 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 123.983 0.913 . . . . 0.0 109.06 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -82.21 14.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.348 1.071 . . . . 0.0 109.86 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.0 -58.53 2.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 167.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -54.49 -41.62 69.79 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.705 1.602 . . . . 0.0 111.804 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' HG22 ' B' ' 51' ' ' THR . 16.9 m -65.24 -21.81 66.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 120.794 -1.191 . . . . 0.0 113.723 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.25 -53.82 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -47.33 -50.63 21.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 126.682 1.993 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.407 HG22 ' HA ' ' B' ' 48' ' ' SER . 15.2 t -71.99 -30.16 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.772 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.23 60.65 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.223 -0.923 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -83.57 -1.18 53.22 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 122.963 0.505 . . . . 0.0 111.092 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.278 3.4 p 53.89 56.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.323 1.849 . . . . 0.0 112.505 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.0 t -120.54 -72.71 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.05 60.91 1.89 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -19.11 10.38 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.98 27.48 16.28 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.303 -1.498 . . . . 0.0 109.703 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -70.28 -63.67 1.04 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.031 2.133 . . . . 0.0 107.553 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -138.85 170.32 16.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -173.05 138.41 0.82 Allowed Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-O 115.696 -2.097 . . . . 0.0 105.356 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.92 179.38 6.04 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.069 2.513 . . . . 0.0 111.595 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.472 HG22 ' H ' ' B' ' 64' ' ' THR . 12.7 p -123.19 175.34 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.472 ' H ' HG22 ' B' ' 63' ' ' VAL . 19.5 m -48.81 -50.39 34.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 129.25 3.02 . . . . 0.0 113.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.6 -11.88 61.21 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.905 1.282 . . . . 0.0 109.593 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -104.33 5.37 34.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 O-C-N 121.894 -0.504 . . . . 0.0 111.368 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.35 84.07 0.38 Allowed Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 104.543 -3.423 . . . . 0.0 104.543 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.76 -20.37 56.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.535 -1.568 . . . . 0.0 111.125 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -54.84 -13.48 1.08 Allowed 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.828 1.651 . . . . 0.0 113.082 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.98 -40.99 84.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 120.651 -1.281 . . . . 0.0 110.087 169.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.18 -50.17 29.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -48.79 -44.15 38.73 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.989 1.715 . . . . 0.0 111.038 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -48.1 79.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.142 1.377 . . . . 0.0 111.269 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.25 -43.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.53 -46.14 89.72 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.645 1.178 . . . . 0.0 110.413 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.54 -43.03 99.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.29 97.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 122.599 0.36 . . . . 0.0 110.963 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.58 -47.0 93.13 Favored Glycine 0 CA--C 1.495 -1.179 0 C-N-CA 124.358 0.98 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.38 -50.53 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 124.301 1.04 . . . . 0.0 109.054 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -63.28 -33.53 75.71 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 121.802 -0.561 . . . . 0.0 111.782 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.52 -59.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 C-N-CA 124.125 0.97 . . . . 0.0 110.48 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -64.79 -35.62 81.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 121.384 -0.823 . . . . 0.0 110.151 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.62 88.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 111.266 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.45 -35.62 81.52 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.4 1.08 . . . . 0.0 110.533 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.72 -16.11 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.796 1.238 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -59.79 -18.65 45.17 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 120.494 -1.379 . . . . 0.0 111.608 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.53 75.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 119.565 -1.96 . . . . 0.0 112.456 171.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.35 -38.73 55.44 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 121.182 -0.949 . . . . 0.0 109.29 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -32.69 69.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.73 67.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 120.389 -1.444 . . . . 0.0 111.685 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -90.63 3.3 54.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 120.706 -1.246 . . . . 0.0 109.014 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -75.34 -33.75 61.13 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 122.118 0.961 . . . . 0.0 108.72 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -68.55 -32.06 71.73 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.403 -1.435 . . . . 0.0 111.944 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 -22.75 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.912 1.285 . . . . 0.0 109.116 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -59.61 -26.32 65.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.329 1.052 . . . . 0.0 112.07 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -67.97 -24.27 65.14 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 120.242 1.383 . . . . 0.0 111.836 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 C--N 1.354 0.77 0 O-C-N 121.046 -1.033 . . . . 0.0 108.776 177.881 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.682 0 CA-C-O 122.938 1.352 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.644 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 48.8 p-80 -72.56 -18.01 61.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.958 1.303 . . . . 0.0 112.88 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -75.99 -41.04 52.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -72.51 -31.97 65.78 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.949 -1.094 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -75.1 -27.21 59.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.369 -0.832 . . . . 0.0 110.032 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -45.82 78.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.161 0.984 . . . . 0.0 110.579 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -62.25 -40.69 97.02 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.475 1.11 . . . . 0.0 110.763 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -60.12 -36.08 76.69 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 124.541 1.136 . . . . 0.0 110.839 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.87 76.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.56 0.744 . . . . 0.0 111.384 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.13 -34.65 78.9 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.184 -0.948 . . . . 0.0 111.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -72.69 -31.9 65.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 110.117 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.85 -33.56 74.02 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.4 1.48 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.93 -42.61 94.54 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.649 0.779 . . . . 0.0 110.663 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -61.9 -36.63 81.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.428 -0.795 . . . . 0.0 111.55 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.65 -43.49 97.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.85 0.86 . . . . 0.0 111.277 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.96 -23.89 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 121.119 -0.988 . . . . 0.0 110.692 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.8 mt -68.86 -38.92 80.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 123.789 0.836 . . . . 0.0 110.509 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -65.47 -38.5 89.97 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.568 1.147 . . . . 0.0 110.452 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.02 -38.03 61.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.683 -1.261 . . . . 0.0 109.155 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -37.97 76.34 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 125.107 1.363 . . . . 0.0 111.493 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -43.21 81.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 118.906 0.775 . . . . 0.0 110.358 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.69 -50.6 62.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -59.58 -45.91 90.47 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 124.021 0.928 . . . . 0.0 109.524 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -42.69 99.89 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.968 0.907 . . . . 0.0 111.897 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' C' ' 44' ' ' ALA . 91.5 t -71.52 -33.16 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 O-C-N 120.973 -1.079 . . . . 0.0 110.326 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.64 -33.34 64.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.464 -0.772 . . . . 0.0 109.338 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.55 79.38 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 126.789 2.036 . . . . 0.0 109.725 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -74.44 -12.65 60.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.47 0.652 . . . . 0.0 112.12 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -79.63 77.19 6.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 120.487 -1.383 . . . . 0.0 110.327 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.82 -11.12 1.66 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.67 147.41 46.25 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 117.847 0.824 . . . . 0.0 110.773 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.32 121.73 3.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.843 2.362 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.87 29.91 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.95 124.34 20.51 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.075 1.75 . . . . 0.0 112.74 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.94 -21.47 6.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.033 0.533 . . . . 0.0 110.638 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -36.64 80.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.648 1.179 . . . . 0.0 110.524 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tp -47.56 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 128.994 2.918 . . . . 0.0 112.067 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -168.3 103.8 0.45 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -60.77 -36.64 37.14 Favored Pre-proline 0 C--N 1.35 0.612 0 CA-C-O 115.315 -2.279 . . . . 0.0 113.101 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.93 -48.79 0.62 Allowed 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 126.757 3.449 . . . . 0.0 110.473 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -6.51 47.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.986 1.314 . . . . 0.0 111.246 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' C' ' 27' ' ' VAL . . . -58.78 -48.62 80.63 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 125.636 1.574 . . . . 0.0 110.876 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.96 -24.84 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.55 -44.66 77.72 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.895 -1.128 . . . . 0.0 108.61 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.7 -41.26 99.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.636 -0.665 . . . . 0.0 110.833 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -57.93 -46.12 85.5 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.092 -1.005 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -80.25 74.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 122.206 1.003 . . . . 0.0 108.851 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -165.14 -40.62 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -31.55 71.08 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.968 0.907 . . . . 0.0 110.485 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -68.31 -24.12 64.81 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.441 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.46 6.61 48.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 123.279 0.632 . . . . 0.0 109.55 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 55.92 52.28 10.88 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 126.125 1.77 . . . . 0.0 112.418 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.3 -156.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.37 103.95 0.33 Allowed Glycine 0 CA--C 1.475 -2.467 1 N-CA-C 99.133 -5.587 . . . . 0.0 99.133 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.96 -28.28 62.32 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 118.101 0.951 . . . . 0.0 110.214 -172.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.0 46.04 0.84 Allowed Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -75.44 -51.75 12.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -137.69 172.48 12.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.35 125.17 5.92 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 101.843 -3.391 . . . . 0.0 101.843 -168.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.85 168.68 21.87 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 123.83 3.02 . . . . 0.0 110.757 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.29 -90.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.011 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 12.7 m -165.01 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.624 -1.922 . . . . 0.0 106.732 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -73.74 -18.8 60.94 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.815 1.246 . . . . 0.0 108.979 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -62.07 -36.48 81.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 125.043 1.337 . . . . 0.0 109.576 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.22 -15.62 1.49 Allowed Glycine 0 CA--C 1.481 -2.087 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 172.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' C' ' 66' ' ' GLU 0.352 3.5 ptp85 63.18 -48.63 0.22 Allowed 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 131.481 3.912 . . . . 0.0 111.734 -170.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.25 12.71 2.2 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.51 -49.42 59.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -49.12 65.59 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 122.897 0.479 . . . . 0.0 110.008 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.92 -42.92 69.3 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.067 0.947 . . . . 0.0 111.433 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -67.37 -32.27 73.07 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 111.224 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.74 -42.29 61.91 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.36 -47.39 85.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 110.502 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.22 -40.67 94.86 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.271 1.029 . . . . 0.0 110.914 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.73 85.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.466 0.707 . . . . 0.0 111.18 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.68 -44.27 92.79 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 124.036 0.827 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.7 -43.23 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.689 0.795 . . . . 0.0 109.116 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.09 -52.99 63.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 123.504 0.722 . . . . 0.0 111.608 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.82 -41.57 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 121.952 -0.468 . . . . 0.0 111.028 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -75.38 -25.23 57.49 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.559 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.77 -33.68 34.76 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.67 -1.269 . . . . 0.0 109.773 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.2 -41.59 75.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.789 1.636 . . . . 0.0 110.873 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.42 -8.03 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.489 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 13.0 m -62.98 -17.43 62.1 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.998 -1.064 . . . . 0.0 109.842 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.05 75.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.185 -1.572 . . . . 0.0 112.337 169.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.644 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.72 -52.64 10.02 Favored 'General case' 0 CA--C 1.492 -1.283 0 O-C-N 120.694 -1.254 . . . . 0.0 107.887 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.76 -29.05 70.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.03 0.443 . . . . 0.0 111.938 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.57 -20.72 64.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.587 -1.321 . . . . 0.0 111.074 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -80.95 -10.96 59.65 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.638 -1.289 . . . . 0.0 110.506 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.26 1.8 m-20 -79.39 -12.97 59.9 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 119.869 1.213 . . . . 0.0 110.817 -167.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.49 -19.97 41.15 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.329 -1.482 . . . . 0.0 109.928 167.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.13 -38.4 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 124.718 1.207 . . . . 0.0 108.077 -172.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -50.79 -31.3 16.51 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 125.816 1.646 . . . . 0.0 113.239 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -60.33 -32.18 71.0 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -172.975 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.215 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.59 -29.83 69.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.073 -1.017 . . . . 0.0 111.076 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -68.38 -22.53 64.64 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.051 -1.031 . . . . 0.0 111.908 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.82 -36.02 23.8 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -62.35 -40.81 97.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.125 0.97 . . . . 0.0 110.488 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.62 -38.44 90.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.483 1.113 . . . . 0.0 110.437 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.74 75.35 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.109 0.964 . . . . 0.0 111.207 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -65.15 -41.49 94.69 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.754 -0.591 . . . . 0.0 110.449 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -64.93 -31.75 73.14 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 122.81 0.444 . . . . 0.0 111.76 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.12 81.52 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.897 -0.502 . . . . 0.0 110.35 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.51 -50.65 72.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.97 0.508 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.56 -34.34 75.42 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.805 0.842 . . . . 0.0 111.462 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -73.97 -32.02 63.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.032 -1.042 . . . . 0.0 110.503 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.43 -38.18 90.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.722 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -75.41 -9.03 58.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.961 -1.087 . . . . 0.0 112.525 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -82.9 -38.97 22.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.07 -38.16 81.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.227 -0.921 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.8 mt -51.94 -42.95 63.23 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.798 1.239 . . . . 0.0 112.518 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -68.32 -42.93 78.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.785 0.834 . . . . 0.0 110.48 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.21 -38.51 68.98 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.22 73.23 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 125.154 1.381 . . . . 0.0 111.955 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -57.55 -47.96 80.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.069 1.414 . . . . 0.0 110.697 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -73.39 -43.15 61.16 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.723 1.209 . . . . 0.0 108.514 -171.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -73.39 -29.66 62.75 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.723 0.809 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.79 79.15 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.035 0.934 . . . . 0.0 111.492 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.95 -43.59 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-O 122.424 1.106 . . . . 0.0 109.846 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -62.55 -32.97 74.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.48 1.512 . . . . 0.0 109.594 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.14 -50.43 71.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 126.099 1.76 . . . . 0.0 110.643 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 111.3 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -80.73 68.24 6.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.414 -1.429 . . . . 0.0 110.987 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.14 -30.43 0.48 Allowed Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.73 150.08 81.35 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.345 1.058 . . . . 0.0 111.778 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -84.27 145.22 10.77 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 122.808 2.339 . . . . 0.0 109.861 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 33.41 55.59 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 147.25 47.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.315 1.046 . . . . 0.0 110.95 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.53 -52.93 1.59 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.98 97.74 10.92 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -137.84 114.05 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -179.6 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -174.86 -65.41 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 116.218 -1.848 . . . . 0.0 106.112 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.84 -16.81 29.44 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 CA-C-N 125.386 2.959 . . . . 0.0 112.637 -166.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -95.03 -8.43 36.79 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.948 1.299 . . . . 0.0 109.639 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.26 62.92 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.757 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.99 -33.58 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.029 0.931 . . . . 0.0 109.626 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -27.38 59.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 119.577 -1.952 . . . . 0.0 110.335 -174.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -69.03 -42.36 76.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.0 p -69.28 -32.26 71.31 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.193 -1.567 . . . . 0.0 110.866 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.81 -46.59 83.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 125.334 1.453 . . . . 0.0 110.936 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -80.61 -2.14 45.21 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 118.757 0.708 . . . . 0.0 112.013 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -101.22 -40.65 7.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 -22.92 66.31 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.765 -1.21 . . . . 0.0 111.685 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -91.83 2.8 56.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 125.026 1.33 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 25.6 p 52.03 70.42 0.56 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.343 1.857 . . . . 0.0 112.785 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.566 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.2 p -129.24 -80.01 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 104.184 -2.525 . . . . 0.0 104.184 169.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.566 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 80.63 80.36 0.85 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -171.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -74.55 -16.15 60.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.028 -1.278 . . . . 0.0 110.983 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.23 5.76 Favored Glycine 0 CA--C 1.492 -1.378 0 O-C-N 121.393 -0.817 . . . . 0.0 111.103 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -70.12 -59.07 3.12 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -137.97 162.64 33.56 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -158.24 154.68 24.39 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.12 177.77 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.483 2.789 . . . . 0.0 109.878 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.427 HG13 ' H ' ' D' ' 64' ' ' THR 0.264 5.6 p -115.01 -118.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 174.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.427 ' H ' HG13 ' D' ' 63' ' ' VAL . 12.2 m -104.93 -85.62 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.189 -1.569 . . . . 0.0 108.988 -170.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.88 128.77 37.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.576 1.15 . . . . 0.0 109.086 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . 0.3 51.7 mt-10 62.2 -111.26 0.4 Allowed 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 115.441 -2.219 . . . . 0.0 106.972 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 35.51 -80.88 0.0 OUTLIER Glycine 0 C--N 1.353 1.49 0 C-N-CA 129.772 3.558 . . . . 0.0 113.786 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -58.92 -41.97 88.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 127.381 2.272 . . . . 0.0 113.196 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.35 -18.1 62.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.473 1.109 . . . . 0.0 109.464 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' D' ' 29' ' ' ALA . 40.8 t -84.63 -45.11 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 172.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.22 -50.91 69.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.666 1.187 . . . . 0.0 113.104 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.86 -35.46 70.99 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.875 0.87 . . . . 0.0 111.62 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -67.96 -45.51 74.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.248 1.019 . . . . 0.0 109.034 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.53 -43.62 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.932 0.893 . . . . 0.0 109.522 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.9 -43.64 98.26 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.387 0.675 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.08 -37.8 83.99 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.234 0.614 . . . . 0.0 111.097 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.11 85.9 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.147 0.579 . . . . 0.0 111.237 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.44 -46.52 55.62 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.81 -47.49 85.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 109.628 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -66.97 -26.69 66.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.13 -0.981 . . . . 0.0 112.372 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.28 -45.18 71.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.748 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.59 -35.2 80.24 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.078 0.942 . . . . 0.0 110.062 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -32.62 67.06 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.391 -0.818 . . . . 0.0 111.332 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.04 -43.92 94.09 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 124.628 1.171 . . . . 0.0 109.727 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -69.96 -4.83 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.375 -0.828 . . . . 0.0 112.061 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -57.49 -24.85 58.22 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.186 1.394 . . . . 0.0 110.344 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.84 78.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 119.847 -1.783 . . . . 0.0 112.163 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.84 -42.87 69.6 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -28.34 63.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.768 0.827 . . . . 0.0 110.858 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.32 76.48 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 119.982 -1.699 . . . . 0.0 109.442 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -11.53 52.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.87 -1.144 . . . . 0.0 112.593 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.37 -26.53 61.94 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.831 1.65 . . . . 0.0 111.595 -170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -79.06 -24.14 43.75 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.212 0.915 . . . . 0.0 110.062 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.97 -36.53 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.414 1.085 . . . . 0.0 108.701 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -55.5 -32.94 63.29 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 126.421 1.888 . . . . 0.0 110.83 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -61.7 -23.58 66.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.296 1.038 . . . . 0.0 111.74 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 . . . . . 0 C--N 1.358 0.968 0 O-C-N 121.797 -0.565 . . . . 0.0 109.934 -174.077 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.59 -43.23 97.6 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.033 1.733 . . . . 0.0 110.604 -171.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -47.09 72.07 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.634 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -38.29 89.06 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 122.578 0.351 . . . . 0.0 110.101 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -64.23 -46.27 84.57 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.682 -0.637 . . . . 0.0 110.871 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 121.796 -0.565 . . . . 0.0 111.04 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.47 85.61 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 110.805 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.8 -36.1 77.84 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.11 -38.07 85.03 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.904 1.282 . . . . 0.0 109.974 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.44 -37.22 86.76 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 111.711 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.38 -29.17 70.24 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.86 -1.15 . . . . 0.0 111.607 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -68.08 -31.94 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -71.9 -29.29 64.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.0 -37.22 83.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.985 -1.072 . . . . 0.0 110.204 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.19 -26.78 66.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.889 -1.132 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -63.85 -50.12 70.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 123.884 0.873 . . . . 0.0 109.605 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.42 -23.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 121.627 -0.671 . . . . 0.0 110.334 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.6 -50.18 74.56 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.364 0.984 . . . . 0.0 109.711 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -64.09 -42.79 96.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.807 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.05 -44.31 76.7 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.938 -0.476 . . . . 0.0 109.921 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.07 -37.45 85.04 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.144 -0.972 . . . . 0.0 112.026 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 -43.89 86.79 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.941 0.896 . . . . 0.0 110.738 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.21 -43.54 91.22 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.684 1.194 . . . . 0.0 107.973 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -64.52 -49.02 72.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.35 1.06 . . . . 0.0 110.839 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.09 92.97 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.526 1.53 . . . . 0.0 111.216 -173.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.7 -37.78 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 121.465 -0.772 . . . . 0.0 110.344 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -69.72 -38.48 76.91 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.747 -1.221 . . . . 0.0 110.466 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.15 -47.87 66.87 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 126.144 1.777 . . . . 0.0 109.501 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.15 -38.97 79.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.385 1.074 . . . . 0.0 110.977 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -69.74 99.14 1.3 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 119.99 -1.694 . . . . 0.0 113.073 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.81 -3.27 19.54 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.29 148.87 37.42 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 118.193 0.997 . . . . 0.0 108.446 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -80.26 145.59 17.15 Favored 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.418 2.079 . . . . 0.0 109.967 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.31 -8.83 69.35 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 119.239 0.927 . . . . 0.0 111.374 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.01 53.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.92 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.06 -29.25 4.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.31 58.17 4.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.994 1.378 . . . . 0.0 107.959 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -87.5 42.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 O-C-N 119.852 -1.78 . . . . 0.0 111.276 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -135.29 -117.0 0.18 Allowed 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.745 -1.222 . . . . 0.0 109.672 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 t80 171.7 -66.65 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.904 0 CA-C-O 116.315 -1.802 . . . . 0.0 108.766 -172.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -4.64 15.7 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 CA-C-N 125.175 2.884 . . . . 0.0 111.796 -164.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -103.99 -10.15 18.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 127.157 2.183 . . . . 0.0 109.1 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.85 63.89 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.231 -0.918 . . . . 0.0 110.31 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.79 -38.17 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.91 0.862 . . . . 0.0 110.479 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.32 -31.45 26.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -55.77 -40.87 73.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.297 1.039 . . . . 0.0 110.854 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -62.37 -29.36 70.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.698 0.799 . . . . 0.0 112.596 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.78 -36.07 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 120.846 -1.159 . . . . 0.0 108.52 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -65.69 -17.39 64.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.448 1.099 . . . . 0.0 112.166 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 t -109.31 -31.35 7.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.59 -1.319 . . . . 0.0 108.554 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.05 65.57 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.31 -1.494 . . . . 0.0 112.569 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 p -97.9 3.41 49.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.268 12.2 p 55.53 26.71 9.36 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 128.739 2.816 . . . . 0.0 112.569 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG21 ' SD ' ' B' ' 75' ' ' MET . 16.3 m -80.02 -54.48 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 55.87 11.42 Favored Glycine 0 CA--C 1.485 -1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.85 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.89 -17.25 61.36 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.805 0.812 . . . . 0.0 111.96 -173.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.6 40.36 6.82 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.98 -46.61 70.84 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.59 -168.15 1.69 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.04 108.43 5.0 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.11 175.41 10.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.417 2.745 . . . . 0.0 109.281 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 64' ' ' THR . 15.0 p -140.14 -176.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.564 ' H ' HG22 ' A' ' 63' ' ' VAL . 65.7 m -66.7 -45.25 79.36 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.714 -1.866 . . . . 0.0 112.158 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -80.0 -6.77 58.18 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 119.206 0.912 . . . . 0.0 111.156 -170.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.56 -32.68 74.18 Favored 'General case' 0 C--N 1.359 0.986 0 CA-C-O 123.888 1.804 . . . . 0.0 106.259 168.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.26 65.82 1.02 Allowed Glycine 0 CA--C 1.463 -3.168 1 N-CA-C 102.22 -4.352 . . . . 0.0 102.22 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -27.09 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.374 1.665 1 C-N-CA 131.95 4.1 . . . . 0.0 115.472 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -50.72 -12.23 0.1 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 164.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.73 -49.64 49.85 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 123.023 2.647 . . . . 0.0 106.942 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.03 -43.39 98.96 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.871 0.868 . . . . 0.0 110.426 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -65.23 -43.69 90.62 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.705 0.402 . . . . 0.0 111.386 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.68 -41.0 96.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 121.184 -0.948 . . . . 0.0 110.767 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.47 -34.44 35.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.889 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 55.9 ttm -62.72 -52.21 64.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.15 -32.49 70.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.426 -0.796 . . . . 0.0 110.481 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.3 -35.08 77.92 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.835 -0.541 . . . . 0.0 110.907 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.78 96.62 Favored Glycine 0 CA--C 1.492 -1.377 0 C-N-CA 123.646 0.641 . . . . 0.0 111.743 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.14 -47.04 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 124.264 1.026 . . . . 0.0 109.016 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.79 -30.21 68.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.139 -0.976 . . . . 0.0 111.572 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.65 -55.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.618 0.767 . . . . 0.0 109.461 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.37 -33.6 74.56 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 121.464 -0.772 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.72 72.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.153 -0.967 . . . . 0.0 110.529 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.74 -29.06 70.03 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 120.6 -1.312 . . . . 0.0 111.108 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.68 -11.7 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.489 1.515 . . . . 0.0 111.121 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.3 m -51.42 -29.39 15.74 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 119.428 -2.045 . . . . 0.0 112.581 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.14 62.88 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.407 -1.433 . . . . 0.0 112.065 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.2 -56.4 3.29 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 125.695 1.598 . . . . 0.0 108.686 172.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.09 -39.64 75.42 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.994 0.918 . . . . 0.0 112.816 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.9 -14.99 60.27 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.048 -1.033 . . . . 0.0 111.372 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.36 -9.52 47.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 120.683 -1.26 . . . . 0.0 107.702 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -37.52 73.81 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.415 -0.803 . . . . 0.0 109.618 -172.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -71.38 -24.9 62.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.987 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.5 t -70.52 -24.48 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 108.4 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -65.23 -15.7 62.75 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.081 -1.012 . . . . 0.0 111.735 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -55.91 -40.74 73.51 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 124.027 0.931 . . . . 0.0 110.438 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . 0.297 11.3 pt-20 . . . . . 0 CA--C 1.501 -0.928 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.32 -172.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p30 . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.36 -20.17 62.69 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.82 -34.37 62.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.048 -1.033 . . . . 0.0 108.537 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -69.1 -25.61 64.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.69 -0.631 . . . . 0.0 111.008 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -69.78 -44.16 70.7 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.87 87.95 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.261 1.424 . . . . 0.0 111.677 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -56.31 -38.7 71.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.771 1.629 . . . . 0.0 111.161 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -79.34 -13.77 59.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.391 -0.818 . . . . 0.0 111.396 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.55 -36.33 63.12 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -62.99 -43.18 99.5 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.78 0.8 . . . . 0.0 110.395 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.86 -43.43 98.81 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.26 1.424 . . . . 0.0 109.932 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.39 -39.93 77.13 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.931 1.692 . . . . 0.0 110.369 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.71 -41.11 98.14 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 123.381 0.672 . . . . 0.0 111.026 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -59.48 -35.63 74.47 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.426 1.091 . . . . 0.0 110.801 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.33 -34.94 79.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.638 1.175 . . . . 0.0 110.595 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.6 -39.67 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.93 -34.49 78.09 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -72.01 -30.71 65.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 111.864 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -81.89 -37.09 27.41 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.599 -1.313 . . . . 0.0 108.892 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.46 92.87 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.494 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 21.5 p -60.62 -38.7 85.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.492 0.717 . . . . 0.0 111.878 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -75.42 -53.84 8.03 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -62.4 -26.52 68.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.874 0.87 . . . . 0.0 111.186 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -43.85 72.14 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.837 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.16 -12.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.603 1.192 . . . . 0.0 109.153 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.52 21.5 17.35 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.842 -1.786 . . . . 0.0 107.119 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -92.34 -51.7 5.02 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' B' ' 31' ' ' ARG 0.286 0.6 OUTLIER -76.98 -80.42 0.1 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.129 -170.54 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 9.8 mmm180 59.72 -27.73 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 129.611 3.164 . . . . 0.0 116.584 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.45 37.66 0.23 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.19 156.35 79.15 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.968 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.83 123.14 8.74 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.249 2.633 . . . . 0.0 109.899 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.95 -58.41 3.25 Favored Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.3 174.1 0.16 Allowed 'General case' 0 C--N 1.35 0.598 0 C-N-CA 127.539 2.335 . . . . 0.0 109.515 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 61' ' ' TYR . . . -174.92 -53.2 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.76 -1.212 . . . . 0.0 108.93 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.22 138.34 31.57 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 pt -163.18 177.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t 71.97 102.85 0.07 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.751 2.02 . . . . 0.0 110.662 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -49.67 -53.43 41.59 Favored Pre-proline 0 C--N 1.35 0.627 0 CA-C-O 116.782 -1.58 . . . . 0.0 113.264 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.86 -11.68 25.85 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 124.709 2.718 . . . . 0.0 111.921 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -95.52 -27.96 15.12 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.77 72.13 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.442 1.497 . . . . 0.0 111.491 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.08 -30.37 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 121.506 -0.746 . . . . 0.0 111.206 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.03 -20.9 40.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.659 -1.275 . . . . 0.0 109.912 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -65.32 -47.2 77.36 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -57.85 -30.91 66.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.88 -27.95 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.73 0.812 . . . . 0.0 111.296 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -88.36 -3.55 58.82 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.269 -1.519 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -113.18 -175.75 2.74 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 81.11 -50.21 0.28 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.351 1.86 . . . . 0.0 109.391 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -88.12 32.27 0.76 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.204 1.401 . . . . 0.0 111.532 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 42.07 61.7 1.87 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.318 2.247 . . . . 0.0 114.313 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.643 HG13 ' H ' ' B' ' 56' ' ' GLY . 1.0 OUTLIER -134.62 -93.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 176.388 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.643 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 84.97 87.74 0.9 Allowed Glycine 0 CA--C 1.495 -1.2 0 N-CA-C 104.976 -3.25 . . . . 0.0 104.976 -171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -77.73 -18.8 56.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.813 -1.404 . . . . 0.0 108.712 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 45.53 1.8 Allowed Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.95 -59.55 2.73 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.82 162.04 36.5 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' B' ' 37' ' ' ALA . 34.3 p90 -144.9 148.89 40.68 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.448 ' HB2' ' HG3' ' B' ' 66' ' ' GLU . 32.7 Cg_endo -81.52 160.64 19.53 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 123.381 2.721 . . . . 0.0 108.622 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.23 -99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-N 121.02 1.736 . . . . 0.0 110.424 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -141.57 -48.31 0.39 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 120.13 1.332 . . . . 0.0 111.299 -167.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -27.57 64.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 125.522 1.529 . . . . 0.0 108.196 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' B' ' 62' ' ' PRO . 1.4 pm0 -53.47 -25.44 16.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.067 2.147 . . . . 0.0 111.963 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.32 93.86 1.31 Allowed Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 98.736 -5.746 . . . . 0.0 98.736 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -63.49 -11.6 25.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.69 -1.477 . . . . 0.0 111.9 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -61.58 -17.3 54.47 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.999 0.92 . . . . 0.0 112.328 168.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.78 -33.44 59.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.811 -1.181 . . . . 0.0 109.379 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.99 7.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 120.467 -1.395 . . . . 0.0 108.007 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -48.09 -52.43 20.37 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 125.916 1.687 . . . . 0.0 110.29 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -69.36 -29.57 67.39 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.983 -0.448 . . . . 0.0 111.234 -170.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.8 t -75.41 -44.01 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 O-C-N 120.824 -1.172 . . . . 0.0 108.673 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 36.0 mtm -64.75 -45.68 85.4 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 110.516 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -75.39 -21.7 58.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.378 -0.826 . . . . 0.0 111.15 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.24 -31.11 70.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.889 -1.132 . . . . 0.0 110.486 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.26 -39.23 95.9 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.6 mt -61.84 -38.44 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.09 0.956 . . . . 0.0 108.946 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.97 -54.79 24.93 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.623 -1.298 . . . . 0.0 112.065 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 m -66.74 -45.38 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 123.119 0.568 . . . . 0.0 110.513 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.97 -33.29 63.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.04 -28.88 67.77 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.958 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -65.55 -36.79 84.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 120.925 -1.11 . . . . 0.0 109.984 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.1 -17.97 20.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 125.135 1.374 . . . . 0.0 110.766 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -54.49 -24.41 20.32 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.701 1.2 . . . . 0.0 111.895 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.66 86.93 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.233 -1.542 . . . . 0.0 112.472 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.1 -45.17 70.91 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.66 1.184 . . . . 0.0 108.683 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.86 -37.36 85.97 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.621 0.724 . . . . 0.0 110.353 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.21 76.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.901 -1.124 . . . . 0.0 111.387 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.7 t -78.51 -0.38 29.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 120.607 -1.308 . . . . 0.0 110.27 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -33.89 65.43 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 119.25 0.932 . . . . 0.0 109.758 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -71.11 -31.07 67.3 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.767 -1.208 . . . . 0.0 110.508 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.07 -24.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.89 1.276 . . . . 0.0 109.455 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -58.52 -21.74 53.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.213 1.005 . . . . 0.0 112.38 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.88 -23.01 67.1 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.63 -1.294 . . . . 0.0 111.049 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 C--N 1.357 0.899 0 O-C-N 121.074 -1.016 . . . . 0.0 110.013 179.674 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.383 0 CA-C-O 122.759 1.266 . . . . 0.0 114.126 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.596 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 36.6 p-80 -58.35 -25.43 61.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.512 2.325 . . . . 0.0 115.413 -174.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -75.31 -27.15 59.18 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.338 -1.476 . . . . 0.0 110.435 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.47 -36.4 71.17 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.2 -0.937 . . . . 0.0 109.603 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.28 -38.44 65.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.93 0.892 . . . . 0.0 109.29 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.31 93.57 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.235 1.014 . . . . 0.0 111.858 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.23 -27.75 60.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.397 -0.815 . . . . 0.0 110.578 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.69 -33.0 66.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.9 84.72 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -58.8 -35.13 72.34 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.552 0.741 . . . . 0.0 112.128 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.33 -24.08 61.25 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.345 -0.847 . . . . 0.0 111.384 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -73.77 -35.96 65.04 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.82 -42.46 99.05 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.303 -0.873 . . . . 0.0 110.928 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -57.83 -38.07 74.97 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.346 1.058 . . . . 0.0 111.97 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.81 81.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.567 1.147 . . . . 0.0 109.892 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.67 -37.7 79.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 O-C-N 121.15 -0.969 . . . . 0.0 108.748 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.33 -36.48 73.46 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.742 0.817 . . . . 0.0 112.226 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -63.42 -51.91 63.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.703 1.201 . . . . 0.0 109.169 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -63.77 -40.43 96.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.494 0.664 . . . . 0.0 110.216 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -32.27 73.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.386 1.474 . . . . 0.0 112.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -68.94 -34.87 76.06 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.387 -0.821 . . . . 0.0 110.378 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -70.89 -37.59 73.01 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.22 -51.54 63.2 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 -17.55 63.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -82.66 -36.07 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 O-C-N 120.327 -1.483 . . . . 0.0 108.402 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -78.33 -41.8 32.53 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.81 90.23 7.83 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 143.99 2.09 0.0 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.987 3.715 . . . . 0.0 110.085 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -91.05 41.36 1.06 Allowed 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.594 -1.941 . . . . 0.0 112.408 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.31 44.67 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.389 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' C' ' 36' ' ' ALA . . . -103.75 157.42 33.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.21 98.64 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.658 2.239 . . . . 0.0 112.647 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 9.36 36.79 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -52.68 143.6 15.83 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.604 1.562 . . . . 0.0 112.591 -177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.88 -32.4 3.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 124.639 1.176 . . . . 0.0 108.807 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 tt -89.49 50.6 1.94 Allowed 'General case' 0 C--N 1.35 0.603 0 CA-C-O 122.898 1.332 . . . . 0.0 108.144 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.53 53.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 O-C-N 119.915 -1.741 . . . . 0.0 110.083 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -125.87 -151.17 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.89 -1.131 . . . . 0.0 108.401 -167.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -171.32 -64.12 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -69.6 -32.11 19.89 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.214 2.898 . . . . 0.0 112.386 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.469 ' CG ' HH22 ' C' ' 60' ' ' ARG . 8.3 p-10 -95.32 15.71 18.66 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.504 1.047 . . . . 0.0 109.88 -178.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -32.9 73.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.636 -1.29 . . . . 0.0 110.009 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -73.2 -22.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 O-C-N 121.562 -0.711 . . . . 0.0 109.84 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.24 -43.1 58.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.84 -37.24 86.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.75 1.22 . . . . 0.0 109.651 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -58.74 -35.22 72.37 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.73 1.212 . . . . 0.0 111.262 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.54 -52.72 56.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.007 0.923 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.36 -24.98 60.4 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 121.834 -0.541 . . . . 0.0 110.922 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -63.87 -42.77 97.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.002 1.321 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.38 73.9 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.34 -0.85 . . . . 0.0 112.05 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -3.02 45.54 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.158 -0.964 . . . . 0.0 111.405 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.255 3.1 p 59.8 21.71 10.57 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 127.479 2.312 . . . . 0.0 111.578 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.66 -48.05 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.53 74.53 0.35 Allowed Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -69.13 -24.96 64.16 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.217 -1.167 . . . . 0.0 110.867 -170.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.31 10.27 9.75 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.7 -61.4 2.38 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 126.737 2.015 . . . . 0.0 109.509 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.469 HH22 ' CG ' ' C' ' 43' ' ' ASP . 0.0 OUTLIER -145.6 174.14 11.44 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 171.5 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -167.53 154.37 7.86 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.14 170.63 8.22 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.005 2.47 . . . . 0.0 110.73 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.87 -146.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -76.83 -60.52 2.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 126.172 1.789 . . . . 0.0 109.914 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.91 -16.74 61.09 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.897 0.856 . . . . 0.0 110.264 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.412 ' CD ' ' HB2' ' C' ' 33' ' ' ALA . 13.6 mm-40 -75.35 -16.42 60.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.608 -0.682 . . . . 0.0 109.352 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.77 88.76 0.64 Allowed Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 101.252 -4.739 . . . . 0.0 101.252 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -64.47 -13.03 49.77 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.426 -1.632 . . . . 0.0 110.846 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -60.77 -14.07 19.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.165 0.986 . . . . 0.0 113.172 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.09 -37.4 79.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 O-C-N 120.833 -1.167 . . . . 0.0 109.584 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.83 57.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.085 -1.009 . . . . 0.0 108.953 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.69 -48.77 49.45 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.045 1.738 . . . . 0.0 112.235 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -67.69 -32.06 72.44 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 120.47 -1.394 . . . . 0.0 112.056 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.77 -37.62 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.057 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 55' ' ' VAL . 69.5 mtm -63.07 -45.89 90.0 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.538 0.735 . . . . 0.0 110.807 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -62.9 -35.61 80.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.718 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.3 77.93 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 118.271 0.487 . . . . 0.0 111.815 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.18 -53.32 22.69 Favored Glycine 0 CA--C 1.49 -1.482 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.76 -44.59 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.195 0.998 . . . . 0.0 109.382 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -65.39 -40.0 92.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.441 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.58 -50.1 69.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -66.9 -37.39 84.29 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.655 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.82 -32.89 74.67 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.104 0.962 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.19 -35.72 77.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 124.874 1.27 . . . . 0.0 110.963 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.69 -13.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 125.408 1.483 . . . . 0.0 111.118 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.8 m -62.04 -18.1 59.52 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.654 -1.904 . . . . 0.0 111.986 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.71 -17.33 62.87 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.571 -1.331 . . . . 0.0 111.594 170.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -83.45 -54.46 4.95 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.74 -28.44 66.82 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -165.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.76 -14.18 60.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.61 -1.931 . . . . 0.0 111.029 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -73.78 -17.14 61.13 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 119.94 -1.725 . . . . 0.0 109.828 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -30.13 70.43 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.245 0.618 . . . . 0.0 111.064 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -75.42 -23.89 57.04 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.027 -1.046 . . . . 0.0 110.911 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.67 -27.24 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 123.914 0.885 . . . . 0.0 108.675 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -67.49 -10.83 55.3 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.698 -0.626 . . . . 0.0 112.538 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -67.24 -36.65 82.09 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 120.782 -1.199 . . . . 0.0 109.074 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.436 -1.125 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -176.175 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.433 -1.277 0 CA-C-O 121.394 0.616 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.25 -64.86 0.46 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 129.017 2.927 . . . . 0.0 112.688 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' D' ' 2' ' ' ALA . 39.3 p-80 -62.91 -25.6 68.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 112.996 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -79.61 -39.67 31.08 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -64.07 -44.65 91.75 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.592 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.54 -37.21 86.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 110.563 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.84 72.6 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.092 -1.005 . . . . 0.0 110.215 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.32 -28.31 67.04 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.424 0.69 . . . . 0.0 110.646 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.97 -41.81 75.33 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 125.697 1.599 . . . . 0.0 110.964 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.15 86.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.286 0.634 . . . . 0.0 111.5 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.91 -26.03 65.79 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.069 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -71.43 -33.2 69.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.9 -1.125 . . . . 0.0 109.969 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -65.42 -40.04 92.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 123.905 0.882 . . . . 0.0 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.88 -42.61 89.91 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.09 0.556 . . . . 0.0 111.527 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.3 -36.98 79.14 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 112.28 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -68.87 -39.79 79.64 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 110.003 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.06 -40.41 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.15 -53.1 60.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.951 0.796 . . . . 0.0 110.554 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -59.72 -50.02 75.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.869 0.868 . . . . 0.0 111.166 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -73.67 -29.05 62.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.857 -1.152 . . . . 0.0 111.513 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.88 63.94 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -58.51 -45.08 89.54 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.377 1.071 . . . . 0.0 110.565 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -60.9 -49.91 75.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -64.16 -31.82 73.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 123.923 0.889 . . . . 0.0 111.599 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.33 68.77 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.346 0.975 . . . . 0.0 110.693 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -88.01 -32.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 O-C-N 121.393 -0.817 . . . . 0.0 111.793 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -75.29 -23.87 57.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.227 -1.545 . . . . 0.0 111.413 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.0 37.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.72 -86.54 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 mtm-85 -17.32 90.45 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 129.121 2.968 . . . . 0.0 115.361 -151.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -30.79 2.0 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 107.021 -2.432 . . . . 0.0 107.021 -171.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.62 141.24 25.57 Favored Pre-proline 0 C--N 1.353 0.727 0 C-N-CA 125.728 1.611 . . . . 0.0 114.396 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.07 92.83 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.698 2.266 . . . . 0.0 113.345 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.68 -43.55 1.48 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 103.667 -3.773 . . . . 0.0 103.667 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.68 -179.17 0.17 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.551 1.94 . . . . 0.0 109.894 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.7 -41.79 0.05 Allowed 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.75 -14.75 13.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.05 1.34 . . . . 0.0 112.39 -167.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 pt -43.2 105.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -174.91 -143.53 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.6 -58.8 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.09 0 C-N-CA 126.641 1.977 . . . . 0.0 107.553 173.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.6 -20.71 26.53 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 126.064 3.201 . . . . 0.0 112.334 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.68 6.11 42.87 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 118.632 0.651 . . . . 0.0 110.241 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.0 -50.69 67.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.394 -0.817 . . . . 0.0 109.758 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.6 -7.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.013 0.911 . . . . 0.0 110.625 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 -28.24 15.92 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -83.74 -28.51 28.18 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.4 1.0 . . . . 0.0 108.947 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.8 t -78.17 62.69 2.94 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.484 -1.385 . . . . 0.0 108.717 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 84.4 t -137.87 -77.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.99 -5.61 54.29 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.003 -1.061 . . . . 0.0 111.606 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -82.04 -17.16 47.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 121.076 -1.015 . . . . 0.0 108.493 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.09 -32.77 56.88 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.898 -1.126 . . . . 0.0 109.158 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -91.36 16.86 9.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.193 0.597 . . . . 0.0 110.336 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p 55.1 52.45 11.7 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.143 1.777 . . . . 0.0 114.373 170.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -127.11 -61.87 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 87.65 -51.32 4.11 Favored Glycine 0 CA--C 1.496 -1.13 0 O-C-N 119.997 -1.689 . . . . 0.0 109.785 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 74.89 -24.76 0.21 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 128.151 2.58 . . . . 0.0 110.615 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 111.25 23.87 5.61 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.02 -65.91 0.64 Allowed 'General case' 0 C--N 1.36 1.063 0 CA-C-N 118.905 1.352 . . . . 0.0 110.056 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -126.81 161.72 27.55 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.57 89.06 7.61 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 117.858 -1.067 . . . . 0.0 109.168 -170.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.17 158.85 56.14 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.823 2.349 . . . . 0.0 111.875 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.539 HG22 ' H ' ' D' ' 64' ' ' THR . 3.6 p -111.8 -162.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 120.161 1.346 . . . . 0.0 110.788 -174.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.539 ' H ' HG22 ' D' ' 63' ' ' VAL . 1.3 p -70.09 -49.73 47.97 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 128.968 2.907 . . . . 0.0 111.258 -174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -69.65 -30.63 68.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.003 0.921 . . . . 0.0 110.942 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 8.4 pt-20 -79.49 -1.27 36.77 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.83 82.44 0.21 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 104.131 -3.588 . . . . 0.0 104.131 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -50.87 -22.09 2.03 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 120.642 2.221 . . . . 0.0 111.75 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -43.8 -23.08 0.07 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.412 1.885 . . . . 0.0 115.42 161.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.37 -43.91 97.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.588 1.54 . . . . 0.0 108.778 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.54 87.29 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.026 0.53 . . . . 0.0 110.22 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -57.56 -41.91 81.96 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.722 1.209 . . . . 0.0 110.466 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -62.23 -40.36 95.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.347 1.059 . . . . 0.0 111.429 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.06 -42.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -60.98 -46.43 90.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.526 0.73 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -66.84 -36.12 81.61 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 121.438 -0.789 . . . . 0.0 111.523 -175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -44.75 93.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 121.764 -0.585 . . . . 0.0 110.047 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.04 -47.81 89.21 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 124.465 1.031 . . . . 0.0 112.537 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.17 -49.39 81.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.63 1.172 . . . . 0.0 109.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.36 -31.46 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.477 -0.764 . . . . 0.0 111.429 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.4 -53.0 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 118.862 0.756 . . . . 0.0 110.136 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.53 -32.29 72.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.811 -0.555 . . . . 0.0 110.957 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.54 -39.86 92.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.694 1.198 . . . . 0.0 110.802 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.77 -22.42 12.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 124.766 1.226 . . . . 0.0 110.982 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -60.87 -12.21 10.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.0 95.16 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 118.784 -2.447 . . . . 0.0 112.27 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.88 72.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 36.9 mt -80.36 -28.51 38.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.722 0.772 . . . . 0.0 110.876 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.94 -26.32 59.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 120.326 -1.484 . . . . 0.0 110.025 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -78.65 -2.78 40.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.773 -1.204 . . . . 0.0 109.949 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.251 11.8 m-20 -78.68 -16.83 56.83 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 120.68 1.582 . . . . 0.0 111.663 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -80.68 -11.89 59.56 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.227 -1.546 . . . . 0.0 109.846 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.75 -32.85 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -61.7 -19.29 62.2 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.804 1.642 . . . . 0.0 111.872 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -65.18 -22.16 66.86 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.445 1.098 . . . . 0.0 111.439 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.433 -1.281 0 C-N-CA 126.359 1.864 . . . . 0.0 106.16 -170.954 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 73.13 -58.27 0.61 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.958 2.103 . . . . 0.0 111.11 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 2' ' ' ALA . 28.9 p80 -61.99 -30.51 70.99 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.962 1.705 . . . . 0.0 111.098 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -67.06 -45.13 78.33 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.67 1.188 . . . . 0.0 108.46 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.04 -44.53 96.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.98 0.912 . . . . 0.0 109.687 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -66.23 -32.97 74.71 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.443 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.38 88.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 121.569 -0.707 . . . . 0.0 110.454 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -69.91 -31.13 68.76 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.614 0.721 . . . . 0.0 110.967 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -66.7 -38.52 86.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.907 0.883 . . . . 0.0 110.088 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.04 77.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.772 0.829 . . . . 0.0 111.075 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.45 -37.11 84.63 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.79 0.836 . . . . 0.0 111.559 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -65.87 -43.42 88.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.78 -32.73 73.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 110.224 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.7 -39.95 91.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.375 0.67 . . . . 0.0 111.525 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -64.64 -32.93 74.81 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.592 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -64.82 -39.76 94.1 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.71 0.804 . . . . 0.0 109.915 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.03 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 O-C-N 120.704 -1.248 . . . . 0.0 109.479 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.2 mt -60.99 -37.41 82.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.292 -0.88 . . . . 0.0 111.573 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.99 -45.48 73.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.933 0.893 . . . . 0.0 109.16 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -63.0 -43.64 98.22 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.969 -0.457 . . . . 0.0 109.814 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.31 74.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.873 1.669 . . . . 0.0 111.554 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -65.96 -37.38 85.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 122.153 -0.342 . . . . 0.0 110.964 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -73.09 -45.59 56.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -61.47 -46.28 90.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.07 53.16 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.027 1.331 . . . . 0.0 111.271 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.99 -39.39 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.767 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -81.96 -15.03 55.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.267 -1.521 . . . . 0.0 111.383 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.65 7.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.84 -33.15 74.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.251 1.021 . . . . 0.0 111.465 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -72.31 108.48 5.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 119.541 -1.974 . . . . 0.0 110.356 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.07 -18.83 7.4 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.43 143.82 42.24 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 117.519 0.66 . . . . 0.0 111.0 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.63 116.12 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.575 2.183 . . . . 0.0 111.983 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.3 45.18 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.95 -67.37 0.27 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 127.616 2.366 . . . . 0.0 109.845 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 90.22 -31.1 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 126.754 2.022 . . . . 0.0 108.733 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -89.46 124.92 34.93 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.3 pt -137.63 -3.97 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.986 -1.071 . . . . 0.0 112.483 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -117.99 152.86 34.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 120.097 1.317 . . . . 0.0 109.942 -164.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -83.03 -55.69 0.5 Allowed Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.02 -17.92 28.03 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 CA-C-N 125.404 2.966 . . . . 0.0 111.706 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.64 -21.05 25.52 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.39 70.53 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 120.997 -1.064 . . . . 0.0 110.541 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.68 -28.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.541 -0.725 . . . . 0.0 109.553 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.37 68.71 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 119.752 -1.843 . . . . 0.0 109.927 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -62.79 -47.63 82.63 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.165 0.986 . . . . 0.0 109.815 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -68.73 -28.44 66.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.291 -1.505 . . . . 0.0 111.698 -172.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.4 t -56.83 -54.31 31.11 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 124.153 0.981 . . . . 0.0 109.974 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -20.26 61.29 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.787 -0.57 . . . . 0.0 111.116 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.6 m -75.14 -40.36 59.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.37 1.068 . . . . 0.0 109.218 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -26.55 63.07 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 120.86 -1.15 . . . . 0.0 111.359 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 p -83.37 -1.18 52.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.916 -0.49 . . . . 0.0 110.12 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 p 55.3 39.76 31.38 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 126.386 1.874 . . . . 0.0 111.538 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -104.23 -75.12 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.42 91.77 0.12 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CZ ' ' HA3' ' B' ' 56' ' ' GLY . 0.3 OUTLIER -75.95 -28.24 57.86 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.834 -1.392 . . . . 0.0 109.734 -172.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.33 3.64 5.63 Favored Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.6 -50.94 70.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.5 1.52 . . . . 0.0 113.29 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -142.06 158.62 43.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.33 148.06 20.51 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 102.934 -2.987 . . . . 0.0 102.934 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -90.79 171.09 3.41 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.901 2.4 . . . . 0.0 110.707 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.01 -154.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.686 0 CA-C-O 122.61 1.195 . . . . 0.0 110.291 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -83.51 -52.89 6.11 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.029 -1.669 . . . . 0.0 110.89 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -63.65 -32.2 73.6 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.798 2.439 . . . . 0.0 111.657 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -28.04 69.57 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 123.309 1.528 . . . . 0.0 108.1 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 65.74 1.22 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 103.097 -4.001 . . . . 0.0 103.097 174.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -27.78 -26.79 0.0 OUTLIER 'General case' 0 C--N 1.376 1.742 1 C-N-CA 131.715 4.006 . . . . 0.0 116.043 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -55.02 -12.77 0.92 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.366 2.666 . . . . 0.0 113.201 167.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 -52.13 34.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.11 99.68 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.555 -0.716 . . . . 0.0 111.347 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -50.6 -47.46 58.14 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.364 1.466 . . . . 0.0 111.379 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.66 -40.91 96.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.58 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.84 -43.77 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.205 1.002 . . . . 0.0 109.375 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.04 -49.1 78.98 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 124.391 1.076 . . . . 0.0 110.111 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -64.38 -35.04 79.6 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.631 -0.668 . . . . 0.0 110.897 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.38 80.6 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.147 0.579 . . . . 0.0 111.262 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.05 -43.65 80.71 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.54 -43.66 97.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 124.279 1.032 . . . . 0.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -60.41 -39.96 89.25 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.393 -0.817 . . . . 0.0 111.271 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.06 -54.28 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.103 0.961 . . . . 0.0 109.537 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -61.67 -40.08 93.67 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.421 0.689 . . . . 0.0 111.302 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.36 80.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.914 0.885 . . . . 0.0 110.981 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.58 -35.24 79.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.529 1.132 . . . . 0.0 110.804 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.12 -16.79 7.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 125.301 1.44 . . . . 0.0 111.206 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.0 m -56.6 -24.35 47.16 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.12 -1.612 . . . . 0.0 112.48 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.18 -23.78 62.52 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.842 -1.161 . . . . 0.0 112.439 172.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.59 -3.88 21.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.623 1.169 . . . . 0.0 111.587 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.5 mt -96.67 -42.98 7.76 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.45 64.64 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.343 -0.848 . . . . 0.0 111.067 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -71.32 -20.48 62.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 120.632 -1.292 . . . . 0.0 111.161 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.265 25.5 m-20 -86.8 -8.95 56.88 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.249 -162.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -81.96 -32.36 30.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.442 165.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.67 -32.67 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.789 1.236 . . . . 0.0 109.075 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -53.22 -24.67 11.65 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.583 1.553 . . . . 0.0 112.543 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -54.26 -39.33 66.76 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.596 1.559 . . . . 0.0 110.774 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 N--CA 1.444 -0.753 0 O-C-N 121.591 -0.693 . . . . 0.0 111.643 -175.481 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 121.871 0.844 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.714 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 35.1 p-80 -63.9 -21.48 66.48 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.501 1.52 . . . . 0.0 111.769 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -35.09 76.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.666 1.187 . . . . 0.0 109.044 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -68.69 -31.68 70.94 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.407 -0.808 . . . . 0.0 110.894 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.07 -27.9 63.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.297 0.57 . . . . 0.0 110.075 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.35 -35.62 78.01 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.305 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.73 -28.72 61.85 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.436 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.69 -38.34 90.66 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.393 -0.817 . . . . 0.0 109.817 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.45 89.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.956 0.903 . . . . 0.0 110.99 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.45 -37.91 89.18 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 121.302 -0.874 . . . . 0.0 111.335 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -65.62 -41.25 92.9 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.386 -0.821 . . . . 0.0 109.713 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.39 -37.23 74.88 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.765 1.226 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -63.67 -42.67 98.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.26 -29.07 68.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.543 -0.723 . . . . 0.0 111.423 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -66.47 -46.89 74.85 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.804 1.242 . . . . 0.0 109.851 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -76.01 -19.33 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 121.534 -0.729 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.75 -43.3 99.16 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 119.533 1.06 . . . . 0.0 110.323 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.54 -39.18 77.63 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -68.87 -31.93 71.23 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.199 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.32 -32.36 73.93 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.752 1.221 . . . . 0.0 110.636 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.0 t -62.2 -48.23 80.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.429 1.092 . . . . 0.0 109.269 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -60.98 -53.39 57.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 108.793 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -65.15 -38.44 90.58 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.33 -54.05 43.06 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.676 1.126 . . . . 0.0 110.984 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.24 -36.59 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.814 -0.554 . . . . 0.0 110.082 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.51 -31.88 57.94 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.18 -0.95 . . . . 0.0 110.33 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.5 -41.87 37.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 O-C-N 121.911 -0.493 . . . . 0.0 110.011 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.31 -28.23 69.17 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 121.87 0.843 . . . . 0.0 111.954 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -72.28 107.53 4.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 119.73 -1.856 . . . . 0.0 110.621 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.02 -24.13 4.56 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 106.594 -2.602 . . . . 0.0 106.594 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 147.22 84.37 Favored Pre-proline 0 N--CA 1.444 -0.759 0 O-C-N 121.94 -0.741 . . . . 0.0 111.444 -171.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.92 145.62 22.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.441 2.094 . . . . 0.0 109.689 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.95 -67.55 3.69 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.04 157.45 0.11 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.936 2.894 . . . . 0.0 109.946 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.27 -43.82 0.37 Allowed 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 120.922 -1.111 . . . . 0.0 108.907 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' B' ' 60' ' ' ARG . 12.7 tp -121.64 111.43 17.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.8 80.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 120.336 -1.478 . . . . 0.0 108.649 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -159.11 158.86 33.74 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.81 -61.58 0.24 Allowed Pre-proline 0 C--N 1.347 0.5 0 CA-C-O 116.971 -1.49 . . . . 0.0 109.204 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.5 -9.53 24.22 Favored 'Trans proline' 0 CA--C 1.511 -0.646 0 CA-C-N 124.835 2.763 . . . . 0.0 112.121 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.08 -22.22 16.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -40.33 82.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 121.452 -0.78 . . . . 0.0 109.25 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -66.16 -27.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 122.737 0.415 . . . . 0.0 110.937 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -73.14 -43.17 61.97 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.465 -0.772 . . . . 0.0 109.09 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.47 -31.93 73.24 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 125.071 1.349 . . . . 0.0 110.036 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 m -63.06 -36.47 83.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 119.08 -2.262 . . . . 0.0 112.45 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 t -64.87 -45.51 94.66 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 121.534 -0.729 . . . . 0.0 110.54 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -65.42 -33.83 76.86 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 122.008 0.909 . . . . 0.0 110.302 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 87.4 m -67.56 -41.3 84.45 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.285 -0.884 . . . . 0.0 109.85 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.75 61.78 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.173 -0.954 . . . . 0.0 112.189 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -97.29 0.86 48.79 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.263 18.7 p 62.21 31.37 17.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.863 1.665 . . . . 0.0 113.775 173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 78.87 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 57' ' ' TYR . . . -90.93 120.08 5.83 Favored Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 103.584 -3.806 . . . . 0.0 103.584 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -86.08 -84.95 0.16 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -168.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.95 37.6 0.31 Allowed Glycine 0 CA--C 1.479 -2.205 0 N-CA-C 106.292 -2.723 . . . . 0.0 106.292 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.1 -62.1 1.56 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' B' ' 38' ' ' LEU . 62.4 mtt-85 -143.22 170.61 15.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -156.76 153.58 24.75 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.96 173.83 8.84 Favored 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 124.25 3.3 . . . . 0.0 109.692 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.34 -99.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 119.695 1.134 . . . . 0.0 112.505 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.7 m -150.46 -40.07 0.13 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.029 1.732 . . . . 0.0 109.106 -172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -88.45 -20.5 25.11 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.283 -0.886 . . . . 0.0 110.645 -169.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -35.08 73.51 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 126.303 1.841 . . . . 0.0 108.315 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.38 90.02 1.88 Allowed Glycine 0 CA--C 1.467 -2.927 1 N-CA-C 97.802 -6.119 . . . . 0.0 97.802 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -56.42 -18.99 12.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.261 1.825 . . . . 0.0 111.382 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -54.72 -22.65 14.63 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 127.104 2.162 . . . . 0.0 113.135 168.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.26 -43.62 98.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.806 -1.184 . . . . 0.0 108.841 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.76 67.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.742 -0.599 . . . . 0.0 109.485 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -52.87 -45.04 67.26 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.482 1.513 . . . . 0.0 110.818 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.57 -39.82 85.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.001 0.92 . . . . 0.0 111.364 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.96 -41.22 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 109.086 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.5 mtt -60.43 -47.54 85.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.81 0.844 . . . . 0.0 110.049 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.927 -0.483 . . . . 0.0 111.134 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.37 90.76 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.766 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.23 -46.17 88.38 Favored Glycine 0 CA--C 1.495 -1.198 0 C-N-CA 124.061 0.839 . . . . 0.0 111.153 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.89 -46.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 C-N-CA 124.443 1.097 . . . . 0.0 109.182 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -62.76 -51.48 66.96 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.315 -0.866 . . . . 0.0 112.327 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.24 -40.84 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 O-C-N 121.76 -0.587 . . . . 0.0 111.081 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -74.22 -38.57 63.52 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.96 74.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.54 -0.725 . . . . 0.0 111.016 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.28 -30.57 71.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.756 1.222 . . . . 0.0 111.068 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.537 HG12 HD23 ' B' ' 89' ' ' LEU . 92.1 t -63.93 -14.91 15.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.879 1.272 . . . . 0.0 110.397 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 20.6 m -55.86 -23.46 30.96 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.6 -1.313 . . . . 0.0 110.894 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.45 74.92 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 119.251 -2.156 . . . . 0.0 112.446 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.714 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.61 -45.15 17.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 120.903 -1.123 . . . . 0.0 108.047 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.537 HD23 HG12 ' B' ' 85' ' ' VAL . 2.2 mm? -70.9 -27.7 63.99 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.877 0.871 . . . . 0.0 111.336 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.06 -17.07 62.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 120.689 -1.257 . . . . 0.0 111.192 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -76.72 -13.92 59.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 120.559 -1.338 . . . . 0.0 111.128 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.259 7.4 t70 -75.71 -18.23 59.67 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 120.231 1.378 . . . . 0.0 111.218 -167.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.43 -36.13 60.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 119.895 -1.753 . . . . 0.0 110.234 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.35 -28.82 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 126.029 1.731 . . . . 0.0 109.437 -171.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -44.21 -36.75 2.83 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 126.835 2.054 . . . . 0.0 112.013 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -58.33 -33.12 69.15 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 123.917 0.887 . . . . 0.0 111.753 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 N--CA 1.44 -0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 107.971 -173.181 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.495 -1.173 0 CA-C-O 120.811 0.338 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -61.29 -28.34 69.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.93 -37.57 64.55 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 120.137 1.335 . . . . 0.0 107.837 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -73.84 -38.31 64.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -68.43 -35.19 77.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.969 -0.457 . . . . 0.0 110.345 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.56 90.07 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.8 0.84 . . . . 0.0 110.796 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.64 -38.22 83.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.832 -0.542 . . . . 0.0 110.556 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.89 -40.42 92.98 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.72 0.808 . . . . 0.0 110.328 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.15 75.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.588 0.755 . . . . 0.0 111.588 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -38.49 86.41 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.791 -0.568 . . . . 0.0 111.403 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.71 -30.67 69.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 122.219 1.009 . . . . 0.0 109.846 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.29 -33.56 71.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.803 0.841 . . . . 0.0 109.213 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.35 -43.87 93.22 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.42 0.688 . . . . 0.0 110.649 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -52.36 -41.04 62.73 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.906 1.282 . . . . 0.0 111.771 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -24.17 61.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.845 0.858 . . . . 0.0 111.199 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -78.42 -36.55 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.73 -41.85 91.82 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.815 1.246 . . . . 0.0 111.14 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -74.36 -14.95 60.95 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.58 -36.15 19.05 Favored 'General case' 0 CA--C 1.493 -1.232 0 O-C-N 120.672 -1.268 . . . . 0.0 108.023 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.49 72.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.033 0.933 . . . . 0.0 111.152 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -68.95 -36.84 78.39 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.992 0.815 . . . . 0.0 110.432 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -71.15 -43.8 66.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.93 -49.88 76.15 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.591 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.8 86.65 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.432 1.093 . . . . 0.0 112.017 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -37.07 74.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.283 -1.511 . . . . 0.0 110.187 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -73.85 -31.92 63.41 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 120.751 -1.218 . . . . 0.0 109.279 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.24 15.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 126.06 1.744 . . . . 0.0 109.053 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.64 -25.96 64.18 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.143 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.61 104.91 2.5 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 119.481 -2.012 . . . . 0.0 110.59 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.47 -5.76 21.09 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 144.31 28.87 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.68 139.6 11.27 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.367 2.045 . . . . 0.0 110.277 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.65 81.46 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.58 116.01 4.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 125.74 1.616 . . . . 0.0 106.906 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.74 -33.55 15.7 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' C' ' 44' ' ' ALA . 24.5 tp -90.72 127.84 36.45 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 pt -144.88 168.8 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 101.222 -3.622 . . . . 0.0 101.222 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m 74.8 131.2 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.407 1.883 . . . . 0.0 113.402 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -58.64 -49.09 95.35 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 116.194 -1.86 . . . . 0.0 112.527 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.53 -27.94 38.78 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.297 2.928 . . . . 0.0 113.491 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.339 4.8 p-10 -98.7 -1.64 40.15 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 120.739 1.609 . . . . 0.0 111.035 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 38' ' ' LEU . . . -69.08 -34.17 74.69 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 120.713 -1.242 . . . . 0.0 110.878 173.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.66 -16.71 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 O-C-N 121.091 -1.006 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.08 -41.48 28.63 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.887 -1.133 . . . . 0.0 108.304 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.7 -33.29 75.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.858 0.837 . . . . 0.0 109.977 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -77.29 53.85 1.05 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 120.935 -1.103 . . . . 0.0 111.144 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -141.69 -54.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -34.25 71.13 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.741 1.216 . . . . 0.0 112.422 -172.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -72.68 -33.29 66.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 125.313 1.445 . . . . 0.0 109.898 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.1 -31.09 58.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.411 -1.431 . . . . 0.0 110.309 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -85.01 -1.74 57.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.171 0.588 . . . . 0.0 110.727 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p 51.13 68.01 0.86 Allowed 'General case' 0 C--N 1.352 0.709 0 C-N-CA 127.695 2.398 . . . . 0.0 112.099 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.12 -75.87 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.65 -78.94 0.63 Allowed Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -173.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 83.28 -49.62 0.15 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 127.746 2.419 . . . . 0.0 106.434 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.24 42.49 0.25 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -70.24 -54.12 14.12 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -139.4 -169.57 2.71 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.09 137.71 11.49 Favored Pre-proline 0 N--CA 1.438 -1.067 1 N-CA-C 100.153 -4.017 . . . . 0.0 100.153 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.07 163.0 0.26 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 CA-C-N 123.695 2.355 . . . . 0.0 109.389 166.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.596 HG22 ' H ' ' C' ' 64' ' ' THR . 9.8 p -107.19 -177.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-O 123.24 1.495 . . . . 0.0 111.558 -169.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.596 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.9 m -68.64 -34.82 76.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 119.085 -2.259 . . . . 0.0 111.211 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -78.68 -23.64 45.53 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 -170.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -67.07 -34.76 78.37 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.34 67.32 0.81 Allowed Glycine 0 CA--C 1.461 -3.327 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 171.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.44 ' HA ' ' OE2' ' C' ' 66' ' ' GLU 0.272 6.4 ttm180 -54.24 1.54 0.02 OUTLIER 'General case' 0 C--N 1.373 1.617 0 C-N-CA 127.582 2.353 . . . . 0.0 116.539 -166.061 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -54.54 -24.17 19.67 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 127.1 2.16 . . . . 0.0 111.48 155.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.24 -50.25 69.76 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 CA-C-N 120.639 1.563 . . . . 0.0 108.439 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.8 75.42 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.901 0.88 . . . . 0.0 110.869 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -51.87 -44.17 63.59 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.782 1.633 . . . . 0.0 112.081 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -62.4 -35.4 79.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.071 1.348 . . . . 0.0 110.899 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.43 -40.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 O-C-N 121.61 -0.681 . . . . 0.0 109.358 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -59.65 -46.79 87.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.853 1.261 . . . . 0.0 110.115 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.67 -41.08 98.89 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.966 -0.459 . . . . 0.0 110.707 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.98 89.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.883 0.473 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.78 87.87 Favored Glycine 0 CA--C 1.494 -1.232 0 C-N-CA 123.744 0.687 . . . . 0.0 111.534 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.66 -44.27 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 123.983 0.913 . . . . 0.0 109.648 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.91 -33.63 76.48 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.397 -0.815 . . . . 0.0 111.911 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.78 -53.68 28.91 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 123.642 0.777 . . . . 0.0 109.581 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -67.11 -36.13 81.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.53 87.58 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.342 0.657 . . . . 0.0 110.644 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.67 -35.39 74.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.213 1.405 . . . . 0.0 111.775 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.63 -16.46 10.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 C-N-CA 125.255 1.422 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -62.72 -13.26 30.46 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 119.602 -1.936 . . . . 0.0 112.166 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.85 67.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.923 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.2 -55.69 4.57 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.01 -38.63 86.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.403 1.481 . . . . 0.0 113.304 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.68 61.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.558 -1.339 . . . . 0.0 110.852 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 68.7 p -88.78 -12.37 42.26 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 120.82 -1.175 . . . . 0.0 110.616 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.37 -28.45 67.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.229 0.922 . . . . 0.0 110.537 -167.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -77.08 -33.44 57.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.93 -33.06 56.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 125.366 1.466 . . . . 0.0 108.685 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -52.51 -24.17 7.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.636 1.974 . . . . 0.0 113.956 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -58.01 -32.98 68.45 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 119.756 1.162 . . . . 0.0 112.111 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.438 -1.048 0 O-C-N 121.144 -0.973 . . . . 0.0 111.04 -178.486 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.74 -35.65 81.76 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 121.722 -0.612 . . . . 0.0 111.326 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.446 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 7.3 p80 -73.32 -23.93 60.31 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 121.013 -1.055 . . . . 0.0 111.42 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.446 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 0.1 OUTLIER -83.16 -27.95 29.71 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -63.78 -42.32 97.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.361 1.065 . . . . 0.0 110.361 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.7 -38.74 84.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.839 0.828 . . . . 0.0 109.148 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.26 89.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.39 1.076 . . . . 0.0 111.413 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -69.84 -28.76 65.96 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.529 -0.732 . . . . 0.0 110.766 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.75 69.67 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.337 0.655 . . . . 0.0 111.738 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.97 -36.13 82.49 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.44 -0.787 . . . . 0.0 111.365 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.07 -27.11 60.75 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.927 -1.108 . . . . 0.0 110.647 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.72 -27.5 65.03 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.475 -0.765 . . . . 0.0 110.463 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 tp -71.79 -39.19 70.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.342 -0.848 . . . . 0.0 109.996 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -62.42 -31.92 72.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 123.424 0.69 . . . . 0.0 111.519 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.03 -45.5 92.6 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.504 1.122 . . . . 0.0 110.224 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -67.8 -35.67 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 123.917 0.887 . . . . 0.0 109.244 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.27 -53.69 54.71 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.288 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -68.68 -40.89 79.87 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.451 -0.78 . . . . 0.0 110.777 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.93 -47.33 83.72 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 109.837 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.56 60.93 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 121.009 -1.057 . . . . 0.0 111.771 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -66.04 -40.33 90.89 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 109.742 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -71.23 -25.57 62.55 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.34 1.456 . . . . 0.0 110.084 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -79.22 -55.5 5.05 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.4 -43.87 79.72 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 126.228 1.811 . . . . 0.0 112.531 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -31.8 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -83.96 -34.45 24.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.12 -50.45 54.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 127.009 2.124 . . . . 0.0 109.92 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.88 -41.84 99.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.999 1.32 . . . . 0.0 110.231 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -62.2 121.77 13.95 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 119.722 -1.861 . . . . 0.0 110.233 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.19 -12.44 48.48 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.22 56.66 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 118.144 0.972 . . . . 0.0 110.504 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.85 141.81 19.49 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.894 1.73 . . . . 0.0 109.775 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.81 75.51 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.57 139.28 58.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 111.666 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.91 -29.39 2.33 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 124.5 1.12 . . . . 0.0 110.185 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 30.0 tp -81.4 -106.77 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' D' ' 40' ' ' SER 0.285 35.5 mt 71.97 173.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 -172.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.469 ' H ' HG22 ' D' ' 39' ' ' ILE . 39.0 t 73.17 124.36 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.225 1.488 . . . . 0.0 110.511 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -66.66 -50.11 47.13 Favored Pre-proline 0 C--N 1.348 0.503 0 O-C-N 119.802 -1.811 . . . . 0.0 110.778 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -71.67 -11.71 28.23 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 125.074 2.848 . . . . 0.0 112.227 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.92 -45.3 12.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.61 72.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.048 0.939 . . . . 0.0 112.394 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -82.81 1.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.723 0.773 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -43.27 7.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 119.693 -1.879 . . . . 0.0 106.202 171.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -57.79 -32.57 67.67 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.346 1.858 . . . . 0.0 111.967 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 p -68.9 -34.6 75.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.026 -2.296 . . . . 0.0 110.321 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 t -87.93 63.43 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 0.0 108.795 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -175.87 -31.43 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 50.2 m -62.51 -39.28 93.03 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.346 1.458 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.62 65.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.135 -0.978 . . . . 0.0 112.176 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.97 4.38 45.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 122.68 0.392 . . . . 0.0 110.177 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.26 1.0 OUTLIER 64.67 10.63 6.11 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.04 1.736 . . . . 0.0 112.927 174.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.65 -65.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 -63.82 4.22 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.55 -60.57 0.53 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.301 2.24 . . . . 0.0 109.692 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.47 -95.07 0.1 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . 0.286 10.7 t70 43.62 -101.73 0.04 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.178 2.191 . . . . 0.0 113.79 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 170.05 15.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -124.94 150.62 66.84 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.82 165.72 19.72 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.142 2.561 . . . . 0.0 109.427 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.44 -162.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 122.913 1.34 . . . . 0.0 107.837 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -86.58 -52.18 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 125.639 1.576 . . . . 0.0 109.059 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.54 -23.41 64.52 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 128.83 2.852 . . . . 0.0 110.345 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.99 -26.42 66.02 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 123.888 1.804 . . . . 0.0 108.398 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.8 67.6 1.31 Allowed Glycine 0 CA--C 1.462 -3.239 1 N-CA-C 99.483 -5.447 . . . . 0.0 99.483 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -34.22 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.36 1.028 1 C-N-CA 132.134 4.174 . . . . 0.0 114.765 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -55.75 -15.27 2.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 127.387 2.275 . . . . 0.0 113.273 165.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -72.29 -54.9 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.28 85.48 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.014 0.926 . . . . 0.0 112.14 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.13 -45.29 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.808 2.043 . . . . 0.0 112.108 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.59 -29.65 64.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 121.832 -0.542 . . . . 0.0 110.94 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -72.68 -47.22 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -70.88 -41.39 71.42 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.092 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -64.02 -41.83 97.32 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 121.272 -0.892 . . . . 0.0 110.736 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.07 79.23 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.604 -0.685 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.7 -45.54 96.06 Favored Glycine 0 CA--C 1.494 -1.278 0 C-N-CA 123.827 0.727 . . . . 0.0 111.654 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 86.7 mt -58.67 -47.06 90.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 124.273 1.029 . . . . 0.0 109.409 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -63.72 -34.78 78.63 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.383 -0.823 . . . . 0.0 112.125 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.93 -50.07 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.604 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.72 -21.25 64.41 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.599 -0.688 . . . . 0.0 111.142 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.11 -37.7 25.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.35 -37.2 84.74 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.975 1.31 . . . . 0.0 110.652 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.32 -2.73 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.335 -0.853 . . . . 0.0 112.39 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 24.9 m -63.09 -16.84 61.29 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.818 -1.176 . . . . 0.0 110.856 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.91 -38.05 81.19 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.863 -1.773 . . . . 0.0 111.908 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.24 63.37 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 120.555 -1.341 . . . . 0.0 108.423 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.57 -37.8 87.58 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.807 1.243 . . . . 0.0 111.532 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -21.37 63.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.419 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -85.23 -16.19 41.04 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.48 -38.48 84.44 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.765 -1.209 . . . . 0.0 110.112 -170.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -70.59 -29.51 65.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.291 -1.505 . . . . 0.0 111.043 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.26 -20.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 109.502 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -50.74 -37.45 41.89 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.888 1.675 . . . . 0.0 110.233 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -56.77 -36.22 69.56 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.987 1.315 . . . . 0.0 111.197 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -171.02 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.272 0 CA-C-O 123.547 1.641 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -57.1 2.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -57.04 -24.16 51.77 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 128.079 2.552 . . . . 0.0 114.941 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.88 -28.58 61.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.509 -1.369 . . . . 0.0 110.07 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.87 -32.44 65.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.003 -1.06 . . . . 0.0 110.187 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -71.57 -38.23 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.212 1.005 . . . . 0.0 109.183 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.33 86.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.821 0.848 . . . . 0.0 111.158 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -73.32 -22.28 60.36 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.085 -1.009 . . . . 0.0 111.788 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -73.05 -23.84 60.63 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.129 -0.982 . . . . 0.0 109.879 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.43 77.85 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.9 -1.125 . . . . 0.0 109.98 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.8 -30.26 71.37 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.574 -0.704 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 120.891 -1.13 . . . . 0.0 111.176 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -68.79 -31.2 70.04 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.618 0.767 . . . . 0.0 109.074 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.07 -40.48 94.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.649 0.737 . . . . 0.0 110.635 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -70.06 -25.27 63.46 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.16 -0.962 . . . . 0.0 111.419 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -71.2 -46.68 60.73 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -70.94 -25.2 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 121.604 -0.685 . . . . 0.0 110.132 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.55 -55.17 38.52 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 118.963 0.802 . . . . 0.0 110.471 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.38 -31.47 67.34 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.624 -0.673 . . . . 0.0 110.986 -174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.23 -48.31 70.99 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.916 -1.115 . . . . 0.0 109.627 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.14 63.39 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 123.989 0.915 . . . . 0.0 112.144 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.4 m -65.65 -39.74 91.74 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.639 -0.663 . . . . 0.0 110.156 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -69.36 -43.45 73.58 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.44 -53.12 61.85 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.499 0.72 . . . . 0.0 110.61 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.47 98.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.08 1.352 . . . . 0.0 112.648 -172.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -71.2 -35.25 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.945 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -77.0 -25.2 52.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 120.934 -1.104 . . . . 0.0 109.576 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.68 96.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.984 1.713 . . . . 0.0 109.495 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.4 -17.62 64.26 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.706 1.202 . . . . 0.0 113.133 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -78.23 80.43 4.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.24 -1.537 . . . . 0.0 110.369 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.09 2.76 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.33 143.8 37.23 Favored Pre-proline 0 N--CA 1.444 -0.757 0 O-C-N 120.926 -1.338 . . . . 0.0 110.525 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.71 128.42 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.985 2.456 . . . . 0.0 112.333 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 34.04 45.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.36 147.69 47.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.579 1.151 . . . . 0.0 110.624 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -44.43 0.93 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.217 0.607 . . . . 0.0 109.784 -170.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -87.08 46.48 1.38 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-O 123.13 1.443 . . . . 0.0 108.803 -171.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.04 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 119.4 -2.063 . . . . 0.0 108.94 -171.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 m -141.66 -122.01 0.1 Allowed 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -173.13 -71.51 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -20.89 25.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 125.512 3.004 . . . . 0.0 111.341 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.59 -33.17 64.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.443 1.497 . . . . 0.0 109.92 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.776 0.83 . . . . 0.0 109.703 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.96 -34.9 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 122.065 -0.397 . . . . 0.0 110.082 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 109.674 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -64.46 -35.12 79.88 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.512 1.148 . . . . 0.0 110.276 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -65.04 -42.35 94.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.722 -1.236 . . . . 0.0 109.684 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -56.62 -54.37 29.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.212 1.405 . . . . 0.0 110.031 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -69.46 -26.45 64.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.614 0.366 . . . . 0.0 111.455 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.6 m -69.34 -39.43 78.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.431 1.092 . . . . 0.0 109.707 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.37 -30.01 70.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.549 -1.344 . . . . 0.0 111.658 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.67 3.49 47.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.716 -0.615 . . . . 0.0 110.651 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p 59.85 36.93 21.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.012 1.725 . . . . 0.0 112.324 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 -85.63 0.55 Allowed Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 105.951 -2.859 . . . . 0.0 105.951 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 69.86 -65.18 0.32 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.872 2.469 . . . . 0.0 110.674 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.65 54.68 0.59 Allowed Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.401 ' CG ' HH22 ' B' ' 68' ' ' ARG . 36.1 t70 -83.09 -44.23 15.38 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -138.04 168.54 19.51 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.59 128.18 17.92 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.426 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 71.6 Cg_endo -80.29 172.78 13.27 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.265 3.31 . . . . 0.0 109.543 169.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.91 -137.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 p -124.04 -27.69 3.85 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.025 1.33 . . . . 0.0 110.723 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.12 6.05 50.13 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -74.25 -36.12 63.84 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.46 -11.44 0.55 Allowed Glycine 0 CA--C 1.477 -2.321 0 CA-C-O 117.096 -1.947 . . . . 0.0 108.968 171.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HA ' ' HE1' ' D' ' 46' ' ' TRP . 43.1 ttm180 67.14 -56.45 0.44 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 130.232 3.413 . . . . 0.0 109.33 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -84.81 20.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.029 1.331 . . . . 0.0 111.061 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.0 -49.39 44.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.7 74.92 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.179 0.592 . . . . 0.0 109.41 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.44 -41.78 69.81 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.226 1.41 . . . . 0.0 111.696 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.87 -49.28 76.85 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.846 -0.533 . . . . 0.0 110.775 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.96 -38.41 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 O-C-N 121.744 -0.597 . . . . 0.0 109.44 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.0 tpp -55.73 -53.74 52.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.572 1.549 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -66.22 -40.8 90.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.112 0.965 . . . . 0.0 109.935 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.11 82.84 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.827 0.851 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -46.37 91.66 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.98 -30.76 47.85 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 O-C-N 121.658 -0.907 . . . . 0.0 109.582 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.98 -46.44 81.44 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.661 -1.9 . . . . 0.0 109.866 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 t -63.44 -52.81 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 124.477 1.111 . . . . 0.0 109.782 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -74.41 -8.11 55.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.647 -0.658 . . . . 0.0 112.049 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.89 -32.65 15.94 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.817 -1.177 . . . . 0.0 110.103 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.33 -36.85 85.31 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.781 -1.199 . . . . 0.0 110.096 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -63.44 -12.53 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.0 m -65.16 -15.93 62.96 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.853 1.261 . . . . 0.0 111.173 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.11 71.6 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 111.213 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 -31.86 38.39 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 120.507 -1.371 . . . . 0.0 109.427 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.29 -39.46 39.83 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.411 0.624 . . . . 0.0 111.231 -173.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.97 64.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.198 -0.938 . . . . 0.0 111.734 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -96.6 -0.18 49.03 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.606 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -77.92 -22.84 49.03 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.556 1.525 . . . . 0.0 109.751 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -73.59 -33.02 64.42 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 119.511 -1.993 . . . . 0.0 110.467 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.41 -24.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 124.945 1.298 . . . . 0.0 109.102 -170.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -62.11 -19.06 62.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.428 1.891 . . . . 0.0 110.706 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -65.33 -31.35 72.44 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 120.99 -1.069 . . . . 0.0 110.674 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.444 -0.746 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 -172.33 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 120.957 -1.089 . . . . 0.0 110.4 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -67.27 -19.53 65.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -75.23 -46.68 32.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 124.853 1.261 . . . . 0.0 108.487 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.399 1.08 . . . . 0.0 109.657 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.2 90.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.856 0.862 . . . . 0.0 111.568 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -69.15 -34.15 74.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.69 0.757 . . . . 0.0 111.028 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.084 -1.01 . . . . 0.0 111.224 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.45 -46.38 73.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.895 0.878 . . . . 0.0 109.199 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.91 -38.41 88.28 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.647 1.213 . . . . 0.0 111.625 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.1 -24.07 60.59 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.953 1.301 . . . . 0.0 110.322 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.1 -41.48 61.6 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 120.259 -1.525 . . . . 0.0 107.847 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' B' ' 81' ' ' VAL . 22.4 tp -55.79 -46.76 77.9 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.658 1.183 . . . . 0.0 111.552 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -54.87 -37.73 66.62 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.091 0.957 . . . . 0.0 112.236 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -73.86 -32.44 63.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.86 -0.525 . . . . 0.0 110.512 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.3 -35.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.298 -0.876 . . . . 0.0 108.766 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.53 -37.41 87.22 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.065 -1.022 . . . . 0.0 111.279 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.11 -38.83 69.22 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.813 0.845 . . . . 0.0 110.745 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -73.62 -43.65 59.06 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.112 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.43 62.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 121.141 -0.974 . . . . 0.0 111.963 -175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' B' ' 45' ' ' ILE . 3.0 p -71.96 -37.46 69.94 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.204 0.911 . . . . 0.0 110.345 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -43.33 99.07 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 125.323 1.449 . . . . 0.0 108.433 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -66.13 -45.96 79.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.629 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.07 77.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.047 1.339 . . . . 0.0 112.746 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.2 -44.45 97.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 121.817 -0.552 . . . . 0.0 109.832 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.69 -28.29 62.6 Favored 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 120.872 -1.143 . . . . 0.0 111.629 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.32 80.31 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.644 1.578 . . . . 0.0 109.24 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -20.11 51.92 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.286 0.565 . . . . 0.0 110.842 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -70.95 72.63 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 125.055 1.342 . . . . 0.0 113.086 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.28 -18.3 1.04 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.82 147.07 61.31 Favored Pre-proline 0 N--CA 1.444 -0.735 0 O-C-N 121.7 -0.882 . . . . 0.0 110.375 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.413 ' O ' HG11 ' B' ' 63' ' ' VAL . 68.1 Cg_endo -82.66 129.66 5.71 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.54 2.16 . . . . 0.0 111.405 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 27.43 42.46 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.64 139.17 32.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.268 2.227 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.25 -32.36 2.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.398 0.679 . . . . 0.0 109.226 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -99.44 118.82 36.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.41 -154.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.6 t 75.1 -149.53 0.03 OUTLIER 'General case' 0 C--N 1.358 0.961 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.466 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 76.7 m-85 -145.64 -56.18 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 116.309 -1.805 . . . . 0.0 106.295 175.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 17.7 Cg_endo -67.33 -29.26 38.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 125.028 2.831 . . . . 0.0 110.734 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.17 -42.93 93.2 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.068 0.947 . . . . 0.0 110.183 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.28 95.2 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 111.121 -172.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' B' ' 23' ' ' SER . 21.6 tt -76.2 -27.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 121.027 0.441 . . . . 0.0 110.843 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -33.62 61.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.385 -1.447 . . . . 0.0 109.696 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -67.76 -34.19 76.31 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.864 0.866 . . . . 0.0 111.413 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.7 p -69.05 -20.76 64.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 119.727 -1.858 . . . . 0.0 111.35 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 -47.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.011 0.924 . . . . 0.0 109.5 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.58 -27.22 65.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.672 1.225 . . . . 0.0 110.933 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -73.98 -32.19 63.33 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.845 -1.16 . . . . 0.0 109.721 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.44 70.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.356 -0.84 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.9 p -93.58 10.89 30.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.446 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p 52.79 26.71 4.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.701 2.001 . . . . 0.0 112.721 174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.11 -41.92 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -61.51 4.62 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 62.94 -85.54 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 128.446 2.698 . . . . 0.0 108.481 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.19 40.97 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.14 -62.57 1.35 Allowed 'General case' 0 C--N 1.358 0.943 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -141.1 170.81 15.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -131.38 146.13 60.64 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -94.06 158.58 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.043 2.495 . . . . 0.0 108.217 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' O ' ' B' ' 34' ' ' PRO . 13.3 t -79.21 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 42.0 m -156.2 -36.67 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 O-C-N 119.047 -2.283 . . . . 0.0 106.927 -170.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -95.61 11.24 33.92 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.367 -0.833 . . . . 0.0 108.918 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.04 -33.41 61.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 168.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 88.73 1.24 Allowed Glycine 0 N--CA 1.418 -2.566 1 N-CA-C 98.403 -5.879 . . . . 0.0 98.403 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.401 HH22 ' CG ' ' A' ' 59' ' ' ASP . 34.7 ttm180 -63.53 -11.77 26.94 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 119.439 1.619 . . . . 0.0 110.935 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -46.55 -26.24 0.85 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.494 2.318 . . . . 0.0 113.821 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -68.56 -40.99 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.698 1.199 . . . . 0.0 108.734 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.49 -45.49 68.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -51.92 -41.66 62.18 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 126.441 1.897 . . . . 0.0 111.758 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.47 -42.56 92.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.914 1.286 . . . . 0.0 111.064 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.13 -38.38 70.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.422 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 42.4 mtt -62.79 -47.85 81.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.862 0.865 . . . . 0.0 110.177 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -61.26 -40.28 93.47 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.609 -0.682 . . . . 0.0 110.772 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.6 -34.8 77.75 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 122.758 0.423 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.97 -52.07 9.61 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.09 -47.01 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 124.39 1.076 . . . . 0.0 109.947 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.9 -38.27 90.4 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.051 -1.03 . . . . 0.0 111.565 -176.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' B' ' 15' ' ' LEU . 33.2 m -73.97 -38.4 49.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 O-C-N 120.642 -1.286 . . . . 0.0 110.906 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.52 -19.85 62.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.787 -0.571 . . . . 0.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.84 -38.19 13.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.655 0.782 . . . . 0.0 110.396 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.85 -35.91 71.58 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.008 1.723 . . . . 0.0 111.408 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.67 -6.98 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.751 0.82 . . . . 0.0 112.606 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -55.04 -24.34 24.34 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.364 1.466 . . . . 0.0 110.414 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.26 74.06 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.357 -1.464 . . . . 0.0 113.155 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.68 -33.16 23.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.868 -1.145 . . . . 0.0 108.33 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 72.4 mt -78.91 -28.4 43.94 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.928 0.891 . . . . 0.0 112.066 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -10.64 59.53 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.058 -1.651 . . . . 0.0 111.337 172.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.44 -36.59 74.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.097 1.317 . . . . 0.0 110.664 -169.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -75.21 -20.71 59.12 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.417 -1.427 . . . . 0.0 112.148 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.55 -33.09 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.234 -1.541 . . . . 0.0 107.596 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -60.88 -19.88 60.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.604 1.561 . . . . 0.0 112.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -55.81 -25.25 40.63 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.557 1.143 . . . . 0.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.439 -0.976 0 O-C-N 120.59 -1.319 . . . . 0.0 111.162 -177.403 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -16.46 53.91 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.243 -1.535 . . . . 0.0 109.651 -167.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -65.8 -36.5 83.68 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.204 1.802 . . . . 0.0 111.161 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -81.87 -33.67 30.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -35.42 74.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.461 0.304 . . . . 0.0 110.544 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.85 96.7 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.824 0.85 . . . . 0.0 111.384 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -71.59 -34.61 70.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.075 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -66.04 -36.6 83.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.535 1.134 . . . . 0.0 109.574 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.41 91.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 124.517 1.127 . . . . 0.0 111.445 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -59.63 -38.6 81.79 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.802 0.811 . . . . 0.0 111.287 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -74.04 -27.56 60.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.583 0.753 . . . . 0.0 110.183 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -66.77 -38.21 86.13 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.147 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.86 -38.1 89.51 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.289 -0.882 . . . . 0.0 111.402 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -55.22 -38.68 68.75 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 111.876 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -70.82 -38.91 73.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.171 1.388 . . . . 0.0 109.352 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.9 -28.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 123.872 0.869 . . . . 0.0 108.998 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.09 -39.7 95.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.905 -1.122 . . . . 0.0 111.435 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.24 -46.41 87.03 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.284 -0.885 . . . . 0.0 109.927 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.33 -52.08 67.11 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-O 121.22 0.533 . . . . 0.0 109.615 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.44 -34.74 74.42 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 126.014 1.726 . . . . 0.0 111.454 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.9 m -63.36 -46.59 85.84 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.812 0.845 . . . . 0.0 110.799 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.45 -40.75 73.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.88 -39.81 95.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.821 0.848 . . . . 0.0 110.913 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -47.38 80.91 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.17 1.388 . . . . 0.0 111.466 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.01 -15.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.4 1.095 . . . . 0.0 110.102 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -101.23 -5.1 25.99 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 119.979 -1.701 . . . . 0.0 108.599 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.42 -18.85 18.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 124.808 1.243 . . . . 0.0 110.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.81 -30.89 69.54 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 121.028 -1.045 . . . . 0.0 108.553 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.44 113.96 4.0 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.32 1.848 . . . . 0.0 108.587 -169.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.02 -5.62 72.3 Favored Glycine 0 CA--C 1.498 -0.999 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.09 148.44 34.4 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.57 125.14 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.353 2.035 . . . . 0.0 111.1 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 45.48 3.08 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.83 24.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.897 -0.766 . . . . 0.0 112.195 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.01 -36.6 1.17 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.663 0.744 . . . . 0.0 110.063 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -85.85 37.42 0.71 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 108.675 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' C' ' 39' ' ' ILE . 16.2 tt -75.08 -22.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.224 2.21 . . . . 0.0 109.519 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -79.93 121.09 25.01 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.738 0.78 . . . . 0.0 109.252 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.84 -55.93 15.64 Favored Pre-proline 0 C--N 1.351 0.631 0 C-N-CA 126.885 2.074 . . . . 0.0 111.369 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.13 -11.96 23.34 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 CA-C-N 125.769 3.096 . . . . 0.0 111.339 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.33 -26.28 28.6 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 124.827 1.251 . . . . 0.0 108.747 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.47 91.32 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.091 0.956 . . . . 0.0 110.706 -167.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.4 -33.43 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.045 0.938 . . . . 0.0 111.267 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -32.51 48.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.909 -1.119 . . . . 0.0 109.964 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.458 ' CD2' HD11 ' C' ' 38' ' ' LEU . 50.0 t90 -67.04 -37.53 84.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.404 -0.81 . . . . 0.0 110.259 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -60.25 -25.11 65.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.239 -0.913 . . . . 0.0 112.735 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.14 -51.41 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 123.694 0.798 . . . . 0.0 109.437 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.76 40.52 0.9 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.62 1.168 . . . . 0.0 111.181 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 17.6 m -141.68 -56.92 0.47 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.75 73.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.353 -0.842 . . . . 0.0 112.923 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 16.5 p -95.01 23.69 5.42 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p 51.24 78.49 0.11 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.619 1.968 . . . . 0.0 111.871 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 t -122.23 -92.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.6 45.67 9.37 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 111.064 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -43.14 92.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.53 1.157 . . . . 0.0 110.375 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.52 -139.92 7.47 Favored Glycine 0 CA--C 1.483 -1.945 1 N-CA-C 101.645 -4.582 . . . . 0.0 101.645 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.3 34.5 t0 65.2 -71.83 0.08 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 127.27 2.228 . . . . 0.0 111.327 -173.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -124.54 158.9 31.84 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.66 154.13 55.58 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 166.8 27.09 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.203 2.602 . . . . 0.0 110.504 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.2 164.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -62.71 -69.19 0.27 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.337 1.455 . . . . 0.0 114.367 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.75 -72.88 0.06 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.651 1.18 . . . . 0.0 111.484 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -94.58 -39.79 10.18 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.155 -0.965 . . . . 0.0 113.317 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.92 -39.46 25.5 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 120.41 1.459 . . . . 0.0 113.938 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.14 -36.87 64.17 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 117.629 0.714 . . . . 0.0 112.26 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -74.29 -30.07 61.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 121.379 -0.826 . . . . 0.0 110.127 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.0 -40.84 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 O-C-N 121.168 -0.957 . . . . 0.0 109.662 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.36 92.9 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -58.13 -36.01 72.34 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 125.729 1.612 . . . . 0.0 111.395 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -66.04 -52.15 51.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.204 1.001 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 p -73.19 -27.27 23.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 121.576 -0.703 . . . . 0.0 109.636 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 19.5 tpp -58.54 -48.24 81.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 110.335 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -66.21 -36.75 83.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.993 -0.442 . . . . 0.0 110.518 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.26 78.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.366 0.666 . . . . 0.0 111.425 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.45 -40.94 78.85 Favored Glycine 0 CA--C 1.494 -1.266 0 O-C-N 121.664 -0.647 . . . . 0.0 111.546 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 81.2 mt -63.16 -46.57 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -57.26 -47.68 80.8 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.197 0.999 . . . . 0.0 110.774 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.99 -55.04 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.459 1.104 . . . . 0.0 111.086 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -71.61 -33.45 69.0 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 118.551 0.614 . . . . 0.0 110.695 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.33 -30.24 65.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.781 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.75 -12.79 60.82 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.138 -0.976 . . . . 0.0 111.589 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.19 -10.99 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 119.988 -1.695 . . . . 0.0 110.51 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -49.39 -27.24 3.87 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.383 1.873 . . . . 0.0 112.717 170.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.7 -27.16 48.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.499 1.12 . . . . 0.0 112.824 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.67 -51.66 2.79 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 112.063 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.15 -2.25 54.99 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.461 -1.399 . . . . 0.0 109.433 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.25 -11.85 45.39 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -33.8 76.49 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.7 -1.25 . . . . 0.0 109.91 -166.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.51 -12.68 60.54 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.055 -1.028 . . . . 0.0 112.608 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.48 -32.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -69.14 -8.24 43.6 Favored 'General case' 0 C--N 1.359 1.021 0 O-C-N 121.026 -1.046 . . . . 0.0 111.483 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 48.3 ttp85 -64.73 -29.97 70.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -175.55 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.45 -36.38 78.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 122.388 1.089 . . . . 0.0 110.763 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -71.02 -17.61 62.62 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.09 -1.006 . . . . 0.0 112.061 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -86.92 -38.95 16.22 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -66.82 -37.59 84.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.077 0.951 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -68.23 -36.88 80.19 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.618 -0.676 . . . . 0.0 110.34 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.62 75.4 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.035 0.934 . . . . 0.0 110.188 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -65.06 -35.99 82.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.204 1.402 . . . . 0.0 111.205 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -69.01 -30.42 68.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.849 -1.157 . . . . 0.0 110.742 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.33 75.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.063 -1.023 . . . . 0.0 110.649 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.94 -38.41 90.93 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.737 0.815 . . . . 0.0 110.516 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.58 1.152 . . . . 0.0 110.219 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.65 -41.68 98.19 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.878 0.871 . . . . 0.0 109.086 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 tp -62.97 -37.52 87.43 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.436 0.694 . . . . 0.0 111.503 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.57 -31.48 72.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.223 -0.923 . . . . 0.0 112.285 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -71.39 -35.46 71.05 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.35 -38.89 83.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 109.307 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.8 -42.39 84.14 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.24 1.019 . . . . 0.0 111.323 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.27 -44.11 65.89 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.957 0.903 . . . . 0.0 109.282 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -66.21 -39.05 89.34 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.04 72.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.191 1.396 . . . . 0.0 112.165 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.49 -43.34 73.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.493 0.717 . . . . 0.0 109.807 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -43.86 75.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.778 1.231 . . . . 0.0 108.677 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -63.91 -48.4 76.74 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.699 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.44 70.06 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 119.769 1.168 . . . . 0.0 110.818 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.74 -39.74 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.67 -30.03 59.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.779 -1.826 . . . . 0.0 110.758 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.34 35.27 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.067 0.947 . . . . 0.0 109.752 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -22.56 60.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.507 -0.746 . . . . 0.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -68.9 98.6 0.95 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.028 0.918 . . . . 0.0 111.619 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.24 -4.41 12.42 Favored Glycine 0 CA--C 1.494 -1.251 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.75 146.36 46.25 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 121.629 -0.924 . . . . 0.0 109.088 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -80.5 131.7 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.952 1.768 . . . . 0.0 111.42 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.44 2.91 69.81 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.52 136.65 57.59 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.006 1.722 . . . . 0.0 112.42 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.63 4.31 1.93 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.35 -38.16 20.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.3 tt -5.93 88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 1 C-N-CA 133.248 4.619 . . . . 0.0 114.387 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 33.1 p -162.96 -131.3 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.79 -65.5 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 127.925 2.49 . . . . 0.0 106.051 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.93 -14.03 26.47 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 CA-C-N 125.649 3.053 . . . . 0.0 111.687 -171.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -100.74 -11.36 19.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.66 64.93 Favored 'General case' 0 CA--C 1.504 -0.826 0 O-C-N 120.776 -1.203 . . . . 0.0 109.854 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.25 -7.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 125.178 1.391 . . . . 0.0 109.675 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 68' ' ' ARG . 1.2 t90 -81.84 -49.56 10.22 Favored 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 119.423 -2.048 . . . . 0.0 106.081 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -53.24 -41.68 65.66 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.791 1.636 . . . . 0.0 111.115 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.4 p -69.51 -28.84 66.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.696 -1.877 . . . . 0.0 111.683 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.46 -45.66 81.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 C-N-CA 123.699 0.799 . . . . 0.0 109.284 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.9 -9.35 57.57 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.445 -0.784 . . . . 0.0 112.006 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 72.4 m -86.14 -48.45 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 120.697 -1.252 . . . . 0.0 111.082 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.18 62.51 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.662 -1.274 . . . . 0.0 112.007 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -87.8 0.86 55.21 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.879 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 55.18 67.97 0.94 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.875 2.07 . . . . 0.0 110.904 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.83 -98.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.58 102.24 0.46 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 106.58 -2.608 . . . . 0.0 106.58 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -75.73 -33.68 60.3 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.65 39.7 2.32 Favored Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.96 -50.27 30.39 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -130.87 160.95 32.94 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.53 151.78 36.88 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 167.71 26.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.059 2.506 . . . . 0.0 111.275 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.74 -148.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -107.07 -60.35 1.69 Allowed 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.039 1.736 . . . . 0.0 107.573 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -80.13 0.61 31.42 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.352 1.461 . . . . 0.0 111.179 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -64.84 -30.13 71.12 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.845 1.307 . . . . 0.0 108.773 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.26 83.57 1.37 Allowed Glycine 0 CA--C 1.473 -2.557 1 N-CA-C 99.277 -5.529 . . . . 0.0 99.277 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttt85 -60.95 -11.24 7.39 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 122.876 1.322 . . . . 0.0 111.44 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -61.51 -12.92 17.16 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.452 1.101 . . . . 0.0 113.302 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.43 -52.59 58.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.33 97.58 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 123.168 0.587 . . . . 0.0 110.535 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.11 -50.11 38.77 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.946 1.699 . . . . 0.0 111.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.65 -40.08 95.94 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.646 0.779 . . . . 0.0 110.879 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.66 -43.39 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 123.704 0.801 . . . . 0.0 109.579 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.7 mtm -66.91 -42.83 84.77 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 121.806 -0.559 . . . . 0.0 110.621 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -65.58 -35.0 79.55 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.844 -0.535 . . . . 0.0 110.517 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.25 99.13 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.524 0.729 . . . . 0.0 110.494 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.03 81.33 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.1 -46.72 88.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 109.804 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.12 -42.01 94.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.299 -0.876 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.98 -46.94 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.24 -0.913 . . . . 0.0 110.4 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -71.12 -9.0 57.32 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.392 -0.817 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.32 -39.76 8.25 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.199 1.0 . . . . 0.0 109.84 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -52.1 -34.93 46.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 127.133 2.173 . . . . 0.0 110.697 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.45 -8.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 124.372 1.069 . . . . 0.0 113.833 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -68.85 -14.28 62.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 120.113 -1.617 . . . . 0.0 111.832 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.16 -27.56 65.77 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.748 -1.22 . . . . 0.0 111.494 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.88 -37.04 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.458 1.103 . . . . 0.0 109.554 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.32 -37.72 66.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.564 -0.71 . . . . 0.0 112.231 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.73 -21.19 63.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.57 -1.331 . . . . 0.0 111.008 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 10.9 t -96.32 11.19 35.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.842 -1.162 . . . . 0.0 108.765 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.3 -33.65 25.91 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -71.67 -32.68 68.14 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.191 -1.568 . . . . 0.0 112.865 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.8 -11.34 14.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 121.461 -0.774 . . . . 0.0 111.275 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -60.99 -19.73 61.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.033 1.333 . . . . 0.0 112.132 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -6.67 58.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.457 1.026 . . . . 0.0 110.81 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.34 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -132.89 -78.1 0.49 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -71.52 -15.83 62.31 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 123.572 0.749 . . . . 0.0 111.69 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -63.88 -36.9 85.45 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.977 1.711 . . . . 0.0 110.137 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -77.15 -24.11 51.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.455 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -74.27 -41.65 60.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.673 1.189 . . . . 0.0 108.185 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.32 96.87 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.17 -34.07 77.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.732 1.213 . . . . 0.0 111.387 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -71.4 -39.14 71.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.371 -0.831 . . . . 0.0 108.904 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.85 78.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.532 0.733 . . . . 0.0 111.648 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -65.3 -28.35 69.26 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.05 -1.031 . . . . 0.0 111.808 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -73.81 -31.96 63.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.794 0.837 . . . . 0.0 110.06 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.04 -38.94 92.52 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 121.469 -0.769 . . . . 0.0 110.743 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.26 -41.67 84.77 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.532 0.733 . . . . 0.0 111.992 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.735 1.214 . . . . 0.0 109.633 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.31 -40.53 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.053 0.941 . . . . 0.0 109.486 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 52' ' ' ALA . 76.2 mt -58.74 -40.76 84.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.083 0.953 . . . . 0.0 111.906 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.25 -41.6 73.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.63 1.572 . . . . 0.0 110.066 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -67.32 -52.32 41.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.521 1.529 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.56 -29.88 63.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.484 1.114 . . . . 0.0 111.977 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -63.05 -41.69 99.55 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 119.129 0.877 . . . . 0.0 110.178 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.82 -43.55 71.8 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.872 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -67.34 -18.96 65.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 120.709 -1.244 . . . . 0.0 111.033 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.86 70.57 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.45 0.7 . . . . 0.0 110.289 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.15 -33.15 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.775 0.798 . . . . 0.0 111.768 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -28.92 61.66 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.87 68.1 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.349 1.059 . . . . 0.0 111.263 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.24 -5.95 53.46 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.462 1.105 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -105.64 71.87 0.94 Allowed 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.647 -1.908 . . . . 0.0 108.508 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.45 -42.32 0.33 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -92.74 157.94 38.86 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 123.206 0.603 . . . . 0.0 109.665 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -80.9 153.07 19.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.221 1.948 . . . . 0.0 111.121 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.33 15.93 31.18 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.207 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 131.46 50.6 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -166.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.65 -46.99 0.24 Allowed 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.554 0.741 . . . . 0.0 110.009 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.82 62.08 6.73 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 123.01 1.386 . . . . 0.0 107.902 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.9 pt -91.46 -1.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.805 -1.81 . . . . 0.0 109.5 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -89.43 127.85 35.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.469 -0.77 . . . . 0.0 110.997 -174.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -79.44 -54.64 0.95 Allowed Pre-proline 0 C--N 1.347 0.457 0 CA-C-O 116.196 -1.859 . . . . 0.0 112.73 -172.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -73.54 -12.02 24.59 Favored 'Trans proline' 0 CA--C 1.511 -0.658 0 CA-C-N 126.718 3.435 . . . . 0.0 111.813 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.12 -13.17 48.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.38 89.86 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.298 1.039 . . . . 0.0 111.59 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.92 -33.66 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.643 0.735 . . . . 0.0 109.535 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -24.76 57.74 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 119.92 -1.737 . . . . 0.0 109.572 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -69.52 -46.55 66.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.418 1.087 . . . . 0.0 108.396 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.4 p -67.35 -29.81 69.45 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.822 -1.173 . . . . 0.0 111.819 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -51.94 -50.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 124.447 1.099 . . . . 0.0 110.633 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.01 -0.3 43.64 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.488 -0.757 . . . . 0.0 111.792 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.3 m -91.62 -39.92 11.61 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 121.546 -0.721 . . . . 0.0 109.296 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -70.72 -23.83 62.52 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 120.503 -1.373 . . . . 0.0 111.357 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 p -89.35 9.29 26.67 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.473 0.709 . . . . 0.0 110.152 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 51.17 50.03 19.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.422 1.889 . . . . 0.0 112.973 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 56' ' ' GLY . 7.6 p -122.68 -77.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.484 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.82 95.12 0.11 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.07 -69.91 0.58 Allowed 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.666 -1.49 . . . . 0.0 109.958 -170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.8 41.57 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.75 -52.74 7.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -134.44 -175.06 3.75 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -143.06 135.78 13.63 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 101.994 -3.336 . . . . 0.0 101.994 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.8 166.2 10.14 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.026 2.484 . . . . 0.0 110.236 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 67' ' ' GLY . 17.5 m -69.41 166.07 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.603 1.192 . . . . 0.0 110.94 173.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 m -78.53 -67.77 0.71 Allowed 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.345 -0.847 . . . . 0.0 109.173 -174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -50.36 -63.5 1.1 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.586 1.555 . . . . 0.0 112.115 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.69 -67.05 0.87 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.324 -0.86 . . . . 0.0 111.412 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.612 ' H ' HG23 ' A' ' 63' ' ' VAL . . . -30.76 -46.22 0.13 Allowed Glycine 0 C--N 1.349 1.293 0 C-N-CA 129.212 3.291 . . . . 0.0 116.114 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -68.19 -51.9 40.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.105 0.952 . . . . 0.0 112.483 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.7 -25.64 68.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 119.419 1.009 . . . . 0.0 110.803 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.88 -50.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.18 85.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.062 1.345 . . . . 0.0 112.129 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -51.63 -39.19 57.61 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.893 1.677 . . . . 0.0 110.846 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -29.58 64.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.08 -43.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.8 mtt -58.62 -52.32 66.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.414 1.485 . . . . 0.0 109.917 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -66.04 -36.95 84.63 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.614 -0.679 . . . . 0.0 110.652 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.41 87.77 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.168 -0.958 . . . . 0.0 111.313 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.86 -48.11 75.44 Favored Glycine 0 CA--C 1.492 -1.349 0 C-N-CA 124.646 1.117 . . . . 0.0 110.903 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -43.76 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.113 0.965 . . . . 0.0 109.257 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -61.43 -39.18 89.86 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 120.438 -1.414 . . . . 0.0 111.97 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.16 -54.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 124.41 1.084 . . . . 0.0 108.928 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.47 -40.87 93.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.82 -0.55 . . . . 0.0 110.913 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -27.15 65.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.394 -0.816 . . . . 0.0 111.522 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.82 -35.67 81.86 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.887 -1.133 . . . . 0.0 110.031 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.8 t -59.65 -14.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 125.524 1.53 . . . . 0.0 111.262 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -55.82 -23.31 29.67 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 120.066 -1.646 . . . . 0.0 111.989 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.9 -31.45 69.82 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 120.82 -1.175 . . . . 0.0 112.33 172.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 -45.44 14.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.688 -1.257 . . . . 0.0 107.789 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -62.77 -40.29 96.82 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.182 0.993 . . . . 0.0 113.297 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.36 -11.3 60.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.129 -0.982 . . . . 0.0 111.519 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 m -82.6 -22.66 34.73 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.022 -1.049 . . . . 0.0 108.384 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -71.08 -24.5 62.33 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 120.698 -1.252 . . . . 0.0 112.86 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -81.03 -25.33 37.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.85 -1.156 . . . . 0.0 111.879 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.78 -28.03 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -70.14 -5.42 26.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 112.05 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -66.57 -31.04 71.49 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.913 -1.117 . . . . 0.0 109.319 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -170.015 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.498 -1.034 0 CA-C-O 121.94 0.876 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -72.8 -32.26 65.42 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.92 -33.95 66.3 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.734 0.814 . . . . 0.0 109.026 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -58.29 -45.28 88.25 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.324 1.05 . . . . 0.0 110.582 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.22 -45.84 79.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.82 1.248 . . . . 0.0 109.051 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.5 92.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 111.567 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.84 -37.1 76.06 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.643 0.777 . . . . 0.0 109.617 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.02 -33.38 75.6 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.784 -1.198 . . . . 0.0 110.251 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.74 75.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.329 -0.857 . . . . 0.0 111.373 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.43 -31.99 73.43 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.844 0.858 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -67.99 -41.22 82.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 121.562 -0.711 . . . . 0.0 109.781 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -66.21 -28.46 68.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.593 -0.692 . . . . 0.0 111.277 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 118.42 0.554 . . . . 0.0 110.738 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -62.32 -36.11 81.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 110.683 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.37 -37.79 86.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.754 0.821 . . . . 0.0 110.741 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.43 -40.19 88.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 121.071 -1.018 . . . . 0.0 109.036 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.93 -42.96 85.92 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 123.634 0.774 . . . . 0.0 111.359 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.77 -46.17 83.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.015 1.326 . . . . 0.0 109.949 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -68.48 -41.95 79.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 122.046 -0.409 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -29.64 69.79 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.726 1.21 . . . . 0.0 111.601 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -61.58 -43.23 99.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.145 0.978 . . . . 0.0 109.491 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -38.57 81.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.486 1.114 . . . . 0.0 108.822 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.22 -54.01 40.28 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.108 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.03 75.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.005 1.322 . . . . 0.0 112.915 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.15 -28.18 39.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 120.683 -1.26 . . . . 0.0 113.041 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.63 -34.76 18.37 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -49.46 67.7 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.697 1.599 . . . . 0.0 110.268 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.36 -26.85 66.68 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 112.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 119.614 -1.929 . . . . 0.0 110.801 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.05 -15.14 6.53 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.63 145.33 41.58 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 118.071 0.935 . . . . 0.0 109.801 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.78 135.53 11.46 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 110.136 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 14.41 76.91 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.38 145.49 55.97 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.12 0.968 . . . . 0.0 110.605 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.89 -37.98 0.9 Allowed 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 108.943 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 44' ' ' ALA . 42.1 tp -88.84 129.98 35.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -150.26 -179.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 t 76.23 127.21 0.04 OUTLIER 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.226 1.41 . . . . 0.0 109.502 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -65.13 -46.53 73.1 Favored Pre-proline 0 C--N 1.35 0.623 0 CA-C-O 116.921 -1.514 . . . . 0.0 111.611 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 -10.54 25.15 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 124.953 2.805 . . . . 0.0 112.608 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.02 -39.13 15.93 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.45 ' HA ' HD11 ' B' ' 38' ' ' LEU . . . -64.08 -36.47 84.11 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 123.416 0.686 . . . . 0.0 112.581 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -68.79 -29.19 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 O-C-N 122.03 -0.419 . . . . 0.0 110.08 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -38.22 70.41 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.755 -1.216 . . . . 0.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.09 -38.29 82.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.679 0.752 . . . . 0.0 109.368 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -59.27 -47.77 84.11 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.013 1.325 . . . . 0.0 110.191 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -54.51 -52.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 125.486 1.514 . . . . 0.0 111.099 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.96 -24.46 63.34 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 121.349 -0.844 . . . . 0.0 111.836 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -76.03 -33.59 59.64 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 123.897 0.879 . . . . 0.0 109.393 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.23 -24.61 65.84 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.964 -1.085 . . . . 0.0 111.693 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -92.92 10.41 31.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.542 0.737 . . . . 0.0 111.499 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 p 51.23 53.86 12.18 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 125.675 1.59 . . . . 0.0 112.838 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.56 -87.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.92 74.61 1.2 Allowed Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.53 -21.64 60.33 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 120.781 -1.423 . . . . 0.0 109.756 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.62 40.84 1.82 Allowed Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.26 -29.51 26.39 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 120.884 -1.362 . . . . 0.0 111.25 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.428 ' HG3' HD13 ' B' ' 38' ' ' LEU . 85.7 mmt-85 -144.41 166.89 23.84 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -143.03 115.14 5.94 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.67 161.16 16.6 Favored 'Trans proline' 0 CA--C 1.512 -0.617 0 C-N-CA 122.527 2.151 . . . . 0.0 110.15 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.05 -159.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.742 1.258 . . . . 0.0 110.769 -173.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -86.7 -36.22 18.83 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 119.734 -1.853 . . . . 0.0 110.612 -165.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.63 -15.87 41.07 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.486 1.114 . . . . 0.0 109.499 -167.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -28.77 69.91 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 123.478 1.609 . . . . 0.0 107.417 172.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.17 82.39 1.25 Allowed Glycine 0 CA--C 1.464 -3.152 1 N-CA-C 99.974 -5.25 . . . . 0.0 99.974 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm105 -66.97 3.93 0.98 Allowed 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.643 1.222 . . . . 0.0 112.999 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.14 -12.9 56.02 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 120.987 -1.071 . . . . 0.0 111.895 160.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -50.18 79.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.63 92.79 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.01 0.924 . . . . 0.0 111.701 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -53.95 -42.04 68.43 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.157 1.383 . . . . 0.0 110.623 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -63.76 -40.45 96.74 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.755 -0.591 . . . . 0.0 110.851 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.42 -49.02 80.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.018 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -69.92 -40.86 75.3 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 121.949 -0.469 . . . . 0.0 110.516 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -64.65 -41.59 96.02 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.324 -0.86 . . . . 0.0 109.725 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.94 85.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 122.028 -0.42 . . . . 0.0 111.388 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.34 -47.65 77.4 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.76 -45.18 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.778 1.231 . . . . 0.0 109.006 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.61 -44.21 80.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.112 -0.993 . . . . 0.0 111.357 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.86 -52.49 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.071 0.949 . . . . 0.0 109.599 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -72.19 -18.19 61.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.924 0.489 . . . . 0.0 111.492 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.78 -31.54 16.48 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.08 -31.85 73.19 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 120.38 -1.45 . . . . 0.0 110.018 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.48 -11.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 123.378 0.671 . . . . 0.0 112.098 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 22.8 m -60.35 -15.79 29.06 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.95 1.3 . . . . 0.0 111.426 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.53 -50.55 69.69 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.215 166.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.37 92.63 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 124.609 1.164 . . . . 0.0 110.272 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.03 -39.97 95.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 120.873 -1.142 . . . . 0.0 111.071 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 -15.74 60.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.677 -0.639 . . . . 0.0 110.701 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.4 m -83.25 -32.94 26.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 121.0 -1.062 . . . . 0.0 108.167 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.08 -11.45 59.99 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 111.801 -156.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -72.77 -31.93 65.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 121.387 -0.821 . . . . 0.0 110.299 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 t -74.08 -24.32 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.475 1.51 . . . . 0.0 109.047 -170.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -51.36 -31.91 23.85 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 124.851 1.26 . . . . 0.0 110.184 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -53.93 -31.8 51.5 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.98 1.312 . . . . 0.0 112.56 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 . . . . . 0 N--CA 1.444 -0.75 0 O-C-N 120.806 -1.184 . . . . 0.0 111.283 -174.903 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 . . . . . 0 CA--C 1.494 -1.193 0 CA-C-O 122.189 0.995 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' C' ' 5' ' ' GLU . 16.0 p80 -67.3 -29.57 69.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.477 -0.764 . . . . 0.0 110.928 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' C' ' 4' ' ' HIS . 56.1 mt-10 -78.05 -37.6 46.42 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -57.32 -43.81 83.65 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.693 0.797 . . . . 0.0 111.941 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.57 -24.42 53.53 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.624 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.1 93.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.917 -1.114 . . . . 0.0 110.209 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -65.05 -37.11 86.5 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.659 -0.651 . . . . 0.0 111.225 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -62.44 -35.65 79.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.791 1.236 . . . . 0.0 110.261 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.96 82.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.783 0.833 . . . . 0.0 111.482 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -60.97 -37.79 83.65 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -63.38 -39.48 94.63 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.913 0.885 . . . . 0.0 110.018 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -67.69 -35.9 79.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.005 0.922 . . . . 0.0 109.469 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.7 tp -65.4 -37.76 87.95 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.229 1.014 . . . . 0.0 110.624 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.74 -21.67 61.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.879 -1.138 . . . . 0.0 111.635 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -69.81 -47.2 63.71 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.554 0.742 . . . . 0.0 109.624 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.45 -25.63 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.381 -0.824 . . . . 0.0 110.43 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' C' ' 52' ' ' ALA . 50.8 mt -62.84 -40.66 98.14 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.405 0.682 . . . . 0.0 111.059 172.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.91 -47.11 86.41 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.392 0.997 . . . . 0.0 110.229 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -58.86 -55.11 39.38 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.33 83.24 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 125.964 1.706 . . . . 0.0 112.014 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 60.7 m -54.57 -51.2 65.99 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 124.367 1.067 . . . . 0.0 110.066 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -82.63 -35.66 26.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 121.905 -0.497 . . . . 0.0 110.566 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -63.57 -35.12 79.44 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.815 -1.178 . . . . 0.0 109.986 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.53 72.62 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.404 1.081 . . . . 0.0 111.887 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -34.92 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.688 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.42 -18.98 25.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.181 -0.949 . . . . 0.0 108.638 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -28.24 60.99 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.46 -0.775 . . . . 0.0 111.04 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -33.97 57.22 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -70.65 89.73 0.74 Allowed 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 125.972 1.709 . . . . 0.0 110.591 -167.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.24 2.03 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.61 155.11 56.54 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 153.94 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.119 1.879 . . . . 0.0 109.383 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.91 30.63 57.32 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -36.0 141.44 0.1 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 129.057 2.943 . . . . 0.0 113.493 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -115.51 0.17 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -164.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.403 ' H ' HD13 ' C' ' 38' ' ' LEU . 0.0 OUTLIER -75.79 153.49 36.9 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 19.0 pt -136.23 -158.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -62.21 -169.8 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.508 2.723 . . . . 0.0 111.482 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.417 ' HB3' ' HD2' ' C' ' 42' ' ' PRO . 4.0 m-85 81.38 -178.23 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' C' ' 41' ' ' TYR . 12.7 Cg_endo -74.54 9.24 1.94 Allowed 'Trans proline' 0 CA--C 1.517 -0.35 0 CA-C-N 125.645 3.052 . . . . 0.0 112.262 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.68 -35.81 60.26 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.169 0.988 . . . . 0.0 109.061 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.33 -47.56 72.36 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 125.503 1.521 . . . . 0.0 112.727 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.425 HG22 ' H ' ' C' ' 45' ' ' ILE . 9.3 tt -74.92 -26.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.142 -174.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -39.57 82.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.056 -1.028 . . . . 0.0 110.093 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -71.57 -35.45 70.58 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 118.661 0.664 . . . . 0.0 110.191 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -59.59 -39.21 83.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.823 -1.173 . . . . 0.0 110.048 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.04 68.43 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.019 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.501 ' HB3' HH12 ' D' ' 68' ' ' ARG . 21.4 pt-20 -164.05 -39.48 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -66.28 -41.03 90.41 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.104 0.962 . . . . 0.0 110.653 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -69.51 -24.0 63.69 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 120.929 -1.107 . . . . 0.0 112.358 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.96 -1.2 57.39 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 121.448 -0.783 . . . . 0.0 109.483 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.8 p 52.25 49.43 20.56 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.302 1.841 . . . . 0.0 112.307 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.42 82.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.54 98.33 1.99 Allowed Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -79.28 -21.36 46.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.309 1.052 . . . . 0.0 108.307 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.91 39.76 1.14 Allowed Glycine 0 CA--C 1.483 -1.951 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.488 ' HB2' HH21 ' D' ' 68' ' ' ARG . 40.7 t0 -84.74 -50.34 7.69 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -131.92 -155.82 0.71 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 107.509 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.99 153.37 15.44 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 101.692 -3.447 . . . . 0.0 101.692 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -89.71 -177.36 1.41 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 123.392 2.728 . . . . 0.0 108.73 169.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.39 -167.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 119.81 1.186 . . . . 0.0 108.813 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.46 -56.46 2.18 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.158 0.983 . . . . 0.0 109.806 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.65 -41.33 77.02 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.258 -0.902 . . . . 0.0 112.313 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.52 -138.45 0.19 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 100.686 -3.82 . . . . 0.0 100.686 162.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.21 -73.35 1.09 Allowed Glycine 0 CA--C 1.492 -1.381 0 CA-C-N 120.454 1.479 . . . . 0.0 109.447 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -32.42 68.09 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.343 1.457 . . . . 0.0 110.295 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -69.97 -33.45 72.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.8 t -73.42 -47.49 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.89 76.6 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.453 1.501 . . . . 0.0 112.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -48.07 -47.05 34.18 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 126.979 2.112 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.7 -33.13 75.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.012 1.325 . . . . 0.0 110.735 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.65 -42.25 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.347 1.059 . . . . 0.0 109.416 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -60.18 -45.12 94.22 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.691 -0.63 . . . . 0.0 109.943 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -55.01 -50.09 69.89 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.316 1.446 . . . . 0.0 110.98 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -32.17 72.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.473 1.109 . . . . 0.0 110.835 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.72 -47.96 18.78 Favored Glycine 0 CA--C 1.491 -1.435 0 O-C-N 121.779 -0.576 . . . . 0.0 111.784 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.7 -41.14 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 122.068 -0.666 . . . . 0.0 110.084 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.68 -29.81 68.35 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 120.505 -1.372 . . . . 0.0 112.089 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.36 -49.17 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -73.49 -12.71 60.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.52 -0.737 . . . . 0.0 111.201 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.85 -53.94 7.24 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -50.88 -42.14 58.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.452 2.301 . . . . 0.0 112.939 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 m -60.51 -19.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 112.248 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 4.9 m -69.29 -13.39 62.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.919 -1.113 . . . . 0.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.92 68.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.805 -1.81 . . . . 0.0 111.075 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.16 32.6 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.725 -1.234 . . . . 0.0 108.661 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.44 -31.18 66.91 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.13 0.972 . . . . 0.0 110.777 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.799 -1.188 . . . . 0.0 111.562 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 10.3 t -94.31 1.39 55.93 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.838 -1.163 . . . . 0.0 108.865 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -26.8 58.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 120.341 1.428 . . . . 0.0 110.055 -176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -69.9 -38.9 76.46 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.716 -1.24 . . . . 0.0 109.521 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.09 -25.0 37.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 125.533 1.533 . . . . 0.0 110.643 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -57.08 -24.6 55.12 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.114 1.366 . . . . 0.0 112.678 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -58.31 -31.82 67.88 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 121.138 -0.976 . . . . 0.0 111.628 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 N--CA 1.439 -1.019 0 O-C-N 121.756 -0.59 . . . . 0.0 109.821 -172.821 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -173.71 -120.8 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.056 1 N-CA-C 99.641 -4.207 . . . . 0.0 99.641 -157.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 28.4 p-80 -53.17 -21.58 5.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 129.052 2.941 . . . . 0.0 114.521 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.8 -31.72 71.09 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.857 0.863 . . . . 0.0 111.007 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -68.67 -43.22 76.62 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.946 -1.096 . . . . 0.0 109.951 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.5 -32.05 69.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.86 -46.56 90.09 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.562 0.745 . . . . 0.0 111.457 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.62 -31.98 73.02 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 121.645 -0.659 . . . . 0.0 111.778 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -69.78 -35.65 75.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.479 -0.763 . . . . 0.0 109.438 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.91 82.27 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.941 -1.099 . . . . 0.0 111.353 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.8 -20.79 62.54 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.784 -1.198 . . . . 0.0 112.064 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.16 -39.28 63.36 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.031 1.332 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -64.38 -34.83 79.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.254 1.822 . . . . 0.0 110.257 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.94 -41.29 91.51 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 121.895 -0.503 . . . . 0.0 110.311 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.44 -32.75 74.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.308 0.643 . . . . 0.0 110.924 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -64.65 -42.68 95.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.237 1.415 . . . . 0.0 110.904 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.0 -25.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 O-C-N 121.079 -1.013 . . . . 0.0 110.568 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -60.57 -47.98 83.79 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-N 119.361 0.982 . . . . 0.0 109.771 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -61.61 -46.52 89.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.556 0.742 . . . . 0.0 111.137 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -74.39 -34.74 63.4 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.442 -0.786 . . . . 0.0 109.402 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.84 73.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 120.314 -1.491 . . . . 0.0 111.923 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -61.9 -41.75 98.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.413 1.085 . . . . 0.0 110.926 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -69.14 -38.16 78.67 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.56 -53.89 44.63 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.733 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -47.74 74.27 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.181 1.392 . . . . 0.0 112.549 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.495 HG22 HH21 ' D' ' 31' ' ' ARG . 11.2 p -71.13 -26.29 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 120.527 -1.358 . . . . 0.0 111.523 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -89.96 -28.09 19.37 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 109.02 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.92 -55.68 7.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.17 2.588 . . . . 0.0 108.797 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.41 -26.1 68.3 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.95 1.3 . . . . 0.0 111.527 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' ARG . . . . . 0.495 HH21 HG22 ' D' ' 27' ' ' VAL . 6.8 tpp180 -69.01 104.85 2.22 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 120.035 -1.666 . . . . 0.0 109.876 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.04 -7.8 29.2 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.0 140.26 29.08 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.26 134.46 5.89 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.308 2.005 . . . . 0.0 110.634 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.86 0.46 66.33 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.16 115.48 6.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.976 1.71 . . . . 0.0 108.518 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.49 -26.89 13.96 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.23 104.18 16.14 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -148.14 70.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 120.218 -1.551 . . . . 0.0 109.333 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -167.61 157.61 10.59 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -77.18 -50.99 2.11 Favored Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 115.774 -2.06 . . . . 0.0 110.84 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.01 -15.96 36.35 Favored 'Trans proline' 0 CA--C 1.512 -0.575 0 CA-C-N 126.063 3.201 . . . . 0.0 111.396 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -82.26 -36.61 26.94 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.43 90.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.034 0.933 . . . . 0.0 111.999 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tp -72.85 -21.45 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.503 1.144 . . . . 0.0 109.906 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -40.1 25.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 120.266 -1.521 . . . . 0.0 109.311 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -65.0 -35.99 82.98 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.931 1.292 . . . . 0.0 110.64 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -86.27 62.14 7.25 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 120.29 -1.506 . . . . 0.0 109.51 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.84 -61.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -30.17 69.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.236 0.925 . . . . 0.0 110.62 -167.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -57.12 -35.31 69.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 125.617 1.567 . . . . 0.0 111.077 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.15 -25.26 55.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 119.869 -1.769 . . . . 0.0 110.697 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.67 -0.75 39.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.443 1.497 . . . . 0.0 108.404 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.265 4.1 p 60.72 47.95 7.59 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.007 2.123 . . . . 0.0 111.437 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.2 152.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 99.035 -4.432 . . . . 0.0 99.035 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.6 110.08 0.51 Allowed Glycine 0 CA--C 1.472 -2.645 1 N-CA-C 99.61 -5.396 . . . . 0.0 99.61 176.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -37.78 64.1 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 45.83 0.21 Allowed Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 168.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.9 -48.95 50.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 117.3 0.55 . . . . 0.0 110.463 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -137.7 177.45 7.86 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -149.05 140.65 14.45 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.95 -175.36 2.63 Favored 'Trans proline' 0 CA--C 1.516 -0.382 0 C-N-CA 124.627 3.552 . . . . 0.0 110.311 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.444 HG12 ' H ' ' D' ' 64' ' ' THR . 0.6 OUTLIER -134.78 -157.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.46 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.444 ' H ' HG12 ' D' ' 63' ' ' VAL . 1.8 p -77.46 -49.93 13.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 127.618 2.367 . . . . 0.0 109.368 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -85.67 -13.95 46.98 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.846 1.258 . . . . 0.0 111.193 -162.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -22.15 62.75 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.443 1.592 . . . . 0.0 107.484 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.27 54.03 2.51 Favored Glycine 0 CA--C 1.464 -3.104 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.501 HH12 ' HB3' ' C' ' 50' ' ' GLU . 62.0 ttt-85 -20.53 -28.13 0.0 OUTLIER 'General case' 0 C--N 1.368 1.386 1 C-N-CA 134.509 5.124 . . . . 0.0 117.392 -175.349 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -61.98 2.04 0.25 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.584 1.954 . . . . 0.0 113.263 166.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -70.96 -47.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 168.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.687 0.795 . . . . 0.0 110.516 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.57 -44.52 69.4 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 124.658 1.183 . . . . 0.0 111.036 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -61.52 -44.5 96.95 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.61 -44.91 82.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 121.76 -0.588 . . . . 0.0 109.774 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.6 mtm -61.92 -47.69 83.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.84 -31.63 68.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.076 -1.015 . . . . 0.0 111.355 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.28 81.32 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.154 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.63 96.62 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 123.551 0.596 . . . . 0.0 111.748 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -57.9 -49.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.789 0 C-N-CA 124.22 1.008 . . . . 0.0 109.599 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.94 -45.34 71.21 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.019 1.328 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.77 -57.0 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 124.695 1.198 . . . . 0.0 109.384 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -68.17 -34.74 76.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 121.64 -0.663 . . . . 0.0 110.669 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.73 78.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 110.637 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.94 -36.09 82.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.866 -1.146 . . . . 0.0 110.474 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.58 -10.86 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.042 1.337 . . . . 0.0 110.947 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -58.65 -21.12 53.19 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.665 -1.897 . . . . 0.0 111.015 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.33 68.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 120.314 -1.491 . . . . 0.0 112.525 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.641 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.11 -47.86 22.86 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.22 -32.62 74.15 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.883 0.849 . . . . 0.0 112.022 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.93 -11.84 60.97 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.323 -1.486 . . . . 0.0 111.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.427 HG21 ' CE1' ' D' ' 4' ' ' HIS . 62.6 p -82.93 -19.06 37.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 120.391 -1.443 . . . . 0.0 109.748 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.05 -34.19 77.16 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.987 0.812 . . . . 0.0 111.14 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -77.88 -18.1 56.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.626 -1.296 . . . . 0.0 111.479 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -81.45 -30.08 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -57.13 -23.53 47.82 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 124.909 1.284 . . . . 0.0 111.213 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -59.86 -25.95 65.46 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.242 1.017 . . . . 0.0 112.178 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.437 -1.104 0 O-C-N 120.83 -1.169 . . . . 0.0 110.509 179.607 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.063 0 CA-C-O 121.846 0.831 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 4' ' ' HIS . 6.9 p-10 -66.24 -43.35 86.83 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.961 1.704 . . . . 0.0 108.815 -175.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' OD2' ' A' ' 3' ' ' ASP . 57.0 m170 -69.7 -31.07 68.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.355 -0.841 . . . . 0.0 111.75 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.39 -43.58 60.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -66.09 -44.59 83.97 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.081 0.952 . . . . 0.0 110.243 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -66.57 -36.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.901 0.858 . . . . 0.0 110.771 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.84 -43.49 79.41 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 121.162 -0.961 . . . . 0.0 110.367 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -69.83 -31.22 68.97 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.1 0.56 . . . . 0.0 110.348 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -59.45 -40.84 88.14 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.743 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.73 -33.84 75.67 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.715 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.47 -34.24 77.32 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.571 -0.706 . . . . 0.0 111.504 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -60.78 -45.99 92.22 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.133 0.973 . . . . 0.0 109.854 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.53 -34.33 77.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.265 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.78 -35.23 77.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.385 -0.822 . . . . 0.0 111.1 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.13 -36.03 66.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 121.508 -0.745 . . . . 0.0 110.537 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.74 -45.56 93.8 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.498 1.119 . . . . 0.0 110.987 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.04 -20.19 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 O-C-N 121.254 -0.904 . . . . 0.0 111.238 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.29 -41.66 96.77 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 119.435 1.016 . . . . 0.0 110.194 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.68 -26.52 59.9 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.378 1.071 . . . . 0.0 110.328 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -79.52 -41.41 27.4 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.483 -1.386 . . . . 0.0 108.51 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.55 69.93 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.102 1.361 . . . . 0.0 111.903 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 45' ' ' ILE . 12.1 p -66.24 -50.54 63.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 119.224 0.92 . . . . 0.0 109.563 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -63.31 -47.15 83.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.363 1.865 . . . . 0.0 109.044 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.5 -32.61 71.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.313 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.21 50.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 119.942 1.247 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.19 -38.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 121.759 0.79 . . . . 0.0 109.58 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.24 -33.74 70.13 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.966 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.19 94.59 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.504 1.122 . . . . 0.0 111.169 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.93 -14.0 54.97 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.933 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -74.11 73.84 1.74 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.055 0.931 . . . . 0.0 111.049 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.73 23.92 0.69 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.274 -1.931 . . . . 0.0 108.274 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.49 142.58 43.45 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -77.86 121.63 5.52 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.936 2.424 . . . . 0.0 110.662 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.23 22.9 6.28 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.58 149.77 20.66 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 126.119 1.768 . . . . 0.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.77 -65.81 0.51 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.244 0.618 . . . . 0.0 111.706 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.56 55.91 3.38 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.591 1.186 . . . . 0.0 108.703 -171.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 tt -72.96 -13.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 125.979 1.712 . . . . 0.0 111.016 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.3 m -90.9 126.92 36.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.95 -51.21 80.98 Favored Pre-proline 0 C--N 1.349 0.558 0 CA-C-O 116.219 -1.848 . . . . 0.0 113.939 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.64 -8.83 23.13 Favored 'Trans proline' 0 CA--C 1.514 -0.482 0 CA-C-N 126.003 3.18 . . . . 0.0 111.932 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.68 -35.38 14.22 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.579 1.152 . . . . 0.0 108.136 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.29 88.14 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.618 1.567 . . . . 0.0 110.651 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 19.8 tt -66.33 -29.78 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.784 -0.573 . . . . 0.0 111.941 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -27.39 56.91 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.937 -1.102 . . . . 0.0 109.75 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -72.18 -38.85 69.01 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -55.41 -35.38 65.3 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.67 -0.644 . . . . 0.0 111.964 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.42 -39.09 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 110.261 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -80.28 -15.96 55.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.378 -0.826 . . . . 0.0 112.268 -168.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -97.2 -31.06 12.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 110.267 -173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -23.04 62.39 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.04 -1.038 . . . . 0.0 111.701 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -84.35 -2.75 57.59 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.424 1.09 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 53.27 65.37 1.54 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 126.067 1.747 . . . . 0.0 112.18 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.47 -84.41 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.75 76.85 1.27 Allowed Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.95 -49.14 16.19 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.1 -122.56 1.18 Allowed Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 104.053 -3.619 . . . . 0.0 104.053 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.547 ' HB3' HH12 ' B' ' 68' ' ' ARG 0.287 8.8 t0 62.95 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.428 1.891 . . . . 0.0 111.211 -169.073 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.79 -176.95 3.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -156.13 147.12 16.46 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.24 177.55 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.268 2.646 . . . . 0.0 110.199 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.81 170.57 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.27 1.428 . . . . 0.0 107.92 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -62.31 1.69 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.122 2.169 . . . . 0.0 112.47 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.7 -40.9 80.56 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.093 0.957 . . . . 0.0 112.451 -165.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.96 -108.75 0.34 Allowed 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.53 -83.01 0.0 OUTLIER Glycine 0 C--N 1.358 1.79 0 C-N-CA 128.239 2.828 . . . . 0.0 114.53 171.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 68' ' ' ARG . 57.5 ttm-85 -54.79 -44.16 73.49 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.046 2.538 . . . . 0.0 112.439 174.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.98 -30.05 63.51 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.214 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.82 -45.1 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.49 78.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.837 2.055 . . . . 0.0 112.041 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -51.7 -44.44 63.17 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 109.736 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -72.33 -30.27 64.59 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.15 -47.89 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.62 -37.28 82.27 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.97 -38.11 87.3 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.505 -0.747 . . . . 0.0 111.08 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.45 -28.21 69.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.655 0.782 . . . . 0.0 111.385 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.52 -42.59 11.38 Favored Glycine 0 CA--C 1.49 -1.484 0 C-N-CA 124.709 1.147 . . . . 0.0 110.722 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.7 -47.84 81.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.678 1.191 . . . . 0.0 109.198 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -69.16 -25.71 64.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.317 -0.865 . . . . 0.0 111.916 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.47 -51.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.178 -0.951 . . . . 0.0 108.526 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.25 -26.03 66.37 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.48 -0.762 . . . . 0.0 111.231 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.57 48.59 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.023 0.929 . . . . 0.0 110.506 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.75 -39.12 87.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 124.803 1.241 . . . . 0.0 111.246 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.72 -6.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 121.366 -0.834 . . . . 0.0 112.679 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -60.31 -20.29 58.63 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.815 1.246 . . . . 0.0 110.682 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.11 78.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.345 -1.472 . . . . 0.0 112.688 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.18 -45.38 60.61 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.39 -37.63 88.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.562 0.745 . . . . 0.0 110.99 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.41 97.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.867 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -15.99 41.03 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.68 -1.263 . . . . 0.0 113.191 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.96 -17.1 60.6 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 111.853 -172.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -77.94 -24.71 48.12 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.239 -1.538 . . . . 0.0 110.734 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.72 -39.57 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -61.86 -20.89 64.18 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.18 1.392 . . . . 0.0 112.414 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttp85 -58.81 -22.35 58.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 125.005 1.322 . . . . 0.0 111.896 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 . . . . . 0 C--N 1.353 0.739 0 O-C-N 120.07 -1.644 . . . . 0.0 111.5 177.004 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.389 0 CA-C-O 122.184 0.992 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.468 ' CE1' ' OE1' ' B' ' 5' ' ' GLU . 7.7 p80 -59.91 -28.6 67.73 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.451 1.1 . . . . 0.0 112.413 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.468 ' OE1' ' CE1' ' B' ' 4' ' ' HIS . 9.3 tp10 -80.5 -34.61 35.59 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -167.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -71.34 -37.2 71.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.169 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -60.7 -43.07 98.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.931 1.692 . . . . 0.0 110.076 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.8 -45.42 82.42 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.351 1.06 . . . . 0.0 110.994 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.04 -37.43 87.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.436 1.094 . . . . 0.0 110.996 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.51 -33.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.382 1.473 . . . . 0.0 110.917 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.72 -37.93 79.84 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.663 -1.273 . . . . 0.0 110.072 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.17 -30.45 71.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.65 -38.39 90.12 Favored 'General case' 0 C--N 1.357 0.906 0 O-C-N 121.223 -0.923 . . . . 0.0 110.865 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -67.74 -36.25 80.22 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 121.627 -0.67 . . . . 0.0 109.795 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -61.61 -40.55 95.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.628 -0.67 . . . . 0.0 110.669 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.21 -27.24 67.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.361 -0.837 . . . . 0.0 111.989 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.63 -39.64 73.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.79 -38.9 83.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 124.426 1.09 . . . . 0.0 109.421 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -42.11 76.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.236 1.014 . . . . 0.0 112.301 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.86 -43.88 67.54 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.46 -33.17 73.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.101 -1.0 . . . . 0.0 111.394 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.73 -32.69 72.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.049 1.339 . . . . 0.0 110.993 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.0 p -66.83 -41.98 86.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -64.63 -45.37 87.13 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.98 1.312 . . . . 0.0 108.646 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -60.82 -58.16 9.63 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 109.807 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.72 79.9 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.824 1.249 . . . . 0.0 112.858 -172.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.57 -49.57 81.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 CA-C-N 118.814 0.734 . . . . 0.0 109.495 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -76.27 -25.11 54.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.504 0.669 . . . . 0.0 109.644 -170.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 125.544 1.538 . . . . 0.0 110.159 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.18 -12.66 60.13 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.025 -1.047 . . . . 0.0 113.128 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.83 77.68 1.6 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.557 -1.339 . . . . 0.0 110.986 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.04 -19.62 1.58 Allowed Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.41 140.95 45.2 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 121.248 -1.148 . . . . 0.0 109.911 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.62 151.25 25.15 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 122.11 1.873 . . . . 0.0 109.131 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 16.37 79.07 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 119.179 0.899 . . . . 0.0 112.19 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.53 142.93 57.72 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.355 1.862 . . . . 0.0 110.61 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.72 -25.12 0.32 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.324 0.583 . . . . 0.0 110.702 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.25 -38.14 66.09 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.535 1.534 . . . . 0.0 108.512 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -37.85 115.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 130.169 3.388 . . . . 0.0 111.854 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 47.1 t -177.88 -152.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 99.975 -4.083 . . . . 0.0 99.975 -168.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.26 -56.62 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -69.73 -31.3 20.93 Favored 'Trans proline' 0 CA--C 1.503 -1.034 0 CA-C-N 124.416 2.613 . . . . 0.0 111.404 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -107.77 14.51 25.44 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 119.757 1.162 . . . . 0.0 110.148 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.22 -35.37 73.84 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.404 -0.81 . . . . 0.0 109.336 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -28.2 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 123.814 0.845 . . . . 0.0 109.764 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -34.03 76.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.255 -1.528 . . . . 0.0 110.896 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -68.5 -42.76 78.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.685 0.794 . . . . 0.0 109.581 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.6 p -68.38 -28.37 67.05 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.395 -1.441 . . . . 0.0 111.376 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.08 -53.94 24.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 124.568 1.147 . . . . 0.0 110.737 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -73.82 -21.05 60.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.358 -0.838 . . . . 0.0 111.98 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.0 m -72.22 -39.56 68.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.46 67.48 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.371 -0.831 . . . . 0.0 111.727 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 4.37 44.82 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.943 -0.473 . . . . 0.0 110.918 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 24.2 p 55.67 56.58 6.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.273 1.429 . . . . 0.0 112.547 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 55.1 t -121.27 -93.29 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 101.972 -3.344 . . . . 0.0 101.972 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.03 82.98 1.1 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -174.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -73.9 -24.7 59.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.425 -1.044 . . . . 0.0 111.562 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.42 38.58 0.91 Allowed Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -82.32 -60.89 2.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.47 153.99 43.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.7 146.85 36.89 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 161.87 17.28 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.868 2.378 . . . . 0.0 108.797 164.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.18 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 119.465 1.029 . . . . 0.0 108.539 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -114.74 -36.63 4.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.68 1.229 . . . . 0.0 109.054 -172.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.95 -3.63 57.14 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 121.361 -0.837 . . . . 0.0 109.385 -166.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -26.26 60.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 77.11 1.32 Allowed Glycine 0 CA--C 1.471 -2.705 1 N-CA-C 101.445 -4.662 . . . . 0.0 101.445 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.547 HH12 ' HB3' ' A' ' 59' ' ' ASP . 21.0 ttm180 -53.52 -7.9 0.12 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 128.401 2.68 . . . . 0.0 114.263 -170.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -53.14 -19.98 3.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 120.716 -1.24 . . . . 0.0 113.276 157.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.17 -52.04 63.75 Favored 'Isoleucine or valine' 0 C--N 1.363 1.16 0 CA-C-N 120.464 1.484 . . . . 0.0 107.644 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.78 77.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.681 -0.637 . . . . 0.0 109.642 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.06 -46.98 75.42 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.232 1.013 . . . . 0.0 110.553 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.96 -44.04 91.41 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 124.899 1.28 . . . . 0.0 111.094 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.1 -44.16 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.367 0.667 . . . . 0.0 109.969 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.0 mtm -63.16 -46.54 86.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.346 0.593 . . . . 0.0 109.823 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -61.31 -41.51 97.12 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.063 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.13 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.765 0.826 . . . . 0.0 111.033 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.46 -48.17 76.44 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.87 -43.35 91.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 C-N-CA 124.47 1.108 . . . . 0.0 110.206 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.25 -40.9 94.63 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.118 -0.989 . . . . 0.0 111.684 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.9 -47.63 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.26 -11.15 60.76 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 121.562 -0.711 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.76 -42.3 12.7 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.835 -1.166 . . . . 0.0 109.144 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.53 -36.69 74.25 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 126.112 1.765 . . . . 0.0 111.04 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.64 -7.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 112.498 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.6 m -63.65 -16.86 62.1 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.314 -1.492 . . . . 0.0 110.985 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.45 -19.34 63.4 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.52 -1.987 . . . . 0.0 111.751 169.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.08 -54.48 4.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.124 1.37 . . . . 0.0 108.705 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.69 -36.34 70.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.468 -0.77 . . . . 0.0 112.533 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.14 -17.2 61.41 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 119.834 -1.791 . . . . 0.0 110.2 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -87.41 -2.27 58.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.729 -1.232 . . . . 0.0 109.36 175.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.02 -31.45 67.94 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 120.674 1.579 . . . . 0.0 111.302 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -72.94 -25.71 61.13 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.84 -1.163 . . . . 0.0 111.22 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.64 -32.5 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -63.37 -26.1 68.6 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.294 1.038 . . . . 0.0 111.552 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -50.57 -39.77 50.42 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.283 1.433 . . . . 0.0 111.438 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 CA--C 1.507 -0.689 0 O-C-N 120.926 -1.109 . . . . 0.0 112.128 -179.496 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 CA--C 1.505 -0.752 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -52.39 -29.8 25.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.365 1.466 . . . . 0.0 113.769 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.82 -25.96 56.8 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.943 -1.098 . . . . 0.0 111.326 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.94 -38.72 69.77 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.186 -0.946 . . . . 0.0 108.524 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.62 -27.95 66.48 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.28 0.562 . . . . 0.0 109.852 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.79 75.97 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.253 -0.905 . . . . 0.0 111.193 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -74.53 -29.5 61.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 120.872 -1.143 . . . . 0.0 111.08 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -64.17 -28.79 70.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 111.286 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.36 65.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.893 -1.13 . . . . 0.0 110.438 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.43 -32.35 73.67 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 120.898 -1.126 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.6 -29.31 66.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.793 -1.192 . . . . 0.0 110.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.67 -37.49 79.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.324 1.449 . . . . 0.0 109.181 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 27.4 tp -56.86 -48.89 77.05 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 126.073 1.749 . . . . 0.0 110.026 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.03 -39.79 79.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.673 1.589 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -74.12 -46.7 40.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.338 1.455 . . . . 0.0 110.742 -172.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.98 -36.23 72.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.101 -0.999 . . . . 0.0 111.111 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.19 -28.04 57.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -49.59 74.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -63.19 -43.41 98.28 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.44 1.114 . . . . 0.0 109.197 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.16 63.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.637 -0.665 . . . . 0.0 112.518 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 m -69.13 -47.73 64.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 124.075 0.95 . . . . 0.0 109.702 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -66.24 -43.79 85.58 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.43 -20.61 64.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.461 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -45.09 73.69 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 119.975 1.261 . . . . 0.0 110.451 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.04 -44.29 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.91 -45.02 94.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.801 1.64 . . . . 0.0 110.258 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.18 86.45 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 124.869 1.267 . . . . 0.0 111.174 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -32.45 58.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 121.959 -0.463 . . . . 0.0 109.9 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.6 90.49 1.03 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.443 1.097 . . . . 0.0 109.637 -174.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.75 -27.41 2.82 Favored Glycine 0 CA--C 1.491 -1.463 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -93.57 156.07 40.06 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -76.77 154.08 34.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.23 1.953 . . . . 0.0 110.734 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.41 49.73 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.16 136.41 15.12 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.636 1.974 . . . . 0.0 113.536 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.7 -30.42 0.19 Allowed 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.185 0.994 . . . . 0.0 111.007 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -102.88 148.08 26.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -168.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -156.47 179.43 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m 65.32 109.36 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.572 1.549 . . . . 0.0 114.258 161.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -57.59 -37.89 61.53 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 116.227 -1.844 . . . . 0.0 114.757 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.6 -21.77 14.44 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 CA-C-N 125.628 3.046 . . . . 0.0 112.666 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -82.84 -25.45 32.62 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.72 71.86 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.96 1.704 . . . . 0.0 112.507 -172.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -67.13 -25.16 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 123.338 0.655 . . . . 0.0 111.114 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -21.01 56.25 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 120.822 -1.174 . . . . 0.0 110.867 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -80.62 -40.16 26.14 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.372 1.082 . . . . 0.0 108.126 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m -70.61 -31.42 68.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 O-C-N 120.328 -1.483 . . . . 0.0 112.634 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -62.62 -51.05 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.68 -15.76 61.69 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.08 1.352 . . . . 0.0 112.291 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 50.3 m -82.3 -36.73 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.066 -1.021 . . . . 0.0 108.525 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -27.74 61.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.37 -0.831 . . . . 0.0 110.451 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -93.0 6.91 46.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.452 0.701 . . . . 0.0 110.211 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.259 7.9 p 54.2 55.02 8.71 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 126.855 2.062 . . . . 0.0 114.317 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.87 -75.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.96 -64.06 3.09 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 t80 78.68 -47.6 0.43 Allowed 'General case' 0 C--N 1.351 0.668 0 C-N-CA 127.369 2.267 . . . . 0.0 109.437 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.05 13.72 0.42 Allowed Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -57.57 4.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.658 -0.907 . . . . 0.0 111.144 -173.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 26.0 mtm-85 -138.13 154.95 49.17 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -134.27 150.41 73.97 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.23 166.82 20.21 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 109.556 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' C' ' 33' ' ' ALA . 32.8 m -87.1 -179.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p -82.54 -79.85 0.18 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -32.47 -61.68 0.26 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.596 2.758 . . . . 0.0 110.912 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.77 -59.41 1.8 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -41.02 -41.45 2.67 Favored Glycine 0 CA--C 1.488 -1.639 0 C-N-CA 127.47 2.462 . . . . 0.0 114.819 -169.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -76.36 -30.68 57.68 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.292 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -35.35 71.59 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 121.528 1.967 . . . . 0.0 108.888 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.93 -51.38 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.79 98.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 125.094 1.358 . . . . 0.0 112.551 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.98 -46.89 52.95 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 127.328 2.251 . . . . 0.0 109.457 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -66.59 -36.39 82.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.75 -44.46 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.6 mtt -59.5 -46.26 89.32 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.679 0.791 . . . . 0.0 110.664 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -61.94 -43.61 98.48 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.48 84.12 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.226 0.61 . . . . 0.0 110.931 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.19 86.64 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 123.821 0.724 . . . . 0.0 111.833 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.99 -43.11 97.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.938 0.895 . . . . 0.0 109.527 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.77 -33.36 73.94 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.342 -0.848 . . . . 0.0 111.94 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.21 -53.59 35.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 123.689 0.796 . . . . 0.0 109.558 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -66.09 -38.79 89.14 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.85 -30.47 71.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.423 0.689 . . . . 0.0 111.842 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.68 -36.86 81.48 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 121.026 -1.046 . . . . 0.0 110.443 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.64 -20.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.932 1.293 . . . . 0.0 110.416 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 2.9 m -55.76 -22.79 25.94 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.927 1.291 . . . . 0.0 112.185 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.66 70.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.662 -1.899 . . . . 0.0 112.826 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.0 -16.68 35.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 123.961 0.904 . . . . 0.0 110.381 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.4 -35.6 17.03 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.33 62.07 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.611 -1.306 . . . . 0.0 111.179 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -73.26 -19.22 61.11 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 120.44 -1.412 . . . . 0.0 110.787 171.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.7 -11.37 57.28 Favored 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 120.935 -1.103 . . . . 0.0 111.136 -157.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -84.58 -21.3 30.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.109 -0.994 . . . . 0.0 110.336 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.84 -35.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -55.35 -19.46 8.92 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.036 1.334 . . . . 0.0 113.217 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -57.46 -28.87 63.73 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.296 -0.877 . . . . 0.0 110.947 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 N--CA 1.436 -1.17 0 O-C-N 121.319 -0.863 . . . . 0.0 110.805 -176.772 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 74.48 -67.69 0.24 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.866 2.066 . . . . 0.0 110.645 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -70.83 -28.93 64.98 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 126.662 1.985 . . . . 0.0 111.857 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -23.46 63.79 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 120.967 -1.083 . . . . 0.0 111.47 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.07 -42.78 88.94 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.453 -0.779 . . . . 0.0 109.908 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.76 -39.64 80.17 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.63 93.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.536 0.735 . . . . 0.0 111.17 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.34 -39.52 85.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.469 0.708 . . . . 0.0 110.389 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -64.06 -35.61 81.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.005 0.922 . . . . 0.0 110.808 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.03 79.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.388 1.075 . . . . 0.0 111.122 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -65.26 -34.69 78.96 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 120.901 -1.125 . . . . 0.0 111.17 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.96 -33.67 74.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 121.595 -0.69 . . . . 0.0 110.867 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -61.68 -41.94 98.24 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.194 1.398 . . . . 0.0 109.297 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.61 -38.84 91.76 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.051 -1.031 . . . . 0.0 111.417 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -69.12 -22.65 63.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.157 -0.964 . . . . 0.0 112.405 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.48 -39.96 36.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.25 -38.33 80.8 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 124.379 1.071 . . . . 0.0 109.544 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.79 -45.9 63.99 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.556 1.142 . . . . 0.0 112.056 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -71.41 -41.14 69.94 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 122.776 0.431 . . . . 0.0 110.585 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -62.68 -43.37 98.99 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.38 68.69 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.875 1.67 . . . . 0.0 112.17 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -67.08 -37.95 84.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 110.163 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -35.21 63.85 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -64.66 -50.06 68.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.57 0.748 . . . . 0.0 109.185 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.39 69.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.678 1.191 . . . . 0.0 113.507 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.23 -28.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 O-C-N 120.187 -1.57 . . . . 0.0 109.888 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -75.75 -49.17 18.97 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.797 -1.19 . . . . 0.0 108.304 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.27 78.62 6.49 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.82 -55.05 0.06 Allowed 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.889 1.368 . . . . 0.0 108.051 163.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -79.42 103.54 9.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 119.406 -2.058 . . . . 0.0 110.303 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.38 -49.59 0.26 Allowed Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 105.181 -3.168 . . . . 0.0 105.181 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' D' ' 66' ' ' GLU . . . -78.0 161.69 70.05 Favored Pre-proline 0 CA--C 1.504 -0.807 0 C-N-CA 123.446 0.698 . . . . 0.0 112.759 -171.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -78.65 113.78 3.36 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.589 2.193 . . . . 0.0 110.766 172.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.33 2.25 13.55 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.129 -0.817 . . . . 0.0 111.202 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.03 145.09 21.42 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.858 1.263 . . . . 0.0 113.172 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.16 -48.56 1.33 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.626 1.171 . . . . 0.0 111.128 -167.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.78 133.81 34.51 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 pt -148.11 17.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.11 138.65 33.66 Favored 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 120.484 -1.385 . . . . 0.0 108.228 -170.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.58 -49.39 8.57 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.982 -1.961 . . . . 0.0 111.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.27 -8.04 21.35 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 CA-C-N 125.865 3.13 . . . . 0.0 111.101 -173.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -98.82 -25.63 14.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.09 80.5 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.532 1.133 . . . . 0.0 111.086 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.37 -35.53 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 121.977 -0.452 . . . . 0.0 110.445 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -28.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.487 -1.383 . . . . 0.0 110.429 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -63.79 -42.93 97.63 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.417 1.103 . . . . 0.0 108.457 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -58.33 -37.47 75.21 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.307 1.443 . . . . 0.0 111.388 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.53 -49.77 71.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 124.328 1.051 . . . . 0.0 110.591 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -75.36 -23.85 57.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.849 0.833 . . . . 0.0 110.863 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 64.3 m -70.31 -39.33 74.87 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.72 67.12 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.098 -1.001 . . . . 0.0 111.942 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -88.65 5.82 41.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 119.149 -0.453 . . . . 0.0 110.077 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 51.48 29.7 5.6 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 127.614 2.366 . . . . 0.0 112.437 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.07 -47.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.31 51.48 58.54 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -71.11 -33.23 69.94 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.978 0.894 . . . . 0.0 109.361 -166.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 155.68 -123.47 1.34 Allowed Glycine 0 CA--C 1.476 -2.36 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 75.13 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.345 1.458 . . . . 0.0 108.016 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -145.37 171.58 14.41 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.478 ' HB2' HH12 ' D' ' 68' ' ' ARG . 11.7 p90 -164.36 148.21 7.97 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -91.67 155.06 3.5 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 C-N-CA 122.468 2.112 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -155.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.937 0.875 . . . . 0.0 110.424 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -53.84 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.382 -1.449 . . . . 0.0 112.26 -164.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -79.86 -7.78 58.91 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.784 1.233 . . . . 0.0 109.621 -165.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' D' ' 33' ' ' ALA . 40.2 mm-40 -95.98 41.26 1.11 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 15.16 81.56 0.01 OUTLIER Glycine 0 CA--C 1.462 -3.253 1 C-N-CA 133.139 5.162 . . . . 0.0 110.434 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.478 HH12 ' HB2' ' D' ' 61' ' ' TYR . 20.7 ttt85 -53.37 -13.8 0.63 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.599 1.96 . . . . 0.0 113.457 -164.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.05 -6.01 0.32 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 160.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.12 -49.15 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 O-C-N 120.274 -1.517 . . . . 0.0 107.713 167.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.23 82.06 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -48.67 -46.28 40.06 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.604 1.161 . . . . 0.0 113.324 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.27 -37.43 83.44 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.107 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.34 -44.97 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 58.2 mtm -63.05 -48.34 79.13 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.21 1.004 . . . . 0.0 110.62 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.39 -38.27 88.98 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.531 -0.731 . . . . 0.0 110.505 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.698 -0.626 . . . . 0.0 111.911 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.17 -46.98 66.97 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.74 -44.89 94.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 C-N-CA 124.559 1.144 . . . . 0.0 109.663 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.78 -47.56 84.3 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 111.388 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.16 -49.99 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 124.284 1.034 . . . . 0.0 109.768 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -71.75 -16.23 62.2 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.903 -0.498 . . . . 0.0 111.482 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.27 -35.55 16.08 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.256 -0.903 . . . . 0.0 109.859 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.52 -31.48 72.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.584 1.554 . . . . 0.0 110.927 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.08 -3.02 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.696 0 O-C-N 121.326 -0.858 . . . . 0.0 112.609 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 88.0 m -58.35 -22.85 54.91 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.476 1.51 . . . . 0.0 111.571 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.88 66.33 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.198 -1.564 . . . . 0.0 111.935 172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.69 -49.06 6.68 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.09 -39.9 91.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.726 -1.234 . . . . 0.0 113.657 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.85 61.81 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.945 -1.097 . . . . 0.0 110.892 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 80.8 p -85.31 -14.47 46.43 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.568 -1.333 . . . . 0.0 110.566 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.39 -16.2 61.34 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.14 -1.6 . . . . 0.0 111.067 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -80.31 -31.36 38.15 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.651 -1.281 . . . . 0.0 111.874 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.19 -11.74 14.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 CA-C-O 121.562 0.696 . . . . 0.0 110.168 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -61.41 -17.26 53.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.788 0.835 . . . . 0.0 110.848 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.58 -22.21 63.46 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.586 1.085 . . . . 0.0 112.021 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 N--CA 1.441 -0.883 0 C-N-CA 123.682 0.793 . . . . 0.0 109.474 -178.344 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.865 0 CA-C-O 121.61 0.719 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -136.42 129.47 31.24 Favored 'General case' 0 CA--C 1.477 -1.857 1 N-CA-C 96.573 -5.343 . . . . 0.0 96.573 153.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.299 7.0 p-80 144.07 -60.88 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 128.5 2.72 . . . . 0.0 107.251 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -76.34 -28.15 56.75 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 120.745 -1.222 . . . . 0.0 110.803 -171.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -64.02 -37.54 87.79 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.06 -1.025 . . . . 0.0 111.167 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -73.48 -34.21 65.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.085 1.354 . . . . 0.0 108.27 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.96 90.34 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.953 1.301 . . . . 0.0 110.587 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -61.8 -42.16 98.66 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 110.082 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -64.03 -34.3 77.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.911 0.862 . . . . 0.0 110.947 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.48 70.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.003 -1.061 . . . . 0.0 110.987 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.02 -32.8 74.7 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.191 -0.943 . . . . 0.0 111.038 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.89 -34.81 74.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.744 -1.223 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.54 -36.54 82.93 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.46 -48.77 76.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.594 1.158 . . . . 0.0 110.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -71.49 -27.07 62.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.733 -1.229 . . . . 0.0 112.283 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -67.09 -44.34 80.26 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.211 1.404 . . . . 0.0 109.805 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 77' ' ' ALA . 21.9 m -72.48 -29.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.946 -1.096 . . . . 0.0 110.249 -177.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.0 mt -61.75 -38.87 89.57 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 123.799 0.839 . . . . 0.0 111.168 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.93 -31.55 63.11 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.197 0.999 . . . . 0.0 110.826 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -77.88 -39.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.03 78.79 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.274 1.029 . . . . 0.0 111.715 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -65.83 -32.69 74.36 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.862 -0.524 . . . . 0.0 110.587 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -62.55 -47.43 83.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.395 0.678 . . . . 0.0 109.576 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -64.96 -38.04 89.66 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 110.115 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.23 75.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.149 0.98 . . . . 0.0 112.555 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.8 t -72.71 -43.19 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 121.089 -1.007 . . . . 0.0 109.175 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.0 -37.87 81.98 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.65 -1.282 . . . . 0.0 110.104 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 64.74 6.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.919 1.688 . . . . 0.0 108.219 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -164.74 -53.86 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.91 89.53 0.01 OUTLIER 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.119 1.768 . . . . 0.0 112.269 -170.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.58 10.12 25.74 Favored Glycine 0 CA--C 1.498 -0.995 0 O-C-N 121.035 -1.041 . . . . 0.0 111.792 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.71 133.46 25.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.722 1.261 . . . . 0.0 107.945 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.39 130.0 8.83 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.696 2.264 . . . . 0.0 110.645 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.76 74.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 160.38 16.39 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.9 9.17 Favored 'General case' 0 N--CA 1.427 -1.595 1 N-CA-C 99.04 -4.43 . . . . 0.0 99.04 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' CE3' ' A' ' 47' ' ' TRP . 1.9 tt 82.63 87.99 0.04 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 tt -138.57 142.83 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.71 138.73 0.06 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.324 1.849 . . . . 0.0 112.73 169.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -51.65 -53.48 50.01 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 126.033 1.733 . . . . 0.0 114.37 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.77 -6.94 18.83 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 CA-C-N 124.366 2.595 . . . . 0.0 112.316 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.48 -48.08 4.9 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.6 77.77 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 125.382 1.473 . . . . 0.0 112.441 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -66.42 -31.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.509 -0.744 . . . . 0.0 110.452 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -23.16 36.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.394 -0.816 . . . . 0.0 109.916 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CE3' HD11 ' A' ' 38' ' ' LEU . 72.5 t90 -72.37 -38.56 68.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -75.92 65.84 2.06 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.551 1.54 . . . . 0.0 108.318 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.69 -71.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.616 ' CD ' HH22 ' B' ' 68' ' ' ARG . 20.0 pt-20 -69.37 -24.4 63.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.869 0.842 . . . . 0.0 111.946 -165.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 51' ' ' THR . 2.5 t -66.93 -35.37 79.84 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 124.837 1.255 . . . . 0.0 107.988 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -76.84 -23.64 52.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 120.358 -1.464 . . . . 0.0 110.695 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -87.31 9.93 18.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.282 5.4 t 48.08 48.29 18.41 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 127.723 2.409 . . . . 0.0 112.569 172.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -110.99 -99.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 171.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 109.88 67.01 0.57 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 103.142 -3.983 . . . . 0.0 103.142 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -68.12 -30.55 69.73 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 122.134 0.969 . . . . 0.0 108.466 -174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.62 49.07 0.53 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.492 ' CG ' HH21 ' B' ' 68' ' ' ARG 0.479 4.6 p-10 -80.48 -28.96 37.41 Favored 'General case' 0 C--N 1.362 1.11 0 CA-C-N 119.063 1.431 . . . . 0.0 110.372 170.382 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -147.03 -179.84 7.1 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -146.05 137.54 12.97 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -84.49 -177.12 2.8 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 C-N-CA 124.422 3.415 . . . . 0.0 108.863 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' GLU 0.308 7.8 p -112.1 -128.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.657 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 -37.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.443 1.897 . . . . 0.0 107.183 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -84.22 -2.19 56.47 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.77 0.828 . . . . 0.0 109.78 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -73.86 -35.51 64.75 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.81 60.29 0.66 Allowed Glycine 0 CA--C 1.466 -3.017 1 N-CA-C 102.772 -4.131 . . . . 0.0 102.772 168.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -13.84 -30.75 0.0 OUTLIER 'General case' 0 C--N 1.364 1.214 1 C-N-CA 135.489 5.515 . . . . 0.0 117.738 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -53.36 -22.31 7.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 126.737 2.015 . . . . 0.0 112.626 163.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.3 -51.35 65.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.52 -1.363 . . . . 0.0 108.439 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.79 -45.09 68.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.376 0.67 . . . . 0.0 110.341 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.81 -37.09 75.6 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 110.841 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -58.18 -39.65 79.46 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 121.4 -0.812 . . . . 0.0 110.601 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.51 -36.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mmt -57.9 -57.49 12.58 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.397 1.079 . . . . 0.0 109.741 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.95 -28.06 67.98 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 121.345 -0.847 . . . . 0.0 111.057 -175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 18' ' ' VAL . . . -66.92 -22.74 65.94 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.588 -0.695 . . . . 0.0 110.883 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.93 -36.78 10.85 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.25 -42.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 125.359 1.464 . . . . 0.0 110.426 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.76 -37.27 84.29 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.438 -0.789 . . . . 0.0 110.91 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.36 -57.99 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 124.535 1.134 . . . . 0.0 109.979 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.01 -13.7 62.6 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.709 -0.619 . . . . 0.0 110.691 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.62 -46.97 16.23 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 121.112 -0.992 . . . . 0.0 110.091 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.47 -36.9 79.39 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.065 1.346 . . . . 0.0 111.64 -172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.0 m -62.71 -9.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.408 -0.807 . . . . 0.0 112.602 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -62.91 -18.58 63.22 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.121 1.369 . . . . 0.0 110.941 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.82 -24.28 66.78 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.682 -1.261 . . . . 0.0 111.636 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.47 -46.52 10.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 108.197 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.43 -41.55 98.79 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.17 0.988 . . . . 0.0 112.902 -171.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.04 -9.96 59.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.13 -0.981 . . . . 0.0 111.466 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.6 p -83.78 -16.18 45.64 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 120.768 -1.208 . . . . 0.0 110.323 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.73 -24.77 58.77 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.628 -163.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -74.65 -32.02 62.12 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.644 -1.285 . . . . 0.0 110.995 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 t -69.43 -32.87 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 125.399 1.48 . . . . 0.0 108.423 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -61.84 -11.63 13.64 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.398 1.479 . . . . 0.0 112.442 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -68.34 -22.34 64.69 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 120.001 -1.687 . . . . 0.0 110.595 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--N 1.353 0.749 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.459 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 CA--C 1.507 -0.683 0 CA-C-O 123.537 1.637 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.25 -21.05 63.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.191 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -85.66 -39.11 17.63 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -70.84 -31.25 67.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.478 -0.764 . . . . 0.0 110.864 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.11 -47.64 79.24 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.0 70.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.294 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.14 -35.91 80.72 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.218 1.007 . . . . 0.0 110.208 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.25 -28.12 64.99 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -39.35 93.37 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.09 -47.79 76.0 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.404 -0.81 . . . . 0.0 110.548 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -52.88 -51.97 59.16 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.312 1.845 . . . . 0.0 110.222 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -76.03 -12.59 60.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.443 -0.786 . . . . 0.0 112.045 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.733 -1.229 . . . . 0.0 108.12 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.77 -14.05 60.66 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.54 -1.35 . . . . 0.0 111.193 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.93 -51.65 21.03 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.15 -23.75 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.859 -0.526 . . . . 0.0 111.393 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.14 -39.71 83.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.369 -0.832 . . . . 0.0 112.076 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.74 -24.34 38.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.293 0.568 . . . . 0.0 110.583 -174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.33 -42.15 46.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.82 82.15 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 126.309 1.844 . . . . 0.0 111.584 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -65.99 -44.97 83.29 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 122.111 -0.368 . . . . 0.0 110.324 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.11 -48.16 77.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.248 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -68.31 -25.55 65.19 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.098 -175.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -43.9 58.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 109.673 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 73.7 t -60.43 -45.72 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.241 -0.912 . . . . 0.0 110.127 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.59 17.96 15.2 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 121.638 -0.664 . . . . 0.0 111.099 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.507 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -75.69 -48.52 21.66 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 170.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' B' ' 36' ' ' ALA . 0.5 OUTLIER -56.66 -27.53 58.78 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 126.396 1.878 . . . . 0.0 115.082 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -73.77 75.88 1.58 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.61 0.764 . . . . 0.0 109.393 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.59 -43.23 0.77 Allowed Glycine 0 CA--C 1.488 -1.618 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.41 152.12 60.35 Favored Pre-proline 0 N--CA 1.445 -0.713 0 O-C-N 121.486 -1.008 . . . . 0.0 111.263 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.05 153.5 11.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.136 1.891 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.17 41.61 10.13 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' B' ' 30' ' ' GLU . . . -62.71 132.44 52.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 -42.06 0.17 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.358 0.263 . . . . 0.0 110.683 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -6.61 54.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.896 1.678 . . . . 0.0 110.739 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.14 84.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 O-C-N 120.634 -1.291 . . . . 0.0 111.929 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.1 112.05 0.74 Allowed 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -53.37 -47.7 95.26 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.404 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -71.47 -20.14 27.7 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-N 124.962 2.808 . . . . 0.0 113.011 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.73 0.63 17.47 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 119.941 1.246 . . . . 0.0 109.922 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.44 -34.72 76.46 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.189 -0.944 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.422 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.6 tt -70.99 -35.75 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.287 1.035 . . . . 0.0 109.614 175.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.63 -38.83 67.6 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.466 -1.396 . . . . 0.0 108.815 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -65.18 -44.86 87.11 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 123.356 0.662 . . . . 0.0 110.152 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -66.96 -29.43 69.28 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.953 -1.092 . . . . 0.0 110.851 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 23.3 t -58.35 -43.25 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.453 1.101 . . . . 0.0 111.117 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -82.45 -15.0 54.16 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.794 1.179 . . . . 0.0 112.298 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.48 -36.14 29.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.756 -1.215 . . . . 0.0 107.804 -174.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.37 -23.39 61.12 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.882 -1.136 . . . . 0.0 112.066 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.96 -6.28 59.0 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.188 0.995 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 14.6 p 55.7 54.48 8.22 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.863 1.665 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.89 -91.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 1 N-CA-C 100.031 -4.062 . . . . 0.0 100.031 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.52 76.72 1.34 Allowed Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.65 -18.23 51.93 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.49 -1.006 . . . . 0.0 108.605 -171.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.3 48.93 0.68 Allowed Glycine 0 CA--C 1.484 -1.877 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 168.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.61 -54.34 9.37 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -131.33 -136.62 0.2 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.191 0.596 . . . . 0.0 109.594 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -171.91 121.57 0.47 Allowed Pre-proline 0 N--CA 1.444 -0.726 1 N-CA-C 100.029 -4.063 . . . . 0.0 100.029 -168.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.85 158.15 13.82 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 124.59 2.675 . . . . 0.0 109.791 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.407 HG22 ' H ' ' B' ' 63' ' ' VAL . 2.9 m -76.11 169.92 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.635 1.207 . . . . 0.0 111.819 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -59.63 2.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.38 1.072 . . . . 0.0 110.793 -169.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.31 -17.26 64.7 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 -168.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -130.56 -108.05 0.27 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.507 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 25.94 -70.87 0.0 OUTLIER Glycine 0 CA--C 1.486 -1.758 1 C-N-CA 132.442 4.83 . . . . 0.0 116.204 170.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.616 HH22 ' CD ' ' A' ' 50' ' ' GLU . 52.7 ttm-85 -61.78 -42.92 99.61 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 126.083 1.753 . . . . 0.0 112.575 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -67.79 -34.5 76.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 120.251 1.387 . . . . 0.0 109.589 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.99 -47.75 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.2 90.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.876 1.671 . . . . 0.0 110.9 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -50.91 -46.1 60.55 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 127.648 2.379 . . . . 0.0 110.482 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -66.73 -37.46 84.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -74.51 -45.76 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.223 1.009 . . . . 0.0 109.372 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 71.7 mtm -61.06 -45.01 96.48 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.629 1.172 . . . . 0.0 109.759 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -64.8 -32.49 74.2 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.909 -0.495 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.512 -0.743 . . . . 0.0 110.329 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -40.59 97.02 Favored Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 124.186 0.898 . . . . 0.0 111.732 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.63 -51.0 77.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 C-N-CA 124.086 0.954 . . . . 0.0 108.456 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -65.41 -27.4 68.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.541 -0.724 . . . . 0.0 111.724 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.87 -58.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 124.391 1.076 . . . . 0.0 110.333 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -65.28 -25.41 67.63 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 121.539 0.685 . . . . 0.0 110.148 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.21 -41.97 32.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 121.367 -0.833 . . . . 0.0 111.268 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.16 -36.93 85.26 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.522 -1.361 . . . . 0.0 110.682 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.79 -3.45 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 O-C-N 121.563 -0.711 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 56.5 m -56.6 -22.77 36.17 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.992 1.317 . . . . 0.0 109.985 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.05 72.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.329 -1.482 . . . . 0.0 112.503 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.01 -35.42 61.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 120.954 -1.091 . . . . 0.0 109.191 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.5 -32.49 62.54 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 122.967 0.507 . . . . 0.0 110.67 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.844 -1.16 . . . . 0.0 111.115 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -11.21 60.62 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.066 -1.021 . . . . 0.0 113.22 174.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.7 -47.61 80.46 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 120.208 1.367 . . . . 0.0 109.839 -171.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -71.54 -27.16 62.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.941 -1.099 . . . . 0.0 111.736 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.01 -17.75 22.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.982 1.313 . . . . 0.0 109.455 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -70.37 -17.73 63.05 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.082 -1.636 . . . . 0.0 111.707 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -66.41 -13.48 60.77 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 120.496 -1.377 . . . . 0.0 110.478 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 . . . . . 0 CA--C 1.497 -1.064 0 C-N-CA 126.195 1.798 . . . . 0.0 109.876 176.482 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.498 -1.036 0 CA-C-O 121.639 0.733 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.407 ' CD2' ' HG3' ' C' ' 5' ' ' GLU . 40.5 p-80 -65.82 -30.33 70.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.803 -0.561 . . . . 0.0 112.004 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.407 ' HG3' ' CD2' ' C' ' 4' ' ' HIS . 7.2 mt-10 -77.36 -40.72 42.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.04 -44.46 96.66 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.521 -0.737 . . . . 0.0 109.986 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -33.98 75.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.025 0.441 . . . . 0.0 110.685 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.73 90.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.669 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -68.64 -34.39 75.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 121.674 -0.641 . . . . 0.0 110.62 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -66.56 -35.39 80.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.219 1.408 . . . . 0.0 110.73 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.42 87.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.351 -0.843 . . . . 0.0 111.069 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -63.76 -33.89 76.67 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.978 0.894 . . . . 0.0 111.5 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -68.33 -30.84 69.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.103 1.361 . . . . 0.0 110.518 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -69.22 -37.01 77.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.777 -1.202 . . . . 0.0 108.987 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.5 -44.43 97.09 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.222 1.009 . . . . 0.0 110.838 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.61 -39.6 70.99 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.254 1.021 . . . . 0.0 112.376 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.2 71.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.274 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.61 -40.66 88.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.73 -42.68 84.36 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.319 1.048 . . . . 0.0 111.095 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.7 -39.96 94.54 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -88.31 -12.54 43.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.949 -1.094 . . . . 0.0 109.983 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.51 -37.51 42.91 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.783 -1.198 . . . . 0.0 109.286 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -37.65 84.97 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.232 0.613 . . . . 0.0 110.311 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -44.26 81.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.285 1.434 . . . . 0.0 109.218 172.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -69.14 -48.77 61.48 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.652 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.98 80.91 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.302 1.041 . . . . 0.0 112.924 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.27 -23.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 O-C-N 121.294 -0.879 . . . . 0.0 110.839 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.85 -4.26 47.36 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 119.854 -1.779 . . . . 0.0 109.016 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.63 -48.62 12.39 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -173.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.85 -110.67 0.13 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . 0.305 11.5 mtm-85 43.23 71.57 0.23 Allowed 'General case' 0 C--N 1.358 0.945 0 C-N-CA 126.32 1.848 . . . . 0.0 112.942 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.14 36.97 2.05 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.83 153.7 42.22 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.19 121.34 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.996 2.464 . . . . 0.0 110.041 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.19 25.78 39.03 Favored Glycine 0 CA--C 1.496 -1.107 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.69 151.65 46.4 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.116 1.366 . . . . 0.0 109.575 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.25 -34.9 0.52 Allowed 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.255 0.622 . . . . 0.0 109.759 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.4 tp -94.75 55.06 1.84 Allowed 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.87 19.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 124.646 1.178 . . . . 0.0 110.28 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.5 t -129.42 125.61 36.91 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.14 -53.05 20.47 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-O 115.85 -2.024 . . . . 0.0 112.109 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.54 -16.2 34.27 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 CA-C-N 126.252 3.269 . . . . 0.0 111.109 -173.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.01 -20.62 44.96 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.8 79.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.159 -0.963 . . . . 0.0 111.63 -167.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.06 -21.86 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.628 0.728 . . . . 0.0 110.632 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -25.34 21.91 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.875 0.87 . . . . 0.0 109.147 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -67.48 -46.67 72.28 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 170.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -77.37 64.25 2.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.734 -0.604 . . . . 0.0 110.037 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 66.2 t -136.1 -71.07 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.38 -15.1 62.36 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-O 121.95 0.881 . . . . 0.0 112.598 -164.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.409 ' H ' HG22 ' C' ' 51' ' ' THR . 2.7 t -73.03 -32.37 65.06 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 124.719 1.207 . . . . 0.0 109.102 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.39 58.71 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 121.08 -1.012 . . . . 0.0 110.55 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -92.23 7.46 42.56 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.05 0.54 . . . . 0.0 110.128 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 51.2 p 49.68 42.33 23.21 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.482 1.913 . . . . 0.0 113.772 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.64 -56.24 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.77 3.06 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' D' ' 56' ' ' GLY . 1.8 t80 -71.23 -45.85 62.38 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -172.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.68 52.25 0.23 Allowed Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.66 -36.42 73.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.863 -0.786 . . . . 0.0 111.493 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -126.79 -163.71 1.27 Allowed 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -148.43 112.2 3.73 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 168.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.57 -173.61 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.769 2.979 . . . . 0.0 108.779 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.268 7.4 p -128.39 -128.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -121.35 -37.16 2.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.279 1.432 . . . . 0.0 108.035 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.71 -12.2 58.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.869 1.268 . . . . 0.0 110.371 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -32.94 68.23 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.09 64.83 0.84 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 102.348 -4.301 . . . . 0.0 102.348 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -14.21 -38.6 0.0 OUTLIER 'General case' 0 C--N 1.366 1.284 1 C-N-CA 132.491 4.316 . . . . 0.0 116.434 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.49 -26.88 0.24 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.637 1.575 . . . . 0.0 113.791 165.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.46 -42.78 92.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.409 -1.432 . . . . 0.0 110.833 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.2 31.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -60.27 -31.19 69.99 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 123.681 0.792 . . . . 0.0 113.026 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -69.23 -32.45 71.7 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.407 -1.433 . . . . 0.0 110.545 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.92 62.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -57.2 -52.29 65.9 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.706 1.202 . . . . 0.0 110.381 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.83 -42.84 99.52 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 122.015 -0.428 . . . . 0.0 110.88 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.01 -33.92 75.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.688 0.395 . . . . 0.0 111.549 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -45.49 86.41 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 123.837 0.732 . . . . 0.0 111.329 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.34 -45.82 93.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.35 1.06 . . . . 0.0 109.352 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.94 -38.46 85.93 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.519 -0.738 . . . . 0.0 112.31 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.15 -53.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 109.198 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -66.73 -38.91 87.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.919 -0.488 . . . . 0.0 111.041 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.36 73.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 110.997 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.04 -30.93 71.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.314 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.88 -18.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 124.911 1.284 . . . . 0.0 110.775 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -56.53 -20.64 21.53 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 112.424 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.04 72.06 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.136 -1.602 . . . . 0.0 111.898 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -80.08 -50.66 10.03 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.732 -1.23 . . . . 0.0 108.233 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 44.1 mt -59.63 -39.28 83.8 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.802 1.241 . . . . 0.0 112.27 -173.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.13 60.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.039 -1.038 . . . . 0.0 111.396 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 27.0 m -85.65 -18.01 34.45 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.7 -25.03 61.09 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.126 -1.609 . . . . 0.0 111.643 -164.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -77.55 -20.65 53.79 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.669 -1.27 . . . . 0.0 111.176 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.27 -24.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -172.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.03 -36.56 60.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.03 1.332 . . . . 0.0 111.846 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -54.84 -40.22 69.4 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 125.057 1.343 . . . . 0.0 110.955 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 . . . . . 0 N--CA 1.44 -0.973 0 C-N-CA 123.793 0.837 . . . . 0.0 110.206 -176.828 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.74 -66.63 0.31 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 130.042 3.337 . . . . 0.0 112.017 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 46.8 p-80 -65.05 -27.62 68.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.333 1.853 . . . . 0.0 112.763 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.76 -31.41 61.77 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.237 -0.914 . . . . 0.0 108.928 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.93 -41.15 91.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.995 0.918 . . . . 0.0 109.282 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.79 -41.87 95.48 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.81 1.244 . . . . 0.0 109.159 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.68 98.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.059 0.944 . . . . 0.0 111.48 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -70.54 -29.81 66.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.556 -0.715 . . . . 0.0 111.832 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -63.95 -34.24 77.52 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.129 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.41 94.05 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.634 0.774 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.67 -36.25 83.22 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -71.12 -24.86 62.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.053 -1.03 . . . . 0.0 111.325 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.2 -35.02 73.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.982 0.913 . . . . 0.0 109.185 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 tp -64.66 -40.51 95.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.365 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -60.21 -28.36 67.93 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.023 0.929 . . . . 0.0 112.334 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -70.25 -42.98 71.49 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.35 -29.81 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 123.992 0.917 . . . . 0.0 109.745 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.44 -44.04 97.37 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.283 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -77.54 -31.58 53.41 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.111 1.364 . . . . 0.0 110.988 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -65.14 -53.68 41.38 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.915 1.34 . . . . 0.0 108.962 171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.49 -24.5 60.19 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 124.642 1.177 . . . . 0.0 111.524 -167.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 12.0 p -64.43 -46.33 83.66 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.254 1.026 . . . . 0.0 109.247 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.77 -46.36 88.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.343 1.857 . . . . 0.0 108.586 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.32 -47.9 77.66 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.326 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.63 84.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.411 1.084 . . . . 0.0 110.763 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.978 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.77 -34.35 34.3 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.5 91.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.75 1.62 . . . . 0.0 109.364 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 2.2 tp10 -68.22 -26.54 65.76 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.358 1.063 . . . . 0.0 111.889 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -74.12 112.62 10.44 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.64 -1.913 . . . . 0.0 107.836 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.5 -22.97 8.63 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.98 64.73 Favored Pre-proline 0 N--CA 1.443 -0.806 0 O-C-N 121.735 -0.862 . . . . 0.0 110.927 -176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -84.09 128.02 4.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.104 2.536 . . . . 0.0 111.864 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.78 46.88 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' D' ' 30' ' ' GLU . . . -55.43 135.0 50.75 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 127.668 2.387 . . . . 0.0 112.388 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.22 -31.17 1.13 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 123.795 0.838 . . . . 0.0 109.846 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.08 49.83 1.87 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 107.737 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.87 -164.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER 80.88 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 116.51 -1.71 . . . . 0.0 106.966 178.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -157.54 -62.8 0.02 OUTLIER Pre-proline 0 C--N 1.35 0.624 0 CA-C-O 116.135 -1.888 . . . . 0.0 109.037 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.48 -14.37 25.04 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 CA-C-N 125.709 3.075 . . . . 0.0 111.084 -169.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -34.18 29.53 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.284 2.634 . . . . 0.0 107.867 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.85 69.49 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.129 0.972 . . . . 0.0 111.62 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 tt -70.6 -33.01 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.341 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -19.29 59.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.316 -1.49 . . . . 0.0 109.984 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -70.03 -53.71 16.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 p -65.1 -19.11 65.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.08 -44.53 99.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 124.097 0.959 . . . . 0.0 111.159 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.2 -32.35 49.94 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.602 1.092 . . . . 0.0 108.494 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -81.36 63.36 5.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.903 0.881 . . . . 0.0 111.055 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.71 -52.14 0.07 Allowed 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 20.8 p -95.53 46.18 1.1 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.954 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 11.9 p 42.86 65.94 0.86 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.919 1.688 . . . . 0.0 113.641 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.01 -108.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' C' ' 57' ' ' TYR . . . 98.15 48.36 1.9 Allowed Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 105.813 -2.915 . . . . 0.0 105.813 -174.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -11.98 59.88 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.913 -0.757 . . . . 0.0 111.327 -166.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.16 40.55 3.98 Favored Glycine 0 CA--C 1.495 -1.207 0 O-C-N 120.288 -1.507 . . . . 0.0 110.001 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.0 -56.73 6.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.856 1.263 . . . . 0.0 108.773 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -144.34 167.76 21.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.32 122.91 18.37 Favored Pre-proline 0 CA--C 1.499 -0.985 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.05 169.96 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.374 2.049 . . . . 0.0 108.716 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.99 -106.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-N 119.07 0.85 . . . . 0.0 112.864 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -155.79 -39.46 0.08 Allowed 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -170.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -77.54 -11.7 59.88 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.622 1.969 . . . . 0.0 109.894 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.17 60.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.26 90.5 1.81 Allowed Glycine 0 N--CA 1.418 -2.524 1 N-CA-C 98.029 -6.028 . . . . 0.0 98.029 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -56.49 -18.86 12.87 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 119.664 1.732 . . . . 0.0 110.694 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -49.95 -21.82 1.33 Allowed 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.574 1.55 . . . . 0.0 114.384 165.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.06 -46.22 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 O-C-N 120.562 -1.336 . . . . 0.0 108.809 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -43.06 93.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.249 0.62 . . . . 0.0 109.476 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.51 -44.33 69.01 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.444 1.498 . . . . 0.0 111.102 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -57.85 -47.73 81.83 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.352 1.061 . . . . 0.0 111.362 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -45.14 85.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-O 121.535 0.683 . . . . 0.0 109.531 -172.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.46 -43.49 85.38 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.129 0.572 . . . . 0.0 110.807 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.64 -34.67 78.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 121.504 -0.748 . . . . 0.0 110.28 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.65 88.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.797 -0.564 . . . . 0.0 110.684 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.33 96.16 Favored Glycine 0 CA--C 1.495 -1.17 0 C-N-CA 124.058 0.837 . . . . 0.0 112.053 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.48 -46.91 92.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 124.413 1.085 . . . . 0.0 109.69 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.22 -36.96 85.79 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.204 -0.935 . . . . 0.0 112.23 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.47 -51.15 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.908 0.883 . . . . 0.0 109.822 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.48 -4.8 50.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.515 -0.741 . . . . 0.0 111.444 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.17 -40.55 12.15 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.353 -0.842 . . . . 0.0 108.991 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -57.05 -39.93 75.83 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 126.495 1.918 . . . . 0.0 111.082 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.9 m -62.95 -6.82 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.28 1.032 . . . . 0.0 112.92 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.2 m -62.17 -17.72 58.84 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.617 -1.302 . . . . 0.0 110.641 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.9 69.62 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.305 -1.497 . . . . 0.0 111.846 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -82.16 -45.82 14.63 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.046 -1.034 . . . . 0.0 108.519 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -62.79 -34.05 76.46 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.804 0.812 . . . . 0.0 111.915 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.44 66.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.977 -1.077 . . . . 0.0 111.941 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.5 t -92.45 0.48 57.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.062 -1.024 . . . . 0.0 108.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.69 -34.52 62.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.69 0.757 . . . . 0.0 109.157 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -73.65 -34.87 65.15 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.786 -1.197 . . . . 0.0 110.764 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.66 -25.85 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 125.582 1.553 . . . . 0.0 109.376 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -47.73 -38.58 15.63 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 125.876 1.67 . . . . 0.0 111.357 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -61.18 -14.05 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.354 0.799 0 O-C-N 121.398 -0.814 . . . . 0.0 109.885 170.589 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.393 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 4' ' ' HIS 0.279 33.9 t70 -176.74 -116.79 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -137.596 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.582 ' CD2' HG21 ' A' ' 91' ' ' THR . 30.9 p80 -44.38 -35.36 2.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 130.611 3.564 . . . . 0.0 114.919 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.81 -31.35 72.5 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.679 0.792 . . . . 0.0 111.624 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -71.44 -32.06 67.9 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -78.46 -34.86 47.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.7 79.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.012 0.925 . . . . 0.0 110.487 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -66.0 -35.73 81.37 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 123.992 0.917 . . . . 0.0 111.378 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -62.83 -41.34 99.28 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.313 -0.867 . . . . 0.0 109.818 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.12 71.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.458 0.703 . . . . 0.0 111.579 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -62.94 -30.54 71.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.524 -0.735 . . . . 0.0 111.319 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.43 -33.69 67.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.62 -42.86 97.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 110.254 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.68 -42.15 95.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 123.094 0.558 . . . . 0.0 111.03 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.85 -37.63 79.8 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -67.04 -33.87 76.47 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 121.558 -0.714 . . . . 0.0 111.322 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.35 -30.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.265 -0.897 . . . . 0.0 109.048 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.52 -37.52 81.42 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.948 -1.095 . . . . 0.0 111.72 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.02 -44.56 72.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.643 1.177 . . . . 0.0 110.327 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.43 -39.4 92.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 121.322 -0.861 . . . . 0.0 109.567 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.58 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.792 1.237 . . . . 0.0 111.337 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 p -66.65 -43.12 85.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.689 0.677 . . . . 0.0 109.818 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.39 -54.9 37.67 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.062 0.945 . . . . 0.0 110.548 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -71.62 -31.34 66.77 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.865 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.99 71.84 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 119.142 0.883 . . . . 0.0 110.194 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 41' ' ' TYR . 74.2 t -64.68 -38.72 83.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-O 121.856 0.836 . . . . 0.0 110.035 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.03 -33.97 72.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.474 -0.766 . . . . 0.0 110.286 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.9 84.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.433 1.111 . . . . 0.0 111.794 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -36.7 85.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 126.809 2.043 . . . . 0.0 111.207 176.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.72 77.87 9.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.508 1.147 . . . . 0.0 109.493 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.28 -35.55 0.71 Allowed Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 106.239 -2.744 . . . . 0.0 106.239 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.36 156.67 62.62 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 122.305 -0.527 . . . . 0.0 110.221 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.15 152.19 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.053 1.835 . . . . 0.0 110.033 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.32 56.59 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.24 26.38 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.046 1.338 . . . . 0.0 114.145 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -58.27 0.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.599 1.159 . . . . 0.0 111.944 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.8 tp -82.2 76.1 9.1 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.892 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.02 75.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 O-C-N 120.484 -1.385 . . . . 0.0 108.439 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -158.03 120.41 3.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 t80 -59.07 -54.01 60.66 Favored Pre-proline 0 C--N 1.352 0.716 0 CA-C-O 116.355 -1.784 . . . . 0.0 112.518 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.47 -3.91 14.6 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 CA-C-N 125.277 2.92 . . . . 0.0 112.044 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -105.4 -33.12 8.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.47 -24.41 61.99 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 120.459 -1.401 . . . . 0.0 112.081 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.68 -23.7 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.771 0.796 . . . . 0.0 110.005 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -39.91 51.34 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.542 -1.349 . . . . 0.0 108.173 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.2 t90 -64.94 -46.83 79.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 123.81 0.844 . . . . 0.0 108.851 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -64.32 -27.1 68.8 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.71 -54.12 37.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 C-N-CA 123.794 0.838 . . . . 0.0 109.011 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.59 -27.24 62.05 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.675 -0.641 . . . . 0.0 111.177 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -62.22 -40.42 96.06 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.962 0.905 . . . . 0.0 110.769 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.52 74.05 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 121.427 -0.796 . . . . 0.0 111.815 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.53 1.05 39.74 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.937 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p 56.54 21.44 5.69 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.335 1.854 . . . . 0.0 112.474 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.35 -58.72 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.7 72.51 0.63 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.74 -22.19 62.44 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.136 0.97 . . . . 0.0 109.962 -166.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.23 26.06 3.88 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' B' ' 68' ' ' ARG . 19.0 t70 -65.5 -53.74 38.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.966 1.306 . . . . 0.0 110.335 177.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.43 164.73 28.6 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.82 137.19 30.24 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.53 169.17 12.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.621 2.214 . . . . 0.0 110.41 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -71.13 176.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.759 1.266 . . . . 0.0 111.743 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 m -96.96 -51.24 4.32 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.711 1.205 . . . . 0.0 109.959 -172.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.57 -42.9 89.02 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 111.237 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -130.85 -137.1 0.21 Allowed 'General case' 0 CA--C 1.492 -1.27 1 N-CA-C 100.184 -4.006 . . . . 0.0 100.184 165.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.46 -77.98 1.18 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -63.08 -40.81 98.75 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.585 1.954 . . . . 0.0 110.492 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -75.17 -19.26 59.93 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.734 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.01 -50.12 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.6 74.0 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.745 1.618 . . . . 0.0 111.588 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -42.13 -51.96 4.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 127.654 2.382 . . . . 0.0 112.32 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.62 -35.28 75.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.299 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.04 -46.35 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.454 1.102 . . . . 0.0 109.126 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.69 -45.38 94.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.001 1.321 . . . . 0.0 109.717 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -59.73 -37.69 79.65 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.545 0.738 . . . . 0.0 111.947 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.67 89.38 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.587 -0.696 . . . . 0.0 110.543 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.3 -46.85 85.15 Favored Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.8 -47.45 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 109.188 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.9 -42.75 99.89 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.127 -0.983 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.9 t -63.6 -52.13 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.264 0.938 . . . . 0.0 110.142 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.92 -28.94 67.92 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.063 0.545 . . . . 0.0 111.077 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.13 -34.32 32.58 Favored 'General case' 0 CA--C 1.505 -0.75 0 O-C-N 120.932 -1.105 . . . . 0.0 110.606 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.45 -32.68 74.19 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.39 -1.444 . . . . 0.0 110.865 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -65.6 -5.15 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 121.56 -0.713 . . . . 0.0 112.41 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -55.35 -20.88 13.0 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.596 1.559 . . . . 0.0 111.566 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.56 -21.07 65.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 120.422 -1.424 . . . . 0.0 113.046 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.27 -39.16 14.63 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 124.821 1.248 . . . . 0.0 108.727 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.58 -45.53 91.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.883 1.273 . . . . 0.0 110.013 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.33 60.21 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER -79.91 -15.98 56.23 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 119.781 -1.825 . . . . 0.0 107.653 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.413 55.1 m-20 -98.55 14.67 27.53 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.606 -160.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -89.62 -30.86 17.85 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 153.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.65 -24.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.402 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -56.19 -23.79 37.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.597 1.159 . . . . 0.0 111.99 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -64.52 -19.7 65.76 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.182 -1.574 . . . . 0.0 112.061 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 C--N 1.355 0.846 0 O-C-N 121.226 -0.921 . . . . 0.0 110.322 178.084 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 122.642 1.21 . . . . 0.0 108.363 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -60.2 -31.75 70.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.819 2.048 . . . . 0.0 113.735 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.66 -35.64 62.82 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.047 -1.033 . . . . 0.0 110.959 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -73.95 -36.52 64.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.794 -0.566 . . . . 0.0 110.491 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.82 -37.8 82.42 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.96 90.35 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.908 0.883 . . . . 0.0 111.112 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.13 -35.2 78.02 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.099 0.96 . . . . 0.0 110.913 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -65.13 -38.22 89.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.283 1.033 . . . . 0.0 110.545 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.18 80.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.429 1.092 . . . . 0.0 110.782 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.51 -36.26 83.63 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.474 -0.766 . . . . 0.0 111.042 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -75.61 -25.13 56.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.023 -1.048 . . . . 0.0 111.354 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.58 -38.33 83.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.57 -46.18 89.66 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.423 0.689 . . . . 0.0 110.886 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -57.23 -41.02 78.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.339 1.456 . . . . 0.0 111.367 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -66.38 -37.37 85.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.356 1.063 . . . . 0.0 110.761 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.25 -38.34 81.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 O-C-N 120.938 -1.101 . . . . 0.0 108.643 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.47 -44.09 89.16 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 123.736 0.815 . . . . 0.0 110.526 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.68 -48.7 74.63 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 110.592 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -75.57 -36.79 60.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.783 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.16 -29.05 69.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.357 1.063 . . . . 0.0 111.87 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -62.24 -42.3 99.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.758 1.223 . . . . 0.0 110.443 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -67.77 -48.11 67.28 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 125.363 1.465 . . . . 0.0 107.37 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -58.07 -47.48 83.04 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 124.626 1.17 . . . . 0.0 111.299 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.87 78.81 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.979 0.912 . . . . 0.0 111.366 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.95 -44.17 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 -29.26 65.05 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 119.817 1.189 . . . . 0.0 110.947 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.8 -42.67 60.63 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 125.092 1.357 . . . . 0.0 109.611 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -74.98 -21.0 59.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.618 0.723 . . . . 0.0 111.022 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -74.67 89.47 2.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 120.276 -1.515 . . . . 0.0 110.636 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.78 -4.01 11.78 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.92 150.95 56.83 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 118.065 0.933 . . . . 0.0 109.082 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -82.26 132.58 7.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.937 2.425 . . . . 0.0 110.723 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 5.19 88.07 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.47 146.02 55.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 123.671 0.789 . . . . 0.0 111.497 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.43 -47.48 4.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 124.906 1.282 . . . . 0.0 108.078 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -90.47 66.07 6.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 122.807 1.289 . . . . 0.0 108.836 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -101.03 26.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 O-C-N 120.344 -1.472 . . . . 0.0 108.485 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 11.6 p -91.05 -114.86 0.08 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 t80 162.2 -70.99 0.0 OUTLIER Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 126.757 2.023 . . . . 0.0 106.296 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.92 -12.03 19.8 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-N 125.112 2.862 . . . . 0.0 111.868 -163.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.0 6.31 36.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.296 1.038 . . . . 0.0 109.059 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.96 74.68 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.368 -0.832 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.63 -30.35 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.075 0.95 . . . . 0.0 111.574 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -85.61 -18.47 33.18 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.343 -0.848 . . . . 0.0 109.962 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -80.72 -41.05 24.24 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.88 60.53 0.96 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 111.452 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.43 -64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.86 -19.06 64.99 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -167.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -72.62 -30.76 64.6 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.123 0.969 . . . . 0.0 108.947 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.59 62.17 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.502 -1.374 . . . . 0.0 110.381 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -93.52 14.84 17.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.685 0.794 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 67.5 p 55.4 51.72 12.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.751 1.62 . . . . 0.0 113.728 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.87 -145.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.047 1 N-CA-C 99.473 -4.269 . . . . 0.0 99.473 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.9 90.31 0.13 Allowed Glycine 0 CA--C 1.481 -2.047 1 N-CA-C 99.058 -5.617 . . . . 0.0 99.058 -171.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -81.58 -17.57 47.85 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.447 -1.031 . . . . 0.0 108.673 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.41 44.22 1.49 Allowed Glycine 0 CA--C 1.486 -1.764 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -72.28 -63.72 1.09 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -102.06 -169.24 1.65 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -155.35 100.9 2.25 Favored Pre-proline 0 N--CA 1.443 -0.805 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.81 153.34 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.698 2.265 . . . . 0.0 110.255 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.51 -124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -135.2 -11.14 2.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.036 -1.04 . . . . 0.0 109.046 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -112.54 2.67 16.37 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 125.64 1.576 . . . . 0.0 107.433 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.27 43.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.06 91.26 1.54 Allowed Glycine 0 N--CA 1.418 -2.564 1 N-CA-C 98.14 -5.984 . . . . 0.0 98.14 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.457 HH12 ' CG ' ' A' ' 59' ' ' ASP . 37.6 ttm180 -68.74 -3.98 14.21 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.073 1.937 . . . . 0.0 110.648 -174.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.168 1.787 . . . . 0.0 111.638 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -47.89 84.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 124.994 1.317 . . . . 0.0 109.4 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.41 77.44 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -55.18 -41.56 72.07 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.711 1.605 . . . . 0.0 111.114 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -65.38 -35.39 80.83 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.428 -0.795 . . . . 0.0 111.578 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.17 -41.78 44.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 9.2 tpp -53.59 -54.94 30.29 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 126.249 1.819 . . . . 0.0 109.96 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -68.81 -36.11 77.82 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.162 0.985 . . . . 0.0 110.499 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.67 87.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.594 -0.691 . . . . 0.0 110.939 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.95 96.96 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 124.455 1.026 . . . . 0.0 111.322 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 72.3 mt -60.36 -42.95 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 109.114 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -73.09 -31.31 64.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.061 -1.025 . . . . 0.0 113.262 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.43 -43.44 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.256 -0.902 . . . . 0.0 109.702 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.81 -36.56 78.39 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 118.686 0.675 . . . . 0.0 110.073 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.46 92.39 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.896 0.878 . . . . 0.0 110.944 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.28 -31.97 73.38 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.579 -1.326 . . . . 0.0 111.651 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.77 -25.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 124.194 0.998 . . . . 0.0 109.762 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -68.33 -3.11 9.93 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 121.142 -0.974 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.52 82.65 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.679 -2.513 . . . . 0.0 110.84 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.53 59.72 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 39.4 mt -110.02 27.22 9.82 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.25 -9.33 8.62 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -100.36 3.36 43.21 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -71.71 -45.41 61.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.517 1.127 . . . . 0.0 109.197 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.59 -26.36 68.65 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.8 -1.187 . . . . 0.0 112.386 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.2 -29.16 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 123.984 0.914 . . . . 0.0 109.993 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -26.06 64.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 120.423 -1.423 . . . . 0.0 109.53 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -70.62 -19.45 62.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.796 -0.565 . . . . 0.0 111.696 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--N 1.347 0.497 0 O-C-N 120.03 -1.669 . . . . 0.0 109.565 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 123.754 1.74 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -60.38 -36.07 77.2 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 130.312 3.445 . . . . 0.0 110.424 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -75.38 -36.41 60.9 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -33.87 76.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.701 0.801 . . . . 0.0 111.202 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -45.9 64.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.779 0.832 . . . . 0.0 108.877 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.65 98.89 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.163 0.985 . . . . 0.0 111.552 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -71.33 -26.23 62.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.105 1.362 . . . . 0.0 110.702 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.39 -37.93 63.26 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.99 95.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.233 -0.917 . . . . 0.0 111.235 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.98 -34.58 78.77 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.413 -0.805 . . . . 0.0 111.094 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -62.98 -33.48 75.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.606 1.162 . . . . 0.0 110.457 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.98 -42.56 84.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 109.146 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.6 tp -62.04 -37.11 83.72 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.16 0.984 . . . . 0.0 110.968 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.64 -27.67 69.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -34.91 63.31 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.518 -1.364 . . . . 0.0 109.289 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.75 -36.51 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.03 -41.04 77.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 123.877 0.871 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -72.07 -35.51 69.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.851 0.86 . . . . 0.0 111.2 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.92 -46.74 56.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.731 1.253 . . . . 0.0 107.992 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.79 64.35 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 125.787 1.635 . . . . 0.0 111.432 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.497 ' HB3' ' HA ' ' C' ' 45' ' ' ILE . 1.4 p -74.21 -36.6 63.97 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.296 -0.877 . . . . 0.0 110.014 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -64.94 -47.66 76.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -64.3 -35.61 81.42 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.338 0.655 . . . . 0.0 111.004 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.04 60.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.35 1.06 . . . . 0.0 110.943 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.16 -36.07 73.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 CA-C-O 122.08 0.943 . . . . 0.0 110.069 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.13 -36.16 77.18 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.056 -1.028 . . . . 0.0 110.298 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.8 67.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.635 1.574 . . . . 0.0 111.706 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -75.63 -17.6 59.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 121.451 -0.781 . . . . 0.0 110.72 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -85.58 75.48 10.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.363 -1.46 . . . . 0.0 110.152 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.37 -42.3 0.44 Allowed Glycine 0 CA--C 1.478 -2.237 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -82.14 151.11 66.02 Favored Pre-proline 0 N--CA 1.437 -1.093 0 O-C-N 122.36 -0.494 . . . . 0.0 110.806 -173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.72 147.73 24.99 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.868 1.712 . . . . 0.0 110.214 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 28.87 35.25 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.509 -0.606 . . . . 0.0 112.17 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.08 132.66 54.16 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 112.703 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.8 -37.21 0.6 Allowed 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.175 0.99 . . . . 0.0 109.539 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.71 35.67 0.78 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.749 1.22 . . . . 0.0 107.906 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 tt -77.41 4.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 123.673 1.702 . . . . 0.0 108.651 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -71.68 125.8 28.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.03 2.132 . . . . 0.0 110.373 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -87.71 -55.85 0.33 Allowed Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.908 -1.52 . . . . 0.0 111.225 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.42 -24.52 16.32 Favored 'Trans proline' 0 CA--C 1.501 -1.172 0 CA-C-N 125.075 2.848 . . . . 0.0 111.228 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.0 -7.2 58.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.89 79.45 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.043 -1.035 . . . . 0.0 111.126 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' C' ' 23' ' ' SER . 20.3 tt -69.17 -29.34 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.485 -0.759 . . . . 0.0 110.186 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -36.71 74.57 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 121.017 -1.052 . . . . 0.0 111.318 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -71.4 -33.32 69.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.632 0.729 . . . . 0.0 109.639 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -59.93 -41.56 92.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.95 -55.03 18.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.174 1.39 . . . . 0.0 110.753 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.89 -13.22 60.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.593 -0.692 . . . . 0.0 112.196 -173.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -79.47 -39.47 32.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.964 0.906 . . . . 0.0 109.252 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -24.02 64.88 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 120.88 -1.137 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p -92.81 2.43 56.76 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.477 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p 50.03 36.98 13.07 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.119 1.768 . . . . 0.0 111.269 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.6 -59.13 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 61.17 6.85 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -43.49 60.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -170.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.93 -114.26 0.59 Allowed Glycine 0 CA--C 1.482 -1.983 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.305 27.2 t70 62.17 -71.38 0.05 OUTLIER 'General case' 0 C--N 1.351 0.672 0 C-N-CA 127.199 2.2 . . . . 0.0 111.185 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -117.19 -163.98 0.96 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -155.53 148.08 17.8 Favored Pre-proline 0 N--CA 1.433 -1.301 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -90.24 159.55 4.67 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.197 1.932 . . . . 0.0 109.684 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 33' ' ' ALA . 16.1 m -82.94 -175.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.91 1.684 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 -79.64 0.2 Allowed 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.461 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -39.7 -43.8 1.43 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.174 2.189 . . . . 0.0 113.31 -165.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -113.92 -91.18 0.51 Allowed 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 8.04 -69.04 0.0 OUTLIER Glycine 0 C--N 1.36 1.863 1 C-N-CA 131.584 4.421 . . . . 0.0 117.267 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -66.61 -41.23 88.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.475 1.51 . . . . 0.0 113.033 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -80.42 -20.2 44.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.098 -1.001 . . . . 0.0 109.031 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.93 -46.41 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 172.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.78 76.67 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 126.116 1.766 . . . . 0.0 111.576 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.51 -53.54 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.495 2.318 . . . . 0.0 111.074 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.24 -39.91 89.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.188 1.395 . . . . 0.0 110.551 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.98 -45.42 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.55 1.14 . . . . 0.0 109.315 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.0 mtm -59.67 -46.81 87.94 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 109.888 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -60.09 -38.68 83.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 111.302 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.58 82.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.609 0.764 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.99 -46.54 58.96 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.99 -45.62 92.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.556 0 C-N-CA 124.388 1.075 . . . . 0.0 109.536 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -61.7 -42.43 98.94 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.445 -0.784 . . . . 0.0 111.692 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.68 -49.88 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 123.956 0.902 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -67.96 -35.02 77.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.925 -0.484 . . . . 0.0 110.648 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.06 -28.46 61.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.055 -1.028 . . . . 0.0 110.715 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.08 -18.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 120.503 -1.373 . . . . 0.0 111.384 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.66 1.5 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 120.144 -1.598 . . . . 0.0 111.22 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 31.4 m -62.9 -20.53 65.26 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.104 -1.623 . . . . 0.0 111.31 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.89 44.82 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 124.785 1.234 . . . . 0.0 112.159 169.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.23 -40.21 13.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.529 1.532 . . . . 0.0 110.269 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.65 -46.08 48.79 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.141 0.577 . . . . 0.0 111.297 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.3 -28.16 66.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.603 -0.685 . . . . 0.0 110.815 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -85.59 -14.49 45.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.067 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.363 16.5 t70 -74.29 -30.08 61.93 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-N 121.776 2.08 . . . . 0.0 110.767 -168.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -70.49 -26.13 63.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 119.693 -1.879 . . . . 0.0 112.413 174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.84 -22.47 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 124.521 1.129 . . . . 0.0 108.559 -174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -63.26 -17.42 62.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.331 1.053 . . . . 0.0 111.463 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -71.36 -22.35 61.91 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 120.818 -1.176 . . . . 0.0 112.321 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--N 1.354 0.778 0 O-C-N 121.48 -0.762 . . . . 0.0 109.565 -178.166 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -52.08 -29.93 23.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -59.56 -33.63 71.67 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -79.27 -42.09 26.63 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 23.7 ttp85 -60.87 -38.77 86.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 110.279 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.7 -32.07 71.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.302 -0.873 . . . . 0.0 111.668 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.31 84.06 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.435 0.636 . . . . 0.0 109.597 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -66.83 -37.6 84.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.38 -0.825 . . . . 0.0 110.382 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -69.24 -23.68 63.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.288 -0.882 . . . . 0.0 111.346 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.74 86.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.608 -1.308 . . . . 0.0 111.079 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.12 -31.0 72.04 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.78 -1.2 . . . . 0.0 111.877 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.98 -34.87 79.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.049 1.34 . . . . 0.0 109.3 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -67.91 -41.05 83.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.792 1.237 . . . . 0.0 108.785 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.01 -45.33 95.24 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.689 0.796 . . . . 0.0 110.29 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.946 0.794 . . . . 0.0 112.164 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -74.1 -13.49 60.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.096 -1.003 . . . . 0.0 113.405 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.27 -46.51 12.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -53.06 -49.25 66.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 128.126 2.57 . . . . 0.0 110.459 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -78.11 -17.04 57.42 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.533 -1.354 . . . . 0.0 111.0 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -76.98 -31.9 56.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.44 82.81 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 124.767 1.227 . . . . 0.0 111.544 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -59.4 -42.7 92.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.75 1.22 . . . . 0.0 112.168 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -69.59 -37.99 77.15 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.827 0.851 . . . . 0.0 109.005 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -70.51 -51.01 31.86 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.433 0.693 . . . . 0.0 110.09 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.47 92.2 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 126.18 1.792 . . . . 0.0 112.304 -171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.46 -35.7 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -75.45 -36.13 60.78 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -62.4 -42.05 99.13 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.902 2.081 . . . . 0.0 110.201 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -88.48 -21.88 23.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -70.0 84.95 0.51 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 120.444 -1.41 . . . . 0.0 109.787 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.49 -2.2 4.14 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.23 157.55 82.86 Favored Pre-proline 0 N--CA 1.446 -0.644 0 O-C-N 121.138 -1.213 . . . . 0.0 112.55 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.63 131.29 11.29 Favored 'Trans proline' 0 CA--C 1.508 -0.798 0 C-N-CA 123.585 2.856 . . . . 0.0 110.643 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.76 -59.39 4.57 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.37 166.9 0.11 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.729 2.812 . . . . 0.0 110.327 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.05 -53.93 0.13 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.293 -1.744 . . . . 0.0 106.293 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 34.0 tp -99.68 134.83 42.0 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -149.88 167.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m 73.61 131.8 0.04 OUTLIER 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.278 1.831 . . . . 0.0 112.918 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -58.08 -51.65 80.25 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.448 -1.739 . . . . 0.0 113.183 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.53 -13.16 24.99 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 CA-C-N 124.306 2.574 . . . . 0.0 111.967 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 -46.84 9.08 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.16 73.78 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.333 1.453 . . . . 0.0 111.716 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -65.98 -31.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 121.686 -0.634 . . . . 0.0 111.178 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -31.97 47.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 120.727 -1.233 . . . . 0.0 109.854 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -61.92 -40.44 95.5 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.388 1.089 . . . . 0.0 109.443 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -64.5 -35.84 82.26 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 119.898 -1.751 . . . . 0.0 112.169 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.98 -53.35 49.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.007 0.923 . . . . 0.0 109.468 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.03 -24.71 64.23 Favored 'General case' 0 C--N 1.351 0.63 0 C-N-CA 123.275 0.63 . . . . 0.0 111.662 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -76.05 -38.54 57.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.337 -0.852 . . . . 0.0 108.74 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.53 -28.19 65.81 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.981 -1.074 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 10.4 p -93.81 9.63 36.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 123.162 0.585 . . . . 0.0 110.335 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 18.3 p 58.68 43.47 18.75 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.901 1.68 . . . . 0.0 114.702 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.68 -69.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.59 -55.66 4.69 Favored Glycine 0 N--CA 1.435 -1.385 0 O-C-N 120.564 -1.335 . . . . 0.0 111.908 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.1 -30.92 0.21 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.5 1.92 . . . . 0.0 113.296 173.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.83 26.26 5.36 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.8 -67.99 0.43 Allowed 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.683 0.793 . . . . 0.0 109.023 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 157.64 46.05 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 102.666 -3.086 . . . . 0.0 102.666 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.9 122.26 4.98 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.78 178.06 6.87 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 C-N-CA 123.022 2.481 . . . . 0.0 110.67 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.626 HG22 ' H ' ' D' ' 64' ' ' THR . 9.8 p -113.27 -177.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 122.895 1.331 . . . . 0.0 111.27 -170.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.626 ' H ' HG22 ' D' ' 63' ' ' VAL . 7.1 m -52.41 -40.65 62.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.733 2.813 . . . . 0.0 113.048 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.63 -11.72 59.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.424 1.09 . . . . 0.0 110.696 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' D' ' 29' ' ' ALA . 0.4 OUTLIER -68.64 -33.27 73.71 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 170.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 131.93 -26.57 3.78 Favored Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.348 9.4 ttt85 57.19 -35.92 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.031 1 C-N-CA 132.458 4.303 . . . . 0.0 113.702 -168.339 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' D' ' 67' ' ' GLY . 9.7 tptm -69.81 -9.28 54.1 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 126.243 1.817 . . . . 0.0 109.957 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 t -72.74 -37.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -53.86 37.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -46.94 -55.17 8.54 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 125.862 1.665 . . . . 0.0 112.947 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -70.02 -25.49 63.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.889 -0.507 . . . . 0.0 111.732 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.39 -45.9 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 8.5 mtp -56.5 -45.89 80.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.064 1.346 . . . . 0.0 110.252 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -59.41 -38.03 79.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.635 1.174 . . . . 0.0 112.101 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -36.99 84.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.998 -0.439 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.55 -43.77 85.05 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 123.731 0.681 . . . . 0.0 111.444 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.78 -47.97 89.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 C-N-CA 124.308 1.043 . . . . 0.0 109.419 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -63.75 -43.43 96.46 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 123.848 0.859 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -61.93 -49.8 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 O-C-N 120.86 -1.15 . . . . 0.0 110.592 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.11 0.56 27.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.84 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.25 -40.34 10.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.37 -39.14 72.43 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 126.681 1.992 . . . . 0.0 111.276 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 m -59.1 -15.54 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.106 1.362 . . . . 0.0 112.988 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -70.4 -5.23 26.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.918 1.287 . . . . 0.0 110.12 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.01 70.78 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 119.985 -1.697 . . . . 0.0 109.797 166.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.13 -41.62 90.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.827 -1.17 . . . . 0.0 110.476 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.44 -37.96 80.73 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.086 0.554 . . . . 0.0 111.165 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.03 -17.46 60.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.005 -1.06 . . . . 0.0 110.409 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -73.07 -27.84 61.97 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.56 70.47 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.279 -0.888 . . . . 0.0 111.284 -159.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -68.49 -30.12 68.89 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.676 -1.265 . . . . 0.0 111.563 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 12.4 t -74.82 -25.72 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 123.857 0.863 . . . . 0.0 109.063 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.8 mtp-105 -63.55 -25.92 68.46 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 120.992 -1.068 . . . . 0.0 110.931 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.4 -20.88 64.91 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.751 -0.593 . . . . 0.0 111.081 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 . . . . . 0 N--CA 1.436 -1.126 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -177.676 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.56 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.3 51.9 m-20 74.21 -41.7 0.49 Allowed 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.799 2.039 . . . . 0.0 111.009 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -43.98 83.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.483 1.113 . . . . 0.0 112.643 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.259 1.8 pm0 -72.71 -15.25 61.69 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.333 -2.105 . . . . 0.0 112.959 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -74.43 -42.86 58.44 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 120.432 -1.417 . . . . 0.0 108.521 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.63 -39.29 83.82 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.828 2.051 . . . . 0.0 109.212 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.11 92.4 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.856 1.263 . . . . 0.0 112.279 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.63 -26.22 60.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.394 -0.816 . . . . 0.0 111.169 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -65.7 -40.41 92.27 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.936 -1.103 . . . . 0.0 108.861 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.22 77.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.81 0.844 . . . . 0.0 112.09 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -34.83 76.04 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.495 -0.753 . . . . 0.0 111.735 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -68.87 -27.06 65.47 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 120.617 -1.302 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -64.8 -35.17 80.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.025 1.33 . . . . 0.0 109.375 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.96 -43.94 81.84 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.843 0.857 . . . . 0.0 110.141 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.61 -34.16 72.4 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 124.301 1.04 . . . . 0.0 111.912 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -66.91 -41.98 86.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.621 1.169 . . . . 0.0 110.185 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.13 -42.13 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.5 mt -55.32 -42.92 74.38 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.406 1.082 . . . . 0.0 112.397 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -69.71 -38.63 77.02 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.797 1.239 . . . . 0.0 110.873 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.39 -42.51 65.13 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 120.52 -1.362 . . . . 0.0 108.589 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.66 72.51 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.735 1.614 . . . . 0.0 112.351 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -69.66 -35.03 74.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -35.15 68.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.415 1.086 . . . . 0.0 109.277 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -69.24 -55.38 10.71 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 124.534 1.134 . . . . 0.0 108.595 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.02 84.1 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.483 1.513 . . . . 0.0 111.658 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -37.09 78.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.214 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.11 -35.09 64.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.148 -1.595 . . . . 0.0 110.013 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.2 -49.75 63.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.095 1.758 . . . . 0.0 108.342 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.7 tp10 -68.64 -38.12 80.25 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.655 1.182 . . . . 0.0 111.409 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -71.34 109.27 5.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 119.289 -2.132 . . . . 0.0 110.971 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -9.6 16.83 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.79 152.11 48.41 Favored Pre-proline 0 C--N 1.352 0.683 0 CA-C-N 118.391 1.095 . . . . 0.0 109.713 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.82 144.21 24.27 Favored 'Trans proline' 0 CA--C 1.502 -1.09 0 C-N-CA 122.751 2.301 . . . . 0.0 109.481 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.66 78.99 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -55.73 115.85 2.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 125.966 1.707 . . . . 0.0 109.975 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.98 -43.56 8.48 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.8 tp -90.51 65.31 6.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.928 1.347 . . . . 0.0 110.04 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.93 -0.76 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 119.851 -1.78 . . . . 0.0 112.304 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.5 m -109.44 123.35 49.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.147 -0.971 . . . . 0.0 111.247 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.13 -58.65 11.88 Favored Pre-proline 0 C--N 1.351 0.641 0 C-N-CA 125.83 1.652 . . . . 0.0 111.234 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.12 -6.45 17.99 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.078 2.849 . . . . 0.0 111.13 -171.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -100.59 -3.06 31.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.36 -32.9 69.05 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 119.737 -1.852 . . . . 0.0 109.15 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 tt -68.59 -30.0 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.826 0.851 . . . . 0.0 109.684 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.95 -47.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 125.919 1.687 . . . . 0.0 110.054 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.69 -41.93 87.29 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.954 1.702 . . . . 0.0 108.554 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -56.21 -45.74 79.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 111.679 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' ILE . 1.9 t -64.22 -46.22 94.04 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 121.269 -0.894 . . . . 0.0 111.444 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.03 -13.92 59.7 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 118.894 -1.122 . . . . 0.0 112.537 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -69.69 -36.4 75.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.136 -0.978 . . . . 0.0 108.555 171.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.0 63.2 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.297 -1.502 . . . . 0.0 112.186 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -95.42 15.09 20.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.443 0.565 . . . . 0.0 109.686 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p 53.35 29.2 8.33 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 126.932 2.093 . . . . 0.0 113.499 166.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.3 p -101.31 -74.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -172.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 81.06 80.65 0.86 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -10.5 59.48 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.992 -1.299 . . . . 0.0 111.4 -170.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.23 18.4 13.53 Favored Glycine 0 CA--C 1.491 -1.443 0 O-C-N 121.061 -1.024 . . . . 0.0 111.79 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -73.16 -46.3 51.62 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 118.533 1.167 . . . . 0.0 109.312 177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.01 164.26 27.72 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.28 146.69 28.66 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 102.019 -3.326 . . . . 0.0 102.019 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.96 -165.36 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.29 3.327 . . . . 0.0 109.858 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 64' ' ' THR . 13.8 p -139.0 -147.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 63' ' ' VAL . 89.6 m -102.49 -48.19 4.23 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.017 1.327 . . . . 0.0 108.282 -170.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -78.97 -17.08 56.05 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.435 0.694 . . . . 0.0 110.47 -169.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.32 -34.3 75.02 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 123.354 1.55 . . . . 0.0 107.477 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.38 79.2 1.43 Allowed Glycine 0 CA--C 1.462 -3.229 1 N-CA-C 98.594 -5.802 . . . . 0.0 98.594 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' D' ' 59' ' ' ASP . 19.8 ttt85 -50.61 -18.16 0.64 Allowed 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.358 1.863 . . . . 0.0 113.731 -171.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -38.78 -31.31 0.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 127.318 2.247 . . . . 0.0 114.697 159.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.06 -43.56 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 119.01 0.823 . . . . 0.0 108.877 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.46 64.38 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.594 -0.691 . . . . 0.0 109.646 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.76 -47.11 51.11 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.402 1.481 . . . . 0.0 112.177 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -68.27 -37.22 80.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.466 0.707 . . . . 0.0 111.033 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.45 -43.47 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.68 -44.27 97.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.2 1.0 . . . . 0.0 110.441 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -66.38 -33.69 76.29 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.204 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.5 74.08 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.347 -0.845 . . . . 0.0 110.928 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.2 86.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.05 -41.47 83.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.855 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -65.92 -43.79 87.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.391 -1.443 . . . . 0.0 113.73 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.2 -45.82 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 118.274 0.488 . . . . 0.0 109.811 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.91 -39.14 72.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.93 81.97 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 121.535 -0.728 . . . . 0.0 111.198 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.43 -31.98 73.37 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 111.736 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.29 -19.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.957 1.303 . . . . 0.0 110.051 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -62.41 -18.1 60.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.914 -1.116 . . . . 0.0 112.394 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.1 -55.49 34.31 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.48 -1.388 . . . . 0.0 110.244 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.46 87.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.93 -42.48 90.04 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.386 -0.821 . . . . 0.0 110.879 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.38 -14.04 60.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.959 -1.088 . . . . 0.0 110.643 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 m -77.06 -21.98 53.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.837 -1.164 . . . . 0.0 108.786 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.16 -42.95 82.04 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 122.012 0.91 . . . . 0.0 111.311 -165.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -70.76 -18.26 62.77 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.727 -1.233 . . . . 0.0 113.364 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -75.12 -20.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -75.67 -11.87 60.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 120.982 -1.074 . . . . 0.0 110.244 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -77.55 -17.42 57.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.865 -1.147 . . . . 0.0 110.926 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.717 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 CA--C 1.504 -0.805 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -58.02 -30.51 66.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.93 -28.97 58.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.812 0.845 . . . . 0.0 110.499 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -72.0 -39.72 69.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -32.72 74.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.62 0.724 . . . . 0.0 110.481 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.98 -46.45 81.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.773 0.829 . . . . 0.0 111.127 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -72.6 -34.63 67.52 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.654 0.74 . . . . 0.0 110.729 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.03 -35.09 79.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.492 1.917 . . . . 0.0 110.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.76 75.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 111.585 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -32.19 73.59 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.165 0.986 . . . . 0.0 110.998 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.04 -36.32 72.31 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 120.649 -1.282 . . . . 0.0 108.913 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -66.28 -35.73 81.16 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.028 0.931 . . . . 0.0 109.295 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -60.4 -42.26 95.55 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.484 -0.76 . . . . 0.0 111.287 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -59.28 -35.52 73.89 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 123.933 0.893 . . . . 0.0 111.584 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -70.55 -34.98 72.84 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 110.209 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.22 -41.31 86.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 124.516 1.126 . . . . 0.0 108.335 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 48.0 mt -56.42 -44.63 80.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.447 1.099 . . . . 0.0 111.547 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.61 -31.61 71.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.183 0.993 . . . . 0.0 111.488 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.99 -33.33 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.317 -1.489 . . . . 0.0 108.744 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.56 -31.29 71.91 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.917 1.287 . . . . 0.0 111.509 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 59.1 p -66.22 -39.9 89.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 119.026 0.83 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.34 93.39 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.084 1.754 . . . . 0.0 108.64 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.22 -57.96 5.19 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 117.671 -1.157 . . . . 0.0 108.25 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.52 -48.32 57.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 126.171 1.788 . . . . 0.0 112.855 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.12 -39.63 84.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.77 -1.206 . . . . 0.0 111.357 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.1 -25.67 31.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.117 -0.989 . . . . 0.0 109.464 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 126.465 1.906 . . . . 0.0 108.516 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.06 -34.18 77.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.14 0.976 . . . . 0.0 111.73 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -68.15 109.13 3.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.34 -2.1 . . . . 0.0 111.433 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -10.89 16.31 Favored Glycine 0 CA--C 1.496 -1.104 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.72 147.08 40.52 Favored Pre-proline 0 N--CA 1.442 -0.84 0 O-C-N 121.802 -0.822 . . . . 0.0 109.439 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.51 137.81 11.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.49 2.127 . . . . 0.0 110.067 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.28 81.85 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.1 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.23 104.01 0.22 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.19 1.396 . . . . 0.0 109.56 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.72 -28.63 21.65 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.79 132.71 37.91 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -148.36 170.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 81.47 124.77 0.04 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.741 1.616 . . . . 0.0 109.003 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -66.04 -52.45 39.82 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.602 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.97 -3.48 13.84 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 125.226 2.902 . . . . 0.0 112.314 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -110.61 -10.78 14.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.45 75.88 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.25 -0.906 . . . . 0.0 108.846 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -60.24 -26.15 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 125.765 1.626 . . . . 0.0 111.205 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.731 -1.23 . . . . 0.0 109.569 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -79.26 -35.76 40.96 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.8 p -77.31 57.82 1.54 Allowed 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 122.113 -0.367 . . . . 0.0 110.579 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.35 -53.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.77 -26.88 68.55 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 119.328 0.967 . . . . 0.0 111.977 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -67.06 -34.39 77.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.55 1.14 . . . . 0.0 109.439 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.5 62.67 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.449 -1.407 . . . . 0.0 111.013 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -93.39 11.92 26.66 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.688 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.7 p 48.89 55.5 9.13 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.267 1.427 . . . . 0.0 113.17 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' B' ' 56' ' ' GLY . 0.2 OUTLIER -121.95 -87.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.45 ' H ' HG23 ' B' ' 55' ' ' VAL . . . 87.15 73.66 1.28 Allowed Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 -19.42 62.12 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.344 -1.092 . . . . 0.0 110.429 -173.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.1 37.99 1.3 Allowed Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -93.2 -30.89 14.98 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 118.125 0.963 . . . . 0.0 110.066 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -140.3 176.55 8.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -155.02 149.66 20.01 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 102.295 -3.224 . . . . 0.0 102.295 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -85.04 -178.21 3.09 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 124.74 3.626 . . . . 0.0 109.949 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 0.8 OUTLIER -133.76 -153.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.036 0.922 . . . . 0.0 108.799 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 -46.78 7.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.03 -1.669 . . . . 0.0 110.676 -169.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -30.67 67.24 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 109.796 -170.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' B' ' 68' ' ' ARG . 0.8 OUTLIER -64.2 -26.37 68.48 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 123.128 1.442 . . . . 0.0 108.592 -178.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.91 67.67 1.3 Allowed Glycine 0 CA--C 1.461 -3.329 1 N-CA-C 102.534 -4.226 . . . . 0.0 102.534 174.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' OE2' ' B' ' 66' ' ' GLU . 22.0 ttp85 -40.11 -15.32 0.01 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.578 3.551 . . . . 0.0 116.097 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -55.27 -17.84 5.24 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 120.507 -1.371 . . . . 0.0 113.622 160.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.97 -53.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 CA-C-N 121.07 1.759 . . . . 0.0 107.718 173.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.79 91.08 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.272 0.629 . . . . 0.0 111.061 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.1 -38.44 70.73 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.621 1.168 . . . . 0.0 111.66 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.84 -37.47 84.55 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 124.071 0.948 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.53 -42.53 72.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.2 mtm -61.16 -48.92 79.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.094 0.958 . . . . 0.0 110.319 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.16 -38.43 88.06 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.81 92.57 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.056 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.28 -46.07 91.76 Favored Glycine 0 CA--C 1.494 -1.257 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -46.64 87.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.666 1.186 . . . . 0.0 109.338 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.15 -45.82 86.73 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.173 -0.954 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.68 -51.13 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 124.167 0.987 . . . . 0.0 109.963 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -72.83 -19.46 61.31 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.631 -0.668 . . . . 0.0 111.257 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.5 -27.62 19.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.885 0.874 . . . . 0.0 110.283 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.08 -39.18 85.17 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 126.207 1.803 . . . . 0.0 109.47 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.2 -13.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.823 0.849 . . . . 0.0 111.912 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.8 m -61.68 -16.38 48.32 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.624 1.169 . . . . 0.0 110.852 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.58 -51.0 64.4 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.509 1.123 . . . . 0.0 110.629 165.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.16 75.72 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.71 1.604 . . . . 0.0 110.451 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.02 -42.61 97.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.73 -18.96 61.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.872 -0.518 . . . . 0.0 110.687 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.6 m -80.51 -36.61 33.03 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 121.276 -0.89 . . . . 0.0 108.998 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.34 -8.46 58.45 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.904 -1.123 . . . . 0.0 111.791 -157.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -75.4 -36.77 60.79 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 165.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 t -71.12 -22.28 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 109.978 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -47.92 -31.57 5.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.694 1.998 . . . . 0.0 111.666 171.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -62.11 -30.7 71.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.686 1.194 . . . . 0.0 112.129 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 CA--C 1.505 -0.786 0 O-C-N 120.785 -1.197 . . . . 0.0 109.541 -175.613 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 122.779 1.276 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -66.97 -21.99 65.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 125.791 1.636 . . . . 0.0 111.97 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -77.34 -32.65 55.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -72.87 -32.27 65.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.668 0.747 . . . . 0.0 109.95 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.3 -41.56 93.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.642 1.177 . . . . 0.0 109.512 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.08 78.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.357 1.063 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -57.01 -38.25 72.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.282 1.833 . . . . 0.0 111.243 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -64.73 -33.26 75.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.495 1.118 . . . . 0.0 110.815 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.61 68.2 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.037 -1.039 . . . . 0.0 110.287 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.453 -0.78 . . . . 0.0 112.017 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -27.89 63.76 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.889 -1.132 . . . . 0.0 110.473 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.74 -33.29 73.67 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.994 0.918 . . . . 0.0 109.128 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.41 -36.95 84.12 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.941 -1.099 . . . . 0.0 110.687 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.08 -27.65 67.54 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.264 -0.898 . . . . 0.0 111.083 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.61 -45.67 64.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.684 1.194 . . . . 0.0 110.068 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.31 -24.14 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 O-C-N 121.534 -0.729 . . . . 0.0 110.819 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.13 -37.66 80.73 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.417 -0.802 . . . . 0.0 111.408 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -74.34 -24.29 59.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.617 0.767 . . . . 0.0 111.241 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -87.89 -30.87 19.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.812 -1.18 . . . . 0.0 107.848 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.98 88.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.655 1.182 . . . . 0.0 111.362 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.0 p -65.2 -38.94 92.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.29 0.636 . . . . 0.0 111.173 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -71.08 -48.88 49.98 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.576 -0.703 . . . . 0.0 110.064 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -72.21 -23.16 61.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 121.262 -0.899 . . . . 0.0 110.931 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.92 -48.45 76.54 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.819 0.736 . . . . 0.0 110.885 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.72 -19.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.03 -176.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -80.2 -25.82 39.48 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.157 -1.59 . . . . 0.0 109.531 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.05 73.49 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.67 1.188 . . . . 0.0 108.874 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' C' ' 38' ' ' LEU . 16.8 mt-10 -85.63 -141.09 0.09 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 122.884 1.326 . . . . 0.0 111.115 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 59.86 52.23 5.51 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 126.763 2.025 . . . . 0.0 111.316 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.37 34.35 0.2 Allowed Glycine 0 CA--C 1.487 -1.696 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.45 155.42 78.67 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.78 152.39 11.44 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.324 2.016 . . . . 0.0 109.498 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 -41.03 2.77 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.974 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -3.02 123.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.808 1 C-N-CA 132.486 4.314 . . . . 0.0 117.292 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.48 -38.38 3.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.566 1.146 . . . . 0.0 110.048 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.437 ' H ' ' CD ' ' C' ' 30' ' ' GLU . 5.2 tt -100.98 66.23 1.14 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.033 2.533 . . . . 0.0 109.436 -169.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.45 33.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 119.463 -2.023 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.2 m -134.0 143.62 48.23 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -80.99 -53.14 0.81 Allowed Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.471 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -20.32 24.2 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 CA-C-N 126.404 3.323 . . . . 0.0 110.643 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.9 -13.04 49.07 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 -35.79 81.65 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.186 -0.946 . . . . 0.0 110.928 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.61 -29.08 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.441 0.639 . . . . 0.0 110.278 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -28.75 61.29 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 119.83 -1.794 . . . . 0.0 110.22 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.434 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 31.8 t90 -69.66 -40.99 76.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.841 -0.537 . . . . 0.0 109.68 172.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -69.58 -14.71 62.98 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.83 -49.9 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 120.884 -1.135 . . . . 0.0 110.504 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -76.04 0.45 18.6 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.036 -1.04 . . . . 0.0 112.247 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.27 -38.69 6.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.122 -0.987 . . . . 0.0 109.096 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.73 61.05 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 120.771 -1.206 . . . . 0.0 111.535 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 5.3 p -90.61 1.31 56.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 110.647 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.297 15.5 p 62.65 30.72 16.95 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.46 2.304 . . . . 0.0 112.751 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.18 -59.33 2.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.92 63.26 3.74 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.858 -1.151 . . . . 0.0 112.493 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -23.14 66.86 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.642 0.777 . . . . 0.0 113.006 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 23.51 10.1 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -50.33 18.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 16.1 mtm-85 -142.52 163.86 31.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -163.12 142.05 6.58 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.98 161.95 20.79 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.044 2.496 . . . . 0.0 110.86 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 1.1 t -107.02 -162.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 123.118 1.437 . . . . 0.0 109.157 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 2.1 m -66.29 -55.5 15.76 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 127.601 2.361 . . . . 0.0 111.553 -167.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -74.12 -16.43 61.01 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.533 1.159 . . . . 0.0 109.27 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -78.08 -23.35 48.02 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 125.514 1.526 . . . . 0.0 107.803 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.89 86.12 0.94 Allowed Glycine 0 CA--C 1.478 -2.276 1 N-CA-C 102.04 -4.424 . . . . 0.0 102.04 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -43.14 -34.81 1.17 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.446 1.898 . . . . 0.0 111.482 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -43.44 -26.87 0.23 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.037 2.135 . . . . 0.0 113.721 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.92 -37.72 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.986 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.09 9.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.33 -47.04 69.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.481 2.312 . . . . 0.0 112.136 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 -37.22 71.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.552 -0.718 . . . . 0.0 110.492 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.33 -42.64 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 58.9 ttm -59.1 -45.19 91.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.602 1.161 . . . . 0.0 110.615 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -64.65 -31.75 73.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.861 0.464 . . . . 0.0 111.477 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.94 70.17 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.734 -0.604 . . . . 0.0 111.055 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.47 -39.93 86.83 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.28 -46.69 94.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 124.354 1.062 . . . . 0.0 108.947 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -61.24 -39.51 90.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.547 0.739 . . . . 0.0 112.173 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 t -64.06 -52.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.333 1.053 . . . . 0.0 109.575 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.32 -18.67 61.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.7 -0.625 . . . . 0.0 111.297 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.51 8.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.227 -0.92 . . . . 0.0 109.197 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -51.95 -42.01 62.53 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 126.793 2.037 . . . . 0.0 112.832 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 26.5 m -64.56 -11.38 10.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.481 -0.762 . . . . 0.0 112.515 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.7 m -67.95 -15.36 63.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.701 -1.25 . . . . 0.0 110.831 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.49 65.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.437 -1.414 . . . . 0.0 111.448 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.87 -46.37 13.09 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.78 -1.2 . . . . 0.0 107.963 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -65.05 -32.47 74.21 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.222 1.009 . . . . 0.0 112.34 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.32 -11.68 60.58 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 120.839 -1.163 . . . . 0.0 111.874 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 51.3 p -82.01 -19.48 40.37 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.074 -1.641 . . . . 0.0 109.171 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.27 -16.16 59.86 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.675 -0.641 . . . . 0.0 112.026 -165.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -91.16 -23.69 20.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.874 0.845 . . . . 0.0 110.743 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.02 -29.21 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 O-C-N 120.135 -1.603 . . . . 0.0 108.297 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -62.44 -7.56 4.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.495 1.118 . . . . 0.0 112.961 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -75.51 -26.71 58.34 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.284 -1.51 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -176.401 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.099 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.03 -43.59 98.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -18.58 63.74 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.201 -0.937 . . . . 0.0 112.385 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -76.58 -44.07 36.11 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -68.06 -36.42 79.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.427 0.632 . . . . 0.0 109.564 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.07 -51.04 67.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.158 2.583 . . . . 0.0 110.016 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.37 81.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.655 1.182 . . . . 0.0 111.901 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -40.67 84.67 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.208 -0.933 . . . . 0.0 110.186 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -68.69 -27.16 65.71 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 121.192 -0.943 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.22 70.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.473 -1.392 . . . . 0.0 111.87 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -67.02 -25.35 66.24 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.568 -0.707 . . . . 0.0 112.032 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.94 -35.76 64.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 109.08 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.61 -17.17 56.46 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.647 -0.658 . . . . 0.0 109.489 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.459 HD13 ' HA2' ' D' ' 78' ' ' GLY . 13.2 tp -68.78 -44.64 73.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.225 -0.922 . . . . 0.0 109.187 171.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.88 -41.05 67.14 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 111.169 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -53.45 -47.79 69.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.324 1.85 . . . . 0.0 112.123 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -87.83 -33.02 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.005 -1.06 . . . . 0.0 111.123 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.55 -49.95 74.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 127.863 2.465 . . . . 0.0 109.859 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.12 -42.87 72.06 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.27 -31.24 72.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.653 -0.654 . . . . 0.0 112.012 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.72 71.73 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.469 0.708 . . . . 0.0 111.278 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 92.3 p -67.15 -41.0 86.76 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.99 -27.68 61.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 109.723 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -79.61 -51.34 9.4 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.21 97.46 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 111.731 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.49 -29.42 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 119.413 -2.054 . . . . 0.0 112.106 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -89.05 -27.34 20.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 66' ' ' GLU . . . -68.54 -57.09 6.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.935 1.694 . . . . 0.0 108.358 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.43 -7.9 46.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.359 0.663 . . . . 0.0 112.53 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.12 99.55 1.5 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 120.075 -1.641 . . . . 0.0 109.263 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 4.19 35.1 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.5 138.53 26.78 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 118.649 1.224 . . . . 0.0 108.689 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.52 139.49 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.491 2.128 . . . . 0.0 110.178 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.1 16.5 80.65 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.14 147.21 53.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.343 0.657 . . . . 0.0 110.74 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 -35.99 5.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -89.07 136.58 32.94 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 pt -165.89 172.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.6 m 67.65 129.07 0.02 OUTLIER 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.973 2.509 . . . . 0.0 114.285 167.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -61.78 -57.72 22.59 Favored Pre-proline 0 C--N 1.351 0.659 0 CA-C-O 116.976 -1.487 . . . . 0.0 113.397 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.48 -12.13 22.62 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 124.482 2.637 . . . . 0.0 110.653 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.79 -38.83 20.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -36.71 81.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.733 1.213 . . . . 0.0 112.016 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.29 -30.39 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.656 -0.653 . . . . 0.0 110.55 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 -19.5 56.93 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.08 -1.013 . . . . 0.0 110.764 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -91.25 -30.33 16.68 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.94 -37.56 87.86 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.501 -1.375 . . . . 0.0 110.489 -173.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.21 -25.96 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 123.357 0.663 . . . . 0.0 112.091 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.52 -45.81 21.05 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.242 1.017 . . . . 0.0 110.485 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -77.19 -24.52 51.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 120.784 -1.198 . . . . 0.0 109.581 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.38 -29.69 62.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.196 0.598 . . . . 0.0 110.051 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 25.6 p -92.15 -2.46 56.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 118.283 0.492 . . . . 0.0 110.72 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 55.3 p 54.39 59.41 4.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.095 2.158 . . . . 0.0 112.976 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.575 HG23 ' H ' ' D' ' 56' ' ' GLY . 27.4 m -102.98 -75.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.575 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 91.04 54.3 2.05 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -19.53 63.94 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 122.093 0.949 . . . . 0.0 111.87 -170.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.2 11.1 22.82 Favored Glycine 0 CA--C 1.49 -1.481 0 O-C-N 120.325 -1.484 . . . . 0.0 111.421 168.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -68.84 -52.14 33.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.926 -0.749 . . . . 0.0 110.924 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -139.57 163.25 33.07 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.42 151.26 26.9 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -171.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.05 -179.98 5.95 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 124.346 3.364 . . . . 0.0 109.469 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.44 HG13 ' H ' ' D' ' 64' ' ' THR 0.324 3.7 p -123.13 -89.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 CA-C-N 120.705 1.593 . . . . 0.0 111.869 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.44 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.5 m -152.32 -50.31 0.11 Allowed 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 119.376 -2.077 . . . . 0.0 107.019 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.44 -5.66 59.22 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.731 1.212 . . . . 0.0 110.878 -168.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' D' ' 29' ' ' ALA . 2.8 pm0 -66.1 -34.39 77.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.64 -1.287 . . . . 0.0 107.588 165.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.25 88.52 1.32 Allowed Glycine 0 N--CA 1.419 -2.488 1 N-CA-C 98.784 -5.726 . . . . 0.0 98.784 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 26.5 ttm-85 -55.6 -19.81 11.5 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 125.768 1.627 . . . . 0.0 111.076 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -58.27 -17.1 16.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.1 -47.88 76.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 120.064 1.302 . . . . 0.0 108.424 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.1 78.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -53.37 -44.13 68.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.536 1.534 . . . . 0.0 112.328 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -60.38 -47.58 85.44 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.039 0.936 . . . . 0.0 110.51 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.01 -34.28 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 43.3 mtt -56.74 -50.89 70.9 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.838 0.828 . . . . 0.0 110.437 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -68.81 -29.83 68.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.876 -0.515 . . . . 0.0 110.42 -171.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.32 71.7 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.953 -0.467 . . . . 0.0 110.303 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -62.05 -46.32 94.28 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 123.927 0.775 . . . . 0.0 111.733 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.6 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.9 0.88 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.56 -30.8 71.18 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.957 -1.089 . . . . 0.0 112.521 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 21.0 t -65.87 -53.77 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 109.121 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.5 -35.2 77.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 121.704 -0.623 . . . . 0.0 110.429 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.0 74.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.392 -0.818 . . . . 0.0 111.256 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.46 -28.56 69.31 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.608 -1.307 . . . . 0.0 110.929 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.5 -7.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.045 1.338 . . . . 0.0 110.944 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.8 m -58.84 -21.23 56.33 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 118.937 -2.352 . . . . 0.0 112.315 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.09 -29.15 67.14 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.762 -1.211 . . . . 0.0 110.881 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 -46.54 14.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.988 -1.695 . . . . 0.0 109.163 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.6 -47.58 72.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -167.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.42 -9.84 58.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.112 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -77.72 -38.33 47.43 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 120.447 -1.408 . . . . 0.0 108.148 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.27 55.2 m-20 -83.07 8.64 12.33 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.376 -1.452 . . . . 0.0 112.591 -155.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -96.93 -38.06 9.96 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 117.573 -1.203 . . . . 0.0 111.514 161.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.18 -20.46 27.57 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-N 120.789 1.631 . . . . 0.0 111.113 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -54.08 -22.93 12.06 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.642 1.177 . . . . 0.0 112.308 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.08 -21.73 9.21 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.715 1.606 . . . . 0.0 113.008 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -176.35 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.101 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.0 -62.55 0.71 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.037 2.535 . . . . 0.0 112.631 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -64.61 -23.41 67.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 113.974 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -82.78 -44.41 15.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.7 -40.84 98.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.335 1.054 . . . . 0.0 110.401 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.41 -29.72 67.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.357 0.598 . . . . 0.0 110.658 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.44 86.65 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.271 -0.893 . . . . 0.0 110.479 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -63.17 -43.62 97.74 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.577 -0.702 . . . . 0.0 110.5 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.7 -42.36 75.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.084 1.754 . . . . 0.0 110.419 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.32 93.01 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.441 1.096 . . . . 0.0 110.702 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -63.95 -36.52 84.22 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -74.61 -25.91 59.55 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.798 -1.189 . . . . 0.0 111.875 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.52 -35.95 63.18 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.77 -42.51 79.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.417 1.087 . . . . 0.0 111.874 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.0 -34.19 69.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.129 1.372 . . . . 0.0 112.203 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -74.85 -35.17 62.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.621 -0.674 . . . . 0.0 109.392 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.98 -33.76 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.47 -42.69 92.6 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.459 -0.775 . . . . 0.0 112.0 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.65 -42.61 74.01 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 122.098 -0.376 . . . . 0.0 110.493 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.89 -40.65 87.82 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.703 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.19 79.39 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 125.043 1.337 . . . . 0.0 111.479 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -52.56 -47.02 67.05 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 126.016 1.726 . . . . 0.0 109.938 175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -65.39 -46.2 80.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.265 1.026 . . . . 0.0 109.985 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.99 -43.18 88.53 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 123.885 0.874 . . . . 0.0 110.563 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.67 71.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.694 1.198 . . . . 0.0 111.527 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.28 -51.79 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 120.765 -1.209 . . . . 0.0 109.912 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.46 -28.86 63.19 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.722 -0.612 . . . . 0.0 111.092 -166.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.0 81.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.608 0.763 . . . . 0.0 110.311 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.73 -88.93 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 122.545 0.338 . . . . 0.0 111.51 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 20.09 67.59 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 128.302 2.641 . . . . 0.0 116.69 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.29 -23.45 4.31 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 133.63 90.76 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -174.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.62 125.39 4.94 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.35 2.033 . . . . 0.0 111.71 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.7 54.06 Favored Glycine 0 CA--C 1.485 -1.805 0 CA-C-O 117.906 -1.497 . . . . 0.0 109.828 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -32.1 -65.21 0.15 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 114.345 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 73.39 -15.54 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.769 1.627 . . . . 0.0 111.297 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.2 118.23 36.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 pt -143.72 0.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.843 -0.536 . . . . 0.0 111.235 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.9 m -128.24 130.62 48.21 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.372 -1.455 . . . . 0.0 109.449 -165.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -57.22 -50.31 88.89 Favored Pre-proline 0 C--N 1.351 0.64 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.783 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.38 -11.98 24.93 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 125.301 2.929 . . . . 0.0 111.881 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.79 -25.09 16.19 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.19 -35.11 78.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.656 0.783 . . . . 0.0 111.432 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -69.91 -33.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -31.84 61.04 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.333 -0.854 . . . . 0.0 109.739 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -65.33 -45.18 85.27 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.523 1.129 . . . . 0.0 108.919 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -34.33 68.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.243 1.417 . . . . 0.0 111.419 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.89 -52.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 124.254 1.022 . . . . 0.0 110.719 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.21 -22.84 60.36 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 121.537 -0.727 . . . . 0.0 110.961 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.7 m -73.34 -39.49 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.22 64.95 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.264 -0.898 . . . . 0.0 111.546 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 p -88.23 12.12 14.69 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.371 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 p 48.96 61.33 3.17 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.949 1.7 . . . . 0.0 112.717 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.4 p -128.48 -77.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 82.88 75.04 1.18 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -69.17 -34.19 74.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.985 -1.303 . . . . 0.0 110.787 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.13 38.61 0.25 Allowed Glycine 0 CA--C 1.487 -1.714 0 N-CA-C 107.926 -2.069 . . . . 0.0 107.926 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.85 -48.2 22.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -135.3 178.89 6.68 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -149.16 93.89 4.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.131 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.18 166.23 30.54 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.572 2.181 . . . . 0.0 110.842 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 64' ' ' THR . 11.8 p -141.89 177.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 123.002 1.382 . . . . 0.0 107.908 -170.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 63' ' ' VAL . 16.9 m -65.19 -25.01 67.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.853 2.461 . . . . 0.0 112.585 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -75.51 -36.23 60.59 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.304 1.042 . . . . 0.0 109.056 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -53.21 58.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.91 66.67 0.37 Allowed Glycine 0 CA--C 1.461 -3.334 1 N-CA-C 100.797 -4.921 . . . . 0.0 100.797 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.5 ttm-85 -23.18 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.382 2.017 1 C-N-CA 132.258 4.223 . . . . 0.0 115.921 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -54.79 -6.82 0.13 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 116.622 -1.656 . . . . 0.0 115.389 167.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.265 54.8 t -76.01 -46.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.365 1.26 0 CA-C-N 123.771 2.987 . . . . 0.0 107.809 167.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.7 67.75 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.435 1.016 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.64 -34.61 73.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.474 1.11 . . . . 0.0 112.258 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.74 -40.36 84.16 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 120.728 -1.232 . . . . 0.0 110.365 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.38 -43.14 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.3 mtt -59.23 -45.83 90.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 110.147 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.85 -40.44 92.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.929 0.892 . . . . 0.0 111.683 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 81.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.788 0.835 . . . . 0.0 111.071 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.88 -46.22 90.13 Favored Glycine 0 C--N 1.35 1.326 0 C-N-CA 124.678 1.132 . . . . 0.0 110.446 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.04 -41.17 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.894 0.877 . . . . 0.0 109.376 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -59.7 -52.03 67.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.202 -0.936 . . . . 0.0 111.625 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.55 -41.69 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 121.959 -0.463 . . . . 0.0 110.527 -172.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.8 -39.46 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.025 0.53 . . . . 0.0 109.688 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 121.42 -0.8 . . . . 0.0 110.919 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.16 -24.85 64.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 121.021 -1.05 . . . . 0.0 111.538 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.92 -15.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 O-C-N 121.012 -1.055 . . . . 0.0 110.697 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.9 m -53.57 -25.38 16.97 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.023 -1.673 . . . . 0.0 113.067 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.0 66.68 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.509 -1.369 . . . . 0.0 111.294 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.96 -52.75 5.52 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 108.738 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.1 mt -59.34 -40.25 85.74 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.303 1.041 . . . . 0.0 112.958 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.5 -19.37 62.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 121.073 -1.017 . . . . 0.0 111.228 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.2 p -72.26 -22.32 61.24 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.221 -1.549 . . . . 0.0 110.283 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.86 -5.67 55.92 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.924 -1.11 . . . . 0.0 112.128 -167.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.78 -22.72 19.17 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.867 -1.77 . . . . 0.0 109.347 168.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -76.84 -37.72 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 107.983 -170.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -57.9 -18.44 22.98 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.413 1.485 . . . . 0.0 112.479 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -64.97 -32.72 74.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.758 -1.214 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 C--N 1.353 0.72 0 O-C-N 121.038 -1.039 . . . . 0.0 108.917 179.843 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.488 -1.429 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -4.27 58.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.881 -1.137 . . . . 0.0 112.159 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -29.75 56.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.787 1.235 . . . . 0.0 108.37 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -70.85 -33.78 70.98 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.931 -1.106 . . . . 0.0 110.432 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.87 -38.81 92.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 122.174 0.988 . . . . 0.0 109.236 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' B' ' 85' ' ' VAL . . . -66.06 -38.51 88.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.541 0.737 . . . . 0.0 111.711 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.13 -41.04 86.82 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.698 -0.626 . . . . 0.0 110.362 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -62.56 -30.96 71.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.625 1.17 . . . . 0.0 111.139 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.414 -0.804 . . . . 0.0 111.354 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -67.58 -33.78 75.71 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.459 -0.776 . . . . 0.0 109.639 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.38 -35.56 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.517 1.127 . . . . 0.0 111.04 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.32 -40.44 95.92 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.78 0.832 . . . . 0.0 109.156 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.728 -0.607 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -58.4 -38.95 78.4 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.094 0.958 . . . . 0.0 112.006 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -62.78 -44.65 95.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.228 1.011 . . . . 0.0 109.452 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.5 -33.39 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.046 0.938 . . . . 0.0 110.062 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.49 HD13 HG22 ' B' ' 49' ' ' VAL . 20.9 mt -66.92 -36.37 82.09 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.52 -1.362 . . . . 0.0 111.205 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -72.01 -35.17 69.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.514 -0.741 . . . . 0.0 110.435 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.723 -1.236 . . . . 0.0 109.189 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.7 74.32 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 126.251 1.82 . . . . 0.0 111.69 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.44 -36.11 63.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -43.16 85.64 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.814 0.846 . . . . 0.0 109.18 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.96 -51.73 44.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.816 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.37 96.98 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 124.066 0.946 . . . . 0.0 111.482 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -67.57 -44.78 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.112 -0.992 . . . . 0.0 109.501 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -50.59 31.74 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 110.289 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.64 -29.06 67.47 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.451 -0.78 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -67.06 100.47 0.76 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.352 -1.468 . . . . 0.0 111.413 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.31 -30.18 3.35 Favored Glycine 0 CA--C 1.488 -1.655 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.08 60.21 Favored Pre-proline 0 N--CA 1.443 -0.781 0 C-N-CA 123.588 0.755 . . . . 0.0 110.478 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.72 148.31 12.42 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 C-N-CA 122.553 2.169 . . . . 0.0 109.449 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.58 -17.18 45.93 Favored Glycine 0 CA--C 1.489 -1.538 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.19 114.36 2.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.002 2.521 . . . . 0.0 107.835 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.78 -18.46 14.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -84.29 -8.67 58.95 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.725 0.81 . . . . 0.0 108.901 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 tt -54.02 69.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 128.809 2.844 . . . . 0.0 114.981 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -140.66 -122.01 0.11 Allowed 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 119.476 -2.015 . . . . 0.0 107.373 -165.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -179.21 -67.45 0.0 OUTLIER Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.9 -29.09 18.95 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 125.201 2.893 . . . . 0.0 111.491 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -91.17 0.85 57.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.407 1.083 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.58 64.32 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.246 -0.909 . . . . 0.0 108.712 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -72.52 -20.46 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 123.084 0.554 . . . . 0.0 110.478 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -66.32 -47.55 73.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -67.06 -44.04 81.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.879 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.3 m -56.02 -33.55 65.01 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.49 HG22 HD13 ' B' ' 19' ' ' LEU . 58.3 t -74.0 -41.52 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.93 -40.73 94.33 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -57.1 -37.51 72.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.653 1.181 . . . . 0.0 111.608 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.18 -22.42 63.91 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 123.089 0.556 . . . . 0.0 112.119 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.0 p -84.67 -14.57 48.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.422 HG22 ' HB2' ' B' ' 75' ' ' MET 0.291 19.9 p 76.19 0.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.569 2.348 . . . . 0.0 111.18 -178.344 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.65 -50.1 77.29 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 C-N-CA 123.465 0.706 . . . . 0.0 109.424 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.93 47.1 92.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.273 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -45.63 -32.31 2.3 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.72 12.46 5.0 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.95 -54.98 16.61 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.628 -0.925 . . . . 0.0 111.108 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -121.78 156.12 33.85 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.83 139.52 34.83 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 102.08 -3.304 . . . . 0.0 102.08 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.11 -173.26 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.145 3.23 . . . . 0.0 108.873 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.664 HG22 ' H ' ' B' ' 64' ' ' THR . 12.9 p -137.23 -158.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.664 ' H ' HG22 ' B' ' 63' ' ' VAL . 53.2 m -92.92 -39.18 11.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 109.672 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.35 -23.59 59.05 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.386 -0.821 . . . . 0.0 110.612 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -29.33 70.59 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 123.732 1.73 . . . . 0.0 108.254 173.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.86 67.21 1.18 Allowed Glycine 0 CA--C 1.461 -3.321 1 N-CA-C 102.335 -4.306 . . . . 0.0 102.335 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -29.61 -24.43 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 133.034 4.534 . . . . 0.0 115.342 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -62.82 0.68 0.49 Allowed 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 125.961 1.704 . . . . 0.0 114.03 165.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.24 -56.11 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.125 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 165.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.21 -43.6 78.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.228 1.411 . . . . 0.0 111.487 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.04 -46.4 61.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.484 1.914 . . . . 0.0 110.805 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.18 -40.13 86.52 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.353 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.23 -49.0 79.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 119.19 0.905 . . . . 0.0 110.055 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.422 ' HB2' HG22 ' B' ' 54' ' ' THR . 21.3 ptp -68.08 -41.45 81.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.936 -0.478 . . . . 0.0 110.338 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -69.37 -32.85 72.15 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.08 89.77 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 123.292 0.637 . . . . 0.0 110.457 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.41 -49.69 63.94 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.42 -51.25 66.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 109.841 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.77 -7.11 56.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.519 -1.363 . . . . 0.0 112.954 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -83.86 -54.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -60.66 -29.79 69.5 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.73 0.812 . . . . 0.0 110.155 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.09 -19.74 36.21 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.418 0.687 . . . . 0.0 112.58 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.74 -37.32 59.45 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 119.153 -2.217 . . . . 0.0 107.747 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' B' ' 8' ' ' ALA . 10.4 m -73.07 -5.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 121.383 -0.823 . . . . 0.0 111.544 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.1 m -55.96 -20.54 16.67 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 110.593 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.94 95.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 119.859 -1.776 . . . . 0.0 113.032 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.25 70.55 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 124.516 1.127 . . . . 0.0 108.042 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.54 -27.61 61.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.53 75.48 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.775 -1.828 . . . . 0.0 110.594 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -12.32 28.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.006 -1.059 . . . . 0.0 112.577 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.38 -15.66 61.85 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 119.789 1.177 . . . . 0.0 111.12 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' C' ' 91' ' ' THR . 5.4 p90 -76.14 -26.64 56.51 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.336 -1.477 . . . . 0.0 111.067 171.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.93 -34.0 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.135 0.974 . . . . 0.0 108.504 -171.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -61.59 -20.01 62.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.501 1.12 . . . . 0.0 112.348 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -64.66 -32.93 74.82 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.77 0.828 . . . . 0.0 110.813 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.354 0.776 0 O-C-N 120.479 -1.388 . . . . 0.0 109.938 178.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 N--CA 1.429 -1.498 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -58.86 -28.96 66.59 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 127.082 2.153 . . . . 0.0 113.492 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.86 -32.86 72.84 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.848 1.259 . . . . 0.0 109.92 -168.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -65.35 -43.67 90.11 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.533 1.133 . . . . 0.0 109.992 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -72.11 -37.06 69.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.986 0.914 . . . . 0.0 108.915 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.16 95.89 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -71.3 -35.36 71.26 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.899 0.88 . . . . 0.0 110.317 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.3 88.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.085 0.954 . . . . 0.0 111.833 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.8 -33.83 76.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.42 -0.8 . . . . 0.0 111.623 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.01 -35.2 74.19 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.658 0.742 . . . . 0.0 109.601 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -69.62 -29.71 67.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.534 0.734 . . . . 0.0 110.24 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.94 -40.84 95.64 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.77 -34.96 75.27 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.55 -0.719 . . . . 0.0 110.775 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -64.48 -40.72 96.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.505 1.122 . . . . 0.0 111.23 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.4 -31.36 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.618 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.49 -50.23 74.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 126.223 1.809 . . . . 0.0 109.543 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -72.69 -23.93 60.94 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.88 -1.137 . . . . 0.0 110.601 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -72.36 -37.15 68.88 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 -31.58 72.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.156 0.982 . . . . 0.0 112.178 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -58.21 -45.23 88.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.894 1.331 . . . . 0.0 111.578 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -70.63 -47.16 61.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.181 1.792 . . . . 0.0 107.506 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -65.28 -31.0 71.92 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 124.452 1.101 . . . . 0.0 112.674 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.69 68.61 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.93 1.292 . . . . 0.0 110.391 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.43 -36.86 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.399 0.68 . . . . 0.0 110.348 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.72 -38.95 89.81 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.466 -0.772 . . . . 0.0 109.701 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.41 71.54 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.175 1.79 . . . . 0.0 111.562 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -67.32 -24.33 65.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 125.178 1.391 . . . . 0.0 112.307 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -91.91 115.95 28.5 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.79 -48.26 0.98 Allowed Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.88 150.52 38.72 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.322 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.81 162.89 18.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.821 1.681 . . . . 0.0 110.263 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 30.76 12.8 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.11 137.14 56.11 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 117.995 0.898 . . . . 0.0 111.94 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.62 -41.96 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 123.828 0.851 . . . . 0.0 110.024 -170.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.85 -27.04 57.67 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.866 1.266 . . . . 0.0 108.412 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 tp -37.22 106.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 127.911 2.484 . . . . 0.0 113.343 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t -172.03 -131.39 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.3 -70.42 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.731 0 CA-C-O 116.914 -1.517 . . . . 0.0 107.038 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.21 -11.55 19.32 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 CA-C-N 125.004 2.823 . . . . 0.0 111.925 -163.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.57 1.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.341 2.657 . . . . 0.0 107.725 -175.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.28 -34.38 70.61 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.065 0.936 . . . . 0.0 110.214 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.01 -19.5 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 125.334 1.454 . . . . 0.0 109.994 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -50.85 28.77 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.599 -1.938 . . . . 0.0 107.511 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -63.32 -34.25 77.29 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 121.957 0.884 . . . . 0.0 111.399 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -73.06 -31.16 64.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.587 -1.945 . . . . 0.0 110.907 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.95 -53.39 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 123.922 0.889 . . . . 0.0 108.677 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' C' ' 56' ' ' GLY . 20.3 pt-20 -64.37 -30.91 71.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.014 0.526 . . . . 0.0 111.773 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 79.5 m -70.83 -48.37 54.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.814 0.846 . . . . 0.0 110.754 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -27.52 64.38 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.792 -1.193 . . . . 0.0 111.232 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -85.37 -4.26 59.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.927 -0.483 . . . . 0.0 111.124 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p 55.23 64.2 1.86 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 125.495 1.518 . . . . 0.0 112.059 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.86 -87.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 101.592 -3.485 . . . . 0.0 101.592 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' C' ' 50' ' ' GLU . . . 87.21 80.73 1.21 Allowed Glycine 0 CA--C 1.494 -1.254 0 N-CA-C 104.722 -3.351 . . . . 0.0 104.722 -172.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.447 ' CD2' ' HA3' ' D' ' 56' ' ' GLY . 17.8 t80 -76.34 -30.37 57.61 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.97 35.22 3.77 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.99 -38.44 57.39 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -135.07 157.34 47.19 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -129.41 138.11 32.42 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.37 168.04 22.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.515 2.143 . . . . 0.0 109.307 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' C' ' 63' ' ' VAL . 1.1 m -63.74 175.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 122.242 1.02 . . . . 0.0 111.688 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -83.36 -88.06 0.1 Allowed 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 120.958 -1.089 . . . . 0.0 108.323 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -34.17 -58.03 0.47 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.954 2.502 . . . . 0.0 116.589 -169.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -82.67 -98.93 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.68 -86.52 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.378 0 C-N-CA 126.395 1.95 . . . . 0.0 113.496 160.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -58.11 -42.43 85.72 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.301 1.44 . . . . 0.0 112.157 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -58.87 -27.08 64.84 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 118.902 -2.374 . . . . 0.0 112.283 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.18 -55.25 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.5 77.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.001 1.721 . . . . 0.0 112.713 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.0 -43.06 73.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 128.428 2.691 . . . . 0.0 108.555 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -68.2 -43.71 77.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 123.894 0.878 . . . . 0.0 110.188 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.51 -48.88 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 124.32 1.048 . . . . 0.0 110.16 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 23.2 ptp -66.56 -34.47 77.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.557 -0.715 . . . . 0.0 110.333 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -68.7 -30.53 69.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.308 -0.87 . . . . 0.0 110.744 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.11 86.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.909 -0.494 . . . . 0.0 110.206 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.42 92.0 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 123.823 0.725 . . . . 0.0 111.338 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -54.7 -47.46 73.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 125.378 1.471 . . . . 0.0 110.527 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -70.25 -28.41 65.21 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.769 -0.582 . . . . 0.0 112.027 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.58 -48.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 121.008 -1.057 . . . . 0.0 109.509 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -67.14 -25.85 66.38 Favored 'General case' 0 CA--C 1.509 -0.609 0 O-C-N 121.495 -0.753 . . . . 0.0 110.927 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.39 -36.89 57.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.79 -41.83 97.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 124.676 1.19 . . . . 0.0 110.516 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.04 -9.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 O-C-N 121.113 -0.992 . . . . 0.0 111.673 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -19.46 64.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 110.078 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.86 -32.94 74.88 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.434 1.093 . . . . 0.0 111.771 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.4 63.12 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.446 1.098 . . . . 0.0 109.914 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 -32.68 26.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.56 63.64 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.003 -1.061 . . . . 0.0 111.161 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.438 HG23 ' HB2' ' B' ' 93' ' ' PHE . 8.7 p -75.66 -10.82 59.77 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 120.035 -1.665 . . . . 0.0 110.823 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.337 46.5 m-20 -90.9 -0.77 57.82 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.582 -1.647 . . . . 0.0 109.511 -158.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -89.01 -10.37 47.85 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.906 161.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -96.13 -51.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.49 -17.87 24.5 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.396 2.279 . . . . 0.0 111.983 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -68.01 -12.57 61.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.655 -1.278 . . . . 0.0 112.255 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 . . . . . 0 C--N 1.353 0.756 0 O-C-N 119.956 -1.715 . . . . 0.0 108.097 175.345 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -28.91 70.38 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.117 -0.989 . . . . 0.0 112.703 -169.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -63.02 -33.19 74.89 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.202 -0.936 . . . . 0.0 112.44 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.44 -31.99 37.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.876 -1.14 . . . . 0.0 108.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.16 -35.96 74.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.902 -1.124 . . . . 0.0 110.725 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.25 -38.99 93.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.947 1.699 . . . . 0.0 110.154 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.21 92.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.153 0.981 . . . . 0.0 111.896 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -65.34 -32.94 74.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.522 1.129 . . . . 0.0 111.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -68.79 -36.16 77.93 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.742 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.63 94.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.485 0.714 . . . . 0.0 110.752 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.19 -44.14 87.91 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.416 1.086 . . . . 0.0 111.525 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -68.34 -44.1 76.06 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.266 1.026 . . . . 0.0 109.148 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -68.41 -31.57 71.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.584 -0.698 . . . . 0.0 110.409 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.43 -44.03 92.99 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.509 0.723 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.0 -30.83 71.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -65.91 -41.04 91.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.732 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.67 -38.28 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 C-N-CA 123.965 0.906 . . . . 0.0 108.897 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 37.3 mt -60.37 -48.44 81.73 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.204 1.002 . . . . 0.0 110.279 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -67.45 -36.49 81.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.565 -0.709 . . . . 0.0 111.736 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.63 -47.48 78.4 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.66 -41.52 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.367 1.467 . . . . 0.0 110.997 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 58.4 m -52.21 -49.45 63.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 126.064 1.746 . . . . 0.0 112.134 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -61.94 -50.89 70.34 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -62.66 -42.9 99.87 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 117.676 -1.154 . . . . 0.0 110.12 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.34 -47.69 62.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.822 2.049 . . . . 0.0 111.519 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.9 -41.62 76.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.776 -1.202 . . . . 0.0 111.372 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.53 -16.12 37.92 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.128 0.971 . . . . 0.0 109.982 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.12 -56.74 3.89 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.798 1.639 . . . . 0.0 106.73 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.94 -33.65 76.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.999 -0.438 . . . . 0.0 110.418 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -71.3 111.9 7.0 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.942 -1.098 . . . . 0.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.88 -32.18 4.69 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.31 73.5 Favored Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 123.521 0.728 . . . . 0.0 110.025 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.73 110.18 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.073 1.848 . . . . 0.0 113.255 -171.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.39 42.88 2.87 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.719 -2.952 . . . . 0.0 105.719 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.01 163.71 24.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.686 1.194 . . . . 0.0 109.301 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.67 -59.59 0.76 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' D' ' 60' ' ' ARG . 8.3 tt -84.67 130.76 34.67 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -150.29 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -142.1 125.74 16.88 Favored 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 119.784 -1.822 . . . . 0.0 109.362 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.04 -48.9 95.79 Favored Pre-proline 0 C--N 1.353 0.735 0 CA-C-O 116.473 -1.727 . . . . 0.0 112.282 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.36 -8.17 22.2 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 CA-C-N 125.33 2.939 . . . . 0.0 112.345 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -101.27 -19.59 15.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.27 75.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 121.043 -1.036 . . . . 0.0 111.519 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -65.92 -28.88 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.612 1.165 . . . . 0.0 110.092 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -86.19 -26.18 25.25 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.483 -0.761 . . . . 0.0 109.788 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -79.17 -34.42 43.15 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.8 m -79.06 51.07 1.1 Allowed 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.721 -0.612 . . . . 0.0 110.669 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.21 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.33 -22.92 55.04 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.416 1.486 . . . . 0.0 113.713 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.411 HG22 ' H ' ' D' ' 51' ' ' THR . 5.1 t -72.15 -35.82 69.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.666 -1.271 . . . . 0.0 109.795 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.29 42.39 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.035 -1.041 . . . . 0.0 109.613 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.22 -2.03 54.56 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.861 0.865 . . . . 0.0 109.615 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p 58.93 40.8 22.09 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 127.062 2.145 . . . . 0.0 112.733 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.41 65.69 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' C' ' 57' ' ' TYR . . . -70.25 99.78 0.74 Allowed Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -35.05 40.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.08 39.99 0.17 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.0 -51.38 16.12 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 118.827 1.314 . . . . 0.0 109.249 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.424 ' HD3' HD12 ' D' ' 38' ' ' LEU . 0.1 OUTLIER -141.49 173.27 11.65 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -137.16 127.93 16.16 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.08 -179.44 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.185 3.257 . . . . 0.0 109.481 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.507 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 6.8 t -112.26 -97.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 124.087 0.955 . . . . 0.0 110.076 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -165.67 -46.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -71.96 -10.22 59.47 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.507 ' CG ' ' H ' ' D' ' 63' ' ' VAL . 0.9 OUTLIER -60.84 -33.11 72.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.502 1.121 . . . . 0.0 109.996 172.166 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.25 -33.02 1.13 Allowed Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.391 -3.483 . . . . 0.0 104.391 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.435 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 37.6 ttm180 74.09 -50.74 0.69 Allowed 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 130.071 3.348 . . . . 0.0 107.578 -171.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -71.76 12.11 0.42 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.672 2.789 . . . . 0.0 110.884 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.89 -61.03 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -49.18 69.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 123.168 0.587 . . . . 0.0 111.031 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.02 -40.24 66.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.935 0.894 . . . . 0.0 111.418 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.8 -37.03 73.26 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 121.708 -0.62 . . . . 0.0 111.348 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.36 -41.95 57.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.146 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 10.3 mtp -56.37 -51.66 67.49 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.826 1.251 . . . . 0.0 110.587 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.75 -40.66 97.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.388 0.675 . . . . 0.0 110.768 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.04 87.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.763 0.825 . . . . 0.0 110.985 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.63 -49.44 64.35 Favored Glycine 0 CA--C 1.496 -1.119 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.62 -49.44 80.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 124.186 0.995 . . . . 0.0 110.339 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . 0.273 11.9 pt-20 -77.95 -9.61 59.18 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 120.202 -1.561 . . . . 0.0 112.664 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.69 -47.17 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -67.47 -20.78 65.52 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 121.462 -0.774 . . . . 0.0 111.137 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.6 -14.78 29.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.659 0.742 . . . . 0.0 111.717 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.18 -38.56 56.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 119.876 -1.765 . . . . 0.0 107.651 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 6.6 m -66.96 -6.39 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.646 0.778 . . . . 0.0 111.458 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.1 m -63.11 -17.77 62.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.375 1.47 . . . . 0.0 111.487 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.56 62.41 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 120.053 -1.655 . . . . 0.0 111.759 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.32 6.32 17.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 125.166 1.386 . . . . 0.0 111.087 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 92.5 mt -113.47 -39.29 4.13 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.28 -13.16 61.44 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.779 -1.2 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -70.7 -19.17 62.79 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 120.956 -1.09 . . . . 0.0 110.879 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.19 7.47 46.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 119.699 1.136 . . . . 0.0 110.6 -160.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -91.99 -20.5 21.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 158.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.9 -40.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -57.75 -38.24 75.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 126.711 2.005 . . . . 0.0 111.163 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.13 -8.64 55.78 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.386 0.674 . . . . 0.0 112.732 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.174 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 122.317 1.056 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.73 151.57 34.07 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.2 -29.99 71.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.041 1.336 . . . . 0.0 109.323 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -91.94 -2.46 56.76 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 121.267 -0.896 . . . . 0.0 111.712 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.21 -36.46 19.44 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 119.599 1.09 . . . . 0.0 108.965 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -67.71 -35.01 78.01 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.894 -1.129 . . . . 0.0 110.305 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -75.43 -34.38 60.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 121.769 -0.582 . . . . 0.0 109.651 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.04 82.45 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.798 0.839 . . . . 0.0 109.715 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -60.49 -38.37 84.08 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.662 1.185 . . . . 0.0 111.417 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -56.3 -42.5 77.65 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.569 1.148 . . . . 0.0 110.612 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.06 -32.29 73.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.632 -0.668 . . . . 0.0 111.061 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.11 -27.68 67.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.625 -0.672 . . . . 0.0 111.853 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.35 -39.26 81.92 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 109.158 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.47 -36.17 82.88 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.488 0.715 . . . . 0.0 110.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -38.89 92.91 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.607 0.717 . . . . 0.0 111.057 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -69.08 -21.01 64.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.364 1.066 . . . . 0.0 111.883 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -72.51 -40.72 66.62 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -64.46 -38.88 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.845 0.858 . . . . 0.0 108.709 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.92 -43.26 86.15 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.556 1.142 . . . . 0.0 111.859 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.82 -53.86 53.39 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.321 1.058 . . . . 0.0 110.251 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -73.06 -28.96 62.62 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.265 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.06 89.19 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 124.925 1.29 . . . . 0.0 110.428 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m -56.96 -37.82 72.11 Favored 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.498 1.119 . . . . 0.0 112.042 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -75.59 -51.68 12.32 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.387 0.675 . . . . 0.0 110.854 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.3 -38.22 88.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 120.989 -1.069 . . . . 0.0 109.498 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.96 75.25 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.353 1.461 . . . . 0.0 112.505 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.38 -33.05 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 O-C-N 121.375 -0.828 . . . . 0.0 111.415 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.34 -44.82 50.73 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -66.88 -42.8 84.95 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.577 1.551 . . . . 0.0 108.721 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -79.59 -44.26 21.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -77.11 93.88 3.96 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 119.372 -2.08 . . . . 0.0 110.537 -172.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.87 -17.85 3.41 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.98 151.4 54.6 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.025 0.912 . . . . 0.0 109.196 -176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.84 137.07 13.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.839 2.36 . . . . 0.0 110.731 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 -4.61 83.64 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 118.784 0.72 . . . . 0.0 111.306 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.88 146.76 54.06 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.492 1.117 . . . . 0.0 111.662 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.66 -11.1 1.59 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.519 1.128 . . . . 0.0 111.138 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.11 -66.32 0.73 Allowed 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.088 -1.007 . . . . 0.0 111.152 -172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 40' ' ' SER 0.495 44.9 pt 58.28 -100.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 174.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 39' ' ' ILE . 24.7 m -54.11 143.23 22.97 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -56.05 -57.45 22.12 Favored Pre-proline 0 C--N 1.356 0.859 0 C-N-CA 125.866 1.666 . . . . 0.0 114.991 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.22 -5.58 17.16 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.258 2.913 . . . . 0.0 111.207 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -107.98 1.97 22.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.17 -45.21 9.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.79 -32.15 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 124.237 1.015 . . . . 0.0 110.781 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.86 -10.54 59.71 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.122 -0.986 . . . . 0.0 112.143 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -90.14 -22.95 21.49 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -89.32 54.7 3.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 120.151 -1.593 . . . . 0.0 109.36 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.21 -73.72 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.44 -31.72 65.7 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.506 1.922 . . . . 0.0 108.638 -169.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -52.64 -37.67 58.9 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.091 1.357 . . . . 0.0 111.627 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -16.48 58.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 119.664 -1.898 . . . . 0.0 111.919 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t -108.55 38.48 2.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.388 4.6 p 62.74 -110.31 0.34 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.597 2.359 . . . . 0.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t 70.51 -70.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.891 1.676 . . . . 0.0 110.116 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.5 -24.3 29.14 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -78.27 55.92 1.61 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 109.787 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.76 -13.65 66.43 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 120.369 -1.457 . . . . 0.0 110.358 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 t0 76.09 14.37 2.54 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 127.583 2.353 . . . . 0.0 108.751 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -148.79 -178.3 6.27 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.26 139.76 21.69 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.59 175.93 8.35 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.992 3.128 . . . . 0.0 107.766 161.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.314 2.6 p -113.43 -88.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-N 120.832 1.651 . . . . 0.0 112.046 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -157.64 -40.45 0.07 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.496 -2.003 . . . . 0.0 107.21 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.91 -23.5 31.16 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 123.121 0.568 . . . . 0.0 110.795 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 1.2 pm0 -57.8 -35.95 71.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.492 1.517 . . . . 0.0 108.043 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.04 96.35 2.08 Favored Glycine 0 CA--C 1.47 -2.74 1 N-CA-C 97.992 -6.043 . . . . 0.0 97.992 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -62.64 -17.21 59.94 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 118.726 1.263 . . . . 0.0 110.072 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -44.06 -29.63 0.63 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.561 2.744 . . . . 0.0 113.813 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.93 -40.99 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 124.593 1.157 . . . . 0.0 109.137 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 -49.05 12.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.196 -0.94 . . . . 0.0 108.617 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -47.85 -50.32 26.63 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.703 2.001 . . . . 0.0 111.721 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.1 -27.31 61.63 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.662 -0.649 . . . . 0.0 111.562 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.97 -44.15 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.9 mtm -63.19 -44.23 95.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.135 0.574 . . . . 0.0 110.539 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -65.84 -32.54 74.12 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.342 -0.849 . . . . 0.0 111.473 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.06 79.2 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.355 -0.841 . . . . 0.0 110.403 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.43 -41.34 96.46 Favored Glycine 0 CA--C 1.487 -1.695 0 C-N-CA 123.969 0.795 . . . . 0.0 111.145 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.71 -46.95 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 C-N-CA 124.078 0.951 . . . . 0.0 108.722 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.13 -39.4 94.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 120.734 -1.229 . . . . 0.0 112.302 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.85 -55.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.71 0.804 . . . . 0.0 109.361 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.39 -18.65 61.13 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.579 -0.7 . . . . 0.0 111.667 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.35 23.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.073 -1.017 . . . . 0.0 109.861 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.81 -37.27 87.05 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.935 -1.103 . . . . 0.0 110.585 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.33 -7.62 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 O-C-N 121.188 -0.945 . . . . 0.0 112.246 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -57.97 -23.95 55.98 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 124.706 1.202 . . . . 0.0 110.72 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.75 72.96 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.182 -1.574 . . . . 0.0 112.457 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.77 -39.98 56.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 120.998 -1.064 . . . . 0.0 108.612 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.59 -35.05 78.26 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.689 0.757 . . . . 0.0 110.425 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.74 68.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.672 -1.268 . . . . 0.0 112.343 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 t -84.57 5.12 29.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.709 -1.245 . . . . 0.0 109.709 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.72 -48.39 59.69 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 118.786 0.721 . . . . 0.0 109.693 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -67.98 -27.94 67.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.723 -1.235 . . . . 0.0 111.551 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -29.1 46.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 125.085 1.354 . . . . 0.0 109.115 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -59.96 -18.51 45.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.243 1.817 . . . . 0.0 111.847 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -61.81 -36.68 81.83 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.974 1.31 . . . . 0.0 109.676 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -78.14 -18.56 55.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 120.683 -1.261 . . . . 0.0 109.815 -169.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -78.53 -37.42 43.0 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.763 1.225 . . . . 0.0 107.92 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.27 -42.9 99.74 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.747 2.019 . . . . 0.0 109.71 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.29 -10.12 58.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -114.55 -12.85 12.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.56 30.29 64.5 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 110.447 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -170.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.67 -159.24 0.21 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.303 1.441 . . . . 0.0 112.424 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -67.33 0.64 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' B' ' 5' ' ' GLU . 36.8 p-80 -56.16 -30.07 61.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.425 2.29 . . . . 0.0 114.348 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' CD2' ' B' ' 4' ' ' HIS . 8.3 mt-10 -74.62 -21.2 59.59 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -79.38 -42.57 25.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.59 -31.25 66.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.038 0.447 . . . . 0.0 110.473 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.53 -43.31 93.48 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.754 0.822 . . . . 0.0 111.558 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -72.83 -30.57 64.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.773 0.797 . . . . 0.0 110.351 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -66.45 -34.4 77.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.742 0.817 . . . . 0.0 110.214 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.94 79.28 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -63.29 -36.62 84.27 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.494 -0.753 . . . . 0.0 111.0 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.99 -33.95 76.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.916 0.886 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -62.81 -41.83 99.47 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 121.246 -0.909 . . . . 0.0 109.32 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.64 -39.65 94.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.795 -0.566 . . . . 0.0 110.939 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.97 -38.05 84.58 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.368 0.667 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -62.57 -45.2 94.01 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.339 0.656 . . . . 0.0 109.568 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.53 -38.72 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 123.756 0.823 . . . . 0.0 109.72 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.91 -45.92 85.75 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.824 0.85 . . . . 0.0 111.261 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.58 -37.63 77.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.592 1.157 . . . . 0.0 110.712 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.48 -35.59 63.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.72 -0.613 . . . . 0.0 109.898 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.73 -36.79 85.02 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.142 0.977 . . . . 0.0 111.068 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -28.94 69.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.727 1.149 . . . . 0.0 112.949 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.05 -53.71 10.42 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -58.18 -48.11 81.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 125.073 1.349 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.56 -43.87 84.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.644 1.178 . . . . 0.0 112.224 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 -48.69 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 -20.35 49.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -50.67 43.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 108.504 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.83 -21.66 63.36 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 mmm-85 -70.68 90.57 0.77 Allowed 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 120.149 -1.595 . . . . 0.0 110.694 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.87 -21.45 3.01 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 107.519 -2.233 . . . . 0.0 107.519 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.44 152.26 66.91 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 117.761 0.78 . . . . 0.0 110.771 -172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.57 128.32 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.87 2.38 . . . . 0.0 110.667 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.38 -63.05 0.28 Allowed Glycine 0 CA--C 1.471 -2.688 1 N-CA-C 103.036 -4.026 . . . . 0.0 103.036 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.416 ' H ' HG21 ' B' ' 63' ' ' VAL . . . 45.41 -94.53 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 128.643 2.777 . . . . 0.0 111.503 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 83.75 -29.09 0.09 Allowed 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 127.165 2.186 . . . . 0.0 109.042 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.92 122.5 39.96 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 pt -154.44 170.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 76.61 139.83 0.07 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.017 1.727 . . . . 0.0 111.673 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -47.3 23.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.585 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -70.48 -21.6 29.91 Favored 'Trans proline' 0 CA--C 1.502 -1.089 0 CA-C-N 124.512 2.647 . . . . 0.0 112.952 -168.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.38 6.52 24.43 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 119.945 1.248 . . . . 0.0 110.37 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.67 -38.85 67.48 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.631 0.729 . . . . 0.0 109.25 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -65.09 -33.24 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 123.414 0.686 . . . . 0.0 109.773 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -41.63 84.02 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.971 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.19 0.995 . . . . 0.0 109.177 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -58.02 -41.42 83.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.976 1.31 . . . . 0.0 111.165 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.79 -51.88 67.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 O-C-N 121.49 -0.756 . . . . 0.0 111.114 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . 0.285 6.6 pt-20 -76.37 -12.1 60.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.028 -1.045 . . . . 0.0 112.538 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 90.0 m -68.33 -42.94 78.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.6 67.38 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.323 -1.486 . . . . 0.0 112.287 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -76.58 -18.86 58.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.851 -0.531 . . . . 0.0 111.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.311 13.9 p 68.6 10.31 7.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.616 2.366 . . . . 0.0 111.307 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.23 -53.72 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.14 -46.65 3.67 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 120.838 -1.164 . . . . 0.0 110.554 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 76.91 -67.08 0.22 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 128.187 2.595 . . . . 0.0 109.002 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.69 27.79 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.03 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.36 178.22 7.45 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -156.23 154.62 27.7 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.91 174.5 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.073 2.515 . . . . 0.0 111.465 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.416 HG21 ' H ' ' B' ' 36' ' ' ALA . 2.4 t -95.83 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.914 0.885 . . . . 0.0 111.165 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -128.62 -32.08 2.18 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.448 1.899 . . . . 0.0 107.657 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -92.58 -6.2 50.01 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.769 0.827 . . . . 0.0 108.801 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -35.4 59.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.62 64.44 0.67 Allowed Glycine 0 CA--C 1.468 -2.897 0 N-CA-C 103.12 -3.992 . . . . 0.0 103.12 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -31.79 -16.82 0.0 OUTLIER 'General case' 0 C--N 1.369 1.45 1 C-N-CA 132.816 4.446 . . . . 0.0 117.7 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.46 -15.41 2.69 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.275 -1.516 . . . . 0.0 113.428 158.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.25 -54.6 32.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.171 1.388 . . . . 0.0 107.973 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.1 -46.0 75.55 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.463 -0.773 . . . . 0.0 110.31 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -49.73 -43.12 47.52 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 126.084 1.754 . . . . 0.0 111.393 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.38 -50.02 73.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.442 1.097 . . . . 0.0 110.913 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.84 -43.44 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.597 0.759 . . . . 0.0 109.624 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtm -63.14 -48.8 76.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.373 1.069 . . . . 0.0 110.134 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -71.61 -27.25 62.99 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.289 -0.882 . . . . 0.0 110.813 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.78 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.872 -1.142 . . . . 0.0 109.824 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.82 61.42 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -58.71 -45.56 90.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 C-N-CA 124.035 0.934 . . . . 0.0 110.52 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.55 -27.97 68.83 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.516 -1.365 . . . . 0.0 112.569 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.75 -46.71 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 120.368 -1.458 . . . . 0.0 108.247 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -65.95 -21.57 66.43 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.934 0.894 . . . . 0.0 110.956 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -42.78 16.43 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.619 1.167 . . . . 0.0 110.732 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.8 -40.4 83.96 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.208 1.403 . . . . 0.0 111.031 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 29.2 m -63.33 -8.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 123.836 0.855 . . . . 0.0 112.393 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.7 m -64.72 -12.58 48.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.678 -1.264 . . . . 0.0 110.535 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.96 65.98 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.828 -1.795 . . . . 0.0 112.098 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.51 -37.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.951 -1.093 . . . . 0.0 109.108 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.02 -36.59 64.46 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.417 -0.802 . . . . 0.0 111.267 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.33 -12.82 60.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.847 -1.158 . . . . 0.0 111.187 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -96.88 1.44 50.55 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.945 -1.097 . . . . 0.0 108.974 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.3 -37.3 66.26 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 120.305 1.411 . . . . 0.0 109.017 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -66.74 -30.01 70.13 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 120.289 -1.507 . . . . 0.0 111.406 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.6 -22.95 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.091 1.357 . . . . 0.0 109.6 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.92 -25.31 65.03 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.07 -1.019 . . . . 0.0 111.519 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -8.51 54.04 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.526 -1.359 . . . . 0.0 112.36 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -83.41 -43.63 15.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 120.298 -1.501 . . . . 0.0 107.625 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.67 -43.97 97.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.905 1.282 . . . . 0.0 109.661 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.0 -10.45 59.43 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.598 -0.689 . . . . 0.0 112.329 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -79.02 -35.88 42.04 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.764 -1.21 . . . . 0.0 108.156 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -79.24 -35.63 41.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.03 12.26 62.17 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 21.5 m80 . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.662 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.96 176.15 6.36 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -57.56 -52.4 65.57 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 125.497 1.519 . . . . 0.0 109.4 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -19.99 63.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.691 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.15 -38.67 20.37 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -62.78 -32.2 73.32 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.503 -1.373 . . . . 0.0 112.182 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -64.48 -36.09 83.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.07 0.948 . . . . 0.0 110.936 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -44.73 62.04 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.173 -0.954 . . . . 0.0 109.519 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -66.83 -33.36 75.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.487 0.66 . . . . 0.0 111.345 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.97 -37.51 79.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.672 1.989 . . . . 0.0 111.113 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.01 -38.86 66.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.948 0.899 . . . . 0.0 110.291 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.05 -40.82 90.75 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.084 -1.01 . . . . 0.0 110.962 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.61 -18.03 62.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.298 -0.876 . . . . 0.0 111.728 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -73.83 -38.39 64.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.94 -38.11 89.89 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.249 0.62 . . . . 0.0 110.544 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.26 -24.94 68.09 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.604 -0.685 . . . . 0.0 112.449 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -80.12 -23.75 40.98 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.373 1.469 . . . . 0.0 109.55 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.17 -35.52 20.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 124.46 1.104 . . . . 0.0 108.034 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -60.55 -33.94 73.41 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.88 0.872 . . . . 0.0 111.462 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -60.62 -50.14 74.71 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.663 1.185 . . . . 0.0 110.225 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.38 -41.0 96.93 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 121.573 -0.704 . . . . 0.0 109.995 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.25 87.18 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.536 1.135 . . . . 0.0 110.389 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 83.5 p -62.72 -33.41 75.06 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.63 0.728 . . . . 0.0 112.116 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -80.15 -54.31 5.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.57 -30.79 67.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.772 0.829 . . . . 0.0 109.467 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.95 76.1 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 125.052 1.341 . . . . 0.0 112.736 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.23 -34.21 57.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 O-C-N 120.896 -1.128 . . . . 0.0 110.615 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.61 -40.63 73.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.852 -1.155 . . . . 0.0 109.389 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.6 1.09 Allowed 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.398 1.479 . . . . 0.0 109.53 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.34 -31.4 0.05 Allowed 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 123.694 0.621 . . . . 0.0 109.446 171.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -70.4 81.65 0.56 Allowed 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.224 -1.547 . . . . 0.0 111.915 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.66 -4.24 1.43 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.6 148.1 68.88 Favored Pre-proline 0 N--CA 1.442 -0.867 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -169.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -78.01 81.83 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.141 2.56 . . . . 0.0 113.182 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.68 34.11 3.15 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 146.18 13.89 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 126.813 2.045 . . . . 0.0 112.402 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.46 -46.07 1.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 125.169 1.388 . . . . 0.0 108.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.1 115.81 18.11 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 122.111 0.958 . . . . 0.0 108.603 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.8 163.21 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t 75.28 131.39 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.882 1.273 . . . . 0.0 112.377 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -67.29 -45.82 49.84 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 116.333 -1.794 . . . . 0.0 111.929 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.23 -10.54 27.4 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 CA-C-N 125.208 2.896 . . . . 0.0 113.904 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.361 0.7 OUTLIER -103.66 -19.43 14.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 121.372 1.896 . . . . 0.0 110.408 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.24 73.92 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.086 0.954 . . . . 0.0 112.214 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tp -66.05 -29.97 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.482 -0.762 . . . . 0.0 110.846 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -34.7 55.04 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -58.71 -41.99 87.59 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 122.385 1.088 . . . . 0.0 109.743 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -10.54 55.24 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.761 -1.212 . . . . 0.0 114.006 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.29 -47.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.5 57.56 4.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.607 1.563 . . . . 0.0 110.722 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -160.66 -51.21 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.64 -6.33 51.61 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.398 -1.439 . . . . 0.0 111.373 -170.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -80.52 -7.44 59.2 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.075 2.15 . . . . 0.0 110.459 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.309 34.2 p 76.93 17.76 1.63 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.689 2.396 . . . . 0.0 110.44 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.71 111.55 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.54 0.83 Allowed Glycine 0 CA--C 1.481 -2.075 1 N-CA-C 101.805 -4.518 . . . . 0.0 101.805 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.18 -33.06 38.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.92 -116.49 1.33 Allowed Glycine 0 CA--C 1.479 -2.187 0 N-CA-C 103.269 -3.932 . . . . 0.0 103.269 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.302 43.7 t0 64.13 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.348 0.52 0 C-N-CA 126.686 1.994 . . . . 0.0 109.825 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -128.75 158.96 37.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -161.05 147.0 11.16 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.01 163.62 22.9 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 122.795 2.33 . . . . 0.0 109.65 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.259 8.2 t -98.88 -105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -168.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -134.72 -60.04 0.79 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.371 -2.081 . . . . 0.0 108.827 -162.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -78.26 -6.35 54.72 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.377 1.471 . . . . 0.0 108.881 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.35 -20.77 46.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 C-N-CA 131.827 4.051 . . . . 0.0 108.028 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.69 84.36 0.84 Allowed Glycine 0 CA--C 1.482 -1.982 1 N-CA-C 101.473 -4.651 . . . . 0.0 101.473 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -23.52 24.66 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 110.92 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -57.65 -10.34 1.53 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.83 -41.21 87.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 120.059 1.3 . . . . 0.0 110.297 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.62 -51.09 21.09 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 120.991 -1.068 . . . . 0.0 109.163 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -46.05 -51.34 13.88 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 127.213 2.205 . . . . 0.0 112.966 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.98 -28.14 61.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.594 0.758 . . . . 0.0 110.714 -171.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 68.1 t -74.1 -46.08 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 79.2 mtm -59.98 -42.75 94.86 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.36 0.664 . . . . 0.0 111.231 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -65.37 -27.27 68.45 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 121.706 -0.621 . . . . 0.0 111.649 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.73 71.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.196 -0.94 . . . . 0.0 110.681 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.83 -35.83 61.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.57 -46.57 96.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 108.672 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.0 -50.33 73.76 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.73 -52.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 124.979 1.312 . . . . 0.0 110.379 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.29 -0.7 42.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.247 -0.908 . . . . 0.0 111.337 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.12 -37.58 14.12 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 120.733 -1.23 . . . . 0.0 108.295 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.48 -34.83 76.13 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 125.215 1.406 . . . . 0.0 111.344 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.88 -9.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 C-N-CA 124.079 0.952 . . . . 0.0 113.069 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -59.57 -24.19 63.53 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 125.52 1.528 . . . . 0.0 111.396 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.01 -23.56 66.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.771 -1.206 . . . . 0.0 111.562 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.43 -42.93 13.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.86 -41.59 91.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.44 1.096 . . . . 0.0 112.806 -171.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.75 -5.82 40.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.869 -1.144 . . . . 0.0 111.769 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.14 -8.48 25.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.35 -39.64 74.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.504 1.047 . . . . 0.0 109.305 -167.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -80.31 -15.02 57.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.195 -1.565 . . . . 0.0 113.04 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.16 -27.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.608 -1.308 . . . . 0.0 107.562 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 35.3 ttm105 -55.83 -23.4 30.28 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 126.405 1.882 . . . . 0.0 111.937 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -59.54 -32.67 70.54 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.421 -1.424 . . . . 0.0 111.732 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.69 -23.44 45.6 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.005 -1.059 . . . . 0.0 108.487 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -75.25 -46.84 31.18 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.04 -36.11 76.59 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.729 1.612 . . . . 0.0 111.01 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.86 -44.17 39.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.723 2.009 . . . . 0.0 113.314 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -103.4 -25.03 13.43 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.768 -0.583 . . . . 0.0 110.45 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.32 45.6 5.82 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 106.658 -2.577 . . . . 0.0 106.658 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 . . . . . 0 CA--C 1.506 -0.731 0 O-C-N 121.178 -1.189 . . . . 0.0 109.552 -178.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.434 -1.252 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.33 101.92 0.04 OUTLIER 'General case' 0 C--N 1.351 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 111.175 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.98 -26.0 68.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.463 -1.398 . . . . 0.0 111.56 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.18 -24.86 60.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.259 -0.9 . . . . 0.0 111.308 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -30.2 38.58 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -67.42 -44.77 77.94 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.57 -0.706 . . . . 0.0 110.31 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.49 -38.36 74.34 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.769 -0.582 . . . . 0.0 110.384 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.85 -48.08 80.58 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.939 0.896 . . . . 0.0 111.588 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.02 -35.34 79.7 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.519 -0.738 . . . . 0.0 110.487 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.58 -31.81 73.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.837 0.855 . . . . 0.0 110.496 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.27 97.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.401 -0.812 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -29.69 70.76 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.522 0.677 . . . . 0.0 111.552 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.2 -28.85 66.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 121.251 -0.906 . . . . 0.0 110.42 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -82.47 -23.71 34.58 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.749 -1.219 . . . . 0.0 109.9 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.48 -42.97 99.6 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 120.637 -1.289 . . . . 0.0 110.5 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -59.36 -35.59 74.17 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.435 1.094 . . . . 0.0 112.162 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -66.83 -44.9 79.88 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.611 1.164 . . . . 0.0 108.926 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.24 -38.04 81.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 C-N-CA 124.259 1.023 . . . . 0.0 109.416 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.47 -44.87 81.01 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.642 0.777 . . . . 0.0 112.076 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.89 -43.69 71.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.025 0.53 . . . . 0.0 110.701 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.34 -47.21 80.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.59 1.186 . . . . 0.0 109.825 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.0 -28.68 64.61 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.017 -1.052 . . . . 0.0 111.876 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -74.42 -31.08 62.18 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 119.582 1.083 . . . . 0.0 110.769 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -62.05 -48.02 82.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -63.55 -50.68 68.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.208 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.06 70.06 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 125.291 1.437 . . . . 0.0 113.236 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.44 -35.34 61.59 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 120.947 -1.096 . . . . 0.0 110.59 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -81.78 -22.73 37.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.411 -1.431 . . . . 0.0 110.096 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -52.58 14.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 127.093 2.157 . . . . 0.0 107.778 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.84 -35.73 79.12 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.451 1.12 . . . . 0.0 110.967 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.84 103.51 2.64 Favored 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 120.184 -1.572 . . . . 0.0 111.586 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.41 -25.21 3.65 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 106.231 -2.747 . . . . 0.0 106.231 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 148.27 74.94 Favored Pre-proline 0 N--CA 1.439 -0.999 0 O-C-N 121.675 -0.897 . . . . 0.0 110.228 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 134.88 17.77 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.253 1.969 . . . . 0.0 110.131 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 26.63 61.26 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 137.28 51.26 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.287 1.835 . . . . 0.0 111.416 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.08 -47.08 2.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tt -85.93 71.27 10.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.728 1.251 . . . . 0.0 110.142 -172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -96.61 -6.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 O-C-N 120.159 -1.588 . . . . 0.0 111.205 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.2 p -95.96 141.98 28.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.097 -1.002 . . . . 0.0 110.862 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -89.73 -61.11 0.22 Allowed Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.318 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.25 -5.92 17.26 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 CA-C-N 125.797 3.106 . . . . 0.0 110.818 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.29 -18.56 21.51 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.076 1.751 . . . . 0.0 107.492 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.21 72.32 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 111.083 -168.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.26 -35.34 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 124.115 0.966 . . . . 0.0 110.515 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -36.15 74.23 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -67.95 -41.06 83.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.399 1.095 . . . . 0.0 109.393 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.8 t -60.62 -41.17 94.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.961 -1.087 . . . . 0.0 110.339 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.51 -53.35 31.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 125.432 1.493 . . . . 0.0 110.6 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -76.1 -15.35 60.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.684 -0.635 . . . . 0.0 111.62 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 73.8 m -76.41 -36.82 57.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.45 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.234 -0.916 . . . . 0.0 111.574 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.5 p -87.59 13.15 10.84 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.781 -0.575 . . . . 0.0 110.736 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p 52.56 49.02 21.3 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.296 1.839 . . . . 0.0 114.0 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.11 -55.05 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.87 -44.31 3.22 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 120.52 -1.363 . . . . 0.0 110.014 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.38 -75.72 0.07 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 127.111 2.164 . . . . 0.0 108.29 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.29 37.4 0.02 OUTLIER Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.0 -66.06 0.95 Allowed 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -130.52 -160.81 1.07 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -165.54 150.19 7.73 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.57 161.67 12.6 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.967 3.111 . . . . 0.0 108.707 168.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -154.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-N 119.893 1.224 . . . . 0.0 108.116 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -91.13 -50.07 6.05 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 119.672 -1.893 . . . . 0.0 108.687 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -77.34 -3.23 38.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.076 1.751 . . . . 0.0 110.847 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -29.8 69.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.59 80.23 1.19 Allowed Glycine 0 CA--C 1.468 -2.891 1 N-CA-C 99.1 -5.6 . . . . 0.0 99.1 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -63.16 -1.68 1.09 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.544 1.537 . . . . 0.0 112.613 -166.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -69.46 -13.3 62.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.602 1.161 . . . . 0.0 112.394 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -53.08 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.28 73.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.313 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -63.62 -34.57 78.12 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.718 0.807 . . . . 0.0 111.893 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.7 -37.08 85.99 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.967 -1.083 . . . . 0.0 111.206 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.22 -39.22 82.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 O-C-N 121.067 -1.021 . . . . 0.0 109.893 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 64.5 mtt -62.01 -50.37 72.33 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.67 0.788 . . . . 0.0 110.024 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.71 -30.64 70.93 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.496 -0.752 . . . . 0.0 110.641 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.13 96.12 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.066 -1.021 . . . . 0.0 110.469 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.09 -44.68 95.43 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 124.349 0.976 . . . . 0.0 111.428 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.64 -47.47 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 O-C-N 121.891 -0.77 . . . . 0.0 109.552 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -69.75 -32.82 71.56 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.927 -1.108 . . . . 0.0 113.306 -173.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.41 -42.48 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 110.109 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.14 -36.81 64.18 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 121.634 -0.666 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.28 -23.12 62.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.872 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.55 -32.63 72.7 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.856 -1.778 . . . . 0.0 109.797 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.48 -18.77 21.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 124.792 1.237 . . . . 0.0 110.276 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -60.05 -14.29 15.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 120.809 -1.182 . . . . 0.0 111.663 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.0 2.75 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.37 -1.456 . . . . 0.0 111.24 167.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.7 98.5 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.947 1.299 . . . . 0.0 109.517 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.12 -41.89 89.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 111.915 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.9 -11.45 60.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.978 -1.076 . . . . 0.0 110.356 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -74.72 -26.83 60.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 120.805 -1.184 . . . . 0.0 108.384 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.268 0.6 OUTLIER -80.14 -4.7 54.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 120.317 -1.489 . . . . 0.0 112.818 -160.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -81.78 -29.79 32.6 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 120.674 -1.266 . . . . 0.0 109.337 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.56 -28.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.49 1.116 . . . . 0.0 109.288 -172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -62.72 -12.38 23.45 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.272 -0.893 . . . . 0.0 111.691 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -68.96 -16.55 63.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.434 -0.791 . . . . 0.0 112.37 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -71.32 -45.54 62.75 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.683 -1.261 . . . . 0.0 109.304 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.31 -35.17 80.19 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.736 0.815 . . . . 0.0 110.193 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -60.12 -47.28 86.55 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.893 1.677 . . . . 0.0 110.06 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -63.14 -37.84 88.8 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.818 1.647 . . . . 0.0 110.195 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -75.31 -26.44 58.67 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.348 1.459 . . . . 0.0 110.292 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.11 3.68 79.02 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 124.161 0.886 . . . . 0.0 110.947 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 -177.826 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.19 37.29 0.05 OUTLIER 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 59.26 -80.6 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.692 2.397 . . . . 0.0 111.379 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -9.59 49.75 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.82 -42.1 91.03 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.337 -0.852 . . . . 0.0 109.18 164.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -71.73 -33.06 68.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 O-C-N 120.569 -1.332 . . . . 0.0 110.437 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.47 -38.5 87.46 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.01 93.5 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.502 1.121 . . . . 0.0 111.44 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -63.78 -36.35 83.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.476 1.51 . . . . 0.0 111.216 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -75.02 -23.87 58.25 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 121.361 0.6 . . . . 0.0 110.038 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.65 86.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.448 -2.033 . . . . 0.0 111.1 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -61.31 -37.47 83.37 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.896 0.855 . . . . 0.0 110.978 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.68 -32.86 74.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.47 1.908 . . . . 0.0 110.214 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -78.15 -32.1 50.11 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 120.895 -1.128 . . . . 0.0 109.083 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.27 -43.76 98.35 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.966 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -59.76 -35.89 75.53 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.309 0.644 . . . . 0.0 112.1 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -32.71 73.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.833 0.853 . . . . 0.0 110.908 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.57 -40.08 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.44 -37.26 86.9 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.488 -0.758 . . . . 0.0 110.917 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.19 -39.58 82.45 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.903 -1.123 . . . . 0.0 111.306 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -69.49 -37.84 77.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.715 0.806 . . . . 0.0 109.762 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.83 89.51 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 125.887 1.675 . . . . 0.0 110.746 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m -63.89 -31.68 72.94 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.968 0.907 . . . . 0.0 111.93 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -75.2 -49.56 19.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.387 -0.821 . . . . 0.0 108.826 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -73.98 -22.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.316 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.42 4.58 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 125.202 1.401 . . . . 0.0 108.553 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.6 t -64.01 -28.78 45.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 O-C-N 119.811 -1.805 . . . . 0.0 111.18 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.36 -35.09 77.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.801 -1.187 . . . . 0.0 110.757 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.73 -59.27 2.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.595 1.558 . . . . 0.0 107.804 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.12 -30.67 62.44 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.287 1.835 . . . . 0.0 112.581 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -77.89 87.12 4.09 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.316 -2.115 . . . . 0.0 110.586 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.0 -21.87 1.13 Allowed Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.39 157.9 35.51 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 118.57 1.185 . . . . 0.0 110.598 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -85.97 131.96 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.391 2.061 . . . . 0.0 111.552 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.0 60.34 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.26 137.45 58.26 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.741 1.216 . . . . 0.0 110.853 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.16 -55.97 2.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.594 0.757 . . . . 0.0 109.727 -173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.33 91.25 8.43 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.196 0.998 . . . . 0.0 109.369 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.04 50.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.322 -1.486 . . . . 0.0 109.279 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.97 148.03 23.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.996 -1.69 . . . . 0.0 109.415 170.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -69.97 -45.58 22.87 Favored Pre-proline 0 C--N 1.353 0.726 0 CA-C-O 116.184 -1.865 . . . . 0.0 112.555 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.33 -19.08 33.87 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 125.545 3.016 . . . . 0.0 113.366 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -103.89 -3.91 24.17 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 120.118 1.326 . . . . 0.0 109.91 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.57 85.7 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.347 1.07 . . . . 0.0 110.41 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 45' ' ' ILE . 14.0 tt -68.57 -22.08 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 C-N-CA 124.702 1.201 . . . . 0.0 111.081 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.03 -26.54 26.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.603 -0.685 . . . . 0.0 109.457 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -68.96 -45.15 71.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.9 m -59.28 -12.29 5.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.444 1.098 . . . . 0.0 113.776 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -71.25 -58.22 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 123.999 0.92 . . . . 0.0 108.726 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' B' ' 68' ' ' ARG . 92.2 mt-10 -83.57 75.59 10.02 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.416 -0.802 . . . . 0.0 109.434 -172.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -170.37 -45.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.35 81.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 124.358 1.063 . . . . 0.0 111.97 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 p -96.24 18.37 13.85 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 124.006 0.922 . . . . 0.0 110.652 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.65 62.92 2.21 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 127.104 2.161 . . . . 0.0 115.07 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.77 165.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 1 N-CA-C 95.267 -5.827 . . . . 0.0 95.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' D' ' 57' ' ' TYR . . . -160.65 120.74 0.97 Allowed Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 99.06 -5.616 . . . . 0.0 99.06 170.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -84.8 -17.66 37.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 119.06 1.43 . . . . 0.0 109.071 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.36 21.01 4.93 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 121.129 -0.982 . . . . 0.0 112.886 171.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.27 -39.83 22.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.031 -1.276 . . . . 0.0 112.805 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -147.86 153.05 38.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -162.96 145.14 8.03 Favored Pre-proline 0 C--N 1.354 0.776 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.08 178.77 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 2.965 . . . . 0.0 111.793 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 ' H ' ' A' ' 64' ' ' THR 0.275 9.4 p -119.54 -129.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 125.416 1.486 . . . . 0.0 108.412 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.422 ' H ' HG13 ' A' ' 63' ' ' VAL . 21.1 m -99.45 -57.87 2.06 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 119.493 -2.005 . . . . 0.0 112.069 -160.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -75.41 -9.82 58.91 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 119.182 0.901 . . . . 0.0 109.835 -171.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -71.65 -13.62 61.81 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.672 1.989 . . . . 0.0 108.89 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.5 85.26 0.87 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 100.847 -4.901 . . . . 0.0 100.847 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -56.13 -20.92 19.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.327 1.061 . . . . 0.0 112.22 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.31 -15.74 17.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 118.283 -0.865 . . . . 0.0 113.066 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.01 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.007 1.73 . . . . 0.0 109.325 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.13 -52.75 21.18 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 121.064 -1.023 . . . . 0.0 109.132 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.98 -36.65 79.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.51 -34.88 78.75 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.71 -40.79 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.208 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 53.0 mtt -60.73 -48.38 82.06 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.11 0.964 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -66.08 -33.6 76.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 110.519 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.32 89.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.77 -0.581 . . . . 0.0 110.402 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -45.83 94.86 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 124.047 0.832 . . . . 0.0 111.124 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.84 -47.75 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 124.591 1.156 . . . . 0.0 109.702 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -67.82 -31.58 71.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.784 -1.197 . . . . 0.0 112.254 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 t -66.18 -53.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 O-C-N 121.59 -0.694 . . . . 0.0 109.16 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.24 -19.2 62.39 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 121.403 -0.81 . . . . 0.0 111.358 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.18 40.37 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 120.721 -1.237 . . . . 0.0 109.998 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.44 -43.72 84.14 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.101 1.361 . . . . 0.0 110.474 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 m -68.82 -6.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -59.71 -21.48 60.68 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.491 1.041 . . . . 0.0 110.495 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.89 73.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.794 -1.191 . . . . 0.0 112.433 171.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.88 -37.6 55.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.888 0.875 . . . . 0.0 108.849 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.13 -0.357 . . . . 0.0 111.154 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.15 80.21 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.562 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -7.27 58.4 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 120.889 -1.132 . . . . 0.0 111.878 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -30.69 66.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.59 1.087 . . . . 0.0 109.557 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.85 -27.56 60.31 Favored 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 120.596 -1.315 . . . . 0.0 112.019 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.32 -22.62 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.415 1.086 . . . . 0.0 108.664 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -63.46 -21.61 66.41 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.61 -1.306 . . . . 0.0 111.615 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -71.46 -8.56 54.64 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.469 -1.394 . . . . 0.0 112.094 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.89 -20.07 53.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 120.811 -1.18 . . . . 0.0 110.011 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -106.27 -177.67 3.43 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 69.28 -65.15 0.31 Allowed 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.036 1.734 . . . . 0.0 112.413 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -65.87 -43.99 86.7 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 127.308 2.243 . . . . 0.0 108.182 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -115.57 129.0 56.37 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.37 -8.9 57.26 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 178.888 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . 0.483 . . 11.5 -103.43 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.414 3.086 . . . . 0.0 117.834 -158.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -154.45 -58.79 0.11 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -158.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.42 -26.65 58.53 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.383 1.073 . . . . 0.0 110.326 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -68.11 -32.82 73.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.725 1.61 . . . . 0.0 111.471 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.6 -40.0 80.64 Favored 'General case' 0 CA--C 1.503 -0.848 0 O-C-N 121.881 -0.512 . . . . 0.0 110.071 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.84 -37.87 79.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.08 70.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -67.26 -35.14 78.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.786 -0.571 . . . . 0.0 110.927 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -78.66 -15.22 58.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.96 -1.088 . . . . 0.0 110.771 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.17 72.18 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.564 -1.335 . . . . 0.0 108.917 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -30.45 70.01 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.714 0.805 . . . . 0.0 111.593 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.01 -36.06 81.31 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.738 0.815 . . . . 0.0 110.147 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.59 -33.08 73.44 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 123.441 0.696 . . . . 0.0 109.321 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -63.54 -40.19 96.36 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 121.396 -0.815 . . . . 0.0 110.331 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.72 -41.13 66.69 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 124.32 1.048 . . . . 0.0 111.16 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.57 -41.41 98.39 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.291 0.636 . . . . 0.0 110.875 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.58 -44.39 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 121.727 -0.608 . . . . 0.0 109.416 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tp -53.8 -52.31 60.71 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 128.018 2.527 . . . . 0.0 110.149 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.68 -34.48 64.89 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 121.382 -0.824 . . . . 0.0 110.038 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -68.05 -29.24 68.17 Favored 'General case' 0 C--N 1.355 0.848 0 CA-C-N 120.241 1.382 . . . . 0.0 109.872 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.06 66.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.906 0.882 . . . . 0.0 112.398 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 90.0 p -68.94 -42.72 76.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 O-C-N 121.114 -0.991 . . . . 0.0 110.43 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -38.05 84.87 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.04 -36.44 72.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.259 -0.901 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.61 29.42 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.927 1.291 . . . . 0.0 110.382 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.33 -33.11 52.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 123.954 0.902 . . . . 0.0 111.677 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -83.89 -16.78 43.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.958 0.903 . . . . 0.0 109.647 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.59 70.37 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.186 0.994 . . . . 0.0 109.754 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -65.14 -27.11 68.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 121.806 -0.559 . . . . 0.0 111.822 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.87 83.72 4.97 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.8 -23.74 2.77 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.69 138.67 20.75 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.892 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -82.14 105.72 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.86 2.373 . . . . 0.0 112.916 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.54 47.38 0.15 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.56 137.24 57.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.884 0.873 . . . . 0.0 111.685 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.0 -45.57 0.14 Allowed 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.137 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.38 -63.72 1.0 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.991 0.917 . . . . 0.0 108.807 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . 0.369 40.2 pt 53.8 -127.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 126.173 1.789 . . . . 0.0 112.93 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -13.01 134.85 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 132.236 4.215 . . . . 0.0 121.332 -167.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -65.21 -55.5 25.74 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 116.645 -1.645 . . . . 0.0 115.173 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.03 -5.0 15.87 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 125.076 2.848 . . . . 0.0 110.559 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.8 -42.13 12.78 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.205 1.802 . . . . 0.0 106.834 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -33.69 72.98 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.368 1.467 . . . . 0.0 112.496 -170.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.9 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 121.724 -0.61 . . . . 0.0 110.629 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -29.55 54.42 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.727 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.42 -48.3 61.4 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -60.43 -33.43 72.52 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.773 -1.205 . . . . 0.0 112.952 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.94 -24.81 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.889 1.276 . . . . 0.0 112.537 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.24 -17.93 53.84 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.013 -1.679 . . . . 0.0 109.932 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.447 ' C ' ' H ' ' B' ' 53' ' ' THR . 9.3 t -116.94 -166.17 1.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.71 -21.28 0.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 127.131 2.172 . . . . 0.0 110.846 -167.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.447 ' H ' ' C ' ' B' ' 51' ' ' THR . 2.8 p -93.51 -1.43 55.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.568 2.347 . . . . 0.0 110.759 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.274 0.0 OUTLIER 62.7 61.76 1.16 Allowed 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.308 1.443 . . . . 0.0 110.895 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.437 HG13 ' H ' ' B' ' 56' ' ' GLY . 7.6 p -137.91 -69.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.437 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 74.69 72.75 1.0 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -39.91 86.6 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 122.229 -0.571 . . . . 0.0 110.092 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.0 47.47 1.59 Allowed Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.25 -55.59 8.9 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -110.77 165.03 12.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -108.86 127.74 26.78 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.35 170.83 14.34 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.788 2.325 . . . . 0.0 109.66 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 64' ' ' THR . 1.2 t -92.86 -166.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.594 ' H ' HG12 ' B' ' 63' ' ' VAL . 32.7 m -101.09 -63.71 1.11 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.994 0.918 . . . . 0.0 109.132 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -54.61 -28.64 47.98 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -168.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -146.42 -164.36 1.96 Allowed 'General case' 0 N--CA 1.436 -1.17 1 N-CA-C 97.994 -4.817 . . . . 0.0 97.994 160.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.82 -75.34 1.1 Allowed Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 104.334 -3.506 . . . . 0.0 104.334 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 50' ' ' GLU . 17.1 ttt180 -69.53 -38.63 77.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.953 0.883 . . . . 0.0 109.996 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.13 -17.3 60.95 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.122 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.03 -45.82 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 O-C-N 119.664 -1.897 . . . . 0.0 106.1 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -35.32 64.48 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 126.182 1.793 . . . . 0.0 112.401 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -50.43 -51.95 42.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 126.586 1.954 . . . . 0.0 111.245 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.25 -37.93 88.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.912 0.885 . . . . 0.0 109.508 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.07 -41.63 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 121.727 -0.608 . . . . 0.0 110.575 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.7 mtm -63.15 -54.58 35.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 122.982 0.513 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -69.59 -27.48 65.14 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 121.554 -0.716 . . . . 0.0 111.084 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.73 -45.09 91.47 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 120.457 -1.402 . . . . 0.0 110.228 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.68 76.66 Favored Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 124.148 0.88 . . . . 0.0 111.318 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.5 -49.17 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 C-N-CA 124.842 1.257 . . . . 0.0 109.705 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.31 -21.68 62.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 120.919 -1.113 . . . . 0.0 111.628 -171.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.98 -54.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.44 -31.21 70.36 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.184 -0.947 . . . . 0.0 111.824 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.9 -22.29 61.52 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.656 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.69 -35.45 75.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 120.069 -1.645 . . . . 0.0 108.291 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.71 -17.05 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 125.051 1.34 . . . . 0.0 110.217 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -63.85 -13.39 44.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.938 -1.101 . . . . 0.0 110.937 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.84 68.7 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 110.76 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.69 85.59 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.563 1.145 . . . . 0.0 110.692 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.86 -40.8 79.13 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.217 0.607 . . . . 0.0 109.8 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.65 -22.54 63.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.445 -0.784 . . . . 0.0 110.417 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -75.18 -26.57 59.16 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.048 -1.033 . . . . 0.0 109.027 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.488 -1.383 . . . . 0.0 111.513 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -70.81 -28.5 64.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.288 -1.508 . . . . 0.0 112.012 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.55 -29.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 C-N-CA 125.28 1.432 . . . . 0.0 108.529 -173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -60.58 -28.79 68.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.508 1.523 . . . . 0.0 110.316 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -60.49 -26.16 66.61 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.289 -0.882 . . . . 0.0 111.936 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.08 -27.03 65.25 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.711 -1.243 . . . . 0.0 110.79 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -80.02 -19.95 46.51 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.907 0.483 . . . . 0.0 110.268 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -76.46 -45.51 30.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -61.06 -46.05 92.27 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.689 1.996 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -120.03 123.82 44.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.03 -38.94 3.03 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 CA--C 1.502 -0.892 0 C-N-CA 123.922 0.889 . . . . 0.0 109.743 -173.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 102.456 -3.165 . . . . 0.0 102.456 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.75 156.46 16.32 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.81 -37.14 83.96 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.015 -1.053 . . . . 0.0 109.771 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -65.58 -26.12 67.71 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.435 -0.79 . . . . 0.0 112.151 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -77.75 -37.1 49.9 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -171.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.47 -42.41 99.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 110.569 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -70.45 -33.98 71.91 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.667 -0.645 . . . . 0.0 111.001 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.86 96.79 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -76.38 -20.42 57.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.124 -0.985 . . . . 0.0 112.141 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -70.61 -37.43 73.84 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.214 -0.929 . . . . 0.0 108.767 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.24 81.31 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.554 -0.717 . . . . 0.0 111.054 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -63.24 -36.98 85.46 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -64.52 -41.9 96.11 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 122.282 1.039 . . . . 0.0 108.655 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.15 -32.33 73.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.325 1.45 . . . . 0.0 109.711 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.48 -45.47 87.21 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.671 0.789 . . . . 0.0 110.682 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.81 -23.44 62.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.97 -1.081 . . . . 0.0 111.742 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -65.69 -46.63 78.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.75 . . . . 0.0 110.075 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.15 -25.98 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 121.068 -1.02 . . . . 0.0 110.758 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' C' ' 52' ' ' ALA . 81.8 mt -64.66 -41.38 96.14 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.385 -0.822 . . . . 0.0 111.119 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.4 -33.39 67.12 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.955 0.902 . . . . 0.0 111.531 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -67.62 -45.8 74.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.032 0.933 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.98 62.52 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.072 1.349 . . . . 0.0 110.97 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p -67.16 -39.41 86.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 119.433 1.015 . . . . 0.0 110.275 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -44.22 93.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.604 1.162 . . . . 0.0 108.427 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -67.6 -39.31 84.77 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.563 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.75 87.7 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.676 1.19 . . . . 0.0 111.878 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.93 -31.16 49.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 O-C-N 120.87 -1.144 . . . . 0.0 110.029 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.25 -19.21 43.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.763 0.825 . . . . 0.0 110.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.22 14.43 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.736 1.614 . . . . 0.0 107.024 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -80.29 -0.86 38.38 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.98 0.895 . . . . 0.0 110.869 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -74.42 81.88 1.92 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.816 1.647 . . . . 0.0 110.084 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.1 19.68 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 139.13 54.3 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 121.322 -1.105 . . . . 0.0 108.113 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.447 ' O ' HG11 ' C' ' 63' ' ' VAL . 50.8 Cg_endo -79.22 136.28 12.67 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.355 2.036 . . . . 0.0 110.437 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 4.16 89.34 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 119.529 1.059 . . . . 0.0 111.971 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 129.11 20.17 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 126.896 2.078 . . . . 0.0 114.107 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.34 -38.02 11.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.992 0.901 . . . . 0.0 108.682 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.3 tp -89.27 125.35 35.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 pt -144.45 -22.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -80.22 150.42 30.1 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.726 -0.609 . . . . 0.0 111.894 -171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.46 -64.52 0.3 Allowed Pre-proline 0 C--N 1.35 0.62 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.198 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.86 -26.89 21.89 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 125.691 3.068 . . . . 0.0 109.936 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 -14.89 61.2 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.538 0.735 . . . . 0.0 109.723 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.39 85.15 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.147 -0.971 . . . . 0.0 110.439 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -72.65 -22.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 121.736 -0.603 . . . . 0.0 110.488 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -72.52 -31.08 65.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -74.87 -37.21 62.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.485 -1.385 . . . . 0.0 108.647 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -76.13 64.38 1.96 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.916 1.287 . . . . 0.0 108.594 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -144.95 -67.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.76 -23.29 66.69 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.689 1.196 . . . . 0.0 112.561 -167.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m -68.06 -37.28 81.1 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.567 1.547 . . . . 0.0 110.629 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -77.24 -24.42 51.18 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.549 -0.719 . . . . 0.0 110.138 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 6.9 p -90.98 9.33 31.09 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.778 -0.576 . . . . 0.0 109.796 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 48.63 60.73 3.48 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 126.823 2.049 . . . . 0.0 113.684 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.1 -87.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.91 76.38 1.3 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -73.85 -20.48 60.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.415 -1.05 . . . . 0.0 111.411 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.16 32.66 3.68 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.64 -53.42 22.63 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -147.0 169.02 20.08 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -148.14 148.92 30.99 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.92 163.11 18.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.125 3.217 . . . . 0.0 109.195 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.447 HG11 ' O ' ' C' ' 34' ' ' PRO . 18.8 t -95.44 -102.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 120.437 1.471 . . . . 0.0 111.869 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -154.06 -30.73 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.622 -1.299 . . . . 0.0 109.61 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -101.26 11.74 38.77 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 120.2 -1.562 . . . . 0.0 108.786 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -44.01 88.04 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.74 86.28 1.62 Allowed Glycine 0 N--CA 1.416 -2.67 1 N-CA-C 98.033 -6.027 . . . . 0.0 98.033 -167.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -56.22 -20.04 16.45 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 125.642 1.577 . . . . 0.0 112.278 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -46.02 -28.22 1.12 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 126.677 1.991 . . . . 0.0 113.05 164.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.27 -43.94 95.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.849 -1.157 . . . . 0.0 109.682 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.48 62.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.344 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -51.2 -47.17 62.32 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.099 2.16 . . . . 0.0 111.116 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.37 -41.34 98.8 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.251 1.02 . . . . 0.0 111.329 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -41.41 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 C-N-CA 123.644 0.778 . . . . 0.0 109.635 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 37.6 mtt -58.99 -52.49 65.54 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.903 0.881 . . . . 0.0 110.299 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.58 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.09 82.87 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.412 -0.805 . . . . 0.0 111.403 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.86 -43.51 93.73 Favored Glycine 0 CA--C 1.494 -1.257 0 C-N-CA 124.202 0.906 . . . . 0.0 111.342 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.87 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 O-C-N 121.735 -0.862 . . . . 0.0 109.159 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.18 -47.6 84.72 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.492 -0.755 . . . . 0.0 111.956 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.49 -40.71 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.799 -0.563 . . . . 0.0 111.471 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.97 -38.48 61.66 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.678 0.672 . . . . 0.0 109.745 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.23 82.83 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.54 -36.42 69.24 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.4 -18.38 11.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.915 1.286 . . . . 0.0 111.043 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.6 m -59.23 -23.95 62.75 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.68 -1.887 . . . . 0.0 111.984 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.46 68.06 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.357 -1.465 . . . . 0.0 111.197 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.24 -52.35 7.84 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.33 -34.65 78.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.217 1.007 . . . . 0.0 113.537 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.76 -14.68 62.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.837 -1.164 . . . . 0.0 110.985 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 81.0 p -85.06 -11.16 55.94 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.55 -1.344 . . . . 0.0 110.855 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -17.55 61.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 119.243 0.929 . . . . 0.0 111.065 -169.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -82.24 -34.66 28.74 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.387 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 26.4 t -65.51 -35.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.463 1.505 . . . . 0.0 109.103 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -42.5 -34.89 0.92 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 128.21 2.604 . . . . 0.0 112.976 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -63.71 -27.05 68.94 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.056 -1.028 . . . . 0.0 111.836 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.51 -39.03 77.82 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.03 -36.01 61.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.627 -0.671 . . . . 0.0 109.852 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -69.6 -15.74 63.26 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.407 -0.808 . . . . 0.0 112.11 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -67.0 -31.47 72.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.43 -0.793 . . . . 0.0 110.616 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -74.63 -39.79 61.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.073 -1.017 . . . . 0.0 108.644 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.89 10.23 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 77.7 m80 . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 177.775 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.438 -1.075 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.68 140.48 49.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.613 1.197 . . . . 0.0 111.352 -166.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -74.05 -52.52 12.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.639 2.375 . . . . 0.0 108.513 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -58.89 -29.53 67.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 126.1 1.76 . . . . 0.0 112.686 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.1 -39.75 82.77 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.681 -0.637 . . . . 0.0 109.69 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -68.5 -36.21 78.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.71 -40.55 84.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.28 95.79 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.622 0.769 . . . . 0.0 111.919 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.33 -40.24 74.28 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 123.301 0.641 . . . . 0.0 110.566 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -61.69 -41.21 97.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.489 0.716 . . . . 0.0 110.28 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.21 70.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.117 0.967 . . . . 0.0 111.877 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.27 -37.14 86.28 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.669 -0.645 . . . . 0.0 111.655 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.81 -31.42 64.82 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -67.52 -35.25 78.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.703 0.801 . . . . 0.0 109.764 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.25 -38.41 90.95 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 111.645 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.43 -36.65 76.3 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.883 0.873 . . . . 0.0 110.756 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.46 -44.84 77.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.184 0.994 . . . . 0.0 110.058 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.02 -47.34 90.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.23 -38.36 85.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.923 -0.485 . . . . 0.0 110.455 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.58 -32.19 65.81 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.489 1.04 . . . . 0.0 113.343 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -69.18 -39.73 78.54 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 119.698 -1.877 . . . . 0.0 108.397 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -32.95 74.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -50.46 -52.08 41.29 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 125.769 1.627 . . . . 0.0 111.648 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -65.98 -34.71 78.73 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -84.48 -15.14 47.03 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.243 0.617 . . . . 0.0 110.972 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -44.61 65.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.513 1.125 . . . . 0.0 109.834 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.25 -40.39 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 122.371 1.081 . . . . 0.0 109.423 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.39 -29.81 68.6 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.954 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.92 92.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 125.189 1.396 . . . . 0.0 110.372 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -77.92 -6.32 53.96 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -76.41 90.62 3.25 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 119.9 -1.75 . . . . 0.0 107.188 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.94 -28.83 1.41 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.75 150.31 47.93 Favored Pre-proline 0 N--CA 1.443 -0.79 0 O-C-N 121.397 -1.061 . . . . 0.0 111.133 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.54 97.06 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.792 2.328 . . . . 0.0 112.723 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.35 -41.69 1.31 Allowed Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.23 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.526 2.331 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 72.81 -66.49 0.31 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.7 1.6 . . . . 0.0 112.401 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 49.4 tp -83.37 64.25 7.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.06 112.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 45.4 t -177.57 -141.72 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.9 -63.83 0.01 OUTLIER Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -72.53 -13.94 27.57 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 CA-C-N 125.541 3.015 . . . . 0.0 112.344 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -86.88 -11.06 51.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.04 85.51 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.596 0.758 . . . . 0.0 110.009 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.65 -41.97 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 109.522 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -38.91 83.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.204 -0.935 . . . . 0.0 109.865 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.427 ' HB2' ' HE ' ' D' ' 60' ' ' ARG . 70.4 t90 -66.07 -37.66 86.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.519 0.728 . . . . 0.0 110.499 172.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -36.53 71.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.077 -1.014 . . . . 0.0 109.808 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -54.65 -56.96 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 126.17 1.788 . . . . 0.0 109.578 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -71.66 -17.31 62.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 112.024 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -82.49 -37.01 25.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.691 -1.256 . . . . 0.0 109.237 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.93 73.36 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.422 -0.799 . . . . 0.0 110.739 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -95.44 11.91 31.2 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.683 0.793 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.508 HG22 ' HB2' ' D' ' 75' ' ' MET . 16.5 p 55.29 38.63 30.64 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.32 1.848 . . . . 0.0 112.035 169.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.02 -68.29 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.46 95.69 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.98 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 2.4 t80 -61.21 -32.73 72.5 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.542 1.163 . . . . 0.0 111.288 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.35 39.31 0.15 Allowed Glycine 0 CA--C 1.48 -2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 165.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -90.91 -59.11 2.26 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' D' ' 47' ' ' TRP . 15.8 mtm-85 -138.07 164.85 28.08 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 158.01 36.57 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 -175.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 168.99 19.84 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.253 2.635 . . . . 0.0 109.829 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.57 -93.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.214 0.461 . . . . 0.0 110.292 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -137.73 -81.57 0.35 Allowed 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 129.0 38.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 61.25 -61.87 0.08 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 126.808 2.043 . . . . 0.0 115.566 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . -34.54 -49.63 0.71 Allowed Glycine 0 CA--C 1.488 -1.64 0 C-N-CA 128.917 3.151 . . . . 0.0 114.524 -170.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.221 0.608 . . . . 0.0 112.094 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -71.15 -32.68 69.24 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.609 0.764 . . . . 0.0 109.231 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.41 -51.45 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.09 89.28 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.606 1.162 . . . . 0.0 113.121 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -53.6 -42.32 67.55 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.22 2.208 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -67.55 -39.08 84.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.647 -0.658 . . . . 0.0 110.445 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.64 -48.08 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 O-C-N 121.622 -0.674 . . . . 0.0 110.059 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.508 ' HB2' HG22 ' D' ' 54' ' ' THR . 21.1 ptp -65.82 -37.15 85.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.549 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -64.88 -41.34 95.71 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 121.467 -0.771 . . . . 0.0 110.678 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.154 0.582 . . . . 0.0 110.569 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.06 -46.21 93.89 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 123.633 0.635 . . . . 0.0 112.265 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.84 -43.64 92.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 124.026 0.931 . . . . 0.0 109.983 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -63.9 -41.5 97.68 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.01 -47.13 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 C-N-CA 124.204 1.002 . . . . 0.0 110.679 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -73.3 -10.79 60.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.407 -0.808 . . . . 0.0 111.186 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.81 14.11 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.82 0.848 . . . . 0.0 109.606 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.45 -33.05 74.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.419 1.887 . . . . 0.0 111.041 -174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.93 -7.64 2.11 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 112.724 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 40.3 m -62.01 -20.94 64.44 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.8 63.34 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.248 -1.532 . . . . 0.0 111.401 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.51 -53.72 4.82 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.236 1.014 . . . . 0.0 108.706 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.86 -36.96 70.64 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 124.486 1.114 . . . . 0.0 112.918 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 -22.54 61.49 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.008 -1.058 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 81.7 p -78.37 -17.56 56.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.325 -1.484 . . . . 0.0 109.813 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -69.98 -34.76 73.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.7 0.762 . . . . 0.0 109.453 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.96 -30.4 65.26 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.485 -1.385 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.76 -26.38 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 C-N-CA 124.284 1.033 . . . . 0.0 109.299 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -57.9 -14.92 7.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.83 1.252 . . . . 0.0 113.59 172.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -68.9 -38.56 79.68 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.394 1.092 . . . . 0.0 108.672 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -82.71 167.48 18.16 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 73.15 -51.03 0.71 Allowed 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.937 1.295 . . . . 0.0 111.169 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.68 -42.09 95.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 120.417 -1.427 . . . . 0.0 110.603 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -74.36 -16.96 60.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.374 -0.829 . . . . 0.0 112.129 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -128.85 82.89 2.11 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -170.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.49 -31.03 2.92 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.224 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.36 -70.94 0.67 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -170.97 -64.22 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -61.88 -22.33 65.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.126 1.37 . . . . 0.0 113.449 -173.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -75.73 -22.04 56.94 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.546 -1.346 . . . . 0.0 110.224 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -66.77 -41.92 86.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -60.56 -47.51 85.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.43 96.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 111.545 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -61.23 -45.54 94.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 124.587 1.155 . . . . 0.0 109.493 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -61.57 -36.17 79.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.752 1.221 . . . . 0.0 110.179 -175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.41 72.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -66.95 -30.4 70.53 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.822 -1.174 . . . . 0.0 111.515 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.2 -26.04 55.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.312 -0.868 . . . . 0.0 109.872 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.41 -37.98 74.54 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.81 0.844 . . . . 0.0 109.371 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.36 -40.25 95.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.307 0.575 . . . . 0.0 110.917 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -63.53 -26.36 68.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.3 0.64 . . . . 0.0 112.058 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.83 -41.7 87.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.178 0.991 . . . . 0.0 109.333 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -39.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.524 1.129 . . . . 0.0 108.974 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.88 -42.29 84.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.299 1.04 . . . . 0.0 111.995 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.55 -23.45 58.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.107 0.963 . . . . 0.0 111.309 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.76 -32.27 19.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.789 -1.194 . . . . 0.0 108.348 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.21 73.68 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.525 1.53 . . . . 0.0 111.155 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.8 p -68.11 -39.68 82.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 118.716 0.689 . . . . 0.0 110.115 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -64.1 -49.1 73.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -63.94 -38.44 91.1 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.58 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 119.987 1.267 . . . . 0.0 111.431 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.14 -42.43 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.09 -19.58 59.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.152 -1.592 . . . . 0.0 112.002 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.5 -49.2 27.85 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.555 1.142 . . . . 0.0 108.443 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -58.52 -47.05 85.44 Favored 'General case' 0 CA--C 1.476 -1.9 0 C-N-CA 124.344 1.058 . . . . 0.0 110.646 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -63.45 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.17 0.988 . . . . 0.0 111.995 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.28 2.58 5.92 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.29 128.56 38.08 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 118.731 1.265 . . . . 0.0 108.771 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.44 146.01 17.04 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.402 2.068 . . . . 0.0 109.499 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.6 -18.88 47.71 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 118.972 0.805 . . . . 0.0 112.311 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.05 164.4 26.67 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.261 1.425 . . . . 0.0 112.888 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.04 2.44 3.63 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.18 0.592 . . . . 0.0 111.999 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 52.93 1.89 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 120.31 -1.494 . . . . 0.0 111.408 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -84.4 164.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.02 -1.675 . . . . 0.0 109.766 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.9 t 81.29 129.59 0.05 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.939 1.696 . . . . 0.0 110.686 166.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -67.39 -47.65 47.83 Favored Pre-proline 0 C--N 1.358 0.936 0 CA-C-O 116.213 -1.851 . . . . 0.0 112.152 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.26 -11.59 30.45 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 125.482 2.993 . . . . 0.0 111.892 -175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.63 -48.09 9.21 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.342 1.457 . . . . 0.0 107.248 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.29 74.05 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 125.103 1.361 . . . . 0.0 112.533 -174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.63 -30.39 48.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 O-C-N 121.685 -0.635 . . . . 0.0 111.145 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -33.34 55.68 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.777 -1.202 . . . . 0.0 108.967 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.0 -34.38 78.29 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.328 0.651 . . . . 0.0 110.297 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -56.3 -38.45 71.27 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 120.788 -1.195 . . . . 0.0 111.769 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.67 60.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -158.29 -36.37 0.07 Allowed 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 51' ' ' THR . 1.8 t -67.57 -33.78 75.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.825 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.27 -21.94 65.68 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.613 -1.305 . . . . 0.0 112.791 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.23 4.22 52.84 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.281 0.632 . . . . 0.0 109.97 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 p 48.46 47.31 20.29 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 127.139 2.176 . . . . 0.0 112.184 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -100.37 -69.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 85.63 72.87 1.29 Allowed Glycine 0 CA--C 1.492 -1.396 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -19.08 52.83 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.76 5.25 Favored Glycine 0 CA--C 1.486 -1.755 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -71.49 -46.09 60.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -132.01 165.2 24.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -140.09 130.8 14.08 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 100.804 -3.776 . . . . 0.0 100.804 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -86.11 176.22 5.26 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.721 2.947 . . . . 0.0 109.168 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.13 -142.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-O 123.103 1.43 . . . . 0.0 107.744 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 p -92.14 -43.63 9.25 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 119.657 -1.902 . . . . 0.0 111.094 -165.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.85 -29.56 70.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 127.799 2.44 . . . . 0.0 110.218 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.73 -24.65 67.63 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.71 2.004 . . . . 0.0 109.975 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.85 88.81 0.57 Allowed Glycine 0 CA--C 1.476 -2.366 1 N-CA-C 101.052 -4.819 . . . . 0.0 101.052 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.47 -17.81 2.26 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-O 123.291 1.519 . . . . 0.0 113.096 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -63.26 -14.68 52.18 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 125.071 1.348 . . . . 0.0 112.378 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.73 -45.01 99.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 CA-C-N 119.77 1.168 . . . . 0.0 108.592 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.72 67.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.837 -0.539 . . . . 0.0 110.046 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -48.84 -46.26 41.92 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.631 1.572 . . . . 0.0 110.908 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.73 -38.81 92.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.396 1.078 . . . . 0.0 111.725 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.97 -42.0 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 121.352 -0.842 . . . . 0.0 108.928 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.3 mtm -61.81 -46.07 91.11 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.103 0.561 . . . . 0.0 111.093 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -63.72 -38.66 91.93 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.812 -0.555 . . . . 0.0 110.953 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.19 90.91 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.937 0.495 . . . . 0.0 110.911 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.05 92.46 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 124.225 0.917 . . . . 0.0 111.104 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.91 -46.81 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.448 1.099 . . . . 0.0 109.14 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.33 -37.84 84.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 121.069 -1.02 . . . . 0.0 111.993 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.49 -56.65 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 109.598 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.1 -41.51 98.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.362 0.665 . . . . 0.0 110.835 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.7 -34.63 78.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.75 0.82 . . . . 0.0 111.113 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -66.64 -30.85 71.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.472 -1.392 . . . . 0.0 111.063 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.73 -12.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 110.829 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -58.35 -22.8 54.82 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.597 -1.939 . . . . 0.0 112.652 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.23 -24.99 61.12 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.893 -1.129 . . . . 0.0 111.685 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.83 -40.58 9.26 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.871 1.268 . . . . 0.0 110.969 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.7 -39.8 91.6 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.818 0.818 . . . . 0.0 111.126 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -28.05 62.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.008 -1.057 . . . . 0.0 110.984 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -71.89 -10.52 59.89 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.223 -1.548 . . . . 0.0 111.563 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.77 -38.51 86.72 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 122.235 1.016 . . . . 0.0 109.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -81.4 -11.83 59.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 119.355 -2.09 . . . . 0.0 112.967 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.36 -27.48 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.4 -27.36 47.22 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.56 1.544 . . . . 0.0 113.053 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -64.76 -21.32 66.74 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-O 122.038 0.923 . . . . 0.0 111.825 -172.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.2 -34.47 28.95 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 125.77 1.628 . . . . 0.0 108.223 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -91.26 -162.67 0.94 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 61.59 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.356 0.852 0 C-N-CA 127.209 2.203 . . . . 0.0 111.632 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -62.7 -39.06 92.81 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.977 2.511 . . . . 0.0 110.271 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -90.87 -1.46 57.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.858 -0.526 . . . . 0.0 109.902 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.11 70.08 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 124.97 1.271 . . . . 0.0 113.911 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.0 m80 . . . . . 0 CA--C 1.493 -1.236 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 -170.15 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 -112.63 0.03 OUTLIER 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -115.65 -69.98 0.82 Allowed 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.807 1.243 . . . . 0.0 108.102 -173.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.521 ' HD2' ' HA ' ' B' ' 88' ' ' ALA . 13.0 p-80 -61.69 -26.65 68.16 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 128.741 2.816 . . . . 0.0 112.039 -174.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.517 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 8.9 mt-10 -75.04 -28.57 60.49 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.674 1.19 . . . . 0.0 110.348 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.88 -35.87 64.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.092 -1.005 . . . . 0.0 109.898 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.99 -31.18 69.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 122.011 0.91 . . . . 0.0 109.418 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.02 86.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.815 0.846 . . . . 0.0 110.67 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -71.96 -36.44 69.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.893 -0.505 . . . . 0.0 110.092 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -58.15 -35.99 72.35 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.415 1.486 . . . . 0.0 110.991 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.89 89.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.488 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.36 -36.62 83.36 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 120.928 -1.108 . . . . 0.0 110.658 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -66.5 -36.68 83.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.666 -0.646 . . . . 0.0 110.222 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -63.44 -42.92 98.69 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.785 1.234 . . . . 0.0 109.528 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.62 -37.21 72.91 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-O 121.804 0.811 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.8 -21.35 62.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.164 -0.96 . . . . 0.0 112.029 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -78.19 -30.28 48.91 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.15 -0.969 . . . . 0.0 108.883 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.32 -32.4 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 120.455 -1.403 . . . . 0.0 109.214 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.94 -36.55 77.29 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.217 -0.927 . . . . 0.0 111.949 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.27 -46.53 83.27 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.663 1.185 . . . . 0.0 109.782 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -70.61 -41.03 72.8 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 108.225 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 126.812 2.045 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 -49.96 75.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.145 1.378 . . . . 0.0 109.924 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -67.21 -46.42 73.93 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -61.69 -44.98 95.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.55 -53.15 52.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.72 -37.0 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -92.79 -1.05 57.12 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.887 -1.133 . . . . 0.0 110.895 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.72 -46.96 8.59 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.25 -24.47 59.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.954 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -74.48 108.83 7.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.198 -1.563 . . . . 0.0 111.242 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.96 -21.83 5.21 Favored Glycine 0 CA--C 1.495 -1.181 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.03 152.87 53.95 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.022 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.53 146.54 19.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.628 2.219 . . . . 0.0 110.492 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 34.87 89.47 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 124.092 0.853 . . . . 0.0 111.303 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 134.16 45.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.066 0.947 . . . . 0.0 109.474 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.34 -39.53 1.87 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.358 . . . . 0.0 109.87 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 tp -68.46 -33.29 73.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.956 . . . . 0.0 110.574 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 tt -41.47 76.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 1 C-N-CA 131.979 4.112 . . . . 0.0 116.94 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.84 136.11 7.81 Favored 'General case' 0 CA--C 1.494 -1.185 0 O-C-N 119.24 -2.162 . . . . 0.0 105.409 166.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -64.68 -54.21 38.08 Favored Pre-proline 0 C--N 1.349 0.559 0 CA-C-O 116.849 -1.548 . . . . 0.0 111.728 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.7 -16.87 23.56 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.007 2.824 . . . . 0.0 110.695 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -94.39 -22.9 18.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.62 76.43 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.092 1.357 . . . . 0.0 108.73 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.41 -27.55 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.197 0.522 . . . . 0.0 110.992 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.07 55.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -76.18 -33.58 59.31 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 123.37 0.668 . . . . 0.0 109.573 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -54.42 -29.77 50.32 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.955 -1.091 . . . . 0.0 112.042 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.01 -40.45 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 124.926 1.291 . . . . 0.0 110.356 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.95 -20.78 66.32 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.841 1.657 . . . . 0.0 112.139 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.07 -38.7 6.84 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -164.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -29.05 65.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.774 -1.204 . . . . 0.0 111.766 -170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -86.91 1.01 54.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.704 -0.623 . . . . 0.0 110.329 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.8 p 55.03 50.72 14.8 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 125.968 1.707 . . . . 0.0 110.984 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -103.44 -59.34 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.64 48.04 64.71 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 120.857 -1.152 . . . . 0.0 112.331 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -29.26 69.86 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.443 1.116 . . . . 0.0 112.393 -168.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.97 29.11 2.26 Favored Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.5 -63.94 0.96 Allowed 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.044 -0.68 . . . . 0.0 110.182 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -138.86 163.33 32.55 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -134.92 148.67 67.91 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.05 165.65 21.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 123.55 2.834 . . . . 0.0 110.421 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.91 -154.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -95.15 -54.52 3.4 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.546 1.138 . . . . 0.0 108.746 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.4 -4.7 46.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.576 1.551 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.17 -28.77 68.39 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.852 1.31 . . . . 0.0 107.817 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.38 87.5 1.02 Allowed Glycine 0 CA--C 1.479 -2.159 1 N-CA-C 101.074 -4.811 . . . . 0.0 101.074 -170.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -59.96 -12.0 6.93 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.235 1.518 . . . . 0.0 111.5 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -54.95 -17.93 4.35 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.469 1.908 . . . . 0.0 113.029 164.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -52.85 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 O-C-N 120.493 -1.38 . . . . 0.0 107.315 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.51 92.07 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.471 0.708 . . . . 0.0 110.633 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -49.76 -46.55 50.73 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.955 1.702 . . . . 0.0 111.235 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -62.95 -40.19 96.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.289 1.036 . . . . 0.0 111.301 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.62 -41.44 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.0 mtm -62.64 -45.67 91.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.383 0.673 . . . . 0.0 110.029 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.38 -36.35 83.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 121.502 -0.749 . . . . 0.0 111.364 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.89 89.08 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.48 0.712 . . . . 0.0 110.669 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.16 -45.15 92.6 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.59 -42.78 89.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 C-N-CA 124.109 0.964 . . . . 0.0 109.706 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -60.42 -42.78 96.74 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.078 -1.014 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 t -64.81 -52.35 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.389 1.076 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.63 -13.63 61.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 121.597 -0.689 . . . . 0.0 111.528 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.34 -36.87 14.4 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.327 -0.858 . . . . 0.0 109.88 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.1 -33.19 74.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.038 1.335 . . . . 0.0 110.41 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.06 -10.32 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 121.491 -0.756 . . . . 0.0 112.3 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -58.66 -18.89 34.5 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.871 1.669 . . . . 0.0 110.618 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.62 -65.07 0.63 Allowed 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.709 -1.245 . . . . 0.0 109.673 165.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' B' ' 4' ' ' HIS . . . -68.67 -42.03 78.45 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 120.775 -1.203 . . . . 0.0 111.3 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.5 -33.93 76.1 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.357 0.663 . . . . 0.0 111.195 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.03 -23.86 33.05 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.436 -1.415 . . . . 0.0 110.784 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.5 m -69.04 -21.81 64.08 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.293 -1.505 . . . . 0.0 108.392 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.28 -39.96 84.59 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.184 -0.947 . . . . 0.0 110.843 -164.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.48 ' CE1' HG21 ' C' ' 94' ' ' VAL . 10.0 p90 -65.73 -23.99 66.87 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.441 -0.787 . . . . 0.0 112.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -79.04 -20.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -68.01 -16.23 63.95 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.496 -1.377 . . . . 0.0 110.377 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -67.38 -2.0 5.57 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.824 -0.548 . . . . 0.0 112.422 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -55.36 -50.15 70.44 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 120.917 -1.114 . . . . 0.0 110.085 163.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.8 -34.89 51.92 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -172.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.13 -33.44 75.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.42 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -65.09 -42.0 94.46 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.207 -0.933 . . . . 0.0 110.998 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -83.92 -26.61 29.18 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 121.692 -0.63 . . . . 0.0 109.982 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.75 15.12 66.24 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 175.253 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.42 58.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 46.01 50.86 11.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 128.912 2.885 . . . . 0.0 110.178 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.445 ' CD2' HG21 ' C' ' 91' ' ' THR . 34.2 p80 -174.07 -50.24 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -69.07 -39.32 79.16 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.976 1.31 . . . . 0.0 110.518 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -54.7 -51.85 64.26 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.762 2.025 . . . . 0.0 110.733 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -75.05 -30.28 60.97 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.34 93.7 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.929 -1.107 . . . . 0.0 111.256 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -71.04 -36.67 72.43 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.609 -0.682 . . . . 0.0 110.886 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.1 -38.03 89.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.86 0.864 . . . . 0.0 110.548 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.3 86.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.499 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.41 -40.32 86.31 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.251 0.62 . . . . 0.0 110.813 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -70.34 -22.83 62.76 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.537 -0.727 . . . . 0.0 111.937 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.26 -32.2 58.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.113 -0.992 . . . . 0.0 108.683 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.48 -40.22 95.27 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.622 -0.674 . . . . 0.0 110.443 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -58.44 -38.31 77.23 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 112.048 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -66.66 -42.26 86.91 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.96 -40.34 85.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 124.39 1.076 . . . . 0.0 109.515 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.24 -42.65 77.69 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 124.124 0.969 . . . . 0.0 112.571 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.22 -42.84 75.17 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.413 -0.804 . . . . 0.0 110.058 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.45 -36.02 73.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.52 0.728 . . . . 0.0 109.607 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.39 83.67 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 126.191 1.796 . . . . 0.0 111.35 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 24.1 m -64.8 -39.24 93.26 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.495 0.718 . . . . 0.0 110.761 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -71.28 -44.4 65.29 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -68.35 -45.66 72.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.543 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.32 94.41 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 120.041 1.292 . . . . 0.0 111.532 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.51 -41.09 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 121.564 -0.71 . . . . 0.0 109.934 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.47 -22.78 43.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.342 -0.849 . . . . 0.0 110.146 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.3 71.78 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 125.026 1.33 . . . . 0.0 109.147 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.22 -23.81 62.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.256 0.622 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -71.07 87.61 0.77 Allowed 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.61 1.85 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.35 141.72 57.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 117.511 0.655 . . . . 0.0 111.483 -168.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 134.45 7.51 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 122.149 1.899 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.79 19.84 60.79 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.69 140.19 56.77 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 109.971 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.6 -42.82 3.39 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.417 HD21 ' CG ' ' C' ' 47' ' ' TRP . 2.0 mt -83.72 17.37 2.31 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.4 1.88 . . . . 0.0 110.523 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -75.48 76.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.054 1.407 . . . . 0.0 110.183 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.8 m -143.3 -123.38 0.09 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . 0.28 1.5 t80 173.56 -58.12 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.91 0 C-N-CA 128.755 2.822 . . . . 0.0 106.557 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.04 -18.21 31.22 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 CA-C-N 126.451 3.34 . . . . 0.0 112.838 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.426 ' CG ' HH12 ' C' ' 60' ' ' ARG . 31.3 p30 -106.1 14.97 27.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 119.398 0.999 . . . . 0.0 109.007 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.06 -35.87 66.78 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.937 -1.102 . . . . 0.0 108.761 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.404 ' O ' HG23 ' C' ' 49' ' ' VAL . 20.1 tt -67.28 -29.32 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 123.57 0.748 . . . . 0.0 110.162 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -64.32 -45.83 86.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.895 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CG ' HD21 ' C' ' 38' ' ' LEU . 76.0 t90 -69.41 -37.1 77.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.971 0.908 . . . . 0.0 108.919 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -56.26 -44.02 79.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.27 1.028 . . . . 0.0 111.538 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 45' ' ' ILE . 3.3 t -68.94 -38.98 79.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 O-C-N 120.739 -1.226 . . . . 0.0 111.73 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.17 -30.01 68.14 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 120.138 1.335 . . . . 0.0 110.861 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -61.23 -43.72 98.42 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.645 1.178 . . . . 0.0 109.866 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.42 65.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.945 -1.097 . . . . 0.0 112.26 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -87.26 4.19 43.66 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.419 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.2 p 57.63 29.32 17.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.426 1.49 . . . . 0.0 112.655 169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.411 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -94.5 -85.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.411 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 82.1 86.12 0.74 Allowed Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -73.44 -22.25 60.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.001 -1.294 . . . . 0.0 109.343 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 35.57 2.86 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.73 -47.74 51.78 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' C' ' 43' ' ' ASP . 69.6 mtt180 -140.98 173.44 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.39 148.85 21.61 Favored Pre-proline 0 N--CA 1.435 -1.217 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.54 171.26 12.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.888 3.059 . . . . 0.0 109.14 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.6 -109.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 119.392 0.996 . . . . 0.0 112.271 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 45.0 m -150.22 -40.53 0.13 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -82.78 -6.35 59.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.447 0.699 . . . . 0.0 110.007 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -31.84 66.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.23 56.47 0.93 Allowed Glycine 0 CA--C 1.472 -2.595 0 N-CA-C 104.564 -3.414 . . . . 0.0 104.564 167.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -22.22 -21.28 0.0 OUTLIER 'General case' 0 C--N 1.366 1.325 1 C-N-CA 134.048 4.939 . . . . 0.0 118.947 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -19.16 5.74 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 119.625 -1.922 . . . . 0.0 112.751 159.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.84 -45.67 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 119.549 1.068 . . . . 0.0 109.577 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -47.71 58.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.504 -0.747 . . . . 0.0 109.205 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.61 -47.95 58.07 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 124.757 1.223 . . . . 0.0 110.771 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -67.35 -33.87 76.15 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.94 -0.475 . . . . 0.0 111.716 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.02 -44.22 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 121.33 -0.856 . . . . 0.0 109.01 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 67.0 mtm -63.5 -46.8 84.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.25 1.02 . . . . 0.0 110.027 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -64.5 -40.7 96.14 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.51 0.724 . . . . 0.0 110.814 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.27 84.03 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.456 0.702 . . . . 0.0 111.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.2 -48.15 77.74 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -58.43 -46.41 89.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 124.532 1.133 . . . . 0.0 109.842 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -59.55 -45.14 92.66 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.909 0.884 . . . . 0.0 111.19 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.91 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.568 1.147 . . . . 0.0 109.966 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -66.39 -37.46 85.3 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.636 -0.665 . . . . 0.0 110.815 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.16 73.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.754 0.822 . . . . 0.0 110.596 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.46 -34.03 73.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.892 1.277 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.88 -12.05 3.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 125.433 1.493 . . . . 0.0 111.43 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -59.38 -25.66 64.45 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 112.449 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 -23.92 66.96 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-O 122.601 1.191 . . . . 0.0 111.618 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.73 -30.39 20.36 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.531 -1.355 . . . . 0.0 109.791 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.82 -49.86 13.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.888 0.851 . . . . 0.0 110.698 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.42 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.954 -1.091 . . . . 0.0 112.34 -170.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.445 HG21 ' CD2' ' C' ' 4' ' ' HIS . 13.0 t -72.86 -12.57 61.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 120.325 -1.485 . . . . 0.0 110.239 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -88.34 3.16 50.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.531 1.059 . . . . 0.0 110.531 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -34.65 18.69 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 160.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' B' ' 93' ' ' PHE . 38.7 t -72.01 -29.74 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 O-C-N 121.059 -1.025 . . . . 0.0 110.434 -171.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -61.24 -14.21 24.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -64.92 -32.27 73.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.101 -0.999 . . . . 0.0 110.689 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -73.23 -34.88 66.13 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.269 0.941 . . . . 0.0 108.782 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.02 -46.89 82.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 109.606 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -70.84 -38.66 73.22 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.855 -0.528 . . . . 0.0 110.749 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -57.31 -41.88 80.72 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.721 1.208 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -73.51 -29.02 62.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.759 -0.588 . . . . 0.0 111.014 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.23 50.07 Favored Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 . . . . . 0 CA--C 1.493 -1.25 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.029 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 170.63 18.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.84 -59.55 2.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 131.118 3.767 . . . . 0.0 108.466 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 17.2 p-80 -60.1 -33.14 71.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.79 2.836 . . . . 0.0 112.011 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.05 -36.19 81.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.09 0.956 . . . . 0.0 109.862 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtp-105 -71.07 -38.35 72.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.423 -0.798 . . . . 0.0 110.511 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.22 -26.25 61.07 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.81 79.52 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.757 -1.214 . . . . 0.0 110.801 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -68.34 -29.38 68.1 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.216 -0.928 . . . . 0.0 111.708 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -64.1 -42.62 96.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 109.691 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.77 88.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.721 0.808 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.31 -38.38 83.5 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.787 -0.57 . . . . 0.0 111.717 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.97 -36.72 78.2 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.43 -26.77 67.38 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.316 -0.865 . . . . 0.0 110.799 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.21 -36.47 77.3 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 120.944 -1.097 . . . . 0.0 111.06 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -64.16 -31.91 73.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.196 0.999 . . . . 0.0 110.865 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.04 1.336 . . . . 0.0 110.109 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.6 -33.45 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.98 -40.65 89.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.685 0.794 . . . . 0.0 110.91 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.3 -43.2 78.19 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.176 0.591 . . . . 0.0 111.192 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.18 -38.99 86.33 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.95 75.55 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 124.607 1.163 . . . . 0.0 111.438 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -60.05 -46.74 88.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.163 0.892 . . . . 0.0 111.364 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -68.86 -51.72 37.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.927 1.691 . . . . 0.0 108.207 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -68.88 -43.83 74.51 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.942 0.897 . . . . 0.0 110.309 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.24 75.14 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 119.555 1.07 . . . . 0.0 110.72 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.55 -36.14 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.746 0.784 . . . . 0.0 109.314 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.49 -22.8 54.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 121.429 -0.794 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.64 -36.65 83.5 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 126.271 1.828 . . . . 0.0 110.486 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' D' ' 36' ' ' ALA . 0.6 OUTLIER -75.72 -16.03 60.21 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.412 -174.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -85.63 85.12 7.43 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.281 -1.512 . . . . 0.0 107.636 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.92 -33.66 0.56 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 105.117 -3.193 . . . . 0.0 105.117 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.37 149.16 57.47 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 124.225 1.01 . . . . 0.0 111.565 -171.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.82 97.89 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.888 2.392 . . . . 0.0 113.528 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.32 47.74 0.45 Allowed Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' D' ' 30' ' ' GLU . . . -54.8 106.61 0.23 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.572 1.149 . . . . 0.0 113.494 -169.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.98 -59.34 1.93 Allowed 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 109.64 -169.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' D' ' 47' ' ' TRP . 3.4 tt -84.55 63.07 7.67 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.7 tt -96.23 -6.08 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.116 -1.615 . . . . 0.0 109.082 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -88.57 120.98 30.47 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.672 0.789 . . . . 0.0 111.687 -171.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -74.4 -59.14 1.68 Allowed Pre-proline 0 C--N 1.353 0.73 0 CA-C-O 116.05 -1.929 . . . . 0.0 112.506 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.45 -14.13 30.69 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 CA-C-N 125.941 3.157 . . . . 0.0 110.906 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.31 -11.7 42.68 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 124.196 0.998 . . . . 0.0 109.471 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.2 67.32 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 120.872 -1.143 . . . . 0.0 110.384 -170.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -16.24 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.061 1.41 . . . . 0.0 109.225 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -76.64 -51.85 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 119.794 -1.816 . . . . 0.0 106.566 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.449 ' CD2' HD11 ' D' ' 38' ' ' LEU . 74.4 t90 -55.44 -46.12 76.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.117 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -64.82 -16.91 63.73 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.17 -50.97 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.07 65.64 9.19 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -159.55 -52.64 0.06 Allowed 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -18.45 64.94 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.43 -0.794 . . . . 0.0 112.042 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -87.06 -3.6 59.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.116 1.766 . . . . 0.0 111.057 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 56.15 38.4 29.82 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 125.544 1.538 . . . . 0.0 111.149 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.61 -37.58 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 121.771 -0.581 . . . . 0.0 110.905 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.34 -81.61 0.29 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.08 142.03 52.7 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.75 34.55 0.68 Allowed Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.21 -59.86 0.5 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.288 2.235 . . . . 0.0 109.011 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -97.28 156.24 16.52 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -142.55 148.26 46.14 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -80.36 167.77 19.02 Favored 'Trans proline' 0 CA--C 1.503 -1.057 0 C-N-CA 122.59 2.193 . . . . 0.0 110.266 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' D' ' 64' ' ' THR . 4.1 t -97.56 -150.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 174.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' D' ' 63' ' ' VAL . 4.6 p -91.23 -60.09 1.99 Allowed 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.755 -1.84 . . . . 0.0 112.541 -162.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -75.07 129.73 38.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 58.08 -104.78 0.23 Allowed 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.54 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 42.35 -82.19 0.0 OUTLIER Glycine 0 C--N 1.357 1.705 0 C-N-CA 130.006 3.669 . . . . 0.0 112.579 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -72.13 -32.53 67.02 Favored 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 126.074 1.75 . . . . 0.0 112.025 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.5 -24.11 65.54 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.155 1.343 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -78.8 -50.58 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.9 -39.7 71.98 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 111.919 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.88 -48.89 21.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 128.497 2.719 . . . . 0.0 112.055 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.69 -38.35 76.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.428 0.691 . . . . 0.0 110.132 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.12 -45.03 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 C-N-CA 124.181 0.993 . . . . 0.0 109.39 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -61.7 -45.64 93.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.298 1.039 . . . . 0.0 110.867 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.21 -41.59 93.36 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 110.857 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -36.72 84.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.388 0.675 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.64 64.12 Favored Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 123.979 0.799 . . . . 0.0 111.297 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.62 -46.36 90.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 124.203 1.001 . . . . 0.0 109.768 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -61.87 -30.52 70.92 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.421 1.088 . . . . 0.0 113.046 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 t -74.31 -50.43 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.56 -44.15 97.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.453 0.701 . . . . 0.0 109.999 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.33 -23.32 63.77 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.929 0.891 . . . . 0.0 111.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.89 -30.63 68.12 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.147 -1.595 . . . . 0.0 109.355 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -61.83 -13.42 9.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.411 1.084 . . . . 0.0 110.385 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.5 m -58.89 -20.68 53.64 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 119.537 -1.977 . . . . 0.0 112.596 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.37 68.5 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.983 -1.698 . . . . 0.0 111.445 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -86.15 -35.97 19.82 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.14 0.976 . . . . 0.0 109.643 175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 mt -73.16 -44.75 59.5 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.426 0.631 . . . . 0.0 112.197 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.19 70.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.835 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -73.31 -6.48 46.38 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.067 -1.021 . . . . 0.0 110.607 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.82 -14.62 58.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.692 1.133 . . . . 0.0 110.739 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -33.1 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 119.842 1.201 . . . . 0.0 108.726 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.97 -29.12 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.294 1.038 . . . . 0.0 109.594 -174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -68.39 -12.08 60.6 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.335 -0.853 . . . . 0.0 111.793 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -61.62 -37.12 82.79 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.265 1.031 . . . . 0.0 110.146 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.03 -27.29 48.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 119.862 -1.774 . . . . 0.0 109.572 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -83.31 -29.4 28.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.617 -0.677 . . . . 0.0 109.624 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.56 -44.36 76.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.888 2.075 . . . . 0.0 109.494 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -58.79 -25.7 63.36 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 124.909 1.284 . . . . 0.0 112.658 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -72.05 -49.03 39.98 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.81 -8.78 54.78 Favored Glycine 0 CA--C 1.493 -1.294 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 m80 . . . . . 0 CA--C 1.505 -0.753 0 C-N-CA 125.849 1.659 . . . . 0.0 108.331 -173.025 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 121.701 0.763 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.37 -93.21 0.1 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.11 -71.97 0.4 Allowed 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.1 -23.96 67.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -75.82 -26.42 57.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 109.624 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -64.89 -44.99 87.85 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.32 1.048 . . . . 0.0 108.445 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.21 -40.54 90.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.033 1.333 . . . . 0.0 109.781 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.54 91.72 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 110.844 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.51 -28.14 64.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.62 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -68.49 -34.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.9 90.35 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.343 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.82 -31.9 73.0 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.394 -0.816 . . . . 0.0 111.975 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.93 -41.45 97.63 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.96 0.904 . . . . 0.0 109.392 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -65.74 -34.33 77.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.499 1.119 . . . . 0.0 109.63 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.28 -44.91 94.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.738 0.815 . . . . 0.0 111.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -62.77 -38.21 89.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.238 0.542 . . . . 0.0 111.082 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.18 -37.66 88.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.926 0.89 . . . . 0.0 110.363 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.98 -41.62 84.75 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 C-N-CA 124.127 0.971 . . . . 0.0 108.885 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.2 -45.01 79.98 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.941 0.896 . . . . 0.0 111.802 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -75.2 -24.74 57.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.945 0.898 . . . . 0.0 111.285 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -81.0 -37.93 28.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.63 76.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.459 1.504 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -66.76 -39.7 87.98 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 119.394 0.997 . . . . 0.0 109.79 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.14 -48.45 70.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.733 -0.604 . . . . 0.0 110.174 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -60.81 -48.44 81.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 121.399 -0.813 . . . . 0.0 110.381 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.81 80.15 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.272 1.429 . . . . 0.0 111.903 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.3 -43.45 98.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 O-C-N 121.281 -0.887 . . . . 0.0 110.356 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.36 -29.3 57.14 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.352 -0.843 . . . . 0.0 110.46 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.0 71.76 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.479 1.512 . . . . 0.0 108.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.578 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.3 tp10 -69.9 -28.63 65.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.064 1.345 . . . . 0.0 110.819 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -67.03 107.3 2.22 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.341 -1.474 . . . . 0.0 110.746 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.62 -13.24 32.74 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.15 150.9 72.15 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 118.264 1.032 . . . . 0.0 109.483 -171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 36' ' ' ALA . 57.5 Cg_endo -78.03 148.67 24.93 Favored 'Trans proline' 0 CA--C 1.505 -0.938 0 C-N-CA 122.827 2.351 . . . . 0.0 108.871 175.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.63 -25.92 5.52 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 119.855 1.207 . . . . 0.0 111.645 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.31 135.6 0.73 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 131.282 3.833 . . . . 0.0 115.565 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.48 -29.23 1.22 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.113 0.965 . . . . 0.0 110.532 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.01 51.87 1.85 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.094 1.757 . . . . 0.0 110.984 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 tt -108.67 73.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 119.131 -2.23 . . . . 0.0 109.924 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 t -174.7 137.31 0.46 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -66.8 -53.14 29.07 Favored Pre-proline 0 C--N 1.351 0.647 0 CA-C-O 115.611 -2.138 . . . . 0.0 112.652 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -69.78 -20.57 34.59 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 125.568 3.024 . . . . 0.0 113.126 -170.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.278 0.6 OUTLIER -103.04 -12.27 17.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 119.541 1.064 . . . . 0.0 110.34 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.89 -31.53 63.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 120.546 -1.346 . . . . 0.0 110.867 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tp -67.26 -32.47 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -33.95 68.32 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.534 -1.353 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -67.04 -38.62 86.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.657 1.218 . . . . 0.0 108.981 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -60.0 -43.53 95.13 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.56 1.144 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.61 -49.85 79.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 124.275 1.03 . . . . 0.0 110.415 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.61 -17.03 62.3 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.683 -0.636 . . . . 0.0 111.605 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m -80.14 -38.59 31.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.672 -0.642 . . . . 0.0 109.697 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.8 67.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.844 -1.16 . . . . 0.0 111.528 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -86.19 6.82 27.62 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.9 0.48 . . . . 0.0 110.121 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p 50.08 54.13 11.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.587 1.955 . . . . 0.0 112.584 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 56' ' ' GLY . 8.2 p -116.99 -77.42 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.558 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.05 85.06 0.23 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -74.39 -14.82 60.92 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.664 -1.492 . . . . 0.0 111.061 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 32.08 3.88 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 49.0 t0 -73.28 -48.97 30.27 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -136.85 169.83 17.1 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.32 146.56 33.56 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.89 -172.61 1.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 124.61 3.54 . . . . 0.0 109.432 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 64' ' ' THR 0.253 13.3 p -129.02 -146.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 63' ' ' VAL . 18.9 m -100.63 -49.97 4.03 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.562 1.545 . . . . 0.0 107.946 -172.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -79.4 -12.27 59.91 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.452 0.701 . . . . 0.0 111.179 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -63.78 -30.36 71.47 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 122.931 1.348 . . . . 0.0 107.649 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.55 81.14 1.49 Allowed Glycine 0 CA--C 1.469 -2.794 1 N-CA-C 99.601 -5.4 . . . . 0.0 99.601 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -59.18 -8.04 1.42 Allowed 'General case' 0 C--N 1.362 1.144 0 CA-C-O 123.238 1.494 . . . . 0.0 112.929 -168.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -60.17 -15.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 120.144 -1.597 . . . . 0.0 113.171 164.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.91 -50.53 74.64 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-N 120.688 1.585 . . . . 0.0 107.367 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.86 -47.21 83.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.311 0.644 . . . . 0.0 111.798 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.89 -45.86 71.22 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.096 1.358 . . . . 0.0 110.728 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -33.6 75.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.909 0.884 . . . . 0.0 111.539 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.43 -49.31 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.4 ptp -65.68 -38.31 88.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 122.01 -0.431 . . . . 0.0 110.332 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -65.14 -38.05 89.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.484 -0.76 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.59 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.315 0.646 . . . . 0.0 110.702 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -44.56 97.55 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.405 1.002 . . . . 0.0 110.71 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.93 -44.17 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 121.894 -0.768 . . . . 0.0 109.294 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.36 -47.43 85.9 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.068 -1.02 . . . . 0.0 112.02 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.83 -39.2 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 O-C-N 121.719 -0.613 . . . . 0.0 111.202 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.69 -39.04 64.67 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.687 0.676 . . . . 0.0 109.387 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.29 73.86 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 121.455 -0.778 . . . . 0.0 111.172 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.77 -36.22 76.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.296 1.438 . . . . 0.0 111.267 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.84 -12.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 125.202 1.401 . . . . 0.0 111.198 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -58.99 -21.52 59.05 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.762 -1.836 . . . . 0.0 111.58 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.92 -26.51 68.84 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 120.815 -1.178 . . . . 0.0 112.15 172.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.54 -47.65 11.1 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.19 -40.58 94.45 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.079 0.951 . . . . 0.0 113.342 -170.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -16.5 63.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.102 -0.999 . . . . 0.0 111.616 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.6 p -87.59 -12.51 45.45 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.89 -1.131 . . . . 0.0 110.641 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -76.26 -17.48 59.45 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -166.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -81.36 -31.64 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.962 -1.086 . . . . 0.0 110.379 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -71.54 -22.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 125.904 1.682 . . . . 0.0 109.025 -169.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -53.85 -24.04 14.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.362 1.465 . . . . 0.0 112.585 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -65.91 -16.16 63.61 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 120.221 -1.55 . . . . 0.0 112.029 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -68.03 -30.6 69.87 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.018 0.913 . . . . 0.0 109.494 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.59 -48.03 50.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -64.85 -35.56 81.52 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 125.644 1.578 . . . . 0.0 110.984 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.98 -43.62 86.65 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.39 1.476 . . . . 0.0 111.216 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -97.71 -20.42 17.61 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.978 0.911 . . . . 0.0 110.128 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.32 61.67 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -171.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 t60 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.21 162.18 33.27 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.118 0.961 . . . . 0.0 109.008 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -70.43 -26.0 63.47 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.404 -171.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.32 -21.45 56.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.897 -1.127 . . . . 0.0 110.98 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -81.59 -48.08 12.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -64.14 -40.22 95.69 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.405 -0.809 . . . . 0.0 112.198 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.46 -27.46 60.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.43 71.71 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.432 -0.792 . . . . 0.0 109.844 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.38 -37.55 86.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.759 0.824 . . . . 0.0 111.075 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -64.43 -37.16 86.55 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.409 0.683 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -29.46 70.8 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.477 -0.764 . . . . 0.0 111.208 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -67.33 -30.12 69.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.109 -0.994 . . . . 0.0 111.528 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.4 -28.45 61.09 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.79 -1.194 . . . . 0.0 110.141 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.38 -42.76 95.98 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.227 1.011 . . . . 0.0 109.138 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.6 -40.53 97.22 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.459 -0.776 . . . . 0.0 110.749 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -67.44 -27.31 66.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -69.5 -43.88 72.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.485 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.11 -35.31 74.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 123.921 0.889 . . . . 0.0 109.34 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.9 mt -53.82 -53.95 45.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 123.938 0.895 . . . . 0.0 109.73 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -66.89 -32.86 74.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.782 -0.574 . . . . 0.0 111.944 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.18 -51.7 50.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.843 0.83 . . . . 0.0 109.535 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.53 83.43 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.991 0.916 . . . . 0.0 111.388 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -63.57 -40.14 96.2 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 123.61 0.764 . . . . 0.0 110.852 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -63.93 -40.39 96.35 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -68.73 -40.65 79.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.384 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.69 67.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.911 1.684 . . . . 0.0 113.086 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.87 -25.49 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.801 0.81 . . . . 0.0 111.721 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.17 -36.2 13.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.04 -50.67 63.38 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.698 1.999 . . . . 0.0 110.187 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.18 56.46 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.375 -0.828 . . . . 0.0 109.98 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -138.61 101.85 4.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.04 -2.1 38.18 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.16 64.74 Favored Pre-proline 0 N--CA 1.442 -0.844 0 O-C-N 121.586 -0.95 . . . . 0.0 109.658 -172.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.45 113.07 2.56 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.366 2.71 . . . . 0.0 112.423 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.0 23.86 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.31 163.15 17.86 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.56 -25.9 0.27 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.33 52.0 2.26 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.65 1.214 . . . . 0.0 108.718 -172.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 43.8 pt -80.06 27.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 124.932 1.293 . . . . 0.0 111.1 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -122.34 142.5 50.44 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.89 -1.131 . . . . 0.0 109.429 -168.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.73 -62.02 0.23 Allowed Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-O 116.937 -1.506 . . . . 0.0 110.198 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.14 -12.55 23.44 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 CA-C-N 125.496 2.998 . . . . 0.0 111.659 -172.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -87.72 -8.85 55.53 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.26 99.43 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 121.687 -0.633 . . . . 0.0 110.016 -173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.54 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.028 0.531 . . . . 0.0 110.338 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -20.47 55.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 120.713 -1.242 . . . . 0.0 111.877 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -75.85 -53.48 8.39 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 m -54.82 -33.1 61.19 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.7 t -56.75 -48.76 80.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 124.281 1.032 . . . . 0.0 110.584 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.63 -16.43 55.82 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 119.798 1.181 . . . . 0.0 111.795 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -65.71 -42.17 91.44 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 109.318 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -29.14 68.77 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 123.353 0.661 . . . . 0.0 111.416 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.0 p -87.17 -0.75 57.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 16.6 p 54.44 33.89 19.7 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.759 1.624 . . . . 0.0 110.806 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.89 -60.76 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 103.255 -2.868 . . . . 0.0 103.255 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 50.13 64.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.03 -41.3 91.12 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 118.095 0.948 . . . . 0.0 108.628 -171.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.68 -111.05 0.46 Allowed Glycine 0 CA--C 1.471 -2.713 0 N-CA-C 103.398 -3.881 . . . . 0.0 103.398 172.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.8 t0 76.5 -72.55 0.1 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.184 0.993 . . . . 0.0 109.741 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.62 167.42 19.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.64 128.31 13.52 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -88.07 161.38 7.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.027 2.485 . . . . 0.0 109.708 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.452 HG13 ' H ' ' B' ' 64' ' ' THR 0.348 14.6 p -96.71 -126.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.452 ' H ' HG13 ' B' ' 63' ' ' VAL . 3.1 m -119.87 -38.86 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.864 1.666 . . . . 0.0 109.266 -170.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -93.04 5.45 51.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.718 0.807 . . . . 0.0 109.976 -168.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.11 38.11 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.63 73.87 1.27 Allowed Glycine 0 CA--C 1.469 -2.832 1 N-CA-C 101.444 -4.662 . . . . 0.0 101.444 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -48.26 -8.02 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 130.293 3.437 . . . . 0.0 114.738 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' B' ' 72' ' ' GLU . 61.4 mttt -48.22 -26.34 1.91 Allowed 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 127.015 2.126 . . . . 0.0 112.804 154.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.95 -48.18 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 125.022 1.329 . . . . 0.0 108.826 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.26 60.64 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 109.886 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.456 ' HB3' ' HA ' ' B' ' 69' ' ' LYS . 14.7 tt0 -49.76 -46.65 50.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 127.856 2.462 . . . . 0.0 109.961 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -61.67 -43.9 97.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.086 0.954 . . . . 0.0 111.019 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.25 -43.84 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -61.39 -51.76 67.44 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.05 0.54 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -66.39 -35.57 80.66 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.822 -0.549 . . . . 0.0 110.094 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.3 93.64 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.608 -0.683 . . . . 0.0 110.836 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.53 -48.79 79.26 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.98 -48.11 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.808 1.243 . . . . 0.0 109.943 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.28 -33.79 76.81 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.638 -1.289 . . . . 0.0 111.947 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.82 -49.51 68.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.553 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -66.82 -22.78 66.0 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.381 0.672 . . . . 0.0 111.135 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.12 -39.42 25.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.33 -34.36 76.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.676 1.191 . . . . 0.0 111.312 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 m -66.25 -7.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 121.442 -0.786 . . . . 0.0 112.124 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 72.2 m -59.19 -22.03 60.36 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.128 1.371 . . . . 0.0 111.085 171.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.19 68.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 118.852 -2.405 . . . . 0.0 112.382 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.99 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.5 -35.72 72.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.232 1.413 . . . . 0.0 112.45 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . . . -71.38 -16.94 62.43 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 121.005 -1.06 . . . . 0.0 112.011 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -76.53 -24.51 53.65 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.7 -9.14 59.3 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.813 -1.179 . . . . 0.0 110.327 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' B' ' 90' ' ' ALA . 3.1 m-30 -73.82 -34.43 64.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.55 1.14 . . . . 0.0 108.423 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.29 -31.76 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 125.101 1.36 . . . . 0.0 108.457 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -62.99 -5.11 2.63 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.214 -0.929 . . . . 0.0 112.829 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -64.78 -23.29 67.2 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.6 -33.67 41.4 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -86.68 177.0 7.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 64.93 -63.63 0.18 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.817 2.047 . . . . 0.0 112.96 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -70.78 -36.24 72.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.665 1.586 . . . . 0.0 109.441 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -116.76 143.66 45.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 102.077 -3.305 . . . . 0.0 102.077 168.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.09 -27.15 5.67 Favored Glycine 0 CA--C 1.495 -1.162 0 O-C-N 121.271 -0.893 . . . . 0.0 113.374 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . 0.261 2.3 m-70 . . . . . 0 CA--C 1.502 -0.879 0 C-N-CA 124.515 1.126 . . . . 0.0 110.961 -171.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 73.58 -55.49 0.67 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.282 1.833 . . . . 0.0 110.479 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 78.27 -43.19 0.36 Allowed 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 128.613 2.765 . . . . 0.0 109.274 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 0.5 OUTLIER -45.91 -33.97 3.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 128.507 2.723 . . . . 0.0 112.441 166.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.43 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 7.0 pt-20 -79.61 -28.2 41.02 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -71.57 -40.31 70.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -70.14 -35.41 74.04 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.674 0.75 . . . . 0.0 109.117 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.54 83.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.511 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.27 -35.55 75.8 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.795 1.638 . . . . 0.0 111.373 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -66.4 -42.44 87.84 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.962 1.305 . . . . 0.0 109.43 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 110.877 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.63 -39.87 68.39 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.683 1.193 . . . . 0.0 111.418 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -71.38 -36.48 71.43 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.501 1.12 . . . . 0.0 110.105 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.69 -39.1 87.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.542 1.137 . . . . 0.0 109.875 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.15 -40.49 97.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.012 -1.055 . . . . 0.0 111.369 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -65.58 -40.14 92.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.67 1.188 . . . . 0.0 111.74 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -73.48 -29.29 62.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.767 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.79 -34.95 70.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.125 -0.984 . . . . 0.0 109.599 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.41 -37.72 78.77 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.077 -1.014 . . . . 0.0 111.684 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -64.08 -46.23 85.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.235 -0.915 . . . . 0.0 109.958 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.26 -37.52 85.67 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.353 -0.842 . . . . 0.0 110.316 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.36 74.25 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.792 1.237 . . . . 0.0 111.671 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -63.31 -42.55 99.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.149 0.5 . . . . 0.0 110.967 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.62 -50.45 62.94 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.54 1.536 . . . . 0.0 107.829 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.89 -41.17 87.64 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.128 -0.357 . . . . 0.0 110.821 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.24 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 123.573 0.749 . . . . 0.0 110.499 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.81 72.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 O-C-N 120.431 -1.418 . . . . 0.0 110.551 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -70.39 -32.11 69.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.16 1.384 . . . . 0.0 109.409 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.56 -49.52 76.31 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.978 1.311 . . . . 0.0 110.808 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' C' ' 38' ' ' LEU . 6.2 mp0 -74.92 -17.68 60.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 121.769 -0.582 . . . . 0.0 111.354 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -94.55 79.46 3.82 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.128 -1.608 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.74 -29.75 0.83 Allowed Glycine 0 CA--C 1.491 -1.444 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.93 155.19 36.73 Favored Pre-proline 0 N--CA 1.443 -0.788 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.43 161.5 31.48 Favored 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.236 1.957 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.88 6.24 76.29 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 123.932 0.777 . . . . 0.0 111.751 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 122.36 6.34 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 126.087 1.755 . . . . 0.0 114.228 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 -24.5 0.86 Allowed 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' C' ' 30' ' ' GLU . 3.6 tt -76.04 -87.32 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 mt 64.8 161.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.778 0 C-N-CA 125.411 1.484 . . . . 0.0 109.466 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.9 t 81.88 115.23 0.06 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.659 1.583 . . . . 0.0 112.118 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -68.73 -52.19 18.98 Favored Pre-proline 0 C--N 1.349 0.568 0 CA-C-O 115.973 -1.965 . . . . 0.0 112.408 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.85 -7.49 20.1 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 126.094 3.212 . . . . 0.0 111.542 -170.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -93.51 -33.3 13.83 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.79 74.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.677 1.191 . . . . 0.0 111.699 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 tt -60.76 -29.04 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 124.63 1.172 . . . . 0.0 111.493 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -23.28 29.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.286 -0.884 . . . . 0.0 109.606 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -78.94 -37.57 39.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 12.5 p -77.79 55.59 1.4 Allowed 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 121.427 -0.795 . . . . 0.0 110.115 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -131.43 -68.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.45 -19.24 64.56 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -67.58 -35.86 79.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.183 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.12 56.91 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 120.774 -1.204 . . . . 0.0 110.325 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -93.33 15.74 14.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.22 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.266 10.2 t 49.69 55.24 9.69 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 112.803 168.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.6 m -143.3 -164.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 N-CA-C 98.336 -4.69 . . . . 0.0 98.336 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.32 106.22 0.19 Allowed Glycine 0 CA--C 1.467 -2.909 1 N-CA-C 100.057 -5.217 . . . . 0.0 100.057 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.418 ' CE1' ' HA3' ' D' ' 56' ' ' GLY . 6.2 m-30 -87.39 -6.91 58.26 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -167.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.94 42.0 2.02 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.72 -51.1 12.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -144.78 -177.27 5.43 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.99 138.66 13.42 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.81 169.34 15.05 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.54 2.827 . . . . 0.0 110.078 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -101.86 -175.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-O 122.605 1.193 . . . . 0.0 111.897 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -87.62 -61.48 1.71 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 124.562 1.145 . . . . 0.0 110.375 -166.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -59.44 -37.64 78.63 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.514 0.726 . . . . 0.0 111.514 -169.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.69 -76.29 0.57 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.048 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -23.72 -51.07 0.03 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 129.473 3.416 . . . . 0.0 117.305 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -58.76 -47.34 85.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.01 1.724 . . . . 0.0 112.736 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -75.58 -27.82 58.7 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.114 . . . . 0.0 108.803 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.05 -52.57 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.83 95.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.076 1.35 . . . . 0.0 111.464 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -34.01 72.7 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 119.18 0.9 . . . . 0.0 111.584 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.78 -42.56 94.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.277 1.031 . . . . 0.0 109.984 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.34 -44.34 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.252 1.021 . . . . 0.0 109.59 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mtp -57.03 -48.79 77.65 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.374 1.069 . . . . 0.0 110.078 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -62.32 -31.9 72.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.303 1.841 . . . . 0.0 111.97 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.99 71.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.627 0.771 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.33 -42.16 75.65 Favored Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.65 -42.73 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 109.797 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -53.77 -56.33 18.45 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 110.544 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.45 -49.82 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 C-N-CA 125.358 1.463 . . . . 0.0 109.516 -171.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.87 -24.01 62.42 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.716 -0.615 . . . . 0.0 111.098 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.52 47.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.961 -1.087 . . . . 0.0 110.144 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.96 -37.31 81.94 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 111.661 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.56 -1.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.623 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -58.5 -24.03 59.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.178 1.791 . . . . 0.0 113.784 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.18 84.78 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 119.14 -2.225 . . . . 0.0 112.216 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -66.27 -42.08 88.98 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.2 -43.73 66.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.172 0.51 . . . . 0.0 111.093 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.71 -41.59 26.42 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 120.357 -1.464 . . . . 0.0 112.667 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 34.1 p -69.07 -7.01 31.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.619 -1.3 . . . . 0.0 111.41 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -74.23 -5.46 42.11 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.835 -0.541 . . . . 0.0 110.41 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -35.56 71.66 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 120.043 -1.661 . . . . 0.0 111.02 167.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.39 -17.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.42 1.488 . . . . 0.0 108.934 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.69 -29.81 40.61 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.512 1.525 . . . . 0.0 111.966 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -60.48 -39.82 89.03 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.71 1.204 . . . . 0.0 110.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.04 -32.86 73.51 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 121.422 -0.799 . . . . 0.0 109.58 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -97.93 0.94 47.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 120.993 0.425 . . . . 0.0 111.1 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -74.97 -31.71 61.52 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.426 -1.421 . . . . 0.0 108.638 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -78.5 -17.52 56.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.866 -0.521 . . . . 0.0 110.939 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -79.53 -37.94 35.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.53 25.76 41.59 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 CA--C 1.486 -1.491 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 171.412 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.431 -1.385 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 164.18 24.52 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.259 1.424 . . . . 0.0 109.356 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.21 -39.82 94.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.796 1.638 . . . . 0.0 111.407 -169.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.419 ' CD2' ' HG3' ' D' ' 5' ' ' GLU . 24.1 p-80 -78.54 -20.68 50.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.403 -0.811 . . . . 0.0 111.232 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' D' ' 4' ' ' HIS . 18.3 mt-10 -89.86 -21.69 22.42 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.096 -1.003 . . . . 0.0 108.561 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.55 -43.71 96.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.121 1.768 . . . . 0.0 109.784 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.47 -32.16 71.96 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 109.362 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.38 -35.46 73.52 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.206 1.003 . . . . 0.0 111.321 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.53 -31.75 72.99 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.469 -0.769 . . . . 0.0 111.439 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.73 -33.66 74.44 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.795 -0.566 . . . . 0.0 110.836 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.682 0.793 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.48 -39.4 88.73 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.872 0.869 . . . . 0.0 110.262 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -46.02 91.35 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 121.287 -0.883 . . . . 0.0 109.846 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.6 -41.68 81.71 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.825 2.05 . . . . 0.0 109.942 -175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.89 -40.79 96.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.068 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.23 -27.69 67.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.513 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -69.57 -42.79 74.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.27 -0.893 . . . . 0.0 110.342 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 m -72.59 -26.37 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 121.657 -0.652 . . . . 0.0 110.941 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.56 -41.27 96.42 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.307 -0.871 . . . . 0.0 111.096 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.46 -30.38 59.92 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 124.073 0.949 . . . . 0.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.93 -39.25 72.79 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 119.787 -1.821 . . . . 0.0 109.507 173.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.11 85.58 Favored 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.013 1.325 . . . . 0.0 110.85 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.1 p -67.19 -37.15 83.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 119.202 0.91 . . . . 0.0 111.196 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.13 -52.7 31.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.506 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -71.07 -25.12 62.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.076 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.82 -53.64 47.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.396 1.078 . . . . 0.0 110.016 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.74 -38.61 83.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -77.05 -6.59 53.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.332 -1.48 . . . . 0.0 112.421 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.48 -52.32 5.42 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -48.48 -50.58 31.01 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 129.034 2.934 . . . . 0.0 114.382 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -74.07 85.68 1.83 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.731 0.777 . . . . 0.0 110.413 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.34 -18.36 1.7 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.63 140.03 31.56 Favored Pre-proline 0 N--CA 1.445 -0.705 0 O-C-N 121.128 -1.219 . . . . 0.0 111.15 -170.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.39 132.82 6.06 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.77 2.314 . . . . 0.0 111.232 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.57 27.85 37.64 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.9 157.4 5.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.43 2.292 . . . . 0.0 111.9 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.02 -36.04 0.83 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.132 1.373 . . . . 0.0 110.072 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.45 81.5 1.48 Allowed 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.927 1.346 . . . . 0.0 112.865 -164.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 35.0 pt -93.79 -8.67 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 118.871 2.915 . . . . 0.0 118.871 -166.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.7 m -121.32 141.2 51.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 123.656 2.935 . . . . 0.0 110.708 -164.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -59.21 -47.77 97.66 Favored Pre-proline 0 C--N 1.353 0.757 0 CA-C-O 116.172 -1.871 . . . . 0.0 112.909 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -72.62 -5.59 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 CA-C-N 125.374 2.955 . . . . 0.0 112.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -30.76 12.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.6 76.4 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.294 1.037 . . . . 0.0 111.931 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.9 tt -72.06 -27.39 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 110.022 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.01 -35.75 49.52 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 108.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -63.6 -44.85 92.78 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.957 0.903 . . . . 0.0 110.578 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.5 p -65.74 -27.16 68.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 120.609 -1.307 . . . . 0.0 111.175 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.51 -20.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 111.452 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.9 -16.14 57.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.17 -1.581 . . . . 0.0 110.177 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.48 HG22 ' H ' ' D' ' 52' ' ' ALA . 7.1 m -99.8 -177.45 3.56 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 102.038 -3.319 . . . . 0.0 102.038 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.48 ' H ' HG22 ' D' ' 51' ' ' THR . . . 76.4 -30.14 0.18 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.793 1.637 . . . . 0.0 111.263 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.8 p -90.96 -10.92 40.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.65 1.58 . . . . 0.0 111.397 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p 58.45 30.83 20.23 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.359 1.463 . . . . 0.0 111.223 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.92 -87.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 101.446 -3.539 . . . . 0.0 101.446 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' C' ' 57' ' ' TYR . . . 81.32 73.33 1.19 Allowed Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -44.62 93.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.65 0.78 . . . . 0.0 111.099 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.3 -62.7 0.27 Allowed Glycine 0 CA--C 1.477 -2.331 0 C-N-CA 117.36 -2.352 . . . . 0.0 112.6 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -10.33 -67.24 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 128.948 2.899 . . . . 0.0 117.747 -162.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.94 155.13 43.58 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 104.424 -2.435 . . . . 0.0 104.424 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.43 152.22 19.52 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.66 158.37 19.0 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.085 2.524 . . . . 0.0 111.518 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.457 HG22 ' H ' ' D' ' 64' ' ' THR . 8.5 p -101.99 -151.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.457 ' H ' HG22 ' D' ' 63' ' ' VAL . 2.2 m -76.65 -50.11 14.55 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.547 1.939 . . . . 0.0 111.157 -171.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -77.59 -14.51 59.63 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.457 1.503 . . . . 0.0 110.498 -162.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.62 -20.18 62.76 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.165 0.983 . . . . 0.0 109.658 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.72 89.38 0.84 Allowed Glycine 0 CA--C 1.478 -2.265 1 N-CA-C 98.691 -5.764 . . . . 0.0 98.691 -170.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -65.06 -11.36 38.58 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.056 1.928 . . . . 0.0 110.02 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -57.28 -14.84 4.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.324 1.05 . . . . 0.0 113.597 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.88 -43.32 97.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.487 1.494 . . . . 0.0 109.116 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.98 -43.08 75.63 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -44.93 82.33 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.596 1.158 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.76 -45.51 93.61 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.402 0.681 . . . . 0.0 111.364 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.8 -39.73 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.634 0.774 . . . . 0.0 109.32 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.7 ttm -62.9 -48.14 80.27 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.384 1.074 . . . . 0.0 110.303 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -63.57 -42.18 98.34 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 109.846 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.3 80.7 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 111.439 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.79 -36.67 93.66 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.211 0.91 . . . . 0.0 112.249 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -68.66 -42.85 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 121.311 -1.111 . . . . 0.0 108.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.95 -43.08 99.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 121.432 -0.793 . . . . 0.0 111.604 -175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.69 -40.78 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 O-C-N 121.79 -0.569 . . . . 0.0 111.355 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.29 -21.09 56.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.75 25.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.166 -0.959 . . . . 0.0 110.367 174.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.1 -42.54 90.74 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 125.837 1.655 . . . . 0.0 109.877 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.71 -4.26 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.564 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -62.2 -19.79 63.49 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.856 -1.152 . . . . 0.0 110.427 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.07 77.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.341 -1.475 . . . . 0.0 111.841 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.35 -33.07 49.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 120.926 -1.109 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.01 -31.49 68.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.125 0.488 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.87 70.47 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.834 -1.166 . . . . 0.0 111.257 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -9.94 59.03 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.876 -1.14 . . . . 0.0 111.922 173.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.45 -40.17 70.5 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 119.644 1.111 . . . . 0.0 109.359 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -68.46 -29.64 68.33 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.959 -1.088 . . . . 0.0 111.239 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.83 -21.92 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.914 1.286 . . . . 0.0 108.97 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -62.18 -12.55 20.6 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.438 1.095 . . . . 0.0 111.485 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.79 -24.94 67.96 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.404 1.082 . . . . 0.0 112.229 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.73 166.99 21.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 64.8 -70.88 0.08 Allowed 'General case' 0 C--N 1.351 0.665 0 C-N-CA 125.93 1.692 . . . . 0.0 111.634 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.69 -53.31 59.48 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.933 1.693 . . . . 0.0 109.513 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -70.75 -29.63 65.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.891 -1.131 . . . . 0.0 111.093 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.86 91.34 2.96 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.28 35.4 2.7 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 21.1 p80 . . . . . 0 C--N 1.354 0.78 0 C-N-CA 124.591 1.156 . . . . 0.0 112.546 -178.229 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.425 -1.696 1 N-CA-C 100.062 -4.051 . . . . 0.0 100.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.95 -176.73 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.057 2.143 . . . . 0.0 112.28 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -105.68 -42.17 5.25 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -71.17 -31.36 67.58 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.207 -0.933 . . . . 0.0 111.623 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.55 -40.79 61.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.601 0.715 . . . . 0.0 110.193 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -68.47 -31.64 71.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.48 -0.763 . . . . 0.0 110.359 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -81.0 -30.92 34.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.018 -0.426 . . . . 0.0 110.243 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.6 76.04 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.931 -1.106 . . . . 0.0 110.197 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -57.1 -35.63 69.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.573 1.949 . . . . 0.0 111.691 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -64.42 -39.18 93.34 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.563 1.145 . . . . 0.0 109.84 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.93 80.52 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.693 -0.629 . . . . 0.0 110.156 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.41 -33.67 74.09 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.621 0.769 . . . . 0.0 111.449 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.83 -42.56 94.85 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 109.89 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.55 -36.89 81.88 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.874 0.87 . . . . 0.0 109.459 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -56.87 -44.72 82.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.121 0.569 . . . . 0.0 111.264 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -63.14 -38.14 90.01 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.104 0.962 . . . . 0.0 111.606 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.19 -39.12 92.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.887 1.275 . . . . 0.0 109.83 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.93 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.715 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.1 mt -59.74 -43.95 93.99 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.32 -0.862 . . . . 0.0 111.185 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -74.53 -22.33 59.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.234 1.014 . . . . 0.0 111.798 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.91 -41.04 21.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 120.573 -1.329 . . . . 0.0 108.385 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.6 76.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.716 1.207 . . . . 0.0 111.412 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 p -66.85 -38.35 86.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.454 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -61.37 -47.91 83.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.235 1.414 . . . . 0.0 107.812 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -65.63 -47.06 76.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 122.662 0.385 . . . . 0.0 110.572 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.48 90.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.03 1.332 . . . . 0.0 112.058 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.86 -34.66 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.434 -0.791 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.23 -24.79 27.68 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 120.271 -1.518 . . . . 0.0 110.357 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -79.85 -53.66 6.57 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.83 -34.88 69.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 119.073 0.851 . . . . 0.0 110.98 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -74.65 108.88 7.69 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 119.569 -1.957 . . . . 0.0 110.455 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.66 -33.12 2.8 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.57 144.53 83.65 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.309 -170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.64 138.7 21.85 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 C-N-CA 122.799 2.333 . . . . 0.0 109.833 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.45 -0.07 89.31 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.16 146.8 54.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.054 0.942 . . . . 0.0 111.543 -171.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.55 -42.45 3.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.78 131.11 34.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 pt -149.45 173.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.3 m 66.64 132.94 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.526 1.931 . . . . 0.0 114.163 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.32 -46.82 38.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 115.77 -2.062 . . . . 0.0 112.309 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.5 -11.65 30.2 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 CA-C-N 126.056 3.199 . . . . 0.0 112.293 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.15 -47.63 7.95 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.59 75.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 126.166 1.786 . . . . 0.0 112.37 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.73 -28.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 121.359 0.599 . . . . 0.0 111.115 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -22.29 32.19 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.235 -0.916 . . . . 0.0 109.69 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -78.14 -33.84 50.2 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.76 61.26 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.123 -0.985 . . . . 0.0 110.862 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -138.84 -76.1 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -67.71 -14.88 63.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 112.031 -169.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -64.88 -36.56 84.76 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 126.331 1.852 . . . . 0.0 108.582 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.23 60.28 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.207 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -88.99 13.41 12.96 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 p 56.79 51.1 11.35 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.514 1.526 . . . . 0.0 113.065 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 ' SD ' ' B' ' 75' ' ' MET . 21.3 t -116.19 -104.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.22 71.46 0.73 Allowed Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -66.75 -18.98 65.65 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.587 -0.949 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.51 22.23 6.18 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -56.21 17.12 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.995 0.898 . . . . 0.0 110.131 174.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -147.47 161.68 40.58 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.97 146.94 18.44 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.9 176.53 9.9 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 124.481 3.454 . . . . 0.0 110.341 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 t -112.5 -102.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 120.053 1.297 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -139.53 -41.53 0.45 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -88.07 -19.19 27.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.577 0.751 . . . . 0.0 111.146 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -63.02 -34.56 77.83 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 108.036 170.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.57 79.52 1.44 Allowed Glycine 0 CA--C 1.471 -2.659 1 N-CA-C 100.297 -5.121 . . . . 0.0 100.297 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.447 HH22 ' CG ' ' D' ' 59' ' ' ASP . 49.5 ttm-85 -39.07 -28.15 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 128.806 2.842 . . . . 0.0 114.512 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -53.27 -15.74 1.05 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.53 -46.82 92.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 125.216 1.407 . . . . 0.0 109.399 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.163 0.985 . . . . 0.0 108.899 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.37 -43.24 33.48 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.595 1.558 . . . . 0.0 111.667 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -62.58 -38.17 89.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.13 0.572 . . . . 0.0 111.437 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.71 -38.63 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -176.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -59.95 -44.62 94.27 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.046 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -63.17 -34.3 77.32 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.493 -0.754 . . . . 0.0 110.961 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.92 85.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.753 0.706 . . . . 0.0 111.291 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.29 50.97 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.04 -38.89 62.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 124.562 1.145 . . . . 0.0 108.897 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -70.35 -49.28 50.93 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.815 -1.178 . . . . 0.0 111.177 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.89 -45.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 O-C-N 121.33 -0.856 . . . . 0.0 110.199 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -73.48 -29.69 62.68 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 121.447 -0.783 . . . . 0.0 110.2 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.0 62.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 120.665 -1.272 . . . . 0.0 110.314 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.93 -35.4 80.56 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.935 -1.103 . . . . 0.0 110.769 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.92 -9.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.161 1.385 . . . . 0.0 111.26 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 m -59.34 -23.01 62.15 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 118.986 -2.321 . . . . 0.0 111.931 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.33 61.26 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.551 -1.343 . . . . 0.0 112.36 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.37 -41.94 9.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.512 1.525 . . . . 0.0 109.577 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -41.76 63.2 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.637 -1.289 . . . . 0.0 111.582 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.19 -5.43 41.85 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 121.037 -1.039 . . . . 0.0 111.12 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -97.54 -5.42 35.8 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.701 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.26 18.2 m-20 -80.13 -16.86 54.04 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 121.094 1.77 . . . . 0.0 111.268 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.49 -29.55 37.37 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.837 -1.164 . . . . 0.0 109.602 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.41 -30.87 50.45 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 124.429 1.092 . . . . 0.0 109.248 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -53.5 -26.44 20.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.001 1.32 . . . . 0.0 112.916 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -62.59 -34.75 77.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.524 1.13 . . . . 0.0 110.689 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.02 -3.18 58.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 121.919 -0.488 . . . . 0.0 110.132 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.61 -174.91 2.61 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 66.52 -64.13 0.23 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.064 2.146 . . . . 0.0 112.432 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -50.83 -51.57 49.76 Favored 'General case' 0 N--CA 1.432 -1.361 1 C-N-CA 131.908 4.083 . . . . 0.0 110.457 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -92.22 -0.06 57.43 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.473 0.709 . . . . 0.0 110.543 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.59 28.51 72.18 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 121.819 -0.551 . . . . 0.0 111.765 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.9 t60 . . . . . 0 CA--C 1.505 -0.754 0 O-C-N 121.619 -0.93 . . . . 0.0 109.419 -174.833 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p . . . . . 0 N--CA 1.432 -1.375 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.69 169.02 10.63 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -47.45 -65.7 0.52 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 127.443 2.297 . . . . 0.0 111.598 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -62.81 -23.63 67.35 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.588 1.955 . . . . 0.0 112.709 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -81.83 -41.58 20.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -70.08 -35.18 74.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.379 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.8 -39.66 85.75 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.494 0.718 . . . . 0.0 110.304 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.61 91.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.408 0.683 . . . . 0.0 111.495 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -68.31 -38.55 81.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 121.594 -0.691 . . . . 0.0 110.219 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.85 -36.27 80.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.46 0.648 . . . . 0.0 110.892 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.14 83.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.839 0.856 . . . . 0.0 111.193 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.27 -32.39 73.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.508 -0.745 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.23 -35.83 71.62 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.165 -0.959 . . . . 0.0 109.597 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.81 -30.21 69.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 120.641 -1.287 . . . . 0.0 110.325 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -61.16 -43.68 98.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 122.978 0.511 . . . . 0.0 111.186 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.33 -35.15 79.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.344 0.658 . . . . 0.0 110.892 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -67.61 -39.11 84.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.274 0.63 . . . . 0.0 110.668 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.76 -39.87 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.797 0.839 . . . . 0.0 109.302 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.22 -43.45 87.73 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.179 0.899 . . . . 0.0 111.969 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.35 -37.39 80.44 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.59 1.156 . . . . 0.0 110.501 -177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.22 -46.06 52.57 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.681 1.229 . . . . 0.0 108.788 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.31 64.57 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 125.043 1.337 . . . . 0.0 112.236 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.8 p -73.32 -31.57 64.08 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.341 -0.849 . . . . 0.0 110.006 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -40.96 71.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.028 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.5 75.22 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.796 1.239 . . . . 0.0 112.742 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.04 -29.96 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 O-C-N 120.912 -1.117 . . . . 0.0 111.381 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.96 -20.57 28.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.153 0.501 . . . . 0.0 110.52 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.34 94.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.412 1.885 . . . . 0.0 109.462 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -69.39 -106.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.571 0.7 . . . . 0.0 111.58 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 58.17 9.66 1.04 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.48 34.63 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.72 149.14 38.64 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -77.14 113.09 3.53 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.486 2.124 . . . . 0.0 110.693 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -65.37 0.28 Allowed Glycine 0 CA--C 1.484 -1.901 0 N-CA-C 103.109 -3.996 . . . . 0.0 103.109 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 75.23 162.47 0.25 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 127.65 2.38 . . . . 0.0 108.424 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.98 -72.61 0.08 Allowed 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.595 -0.691 . . . . 0.0 110.265 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.34 80.5 1.59 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 tt -122.99 93.99 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.5 m -156.07 -150.73 0.3 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -167.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.05 -58.36 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 116.445 -1.741 . . . . 0.0 106.447 169.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.51 -29.03 20.89 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.803 3.108 . . . . 0.0 112.434 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.52 9.12 39.8 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 123.809 0.843 . . . . 0.0 110.148 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.05 -41.22 82.35 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.679 -1.263 . . . . 0.0 109.675 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -73.45 -24.86 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 O-C-N 121.559 -0.713 . . . . 0.0 110.034 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -58.27 -55.66 32.18 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 125.687 1.595 . . . . 0.0 110.195 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -71.09 -34.82 71.51 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -55.84 -43.41 77.0 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.526 1.13 . . . . 0.0 110.954 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.7 t -55.19 -51.15 58.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 124.414 1.086 . . . . 0.0 111.061 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.42 -22.16 55.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.31 -0.869 . . . . 0.0 111.693 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -65.07 -40.96 95.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.183 0.993 . . . . 0.0 109.093 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.17 65.5 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 121.235 -0.916 . . . . 0.0 112.175 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -89.04 5.49 44.14 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.872 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 56.09 28.97 13.75 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.665 1.186 . . . . 0.0 111.463 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.17 -56.66 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.55 62.39 5.84 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.4 -27.5 66.27 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 123.14 1.448 . . . . 0.0 108.115 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.47 43.96 1.4 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 107.446 -2.261 . . . . 0.0 107.446 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.55 -50.97 9.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -133.87 172.57 12.61 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -146.25 149.88 39.54 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.77 166.75 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.524 2.816 . . . . 0.0 109.36 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.24 -144.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 7.3 p -107.12 -59.75 1.77 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.213 1.405 . . . . 0.0 107.781 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.84 -16.28 48.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 130.185 3.394 . . . . 0.0 111.99 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -67.63 -22.71 65.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 124.137 1.923 . . . . 0.0 108.482 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.82 67.92 1.41 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 101.557 -4.617 . . . . 0.0 101.557 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -37.76 -20.71 0.01 OUTLIER 'General case' 0 C--N 1.362 1.124 0 C-N-CA 131.62 3.968 . . . . 0.0 115.461 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -54.69 -14.62 1.42 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.75 1.62 . . . . 0.0 114.499 162.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.98 -44.11 92.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.134 0 CA-C-N 121.709 2.05 . . . . 0.0 107.305 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.54 86.37 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.575 -0.703 . . . . 0.0 110.193 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.42 -45.31 80.77 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 123.762 0.825 . . . . 0.0 110.872 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -55.19 -46.76 75.87 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.627 1.971 . . . . 0.0 111.56 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.5 t -72.35 -44.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 C-N-CA 123.256 0.623 . . . . 0.0 109.494 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 55' ' ' VAL . 72.9 mtm -58.89 -49.18 78.74 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.895 0.878 . . . . 0.0 110.293 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.77 -40.2 94.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.071 0.548 . . . . 0.0 110.783 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.98 76.27 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.116 0.566 . . . . 0.0 111.418 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -44.02 91.78 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 124.259 0.933 . . . . 0.0 111.172 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.96 -42.07 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.796 -0.826 . . . . 0.0 108.954 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.36 -50.85 71.65 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.174 -0.954 . . . . 0.0 111.995 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.3 -41.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 O-C-N 121.829 -0.544 . . . . 0.0 110.577 -173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -75.75 -27.97 58.31 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.588 -0.695 . . . . 0.0 110.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.6 -34.5 69.94 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.008 -1.057 . . . . 0.0 109.584 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.37 -34.0 76.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.296 1.038 . . . . 0.0 110.86 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.44 -21.9 19.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 124.847 1.259 . . . . 0.0 110.691 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 2.5 m -62.23 -16.33 52.7 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.574 -1.329 . . . . 0.0 111.531 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.41 -35.31 80.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.3 -2.125 . . . . 0.0 111.17 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.34 -33.75 61.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.83 -25.03 40.94 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.141 0.577 . . . . 0.0 111.569 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.35 -27.96 64.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 120.036 -1.665 . . . . 0.0 109.268 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -9.01 55.28 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.025 -1.047 . . . . 0.0 112.314 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -72.45 -23.09 61.01 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.397 -1.44 . . . . 0.0 110.728 -172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' C' ' 91' ' ' THR . 19.0 p90 -75.23 -28.27 59.83 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.41 -0.806 . . . . 0.0 110.404 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.96 -40.15 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 124.131 0.972 . . . . 0.0 108.64 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -60.5 -23.56 64.63 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.352 -0.842 . . . . 0.0 112.663 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -52.67 -46.51 67.26 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.852 1.261 . . . . 0.0 109.983 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -77.98 -27.2 49.07 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.807 -0.558 . . . . 0.0 110.466 -173.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.25 -36.15 76.86 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.227 0.611 . . . . 0.0 110.305 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.09 -45.35 67.14 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -53.47 -42.09 66.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 112.839 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -122.96 106.52 10.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 -48.91 0.93 Allowed Glycine 0 CA--C 1.486 -1.726 0 N-CA-C 105.907 -2.877 . . . . 0.0 105.907 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 CA--C 1.502 -0.896 0 C-N-CA 126.191 1.796 . . . . 0.0 112.318 -172.187 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.433 -1.297 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.1 27.58 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.61 -46.93 77.28 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 123.003 1.382 . . . . 0.0 109.52 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.491 ' CG ' ' HA ' ' C' ' 88' ' ' ALA . 0.1 OUTLIER -59.09 -29.35 67.29 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.038 1.335 . . . . 0.0 113.733 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -80.64 -43.71 20.03 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -171.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -65.83 -41.55 91.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 123.832 0.853 . . . . 0.0 110.796 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -65.48 -35.67 81.57 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.259 0.624 . . . . 0.0 110.718 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.79 94.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.75 -31.72 66.97 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.952 -0.467 . . . . 0.0 111.676 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.0 -36.37 84.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.94 0.896 . . . . 0.0 110.001 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.59 72.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.29 -40.36 85.9 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 111.069 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.65 -25.43 59.19 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.167 1.387 . . . . 0.0 110.533 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.74 -36.74 67.8 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.305 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -63.72 -44.78 92.59 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -65.44 -24.49 67.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.458 -0.776 . . . . 0.0 112.488 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -60.31 -43.81 95.99 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.532 1.133 . . . . 0.0 109.911 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.14 -40.74 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.263 1.025 . . . . 0.0 109.057 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -40.16 95.24 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.721 0.809 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.56 -21.86 38.19 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.0 111.969 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.41 -47.57 17.3 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.33 60.17 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 124.149 0.979 . . . . 0.0 112.592 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.3 p -67.76 -40.36 84.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.034 1.288 . . . . 0.0 109.089 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -68.52 -44.61 74.26 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.45 -42.72 88.01 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.237 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.58 65.0 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.905 1.282 . . . . 0.0 111.48 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 m -72.3 -27.9 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 O-C-N 121.171 -0.956 . . . . 0.0 111.694 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.89 -37.67 67.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.44 -50.34 16.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 126.277 1.831 . . . . 0.0 109.614 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.58 -34.82 78.74 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.967 0.907 . . . . 0.0 111.266 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -66.49 122.83 18.44 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 119.48 -2.013 . . . . 0.0 109.379 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.26 7.04 59.69 Favored Glycine 0 CA--C 1.496 -1.12 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.83 147.43 34.74 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -77.49 131.74 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.976 2.45 . . . . 0.0 110.792 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 0.1 82.16 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.55 26.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.39 1.476 . . . . 0.0 109.825 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.88 -28.25 8.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 14.1 tp -98.74 83.25 2.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.612 -1.305 . . . . 0.0 108.271 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.2 pt -127.3 64.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -154.03 125.17 7.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -60.43 -47.49 96.22 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-O 115.944 -1.979 . . . . 0.0 113.754 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -71.7 -26.54 19.32 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 CA-C-N 126.04 3.193 . . . . 0.0 110.908 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -85.65 -8.81 58.0 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.97 79.68 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.105 -0.997 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.82 -33.32 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.95 -26.96 49.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.56 -1.337 . . . . 0.0 111.174 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -70.87 -46.43 62.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -66.25 -20.79 66.21 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.313 -0.867 . . . . 0.0 112.941 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.54 -51.47 72.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 124.457 1.103 . . . . 0.0 110.337 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.26 -27.45 61.58 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 118.803 0.728 . . . . 0.0 110.333 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -69.88 -37.9 76.19 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.94 -29.27 68.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.187 -0.945 . . . . 0.0 111.587 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -88.62 4.67 46.21 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.145 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.384 12.7 p 79.34 -63.62 0.26 Allowed 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 127.762 2.425 . . . . 0.0 107.889 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -1.19 -77.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.023 1 C-N-CA 131.964 4.106 . . . . 0.0 113.064 -177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.57 68.96 1.48 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -63.59 -29.35 70.61 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 121.584 -0.95 . . . . 0.0 111.941 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 42.7 0.88 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -65.24 -46.29 81.2 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -138.95 -152.51 0.42 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -165.99 146.29 5.46 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 100.598 -3.852 . . . . 0.0 100.598 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.83 -174.65 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 124.72 3.613 . . . . 0.0 108.791 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.646 HG22 ' H ' ' C' ' 64' ' ' THR . 13.8 p -135.35 -171.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.646 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.6 m -75.31 -41.86 55.98 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 126.394 1.877 . . . . 0.0 110.389 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.23 -24.42 59.32 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.833 0.853 . . . . 0.0 109.619 -167.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -59.49 -45.91 90.33 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.45 78.03 0.73 Allowed Glycine 0 CA--C 1.465 -3.089 1 N-CA-C 97.44 -6.264 . . . . 0.0 97.44 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -47.51 -17.71 0.1 Allowed 'General case' 0 C--N 1.37 1.499 0 C-N-CA 127.984 2.513 . . . . 0.0 114.629 -166.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -51.18 -16.03 0.44 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 127.637 2.375 . . . . 0.0 113.689 165.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . 0.267 30.0 t -72.04 -39.67 66.36 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 CA-C-N 123.504 2.865 . . . . 0.0 109.2 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.89 95.97 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 110.757 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.34 -43.82 97.93 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.066 0.946 . . . . 0.0 111.066 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -59.58 -51.05 71.51 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 125.077 1.351 . . . . 0.0 111.17 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.08 -43.19 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 26.8 ttp -60.1 -50.32 74.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.266 1.026 . . . . 0.0 110.561 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -65.57 -39.55 91.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.691 -0.631 . . . . 0.0 110.181 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.65 91.73 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.067 0.547 . . . . 0.0 111.059 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.04 -48.22 82.12 Favored Glycine 0 CA--C 1.494 -1.237 0 C-N-CA 123.74 0.686 . . . . 0.0 112.013 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.22 -45.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 124.03 0.932 . . . . 0.0 109.365 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.2 -42.79 95.84 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.27 1.028 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.88 -50.1 78.98 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 110.914 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.27 -35.01 78.63 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 121.363 -0.836 . . . . 0.0 111.167 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.66 -36.95 79.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.128 0.571 . . . . 0.0 110.405 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.01 -25.18 68.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.186 1.394 . . . . 0.0 111.968 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.44 -16.9 8.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 125.155 1.382 . . . . 0.0 110.745 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.8 t -66.16 -11.73 51.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 119.707 -1.87 . . . . 0.0 111.936 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.39 -19.91 63.9 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 110.902 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' C' ' 4' ' ' HIS . . . -89.78 -61.27 1.73 Allowed 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 125.329 1.452 . . . . 0.0 107.722 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.3 mt -68.48 -28.39 66.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -165.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.31 -12.0 60.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 120.626 -1.296 . . . . 0.0 110.632 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -81.58 -15.07 55.89 Favored 'General case' 0 CA--C 1.492 -1.257 0 O-C-N 120.365 -1.46 . . . . 0.0 107.905 175.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.307 63.7 m-20 -93.38 10.57 31.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.222 -155.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -100.12 -19.1 16.63 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 121.515 -0.741 . . . . 0.0 109.793 159.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.9 -25.85 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.487 -1.383 . . . . 0.0 107.339 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -72.22 -3.21 22.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.868 -1.145 . . . . 0.0 112.365 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -61.65 -25.53 67.44 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.435 -1.416 . . . . 0.0 109.9 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.25 -32.75 61.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 124.419 1.088 . . . . 0.0 109.311 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -76.09 -35.38 59.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.357 1.863 . . . . 0.0 108.28 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -77.1 -41.69 41.08 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.235 -0.915 . . . . 0.0 112.114 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -89.54 -12.93 38.49 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.074 -1.016 . . . . 0.0 110.91 -172.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -126.53 112.06 15.11 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.81 -10.69 34.86 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 . . . . . 0 CA--C 1.495 -1.135 0 O-C-N 121.085 -1.244 . . . . 0.0 107.731 -177.686 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.432 -1.357 0 N-CA-C 102.602 -3.11 . . . . 0.0 102.602 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.47 -61.02 1.77 Allowed 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -168.3 -89.77 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 -162.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -59.26 -22.65 61.47 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.557 2.743 . . . . 0.0 114.371 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -67.68 -27.76 67.11 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -69.84 -37.92 76.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -79.36 -34.18 42.26 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.72 95.7 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.424 -0.798 . . . . 0.0 111.355 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.23 67.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.873 -0.517 . . . . 0.0 110.184 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.45 -35.2 79.65 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 124.213 1.005 . . . . 0.0 110.627 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.29 69.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 111.463 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -62.18 -41.07 97.99 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.157 -0.964 . . . . 0.0 110.983 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 -27.46 68.92 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 111.756 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -73.69 -35.32 65.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.0 -41.73 95.12 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.802 -1.187 . . . . 0.0 110.458 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -59.92 -31.35 69.75 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.788 1.235 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -66.67 -47.63 71.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.911 1.284 . . . . 0.0 108.941 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.68 -30.44 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.26 -47.58 83.12 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.06 -48.64 73.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 124.657 1.183 . . . . 0.0 109.246 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -66.03 -34.98 79.33 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.506 1.122 . . . . 0.0 110.575 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.27 43.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.534 -1.354 . . . . 0.0 111.295 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -64.31 -43.77 93.66 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.534 -0.729 . . . . 0.0 109.969 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -69.76 -30.18 67.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -66.49 -50.95 61.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -45.54 78.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.895 1.278 . . . . 0.0 112.248 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.88 -28.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.065 -1.022 . . . . 0.0 111.151 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.29 -33.3 22.16 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.545 -1.347 . . . . 0.0 108.674 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.26 74.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.834 2.054 . . . . 0.0 109.408 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -36.51 84.12 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.52 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp85 -78.38 89.07 4.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.239 1.019 . . . . 0.0 111.653 -165.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.42 -12.74 4.32 Favored Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.69 53.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 124.776 1.23 . . . . 0.0 108.493 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.22 141.99 13.19 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 123.108 2.146 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.19 77.33 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 170.87 9.46 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.3 92.32 1.86 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.05 58.46 0.07 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.013 0.911 . . . . 0.0 109.057 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 28.0 pt -95.23 -179.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 O-C-N 119.908 -1.745 . . . . 0.0 108.801 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.8 134.74 0.02 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.411 2.685 . . . . 0.0 114.044 172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -65.97 -46.11 64.1 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 119.715 -1.865 . . . . 0.0 110.484 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -73.45 -11.75 24.67 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 124.185 2.53 . . . . 0.0 113.971 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . 0.251 1.5 m-20 -90.64 -44.6 9.42 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -31.51 72.78 Favored 'General case' 0 CA--C 1.494 -1.205 0 O-C-N 121.178 -0.951 . . . . 0.0 112.238 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.17 -31.98 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 121.892 -0.505 . . . . 0.0 110.698 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -36.51 76.06 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 120.528 -1.357 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' D' ' 60' ' ' ARG . 65.7 t90 -70.55 -35.11 72.94 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.377 -0.827 . . . . 0.0 110.024 174.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -61.69 -42.06 98.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.178 0.991 . . . . 0.0 109.413 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.37 -53.54 42.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 125.159 1.384 . . . . 0.0 110.196 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.79 -45.89 70.86 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.435 1.494 . . . . 0.0 111.782 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.9 m -66.9 -38.13 85.67 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.071 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.35 73.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.461 -0.775 . . . . 0.0 111.36 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -86.22 5.07 35.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 118.98 -0.534 . . . . 0.0 112.273 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 62.7 p 55.98 46.04 22.66 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.658 1.183 . . . . 0.0 112.982 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.527 HG23 ' H ' ' D' ' 56' ' ' GLY . 0.3 OUTLIER -112.03 -93.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.527 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 101.89 64.68 0.75 Allowed Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -28.57 68.01 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -172.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 129.01 2.27 5.63 Favored Glycine 0 CA--C 1.488 -1.654 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.447 ' CG ' HH22 ' A' ' 68' ' ' ARG . 1.7 m-20 -64.79 -41.79 95.54 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.446 ' HB2' ' CD1' ' D' ' 47' ' ' TRP . 50.5 mmt-85 -134.56 143.72 47.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 102.634 -3.099 . . . . 0.0 102.634 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -128.41 130.61 23.53 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.61 170.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 108.841 172.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -128.96 -167.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -76.8 -36.21 57.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 120.606 -1.309 . . . . 0.0 109.125 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -72.4 -24.06 61.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.059 1.344 . . . . 0.0 112.369 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.11 -24.44 51.74 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 123.108 1.432 . . . . 0.0 107.249 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 60.72 1.17 Allowed Glycine 0 CA--C 1.463 -3.209 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -31.88 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 1 C-N-CA 131.963 4.105 . . . . 0.0 116.927 -171.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.06 1.34 2.81 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 120.375 -1.453 . . . . 0.0 113.309 167.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -51.55 57.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.36 67.88 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.605 1.162 . . . . 0.0 110.965 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -52.44 -40.13 61.86 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.033 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -67.64 -33.75 75.59 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.61 -38.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 120.788 -1.195 . . . . 0.0 109.463 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -60.52 -39.61 88.45 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.761 -0.587 . . . . 0.0 110.902 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -57.52 -47.37 82.14 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.738 0.815 . . . . 0.0 110.76 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.06 97.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.875 0.47 . . . . 0.0 110.993 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.09 -50.57 50.95 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.15 -48.29 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.35 1.06 . . . . 0.0 109.385 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.29 -36.86 84.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.88 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.99 -51.83 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 119.388 0.995 . . . . 0.0 109.658 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.87 -21.84 63.3 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.448 -0.783 . . . . 0.0 111.114 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.02 -33.63 20.99 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.89 -39.19 88.31 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 124.529 1.132 . . . . 0.0 110.233 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.94 -7.99 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 121.519 -0.738 . . . . 0.0 112.321 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -60.86 -18.06 53.84 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-N 119.205 0.911 . . . . 0.0 110.229 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 119.704 -1.873 . . . . 0.0 112.372 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.79 71.69 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.06 -25.83 58.93 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.878 0.371 . . . . 0.0 110.9 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.19 -49.71 33.31 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 120.578 -1.326 . . . . 0.0 109.816 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -71.26 1.8 5.6 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.987 -1.07 . . . . 0.0 111.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.34 -24.09 63.86 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.957 -1.09 . . . . 0.0 108.56 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -67.3 -16.52 64.32 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 119.913 -1.742 . . . . 0.0 112.5 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 5.1 m -73.61 -21.64 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 O-C-N 119.652 -1.905 . . . . 0.0 110.561 -173.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -74.6 3.76 7.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.746 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -80.12 -35.77 36.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -92.29 -48.84 6.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -86.25 174.04 9.36 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 68.82 -66.48 0.24 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.682 1.993 . . . . 0.0 110.285 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -54.74 -53.76 50.86 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 129.395 3.078 . . . . 0.0 109.228 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -115.09 134.87 54.8 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.69 -31.29 6.6 Favored Glycine 0 CA--C 1.494 -1.273 0 O-C-N 121.54 -0.725 . . . . 0.0 111.349 172.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 35.2 p80 . . . . . 0 CA--C 1.502 -0.872 0 C-N-CA 125.072 1.349 . . . . 0.0 112.719 -172.037 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.17 23.12 1.08 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.745 2.418 . . . . 0.0 113.544 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 62.96 12.04 5.56 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.938 2.095 . . . . 0.0 112.113 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -154.68 -36.35 0.09 Allowed 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 120.84 -1.163 . . . . 0.0 111.0 -164.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.6 -45.76 71.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -62.26 -37.76 86.67 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.386 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.47 -37.62 56.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.99 0.916 . . . . 0.0 109.289 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.57 89.45 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.948 0.899 . . . . 0.0 111.434 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -75.79 -16.75 60.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.315 -0.866 . . . . 0.0 111.583 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -76.6 -36.89 57.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.2 80.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.655 1.182 . . . . 0.0 111.19 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -55.83 -42.45 75.74 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 123.719 0.807 . . . . 0.0 111.7 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.9 -28.82 67.03 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.27 1.028 . . . . 0.0 110.601 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -41.59 87.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 81' ' ' VAL . 24.9 tp -64.83 -39.43 93.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 122.632 0.373 . . . . 0.0 111.36 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -54.52 -46.09 73.48 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.206 0.602 . . . . 0.0 111.847 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -74.44 -32.26 62.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.88 -1.137 . . . . 0.0 111.855 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.65 -42.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.781 -1.2 . . . . 0.0 109.706 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.47 -30.42 69.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.923 -1.11 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -65.04 -41.64 95.01 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.607 -1.308 . . . . 0.0 111.033 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -62.29 -47.05 86.02 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.16 0.981 . . . . 0.0 109.268 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -27.89 69.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.76 0.824 . . . . 0.0 112.39 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.7 m -63.18 -33.33 75.24 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.366 1.067 . . . . 0.0 111.379 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -72.56 -36.37 68.21 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.22 -47.55 67.56 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -47.17 79.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.992 1.717 . . . . 0.0 112.672 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.6 -30.33 46.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 O-C-N 120.748 -1.22 . . . . 0.0 110.789 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.06 -41.74 41.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.677 -1.264 . . . . 0.0 108.515 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.51 38.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 128.005 2.522 . . . . 0.0 108.634 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -63.82 -50.71 67.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.509 1.124 . . . . 0.0 111.134 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.0 ttp85 -81.55 101.58 10.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 119.681 -1.887 . . . . 0.0 111.266 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -27.18 2.16 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 104.593 -3.403 . . . . 0.0 104.593 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 151.13 62.79 Favored Pre-proline 0 N--CA 1.439 -1.025 0 C-N-CA 124.016 0.927 . . . . 0.0 111.932 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -77.62 105.5 2.04 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.878 2.386 . . . . 0.0 112.12 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.67 11.62 11.28 Favored Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.91 132.3 5.34 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 127.442 2.297 . . . . 0.0 115.276 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.06 -61.69 1.65 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.279 1.032 . . . . 0.0 111.166 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.79 106.85 18.35 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-O 122.257 1.027 . . . . 0.0 112.798 -171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -111.41 169.58 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 O-C-N 120.266 -1.521 . . . . 0.0 108.586 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 m 71.81 146.01 0.07 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.771 2.428 . . . . 0.0 113.141 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -72.69 -51.58 6.8 Favored Pre-proline 0 C--N 1.349 0.583 0 CA-C-O 115.925 -1.988 . . . . 0.0 111.886 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.14 -11.02 26.71 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 125.338 2.942 . . . . 0.0 111.992 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.2 -34.7 11.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.1 96.04 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.037 -1.04 . . . . 0.0 110.771 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.88 -33.4 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 122.753 0.421 . . . . 0.0 111.562 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -28.79 65.45 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.152 -1.592 . . . . 0.0 110.763 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -76.93 -40.55 46.77 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 107.962 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -63.87 -30.81 71.86 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 121.026 -1.046 . . . . 0.0 112.61 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.23 -36.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-N 118.723 0.692 . . . . 0.0 110.155 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -63.19 -61.1 2.6 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -50.33 -36.99 34.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.176 1.79 . . . . 0.0 113.25 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.38 97.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.707 1.203 . . . . 0.0 111.71 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -91.51 4.68 51.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.283 30.1 p 66.86 -136.54 0.14 Allowed 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 127.304 2.242 . . . . 0.0 108.244 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 t 69.19 -79.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.64 87.45 0.47 Allowed Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -72.01 -33.31 67.97 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.399 -1.059 . . . . 0.0 108.263 -170.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.57 16.55 1.65 Allowed Glycine 0 CA--C 1.489 -1.575 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -58.93 -56.36 23.25 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 117.838 0.819 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 166.34 24.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 174.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.8 142.7 19.21 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 102.314 -3.217 . . . . 0.0 102.314 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -84.06 162.53 13.6 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.02 2.48 . . . . 0.0 110.132 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 64' ' ' THR . 1.7 p -104.77 176.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 122.288 1.042 . . . . 0.0 108.965 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.551 ' HA ' ' CE2' ' D' ' 46' ' ' TRP . 0.2 OUTLIER -61.67 -47.8 83.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 127.59 2.356 . . . . 0.0 114.219 -166.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -81.48 1.09 34.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 118.967 -2.333 . . . . 0.0 110.246 -170.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -32.43 72.23 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-O 123.372 1.558 . . . . 0.0 107.797 175.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.0 85.78 0.96 Allowed Glycine 0 CA--C 1.471 -2.714 1 N-CA-C 100.995 -4.842 . . . . 0.0 100.995 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.59 ' HB2' ' CE2' ' D' ' 46' ' ' TRP . 1.7 ttp85 -58.62 -9.0 1.44 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 118.24 1.02 . . . . 0.0 113.202 -169.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -45.96 -35.9 5.07 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.207 1.403 . . . . 0.0 112.659 160.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.36 -59.5 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.12 77.21 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.503 0.721 . . . . 0.0 112.436 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.16 -39.08 71.78 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.595 2.358 . . . . 0.0 111.57 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -70.13 -31.03 68.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 t -71.65 -41.76 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 O-C-N 121.512 -0.742 . . . . 0.0 109.073 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 59.9 mtt -56.28 -49.52 74.01 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.604 1.162 . . . . 0.0 110.433 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -66.76 -37.24 84.23 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.15 -0.969 . . . . 0.0 110.647 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.56 87.34 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.152 -0.968 . . . . 0.0 111.015 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -71.08 -38.94 63.51 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -70.88 -35.77 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 O-C-N 121.289 -1.124 . . . . 0.0 109.348 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.87 -38.15 89.7 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 120.429 -1.419 . . . . 0.0 112.285 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 15' ' ' LEU . 30.7 m -68.51 -39.11 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -78.17 -30.43 49.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.477 0.58 . . . . 0.0 109.922 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.89 89.08 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 123.575 0.75 . . . . 0.0 110.494 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.91 -30.31 71.3 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.849 1.26 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.48 -11.99 7.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 C-N-CA 125.327 1.451 . . . . 0.0 110.614 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.681 HG21 ' HB3' ' D' ' 89' ' ' LEU . 6.8 t -53.55 -25.74 18.33 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 119.728 -1.857 . . . . 0.0 112.621 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -18.98 63.82 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.094 -1.004 . . . . 0.0 109.716 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.85 -50.8 7.23 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.47 -48.42 69.94 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.428 1.091 . . . . 0.0 113.423 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.18 -12.6 60.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -84.7 -27.25 27.15 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -32.97 74.6 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.557 -1.339 . . . . 0.0 110.991 -159.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -62.38 -30.64 71.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.32 -0.862 . . . . 0.0 112.837 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.78 -24.37 35.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.237 1.415 . . . . 0.0 108.819 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -59.35 -24.14 63.12 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.31 -0.869 . . . . 0.0 112.471 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -64.87 -28.55 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.972 -1.08 . . . . 0.0 110.395 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.51 -24.34 58.98 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 119.253 0.933 . . . . 0.0 109.805 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.4 -42.3 54.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.195 -0.941 . . . . 0.0 108.922 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -72.05 -30.51 65.22 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.663 -0.648 . . . . 0.0 110.726 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -66.98 -31.37 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.865 -1.147 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -72.59 -41.34 65.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.143 -0.973 . . . . 0.0 108.686 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.94 27.01 27.46 Favored Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.963 . . . . 0.0 111.266 -179.477 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' B' ' 5' ' ' GLU . . . -81.51 175.44 10.52 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.367 0.603 . . . . 0.0 109.773 -174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.92 -52.63 31.68 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 127.696 2.398 . . . . 0.0 111.709 -172.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -73.33 -19.53 61.0 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.264 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' B' ' 2' ' ' ALA . 3.1 mm-40 -82.33 -32.53 29.33 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.49 -25.44 61.41 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.623 -0.673 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.27 -49.85 72.46 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.568 1.147 . . . . 0.0 108.879 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.56 87.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.03 1.332 . . . . 0.0 110.838 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.23 -37.95 87.36 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.924 0.89 . . . . 0.0 110.75 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -69.46 -25.94 64.34 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.42 -1.425 . . . . 0.0 110.702 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.91 71.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 120.701 -1.249 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.0 -37.61 77.26 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.742 1.217 . . . . 0.0 111.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.29 -30.78 71.27 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.587 1.555 . . . . 0.0 110.11 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -70.64 -42.67 70.53 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.536 1.134 . . . . 0.0 108.57 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.21 -38.61 91.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 123.865 0.866 . . . . 0.0 111.364 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -63.77 -29.72 70.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.446 -0.784 . . . . 0.0 111.789 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -75.58 -30.28 59.59 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.858 -1.151 . . . . 0.0 110.637 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.11 -38.9 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.87 -44.95 78.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 124.069 0.948 . . . . 0.0 111.784 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.85 -48.88 67.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.337 0.655 . . . . 0.0 110.31 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.14 -24.2 60.56 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.936 -1.102 . . . . 0.0 110.898 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 -26.03 62.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 120.981 -1.075 . . . . 0.0 111.532 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -63.75 -46.8 83.66 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.64 -45.31 87.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.667 1.187 . . . . 0.0 109.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -60.55 -59.11 5.92 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.446 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.02 89.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 111.804 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.79 -35.71 61.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.72 -1.238 . . . . 0.0 110.317 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.16 -39.17 55.53 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.047 -1.033 . . . . 0.0 109.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.59 70.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 127.072 2.149 . . . . 0.0 109.461 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.58 61.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.816 -0.552 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -72.83 95.94 2.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.693 -1.879 . . . . 0.0 111.379 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.18 -11.95 3.3 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.63 152.65 47.32 Favored Pre-proline 0 N--CA 1.442 -0.845 0 O-C-N 121.254 -1.144 . . . . 0.0 109.496 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.64 152.75 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.022 2.481 . . . . 0.0 109.576 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -78.14 1.8 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.509 -3.437 . . . . 0.0 104.509 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.13 138.71 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 129.226 3.01 . . . . 0.0 111.247 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.73 -39.85 1.95 Allowed 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 120.278 -1.514 . . . . 0.0 108.289 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -100.18 137.24 38.88 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.79 0.805 . . . . 0.0 109.575 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.6 pt -147.02 175.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 100.497 -3.89 . . . . 0.0 100.497 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m 72.77 129.88 0.04 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 112.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -67.77 -48.71 41.13 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 116.818 -1.563 . . . . 0.0 110.102 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.66 -13.08 29.66 Favored 'Trans proline' 0 CA--C 1.509 -0.751 0 CA-C-N 124.987 2.817 . . . . 0.0 113.004 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.24 -25.83 17.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.988 1.267 . . . . 0.0 107.649 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.66 81.48 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.359 -0.838 . . . . 0.0 111.162 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.04 -34.12 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 121.444 -0.785 . . . . 0.0 110.301 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -36.35 72.08 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.801 -1.187 . . . . 0.0 110.327 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -64.49 -44.26 91.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.44 1.496 . . . . 0.0 109.368 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -57.74 -39.36 77.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.867 1.667 . . . . 0.0 111.3 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -53.84 -51.98 39.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 124.716 1.206 . . . . 0.0 111.271 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -71.9 -22.08 61.55 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.762 0.71 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.0 m -74.07 -40.71 62.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.017 0.927 . . . . 0.0 108.757 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -28.83 63.49 Favored 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 121.142 -0.974 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.4 p -84.64 3.83 35.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.568 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 53.82 51.58 14.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.822 1.649 . . . . 0.0 111.062 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -117.81 -111.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.105 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.21 76.39 1.22 Allowed Glycine 0 CA--C 1.483 -1.924 0 N-CA-C 104.804 -3.318 . . . . 0.0 104.804 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -74.49 -16.59 60.84 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.868 -1.371 . . . . 0.0 109.745 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.75 52.85 0.53 Allowed Glycine 0 CA--C 1.481 -2.092 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.15 -59.12 2.9 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -144.02 174.93 10.42 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -142.28 129.35 11.19 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.82 165.87 27.89 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 124.116 3.211 . . . . 0.0 110.318 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.526 HG22 ' H ' ' B' ' 64' ' ' THR . 3.8 p -101.61 -167.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 122.752 1.263 . . . . 0.0 109.234 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.526 ' H ' HG22 ' B' ' 63' ' ' VAL . 3.1 p -86.89 -39.68 15.58 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.872 -1.767 . . . . 0.0 109.245 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.62 -9.12 59.8 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.011 1.725 . . . . 0.0 110.884 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.39 -23.79 61.95 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-O 124.297 1.998 . . . . 0.0 107.18 169.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.54 75.72 1.27 Allowed Glycine 0 CA--C 1.468 -2.873 1 N-CA-C 101.978 -4.449 . . . . 0.0 101.978 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -47.61 -12.2 0.03 OUTLIER 'General case' 0 C--N 1.373 1.587 0 C-N-CA 129.96 3.304 . . . . 0.0 113.729 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -50.63 -19.62 0.97 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.458 1.903 . . . . 0.0 113.627 158.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.93 -54.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 CA-C-N 122.089 2.222 . . . . 0.0 107.342 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.54 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.324 0.583 . . . . 0.0 110.733 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.89 -42.66 80.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.269 1.428 . . . . 0.0 111.996 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.96 -40.96 95.79 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.392 1.077 . . . . 0.0 110.1 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.09 -46.92 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 C-N-CA 123.536 0.734 . . . . 0.0 109.578 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 46.1 mtp -59.23 -48.77 80.37 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.18 0.992 . . . . 0.0 110.285 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -61.99 -41.02 97.58 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.167 0.987 . . . . 0.0 110.771 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.59 91.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 123.01 0.524 . . . . 0.0 111.122 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.64 -49.57 63.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.37 -44.66 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 124.192 0.997 . . . . 0.0 109.316 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.68 -38.35 90.71 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.788 -1.195 . . . . 0.0 111.754 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.48 -53.03 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.207 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.2 -11.63 60.58 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.336 0.655 . . . . 0.0 112.118 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.99 -21.13 15.13 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 123.755 0.822 . . . . 0.0 109.657 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.94 -28.13 64.27 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 119.632 -1.918 . . . . 0.0 108.976 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.16 -14.94 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.943 0.897 . . . . 0.0 111.996 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 66.8 m -58.95 -12.44 4.55 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 125.936 1.694 . . . . 0.0 111.674 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.82 -26.05 68.55 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.538 -1.976 . . . . 0.0 112.388 167.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.01 -30.81 27.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 119.856 -1.778 . . . . 0.0 108.742 175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.26 31.42 0.65 Allowed 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 126.04 1.736 . . . . 0.0 109.29 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.6 -1.98 1.11 Allowed 'General case' 0 N--CA 1.433 -1.316 0 O-C-N 120.59 -1.318 . . . . 0.0 108.26 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -116.85 16.94 15.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -83.2 -48.52 10.41 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.354 2.262 . . . . 0.0 107.188 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -65.2 -20.41 66.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.481 1.113 . . . . 0.0 111.648 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.55 -28.53 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 124.657 1.183 . . . . 0.0 109.375 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -65.65 -21.72 66.58 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 124.51 1.124 . . . . 0.0 111.916 -172.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -19.18 63.33 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.828 -1.17 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -96.26 179.58 4.99 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.311 7.6 mt-10 70.21 -59.26 0.52 Allowed 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.355 1.462 . . . . 0.0 112.058 -172.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -30.71 70.16 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.935 1.294 . . . . 0.0 109.762 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.91 -33.35 61.98 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 126.568 1.947 . . . . 0.0 112.796 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -110.35 -0.8 17.47 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 108.651 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.2 11.46 85.03 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 121.402 -0.811 . . . . 0.0 112.363 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 CA--C 1.504 -0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 110.865 -171.289 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.15 -7.53 0.95 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.304 2.242 . . . . 0.0 113.69 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . 0.28 38.1 m-20 19.17 68.35 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.911 1 C-N-CA 132.657 4.383 . . . . 0.0 113.328 -173.68 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -161.68 -45.61 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.48 -47.69 83.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.879 2.072 . . . . 0.0 110.263 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -80.73 -6.63 58.72 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.645 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.84 -47.36 11.95 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.65 93.85 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.044 0.938 . . . . 0.0 110.632 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -57.11 -38.28 73.18 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.815 1.246 . . . . 0.0 111.751 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -72.92 -28.11 62.26 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.167 -0.958 . . . . 0.0 110.446 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.27 -40.29 77.9 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.056 0.542 . . . . 0.0 109.695 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.11 -40.33 93.36 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.515 0.726 . . . . 0.0 110.947 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.36 -38.8 81.33 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.74 0.816 . . . . 0.0 111.442 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.29 -40.09 93.39 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.116 1.366 . . . . 0.0 109.519 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.49 -38.65 91.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.555 -0.716 . . . . 0.0 111.055 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.44 -31.8 72.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.382 -0.824 . . . . 0.0 112.149 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -67.73 -39.65 84.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.05 0.94 . . . . 0.0 109.368 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.54 -32.61 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 124.286 1.034 . . . . 0.0 109.035 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.3 -44.95 88.78 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.016 0.825 . . . . 0.0 111.176 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.54 -38.27 80.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.398 0.679 . . . . 0.0 110.242 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.56 -44.42 86.79 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 121.186 -0.946 . . . . 0.0 109.077 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.18 72.91 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.807 1.643 . . . . 0.0 111.41 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -59.42 -47.6 84.84 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.006 0.922 . . . . 0.0 111.553 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -45.69 69.76 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 125.149 1.38 . . . . 0.0 108.221 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.64 -36.07 78.12 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.893 0.477 . . . . 0.0 111.01 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.73 -44.42 61.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 123.825 0.85 . . . . 0.0 110.73 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.57 -32.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 121.471 -0.768 . . . . 0.0 110.018 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -84.66 -12.85 53.09 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.108 -0.995 . . . . 0.0 111.382 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.4 78.73 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.494 ' OE1' HG12 ' C' ' 63' ' ' VAL . 80.6 mm-40 -81.33 -10.12 59.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.764 0.792 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -78.97 81.96 5.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 119.921 -1.737 . . . . 0.0 108.3 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.09 0.51 4.22 Favored Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.21 42.89 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.37 112.51 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.533 2.155 . . . . 0.0 113.388 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.26 -46.27 0.67 Allowed Glycine 0 CA--C 1.482 -1.999 1 N-CA-C 101.949 -4.461 . . . . 0.0 101.949 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 73.16 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.626 1.97 . . . . 0.0 108.419 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.6 -71.39 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 112.573 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 tt -100.68 120.35 39.94 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.48 13.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 28.3 t -109.67 130.49 55.51 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.72 -56.36 9.74 Favored Pre-proline 0 C--N 1.349 0.572 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.026 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.02 -12.07 25.73 Favored 'Trans proline' 0 CA--C 1.511 -0.669 0 CA-C-N 124.988 2.817 . . . . 0.0 111.386 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.83 -20.34 21.58 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 119.366 0.985 . . . . 0.0 108.7 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.49 -36.25 83.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.338 -0.851 . . . . 0.0 109.95 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -72.35 -25.92 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.876 1.27 . . . . 0.0 110.557 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 -42.27 37.02 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.525 -1.359 . . . . 0.0 107.812 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -70.07 -32.47 70.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.657 0.783 . . . . 0.0 110.684 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 54.6 p -68.67 -27.52 66.06 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.249 -1.532 . . . . 0.0 111.311 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.03 -53.57 47.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 CA-C-N 119.14 0.882 . . . . 0.0 109.601 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.96 -10.94 59.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.812 -0.555 . . . . 0.0 112.005 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -81.12 -33.32 33.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.172 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -35.55 75.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.775 -1.203 . . . . 0.0 111.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.46 0.73 48.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 122.039 -0.413 . . . . 0.0 110.596 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.9 p 65.42 20.18 11.72 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 126.085 1.754 . . . . 0.0 111.493 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.79 -55.89 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.39 44.31 97.81 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 121.629 -0.669 . . . . 0.0 112.125 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 1.5 t80 -55.84 -40.65 73.13 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.616 1.567 . . . . 0.0 110.518 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.59 -122.79 1.12 Allowed Glycine 0 CA--C 1.48 -2.14 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.322 4.4 t0 62.62 -85.29 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 127.072 2.149 . . . . 0.0 108.947 -168.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -119.67 169.07 10.42 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.34 148.72 21.48 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.92 176.58 7.49 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.033 2.488 . . . . 0.0 108.695 171.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.755 HG13 ' H ' ' C' ' 64' ' ' THR 0.285 9.9 p -101.2 -121.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 170.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.755 ' H ' HG13 ' C' ' 63' ' ' VAL . 12.6 m -107.34 -82.67 0.55 Allowed 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 120.283 -1.511 . . . . 0.0 107.174 -171.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.05 122.41 12.98 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.101 1.36 . . . . 0.0 109.406 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . 0.28 6.6 tt0 76.33 -68.63 0.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.301 -1.333 . . . . 0.0 112.637 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -37.15 -49.07 1.54 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 128.216 2.817 . . . . 0.0 114.646 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -75.31 -38.46 60.26 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.798 1.239 . . . . 0.0 112.094 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -76.48 -29.74 56.99 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.84 -44.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 O-C-N 119.766 -1.834 . . . . 0.0 109.08 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.14 99.37 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 111.205 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -48.82 -44.85 39.69 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.692 1.997 . . . . 0.0 112.194 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -63.94 -40.1 95.66 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.69 -39.23 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 124.342 1.057 . . . . 0.0 109.263 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.42 -45.86 87.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.28 -39.34 94.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.696 0.799 . . . . 0.0 110.931 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.48 71.61 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.914 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.65 -49.87 7.63 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.13 -46.29 84.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 110.167 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.62 -31.83 73.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.421 -0.799 . . . . 0.0 112.572 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.59 -51.59 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -66.17 -33.98 77.01 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 122.878 0.471 . . . . 0.0 110.975 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.56 83.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.53 1.132 . . . . 0.0 110.517 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.72 -22.16 66.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.772 1.229 . . . . 0.0 112.935 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -59.59 -19.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 124.892 1.277 . . . . 0.0 110.401 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -57.77 -20.42 34.95 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 112.631 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.0 51.15 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.311 -1.493 . . . . 0.0 112.422 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.09 -31.57 11.7 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.792 1.237 . . . . 0.0 110.644 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 35.1 mt -82.62 -41.43 19.47 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.428 -0.795 . . . . 0.0 109.956 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.84 72.75 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.5 1.12 . . . . 0.0 109.62 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -16.79 64.13 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.522 -1.361 . . . . 0.0 112.098 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 26.4 t70 -74.36 -24.42 59.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.497 1.044 . . . . 0.0 110.518 -168.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -37.97 61.3 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 120.705 -1.247 . . . . 0.0 109.705 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.25 -27.85 42.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 125.32 1.448 . . . . 0.0 110.191 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -59.72 -22.52 62.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.342 1.057 . . . . 0.0 113.027 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . 0.3 18.3 ptt85 -69.46 -28.59 66.23 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 121.254 1.843 . . . . 0.0 111.506 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.8 -13.45 59.8 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 119.621 -1.924 . . . . 0.0 110.345 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -87.76 -36.72 17.16 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.269 -0.895 . . . . 0.0 108.924 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -51.97 -42.73 63.13 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 128.008 2.523 . . . . 0.0 109.545 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -45.66 -37.66 5.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.368 2.667 . . . . 0.0 114.289 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -90.62 -12.91 35.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.329 -0.857 . . . . 0.0 110.459 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.08 82.38 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 123.85 0.738 . . . . 0.0 111.74 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 CA--C 1.504 -0.795 0 C-N-CA 124.527 1.131 . . . . 0.0 111.202 -172.112 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 144.98 33.96 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -55.85 -46.28 78.23 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.087 2.155 . . . . 0.0 110.466 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CD2' ' HB1' ' D' ' 87' ' ' ALA 0.252 1.4 m80 -81.15 -16.34 53.25 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -169.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.06 -30.82 31.17 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.418 1.008 . . . . 0.0 109.166 169.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -63.42 -46.1 87.94 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.54 -31.17 66.74 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.97 -0.457 . . . . 0.0 110.4 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.21 70.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 121.353 -0.842 . . . . 0.0 110.744 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -69.84 -29.95 67.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.835 -0.54 . . . . 0.0 111.574 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.27 -40.62 91.0 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.713 0.805 . . . . 0.0 110.232 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.46 84.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.591 0.756 . . . . 0.0 111.445 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.19 -37.88 81.56 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 121.459 -0.775 . . . . 0.0 110.912 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -70.96 -26.53 63.2 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.981 -1.075 . . . . 0.0 111.337 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -76.15 -34.19 59.38 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.23 -39.53 93.12 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.33 0.652 . . . . 0.0 111.164 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.02 -35.19 74.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.615 0.766 . . . . 0.0 111.916 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -67.11 -39.25 86.64 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.691 -0.631 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.65 -39.85 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.075 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.738 HD22 ' H ' ' D' ' 49' ' ' VAL . 87.3 mt -64.84 -37.5 87.84 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.136 0.974 . . . . 0.0 112.478 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -67.84 -32.69 73.38 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.61 0.719 . . . . 0.0 111.577 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.79 -36.4 28.48 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.417 -0.802 . . . . 0.0 108.949 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.35 84.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 125.455 1.502 . . . . 0.0 111.992 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -66.77 -40.95 88.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.597 0.713 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -69.09 -39.47 78.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 109.175 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -73.59 -40.33 63.96 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.855 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.21 80.89 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.092 1.357 . . . . 0.0 112.642 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.96 -38.05 81.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 O-C-N 120.832 -1.168 . . . . 0.0 111.647 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.91 -23.17 36.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.964 -1.085 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.24 -52.81 20.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.641 1.976 . . . . 0.0 107.774 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.02 -33.44 70.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.582 1.182 . . . . 0.0 111.946 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -68.93 104.77 2.17 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.63 -1.919 . . . . 0.0 112.14 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.06 -33.92 1.98 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 104.824 -3.311 . . . . 0.0 104.824 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.41 150.64 73.95 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 123.771 0.828 . . . . 0.0 110.412 -173.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.46 145.63 23.81 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.064 1.842 . . . . 0.0 109.301 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.11 17.57 74.07 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 118.563 0.619 . . . . 0.0 112.125 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.49 128.41 22.79 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.891 1.676 . . . . 0.0 113.573 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.44 -39.46 1.02 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.993 1.317 . . . . 0.0 109.709 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.39 15.3 1.28 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.84 1.656 . . . . 0.0 111.609 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tp -98.63 121.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 119.6 -1.937 . . . . 0.0 108.257 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.8 p -172.82 -105.06 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.81 -65.21 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.006 0 C-N-CA 128.111 2.565 . . . . 0.0 106.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 -18.98 28.24 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 124.837 2.763 . . . . 0.0 110.804 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.62 -22.56 26.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.87 -33.64 62.11 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 120.941 -1.099 . . . . 0.0 111.468 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.67 -20.79 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.607 1.194 . . . . 0.0 108.747 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.59 ' CE2' ' HB2' ' A' ' 68' ' ' ARG . 24.9 t90 -77.55 -40.43 42.51 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.336 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -60.14 -44.14 95.19 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.19 1.396 . . . . 0.0 109.925 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 82.3 p -74.97 -169.76 0.97 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.999 0.904 . . . . 0.0 108.982 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.738 ' H ' HD22 ' D' ' 19' ' ' LEU 0.352 2.1 t 71.58 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.955 2.102 . . . . 0.0 110.683 -170.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -28.63 70.13 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.618 1.099 . . . . 0.0 110.415 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -29.87 69.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.037 0.935 . . . . 0.0 111.126 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -77.94 -27.75 49.42 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.809 -1.182 . . . . 0.0 109.844 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -83.74 3.63 32.43 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.442 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 71.2 p 54.61 59.59 4.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.252 2.221 . . . . 0.0 111.871 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -109.06 -89.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 89.45 60.45 1.45 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -9.95 59.24 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 121.674 -0.898 . . . . 0.0 111.498 -170.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.37 35.35 3.63 Favored Glycine 0 CA--C 1.486 -1.763 0 O-C-N 120.467 -1.395 . . . . 0.0 110.81 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.02 -65.23 0.8 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -138.01 153.76 49.37 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 102.957 -2.979 . . . . 0.0 102.957 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.69 144.22 48.05 Favored Pre-proline 0 N--CA 1.44 -0.937 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.01 165.9 25.62 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.249 2.632 . . . . 0.0 109.546 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.546 HG12 ' H ' ' D' ' 64' ' ' THR . 2.8 t -103.69 -153.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.546 ' H ' HG12 ' D' ' 63' ' ' VAL . 0.2 OUTLIER -93.14 -54.29 3.78 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 119.619 -1.926 . . . . 0.0 109.279 -161.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.03 3.65 33.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 109.245 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -25.91 62.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.85 55.54 1.4 Allowed Glycine 0 CA--C 1.466 -3.012 0 N-CA-C 104.575 -3.41 . . . . 0.0 104.575 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -21.42 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.376 1.733 1 C-N-CA 133.878 4.871 . . . . 0.0 116.825 -174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -52.47 -16.21 0.84 Allowed 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 125.601 1.56 . . . . 0.0 113.256 162.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.05 -47.39 88.09 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 122.246 2.294 . . . . 0.0 108.449 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.94 -47.84 73.35 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.099 0.56 . . . . 0.0 110.63 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.03 -38.95 80.5 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 111.704 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -67.79 -29.33 68.49 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.561 -1.337 . . . . 0.0 111.44 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.71 -42.13 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 121.307 -0.87 . . . . 0.0 108.672 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.54 -49.71 76.44 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.717 1.207 . . . . 0.0 109.829 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -65.32 -37.77 88.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.015 -0.428 . . . . 0.0 111.298 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.94 92.38 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -50.39 61.49 Favored Glycine 0 CA--C 1.49 -1.478 0 C-N-CA 124.129 0.871 . . . . 0.0 111.067 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -57.83 -48.29 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.387 1.075 . . . . 0.0 109.598 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.05 -32.05 73.57 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 t -65.62 -55.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-N 119.371 0.987 . . . . 0.0 109.388 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.63 -38.6 84.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.324 0.583 . . . . 0.0 110.375 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.53 63.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.346 -0.847 . . . . 0.0 111.047 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.06 -30.9 71.5 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.182 -1.574 . . . . 0.0 110.118 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 -12.47 7.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.804 1.242 . . . . 0.0 110.68 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -52.79 -22.82 5.78 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.448 -1.408 . . . . 0.0 111.621 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' D' ' 4' ' ' HIS . . . -73.54 -19.26 60.95 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 119.466 -2.021 . . . . 0.0 114.423 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.32 -41.8 15.19 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.681 ' HB3' HG21 ' A' ' 86' ' ' THR . 39.8 mt -59.91 -40.98 90.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 112.525 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.83 64.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.201 -0.937 . . . . 0.0 111.871 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -92.14 -1.0 57.42 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 120.777 -1.202 . . . . 0.0 108.462 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -74.58 -30.22 61.63 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 119.253 0.933 . . . . 0.0 109.753 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -80.83 -31.8 35.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 120.597 -1.314 . . . . 0.0 111.524 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -23.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 125.163 1.385 . . . . 0.0 109.294 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -50.16 -35.35 25.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 125.606 1.563 . . . . 0.0 113.256 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -71.24 -16.57 62.5 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.315 -0.866 . . . . 0.0 110.87 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -77.45 -43.88 30.91 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.38 -45.29 76.69 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.517 -0.74 . . . . 0.0 111.454 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.4 -9.91 59.19 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.281 -0.887 . . . . 0.0 111.5 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 18.8 ttp-105 -70.25 -31.09 68.32 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -78.92 -23.6 44.59 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.163 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.07 17.15 59.78 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 . . . . . 0 C--N 1.357 0.905 0 C-N-CA 125.916 1.686 . . . . 0.0 112.409 -178.182 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -72.08 0.23 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 123.225 0.61 . . . . 0.0 109.407 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -151.85 -82.49 0.09 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -0.28 31.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 121.068 -1.02 . . . . 0.0 113.324 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -30.06 68.26 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.334 1.454 . . . . 0.0 108.248 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -66.88 -37.9 85.29 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.606 0.763 . . . . 0.0 109.05 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.7 -28.55 36.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.38 76.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.421 0.629 . . . . 0.0 111.16 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -75.32 -23.49 57.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.568 -0.707 . . . . 0.0 111.043 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.84 -36.03 77.68 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.588 -0.695 . . . . 0.0 109.51 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.84 71.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.976 -1.078 . . . . 0.0 111.471 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.83 -23.22 65.14 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.417 -0.802 . . . . 0.0 111.97 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.47 -43.09 67.24 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 120.658 -1.276 . . . . 0.0 109.242 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.48 -39.14 92.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.653 1.181 . . . . 0.0 108.645 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.24 -43.29 92.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.003 0.521 . . . . 0.0 111.562 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.17 -30.9 71.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.812 0.845 . . . . 0.0 111.905 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -69.43 -39.8 77.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.49 -0.756 . . . . 0.0 109.646 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.8 -38.79 82.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 O-C-N 121.29 -0.881 . . . . 0.0 109.202 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -58.77 -42.68 89.53 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.788 0.835 . . . . 0.0 111.618 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.82 -28.53 62.61 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.33 1.052 . . . . 0.0 111.737 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -73.73 -46.12 47.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.745 -1.222 . . . . 0.0 107.798 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -27.95 68.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.761 1.225 . . . . 0.0 112.221 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 p -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.654 1.116 . . . . 0.0 110.791 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.32 -43.62 77.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.58 -44.72 95.61 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.02 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 126.212 1.805 . . . . 0.0 112.42 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 41' ' ' TYR . 26.2 m -64.66 -34.94 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 119.955 1.252 . . . . 0.0 112.131 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -78.18 -35.48 48.64 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 125.256 1.423 . . . . 0.0 108.38 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -77.67 -51.2 10.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 124.662 1.185 . . . . 0.0 108.505 -175.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.03 -40.66 87.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.085 0.945 . . . . 0.0 110.267 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -77.23 104.82 7.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 119.802 -1.811 . . . . 0.0 111.349 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -21.89 2.36 Favored Glycine 0 CA--C 1.49 -1.489 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.23 89.0 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 123.4 0.68 . . . . 0.0 110.702 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.68 126.05 11.69 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.971 2.448 . . . . 0.0 110.105 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -67.81 3.26 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 106.069 -2.812 . . . . 0.0 106.069 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.7 -172.98 0.18 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 126.516 1.926 . . . . 0.0 108.55 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.81 -40.41 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.969 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.33 -68.47 0.64 Allowed 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt 32.02 37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 128.326 2.65 . . . . 0.0 114.934 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -148.72 133.6 18.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' HG11 ' A' ' 27' ' ' VAL . 73.8 t80 -79.67 -52.14 1.12 Allowed Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-O 116.01 -1.947 . . . . 0.0 110.8 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.71 -13.42 29.66 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 CA-C-N 126.145 3.23 . . . . 0.0 111.73 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.57 -27.79 29.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.487 1.515 . . . . 0.0 108.559 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.46 -33.72 76.6 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.778 0.831 . . . . 0.0 111.785 -167.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -73.56 -24.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 123.836 0.855 . . . . 0.0 110.376 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.85 -32.45 21.71 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 120.744 -1.222 . . . . 0.0 108.766 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -70.23 -35.57 73.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.554 1.169 . . . . 0.0 108.974 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -81.27 62.47 5.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 120.674 -1.266 . . . . 0.0 108.907 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.87 -68.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -46.88 -32.99 4.15 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 130.107 3.363 . . . . 0.0 114.231 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -69.21 -37.61 78.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.879 1.672 . . . . 0.0 109.851 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.43 58.17 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 120.177 -1.577 . . . . 0.0 109.724 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -79.59 -11.09 59.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.416 1.487 . . . . 0.0 109.319 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 54.11 62.88 2.38 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.848 2.059 . . . . 0.0 112.144 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.49 -84.17 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.58 -84.66 0.36 Allowed Glycine 0 CA--C 1.482 -2.0 1 N-CA-C 101.902 -4.479 . . . . 0.0 101.902 -173.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CZ ' ' HA2' ' B' ' 56' ' ' GLY . 0.1 OUTLIER 65.13 -69.87 0.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 127.046 2.138 . . . . 0.0 111.448 179.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.32 53.15 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.722 0 O-C-N 120.529 -1.357 . . . . 0.0 115.507 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.12 -64.87 0.89 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.241 2.02 . . . . 0.0 108.113 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.82 179.05 6.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -157.72 152.82 21.51 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.47 172.22 13.8 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.782 2.988 . . . . 0.0 109.409 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 t -115.92 -100.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 119.463 1.029 . . . . 0.0 108.535 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -140.77 -44.0 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.12 -16.21 41.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.406 -0.809 . . . . 0.0 111.793 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -61.06 -35.95 78.31 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.928 1.291 . . . . 0.0 108.11 171.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 97.81 2.02 Favored Glycine 0 N--CA 1.418 -2.53 1 N-CA-C 97.548 -6.221 . . . . 0.0 97.548 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -62.08 -16.62 53.53 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 119.239 1.519 . . . . 0.0 110.112 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.46 -10.14 4.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 125.196 1.398 . . . . 0.0 112.97 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.55 -46.35 75.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 120.748 -1.22 . . . . 0.0 108.165 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.11 74.28 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -49.22 -45.15 44.04 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.529 1.532 . . . . 0.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -58.69 -47.71 83.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.759 1.224 . . . . 0.0 111.232 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.5 -42.31 72.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 O-C-N 121.749 -0.594 . . . . 0.0 109.574 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.444 ' SD ' HG11 ' D' ' 55' ' ' VAL . 48.9 mtm -61.59 -48.18 82.1 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.111 0.964 . . . . 0.0 110.105 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.52 -36.22 78.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.295 -0.878 . . . . 0.0 110.862 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.85 98.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.709 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.91 92.75 Favored Glycine 0 CA--C 1.491 -1.427 0 C-N-CA 124.244 0.926 . . . . 0.0 111.135 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.83 -45.39 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.127 0.971 . . . . 0.0 109.562 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -64.78 -33.7 76.6 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.587 -1.32 . . . . 0.0 111.6 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.8 -53.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 124.098 0.959 . . . . 0.0 109.692 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -71.36 -20.91 62.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.832 0.825 . . . . 0.0 111.395 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 -33.54 31.0 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.084 -1.635 . . . . 0.0 110.082 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.16 -39.8 91.49 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.501 1.12 . . . . 0.0 110.622 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.3 m -66.88 -6.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 O-C-N 121.65 -0.656 . . . . 0.0 112.522 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.4 m -53.69 -25.69 19.4 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 125.66 1.584 . . . . 0.0 110.427 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.14 -43.27 74.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.56 -1.337 . . . . 0.0 112.764 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -42.33 58.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.39 1.076 . . . . 0.0 109.257 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.29 -34.3 77.1 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.156 0.503 . . . . 0.0 110.68 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.41 75.88 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.824 -1.173 . . . . 0.0 111.751 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -13.1 60.0 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.757 -1.214 . . . . 0.0 111.954 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.86 -35.93 81.16 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.615 1.197 . . . . 0.0 109.106 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -73.89 -35.53 64.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 119.794 -1.816 . . . . 0.0 112.068 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.92 -25.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 125.929 1.692 . . . . 0.0 109.229 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -56.47 -24.91 49.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.775 1.63 . . . . 0.0 112.71 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.71 -16.95 59.37 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.015 -1.053 . . . . 0.0 111.132 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -72.2 -30.55 65.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.02 -41.32 91.1 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 123.31 0.644 . . . . 0.0 110.296 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.01 -30.82 71.87 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 111.339 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -65.89 -38.68 89.39 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.76 0.824 . . . . 0.0 110.363 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -96.02 -7.07 37.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.126 0.571 . . . . 0.0 110.596 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.18 24.99 60.32 Favored Glycine 0 C--N 1.347 1.142 0 C-N-CA 124.707 1.146 . . . . 0.0 111.744 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t60 . . . . . 0 C--N 1.351 0.648 0 C-N-CA 126.508 1.923 . . . . 0.0 111.416 -168.868 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.98 175.57 10.88 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.72 -63.94 0.8 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 129.811 3.245 . . . . 0.0 111.589 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -59.97 -31.95 70.36 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.849 1.26 . . . . 0.0 113.382 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -71.56 -34.03 69.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.038 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -70.69 -35.7 72.92 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 120.968 -1.082 . . . . 0.0 110.397 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.56 -35.32 67.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 -46.48 81.15 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.015 0.926 . . . . 0.0 111.334 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -66.53 -34.28 77.55 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.541 -0.725 . . . . 0.0 110.467 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.91 -41.3 99.4 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 109.996 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.87 80.72 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.652 0.781 . . . . 0.0 111.228 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.55 -31.88 73.29 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.478 -0.764 . . . . 0.0 111.957 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -70.75 -32.87 70.18 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.038 -1.038 . . . . 0.0 109.425 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.82 -34.25 77.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.88 -1.138 . . . . 0.0 109.395 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.23 -38.14 87.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.447 0.699 . . . . 0.0 110.24 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -58.42 -36.48 73.66 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 124.221 1.008 . . . . 0.0 111.766 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.23 -44.77 87.17 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.867 0.867 . . . . 0.0 110.057 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 -20.05 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 121.438 -0.789 . . . . 0.0 110.698 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.76 -48.76 79.23 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 119.564 1.074 . . . . 0.0 109.874 172.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.29 -40.5 90.07 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.06 -1.025 . . . . 0.0 110.347 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -63.55 -40.05 95.98 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.735 0.814 . . . . 0.0 111.277 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.63 98.58 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.204 1.401 . . . . 0.0 109.575 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -57.38 -35.28 69.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.187 1.395 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.71 -51.84 9.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.563 -0.711 . . . . 0.0 109.925 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -63.89 -28.61 69.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.58 -1.325 . . . . 0.0 110.796 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.75 94.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.408 1.083 . . . . 0.0 112.244 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.59 -14.69 13.77 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-O 122.35 1.071 . . . . 0.0 110.395 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -87.17 -38.61 16.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.726 -2.484 . . . . 0.0 107.862 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.22 65.79 6.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.014 1.726 . . . . 0.0 108.692 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -31.54 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.13 30.47 0.0 OUTLIER 'General case' 0 C--N 1.355 0.821 0 C-N-CA 130.527 3.531 . . . . 0.0 117.549 -168.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.84 36.66 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.12 156.69 35.74 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 119.062 1.431 . . . . 0.0 108.947 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -85.14 117.41 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.711 2.274 . . . . 0.0 112.517 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 31.35 26.34 Favored Glycine 0 CA--C 1.494 -1.269 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.84 137.87 47.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.034 0.933 . . . . 0.0 109.272 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.04 -37.99 8.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 123.529 0.732 . . . . 0.0 109.924 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.04 140.56 29.53 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 pt -156.35 37.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 CA-C-N 118.971 0.805 . . . . 0.0 109.164 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -137.59 -117.87 0.15 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 118.255 -2.778 . . . . 0.0 112.101 -158.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.68 -68.95 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.755 0 C-N-CA 128.487 2.715 . . . . 0.0 103.951 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.61 -20.05 27.32 Favored 'Trans proline' 0 CA--C 1.513 -0.55 0 CA-C-N 125.654 3.055 . . . . 0.0 111.419 -173.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.88 -25.31 61.88 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.649 1.18 . . . . 0.0 109.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.23 -36.51 79.62 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 123.542 0.737 . . . . 0.0 110.284 -167.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.89 -29.15 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.899 -0.501 . . . . 0.0 110.686 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -42.18 76.48 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.881 -1.137 . . . . 0.0 108.735 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -59.16 -48.01 83.21 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 110.09 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.5 m -57.89 -36.41 72.38 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.422 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.2 -53.69 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 123.762 0.825 . . . . 0.0 109.253 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.48 -20.88 63.73 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.279 1.038 . . . . 0.0 111.757 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -74.64 -39.77 61.89 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 120.664 -1.272 . . . . 0.0 109.253 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.29 66.91 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 120.712 -1.242 . . . . 0.0 111.933 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -1.18 56.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.646 0.778 . . . . 0.0 110.124 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 42.9 p 65.64 16.14 10.36 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.44 1.896 . . . . 0.0 111.92 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.98 -58.45 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . 62.2 56.36 22.57 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 174.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' HA2' ' C' ' 56' ' ' GLY . 6.2 t80 -57.43 -41.85 81.25 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.736 1.214 . . . . 0.0 110.422 -168.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.69 8.63 0.58 Allowed Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.13 -55.57 5.93 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 118.959 1.38 . . . . 0.0 111.734 -170.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.97 155.86 49.2 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -160.3 137.59 6.88 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.428 ' HA ' ' OE1' ' B' ' 66' ' ' GLU . 34.8 Cg_endo -82.21 159.22 17.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 122.687 1.995 . . . . 0.0 112.119 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.263 34.9 m -106.33 -154.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 122.663 1.22 . . . . 0.0 111.32 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -73.41 -54.82 7.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.257 1.823 . . . . 0.0 111.434 -165.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -69.39 -16.84 63.6 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.154 1.782 . . . . 0.0 109.376 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' B' ' 62' ' ' PRO . 94.8 mt-10 -81.97 -18.5 43.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.53 93.34 0.65 Allowed Glycine 0 CA--C 1.483 -1.917 1 N-CA-C 102.129 -4.388 . . . . 0.0 102.129 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -53.72 -28.66 35.33 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 119.162 1.481 . . . . 0.0 110.709 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -58.16 -11.95 3.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.18 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 120.988 1.722 . . . . 0.0 109.756 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.57 -57.94 3.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -53.39 -38.89 63.82 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.089 1.356 . . . . 0.0 112.93 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -76.76 -24.56 52.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.953 -1.092 . . . . 0.0 111.104 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.16 -43.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.03 -49.95 75.96 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.236 1.014 . . . . 0.0 110.647 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -72.8 -15.72 61.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.877 -1.139 . . . . 0.0 112.162 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.18 65.5 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 120.051 -1.656 . . . . 0.0 108.626 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.05 -46.97 89.87 Favored Glycine 0 CA--C 1.492 -1.347 0 C-N-CA 124.676 1.131 . . . . 0.0 111.217 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.15 -48.5 65.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 C-N-CA 124.869 1.268 . . . . 0.0 110.421 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.35 -22.55 63.73 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 120.914 -1.116 . . . . 0.0 112.523 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.84 -53.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -62.83 -41.19 99.22 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.896 0.878 . . . . 0.0 110.439 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -30.53 71.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.766 0.826 . . . . 0.0 111.381 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.85 -30.36 67.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.965 -1.085 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.5 -14.87 11.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 120.843 -1.16 . . . . 0.0 110.324 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -61.28 -20.91 63.43 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.341 -2.099 . . . . 0.0 112.241 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.35 -17.39 62.54 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 120.47 -1.394 . . . . 0.0 111.593 172.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.5 -46.87 6.8 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 124.87 1.268 . . . . 0.0 108.605 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 55.0 mt -61.2 -38.49 86.75 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.294 -0.879 . . . . 0.0 112.414 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.87 0.13 19.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.038 -1.039 . . . . 0.0 111.212 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.1 p -97.94 -14.27 20.72 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 120.835 -1.166 . . . . 0.0 109.716 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.33 -18.86 60.64 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 119.557 1.071 . . . . 0.0 111.054 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -91.24 -16.76 27.11 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 120.658 -1.276 . . . . 0.0 112.295 170.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.43 -27.09 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -53.69 -22.35 8.85 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 126.028 1.731 . . . . 0.0 114.572 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -66.66 -28.0 68.12 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.585 -0.697 . . . . 0.0 110.063 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.14 172.19 9.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.275 46.6 mt-10 69.88 -50.2 0.63 Allowed 'General case' 0 C--N 1.35 0.589 0 C-N-CA 126.444 1.898 . . . . 0.0 112.426 -173.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -71.53 -45.2 63.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 120.154 -1.592 . . . . 0.0 108.534 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -77.04 -31.08 55.96 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.82 -0.55 . . . . 0.0 111.986 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 36.9 ttp-105 -117.12 108.71 16.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.54 -52.59 0.76 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 105.272 -3.131 . . . . 0.0 105.272 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 CA--C 1.501 -0.934 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -170.173 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 122.772 1.272 . . . . 0.0 107.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.58 142.27 18.83 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -89.14 -53.41 4.59 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -48.87 -35.83 15.64 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.497 1.919 . . . . 0.0 114.691 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -80.15 -33.57 38.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.316 -1.49 . . . . 0.0 110.567 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -73.31 -31.12 63.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.676 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.87 -49.81 69.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.148 2.179 . . . . 0.0 108.798 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.9 87.82 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.807 1.243 . . . . 0.0 112.067 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -60.17 -36.71 78.19 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.189 0.996 . . . . 0.0 111.174 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -74.66 -19.98 60.06 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.116 -0.99 . . . . 0.0 111.705 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.99 90.56 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.573 -0.704 . . . . 0.0 109.185 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -63.24 -39.0 93.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.682 1.193 . . . . 0.0 111.344 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.24 -39.83 71.43 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.762 0.825 . . . . 0.0 109.827 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.37 -31.21 71.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.405 1.082 . . . . 0.0 110.148 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.01 -47.96 73.98 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 125.505 1.522 . . . . 0.0 110.414 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.03 -35.56 80.89 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.519 0.727 . . . . 0.0 110.374 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -67.3 -49.33 64.68 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 111.308 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.9 -40.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 121.806 -0.558 . . . . 0.0 110.322 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.73 -35.06 72.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 O-C-N 122.02 -0.425 . . . . 0.0 109.99 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.82 -38.2 76.48 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 119.264 0.938 . . . . 0.0 111.465 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -20.62 46.25 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.103 -0.998 . . . . 0.0 108.399 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.04 46.75 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.958 -1.089 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m -52.48 -46.41 66.56 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 125.384 1.474 . . . . 0.0 111.528 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.72 -43.31 98.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 126.383 1.873 . . . . 0.0 108.859 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -71.48 -41.78 68.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 117.344 -1.312 . . . . 0.0 109.231 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.42 -51.8 67.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.874 1.215 . . . . 0.0 110.998 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.61 -37.23 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 O-C-N 121.617 -0.677 . . . . 0.0 110.538 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -75.39 -28.04 59.3 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.248 -1.533 . . . . 0.0 110.166 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.11 68.41 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.245 1.418 . . . . 0.0 109.335 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -2.15 58.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.5 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -67.34 95.66 0.45 Allowed 'General case' 0 C--N 1.357 0.897 0 O-C-N 120.981 -1.074 . . . . 0.0 109.653 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.76 6.05 30.84 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.96 152.6 68.9 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 118.586 1.193 . . . . 0.0 108.841 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.52 137.51 14.7 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.115 1.877 . . . . 0.0 110.217 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.15 70.58 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.54 155.21 19.08 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.455 1.902 . . . . 0.0 111.236 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.76 -22.59 0.87 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.675 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.29 37.34 2.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.655 1.982 . . . . 0.0 108.511 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.03 -15.77 20.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 50.8 m -89.68 124.89 35.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 121.163 -0.96 . . . . 0.0 112.47 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -67.21 -61.05 5.1 Favored Pre-proline 0 C--N 1.348 0.522 0 C-N-CA 127.059 2.143 . . . . 0.0 113.221 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -14.03 24.66 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 CA-C-N 125.679 3.064 . . . . 0.0 110.874 -172.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.36 -16.4 49.29 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 124.357 1.063 . . . . 0.0 108.73 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.03 74.22 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 123.469 0.708 . . . . 0.0 111.224 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.63 -31.99 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 123.753 0.821 . . . . 0.0 110.542 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.74 -34.39 69.49 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 119.758 -1.839 . . . . 0.0 109.282 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -72.33 -43.64 63.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -68.91 -28.0 66.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.779 -1.201 . . . . 0.0 112.051 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.8 t -56.52 -54.63 26.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 124.064 0.946 . . . . 0.0 109.967 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.68 -21.63 51.79 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.703 -0.623 . . . . 0.0 111.431 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -67.8 -39.22 84.04 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.126 0.97 . . . . 0.0 110.038 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.78 -22.93 62.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.889 -1.132 . . . . 0.0 111.631 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -91.92 4.02 53.89 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.607 -0.683 . . . . 0.0 110.199 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 56.9 p 49.38 41.77 21.14 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.859 2.064 . . . . 0.0 111.453 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.3 -66.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' B' ' 57' ' ' TYR . . . 74.14 52.02 8.23 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 174.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.409 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 0.1 OUTLIER -73.86 -14.44 61.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.652 -0.911 . . . . 0.0 110.907 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.99 29.89 3.88 Favored Glycine 0 CA--C 1.49 -1.478 0 O-C-N 121.019 -1.051 . . . . 0.0 110.917 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -70.95 -59.77 2.6 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -138.87 173.36 11.65 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -143.96 144.81 27.89 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.74 164.36 14.0 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.543 2.829 . . . . 0.0 110.03 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.8 -162.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -91.17 -47.77 7.33 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.775 1.63 . . . . 0.0 107.548 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.13 2.19 18.8 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.556 1.542 . . . . 0.0 111.864 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.81 -27.31 63.78 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.296 1.998 . . . . 0.0 106.354 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.95 82.89 0.97 Allowed Glycine 0 CA--C 1.471 -2.673 1 N-CA-C 100.451 -5.06 . . . . 0.0 100.451 -170.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -57.79 -7.69 0.77 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.513 1.525 . . . . 0.0 112.768 -170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.74 -13.17 53.87 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 119.918 -1.739 . . . . 0.0 113.193 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.7 -58.39 5.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 120.821 1.646 . . . . 0.0 106.689 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.43 68.53 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.201 1.0 . . . . 0.0 112.627 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -62.44 -34.22 76.36 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.423 1.089 . . . . 0.0 111.654 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.56 -33.89 76.98 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.132 -1.605 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.25 -43.29 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 O-C-N 121.731 -0.605 . . . . 0.0 109.47 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.12 -49.79 76.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.458 1.103 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -66.29 -35.59 80.78 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.474 -0.766 . . . . 0.0 111.293 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.91 79.09 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.502 -0.749 . . . . 0.0 110.668 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.38 -45.66 77.25 Favored Glycine 0 CA--C 1.495 -1.178 0 C-N-CA 124.144 0.878 . . . . 0.0 111.584 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -44.94 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.312 1.045 . . . . 0.0 109.449 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -65.84 -24.82 66.97 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.118 -0.989 . . . . 0.0 112.288 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.37 -53.38 32.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 120.439 1.472 . . . . 0.0 109.418 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -71.81 -21.9 61.64 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.474 0.654 . . . . 0.0 111.211 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.79 -35.31 26.6 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.361 -0.837 . . . . 0.0 110.949 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.61 -35.28 77.11 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 119.939 -1.726 . . . . 0.0 110.78 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.33 -9.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 121.145 -0.972 . . . . 0.0 112.258 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 20.0 m -65.42 -9.69 27.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.647 1.179 . . . . 0.0 111.804 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.99 -58.21 9.17 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.441 -1.412 . . . . 0.0 110.532 166.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.1 86.84 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.978 -1.076 . . . . 0.0 110.692 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.25 -40.64 86.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.043 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -12.46 60.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 121.092 -1.005 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 7.3 m -82.21 -23.69 35.3 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.77 -35.39 79.99 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 120.903 -1.123 . . . . 0.0 110.504 -159.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -66.34 -26.52 67.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.795 -0.566 . . . . 0.0 112.196 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.32 -27.33 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 124.455 1.102 . . . . 0.0 108.228 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -59.73 -14.41 14.22 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.164 -0.96 . . . . 0.0 112.423 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.986 -1.071 . . . . 0.0 111.018 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -74.04 138.42 44.03 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.258 29.7 mt-10 71.28 -55.91 0.64 Allowed 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.049 1.34 . . . . 0.0 112.565 -173.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.6 -32.74 74.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.013 1.279 . . . . 0.0 112.827 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -81.38 -16.44 52.22 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.326 0.967 . . . . 0.0 110.962 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -82.47 -39.0 23.13 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.109 -1.619 . . . . 0.0 107.325 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.81 25.13 11.97 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.5 t60 . . . . . 0 C--N 1.352 0.714 0 C-N-CA 124.925 1.29 . . . . 0.0 111.56 -173.158 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 102.783 -3.043 . . . . 0.0 102.783 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.31 -66.57 0.91 Allowed 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -162.96 -92.31 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -168.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 1.9 p80 -63.97 -18.07 63.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.493 1.517 . . . . 0.0 113.343 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 35.3 mp0 -69.92 -34.16 73.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 120.652 -1.28 . . . . 0.0 109.582 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -73.47 -38.76 65.33 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.036 -1.04 . . . . 0.0 108.633 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.95 -42.51 99.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.64 87.59 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.6 1.16 . . . . 0.0 112.119 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.15 -42.36 94.74 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.261 0.625 . . . . 0.0 111.181 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.79 -38.2 90.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.177 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.81 89.62 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.41 -0.806 . . . . 0.0 111.014 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.83 -36.94 84.86 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.453 -0.78 . . . . 0.0 111.027 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.61 -29.99 70.65 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.548 1.139 . . . . 0.0 110.748 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -74.97 -38.44 61.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.561 1.144 . . . . 0.0 108.259 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.95 -45.73 93.54 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.571 0.748 . . . . 0.0 110.666 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -58.2 -31.42 67.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 112.67 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -69.78 -41.1 75.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.424 0.69 . . . . 0.0 109.677 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.39 -35.45 74.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 124.061 0.944 . . . . 0.0 109.175 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.38 -37.8 84.73 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 121.238 -0.914 . . . . 0.0 111.708 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -82.79 -16.89 46.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.514 0.726 . . . . 0.0 111.278 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -77.64 -46.34 22.36 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 168.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.37 74.38 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 126.327 1.851 . . . . 0.0 111.374 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -62.52 -44.35 96.57 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.388 0.675 . . . . 0.0 110.772 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -67.99 -50.09 57.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -61.47 -42.46 98.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.793 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.06 99.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.217 1.407 . . . . 0.0 111.673 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.8 -45.16 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 O-C-N 121.025 -1.047 . . . . 0.0 109.448 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -70.23 -27.82 64.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.317 -0.864 . . . . 0.0 110.703 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -57.03 4.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.421 1.889 . . . . 0.0 108.782 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.53 -32.44 74.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.095 0.958 . . . . 0.0 111.776 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -66.84 104.32 1.32 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.135 -1.603 . . . . 0.0 110.559 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.98 -28.29 3.7 Favored Glycine 0 CA--C 1.489 -1.556 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.52 145.01 70.89 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 123.351 0.661 . . . . 0.0 110.75 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -78.78 138.37 14.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.192 1.928 . . . . 0.0 110.231 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.06 80.91 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.439 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.84 147.95 36.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.813 1.245 . . . . 0.0 111.698 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.53 -37.7 2.48 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 tp -106.93 93.98 4.86 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.124 -0.985 . . . . 0.0 108.883 -173.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -135.58 57.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 120.229 -1.545 . . . . 0.0 109.047 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 30.9 t -150.31 135.03 17.5 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -68.82 -43.09 26.65 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 115.625 -2.131 . . . . 0.0 111.256 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -68.53 -28.18 32.19 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-N 126.106 3.216 . . . . 0.0 111.966 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.83 -17.65 31.06 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 118.957 0.799 . . . . 0.0 108.949 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.68 86.82 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 124.677 1.191 . . . . 0.0 112.039 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.54 -14.87 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 123.579 0.751 . . . . 0.0 110.305 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 -33.19 18.35 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 120.881 -1.137 . . . . 0.0 107.944 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -73.3 -40.02 64.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 15.0 p -76.18 59.05 1.31 Allowed 'General case' 0 C--N 1.358 0.943 0 O-C-N 121.234 -0.916 . . . . 0.0 111.419 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 72.0 t -133.48 -65.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 -21.41 65.26 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.505 0.722 . . . . 0.0 111.784 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -69.69 -28.91 66.25 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 121.507 -0.745 . . . . 0.0 110.394 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.17 -26.47 42.69 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.161 -0.962 . . . . 0.0 109.655 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 15.3 p -91.89 3.35 55.39 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.578 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 12.7 p 54.04 25.88 5.93 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.427 1.891 . . . . 0.0 113.095 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.444 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.8 p -86.22 -53.0 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.409 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 70.85 73.07 0.82 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -23.77 53.56 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.621 -1.517 . . . . 0.0 109.852 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.57 35.71 1.85 Allowed Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -155.2 176.37 12.65 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -149.2 145.92 20.29 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -80.3 165.78 20.84 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 CA-C-N 121.944 1.73 . . . . 0.0 110.527 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.29 -146.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.538 0 CA-C-N 119.218 0.917 . . . . 0.0 109.959 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -91.59 -54.09 4.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.273 -1.517 . . . . 0.0 109.849 -163.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -89.34 16.73 6.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.439 0.696 . . . . 0.0 109.608 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -30.29 62.6 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 163.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.34 83.48 1.18 Allowed Glycine 0 CA--C 1.476 -2.385 1 N-CA-C 99.583 -5.407 . . . . 0.0 99.583 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.58 HH11 ' HG3' ' D' ' 68' ' ' ARG . 20.1 ttm-85 -52.44 -18.57 1.71 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.056 1.742 . . . . 0.0 112.003 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -53.97 -28.22 36.2 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.504 2.322 . . . . 0.0 113.26 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.57 -53.2 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.391 0.677 . . . . 0.0 111.88 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.3 -46.65 55.53 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 126.233 1.813 . . . . 0.0 110.721 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.84 -38.06 89.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.493 0.717 . . . . 0.0 110.8 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.77 -39.05 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 123.446 0.698 . . . . 0.0 109.125 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -57.81 -52.91 63.53 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.984 1.314 . . . . 0.0 110.253 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.8 -38.0 89.47 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.033 0.533 . . . . 0.0 110.659 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.16 79.03 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.661 0.784 . . . . 0.0 111.58 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.81 -45.77 80.78 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.57 -48.97 85.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 C-N-CA 124.268 1.027 . . . . 0.0 108.932 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -57.03 -42.29 80.17 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.208 1.403 . . . . 0.0 112.503 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -65.56 -55.48 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 124.744 1.218 . . . . 0.0 109.248 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -67.26 -34.84 78.27 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.748 -0.595 . . . . 0.0 110.617 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.38 78.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.463 1.105 . . . . 0.0 111.135 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.65 -38.2 90.2 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 124.536 1.135 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.1 -14.5 7.75 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 125.128 1.371 . . . . 0.0 111.279 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 6.3 m -61.81 -20.59 63.79 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 119.376 -2.078 . . . . 0.0 111.696 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.66 66.73 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.684 -1.26 . . . . 0.0 111.336 171.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.91 -49.75 11.45 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.33 -32.25 73.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.736 0.814 . . . . 0.0 112.741 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.99 63.64 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.26 -1.525 . . . . 0.0 111.121 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -82.45 -11.02 58.8 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.701 -1.249 . . . . 0.0 111.225 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -32.55 74.17 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 119.454 1.024 . . . . 0.0 111.206 -171.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -77.17 -32.99 56.55 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.969 -1.082 . . . . 0.0 111.173 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.71 -26.64 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 125.884 1.674 . . . . 0.0 108.973 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -66.55 -5.73 12.47 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 112.331 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -69.16 -18.41 63.93 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 119.81 1.187 . . . . 0.0 110.997 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.73 159.76 23.1 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 61.73 -78.48 0.03 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.729 2.012 . . . . 0.0 111.881 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -55.14 -37.59 67.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.032 2.533 . . . . 0.0 110.15 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -61.29 -27.91 68.81 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.485 -0.759 . . . . 0.0 112.255 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -82.05 -22.74 36.22 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.328 -0.857 . . . . 0.0 109.291 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.34 3.97 89.9 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 121.463 -0.773 . . . . 0.0 112.072 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 8.1 t60 . . . . . 0 N--CA 1.442 -0.834 0 C-N-CA 125.989 1.715 . . . . 0.0 111.301 -169.805 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.95 169.76 9.41 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -41.68 -57.87 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 128.786 2.835 . . . . 0.0 112.446 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.572 ' HB3' HH12 ' D' ' 96' ' ' ARG . 51.7 p-80 -77.97 -19.21 54.94 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 125.082 1.353 . . . . 0.0 112.674 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.93 -38.47 57.61 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -60.96 -35.31 76.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 123.816 0.846 . . . . 0.0 111.622 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -59.96 -41.93 92.98 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.737 2.015 . . . . 0.0 110.175 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -41.75 74.4 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.593 0.757 . . . . 0.0 110.263 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.39 -32.56 72.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.799 0.84 . . . . 0.0 111.408 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -71.94 -32.67 67.55 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.363 1.065 . . . . 0.0 110.527 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.123 0.569 . . . . 0.0 110.213 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -55.64 -42.84 75.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.709 1.204 . . . . 0.0 111.795 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -76.7 -29.89 56.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.777 -0.577 . . . . 0.0 109.578 -174.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.22 -31.21 69.63 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.477 -0.764 . . . . 0.0 109.975 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.18 -43.1 92.15 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 121.725 -0.609 . . . . 0.0 111.326 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -62.46 -29.43 70.51 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.187 -0.946 . . . . 0.0 112.209 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.37 -31.62 67.53 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.654 -0.654 . . . . 0.0 110.267 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.65 -41.55 90.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.187 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.92 -42.81 85.57 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.914 0.886 . . . . 0.0 110.305 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.31 -42.7 99.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.378 -0.826 . . . . 0.0 111.699 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.16 -38.63 69.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.65 79.46 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 124.914 1.286 . . . . 0.0 111.639 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -66.56 -32.96 74.63 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 124.146 0.978 . . . . 0.0 111.124 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -70.75 -47.1 61.44 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 121.568 -0.708 . . . . 0.0 109.747 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -60.14 -50.39 73.88 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.129 0.972 . . . . 0.0 109.35 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.81 88.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.646 1.579 . . . . 0.0 112.554 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.88 -48.14 89.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.191 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.33 -29.02 61.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.41 -0.806 . . . . 0.0 111.216 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.16 91.53 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.079 1.352 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.43 -20.0 60.2 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.544 -0.722 . . . . 0.0 112.021 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -75.09 87.13 2.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 120.194 -1.566 . . . . 0.0 110.577 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.88 3.11 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.61 140.58 59.57 Favored Pre-proline 0 N--CA 1.442 -0.825 0 O-C-N 121.703 -0.881 . . . . 0.0 110.046 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.15 135.43 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.495 2.13 . . . . 0.0 110.245 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.86 24.75 68.71 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.67 144.59 56.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.085 0.954 . . . . 0.0 110.103 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.08 -34.47 2.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.79 131.66 36.99 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 pt -151.23 169.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 100.649 -3.834 . . . . 0.0 100.649 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t 76.89 134.07 0.06 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.963 1.705 . . . . 0.0 111.082 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -66.01 -49.48 56.9 Favored Pre-proline 0 C--N 1.352 0.701 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.072 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -70.21 -14.46 34.68 Favored 'Trans proline' 0 CA--C 1.514 -0.513 0 CA-C-N 125.308 2.932 . . . . 0.0 112.584 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.23 -43.14 12.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.97 77.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.235 1.014 . . . . 0.0 112.215 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.14 -16.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-O 121.714 0.769 . . . . 0.0 111.397 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -31.76 17.31 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 120.757 -1.214 . . . . 0.0 108.162 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.33 -40.02 94.97 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 120.795 -1.19 . . . . 0.0 110.244 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -67.05 -17.3 64.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.948 -1.095 . . . . 0.0 111.669 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.5 -51.09 67.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.682 1.193 . . . . 0.0 109.315 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.61 -7.41 50.08 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 124.07 0.948 . . . . 0.0 111.167 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.6 m -94.13 -45.11 7.69 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 120.36 -1.462 . . . . 0.0 107.058 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.01 70.15 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.308 -0.87 . . . . 0.0 112.325 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -91.77 3.83 54.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.272 67.8 p 59.53 -142.46 0.6 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.447 1.899 . . . . 0.0 107.334 -167.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t 75.63 -90.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.94 94.28 0.25 Allowed Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -80.07 -20.8 44.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.305 -1.703 . . . . 0.0 109.711 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.73 25.29 4.31 Favored Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.58 -48.19 34.74 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.277 1.539 . . . . 0.0 110.055 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.36 152.88 51.12 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.457 ' CD1' ' HD2' ' A' ' 62' ' ' PRO . 17.6 t80 -145.17 137.71 13.55 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 46.5 Cg_endo -80.97 168.17 17.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.908 2.405 . . . . 0.0 110.951 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -88.91 -111.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -134.83 -39.42 0.78 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 122.224 1.011 . . . . 0.0 109.225 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -79.28 -22.58 44.46 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.601 -1.312 . . . . 0.0 109.627 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -62.08 -32.03 72.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.075 1.75 . . . . 0.0 108.386 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.42 65.18 0.93 Allowed Glycine 0 CA--C 1.465 -3.081 1 N-CA-C 102.483 -4.247 . . . . 0.0 102.483 168.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -26.33 -26.39 0.0 OUTLIER 'General case' 0 C--N 1.363 1.185 1 C-N-CA 132.65 4.38 . . . . 0.0 116.851 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -49.34 -20.47 0.67 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.06 -42.92 94.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 124.954 1.301 . . . . 0.0 109.693 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -48.51 31.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.12 -50.82 19.46 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 126.463 1.905 . . . . 0.0 111.303 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.27 -35.53 81.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.427 0.632 . . . . 0.0 110.692 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.1 t -73.22 -37.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.41 -0.806 . . . . 0.0 109.14 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.5 mtt -61.83 -46.36 89.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 123.632 0.773 . . . . 0.0 109.656 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.48 -33.27 75.31 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.078 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.18 97.04 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 121.746 -0.596 . . . . 0.0 110.656 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.06 -46.93 77.5 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.35 -45.49 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 109.602 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.87 -36.38 83.72 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.855 -1.153 . . . . 0.0 110.681 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.03 -52.07 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 119.959 1.254 . . . . 0.0 110.563 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -70.47 -22.76 62.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.809 -0.557 . . . . 0.0 111.126 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.54 -32.94 23.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.382 -0.824 . . . . 0.0 110.546 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.43 -24.25 67.14 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.496 -1.377 . . . . 0.0 111.207 -172.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.17 -11.26 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.484 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.402 HG23 ' HB2' ' A' ' 90' ' ' ALA . 56.0 m -45.24 -29.68 1.04 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 127.826 2.45 . . . . 0.0 112.058 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.72 -39.77 52.64 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.406 1.482 . . . . 0.0 113.889 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 -36.12 6.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.94 1.296 . . . . 0.0 109.307 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.31 -41.57 66.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.736 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -78.21 -32.19 49.81 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 119.813 -1.805 . . . . 0.0 111.229 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -73.86 -0.36 15.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.529 -1.357 . . . . 0.0 110.003 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.24 -26.56 64.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 121.245 -0.909 . . . . 0.0 109.414 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -72.83 -33.4 66.15 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.454 -1.404 . . . . 0.0 110.634 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.17 -21.91 27.11 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.223 1.409 . . . . 0.0 109.171 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.39 -29.47 48.83 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 125.399 1.48 . . . . 0.0 112.247 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -65.57 -36.56 84.14 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.541 0.686 . . . . 0.0 110.479 -174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.18 154.01 18.95 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -170.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.292 40.1 mm-40 71.03 -51.59 0.69 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.446 1.898 . . . . 0.0 112.036 -168.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.05 -46.59 71.97 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.645 1.978 . . . . 0.0 109.871 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.53 -24.54 67.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.322 -0.861 . . . . 0.0 112.936 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -80.91 -20.17 42.7 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.45 -0.781 . . . . 0.0 110.094 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.96 34.66 61.83 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.9 m170 . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.65 170.68 15.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.03 -34.77 78.29 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 124.588 1.155 . . . . 0.0 112.242 -167.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -83.77 -23.64 31.44 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.58 -0.7 . . . . 0.0 110.601 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.16 -38.06 21.13 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -63.19 -47.61 81.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.225 1.41 . . . . 0.0 110.954 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -26.44 65.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.371 -0.83 . . . . 0.0 111.256 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.91 -35.44 74.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.319 -0.863 . . . . 0.0 110.657 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -64.74 -45.87 84.64 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.999 0.92 . . . . 0.0 109.231 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -64.34 -31.94 73.35 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.112 0.565 . . . . 0.0 111.534 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.93 81.62 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.755 0.822 . . . . 0.0 110.685 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -39.5 81.5 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.074 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.53 -43.04 84.04 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 125.748 1.619 . . . . 0.0 110.484 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.37 -38.92 91.42 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.138 1.375 . . . . 0.0 110.079 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.441 ' HB2' HG21 ' B' ' 81' ' ' VAL . 21.3 tp -59.3 -41.56 89.29 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 123.908 0.883 . . . . 0.0 111.391 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -63.91 -29.58 70.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.866 1.266 . . . . 0.0 110.73 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -76.08 -30.33 58.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.246 1.019 . . . . 0.0 110.217 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -70.35 -35.67 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 31.2 mt -61.76 -42.32 98.83 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.809 -0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -60.75 -45.54 93.9 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.086 0.857 . . . . 0.0 110.519 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -68.93 -40.18 79.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.874 0.845 . . . . 0.0 110.486 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -31.11 71.29 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.264 1.426 . . . . 0.0 111.256 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -66.0 -44.25 85.34 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.085 0.954 . . . . 0.0 110.199 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -61.03 -49.68 76.4 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.025 1.33 . . . . 0.0 107.785 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.83 -41.96 99.54 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.388 0.675 . . . . 0.0 111.232 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.21 91.38 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 124.892 1.277 . . . . 0.0 111.965 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.45 -40.97 73.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.17 -10.67 59.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.291 -1.506 . . . . 0.0 111.704 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.485 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -70.58 -21.25 62.7 Favored 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.907 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.97 -1.99 41.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.27 79.36 2.8 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.2 -41.6 0.71 Allowed Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.81 154.93 70.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 O-C-N 122.185 -0.597 . . . . 0.0 111.457 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.1 151.27 23.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.014 2.476 . . . . 0.0 110.41 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.61 41.23 65.54 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 173.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 136.64 57.92 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.376 1.071 . . . . 0.0 112.205 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.11 -57.28 2.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.62 97.95 10.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.094 0.95 . . . . 0.0 108.455 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.49 12.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -105.08 129.99 53.37 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -78.93 -57.81 0.75 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 127.257 2.223 . . . . 0.0 108.692 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.45 -13.89 25.13 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.344 2.944 . . . . 0.0 111.69 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -93.35 -10.34 35.65 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.397 0.998 . . . . 0.0 108.417 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.64 83.73 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.61 -1.306 . . . . 0.0 110.512 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.92 -9.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 124.454 1.102 . . . . 0.0 110.562 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.85 -41.08 16.37 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 120.14 -1.6 . . . . 0.0 107.28 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -68.87 -32.83 72.76 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.538 -0.727 . . . . 0.0 110.815 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 7.0 p -66.41 -17.41 64.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.978 -1.076 . . . . 0.0 111.586 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.76 -17.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.924 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -97.72 10.82 39.07 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.488 -1.383 . . . . 0.0 109.177 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -123.26 -173.75 2.79 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.45 -3.537 . . . . 0.0 101.45 173.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 77.24 -42.27 0.4 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 126.1 1.76 . . . . 0.0 111.095 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.0 p -81.19 2.75 26.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 126.22 1.808 . . . . 0.0 111.692 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p 52.07 59.3 4.63 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.826 2.051 . . . . 0.0 111.595 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.41 -77.01 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.08 66.49 1.96 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -72.45 -46.04 56.81 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.64 -105.48 0.24 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.327 5.2 t70 56.92 -72.63 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 128.271 2.628 . . . . 0.0 112.232 -163.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -163.59 1.35 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -173.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -153.24 153.49 29.52 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.6 168.41 9.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.331 3.354 . . . . 0.0 112.847 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 m -83.14 177.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.55 1.14 . . . . 0.0 112.442 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -83.21 -69.44 0.63 Allowed 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 125.475 1.51 . . . . 0.0 111.337 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.99 -37.5 64.07 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 124.611 1.165 . . . . 0.0 112.907 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -121.16 -107.62 0.36 Allowed 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 167.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.485 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 40.13 -73.55 0.0 OUTLIER Glycine 0 C--N 1.358 1.785 0 C-N-CA 129.748 3.547 . . . . 0.0 116.165 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.39 -37.86 87.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.363 2.665 . . . . 0.0 111.488 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.838 0.827 . . . . 0.0 109.275 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.05 -46.42 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.58 84.49 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.408 1.483 . . . . 0.0 111.603 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.67 -47.22 29.55 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.049 1.739 . . . . 0.0 110.938 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.72 -36.59 84.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.119 1.368 . . . . 0.0 110.283 -176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.33 -42.01 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.679 -0.638 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -60.59 -46.74 89.09 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -63.13 -38.3 90.62 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 122.121 -0.362 . . . . 0.0 111.158 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.02 80.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.159 0.584 . . . . 0.0 111.301 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.13 91.65 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 124.483 1.039 . . . . 0.0 111.214 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.08 -42.52 90.17 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 123.853 0.861 . . . . 0.0 108.707 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.81 -51.19 65.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 120.94 -1.1 . . . . 0.0 112.275 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' B' ' 15' ' ' LEU . 27.7 m -72.88 -41.32 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 112.144 -171.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -74.15 -38.51 63.7 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.25 -32.18 71.22 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.69 -31.88 62.8 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.759 1.223 . . . . 0.0 111.406 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.9 -12.05 8.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.666 1.186 . . . . 0.0 111.099 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 16.2 m -64.4 -24.82 67.77 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 118.897 -2.377 . . . . 0.0 110.761 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.58 -20.35 65.99 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.154 -1.591 . . . . 0.0 111.318 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.27 -40.71 11.99 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.38 1.072 . . . . 0.0 108.913 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.96 -31.75 51.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 122.785 0.434 . . . . 0.0 111.545 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.29 -23.02 66.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.122 -0.986 . . . . 0.0 111.374 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . 0.343 0.6 OUTLIER -83.36 -10.72 58.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.916 -1.115 . . . . 0.0 109.47 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.275 46.1 m-20 -82.46 -2.68 54.02 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.458 -1.401 . . . . 0.0 111.801 -172.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.19 -35.88 15.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.27 -1.519 . . . . 0.0 108.538 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 t -66.84 -25.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 125.074 1.349 . . . . 0.0 110.224 -169.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -63.58 -8.92 11.02 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.422 -0.799 . . . . 0.0 112.844 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -66.34 -32.85 74.49 Favored 'General case' 0 C--N 1.359 1.004 0 O-C-N 120.851 -1.156 . . . . 0.0 110.068 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -87.88 159.09 18.52 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -172.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 74.59 -59.98 0.53 Allowed 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.326 1.85 . . . . 0.0 110.514 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -59.59 -29.22 67.82 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.11 2.164 . . . . 0.0 109.857 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -62.6 -38.87 91.85 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.576 -0.703 . . . . 0.0 111.465 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -78.6 -27.18 45.55 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.712 -1.243 . . . . 0.0 108.553 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.21 33.94 27.65 Favored Glycine 0 CA--C 1.491 -1.466 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--N 1.357 0.929 0 C-N-CA 123.712 0.805 . . . . 0.0 111.955 176.423 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 102.118 -3.29 . . . . 0.0 102.118 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.13 158.32 15.51 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.28 -46.86 85.29 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.428 1.091 . . . . 0.0 110.671 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CE1' HG21 ' C' ' 91' ' ' THR . 4.5 p80 -67.07 -27.83 67.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.56 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.61 -42.88 57.83 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -65.75 -37.71 87.12 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.827 -1.171 . . . . 0.0 110.826 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.87 -31.44 72.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.379 1.072 . . . . 0.0 110.987 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.84 -47.68 71.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.729 0.812 . . . . 0.0 110.203 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.357 -0.839 . . . . 0.0 111.615 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -65.44 -39.63 92.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.873 1.269 . . . . 0.0 109.311 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.4 82.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.896 0.878 . . . . 0.0 110.681 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -55.53 -42.76 75.03 Favored 'General case' 0 C--N 1.36 1.03 0 CA-C-O 121.667 0.746 . . . . 0.0 110.829 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -60.93 -39.38 89.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.139 1.376 . . . . 0.0 110.363 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.98 -34.2 76.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.149 0.979 . . . . 0.0 109.505 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.47 -40.33 89.29 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.819 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.31 -28.02 68.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.558 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -66.04 -39.77 90.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.977 0.911 . . . . 0.0 110.181 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.7 -35.15 74.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 124.247 1.019 . . . . 0.0 109.198 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.57 -35.67 80.22 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 121.29 -0.881 . . . . 0.0 111.898 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.8 -32.62 59.94 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.137 0.575 . . . . 0.0 110.337 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 -42.06 59.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.12 -0.987 . . . . 0.0 108.767 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -36.01 78.24 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.758 1.623 . . . . 0.0 111.895 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -69.4 -36.63 76.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.909 -0.494 . . . . 0.0 110.299 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -67.58 -38.03 83.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -66.19 -55.24 17.24 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.0 68.69 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.739 1.215 . . . . 0.0 111.984 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.68 -43.92 96.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 O-C-N 119.962 -1.712 . . . . 0.0 111.985 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.79 -34.99 20.99 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 121.211 -0.931 . . . . 0.0 109.274 -171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.37 -50.77 58.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.552 1.941 . . . . 0.0 109.546 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.04 -24.1 62.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.236 -0.915 . . . . 0.0 111.637 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.95 95.19 6.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.455 -1.403 . . . . 0.0 111.918 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.46 -7.57 4.98 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.71 148.02 37.53 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 123.577 0.751 . . . . 0.0 109.788 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -77.69 103.46 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.895 2.397 . . . . 0.0 113.051 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 -52.44 0.72 Allowed Glycine 0 CA--C 1.477 -2.324 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.719 2.008 . . . . 0.0 110.901 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.34 -91.62 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.92 127.14 31.62 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.27 131.18 1.84 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 169.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.86 -49.03 60.83 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.038 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.0 -5.52 17.13 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 CA-C-N 124.777 2.742 . . . . 0.0 111.955 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -99.88 -29.27 12.68 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.67 76.32 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 111.939 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.71 -36.89 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 123.418 0.687 . . . . 0.0 110.222 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -30.22 60.59 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.474 -1.391 . . . . 0.0 109.92 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -72.85 -32.05 65.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.984 0.897 . . . . 0.0 109.124 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -67.04 -42.24 85.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.279 -0.888 . . . . 0.0 110.358 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -67.66 -23.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 C-N-CA 124.155 0.982 . . . . 0.0 112.87 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.4 -13.72 51.4 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 120.07 -1.644 . . . . 0.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -104.61 -175.02 2.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . 79.47 -33.63 0.14 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 126.952 2.101 . . . . 0.0 110.672 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.1 p -89.73 3.78 51.69 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 125.956 1.703 . . . . 0.0 111.949 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.278 41.5 p 52.43 63.87 2.07 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.503 1.921 . . . . 0.0 111.917 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.21 -107.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 1 N-CA-C 98.546 -4.613 . . . . 0.0 98.546 173.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.3 87.48 1.09 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 106.651 -2.58 . . . . 0.0 106.651 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -69.2 -45.63 69.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.357 1.075 . . . . 0.0 109.118 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.44 48.48 0.28 Allowed Glycine 0 CA--C 1.485 -1.797 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.414 ' CG ' HH22 ' D' ' 68' ' ' ARG . 34.8 t70 -73.48 -45.35 54.59 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -132.96 -154.2 0.6 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.83 142.86 2.04 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 100.829 -3.767 . . . . 0.0 100.829 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.07 179.8 3.53 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 123.664 2.344 . . . . 0.0 107.49 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.487 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.7 t -100.6 -121.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.405 1.482 . . . . 0.0 110.118 -168.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 73.4 m -136.48 -38.8 0.66 Allowed 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.692 -1.255 . . . . 0.0 108.584 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -86.17 -6.11 59.06 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.979 -1.076 . . . . 0.0 109.834 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -63.98 -36.83 85.24 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 123.216 1.484 . . . . 0.0 107.373 175.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.94 62.41 0.85 Allowed Glycine 0 CA--C 1.464 -3.111 1 N-CA-C 100.643 -4.983 . . . . 0.0 100.643 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -26.86 -25.2 0.0 OUTLIER 'General case' 0 C--N 1.36 1.04 1 C-N-CA 132.989 4.516 . . . . 0.0 117.778 -175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -52.87 -15.44 0.75 Allowed 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 161.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.23 -44.39 87.84 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 O-C-N 120.153 -1.592 . . . . 0.0 109.294 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.59 66.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 123.142 0.577 . . . . 0.0 109.681 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . 0.258 1.1 pp20? -65.38 -33.72 76.63 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 121.799 -0.563 . . . . 0.0 111.836 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.31 -36.99 79.18 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 121.55 0.691 . . . . 0.0 110.624 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.3 t -72.77 -37.82 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.507 -0.745 . . . . 0.0 109.477 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 50.8 mtt -64.42 -47.91 77.34 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 123.856 0.863 . . . . 0.0 109.55 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -61.83 -40.58 95.79 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.425 0.69 . . . . 0.0 110.747 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.05 94.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.546 0.738 . . . . 0.0 110.872 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.64 78.09 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.28 -49.54 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 124.195 0.998 . . . . 0.0 108.943 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.83 -39.19 87.56 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 118.531 0.605 . . . . 0.0 111.474 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.32 -54.85 28.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 119.331 0.969 . . . . 0.0 110.4 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.58 -14.02 60.03 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 111.737 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.94 -37.62 22.07 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.623 -1.298 . . . . 0.0 108.035 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.97 -33.63 72.2 Favored 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 124.996 1.318 . . . . 0.0 111.738 -175.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -64.56 -5.31 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 O-C-N 121.335 -0.853 . . . . 0.0 112.663 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 26.3 m -59.2 -18.52 37.32 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.742 1.217 . . . . 0.0 111.167 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.62 68.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.847 -1.783 . . . . 0.0 113.104 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.58 -43.46 13.47 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.0 -38.86 92.6 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.079 0.942 . . . . 0.0 111.318 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.29 -20.32 62.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.982 -1.073 . . . . 0.0 111.833 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.515 HG21 ' CE1' ' C' ' 4' ' ' HIS . 9.7 t -99.52 7.71 45.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.4 -45.34 60.14 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.833 1.197 . . . . 0.0 107.978 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -63.09 -34.62 77.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.48 -0.762 . . . . 0.0 111.556 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.03 -23.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.007 1.723 . . . . 0.0 110.033 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -65.48 -16.16 63.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.1 -1.0 . . . . 0.0 111.435 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -64.19 -25.2 67.97 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.32 -0.862 . . . . 0.0 111.833 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.89 -33.16 62.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -76.1 -43.2 44.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 121.314 -0.867 . . . . 0.0 109.289 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -63.76 -26.28 68.57 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.262 1.425 . . . . 0.0 110.356 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.78 -44.79 74.03 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 125.424 1.49 . . . . 0.0 110.845 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -97.18 -26.14 15.05 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.58 35.23 33.07 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 42.6 t60 . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 -179.071 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' D' ' 5' ' ' GLU . . . -88.76 152.9 21.5 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.16 -45.63 84.16 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 123.199 1.476 . . . . 0.0 109.657 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -69.93 -17.48 63.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.079 1.352 . . . . 0.0 111.917 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' D' ' 2' ' ' ALA . 56.0 tt0 -77.11 -40.12 46.99 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -173.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -55.55 -50.59 69.61 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.195 1.398 . . . . 0.0 110.485 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.88 -37.9 87.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.938 0.895 . . . . 0.0 109.667 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.55 95.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.553 0.741 . . . . 0.0 111.643 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -68.33 -36.7 79.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.669 -0.644 . . . . 0.0 110.774 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -68.12 -35.09 77.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.705 -0.622 . . . . 0.0 111.039 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.14 98.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.363 1.065 . . . . 0.0 111.104 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -66.76 -35.44 80.11 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.323 -0.86 . . . . 0.0 111.636 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -72.42 -34.12 67.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.676 -1.265 . . . . 0.0 111.161 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -64.84 -35.19 80.31 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.831 1.252 . . . . 0.0 108.844 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -63.22 -39.15 93.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.454 -0.779 . . . . 0.0 111.11 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.13 -21.58 63.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.615 -1.303 . . . . 0.0 112.035 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.4 -36.11 71.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.626 0.727 . . . . 0.0 110.464 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.35 -26.25 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 O-C-N 119.854 -1.779 . . . . 0.0 110.358 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.28 -46.13 90.16 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 121.957 0.884 . . . . 0.0 110.864 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.1 -39.15 86.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.52 -1.363 . . . . 0.0 110.177 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.87 96.02 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.361 1.065 . . . . 0.0 110.798 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.69 76.43 Favored 'General case' 0 CA--C 1.496 -1.123 0 O-C-N 121.301 -0.874 . . . . 0.0 111.469 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -65.06 -44.1 90.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 110.496 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.86 -53.32 48.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 125.124 1.37 . . . . 0.0 109.547 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -65.69 -37.98 87.95 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.308 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.91 83.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 124.37 1.068 . . . . 0.0 111.747 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.14 -50.05 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-N 118.509 0.595 . . . . 0.0 109.857 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -72.43 -31.59 65.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.447 -0.783 . . . . 0.0 110.732 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.49 67.83 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.955 0.902 . . . . 0.0 109.326 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.9 -40.61 96.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 125.482 1.513 . . . . 0.0 110.219 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.76 91.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.928 1.291 . . . . 0.0 112.387 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.65 -5.84 7.5 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.07 59.15 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 118.677 1.238 . . . . 0.0 111.76 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -80.82 137.54 11.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.585 2.19 . . . . 0.0 110.692 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.46 78.15 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 165.2 24.4 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.921 1.289 . . . . 0.0 111.292 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.9 32.51 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 121.808 -0.557 . . . . 0.0 110.472 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -145.14 74.43 1.4 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 120.792 -1.192 . . . . 0.0 107.912 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.67 165.19 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 O-C-N 120.948 -1.095 . . . . 0.0 108.197 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t 81.39 131.37 0.05 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.64 1.576 . . . . 0.0 112.201 165.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -62.69 -42.51 79.16 Favored Pre-proline 0 C--N 1.349 0.581 0 CA-C-O 116.864 -1.541 . . . . 0.0 113.328 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -69.06 -24.56 32.76 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 CA-C-N 124.158 2.521 . . . . 0.0 112.404 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 -32.94 19.98 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 124.745 1.218 . . . . 0.0 107.96 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.07 73.45 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.44 -32.95 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 121.729 -0.607 . . . . 0.0 110.118 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -36.18 76.87 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -65.44 -37.6 87.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.848 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -64.56 -44.42 90.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.464 -0.772 . . . . 0.0 109.491 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.86 64.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.705 0 CA-C-O 121.767 0.794 . . . . 0.0 110.856 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -162.42 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -68.48 -36.65 79.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.099 -1.001 . . . . 0.0 110.964 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.05 65.31 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.281 -0.887 . . . . 0.0 111.681 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -93.79 15.21 17.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 33.0 p 47.34 54.47 9.5 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 126.066 1.746 . . . . 0.0 113.06 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.554 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.0 OUTLIER -121.12 -82.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 178.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.554 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 77.78 64.61 2.02 Favored Glycine 0 CA--C 1.491 -1.426 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.82 -27.86 64.19 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.231 1.015 . . . . 0.0 109.899 -165.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.66 31.14 0.16 Allowed Glycine 0 CA--C 1.486 -1.779 0 O-C-N 120.728 -1.232 . . . . 0.0 110.776 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -81.71 -76.06 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 118.751 1.275 . . . . 0.0 110.837 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -128.54 159.42 35.56 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.31 149.23 18.29 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' PRO . . . . . 0.443 ' CB ' ' HG3' ' D' ' 66' ' ' GLU . 20.6 Cg_endo -73.94 149.89 42.83 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.361 2.707 . . . . 0.0 111.534 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.495 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 14.7 t -86.38 -93.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 124.116 0.966 . . . . 0.0 111.03 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -140.04 -52.58 0.51 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.734 -1.229 . . . . 0.0 108.468 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.73 -16.77 46.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.674 1.189 . . . . 0.0 109.587 -168.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 1.4 pm0 -73.74 -7.27 51.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.09 88.49 0.4 Allowed Glycine 0 CA--C 1.477 -2.303 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.414 HH22 ' CG ' ' C' ' 59' ' ' ASP . 24.9 ttm180 -60.78 -19.77 60.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.39 -1.653 . . . . 0.0 111.235 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -54.57 -16.62 2.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.685 1.194 . . . . 0.0 113.403 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.01 -39.23 84.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 119.992 -1.692 . . . . 0.0 109.229 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -39.84 70.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.115 -0.991 . . . . 0.0 109.922 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -38.01 79.36 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-O 121.876 0.846 . . . . 0.0 110.53 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -29.93 66.56 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.62 -0.675 . . . . 0.0 111.601 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.67 -46.4 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 121.053 -1.029 . . . . 0.0 108.718 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.23 -39.82 89.83 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 122.003 -0.436 . . . . 0.0 110.124 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.56 -47.19 87.29 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.083 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.29 72.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 122.951 0.5 . . . . 0.0 111.275 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -44.22 89.31 Favored Glycine 0 CA--C 1.496 -1.143 0 O-C-N 121.506 -0.746 . . . . 0.0 111.638 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.56 -46.5 95.46 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 124.357 1.063 . . . . 0.0 108.79 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.43 -46.33 69.78 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.075 1.35 . . . . 0.0 111.24 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.21 -57.35 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 C-N-CA 124.929 1.292 . . . . 0.0 110.522 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -66.78 -35.98 81.34 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.42 -0.8 . . . . 0.0 110.467 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.39 95.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.998 0.919 . . . . 0.0 110.863 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.87 -39.9 95.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.71 -15.82 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.422 1.489 . . . . 0.0 111.137 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -59.24 -13.9 9.2 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.623 1.169 . . . . 0.0 111.544 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.27 -48.44 78.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 119.905 -1.747 . . . . 0.0 112.395 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.51 -35.72 77.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 O-C-N 121.348 -0.845 . . . . 0.0 110.156 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.06 -32.65 63.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.42 0.688 . . . . 0.0 110.055 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.43 75.8 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.077 -1.639 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -14.48 62.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.782 -1.199 . . . . 0.0 113.128 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.21 -32.68 74.47 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 120.576 1.535 . . . . 0.0 111.032 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -77.69 -28.64 51.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.064 -1.023 . . . . 0.0 111.421 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -68.86 -24.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 125.291 1.436 . . . . 0.0 108.347 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -59.48 -12.05 5.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.501 1.52 . . . . 0.0 113.797 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 4' ' ' HIS . 1.1 ptp180 -72.88 -33.13 65.86 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 121.169 -0.957 . . . . 0.0 111.569 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -80.8 174.37 11.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.28 7.3 mp0 71.04 -59.64 0.54 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.309 1.843 . . . . 0.0 111.25 -171.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.06 -52.74 64.44 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.552 1.941 . . . . 0.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -67.8 -25.73 65.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.028 0.918 . . . . 0.0 111.656 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -76.3 -25.66 55.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.5 39.08 36.32 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 m170 . . . . . 0 CA--C 1.504 -0.8 0 O-C-N 121.528 -0.983 . . . . 0.0 108.76 178.008 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.425 -1.699 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.24 -62.53 1.48 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.735 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.56 -68.17 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -42.65 86.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.047 2.539 . . . . 0.0 112.08 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 2.3 pm0 -71.0 -26.24 63.04 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.661 0.785 . . . . 0.0 110.585 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.5 -37.04 77.02 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -71.32 -35.05 71.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.309 0.576 . . . . 0.0 109.863 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.0 95.95 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 121.411 -0.805 . . . . 0.0 111.362 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -71.77 -28.81 63.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 121.385 -0.822 . . . . 0.0 111.535 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -69.92 -37.52 75.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.898 -1.126 . . . . 0.0 109.361 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.73 97.36 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.98 0.912 . . . . 0.0 111.363 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -63.0 -36.68 84.37 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.44 -0.787 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.11 -35.36 69.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.028 -1.045 . . . . 0.0 110.792 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.29 -32.82 74.57 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.26 -42.31 98.41 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.924 -1.11 . . . . 0.0 111.61 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -64.31 -28.31 69.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.677 1.191 . . . . 0.0 111.212 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -69.59 -33.76 73.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.899 1.28 . . . . 0.0 110.452 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -71.62 -29.58 35.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.99 -1.068 . . . . 0.0 108.641 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.21 -29.8 66.74 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.01 -1.056 . . . . 0.0 111.223 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -71.31 -33.6 69.83 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.47 1.508 . . . . 0.0 110.329 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -72.44 -45.47 59.45 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 120.388 -1.445 . . . . 0.0 108.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.02 84.87 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 126.233 1.813 . . . . 0.0 111.483 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -67.6 -38.26 83.72 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 122.655 0.382 . . . . 0.0 110.269 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.959 0.904 . . . . 0.0 109.575 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -67.11 -55.0 16.14 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -41.25 73.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 125.688 1.595 . . . . 0.0 113.015 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.16 -37.1 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 O-C-N 120.735 -1.228 . . . . 0.0 112.582 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.67 -34.2 30.87 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.6 -53.72 37.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.543 1.537 . . . . 0.0 109.219 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.38 12.16 5.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.927 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -71.81 94.87 1.45 Allowed 'General case' 0 C--N 1.351 0.664 0 O-C-N 119.672 -1.892 . . . . 0.0 109.626 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.62 61.86 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 150.13 51.7 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -76.33 145.03 26.66 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 122.836 2.358 . . . . 0.0 108.807 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.25 5.22 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 118.956 0.798 . . . . 0.0 112.575 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 151.79 39.5 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 126.361 1.865 . . . . 0.0 110.039 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.75 6.75 0.54 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.075 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.03 -58.13 3.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.9 pt 34.97 29.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 119.228 3.047 . . . . 0.0 119.228 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -162.98 156.61 19.98 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 119.941 -1.724 . . . . 0.0 106.874 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.88 -44.78 0.61 Allowed Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.671 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.26 -17.6 16.76 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 CA-C-N 125.962 3.165 . . . . 0.0 111.413 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.0 -14.77 24.05 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.478 1.111 . . . . 0.0 109.047 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.43 98.53 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.934 0.873 . . . . 0.0 111.766 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.41 -11.68 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.57 0.7 . . . . 0.0 109.769 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.13 -41.58 15.56 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.08 -27.95 60.13 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.714 -0.617 . . . . 0.0 111.02 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.6 p -66.97 -20.27 65.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.518 -1.364 . . . . 0.0 111.924 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.47 -18.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.291 1.037 . . . . 0.0 109.844 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -73.19 -42.05 63.13 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 120.367 -1.458 . . . . 0.0 108.337 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.3 t -85.32 -167.76 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 78.98 -31.16 0.14 Allowed 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 127.179 2.192 . . . . 0.0 111.115 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 p -66.27 -24.53 66.58 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 129.834 3.254 . . . . 0.0 110.191 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.358 28.7 p 64.29 37.49 8.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 129.696 3.198 . . . . 0.0 109.712 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.85 147.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 167.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.51 130.82 5.82 Favored Glycine 0 CA--C 1.474 -2.529 1 N-CA-C 95.085 -7.206 . . . . 0.0 95.085 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.493 ' CE2' ' HA2' ' B' ' 56' ' ' GLY . 7.2 t80 -87.51 -36.5 17.59 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.38 47.65 0.25 Allowed Glycine 0 CA--C 1.479 -2.186 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 168.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.99 -55.78 6.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.53 1.165 . . . . 0.0 108.448 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -112.81 171.19 7.68 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -140.12 110.88 7.16 Favored Pre-proline 0 N--CA 1.445 -0.715 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.07 175.49 11.09 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.451 2.768 . . . . 0.0 109.835 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 64' ' ' THR . 13.2 p -143.13 176.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -173.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 63' ' ' VAL . 3.3 m -63.48 -36.61 84.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 113.106 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.25 -27.94 61.86 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.77 0.828 . . . . 0.0 110.026 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -66.58 -30.43 70.73 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 123.577 1.656 . . . . 0.0 106.829 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 75.78 1.3 Allowed Glycine 0 CA--C 1.463 -3.174 1 N-CA-C 99.53 -5.428 . . . . 0.0 99.53 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -46.12 -13.77 0.02 OUTLIER 'General case' 0 C--N 1.367 1.342 0 C-N-CA 128.742 2.817 . . . . 0.0 114.22 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 72' ' ' GLU . 13.8 mtpp -54.19 -18.3 3.69 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 126.992 2.117 . . . . 0.0 114.131 162.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.88 -52.9 24.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-N 120.892 1.678 . . . . 0.0 107.442 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.43 80.32 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 118.386 0.539 . . . . 0.0 111.658 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 28.4 tt0 -52.48 -47.15 66.69 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 126.614 1.966 . . . . 0.0 111.449 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -62.68 -41.57 99.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.469 -0.769 . . . . 0.0 109.556 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.2 -36.17 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.09 0.556 . . . . 0.0 110.012 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.3 mtt -58.59 -53.12 61.9 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.296 0.638 . . . . 0.0 109.921 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.94 -40.11 96.64 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 122.931 0.492 . . . . 0.0 110.336 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.54 79.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.684 0.793 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.74 -45.17 59.69 Favored Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 124.75 1.166 . . . . 0.0 111.144 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -57.66 -45.83 86.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.237 1.015 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -57.31 -43.75 83.52 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.599 0.76 . . . . 0.0 110.562 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.92 -52.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 124.429 1.091 . . . . 0.0 109.451 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.15 -39.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 121.903 -0.498 . . . . 0.0 110.632 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.46 94.33 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 110.776 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.05 -33.38 75.3 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 124.771 1.228 . . . . 0.0 111.616 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.5 -18.08 13.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.806 1.242 . . . . 0.0 110.707 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -58.75 -22.99 59.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.05 -1.656 . . . . 0.0 112.134 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.17 -24.09 66.98 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.295 -1.503 . . . . 0.0 111.859 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.79 -43.08 11.51 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.008 0.923 . . . . 0.0 108.561 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.9 -39.58 94.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 122.006 0.907 . . . . 0.0 111.552 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -24.74 63.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.607 0.763 . . . . 0.0 112.294 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.9 t -90.72 -2.81 57.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.5 -41.49 72.57 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 120.534 1.516 . . . . 0.0 108.93 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' B' ' 91' ' ' THR . 7.2 p90 -70.45 -22.2 62.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.732 -1.23 . . . . 0.0 112.978 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.66 -24.98 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.301 1.04 . . . . 0.0 108.783 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -59.0 -19.4 43.15 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 125.626 1.57 . . . . 0.0 113.309 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -72.83 -28.17 62.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.862 -1.149 . . . . 0.0 109.234 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -108.07 -60.36 1.73 Allowed 'General case' 0 CA--C 1.502 -0.904 0 O-C-N 120.944 -1.098 . . . . 0.0 108.634 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -77.29 157.61 30.65 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 77.41 -41.55 0.37 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.155 1.382 . . . . 0.0 111.736 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -52.29 -56.05 17.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 110.548 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -86.35 -0.41 55.83 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.491 -0.756 . . . . 0.0 111.049 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.91 -12.67 61.22 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 121.244 -0.91 . . . . 0.0 112.255 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 m80 . . . . . 0 CA--C 1.507 -0.702 0 C-N-CA 125.88 1.672 . . . . 0.0 107.096 -173.315 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.429 -1.513 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.96 -144.77 0.47 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 111.058 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -144.7 -66.51 0.33 Allowed 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 88' ' ' ALA . 10.9 p80 -55.45 -23.18 24.0 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -68.52 -28.38 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.278 -0.889 . . . . 0.0 109.246 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.42 -23.31 40.43 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.17 -0.956 . . . . 0.0 110.966 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -83.05 -41.5 18.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.22 76.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 112.024 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -61.75 -49.12 77.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.589 1.155 . . . . 0.0 109.784 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -64.56 -35.86 82.35 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.698 0.799 . . . . 0.0 110.551 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -44.74 94.69 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -63.55 -43.25 97.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.256 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 123.33 0.652 . . . . 0.0 110.062 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . 0.295 4.1 tt0 -77.13 -11.89 59.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.213 -0.929 . . . . 0.0 112.127 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -70.22 -35.04 73.6 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -60.35 -35.66 76.18 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.845 0.858 . . . . 0.0 110.736 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.7 -39.88 95.41 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.726 1.21 . . . . 0.0 109.923 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.05 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 O-C-N 121.379 -0.826 . . . . 0.0 109.526 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.56 -40.19 96.04 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.903 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.47 -44.29 78.94 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.117 -0.989 . . . . 0.0 109.532 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.87 -39.15 90.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.758 1.223 . . . . 0.0 110.477 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.27 77.22 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 126.025 1.73 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -66.43 -44.1 83.81 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.3 1.04 . . . . 0.0 110.197 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -65.44 -53.72 38.83 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.49 1.116 . . . . 0.0 108.68 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -57.39 -48.6 78.65 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.699 1.199 . . . . 0.0 110.698 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 -41.86 65.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 125.057 1.343 . . . . 0.0 111.666 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.22 -47.08 82.6 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.797 -1.189 . . . . 0.0 107.949 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.34 -1.89 38.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.06 -1.025 . . . . 0.0 110.918 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.505 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -69.91 -47.76 61.23 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 109.594 176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -80.06 -110.93 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 71.18 -33.34 0.27 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.754 2.022 . . . . 0.0 113.515 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.15 41.05 0.38 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.07 153.86 39.03 Favored Pre-proline 0 C--N 1.35 0.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.75 123.21 3.21 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 C-N-CA 123.265 2.643 . . . . 0.0 111.43 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 23.0 53.05 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.94 33.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 126.851 2.061 . . . . 0.0 111.157 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -37.63 0.22 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.873 0.469 . . . . 0.0 110.528 -172.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.98 60.32 4.76 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-O 124.011 1.862 . . . . 0.0 107.865 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.72 -14.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 O-C-N 120.051 -1.656 . . . . 0.0 112.255 -168.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -99.2 132.41 44.53 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.061 -1.649 . . . . 0.0 112.399 -167.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.36 -54.41 11.4 Favored Pre-proline 0 C--N 1.351 0.644 0 CA-C-O 116.619 -1.658 . . . . 0.0 109.606 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.89 -13.07 24.14 Favored 'Trans proline' 0 CA--C 1.508 -0.815 0 CA-C-N 125.552 3.018 . . . . 0.0 111.297 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.51 -10.83 26.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.62 95.07 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.97 -28.72 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 123.989 0.916 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -37.87 62.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.117 0.967 . . . . 0.0 108.793 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -66.69 -43.17 85.11 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.779 0.831 . . . . 0.0 109.475 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 42.0 m -53.53 -30.4 41.47 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.988 1.315 . . . . 0.0 113.572 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.34 -34.87 51.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.435 1.094 . . . . 0.0 110.715 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -77.81 -36.46 50.25 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.842 -1.161 . . . . 0.0 113.174 -171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -77.26 -37.32 53.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -166.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.11 -26.8 64.14 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.522 -0.736 . . . . 0.0 112.071 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -89.23 7.43 35.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p 55.08 64.07 1.91 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.62 1.568 . . . . 0.0 111.778 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.71 -106.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 57' ' ' TYR . . . 98.4 76.55 1.28 Allowed Glycine 0 CA--C 1.484 -1.866 0 N-CA-C 104.634 -3.387 . . . . 0.0 104.634 -174.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -35.78 58.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.65 -0.912 . . . . 0.0 108.911 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 39.45 0.73 Allowed Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.42 ' HB2' HH12 ' C' ' 68' ' ' ARG . 6.5 t70 -77.72 -51.23 10.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 118.554 1.177 . . . . 0.0 108.69 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.32 160.16 38.78 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -130.79 114.45 16.62 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.62 173.08 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.582 2.854 . . . . 0.0 109.349 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.25 -112.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.021 0.929 . . . . 0.0 110.735 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.0 m -136.33 -41.16 0.64 Allowed 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.658 -1.276 . . . . 0.0 108.627 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -81.72 -2.67 51.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.202 -0.936 . . . . 0.0 109.277 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -79.08 -29.52 43.42 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.01 69.66 1.26 Allowed Glycine 0 CA--C 1.47 -2.77 0 N-CA-C 103.795 -3.722 . . . . 0.0 103.795 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -36.03 -18.49 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.444 3.498 . . . . 0.0 116.869 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -53.12 -17.57 1.66 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 119.988 -1.695 . . . . 0.0 113.132 158.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.13 -46.29 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 119.56 -1.962 . . . . 0.0 108.756 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.61 -48.73 63.37 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.59 -47.05 77.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.38 1.072 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -69.85 -37.82 76.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.307 -0.871 . . . . 0.0 112.356 -173.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.35 -43.73 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ttp -62.14 -51.03 69.5 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.298 1.039 . . . . 0.0 110.537 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.31 -30.96 70.95 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.631 0.772 . . . . 0.0 110.044 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.5 73.88 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.331 -0.856 . . . . 0.0 111.12 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.19 85.95 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 mt -60.61 -45.29 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 C-N-CA 124.307 1.043 . . . . 0.0 109.562 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -29.27 70.35 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.111 -0.993 . . . . 0.0 112.078 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.08 -54.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -62.52 -42.19 99.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.728 0.811 . . . . 0.0 110.69 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.11 79.25 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.079 1.352 . . . . 0.0 111.158 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tt -66.77 -34.18 77.27 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.109 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.07 -10.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 124.451 1.101 . . . . 0.0 110.236 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 8.4 m -60.7 -22.98 64.51 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 119.303 -2.123 . . . . 0.0 111.49 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.65 69.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.327 -1.483 . . . . 0.0 111.811 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.469 ' HA ' ' CG ' ' B' ' 4' ' ' HIS . . . -80.27 -45.63 17.6 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.12 -37.8 88.65 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 124.5 1.12 . . . . 0.0 111.795 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.61 65.75 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.598 -0.688 . . . . 0.0 112.202 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -91.5 -6.58 52.35 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.603 -1.311 . . . . 0.0 109.291 176.024 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.299 0.2 OUTLIER -79.12 -12.38 60.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 120.402 1.455 . . . . 0.0 110.616 -167.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.44 -31.75 54.08 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 168.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.53 -22.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.895 1.278 . . . . 0.0 108.672 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -55.62 -24.79 35.4 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.951 1.7 . . . . 0.0 112.18 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -64.19 -22.02 66.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 120.828 -1.17 . . . . 0.0 110.894 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.05 -37.01 72.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -62.47 -54.7 36.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.07 -31.94 61.55 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -62.34 -40.11 95.3 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -94.97 -20.74 19.12 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.1 0.952 . . . . 0.0 109.461 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.18 17.71 57.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 . . . . . 0 CA--C 1.495 -1.162 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 174.617 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.34 119.23 4.55 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 93.103 -6.629 . . . . 0.0 93.103 165.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.22 93.65 0.07 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 119.837 1.198 . . . . 0.0 109.906 -169.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.553 ' HE1' ' OD1' ' C' ' 92' ' ' ASP . 0.6 OUTLIER -176.09 -37.97 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.89 2.076 . . . . 0.0 105.486 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.17 -35.82 74.24 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.131 0.967 . . . . 0.0 110.325 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -58.27 -36.04 72.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.473 1.909 . . . . 0.0 111.389 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.94 -42.42 39.35 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.196 1.398 . . . . 0.0 108.513 -176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.44 85.62 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.302 1.041 . . . . 0.0 110.889 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.27 -37.53 87.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.391 1.476 . . . . 0.0 110.697 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -67.57 -36.03 80.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.009 0.924 . . . . 0.0 109.154 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.92 97.39 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.998 0.919 . . . . 0.0 111.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.66 -27.84 68.66 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 121.235 -0.915 . . . . 0.0 112.435 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.31 -35.73 81.89 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.671 -1.268 . . . . 0.0 109.542 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.74 -44.51 93.76 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.48 -44.05 92.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.034 0.534 . . . . 0.0 110.88 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.35 -40.13 74.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.769 0.827 . . . . 0.0 112.339 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -73.69 -28.53 61.79 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 120.872 -1.142 . . . . 0.0 111.044 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.05 -37.26 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.01 -49.09 69.65 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.085 0.954 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.71 -45.96 91.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.852 0.751 . . . . 0.0 111.672 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -42.71 82.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.715 -0.615 . . . . 0.0 109.99 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.43 84.3 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.963 1.305 . . . . 0.0 111.651 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -62.86 -50.27 71.6 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.977 1.311 . . . . 0.0 109.593 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -67.2 -40.37 86.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -62.0 -48.88 78.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.384 1.074 . . . . 0.0 110.724 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.34 72.66 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 111.824 -173.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.79 -42.39 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 O-C-N 122.204 -0.31 . . . . 0.0 110.396 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.17 -23.63 60.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 120.365 -1.459 . . . . 0.0 112.148 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.55 69.7 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.361 1.464 . . . . 0.0 107.983 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.92 -28.21 63.33 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.739 0.78 . . . . 0.0 111.001 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.34 95.87 1.07 Allowed 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.618 -1.301 . . . . 0.0 110.378 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.0 -11.56 6.54 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.76 142.83 26.12 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 118.272 1.036 . . . . 0.0 109.061 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.54 129.72 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.407 2.071 . . . . 0.0 112.064 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.88 45.01 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 141.69 31.25 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.494 2.318 . . . . 0.0 112.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.89 -45.21 2.59 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.78 65.88 5.92 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 123.018 1.39 . . . . 0.0 109.449 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -96.79 -10.87 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 O-C-N 119.851 -1.781 . . . . 0.0 111.447 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.3 m -98.71 127.23 44.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.514 -0.741 . . . . 0.0 109.668 -169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.84 -52.19 65.87 Favored Pre-proline 0 N--CA 1.445 -0.712 0 C-N-CA 126.148 1.779 . . . . 0.0 112.187 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.75 -8.41 20.31 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 CA-C-N 125.086 2.852 . . . . 0.0 111.624 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.79 -25.97 20.82 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.55 76.16 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.624 0.77 . . . . 0.0 111.348 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.2 -25.23 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 124.609 1.163 . . . . 0.0 110.411 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -79.57 -44.68 20.62 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 119.737 -1.852 . . . . 0.0 107.164 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.03 -37.5 87.43 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.176 0.991 . . . . 0.0 110.547 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -67.59 -35.34 78.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.025 -1.672 . . . . 0.0 111.519 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.26 -51.99 66.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.293 1.037 . . . . 0.0 109.554 -178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.75 -30.81 65.99 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.487 -0.758 . . . . 0.0 110.727 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 80.5 m -62.82 -36.35 82.89 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.955 -1.09 . . . . 0.0 110.783 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -16.05 63.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 120.632 -1.292 . . . . 0.0 113.036 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -89.34 -3.99 58.26 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.458 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.314 11.3 p 68.41 2.09 3.19 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 127.343 2.257 . . . . 0.0 112.66 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.81 -53.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.38 1.472 . . . . 0.0 107.418 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.34 -62.02 4.68 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 74.4 -44.95 0.57 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.798 2.839 . . . . 0.0 109.914 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.57 40.0 0.55 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 107.157 -2.377 . . . . 0.0 107.157 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.55 -55.73 9.33 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.503 1.151 . . . . 0.0 108.275 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -149.25 168.34 23.56 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -134.88 126.71 17.98 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -165.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.52 172.19 13.78 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 123.368 2.712 . . . . 0.0 109.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -93.37 -106.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.306 1.042 . . . . 0.0 113.641 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 18.7 m -155.86 -38.44 0.08 Allowed 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 119.013 -2.304 . . . . 0.0 106.411 -171.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -91.52 10.26 28.59 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 120.851 -1.156 . . . . 0.0 109.084 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -42.16 67.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.56 91.38 1.91 Allowed Glycine 0 N--CA 1.418 -2.537 1 N-CA-C 96.662 -6.575 . . . . 0.0 96.662 -170.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.42 HH12 ' HB2' ' B' ' 59' ' ' ASP . 24.9 ttm180 -65.87 -11.52 47.4 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.04 1.92 . . . . 0.0 110.388 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -46.14 -23.87 0.38 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.456 1.902 . . . . 0.0 113.971 159.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.84 -41.61 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 119.99 -1.694 . . . . 0.0 109.385 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.98 61.76 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -49.8 -49.19 49.6 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 126.236 1.814 . . . . 0.0 111.55 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -44.51 90.05 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.188 0.995 . . . . 0.0 111.813 -173.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.28 -37.92 60.17 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.415 -0.803 . . . . 0.0 109.252 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 73.7 mtm -66.36 -44.77 82.25 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 123.359 0.664 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -59.01 -43.1 91.49 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 123.846 0.858 . . . . 0.0 110.631 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.13 96.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.022 0.529 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.85 91.89 Favored Glycine 0 CA--C 1.493 -1.333 0 C-N-CA 123.905 0.764 . . . . 0.0 111.546 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.25 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 109.017 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.25 -37.97 86.76 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.634 -0.666 . . . . 0.0 111.674 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.57 -53.56 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 119.298 0.953 . . . . 0.0 110.054 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.07 -34.23 76.04 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 122.857 0.463 . . . . 0.0 110.71 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.12 65.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.915 -1.115 . . . . 0.0 110.489 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.03 -32.1 73.38 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 120.647 -1.283 . . . . 0.0 111.481 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.93 -1.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 120.99 -1.069 . . . . 0.0 112.271 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -58.65 -18.06 27.51 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 111.181 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.0 68.44 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.563 -1.336 . . . . 0.0 112.123 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.87 -44.62 16.61 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.317 -0.864 . . . . 0.0 108.857 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.4 -40.62 95.07 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.331 1.053 . . . . 0.0 111.633 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.25 99.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.471 0.708 . . . . 0.0 111.312 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -17.78 64.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 120.924 -1.11 . . . . 0.0 113.303 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.553 ' OD1' ' HE1' ' C' ' 4' ' ' HIS . 1.3 m-20 -74.7 -20.07 60.0 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 119.907 1.231 . . . . 0.0 111.028 -167.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -82.41 -31.83 29.39 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.035 -1.04 . . . . 0.0 110.519 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.04 -19.96 26.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.371 1.468 . . . . 0.0 109.382 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -65.17 -15.51 62.51 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 120.319 -1.488 . . . . 0.0 111.543 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -72.36 -14.01 61.62 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.129 -1.607 . . . . 0.0 111.48 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -63.65 -41.25 98.25 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' C' ' 98' ' ' GLU . 4.1 pt-20 -73.59 -34.64 65.18 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 123.98 0.912 . . . . 0.0 110.118 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -74.43 -11.31 60.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.036 0.934 . . . . 0.0 112.79 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -68.86 -31.02 69.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.928 -1.107 . . . . 0.0 110.234 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -112.72 -4.26 14.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.245 -0.91 . . . . 0.0 109.426 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.04 32.75 83.42 Favored Glycine 0 CA--C 1.498 -1.03 0 O-C-N 121.25 -0.907 . . . . 0.0 111.338 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.433 -1.322 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.23 -46.73 0.57 Allowed 'General case' 0 C--N 1.355 0.809 0 C-N-CA 127.207 2.203 . . . . 0.0 114.32 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . 0.308 3.3 m-20 67.9 -35.08 0.26 Allowed 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 131.358 3.863 . . . . 0.0 111.807 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -68.57 -22.54 64.47 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.856 -1.153 . . . . 0.0 112.528 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.89 -45.77 92.3 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 122.191 0.996 . . . . 0.0 108.845 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -67.1 -38.53 85.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 124.409 1.084 . . . . 0.0 110.142 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.14 -35.39 69.07 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.956 -0.465 . . . . 0.0 109.893 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.68 86.69 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 121.693 -0.63 . . . . 0.0 110.104 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -60.97 -39.71 90.61 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.625 1.57 . . . . 0.0 111.473 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.09 -30.31 62.29 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.358 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.76 79.2 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.822 -1.174 . . . . 0.0 110.982 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.02 -35.92 82.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.596 -0.69 . . . . 0.0 111.966 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.76 -42.82 81.16 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.766 1.226 . . . . 0.0 108.334 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -55.83 -45.13 78.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 125.576 1.55 . . . . 0.0 109.839 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.78 -36.83 79.96 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.542 -0.724 . . . . 0.0 112.348 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -65.01 -34.91 79.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.65 0.78 . . . . 0.0 109.988 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -75.59 -29.3 59.23 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 120.839 -1.163 . . . . 0.0 110.513 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.05 -47.82 52.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.27 -31.84 73.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.512 -0.742 . . . . 0.0 110.445 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -67.39 -43.51 81.15 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.797 -1.189 . . . . 0.0 111.064 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.48 -39.93 95.75 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.82 -1.175 . . . . 0.0 110.456 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.26 -25.6 68.13 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.31 -0.868 . . . . 0.0 112.343 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -66.09 -42.59 89.14 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.389 1.076 . . . . 0.0 111.021 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -66.54 -34.83 78.78 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.471 1.109 . . . . 0.0 108.461 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -74.41 -50.49 18.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 118.273 -0.87 . . . . 0.0 108.722 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.11 -41.8 75.81 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 126.83 2.052 . . . . 0.0 113.166 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.82 -31.12 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 O-C-N 120.722 -1.236 . . . . 0.0 110.896 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 -34.11 22.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.69 47.2 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 0.0 109.373 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.37 -36.5 71.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 120.997 0.427 . . . . 0.0 111.191 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.02 106.53 1.63 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 120.024 -1.673 . . . . 0.0 111.568 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.41 -25.13 4.32 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.94 153.81 75.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 123.657 0.783 . . . . 0.0 110.979 -170.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -80.43 135.78 10.78 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.312 2.008 . . . . 0.0 109.988 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.64 14.07 74.14 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.0 135.0 56.28 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.01 1.724 . . . . 0.0 111.725 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.82 -31.08 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.984 1.314 . . . . 0.0 109.047 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' D' ' 60' ' ' ARG . 4.6 tt -86.72 121.97 29.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.246 1.418 . . . . 0.0 109.103 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 pt -148.88 175.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 73.3 m 67.13 122.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.212 2.205 . . . . 0.0 113.662 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.9 -50.5 87.65 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 116.815 -1.564 . . . . 0.0 113.189 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.61 -11.93 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 124.459 2.628 . . . . 0.0 111.525 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.56 -37.85 14.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.6 83.59 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.939 1.696 . . . . 0.0 112.207 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -64.8 -31.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.47 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.69 -18.25 41.58 Favored 'General case' 0 N--CA 1.437 -1.108 0 O-C-N 120.674 -1.266 . . . . 0.0 110.878 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -72.01 -43.47 65.0 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -66.03 -26.11 67.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 121.33 -0.856 . . . . 0.0 113.202 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.4 -36.18 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 C-N-CA 124.403 1.081 . . . . 0.0 111.351 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.61 -5.9 57.87 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.649 -1.282 . . . . 0.0 110.133 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.43 HG22 ' H ' ' D' ' 52' ' ' ALA . 23.7 m -96.95 177.72 5.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 174.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.43 ' H ' HG22 ' D' ' 51' ' ' THR . . . 80.96 -41.12 0.16 Allowed 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.328 1.451 . . . . 0.0 110.208 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.6 p -85.33 3.54 39.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.982 1.713 . . . . 0.0 111.939 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p 59.24 53.68 5.23 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 126.095 1.758 . . . . 0.0 112.314 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.28 -99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.13 106.22 0.5 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 106.78 -2.528 . . . . 0.0 106.78 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -86.88 -15.64 38.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.747 -1.443 . . . . 0.0 109.233 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.84 28.6 5.27 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -65.57 -56.21 13.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' D' ' 38' ' ' LEU . 88.5 mtt-85 -137.2 156.97 47.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -128.49 149.92 73.04 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 101.206 -3.628 . . . . 0.0 101.206 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.26 152.06 3.72 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 123.313 2.676 . . . . 0.0 110.057 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.486 HG22 ' H ' ' D' ' 64' ' ' THR . 3.1 p -109.32 -179.59 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 122.328 1.061 . . . . 0.0 109.09 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.486 ' H ' HG22 ' D' ' 63' ' ' VAL . 4.9 m -62.63 -49.13 76.39 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.18 2.192 . . . . 0.0 113.913 -167.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -83.64 -0.0 48.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.744 1.218 . . . . 0.0 110.019 -167.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -28.19 67.41 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 123.745 1.736 . . . . 0.0 106.674 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 75.17 1.27 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 99.973 -5.251 . . . . 0.0 99.973 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.26 8.4 mtm180 -55.18 -2.35 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 126.104 1.762 . . . . 0.0 114.92 -169.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HG3' ' D' ' 72' ' ' GLU . 94.1 mttt -67.82 -0.77 4.5 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.828 1.251 . . . . 0.0 112.984 160.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.23 -59.82 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.81 -56.24 17.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 114.647 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' D' ' 69' ' ' LYS 0.302 1.5 pp20? -68.38 -26.63 65.67 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.313 -0.867 . . . . 0.0 111.551 -172.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -67.54 -31.08 70.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.613 -0.679 . . . . 0.0 110.777 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.15 -45.27 86.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.1 mtp -64.99 -46.54 81.0 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.662 0.785 . . . . 0.0 110.056 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -63.76 -37.89 89.06 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.222 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.57 91.62 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.396 0.617 . . . . 0.0 110.939 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.59 -41.52 89.69 Favored Glycine 0 CA--C 1.489 -1.588 0 O-C-N 121.615 -0.678 . . . . 0.0 112.469 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.47 -47.35 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.919 0.888 . . . . 0.0 109.709 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.27 -26.14 61.87 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.101 -0.999 . . . . 0.0 111.934 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 t -64.64 -50.91 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.82 -2.87 32.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.527 -0.733 . . . . 0.0 111.397 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -30.94 13.01 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.067 0.947 . . . . 0.0 109.491 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.84 -33.97 75.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.617 -1.302 . . . . 0.0 109.83 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -62.69 -12.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.183 0.993 . . . . 0.0 111.899 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 21.3 m -68.26 -14.87 63.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 120.337 -1.477 . . . . 0.0 111.73 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -16.39 64.19 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 120.007 -1.683 . . . . 0.0 111.31 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.82 -49.33 7.18 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 62.9 mt -60.39 -35.54 75.98 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.652 1.181 . . . . 0.0 112.085 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 120.924 -1.11 . . . . 0.0 112.435 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -4.45 55.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 120.777 -1.202 . . . . 0.0 108.415 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.9 -32.17 67.14 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 119.382 0.992 . . . . 0.0 109.454 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -75.84 -28.59 58.29 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.379 -1.45 . . . . 0.0 111.079 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 t -70.55 -17.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 108.74 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -59.1 -22.21 60.47 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 125.656 1.582 . . . . 0.0 111.606 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -60.66 -33.0 72.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 123.013 1.387 . . . . 0.0 110.242 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -96.54 154.54 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 103.25 -2.871 . . . . 0.0 103.25 -161.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.29 32.1 mt-10 76.23 -47.97 0.56 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.423 1.489 . . . . 0.0 110.546 -171.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -63.29 -35.95 82.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.277 1.431 . . . . 0.0 112.149 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -71.07 -23.35 62.11 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.888 -0.507 . . . . 0.0 111.94 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -85.26 -23.94 27.98 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.177 -0.952 . . . . 0.0 108.52 172.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.22 32.72 25.02 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.701 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.64 -79.08 0.06 Allowed 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.822 0.82 . . . . 0.0 109.103 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -157.03 -74.17 0.09 Allowed 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 23.4 p-80 -58.4 -35.59 72.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 129.456 3.102 . . . . 0.0 112.313 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.477 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 7.7 mt-10 -68.21 -32.66 73.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.113 0.965 . . . . 0.0 111.498 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -65.61 -40.0 92.15 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.72 -31.89 68.9 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.74 0.816 . . . . 0.0 109.636 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.58 -43.05 70.21 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.544 0.738 . . . . 0.0 109.981 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -68.27 -35.98 78.7 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.914 -0.491 . . . . 0.0 110.305 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.71 -40.12 78.8 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.689 1.196 . . . . 0.0 110.889 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.45 94.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.729 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -64.67 -28.0 69.31 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.427 -0.796 . . . . 0.0 111.608 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.72 -35.94 72.97 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.789 -1.194 . . . . 0.0 110.246 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -68.15 -38.48 82.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.28 -38.71 84.43 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.309 -0.869 . . . . 0.0 111.747 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -71.18 -27.05 63.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 121.403 -0.811 . . . . 0.0 111.458 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -72.17 -39.14 68.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.443 -0.786 . . . . 0.0 109.488 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.2 -34.57 64.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.568 1.147 . . . . 0.0 109.792 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.95 -48.04 82.93 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.926 -1.109 . . . . 0.0 111.342 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.49 -42.51 87.33 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.808 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.28 -49.18 78.64 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 110.072 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.69 88.24 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 125.732 1.613 . . . . 0.0 111.243 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -43.47 98.81 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.588 0.755 . . . . 0.0 111.103 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -66.08 -40.73 91.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 124.398 1.079 . . . . 0.0 108.916 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -76.27 -44.66 36.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.699 -0.626 . . . . 0.0 111.18 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.6 95.54 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.665 1.586 . . . . 0.0 111.09 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.82 -38.05 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 122.189 -0.319 . . . . 0.0 110.212 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.283 89.0 mt-10 -67.98 -40.03 83.19 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.022 -1.049 . . . . 0.0 109.352 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.02 -47.3 85.38 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.76 1.624 . . . . 0.0 109.613 -171.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.15 -8.62 59.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 121.666 -0.646 . . . . 0.0 111.929 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HD2' HG23 ' A' ' 39' ' ' ILE . 34.9 tpt85 -76.17 80.95 2.98 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.081 -1.637 . . . . 0.0 110.141 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.65 -13.74 5.84 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.89 150.08 97.71 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 118.124 0.962 . . . . 0.0 109.903 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' O ' HG11 ' A' ' 63' ' ' VAL . 37.3 Cg_endo -75.55 147.76 32.35 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 121.984 1.79 . . . . 0.0 108.525 -177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 4.21 64.86 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 120.192 1.36 . . . . 0.0 113.957 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 159.44 27.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.755 0.822 . . . . 0.0 111.736 -171.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.96 -32.32 0.8 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.137 0.975 . . . . 0.0 109.78 -171.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.12 40.73 0.72 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 123.828 1.775 . . . . 0.0 109.392 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG23 ' HD2' ' A' ' 31' ' ' ARG . 7.9 mt -86.66 72.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 O-C-N 119.158 -2.214 . . . . 0.0 105.388 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -158.06 -120.37 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 116.553 -1.689 . . . . 0.0 107.041 -168.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.6 t80 178.23 -64.28 0.0 OUTLIER Pre-proline 0 C--N 1.359 1.0 0 CA-C-N 121.052 1.751 . . . . 0.0 110.355 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -75.14 -8.46 19.92 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 CA-C-N 125.515 3.005 . . . . 0.0 111.887 -167.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -10.18 28.33 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 129.662 3.185 . . . . 0.0 107.136 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -48.7 51.31 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.13 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.3 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -17.51 60.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.498 -1.376 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -86.29 -39.21 16.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.23 -38.3 76.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.745 -1.222 . . . . 0.0 111.726 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.57 -25.85 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.695 1.198 . . . . 0.0 110.824 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.99 -23.03 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.976 -1.078 . . . . 0.0 110.809 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -107.47 -22.85 12.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 -165.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.2 64.17 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.372 -1.455 . . . . 0.0 111.999 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.95 2.35 51.86 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.919 1.288 . . . . 0.0 110.578 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.252 9.6 p 56.67 63.09 2.05 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.34 1.856 . . . . 0.0 111.261 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 56' ' ' GLY . 2.6 t -145.79 -164.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -177.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 156.67 101.72 0.19 Allowed Glycine 0 CA--C 1.475 -2.459 1 N-CA-C 100.191 -5.164 . . . . 0.0 100.191 -177.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.89 -26.87 29.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.3 33.57 1.6 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' CG ' HH22 ' B' ' 68' ' ' ARG . 30.8 t70 -83.67 -26.46 29.84 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.434 -1.039 . . . . 0.0 109.418 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -179.58 4.69 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -158.7 114.99 1.67 Allowed Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.71 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.697 2.932 . . . . 0.0 109.417 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 34' ' ' PRO . 3.5 t -106.36 -120.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.909 0.883 . . . . 0.0 110.372 -173.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -141.67 -36.28 0.43 Allowed 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -89.41 9.97 24.31 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 120.881 -1.137 . . . . 0.0 108.187 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -43.92 63.21 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.44 90.92 2.03 Favored Glycine 0 N--CA 1.417 -2.594 1 N-CA-C 96.397 -6.681 . . . . 0.0 96.397 -172.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.407 HH12 ' HB2' ' D' ' 59' ' ' ASP . 22.6 ttm180 -64.36 -12.03 38.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 119.364 1.582 . . . . 0.0 111.081 -172.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -46.95 -28.97 1.8 Allowed 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.002 0.921 . . . . 0.0 113.215 162.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.8 t -66.92 -39.4 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 0.0 110.133 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.48 -50.46 18.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 120.951 -1.093 . . . . 0.0 108.42 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -50.81 -44.5 59.05 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.612 1.565 . . . . 0.0 111.998 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -65.64 -36.02 82.48 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.416 0.686 . . . . 0.0 110.148 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.38 -42.59 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.9 mtt -59.79 -50.89 72.03 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.243 1.017 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -64.55 -38.27 90.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.149 0.98 . . . . 0.0 110.83 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.08 96.55 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.188 0.595 . . . . 0.0 110.518 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.69 -48.72 79.21 Favored Glycine 0 CA--C 1.49 -1.522 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.36 -47.48 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.387 1.075 . . . . 0.0 109.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.72 -39.92 95.48 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 120.929 -1.107 . . . . 0.0 111.397 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 t -64.22 -52.89 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.738 0.815 . . . . 0.0 109.851 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.26 -41.22 94.45 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 110.499 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.13 -30.9 71.48 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 123.565 0.746 . . . . 0.0 111.019 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.57 -30.38 69.99 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.059 -1.026 . . . . 0.0 110.852 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.3 t -59.87 -18.44 15.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 124.375 1.07 . . . . 0.0 110.582 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 m -56.42 -27.71 57.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.248 1.419 . . . . 0.0 112.739 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.04 -28.28 64.36 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.485 1.114 . . . . 0.0 111.376 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 4' ' ' HIS . . . -89.05 -45.92 9.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.088 0.955 . . . . 0.0 109.495 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.7 mt -49.62 -46.71 49.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.476 1.91 . . . . 0.0 113.434 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.82 42.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.756 -1.215 . . . . 0.0 111.222 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.8 p -64.11 -6.14 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.381 1.072 . . . . 0.0 113.259 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.36 -74.79 0.14 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.31 0.93 57.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.439 -1.413 . . . . 0.0 112.347 -168.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.68 -29.52 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 O-C-N 119.761 -1.837 . . . . 0.0 108.761 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -59.5 -18.08 37.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.001 1.32 . . . . 0.0 113.2 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -52.22 -35.46 49.47 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.28 1.432 . . . . 0.0 111.593 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 100' ' ' ARG . 7.5 tp10 -75.0 -49.76 18.78 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.57 -26.18 63.42 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.575 -0.703 . . . . 0.0 110.919 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -73.77 -27.41 61.14 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 119.816 -1.802 . . . . 0.0 111.412 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' A' ' 97' ' ' GLU . 50.5 ttp180 -74.81 -46.01 39.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -131.03 87.79 2.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -172.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.37 -53.7 0.51 Allowed Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 106.445 -2.662 . . . . 0.0 106.445 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . 0.316 14.1 p80 . . . . . 0 CA--C 1.502 -0.872 0 C-N-CA 128.389 2.675 . . . . 0.0 114.274 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.68 169.11 8.76 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.48 -39.55 88.05 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 123.15 1.453 . . . . 0.0 110.405 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' B' ' 91' ' ' THR . 24.7 p80 -72.02 -28.92 63.69 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.159 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.62 -43.05 23.61 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.32 -37.47 87.4 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.962 -0.461 . . . . 0.0 110.32 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.35 -34.83 65.83 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.979 0.418 . . . . 0.0 110.036 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.28 78.59 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 123.674 0.79 . . . . 0.0 110.287 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -77.97 -11.98 59.95 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.633 -0.667 . . . . 0.0 111.452 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -77.77 -29.34 50.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 121.394 -0.816 . . . . 0.0 109.349 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.62 87.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.41 -23.48 63.71 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.693 0.797 . . . . 0.0 111.905 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -72.28 -44.66 62.44 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.931 -1.106 . . . . 0.0 108.161 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.81 -33.75 76.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.693 1.197 . . . . 0.0 109.818 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.02 -45.58 82.99 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 111.913 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.13 -38.89 90.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.286 1.034 . . . . 0.0 109.916 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -63.48 -41.21 98.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.011 0.924 . . . . 0.0 111.382 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.52 -48.41 47.2 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 124.175 0.99 . . . . 0.0 110.372 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.71 -35.22 80.36 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -65.51 -39.03 91.36 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.795 -1.191 . . . . 0.0 110.929 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.79 -37.62 86.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.437 -1.415 . . . . 0.0 109.217 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.62 66.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 123.387 0.675 . . . . 0.0 111.841 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.5 p -66.93 -39.01 87.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 118.767 0.712 . . . . 0.0 110.694 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.34 -46.03 81.88 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.45 -43.14 99.53 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.621 1.169 . . . . 0.0 108.936 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.99 84.64 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.147 1.379 . . . . 0.0 113.279 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.88 -47.78 91.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-O 121.88 0.847 . . . . 0.0 109.502 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -79.96 -20.79 44.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 O-C-N 121.663 -0.648 . . . . 0.0 110.673 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -51.43 22.74 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 125.9 1.68 . . . . 0.0 109.664 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 -18.37 55.35 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.834 -0.542 . . . . 0.0 111.869 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.51 87.67 1.2 Allowed 'General case' 0 C--N 1.353 0.754 0 O-C-N 119.973 -1.704 . . . . 0.0 110.107 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.31 -11.46 3.27 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' B' ' 36' ' ' ALA . . . -88.4 143.77 32.92 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 118.398 1.099 . . . . 0.0 111.69 -170.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.18 125.19 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.359 2.706 . . . . 0.0 111.636 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 23.28 68.0 Favored Glycine 0 CA--C 1.495 -1.206 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' B' ' 33' ' ' ALA . . . -78.19 167.11 21.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.157 1.383 . . . . 0.0 109.524 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.58 -39.51 1.28 Allowed 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.222 0.609 . . . . 0.0 109.615 -166.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -94.78 130.57 41.28 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.6 pt -140.56 6.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 O-C-N 120.81 -1.182 . . . . 0.0 111.124 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.9 138.51 26.99 Favored 'General case' 0 CA--C 1.499 -0.99 0 O-C-N 119.944 -1.723 . . . . 0.0 109.502 -161.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -52.98 65.83 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 126.234 1.813 . . . . 0.0 113.347 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.19 -15.28 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 123.732 2.369 . . . . 0.0 111.827 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.86 -40.39 14.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.16 86.19 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 124.891 1.277 . . . . 0.0 111.886 -170.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.42 -38.73 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 122.749 0.419 . . . . 0.0 110.338 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -38.5 72.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.658 -0.651 . . . . 0.0 110.172 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.49 -43.0 99.88 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-O 122.157 0.979 . . . . 0.0 109.796 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 55.9 m -63.58 -30.61 71.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.517 -1.364 . . . . 0.0 113.006 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.36 -53.8 43.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 123.687 0.795 . . . . 0.0 109.622 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.91 -18.18 60.45 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 121.35 -0.844 . . . . 0.0 111.89 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -69.49 -36.81 76.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.454 0.702 . . . . 0.0 109.19 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.49 71.3 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.147 0.979 . . . . 0.0 111.664 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -82.97 3.4 30.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.358 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p 55.49 53.17 10.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.889 1.676 . . . . 0.0 112.574 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.71 -69.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.91 80.19 0.25 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -62.61 -43.29 99.19 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.463 1.125 . . . . 0.0 108.499 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.48 -120.67 0.99 Allowed Glycine 0 CA--C 1.48 -2.127 1 N-CA-C 102.043 -4.423 . . . . 0.0 102.043 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.341 0.2 OUTLIER 66.08 -64.05 0.22 Allowed 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 127.241 2.216 . . . . 0.0 114.594 -177.051 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -132.88 166.71 21.69 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -160.19 135.97 6.05 Favored Pre-proline 0 N--CA 1.436 -1.145 0 CA-C-O 117.391 -1.29 . . . . 0.0 107.536 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.45 151.04 15.23 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.967 2.445 . . . . 0.0 110.801 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' B' ' 66' ' ' GLU . 2.8 t -92.77 -119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 124.524 1.13 . . . . 0.0 109.145 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 13.4 p -113.93 -43.93 3.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.285 -1.51 . . . . 0.0 111.813 -166.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -83.03 -23.63 33.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.745 1.618 . . . . 0.0 108.041 -163.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' B' ' 63' ' ' VAL . 1.2 pm0 -68.23 -14.62 63.12 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.592 1.957 . . . . 0.0 110.169 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.65 87.85 0.39 Allowed Glycine 0 CA--C 1.481 -2.087 1 N-CA-C 103.055 -4.018 . . . . 0.0 103.055 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.502 HH22 ' CG ' ' A' ' 59' ' ' ASP . 36.9 ttm180 -58.27 -21.21 47.73 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.59 -1.535 . . . . 0.0 111.872 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -55.86 -15.75 3.71 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.43 -43.73 97.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 O-C-N 120.722 -1.236 . . . . 0.0 108.729 172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.04 -43.68 67.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.403 0.681 . . . . 0.0 109.601 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.13 -39.85 69.89 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.819 1.648 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -64.52 -40.52 95.78 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.035 1.334 . . . . 0.0 110.703 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.93 -43.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.8 mtt -57.84 -49.92 75.05 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.096 0.958 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.17 90.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.668 -0.645 . . . . 0.0 111.157 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.5 98.78 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.877 1.227 . . . . 0.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.59 -43.38 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 121.641 -0.917 . . . . 0.0 108.927 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.24 -31.95 70.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.914 -1.116 . . . . 0.0 113.262 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.96 -41.06 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 120.058 1.299 . . . . 0.0 110.607 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.14 -38.58 75.53 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.617 0.644 . . . . 0.0 109.428 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.83 69.86 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.103 -0.998 . . . . 0.0 111.363 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.01 -15.46 63.48 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.546 -1.347 . . . . 0.0 111.207 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -5.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.5 -1.375 . . . . 0.0 110.157 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 14.8 t -49.58 -26.01 3.21 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 119.602 -1.936 . . . . 0.0 113.048 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.63 -36.49 71.9 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.975 1.31 . . . . 0.0 110.893 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.45 23.97 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.305 1.042 . . . . 0.0 108.46 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.44 -42.15 96.16 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 120.788 -1.195 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.84 -1.61 23.04 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.897 -1.127 . . . . 0.0 111.731 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.412 HG21 ' CD2' ' B' ' 4' ' ' HIS . 44.4 p -85.72 -42.1 14.54 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.92 -25.23 52.68 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.789 0.804 . . . . 0.0 110.666 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.96 -50.04 37.54 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 126.736 2.015 . . . . 0.0 111.693 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.61 -30.4 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.749 1.22 . . . . 0.0 109.418 -171.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -58.67 -12.28 4.02 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.371 1.068 . . . . 0.0 112.964 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -54.98 -33.92 62.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.394 -0.816 . . . . 0.0 111.126 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.51 176.24 6.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.264 20.0 mt-10 69.8 -44.46 0.56 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 126.367 1.867 . . . . 0.0 111.786 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -76.1 -50.96 13.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 112.453 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 -78.3 5.96 9.3 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 119.965 1.257 . . . . 0.0 113.507 -172.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -87.88 -28.11 21.77 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 164.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.35 40.65 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 56.1 t60 . . . . . 0 CA--C 1.509 -0.604 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 -176.081 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.81 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.736 2.015 . . . . 0.0 114.399 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -33.21 73.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 119.946 -1.721 . . . . 0.0 109.377 -174.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -79.85 -19.96 47.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.1 0.96 . . . . 0.0 112.165 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -30.76 62.85 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -61.63 -39.8 92.59 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.078 0.951 . . . . 0.0 110.827 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -32.17 73.49 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.346 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' C' ' 85' ' ' VAL . . . -71.69 -35.1 70.15 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 123.482 0.713 . . . . 0.0 110.975 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.15 -33.34 73.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -63.35 -34.3 77.41 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.031 1.733 . . . . 0.0 110.28 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.94 -37.35 81.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.7 -15.56 62.21 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.975 -1.078 . . . . 0.0 111.873 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -69.95 -42.81 72.72 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.48 -1.388 . . . . 0.0 109.034 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.0 -35.78 81.82 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.32 0.648 . . . . 0.0 110.803 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -42.91 88.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.54 -35.14 78.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.331 -0.856 . . . . 0.0 111.706 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -60.16 -46.5 89.47 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.089 1.356 . . . . 0.0 110.058 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.7 -39.07 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.195 0.998 . . . . 0.0 109.819 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.81 -45.32 82.34 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.299 0.954 . . . . 0.0 111.925 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.77 -38.08 79.79 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 122.971 0.508 . . . . 0.0 110.851 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -74.33 -39.89 62.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.78 -1.2 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.17 74.58 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 124.883 1.273 . . . . 0.0 112.339 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -70.74 -36.99 73.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.217 0.917 . . . . 0.0 110.473 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -66.73 -41.28 88.16 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -65.5 -46.9 77.88 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.31 -49.02 65.03 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.87 1.668 . . . . 0.0 112.576 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 27.1 m -67.42 -34.27 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 O-C-N 121.795 -0.566 . . . . 0.0 112.17 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -87.91 -24.15 23.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.539 0.685 . . . . 0.0 109.394 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 66' ' ' GLU . . . -73.6 -47.84 37.22 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.54 -8.68 53.24 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 122.058 0.932 . . . . 0.0 112.316 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.52 107.57 13.44 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 119.647 -1.908 . . . . 0.0 108.125 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.03 15.8 40.71 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.18 21.72 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.79 107.64 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.432 2.088 . . . . 0.0 113.179 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.23 27.36 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.14 145.09 22.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.337 1.855 . . . . 0.0 112.911 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.0 -16.08 5.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.344 1.058 . . . . 0.0 110.785 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.59 -79.84 0.3 Allowed 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 121.221 -0.924 . . . . 0.0 108.595 -168.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . 0.359 12.7 pt 38.94 -128.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 126.779 2.032 . . . . 0.0 111.048 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.4 -135.58 0.82 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.913 1.688 . . . . 0.0 109.752 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -173.03 -68.12 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-O 116.653 -1.642 . . . . 0.0 106.758 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.73 -17.84 22.67 Favored 'Trans proline' 0 CA--C 1.51 -0.685 0 CA-C-N 125.321 2.936 . . . . 0.0 111.197 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.44 -23.75 65.56 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.269 1.427 . . . . 0.0 109.947 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -63.2 -42.42 99.31 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 112.259 -167.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -69.3 -33.71 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.18 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 121.543 -0.723 . . . . 0.0 110.19 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -63.16 -45.4 92.01 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.84 0.456 . . . . 0.0 110.508 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 62.0 m -58.94 -36.09 74.21 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.678 -0.639 . . . . 0.0 112.062 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.32 -45.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 C-N-CA 123.89 0.876 . . . . 0.0 110.191 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -73.84 3.24 6.91 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 122.1 0.952 . . . . 0.0 112.785 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -104.71 -36.3 7.49 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.702 -1.249 . . . . 0.0 108.856 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.68 61.39 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.426 -1.421 . . . . 0.0 111.768 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.8 p -87.69 -3.01 58.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.728 1.211 . . . . 0.0 109.983 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.254 6.9 p 55.62 36.35 27.02 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.522 1.929 . . . . 0.0 112.77 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -91.19 -19.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 O-C-N 121.61 -0.681 . . . . 0.0 111.474 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.48 -60.14 1.55 Allowed Glycine 0 CA--C 1.493 -1.334 0 O-C-N 120.59 -1.319 . . . . 0.0 112.412 168.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -75.71 73.09 2.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.875 1.321 . . . . 0.0 113.62 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.09 10.15 75.77 Favored Glycine 0 CA--C 1.492 -1.399 0 O-C-N 118.512 -2.618 . . . . 0.0 114.552 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t0 71.7 -4.73 1.83 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 126.095 1.758 . . . . 0.0 111.562 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -136.53 163.25 30.96 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -136.0 148.32 64.38 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.13 171.19 15.47 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.812 3.008 . . . . 0.0 108.488 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 t -115.21 -95.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 120.655 1.57 . . . . 0.0 110.282 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -140.48 -49.97 0.45 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -85.13 -16.35 40.77 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 123.646 0.778 . . . . 0.0 110.085 -165.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HB1' ' C' ' 29' ' ' ALA . 0.9 OUTLIER -62.16 -33.21 74.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 108.33 171.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.35 95.32 1.81 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 98.229 -5.948 . . . . 0.0 98.229 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -61.92 -16.22 49.2 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 118.836 1.318 . . . . 0.0 110.62 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -59.81 -11.21 4.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.22 -39.88 86.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.084 -1.635 . . . . 0.0 108.99 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -45.18 69.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.82 -44.57 66.79 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.789 1.636 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -63.85 -36.0 82.48 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 112.34 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -71.84 -43.85 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 121.062 -1.024 . . . . 0.0 108.801 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.78 -42.51 97.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.606 0.762 . . . . 0.0 110.486 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.69 -47.15 83.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.621 1.168 . . . . 0.0 110.294 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.9 98.14 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.233 0.613 . . . . 0.0 110.509 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.13 77.92 Favored Glycine 0 CA--C 1.496 -1.119 0 C-N-CA 123.75 0.69 . . . . 0.0 111.832 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.75 -49.33 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 125.066 1.346 . . . . 0.0 108.675 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.42 -45.12 94.54 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 111.044 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.2 -52.87 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 C-N-CA 124.258 1.023 . . . . 0.0 110.367 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -72.27 -21.92 61.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.222 -0.924 . . . . 0.0 111.18 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.43 -37.88 36.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.115 -0.991 . . . . 0.0 110.111 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.23 -41.72 84.72 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.421 1.488 . . . . 0.0 110.609 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' C' ' 8' ' ' ALA . 17.1 m -69.04 -2.93 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -62.49 -12.57 22.98 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.361 1.065 . . . . 0.0 110.394 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.21 -57.3 12.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.122 -1.611 . . . . 0.0 111.841 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.4 77.6 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 126.07 1.748 . . . . 0.0 109.807 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.43 -33.37 75.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.35 40.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.007 -1.058 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.437 ' O ' HG22 ' C' ' 94' ' ' VAL 0.334 0.1 OUTLIER -70.36 -2.39 13.49 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.517 -1.23 . . . . 0.0 110.617 -176.93 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.281 0.6 OUTLIER -76.25 1.65 15.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 122.148 2.249 . . . . 0.0 111.531 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.24 -24.03 61.32 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 119.673 -1.892 . . . . 0.0 111.05 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.437 HG22 ' O ' ' C' ' 91' ' ' THR . 4.2 m -75.78 -12.95 14.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 O-C-N 120.112 -1.617 . . . . 0.0 110.275 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -79.64 -3.97 49.58 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.893 1.277 . . . . 0.0 109.388 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -77.77 -27.37 50.27 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.009 -1.682 . . . . 0.0 108.489 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -103.16 159.73 15.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -169.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.312 10.3 mt-10 73.9 -46.25 0.62 Allowed 'General case' 0 C--N 1.35 0.62 0 C-N-CA 126.171 1.789 . . . . 0.0 111.098 -168.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -68.22 -32.55 72.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 125.739 1.616 . . . . 0.0 114.971 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -64.8 -19.02 65.6 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.974 -1.079 . . . . 0.0 113.867 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -90.12 -21.92 22.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.095 -1.003 . . . . 0.0 109.499 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.17 32.32 56.2 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 124.016 0.817 . . . . 0.0 111.42 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 . . . . . 0 CA--C 1.487 -1.469 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.522 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.03 80.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.378 0.671 . . . . 0.0 111.314 -169.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -170.14 -104.38 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 -166.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -53.11 -22.54 6.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.989 3.316 . . . . 0.0 114.366 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.64 -28.56 67.82 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 125.385 1.474 . . . . 0.0 110.447 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -68.28 -43.3 78.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.923 0.889 . . . . 0.0 109.742 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.07 -31.34 62.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.503 -0.748 . . . . 0.0 109.588 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.95 91.44 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.871 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -66.12 -38.4 88.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.56 -42.99 99.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 109.904 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.32 84.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.74 0.816 . . . . 0.0 111.566 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.74 -38.16 77.8 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.564 0.745 . . . . 0.0 110.807 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.6 -30.14 65.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.303 -0.873 . . . . 0.0 110.406 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.76 -32.97 73.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.5 -43.2 97.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.357 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -56.05 -33.55 65.08 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.394 1.078 . . . . 0.0 111.745 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -71.19 -23.63 62.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.143 1.377 . . . . 0.0 111.174 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.68 -42.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.48 -40.23 74.57 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 124.939 1.296 . . . . 0.0 111.261 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -54.3 -51.68 63.85 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.273 1.029 . . . . 0.0 111.728 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.58 -38.37 67.92 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.65 0.78 . . . . 0.0 109.254 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.33 77.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.727 1.611 . . . . 0.0 111.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -64.46 -40.06 94.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.629 1.172 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -68.7 -46.62 68.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.49 -49.07 75.03 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.326 -0.859 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.08 -46.57 87.95 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 126.086 1.755 . . . . 0.0 111.836 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.34 -37.32 78.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 118.42 0.554 . . . . 0.0 110.139 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.34 -33.62 61.13 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.944 -1.098 . . . . 0.0 109.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.8 -55.51 14.55 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.249 1.82 . . . . 0.0 109.195 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.09 -32.9 74.38 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.019 0.928 . . . . 0.0 111.135 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -74.18 101.6 4.01 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 120.339 -1.476 . . . . 0.0 110.892 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.05 -22.49 4.79 Favored Glycine 0 CA--C 1.489 -1.541 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.8 142.96 66.1 Favored Pre-proline 0 N--CA 1.443 -0.801 0 O-C-N 121.547 -0.972 . . . . 0.0 109.653 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.94 140.38 12.64 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 122.781 2.321 . . . . 0.0 109.703 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.04 -8.84 71.67 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 119.132 0.878 . . . . 0.0 110.956 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.89 150.65 27.96 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 126.71 2.004 . . . . 0.0 111.287 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.93 -28.89 1.52 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.035 0.534 . . . . 0.0 110.572 -170.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.7 91.4 8.63 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 120.278 -1.514 . . . . 0.0 107.067 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 tt -122.49 53.13 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 O-C-N 120.848 -1.158 . . . . 0.0 108.117 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 26.4 t -153.97 142.0 20.28 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 119.489 -2.007 . . . . 0.0 106.948 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -80.64 -49.7 1.11 Allowed Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 115.807 -2.044 . . . . 0.0 109.929 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -69.18 -15.24 39.1 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 CA-C-N 126.036 3.192 . . . . 0.0 111.723 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.06 -13.53 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.22 80.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.03 -1.044 . . . . 0.0 109.044 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -67.9 -29.33 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 123.132 0.573 . . . . 0.0 110.909 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -47.48 63.85 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -67.23 -32.99 74.4 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.301 -0.875 . . . . 0.0 111.015 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -57.71 -24.85 58.93 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.618 -1.301 . . . . 0.0 112.523 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -40.65 15.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.709 -1.245 . . . . 0.0 110.228 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.38 -27.38 62.26 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 127.502 2.321 . . . . 0.0 110.835 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -99.31 -37.25 9.33 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 120.06 -1.65 . . . . 0.0 109.865 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.82 -14.12 61.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.394 -1.441 . . . . 0.0 112.262 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -99.0 2.07 46.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.257 63.5 p 56.31 28.96 14.18 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.343 2.257 . . . . 0.0 111.856 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.89 -52.88 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.88 63.43 4.79 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.816 -0.436 . . . . 0.0 113.626 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.39 -16.74 63.58 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 118.879 1.34 . . . . 0.0 110.092 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.24 36.8 4.28 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.407 ' HB2' HH12 ' A' ' 68' ' ' ARG . 11.6 t70 -70.25 -54.43 12.73 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.65 169.01 14.96 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.06 130.17 10.0 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 100.366 -3.939 . . . . 0.0 100.366 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.35 177.57 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.253 2.635 . . . . 0.0 107.841 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.38 -119.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 C-N-CA 123.696 0.798 . . . . 0.0 110.949 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -132.63 -38.68 1.01 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.88 -14.62 53.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.791 1.636 . . . . 0.0 108.81 -168.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -33.51 68.84 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.18 63.44 0.81 Allowed Glycine 0 CA--C 1.464 -3.127 1 N-CA-C 102.69 -4.164 . . . . 0.0 102.69 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -30.95 -18.76 0.0 OUTLIER 'General case' 0 C--N 1.361 1.077 1 C-N-CA 132.647 4.379 . . . . 0.0 117.466 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.33 -19.08 7.74 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 119.931 -1.73 . . . . 0.0 113.436 160.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.38 -44.18 98.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 124.451 1.1 . . . . 0.0 108.946 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.72 -55.08 7.3 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -40.08 -58.19 1.5 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.833 2.053 . . . . 0.0 112.326 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.14 -34.23 72.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.421 -169.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -74.23 -42.18 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 52.4 mtm -61.66 -49.72 75.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.524 0.73 . . . . 0.0 110.418 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.92 -27.47 66.66 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.514 -0.741 . . . . 0.0 111.185 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.35 81.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.677 -0.639 . . . . 0.0 110.811 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.69 89.57 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.91 -47.12 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.24 1.016 . . . . 0.0 109.907 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -69.26 -30.6 68.76 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.113 -0.992 . . . . 0.0 112.112 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.27 -52.1 60.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 C-N-CA 123.709 0.804 . . . . 0.0 109.265 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -69.1 -32.12 71.31 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.744 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.28 77.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.376 -0.827 . . . . 0.0 111.243 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -65.68 -36.14 82.8 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.651 1.18 . . . . 0.0 110.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.92 -19.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.405 1.482 . . . . 0.0 110.497 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -59.88 -20.48 57.47 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.791 -1.193 . . . . 0.0 112.714 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.93 74.8 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.228 -2.17 . . . . 0.0 111.539 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.96 53.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.005 0.922 . . . . 0.0 110.178 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.5 -27.93 18.88 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.864 1.316 . . . . 0.0 108.717 175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.77 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 119.836 -1.79 . . . . 0.0 110.757 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -68.28 -12.23 60.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.992 -1.068 . . . . 0.0 109.487 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.09 -20.78 59.32 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.024 -1.047 . . . . 0.0 111.37 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.02 -31.64 72.9 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.153 0.981 . . . . 0.0 108.976 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 t -90.63 -38.3 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 108.37 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -55.96 -35.76 67.05 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.724 1.61 . . . . 0.0 112.238 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -64.51 -20.36 66.16 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.029 -1.045 . . . . 0.0 112.407 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.17 -33.16 50.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 119.957 -1.714 . . . . 0.0 110.278 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -66.93 -34.22 77.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 119.017 0.826 . . . . 0.0 109.701 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.37 -41.28 75.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.799 1.639 . . . . 0.0 110.911 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -63.22 -41.16 99.08 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.547 0.739 . . . . 0.0 111.368 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -70.6 -31.34 68.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.751 0.821 . . . . 0.0 108.819 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.71 13.82 56.19 Favored Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 25.3 t60 . . . . . 0 C--N 1.353 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 112.328 -178.71 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.432 -1.345 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -73.47 174.49 8.13 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -52.34 62.6 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.404 1.881 . . . . 0.0 109.908 -167.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.605 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 42.7 p-80 -76.53 -15.13 59.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.774 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 8.8 mm-40 -80.66 -32.8 35.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -63.86 -44.66 92.45 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.12 0.968 . . . . 0.0 110.0 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.59 -33.76 76.65 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.87 -0.519 . . . . 0.0 111.579 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.98 80.97 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.374 -0.829 . . . . 0.0 110.754 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -67.57 -39.22 84.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.757 -0.589 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.95 -35.88 82.14 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.5 0.72 . . . . 0.0 110.854 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.84 92.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.163 0.985 . . . . 0.0 110.554 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.36 -47.42 81.69 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.839 0.828 . . . . 0.0 110.782 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -70.71 -32.23 69.37 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.725 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -35.79 76.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.749 1.219 . . . . 0.0 109.032 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 tp -67.84 -41.71 82.54 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 121.618 -0.676 . . . . 0.0 111.191 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -66.33 -27.47 67.92 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.564 -0.71 . . . . 0.0 111.731 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -67.71 -39.69 84.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.73 1.212 . . . . 0.0 110.137 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.14 -37.83 77.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.997 0.919 . . . . 0.0 109.101 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.0 mt -56.92 -41.81 78.85 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.124 0.97 . . . . 0.0 112.182 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.54 -46.14 84.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.142 -0.974 . . . . 0.0 110.059 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -67.07 -33.44 75.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.918 -1.114 . . . . 0.0 111.54 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.16 -36.37 79.63 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.004 1.321 . . . . 0.0 110.617 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -63.83 -45.11 91.04 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 123.739 0.815 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -67.76 -49.29 63.28 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.565 0.698 . . . . 0.0 110.668 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -67.29 -34.41 77.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.64 0.776 . . . . 0.0 110.842 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.8 -49.09 61.45 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.297 1.039 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.29 -45.86 89.11 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-O 122.417 1.103 . . . . 0.0 110.189 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -86.87 2.07 50.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.525 -0.734 . . . . 0.0 111.302 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.87 27.6 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.23 -42.49 75.61 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 125.048 1.339 . . . . 0.0 108.911 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -69.58 85.93 0.45 Allowed 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.339 -0.851 . . . . 0.0 111.572 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.14 2.26 Favored Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.02 151.07 37.39 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 117.817 0.808 . . . . 0.0 109.24 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.01 131.84 8.13 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.17 1.914 . . . . 0.0 110.79 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.73 16.74 23.27 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.81 134.81 48.05 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 125.898 1.679 . . . . 0.0 114.177 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.03 -58.93 1.36 Allowed 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.466 1.107 . . . . 0.0 110.543 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.26 93.82 9.63 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 122.553 1.168 . . . . 0.0 112.067 -166.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.61 62.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 O-C-N 119.515 -1.991 . . . . 0.0 111.279 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -152.06 118.34 5.59 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 119.904 -1.747 . . . . 0.0 108.52 169.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.9 -48.93 96.55 Favored Pre-proline 0 C--N 1.359 0.993 0 CA-C-O 116.373 -1.775 . . . . 0.0 112.433 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.36 -8.96 23.58 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 CA-C-N 125.551 3.018 . . . . 0.0 112.947 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -101.78 -24.03 14.11 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.05 98.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 124.035 0.934 . . . . 0.0 110.058 -171.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.75 -32.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 124.567 1.147 . . . . 0.0 111.73 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -42.04 61.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 O-C-N 121.388 -0.82 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -67.33 -35.02 78.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -55.98 -34.46 65.75 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.819 -1.176 . . . . 0.0 112.013 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.31 -49.22 84.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -60.15 -38.03 81.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.819 1.648 . . . . 0.0 111.324 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -65.15 -45.56 84.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.554 1.942 . . . . 0.0 109.435 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.46 64.95 Favored 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 121.143 -0.973 . . . . 0.0 111.266 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 p -84.26 1.85 42.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.734 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.365 18.3 p 75.85 -41.04 0.42 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 128.339 2.655 . . . . 0.0 111.289 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.8 t -39.58 -54.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 128.183 2.593 . . . . 0.0 114.277 -169.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.89 65.93 3.03 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -67.16 -9.42 39.84 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.784 1.234 . . . . 0.0 113.464 -167.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 28.06 6.89 Favored Glycine 0 CA--C 1.488 -1.651 0 O-C-N 120.973 -1.079 . . . . 0.0 110.436 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.61 -47.64 31.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.367 -1.078 . . . . 0.0 109.05 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -123.7 160.45 27.2 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -136.57 147.25 58.98 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.98 167.1 12.79 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.617 2.211 . . . . 0.0 110.577 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 64' ' ' THR . 9.8 p -76.79 178.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 125.874 1.67 . . . . 0.0 108.823 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.588 ' H ' HG22 ' A' ' 63' ' ' VAL . 11.4 m -74.56 -83.89 0.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.779 1.632 . . . . 0.0 109.85 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -57.81 -55.08 39.54 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 120.084 1.311 . . . . 0.0 113.958 -161.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -89.87 -56.95 3.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.705 -0.622 . . . . 0.0 111.721 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' H ' ' CG1' ' A' ' 63' ' ' VAL . . . -53.23 -35.17 49.2 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 125.438 1.494 . . . . 0.0 113.81 -169.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -68.39 -38.32 81.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 118.072 0.936 . . . . 0.0 110.775 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -69.75 -39.7 76.56 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 123.654 0.782 . . . . 0.0 109.888 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.71 -46.64 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.29 86.42 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 124.673 1.189 . . . . 0.0 110.41 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -48.53 -51.93 25.13 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 126.675 1.99 . . . . 0.0 110.375 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -71.1 -42.52 69.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.296 -0.877 . . . . 0.0 111.958 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.74 -42.98 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 124.022 0.929 . . . . 0.0 109.748 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.23 -47.87 82.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 124.758 1.223 . . . . 0.0 109.71 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -60.48 -35.59 76.27 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.504 0.722 . . . . 0.0 110.44 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.21 72.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.705 -0.622 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.53 -41.29 90.43 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.65 -46.79 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 124.33 1.052 . . . . 0.0 108.726 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -62.63 -32.72 73.81 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.8 -0.563 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.15 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 123.914 0.886 . . . . 0.0 110.567 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -62.56 -37.42 86.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.736 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.13 63.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.784 -0.572 . . . . 0.0 111.954 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -73.61 -26.21 60.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.099 -1.625 . . . . 0.0 110.309 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.82 -15.46 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.093 1.357 . . . . 0.0 110.348 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 m -54.08 -24.31 16.96 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 126.207 1.803 . . . . 0.0 112.849 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.49 64.03 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 120.179 -1.576 . . . . 0.0 112.264 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -92.62 -48.35 6.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.555 1.142 . . . . 0.0 108.746 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.47 -39.91 92.53 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 112.598 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.81 61.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -97.28 11.14 37.52 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 120.805 -1.184 . . . . 0.0 108.824 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -79.36 -29.67 42.28 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.396 -1.44 . . . . 0.0 109.048 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -78.7 -24.71 44.85 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.723 -1.236 . . . . 0.0 110.691 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.76 -32.57 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 123.586 0.754 . . . . 0.0 109.698 -171.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -63.35 -16.58 60.85 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.759 1.224 . . . . 0.0 111.884 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 96' ' ' ARG . 21.6 ttp85 -71.34 -31.76 67.76 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.289 1.036 . . . . 0.0 110.562 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -93.68 157.97 15.91 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 73.08 -47.47 0.67 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.189 1.796 . . . . 0.0 110.851 -173.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.61 -42.96 99.61 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.738 -1.226 . . . . 0.0 110.934 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 mtp-105 -81.51 -10.47 59.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.883 -1.136 . . . . 0.0 111.156 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -133.6 73.3 1.5 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.905 0.882 . . . . 0.0 109.103 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.55 -27.53 2.6 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 176.929 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 -161.58 0.26 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.272 1.429 . . . . 0.0 110.671 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -139.41 -59.81 0.57 Allowed 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' HG3' ' B' ' 5' ' ' GLU . 12.5 p80 -50.46 -35.34 28.49 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 125.501 1.521 . . . . 0.0 114.743 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' B' ' 4' ' ' HIS . 4.9 mt-10 -67.59 -33.25 74.63 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.36 1.064 . . . . 0.0 110.78 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -81.03 -20.31 41.97 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.613 -0.679 . . . . 0.0 109.764 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -27.06 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -46.06 84.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.833 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.97 -28.59 62.49 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.446 -0.784 . . . . 0.0 111.007 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.9 -40.08 95.66 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.985 0.914 . . . . 0.0 109.8 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.62 76.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.049 0.939 . . . . 0.0 111.401 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -65.28 -39.5 92.65 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.9 -47.35 80.93 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.502 -0.748 . . . . 0.0 110.255 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' B' ' 14' ' ' GLU . 0.8 OUTLIER -70.66 -25.15 62.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.539 -0.726 . . . . 0.0 111.278 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -63.55 -39.73 95.16 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 120.831 -1.168 . . . . 0.0 111.334 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -62.05 -38.93 90.6 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.446 -0.784 . . . . 0.0 110.06 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.58 84.75 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.093 0.957 . . . . 0.0 110.27 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.44 -47.94 89.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.551 -0.718 . . . . 0.0 110.31 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.43 -36.29 80.94 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.673 -0.642 . . . . 0.0 110.486 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -62.75 -42.04 99.49 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.116 -1.615 . . . . 0.0 110.104 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -66.49 -36.79 83.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.848 0.832 . . . . 0.0 109.698 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.98 73.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.752 0.821 . . . . 0.0 111.552 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -60.93 -38.02 84.32 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.506 1.123 . . . . 0.0 111.98 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -69.03 -41.64 77.44 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.311 -0.868 . . . . 0.0 109.094 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -70.13 -26.37 63.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 121.822 -0.549 . . . . 0.0 110.933 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.07 95.72 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.303 1.041 . . . . 0.0 111.217 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.31 42.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 124.255 1.979 . . . . 0.0 108.474 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -147.19 -42.24 0.18 Allowed 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 100.875 -3.75 . . . . 0.0 100.875 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 56.52 0.46 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.689 1.996 . . . . 0.0 110.216 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 1.8 pp20? 179.68 -27.49 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 125.921 1.688 . . . . 0.0 108.289 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.43 71.73 6.02 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.495 -0.753 . . . . 0.0 109.985 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.22 -34.47 0.84 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 159.24 57.8 Favored Pre-proline 0 CA--C 1.51 -0.586 0 O-C-N 120.681 -1.482 . . . . 0.0 112.817 -173.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.17 152.26 24.01 Favored 'Trans proline' 0 CA--C 1.501 -1.163 0 C-N-CA 122.062 1.842 . . . . 0.0 109.848 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.13 42.34 84.42 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -66.63 -60.18 2.94 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.859 0.864 . . . . 0.0 109.716 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 65.43 -9.32 0.24 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.557 1.543 . . . . 0.0 113.597 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -123.52 31.64 5.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.732 1.613 . . . . 0.0 107.804 -165.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 45.0 pt -70.45 38.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.425 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -161.72 142.68 10.92 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 119.571 -1.956 . . . . 0.0 109.583 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.81 -57.29 1.55 Allowed Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 126.899 2.079 . . . . 0.0 110.978 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.66 -11.84 26.34 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 CA-C-N 126.076 3.206 . . . . 0.0 111.228 -169.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.71 -7.13 44.53 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 125.67 1.588 . . . . 0.0 107.954 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.09 66.86 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 123.983 0.913 . . . . 0.0 109.06 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -82.21 14.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.348 1.071 . . . . 0.0 109.86 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.0 -58.53 2.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 167.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -54.49 -41.62 69.79 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.705 1.602 . . . . 0.0 111.804 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' HG22 ' B' ' 51' ' ' THR . 16.9 m -65.24 -21.81 66.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 120.794 -1.191 . . . . 0.0 113.723 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.25 -53.82 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -47.33 -50.63 21.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 126.682 1.993 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.407 HG22 ' HA ' ' B' ' 48' ' ' SER . 15.2 t -71.99 -30.16 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.772 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.23 60.65 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.223 -0.923 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -83.57 -1.18 53.22 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 122.963 0.505 . . . . 0.0 111.092 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.278 3.4 p 53.89 56.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.323 1.849 . . . . 0.0 112.505 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.0 t -120.54 -72.71 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.05 60.91 1.89 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -19.11 10.38 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.98 27.48 16.28 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.303 -1.498 . . . . 0.0 109.703 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -70.28 -63.67 1.04 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.031 2.133 . . . . 0.0 107.553 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -138.85 170.32 16.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -173.05 138.41 0.82 Allowed Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-O 115.696 -2.097 . . . . 0.0 105.356 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.92 179.38 6.04 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.069 2.513 . . . . 0.0 111.595 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.472 HG22 ' H ' ' B' ' 64' ' ' THR . 12.7 p -123.19 175.34 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.472 ' H ' HG22 ' B' ' 63' ' ' VAL . 19.5 m -48.81 -50.39 34.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 129.25 3.02 . . . . 0.0 113.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.6 -11.88 61.21 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.905 1.282 . . . . 0.0 109.593 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -104.33 5.37 34.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 O-C-N 121.894 -0.504 . . . . 0.0 111.368 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.35 84.07 0.38 Allowed Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 104.543 -3.423 . . . . 0.0 104.543 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.76 -20.37 56.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.535 -1.568 . . . . 0.0 111.125 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -54.84 -13.48 1.08 Allowed 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.828 1.651 . . . . 0.0 113.082 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.98 -40.99 84.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 120.651 -1.281 . . . . 0.0 110.087 169.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.18 -50.17 29.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -48.79 -44.15 38.73 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.989 1.715 . . . . 0.0 111.038 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -48.1 79.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.142 1.377 . . . . 0.0 111.269 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.25 -43.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.53 -46.14 89.72 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.645 1.178 . . . . 0.0 110.413 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.54 -43.03 99.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.29 97.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 122.599 0.36 . . . . 0.0 110.963 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.58 -47.0 93.13 Favored Glycine 0 CA--C 1.495 -1.179 0 C-N-CA 124.358 0.98 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.38 -50.53 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 124.301 1.04 . . . . 0.0 109.054 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -63.28 -33.53 75.71 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 121.802 -0.561 . . . . 0.0 111.782 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.52 -59.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 C-N-CA 124.125 0.97 . . . . 0.0 110.48 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -64.79 -35.62 81.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 121.384 -0.823 . . . . 0.0 110.151 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.62 88.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 111.266 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.45 -35.62 81.52 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.4 1.08 . . . . 0.0 110.533 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.72 -16.11 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.796 1.238 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -59.79 -18.65 45.17 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 120.494 -1.379 . . . . 0.0 111.608 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.53 75.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 119.565 -1.96 . . . . 0.0 112.456 171.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.35 -38.73 55.44 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 121.182 -0.949 . . . . 0.0 109.29 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -32.69 69.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.73 67.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 120.389 -1.444 . . . . 0.0 111.685 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -90.63 3.3 54.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 120.706 -1.246 . . . . 0.0 109.014 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -75.34 -33.75 61.13 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 122.118 0.961 . . . . 0.0 108.72 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -68.55 -32.06 71.73 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.403 -1.435 . . . . 0.0 111.944 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 -22.75 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.912 1.285 . . . . 0.0 109.116 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -59.61 -26.32 65.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.329 1.052 . . . . 0.0 112.07 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -67.97 -24.27 65.14 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 120.242 1.383 . . . . 0.0 111.836 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -71.72 -39.54 70.07 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.046 -1.033 . . . . 0.0 108.776 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.63 -43.48 69.15 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.272 0.629 . . . . 0.0 109.793 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -58.24 -43.34 87.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 126.97 2.108 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -59.49 -44.17 93.15 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 111.333 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -92.12 -14.77 28.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.355 -0.841 . . . . 0.0 111.251 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.96 21.89 70.07 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.508 -0.644 0 C-N-CA 124.626 1.17 . . . . 0.0 111.898 -179.759 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.428 -1.562 0 N-CA-C 100.559 -3.867 . . . . 0.0 100.559 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' C' ' 5' ' ' GLU . . . -85.78 179.24 7.09 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.95 -68.82 0.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 129.623 3.169 . . . . 0.0 111.234 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.644 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 48.8 p-80 -72.56 -18.01 61.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.958 1.303 . . . . 0.0 112.88 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' C' ' 2' ' ' ALA . 34.5 mm-40 -75.99 -41.04 52.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -72.51 -31.97 65.78 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.949 -1.094 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -75.1 -27.21 59.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.369 -0.832 . . . . 0.0 110.032 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -45.82 78.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.161 0.984 . . . . 0.0 110.579 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -62.25 -40.69 97.02 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.475 1.11 . . . . 0.0 110.763 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -60.12 -36.08 76.69 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 124.541 1.136 . . . . 0.0 110.839 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.87 76.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.56 0.744 . . . . 0.0 111.384 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.13 -34.65 78.9 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.184 -0.948 . . . . 0.0 111.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -72.69 -31.9 65.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 110.117 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.85 -33.56 74.02 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.4 1.48 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.93 -42.61 94.54 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.649 0.779 . . . . 0.0 110.663 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -61.9 -36.63 81.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.428 -0.795 . . . . 0.0 111.55 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.65 -43.49 97.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.85 0.86 . . . . 0.0 111.277 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.96 -23.89 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 121.119 -0.988 . . . . 0.0 110.692 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.8 mt -68.86 -38.92 80.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 123.789 0.836 . . . . 0.0 110.509 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -65.47 -38.5 89.97 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.568 1.147 . . . . 0.0 110.452 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.02 -38.03 61.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.683 -1.261 . . . . 0.0 109.155 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -37.97 76.34 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 125.107 1.363 . . . . 0.0 111.493 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -43.21 81.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 118.906 0.775 . . . . 0.0 110.358 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.69 -50.6 62.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -59.58 -45.91 90.47 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 124.021 0.928 . . . . 0.0 109.524 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -42.69 99.89 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.968 0.907 . . . . 0.0 111.897 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' C' ' 44' ' ' ALA . 91.5 t -71.52 -33.16 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 O-C-N 120.973 -1.079 . . . . 0.0 110.326 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.64 -33.34 64.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.464 -0.772 . . . . 0.0 109.338 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.55 79.38 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 126.789 2.036 . . . . 0.0 109.725 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -74.44 -12.65 60.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.47 0.652 . . . . 0.0 112.12 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -79.63 77.19 6.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 120.487 -1.383 . . . . 0.0 110.327 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.82 -11.12 1.66 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.67 147.41 46.25 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 117.847 0.824 . . . . 0.0 110.773 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.32 121.73 3.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.843 2.362 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.87 29.91 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.95 124.34 20.51 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.075 1.75 . . . . 0.0 112.74 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.94 -21.47 6.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.033 0.533 . . . . 0.0 110.638 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -36.64 80.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.648 1.179 . . . . 0.0 110.524 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tp -47.56 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 128.994 2.918 . . . . 0.0 112.067 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -168.3 103.8 0.45 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -60.77 -36.64 37.14 Favored Pre-proline 0 C--N 1.35 0.612 0 CA-C-O 115.315 -2.279 . . . . 0.0 113.101 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.93 -48.79 0.62 Allowed 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 126.757 3.449 . . . . 0.0 110.473 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -6.51 47.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.986 1.314 . . . . 0.0 111.246 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' C' ' 27' ' ' VAL . . . -58.78 -48.62 80.63 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 125.636 1.574 . . . . 0.0 110.876 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.96 -24.84 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.55 -44.66 77.72 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.895 -1.128 . . . . 0.0 108.61 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.7 -41.26 99.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.636 -0.665 . . . . 0.0 110.833 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -57.93 -46.12 85.5 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.092 -1.005 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -80.25 74.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 122.206 1.003 . . . . 0.0 108.851 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -165.14 -40.62 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -31.55 71.08 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.968 0.907 . . . . 0.0 110.485 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -68.31 -24.12 64.81 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.441 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.46 6.61 48.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 123.279 0.632 . . . . 0.0 109.55 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 55.92 52.28 10.88 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 126.125 1.77 . . . . 0.0 112.418 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.3 -156.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.37 103.95 0.33 Allowed Glycine 0 CA--C 1.475 -2.467 1 N-CA-C 99.133 -5.587 . . . . 0.0 99.133 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.96 -28.28 62.32 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 118.101 0.951 . . . . 0.0 110.214 -172.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.0 46.04 0.84 Allowed Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -75.44 -51.75 12.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -137.69 172.48 12.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.35 125.17 5.92 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 101.843 -3.391 . . . . 0.0 101.843 -168.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.85 168.68 21.87 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 123.83 3.02 . . . . 0.0 110.757 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.29 -90.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.011 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 12.7 m -165.01 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.624 -1.922 . . . . 0.0 106.732 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -73.74 -18.8 60.94 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.815 1.246 . . . . 0.0 108.979 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -62.07 -36.48 81.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 125.043 1.337 . . . . 0.0 109.576 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.22 -15.62 1.49 Allowed Glycine 0 CA--C 1.481 -2.087 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 172.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' C' ' 66' ' ' GLU 0.352 3.5 ptp85 63.18 -48.63 0.22 Allowed 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 131.481 3.912 . . . . 0.0 111.734 -170.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.25 12.71 2.2 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.51 -49.42 59.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -49.12 65.59 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 122.897 0.479 . . . . 0.0 110.008 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.92 -42.92 69.3 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.067 0.947 . . . . 0.0 111.433 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -67.37 -32.27 73.07 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 111.224 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.74 -42.29 61.91 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.36 -47.39 85.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 110.502 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.22 -40.67 94.86 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.271 1.029 . . . . 0.0 110.914 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.73 85.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.466 0.707 . . . . 0.0 111.18 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.68 -44.27 92.79 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 124.036 0.827 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.7 -43.23 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.689 0.795 . . . . 0.0 109.116 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.09 -52.99 63.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 123.504 0.722 . . . . 0.0 111.608 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.82 -41.57 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 121.952 -0.468 . . . . 0.0 111.028 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -75.38 -25.23 57.49 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.559 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.77 -33.68 34.76 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.67 -1.269 . . . . 0.0 109.773 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.2 -41.59 75.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.789 1.636 . . . . 0.0 110.873 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.42 -8.03 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.489 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 13.0 m -62.98 -17.43 62.1 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.998 -1.064 . . . . 0.0 109.842 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.05 75.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.185 -1.572 . . . . 0.0 112.337 169.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.644 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.72 -52.64 10.02 Favored 'General case' 0 CA--C 1.492 -1.283 0 O-C-N 120.694 -1.254 . . . . 0.0 107.887 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.76 -29.05 70.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.03 0.443 . . . . 0.0 111.938 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.57 -20.72 64.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.587 -1.321 . . . . 0.0 111.074 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -80.95 -10.96 59.65 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.638 -1.289 . . . . 0.0 110.506 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.26 1.8 m-20 -79.39 -12.97 59.9 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 119.869 1.213 . . . . 0.0 110.817 -167.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.49 -19.97 41.15 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.329 -1.482 . . . . 0.0 109.928 167.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.13 -38.4 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 124.718 1.207 . . . . 0.0 108.077 -172.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -50.79 -31.3 16.51 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 125.816 1.646 . . . . 0.0 113.239 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -60.33 -32.18 71.0 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -87.22 147.5 25.54 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.278 23.9 mm-40 73.68 -41.56 0.49 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.845 2.058 . . . . 0.0 112.514 -171.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -70.89 -40.92 71.93 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 119.673 -1.892 . . . . 0.0 109.309 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -63.09 -36.64 84.27 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.481 -0.762 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -139.09 109.1 6.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.62 38.32 4.49 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 . . . . . 0 C--N 1.354 0.778 0 O-C-N 121.49 -1.006 . . . . 0.0 109.901 179.002 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.428 -1.549 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.38 141.58 35.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.59 -29.83 69.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.073 -1.017 . . . . 0.0 111.076 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -68.38 -22.53 64.64 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.051 -1.031 . . . . 0.0 111.908 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.82 -36.02 23.8 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -62.35 -40.81 97.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.125 0.97 . . . . 0.0 110.488 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.62 -38.44 90.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.483 1.113 . . . . 0.0 110.437 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.74 75.35 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.109 0.964 . . . . 0.0 111.207 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -65.15 -41.49 94.69 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.754 -0.591 . . . . 0.0 110.449 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -64.93 -31.75 73.14 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 122.81 0.444 . . . . 0.0 111.76 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.12 81.52 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.897 -0.502 . . . . 0.0 110.35 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.51 -50.65 72.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.97 0.508 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.56 -34.34 75.42 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.805 0.842 . . . . 0.0 111.462 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -73.97 -32.02 63.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.032 -1.042 . . . . 0.0 110.503 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.43 -38.18 90.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.722 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -75.41 -9.03 58.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.961 -1.087 . . . . 0.0 112.525 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -82.9 -38.97 22.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.07 -38.16 81.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.227 -0.921 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.8 mt -51.94 -42.95 63.23 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.798 1.239 . . . . 0.0 112.518 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -68.32 -42.93 78.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.785 0.834 . . . . 0.0 110.48 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.21 -38.51 68.98 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.22 73.23 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 125.154 1.381 . . . . 0.0 111.955 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -57.55 -47.96 80.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.069 1.414 . . . . 0.0 110.697 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -73.39 -43.15 61.16 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.723 1.209 . . . . 0.0 108.514 -171.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -73.39 -29.66 62.75 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.723 0.809 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.79 79.15 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.035 0.934 . . . . 0.0 111.492 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.95 -43.59 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-O 122.424 1.106 . . . . 0.0 109.846 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -62.55 -32.97 74.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.48 1.512 . . . . 0.0 109.594 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.14 -50.43 71.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 126.099 1.76 . . . . 0.0 110.643 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 111.3 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -80.73 68.24 6.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.414 -1.429 . . . . 0.0 110.987 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.14 -30.43 0.48 Allowed Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.73 150.08 81.35 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.345 1.058 . . . . 0.0 111.778 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -84.27 145.22 10.77 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 122.808 2.339 . . . . 0.0 109.861 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 33.41 55.59 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 147.25 47.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.315 1.046 . . . . 0.0 110.95 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.53 -52.93 1.59 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.98 97.74 10.92 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -137.84 114.05 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -179.6 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -174.86 -65.41 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 116.218 -1.848 . . . . 0.0 106.112 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.84 -16.81 29.44 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 CA-C-N 125.386 2.959 . . . . 0.0 112.637 -166.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -95.03 -8.43 36.79 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.948 1.299 . . . . 0.0 109.639 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.26 62.92 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.757 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.99 -33.58 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.029 0.931 . . . . 0.0 109.626 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -27.38 59.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 119.577 -1.952 . . . . 0.0 110.335 -174.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -69.03 -42.36 76.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.0 p -69.28 -32.26 71.31 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.193 -1.567 . . . . 0.0 110.866 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.81 -46.59 83.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 125.334 1.453 . . . . 0.0 110.936 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -80.61 -2.14 45.21 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 118.757 0.708 . . . . 0.0 112.013 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -101.22 -40.65 7.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 -22.92 66.31 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.765 -1.21 . . . . 0.0 111.685 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -91.83 2.8 56.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 125.026 1.33 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 25.6 p 52.03 70.42 0.56 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.343 1.857 . . . . 0.0 112.785 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.566 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.2 p -129.24 -80.01 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 104.184 -2.525 . . . . 0.0 104.184 169.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.566 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 80.63 80.36 0.85 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -171.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -74.55 -16.15 60.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.028 -1.278 . . . . 0.0 110.983 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.23 5.76 Favored Glycine 0 CA--C 1.492 -1.378 0 O-C-N 121.393 -0.817 . . . . 0.0 111.103 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -70.12 -59.07 3.12 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -137.97 162.64 33.56 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -158.24 154.68 24.39 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.12 177.77 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.483 2.789 . . . . 0.0 109.878 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.427 HG13 ' H ' ' D' ' 64' ' ' THR 0.264 5.6 p -115.01 -118.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 174.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.427 ' H ' HG13 ' D' ' 63' ' ' VAL . 12.2 m -104.93 -85.62 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.189 -1.569 . . . . 0.0 108.988 -170.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.88 128.77 37.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.576 1.15 . . . . 0.0 109.086 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . 0.3 51.7 mt-10 62.2 -111.26 0.4 Allowed 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 115.441 -2.219 . . . . 0.0 106.972 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 35.51 -80.88 0.0 OUTLIER Glycine 0 C--N 1.353 1.49 0 C-N-CA 129.772 3.558 . . . . 0.0 113.786 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -58.92 -41.97 88.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 127.381 2.272 . . . . 0.0 113.196 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.35 -18.1 62.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.473 1.109 . . . . 0.0 109.464 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' D' ' 29' ' ' ALA . 40.8 t -84.63 -45.11 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 172.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.22 -50.91 69.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.666 1.187 . . . . 0.0 113.104 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.86 -35.46 70.99 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.875 0.87 . . . . 0.0 111.62 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -67.96 -45.51 74.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.248 1.019 . . . . 0.0 109.034 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.53 -43.62 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.932 0.893 . . . . 0.0 109.522 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.9 -43.64 98.26 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.387 0.675 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.08 -37.8 83.99 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.234 0.614 . . . . 0.0 111.097 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.11 85.9 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.147 0.579 . . . . 0.0 111.237 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.44 -46.52 55.62 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.81 -47.49 85.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 109.628 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -66.97 -26.69 66.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.13 -0.981 . . . . 0.0 112.372 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.28 -45.18 71.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.748 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.59 -35.2 80.24 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.078 0.942 . . . . 0.0 110.062 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -32.62 67.06 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.391 -0.818 . . . . 0.0 111.332 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.04 -43.92 94.09 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 124.628 1.171 . . . . 0.0 109.727 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -69.96 -4.83 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.375 -0.828 . . . . 0.0 112.061 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -57.49 -24.85 58.22 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.186 1.394 . . . . 0.0 110.344 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.84 78.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 119.847 -1.783 . . . . 0.0 112.163 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.84 -42.87 69.6 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -28.34 63.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.768 0.827 . . . . 0.0 110.858 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.32 76.48 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 119.982 -1.699 . . . . 0.0 109.442 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -11.53 52.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.87 -1.144 . . . . 0.0 112.593 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.37 -26.53 61.94 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.831 1.65 . . . . 0.0 111.595 -170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -79.06 -24.14 43.75 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.212 0.915 . . . . 0.0 110.062 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.97 -36.53 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.414 1.085 . . . . 0.0 108.701 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.4 HH12 ' CD ' ' D' ' 99' ' ' GLU . 14.5 ttt-85 -55.5 -32.94 63.29 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 126.421 1.888 . . . . 0.0 110.83 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -61.7 -23.58 66.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.296 1.038 . . . . 0.0 111.74 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.45 -21.05 64.66 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.797 -0.565 . . . . 0.0 109.934 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.93 -39.77 15.43 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' D' ' 95' ' ' ARG . 3.9 tp10 -68.52 -33.75 74.67 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.643 -0.661 . . . . 0.0 111.008 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 55.6 ptt85 -70.24 -19.83 63.11 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.297 -0.877 . . . . 0.0 111.975 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -78.31 -28.31 47.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.323 -0.861 . . . . 0.0 109.469 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.17 13.98 75.68 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 121.618 -0.676 . . . . 0.0 111.671 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.228 0 N-CA-C 102.178 -3.267 . . . . 0.0 102.178 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.17 168.53 27.01 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.59 -43.23 97.6 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.033 1.733 . . . . 0.0 110.604 -171.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -47.09 72.07 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.634 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -38.29 89.06 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 122.578 0.351 . . . . 0.0 110.101 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -64.23 -46.27 84.57 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.682 -0.637 . . . . 0.0 110.871 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 121.796 -0.565 . . . . 0.0 111.04 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.47 85.61 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 110.805 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.8 -36.1 77.84 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.11 -38.07 85.03 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.904 1.282 . . . . 0.0 109.974 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.44 -37.22 86.76 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 111.711 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.38 -29.17 70.24 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.86 -1.15 . . . . 0.0 111.607 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -68.08 -31.94 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -71.9 -29.29 64.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.0 -37.22 83.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.985 -1.072 . . . . 0.0 110.204 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.19 -26.78 66.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.889 -1.132 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -63.85 -50.12 70.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 123.884 0.873 . . . . 0.0 109.605 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.42 -23.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 121.627 -0.671 . . . . 0.0 110.334 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.6 -50.18 74.56 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.364 0.984 . . . . 0.0 109.711 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -64.09 -42.79 96.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.807 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.05 -44.31 76.7 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.938 -0.476 . . . . 0.0 109.921 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.07 -37.45 85.04 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.144 -0.972 . . . . 0.0 112.026 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 -43.89 86.79 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.941 0.896 . . . . 0.0 110.738 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.21 -43.54 91.22 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.684 1.194 . . . . 0.0 107.973 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -64.52 -49.02 72.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.35 1.06 . . . . 0.0 110.839 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.09 92.97 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.526 1.53 . . . . 0.0 111.216 -173.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.7 -37.78 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 121.465 -0.772 . . . . 0.0 110.344 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -69.72 -38.48 76.91 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.747 -1.221 . . . . 0.0 110.466 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.15 -47.87 66.87 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 126.144 1.777 . . . . 0.0 109.501 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.15 -38.97 79.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.385 1.074 . . . . 0.0 110.977 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -69.74 99.14 1.3 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 119.99 -1.694 . . . . 0.0 113.073 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.81 -3.27 19.54 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.29 148.87 37.42 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 118.193 0.997 . . . . 0.0 108.446 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -80.26 145.59 17.15 Favored 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.418 2.079 . . . . 0.0 109.967 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.31 -8.83 69.35 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 119.239 0.927 . . . . 0.0 111.374 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.01 53.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.92 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.06 -29.25 4.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.31 58.17 4.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.994 1.378 . . . . 0.0 107.959 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -87.5 42.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 O-C-N 119.852 -1.78 . . . . 0.0 111.276 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -135.29 -117.0 0.18 Allowed 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.745 -1.222 . . . . 0.0 109.672 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 t80 171.7 -66.65 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.904 0 CA-C-O 116.315 -1.802 . . . . 0.0 108.766 -172.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -4.64 15.7 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 CA-C-N 125.175 2.884 . . . . 0.0 111.796 -164.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -103.99 -10.15 18.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 127.157 2.183 . . . . 0.0 109.1 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.85 63.89 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.231 -0.918 . . . . 0.0 110.31 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.79 -38.17 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.91 0.862 . . . . 0.0 110.479 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.32 -31.45 26.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -55.77 -40.87 73.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.297 1.039 . . . . 0.0 110.854 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -62.37 -29.36 70.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.698 0.799 . . . . 0.0 112.596 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.78 -36.07 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 120.846 -1.159 . . . . 0.0 108.52 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -65.69 -17.39 64.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.448 1.099 . . . . 0.0 112.166 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 t -109.31 -31.35 7.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.59 -1.319 . . . . 0.0 108.554 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.05 65.57 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.31 -1.494 . . . . 0.0 112.569 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 p -97.9 3.41 49.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.268 12.2 p 55.53 26.71 9.36 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 128.739 2.816 . . . . 0.0 112.569 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG21 ' SD ' ' B' ' 75' ' ' MET . 16.3 m -80.02 -54.48 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 55.87 11.42 Favored Glycine 0 CA--C 1.485 -1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.85 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.89 -17.25 61.36 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.805 0.812 . . . . 0.0 111.96 -173.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.6 40.36 6.82 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.98 -46.61 70.84 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.59 -168.15 1.69 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.04 108.43 5.0 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.11 175.41 10.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.417 2.745 . . . . 0.0 109.281 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 64' ' ' THR . 15.0 p -140.14 -176.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.564 ' H ' HG22 ' A' ' 63' ' ' VAL . 65.7 m -66.7 -45.25 79.36 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.714 -1.866 . . . . 0.0 112.158 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -80.0 -6.77 58.18 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 119.206 0.912 . . . . 0.0 111.156 -170.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.56 -32.68 74.18 Favored 'General case' 0 C--N 1.359 0.986 0 CA-C-O 123.888 1.804 . . . . 0.0 106.259 168.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.26 65.82 1.02 Allowed Glycine 0 CA--C 1.463 -3.168 1 N-CA-C 102.22 -4.352 . . . . 0.0 102.22 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -27.09 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.374 1.665 1 C-N-CA 131.95 4.1 . . . . 0.0 115.472 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -50.72 -12.23 0.1 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 164.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.73 -49.64 49.85 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 123.023 2.647 . . . . 0.0 106.942 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.03 -43.39 98.96 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.871 0.868 . . . . 0.0 110.426 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -65.23 -43.69 90.62 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.705 0.402 . . . . 0.0 111.386 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.68 -41.0 96.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 121.184 -0.948 . . . . 0.0 110.767 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.47 -34.44 35.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.889 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 55.9 ttm -62.72 -52.21 64.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.15 -32.49 70.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.426 -0.796 . . . . 0.0 110.481 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.3 -35.08 77.92 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.835 -0.541 . . . . 0.0 110.907 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.78 96.62 Favored Glycine 0 CA--C 1.492 -1.377 0 C-N-CA 123.646 0.641 . . . . 0.0 111.743 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.14 -47.04 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 124.264 1.026 . . . . 0.0 109.016 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.79 -30.21 68.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.139 -0.976 . . . . 0.0 111.572 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.65 -55.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.618 0.767 . . . . 0.0 109.461 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.37 -33.6 74.56 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 121.464 -0.772 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.72 72.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.153 -0.967 . . . . 0.0 110.529 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.74 -29.06 70.03 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 120.6 -1.312 . . . . 0.0 111.108 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.68 -11.7 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.489 1.515 . . . . 0.0 111.121 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.3 m -51.42 -29.39 15.74 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 119.428 -2.045 . . . . 0.0 112.581 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.14 62.88 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.407 -1.433 . . . . 0.0 112.065 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.2 -56.4 3.29 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 125.695 1.598 . . . . 0.0 108.686 172.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.09 -39.64 75.42 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.994 0.918 . . . . 0.0 112.816 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.9 -14.99 60.27 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.048 -1.033 . . . . 0.0 111.372 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.36 -9.52 47.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 120.683 -1.26 . . . . 0.0 107.702 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -37.52 73.81 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.415 -0.803 . . . . 0.0 109.618 -172.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -71.38 -24.9 62.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.987 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.5 t -70.52 -24.48 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 108.4 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -65.23 -15.7 62.75 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.081 -1.012 . . . . 0.0 111.735 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -55.91 -40.74 73.51 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 124.027 0.931 . . . . 0.0 110.438 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . 0.297 11.3 pt-20 -76.2 -19.28 58.54 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.32 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.58 -45.69 64.89 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -42.58 98.94 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.427 1.091 . . . . 0.0 109.937 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -52.65 -43.46 65.48 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 127.345 2.258 . . . . 0.0 112.818 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -106.41 2.7 26.64 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.603 -0.686 . . . . 0.0 111.469 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.62 19.24 68.9 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 120.888 -1.133 . . . . 0.0 112.759 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.564 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.49 163.18 20.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 120.91 -1.119 . . . . 0.0 108.165 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -69.88 -45.2 68.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 120.262 -1.524 . . . . 0.0 109.736 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.36 -20.17 62.69 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.82 -34.37 62.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.048 -1.033 . . . . 0.0 108.537 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -69.1 -25.61 64.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.69 -0.631 . . . . 0.0 111.008 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -69.78 -44.16 70.7 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.87 87.95 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.261 1.424 . . . . 0.0 111.677 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -56.31 -38.7 71.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.771 1.629 . . . . 0.0 111.161 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -79.34 -13.77 59.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.391 -0.818 . . . . 0.0 111.396 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.55 -36.33 63.12 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -62.99 -43.18 99.5 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.78 0.8 . . . . 0.0 110.395 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.86 -43.43 98.81 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.26 1.424 . . . . 0.0 109.932 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.39 -39.93 77.13 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.931 1.692 . . . . 0.0 110.369 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.71 -41.11 98.14 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 123.381 0.672 . . . . 0.0 111.026 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -59.48 -35.63 74.47 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.426 1.091 . . . . 0.0 110.801 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.33 -34.94 79.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.638 1.175 . . . . 0.0 110.595 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.6 -39.67 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.93 -34.49 78.09 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -72.01 -30.71 65.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 111.864 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -81.89 -37.09 27.41 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.599 -1.313 . . . . 0.0 108.892 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.46 92.87 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.494 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 21.5 p -60.62 -38.7 85.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.492 0.717 . . . . 0.0 111.878 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -75.42 -53.84 8.03 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -62.4 -26.52 68.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.874 0.87 . . . . 0.0 111.186 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -43.85 72.14 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.837 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.16 -12.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.603 1.192 . . . . 0.0 109.153 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.52 21.5 17.35 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.842 -1.786 . . . . 0.0 107.119 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -92.34 -51.7 5.02 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' B' ' 31' ' ' ARG 0.286 0.6 OUTLIER -76.98 -80.42 0.1 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.129 -170.54 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 9.8 mmm180 59.72 -27.73 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 129.611 3.164 . . . . 0.0 116.584 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.45 37.66 0.23 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.19 156.35 79.15 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.968 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.83 123.14 8.74 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.249 2.633 . . . . 0.0 109.899 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.95 -58.41 3.25 Favored Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.3 174.1 0.16 Allowed 'General case' 0 C--N 1.35 0.598 0 C-N-CA 127.539 2.335 . . . . 0.0 109.515 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 61' ' ' TYR . . . -174.92 -53.2 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.76 -1.212 . . . . 0.0 108.93 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.22 138.34 31.57 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 pt -163.18 177.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t 71.97 102.85 0.07 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.751 2.02 . . . . 0.0 110.662 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -49.67 -53.43 41.59 Favored Pre-proline 0 C--N 1.35 0.627 0 CA-C-O 116.782 -1.58 . . . . 0.0 113.264 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.86 -11.68 25.85 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 124.709 2.718 . . . . 0.0 111.921 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -95.52 -27.96 15.12 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.77 72.13 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.442 1.497 . . . . 0.0 111.491 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.08 -30.37 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 121.506 -0.746 . . . . 0.0 111.206 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.03 -20.9 40.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.659 -1.275 . . . . 0.0 109.912 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -65.32 -47.2 77.36 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -57.85 -30.91 66.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.88 -27.95 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.73 0.812 . . . . 0.0 111.296 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -88.36 -3.55 58.82 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.269 -1.519 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -113.18 -175.75 2.74 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 81.11 -50.21 0.28 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.351 1.86 . . . . 0.0 109.391 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -88.12 32.27 0.76 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.204 1.401 . . . . 0.0 111.532 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 42.07 61.7 1.87 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.318 2.247 . . . . 0.0 114.313 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.643 HG13 ' H ' ' B' ' 56' ' ' GLY . 1.0 OUTLIER -134.62 -93.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 176.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.643 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 84.97 87.74 0.9 Allowed Glycine 0 CA--C 1.495 -1.2 0 N-CA-C 104.976 -3.25 . . . . 0.0 104.976 -171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -77.73 -18.8 56.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.813 -1.404 . . . . 0.0 108.712 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 45.53 1.8 Allowed Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.95 -59.55 2.73 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.82 162.04 36.5 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' B' ' 37' ' ' ALA . 34.3 p90 -144.9 148.89 40.68 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.448 ' HB2' ' HG3' ' B' ' 66' ' ' GLU . 32.7 Cg_endo -81.52 160.64 19.53 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 123.381 2.721 . . . . 0.0 108.622 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.23 -99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-N 121.02 1.736 . . . . 0.0 110.424 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -141.57 -48.31 0.39 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 120.13 1.332 . . . . 0.0 111.299 -167.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -27.57 64.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 125.522 1.529 . . . . 0.0 108.196 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' B' ' 62' ' ' PRO . 1.4 pm0 -53.47 -25.44 16.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.067 2.147 . . . . 0.0 111.963 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.32 93.86 1.31 Allowed Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 98.736 -5.746 . . . . 0.0 98.736 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -63.49 -11.6 25.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.69 -1.477 . . . . 0.0 111.9 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -61.58 -17.3 54.47 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.999 0.92 . . . . 0.0 112.328 168.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.78 -33.44 59.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.811 -1.181 . . . . 0.0 109.379 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.99 7.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 120.467 -1.395 . . . . 0.0 108.007 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -48.09 -52.43 20.37 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 125.916 1.687 . . . . 0.0 110.29 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -69.36 -29.57 67.39 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.983 -0.448 . . . . 0.0 111.234 -170.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.8 t -75.41 -44.01 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 O-C-N 120.824 -1.172 . . . . 0.0 108.673 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 36.0 mtm -64.75 -45.68 85.4 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 110.516 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -75.39 -21.7 58.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.378 -0.826 . . . . 0.0 111.15 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.24 -31.11 70.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.889 -1.132 . . . . 0.0 110.486 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.26 -39.23 95.9 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.6 mt -61.84 -38.44 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.09 0.956 . . . . 0.0 108.946 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.97 -54.79 24.93 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.623 -1.298 . . . . 0.0 112.065 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 m -66.74 -45.38 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 123.119 0.568 . . . . 0.0 110.513 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.97 -33.29 63.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.04 -28.88 67.77 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.958 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -65.55 -36.79 84.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 120.925 -1.11 . . . . 0.0 109.984 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.1 -17.97 20.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 125.135 1.374 . . . . 0.0 110.766 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -54.49 -24.41 20.32 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.701 1.2 . . . . 0.0 111.895 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.66 86.93 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.233 -1.542 . . . . 0.0 112.472 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.1 -45.17 70.91 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.66 1.184 . . . . 0.0 108.683 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.86 -37.36 85.97 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.621 0.724 . . . . 0.0 110.353 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.21 76.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.901 -1.124 . . . . 0.0 111.387 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.7 t -78.51 -0.38 29.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 120.607 -1.308 . . . . 0.0 110.27 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -33.89 65.43 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 119.25 0.932 . . . . 0.0 109.758 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -71.11 -31.07 67.3 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.767 -1.208 . . . . 0.0 110.508 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.07 -24.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.89 1.276 . . . . 0.0 109.455 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -58.52 -21.74 53.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.213 1.005 . . . . 0.0 112.38 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.88 -23.01 67.1 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.63 -1.294 . . . . 0.0 111.049 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.25 -21.49 62.1 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.074 -1.016 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -66.53 -49.5 66.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -16.14 54.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.748 -0.595 . . . . 0.0 112.224 -175.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -66.13 -44.58 83.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.867 0.867 . . . . 0.0 109.391 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -87.57 -20.98 25.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.91 -0.494 . . . . 0.0 110.774 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.17 39.91 25.85 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 62.3 t60 . . . . . 0 N--CA 1.438 -1.06 0 C-N-CA 125.004 1.321 . . . . 0.0 108.373 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.05 86.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 172.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.18 -65.89 0.04 OUTLIER 'General case' 0 C--N 1.346 0.42 0 C-N-CA 130.043 3.337 . . . . 0.0 114.126 163.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.596 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 36.6 p-80 -58.35 -25.43 61.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.512 2.325 . . . . 0.0 115.413 -174.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -75.31 -27.15 59.18 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.338 -1.476 . . . . 0.0 110.435 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.47 -36.4 71.17 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.2 -0.937 . . . . 0.0 109.603 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.28 -38.44 65.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.93 0.892 . . . . 0.0 109.29 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.31 93.57 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.235 1.014 . . . . 0.0 111.858 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.23 -27.75 60.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.397 -0.815 . . . . 0.0 110.578 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.69 -33.0 66.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.9 84.72 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -58.8 -35.13 72.34 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.552 0.741 . . . . 0.0 112.128 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.33 -24.08 61.25 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.345 -0.847 . . . . 0.0 111.384 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -73.77 -35.96 65.04 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.82 -42.46 99.05 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.303 -0.873 . . . . 0.0 110.928 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -57.83 -38.07 74.97 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.346 1.058 . . . . 0.0 111.97 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.81 81.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.567 1.147 . . . . 0.0 109.892 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.67 -37.7 79.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 O-C-N 121.15 -0.969 . . . . 0.0 108.748 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.33 -36.48 73.46 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.742 0.817 . . . . 0.0 112.226 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -63.42 -51.91 63.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.703 1.201 . . . . 0.0 109.169 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -63.77 -40.43 96.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.494 0.664 . . . . 0.0 110.216 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -32.27 73.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.386 1.474 . . . . 0.0 112.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -68.94 -34.87 76.06 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.387 -0.821 . . . . 0.0 110.378 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -70.89 -37.59 73.01 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.22 -51.54 63.2 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 -17.55 63.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -82.66 -36.07 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 O-C-N 120.327 -1.483 . . . . 0.0 108.402 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -78.33 -41.8 32.53 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.81 90.23 7.83 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 143.99 2.09 0.0 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.987 3.715 . . . . 0.0 110.085 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -91.05 41.36 1.06 Allowed 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.594 -1.941 . . . . 0.0 112.408 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.31 44.67 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.389 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' C' ' 36' ' ' ALA . . . -103.75 157.42 33.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.21 98.64 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.658 2.239 . . . . 0.0 112.647 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 9.36 36.79 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -52.68 143.6 15.83 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.604 1.562 . . . . 0.0 112.591 -177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.88 -32.4 3.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 124.639 1.176 . . . . 0.0 108.807 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 tt -89.49 50.6 1.94 Allowed 'General case' 0 C--N 1.35 0.603 0 CA-C-O 122.898 1.332 . . . . 0.0 108.144 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.53 53.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 O-C-N 119.915 -1.741 . . . . 0.0 110.083 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -125.87 -151.17 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.89 -1.131 . . . . 0.0 108.401 -167.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -171.32 -64.12 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -69.6 -32.11 19.89 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.214 2.898 . . . . 0.0 112.386 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.469 ' CG ' HH22 ' C' ' 60' ' ' ARG . 8.3 p-10 -95.32 15.71 18.66 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.504 1.047 . . . . 0.0 109.88 -178.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -32.9 73.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.636 -1.29 . . . . 0.0 110.009 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -73.2 -22.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 O-C-N 121.562 -0.711 . . . . 0.0 109.84 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.24 -43.1 58.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.84 -37.24 86.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.75 1.22 . . . . 0.0 109.651 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -58.74 -35.22 72.37 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.73 1.212 . . . . 0.0 111.262 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.54 -52.72 56.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.007 0.923 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.36 -24.98 60.4 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 121.834 -0.541 . . . . 0.0 110.922 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -63.87 -42.77 97.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.002 1.321 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.38 73.9 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.34 -0.85 . . . . 0.0 112.05 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -3.02 45.54 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.158 -0.964 . . . . 0.0 111.405 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.255 3.1 p 59.8 21.71 10.57 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 127.479 2.312 . . . . 0.0 111.578 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.66 -48.05 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.53 74.53 0.35 Allowed Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -69.13 -24.96 64.16 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.217 -1.167 . . . . 0.0 110.867 -170.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.31 10.27 9.75 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.7 -61.4 2.38 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 126.737 2.015 . . . . 0.0 109.509 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.469 HH22 ' CG ' ' C' ' 43' ' ' ASP . 0.0 OUTLIER -145.6 174.14 11.44 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 171.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -167.53 154.37 7.86 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.14 170.63 8.22 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.005 2.47 . . . . 0.0 110.73 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.87 -146.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -76.83 -60.52 2.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 126.172 1.789 . . . . 0.0 109.914 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.91 -16.74 61.09 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.897 0.856 . . . . 0.0 110.264 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.412 ' CD ' ' HB2' ' C' ' 33' ' ' ALA . 13.6 mm-40 -75.35 -16.42 60.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.608 -0.682 . . . . 0.0 109.352 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.77 88.76 0.64 Allowed Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 101.252 -4.739 . . . . 0.0 101.252 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -64.47 -13.03 49.77 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.426 -1.632 . . . . 0.0 110.846 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -60.77 -14.07 19.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.165 0.986 . . . . 0.0 113.172 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.09 -37.4 79.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 O-C-N 120.833 -1.167 . . . . 0.0 109.584 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.83 57.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.085 -1.009 . . . . 0.0 108.953 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.69 -48.77 49.45 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.045 1.738 . . . . 0.0 112.235 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -67.69 -32.06 72.44 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 120.47 -1.394 . . . . 0.0 112.056 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.77 -37.62 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.057 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 55' ' ' VAL . 69.5 mtm -63.07 -45.89 90.0 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.538 0.735 . . . . 0.0 110.807 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -62.9 -35.61 80.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.718 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.3 77.93 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 118.271 0.487 . . . . 0.0 111.815 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.18 -53.32 22.69 Favored Glycine 0 CA--C 1.49 -1.482 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.76 -44.59 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.195 0.998 . . . . 0.0 109.382 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -65.39 -40.0 92.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.441 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.58 -50.1 69.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -66.9 -37.39 84.29 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.655 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.82 -32.89 74.67 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.104 0.962 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.19 -35.72 77.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 124.874 1.27 . . . . 0.0 110.963 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.69 -13.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 125.408 1.483 . . . . 0.0 111.118 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.8 m -62.04 -18.1 59.52 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.654 -1.904 . . . . 0.0 111.986 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.71 -17.33 62.87 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.571 -1.331 . . . . 0.0 111.594 170.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -83.45 -54.46 4.95 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.74 -28.44 66.82 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -165.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.76 -14.18 60.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.61 -1.931 . . . . 0.0 111.029 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -73.78 -17.14 61.13 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 119.94 -1.725 . . . . 0.0 109.828 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -30.13 70.43 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.245 0.618 . . . . 0.0 111.064 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -75.42 -23.89 57.04 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.027 -1.046 . . . . 0.0 110.911 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.67 -27.24 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 123.914 0.885 . . . . 0.0 108.675 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -67.49 -10.83 55.3 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.698 -0.626 . . . . 0.0 112.538 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -67.24 -36.65 82.09 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 120.782 -1.199 . . . . 0.0 109.074 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.35 166.41 12.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 71.38 -58.53 0.57 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.132 1.773 . . . . 0.0 111.313 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.95 -39.24 93.19 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.418 -1.427 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -76.98 -30.88 56.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.973 -0.455 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -127.48 92.18 3.45 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.35 -28.27 2.8 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 CA--C 1.496 -1.127 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -172.859 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 N--CA 1.427 -1.609 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' D' ' 4' ' ' HIS . . . -85.37 170.86 12.32 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.394 0.616 . . . . 0.0 109.347 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.25 -64.86 0.46 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 129.017 2.927 . . . . 0.0 112.688 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' D' ' 2' ' ' ALA . 39.3 p-80 -62.91 -25.6 68.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 112.996 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -79.61 -39.67 31.08 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -64.07 -44.65 91.75 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.592 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.54 -37.21 86.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 110.563 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.84 72.6 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.092 -1.005 . . . . 0.0 110.215 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.32 -28.31 67.04 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.424 0.69 . . . . 0.0 110.646 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.97 -41.81 75.33 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 125.697 1.599 . . . . 0.0 110.964 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.15 86.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.286 0.634 . . . . 0.0 111.5 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.91 -26.03 65.79 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.069 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -71.43 -33.2 69.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.9 -1.125 . . . . 0.0 109.969 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -65.42 -40.04 92.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 123.905 0.882 . . . . 0.0 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.88 -42.61 89.91 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.09 0.556 . . . . 0.0 111.527 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.3 -36.98 79.14 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 112.28 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -68.87 -39.79 79.64 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 110.003 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.06 -40.41 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.15 -53.1 60.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.951 0.796 . . . . 0.0 110.554 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -59.72 -50.02 75.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.869 0.868 . . . . 0.0 111.166 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -73.67 -29.05 62.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.857 -1.152 . . . . 0.0 111.513 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.88 63.94 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -58.51 -45.08 89.54 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.377 1.071 . . . . 0.0 110.565 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -60.9 -49.91 75.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -64.16 -31.82 73.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 123.923 0.889 . . . . 0.0 111.599 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.33 68.77 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.346 0.975 . . . . 0.0 110.693 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -88.01 -32.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 O-C-N 121.393 -0.817 . . . . 0.0 111.793 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -75.29 -23.87 57.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.227 -1.545 . . . . 0.0 111.413 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.0 37.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.72 -86.54 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 mtm-85 -17.32 90.45 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 129.121 2.968 . . . . 0.0 115.361 -151.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -30.79 2.0 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 107.021 -2.432 . . . . 0.0 107.021 -171.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.62 141.24 25.57 Favored Pre-proline 0 C--N 1.353 0.727 0 C-N-CA 125.728 1.611 . . . . 0.0 114.396 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.07 92.83 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.698 2.266 . . . . 0.0 113.345 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.68 -43.55 1.48 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 103.667 -3.773 . . . . 0.0 103.667 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.68 -179.17 0.17 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.551 1.94 . . . . 0.0 109.894 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.7 -41.79 0.05 Allowed 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.75 -14.75 13.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.05 1.34 . . . . 0.0 112.39 -167.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 pt -43.2 105.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -174.91 -143.53 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.6 -58.8 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.09 0 C-N-CA 126.641 1.977 . . . . 0.0 107.553 173.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.6 -20.71 26.53 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 126.064 3.201 . . . . 0.0 112.334 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.68 6.11 42.87 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 118.632 0.651 . . . . 0.0 110.241 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.0 -50.69 67.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.394 -0.817 . . . . 0.0 109.758 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.6 -7.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.013 0.911 . . . . 0.0 110.625 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 -28.24 15.92 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -83.74 -28.51 28.18 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.4 1.0 . . . . 0.0 108.947 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.8 t -78.17 62.69 2.94 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.484 -1.385 . . . . 0.0 108.717 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 84.4 t -137.87 -77.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.99 -5.61 54.29 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.003 -1.061 . . . . 0.0 111.606 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -82.04 -17.16 47.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 121.076 -1.015 . . . . 0.0 108.493 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.09 -32.77 56.88 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.898 -1.126 . . . . 0.0 109.158 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -91.36 16.86 9.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.193 0.597 . . . . 0.0 110.336 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p 55.1 52.45 11.7 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.143 1.777 . . . . 0.0 114.373 170.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -127.11 -61.87 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 87.65 -51.32 4.11 Favored Glycine 0 CA--C 1.496 -1.13 0 O-C-N 119.997 -1.689 . . . . 0.0 109.785 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 74.89 -24.76 0.21 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 128.151 2.58 . . . . 0.0 110.615 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 111.25 23.87 5.61 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.02 -65.91 0.64 Allowed 'General case' 0 C--N 1.36 1.063 0 CA-C-N 118.905 1.352 . . . . 0.0 110.056 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -126.81 161.72 27.55 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.57 89.06 7.61 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 117.858 -1.067 . . . . 0.0 109.168 -170.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.17 158.85 56.14 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.823 2.349 . . . . 0.0 111.875 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.539 HG22 ' H ' ' D' ' 64' ' ' THR . 3.6 p -111.8 -162.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 120.161 1.346 . . . . 0.0 110.788 -174.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.539 ' H ' HG22 ' D' ' 63' ' ' VAL . 1.3 p -70.09 -49.73 47.97 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 128.968 2.907 . . . . 0.0 111.258 -174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -69.65 -30.63 68.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.003 0.921 . . . . 0.0 110.942 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 8.4 pt-20 -79.49 -1.27 36.77 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.83 82.44 0.21 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 104.131 -3.588 . . . . 0.0 104.131 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -50.87 -22.09 2.03 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 120.642 2.221 . . . . 0.0 111.75 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -43.8 -23.08 0.07 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.412 1.885 . . . . 0.0 115.42 161.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.37 -43.91 97.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.588 1.54 . . . . 0.0 108.778 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.54 87.29 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.026 0.53 . . . . 0.0 110.22 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -57.56 -41.91 81.96 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.722 1.209 . . . . 0.0 110.466 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -62.23 -40.36 95.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.347 1.059 . . . . 0.0 111.429 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.06 -42.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -60.98 -46.43 90.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.526 0.73 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -66.84 -36.12 81.61 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 121.438 -0.789 . . . . 0.0 111.523 -175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -44.75 93.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 121.764 -0.585 . . . . 0.0 110.047 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.04 -47.81 89.21 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 124.465 1.031 . . . . 0.0 112.537 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.17 -49.39 81.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.63 1.172 . . . . 0.0 109.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.36 -31.46 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.477 -0.764 . . . . 0.0 111.429 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.4 -53.0 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 118.862 0.756 . . . . 0.0 110.136 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.53 -32.29 72.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.811 -0.555 . . . . 0.0 110.957 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.54 -39.86 92.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.694 1.198 . . . . 0.0 110.802 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.77 -22.42 12.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 124.766 1.226 . . . . 0.0 110.982 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -60.87 -12.21 10.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.0 95.16 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 118.784 -2.447 . . . . 0.0 112.27 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.88 72.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 36.9 mt -80.36 -28.51 38.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.722 0.772 . . . . 0.0 110.876 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.94 -26.32 59.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 120.326 -1.484 . . . . 0.0 110.025 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -78.65 -2.78 40.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.773 -1.204 . . . . 0.0 109.949 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.251 11.8 m-20 -78.68 -16.83 56.83 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 120.68 1.582 . . . . 0.0 111.663 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -80.68 -11.89 59.56 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.227 -1.546 . . . . 0.0 109.846 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.75 -32.85 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -61.7 -19.29 62.2 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.804 1.642 . . . . 0.0 111.872 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -65.18 -22.16 66.86 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.445 1.098 . . . . 0.0 111.439 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.33 132.15 40.77 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 126.359 1.864 . . . . 0.0 106.16 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.284 4.3 mt-10 71.88 -32.3 0.24 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.307 1.843 . . . . 0.0 112.61 -170.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.4 -46.69 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.833 1.253 . . . . 0.0 111.741 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . 0.25 37.7 ptt85 -74.6 0.12 16.01 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 120.507 -1.371 . . . . 0.0 112.742 -172.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -69.8 -36.7 75.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.252 -0.905 . . . . 0.0 108.784 167.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.92 27.86 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 CA--C 1.501 -0.914 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.953 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.427 -1.618 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 4' ' ' HIS . . . -77.93 -43.66 29.25 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 73.13 -58.27 0.61 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.958 2.103 . . . . 0.0 111.11 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 2' ' ' ALA . 28.9 p80 -61.99 -30.51 70.99 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.962 1.705 . . . . 0.0 111.098 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -67.06 -45.13 78.33 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.67 1.188 . . . . 0.0 108.46 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.04 -44.53 96.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.98 0.912 . . . . 0.0 109.687 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -66.23 -32.97 74.71 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.443 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.38 88.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 121.569 -0.707 . . . . 0.0 110.454 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -69.91 -31.13 68.76 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.614 0.721 . . . . 0.0 110.967 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -66.7 -38.52 86.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.907 0.883 . . . . 0.0 110.088 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.04 77.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.772 0.829 . . . . 0.0 111.075 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.45 -37.11 84.63 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.79 0.836 . . . . 0.0 111.559 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -65.87 -43.42 88.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.78 -32.73 73.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 110.224 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.7 -39.95 91.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.375 0.67 . . . . 0.0 111.525 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -64.64 -32.93 74.81 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.592 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -64.82 -39.76 94.1 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.71 0.804 . . . . 0.0 109.915 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.03 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 O-C-N 120.704 -1.248 . . . . 0.0 109.479 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.2 mt -60.99 -37.41 82.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.292 -0.88 . . . . 0.0 111.573 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.99 -45.48 73.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.933 0.893 . . . . 0.0 109.16 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -63.0 -43.64 98.22 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.969 -0.457 . . . . 0.0 109.814 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.31 74.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.873 1.669 . . . . 0.0 111.554 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -65.96 -37.38 85.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 122.153 -0.342 . . . . 0.0 110.964 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -73.09 -45.59 56.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -61.47 -46.28 90.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.07 53.16 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.027 1.331 . . . . 0.0 111.271 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.99 -39.39 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.767 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -81.96 -15.03 55.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.267 -1.521 . . . . 0.0 111.383 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.65 7.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.84 -33.15 74.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.251 1.021 . . . . 0.0 111.465 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -72.31 108.48 5.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 119.541 -1.974 . . . . 0.0 110.356 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.07 -18.83 7.4 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.43 143.82 42.24 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 117.519 0.66 . . . . 0.0 111.0 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.63 116.12 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.575 2.183 . . . . 0.0 111.983 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.3 45.18 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.95 -67.37 0.27 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 127.616 2.366 . . . . 0.0 109.845 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 90.22 -31.1 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 126.754 2.022 . . . . 0.0 108.733 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -89.46 124.92 34.93 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.3 pt -137.63 -3.97 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.986 -1.071 . . . . 0.0 112.483 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -117.99 152.86 34.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 120.097 1.317 . . . . 0.0 109.942 -164.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -83.03 -55.69 0.5 Allowed Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.02 -17.92 28.03 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 CA-C-N 125.404 2.966 . . . . 0.0 111.706 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.64 -21.05 25.52 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.39 70.53 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 120.997 -1.064 . . . . 0.0 110.541 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.68 -28.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.541 -0.725 . . . . 0.0 109.553 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.37 68.71 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 119.752 -1.843 . . . . 0.0 109.927 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -62.79 -47.63 82.63 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.165 0.986 . . . . 0.0 109.815 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -68.73 -28.44 66.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.291 -1.505 . . . . 0.0 111.698 -172.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.4 t -56.83 -54.31 31.11 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 124.153 0.981 . . . . 0.0 109.974 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -20.26 61.29 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.787 -0.57 . . . . 0.0 111.116 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.6 m -75.14 -40.36 59.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.37 1.068 . . . . 0.0 109.218 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -26.55 63.07 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 120.86 -1.15 . . . . 0.0 111.359 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 p -83.37 -1.18 52.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.916 -0.49 . . . . 0.0 110.12 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 p 55.3 39.76 31.38 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 126.386 1.874 . . . . 0.0 111.538 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -104.23 -75.12 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.42 91.77 0.12 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CZ ' ' HA3' ' B' ' 56' ' ' GLY . 0.3 OUTLIER -75.95 -28.24 57.86 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.834 -1.392 . . . . 0.0 109.734 -172.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.33 3.64 5.63 Favored Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.6 -50.94 70.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.5 1.52 . . . . 0.0 113.29 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -142.06 158.62 43.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.33 148.06 20.51 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 102.934 -2.987 . . . . 0.0 102.934 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -90.79 171.09 3.41 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.901 2.4 . . . . 0.0 110.707 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.01 -154.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.686 0 CA-C-O 122.61 1.195 . . . . 0.0 110.291 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -83.51 -52.89 6.11 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.029 -1.669 . . . . 0.0 110.89 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -63.65 -32.2 73.6 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.798 2.439 . . . . 0.0 111.657 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -28.04 69.57 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 123.309 1.528 . . . . 0.0 108.1 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 65.74 1.22 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 103.097 -4.001 . . . . 0.0 103.097 174.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -27.78 -26.79 0.0 OUTLIER 'General case' 0 C--N 1.376 1.742 1 C-N-CA 131.715 4.006 . . . . 0.0 116.043 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -55.02 -12.77 0.92 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.366 2.666 . . . . 0.0 113.201 167.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 -52.13 34.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.11 99.68 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.555 -0.716 . . . . 0.0 111.347 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -50.6 -47.46 58.14 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.364 1.466 . . . . 0.0 111.379 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.66 -40.91 96.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.58 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.84 -43.77 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.205 1.002 . . . . 0.0 109.375 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.04 -49.1 78.98 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 124.391 1.076 . . . . 0.0 110.111 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -64.38 -35.04 79.6 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.631 -0.668 . . . . 0.0 110.897 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.38 80.6 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.147 0.579 . . . . 0.0 111.262 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.05 -43.65 80.71 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.54 -43.66 97.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 124.279 1.032 . . . . 0.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -60.41 -39.96 89.25 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.393 -0.817 . . . . 0.0 111.271 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.06 -54.28 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.103 0.961 . . . . 0.0 109.537 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -61.67 -40.08 93.67 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.421 0.689 . . . . 0.0 111.302 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.36 80.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.914 0.885 . . . . 0.0 110.981 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.58 -35.24 79.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.529 1.132 . . . . 0.0 110.804 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.12 -16.79 7.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 125.301 1.44 . . . . 0.0 111.206 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.0 m -56.6 -24.35 47.16 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.12 -1.612 . . . . 0.0 112.48 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.18 -23.78 62.52 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.842 -1.161 . . . . 0.0 112.439 172.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.59 -3.88 21.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.623 1.169 . . . . 0.0 111.587 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.5 mt -96.67 -42.98 7.76 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.45 64.64 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.343 -0.848 . . . . 0.0 111.067 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -71.32 -20.48 62.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 120.632 -1.292 . . . . 0.0 111.161 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.265 25.5 m-20 -86.8 -8.95 56.88 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.249 -162.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -81.96 -32.36 30.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.442 165.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.67 -32.67 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.789 1.236 . . . . 0.0 109.075 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -53.22 -24.67 11.65 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.583 1.553 . . . . 0.0 112.543 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -54.26 -39.33 66.76 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.596 1.559 . . . . 0.0 110.774 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -69.83 -27.46 64.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.591 -0.693 . . . . 0.0 111.643 -175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -86.14 -34.36 20.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -68.63 -25.2 64.71 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.636 -1.29 . . . . 0.0 111.865 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -67.29 -26.51 66.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 121.262 -0.899 . . . . 0.0 111.26 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -83.32 -31.29 26.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.552 -0.717 . . . . 0.0 109.457 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.62 69.97 Favored Glycine 0 CA--C 1.496 -1.112 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.1 m80 . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -170.079 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.44 ' H ' ' HB2' ' B' ' 5' ' ' GLU . . . -126.74 44.35 2.91 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 118.443 0.565 . . . . 0.0 111.521 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.84 -67.38 0.23 Allowed 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 128.794 2.838 . . . . 0.0 110.678 173.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.714 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 35.1 p-80 -63.9 -21.48 66.48 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.501 1.52 . . . . 0.0 111.769 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' B' ' 2' ' ' ALA . 0.8 OUTLIER -68.73 -35.09 76.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.666 1.187 . . . . 0.0 109.044 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -68.69 -31.68 70.94 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.407 -0.808 . . . . 0.0 110.894 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.07 -27.9 63.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.297 0.57 . . . . 0.0 110.075 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.35 -35.62 78.01 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.305 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.73 -28.72 61.85 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.436 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.69 -38.34 90.66 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.393 -0.817 . . . . 0.0 109.817 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.45 89.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.956 0.903 . . . . 0.0 110.99 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.45 -37.91 89.18 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 121.302 -0.874 . . . . 0.0 111.335 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -65.62 -41.25 92.9 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.386 -0.821 . . . . 0.0 109.713 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.39 -37.23 74.88 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.765 1.226 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -63.67 -42.67 98.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.26 -29.07 68.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.543 -0.723 . . . . 0.0 111.423 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -66.47 -46.89 74.85 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.804 1.242 . . . . 0.0 109.851 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -76.01 -19.33 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 121.534 -0.729 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.75 -43.3 99.16 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 119.533 1.06 . . . . 0.0 110.323 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.54 -39.18 77.63 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -68.87 -31.93 71.23 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.199 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.32 -32.36 73.93 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.752 1.221 . . . . 0.0 110.636 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.0 t -62.2 -48.23 80.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.429 1.092 . . . . 0.0 109.269 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -60.98 -53.39 57.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 108.793 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -65.15 -38.44 90.58 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.33 -54.05 43.06 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.676 1.126 . . . . 0.0 110.984 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.24 -36.59 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.814 -0.554 . . . . 0.0 110.082 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.51 -31.88 57.94 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.18 -0.95 . . . . 0.0 110.33 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.5 -41.87 37.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 O-C-N 121.911 -0.493 . . . . 0.0 110.011 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.31 -28.23 69.17 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 121.87 0.843 . . . . 0.0 111.954 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -72.28 107.53 4.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 119.73 -1.856 . . . . 0.0 110.621 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.02 -24.13 4.56 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 106.594 -2.602 . . . . 0.0 106.594 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 147.22 84.37 Favored Pre-proline 0 N--CA 1.444 -0.759 0 O-C-N 121.94 -0.741 . . . . 0.0 111.444 -171.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.92 145.62 22.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.441 2.094 . . . . 0.0 109.689 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.95 -67.55 3.69 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.04 157.45 0.11 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.936 2.894 . . . . 0.0 109.946 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.27 -43.82 0.37 Allowed 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 120.922 -1.111 . . . . 0.0 108.907 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' B' ' 60' ' ' ARG . 12.7 tp -121.64 111.43 17.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.8 80.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 120.336 -1.478 . . . . 0.0 108.649 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -159.11 158.86 33.74 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.81 -61.58 0.24 Allowed Pre-proline 0 C--N 1.347 0.5 0 CA-C-O 116.971 -1.49 . . . . 0.0 109.204 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.5 -9.53 24.22 Favored 'Trans proline' 0 CA--C 1.511 -0.646 0 CA-C-N 124.835 2.763 . . . . 0.0 112.121 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.08 -22.22 16.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -40.33 82.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 121.452 -0.78 . . . . 0.0 109.25 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -66.16 -27.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 122.737 0.415 . . . . 0.0 110.937 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -73.14 -43.17 61.97 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.465 -0.772 . . . . 0.0 109.09 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.47 -31.93 73.24 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 125.071 1.349 . . . . 0.0 110.036 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 m -63.06 -36.47 83.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 119.08 -2.262 . . . . 0.0 112.45 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 t -64.87 -45.51 94.66 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 121.534 -0.729 . . . . 0.0 110.54 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -65.42 -33.83 76.86 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 122.008 0.909 . . . . 0.0 110.302 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 87.4 m -67.56 -41.3 84.45 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.285 -0.884 . . . . 0.0 109.85 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.75 61.78 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.173 -0.954 . . . . 0.0 112.189 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -97.29 0.86 48.79 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.263 18.7 p 62.21 31.37 17.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.863 1.665 . . . . 0.0 113.775 173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 78.87 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 57' ' ' TYR . . . -90.93 120.08 5.83 Favored Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 103.584 -3.806 . . . . 0.0 103.584 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -86.08 -84.95 0.16 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -168.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.95 37.6 0.31 Allowed Glycine 0 CA--C 1.479 -2.205 0 N-CA-C 106.292 -2.723 . . . . 0.0 106.292 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.1 -62.1 1.56 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' B' ' 38' ' ' LEU . 62.4 mtt-85 -143.22 170.61 15.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -156.76 153.58 24.75 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.96 173.83 8.84 Favored 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 124.25 3.3 . . . . 0.0 109.692 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.34 -99.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 119.695 1.134 . . . . 0.0 112.505 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.7 m -150.46 -40.07 0.13 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.029 1.732 . . . . 0.0 109.106 -172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -88.45 -20.5 25.11 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.283 -0.886 . . . . 0.0 110.645 -169.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -35.08 73.51 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 126.303 1.841 . . . . 0.0 108.315 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.38 90.02 1.88 Allowed Glycine 0 CA--C 1.467 -2.927 1 N-CA-C 97.802 -6.119 . . . . 0.0 97.802 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -56.42 -18.99 12.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.261 1.825 . . . . 0.0 111.382 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -54.72 -22.65 14.63 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 127.104 2.162 . . . . 0.0 113.135 168.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.26 -43.62 98.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.806 -1.184 . . . . 0.0 108.841 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.76 67.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.742 -0.599 . . . . 0.0 109.485 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -52.87 -45.04 67.26 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.482 1.513 . . . . 0.0 110.818 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.57 -39.82 85.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.001 0.92 . . . . 0.0 111.364 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.96 -41.22 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 109.086 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.5 mtt -60.43 -47.54 85.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.81 0.844 . . . . 0.0 110.049 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.927 -0.483 . . . . 0.0 111.134 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.37 90.76 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.766 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.23 -46.17 88.38 Favored Glycine 0 CA--C 1.495 -1.198 0 C-N-CA 124.061 0.839 . . . . 0.0 111.153 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.89 -46.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 C-N-CA 124.443 1.097 . . . . 0.0 109.182 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -62.76 -51.48 66.96 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.315 -0.866 . . . . 0.0 112.327 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.24 -40.84 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 O-C-N 121.76 -0.587 . . . . 0.0 111.081 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -74.22 -38.57 63.52 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.96 74.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.54 -0.725 . . . . 0.0 111.016 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.28 -30.57 71.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.756 1.222 . . . . 0.0 111.068 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.537 HG12 HD23 ' B' ' 89' ' ' LEU . 92.1 t -63.93 -14.91 15.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.879 1.272 . . . . 0.0 110.397 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 20.6 m -55.86 -23.46 30.96 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.6 -1.313 . . . . 0.0 110.894 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.45 74.92 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 119.251 -2.156 . . . . 0.0 112.446 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.714 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.61 -45.15 17.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 120.903 -1.123 . . . . 0.0 108.047 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.537 HD23 HG12 ' B' ' 85' ' ' VAL . 2.2 mm? -70.9 -27.7 63.99 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.877 0.871 . . . . 0.0 111.336 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.06 -17.07 62.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 120.689 -1.257 . . . . 0.0 111.192 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -76.72 -13.92 59.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 120.559 -1.338 . . . . 0.0 111.128 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.259 7.4 t70 -75.71 -18.23 59.67 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 120.231 1.378 . . . . 0.0 111.218 -167.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.43 -36.13 60.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 119.895 -1.753 . . . . 0.0 110.234 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.35 -28.82 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 126.029 1.731 . . . . 0.0 109.437 -171.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -44.21 -36.75 2.83 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 126.835 2.054 . . . . 0.0 112.013 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -58.33 -33.12 69.15 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 123.917 0.887 . . . . 0.0 111.753 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -70.23 -36.25 74.39 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 107.971 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.32 -24.51 46.55 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.666 1.587 . . . . 0.0 110.84 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -81.54 -33.8 31.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.603 -0.686 . . . . 0.0 110.258 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -77.81 -48.12 17.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 86.4 mtt85 -92.65 112.21 24.08 Favored 'General case' 0 CA--C 1.498 -1.031 0 O-C-N 121.105 -0.997 . . . . 0.0 109.187 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.96 -2.61 55.49 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 -175.373 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -26.9 113.94 0.06 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.475 3.11 . . . . 0.0 116.625 -163.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.42 -34.03 77.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 125.677 1.591 . . . . 0.0 110.281 -165.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -61.29 -28.34 69.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.93 -37.57 64.55 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 120.137 1.335 . . . . 0.0 107.837 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -73.84 -38.31 64.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -68.43 -35.19 77.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.969 -0.457 . . . . 0.0 110.345 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.56 90.07 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.8 0.84 . . . . 0.0 110.796 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.64 -38.22 83.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.832 -0.542 . . . . 0.0 110.556 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.89 -40.42 92.98 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.72 0.808 . . . . 0.0 110.328 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.15 75.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.588 0.755 . . . . 0.0 111.588 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -38.49 86.41 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.791 -0.568 . . . . 0.0 111.403 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.71 -30.67 69.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 122.219 1.009 . . . . 0.0 109.846 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.29 -33.56 71.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.803 0.841 . . . . 0.0 109.213 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.35 -43.87 93.22 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.42 0.688 . . . . 0.0 110.649 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -52.36 -41.04 62.73 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.906 1.282 . . . . 0.0 111.771 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -24.17 61.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.845 0.858 . . . . 0.0 111.199 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -78.42 -36.55 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.73 -41.85 91.82 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.815 1.246 . . . . 0.0 111.14 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -74.36 -14.95 60.95 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.58 -36.15 19.05 Favored 'General case' 0 CA--C 1.493 -1.232 0 O-C-N 120.672 -1.268 . . . . 0.0 108.023 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.49 72.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.033 0.933 . . . . 0.0 111.152 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -68.95 -36.84 78.39 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.992 0.815 . . . . 0.0 110.432 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -71.15 -43.8 66.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.93 -49.88 76.15 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.591 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.8 86.65 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.432 1.093 . . . . 0.0 112.017 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -37.07 74.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.283 -1.511 . . . . 0.0 110.187 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -73.85 -31.92 63.41 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 120.751 -1.218 . . . . 0.0 109.279 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.24 15.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 126.06 1.744 . . . . 0.0 109.053 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.64 -25.96 64.18 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.143 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.61 104.91 2.5 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 119.481 -2.012 . . . . 0.0 110.59 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.47 -5.76 21.09 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 144.31 28.87 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.68 139.6 11.27 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.367 2.045 . . . . 0.0 110.277 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.65 81.46 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.58 116.01 4.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 125.74 1.616 . . . . 0.0 106.906 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.74 -33.55 15.7 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' C' ' 44' ' ' ALA . 24.5 tp -90.72 127.84 36.45 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 pt -144.88 168.8 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 101.222 -3.622 . . . . 0.0 101.222 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m 74.8 131.2 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.407 1.883 . . . . 0.0 113.402 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -58.64 -49.09 95.35 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 116.194 -1.86 . . . . 0.0 112.527 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.53 -27.94 38.78 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.297 2.928 . . . . 0.0 113.491 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.339 4.8 p-10 -98.7 -1.64 40.15 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 120.739 1.609 . . . . 0.0 111.035 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 38' ' ' LEU . . . -69.08 -34.17 74.69 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 120.713 -1.242 . . . . 0.0 110.878 173.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.66 -16.71 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 O-C-N 121.091 -1.006 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.08 -41.48 28.63 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.887 -1.133 . . . . 0.0 108.304 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.7 -33.29 75.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.858 0.837 . . . . 0.0 109.977 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -77.29 53.85 1.05 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 120.935 -1.103 . . . . 0.0 111.144 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -141.69 -54.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -34.25 71.13 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.741 1.216 . . . . 0.0 112.422 -172.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -72.68 -33.29 66.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 125.313 1.445 . . . . 0.0 109.898 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.1 -31.09 58.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.411 -1.431 . . . . 0.0 110.309 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -85.01 -1.74 57.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.171 0.588 . . . . 0.0 110.727 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p 51.13 68.01 0.86 Allowed 'General case' 0 C--N 1.352 0.709 0 C-N-CA 127.695 2.398 . . . . 0.0 112.099 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.12 -75.87 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.65 -78.94 0.63 Allowed Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -173.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 83.28 -49.62 0.15 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 127.746 2.419 . . . . 0.0 106.434 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.24 42.49 0.25 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -70.24 -54.12 14.12 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -139.4 -169.57 2.71 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.09 137.71 11.49 Favored Pre-proline 0 N--CA 1.438 -1.067 1 N-CA-C 100.153 -4.017 . . . . 0.0 100.153 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.07 163.0 0.26 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 CA-C-N 123.695 2.355 . . . . 0.0 109.389 166.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.596 HG22 ' H ' ' C' ' 64' ' ' THR . 9.8 p -107.19 -177.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-O 123.24 1.495 . . . . 0.0 111.558 -169.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.596 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.9 m -68.64 -34.82 76.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 119.085 -2.259 . . . . 0.0 111.211 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -78.68 -23.64 45.53 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 -170.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -67.07 -34.76 78.37 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.34 67.32 0.81 Allowed Glycine 0 CA--C 1.461 -3.327 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 171.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.44 ' HA ' ' OE2' ' C' ' 66' ' ' GLU 0.272 6.4 ttm180 -54.24 1.54 0.02 OUTLIER 'General case' 0 C--N 1.373 1.617 0 C-N-CA 127.582 2.353 . . . . 0.0 116.539 -166.061 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -54.54 -24.17 19.67 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 127.1 2.16 . . . . 0.0 111.48 155.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.24 -50.25 69.76 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 CA-C-N 120.639 1.563 . . . . 0.0 108.439 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.8 75.42 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.901 0.88 . . . . 0.0 110.869 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -51.87 -44.17 63.59 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.782 1.633 . . . . 0.0 112.081 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -62.4 -35.4 79.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.071 1.348 . . . . 0.0 110.899 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.43 -40.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 O-C-N 121.61 -0.681 . . . . 0.0 109.358 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -59.65 -46.79 87.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.853 1.261 . . . . 0.0 110.115 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.67 -41.08 98.89 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.966 -0.459 . . . . 0.0 110.707 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.98 89.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.883 0.473 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.78 87.87 Favored Glycine 0 CA--C 1.494 -1.232 0 C-N-CA 123.744 0.687 . . . . 0.0 111.534 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.66 -44.27 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 123.983 0.913 . . . . 0.0 109.648 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.91 -33.63 76.48 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.397 -0.815 . . . . 0.0 111.911 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.78 -53.68 28.91 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 123.642 0.777 . . . . 0.0 109.581 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -67.11 -36.13 81.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.53 87.58 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.342 0.657 . . . . 0.0 110.644 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.67 -35.39 74.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.213 1.405 . . . . 0.0 111.775 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.63 -16.46 10.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 C-N-CA 125.255 1.422 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -62.72 -13.26 30.46 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 119.602 -1.936 . . . . 0.0 112.166 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.85 67.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.923 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.2 -55.69 4.57 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.01 -38.63 86.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.403 1.481 . . . . 0.0 113.304 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.68 61.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.558 -1.339 . . . . 0.0 110.852 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 68.7 p -88.78 -12.37 42.26 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 120.82 -1.175 . . . . 0.0 110.616 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.37 -28.45 67.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.229 0.922 . . . . 0.0 110.537 -167.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -77.08 -33.44 57.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.93 -33.06 56.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 125.366 1.466 . . . . 0.0 108.685 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -52.51 -24.17 7.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.636 1.974 . . . . 0.0 113.956 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -58.01 -32.98 68.45 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 119.756 1.162 . . . . 0.0 112.111 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.99 -13.79 43.51 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.144 -0.973 . . . . 0.0 111.04 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -89.5 -19.33 25.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.298 0.499 . . . . 0.0 109.849 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -77.04 -54.66 6.26 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.593 -0.692 . . . . 0.0 111.573 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -58.83 -27.75 65.38 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -83.73 -18.62 37.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.817 -0.552 . . . . 0.0 111.299 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.6 44.85 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.501 -0.912 0 O-C-N 121.39 -1.065 . . . . 0.0 108.288 177.63 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.9 165.49 17.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.74 -35.65 81.76 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 121.722 -0.612 . . . . 0.0 111.326 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.446 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 7.3 p80 -73.32 -23.93 60.31 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 121.013 -1.055 . . . . 0.0 111.42 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.446 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 0.1 OUTLIER -83.16 -27.95 29.71 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -63.78 -42.32 97.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.361 1.065 . . . . 0.0 110.361 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.7 -38.74 84.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.839 0.828 . . . . 0.0 109.148 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.26 89.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.39 1.076 . . . . 0.0 111.413 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -69.84 -28.76 65.96 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.529 -0.732 . . . . 0.0 110.766 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.75 69.67 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.337 0.655 . . . . 0.0 111.738 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.97 -36.13 82.49 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.44 -0.787 . . . . 0.0 111.365 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.07 -27.11 60.75 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.927 -1.108 . . . . 0.0 110.647 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.72 -27.5 65.03 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.475 -0.765 . . . . 0.0 110.463 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 tp -71.79 -39.19 70.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.342 -0.848 . . . . 0.0 109.996 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -62.42 -31.92 72.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 123.424 0.69 . . . . 0.0 111.519 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.03 -45.5 92.6 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.504 1.122 . . . . 0.0 110.224 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -67.8 -35.67 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 123.917 0.887 . . . . 0.0 109.244 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.27 -53.69 54.71 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.288 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -68.68 -40.89 79.87 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.451 -0.78 . . . . 0.0 110.777 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.93 -47.33 83.72 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 109.837 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.56 60.93 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 121.009 -1.057 . . . . 0.0 111.771 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -66.04 -40.33 90.89 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 109.742 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -71.23 -25.57 62.55 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.34 1.456 . . . . 0.0 110.084 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -79.22 -55.5 5.05 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.4 -43.87 79.72 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 126.228 1.811 . . . . 0.0 112.531 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -31.8 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -83.96 -34.45 24.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.12 -50.45 54.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 127.009 2.124 . . . . 0.0 109.92 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.88 -41.84 99.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.999 1.32 . . . . 0.0 110.231 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -62.2 121.77 13.95 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 119.722 -1.861 . . . . 0.0 110.233 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.19 -12.44 48.48 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.22 56.66 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 118.144 0.972 . . . . 0.0 110.504 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.85 141.81 19.49 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.894 1.73 . . . . 0.0 109.775 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.81 75.51 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.57 139.28 58.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 111.666 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.91 -29.39 2.33 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 124.5 1.12 . . . . 0.0 110.185 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 30.0 tp -81.4 -106.77 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' D' ' 40' ' ' SER 0.285 35.5 mt 71.97 173.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 -172.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.469 ' H ' HG22 ' D' ' 39' ' ' ILE . 39.0 t 73.17 124.36 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.225 1.488 . . . . 0.0 110.511 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -66.66 -50.11 47.13 Favored Pre-proline 0 C--N 1.348 0.503 0 O-C-N 119.802 -1.811 . . . . 0.0 110.778 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -71.67 -11.71 28.23 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 125.074 2.848 . . . . 0.0 112.227 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.92 -45.3 12.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.61 72.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.048 0.939 . . . . 0.0 112.394 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -82.81 1.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.723 0.773 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -43.27 7.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 119.693 -1.879 . . . . 0.0 106.202 171.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -57.79 -32.57 67.67 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.346 1.858 . . . . 0.0 111.967 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 p -68.9 -34.6 75.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.026 -2.296 . . . . 0.0 110.321 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 t -87.93 63.43 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 0.0 108.795 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -175.87 -31.43 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 50.2 m -62.51 -39.28 93.03 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.346 1.458 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.62 65.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.135 -0.978 . . . . 0.0 112.176 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.97 4.38 45.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 122.68 0.392 . . . . 0.0 110.177 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.26 1.0 OUTLIER 64.67 10.63 6.11 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.04 1.736 . . . . 0.0 112.927 174.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.65 -65.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 -63.82 4.22 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.55 -60.57 0.53 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.301 2.24 . . . . 0.0 109.692 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.47 -95.07 0.1 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . 0.286 10.7 t70 43.62 -101.73 0.04 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.178 2.191 . . . . 0.0 113.79 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 170.05 15.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -124.94 150.62 66.84 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.82 165.72 19.72 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.142 2.561 . . . . 0.0 109.427 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.44 -162.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 122.913 1.34 . . . . 0.0 107.837 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -86.58 -52.18 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 125.639 1.576 . . . . 0.0 109.059 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.54 -23.41 64.52 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 128.83 2.852 . . . . 0.0 110.345 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.99 -26.42 66.02 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 123.888 1.804 . . . . 0.0 108.398 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.8 67.6 1.31 Allowed Glycine 0 CA--C 1.462 -3.239 1 N-CA-C 99.483 -5.447 . . . . 0.0 99.483 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -34.22 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.36 1.028 1 C-N-CA 132.134 4.174 . . . . 0.0 114.765 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -55.75 -15.27 2.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 127.387 2.275 . . . . 0.0 113.273 165.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -72.29 -54.9 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.28 85.48 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.014 0.926 . . . . 0.0 112.14 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.13 -45.29 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.808 2.043 . . . . 0.0 112.108 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.59 -29.65 64.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 121.832 -0.542 . . . . 0.0 110.94 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -72.68 -47.22 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -70.88 -41.39 71.42 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.092 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -64.02 -41.83 97.32 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 121.272 -0.892 . . . . 0.0 110.736 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.07 79.23 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.604 -0.685 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.7 -45.54 96.06 Favored Glycine 0 CA--C 1.494 -1.278 0 C-N-CA 123.827 0.727 . . . . 0.0 111.654 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 86.7 mt -58.67 -47.06 90.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 124.273 1.029 . . . . 0.0 109.409 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -63.72 -34.78 78.63 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.383 -0.823 . . . . 0.0 112.125 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.93 -50.07 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.604 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.72 -21.25 64.41 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.599 -0.688 . . . . 0.0 111.142 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.11 -37.7 25.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.35 -37.2 84.74 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.975 1.31 . . . . 0.0 110.652 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.32 -2.73 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.335 -0.853 . . . . 0.0 112.39 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 24.9 m -63.09 -16.84 61.29 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.818 -1.176 . . . . 0.0 110.856 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.91 -38.05 81.19 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.863 -1.773 . . . . 0.0 111.908 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.24 63.37 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 120.555 -1.341 . . . . 0.0 108.423 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.57 -37.8 87.58 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.807 1.243 . . . . 0.0 111.532 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -21.37 63.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.419 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -85.23 -16.19 41.04 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.48 -38.48 84.44 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.765 -1.209 . . . . 0.0 110.112 -170.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -70.59 -29.51 65.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.291 -1.505 . . . . 0.0 111.043 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.26 -20.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 109.502 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -50.74 -37.45 41.89 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.888 1.675 . . . . 0.0 110.233 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -56.77 -36.22 69.56 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.987 1.315 . . . . 0.0 111.197 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.77 -36.32 43.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -171.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.24 -39.77 78.28 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.905 -0.497 . . . . 0.0 110.49 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -65.9 -43.45 88.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.406 1.082 . . . . 0.0 109.741 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.46 -40.76 96.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.246 1.018 . . . . 0.0 111.14 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -73.96 -39.89 63.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.403 -0.811 . . . . 0.0 110.001 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.85 25.48 22.44 Favored Glycine 0 CA--C 1.496 -1.149 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 66.2 m80 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 125.965 1.706 . . . . 0.0 112.831 -179.168 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.01 163.78 0.27 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 126.73 2.012 . . . . 0.0 111.707 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -57.1 2.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -57.04 -24.16 51.77 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 128.079 2.552 . . . . 0.0 114.941 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.88 -28.58 61.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.509 -1.369 . . . . 0.0 110.07 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.87 -32.44 65.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.003 -1.06 . . . . 0.0 110.187 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -71.57 -38.23 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.212 1.005 . . . . 0.0 109.183 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.33 86.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.821 0.848 . . . . 0.0 111.158 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -73.32 -22.28 60.36 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.085 -1.009 . . . . 0.0 111.788 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -73.05 -23.84 60.63 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.129 -0.982 . . . . 0.0 109.879 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.43 77.85 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.9 -1.125 . . . . 0.0 109.98 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.8 -30.26 71.37 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.574 -0.704 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 120.891 -1.13 . . . . 0.0 111.176 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -68.79 -31.2 70.04 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.618 0.767 . . . . 0.0 109.074 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.07 -40.48 94.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.649 0.737 . . . . 0.0 110.635 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -70.06 -25.27 63.46 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.16 -0.962 . . . . 0.0 111.419 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -71.2 -46.68 60.73 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -70.94 -25.2 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 121.604 -0.685 . . . . 0.0 110.132 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.55 -55.17 38.52 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 118.963 0.802 . . . . 0.0 110.471 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.38 -31.47 67.34 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.624 -0.673 . . . . 0.0 110.986 -174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.23 -48.31 70.99 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.916 -1.115 . . . . 0.0 109.627 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.14 63.39 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 123.989 0.915 . . . . 0.0 112.144 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.4 m -65.65 -39.74 91.74 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.639 -0.663 . . . . 0.0 110.156 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -69.36 -43.45 73.58 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.44 -53.12 61.85 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.499 0.72 . . . . 0.0 110.61 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.47 98.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.08 1.352 . . . . 0.0 112.648 -172.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -71.2 -35.25 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.945 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -77.0 -25.2 52.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 120.934 -1.104 . . . . 0.0 109.576 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.68 96.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.984 1.713 . . . . 0.0 109.495 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.4 -17.62 64.26 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.706 1.202 . . . . 0.0 113.133 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -78.23 80.43 4.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.24 -1.537 . . . . 0.0 110.369 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.09 2.76 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.33 143.8 37.23 Favored Pre-proline 0 N--CA 1.444 -0.757 0 O-C-N 120.926 -1.338 . . . . 0.0 110.525 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.71 128.42 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.985 2.456 . . . . 0.0 112.333 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 34.04 45.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.36 147.69 47.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.579 1.151 . . . . 0.0 110.624 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -44.43 0.93 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.217 0.607 . . . . 0.0 109.784 -170.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -87.08 46.48 1.38 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-O 123.13 1.443 . . . . 0.0 108.803 -171.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.04 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 119.4 -2.063 . . . . 0.0 108.94 -171.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 m -141.66 -122.01 0.1 Allowed 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -173.13 -71.51 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -20.89 25.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 125.512 3.004 . . . . 0.0 111.341 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.59 -33.17 64.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.443 1.497 . . . . 0.0 109.92 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.776 0.83 . . . . 0.0 109.703 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.96 -34.9 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 122.065 -0.397 . . . . 0.0 110.082 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 109.674 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -64.46 -35.12 79.88 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.512 1.148 . . . . 0.0 110.276 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -65.04 -42.35 94.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.722 -1.236 . . . . 0.0 109.684 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -56.62 -54.37 29.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.212 1.405 . . . . 0.0 110.031 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -69.46 -26.45 64.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.614 0.366 . . . . 0.0 111.455 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.6 m -69.34 -39.43 78.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.431 1.092 . . . . 0.0 109.707 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.37 -30.01 70.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.549 -1.344 . . . . 0.0 111.658 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.67 3.49 47.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.716 -0.615 . . . . 0.0 110.651 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p 59.85 36.93 21.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.012 1.725 . . . . 0.0 112.324 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 -85.63 0.55 Allowed Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 105.951 -2.859 . . . . 0.0 105.951 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 69.86 -65.18 0.32 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.872 2.469 . . . . 0.0 110.674 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.65 54.68 0.59 Allowed Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' CG ' HH22 ' B' ' 68' ' ' ARG . 36.1 t70 -83.09 -44.23 15.38 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -138.04 168.54 19.51 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.59 128.18 17.92 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 71.6 Cg_endo -80.29 172.78 13.27 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.265 3.31 . . . . 0.0 109.543 169.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.91 -137.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 p -124.04 -27.69 3.85 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.025 1.33 . . . . 0.0 110.723 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.12 6.05 50.13 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -74.25 -36.12 63.84 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.46 -11.44 0.55 Allowed Glycine 0 CA--C 1.477 -2.321 0 CA-C-O 117.096 -1.947 . . . . 0.0 108.968 171.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HA ' ' HE1' ' D' ' 46' ' ' TRP . 43.1 ttm180 67.14 -56.45 0.44 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 130.232 3.413 . . . . 0.0 109.33 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -84.81 20.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.029 1.331 . . . . 0.0 111.061 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.0 -49.39 44.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.7 74.92 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.179 0.592 . . . . 0.0 109.41 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.44 -41.78 69.81 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.226 1.41 . . . . 0.0 111.696 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.87 -49.28 76.85 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.846 -0.533 . . . . 0.0 110.775 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.96 -38.41 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 O-C-N 121.744 -0.597 . . . . 0.0 109.44 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.0 tpp -55.73 -53.74 52.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.572 1.549 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -66.22 -40.8 90.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.112 0.965 . . . . 0.0 109.935 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.11 82.84 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.827 0.851 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -46.37 91.66 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.98 -30.76 47.85 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 O-C-N 121.658 -0.907 . . . . 0.0 109.582 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.98 -46.44 81.44 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.661 -1.9 . . . . 0.0 109.866 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 t -63.44 -52.81 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 124.477 1.111 . . . . 0.0 109.782 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -74.41 -8.11 55.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.647 -0.658 . . . . 0.0 112.049 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.89 -32.65 15.94 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.817 -1.177 . . . . 0.0 110.103 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.33 -36.85 85.31 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.781 -1.199 . . . . 0.0 110.096 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -63.44 -12.53 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.0 m -65.16 -15.93 62.96 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.853 1.261 . . . . 0.0 111.173 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.11 71.6 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 111.213 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 -31.86 38.39 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 120.507 -1.371 . . . . 0.0 109.427 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.29 -39.46 39.83 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.411 0.624 . . . . 0.0 111.231 -173.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.97 64.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.198 -0.938 . . . . 0.0 111.734 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -96.6 -0.18 49.03 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.606 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -77.92 -22.84 49.03 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.556 1.525 . . . . 0.0 109.751 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -73.59 -33.02 64.42 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 119.511 -1.993 . . . . 0.0 110.467 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.41 -24.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 124.945 1.298 . . . . 0.0 109.102 -170.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -62.11 -19.06 62.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.428 1.891 . . . . 0.0 110.706 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -65.33 -31.35 72.44 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 120.99 -1.069 . . . . 0.0 110.674 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -72.18 -27.33 62.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 -172.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.43 -49.86 65.31 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.64 -44.26 96.73 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.498 1.519 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.4 -45.16 84.83 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 127.707 2.403 . . . . 0.0 110.533 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -84.96 -27.57 26.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.678 -0.639 . . . . 0.0 109.843 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.39 38.25 33.98 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 t60 . . . . . 0 N--CA 1.445 -0.7 0 C-N-CA 126.074 1.75 . . . . 0.0 114.587 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.416 -2.137 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.98 4.74 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.67 -94.55 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 120.957 -1.089 . . . . 0.0 110.4 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -67.27 -19.53 65.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -75.23 -46.68 32.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 124.853 1.261 . . . . 0.0 108.487 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.399 1.08 . . . . 0.0 109.657 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.2 90.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.856 0.862 . . . . 0.0 111.568 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -69.15 -34.15 74.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.69 0.757 . . . . 0.0 111.028 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.084 -1.01 . . . . 0.0 111.224 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.45 -46.38 73.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.895 0.878 . . . . 0.0 109.199 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.91 -38.41 88.28 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.647 1.213 . . . . 0.0 111.625 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.1 -24.07 60.59 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.953 1.301 . . . . 0.0 110.322 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.1 -41.48 61.6 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 120.259 -1.525 . . . . 0.0 107.847 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' B' ' 81' ' ' VAL . 22.4 tp -55.79 -46.76 77.9 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.658 1.183 . . . . 0.0 111.552 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -54.87 -37.73 66.62 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.091 0.957 . . . . 0.0 112.236 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -73.86 -32.44 63.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.86 -0.525 . . . . 0.0 110.512 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.3 -35.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.298 -0.876 . . . . 0.0 108.766 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.53 -37.41 87.22 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.065 -1.022 . . . . 0.0 111.279 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.11 -38.83 69.22 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.813 0.845 . . . . 0.0 110.745 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -73.62 -43.65 59.06 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.112 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.43 62.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 121.141 -0.974 . . . . 0.0 111.963 -175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' B' ' 45' ' ' ILE . 3.0 p -71.96 -37.46 69.94 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.204 0.911 . . . . 0.0 110.345 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -43.33 99.07 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 125.323 1.449 . . . . 0.0 108.433 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -66.13 -45.96 79.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.629 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.07 77.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.047 1.339 . . . . 0.0 112.746 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.2 -44.45 97.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 121.817 -0.552 . . . . 0.0 109.832 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.69 -28.29 62.6 Favored 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 120.872 -1.143 . . . . 0.0 111.629 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.32 80.31 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.644 1.578 . . . . 0.0 109.24 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -20.11 51.92 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.286 0.565 . . . . 0.0 110.842 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -70.95 72.63 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 125.055 1.342 . . . . 0.0 113.086 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.28 -18.3 1.04 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.82 147.07 61.31 Favored Pre-proline 0 N--CA 1.444 -0.735 0 O-C-N 121.7 -0.882 . . . . 0.0 110.375 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.413 ' O ' HG11 ' B' ' 63' ' ' VAL . 68.1 Cg_endo -82.66 129.66 5.71 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.54 2.16 . . . . 0.0 111.405 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 27.43 42.46 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.64 139.17 32.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.268 2.227 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.25 -32.36 2.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.398 0.679 . . . . 0.0 109.226 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -99.44 118.82 36.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.41 -154.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.6 t 75.1 -149.53 0.03 OUTLIER 'General case' 0 C--N 1.358 0.961 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.466 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 76.7 m-85 -145.64 -56.18 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 116.309 -1.805 . . . . 0.0 106.295 175.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 17.7 Cg_endo -67.33 -29.26 38.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 125.028 2.831 . . . . 0.0 110.734 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.17 -42.93 93.2 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.068 0.947 . . . . 0.0 110.183 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.28 95.2 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 111.121 -172.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' B' ' 23' ' ' SER . 21.6 tt -76.2 -27.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 121.027 0.441 . . . . 0.0 110.843 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -33.62 61.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.385 -1.447 . . . . 0.0 109.696 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -67.76 -34.19 76.31 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.864 0.866 . . . . 0.0 111.413 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.7 p -69.05 -20.76 64.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 119.727 -1.858 . . . . 0.0 111.35 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 -47.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.011 0.924 . . . . 0.0 109.5 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.58 -27.22 65.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.672 1.225 . . . . 0.0 110.933 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -73.98 -32.19 63.33 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.845 -1.16 . . . . 0.0 109.721 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.44 70.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.356 -0.84 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.9 p -93.58 10.89 30.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.446 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p 52.79 26.71 4.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.701 2.001 . . . . 0.0 112.721 174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.11 -41.92 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -61.51 4.62 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 62.94 -85.54 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 128.446 2.698 . . . . 0.0 108.481 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.19 40.97 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.14 -62.57 1.35 Allowed 'General case' 0 C--N 1.358 0.943 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -141.1 170.81 15.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -131.38 146.13 60.64 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -94.06 158.58 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.043 2.495 . . . . 0.0 108.217 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' O ' ' B' ' 34' ' ' PRO . 13.3 t -79.21 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 42.0 m -156.2 -36.67 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 O-C-N 119.047 -2.283 . . . . 0.0 106.927 -170.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -95.61 11.24 33.92 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.367 -0.833 . . . . 0.0 108.918 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.04 -33.41 61.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 168.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 88.73 1.24 Allowed Glycine 0 N--CA 1.418 -2.566 1 N-CA-C 98.403 -5.879 . . . . 0.0 98.403 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.401 HH22 ' CG ' ' A' ' 59' ' ' ASP . 34.7 ttm180 -63.53 -11.77 26.94 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 119.439 1.619 . . . . 0.0 110.935 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -46.55 -26.24 0.85 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.494 2.318 . . . . 0.0 113.821 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -68.56 -40.99 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.698 1.199 . . . . 0.0 108.734 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.49 -45.49 68.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -51.92 -41.66 62.18 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 126.441 1.897 . . . . 0.0 111.758 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.47 -42.56 92.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.914 1.286 . . . . 0.0 111.064 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.13 -38.38 70.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.422 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 42.4 mtt -62.79 -47.85 81.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.862 0.865 . . . . 0.0 110.177 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -61.26 -40.28 93.47 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.609 -0.682 . . . . 0.0 110.772 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.6 -34.8 77.75 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 122.758 0.423 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.97 -52.07 9.61 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.09 -47.01 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 124.39 1.076 . . . . 0.0 109.947 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.9 -38.27 90.4 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.051 -1.03 . . . . 0.0 111.565 -176.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' B' ' 15' ' ' LEU . 33.2 m -73.97 -38.4 49.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 O-C-N 120.642 -1.286 . . . . 0.0 110.906 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.52 -19.85 62.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.787 -0.571 . . . . 0.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.84 -38.19 13.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.655 0.782 . . . . 0.0 110.396 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.85 -35.91 71.58 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.008 1.723 . . . . 0.0 111.408 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.67 -6.98 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.751 0.82 . . . . 0.0 112.606 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -55.04 -24.34 24.34 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.364 1.466 . . . . 0.0 110.414 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.26 74.06 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.357 -1.464 . . . . 0.0 113.155 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.68 -33.16 23.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.868 -1.145 . . . . 0.0 108.33 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 72.4 mt -78.91 -28.4 43.94 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.928 0.891 . . . . 0.0 112.066 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -10.64 59.53 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.058 -1.651 . . . . 0.0 111.337 172.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.44 -36.59 74.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.097 1.317 . . . . 0.0 110.664 -169.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -75.21 -20.71 59.12 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.417 -1.427 . . . . 0.0 112.148 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.55 -33.09 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.234 -1.541 . . . . 0.0 107.596 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -60.88 -19.88 60.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.604 1.561 . . . . 0.0 112.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -55.81 -25.25 40.63 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.557 1.143 . . . . 0.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.95 -27.34 54.78 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.59 -1.319 . . . . 0.0 111.162 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.46 -39.67 45.79 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -57.24 -46.4 83.02 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 127.483 2.313 . . . . 0.0 109.552 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -65.43 -28.82 69.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.228 0.611 . . . . 0.0 112.622 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -87.37 -21.88 25.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.16 -0.962 . . . . 0.0 108.822 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.72 41.25 64.42 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.765 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.7 -84.46 0.11 Allowed 'General case' 0 C--N 1.355 0.846 0 CA-C-N 118.458 0.572 . . . . 0.0 109.503 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -136.43 -72.61 0.45 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -16.46 53.91 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.243 -1.535 . . . . 0.0 109.651 -167.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -65.8 -36.5 83.68 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.204 1.802 . . . . 0.0 111.161 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -81.87 -33.67 30.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -35.42 74.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.461 0.304 . . . . 0.0 110.544 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.85 96.7 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.824 0.85 . . . . 0.0 111.384 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -71.59 -34.61 70.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.075 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -66.04 -36.6 83.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.535 1.134 . . . . 0.0 109.574 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.41 91.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 124.517 1.127 . . . . 0.0 111.445 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -59.63 -38.6 81.79 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.802 0.811 . . . . 0.0 111.287 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -74.04 -27.56 60.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.583 0.753 . . . . 0.0 110.183 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -66.77 -38.21 86.13 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.147 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.86 -38.1 89.51 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.289 -0.882 . . . . 0.0 111.402 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -55.22 -38.68 68.75 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 111.876 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -70.82 -38.91 73.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.171 1.388 . . . . 0.0 109.352 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.9 -28.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 123.872 0.869 . . . . 0.0 108.998 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.09 -39.7 95.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.905 -1.122 . . . . 0.0 111.435 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.24 -46.41 87.03 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.284 -0.885 . . . . 0.0 109.927 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.33 -52.08 67.11 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-O 121.22 0.533 . . . . 0.0 109.615 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.44 -34.74 74.42 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 126.014 1.726 . . . . 0.0 111.454 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.9 m -63.36 -46.59 85.84 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.812 0.845 . . . . 0.0 110.799 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.45 -40.75 73.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.88 -39.81 95.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.821 0.848 . . . . 0.0 110.913 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -47.38 80.91 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.17 1.388 . . . . 0.0 111.466 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.01 -15.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.4 1.095 . . . . 0.0 110.102 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -101.23 -5.1 25.99 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 119.979 -1.701 . . . . 0.0 108.599 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.42 -18.85 18.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 124.808 1.243 . . . . 0.0 110.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.81 -30.89 69.54 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 121.028 -1.045 . . . . 0.0 108.553 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.44 113.96 4.0 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.32 1.848 . . . . 0.0 108.587 -169.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.02 -5.62 72.3 Favored Glycine 0 CA--C 1.498 -0.999 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.09 148.44 34.4 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.57 125.14 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.353 2.035 . . . . 0.0 111.1 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 45.48 3.08 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.83 24.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.897 -0.766 . . . . 0.0 112.195 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.01 -36.6 1.17 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.663 0.744 . . . . 0.0 110.063 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -85.85 37.42 0.71 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 108.675 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' C' ' 39' ' ' ILE . 16.2 tt -75.08 -22.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.224 2.21 . . . . 0.0 109.519 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -79.93 121.09 25.01 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.738 0.78 . . . . 0.0 109.252 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.84 -55.93 15.64 Favored Pre-proline 0 C--N 1.351 0.631 0 C-N-CA 126.885 2.074 . . . . 0.0 111.369 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.13 -11.96 23.34 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 CA-C-N 125.769 3.096 . . . . 0.0 111.339 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.33 -26.28 28.6 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 124.827 1.251 . . . . 0.0 108.747 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.47 91.32 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.091 0.956 . . . . 0.0 110.706 -167.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.4 -33.43 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.045 0.938 . . . . 0.0 111.267 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -32.51 48.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.909 -1.119 . . . . 0.0 109.964 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.458 ' CD2' HD11 ' C' ' 38' ' ' LEU . 50.0 t90 -67.04 -37.53 84.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.404 -0.81 . . . . 0.0 110.259 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -60.25 -25.11 65.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.239 -0.913 . . . . 0.0 112.735 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.14 -51.41 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 123.694 0.798 . . . . 0.0 109.437 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.76 40.52 0.9 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.62 1.168 . . . . 0.0 111.181 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 17.6 m -141.68 -56.92 0.47 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.75 73.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.353 -0.842 . . . . 0.0 112.923 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 16.5 p -95.01 23.69 5.42 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p 51.24 78.49 0.11 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.619 1.968 . . . . 0.0 111.871 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 t -122.23 -92.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.6 45.67 9.37 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 111.064 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -43.14 92.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.53 1.157 . . . . 0.0 110.375 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.52 -139.92 7.47 Favored Glycine 0 CA--C 1.483 -1.945 1 N-CA-C 101.645 -4.582 . . . . 0.0 101.645 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.3 34.5 t0 65.2 -71.83 0.08 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 127.27 2.228 . . . . 0.0 111.327 -173.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -124.54 158.9 31.84 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.66 154.13 55.58 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 166.8 27.09 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.203 2.602 . . . . 0.0 110.504 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.2 164.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -62.71 -69.19 0.27 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.337 1.455 . . . . 0.0 114.367 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.75 -72.88 0.06 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.651 1.18 . . . . 0.0 111.484 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -94.58 -39.79 10.18 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.155 -0.965 . . . . 0.0 113.317 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.92 -39.46 25.5 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 120.41 1.459 . . . . 0.0 113.938 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.14 -36.87 64.17 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 117.629 0.714 . . . . 0.0 112.26 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -74.29 -30.07 61.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 121.379 -0.826 . . . . 0.0 110.127 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.0 -40.84 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 O-C-N 121.168 -0.957 . . . . 0.0 109.662 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.36 92.9 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -58.13 -36.01 72.34 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 125.729 1.612 . . . . 0.0 111.395 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -66.04 -52.15 51.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.204 1.001 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 p -73.19 -27.27 23.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 121.576 -0.703 . . . . 0.0 109.636 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 19.5 tpp -58.54 -48.24 81.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 110.335 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -66.21 -36.75 83.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.993 -0.442 . . . . 0.0 110.518 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.26 78.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.366 0.666 . . . . 0.0 111.425 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.45 -40.94 78.85 Favored Glycine 0 CA--C 1.494 -1.266 0 O-C-N 121.664 -0.647 . . . . 0.0 111.546 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 81.2 mt -63.16 -46.57 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -57.26 -47.68 80.8 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.197 0.999 . . . . 0.0 110.774 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.99 -55.04 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.459 1.104 . . . . 0.0 111.086 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -71.61 -33.45 69.0 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 118.551 0.614 . . . . 0.0 110.695 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.33 -30.24 65.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.781 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.75 -12.79 60.82 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.138 -0.976 . . . . 0.0 111.589 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.19 -10.99 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 119.988 -1.695 . . . . 0.0 110.51 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -49.39 -27.24 3.87 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.383 1.873 . . . . 0.0 112.717 170.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.7 -27.16 48.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.499 1.12 . . . . 0.0 112.824 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.67 -51.66 2.79 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 112.063 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.15 -2.25 54.99 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.461 -1.399 . . . . 0.0 109.433 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.25 -11.85 45.39 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -33.8 76.49 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.7 -1.25 . . . . 0.0 109.91 -166.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.51 -12.68 60.54 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.055 -1.028 . . . . 0.0 112.608 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.48 -32.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -69.14 -8.24 43.6 Favored 'General case' 0 C--N 1.359 1.021 0 O-C-N 121.026 -1.046 . . . . 0.0 111.483 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 48.3 ttp85 -64.73 -29.97 70.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -96.04 156.36 16.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.289 37.3 mt-10 69.91 -60.38 0.48 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.283 1.833 . . . . 0.0 112.6 -167.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.03 -17.46 62.25 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 119.123 0.874 . . . . 0.0 110.771 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -53.2 -38.48 62.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 126.391 1.877 . . . . 0.0 112.91 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -82.69 -47.56 11.88 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.09 57.0 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 CA--C 1.501 -0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 110.107 -177.734 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.48 154.73 24.96 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.45 -36.38 78.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 122.388 1.089 . . . . 0.0 110.763 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -71.02 -17.61 62.62 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.09 -1.006 . . . . 0.0 112.061 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -86.92 -38.95 16.22 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -66.82 -37.59 84.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.077 0.951 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -68.23 -36.88 80.19 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.618 -0.676 . . . . 0.0 110.34 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.62 75.4 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.035 0.934 . . . . 0.0 110.188 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -65.06 -35.99 82.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.204 1.402 . . . . 0.0 111.205 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -69.01 -30.42 68.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.849 -1.157 . . . . 0.0 110.742 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.33 75.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.063 -1.023 . . . . 0.0 110.649 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.94 -38.41 90.93 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.737 0.815 . . . . 0.0 110.516 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.58 1.152 . . . . 0.0 110.219 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.65 -41.68 98.19 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.878 0.871 . . . . 0.0 109.086 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 tp -62.97 -37.52 87.43 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.436 0.694 . . . . 0.0 111.503 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.57 -31.48 72.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.223 -0.923 . . . . 0.0 112.285 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -71.39 -35.46 71.05 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.35 -38.89 83.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 109.307 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.8 -42.39 84.14 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.24 1.019 . . . . 0.0 111.323 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.27 -44.11 65.89 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.957 0.903 . . . . 0.0 109.282 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -66.21 -39.05 89.34 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.04 72.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.191 1.396 . . . . 0.0 112.165 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.49 -43.34 73.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.493 0.717 . . . . 0.0 109.807 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -43.86 75.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.778 1.231 . . . . 0.0 108.677 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -63.91 -48.4 76.74 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.699 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.44 70.06 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 119.769 1.168 . . . . 0.0 110.818 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.74 -39.74 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.67 -30.03 59.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.779 -1.826 . . . . 0.0 110.758 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.34 35.27 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.067 0.947 . . . . 0.0 109.752 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -22.56 60.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.507 -0.746 . . . . 0.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -68.9 98.6 0.95 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.028 0.918 . . . . 0.0 111.619 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.24 -4.41 12.42 Favored Glycine 0 CA--C 1.494 -1.251 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.75 146.36 46.25 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 121.629 -0.924 . . . . 0.0 109.088 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -80.5 131.7 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.952 1.768 . . . . 0.0 111.42 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.44 2.91 69.81 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.52 136.65 57.59 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.006 1.722 . . . . 0.0 112.42 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.63 4.31 1.93 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.35 -38.16 20.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.3 tt -5.93 88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 1 C-N-CA 133.248 4.619 . . . . 0.0 114.387 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 33.1 p -162.96 -131.3 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.79 -65.5 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 127.925 2.49 . . . . 0.0 106.051 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.93 -14.03 26.47 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 CA-C-N 125.649 3.053 . . . . 0.0 111.687 -171.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -100.74 -11.36 19.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.66 64.93 Favored 'General case' 0 CA--C 1.504 -0.826 0 O-C-N 120.776 -1.203 . . . . 0.0 109.854 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.25 -7.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 125.178 1.391 . . . . 0.0 109.675 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 68' ' ' ARG . 1.2 t90 -81.84 -49.56 10.22 Favored 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 119.423 -2.048 . . . . 0.0 106.081 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -53.24 -41.68 65.66 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.791 1.636 . . . . 0.0 111.115 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.4 p -69.51 -28.84 66.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.696 -1.877 . . . . 0.0 111.683 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.46 -45.66 81.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 C-N-CA 123.699 0.799 . . . . 0.0 109.284 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.9 -9.35 57.57 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.445 -0.784 . . . . 0.0 112.006 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 72.4 m -86.14 -48.45 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 120.697 -1.252 . . . . 0.0 111.082 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.18 62.51 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.662 -1.274 . . . . 0.0 112.007 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -87.8 0.86 55.21 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.879 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 55.18 67.97 0.94 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.875 2.07 . . . . 0.0 110.904 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.83 -98.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.58 102.24 0.46 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 106.58 -2.608 . . . . 0.0 106.58 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -75.73 -33.68 60.3 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.65 39.7 2.32 Favored Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.96 -50.27 30.39 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -130.87 160.95 32.94 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.53 151.78 36.88 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 167.71 26.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.059 2.506 . . . . 0.0 111.275 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.74 -148.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -107.07 -60.35 1.69 Allowed 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.039 1.736 . . . . 0.0 107.573 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -80.13 0.61 31.42 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.352 1.461 . . . . 0.0 111.179 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -64.84 -30.13 71.12 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.845 1.307 . . . . 0.0 108.773 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.26 83.57 1.37 Allowed Glycine 0 CA--C 1.473 -2.557 1 N-CA-C 99.277 -5.529 . . . . 0.0 99.277 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttt85 -60.95 -11.24 7.39 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 122.876 1.322 . . . . 0.0 111.44 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -61.51 -12.92 17.16 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.452 1.101 . . . . 0.0 113.302 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.43 -52.59 58.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.33 97.58 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 123.168 0.587 . . . . 0.0 110.535 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.11 -50.11 38.77 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.946 1.699 . . . . 0.0 111.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.65 -40.08 95.94 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.646 0.779 . . . . 0.0 110.879 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.66 -43.39 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 123.704 0.801 . . . . 0.0 109.579 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.7 mtm -66.91 -42.83 84.77 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 121.806 -0.559 . . . . 0.0 110.621 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -65.58 -35.0 79.55 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.844 -0.535 . . . . 0.0 110.517 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.25 99.13 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.524 0.729 . . . . 0.0 110.494 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.03 81.33 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.1 -46.72 88.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 109.804 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.12 -42.01 94.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.299 -0.876 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.98 -46.94 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.24 -0.913 . . . . 0.0 110.4 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -71.12 -9.0 57.32 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.392 -0.817 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.32 -39.76 8.25 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.199 1.0 . . . . 0.0 109.84 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -52.1 -34.93 46.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 127.133 2.173 . . . . 0.0 110.697 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.45 -8.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 124.372 1.069 . . . . 0.0 113.833 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -68.85 -14.28 62.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 120.113 -1.617 . . . . 0.0 111.832 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.16 -27.56 65.77 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.748 -1.22 . . . . 0.0 111.494 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.88 -37.04 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.458 1.103 . . . . 0.0 109.554 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.32 -37.72 66.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.564 -0.71 . . . . 0.0 112.231 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.73 -21.19 63.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.57 -1.331 . . . . 0.0 111.008 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 10.9 t -96.32 11.19 35.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.842 -1.162 . . . . 0.0 108.765 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.3 -33.65 25.91 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -71.67 -32.68 68.14 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.191 -1.568 . . . . 0.0 112.865 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.8 -11.34 14.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 121.461 -0.774 . . . . 0.0 111.275 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -60.99 -19.73 61.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.033 1.333 . . . . 0.0 112.132 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -6.67 58.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.457 1.026 . . . . 0.0 110.81 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -85.02 153.22 22.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 72.32 -50.07 0.7 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.114 1.765 . . . . 0.0 111.436 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -61.49 -32.86 72.89 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.72 2.008 . . . . 0.0 110.708 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -58.13 -23.9 56.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.284 1.434 . . . . 0.0 113.356 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -92.92 -10.12 37.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.163 -0.96 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.09 74.17 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.364 0.983 . . . . 0.0 113.426 172.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 31.7 m80 . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.506 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.36 -94.63 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -132.89 -78.1 0.49 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -71.52 -15.83 62.31 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 123.572 0.749 . . . . 0.0 111.69 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -63.88 -36.9 85.45 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.977 1.711 . . . . 0.0 110.137 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -77.15 -24.11 51.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.455 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -74.27 -41.65 60.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.673 1.189 . . . . 0.0 108.185 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.32 96.87 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.17 -34.07 77.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.732 1.213 . . . . 0.0 111.387 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -71.4 -39.14 71.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.371 -0.831 . . . . 0.0 108.904 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.85 78.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.532 0.733 . . . . 0.0 111.648 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -65.3 -28.35 69.26 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.05 -1.031 . . . . 0.0 111.808 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -73.81 -31.96 63.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.794 0.837 . . . . 0.0 110.06 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.04 -38.94 92.52 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 121.469 -0.769 . . . . 0.0 110.743 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.26 -41.67 84.77 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.532 0.733 . . . . 0.0 111.992 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.735 1.214 . . . . 0.0 109.633 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.31 -40.53 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.053 0.941 . . . . 0.0 109.486 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 52' ' ' ALA . 76.2 mt -58.74 -40.76 84.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.083 0.953 . . . . 0.0 111.906 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.25 -41.6 73.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.63 1.572 . . . . 0.0 110.066 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -67.32 -52.32 41.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.521 1.529 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.56 -29.88 63.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.484 1.114 . . . . 0.0 111.977 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -63.05 -41.69 99.55 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 119.129 0.877 . . . . 0.0 110.178 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.82 -43.55 71.8 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.872 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -67.34 -18.96 65.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 120.709 -1.244 . . . . 0.0 111.033 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.86 70.57 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.45 0.7 . . . . 0.0 110.289 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.15 -33.15 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.775 0.798 . . . . 0.0 111.768 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -28.92 61.66 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.87 68.1 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.349 1.059 . . . . 0.0 111.263 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.24 -5.95 53.46 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.462 1.105 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -105.64 71.87 0.94 Allowed 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.647 -1.908 . . . . 0.0 108.508 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.45 -42.32 0.33 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -92.74 157.94 38.86 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 123.206 0.603 . . . . 0.0 109.665 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -80.9 153.07 19.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.221 1.948 . . . . 0.0 111.121 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.33 15.93 31.18 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.207 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 131.46 50.6 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -166.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.65 -46.99 0.24 Allowed 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.554 0.741 . . . . 0.0 110.009 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.82 62.08 6.73 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 123.01 1.386 . . . . 0.0 107.902 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.9 pt -91.46 -1.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.805 -1.81 . . . . 0.0 109.5 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -89.43 127.85 35.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.469 -0.77 . . . . 0.0 110.997 -174.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -79.44 -54.64 0.95 Allowed Pre-proline 0 C--N 1.347 0.457 0 CA-C-O 116.196 -1.859 . . . . 0.0 112.73 -172.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -73.54 -12.02 24.59 Favored 'Trans proline' 0 CA--C 1.511 -0.658 0 CA-C-N 126.718 3.435 . . . . 0.0 111.813 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.12 -13.17 48.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.38 89.86 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.298 1.039 . . . . 0.0 111.59 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.92 -33.66 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.643 0.735 . . . . 0.0 109.535 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -24.76 57.74 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 119.92 -1.737 . . . . 0.0 109.572 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -69.52 -46.55 66.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.418 1.087 . . . . 0.0 108.396 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.4 p -67.35 -29.81 69.45 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.822 -1.173 . . . . 0.0 111.819 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -51.94 -50.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 124.447 1.099 . . . . 0.0 110.633 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.01 -0.3 43.64 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.488 -0.757 . . . . 0.0 111.792 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.3 m -91.62 -39.92 11.61 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 121.546 -0.721 . . . . 0.0 109.296 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -70.72 -23.83 62.52 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 120.503 -1.373 . . . . 0.0 111.357 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 p -89.35 9.29 26.67 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.473 0.709 . . . . 0.0 110.152 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 51.17 50.03 19.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.422 1.889 . . . . 0.0 112.973 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 56' ' ' GLY . 7.6 p -122.68 -77.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.484 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.82 95.12 0.11 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.07 -69.91 0.58 Allowed 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.666 -1.49 . . . . 0.0 109.958 -170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.8 41.57 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.75 -52.74 7.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -134.44 -175.06 3.75 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -143.06 135.78 13.63 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 101.994 -3.336 . . . . 0.0 101.994 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.8 166.2 10.14 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.026 2.484 . . . . 0.0 110.236 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 67' ' ' GLY . 17.5 m -69.41 166.07 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.603 1.192 . . . . 0.0 110.94 173.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 m -78.53 -67.77 0.71 Allowed 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.345 -0.847 . . . . 0.0 109.173 -174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -50.36 -63.5 1.1 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.586 1.555 . . . . 0.0 112.115 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.69 -67.05 0.87 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.324 -0.86 . . . . 0.0 111.412 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.612 ' H ' HG23 ' A' ' 63' ' ' VAL . . . -30.76 -46.22 0.13 Allowed Glycine 0 C--N 1.349 1.293 0 C-N-CA 129.212 3.291 . . . . 0.0 116.114 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -68.19 -51.9 40.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.105 0.952 . . . . 0.0 112.483 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.7 -25.64 68.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 119.419 1.009 . . . . 0.0 110.803 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.88 -50.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.18 85.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.062 1.345 . . . . 0.0 112.129 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -51.63 -39.19 57.61 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.893 1.677 . . . . 0.0 110.846 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -29.58 64.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.08 -43.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.8 mtt -58.62 -52.32 66.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.414 1.485 . . . . 0.0 109.917 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -66.04 -36.95 84.63 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.614 -0.679 . . . . 0.0 110.652 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.41 87.77 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.168 -0.958 . . . . 0.0 111.313 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.86 -48.11 75.44 Favored Glycine 0 CA--C 1.492 -1.349 0 C-N-CA 124.646 1.117 . . . . 0.0 110.903 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -43.76 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.113 0.965 . . . . 0.0 109.257 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -61.43 -39.18 89.86 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 120.438 -1.414 . . . . 0.0 111.97 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.16 -54.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 124.41 1.084 . . . . 0.0 108.928 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.47 -40.87 93.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.82 -0.55 . . . . 0.0 110.913 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -27.15 65.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.394 -0.816 . . . . 0.0 111.522 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.82 -35.67 81.86 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.887 -1.133 . . . . 0.0 110.031 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.8 t -59.65 -14.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 125.524 1.53 . . . . 0.0 111.262 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -55.82 -23.31 29.67 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 120.066 -1.646 . . . . 0.0 111.989 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.9 -31.45 69.82 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 120.82 -1.175 . . . . 0.0 112.33 172.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 -45.44 14.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.688 -1.257 . . . . 0.0 107.789 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -62.77 -40.29 96.82 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.182 0.993 . . . . 0.0 113.297 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.36 -11.3 60.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.129 -0.982 . . . . 0.0 111.519 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 m -82.6 -22.66 34.73 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.022 -1.049 . . . . 0.0 108.384 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -71.08 -24.5 62.33 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 120.698 -1.252 . . . . 0.0 112.86 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -81.03 -25.33 37.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.85 -1.156 . . . . 0.0 111.879 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.78 -28.03 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -70.14 -5.42 26.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 112.05 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -66.57 -31.04 71.49 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.913 -1.117 . . . . 0.0 109.319 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -96.1 173.98 7.14 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -170.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.252 33.1 mt-10 74.08 -65.0 0.37 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 126.301 1.84 . . . . 0.0 109.44 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.02 -8.31 48.11 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.627 1.171 . . . . 0.0 111.872 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -71.82 -35.53 69.95 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.315 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -93.91 -26.68 16.77 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.22 -6.46 68.77 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 175.929 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.88 161.32 39.61 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.133 0.968 . . . . 0.0 108.752 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.25 -29.85 68.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 126.693 1.997 . . . . 0.0 111.439 -170.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -72.8 -32.26 65.42 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.92 -33.95 66.3 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.734 0.814 . . . . 0.0 109.026 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -58.29 -45.28 88.25 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.324 1.05 . . . . 0.0 110.582 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.22 -45.84 79.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.82 1.248 . . . . 0.0 109.051 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.5 92.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 111.567 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.84 -37.1 76.06 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.643 0.777 . . . . 0.0 109.617 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.02 -33.38 75.6 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.784 -1.198 . . . . 0.0 110.251 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.74 75.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.329 -0.857 . . . . 0.0 111.373 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.43 -31.99 73.43 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.844 0.858 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -67.99 -41.22 82.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 121.562 -0.711 . . . . 0.0 109.781 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -66.21 -28.46 68.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.593 -0.692 . . . . 0.0 111.277 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 118.42 0.554 . . . . 0.0 110.738 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -62.32 -36.11 81.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 110.683 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.37 -37.79 86.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.754 0.821 . . . . 0.0 110.741 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.43 -40.19 88.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 121.071 -1.018 . . . . 0.0 109.036 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.93 -42.96 85.92 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 123.634 0.774 . . . . 0.0 111.359 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.77 -46.17 83.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.015 1.326 . . . . 0.0 109.949 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -68.48 -41.95 79.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 122.046 -0.409 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -29.64 69.79 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.726 1.21 . . . . 0.0 111.601 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -61.58 -43.23 99.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.145 0.978 . . . . 0.0 109.491 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -38.57 81.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.486 1.114 . . . . 0.0 108.822 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.22 -54.01 40.28 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.108 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.03 75.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.005 1.322 . . . . 0.0 112.915 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.15 -28.18 39.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 120.683 -1.26 . . . . 0.0 113.041 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.63 -34.76 18.37 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -49.46 67.7 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.697 1.599 . . . . 0.0 110.268 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.36 -26.85 66.68 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 112.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 119.614 -1.929 . . . . 0.0 110.801 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.05 -15.14 6.53 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.63 145.33 41.58 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 118.071 0.935 . . . . 0.0 109.801 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.78 135.53 11.46 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 110.136 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 14.41 76.91 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.38 145.49 55.97 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.12 0.968 . . . . 0.0 110.605 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.89 -37.98 0.9 Allowed 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 108.943 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 44' ' ' ALA . 42.1 tp -88.84 129.98 35.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -150.26 -179.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 t 76.23 127.21 0.04 OUTLIER 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.226 1.41 . . . . 0.0 109.502 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -65.13 -46.53 73.1 Favored Pre-proline 0 C--N 1.35 0.623 0 CA-C-O 116.921 -1.514 . . . . 0.0 111.611 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 -10.54 25.15 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 124.953 2.805 . . . . 0.0 112.608 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.02 -39.13 15.93 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.45 ' HA ' HD11 ' B' ' 38' ' ' LEU . . . -64.08 -36.47 84.11 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 123.416 0.686 . . . . 0.0 112.581 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -68.79 -29.19 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 O-C-N 122.03 -0.419 . . . . 0.0 110.08 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -38.22 70.41 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.755 -1.216 . . . . 0.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.09 -38.29 82.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.679 0.752 . . . . 0.0 109.368 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -59.27 -47.77 84.11 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.013 1.325 . . . . 0.0 110.191 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -54.51 -52.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 125.486 1.514 . . . . 0.0 111.099 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.96 -24.46 63.34 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 121.349 -0.844 . . . . 0.0 111.836 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -76.03 -33.59 59.64 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 123.897 0.879 . . . . 0.0 109.393 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.23 -24.61 65.84 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.964 -1.085 . . . . 0.0 111.693 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -92.92 10.41 31.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.542 0.737 . . . . 0.0 111.499 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 p 51.23 53.86 12.18 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 125.675 1.59 . . . . 0.0 112.838 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.56 -87.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.92 74.61 1.2 Allowed Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.53 -21.64 60.33 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 120.781 -1.423 . . . . 0.0 109.756 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.62 40.84 1.82 Allowed Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.26 -29.51 26.39 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 120.884 -1.362 . . . . 0.0 111.25 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.428 ' HG3' HD13 ' B' ' 38' ' ' LEU . 85.7 mmt-85 -144.41 166.89 23.84 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -143.03 115.14 5.94 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.67 161.16 16.6 Favored 'Trans proline' 0 CA--C 1.512 -0.617 0 C-N-CA 122.527 2.151 . . . . 0.0 110.15 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.05 -159.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.742 1.258 . . . . 0.0 110.769 -173.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -86.7 -36.22 18.83 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 119.734 -1.853 . . . . 0.0 110.612 -165.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.63 -15.87 41.07 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.486 1.114 . . . . 0.0 109.499 -167.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -28.77 69.91 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 123.478 1.609 . . . . 0.0 107.417 172.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.17 82.39 1.25 Allowed Glycine 0 CA--C 1.464 -3.152 1 N-CA-C 99.974 -5.25 . . . . 0.0 99.974 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm105 -66.97 3.93 0.98 Allowed 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.643 1.222 . . . . 0.0 112.999 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.14 -12.9 56.02 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 120.987 -1.071 . . . . 0.0 111.895 160.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -50.18 79.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.63 92.79 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.01 0.924 . . . . 0.0 111.701 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -53.95 -42.04 68.43 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.157 1.383 . . . . 0.0 110.623 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -63.76 -40.45 96.74 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.755 -0.591 . . . . 0.0 110.851 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.42 -49.02 80.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.018 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -69.92 -40.86 75.3 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 121.949 -0.469 . . . . 0.0 110.516 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -64.65 -41.59 96.02 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.324 -0.86 . . . . 0.0 109.725 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.94 85.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 122.028 -0.42 . . . . 0.0 111.388 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.34 -47.65 77.4 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.76 -45.18 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.778 1.231 . . . . 0.0 109.006 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.61 -44.21 80.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.112 -0.993 . . . . 0.0 111.357 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.86 -52.49 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.071 0.949 . . . . 0.0 109.599 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -72.19 -18.19 61.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.924 0.489 . . . . 0.0 111.492 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.78 -31.54 16.48 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.08 -31.85 73.19 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 120.38 -1.45 . . . . 0.0 110.018 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.48 -11.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 123.378 0.671 . . . . 0.0 112.098 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 22.8 m -60.35 -15.79 29.06 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.95 1.3 . . . . 0.0 111.426 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.53 -50.55 69.69 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.215 166.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.37 92.63 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 124.609 1.164 . . . . 0.0 110.272 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.03 -39.97 95.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 120.873 -1.142 . . . . 0.0 111.071 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 -15.74 60.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.677 -0.639 . . . . 0.0 110.701 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.4 m -83.25 -32.94 26.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 121.0 -1.062 . . . . 0.0 108.167 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.08 -11.45 59.99 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 111.801 -156.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -72.77 -31.93 65.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 121.387 -0.821 . . . . 0.0 110.299 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 t -74.08 -24.32 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.475 1.51 . . . . 0.0 109.047 -170.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -51.36 -31.91 23.85 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 124.851 1.26 . . . . 0.0 110.184 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -53.93 -31.8 51.5 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.98 1.312 . . . . 0.0 112.56 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -78.24 -19.56 53.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 120.806 -1.184 . . . . 0.0 111.283 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.92 -55.15 3.74 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 165.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -68.43 -34.32 75.78 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.226 2.21 . . . . 0.0 114.853 -163.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 27.4 ttm105 -57.31 -38.65 74.34 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 120.369 1.44 . . . . 0.0 110.969 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -103.85 3.48 33.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.966 0.907 . . . . 0.0 108.813 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.6 12.68 64.54 Favored Glycine 0 C--N 1.347 1.175 0 C-N-CA 124.981 1.277 . . . . 0.0 112.524 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 CA--C 1.496 -1.132 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.112 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.428 -1.548 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.6 128.0 46.12 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.974 0.892 . . . . 0.0 110.438 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -75.15 -26.9 59.47 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.189 0.995 . . . . 0.0 109.242 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' C' ' 5' ' ' GLU . 16.0 p80 -67.3 -29.57 69.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.477 -0.764 . . . . 0.0 110.928 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' C' ' 4' ' ' HIS . 56.1 mt-10 -78.05 -37.6 46.42 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -57.32 -43.81 83.65 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.693 0.797 . . . . 0.0 111.941 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.57 -24.42 53.53 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.624 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.1 93.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.917 -1.114 . . . . 0.0 110.209 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -65.05 -37.11 86.5 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.659 -0.651 . . . . 0.0 111.225 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -62.44 -35.65 79.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.791 1.236 . . . . 0.0 110.261 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.96 82.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.783 0.833 . . . . 0.0 111.482 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -60.97 -37.79 83.65 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -63.38 -39.48 94.63 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.913 0.885 . . . . 0.0 110.018 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -67.69 -35.9 79.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.005 0.922 . . . . 0.0 109.469 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.7 tp -65.4 -37.76 87.95 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.229 1.014 . . . . 0.0 110.624 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.74 -21.67 61.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.879 -1.138 . . . . 0.0 111.635 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -69.81 -47.2 63.71 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.554 0.742 . . . . 0.0 109.624 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.45 -25.63 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.381 -0.824 . . . . 0.0 110.43 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' C' ' 52' ' ' ALA . 50.8 mt -62.84 -40.66 98.14 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.405 0.682 . . . . 0.0 111.059 172.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.91 -47.11 86.41 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.392 0.997 . . . . 0.0 110.229 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -58.86 -55.11 39.38 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.33 83.24 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 125.964 1.706 . . . . 0.0 112.014 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 60.7 m -54.57 -51.2 65.99 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 124.367 1.067 . . . . 0.0 110.066 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -82.63 -35.66 26.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 121.905 -0.497 . . . . 0.0 110.566 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -63.57 -35.12 79.44 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.815 -1.178 . . . . 0.0 109.986 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.53 72.62 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.404 1.081 . . . . 0.0 111.887 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -34.92 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.688 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.42 -18.98 25.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.181 -0.949 . . . . 0.0 108.638 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -28.24 60.99 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.46 -0.775 . . . . 0.0 111.04 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -33.97 57.22 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -70.65 89.73 0.74 Allowed 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 125.972 1.709 . . . . 0.0 110.591 -167.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.24 2.03 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.61 155.11 56.54 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 153.94 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.119 1.879 . . . . 0.0 109.383 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.91 30.63 57.32 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -36.0 141.44 0.1 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 129.057 2.943 . . . . 0.0 113.493 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -115.51 0.17 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -164.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.403 ' H ' HD13 ' C' ' 38' ' ' LEU . 0.0 OUTLIER -75.79 153.49 36.9 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 19.0 pt -136.23 -158.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -62.21 -169.8 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.508 2.723 . . . . 0.0 111.482 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.417 ' HB3' ' HD2' ' C' ' 42' ' ' PRO . 4.0 m-85 81.38 -178.23 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' C' ' 41' ' ' TYR . 12.7 Cg_endo -74.54 9.24 1.94 Allowed 'Trans proline' 0 CA--C 1.517 -0.35 0 CA-C-N 125.645 3.052 . . . . 0.0 112.262 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.68 -35.81 60.26 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.169 0.988 . . . . 0.0 109.061 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.33 -47.56 72.36 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 125.503 1.521 . . . . 0.0 112.727 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.425 HG22 ' H ' ' C' ' 45' ' ' ILE . 9.3 tt -74.92 -26.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.142 -174.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -39.57 82.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.056 -1.028 . . . . 0.0 110.093 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -71.57 -35.45 70.58 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 118.661 0.664 . . . . 0.0 110.191 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -59.59 -39.21 83.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.823 -1.173 . . . . 0.0 110.048 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.04 68.43 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.019 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.501 ' HB3' HH12 ' D' ' 68' ' ' ARG . 21.4 pt-20 -164.05 -39.48 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -66.28 -41.03 90.41 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.104 0.962 . . . . 0.0 110.653 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -69.51 -24.0 63.69 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 120.929 -1.107 . . . . 0.0 112.358 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.96 -1.2 57.39 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 121.448 -0.783 . . . . 0.0 109.483 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.8 p 52.25 49.43 20.56 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.302 1.841 . . . . 0.0 112.307 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.42 82.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.54 98.33 1.99 Allowed Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -79.28 -21.36 46.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.309 1.052 . . . . 0.0 108.307 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.91 39.76 1.14 Allowed Glycine 0 CA--C 1.483 -1.951 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.488 ' HB2' HH21 ' D' ' 68' ' ' ARG . 40.7 t0 -84.74 -50.34 7.69 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -131.92 -155.82 0.71 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 107.509 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.99 153.37 15.44 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 101.692 -3.447 . . . . 0.0 101.692 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -89.71 -177.36 1.41 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 123.392 2.728 . . . . 0.0 108.73 169.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.39 -167.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 119.81 1.186 . . . . 0.0 108.813 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.46 -56.46 2.18 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.158 0.983 . . . . 0.0 109.806 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.65 -41.33 77.02 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.258 -0.902 . . . . 0.0 112.313 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.52 -138.45 0.19 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 100.686 -3.82 . . . . 0.0 100.686 162.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.21 -73.35 1.09 Allowed Glycine 0 CA--C 1.492 -1.381 0 CA-C-N 120.454 1.479 . . . . 0.0 109.447 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -32.42 68.09 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.343 1.457 . . . . 0.0 110.295 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -69.97 -33.45 72.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.8 t -73.42 -47.49 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.89 76.6 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.453 1.501 . . . . 0.0 112.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -48.07 -47.05 34.18 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 126.979 2.112 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.7 -33.13 75.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.012 1.325 . . . . 0.0 110.735 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.65 -42.25 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.347 1.059 . . . . 0.0 109.416 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -60.18 -45.12 94.22 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.691 -0.63 . . . . 0.0 109.943 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -55.01 -50.09 69.89 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.316 1.446 . . . . 0.0 110.98 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -32.17 72.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.473 1.109 . . . . 0.0 110.835 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.72 -47.96 18.78 Favored Glycine 0 CA--C 1.491 -1.435 0 O-C-N 121.779 -0.576 . . . . 0.0 111.784 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.7 -41.14 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 122.068 -0.666 . . . . 0.0 110.084 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.68 -29.81 68.35 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 120.505 -1.372 . . . . 0.0 112.089 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.36 -49.17 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -73.49 -12.71 60.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.52 -0.737 . . . . 0.0 111.201 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.85 -53.94 7.24 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -50.88 -42.14 58.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.452 2.301 . . . . 0.0 112.939 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 m -60.51 -19.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 112.248 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 4.9 m -69.29 -13.39 62.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.919 -1.113 . . . . 0.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.92 68.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.805 -1.81 . . . . 0.0 111.075 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.16 32.6 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.725 -1.234 . . . . 0.0 108.661 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.44 -31.18 66.91 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.13 0.972 . . . . 0.0 110.777 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.799 -1.188 . . . . 0.0 111.562 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 10.3 t -94.31 1.39 55.93 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.838 -1.163 . . . . 0.0 108.865 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -26.8 58.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 120.341 1.428 . . . . 0.0 110.055 -176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -69.9 -38.9 76.46 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.716 -1.24 . . . . 0.0 109.521 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.09 -25.0 37.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 125.533 1.533 . . . . 0.0 110.643 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -57.08 -24.6 55.12 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.114 1.366 . . . . 0.0 112.678 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -58.31 -31.82 67.88 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 121.138 -0.976 . . . . 0.0 111.628 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -77.33 -15.28 59.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.756 -0.59 . . . . 0.0 109.821 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -85.86 -42.88 13.73 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.76 -37.32 86.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -74.98 -14.96 60.68 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.73 -1.231 . . . . 0.0 112.428 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -89.39 -25.15 21.7 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.021 -1.049 . . . . 0.0 108.956 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.24 32.23 48.91 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 73.4 m80 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -178.524 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.35 68.92 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 122.607 0.363 . . . . 0.0 111.911 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -173.71 -120.8 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.056 1 N-CA-C 99.641 -4.207 . . . . 0.0 99.641 -157.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 28.4 p-80 -53.17 -21.58 5.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 129.052 2.941 . . . . 0.0 114.521 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.8 -31.72 71.09 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.857 0.863 . . . . 0.0 111.007 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -68.67 -43.22 76.62 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.946 -1.096 . . . . 0.0 109.951 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.5 -32.05 69.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.86 -46.56 90.09 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.562 0.745 . . . . 0.0 111.457 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.62 -31.98 73.02 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 121.645 -0.659 . . . . 0.0 111.778 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -69.78 -35.65 75.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.479 -0.763 . . . . 0.0 109.438 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.91 82.27 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.941 -1.099 . . . . 0.0 111.353 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.8 -20.79 62.54 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.784 -1.198 . . . . 0.0 112.064 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.16 -39.28 63.36 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.031 1.332 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -64.38 -34.83 79.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.254 1.822 . . . . 0.0 110.257 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.94 -41.29 91.51 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 121.895 -0.503 . . . . 0.0 110.311 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.44 -32.75 74.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.308 0.643 . . . . 0.0 110.924 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -64.65 -42.68 95.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.237 1.415 . . . . 0.0 110.904 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.0 -25.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 O-C-N 121.079 -1.013 . . . . 0.0 110.568 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -60.57 -47.98 83.79 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-N 119.361 0.982 . . . . 0.0 109.771 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -61.61 -46.52 89.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.556 0.742 . . . . 0.0 111.137 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -74.39 -34.74 63.4 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.442 -0.786 . . . . 0.0 109.402 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.84 73.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 120.314 -1.491 . . . . 0.0 111.923 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -61.9 -41.75 98.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.413 1.085 . . . . 0.0 110.926 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -69.14 -38.16 78.67 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.56 -53.89 44.63 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.733 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -47.74 74.27 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.181 1.392 . . . . 0.0 112.549 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.495 HG22 HH21 ' D' ' 31' ' ' ARG . 11.2 p -71.13 -26.29 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 120.527 -1.358 . . . . 0.0 111.523 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -89.96 -28.09 19.37 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 109.02 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.92 -55.68 7.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.17 2.588 . . . . 0.0 108.797 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.41 -26.1 68.3 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.95 1.3 . . . . 0.0 111.527 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' ARG . . . . . 0.495 HH21 HG22 ' D' ' 27' ' ' VAL . 6.8 tpp180 -69.01 104.85 2.22 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 120.035 -1.666 . . . . 0.0 109.876 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.04 -7.8 29.2 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.0 140.26 29.08 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.26 134.46 5.89 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.308 2.005 . . . . 0.0 110.634 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.86 0.46 66.33 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.16 115.48 6.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.976 1.71 . . . . 0.0 108.518 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.49 -26.89 13.96 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.23 104.18 16.14 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -148.14 70.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 120.218 -1.551 . . . . 0.0 109.333 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -167.61 157.61 10.59 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -77.18 -50.99 2.11 Favored Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 115.774 -2.06 . . . . 0.0 110.84 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.01 -15.96 36.35 Favored 'Trans proline' 0 CA--C 1.512 -0.575 0 CA-C-N 126.063 3.201 . . . . 0.0 111.396 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -82.26 -36.61 26.94 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.43 90.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.034 0.933 . . . . 0.0 111.999 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tp -72.85 -21.45 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.503 1.144 . . . . 0.0 109.906 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -40.1 25.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 120.266 -1.521 . . . . 0.0 109.311 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -65.0 -35.99 82.98 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.931 1.292 . . . . 0.0 110.64 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -86.27 62.14 7.25 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 120.29 -1.506 . . . . 0.0 109.51 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.84 -61.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -30.17 69.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.236 0.925 . . . . 0.0 110.62 -167.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -57.12 -35.31 69.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 125.617 1.567 . . . . 0.0 111.077 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.15 -25.26 55.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 119.869 -1.769 . . . . 0.0 110.697 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.67 -0.75 39.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.443 1.497 . . . . 0.0 108.404 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.265 4.1 p 60.72 47.95 7.59 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.007 2.123 . . . . 0.0 111.437 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.2 152.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 99.035 -4.432 . . . . 0.0 99.035 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.6 110.08 0.51 Allowed Glycine 0 CA--C 1.472 -2.645 1 N-CA-C 99.61 -5.396 . . . . 0.0 99.61 176.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -37.78 64.1 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 45.83 0.21 Allowed Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 168.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.9 -48.95 50.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 117.3 0.55 . . . . 0.0 110.463 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -137.7 177.45 7.86 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -149.05 140.65 14.45 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.95 -175.36 2.63 Favored 'Trans proline' 0 CA--C 1.516 -0.382 0 C-N-CA 124.627 3.552 . . . . 0.0 110.311 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.444 HG12 ' H ' ' D' ' 64' ' ' THR . 0.6 OUTLIER -134.78 -157.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.444 ' H ' HG12 ' D' ' 63' ' ' VAL . 1.8 p -77.46 -49.93 13.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 127.618 2.367 . . . . 0.0 109.368 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -85.67 -13.95 46.98 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.846 1.258 . . . . 0.0 111.193 -162.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -22.15 62.75 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.443 1.592 . . . . 0.0 107.484 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.27 54.03 2.51 Favored Glycine 0 CA--C 1.464 -3.104 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.501 HH12 ' HB3' ' C' ' 50' ' ' GLU . 62.0 ttt-85 -20.53 -28.13 0.0 OUTLIER 'General case' 0 C--N 1.368 1.386 1 C-N-CA 134.509 5.124 . . . . 0.0 117.392 -175.349 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -61.98 2.04 0.25 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.584 1.954 . . . . 0.0 113.263 166.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -70.96 -47.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 168.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.687 0.795 . . . . 0.0 110.516 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.57 -44.52 69.4 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 124.658 1.183 . . . . 0.0 111.036 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -61.52 -44.5 96.95 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.61 -44.91 82.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 121.76 -0.588 . . . . 0.0 109.774 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.6 mtm -61.92 -47.69 83.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.84 -31.63 68.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.076 -1.015 . . . . 0.0 111.355 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.28 81.32 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.154 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.63 96.62 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 123.551 0.596 . . . . 0.0 111.748 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -57.9 -49.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.789 0 C-N-CA 124.22 1.008 . . . . 0.0 109.599 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.94 -45.34 71.21 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.019 1.328 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.77 -57.0 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 124.695 1.198 . . . . 0.0 109.384 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -68.17 -34.74 76.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 121.64 -0.663 . . . . 0.0 110.669 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.73 78.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 110.637 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.94 -36.09 82.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.866 -1.146 . . . . 0.0 110.474 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.58 -10.86 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.042 1.337 . . . . 0.0 110.947 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -58.65 -21.12 53.19 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.665 -1.897 . . . . 0.0 111.015 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.33 68.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 120.314 -1.491 . . . . 0.0 112.525 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.641 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.11 -47.86 22.86 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.22 -32.62 74.15 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.883 0.849 . . . . 0.0 112.022 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.93 -11.84 60.97 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.323 -1.486 . . . . 0.0 111.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.427 HG21 ' CE1' ' D' ' 4' ' ' HIS . 62.6 p -82.93 -19.06 37.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 120.391 -1.443 . . . . 0.0 109.748 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.05 -34.19 77.16 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.987 0.812 . . . . 0.0 111.14 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -77.88 -18.1 56.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.626 -1.296 . . . . 0.0 111.479 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -81.45 -30.08 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -57.13 -23.53 47.82 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 124.909 1.284 . . . . 0.0 111.213 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -59.86 -25.95 65.46 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.242 1.017 . . . . 0.0 112.178 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.418 ' CG ' ' HE ' ' D' ' 100' ' ' ARG . 8.5 tt0 -75.14 -22.06 58.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 120.83 -1.169 . . . . 0.0 110.509 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -88.65 -26.24 21.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.373 -0.829 . . . . 0.0 109.793 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.25 -43.9 96.72 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.452 -0.78 . . . . 0.0 110.1 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.418 ' HE ' ' CG ' ' D' ' 97' ' ' GLU . 44.3 ptt85 -70.16 -19.14 63.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.872 -0.518 . . . . 0.0 112.356 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -73.38 -47.56 41.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.44 41.78 5.04 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 106.749 -2.541 . . . . 0.0 106.749 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 t60 . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.777 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 159.87 25.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 120.82 -1.175 . . . . 0.0 108.896 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 4' ' ' HIS . 6.9 p-10 -66.24 -43.35 86.83 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.961 1.704 . . . . 0.0 108.815 -175.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' OD2' ' A' ' 3' ' ' ASP . 57.0 m170 -69.7 -31.07 68.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.355 -0.841 . . . . 0.0 111.75 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.39 -43.58 60.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -66.09 -44.59 83.97 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.081 0.952 . . . . 0.0 110.243 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -66.57 -36.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.901 0.858 . . . . 0.0 110.771 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.84 -43.49 79.41 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 121.162 -0.961 . . . . 0.0 110.367 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -69.83 -31.22 68.97 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.1 0.56 . . . . 0.0 110.348 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -59.45 -40.84 88.14 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.743 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.73 -33.84 75.67 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.715 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.47 -34.24 77.32 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.571 -0.706 . . . . 0.0 111.504 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -60.78 -45.99 92.22 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.133 0.973 . . . . 0.0 109.854 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.53 -34.33 77.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.265 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.78 -35.23 77.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.385 -0.822 . . . . 0.0 111.1 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.13 -36.03 66.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 121.508 -0.745 . . . . 0.0 110.537 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.74 -45.56 93.8 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.498 1.119 . . . . 0.0 110.987 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.04 -20.19 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 O-C-N 121.254 -0.904 . . . . 0.0 111.238 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.29 -41.66 96.77 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 119.435 1.016 . . . . 0.0 110.194 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.68 -26.52 59.9 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.378 1.071 . . . . 0.0 110.328 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -79.52 -41.41 27.4 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.483 -1.386 . . . . 0.0 108.51 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.55 69.93 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.102 1.361 . . . . 0.0 111.903 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 45' ' ' ILE . 12.1 p -66.24 -50.54 63.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 119.224 0.92 . . . . 0.0 109.563 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -63.31 -47.15 83.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.363 1.865 . . . . 0.0 109.044 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.5 -32.61 71.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.313 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.21 50.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 119.942 1.247 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.19 -38.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 121.759 0.79 . . . . 0.0 109.58 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.24 -33.74 70.13 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.966 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.19 94.59 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.504 1.122 . . . . 0.0 111.169 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.93 -14.0 54.97 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.933 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -74.11 73.84 1.74 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.055 0.931 . . . . 0.0 111.049 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.73 23.92 0.69 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.274 -1.931 . . . . 0.0 108.274 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.49 142.58 43.45 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -77.86 121.63 5.52 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.936 2.424 . . . . 0.0 110.662 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.23 22.9 6.28 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.58 149.77 20.66 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 126.119 1.768 . . . . 0.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.77 -65.81 0.51 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.244 0.618 . . . . 0.0 111.706 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.56 55.91 3.38 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.591 1.186 . . . . 0.0 108.703 -171.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 tt -72.96 -13.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 125.979 1.712 . . . . 0.0 111.016 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.3 m -90.9 126.92 36.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.95 -51.21 80.98 Favored Pre-proline 0 C--N 1.349 0.558 0 CA-C-O 116.219 -1.848 . . . . 0.0 113.939 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.64 -8.83 23.13 Favored 'Trans proline' 0 CA--C 1.514 -0.482 0 CA-C-N 126.003 3.18 . . . . 0.0 111.932 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.68 -35.38 14.22 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.579 1.152 . . . . 0.0 108.136 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.29 88.14 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.618 1.567 . . . . 0.0 110.651 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 19.8 tt -66.33 -29.78 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.784 -0.573 . . . . 0.0 111.941 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -27.39 56.91 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.937 -1.102 . . . . 0.0 109.75 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -72.18 -38.85 69.01 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -55.41 -35.38 65.3 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.67 -0.644 . . . . 0.0 111.964 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.42 -39.09 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 110.261 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -80.28 -15.96 55.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.378 -0.826 . . . . 0.0 112.268 -168.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -97.2 -31.06 12.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 110.267 -173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -23.04 62.39 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.04 -1.038 . . . . 0.0 111.701 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -84.35 -2.75 57.59 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.424 1.09 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 53.27 65.37 1.54 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 126.067 1.747 . . . . 0.0 112.18 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.47 -84.41 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.75 76.85 1.27 Allowed Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.95 -49.14 16.19 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.1 -122.56 1.18 Allowed Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 104.053 -3.619 . . . . 0.0 104.053 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.547 ' HB3' HH12 ' B' ' 68' ' ' ARG 0.287 8.8 t0 62.95 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.428 1.891 . . . . 0.0 111.211 -169.073 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.79 -176.95 3.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -156.13 147.12 16.46 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.24 177.55 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.268 2.646 . . . . 0.0 110.199 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.81 170.57 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.27 1.428 . . . . 0.0 107.92 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -62.31 1.69 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.122 2.169 . . . . 0.0 112.47 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.7 -40.9 80.56 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.093 0.957 . . . . 0.0 112.451 -165.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.96 -108.75 0.34 Allowed 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.53 -83.01 0.0 OUTLIER Glycine 0 C--N 1.358 1.79 0 C-N-CA 128.239 2.828 . . . . 0.0 114.53 171.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 68' ' ' ARG . 57.5 ttm-85 -54.79 -44.16 73.49 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.046 2.538 . . . . 0.0 112.439 174.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.98 -30.05 63.51 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.214 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.82 -45.1 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.49 78.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.837 2.055 . . . . 0.0 112.041 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -51.7 -44.44 63.17 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 109.736 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -72.33 -30.27 64.59 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.15 -47.89 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.62 -37.28 82.27 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.97 -38.11 87.3 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.505 -0.747 . . . . 0.0 111.08 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.45 -28.21 69.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.655 0.782 . . . . 0.0 111.385 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.52 -42.59 11.38 Favored Glycine 0 CA--C 1.49 -1.484 0 C-N-CA 124.709 1.147 . . . . 0.0 110.722 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.7 -47.84 81.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.678 1.191 . . . . 0.0 109.198 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -69.16 -25.71 64.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.317 -0.865 . . . . 0.0 111.916 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.47 -51.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.178 -0.951 . . . . 0.0 108.526 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.25 -26.03 66.37 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.48 -0.762 . . . . 0.0 111.231 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.57 48.59 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.023 0.929 . . . . 0.0 110.506 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.75 -39.12 87.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 124.803 1.241 . . . . 0.0 111.246 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.72 -6.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 121.366 -0.834 . . . . 0.0 112.679 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -60.31 -20.29 58.63 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.815 1.246 . . . . 0.0 110.682 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.11 78.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.345 -1.472 . . . . 0.0 112.688 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.18 -45.38 60.61 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.39 -37.63 88.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.562 0.745 . . . . 0.0 110.99 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.41 97.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.867 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -15.99 41.03 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.68 -1.263 . . . . 0.0 113.191 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.96 -17.1 60.6 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 111.853 -172.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -77.94 -24.71 48.12 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.239 -1.538 . . . . 0.0 110.734 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.72 -39.57 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -61.86 -20.89 64.18 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.18 1.392 . . . . 0.0 112.414 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttp85 -58.81 -22.35 58.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 125.005 1.322 . . . . 0.0 111.896 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -67.14 -29.0 68.6 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.07 -1.644 . . . . 0.0 111.5 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -73.3 -36.37 66.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.303 -0.873 . . . . 0.0 109.621 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -68.56 -29.17 67.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.124 1.37 . . . . 0.0 110.095 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -73.54 -33.69 64.84 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.028 1.331 . . . . 0.0 110.434 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -75.96 -36.22 59.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.532 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.67 38.05 8.35 Favored Glycine 0 CA--C 1.493 -1.307 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.582 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.44 135.16 34.95 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -30.38 71.47 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.184 0.992 . . . . 0.0 111.175 -174.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.468 ' CE1' ' OE1' ' B' ' 5' ' ' GLU . 7.7 p80 -59.91 -28.6 67.73 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.451 1.1 . . . . 0.0 112.413 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.468 ' OE1' ' CE1' ' B' ' 4' ' ' HIS . 9.3 tp10 -80.5 -34.61 35.59 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -167.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -71.34 -37.2 71.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.169 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -60.7 -43.07 98.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.931 1.692 . . . . 0.0 110.076 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.8 -45.42 82.42 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.351 1.06 . . . . 0.0 110.994 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.04 -37.43 87.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.436 1.094 . . . . 0.0 110.996 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.51 -33.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.382 1.473 . . . . 0.0 110.917 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.72 -37.93 79.84 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.663 -1.273 . . . . 0.0 110.072 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.17 -30.45 71.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.65 -38.39 90.12 Favored 'General case' 0 C--N 1.357 0.906 0 O-C-N 121.223 -0.923 . . . . 0.0 110.865 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -67.74 -36.25 80.22 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 121.627 -0.67 . . . . 0.0 109.795 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -61.61 -40.55 95.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.628 -0.67 . . . . 0.0 110.669 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.21 -27.24 67.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.361 -0.837 . . . . 0.0 111.989 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.63 -39.64 73.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.79 -38.9 83.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 124.426 1.09 . . . . 0.0 109.421 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -42.11 76.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.236 1.014 . . . . 0.0 112.301 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.86 -43.88 67.54 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.46 -33.17 73.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.101 -1.0 . . . . 0.0 111.394 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.73 -32.69 72.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.049 1.339 . . . . 0.0 110.993 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.0 p -66.83 -41.98 86.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -64.63 -45.37 87.13 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.98 1.312 . . . . 0.0 108.646 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -60.82 -58.16 9.63 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 109.807 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.72 79.9 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.824 1.249 . . . . 0.0 112.858 -172.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.57 -49.57 81.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 CA-C-N 118.814 0.734 . . . . 0.0 109.495 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -76.27 -25.11 54.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.504 0.669 . . . . 0.0 109.644 -170.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 125.544 1.538 . . . . 0.0 110.159 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.18 -12.66 60.13 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.025 -1.047 . . . . 0.0 113.128 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.83 77.68 1.6 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.557 -1.339 . . . . 0.0 110.986 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.04 -19.62 1.58 Allowed Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.41 140.95 45.2 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 121.248 -1.148 . . . . 0.0 109.911 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.62 151.25 25.15 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 122.11 1.873 . . . . 0.0 109.131 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 16.37 79.07 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 119.179 0.899 . . . . 0.0 112.19 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.53 142.93 57.72 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.355 1.862 . . . . 0.0 110.61 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.72 -25.12 0.32 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.324 0.583 . . . . 0.0 110.702 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.25 -38.14 66.09 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.535 1.534 . . . . 0.0 108.512 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -37.85 115.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 130.169 3.388 . . . . 0.0 111.854 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 47.1 t -177.88 -152.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 99.975 -4.083 . . . . 0.0 99.975 -168.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.26 -56.62 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -69.73 -31.3 20.93 Favored 'Trans proline' 0 CA--C 1.503 -1.034 0 CA-C-N 124.416 2.613 . . . . 0.0 111.404 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -107.77 14.51 25.44 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 119.757 1.162 . . . . 0.0 110.148 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.22 -35.37 73.84 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.404 -0.81 . . . . 0.0 109.336 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -28.2 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 123.814 0.845 . . . . 0.0 109.764 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -34.03 76.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.255 -1.528 . . . . 0.0 110.896 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -68.5 -42.76 78.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.685 0.794 . . . . 0.0 109.581 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.6 p -68.38 -28.37 67.05 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.395 -1.441 . . . . 0.0 111.376 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.08 -53.94 24.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 124.568 1.147 . . . . 0.0 110.737 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -73.82 -21.05 60.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.358 -0.838 . . . . 0.0 111.98 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.0 m -72.22 -39.56 68.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.46 67.48 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.371 -0.831 . . . . 0.0 111.727 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 4.37 44.82 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.943 -0.473 . . . . 0.0 110.918 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 24.2 p 55.67 56.58 6.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.273 1.429 . . . . 0.0 112.547 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 55.1 t -121.27 -93.29 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 101.972 -3.344 . . . . 0.0 101.972 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.03 82.98 1.1 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -174.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -73.9 -24.7 59.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.425 -1.044 . . . . 0.0 111.562 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.42 38.58 0.91 Allowed Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -82.32 -60.89 2.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.47 153.99 43.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.7 146.85 36.89 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 161.87 17.28 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.868 2.378 . . . . 0.0 108.797 164.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.18 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 119.465 1.029 . . . . 0.0 108.539 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -114.74 -36.63 4.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.68 1.229 . . . . 0.0 109.054 -172.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.95 -3.63 57.14 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 121.361 -0.837 . . . . 0.0 109.385 -166.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -26.26 60.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 77.11 1.32 Allowed Glycine 0 CA--C 1.471 -2.705 1 N-CA-C 101.445 -4.662 . . . . 0.0 101.445 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.547 HH12 ' HB3' ' A' ' 59' ' ' ASP . 21.0 ttm180 -53.52 -7.9 0.12 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 128.401 2.68 . . . . 0.0 114.263 -170.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -53.14 -19.98 3.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 120.716 -1.24 . . . . 0.0 113.276 157.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.17 -52.04 63.75 Favored 'Isoleucine or valine' 0 C--N 1.363 1.16 0 CA-C-N 120.464 1.484 . . . . 0.0 107.644 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.78 77.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.681 -0.637 . . . . 0.0 109.642 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.06 -46.98 75.42 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.232 1.013 . . . . 0.0 110.553 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.96 -44.04 91.41 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 124.899 1.28 . . . . 0.0 111.094 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.1 -44.16 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.367 0.667 . . . . 0.0 109.969 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.0 mtm -63.16 -46.54 86.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.346 0.593 . . . . 0.0 109.823 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -61.31 -41.51 97.12 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.063 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.13 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.765 0.826 . . . . 0.0 111.033 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.46 -48.17 76.44 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.87 -43.35 91.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 C-N-CA 124.47 1.108 . . . . 0.0 110.206 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.25 -40.9 94.63 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.118 -0.989 . . . . 0.0 111.684 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.9 -47.63 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.26 -11.15 60.76 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 121.562 -0.711 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.76 -42.3 12.7 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.835 -1.166 . . . . 0.0 109.144 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.53 -36.69 74.25 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 126.112 1.765 . . . . 0.0 111.04 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.64 -7.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 112.498 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.6 m -63.65 -16.86 62.1 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.314 -1.492 . . . . 0.0 110.985 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.45 -19.34 63.4 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.52 -1.987 . . . . 0.0 111.751 169.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.08 -54.48 4.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.124 1.37 . . . . 0.0 108.705 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.69 -36.34 70.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.468 -0.77 . . . . 0.0 112.533 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.14 -17.2 61.41 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 119.834 -1.791 . . . . 0.0 110.2 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -87.41 -2.27 58.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.729 -1.232 . . . . 0.0 109.36 175.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.02 -31.45 67.94 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 120.674 1.579 . . . . 0.0 111.302 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -72.94 -25.71 61.13 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.84 -1.163 . . . . 0.0 111.22 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.64 -32.5 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -63.37 -26.1 68.6 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.294 1.038 . . . . 0.0 111.552 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -50.57 -39.77 50.42 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.283 1.433 . . . . 0.0 111.438 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.38 -34.37 77.14 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 120.926 -1.109 . . . . 0.0 112.128 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.64 -35.81 57.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.82 -31.71 73.07 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.607 1.163 . . . . 0.0 111.199 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -63.67 -34.08 77.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.2 1.4 . . . . 0.0 111.579 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.2 -14.41 33.52 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.638 -0.664 . . . . 0.0 109.384 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.0 14.64 66.64 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 10.6 p80 . . . . . 0 CA--C 1.508 -0.67 0 C-N-CA 124.644 1.178 . . . . 0.0 113.002 -179.292 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.7 106.63 17.11 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 171.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 24.13 -78.8 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 130.528 3.531 . . . . 0.0 116.046 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 4.4 p-80 -52.39 -29.8 25.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.365 1.466 . . . . 0.0 113.769 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.506 ' OE2' ' HE1' ' C' ' 4' ' ' HIS . 12.9 mt-10 -75.82 -25.96 56.8 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.943 -1.098 . . . . 0.0 111.326 177.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.94 -38.72 69.77 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.186 -0.946 . . . . 0.0 108.524 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.62 -27.95 66.48 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.28 0.562 . . . . 0.0 109.852 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.79 75.97 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.253 -0.905 . . . . 0.0 111.193 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -74.53 -29.5 61.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 120.872 -1.143 . . . . 0.0 111.08 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -64.17 -28.79 70.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 111.286 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.36 65.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.893 -1.13 . . . . 0.0 110.438 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.43 -32.35 73.67 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 120.898 -1.126 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.6 -29.31 66.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.793 -1.192 . . . . 0.0 110.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.67 -37.49 79.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.324 1.449 . . . . 0.0 109.181 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 27.4 tp -56.86 -48.89 77.05 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 126.073 1.749 . . . . 0.0 110.026 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.03 -39.79 79.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.673 1.589 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -74.12 -46.7 40.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.338 1.455 . . . . 0.0 110.742 -172.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.98 -36.23 72.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.101 -0.999 . . . . 0.0 111.111 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.19 -28.04 57.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -49.59 74.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -63.19 -43.41 98.28 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.44 1.114 . . . . 0.0 109.197 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.16 63.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.637 -0.665 . . . . 0.0 112.518 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 m -69.13 -47.73 64.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 124.075 0.95 . . . . 0.0 109.702 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -66.24 -43.79 85.58 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.43 -20.61 64.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.461 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -45.09 73.69 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 119.975 1.261 . . . . 0.0 110.451 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.04 -44.29 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.91 -45.02 94.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.801 1.64 . . . . 0.0 110.258 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.18 86.45 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 124.869 1.267 . . . . 0.0 111.174 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -32.45 58.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 121.959 -0.463 . . . . 0.0 109.9 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.6 90.49 1.03 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.443 1.097 . . . . 0.0 109.637 -174.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.75 -27.41 2.82 Favored Glycine 0 CA--C 1.491 -1.463 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -93.57 156.07 40.06 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -76.77 154.08 34.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.23 1.953 . . . . 0.0 110.734 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.41 49.73 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.16 136.41 15.12 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.636 1.974 . . . . 0.0 113.536 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.7 -30.42 0.19 Allowed 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.185 0.994 . . . . 0.0 111.007 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -102.88 148.08 26.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -168.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -156.47 179.43 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m 65.32 109.36 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.572 1.549 . . . . 0.0 114.258 161.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -57.59 -37.89 61.53 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 116.227 -1.844 . . . . 0.0 114.757 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.6 -21.77 14.44 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 CA-C-N 125.628 3.046 . . . . 0.0 112.666 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -82.84 -25.45 32.62 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.72 71.86 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.96 1.704 . . . . 0.0 112.507 -172.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -67.13 -25.16 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 123.338 0.655 . . . . 0.0 111.114 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -21.01 56.25 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 120.822 -1.174 . . . . 0.0 110.867 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -80.62 -40.16 26.14 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.372 1.082 . . . . 0.0 108.126 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m -70.61 -31.42 68.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 O-C-N 120.328 -1.483 . . . . 0.0 112.634 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -62.62 -51.05 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.68 -15.76 61.69 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.08 1.352 . . . . 0.0 112.291 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 50.3 m -82.3 -36.73 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.066 -1.021 . . . . 0.0 108.525 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -27.74 61.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.37 -0.831 . . . . 0.0 110.451 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -93.0 6.91 46.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.452 0.701 . . . . 0.0 110.211 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.259 7.9 p 54.2 55.02 8.71 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 126.855 2.062 . . . . 0.0 114.317 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.87 -75.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.96 -64.06 3.09 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 t80 78.68 -47.6 0.43 Allowed 'General case' 0 C--N 1.351 0.668 0 C-N-CA 127.369 2.267 . . . . 0.0 109.437 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.05 13.72 0.42 Allowed Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -57.57 4.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.658 -0.907 . . . . 0.0 111.144 -173.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 26.0 mtm-85 -138.13 154.95 49.17 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -134.27 150.41 73.97 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.23 166.82 20.21 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 109.556 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' C' ' 33' ' ' ALA . 32.8 m -87.1 -179.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p -82.54 -79.85 0.18 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -32.47 -61.68 0.26 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.596 2.758 . . . . 0.0 110.912 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.77 -59.41 1.8 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -41.02 -41.45 2.67 Favored Glycine 0 CA--C 1.488 -1.639 0 C-N-CA 127.47 2.462 . . . . 0.0 114.819 -169.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -76.36 -30.68 57.68 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.292 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -35.35 71.59 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 121.528 1.967 . . . . 0.0 108.888 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.93 -51.38 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.79 98.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 125.094 1.358 . . . . 0.0 112.551 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.98 -46.89 52.95 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 127.328 2.251 . . . . 0.0 109.457 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -66.59 -36.39 82.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.75 -44.46 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.6 mtt -59.5 -46.26 89.32 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.679 0.791 . . . . 0.0 110.664 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -61.94 -43.61 98.48 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.48 84.12 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.226 0.61 . . . . 0.0 110.931 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.19 86.64 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 123.821 0.724 . . . . 0.0 111.833 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.99 -43.11 97.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.938 0.895 . . . . 0.0 109.527 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.77 -33.36 73.94 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.342 -0.848 . . . . 0.0 111.94 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.21 -53.59 35.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 123.689 0.796 . . . . 0.0 109.558 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -66.09 -38.79 89.14 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.85 -30.47 71.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.423 0.689 . . . . 0.0 111.842 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.68 -36.86 81.48 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 121.026 -1.046 . . . . 0.0 110.443 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.64 -20.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.932 1.293 . . . . 0.0 110.416 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 2.9 m -55.76 -22.79 25.94 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.927 1.291 . . . . 0.0 112.185 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.66 70.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.662 -1.899 . . . . 0.0 112.826 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -87.0 -16.68 35.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 123.961 0.904 . . . . 0.0 110.381 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.4 -35.6 17.03 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.33 62.07 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.611 -1.306 . . . . 0.0 111.179 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -73.26 -19.22 61.11 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 120.44 -1.412 . . . . 0.0 110.787 171.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.7 -11.37 57.28 Favored 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 120.935 -1.103 . . . . 0.0 111.136 -157.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -84.58 -21.3 30.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.109 -0.994 . . . . 0.0 110.336 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.84 -35.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -55.35 -19.46 8.92 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.036 1.334 . . . . 0.0 113.217 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -57.46 -28.87 63.73 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.296 -0.877 . . . . 0.0 110.947 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -75.65 -23.41 56.3 Favored 'General case' 0 N--CA 1.436 -1.17 0 O-C-N 121.319 -0.863 . . . . 0.0 110.805 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -83.78 -31.81 25.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -68.13 -41.9 81.0 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.067 -1.646 . . . . 0.0 110.233 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -67.94 -38.73 83.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.679 1.192 . . . . 0.0 110.967 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -131.7 108.62 9.61 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.1 41.41 4.32 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 . . . . . 0 CA--C 1.502 -0.874 0 O-C-N 121.223 -1.163 . . . . 0.0 109.358 178.505 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.76 57.67 4.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 74.48 -67.69 0.24 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.866 2.066 . . . . 0.0 110.645 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -70.83 -28.93 64.98 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 126.662 1.985 . . . . 0.0 111.857 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -23.46 63.79 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 120.967 -1.083 . . . . 0.0 111.47 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.07 -42.78 88.94 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.453 -0.779 . . . . 0.0 109.908 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.76 -39.64 80.17 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.63 93.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.536 0.735 . . . . 0.0 111.17 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.34 -39.52 85.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.469 0.708 . . . . 0.0 110.389 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -64.06 -35.61 81.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.005 0.922 . . . . 0.0 110.808 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.03 79.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.388 1.075 . . . . 0.0 111.122 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -65.26 -34.69 78.96 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 120.901 -1.125 . . . . 0.0 111.17 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.96 -33.67 74.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 121.595 -0.69 . . . . 0.0 110.867 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -61.68 -41.94 98.24 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.194 1.398 . . . . 0.0 109.297 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.61 -38.84 91.76 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.051 -1.031 . . . . 0.0 111.417 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -69.12 -22.65 63.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.157 -0.964 . . . . 0.0 112.405 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.48 -39.96 36.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.25 -38.33 80.8 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 124.379 1.071 . . . . 0.0 109.544 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.79 -45.9 63.99 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.556 1.142 . . . . 0.0 112.056 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -71.41 -41.14 69.94 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 122.776 0.431 . . . . 0.0 110.585 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -62.68 -43.37 98.99 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.38 68.69 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.875 1.67 . . . . 0.0 112.17 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -67.08 -37.95 84.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 110.163 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -35.21 63.85 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -64.66 -50.06 68.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.57 0.748 . . . . 0.0 109.185 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.39 69.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.678 1.191 . . . . 0.0 113.507 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.23 -28.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 O-C-N 120.187 -1.57 . . . . 0.0 109.888 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -75.75 -49.17 18.97 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.797 -1.19 . . . . 0.0 108.304 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.27 78.62 6.49 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.82 -55.05 0.06 Allowed 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.889 1.368 . . . . 0.0 108.051 163.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -79.42 103.54 9.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 119.406 -2.058 . . . . 0.0 110.303 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.38 -49.59 0.26 Allowed Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 105.181 -3.168 . . . . 0.0 105.181 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' D' ' 66' ' ' GLU . . . -78.0 161.69 70.05 Favored Pre-proline 0 CA--C 1.504 -0.807 0 C-N-CA 123.446 0.698 . . . . 0.0 112.759 -171.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -78.65 113.78 3.36 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.589 2.193 . . . . 0.0 110.766 172.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.33 2.25 13.55 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.129 -0.817 . . . . 0.0 111.202 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.03 145.09 21.42 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.858 1.263 . . . . 0.0 113.172 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.16 -48.56 1.33 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.626 1.171 . . . . 0.0 111.128 -167.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.78 133.81 34.51 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 pt -148.11 17.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.11 138.65 33.66 Favored 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 120.484 -1.385 . . . . 0.0 108.228 -170.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.58 -49.39 8.57 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.982 -1.961 . . . . 0.0 111.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.27 -8.04 21.35 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 CA-C-N 125.865 3.13 . . . . 0.0 111.101 -173.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -98.82 -25.63 14.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.09 80.5 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.532 1.133 . . . . 0.0 111.086 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.37 -35.53 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 121.977 -0.452 . . . . 0.0 110.445 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -28.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.487 -1.383 . . . . 0.0 110.429 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -63.79 -42.93 97.63 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.417 1.103 . . . . 0.0 108.457 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -58.33 -37.47 75.21 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.307 1.443 . . . . 0.0 111.388 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.53 -49.77 71.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 124.328 1.051 . . . . 0.0 110.591 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -75.36 -23.85 57.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.849 0.833 . . . . 0.0 110.863 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 64.3 m -70.31 -39.33 74.87 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.72 67.12 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.098 -1.001 . . . . 0.0 111.942 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -88.65 5.82 41.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 119.149 -0.453 . . . . 0.0 110.077 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 51.48 29.7 5.6 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 127.614 2.366 . . . . 0.0 112.437 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.07 -47.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.31 51.48 58.54 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -71.11 -33.23 69.94 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.978 0.894 . . . . 0.0 109.361 -166.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 155.68 -123.47 1.34 Allowed Glycine 0 CA--C 1.476 -2.36 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 75.13 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.345 1.458 . . . . 0.0 108.016 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -145.37 171.58 14.41 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.478 ' HB2' HH12 ' D' ' 68' ' ' ARG . 11.7 p90 -164.36 148.21 7.97 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -91.67 155.06 3.5 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 C-N-CA 122.468 2.112 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -155.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.937 0.875 . . . . 0.0 110.424 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -53.84 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.382 -1.449 . . . . 0.0 112.26 -164.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -79.86 -7.78 58.91 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.784 1.233 . . . . 0.0 109.621 -165.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' D' ' 33' ' ' ALA . 40.2 mm-40 -95.98 41.26 1.11 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 15.16 81.56 0.01 OUTLIER Glycine 0 CA--C 1.462 -3.253 1 C-N-CA 133.139 5.162 . . . . 0.0 110.434 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.478 HH12 ' HB2' ' D' ' 61' ' ' TYR . 20.7 ttt85 -53.37 -13.8 0.63 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.599 1.96 . . . . 0.0 113.457 -164.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.05 -6.01 0.32 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 160.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.12 -49.15 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 O-C-N 120.274 -1.517 . . . . 0.0 107.713 167.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.23 82.06 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -48.67 -46.28 40.06 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.604 1.161 . . . . 0.0 113.324 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.27 -37.43 83.44 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.107 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.34 -44.97 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 58.2 mtm -63.05 -48.34 79.13 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.21 1.004 . . . . 0.0 110.62 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.39 -38.27 88.98 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.531 -0.731 . . . . 0.0 110.505 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.698 -0.626 . . . . 0.0 111.911 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.17 -46.98 66.97 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.74 -44.89 94.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 C-N-CA 124.559 1.144 . . . . 0.0 109.663 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.78 -47.56 84.3 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 111.388 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.16 -49.99 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 124.284 1.034 . . . . 0.0 109.768 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -71.75 -16.23 62.2 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.903 -0.498 . . . . 0.0 111.482 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.27 -35.55 16.08 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.256 -0.903 . . . . 0.0 109.859 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.52 -31.48 72.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.584 1.554 . . . . 0.0 110.927 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.08 -3.02 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.696 0 O-C-N 121.326 -0.858 . . . . 0.0 112.609 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 88.0 m -58.35 -22.85 54.91 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.476 1.51 . . . . 0.0 111.571 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.88 66.33 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.198 -1.564 . . . . 0.0 111.935 172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.69 -49.06 6.68 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.09 -39.9 91.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.726 -1.234 . . . . 0.0 113.657 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.85 61.81 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.945 -1.097 . . . . 0.0 110.892 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 80.8 p -85.31 -14.47 46.43 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.568 -1.333 . . . . 0.0 110.566 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.39 -16.2 61.34 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.14 -1.6 . . . . 0.0 111.067 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -80.31 -31.36 38.15 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.651 -1.281 . . . . 0.0 111.874 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.19 -11.74 14.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 CA-C-O 121.562 0.696 . . . . 0.0 110.168 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -61.41 -17.26 53.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.788 0.835 . . . . 0.0 110.848 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.58 -22.21 63.46 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.586 1.085 . . . . 0.0 112.021 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.66 -47.84 51.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.682 0.793 . . . . 0.0 109.474 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.14 -35.98 30.84 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.465 -0.772 . . . . 0.0 109.54 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.1 -4.72 37.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.282 -0.886 . . . . 0.0 112.057 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -67.82 -40.71 83.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.269 -0.894 . . . . 0.0 109.523 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -91.94 -14.7 29.11 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.514 -0.741 . . . . 0.0 109.19 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.24 62.56 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 2.6 m80 . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 179.032 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.76 -161.57 0.23 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.51 2.324 . . . . 0.0 110.558 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -136.42 129.47 31.24 Favored 'General case' 0 CA--C 1.477 -1.857 1 N-CA-C 96.573 -5.343 . . . . 0.0 96.573 153.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.299 7.0 p-80 144.07 -60.88 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 128.5 2.72 . . . . 0.0 107.251 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -76.34 -28.15 56.75 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 120.745 -1.222 . . . . 0.0 110.803 -171.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -64.02 -37.54 87.79 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.06 -1.025 . . . . 0.0 111.167 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -73.48 -34.21 65.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.085 1.354 . . . . 0.0 108.27 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.96 90.34 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.953 1.301 . . . . 0.0 110.587 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -61.8 -42.16 98.66 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 110.082 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -64.03 -34.3 77.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.911 0.862 . . . . 0.0 110.947 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.48 70.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.003 -1.061 . . . . 0.0 110.987 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.02 -32.8 74.7 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.191 -0.943 . . . . 0.0 111.038 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.89 -34.81 74.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.744 -1.223 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.54 -36.54 82.93 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.46 -48.77 76.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.594 1.158 . . . . 0.0 110.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -71.49 -27.07 62.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.733 -1.229 . . . . 0.0 112.283 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -67.09 -44.34 80.26 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.211 1.404 . . . . 0.0 109.805 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 77' ' ' ALA . 21.9 m -72.48 -29.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.946 -1.096 . . . . 0.0 110.249 -177.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.0 mt -61.75 -38.87 89.57 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 123.799 0.839 . . . . 0.0 111.168 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.93 -31.55 63.11 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.197 0.999 . . . . 0.0 110.826 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -77.88 -39.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.03 78.79 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.274 1.029 . . . . 0.0 111.715 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -65.83 -32.69 74.36 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.862 -0.524 . . . . 0.0 110.587 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -62.55 -47.43 83.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.395 0.678 . . . . 0.0 109.576 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -64.96 -38.04 89.66 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 110.115 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.23 75.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.149 0.98 . . . . 0.0 112.555 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.8 t -72.71 -43.19 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 121.089 -1.007 . . . . 0.0 109.175 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.0 -37.87 81.98 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.65 -1.282 . . . . 0.0 110.104 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 64.74 6.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.919 1.688 . . . . 0.0 108.219 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -164.74 -53.86 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.91 89.53 0.01 OUTLIER 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.119 1.768 . . . . 0.0 112.269 -170.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.58 10.12 25.74 Favored Glycine 0 CA--C 1.498 -0.995 0 O-C-N 121.035 -1.041 . . . . 0.0 111.792 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.71 133.46 25.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.722 1.261 . . . . 0.0 107.945 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.39 130.0 8.83 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.696 2.264 . . . . 0.0 110.645 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.76 74.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 160.38 16.39 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.9 9.17 Favored 'General case' 0 N--CA 1.427 -1.595 1 N-CA-C 99.04 -4.43 . . . . 0.0 99.04 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' CE3' ' A' ' 47' ' ' TRP . 1.9 tt 82.63 87.99 0.04 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 tt -138.57 142.83 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.71 138.73 0.06 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.324 1.849 . . . . 0.0 112.73 169.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -51.65 -53.48 50.01 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 126.033 1.733 . . . . 0.0 114.37 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.77 -6.94 18.83 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 CA-C-N 124.366 2.595 . . . . 0.0 112.316 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.48 -48.08 4.9 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.6 77.77 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 125.382 1.473 . . . . 0.0 112.441 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -66.42 -31.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.509 -0.744 . . . . 0.0 110.452 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -23.16 36.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.394 -0.816 . . . . 0.0 109.916 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CE3' HD11 ' A' ' 38' ' ' LEU . 72.5 t90 -72.37 -38.56 68.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -75.92 65.84 2.06 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.551 1.54 . . . . 0.0 108.318 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.69 -71.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.616 ' CD ' HH22 ' B' ' 68' ' ' ARG . 20.0 pt-20 -69.37 -24.4 63.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.869 0.842 . . . . 0.0 111.946 -165.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 51' ' ' THR . 2.5 t -66.93 -35.37 79.84 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 124.837 1.255 . . . . 0.0 107.988 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -76.84 -23.64 52.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 120.358 -1.464 . . . . 0.0 110.695 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -87.31 9.93 18.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.282 5.4 t 48.08 48.29 18.41 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 127.723 2.409 . . . . 0.0 112.569 172.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -110.99 -99.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 171.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 109.88 67.01 0.57 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 103.142 -3.983 . . . . 0.0 103.142 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -68.12 -30.55 69.73 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 122.134 0.969 . . . . 0.0 108.466 -174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.62 49.07 0.53 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.492 ' CG ' HH21 ' B' ' 68' ' ' ARG 0.479 4.6 p-10 -80.48 -28.96 37.41 Favored 'General case' 0 C--N 1.362 1.11 0 CA-C-N 119.063 1.431 . . . . 0.0 110.372 170.382 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -147.03 -179.84 7.1 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -146.05 137.54 12.97 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -84.49 -177.12 2.8 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 C-N-CA 124.422 3.415 . . . . 0.0 108.863 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' GLU 0.308 7.8 p -112.1 -128.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.657 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 -37.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.443 1.897 . . . . 0.0 107.183 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -84.22 -2.19 56.47 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.77 0.828 . . . . 0.0 109.78 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -73.86 -35.51 64.75 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.81 60.29 0.66 Allowed Glycine 0 CA--C 1.466 -3.017 1 N-CA-C 102.772 -4.131 . . . . 0.0 102.772 168.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -13.84 -30.75 0.0 OUTLIER 'General case' 0 C--N 1.364 1.214 1 C-N-CA 135.489 5.515 . . . . 0.0 117.738 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -53.36 -22.31 7.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 126.737 2.015 . . . . 0.0 112.626 163.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.3 -51.35 65.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.52 -1.363 . . . . 0.0 108.439 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.79 -45.09 68.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.376 0.67 . . . . 0.0 110.341 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.81 -37.09 75.6 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 110.841 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -58.18 -39.65 79.46 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 121.4 -0.812 . . . . 0.0 110.601 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.51 -36.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mmt -57.9 -57.49 12.58 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.397 1.079 . . . . 0.0 109.741 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.95 -28.06 67.98 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 121.345 -0.847 . . . . 0.0 111.057 -175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 18' ' ' VAL . . . -66.92 -22.74 65.94 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.588 -0.695 . . . . 0.0 110.883 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.93 -36.78 10.85 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.25 -42.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 125.359 1.464 . . . . 0.0 110.426 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.76 -37.27 84.29 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.438 -0.789 . . . . 0.0 110.91 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.36 -57.99 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 124.535 1.134 . . . . 0.0 109.979 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.01 -13.7 62.6 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.709 -0.619 . . . . 0.0 110.691 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.62 -46.97 16.23 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 121.112 -0.992 . . . . 0.0 110.091 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.47 -36.9 79.39 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.065 1.346 . . . . 0.0 111.64 -172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.0 m -62.71 -9.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.408 -0.807 . . . . 0.0 112.602 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -62.91 -18.58 63.22 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.121 1.369 . . . . 0.0 110.941 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.82 -24.28 66.78 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.682 -1.261 . . . . 0.0 111.636 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.47 -46.52 10.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 108.197 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.43 -41.55 98.79 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.17 0.988 . . . . 0.0 112.902 -171.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.04 -9.96 59.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.13 -0.981 . . . . 0.0 111.466 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.6 p -83.78 -16.18 45.64 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 120.768 -1.208 . . . . 0.0 110.323 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.73 -24.77 58.77 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.628 -163.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -74.65 -32.02 62.12 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.644 -1.285 . . . . 0.0 110.995 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 t -69.43 -32.87 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 125.399 1.48 . . . . 0.0 108.423 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -61.84 -11.63 13.64 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.398 1.479 . . . . 0.0 112.442 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -68.34 -22.34 64.69 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 120.001 -1.687 . . . . 0.0 110.595 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.33 -44.6 74.96 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -61.4 -52.36 64.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.913 1.685 . . . . 0.0 109.605 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.53 -41.66 92.85 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.851 -0.53 . . . . 0.0 110.068 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -66.26 -33.74 76.43 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.951 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -77.32 -27.67 52.94 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.4 28.4 52.66 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.4 m80 . . . . . 0 CA--C 1.492 -1.287 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 -175.514 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.434 -1.254 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.34 173.24 11.73 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.313 -0.867 . . . . 0.0 108.923 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -53.66 -53.08 57.06 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 123.537 1.637 . . . . 0.0 109.678 -171.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.25 -21.05 63.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.191 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -85.66 -39.11 17.63 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -70.84 -31.25 67.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.478 -0.764 . . . . 0.0 110.864 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.11 -47.64 79.24 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.0 70.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.294 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.14 -35.91 80.72 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.218 1.007 . . . . 0.0 110.208 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.25 -28.12 64.99 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -39.35 93.37 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.09 -47.79 76.0 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.404 -0.81 . . . . 0.0 110.548 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -52.88 -51.97 59.16 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.312 1.845 . . . . 0.0 110.222 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -76.03 -12.59 60.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.443 -0.786 . . . . 0.0 112.045 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.733 -1.229 . . . . 0.0 108.12 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.77 -14.05 60.66 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.54 -1.35 . . . . 0.0 111.193 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.93 -51.65 21.03 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.15 -23.75 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.859 -0.526 . . . . 0.0 111.393 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.14 -39.71 83.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.369 -0.832 . . . . 0.0 112.076 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.74 -24.34 38.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.293 0.568 . . . . 0.0 110.583 -174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.33 -42.15 46.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.82 82.15 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 126.309 1.844 . . . . 0.0 111.584 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -65.99 -44.97 83.29 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 122.111 -0.368 . . . . 0.0 110.324 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.11 -48.16 77.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.248 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -68.31 -25.55 65.19 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.098 -175.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -43.9 58.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 109.673 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 73.7 t -60.43 -45.72 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.241 -0.912 . . . . 0.0 110.127 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.59 17.96 15.2 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 121.638 -0.664 . . . . 0.0 111.099 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.507 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -75.69 -48.52 21.66 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 170.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' B' ' 36' ' ' ALA . 0.5 OUTLIER -56.66 -27.53 58.78 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 126.396 1.878 . . . . 0.0 115.082 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -73.77 75.88 1.58 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.61 0.764 . . . . 0.0 109.393 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.59 -43.23 0.77 Allowed Glycine 0 CA--C 1.488 -1.618 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.41 152.12 60.35 Favored Pre-proline 0 N--CA 1.445 -0.713 0 O-C-N 121.486 -1.008 . . . . 0.0 111.263 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.05 153.5 11.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.136 1.891 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.17 41.61 10.13 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' B' ' 30' ' ' GLU . . . -62.71 132.44 52.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 -42.06 0.17 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.358 0.263 . . . . 0.0 110.683 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -6.61 54.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.896 1.678 . . . . 0.0 110.739 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.14 84.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 O-C-N 120.634 -1.291 . . . . 0.0 111.929 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.1 112.05 0.74 Allowed 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -53.37 -47.7 95.26 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.404 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -71.47 -20.14 27.7 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-N 124.962 2.808 . . . . 0.0 113.011 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.73 0.63 17.47 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 119.941 1.246 . . . . 0.0 109.922 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.44 -34.72 76.46 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.189 -0.944 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.422 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.6 tt -70.99 -35.75 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.287 1.035 . . . . 0.0 109.614 175.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.63 -38.83 67.6 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.466 -1.396 . . . . 0.0 108.815 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -65.18 -44.86 87.11 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 123.356 0.662 . . . . 0.0 110.152 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -66.96 -29.43 69.28 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.953 -1.092 . . . . 0.0 110.851 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 23.3 t -58.35 -43.25 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.453 1.101 . . . . 0.0 111.117 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -82.45 -15.0 54.16 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.794 1.179 . . . . 0.0 112.298 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.48 -36.14 29.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.756 -1.215 . . . . 0.0 107.804 -174.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.37 -23.39 61.12 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.882 -1.136 . . . . 0.0 112.066 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.96 -6.28 59.0 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.188 0.995 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 14.6 p 55.7 54.48 8.22 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.863 1.665 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.89 -91.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 1 N-CA-C 100.031 -4.062 . . . . 0.0 100.031 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.52 76.72 1.34 Allowed Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.65 -18.23 51.93 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.49 -1.006 . . . . 0.0 108.605 -171.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.3 48.93 0.68 Allowed Glycine 0 CA--C 1.484 -1.877 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 168.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.61 -54.34 9.37 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -131.33 -136.62 0.2 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.191 0.596 . . . . 0.0 109.594 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -171.91 121.57 0.47 Allowed Pre-proline 0 N--CA 1.444 -0.726 1 N-CA-C 100.029 -4.063 . . . . 0.0 100.029 -168.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.85 158.15 13.82 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 124.59 2.675 . . . . 0.0 109.791 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.407 HG22 ' H ' ' B' ' 63' ' ' VAL . 2.9 m -76.11 169.92 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.635 1.207 . . . . 0.0 111.819 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -59.63 2.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.38 1.072 . . . . 0.0 110.793 -169.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.31 -17.26 64.7 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 -168.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -130.56 -108.05 0.27 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.507 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 25.94 -70.87 0.0 OUTLIER Glycine 0 CA--C 1.486 -1.758 1 C-N-CA 132.442 4.83 . . . . 0.0 116.204 170.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.616 HH22 ' CD ' ' A' ' 50' ' ' GLU . 52.7 ttm-85 -61.78 -42.92 99.61 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 126.083 1.753 . . . . 0.0 112.575 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -67.79 -34.5 76.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 120.251 1.387 . . . . 0.0 109.589 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.99 -47.75 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.2 90.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.876 1.671 . . . . 0.0 110.9 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -50.91 -46.1 60.55 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 127.648 2.379 . . . . 0.0 110.482 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -66.73 -37.46 84.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -74.51 -45.76 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.223 1.009 . . . . 0.0 109.372 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 71.7 mtm -61.06 -45.01 96.48 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.629 1.172 . . . . 0.0 109.759 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -64.8 -32.49 74.2 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.909 -0.495 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.512 -0.743 . . . . 0.0 110.329 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -40.59 97.02 Favored Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 124.186 0.898 . . . . 0.0 111.732 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.63 -51.0 77.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 C-N-CA 124.086 0.954 . . . . 0.0 108.456 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -65.41 -27.4 68.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.541 -0.724 . . . . 0.0 111.724 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.87 -58.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 124.391 1.076 . . . . 0.0 110.333 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -65.28 -25.41 67.63 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 121.539 0.685 . . . . 0.0 110.148 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.21 -41.97 32.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 121.367 -0.833 . . . . 0.0 111.268 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.16 -36.93 85.26 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.522 -1.361 . . . . 0.0 110.682 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.79 -3.45 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 O-C-N 121.563 -0.711 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 56.5 m -56.6 -22.77 36.17 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.992 1.317 . . . . 0.0 109.985 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.05 72.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.329 -1.482 . . . . 0.0 112.503 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.01 -35.42 61.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 120.954 -1.091 . . . . 0.0 109.191 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.5 -32.49 62.54 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 122.967 0.507 . . . . 0.0 110.67 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.844 -1.16 . . . . 0.0 111.115 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -11.21 60.62 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.066 -1.021 . . . . 0.0 113.22 174.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.7 -47.61 80.46 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 120.208 1.367 . . . . 0.0 109.839 -171.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -71.54 -27.16 62.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.941 -1.099 . . . . 0.0 111.736 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.01 -17.75 22.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.982 1.313 . . . . 0.0 109.455 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -70.37 -17.73 63.05 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.082 -1.636 . . . . 0.0 111.707 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -66.41 -13.48 60.77 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 120.496 -1.377 . . . . 0.0 110.478 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -58.1 -47.29 83.69 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 126.195 1.798 . . . . 0.0 109.876 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -60.75 -49.82 75.95 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.63 1.172 . . . . 0.0 109.565 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -0.64 57.69 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.816 -171.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 26.9 ttp-105 -79.98 -40.9 27.0 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.41 -34.37 58.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.712 0.767 . . . . 0.0 109.117 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.28 13.82 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 . . . . . 0 CA--C 1.508 -0.642 0 C-N-CA 127.544 2.338 . . . . 0.0 115.572 -174.426 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.53 172.55 18.34 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -48.75 80.25 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 124.765 1.226 . . . . 0.0 109.826 -172.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.407 ' CD2' ' HG3' ' C' ' 5' ' ' GLU . 40.5 p-80 -65.82 -30.33 70.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.803 -0.561 . . . . 0.0 112.004 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.407 ' HG3' ' CD2' ' C' ' 4' ' ' HIS . 7.2 mt-10 -77.36 -40.72 42.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.04 -44.46 96.66 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.521 -0.737 . . . . 0.0 109.986 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -33.98 75.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.025 0.441 . . . . 0.0 110.685 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.73 90.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.669 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -68.64 -34.39 75.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 121.674 -0.641 . . . . 0.0 110.62 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -66.56 -35.39 80.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.219 1.408 . . . . 0.0 110.73 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.42 87.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.351 -0.843 . . . . 0.0 111.069 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -63.76 -33.89 76.67 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.978 0.894 . . . . 0.0 111.5 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -68.33 -30.84 69.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.103 1.361 . . . . 0.0 110.518 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -69.22 -37.01 77.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.777 -1.202 . . . . 0.0 108.987 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.5 -44.43 97.09 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.222 1.009 . . . . 0.0 110.838 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.61 -39.6 70.99 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.254 1.021 . . . . 0.0 112.376 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.2 71.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.274 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.61 -40.66 88.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.73 -42.68 84.36 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.319 1.048 . . . . 0.0 111.095 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.7 -39.96 94.54 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -88.31 -12.54 43.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.949 -1.094 . . . . 0.0 109.983 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.51 -37.51 42.91 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.783 -1.198 . . . . 0.0 109.286 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -37.65 84.97 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.232 0.613 . . . . 0.0 110.311 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -44.26 81.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.285 1.434 . . . . 0.0 109.218 172.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -69.14 -48.77 61.48 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.652 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.98 80.91 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.302 1.041 . . . . 0.0 112.924 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.27 -23.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 O-C-N 121.294 -0.879 . . . . 0.0 110.839 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.85 -4.26 47.36 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 119.854 -1.779 . . . . 0.0 109.016 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.63 -48.62 12.39 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -173.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.85 -110.67 0.13 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . 0.305 11.5 mtm-85 43.23 71.57 0.23 Allowed 'General case' 0 C--N 1.358 0.945 0 C-N-CA 126.32 1.848 . . . . 0.0 112.942 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.14 36.97 2.05 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.83 153.7 42.22 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.19 121.34 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.996 2.464 . . . . 0.0 110.041 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.19 25.78 39.03 Favored Glycine 0 CA--C 1.496 -1.107 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.69 151.65 46.4 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.116 1.366 . . . . 0.0 109.575 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.25 -34.9 0.52 Allowed 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.255 0.622 . . . . 0.0 109.759 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.4 tp -94.75 55.06 1.84 Allowed 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.87 19.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 124.646 1.178 . . . . 0.0 110.28 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.5 t -129.42 125.61 36.91 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.14 -53.05 20.47 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-O 115.85 -2.024 . . . . 0.0 112.109 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.54 -16.2 34.27 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 CA-C-N 126.252 3.269 . . . . 0.0 111.109 -173.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.01 -20.62 44.96 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.8 79.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.159 -0.963 . . . . 0.0 111.63 -167.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.06 -21.86 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.628 0.728 . . . . 0.0 110.632 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -25.34 21.91 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.875 0.87 . . . . 0.0 109.147 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -67.48 -46.67 72.28 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 170.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -77.37 64.25 2.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.734 -0.604 . . . . 0.0 110.037 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 66.2 t -136.1 -71.07 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.38 -15.1 62.36 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-O 121.95 0.881 . . . . 0.0 112.598 -164.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.409 ' H ' HG22 ' C' ' 51' ' ' THR . 2.7 t -73.03 -32.37 65.06 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 124.719 1.207 . . . . 0.0 109.102 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.39 58.71 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 121.08 -1.012 . . . . 0.0 110.55 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -92.23 7.46 42.56 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.05 0.54 . . . . 0.0 110.128 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 51.2 p 49.68 42.33 23.21 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.482 1.913 . . . . 0.0 113.772 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.64 -56.24 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.77 3.06 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' D' ' 56' ' ' GLY . 1.8 t80 -71.23 -45.85 62.38 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -172.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.68 52.25 0.23 Allowed Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.66 -36.42 73.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.863 -0.786 . . . . 0.0 111.493 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -126.79 -163.71 1.27 Allowed 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -148.43 112.2 3.73 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 168.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.57 -173.61 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.769 2.979 . . . . 0.0 108.779 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.268 7.4 p -128.39 -128.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -121.35 -37.16 2.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.279 1.432 . . . . 0.0 108.035 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.71 -12.2 58.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.869 1.268 . . . . 0.0 110.371 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -32.94 68.23 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.09 64.83 0.84 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 102.348 -4.301 . . . . 0.0 102.348 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -14.21 -38.6 0.0 OUTLIER 'General case' 0 C--N 1.366 1.284 1 C-N-CA 132.491 4.316 . . . . 0.0 116.434 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.49 -26.88 0.24 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.637 1.575 . . . . 0.0 113.791 165.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.46 -42.78 92.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.409 -1.432 . . . . 0.0 110.833 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.2 31.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -60.27 -31.19 69.99 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 123.681 0.792 . . . . 0.0 113.026 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -69.23 -32.45 71.7 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.407 -1.433 . . . . 0.0 110.545 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.92 62.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -57.2 -52.29 65.9 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.706 1.202 . . . . 0.0 110.381 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.83 -42.84 99.52 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 122.015 -0.428 . . . . 0.0 110.88 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.01 -33.92 75.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.688 0.395 . . . . 0.0 111.549 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -45.49 86.41 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 123.837 0.732 . . . . 0.0 111.329 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.34 -45.82 93.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.35 1.06 . . . . 0.0 109.352 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.94 -38.46 85.93 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.519 -0.738 . . . . 0.0 112.31 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.15 -53.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 109.198 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -66.73 -38.91 87.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.919 -0.488 . . . . 0.0 111.041 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.36 73.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 110.997 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.04 -30.93 71.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.314 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.88 -18.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 124.911 1.284 . . . . 0.0 110.775 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -56.53 -20.64 21.53 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 112.424 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.04 72.06 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.136 -1.602 . . . . 0.0 111.898 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -80.08 -50.66 10.03 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.732 -1.23 . . . . 0.0 108.233 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 44.1 mt -59.63 -39.28 83.8 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.802 1.241 . . . . 0.0 112.27 -173.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.13 60.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.039 -1.038 . . . . 0.0 111.396 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 27.0 m -85.65 -18.01 34.45 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.7 -25.03 61.09 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.126 -1.609 . . . . 0.0 111.643 -164.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -77.55 -20.65 53.79 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.669 -1.27 . . . . 0.0 111.176 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.27 -24.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -172.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.03 -36.56 60.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.03 1.332 . . . . 0.0 111.846 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -54.84 -40.22 69.4 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 125.057 1.343 . . . . 0.0 110.955 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.83 -33.07 74.81 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.793 0.837 . . . . 0.0 110.206 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -79.79 -37.73 34.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.65 -20.98 60.42 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.147 -0.971 . . . . 0.0 112.451 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -67.5 -38.77 84.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.463 1.505 . . . . 0.0 110.131 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -80.91 -26.27 36.9 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.733 -0.604 . . . . 0.0 110.261 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.63 70.38 Favored Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 79.6 m80 . . . . . 0 CA--C 1.494 -1.2 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -175.073 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.17 175.21 8.17 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.74 -66.63 0.31 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 130.042 3.337 . . . . 0.0 112.017 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 46.8 p-80 -65.05 -27.62 68.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.333 1.853 . . . . 0.0 112.763 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.76 -31.41 61.77 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.237 -0.914 . . . . 0.0 108.928 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.93 -41.15 91.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.995 0.918 . . . . 0.0 109.282 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.79 -41.87 95.48 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.81 1.244 . . . . 0.0 109.159 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.68 98.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.059 0.944 . . . . 0.0 111.48 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -70.54 -29.81 66.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.556 -0.715 . . . . 0.0 111.832 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -63.95 -34.24 77.52 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.129 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.41 94.05 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.634 0.774 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.67 -36.25 83.22 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -71.12 -24.86 62.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.053 -1.03 . . . . 0.0 111.325 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.2 -35.02 73.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.982 0.913 . . . . 0.0 109.185 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 tp -64.66 -40.51 95.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.365 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -60.21 -28.36 67.93 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.023 0.929 . . . . 0.0 112.334 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -70.25 -42.98 71.49 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.35 -29.81 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 123.992 0.917 . . . . 0.0 109.745 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.44 -44.04 97.37 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.283 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -77.54 -31.58 53.41 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.111 1.364 . . . . 0.0 110.988 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -65.14 -53.68 41.38 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.915 1.34 . . . . 0.0 108.962 171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.49 -24.5 60.19 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 124.642 1.177 . . . . 0.0 111.524 -167.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 12.0 p -64.43 -46.33 83.66 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.254 1.026 . . . . 0.0 109.247 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.77 -46.36 88.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.343 1.857 . . . . 0.0 108.586 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.32 -47.9 77.66 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.326 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.63 84.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.411 1.084 . . . . 0.0 110.763 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.978 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.77 -34.35 34.3 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.5 91.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.75 1.62 . . . . 0.0 109.364 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 2.2 tp10 -68.22 -26.54 65.76 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.358 1.063 . . . . 0.0 111.889 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -74.12 112.62 10.44 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.64 -1.913 . . . . 0.0 107.836 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.5 -22.97 8.63 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.98 64.73 Favored Pre-proline 0 N--CA 1.443 -0.806 0 O-C-N 121.735 -0.862 . . . . 0.0 110.927 -176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -84.09 128.02 4.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.104 2.536 . . . . 0.0 111.864 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.78 46.88 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' D' ' 30' ' ' GLU . . . -55.43 135.0 50.75 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 127.668 2.387 . . . . 0.0 112.388 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.22 -31.17 1.13 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 123.795 0.838 . . . . 0.0 109.846 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.08 49.83 1.87 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 107.737 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.87 -164.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER 80.88 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 116.51 -1.71 . . . . 0.0 106.966 178.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -157.54 -62.8 0.02 OUTLIER Pre-proline 0 C--N 1.35 0.624 0 CA-C-O 116.135 -1.888 . . . . 0.0 109.037 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.48 -14.37 25.04 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 CA-C-N 125.709 3.075 . . . . 0.0 111.084 -169.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -34.18 29.53 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.284 2.634 . . . . 0.0 107.867 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.85 69.49 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.129 0.972 . . . . 0.0 111.62 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 tt -70.6 -33.01 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.341 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -19.29 59.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.316 -1.49 . . . . 0.0 109.984 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -70.03 -53.71 16.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 p -65.1 -19.11 65.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.08 -44.53 99.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 124.097 0.959 . . . . 0.0 111.159 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.2 -32.35 49.94 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.602 1.092 . . . . 0.0 108.494 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -81.36 63.36 5.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.903 0.881 . . . . 0.0 111.055 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.71 -52.14 0.07 Allowed 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 20.8 p -95.53 46.18 1.1 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.954 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 11.9 p 42.86 65.94 0.86 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.919 1.688 . . . . 0.0 113.641 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.01 -108.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' C' ' 57' ' ' TYR . . . 98.15 48.36 1.9 Allowed Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 105.813 -2.915 . . . . 0.0 105.813 -174.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -11.98 59.88 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.913 -0.757 . . . . 0.0 111.327 -166.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.16 40.55 3.98 Favored Glycine 0 CA--C 1.495 -1.207 0 O-C-N 120.288 -1.507 . . . . 0.0 110.001 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.0 -56.73 6.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.856 1.263 . . . . 0.0 108.773 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -144.34 167.76 21.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.32 122.91 18.37 Favored Pre-proline 0 CA--C 1.499 -0.985 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.05 169.96 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.374 2.049 . . . . 0.0 108.716 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.99 -106.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-N 119.07 0.85 . . . . 0.0 112.864 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -155.79 -39.46 0.08 Allowed 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -170.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -77.54 -11.7 59.88 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.622 1.969 . . . . 0.0 109.894 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.17 60.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.26 90.5 1.81 Allowed Glycine 0 N--CA 1.418 -2.524 1 N-CA-C 98.029 -6.028 . . . . 0.0 98.029 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -56.49 -18.86 12.87 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 119.664 1.732 . . . . 0.0 110.694 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -49.95 -21.82 1.33 Allowed 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.574 1.55 . . . . 0.0 114.384 165.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.06 -46.22 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 O-C-N 120.562 -1.336 . . . . 0.0 108.809 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -43.06 93.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.249 0.62 . . . . 0.0 109.476 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.51 -44.33 69.01 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.444 1.498 . . . . 0.0 111.102 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -57.85 -47.73 81.83 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.352 1.061 . . . . 0.0 111.362 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -45.14 85.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-O 121.535 0.683 . . . . 0.0 109.531 -172.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.46 -43.49 85.38 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.129 0.572 . . . . 0.0 110.807 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.64 -34.67 78.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 121.504 -0.748 . . . . 0.0 110.28 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.65 88.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.797 -0.564 . . . . 0.0 110.684 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.33 96.16 Favored Glycine 0 CA--C 1.495 -1.17 0 C-N-CA 124.058 0.837 . . . . 0.0 112.053 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.48 -46.91 92.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 124.413 1.085 . . . . 0.0 109.69 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.22 -36.96 85.79 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.204 -0.935 . . . . 0.0 112.23 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.47 -51.15 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.908 0.883 . . . . 0.0 109.822 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.48 -4.8 50.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.515 -0.741 . . . . 0.0 111.444 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.17 -40.55 12.15 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.353 -0.842 . . . . 0.0 108.991 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -57.05 -39.93 75.83 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 126.495 1.918 . . . . 0.0 111.082 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.9 m -62.95 -6.82 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.28 1.032 . . . . 0.0 112.92 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.2 m -62.17 -17.72 58.84 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.617 -1.302 . . . . 0.0 110.641 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.9 69.62 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.305 -1.497 . . . . 0.0 111.846 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -82.16 -45.82 14.63 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.046 -1.034 . . . . 0.0 108.519 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -62.79 -34.05 76.46 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.804 0.812 . . . . 0.0 111.915 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.44 66.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.977 -1.077 . . . . 0.0 111.941 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.5 t -92.45 0.48 57.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.062 -1.024 . . . . 0.0 108.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.69 -34.52 62.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.69 0.757 . . . . 0.0 109.157 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -73.65 -34.87 65.15 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.786 -1.197 . . . . 0.0 110.764 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.66 -25.85 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 125.582 1.553 . . . . 0.0 109.376 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -47.73 -38.58 15.63 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 125.876 1.67 . . . . 0.0 111.357 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -61.18 -14.05 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -58.35 -37.05 74.4 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.398 -0.814 . . . . 0.0 109.885 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -67.98 -53.0 29.38 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.922 1.289 . . . . 0.0 108.966 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -64.89 -33.01 74.99 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 123.954 0.902 . . . . 0.0 112.355 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -69.08 -41.44 77.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.76 -1.213 . . . . 0.0 110.123 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -73.65 -37.84 65.19 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.49 -0.757 . . . . 0.0 109.589 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.6 12.65 50.15 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 CA--C 1.491 -1.296 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 177.182 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 -56.67 3.62 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.135 -175.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 4' ' ' HIS 0.279 33.9 t70 -176.74 -116.79 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -137.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.582 ' CD2' HG21 ' A' ' 91' ' ' THR . 30.9 p80 -44.38 -35.36 2.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 130.611 3.564 . . . . 0.0 114.919 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.81 -31.35 72.5 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.679 0.792 . . . . 0.0 111.624 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -71.44 -32.06 67.9 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -78.46 -34.86 47.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.7 79.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.012 0.925 . . . . 0.0 110.487 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -66.0 -35.73 81.37 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 123.992 0.917 . . . . 0.0 111.378 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -62.83 -41.34 99.28 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.313 -0.867 . . . . 0.0 109.818 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.12 71.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.458 0.703 . . . . 0.0 111.579 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -62.94 -30.54 71.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.524 -0.735 . . . . 0.0 111.319 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.43 -33.69 67.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.62 -42.86 97.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 110.254 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.68 -42.15 95.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 123.094 0.558 . . . . 0.0 111.03 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.85 -37.63 79.8 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -67.04 -33.87 76.47 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 121.558 -0.714 . . . . 0.0 111.322 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.35 -30.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.265 -0.897 . . . . 0.0 109.048 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.52 -37.52 81.42 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.948 -1.095 . . . . 0.0 111.72 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.02 -44.56 72.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.643 1.177 . . . . 0.0 110.327 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.43 -39.4 92.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 121.322 -0.861 . . . . 0.0 109.567 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.58 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.792 1.237 . . . . 0.0 111.337 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 p -66.65 -43.12 85.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.689 0.677 . . . . 0.0 109.818 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.39 -54.9 37.67 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.062 0.945 . . . . 0.0 110.548 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -71.62 -31.34 66.77 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.865 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.99 71.84 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 119.142 0.883 . . . . 0.0 110.194 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 41' ' ' TYR . 74.2 t -64.68 -38.72 83.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-O 121.856 0.836 . . . . 0.0 110.035 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.03 -33.97 72.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.474 -0.766 . . . . 0.0 110.286 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.9 84.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.433 1.111 . . . . 0.0 111.794 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -36.7 85.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 126.809 2.043 . . . . 0.0 111.207 176.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.72 77.87 9.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.508 1.147 . . . . 0.0 109.493 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.28 -35.55 0.71 Allowed Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 106.239 -2.744 . . . . 0.0 106.239 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.36 156.67 62.62 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 122.305 -0.527 . . . . 0.0 110.221 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.15 152.19 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.053 1.835 . . . . 0.0 110.033 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.32 56.59 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.24 26.38 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.046 1.338 . . . . 0.0 114.145 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -58.27 0.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.599 1.159 . . . . 0.0 111.944 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.8 tp -82.2 76.1 9.1 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.892 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.02 75.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 O-C-N 120.484 -1.385 . . . . 0.0 108.439 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -158.03 120.41 3.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 t80 -59.07 -54.01 60.66 Favored Pre-proline 0 C--N 1.352 0.716 0 CA-C-O 116.355 -1.784 . . . . 0.0 112.518 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.47 -3.91 14.6 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 CA-C-N 125.277 2.92 . . . . 0.0 112.044 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -105.4 -33.12 8.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.47 -24.41 61.99 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 120.459 -1.401 . . . . 0.0 112.081 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.68 -23.7 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.771 0.796 . . . . 0.0 110.005 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -39.91 51.34 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.542 -1.349 . . . . 0.0 108.173 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.2 t90 -64.94 -46.83 79.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 123.81 0.844 . . . . 0.0 108.851 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -64.32 -27.1 68.8 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.71 -54.12 37.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 C-N-CA 123.794 0.838 . . . . 0.0 109.011 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.59 -27.24 62.05 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.675 -0.641 . . . . 0.0 111.177 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -62.22 -40.42 96.06 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.962 0.905 . . . . 0.0 110.769 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.52 74.05 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 121.427 -0.796 . . . . 0.0 111.815 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.53 1.05 39.74 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.937 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p 56.54 21.44 5.69 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.335 1.854 . . . . 0.0 112.474 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.35 -58.72 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.7 72.51 0.63 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.74 -22.19 62.44 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.136 0.97 . . . . 0.0 109.962 -166.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.23 26.06 3.88 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' B' ' 68' ' ' ARG . 19.0 t70 -65.5 -53.74 38.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.966 1.306 . . . . 0.0 110.335 177.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.43 164.73 28.6 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.82 137.19 30.24 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.53 169.17 12.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.621 2.214 . . . . 0.0 110.41 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -71.13 176.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.759 1.266 . . . . 0.0 111.743 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 m -96.96 -51.24 4.32 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.711 1.205 . . . . 0.0 109.959 -172.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.57 -42.9 89.02 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 111.237 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -130.85 -137.1 0.21 Allowed 'General case' 0 CA--C 1.492 -1.27 1 N-CA-C 100.184 -4.006 . . . . 0.0 100.184 165.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.46 -77.98 1.18 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -63.08 -40.81 98.75 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.585 1.954 . . . . 0.0 110.492 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -75.17 -19.26 59.93 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.734 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.01 -50.12 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.6 74.0 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.745 1.618 . . . . 0.0 111.588 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -42.13 -51.96 4.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 127.654 2.382 . . . . 0.0 112.32 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.62 -35.28 75.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.299 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.04 -46.35 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.454 1.102 . . . . 0.0 109.126 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.69 -45.38 94.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.001 1.321 . . . . 0.0 109.717 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -59.73 -37.69 79.65 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.545 0.738 . . . . 0.0 111.947 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.67 89.38 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.587 -0.696 . . . . 0.0 110.543 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.3 -46.85 85.15 Favored Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.8 -47.45 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 109.188 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.9 -42.75 99.89 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.127 -0.983 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.9 t -63.6 -52.13 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.264 0.938 . . . . 0.0 110.142 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.92 -28.94 67.92 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.063 0.545 . . . . 0.0 111.077 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.13 -34.32 32.58 Favored 'General case' 0 CA--C 1.505 -0.75 0 O-C-N 120.932 -1.105 . . . . 0.0 110.606 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.45 -32.68 74.19 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.39 -1.444 . . . . 0.0 110.865 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -65.6 -5.15 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 121.56 -0.713 . . . . 0.0 112.41 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -55.35 -20.88 13.0 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.596 1.559 . . . . 0.0 111.566 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.56 -21.07 65.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 120.422 -1.424 . . . . 0.0 113.046 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.27 -39.16 14.63 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 124.821 1.248 . . . . 0.0 108.727 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.58 -45.53 91.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.883 1.273 . . . . 0.0 110.013 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.33 60.21 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER -79.91 -15.98 56.23 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 119.781 -1.825 . . . . 0.0 107.653 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.413 55.1 m-20 -98.55 14.67 27.53 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.606 -160.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -89.62 -30.86 17.85 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 153.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.65 -24.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.402 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -56.19 -23.79 37.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.597 1.159 . . . . 0.0 111.99 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -64.52 -19.7 65.76 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.182 -1.574 . . . . 0.0 112.061 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -71.43 -25.14 62.2 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.226 -0.921 . . . . 0.0 110.322 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.41 -42.87 34.6 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -61.01 -31.03 70.65 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.17 0.988 . . . . 0.0 111.355 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -66.74 -25.92 66.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.587 -0.696 . . . . 0.0 111.42 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -82.2 -36.82 26.9 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.29 19.24 46.58 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 . . . . . 0 CA--C 1.501 -0.94 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.682 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.32 -177.45 4.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.714 -1.241 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -62.5 1.82 Allowed 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.713 2.005 . . . . 0.0 108.363 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -60.2 -31.75 70.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.819 2.048 . . . . 0.0 113.735 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.66 -35.64 62.82 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.047 -1.033 . . . . 0.0 110.959 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -73.95 -36.52 64.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.794 -0.566 . . . . 0.0 110.491 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.82 -37.8 82.42 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.96 90.35 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.908 0.883 . . . . 0.0 111.112 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.13 -35.2 78.02 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.099 0.96 . . . . 0.0 110.913 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -65.13 -38.22 89.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.283 1.033 . . . . 0.0 110.545 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.18 80.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.429 1.092 . . . . 0.0 110.782 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.51 -36.26 83.63 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.474 -0.766 . . . . 0.0 111.042 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -75.61 -25.13 56.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.023 -1.048 . . . . 0.0 111.354 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.58 -38.33 83.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.57 -46.18 89.66 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.423 0.689 . . . . 0.0 110.886 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -57.23 -41.02 78.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.339 1.456 . . . . 0.0 111.367 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -66.38 -37.37 85.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.356 1.063 . . . . 0.0 110.761 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.25 -38.34 81.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 O-C-N 120.938 -1.101 . . . . 0.0 108.643 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.47 -44.09 89.16 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 123.736 0.815 . . . . 0.0 110.526 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.68 -48.7 74.63 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 110.592 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -75.57 -36.79 60.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.783 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.16 -29.05 69.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.357 1.063 . . . . 0.0 111.87 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -62.24 -42.3 99.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.758 1.223 . . . . 0.0 110.443 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -67.77 -48.11 67.28 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 125.363 1.465 . . . . 0.0 107.37 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -58.07 -47.48 83.04 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 124.626 1.17 . . . . 0.0 111.299 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.87 78.81 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.979 0.912 . . . . 0.0 111.366 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.95 -44.17 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 -29.26 65.05 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 119.817 1.189 . . . . 0.0 110.947 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.8 -42.67 60.63 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 125.092 1.357 . . . . 0.0 109.611 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -74.98 -21.0 59.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.618 0.723 . . . . 0.0 111.022 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -74.67 89.47 2.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 120.276 -1.515 . . . . 0.0 110.636 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.78 -4.01 11.78 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.92 150.95 56.83 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 118.065 0.933 . . . . 0.0 109.082 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -82.26 132.58 7.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.937 2.425 . . . . 0.0 110.723 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 5.19 88.07 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.47 146.02 55.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 123.671 0.789 . . . . 0.0 111.497 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.43 -47.48 4.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 124.906 1.282 . . . . 0.0 108.078 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -90.47 66.07 6.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 122.807 1.289 . . . . 0.0 108.836 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -101.03 26.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 O-C-N 120.344 -1.472 . . . . 0.0 108.485 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 11.6 p -91.05 -114.86 0.08 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 t80 162.2 -70.99 0.0 OUTLIER Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 126.757 2.023 . . . . 0.0 106.296 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.92 -12.03 19.8 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-N 125.112 2.862 . . . . 0.0 111.868 -163.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.0 6.31 36.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.296 1.038 . . . . 0.0 109.059 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.96 74.68 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.368 -0.832 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.63 -30.35 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.075 0.95 . . . . 0.0 111.574 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -85.61 -18.47 33.18 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.343 -0.848 . . . . 0.0 109.962 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -80.72 -41.05 24.24 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.88 60.53 0.96 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 111.452 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.43 -64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.86 -19.06 64.99 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -167.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -72.62 -30.76 64.6 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.123 0.969 . . . . 0.0 108.947 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.59 62.17 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.502 -1.374 . . . . 0.0 110.381 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -93.52 14.84 17.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.685 0.794 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 67.5 p 55.4 51.72 12.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.751 1.62 . . . . 0.0 113.728 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.87 -145.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.047 1 N-CA-C 99.473 -4.269 . . . . 0.0 99.473 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.9 90.31 0.13 Allowed Glycine 0 CA--C 1.481 -2.047 1 N-CA-C 99.058 -5.617 . . . . 0.0 99.058 -171.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -81.58 -17.57 47.85 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.447 -1.031 . . . . 0.0 108.673 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.41 44.22 1.49 Allowed Glycine 0 CA--C 1.486 -1.764 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -72.28 -63.72 1.09 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -102.06 -169.24 1.65 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -155.35 100.9 2.25 Favored Pre-proline 0 N--CA 1.443 -0.805 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.81 153.34 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.698 2.265 . . . . 0.0 110.255 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.51 -124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -135.2 -11.14 2.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.036 -1.04 . . . . 0.0 109.046 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -112.54 2.67 16.37 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 125.64 1.576 . . . . 0.0 107.433 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.27 43.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.06 91.26 1.54 Allowed Glycine 0 N--CA 1.418 -2.564 1 N-CA-C 98.14 -5.984 . . . . 0.0 98.14 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.457 HH12 ' CG ' ' A' ' 59' ' ' ASP . 37.6 ttm180 -68.74 -3.98 14.21 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.073 1.937 . . . . 0.0 110.648 -174.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.168 1.787 . . . . 0.0 111.638 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -47.89 84.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 124.994 1.317 . . . . 0.0 109.4 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.41 77.44 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -55.18 -41.56 72.07 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.711 1.605 . . . . 0.0 111.114 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -65.38 -35.39 80.83 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.428 -0.795 . . . . 0.0 111.578 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.17 -41.78 44.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 9.2 tpp -53.59 -54.94 30.29 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 126.249 1.819 . . . . 0.0 109.96 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -68.81 -36.11 77.82 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.162 0.985 . . . . 0.0 110.499 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.67 87.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.594 -0.691 . . . . 0.0 110.939 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.95 96.96 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 124.455 1.026 . . . . 0.0 111.322 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 72.3 mt -60.36 -42.95 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 109.114 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -73.09 -31.31 64.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.061 -1.025 . . . . 0.0 113.262 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.43 -43.44 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.256 -0.902 . . . . 0.0 109.702 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.81 -36.56 78.39 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 118.686 0.675 . . . . 0.0 110.073 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.46 92.39 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.896 0.878 . . . . 0.0 110.944 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.28 -31.97 73.38 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.579 -1.326 . . . . 0.0 111.651 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.77 -25.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 124.194 0.998 . . . . 0.0 109.762 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -68.33 -3.11 9.93 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 121.142 -0.974 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.52 82.65 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.679 -2.513 . . . . 0.0 110.84 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.53 59.72 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 39.4 mt -110.02 27.22 9.82 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.25 -9.33 8.62 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -100.36 3.36 43.21 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -71.71 -45.41 61.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.517 1.127 . . . . 0.0 109.197 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.59 -26.36 68.65 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.8 -1.187 . . . . 0.0 112.386 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.2 -29.16 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 123.984 0.914 . . . . 0.0 109.993 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -26.06 64.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 120.423 -1.423 . . . . 0.0 109.53 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -70.62 -19.45 62.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.796 -0.565 . . . . 0.0 111.696 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -70.77 -45.28 65.02 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.03 -1.669 . . . . 0.0 109.565 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -92.17 4.41 53.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.259 0.623 . . . . 0.0 110.553 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -80.41 -55.85 4.6 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 167.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -62.53 -51.3 67.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.997 0.903 . . . . 0.0 112.004 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -94.0 116.46 28.9 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.65 -28.04 6.34 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.904 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.63 20.27 0.49 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.086 2.555 . . . . 0.0 115.344 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 63.81 -73.3 0.05 OUTLIER 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.415 2.686 . . . . 0.0 110.061 -175.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -60.38 -36.07 77.2 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 130.312 3.445 . . . . 0.0 110.424 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -75.38 -36.41 60.9 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -33.87 76.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.701 0.801 . . . . 0.0 111.202 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -45.9 64.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.779 0.832 . . . . 0.0 108.877 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.65 98.89 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.163 0.985 . . . . 0.0 111.552 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -71.33 -26.23 62.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.105 1.362 . . . . 0.0 110.702 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.39 -37.93 63.26 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.99 95.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.233 -0.917 . . . . 0.0 111.235 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.98 -34.58 78.77 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.413 -0.805 . . . . 0.0 111.094 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -62.98 -33.48 75.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.606 1.162 . . . . 0.0 110.457 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.98 -42.56 84.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 109.146 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.6 tp -62.04 -37.11 83.72 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.16 0.984 . . . . 0.0 110.968 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.64 -27.67 69.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -34.91 63.31 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.518 -1.364 . . . . 0.0 109.289 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.75 -36.51 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.03 -41.04 77.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 123.877 0.871 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -72.07 -35.51 69.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.851 0.86 . . . . 0.0 111.2 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.92 -46.74 56.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.731 1.253 . . . . 0.0 107.992 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.79 64.35 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 125.787 1.635 . . . . 0.0 111.432 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.497 ' HB3' ' HA ' ' C' ' 45' ' ' ILE . 1.4 p -74.21 -36.6 63.97 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.296 -0.877 . . . . 0.0 110.014 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -64.94 -47.66 76.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -64.3 -35.61 81.42 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.338 0.655 . . . . 0.0 111.004 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.04 60.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.35 1.06 . . . . 0.0 110.943 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.16 -36.07 73.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 CA-C-O 122.08 0.943 . . . . 0.0 110.069 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.13 -36.16 77.18 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.056 -1.028 . . . . 0.0 110.298 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.8 67.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.635 1.574 . . . . 0.0 111.706 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -75.63 -17.6 59.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 121.451 -0.781 . . . . 0.0 110.72 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -85.58 75.48 10.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.363 -1.46 . . . . 0.0 110.152 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.37 -42.3 0.44 Allowed Glycine 0 CA--C 1.478 -2.237 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -82.14 151.11 66.02 Favored Pre-proline 0 N--CA 1.437 -1.093 0 O-C-N 122.36 -0.494 . . . . 0.0 110.806 -173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.72 147.73 24.99 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.868 1.712 . . . . 0.0 110.214 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 28.87 35.25 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.509 -0.606 . . . . 0.0 112.17 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.08 132.66 54.16 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 112.703 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.8 -37.21 0.6 Allowed 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.175 0.99 . . . . 0.0 109.539 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.71 35.67 0.78 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.749 1.22 . . . . 0.0 107.906 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 tt -77.41 4.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 123.673 1.702 . . . . 0.0 108.651 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -71.68 125.8 28.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.03 2.132 . . . . 0.0 110.373 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -87.71 -55.85 0.33 Allowed Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.908 -1.52 . . . . 0.0 111.225 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.42 -24.52 16.32 Favored 'Trans proline' 0 CA--C 1.501 -1.172 0 CA-C-N 125.075 2.848 . . . . 0.0 111.228 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.0 -7.2 58.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.89 79.45 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.043 -1.035 . . . . 0.0 111.126 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' C' ' 23' ' ' SER . 20.3 tt -69.17 -29.34 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.485 -0.759 . . . . 0.0 110.186 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -36.71 74.57 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 121.017 -1.052 . . . . 0.0 111.318 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -71.4 -33.32 69.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.632 0.729 . . . . 0.0 109.639 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -59.93 -41.56 92.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.95 -55.03 18.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.174 1.39 . . . . 0.0 110.753 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.89 -13.22 60.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.593 -0.692 . . . . 0.0 112.196 -173.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -79.47 -39.47 32.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.964 0.906 . . . . 0.0 109.252 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -24.02 64.88 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 120.88 -1.137 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p -92.81 2.43 56.76 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.477 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p 50.03 36.98 13.07 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.119 1.768 . . . . 0.0 111.269 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.6 -59.13 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 61.17 6.85 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -43.49 60.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -170.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.93 -114.26 0.59 Allowed Glycine 0 CA--C 1.482 -1.983 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.305 27.2 t70 62.17 -71.38 0.05 OUTLIER 'General case' 0 C--N 1.351 0.672 0 C-N-CA 127.199 2.2 . . . . 0.0 111.185 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -117.19 -163.98 0.96 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -155.53 148.08 17.8 Favored Pre-proline 0 N--CA 1.433 -1.301 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -90.24 159.55 4.67 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.197 1.932 . . . . 0.0 109.684 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 33' ' ' ALA . 16.1 m -82.94 -175.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.91 1.684 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 -79.64 0.2 Allowed 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.461 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -39.7 -43.8 1.43 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.174 2.189 . . . . 0.0 113.31 -165.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -113.92 -91.18 0.51 Allowed 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 8.04 -69.04 0.0 OUTLIER Glycine 0 C--N 1.36 1.863 1 C-N-CA 131.584 4.421 . . . . 0.0 117.267 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -66.61 -41.23 88.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.475 1.51 . . . . 0.0 113.033 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -80.42 -20.2 44.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.098 -1.001 . . . . 0.0 109.031 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.93 -46.41 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 172.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.78 76.67 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 126.116 1.766 . . . . 0.0 111.576 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.51 -53.54 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.495 2.318 . . . . 0.0 111.074 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.24 -39.91 89.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.188 1.395 . . . . 0.0 110.551 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.98 -45.42 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.55 1.14 . . . . 0.0 109.315 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.0 mtm -59.67 -46.81 87.94 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 109.888 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -60.09 -38.68 83.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 111.302 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.58 82.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.609 0.764 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.99 -46.54 58.96 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.99 -45.62 92.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.556 0 C-N-CA 124.388 1.075 . . . . 0.0 109.536 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -61.7 -42.43 98.94 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.445 -0.784 . . . . 0.0 111.692 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.68 -49.88 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 123.956 0.902 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -67.96 -35.02 77.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.925 -0.484 . . . . 0.0 110.648 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.06 -28.46 61.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.055 -1.028 . . . . 0.0 110.715 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.08 -18.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 120.503 -1.373 . . . . 0.0 111.384 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.66 1.5 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 120.144 -1.598 . . . . 0.0 111.22 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 31.4 m -62.9 -20.53 65.26 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.104 -1.623 . . . . 0.0 111.31 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.89 44.82 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 124.785 1.234 . . . . 0.0 112.159 169.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.23 -40.21 13.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.529 1.532 . . . . 0.0 110.269 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.65 -46.08 48.79 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.141 0.577 . . . . 0.0 111.297 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.3 -28.16 66.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.603 -0.685 . . . . 0.0 110.815 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -85.59 -14.49 45.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.067 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.363 16.5 t70 -74.29 -30.08 61.93 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-N 121.776 2.08 . . . . 0.0 110.767 -168.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -70.49 -26.13 63.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 119.693 -1.879 . . . . 0.0 112.413 174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.84 -22.47 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 124.521 1.129 . . . . 0.0 108.559 -174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -63.26 -17.42 62.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.331 1.053 . . . . 0.0 111.463 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -71.36 -22.35 61.91 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 120.818 -1.176 . . . . 0.0 112.321 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -92.08 -15.79 27.29 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.48 -0.762 . . . . 0.0 109.565 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -102.76 -172.64 2.16 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.16 -64.45 0.33 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.243 1.817 . . . . 0.0 111.695 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 30.6 ttp85 -59.91 -33.45 71.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 129.796 3.238 . . . . 0.0 110.994 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -42.33 92.01 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.278 1.031 . . . . 0.0 111.023 174.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.59 56.89 5.27 Favored Glycine 0 CA--C 1.493 -1.319 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -172.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 177.397 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.97 66.35 1.07 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.388 1.475 . . . . 0.0 113.207 172.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -52.08 -29.93 23.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -59.56 -33.63 71.67 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -79.27 -42.09 26.63 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 23.7 ttp85 -60.87 -38.77 86.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 110.279 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.7 -32.07 71.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.302 -0.873 . . . . 0.0 111.668 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.31 84.06 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.435 0.636 . . . . 0.0 109.597 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -66.83 -37.6 84.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.38 -0.825 . . . . 0.0 110.382 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -69.24 -23.68 63.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.288 -0.882 . . . . 0.0 111.346 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.74 86.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.608 -1.308 . . . . 0.0 111.079 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.12 -31.0 72.04 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.78 -1.2 . . . . 0.0 111.877 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.98 -34.87 79.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.049 1.34 . . . . 0.0 109.3 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -67.91 -41.05 83.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.792 1.237 . . . . 0.0 108.785 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.01 -45.33 95.24 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.689 0.796 . . . . 0.0 110.29 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.946 0.794 . . . . 0.0 112.164 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -74.1 -13.49 60.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.096 -1.003 . . . . 0.0 113.405 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.27 -46.51 12.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -53.06 -49.25 66.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 128.126 2.57 . . . . 0.0 110.459 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -78.11 -17.04 57.42 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.533 -1.354 . . . . 0.0 111.0 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -76.98 -31.9 56.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.44 82.81 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 124.767 1.227 . . . . 0.0 111.544 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -59.4 -42.7 92.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.75 1.22 . . . . 0.0 112.168 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -69.59 -37.99 77.15 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.827 0.851 . . . . 0.0 109.005 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -70.51 -51.01 31.86 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.433 0.693 . . . . 0.0 110.09 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.47 92.2 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 126.18 1.792 . . . . 0.0 112.304 -171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.46 -35.7 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -75.45 -36.13 60.78 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -62.4 -42.05 99.13 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.902 2.081 . . . . 0.0 110.201 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -88.48 -21.88 23.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -70.0 84.95 0.51 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 120.444 -1.41 . . . . 0.0 109.787 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.49 -2.2 4.14 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.23 157.55 82.86 Favored Pre-proline 0 N--CA 1.446 -0.644 0 O-C-N 121.138 -1.213 . . . . 0.0 112.55 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.63 131.29 11.29 Favored 'Trans proline' 0 CA--C 1.508 -0.798 0 C-N-CA 123.585 2.856 . . . . 0.0 110.643 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.76 -59.39 4.57 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.37 166.9 0.11 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.729 2.812 . . . . 0.0 110.327 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.05 -53.93 0.13 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.293 -1.744 . . . . 0.0 106.293 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 34.0 tp -99.68 134.83 42.0 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -149.88 167.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m 73.61 131.8 0.04 OUTLIER 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.278 1.831 . . . . 0.0 112.918 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -58.08 -51.65 80.25 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.448 -1.739 . . . . 0.0 113.183 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.53 -13.16 24.99 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 CA-C-N 124.306 2.574 . . . . 0.0 111.967 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 -46.84 9.08 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.16 73.78 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.333 1.453 . . . . 0.0 111.716 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -65.98 -31.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 121.686 -0.634 . . . . 0.0 111.178 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -31.97 47.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 120.727 -1.233 . . . . 0.0 109.854 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -61.92 -40.44 95.5 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.388 1.089 . . . . 0.0 109.443 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -64.5 -35.84 82.26 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 119.898 -1.751 . . . . 0.0 112.169 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.98 -53.35 49.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.007 0.923 . . . . 0.0 109.468 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.03 -24.71 64.23 Favored 'General case' 0 C--N 1.351 0.63 0 C-N-CA 123.275 0.63 . . . . 0.0 111.662 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -76.05 -38.54 57.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.337 -0.852 . . . . 0.0 108.74 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.53 -28.19 65.81 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.981 -1.074 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 10.4 p -93.81 9.63 36.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 123.162 0.585 . . . . 0.0 110.335 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 18.3 p 58.68 43.47 18.75 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.901 1.68 . . . . 0.0 114.702 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.68 -69.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.59 -55.66 4.69 Favored Glycine 0 N--CA 1.435 -1.385 0 O-C-N 120.564 -1.335 . . . . 0.0 111.908 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.1 -30.92 0.21 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.5 1.92 . . . . 0.0 113.296 173.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.83 26.26 5.36 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.8 -67.99 0.43 Allowed 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.683 0.793 . . . . 0.0 109.023 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 157.64 46.05 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 102.666 -3.086 . . . . 0.0 102.666 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.9 122.26 4.98 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.78 178.06 6.87 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 C-N-CA 123.022 2.481 . . . . 0.0 110.67 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.626 HG22 ' H ' ' D' ' 64' ' ' THR . 9.8 p -113.27 -177.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 122.895 1.331 . . . . 0.0 111.27 -170.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.626 ' H ' HG22 ' D' ' 63' ' ' VAL . 7.1 m -52.41 -40.65 62.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.733 2.813 . . . . 0.0 113.048 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.63 -11.72 59.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.424 1.09 . . . . 0.0 110.696 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' D' ' 29' ' ' ALA . 0.4 OUTLIER -68.64 -33.27 73.71 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 170.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 131.93 -26.57 3.78 Favored Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.348 9.4 ttt85 57.19 -35.92 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.031 1 C-N-CA 132.458 4.303 . . . . 0.0 113.702 -168.339 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' D' ' 67' ' ' GLY . 9.7 tptm -69.81 -9.28 54.1 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 126.243 1.817 . . . . 0.0 109.957 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 t -72.74 -37.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -53.86 37.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -46.94 -55.17 8.54 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 125.862 1.665 . . . . 0.0 112.947 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -70.02 -25.49 63.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.889 -0.507 . . . . 0.0 111.732 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.39 -45.9 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 8.5 mtp -56.5 -45.89 80.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.064 1.346 . . . . 0.0 110.252 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -59.41 -38.03 79.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.635 1.174 . . . . 0.0 112.101 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -36.99 84.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.998 -0.439 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.55 -43.77 85.05 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 123.731 0.681 . . . . 0.0 111.444 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.78 -47.97 89.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 C-N-CA 124.308 1.043 . . . . 0.0 109.419 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -63.75 -43.43 96.46 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 123.848 0.859 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -61.93 -49.8 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 O-C-N 120.86 -1.15 . . . . 0.0 110.592 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.11 0.56 27.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.84 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.25 -40.34 10.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.37 -39.14 72.43 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 126.681 1.992 . . . . 0.0 111.276 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 m -59.1 -15.54 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.106 1.362 . . . . 0.0 112.988 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -70.4 -5.23 26.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.918 1.287 . . . . 0.0 110.12 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.01 70.78 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 119.985 -1.697 . . . . 0.0 109.797 166.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.13 -41.62 90.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.827 -1.17 . . . . 0.0 110.476 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.44 -37.96 80.73 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.086 0.554 . . . . 0.0 111.165 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.03 -17.46 60.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.005 -1.06 . . . . 0.0 110.409 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -73.07 -27.84 61.97 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.56 70.47 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.279 -0.888 . . . . 0.0 111.284 -159.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -68.49 -30.12 68.89 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.676 -1.265 . . . . 0.0 111.563 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 12.4 t -74.82 -25.72 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 123.857 0.863 . . . . 0.0 109.063 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.8 mtp-105 -63.55 -25.92 68.46 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 120.992 -1.068 . . . . 0.0 110.931 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.4 -20.88 64.91 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.751 -0.593 . . . . 0.0 111.081 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.5 -14.16 61.59 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -110.53 -36.72 5.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -62.87 -32.0 73.16 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.042 -1.036 . . . . 0.0 112.602 -174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -83.51 -6.68 59.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.519 -0.738 . . . . 0.0 112.123 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -102.34 -40.8 6.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.76 0.58 32.24 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 72.6 t60 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 177.612 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.11 -70.74 0.25 Allowed 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.3 51.9 m-20 74.21 -41.7 0.49 Allowed 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.799 2.039 . . . . 0.0 111.009 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -43.98 83.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.483 1.113 . . . . 0.0 112.643 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.259 1.8 pm0 -72.71 -15.25 61.69 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.333 -2.105 . . . . 0.0 112.959 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -74.43 -42.86 58.44 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 120.432 -1.417 . . . . 0.0 108.521 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.63 -39.29 83.82 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.828 2.051 . . . . 0.0 109.212 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.11 92.4 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.856 1.263 . . . . 0.0 112.279 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.63 -26.22 60.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.394 -0.816 . . . . 0.0 111.169 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -65.7 -40.41 92.27 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.936 -1.103 . . . . 0.0 108.861 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.22 77.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.81 0.844 . . . . 0.0 112.09 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -34.83 76.04 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.495 -0.753 . . . . 0.0 111.735 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -68.87 -27.06 65.47 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 120.617 -1.302 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -64.8 -35.17 80.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.025 1.33 . . . . 0.0 109.375 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.96 -43.94 81.84 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.843 0.857 . . . . 0.0 110.141 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.61 -34.16 72.4 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 124.301 1.04 . . . . 0.0 111.912 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -66.91 -41.98 86.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.621 1.169 . . . . 0.0 110.185 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.13 -42.13 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.5 mt -55.32 -42.92 74.38 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.406 1.082 . . . . 0.0 112.397 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -69.71 -38.63 77.02 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.797 1.239 . . . . 0.0 110.873 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.39 -42.51 65.13 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 120.52 -1.362 . . . . 0.0 108.589 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.66 72.51 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.735 1.614 . . . . 0.0 112.351 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -69.66 -35.03 74.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -35.15 68.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.415 1.086 . . . . 0.0 109.277 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -69.24 -55.38 10.71 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 124.534 1.134 . . . . 0.0 108.595 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.02 84.1 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.483 1.513 . . . . 0.0 111.658 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -37.09 78.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.214 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.11 -35.09 64.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.148 -1.595 . . . . 0.0 110.013 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.2 -49.75 63.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.095 1.758 . . . . 0.0 108.342 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.7 tp10 -68.64 -38.12 80.25 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.655 1.182 . . . . 0.0 111.409 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -71.34 109.27 5.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 119.289 -2.132 . . . . 0.0 110.971 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -9.6 16.83 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.79 152.11 48.41 Favored Pre-proline 0 C--N 1.352 0.683 0 CA-C-N 118.391 1.095 . . . . 0.0 109.713 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.82 144.21 24.27 Favored 'Trans proline' 0 CA--C 1.502 -1.09 0 C-N-CA 122.751 2.301 . . . . 0.0 109.481 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.66 78.99 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -55.73 115.85 2.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 125.966 1.707 . . . . 0.0 109.975 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.98 -43.56 8.48 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.8 tp -90.51 65.31 6.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.928 1.347 . . . . 0.0 110.04 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.93 -0.76 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 119.851 -1.78 . . . . 0.0 112.304 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.5 m -109.44 123.35 49.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.147 -0.971 . . . . 0.0 111.247 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.13 -58.65 11.88 Favored Pre-proline 0 C--N 1.351 0.641 0 C-N-CA 125.83 1.652 . . . . 0.0 111.234 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.12 -6.45 17.99 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.078 2.849 . . . . 0.0 111.13 -171.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -100.59 -3.06 31.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.36 -32.9 69.05 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 119.737 -1.852 . . . . 0.0 109.15 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 tt -68.59 -30.0 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.826 0.851 . . . . 0.0 109.684 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.95 -47.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 125.919 1.687 . . . . 0.0 110.054 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.69 -41.93 87.29 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.954 1.702 . . . . 0.0 108.554 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -56.21 -45.74 79.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 111.679 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' ILE . 1.9 t -64.22 -46.22 94.04 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 121.269 -0.894 . . . . 0.0 111.444 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.03 -13.92 59.7 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 118.894 -1.122 . . . . 0.0 112.537 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -69.69 -36.4 75.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.136 -0.978 . . . . 0.0 108.555 171.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.0 63.2 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.297 -1.502 . . . . 0.0 112.186 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -95.42 15.09 20.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.443 0.565 . . . . 0.0 109.686 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p 53.35 29.2 8.33 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 126.932 2.093 . . . . 0.0 113.499 166.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.3 p -101.31 -74.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -172.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 81.06 80.65 0.86 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -10.5 59.48 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.992 -1.299 . . . . 0.0 111.4 -170.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.23 18.4 13.53 Favored Glycine 0 CA--C 1.491 -1.443 0 O-C-N 121.061 -1.024 . . . . 0.0 111.79 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -73.16 -46.3 51.62 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 118.533 1.167 . . . . 0.0 109.312 177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.01 164.26 27.72 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.28 146.69 28.66 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 102.019 -3.326 . . . . 0.0 102.019 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.96 -165.36 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.29 3.327 . . . . 0.0 109.858 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 64' ' ' THR . 13.8 p -139.0 -147.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 63' ' ' VAL . 89.6 m -102.49 -48.19 4.23 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.017 1.327 . . . . 0.0 108.282 -170.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -78.97 -17.08 56.05 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.435 0.694 . . . . 0.0 110.47 -169.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.32 -34.3 75.02 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 123.354 1.55 . . . . 0.0 107.477 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.38 79.2 1.43 Allowed Glycine 0 CA--C 1.462 -3.229 1 N-CA-C 98.594 -5.802 . . . . 0.0 98.594 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' D' ' 59' ' ' ASP . 19.8 ttt85 -50.61 -18.16 0.64 Allowed 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.358 1.863 . . . . 0.0 113.731 -171.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -38.78 -31.31 0.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 127.318 2.247 . . . . 0.0 114.697 159.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.06 -43.56 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 119.01 0.823 . . . . 0.0 108.877 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.46 64.38 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.594 -0.691 . . . . 0.0 109.646 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.76 -47.11 51.11 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.402 1.481 . . . . 0.0 112.177 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -68.27 -37.22 80.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.466 0.707 . . . . 0.0 111.033 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.45 -43.47 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.68 -44.27 97.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.2 1.0 . . . . 0.0 110.441 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -66.38 -33.69 76.29 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.204 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.5 74.08 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.347 -0.845 . . . . 0.0 110.928 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.2 86.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.05 -41.47 83.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.855 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -65.92 -43.79 87.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.391 -1.443 . . . . 0.0 113.73 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.2 -45.82 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 118.274 0.488 . . . . 0.0 109.811 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.91 -39.14 72.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.93 81.97 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 121.535 -0.728 . . . . 0.0 111.198 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.43 -31.98 73.37 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 111.736 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.29 -19.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.957 1.303 . . . . 0.0 110.051 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -62.41 -18.1 60.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.914 -1.116 . . . . 0.0 112.394 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.1 -55.49 34.31 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.48 -1.388 . . . . 0.0 110.244 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.46 87.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.93 -42.48 90.04 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.386 -0.821 . . . . 0.0 110.879 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.38 -14.04 60.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.959 -1.088 . . . . 0.0 110.643 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 m -77.06 -21.98 53.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.837 -1.164 . . . . 0.0 108.786 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.16 -42.95 82.04 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 122.012 0.91 . . . . 0.0 111.311 -165.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -70.76 -18.26 62.77 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.727 -1.233 . . . . 0.0 113.364 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -75.12 -20.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -75.67 -11.87 60.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 120.982 -1.074 . . . . 0.0 110.244 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -77.55 -17.42 57.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.865 -1.147 . . . . 0.0 110.926 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -96.35 159.89 14.71 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 73.12 -39.35 0.44 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.261 1.824 . . . . 0.0 110.934 -164.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.11 -44.32 91.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 127.119 2.168 . . . . 0.0 112.021 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -63.9 -31.26 72.38 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.848 0.833 . . . . 0.0 112.152 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -88.1 -19.46 27.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.151 0.98 . . . . 0.0 108.999 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.59 73.61 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -177.705 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.426 -1.646 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.94 -134.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -98.5 -62.37 1.25 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -58.02 -30.51 66.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.93 -28.97 58.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.812 0.845 . . . . 0.0 110.499 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -72.0 -39.72 69.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -32.72 74.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.62 0.724 . . . . 0.0 110.481 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.98 -46.45 81.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.773 0.829 . . . . 0.0 111.127 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -72.6 -34.63 67.52 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.654 0.74 . . . . 0.0 110.729 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.03 -35.09 79.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.492 1.917 . . . . 0.0 110.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.76 75.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 111.585 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -32.19 73.59 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.165 0.986 . . . . 0.0 110.998 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.04 -36.32 72.31 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 120.649 -1.282 . . . . 0.0 108.913 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -66.28 -35.73 81.16 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.028 0.931 . . . . 0.0 109.295 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -60.4 -42.26 95.55 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.484 -0.76 . . . . 0.0 111.287 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -59.28 -35.52 73.89 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 123.933 0.893 . . . . 0.0 111.584 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -70.55 -34.98 72.84 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 110.209 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.22 -41.31 86.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 124.516 1.126 . . . . 0.0 108.335 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 48.0 mt -56.42 -44.63 80.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.447 1.099 . . . . 0.0 111.547 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.61 -31.61 71.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.183 0.993 . . . . 0.0 111.488 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.99 -33.33 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.317 -1.489 . . . . 0.0 108.744 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.56 -31.29 71.91 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.917 1.287 . . . . 0.0 111.509 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 59.1 p -66.22 -39.9 89.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 119.026 0.83 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.34 93.39 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.084 1.754 . . . . 0.0 108.64 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.22 -57.96 5.19 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 117.671 -1.157 . . . . 0.0 108.25 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.52 -48.32 57.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 126.171 1.788 . . . . 0.0 112.855 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.12 -39.63 84.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.77 -1.206 . . . . 0.0 111.357 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.1 -25.67 31.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.117 -0.989 . . . . 0.0 109.464 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 126.465 1.906 . . . . 0.0 108.516 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.06 -34.18 77.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.14 0.976 . . . . 0.0 111.73 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -68.15 109.13 3.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.34 -2.1 . . . . 0.0 111.433 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -10.89 16.31 Favored Glycine 0 CA--C 1.496 -1.104 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.72 147.08 40.52 Favored Pre-proline 0 N--CA 1.442 -0.84 0 O-C-N 121.802 -0.822 . . . . 0.0 109.439 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.51 137.81 11.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.49 2.127 . . . . 0.0 110.067 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.28 81.85 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.1 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.23 104.01 0.22 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.19 1.396 . . . . 0.0 109.56 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.72 -28.63 21.65 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.79 132.71 37.91 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -148.36 170.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 81.47 124.77 0.04 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.741 1.616 . . . . 0.0 109.003 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -66.04 -52.45 39.82 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.602 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.97 -3.48 13.84 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 125.226 2.902 . . . . 0.0 112.314 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -110.61 -10.78 14.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.45 75.88 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.25 -0.906 . . . . 0.0 108.846 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -60.24 -26.15 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 125.765 1.626 . . . . 0.0 111.205 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.731 -1.23 . . . . 0.0 109.569 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -79.26 -35.76 40.96 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.8 p -77.31 57.82 1.54 Allowed 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 122.113 -0.367 . . . . 0.0 110.579 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.35 -53.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.77 -26.88 68.55 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 119.328 0.967 . . . . 0.0 111.977 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -67.06 -34.39 77.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.55 1.14 . . . . 0.0 109.439 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.5 62.67 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.449 -1.407 . . . . 0.0 111.013 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -93.39 11.92 26.66 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.688 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.7 p 48.89 55.5 9.13 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.267 1.427 . . . . 0.0 113.17 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' B' ' 56' ' ' GLY . 0.2 OUTLIER -121.95 -87.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.45 ' H ' HG23 ' B' ' 55' ' ' VAL . . . 87.15 73.66 1.28 Allowed Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 -19.42 62.12 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.344 -1.092 . . . . 0.0 110.429 -173.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.1 37.99 1.3 Allowed Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -93.2 -30.89 14.98 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 118.125 0.963 . . . . 0.0 110.066 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -140.3 176.55 8.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -155.02 149.66 20.01 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 102.295 -3.224 . . . . 0.0 102.295 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -85.04 -178.21 3.09 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 124.74 3.626 . . . . 0.0 109.949 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 0.8 OUTLIER -133.76 -153.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.036 0.922 . . . . 0.0 108.799 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 -46.78 7.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.03 -1.669 . . . . 0.0 110.676 -169.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -30.67 67.24 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 109.796 -170.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' B' ' 68' ' ' ARG . 0.8 OUTLIER -64.2 -26.37 68.48 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 123.128 1.442 . . . . 0.0 108.592 -178.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.91 67.67 1.3 Allowed Glycine 0 CA--C 1.461 -3.329 1 N-CA-C 102.534 -4.226 . . . . 0.0 102.534 174.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' OE2' ' B' ' 66' ' ' GLU . 22.0 ttp85 -40.11 -15.32 0.01 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.578 3.551 . . . . 0.0 116.097 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -55.27 -17.84 5.24 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 120.507 -1.371 . . . . 0.0 113.622 160.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.97 -53.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 CA-C-N 121.07 1.759 . . . . 0.0 107.718 173.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.79 91.08 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.272 0.629 . . . . 0.0 111.061 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.1 -38.44 70.73 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.621 1.168 . . . . 0.0 111.66 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.84 -37.47 84.55 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 124.071 0.948 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.53 -42.53 72.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.2 mtm -61.16 -48.92 79.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.094 0.958 . . . . 0.0 110.319 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.16 -38.43 88.06 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.81 92.57 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.056 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.28 -46.07 91.76 Favored Glycine 0 CA--C 1.494 -1.257 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -46.64 87.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.666 1.186 . . . . 0.0 109.338 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.15 -45.82 86.73 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.173 -0.954 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.68 -51.13 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 124.167 0.987 . . . . 0.0 109.963 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -72.83 -19.46 61.31 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.631 -0.668 . . . . 0.0 111.257 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.5 -27.62 19.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.885 0.874 . . . . 0.0 110.283 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.08 -39.18 85.17 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 126.207 1.803 . . . . 0.0 109.47 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.2 -13.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.823 0.849 . . . . 0.0 111.912 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.8 m -61.68 -16.38 48.32 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.624 1.169 . . . . 0.0 110.852 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.58 -51.0 64.4 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.509 1.123 . . . . 0.0 110.629 165.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.16 75.72 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.71 1.604 . . . . 0.0 110.451 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.02 -42.61 97.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.73 -18.96 61.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.872 -0.518 . . . . 0.0 110.687 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.6 m -80.51 -36.61 33.03 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 121.276 -0.89 . . . . 0.0 108.998 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.34 -8.46 58.45 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.904 -1.123 . . . . 0.0 111.791 -157.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -75.4 -36.77 60.79 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 165.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 t -71.12 -22.28 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 109.978 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -47.92 -31.57 5.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.694 1.998 . . . . 0.0 111.666 171.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -62.11 -30.7 71.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.686 1.194 . . . . 0.0 112.129 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.31 -27.41 63.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 120.785 -1.197 . . . . 0.0 109.541 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.38 -37.21 80.19 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.999 -1.063 . . . . 0.0 110.241 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -70.52 -23.35 62.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -66.55 -35.65 80.75 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.015 -1.053 . . . . 0.0 109.944 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -89.88 -7.72 53.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 121.594 -0.692 . . . . 0.0 109.519 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.37 90.17 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 121.477 -0.764 . . . . 0.0 111.494 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.769 178.888 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.98 166.04 32.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -65.45 -55.85 15.68 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 129.378 3.071 . . . . 0.0 108.26 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -66.97 -21.99 65.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 125.791 1.636 . . . . 0.0 111.97 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -77.34 -32.65 55.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -72.87 -32.27 65.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.668 0.747 . . . . 0.0 109.95 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.3 -41.56 93.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.642 1.177 . . . . 0.0 109.512 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.08 78.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.357 1.063 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -57.01 -38.25 72.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.282 1.833 . . . . 0.0 111.243 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -64.73 -33.26 75.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.495 1.118 . . . . 0.0 110.815 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.61 68.2 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.037 -1.039 . . . . 0.0 110.287 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.453 -0.78 . . . . 0.0 112.017 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -27.89 63.76 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.889 -1.132 . . . . 0.0 110.473 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.74 -33.29 73.67 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.994 0.918 . . . . 0.0 109.128 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.41 -36.95 84.12 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.941 -1.099 . . . . 0.0 110.687 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.08 -27.65 67.54 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.264 -0.898 . . . . 0.0 111.083 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.61 -45.67 64.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.684 1.194 . . . . 0.0 110.068 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.31 -24.14 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 O-C-N 121.534 -0.729 . . . . 0.0 110.819 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.13 -37.66 80.73 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.417 -0.802 . . . . 0.0 111.408 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -74.34 -24.29 59.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.617 0.767 . . . . 0.0 111.241 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -87.89 -30.87 19.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.812 -1.18 . . . . 0.0 107.848 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.98 88.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.655 1.182 . . . . 0.0 111.362 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.0 p -65.2 -38.94 92.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.29 0.636 . . . . 0.0 111.173 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -71.08 -48.88 49.98 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.576 -0.703 . . . . 0.0 110.064 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -72.21 -23.16 61.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 121.262 -0.899 . . . . 0.0 110.931 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.92 -48.45 76.54 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.819 0.736 . . . . 0.0 110.885 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.72 -19.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.03 -176.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -80.2 -25.82 39.48 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.157 -1.59 . . . . 0.0 109.531 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.05 73.49 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.67 1.188 . . . . 0.0 108.874 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' C' ' 38' ' ' LEU . 16.8 mt-10 -85.63 -141.09 0.09 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 122.884 1.326 . . . . 0.0 111.115 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 59.86 52.23 5.51 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 126.763 2.025 . . . . 0.0 111.316 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.37 34.35 0.2 Allowed Glycine 0 CA--C 1.487 -1.696 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.45 155.42 78.67 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.78 152.39 11.44 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.324 2.016 . . . . 0.0 109.498 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 -41.03 2.77 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.974 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -3.02 123.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.808 1 C-N-CA 132.486 4.314 . . . . 0.0 117.292 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.48 -38.38 3.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.566 1.146 . . . . 0.0 110.048 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.437 ' H ' ' CD ' ' C' ' 30' ' ' GLU . 5.2 tt -100.98 66.23 1.14 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.033 2.533 . . . . 0.0 109.436 -169.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.45 33.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 119.463 -2.023 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.2 m -134.0 143.62 48.23 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -80.99 -53.14 0.81 Allowed Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.471 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -20.32 24.2 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 CA-C-N 126.404 3.323 . . . . 0.0 110.643 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.9 -13.04 49.07 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 -35.79 81.65 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.186 -0.946 . . . . 0.0 110.928 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.61 -29.08 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.441 0.639 . . . . 0.0 110.278 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -28.75 61.29 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 119.83 -1.794 . . . . 0.0 110.22 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.434 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 31.8 t90 -69.66 -40.99 76.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.841 -0.537 . . . . 0.0 109.68 172.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -69.58 -14.71 62.98 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.83 -49.9 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 120.884 -1.135 . . . . 0.0 110.504 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -76.04 0.45 18.6 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.036 -1.04 . . . . 0.0 112.247 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.27 -38.69 6.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.122 -0.987 . . . . 0.0 109.096 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.73 61.05 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 120.771 -1.206 . . . . 0.0 111.535 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 5.3 p -90.61 1.31 56.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 110.647 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.297 15.5 p 62.65 30.72 16.95 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.46 2.304 . . . . 0.0 112.751 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.18 -59.33 2.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.92 63.26 3.74 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.858 -1.151 . . . . 0.0 112.493 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -23.14 66.86 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.642 0.777 . . . . 0.0 113.006 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 23.51 10.1 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -50.33 18.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 16.1 mtm-85 -142.52 163.86 31.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -163.12 142.05 6.58 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.98 161.95 20.79 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.044 2.496 . . . . 0.0 110.86 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 1.1 t -107.02 -162.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 123.118 1.437 . . . . 0.0 109.157 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 2.1 m -66.29 -55.5 15.76 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 127.601 2.361 . . . . 0.0 111.553 -167.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -74.12 -16.43 61.01 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.533 1.159 . . . . 0.0 109.27 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -78.08 -23.35 48.02 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 125.514 1.526 . . . . 0.0 107.803 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.89 86.12 0.94 Allowed Glycine 0 CA--C 1.478 -2.276 1 N-CA-C 102.04 -4.424 . . . . 0.0 102.04 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -43.14 -34.81 1.17 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.446 1.898 . . . . 0.0 111.482 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -43.44 -26.87 0.23 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.037 2.135 . . . . 0.0 113.721 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.92 -37.72 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.986 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.09 9.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.33 -47.04 69.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.481 2.312 . . . . 0.0 112.136 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 -37.22 71.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.552 -0.718 . . . . 0.0 110.492 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.33 -42.64 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 58.9 ttm -59.1 -45.19 91.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.602 1.161 . . . . 0.0 110.615 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -64.65 -31.75 73.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.861 0.464 . . . . 0.0 111.477 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.94 70.17 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.734 -0.604 . . . . 0.0 111.055 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.47 -39.93 86.83 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.28 -46.69 94.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 124.354 1.062 . . . . 0.0 108.947 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -61.24 -39.51 90.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.547 0.739 . . . . 0.0 112.173 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 t -64.06 -52.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.333 1.053 . . . . 0.0 109.575 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.32 -18.67 61.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.7 -0.625 . . . . 0.0 111.297 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.51 8.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.227 -0.92 . . . . 0.0 109.197 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -51.95 -42.01 62.53 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 126.793 2.037 . . . . 0.0 112.832 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 26.5 m -64.56 -11.38 10.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.481 -0.762 . . . . 0.0 112.515 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.7 m -67.95 -15.36 63.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.701 -1.25 . . . . 0.0 110.831 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.49 65.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.437 -1.414 . . . . 0.0 111.448 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.87 -46.37 13.09 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.78 -1.2 . . . . 0.0 107.963 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -65.05 -32.47 74.21 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.222 1.009 . . . . 0.0 112.34 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.32 -11.68 60.58 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 120.839 -1.163 . . . . 0.0 111.874 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 51.3 p -82.01 -19.48 40.37 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.074 -1.641 . . . . 0.0 109.171 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.27 -16.16 59.86 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.675 -0.641 . . . . 0.0 112.026 -165.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -91.16 -23.69 20.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.874 0.845 . . . . 0.0 110.743 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.02 -29.21 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 O-C-N 120.135 -1.603 . . . . 0.0 108.297 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -62.44 -7.56 4.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.495 1.118 . . . . 0.0 112.961 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -75.51 -26.71 58.34 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.284 -1.51 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 160.4 14.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.499 8.9 pt-20 61.68 -37.14 0.11 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.788 2.435 . . . . 0.0 115.31 -167.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -63.02 -49.48 74.46 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 121.122 1.783 . . . . 0.0 110.368 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 13.0 ttp85 -77.38 -12.94 60.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.333 0.587 . . . . 0.0 111.411 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.61 -29.12 16.3 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.393 -0.817 . . . . 0.0 109.659 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.94 50.47 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 124.276 0.941 . . . . 0.0 111.153 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 28.1 t60 . . . . . 0 C--N 1.35 0.615 0 C-N-CA 124.936 1.294 . . . . 0.0 111.507 -174.548 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.57 150.63 21.66 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.03 -43.59 98.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -18.58 63.74 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.201 -0.937 . . . . 0.0 112.385 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -76.58 -44.07 36.11 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -68.06 -36.42 79.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.427 0.632 . . . . 0.0 109.564 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.07 -51.04 67.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.158 2.583 . . . . 0.0 110.016 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.37 81.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.655 1.182 . . . . 0.0 111.901 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -40.67 84.67 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.208 -0.933 . . . . 0.0 110.186 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -68.69 -27.16 65.71 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 121.192 -0.943 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.22 70.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.473 -1.392 . . . . 0.0 111.87 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -67.02 -25.35 66.24 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.568 -0.707 . . . . 0.0 112.032 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.94 -35.76 64.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 109.08 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.61 -17.17 56.46 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.647 -0.658 . . . . 0.0 109.489 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.459 HD13 ' HA2' ' D' ' 78' ' ' GLY . 13.2 tp -68.78 -44.64 73.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.225 -0.922 . . . . 0.0 109.187 171.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.88 -41.05 67.14 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 111.169 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -53.45 -47.79 69.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.324 1.85 . . . . 0.0 112.123 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -87.83 -33.02 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.005 -1.06 . . . . 0.0 111.123 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.55 -49.95 74.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 127.863 2.465 . . . . 0.0 109.859 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.12 -42.87 72.06 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.27 -31.24 72.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.653 -0.654 . . . . 0.0 112.012 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.72 71.73 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.469 0.708 . . . . 0.0 111.278 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 92.3 p -67.15 -41.0 86.76 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.99 -27.68 61.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 109.723 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -79.61 -51.34 9.4 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.21 97.46 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 111.731 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.49 -29.42 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 119.413 -2.054 . . . . 0.0 112.106 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -89.05 -27.34 20.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 66' ' ' GLU . . . -68.54 -57.09 6.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.935 1.694 . . . . 0.0 108.358 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.43 -7.9 46.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.359 0.663 . . . . 0.0 112.53 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.12 99.55 1.5 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 120.075 -1.641 . . . . 0.0 109.263 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 4.19 35.1 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.5 138.53 26.78 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 118.649 1.224 . . . . 0.0 108.689 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.52 139.49 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.491 2.128 . . . . 0.0 110.178 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.1 16.5 80.65 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.14 147.21 53.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.343 0.657 . . . . 0.0 110.74 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 -35.99 5.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -89.07 136.58 32.94 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 pt -165.89 172.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.6 m 67.65 129.07 0.02 OUTLIER 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.973 2.509 . . . . 0.0 114.285 167.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -61.78 -57.72 22.59 Favored Pre-proline 0 C--N 1.351 0.659 0 CA-C-O 116.976 -1.487 . . . . 0.0 113.397 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.48 -12.13 22.62 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 124.482 2.637 . . . . 0.0 110.653 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.79 -38.83 20.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -36.71 81.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.733 1.213 . . . . 0.0 112.016 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.29 -30.39 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.656 -0.653 . . . . 0.0 110.55 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 -19.5 56.93 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.08 -1.013 . . . . 0.0 110.764 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -91.25 -30.33 16.68 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.94 -37.56 87.86 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.501 -1.375 . . . . 0.0 110.489 -173.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.21 -25.96 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 123.357 0.663 . . . . 0.0 112.091 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.52 -45.81 21.05 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.242 1.017 . . . . 0.0 110.485 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -77.19 -24.52 51.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 120.784 -1.198 . . . . 0.0 109.581 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.38 -29.69 62.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.196 0.598 . . . . 0.0 110.051 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 25.6 p -92.15 -2.46 56.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 118.283 0.492 . . . . 0.0 110.72 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 55.3 p 54.39 59.41 4.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.095 2.158 . . . . 0.0 112.976 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.575 HG23 ' H ' ' D' ' 56' ' ' GLY . 27.4 m -102.98 -75.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.575 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 91.04 54.3 2.05 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -19.53 63.94 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 122.093 0.949 . . . . 0.0 111.87 -170.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.2 11.1 22.82 Favored Glycine 0 CA--C 1.49 -1.481 0 O-C-N 120.325 -1.484 . . . . 0.0 111.421 168.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -68.84 -52.14 33.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.926 -0.749 . . . . 0.0 110.924 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -139.57 163.25 33.07 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.42 151.26 26.9 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -171.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.05 -179.98 5.95 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 124.346 3.364 . . . . 0.0 109.469 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.44 HG13 ' H ' ' D' ' 64' ' ' THR 0.324 3.7 p -123.13 -89.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 CA-C-N 120.705 1.593 . . . . 0.0 111.869 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.44 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.5 m -152.32 -50.31 0.11 Allowed 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 119.376 -2.077 . . . . 0.0 107.019 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.44 -5.66 59.22 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.731 1.212 . . . . 0.0 110.878 -168.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' D' ' 29' ' ' ALA . 2.8 pm0 -66.1 -34.39 77.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.64 -1.287 . . . . 0.0 107.588 165.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.25 88.52 1.32 Allowed Glycine 0 N--CA 1.419 -2.488 1 N-CA-C 98.784 -5.726 . . . . 0.0 98.784 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 26.5 ttm-85 -55.6 -19.81 11.5 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 125.768 1.627 . . . . 0.0 111.076 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -58.27 -17.1 16.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.1 -47.88 76.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 120.064 1.302 . . . . 0.0 108.424 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.1 78.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -53.37 -44.13 68.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.536 1.534 . . . . 0.0 112.328 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -60.38 -47.58 85.44 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.039 0.936 . . . . 0.0 110.51 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.01 -34.28 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 43.3 mtt -56.74 -50.89 70.9 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.838 0.828 . . . . 0.0 110.437 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -68.81 -29.83 68.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.876 -0.515 . . . . 0.0 110.42 -171.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.32 71.7 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.953 -0.467 . . . . 0.0 110.303 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -62.05 -46.32 94.28 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 123.927 0.775 . . . . 0.0 111.733 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.6 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.9 0.88 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.56 -30.8 71.18 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.957 -1.089 . . . . 0.0 112.521 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 21.0 t -65.87 -53.77 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 109.121 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.5 -35.2 77.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 121.704 -0.623 . . . . 0.0 110.429 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.0 74.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.392 -0.818 . . . . 0.0 111.256 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.46 -28.56 69.31 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.608 -1.307 . . . . 0.0 110.929 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.5 -7.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.045 1.338 . . . . 0.0 110.944 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.8 m -58.84 -21.23 56.33 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 118.937 -2.352 . . . . 0.0 112.315 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.09 -29.15 67.14 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.762 -1.211 . . . . 0.0 110.881 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 -46.54 14.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.988 -1.695 . . . . 0.0 109.163 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.6 -47.58 72.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -167.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.42 -9.84 58.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.112 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -77.72 -38.33 47.43 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 120.447 -1.408 . . . . 0.0 108.148 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.27 55.2 m-20 -83.07 8.64 12.33 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.376 -1.452 . . . . 0.0 112.591 -155.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -96.93 -38.06 9.96 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 117.573 -1.203 . . . . 0.0 111.514 161.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.18 -20.46 27.57 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-N 120.789 1.631 . . . . 0.0 111.113 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -54.08 -22.93 12.06 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.642 1.177 . . . . 0.0 112.308 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.08 -21.73 9.21 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.715 1.606 . . . . 0.0 113.008 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -76.89 -49.18 16.27 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -98.47 -160.36 0.8 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.65 -60.57 0.27 Allowed 'General case' 0 C--N 1.355 0.817 0 C-N-CA 127.506 2.323 . . . . 0.0 110.975 -169.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -59.47 -36.32 75.77 Favored 'General case' 0 N--CA 1.433 -1.317 1 C-N-CA 132.563 4.345 . . . . 0.0 111.181 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -79.15 -21.5 46.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.311 -0.868 . . . . 0.0 110.705 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.83 15.55 61.18 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 121.715 -0.616 . . . . 0.0 112.057 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 37.7 m80 . . . . . 0 CA--C 1.501 -0.919 0 O-C-N 120.568 -1.548 . . . . 0.0 108.544 178.734 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.03 165.16 18.81 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.704 -0.623 . . . . 0.0 109.49 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.0 -62.55 0.71 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.037 2.535 . . . . 0.0 112.631 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -64.61 -23.41 67.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 113.974 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -82.78 -44.41 15.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.7 -40.84 98.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.335 1.054 . . . . 0.0 110.401 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.41 -29.72 67.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.357 0.598 . . . . 0.0 110.658 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.44 86.65 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.271 -0.893 . . . . 0.0 110.479 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -63.17 -43.62 97.74 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.577 -0.702 . . . . 0.0 110.5 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.7 -42.36 75.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.084 1.754 . . . . 0.0 110.419 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.32 93.01 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.441 1.096 . . . . 0.0 110.702 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -63.95 -36.52 84.22 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -74.61 -25.91 59.55 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.798 -1.189 . . . . 0.0 111.875 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.52 -35.95 63.18 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.77 -42.51 79.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.417 1.087 . . . . 0.0 111.874 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.0 -34.19 69.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.129 1.372 . . . . 0.0 112.203 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -74.85 -35.17 62.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.621 -0.674 . . . . 0.0 109.392 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.98 -33.76 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.47 -42.69 92.6 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.459 -0.775 . . . . 0.0 112.0 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.65 -42.61 74.01 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 122.098 -0.376 . . . . 0.0 110.493 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.89 -40.65 87.82 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.703 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.19 79.39 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 125.043 1.337 . . . . 0.0 111.479 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -52.56 -47.02 67.05 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 126.016 1.726 . . . . 0.0 109.938 175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -65.39 -46.2 80.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.265 1.026 . . . . 0.0 109.985 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.99 -43.18 88.53 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 123.885 0.874 . . . . 0.0 110.563 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.67 71.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.694 1.198 . . . . 0.0 111.527 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.28 -51.79 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 120.765 -1.209 . . . . 0.0 109.912 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.46 -28.86 63.19 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.722 -0.612 . . . . 0.0 111.092 -166.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.0 81.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.608 0.763 . . . . 0.0 110.311 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.73 -88.93 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 122.545 0.338 . . . . 0.0 111.51 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 20.09 67.59 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 128.302 2.641 . . . . 0.0 116.69 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.29 -23.45 4.31 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 133.63 90.76 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -174.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.62 125.39 4.94 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.35 2.033 . . . . 0.0 111.71 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.7 54.06 Favored Glycine 0 CA--C 1.485 -1.805 0 CA-C-O 117.906 -1.497 . . . . 0.0 109.828 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -32.1 -65.21 0.15 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 114.345 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 73.39 -15.54 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.769 1.627 . . . . 0.0 111.297 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.2 118.23 36.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 pt -143.72 0.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.843 -0.536 . . . . 0.0 111.235 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.9 m -128.24 130.62 48.21 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.372 -1.455 . . . . 0.0 109.449 -165.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -57.22 -50.31 88.89 Favored Pre-proline 0 C--N 1.351 0.64 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.783 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.38 -11.98 24.93 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 125.301 2.929 . . . . 0.0 111.881 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.79 -25.09 16.19 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.19 -35.11 78.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.656 0.783 . . . . 0.0 111.432 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -69.91 -33.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -31.84 61.04 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.333 -0.854 . . . . 0.0 109.739 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -65.33 -45.18 85.27 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.523 1.129 . . . . 0.0 108.919 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -34.33 68.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.243 1.417 . . . . 0.0 111.419 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.89 -52.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 124.254 1.022 . . . . 0.0 110.719 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.21 -22.84 60.36 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 121.537 -0.727 . . . . 0.0 110.961 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.7 m -73.34 -39.49 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.22 64.95 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.264 -0.898 . . . . 0.0 111.546 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 p -88.23 12.12 14.69 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.371 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 p 48.96 61.33 3.17 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.949 1.7 . . . . 0.0 112.717 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.4 p -128.48 -77.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 82.88 75.04 1.18 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -69.17 -34.19 74.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.985 -1.303 . . . . 0.0 110.787 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.13 38.61 0.25 Allowed Glycine 0 CA--C 1.487 -1.714 0 N-CA-C 107.926 -2.069 . . . . 0.0 107.926 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.85 -48.2 22.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -135.3 178.89 6.68 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -149.16 93.89 4.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.131 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.18 166.23 30.54 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.572 2.181 . . . . 0.0 110.842 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 64' ' ' THR . 11.8 p -141.89 177.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 123.002 1.382 . . . . 0.0 107.908 -170.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 63' ' ' VAL . 16.9 m -65.19 -25.01 67.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.853 2.461 . . . . 0.0 112.585 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -75.51 -36.23 60.59 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.304 1.042 . . . . 0.0 109.056 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -53.21 58.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.91 66.67 0.37 Allowed Glycine 0 CA--C 1.461 -3.334 1 N-CA-C 100.797 -4.921 . . . . 0.0 100.797 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.5 ttm-85 -23.18 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.382 2.017 1 C-N-CA 132.258 4.223 . . . . 0.0 115.921 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -54.79 -6.82 0.13 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 116.622 -1.656 . . . . 0.0 115.389 167.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.265 54.8 t -76.01 -46.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.365 1.26 0 CA-C-N 123.771 2.987 . . . . 0.0 107.809 167.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.7 67.75 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.435 1.016 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.64 -34.61 73.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.474 1.11 . . . . 0.0 112.258 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.74 -40.36 84.16 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 120.728 -1.232 . . . . 0.0 110.365 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.38 -43.14 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.3 mtt -59.23 -45.83 90.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 110.147 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.85 -40.44 92.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.929 0.892 . . . . 0.0 111.683 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 81.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.788 0.835 . . . . 0.0 111.071 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.88 -46.22 90.13 Favored Glycine 0 C--N 1.35 1.326 0 C-N-CA 124.678 1.132 . . . . 0.0 110.446 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.04 -41.17 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.894 0.877 . . . . 0.0 109.376 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -59.7 -52.03 67.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.202 -0.936 . . . . 0.0 111.625 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.55 -41.69 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 121.959 -0.463 . . . . 0.0 110.527 -172.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.8 -39.46 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.025 0.53 . . . . 0.0 109.688 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 121.42 -0.8 . . . . 0.0 110.919 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.16 -24.85 64.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 121.021 -1.05 . . . . 0.0 111.538 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.92 -15.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 O-C-N 121.012 -1.055 . . . . 0.0 110.697 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.9 m -53.57 -25.38 16.97 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.023 -1.673 . . . . 0.0 113.067 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.0 66.68 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.509 -1.369 . . . . 0.0 111.294 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.96 -52.75 5.52 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 108.738 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.1 mt -59.34 -40.25 85.74 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.303 1.041 . . . . 0.0 112.958 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.5 -19.37 62.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 121.073 -1.017 . . . . 0.0 111.228 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.2 p -72.26 -22.32 61.24 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.221 -1.549 . . . . 0.0 110.283 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.86 -5.67 55.92 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.924 -1.11 . . . . 0.0 112.128 -167.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.78 -22.72 19.17 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.867 -1.77 . . . . 0.0 109.347 168.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -76.84 -37.72 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 107.983 -170.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -57.9 -18.44 22.98 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.413 1.485 . . . . 0.0 112.479 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -64.97 -32.72 74.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.758 -1.214 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.43 -32.2 66.13 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.038 -1.039 . . . . 0.0 108.917 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.13 -48.3 68.5 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.42 -37.1 84.51 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.518 1.127 . . . . 0.0 110.585 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -61.19 -33.76 73.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.893 1.277 . . . . 0.0 112.115 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -80.61 -24.31 39.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.424 -1.423 . . . . 0.0 110.141 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.53 63.81 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 61.6 t60 . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.146 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . 0.392 . . 21.78 -122.94 0.01 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 129.135 2.974 . . . . 0.0 115.688 -169.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.88 -55.94 0.42 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -165.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -4.27 58.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.881 -1.137 . . . . 0.0 112.159 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -29.75 56.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.787 1.235 . . . . 0.0 108.37 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -70.85 -33.78 70.98 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.931 -1.106 . . . . 0.0 110.432 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.87 -38.81 92.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 122.174 0.988 . . . . 0.0 109.236 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' B' ' 85' ' ' VAL . . . -66.06 -38.51 88.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.541 0.737 . . . . 0.0 111.711 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.13 -41.04 86.82 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.698 -0.626 . . . . 0.0 110.362 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -62.56 -30.96 71.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.625 1.17 . . . . 0.0 111.139 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.414 -0.804 . . . . 0.0 111.354 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -67.58 -33.78 75.71 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.459 -0.776 . . . . 0.0 109.639 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.38 -35.56 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.517 1.127 . . . . 0.0 111.04 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.32 -40.44 95.92 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.78 0.832 . . . . 0.0 109.156 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.728 -0.607 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -58.4 -38.95 78.4 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.094 0.958 . . . . 0.0 112.006 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -62.78 -44.65 95.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.228 1.011 . . . . 0.0 109.452 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.5 -33.39 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.046 0.938 . . . . 0.0 110.062 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.49 HD13 HG22 ' B' ' 49' ' ' VAL . 20.9 mt -66.92 -36.37 82.09 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.52 -1.362 . . . . 0.0 111.205 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -72.01 -35.17 69.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.514 -0.741 . . . . 0.0 110.435 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.723 -1.236 . . . . 0.0 109.189 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.7 74.32 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 126.251 1.82 . . . . 0.0 111.69 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.44 -36.11 63.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -43.16 85.64 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.814 0.846 . . . . 0.0 109.18 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.96 -51.73 44.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.816 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.37 96.98 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 124.066 0.946 . . . . 0.0 111.482 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -67.57 -44.78 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.112 -0.992 . . . . 0.0 109.501 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -50.59 31.74 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 110.289 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.64 -29.06 67.47 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.451 -0.78 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -67.06 100.47 0.76 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.352 -1.468 . . . . 0.0 111.413 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.31 -30.18 3.35 Favored Glycine 0 CA--C 1.488 -1.655 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.08 60.21 Favored Pre-proline 0 N--CA 1.443 -0.781 0 C-N-CA 123.588 0.755 . . . . 0.0 110.478 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.72 148.31 12.42 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 C-N-CA 122.553 2.169 . . . . 0.0 109.449 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.58 -17.18 45.93 Favored Glycine 0 CA--C 1.489 -1.538 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.19 114.36 2.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.002 2.521 . . . . 0.0 107.835 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.78 -18.46 14.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -84.29 -8.67 58.95 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.725 0.81 . . . . 0.0 108.901 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 tt -54.02 69.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 128.809 2.844 . . . . 0.0 114.981 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -140.66 -122.01 0.11 Allowed 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 119.476 -2.015 . . . . 0.0 107.373 -165.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -179.21 -67.45 0.0 OUTLIER Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.9 -29.09 18.95 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 125.201 2.893 . . . . 0.0 111.491 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -91.17 0.85 57.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.407 1.083 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.58 64.32 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.246 -0.909 . . . . 0.0 108.712 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -72.52 -20.46 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 123.084 0.554 . . . . 0.0 110.478 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -66.32 -47.55 73.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -67.06 -44.04 81.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.879 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.3 m -56.02 -33.55 65.01 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.49 HG22 HD13 ' B' ' 19' ' ' LEU . 58.3 t -74.0 -41.52 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.93 -40.73 94.33 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -57.1 -37.51 72.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.653 1.181 . . . . 0.0 111.608 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.18 -22.42 63.91 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 123.089 0.556 . . . . 0.0 112.119 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.0 p -84.67 -14.57 48.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.422 HG22 ' HB2' ' B' ' 75' ' ' MET 0.291 19.9 p 76.19 0.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.569 2.348 . . . . 0.0 111.18 -178.344 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.65 -50.1 77.29 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 C-N-CA 123.465 0.706 . . . . 0.0 109.424 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.93 47.1 92.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.273 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -45.63 -32.31 2.3 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.72 12.46 5.0 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.95 -54.98 16.61 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.628 -0.925 . . . . 0.0 111.108 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -121.78 156.12 33.85 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.83 139.52 34.83 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 102.08 -3.304 . . . . 0.0 102.08 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.11 -173.26 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.145 3.23 . . . . 0.0 108.873 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.664 HG22 ' H ' ' B' ' 64' ' ' THR . 12.9 p -137.23 -158.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.664 ' H ' HG22 ' B' ' 63' ' ' VAL . 53.2 m -92.92 -39.18 11.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 109.672 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.35 -23.59 59.05 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.386 -0.821 . . . . 0.0 110.612 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -29.33 70.59 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 123.732 1.73 . . . . 0.0 108.254 173.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.86 67.21 1.18 Allowed Glycine 0 CA--C 1.461 -3.321 1 N-CA-C 102.335 -4.306 . . . . 0.0 102.335 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -29.61 -24.43 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 133.034 4.534 . . . . 0.0 115.342 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -62.82 0.68 0.49 Allowed 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 125.961 1.704 . . . . 0.0 114.03 165.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.24 -56.11 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.125 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 165.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.21 -43.6 78.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.228 1.411 . . . . 0.0 111.487 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.04 -46.4 61.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.484 1.914 . . . . 0.0 110.805 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.18 -40.13 86.52 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.353 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.23 -49.0 79.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 119.19 0.905 . . . . 0.0 110.055 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.422 ' HB2' HG22 ' B' ' 54' ' ' THR . 21.3 ptp -68.08 -41.45 81.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.936 -0.478 . . . . 0.0 110.338 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -69.37 -32.85 72.15 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.08 89.77 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 123.292 0.637 . . . . 0.0 110.457 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.41 -49.69 63.94 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.42 -51.25 66.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 109.841 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.77 -7.11 56.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.519 -1.363 . . . . 0.0 112.954 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -83.86 -54.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -60.66 -29.79 69.5 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.73 0.812 . . . . 0.0 110.155 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.09 -19.74 36.21 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.418 0.687 . . . . 0.0 112.58 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.74 -37.32 59.45 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 119.153 -2.217 . . . . 0.0 107.747 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' B' ' 8' ' ' ALA . 10.4 m -73.07 -5.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 121.383 -0.823 . . . . 0.0 111.544 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.1 m -55.96 -20.54 16.67 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 110.593 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.94 95.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 119.859 -1.776 . . . . 0.0 113.032 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.25 70.55 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 124.516 1.127 . . . . 0.0 108.042 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.54 -27.61 61.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.53 75.48 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.775 -1.828 . . . . 0.0 110.594 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -12.32 28.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.006 -1.059 . . . . 0.0 112.577 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.38 -15.66 61.85 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 119.789 1.177 . . . . 0.0 111.12 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' C' ' 91' ' ' THR . 5.4 p90 -76.14 -26.64 56.51 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.336 -1.477 . . . . 0.0 111.067 171.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.93 -34.0 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.135 0.974 . . . . 0.0 108.504 -171.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -61.59 -20.01 62.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.501 1.12 . . . . 0.0 112.348 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -64.66 -32.93 74.82 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.77 0.828 . . . . 0.0 110.813 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -71.94 -32.45 67.34 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.479 -1.388 . . . . 0.0 109.938 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.62 -42.55 86.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.11 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' HE1' ' B' ' 103' ' ' HIS . 61.6 mm-40 -76.11 -9.63 58.78 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -69.83 -27.6 65.0 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 120.987 -1.071 . . . . 0.0 109.82 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -79.03 -31.92 44.78 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.57 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.57 -11.49 64.86 Favored Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.412 ' HE1' ' OE2' ' B' ' 99' ' ' GLU . 80.9 m80 . . . . . 0 CA--C 1.508 -0.645 0 C-N-CA 125.321 1.448 . . . . 0.0 108.739 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.23 -100.47 0.06 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 127.841 2.456 . . . . 0.0 111.585 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -171.49 -62.92 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -58.86 -28.96 66.59 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 127.082 2.153 . . . . 0.0 113.492 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.86 -32.86 72.84 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.848 1.259 . . . . 0.0 109.92 -168.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -65.35 -43.67 90.11 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.533 1.133 . . . . 0.0 109.992 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -72.11 -37.06 69.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.986 0.914 . . . . 0.0 108.915 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.16 95.89 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -71.3 -35.36 71.26 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.899 0.88 . . . . 0.0 110.317 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.3 88.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.085 0.954 . . . . 0.0 111.833 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.8 -33.83 76.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.42 -0.8 . . . . 0.0 111.623 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.01 -35.2 74.19 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.658 0.742 . . . . 0.0 109.601 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -69.62 -29.71 67.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.534 0.734 . . . . 0.0 110.24 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.94 -40.84 95.64 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.77 -34.96 75.27 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.55 -0.719 . . . . 0.0 110.775 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -64.48 -40.72 96.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.505 1.122 . . . . 0.0 111.23 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.4 -31.36 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.618 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.49 -50.23 74.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 126.223 1.809 . . . . 0.0 109.543 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -72.69 -23.93 60.94 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.88 -1.137 . . . . 0.0 110.601 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -72.36 -37.15 68.88 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 -31.58 72.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.156 0.982 . . . . 0.0 112.178 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -58.21 -45.23 88.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.894 1.331 . . . . 0.0 111.578 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -70.63 -47.16 61.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.181 1.792 . . . . 0.0 107.506 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -65.28 -31.0 71.92 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 124.452 1.101 . . . . 0.0 112.674 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.69 68.61 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.93 1.292 . . . . 0.0 110.391 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.43 -36.86 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.399 0.68 . . . . 0.0 110.348 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.72 -38.95 89.81 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.466 -0.772 . . . . 0.0 109.701 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.41 71.54 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.175 1.79 . . . . 0.0 111.562 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -67.32 -24.33 65.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 125.178 1.391 . . . . 0.0 112.307 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -91.91 115.95 28.5 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.79 -48.26 0.98 Allowed Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.88 150.52 38.72 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.322 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.81 162.89 18.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.821 1.681 . . . . 0.0 110.263 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 30.76 12.8 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.11 137.14 56.11 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 117.995 0.898 . . . . 0.0 111.94 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.62 -41.96 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 123.828 0.851 . . . . 0.0 110.024 -170.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.85 -27.04 57.67 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.866 1.266 . . . . 0.0 108.412 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 tp -37.22 106.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 127.911 2.484 . . . . 0.0 113.343 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t -172.03 -131.39 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.3 -70.42 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.731 0 CA-C-O 116.914 -1.517 . . . . 0.0 107.038 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.21 -11.55 19.32 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 CA-C-N 125.004 2.823 . . . . 0.0 111.925 -163.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.57 1.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.341 2.657 . . . . 0.0 107.725 -175.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.28 -34.38 70.61 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.065 0.936 . . . . 0.0 110.214 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.01 -19.5 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 125.334 1.454 . . . . 0.0 109.994 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -50.85 28.77 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.599 -1.938 . . . . 0.0 107.511 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -63.32 -34.25 77.29 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 121.957 0.884 . . . . 0.0 111.399 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -73.06 -31.16 64.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.587 -1.945 . . . . 0.0 110.907 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.95 -53.39 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 123.922 0.889 . . . . 0.0 108.677 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' C' ' 56' ' ' GLY . 20.3 pt-20 -64.37 -30.91 71.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.014 0.526 . . . . 0.0 111.773 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 79.5 m -70.83 -48.37 54.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.814 0.846 . . . . 0.0 110.754 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -27.52 64.38 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.792 -1.193 . . . . 0.0 111.232 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -85.37 -4.26 59.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.927 -0.483 . . . . 0.0 111.124 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p 55.23 64.2 1.86 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 125.495 1.518 . . . . 0.0 112.059 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.86 -87.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 101.592 -3.485 . . . . 0.0 101.592 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' C' ' 50' ' ' GLU . . . 87.21 80.73 1.21 Allowed Glycine 0 CA--C 1.494 -1.254 0 N-CA-C 104.722 -3.351 . . . . 0.0 104.722 -172.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.447 ' CD2' ' HA3' ' D' ' 56' ' ' GLY . 17.8 t80 -76.34 -30.37 57.61 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.97 35.22 3.77 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.99 -38.44 57.39 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -135.07 157.34 47.19 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -129.41 138.11 32.42 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.37 168.04 22.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.515 2.143 . . . . 0.0 109.307 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' C' ' 63' ' ' VAL . 1.1 m -63.74 175.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 122.242 1.02 . . . . 0.0 111.688 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -83.36 -88.06 0.1 Allowed 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 120.958 -1.089 . . . . 0.0 108.323 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -34.17 -58.03 0.47 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.954 2.502 . . . . 0.0 116.589 -169.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -82.67 -98.93 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.68 -86.52 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.378 0 C-N-CA 126.395 1.95 . . . . 0.0 113.496 160.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -58.11 -42.43 85.72 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.301 1.44 . . . . 0.0 112.157 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -58.87 -27.08 64.84 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 118.902 -2.374 . . . . 0.0 112.283 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.18 -55.25 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.5 77.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.001 1.721 . . . . 0.0 112.713 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.0 -43.06 73.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 128.428 2.691 . . . . 0.0 108.555 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -68.2 -43.71 77.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 123.894 0.878 . . . . 0.0 110.188 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.51 -48.88 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 124.32 1.048 . . . . 0.0 110.16 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 23.2 ptp -66.56 -34.47 77.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.557 -0.715 . . . . 0.0 110.333 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -68.7 -30.53 69.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.308 -0.87 . . . . 0.0 110.744 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.11 86.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.909 -0.494 . . . . 0.0 110.206 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.42 92.0 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 123.823 0.725 . . . . 0.0 111.338 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -54.7 -47.46 73.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 125.378 1.471 . . . . 0.0 110.527 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -70.25 -28.41 65.21 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.769 -0.582 . . . . 0.0 112.027 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.58 -48.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 121.008 -1.057 . . . . 0.0 109.509 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -67.14 -25.85 66.38 Favored 'General case' 0 CA--C 1.509 -0.609 0 O-C-N 121.495 -0.753 . . . . 0.0 110.927 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.39 -36.89 57.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.79 -41.83 97.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 124.676 1.19 . . . . 0.0 110.516 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.04 -9.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 O-C-N 121.113 -0.992 . . . . 0.0 111.673 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -19.46 64.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 110.078 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.86 -32.94 74.88 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.434 1.093 . . . . 0.0 111.771 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.4 63.12 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.446 1.098 . . . . 0.0 109.914 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 -32.68 26.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.56 63.64 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.003 -1.061 . . . . 0.0 111.161 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.438 HG23 ' HB2' ' B' ' 93' ' ' PHE . 8.7 p -75.66 -10.82 59.77 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 120.035 -1.665 . . . . 0.0 110.823 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.337 46.5 m-20 -90.9 -0.77 57.82 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.582 -1.647 . . . . 0.0 109.511 -158.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -89.01 -10.37 47.85 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.906 161.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -96.13 -51.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.49 -17.87 24.5 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.396 2.279 . . . . 0.0 111.983 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -68.01 -12.57 61.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.655 -1.278 . . . . 0.0 112.255 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -63.41 145.95 54.55 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 119.956 -1.715 . . . . 0.0 108.097 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 69.01 -63.93 0.35 Allowed 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.204 1.402 . . . . 0.0 111.915 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -63.04 -19.07 64.02 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.05 1.74 . . . . 0.0 111.563 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.8 -33.04 74.37 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.87 -1.144 . . . . 0.0 111.5 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -66.94 -40.28 87.51 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.467 -0.771 . . . . 0.0 109.512 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.83 44.66 19.11 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 CA--C 1.492 -1.26 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 177.049 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.15 80.88 0.06 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.789 2.435 . . . . 0.0 114.006 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -28.91 70.38 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.117 -0.989 . . . . 0.0 112.703 -169.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -63.02 -33.19 74.89 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.202 -0.936 . . . . 0.0 112.44 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.44 -31.99 37.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.876 -1.14 . . . . 0.0 108.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.16 -35.96 74.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.902 -1.124 . . . . 0.0 110.725 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.25 -38.99 93.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.947 1.699 . . . . 0.0 110.154 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.21 92.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.153 0.981 . . . . 0.0 111.896 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -65.34 -32.94 74.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.522 1.129 . . . . 0.0 111.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -68.79 -36.16 77.93 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.742 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.63 94.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.485 0.714 . . . . 0.0 110.752 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.19 -44.14 87.91 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.416 1.086 . . . . 0.0 111.525 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -68.34 -44.1 76.06 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.266 1.026 . . . . 0.0 109.148 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -68.41 -31.57 71.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.584 -0.698 . . . . 0.0 110.409 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.43 -44.03 92.99 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.509 0.723 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.0 -30.83 71.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -65.91 -41.04 91.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.732 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.67 -38.28 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 C-N-CA 123.965 0.906 . . . . 0.0 108.897 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 37.3 mt -60.37 -48.44 81.73 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.204 1.002 . . . . 0.0 110.279 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -67.45 -36.49 81.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.565 -0.709 . . . . 0.0 111.736 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.63 -47.48 78.4 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.66 -41.52 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.367 1.467 . . . . 0.0 110.997 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 58.4 m -52.21 -49.45 63.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 126.064 1.746 . . . . 0.0 112.134 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -61.94 -50.89 70.34 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -62.66 -42.9 99.87 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 117.676 -1.154 . . . . 0.0 110.12 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.34 -47.69 62.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.822 2.049 . . . . 0.0 111.519 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.9 -41.62 76.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.776 -1.202 . . . . 0.0 111.372 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.53 -16.12 37.92 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.128 0.971 . . . . 0.0 109.982 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.12 -56.74 3.89 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.798 1.639 . . . . 0.0 106.73 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.94 -33.65 76.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.999 -0.438 . . . . 0.0 110.418 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -71.3 111.9 7.0 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.942 -1.098 . . . . 0.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.88 -32.18 4.69 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.31 73.5 Favored Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 123.521 0.728 . . . . 0.0 110.025 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.73 110.18 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.073 1.848 . . . . 0.0 113.255 -171.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.39 42.88 2.87 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.719 -2.952 . . . . 0.0 105.719 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.01 163.71 24.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.686 1.194 . . . . 0.0 109.301 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.67 -59.59 0.76 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' D' ' 60' ' ' ARG . 8.3 tt -84.67 130.76 34.67 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -150.29 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -142.1 125.74 16.88 Favored 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 119.784 -1.822 . . . . 0.0 109.362 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.04 -48.9 95.79 Favored Pre-proline 0 C--N 1.353 0.735 0 CA-C-O 116.473 -1.727 . . . . 0.0 112.282 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.36 -8.17 22.2 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 CA-C-N 125.33 2.939 . . . . 0.0 112.345 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -101.27 -19.59 15.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.27 75.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 121.043 -1.036 . . . . 0.0 111.519 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -65.92 -28.88 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.612 1.165 . . . . 0.0 110.092 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -86.19 -26.18 25.25 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.483 -0.761 . . . . 0.0 109.788 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -79.17 -34.42 43.15 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.8 m -79.06 51.07 1.1 Allowed 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.721 -0.612 . . . . 0.0 110.669 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.21 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.33 -22.92 55.04 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.416 1.486 . . . . 0.0 113.713 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.411 HG22 ' H ' ' D' ' 51' ' ' THR . 5.1 t -72.15 -35.82 69.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.666 -1.271 . . . . 0.0 109.795 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.29 42.39 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.035 -1.041 . . . . 0.0 109.613 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.22 -2.03 54.56 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.861 0.865 . . . . 0.0 109.615 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p 58.93 40.8 22.09 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 127.062 2.145 . . . . 0.0 112.733 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.41 65.69 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' C' ' 57' ' ' TYR . . . -70.25 99.78 0.74 Allowed Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -35.05 40.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.08 39.99 0.17 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.0 -51.38 16.12 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 118.827 1.314 . . . . 0.0 109.249 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.424 ' HD3' HD12 ' D' ' 38' ' ' LEU . 0.1 OUTLIER -141.49 173.27 11.65 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -137.16 127.93 16.16 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.08 -179.44 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.185 3.257 . . . . 0.0 109.481 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.507 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 6.8 t -112.26 -97.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 124.087 0.955 . . . . 0.0 110.076 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -165.67 -46.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -71.96 -10.22 59.47 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.507 ' CG ' ' H ' ' D' ' 63' ' ' VAL . 0.9 OUTLIER -60.84 -33.11 72.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.502 1.121 . . . . 0.0 109.996 172.166 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.25 -33.02 1.13 Allowed Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.391 -3.483 . . . . 0.0 104.391 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.435 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 37.6 ttm180 74.09 -50.74 0.69 Allowed 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 130.071 3.348 . . . . 0.0 107.578 -171.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -71.76 12.11 0.42 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.672 2.789 . . . . 0.0 110.884 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.89 -61.03 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -49.18 69.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 123.168 0.587 . . . . 0.0 111.031 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.02 -40.24 66.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.935 0.894 . . . . 0.0 111.418 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.8 -37.03 73.26 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 121.708 -0.62 . . . . 0.0 111.348 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.36 -41.95 57.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.146 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 10.3 mtp -56.37 -51.66 67.49 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.826 1.251 . . . . 0.0 110.587 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.75 -40.66 97.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.388 0.675 . . . . 0.0 110.768 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.04 87.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.763 0.825 . . . . 0.0 110.985 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.63 -49.44 64.35 Favored Glycine 0 CA--C 1.496 -1.119 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.62 -49.44 80.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 124.186 0.995 . . . . 0.0 110.339 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . 0.273 11.9 pt-20 -77.95 -9.61 59.18 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 120.202 -1.561 . . . . 0.0 112.664 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.69 -47.17 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -67.47 -20.78 65.52 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 121.462 -0.774 . . . . 0.0 111.137 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.6 -14.78 29.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.659 0.742 . . . . 0.0 111.717 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.18 -38.56 56.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 119.876 -1.765 . . . . 0.0 107.651 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 6.6 m -66.96 -6.39 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.646 0.778 . . . . 0.0 111.458 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.1 m -63.11 -17.77 62.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.375 1.47 . . . . 0.0 111.487 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.56 62.41 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 120.053 -1.655 . . . . 0.0 111.759 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.32 6.32 17.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 125.166 1.386 . . . . 0.0 111.087 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 92.5 mt -113.47 -39.29 4.13 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.28 -13.16 61.44 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.779 -1.2 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -70.7 -19.17 62.79 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 120.956 -1.09 . . . . 0.0 110.879 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.19 7.47 46.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 119.699 1.136 . . . . 0.0 110.6 -160.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -91.99 -20.5 21.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 158.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.9 -40.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -57.75 -38.24 75.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 126.711 2.005 . . . . 0.0 111.163 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.13 -8.64 55.78 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.386 0.674 . . . . 0.0 112.732 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -105.07 148.67 26.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.268 48.9 mt-10 71.58 -55.96 0.65 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 126.705 2.002 . . . . 0.0 111.813 -174.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.65 -22.18 66.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.354 1.062 . . . . 0.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -68.75 -17.69 64.09 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.641 -1.287 . . . . 0.0 113.202 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -92.49 -10.29 38.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.63 66.64 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 . . . . . 0 CA--C 1.493 -1.243 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 -175.042 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.2 -29.99 71.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.041 1.336 . . . . 0.0 109.323 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -91.94 -2.46 56.76 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 121.267 -0.896 . . . . 0.0 111.712 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.21 -36.46 19.44 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 119.599 1.09 . . . . 0.0 108.965 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -67.71 -35.01 78.01 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.894 -1.129 . . . . 0.0 110.305 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -75.43 -34.38 60.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 121.769 -0.582 . . . . 0.0 109.651 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.04 82.45 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.798 0.839 . . . . 0.0 109.715 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -60.49 -38.37 84.08 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.662 1.185 . . . . 0.0 111.417 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -56.3 -42.5 77.65 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.569 1.148 . . . . 0.0 110.612 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.06 -32.29 73.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.632 -0.668 . . . . 0.0 111.061 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.11 -27.68 67.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.625 -0.672 . . . . 0.0 111.853 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.35 -39.26 81.92 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 109.158 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.47 -36.17 82.88 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.488 0.715 . . . . 0.0 110.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -38.89 92.91 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.607 0.717 . . . . 0.0 111.057 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -69.08 -21.01 64.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.364 1.066 . . . . 0.0 111.883 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -72.51 -40.72 66.62 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -64.46 -38.88 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.845 0.858 . . . . 0.0 108.709 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.92 -43.26 86.15 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.556 1.142 . . . . 0.0 111.859 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.82 -53.86 53.39 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.321 1.058 . . . . 0.0 110.251 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -73.06 -28.96 62.62 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.265 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.06 89.19 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 124.925 1.29 . . . . 0.0 110.428 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m -56.96 -37.82 72.11 Favored 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.498 1.119 . . . . 0.0 112.042 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -75.59 -51.68 12.32 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.387 0.675 . . . . 0.0 110.854 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.3 -38.22 88.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 120.989 -1.069 . . . . 0.0 109.498 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.96 75.25 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.353 1.461 . . . . 0.0 112.505 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.38 -33.05 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 O-C-N 121.375 -0.828 . . . . 0.0 111.415 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.34 -44.82 50.73 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -66.88 -42.8 84.95 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.577 1.551 . . . . 0.0 108.721 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -79.59 -44.26 21.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -77.11 93.88 3.96 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 119.372 -2.08 . . . . 0.0 110.537 -172.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.87 -17.85 3.41 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.98 151.4 54.6 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.025 0.912 . . . . 0.0 109.196 -176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.84 137.07 13.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.839 2.36 . . . . 0.0 110.731 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 -4.61 83.64 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 118.784 0.72 . . . . 0.0 111.306 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.88 146.76 54.06 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.492 1.117 . . . . 0.0 111.662 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.66 -11.1 1.59 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.519 1.128 . . . . 0.0 111.138 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.11 -66.32 0.73 Allowed 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.088 -1.007 . . . . 0.0 111.152 -172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 40' ' ' SER 0.495 44.9 pt 58.28 -100.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 174.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 39' ' ' ILE . 24.7 m -54.11 143.23 22.97 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -56.05 -57.45 22.12 Favored Pre-proline 0 C--N 1.356 0.859 0 C-N-CA 125.866 1.666 . . . . 0.0 114.991 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.22 -5.58 17.16 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.258 2.913 . . . . 0.0 111.207 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -107.98 1.97 22.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.17 -45.21 9.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.79 -32.15 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 124.237 1.015 . . . . 0.0 110.781 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.86 -10.54 59.71 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.122 -0.986 . . . . 0.0 112.143 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -90.14 -22.95 21.49 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -89.32 54.7 3.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 120.151 -1.593 . . . . 0.0 109.36 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.21 -73.72 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.44 -31.72 65.7 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.506 1.922 . . . . 0.0 108.638 -169.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -52.64 -37.67 58.9 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.091 1.357 . . . . 0.0 111.627 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -16.48 58.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 119.664 -1.898 . . . . 0.0 111.919 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t -108.55 38.48 2.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.388 4.6 p 62.74 -110.31 0.34 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.597 2.359 . . . . 0.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t 70.51 -70.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.891 1.676 . . . . 0.0 110.116 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.5 -24.3 29.14 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -78.27 55.92 1.61 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 109.787 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.76 -13.65 66.43 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 120.369 -1.457 . . . . 0.0 110.358 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 t0 76.09 14.37 2.54 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 127.583 2.353 . . . . 0.0 108.751 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -148.79 -178.3 6.27 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.26 139.76 21.69 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.59 175.93 8.35 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.992 3.128 . . . . 0.0 107.766 161.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.314 2.6 p -113.43 -88.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-N 120.832 1.651 . . . . 0.0 112.046 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -157.64 -40.45 0.07 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.496 -2.003 . . . . 0.0 107.21 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.91 -23.5 31.16 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 123.121 0.568 . . . . 0.0 110.795 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 1.2 pm0 -57.8 -35.95 71.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.492 1.517 . . . . 0.0 108.043 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.04 96.35 2.08 Favored Glycine 0 CA--C 1.47 -2.74 1 N-CA-C 97.992 -6.043 . . . . 0.0 97.992 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -62.64 -17.21 59.94 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 118.726 1.263 . . . . 0.0 110.072 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -44.06 -29.63 0.63 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.561 2.744 . . . . 0.0 113.813 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.93 -40.99 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 124.593 1.157 . . . . 0.0 109.137 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 -49.05 12.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.196 -0.94 . . . . 0.0 108.617 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -47.85 -50.32 26.63 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.703 2.001 . . . . 0.0 111.721 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.1 -27.31 61.63 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.662 -0.649 . . . . 0.0 111.562 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.97 -44.15 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.9 mtm -63.19 -44.23 95.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.135 0.574 . . . . 0.0 110.539 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -65.84 -32.54 74.12 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.342 -0.849 . . . . 0.0 111.473 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.06 79.2 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.355 -0.841 . . . . 0.0 110.403 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.43 -41.34 96.46 Favored Glycine 0 CA--C 1.487 -1.695 0 C-N-CA 123.969 0.795 . . . . 0.0 111.145 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.71 -46.95 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 C-N-CA 124.078 0.951 . . . . 0.0 108.722 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.13 -39.4 94.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 120.734 -1.229 . . . . 0.0 112.302 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.85 -55.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.71 0.804 . . . . 0.0 109.361 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.39 -18.65 61.13 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.579 -0.7 . . . . 0.0 111.667 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.35 23.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.073 -1.017 . . . . 0.0 109.861 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.81 -37.27 87.05 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.935 -1.103 . . . . 0.0 110.585 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.33 -7.62 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 O-C-N 121.188 -0.945 . . . . 0.0 112.246 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -57.97 -23.95 55.98 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 124.706 1.202 . . . . 0.0 110.72 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.75 72.96 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.182 -1.574 . . . . 0.0 112.457 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.77 -39.98 56.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 120.998 -1.064 . . . . 0.0 108.612 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.59 -35.05 78.26 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.689 0.757 . . . . 0.0 110.425 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.74 68.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.672 -1.268 . . . . 0.0 112.343 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 t -84.57 5.12 29.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.709 -1.245 . . . . 0.0 109.709 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.72 -48.39 59.69 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 118.786 0.721 . . . . 0.0 109.693 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -67.98 -27.94 67.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.723 -1.235 . . . . 0.0 111.551 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -29.1 46.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 125.085 1.354 . . . . 0.0 109.115 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -59.96 -18.51 45.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.243 1.817 . . . . 0.0 111.847 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -61.81 -36.68 81.83 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.974 1.31 . . . . 0.0 109.676 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 CA--C 1.499 -1.015 0 O-C-N 120.683 -1.261 . . . . 0.0 109.815 -169.151 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.926 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' B' ' 5' ' ' GLU . 36.8 p-80 -56.16 -30.07 61.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.425 2.29 . . . . 0.0 114.348 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' CD2' ' B' ' 4' ' ' HIS . 8.3 mt-10 -74.62 -21.2 59.59 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -79.38 -42.57 25.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.59 -31.25 66.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.038 0.447 . . . . 0.0 110.473 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.53 -43.31 93.48 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.754 0.822 . . . . 0.0 111.558 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -72.83 -30.57 64.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.773 0.797 . . . . 0.0 110.351 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -66.45 -34.4 77.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.742 0.817 . . . . 0.0 110.214 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.94 79.28 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -63.29 -36.62 84.27 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.494 -0.753 . . . . 0.0 111.0 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.99 -33.95 76.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.916 0.886 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -62.81 -41.83 99.47 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 121.246 -0.909 . . . . 0.0 109.32 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.64 -39.65 94.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.795 -0.566 . . . . 0.0 110.939 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.97 -38.05 84.58 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.368 0.667 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -62.57 -45.2 94.01 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.339 0.656 . . . . 0.0 109.568 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.53 -38.72 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 123.756 0.823 . . . . 0.0 109.72 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.91 -45.92 85.75 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.824 0.85 . . . . 0.0 111.261 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.58 -37.63 77.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.592 1.157 . . . . 0.0 110.712 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.48 -35.59 63.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.72 -0.613 . . . . 0.0 109.898 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.73 -36.79 85.02 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.142 0.977 . . . . 0.0 111.068 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -28.94 69.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.727 1.149 . . . . 0.0 112.949 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.05 -53.71 10.42 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -58.18 -48.11 81.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 125.073 1.349 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.56 -43.87 84.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.644 1.178 . . . . 0.0 112.224 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 -48.69 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 -20.35 49.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -50.67 43.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 108.504 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.83 -21.66 63.36 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 mmm-85 -70.68 90.57 0.77 Allowed 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 120.149 -1.595 . . . . 0.0 110.694 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.87 -21.45 3.01 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 107.519 -2.233 . . . . 0.0 107.519 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.44 152.26 66.91 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 117.761 0.78 . . . . 0.0 110.771 -172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.57 128.32 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.87 2.38 . . . . 0.0 110.667 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.38 -63.05 0.28 Allowed Glycine 0 CA--C 1.471 -2.688 1 N-CA-C 103.036 -4.026 . . . . 0.0 103.036 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.416 ' H ' HG21 ' B' ' 63' ' ' VAL . . . 45.41 -94.53 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 128.643 2.777 . . . . 0.0 111.503 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 83.75 -29.09 0.09 Allowed 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 127.165 2.186 . . . . 0.0 109.042 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.92 122.5 39.96 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 pt -154.44 170.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 76.61 139.83 0.07 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.017 1.727 . . . . 0.0 111.673 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -47.3 23.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.585 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -70.48 -21.6 29.91 Favored 'Trans proline' 0 CA--C 1.502 -1.089 0 CA-C-N 124.512 2.647 . . . . 0.0 112.952 -168.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.38 6.52 24.43 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 119.945 1.248 . . . . 0.0 110.37 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.67 -38.85 67.48 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.631 0.729 . . . . 0.0 109.25 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -65.09 -33.24 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 123.414 0.686 . . . . 0.0 109.773 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -41.63 84.02 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.971 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.19 0.995 . . . . 0.0 109.177 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -58.02 -41.42 83.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.976 1.31 . . . . 0.0 111.165 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.79 -51.88 67.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 O-C-N 121.49 -0.756 . . . . 0.0 111.114 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . 0.285 6.6 pt-20 -76.37 -12.1 60.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.028 -1.045 . . . . 0.0 112.538 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 90.0 m -68.33 -42.94 78.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.6 67.38 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.323 -1.486 . . . . 0.0 112.287 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -76.58 -18.86 58.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.851 -0.531 . . . . 0.0 111.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.311 13.9 p 68.6 10.31 7.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.616 2.366 . . . . 0.0 111.307 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.23 -53.72 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.14 -46.65 3.67 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 120.838 -1.164 . . . . 0.0 110.554 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 76.91 -67.08 0.22 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 128.187 2.595 . . . . 0.0 109.002 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.69 27.79 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.03 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.36 178.22 7.45 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -156.23 154.62 27.7 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.91 174.5 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.073 2.515 . . . . 0.0 111.465 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.416 HG21 ' H ' ' B' ' 36' ' ' ALA . 2.4 t -95.83 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.914 0.885 . . . . 0.0 111.165 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -128.62 -32.08 2.18 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.448 1.899 . . . . 0.0 107.657 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -92.58 -6.2 50.01 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.769 0.827 . . . . 0.0 108.801 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -35.4 59.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.62 64.44 0.67 Allowed Glycine 0 CA--C 1.468 -2.897 0 N-CA-C 103.12 -3.992 . . . . 0.0 103.12 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -31.79 -16.82 0.0 OUTLIER 'General case' 0 C--N 1.369 1.45 1 C-N-CA 132.816 4.446 . . . . 0.0 117.7 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.46 -15.41 2.69 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.275 -1.516 . . . . 0.0 113.428 158.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.25 -54.6 32.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.171 1.388 . . . . 0.0 107.973 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.1 -46.0 75.55 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.463 -0.773 . . . . 0.0 110.31 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -49.73 -43.12 47.52 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 126.084 1.754 . . . . 0.0 111.393 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.38 -50.02 73.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.442 1.097 . . . . 0.0 110.913 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.84 -43.44 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.597 0.759 . . . . 0.0 109.624 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtm -63.14 -48.8 76.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.373 1.069 . . . . 0.0 110.134 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -71.61 -27.25 62.99 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.289 -0.882 . . . . 0.0 110.813 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.78 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.872 -1.142 . . . . 0.0 109.824 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.82 61.42 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -58.71 -45.56 90.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 C-N-CA 124.035 0.934 . . . . 0.0 110.52 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.55 -27.97 68.83 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.516 -1.365 . . . . 0.0 112.569 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.75 -46.71 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 120.368 -1.458 . . . . 0.0 108.247 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -65.95 -21.57 66.43 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.934 0.894 . . . . 0.0 110.956 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -42.78 16.43 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.619 1.167 . . . . 0.0 110.732 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.8 -40.4 83.96 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.208 1.403 . . . . 0.0 111.031 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 29.2 m -63.33 -8.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 123.836 0.855 . . . . 0.0 112.393 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.7 m -64.72 -12.58 48.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.678 -1.264 . . . . 0.0 110.535 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.96 65.98 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.828 -1.795 . . . . 0.0 112.098 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.51 -37.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.951 -1.093 . . . . 0.0 109.108 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.02 -36.59 64.46 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.417 -0.802 . . . . 0.0 111.267 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.33 -12.82 60.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.847 -1.158 . . . . 0.0 111.187 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -96.88 1.44 50.55 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.945 -1.097 . . . . 0.0 108.974 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.3 -37.3 66.26 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 120.305 1.411 . . . . 0.0 109.017 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -66.74 -30.01 70.13 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 120.289 -1.507 . . . . 0.0 111.406 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.6 -22.95 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.091 1.357 . . . . 0.0 109.6 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.92 -25.31 65.03 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.07 -1.019 . . . . 0.0 111.519 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -8.51 54.04 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.526 -1.359 . . . . 0.0 112.36 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 CA--C 1.496 -1.098 0 O-C-N 120.298 -1.501 . . . . 0.0 107.625 173.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 . . . . . 0 CA--C 1.501 -0.906 0 CA-C-O 122.88 1.324 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -19.99 63.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.691 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.15 -38.67 20.37 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -62.78 -32.2 73.32 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.503 -1.373 . . . . 0.0 112.182 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -64.48 -36.09 83.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.07 0.948 . . . . 0.0 110.936 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -44.73 62.04 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.173 -0.954 . . . . 0.0 109.519 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -66.83 -33.36 75.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.487 0.66 . . . . 0.0 111.345 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.97 -37.51 79.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.672 1.989 . . . . 0.0 111.113 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.01 -38.86 66.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.948 0.899 . . . . 0.0 110.291 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.05 -40.82 90.75 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.084 -1.01 . . . . 0.0 110.962 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.61 -18.03 62.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.298 -0.876 . . . . 0.0 111.728 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -73.83 -38.39 64.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.94 -38.11 89.89 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.249 0.62 . . . . 0.0 110.544 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.26 -24.94 68.09 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.604 -0.685 . . . . 0.0 112.449 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -80.12 -23.75 40.98 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.373 1.469 . . . . 0.0 109.55 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.17 -35.52 20.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 124.46 1.104 . . . . 0.0 108.034 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -60.55 -33.94 73.41 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.88 0.872 . . . . 0.0 111.462 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -60.62 -50.14 74.71 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.663 1.185 . . . . 0.0 110.225 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.38 -41.0 96.93 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 121.573 -0.704 . . . . 0.0 109.995 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.25 87.18 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.536 1.135 . . . . 0.0 110.389 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 83.5 p -62.72 -33.41 75.06 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.63 0.728 . . . . 0.0 112.116 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -80.15 -54.31 5.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.57 -30.79 67.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.772 0.829 . . . . 0.0 109.467 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.95 76.1 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 125.052 1.341 . . . . 0.0 112.736 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.23 -34.21 57.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 O-C-N 120.896 -1.128 . . . . 0.0 110.615 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.61 -40.63 73.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.852 -1.155 . . . . 0.0 109.389 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.6 1.09 Allowed 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.398 1.479 . . . . 0.0 109.53 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.34 -31.4 0.05 Allowed 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 123.694 0.621 . . . . 0.0 109.446 171.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -70.4 81.65 0.56 Allowed 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.224 -1.547 . . . . 0.0 111.915 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.66 -4.24 1.43 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.6 148.1 68.88 Favored Pre-proline 0 N--CA 1.442 -0.867 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -169.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -78.01 81.83 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.141 2.56 . . . . 0.0 113.182 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.68 34.11 3.15 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 146.18 13.89 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 126.813 2.045 . . . . 0.0 112.402 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.46 -46.07 1.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 125.169 1.388 . . . . 0.0 108.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.1 115.81 18.11 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 122.111 0.958 . . . . 0.0 108.603 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.8 163.21 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t 75.28 131.39 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.882 1.273 . . . . 0.0 112.377 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -67.29 -45.82 49.84 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 116.333 -1.794 . . . . 0.0 111.929 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.23 -10.54 27.4 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 CA-C-N 125.208 2.896 . . . . 0.0 113.904 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.361 0.7 OUTLIER -103.66 -19.43 14.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 121.372 1.896 . . . . 0.0 110.408 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.24 73.92 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.086 0.954 . . . . 0.0 112.214 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tp -66.05 -29.97 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.482 -0.762 . . . . 0.0 110.846 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -34.7 55.04 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -58.71 -41.99 87.59 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 122.385 1.088 . . . . 0.0 109.743 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -10.54 55.24 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.761 -1.212 . . . . 0.0 114.006 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.29 -47.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.5 57.56 4.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.607 1.563 . . . . 0.0 110.722 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -160.66 -51.21 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.64 -6.33 51.61 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.398 -1.439 . . . . 0.0 111.373 -170.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -80.52 -7.44 59.2 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.075 2.15 . . . . 0.0 110.459 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.309 34.2 p 76.93 17.76 1.63 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.689 2.396 . . . . 0.0 110.44 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.71 111.55 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.54 0.83 Allowed Glycine 0 CA--C 1.481 -2.075 1 N-CA-C 101.805 -4.518 . . . . 0.0 101.805 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.18 -33.06 38.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.92 -116.49 1.33 Allowed Glycine 0 CA--C 1.479 -2.187 0 N-CA-C 103.269 -3.932 . . . . 0.0 103.269 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.302 43.7 t0 64.13 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.348 0.52 0 C-N-CA 126.686 1.994 . . . . 0.0 109.825 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -128.75 158.96 37.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -161.05 147.0 11.16 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.01 163.62 22.9 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 122.795 2.33 . . . . 0.0 109.65 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.259 8.2 t -98.88 -105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -168.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -134.72 -60.04 0.79 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.371 -2.081 . . . . 0.0 108.827 -162.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -78.26 -6.35 54.72 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.377 1.471 . . . . 0.0 108.881 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.35 -20.77 46.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 C-N-CA 131.827 4.051 . . . . 0.0 108.028 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.69 84.36 0.84 Allowed Glycine 0 CA--C 1.482 -1.982 1 N-CA-C 101.473 -4.651 . . . . 0.0 101.473 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -23.52 24.66 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 110.92 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -57.65 -10.34 1.53 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.83 -41.21 87.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 120.059 1.3 . . . . 0.0 110.297 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.62 -51.09 21.09 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 120.991 -1.068 . . . . 0.0 109.163 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -46.05 -51.34 13.88 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 127.213 2.205 . . . . 0.0 112.966 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.98 -28.14 61.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.594 0.758 . . . . 0.0 110.714 -171.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 68.1 t -74.1 -46.08 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 79.2 mtm -59.98 -42.75 94.86 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.36 0.664 . . . . 0.0 111.231 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -65.37 -27.27 68.45 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 121.706 -0.621 . . . . 0.0 111.649 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.73 71.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.196 -0.94 . . . . 0.0 110.681 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.83 -35.83 61.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.57 -46.57 96.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 108.672 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.0 -50.33 73.76 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.73 -52.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 124.979 1.312 . . . . 0.0 110.379 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.29 -0.7 42.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.247 -0.908 . . . . 0.0 111.337 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.12 -37.58 14.12 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 120.733 -1.23 . . . . 0.0 108.295 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.48 -34.83 76.13 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 125.215 1.406 . . . . 0.0 111.344 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.88 -9.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 C-N-CA 124.079 0.952 . . . . 0.0 113.069 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -59.57 -24.19 63.53 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 125.52 1.528 . . . . 0.0 111.396 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.01 -23.56 66.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.771 -1.206 . . . . 0.0 111.562 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.43 -42.93 13.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.86 -41.59 91.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.44 1.096 . . . . 0.0 112.806 -171.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.75 -5.82 40.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.869 -1.144 . . . . 0.0 111.769 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.14 -8.48 25.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.35 -39.64 74.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.504 1.047 . . . . 0.0 109.305 -167.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -80.31 -15.02 57.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.195 -1.565 . . . . 0.0 113.04 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.16 -27.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.608 -1.308 . . . . 0.0 107.562 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 35.3 ttm105 -55.83 -23.4 30.28 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 126.405 1.882 . . . . 0.0 111.937 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -59.54 -32.67 70.54 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.421 -1.424 . . . . 0.0 111.732 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--N 1.355 0.822 0 O-C-N 121.005 -1.059 . . . . 0.0 108.487 -175.37 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 CA-C-O 121.851 0.834 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.98 -26.0 68.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.463 -1.398 . . . . 0.0 111.56 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.18 -24.86 60.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.259 -0.9 . . . . 0.0 111.308 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -30.2 38.58 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -67.42 -44.77 77.94 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.57 -0.706 . . . . 0.0 110.31 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.49 -38.36 74.34 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.769 -0.582 . . . . 0.0 110.384 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.85 -48.08 80.58 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.939 0.896 . . . . 0.0 111.588 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.02 -35.34 79.7 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.519 -0.738 . . . . 0.0 110.487 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.58 -31.81 73.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.837 0.855 . . . . 0.0 110.496 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.27 97.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.401 -0.812 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -29.69 70.76 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.522 0.677 . . . . 0.0 111.552 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.2 -28.85 66.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 121.251 -0.906 . . . . 0.0 110.42 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -82.47 -23.71 34.58 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.749 -1.219 . . . . 0.0 109.9 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.48 -42.97 99.6 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 120.637 -1.289 . . . . 0.0 110.5 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -59.36 -35.59 74.17 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.435 1.094 . . . . 0.0 112.162 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -66.83 -44.9 79.88 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.611 1.164 . . . . 0.0 108.926 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.24 -38.04 81.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 C-N-CA 124.259 1.023 . . . . 0.0 109.416 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.47 -44.87 81.01 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.642 0.777 . . . . 0.0 112.076 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.89 -43.69 71.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.025 0.53 . . . . 0.0 110.701 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.34 -47.21 80.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.59 1.186 . . . . 0.0 109.825 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.0 -28.68 64.61 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.017 -1.052 . . . . 0.0 111.876 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -74.42 -31.08 62.18 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 119.582 1.083 . . . . 0.0 110.769 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -62.05 -48.02 82.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -63.55 -50.68 68.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.208 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.06 70.06 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 125.291 1.437 . . . . 0.0 113.236 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.44 -35.34 61.59 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 120.947 -1.096 . . . . 0.0 110.59 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -81.78 -22.73 37.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.411 -1.431 . . . . 0.0 110.096 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -52.58 14.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 127.093 2.157 . . . . 0.0 107.778 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.84 -35.73 79.12 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.451 1.12 . . . . 0.0 110.967 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.84 103.51 2.64 Favored 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 120.184 -1.572 . . . . 0.0 111.586 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.41 -25.21 3.65 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 106.231 -2.747 . . . . 0.0 106.231 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 148.27 74.94 Favored Pre-proline 0 N--CA 1.439 -0.999 0 O-C-N 121.675 -0.897 . . . . 0.0 110.228 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 134.88 17.77 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.253 1.969 . . . . 0.0 110.131 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 26.63 61.26 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 137.28 51.26 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.287 1.835 . . . . 0.0 111.416 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.08 -47.08 2.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tt -85.93 71.27 10.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.728 1.251 . . . . 0.0 110.142 -172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -96.61 -6.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 O-C-N 120.159 -1.588 . . . . 0.0 111.205 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.2 p -95.96 141.98 28.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.097 -1.002 . . . . 0.0 110.862 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -89.73 -61.11 0.22 Allowed Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.318 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.25 -5.92 17.26 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 CA-C-N 125.797 3.106 . . . . 0.0 110.818 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.29 -18.56 21.51 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.076 1.751 . . . . 0.0 107.492 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.21 72.32 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 111.083 -168.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.26 -35.34 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 124.115 0.966 . . . . 0.0 110.515 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -36.15 74.23 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -67.95 -41.06 83.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.399 1.095 . . . . 0.0 109.393 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.8 t -60.62 -41.17 94.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.961 -1.087 . . . . 0.0 110.339 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.51 -53.35 31.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 125.432 1.493 . . . . 0.0 110.6 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -76.1 -15.35 60.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.684 -0.635 . . . . 0.0 111.62 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 73.8 m -76.41 -36.82 57.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.45 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.234 -0.916 . . . . 0.0 111.574 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.5 p -87.59 13.15 10.84 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.781 -0.575 . . . . 0.0 110.736 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p 52.56 49.02 21.3 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.296 1.839 . . . . 0.0 114.0 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.11 -55.05 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.87 -44.31 3.22 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 120.52 -1.363 . . . . 0.0 110.014 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.38 -75.72 0.07 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 127.111 2.164 . . . . 0.0 108.29 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.29 37.4 0.02 OUTLIER Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.0 -66.06 0.95 Allowed 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -130.52 -160.81 1.07 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -165.54 150.19 7.73 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.57 161.67 12.6 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.967 3.111 . . . . 0.0 108.707 168.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -154.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-N 119.893 1.224 . . . . 0.0 108.116 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -91.13 -50.07 6.05 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 119.672 -1.893 . . . . 0.0 108.687 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -77.34 -3.23 38.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.076 1.751 . . . . 0.0 110.847 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -29.8 69.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.59 80.23 1.19 Allowed Glycine 0 CA--C 1.468 -2.891 1 N-CA-C 99.1 -5.6 . . . . 0.0 99.1 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -63.16 -1.68 1.09 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.544 1.537 . . . . 0.0 112.613 -166.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -69.46 -13.3 62.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.602 1.161 . . . . 0.0 112.394 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -53.08 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.28 73.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.313 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -63.62 -34.57 78.12 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.718 0.807 . . . . 0.0 111.893 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.7 -37.08 85.99 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.967 -1.083 . . . . 0.0 111.206 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.22 -39.22 82.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 O-C-N 121.067 -1.021 . . . . 0.0 109.893 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 64.5 mtt -62.01 -50.37 72.33 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.67 0.788 . . . . 0.0 110.024 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.71 -30.64 70.93 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.496 -0.752 . . . . 0.0 110.641 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.13 96.12 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.066 -1.021 . . . . 0.0 110.469 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.09 -44.68 95.43 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 124.349 0.976 . . . . 0.0 111.428 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.64 -47.47 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 O-C-N 121.891 -0.77 . . . . 0.0 109.552 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -69.75 -32.82 71.56 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.927 -1.108 . . . . 0.0 113.306 -173.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.41 -42.48 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 110.109 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.14 -36.81 64.18 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 121.634 -0.666 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.28 -23.12 62.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.872 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.55 -32.63 72.7 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.856 -1.778 . . . . 0.0 109.797 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.48 -18.77 21.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 124.792 1.237 . . . . 0.0 110.276 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -60.05 -14.29 15.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 120.809 -1.182 . . . . 0.0 111.663 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.0 2.75 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.37 -1.456 . . . . 0.0 111.24 167.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.7 98.5 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.947 1.299 . . . . 0.0 109.517 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.12 -41.89 89.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 111.915 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.9 -11.45 60.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.978 -1.076 . . . . 0.0 110.356 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -74.72 -26.83 60.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 120.805 -1.184 . . . . 0.0 108.384 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.268 0.6 OUTLIER -80.14 -4.7 54.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 120.317 -1.489 . . . . 0.0 112.818 -160.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -81.78 -29.79 32.6 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 120.674 -1.266 . . . . 0.0 109.337 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.56 -28.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.49 1.116 . . . . 0.0 109.288 -172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -62.72 -12.38 23.45 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.272 -0.893 . . . . 0.0 111.691 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -68.96 -16.55 63.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.434 -0.791 . . . . 0.0 112.37 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 . . . . . 0 C--N 1.353 0.721 0 O-C-N 120.683 -1.261 . . . . 0.0 109.304 175.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.45 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 59.26 -80.6 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.692 2.397 . . . . 0.0 111.379 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -9.59 49.75 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.82 -42.1 91.03 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.337 -0.852 . . . . 0.0 109.18 164.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -71.73 -33.06 68.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 O-C-N 120.569 -1.332 . . . . 0.0 110.437 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.47 -38.5 87.46 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.01 93.5 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.502 1.121 . . . . 0.0 111.44 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -63.78 -36.35 83.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.476 1.51 . . . . 0.0 111.216 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -75.02 -23.87 58.25 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 121.361 0.6 . . . . 0.0 110.038 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.65 86.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.448 -2.033 . . . . 0.0 111.1 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -61.31 -37.47 83.37 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.896 0.855 . . . . 0.0 110.978 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.68 -32.86 74.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.47 1.908 . . . . 0.0 110.214 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -78.15 -32.1 50.11 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 120.895 -1.128 . . . . 0.0 109.083 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.27 -43.76 98.35 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.966 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -59.76 -35.89 75.53 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.309 0.644 . . . . 0.0 112.1 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -32.71 73.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.833 0.853 . . . . 0.0 110.908 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.57 -40.08 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.44 -37.26 86.9 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.488 -0.758 . . . . 0.0 110.917 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.19 -39.58 82.45 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.903 -1.123 . . . . 0.0 111.306 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -69.49 -37.84 77.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.715 0.806 . . . . 0.0 109.762 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.83 89.51 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 125.887 1.675 . . . . 0.0 110.746 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m -63.89 -31.68 72.94 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.968 0.907 . . . . 0.0 111.93 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -75.2 -49.56 19.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.387 -0.821 . . . . 0.0 108.826 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -73.98 -22.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.316 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.42 4.58 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 125.202 1.401 . . . . 0.0 108.553 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.6 t -64.01 -28.78 45.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 O-C-N 119.811 -1.805 . . . . 0.0 111.18 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.36 -35.09 77.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.801 -1.187 . . . . 0.0 110.757 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.73 -59.27 2.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.595 1.558 . . . . 0.0 107.804 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.12 -30.67 62.44 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.287 1.835 . . . . 0.0 112.581 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -77.89 87.12 4.09 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.316 -2.115 . . . . 0.0 110.586 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.0 -21.87 1.13 Allowed Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.39 157.9 35.51 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 118.57 1.185 . . . . 0.0 110.598 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -85.97 131.96 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.391 2.061 . . . . 0.0 111.552 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.0 60.34 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.26 137.45 58.26 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.741 1.216 . . . . 0.0 110.853 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.16 -55.97 2.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.594 0.757 . . . . 0.0 109.727 -173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.33 91.25 8.43 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.196 0.998 . . . . 0.0 109.369 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.04 50.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.322 -1.486 . . . . 0.0 109.279 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.97 148.03 23.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.996 -1.69 . . . . 0.0 109.415 170.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -69.97 -45.58 22.87 Favored Pre-proline 0 C--N 1.353 0.726 0 CA-C-O 116.184 -1.865 . . . . 0.0 112.555 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.33 -19.08 33.87 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 125.545 3.016 . . . . 0.0 113.366 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -103.89 -3.91 24.17 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 120.118 1.326 . . . . 0.0 109.91 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.57 85.7 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.347 1.07 . . . . 0.0 110.41 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 45' ' ' ILE . 14.0 tt -68.57 -22.08 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 C-N-CA 124.702 1.201 . . . . 0.0 111.081 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.03 -26.54 26.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.603 -0.685 . . . . 0.0 109.457 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -68.96 -45.15 71.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.9 m -59.28 -12.29 5.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.444 1.098 . . . . 0.0 113.776 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -71.25 -58.22 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 123.999 0.92 . . . . 0.0 108.726 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' B' ' 68' ' ' ARG . 92.2 mt-10 -83.57 75.59 10.02 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.416 -0.802 . . . . 0.0 109.434 -172.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -170.37 -45.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.35 81.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 124.358 1.063 . . . . 0.0 111.97 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 p -96.24 18.37 13.85 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 124.006 0.922 . . . . 0.0 110.652 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.65 62.92 2.21 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 127.104 2.161 . . . . 0.0 115.07 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.77 165.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 1 N-CA-C 95.267 -5.827 . . . . 0.0 95.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' D' ' 57' ' ' TYR . . . -160.65 120.74 0.97 Allowed Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 99.06 -5.616 . . . . 0.0 99.06 170.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -84.8 -17.66 37.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 119.06 1.43 . . . . 0.0 109.071 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.36 21.01 4.93 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 121.129 -0.982 . . . . 0.0 112.886 171.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.27 -39.83 22.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.031 -1.276 . . . . 0.0 112.805 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -147.86 153.05 38.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -162.96 145.14 8.03 Favored Pre-proline 0 C--N 1.354 0.776 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.08 178.77 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 2.965 . . . . 0.0 111.793 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 ' H ' ' A' ' 64' ' ' THR 0.275 9.4 p -119.54 -129.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 125.416 1.486 . . . . 0.0 108.412 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.422 ' H ' HG13 ' A' ' 63' ' ' VAL . 21.1 m -99.45 -57.87 2.06 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 119.493 -2.005 . . . . 0.0 112.069 -160.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -75.41 -9.82 58.91 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 119.182 0.901 . . . . 0.0 109.835 -171.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -71.65 -13.62 61.81 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.672 1.989 . . . . 0.0 108.89 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.5 85.26 0.87 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 100.847 -4.901 . . . . 0.0 100.847 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -56.13 -20.92 19.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.327 1.061 . . . . 0.0 112.22 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.31 -15.74 17.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 118.283 -0.865 . . . . 0.0 113.066 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.01 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.007 1.73 . . . . 0.0 109.325 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.13 -52.75 21.18 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 121.064 -1.023 . . . . 0.0 109.132 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.98 -36.65 79.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.51 -34.88 78.75 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.71 -40.79 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.208 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 53.0 mtt -60.73 -48.38 82.06 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.11 0.964 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -66.08 -33.6 76.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 110.519 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.32 89.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.77 -0.581 . . . . 0.0 110.402 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -45.83 94.86 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 124.047 0.832 . . . . 0.0 111.124 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.84 -47.75 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 124.591 1.156 . . . . 0.0 109.702 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -67.82 -31.58 71.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.784 -1.197 . . . . 0.0 112.254 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 t -66.18 -53.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 O-C-N 121.59 -0.694 . . . . 0.0 109.16 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.24 -19.2 62.39 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 121.403 -0.81 . . . . 0.0 111.358 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.18 40.37 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 120.721 -1.237 . . . . 0.0 109.998 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.44 -43.72 84.14 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.101 1.361 . . . . 0.0 110.474 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 m -68.82 -6.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -59.71 -21.48 60.68 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.491 1.041 . . . . 0.0 110.495 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.89 73.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.794 -1.191 . . . . 0.0 112.433 171.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.88 -37.6 55.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.888 0.875 . . . . 0.0 108.849 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.13 -0.357 . . . . 0.0 111.154 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.15 80.21 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.562 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -7.27 58.4 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 120.889 -1.132 . . . . 0.0 111.878 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -30.69 66.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.59 1.087 . . . . 0.0 109.557 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.85 -27.56 60.31 Favored 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 120.596 -1.315 . . . . 0.0 112.019 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.32 -22.62 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.415 1.086 . . . . 0.0 108.664 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -63.46 -21.61 66.41 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.61 -1.306 . . . . 0.0 111.615 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -71.46 -8.56 54.64 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.469 -1.394 . . . . 0.0 112.094 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.44 -0.958 0 O-C-N 120.811 -1.18 . . . . 0.0 110.011 175.009 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 61.2 t0 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.42 -26.65 58.53 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.383 1.073 . . . . 0.0 110.326 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -68.11 -32.82 73.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.725 1.61 . . . . 0.0 111.471 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.6 -40.0 80.64 Favored 'General case' 0 CA--C 1.503 -0.848 0 O-C-N 121.881 -0.512 . . . . 0.0 110.071 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.84 -37.87 79.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.08 70.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -67.26 -35.14 78.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.786 -0.571 . . . . 0.0 110.927 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -78.66 -15.22 58.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.96 -1.088 . . . . 0.0 110.771 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.17 72.18 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.564 -1.335 . . . . 0.0 108.917 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -30.45 70.01 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.714 0.805 . . . . 0.0 111.593 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.01 -36.06 81.31 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.738 0.815 . . . . 0.0 110.147 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.59 -33.08 73.44 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 123.441 0.696 . . . . 0.0 109.321 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -63.54 -40.19 96.36 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 121.396 -0.815 . . . . 0.0 110.331 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.72 -41.13 66.69 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 124.32 1.048 . . . . 0.0 111.16 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.57 -41.41 98.39 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.291 0.636 . . . . 0.0 110.875 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.58 -44.39 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 121.727 -0.608 . . . . 0.0 109.416 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tp -53.8 -52.31 60.71 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 128.018 2.527 . . . . 0.0 110.149 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.68 -34.48 64.89 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 121.382 -0.824 . . . . 0.0 110.038 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -68.05 -29.24 68.17 Favored 'General case' 0 C--N 1.355 0.848 0 CA-C-N 120.241 1.382 . . . . 0.0 109.872 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.06 66.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.906 0.882 . . . . 0.0 112.398 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 90.0 p -68.94 -42.72 76.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 O-C-N 121.114 -0.991 . . . . 0.0 110.43 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -38.05 84.87 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.04 -36.44 72.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.259 -0.901 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.61 29.42 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.927 1.291 . . . . 0.0 110.382 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.33 -33.11 52.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 123.954 0.902 . . . . 0.0 111.677 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -83.89 -16.78 43.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.958 0.903 . . . . 0.0 109.647 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.59 70.37 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.186 0.994 . . . . 0.0 109.754 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -65.14 -27.11 68.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 121.806 -0.559 . . . . 0.0 111.822 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.87 83.72 4.97 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.8 -23.74 2.77 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.69 138.67 20.75 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.892 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -82.14 105.72 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.86 2.373 . . . . 0.0 112.916 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.54 47.38 0.15 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.56 137.24 57.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.884 0.873 . . . . 0.0 111.685 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.0 -45.57 0.14 Allowed 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.137 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.38 -63.72 1.0 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.991 0.917 . . . . 0.0 108.807 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . 0.369 40.2 pt 53.8 -127.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 126.173 1.789 . . . . 0.0 112.93 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -13.01 134.85 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 132.236 4.215 . . . . 0.0 121.332 -167.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -65.21 -55.5 25.74 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 116.645 -1.645 . . . . 0.0 115.173 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.03 -5.0 15.87 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 125.076 2.848 . . . . 0.0 110.559 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.8 -42.13 12.78 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.205 1.802 . . . . 0.0 106.834 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -33.69 72.98 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.368 1.467 . . . . 0.0 112.496 -170.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.9 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 121.724 -0.61 . . . . 0.0 110.629 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -29.55 54.42 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.727 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.42 -48.3 61.4 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -60.43 -33.43 72.52 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.773 -1.205 . . . . 0.0 112.952 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.94 -24.81 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.889 1.276 . . . . 0.0 112.537 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.24 -17.93 53.84 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.013 -1.679 . . . . 0.0 109.932 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.447 ' C ' ' H ' ' B' ' 53' ' ' THR . 9.3 t -116.94 -166.17 1.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.71 -21.28 0.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 127.131 2.172 . . . . 0.0 110.846 -167.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.447 ' H ' ' C ' ' B' ' 51' ' ' THR . 2.8 p -93.51 -1.43 55.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.568 2.347 . . . . 0.0 110.759 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.274 0.0 OUTLIER 62.7 61.76 1.16 Allowed 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.308 1.443 . . . . 0.0 110.895 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.437 HG13 ' H ' ' B' ' 56' ' ' GLY . 7.6 p -137.91 -69.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.437 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 74.69 72.75 1.0 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -39.91 86.6 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 122.229 -0.571 . . . . 0.0 110.092 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.0 47.47 1.59 Allowed Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.25 -55.59 8.9 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -110.77 165.03 12.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -108.86 127.74 26.78 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.35 170.83 14.34 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.788 2.325 . . . . 0.0 109.66 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 64' ' ' THR . 1.2 t -92.86 -166.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.594 ' H ' HG12 ' B' ' 63' ' ' VAL . 32.7 m -101.09 -63.71 1.11 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.994 0.918 . . . . 0.0 109.132 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -54.61 -28.64 47.98 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -168.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -146.42 -164.36 1.96 Allowed 'General case' 0 N--CA 1.436 -1.17 1 N-CA-C 97.994 -4.817 . . . . 0.0 97.994 160.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.82 -75.34 1.1 Allowed Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 104.334 -3.506 . . . . 0.0 104.334 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 50' ' ' GLU . 17.1 ttt180 -69.53 -38.63 77.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.953 0.883 . . . . 0.0 109.996 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.13 -17.3 60.95 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.122 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.03 -45.82 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 O-C-N 119.664 -1.897 . . . . 0.0 106.1 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -35.32 64.48 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 126.182 1.793 . . . . 0.0 112.401 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -50.43 -51.95 42.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 126.586 1.954 . . . . 0.0 111.245 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.25 -37.93 88.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.912 0.885 . . . . 0.0 109.508 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.07 -41.63 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 121.727 -0.608 . . . . 0.0 110.575 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.7 mtm -63.15 -54.58 35.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 122.982 0.513 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -69.59 -27.48 65.14 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 121.554 -0.716 . . . . 0.0 111.084 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.73 -45.09 91.47 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 120.457 -1.402 . . . . 0.0 110.228 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.68 76.66 Favored Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 124.148 0.88 . . . . 0.0 111.318 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.5 -49.17 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 C-N-CA 124.842 1.257 . . . . 0.0 109.705 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.31 -21.68 62.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 120.919 -1.113 . . . . 0.0 111.628 -171.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.98 -54.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.44 -31.21 70.36 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.184 -0.947 . . . . 0.0 111.824 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.9 -22.29 61.52 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.656 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.69 -35.45 75.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 120.069 -1.645 . . . . 0.0 108.291 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.71 -17.05 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 125.051 1.34 . . . . 0.0 110.217 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -63.85 -13.39 44.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.938 -1.101 . . . . 0.0 110.937 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.84 68.7 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 110.76 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.69 85.59 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.563 1.145 . . . . 0.0 110.692 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.86 -40.8 79.13 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.217 0.607 . . . . 0.0 109.8 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.65 -22.54 63.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.445 -0.784 . . . . 0.0 110.417 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -75.18 -26.57 59.16 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.048 -1.033 . . . . 0.0 109.027 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.488 -1.383 . . . . 0.0 111.513 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -70.81 -28.5 64.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.288 -1.508 . . . . 0.0 112.012 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.55 -29.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 C-N-CA 125.28 1.432 . . . . 0.0 108.529 -173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -60.58 -28.79 68.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.508 1.523 . . . . 0.0 110.316 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -60.49 -26.16 66.61 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.289 -0.882 . . . . 0.0 111.936 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.442 -0.84 0 O-C-N 120.711 -1.243 . . . . 0.0 110.79 -176.664 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 CA--C 1.502 -0.9 0 CA-C-O 121.32 0.581 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -65.58 -26.12 67.71 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.435 -0.79 . . . . 0.0 112.151 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -77.75 -37.1 49.9 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -171.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.47 -42.41 99.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 110.569 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -70.45 -33.98 71.91 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.667 -0.645 . . . . 0.0 111.001 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.86 96.79 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -76.38 -20.42 57.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.124 -0.985 . . . . 0.0 112.141 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -70.61 -37.43 73.84 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.214 -0.929 . . . . 0.0 108.767 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.24 81.31 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.554 -0.717 . . . . 0.0 111.054 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -63.24 -36.98 85.46 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -64.52 -41.9 96.11 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 122.282 1.039 . . . . 0.0 108.655 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.15 -32.33 73.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.325 1.45 . . . . 0.0 109.711 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.48 -45.47 87.21 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.671 0.789 . . . . 0.0 110.682 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.81 -23.44 62.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.97 -1.081 . . . . 0.0 111.742 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -65.69 -46.63 78.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.75 . . . . 0.0 110.075 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.15 -25.98 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 121.068 -1.02 . . . . 0.0 110.758 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' C' ' 52' ' ' ALA . 81.8 mt -64.66 -41.38 96.14 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.385 -0.822 . . . . 0.0 111.119 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.4 -33.39 67.12 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.955 0.902 . . . . 0.0 111.531 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -67.62 -45.8 74.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.032 0.933 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.98 62.52 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.072 1.349 . . . . 0.0 110.97 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p -67.16 -39.41 86.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 119.433 1.015 . . . . 0.0 110.275 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -44.22 93.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.604 1.162 . . . . 0.0 108.427 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -67.6 -39.31 84.77 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.563 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.75 87.7 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.676 1.19 . . . . 0.0 111.878 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.93 -31.16 49.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 O-C-N 120.87 -1.144 . . . . 0.0 110.029 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.25 -19.21 43.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.763 0.825 . . . . 0.0 110.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.22 14.43 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.736 1.614 . . . . 0.0 107.024 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -80.29 -0.86 38.38 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.98 0.895 . . . . 0.0 110.869 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -74.42 81.88 1.92 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.816 1.647 . . . . 0.0 110.084 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.1 19.68 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 139.13 54.3 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 121.322 -1.105 . . . . 0.0 108.113 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.447 ' O ' HG11 ' C' ' 63' ' ' VAL . 50.8 Cg_endo -79.22 136.28 12.67 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.355 2.036 . . . . 0.0 110.437 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 4.16 89.34 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 119.529 1.059 . . . . 0.0 111.971 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 129.11 20.17 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 126.896 2.078 . . . . 0.0 114.107 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.34 -38.02 11.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.992 0.901 . . . . 0.0 108.682 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.3 tp -89.27 125.35 35.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 pt -144.45 -22.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -80.22 150.42 30.1 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.726 -0.609 . . . . 0.0 111.894 -171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.46 -64.52 0.3 Allowed Pre-proline 0 C--N 1.35 0.62 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.198 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.86 -26.89 21.89 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 125.691 3.068 . . . . 0.0 109.936 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 -14.89 61.2 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.538 0.735 . . . . 0.0 109.723 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.39 85.15 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.147 -0.971 . . . . 0.0 110.439 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -72.65 -22.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 121.736 -0.603 . . . . 0.0 110.488 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -72.52 -31.08 65.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -74.87 -37.21 62.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.485 -1.385 . . . . 0.0 108.647 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -76.13 64.38 1.96 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.916 1.287 . . . . 0.0 108.594 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -144.95 -67.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.76 -23.29 66.69 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.689 1.196 . . . . 0.0 112.561 -167.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m -68.06 -37.28 81.1 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.567 1.547 . . . . 0.0 110.629 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -77.24 -24.42 51.18 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.549 -0.719 . . . . 0.0 110.138 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 6.9 p -90.98 9.33 31.09 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.778 -0.576 . . . . 0.0 109.796 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 48.63 60.73 3.48 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 126.823 2.049 . . . . 0.0 113.684 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.1 -87.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.91 76.38 1.3 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -73.85 -20.48 60.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.415 -1.05 . . . . 0.0 111.411 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.16 32.66 3.68 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.64 -53.42 22.63 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -147.0 169.02 20.08 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -148.14 148.92 30.99 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.92 163.11 18.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.125 3.217 . . . . 0.0 109.195 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.447 HG11 ' O ' ' C' ' 34' ' ' PRO . 18.8 t -95.44 -102.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 120.437 1.471 . . . . 0.0 111.869 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -154.06 -30.73 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.622 -1.299 . . . . 0.0 109.61 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -101.26 11.74 38.77 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 120.2 -1.562 . . . . 0.0 108.786 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -44.01 88.04 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.74 86.28 1.62 Allowed Glycine 0 N--CA 1.416 -2.67 1 N-CA-C 98.033 -6.027 . . . . 0.0 98.033 -167.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -56.22 -20.04 16.45 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 125.642 1.577 . . . . 0.0 112.278 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -46.02 -28.22 1.12 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 126.677 1.991 . . . . 0.0 113.05 164.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.27 -43.94 95.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.849 -1.157 . . . . 0.0 109.682 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.48 62.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.344 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -51.2 -47.17 62.32 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.099 2.16 . . . . 0.0 111.116 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.37 -41.34 98.8 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.251 1.02 . . . . 0.0 111.329 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -41.41 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 C-N-CA 123.644 0.778 . . . . 0.0 109.635 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 37.6 mtt -58.99 -52.49 65.54 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.903 0.881 . . . . 0.0 110.299 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.58 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.09 82.87 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.412 -0.805 . . . . 0.0 111.403 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.86 -43.51 93.73 Favored Glycine 0 CA--C 1.494 -1.257 0 C-N-CA 124.202 0.906 . . . . 0.0 111.342 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.87 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 O-C-N 121.735 -0.862 . . . . 0.0 109.159 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.18 -47.6 84.72 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.492 -0.755 . . . . 0.0 111.956 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.49 -40.71 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.799 -0.563 . . . . 0.0 111.471 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.97 -38.48 61.66 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.678 0.672 . . . . 0.0 109.745 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.23 82.83 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.54 -36.42 69.24 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.4 -18.38 11.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.915 1.286 . . . . 0.0 111.043 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.6 m -59.23 -23.95 62.75 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.68 -1.887 . . . . 0.0 111.984 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.46 68.06 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.357 -1.465 . . . . 0.0 111.197 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.24 -52.35 7.84 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.33 -34.65 78.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.217 1.007 . . . . 0.0 113.537 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.76 -14.68 62.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.837 -1.164 . . . . 0.0 110.985 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 81.0 p -85.06 -11.16 55.94 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.55 -1.344 . . . . 0.0 110.855 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -17.55 61.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 119.243 0.929 . . . . 0.0 111.065 -169.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -82.24 -34.66 28.74 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.387 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 26.4 t -65.51 -35.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.463 1.505 . . . . 0.0 109.103 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -42.5 -34.89 0.92 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 128.21 2.604 . . . . 0.0 112.976 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -63.71 -27.05 68.94 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.056 -1.028 . . . . 0.0 111.836 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.44 -0.936 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -177.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.883 0 CA-C-O 122.613 1.197 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -74.05 -52.52 12.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.639 2.375 . . . . 0.0 108.513 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -58.89 -29.53 67.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 126.1 1.76 . . . . 0.0 112.686 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.1 -39.75 82.77 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.681 -0.637 . . . . 0.0 109.69 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -68.5 -36.21 78.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.71 -40.55 84.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.28 95.79 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.622 0.769 . . . . 0.0 111.919 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.33 -40.24 74.28 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 123.301 0.641 . . . . 0.0 110.566 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -61.69 -41.21 97.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.489 0.716 . . . . 0.0 110.28 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.21 70.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.117 0.967 . . . . 0.0 111.877 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.27 -37.14 86.28 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.669 -0.645 . . . . 0.0 111.655 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.81 -31.42 64.82 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -67.52 -35.25 78.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.703 0.801 . . . . 0.0 109.764 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.25 -38.41 90.95 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 111.645 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.43 -36.65 76.3 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.883 0.873 . . . . 0.0 110.756 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.46 -44.84 77.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.184 0.994 . . . . 0.0 110.058 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.02 -47.34 90.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.23 -38.36 85.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.923 -0.485 . . . . 0.0 110.455 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.58 -32.19 65.81 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.489 1.04 . . . . 0.0 113.343 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -69.18 -39.73 78.54 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 119.698 -1.877 . . . . 0.0 108.397 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -32.95 74.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -50.46 -52.08 41.29 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 125.769 1.627 . . . . 0.0 111.648 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -65.98 -34.71 78.73 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -84.48 -15.14 47.03 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.243 0.617 . . . . 0.0 110.972 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -44.61 65.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.513 1.125 . . . . 0.0 109.834 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.25 -40.39 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 122.371 1.081 . . . . 0.0 109.423 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.39 -29.81 68.6 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.954 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.92 92.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 125.189 1.396 . . . . 0.0 110.372 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -77.92 -6.32 53.96 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -76.41 90.62 3.25 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 119.9 -1.75 . . . . 0.0 107.188 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.94 -28.83 1.41 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.75 150.31 47.93 Favored Pre-proline 0 N--CA 1.443 -0.79 0 O-C-N 121.397 -1.061 . . . . 0.0 111.133 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.54 97.06 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.792 2.328 . . . . 0.0 112.723 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.35 -41.69 1.31 Allowed Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.23 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.526 2.331 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 72.81 -66.49 0.31 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.7 1.6 . . . . 0.0 112.401 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 49.4 tp -83.37 64.25 7.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.06 112.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 45.4 t -177.57 -141.72 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.9 -63.83 0.01 OUTLIER Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -72.53 -13.94 27.57 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 CA-C-N 125.541 3.015 . . . . 0.0 112.344 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -86.88 -11.06 51.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.04 85.51 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.596 0.758 . . . . 0.0 110.009 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.65 -41.97 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 109.522 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -38.91 83.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.204 -0.935 . . . . 0.0 109.865 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.427 ' HB2' ' HE ' ' D' ' 60' ' ' ARG . 70.4 t90 -66.07 -37.66 86.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.519 0.728 . . . . 0.0 110.499 172.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -36.53 71.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.077 -1.014 . . . . 0.0 109.808 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -54.65 -56.96 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 126.17 1.788 . . . . 0.0 109.578 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -71.66 -17.31 62.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 112.024 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -82.49 -37.01 25.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.691 -1.256 . . . . 0.0 109.237 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.93 73.36 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.422 -0.799 . . . . 0.0 110.739 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -95.44 11.91 31.2 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.683 0.793 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.508 HG22 ' HB2' ' D' ' 75' ' ' MET . 16.5 p 55.29 38.63 30.64 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.32 1.848 . . . . 0.0 112.035 169.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.02 -68.29 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.46 95.69 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.98 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 2.4 t80 -61.21 -32.73 72.5 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.542 1.163 . . . . 0.0 111.288 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.35 39.31 0.15 Allowed Glycine 0 CA--C 1.48 -2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 165.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -90.91 -59.11 2.26 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' D' ' 47' ' ' TRP . 15.8 mtm-85 -138.07 164.85 28.08 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 158.01 36.57 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 -175.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 168.99 19.84 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.253 2.635 . . . . 0.0 109.829 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.57 -93.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.214 0.461 . . . . 0.0 110.292 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -137.73 -81.57 0.35 Allowed 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 129.0 38.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 61.25 -61.87 0.08 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 126.808 2.043 . . . . 0.0 115.566 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . -34.54 -49.63 0.71 Allowed Glycine 0 CA--C 1.488 -1.64 0 C-N-CA 128.917 3.151 . . . . 0.0 114.524 -170.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.221 0.608 . . . . 0.0 112.094 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -71.15 -32.68 69.24 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.609 0.764 . . . . 0.0 109.231 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.41 -51.45 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.09 89.28 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.606 1.162 . . . . 0.0 113.121 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -53.6 -42.32 67.55 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.22 2.208 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -67.55 -39.08 84.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.647 -0.658 . . . . 0.0 110.445 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.64 -48.08 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 O-C-N 121.622 -0.674 . . . . 0.0 110.059 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.508 ' HB2' HG22 ' D' ' 54' ' ' THR . 21.1 ptp -65.82 -37.15 85.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.549 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -64.88 -41.34 95.71 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 121.467 -0.771 . . . . 0.0 110.678 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.154 0.582 . . . . 0.0 110.569 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.06 -46.21 93.89 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 123.633 0.635 . . . . 0.0 112.265 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.84 -43.64 92.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 124.026 0.931 . . . . 0.0 109.983 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -63.9 -41.5 97.68 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.01 -47.13 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 C-N-CA 124.204 1.002 . . . . 0.0 110.679 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -73.3 -10.79 60.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.407 -0.808 . . . . 0.0 111.186 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.81 14.11 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.82 0.848 . . . . 0.0 109.606 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.45 -33.05 74.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.419 1.887 . . . . 0.0 111.041 -174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.93 -7.64 2.11 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 112.724 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 40.3 m -62.01 -20.94 64.44 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.8 63.34 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.248 -1.532 . . . . 0.0 111.401 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.51 -53.72 4.82 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.236 1.014 . . . . 0.0 108.706 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.86 -36.96 70.64 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 124.486 1.114 . . . . 0.0 112.918 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 -22.54 61.49 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.008 -1.058 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 81.7 p -78.37 -17.56 56.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.325 -1.484 . . . . 0.0 109.813 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -69.98 -34.76 73.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.7 0.762 . . . . 0.0 109.453 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.96 -30.4 65.26 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.485 -1.385 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.76 -26.38 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 C-N-CA 124.284 1.033 . . . . 0.0 109.299 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -57.9 -14.92 7.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.83 1.252 . . . . 0.0 113.59 172.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -68.9 -38.56 79.68 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.394 1.092 . . . . 0.0 108.672 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -176.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -170.97 -64.22 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.528 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 45.9 p-80 -61.88 -22.33 65.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.126 1.37 . . . . 0.0 113.449 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 18.4 mp0 -75.73 -22.04 56.94 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.546 -1.346 . . . . 0.0 110.224 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -66.77 -41.92 86.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -60.56 -47.51 85.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.43 96.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 111.545 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -61.23 -45.54 94.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 124.587 1.155 . . . . 0.0 109.493 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -61.57 -36.17 79.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.752 1.221 . . . . 0.0 110.179 -175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.41 72.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -66.95 -30.4 70.53 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.822 -1.174 . . . . 0.0 111.515 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.2 -26.04 55.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.312 -0.868 . . . . 0.0 109.872 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.41 -37.98 74.54 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.81 0.844 . . . . 0.0 109.371 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.36 -40.25 95.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.307 0.575 . . . . 0.0 110.917 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -63.53 -26.36 68.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.3 0.64 . . . . 0.0 112.058 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.83 -41.7 87.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.178 0.991 . . . . 0.0 109.333 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -39.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.524 1.129 . . . . 0.0 108.974 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.88 -42.29 84.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.299 1.04 . . . . 0.0 111.995 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.55 -23.45 58.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.107 0.963 . . . . 0.0 111.309 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.76 -32.27 19.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.789 -1.194 . . . . 0.0 108.348 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.21 73.68 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.525 1.53 . . . . 0.0 111.155 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.8 p -68.11 -39.68 82.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 118.716 0.689 . . . . 0.0 110.115 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -64.1 -49.1 73.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -63.94 -38.44 91.1 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.58 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 119.987 1.267 . . . . 0.0 111.431 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.14 -42.43 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.09 -19.58 59.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.152 -1.592 . . . . 0.0 112.002 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.5 -49.2 27.85 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.555 1.142 . . . . 0.0 108.443 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -58.52 -47.05 85.44 Favored 'General case' 0 CA--C 1.476 -1.9 0 C-N-CA 124.344 1.058 . . . . 0.0 110.646 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -63.45 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.17 0.988 . . . . 0.0 111.995 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.28 2.58 5.92 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.29 128.56 38.08 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 118.731 1.265 . . . . 0.0 108.771 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.44 146.01 17.04 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.402 2.068 . . . . 0.0 109.499 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.6 -18.88 47.71 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 118.972 0.805 . . . . 0.0 112.311 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.05 164.4 26.67 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.261 1.425 . . . . 0.0 112.888 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.04 2.44 3.63 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.18 0.592 . . . . 0.0 111.999 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 52.93 1.89 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 120.31 -1.494 . . . . 0.0 111.408 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -84.4 164.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.02 -1.675 . . . . 0.0 109.766 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.9 t 81.29 129.59 0.05 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.939 1.696 . . . . 0.0 110.686 166.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -67.39 -47.65 47.83 Favored Pre-proline 0 C--N 1.358 0.936 0 CA-C-O 116.213 -1.851 . . . . 0.0 112.152 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.26 -11.59 30.45 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 125.482 2.993 . . . . 0.0 111.892 -175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.63 -48.09 9.21 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.342 1.457 . . . . 0.0 107.248 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.29 74.05 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 125.103 1.361 . . . . 0.0 112.533 -174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.63 -30.39 48.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 O-C-N 121.685 -0.635 . . . . 0.0 111.145 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -33.34 55.68 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.777 -1.202 . . . . 0.0 108.967 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.0 -34.38 78.29 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.328 0.651 . . . . 0.0 110.297 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -56.3 -38.45 71.27 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 120.788 -1.195 . . . . 0.0 111.769 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.67 60.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -158.29 -36.37 0.07 Allowed 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 51' ' ' THR . 1.8 t -67.57 -33.78 75.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.825 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.27 -21.94 65.68 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.613 -1.305 . . . . 0.0 112.791 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.23 4.22 52.84 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.281 0.632 . . . . 0.0 109.97 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 p 48.46 47.31 20.29 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 127.139 2.176 . . . . 0.0 112.184 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -100.37 -69.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 85.63 72.87 1.29 Allowed Glycine 0 CA--C 1.492 -1.396 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -19.08 52.83 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.76 5.25 Favored Glycine 0 CA--C 1.486 -1.755 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -71.49 -46.09 60.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -132.01 165.2 24.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -140.09 130.8 14.08 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 100.804 -3.776 . . . . 0.0 100.804 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -86.11 176.22 5.26 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.721 2.947 . . . . 0.0 109.168 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.13 -142.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-O 123.103 1.43 . . . . 0.0 107.744 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 p -92.14 -43.63 9.25 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 119.657 -1.902 . . . . 0.0 111.094 -165.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.85 -29.56 70.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 127.799 2.44 . . . . 0.0 110.218 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.73 -24.65 67.63 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.71 2.004 . . . . 0.0 109.975 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.85 88.81 0.57 Allowed Glycine 0 CA--C 1.476 -2.366 1 N-CA-C 101.052 -4.819 . . . . 0.0 101.052 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.47 -17.81 2.26 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-O 123.291 1.519 . . . . 0.0 113.096 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -63.26 -14.68 52.18 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 125.071 1.348 . . . . 0.0 112.378 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.73 -45.01 99.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 CA-C-N 119.77 1.168 . . . . 0.0 108.592 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.72 67.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.837 -0.539 . . . . 0.0 110.046 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -48.84 -46.26 41.92 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.631 1.572 . . . . 0.0 110.908 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.73 -38.81 92.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.396 1.078 . . . . 0.0 111.725 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.97 -42.0 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 121.352 -0.842 . . . . 0.0 108.928 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.3 mtm -61.81 -46.07 91.11 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.103 0.561 . . . . 0.0 111.093 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -63.72 -38.66 91.93 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.812 -0.555 . . . . 0.0 110.953 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.19 90.91 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.937 0.495 . . . . 0.0 110.911 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.05 92.46 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 124.225 0.917 . . . . 0.0 111.104 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.91 -46.81 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.448 1.099 . . . . 0.0 109.14 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.33 -37.84 84.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 121.069 -1.02 . . . . 0.0 111.993 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.49 -56.65 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 109.598 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.1 -41.51 98.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.362 0.665 . . . . 0.0 110.835 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.7 -34.63 78.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.75 0.82 . . . . 0.0 111.113 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -66.64 -30.85 71.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.472 -1.392 . . . . 0.0 111.063 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.73 -12.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 110.829 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -58.35 -22.8 54.82 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.597 -1.939 . . . . 0.0 112.652 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.23 -24.99 61.12 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.893 -1.129 . . . . 0.0 111.685 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 4' ' ' HIS . . . -95.83 -40.58 9.26 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.871 1.268 . . . . 0.0 110.969 176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.7 -39.8 91.6 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.818 0.818 . . . . 0.0 111.126 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -28.05 62.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.008 -1.057 . . . . 0.0 110.984 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -71.89 -10.52 59.89 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.223 -1.548 . . . . 0.0 111.563 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.77 -38.51 86.72 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 122.235 1.016 . . . . 0.0 109.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -81.4 -11.83 59.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 119.355 -2.09 . . . . 0.0 112.967 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.36 -27.48 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.4 -27.36 47.22 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.56 1.544 . . . . 0.0 113.053 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -64.76 -21.32 66.74 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-O 122.038 0.923 . . . . 0.0 111.825 -172.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.433 -1.278 0 C-N-CA 125.77 1.628 . . . . 0.0 108.223 -178.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.521 ' HD2' ' HA ' ' B' ' 88' ' ' ALA . 13.0 p-80 -61.69 -26.65 68.16 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 128.741 2.816 . . . . 0.0 112.039 -174.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.517 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 8.9 mt-10 -75.04 -28.57 60.49 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.674 1.19 . . . . 0.0 110.348 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.88 -35.87 64.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.092 -1.005 . . . . 0.0 109.898 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.99 -31.18 69.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 122.011 0.91 . . . . 0.0 109.418 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.02 86.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.815 0.846 . . . . 0.0 110.67 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -71.96 -36.44 69.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.893 -0.505 . . . . 0.0 110.092 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -58.15 -35.99 72.35 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.415 1.486 . . . . 0.0 110.991 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.89 89.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.488 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.36 -36.62 83.36 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 120.928 -1.108 . . . . 0.0 110.658 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -66.5 -36.68 83.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.666 -0.646 . . . . 0.0 110.222 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -63.44 -42.92 98.69 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.785 1.234 . . . . 0.0 109.528 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.62 -37.21 72.91 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-O 121.804 0.811 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.8 -21.35 62.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.164 -0.96 . . . . 0.0 112.029 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -78.19 -30.28 48.91 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.15 -0.969 . . . . 0.0 108.883 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.32 -32.4 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 120.455 -1.403 . . . . 0.0 109.214 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.94 -36.55 77.29 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.217 -0.927 . . . . 0.0 111.949 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.27 -46.53 83.27 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.663 1.185 . . . . 0.0 109.782 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -70.61 -41.03 72.8 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 108.225 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 126.812 2.045 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 -49.96 75.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.145 1.378 . . . . 0.0 109.924 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -67.21 -46.42 73.93 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -61.69 -44.98 95.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.55 -53.15 52.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.72 -37.0 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -92.79 -1.05 57.12 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.887 -1.133 . . . . 0.0 110.895 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.72 -46.96 8.59 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.25 -24.47 59.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.954 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -74.48 108.83 7.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.198 -1.563 . . . . 0.0 111.242 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.96 -21.83 5.21 Favored Glycine 0 CA--C 1.495 -1.181 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.03 152.87 53.95 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.022 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.53 146.54 19.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.628 2.219 . . . . 0.0 110.492 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 34.87 89.47 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 124.092 0.853 . . . . 0.0 111.303 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 134.16 45.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.066 0.947 . . . . 0.0 109.474 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.34 -39.53 1.87 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.358 . . . . 0.0 109.87 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 tp -68.46 -33.29 73.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.956 . . . . 0.0 110.574 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 tt -41.47 76.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 1 C-N-CA 131.979 4.112 . . . . 0.0 116.94 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.84 136.11 7.81 Favored 'General case' 0 CA--C 1.494 -1.185 0 O-C-N 119.24 -2.162 . . . . 0.0 105.409 166.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -64.68 -54.21 38.08 Favored Pre-proline 0 C--N 1.349 0.559 0 CA-C-O 116.849 -1.548 . . . . 0.0 111.728 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.7 -16.87 23.56 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.007 2.824 . . . . 0.0 110.695 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -94.39 -22.9 18.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.62 76.43 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.092 1.357 . . . . 0.0 108.73 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.41 -27.55 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.197 0.522 . . . . 0.0 110.992 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.07 55.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -76.18 -33.58 59.31 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 123.37 0.668 . . . . 0.0 109.573 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -54.42 -29.77 50.32 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.955 -1.091 . . . . 0.0 112.042 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.01 -40.45 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 124.926 1.291 . . . . 0.0 110.356 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.95 -20.78 66.32 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.841 1.657 . . . . 0.0 112.139 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.07 -38.7 6.84 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -164.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -29.05 65.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.774 -1.204 . . . . 0.0 111.766 -170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -86.91 1.01 54.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.704 -0.623 . . . . 0.0 110.329 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.8 p 55.03 50.72 14.8 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 125.968 1.707 . . . . 0.0 110.984 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -103.44 -59.34 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.64 48.04 64.71 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 120.857 -1.152 . . . . 0.0 112.331 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -29.26 69.86 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.443 1.116 . . . . 0.0 112.393 -168.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.97 29.11 2.26 Favored Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.5 -63.94 0.96 Allowed 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.044 -0.68 . . . . 0.0 110.182 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -138.86 163.33 32.55 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -134.92 148.67 67.91 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.05 165.65 21.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 123.55 2.834 . . . . 0.0 110.421 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.91 -154.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -95.15 -54.52 3.4 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.546 1.138 . . . . 0.0 108.746 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.4 -4.7 46.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.576 1.551 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.17 -28.77 68.39 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.852 1.31 . . . . 0.0 107.817 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.38 87.5 1.02 Allowed Glycine 0 CA--C 1.479 -2.159 1 N-CA-C 101.074 -4.811 . . . . 0.0 101.074 -170.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -59.96 -12.0 6.93 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.235 1.518 . . . . 0.0 111.5 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -54.95 -17.93 4.35 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.469 1.908 . . . . 0.0 113.029 164.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -52.85 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 O-C-N 120.493 -1.38 . . . . 0.0 107.315 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.51 92.07 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.471 0.708 . . . . 0.0 110.633 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -49.76 -46.55 50.73 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.955 1.702 . . . . 0.0 111.235 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -62.95 -40.19 96.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.289 1.036 . . . . 0.0 111.301 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.62 -41.44 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.0 mtm -62.64 -45.67 91.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.383 0.673 . . . . 0.0 110.029 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.38 -36.35 83.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 121.502 -0.749 . . . . 0.0 111.364 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.89 89.08 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.48 0.712 . . . . 0.0 110.669 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.16 -45.15 92.6 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.59 -42.78 89.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 C-N-CA 124.109 0.964 . . . . 0.0 109.706 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -60.42 -42.78 96.74 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.078 -1.014 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 t -64.81 -52.35 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.389 1.076 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.63 -13.63 61.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 121.597 -0.689 . . . . 0.0 111.528 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.34 -36.87 14.4 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.327 -0.858 . . . . 0.0 109.88 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.1 -33.19 74.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.038 1.335 . . . . 0.0 110.41 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.06 -10.32 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 121.491 -0.756 . . . . 0.0 112.3 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -58.66 -18.89 34.5 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.871 1.669 . . . . 0.0 110.618 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.62 -65.07 0.63 Allowed 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.709 -1.245 . . . . 0.0 109.673 165.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' B' ' 4' ' ' HIS . . . -68.67 -42.03 78.45 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 120.775 -1.203 . . . . 0.0 111.3 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.5 -33.93 76.1 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.357 0.663 . . . . 0.0 111.195 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.03 -23.86 33.05 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.436 -1.415 . . . . 0.0 110.784 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.5 m -69.04 -21.81 64.08 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.293 -1.505 . . . . 0.0 108.392 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.28 -39.96 84.59 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.184 -0.947 . . . . 0.0 110.843 -164.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.48 ' CE1' HG21 ' C' ' 94' ' ' VAL . 10.0 p90 -65.73 -23.99 66.87 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.441 -0.787 . . . . 0.0 112.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -79.04 -20.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -68.01 -16.23 63.95 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.496 -1.377 . . . . 0.0 110.377 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -67.38 -2.0 5.57 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.824 -0.548 . . . . 0.0 112.422 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 C--N 1.36 1.032 0 O-C-N 120.917 -1.114 . . . . 0.0 110.085 163.687 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 123.067 1.413 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.445 ' CD2' HG21 ' C' ' 91' ' ' THR . 34.2 p80 -174.07 -50.24 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -69.07 -39.32 79.16 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.976 1.31 . . . . 0.0 110.518 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -54.7 -51.85 64.26 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.762 2.025 . . . . 0.0 110.733 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -75.05 -30.28 60.97 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.34 93.7 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.929 -1.107 . . . . 0.0 111.256 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -71.04 -36.67 72.43 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.609 -0.682 . . . . 0.0 110.886 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.1 -38.03 89.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.86 0.864 . . . . 0.0 110.548 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.3 86.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.499 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.41 -40.32 86.31 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.251 0.62 . . . . 0.0 110.813 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -70.34 -22.83 62.76 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.537 -0.727 . . . . 0.0 111.937 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.26 -32.2 58.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.113 -0.992 . . . . 0.0 108.683 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.48 -40.22 95.27 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.622 -0.674 . . . . 0.0 110.443 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -58.44 -38.31 77.23 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 112.048 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -66.66 -42.26 86.91 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.96 -40.34 85.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 124.39 1.076 . . . . 0.0 109.515 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.24 -42.65 77.69 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 124.124 0.969 . . . . 0.0 112.571 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.22 -42.84 75.17 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.413 -0.804 . . . . 0.0 110.058 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.45 -36.02 73.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.52 0.728 . . . . 0.0 109.607 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.39 83.67 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 126.191 1.796 . . . . 0.0 111.35 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 24.1 m -64.8 -39.24 93.26 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.495 0.718 . . . . 0.0 110.761 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -71.28 -44.4 65.29 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -68.35 -45.66 72.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.543 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.32 94.41 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 120.041 1.292 . . . . 0.0 111.532 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.51 -41.09 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 121.564 -0.71 . . . . 0.0 109.934 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.47 -22.78 43.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.342 -0.849 . . . . 0.0 110.146 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.3 71.78 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 125.026 1.33 . . . . 0.0 109.147 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.22 -23.81 62.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.256 0.622 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -71.07 87.61 0.77 Allowed 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.61 1.85 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.35 141.72 57.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 117.511 0.655 . . . . 0.0 111.483 -168.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 134.45 7.51 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 122.149 1.899 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.79 19.84 60.79 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.69 140.19 56.77 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 109.971 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.6 -42.82 3.39 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.417 HD21 ' CG ' ' C' ' 47' ' ' TRP . 2.0 mt -83.72 17.37 2.31 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.4 1.88 . . . . 0.0 110.523 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -75.48 76.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.054 1.407 . . . . 0.0 110.183 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.8 m -143.3 -123.38 0.09 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . 0.28 1.5 t80 173.56 -58.12 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.91 0 C-N-CA 128.755 2.822 . . . . 0.0 106.557 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.04 -18.21 31.22 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 CA-C-N 126.451 3.34 . . . . 0.0 112.838 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.426 ' CG ' HH12 ' C' ' 60' ' ' ARG . 31.3 p30 -106.1 14.97 27.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 119.398 0.999 . . . . 0.0 109.007 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.06 -35.87 66.78 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.937 -1.102 . . . . 0.0 108.761 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.404 ' O ' HG23 ' C' ' 49' ' ' VAL . 20.1 tt -67.28 -29.32 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 123.57 0.748 . . . . 0.0 110.162 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -64.32 -45.83 86.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.895 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CG ' HD21 ' C' ' 38' ' ' LEU . 76.0 t90 -69.41 -37.1 77.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.971 0.908 . . . . 0.0 108.919 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -56.26 -44.02 79.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.27 1.028 . . . . 0.0 111.538 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 45' ' ' ILE . 3.3 t -68.94 -38.98 79.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 O-C-N 120.739 -1.226 . . . . 0.0 111.73 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.17 -30.01 68.14 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 120.138 1.335 . . . . 0.0 110.861 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -61.23 -43.72 98.42 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.645 1.178 . . . . 0.0 109.866 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.42 65.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.945 -1.097 . . . . 0.0 112.26 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -87.26 4.19 43.66 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.419 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.2 p 57.63 29.32 17.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.426 1.49 . . . . 0.0 112.655 169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.411 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -94.5 -85.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.411 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 82.1 86.12 0.74 Allowed Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -73.44 -22.25 60.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.001 -1.294 . . . . 0.0 109.343 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 35.57 2.86 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.73 -47.74 51.78 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' C' ' 43' ' ' ASP . 69.6 mtt180 -140.98 173.44 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.39 148.85 21.61 Favored Pre-proline 0 N--CA 1.435 -1.217 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.54 171.26 12.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.888 3.059 . . . . 0.0 109.14 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.6 -109.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 119.392 0.996 . . . . 0.0 112.271 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 45.0 m -150.22 -40.53 0.13 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -82.78 -6.35 59.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.447 0.699 . . . . 0.0 110.007 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -31.84 66.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.23 56.47 0.93 Allowed Glycine 0 CA--C 1.472 -2.595 0 N-CA-C 104.564 -3.414 . . . . 0.0 104.564 167.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -22.22 -21.28 0.0 OUTLIER 'General case' 0 C--N 1.366 1.325 1 C-N-CA 134.048 4.939 . . . . 0.0 118.947 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -19.16 5.74 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 119.625 -1.922 . . . . 0.0 112.751 159.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.84 -45.67 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 119.549 1.068 . . . . 0.0 109.577 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -47.71 58.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.504 -0.747 . . . . 0.0 109.205 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.61 -47.95 58.07 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 124.757 1.223 . . . . 0.0 110.771 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -67.35 -33.87 76.15 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.94 -0.475 . . . . 0.0 111.716 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.02 -44.22 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 121.33 -0.856 . . . . 0.0 109.01 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 67.0 mtm -63.5 -46.8 84.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.25 1.02 . . . . 0.0 110.027 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -64.5 -40.7 96.14 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.51 0.724 . . . . 0.0 110.814 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.27 84.03 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.456 0.702 . . . . 0.0 111.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.2 -48.15 77.74 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -58.43 -46.41 89.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 124.532 1.133 . . . . 0.0 109.842 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -59.55 -45.14 92.66 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.909 0.884 . . . . 0.0 111.19 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.91 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.568 1.147 . . . . 0.0 109.966 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -66.39 -37.46 85.3 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.636 -0.665 . . . . 0.0 110.815 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.16 73.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.754 0.822 . . . . 0.0 110.596 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.46 -34.03 73.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.892 1.277 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.88 -12.05 3.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 125.433 1.493 . . . . 0.0 111.43 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -59.38 -25.66 64.45 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 112.449 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 -23.92 66.96 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-O 122.601 1.191 . . . . 0.0 111.618 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.73 -30.39 20.36 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.531 -1.355 . . . . 0.0 109.791 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.82 -49.86 13.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.888 0.851 . . . . 0.0 110.698 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.42 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.954 -1.091 . . . . 0.0 112.34 -170.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.445 HG21 ' CD2' ' C' ' 4' ' ' HIS . 13.0 t -72.86 -12.57 61.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 120.325 -1.485 . . . . 0.0 110.239 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -88.34 3.16 50.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.531 1.059 . . . . 0.0 110.531 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -34.65 18.69 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 160.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' B' ' 93' ' ' PHE . 38.7 t -72.01 -29.74 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 O-C-N 121.059 -1.025 . . . . 0.0 110.434 -171.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -61.24 -14.21 24.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -64.92 -32.27 73.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.101 -0.999 . . . . 0.0 110.689 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 . . . . . 0 C--N 1.356 0.856 0 CA-C-N 119.269 0.941 . . . . 0.0 108.782 -178.657 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.84 -59.55 2.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 131.118 3.767 . . . . 0.0 108.466 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.517 ' CD2' HG21 ' D' ' 91' ' ' THR . 24.5 p80 -60.1 -33.14 71.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.79 2.836 . . . . 0.0 112.011 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.05 -36.19 81.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.09 0.956 . . . . 0.0 109.862 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtp-105 -71.07 -38.35 72.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.423 -0.798 . . . . 0.0 110.511 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.22 -26.25 61.07 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.81 79.52 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.757 -1.214 . . . . 0.0 110.801 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -68.34 -29.38 68.1 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.216 -0.928 . . . . 0.0 111.708 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -64.1 -42.62 96.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 109.691 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.77 88.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.721 0.808 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.31 -38.38 83.5 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.787 -0.57 . . . . 0.0 111.717 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.97 -36.72 78.2 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.43 -26.77 67.38 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.316 -0.865 . . . . 0.0 110.799 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.21 -36.47 77.3 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 120.944 -1.097 . . . . 0.0 111.06 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -64.16 -31.91 73.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.196 0.999 . . . . 0.0 110.865 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.04 1.336 . . . . 0.0 110.109 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.6 -33.45 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.98 -40.65 89.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.685 0.794 . . . . 0.0 110.91 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.3 -43.2 78.19 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.176 0.591 . . . . 0.0 111.192 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.18 -38.99 86.33 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.95 75.55 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 124.607 1.163 . . . . 0.0 111.438 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -60.05 -46.74 88.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.163 0.892 . . . . 0.0 111.364 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -68.86 -51.72 37.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.927 1.691 . . . . 0.0 108.207 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -68.88 -43.83 74.51 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.942 0.897 . . . . 0.0 110.309 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.24 75.14 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 119.555 1.07 . . . . 0.0 110.72 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.55 -36.14 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.746 0.784 . . . . 0.0 109.314 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.49 -22.8 54.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 121.429 -0.794 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.64 -36.65 83.5 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 126.271 1.828 . . . . 0.0 110.486 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' D' ' 36' ' ' ALA . 0.6 OUTLIER -75.72 -16.03 60.21 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.412 -174.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -85.63 85.12 7.43 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.281 -1.512 . . . . 0.0 107.636 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.92 -33.66 0.56 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 105.117 -3.193 . . . . 0.0 105.117 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.37 149.16 57.47 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 124.225 1.01 . . . . 0.0 111.565 -171.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.82 97.89 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.888 2.392 . . . . 0.0 113.528 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.32 47.74 0.45 Allowed Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' D' ' 30' ' ' GLU . . . -54.8 106.61 0.23 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.572 1.149 . . . . 0.0 113.494 -169.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.98 -59.34 1.93 Allowed 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 109.64 -169.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' D' ' 47' ' ' TRP . 3.4 tt -84.55 63.07 7.67 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.7 tt -96.23 -6.08 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.116 -1.615 . . . . 0.0 109.082 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -88.57 120.98 30.47 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.672 0.789 . . . . 0.0 111.687 -171.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -74.4 -59.14 1.68 Allowed Pre-proline 0 C--N 1.353 0.73 0 CA-C-O 116.05 -1.929 . . . . 0.0 112.506 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.45 -14.13 30.69 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 CA-C-N 125.941 3.157 . . . . 0.0 110.906 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.31 -11.7 42.68 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 124.196 0.998 . . . . 0.0 109.471 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.2 67.32 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 120.872 -1.143 . . . . 0.0 110.384 -170.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -16.24 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.061 1.41 . . . . 0.0 109.225 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -76.64 -51.85 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 119.794 -1.816 . . . . 0.0 106.566 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.449 ' CD2' HD11 ' D' ' 38' ' ' LEU . 74.4 t90 -55.44 -46.12 76.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.117 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -64.82 -16.91 63.73 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.17 -50.97 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.07 65.64 9.19 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -159.55 -52.64 0.06 Allowed 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -18.45 64.94 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.43 -0.794 . . . . 0.0 112.042 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -87.06 -3.6 59.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.116 1.766 . . . . 0.0 111.057 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 56.15 38.4 29.82 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 125.544 1.538 . . . . 0.0 111.149 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.61 -37.58 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 121.771 -0.581 . . . . 0.0 110.905 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.34 -81.61 0.29 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.08 142.03 52.7 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.75 34.55 0.68 Allowed Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.21 -59.86 0.5 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.288 2.235 . . . . 0.0 109.011 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -97.28 156.24 16.52 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -142.55 148.26 46.14 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -80.36 167.77 19.02 Favored 'Trans proline' 0 CA--C 1.503 -1.057 0 C-N-CA 122.59 2.193 . . . . 0.0 110.266 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' D' ' 64' ' ' THR . 4.1 t -97.56 -150.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 174.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' D' ' 63' ' ' VAL . 4.6 p -91.23 -60.09 1.99 Allowed 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.755 -1.84 . . . . 0.0 112.541 -162.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -75.07 129.73 38.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 58.08 -104.78 0.23 Allowed 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.54 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 42.35 -82.19 0.0 OUTLIER Glycine 0 C--N 1.357 1.705 0 C-N-CA 130.006 3.669 . . . . 0.0 112.579 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -72.13 -32.53 67.02 Favored 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 126.074 1.75 . . . . 0.0 112.025 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.5 -24.11 65.54 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.155 1.343 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -78.8 -50.58 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.9 -39.7 71.98 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 111.919 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.88 -48.89 21.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 128.497 2.719 . . . . 0.0 112.055 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.69 -38.35 76.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.428 0.691 . . . . 0.0 110.132 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.12 -45.03 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 C-N-CA 124.181 0.993 . . . . 0.0 109.39 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -61.7 -45.64 93.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.298 1.039 . . . . 0.0 110.867 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.21 -41.59 93.36 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 110.857 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -36.72 84.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.388 0.675 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.64 64.12 Favored Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 123.979 0.799 . . . . 0.0 111.297 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.62 -46.36 90.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 124.203 1.001 . . . . 0.0 109.768 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -61.87 -30.52 70.92 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.421 1.088 . . . . 0.0 113.046 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 t -74.31 -50.43 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.56 -44.15 97.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.453 0.701 . . . . 0.0 109.999 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.33 -23.32 63.77 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.929 0.891 . . . . 0.0 111.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.89 -30.63 68.12 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.147 -1.595 . . . . 0.0 109.355 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -61.83 -13.42 9.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.411 1.084 . . . . 0.0 110.385 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.5 m -58.89 -20.68 53.64 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 119.537 -1.977 . . . . 0.0 112.596 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.37 68.5 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.983 -1.698 . . . . 0.0 111.445 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.15 -35.97 19.82 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.14 0.976 . . . . 0.0 109.643 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 mt -73.16 -44.75 59.5 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.426 0.631 . . . . 0.0 112.197 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.19 70.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.835 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.517 HG21 ' CD2' ' D' ' 4' ' ' HIS . 9.0 t -73.31 -6.48 46.38 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.067 -1.021 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.82 -14.62 58.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.692 1.133 . . . . 0.0 110.739 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -33.1 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 119.842 1.201 . . . . 0.0 108.726 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.97 -29.12 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.294 1.038 . . . . 0.0 109.594 -174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -68.39 -12.08 60.6 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.335 -0.853 . . . . 0.0 111.793 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -61.62 -37.12 82.79 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.265 1.031 . . . . 0.0 110.146 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 N--CA 1.442 -0.829 0 O-C-N 119.862 -1.774 . . . . 0.0 109.572 -175.268 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.11 -71.97 0.4 Allowed 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.1 -23.96 67.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -75.82 -26.42 57.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 109.624 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -64.89 -44.99 87.85 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.32 1.048 . . . . 0.0 108.445 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.21 -40.54 90.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.033 1.333 . . . . 0.0 109.781 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.54 91.72 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 110.844 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.51 -28.14 64.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.62 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -68.49 -34.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.9 90.35 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.343 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.82 -31.9 73.0 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.394 -0.816 . . . . 0.0 111.975 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.93 -41.45 97.63 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.96 0.904 . . . . 0.0 109.392 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -65.74 -34.33 77.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.499 1.119 . . . . 0.0 109.63 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.28 -44.91 94.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.738 0.815 . . . . 0.0 111.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -62.77 -38.21 89.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.238 0.542 . . . . 0.0 111.082 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.18 -37.66 88.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.926 0.89 . . . . 0.0 110.363 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.98 -41.62 84.75 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 C-N-CA 124.127 0.971 . . . . 0.0 108.885 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.2 -45.01 79.98 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.941 0.896 . . . . 0.0 111.802 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -75.2 -24.74 57.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.945 0.898 . . . . 0.0 111.285 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -81.0 -37.93 28.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.63 76.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.459 1.504 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -66.76 -39.7 87.98 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 119.394 0.997 . . . . 0.0 109.79 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.14 -48.45 70.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.733 -0.604 . . . . 0.0 110.174 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -60.81 -48.44 81.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 121.399 -0.813 . . . . 0.0 110.381 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.81 80.15 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.272 1.429 . . . . 0.0 111.903 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.3 -43.45 98.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 O-C-N 121.281 -0.887 . . . . 0.0 110.356 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.36 -29.3 57.14 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.352 -0.843 . . . . 0.0 110.46 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.0 71.76 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.479 1.512 . . . . 0.0 108.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.578 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.3 tp10 -69.9 -28.63 65.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.064 1.345 . . . . 0.0 110.819 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -67.03 107.3 2.22 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.341 -1.474 . . . . 0.0 110.746 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.62 -13.24 32.74 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.15 150.9 72.15 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 118.264 1.032 . . . . 0.0 109.483 -171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 36' ' ' ALA . 57.5 Cg_endo -78.03 148.67 24.93 Favored 'Trans proline' 0 CA--C 1.505 -0.938 0 C-N-CA 122.827 2.351 . . . . 0.0 108.871 175.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.63 -25.92 5.52 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 119.855 1.207 . . . . 0.0 111.645 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.31 135.6 0.73 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 131.282 3.833 . . . . 0.0 115.565 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.48 -29.23 1.22 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.113 0.965 . . . . 0.0 110.532 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.01 51.87 1.85 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.094 1.757 . . . . 0.0 110.984 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 tt -108.67 73.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 119.131 -2.23 . . . . 0.0 109.924 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 t -174.7 137.31 0.46 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -66.8 -53.14 29.07 Favored Pre-proline 0 C--N 1.351 0.647 0 CA-C-O 115.611 -2.138 . . . . 0.0 112.652 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -69.78 -20.57 34.59 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 125.568 3.024 . . . . 0.0 113.126 -170.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.278 0.6 OUTLIER -103.04 -12.27 17.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 119.541 1.064 . . . . 0.0 110.34 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.89 -31.53 63.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 120.546 -1.346 . . . . 0.0 110.867 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tp -67.26 -32.47 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -33.95 68.32 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.534 -1.353 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -67.04 -38.62 86.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.657 1.218 . . . . 0.0 108.981 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -60.0 -43.53 95.13 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.56 1.144 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.61 -49.85 79.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 124.275 1.03 . . . . 0.0 110.415 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.61 -17.03 62.3 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.683 -0.636 . . . . 0.0 111.605 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m -80.14 -38.59 31.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.672 -0.642 . . . . 0.0 109.697 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.8 67.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.844 -1.16 . . . . 0.0 111.528 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -86.19 6.82 27.62 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.9 0.48 . . . . 0.0 110.121 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p 50.08 54.13 11.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.587 1.955 . . . . 0.0 112.584 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 56' ' ' GLY . 8.2 p -116.99 -77.42 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.558 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.05 85.06 0.23 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -74.39 -14.82 60.92 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.664 -1.492 . . . . 0.0 111.061 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 32.08 3.88 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 49.0 t0 -73.28 -48.97 30.27 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -136.85 169.83 17.1 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.32 146.56 33.56 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.89 -172.61 1.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 124.61 3.54 . . . . 0.0 109.432 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 64' ' ' THR 0.253 13.3 p -129.02 -146.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 63' ' ' VAL . 18.9 m -100.63 -49.97 4.03 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.562 1.545 . . . . 0.0 107.946 -172.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -79.4 -12.27 59.91 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.452 0.701 . . . . 0.0 111.179 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -63.78 -30.36 71.47 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 122.931 1.348 . . . . 0.0 107.649 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.55 81.14 1.49 Allowed Glycine 0 CA--C 1.469 -2.794 1 N-CA-C 99.601 -5.4 . . . . 0.0 99.601 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -59.18 -8.04 1.42 Allowed 'General case' 0 C--N 1.362 1.144 0 CA-C-O 123.238 1.494 . . . . 0.0 112.929 -168.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -60.17 -15.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 120.144 -1.597 . . . . 0.0 113.171 164.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.91 -50.53 74.64 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-N 120.688 1.585 . . . . 0.0 107.367 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.86 -47.21 83.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.311 0.644 . . . . 0.0 111.798 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.89 -45.86 71.22 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.096 1.358 . . . . 0.0 110.728 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -33.6 75.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.909 0.884 . . . . 0.0 111.539 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.43 -49.31 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.4 ptp -65.68 -38.31 88.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 122.01 -0.431 . . . . 0.0 110.332 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -65.14 -38.05 89.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.484 -0.76 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.59 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.315 0.646 . . . . 0.0 110.702 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -44.56 97.55 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.405 1.002 . . . . 0.0 110.71 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.93 -44.17 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 121.894 -0.768 . . . . 0.0 109.294 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.36 -47.43 85.9 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.068 -1.02 . . . . 0.0 112.02 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.83 -39.2 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 O-C-N 121.719 -0.613 . . . . 0.0 111.202 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.69 -39.04 64.67 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.687 0.676 . . . . 0.0 109.387 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.29 73.86 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 121.455 -0.778 . . . . 0.0 111.172 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.77 -36.22 76.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.296 1.438 . . . . 0.0 111.267 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.84 -12.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 125.202 1.401 . . . . 0.0 111.198 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -58.99 -21.52 59.05 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.762 -1.836 . . . . 0.0 111.58 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.92 -26.51 68.84 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 120.815 -1.178 . . . . 0.0 112.15 172.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.54 -47.65 11.1 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.19 -40.58 94.45 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.079 0.951 . . . . 0.0 113.342 -170.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -16.5 63.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.102 -0.999 . . . . 0.0 111.616 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.6 p -87.59 -12.51 45.45 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.89 -1.131 . . . . 0.0 110.641 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -76.26 -17.48 59.45 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -166.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.537 ' HA ' ' CE1' ' B' ' 4' ' ' HIS . 4.5 p90 -81.36 -31.64 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.962 -1.086 . . . . 0.0 110.379 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -71.54 -22.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 125.904 1.682 . . . . 0.0 109.025 -169.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -53.85 -24.04 14.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.362 1.465 . . . . 0.0 112.585 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -65.91 -16.16 63.61 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 120.221 -1.55 . . . . 0.0 112.029 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.35 0.628 0 CA-C-O 122.018 0.913 . . . . 0.0 109.494 176.802 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 120.683 0.277 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 93' ' ' PHE . 31.8 m170 -76.32 -21.45 56.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.897 -1.127 . . . . 0.0 110.98 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -81.59 -48.08 12.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -64.14 -40.22 95.69 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.405 -0.809 . . . . 0.0 112.198 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.46 -27.46 60.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.43 71.71 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.432 -0.792 . . . . 0.0 109.844 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.38 -37.55 86.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.759 0.824 . . . . 0.0 111.075 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -64.43 -37.16 86.55 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.409 0.683 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -29.46 70.8 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.477 -0.764 . . . . 0.0 111.208 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -67.33 -30.12 69.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.109 -0.994 . . . . 0.0 111.528 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.4 -28.45 61.09 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.79 -1.194 . . . . 0.0 110.141 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.38 -42.76 95.98 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.227 1.011 . . . . 0.0 109.138 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.6 -40.53 97.22 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.459 -0.776 . . . . 0.0 110.749 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -67.44 -27.31 66.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -69.5 -43.88 72.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.485 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.11 -35.31 74.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 123.921 0.889 . . . . 0.0 109.34 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.9 mt -53.82 -53.95 45.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 123.938 0.895 . . . . 0.0 109.73 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -66.89 -32.86 74.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.782 -0.574 . . . . 0.0 111.944 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.18 -51.7 50.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.843 0.83 . . . . 0.0 109.535 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.53 83.43 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.991 0.916 . . . . 0.0 111.388 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -63.57 -40.14 96.2 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 123.61 0.764 . . . . 0.0 110.852 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -63.93 -40.39 96.35 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -68.73 -40.65 79.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.384 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.69 67.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.911 1.684 . . . . 0.0 113.086 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.87 -25.49 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.801 0.81 . . . . 0.0 111.721 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.17 -36.2 13.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.04 -50.67 63.38 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.698 1.999 . . . . 0.0 110.187 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.18 56.46 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.375 -0.828 . . . . 0.0 109.98 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -138.61 101.85 4.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.04 -2.1 38.18 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.16 64.74 Favored Pre-proline 0 N--CA 1.442 -0.844 0 O-C-N 121.586 -0.95 . . . . 0.0 109.658 -172.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.45 113.07 2.56 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.366 2.71 . . . . 0.0 112.423 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.0 23.86 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.31 163.15 17.86 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.56 -25.9 0.27 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.33 52.0 2.26 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.65 1.214 . . . . 0.0 108.718 -172.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 43.8 pt -80.06 27.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 124.932 1.293 . . . . 0.0 111.1 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -122.34 142.5 50.44 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.89 -1.131 . . . . 0.0 109.429 -168.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.73 -62.02 0.23 Allowed Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-O 116.937 -1.506 . . . . 0.0 110.198 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.14 -12.55 23.44 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 CA-C-N 125.496 2.998 . . . . 0.0 111.659 -172.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -87.72 -8.85 55.53 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.26 99.43 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 121.687 -0.633 . . . . 0.0 110.016 -173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.54 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.028 0.531 . . . . 0.0 110.338 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -20.47 55.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 120.713 -1.242 . . . . 0.0 111.877 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -75.85 -53.48 8.39 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 m -54.82 -33.1 61.19 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.7 t -56.75 -48.76 80.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 124.281 1.032 . . . . 0.0 110.584 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.63 -16.43 55.82 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 119.798 1.181 . . . . 0.0 111.795 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -65.71 -42.17 91.44 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 109.318 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -29.14 68.77 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 123.353 0.661 . . . . 0.0 111.416 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.0 p -87.17 -0.75 57.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 16.6 p 54.44 33.89 19.7 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.759 1.624 . . . . 0.0 110.806 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.89 -60.76 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 103.255 -2.868 . . . . 0.0 103.255 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 50.13 64.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.03 -41.3 91.12 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 118.095 0.948 . . . . 0.0 108.628 -171.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.68 -111.05 0.46 Allowed Glycine 0 CA--C 1.471 -2.713 0 N-CA-C 103.398 -3.881 . . . . 0.0 103.398 172.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.8 t0 76.5 -72.55 0.1 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.184 0.993 . . . . 0.0 109.741 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.62 167.42 19.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.64 128.31 13.52 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -88.07 161.38 7.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.027 2.485 . . . . 0.0 109.708 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.452 HG13 ' H ' ' B' ' 64' ' ' THR 0.348 14.6 p -96.71 -126.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.452 ' H ' HG13 ' B' ' 63' ' ' VAL . 3.1 m -119.87 -38.86 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.864 1.666 . . . . 0.0 109.266 -170.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -93.04 5.45 51.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.718 0.807 . . . . 0.0 109.976 -168.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.11 38.11 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.63 73.87 1.27 Allowed Glycine 0 CA--C 1.469 -2.832 1 N-CA-C 101.444 -4.662 . . . . 0.0 101.444 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -48.26 -8.02 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 130.293 3.437 . . . . 0.0 114.738 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' B' ' 72' ' ' GLU . 61.4 mttt -48.22 -26.34 1.91 Allowed 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 127.015 2.126 . . . . 0.0 112.804 154.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.95 -48.18 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 125.022 1.329 . . . . 0.0 108.826 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.26 60.64 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 109.886 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.456 ' HB3' ' HA ' ' B' ' 69' ' ' LYS . 14.7 tt0 -49.76 -46.65 50.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 127.856 2.462 . . . . 0.0 109.961 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -61.67 -43.9 97.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.086 0.954 . . . . 0.0 111.019 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.25 -43.84 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -61.39 -51.76 67.44 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.05 0.54 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -66.39 -35.57 80.66 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.822 -0.549 . . . . 0.0 110.094 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.3 93.64 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.608 -0.683 . . . . 0.0 110.836 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.53 -48.79 79.26 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.98 -48.11 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.808 1.243 . . . . 0.0 109.943 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.28 -33.79 76.81 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.638 -1.289 . . . . 0.0 111.947 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.82 -49.51 68.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.553 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -66.82 -22.78 66.0 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.381 0.672 . . . . 0.0 111.135 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.12 -39.42 25.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.33 -34.36 76.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.676 1.191 . . . . 0.0 111.312 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 m -66.25 -7.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 121.442 -0.786 . . . . 0.0 112.124 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 72.2 m -59.19 -22.03 60.36 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.128 1.371 . . . . 0.0 111.085 171.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.19 68.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 118.852 -2.405 . . . . 0.0 112.382 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.99 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.5 -35.72 72.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.232 1.413 . . . . 0.0 112.45 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . . . -71.38 -16.94 62.43 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 121.005 -1.06 . . . . 0.0 112.011 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -76.53 -24.51 53.65 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.7 -9.14 59.3 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.813 -1.179 . . . . 0.0 110.327 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' B' ' 90' ' ' ALA . 3.1 m-30 -73.82 -34.43 64.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.55 1.14 . . . . 0.0 108.423 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.29 -31.76 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 125.101 1.36 . . . . 0.0 108.457 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -62.99 -5.11 2.63 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.214 -0.929 . . . . 0.0 112.829 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -64.78 -23.29 67.2 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.744 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 0.5 OUTLIER -45.91 -33.97 3.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 128.507 2.723 . . . . 0.0 112.441 166.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.43 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 7.0 pt-20 -79.61 -28.2 41.02 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -71.57 -40.31 70.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -70.14 -35.41 74.04 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.674 0.75 . . . . 0.0 109.117 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.54 83.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.511 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.27 -35.55 75.8 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.795 1.638 . . . . 0.0 111.373 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -66.4 -42.44 87.84 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.962 1.305 . . . . 0.0 109.43 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 110.877 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.63 -39.87 68.39 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.683 1.193 . . . . 0.0 111.418 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -71.38 -36.48 71.43 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.501 1.12 . . . . 0.0 110.105 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.69 -39.1 87.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.542 1.137 . . . . 0.0 109.875 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.15 -40.49 97.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.012 -1.055 . . . . 0.0 111.369 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -65.58 -40.14 92.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.67 1.188 . . . . 0.0 111.74 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -73.48 -29.29 62.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.767 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.79 -34.95 70.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.125 -0.984 . . . . 0.0 109.599 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.41 -37.72 78.77 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.077 -1.014 . . . . 0.0 111.684 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -64.08 -46.23 85.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.235 -0.915 . . . . 0.0 109.958 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.26 -37.52 85.67 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.353 -0.842 . . . . 0.0 110.316 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.36 74.25 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.792 1.237 . . . . 0.0 111.671 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -63.31 -42.55 99.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.149 0.5 . . . . 0.0 110.967 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.62 -50.45 62.94 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.54 1.536 . . . . 0.0 107.829 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.89 -41.17 87.64 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.128 -0.357 . . . . 0.0 110.821 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.24 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 123.573 0.749 . . . . 0.0 110.499 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.81 72.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 O-C-N 120.431 -1.418 . . . . 0.0 110.551 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -70.39 -32.11 69.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.16 1.384 . . . . 0.0 109.409 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.56 -49.52 76.31 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.978 1.311 . . . . 0.0 110.808 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' C' ' 38' ' ' LEU . 6.2 mp0 -74.92 -17.68 60.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 121.769 -0.582 . . . . 0.0 111.354 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -94.55 79.46 3.82 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.128 -1.608 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.74 -29.75 0.83 Allowed Glycine 0 CA--C 1.491 -1.444 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.93 155.19 36.73 Favored Pre-proline 0 N--CA 1.443 -0.788 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.43 161.5 31.48 Favored 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.236 1.957 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.88 6.24 76.29 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 123.932 0.777 . . . . 0.0 111.751 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 122.36 6.34 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 126.087 1.755 . . . . 0.0 114.228 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 -24.5 0.86 Allowed 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' C' ' 30' ' ' GLU . 3.6 tt -76.04 -87.32 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 mt 64.8 161.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.778 0 C-N-CA 125.411 1.484 . . . . 0.0 109.466 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.9 t 81.88 115.23 0.06 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.659 1.583 . . . . 0.0 112.118 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -68.73 -52.19 18.98 Favored Pre-proline 0 C--N 1.349 0.568 0 CA-C-O 115.973 -1.965 . . . . 0.0 112.408 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.85 -7.49 20.1 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 126.094 3.212 . . . . 0.0 111.542 -170.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -93.51 -33.3 13.83 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.79 74.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.677 1.191 . . . . 0.0 111.699 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 tt -60.76 -29.04 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 124.63 1.172 . . . . 0.0 111.493 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -23.28 29.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.286 -0.884 . . . . 0.0 109.606 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -78.94 -37.57 39.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 12.5 p -77.79 55.59 1.4 Allowed 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 121.427 -0.795 . . . . 0.0 110.115 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -131.43 -68.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.45 -19.24 64.56 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -67.58 -35.86 79.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.183 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.12 56.91 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 120.774 -1.204 . . . . 0.0 110.325 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -93.33 15.74 14.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.22 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.266 10.2 t 49.69 55.24 9.69 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 112.803 168.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.6 m -143.3 -164.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 N-CA-C 98.336 -4.69 . . . . 0.0 98.336 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.32 106.22 0.19 Allowed Glycine 0 CA--C 1.467 -2.909 1 N-CA-C 100.057 -5.217 . . . . 0.0 100.057 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.418 ' CE1' ' HA3' ' D' ' 56' ' ' GLY . 6.2 m-30 -87.39 -6.91 58.26 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -167.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.94 42.0 2.02 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.72 -51.1 12.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -144.78 -177.27 5.43 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.99 138.66 13.42 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.81 169.34 15.05 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.54 2.827 . . . . 0.0 110.078 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -101.86 -175.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-O 122.605 1.193 . . . . 0.0 111.897 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -87.62 -61.48 1.71 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 124.562 1.145 . . . . 0.0 110.375 -166.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -59.44 -37.64 78.63 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.514 0.726 . . . . 0.0 111.514 -169.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.69 -76.29 0.57 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.048 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -23.72 -51.07 0.03 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 129.473 3.416 . . . . 0.0 117.305 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -58.76 -47.34 85.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.01 1.724 . . . . 0.0 112.736 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -75.58 -27.82 58.7 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.114 . . . . 0.0 108.803 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.05 -52.57 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.83 95.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.076 1.35 . . . . 0.0 111.464 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -34.01 72.7 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 119.18 0.9 . . . . 0.0 111.584 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.78 -42.56 94.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.277 1.031 . . . . 0.0 109.984 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.34 -44.34 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.252 1.021 . . . . 0.0 109.59 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mtp -57.03 -48.79 77.65 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.374 1.069 . . . . 0.0 110.078 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -62.32 -31.9 72.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.303 1.841 . . . . 0.0 111.97 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.99 71.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.627 0.771 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.33 -42.16 75.65 Favored Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.65 -42.73 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 109.797 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -53.77 -56.33 18.45 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 110.544 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.45 -49.82 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 C-N-CA 125.358 1.463 . . . . 0.0 109.516 -171.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.87 -24.01 62.42 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.716 -0.615 . . . . 0.0 111.098 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.52 47.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.961 -1.087 . . . . 0.0 110.144 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.96 -37.31 81.94 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 111.661 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.56 -1.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.623 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -58.5 -24.03 59.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.178 1.791 . . . . 0.0 113.784 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.18 84.78 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 119.14 -2.225 . . . . 0.0 112.216 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -66.27 -42.08 88.98 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.2 -43.73 66.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.172 0.51 . . . . 0.0 111.093 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.71 -41.59 26.42 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 120.357 -1.464 . . . . 0.0 112.667 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 34.1 p -69.07 -7.01 31.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.619 -1.3 . . . . 0.0 111.41 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -74.23 -5.46 42.11 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.835 -0.541 . . . . 0.0 110.41 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -35.56 71.66 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 120.043 -1.661 . . . . 0.0 111.02 167.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.39 -17.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.42 1.488 . . . . 0.0 108.934 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.69 -29.81 40.61 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.512 1.525 . . . . 0.0 111.966 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -60.48 -39.82 89.03 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.71 1.204 . . . . 0.0 110.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.436 -1.157 0 O-C-N 121.422 -0.799 . . . . 0.0 109.58 -177.074 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.21 -39.82 94.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.796 1.638 . . . . 0.0 111.407 -169.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.431 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 19.6 p80 -78.54 -20.68 50.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.403 -0.811 . . . . 0.0 111.232 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.431 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 18.3 mt-10 -89.86 -21.69 22.42 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.096 -1.003 . . . . 0.0 108.561 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.55 -43.71 96.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.121 1.768 . . . . 0.0 109.784 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.47 -32.16 71.96 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 109.362 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.38 -35.46 73.52 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.206 1.003 . . . . 0.0 111.321 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.53 -31.75 72.99 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.469 -0.769 . . . . 0.0 111.439 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.73 -33.66 74.44 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.795 -0.566 . . . . 0.0 110.836 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.682 0.793 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.48 -39.4 88.73 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.872 0.869 . . . . 0.0 110.262 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -46.02 91.35 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 121.287 -0.883 . . . . 0.0 109.846 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.6 -41.68 81.71 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.825 2.05 . . . . 0.0 109.942 -175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.89 -40.79 96.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.068 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.23 -27.69 67.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.513 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -69.57 -42.79 74.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.27 -0.893 . . . . 0.0 110.342 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 m -72.59 -26.37 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 121.657 -0.652 . . . . 0.0 110.941 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.56 -41.27 96.42 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.307 -0.871 . . . . 0.0 111.096 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.46 -30.38 59.92 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 124.073 0.949 . . . . 0.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.93 -39.25 72.79 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 119.787 -1.821 . . . . 0.0 109.507 173.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.11 85.58 Favored 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.013 1.325 . . . . 0.0 110.85 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.1 p -67.19 -37.15 83.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 119.202 0.91 . . . . 0.0 111.196 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.13 -52.7 31.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.506 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -71.07 -25.12 62.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.076 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.82 -53.64 47.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.396 1.078 . . . . 0.0 110.016 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.74 -38.61 83.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -77.05 -6.59 53.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.332 -1.48 . . . . 0.0 112.421 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.48 -52.32 5.42 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -48.48 -50.58 31.01 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 129.034 2.934 . . . . 0.0 114.382 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -74.07 85.68 1.83 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.731 0.777 . . . . 0.0 110.413 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.34 -18.36 1.7 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.63 140.03 31.56 Favored Pre-proline 0 N--CA 1.445 -0.705 0 O-C-N 121.128 -1.219 . . . . 0.0 111.15 -170.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.39 132.82 6.06 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.77 2.314 . . . . 0.0 111.232 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.57 27.85 37.64 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.9 157.4 5.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.43 2.292 . . . . 0.0 111.9 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.02 -36.04 0.83 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.132 1.373 . . . . 0.0 110.072 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.45 81.5 1.48 Allowed 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.927 1.346 . . . . 0.0 112.865 -164.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 35.0 pt -93.79 -8.67 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 118.871 2.915 . . . . 0.0 118.871 -166.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.7 m -121.32 141.2 51.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 123.656 2.935 . . . . 0.0 110.708 -164.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -59.21 -47.77 97.66 Favored Pre-proline 0 C--N 1.353 0.757 0 CA-C-O 116.172 -1.871 . . . . 0.0 112.909 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -72.62 -5.59 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 CA-C-N 125.374 2.955 . . . . 0.0 112.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -30.76 12.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.6 76.4 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.294 1.037 . . . . 0.0 111.931 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.9 tt -72.06 -27.39 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 110.022 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.01 -35.75 49.52 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 108.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -63.6 -44.85 92.78 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.957 0.903 . . . . 0.0 110.578 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.5 p -65.74 -27.16 68.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 120.609 -1.307 . . . . 0.0 111.175 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.51 -20.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 111.452 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.9 -16.14 57.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.17 -1.581 . . . . 0.0 110.177 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.48 HG22 ' H ' ' D' ' 52' ' ' ALA . 7.1 m -99.8 -177.45 3.56 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 102.038 -3.319 . . . . 0.0 102.038 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.48 ' H ' HG22 ' D' ' 51' ' ' THR . . . 76.4 -30.14 0.18 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.793 1.637 . . . . 0.0 111.263 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.8 p -90.96 -10.92 40.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.65 1.58 . . . . 0.0 111.397 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p 58.45 30.83 20.23 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.359 1.463 . . . . 0.0 111.223 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.92 -87.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 101.446 -3.539 . . . . 0.0 101.446 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' C' ' 57' ' ' TYR . . . 81.32 73.33 1.19 Allowed Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -44.62 93.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.65 0.78 . . . . 0.0 111.099 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.3 -62.7 0.27 Allowed Glycine 0 CA--C 1.477 -2.331 0 C-N-CA 117.36 -2.352 . . . . 0.0 112.6 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -10.33 -67.24 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 128.948 2.899 . . . . 0.0 117.747 -162.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.94 155.13 43.58 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 104.424 -2.435 . . . . 0.0 104.424 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.43 152.22 19.52 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.66 158.37 19.0 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.085 2.524 . . . . 0.0 111.518 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.457 HG22 ' H ' ' D' ' 64' ' ' THR . 8.5 p -101.99 -151.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.457 ' H ' HG22 ' D' ' 63' ' ' VAL . 2.2 m -76.65 -50.11 14.55 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.547 1.939 . . . . 0.0 111.157 -171.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -77.59 -14.51 59.63 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.457 1.503 . . . . 0.0 110.498 -162.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.62 -20.18 62.76 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.165 0.983 . . . . 0.0 109.658 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.72 89.38 0.84 Allowed Glycine 0 CA--C 1.478 -2.265 1 N-CA-C 98.691 -5.764 . . . . 0.0 98.691 -170.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -65.06 -11.36 38.58 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.056 1.928 . . . . 0.0 110.02 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -57.28 -14.84 4.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.324 1.05 . . . . 0.0 113.597 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.88 -43.32 97.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.487 1.494 . . . . 0.0 109.116 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.98 -43.08 75.63 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -44.93 82.33 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.596 1.158 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.76 -45.51 93.61 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.402 0.681 . . . . 0.0 111.364 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.8 -39.73 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.634 0.774 . . . . 0.0 109.32 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.7 ttm -62.9 -48.14 80.27 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.384 1.074 . . . . 0.0 110.303 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -63.57 -42.18 98.34 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 109.846 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.3 80.7 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 111.439 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.79 -36.67 93.66 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.211 0.91 . . . . 0.0 112.249 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -68.66 -42.85 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 121.311 -1.111 . . . . 0.0 108.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.95 -43.08 99.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 121.432 -0.793 . . . . 0.0 111.604 -175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.69 -40.78 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 O-C-N 121.79 -0.569 . . . . 0.0 111.355 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.29 -21.09 56.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.75 25.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.166 -0.959 . . . . 0.0 110.367 174.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.1 -42.54 90.74 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 125.837 1.655 . . . . 0.0 109.877 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.71 -4.26 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.564 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -62.2 -19.79 63.49 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.856 -1.152 . . . . 0.0 110.427 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.07 77.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.341 -1.475 . . . . 0.0 111.841 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.35 -33.07 49.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 120.926 -1.109 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.01 -31.49 68.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.125 0.488 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.87 70.47 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.834 -1.166 . . . . 0.0 111.257 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -9.94 59.03 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.876 -1.14 . . . . 0.0 111.922 173.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.45 -40.17 70.5 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 119.644 1.111 . . . . 0.0 109.359 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -68.46 -29.64 68.33 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.959 -1.088 . . . . 0.0 111.239 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.83 -21.92 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.914 1.286 . . . . 0.0 108.97 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -62.18 -12.55 20.6 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.438 1.095 . . . . 0.0 111.485 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.79 -24.94 67.96 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.404 1.082 . . . . 0.0 112.229 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -176.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 122.639 1.209 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -105.68 -42.17 5.25 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -71.17 -31.36 67.58 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.207 -0.933 . . . . 0.0 111.623 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.55 -40.79 61.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.601 0.715 . . . . 0.0 110.193 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -68.47 -31.64 71.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.48 -0.763 . . . . 0.0 110.359 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -81.0 -30.92 34.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.018 -0.426 . . . . 0.0 110.243 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.6 76.04 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.931 -1.106 . . . . 0.0 110.197 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -57.1 -35.63 69.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.573 1.949 . . . . 0.0 111.691 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -64.42 -39.18 93.34 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.563 1.145 . . . . 0.0 109.84 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.93 80.52 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.693 -0.629 . . . . 0.0 110.156 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.41 -33.67 74.09 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.621 0.769 . . . . 0.0 111.449 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.83 -42.56 94.85 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 109.89 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.55 -36.89 81.88 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.874 0.87 . . . . 0.0 109.459 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -56.87 -44.72 82.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.121 0.569 . . . . 0.0 111.264 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -63.14 -38.14 90.01 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.104 0.962 . . . . 0.0 111.606 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.19 -39.12 92.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.887 1.275 . . . . 0.0 109.83 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.93 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.715 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.1 mt -59.74 -43.95 93.99 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.32 -0.862 . . . . 0.0 111.185 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -74.53 -22.33 59.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.234 1.014 . . . . 0.0 111.798 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.91 -41.04 21.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 120.573 -1.329 . . . . 0.0 108.385 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.6 76.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.716 1.207 . . . . 0.0 111.412 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 p -66.85 -38.35 86.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.454 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -61.37 -47.91 83.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.235 1.414 . . . . 0.0 107.812 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -65.63 -47.06 76.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 122.662 0.385 . . . . 0.0 110.572 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.48 90.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.03 1.332 . . . . 0.0 112.058 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.86 -34.66 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.434 -0.791 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.23 -24.79 27.68 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 120.271 -1.518 . . . . 0.0 110.357 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -79.85 -53.66 6.57 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.83 -34.88 69.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 119.073 0.851 . . . . 0.0 110.98 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -74.65 108.88 7.69 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 119.569 -1.957 . . . . 0.0 110.455 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.66 -33.12 2.8 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.57 144.53 83.65 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.309 -170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.64 138.7 21.85 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 C-N-CA 122.799 2.333 . . . . 0.0 109.833 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.45 -0.07 89.31 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.16 146.8 54.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.054 0.942 . . . . 0.0 111.543 -171.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.55 -42.45 3.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.78 131.11 34.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 pt -149.45 173.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.3 m 66.64 132.94 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.526 1.931 . . . . 0.0 114.163 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.32 -46.82 38.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 115.77 -2.062 . . . . 0.0 112.309 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.5 -11.65 30.2 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 CA-C-N 126.056 3.199 . . . . 0.0 112.293 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.15 -47.63 7.95 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.59 75.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 126.166 1.786 . . . . 0.0 112.37 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.73 -28.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 121.359 0.599 . . . . 0.0 111.115 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -22.29 32.19 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.235 -0.916 . . . . 0.0 109.69 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -78.14 -33.84 50.2 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.76 61.26 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.123 -0.985 . . . . 0.0 110.862 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -138.84 -76.1 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -67.71 -14.88 63.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 112.031 -169.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -64.88 -36.56 84.76 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 126.331 1.852 . . . . 0.0 108.582 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.23 60.28 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.207 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -88.99 13.41 12.96 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 p 56.79 51.1 11.35 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.514 1.526 . . . . 0.0 113.065 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 ' SD ' ' B' ' 75' ' ' MET . 21.3 t -116.19 -104.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.22 71.46 0.73 Allowed Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -66.75 -18.98 65.65 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.587 -0.949 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.51 22.23 6.18 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -56.21 17.12 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.995 0.898 . . . . 0.0 110.131 174.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -147.47 161.68 40.58 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.97 146.94 18.44 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.9 176.53 9.9 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 124.481 3.454 . . . . 0.0 110.341 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 t -112.5 -102.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 120.053 1.297 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -139.53 -41.53 0.45 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -88.07 -19.19 27.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.577 0.751 . . . . 0.0 111.146 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -63.02 -34.56 77.83 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 108.036 170.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.57 79.52 1.44 Allowed Glycine 0 CA--C 1.471 -2.659 1 N-CA-C 100.297 -5.121 . . . . 0.0 100.297 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.447 HH22 ' CG ' ' D' ' 59' ' ' ASP . 49.5 ttm-85 -39.07 -28.15 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 128.806 2.842 . . . . 0.0 114.512 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -53.27 -15.74 1.05 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.53 -46.82 92.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 125.216 1.407 . . . . 0.0 109.399 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.163 0.985 . . . . 0.0 108.899 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.37 -43.24 33.48 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.595 1.558 . . . . 0.0 111.667 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -62.58 -38.17 89.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.13 0.572 . . . . 0.0 111.437 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.71 -38.63 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -176.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -59.95 -44.62 94.27 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.046 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -63.17 -34.3 77.32 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.493 -0.754 . . . . 0.0 110.961 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.92 85.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.753 0.706 . . . . 0.0 111.291 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.29 50.97 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.04 -38.89 62.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 124.562 1.145 . . . . 0.0 108.897 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -70.35 -49.28 50.93 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.815 -1.178 . . . . 0.0 111.177 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.89 -45.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 O-C-N 121.33 -0.856 . . . . 0.0 110.199 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -73.48 -29.69 62.68 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 121.447 -0.783 . . . . 0.0 110.2 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.0 62.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 120.665 -1.272 . . . . 0.0 110.314 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.93 -35.4 80.56 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.935 -1.103 . . . . 0.0 110.769 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.92 -9.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.161 1.385 . . . . 0.0 111.26 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 m -59.34 -23.01 62.15 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 118.986 -2.321 . . . . 0.0 111.931 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.33 61.26 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.551 -1.343 . . . . 0.0 112.36 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.37 -41.94 9.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.512 1.525 . . . . 0.0 109.577 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -41.76 63.2 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.637 -1.289 . . . . 0.0 111.582 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.19 -5.43 41.85 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 121.037 -1.039 . . . . 0.0 111.12 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -97.54 -5.42 35.8 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.701 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.26 18.2 m-20 -80.13 -16.86 54.04 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 121.094 1.77 . . . . 0.0 111.268 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.49 -29.55 37.37 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.837 -1.164 . . . . 0.0 109.602 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.41 -30.87 50.45 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 124.429 1.092 . . . . 0.0 109.248 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -53.5 -26.44 20.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.001 1.32 . . . . 0.0 112.916 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -62.59 -34.75 77.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.524 1.13 . . . . 0.0 110.689 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 O-C-N 121.919 -0.488 . . . . 0.0 110.132 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.504 -0.789 0 CA-C-O 121.812 0.815 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -62.81 -23.63 67.35 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.588 1.955 . . . . 0.0 112.709 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -81.83 -41.58 20.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -70.08 -35.18 74.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.379 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.8 -39.66 85.75 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.494 0.718 . . . . 0.0 110.304 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.61 91.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.408 0.683 . . . . 0.0 111.495 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -68.31 -38.55 81.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 121.594 -0.691 . . . . 0.0 110.219 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.85 -36.27 80.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.46 0.648 . . . . 0.0 110.892 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.14 83.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.839 0.856 . . . . 0.0 111.193 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.27 -32.39 73.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.508 -0.745 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.23 -35.83 71.62 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.165 -0.959 . . . . 0.0 109.597 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.81 -30.21 69.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 120.641 -1.287 . . . . 0.0 110.325 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -61.16 -43.68 98.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 122.978 0.511 . . . . 0.0 111.186 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.33 -35.15 79.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.344 0.658 . . . . 0.0 110.892 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -67.61 -39.11 84.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.274 0.63 . . . . 0.0 110.668 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.76 -39.87 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.797 0.839 . . . . 0.0 109.302 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.22 -43.45 87.73 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.179 0.899 . . . . 0.0 111.969 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.35 -37.39 80.44 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.59 1.156 . . . . 0.0 110.501 -177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.22 -46.06 52.57 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.681 1.229 . . . . 0.0 108.788 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.31 64.57 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 125.043 1.337 . . . . 0.0 112.236 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.8 p -73.32 -31.57 64.08 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.341 -0.849 . . . . 0.0 110.006 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -40.96 71.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.028 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.5 75.22 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.796 1.239 . . . . 0.0 112.742 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.04 -29.96 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 O-C-N 120.912 -1.117 . . . . 0.0 111.381 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.96 -20.57 28.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.153 0.501 . . . . 0.0 110.52 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.34 94.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.412 1.885 . . . . 0.0 109.462 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -69.39 -106.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.571 0.7 . . . . 0.0 111.58 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 58.17 9.66 1.04 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.48 34.63 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.72 149.14 38.64 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -77.14 113.09 3.53 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.486 2.124 . . . . 0.0 110.693 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -65.37 0.28 Allowed Glycine 0 CA--C 1.484 -1.901 0 N-CA-C 103.109 -3.996 . . . . 0.0 103.109 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 75.23 162.47 0.25 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 127.65 2.38 . . . . 0.0 108.424 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.98 -72.61 0.08 Allowed 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.595 -0.691 . . . . 0.0 110.265 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.34 80.5 1.59 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 tt -122.99 93.99 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.5 m -156.07 -150.73 0.3 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -167.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.05 -58.36 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 116.445 -1.741 . . . . 0.0 106.447 169.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.51 -29.03 20.89 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.803 3.108 . . . . 0.0 112.434 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.52 9.12 39.8 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 123.809 0.843 . . . . 0.0 110.148 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.05 -41.22 82.35 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.679 -1.263 . . . . 0.0 109.675 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -73.45 -24.86 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 O-C-N 121.559 -0.713 . . . . 0.0 110.034 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -58.27 -55.66 32.18 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 125.687 1.595 . . . . 0.0 110.195 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -71.09 -34.82 71.51 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -55.84 -43.41 77.0 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.526 1.13 . . . . 0.0 110.954 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.7 t -55.19 -51.15 58.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 124.414 1.086 . . . . 0.0 111.061 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.42 -22.16 55.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.31 -0.869 . . . . 0.0 111.693 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -65.07 -40.96 95.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.183 0.993 . . . . 0.0 109.093 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.17 65.5 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 121.235 -0.916 . . . . 0.0 112.175 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -89.04 5.49 44.14 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.872 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 56.09 28.97 13.75 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.665 1.186 . . . . 0.0 111.463 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.17 -56.66 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.55 62.39 5.84 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.4 -27.5 66.27 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 123.14 1.448 . . . . 0.0 108.115 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.47 43.96 1.4 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 107.446 -2.261 . . . . 0.0 107.446 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.55 -50.97 9.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -133.87 172.57 12.61 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -146.25 149.88 39.54 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.77 166.75 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.524 2.816 . . . . 0.0 109.36 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.24 -144.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 7.3 p -107.12 -59.75 1.77 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.213 1.405 . . . . 0.0 107.781 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.84 -16.28 48.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 130.185 3.394 . . . . 0.0 111.99 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -67.63 -22.71 65.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 124.137 1.923 . . . . 0.0 108.482 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.82 67.92 1.41 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 101.557 -4.617 . . . . 0.0 101.557 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -37.76 -20.71 0.01 OUTLIER 'General case' 0 C--N 1.362 1.124 0 C-N-CA 131.62 3.968 . . . . 0.0 115.461 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -54.69 -14.62 1.42 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.75 1.62 . . . . 0.0 114.499 162.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.98 -44.11 92.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.134 0 CA-C-N 121.709 2.05 . . . . 0.0 107.305 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.54 86.37 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.575 -0.703 . . . . 0.0 110.193 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.42 -45.31 80.77 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 123.762 0.825 . . . . 0.0 110.872 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -55.19 -46.76 75.87 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.627 1.971 . . . . 0.0 111.56 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.5 t -72.35 -44.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 C-N-CA 123.256 0.623 . . . . 0.0 109.494 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 55' ' ' VAL . 72.9 mtm -58.89 -49.18 78.74 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.895 0.878 . . . . 0.0 110.293 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.77 -40.2 94.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.071 0.548 . . . . 0.0 110.783 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.98 76.27 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.116 0.566 . . . . 0.0 111.418 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -44.02 91.78 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 124.259 0.933 . . . . 0.0 111.172 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.96 -42.07 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.796 -0.826 . . . . 0.0 108.954 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.36 -50.85 71.65 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.174 -0.954 . . . . 0.0 111.995 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.3 -41.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 O-C-N 121.829 -0.544 . . . . 0.0 110.577 -173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -75.75 -27.97 58.31 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.588 -0.695 . . . . 0.0 110.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.6 -34.5 69.94 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.008 -1.057 . . . . 0.0 109.584 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.37 -34.0 76.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.296 1.038 . . . . 0.0 110.86 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.44 -21.9 19.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 124.847 1.259 . . . . 0.0 110.691 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 2.5 m -62.23 -16.33 52.7 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.574 -1.329 . . . . 0.0 111.531 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.41 -35.31 80.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.3 -2.125 . . . . 0.0 111.17 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.34 -33.75 61.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.83 -25.03 40.94 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.141 0.577 . . . . 0.0 111.569 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.35 -27.96 64.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 120.036 -1.665 . . . . 0.0 109.268 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -9.01 55.28 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.025 -1.047 . . . . 0.0 112.314 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -72.45 -23.09 61.01 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.397 -1.44 . . . . 0.0 110.728 -172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' C' ' 91' ' ' THR . 19.0 p90 -75.23 -28.27 59.83 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.41 -0.806 . . . . 0.0 110.404 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.96 -40.15 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 124.131 0.972 . . . . 0.0 108.64 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -60.5 -23.56 64.63 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.352 -0.842 . . . . 0.0 112.663 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -52.67 -46.51 67.26 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.852 1.261 . . . . 0.0 109.983 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 N--CA 1.439 -0.977 0 O-C-N 121.807 -0.558 . . . . 0.0 110.466 -173.042 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 123.003 1.382 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.491 ' CG ' ' HA ' ' C' ' 88' ' ' ALA . 0.1 OUTLIER -59.09 -29.35 67.29 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.038 1.335 . . . . 0.0 113.733 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -80.64 -43.71 20.03 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -171.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -65.83 -41.55 91.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 123.832 0.853 . . . . 0.0 110.796 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -65.48 -35.67 81.57 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.259 0.624 . . . . 0.0 110.718 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.79 94.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.75 -31.72 66.97 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.952 -0.467 . . . . 0.0 111.676 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.0 -36.37 84.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.94 0.896 . . . . 0.0 110.001 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.59 72.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.29 -40.36 85.9 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 111.069 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.65 -25.43 59.19 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.167 1.387 . . . . 0.0 110.533 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.74 -36.74 67.8 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.305 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -63.72 -44.78 92.59 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -65.44 -24.49 67.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.458 -0.776 . . . . 0.0 112.488 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -60.31 -43.81 95.99 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.532 1.133 . . . . 0.0 109.911 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.14 -40.74 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.263 1.025 . . . . 0.0 109.057 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -40.16 95.24 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.721 0.809 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.56 -21.86 38.19 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.0 111.969 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.41 -47.57 17.3 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.33 60.17 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 124.149 0.979 . . . . 0.0 112.592 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.3 p -67.76 -40.36 84.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.034 1.288 . . . . 0.0 109.089 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -68.52 -44.61 74.26 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.45 -42.72 88.01 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.237 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.58 65.0 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.905 1.282 . . . . 0.0 111.48 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 m -72.3 -27.9 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 O-C-N 121.171 -0.956 . . . . 0.0 111.694 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.89 -37.67 67.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.44 -50.34 16.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 126.277 1.831 . . . . 0.0 109.614 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.58 -34.82 78.74 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.967 0.907 . . . . 0.0 111.266 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -66.49 122.83 18.44 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 119.48 -2.013 . . . . 0.0 109.379 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.26 7.04 59.69 Favored Glycine 0 CA--C 1.496 -1.12 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.83 147.43 34.74 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -77.49 131.74 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.976 2.45 . . . . 0.0 110.792 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 0.1 82.16 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.55 26.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.39 1.476 . . . . 0.0 109.825 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.88 -28.25 8.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 14.1 tp -98.74 83.25 2.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.612 -1.305 . . . . 0.0 108.271 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.2 pt -127.3 64.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -154.03 125.17 7.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -60.43 -47.49 96.22 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-O 115.944 -1.979 . . . . 0.0 113.754 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -71.7 -26.54 19.32 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 CA-C-N 126.04 3.193 . . . . 0.0 110.908 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -85.65 -8.81 58.0 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.97 79.68 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.105 -0.997 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.82 -33.32 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.95 -26.96 49.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.56 -1.337 . . . . 0.0 111.174 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -70.87 -46.43 62.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -66.25 -20.79 66.21 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.313 -0.867 . . . . 0.0 112.941 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.54 -51.47 72.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 124.457 1.103 . . . . 0.0 110.337 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.26 -27.45 61.58 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 118.803 0.728 . . . . 0.0 110.333 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -69.88 -37.9 76.19 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.94 -29.27 68.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.187 -0.945 . . . . 0.0 111.587 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -88.62 4.67 46.21 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.145 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.384 12.7 p 79.34 -63.62 0.26 Allowed 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 127.762 2.425 . . . . 0.0 107.889 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -1.19 -77.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.023 1 C-N-CA 131.964 4.106 . . . . 0.0 113.064 -177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.57 68.96 1.48 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -63.59 -29.35 70.61 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 121.584 -0.95 . . . . 0.0 111.941 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 42.7 0.88 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -65.24 -46.29 81.2 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -138.95 -152.51 0.42 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -165.99 146.29 5.46 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 100.598 -3.852 . . . . 0.0 100.598 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.83 -174.65 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 124.72 3.613 . . . . 0.0 108.791 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.646 HG22 ' H ' ' C' ' 64' ' ' THR . 13.8 p -135.35 -171.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.646 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.6 m -75.31 -41.86 55.98 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 126.394 1.877 . . . . 0.0 110.389 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.23 -24.42 59.32 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.833 0.853 . . . . 0.0 109.619 -167.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -59.49 -45.91 90.33 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.45 78.03 0.73 Allowed Glycine 0 CA--C 1.465 -3.089 1 N-CA-C 97.44 -6.264 . . . . 0.0 97.44 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -47.51 -17.71 0.1 Allowed 'General case' 0 C--N 1.37 1.499 0 C-N-CA 127.984 2.513 . . . . 0.0 114.629 -166.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -51.18 -16.03 0.44 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 127.637 2.375 . . . . 0.0 113.689 165.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . 0.267 30.0 t -72.04 -39.67 66.36 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 CA-C-N 123.504 2.865 . . . . 0.0 109.2 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.89 95.97 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 110.757 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.34 -43.82 97.93 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.066 0.946 . . . . 0.0 111.066 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -59.58 -51.05 71.51 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 125.077 1.351 . . . . 0.0 111.17 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.08 -43.19 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 26.8 ttp -60.1 -50.32 74.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.266 1.026 . . . . 0.0 110.561 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -65.57 -39.55 91.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.691 -0.631 . . . . 0.0 110.181 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.65 91.73 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.067 0.547 . . . . 0.0 111.059 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.04 -48.22 82.12 Favored Glycine 0 CA--C 1.494 -1.237 0 C-N-CA 123.74 0.686 . . . . 0.0 112.013 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.22 -45.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 124.03 0.932 . . . . 0.0 109.365 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.2 -42.79 95.84 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.27 1.028 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.88 -50.1 78.98 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 110.914 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.27 -35.01 78.63 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 121.363 -0.836 . . . . 0.0 111.167 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.66 -36.95 79.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.128 0.571 . . . . 0.0 110.405 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.01 -25.18 68.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.186 1.394 . . . . 0.0 111.968 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.44 -16.9 8.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 125.155 1.382 . . . . 0.0 110.745 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.8 t -66.16 -11.73 51.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 119.707 -1.87 . . . . 0.0 111.936 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.39 -19.91 63.9 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 110.902 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' C' ' 4' ' ' HIS . . . -89.78 -61.27 1.73 Allowed 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 125.329 1.452 . . . . 0.0 107.722 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.3 mt -68.48 -28.39 66.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -165.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.31 -12.0 60.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 120.626 -1.296 . . . . 0.0 110.632 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -81.58 -15.07 55.89 Favored 'General case' 0 CA--C 1.492 -1.257 0 O-C-N 120.365 -1.46 . . . . 0.0 107.905 175.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.307 63.7 m-20 -93.38 10.57 31.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.222 -155.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -100.12 -19.1 16.63 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 121.515 -0.741 . . . . 0.0 109.793 159.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.9 -25.85 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.487 -1.383 . . . . 0.0 107.339 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -72.22 -3.21 22.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.868 -1.145 . . . . 0.0 112.365 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -61.65 -25.53 67.44 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.435 -1.416 . . . . 0.0 109.9 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 . . . . . 0 N--CA 1.436 -1.143 0 C-N-CA 124.419 1.088 . . . . 0.0 109.311 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -168.3 -89.77 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 -162.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.508 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 5.3 p80 -59.26 -22.65 61.47 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.557 2.743 . . . . 0.0 114.371 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.466 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 44.1 mp0 -67.68 -27.76 67.11 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -69.84 -37.92 76.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -79.36 -34.18 42.26 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.72 95.7 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.424 -0.798 . . . . 0.0 111.355 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.23 67.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.873 -0.517 . . . . 0.0 110.184 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.45 -35.2 79.65 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 124.213 1.005 . . . . 0.0 110.627 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.29 69.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 111.463 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -62.18 -41.07 97.99 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.157 -0.964 . . . . 0.0 110.983 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 -27.46 68.92 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 111.756 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -73.69 -35.32 65.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.0 -41.73 95.12 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.802 -1.187 . . . . 0.0 110.458 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -59.92 -31.35 69.75 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.788 1.235 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -66.67 -47.63 71.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.911 1.284 . . . . 0.0 108.941 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.68 -30.44 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.26 -47.58 83.12 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.06 -48.64 73.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 124.657 1.183 . . . . 0.0 109.246 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -66.03 -34.98 79.33 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.506 1.122 . . . . 0.0 110.575 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.27 43.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.534 -1.354 . . . . 0.0 111.295 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -64.31 -43.77 93.66 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.534 -0.729 . . . . 0.0 109.969 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -69.76 -30.18 67.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -66.49 -50.95 61.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -45.54 78.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.895 1.278 . . . . 0.0 112.248 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.88 -28.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.065 -1.022 . . . . 0.0 111.151 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.29 -33.3 22.16 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.545 -1.347 . . . . 0.0 108.674 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.26 74.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.834 2.054 . . . . 0.0 109.408 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -36.51 84.12 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.52 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp85 -78.38 89.07 4.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.239 1.019 . . . . 0.0 111.653 -165.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.42 -12.74 4.32 Favored Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.69 53.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 124.776 1.23 . . . . 0.0 108.493 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.22 141.99 13.19 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 123.108 2.146 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.19 77.33 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 170.87 9.46 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.3 92.32 1.86 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.05 58.46 0.07 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.013 0.911 . . . . 0.0 109.057 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 28.0 pt -95.23 -179.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 O-C-N 119.908 -1.745 . . . . 0.0 108.801 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.8 134.74 0.02 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.411 2.685 . . . . 0.0 114.044 172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -65.97 -46.11 64.1 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 119.715 -1.865 . . . . 0.0 110.484 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -73.45 -11.75 24.67 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 124.185 2.53 . . . . 0.0 113.971 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . 0.251 1.5 m-20 -90.64 -44.6 9.42 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -31.51 72.78 Favored 'General case' 0 CA--C 1.494 -1.205 0 O-C-N 121.178 -0.951 . . . . 0.0 112.238 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.17 -31.98 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 121.892 -0.505 . . . . 0.0 110.698 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -36.51 76.06 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 120.528 -1.357 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' D' ' 60' ' ' ARG . 65.7 t90 -70.55 -35.11 72.94 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.377 -0.827 . . . . 0.0 110.024 174.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -61.69 -42.06 98.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.178 0.991 . . . . 0.0 109.413 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.37 -53.54 42.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 125.159 1.384 . . . . 0.0 110.196 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.79 -45.89 70.86 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.435 1.494 . . . . 0.0 111.782 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.9 m -66.9 -38.13 85.67 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.071 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.35 73.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.461 -0.775 . . . . 0.0 111.36 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -86.22 5.07 35.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 118.98 -0.534 . . . . 0.0 112.273 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 62.7 p 55.98 46.04 22.66 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.658 1.183 . . . . 0.0 112.982 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.527 HG23 ' H ' ' D' ' 56' ' ' GLY . 0.3 OUTLIER -112.03 -93.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.527 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 101.89 64.68 0.75 Allowed Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -28.57 68.01 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -172.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 129.01 2.27 5.63 Favored Glycine 0 CA--C 1.488 -1.654 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.447 ' CG ' HH22 ' A' ' 68' ' ' ARG . 1.7 m-20 -64.79 -41.79 95.54 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.446 ' HB2' ' CD1' ' D' ' 47' ' ' TRP . 50.5 mmt-85 -134.56 143.72 47.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 102.634 -3.099 . . . . 0.0 102.634 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -128.41 130.61 23.53 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.61 170.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 108.841 172.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -128.96 -167.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -76.8 -36.21 57.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 120.606 -1.309 . . . . 0.0 109.125 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -72.4 -24.06 61.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.059 1.344 . . . . 0.0 112.369 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.11 -24.44 51.74 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 123.108 1.432 . . . . 0.0 107.249 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 60.72 1.17 Allowed Glycine 0 CA--C 1.463 -3.209 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -31.88 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 1 C-N-CA 131.963 4.105 . . . . 0.0 116.927 -171.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.06 1.34 2.81 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 120.375 -1.453 . . . . 0.0 113.309 167.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -51.55 57.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.36 67.88 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.605 1.162 . . . . 0.0 110.965 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -52.44 -40.13 61.86 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.033 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -67.64 -33.75 75.59 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.61 -38.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 120.788 -1.195 . . . . 0.0 109.463 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -60.52 -39.61 88.45 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.761 -0.587 . . . . 0.0 110.902 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -57.52 -47.37 82.14 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.738 0.815 . . . . 0.0 110.76 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.06 97.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.875 0.47 . . . . 0.0 110.993 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.09 -50.57 50.95 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.15 -48.29 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.35 1.06 . . . . 0.0 109.385 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.29 -36.86 84.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.88 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.99 -51.83 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 119.388 0.995 . . . . 0.0 109.658 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.87 -21.84 63.3 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.448 -0.783 . . . . 0.0 111.114 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.02 -33.63 20.99 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.89 -39.19 88.31 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 124.529 1.132 . . . . 0.0 110.233 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.94 -7.99 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 121.519 -0.738 . . . . 0.0 112.321 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -60.86 -18.06 53.84 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-N 119.205 0.911 . . . . 0.0 110.229 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 119.704 -1.873 . . . . 0.0 112.372 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.79 71.69 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.06 -25.83 58.93 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.878 0.371 . . . . 0.0 110.9 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.19 -49.71 33.31 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 120.578 -1.326 . . . . 0.0 109.816 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -71.26 1.8 5.6 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.987 -1.07 . . . . 0.0 111.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.34 -24.09 63.86 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.957 -1.09 . . . . 0.0 108.56 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -67.3 -16.52 64.32 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 119.913 -1.742 . . . . 0.0 112.5 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 5.1 m -73.61 -21.64 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 O-C-N 119.652 -1.905 . . . . 0.0 110.561 -173.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -74.6 3.76 7.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.746 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -80.12 -35.77 36.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -176.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 62.96 12.04 5.56 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.938 2.095 . . . . 0.0 112.113 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -154.68 -36.35 0.09 Allowed 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 120.84 -1.163 . . . . 0.0 111.0 -164.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.6 -45.76 71.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -62.26 -37.76 86.67 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.386 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.47 -37.62 56.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.99 0.916 . . . . 0.0 109.289 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.57 89.45 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.948 0.899 . . . . 0.0 111.434 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -75.79 -16.75 60.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.315 -0.866 . . . . 0.0 111.583 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -76.6 -36.89 57.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.2 80.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.655 1.182 . . . . 0.0 111.19 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -55.83 -42.45 75.74 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 123.719 0.807 . . . . 0.0 111.7 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.9 -28.82 67.03 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.27 1.028 . . . . 0.0 110.601 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -41.59 87.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 81' ' ' VAL . 24.9 tp -64.83 -39.43 93.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 122.632 0.373 . . . . 0.0 111.36 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -54.52 -46.09 73.48 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.206 0.602 . . . . 0.0 111.847 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -74.44 -32.26 62.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.88 -1.137 . . . . 0.0 111.855 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.65 -42.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.781 -1.2 . . . . 0.0 109.706 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.47 -30.42 69.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.923 -1.11 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -65.04 -41.64 95.01 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.607 -1.308 . . . . 0.0 111.033 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -62.29 -47.05 86.02 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.16 0.981 . . . . 0.0 109.268 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -27.89 69.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.76 0.824 . . . . 0.0 112.39 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.7 m -63.18 -33.33 75.24 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.366 1.067 . . . . 0.0 111.379 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -72.56 -36.37 68.21 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.22 -47.55 67.56 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -47.17 79.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.992 1.717 . . . . 0.0 112.672 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.6 -30.33 46.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 O-C-N 120.748 -1.22 . . . . 0.0 110.789 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.06 -41.74 41.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.677 -1.264 . . . . 0.0 108.515 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.51 38.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 128.005 2.522 . . . . 0.0 108.634 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -63.82 -50.71 67.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.509 1.124 . . . . 0.0 111.134 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.0 ttp85 -81.55 101.58 10.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 119.681 -1.887 . . . . 0.0 111.266 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -27.18 2.16 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 104.593 -3.403 . . . . 0.0 104.593 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 151.13 62.79 Favored Pre-proline 0 N--CA 1.439 -1.025 0 C-N-CA 124.016 0.927 . . . . 0.0 111.932 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -77.62 105.5 2.04 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.878 2.386 . . . . 0.0 112.12 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.67 11.62 11.28 Favored Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.91 132.3 5.34 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 127.442 2.297 . . . . 0.0 115.276 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.06 -61.69 1.65 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.279 1.032 . . . . 0.0 111.166 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.79 106.85 18.35 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-O 122.257 1.027 . . . . 0.0 112.798 -171.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -111.41 169.58 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 O-C-N 120.266 -1.521 . . . . 0.0 108.586 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 m 71.81 146.01 0.07 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.771 2.428 . . . . 0.0 113.141 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -72.69 -51.58 6.8 Favored Pre-proline 0 C--N 1.349 0.583 0 CA-C-O 115.925 -1.988 . . . . 0.0 111.886 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.14 -11.02 26.71 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 125.338 2.942 . . . . 0.0 111.992 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.2 -34.7 11.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.1 96.04 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.037 -1.04 . . . . 0.0 110.771 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.88 -33.4 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 122.753 0.421 . . . . 0.0 111.562 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -28.79 65.45 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.152 -1.592 . . . . 0.0 110.763 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -76.93 -40.55 46.77 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 107.962 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -63.87 -30.81 71.86 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 121.026 -1.046 . . . . 0.0 112.61 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.23 -36.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-N 118.723 0.692 . . . . 0.0 110.155 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -63.19 -61.1 2.6 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -50.33 -36.99 34.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.176 1.79 . . . . 0.0 113.25 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.38 97.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.707 1.203 . . . . 0.0 111.71 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -91.51 4.68 51.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.283 30.1 p 66.86 -136.54 0.14 Allowed 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 127.304 2.242 . . . . 0.0 108.244 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 t 69.19 -79.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.64 87.45 0.47 Allowed Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -72.01 -33.31 67.97 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.399 -1.059 . . . . 0.0 108.263 -170.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.57 16.55 1.65 Allowed Glycine 0 CA--C 1.489 -1.575 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -58.93 -56.36 23.25 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 117.838 0.819 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 166.34 24.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 174.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.8 142.7 19.21 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 102.314 -3.217 . . . . 0.0 102.314 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -84.06 162.53 13.6 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.02 2.48 . . . . 0.0 110.132 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 64' ' ' THR . 1.7 p -104.77 176.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 122.288 1.042 . . . . 0.0 108.965 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.551 ' HA ' ' CE2' ' D' ' 46' ' ' TRP . 0.2 OUTLIER -61.67 -47.8 83.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 127.59 2.356 . . . . 0.0 114.219 -166.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -81.48 1.09 34.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 118.967 -2.333 . . . . 0.0 110.246 -170.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -32.43 72.23 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-O 123.372 1.558 . . . . 0.0 107.797 175.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.0 85.78 0.96 Allowed Glycine 0 CA--C 1.471 -2.714 1 N-CA-C 100.995 -4.842 . . . . 0.0 100.995 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.59 ' HB2' ' CE2' ' D' ' 46' ' ' TRP . 1.7 ttp85 -58.62 -9.0 1.44 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 118.24 1.02 . . . . 0.0 113.202 -169.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -45.96 -35.9 5.07 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.207 1.403 . . . . 0.0 112.659 160.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.36 -59.5 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.12 77.21 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.503 0.721 . . . . 0.0 112.436 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.16 -39.08 71.78 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.595 2.358 . . . . 0.0 111.57 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -70.13 -31.03 68.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 t -71.65 -41.76 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 O-C-N 121.512 -0.742 . . . . 0.0 109.073 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 59.9 mtt -56.28 -49.52 74.01 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.604 1.162 . . . . 0.0 110.433 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -66.76 -37.24 84.23 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.15 -0.969 . . . . 0.0 110.647 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.56 87.34 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.152 -0.968 . . . . 0.0 111.015 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -71.08 -38.94 63.51 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -70.88 -35.77 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 O-C-N 121.289 -1.124 . . . . 0.0 109.348 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.87 -38.15 89.7 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 120.429 -1.419 . . . . 0.0 112.285 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 15' ' ' LEU . 30.7 m -68.51 -39.11 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -78.17 -30.43 49.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.477 0.58 . . . . 0.0 109.922 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.89 89.08 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 123.575 0.75 . . . . 0.0 110.494 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.91 -30.31 71.3 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.849 1.26 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.48 -11.99 7.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 C-N-CA 125.327 1.451 . . . . 0.0 110.614 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.681 HG21 ' HB3' ' D' ' 89' ' ' LEU . 6.8 t -53.55 -25.74 18.33 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 119.728 -1.857 . . . . 0.0 112.621 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -18.98 63.82 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.094 -1.004 . . . . 0.0 109.716 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.85 -50.8 7.23 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.47 -48.42 69.94 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.428 1.091 . . . . 0.0 113.423 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.18 -12.6 60.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -84.7 -27.25 27.15 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -32.97 74.6 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.557 -1.339 . . . . 0.0 110.991 -159.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -62.38 -30.64 71.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.32 -0.862 . . . . 0.0 112.837 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.78 -24.37 35.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.237 1.415 . . . . 0.0 108.819 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -59.35 -24.14 63.12 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.31 -0.869 . . . . 0.0 112.471 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -64.87 -28.55 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.972 -1.08 . . . . 0.0 110.395 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 . . . . . 0 C--N 1.354 0.794 0 CA-C-N 119.253 0.933 . . . . 0.0 109.805 -179.243 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.5 -0.967 0 CA-C-O 122.859 1.314 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -73.33 -19.53 61.0 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.264 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -82.33 -32.53 29.33 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.49 -25.44 61.41 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.623 -0.673 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.27 -49.85 72.46 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.568 1.147 . . . . 0.0 108.879 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.56 87.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.03 1.332 . . . . 0.0 110.838 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.23 -37.95 87.36 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.924 0.89 . . . . 0.0 110.75 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -69.46 -25.94 64.34 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.42 -1.425 . . . . 0.0 110.702 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.91 71.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 120.701 -1.249 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.0 -37.61 77.26 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.742 1.217 . . . . 0.0 111.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.29 -30.78 71.27 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.587 1.555 . . . . 0.0 110.11 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -70.64 -42.67 70.53 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.536 1.134 . . . . 0.0 108.57 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.21 -38.61 91.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 123.865 0.866 . . . . 0.0 111.364 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -63.77 -29.72 70.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.446 -0.784 . . . . 0.0 111.789 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -75.58 -30.28 59.59 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.858 -1.151 . . . . 0.0 110.637 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.11 -38.9 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.87 -44.95 78.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 124.069 0.948 . . . . 0.0 111.784 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.85 -48.88 67.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.337 0.655 . . . . 0.0 110.31 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.14 -24.2 60.56 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.936 -1.102 . . . . 0.0 110.898 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 -26.03 62.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 120.981 -1.075 . . . . 0.0 111.532 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -63.75 -46.8 83.66 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.64 -45.31 87.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.667 1.187 . . . . 0.0 109.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -60.55 -59.11 5.92 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.446 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.02 89.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 111.804 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.79 -35.71 61.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.72 -1.238 . . . . 0.0 110.317 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.16 -39.17 55.53 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.047 -1.033 . . . . 0.0 109.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.59 70.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 127.072 2.149 . . . . 0.0 109.461 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.58 61.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.816 -0.552 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -72.83 95.94 2.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.693 -1.879 . . . . 0.0 111.379 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.18 -11.95 3.3 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.63 152.65 47.32 Favored Pre-proline 0 N--CA 1.442 -0.845 0 O-C-N 121.254 -1.144 . . . . 0.0 109.496 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.64 152.75 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.022 2.481 . . . . 0.0 109.576 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -78.14 1.8 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.509 -3.437 . . . . 0.0 104.509 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.13 138.71 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 129.226 3.01 . . . . 0.0 111.247 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.73 -39.85 1.95 Allowed 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 120.278 -1.514 . . . . 0.0 108.289 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -100.18 137.24 38.88 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.79 0.805 . . . . 0.0 109.575 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.6 pt -147.02 175.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 100.497 -3.89 . . . . 0.0 100.497 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m 72.77 129.88 0.04 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 112.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -67.77 -48.71 41.13 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 116.818 -1.563 . . . . 0.0 110.102 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.66 -13.08 29.66 Favored 'Trans proline' 0 CA--C 1.509 -0.751 0 CA-C-N 124.987 2.817 . . . . 0.0 113.004 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.24 -25.83 17.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.988 1.267 . . . . 0.0 107.649 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.66 81.48 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.359 -0.838 . . . . 0.0 111.162 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.04 -34.12 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 121.444 -0.785 . . . . 0.0 110.301 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -36.35 72.08 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.801 -1.187 . . . . 0.0 110.327 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -64.49 -44.26 91.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.44 1.496 . . . . 0.0 109.368 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -57.74 -39.36 77.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.867 1.667 . . . . 0.0 111.3 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -53.84 -51.98 39.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 124.716 1.206 . . . . 0.0 111.271 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -71.9 -22.08 61.55 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.762 0.71 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.0 m -74.07 -40.71 62.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.017 0.927 . . . . 0.0 108.757 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -28.83 63.49 Favored 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 121.142 -0.974 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.4 p -84.64 3.83 35.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.568 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 53.82 51.58 14.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.822 1.649 . . . . 0.0 111.062 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -117.81 -111.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.105 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.21 76.39 1.22 Allowed Glycine 0 CA--C 1.483 -1.924 0 N-CA-C 104.804 -3.318 . . . . 0.0 104.804 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -74.49 -16.59 60.84 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.868 -1.371 . . . . 0.0 109.745 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.75 52.85 0.53 Allowed Glycine 0 CA--C 1.481 -2.092 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.15 -59.12 2.9 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -144.02 174.93 10.42 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -142.28 129.35 11.19 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.82 165.87 27.89 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 124.116 3.211 . . . . 0.0 110.318 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.526 HG22 ' H ' ' B' ' 64' ' ' THR . 3.8 p -101.61 -167.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 122.752 1.263 . . . . 0.0 109.234 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.526 ' H ' HG22 ' B' ' 63' ' ' VAL . 3.1 p -86.89 -39.68 15.58 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.872 -1.767 . . . . 0.0 109.245 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.62 -9.12 59.8 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.011 1.725 . . . . 0.0 110.884 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.39 -23.79 61.95 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-O 124.297 1.998 . . . . 0.0 107.18 169.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.54 75.72 1.27 Allowed Glycine 0 CA--C 1.468 -2.873 1 N-CA-C 101.978 -4.449 . . . . 0.0 101.978 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -47.61 -12.2 0.03 OUTLIER 'General case' 0 C--N 1.373 1.587 0 C-N-CA 129.96 3.304 . . . . 0.0 113.729 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -50.63 -19.62 0.97 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.458 1.903 . . . . 0.0 113.627 158.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.93 -54.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 CA-C-N 122.089 2.222 . . . . 0.0 107.342 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.54 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.324 0.583 . . . . 0.0 110.733 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.89 -42.66 80.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.269 1.428 . . . . 0.0 111.996 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.96 -40.96 95.79 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.392 1.077 . . . . 0.0 110.1 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.09 -46.92 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 C-N-CA 123.536 0.734 . . . . 0.0 109.578 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 46.1 mtp -59.23 -48.77 80.37 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.18 0.992 . . . . 0.0 110.285 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -61.99 -41.02 97.58 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.167 0.987 . . . . 0.0 110.771 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.59 91.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 123.01 0.524 . . . . 0.0 111.122 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.64 -49.57 63.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.37 -44.66 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 124.192 0.997 . . . . 0.0 109.316 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.68 -38.35 90.71 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.788 -1.195 . . . . 0.0 111.754 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.48 -53.03 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.207 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.2 -11.63 60.58 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.336 0.655 . . . . 0.0 112.118 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.99 -21.13 15.13 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 123.755 0.822 . . . . 0.0 109.657 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.94 -28.13 64.27 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 119.632 -1.918 . . . . 0.0 108.976 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.16 -14.94 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.943 0.897 . . . . 0.0 111.996 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 66.8 m -58.95 -12.44 4.55 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 125.936 1.694 . . . . 0.0 111.674 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.82 -26.05 68.55 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.538 -1.976 . . . . 0.0 112.388 167.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.01 -30.81 27.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 119.856 -1.778 . . . . 0.0 108.742 175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.26 31.42 0.65 Allowed 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 126.04 1.736 . . . . 0.0 109.29 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.6 -1.98 1.11 Allowed 'General case' 0 N--CA 1.433 -1.316 0 O-C-N 120.59 -1.318 . . . . 0.0 108.26 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -116.85 16.94 15.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -83.2 -48.52 10.41 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.354 2.262 . . . . 0.0 107.188 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -65.2 -20.41 66.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.481 1.113 . . . . 0.0 111.648 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.55 -28.53 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 124.657 1.183 . . . . 0.0 109.375 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -65.65 -21.72 66.58 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 124.51 1.124 . . . . 0.0 111.916 -172.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -19.18 63.33 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.828 -1.17 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.127 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . 0.28 38.1 m-20 . . . . . 0 CA--C 1.501 -0.911 0 CA-C-O 122.845 1.307 . . . . 0.0 113.328 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -161.68 -45.61 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.48 -47.69 83.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.879 2.072 . . . . 0.0 110.263 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -80.73 -6.63 58.72 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.645 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.84 -47.36 11.95 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.65 93.85 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.044 0.938 . . . . 0.0 110.632 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -57.11 -38.28 73.18 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.815 1.246 . . . . 0.0 111.751 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -72.92 -28.11 62.26 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.167 -0.958 . . . . 0.0 110.446 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.27 -40.29 77.9 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.056 0.542 . . . . 0.0 109.695 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.11 -40.33 93.36 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.515 0.726 . . . . 0.0 110.947 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.36 -38.8 81.33 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.74 0.816 . . . . 0.0 111.442 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.29 -40.09 93.39 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.116 1.366 . . . . 0.0 109.519 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.49 -38.65 91.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.555 -0.716 . . . . 0.0 111.055 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.44 -31.8 72.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.382 -0.824 . . . . 0.0 112.149 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -67.73 -39.65 84.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.05 0.94 . . . . 0.0 109.368 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.54 -32.61 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 124.286 1.034 . . . . 0.0 109.035 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.3 -44.95 88.78 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.016 0.825 . . . . 0.0 111.176 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.54 -38.27 80.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.398 0.679 . . . . 0.0 110.242 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.56 -44.42 86.79 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 121.186 -0.946 . . . . 0.0 109.077 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.18 72.91 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.807 1.643 . . . . 0.0 111.41 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -59.42 -47.6 84.84 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.006 0.922 . . . . 0.0 111.553 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -45.69 69.76 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 125.149 1.38 . . . . 0.0 108.221 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.64 -36.07 78.12 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.893 0.477 . . . . 0.0 111.01 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.73 -44.42 61.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 123.825 0.85 . . . . 0.0 110.73 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.57 -32.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 121.471 -0.768 . . . . 0.0 110.018 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -84.66 -12.85 53.09 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.108 -0.995 . . . . 0.0 111.382 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.4 78.73 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.494 ' OE1' HG12 ' C' ' 63' ' ' VAL . 80.6 mm-40 -81.33 -10.12 59.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.764 0.792 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -78.97 81.96 5.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 119.921 -1.737 . . . . 0.0 108.3 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.09 0.51 4.22 Favored Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.21 42.89 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.37 112.51 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.533 2.155 . . . . 0.0 113.388 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.26 -46.27 0.67 Allowed Glycine 0 CA--C 1.482 -1.999 1 N-CA-C 101.949 -4.461 . . . . 0.0 101.949 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 73.16 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.626 1.97 . . . . 0.0 108.419 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.6 -71.39 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 112.573 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 tt -100.68 120.35 39.94 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.48 13.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 28.3 t -109.67 130.49 55.51 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.72 -56.36 9.74 Favored Pre-proline 0 C--N 1.349 0.572 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.026 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.02 -12.07 25.73 Favored 'Trans proline' 0 CA--C 1.511 -0.669 0 CA-C-N 124.988 2.817 . . . . 0.0 111.386 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.83 -20.34 21.58 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 119.366 0.985 . . . . 0.0 108.7 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.49 -36.25 83.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.338 -0.851 . . . . 0.0 109.95 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -72.35 -25.92 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.876 1.27 . . . . 0.0 110.557 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 -42.27 37.02 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.525 -1.359 . . . . 0.0 107.812 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -70.07 -32.47 70.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.657 0.783 . . . . 0.0 110.684 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 54.6 p -68.67 -27.52 66.06 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.249 -1.532 . . . . 0.0 111.311 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.03 -53.57 47.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 CA-C-N 119.14 0.882 . . . . 0.0 109.601 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.96 -10.94 59.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.812 -0.555 . . . . 0.0 112.005 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -81.12 -33.32 33.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.172 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -35.55 75.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.775 -1.203 . . . . 0.0 111.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.46 0.73 48.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 122.039 -0.413 . . . . 0.0 110.596 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.9 p 65.42 20.18 11.72 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 126.085 1.754 . . . . 0.0 111.493 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.79 -55.89 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.39 44.31 97.81 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 121.629 -0.669 . . . . 0.0 112.125 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 1.5 t80 -55.84 -40.65 73.13 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.616 1.567 . . . . 0.0 110.518 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.59 -122.79 1.12 Allowed Glycine 0 CA--C 1.48 -2.14 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.322 4.4 t0 62.62 -85.29 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 127.072 2.149 . . . . 0.0 108.947 -168.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -119.67 169.07 10.42 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.34 148.72 21.48 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.92 176.58 7.49 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.033 2.488 . . . . 0.0 108.695 171.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.755 HG13 ' H ' ' C' ' 64' ' ' THR 0.285 9.9 p -101.2 -121.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 170.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.755 ' H ' HG13 ' C' ' 63' ' ' VAL . 12.6 m -107.34 -82.67 0.55 Allowed 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 120.283 -1.511 . . . . 0.0 107.174 -171.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.05 122.41 12.98 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.101 1.36 . . . . 0.0 109.406 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . 0.28 6.6 tt0 76.33 -68.63 0.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.301 -1.333 . . . . 0.0 112.637 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -37.15 -49.07 1.54 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 128.216 2.817 . . . . 0.0 114.646 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -75.31 -38.46 60.26 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.798 1.239 . . . . 0.0 112.094 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -76.48 -29.74 56.99 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.84 -44.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 O-C-N 119.766 -1.834 . . . . 0.0 109.08 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.14 99.37 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 111.205 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -48.82 -44.85 39.69 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.692 1.997 . . . . 0.0 112.194 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -63.94 -40.1 95.66 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.69 -39.23 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 124.342 1.057 . . . . 0.0 109.263 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.42 -45.86 87.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.28 -39.34 94.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.696 0.799 . . . . 0.0 110.931 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.48 71.61 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.914 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.65 -49.87 7.63 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.13 -46.29 84.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 110.167 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.62 -31.83 73.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.421 -0.799 . . . . 0.0 112.572 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.59 -51.59 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -66.17 -33.98 77.01 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 122.878 0.471 . . . . 0.0 110.975 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.56 83.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.53 1.132 . . . . 0.0 110.517 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.72 -22.16 66.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.772 1.229 . . . . 0.0 112.935 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -59.59 -19.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 124.892 1.277 . . . . 0.0 110.401 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -57.77 -20.42 34.95 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 112.631 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.0 51.15 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.311 -1.493 . . . . 0.0 112.422 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.09 -31.57 11.7 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.792 1.237 . . . . 0.0 110.644 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 35.1 mt -82.62 -41.43 19.47 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.428 -0.795 . . . . 0.0 109.956 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.84 72.75 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.5 1.12 . . . . 0.0 109.62 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -16.79 64.13 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.522 -1.361 . . . . 0.0 112.098 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 26.4 t70 -74.36 -24.42 59.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.497 1.044 . . . . 0.0 110.518 -168.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -37.97 61.3 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 120.705 -1.247 . . . . 0.0 109.705 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.25 -27.85 42.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 125.32 1.448 . . . . 0.0 110.191 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -59.72 -22.52 62.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.342 1.057 . . . . 0.0 113.027 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . 0.3 18.3 ptt85 -69.46 -28.59 66.23 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 121.254 1.843 . . . . 0.0 111.506 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 C--N 1.351 0.669 0 O-C-N 119.621 -1.924 . . . . 0.0 110.345 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -55.85 -46.28 78.23 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.087 2.155 . . . . 0.0 110.466 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CD2' ' HB1' ' D' ' 87' ' ' ALA 0.252 1.4 m80 -81.15 -16.34 53.25 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -169.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.06 -30.82 31.17 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.418 1.008 . . . . 0.0 109.166 169.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -63.42 -46.1 87.94 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.54 -31.17 66.74 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.97 -0.457 . . . . 0.0 110.4 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.21 70.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 121.353 -0.842 . . . . 0.0 110.744 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -69.84 -29.95 67.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.835 -0.54 . . . . 0.0 111.574 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.27 -40.62 91.0 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.713 0.805 . . . . 0.0 110.232 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.46 84.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.591 0.756 . . . . 0.0 111.445 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.19 -37.88 81.56 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 121.459 -0.775 . . . . 0.0 110.912 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -70.96 -26.53 63.2 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.981 -1.075 . . . . 0.0 111.337 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -76.15 -34.19 59.38 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.23 -39.53 93.12 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.33 0.652 . . . . 0.0 111.164 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.02 -35.19 74.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.615 0.766 . . . . 0.0 111.916 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -67.11 -39.25 86.64 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.691 -0.631 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.65 -39.85 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.075 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.738 HD22 ' H ' ' D' ' 49' ' ' VAL . 87.3 mt -64.84 -37.5 87.84 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.136 0.974 . . . . 0.0 112.478 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -67.84 -32.69 73.38 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.61 0.719 . . . . 0.0 111.577 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.79 -36.4 28.48 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.417 -0.802 . . . . 0.0 108.949 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.35 84.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 125.455 1.502 . . . . 0.0 111.992 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -66.77 -40.95 88.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.597 0.713 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -69.09 -39.47 78.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 109.175 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -73.59 -40.33 63.96 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.855 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.21 80.89 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.092 1.357 . . . . 0.0 112.642 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.96 -38.05 81.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 O-C-N 120.832 -1.168 . . . . 0.0 111.647 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.91 -23.17 36.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.964 -1.085 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.24 -52.81 20.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.641 1.976 . . . . 0.0 107.774 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.02 -33.44 70.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.582 1.182 . . . . 0.0 111.946 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -68.93 104.77 2.17 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.63 -1.919 . . . . 0.0 112.14 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.06 -33.92 1.98 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 104.824 -3.311 . . . . 0.0 104.824 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.41 150.64 73.95 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 123.771 0.828 . . . . 0.0 110.412 -173.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.46 145.63 23.81 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.064 1.842 . . . . 0.0 109.301 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.11 17.57 74.07 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 118.563 0.619 . . . . 0.0 112.125 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.49 128.41 22.79 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.891 1.676 . . . . 0.0 113.573 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.44 -39.46 1.02 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.993 1.317 . . . . 0.0 109.709 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.39 15.3 1.28 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.84 1.656 . . . . 0.0 111.609 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tp -98.63 121.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 119.6 -1.937 . . . . 0.0 108.257 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.8 p -172.82 -105.06 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.81 -65.21 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.006 0 C-N-CA 128.111 2.565 . . . . 0.0 106.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 -18.98 28.24 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 124.837 2.763 . . . . 0.0 110.804 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.62 -22.56 26.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.87 -33.64 62.11 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 120.941 -1.099 . . . . 0.0 111.468 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.67 -20.79 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.607 1.194 . . . . 0.0 108.747 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.59 ' CE2' ' HB2' ' A' ' 68' ' ' ARG . 24.9 t90 -77.55 -40.43 42.51 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.336 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -60.14 -44.14 95.19 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.19 1.396 . . . . 0.0 109.925 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 82.3 p -74.97 -169.76 0.97 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.999 0.904 . . . . 0.0 108.982 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.738 ' H ' HD22 ' D' ' 19' ' ' LEU 0.352 2.1 t 71.58 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.955 2.102 . . . . 0.0 110.683 -170.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -28.63 70.13 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.618 1.099 . . . . 0.0 110.415 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -29.87 69.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.037 0.935 . . . . 0.0 111.126 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -77.94 -27.75 49.42 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.809 -1.182 . . . . 0.0 109.844 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -83.74 3.63 32.43 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.442 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 71.2 p 54.61 59.59 4.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.252 2.221 . . . . 0.0 111.871 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -109.06 -89.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 89.45 60.45 1.45 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -9.95 59.24 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 121.674 -0.898 . . . . 0.0 111.498 -170.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.37 35.35 3.63 Favored Glycine 0 CA--C 1.486 -1.763 0 O-C-N 120.467 -1.395 . . . . 0.0 110.81 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.02 -65.23 0.8 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -138.01 153.76 49.37 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 102.957 -2.979 . . . . 0.0 102.957 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.69 144.22 48.05 Favored Pre-proline 0 N--CA 1.44 -0.937 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.01 165.9 25.62 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.249 2.632 . . . . 0.0 109.546 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.546 HG12 ' H ' ' D' ' 64' ' ' THR . 2.8 t -103.69 -153.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.546 ' H ' HG12 ' D' ' 63' ' ' VAL . 0.2 OUTLIER -93.14 -54.29 3.78 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 119.619 -1.926 . . . . 0.0 109.279 -161.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.03 3.65 33.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 109.245 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -25.91 62.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.85 55.54 1.4 Allowed Glycine 0 CA--C 1.466 -3.012 0 N-CA-C 104.575 -3.41 . . . . 0.0 104.575 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -21.42 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.376 1.733 1 C-N-CA 133.878 4.871 . . . . 0.0 116.825 -174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -52.47 -16.21 0.84 Allowed 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 125.601 1.56 . . . . 0.0 113.256 162.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.05 -47.39 88.09 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 122.246 2.294 . . . . 0.0 108.449 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.94 -47.84 73.35 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.099 0.56 . . . . 0.0 110.63 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.03 -38.95 80.5 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 111.704 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -67.79 -29.33 68.49 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.561 -1.337 . . . . 0.0 111.44 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.71 -42.13 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 121.307 -0.87 . . . . 0.0 108.672 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.54 -49.71 76.44 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.717 1.207 . . . . 0.0 109.829 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -65.32 -37.77 88.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.015 -0.428 . . . . 0.0 111.298 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.94 92.38 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -50.39 61.49 Favored Glycine 0 CA--C 1.49 -1.478 0 C-N-CA 124.129 0.871 . . . . 0.0 111.067 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -57.83 -48.29 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.387 1.075 . . . . 0.0 109.598 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.05 -32.05 73.57 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 t -65.62 -55.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-N 119.371 0.987 . . . . 0.0 109.388 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.63 -38.6 84.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.324 0.583 . . . . 0.0 110.375 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.53 63.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.346 -0.847 . . . . 0.0 111.047 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.06 -30.9 71.5 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.182 -1.574 . . . . 0.0 110.118 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 -12.47 7.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.804 1.242 . . . . 0.0 110.68 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -52.79 -22.82 5.78 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.448 -1.408 . . . . 0.0 111.621 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' D' ' 4' ' ' HIS . . . -73.54 -19.26 60.95 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 119.466 -2.021 . . . . 0.0 114.423 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.32 -41.8 15.19 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.681 ' HB3' HG21 ' A' ' 86' ' ' THR . 39.8 mt -59.91 -40.98 90.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 112.525 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.83 64.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.201 -0.937 . . . . 0.0 111.871 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -92.14 -1.0 57.42 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 120.777 -1.202 . . . . 0.0 108.462 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -74.58 -30.22 61.63 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 119.253 0.933 . . . . 0.0 109.753 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -80.83 -31.8 35.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 120.597 -1.314 . . . . 0.0 111.524 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -23.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 125.163 1.385 . . . . 0.0 109.294 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -50.16 -35.35 25.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 125.606 1.563 . . . . 0.0 113.256 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -71.24 -16.57 62.5 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.315 -0.866 . . . . 0.0 110.87 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.825 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -151.85 -82.49 0.09 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -0.28 31.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 121.068 -1.02 . . . . 0.0 113.324 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -30.06 68.26 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.334 1.454 . . . . 0.0 108.248 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -66.88 -37.9 85.29 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.606 0.763 . . . . 0.0 109.05 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.7 -28.55 36.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.38 76.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.421 0.629 . . . . 0.0 111.16 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -75.32 -23.49 57.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.568 -0.707 . . . . 0.0 111.043 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.84 -36.03 77.68 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.588 -0.695 . . . . 0.0 109.51 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.84 71.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.976 -1.078 . . . . 0.0 111.471 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.83 -23.22 65.14 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.417 -0.802 . . . . 0.0 111.97 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.47 -43.09 67.24 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 120.658 -1.276 . . . . 0.0 109.242 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.48 -39.14 92.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.653 1.181 . . . . 0.0 108.645 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.24 -43.29 92.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.003 0.521 . . . . 0.0 111.562 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.17 -30.9 71.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.812 0.845 . . . . 0.0 111.905 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -69.43 -39.8 77.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.49 -0.756 . . . . 0.0 109.646 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.8 -38.79 82.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 O-C-N 121.29 -0.881 . . . . 0.0 109.202 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -58.77 -42.68 89.53 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.788 0.835 . . . . 0.0 111.618 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.82 -28.53 62.61 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.33 1.052 . . . . 0.0 111.737 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -73.73 -46.12 47.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.745 -1.222 . . . . 0.0 107.798 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -27.95 68.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.761 1.225 . . . . 0.0 112.221 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 p -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.654 1.116 . . . . 0.0 110.791 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.32 -43.62 77.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.58 -44.72 95.61 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.02 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 126.212 1.805 . . . . 0.0 112.42 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 41' ' ' TYR . 26.2 m -64.66 -34.94 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 119.955 1.252 . . . . 0.0 112.131 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -78.18 -35.48 48.64 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 125.256 1.423 . . . . 0.0 108.38 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -77.67 -51.2 10.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 124.662 1.185 . . . . 0.0 108.505 -175.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.03 -40.66 87.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.085 0.945 . . . . 0.0 110.267 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -77.23 104.82 7.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 119.802 -1.811 . . . . 0.0 111.349 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -21.89 2.36 Favored Glycine 0 CA--C 1.49 -1.489 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.23 89.0 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 123.4 0.68 . . . . 0.0 110.702 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.68 126.05 11.69 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.971 2.448 . . . . 0.0 110.105 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -67.81 3.26 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 106.069 -2.812 . . . . 0.0 106.069 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.7 -172.98 0.18 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 126.516 1.926 . . . . 0.0 108.55 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.81 -40.41 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.969 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.33 -68.47 0.64 Allowed 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt 32.02 37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 128.326 2.65 . . . . 0.0 114.934 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -148.72 133.6 18.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' HG11 ' A' ' 27' ' ' VAL . 73.8 t80 -79.67 -52.14 1.12 Allowed Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-O 116.01 -1.947 . . . . 0.0 110.8 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.71 -13.42 29.66 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 CA-C-N 126.145 3.23 . . . . 0.0 111.73 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.57 -27.79 29.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.487 1.515 . . . . 0.0 108.559 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.46 -33.72 76.6 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.778 0.831 . . . . 0.0 111.785 -167.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -73.56 -24.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 123.836 0.855 . . . . 0.0 110.376 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.85 -32.45 21.71 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 120.744 -1.222 . . . . 0.0 108.766 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -70.23 -35.57 73.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.554 1.169 . . . . 0.0 108.974 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -81.27 62.47 5.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 120.674 -1.266 . . . . 0.0 108.907 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.87 -68.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -46.88 -32.99 4.15 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 130.107 3.363 . . . . 0.0 114.231 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -69.21 -37.61 78.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.879 1.672 . . . . 0.0 109.851 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.43 58.17 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 120.177 -1.577 . . . . 0.0 109.724 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -79.59 -11.09 59.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.416 1.487 . . . . 0.0 109.319 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 54.11 62.88 2.38 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.848 2.059 . . . . 0.0 112.144 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.49 -84.17 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.58 -84.66 0.36 Allowed Glycine 0 CA--C 1.482 -2.0 1 N-CA-C 101.902 -4.479 . . . . 0.0 101.902 -173.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CZ ' ' HA2' ' B' ' 56' ' ' GLY . 0.1 OUTLIER 65.13 -69.87 0.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 127.046 2.138 . . . . 0.0 111.448 179.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.32 53.15 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.722 0 O-C-N 120.529 -1.357 . . . . 0.0 115.507 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.12 -64.87 0.89 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.241 2.02 . . . . 0.0 108.113 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.82 179.05 6.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -157.72 152.82 21.51 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.47 172.22 13.8 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.782 2.988 . . . . 0.0 109.409 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 t -115.92 -100.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 119.463 1.029 . . . . 0.0 108.535 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -140.77 -44.0 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.12 -16.21 41.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.406 -0.809 . . . . 0.0 111.793 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -61.06 -35.95 78.31 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.928 1.291 . . . . 0.0 108.11 171.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 97.81 2.02 Favored Glycine 0 N--CA 1.418 -2.53 1 N-CA-C 97.548 -6.221 . . . . 0.0 97.548 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -62.08 -16.62 53.53 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 119.239 1.519 . . . . 0.0 110.112 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.46 -10.14 4.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 125.196 1.398 . . . . 0.0 112.97 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.55 -46.35 75.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 120.748 -1.22 . . . . 0.0 108.165 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.11 74.28 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -49.22 -45.15 44.04 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.529 1.532 . . . . 0.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -58.69 -47.71 83.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.759 1.224 . . . . 0.0 111.232 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.5 -42.31 72.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 O-C-N 121.749 -0.594 . . . . 0.0 109.574 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.444 ' SD ' HG11 ' D' ' 55' ' ' VAL . 48.9 mtm -61.59 -48.18 82.1 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.111 0.964 . . . . 0.0 110.105 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.52 -36.22 78.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.295 -0.878 . . . . 0.0 110.862 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.85 98.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.709 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.91 92.75 Favored Glycine 0 CA--C 1.491 -1.427 0 C-N-CA 124.244 0.926 . . . . 0.0 111.135 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.83 -45.39 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.127 0.971 . . . . 0.0 109.562 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -64.78 -33.7 76.6 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.587 -1.32 . . . . 0.0 111.6 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.8 -53.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 124.098 0.959 . . . . 0.0 109.692 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -71.36 -20.91 62.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.832 0.825 . . . . 0.0 111.395 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 -33.54 31.0 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.084 -1.635 . . . . 0.0 110.082 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.16 -39.8 91.49 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.501 1.12 . . . . 0.0 110.622 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.3 m -66.88 -6.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 O-C-N 121.65 -0.656 . . . . 0.0 112.522 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.4 m -53.69 -25.69 19.4 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 125.66 1.584 . . . . 0.0 110.427 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.14 -43.27 74.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.56 -1.337 . . . . 0.0 112.764 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -42.33 58.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.39 1.076 . . . . 0.0 109.257 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.29 -34.3 77.1 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.156 0.503 . . . . 0.0 110.68 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.41 75.88 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.824 -1.173 . . . . 0.0 111.751 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -13.1 60.0 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.757 -1.214 . . . . 0.0 111.954 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.86 -35.93 81.16 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.615 1.197 . . . . 0.0 109.106 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -73.89 -35.53 64.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 119.794 -1.816 . . . . 0.0 112.068 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.92 -25.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 125.929 1.692 . . . . 0.0 109.229 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -56.47 -24.91 49.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.775 1.63 . . . . 0.0 112.71 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.71 -16.95 59.37 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.015 -1.053 . . . . 0.0 111.132 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--N 1.357 0.896 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.144 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.503 -0.857 0 CA-C-O 121.604 0.716 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -59.97 -31.95 70.36 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.849 1.26 . . . . 0.0 113.382 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -71.56 -34.03 69.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.038 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -70.69 -35.7 72.92 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 120.968 -1.082 . . . . 0.0 110.397 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.56 -35.32 67.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 -46.48 81.15 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.015 0.926 . . . . 0.0 111.334 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -66.53 -34.28 77.55 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.541 -0.725 . . . . 0.0 110.467 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.91 -41.3 99.4 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 109.996 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.87 80.72 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.652 0.781 . . . . 0.0 111.228 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.55 -31.88 73.29 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.478 -0.764 . . . . 0.0 111.957 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -70.75 -32.87 70.18 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.038 -1.038 . . . . 0.0 109.425 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.82 -34.25 77.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.88 -1.138 . . . . 0.0 109.395 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.23 -38.14 87.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.447 0.699 . . . . 0.0 110.24 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -58.42 -36.48 73.66 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 124.221 1.008 . . . . 0.0 111.766 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.23 -44.77 87.17 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.867 0.867 . . . . 0.0 110.057 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 -20.05 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 121.438 -0.789 . . . . 0.0 110.698 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.76 -48.76 79.23 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 119.564 1.074 . . . . 0.0 109.874 172.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.29 -40.5 90.07 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.06 -1.025 . . . . 0.0 110.347 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -63.55 -40.05 95.98 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.735 0.814 . . . . 0.0 111.277 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.63 98.58 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.204 1.401 . . . . 0.0 109.575 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -57.38 -35.28 69.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.187 1.395 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.71 -51.84 9.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.563 -0.711 . . . . 0.0 109.925 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -63.89 -28.61 69.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.58 -1.325 . . . . 0.0 110.796 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.75 94.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.408 1.083 . . . . 0.0 112.244 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.59 -14.69 13.77 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-O 122.35 1.071 . . . . 0.0 110.395 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -87.17 -38.61 16.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.726 -2.484 . . . . 0.0 107.862 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.22 65.79 6.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.014 1.726 . . . . 0.0 108.692 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -31.54 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.13 30.47 0.0 OUTLIER 'General case' 0 C--N 1.355 0.821 0 C-N-CA 130.527 3.531 . . . . 0.0 117.549 -168.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.84 36.66 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.12 156.69 35.74 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 119.062 1.431 . . . . 0.0 108.947 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -85.14 117.41 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.711 2.274 . . . . 0.0 112.517 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 31.35 26.34 Favored Glycine 0 CA--C 1.494 -1.269 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.84 137.87 47.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.034 0.933 . . . . 0.0 109.272 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.04 -37.99 8.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 123.529 0.732 . . . . 0.0 109.924 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.04 140.56 29.53 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 pt -156.35 37.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 CA-C-N 118.971 0.805 . . . . 0.0 109.164 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -137.59 -117.87 0.15 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 118.255 -2.778 . . . . 0.0 112.101 -158.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.68 -68.95 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.755 0 C-N-CA 128.487 2.715 . . . . 0.0 103.951 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.61 -20.05 27.32 Favored 'Trans proline' 0 CA--C 1.513 -0.55 0 CA-C-N 125.654 3.055 . . . . 0.0 111.419 -173.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.88 -25.31 61.88 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.649 1.18 . . . . 0.0 109.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.23 -36.51 79.62 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 123.542 0.737 . . . . 0.0 110.284 -167.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.89 -29.15 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.899 -0.501 . . . . 0.0 110.686 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -42.18 76.48 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.881 -1.137 . . . . 0.0 108.735 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -59.16 -48.01 83.21 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 110.09 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.5 m -57.89 -36.41 72.38 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.422 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.2 -53.69 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 123.762 0.825 . . . . 0.0 109.253 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.48 -20.88 63.73 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.279 1.038 . . . . 0.0 111.757 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -74.64 -39.77 61.89 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 120.664 -1.272 . . . . 0.0 109.253 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.29 66.91 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 120.712 -1.242 . . . . 0.0 111.933 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -1.18 56.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.646 0.778 . . . . 0.0 110.124 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 42.9 p 65.64 16.14 10.36 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.44 1.896 . . . . 0.0 111.92 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.98 -58.45 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . 62.2 56.36 22.57 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 174.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' HA2' ' C' ' 56' ' ' GLY . 6.2 t80 -57.43 -41.85 81.25 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.736 1.214 . . . . 0.0 110.422 -168.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.69 8.63 0.58 Allowed Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.13 -55.57 5.93 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 118.959 1.38 . . . . 0.0 111.734 -170.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.97 155.86 49.2 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -160.3 137.59 6.88 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.428 ' HA ' ' OE1' ' B' ' 66' ' ' GLU . 34.8 Cg_endo -82.21 159.22 17.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 122.687 1.995 . . . . 0.0 112.119 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.263 34.9 m -106.33 -154.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 122.663 1.22 . . . . 0.0 111.32 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -73.41 -54.82 7.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.257 1.823 . . . . 0.0 111.434 -165.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -69.39 -16.84 63.6 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.154 1.782 . . . . 0.0 109.376 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' B' ' 62' ' ' PRO . 94.8 mt-10 -81.97 -18.5 43.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.53 93.34 0.65 Allowed Glycine 0 CA--C 1.483 -1.917 1 N-CA-C 102.129 -4.388 . . . . 0.0 102.129 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -53.72 -28.66 35.33 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 119.162 1.481 . . . . 0.0 110.709 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -58.16 -11.95 3.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.18 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 120.988 1.722 . . . . 0.0 109.756 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.57 -57.94 3.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -53.39 -38.89 63.82 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.089 1.356 . . . . 0.0 112.93 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -76.76 -24.56 52.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.953 -1.092 . . . . 0.0 111.104 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.16 -43.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.03 -49.95 75.96 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.236 1.014 . . . . 0.0 110.647 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -72.8 -15.72 61.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.877 -1.139 . . . . 0.0 112.162 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.18 65.5 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 120.051 -1.656 . . . . 0.0 108.626 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.05 -46.97 89.87 Favored Glycine 0 CA--C 1.492 -1.347 0 C-N-CA 124.676 1.131 . . . . 0.0 111.217 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.15 -48.5 65.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 C-N-CA 124.869 1.268 . . . . 0.0 110.421 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.35 -22.55 63.73 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 120.914 -1.116 . . . . 0.0 112.523 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.84 -53.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -62.83 -41.19 99.22 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.896 0.878 . . . . 0.0 110.439 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -30.53 71.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.766 0.826 . . . . 0.0 111.381 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.85 -30.36 67.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.965 -1.085 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.5 -14.87 11.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 120.843 -1.16 . . . . 0.0 110.324 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -61.28 -20.91 63.43 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.341 -2.099 . . . . 0.0 112.241 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.35 -17.39 62.54 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 120.47 -1.394 . . . . 0.0 111.593 172.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.5 -46.87 6.8 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 124.87 1.268 . . . . 0.0 108.605 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 55.0 mt -61.2 -38.49 86.75 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.294 -0.879 . . . . 0.0 112.414 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.87 0.13 19.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.038 -1.039 . . . . 0.0 111.212 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.1 p -97.94 -14.27 20.72 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 120.835 -1.166 . . . . 0.0 109.716 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.33 -18.86 60.64 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 119.557 1.071 . . . . 0.0 111.054 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -91.24 -16.76 27.11 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 120.658 -1.276 . . . . 0.0 112.295 170.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.43 -27.09 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -53.69 -22.35 8.85 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 126.028 1.731 . . . . 0.0 114.572 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -66.66 -28.0 68.12 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.585 -0.697 . . . . 0.0 110.063 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.441 -0.901 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.138 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 CA--C 1.486 -1.494 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.433 ' HE1' ' OE2' ' C' ' 5' ' ' GLU . 18.6 p80 -48.87 -35.83 15.64 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.497 1.919 . . . . 0.0 114.691 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.433 ' OE2' ' HE1' ' C' ' 4' ' ' HIS . 14.0 mt-10 -80.15 -33.57 38.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.316 -1.49 . . . . 0.0 110.567 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -73.31 -31.12 63.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.676 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.87 -49.81 69.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.148 2.179 . . . . 0.0 108.798 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.9 87.82 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.807 1.243 . . . . 0.0 112.067 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -60.17 -36.71 78.19 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.189 0.996 . . . . 0.0 111.174 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -74.66 -19.98 60.06 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.116 -0.99 . . . . 0.0 111.705 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.99 90.56 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.573 -0.704 . . . . 0.0 109.185 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -63.24 -39.0 93.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.682 1.193 . . . . 0.0 111.344 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.24 -39.83 71.43 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.762 0.825 . . . . 0.0 109.827 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.37 -31.21 71.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.405 1.082 . . . . 0.0 110.148 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.01 -47.96 73.98 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 125.505 1.522 . . . . 0.0 110.414 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.03 -35.56 80.89 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.519 0.727 . . . . 0.0 110.374 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -67.3 -49.33 64.68 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 111.308 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.9 -40.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 121.806 -0.558 . . . . 0.0 110.322 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.73 -35.06 72.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 O-C-N 122.02 -0.425 . . . . 0.0 109.99 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.82 -38.2 76.48 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 119.264 0.938 . . . . 0.0 111.465 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -20.62 46.25 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.103 -0.998 . . . . 0.0 108.399 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.04 46.75 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.958 -1.089 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m -52.48 -46.41 66.56 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 125.384 1.474 . . . . 0.0 111.528 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.72 -43.31 98.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 126.383 1.873 . . . . 0.0 108.859 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -71.48 -41.78 68.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 117.344 -1.312 . . . . 0.0 109.231 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.42 -51.8 67.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.874 1.215 . . . . 0.0 110.998 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.61 -37.23 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 O-C-N 121.617 -0.677 . . . . 0.0 110.538 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -75.39 -28.04 59.3 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.248 -1.533 . . . . 0.0 110.166 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.11 68.41 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.245 1.418 . . . . 0.0 109.335 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -2.15 58.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.5 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -67.34 95.66 0.45 Allowed 'General case' 0 C--N 1.357 0.897 0 O-C-N 120.981 -1.074 . . . . 0.0 109.653 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.76 6.05 30.84 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.96 152.6 68.9 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 118.586 1.193 . . . . 0.0 108.841 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.52 137.51 14.7 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.115 1.877 . . . . 0.0 110.217 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.15 70.58 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.54 155.21 19.08 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.455 1.902 . . . . 0.0 111.236 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.76 -22.59 0.87 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.675 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.29 37.34 2.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.655 1.982 . . . . 0.0 108.511 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.03 -15.77 20.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 50.8 m -89.68 124.89 35.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 121.163 -0.96 . . . . 0.0 112.47 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -67.21 -61.05 5.1 Favored Pre-proline 0 C--N 1.348 0.522 0 C-N-CA 127.059 2.143 . . . . 0.0 113.221 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -14.03 24.66 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 CA-C-N 125.679 3.064 . . . . 0.0 110.874 -172.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.36 -16.4 49.29 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 124.357 1.063 . . . . 0.0 108.73 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.03 74.22 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 123.469 0.708 . . . . 0.0 111.224 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.63 -31.99 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 123.753 0.821 . . . . 0.0 110.542 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.74 -34.39 69.49 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 119.758 -1.839 . . . . 0.0 109.282 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -72.33 -43.64 63.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -68.91 -28.0 66.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.779 -1.201 . . . . 0.0 112.051 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.8 t -56.52 -54.63 26.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 124.064 0.946 . . . . 0.0 109.967 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.68 -21.63 51.79 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.703 -0.623 . . . . 0.0 111.431 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -67.8 -39.22 84.04 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.126 0.97 . . . . 0.0 110.038 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.78 -22.93 62.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.889 -1.132 . . . . 0.0 111.631 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -91.92 4.02 53.89 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.607 -0.683 . . . . 0.0 110.199 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 56.9 p 49.38 41.77 21.14 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.859 2.064 . . . . 0.0 111.453 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.3 -66.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' B' ' 57' ' ' TYR . . . 74.14 52.02 8.23 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 174.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.409 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 0.1 OUTLIER -73.86 -14.44 61.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.652 -0.911 . . . . 0.0 110.907 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.99 29.89 3.88 Favored Glycine 0 CA--C 1.49 -1.478 0 O-C-N 121.019 -1.051 . . . . 0.0 110.917 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -70.95 -59.77 2.6 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -138.87 173.36 11.65 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -143.96 144.81 27.89 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.74 164.36 14.0 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.543 2.829 . . . . 0.0 110.03 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.8 -162.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -91.17 -47.77 7.33 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.775 1.63 . . . . 0.0 107.548 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.13 2.19 18.8 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.556 1.542 . . . . 0.0 111.864 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.81 -27.31 63.78 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.296 1.998 . . . . 0.0 106.354 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.95 82.89 0.97 Allowed Glycine 0 CA--C 1.471 -2.673 1 N-CA-C 100.451 -5.06 . . . . 0.0 100.451 -170.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -57.79 -7.69 0.77 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.513 1.525 . . . . 0.0 112.768 -170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.74 -13.17 53.87 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 119.918 -1.739 . . . . 0.0 113.193 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.7 -58.39 5.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 120.821 1.646 . . . . 0.0 106.689 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.43 68.53 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.201 1.0 . . . . 0.0 112.627 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -62.44 -34.22 76.36 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.423 1.089 . . . . 0.0 111.654 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.56 -33.89 76.98 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.132 -1.605 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.25 -43.29 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 O-C-N 121.731 -0.605 . . . . 0.0 109.47 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.12 -49.79 76.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.458 1.103 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -66.29 -35.59 80.78 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.474 -0.766 . . . . 0.0 111.293 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.91 79.09 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.502 -0.749 . . . . 0.0 110.668 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.38 -45.66 77.25 Favored Glycine 0 CA--C 1.495 -1.178 0 C-N-CA 124.144 0.878 . . . . 0.0 111.584 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -44.94 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.312 1.045 . . . . 0.0 109.449 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -65.84 -24.82 66.97 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.118 -0.989 . . . . 0.0 112.288 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.37 -53.38 32.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 120.439 1.472 . . . . 0.0 109.418 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -71.81 -21.9 61.64 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.474 0.654 . . . . 0.0 111.211 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.79 -35.31 26.6 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.361 -0.837 . . . . 0.0 110.949 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.61 -35.28 77.11 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 119.939 -1.726 . . . . 0.0 110.78 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.33 -9.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 121.145 -0.972 . . . . 0.0 112.258 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 20.0 m -65.42 -9.69 27.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.647 1.179 . . . . 0.0 111.804 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.99 -58.21 9.17 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.441 -1.412 . . . . 0.0 110.532 166.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.1 86.84 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.978 -1.076 . . . . 0.0 110.692 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.25 -40.64 86.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.043 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -12.46 60.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 121.092 -1.005 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 7.3 m -82.21 -23.69 35.3 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.77 -35.39 79.99 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 120.903 -1.123 . . . . 0.0 110.504 -159.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -66.34 -26.52 67.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.795 -0.566 . . . . 0.0 112.196 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.32 -27.33 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 124.455 1.102 . . . . 0.0 108.228 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -59.73 -14.41 14.22 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.164 -0.96 . . . . 0.0 112.423 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.986 -1.071 . . . . 0.0 111.018 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -174.376 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -162.96 -92.31 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -168.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 1.9 p80 -63.97 -18.07 63.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.493 1.517 . . . . 0.0 113.343 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 35.3 mp0 -69.92 -34.16 73.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 120.652 -1.28 . . . . 0.0 109.582 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -73.47 -38.76 65.33 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.036 -1.04 . . . . 0.0 108.633 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.95 -42.51 99.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.64 87.59 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.6 1.16 . . . . 0.0 112.119 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.15 -42.36 94.74 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.261 0.625 . . . . 0.0 111.181 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.79 -38.2 90.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.177 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.81 89.62 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.41 -0.806 . . . . 0.0 111.014 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.83 -36.94 84.86 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.453 -0.78 . . . . 0.0 111.027 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.61 -29.99 70.65 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.548 1.139 . . . . 0.0 110.748 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -74.97 -38.44 61.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.561 1.144 . . . . 0.0 108.259 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.95 -45.73 93.54 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.571 0.748 . . . . 0.0 110.666 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -58.2 -31.42 67.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 112.67 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -69.78 -41.1 75.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.424 0.69 . . . . 0.0 109.677 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.39 -35.45 74.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 124.061 0.944 . . . . 0.0 109.175 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.38 -37.8 84.73 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 121.238 -0.914 . . . . 0.0 111.708 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -82.79 -16.89 46.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.514 0.726 . . . . 0.0 111.278 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -77.64 -46.34 22.36 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 168.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.37 74.38 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 126.327 1.851 . . . . 0.0 111.374 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -62.52 -44.35 96.57 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.388 0.675 . . . . 0.0 110.772 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -67.99 -50.09 57.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -61.47 -42.46 98.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.793 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.06 99.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.217 1.407 . . . . 0.0 111.673 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.8 -45.16 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 O-C-N 121.025 -1.047 . . . . 0.0 109.448 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -70.23 -27.82 64.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.317 -0.864 . . . . 0.0 110.703 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -57.03 4.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.421 1.889 . . . . 0.0 108.782 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.53 -32.44 74.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.095 0.958 . . . . 0.0 111.776 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -66.84 104.32 1.32 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.135 -1.603 . . . . 0.0 110.559 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.98 -28.29 3.7 Favored Glycine 0 CA--C 1.489 -1.556 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.52 145.01 70.89 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 123.351 0.661 . . . . 0.0 110.75 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -78.78 138.37 14.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.192 1.928 . . . . 0.0 110.231 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.06 80.91 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.439 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.84 147.95 36.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.813 1.245 . . . . 0.0 111.698 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.53 -37.7 2.48 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 tp -106.93 93.98 4.86 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.124 -0.985 . . . . 0.0 108.883 -173.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -135.58 57.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 120.229 -1.545 . . . . 0.0 109.047 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 30.9 t -150.31 135.03 17.5 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -68.82 -43.09 26.65 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 115.625 -2.131 . . . . 0.0 111.256 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -68.53 -28.18 32.19 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-N 126.106 3.216 . . . . 0.0 111.966 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.83 -17.65 31.06 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 118.957 0.799 . . . . 0.0 108.949 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.68 86.82 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 124.677 1.191 . . . . 0.0 112.039 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.54 -14.87 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 123.579 0.751 . . . . 0.0 110.305 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 -33.19 18.35 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 120.881 -1.137 . . . . 0.0 107.944 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -73.3 -40.02 64.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 15.0 p -76.18 59.05 1.31 Allowed 'General case' 0 C--N 1.358 0.943 0 O-C-N 121.234 -0.916 . . . . 0.0 111.419 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 72.0 t -133.48 -65.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 -21.41 65.26 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.505 0.722 . . . . 0.0 111.784 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -69.69 -28.91 66.25 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 121.507 -0.745 . . . . 0.0 110.394 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.17 -26.47 42.69 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.161 -0.962 . . . . 0.0 109.655 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 15.3 p -91.89 3.35 55.39 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.578 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 12.7 p 54.04 25.88 5.93 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.427 1.891 . . . . 0.0 113.095 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.444 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.8 p -86.22 -53.0 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.409 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 70.85 73.07 0.82 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -23.77 53.56 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.621 -1.517 . . . . 0.0 109.852 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.57 35.71 1.85 Allowed Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -155.2 176.37 12.65 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -149.2 145.92 20.29 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -80.3 165.78 20.84 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 CA-C-N 121.944 1.73 . . . . 0.0 110.527 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.29 -146.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.538 0 CA-C-N 119.218 0.917 . . . . 0.0 109.959 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -91.59 -54.09 4.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.273 -1.517 . . . . 0.0 109.849 -163.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -89.34 16.73 6.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.439 0.696 . . . . 0.0 109.608 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -30.29 62.6 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 163.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.34 83.48 1.18 Allowed Glycine 0 CA--C 1.476 -2.385 1 N-CA-C 99.583 -5.407 . . . . 0.0 99.583 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.58 HH11 ' HG3' ' D' ' 68' ' ' ARG . 20.1 ttm-85 -52.44 -18.57 1.71 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.056 1.742 . . . . 0.0 112.003 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -53.97 -28.22 36.2 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.504 2.322 . . . . 0.0 113.26 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.57 -53.2 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.391 0.677 . . . . 0.0 111.88 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.3 -46.65 55.53 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 126.233 1.813 . . . . 0.0 110.721 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.84 -38.06 89.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.493 0.717 . . . . 0.0 110.8 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.77 -39.05 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 123.446 0.698 . . . . 0.0 109.125 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -57.81 -52.91 63.53 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.984 1.314 . . . . 0.0 110.253 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.8 -38.0 89.47 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.033 0.533 . . . . 0.0 110.659 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.16 79.03 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.661 0.784 . . . . 0.0 111.58 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.81 -45.77 80.78 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.57 -48.97 85.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 C-N-CA 124.268 1.027 . . . . 0.0 108.932 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -57.03 -42.29 80.17 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.208 1.403 . . . . 0.0 112.503 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -65.56 -55.48 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 124.744 1.218 . . . . 0.0 109.248 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -67.26 -34.84 78.27 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.748 -0.595 . . . . 0.0 110.617 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.38 78.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.463 1.105 . . . . 0.0 111.135 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.65 -38.2 90.2 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 124.536 1.135 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.1 -14.5 7.75 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 125.128 1.371 . . . . 0.0 111.279 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 6.3 m -61.81 -20.59 63.79 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 119.376 -2.078 . . . . 0.0 111.696 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.66 66.73 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.684 -1.26 . . . . 0.0 111.336 171.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.91 -49.75 11.45 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.33 -32.25 73.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.736 0.814 . . . . 0.0 112.741 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.99 63.64 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.26 -1.525 . . . . 0.0 111.121 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -82.45 -11.02 58.8 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.701 -1.249 . . . . 0.0 111.225 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -32.55 74.17 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 119.454 1.024 . . . . 0.0 111.206 -171.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -77.17 -32.99 56.55 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.969 -1.082 . . . . 0.0 111.173 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.71 -26.64 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 125.884 1.674 . . . . 0.0 108.973 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -66.55 -5.73 12.47 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 112.331 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -69.16 -18.41 63.93 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 119.81 1.187 . . . . 0.0 110.997 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 -178.167 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.048 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -41.68 -57.87 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 128.786 2.835 . . . . 0.0 112.446 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.572 ' HB3' HH12 ' D' ' 96' ' ' ARG . 22.9 p80 -77.97 -19.21 54.94 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 125.082 1.353 . . . . 0.0 112.674 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.93 -38.47 57.61 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -60.96 -35.31 76.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 123.816 0.846 . . . . 0.0 111.622 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -59.96 -41.93 92.98 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.737 2.015 . . . . 0.0 110.175 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -41.75 74.4 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.593 0.757 . . . . 0.0 110.263 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.39 -32.56 72.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.799 0.84 . . . . 0.0 111.408 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -71.94 -32.67 67.55 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.363 1.065 . . . . 0.0 110.527 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.123 0.569 . . . . 0.0 110.213 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -55.64 -42.84 75.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.709 1.204 . . . . 0.0 111.795 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -76.7 -29.89 56.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.777 -0.577 . . . . 0.0 109.578 -174.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.22 -31.21 69.63 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.477 -0.764 . . . . 0.0 109.975 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.18 -43.1 92.15 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 121.725 -0.609 . . . . 0.0 111.326 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -62.46 -29.43 70.51 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.187 -0.946 . . . . 0.0 112.209 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.37 -31.62 67.53 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.654 -0.654 . . . . 0.0 110.267 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.65 -41.55 90.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.187 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.92 -42.81 85.57 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.914 0.886 . . . . 0.0 110.305 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.31 -42.7 99.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.378 -0.826 . . . . 0.0 111.699 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.16 -38.63 69.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.65 79.46 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 124.914 1.286 . . . . 0.0 111.639 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -66.56 -32.96 74.63 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 124.146 0.978 . . . . 0.0 111.124 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -70.75 -47.1 61.44 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 121.568 -0.708 . . . . 0.0 109.747 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -60.14 -50.39 73.88 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.129 0.972 . . . . 0.0 109.35 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.81 88.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.646 1.579 . . . . 0.0 112.554 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.88 -48.14 89.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.191 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.33 -29.02 61.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.41 -0.806 . . . . 0.0 111.216 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.16 91.53 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.079 1.352 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.43 -20.0 60.2 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.544 -0.722 . . . . 0.0 112.021 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -75.09 87.13 2.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 120.194 -1.566 . . . . 0.0 110.577 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.88 3.11 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.61 140.58 59.57 Favored Pre-proline 0 N--CA 1.442 -0.825 0 O-C-N 121.703 -0.881 . . . . 0.0 110.046 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.15 135.43 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.495 2.13 . . . . 0.0 110.245 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.86 24.75 68.71 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.67 144.59 56.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.085 0.954 . . . . 0.0 110.103 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.08 -34.47 2.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.79 131.66 36.99 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 pt -151.23 169.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 100.649 -3.834 . . . . 0.0 100.649 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t 76.89 134.07 0.06 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.963 1.705 . . . . 0.0 111.082 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -66.01 -49.48 56.9 Favored Pre-proline 0 C--N 1.352 0.701 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.072 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -70.21 -14.46 34.68 Favored 'Trans proline' 0 CA--C 1.514 -0.513 0 CA-C-N 125.308 2.932 . . . . 0.0 112.584 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.23 -43.14 12.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.97 77.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.235 1.014 . . . . 0.0 112.215 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.14 -16.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-O 121.714 0.769 . . . . 0.0 111.397 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -31.76 17.31 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 120.757 -1.214 . . . . 0.0 108.162 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.33 -40.02 94.97 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 120.795 -1.19 . . . . 0.0 110.244 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -67.05 -17.3 64.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.948 -1.095 . . . . 0.0 111.669 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.5 -51.09 67.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.682 1.193 . . . . 0.0 109.315 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.61 -7.41 50.08 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 124.07 0.948 . . . . 0.0 111.167 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.6 m -94.13 -45.11 7.69 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 120.36 -1.462 . . . . 0.0 107.058 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.01 70.15 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.308 -0.87 . . . . 0.0 112.325 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -91.77 3.83 54.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.272 67.8 p 59.53 -142.46 0.6 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.447 1.899 . . . . 0.0 107.334 -167.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t 75.63 -90.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.94 94.28 0.25 Allowed Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -80.07 -20.8 44.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.305 -1.703 . . . . 0.0 109.711 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.73 25.29 4.31 Favored Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.58 -48.19 34.74 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.277 1.539 . . . . 0.0 110.055 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.36 152.88 51.12 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.457 ' CD1' ' HD2' ' A' ' 62' ' ' PRO . 17.6 t80 -145.17 137.71 13.55 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 46.5 Cg_endo -80.97 168.17 17.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.908 2.405 . . . . 0.0 110.951 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -88.91 -111.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -134.83 -39.42 0.78 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 122.224 1.011 . . . . 0.0 109.225 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -79.28 -22.58 44.46 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.601 -1.312 . . . . 0.0 109.627 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -62.08 -32.03 72.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.075 1.75 . . . . 0.0 108.386 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.42 65.18 0.93 Allowed Glycine 0 CA--C 1.465 -3.081 1 N-CA-C 102.483 -4.247 . . . . 0.0 102.483 168.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -26.33 -26.39 0.0 OUTLIER 'General case' 0 C--N 1.363 1.185 1 C-N-CA 132.65 4.38 . . . . 0.0 116.851 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -49.34 -20.47 0.67 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.06 -42.92 94.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 124.954 1.301 . . . . 0.0 109.693 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -48.51 31.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.12 -50.82 19.46 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 126.463 1.905 . . . . 0.0 111.303 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.27 -35.53 81.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.427 0.632 . . . . 0.0 110.692 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.1 t -73.22 -37.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.41 -0.806 . . . . 0.0 109.14 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.5 mtt -61.83 -46.36 89.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 123.632 0.773 . . . . 0.0 109.656 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.48 -33.27 75.31 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.078 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.18 97.04 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 121.746 -0.596 . . . . 0.0 110.656 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.06 -46.93 77.5 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.35 -45.49 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 109.602 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.87 -36.38 83.72 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.855 -1.153 . . . . 0.0 110.681 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.03 -52.07 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 119.959 1.254 . . . . 0.0 110.563 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -70.47 -22.76 62.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.809 -0.557 . . . . 0.0 111.126 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.54 -32.94 23.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.382 -0.824 . . . . 0.0 110.546 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.43 -24.25 67.14 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.496 -1.377 . . . . 0.0 111.207 -172.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.17 -11.26 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.484 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.402 HG23 ' HB2' ' A' ' 90' ' ' ALA . 56.0 m -45.24 -29.68 1.04 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 127.826 2.45 . . . . 0.0 112.058 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.72 -39.77 52.64 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.406 1.482 . . . . 0.0 113.889 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 -36.12 6.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.94 1.296 . . . . 0.0 109.307 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.31 -41.57 66.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.736 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -78.21 -32.19 49.81 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 119.813 -1.805 . . . . 0.0 111.229 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -73.86 -0.36 15.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.529 -1.357 . . . . 0.0 110.003 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.24 -26.56 64.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 121.245 -0.909 . . . . 0.0 109.414 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -72.83 -33.4 66.15 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.454 -1.404 . . . . 0.0 110.634 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.17 -21.91 27.11 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.223 1.409 . . . . 0.0 109.171 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.39 -29.47 48.83 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 125.399 1.48 . . . . 0.0 112.247 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -65.57 -36.56 84.14 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.541 0.686 . . . . 0.0 110.479 -174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -170.757 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 122.065 0.936 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 3.5 p-80 -83.77 -23.64 31.44 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.58 -0.7 . . . . 0.0 110.601 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.16 -38.06 21.13 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -63.19 -47.61 81.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.225 1.41 . . . . 0.0 110.954 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -26.44 65.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.371 -0.83 . . . . 0.0 111.256 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.91 -35.44 74.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.319 -0.863 . . . . 0.0 110.657 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -64.74 -45.87 84.64 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.999 0.92 . . . . 0.0 109.231 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -64.34 -31.94 73.35 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.112 0.565 . . . . 0.0 111.534 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.93 81.62 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.755 0.822 . . . . 0.0 110.685 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -39.5 81.5 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.074 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.53 -43.04 84.04 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 125.748 1.619 . . . . 0.0 110.484 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.37 -38.92 91.42 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.138 1.375 . . . . 0.0 110.079 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.441 ' HB2' HG21 ' B' ' 81' ' ' VAL . 21.3 tp -59.3 -41.56 89.29 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 123.908 0.883 . . . . 0.0 111.391 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -63.91 -29.58 70.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.866 1.266 . . . . 0.0 110.73 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -76.08 -30.33 58.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.246 1.019 . . . . 0.0 110.217 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -70.35 -35.67 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 31.2 mt -61.76 -42.32 98.83 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.809 -0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -60.75 -45.54 93.9 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.086 0.857 . . . . 0.0 110.519 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -68.93 -40.18 79.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.874 0.845 . . . . 0.0 110.486 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -31.11 71.29 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.264 1.426 . . . . 0.0 111.256 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -66.0 -44.25 85.34 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.085 0.954 . . . . 0.0 110.199 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -61.03 -49.68 76.4 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.025 1.33 . . . . 0.0 107.785 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.83 -41.96 99.54 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.388 0.675 . . . . 0.0 111.232 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.21 91.38 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 124.892 1.277 . . . . 0.0 111.965 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.45 -40.97 73.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.17 -10.67 59.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.291 -1.506 . . . . 0.0 111.704 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.485 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -70.58 -21.25 62.7 Favored 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.907 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.97 -1.99 41.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.27 79.36 2.8 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.2 -41.6 0.71 Allowed Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.81 154.93 70.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 O-C-N 122.185 -0.597 . . . . 0.0 111.457 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.1 151.27 23.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.014 2.476 . . . . 0.0 110.41 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.61 41.23 65.54 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 173.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 136.64 57.92 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.376 1.071 . . . . 0.0 112.205 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.11 -57.28 2.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.62 97.95 10.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.094 0.95 . . . . 0.0 108.455 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.49 12.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -105.08 129.99 53.37 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -78.93 -57.81 0.75 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 127.257 2.223 . . . . 0.0 108.692 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.45 -13.89 25.13 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.344 2.944 . . . . 0.0 111.69 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -93.35 -10.34 35.65 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.397 0.998 . . . . 0.0 108.417 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.64 83.73 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.61 -1.306 . . . . 0.0 110.512 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.92 -9.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 124.454 1.102 . . . . 0.0 110.562 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.85 -41.08 16.37 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 120.14 -1.6 . . . . 0.0 107.28 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -68.87 -32.83 72.76 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.538 -0.727 . . . . 0.0 110.815 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 7.0 p -66.41 -17.41 64.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.978 -1.076 . . . . 0.0 111.586 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.76 -17.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.924 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -97.72 10.82 39.07 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.488 -1.383 . . . . 0.0 109.177 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -123.26 -173.75 2.79 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.45 -3.537 . . . . 0.0 101.45 173.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 77.24 -42.27 0.4 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 126.1 1.76 . . . . 0.0 111.095 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.0 p -81.19 2.75 26.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 126.22 1.808 . . . . 0.0 111.692 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p 52.07 59.3 4.63 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.826 2.051 . . . . 0.0 111.595 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.41 -77.01 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.08 66.49 1.96 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -72.45 -46.04 56.81 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.64 -105.48 0.24 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.327 5.2 t70 56.92 -72.63 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 128.271 2.628 . . . . 0.0 112.232 -163.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -163.59 1.35 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -173.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -153.24 153.49 29.52 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.6 168.41 9.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.331 3.354 . . . . 0.0 112.847 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 m -83.14 177.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.55 1.14 . . . . 0.0 112.442 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -83.21 -69.44 0.63 Allowed 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 125.475 1.51 . . . . 0.0 111.337 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.99 -37.5 64.07 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 124.611 1.165 . . . . 0.0 112.907 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -121.16 -107.62 0.36 Allowed 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 167.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.485 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 40.13 -73.55 0.0 OUTLIER Glycine 0 C--N 1.358 1.785 0 C-N-CA 129.748 3.547 . . . . 0.0 116.165 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.39 -37.86 87.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.363 2.665 . . . . 0.0 111.488 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.838 0.827 . . . . 0.0 109.275 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.05 -46.42 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.58 84.49 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.408 1.483 . . . . 0.0 111.603 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.67 -47.22 29.55 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.049 1.739 . . . . 0.0 110.938 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.72 -36.59 84.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.119 1.368 . . . . 0.0 110.283 -176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.33 -42.01 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.679 -0.638 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -60.59 -46.74 89.09 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -63.13 -38.3 90.62 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 122.121 -0.362 . . . . 0.0 111.158 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.02 80.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.159 0.584 . . . . 0.0 111.301 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.13 91.65 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 124.483 1.039 . . . . 0.0 111.214 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.08 -42.52 90.17 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 123.853 0.861 . . . . 0.0 108.707 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.81 -51.19 65.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 120.94 -1.1 . . . . 0.0 112.275 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' B' ' 15' ' ' LEU . 27.7 m -72.88 -41.32 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 112.144 -171.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -74.15 -38.51 63.7 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.25 -32.18 71.22 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.69 -31.88 62.8 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.759 1.223 . . . . 0.0 111.406 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.9 -12.05 8.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.666 1.186 . . . . 0.0 111.099 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 16.2 m -64.4 -24.82 67.77 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 118.897 -2.377 . . . . 0.0 110.761 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.58 -20.35 65.99 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.154 -1.591 . . . . 0.0 111.318 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -90.27 -40.71 11.99 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.38 1.072 . . . . 0.0 108.913 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.96 -31.75 51.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 122.785 0.434 . . . . 0.0 111.545 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.29 -23.02 66.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.122 -0.986 . . . . 0.0 111.374 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . 0.343 0.6 OUTLIER -83.36 -10.72 58.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.916 -1.115 . . . . 0.0 109.47 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.275 46.1 m-20 -82.46 -2.68 54.02 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.458 -1.401 . . . . 0.0 111.801 -172.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.19 -35.88 15.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.27 -1.519 . . . . 0.0 108.538 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 t -66.84 -25.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 125.074 1.349 . . . . 0.0 110.224 -169.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -63.58 -8.92 11.02 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.422 -0.799 . . . . 0.0 112.844 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -66.34 -32.85 74.49 Favored 'General case' 0 C--N 1.359 1.004 0 O-C-N 120.851 -1.156 . . . . 0.0 110.068 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -172.905 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 CA--C 1.492 -1.258 0 CA-C-O 121.913 0.863 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CE1' HG21 ' C' ' 91' ' ' THR . 4.5 p80 -67.07 -27.83 67.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.56 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.61 -42.88 57.83 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -65.75 -37.71 87.12 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.827 -1.171 . . . . 0.0 110.826 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.87 -31.44 72.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.379 1.072 . . . . 0.0 110.987 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.84 -47.68 71.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.729 0.812 . . . . 0.0 110.203 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.357 -0.839 . . . . 0.0 111.615 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -65.44 -39.63 92.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.873 1.269 . . . . 0.0 109.311 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.4 82.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.896 0.878 . . . . 0.0 110.681 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -55.53 -42.76 75.03 Favored 'General case' 0 C--N 1.36 1.03 0 CA-C-O 121.667 0.746 . . . . 0.0 110.829 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -60.93 -39.38 89.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.139 1.376 . . . . 0.0 110.363 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.98 -34.2 76.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.149 0.979 . . . . 0.0 109.505 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.47 -40.33 89.29 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.819 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.31 -28.02 68.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.558 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -66.04 -39.77 90.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.977 0.911 . . . . 0.0 110.181 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.7 -35.15 74.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 124.247 1.019 . . . . 0.0 109.198 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.57 -35.67 80.22 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 121.29 -0.881 . . . . 0.0 111.898 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.8 -32.62 59.94 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.137 0.575 . . . . 0.0 110.337 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 -42.06 59.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.12 -0.987 . . . . 0.0 108.767 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -36.01 78.24 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.758 1.623 . . . . 0.0 111.895 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -69.4 -36.63 76.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.909 -0.494 . . . . 0.0 110.299 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -67.58 -38.03 83.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -66.19 -55.24 17.24 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.0 68.69 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.739 1.215 . . . . 0.0 111.984 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.68 -43.92 96.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 O-C-N 119.962 -1.712 . . . . 0.0 111.985 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.79 -34.99 20.99 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 121.211 -0.931 . . . . 0.0 109.274 -171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.37 -50.77 58.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.552 1.941 . . . . 0.0 109.546 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.04 -24.1 62.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.236 -0.915 . . . . 0.0 111.637 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.95 95.19 6.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.455 -1.403 . . . . 0.0 111.918 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.46 -7.57 4.98 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.71 148.02 37.53 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 123.577 0.751 . . . . 0.0 109.788 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -77.69 103.46 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.895 2.397 . . . . 0.0 113.051 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 -52.44 0.72 Allowed Glycine 0 CA--C 1.477 -2.324 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.719 2.008 . . . . 0.0 110.901 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.34 -91.62 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.92 127.14 31.62 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.27 131.18 1.84 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 169.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.86 -49.03 60.83 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.038 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.0 -5.52 17.13 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 CA-C-N 124.777 2.742 . . . . 0.0 111.955 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -99.88 -29.27 12.68 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.67 76.32 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 111.939 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.71 -36.89 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 123.418 0.687 . . . . 0.0 110.222 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -30.22 60.59 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.474 -1.391 . . . . 0.0 109.92 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -72.85 -32.05 65.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.984 0.897 . . . . 0.0 109.124 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -67.04 -42.24 85.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.279 -0.888 . . . . 0.0 110.358 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -67.66 -23.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 C-N-CA 124.155 0.982 . . . . 0.0 112.87 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.4 -13.72 51.4 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 120.07 -1.644 . . . . 0.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -104.61 -175.02 2.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . 79.47 -33.63 0.14 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 126.952 2.101 . . . . 0.0 110.672 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.1 p -89.73 3.78 51.69 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 125.956 1.703 . . . . 0.0 111.949 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.278 41.5 p 52.43 63.87 2.07 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.503 1.921 . . . . 0.0 111.917 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.21 -107.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 1 N-CA-C 98.546 -4.613 . . . . 0.0 98.546 173.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.3 87.48 1.09 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 106.651 -2.58 . . . . 0.0 106.651 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -69.2 -45.63 69.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.357 1.075 . . . . 0.0 109.118 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.44 48.48 0.28 Allowed Glycine 0 CA--C 1.485 -1.797 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.414 ' CG ' HH22 ' D' ' 68' ' ' ARG . 34.8 t70 -73.48 -45.35 54.59 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -132.96 -154.2 0.6 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.83 142.86 2.04 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 100.829 -3.767 . . . . 0.0 100.829 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.07 179.8 3.53 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 123.664 2.344 . . . . 0.0 107.49 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.487 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.7 t -100.6 -121.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.405 1.482 . . . . 0.0 110.118 -168.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 73.4 m -136.48 -38.8 0.66 Allowed 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.692 -1.255 . . . . 0.0 108.584 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -86.17 -6.11 59.06 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.979 -1.076 . . . . 0.0 109.834 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -63.98 -36.83 85.24 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 123.216 1.484 . . . . 0.0 107.373 175.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.94 62.41 0.85 Allowed Glycine 0 CA--C 1.464 -3.111 1 N-CA-C 100.643 -4.983 . . . . 0.0 100.643 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -26.86 -25.2 0.0 OUTLIER 'General case' 0 C--N 1.36 1.04 1 C-N-CA 132.989 4.516 . . . . 0.0 117.778 -175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -52.87 -15.44 0.75 Allowed 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 161.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.23 -44.39 87.84 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 O-C-N 120.153 -1.592 . . . . 0.0 109.294 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.59 66.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 123.142 0.577 . . . . 0.0 109.681 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . 0.258 1.1 pp20? -65.38 -33.72 76.63 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 121.799 -0.563 . . . . 0.0 111.836 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.31 -36.99 79.18 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 121.55 0.691 . . . . 0.0 110.624 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.3 t -72.77 -37.82 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.507 -0.745 . . . . 0.0 109.477 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 50.8 mtt -64.42 -47.91 77.34 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 123.856 0.863 . . . . 0.0 109.55 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -61.83 -40.58 95.79 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.425 0.69 . . . . 0.0 110.747 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.05 94.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.546 0.738 . . . . 0.0 110.872 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.64 78.09 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.28 -49.54 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 124.195 0.998 . . . . 0.0 108.943 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.83 -39.19 87.56 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 118.531 0.605 . . . . 0.0 111.474 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.32 -54.85 28.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 119.331 0.969 . . . . 0.0 110.4 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.58 -14.02 60.03 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 111.737 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.94 -37.62 22.07 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.623 -1.298 . . . . 0.0 108.035 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.97 -33.63 72.2 Favored 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 124.996 1.318 . . . . 0.0 111.738 -175.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -64.56 -5.31 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 O-C-N 121.335 -0.853 . . . . 0.0 112.663 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 26.3 m -59.2 -18.52 37.32 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.742 1.217 . . . . 0.0 111.167 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.62 68.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.847 -1.783 . . . . 0.0 113.104 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.58 -43.46 13.47 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.0 -38.86 92.6 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.079 0.942 . . . . 0.0 111.318 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.29 -20.32 62.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.982 -1.073 . . . . 0.0 111.833 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.515 HG21 ' CE1' ' C' ' 4' ' ' HIS . 9.7 t -99.52 7.71 45.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.4 -45.34 60.14 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.833 1.197 . . . . 0.0 107.978 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -63.09 -34.62 77.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.48 -0.762 . . . . 0.0 111.556 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.03 -23.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.007 1.723 . . . . 0.0 110.033 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -65.48 -16.16 63.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.1 -1.0 . . . . 0.0 111.435 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -64.19 -25.2 67.97 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.32 -0.862 . . . . 0.0 111.833 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 . . . . . 0 C--N 1.356 0.864 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.782 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' D' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.16 -45.63 84.16 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 123.199 1.476 . . . . 0.0 109.657 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.567 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 17.2 p-80 -69.93 -17.48 63.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.079 1.352 . . . . 0.0 111.917 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' D' ' 2' ' ' ALA . 56.0 tt0 -77.11 -40.12 46.99 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -173.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -55.55 -50.59 69.61 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.195 1.398 . . . . 0.0 110.485 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.88 -37.9 87.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.938 0.895 . . . . 0.0 109.667 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.55 95.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.553 0.741 . . . . 0.0 111.643 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -68.33 -36.7 79.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.669 -0.644 . . . . 0.0 110.774 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -68.12 -35.09 77.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.705 -0.622 . . . . 0.0 111.039 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.14 98.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.363 1.065 . . . . 0.0 111.104 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -66.76 -35.44 80.11 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.323 -0.86 . . . . 0.0 111.636 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -72.42 -34.12 67.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.676 -1.265 . . . . 0.0 111.161 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -64.84 -35.19 80.31 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.831 1.252 . . . . 0.0 108.844 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -63.22 -39.15 93.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.454 -0.779 . . . . 0.0 111.11 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.13 -21.58 63.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.615 -1.303 . . . . 0.0 112.035 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.4 -36.11 71.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.626 0.727 . . . . 0.0 110.464 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.35 -26.25 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 O-C-N 119.854 -1.779 . . . . 0.0 110.358 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.28 -46.13 90.16 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 121.957 0.884 . . . . 0.0 110.864 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.1 -39.15 86.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.52 -1.363 . . . . 0.0 110.177 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.87 96.02 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.361 1.065 . . . . 0.0 110.798 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.69 76.43 Favored 'General case' 0 CA--C 1.496 -1.123 0 O-C-N 121.301 -0.874 . . . . 0.0 111.469 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -65.06 -44.1 90.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 110.496 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.86 -53.32 48.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 125.124 1.37 . . . . 0.0 109.547 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -65.69 -37.98 87.95 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.308 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.91 83.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 124.37 1.068 . . . . 0.0 111.747 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.14 -50.05 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-N 118.509 0.595 . . . . 0.0 109.857 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -72.43 -31.59 65.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.447 -0.783 . . . . 0.0 110.732 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.49 67.83 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.955 0.902 . . . . 0.0 109.326 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.9 -40.61 96.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 125.482 1.513 . . . . 0.0 110.219 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.76 91.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.928 1.291 . . . . 0.0 112.387 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.65 -5.84 7.5 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.07 59.15 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 118.677 1.238 . . . . 0.0 111.76 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -80.82 137.54 11.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.585 2.19 . . . . 0.0 110.692 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.46 78.15 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 165.2 24.4 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.921 1.289 . . . . 0.0 111.292 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.9 32.51 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 121.808 -0.557 . . . . 0.0 110.472 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -145.14 74.43 1.4 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 120.792 -1.192 . . . . 0.0 107.912 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.67 165.19 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 O-C-N 120.948 -1.095 . . . . 0.0 108.197 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t 81.39 131.37 0.05 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.64 1.576 . . . . 0.0 112.201 165.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -62.69 -42.51 79.16 Favored Pre-proline 0 C--N 1.349 0.581 0 CA-C-O 116.864 -1.541 . . . . 0.0 113.328 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -69.06 -24.56 32.76 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 CA-C-N 124.158 2.521 . . . . 0.0 112.404 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 -32.94 19.98 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 124.745 1.218 . . . . 0.0 107.96 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.07 73.45 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.44 -32.95 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 121.729 -0.607 . . . . 0.0 110.118 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -36.18 76.87 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -65.44 -37.6 87.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.848 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -64.56 -44.42 90.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.464 -0.772 . . . . 0.0 109.491 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.86 64.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.705 0 CA-C-O 121.767 0.794 . . . . 0.0 110.856 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -162.42 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -68.48 -36.65 79.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.099 -1.001 . . . . 0.0 110.964 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.05 65.31 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.281 -0.887 . . . . 0.0 111.681 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -93.79 15.21 17.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 33.0 p 47.34 54.47 9.5 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 126.066 1.746 . . . . 0.0 113.06 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.554 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.0 OUTLIER -121.12 -82.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 178.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.554 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 77.78 64.61 2.02 Favored Glycine 0 CA--C 1.491 -1.426 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.82 -27.86 64.19 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.231 1.015 . . . . 0.0 109.899 -165.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.66 31.14 0.16 Allowed Glycine 0 CA--C 1.486 -1.779 0 O-C-N 120.728 -1.232 . . . . 0.0 110.776 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -81.71 -76.06 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 118.751 1.275 . . . . 0.0 110.837 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -128.54 159.42 35.56 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.31 149.23 18.29 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . 0.443 ' CB ' ' HG3' ' D' ' 66' ' ' GLU . 20.6 Cg_endo -73.94 149.89 42.83 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.361 2.707 . . . . 0.0 111.534 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.495 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 14.7 t -86.38 -93.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 124.116 0.966 . . . . 0.0 111.03 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -140.04 -52.58 0.51 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.734 -1.229 . . . . 0.0 108.468 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.73 -16.77 46.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.674 1.189 . . . . 0.0 109.587 -168.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 1.4 pm0 -73.74 -7.27 51.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.09 88.49 0.4 Allowed Glycine 0 CA--C 1.477 -2.303 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.414 HH22 ' CG ' ' C' ' 59' ' ' ASP . 24.9 ttm180 -60.78 -19.77 60.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.39 -1.653 . . . . 0.0 111.235 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -54.57 -16.62 2.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.685 1.194 . . . . 0.0 113.403 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.01 -39.23 84.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 119.992 -1.692 . . . . 0.0 109.229 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -39.84 70.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.115 -0.991 . . . . 0.0 109.922 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -38.01 79.36 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-O 121.876 0.846 . . . . 0.0 110.53 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -29.93 66.56 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.62 -0.675 . . . . 0.0 111.601 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.67 -46.4 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 121.053 -1.029 . . . . 0.0 108.718 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.23 -39.82 89.83 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 122.003 -0.436 . . . . 0.0 110.124 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.56 -47.19 87.29 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.083 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.29 72.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 122.951 0.5 . . . . 0.0 111.275 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -44.22 89.31 Favored Glycine 0 CA--C 1.496 -1.143 0 O-C-N 121.506 -0.746 . . . . 0.0 111.638 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.56 -46.5 95.46 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 124.357 1.063 . . . . 0.0 108.79 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.43 -46.33 69.78 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.075 1.35 . . . . 0.0 111.24 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.21 -57.35 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 C-N-CA 124.929 1.292 . . . . 0.0 110.522 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -66.78 -35.98 81.34 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.42 -0.8 . . . . 0.0 110.467 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.39 95.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.998 0.919 . . . . 0.0 110.863 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.87 -39.9 95.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.71 -15.82 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.422 1.489 . . . . 0.0 111.137 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -59.24 -13.9 9.2 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.623 1.169 . . . . 0.0 111.544 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.27 -48.44 78.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 119.905 -1.747 . . . . 0.0 112.395 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -68.51 -35.72 77.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 O-C-N 121.348 -0.845 . . . . 0.0 110.156 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.06 -32.65 63.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.42 0.688 . . . . 0.0 110.055 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.43 75.8 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.077 -1.639 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -14.48 62.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.782 -1.199 . . . . 0.0 113.128 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.21 -32.68 74.47 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 120.576 1.535 . . . . 0.0 111.032 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -77.69 -28.64 51.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.064 -1.023 . . . . 0.0 111.421 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -68.86 -24.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 125.291 1.436 . . . . 0.0 108.347 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -59.48 -12.05 5.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.501 1.52 . . . . 0.0 113.797 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 4' ' ' HIS . 1.1 ptp180 -72.88 -33.13 65.86 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 121.169 -0.957 . . . . 0.0 111.569 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.438 -1.074 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.069 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.56 -68.17 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -42.65 86.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.047 2.539 . . . . 0.0 112.08 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 2.3 pm0 -71.0 -26.24 63.04 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.661 0.785 . . . . 0.0 110.585 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.5 -37.04 77.02 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -71.32 -35.05 71.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.309 0.576 . . . . 0.0 109.863 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.0 95.95 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 121.411 -0.805 . . . . 0.0 111.362 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -71.77 -28.81 63.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 121.385 -0.822 . . . . 0.0 111.535 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -69.92 -37.52 75.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.898 -1.126 . . . . 0.0 109.361 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.73 97.36 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.98 0.912 . . . . 0.0 111.363 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -63.0 -36.68 84.37 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.44 -0.787 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.11 -35.36 69.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.028 -1.045 . . . . 0.0 110.792 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.29 -32.82 74.57 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.26 -42.31 98.41 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.924 -1.11 . . . . 0.0 111.61 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -64.31 -28.31 69.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.677 1.191 . . . . 0.0 111.212 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -69.59 -33.76 73.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.899 1.28 . . . . 0.0 110.452 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -71.62 -29.58 35.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.99 -1.068 . . . . 0.0 108.641 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.21 -29.8 66.74 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.01 -1.056 . . . . 0.0 111.223 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -71.31 -33.6 69.83 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.47 1.508 . . . . 0.0 110.329 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -72.44 -45.47 59.45 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 120.388 -1.445 . . . . 0.0 108.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.02 84.87 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 126.233 1.813 . . . . 0.0 111.483 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -67.6 -38.26 83.72 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 122.655 0.382 . . . . 0.0 110.269 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.959 0.904 . . . . 0.0 109.575 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -67.11 -55.0 16.14 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -41.25 73.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 125.688 1.595 . . . . 0.0 113.015 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.16 -37.1 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 O-C-N 120.735 -1.228 . . . . 0.0 112.582 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.67 -34.2 30.87 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.6 -53.72 37.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.543 1.537 . . . . 0.0 109.219 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.38 12.16 5.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.927 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -71.81 94.87 1.45 Allowed 'General case' 0 C--N 1.351 0.664 0 O-C-N 119.672 -1.892 . . . . 0.0 109.626 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.62 61.86 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 150.13 51.7 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -76.33 145.03 26.66 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 122.836 2.358 . . . . 0.0 108.807 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.25 5.22 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 118.956 0.798 . . . . 0.0 112.575 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 151.79 39.5 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 126.361 1.865 . . . . 0.0 110.039 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.75 6.75 0.54 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.075 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.03 -58.13 3.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.9 pt 34.97 29.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 119.228 3.047 . . . . 0.0 119.228 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -162.98 156.61 19.98 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 119.941 -1.724 . . . . 0.0 106.874 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.88 -44.78 0.61 Allowed Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.671 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.26 -17.6 16.76 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 CA-C-N 125.962 3.165 . . . . 0.0 111.413 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.0 -14.77 24.05 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.478 1.111 . . . . 0.0 109.047 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.43 98.53 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.934 0.873 . . . . 0.0 111.766 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.41 -11.68 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.57 0.7 . . . . 0.0 109.769 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.13 -41.58 15.56 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.08 -27.95 60.13 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.714 -0.617 . . . . 0.0 111.02 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.6 p -66.97 -20.27 65.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.518 -1.364 . . . . 0.0 111.924 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.47 -18.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.291 1.037 . . . . 0.0 109.844 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -73.19 -42.05 63.13 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 120.367 -1.458 . . . . 0.0 108.337 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.3 t -85.32 -167.76 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 78.98 -31.16 0.14 Allowed 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 127.179 2.192 . . . . 0.0 111.115 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 p -66.27 -24.53 66.58 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 129.834 3.254 . . . . 0.0 110.191 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.358 28.7 p 64.29 37.49 8.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 129.696 3.198 . . . . 0.0 109.712 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.85 147.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 167.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.51 130.82 5.82 Favored Glycine 0 CA--C 1.474 -2.529 1 N-CA-C 95.085 -7.206 . . . . 0.0 95.085 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.493 ' CE2' ' HA2' ' B' ' 56' ' ' GLY . 7.2 t80 -87.51 -36.5 17.59 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.38 47.65 0.25 Allowed Glycine 0 CA--C 1.479 -2.186 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 168.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.99 -55.78 6.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.53 1.165 . . . . 0.0 108.448 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -112.81 171.19 7.68 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -140.12 110.88 7.16 Favored Pre-proline 0 N--CA 1.445 -0.715 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.07 175.49 11.09 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.451 2.768 . . . . 0.0 109.835 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 64' ' ' THR . 13.2 p -143.13 176.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -173.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 63' ' ' VAL . 3.3 m -63.48 -36.61 84.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 113.106 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.25 -27.94 61.86 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.77 0.828 . . . . 0.0 110.026 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -66.58 -30.43 70.73 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 123.577 1.656 . . . . 0.0 106.829 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 75.78 1.3 Allowed Glycine 0 CA--C 1.463 -3.174 1 N-CA-C 99.53 -5.428 . . . . 0.0 99.53 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -46.12 -13.77 0.02 OUTLIER 'General case' 0 C--N 1.367 1.342 0 C-N-CA 128.742 2.817 . . . . 0.0 114.22 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 72' ' ' GLU . 13.8 mtpp -54.19 -18.3 3.69 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 126.992 2.117 . . . . 0.0 114.131 162.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.88 -52.9 24.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-N 120.892 1.678 . . . . 0.0 107.442 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.43 80.32 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 118.386 0.539 . . . . 0.0 111.658 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 28.4 tt0 -52.48 -47.15 66.69 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 126.614 1.966 . . . . 0.0 111.449 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -62.68 -41.57 99.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.469 -0.769 . . . . 0.0 109.556 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.2 -36.17 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.09 0.556 . . . . 0.0 110.012 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.3 mtt -58.59 -53.12 61.9 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.296 0.638 . . . . 0.0 109.921 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.94 -40.11 96.64 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 122.931 0.492 . . . . 0.0 110.336 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.54 79.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.684 0.793 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.74 -45.17 59.69 Favored Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 124.75 1.166 . . . . 0.0 111.144 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -57.66 -45.83 86.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.237 1.015 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -57.31 -43.75 83.52 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.599 0.76 . . . . 0.0 110.562 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.92 -52.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 124.429 1.091 . . . . 0.0 109.451 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.15 -39.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 121.903 -0.498 . . . . 0.0 110.632 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.46 94.33 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 110.776 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.05 -33.38 75.3 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 124.771 1.228 . . . . 0.0 111.616 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.5 -18.08 13.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.806 1.242 . . . . 0.0 110.707 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -58.75 -22.99 59.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.05 -1.656 . . . . 0.0 112.134 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.17 -24.09 66.98 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.295 -1.503 . . . . 0.0 111.859 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.79 -43.08 11.51 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.008 0.923 . . . . 0.0 108.561 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.9 -39.58 94.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 122.006 0.907 . . . . 0.0 111.552 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -24.74 63.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.607 0.763 . . . . 0.0 112.294 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.9 t -90.72 -2.81 57.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.5 -41.49 72.57 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 120.534 1.516 . . . . 0.0 108.93 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' B' ' 91' ' ' THR . 7.2 p90 -70.45 -22.2 62.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.732 -1.23 . . . . 0.0 112.978 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.66 -24.98 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.301 1.04 . . . . 0.0 108.783 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -59.0 -19.4 43.15 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 125.626 1.57 . . . . 0.0 113.309 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -72.83 -28.17 62.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.862 -1.149 . . . . 0.0 109.234 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 CA--C 1.502 -0.904 0 O-C-N 120.944 -1.098 . . . . 0.0 108.634 -179.125 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 CA--C 1.497 -1.084 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 88' ' ' ALA . 10.9 p80 -55.45 -23.18 24.0 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -68.52 -28.38 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.278 -0.889 . . . . 0.0 109.246 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.42 -23.31 40.43 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.17 -0.956 . . . . 0.0 110.966 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -83.05 -41.5 18.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.22 76.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 112.024 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -61.75 -49.12 77.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.589 1.155 . . . . 0.0 109.784 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -64.56 -35.86 82.35 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.698 0.799 . . . . 0.0 110.551 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -44.74 94.69 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -63.55 -43.25 97.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.256 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 123.33 0.652 . . . . 0.0 110.062 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . 0.295 4.1 tt0 -77.13 -11.89 59.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.213 -0.929 . . . . 0.0 112.127 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -70.22 -35.04 73.6 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -60.35 -35.66 76.18 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.845 0.858 . . . . 0.0 110.736 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.7 -39.88 95.41 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.726 1.21 . . . . 0.0 109.923 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.05 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 O-C-N 121.379 -0.826 . . . . 0.0 109.526 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.56 -40.19 96.04 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.903 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.47 -44.29 78.94 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.117 -0.989 . . . . 0.0 109.532 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.87 -39.15 90.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.758 1.223 . . . . 0.0 110.477 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.27 77.22 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 126.025 1.73 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -66.43 -44.1 83.81 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.3 1.04 . . . . 0.0 110.197 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -65.44 -53.72 38.83 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.49 1.116 . . . . 0.0 108.68 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -57.39 -48.6 78.65 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.699 1.199 . . . . 0.0 110.698 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 -41.86 65.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 125.057 1.343 . . . . 0.0 111.666 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.22 -47.08 82.6 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.797 -1.189 . . . . 0.0 107.949 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.34 -1.89 38.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.06 -1.025 . . . . 0.0 110.918 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.505 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -69.91 -47.76 61.23 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 109.594 176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -80.06 -110.93 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 71.18 -33.34 0.27 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.754 2.022 . . . . 0.0 113.515 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.15 41.05 0.38 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.07 153.86 39.03 Favored Pre-proline 0 C--N 1.35 0.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.75 123.21 3.21 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 C-N-CA 123.265 2.643 . . . . 0.0 111.43 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 23.0 53.05 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.94 33.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 126.851 2.061 . . . . 0.0 111.157 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -37.63 0.22 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.873 0.469 . . . . 0.0 110.528 -172.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.98 60.32 4.76 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-O 124.011 1.862 . . . . 0.0 107.865 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.72 -14.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 O-C-N 120.051 -1.656 . . . . 0.0 112.255 -168.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -99.2 132.41 44.53 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.061 -1.649 . . . . 0.0 112.399 -167.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.36 -54.41 11.4 Favored Pre-proline 0 C--N 1.351 0.644 0 CA-C-O 116.619 -1.658 . . . . 0.0 109.606 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.89 -13.07 24.14 Favored 'Trans proline' 0 CA--C 1.508 -0.815 0 CA-C-N 125.552 3.018 . . . . 0.0 111.297 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.51 -10.83 26.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.62 95.07 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.97 -28.72 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 123.989 0.916 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -37.87 62.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.117 0.967 . . . . 0.0 108.793 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -66.69 -43.17 85.11 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.779 0.831 . . . . 0.0 109.475 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 42.0 m -53.53 -30.4 41.47 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.988 1.315 . . . . 0.0 113.572 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.34 -34.87 51.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.435 1.094 . . . . 0.0 110.715 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -77.81 -36.46 50.25 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.842 -1.161 . . . . 0.0 113.174 -171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -77.26 -37.32 53.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -166.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.11 -26.8 64.14 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.522 -0.736 . . . . 0.0 112.071 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -89.23 7.43 35.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p 55.08 64.07 1.91 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.62 1.568 . . . . 0.0 111.778 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.71 -106.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 57' ' ' TYR . . . 98.4 76.55 1.28 Allowed Glycine 0 CA--C 1.484 -1.866 0 N-CA-C 104.634 -3.387 . . . . 0.0 104.634 -174.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -35.78 58.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.65 -0.912 . . . . 0.0 108.911 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 39.45 0.73 Allowed Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.42 ' HB2' HH12 ' C' ' 68' ' ' ARG . 6.5 t70 -77.72 -51.23 10.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 118.554 1.177 . . . . 0.0 108.69 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.32 160.16 38.78 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -130.79 114.45 16.62 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.62 173.08 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.582 2.854 . . . . 0.0 109.349 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.25 -112.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.021 0.929 . . . . 0.0 110.735 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.0 m -136.33 -41.16 0.64 Allowed 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.658 -1.276 . . . . 0.0 108.627 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -81.72 -2.67 51.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.202 -0.936 . . . . 0.0 109.277 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -79.08 -29.52 43.42 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.01 69.66 1.26 Allowed Glycine 0 CA--C 1.47 -2.77 0 N-CA-C 103.795 -3.722 . . . . 0.0 103.795 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -36.03 -18.49 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.444 3.498 . . . . 0.0 116.869 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -53.12 -17.57 1.66 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 119.988 -1.695 . . . . 0.0 113.132 158.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.13 -46.29 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 119.56 -1.962 . . . . 0.0 108.756 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.61 -48.73 63.37 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.59 -47.05 77.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.38 1.072 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -69.85 -37.82 76.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.307 -0.871 . . . . 0.0 112.356 -173.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.35 -43.73 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ttp -62.14 -51.03 69.5 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.298 1.039 . . . . 0.0 110.537 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.31 -30.96 70.95 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.631 0.772 . . . . 0.0 110.044 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.5 73.88 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.331 -0.856 . . . . 0.0 111.12 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.19 85.95 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 mt -60.61 -45.29 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 C-N-CA 124.307 1.043 . . . . 0.0 109.562 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -29.27 70.35 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.111 -0.993 . . . . 0.0 112.078 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.08 -54.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -62.52 -42.19 99.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.728 0.811 . . . . 0.0 110.69 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.11 79.25 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.079 1.352 . . . . 0.0 111.158 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tt -66.77 -34.18 77.27 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.109 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.07 -10.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 124.451 1.101 . . . . 0.0 110.236 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 8.4 m -60.7 -22.98 64.51 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 119.303 -2.123 . . . . 0.0 111.49 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.65 69.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.327 -1.483 . . . . 0.0 111.811 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.469 ' HA ' ' CG ' ' B' ' 4' ' ' HIS . . . -80.27 -45.63 17.6 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.12 -37.8 88.65 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 124.5 1.12 . . . . 0.0 111.795 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.61 65.75 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.598 -0.688 . . . . 0.0 112.202 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -91.5 -6.58 52.35 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.603 -1.311 . . . . 0.0 109.291 176.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.299 0.2 OUTLIER -79.12 -12.38 60.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 120.402 1.455 . . . . 0.0 110.616 -167.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.44 -31.75 54.08 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 168.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.53 -22.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.895 1.278 . . . . 0.0 108.672 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -55.62 -24.79 35.4 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.951 1.7 . . . . 0.0 112.18 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -64.19 -22.02 66.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 120.828 -1.17 . . . . 0.0 110.894 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.5 -0.96 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 -178.891 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.505 -0.774 0 CA-C-O 122.452 1.12 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.553 ' HE1' ' OD1' ' C' ' 92' ' ' ASP . 0.6 OUTLIER -176.09 -37.97 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.89 2.076 . . . . 0.0 105.486 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.17 -35.82 74.24 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.131 0.967 . . . . 0.0 110.325 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -58.27 -36.04 72.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.473 1.909 . . . . 0.0 111.389 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.94 -42.42 39.35 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.196 1.398 . . . . 0.0 108.513 -176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.44 85.62 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.302 1.041 . . . . 0.0 110.889 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.27 -37.53 87.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.391 1.476 . . . . 0.0 110.697 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -67.57 -36.03 80.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.009 0.924 . . . . 0.0 109.154 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.92 97.39 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.998 0.919 . . . . 0.0 111.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.66 -27.84 68.66 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 121.235 -0.915 . . . . 0.0 112.435 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.31 -35.73 81.89 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.671 -1.268 . . . . 0.0 109.542 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.74 -44.51 93.76 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.48 -44.05 92.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.034 0.534 . . . . 0.0 110.88 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.35 -40.13 74.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.769 0.827 . . . . 0.0 112.339 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -73.69 -28.53 61.79 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 120.872 -1.142 . . . . 0.0 111.044 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.05 -37.26 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.01 -49.09 69.65 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.085 0.954 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.71 -45.96 91.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.852 0.751 . . . . 0.0 111.672 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -42.71 82.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.715 -0.615 . . . . 0.0 109.99 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.43 84.3 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.963 1.305 . . . . 0.0 111.651 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -62.86 -50.27 71.6 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.977 1.311 . . . . 0.0 109.593 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -67.2 -40.37 86.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -62.0 -48.88 78.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.384 1.074 . . . . 0.0 110.724 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.34 72.66 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 111.824 -173.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.79 -42.39 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 O-C-N 122.204 -0.31 . . . . 0.0 110.396 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.17 -23.63 60.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 120.365 -1.459 . . . . 0.0 112.148 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.55 69.7 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.361 1.464 . . . . 0.0 107.983 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.92 -28.21 63.33 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.739 0.78 . . . . 0.0 111.001 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.34 95.87 1.07 Allowed 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.618 -1.301 . . . . 0.0 110.378 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.0 -11.56 6.54 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.76 142.83 26.12 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 118.272 1.036 . . . . 0.0 109.061 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.54 129.72 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.407 2.071 . . . . 0.0 112.064 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.88 45.01 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 141.69 31.25 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.494 2.318 . . . . 0.0 112.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.89 -45.21 2.59 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.78 65.88 5.92 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 123.018 1.39 . . . . 0.0 109.449 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -96.79 -10.87 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 O-C-N 119.851 -1.781 . . . . 0.0 111.447 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.3 m -98.71 127.23 44.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.514 -0.741 . . . . 0.0 109.668 -169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.84 -52.19 65.87 Favored Pre-proline 0 N--CA 1.445 -0.712 0 C-N-CA 126.148 1.779 . . . . 0.0 112.187 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.75 -8.41 20.31 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 CA-C-N 125.086 2.852 . . . . 0.0 111.624 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.79 -25.97 20.82 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.55 76.16 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.624 0.77 . . . . 0.0 111.348 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.2 -25.23 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 124.609 1.163 . . . . 0.0 110.411 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -79.57 -44.68 20.62 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 119.737 -1.852 . . . . 0.0 107.164 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.03 -37.5 87.43 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.176 0.991 . . . . 0.0 110.547 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -67.59 -35.34 78.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.025 -1.672 . . . . 0.0 111.519 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.26 -51.99 66.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.293 1.037 . . . . 0.0 109.554 -178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.75 -30.81 65.99 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.487 -0.758 . . . . 0.0 110.727 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 80.5 m -62.82 -36.35 82.89 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.955 -1.09 . . . . 0.0 110.783 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -16.05 63.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 120.632 -1.292 . . . . 0.0 113.036 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -89.34 -3.99 58.26 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.458 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.314 11.3 p 68.41 2.09 3.19 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 127.343 2.257 . . . . 0.0 112.66 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.81 -53.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.38 1.472 . . . . 0.0 107.418 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.34 -62.02 4.68 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 74.4 -44.95 0.57 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.798 2.839 . . . . 0.0 109.914 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.57 40.0 0.55 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 107.157 -2.377 . . . . 0.0 107.157 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.55 -55.73 9.33 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.503 1.151 . . . . 0.0 108.275 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -149.25 168.34 23.56 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -134.88 126.71 17.98 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -165.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.52 172.19 13.78 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 123.368 2.712 . . . . 0.0 109.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -93.37 -106.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.306 1.042 . . . . 0.0 113.641 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 18.7 m -155.86 -38.44 0.08 Allowed 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 119.013 -2.304 . . . . 0.0 106.411 -171.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -91.52 10.26 28.59 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 120.851 -1.156 . . . . 0.0 109.084 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -42.16 67.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.56 91.38 1.91 Allowed Glycine 0 N--CA 1.418 -2.537 1 N-CA-C 96.662 -6.575 . . . . 0.0 96.662 -170.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.42 HH12 ' HB2' ' B' ' 59' ' ' ASP . 24.9 ttm180 -65.87 -11.52 47.4 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.04 1.92 . . . . 0.0 110.388 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -46.14 -23.87 0.38 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.456 1.902 . . . . 0.0 113.971 159.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.84 -41.61 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 119.99 -1.694 . . . . 0.0 109.385 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.98 61.76 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -49.8 -49.19 49.6 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 126.236 1.814 . . . . 0.0 111.55 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -44.51 90.05 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.188 0.995 . . . . 0.0 111.813 -173.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.28 -37.92 60.17 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.415 -0.803 . . . . 0.0 109.252 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 73.7 mtm -66.36 -44.77 82.25 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 123.359 0.664 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -59.01 -43.1 91.49 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 123.846 0.858 . . . . 0.0 110.631 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.13 96.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.022 0.529 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.85 91.89 Favored Glycine 0 CA--C 1.493 -1.333 0 C-N-CA 123.905 0.764 . . . . 0.0 111.546 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.25 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 109.017 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.25 -37.97 86.76 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.634 -0.666 . . . . 0.0 111.674 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.57 -53.56 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 119.298 0.953 . . . . 0.0 110.054 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.07 -34.23 76.04 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 122.857 0.463 . . . . 0.0 110.71 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.12 65.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.915 -1.115 . . . . 0.0 110.489 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.03 -32.1 73.38 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 120.647 -1.283 . . . . 0.0 111.481 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.93 -1.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 120.99 -1.069 . . . . 0.0 112.271 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -58.65 -18.06 27.51 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 111.181 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.0 68.44 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.563 -1.336 . . . . 0.0 112.123 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.87 -44.62 16.61 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.317 -0.864 . . . . 0.0 108.857 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.4 -40.62 95.07 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.331 1.053 . . . . 0.0 111.633 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.25 99.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.471 0.708 . . . . 0.0 111.312 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -17.78 64.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 120.924 -1.11 . . . . 0.0 113.303 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.553 ' OD1' ' HE1' ' C' ' 4' ' ' HIS . 1.3 m-20 -74.7 -20.07 60.0 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 119.907 1.231 . . . . 0.0 111.028 -167.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -82.41 -31.83 29.39 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.035 -1.04 . . . . 0.0 110.519 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.04 -19.96 26.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.371 1.468 . . . . 0.0 109.382 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -65.17 -15.51 62.51 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 120.319 -1.488 . . . . 0.0 111.543 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -72.36 -14.01 61.62 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.129 -1.607 . . . . 0.0 111.48 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--N 1.355 0.819 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -170.368 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . 0.308 3.3 m-20 67.9 -35.08 0.26 Allowed 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 131.358 3.863 . . . . 0.0 111.807 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -68.57 -22.54 64.47 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.856 -1.153 . . . . 0.0 112.528 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.89 -45.77 92.3 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 122.191 0.996 . . . . 0.0 108.845 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -67.1 -38.53 85.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 124.409 1.084 . . . . 0.0 110.142 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.14 -35.39 69.07 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.956 -0.465 . . . . 0.0 109.893 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.68 86.69 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 121.693 -0.63 . . . . 0.0 110.104 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -60.97 -39.71 90.61 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.625 1.57 . . . . 0.0 111.473 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.09 -30.31 62.29 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.358 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.76 79.2 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.822 -1.174 . . . . 0.0 110.982 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.02 -35.92 82.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.596 -0.69 . . . . 0.0 111.966 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.76 -42.82 81.16 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.766 1.226 . . . . 0.0 108.334 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -55.83 -45.13 78.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 125.576 1.55 . . . . 0.0 109.839 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.78 -36.83 79.96 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.542 -0.724 . . . . 0.0 112.348 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -65.01 -34.91 79.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.65 0.78 . . . . 0.0 109.988 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -75.59 -29.3 59.23 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 120.839 -1.163 . . . . 0.0 110.513 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.05 -47.82 52.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.27 -31.84 73.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.512 -0.742 . . . . 0.0 110.445 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -67.39 -43.51 81.15 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.797 -1.189 . . . . 0.0 111.064 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.48 -39.93 95.75 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.82 -1.175 . . . . 0.0 110.456 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.26 -25.6 68.13 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.31 -0.868 . . . . 0.0 112.343 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -66.09 -42.59 89.14 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.389 1.076 . . . . 0.0 111.021 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -66.54 -34.83 78.78 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.471 1.109 . . . . 0.0 108.461 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -74.41 -50.49 18.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 118.273 -0.87 . . . . 0.0 108.722 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.11 -41.8 75.81 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 126.83 2.052 . . . . 0.0 113.166 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.82 -31.12 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 O-C-N 120.722 -1.236 . . . . 0.0 110.896 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 -34.11 22.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.69 47.2 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 0.0 109.373 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.37 -36.5 71.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 120.997 0.427 . . . . 0.0 111.191 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.02 106.53 1.63 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 120.024 -1.673 . . . . 0.0 111.568 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.41 -25.13 4.32 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.94 153.81 75.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 123.657 0.783 . . . . 0.0 110.979 -170.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -80.43 135.78 10.78 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.312 2.008 . . . . 0.0 109.988 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.64 14.07 74.14 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.0 135.0 56.28 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.01 1.724 . . . . 0.0 111.725 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.82 -31.08 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.984 1.314 . . . . 0.0 109.047 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' D' ' 60' ' ' ARG . 4.6 tt -86.72 121.97 29.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.246 1.418 . . . . 0.0 109.103 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 pt -148.88 175.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 73.3 m 67.13 122.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.212 2.205 . . . . 0.0 113.662 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.9 -50.5 87.65 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 116.815 -1.564 . . . . 0.0 113.189 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.61 -11.93 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 124.459 2.628 . . . . 0.0 111.525 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.56 -37.85 14.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.6 83.59 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.939 1.696 . . . . 0.0 112.207 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -64.8 -31.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.47 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.69 -18.25 41.58 Favored 'General case' 0 N--CA 1.437 -1.108 0 O-C-N 120.674 -1.266 . . . . 0.0 110.878 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -72.01 -43.47 65.0 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -66.03 -26.11 67.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 121.33 -0.856 . . . . 0.0 113.202 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.4 -36.18 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 C-N-CA 124.403 1.081 . . . . 0.0 111.351 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.61 -5.9 57.87 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.649 -1.282 . . . . 0.0 110.133 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.43 HG22 ' H ' ' D' ' 52' ' ' ALA . 23.7 m -96.95 177.72 5.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 174.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.43 ' H ' HG22 ' D' ' 51' ' ' THR . . . 80.96 -41.12 0.16 Allowed 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.328 1.451 . . . . 0.0 110.208 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.6 p -85.33 3.54 39.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.982 1.713 . . . . 0.0 111.939 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p 59.24 53.68 5.23 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 126.095 1.758 . . . . 0.0 112.314 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.28 -99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.13 106.22 0.5 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 106.78 -2.528 . . . . 0.0 106.78 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -86.88 -15.64 38.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.747 -1.443 . . . . 0.0 109.233 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.84 28.6 5.27 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -65.57 -56.21 13.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' D' ' 38' ' ' LEU . 88.5 mtt-85 -137.2 156.97 47.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -128.49 149.92 73.04 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 101.206 -3.628 . . . . 0.0 101.206 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.26 152.06 3.72 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 123.313 2.676 . . . . 0.0 110.057 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.486 HG22 ' H ' ' D' ' 64' ' ' THR . 3.1 p -109.32 -179.59 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 122.328 1.061 . . . . 0.0 109.09 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.486 ' H ' HG22 ' D' ' 63' ' ' VAL . 4.9 m -62.63 -49.13 76.39 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.18 2.192 . . . . 0.0 113.913 -167.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -83.64 -0.0 48.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.744 1.218 . . . . 0.0 110.019 -167.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -28.19 67.41 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 123.745 1.736 . . . . 0.0 106.674 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 75.17 1.27 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 99.973 -5.251 . . . . 0.0 99.973 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.26 8.4 mtm180 -55.18 -2.35 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 126.104 1.762 . . . . 0.0 114.92 -169.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HG3' ' D' ' 72' ' ' GLU . 94.1 mttt -67.82 -0.77 4.5 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.828 1.251 . . . . 0.0 112.984 160.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.23 -59.82 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.81 -56.24 17.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 114.647 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' D' ' 69' ' ' LYS 0.302 1.5 pp20? -68.38 -26.63 65.67 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.313 -0.867 . . . . 0.0 111.551 -172.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -67.54 -31.08 70.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.613 -0.679 . . . . 0.0 110.777 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.15 -45.27 86.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.1 mtp -64.99 -46.54 81.0 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.662 0.785 . . . . 0.0 110.056 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -63.76 -37.89 89.06 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.222 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.57 91.62 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.396 0.617 . . . . 0.0 110.939 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.59 -41.52 89.69 Favored Glycine 0 CA--C 1.489 -1.588 0 O-C-N 121.615 -0.678 . . . . 0.0 112.469 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.47 -47.35 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.919 0.888 . . . . 0.0 109.709 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.27 -26.14 61.87 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.101 -0.999 . . . . 0.0 111.934 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 t -64.64 -50.91 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.82 -2.87 32.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.527 -0.733 . . . . 0.0 111.397 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -30.94 13.01 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.067 0.947 . . . . 0.0 109.491 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.84 -33.97 75.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.617 -1.302 . . . . 0.0 109.83 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -62.69 -12.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.183 0.993 . . . . 0.0 111.899 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 21.3 m -68.26 -14.87 63.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 120.337 -1.477 . . . . 0.0 111.73 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -16.39 64.19 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 120.007 -1.683 . . . . 0.0 111.31 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.82 -49.33 7.18 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 62.9 mt -60.39 -35.54 75.98 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.652 1.181 . . . . 0.0 112.085 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 120.924 -1.11 . . . . 0.0 112.435 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -4.45 55.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 120.777 -1.202 . . . . 0.0 108.415 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.9 -32.17 67.14 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 119.382 0.992 . . . . 0.0 109.454 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -75.84 -28.59 58.29 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.379 -1.45 . . . . 0.0 111.079 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 t -70.55 -17.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 108.74 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -59.1 -22.21 60.47 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 125.656 1.582 . . . . 0.0 111.606 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -60.66 -33.0 72.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 123.013 1.387 . . . . 0.0 110.242 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 103.25 -2.871 . . . . 0.0 103.25 -161.129 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.826 0 CA-C-O 121.822 0.82 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -157.03 -74.17 0.09 Allowed 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 23.4 p-80 -58.4 -35.59 72.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 129.456 3.102 . . . . 0.0 112.313 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.477 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 7.7 mt-10 -68.21 -32.66 73.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.113 0.965 . . . . 0.0 111.498 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -65.61 -40.0 92.15 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.72 -31.89 68.9 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.74 0.816 . . . . 0.0 109.636 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.58 -43.05 70.21 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.544 0.738 . . . . 0.0 109.981 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -68.27 -35.98 78.7 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.914 -0.491 . . . . 0.0 110.305 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.71 -40.12 78.8 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.689 1.196 . . . . 0.0 110.889 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.45 94.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.729 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -64.67 -28.0 69.31 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.427 -0.796 . . . . 0.0 111.608 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.72 -35.94 72.97 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.789 -1.194 . . . . 0.0 110.246 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -68.15 -38.48 82.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.28 -38.71 84.43 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.309 -0.869 . . . . 0.0 111.747 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -71.18 -27.05 63.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 121.403 -0.811 . . . . 0.0 111.458 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -72.17 -39.14 68.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.443 -0.786 . . . . 0.0 109.488 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.2 -34.57 64.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.568 1.147 . . . . 0.0 109.792 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.95 -48.04 82.93 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.926 -1.109 . . . . 0.0 111.342 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.49 -42.51 87.33 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.808 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.28 -49.18 78.64 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 110.072 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.69 88.24 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 125.732 1.613 . . . . 0.0 111.243 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -43.47 98.81 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.588 0.755 . . . . 0.0 111.103 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -66.08 -40.73 91.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 124.398 1.079 . . . . 0.0 108.916 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -76.27 -44.66 36.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.699 -0.626 . . . . 0.0 111.18 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.6 95.54 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.665 1.586 . . . . 0.0 111.09 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.82 -38.05 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 122.189 -0.319 . . . . 0.0 110.212 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.283 89.0 mt-10 -67.98 -40.03 83.19 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.022 -1.049 . . . . 0.0 109.352 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.02 -47.3 85.38 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.76 1.624 . . . . 0.0 109.613 -171.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.15 -8.62 59.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 121.666 -0.646 . . . . 0.0 111.929 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HD2' HG23 ' A' ' 39' ' ' ILE . 34.9 tpt85 -76.17 80.95 2.98 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.081 -1.637 . . . . 0.0 110.141 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.65 -13.74 5.84 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.89 150.08 97.71 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 118.124 0.962 . . . . 0.0 109.903 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' O ' HG11 ' A' ' 63' ' ' VAL . 37.3 Cg_endo -75.55 147.76 32.35 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 121.984 1.79 . . . . 0.0 108.525 -177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 4.21 64.86 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 120.192 1.36 . . . . 0.0 113.957 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 159.44 27.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.755 0.822 . . . . 0.0 111.736 -171.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.96 -32.32 0.8 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.137 0.975 . . . . 0.0 109.78 -171.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.12 40.73 0.72 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 123.828 1.775 . . . . 0.0 109.392 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG23 ' HD2' ' A' ' 31' ' ' ARG . 7.9 mt -86.66 72.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 O-C-N 119.158 -2.214 . . . . 0.0 105.388 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -158.06 -120.37 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 116.553 -1.689 . . . . 0.0 107.041 -168.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.6 t80 178.23 -64.28 0.0 OUTLIER Pre-proline 0 C--N 1.359 1.0 0 CA-C-N 121.052 1.751 . . . . 0.0 110.355 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -75.14 -8.46 19.92 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 CA-C-N 125.515 3.005 . . . . 0.0 111.887 -167.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -10.18 28.33 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 129.662 3.185 . . . . 0.0 107.136 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -48.7 51.31 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.13 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.3 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -17.51 60.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.498 -1.376 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -86.29 -39.21 16.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.23 -38.3 76.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.745 -1.222 . . . . 0.0 111.726 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.57 -25.85 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.695 1.198 . . . . 0.0 110.824 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.99 -23.03 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.976 -1.078 . . . . 0.0 110.809 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -107.47 -22.85 12.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 -165.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.2 64.17 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.372 -1.455 . . . . 0.0 111.999 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.95 2.35 51.86 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.919 1.288 . . . . 0.0 110.578 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.252 9.6 p 56.67 63.09 2.05 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.34 1.856 . . . . 0.0 111.261 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 56' ' ' GLY . 2.6 t -145.79 -164.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -177.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 156.67 101.72 0.19 Allowed Glycine 0 CA--C 1.475 -2.459 1 N-CA-C 100.191 -5.164 . . . . 0.0 100.191 -177.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.89 -26.87 29.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.3 33.57 1.6 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' CG ' HH22 ' B' ' 68' ' ' ARG . 30.8 t70 -83.67 -26.46 29.84 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.434 -1.039 . . . . 0.0 109.418 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -179.58 4.69 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -158.7 114.99 1.67 Allowed Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.71 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.697 2.932 . . . . 0.0 109.417 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 34' ' ' PRO . 3.5 t -106.36 -120.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.909 0.883 . . . . 0.0 110.372 -173.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -141.67 -36.28 0.43 Allowed 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -89.41 9.97 24.31 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 120.881 -1.137 . . . . 0.0 108.187 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -43.92 63.21 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.44 90.92 2.03 Favored Glycine 0 N--CA 1.417 -2.594 1 N-CA-C 96.397 -6.681 . . . . 0.0 96.397 -172.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.407 HH12 ' HB2' ' D' ' 59' ' ' ASP . 22.6 ttm180 -64.36 -12.03 38.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 119.364 1.582 . . . . 0.0 111.081 -172.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -46.95 -28.97 1.8 Allowed 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.002 0.921 . . . . 0.0 113.215 162.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.8 t -66.92 -39.4 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 0.0 110.133 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.48 -50.46 18.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 120.951 -1.093 . . . . 0.0 108.42 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -50.81 -44.5 59.05 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.612 1.565 . . . . 0.0 111.998 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -65.64 -36.02 82.48 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.416 0.686 . . . . 0.0 110.148 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.38 -42.59 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.9 mtt -59.79 -50.89 72.03 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.243 1.017 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -64.55 -38.27 90.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.149 0.98 . . . . 0.0 110.83 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.08 96.55 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.188 0.595 . . . . 0.0 110.518 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.69 -48.72 79.21 Favored Glycine 0 CA--C 1.49 -1.522 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.36 -47.48 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.387 1.075 . . . . 0.0 109.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.72 -39.92 95.48 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 120.929 -1.107 . . . . 0.0 111.397 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 t -64.22 -52.89 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.738 0.815 . . . . 0.0 109.851 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.26 -41.22 94.45 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 110.499 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.13 -30.9 71.48 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 123.565 0.746 . . . . 0.0 111.019 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.57 -30.38 69.99 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.059 -1.026 . . . . 0.0 110.852 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.3 t -59.87 -18.44 15.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 124.375 1.07 . . . . 0.0 110.582 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 m -56.42 -27.71 57.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.248 1.419 . . . . 0.0 112.739 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.04 -28.28 64.36 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.485 1.114 . . . . 0.0 111.376 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 4' ' ' HIS . . . -89.05 -45.92 9.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.088 0.955 . . . . 0.0 109.495 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.7 mt -49.62 -46.71 49.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.476 1.91 . . . . 0.0 113.434 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.82 42.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.756 -1.215 . . . . 0.0 111.222 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.8 p -64.11 -6.14 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.381 1.072 . . . . 0.0 113.259 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.36 -74.79 0.14 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.31 0.93 57.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.439 -1.413 . . . . 0.0 112.347 -168.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.68 -29.52 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 O-C-N 119.761 -1.837 . . . . 0.0 108.761 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -59.5 -18.08 37.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.001 1.32 . . . . 0.0 113.2 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -52.22 -35.46 49.47 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.28 1.432 . . . . 0.0 111.593 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -175.437 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 CA--C 1.506 -0.736 0 CA-C-O 123.15 1.453 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 37.3 p-80 -72.02 -28.92 63.69 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.159 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.62 -43.05 23.61 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.32 -37.47 87.4 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.962 -0.461 . . . . 0.0 110.32 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.35 -34.83 65.83 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.979 0.418 . . . . 0.0 110.036 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.28 78.59 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 123.674 0.79 . . . . 0.0 110.287 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -77.97 -11.98 59.95 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.633 -0.667 . . . . 0.0 111.452 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -77.77 -29.34 50.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 121.394 -0.816 . . . . 0.0 109.349 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.62 87.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.41 -23.48 63.71 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.693 0.797 . . . . 0.0 111.905 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -72.28 -44.66 62.44 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.931 -1.106 . . . . 0.0 108.161 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.81 -33.75 76.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.693 1.197 . . . . 0.0 109.818 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.02 -45.58 82.99 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 111.913 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.13 -38.89 90.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.286 1.034 . . . . 0.0 109.916 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -63.48 -41.21 98.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.011 0.924 . . . . 0.0 111.382 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.52 -48.41 47.2 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 124.175 0.99 . . . . 0.0 110.372 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.71 -35.22 80.36 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -65.51 -39.03 91.36 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.795 -1.191 . . . . 0.0 110.929 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.79 -37.62 86.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.437 -1.415 . . . . 0.0 109.217 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.62 66.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 123.387 0.675 . . . . 0.0 111.841 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.5 p -66.93 -39.01 87.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 118.767 0.712 . . . . 0.0 110.694 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.34 -46.03 81.88 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.45 -43.14 99.53 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.621 1.169 . . . . 0.0 108.936 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.99 84.64 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.147 1.379 . . . . 0.0 113.279 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.88 -47.78 91.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-O 121.88 0.847 . . . . 0.0 109.502 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -79.96 -20.79 44.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 O-C-N 121.663 -0.648 . . . . 0.0 110.673 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -51.43 22.74 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 125.9 1.68 . . . . 0.0 109.664 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 -18.37 55.35 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.834 -0.542 . . . . 0.0 111.869 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.51 87.67 1.2 Allowed 'General case' 0 C--N 1.353 0.754 0 O-C-N 119.973 -1.704 . . . . 0.0 110.107 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.31 -11.46 3.27 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' B' ' 36' ' ' ALA . . . -88.4 143.77 32.92 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 118.398 1.099 . . . . 0.0 111.69 -170.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.18 125.19 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.359 2.706 . . . . 0.0 111.636 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 23.28 68.0 Favored Glycine 0 CA--C 1.495 -1.206 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' B' ' 33' ' ' ALA . . . -78.19 167.11 21.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.157 1.383 . . . . 0.0 109.524 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.58 -39.51 1.28 Allowed 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.222 0.609 . . . . 0.0 109.615 -166.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -94.78 130.57 41.28 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.6 pt -140.56 6.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 O-C-N 120.81 -1.182 . . . . 0.0 111.124 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.9 138.51 26.99 Favored 'General case' 0 CA--C 1.499 -0.99 0 O-C-N 119.944 -1.723 . . . . 0.0 109.502 -161.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -52.98 65.83 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 126.234 1.813 . . . . 0.0 113.347 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.19 -15.28 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 123.732 2.369 . . . . 0.0 111.827 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.86 -40.39 14.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.16 86.19 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 124.891 1.277 . . . . 0.0 111.886 -170.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.42 -38.73 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 122.749 0.419 . . . . 0.0 110.338 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -38.5 72.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.658 -0.651 . . . . 0.0 110.172 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.49 -43.0 99.88 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-O 122.157 0.979 . . . . 0.0 109.796 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 55.9 m -63.58 -30.61 71.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.517 -1.364 . . . . 0.0 113.006 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.36 -53.8 43.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 123.687 0.795 . . . . 0.0 109.622 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.91 -18.18 60.45 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 121.35 -0.844 . . . . 0.0 111.89 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -69.49 -36.81 76.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.454 0.702 . . . . 0.0 109.19 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.49 71.3 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.147 0.979 . . . . 0.0 111.664 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -82.97 3.4 30.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.358 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p 55.49 53.17 10.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.889 1.676 . . . . 0.0 112.574 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.71 -69.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.91 80.19 0.25 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -62.61 -43.29 99.19 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.463 1.125 . . . . 0.0 108.499 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.48 -120.67 0.99 Allowed Glycine 0 CA--C 1.48 -2.127 1 N-CA-C 102.043 -4.423 . . . . 0.0 102.043 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.341 0.2 OUTLIER 66.08 -64.05 0.22 Allowed 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 127.241 2.216 . . . . 0.0 114.594 -177.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -132.88 166.71 21.69 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -160.19 135.97 6.05 Favored Pre-proline 0 N--CA 1.436 -1.145 0 CA-C-O 117.391 -1.29 . . . . 0.0 107.536 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.45 151.04 15.23 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.967 2.445 . . . . 0.0 110.801 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' B' ' 66' ' ' GLU . 2.8 t -92.77 -119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 124.524 1.13 . . . . 0.0 109.145 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 13.4 p -113.93 -43.93 3.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.285 -1.51 . . . . 0.0 111.813 -166.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -83.03 -23.63 33.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.745 1.618 . . . . 0.0 108.041 -163.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' B' ' 63' ' ' VAL . 1.2 pm0 -68.23 -14.62 63.12 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.592 1.957 . . . . 0.0 110.169 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.65 87.85 0.39 Allowed Glycine 0 CA--C 1.481 -2.087 1 N-CA-C 103.055 -4.018 . . . . 0.0 103.055 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.502 HH22 ' CG ' ' A' ' 59' ' ' ASP . 36.9 ttm180 -58.27 -21.21 47.73 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.59 -1.535 . . . . 0.0 111.872 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -55.86 -15.75 3.71 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.43 -43.73 97.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 O-C-N 120.722 -1.236 . . . . 0.0 108.729 172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.04 -43.68 67.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.403 0.681 . . . . 0.0 109.601 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.13 -39.85 69.89 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.819 1.648 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' B' ' 73' ' ' GLN . 0.6 OUTLIER -64.52 -40.52 95.78 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.035 1.334 . . . . 0.0 110.703 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.93 -43.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.8 mtt -57.84 -49.92 75.05 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.096 0.958 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.17 90.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.668 -0.645 . . . . 0.0 111.157 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.5 98.78 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.877 1.227 . . . . 0.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.59 -43.38 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 121.641 -0.917 . . . . 0.0 108.927 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.24 -31.95 70.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.914 -1.116 . . . . 0.0 113.262 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.96 -41.06 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 120.058 1.299 . . . . 0.0 110.607 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.14 -38.58 75.53 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.617 0.644 . . . . 0.0 109.428 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.83 69.86 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.103 -0.998 . . . . 0.0 111.363 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.01 -15.46 63.48 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.546 -1.347 . . . . 0.0 111.207 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -5.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.5 -1.375 . . . . 0.0 110.157 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 14.8 t -49.58 -26.01 3.21 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 119.602 -1.936 . . . . 0.0 113.048 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.63 -36.49 71.9 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.975 1.31 . . . . 0.0 110.893 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.59 -41.45 23.97 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.305 1.042 . . . . 0.0 108.46 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.44 -42.15 96.16 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 120.788 -1.195 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.84 -1.61 23.04 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.897 -1.127 . . . . 0.0 111.731 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 44.4 p -85.72 -42.1 14.54 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.92 -25.23 52.68 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.789 0.804 . . . . 0.0 110.666 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.96 -50.04 37.54 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 126.736 2.015 . . . . 0.0 111.693 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.61 -30.4 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.749 1.22 . . . . 0.0 109.418 -171.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -58.67 -12.28 4.02 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.371 1.068 . . . . 0.0 112.964 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -54.98 -33.92 62.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.394 -0.816 . . . . 0.0 111.126 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -175.046 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.507 -0.68 0 CA-C-O 121.759 0.79 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -79.85 -19.96 47.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.1 0.96 . . . . 0.0 112.165 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -30.76 62.85 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -61.63 -39.8 92.59 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.078 0.951 . . . . 0.0 110.827 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -32.17 73.49 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.346 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' C' ' 85' ' ' VAL . . . -71.69 -35.1 70.15 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 123.482 0.713 . . . . 0.0 110.975 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.15 -33.34 73.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -63.35 -34.3 77.41 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.031 1.733 . . . . 0.0 110.28 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.94 -37.35 81.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.7 -15.56 62.21 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.975 -1.078 . . . . 0.0 111.873 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -69.95 -42.81 72.72 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.48 -1.388 . . . . 0.0 109.034 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.0 -35.78 81.82 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.32 0.648 . . . . 0.0 110.803 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -42.91 88.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.54 -35.14 78.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.331 -0.856 . . . . 0.0 111.706 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -60.16 -46.5 89.47 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.089 1.356 . . . . 0.0 110.058 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.7 -39.07 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.195 0.998 . . . . 0.0 109.819 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.81 -45.32 82.34 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.299 0.954 . . . . 0.0 111.925 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.77 -38.08 79.79 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 122.971 0.508 . . . . 0.0 110.851 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -74.33 -39.89 62.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.78 -1.2 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.17 74.58 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 124.883 1.273 . . . . 0.0 112.339 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -70.74 -36.99 73.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.217 0.917 . . . . 0.0 110.473 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -66.73 -41.28 88.16 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -65.5 -46.9 77.88 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.31 -49.02 65.03 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.87 1.668 . . . . 0.0 112.576 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 27.1 m -67.42 -34.27 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 O-C-N 121.795 -0.566 . . . . 0.0 112.17 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -87.91 -24.15 23.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.539 0.685 . . . . 0.0 109.394 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 66' ' ' GLU . . . -73.6 -47.84 37.22 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.54 -8.68 53.24 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 122.058 0.932 . . . . 0.0 112.316 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.52 107.57 13.44 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 119.647 -1.908 . . . . 0.0 108.125 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.03 15.8 40.71 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.18 21.72 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.79 107.64 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.432 2.088 . . . . 0.0 113.179 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.23 27.36 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.14 145.09 22.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.337 1.855 . . . . 0.0 112.911 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.0 -16.08 5.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.344 1.058 . . . . 0.0 110.785 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.59 -79.84 0.3 Allowed 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 121.221 -0.924 . . . . 0.0 108.595 -168.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . 0.359 12.7 pt 38.94 -128.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 126.779 2.032 . . . . 0.0 111.048 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.4 -135.58 0.82 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.913 1.688 . . . . 0.0 109.752 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -173.03 -68.12 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-O 116.653 -1.642 . . . . 0.0 106.758 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.73 -17.84 22.67 Favored 'Trans proline' 0 CA--C 1.51 -0.685 0 CA-C-N 125.321 2.936 . . . . 0.0 111.197 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.44 -23.75 65.56 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.269 1.427 . . . . 0.0 109.947 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -63.2 -42.42 99.31 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 112.259 -167.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -69.3 -33.71 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.18 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 121.543 -0.723 . . . . 0.0 110.19 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -63.16 -45.4 92.01 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.84 0.456 . . . . 0.0 110.508 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 62.0 m -58.94 -36.09 74.21 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.678 -0.639 . . . . 0.0 112.062 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.32 -45.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 C-N-CA 123.89 0.876 . . . . 0.0 110.191 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -73.84 3.24 6.91 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 122.1 0.952 . . . . 0.0 112.785 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -104.71 -36.3 7.49 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.702 -1.249 . . . . 0.0 108.856 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.68 61.39 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.426 -1.421 . . . . 0.0 111.768 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.8 p -87.69 -3.01 58.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.728 1.211 . . . . 0.0 109.983 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.254 6.9 p 55.62 36.35 27.02 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.522 1.929 . . . . 0.0 112.77 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -91.19 -19.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 O-C-N 121.61 -0.681 . . . . 0.0 111.474 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.48 -60.14 1.55 Allowed Glycine 0 CA--C 1.493 -1.334 0 O-C-N 120.59 -1.319 . . . . 0.0 112.412 168.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -75.71 73.09 2.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.875 1.321 . . . . 0.0 113.62 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.09 10.15 75.77 Favored Glycine 0 CA--C 1.492 -1.399 0 O-C-N 118.512 -2.618 . . . . 0.0 114.552 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t0 71.7 -4.73 1.83 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 126.095 1.758 . . . . 0.0 111.562 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -136.53 163.25 30.96 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -136.0 148.32 64.38 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.13 171.19 15.47 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.812 3.008 . . . . 0.0 108.488 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 t -115.21 -95.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 120.655 1.57 . . . . 0.0 110.282 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -140.48 -49.97 0.45 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -85.13 -16.35 40.77 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 123.646 0.778 . . . . 0.0 110.085 -165.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HB1' ' C' ' 29' ' ' ALA . 0.9 OUTLIER -62.16 -33.21 74.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 108.33 171.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.35 95.32 1.81 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 98.229 -5.948 . . . . 0.0 98.229 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -61.92 -16.22 49.2 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 118.836 1.318 . . . . 0.0 110.62 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -59.81 -11.21 4.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.22 -39.88 86.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.084 -1.635 . . . . 0.0 108.99 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -45.18 69.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.82 -44.57 66.79 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.789 1.636 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -63.85 -36.0 82.48 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 112.34 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -71.84 -43.85 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 121.062 -1.024 . . . . 0.0 108.801 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.78 -42.51 97.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.606 0.762 . . . . 0.0 110.486 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.69 -47.15 83.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.621 1.168 . . . . 0.0 110.294 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.9 98.14 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.233 0.613 . . . . 0.0 110.509 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.13 77.92 Favored Glycine 0 CA--C 1.496 -1.119 0 C-N-CA 123.75 0.69 . . . . 0.0 111.832 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.75 -49.33 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 125.066 1.346 . . . . 0.0 108.675 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.42 -45.12 94.54 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 111.044 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.2 -52.87 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 C-N-CA 124.258 1.023 . . . . 0.0 110.367 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -72.27 -21.92 61.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.222 -0.924 . . . . 0.0 111.18 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.43 -37.88 36.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.115 -0.991 . . . . 0.0 110.111 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.23 -41.72 84.72 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.421 1.488 . . . . 0.0 110.609 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' C' ' 8' ' ' ALA . 17.1 m -69.04 -2.93 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -62.49 -12.57 22.98 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.361 1.065 . . . . 0.0 110.394 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.21 -57.3 12.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.122 -1.611 . . . . 0.0 111.841 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.4 77.6 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 126.07 1.748 . . . . 0.0 109.807 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.43 -33.37 75.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.35 40.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.007 -1.058 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.437 ' O ' HG22 ' C' ' 94' ' ' VAL 0.334 0.1 OUTLIER -70.36 -2.39 13.49 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.517 -1.23 . . . . 0.0 110.617 -176.93 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.281 0.6 OUTLIER -76.25 1.65 15.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 122.148 2.249 . . . . 0.0 111.531 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.24 -24.03 61.32 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 119.673 -1.892 . . . . 0.0 111.05 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.437 HG22 ' O ' ' C' ' 91' ' ' THR . 4.2 m -75.78 -12.95 14.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 O-C-N 120.112 -1.617 . . . . 0.0 110.275 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -79.64 -3.97 49.58 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.893 1.277 . . . . 0.0 109.388 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -77.77 -27.37 50.27 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.009 -1.682 . . . . 0.0 108.489 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -169.778 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.327 0.584 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -170.14 -104.38 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 -166.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -53.11 -22.54 6.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.989 3.316 . . . . 0.0 114.366 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.64 -28.56 67.82 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 125.385 1.474 . . . . 0.0 110.447 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -68.28 -43.3 78.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.923 0.889 . . . . 0.0 109.742 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.07 -31.34 62.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.503 -0.748 . . . . 0.0 109.588 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.95 91.44 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.871 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -66.12 -38.4 88.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.56 -42.99 99.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 109.904 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.32 84.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.74 0.816 . . . . 0.0 111.566 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.74 -38.16 77.8 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.564 0.745 . . . . 0.0 110.807 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.6 -30.14 65.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.303 -0.873 . . . . 0.0 110.406 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.76 -32.97 73.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.5 -43.2 97.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.357 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -56.05 -33.55 65.08 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.394 1.078 . . . . 0.0 111.745 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -71.19 -23.63 62.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.143 1.377 . . . . 0.0 111.174 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.68 -42.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.48 -40.23 74.57 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 124.939 1.296 . . . . 0.0 111.261 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -54.3 -51.68 63.85 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.273 1.029 . . . . 0.0 111.728 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.58 -38.37 67.92 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.65 0.78 . . . . 0.0 109.254 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.33 77.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.727 1.611 . . . . 0.0 111.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -64.46 -40.06 94.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.629 1.172 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -68.7 -46.62 68.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.49 -49.07 75.03 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.326 -0.859 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.08 -46.57 87.95 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 126.086 1.755 . . . . 0.0 111.836 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.34 -37.32 78.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 118.42 0.554 . . . . 0.0 110.139 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.34 -33.62 61.13 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.944 -1.098 . . . . 0.0 109.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.8 -55.51 14.55 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.249 1.82 . . . . 0.0 109.195 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.09 -32.9 74.38 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.019 0.928 . . . . 0.0 111.135 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -74.18 101.6 4.01 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 120.339 -1.476 . . . . 0.0 110.892 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.05 -22.49 4.79 Favored Glycine 0 CA--C 1.489 -1.541 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.8 142.96 66.1 Favored Pre-proline 0 N--CA 1.443 -0.801 0 O-C-N 121.547 -0.972 . . . . 0.0 109.653 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.94 140.38 12.64 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 122.781 2.321 . . . . 0.0 109.703 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.04 -8.84 71.67 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 119.132 0.878 . . . . 0.0 110.956 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.89 150.65 27.96 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 126.71 2.004 . . . . 0.0 111.287 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.93 -28.89 1.52 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.035 0.534 . . . . 0.0 110.572 -170.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.7 91.4 8.63 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 120.278 -1.514 . . . . 0.0 107.067 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 tt -122.49 53.13 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 O-C-N 120.848 -1.158 . . . . 0.0 108.117 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 26.4 t -153.97 142.0 20.28 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 119.489 -2.007 . . . . 0.0 106.948 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -80.64 -49.7 1.11 Allowed Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 115.807 -2.044 . . . . 0.0 109.929 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -69.18 -15.24 39.1 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 CA-C-N 126.036 3.192 . . . . 0.0 111.723 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.06 -13.53 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.22 80.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.03 -1.044 . . . . 0.0 109.044 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -67.9 -29.33 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 123.132 0.573 . . . . 0.0 110.909 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -47.48 63.85 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -67.23 -32.99 74.4 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.301 -0.875 . . . . 0.0 111.015 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -57.71 -24.85 58.93 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.618 -1.301 . . . . 0.0 112.523 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -40.65 15.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.709 -1.245 . . . . 0.0 110.228 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.38 -27.38 62.26 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 127.502 2.321 . . . . 0.0 110.835 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -99.31 -37.25 9.33 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 120.06 -1.65 . . . . 0.0 109.865 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.82 -14.12 61.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.394 -1.441 . . . . 0.0 112.262 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -99.0 2.07 46.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.257 63.5 p 56.31 28.96 14.18 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.343 2.257 . . . . 0.0 111.856 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.89 -52.88 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.88 63.43 4.79 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.816 -0.436 . . . . 0.0 113.626 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.39 -16.74 63.58 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 118.879 1.34 . . . . 0.0 110.092 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.24 36.8 4.28 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.407 ' HB2' HH12 ' A' ' 68' ' ' ARG . 11.6 t70 -70.25 -54.43 12.73 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.65 169.01 14.96 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.06 130.17 10.0 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 100.366 -3.939 . . . . 0.0 100.366 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.35 177.57 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.253 2.635 . . . . 0.0 107.841 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.38 -119.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 C-N-CA 123.696 0.798 . . . . 0.0 110.949 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -132.63 -38.68 1.01 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.88 -14.62 53.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.791 1.636 . . . . 0.0 108.81 -168.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -33.51 68.84 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.18 63.44 0.81 Allowed Glycine 0 CA--C 1.464 -3.127 1 N-CA-C 102.69 -4.164 . . . . 0.0 102.69 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -30.95 -18.76 0.0 OUTLIER 'General case' 0 C--N 1.361 1.077 1 C-N-CA 132.647 4.379 . . . . 0.0 117.466 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.33 -19.08 7.74 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 119.931 -1.73 . . . . 0.0 113.436 160.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.38 -44.18 98.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 124.451 1.1 . . . . 0.0 108.946 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.72 -55.08 7.3 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -40.08 -58.19 1.5 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.833 2.053 . . . . 0.0 112.326 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.14 -34.23 72.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.421 -169.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -74.23 -42.18 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 52.4 mtm -61.66 -49.72 75.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.524 0.73 . . . . 0.0 110.418 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.92 -27.47 66.66 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.514 -0.741 . . . . 0.0 111.185 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.35 81.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.677 -0.639 . . . . 0.0 110.811 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.69 89.57 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.91 -47.12 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.24 1.016 . . . . 0.0 109.907 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -69.26 -30.6 68.76 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.113 -0.992 . . . . 0.0 112.112 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.27 -52.1 60.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 C-N-CA 123.709 0.804 . . . . 0.0 109.265 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -69.1 -32.12 71.31 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.744 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.28 77.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.376 -0.827 . . . . 0.0 111.243 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -65.68 -36.14 82.8 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.651 1.18 . . . . 0.0 110.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.92 -19.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.405 1.482 . . . . 0.0 110.497 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -59.88 -20.48 57.47 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.791 -1.193 . . . . 0.0 112.714 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.93 74.8 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.228 -2.17 . . . . 0.0 111.539 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.96 53.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.005 0.922 . . . . 0.0 110.178 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.5 -27.93 18.88 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.864 1.316 . . . . 0.0 108.717 175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.77 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 119.836 -1.79 . . . . 0.0 110.757 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -68.28 -12.23 60.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.992 -1.068 . . . . 0.0 109.487 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.09 -20.78 59.32 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.024 -1.047 . . . . 0.0 111.37 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.02 -31.64 72.9 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.153 0.981 . . . . 0.0 108.976 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 t -90.63 -38.3 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 108.37 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -55.96 -35.76 67.05 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.724 1.61 . . . . 0.0 112.238 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -64.51 -20.36 66.16 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.029 -1.045 . . . . 0.0 112.407 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.445 -0.718 0 O-C-N 119.957 -1.714 . . . . 0.0 110.278 172.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -52.34 62.6 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.404 1.881 . . . . 0.0 109.908 -167.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.605 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 42.7 p-80 -76.53 -15.13 59.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.774 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.66 -32.8 35.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -63.86 -44.66 92.45 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.12 0.968 . . . . 0.0 110.0 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.59 -33.76 76.65 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.87 -0.519 . . . . 0.0 111.579 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.98 80.97 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.374 -0.829 . . . . 0.0 110.754 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -67.57 -39.22 84.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.757 -0.589 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.95 -35.88 82.14 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.5 0.72 . . . . 0.0 110.854 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.84 92.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.163 0.985 . . . . 0.0 110.554 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.36 -47.42 81.69 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.839 0.828 . . . . 0.0 110.782 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -70.71 -32.23 69.37 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.725 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -35.79 76.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.749 1.219 . . . . 0.0 109.032 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 tp -67.84 -41.71 82.54 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 121.618 -0.676 . . . . 0.0 111.191 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -66.33 -27.47 67.92 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.564 -0.71 . . . . 0.0 111.731 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -67.71 -39.69 84.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.73 1.212 . . . . 0.0 110.137 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.14 -37.83 77.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.997 0.919 . . . . 0.0 109.101 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.0 mt -56.92 -41.81 78.85 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.124 0.97 . . . . 0.0 112.182 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.54 -46.14 84.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.142 -0.974 . . . . 0.0 110.059 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -67.07 -33.44 75.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.918 -1.114 . . . . 0.0 111.54 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.16 -36.37 79.63 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.004 1.321 . . . . 0.0 110.617 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -63.83 -45.11 91.04 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 123.739 0.815 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -67.76 -49.29 63.28 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.565 0.698 . . . . 0.0 110.668 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -67.29 -34.41 77.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.64 0.776 . . . . 0.0 110.842 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.8 -49.09 61.45 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.297 1.039 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.29 -45.86 89.11 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-O 122.417 1.103 . . . . 0.0 110.189 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -86.87 2.07 50.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.525 -0.734 . . . . 0.0 111.302 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.87 27.6 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.23 -42.49 75.61 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 125.048 1.339 . . . . 0.0 108.911 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -69.58 85.93 0.45 Allowed 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.339 -0.851 . . . . 0.0 111.572 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.14 2.26 Favored Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.02 151.07 37.39 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 117.817 0.808 . . . . 0.0 109.24 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.01 131.84 8.13 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.17 1.914 . . . . 0.0 110.79 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.73 16.74 23.27 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.81 134.81 48.05 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 125.898 1.679 . . . . 0.0 114.177 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.03 -58.93 1.36 Allowed 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.466 1.107 . . . . 0.0 110.543 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.26 93.82 9.63 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 122.553 1.168 . . . . 0.0 112.067 -166.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.61 62.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 O-C-N 119.515 -1.991 . . . . 0.0 111.279 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -152.06 118.34 5.59 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 119.904 -1.747 . . . . 0.0 108.52 169.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.9 -48.93 96.55 Favored Pre-proline 0 C--N 1.359 0.993 0 CA-C-O 116.373 -1.775 . . . . 0.0 112.433 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.36 -8.96 23.58 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 CA-C-N 125.551 3.018 . . . . 0.0 112.947 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -101.78 -24.03 14.11 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.05 98.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 124.035 0.934 . . . . 0.0 110.058 -171.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.75 -32.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 124.567 1.147 . . . . 0.0 111.73 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -42.04 61.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 O-C-N 121.388 -0.82 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -67.33 -35.02 78.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -55.98 -34.46 65.75 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.819 -1.176 . . . . 0.0 112.013 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.31 -49.22 84.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -60.15 -38.03 81.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.819 1.648 . . . . 0.0 111.324 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -65.15 -45.56 84.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.554 1.942 . . . . 0.0 109.435 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.46 64.95 Favored 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 121.143 -0.973 . . . . 0.0 111.266 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 p -84.26 1.85 42.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.734 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.365 18.3 p 75.85 -41.04 0.42 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 128.339 2.655 . . . . 0.0 111.289 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.8 t -39.58 -54.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 128.183 2.593 . . . . 0.0 114.277 -169.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.89 65.93 3.03 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -67.16 -9.42 39.84 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.784 1.234 . . . . 0.0 113.464 -167.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 28.06 6.89 Favored Glycine 0 CA--C 1.488 -1.651 0 O-C-N 120.973 -1.079 . . . . 0.0 110.436 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.61 -47.64 31.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.367 -1.078 . . . . 0.0 109.05 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -123.7 160.45 27.2 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -136.57 147.25 58.98 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.98 167.1 12.79 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.617 2.211 . . . . 0.0 110.577 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 64' ' ' THR . 9.8 p -76.79 178.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 125.874 1.67 . . . . 0.0 108.823 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.588 ' H ' HG22 ' A' ' 63' ' ' VAL . 11.4 m -74.56 -83.89 0.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.779 1.632 . . . . 0.0 109.85 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -57.81 -55.08 39.54 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 120.084 1.311 . . . . 0.0 113.958 -161.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -89.87 -56.95 3.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.705 -0.622 . . . . 0.0 111.721 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.402 ' H ' ' CG1' ' A' ' 63' ' ' VAL . . . -53.23 -35.17 49.2 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 125.438 1.494 . . . . 0.0 113.81 -169.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -68.39 -38.32 81.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 118.072 0.936 . . . . 0.0 110.775 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -69.75 -39.7 76.56 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 123.654 0.782 . . . . 0.0 109.888 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.71 -46.64 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.29 86.42 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 124.673 1.189 . . . . 0.0 110.41 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -48.53 -51.93 25.13 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 126.675 1.99 . . . . 0.0 110.375 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -71.1 -42.52 69.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.296 -0.877 . . . . 0.0 111.958 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.74 -42.98 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 124.022 0.929 . . . . 0.0 109.748 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.23 -47.87 82.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 124.758 1.223 . . . . 0.0 109.71 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -60.48 -35.59 76.27 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.504 0.722 . . . . 0.0 110.44 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.21 72.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.705 -0.622 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.53 -41.29 90.43 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.65 -46.79 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 124.33 1.052 . . . . 0.0 108.726 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -62.63 -32.72 73.81 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.8 -0.563 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.15 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 123.914 0.886 . . . . 0.0 110.567 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -62.56 -37.42 86.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.736 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.13 63.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.784 -0.572 . . . . 0.0 111.954 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -73.61 -26.21 60.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.099 -1.625 . . . . 0.0 110.309 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.82 -15.46 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.093 1.357 . . . . 0.0 110.348 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 m -54.08 -24.31 16.96 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 126.207 1.803 . . . . 0.0 112.849 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.49 64.03 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 120.179 -1.576 . . . . 0.0 112.264 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -92.62 -48.35 6.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.555 1.142 . . . . 0.0 108.746 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.47 -39.91 92.53 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 112.598 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.81 61.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -97.28 11.14 37.52 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 120.805 -1.184 . . . . 0.0 108.824 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -79.36 -29.67 42.28 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.396 -1.44 . . . . 0.0 109.048 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -78.7 -24.71 44.85 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.723 -1.236 . . . . 0.0 110.691 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.76 -32.57 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 123.586 0.754 . . . . 0.0 109.698 -171.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -63.35 -16.58 60.85 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.759 1.224 . . . . 0.0 111.884 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 96' ' ' ARG . 21.6 ttp85 -71.34 -31.76 67.76 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.289 1.036 . . . . 0.0 110.562 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -177.279 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 . . . . . 0 CA--C 1.483 -1.624 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' HG3' ' B' ' 5' ' ' GLU . 12.5 p80 -50.46 -35.34 28.49 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 125.501 1.521 . . . . 0.0 114.743 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' B' ' 4' ' ' HIS . 4.9 mt-10 -67.59 -33.25 74.63 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.36 1.064 . . . . 0.0 110.78 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -81.03 -20.31 41.97 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.613 -0.679 . . . . 0.0 109.764 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -27.06 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -46.06 84.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.833 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.97 -28.59 62.49 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.446 -0.784 . . . . 0.0 111.007 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.9 -40.08 95.66 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.985 0.914 . . . . 0.0 109.8 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.62 76.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.049 0.939 . . . . 0.0 111.401 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -65.28 -39.5 92.65 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.9 -47.35 80.93 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.502 -0.748 . . . . 0.0 110.255 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' B' ' 14' ' ' GLU . 0.8 OUTLIER -70.66 -25.15 62.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.539 -0.726 . . . . 0.0 111.278 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -63.55 -39.73 95.16 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 120.831 -1.168 . . . . 0.0 111.334 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -62.05 -38.93 90.6 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.446 -0.784 . . . . 0.0 110.06 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.58 84.75 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.093 0.957 . . . . 0.0 110.27 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.44 -47.94 89.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.551 -0.718 . . . . 0.0 110.31 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.43 -36.29 80.94 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.673 -0.642 . . . . 0.0 110.486 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -62.75 -42.04 99.49 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.116 -1.615 . . . . 0.0 110.104 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -66.49 -36.79 83.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.848 0.832 . . . . 0.0 109.698 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.98 73.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.752 0.821 . . . . 0.0 111.552 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -60.93 -38.02 84.32 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.506 1.123 . . . . 0.0 111.98 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -69.03 -41.64 77.44 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.311 -0.868 . . . . 0.0 109.094 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -70.13 -26.37 63.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 121.822 -0.549 . . . . 0.0 110.933 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.07 95.72 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.303 1.041 . . . . 0.0 111.217 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.31 42.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 124.255 1.979 . . . . 0.0 108.474 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -147.19 -42.24 0.18 Allowed 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 100.875 -3.75 . . . . 0.0 100.875 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 56.52 0.46 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.689 1.996 . . . . 0.0 110.216 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 1.8 pp20? 179.68 -27.49 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 125.921 1.688 . . . . 0.0 108.289 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.43 71.73 6.02 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.495 -0.753 . . . . 0.0 109.985 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.22 -34.47 0.84 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 159.24 57.8 Favored Pre-proline 0 CA--C 1.51 -0.586 0 O-C-N 120.681 -1.482 . . . . 0.0 112.817 -173.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.17 152.26 24.01 Favored 'Trans proline' 0 CA--C 1.501 -1.163 0 C-N-CA 122.062 1.842 . . . . 0.0 109.848 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.13 42.34 84.42 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -66.63 -60.18 2.94 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.859 0.864 . . . . 0.0 109.716 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 65.43 -9.32 0.24 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.557 1.543 . . . . 0.0 113.597 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -123.52 31.64 5.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.732 1.613 . . . . 0.0 107.804 -165.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 45.0 pt -70.45 38.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.425 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -161.72 142.68 10.92 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 119.571 -1.956 . . . . 0.0 109.583 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.81 -57.29 1.55 Allowed Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 126.899 2.079 . . . . 0.0 110.978 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.66 -11.84 26.34 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 CA-C-N 126.076 3.206 . . . . 0.0 111.228 -169.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.71 -7.13 44.53 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 125.67 1.588 . . . . 0.0 107.954 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.09 66.86 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 123.983 0.913 . . . . 0.0 109.06 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -82.21 14.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.348 1.071 . . . . 0.0 109.86 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.0 -58.53 2.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 167.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -54.49 -41.62 69.79 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.705 1.602 . . . . 0.0 111.804 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' HG22 ' B' ' 51' ' ' THR . 16.9 m -65.24 -21.81 66.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 120.794 -1.191 . . . . 0.0 113.723 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.25 -53.82 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -47.33 -50.63 21.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 126.682 1.993 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.407 HG22 ' HA ' ' B' ' 48' ' ' SER . 15.2 t -71.99 -30.16 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.772 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.23 60.65 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.223 -0.923 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -83.57 -1.18 53.22 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 122.963 0.505 . . . . 0.0 111.092 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.278 3.4 p 53.89 56.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.323 1.849 . . . . 0.0 112.505 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.0 t -120.54 -72.71 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.05 60.91 1.89 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -19.11 10.38 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.98 27.48 16.28 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.303 -1.498 . . . . 0.0 109.703 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -70.28 -63.67 1.04 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.031 2.133 . . . . 0.0 107.553 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -138.85 170.32 16.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -173.05 138.41 0.82 Allowed Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-O 115.696 -2.097 . . . . 0.0 105.356 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.92 179.38 6.04 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.069 2.513 . . . . 0.0 111.595 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.472 HG22 ' H ' ' B' ' 64' ' ' THR . 12.7 p -123.19 175.34 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.472 ' H ' HG22 ' B' ' 63' ' ' VAL . 19.5 m -48.81 -50.39 34.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 129.25 3.02 . . . . 0.0 113.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.6 -11.88 61.21 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.905 1.282 . . . . 0.0 109.593 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -104.33 5.37 34.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 O-C-N 121.894 -0.504 . . . . 0.0 111.368 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.35 84.07 0.38 Allowed Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 104.543 -3.423 . . . . 0.0 104.543 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.76 -20.37 56.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.535 -1.568 . . . . 0.0 111.125 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -54.84 -13.48 1.08 Allowed 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.828 1.651 . . . . 0.0 113.082 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.98 -40.99 84.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 120.651 -1.281 . . . . 0.0 110.087 169.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.18 -50.17 29.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -48.79 -44.15 38.73 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.989 1.715 . . . . 0.0 111.038 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -48.1 79.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.142 1.377 . . . . 0.0 111.269 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.25 -43.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.53 -46.14 89.72 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.645 1.178 . . . . 0.0 110.413 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.54 -43.03 99.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.29 97.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 122.599 0.36 . . . . 0.0 110.963 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.58 -47.0 93.13 Favored Glycine 0 CA--C 1.495 -1.179 0 C-N-CA 124.358 0.98 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.38 -50.53 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 124.301 1.04 . . . . 0.0 109.054 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -63.28 -33.53 75.71 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 121.802 -0.561 . . . . 0.0 111.782 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.52 -59.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 C-N-CA 124.125 0.97 . . . . 0.0 110.48 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -64.79 -35.62 81.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 121.384 -0.823 . . . . 0.0 110.151 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.62 88.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 111.266 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.45 -35.62 81.52 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.4 1.08 . . . . 0.0 110.533 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.72 -16.11 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.796 1.238 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -59.79 -18.65 45.17 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 120.494 -1.379 . . . . 0.0 111.608 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.53 75.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 119.565 -1.96 . . . . 0.0 112.456 171.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.35 -38.73 55.44 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 121.182 -0.949 . . . . 0.0 109.29 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -32.69 69.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.73 67.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 120.389 -1.444 . . . . 0.0 111.685 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -90.63 3.3 54.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 120.706 -1.246 . . . . 0.0 109.014 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -75.34 -33.75 61.13 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 122.118 0.961 . . . . 0.0 108.72 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -68.55 -32.06 71.73 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.403 -1.435 . . . . 0.0 111.944 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 -22.75 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.912 1.285 . . . . 0.0 109.116 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -59.61 -26.32 65.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.329 1.052 . . . . 0.0 112.07 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -67.97 -24.27 65.14 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 120.242 1.383 . . . . 0.0 111.836 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 C--N 1.354 0.77 0 O-C-N 121.046 -1.033 . . . . 0.0 108.776 177.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.682 0 CA-C-O 122.938 1.352 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.644 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 48.8 p-80 -72.56 -18.01 61.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.958 1.303 . . . . 0.0 112.88 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -75.99 -41.04 52.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -72.51 -31.97 65.78 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.949 -1.094 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -75.1 -27.21 59.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.369 -0.832 . . . . 0.0 110.032 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -45.82 78.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.161 0.984 . . . . 0.0 110.579 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -62.25 -40.69 97.02 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.475 1.11 . . . . 0.0 110.763 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -60.12 -36.08 76.69 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 124.541 1.136 . . . . 0.0 110.839 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.87 76.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.56 0.744 . . . . 0.0 111.384 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.13 -34.65 78.9 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.184 -0.948 . . . . 0.0 111.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -72.69 -31.9 65.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 110.117 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.85 -33.56 74.02 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.4 1.48 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.93 -42.61 94.54 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.649 0.779 . . . . 0.0 110.663 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -61.9 -36.63 81.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.428 -0.795 . . . . 0.0 111.55 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.65 -43.49 97.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.85 0.86 . . . . 0.0 111.277 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.96 -23.89 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 121.119 -0.988 . . . . 0.0 110.692 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.8 mt -68.86 -38.92 80.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 123.789 0.836 . . . . 0.0 110.509 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -65.47 -38.5 89.97 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.568 1.147 . . . . 0.0 110.452 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.02 -38.03 61.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.683 -1.261 . . . . 0.0 109.155 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -37.97 76.34 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 125.107 1.363 . . . . 0.0 111.493 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -43.21 81.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 118.906 0.775 . . . . 0.0 110.358 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.69 -50.6 62.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -59.58 -45.91 90.47 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 124.021 0.928 . . . . 0.0 109.524 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -42.69 99.89 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.968 0.907 . . . . 0.0 111.897 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' C' ' 44' ' ' ALA . 91.5 t -71.52 -33.16 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 O-C-N 120.973 -1.079 . . . . 0.0 110.326 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.64 -33.34 64.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.464 -0.772 . . . . 0.0 109.338 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.55 79.38 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 126.789 2.036 . . . . 0.0 109.725 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -74.44 -12.65 60.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.47 0.652 . . . . 0.0 112.12 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -79.63 77.19 6.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 120.487 -1.383 . . . . 0.0 110.327 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.82 -11.12 1.66 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.67 147.41 46.25 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 117.847 0.824 . . . . 0.0 110.773 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.32 121.73 3.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.843 2.362 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.87 29.91 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.95 124.34 20.51 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.075 1.75 . . . . 0.0 112.74 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.94 -21.47 6.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.033 0.533 . . . . 0.0 110.638 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -36.64 80.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.648 1.179 . . . . 0.0 110.524 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tp -47.56 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 128.994 2.918 . . . . 0.0 112.067 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -168.3 103.8 0.45 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -60.77 -36.64 37.14 Favored Pre-proline 0 C--N 1.35 0.612 0 CA-C-O 115.315 -2.279 . . . . 0.0 113.101 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.93 -48.79 0.62 Allowed 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 126.757 3.449 . . . . 0.0 110.473 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -6.51 47.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.986 1.314 . . . . 0.0 111.246 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' C' ' 27' ' ' VAL . . . -58.78 -48.62 80.63 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 125.636 1.574 . . . . 0.0 110.876 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.96 -24.84 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.55 -44.66 77.72 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.895 -1.128 . . . . 0.0 108.61 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.7 -41.26 99.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.636 -0.665 . . . . 0.0 110.833 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -57.93 -46.12 85.5 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.092 -1.005 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -80.25 74.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 122.206 1.003 . . . . 0.0 108.851 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -165.14 -40.62 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -31.55 71.08 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.968 0.907 . . . . 0.0 110.485 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -68.31 -24.12 64.81 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.441 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.46 6.61 48.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 123.279 0.632 . . . . 0.0 109.55 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 55.92 52.28 10.88 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 126.125 1.77 . . . . 0.0 112.418 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.3 -156.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.37 103.95 0.33 Allowed Glycine 0 CA--C 1.475 -2.467 1 N-CA-C 99.133 -5.587 . . . . 0.0 99.133 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.96 -28.28 62.32 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 118.101 0.951 . . . . 0.0 110.214 -172.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.0 46.04 0.84 Allowed Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -75.44 -51.75 12.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -137.69 172.48 12.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.35 125.17 5.92 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 101.843 -3.391 . . . . 0.0 101.843 -168.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.85 168.68 21.87 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 123.83 3.02 . . . . 0.0 110.757 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.29 -90.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.011 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 12.7 m -165.01 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.624 -1.922 . . . . 0.0 106.732 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -73.74 -18.8 60.94 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.815 1.246 . . . . 0.0 108.979 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -62.07 -36.48 81.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 125.043 1.337 . . . . 0.0 109.576 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.22 -15.62 1.49 Allowed Glycine 0 CA--C 1.481 -2.087 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 172.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' C' ' 66' ' ' GLU 0.352 3.5 ptp85 63.18 -48.63 0.22 Allowed 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 131.481 3.912 . . . . 0.0 111.734 -170.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.25 12.71 2.2 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.51 -49.42 59.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -49.12 65.59 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 122.897 0.479 . . . . 0.0 110.008 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.92 -42.92 69.3 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.067 0.947 . . . . 0.0 111.433 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -67.37 -32.27 73.07 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 111.224 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.74 -42.29 61.91 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.36 -47.39 85.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 110.502 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.22 -40.67 94.86 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.271 1.029 . . . . 0.0 110.914 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.73 85.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.466 0.707 . . . . 0.0 111.18 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.68 -44.27 92.79 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 124.036 0.827 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.7 -43.23 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.689 0.795 . . . . 0.0 109.116 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.09 -52.99 63.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 123.504 0.722 . . . . 0.0 111.608 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.82 -41.57 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 121.952 -0.468 . . . . 0.0 111.028 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -75.38 -25.23 57.49 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.559 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.77 -33.68 34.76 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.67 -1.269 . . . . 0.0 109.773 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.2 -41.59 75.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.789 1.636 . . . . 0.0 110.873 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.42 -8.03 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.489 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 13.0 m -62.98 -17.43 62.1 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.998 -1.064 . . . . 0.0 109.842 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.05 75.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.185 -1.572 . . . . 0.0 112.337 169.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.644 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.72 -52.64 10.02 Favored 'General case' 0 CA--C 1.492 -1.283 0 O-C-N 120.694 -1.254 . . . . 0.0 107.887 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.76 -29.05 70.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.03 0.443 . . . . 0.0 111.938 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.57 -20.72 64.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.587 -1.321 . . . . 0.0 111.074 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -80.95 -10.96 59.65 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.638 -1.289 . . . . 0.0 110.506 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.26 1.8 m-20 -79.39 -12.97 59.9 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 119.869 1.213 . . . . 0.0 110.817 -167.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.49 -19.97 41.15 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.329 -1.482 . . . . 0.0 109.928 167.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.13 -38.4 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 124.718 1.207 . . . . 0.0 108.077 -172.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -50.79 -31.3 16.51 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 125.816 1.646 . . . . 0.0 113.239 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -60.33 -32.18 71.0 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -172.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.215 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.59 -29.83 69.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.073 -1.017 . . . . 0.0 111.076 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -68.38 -22.53 64.64 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.051 -1.031 . . . . 0.0 111.908 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.82 -36.02 23.8 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -62.35 -40.81 97.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.125 0.97 . . . . 0.0 110.488 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.62 -38.44 90.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.483 1.113 . . . . 0.0 110.437 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.74 75.35 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.109 0.964 . . . . 0.0 111.207 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -65.15 -41.49 94.69 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.754 -0.591 . . . . 0.0 110.449 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -64.93 -31.75 73.14 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 122.81 0.444 . . . . 0.0 111.76 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.12 81.52 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.897 -0.502 . . . . 0.0 110.35 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.51 -50.65 72.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.97 0.508 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.56 -34.34 75.42 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.805 0.842 . . . . 0.0 111.462 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -73.97 -32.02 63.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.032 -1.042 . . . . 0.0 110.503 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.43 -38.18 90.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.722 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -75.41 -9.03 58.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.961 -1.087 . . . . 0.0 112.525 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -82.9 -38.97 22.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.07 -38.16 81.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.227 -0.921 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.8 mt -51.94 -42.95 63.23 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.798 1.239 . . . . 0.0 112.518 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -68.32 -42.93 78.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.785 0.834 . . . . 0.0 110.48 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.21 -38.51 68.98 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.22 73.23 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 125.154 1.381 . . . . 0.0 111.955 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -57.55 -47.96 80.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.069 1.414 . . . . 0.0 110.697 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -73.39 -43.15 61.16 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.723 1.209 . . . . 0.0 108.514 -171.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -73.39 -29.66 62.75 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.723 0.809 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.79 79.15 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.035 0.934 . . . . 0.0 111.492 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.95 -43.59 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-O 122.424 1.106 . . . . 0.0 109.846 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -62.55 -32.97 74.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.48 1.512 . . . . 0.0 109.594 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.14 -50.43 71.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 126.099 1.76 . . . . 0.0 110.643 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 111.3 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -80.73 68.24 6.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.414 -1.429 . . . . 0.0 110.987 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.14 -30.43 0.48 Allowed Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.73 150.08 81.35 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.345 1.058 . . . . 0.0 111.778 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -84.27 145.22 10.77 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 122.808 2.339 . . . . 0.0 109.861 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 33.41 55.59 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 147.25 47.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.315 1.046 . . . . 0.0 110.95 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.53 -52.93 1.59 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.98 97.74 10.92 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -137.84 114.05 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -179.6 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -174.86 -65.41 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 116.218 -1.848 . . . . 0.0 106.112 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.84 -16.81 29.44 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 CA-C-N 125.386 2.959 . . . . 0.0 112.637 -166.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -95.03 -8.43 36.79 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.948 1.299 . . . . 0.0 109.639 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.26 62.92 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.757 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.99 -33.58 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.029 0.931 . . . . 0.0 109.626 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -27.38 59.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 119.577 -1.952 . . . . 0.0 110.335 -174.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -69.03 -42.36 76.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.0 p -69.28 -32.26 71.31 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.193 -1.567 . . . . 0.0 110.866 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.81 -46.59 83.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 125.334 1.453 . . . . 0.0 110.936 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -80.61 -2.14 45.21 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 118.757 0.708 . . . . 0.0 112.013 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -101.22 -40.65 7.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 -22.92 66.31 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.765 -1.21 . . . . 0.0 111.685 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -91.83 2.8 56.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 125.026 1.33 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 25.6 p 52.03 70.42 0.56 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.343 1.857 . . . . 0.0 112.785 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.566 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.2 p -129.24 -80.01 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 104.184 -2.525 . . . . 0.0 104.184 169.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.566 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 80.63 80.36 0.85 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -171.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -74.55 -16.15 60.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.028 -1.278 . . . . 0.0 110.983 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.23 5.76 Favored Glycine 0 CA--C 1.492 -1.378 0 O-C-N 121.393 -0.817 . . . . 0.0 111.103 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -70.12 -59.07 3.12 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -137.97 162.64 33.56 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -158.24 154.68 24.39 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.12 177.77 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.483 2.789 . . . . 0.0 109.878 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.427 HG13 ' H ' ' D' ' 64' ' ' THR 0.264 5.6 p -115.01 -118.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 174.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.427 ' H ' HG13 ' D' ' 63' ' ' VAL . 12.2 m -104.93 -85.62 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.189 -1.569 . . . . 0.0 108.988 -170.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.88 128.77 37.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.576 1.15 . . . . 0.0 109.086 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . 0.3 51.7 mt-10 62.2 -111.26 0.4 Allowed 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 115.441 -2.219 . . . . 0.0 106.972 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 35.51 -80.88 0.0 OUTLIER Glycine 0 C--N 1.353 1.49 0 C-N-CA 129.772 3.558 . . . . 0.0 113.786 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -58.92 -41.97 88.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 127.381 2.272 . . . . 0.0 113.196 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.35 -18.1 62.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.473 1.109 . . . . 0.0 109.464 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' D' ' 29' ' ' ALA . 40.8 t -84.63 -45.11 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 172.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.22 -50.91 69.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.666 1.187 . . . . 0.0 113.104 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.86 -35.46 70.99 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.875 0.87 . . . . 0.0 111.62 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -67.96 -45.51 74.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.248 1.019 . . . . 0.0 109.034 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.53 -43.62 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.932 0.893 . . . . 0.0 109.522 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.9 -43.64 98.26 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.387 0.675 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.08 -37.8 83.99 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.234 0.614 . . . . 0.0 111.097 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.11 85.9 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.147 0.579 . . . . 0.0 111.237 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.44 -46.52 55.62 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.81 -47.49 85.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 109.628 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -66.97 -26.69 66.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.13 -0.981 . . . . 0.0 112.372 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.28 -45.18 71.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.748 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.59 -35.2 80.24 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.078 0.942 . . . . 0.0 110.062 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -32.62 67.06 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.391 -0.818 . . . . 0.0 111.332 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.04 -43.92 94.09 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 124.628 1.171 . . . . 0.0 109.727 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -69.96 -4.83 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.375 -0.828 . . . . 0.0 112.061 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -57.49 -24.85 58.22 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.186 1.394 . . . . 0.0 110.344 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.84 78.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 119.847 -1.783 . . . . 0.0 112.163 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.84 -42.87 69.6 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -28.34 63.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.768 0.827 . . . . 0.0 110.858 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.32 76.48 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 119.982 -1.699 . . . . 0.0 109.442 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -11.53 52.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.87 -1.144 . . . . 0.0 112.593 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.37 -26.53 61.94 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.831 1.65 . . . . 0.0 111.595 -170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -79.06 -24.14 43.75 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.212 0.915 . . . . 0.0 110.062 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.97 -36.53 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.414 1.085 . . . . 0.0 108.701 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -55.5 -32.94 63.29 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 126.421 1.888 . . . . 0.0 110.83 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -61.7 -23.58 66.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.296 1.038 . . . . 0.0 111.74 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 . . . . . 0 C--N 1.358 0.968 0 O-C-N 121.797 -0.565 . . . . 0.0 109.934 -174.077 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.59 -43.23 97.6 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.033 1.733 . . . . 0.0 110.604 -171.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -47.09 72.07 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.634 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -38.29 89.06 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 122.578 0.351 . . . . 0.0 110.101 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -64.23 -46.27 84.57 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.682 -0.637 . . . . 0.0 110.871 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 121.796 -0.565 . . . . 0.0 111.04 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.47 85.61 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 110.805 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.8 -36.1 77.84 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.11 -38.07 85.03 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.904 1.282 . . . . 0.0 109.974 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.44 -37.22 86.76 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 111.711 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.38 -29.17 70.24 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.86 -1.15 . . . . 0.0 111.607 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -68.08 -31.94 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -71.9 -29.29 64.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.0 -37.22 83.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.985 -1.072 . . . . 0.0 110.204 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.19 -26.78 66.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.889 -1.132 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -63.85 -50.12 70.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 123.884 0.873 . . . . 0.0 109.605 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.42 -23.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 121.627 -0.671 . . . . 0.0 110.334 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.6 -50.18 74.56 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.364 0.984 . . . . 0.0 109.711 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -64.09 -42.79 96.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.807 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.05 -44.31 76.7 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.938 -0.476 . . . . 0.0 109.921 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.07 -37.45 85.04 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.144 -0.972 . . . . 0.0 112.026 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 -43.89 86.79 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.941 0.896 . . . . 0.0 110.738 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.21 -43.54 91.22 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.684 1.194 . . . . 0.0 107.973 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -64.52 -49.02 72.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.35 1.06 . . . . 0.0 110.839 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.09 92.97 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.526 1.53 . . . . 0.0 111.216 -173.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.7 -37.78 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 121.465 -0.772 . . . . 0.0 110.344 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -69.72 -38.48 76.91 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.747 -1.221 . . . . 0.0 110.466 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.15 -47.87 66.87 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 126.144 1.777 . . . . 0.0 109.501 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.15 -38.97 79.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.385 1.074 . . . . 0.0 110.977 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -69.74 99.14 1.3 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 119.99 -1.694 . . . . 0.0 113.073 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.81 -3.27 19.54 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.29 148.87 37.42 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 118.193 0.997 . . . . 0.0 108.446 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -80.26 145.59 17.15 Favored 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.418 2.079 . . . . 0.0 109.967 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.31 -8.83 69.35 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 119.239 0.927 . . . . 0.0 111.374 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.01 53.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.92 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.06 -29.25 4.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.31 58.17 4.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.994 1.378 . . . . 0.0 107.959 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -87.5 42.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 O-C-N 119.852 -1.78 . . . . 0.0 111.276 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -135.29 -117.0 0.18 Allowed 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.745 -1.222 . . . . 0.0 109.672 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 t80 171.7 -66.65 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.904 0 CA-C-O 116.315 -1.802 . . . . 0.0 108.766 -172.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -4.64 15.7 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 CA-C-N 125.175 2.884 . . . . 0.0 111.796 -164.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -103.99 -10.15 18.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 127.157 2.183 . . . . 0.0 109.1 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.85 63.89 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.231 -0.918 . . . . 0.0 110.31 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.79 -38.17 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.91 0.862 . . . . 0.0 110.479 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.32 -31.45 26.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -55.77 -40.87 73.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.297 1.039 . . . . 0.0 110.854 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -62.37 -29.36 70.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.698 0.799 . . . . 0.0 112.596 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.78 -36.07 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 120.846 -1.159 . . . . 0.0 108.52 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -65.69 -17.39 64.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.448 1.099 . . . . 0.0 112.166 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 t -109.31 -31.35 7.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.59 -1.319 . . . . 0.0 108.554 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.05 65.57 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.31 -1.494 . . . . 0.0 112.569 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 p -97.9 3.41 49.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.268 12.2 p 55.53 26.71 9.36 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 128.739 2.816 . . . . 0.0 112.569 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG21 ' SD ' ' B' ' 75' ' ' MET . 16.3 m -80.02 -54.48 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 55.87 11.42 Favored Glycine 0 CA--C 1.485 -1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.85 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.89 -17.25 61.36 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.805 0.812 . . . . 0.0 111.96 -173.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.6 40.36 6.82 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.98 -46.61 70.84 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.59 -168.15 1.69 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.04 108.43 5.0 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.11 175.41 10.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.417 2.745 . . . . 0.0 109.281 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 64' ' ' THR . 15.0 p -140.14 -176.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.564 ' H ' HG22 ' A' ' 63' ' ' VAL . 65.7 m -66.7 -45.25 79.36 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.714 -1.866 . . . . 0.0 112.158 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -80.0 -6.77 58.18 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 119.206 0.912 . . . . 0.0 111.156 -170.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.56 -32.68 74.18 Favored 'General case' 0 C--N 1.359 0.986 0 CA-C-O 123.888 1.804 . . . . 0.0 106.259 168.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.26 65.82 1.02 Allowed Glycine 0 CA--C 1.463 -3.168 1 N-CA-C 102.22 -4.352 . . . . 0.0 102.22 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -27.09 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.374 1.665 1 C-N-CA 131.95 4.1 . . . . 0.0 115.472 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -50.72 -12.23 0.1 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 164.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.73 -49.64 49.85 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 123.023 2.647 . . . . 0.0 106.942 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.03 -43.39 98.96 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.871 0.868 . . . . 0.0 110.426 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -65.23 -43.69 90.62 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.705 0.402 . . . . 0.0 111.386 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.68 -41.0 96.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 121.184 -0.948 . . . . 0.0 110.767 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.47 -34.44 35.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.889 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 55.9 ttm -62.72 -52.21 64.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.15 -32.49 70.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.426 -0.796 . . . . 0.0 110.481 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.3 -35.08 77.92 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.835 -0.541 . . . . 0.0 110.907 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.78 96.62 Favored Glycine 0 CA--C 1.492 -1.377 0 C-N-CA 123.646 0.641 . . . . 0.0 111.743 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.14 -47.04 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 124.264 1.026 . . . . 0.0 109.016 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.79 -30.21 68.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.139 -0.976 . . . . 0.0 111.572 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.65 -55.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.618 0.767 . . . . 0.0 109.461 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.37 -33.6 74.56 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 121.464 -0.772 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.72 72.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.153 -0.967 . . . . 0.0 110.529 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.74 -29.06 70.03 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 120.6 -1.312 . . . . 0.0 111.108 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.68 -11.7 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.489 1.515 . . . . 0.0 111.121 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.3 m -51.42 -29.39 15.74 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 119.428 -2.045 . . . . 0.0 112.581 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.14 62.88 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.407 -1.433 . . . . 0.0 112.065 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.2 -56.4 3.29 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 125.695 1.598 . . . . 0.0 108.686 172.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.09 -39.64 75.42 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.994 0.918 . . . . 0.0 112.816 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.9 -14.99 60.27 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.048 -1.033 . . . . 0.0 111.372 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.36 -9.52 47.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 120.683 -1.26 . . . . 0.0 107.702 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -37.52 73.81 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.415 -0.803 . . . . 0.0 109.618 -172.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -71.38 -24.9 62.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.987 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.5 t -70.52 -24.48 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 108.4 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -65.23 -15.7 62.75 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.081 -1.012 . . . . 0.0 111.735 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -55.91 -40.74 73.51 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 124.027 0.931 . . . . 0.0 110.438 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . 0.297 11.3 pt-20 . . . . . 0 CA--C 1.501 -0.928 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.32 -172.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p30 . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -61.36 -20.17 62.69 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.82 -34.37 62.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.048 -1.033 . . . . 0.0 108.537 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -69.1 -25.61 64.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.69 -0.631 . . . . 0.0 111.008 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -69.78 -44.16 70.7 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.87 87.95 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.261 1.424 . . . . 0.0 111.677 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -56.31 -38.7 71.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.771 1.629 . . . . 0.0 111.161 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -79.34 -13.77 59.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.391 -0.818 . . . . 0.0 111.396 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.55 -36.33 63.12 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -62.99 -43.18 99.5 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.78 0.8 . . . . 0.0 110.395 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.86 -43.43 98.81 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.26 1.424 . . . . 0.0 109.932 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.39 -39.93 77.13 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.931 1.692 . . . . 0.0 110.369 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.71 -41.11 98.14 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 123.381 0.672 . . . . 0.0 111.026 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -59.48 -35.63 74.47 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.426 1.091 . . . . 0.0 110.801 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.33 -34.94 79.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.638 1.175 . . . . 0.0 110.595 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.6 -39.67 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.93 -34.49 78.09 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -72.01 -30.71 65.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 111.864 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -81.89 -37.09 27.41 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.599 -1.313 . . . . 0.0 108.892 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.46 92.87 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.494 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 21.5 p -60.62 -38.7 85.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.492 0.717 . . . . 0.0 111.878 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -75.42 -53.84 8.03 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -62.4 -26.52 68.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.874 0.87 . . . . 0.0 111.186 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -43.85 72.14 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.837 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.16 -12.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.603 1.192 . . . . 0.0 109.153 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.52 21.5 17.35 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.842 -1.786 . . . . 0.0 107.119 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -92.34 -51.7 5.02 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' B' ' 31' ' ' ARG 0.286 0.6 OUTLIER -76.98 -80.42 0.1 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.129 -170.54 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 9.8 mmm180 59.72 -27.73 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 129.611 3.164 . . . . 0.0 116.584 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.45 37.66 0.23 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.19 156.35 79.15 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.968 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.83 123.14 8.74 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.249 2.633 . . . . 0.0 109.899 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.95 -58.41 3.25 Favored Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.3 174.1 0.16 Allowed 'General case' 0 C--N 1.35 0.598 0 C-N-CA 127.539 2.335 . . . . 0.0 109.515 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 61' ' ' TYR . . . -174.92 -53.2 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.76 -1.212 . . . . 0.0 108.93 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.22 138.34 31.57 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 pt -163.18 177.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t 71.97 102.85 0.07 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.751 2.02 . . . . 0.0 110.662 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -49.67 -53.43 41.59 Favored Pre-proline 0 C--N 1.35 0.627 0 CA-C-O 116.782 -1.58 . . . . 0.0 113.264 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.86 -11.68 25.85 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 124.709 2.718 . . . . 0.0 111.921 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -95.52 -27.96 15.12 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.77 72.13 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.442 1.497 . . . . 0.0 111.491 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.08 -30.37 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 121.506 -0.746 . . . . 0.0 111.206 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.03 -20.9 40.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.659 -1.275 . . . . 0.0 109.912 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -65.32 -47.2 77.36 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -57.85 -30.91 66.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.88 -27.95 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.73 0.812 . . . . 0.0 111.296 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -88.36 -3.55 58.82 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.269 -1.519 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -113.18 -175.75 2.74 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 81.11 -50.21 0.28 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.351 1.86 . . . . 0.0 109.391 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -88.12 32.27 0.76 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.204 1.401 . . . . 0.0 111.532 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 42.07 61.7 1.87 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.318 2.247 . . . . 0.0 114.313 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.643 HG13 ' H ' ' B' ' 56' ' ' GLY . 1.0 OUTLIER -134.62 -93.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 176.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.643 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 84.97 87.74 0.9 Allowed Glycine 0 CA--C 1.495 -1.2 0 N-CA-C 104.976 -3.25 . . . . 0.0 104.976 -171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -77.73 -18.8 56.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.813 -1.404 . . . . 0.0 108.712 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 45.53 1.8 Allowed Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.95 -59.55 2.73 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.82 162.04 36.5 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' B' ' 37' ' ' ALA . 34.3 p90 -144.9 148.89 40.68 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.448 ' HB2' ' HG3' ' B' ' 66' ' ' GLU . 32.7 Cg_endo -81.52 160.64 19.53 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 123.381 2.721 . . . . 0.0 108.622 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.23 -99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-N 121.02 1.736 . . . . 0.0 110.424 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -141.57 -48.31 0.39 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 120.13 1.332 . . . . 0.0 111.299 -167.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -27.57 64.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 125.522 1.529 . . . . 0.0 108.196 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' B' ' 62' ' ' PRO . 1.4 pm0 -53.47 -25.44 16.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.067 2.147 . . . . 0.0 111.963 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.32 93.86 1.31 Allowed Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 98.736 -5.746 . . . . 0.0 98.736 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -63.49 -11.6 25.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.69 -1.477 . . . . 0.0 111.9 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -61.58 -17.3 54.47 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.999 0.92 . . . . 0.0 112.328 168.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.78 -33.44 59.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.811 -1.181 . . . . 0.0 109.379 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.99 7.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 120.467 -1.395 . . . . 0.0 108.007 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -48.09 -52.43 20.37 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 125.916 1.687 . . . . 0.0 110.29 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -69.36 -29.57 67.39 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.983 -0.448 . . . . 0.0 111.234 -170.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.8 t -75.41 -44.01 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 O-C-N 120.824 -1.172 . . . . 0.0 108.673 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 36.0 mtm -64.75 -45.68 85.4 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 110.516 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -75.39 -21.7 58.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.378 -0.826 . . . . 0.0 111.15 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.24 -31.11 70.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.889 -1.132 . . . . 0.0 110.486 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.26 -39.23 95.9 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.6 mt -61.84 -38.44 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.09 0.956 . . . . 0.0 108.946 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.97 -54.79 24.93 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.623 -1.298 . . . . 0.0 112.065 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 m -66.74 -45.38 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 123.119 0.568 . . . . 0.0 110.513 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.97 -33.29 63.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.04 -28.88 67.77 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.958 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -65.55 -36.79 84.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 120.925 -1.11 . . . . 0.0 109.984 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.1 -17.97 20.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 125.135 1.374 . . . . 0.0 110.766 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -54.49 -24.41 20.32 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.701 1.2 . . . . 0.0 111.895 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.66 86.93 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.233 -1.542 . . . . 0.0 112.472 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.1 -45.17 70.91 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.66 1.184 . . . . 0.0 108.683 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.86 -37.36 85.97 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.621 0.724 . . . . 0.0 110.353 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.21 76.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.901 -1.124 . . . . 0.0 111.387 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.7 t -78.51 -0.38 29.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 120.607 -1.308 . . . . 0.0 110.27 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -33.89 65.43 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 119.25 0.932 . . . . 0.0 109.758 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -71.11 -31.07 67.3 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.767 -1.208 . . . . 0.0 110.508 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.07 -24.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.89 1.276 . . . . 0.0 109.455 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -58.52 -21.74 53.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.213 1.005 . . . . 0.0 112.38 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.88 -23.01 67.1 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.63 -1.294 . . . . 0.0 111.049 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 C--N 1.357 0.899 0 O-C-N 121.074 -1.016 . . . . 0.0 110.013 179.674 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.383 0 CA-C-O 122.759 1.266 . . . . 0.0 114.126 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.596 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 36.6 p-80 -58.35 -25.43 61.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.512 2.325 . . . . 0.0 115.413 -174.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -75.31 -27.15 59.18 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.338 -1.476 . . . . 0.0 110.435 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.47 -36.4 71.17 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.2 -0.937 . . . . 0.0 109.603 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.28 -38.44 65.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.93 0.892 . . . . 0.0 109.29 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.31 93.57 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.235 1.014 . . . . 0.0 111.858 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -27.75 60.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.397 -0.815 . . . . 0.0 110.578 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.69 -33.0 66.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.9 84.72 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -58.8 -35.13 72.34 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.552 0.741 . . . . 0.0 112.128 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.33 -24.08 61.25 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.345 -0.847 . . . . 0.0 111.384 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -73.77 -35.96 65.04 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.82 -42.46 99.05 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.303 -0.873 . . . . 0.0 110.928 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -57.83 -38.07 74.97 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.346 1.058 . . . . 0.0 111.97 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.81 81.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.567 1.147 . . . . 0.0 109.892 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.67 -37.7 79.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 O-C-N 121.15 -0.969 . . . . 0.0 108.748 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.33 -36.48 73.46 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.742 0.817 . . . . 0.0 112.226 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -63.42 -51.91 63.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.703 1.201 . . . . 0.0 109.169 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -63.77 -40.43 96.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.494 0.664 . . . . 0.0 110.216 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -32.27 73.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.386 1.474 . . . . 0.0 112.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -68.94 -34.87 76.06 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.387 -0.821 . . . . 0.0 110.378 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -70.89 -37.59 73.01 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.22 -51.54 63.2 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 -17.55 63.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -82.66 -36.07 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 O-C-N 120.327 -1.483 . . . . 0.0 108.402 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -78.33 -41.8 32.53 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.81 90.23 7.83 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 143.99 2.09 0.0 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.987 3.715 . . . . 0.0 110.085 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -91.05 41.36 1.06 Allowed 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.594 -1.941 . . . . 0.0 112.408 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.31 44.67 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.389 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' C' ' 36' ' ' ALA . . . -103.75 157.42 33.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.21 98.64 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.658 2.239 . . . . 0.0 112.647 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 9.36 36.79 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -52.68 143.6 15.83 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.604 1.562 . . . . 0.0 112.591 -177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.88 -32.4 3.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 124.639 1.176 . . . . 0.0 108.807 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 tt -89.49 50.6 1.94 Allowed 'General case' 0 C--N 1.35 0.603 0 CA-C-O 122.898 1.332 . . . . 0.0 108.144 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.53 53.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 O-C-N 119.915 -1.741 . . . . 0.0 110.083 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -125.87 -151.17 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.89 -1.131 . . . . 0.0 108.401 -167.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -171.32 -64.12 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -69.6 -32.11 19.89 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.214 2.898 . . . . 0.0 112.386 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.469 ' CG ' HH22 ' C' ' 60' ' ' ARG . 8.3 p-10 -95.32 15.71 18.66 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.504 1.047 . . . . 0.0 109.88 -178.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -32.9 73.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.636 -1.29 . . . . 0.0 110.009 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -73.2 -22.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 O-C-N 121.562 -0.711 . . . . 0.0 109.84 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.24 -43.1 58.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.84 -37.24 86.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.75 1.22 . . . . 0.0 109.651 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -58.74 -35.22 72.37 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.73 1.212 . . . . 0.0 111.262 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.54 -52.72 56.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.007 0.923 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.36 -24.98 60.4 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 121.834 -0.541 . . . . 0.0 110.922 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -63.87 -42.77 97.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.002 1.321 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.38 73.9 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.34 -0.85 . . . . 0.0 112.05 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -3.02 45.54 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.158 -0.964 . . . . 0.0 111.405 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.255 3.1 p 59.8 21.71 10.57 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 127.479 2.312 . . . . 0.0 111.578 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.66 -48.05 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.53 74.53 0.35 Allowed Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -69.13 -24.96 64.16 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.217 -1.167 . . . . 0.0 110.867 -170.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.31 10.27 9.75 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.7 -61.4 2.38 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 126.737 2.015 . . . . 0.0 109.509 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.469 HH22 ' CG ' ' C' ' 43' ' ' ASP . 0.0 OUTLIER -145.6 174.14 11.44 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 171.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -167.53 154.37 7.86 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.14 170.63 8.22 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.005 2.47 . . . . 0.0 110.73 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.87 -146.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -76.83 -60.52 2.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 126.172 1.789 . . . . 0.0 109.914 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.91 -16.74 61.09 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.897 0.856 . . . . 0.0 110.264 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.412 ' CD ' ' HB2' ' C' ' 33' ' ' ALA . 13.6 mm-40 -75.35 -16.42 60.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.608 -0.682 . . . . 0.0 109.352 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.77 88.76 0.64 Allowed Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 101.252 -4.739 . . . . 0.0 101.252 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -64.47 -13.03 49.77 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.426 -1.632 . . . . 0.0 110.846 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -60.77 -14.07 19.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.165 0.986 . . . . 0.0 113.172 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.09 -37.4 79.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 O-C-N 120.833 -1.167 . . . . 0.0 109.584 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.83 57.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.085 -1.009 . . . . 0.0 108.953 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.69 -48.77 49.45 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.045 1.738 . . . . 0.0 112.235 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -67.69 -32.06 72.44 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 120.47 -1.394 . . . . 0.0 112.056 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.77 -37.62 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.057 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 55' ' ' VAL . 69.5 mtm -63.07 -45.89 90.0 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.538 0.735 . . . . 0.0 110.807 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -62.9 -35.61 80.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.718 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.3 77.93 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 118.271 0.487 . . . . 0.0 111.815 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.18 -53.32 22.69 Favored Glycine 0 CA--C 1.49 -1.482 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.76 -44.59 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.195 0.998 . . . . 0.0 109.382 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -65.39 -40.0 92.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.441 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.58 -50.1 69.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -66.9 -37.39 84.29 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.655 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.82 -32.89 74.67 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.104 0.962 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.19 -35.72 77.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 124.874 1.27 . . . . 0.0 110.963 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.69 -13.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 125.408 1.483 . . . . 0.0 111.118 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.8 m -62.04 -18.1 59.52 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.654 -1.904 . . . . 0.0 111.986 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.71 -17.33 62.87 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.571 -1.331 . . . . 0.0 111.594 170.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -83.45 -54.46 4.95 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.74 -28.44 66.82 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -165.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.76 -14.18 60.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.61 -1.931 . . . . 0.0 111.029 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -73.78 -17.14 61.13 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 119.94 -1.725 . . . . 0.0 109.828 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -30.13 70.43 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.245 0.618 . . . . 0.0 111.064 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -75.42 -23.89 57.04 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.027 -1.046 . . . . 0.0 110.911 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.67 -27.24 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 123.914 0.885 . . . . 0.0 108.675 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -67.49 -10.83 55.3 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.698 -0.626 . . . . 0.0 112.538 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -67.24 -36.65 82.09 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 120.782 -1.199 . . . . 0.0 109.074 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.436 -1.125 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -176.175 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.433 -1.277 0 CA-C-O 121.394 0.616 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.25 -64.86 0.46 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 129.017 2.927 . . . . 0.0 112.688 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' D' ' 2' ' ' ALA . 39.3 p-80 -62.91 -25.6 68.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 112.996 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -79.61 -39.67 31.08 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -64.07 -44.65 91.75 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.592 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.54 -37.21 86.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 110.563 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.84 72.6 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.092 -1.005 . . . . 0.0 110.215 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.32 -28.31 67.04 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.424 0.69 . . . . 0.0 110.646 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.97 -41.81 75.33 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 125.697 1.599 . . . . 0.0 110.964 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.15 86.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.286 0.634 . . . . 0.0 111.5 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.91 -26.03 65.79 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.069 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -71.43 -33.2 69.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.9 -1.125 . . . . 0.0 109.969 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -65.42 -40.04 92.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 123.905 0.882 . . . . 0.0 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.88 -42.61 89.91 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.09 0.556 . . . . 0.0 111.527 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.3 -36.98 79.14 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 112.28 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -68.87 -39.79 79.64 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 110.003 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.06 -40.41 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.15 -53.1 60.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.951 0.796 . . . . 0.0 110.554 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -59.72 -50.02 75.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.869 0.868 . . . . 0.0 111.166 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -73.67 -29.05 62.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.857 -1.152 . . . . 0.0 111.513 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.88 63.94 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -58.51 -45.08 89.54 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.377 1.071 . . . . 0.0 110.565 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -60.9 -49.91 75.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -64.16 -31.82 73.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 123.923 0.889 . . . . 0.0 111.599 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.33 68.77 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.346 0.975 . . . . 0.0 110.693 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -88.01 -32.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 O-C-N 121.393 -0.817 . . . . 0.0 111.793 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -75.29 -23.87 57.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.227 -1.545 . . . . 0.0 111.413 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.0 37.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.72 -86.54 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 mtm-85 -17.32 90.45 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 129.121 2.968 . . . . 0.0 115.361 -151.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -30.79 2.0 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 107.021 -2.432 . . . . 0.0 107.021 -171.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.62 141.24 25.57 Favored Pre-proline 0 C--N 1.353 0.727 0 C-N-CA 125.728 1.611 . . . . 0.0 114.396 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.07 92.83 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.698 2.266 . . . . 0.0 113.345 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.68 -43.55 1.48 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 103.667 -3.773 . . . . 0.0 103.667 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.68 -179.17 0.17 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.551 1.94 . . . . 0.0 109.894 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.7 -41.79 0.05 Allowed 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.75 -14.75 13.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.05 1.34 . . . . 0.0 112.39 -167.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 pt -43.2 105.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -174.91 -143.53 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.6 -58.8 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.09 0 C-N-CA 126.641 1.977 . . . . 0.0 107.553 173.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.6 -20.71 26.53 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 126.064 3.201 . . . . 0.0 112.334 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.68 6.11 42.87 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 118.632 0.651 . . . . 0.0 110.241 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.0 -50.69 67.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.394 -0.817 . . . . 0.0 109.758 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.6 -7.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.013 0.911 . . . . 0.0 110.625 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 -28.24 15.92 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -83.74 -28.51 28.18 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.4 1.0 . . . . 0.0 108.947 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.8 t -78.17 62.69 2.94 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.484 -1.385 . . . . 0.0 108.717 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 84.4 t -137.87 -77.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.99 -5.61 54.29 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.003 -1.061 . . . . 0.0 111.606 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -82.04 -17.16 47.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 121.076 -1.015 . . . . 0.0 108.493 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.09 -32.77 56.88 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.898 -1.126 . . . . 0.0 109.158 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -91.36 16.86 9.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.193 0.597 . . . . 0.0 110.336 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p 55.1 52.45 11.7 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.143 1.777 . . . . 0.0 114.373 170.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -127.11 -61.87 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 87.65 -51.32 4.11 Favored Glycine 0 CA--C 1.496 -1.13 0 O-C-N 119.997 -1.689 . . . . 0.0 109.785 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 74.89 -24.76 0.21 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 128.151 2.58 . . . . 0.0 110.615 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 111.25 23.87 5.61 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.02 -65.91 0.64 Allowed 'General case' 0 C--N 1.36 1.063 0 CA-C-N 118.905 1.352 . . . . 0.0 110.056 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -126.81 161.72 27.55 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.57 89.06 7.61 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 117.858 -1.067 . . . . 0.0 109.168 -170.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.17 158.85 56.14 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.823 2.349 . . . . 0.0 111.875 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.539 HG22 ' H ' ' D' ' 64' ' ' THR . 3.6 p -111.8 -162.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 120.161 1.346 . . . . 0.0 110.788 -174.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.539 ' H ' HG22 ' D' ' 63' ' ' VAL . 1.3 p -70.09 -49.73 47.97 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 128.968 2.907 . . . . 0.0 111.258 -174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -69.65 -30.63 68.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.003 0.921 . . . . 0.0 110.942 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 8.4 pt-20 -79.49 -1.27 36.77 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.83 82.44 0.21 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 104.131 -3.588 . . . . 0.0 104.131 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -50.87 -22.09 2.03 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 120.642 2.221 . . . . 0.0 111.75 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -43.8 -23.08 0.07 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.412 1.885 . . . . 0.0 115.42 161.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.37 -43.91 97.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.588 1.54 . . . . 0.0 108.778 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.54 87.29 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.026 0.53 . . . . 0.0 110.22 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -57.56 -41.91 81.96 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.722 1.209 . . . . 0.0 110.466 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -62.23 -40.36 95.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.347 1.059 . . . . 0.0 111.429 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.06 -42.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -60.98 -46.43 90.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.526 0.73 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -66.84 -36.12 81.61 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 121.438 -0.789 . . . . 0.0 111.523 -175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -44.75 93.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 121.764 -0.585 . . . . 0.0 110.047 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.04 -47.81 89.21 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 124.465 1.031 . . . . 0.0 112.537 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.17 -49.39 81.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.63 1.172 . . . . 0.0 109.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.36 -31.46 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.477 -0.764 . . . . 0.0 111.429 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.4 -53.0 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 118.862 0.756 . . . . 0.0 110.136 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.53 -32.29 72.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.811 -0.555 . . . . 0.0 110.957 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.54 -39.86 92.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.694 1.198 . . . . 0.0 110.802 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.77 -22.42 12.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 124.766 1.226 . . . . 0.0 110.982 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -60.87 -12.21 10.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.0 95.16 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 118.784 -2.447 . . . . 0.0 112.27 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.88 72.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 36.9 mt -80.36 -28.51 38.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.722 0.772 . . . . 0.0 110.876 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.94 -26.32 59.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 120.326 -1.484 . . . . 0.0 110.025 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -78.65 -2.78 40.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.773 -1.204 . . . . 0.0 109.949 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.251 11.8 m-20 -78.68 -16.83 56.83 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 120.68 1.582 . . . . 0.0 111.663 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -80.68 -11.89 59.56 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.227 -1.546 . . . . 0.0 109.846 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.75 -32.85 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -61.7 -19.29 62.2 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.804 1.642 . . . . 0.0 111.872 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -65.18 -22.16 66.86 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.445 1.098 . . . . 0.0 111.439 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.433 -1.281 0 C-N-CA 126.359 1.864 . . . . 0.0 106.16 -170.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 73.13 -58.27 0.61 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.958 2.103 . . . . 0.0 111.11 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 2' ' ' ALA . 28.9 p80 -61.99 -30.51 70.99 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.962 1.705 . . . . 0.0 111.098 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -67.06 -45.13 78.33 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.67 1.188 . . . . 0.0 108.46 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.04 -44.53 96.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.98 0.912 . . . . 0.0 109.687 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -66.23 -32.97 74.71 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.443 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.38 88.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 121.569 -0.707 . . . . 0.0 110.454 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -69.91 -31.13 68.76 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.614 0.721 . . . . 0.0 110.967 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -66.7 -38.52 86.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.907 0.883 . . . . 0.0 110.088 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.04 77.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.772 0.829 . . . . 0.0 111.075 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.45 -37.11 84.63 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.79 0.836 . . . . 0.0 111.559 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -65.87 -43.42 88.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.78 -32.73 73.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 110.224 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.7 -39.95 91.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.375 0.67 . . . . 0.0 111.525 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -64.64 -32.93 74.81 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.592 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -64.82 -39.76 94.1 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.71 0.804 . . . . 0.0 109.915 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.03 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 O-C-N 120.704 -1.248 . . . . 0.0 109.479 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.2 mt -60.99 -37.41 82.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.292 -0.88 . . . . 0.0 111.573 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.99 -45.48 73.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.933 0.893 . . . . 0.0 109.16 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -63.0 -43.64 98.22 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.969 -0.457 . . . . 0.0 109.814 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.31 74.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.873 1.669 . . . . 0.0 111.554 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -65.96 -37.38 85.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 122.153 -0.342 . . . . 0.0 110.964 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -73.09 -45.59 56.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -61.47 -46.28 90.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.07 53.16 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.027 1.331 . . . . 0.0 111.271 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.99 -39.39 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.767 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -81.96 -15.03 55.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.267 -1.521 . . . . 0.0 111.383 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.65 7.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.84 -33.15 74.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.251 1.021 . . . . 0.0 111.465 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -72.31 108.48 5.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 119.541 -1.974 . . . . 0.0 110.356 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.07 -18.83 7.4 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.43 143.82 42.24 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 117.519 0.66 . . . . 0.0 111.0 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.63 116.12 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.575 2.183 . . . . 0.0 111.983 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.3 45.18 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.95 -67.37 0.27 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 127.616 2.366 . . . . 0.0 109.845 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 90.22 -31.1 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 126.754 2.022 . . . . 0.0 108.733 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -89.46 124.92 34.93 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.3 pt -137.63 -3.97 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.986 -1.071 . . . . 0.0 112.483 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -117.99 152.86 34.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 120.097 1.317 . . . . 0.0 109.942 -164.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -83.03 -55.69 0.5 Allowed Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.02 -17.92 28.03 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 CA-C-N 125.404 2.966 . . . . 0.0 111.706 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.64 -21.05 25.52 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.39 70.53 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 120.997 -1.064 . . . . 0.0 110.541 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.68 -28.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.541 -0.725 . . . . 0.0 109.553 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.37 68.71 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 119.752 -1.843 . . . . 0.0 109.927 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -62.79 -47.63 82.63 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.165 0.986 . . . . 0.0 109.815 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -68.73 -28.44 66.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.291 -1.505 . . . . 0.0 111.698 -172.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.4 t -56.83 -54.31 31.11 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 124.153 0.981 . . . . 0.0 109.974 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -20.26 61.29 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.787 -0.57 . . . . 0.0 111.116 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.6 m -75.14 -40.36 59.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.37 1.068 . . . . 0.0 109.218 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -26.55 63.07 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 120.86 -1.15 . . . . 0.0 111.359 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 p -83.37 -1.18 52.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.916 -0.49 . . . . 0.0 110.12 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 p 55.3 39.76 31.38 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 126.386 1.874 . . . . 0.0 111.538 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -104.23 -75.12 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.42 91.77 0.12 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CZ ' ' HA3' ' B' ' 56' ' ' GLY . 0.3 OUTLIER -75.95 -28.24 57.86 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.834 -1.392 . . . . 0.0 109.734 -172.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.33 3.64 5.63 Favored Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.6 -50.94 70.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.5 1.52 . . . . 0.0 113.29 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -142.06 158.62 43.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.33 148.06 20.51 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 102.934 -2.987 . . . . 0.0 102.934 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -90.79 171.09 3.41 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.901 2.4 . . . . 0.0 110.707 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.01 -154.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.686 0 CA-C-O 122.61 1.195 . . . . 0.0 110.291 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -83.51 -52.89 6.11 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.029 -1.669 . . . . 0.0 110.89 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -63.65 -32.2 73.6 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.798 2.439 . . . . 0.0 111.657 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -28.04 69.57 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 123.309 1.528 . . . . 0.0 108.1 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 65.74 1.22 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 103.097 -4.001 . . . . 0.0 103.097 174.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -27.78 -26.79 0.0 OUTLIER 'General case' 0 C--N 1.376 1.742 1 C-N-CA 131.715 4.006 . . . . 0.0 116.043 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -55.02 -12.77 0.92 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.366 2.666 . . . . 0.0 113.201 167.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 -52.13 34.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.11 99.68 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.555 -0.716 . . . . 0.0 111.347 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -50.6 -47.46 58.14 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.364 1.466 . . . . 0.0 111.379 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.66 -40.91 96.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.58 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.84 -43.77 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.205 1.002 . . . . 0.0 109.375 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.04 -49.1 78.98 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 124.391 1.076 . . . . 0.0 110.111 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -64.38 -35.04 79.6 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.631 -0.668 . . . . 0.0 110.897 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.38 80.6 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.147 0.579 . . . . 0.0 111.262 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.05 -43.65 80.71 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.54 -43.66 97.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 124.279 1.032 . . . . 0.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -60.41 -39.96 89.25 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.393 -0.817 . . . . 0.0 111.271 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.06 -54.28 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.103 0.961 . . . . 0.0 109.537 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -61.67 -40.08 93.67 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.421 0.689 . . . . 0.0 111.302 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.36 80.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.914 0.885 . . . . 0.0 110.981 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.58 -35.24 79.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.529 1.132 . . . . 0.0 110.804 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.12 -16.79 7.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 125.301 1.44 . . . . 0.0 111.206 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.0 m -56.6 -24.35 47.16 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.12 -1.612 . . . . 0.0 112.48 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.18 -23.78 62.52 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.842 -1.161 . . . . 0.0 112.439 172.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.59 -3.88 21.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.623 1.169 . . . . 0.0 111.587 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.5 mt -96.67 -42.98 7.76 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.45 64.64 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.343 -0.848 . . . . 0.0 111.067 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -71.32 -20.48 62.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 120.632 -1.292 . . . . 0.0 111.161 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.265 25.5 m-20 -86.8 -8.95 56.88 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.249 -162.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -81.96 -32.36 30.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.442 165.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.67 -32.67 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.789 1.236 . . . . 0.0 109.075 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -53.22 -24.67 11.65 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.583 1.553 . . . . 0.0 112.543 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -54.26 -39.33 66.76 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.596 1.559 . . . . 0.0 110.774 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 N--CA 1.444 -0.753 0 O-C-N 121.591 -0.693 . . . . 0.0 111.643 -175.481 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 121.871 0.844 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.714 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 35.1 p-80 -63.9 -21.48 66.48 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.501 1.52 . . . . 0.0 111.769 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -35.09 76.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.666 1.187 . . . . 0.0 109.044 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -68.69 -31.68 70.94 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.407 -0.808 . . . . 0.0 110.894 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.07 -27.9 63.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.297 0.57 . . . . 0.0 110.075 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.35 -35.62 78.01 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.305 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.73 -28.72 61.85 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.436 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.69 -38.34 90.66 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.393 -0.817 . . . . 0.0 109.817 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.45 89.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.956 0.903 . . . . 0.0 110.99 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.45 -37.91 89.18 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 121.302 -0.874 . . . . 0.0 111.335 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -65.62 -41.25 92.9 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.386 -0.821 . . . . 0.0 109.713 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.39 -37.23 74.88 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.765 1.226 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -63.67 -42.67 98.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.26 -29.07 68.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.543 -0.723 . . . . 0.0 111.423 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -66.47 -46.89 74.85 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.804 1.242 . . . . 0.0 109.851 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -76.01 -19.33 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 121.534 -0.729 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.75 -43.3 99.16 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 119.533 1.06 . . . . 0.0 110.323 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.54 -39.18 77.63 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -68.87 -31.93 71.23 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.199 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.32 -32.36 73.93 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.752 1.221 . . . . 0.0 110.636 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.0 t -62.2 -48.23 80.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.429 1.092 . . . . 0.0 109.269 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -60.98 -53.39 57.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 108.793 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -65.15 -38.44 90.58 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.33 -54.05 43.06 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.676 1.126 . . . . 0.0 110.984 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.24 -36.59 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.814 -0.554 . . . . 0.0 110.082 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.51 -31.88 57.94 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.18 -0.95 . . . . 0.0 110.33 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.5 -41.87 37.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 O-C-N 121.911 -0.493 . . . . 0.0 110.011 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.31 -28.23 69.17 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 121.87 0.843 . . . . 0.0 111.954 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -72.28 107.53 4.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 119.73 -1.856 . . . . 0.0 110.621 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.02 -24.13 4.56 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 106.594 -2.602 . . . . 0.0 106.594 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 147.22 84.37 Favored Pre-proline 0 N--CA 1.444 -0.759 0 O-C-N 121.94 -0.741 . . . . 0.0 111.444 -171.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.92 145.62 22.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.441 2.094 . . . . 0.0 109.689 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.95 -67.55 3.69 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.04 157.45 0.11 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.936 2.894 . . . . 0.0 109.946 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.27 -43.82 0.37 Allowed 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 120.922 -1.111 . . . . 0.0 108.907 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' B' ' 60' ' ' ARG . 12.7 tp -121.64 111.43 17.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.8 80.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 120.336 -1.478 . . . . 0.0 108.649 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -159.11 158.86 33.74 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.81 -61.58 0.24 Allowed Pre-proline 0 C--N 1.347 0.5 0 CA-C-O 116.971 -1.49 . . . . 0.0 109.204 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.5 -9.53 24.22 Favored 'Trans proline' 0 CA--C 1.511 -0.646 0 CA-C-N 124.835 2.763 . . . . 0.0 112.121 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.08 -22.22 16.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -40.33 82.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 121.452 -0.78 . . . . 0.0 109.25 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -66.16 -27.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 122.737 0.415 . . . . 0.0 110.937 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -73.14 -43.17 61.97 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.465 -0.772 . . . . 0.0 109.09 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.47 -31.93 73.24 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 125.071 1.349 . . . . 0.0 110.036 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 m -63.06 -36.47 83.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 119.08 -2.262 . . . . 0.0 112.45 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 t -64.87 -45.51 94.66 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 121.534 -0.729 . . . . 0.0 110.54 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -65.42 -33.83 76.86 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 122.008 0.909 . . . . 0.0 110.302 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 87.4 m -67.56 -41.3 84.45 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.285 -0.884 . . . . 0.0 109.85 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.75 61.78 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.173 -0.954 . . . . 0.0 112.189 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -97.29 0.86 48.79 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.263 18.7 p 62.21 31.37 17.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.863 1.665 . . . . 0.0 113.775 173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 78.87 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 57' ' ' TYR . . . -90.93 120.08 5.83 Favored Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 103.584 -3.806 . . . . 0.0 103.584 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -86.08 -84.95 0.16 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -168.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.95 37.6 0.31 Allowed Glycine 0 CA--C 1.479 -2.205 0 N-CA-C 106.292 -2.723 . . . . 0.0 106.292 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.1 -62.1 1.56 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' B' ' 38' ' ' LEU . 62.4 mtt-85 -143.22 170.61 15.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -156.76 153.58 24.75 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.96 173.83 8.84 Favored 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 124.25 3.3 . . . . 0.0 109.692 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.34 -99.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 119.695 1.134 . . . . 0.0 112.505 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.7 m -150.46 -40.07 0.13 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.029 1.732 . . . . 0.0 109.106 -172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -88.45 -20.5 25.11 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.283 -0.886 . . . . 0.0 110.645 -169.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -35.08 73.51 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 126.303 1.841 . . . . 0.0 108.315 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.38 90.02 1.88 Allowed Glycine 0 CA--C 1.467 -2.927 1 N-CA-C 97.802 -6.119 . . . . 0.0 97.802 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -56.42 -18.99 12.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.261 1.825 . . . . 0.0 111.382 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -54.72 -22.65 14.63 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 127.104 2.162 . . . . 0.0 113.135 168.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.26 -43.62 98.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.806 -1.184 . . . . 0.0 108.841 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.76 67.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.742 -0.599 . . . . 0.0 109.485 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -52.87 -45.04 67.26 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.482 1.513 . . . . 0.0 110.818 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.57 -39.82 85.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.001 0.92 . . . . 0.0 111.364 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.96 -41.22 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 109.086 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.5 mtt -60.43 -47.54 85.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.81 0.844 . . . . 0.0 110.049 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.927 -0.483 . . . . 0.0 111.134 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.37 90.76 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.766 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.23 -46.17 88.38 Favored Glycine 0 CA--C 1.495 -1.198 0 C-N-CA 124.061 0.839 . . . . 0.0 111.153 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.89 -46.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 C-N-CA 124.443 1.097 . . . . 0.0 109.182 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -62.76 -51.48 66.96 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.315 -0.866 . . . . 0.0 112.327 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.24 -40.84 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 O-C-N 121.76 -0.587 . . . . 0.0 111.081 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -74.22 -38.57 63.52 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.96 74.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.54 -0.725 . . . . 0.0 111.016 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.28 -30.57 71.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.756 1.222 . . . . 0.0 111.068 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.537 HG12 HD23 ' B' ' 89' ' ' LEU . 92.1 t -63.93 -14.91 15.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.879 1.272 . . . . 0.0 110.397 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 20.6 m -55.86 -23.46 30.96 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.6 -1.313 . . . . 0.0 110.894 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.45 74.92 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 119.251 -2.156 . . . . 0.0 112.446 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.714 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.61 -45.15 17.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 120.903 -1.123 . . . . 0.0 108.047 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.537 HD23 HG12 ' B' ' 85' ' ' VAL . 2.2 mm? -70.9 -27.7 63.99 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.877 0.871 . . . . 0.0 111.336 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.06 -17.07 62.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 120.689 -1.257 . . . . 0.0 111.192 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -76.72 -13.92 59.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 120.559 -1.338 . . . . 0.0 111.128 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.259 7.4 t70 -75.71 -18.23 59.67 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 120.231 1.378 . . . . 0.0 111.218 -167.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.43 -36.13 60.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 119.895 -1.753 . . . . 0.0 110.234 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.35 -28.82 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 126.029 1.731 . . . . 0.0 109.437 -171.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -44.21 -36.75 2.83 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 126.835 2.054 . . . . 0.0 112.013 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -58.33 -33.12 69.15 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 123.917 0.887 . . . . 0.0 111.753 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 N--CA 1.44 -0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 107.971 -173.181 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.495 -1.173 0 CA-C-O 120.811 0.338 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -61.29 -28.34 69.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.93 -37.57 64.55 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 120.137 1.335 . . . . 0.0 107.837 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -73.84 -38.31 64.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -68.43 -35.19 77.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.969 -0.457 . . . . 0.0 110.345 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.56 90.07 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.8 0.84 . . . . 0.0 110.796 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.64 -38.22 83.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.832 -0.542 . . . . 0.0 110.556 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.89 -40.42 92.98 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.72 0.808 . . . . 0.0 110.328 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.15 75.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.588 0.755 . . . . 0.0 111.588 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -38.49 86.41 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.791 -0.568 . . . . 0.0 111.403 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.71 -30.67 69.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 122.219 1.009 . . . . 0.0 109.846 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.29 -33.56 71.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.803 0.841 . . . . 0.0 109.213 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.35 -43.87 93.22 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.42 0.688 . . . . 0.0 110.649 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -52.36 -41.04 62.73 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.906 1.282 . . . . 0.0 111.771 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -24.17 61.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.845 0.858 . . . . 0.0 111.199 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -78.42 -36.55 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.73 -41.85 91.82 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.815 1.246 . . . . 0.0 111.14 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -74.36 -14.95 60.95 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.58 -36.15 19.05 Favored 'General case' 0 CA--C 1.493 -1.232 0 O-C-N 120.672 -1.268 . . . . 0.0 108.023 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.49 72.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.033 0.933 . . . . 0.0 111.152 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -68.95 -36.84 78.39 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.992 0.815 . . . . 0.0 110.432 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -71.15 -43.8 66.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.93 -49.88 76.15 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.591 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.8 86.65 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.432 1.093 . . . . 0.0 112.017 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -37.07 74.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.283 -1.511 . . . . 0.0 110.187 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -73.85 -31.92 63.41 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 120.751 -1.218 . . . . 0.0 109.279 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.24 15.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 126.06 1.744 . . . . 0.0 109.053 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.64 -25.96 64.18 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.143 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.61 104.91 2.5 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 119.481 -2.012 . . . . 0.0 110.59 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.47 -5.76 21.09 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 144.31 28.87 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.68 139.6 11.27 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.367 2.045 . . . . 0.0 110.277 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.65 81.46 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.58 116.01 4.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 125.74 1.616 . . . . 0.0 106.906 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.74 -33.55 15.7 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' C' ' 44' ' ' ALA . 24.5 tp -90.72 127.84 36.45 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 pt -144.88 168.8 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 101.222 -3.622 . . . . 0.0 101.222 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m 74.8 131.2 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.407 1.883 . . . . 0.0 113.402 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -58.64 -49.09 95.35 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 116.194 -1.86 . . . . 0.0 112.527 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.53 -27.94 38.78 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.297 2.928 . . . . 0.0 113.491 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.339 4.8 p-10 -98.7 -1.64 40.15 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 120.739 1.609 . . . . 0.0 111.035 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 38' ' ' LEU . . . -69.08 -34.17 74.69 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 120.713 -1.242 . . . . 0.0 110.878 173.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.66 -16.71 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 O-C-N 121.091 -1.006 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.08 -41.48 28.63 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.887 -1.133 . . . . 0.0 108.304 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.7 -33.29 75.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.858 0.837 . . . . 0.0 109.977 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -77.29 53.85 1.05 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 120.935 -1.103 . . . . 0.0 111.144 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -141.69 -54.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -34.25 71.13 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.741 1.216 . . . . 0.0 112.422 -172.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -72.68 -33.29 66.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 125.313 1.445 . . . . 0.0 109.898 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.1 -31.09 58.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.411 -1.431 . . . . 0.0 110.309 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -85.01 -1.74 57.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.171 0.588 . . . . 0.0 110.727 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p 51.13 68.01 0.86 Allowed 'General case' 0 C--N 1.352 0.709 0 C-N-CA 127.695 2.398 . . . . 0.0 112.099 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.12 -75.87 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.65 -78.94 0.63 Allowed Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -173.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 83.28 -49.62 0.15 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 127.746 2.419 . . . . 0.0 106.434 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.24 42.49 0.25 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -70.24 -54.12 14.12 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -139.4 -169.57 2.71 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.09 137.71 11.49 Favored Pre-proline 0 N--CA 1.438 -1.067 1 N-CA-C 100.153 -4.017 . . . . 0.0 100.153 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.07 163.0 0.26 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 CA-C-N 123.695 2.355 . . . . 0.0 109.389 166.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.596 HG22 ' H ' ' C' ' 64' ' ' THR . 9.8 p -107.19 -177.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-O 123.24 1.495 . . . . 0.0 111.558 -169.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.596 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.9 m -68.64 -34.82 76.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 119.085 -2.259 . . . . 0.0 111.211 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -78.68 -23.64 45.53 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 -170.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -67.07 -34.76 78.37 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.34 67.32 0.81 Allowed Glycine 0 CA--C 1.461 -3.327 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 171.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.44 ' HA ' ' OE2' ' C' ' 66' ' ' GLU 0.272 6.4 ttm180 -54.24 1.54 0.02 OUTLIER 'General case' 0 C--N 1.373 1.617 0 C-N-CA 127.582 2.353 . . . . 0.0 116.539 -166.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -54.54 -24.17 19.67 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 127.1 2.16 . . . . 0.0 111.48 155.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.24 -50.25 69.76 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 CA-C-N 120.639 1.563 . . . . 0.0 108.439 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.8 75.42 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.901 0.88 . . . . 0.0 110.869 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -51.87 -44.17 63.59 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.782 1.633 . . . . 0.0 112.081 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -62.4 -35.4 79.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.071 1.348 . . . . 0.0 110.899 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.43 -40.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 O-C-N 121.61 -0.681 . . . . 0.0 109.358 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -59.65 -46.79 87.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.853 1.261 . . . . 0.0 110.115 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.67 -41.08 98.89 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.966 -0.459 . . . . 0.0 110.707 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.98 89.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.883 0.473 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.78 87.87 Favored Glycine 0 CA--C 1.494 -1.232 0 C-N-CA 123.744 0.687 . . . . 0.0 111.534 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.66 -44.27 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 123.983 0.913 . . . . 0.0 109.648 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.91 -33.63 76.48 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.397 -0.815 . . . . 0.0 111.911 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.78 -53.68 28.91 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 123.642 0.777 . . . . 0.0 109.581 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -67.11 -36.13 81.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.53 87.58 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.342 0.657 . . . . 0.0 110.644 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.67 -35.39 74.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.213 1.405 . . . . 0.0 111.775 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.63 -16.46 10.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 C-N-CA 125.255 1.422 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -62.72 -13.26 30.46 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 119.602 -1.936 . . . . 0.0 112.166 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.85 67.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.923 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.2 -55.69 4.57 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.01 -38.63 86.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.403 1.481 . . . . 0.0 113.304 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.68 61.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.558 -1.339 . . . . 0.0 110.852 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 68.7 p -88.78 -12.37 42.26 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 120.82 -1.175 . . . . 0.0 110.616 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.37 -28.45 67.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.229 0.922 . . . . 0.0 110.537 -167.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -77.08 -33.44 57.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.93 -33.06 56.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 125.366 1.466 . . . . 0.0 108.685 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -52.51 -24.17 7.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.636 1.974 . . . . 0.0 113.956 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -58.01 -32.98 68.45 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 119.756 1.162 . . . . 0.0 112.111 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.438 -1.048 0 O-C-N 121.144 -0.973 . . . . 0.0 111.04 -178.486 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.74 -35.65 81.76 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 121.722 -0.612 . . . . 0.0 111.326 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.446 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 7.3 p80 -73.32 -23.93 60.31 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 121.013 -1.055 . . . . 0.0 111.42 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.446 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 0.1 OUTLIER -83.16 -27.95 29.71 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -63.78 -42.32 97.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.361 1.065 . . . . 0.0 110.361 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.7 -38.74 84.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.839 0.828 . . . . 0.0 109.148 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.26 89.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.39 1.076 . . . . 0.0 111.413 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -69.84 -28.76 65.96 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.529 -0.732 . . . . 0.0 110.766 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.75 69.67 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.337 0.655 . . . . 0.0 111.738 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.97 -36.13 82.49 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.44 -0.787 . . . . 0.0 111.365 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.07 -27.11 60.75 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.927 -1.108 . . . . 0.0 110.647 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.72 -27.5 65.03 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.475 -0.765 . . . . 0.0 110.463 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 tp -71.79 -39.19 70.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.342 -0.848 . . . . 0.0 109.996 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -62.42 -31.92 72.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 123.424 0.69 . . . . 0.0 111.519 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.03 -45.5 92.6 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.504 1.122 . . . . 0.0 110.224 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -67.8 -35.67 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 123.917 0.887 . . . . 0.0 109.244 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.27 -53.69 54.71 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.288 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -68.68 -40.89 79.87 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.451 -0.78 . . . . 0.0 110.777 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.93 -47.33 83.72 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 109.837 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.56 60.93 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 121.009 -1.057 . . . . 0.0 111.771 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -66.04 -40.33 90.89 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 109.742 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -71.23 -25.57 62.55 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.34 1.456 . . . . 0.0 110.084 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -79.22 -55.5 5.05 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.4 -43.87 79.72 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 126.228 1.811 . . . . 0.0 112.531 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -31.8 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -83.96 -34.45 24.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.12 -50.45 54.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 127.009 2.124 . . . . 0.0 109.92 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.88 -41.84 99.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.999 1.32 . . . . 0.0 110.231 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -62.2 121.77 13.95 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 119.722 -1.861 . . . . 0.0 110.233 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.19 -12.44 48.48 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.22 56.66 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 118.144 0.972 . . . . 0.0 110.504 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.85 141.81 19.49 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.894 1.73 . . . . 0.0 109.775 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.81 75.51 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.57 139.28 58.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 111.666 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.91 -29.39 2.33 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 124.5 1.12 . . . . 0.0 110.185 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 30.0 tp -81.4 -106.77 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' D' ' 40' ' ' SER 0.285 35.5 mt 71.97 173.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 -172.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.469 ' H ' HG22 ' D' ' 39' ' ' ILE . 39.0 t 73.17 124.36 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.225 1.488 . . . . 0.0 110.511 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -66.66 -50.11 47.13 Favored Pre-proline 0 C--N 1.348 0.503 0 O-C-N 119.802 -1.811 . . . . 0.0 110.778 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -71.67 -11.71 28.23 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 125.074 2.848 . . . . 0.0 112.227 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.92 -45.3 12.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.61 72.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.048 0.939 . . . . 0.0 112.394 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -82.81 1.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.723 0.773 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -43.27 7.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 119.693 -1.879 . . . . 0.0 106.202 171.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -57.79 -32.57 67.67 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.346 1.858 . . . . 0.0 111.967 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 p -68.9 -34.6 75.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.026 -2.296 . . . . 0.0 110.321 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 t -87.93 63.43 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 0.0 108.795 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -175.87 -31.43 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 50.2 m -62.51 -39.28 93.03 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.346 1.458 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.62 65.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.135 -0.978 . . . . 0.0 112.176 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.97 4.38 45.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 122.68 0.392 . . . . 0.0 110.177 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.26 1.0 OUTLIER 64.67 10.63 6.11 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.04 1.736 . . . . 0.0 112.927 174.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.65 -65.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 -63.82 4.22 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.55 -60.57 0.53 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.301 2.24 . . . . 0.0 109.692 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.47 -95.07 0.1 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . 0.286 10.7 t70 43.62 -101.73 0.04 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.178 2.191 . . . . 0.0 113.79 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 170.05 15.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -124.94 150.62 66.84 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.82 165.72 19.72 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.142 2.561 . . . . 0.0 109.427 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.44 -162.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 122.913 1.34 . . . . 0.0 107.837 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -86.58 -52.18 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 125.639 1.576 . . . . 0.0 109.059 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.54 -23.41 64.52 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 128.83 2.852 . . . . 0.0 110.345 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.99 -26.42 66.02 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 123.888 1.804 . . . . 0.0 108.398 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.8 67.6 1.31 Allowed Glycine 0 CA--C 1.462 -3.239 1 N-CA-C 99.483 -5.447 . . . . 0.0 99.483 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -34.22 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.36 1.028 1 C-N-CA 132.134 4.174 . . . . 0.0 114.765 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -55.75 -15.27 2.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 127.387 2.275 . . . . 0.0 113.273 165.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -72.29 -54.9 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.28 85.48 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.014 0.926 . . . . 0.0 112.14 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.13 -45.29 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.808 2.043 . . . . 0.0 112.108 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.59 -29.65 64.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 121.832 -0.542 . . . . 0.0 110.94 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -72.68 -47.22 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -70.88 -41.39 71.42 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.092 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -64.02 -41.83 97.32 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 121.272 -0.892 . . . . 0.0 110.736 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.07 79.23 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.604 -0.685 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.7 -45.54 96.06 Favored Glycine 0 CA--C 1.494 -1.278 0 C-N-CA 123.827 0.727 . . . . 0.0 111.654 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 86.7 mt -58.67 -47.06 90.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 124.273 1.029 . . . . 0.0 109.409 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -63.72 -34.78 78.63 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.383 -0.823 . . . . 0.0 112.125 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.93 -50.07 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.604 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.72 -21.25 64.41 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.599 -0.688 . . . . 0.0 111.142 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.11 -37.7 25.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.35 -37.2 84.74 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.975 1.31 . . . . 0.0 110.652 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.32 -2.73 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.335 -0.853 . . . . 0.0 112.39 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 24.9 m -63.09 -16.84 61.29 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.818 -1.176 . . . . 0.0 110.856 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.91 -38.05 81.19 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.863 -1.773 . . . . 0.0 111.908 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.24 63.37 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 120.555 -1.341 . . . . 0.0 108.423 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.57 -37.8 87.58 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.807 1.243 . . . . 0.0 111.532 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -21.37 63.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.419 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -85.23 -16.19 41.04 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.48 -38.48 84.44 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.765 -1.209 . . . . 0.0 110.112 -170.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -70.59 -29.51 65.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.291 -1.505 . . . . 0.0 111.043 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.26 -20.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 109.502 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -50.74 -37.45 41.89 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.888 1.675 . . . . 0.0 110.233 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -56.77 -36.22 69.56 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.987 1.315 . . . . 0.0 111.197 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -171.02 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.272 0 CA-C-O 123.547 1.641 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -57.1 2.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -57.04 -24.16 51.77 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 128.079 2.552 . . . . 0.0 114.941 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.88 -28.58 61.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.509 -1.369 . . . . 0.0 110.07 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.87 -32.44 65.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.003 -1.06 . . . . 0.0 110.187 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -71.57 -38.23 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.212 1.005 . . . . 0.0 109.183 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.33 86.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.821 0.848 . . . . 0.0 111.158 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -73.32 -22.28 60.36 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.085 -1.009 . . . . 0.0 111.788 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -73.05 -23.84 60.63 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.129 -0.982 . . . . 0.0 109.879 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.43 77.85 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.9 -1.125 . . . . 0.0 109.98 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.8 -30.26 71.37 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.574 -0.704 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 120.891 -1.13 . . . . 0.0 111.176 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -68.79 -31.2 70.04 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.618 0.767 . . . . 0.0 109.074 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.07 -40.48 94.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.649 0.737 . . . . 0.0 110.635 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -70.06 -25.27 63.46 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.16 -0.962 . . . . 0.0 111.419 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -71.2 -46.68 60.73 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -70.94 -25.2 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 121.604 -0.685 . . . . 0.0 110.132 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.55 -55.17 38.52 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 118.963 0.802 . . . . 0.0 110.471 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.38 -31.47 67.34 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.624 -0.673 . . . . 0.0 110.986 -174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.23 -48.31 70.99 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.916 -1.115 . . . . 0.0 109.627 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.14 63.39 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 123.989 0.915 . . . . 0.0 112.144 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.4 m -65.65 -39.74 91.74 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.639 -0.663 . . . . 0.0 110.156 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -69.36 -43.45 73.58 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.44 -53.12 61.85 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.499 0.72 . . . . 0.0 110.61 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.47 98.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.08 1.352 . . . . 0.0 112.648 -172.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -71.2 -35.25 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.945 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -77.0 -25.2 52.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 120.934 -1.104 . . . . 0.0 109.576 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.68 96.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.984 1.713 . . . . 0.0 109.495 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.4 -17.62 64.26 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.706 1.202 . . . . 0.0 113.133 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -78.23 80.43 4.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.24 -1.537 . . . . 0.0 110.369 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.09 2.76 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.33 143.8 37.23 Favored Pre-proline 0 N--CA 1.444 -0.757 0 O-C-N 120.926 -1.338 . . . . 0.0 110.525 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.71 128.42 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.985 2.456 . . . . 0.0 112.333 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 34.04 45.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.36 147.69 47.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.579 1.151 . . . . 0.0 110.624 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -44.43 0.93 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.217 0.607 . . . . 0.0 109.784 -170.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -87.08 46.48 1.38 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-O 123.13 1.443 . . . . 0.0 108.803 -171.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.04 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 119.4 -2.063 . . . . 0.0 108.94 -171.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 m -141.66 -122.01 0.1 Allowed 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -173.13 -71.51 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -20.89 25.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 125.512 3.004 . . . . 0.0 111.341 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.59 -33.17 64.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.443 1.497 . . . . 0.0 109.92 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.776 0.83 . . . . 0.0 109.703 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.96 -34.9 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 122.065 -0.397 . . . . 0.0 110.082 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 109.674 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -64.46 -35.12 79.88 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.512 1.148 . . . . 0.0 110.276 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -65.04 -42.35 94.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.722 -1.236 . . . . 0.0 109.684 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -56.62 -54.37 29.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.212 1.405 . . . . 0.0 110.031 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -69.46 -26.45 64.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.614 0.366 . . . . 0.0 111.455 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.6 m -69.34 -39.43 78.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.431 1.092 . . . . 0.0 109.707 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.37 -30.01 70.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.549 -1.344 . . . . 0.0 111.658 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.67 3.49 47.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.716 -0.615 . . . . 0.0 110.651 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p 59.85 36.93 21.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.012 1.725 . . . . 0.0 112.324 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 -85.63 0.55 Allowed Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 105.951 -2.859 . . . . 0.0 105.951 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 69.86 -65.18 0.32 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.872 2.469 . . . . 0.0 110.674 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.65 54.68 0.59 Allowed Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.401 ' CG ' HH22 ' B' ' 68' ' ' ARG . 36.1 t70 -83.09 -44.23 15.38 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -138.04 168.54 19.51 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.59 128.18 17.92 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.426 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 71.6 Cg_endo -80.29 172.78 13.27 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.265 3.31 . . . . 0.0 109.543 169.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.91 -137.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 p -124.04 -27.69 3.85 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.025 1.33 . . . . 0.0 110.723 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.12 6.05 50.13 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -74.25 -36.12 63.84 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.46 -11.44 0.55 Allowed Glycine 0 CA--C 1.477 -2.321 0 CA-C-O 117.096 -1.947 . . . . 0.0 108.968 171.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HA ' ' HE1' ' D' ' 46' ' ' TRP . 43.1 ttm180 67.14 -56.45 0.44 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 130.232 3.413 . . . . 0.0 109.33 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -84.81 20.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.029 1.331 . . . . 0.0 111.061 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.0 -49.39 44.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.7 74.92 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.179 0.592 . . . . 0.0 109.41 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.44 -41.78 69.81 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.226 1.41 . . . . 0.0 111.696 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.87 -49.28 76.85 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.846 -0.533 . . . . 0.0 110.775 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.96 -38.41 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 O-C-N 121.744 -0.597 . . . . 0.0 109.44 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.0 tpp -55.73 -53.74 52.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.572 1.549 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -66.22 -40.8 90.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.112 0.965 . . . . 0.0 109.935 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.11 82.84 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.827 0.851 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -46.37 91.66 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.98 -30.76 47.85 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 O-C-N 121.658 -0.907 . . . . 0.0 109.582 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.98 -46.44 81.44 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.661 -1.9 . . . . 0.0 109.866 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 t -63.44 -52.81 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 124.477 1.111 . . . . 0.0 109.782 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -74.41 -8.11 55.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.647 -0.658 . . . . 0.0 112.049 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.89 -32.65 15.94 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.817 -1.177 . . . . 0.0 110.103 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.33 -36.85 85.31 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.781 -1.199 . . . . 0.0 110.096 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -63.44 -12.53 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.0 m -65.16 -15.93 62.96 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.853 1.261 . . . . 0.0 111.173 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.11 71.6 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 111.213 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 -31.86 38.39 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 120.507 -1.371 . . . . 0.0 109.427 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.29 -39.46 39.83 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.411 0.624 . . . . 0.0 111.231 -173.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.97 64.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.198 -0.938 . . . . 0.0 111.734 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -96.6 -0.18 49.03 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.606 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -77.92 -22.84 49.03 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.556 1.525 . . . . 0.0 109.751 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -73.59 -33.02 64.42 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 119.511 -1.993 . . . . 0.0 110.467 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.41 -24.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 124.945 1.298 . . . . 0.0 109.102 -170.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -62.11 -19.06 62.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.428 1.891 . . . . 0.0 110.706 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -65.33 -31.35 72.44 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 120.99 -1.069 . . . . 0.0 110.674 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.444 -0.746 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 -172.33 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 120.957 -1.089 . . . . 0.0 110.4 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -67.27 -19.53 65.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -75.23 -46.68 32.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 124.853 1.261 . . . . 0.0 108.487 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.399 1.08 . . . . 0.0 109.657 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.2 90.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.856 0.862 . . . . 0.0 111.568 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -69.15 -34.15 74.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.69 0.757 . . . . 0.0 111.028 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.084 -1.01 . . . . 0.0 111.224 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.45 -46.38 73.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.895 0.878 . . . . 0.0 109.199 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.91 -38.41 88.28 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.647 1.213 . . . . 0.0 111.625 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.1 -24.07 60.59 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.953 1.301 . . . . 0.0 110.322 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.1 -41.48 61.6 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 120.259 -1.525 . . . . 0.0 107.847 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' B' ' 81' ' ' VAL . 22.4 tp -55.79 -46.76 77.9 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.658 1.183 . . . . 0.0 111.552 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -54.87 -37.73 66.62 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.091 0.957 . . . . 0.0 112.236 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -73.86 -32.44 63.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.86 -0.525 . . . . 0.0 110.512 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.3 -35.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.298 -0.876 . . . . 0.0 108.766 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.53 -37.41 87.22 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.065 -1.022 . . . . 0.0 111.279 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.11 -38.83 69.22 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.813 0.845 . . . . 0.0 110.745 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -73.62 -43.65 59.06 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.112 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.43 62.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 121.141 -0.974 . . . . 0.0 111.963 -175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' B' ' 45' ' ' ILE . 3.0 p -71.96 -37.46 69.94 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.204 0.911 . . . . 0.0 110.345 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -43.33 99.07 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 125.323 1.449 . . . . 0.0 108.433 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -66.13 -45.96 79.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.629 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.07 77.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.047 1.339 . . . . 0.0 112.746 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.2 -44.45 97.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 121.817 -0.552 . . . . 0.0 109.832 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.69 -28.29 62.6 Favored 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 120.872 -1.143 . . . . 0.0 111.629 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.32 80.31 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.644 1.578 . . . . 0.0 109.24 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -20.11 51.92 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.286 0.565 . . . . 0.0 110.842 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -70.95 72.63 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 125.055 1.342 . . . . 0.0 113.086 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.28 -18.3 1.04 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.82 147.07 61.31 Favored Pre-proline 0 N--CA 1.444 -0.735 0 O-C-N 121.7 -0.882 . . . . 0.0 110.375 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.413 ' O ' HG11 ' B' ' 63' ' ' VAL . 68.1 Cg_endo -82.66 129.66 5.71 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.54 2.16 . . . . 0.0 111.405 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 27.43 42.46 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.64 139.17 32.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.268 2.227 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.25 -32.36 2.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.398 0.679 . . . . 0.0 109.226 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -99.44 118.82 36.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.41 -154.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.6 t 75.1 -149.53 0.03 OUTLIER 'General case' 0 C--N 1.358 0.961 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.466 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 76.7 m-85 -145.64 -56.18 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 116.309 -1.805 . . . . 0.0 106.295 175.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 17.7 Cg_endo -67.33 -29.26 38.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 125.028 2.831 . . . . 0.0 110.734 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.17 -42.93 93.2 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.068 0.947 . . . . 0.0 110.183 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.28 95.2 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 111.121 -172.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' B' ' 23' ' ' SER . 21.6 tt -76.2 -27.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 121.027 0.441 . . . . 0.0 110.843 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -33.62 61.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.385 -1.447 . . . . 0.0 109.696 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -67.76 -34.19 76.31 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.864 0.866 . . . . 0.0 111.413 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.7 p -69.05 -20.76 64.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 119.727 -1.858 . . . . 0.0 111.35 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 -47.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.011 0.924 . . . . 0.0 109.5 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.58 -27.22 65.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.672 1.225 . . . . 0.0 110.933 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -73.98 -32.19 63.33 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.845 -1.16 . . . . 0.0 109.721 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.44 70.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.356 -0.84 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.9 p -93.58 10.89 30.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.446 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p 52.79 26.71 4.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.701 2.001 . . . . 0.0 112.721 174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.11 -41.92 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -61.51 4.62 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 62.94 -85.54 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 128.446 2.698 . . . . 0.0 108.481 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.19 40.97 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.14 -62.57 1.35 Allowed 'General case' 0 C--N 1.358 0.943 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -141.1 170.81 15.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -131.38 146.13 60.64 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -94.06 158.58 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.043 2.495 . . . . 0.0 108.217 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' O ' ' B' ' 34' ' ' PRO . 13.3 t -79.21 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 42.0 m -156.2 -36.67 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 O-C-N 119.047 -2.283 . . . . 0.0 106.927 -170.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -95.61 11.24 33.92 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.367 -0.833 . . . . 0.0 108.918 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.04 -33.41 61.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 168.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 88.73 1.24 Allowed Glycine 0 N--CA 1.418 -2.566 1 N-CA-C 98.403 -5.879 . . . . 0.0 98.403 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.401 HH22 ' CG ' ' A' ' 59' ' ' ASP . 34.7 ttm180 -63.53 -11.77 26.94 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 119.439 1.619 . . . . 0.0 110.935 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -46.55 -26.24 0.85 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.494 2.318 . . . . 0.0 113.821 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -68.56 -40.99 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.698 1.199 . . . . 0.0 108.734 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.49 -45.49 68.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -51.92 -41.66 62.18 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 126.441 1.897 . . . . 0.0 111.758 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.47 -42.56 92.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.914 1.286 . . . . 0.0 111.064 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.13 -38.38 70.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.422 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 42.4 mtt -62.79 -47.85 81.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.862 0.865 . . . . 0.0 110.177 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -61.26 -40.28 93.47 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.609 -0.682 . . . . 0.0 110.772 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.6 -34.8 77.75 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 122.758 0.423 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.97 -52.07 9.61 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.09 -47.01 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 124.39 1.076 . . . . 0.0 109.947 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.9 -38.27 90.4 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.051 -1.03 . . . . 0.0 111.565 -176.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' B' ' 15' ' ' LEU . 33.2 m -73.97 -38.4 49.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 O-C-N 120.642 -1.286 . . . . 0.0 110.906 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.52 -19.85 62.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.787 -0.571 . . . . 0.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.84 -38.19 13.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.655 0.782 . . . . 0.0 110.396 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.85 -35.91 71.58 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.008 1.723 . . . . 0.0 111.408 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.67 -6.98 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.751 0.82 . . . . 0.0 112.606 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -55.04 -24.34 24.34 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.364 1.466 . . . . 0.0 110.414 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.26 74.06 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.357 -1.464 . . . . 0.0 113.155 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.68 -33.16 23.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.868 -1.145 . . . . 0.0 108.33 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 72.4 mt -78.91 -28.4 43.94 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.928 0.891 . . . . 0.0 112.066 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -10.64 59.53 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.058 -1.651 . . . . 0.0 111.337 172.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.44 -36.59 74.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.097 1.317 . . . . 0.0 110.664 -169.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -75.21 -20.71 59.12 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.417 -1.427 . . . . 0.0 112.148 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.55 -33.09 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.234 -1.541 . . . . 0.0 107.596 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -60.88 -19.88 60.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.604 1.561 . . . . 0.0 112.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -55.81 -25.25 40.63 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.557 1.143 . . . . 0.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.439 -0.976 0 O-C-N 120.59 -1.319 . . . . 0.0 111.162 -177.403 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -16.46 53.91 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.243 -1.535 . . . . 0.0 109.651 -167.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -65.8 -36.5 83.68 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.204 1.802 . . . . 0.0 111.161 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -81.87 -33.67 30.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -35.42 74.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.461 0.304 . . . . 0.0 110.544 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.85 96.7 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.824 0.85 . . . . 0.0 111.384 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -71.59 -34.61 70.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.075 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -66.04 -36.6 83.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.535 1.134 . . . . 0.0 109.574 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.41 91.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 124.517 1.127 . . . . 0.0 111.445 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -59.63 -38.6 81.79 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.802 0.811 . . . . 0.0 111.287 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -74.04 -27.56 60.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.583 0.753 . . . . 0.0 110.183 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -66.77 -38.21 86.13 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.147 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.86 -38.1 89.51 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.289 -0.882 . . . . 0.0 111.402 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -55.22 -38.68 68.75 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 111.876 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -70.82 -38.91 73.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.171 1.388 . . . . 0.0 109.352 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.9 -28.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 123.872 0.869 . . . . 0.0 108.998 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.09 -39.7 95.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.905 -1.122 . . . . 0.0 111.435 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.24 -46.41 87.03 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.284 -0.885 . . . . 0.0 109.927 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.33 -52.08 67.11 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-O 121.22 0.533 . . . . 0.0 109.615 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.44 -34.74 74.42 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 126.014 1.726 . . . . 0.0 111.454 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.9 m -63.36 -46.59 85.84 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.812 0.845 . . . . 0.0 110.799 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.45 -40.75 73.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.88 -39.81 95.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.821 0.848 . . . . 0.0 110.913 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -47.38 80.91 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.17 1.388 . . . . 0.0 111.466 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.01 -15.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.4 1.095 . . . . 0.0 110.102 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -101.23 -5.1 25.99 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 119.979 -1.701 . . . . 0.0 108.599 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.42 -18.85 18.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 124.808 1.243 . . . . 0.0 110.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.81 -30.89 69.54 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 121.028 -1.045 . . . . 0.0 108.553 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.44 113.96 4.0 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.32 1.848 . . . . 0.0 108.587 -169.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.02 -5.62 72.3 Favored Glycine 0 CA--C 1.498 -0.999 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.09 148.44 34.4 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.57 125.14 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.353 2.035 . . . . 0.0 111.1 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 45.48 3.08 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.83 24.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.897 -0.766 . . . . 0.0 112.195 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.01 -36.6 1.17 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.663 0.744 . . . . 0.0 110.063 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -85.85 37.42 0.71 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 108.675 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' C' ' 39' ' ' ILE . 16.2 tt -75.08 -22.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.224 2.21 . . . . 0.0 109.519 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -79.93 121.09 25.01 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.738 0.78 . . . . 0.0 109.252 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.84 -55.93 15.64 Favored Pre-proline 0 C--N 1.351 0.631 0 C-N-CA 126.885 2.074 . . . . 0.0 111.369 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.13 -11.96 23.34 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 CA-C-N 125.769 3.096 . . . . 0.0 111.339 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.33 -26.28 28.6 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 124.827 1.251 . . . . 0.0 108.747 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.47 91.32 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.091 0.956 . . . . 0.0 110.706 -167.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.4 -33.43 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.045 0.938 . . . . 0.0 111.267 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -32.51 48.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.909 -1.119 . . . . 0.0 109.964 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.458 ' CD2' HD11 ' C' ' 38' ' ' LEU . 50.0 t90 -67.04 -37.53 84.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.404 -0.81 . . . . 0.0 110.259 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -60.25 -25.11 65.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.239 -0.913 . . . . 0.0 112.735 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.14 -51.41 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 123.694 0.798 . . . . 0.0 109.437 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.76 40.52 0.9 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.62 1.168 . . . . 0.0 111.181 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 17.6 m -141.68 -56.92 0.47 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.75 73.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.353 -0.842 . . . . 0.0 112.923 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 16.5 p -95.01 23.69 5.42 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p 51.24 78.49 0.11 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.619 1.968 . . . . 0.0 111.871 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 t -122.23 -92.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.6 45.67 9.37 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 111.064 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -43.14 92.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.53 1.157 . . . . 0.0 110.375 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.52 -139.92 7.47 Favored Glycine 0 CA--C 1.483 -1.945 1 N-CA-C 101.645 -4.582 . . . . 0.0 101.645 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.3 34.5 t0 65.2 -71.83 0.08 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 127.27 2.228 . . . . 0.0 111.327 -173.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -124.54 158.9 31.84 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.66 154.13 55.58 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 166.8 27.09 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.203 2.602 . . . . 0.0 110.504 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.2 164.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -62.71 -69.19 0.27 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.337 1.455 . . . . 0.0 114.367 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.75 -72.88 0.06 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.651 1.18 . . . . 0.0 111.484 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -94.58 -39.79 10.18 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.155 -0.965 . . . . 0.0 113.317 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.92 -39.46 25.5 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 120.41 1.459 . . . . 0.0 113.938 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.14 -36.87 64.17 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 117.629 0.714 . . . . 0.0 112.26 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -74.29 -30.07 61.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 121.379 -0.826 . . . . 0.0 110.127 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.0 -40.84 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 O-C-N 121.168 -0.957 . . . . 0.0 109.662 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.36 92.9 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -58.13 -36.01 72.34 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 125.729 1.612 . . . . 0.0 111.395 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -66.04 -52.15 51.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.204 1.001 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 p -73.19 -27.27 23.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 121.576 -0.703 . . . . 0.0 109.636 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 19.5 tpp -58.54 -48.24 81.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 110.335 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -66.21 -36.75 83.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.993 -0.442 . . . . 0.0 110.518 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.26 78.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.366 0.666 . . . . 0.0 111.425 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.45 -40.94 78.85 Favored Glycine 0 CA--C 1.494 -1.266 0 O-C-N 121.664 -0.647 . . . . 0.0 111.546 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 81.2 mt -63.16 -46.57 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -57.26 -47.68 80.8 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.197 0.999 . . . . 0.0 110.774 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.99 -55.04 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.459 1.104 . . . . 0.0 111.086 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -71.61 -33.45 69.0 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 118.551 0.614 . . . . 0.0 110.695 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.33 -30.24 65.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.781 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.75 -12.79 60.82 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.138 -0.976 . . . . 0.0 111.589 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.19 -10.99 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 119.988 -1.695 . . . . 0.0 110.51 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -49.39 -27.24 3.87 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.383 1.873 . . . . 0.0 112.717 170.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.7 -27.16 48.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.499 1.12 . . . . 0.0 112.824 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.67 -51.66 2.79 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 112.063 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.15 -2.25 54.99 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.461 -1.399 . . . . 0.0 109.433 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.25 -11.85 45.39 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -33.8 76.49 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.7 -1.25 . . . . 0.0 109.91 -166.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.51 -12.68 60.54 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.055 -1.028 . . . . 0.0 112.608 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.48 -32.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -69.14 -8.24 43.6 Favored 'General case' 0 C--N 1.359 1.021 0 O-C-N 121.026 -1.046 . . . . 0.0 111.483 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 48.3 ttp85 -64.73 -29.97 70.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -175.55 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.45 -36.38 78.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 122.388 1.089 . . . . 0.0 110.763 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -71.02 -17.61 62.62 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.09 -1.006 . . . . 0.0 112.061 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -86.92 -38.95 16.22 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -66.82 -37.59 84.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.077 0.951 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -68.23 -36.88 80.19 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.618 -0.676 . . . . 0.0 110.34 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.62 75.4 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.035 0.934 . . . . 0.0 110.188 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -65.06 -35.99 82.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.204 1.402 . . . . 0.0 111.205 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -69.01 -30.42 68.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.849 -1.157 . . . . 0.0 110.742 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.33 75.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.063 -1.023 . . . . 0.0 110.649 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.94 -38.41 90.93 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.737 0.815 . . . . 0.0 110.516 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.58 1.152 . . . . 0.0 110.219 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.65 -41.68 98.19 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.878 0.871 . . . . 0.0 109.086 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 tp -62.97 -37.52 87.43 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.436 0.694 . . . . 0.0 111.503 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.57 -31.48 72.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.223 -0.923 . . . . 0.0 112.285 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -71.39 -35.46 71.05 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.35 -38.89 83.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 109.307 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.8 -42.39 84.14 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.24 1.019 . . . . 0.0 111.323 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.27 -44.11 65.89 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.957 0.903 . . . . 0.0 109.282 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -66.21 -39.05 89.34 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.04 72.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.191 1.396 . . . . 0.0 112.165 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.49 -43.34 73.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.493 0.717 . . . . 0.0 109.807 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -43.86 75.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.778 1.231 . . . . 0.0 108.677 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -63.91 -48.4 76.74 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.699 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.44 70.06 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 119.769 1.168 . . . . 0.0 110.818 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.74 -39.74 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.67 -30.03 59.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.779 -1.826 . . . . 0.0 110.758 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.34 35.27 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.067 0.947 . . . . 0.0 109.752 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -22.56 60.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.507 -0.746 . . . . 0.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -68.9 98.6 0.95 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.028 0.918 . . . . 0.0 111.619 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.24 -4.41 12.42 Favored Glycine 0 CA--C 1.494 -1.251 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.75 146.36 46.25 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 121.629 -0.924 . . . . 0.0 109.088 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -80.5 131.7 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.952 1.768 . . . . 0.0 111.42 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.44 2.91 69.81 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.52 136.65 57.59 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.006 1.722 . . . . 0.0 112.42 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.63 4.31 1.93 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.35 -38.16 20.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.3 tt -5.93 88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 1 C-N-CA 133.248 4.619 . . . . 0.0 114.387 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 33.1 p -162.96 -131.3 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.79 -65.5 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 127.925 2.49 . . . . 0.0 106.051 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.93 -14.03 26.47 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 CA-C-N 125.649 3.053 . . . . 0.0 111.687 -171.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -100.74 -11.36 19.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.66 64.93 Favored 'General case' 0 CA--C 1.504 -0.826 0 O-C-N 120.776 -1.203 . . . . 0.0 109.854 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.25 -7.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 125.178 1.391 . . . . 0.0 109.675 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 68' ' ' ARG . 1.2 t90 -81.84 -49.56 10.22 Favored 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 119.423 -2.048 . . . . 0.0 106.081 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -53.24 -41.68 65.66 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.791 1.636 . . . . 0.0 111.115 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.4 p -69.51 -28.84 66.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.696 -1.877 . . . . 0.0 111.683 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.46 -45.66 81.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 C-N-CA 123.699 0.799 . . . . 0.0 109.284 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.9 -9.35 57.57 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.445 -0.784 . . . . 0.0 112.006 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 72.4 m -86.14 -48.45 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 120.697 -1.252 . . . . 0.0 111.082 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.18 62.51 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.662 -1.274 . . . . 0.0 112.007 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -87.8 0.86 55.21 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.879 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 55.18 67.97 0.94 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.875 2.07 . . . . 0.0 110.904 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.83 -98.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.58 102.24 0.46 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 106.58 -2.608 . . . . 0.0 106.58 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -75.73 -33.68 60.3 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.65 39.7 2.32 Favored Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.96 -50.27 30.39 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -130.87 160.95 32.94 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.53 151.78 36.88 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 167.71 26.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.059 2.506 . . . . 0.0 111.275 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.74 -148.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -107.07 -60.35 1.69 Allowed 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.039 1.736 . . . . 0.0 107.573 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -80.13 0.61 31.42 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.352 1.461 . . . . 0.0 111.179 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -64.84 -30.13 71.12 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.845 1.307 . . . . 0.0 108.773 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.26 83.57 1.37 Allowed Glycine 0 CA--C 1.473 -2.557 1 N-CA-C 99.277 -5.529 . . . . 0.0 99.277 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttt85 -60.95 -11.24 7.39 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 122.876 1.322 . . . . 0.0 111.44 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -61.51 -12.92 17.16 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.452 1.101 . . . . 0.0 113.302 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.43 -52.59 58.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.33 97.58 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 123.168 0.587 . . . . 0.0 110.535 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.11 -50.11 38.77 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.946 1.699 . . . . 0.0 111.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.65 -40.08 95.94 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.646 0.779 . . . . 0.0 110.879 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.66 -43.39 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 123.704 0.801 . . . . 0.0 109.579 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.7 mtm -66.91 -42.83 84.77 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 121.806 -0.559 . . . . 0.0 110.621 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -65.58 -35.0 79.55 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.844 -0.535 . . . . 0.0 110.517 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.25 99.13 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.524 0.729 . . . . 0.0 110.494 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.03 81.33 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.1 -46.72 88.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 109.804 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.12 -42.01 94.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.299 -0.876 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.98 -46.94 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.24 -0.913 . . . . 0.0 110.4 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -71.12 -9.0 57.32 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.392 -0.817 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.32 -39.76 8.25 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.199 1.0 . . . . 0.0 109.84 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -52.1 -34.93 46.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 127.133 2.173 . . . . 0.0 110.697 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.45 -8.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 124.372 1.069 . . . . 0.0 113.833 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -68.85 -14.28 62.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 120.113 -1.617 . . . . 0.0 111.832 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.16 -27.56 65.77 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.748 -1.22 . . . . 0.0 111.494 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.88 -37.04 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.458 1.103 . . . . 0.0 109.554 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.32 -37.72 66.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.564 -0.71 . . . . 0.0 112.231 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.73 -21.19 63.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.57 -1.331 . . . . 0.0 111.008 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 10.9 t -96.32 11.19 35.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.842 -1.162 . . . . 0.0 108.765 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.3 -33.65 25.91 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -71.67 -32.68 68.14 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.191 -1.568 . . . . 0.0 112.865 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.8 -11.34 14.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 121.461 -0.774 . . . . 0.0 111.275 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -60.99 -19.73 61.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.033 1.333 . . . . 0.0 112.132 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -6.67 58.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.457 1.026 . . . . 0.0 110.81 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.34 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -132.89 -78.1 0.49 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.403 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 1.8 p80 -71.52 -15.83 62.31 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 123.572 0.749 . . . . 0.0 111.69 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 52.5 mp0 -63.88 -36.9 85.45 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.977 1.711 . . . . 0.0 110.137 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -77.15 -24.11 51.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.455 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -74.27 -41.65 60.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.673 1.189 . . . . 0.0 108.185 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.32 96.87 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.17 -34.07 77.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.732 1.213 . . . . 0.0 111.387 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -71.4 -39.14 71.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.371 -0.831 . . . . 0.0 108.904 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.85 78.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.532 0.733 . . . . 0.0 111.648 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -65.3 -28.35 69.26 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.05 -1.031 . . . . 0.0 111.808 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -73.81 -31.96 63.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.794 0.837 . . . . 0.0 110.06 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.04 -38.94 92.52 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 121.469 -0.769 . . . . 0.0 110.743 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.26 -41.67 84.77 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.532 0.733 . . . . 0.0 111.992 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.735 1.214 . . . . 0.0 109.633 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.31 -40.53 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.053 0.941 . . . . 0.0 109.486 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 52' ' ' ALA . 76.2 mt -58.74 -40.76 84.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.083 0.953 . . . . 0.0 111.906 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.25 -41.6 73.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.63 1.572 . . . . 0.0 110.066 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -67.32 -52.32 41.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.521 1.529 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.56 -29.88 63.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.484 1.114 . . . . 0.0 111.977 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -63.05 -41.69 99.55 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 119.129 0.877 . . . . 0.0 110.178 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.82 -43.55 71.8 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.872 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -67.34 -18.96 65.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 120.709 -1.244 . . . . 0.0 111.033 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.86 70.57 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.45 0.7 . . . . 0.0 110.289 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.15 -33.15 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.775 0.798 . . . . 0.0 111.768 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -28.92 61.66 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.87 68.1 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.349 1.059 . . . . 0.0 111.263 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.24 -5.95 53.46 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.462 1.105 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -105.64 71.87 0.94 Allowed 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.647 -1.908 . . . . 0.0 108.508 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.45 -42.32 0.33 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -92.74 157.94 38.86 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 123.206 0.603 . . . . 0.0 109.665 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -80.9 153.07 19.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.221 1.948 . . . . 0.0 111.121 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.33 15.93 31.18 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.207 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 131.46 50.6 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -166.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.65 -46.99 0.24 Allowed 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.554 0.741 . . . . 0.0 110.009 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.82 62.08 6.73 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 123.01 1.386 . . . . 0.0 107.902 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.9 pt -91.46 -1.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.805 -1.81 . . . . 0.0 109.5 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -89.43 127.85 35.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.469 -0.77 . . . . 0.0 110.997 -174.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -79.44 -54.64 0.95 Allowed Pre-proline 0 C--N 1.347 0.457 0 CA-C-O 116.196 -1.859 . . . . 0.0 112.73 -172.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -73.54 -12.02 24.59 Favored 'Trans proline' 0 CA--C 1.511 -0.658 0 CA-C-N 126.718 3.435 . . . . 0.0 111.813 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.12 -13.17 48.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.38 89.86 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.298 1.039 . . . . 0.0 111.59 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.92 -33.66 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.643 0.735 . . . . 0.0 109.535 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -24.76 57.74 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 119.92 -1.737 . . . . 0.0 109.572 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -69.52 -46.55 66.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.418 1.087 . . . . 0.0 108.396 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.4 p -67.35 -29.81 69.45 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.822 -1.173 . . . . 0.0 111.819 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -51.94 -50.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 124.447 1.099 . . . . 0.0 110.633 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.01 -0.3 43.64 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.488 -0.757 . . . . 0.0 111.792 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.3 m -91.62 -39.92 11.61 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 121.546 -0.721 . . . . 0.0 109.296 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -70.72 -23.83 62.52 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 120.503 -1.373 . . . . 0.0 111.357 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 p -89.35 9.29 26.67 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.473 0.709 . . . . 0.0 110.152 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 51.17 50.03 19.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.422 1.889 . . . . 0.0 112.973 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 56' ' ' GLY . 7.6 p -122.68 -77.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.484 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.82 95.12 0.11 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.07 -69.91 0.58 Allowed 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.666 -1.49 . . . . 0.0 109.958 -170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.8 41.57 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.75 -52.74 7.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -134.44 -175.06 3.75 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -143.06 135.78 13.63 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 101.994 -3.336 . . . . 0.0 101.994 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.8 166.2 10.14 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.026 2.484 . . . . 0.0 110.236 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 67' ' ' GLY . 17.5 m -69.41 166.07 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.603 1.192 . . . . 0.0 110.94 173.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 m -78.53 -67.77 0.71 Allowed 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.345 -0.847 . . . . 0.0 109.173 -174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -50.36 -63.5 1.1 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.586 1.555 . . . . 0.0 112.115 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.69 -67.05 0.87 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.324 -0.86 . . . . 0.0 111.412 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.612 ' H ' HG23 ' A' ' 63' ' ' VAL . . . -30.76 -46.22 0.13 Allowed Glycine 0 C--N 1.349 1.293 0 C-N-CA 129.212 3.291 . . . . 0.0 116.114 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -68.19 -51.9 40.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.105 0.952 . . . . 0.0 112.483 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.7 -25.64 68.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 119.419 1.009 . . . . 0.0 110.803 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.88 -50.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.18 85.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.062 1.345 . . . . 0.0 112.129 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -51.63 -39.19 57.61 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.893 1.677 . . . . 0.0 110.846 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -29.58 64.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.08 -43.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.8 mtt -58.62 -52.32 66.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.414 1.485 . . . . 0.0 109.917 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -66.04 -36.95 84.63 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.614 -0.679 . . . . 0.0 110.652 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.41 87.77 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.168 -0.958 . . . . 0.0 111.313 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.86 -48.11 75.44 Favored Glycine 0 CA--C 1.492 -1.349 0 C-N-CA 124.646 1.117 . . . . 0.0 110.903 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -43.76 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.113 0.965 . . . . 0.0 109.257 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -61.43 -39.18 89.86 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 120.438 -1.414 . . . . 0.0 111.97 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.16 -54.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 124.41 1.084 . . . . 0.0 108.928 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.47 -40.87 93.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.82 -0.55 . . . . 0.0 110.913 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -27.15 65.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.394 -0.816 . . . . 0.0 111.522 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.82 -35.67 81.86 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.887 -1.133 . . . . 0.0 110.031 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.8 t -59.65 -14.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 125.524 1.53 . . . . 0.0 111.262 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -55.82 -23.31 29.67 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 120.066 -1.646 . . . . 0.0 111.989 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.9 -31.45 69.82 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 120.82 -1.175 . . . . 0.0 112.33 172.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 -45.44 14.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.688 -1.257 . . . . 0.0 107.789 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -62.77 -40.29 96.82 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.182 0.993 . . . . 0.0 113.297 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.36 -11.3 60.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.129 -0.982 . . . . 0.0 111.519 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 m -82.6 -22.66 34.73 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.022 -1.049 . . . . 0.0 108.384 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -71.08 -24.5 62.33 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 120.698 -1.252 . . . . 0.0 112.86 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -81.03 -25.33 37.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.85 -1.156 . . . . 0.0 111.879 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.78 -28.03 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -70.14 -5.42 26.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 112.05 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -66.57 -31.04 71.49 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.913 -1.117 . . . . 0.0 109.319 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -170.015 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.498 -1.034 0 CA-C-O 121.94 0.876 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -72.8 -32.26 65.42 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.92 -33.95 66.3 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.734 0.814 . . . . 0.0 109.026 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -58.29 -45.28 88.25 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.324 1.05 . . . . 0.0 110.582 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.22 -45.84 79.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.82 1.248 . . . . 0.0 109.051 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.5 92.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 111.567 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.84 -37.1 76.06 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.643 0.777 . . . . 0.0 109.617 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.02 -33.38 75.6 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.784 -1.198 . . . . 0.0 110.251 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.74 75.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.329 -0.857 . . . . 0.0 111.373 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.43 -31.99 73.43 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.844 0.858 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -67.99 -41.22 82.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 121.562 -0.711 . . . . 0.0 109.781 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -66.21 -28.46 68.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.593 -0.692 . . . . 0.0 111.277 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 118.42 0.554 . . . . 0.0 110.738 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -62.32 -36.11 81.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 110.683 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.37 -37.79 86.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.754 0.821 . . . . 0.0 110.741 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.43 -40.19 88.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 121.071 -1.018 . . . . 0.0 109.036 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.93 -42.96 85.92 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 123.634 0.774 . . . . 0.0 111.359 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.77 -46.17 83.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.015 1.326 . . . . 0.0 109.949 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -68.48 -41.95 79.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 122.046 -0.409 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -29.64 69.79 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.726 1.21 . . . . 0.0 111.601 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -61.58 -43.23 99.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.145 0.978 . . . . 0.0 109.491 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -38.57 81.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.486 1.114 . . . . 0.0 108.822 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.22 -54.01 40.28 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.108 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.03 75.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.005 1.322 . . . . 0.0 112.915 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.15 -28.18 39.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 120.683 -1.26 . . . . 0.0 113.041 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.63 -34.76 18.37 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -49.46 67.7 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.697 1.599 . . . . 0.0 110.268 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.36 -26.85 66.68 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 112.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 119.614 -1.929 . . . . 0.0 110.801 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.05 -15.14 6.53 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.63 145.33 41.58 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 118.071 0.935 . . . . 0.0 109.801 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.78 135.53 11.46 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 110.136 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 14.41 76.91 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.38 145.49 55.97 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.12 0.968 . . . . 0.0 110.605 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.89 -37.98 0.9 Allowed 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 108.943 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 44' ' ' ALA . 42.1 tp -88.84 129.98 35.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -150.26 -179.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 t 76.23 127.21 0.04 OUTLIER 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.226 1.41 . . . . 0.0 109.502 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -65.13 -46.53 73.1 Favored Pre-proline 0 C--N 1.35 0.623 0 CA-C-O 116.921 -1.514 . . . . 0.0 111.611 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 -10.54 25.15 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 124.953 2.805 . . . . 0.0 112.608 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.02 -39.13 15.93 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.45 ' HA ' HD11 ' B' ' 38' ' ' LEU . . . -64.08 -36.47 84.11 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 123.416 0.686 . . . . 0.0 112.581 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -68.79 -29.19 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 O-C-N 122.03 -0.419 . . . . 0.0 110.08 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -38.22 70.41 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.755 -1.216 . . . . 0.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.09 -38.29 82.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.679 0.752 . . . . 0.0 109.368 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -59.27 -47.77 84.11 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.013 1.325 . . . . 0.0 110.191 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -54.51 -52.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 125.486 1.514 . . . . 0.0 111.099 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.96 -24.46 63.34 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 121.349 -0.844 . . . . 0.0 111.836 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -76.03 -33.59 59.64 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 123.897 0.879 . . . . 0.0 109.393 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.23 -24.61 65.84 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.964 -1.085 . . . . 0.0 111.693 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -92.92 10.41 31.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.542 0.737 . . . . 0.0 111.499 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 p 51.23 53.86 12.18 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 125.675 1.59 . . . . 0.0 112.838 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.56 -87.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.92 74.61 1.2 Allowed Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.53 -21.64 60.33 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 120.781 -1.423 . . . . 0.0 109.756 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.62 40.84 1.82 Allowed Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.26 -29.51 26.39 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 120.884 -1.362 . . . . 0.0 111.25 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.428 ' HG3' HD13 ' B' ' 38' ' ' LEU . 85.7 mmt-85 -144.41 166.89 23.84 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -143.03 115.14 5.94 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.67 161.16 16.6 Favored 'Trans proline' 0 CA--C 1.512 -0.617 0 C-N-CA 122.527 2.151 . . . . 0.0 110.15 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.05 -159.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.742 1.258 . . . . 0.0 110.769 -173.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -86.7 -36.22 18.83 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 119.734 -1.853 . . . . 0.0 110.612 -165.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.63 -15.87 41.07 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.486 1.114 . . . . 0.0 109.499 -167.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -28.77 69.91 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 123.478 1.609 . . . . 0.0 107.417 172.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.17 82.39 1.25 Allowed Glycine 0 CA--C 1.464 -3.152 1 N-CA-C 99.974 -5.25 . . . . 0.0 99.974 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm105 -66.97 3.93 0.98 Allowed 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.643 1.222 . . . . 0.0 112.999 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.14 -12.9 56.02 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 120.987 -1.071 . . . . 0.0 111.895 160.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -50.18 79.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.63 92.79 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.01 0.924 . . . . 0.0 111.701 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -53.95 -42.04 68.43 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.157 1.383 . . . . 0.0 110.623 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -63.76 -40.45 96.74 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.755 -0.591 . . . . 0.0 110.851 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.42 -49.02 80.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.018 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -69.92 -40.86 75.3 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 121.949 -0.469 . . . . 0.0 110.516 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -64.65 -41.59 96.02 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.324 -0.86 . . . . 0.0 109.725 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.94 85.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 122.028 -0.42 . . . . 0.0 111.388 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.34 -47.65 77.4 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.76 -45.18 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.778 1.231 . . . . 0.0 109.006 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.61 -44.21 80.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.112 -0.993 . . . . 0.0 111.357 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.86 -52.49 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.071 0.949 . . . . 0.0 109.599 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -72.19 -18.19 61.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.924 0.489 . . . . 0.0 111.492 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.78 -31.54 16.48 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.08 -31.85 73.19 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 120.38 -1.45 . . . . 0.0 110.018 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.48 -11.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 123.378 0.671 . . . . 0.0 112.098 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 22.8 m -60.35 -15.79 29.06 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.95 1.3 . . . . 0.0 111.426 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.53 -50.55 69.69 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.215 166.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.37 92.63 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 124.609 1.164 . . . . 0.0 110.272 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.03 -39.97 95.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 120.873 -1.142 . . . . 0.0 111.071 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 -15.74 60.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.677 -0.639 . . . . 0.0 110.701 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.4 m -83.25 -32.94 26.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 121.0 -1.062 . . . . 0.0 108.167 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.08 -11.45 59.99 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 111.801 -156.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -72.77 -31.93 65.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 121.387 -0.821 . . . . 0.0 110.299 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 t -74.08 -24.32 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.475 1.51 . . . . 0.0 109.047 -170.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -51.36 -31.91 23.85 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 124.851 1.26 . . . . 0.0 110.184 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -53.93 -31.8 51.5 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.98 1.312 . . . . 0.0 112.56 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 . . . . . 0 N--CA 1.444 -0.75 0 O-C-N 120.806 -1.184 . . . . 0.0 111.283 -174.903 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 . . . . . 0 CA--C 1.494 -1.193 0 CA-C-O 122.189 0.995 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.525 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 5.1 p-80 -67.3 -29.57 69.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.477 -0.764 . . . . 0.0 110.928 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.05 -37.6 46.42 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -57.32 -43.81 83.65 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.693 0.797 . . . . 0.0 111.941 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.57 -24.42 53.53 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.624 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.1 93.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.917 -1.114 . . . . 0.0 110.209 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -65.05 -37.11 86.5 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.659 -0.651 . . . . 0.0 111.225 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -62.44 -35.65 79.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.791 1.236 . . . . 0.0 110.261 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.96 82.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.783 0.833 . . . . 0.0 111.482 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -60.97 -37.79 83.65 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -63.38 -39.48 94.63 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.913 0.885 . . . . 0.0 110.018 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -67.69 -35.9 79.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.005 0.922 . . . . 0.0 109.469 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.7 tp -65.4 -37.76 87.95 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.229 1.014 . . . . 0.0 110.624 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.74 -21.67 61.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.879 -1.138 . . . . 0.0 111.635 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -69.81 -47.2 63.71 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.554 0.742 . . . . 0.0 109.624 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.45 -25.63 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.381 -0.824 . . . . 0.0 110.43 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' C' ' 52' ' ' ALA . 50.8 mt -62.84 -40.66 98.14 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.405 0.682 . . . . 0.0 111.059 172.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.91 -47.11 86.41 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.392 0.997 . . . . 0.0 110.229 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -58.86 -55.11 39.38 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.33 83.24 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 125.964 1.706 . . . . 0.0 112.014 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 60.7 m -54.57 -51.2 65.99 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 124.367 1.067 . . . . 0.0 110.066 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -82.63 -35.66 26.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 121.905 -0.497 . . . . 0.0 110.566 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -63.57 -35.12 79.44 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.815 -1.178 . . . . 0.0 109.986 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.53 72.62 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.404 1.081 . . . . 0.0 111.887 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -34.92 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.688 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.42 -18.98 25.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.181 -0.949 . . . . 0.0 108.638 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -28.24 60.99 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.46 -0.775 . . . . 0.0 111.04 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -33.97 57.22 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -70.65 89.73 0.74 Allowed 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 125.972 1.709 . . . . 0.0 110.591 -167.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.24 2.03 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.61 155.11 56.54 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 153.94 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.119 1.879 . . . . 0.0 109.383 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.91 30.63 57.32 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -36.0 141.44 0.1 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 129.057 2.943 . . . . 0.0 113.493 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -115.51 0.17 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -164.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.403 ' H ' HD13 ' C' ' 38' ' ' LEU . 0.0 OUTLIER -75.79 153.49 36.9 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 19.0 pt -136.23 -158.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -62.21 -169.8 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.508 2.723 . . . . 0.0 111.482 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.417 ' HB3' ' HD2' ' C' ' 42' ' ' PRO . 4.0 m-85 81.38 -178.23 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' C' ' 41' ' ' TYR . 12.7 Cg_endo -74.54 9.24 1.94 Allowed 'Trans proline' 0 CA--C 1.517 -0.35 0 CA-C-N 125.645 3.052 . . . . 0.0 112.262 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.68 -35.81 60.26 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.169 0.988 . . . . 0.0 109.061 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.33 -47.56 72.36 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 125.503 1.521 . . . . 0.0 112.727 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.425 HG22 ' H ' ' C' ' 45' ' ' ILE . 9.3 tt -74.92 -26.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.142 -174.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -39.57 82.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.056 -1.028 . . . . 0.0 110.093 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -71.57 -35.45 70.58 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 118.661 0.664 . . . . 0.0 110.191 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -59.59 -39.21 83.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.823 -1.173 . . . . 0.0 110.048 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.04 68.43 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.019 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.501 ' HB3' HH12 ' D' ' 68' ' ' ARG . 21.4 pt-20 -164.05 -39.48 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -66.28 -41.03 90.41 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.104 0.962 . . . . 0.0 110.653 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -69.51 -24.0 63.69 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 120.929 -1.107 . . . . 0.0 112.358 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.96 -1.2 57.39 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 121.448 -0.783 . . . . 0.0 109.483 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.8 p 52.25 49.43 20.56 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.302 1.841 . . . . 0.0 112.307 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.42 82.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.54 98.33 1.99 Allowed Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -79.28 -21.36 46.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.309 1.052 . . . . 0.0 108.307 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.91 39.76 1.14 Allowed Glycine 0 CA--C 1.483 -1.951 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.488 ' HB2' HH21 ' D' ' 68' ' ' ARG . 40.7 t0 -84.74 -50.34 7.69 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -131.92 -155.82 0.71 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 107.509 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.99 153.37 15.44 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 101.692 -3.447 . . . . 0.0 101.692 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -89.71 -177.36 1.41 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 123.392 2.728 . . . . 0.0 108.73 169.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.39 -167.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 119.81 1.186 . . . . 0.0 108.813 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.46 -56.46 2.18 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.158 0.983 . . . . 0.0 109.806 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.65 -41.33 77.02 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.258 -0.902 . . . . 0.0 112.313 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.52 -138.45 0.19 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 100.686 -3.82 . . . . 0.0 100.686 162.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.21 -73.35 1.09 Allowed Glycine 0 CA--C 1.492 -1.381 0 CA-C-N 120.454 1.479 . . . . 0.0 109.447 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -32.42 68.09 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.343 1.457 . . . . 0.0 110.295 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -69.97 -33.45 72.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.8 t -73.42 -47.49 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.89 76.6 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.453 1.501 . . . . 0.0 112.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -48.07 -47.05 34.18 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 126.979 2.112 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.7 -33.13 75.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.012 1.325 . . . . 0.0 110.735 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.65 -42.25 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.347 1.059 . . . . 0.0 109.416 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -60.18 -45.12 94.22 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.691 -0.63 . . . . 0.0 109.943 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -55.01 -50.09 69.89 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.316 1.446 . . . . 0.0 110.98 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -32.17 72.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.473 1.109 . . . . 0.0 110.835 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.72 -47.96 18.78 Favored Glycine 0 CA--C 1.491 -1.435 0 O-C-N 121.779 -0.576 . . . . 0.0 111.784 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.7 -41.14 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 122.068 -0.666 . . . . 0.0 110.084 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.68 -29.81 68.35 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 120.505 -1.372 . . . . 0.0 112.089 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.36 -49.17 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -73.49 -12.71 60.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.52 -0.737 . . . . 0.0 111.201 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.85 -53.94 7.24 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -50.88 -42.14 58.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.452 2.301 . . . . 0.0 112.939 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 m -60.51 -19.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 112.248 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 4.9 m -69.29 -13.39 62.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.919 -1.113 . . . . 0.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.92 68.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.805 -1.81 . . . . 0.0 111.075 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.525 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -74.76 -47.16 32.6 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.725 -1.234 . . . . 0.0 108.661 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.44 -31.18 66.91 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.13 0.972 . . . . 0.0 110.777 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.799 -1.188 . . . . 0.0 111.562 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 10.3 t -94.31 1.39 55.93 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.838 -1.163 . . . . 0.0 108.865 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -26.8 58.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 120.341 1.428 . . . . 0.0 110.055 -176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -69.9 -38.9 76.46 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.716 -1.24 . . . . 0.0 109.521 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.09 -25.0 37.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 125.533 1.533 . . . . 0.0 110.643 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -57.08 -24.6 55.12 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.114 1.366 . . . . 0.0 112.678 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -58.31 -31.82 67.88 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 121.138 -0.976 . . . . 0.0 111.628 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 N--CA 1.439 -1.019 0 O-C-N 121.756 -0.59 . . . . 0.0 109.821 -172.821 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -173.71 -120.8 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.056 1 N-CA-C 99.641 -4.207 . . . . 0.0 99.641 -157.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 28.4 p-80 -53.17 -21.58 5.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 129.052 2.941 . . . . 0.0 114.521 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.8 -31.72 71.09 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.857 0.863 . . . . 0.0 111.007 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -68.67 -43.22 76.62 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.946 -1.096 . . . . 0.0 109.951 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.5 -32.05 69.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.86 -46.56 90.09 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.562 0.745 . . . . 0.0 111.457 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.62 -31.98 73.02 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 121.645 -0.659 . . . . 0.0 111.778 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -69.78 -35.65 75.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.479 -0.763 . . . . 0.0 109.438 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.91 82.27 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.941 -1.099 . . . . 0.0 111.353 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.8 -20.79 62.54 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.784 -1.198 . . . . 0.0 112.064 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.16 -39.28 63.36 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.031 1.332 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -64.38 -34.83 79.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.254 1.822 . . . . 0.0 110.257 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.94 -41.29 91.51 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 121.895 -0.503 . . . . 0.0 110.311 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.44 -32.75 74.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.308 0.643 . . . . 0.0 110.924 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -64.65 -42.68 95.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.237 1.415 . . . . 0.0 110.904 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.0 -25.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 O-C-N 121.079 -1.013 . . . . 0.0 110.568 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -60.57 -47.98 83.79 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-N 119.361 0.982 . . . . 0.0 109.771 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -61.61 -46.52 89.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.556 0.742 . . . . 0.0 111.137 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -74.39 -34.74 63.4 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.442 -0.786 . . . . 0.0 109.402 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.84 73.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 120.314 -1.491 . . . . 0.0 111.923 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -61.9 -41.75 98.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.413 1.085 . . . . 0.0 110.926 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -69.14 -38.16 78.67 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.56 -53.89 44.63 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.733 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -47.74 74.27 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.181 1.392 . . . . 0.0 112.549 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.495 HG22 HH21 ' D' ' 31' ' ' ARG . 11.2 p -71.13 -26.29 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 120.527 -1.358 . . . . 0.0 111.523 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -89.96 -28.09 19.37 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 109.02 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.92 -55.68 7.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.17 2.588 . . . . 0.0 108.797 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.41 -26.1 68.3 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.95 1.3 . . . . 0.0 111.527 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . 0.495 HH21 HG22 ' D' ' 27' ' ' VAL . 6.8 tpp180 -69.01 104.85 2.22 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 120.035 -1.666 . . . . 0.0 109.876 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.04 -7.8 29.2 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.0 140.26 29.08 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.26 134.46 5.89 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.308 2.005 . . . . 0.0 110.634 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.86 0.46 66.33 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.16 115.48 6.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.976 1.71 . . . . 0.0 108.518 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.49 -26.89 13.96 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.23 104.18 16.14 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -148.14 70.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 120.218 -1.551 . . . . 0.0 109.333 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -167.61 157.61 10.59 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -77.18 -50.99 2.11 Favored Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 115.774 -2.06 . . . . 0.0 110.84 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.01 -15.96 36.35 Favored 'Trans proline' 0 CA--C 1.512 -0.575 0 CA-C-N 126.063 3.201 . . . . 0.0 111.396 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -82.26 -36.61 26.94 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.43 90.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.034 0.933 . . . . 0.0 111.999 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tp -72.85 -21.45 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.503 1.144 . . . . 0.0 109.906 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -40.1 25.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 120.266 -1.521 . . . . 0.0 109.311 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -65.0 -35.99 82.98 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.931 1.292 . . . . 0.0 110.64 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -86.27 62.14 7.25 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 120.29 -1.506 . . . . 0.0 109.51 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.84 -61.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -30.17 69.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.236 0.925 . . . . 0.0 110.62 -167.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -57.12 -35.31 69.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 125.617 1.567 . . . . 0.0 111.077 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.15 -25.26 55.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 119.869 -1.769 . . . . 0.0 110.697 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.67 -0.75 39.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.443 1.497 . . . . 0.0 108.404 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.265 4.1 p 60.72 47.95 7.59 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.007 2.123 . . . . 0.0 111.437 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.2 152.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 99.035 -4.432 . . . . 0.0 99.035 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.6 110.08 0.51 Allowed Glycine 0 CA--C 1.472 -2.645 1 N-CA-C 99.61 -5.396 . . . . 0.0 99.61 176.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -37.78 64.1 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 45.83 0.21 Allowed Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 168.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.9 -48.95 50.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 117.3 0.55 . . . . 0.0 110.463 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -137.7 177.45 7.86 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -149.05 140.65 14.45 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.95 -175.36 2.63 Favored 'Trans proline' 0 CA--C 1.516 -0.382 0 C-N-CA 124.627 3.552 . . . . 0.0 110.311 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.444 HG12 ' H ' ' D' ' 64' ' ' THR . 0.6 OUTLIER -134.78 -157.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.444 ' H ' HG12 ' D' ' 63' ' ' VAL . 1.8 p -77.46 -49.93 13.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 127.618 2.367 . . . . 0.0 109.368 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -85.67 -13.95 46.98 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.846 1.258 . . . . 0.0 111.193 -162.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -22.15 62.75 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.443 1.592 . . . . 0.0 107.484 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.27 54.03 2.51 Favored Glycine 0 CA--C 1.464 -3.104 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.501 HH12 ' HB3' ' C' ' 50' ' ' GLU . 62.0 ttt-85 -20.53 -28.13 0.0 OUTLIER 'General case' 0 C--N 1.368 1.386 1 C-N-CA 134.509 5.124 . . . . 0.0 117.392 -175.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -61.98 2.04 0.25 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.584 1.954 . . . . 0.0 113.263 166.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -70.96 -47.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 168.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.687 0.795 . . . . 0.0 110.516 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.57 -44.52 69.4 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 124.658 1.183 . . . . 0.0 111.036 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -61.52 -44.5 96.95 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.61 -44.91 82.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 121.76 -0.588 . . . . 0.0 109.774 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.6 mtm -61.92 -47.69 83.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.84 -31.63 68.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.076 -1.015 . . . . 0.0 111.355 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.28 81.32 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.154 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.63 96.62 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 123.551 0.596 . . . . 0.0 111.748 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -57.9 -49.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.789 0 C-N-CA 124.22 1.008 . . . . 0.0 109.599 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.94 -45.34 71.21 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.019 1.328 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.77 -57.0 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 124.695 1.198 . . . . 0.0 109.384 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -68.17 -34.74 76.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 121.64 -0.663 . . . . 0.0 110.669 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.73 78.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 110.637 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.94 -36.09 82.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.866 -1.146 . . . . 0.0 110.474 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.58 -10.86 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.042 1.337 . . . . 0.0 110.947 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -58.65 -21.12 53.19 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.665 -1.897 . . . . 0.0 111.015 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.33 68.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 120.314 -1.491 . . . . 0.0 112.525 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.641 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.11 -47.86 22.86 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.22 -32.62 74.15 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.883 0.849 . . . . 0.0 112.022 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.93 -11.84 60.97 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.323 -1.486 . . . . 0.0 111.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.427 HG21 ' CE1' ' D' ' 4' ' ' HIS . 62.6 p -82.93 -19.06 37.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 120.391 -1.443 . . . . 0.0 109.748 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.05 -34.19 77.16 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.987 0.812 . . . . 0.0 111.14 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -77.88 -18.1 56.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.626 -1.296 . . . . 0.0 111.479 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -81.45 -30.08 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -57.13 -23.53 47.82 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 124.909 1.284 . . . . 0.0 111.213 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -59.86 -25.95 65.46 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.242 1.017 . . . . 0.0 112.178 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.437 -1.104 0 O-C-N 120.83 -1.169 . . . . 0.0 110.509 179.607 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.063 0 CA-C-O 121.846 0.831 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 4' ' ' HIS . 6.9 p-10 -66.24 -43.35 86.83 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.961 1.704 . . . . 0.0 108.815 -175.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' OD2' ' A' ' 3' ' ' ASP . 57.0 m170 -69.7 -31.07 68.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.355 -0.841 . . . . 0.0 111.75 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.39 -43.58 60.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -66.09 -44.59 83.97 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.081 0.952 . . . . 0.0 110.243 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -66.57 -36.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.901 0.858 . . . . 0.0 110.771 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.84 -43.49 79.41 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 121.162 -0.961 . . . . 0.0 110.367 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -69.83 -31.22 68.97 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.1 0.56 . . . . 0.0 110.348 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -59.45 -40.84 88.14 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.743 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.73 -33.84 75.67 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.715 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.47 -34.24 77.32 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.571 -0.706 . . . . 0.0 111.504 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -60.78 -45.99 92.22 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.133 0.973 . . . . 0.0 109.854 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.53 -34.33 77.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.265 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.78 -35.23 77.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.385 -0.822 . . . . 0.0 111.1 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.13 -36.03 66.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 121.508 -0.745 . . . . 0.0 110.537 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.74 -45.56 93.8 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.498 1.119 . . . . 0.0 110.987 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.04 -20.19 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 O-C-N 121.254 -0.904 . . . . 0.0 111.238 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.29 -41.66 96.77 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 119.435 1.016 . . . . 0.0 110.194 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.68 -26.52 59.9 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.378 1.071 . . . . 0.0 110.328 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -79.52 -41.41 27.4 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.483 -1.386 . . . . 0.0 108.51 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.55 69.93 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.102 1.361 . . . . 0.0 111.903 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 45' ' ' ILE . 12.1 p -66.24 -50.54 63.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 119.224 0.92 . . . . 0.0 109.563 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -63.31 -47.15 83.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.363 1.865 . . . . 0.0 109.044 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.5 -32.61 71.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.313 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.21 50.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 119.942 1.247 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.19 -38.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 121.759 0.79 . . . . 0.0 109.58 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.24 -33.74 70.13 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.966 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.19 94.59 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.504 1.122 . . . . 0.0 111.169 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.93 -14.0 54.97 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.933 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -74.11 73.84 1.74 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.055 0.931 . . . . 0.0 111.049 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.73 23.92 0.69 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.274 -1.931 . . . . 0.0 108.274 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.49 142.58 43.45 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -77.86 121.63 5.52 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.936 2.424 . . . . 0.0 110.662 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.23 22.9 6.28 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.58 149.77 20.66 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 126.119 1.768 . . . . 0.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.77 -65.81 0.51 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.244 0.618 . . . . 0.0 111.706 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.56 55.91 3.38 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.591 1.186 . . . . 0.0 108.703 -171.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 tt -72.96 -13.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 125.979 1.712 . . . . 0.0 111.016 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.3 m -90.9 126.92 36.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.95 -51.21 80.98 Favored Pre-proline 0 C--N 1.349 0.558 0 CA-C-O 116.219 -1.848 . . . . 0.0 113.939 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.64 -8.83 23.13 Favored 'Trans proline' 0 CA--C 1.514 -0.482 0 CA-C-N 126.003 3.18 . . . . 0.0 111.932 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.68 -35.38 14.22 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.579 1.152 . . . . 0.0 108.136 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.29 88.14 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.618 1.567 . . . . 0.0 110.651 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 19.8 tt -66.33 -29.78 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.784 -0.573 . . . . 0.0 111.941 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -27.39 56.91 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.937 -1.102 . . . . 0.0 109.75 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -72.18 -38.85 69.01 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -55.41 -35.38 65.3 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.67 -0.644 . . . . 0.0 111.964 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.42 -39.09 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 110.261 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -80.28 -15.96 55.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.378 -0.826 . . . . 0.0 112.268 -168.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -97.2 -31.06 12.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 110.267 -173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -23.04 62.39 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.04 -1.038 . . . . 0.0 111.701 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -84.35 -2.75 57.59 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.424 1.09 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 53.27 65.37 1.54 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 126.067 1.747 . . . . 0.0 112.18 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.47 -84.41 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.75 76.85 1.27 Allowed Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.95 -49.14 16.19 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.1 -122.56 1.18 Allowed Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 104.053 -3.619 . . . . 0.0 104.053 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.547 ' HB3' HH12 ' B' ' 68' ' ' ARG 0.287 8.8 t0 62.95 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.428 1.891 . . . . 0.0 111.211 -169.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.79 -176.95 3.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -156.13 147.12 16.46 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.24 177.55 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.268 2.646 . . . . 0.0 110.199 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.81 170.57 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.27 1.428 . . . . 0.0 107.92 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -62.31 1.69 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.122 2.169 . . . . 0.0 112.47 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.7 -40.9 80.56 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.093 0.957 . . . . 0.0 112.451 -165.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.96 -108.75 0.34 Allowed 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.53 -83.01 0.0 OUTLIER Glycine 0 C--N 1.358 1.79 0 C-N-CA 128.239 2.828 . . . . 0.0 114.53 171.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 68' ' ' ARG . 57.5 ttm-85 -54.79 -44.16 73.49 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.046 2.538 . . . . 0.0 112.439 174.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.98 -30.05 63.51 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.214 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.82 -45.1 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.49 78.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.837 2.055 . . . . 0.0 112.041 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -51.7 -44.44 63.17 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 109.736 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -72.33 -30.27 64.59 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.15 -47.89 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.62 -37.28 82.27 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.97 -38.11 87.3 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.505 -0.747 . . . . 0.0 111.08 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.45 -28.21 69.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.655 0.782 . . . . 0.0 111.385 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.52 -42.59 11.38 Favored Glycine 0 CA--C 1.49 -1.484 0 C-N-CA 124.709 1.147 . . . . 0.0 110.722 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.7 -47.84 81.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.678 1.191 . . . . 0.0 109.198 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -69.16 -25.71 64.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.317 -0.865 . . . . 0.0 111.916 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.47 -51.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.178 -0.951 . . . . 0.0 108.526 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.25 -26.03 66.37 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.48 -0.762 . . . . 0.0 111.231 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.57 48.59 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.023 0.929 . . . . 0.0 110.506 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.75 -39.12 87.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 124.803 1.241 . . . . 0.0 111.246 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.72 -6.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 121.366 -0.834 . . . . 0.0 112.679 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -60.31 -20.29 58.63 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.815 1.246 . . . . 0.0 110.682 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.11 78.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.345 -1.472 . . . . 0.0 112.688 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.18 -45.38 60.61 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.39 -37.63 88.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.562 0.745 . . . . 0.0 110.99 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.41 97.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.867 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -15.99 41.03 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.68 -1.263 . . . . 0.0 113.191 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.96 -17.1 60.6 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 111.853 -172.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -77.94 -24.71 48.12 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.239 -1.538 . . . . 0.0 110.734 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.72 -39.57 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -61.86 -20.89 64.18 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.18 1.392 . . . . 0.0 112.414 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttp85 -58.81 -22.35 58.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 125.005 1.322 . . . . 0.0 111.896 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 . . . . . 0 C--N 1.353 0.739 0 O-C-N 120.07 -1.644 . . . . 0.0 111.5 177.004 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.389 0 CA-C-O 122.184 0.992 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.468 ' CE1' ' OE1' ' B' ' 5' ' ' GLU . 7.7 p80 -59.91 -28.6 67.73 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.451 1.1 . . . . 0.0 112.413 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.468 ' OE1' ' CE1' ' B' ' 4' ' ' HIS . 9.3 tp10 -80.5 -34.61 35.59 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -167.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -71.34 -37.2 71.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.169 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -60.7 -43.07 98.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.931 1.692 . . . . 0.0 110.076 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.8 -45.42 82.42 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.351 1.06 . . . . 0.0 110.994 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.04 -37.43 87.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.436 1.094 . . . . 0.0 110.996 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.51 -33.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.382 1.473 . . . . 0.0 110.917 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.72 -37.93 79.84 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.663 -1.273 . . . . 0.0 110.072 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.17 -30.45 71.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.65 -38.39 90.12 Favored 'General case' 0 C--N 1.357 0.906 0 O-C-N 121.223 -0.923 . . . . 0.0 110.865 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -67.74 -36.25 80.22 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 121.627 -0.67 . . . . 0.0 109.795 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -61.61 -40.55 95.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.628 -0.67 . . . . 0.0 110.669 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.21 -27.24 67.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.361 -0.837 . . . . 0.0 111.989 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.63 -39.64 73.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.79 -38.9 83.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 124.426 1.09 . . . . 0.0 109.421 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -42.11 76.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.236 1.014 . . . . 0.0 112.301 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.86 -43.88 67.54 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.46 -33.17 73.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.101 -1.0 . . . . 0.0 111.394 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.73 -32.69 72.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.049 1.339 . . . . 0.0 110.993 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.0 p -66.83 -41.98 86.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -64.63 -45.37 87.13 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.98 1.312 . . . . 0.0 108.646 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -60.82 -58.16 9.63 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 109.807 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.72 79.9 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.824 1.249 . . . . 0.0 112.858 -172.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.57 -49.57 81.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 CA-C-N 118.814 0.734 . . . . 0.0 109.495 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -76.27 -25.11 54.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.504 0.669 . . . . 0.0 109.644 -170.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 125.544 1.538 . . . . 0.0 110.159 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.18 -12.66 60.13 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.025 -1.047 . . . . 0.0 113.128 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.83 77.68 1.6 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.557 -1.339 . . . . 0.0 110.986 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.04 -19.62 1.58 Allowed Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.41 140.95 45.2 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 121.248 -1.148 . . . . 0.0 109.911 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.62 151.25 25.15 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 122.11 1.873 . . . . 0.0 109.131 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 16.37 79.07 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 119.179 0.899 . . . . 0.0 112.19 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.53 142.93 57.72 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.355 1.862 . . . . 0.0 110.61 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.72 -25.12 0.32 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.324 0.583 . . . . 0.0 110.702 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.25 -38.14 66.09 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.535 1.534 . . . . 0.0 108.512 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -37.85 115.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 130.169 3.388 . . . . 0.0 111.854 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 47.1 t -177.88 -152.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 99.975 -4.083 . . . . 0.0 99.975 -168.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.26 -56.62 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -69.73 -31.3 20.93 Favored 'Trans proline' 0 CA--C 1.503 -1.034 0 CA-C-N 124.416 2.613 . . . . 0.0 111.404 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -107.77 14.51 25.44 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 119.757 1.162 . . . . 0.0 110.148 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.22 -35.37 73.84 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.404 -0.81 . . . . 0.0 109.336 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -28.2 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 123.814 0.845 . . . . 0.0 109.764 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -34.03 76.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.255 -1.528 . . . . 0.0 110.896 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -68.5 -42.76 78.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.685 0.794 . . . . 0.0 109.581 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.6 p -68.38 -28.37 67.05 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.395 -1.441 . . . . 0.0 111.376 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.08 -53.94 24.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 124.568 1.147 . . . . 0.0 110.737 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -73.82 -21.05 60.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.358 -0.838 . . . . 0.0 111.98 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.0 m -72.22 -39.56 68.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.46 67.48 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.371 -0.831 . . . . 0.0 111.727 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 4.37 44.82 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.943 -0.473 . . . . 0.0 110.918 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 24.2 p 55.67 56.58 6.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.273 1.429 . . . . 0.0 112.547 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 55.1 t -121.27 -93.29 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 101.972 -3.344 . . . . 0.0 101.972 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.03 82.98 1.1 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -174.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -73.9 -24.7 59.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.425 -1.044 . . . . 0.0 111.562 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.42 38.58 0.91 Allowed Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -82.32 -60.89 2.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.47 153.99 43.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.7 146.85 36.89 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 161.87 17.28 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.868 2.378 . . . . 0.0 108.797 164.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.18 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 119.465 1.029 . . . . 0.0 108.539 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -114.74 -36.63 4.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.68 1.229 . . . . 0.0 109.054 -172.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.95 -3.63 57.14 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 121.361 -0.837 . . . . 0.0 109.385 -166.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -26.26 60.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 77.11 1.32 Allowed Glycine 0 CA--C 1.471 -2.705 1 N-CA-C 101.445 -4.662 . . . . 0.0 101.445 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.547 HH12 ' HB3' ' A' ' 59' ' ' ASP . 21.0 ttm180 -53.52 -7.9 0.12 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 128.401 2.68 . . . . 0.0 114.263 -170.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -53.14 -19.98 3.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 120.716 -1.24 . . . . 0.0 113.276 157.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.17 -52.04 63.75 Favored 'Isoleucine or valine' 0 C--N 1.363 1.16 0 CA-C-N 120.464 1.484 . . . . 0.0 107.644 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.78 77.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.681 -0.637 . . . . 0.0 109.642 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.06 -46.98 75.42 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.232 1.013 . . . . 0.0 110.553 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.96 -44.04 91.41 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 124.899 1.28 . . . . 0.0 111.094 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.1 -44.16 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.367 0.667 . . . . 0.0 109.969 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.0 mtm -63.16 -46.54 86.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.346 0.593 . . . . 0.0 109.823 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -61.31 -41.51 97.12 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.063 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.13 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.765 0.826 . . . . 0.0 111.033 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.46 -48.17 76.44 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.87 -43.35 91.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 C-N-CA 124.47 1.108 . . . . 0.0 110.206 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.25 -40.9 94.63 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.118 -0.989 . . . . 0.0 111.684 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.9 -47.63 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.26 -11.15 60.76 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 121.562 -0.711 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.76 -42.3 12.7 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.835 -1.166 . . . . 0.0 109.144 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.53 -36.69 74.25 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 126.112 1.765 . . . . 0.0 111.04 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.64 -7.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 112.498 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.6 m -63.65 -16.86 62.1 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.314 -1.492 . . . . 0.0 110.985 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.45 -19.34 63.4 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.52 -1.987 . . . . 0.0 111.751 169.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.08 -54.48 4.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.124 1.37 . . . . 0.0 108.705 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.69 -36.34 70.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.468 -0.77 . . . . 0.0 112.533 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.14 -17.2 61.41 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 119.834 -1.791 . . . . 0.0 110.2 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -87.41 -2.27 58.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.729 -1.232 . . . . 0.0 109.36 175.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.02 -31.45 67.94 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 120.674 1.579 . . . . 0.0 111.302 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -72.94 -25.71 61.13 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.84 -1.163 . . . . 0.0 111.22 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.64 -32.5 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -63.37 -26.1 68.6 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.294 1.038 . . . . 0.0 111.552 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -50.57 -39.77 50.42 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.283 1.433 . . . . 0.0 111.438 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 CA--C 1.507 -0.689 0 O-C-N 120.926 -1.109 . . . . 0.0 112.128 -179.496 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 CA--C 1.505 -0.752 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -52.39 -29.8 25.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.365 1.466 . . . . 0.0 113.769 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.82 -25.96 56.8 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.943 -1.098 . . . . 0.0 111.326 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.94 -38.72 69.77 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.186 -0.946 . . . . 0.0 108.524 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.62 -27.95 66.48 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.28 0.562 . . . . 0.0 109.852 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.79 75.97 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.253 -0.905 . . . . 0.0 111.193 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -74.53 -29.5 61.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 120.872 -1.143 . . . . 0.0 111.08 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -64.17 -28.79 70.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 111.286 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.36 65.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.893 -1.13 . . . . 0.0 110.438 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.43 -32.35 73.67 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 120.898 -1.126 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.6 -29.31 66.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.793 -1.192 . . . . 0.0 110.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.67 -37.49 79.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.324 1.449 . . . . 0.0 109.181 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 27.4 tp -56.86 -48.89 77.05 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 126.073 1.749 . . . . 0.0 110.026 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.03 -39.79 79.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.673 1.589 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -74.12 -46.7 40.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.338 1.455 . . . . 0.0 110.742 -172.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.98 -36.23 72.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.101 -0.999 . . . . 0.0 111.111 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.19 -28.04 57.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -49.59 74.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -63.19 -43.41 98.28 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.44 1.114 . . . . 0.0 109.197 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.16 63.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.637 -0.665 . . . . 0.0 112.518 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 m -69.13 -47.73 64.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 124.075 0.95 . . . . 0.0 109.702 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -66.24 -43.79 85.58 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.43 -20.61 64.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.461 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -45.09 73.69 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 119.975 1.261 . . . . 0.0 110.451 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.04 -44.29 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.91 -45.02 94.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.801 1.64 . . . . 0.0 110.258 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.18 86.45 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 124.869 1.267 . . . . 0.0 111.174 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -32.45 58.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 121.959 -0.463 . . . . 0.0 109.9 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.6 90.49 1.03 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.443 1.097 . . . . 0.0 109.637 -174.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.75 -27.41 2.82 Favored Glycine 0 CA--C 1.491 -1.463 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -93.57 156.07 40.06 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -76.77 154.08 34.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.23 1.953 . . . . 0.0 110.734 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.41 49.73 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.16 136.41 15.12 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.636 1.974 . . . . 0.0 113.536 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.7 -30.42 0.19 Allowed 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.185 0.994 . . . . 0.0 111.007 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -102.88 148.08 26.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -168.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -156.47 179.43 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m 65.32 109.36 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.572 1.549 . . . . 0.0 114.258 161.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -57.59 -37.89 61.53 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 116.227 -1.844 . . . . 0.0 114.757 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.6 -21.77 14.44 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 CA-C-N 125.628 3.046 . . . . 0.0 112.666 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -82.84 -25.45 32.62 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.72 71.86 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.96 1.704 . . . . 0.0 112.507 -172.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -67.13 -25.16 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 123.338 0.655 . . . . 0.0 111.114 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -21.01 56.25 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 120.822 -1.174 . . . . 0.0 110.867 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -80.62 -40.16 26.14 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.372 1.082 . . . . 0.0 108.126 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m -70.61 -31.42 68.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 O-C-N 120.328 -1.483 . . . . 0.0 112.634 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -62.62 -51.05 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.68 -15.76 61.69 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.08 1.352 . . . . 0.0 112.291 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 50.3 m -82.3 -36.73 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.066 -1.021 . . . . 0.0 108.525 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -27.74 61.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.37 -0.831 . . . . 0.0 110.451 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -93.0 6.91 46.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.452 0.701 . . . . 0.0 110.211 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.259 7.9 p 54.2 55.02 8.71 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 126.855 2.062 . . . . 0.0 114.317 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.87 -75.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.96 -64.06 3.09 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 t80 78.68 -47.6 0.43 Allowed 'General case' 0 C--N 1.351 0.668 0 C-N-CA 127.369 2.267 . . . . 0.0 109.437 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.05 13.72 0.42 Allowed Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -57.57 4.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.658 -0.907 . . . . 0.0 111.144 -173.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 26.0 mtm-85 -138.13 154.95 49.17 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -134.27 150.41 73.97 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.23 166.82 20.21 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 109.556 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' C' ' 33' ' ' ALA . 32.8 m -87.1 -179.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p -82.54 -79.85 0.18 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -32.47 -61.68 0.26 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.596 2.758 . . . . 0.0 110.912 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.77 -59.41 1.8 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -41.02 -41.45 2.67 Favored Glycine 0 CA--C 1.488 -1.639 0 C-N-CA 127.47 2.462 . . . . 0.0 114.819 -169.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -76.36 -30.68 57.68 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.292 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -35.35 71.59 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 121.528 1.967 . . . . 0.0 108.888 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.93 -51.38 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.79 98.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 125.094 1.358 . . . . 0.0 112.551 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.98 -46.89 52.95 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 127.328 2.251 . . . . 0.0 109.457 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -66.59 -36.39 82.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.75 -44.46 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.6 mtt -59.5 -46.26 89.32 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.679 0.791 . . . . 0.0 110.664 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -61.94 -43.61 98.48 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.48 84.12 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.226 0.61 . . . . 0.0 110.931 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.19 86.64 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 123.821 0.724 . . . . 0.0 111.833 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.99 -43.11 97.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.938 0.895 . . . . 0.0 109.527 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.77 -33.36 73.94 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.342 -0.848 . . . . 0.0 111.94 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.21 -53.59 35.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 123.689 0.796 . . . . 0.0 109.558 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -66.09 -38.79 89.14 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.85 -30.47 71.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.423 0.689 . . . . 0.0 111.842 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.68 -36.86 81.48 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 121.026 -1.046 . . . . 0.0 110.443 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.64 -20.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.932 1.293 . . . . 0.0 110.416 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 2.9 m -55.76 -22.79 25.94 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.927 1.291 . . . . 0.0 112.185 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.66 70.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.662 -1.899 . . . . 0.0 112.826 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.0 -16.68 35.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 123.961 0.904 . . . . 0.0 110.381 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.4 -35.6 17.03 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.33 62.07 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.611 -1.306 . . . . 0.0 111.179 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -73.26 -19.22 61.11 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 120.44 -1.412 . . . . 0.0 110.787 171.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.7 -11.37 57.28 Favored 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 120.935 -1.103 . . . . 0.0 111.136 -157.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -84.58 -21.3 30.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.109 -0.994 . . . . 0.0 110.336 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.84 -35.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -55.35 -19.46 8.92 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.036 1.334 . . . . 0.0 113.217 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -57.46 -28.87 63.73 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.296 -0.877 . . . . 0.0 110.947 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 N--CA 1.436 -1.17 0 O-C-N 121.319 -0.863 . . . . 0.0 110.805 -176.772 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 74.48 -67.69 0.24 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.866 2.066 . . . . 0.0 110.645 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 5.7 p80 -70.83 -28.93 64.98 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 126.662 1.985 . . . . 0.0 111.857 -175.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 2.2 mp0 -69.32 -23.46 63.79 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 120.967 -1.083 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.07 -42.78 88.94 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.453 -0.779 . . . . 0.0 109.908 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.76 -39.64 80.17 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.63 93.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.536 0.735 . . . . 0.0 111.17 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.34 -39.52 85.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.469 0.708 . . . . 0.0 110.389 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -64.06 -35.61 81.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.005 0.922 . . . . 0.0 110.808 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.03 79.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.388 1.075 . . . . 0.0 111.122 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -65.26 -34.69 78.96 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 120.901 -1.125 . . . . 0.0 111.17 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.96 -33.67 74.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 121.595 -0.69 . . . . 0.0 110.867 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -61.68 -41.94 98.24 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.194 1.398 . . . . 0.0 109.297 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.61 -38.84 91.76 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.051 -1.031 . . . . 0.0 111.417 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -69.12 -22.65 63.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.157 -0.964 . . . . 0.0 112.405 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.48 -39.96 36.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.25 -38.33 80.8 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 124.379 1.071 . . . . 0.0 109.544 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.79 -45.9 63.99 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.556 1.142 . . . . 0.0 112.056 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -71.41 -41.14 69.94 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 122.776 0.431 . . . . 0.0 110.585 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -62.68 -43.37 98.99 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.38 68.69 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.875 1.67 . . . . 0.0 112.17 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -67.08 -37.95 84.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 110.163 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -35.21 63.85 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -64.66 -50.06 68.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.57 0.748 . . . . 0.0 109.185 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.39 69.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.678 1.191 . . . . 0.0 113.507 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.23 -28.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 O-C-N 120.187 -1.57 . . . . 0.0 109.888 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -75.75 -49.17 18.97 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.797 -1.19 . . . . 0.0 108.304 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.27 78.62 6.49 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.82 -55.05 0.06 Allowed 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.889 1.368 . . . . 0.0 108.051 163.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -79.42 103.54 9.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 119.406 -2.058 . . . . 0.0 110.303 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.38 -49.59 0.26 Allowed Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 105.181 -3.168 . . . . 0.0 105.181 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' D' ' 66' ' ' GLU . . . -78.0 161.69 70.05 Favored Pre-proline 0 CA--C 1.504 -0.807 0 C-N-CA 123.446 0.698 . . . . 0.0 112.759 -171.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -78.65 113.78 3.36 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.589 2.193 . . . . 0.0 110.766 172.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.33 2.25 13.55 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.129 -0.817 . . . . 0.0 111.202 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.03 145.09 21.42 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.858 1.263 . . . . 0.0 113.172 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.16 -48.56 1.33 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.626 1.171 . . . . 0.0 111.128 -167.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.78 133.81 34.51 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 pt -148.11 17.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.11 138.65 33.66 Favored 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 120.484 -1.385 . . . . 0.0 108.228 -170.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.58 -49.39 8.57 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.982 -1.961 . . . . 0.0 111.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.27 -8.04 21.35 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 CA-C-N 125.865 3.13 . . . . 0.0 111.101 -173.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -98.82 -25.63 14.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.09 80.5 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.532 1.133 . . . . 0.0 111.086 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.37 -35.53 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 121.977 -0.452 . . . . 0.0 110.445 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -28.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.487 -1.383 . . . . 0.0 110.429 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -63.79 -42.93 97.63 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.417 1.103 . . . . 0.0 108.457 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -58.33 -37.47 75.21 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.307 1.443 . . . . 0.0 111.388 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.53 -49.77 71.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 124.328 1.051 . . . . 0.0 110.591 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -75.36 -23.85 57.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.849 0.833 . . . . 0.0 110.863 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 64.3 m -70.31 -39.33 74.87 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.72 67.12 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.098 -1.001 . . . . 0.0 111.942 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -88.65 5.82 41.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 119.149 -0.453 . . . . 0.0 110.077 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 51.48 29.7 5.6 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 127.614 2.366 . . . . 0.0 112.437 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.07 -47.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.31 51.48 58.54 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -71.11 -33.23 69.94 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.978 0.894 . . . . 0.0 109.361 -166.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 155.68 -123.47 1.34 Allowed Glycine 0 CA--C 1.476 -2.36 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 75.13 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.345 1.458 . . . . 0.0 108.016 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -145.37 171.58 14.41 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.478 ' HB2' HH12 ' D' ' 68' ' ' ARG . 11.7 p90 -164.36 148.21 7.97 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -91.67 155.06 3.5 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 C-N-CA 122.468 2.112 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -155.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.937 0.875 . . . . 0.0 110.424 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -53.84 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.382 -1.449 . . . . 0.0 112.26 -164.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -79.86 -7.78 58.91 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.784 1.233 . . . . 0.0 109.621 -165.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' D' ' 33' ' ' ALA . 40.2 mm-40 -95.98 41.26 1.11 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 15.16 81.56 0.01 OUTLIER Glycine 0 CA--C 1.462 -3.253 1 C-N-CA 133.139 5.162 . . . . 0.0 110.434 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.478 HH12 ' HB2' ' D' ' 61' ' ' TYR . 20.7 ttt85 -53.37 -13.8 0.63 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.599 1.96 . . . . 0.0 113.457 -164.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.05 -6.01 0.32 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 160.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.12 -49.15 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 O-C-N 120.274 -1.517 . . . . 0.0 107.713 167.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.23 82.06 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -48.67 -46.28 40.06 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.604 1.161 . . . . 0.0 113.324 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.27 -37.43 83.44 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.107 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.34 -44.97 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 58.2 mtm -63.05 -48.34 79.13 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.21 1.004 . . . . 0.0 110.62 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.39 -38.27 88.98 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.531 -0.731 . . . . 0.0 110.505 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.698 -0.626 . . . . 0.0 111.911 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.17 -46.98 66.97 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.74 -44.89 94.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 C-N-CA 124.559 1.144 . . . . 0.0 109.663 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.78 -47.56 84.3 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 111.388 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.16 -49.99 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 124.284 1.034 . . . . 0.0 109.768 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -71.75 -16.23 62.2 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.903 -0.498 . . . . 0.0 111.482 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.27 -35.55 16.08 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.256 -0.903 . . . . 0.0 109.859 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.52 -31.48 72.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.584 1.554 . . . . 0.0 110.927 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.08 -3.02 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.696 0 O-C-N 121.326 -0.858 . . . . 0.0 112.609 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 88.0 m -58.35 -22.85 54.91 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.476 1.51 . . . . 0.0 111.571 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.88 66.33 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.198 -1.564 . . . . 0.0 111.935 172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.69 -49.06 6.68 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.09 -39.9 91.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.726 -1.234 . . . . 0.0 113.657 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.85 61.81 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.945 -1.097 . . . . 0.0 110.892 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 80.8 p -85.31 -14.47 46.43 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.568 -1.333 . . . . 0.0 110.566 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.39 -16.2 61.34 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.14 -1.6 . . . . 0.0 111.067 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -80.31 -31.36 38.15 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.651 -1.281 . . . . 0.0 111.874 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.19 -11.74 14.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 CA-C-O 121.562 0.696 . . . . 0.0 110.168 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -61.41 -17.26 53.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.788 0.835 . . . . 0.0 110.848 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.58 -22.21 63.46 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.586 1.085 . . . . 0.0 112.021 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 N--CA 1.441 -0.883 0 C-N-CA 123.682 0.793 . . . . 0.0 109.474 -178.344 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.865 0 CA-C-O 121.61 0.719 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 14.8 t0 -136.42 129.47 31.24 Favored 'General case' 0 CA--C 1.477 -1.857 1 N-CA-C 96.573 -5.343 . . . . 0.0 96.573 153.116 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' OE1' ' A' ' 5' ' ' GLU 0.299 22.4 p80 144.07 -60.88 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 128.5 2.72 . . . . 0.0 107.251 -177.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.52 ' OE1' ' CE1' ' A' ' 4' ' ' HIS . 2.8 pt-20 -76.34 -28.15 56.75 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 120.745 -1.222 . . . . 0.0 110.803 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -64.02 -37.54 87.79 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.06 -1.025 . . . . 0.0 111.167 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -73.48 -34.21 65.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.085 1.354 . . . . 0.0 108.27 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.96 90.34 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.953 1.301 . . . . 0.0 110.587 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -61.8 -42.16 98.66 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 110.082 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -64.03 -34.3 77.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.911 0.862 . . . . 0.0 110.947 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.48 70.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.003 -1.061 . . . . 0.0 110.987 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.02 -32.8 74.7 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.191 -0.943 . . . . 0.0 111.038 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.89 -34.81 74.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.744 -1.223 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.54 -36.54 82.93 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.46 -48.77 76.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.594 1.158 . . . . 0.0 110.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -71.49 -27.07 62.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.733 -1.229 . . . . 0.0 112.283 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -67.09 -44.34 80.26 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.211 1.404 . . . . 0.0 109.805 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 77' ' ' ALA . 21.9 m -72.48 -29.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.946 -1.096 . . . . 0.0 110.249 -177.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.0 mt -61.75 -38.87 89.57 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 123.799 0.839 . . . . 0.0 111.168 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.93 -31.55 63.11 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.197 0.999 . . . . 0.0 110.826 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -77.88 -39.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.03 78.79 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.274 1.029 . . . . 0.0 111.715 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -65.83 -32.69 74.36 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.862 -0.524 . . . . 0.0 110.587 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -62.55 -47.43 83.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.395 0.678 . . . . 0.0 109.576 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -64.96 -38.04 89.66 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 110.115 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.23 75.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.149 0.98 . . . . 0.0 112.555 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.8 t -72.71 -43.19 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 121.089 -1.007 . . . . 0.0 109.175 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.0 -37.87 81.98 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.65 -1.282 . . . . 0.0 110.104 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 64.74 6.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.919 1.688 . . . . 0.0 108.219 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -164.74 -53.86 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.91 89.53 0.01 OUTLIER 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.119 1.768 . . . . 0.0 112.269 -170.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.58 10.12 25.74 Favored Glycine 0 CA--C 1.498 -0.995 0 O-C-N 121.035 -1.041 . . . . 0.0 111.792 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.71 133.46 25.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.722 1.261 . . . . 0.0 107.945 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.39 130.0 8.83 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.696 2.264 . . . . 0.0 110.645 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.76 74.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 160.38 16.39 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.9 9.17 Favored 'General case' 0 N--CA 1.427 -1.595 1 N-CA-C 99.04 -4.43 . . . . 0.0 99.04 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' CE3' ' A' ' 47' ' ' TRP . 1.9 tt 82.63 87.99 0.04 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 tt -138.57 142.83 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.71 138.73 0.06 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.324 1.849 . . . . 0.0 112.73 169.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -51.65 -53.48 50.01 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 126.033 1.733 . . . . 0.0 114.37 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.77 -6.94 18.83 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 CA-C-N 124.366 2.595 . . . . 0.0 112.316 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.48 -48.08 4.9 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.6 77.77 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 125.382 1.473 . . . . 0.0 112.441 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -66.42 -31.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.509 -0.744 . . . . 0.0 110.452 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -23.16 36.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.394 -0.816 . . . . 0.0 109.916 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CE3' HD11 ' A' ' 38' ' ' LEU . 72.5 t90 -72.37 -38.56 68.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -75.92 65.84 2.06 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.551 1.54 . . . . 0.0 108.318 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.69 -71.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.616 ' CD ' HH22 ' B' ' 68' ' ' ARG . 20.0 pt-20 -69.37 -24.4 63.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.869 0.842 . . . . 0.0 111.946 -165.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 51' ' ' THR . 2.5 t -66.93 -35.37 79.84 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 124.837 1.255 . . . . 0.0 107.988 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -76.84 -23.64 52.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 120.358 -1.464 . . . . 0.0 110.695 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -87.31 9.93 18.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.282 5.4 t 48.08 48.29 18.41 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 127.723 2.409 . . . . 0.0 112.569 172.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -110.99 -99.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 171.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 109.88 67.01 0.57 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 103.142 -3.983 . . . . 0.0 103.142 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -68.12 -30.55 69.73 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 122.134 0.969 . . . . 0.0 108.466 -174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.62 49.07 0.53 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.492 ' CG ' HH21 ' B' ' 68' ' ' ARG 0.479 4.6 p-10 -80.48 -28.96 37.41 Favored 'General case' 0 C--N 1.362 1.11 0 CA-C-N 119.063 1.431 . . . . 0.0 110.372 170.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -147.03 -179.84 7.1 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -146.05 137.54 12.97 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -84.49 -177.12 2.8 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 C-N-CA 124.422 3.415 . . . . 0.0 108.863 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' GLU 0.308 7.8 p -112.1 -128.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.657 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 -37.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.443 1.897 . . . . 0.0 107.183 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -84.22 -2.19 56.47 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.77 0.828 . . . . 0.0 109.78 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -73.86 -35.51 64.75 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.81 60.29 0.66 Allowed Glycine 0 CA--C 1.466 -3.017 1 N-CA-C 102.772 -4.131 . . . . 0.0 102.772 168.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -13.84 -30.75 0.0 OUTLIER 'General case' 0 C--N 1.364 1.214 1 C-N-CA 135.489 5.515 . . . . 0.0 117.738 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -53.36 -22.31 7.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 126.737 2.015 . . . . 0.0 112.626 163.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.3 -51.35 65.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.52 -1.363 . . . . 0.0 108.439 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.79 -45.09 68.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.376 0.67 . . . . 0.0 110.341 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.81 -37.09 75.6 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 110.841 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -58.18 -39.65 79.46 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 121.4 -0.812 . . . . 0.0 110.601 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.51 -36.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mmt -57.9 -57.49 12.58 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.397 1.079 . . . . 0.0 109.741 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.95 -28.06 67.98 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 121.345 -0.847 . . . . 0.0 111.057 -175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 18' ' ' VAL . . . -66.92 -22.74 65.94 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.588 -0.695 . . . . 0.0 110.883 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.93 -36.78 10.85 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.25 -42.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 125.359 1.464 . . . . 0.0 110.426 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.76 -37.27 84.29 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.438 -0.789 . . . . 0.0 110.91 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.36 -57.99 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 124.535 1.134 . . . . 0.0 109.979 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.01 -13.7 62.6 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.709 -0.619 . . . . 0.0 110.691 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.62 -46.97 16.23 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 121.112 -0.992 . . . . 0.0 110.091 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.47 -36.9 79.39 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.065 1.346 . . . . 0.0 111.64 -172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.0 m -62.71 -9.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.408 -0.807 . . . . 0.0 112.602 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -62.91 -18.58 63.22 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.121 1.369 . . . . 0.0 110.941 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.82 -24.28 66.78 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.682 -1.261 . . . . 0.0 111.636 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.47 -46.52 10.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 108.197 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.43 -41.55 98.79 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.17 0.988 . . . . 0.0 112.902 -171.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.04 -9.96 59.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.13 -0.981 . . . . 0.0 111.466 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.6 p -83.78 -16.18 45.64 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 120.768 -1.208 . . . . 0.0 110.323 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.73 -24.77 58.77 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.628 -163.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -74.65 -32.02 62.12 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.644 -1.285 . . . . 0.0 110.995 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 t -69.43 -32.87 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 125.399 1.48 . . . . 0.0 108.423 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -61.84 -11.63 13.64 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.398 1.479 . . . . 0.0 112.442 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -68.34 -22.34 64.69 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 120.001 -1.687 . . . . 0.0 110.595 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--N 1.353 0.749 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.459 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 CA--C 1.507 -0.683 0 CA-C-O 123.537 1.637 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.25 -21.05 63.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.191 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -85.66 -39.11 17.63 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -70.84 -31.25 67.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.478 -0.764 . . . . 0.0 110.864 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.11 -47.64 79.24 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.0 70.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.294 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.14 -35.91 80.72 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.218 1.007 . . . . 0.0 110.208 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.25 -28.12 64.99 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -39.35 93.37 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.09 -47.79 76.0 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.404 -0.81 . . . . 0.0 110.548 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -52.88 -51.97 59.16 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.312 1.845 . . . . 0.0 110.222 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -76.03 -12.59 60.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.443 -0.786 . . . . 0.0 112.045 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.733 -1.229 . . . . 0.0 108.12 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.77 -14.05 60.66 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.54 -1.35 . . . . 0.0 111.193 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.93 -51.65 21.03 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.15 -23.75 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.859 -0.526 . . . . 0.0 111.393 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.14 -39.71 83.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.369 -0.832 . . . . 0.0 112.076 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.74 -24.34 38.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.293 0.568 . . . . 0.0 110.583 -174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.33 -42.15 46.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.82 82.15 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 126.309 1.844 . . . . 0.0 111.584 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -65.99 -44.97 83.29 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 122.111 -0.368 . . . . 0.0 110.324 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.11 -48.16 77.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.248 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -68.31 -25.55 65.19 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.098 -175.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -43.9 58.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 109.673 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 73.7 t -60.43 -45.72 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.241 -0.912 . . . . 0.0 110.127 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.59 17.96 15.2 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 121.638 -0.664 . . . . 0.0 111.099 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.507 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -75.69 -48.52 21.66 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 170.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' B' ' 36' ' ' ALA . 0.5 OUTLIER -56.66 -27.53 58.78 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 126.396 1.878 . . . . 0.0 115.082 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -73.77 75.88 1.58 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.61 0.764 . . . . 0.0 109.393 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.59 -43.23 0.77 Allowed Glycine 0 CA--C 1.488 -1.618 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.41 152.12 60.35 Favored Pre-proline 0 N--CA 1.445 -0.713 0 O-C-N 121.486 -1.008 . . . . 0.0 111.263 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.05 153.5 11.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.136 1.891 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.17 41.61 10.13 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' B' ' 30' ' ' GLU . . . -62.71 132.44 52.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 -42.06 0.17 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.358 0.263 . . . . 0.0 110.683 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -6.61 54.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.896 1.678 . . . . 0.0 110.739 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.14 84.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 O-C-N 120.634 -1.291 . . . . 0.0 111.929 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.1 112.05 0.74 Allowed 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -53.37 -47.7 95.26 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.404 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -71.47 -20.14 27.7 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-N 124.962 2.808 . . . . 0.0 113.011 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.73 0.63 17.47 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 119.941 1.246 . . . . 0.0 109.922 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.44 -34.72 76.46 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.189 -0.944 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.422 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.6 tt -70.99 -35.75 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.287 1.035 . . . . 0.0 109.614 175.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.63 -38.83 67.6 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.466 -1.396 . . . . 0.0 108.815 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -65.18 -44.86 87.11 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 123.356 0.662 . . . . 0.0 110.152 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -66.96 -29.43 69.28 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.953 -1.092 . . . . 0.0 110.851 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 23.3 t -58.35 -43.25 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.453 1.101 . . . . 0.0 111.117 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -82.45 -15.0 54.16 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.794 1.179 . . . . 0.0 112.298 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.48 -36.14 29.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.756 -1.215 . . . . 0.0 107.804 -174.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.37 -23.39 61.12 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.882 -1.136 . . . . 0.0 112.066 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.96 -6.28 59.0 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.188 0.995 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 14.6 p 55.7 54.48 8.22 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.863 1.665 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.89 -91.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 1 N-CA-C 100.031 -4.062 . . . . 0.0 100.031 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.52 76.72 1.34 Allowed Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.65 -18.23 51.93 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.49 -1.006 . . . . 0.0 108.605 -171.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.3 48.93 0.68 Allowed Glycine 0 CA--C 1.484 -1.877 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 168.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.61 -54.34 9.37 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -131.33 -136.62 0.2 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.191 0.596 . . . . 0.0 109.594 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -171.91 121.57 0.47 Allowed Pre-proline 0 N--CA 1.444 -0.726 1 N-CA-C 100.029 -4.063 . . . . 0.0 100.029 -168.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.85 158.15 13.82 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 124.59 2.675 . . . . 0.0 109.791 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.407 HG22 ' H ' ' B' ' 63' ' ' VAL . 2.9 m -76.11 169.92 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.635 1.207 . . . . 0.0 111.819 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -59.63 2.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.38 1.072 . . . . 0.0 110.793 -169.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.31 -17.26 64.7 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 -168.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -130.56 -108.05 0.27 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.507 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 25.94 -70.87 0.0 OUTLIER Glycine 0 CA--C 1.486 -1.758 1 C-N-CA 132.442 4.83 . . . . 0.0 116.204 170.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.616 HH22 ' CD ' ' A' ' 50' ' ' GLU . 52.7 ttm-85 -61.78 -42.92 99.61 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 126.083 1.753 . . . . 0.0 112.575 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -67.79 -34.5 76.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 120.251 1.387 . . . . 0.0 109.589 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.99 -47.75 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.2 90.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.876 1.671 . . . . 0.0 110.9 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -50.91 -46.1 60.55 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 127.648 2.379 . . . . 0.0 110.482 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -66.73 -37.46 84.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -74.51 -45.76 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.223 1.009 . . . . 0.0 109.372 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 71.7 mtm -61.06 -45.01 96.48 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.629 1.172 . . . . 0.0 109.759 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -64.8 -32.49 74.2 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.909 -0.495 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.512 -0.743 . . . . 0.0 110.329 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -40.59 97.02 Favored Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 124.186 0.898 . . . . 0.0 111.732 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.63 -51.0 77.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 C-N-CA 124.086 0.954 . . . . 0.0 108.456 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -65.41 -27.4 68.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.541 -0.724 . . . . 0.0 111.724 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.87 -58.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 124.391 1.076 . . . . 0.0 110.333 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -65.28 -25.41 67.63 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 121.539 0.685 . . . . 0.0 110.148 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.21 -41.97 32.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 121.367 -0.833 . . . . 0.0 111.268 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.16 -36.93 85.26 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.522 -1.361 . . . . 0.0 110.682 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.79 -3.45 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 O-C-N 121.563 -0.711 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 56.5 m -56.6 -22.77 36.17 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.992 1.317 . . . . 0.0 109.985 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.05 72.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.329 -1.482 . . . . 0.0 112.503 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.01 -35.42 61.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 120.954 -1.091 . . . . 0.0 109.191 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.5 -32.49 62.54 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 122.967 0.507 . . . . 0.0 110.67 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.844 -1.16 . . . . 0.0 111.115 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -11.21 60.62 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.066 -1.021 . . . . 0.0 113.22 174.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.7 -47.61 80.46 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 120.208 1.367 . . . . 0.0 109.839 -171.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -71.54 -27.16 62.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.941 -1.099 . . . . 0.0 111.736 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.01 -17.75 22.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.982 1.313 . . . . 0.0 109.455 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -70.37 -17.73 63.05 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.082 -1.636 . . . . 0.0 111.707 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -66.41 -13.48 60.77 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 120.496 -1.377 . . . . 0.0 110.478 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 . . . . . 0 CA--C 1.497 -1.064 0 C-N-CA 126.195 1.798 . . . . 0.0 109.876 176.482 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.498 -1.036 0 CA-C-O 121.639 0.733 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.407 ' CD2' ' HG3' ' C' ' 5' ' ' GLU . 40.5 p-80 -65.82 -30.33 70.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.803 -0.561 . . . . 0.0 112.004 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.407 ' HG3' ' CD2' ' C' ' 4' ' ' HIS . 7.2 mt-10 -77.36 -40.72 42.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.04 -44.46 96.66 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.521 -0.737 . . . . 0.0 109.986 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -33.98 75.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.025 0.441 . . . . 0.0 110.685 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.73 90.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.669 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -68.64 -34.39 75.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 121.674 -0.641 . . . . 0.0 110.62 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -66.56 -35.39 80.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.219 1.408 . . . . 0.0 110.73 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.42 87.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.351 -0.843 . . . . 0.0 111.069 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -63.76 -33.89 76.67 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.978 0.894 . . . . 0.0 111.5 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -68.33 -30.84 69.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.103 1.361 . . . . 0.0 110.518 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -69.22 -37.01 77.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.777 -1.202 . . . . 0.0 108.987 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.5 -44.43 97.09 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.222 1.009 . . . . 0.0 110.838 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.61 -39.6 70.99 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.254 1.021 . . . . 0.0 112.376 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.2 71.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.274 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.61 -40.66 88.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.73 -42.68 84.36 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.319 1.048 . . . . 0.0 111.095 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.7 -39.96 94.54 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -88.31 -12.54 43.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.949 -1.094 . . . . 0.0 109.983 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.51 -37.51 42.91 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.783 -1.198 . . . . 0.0 109.286 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -37.65 84.97 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.232 0.613 . . . . 0.0 110.311 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -44.26 81.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.285 1.434 . . . . 0.0 109.218 172.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -69.14 -48.77 61.48 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.652 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.98 80.91 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.302 1.041 . . . . 0.0 112.924 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.27 -23.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 O-C-N 121.294 -0.879 . . . . 0.0 110.839 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.85 -4.26 47.36 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 119.854 -1.779 . . . . 0.0 109.016 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.63 -48.62 12.39 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -173.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.85 -110.67 0.13 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . 0.305 11.5 mtm-85 43.23 71.57 0.23 Allowed 'General case' 0 C--N 1.358 0.945 0 C-N-CA 126.32 1.848 . . . . 0.0 112.942 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.14 36.97 2.05 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.83 153.7 42.22 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.19 121.34 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.996 2.464 . . . . 0.0 110.041 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.19 25.78 39.03 Favored Glycine 0 CA--C 1.496 -1.107 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.69 151.65 46.4 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.116 1.366 . . . . 0.0 109.575 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.25 -34.9 0.52 Allowed 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.255 0.622 . . . . 0.0 109.759 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.4 tp -94.75 55.06 1.84 Allowed 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.87 19.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 124.646 1.178 . . . . 0.0 110.28 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.5 t -129.42 125.61 36.91 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.14 -53.05 20.47 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-O 115.85 -2.024 . . . . 0.0 112.109 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.54 -16.2 34.27 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 CA-C-N 126.252 3.269 . . . . 0.0 111.109 -173.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.01 -20.62 44.96 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.8 79.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.159 -0.963 . . . . 0.0 111.63 -167.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.06 -21.86 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.628 0.728 . . . . 0.0 110.632 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -25.34 21.91 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.875 0.87 . . . . 0.0 109.147 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -67.48 -46.67 72.28 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 170.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -77.37 64.25 2.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.734 -0.604 . . . . 0.0 110.037 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 66.2 t -136.1 -71.07 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.38 -15.1 62.36 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-O 121.95 0.881 . . . . 0.0 112.598 -164.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.409 ' H ' HG22 ' C' ' 51' ' ' THR . 2.7 t -73.03 -32.37 65.06 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 124.719 1.207 . . . . 0.0 109.102 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.39 58.71 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 121.08 -1.012 . . . . 0.0 110.55 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -92.23 7.46 42.56 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.05 0.54 . . . . 0.0 110.128 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 51.2 p 49.68 42.33 23.21 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.482 1.913 . . . . 0.0 113.772 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.64 -56.24 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.77 3.06 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' D' ' 56' ' ' GLY . 1.8 t80 -71.23 -45.85 62.38 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -172.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.68 52.25 0.23 Allowed Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.66 -36.42 73.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.863 -0.786 . . . . 0.0 111.493 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -126.79 -163.71 1.27 Allowed 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -148.43 112.2 3.73 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 168.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.57 -173.61 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.769 2.979 . . . . 0.0 108.779 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.268 7.4 p -128.39 -128.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -121.35 -37.16 2.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.279 1.432 . . . . 0.0 108.035 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.71 -12.2 58.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.869 1.268 . . . . 0.0 110.371 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -32.94 68.23 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.09 64.83 0.84 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 102.348 -4.301 . . . . 0.0 102.348 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -14.21 -38.6 0.0 OUTLIER 'General case' 0 C--N 1.366 1.284 1 C-N-CA 132.491 4.316 . . . . 0.0 116.434 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.49 -26.88 0.24 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.637 1.575 . . . . 0.0 113.791 165.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.46 -42.78 92.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.409 -1.432 . . . . 0.0 110.833 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.2 31.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -60.27 -31.19 69.99 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 123.681 0.792 . . . . 0.0 113.026 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -69.23 -32.45 71.7 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.407 -1.433 . . . . 0.0 110.545 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.92 62.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -57.2 -52.29 65.9 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.706 1.202 . . . . 0.0 110.381 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.83 -42.84 99.52 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 122.015 -0.428 . . . . 0.0 110.88 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.01 -33.92 75.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.688 0.395 . . . . 0.0 111.549 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -45.49 86.41 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 123.837 0.732 . . . . 0.0 111.329 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.34 -45.82 93.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.35 1.06 . . . . 0.0 109.352 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.94 -38.46 85.93 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.519 -0.738 . . . . 0.0 112.31 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.15 -53.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 109.198 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -66.73 -38.91 87.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.919 -0.488 . . . . 0.0 111.041 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.36 73.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 110.997 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.04 -30.93 71.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.314 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.88 -18.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 124.911 1.284 . . . . 0.0 110.775 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -56.53 -20.64 21.53 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 112.424 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.04 72.06 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.136 -1.602 . . . . 0.0 111.898 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -80.08 -50.66 10.03 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.732 -1.23 . . . . 0.0 108.233 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 44.1 mt -59.63 -39.28 83.8 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.802 1.241 . . . . 0.0 112.27 -173.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.13 60.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.039 -1.038 . . . . 0.0 111.396 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 27.0 m -85.65 -18.01 34.45 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.7 -25.03 61.09 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.126 -1.609 . . . . 0.0 111.643 -164.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -77.55 -20.65 53.79 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.669 -1.27 . . . . 0.0 111.176 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.27 -24.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -172.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.03 -36.56 60.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.03 1.332 . . . . 0.0 111.846 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -54.84 -40.22 69.4 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 125.057 1.343 . . . . 0.0 110.955 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 . . . . . 0 N--CA 1.44 -0.973 0 C-N-CA 123.793 0.837 . . . . 0.0 110.206 -176.828 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.74 -66.63 0.31 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 130.042 3.337 . . . . 0.0 112.017 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 46.8 p-80 -65.05 -27.62 68.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.333 1.853 . . . . 0.0 112.763 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.76 -31.41 61.77 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.237 -0.914 . . . . 0.0 108.928 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.93 -41.15 91.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.995 0.918 . . . . 0.0 109.282 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.79 -41.87 95.48 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.81 1.244 . . . . 0.0 109.159 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.68 98.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.059 0.944 . . . . 0.0 111.48 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -70.54 -29.81 66.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.556 -0.715 . . . . 0.0 111.832 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -63.95 -34.24 77.52 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.129 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.41 94.05 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.634 0.774 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.67 -36.25 83.22 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -71.12 -24.86 62.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.053 -1.03 . . . . 0.0 111.325 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.2 -35.02 73.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.982 0.913 . . . . 0.0 109.185 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 tp -64.66 -40.51 95.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.365 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -60.21 -28.36 67.93 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.023 0.929 . . . . 0.0 112.334 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -70.25 -42.98 71.49 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.35 -29.81 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 123.992 0.917 . . . . 0.0 109.745 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.44 -44.04 97.37 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.283 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -77.54 -31.58 53.41 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.111 1.364 . . . . 0.0 110.988 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -65.14 -53.68 41.38 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.915 1.34 . . . . 0.0 108.962 171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.49 -24.5 60.19 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 124.642 1.177 . . . . 0.0 111.524 -167.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 12.0 p -64.43 -46.33 83.66 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.254 1.026 . . . . 0.0 109.247 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.77 -46.36 88.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.343 1.857 . . . . 0.0 108.586 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.32 -47.9 77.66 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.326 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.63 84.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.411 1.084 . . . . 0.0 110.763 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.978 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.77 -34.35 34.3 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.5 91.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.75 1.62 . . . . 0.0 109.364 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 2.2 tp10 -68.22 -26.54 65.76 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.358 1.063 . . . . 0.0 111.889 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -74.12 112.62 10.44 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.64 -1.913 . . . . 0.0 107.836 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.5 -22.97 8.63 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.98 64.73 Favored Pre-proline 0 N--CA 1.443 -0.806 0 O-C-N 121.735 -0.862 . . . . 0.0 110.927 -176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -84.09 128.02 4.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.104 2.536 . . . . 0.0 111.864 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.78 46.88 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' D' ' 30' ' ' GLU . . . -55.43 135.0 50.75 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 127.668 2.387 . . . . 0.0 112.388 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.22 -31.17 1.13 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 123.795 0.838 . . . . 0.0 109.846 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.08 49.83 1.87 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 107.737 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.87 -164.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER 80.88 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 116.51 -1.71 . . . . 0.0 106.966 178.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -157.54 -62.8 0.02 OUTLIER Pre-proline 0 C--N 1.35 0.624 0 CA-C-O 116.135 -1.888 . . . . 0.0 109.037 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.48 -14.37 25.04 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 CA-C-N 125.709 3.075 . . . . 0.0 111.084 -169.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -34.18 29.53 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.284 2.634 . . . . 0.0 107.867 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.85 69.49 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.129 0.972 . . . . 0.0 111.62 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 tt -70.6 -33.01 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.341 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -19.29 59.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.316 -1.49 . . . . 0.0 109.984 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -70.03 -53.71 16.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 p -65.1 -19.11 65.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.08 -44.53 99.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 124.097 0.959 . . . . 0.0 111.159 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.2 -32.35 49.94 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.602 1.092 . . . . 0.0 108.494 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -81.36 63.36 5.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.903 0.881 . . . . 0.0 111.055 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.71 -52.14 0.07 Allowed 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 20.8 p -95.53 46.18 1.1 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.954 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 11.9 p 42.86 65.94 0.86 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.919 1.688 . . . . 0.0 113.641 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.01 -108.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' C' ' 57' ' ' TYR . . . 98.15 48.36 1.9 Allowed Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 105.813 -2.915 . . . . 0.0 105.813 -174.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -11.98 59.88 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.913 -0.757 . . . . 0.0 111.327 -166.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.16 40.55 3.98 Favored Glycine 0 CA--C 1.495 -1.207 0 O-C-N 120.288 -1.507 . . . . 0.0 110.001 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.0 -56.73 6.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.856 1.263 . . . . 0.0 108.773 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -144.34 167.76 21.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.32 122.91 18.37 Favored Pre-proline 0 CA--C 1.499 -0.985 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.05 169.96 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.374 2.049 . . . . 0.0 108.716 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.99 -106.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-N 119.07 0.85 . . . . 0.0 112.864 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -155.79 -39.46 0.08 Allowed 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -170.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -77.54 -11.7 59.88 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.622 1.969 . . . . 0.0 109.894 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.17 60.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.26 90.5 1.81 Allowed Glycine 0 N--CA 1.418 -2.524 1 N-CA-C 98.029 -6.028 . . . . 0.0 98.029 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -56.49 -18.86 12.87 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 119.664 1.732 . . . . 0.0 110.694 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -49.95 -21.82 1.33 Allowed 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.574 1.55 . . . . 0.0 114.384 165.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.06 -46.22 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 O-C-N 120.562 -1.336 . . . . 0.0 108.809 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -43.06 93.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.249 0.62 . . . . 0.0 109.476 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.51 -44.33 69.01 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.444 1.498 . . . . 0.0 111.102 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -57.85 -47.73 81.83 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.352 1.061 . . . . 0.0 111.362 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -45.14 85.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-O 121.535 0.683 . . . . 0.0 109.531 -172.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.46 -43.49 85.38 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.129 0.572 . . . . 0.0 110.807 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.64 -34.67 78.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 121.504 -0.748 . . . . 0.0 110.28 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.65 88.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.797 -0.564 . . . . 0.0 110.684 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.33 96.16 Favored Glycine 0 CA--C 1.495 -1.17 0 C-N-CA 124.058 0.837 . . . . 0.0 112.053 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.48 -46.91 92.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 124.413 1.085 . . . . 0.0 109.69 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.22 -36.96 85.79 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.204 -0.935 . . . . 0.0 112.23 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.47 -51.15 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.908 0.883 . . . . 0.0 109.822 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.48 -4.8 50.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.515 -0.741 . . . . 0.0 111.444 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.17 -40.55 12.15 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.353 -0.842 . . . . 0.0 108.991 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -57.05 -39.93 75.83 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 126.495 1.918 . . . . 0.0 111.082 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.9 m -62.95 -6.82 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.28 1.032 . . . . 0.0 112.92 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.2 m -62.17 -17.72 58.84 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.617 -1.302 . . . . 0.0 110.641 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.9 69.62 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.305 -1.497 . . . . 0.0 111.846 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -82.16 -45.82 14.63 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.046 -1.034 . . . . 0.0 108.519 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -62.79 -34.05 76.46 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.804 0.812 . . . . 0.0 111.915 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.44 66.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.977 -1.077 . . . . 0.0 111.941 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.5 t -92.45 0.48 57.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.062 -1.024 . . . . 0.0 108.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.69 -34.52 62.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.69 0.757 . . . . 0.0 109.157 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -73.65 -34.87 65.15 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.786 -1.197 . . . . 0.0 110.764 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.66 -25.85 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 125.582 1.553 . . . . 0.0 109.376 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -47.73 -38.58 15.63 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 125.876 1.67 . . . . 0.0 111.357 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -61.18 -14.05 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.354 0.799 0 O-C-N 121.398 -0.814 . . . . 0.0 109.885 170.589 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.393 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 4' ' ' HIS 0.279 33.9 t70 -176.74 -116.79 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -137.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.582 ' CD2' HG21 ' A' ' 91' ' ' THR . 30.9 p80 -44.38 -35.36 2.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 130.611 3.564 . . . . 0.0 114.919 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.81 -31.35 72.5 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.679 0.792 . . . . 0.0 111.624 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -71.44 -32.06 67.9 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -78.46 -34.86 47.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.7 79.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.012 0.925 . . . . 0.0 110.487 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -66.0 -35.73 81.37 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 123.992 0.917 . . . . 0.0 111.378 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -62.83 -41.34 99.28 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.313 -0.867 . . . . 0.0 109.818 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.12 71.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.458 0.703 . . . . 0.0 111.579 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -62.94 -30.54 71.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.524 -0.735 . . . . 0.0 111.319 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.43 -33.69 67.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.62 -42.86 97.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 110.254 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.68 -42.15 95.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 123.094 0.558 . . . . 0.0 111.03 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.85 -37.63 79.8 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -67.04 -33.87 76.47 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 121.558 -0.714 . . . . 0.0 111.322 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.35 -30.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.265 -0.897 . . . . 0.0 109.048 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.52 -37.52 81.42 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.948 -1.095 . . . . 0.0 111.72 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.02 -44.56 72.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.643 1.177 . . . . 0.0 110.327 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.43 -39.4 92.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 121.322 -0.861 . . . . 0.0 109.567 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.58 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.792 1.237 . . . . 0.0 111.337 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 p -66.65 -43.12 85.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.689 0.677 . . . . 0.0 109.818 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.39 -54.9 37.67 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.062 0.945 . . . . 0.0 110.548 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -71.62 -31.34 66.77 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.865 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.99 71.84 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 119.142 0.883 . . . . 0.0 110.194 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 41' ' ' TYR . 74.2 t -64.68 -38.72 83.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-O 121.856 0.836 . . . . 0.0 110.035 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.03 -33.97 72.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.474 -0.766 . . . . 0.0 110.286 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.9 84.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.433 1.111 . . . . 0.0 111.794 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -36.7 85.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 126.809 2.043 . . . . 0.0 111.207 176.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.72 77.87 9.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.508 1.147 . . . . 0.0 109.493 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.28 -35.55 0.71 Allowed Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 106.239 -2.744 . . . . 0.0 106.239 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.36 156.67 62.62 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 122.305 -0.527 . . . . 0.0 110.221 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.15 152.19 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.053 1.835 . . . . 0.0 110.033 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.32 56.59 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.24 26.38 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.046 1.338 . . . . 0.0 114.145 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -58.27 0.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.599 1.159 . . . . 0.0 111.944 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.8 tp -82.2 76.1 9.1 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.892 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.02 75.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 O-C-N 120.484 -1.385 . . . . 0.0 108.439 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -158.03 120.41 3.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 t80 -59.07 -54.01 60.66 Favored Pre-proline 0 C--N 1.352 0.716 0 CA-C-O 116.355 -1.784 . . . . 0.0 112.518 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.47 -3.91 14.6 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 CA-C-N 125.277 2.92 . . . . 0.0 112.044 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -105.4 -33.12 8.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.47 -24.41 61.99 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 120.459 -1.401 . . . . 0.0 112.081 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.68 -23.7 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.771 0.796 . . . . 0.0 110.005 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -39.91 51.34 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.542 -1.349 . . . . 0.0 108.173 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.2 t90 -64.94 -46.83 79.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 123.81 0.844 . . . . 0.0 108.851 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -64.32 -27.1 68.8 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.71 -54.12 37.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 C-N-CA 123.794 0.838 . . . . 0.0 109.011 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.59 -27.24 62.05 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.675 -0.641 . . . . 0.0 111.177 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -62.22 -40.42 96.06 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.962 0.905 . . . . 0.0 110.769 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.52 74.05 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 121.427 -0.796 . . . . 0.0 111.815 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.53 1.05 39.74 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.937 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p 56.54 21.44 5.69 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.335 1.854 . . . . 0.0 112.474 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.35 -58.72 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.7 72.51 0.63 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.74 -22.19 62.44 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.136 0.97 . . . . 0.0 109.962 -166.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.23 26.06 3.88 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' B' ' 68' ' ' ARG . 19.0 t70 -65.5 -53.74 38.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.966 1.306 . . . . 0.0 110.335 177.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.43 164.73 28.6 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.82 137.19 30.24 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.53 169.17 12.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.621 2.214 . . . . 0.0 110.41 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -71.13 176.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.759 1.266 . . . . 0.0 111.743 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 m -96.96 -51.24 4.32 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.711 1.205 . . . . 0.0 109.959 -172.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.57 -42.9 89.02 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 111.237 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -130.85 -137.1 0.21 Allowed 'General case' 0 CA--C 1.492 -1.27 1 N-CA-C 100.184 -4.006 . . . . 0.0 100.184 165.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.46 -77.98 1.18 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -63.08 -40.81 98.75 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.585 1.954 . . . . 0.0 110.492 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -75.17 -19.26 59.93 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.734 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.01 -50.12 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.6 74.0 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.745 1.618 . . . . 0.0 111.588 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -42.13 -51.96 4.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 127.654 2.382 . . . . 0.0 112.32 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.62 -35.28 75.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.299 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.04 -46.35 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.454 1.102 . . . . 0.0 109.126 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.69 -45.38 94.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.001 1.321 . . . . 0.0 109.717 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -59.73 -37.69 79.65 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.545 0.738 . . . . 0.0 111.947 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.67 89.38 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.587 -0.696 . . . . 0.0 110.543 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.3 -46.85 85.15 Favored Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.8 -47.45 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 109.188 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.9 -42.75 99.89 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.127 -0.983 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.9 t -63.6 -52.13 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.264 0.938 . . . . 0.0 110.142 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.92 -28.94 67.92 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.063 0.545 . . . . 0.0 111.077 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.13 -34.32 32.58 Favored 'General case' 0 CA--C 1.505 -0.75 0 O-C-N 120.932 -1.105 . . . . 0.0 110.606 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.45 -32.68 74.19 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.39 -1.444 . . . . 0.0 110.865 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -65.6 -5.15 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 121.56 -0.713 . . . . 0.0 112.41 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -55.35 -20.88 13.0 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.596 1.559 . . . . 0.0 111.566 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.56 -21.07 65.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 120.422 -1.424 . . . . 0.0 113.046 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.27 -39.16 14.63 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 124.821 1.248 . . . . 0.0 108.727 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.58 -45.53 91.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.883 1.273 . . . . 0.0 110.013 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.33 60.21 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER -79.91 -15.98 56.23 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 119.781 -1.825 . . . . 0.0 107.653 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.413 55.1 m-20 -98.55 14.67 27.53 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.606 -160.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -89.62 -30.86 17.85 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 153.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.65 -24.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.402 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -56.19 -23.79 37.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.597 1.159 . . . . 0.0 111.99 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -64.52 -19.7 65.76 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.182 -1.574 . . . . 0.0 112.061 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 C--N 1.355 0.846 0 O-C-N 121.226 -0.921 . . . . 0.0 110.322 178.084 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . 0.411 ' OD1' ' HD2' ' B' ' 4' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 122.642 1.21 . . . . 0.0 108.363 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.411 ' HD2' ' OD1' ' B' ' 3' ' ' ASP . 18.6 p80 -60.2 -31.75 70.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.819 2.048 . . . . 0.0 113.735 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.402 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 6.6 mt-10 -74.66 -35.64 62.82 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.047 -1.033 . . . . 0.0 110.959 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -73.95 -36.52 64.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.794 -0.566 . . . . 0.0 110.491 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.82 -37.8 82.42 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.96 90.35 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.908 0.883 . . . . 0.0 111.112 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.13 -35.2 78.02 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.099 0.96 . . . . 0.0 110.913 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -65.13 -38.22 89.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.283 1.033 . . . . 0.0 110.545 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.18 80.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.429 1.092 . . . . 0.0 110.782 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.51 -36.26 83.63 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.474 -0.766 . . . . 0.0 111.042 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -75.61 -25.13 56.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.023 -1.048 . . . . 0.0 111.354 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.58 -38.33 83.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.57 -46.18 89.66 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.423 0.689 . . . . 0.0 110.886 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -57.23 -41.02 78.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.339 1.456 . . . . 0.0 111.367 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -66.38 -37.37 85.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.356 1.063 . . . . 0.0 110.761 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.25 -38.34 81.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 O-C-N 120.938 -1.101 . . . . 0.0 108.643 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.47 -44.09 89.16 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 123.736 0.815 . . . . 0.0 110.526 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.68 -48.7 74.63 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 110.592 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -75.57 -36.79 60.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.783 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.16 -29.05 69.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.357 1.063 . . . . 0.0 111.87 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -62.24 -42.3 99.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.758 1.223 . . . . 0.0 110.443 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -67.77 -48.11 67.28 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 125.363 1.465 . . . . 0.0 107.37 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -58.07 -47.48 83.04 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 124.626 1.17 . . . . 0.0 111.299 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.87 78.81 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.979 0.912 . . . . 0.0 111.366 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.95 -44.17 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 -29.26 65.05 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 119.817 1.189 . . . . 0.0 110.947 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.8 -42.67 60.63 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 125.092 1.357 . . . . 0.0 109.611 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -74.98 -21.0 59.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.618 0.723 . . . . 0.0 111.022 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -74.67 89.47 2.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 120.276 -1.515 . . . . 0.0 110.636 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.78 -4.01 11.78 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.92 150.95 56.83 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 118.065 0.933 . . . . 0.0 109.082 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -82.26 132.58 7.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.937 2.425 . . . . 0.0 110.723 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 5.19 88.07 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.47 146.02 55.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 123.671 0.789 . . . . 0.0 111.497 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.43 -47.48 4.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 124.906 1.282 . . . . 0.0 108.078 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -90.47 66.07 6.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 122.807 1.289 . . . . 0.0 108.836 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -101.03 26.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 O-C-N 120.344 -1.472 . . . . 0.0 108.485 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 11.6 p -91.05 -114.86 0.08 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 t80 162.2 -70.99 0.0 OUTLIER Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 126.757 2.023 . . . . 0.0 106.296 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.92 -12.03 19.8 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-N 125.112 2.862 . . . . 0.0 111.868 -163.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.0 6.31 36.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.296 1.038 . . . . 0.0 109.059 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.96 74.68 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.368 -0.832 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.63 -30.35 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.075 0.95 . . . . 0.0 111.574 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -85.61 -18.47 33.18 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.343 -0.848 . . . . 0.0 109.962 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -80.72 -41.05 24.24 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.88 60.53 0.96 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 111.452 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.43 -64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.86 -19.06 64.99 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -167.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -72.62 -30.76 64.6 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.123 0.969 . . . . 0.0 108.947 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.59 62.17 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.502 -1.374 . . . . 0.0 110.381 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -93.52 14.84 17.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.685 0.794 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 67.5 p 55.4 51.72 12.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.751 1.62 . . . . 0.0 113.728 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.87 -145.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.047 1 N-CA-C 99.473 -4.269 . . . . 0.0 99.473 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.9 90.31 0.13 Allowed Glycine 0 CA--C 1.481 -2.047 1 N-CA-C 99.058 -5.617 . . . . 0.0 99.058 -171.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -81.58 -17.57 47.85 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.447 -1.031 . . . . 0.0 108.673 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.41 44.22 1.49 Allowed Glycine 0 CA--C 1.486 -1.764 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -72.28 -63.72 1.09 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -102.06 -169.24 1.65 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -155.35 100.9 2.25 Favored Pre-proline 0 N--CA 1.443 -0.805 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.81 153.34 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.698 2.265 . . . . 0.0 110.255 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.51 -124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -135.2 -11.14 2.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.036 -1.04 . . . . 0.0 109.046 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -112.54 2.67 16.37 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 125.64 1.576 . . . . 0.0 107.433 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.27 43.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.06 91.26 1.54 Allowed Glycine 0 N--CA 1.418 -2.564 1 N-CA-C 98.14 -5.984 . . . . 0.0 98.14 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.457 HH12 ' CG ' ' A' ' 59' ' ' ASP . 37.6 ttm180 -68.74 -3.98 14.21 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.073 1.937 . . . . 0.0 110.648 -174.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.168 1.787 . . . . 0.0 111.638 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -47.89 84.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 124.994 1.317 . . . . 0.0 109.4 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.41 77.44 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -55.18 -41.56 72.07 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.711 1.605 . . . . 0.0 111.114 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -65.38 -35.39 80.83 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.428 -0.795 . . . . 0.0 111.578 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.17 -41.78 44.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 9.2 tpp -53.59 -54.94 30.29 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 126.249 1.819 . . . . 0.0 109.96 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -68.81 -36.11 77.82 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.162 0.985 . . . . 0.0 110.499 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.67 87.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.594 -0.691 . . . . 0.0 110.939 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.95 96.96 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 124.455 1.026 . . . . 0.0 111.322 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 72.3 mt -60.36 -42.95 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 109.114 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -73.09 -31.31 64.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.061 -1.025 . . . . 0.0 113.262 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.43 -43.44 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.256 -0.902 . . . . 0.0 109.702 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.81 -36.56 78.39 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 118.686 0.675 . . . . 0.0 110.073 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.46 92.39 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.896 0.878 . . . . 0.0 110.944 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.28 -31.97 73.38 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.579 -1.326 . . . . 0.0 111.651 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.77 -25.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 124.194 0.998 . . . . 0.0 109.762 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -68.33 -3.11 9.93 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 121.142 -0.974 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.52 82.65 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.679 -2.513 . . . . 0.0 110.84 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.53 59.72 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 39.4 mt -110.02 27.22 9.82 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.25 -9.33 8.62 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -100.36 3.36 43.21 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -71.71 -45.41 61.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.517 1.127 . . . . 0.0 109.197 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.59 -26.36 68.65 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.8 -1.187 . . . . 0.0 112.386 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.2 -29.16 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 123.984 0.914 . . . . 0.0 109.993 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -26.06 64.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 120.423 -1.423 . . . . 0.0 109.53 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -70.62 -19.45 62.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.796 -0.565 . . . . 0.0 111.696 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--N 1.347 0.497 0 O-C-N 120.03 -1.669 . . . . 0.0 109.565 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 123.754 1.74 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -60.38 -36.07 77.2 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 130.312 3.445 . . . . 0.0 110.424 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -75.38 -36.41 60.9 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -33.87 76.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.701 0.801 . . . . 0.0 111.202 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -45.9 64.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.779 0.832 . . . . 0.0 108.877 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.65 98.89 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.163 0.985 . . . . 0.0 111.552 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -71.33 -26.23 62.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.105 1.362 . . . . 0.0 110.702 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.39 -37.93 63.26 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.99 95.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.233 -0.917 . . . . 0.0 111.235 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.98 -34.58 78.77 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.413 -0.805 . . . . 0.0 111.094 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -62.98 -33.48 75.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.606 1.162 . . . . 0.0 110.457 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.98 -42.56 84.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 109.146 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.6 tp -62.04 -37.11 83.72 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.16 0.984 . . . . 0.0 110.968 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.64 -27.67 69.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -34.91 63.31 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.518 -1.364 . . . . 0.0 109.289 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.75 -36.51 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.03 -41.04 77.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 123.877 0.871 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -72.07 -35.51 69.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.851 0.86 . . . . 0.0 111.2 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.92 -46.74 56.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.731 1.253 . . . . 0.0 107.992 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.79 64.35 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 125.787 1.635 . . . . 0.0 111.432 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.497 ' HB3' ' HA ' ' C' ' 45' ' ' ILE . 1.4 p -74.21 -36.6 63.97 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.296 -0.877 . . . . 0.0 110.014 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -64.94 -47.66 76.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -64.3 -35.61 81.42 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.338 0.655 . . . . 0.0 111.004 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.04 60.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.35 1.06 . . . . 0.0 110.943 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.16 -36.07 73.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 CA-C-O 122.08 0.943 . . . . 0.0 110.069 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.13 -36.16 77.18 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.056 -1.028 . . . . 0.0 110.298 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.8 67.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.635 1.574 . . . . 0.0 111.706 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -75.63 -17.6 59.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 121.451 -0.781 . . . . 0.0 110.72 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -85.58 75.48 10.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.363 -1.46 . . . . 0.0 110.152 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.37 -42.3 0.44 Allowed Glycine 0 CA--C 1.478 -2.237 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -82.14 151.11 66.02 Favored Pre-proline 0 N--CA 1.437 -1.093 0 O-C-N 122.36 -0.494 . . . . 0.0 110.806 -173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.72 147.73 24.99 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.868 1.712 . . . . 0.0 110.214 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 28.87 35.25 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.509 -0.606 . . . . 0.0 112.17 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.08 132.66 54.16 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 112.703 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.8 -37.21 0.6 Allowed 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.175 0.99 . . . . 0.0 109.539 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.71 35.67 0.78 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.749 1.22 . . . . 0.0 107.906 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 tt -77.41 4.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 123.673 1.702 . . . . 0.0 108.651 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -71.68 125.8 28.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.03 2.132 . . . . 0.0 110.373 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -87.71 -55.85 0.33 Allowed Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.908 -1.52 . . . . 0.0 111.225 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.42 -24.52 16.32 Favored 'Trans proline' 0 CA--C 1.501 -1.172 0 CA-C-N 125.075 2.848 . . . . 0.0 111.228 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.0 -7.2 58.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.89 79.45 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.043 -1.035 . . . . 0.0 111.126 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' C' ' 23' ' ' SER . 20.3 tt -69.17 -29.34 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.485 -0.759 . . . . 0.0 110.186 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -36.71 74.57 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 121.017 -1.052 . . . . 0.0 111.318 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -71.4 -33.32 69.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.632 0.729 . . . . 0.0 109.639 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -59.93 -41.56 92.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.95 -55.03 18.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.174 1.39 . . . . 0.0 110.753 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.89 -13.22 60.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.593 -0.692 . . . . 0.0 112.196 -173.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -79.47 -39.47 32.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.964 0.906 . . . . 0.0 109.252 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -24.02 64.88 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 120.88 -1.137 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p -92.81 2.43 56.76 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.477 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p 50.03 36.98 13.07 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.119 1.768 . . . . 0.0 111.269 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.6 -59.13 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 61.17 6.85 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -43.49 60.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -170.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.93 -114.26 0.59 Allowed Glycine 0 CA--C 1.482 -1.983 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.305 27.2 t70 62.17 -71.38 0.05 OUTLIER 'General case' 0 C--N 1.351 0.672 0 C-N-CA 127.199 2.2 . . . . 0.0 111.185 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -117.19 -163.98 0.96 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -155.53 148.08 17.8 Favored Pre-proline 0 N--CA 1.433 -1.301 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -90.24 159.55 4.67 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.197 1.932 . . . . 0.0 109.684 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 33' ' ' ALA . 16.1 m -82.94 -175.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.91 1.684 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 -79.64 0.2 Allowed 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.461 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -39.7 -43.8 1.43 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.174 2.189 . . . . 0.0 113.31 -165.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -113.92 -91.18 0.51 Allowed 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 8.04 -69.04 0.0 OUTLIER Glycine 0 C--N 1.36 1.863 1 C-N-CA 131.584 4.421 . . . . 0.0 117.267 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -66.61 -41.23 88.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.475 1.51 . . . . 0.0 113.033 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -80.42 -20.2 44.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.098 -1.001 . . . . 0.0 109.031 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.93 -46.41 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 172.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.78 76.67 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 126.116 1.766 . . . . 0.0 111.576 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.51 -53.54 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.495 2.318 . . . . 0.0 111.074 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.24 -39.91 89.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.188 1.395 . . . . 0.0 110.551 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.98 -45.42 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.55 1.14 . . . . 0.0 109.315 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.0 mtm -59.67 -46.81 87.94 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 109.888 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -60.09 -38.68 83.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 111.302 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.58 82.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.609 0.764 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.99 -46.54 58.96 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.99 -45.62 92.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.556 0 C-N-CA 124.388 1.075 . . . . 0.0 109.536 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -61.7 -42.43 98.94 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.445 -0.784 . . . . 0.0 111.692 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.68 -49.88 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 123.956 0.902 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -67.96 -35.02 77.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.925 -0.484 . . . . 0.0 110.648 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.06 -28.46 61.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.055 -1.028 . . . . 0.0 110.715 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.08 -18.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 120.503 -1.373 . . . . 0.0 111.384 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.66 1.5 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 120.144 -1.598 . . . . 0.0 111.22 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 31.4 m -62.9 -20.53 65.26 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.104 -1.623 . . . . 0.0 111.31 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.89 44.82 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 124.785 1.234 . . . . 0.0 112.159 169.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.23 -40.21 13.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.529 1.532 . . . . 0.0 110.269 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.65 -46.08 48.79 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.141 0.577 . . . . 0.0 111.297 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.3 -28.16 66.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.603 -0.685 . . . . 0.0 110.815 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -85.59 -14.49 45.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.067 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.363 16.5 t70 -74.29 -30.08 61.93 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-N 121.776 2.08 . . . . 0.0 110.767 -168.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -70.49 -26.13 63.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 119.693 -1.879 . . . . 0.0 112.413 174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.84 -22.47 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 124.521 1.129 . . . . 0.0 108.559 -174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -63.26 -17.42 62.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.331 1.053 . . . . 0.0 111.463 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -71.36 -22.35 61.91 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 120.818 -1.176 . . . . 0.0 112.321 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--N 1.354 0.778 0 O-C-N 121.48 -0.762 . . . . 0.0 109.565 -178.166 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -52.08 -29.93 23.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.515 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 3.5 p-80 -59.56 -33.63 71.67 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.515 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 9.3 mt-10 -79.27 -42.09 26.63 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 23.7 ttp85 -60.87 -38.77 86.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 110.279 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.7 -32.07 71.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.302 -0.873 . . . . 0.0 111.668 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.31 84.06 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.435 0.636 . . . . 0.0 109.597 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -66.83 -37.6 84.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.38 -0.825 . . . . 0.0 110.382 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -69.24 -23.68 63.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.288 -0.882 . . . . 0.0 111.346 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.74 86.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.608 -1.308 . . . . 0.0 111.079 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.12 -31.0 72.04 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.78 -1.2 . . . . 0.0 111.877 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.98 -34.87 79.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.049 1.34 . . . . 0.0 109.3 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -67.91 -41.05 83.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.792 1.237 . . . . 0.0 108.785 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.01 -45.33 95.24 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.689 0.796 . . . . 0.0 110.29 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.946 0.794 . . . . 0.0 112.164 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -74.1 -13.49 60.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.096 -1.003 . . . . 0.0 113.405 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.27 -46.51 12.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -53.06 -49.25 66.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 128.126 2.57 . . . . 0.0 110.459 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -78.11 -17.04 57.42 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.533 -1.354 . . . . 0.0 111.0 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -76.98 -31.9 56.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.44 82.81 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 124.767 1.227 . . . . 0.0 111.544 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -59.4 -42.7 92.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.75 1.22 . . . . 0.0 112.168 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -69.59 -37.99 77.15 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.827 0.851 . . . . 0.0 109.005 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -70.51 -51.01 31.86 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.433 0.693 . . . . 0.0 110.09 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.47 92.2 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 126.18 1.792 . . . . 0.0 112.304 -171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.46 -35.7 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -75.45 -36.13 60.78 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -62.4 -42.05 99.13 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.902 2.081 . . . . 0.0 110.201 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -88.48 -21.88 23.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -70.0 84.95 0.51 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 120.444 -1.41 . . . . 0.0 109.787 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.49 -2.2 4.14 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.23 157.55 82.86 Favored Pre-proline 0 N--CA 1.446 -0.644 0 O-C-N 121.138 -1.213 . . . . 0.0 112.55 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.63 131.29 11.29 Favored 'Trans proline' 0 CA--C 1.508 -0.798 0 C-N-CA 123.585 2.856 . . . . 0.0 110.643 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.76 -59.39 4.57 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.37 166.9 0.11 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.729 2.812 . . . . 0.0 110.327 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.05 -53.93 0.13 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.293 -1.744 . . . . 0.0 106.293 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 34.0 tp -99.68 134.83 42.0 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -149.88 167.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m 73.61 131.8 0.04 OUTLIER 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.278 1.831 . . . . 0.0 112.918 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -58.08 -51.65 80.25 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.448 -1.739 . . . . 0.0 113.183 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.53 -13.16 24.99 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 CA-C-N 124.306 2.574 . . . . 0.0 111.967 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 -46.84 9.08 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.16 73.78 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.333 1.453 . . . . 0.0 111.716 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -65.98 -31.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 121.686 -0.634 . . . . 0.0 111.178 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -31.97 47.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 120.727 -1.233 . . . . 0.0 109.854 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -61.92 -40.44 95.5 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.388 1.089 . . . . 0.0 109.443 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -64.5 -35.84 82.26 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 119.898 -1.751 . . . . 0.0 112.169 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.98 -53.35 49.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.007 0.923 . . . . 0.0 109.468 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.03 -24.71 64.23 Favored 'General case' 0 C--N 1.351 0.63 0 C-N-CA 123.275 0.63 . . . . 0.0 111.662 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -76.05 -38.54 57.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.337 -0.852 . . . . 0.0 108.74 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.53 -28.19 65.81 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.981 -1.074 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 10.4 p -93.81 9.63 36.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 123.162 0.585 . . . . 0.0 110.335 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 18.3 p 58.68 43.47 18.75 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.901 1.68 . . . . 0.0 114.702 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.68 -69.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.59 -55.66 4.69 Favored Glycine 0 N--CA 1.435 -1.385 0 O-C-N 120.564 -1.335 . . . . 0.0 111.908 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.1 -30.92 0.21 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.5 1.92 . . . . 0.0 113.296 173.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.83 26.26 5.36 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.8 -67.99 0.43 Allowed 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.683 0.793 . . . . 0.0 109.023 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 157.64 46.05 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 102.666 -3.086 . . . . 0.0 102.666 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.9 122.26 4.98 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.78 178.06 6.87 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 C-N-CA 123.022 2.481 . . . . 0.0 110.67 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.626 HG22 ' H ' ' D' ' 64' ' ' THR . 9.8 p -113.27 -177.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 122.895 1.331 . . . . 0.0 111.27 -170.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.626 ' H ' HG22 ' D' ' 63' ' ' VAL . 7.1 m -52.41 -40.65 62.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.733 2.813 . . . . 0.0 113.048 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.63 -11.72 59.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.424 1.09 . . . . 0.0 110.696 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' D' ' 29' ' ' ALA . 0.4 OUTLIER -68.64 -33.27 73.71 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 170.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 131.93 -26.57 3.78 Favored Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.348 9.4 ttt85 57.19 -35.92 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.031 1 C-N-CA 132.458 4.303 . . . . 0.0 113.702 -168.339 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' D' ' 67' ' ' GLY . 9.7 tptm -69.81 -9.28 54.1 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 126.243 1.817 . . . . 0.0 109.957 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 t -72.74 -37.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -53.86 37.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -46.94 -55.17 8.54 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 125.862 1.665 . . . . 0.0 112.947 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -70.02 -25.49 63.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.889 -0.507 . . . . 0.0 111.732 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.39 -45.9 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 8.5 mtp -56.5 -45.89 80.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.064 1.346 . . . . 0.0 110.252 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -59.41 -38.03 79.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.635 1.174 . . . . 0.0 112.101 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -36.99 84.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.998 -0.439 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.55 -43.77 85.05 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 123.731 0.681 . . . . 0.0 111.444 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.78 -47.97 89.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 C-N-CA 124.308 1.043 . . . . 0.0 109.419 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -63.75 -43.43 96.46 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 123.848 0.859 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -61.93 -49.8 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 O-C-N 120.86 -1.15 . . . . 0.0 110.592 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.11 0.56 27.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.84 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.25 -40.34 10.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.37 -39.14 72.43 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 126.681 1.992 . . . . 0.0 111.276 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 m -59.1 -15.54 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.106 1.362 . . . . 0.0 112.988 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -70.4 -5.23 26.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.918 1.287 . . . . 0.0 110.12 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.01 70.78 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 119.985 -1.697 . . . . 0.0 109.797 166.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' D' ' 4' ' ' HIS . . . -66.13 -41.62 90.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.827 -1.17 . . . . 0.0 110.476 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.44 -37.96 80.73 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.086 0.554 . . . . 0.0 111.165 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.03 -17.46 60.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.005 -1.06 . . . . 0.0 110.409 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -73.07 -27.84 61.97 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.56 70.47 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.279 -0.888 . . . . 0.0 111.284 -159.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -68.49 -30.12 68.89 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.676 -1.265 . . . . 0.0 111.563 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 12.4 t -74.82 -25.72 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 123.857 0.863 . . . . 0.0 109.063 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.8 mtp-105 -63.55 -25.92 68.46 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 120.992 -1.068 . . . . 0.0 110.931 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.4 -20.88 64.91 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.751 -0.593 . . . . 0.0 111.081 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 . . . . . 0 N--CA 1.436 -1.126 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -177.676 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.56 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.3 51.9 m-20 74.21 -41.7 0.49 Allowed 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.799 2.039 . . . . 0.0 111.009 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -43.98 83.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.483 1.113 . . . . 0.0 112.643 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.259 1.8 pm0 -72.71 -15.25 61.69 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.333 -2.105 . . . . 0.0 112.959 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -74.43 -42.86 58.44 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 120.432 -1.417 . . . . 0.0 108.521 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.63 -39.29 83.82 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.828 2.051 . . . . 0.0 109.212 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.11 92.4 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.856 1.263 . . . . 0.0 112.279 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.63 -26.22 60.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.394 -0.816 . . . . 0.0 111.169 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -65.7 -40.41 92.27 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.936 -1.103 . . . . 0.0 108.861 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.22 77.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.81 0.844 . . . . 0.0 112.09 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -34.83 76.04 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.495 -0.753 . . . . 0.0 111.735 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -68.87 -27.06 65.47 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 120.617 -1.302 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -64.8 -35.17 80.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.025 1.33 . . . . 0.0 109.375 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.96 -43.94 81.84 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.843 0.857 . . . . 0.0 110.141 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.61 -34.16 72.4 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 124.301 1.04 . . . . 0.0 111.912 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -66.91 -41.98 86.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.621 1.169 . . . . 0.0 110.185 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.13 -42.13 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.5 mt -55.32 -42.92 74.38 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.406 1.082 . . . . 0.0 112.397 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -69.71 -38.63 77.02 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.797 1.239 . . . . 0.0 110.873 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.39 -42.51 65.13 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 120.52 -1.362 . . . . 0.0 108.589 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.66 72.51 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.735 1.614 . . . . 0.0 112.351 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -69.66 -35.03 74.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -35.15 68.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.415 1.086 . . . . 0.0 109.277 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -69.24 -55.38 10.71 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 124.534 1.134 . . . . 0.0 108.595 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.02 84.1 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.483 1.513 . . . . 0.0 111.658 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -37.09 78.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.214 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.11 -35.09 64.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.148 -1.595 . . . . 0.0 110.013 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.2 -49.75 63.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.095 1.758 . . . . 0.0 108.342 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.7 tp10 -68.64 -38.12 80.25 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.655 1.182 . . . . 0.0 111.409 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -71.34 109.27 5.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 119.289 -2.132 . . . . 0.0 110.971 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -9.6 16.83 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.79 152.11 48.41 Favored Pre-proline 0 C--N 1.352 0.683 0 CA-C-N 118.391 1.095 . . . . 0.0 109.713 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.82 144.21 24.27 Favored 'Trans proline' 0 CA--C 1.502 -1.09 0 C-N-CA 122.751 2.301 . . . . 0.0 109.481 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.66 78.99 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -55.73 115.85 2.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 125.966 1.707 . . . . 0.0 109.975 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.98 -43.56 8.48 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.8 tp -90.51 65.31 6.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.928 1.347 . . . . 0.0 110.04 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.93 -0.76 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 119.851 -1.78 . . . . 0.0 112.304 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.5 m -109.44 123.35 49.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.147 -0.971 . . . . 0.0 111.247 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.13 -58.65 11.88 Favored Pre-proline 0 C--N 1.351 0.641 0 C-N-CA 125.83 1.652 . . . . 0.0 111.234 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.12 -6.45 17.99 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.078 2.849 . . . . 0.0 111.13 -171.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -100.59 -3.06 31.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.36 -32.9 69.05 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 119.737 -1.852 . . . . 0.0 109.15 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 tt -68.59 -30.0 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.826 0.851 . . . . 0.0 109.684 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.95 -47.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 125.919 1.687 . . . . 0.0 110.054 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.69 -41.93 87.29 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.954 1.702 . . . . 0.0 108.554 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -56.21 -45.74 79.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 111.679 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' ILE . 1.9 t -64.22 -46.22 94.04 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 121.269 -0.894 . . . . 0.0 111.444 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.03 -13.92 59.7 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 118.894 -1.122 . . . . 0.0 112.537 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -69.69 -36.4 75.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.136 -0.978 . . . . 0.0 108.555 171.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.0 63.2 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.297 -1.502 . . . . 0.0 112.186 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -95.42 15.09 20.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.443 0.565 . . . . 0.0 109.686 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p 53.35 29.2 8.33 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 126.932 2.093 . . . . 0.0 113.499 166.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.3 p -101.31 -74.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -172.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 81.06 80.65 0.86 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -10.5 59.48 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.992 -1.299 . . . . 0.0 111.4 -170.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.23 18.4 13.53 Favored Glycine 0 CA--C 1.491 -1.443 0 O-C-N 121.061 -1.024 . . . . 0.0 111.79 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -73.16 -46.3 51.62 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 118.533 1.167 . . . . 0.0 109.312 177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.01 164.26 27.72 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.28 146.69 28.66 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 102.019 -3.326 . . . . 0.0 102.019 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.96 -165.36 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.29 3.327 . . . . 0.0 109.858 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 64' ' ' THR . 13.8 p -139.0 -147.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 63' ' ' VAL . 89.6 m -102.49 -48.19 4.23 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.017 1.327 . . . . 0.0 108.282 -170.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -78.97 -17.08 56.05 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.435 0.694 . . . . 0.0 110.47 -169.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.32 -34.3 75.02 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 123.354 1.55 . . . . 0.0 107.477 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.38 79.2 1.43 Allowed Glycine 0 CA--C 1.462 -3.229 1 N-CA-C 98.594 -5.802 . . . . 0.0 98.594 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' D' ' 59' ' ' ASP . 19.8 ttt85 -50.61 -18.16 0.64 Allowed 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.358 1.863 . . . . 0.0 113.731 -171.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -38.78 -31.31 0.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 127.318 2.247 . . . . 0.0 114.697 159.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.06 -43.56 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 119.01 0.823 . . . . 0.0 108.877 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.46 64.38 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.594 -0.691 . . . . 0.0 109.646 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.76 -47.11 51.11 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.402 1.481 . . . . 0.0 112.177 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -68.27 -37.22 80.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.466 0.707 . . . . 0.0 111.033 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.45 -43.47 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.68 -44.27 97.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.2 1.0 . . . . 0.0 110.441 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -66.38 -33.69 76.29 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.204 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.5 74.08 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.347 -0.845 . . . . 0.0 110.928 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.2 86.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.05 -41.47 83.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.855 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -65.92 -43.79 87.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.391 -1.443 . . . . 0.0 113.73 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.2 -45.82 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 118.274 0.488 . . . . 0.0 109.811 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.91 -39.14 72.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.93 81.97 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 121.535 -0.728 . . . . 0.0 111.198 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.43 -31.98 73.37 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 111.736 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.29 -19.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.957 1.303 . . . . 0.0 110.051 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -62.41 -18.1 60.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.914 -1.116 . . . . 0.0 112.394 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.1 -55.49 34.31 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.48 -1.388 . . . . 0.0 110.244 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.46 87.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.93 -42.48 90.04 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.386 -0.821 . . . . 0.0 110.879 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.38 -14.04 60.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.959 -1.088 . . . . 0.0 110.643 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 m -77.06 -21.98 53.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.837 -1.164 . . . . 0.0 108.786 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.16 -42.95 82.04 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 122.012 0.91 . . . . 0.0 111.311 -165.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -70.76 -18.26 62.77 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.727 -1.233 . . . . 0.0 113.364 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -75.12 -20.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -75.67 -11.87 60.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 120.982 -1.074 . . . . 0.0 110.244 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -77.55 -17.42 57.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.865 -1.147 . . . . 0.0 110.926 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.717 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 CA--C 1.504 -0.805 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -58.02 -30.51 66.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.93 -28.97 58.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.812 0.845 . . . . 0.0 110.499 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -72.0 -39.72 69.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -32.72 74.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.62 0.724 . . . . 0.0 110.481 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.98 -46.45 81.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.773 0.829 . . . . 0.0 111.127 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -72.6 -34.63 67.52 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.654 0.74 . . . . 0.0 110.729 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.03 -35.09 79.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.492 1.917 . . . . 0.0 110.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.76 75.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 111.585 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -32.19 73.59 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.165 0.986 . . . . 0.0 110.998 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.04 -36.32 72.31 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 120.649 -1.282 . . . . 0.0 108.913 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -66.28 -35.73 81.16 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.028 0.931 . . . . 0.0 109.295 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -60.4 -42.26 95.55 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.484 -0.76 . . . . 0.0 111.287 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -59.28 -35.52 73.89 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 123.933 0.893 . . . . 0.0 111.584 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -70.55 -34.98 72.84 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 110.209 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.22 -41.31 86.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 124.516 1.126 . . . . 0.0 108.335 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 48.0 mt -56.42 -44.63 80.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.447 1.099 . . . . 0.0 111.547 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.61 -31.61 71.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.183 0.993 . . . . 0.0 111.488 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.99 -33.33 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.317 -1.489 . . . . 0.0 108.744 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.56 -31.29 71.91 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.917 1.287 . . . . 0.0 111.509 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 59.1 p -66.22 -39.9 89.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 119.026 0.83 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.34 93.39 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.084 1.754 . . . . 0.0 108.64 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.22 -57.96 5.19 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 117.671 -1.157 . . . . 0.0 108.25 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.52 -48.32 57.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 126.171 1.788 . . . . 0.0 112.855 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.12 -39.63 84.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.77 -1.206 . . . . 0.0 111.357 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.1 -25.67 31.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.117 -0.989 . . . . 0.0 109.464 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 126.465 1.906 . . . . 0.0 108.516 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.06 -34.18 77.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.14 0.976 . . . . 0.0 111.73 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -68.15 109.13 3.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.34 -2.1 . . . . 0.0 111.433 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -10.89 16.31 Favored Glycine 0 CA--C 1.496 -1.104 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.72 147.08 40.52 Favored Pre-proline 0 N--CA 1.442 -0.84 0 O-C-N 121.802 -0.822 . . . . 0.0 109.439 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.51 137.81 11.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.49 2.127 . . . . 0.0 110.067 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.28 81.85 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.1 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.23 104.01 0.22 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.19 1.396 . . . . 0.0 109.56 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.72 -28.63 21.65 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.79 132.71 37.91 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -148.36 170.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 81.47 124.77 0.04 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.741 1.616 . . . . 0.0 109.003 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -66.04 -52.45 39.82 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.602 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.97 -3.48 13.84 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 125.226 2.902 . . . . 0.0 112.314 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -110.61 -10.78 14.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.45 75.88 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.25 -0.906 . . . . 0.0 108.846 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -60.24 -26.15 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 125.765 1.626 . . . . 0.0 111.205 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.731 -1.23 . . . . 0.0 109.569 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -79.26 -35.76 40.96 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.8 p -77.31 57.82 1.54 Allowed 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 122.113 -0.367 . . . . 0.0 110.579 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.35 -53.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.77 -26.88 68.55 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 119.328 0.967 . . . . 0.0 111.977 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -67.06 -34.39 77.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.55 1.14 . . . . 0.0 109.439 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.5 62.67 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.449 -1.407 . . . . 0.0 111.013 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -93.39 11.92 26.66 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.688 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.7 p 48.89 55.5 9.13 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.267 1.427 . . . . 0.0 113.17 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' B' ' 56' ' ' GLY . 0.2 OUTLIER -121.95 -87.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.45 ' H ' HG23 ' B' ' 55' ' ' VAL . . . 87.15 73.66 1.28 Allowed Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 -19.42 62.12 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.344 -1.092 . . . . 0.0 110.429 -173.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.1 37.99 1.3 Allowed Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -93.2 -30.89 14.98 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 118.125 0.963 . . . . 0.0 110.066 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -140.3 176.55 8.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -155.02 149.66 20.01 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 102.295 -3.224 . . . . 0.0 102.295 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -85.04 -178.21 3.09 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 124.74 3.626 . . . . 0.0 109.949 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 0.8 OUTLIER -133.76 -153.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.036 0.922 . . . . 0.0 108.799 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 -46.78 7.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.03 -1.669 . . . . 0.0 110.676 -169.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -30.67 67.24 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 109.796 -170.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' B' ' 68' ' ' ARG . 0.8 OUTLIER -64.2 -26.37 68.48 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 123.128 1.442 . . . . 0.0 108.592 -178.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.91 67.67 1.3 Allowed Glycine 0 CA--C 1.461 -3.329 1 N-CA-C 102.534 -4.226 . . . . 0.0 102.534 174.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' OE2' ' B' ' 66' ' ' GLU . 22.0 ttp85 -40.11 -15.32 0.01 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.578 3.551 . . . . 0.0 116.097 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -55.27 -17.84 5.24 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 120.507 -1.371 . . . . 0.0 113.622 160.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.97 -53.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 CA-C-N 121.07 1.759 . . . . 0.0 107.718 173.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.79 91.08 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.272 0.629 . . . . 0.0 111.061 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.1 -38.44 70.73 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.621 1.168 . . . . 0.0 111.66 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.84 -37.47 84.55 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 124.071 0.948 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.53 -42.53 72.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.2 mtm -61.16 -48.92 79.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.094 0.958 . . . . 0.0 110.319 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.16 -38.43 88.06 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.81 92.57 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.056 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.28 -46.07 91.76 Favored Glycine 0 CA--C 1.494 -1.257 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -46.64 87.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.666 1.186 . . . . 0.0 109.338 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.15 -45.82 86.73 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.173 -0.954 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.68 -51.13 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 124.167 0.987 . . . . 0.0 109.963 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -72.83 -19.46 61.31 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.631 -0.668 . . . . 0.0 111.257 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.5 -27.62 19.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.885 0.874 . . . . 0.0 110.283 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.08 -39.18 85.17 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 126.207 1.803 . . . . 0.0 109.47 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.2 -13.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.823 0.849 . . . . 0.0 111.912 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.8 m -61.68 -16.38 48.32 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.624 1.169 . . . . 0.0 110.852 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.58 -51.0 64.4 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.509 1.123 . . . . 0.0 110.629 165.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.16 75.72 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.71 1.604 . . . . 0.0 110.451 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.02 -42.61 97.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.73 -18.96 61.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.872 -0.518 . . . . 0.0 110.687 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.6 m -80.51 -36.61 33.03 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 121.276 -0.89 . . . . 0.0 108.998 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.34 -8.46 58.45 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.904 -1.123 . . . . 0.0 111.791 -157.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -75.4 -36.77 60.79 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 165.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 t -71.12 -22.28 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 109.978 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -47.92 -31.57 5.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.694 1.998 . . . . 0.0 111.666 171.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -62.11 -30.7 71.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.686 1.194 . . . . 0.0 112.129 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 CA--C 1.505 -0.786 0 O-C-N 120.785 -1.197 . . . . 0.0 109.541 -175.613 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 122.779 1.276 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -66.97 -21.99 65.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 125.791 1.636 . . . . 0.0 111.97 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -77.34 -32.65 55.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -72.87 -32.27 65.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.668 0.747 . . . . 0.0 109.95 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.3 -41.56 93.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.642 1.177 . . . . 0.0 109.512 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.08 78.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.357 1.063 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -57.01 -38.25 72.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.282 1.833 . . . . 0.0 111.243 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -64.73 -33.26 75.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.495 1.118 . . . . 0.0 110.815 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.61 68.2 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.037 -1.039 . . . . 0.0 110.287 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.453 -0.78 . . . . 0.0 112.017 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -27.89 63.76 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.889 -1.132 . . . . 0.0 110.473 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.74 -33.29 73.67 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.994 0.918 . . . . 0.0 109.128 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.41 -36.95 84.12 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.941 -1.099 . . . . 0.0 110.687 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.08 -27.65 67.54 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.264 -0.898 . . . . 0.0 111.083 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.61 -45.67 64.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.684 1.194 . . . . 0.0 110.068 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.31 -24.14 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 O-C-N 121.534 -0.729 . . . . 0.0 110.819 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.13 -37.66 80.73 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.417 -0.802 . . . . 0.0 111.408 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -74.34 -24.29 59.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.617 0.767 . . . . 0.0 111.241 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -87.89 -30.87 19.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.812 -1.18 . . . . 0.0 107.848 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.98 88.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.655 1.182 . . . . 0.0 111.362 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.0 p -65.2 -38.94 92.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.29 0.636 . . . . 0.0 111.173 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -71.08 -48.88 49.98 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.576 -0.703 . . . . 0.0 110.064 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -72.21 -23.16 61.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 121.262 -0.899 . . . . 0.0 110.931 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.92 -48.45 76.54 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.819 0.736 . . . . 0.0 110.885 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.72 -19.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.03 -176.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -80.2 -25.82 39.48 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.157 -1.59 . . . . 0.0 109.531 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.05 73.49 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.67 1.188 . . . . 0.0 108.874 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' C' ' 38' ' ' LEU . 16.8 mt-10 -85.63 -141.09 0.09 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 122.884 1.326 . . . . 0.0 111.115 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 59.86 52.23 5.51 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 126.763 2.025 . . . . 0.0 111.316 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.37 34.35 0.2 Allowed Glycine 0 CA--C 1.487 -1.696 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.45 155.42 78.67 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.78 152.39 11.44 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.324 2.016 . . . . 0.0 109.498 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 -41.03 2.77 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.974 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -3.02 123.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.808 1 C-N-CA 132.486 4.314 . . . . 0.0 117.292 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.48 -38.38 3.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.566 1.146 . . . . 0.0 110.048 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.437 ' H ' ' CD ' ' C' ' 30' ' ' GLU . 5.2 tt -100.98 66.23 1.14 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.033 2.533 . . . . 0.0 109.436 -169.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.45 33.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 119.463 -2.023 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.2 m -134.0 143.62 48.23 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -80.99 -53.14 0.81 Allowed Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.471 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -20.32 24.2 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 CA-C-N 126.404 3.323 . . . . 0.0 110.643 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.9 -13.04 49.07 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 -35.79 81.65 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.186 -0.946 . . . . 0.0 110.928 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.61 -29.08 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.441 0.639 . . . . 0.0 110.278 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -28.75 61.29 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 119.83 -1.794 . . . . 0.0 110.22 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.434 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 31.8 t90 -69.66 -40.99 76.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.841 -0.537 . . . . 0.0 109.68 172.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -69.58 -14.71 62.98 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.83 -49.9 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 120.884 -1.135 . . . . 0.0 110.504 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -76.04 0.45 18.6 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.036 -1.04 . . . . 0.0 112.247 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.27 -38.69 6.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.122 -0.987 . . . . 0.0 109.096 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.73 61.05 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 120.771 -1.206 . . . . 0.0 111.535 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 5.3 p -90.61 1.31 56.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 110.647 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.297 15.5 p 62.65 30.72 16.95 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.46 2.304 . . . . 0.0 112.751 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.18 -59.33 2.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.92 63.26 3.74 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.858 -1.151 . . . . 0.0 112.493 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -23.14 66.86 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.642 0.777 . . . . 0.0 113.006 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 23.51 10.1 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -50.33 18.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 16.1 mtm-85 -142.52 163.86 31.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -163.12 142.05 6.58 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.98 161.95 20.79 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.044 2.496 . . . . 0.0 110.86 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 1.1 t -107.02 -162.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 123.118 1.437 . . . . 0.0 109.157 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 2.1 m -66.29 -55.5 15.76 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 127.601 2.361 . . . . 0.0 111.553 -167.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -74.12 -16.43 61.01 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.533 1.159 . . . . 0.0 109.27 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -78.08 -23.35 48.02 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 125.514 1.526 . . . . 0.0 107.803 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.89 86.12 0.94 Allowed Glycine 0 CA--C 1.478 -2.276 1 N-CA-C 102.04 -4.424 . . . . 0.0 102.04 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -43.14 -34.81 1.17 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.446 1.898 . . . . 0.0 111.482 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -43.44 -26.87 0.23 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.037 2.135 . . . . 0.0 113.721 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.92 -37.72 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.986 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.09 9.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.33 -47.04 69.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.481 2.312 . . . . 0.0 112.136 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 -37.22 71.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.552 -0.718 . . . . 0.0 110.492 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.33 -42.64 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 58.9 ttm -59.1 -45.19 91.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.602 1.161 . . . . 0.0 110.615 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -64.65 -31.75 73.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.861 0.464 . . . . 0.0 111.477 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.94 70.17 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.734 -0.604 . . . . 0.0 111.055 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.47 -39.93 86.83 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.28 -46.69 94.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 124.354 1.062 . . . . 0.0 108.947 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -61.24 -39.51 90.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.547 0.739 . . . . 0.0 112.173 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 t -64.06 -52.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.333 1.053 . . . . 0.0 109.575 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.32 -18.67 61.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.7 -0.625 . . . . 0.0 111.297 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.51 8.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.227 -0.92 . . . . 0.0 109.197 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -51.95 -42.01 62.53 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 126.793 2.037 . . . . 0.0 112.832 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 26.5 m -64.56 -11.38 10.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.481 -0.762 . . . . 0.0 112.515 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.7 m -67.95 -15.36 63.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.701 -1.25 . . . . 0.0 110.831 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.49 65.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.437 -1.414 . . . . 0.0 111.448 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.87 -46.37 13.09 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.78 -1.2 . . . . 0.0 107.963 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -65.05 -32.47 74.21 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.222 1.009 . . . . 0.0 112.34 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.32 -11.68 60.58 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 120.839 -1.163 . . . . 0.0 111.874 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 51.3 p -82.01 -19.48 40.37 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.074 -1.641 . . . . 0.0 109.171 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.27 -16.16 59.86 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.675 -0.641 . . . . 0.0 112.026 -165.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -91.16 -23.69 20.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.874 0.845 . . . . 0.0 110.743 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.02 -29.21 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 O-C-N 120.135 -1.603 . . . . 0.0 108.297 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -62.44 -7.56 4.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.495 1.118 . . . . 0.0 112.961 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -75.51 -26.71 58.34 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.284 -1.51 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -176.401 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.099 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.03 -43.59 98.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -18.58 63.74 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.201 -0.937 . . . . 0.0 112.385 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -76.58 -44.07 36.11 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -68.06 -36.42 79.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.427 0.632 . . . . 0.0 109.564 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.07 -51.04 67.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.158 2.583 . . . . 0.0 110.016 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.37 81.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.655 1.182 . . . . 0.0 111.901 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -40.67 84.67 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.208 -0.933 . . . . 0.0 110.186 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -68.69 -27.16 65.71 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 121.192 -0.943 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.22 70.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.473 -1.392 . . . . 0.0 111.87 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -67.02 -25.35 66.24 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.568 -0.707 . . . . 0.0 112.032 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.94 -35.76 64.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 109.08 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.61 -17.17 56.46 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.647 -0.658 . . . . 0.0 109.489 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.459 HD13 ' HA2' ' D' ' 78' ' ' GLY . 13.2 tp -68.78 -44.64 73.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.225 -0.922 . . . . 0.0 109.187 171.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.88 -41.05 67.14 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 111.169 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -53.45 -47.79 69.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.324 1.85 . . . . 0.0 112.123 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -87.83 -33.02 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.005 -1.06 . . . . 0.0 111.123 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.55 -49.95 74.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 127.863 2.465 . . . . 0.0 109.859 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.12 -42.87 72.06 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.27 -31.24 72.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.653 -0.654 . . . . 0.0 112.012 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.72 71.73 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.469 0.708 . . . . 0.0 111.278 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 92.3 p -67.15 -41.0 86.76 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.99 -27.68 61.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 109.723 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -79.61 -51.34 9.4 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.21 97.46 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 111.731 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.49 -29.42 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 119.413 -2.054 . . . . 0.0 112.106 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -89.05 -27.34 20.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 66' ' ' GLU . . . -68.54 -57.09 6.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.935 1.694 . . . . 0.0 108.358 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.43 -7.9 46.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.359 0.663 . . . . 0.0 112.53 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.12 99.55 1.5 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 120.075 -1.641 . . . . 0.0 109.263 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 4.19 35.1 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.5 138.53 26.78 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 118.649 1.224 . . . . 0.0 108.689 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.52 139.49 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.491 2.128 . . . . 0.0 110.178 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.1 16.5 80.65 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.14 147.21 53.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.343 0.657 . . . . 0.0 110.74 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 -35.99 5.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -89.07 136.58 32.94 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 pt -165.89 172.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.6 m 67.65 129.07 0.02 OUTLIER 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.973 2.509 . . . . 0.0 114.285 167.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -61.78 -57.72 22.59 Favored Pre-proline 0 C--N 1.351 0.659 0 CA-C-O 116.976 -1.487 . . . . 0.0 113.397 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.48 -12.13 22.62 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 124.482 2.637 . . . . 0.0 110.653 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.79 -38.83 20.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -36.71 81.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.733 1.213 . . . . 0.0 112.016 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.29 -30.39 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.656 -0.653 . . . . 0.0 110.55 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 -19.5 56.93 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.08 -1.013 . . . . 0.0 110.764 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -91.25 -30.33 16.68 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.94 -37.56 87.86 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.501 -1.375 . . . . 0.0 110.489 -173.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.21 -25.96 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 123.357 0.663 . . . . 0.0 112.091 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.52 -45.81 21.05 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.242 1.017 . . . . 0.0 110.485 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -77.19 -24.52 51.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 120.784 -1.198 . . . . 0.0 109.581 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.38 -29.69 62.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.196 0.598 . . . . 0.0 110.051 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 25.6 p -92.15 -2.46 56.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 118.283 0.492 . . . . 0.0 110.72 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 55.3 p 54.39 59.41 4.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.095 2.158 . . . . 0.0 112.976 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.575 HG23 ' H ' ' D' ' 56' ' ' GLY . 27.4 m -102.98 -75.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.575 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 91.04 54.3 2.05 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -19.53 63.94 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 122.093 0.949 . . . . 0.0 111.87 -170.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.2 11.1 22.82 Favored Glycine 0 CA--C 1.49 -1.481 0 O-C-N 120.325 -1.484 . . . . 0.0 111.421 168.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -68.84 -52.14 33.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.926 -0.749 . . . . 0.0 110.924 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -139.57 163.25 33.07 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.42 151.26 26.9 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -171.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.05 -179.98 5.95 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 124.346 3.364 . . . . 0.0 109.469 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.44 HG13 ' H ' ' D' ' 64' ' ' THR 0.324 3.7 p -123.13 -89.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 CA-C-N 120.705 1.593 . . . . 0.0 111.869 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.44 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.5 m -152.32 -50.31 0.11 Allowed 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 119.376 -2.077 . . . . 0.0 107.019 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.44 -5.66 59.22 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.731 1.212 . . . . 0.0 110.878 -168.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' D' ' 29' ' ' ALA . 2.8 pm0 -66.1 -34.39 77.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.64 -1.287 . . . . 0.0 107.588 165.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.25 88.52 1.32 Allowed Glycine 0 N--CA 1.419 -2.488 1 N-CA-C 98.784 -5.726 . . . . 0.0 98.784 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 26.5 ttm-85 -55.6 -19.81 11.5 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 125.768 1.627 . . . . 0.0 111.076 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -58.27 -17.1 16.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.1 -47.88 76.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 120.064 1.302 . . . . 0.0 108.424 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.1 78.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -53.37 -44.13 68.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.536 1.534 . . . . 0.0 112.328 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -60.38 -47.58 85.44 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.039 0.936 . . . . 0.0 110.51 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.01 -34.28 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 43.3 mtt -56.74 -50.89 70.9 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.838 0.828 . . . . 0.0 110.437 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -68.81 -29.83 68.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.876 -0.515 . . . . 0.0 110.42 -171.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.32 71.7 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.953 -0.467 . . . . 0.0 110.303 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -62.05 -46.32 94.28 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 123.927 0.775 . . . . 0.0 111.733 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.6 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.9 0.88 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.56 -30.8 71.18 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.957 -1.089 . . . . 0.0 112.521 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 21.0 t -65.87 -53.77 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 109.121 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.5 -35.2 77.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 121.704 -0.623 . . . . 0.0 110.429 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.0 74.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.392 -0.818 . . . . 0.0 111.256 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.46 -28.56 69.31 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.608 -1.307 . . . . 0.0 110.929 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.5 -7.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.045 1.338 . . . . 0.0 110.944 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.8 m -58.84 -21.23 56.33 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 118.937 -2.352 . . . . 0.0 112.315 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.09 -29.15 67.14 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.762 -1.211 . . . . 0.0 110.881 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 -46.54 14.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.988 -1.695 . . . . 0.0 109.163 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.6 -47.58 72.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -167.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.42 -9.84 58.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.112 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -77.72 -38.33 47.43 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 120.447 -1.408 . . . . 0.0 108.148 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.27 55.2 m-20 -83.07 8.64 12.33 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.376 -1.452 . . . . 0.0 112.591 -155.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -96.93 -38.06 9.96 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 117.573 -1.203 . . . . 0.0 111.514 161.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.18 -20.46 27.57 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-N 120.789 1.631 . . . . 0.0 111.113 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -54.08 -22.93 12.06 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.642 1.177 . . . . 0.0 112.308 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.08 -21.73 9.21 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.715 1.606 . . . . 0.0 113.008 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -176.35 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.101 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.0 -62.55 0.71 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.037 2.535 . . . . 0.0 112.631 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -64.61 -23.41 67.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 113.974 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -82.78 -44.41 15.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.7 -40.84 98.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.335 1.054 . . . . 0.0 110.401 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.41 -29.72 67.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.357 0.598 . . . . 0.0 110.658 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.44 86.65 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.271 -0.893 . . . . 0.0 110.479 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -63.17 -43.62 97.74 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.577 -0.702 . . . . 0.0 110.5 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.7 -42.36 75.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.084 1.754 . . . . 0.0 110.419 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.32 93.01 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.441 1.096 . . . . 0.0 110.702 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -63.95 -36.52 84.22 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -74.61 -25.91 59.55 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.798 -1.189 . . . . 0.0 111.875 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.52 -35.95 63.18 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.77 -42.51 79.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.417 1.087 . . . . 0.0 111.874 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.0 -34.19 69.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.129 1.372 . . . . 0.0 112.203 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -74.85 -35.17 62.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.621 -0.674 . . . . 0.0 109.392 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.98 -33.76 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.47 -42.69 92.6 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.459 -0.775 . . . . 0.0 112.0 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.65 -42.61 74.01 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 122.098 -0.376 . . . . 0.0 110.493 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.89 -40.65 87.82 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.703 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.19 79.39 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 125.043 1.337 . . . . 0.0 111.479 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -52.56 -47.02 67.05 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 126.016 1.726 . . . . 0.0 109.938 175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -65.39 -46.2 80.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.265 1.026 . . . . 0.0 109.985 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.99 -43.18 88.53 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 123.885 0.874 . . . . 0.0 110.563 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.67 71.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.694 1.198 . . . . 0.0 111.527 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.28 -51.79 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 120.765 -1.209 . . . . 0.0 109.912 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.46 -28.86 63.19 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.722 -0.612 . . . . 0.0 111.092 -166.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.0 81.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.608 0.763 . . . . 0.0 110.311 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.73 -88.93 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 122.545 0.338 . . . . 0.0 111.51 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 20.09 67.59 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 128.302 2.641 . . . . 0.0 116.69 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.29 -23.45 4.31 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 133.63 90.76 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -174.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.62 125.39 4.94 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.35 2.033 . . . . 0.0 111.71 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.7 54.06 Favored Glycine 0 CA--C 1.485 -1.805 0 CA-C-O 117.906 -1.497 . . . . 0.0 109.828 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -32.1 -65.21 0.15 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 114.345 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 73.39 -15.54 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.769 1.627 . . . . 0.0 111.297 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.2 118.23 36.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 pt -143.72 0.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.843 -0.536 . . . . 0.0 111.235 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.9 m -128.24 130.62 48.21 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.372 -1.455 . . . . 0.0 109.449 -165.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -57.22 -50.31 88.89 Favored Pre-proline 0 C--N 1.351 0.64 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.783 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.38 -11.98 24.93 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 125.301 2.929 . . . . 0.0 111.881 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.79 -25.09 16.19 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.19 -35.11 78.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.656 0.783 . . . . 0.0 111.432 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -69.91 -33.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -31.84 61.04 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.333 -0.854 . . . . 0.0 109.739 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -65.33 -45.18 85.27 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.523 1.129 . . . . 0.0 108.919 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -34.33 68.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.243 1.417 . . . . 0.0 111.419 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.89 -52.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 124.254 1.022 . . . . 0.0 110.719 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.21 -22.84 60.36 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 121.537 -0.727 . . . . 0.0 110.961 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.7 m -73.34 -39.49 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.22 64.95 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.264 -0.898 . . . . 0.0 111.546 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 p -88.23 12.12 14.69 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.371 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 p 48.96 61.33 3.17 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.949 1.7 . . . . 0.0 112.717 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.4 p -128.48 -77.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 82.88 75.04 1.18 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -69.17 -34.19 74.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.985 -1.303 . . . . 0.0 110.787 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.13 38.61 0.25 Allowed Glycine 0 CA--C 1.487 -1.714 0 N-CA-C 107.926 -2.069 . . . . 0.0 107.926 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.85 -48.2 22.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -135.3 178.89 6.68 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -149.16 93.89 4.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.131 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.18 166.23 30.54 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.572 2.181 . . . . 0.0 110.842 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 64' ' ' THR . 11.8 p -141.89 177.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 123.002 1.382 . . . . 0.0 107.908 -170.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 63' ' ' VAL . 16.9 m -65.19 -25.01 67.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.853 2.461 . . . . 0.0 112.585 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -75.51 -36.23 60.59 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.304 1.042 . . . . 0.0 109.056 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -53.21 58.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.91 66.67 0.37 Allowed Glycine 0 CA--C 1.461 -3.334 1 N-CA-C 100.797 -4.921 . . . . 0.0 100.797 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.5 ttm-85 -23.18 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.382 2.017 1 C-N-CA 132.258 4.223 . . . . 0.0 115.921 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -54.79 -6.82 0.13 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 116.622 -1.656 . . . . 0.0 115.389 167.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.265 54.8 t -76.01 -46.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.365 1.26 0 CA-C-N 123.771 2.987 . . . . 0.0 107.809 167.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.7 67.75 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.435 1.016 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.64 -34.61 73.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.474 1.11 . . . . 0.0 112.258 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.74 -40.36 84.16 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 120.728 -1.232 . . . . 0.0 110.365 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.38 -43.14 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.3 mtt -59.23 -45.83 90.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 110.147 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.85 -40.44 92.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.929 0.892 . . . . 0.0 111.683 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 81.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.788 0.835 . . . . 0.0 111.071 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.88 -46.22 90.13 Favored Glycine 0 C--N 1.35 1.326 0 C-N-CA 124.678 1.132 . . . . 0.0 110.446 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.04 -41.17 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.894 0.877 . . . . 0.0 109.376 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -59.7 -52.03 67.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.202 -0.936 . . . . 0.0 111.625 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.55 -41.69 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 121.959 -0.463 . . . . 0.0 110.527 -172.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.8 -39.46 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.025 0.53 . . . . 0.0 109.688 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 121.42 -0.8 . . . . 0.0 110.919 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.16 -24.85 64.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 121.021 -1.05 . . . . 0.0 111.538 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.92 -15.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 O-C-N 121.012 -1.055 . . . . 0.0 110.697 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.9 m -53.57 -25.38 16.97 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.023 -1.673 . . . . 0.0 113.067 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.0 66.68 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.509 -1.369 . . . . 0.0 111.294 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.96 -52.75 5.52 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 108.738 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.1 mt -59.34 -40.25 85.74 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.303 1.041 . . . . 0.0 112.958 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.5 -19.37 62.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 121.073 -1.017 . . . . 0.0 111.228 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.2 p -72.26 -22.32 61.24 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.221 -1.549 . . . . 0.0 110.283 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.86 -5.67 55.92 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.924 -1.11 . . . . 0.0 112.128 -167.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.78 -22.72 19.17 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.867 -1.77 . . . . 0.0 109.347 168.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -76.84 -37.72 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 107.983 -170.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -57.9 -18.44 22.98 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.413 1.485 . . . . 0.0 112.479 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -64.97 -32.72 74.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.758 -1.214 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 C--N 1.353 0.72 0 O-C-N 121.038 -1.039 . . . . 0.0 108.917 179.843 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.488 -1.429 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -4.27 58.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.881 -1.137 . . . . 0.0 112.159 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -29.75 56.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.787 1.235 . . . . 0.0 108.37 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -70.85 -33.78 70.98 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.931 -1.106 . . . . 0.0 110.432 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.87 -38.81 92.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 122.174 0.988 . . . . 0.0 109.236 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' B' ' 85' ' ' VAL . . . -66.06 -38.51 88.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.541 0.737 . . . . 0.0 111.711 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.13 -41.04 86.82 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.698 -0.626 . . . . 0.0 110.362 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -62.56 -30.96 71.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.625 1.17 . . . . 0.0 111.139 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.414 -0.804 . . . . 0.0 111.354 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -67.58 -33.78 75.71 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.459 -0.776 . . . . 0.0 109.639 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.38 -35.56 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.517 1.127 . . . . 0.0 111.04 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.32 -40.44 95.92 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.78 0.832 . . . . 0.0 109.156 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.728 -0.607 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -58.4 -38.95 78.4 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.094 0.958 . . . . 0.0 112.006 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -62.78 -44.65 95.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.228 1.011 . . . . 0.0 109.452 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.5 -33.39 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.046 0.938 . . . . 0.0 110.062 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.49 HD13 HG22 ' B' ' 49' ' ' VAL . 20.9 mt -66.92 -36.37 82.09 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.52 -1.362 . . . . 0.0 111.205 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -72.01 -35.17 69.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.514 -0.741 . . . . 0.0 110.435 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.723 -1.236 . . . . 0.0 109.189 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.7 74.32 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 126.251 1.82 . . . . 0.0 111.69 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.44 -36.11 63.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -43.16 85.64 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.814 0.846 . . . . 0.0 109.18 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.96 -51.73 44.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.816 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.37 96.98 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 124.066 0.946 . . . . 0.0 111.482 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -67.57 -44.78 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.112 -0.992 . . . . 0.0 109.501 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -50.59 31.74 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 110.289 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.64 -29.06 67.47 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.451 -0.78 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -67.06 100.47 0.76 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.352 -1.468 . . . . 0.0 111.413 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.31 -30.18 3.35 Favored Glycine 0 CA--C 1.488 -1.655 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.08 60.21 Favored Pre-proline 0 N--CA 1.443 -0.781 0 C-N-CA 123.588 0.755 . . . . 0.0 110.478 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.72 148.31 12.42 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 C-N-CA 122.553 2.169 . . . . 0.0 109.449 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.58 -17.18 45.93 Favored Glycine 0 CA--C 1.489 -1.538 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.19 114.36 2.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.002 2.521 . . . . 0.0 107.835 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.78 -18.46 14.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -84.29 -8.67 58.95 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.725 0.81 . . . . 0.0 108.901 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 tt -54.02 69.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 128.809 2.844 . . . . 0.0 114.981 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -140.66 -122.01 0.11 Allowed 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 119.476 -2.015 . . . . 0.0 107.373 -165.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -179.21 -67.45 0.0 OUTLIER Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.9 -29.09 18.95 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 125.201 2.893 . . . . 0.0 111.491 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -91.17 0.85 57.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.407 1.083 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.58 64.32 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.246 -0.909 . . . . 0.0 108.712 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -72.52 -20.46 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 123.084 0.554 . . . . 0.0 110.478 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -66.32 -47.55 73.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -67.06 -44.04 81.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.879 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.3 m -56.02 -33.55 65.01 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.49 HG22 HD13 ' B' ' 19' ' ' LEU . 58.3 t -74.0 -41.52 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.93 -40.73 94.33 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -57.1 -37.51 72.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.653 1.181 . . . . 0.0 111.608 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.18 -22.42 63.91 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 123.089 0.556 . . . . 0.0 112.119 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.0 p -84.67 -14.57 48.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.422 HG22 ' HB2' ' B' ' 75' ' ' MET 0.291 19.9 p 76.19 0.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.569 2.348 . . . . 0.0 111.18 -178.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.65 -50.1 77.29 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 C-N-CA 123.465 0.706 . . . . 0.0 109.424 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.93 47.1 92.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.273 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -45.63 -32.31 2.3 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.72 12.46 5.0 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.95 -54.98 16.61 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.628 -0.925 . . . . 0.0 111.108 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -121.78 156.12 33.85 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.83 139.52 34.83 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 102.08 -3.304 . . . . 0.0 102.08 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.11 -173.26 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.145 3.23 . . . . 0.0 108.873 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.664 HG22 ' H ' ' B' ' 64' ' ' THR . 12.9 p -137.23 -158.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.664 ' H ' HG22 ' B' ' 63' ' ' VAL . 53.2 m -92.92 -39.18 11.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 109.672 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.35 -23.59 59.05 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.386 -0.821 . . . . 0.0 110.612 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -29.33 70.59 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 123.732 1.73 . . . . 0.0 108.254 173.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.86 67.21 1.18 Allowed Glycine 0 CA--C 1.461 -3.321 1 N-CA-C 102.335 -4.306 . . . . 0.0 102.335 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -29.61 -24.43 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 133.034 4.534 . . . . 0.0 115.342 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -62.82 0.68 0.49 Allowed 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 125.961 1.704 . . . . 0.0 114.03 165.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.24 -56.11 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.125 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 165.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.21 -43.6 78.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.228 1.411 . . . . 0.0 111.487 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.04 -46.4 61.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.484 1.914 . . . . 0.0 110.805 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.18 -40.13 86.52 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.353 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.23 -49.0 79.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 119.19 0.905 . . . . 0.0 110.055 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.422 ' HB2' HG22 ' B' ' 54' ' ' THR . 21.3 ptp -68.08 -41.45 81.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.936 -0.478 . . . . 0.0 110.338 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -69.37 -32.85 72.15 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.08 89.77 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 123.292 0.637 . . . . 0.0 110.457 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.41 -49.69 63.94 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.42 -51.25 66.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 109.841 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.77 -7.11 56.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.519 -1.363 . . . . 0.0 112.954 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -83.86 -54.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -60.66 -29.79 69.5 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.73 0.812 . . . . 0.0 110.155 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.09 -19.74 36.21 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.418 0.687 . . . . 0.0 112.58 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.74 -37.32 59.45 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 119.153 -2.217 . . . . 0.0 107.747 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' B' ' 8' ' ' ALA . 10.4 m -73.07 -5.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 121.383 -0.823 . . . . 0.0 111.544 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.1 m -55.96 -20.54 16.67 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 110.593 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.94 95.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 119.859 -1.776 . . . . 0.0 113.032 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.25 70.55 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 124.516 1.127 . . . . 0.0 108.042 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.54 -27.61 61.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.53 75.48 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.775 -1.828 . . . . 0.0 110.594 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -12.32 28.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.006 -1.059 . . . . 0.0 112.577 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.38 -15.66 61.85 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 119.789 1.177 . . . . 0.0 111.12 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' C' ' 91' ' ' THR . 5.4 p90 -76.14 -26.64 56.51 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.336 -1.477 . . . . 0.0 111.067 171.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.93 -34.0 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.135 0.974 . . . . 0.0 108.504 -171.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -61.59 -20.01 62.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.501 1.12 . . . . 0.0 112.348 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -64.66 -32.93 74.82 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.77 0.828 . . . . 0.0 110.813 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.354 0.776 0 O-C-N 120.479 -1.388 . . . . 0.0 109.938 178.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 N--CA 1.429 -1.498 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.428 ' CD2' ' HB1' ' C' ' 88' ' ' ALA . 1.4 p-80 -58.86 -28.96 66.59 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 127.082 2.153 . . . . 0.0 113.492 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.86 -32.86 72.84 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.848 1.259 . . . . 0.0 109.92 -168.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -65.35 -43.67 90.11 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.533 1.133 . . . . 0.0 109.992 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -72.11 -37.06 69.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.986 0.914 . . . . 0.0 108.915 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.16 95.89 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -71.3 -35.36 71.26 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.899 0.88 . . . . 0.0 110.317 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.3 88.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.085 0.954 . . . . 0.0 111.833 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.8 -33.83 76.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.42 -0.8 . . . . 0.0 111.623 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.01 -35.2 74.19 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.658 0.742 . . . . 0.0 109.601 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -69.62 -29.71 67.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.534 0.734 . . . . 0.0 110.24 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.94 -40.84 95.64 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.77 -34.96 75.27 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.55 -0.719 . . . . 0.0 110.775 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -64.48 -40.72 96.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.505 1.122 . . . . 0.0 111.23 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.4 -31.36 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.618 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.49 -50.23 74.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 126.223 1.809 . . . . 0.0 109.543 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -72.69 -23.93 60.94 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.88 -1.137 . . . . 0.0 110.601 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -72.36 -37.15 68.88 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 -31.58 72.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.156 0.982 . . . . 0.0 112.178 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -58.21 -45.23 88.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.894 1.331 . . . . 0.0 111.578 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -70.63 -47.16 61.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.181 1.792 . . . . 0.0 107.506 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -65.28 -31.0 71.92 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 124.452 1.101 . . . . 0.0 112.674 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.69 68.61 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.93 1.292 . . . . 0.0 110.391 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.43 -36.86 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.399 0.68 . . . . 0.0 110.348 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.72 -38.95 89.81 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.466 -0.772 . . . . 0.0 109.701 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.41 71.54 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.175 1.79 . . . . 0.0 111.562 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -67.32 -24.33 65.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 125.178 1.391 . . . . 0.0 112.307 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -91.91 115.95 28.5 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.79 -48.26 0.98 Allowed Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.88 150.52 38.72 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.322 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.81 162.89 18.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.821 1.681 . . . . 0.0 110.263 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 30.76 12.8 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.11 137.14 56.11 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 117.995 0.898 . . . . 0.0 111.94 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.62 -41.96 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 123.828 0.851 . . . . 0.0 110.024 -170.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.85 -27.04 57.67 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.866 1.266 . . . . 0.0 108.412 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 tp -37.22 106.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 127.911 2.484 . . . . 0.0 113.343 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t -172.03 -131.39 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.3 -70.42 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.731 0 CA-C-O 116.914 -1.517 . . . . 0.0 107.038 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.21 -11.55 19.32 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 CA-C-N 125.004 2.823 . . . . 0.0 111.925 -163.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.57 1.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.341 2.657 . . . . 0.0 107.725 -175.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.28 -34.38 70.61 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.065 0.936 . . . . 0.0 110.214 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.01 -19.5 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 125.334 1.454 . . . . 0.0 109.994 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -50.85 28.77 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.599 -1.938 . . . . 0.0 107.511 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -63.32 -34.25 77.29 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 121.957 0.884 . . . . 0.0 111.399 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -73.06 -31.16 64.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.587 -1.945 . . . . 0.0 110.907 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.95 -53.39 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 123.922 0.889 . . . . 0.0 108.677 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' C' ' 56' ' ' GLY . 20.3 pt-20 -64.37 -30.91 71.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.014 0.526 . . . . 0.0 111.773 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 79.5 m -70.83 -48.37 54.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.814 0.846 . . . . 0.0 110.754 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -27.52 64.38 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.792 -1.193 . . . . 0.0 111.232 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -85.37 -4.26 59.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.927 -0.483 . . . . 0.0 111.124 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p 55.23 64.2 1.86 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 125.495 1.518 . . . . 0.0 112.059 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.86 -87.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 101.592 -3.485 . . . . 0.0 101.592 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' C' ' 50' ' ' GLU . . . 87.21 80.73 1.21 Allowed Glycine 0 CA--C 1.494 -1.254 0 N-CA-C 104.722 -3.351 . . . . 0.0 104.722 -172.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.447 ' CD2' ' HA3' ' D' ' 56' ' ' GLY . 17.8 t80 -76.34 -30.37 57.61 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.97 35.22 3.77 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.99 -38.44 57.39 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -135.07 157.34 47.19 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -129.41 138.11 32.42 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.37 168.04 22.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.515 2.143 . . . . 0.0 109.307 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' C' ' 63' ' ' VAL . 1.1 m -63.74 175.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 122.242 1.02 . . . . 0.0 111.688 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -83.36 -88.06 0.1 Allowed 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 120.958 -1.089 . . . . 0.0 108.323 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -34.17 -58.03 0.47 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.954 2.502 . . . . 0.0 116.589 -169.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -82.67 -98.93 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.68 -86.52 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.378 0 C-N-CA 126.395 1.95 . . . . 0.0 113.496 160.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -58.11 -42.43 85.72 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.301 1.44 . . . . 0.0 112.157 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -58.87 -27.08 64.84 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 118.902 -2.374 . . . . 0.0 112.283 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.18 -55.25 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.5 77.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.001 1.721 . . . . 0.0 112.713 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.0 -43.06 73.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 128.428 2.691 . . . . 0.0 108.555 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -68.2 -43.71 77.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 123.894 0.878 . . . . 0.0 110.188 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.51 -48.88 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 124.32 1.048 . . . . 0.0 110.16 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 23.2 ptp -66.56 -34.47 77.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.557 -0.715 . . . . 0.0 110.333 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -68.7 -30.53 69.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.308 -0.87 . . . . 0.0 110.744 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.11 86.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.909 -0.494 . . . . 0.0 110.206 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.42 92.0 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 123.823 0.725 . . . . 0.0 111.338 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -54.7 -47.46 73.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 125.378 1.471 . . . . 0.0 110.527 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -70.25 -28.41 65.21 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.769 -0.582 . . . . 0.0 112.027 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.58 -48.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 121.008 -1.057 . . . . 0.0 109.509 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -67.14 -25.85 66.38 Favored 'General case' 0 CA--C 1.509 -0.609 0 O-C-N 121.495 -0.753 . . . . 0.0 110.927 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.39 -36.89 57.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.79 -41.83 97.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 124.676 1.19 . . . . 0.0 110.516 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.04 -9.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 O-C-N 121.113 -0.992 . . . . 0.0 111.673 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -19.46 64.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 110.078 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.86 -32.94 74.88 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.434 1.093 . . . . 0.0 111.771 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -73.88 -31.4 63.12 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.446 1.098 . . . . 0.0 109.914 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 -32.68 26.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.56 63.64 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.003 -1.061 . . . . 0.0 111.161 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.438 HG23 ' HB2' ' B' ' 93' ' ' PHE . 8.7 p -75.66 -10.82 59.77 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 120.035 -1.665 . . . . 0.0 110.823 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.337 46.5 m-20 -90.9 -0.77 57.82 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.582 -1.647 . . . . 0.0 109.511 -158.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -89.01 -10.37 47.85 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.906 161.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -96.13 -51.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.49 -17.87 24.5 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.396 2.279 . . . . 0.0 111.983 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -68.01 -12.57 61.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.655 -1.278 . . . . 0.0 112.255 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 . . . . . 0 C--N 1.353 0.756 0 O-C-N 119.956 -1.715 . . . . 0.0 108.097 175.345 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -28.91 70.38 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.117 -0.989 . . . . 0.0 112.703 -169.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.447 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 21.2 p80 -63.02 -33.19 74.89 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.202 -0.936 . . . . 0.0 112.44 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.447 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 10.8 mt-10 -80.44 -31.99 37.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.876 -1.14 . . . . 0.0 108.812 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.16 -35.96 74.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.902 -1.124 . . . . 0.0 110.725 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.25 -38.99 93.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.947 1.699 . . . . 0.0 110.154 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.21 92.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.153 0.981 . . . . 0.0 111.896 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -65.34 -32.94 74.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.522 1.129 . . . . 0.0 111.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -68.79 -36.16 77.93 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.742 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.63 94.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.485 0.714 . . . . 0.0 110.752 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.19 -44.14 87.91 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.416 1.086 . . . . 0.0 111.525 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -68.34 -44.1 76.06 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.266 1.026 . . . . 0.0 109.148 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -68.41 -31.57 71.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.584 -0.698 . . . . 0.0 110.409 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.43 -44.03 92.99 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.509 0.723 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.0 -30.83 71.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -65.91 -41.04 91.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.732 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.67 -38.28 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 C-N-CA 123.965 0.906 . . . . 0.0 108.897 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 37.3 mt -60.37 -48.44 81.73 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.204 1.002 . . . . 0.0 110.279 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -67.45 -36.49 81.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.565 -0.709 . . . . 0.0 111.736 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.63 -47.48 78.4 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.66 -41.52 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.367 1.467 . . . . 0.0 110.997 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 58.4 m -52.21 -49.45 63.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 126.064 1.746 . . . . 0.0 112.134 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -61.94 -50.89 70.34 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -62.66 -42.9 99.87 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 117.676 -1.154 . . . . 0.0 110.12 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.34 -47.69 62.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.822 2.049 . . . . 0.0 111.519 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.9 -41.62 76.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.776 -1.202 . . . . 0.0 111.372 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.53 -16.12 37.92 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.128 0.971 . . . . 0.0 109.982 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.12 -56.74 3.89 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.798 1.639 . . . . 0.0 106.73 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.94 -33.65 76.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.999 -0.438 . . . . 0.0 110.418 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -71.3 111.9 7.0 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.942 -1.098 . . . . 0.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.88 -32.18 4.69 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.31 73.5 Favored Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 123.521 0.728 . . . . 0.0 110.025 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.73 110.18 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.073 1.848 . . . . 0.0 113.255 -171.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.39 42.88 2.87 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.719 -2.952 . . . . 0.0 105.719 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.01 163.71 24.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.686 1.194 . . . . 0.0 109.301 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.67 -59.59 0.76 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' D' ' 60' ' ' ARG . 8.3 tt -84.67 130.76 34.67 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -150.29 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -142.1 125.74 16.88 Favored 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 119.784 -1.822 . . . . 0.0 109.362 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.04 -48.9 95.79 Favored Pre-proline 0 C--N 1.353 0.735 0 CA-C-O 116.473 -1.727 . . . . 0.0 112.282 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.36 -8.17 22.2 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 CA-C-N 125.33 2.939 . . . . 0.0 112.345 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -101.27 -19.59 15.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.27 75.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 121.043 -1.036 . . . . 0.0 111.519 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -65.92 -28.88 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.612 1.165 . . . . 0.0 110.092 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -86.19 -26.18 25.25 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.483 -0.761 . . . . 0.0 109.788 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -79.17 -34.42 43.15 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.8 m -79.06 51.07 1.1 Allowed 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.721 -0.612 . . . . 0.0 110.669 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.21 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.33 -22.92 55.04 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.416 1.486 . . . . 0.0 113.713 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.411 HG22 ' H ' ' D' ' 51' ' ' THR . 5.1 t -72.15 -35.82 69.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.666 -1.271 . . . . 0.0 109.795 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.29 42.39 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.035 -1.041 . . . . 0.0 109.613 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.22 -2.03 54.56 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.861 0.865 . . . . 0.0 109.615 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p 58.93 40.8 22.09 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 127.062 2.145 . . . . 0.0 112.733 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.41 65.69 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' C' ' 57' ' ' TYR . . . -70.25 99.78 0.74 Allowed Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -35.05 40.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.08 39.99 0.17 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.0 -51.38 16.12 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 118.827 1.314 . . . . 0.0 109.249 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.424 ' HD3' HD12 ' D' ' 38' ' ' LEU . 0.1 OUTLIER -141.49 173.27 11.65 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -137.16 127.93 16.16 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.08 -179.44 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.185 3.257 . . . . 0.0 109.481 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.507 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 6.8 t -112.26 -97.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 124.087 0.955 . . . . 0.0 110.076 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -165.67 -46.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -71.96 -10.22 59.47 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.507 ' CG ' ' H ' ' D' ' 63' ' ' VAL . 0.9 OUTLIER -60.84 -33.11 72.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.502 1.121 . . . . 0.0 109.996 172.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.25 -33.02 1.13 Allowed Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.391 -3.483 . . . . 0.0 104.391 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.435 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 37.6 ttm180 74.09 -50.74 0.69 Allowed 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 130.071 3.348 . . . . 0.0 107.578 -171.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -71.76 12.11 0.42 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.672 2.789 . . . . 0.0 110.884 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.89 -61.03 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -49.18 69.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 123.168 0.587 . . . . 0.0 111.031 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.02 -40.24 66.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.935 0.894 . . . . 0.0 111.418 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.8 -37.03 73.26 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 121.708 -0.62 . . . . 0.0 111.348 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.36 -41.95 57.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.146 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 10.3 mtp -56.37 -51.66 67.49 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.826 1.251 . . . . 0.0 110.587 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.75 -40.66 97.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.388 0.675 . . . . 0.0 110.768 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.04 87.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.763 0.825 . . . . 0.0 110.985 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.63 -49.44 64.35 Favored Glycine 0 CA--C 1.496 -1.119 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.62 -49.44 80.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 124.186 0.995 . . . . 0.0 110.339 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . 0.273 11.9 pt-20 -77.95 -9.61 59.18 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 120.202 -1.561 . . . . 0.0 112.664 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.69 -47.17 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -67.47 -20.78 65.52 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 121.462 -0.774 . . . . 0.0 111.137 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.6 -14.78 29.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.659 0.742 . . . . 0.0 111.717 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.18 -38.56 56.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 119.876 -1.765 . . . . 0.0 107.651 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 6.6 m -66.96 -6.39 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.646 0.778 . . . . 0.0 111.458 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.1 m -63.11 -17.77 62.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.375 1.47 . . . . 0.0 111.487 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.56 62.41 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 120.053 -1.655 . . . . 0.0 111.759 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.32 6.32 17.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 125.166 1.386 . . . . 0.0 111.087 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 92.5 mt -113.47 -39.29 4.13 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.28 -13.16 61.44 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.779 -1.2 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -70.7 -19.17 62.79 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 120.956 -1.09 . . . . 0.0 110.879 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.19 7.47 46.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 119.699 1.136 . . . . 0.0 110.6 -160.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -91.99 -20.5 21.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 158.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.9 -40.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -57.75 -38.24 75.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 126.711 2.005 . . . . 0.0 111.163 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.13 -8.64 55.78 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.386 0.674 . . . . 0.0 112.732 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.174 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 122.317 1.056 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.73 151.57 34.07 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.2 -29.99 71.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.041 1.336 . . . . 0.0 109.323 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -91.94 -2.46 56.76 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 121.267 -0.896 . . . . 0.0 111.712 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.21 -36.46 19.44 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 119.599 1.09 . . . . 0.0 108.965 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -67.71 -35.01 78.01 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.894 -1.129 . . . . 0.0 110.305 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -75.43 -34.38 60.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 121.769 -0.582 . . . . 0.0 109.651 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.04 82.45 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.798 0.839 . . . . 0.0 109.715 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -60.49 -38.37 84.08 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.662 1.185 . . . . 0.0 111.417 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -56.3 -42.5 77.65 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.569 1.148 . . . . 0.0 110.612 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.06 -32.29 73.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.632 -0.668 . . . . 0.0 111.061 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.11 -27.68 67.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.625 -0.672 . . . . 0.0 111.853 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.35 -39.26 81.92 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 109.158 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.47 -36.17 82.88 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.488 0.715 . . . . 0.0 110.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -38.89 92.91 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.607 0.717 . . . . 0.0 111.057 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -69.08 -21.01 64.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.364 1.066 . . . . 0.0 111.883 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -72.51 -40.72 66.62 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -64.46 -38.88 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.845 0.858 . . . . 0.0 108.709 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.92 -43.26 86.15 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.556 1.142 . . . . 0.0 111.859 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.82 -53.86 53.39 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.321 1.058 . . . . 0.0 110.251 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -73.06 -28.96 62.62 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.265 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.06 89.19 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 124.925 1.29 . . . . 0.0 110.428 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m -56.96 -37.82 72.11 Favored 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.498 1.119 . . . . 0.0 112.042 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -75.59 -51.68 12.32 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.387 0.675 . . . . 0.0 110.854 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.3 -38.22 88.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 120.989 -1.069 . . . . 0.0 109.498 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.96 75.25 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.353 1.461 . . . . 0.0 112.505 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.38 -33.05 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 O-C-N 121.375 -0.828 . . . . 0.0 111.415 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.34 -44.82 50.73 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -66.88 -42.8 84.95 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.577 1.551 . . . . 0.0 108.721 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -79.59 -44.26 21.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -77.11 93.88 3.96 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 119.372 -2.08 . . . . 0.0 110.537 -172.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.87 -17.85 3.41 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.98 151.4 54.6 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.025 0.912 . . . . 0.0 109.196 -176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.84 137.07 13.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.839 2.36 . . . . 0.0 110.731 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 -4.61 83.64 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 118.784 0.72 . . . . 0.0 111.306 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.88 146.76 54.06 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.492 1.117 . . . . 0.0 111.662 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.66 -11.1 1.59 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.519 1.128 . . . . 0.0 111.138 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.11 -66.32 0.73 Allowed 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.088 -1.007 . . . . 0.0 111.152 -172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 40' ' ' SER 0.495 44.9 pt 58.28 -100.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 174.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 39' ' ' ILE . 24.7 m -54.11 143.23 22.97 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -56.05 -57.45 22.12 Favored Pre-proline 0 C--N 1.356 0.859 0 C-N-CA 125.866 1.666 . . . . 0.0 114.991 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.22 -5.58 17.16 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.258 2.913 . . . . 0.0 111.207 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -107.98 1.97 22.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.17 -45.21 9.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.79 -32.15 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 124.237 1.015 . . . . 0.0 110.781 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.86 -10.54 59.71 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.122 -0.986 . . . . 0.0 112.143 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -90.14 -22.95 21.49 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -89.32 54.7 3.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 120.151 -1.593 . . . . 0.0 109.36 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.21 -73.72 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.44 -31.72 65.7 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.506 1.922 . . . . 0.0 108.638 -169.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -52.64 -37.67 58.9 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.091 1.357 . . . . 0.0 111.627 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -16.48 58.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 119.664 -1.898 . . . . 0.0 111.919 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t -108.55 38.48 2.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.388 4.6 p 62.74 -110.31 0.34 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.597 2.359 . . . . 0.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t 70.51 -70.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.891 1.676 . . . . 0.0 110.116 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.5 -24.3 29.14 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -78.27 55.92 1.61 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 109.787 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.76 -13.65 66.43 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 120.369 -1.457 . . . . 0.0 110.358 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 t0 76.09 14.37 2.54 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 127.583 2.353 . . . . 0.0 108.751 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -148.79 -178.3 6.27 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.26 139.76 21.69 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.59 175.93 8.35 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.992 3.128 . . . . 0.0 107.766 161.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.314 2.6 p -113.43 -88.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-N 120.832 1.651 . . . . 0.0 112.046 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -157.64 -40.45 0.07 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.496 -2.003 . . . . 0.0 107.21 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.91 -23.5 31.16 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 123.121 0.568 . . . . 0.0 110.795 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.624 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 1.2 pm0 -57.8 -35.95 71.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.492 1.517 . . . . 0.0 108.043 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.04 96.35 2.08 Favored Glycine 0 CA--C 1.47 -2.74 1 N-CA-C 97.992 -6.043 . . . . 0.0 97.992 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -62.64 -17.21 59.94 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 118.726 1.263 . . . . 0.0 110.072 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -44.06 -29.63 0.63 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.561 2.744 . . . . 0.0 113.813 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.93 -40.99 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 124.593 1.157 . . . . 0.0 109.137 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 -49.05 12.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.196 -0.94 . . . . 0.0 108.617 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -47.85 -50.32 26.63 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.703 2.001 . . . . 0.0 111.721 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.1 -27.31 61.63 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.662 -0.649 . . . . 0.0 111.562 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.97 -44.15 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.9 mtm -63.19 -44.23 95.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.135 0.574 . . . . 0.0 110.539 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -65.84 -32.54 74.12 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.342 -0.849 . . . . 0.0 111.473 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.06 79.2 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.355 -0.841 . . . . 0.0 110.403 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.43 -41.34 96.46 Favored Glycine 0 CA--C 1.487 -1.695 0 C-N-CA 123.969 0.795 . . . . 0.0 111.145 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.71 -46.95 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 C-N-CA 124.078 0.951 . . . . 0.0 108.722 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.13 -39.4 94.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 120.734 -1.229 . . . . 0.0 112.302 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.85 -55.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.71 0.804 . . . . 0.0 109.361 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.39 -18.65 61.13 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.579 -0.7 . . . . 0.0 111.667 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.35 23.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.073 -1.017 . . . . 0.0 109.861 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.81 -37.27 87.05 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.935 -1.103 . . . . 0.0 110.585 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.33 -7.62 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 O-C-N 121.188 -0.945 . . . . 0.0 112.246 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -57.97 -23.95 55.98 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 124.706 1.202 . . . . 0.0 110.72 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.75 72.96 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.182 -1.574 . . . . 0.0 112.457 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.77 -39.98 56.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 120.998 -1.064 . . . . 0.0 108.612 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.59 -35.05 78.26 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.689 0.757 . . . . 0.0 110.425 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.74 68.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.672 -1.268 . . . . 0.0 112.343 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 t -84.57 5.12 29.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.709 -1.245 . . . . 0.0 109.709 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.72 -48.39 59.69 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 118.786 0.721 . . . . 0.0 109.693 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -67.98 -27.94 67.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.723 -1.235 . . . . 0.0 111.551 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -29.1 46.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 125.085 1.354 . . . . 0.0 109.115 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -59.96 -18.51 45.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.243 1.817 . . . . 0.0 111.847 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -61.81 -36.68 81.83 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.974 1.31 . . . . 0.0 109.676 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -78.14 -18.56 55.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 120.683 -1.261 . . . . 0.0 109.815 -169.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -78.53 -37.42 43.0 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.763 1.225 . . . . 0.0 107.92 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.27 -42.9 99.74 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.747 2.019 . . . . 0.0 109.71 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.29 -10.12 58.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -114.55 -12.85 12.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.56 30.29 64.5 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 110.447 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -170.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.67 -159.24 0.21 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.303 1.441 . . . . 0.0 112.424 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -67.33 0.64 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' B' ' 5' ' ' GLU . 36.8 p-80 -56.16 -30.07 61.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.425 2.29 . . . . 0.0 114.348 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' CD2' ' B' ' 4' ' ' HIS . 8.3 mt-10 -74.62 -21.2 59.59 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -79.38 -42.57 25.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.59 -31.25 66.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.038 0.447 . . . . 0.0 110.473 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.53 -43.31 93.48 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.754 0.822 . . . . 0.0 111.558 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -72.83 -30.57 64.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.773 0.797 . . . . 0.0 110.351 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -66.45 -34.4 77.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.742 0.817 . . . . 0.0 110.214 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.94 79.28 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -63.29 -36.62 84.27 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.494 -0.753 . . . . 0.0 111.0 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.99 -33.95 76.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.916 0.886 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -62.81 -41.83 99.47 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 121.246 -0.909 . . . . 0.0 109.32 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.64 -39.65 94.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.795 -0.566 . . . . 0.0 110.939 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.97 -38.05 84.58 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.368 0.667 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -62.57 -45.2 94.01 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.339 0.656 . . . . 0.0 109.568 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.53 -38.72 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 123.756 0.823 . . . . 0.0 109.72 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.91 -45.92 85.75 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.824 0.85 . . . . 0.0 111.261 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.58 -37.63 77.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.592 1.157 . . . . 0.0 110.712 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.48 -35.59 63.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.72 -0.613 . . . . 0.0 109.898 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.73 -36.79 85.02 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.142 0.977 . . . . 0.0 111.068 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -28.94 69.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.727 1.149 . . . . 0.0 112.949 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.05 -53.71 10.42 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -58.18 -48.11 81.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 125.073 1.349 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.56 -43.87 84.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.644 1.178 . . . . 0.0 112.224 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 -48.69 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 -20.35 49.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -50.67 43.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 108.504 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.83 -21.66 63.36 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 mmm-85 -70.68 90.57 0.77 Allowed 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 120.149 -1.595 . . . . 0.0 110.694 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.87 -21.45 3.01 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 107.519 -2.233 . . . . 0.0 107.519 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.44 152.26 66.91 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 117.761 0.78 . . . . 0.0 110.771 -172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.57 128.32 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.87 2.38 . . . . 0.0 110.667 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.38 -63.05 0.28 Allowed Glycine 0 CA--C 1.471 -2.688 1 N-CA-C 103.036 -4.026 . . . . 0.0 103.036 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.416 ' H ' HG21 ' B' ' 63' ' ' VAL . . . 45.41 -94.53 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 128.643 2.777 . . . . 0.0 111.503 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 83.75 -29.09 0.09 Allowed 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 127.165 2.186 . . . . 0.0 109.042 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.92 122.5 39.96 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 pt -154.44 170.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 76.61 139.83 0.07 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.017 1.727 . . . . 0.0 111.673 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -47.3 23.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.585 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -70.48 -21.6 29.91 Favored 'Trans proline' 0 CA--C 1.502 -1.089 0 CA-C-N 124.512 2.647 . . . . 0.0 112.952 -168.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.38 6.52 24.43 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 119.945 1.248 . . . . 0.0 110.37 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.67 -38.85 67.48 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.631 0.729 . . . . 0.0 109.25 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -65.09 -33.24 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 123.414 0.686 . . . . 0.0 109.773 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -41.63 84.02 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.971 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.19 0.995 . . . . 0.0 109.177 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -58.02 -41.42 83.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.976 1.31 . . . . 0.0 111.165 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.79 -51.88 67.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 O-C-N 121.49 -0.756 . . . . 0.0 111.114 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . 0.285 6.6 pt-20 -76.37 -12.1 60.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.028 -1.045 . . . . 0.0 112.538 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 90.0 m -68.33 -42.94 78.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.6 67.38 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.323 -1.486 . . . . 0.0 112.287 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -76.58 -18.86 58.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.851 -0.531 . . . . 0.0 111.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.311 13.9 p 68.6 10.31 7.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.616 2.366 . . . . 0.0 111.307 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.23 -53.72 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.14 -46.65 3.67 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 120.838 -1.164 . . . . 0.0 110.554 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 76.91 -67.08 0.22 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 128.187 2.595 . . . . 0.0 109.002 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.69 27.79 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.03 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.36 178.22 7.45 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -156.23 154.62 27.7 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.91 174.5 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.073 2.515 . . . . 0.0 111.465 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.416 HG21 ' H ' ' B' ' 36' ' ' ALA . 2.4 t -95.83 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.914 0.885 . . . . 0.0 111.165 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -128.62 -32.08 2.18 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.448 1.899 . . . . 0.0 107.657 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -92.58 -6.2 50.01 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.769 0.827 . . . . 0.0 108.801 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -35.4 59.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.62 64.44 0.67 Allowed Glycine 0 CA--C 1.468 -2.897 0 N-CA-C 103.12 -3.992 . . . . 0.0 103.12 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -31.79 -16.82 0.0 OUTLIER 'General case' 0 C--N 1.369 1.45 1 C-N-CA 132.816 4.446 . . . . 0.0 117.7 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.46 -15.41 2.69 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.275 -1.516 . . . . 0.0 113.428 158.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.25 -54.6 32.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.171 1.388 . . . . 0.0 107.973 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.1 -46.0 75.55 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.463 -0.773 . . . . 0.0 110.31 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -49.73 -43.12 47.52 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 126.084 1.754 . . . . 0.0 111.393 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.38 -50.02 73.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.442 1.097 . . . . 0.0 110.913 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.84 -43.44 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.597 0.759 . . . . 0.0 109.624 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtm -63.14 -48.8 76.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.373 1.069 . . . . 0.0 110.134 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -71.61 -27.25 62.99 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.289 -0.882 . . . . 0.0 110.813 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.78 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.872 -1.142 . . . . 0.0 109.824 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.82 61.42 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -58.71 -45.56 90.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 C-N-CA 124.035 0.934 . . . . 0.0 110.52 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.55 -27.97 68.83 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.516 -1.365 . . . . 0.0 112.569 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.75 -46.71 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 120.368 -1.458 . . . . 0.0 108.247 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -65.95 -21.57 66.43 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.934 0.894 . . . . 0.0 110.956 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -42.78 16.43 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.619 1.167 . . . . 0.0 110.732 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.8 -40.4 83.96 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.208 1.403 . . . . 0.0 111.031 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 29.2 m -63.33 -8.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 123.836 0.855 . . . . 0.0 112.393 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.7 m -64.72 -12.58 48.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.678 -1.264 . . . . 0.0 110.535 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.96 65.98 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.828 -1.795 . . . . 0.0 112.098 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.51 -37.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.951 -1.093 . . . . 0.0 109.108 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.02 -36.59 64.46 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.417 -0.802 . . . . 0.0 111.267 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.33 -12.82 60.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.847 -1.158 . . . . 0.0 111.187 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -96.88 1.44 50.55 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.945 -1.097 . . . . 0.0 108.974 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.3 -37.3 66.26 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 120.305 1.411 . . . . 0.0 109.017 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -66.74 -30.01 70.13 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 120.289 -1.507 . . . . 0.0 111.406 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.6 -22.95 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.091 1.357 . . . . 0.0 109.6 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.92 -25.31 65.03 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.07 -1.019 . . . . 0.0 111.519 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -8.51 54.04 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.526 -1.359 . . . . 0.0 112.36 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -83.41 -43.63 15.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 120.298 -1.501 . . . . 0.0 107.625 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.67 -43.97 97.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.905 1.282 . . . . 0.0 109.661 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.0 -10.45 59.43 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.598 -0.689 . . . . 0.0 112.329 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -79.02 -35.88 42.04 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.764 -1.21 . . . . 0.0 108.156 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -79.24 -35.63 41.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.03 12.26 62.17 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.96 176.15 6.36 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -57.56 -52.4 65.57 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 125.497 1.519 . . . . 0.0 109.4 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -19.99 63.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.691 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.15 -38.67 20.37 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -62.78 -32.2 73.32 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.503 -1.373 . . . . 0.0 112.182 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -64.48 -36.09 83.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.07 0.948 . . . . 0.0 110.936 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -44.73 62.04 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.173 -0.954 . . . . 0.0 109.519 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -66.83 -33.36 75.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.487 0.66 . . . . 0.0 111.345 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.97 -37.51 79.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.672 1.989 . . . . 0.0 111.113 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.01 -38.86 66.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.948 0.899 . . . . 0.0 110.291 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.05 -40.82 90.75 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.084 -1.01 . . . . 0.0 110.962 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.61 -18.03 62.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.298 -0.876 . . . . 0.0 111.728 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -73.83 -38.39 64.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.94 -38.11 89.89 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.249 0.62 . . . . 0.0 110.544 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.26 -24.94 68.09 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.604 -0.685 . . . . 0.0 112.449 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -80.12 -23.75 40.98 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.373 1.469 . . . . 0.0 109.55 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.17 -35.52 20.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 124.46 1.104 . . . . 0.0 108.034 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -60.55 -33.94 73.41 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.88 0.872 . . . . 0.0 111.462 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -60.62 -50.14 74.71 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.663 1.185 . . . . 0.0 110.225 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.38 -41.0 96.93 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 121.573 -0.704 . . . . 0.0 109.995 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.25 87.18 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.536 1.135 . . . . 0.0 110.389 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 83.5 p -62.72 -33.41 75.06 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.63 0.728 . . . . 0.0 112.116 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -80.15 -54.31 5.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.57 -30.79 67.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.772 0.829 . . . . 0.0 109.467 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.95 76.1 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 125.052 1.341 . . . . 0.0 112.736 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.23 -34.21 57.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 O-C-N 120.896 -1.128 . . . . 0.0 110.615 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.61 -40.63 73.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.852 -1.155 . . . . 0.0 109.389 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.6 1.09 Allowed 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.398 1.479 . . . . 0.0 109.53 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.34 -31.4 0.05 Allowed 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 123.694 0.621 . . . . 0.0 109.446 171.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -70.4 81.65 0.56 Allowed 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.224 -1.547 . . . . 0.0 111.915 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.66 -4.24 1.43 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.6 148.1 68.88 Favored Pre-proline 0 N--CA 1.442 -0.867 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -169.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -78.01 81.83 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.141 2.56 . . . . 0.0 113.182 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.68 34.11 3.15 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 146.18 13.89 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 126.813 2.045 . . . . 0.0 112.402 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.46 -46.07 1.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 125.169 1.388 . . . . 0.0 108.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.1 115.81 18.11 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 122.111 0.958 . . . . 0.0 108.603 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.8 163.21 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t 75.28 131.39 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.882 1.273 . . . . 0.0 112.377 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -67.29 -45.82 49.84 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 116.333 -1.794 . . . . 0.0 111.929 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.23 -10.54 27.4 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 CA-C-N 125.208 2.896 . . . . 0.0 113.904 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.361 0.7 OUTLIER -103.66 -19.43 14.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 121.372 1.896 . . . . 0.0 110.408 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.24 73.92 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.086 0.954 . . . . 0.0 112.214 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tp -66.05 -29.97 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.482 -0.762 . . . . 0.0 110.846 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -34.7 55.04 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.489 -0.757 . . . . 0.0 109.638 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -58.71 -41.99 87.59 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 122.385 1.088 . . . . 0.0 109.743 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -10.54 55.24 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.761 -1.212 . . . . 0.0 114.006 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.29 -47.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.5 57.56 4.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.607 1.563 . . . . 0.0 110.722 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -160.66 -51.21 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.64 -6.33 51.61 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.398 -1.439 . . . . 0.0 111.373 -170.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -80.52 -7.44 59.2 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.075 2.15 . . . . 0.0 110.459 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.309 34.2 p 76.93 17.76 1.63 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.689 2.396 . . . . 0.0 110.44 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.71 111.55 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.54 0.83 Allowed Glycine 0 CA--C 1.481 -2.075 1 N-CA-C 101.805 -4.518 . . . . 0.0 101.805 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.18 -33.06 38.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.92 -116.49 1.33 Allowed Glycine 0 CA--C 1.479 -2.187 0 N-CA-C 103.269 -3.932 . . . . 0.0 103.269 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.302 43.7 t0 64.13 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.348 0.52 0 C-N-CA 126.686 1.994 . . . . 0.0 109.825 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -128.75 158.96 37.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -161.05 147.0 11.16 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.01 163.62 22.9 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 122.795 2.33 . . . . 0.0 109.65 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.259 8.2 t -98.88 -105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -168.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -134.72 -60.04 0.79 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.371 -2.081 . . . . 0.0 108.827 -162.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -78.26 -6.35 54.72 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.377 1.471 . . . . 0.0 108.881 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.35 -20.77 46.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 C-N-CA 131.827 4.051 . . . . 0.0 108.028 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.69 84.36 0.84 Allowed Glycine 0 CA--C 1.482 -1.982 1 N-CA-C 101.473 -4.651 . . . . 0.0 101.473 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -23.52 24.66 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 110.92 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -57.65 -10.34 1.53 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.83 -41.21 87.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 120.059 1.3 . . . . 0.0 110.297 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.62 -51.09 21.09 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 120.991 -1.068 . . . . 0.0 109.163 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -46.05 -51.34 13.88 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 127.213 2.205 . . . . 0.0 112.966 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.98 -28.14 61.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.594 0.758 . . . . 0.0 110.714 -171.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 68.1 t -74.1 -46.08 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 79.2 mtm -59.98 -42.75 94.86 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.36 0.664 . . . . 0.0 111.231 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -65.37 -27.27 68.45 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 121.706 -0.621 . . . . 0.0 111.649 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.73 71.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.196 -0.94 . . . . 0.0 110.681 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.83 -35.83 61.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.57 -46.57 96.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 108.672 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.0 -50.33 73.76 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.73 -52.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 124.979 1.312 . . . . 0.0 110.379 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.29 -0.7 42.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.247 -0.908 . . . . 0.0 111.337 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.12 -37.58 14.12 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 120.733 -1.23 . . . . 0.0 108.295 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.48 -34.83 76.13 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 125.215 1.406 . . . . 0.0 111.344 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.88 -9.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 C-N-CA 124.079 0.952 . . . . 0.0 113.069 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -59.57 -24.19 63.53 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 125.52 1.528 . . . . 0.0 111.396 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.01 -23.56 66.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.771 -1.206 . . . . 0.0 111.562 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.43 -42.93 13.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.86 -41.59 91.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.44 1.096 . . . . 0.0 112.806 -171.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.75 -5.82 40.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.869 -1.144 . . . . 0.0 111.769 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.14 -8.48 25.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.35 -39.64 74.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.504 1.047 . . . . 0.0 109.305 -167.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -80.31 -15.02 57.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.195 -1.565 . . . . 0.0 113.04 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.16 -27.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.608 -1.308 . . . . 0.0 107.562 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 35.3 ttm105 -55.83 -23.4 30.28 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 126.405 1.882 . . . . 0.0 111.937 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -59.54 -32.67 70.54 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.421 -1.424 . . . . 0.0 111.732 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.69 -23.44 45.6 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.005 -1.059 . . . . 0.0 108.487 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -75.25 -46.84 31.18 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.04 -36.11 76.59 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.729 1.612 . . . . 0.0 111.01 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.86 -44.17 39.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.723 2.009 . . . . 0.0 113.314 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -103.4 -25.03 13.43 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.768 -0.583 . . . . 0.0 110.45 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.32 45.6 5.82 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 106.658 -2.577 . . . . 0.0 106.658 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 CA--C 1.506 -0.731 0 O-C-N 121.178 -1.189 . . . . 0.0 109.552 -178.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.434 -1.252 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.33 101.92 0.04 OUTLIER 'General case' 0 C--N 1.351 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 111.175 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.98 -26.0 68.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.463 -1.398 . . . . 0.0 111.56 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.18 -24.86 60.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.259 -0.9 . . . . 0.0 111.308 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -30.2 38.58 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -67.42 -44.77 77.94 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.57 -0.706 . . . . 0.0 110.31 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.49 -38.36 74.34 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.769 -0.582 . . . . 0.0 110.384 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.85 -48.08 80.58 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.939 0.896 . . . . 0.0 111.588 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.02 -35.34 79.7 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.519 -0.738 . . . . 0.0 110.487 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.58 -31.81 73.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.837 0.855 . . . . 0.0 110.496 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.27 97.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.401 -0.812 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -29.69 70.76 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.522 0.677 . . . . 0.0 111.552 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.2 -28.85 66.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 121.251 -0.906 . . . . 0.0 110.42 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -82.47 -23.71 34.58 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.749 -1.219 . . . . 0.0 109.9 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.48 -42.97 99.6 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 120.637 -1.289 . . . . 0.0 110.5 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -59.36 -35.59 74.17 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.435 1.094 . . . . 0.0 112.162 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -66.83 -44.9 79.88 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.611 1.164 . . . . 0.0 108.926 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.24 -38.04 81.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 C-N-CA 124.259 1.023 . . . . 0.0 109.416 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.47 -44.87 81.01 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.642 0.777 . . . . 0.0 112.076 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.89 -43.69 71.28 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.025 0.53 . . . . 0.0 110.701 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.34 -47.21 80.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.59 1.186 . . . . 0.0 109.825 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.0 -28.68 64.61 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.017 -1.052 . . . . 0.0 111.876 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -74.42 -31.08 62.18 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 119.582 1.083 . . . . 0.0 110.769 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -62.05 -48.02 82.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -63.55 -50.68 68.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.208 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.06 70.06 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 125.291 1.437 . . . . 0.0 113.236 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.44 -35.34 61.59 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 120.947 -1.096 . . . . 0.0 110.59 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -81.78 -22.73 37.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.411 -1.431 . . . . 0.0 110.096 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -52.58 14.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 127.093 2.157 . . . . 0.0 107.778 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.84 -35.73 79.12 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.451 1.12 . . . . 0.0 110.967 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.84 103.51 2.64 Favored 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 120.184 -1.572 . . . . 0.0 111.586 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.41 -25.21 3.65 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 106.231 -2.747 . . . . 0.0 106.231 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.0 148.27 74.94 Favored Pre-proline 0 N--CA 1.439 -0.999 0 O-C-N 121.675 -0.897 . . . . 0.0 110.228 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 134.88 17.77 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.253 1.969 . . . . 0.0 110.131 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 26.63 61.26 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 137.28 51.26 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.287 1.835 . . . . 0.0 111.416 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.08 -47.08 2.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tt -85.93 71.27 10.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.728 1.251 . . . . 0.0 110.142 -172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -96.61 -6.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 O-C-N 120.159 -1.588 . . . . 0.0 111.205 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.2 p -95.96 141.98 28.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.097 -1.002 . . . . 0.0 110.862 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -89.73 -61.11 0.22 Allowed Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.318 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.25 -5.92 17.26 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 CA-C-N 125.797 3.106 . . . . 0.0 110.818 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.29 -18.56 21.51 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.076 1.751 . . . . 0.0 107.492 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.21 72.32 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 111.083 -168.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.26 -35.34 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 124.115 0.966 . . . . 0.0 110.515 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -36.15 74.23 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -67.95 -41.06 83.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.399 1.095 . . . . 0.0 109.393 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.8 t -60.62 -41.17 94.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.961 -1.087 . . . . 0.0 110.339 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.51 -53.35 31.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 125.432 1.493 . . . . 0.0 110.6 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -76.1 -15.35 60.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.684 -0.635 . . . . 0.0 111.62 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 73.8 m -76.41 -36.82 57.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.45 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.234 -0.916 . . . . 0.0 111.574 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.5 p -87.59 13.15 10.84 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.781 -0.575 . . . . 0.0 110.736 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p 52.56 49.02 21.3 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.296 1.839 . . . . 0.0 114.0 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.11 -55.05 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.87 -44.31 3.22 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 120.52 -1.363 . . . . 0.0 110.014 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.38 -75.72 0.07 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 127.111 2.164 . . . . 0.0 108.29 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.29 37.4 0.02 OUTLIER Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.0 -66.06 0.95 Allowed 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -130.52 -160.81 1.07 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -165.54 150.19 7.73 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.57 161.67 12.6 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.967 3.111 . . . . 0.0 108.707 168.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -154.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-N 119.893 1.224 . . . . 0.0 108.116 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -91.13 -50.07 6.05 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 119.672 -1.893 . . . . 0.0 108.687 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -77.34 -3.23 38.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.076 1.751 . . . . 0.0 110.847 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -29.8 69.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.59 80.23 1.19 Allowed Glycine 0 CA--C 1.468 -2.891 1 N-CA-C 99.1 -5.6 . . . . 0.0 99.1 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -63.16 -1.68 1.09 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.544 1.537 . . . . 0.0 112.613 -166.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -69.46 -13.3 62.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.602 1.161 . . . . 0.0 112.394 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -53.08 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.28 73.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.313 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -63.62 -34.57 78.12 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.718 0.807 . . . . 0.0 111.893 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -63.7 -37.08 85.99 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.967 -1.083 . . . . 0.0 111.206 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.22 -39.22 82.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 O-C-N 121.067 -1.021 . . . . 0.0 109.893 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 64.5 mtt -62.01 -50.37 72.33 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.67 0.788 . . . . 0.0 110.024 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.71 -30.64 70.93 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.496 -0.752 . . . . 0.0 110.641 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.13 96.12 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.066 -1.021 . . . . 0.0 110.469 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.09 -44.68 95.43 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 124.349 0.976 . . . . 0.0 111.428 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.64 -47.47 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 O-C-N 121.891 -0.77 . . . . 0.0 109.552 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -69.75 -32.82 71.56 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.927 -1.108 . . . . 0.0 113.306 -173.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.41 -42.48 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 110.109 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.14 -36.81 64.18 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 121.634 -0.666 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.28 -23.12 62.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.872 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.55 -32.63 72.7 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.856 -1.778 . . . . 0.0 109.797 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.48 -18.77 21.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 124.792 1.237 . . . . 0.0 110.276 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -60.05 -14.29 15.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 120.809 -1.182 . . . . 0.0 111.663 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.0 2.75 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.37 -1.456 . . . . 0.0 111.24 167.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.7 98.5 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.947 1.299 . . . . 0.0 109.517 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.12 -41.89 89.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 111.915 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.9 -11.45 60.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.978 -1.076 . . . . 0.0 110.356 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -74.72 -26.83 60.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 120.805 -1.184 . . . . 0.0 108.384 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.268 0.6 OUTLIER -80.14 -4.7 54.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 120.317 -1.489 . . . . 0.0 112.818 -160.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -81.78 -29.79 32.6 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 120.674 -1.266 . . . . 0.0 109.337 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.56 -28.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.49 1.116 . . . . 0.0 109.288 -172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -62.72 -12.38 23.45 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.272 -0.893 . . . . 0.0 111.691 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -68.96 -16.55 63.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.434 -0.791 . . . . 0.0 112.37 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -71.32 -45.54 62.75 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.683 -1.261 . . . . 0.0 109.304 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.31 -35.17 80.19 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.736 0.815 . . . . 0.0 110.193 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -60.12 -47.28 86.55 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.893 1.677 . . . . 0.0 110.06 173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -63.14 -37.84 88.8 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.818 1.647 . . . . 0.0 110.195 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -75.31 -26.44 58.67 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.348 1.459 . . . . 0.0 110.292 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.11 3.68 79.02 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 124.161 0.886 . . . . 0.0 110.947 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 -177.826 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.19 37.29 0.05 OUTLIER 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 59.26 -80.6 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.692 2.397 . . . . 0.0 111.379 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -9.59 49.75 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.82 -42.1 91.03 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.337 -0.852 . . . . 0.0 109.18 164.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -71.73 -33.06 68.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 O-C-N 120.569 -1.332 . . . . 0.0 110.437 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.47 -38.5 87.46 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.01 93.5 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.502 1.121 . . . . 0.0 111.44 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -63.78 -36.35 83.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.476 1.51 . . . . 0.0 111.216 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -75.02 -23.87 58.25 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 121.361 0.6 . . . . 0.0 110.038 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.65 86.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.448 -2.033 . . . . 0.0 111.1 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -61.31 -37.47 83.37 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.896 0.855 . . . . 0.0 110.978 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.68 -32.86 74.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.47 1.908 . . . . 0.0 110.214 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -78.15 -32.1 50.11 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 120.895 -1.128 . . . . 0.0 109.083 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.27 -43.76 98.35 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.966 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -59.76 -35.89 75.53 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.309 0.644 . . . . 0.0 112.1 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -32.71 73.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.833 0.853 . . . . 0.0 110.908 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.57 -40.08 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.44 -37.26 86.9 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.488 -0.758 . . . . 0.0 110.917 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.19 -39.58 82.45 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.903 -1.123 . . . . 0.0 111.306 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -69.49 -37.84 77.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.715 0.806 . . . . 0.0 109.762 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.83 89.51 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 125.887 1.675 . . . . 0.0 110.746 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m -63.89 -31.68 72.94 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.968 0.907 . . . . 0.0 111.93 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -75.2 -49.56 19.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.387 -0.821 . . . . 0.0 108.826 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -73.98 -22.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.316 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.42 4.58 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 125.202 1.401 . . . . 0.0 108.553 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.6 t -64.01 -28.78 45.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 O-C-N 119.811 -1.805 . . . . 0.0 111.18 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.36 -35.09 77.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.801 -1.187 . . . . 0.0 110.757 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.73 -59.27 2.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.595 1.558 . . . . 0.0 107.804 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.12 -30.67 62.44 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.287 1.835 . . . . 0.0 112.581 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -77.89 87.12 4.09 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.316 -2.115 . . . . 0.0 110.586 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.0 -21.87 1.13 Allowed Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.39 157.9 35.51 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 118.57 1.185 . . . . 0.0 110.598 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -85.97 131.96 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.391 2.061 . . . . 0.0 111.552 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.0 60.34 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.26 137.45 58.26 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.741 1.216 . . . . 0.0 110.853 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.16 -55.97 2.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.594 0.757 . . . . 0.0 109.727 -173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.33 91.25 8.43 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.196 0.998 . . . . 0.0 109.369 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.04 50.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.322 -1.486 . . . . 0.0 109.279 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.97 148.03 23.33 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.996 -1.69 . . . . 0.0 109.415 170.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -69.97 -45.58 22.87 Favored Pre-proline 0 C--N 1.353 0.726 0 CA-C-O 116.184 -1.865 . . . . 0.0 112.555 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.33 -19.08 33.87 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 125.545 3.016 . . . . 0.0 113.366 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -103.89 -3.91 24.17 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 120.118 1.326 . . . . 0.0 109.91 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.57 85.7 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.347 1.07 . . . . 0.0 110.41 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 45' ' ' ILE . 14.0 tt -68.57 -22.08 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 C-N-CA 124.702 1.201 . . . . 0.0 111.081 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.03 -26.54 26.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.603 -0.685 . . . . 0.0 109.457 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -68.96 -45.15 71.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.9 m -59.28 -12.29 5.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.444 1.098 . . . . 0.0 113.776 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -71.25 -58.22 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 123.999 0.92 . . . . 0.0 108.726 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' B' ' 68' ' ' ARG . 92.2 mt-10 -83.57 75.59 10.02 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.416 -0.802 . . . . 0.0 109.434 -172.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -170.37 -45.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.35 81.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 124.358 1.063 . . . . 0.0 111.97 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 p -96.24 18.37 13.85 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 124.006 0.922 . . . . 0.0 110.652 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.65 62.92 2.21 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 127.104 2.161 . . . . 0.0 115.07 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.77 165.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 1 N-CA-C 95.267 -5.827 . . . . 0.0 95.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' D' ' 57' ' ' TYR . . . -160.65 120.74 0.97 Allowed Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 99.06 -5.616 . . . . 0.0 99.06 170.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -84.8 -17.66 37.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 119.06 1.43 . . . . 0.0 109.071 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.36 21.01 4.93 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 121.129 -0.982 . . . . 0.0 112.886 171.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.27 -39.83 22.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.031 -1.276 . . . . 0.0 112.805 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -147.86 153.05 38.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -162.96 145.14 8.03 Favored Pre-proline 0 C--N 1.354 0.776 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.08 178.77 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 2.965 . . . . 0.0 111.793 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 ' H ' ' A' ' 64' ' ' THR 0.275 9.4 p -119.54 -129.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 125.416 1.486 . . . . 0.0 108.412 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.422 ' H ' HG13 ' A' ' 63' ' ' VAL . 21.1 m -99.45 -57.87 2.06 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 119.493 -2.005 . . . . 0.0 112.069 -160.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -75.41 -9.82 58.91 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 119.182 0.901 . . . . 0.0 109.835 -171.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -71.65 -13.62 61.81 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.672 1.989 . . . . 0.0 108.89 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.5 85.26 0.87 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 100.847 -4.901 . . . . 0.0 100.847 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -56.13 -20.92 19.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.327 1.061 . . . . 0.0 112.22 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.31 -15.74 17.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 118.283 -0.865 . . . . 0.0 113.066 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.01 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.007 1.73 . . . . 0.0 109.325 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.13 -52.75 21.18 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 121.064 -1.023 . . . . 0.0 109.132 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.98 -36.65 79.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -63.51 -34.88 78.75 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.71 -40.79 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.208 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 53.0 mtt -60.73 -48.38 82.06 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.11 0.964 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -66.08 -33.6 76.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 110.519 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.32 89.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.77 -0.581 . . . . 0.0 110.402 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -45.83 94.86 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 124.047 0.832 . . . . 0.0 111.124 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.84 -47.75 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 124.591 1.156 . . . . 0.0 109.702 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -67.82 -31.58 71.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.784 -1.197 . . . . 0.0 112.254 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 t -66.18 -53.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 O-C-N 121.59 -0.694 . . . . 0.0 109.16 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.24 -19.2 62.39 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 121.403 -0.81 . . . . 0.0 111.358 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.18 40.37 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 120.721 -1.237 . . . . 0.0 109.998 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.44 -43.72 84.14 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.101 1.361 . . . . 0.0 110.474 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 m -68.82 -6.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -59.71 -21.48 60.68 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.491 1.041 . . . . 0.0 110.495 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.89 73.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.794 -1.191 . . . . 0.0 112.433 171.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.88 -37.6 55.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.888 0.875 . . . . 0.0 108.849 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.13 -0.357 . . . . 0.0 111.154 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.15 80.21 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.562 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -7.27 58.4 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 120.889 -1.132 . . . . 0.0 111.878 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -30.69 66.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.59 1.087 . . . . 0.0 109.557 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.85 -27.56 60.31 Favored 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 120.596 -1.315 . . . . 0.0 112.019 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.32 -22.62 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.415 1.086 . . . . 0.0 108.664 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -63.46 -21.61 66.41 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.61 -1.306 . . . . 0.0 111.615 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -71.46 -8.56 54.64 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.469 -1.394 . . . . 0.0 112.094 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.89 -20.07 53.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 120.811 -1.18 . . . . 0.0 110.011 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -106.27 -177.67 3.43 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 69.28 -65.15 0.31 Allowed 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.036 1.734 . . . . 0.0 112.413 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -65.87 -43.99 86.7 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 127.308 2.243 . . . . 0.0 108.182 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -115.57 129.0 56.37 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.37 -8.9 57.26 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 178.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . 0.483 . . 11.5 -103.43 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.414 3.086 . . . . 0.0 117.834 -158.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -154.45 -58.79 0.11 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -158.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.42 -26.65 58.53 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.383 1.073 . . . . 0.0 110.326 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -68.11 -32.82 73.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.725 1.61 . . . . 0.0 111.471 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.6 -40.0 80.64 Favored 'General case' 0 CA--C 1.503 -0.848 0 O-C-N 121.881 -0.512 . . . . 0.0 110.071 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.84 -37.87 79.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.08 70.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -67.26 -35.14 78.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.786 -0.571 . . . . 0.0 110.927 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -78.66 -15.22 58.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.96 -1.088 . . . . 0.0 110.771 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.13 -39.17 72.18 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.564 -1.335 . . . . 0.0 108.917 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -30.45 70.01 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.714 0.805 . . . . 0.0 111.593 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.01 -36.06 81.31 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.738 0.815 . . . . 0.0 110.147 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.59 -33.08 73.44 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 123.441 0.696 . . . . 0.0 109.321 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -63.54 -40.19 96.36 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 121.396 -0.815 . . . . 0.0 110.331 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.72 -41.13 66.69 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 124.32 1.048 . . . . 0.0 111.16 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.57 -41.41 98.39 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.291 0.636 . . . . 0.0 110.875 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.58 -44.39 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 121.727 -0.608 . . . . 0.0 109.416 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tp -53.8 -52.31 60.71 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 128.018 2.527 . . . . 0.0 110.149 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.68 -34.48 64.89 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 121.382 -0.824 . . . . 0.0 110.038 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -68.05 -29.24 68.17 Favored 'General case' 0 C--N 1.355 0.848 0 CA-C-N 120.241 1.382 . . . . 0.0 109.872 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.06 66.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.906 0.882 . . . . 0.0 112.398 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 90.0 p -68.94 -42.72 76.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 O-C-N 121.114 -0.991 . . . . 0.0 110.43 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -38.05 84.87 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.04 -36.44 72.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.259 -0.901 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.61 29.42 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.927 1.291 . . . . 0.0 110.382 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.33 -33.11 52.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 123.954 0.902 . . . . 0.0 111.677 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -83.89 -16.78 43.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.958 0.903 . . . . 0.0 109.647 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.59 70.37 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.186 0.994 . . . . 0.0 109.754 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -65.14 -27.11 68.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 121.806 -0.559 . . . . 0.0 111.822 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.87 83.72 4.97 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.8 -23.74 2.77 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.69 138.67 20.75 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.892 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -82.14 105.72 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.86 2.373 . . . . 0.0 112.916 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.54 47.38 0.15 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.56 137.24 57.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.884 0.873 . . . . 0.0 111.685 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.0 -45.57 0.14 Allowed 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.137 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.38 -63.72 1.0 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.991 0.917 . . . . 0.0 108.807 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . 0.369 40.2 pt 53.8 -127.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 126.173 1.789 . . . . 0.0 112.93 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -13.01 134.85 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 132.236 4.215 . . . . 0.0 121.332 -167.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -65.21 -55.5 25.74 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 116.645 -1.645 . . . . 0.0 115.173 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.03 -5.0 15.87 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 125.076 2.848 . . . . 0.0 110.559 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.8 -42.13 12.78 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.205 1.802 . . . . 0.0 106.834 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -33.69 72.98 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.368 1.467 . . . . 0.0 112.496 -170.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.9 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 121.724 -0.61 . . . . 0.0 110.629 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -29.55 54.42 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.727 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.42 -48.3 61.4 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -60.43 -33.43 72.52 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.773 -1.205 . . . . 0.0 112.952 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.94 -24.81 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.889 1.276 . . . . 0.0 112.537 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.24 -17.93 53.84 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.013 -1.679 . . . . 0.0 109.932 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.447 ' C ' ' H ' ' B' ' 53' ' ' THR . 9.3 t -116.94 -166.17 1.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.71 -21.28 0.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 127.131 2.172 . . . . 0.0 110.846 -167.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.447 ' H ' ' C ' ' B' ' 51' ' ' THR . 2.8 p -93.51 -1.43 55.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.568 2.347 . . . . 0.0 110.759 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.274 0.0 OUTLIER 62.7 61.76 1.16 Allowed 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.308 1.443 . . . . 0.0 110.895 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.437 HG13 ' H ' ' B' ' 56' ' ' GLY . 7.6 p -137.91 -69.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.437 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 74.69 72.75 1.0 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -39.91 86.6 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 122.229 -0.571 . . . . 0.0 110.092 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.0 47.47 1.59 Allowed Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.25 -55.59 8.9 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -110.77 165.03 12.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -108.86 127.74 26.78 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.35 170.83 14.34 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.788 2.325 . . . . 0.0 109.66 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 64' ' ' THR . 1.2 t -92.86 -166.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.594 ' H ' HG12 ' B' ' 63' ' ' VAL . 32.7 m -101.09 -63.71 1.11 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.994 0.918 . . . . 0.0 109.132 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -54.61 -28.64 47.98 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -168.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -146.42 -164.36 1.96 Allowed 'General case' 0 N--CA 1.436 -1.17 1 N-CA-C 97.994 -4.817 . . . . 0.0 97.994 160.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.82 -75.34 1.1 Allowed Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 104.334 -3.506 . . . . 0.0 104.334 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 50' ' ' GLU . 17.1 ttt180 -69.53 -38.63 77.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.953 0.883 . . . . 0.0 109.996 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.13 -17.3 60.95 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.122 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.03 -45.82 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 O-C-N 119.664 -1.897 . . . . 0.0 106.1 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -35.32 64.48 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 126.182 1.793 . . . . 0.0 112.401 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -50.43 -51.95 42.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 126.586 1.954 . . . . 0.0 111.245 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.25 -37.93 88.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.912 0.885 . . . . 0.0 109.508 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.07 -41.63 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 121.727 -0.608 . . . . 0.0 110.575 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.7 mtm -63.15 -54.58 35.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 122.982 0.513 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -69.59 -27.48 65.14 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 121.554 -0.716 . . . . 0.0 111.084 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.73 -45.09 91.47 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 120.457 -1.402 . . . . 0.0 110.228 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.68 76.66 Favored Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 124.148 0.88 . . . . 0.0 111.318 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.5 -49.17 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 C-N-CA 124.842 1.257 . . . . 0.0 109.705 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.31 -21.68 62.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 120.919 -1.113 . . . . 0.0 111.628 -171.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.98 -54.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.44 -31.21 70.36 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.184 -0.947 . . . . 0.0 111.824 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.9 -22.29 61.52 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.656 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.69 -35.45 75.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 120.069 -1.645 . . . . 0.0 108.291 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.71 -17.05 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 125.051 1.34 . . . . 0.0 110.217 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -63.85 -13.39 44.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.938 -1.101 . . . . 0.0 110.937 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.84 68.7 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 110.76 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.69 85.59 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.563 1.145 . . . . 0.0 110.692 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.86 -40.8 79.13 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.217 0.607 . . . . 0.0 109.8 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.65 -22.54 63.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.445 -0.784 . . . . 0.0 110.417 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -75.18 -26.57 59.16 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.048 -1.033 . . . . 0.0 109.027 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.488 -1.383 . . . . 0.0 111.513 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -70.81 -28.5 64.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.288 -1.508 . . . . 0.0 112.012 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.55 -29.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 C-N-CA 125.28 1.432 . . . . 0.0 108.529 -173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -60.58 -28.79 68.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.508 1.523 . . . . 0.0 110.316 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -60.49 -26.16 66.61 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.289 -0.882 . . . . 0.0 111.936 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.08 -27.03 65.25 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.711 -1.243 . . . . 0.0 110.79 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -80.02 -19.95 46.51 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.907 0.483 . . . . 0.0 110.268 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -76.46 -45.51 30.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -61.06 -46.05 92.27 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.689 1.996 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -120.03 123.82 44.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.03 -38.94 3.03 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.0 m170 . . . . . 0 CA--C 1.502 -0.892 0 C-N-CA 123.922 0.889 . . . . 0.0 109.743 -173.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 102.456 -3.165 . . . . 0.0 102.456 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.75 156.46 16.32 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.81 -37.14 83.96 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.015 -1.053 . . . . 0.0 109.771 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -65.58 -26.12 67.71 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.435 -0.79 . . . . 0.0 112.151 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -77.75 -37.1 49.9 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -171.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.47 -42.41 99.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 110.569 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -70.45 -33.98 71.91 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.667 -0.645 . . . . 0.0 111.001 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.86 96.79 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -76.38 -20.42 57.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.124 -0.985 . . . . 0.0 112.141 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -70.61 -37.43 73.84 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.214 -0.929 . . . . 0.0 108.767 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.24 81.31 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.554 -0.717 . . . . 0.0 111.054 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -63.24 -36.98 85.46 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -64.52 -41.9 96.11 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 122.282 1.039 . . . . 0.0 108.655 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.15 -32.33 73.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.325 1.45 . . . . 0.0 109.711 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.48 -45.47 87.21 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.671 0.789 . . . . 0.0 110.682 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.81 -23.44 62.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.97 -1.081 . . . . 0.0 111.742 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -65.69 -46.63 78.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.75 . . . . 0.0 110.075 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.15 -25.98 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 121.068 -1.02 . . . . 0.0 110.758 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' C' ' 52' ' ' ALA . 81.8 mt -64.66 -41.38 96.14 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.385 -0.822 . . . . 0.0 111.119 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.4 -33.39 67.12 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.955 0.902 . . . . 0.0 111.531 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -67.62 -45.8 74.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.032 0.933 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.98 62.52 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.072 1.349 . . . . 0.0 110.97 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p -67.16 -39.41 86.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 119.433 1.015 . . . . 0.0 110.275 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -44.22 93.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.604 1.162 . . . . 0.0 108.427 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -67.6 -39.31 84.77 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.563 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.75 87.7 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.676 1.19 . . . . 0.0 111.878 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.93 -31.16 49.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 O-C-N 120.87 -1.144 . . . . 0.0 110.029 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.25 -19.21 43.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.763 0.825 . . . . 0.0 110.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.22 14.43 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.736 1.614 . . . . 0.0 107.024 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -80.29 -0.86 38.38 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.98 0.895 . . . . 0.0 110.869 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -74.42 81.88 1.92 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.816 1.647 . . . . 0.0 110.084 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.1 19.68 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 139.13 54.3 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 121.322 -1.105 . . . . 0.0 108.113 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.447 ' O ' HG11 ' C' ' 63' ' ' VAL . 50.8 Cg_endo -79.22 136.28 12.67 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.355 2.036 . . . . 0.0 110.437 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 4.16 89.34 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 119.529 1.059 . . . . 0.0 111.971 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 129.11 20.17 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 126.896 2.078 . . . . 0.0 114.107 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.34 -38.02 11.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.992 0.901 . . . . 0.0 108.682 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.3 tp -89.27 125.35 35.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 pt -144.45 -22.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -80.22 150.42 30.1 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.726 -0.609 . . . . 0.0 111.894 -171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.46 -64.52 0.3 Allowed Pre-proline 0 C--N 1.35 0.62 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.198 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.86 -26.89 21.89 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 125.691 3.068 . . . . 0.0 109.936 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 -14.89 61.2 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.538 0.735 . . . . 0.0 109.723 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.39 85.15 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.147 -0.971 . . . . 0.0 110.439 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -72.65 -22.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 121.736 -0.603 . . . . 0.0 110.488 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -72.52 -31.08 65.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -74.87 -37.21 62.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.485 -1.385 . . . . 0.0 108.647 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -76.13 64.38 1.96 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.916 1.287 . . . . 0.0 108.594 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -144.95 -67.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.76 -23.29 66.69 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.689 1.196 . . . . 0.0 112.561 -167.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m -68.06 -37.28 81.1 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.567 1.547 . . . . 0.0 110.629 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -77.24 -24.42 51.18 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.549 -0.719 . . . . 0.0 110.138 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 6.9 p -90.98 9.33 31.09 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.778 -0.576 . . . . 0.0 109.796 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 48.63 60.73 3.48 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 126.823 2.049 . . . . 0.0 113.684 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.1 -87.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.91 76.38 1.3 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -73.85 -20.48 60.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.415 -1.05 . . . . 0.0 111.411 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.16 32.66 3.68 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.64 -53.42 22.63 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -147.0 169.02 20.08 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -148.14 148.92 30.99 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.92 163.11 18.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.125 3.217 . . . . 0.0 109.195 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.447 HG11 ' O ' ' C' ' 34' ' ' PRO . 18.8 t -95.44 -102.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 120.437 1.471 . . . . 0.0 111.869 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -154.06 -30.73 0.12 Allowed 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.622 -1.299 . . . . 0.0 109.61 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -101.26 11.74 38.77 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 120.2 -1.562 . . . . 0.0 108.786 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -44.01 88.04 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.74 86.28 1.62 Allowed Glycine 0 N--CA 1.416 -2.67 1 N-CA-C 98.033 -6.027 . . . . 0.0 98.033 -167.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -56.22 -20.04 16.45 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 125.642 1.577 . . . . 0.0 112.278 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -46.02 -28.22 1.12 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 126.677 1.991 . . . . 0.0 113.05 164.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.27 -43.94 95.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.849 -1.157 . . . . 0.0 109.682 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.48 62.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.344 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -51.2 -47.17 62.32 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.099 2.16 . . . . 0.0 111.116 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.37 -41.34 98.8 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.251 1.02 . . . . 0.0 111.329 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -41.41 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 C-N-CA 123.644 0.778 . . . . 0.0 109.635 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 37.6 mtt -58.99 -52.49 65.54 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.903 0.881 . . . . 0.0 110.299 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.58 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.09 82.87 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.412 -0.805 . . . . 0.0 111.403 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.86 -43.51 93.73 Favored Glycine 0 CA--C 1.494 -1.257 0 C-N-CA 124.202 0.906 . . . . 0.0 111.342 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.87 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 O-C-N 121.735 -0.862 . . . . 0.0 109.159 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.18 -47.6 84.72 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.492 -0.755 . . . . 0.0 111.956 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.49 -40.71 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.799 -0.563 . . . . 0.0 111.471 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.97 -38.48 61.66 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.678 0.672 . . . . 0.0 109.745 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.23 82.83 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.54 -36.42 69.24 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.4 -18.38 11.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.915 1.286 . . . . 0.0 111.043 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.6 m -59.23 -23.95 62.75 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.68 -1.887 . . . . 0.0 111.984 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.46 68.06 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.357 -1.465 . . . . 0.0 111.197 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.24 -52.35 7.84 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.33 -34.65 78.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.217 1.007 . . . . 0.0 113.537 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.76 -14.68 62.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.837 -1.164 . . . . 0.0 110.985 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 81.0 p -85.06 -11.16 55.94 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.55 -1.344 . . . . 0.0 110.855 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -17.55 61.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 119.243 0.929 . . . . 0.0 111.065 -169.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -82.24 -34.66 28.74 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.387 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 26.4 t -65.51 -35.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.463 1.505 . . . . 0.0 109.103 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -42.5 -34.89 0.92 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 128.21 2.604 . . . . 0.0 112.976 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -63.71 -27.05 68.94 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.056 -1.028 . . . . 0.0 111.836 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.51 -39.03 77.82 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.03 -36.01 61.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.627 -0.671 . . . . 0.0 109.852 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -69.6 -15.74 63.26 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.407 -0.808 . . . . 0.0 112.11 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -67.0 -31.47 72.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.43 -0.793 . . . . 0.0 110.616 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -74.63 -39.79 61.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.073 -1.017 . . . . 0.0 108.644 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.89 10.23 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 177.775 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.438 -1.075 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.68 140.48 49.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.613 1.197 . . . . 0.0 111.352 -166.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -74.05 -52.52 12.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.639 2.375 . . . . 0.0 108.513 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -58.89 -29.53 67.1 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 126.1 1.76 . . . . 0.0 112.686 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.1 -39.75 82.77 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.681 -0.637 . . . . 0.0 109.69 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -68.5 -36.21 78.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.71 -40.55 84.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.28 95.79 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.622 0.769 . . . . 0.0 111.919 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.33 -40.24 74.28 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 123.301 0.641 . . . . 0.0 110.566 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -61.69 -41.21 97.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.489 0.716 . . . . 0.0 110.28 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.21 70.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.117 0.967 . . . . 0.0 111.877 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.27 -37.14 86.28 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.669 -0.645 . . . . 0.0 111.655 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.81 -31.42 64.82 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -67.52 -35.25 78.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.703 0.801 . . . . 0.0 109.764 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.25 -38.41 90.95 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 111.645 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.43 -36.65 76.3 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.883 0.873 . . . . 0.0 110.756 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.46 -44.84 77.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.184 0.994 . . . . 0.0 110.058 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.02 -47.34 90.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.23 -38.36 85.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.923 -0.485 . . . . 0.0 110.455 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.58 -32.19 65.81 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.489 1.04 . . . . 0.0 113.343 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -69.18 -39.73 78.54 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 119.698 -1.877 . . . . 0.0 108.397 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -32.95 74.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -50.46 -52.08 41.29 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 125.769 1.627 . . . . 0.0 111.648 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -65.98 -34.71 78.73 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -84.48 -15.14 47.03 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.243 0.617 . . . . 0.0 110.972 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -44.61 65.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.513 1.125 . . . . 0.0 109.834 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.25 -40.39 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 122.371 1.081 . . . . 0.0 109.423 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.39 -29.81 68.6 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.954 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.92 92.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 125.189 1.396 . . . . 0.0 110.372 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -77.92 -6.32 53.96 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -76.41 90.62 3.25 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 119.9 -1.75 . . . . 0.0 107.188 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.94 -28.83 1.41 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.75 150.31 47.93 Favored Pre-proline 0 N--CA 1.443 -0.79 0 O-C-N 121.397 -1.061 . . . . 0.0 111.133 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.54 97.06 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.792 2.328 . . . . 0.0 112.723 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.35 -41.69 1.31 Allowed Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.23 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.526 2.331 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 72.81 -66.49 0.31 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.7 1.6 . . . . 0.0 112.401 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 49.4 tp -83.37 64.25 7.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.06 112.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 45.4 t -177.57 -141.72 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.9 -63.83 0.01 OUTLIER Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -72.53 -13.94 27.57 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 CA-C-N 125.541 3.015 . . . . 0.0 112.344 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -86.88 -11.06 51.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.04 85.51 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.596 0.758 . . . . 0.0 110.009 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.65 -41.97 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 109.522 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -38.91 83.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.204 -0.935 . . . . 0.0 109.865 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.427 ' HB2' ' HE ' ' D' ' 60' ' ' ARG . 70.4 t90 -66.07 -37.66 86.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.519 0.728 . . . . 0.0 110.499 172.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -36.53 71.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.077 -1.014 . . . . 0.0 109.808 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -54.65 -56.96 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 126.17 1.788 . . . . 0.0 109.578 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -71.66 -17.31 62.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.18 0.992 . . . . 0.0 112.024 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -82.49 -37.01 25.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.691 -1.256 . . . . 0.0 109.237 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.93 73.36 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.422 -0.799 . . . . 0.0 110.739 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -95.44 11.91 31.2 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.683 0.793 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.508 HG22 ' HB2' ' D' ' 75' ' ' MET . 16.5 p 55.29 38.63 30.64 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.32 1.848 . . . . 0.0 112.035 169.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.02 -68.29 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.46 95.69 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.369 -0.378 . . . . 0.0 112.98 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 2.4 t80 -61.21 -32.73 72.5 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.542 1.163 . . . . 0.0 111.288 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.35 39.31 0.15 Allowed Glycine 0 CA--C 1.48 -2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 165.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -90.91 -59.11 2.26 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' D' ' 47' ' ' TRP . 15.8 mtm-85 -138.07 164.85 28.08 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 158.01 36.57 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 -175.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 168.99 19.84 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.253 2.635 . . . . 0.0 109.829 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.57 -93.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.214 0.461 . . . . 0.0 110.292 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -137.73 -81.57 0.35 Allowed 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 129.0 38.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 61.25 -61.87 0.08 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 126.808 2.043 . . . . 0.0 115.566 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . -34.54 -49.63 0.71 Allowed Glycine 0 CA--C 1.488 -1.64 0 C-N-CA 128.917 3.151 . . . . 0.0 114.524 -170.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.221 0.608 . . . . 0.0 112.094 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -71.15 -32.68 69.24 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.609 0.764 . . . . 0.0 109.231 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.41 -51.45 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.09 89.28 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.606 1.162 . . . . 0.0 113.121 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -53.6 -42.32 67.55 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.22 2.208 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -67.55 -39.08 84.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.647 -0.658 . . . . 0.0 110.445 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.64 -48.08 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 O-C-N 121.622 -0.674 . . . . 0.0 110.059 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.508 ' HB2' HG22 ' D' ' 54' ' ' THR . 21.1 ptp -65.82 -37.15 85.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.549 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -64.88 -41.34 95.71 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 121.467 -0.771 . . . . 0.0 110.678 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.154 0.582 . . . . 0.0 110.569 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.06 -46.21 93.89 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 123.633 0.635 . . . . 0.0 112.265 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.84 -43.64 92.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 124.026 0.931 . . . . 0.0 109.983 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -63.9 -41.5 97.68 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.01 -47.13 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 C-N-CA 124.204 1.002 . . . . 0.0 110.679 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -73.3 -10.79 60.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.407 -0.808 . . . . 0.0 111.186 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.81 14.11 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.82 0.848 . . . . 0.0 109.606 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.45 -33.05 74.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.419 1.887 . . . . 0.0 111.041 -174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.93 -7.64 2.11 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 112.724 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 40.3 m -62.01 -20.94 64.44 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.8 63.34 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.248 -1.532 . . . . 0.0 111.401 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.51 -53.72 4.82 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.236 1.014 . . . . 0.0 108.706 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.86 -36.96 70.64 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 124.486 1.114 . . . . 0.0 112.918 -173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 -22.54 61.49 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.008 -1.058 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 81.7 p -78.37 -17.56 56.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.325 -1.484 . . . . 0.0 109.813 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -69.98 -34.76 73.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.7 0.762 . . . . 0.0 109.453 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.96 -30.4 65.26 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.485 -1.385 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.76 -26.38 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 C-N-CA 124.284 1.033 . . . . 0.0 109.299 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -57.9 -14.92 7.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.83 1.252 . . . . 0.0 113.59 172.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -68.9 -38.56 79.68 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.394 1.092 . . . . 0.0 108.672 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -82.71 167.48 18.16 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 73.15 -51.03 0.71 Allowed 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.937 1.295 . . . . 0.0 111.169 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.68 -42.09 95.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 120.417 -1.427 . . . . 0.0 110.603 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -74.36 -16.96 60.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.374 -0.829 . . . . 0.0 112.129 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -128.85 82.89 2.11 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -170.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.49 -31.03 2.92 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.224 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.36 -70.94 0.67 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -170.97 -64.22 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.528 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 45.9 p-80 -61.88 -22.33 65.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.126 1.37 . . . . 0.0 113.449 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 18.4 mp0 -75.73 -22.04 56.94 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.546 -1.346 . . . . 0.0 110.224 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -66.77 -41.92 86.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -60.56 -47.51 85.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.43 96.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 111.545 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -61.23 -45.54 94.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 124.587 1.155 . . . . 0.0 109.493 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -61.57 -36.17 79.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.752 1.221 . . . . 0.0 110.179 -175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.41 72.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -66.95 -30.4 70.53 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.822 -1.174 . . . . 0.0 111.515 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.2 -26.04 55.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.312 -0.868 . . . . 0.0 109.872 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.41 -37.98 74.54 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.81 0.844 . . . . 0.0 109.371 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.36 -40.25 95.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.307 0.575 . . . . 0.0 110.917 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -63.53 -26.36 68.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.3 0.64 . . . . 0.0 112.058 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.83 -41.7 87.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.178 0.991 . . . . 0.0 109.333 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -39.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.524 1.129 . . . . 0.0 108.974 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.88 -42.29 84.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.299 1.04 . . . . 0.0 111.995 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.55 -23.45 58.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.107 0.963 . . . . 0.0 111.309 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.76 -32.27 19.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.789 -1.194 . . . . 0.0 108.348 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.21 73.68 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.525 1.53 . . . . 0.0 111.155 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.8 p -68.11 -39.68 82.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 118.716 0.689 . . . . 0.0 110.115 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -64.1 -49.1 73.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -63.94 -38.44 91.1 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.58 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 119.987 1.267 . . . . 0.0 111.431 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.14 -42.43 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.09 -19.58 59.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.152 -1.592 . . . . 0.0 112.002 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.5 -49.2 27.85 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.555 1.142 . . . . 0.0 108.443 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -58.52 -47.05 85.44 Favored 'General case' 0 CA--C 1.476 -1.9 0 C-N-CA 124.344 1.058 . . . . 0.0 110.646 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -63.45 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.17 0.988 . . . . 0.0 111.995 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.28 2.58 5.92 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.29 128.56 38.08 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 118.731 1.265 . . . . 0.0 108.771 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.44 146.01 17.04 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.402 2.068 . . . . 0.0 109.499 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.6 -18.88 47.71 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 118.972 0.805 . . . . 0.0 112.311 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.05 164.4 26.67 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.261 1.425 . . . . 0.0 112.888 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.04 2.44 3.63 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.18 0.592 . . . . 0.0 111.999 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 52.93 1.89 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 120.31 -1.494 . . . . 0.0 111.408 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -84.4 164.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.02 -1.675 . . . . 0.0 109.766 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.9 t 81.29 129.59 0.05 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.939 1.696 . . . . 0.0 110.686 166.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -67.39 -47.65 47.83 Favored Pre-proline 0 C--N 1.358 0.936 0 CA-C-O 116.213 -1.851 . . . . 0.0 112.152 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.26 -11.59 30.45 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 125.482 2.993 . . . . 0.0 111.892 -175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.63 -48.09 9.21 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.342 1.457 . . . . 0.0 107.248 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.29 74.05 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 125.103 1.361 . . . . 0.0 112.533 -174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.63 -30.39 48.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 O-C-N 121.685 -0.635 . . . . 0.0 111.145 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -33.34 55.68 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.777 -1.202 . . . . 0.0 108.967 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.0 -34.38 78.29 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.328 0.651 . . . . 0.0 110.297 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -56.3 -38.45 71.27 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 120.788 -1.195 . . . . 0.0 111.769 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.67 60.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -158.29 -36.37 0.07 Allowed 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 51' ' ' THR . 1.8 t -67.57 -33.78 75.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.825 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.27 -21.94 65.68 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.613 -1.305 . . . . 0.0 112.791 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.23 4.22 52.84 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.281 0.632 . . . . 0.0 109.97 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 p 48.46 47.31 20.29 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 127.139 2.176 . . . . 0.0 112.184 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -100.37 -69.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 85.63 72.87 1.29 Allowed Glycine 0 CA--C 1.492 -1.396 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -19.08 52.83 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.76 5.25 Favored Glycine 0 CA--C 1.486 -1.755 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -71.49 -46.09 60.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -132.01 165.2 24.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -140.09 130.8 14.08 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 100.804 -3.776 . . . . 0.0 100.804 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -86.11 176.22 5.26 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.721 2.947 . . . . 0.0 109.168 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.13 -142.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-O 123.103 1.43 . . . . 0.0 107.744 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 p -92.14 -43.63 9.25 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 119.657 -1.902 . . . . 0.0 111.094 -165.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.85 -29.56 70.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 127.799 2.44 . . . . 0.0 110.218 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.73 -24.65 67.63 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.71 2.004 . . . . 0.0 109.975 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.85 88.81 0.57 Allowed Glycine 0 CA--C 1.476 -2.366 1 N-CA-C 101.052 -4.819 . . . . 0.0 101.052 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.47 -17.81 2.26 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-O 123.291 1.519 . . . . 0.0 113.096 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -63.26 -14.68 52.18 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 125.071 1.348 . . . . 0.0 112.378 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.73 -45.01 99.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 CA-C-N 119.77 1.168 . . . . 0.0 108.592 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.72 67.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.837 -0.539 . . . . 0.0 110.046 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -48.84 -46.26 41.92 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.631 1.572 . . . . 0.0 110.908 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.73 -38.81 92.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.396 1.078 . . . . 0.0 111.725 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.97 -42.0 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 121.352 -0.842 . . . . 0.0 108.928 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.3 mtm -61.81 -46.07 91.11 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.103 0.561 . . . . 0.0 111.093 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -63.72 -38.66 91.93 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.812 -0.555 . . . . 0.0 110.953 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.19 90.91 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.937 0.495 . . . . 0.0 110.911 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.05 92.46 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 124.225 0.917 . . . . 0.0 111.104 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.91 -46.81 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.448 1.099 . . . . 0.0 109.14 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.33 -37.84 84.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 121.069 -1.02 . . . . 0.0 111.993 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.49 -56.65 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 109.598 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -62.1 -41.51 98.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.362 0.665 . . . . 0.0 110.835 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.7 -34.63 78.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.75 0.82 . . . . 0.0 111.113 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -66.64 -30.85 71.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.472 -1.392 . . . . 0.0 111.063 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.73 -12.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 110.829 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -58.35 -22.8 54.82 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.597 -1.939 . . . . 0.0 112.652 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.23 -24.99 61.12 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.893 -1.129 . . . . 0.0 111.685 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 4' ' ' HIS . . . -95.83 -40.58 9.26 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.871 1.268 . . . . 0.0 110.969 176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.7 -39.8 91.6 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.818 0.818 . . . . 0.0 111.126 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -28.05 62.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.008 -1.057 . . . . 0.0 110.984 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -71.89 -10.52 59.89 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.223 -1.548 . . . . 0.0 111.563 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.77 -38.51 86.72 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 122.235 1.016 . . . . 0.0 109.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -81.4 -11.83 59.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 119.355 -2.09 . . . . 0.0 112.967 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.36 -27.48 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.4 -27.36 47.22 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.56 1.544 . . . . 0.0 113.053 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -64.76 -21.32 66.74 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-O 122.038 0.923 . . . . 0.0 111.825 -172.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -82.2 -34.47 28.95 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 125.77 1.628 . . . . 0.0 108.223 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -91.26 -162.67 0.94 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 61.59 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.356 0.852 0 C-N-CA 127.209 2.203 . . . . 0.0 111.632 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -62.7 -39.06 92.81 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.977 2.511 . . . . 0.0 110.271 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -90.87 -1.46 57.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.858 -0.526 . . . . 0.0 109.902 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.11 70.08 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 124.97 1.271 . . . . 0.0 113.911 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.0 m80 . . . . . 0 CA--C 1.493 -1.236 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 -170.15 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 -112.63 0.03 OUTLIER 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -115.65 -69.98 0.82 Allowed 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.807 1.243 . . . . 0.0 108.102 -173.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.521 ' HD2' ' HA ' ' B' ' 88' ' ' ALA . 13.0 p-80 -61.69 -26.65 68.16 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 128.741 2.816 . . . . 0.0 112.039 -174.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.517 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 8.9 mt-10 -75.04 -28.57 60.49 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.674 1.19 . . . . 0.0 110.348 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.88 -35.87 64.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.092 -1.005 . . . . 0.0 109.898 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.99 -31.18 69.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 122.011 0.91 . . . . 0.0 109.418 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.02 86.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.815 0.846 . . . . 0.0 110.67 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -71.96 -36.44 69.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.893 -0.505 . . . . 0.0 110.092 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -58.15 -35.99 72.35 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.415 1.486 . . . . 0.0 110.991 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.89 89.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.488 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.36 -36.62 83.36 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 120.928 -1.108 . . . . 0.0 110.658 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -66.5 -36.68 83.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.666 -0.646 . . . . 0.0 110.222 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -63.44 -42.92 98.69 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.785 1.234 . . . . 0.0 109.528 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.62 -37.21 72.91 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-O 121.804 0.811 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.8 -21.35 62.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.164 -0.96 . . . . 0.0 112.029 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -78.19 -30.28 48.91 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.15 -0.969 . . . . 0.0 108.883 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.32 -32.4 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 120.455 -1.403 . . . . 0.0 109.214 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.94 -36.55 77.29 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.217 -0.927 . . . . 0.0 111.949 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.27 -46.53 83.27 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.663 1.185 . . . . 0.0 109.782 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -70.61 -41.03 72.8 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 108.225 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 126.812 2.045 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 -49.96 75.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.145 1.378 . . . . 0.0 109.924 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -67.21 -46.42 73.93 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -61.69 -44.98 95.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.55 -53.15 52.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.72 -37.0 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -92.79 -1.05 57.12 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.887 -1.133 . . . . 0.0 110.895 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.72 -46.96 8.59 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.25 -24.47 59.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.954 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -74.48 108.83 7.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.198 -1.563 . . . . 0.0 111.242 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.96 -21.83 5.21 Favored Glycine 0 CA--C 1.495 -1.181 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.03 152.87 53.95 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.022 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.53 146.54 19.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.628 2.219 . . . . 0.0 110.492 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 34.87 89.47 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 124.092 0.853 . . . . 0.0 111.303 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 134.16 45.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.066 0.947 . . . . 0.0 109.474 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.34 -39.53 1.87 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.358 . . . . 0.0 109.87 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 tp -68.46 -33.29 73.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.956 . . . . 0.0 110.574 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 tt -41.47 76.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 1 C-N-CA 131.979 4.112 . . . . 0.0 116.94 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.84 136.11 7.81 Favored 'General case' 0 CA--C 1.494 -1.185 0 O-C-N 119.24 -2.162 . . . . 0.0 105.409 166.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -64.68 -54.21 38.08 Favored Pre-proline 0 C--N 1.349 0.559 0 CA-C-O 116.849 -1.548 . . . . 0.0 111.728 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.7 -16.87 23.56 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.007 2.824 . . . . 0.0 110.695 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -94.39 -22.9 18.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.62 76.43 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.092 1.357 . . . . 0.0 108.73 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.41 -27.55 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.197 0.522 . . . . 0.0 110.992 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.07 55.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -76.18 -33.58 59.31 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 123.37 0.668 . . . . 0.0 109.573 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -54.42 -29.77 50.32 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.955 -1.091 . . . . 0.0 112.042 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.01 -40.45 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 124.926 1.291 . . . . 0.0 110.356 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.95 -20.78 66.32 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.841 1.657 . . . . 0.0 112.139 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.07 -38.7 6.84 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -164.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -29.05 65.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.774 -1.204 . . . . 0.0 111.766 -170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -86.91 1.01 54.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.704 -0.623 . . . . 0.0 110.329 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.8 p 55.03 50.72 14.8 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 125.968 1.707 . . . . 0.0 110.984 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -103.44 -59.34 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.64 48.04 64.71 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 120.857 -1.152 . . . . 0.0 112.331 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -29.26 69.86 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.443 1.116 . . . . 0.0 112.393 -168.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.97 29.11 2.26 Favored Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.5 -63.94 0.96 Allowed 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.044 -0.68 . . . . 0.0 110.182 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -138.86 163.33 32.55 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -134.92 148.67 67.91 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.05 165.65 21.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 123.55 2.834 . . . . 0.0 110.421 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.91 -154.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -95.15 -54.52 3.4 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.546 1.138 . . . . 0.0 108.746 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.4 -4.7 46.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.576 1.551 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.17 -28.77 68.39 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.852 1.31 . . . . 0.0 107.817 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.38 87.5 1.02 Allowed Glycine 0 CA--C 1.479 -2.159 1 N-CA-C 101.074 -4.811 . . . . 0.0 101.074 -170.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -59.96 -12.0 6.93 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.235 1.518 . . . . 0.0 111.5 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -54.95 -17.93 4.35 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.469 1.908 . . . . 0.0 113.029 164.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -52.85 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 O-C-N 120.493 -1.38 . . . . 0.0 107.315 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.51 92.07 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.471 0.708 . . . . 0.0 110.633 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -49.76 -46.55 50.73 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.955 1.702 . . . . 0.0 111.235 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -62.95 -40.19 96.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.289 1.036 . . . . 0.0 111.301 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.62 -41.44 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.0 mtm -62.64 -45.67 91.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.383 0.673 . . . . 0.0 110.029 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.38 -36.35 83.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 121.502 -0.749 . . . . 0.0 111.364 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.89 89.08 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.48 0.712 . . . . 0.0 110.669 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.16 -45.15 92.6 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.59 -42.78 89.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 C-N-CA 124.109 0.964 . . . . 0.0 109.706 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -60.42 -42.78 96.74 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.078 -1.014 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 t -64.81 -52.35 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.389 1.076 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.63 -13.63 61.04 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 121.597 -0.689 . . . . 0.0 111.528 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.34 -36.87 14.4 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.327 -0.858 . . . . 0.0 109.88 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.1 -33.19 74.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.038 1.335 . . . . 0.0 110.41 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.06 -10.32 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 121.491 -0.756 . . . . 0.0 112.3 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -58.66 -18.89 34.5 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.871 1.669 . . . . 0.0 110.618 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.62 -65.07 0.63 Allowed 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.709 -1.245 . . . . 0.0 109.673 165.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' B' ' 4' ' ' HIS . . . -68.67 -42.03 78.45 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 120.775 -1.203 . . . . 0.0 111.3 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.5 -33.93 76.1 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.357 0.663 . . . . 0.0 111.195 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.03 -23.86 33.05 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.436 -1.415 . . . . 0.0 110.784 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.5 m -69.04 -21.81 64.08 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.293 -1.505 . . . . 0.0 108.392 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.28 -39.96 84.59 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.184 -0.947 . . . . 0.0 110.843 -164.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.48 ' CE1' HG21 ' C' ' 94' ' ' VAL . 10.0 p90 -65.73 -23.99 66.87 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.441 -0.787 . . . . 0.0 112.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -79.04 -20.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -68.01 -16.23 63.95 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.496 -1.377 . . . . 0.0 110.377 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -67.38 -2.0 5.57 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.824 -0.548 . . . . 0.0 112.422 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -55.36 -50.15 70.44 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 120.917 -1.114 . . . . 0.0 110.085 163.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.8 -34.89 51.92 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -172.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.13 -33.44 75.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.42 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -65.09 -42.0 94.46 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.207 -0.933 . . . . 0.0 110.998 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -83.92 -26.61 29.18 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 121.692 -0.63 . . . . 0.0 109.982 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.75 15.12 66.24 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 175.253 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.42 58.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 46.01 50.86 11.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 128.912 2.885 . . . . 0.0 110.178 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.445 ' CD2' HG21 ' C' ' 91' ' ' THR . 34.2 p80 -174.07 -50.24 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -69.07 -39.32 79.16 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.976 1.31 . . . . 0.0 110.518 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -54.7 -51.85 64.26 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.762 2.025 . . . . 0.0 110.733 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -75.05 -30.28 60.97 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.34 93.7 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.929 -1.107 . . . . 0.0 111.256 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -71.04 -36.67 72.43 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.609 -0.682 . . . . 0.0 110.886 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.1 -38.03 89.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.86 0.864 . . . . 0.0 110.548 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.3 86.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.499 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.41 -40.32 86.31 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 123.251 0.62 . . . . 0.0 110.813 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -70.34 -22.83 62.76 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.537 -0.727 . . . . 0.0 111.937 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.26 -32.2 58.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.113 -0.992 . . . . 0.0 108.683 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.48 -40.22 95.27 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.622 -0.674 . . . . 0.0 110.443 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -58.44 -38.31 77.23 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 112.048 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -66.66 -42.26 86.91 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.96 -40.34 85.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 124.39 1.076 . . . . 0.0 109.515 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.24 -42.65 77.69 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 124.124 0.969 . . . . 0.0 112.571 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.22 -42.84 75.17 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.413 -0.804 . . . . 0.0 110.058 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.45 -36.02 73.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.52 0.728 . . . . 0.0 109.607 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.39 83.67 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 126.191 1.796 . . . . 0.0 111.35 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 24.1 m -64.8 -39.24 93.26 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.495 0.718 . . . . 0.0 110.761 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -71.28 -44.4 65.29 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -68.35 -45.66 72.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.543 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.32 94.41 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 120.041 1.292 . . . . 0.0 111.532 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.51 -41.09 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 121.564 -0.71 . . . . 0.0 109.934 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.47 -22.78 43.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.342 -0.849 . . . . 0.0 110.146 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.3 71.78 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 125.026 1.33 . . . . 0.0 109.147 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.22 -23.81 62.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.256 0.622 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -71.07 87.61 0.77 Allowed 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.61 1.85 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.35 141.72 57.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 117.511 0.655 . . . . 0.0 111.483 -168.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 134.45 7.51 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 122.149 1.899 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.79 19.84 60.79 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.69 140.19 56.77 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 109.971 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.6 -42.82 3.39 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.417 HD21 ' CG ' ' C' ' 47' ' ' TRP . 2.0 mt -83.72 17.37 2.31 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.4 1.88 . . . . 0.0 110.523 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 tt -75.48 76.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.054 1.407 . . . . 0.0 110.183 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.8 m -143.3 -123.38 0.09 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . 0.28 1.5 t80 173.56 -58.12 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.91 0 C-N-CA 128.755 2.822 . . . . 0.0 106.557 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.04 -18.21 31.22 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 CA-C-N 126.451 3.34 . . . . 0.0 112.838 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.426 ' CG ' HH12 ' C' ' 60' ' ' ARG . 31.3 p30 -106.1 14.97 27.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 119.398 0.999 . . . . 0.0 109.007 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.06 -35.87 66.78 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.937 -1.102 . . . . 0.0 108.761 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.404 ' O ' HG23 ' C' ' 49' ' ' VAL . 20.1 tt -67.28 -29.32 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 123.57 0.748 . . . . 0.0 110.162 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -64.32 -45.83 86.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.895 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CG ' HD21 ' C' ' 38' ' ' LEU . 76.0 t90 -69.41 -37.1 77.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.971 0.908 . . . . 0.0 108.919 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -56.26 -44.02 79.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.27 1.028 . . . . 0.0 111.538 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 45' ' ' ILE . 3.3 t -68.94 -38.98 79.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 O-C-N 120.739 -1.226 . . . . 0.0 111.73 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.17 -30.01 68.14 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 120.138 1.335 . . . . 0.0 110.861 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -61.23 -43.72 98.42 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.645 1.178 . . . . 0.0 109.866 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.42 65.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.945 -1.097 . . . . 0.0 112.26 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -87.26 4.19 43.66 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.419 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 16.2 p 57.63 29.32 17.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.426 1.49 . . . . 0.0 112.655 169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.411 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -94.5 -85.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.411 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 82.1 86.12 0.74 Allowed Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -73.44 -22.25 60.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.001 -1.294 . . . . 0.0 109.343 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 35.57 2.86 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.73 -47.74 51.78 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' C' ' 43' ' ' ASP . 69.6 mtt180 -140.98 173.44 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.39 148.85 21.61 Favored Pre-proline 0 N--CA 1.435 -1.217 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.54 171.26 12.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.888 3.059 . . . . 0.0 109.14 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.6 -109.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 119.392 0.996 . . . . 0.0 112.271 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 45.0 m -150.22 -40.53 0.13 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -82.78 -6.35 59.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.447 0.699 . . . . 0.0 110.007 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -31.84 66.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.23 56.47 0.93 Allowed Glycine 0 CA--C 1.472 -2.595 0 N-CA-C 104.564 -3.414 . . . . 0.0 104.564 167.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -22.22 -21.28 0.0 OUTLIER 'General case' 0 C--N 1.366 1.325 1 C-N-CA 134.048 4.939 . . . . 0.0 118.947 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -19.16 5.74 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 119.625 -1.922 . . . . 0.0 112.751 159.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.84 -45.67 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 119.549 1.068 . . . . 0.0 109.577 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -47.71 58.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.504 -0.747 . . . . 0.0 109.205 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.61 -47.95 58.07 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 124.757 1.223 . . . . 0.0 110.771 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -67.35 -33.87 76.15 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 121.94 -0.475 . . . . 0.0 111.716 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.02 -44.22 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 121.33 -0.856 . . . . 0.0 109.01 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 67.0 mtm -63.5 -46.8 84.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.25 1.02 . . . . 0.0 110.027 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -64.5 -40.7 96.14 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.51 0.724 . . . . 0.0 110.814 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.27 84.03 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.456 0.702 . . . . 0.0 111.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.2 -48.15 77.74 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -58.43 -46.41 89.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 124.532 1.133 . . . . 0.0 109.842 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -59.55 -45.14 92.66 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.909 0.884 . . . . 0.0 111.19 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.91 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.568 1.147 . . . . 0.0 109.966 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -66.39 -37.46 85.3 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.636 -0.665 . . . . 0.0 110.815 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.16 73.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.754 0.822 . . . . 0.0 110.596 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.46 -34.03 73.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.892 1.277 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.88 -12.05 3.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 125.433 1.493 . . . . 0.0 111.43 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -59.38 -25.66 64.45 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 112.449 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 -23.92 66.96 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-O 122.601 1.191 . . . . 0.0 111.618 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.73 -30.39 20.36 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.531 -1.355 . . . . 0.0 109.791 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.82 -49.86 13.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.888 0.851 . . . . 0.0 110.698 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.42 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.954 -1.091 . . . . 0.0 112.34 -170.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.445 HG21 ' CD2' ' C' ' 4' ' ' HIS . 13.0 t -72.86 -12.57 61.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 120.325 -1.485 . . . . 0.0 110.239 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -88.34 3.16 50.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.531 1.059 . . . . 0.0 110.531 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -34.65 18.69 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 160.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' B' ' 93' ' ' PHE . 38.7 t -72.01 -29.74 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 O-C-N 121.059 -1.025 . . . . 0.0 110.434 -171.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -61.24 -14.21 24.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -64.92 -32.27 73.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.101 -0.999 . . . . 0.0 110.689 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -73.23 -34.88 66.13 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 119.269 0.941 . . . . 0.0 108.782 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.02 -46.89 82.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 109.606 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -70.84 -38.66 73.22 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.855 -0.528 . . . . 0.0 110.749 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -57.31 -41.88 80.72 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.721 1.208 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -73.51 -29.02 62.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.759 -0.588 . . . . 0.0 111.014 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.23 50.07 Favored Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 . . . . . 0 CA--C 1.493 -1.25 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.029 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 170.63 18.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.84 -59.55 2.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 131.118 3.767 . . . . 0.0 108.466 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.517 ' CD2' HG21 ' D' ' 91' ' ' THR . 24.5 p80 -60.1 -33.14 71.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.79 2.836 . . . . 0.0 112.011 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.05 -36.19 81.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.09 0.956 . . . . 0.0 109.862 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtp-105 -71.07 -38.35 72.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.423 -0.798 . . . . 0.0 110.511 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.22 -26.25 61.07 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.81 79.52 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.757 -1.214 . . . . 0.0 110.801 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -68.34 -29.38 68.1 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.216 -0.928 . . . . 0.0 111.708 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -64.1 -42.62 96.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 109.691 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.77 88.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.721 0.808 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.31 -38.38 83.5 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.787 -0.57 . . . . 0.0 111.717 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.97 -36.72 78.2 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.43 -26.77 67.38 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.316 -0.865 . . . . 0.0 110.799 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.21 -36.47 77.3 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 120.944 -1.097 . . . . 0.0 111.06 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -64.16 -31.91 73.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.196 0.999 . . . . 0.0 110.865 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.04 1.336 . . . . 0.0 110.109 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.6 -33.45 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.98 -40.65 89.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.685 0.794 . . . . 0.0 110.91 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.3 -43.2 78.19 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.176 0.591 . . . . 0.0 111.192 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.18 -38.99 86.33 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.95 75.55 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 124.607 1.163 . . . . 0.0 111.438 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -60.05 -46.74 88.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.163 0.892 . . . . 0.0 111.364 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -68.86 -51.72 37.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.927 1.691 . . . . 0.0 108.207 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -68.88 -43.83 74.51 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.942 0.897 . . . . 0.0 110.309 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.24 75.14 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 119.555 1.07 . . . . 0.0 110.72 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.55 -36.14 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.746 0.784 . . . . 0.0 109.314 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.49 -22.8 54.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 121.429 -0.794 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.64 -36.65 83.5 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 126.271 1.828 . . . . 0.0 110.486 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' D' ' 36' ' ' ALA . 0.6 OUTLIER -75.72 -16.03 60.21 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.412 -174.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -85.63 85.12 7.43 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.281 -1.512 . . . . 0.0 107.636 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.92 -33.66 0.56 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 105.117 -3.193 . . . . 0.0 105.117 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.37 149.16 57.47 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 124.225 1.01 . . . . 0.0 111.565 -171.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.82 97.89 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.888 2.392 . . . . 0.0 113.528 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.32 47.74 0.45 Allowed Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' D' ' 30' ' ' GLU . . . -54.8 106.61 0.23 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.572 1.149 . . . . 0.0 113.494 -169.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.98 -59.34 1.93 Allowed 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 109.64 -169.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' D' ' 47' ' ' TRP . 3.4 tt -84.55 63.07 7.67 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.7 tt -96.23 -6.08 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 120.116 -1.615 . . . . 0.0 109.082 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -88.57 120.98 30.47 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.672 0.789 . . . . 0.0 111.687 -171.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -74.4 -59.14 1.68 Allowed Pre-proline 0 C--N 1.353 0.73 0 CA-C-O 116.05 -1.929 . . . . 0.0 112.506 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.45 -14.13 30.69 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 CA-C-N 125.941 3.157 . . . . 0.0 110.906 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.31 -11.7 42.68 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 124.196 0.998 . . . . 0.0 109.471 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.2 67.32 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 120.872 -1.143 . . . . 0.0 110.384 -170.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -16.24 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.061 1.41 . . . . 0.0 109.225 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -76.64 -51.85 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 119.794 -1.816 . . . . 0.0 106.566 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.449 ' CD2' HD11 ' D' ' 38' ' ' LEU . 74.4 t90 -55.44 -46.12 76.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.117 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -64.82 -16.91 63.73 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.17 -50.97 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.07 65.64 9.19 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -159.55 -52.64 0.06 Allowed 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -18.45 64.94 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.43 -0.794 . . . . 0.0 112.042 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -87.06 -3.6 59.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.116 1.766 . . . . 0.0 111.057 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 56.15 38.4 29.82 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 125.544 1.538 . . . . 0.0 111.149 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.61 -37.58 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 121.771 -0.581 . . . . 0.0 110.905 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.34 -81.61 0.29 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.08 142.03 52.7 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.75 34.55 0.68 Allowed Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.21 -59.86 0.5 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.288 2.235 . . . . 0.0 109.011 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -97.28 156.24 16.52 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -142.55 148.26 46.14 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -80.36 167.77 19.02 Favored 'Trans proline' 0 CA--C 1.503 -1.057 0 C-N-CA 122.59 2.193 . . . . 0.0 110.266 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' D' ' 64' ' ' THR . 4.1 t -97.56 -150.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 174.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' D' ' 63' ' ' VAL . 4.6 p -91.23 -60.09 1.99 Allowed 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.755 -1.84 . . . . 0.0 112.541 -162.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -75.07 129.73 38.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 58.08 -104.78 0.23 Allowed 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.54 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 42.35 -82.19 0.0 OUTLIER Glycine 0 C--N 1.357 1.705 0 C-N-CA 130.006 3.669 . . . . 0.0 112.579 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -72.13 -32.53 67.02 Favored 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 126.074 1.75 . . . . 0.0 112.025 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.5 -24.11 65.54 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.155 1.343 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -78.8 -50.58 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.9 -39.7 71.98 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 111.919 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.88 -48.89 21.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 128.497 2.719 . . . . 0.0 112.055 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.69 -38.35 76.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.428 0.691 . . . . 0.0 110.132 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.12 -45.03 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 C-N-CA 124.181 0.993 . . . . 0.0 109.39 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -61.7 -45.64 93.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.298 1.039 . . . . 0.0 110.867 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.21 -41.59 93.36 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 110.857 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -36.72 84.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.388 0.675 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.64 64.12 Favored Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 123.979 0.799 . . . . 0.0 111.297 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.62 -46.36 90.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 124.203 1.001 . . . . 0.0 109.768 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -61.87 -30.52 70.92 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.421 1.088 . . . . 0.0 113.046 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 t -74.31 -50.43 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.56 -44.15 97.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.453 0.701 . . . . 0.0 109.999 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.33 -23.32 63.77 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.929 0.891 . . . . 0.0 111.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.89 -30.63 68.12 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.147 -1.595 . . . . 0.0 109.355 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -61.83 -13.42 9.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.411 1.084 . . . . 0.0 110.385 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.5 m -58.89 -20.68 53.64 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 119.537 -1.977 . . . . 0.0 112.596 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.37 68.5 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.983 -1.698 . . . . 0.0 111.445 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.15 -35.97 19.82 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.14 0.976 . . . . 0.0 109.643 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 mt -73.16 -44.75 59.5 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.426 0.631 . . . . 0.0 112.197 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.19 70.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.835 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.517 HG21 ' CD2' ' D' ' 4' ' ' HIS . 9.0 t -73.31 -6.48 46.38 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.067 -1.021 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.82 -14.62 58.55 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.692 1.133 . . . . 0.0 110.739 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -33.1 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 119.842 1.201 . . . . 0.0 108.726 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.97 -29.12 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.294 1.038 . . . . 0.0 109.594 -174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -68.39 -12.08 60.6 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.335 -0.853 . . . . 0.0 111.793 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -61.62 -37.12 82.79 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.265 1.031 . . . . 0.0 110.146 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.03 -27.29 48.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 119.862 -1.774 . . . . 0.0 109.572 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -83.31 -29.4 28.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.617 -0.677 . . . . 0.0 109.624 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.56 -44.36 76.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.888 2.075 . . . . 0.0 109.494 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -58.79 -25.7 63.36 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 124.909 1.284 . . . . 0.0 112.658 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -72.05 -49.03 39.98 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.81 -8.78 54.78 Favored Glycine 0 CA--C 1.493 -1.294 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 m80 . . . . . 0 CA--C 1.505 -0.753 0 C-N-CA 125.849 1.659 . . . . 0.0 108.331 -173.025 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 121.701 0.763 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.37 -93.21 0.1 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.11 -71.97 0.4 Allowed 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.1 -23.96 67.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -75.82 -26.42 57.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 109.624 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -64.89 -44.99 87.85 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.32 1.048 . . . . 0.0 108.445 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.21 -40.54 90.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.033 1.333 . . . . 0.0 109.781 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.54 91.72 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 110.844 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.51 -28.14 64.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.62 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -68.49 -34.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.9 90.35 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.343 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.82 -31.9 73.0 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.394 -0.816 . . . . 0.0 111.975 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.93 -41.45 97.63 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.96 0.904 . . . . 0.0 109.392 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -65.74 -34.33 77.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.499 1.119 . . . . 0.0 109.63 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.28 -44.91 94.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.738 0.815 . . . . 0.0 111.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -62.77 -38.21 89.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.238 0.542 . . . . 0.0 111.082 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.18 -37.66 88.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.926 0.89 . . . . 0.0 110.363 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.98 -41.62 84.75 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 C-N-CA 124.127 0.971 . . . . 0.0 108.885 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.2 -45.01 79.98 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.941 0.896 . . . . 0.0 111.802 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -75.2 -24.74 57.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.945 0.898 . . . . 0.0 111.285 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -81.0 -37.93 28.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.63 76.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.459 1.504 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -66.76 -39.7 87.98 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 119.394 0.997 . . . . 0.0 109.79 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.14 -48.45 70.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.733 -0.604 . . . . 0.0 110.174 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -60.81 -48.44 81.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 121.399 -0.813 . . . . 0.0 110.381 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.81 80.15 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.272 1.429 . . . . 0.0 111.903 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.3 -43.45 98.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 O-C-N 121.281 -0.887 . . . . 0.0 110.356 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.36 -29.3 57.14 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.352 -0.843 . . . . 0.0 110.46 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.0 71.76 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.479 1.512 . . . . 0.0 108.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.578 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.3 tp10 -69.9 -28.63 65.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.064 1.345 . . . . 0.0 110.819 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -67.03 107.3 2.22 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.341 -1.474 . . . . 0.0 110.746 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.62 -13.24 32.74 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.15 150.9 72.15 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 118.264 1.032 . . . . 0.0 109.483 -171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 36' ' ' ALA . 57.5 Cg_endo -78.03 148.67 24.93 Favored 'Trans proline' 0 CA--C 1.505 -0.938 0 C-N-CA 122.827 2.351 . . . . 0.0 108.871 175.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.63 -25.92 5.52 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 119.855 1.207 . . . . 0.0 111.645 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.31 135.6 0.73 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 131.282 3.833 . . . . 0.0 115.565 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.48 -29.23 1.22 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.113 0.965 . . . . 0.0 110.532 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.01 51.87 1.85 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.094 1.757 . . . . 0.0 110.984 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 tt -108.67 73.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 119.131 -2.23 . . . . 0.0 109.924 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 t -174.7 137.31 0.46 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -66.8 -53.14 29.07 Favored Pre-proline 0 C--N 1.351 0.647 0 CA-C-O 115.611 -2.138 . . . . 0.0 112.652 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -69.78 -20.57 34.59 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 125.568 3.024 . . . . 0.0 113.126 -170.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.278 0.6 OUTLIER -103.04 -12.27 17.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 119.541 1.064 . . . . 0.0 110.34 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.89 -31.53 63.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 120.546 -1.346 . . . . 0.0 110.867 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tp -67.26 -32.47 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -33.95 68.32 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.534 -1.353 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -67.04 -38.62 86.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.657 1.218 . . . . 0.0 108.981 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 t -60.0 -43.53 95.13 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.56 1.144 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.61 -49.85 79.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 124.275 1.03 . . . . 0.0 110.415 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.61 -17.03 62.3 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.683 -0.636 . . . . 0.0 111.605 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m -80.14 -38.59 31.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.672 -0.642 . . . . 0.0 109.697 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.8 67.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.844 -1.16 . . . . 0.0 111.528 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -86.19 6.82 27.62 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.9 0.48 . . . . 0.0 110.121 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p 50.08 54.13 11.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.587 1.955 . . . . 0.0 112.584 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 56' ' ' GLY . 8.2 p -116.99 -77.42 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.558 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.05 85.06 0.23 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -74.39 -14.82 60.92 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.664 -1.492 . . . . 0.0 111.061 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 32.08 3.88 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 49.0 t0 -73.28 -48.97 30.27 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -136.85 169.83 17.1 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.32 146.56 33.56 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.89 -172.61 1.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 124.61 3.54 . . . . 0.0 109.432 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 64' ' ' THR 0.253 13.3 p -129.02 -146.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 63' ' ' VAL . 18.9 m -100.63 -49.97 4.03 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.562 1.545 . . . . 0.0 107.946 -172.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -79.4 -12.27 59.91 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.452 0.701 . . . . 0.0 111.179 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -63.78 -30.36 71.47 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 122.931 1.348 . . . . 0.0 107.649 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.55 81.14 1.49 Allowed Glycine 0 CA--C 1.469 -2.794 1 N-CA-C 99.601 -5.4 . . . . 0.0 99.601 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -59.18 -8.04 1.42 Allowed 'General case' 0 C--N 1.362 1.144 0 CA-C-O 123.238 1.494 . . . . 0.0 112.929 -168.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -60.17 -15.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 120.144 -1.597 . . . . 0.0 113.171 164.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.91 -50.53 74.64 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-N 120.688 1.585 . . . . 0.0 107.367 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.86 -47.21 83.38 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.311 0.644 . . . . 0.0 111.798 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.89 -45.86 71.22 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.096 1.358 . . . . 0.0 110.728 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -33.6 75.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.909 0.884 . . . . 0.0 111.539 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.43 -49.31 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.4 ptp -65.68 -38.31 88.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 122.01 -0.431 . . . . 0.0 110.332 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -65.14 -38.05 89.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.484 -0.76 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.59 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.315 0.646 . . . . 0.0 110.702 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.19 -44.56 97.55 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.405 1.002 . . . . 0.0 110.71 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.93 -44.17 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 121.894 -0.768 . . . . 0.0 109.294 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.36 -47.43 85.9 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.068 -1.02 . . . . 0.0 112.02 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.83 -39.2 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 O-C-N 121.719 -0.613 . . . . 0.0 111.202 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.69 -39.04 64.67 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.687 0.676 . . . . 0.0 109.387 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.29 73.86 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 121.455 -0.778 . . . . 0.0 111.172 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.77 -36.22 76.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.296 1.438 . . . . 0.0 111.267 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.84 -12.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 125.202 1.401 . . . . 0.0 111.198 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -58.99 -21.52 59.05 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.762 -1.836 . . . . 0.0 111.58 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.92 -26.51 68.84 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 120.815 -1.178 . . . . 0.0 112.15 172.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.54 -47.65 11.1 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.19 -40.58 94.45 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.079 0.951 . . . . 0.0 113.342 -170.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -16.5 63.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.102 -0.999 . . . . 0.0 111.616 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.6 p -87.59 -12.51 45.45 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.89 -1.131 . . . . 0.0 110.641 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -76.26 -17.48 59.45 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -166.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.537 ' HA ' ' CE1' ' B' ' 4' ' ' HIS . 4.5 p90 -81.36 -31.64 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.962 -1.086 . . . . 0.0 110.379 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 t -71.54 -22.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 125.904 1.682 . . . . 0.0 109.025 -169.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -53.85 -24.04 14.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.362 1.465 . . . . 0.0 112.585 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -65.91 -16.16 63.61 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 120.221 -1.55 . . . . 0.0 112.029 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -68.03 -30.6 69.87 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.018 0.913 . . . . 0.0 109.494 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.59 -48.03 50.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -64.85 -35.56 81.52 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 125.644 1.578 . . . . 0.0 110.984 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.98 -43.62 86.65 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.39 1.476 . . . . 0.0 111.216 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -97.71 -20.42 17.61 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.978 0.911 . . . . 0.0 110.128 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.32 61.67 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -171.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 t60 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.21 162.18 33.27 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.118 0.961 . . . . 0.0 109.008 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -70.43 -26.0 63.47 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.404 -171.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 93' ' ' PHE . 31.8 m170 -76.32 -21.45 56.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.897 -1.127 . . . . 0.0 110.98 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -81.59 -48.08 12.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -64.14 -40.22 95.69 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.405 -0.809 . . . . 0.0 112.198 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.46 -27.46 60.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.43 71.71 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.432 -0.792 . . . . 0.0 109.844 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.38 -37.55 86.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.759 0.824 . . . . 0.0 111.075 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -64.43 -37.16 86.55 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.409 0.683 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -29.46 70.8 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.477 -0.764 . . . . 0.0 111.208 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -67.33 -30.12 69.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.109 -0.994 . . . . 0.0 111.528 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.4 -28.45 61.09 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.79 -1.194 . . . . 0.0 110.141 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.38 -42.76 95.98 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.227 1.011 . . . . 0.0 109.138 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.6 -40.53 97.22 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.459 -0.776 . . . . 0.0 110.749 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -67.44 -27.31 66.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -69.5 -43.88 72.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.485 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.11 -35.31 74.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 123.921 0.889 . . . . 0.0 109.34 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.9 mt -53.82 -53.95 45.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 123.938 0.895 . . . . 0.0 109.73 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -66.89 -32.86 74.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.782 -0.574 . . . . 0.0 111.944 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.18 -51.7 50.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.843 0.83 . . . . 0.0 109.535 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.53 83.43 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.991 0.916 . . . . 0.0 111.388 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -63.57 -40.14 96.2 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 123.61 0.764 . . . . 0.0 110.852 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -63.93 -40.39 96.35 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -68.73 -40.65 79.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.384 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.69 67.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.911 1.684 . . . . 0.0 113.086 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.87 -25.49 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.801 0.81 . . . . 0.0 111.721 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.17 -36.2 13.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.04 -50.67 63.38 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.698 1.999 . . . . 0.0 110.187 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.18 56.46 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.375 -0.828 . . . . 0.0 109.98 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -138.61 101.85 4.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.04 -2.1 38.18 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.16 64.74 Favored Pre-proline 0 N--CA 1.442 -0.844 0 O-C-N 121.586 -0.95 . . . . 0.0 109.658 -172.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.45 113.07 2.56 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.366 2.71 . . . . 0.0 112.423 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.0 23.86 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.31 163.15 17.86 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.56 -25.9 0.27 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.33 52.0 2.26 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.65 1.214 . . . . 0.0 108.718 -172.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 43.8 pt -80.06 27.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 124.932 1.293 . . . . 0.0 111.1 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -122.34 142.5 50.44 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.89 -1.131 . . . . 0.0 109.429 -168.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.73 -62.02 0.23 Allowed Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-O 116.937 -1.506 . . . . 0.0 110.198 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.14 -12.55 23.44 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 CA-C-N 125.496 2.998 . . . . 0.0 111.659 -172.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -87.72 -8.85 55.53 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.26 99.43 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 121.687 -0.633 . . . . 0.0 110.016 -173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.54 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.028 0.531 . . . . 0.0 110.338 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -20.47 55.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 120.713 -1.242 . . . . 0.0 111.877 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -75.85 -53.48 8.39 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 m -54.82 -33.1 61.19 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.7 t -56.75 -48.76 80.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 124.281 1.032 . . . . 0.0 110.584 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.63 -16.43 55.82 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 119.798 1.181 . . . . 0.0 111.795 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -65.71 -42.17 91.44 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 109.318 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -29.14 68.77 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 123.353 0.661 . . . . 0.0 111.416 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.0 p -87.17 -0.75 57.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 16.6 p 54.44 33.89 19.7 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.759 1.624 . . . . 0.0 110.806 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.89 -60.76 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 103.255 -2.868 . . . . 0.0 103.255 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 50.13 64.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.03 -41.3 91.12 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 118.095 0.948 . . . . 0.0 108.628 -171.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.68 -111.05 0.46 Allowed Glycine 0 CA--C 1.471 -2.713 0 N-CA-C 103.398 -3.881 . . . . 0.0 103.398 172.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.8 t0 76.5 -72.55 0.1 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.184 0.993 . . . . 0.0 109.741 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.62 167.42 19.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 169.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.64 128.31 13.52 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -88.07 161.38 7.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.027 2.485 . . . . 0.0 109.708 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.452 HG13 ' H ' ' B' ' 64' ' ' THR 0.348 14.6 p -96.71 -126.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.452 ' H ' HG13 ' B' ' 63' ' ' VAL . 3.1 m -119.87 -38.86 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.864 1.666 . . . . 0.0 109.266 -170.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -93.04 5.45 51.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.718 0.807 . . . . 0.0 109.976 -168.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.11 38.11 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.63 73.87 1.27 Allowed Glycine 0 CA--C 1.469 -2.832 1 N-CA-C 101.444 -4.662 . . . . 0.0 101.444 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -48.26 -8.02 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 130.293 3.437 . . . . 0.0 114.738 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' B' ' 72' ' ' GLU . 61.4 mttt -48.22 -26.34 1.91 Allowed 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 127.015 2.126 . . . . 0.0 112.804 154.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.95 -48.18 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 125.022 1.329 . . . . 0.0 108.826 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.26 60.64 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 109.886 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.456 ' HB3' ' HA ' ' B' ' 69' ' ' LYS . 14.7 tt0 -49.76 -46.65 50.78 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 127.856 2.462 . . . . 0.0 109.961 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -61.67 -43.9 97.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.086 0.954 . . . . 0.0 111.019 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.25 -43.84 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -61.39 -51.76 67.44 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.05 0.54 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -66.39 -35.57 80.66 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.822 -0.549 . . . . 0.0 110.094 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.3 93.64 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.608 -0.683 . . . . 0.0 110.836 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.53 -48.79 79.26 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.98 -48.11 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.808 1.243 . . . . 0.0 109.943 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.28 -33.79 76.81 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.638 -1.289 . . . . 0.0 111.947 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.82 -49.51 68.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.553 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -66.82 -22.78 66.0 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.381 0.672 . . . . 0.0 111.135 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.12 -39.42 25.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.33 -34.36 76.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.676 1.191 . . . . 0.0 111.312 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 m -66.25 -7.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 121.442 -0.786 . . . . 0.0 112.124 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 72.2 m -59.19 -22.03 60.36 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.128 1.371 . . . . 0.0 111.085 171.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.19 68.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 118.852 -2.405 . . . . 0.0 112.382 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.99 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.5 -35.72 72.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.232 1.413 . . . . 0.0 112.45 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . . . -71.38 -16.94 62.43 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 121.005 -1.06 . . . . 0.0 112.011 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -76.53 -24.51 53.65 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.7 -9.14 59.3 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.813 -1.179 . . . . 0.0 110.327 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' B' ' 90' ' ' ALA . 3.1 m-30 -73.82 -34.43 64.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.55 1.14 . . . . 0.0 108.423 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.29 -31.76 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 125.101 1.36 . . . . 0.0 108.457 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -62.99 -5.11 2.63 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.214 -0.929 . . . . 0.0 112.829 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -64.78 -23.29 67.2 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.6 -33.67 41.4 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -86.68 177.0 7.48 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 64.93 -63.63 0.18 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.817 2.047 . . . . 0.0 112.96 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -70.78 -36.24 72.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.665 1.586 . . . . 0.0 109.441 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -116.76 143.66 45.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 102.077 -3.305 . . . . 0.0 102.077 168.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.09 -27.15 5.67 Favored Glycine 0 CA--C 1.495 -1.162 0 O-C-N 121.271 -0.893 . . . . 0.0 113.374 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . 0.261 2.3 m-70 . . . . . 0 CA--C 1.502 -0.879 0 C-N-CA 124.515 1.126 . . . . 0.0 110.961 -171.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 73.58 -55.49 0.67 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.282 1.833 . . . . 0.0 110.479 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 78.27 -43.19 0.36 Allowed 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 128.613 2.765 . . . . 0.0 109.274 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 0.5 OUTLIER -45.91 -33.97 3.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 128.507 2.723 . . . . 0.0 112.441 166.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.43 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 7.0 pt-20 -79.61 -28.2 41.02 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -71.57 -40.31 70.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -70.14 -35.41 74.04 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.674 0.75 . . . . 0.0 109.117 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.54 83.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.511 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.27 -35.55 75.8 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.795 1.638 . . . . 0.0 111.373 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -66.4 -42.44 87.84 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.962 1.305 . . . . 0.0 109.43 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 110.877 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.63 -39.87 68.39 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.683 1.193 . . . . 0.0 111.418 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -71.38 -36.48 71.43 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.501 1.12 . . . . 0.0 110.105 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.69 -39.1 87.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.542 1.137 . . . . 0.0 109.875 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.15 -40.49 97.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.012 -1.055 . . . . 0.0 111.369 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -65.58 -40.14 92.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.67 1.188 . . . . 0.0 111.74 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -73.48 -29.29 62.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.767 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.79 -34.95 70.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.125 -0.984 . . . . 0.0 109.599 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.41 -37.72 78.77 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.077 -1.014 . . . . 0.0 111.684 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -64.08 -46.23 85.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.235 -0.915 . . . . 0.0 109.958 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.26 -37.52 85.67 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.353 -0.842 . . . . 0.0 110.316 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.36 74.25 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.792 1.237 . . . . 0.0 111.671 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -63.31 -42.55 99.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.149 0.5 . . . . 0.0 110.967 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.62 -50.45 62.94 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.54 1.536 . . . . 0.0 107.829 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.89 -41.17 87.64 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.128 -0.357 . . . . 0.0 110.821 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.24 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 123.573 0.749 . . . . 0.0 110.499 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.81 72.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 O-C-N 120.431 -1.418 . . . . 0.0 110.551 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -70.39 -32.11 69.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.16 1.384 . . . . 0.0 109.409 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.56 -49.52 76.31 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.978 1.311 . . . . 0.0 110.808 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' C' ' 38' ' ' LEU . 6.2 mp0 -74.92 -17.68 60.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 121.769 -0.582 . . . . 0.0 111.354 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -94.55 79.46 3.82 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.128 -1.608 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.74 -29.75 0.83 Allowed Glycine 0 CA--C 1.491 -1.444 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.93 155.19 36.73 Favored Pre-proline 0 N--CA 1.443 -0.788 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.43 161.5 31.48 Favored 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.236 1.957 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.88 6.24 76.29 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 123.932 0.777 . . . . 0.0 111.751 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 122.36 6.34 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 126.087 1.755 . . . . 0.0 114.228 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 -24.5 0.86 Allowed 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' C' ' 30' ' ' GLU . 3.6 tt -76.04 -87.32 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 mt 64.8 161.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.778 0 C-N-CA 125.411 1.484 . . . . 0.0 109.466 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.9 t 81.88 115.23 0.06 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.659 1.583 . . . . 0.0 112.118 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -68.73 -52.19 18.98 Favored Pre-proline 0 C--N 1.349 0.568 0 CA-C-O 115.973 -1.965 . . . . 0.0 112.408 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.85 -7.49 20.1 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 126.094 3.212 . . . . 0.0 111.542 -170.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -93.51 -33.3 13.83 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.79 74.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.677 1.191 . . . . 0.0 111.699 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 tt -60.76 -29.04 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 124.63 1.172 . . . . 0.0 111.493 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -23.28 29.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.286 -0.884 . . . . 0.0 109.606 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -78.94 -37.57 39.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 12.5 p -77.79 55.59 1.4 Allowed 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 121.427 -0.795 . . . . 0.0 110.115 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -131.43 -68.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.45 -19.24 64.56 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -67.58 -35.86 79.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.183 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.12 56.91 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 120.774 -1.204 . . . . 0.0 110.325 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -93.33 15.74 14.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.22 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.266 10.2 t 49.69 55.24 9.69 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 112.803 168.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.6 m -143.3 -164.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 N-CA-C 98.336 -4.69 . . . . 0.0 98.336 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.32 106.22 0.19 Allowed Glycine 0 CA--C 1.467 -2.909 1 N-CA-C 100.057 -5.217 . . . . 0.0 100.057 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.418 ' CE1' ' HA3' ' D' ' 56' ' ' GLY . 6.2 m-30 -87.39 -6.91 58.26 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -167.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.94 42.0 2.02 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.72 -51.1 12.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -144.78 -177.27 5.43 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.99 138.66 13.42 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.81 169.34 15.05 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.54 2.827 . . . . 0.0 110.078 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -101.86 -175.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-O 122.605 1.193 . . . . 0.0 111.897 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -87.62 -61.48 1.71 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 124.562 1.145 . . . . 0.0 110.375 -166.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -59.44 -37.64 78.63 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.514 0.726 . . . . 0.0 111.514 -169.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.69 -76.29 0.57 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.048 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -23.72 -51.07 0.03 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 129.473 3.416 . . . . 0.0 117.305 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -58.76 -47.34 85.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.01 1.724 . . . . 0.0 112.736 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -75.58 -27.82 58.7 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.114 . . . . 0.0 108.803 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.05 -52.57 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.83 95.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.076 1.35 . . . . 0.0 111.464 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -34.01 72.7 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 119.18 0.9 . . . . 0.0 111.584 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.78 -42.56 94.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.277 1.031 . . . . 0.0 109.984 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.34 -44.34 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.252 1.021 . . . . 0.0 109.59 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mtp -57.03 -48.79 77.65 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.374 1.069 . . . . 0.0 110.078 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -62.32 -31.9 72.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.303 1.841 . . . . 0.0 111.97 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.99 71.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 123.627 0.771 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.33 -42.16 75.65 Favored Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.65 -42.73 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 109.797 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -53.77 -56.33 18.45 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 110.544 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.45 -49.82 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 C-N-CA 125.358 1.463 . . . . 0.0 109.516 -171.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.87 -24.01 62.42 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.716 -0.615 . . . . 0.0 111.098 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.52 47.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.961 -1.087 . . . . 0.0 110.144 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.96 -37.31 81.94 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 111.661 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.56 -1.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.623 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -58.5 -24.03 59.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.178 1.791 . . . . 0.0 113.784 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.18 84.78 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 119.14 -2.225 . . . . 0.0 112.216 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -66.27 -42.08 88.98 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.2 -43.73 66.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.172 0.51 . . . . 0.0 111.093 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.71 -41.59 26.42 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 120.357 -1.464 . . . . 0.0 112.667 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 34.1 p -69.07 -7.01 31.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.619 -1.3 . . . . 0.0 111.41 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -74.23 -5.46 42.11 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.835 -0.541 . . . . 0.0 110.41 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -35.56 71.66 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 120.043 -1.661 . . . . 0.0 111.02 167.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.39 -17.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.42 1.488 . . . . 0.0 108.934 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.69 -29.81 40.61 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.512 1.525 . . . . 0.0 111.966 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -60.48 -39.82 89.03 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.71 1.204 . . . . 0.0 110.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.04 -32.86 73.51 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 121.422 -0.799 . . . . 0.0 109.58 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -97.93 0.94 47.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 120.993 0.425 . . . . 0.0 111.1 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -74.97 -31.71 61.52 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.426 -1.421 . . . . 0.0 108.638 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -78.5 -17.52 56.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.866 -0.521 . . . . 0.0 110.939 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -79.53 -37.94 35.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.53 25.76 41.59 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 CA--C 1.486 -1.491 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 171.412 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.431 -1.385 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 164.18 24.52 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.259 1.424 . . . . 0.0 109.356 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.21 -39.82 94.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.796 1.638 . . . . 0.0 111.407 -169.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.431 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 19.6 p80 -78.54 -20.68 50.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.403 -0.811 . . . . 0.0 111.232 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.431 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 18.3 mt-10 -89.86 -21.69 22.42 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.096 -1.003 . . . . 0.0 108.561 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.55 -43.71 96.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.121 1.768 . . . . 0.0 109.784 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.47 -32.16 71.96 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 109.362 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.38 -35.46 73.52 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.206 1.003 . . . . 0.0 111.321 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.53 -31.75 72.99 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.469 -0.769 . . . . 0.0 111.439 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.73 -33.66 74.44 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.795 -0.566 . . . . 0.0 110.836 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 123.682 0.793 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.48 -39.4 88.73 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.872 0.869 . . . . 0.0 110.262 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -46.02 91.35 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 121.287 -0.883 . . . . 0.0 109.846 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.6 -41.68 81.71 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.825 2.05 . . . . 0.0 109.942 -175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.89 -40.79 96.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.068 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.23 -27.69 67.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.513 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -69.57 -42.79 74.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.27 -0.893 . . . . 0.0 110.342 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 m -72.59 -26.37 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 121.657 -0.652 . . . . 0.0 110.941 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.56 -41.27 96.42 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.307 -0.871 . . . . 0.0 111.096 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.46 -30.38 59.92 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 124.073 0.949 . . . . 0.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.93 -39.25 72.79 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 119.787 -1.821 . . . . 0.0 109.507 173.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.11 85.58 Favored 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.013 1.325 . . . . 0.0 110.85 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 3.1 p -67.19 -37.15 83.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 119.202 0.91 . . . . 0.0 111.196 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.13 -52.7 31.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.506 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -71.07 -25.12 62.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.076 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.82 -53.64 47.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.396 1.078 . . . . 0.0 110.016 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.74 -38.61 83.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -77.05 -6.59 53.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.332 -1.48 . . . . 0.0 112.421 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.48 -52.32 5.42 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -48.48 -50.58 31.01 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 129.034 2.934 . . . . 0.0 114.382 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -74.07 85.68 1.83 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.731 0.777 . . . . 0.0 110.413 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.34 -18.36 1.7 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.63 140.03 31.56 Favored Pre-proline 0 N--CA 1.445 -0.705 0 O-C-N 121.128 -1.219 . . . . 0.0 111.15 -170.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.39 132.82 6.06 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.77 2.314 . . . . 0.0 111.232 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.57 27.85 37.64 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.9 157.4 5.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.43 2.292 . . . . 0.0 111.9 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.02 -36.04 0.83 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.132 1.373 . . . . 0.0 110.072 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.45 81.5 1.48 Allowed 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.927 1.346 . . . . 0.0 112.865 -164.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 35.0 pt -93.79 -8.67 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 118.871 2.915 . . . . 0.0 118.871 -166.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 11.7 m -121.32 141.2 51.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 123.656 2.935 . . . . 0.0 110.708 -164.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -59.21 -47.77 97.66 Favored Pre-proline 0 C--N 1.353 0.757 0 CA-C-O 116.172 -1.871 . . . . 0.0 112.909 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -72.62 -5.59 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 CA-C-N 125.374 2.955 . . . . 0.0 112.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -30.76 12.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.6 76.4 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.294 1.037 . . . . 0.0 111.931 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.9 tt -72.06 -27.39 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 110.022 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.01 -35.75 49.52 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 108.336 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -63.6 -44.85 92.78 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.957 0.903 . . . . 0.0 110.578 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.5 p -65.74 -27.16 68.11 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 120.609 -1.307 . . . . 0.0 111.175 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.51 -20.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 111.452 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.9 -16.14 57.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.17 -1.581 . . . . 0.0 110.177 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.48 HG22 ' H ' ' D' ' 52' ' ' ALA . 7.1 m -99.8 -177.45 3.56 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 102.038 -3.319 . . . . 0.0 102.038 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.48 ' H ' HG22 ' D' ' 51' ' ' THR . . . 76.4 -30.14 0.18 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.793 1.637 . . . . 0.0 111.263 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.8 p -90.96 -10.92 40.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.65 1.58 . . . . 0.0 111.397 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p 58.45 30.83 20.23 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.359 1.463 . . . . 0.0 111.223 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.92 -87.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 101.446 -3.539 . . . . 0.0 101.446 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' C' ' 57' ' ' TYR . . . 81.32 73.33 1.19 Allowed Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -44.62 93.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.65 0.78 . . . . 0.0 111.099 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.3 -62.7 0.27 Allowed Glycine 0 CA--C 1.477 -2.331 0 C-N-CA 117.36 -2.352 . . . . 0.0 112.6 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -10.33 -67.24 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 128.948 2.899 . . . . 0.0 117.747 -162.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.94 155.13 43.58 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 104.424 -2.435 . . . . 0.0 104.424 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.43 152.22 19.52 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.66 158.37 19.0 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.085 2.524 . . . . 0.0 111.518 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.457 HG22 ' H ' ' D' ' 64' ' ' THR . 8.5 p -101.99 -151.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.457 ' H ' HG22 ' D' ' 63' ' ' VAL . 2.2 m -76.65 -50.11 14.55 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.547 1.939 . . . . 0.0 111.157 -171.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -77.59 -14.51 59.63 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.457 1.503 . . . . 0.0 110.498 -162.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.62 -20.18 62.76 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.165 0.983 . . . . 0.0 109.658 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.72 89.38 0.84 Allowed Glycine 0 CA--C 1.478 -2.265 1 N-CA-C 98.691 -5.764 . . . . 0.0 98.691 -170.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -65.06 -11.36 38.58 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.056 1.928 . . . . 0.0 110.02 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -57.28 -14.84 4.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.324 1.05 . . . . 0.0 113.597 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.88 -43.32 97.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.487 1.494 . . . . 0.0 109.116 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.98 -43.08 75.63 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -44.93 82.33 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.596 1.158 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.76 -45.51 93.61 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.402 0.681 . . . . 0.0 111.364 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.8 -39.73 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.634 0.774 . . . . 0.0 109.32 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.7 ttm -62.9 -48.14 80.27 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.384 1.074 . . . . 0.0 110.303 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -63.57 -42.18 98.34 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 109.846 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.3 80.7 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 111.439 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.79 -36.67 93.66 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.211 0.91 . . . . 0.0 112.249 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -68.66 -42.85 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 121.311 -1.111 . . . . 0.0 108.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.95 -43.08 99.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 121.432 -0.793 . . . . 0.0 111.604 -175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.69 -40.78 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 O-C-N 121.79 -0.569 . . . . 0.0 111.355 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.29 -21.09 56.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.75 25.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.166 -0.959 . . . . 0.0 110.367 174.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.1 -42.54 90.74 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 125.837 1.655 . . . . 0.0 109.877 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.71 -4.26 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.564 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -62.2 -19.79 63.49 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.856 -1.152 . . . . 0.0 110.427 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.07 77.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.341 -1.475 . . . . 0.0 111.841 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.35 -33.07 49.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 120.926 -1.109 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.01 -31.49 68.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.125 0.488 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.87 70.47 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.834 -1.166 . . . . 0.0 111.257 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -9.94 59.03 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.876 -1.14 . . . . 0.0 111.922 173.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.45 -40.17 70.5 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 119.644 1.111 . . . . 0.0 109.359 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -68.46 -29.64 68.33 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.959 -1.088 . . . . 0.0 111.239 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.83 -21.92 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.914 1.286 . . . . 0.0 108.97 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -62.18 -12.55 20.6 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.438 1.095 . . . . 0.0 111.485 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.79 -24.94 67.96 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.404 1.082 . . . . 0.0 112.229 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.73 166.99 21.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 64.8 -70.88 0.08 Allowed 'General case' 0 C--N 1.351 0.665 0 C-N-CA 125.93 1.692 . . . . 0.0 111.634 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.69 -53.31 59.48 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.933 1.693 . . . . 0.0 109.513 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -70.75 -29.63 65.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.891 -1.131 . . . . 0.0 111.093 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.86 91.34 2.96 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.28 35.4 2.7 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 . . . . . 0 C--N 1.354 0.78 0 C-N-CA 124.591 1.156 . . . . 0.0 112.546 -178.229 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.425 -1.696 1 N-CA-C 100.062 -4.051 . . . . 0.0 100.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.95 -176.73 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.057 2.143 . . . . 0.0 112.28 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -105.68 -42.17 5.25 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -71.17 -31.36 67.58 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.207 -0.933 . . . . 0.0 111.623 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.55 -40.79 61.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.601 0.715 . . . . 0.0 110.193 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -68.47 -31.64 71.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.48 -0.763 . . . . 0.0 110.359 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -81.0 -30.92 34.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.018 -0.426 . . . . 0.0 110.243 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.6 76.04 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.931 -1.106 . . . . 0.0 110.197 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -57.1 -35.63 69.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.573 1.949 . . . . 0.0 111.691 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -64.42 -39.18 93.34 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.563 1.145 . . . . 0.0 109.84 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.93 80.52 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.693 -0.629 . . . . 0.0 110.156 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.41 -33.67 74.09 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.621 0.769 . . . . 0.0 111.449 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.83 -42.56 94.85 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 109.89 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.55 -36.89 81.88 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.874 0.87 . . . . 0.0 109.459 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -56.87 -44.72 82.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.121 0.569 . . . . 0.0 111.264 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -63.14 -38.14 90.01 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.104 0.962 . . . . 0.0 111.606 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.19 -39.12 92.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.887 1.275 . . . . 0.0 109.83 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.93 -35.92 75.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.715 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.1 mt -59.74 -43.95 93.99 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.32 -0.862 . . . . 0.0 111.185 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -74.53 -22.33 59.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.234 1.014 . . . . 0.0 111.798 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.91 -41.04 21.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 120.573 -1.329 . . . . 0.0 108.385 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.6 76.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.716 1.207 . . . . 0.0 111.412 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 p -66.85 -38.35 86.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.454 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -61.37 -47.91 83.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.235 1.414 . . . . 0.0 107.812 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -65.63 -47.06 76.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 122.662 0.385 . . . . 0.0 110.572 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.48 90.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.03 1.332 . . . . 0.0 112.058 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.86 -34.66 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.434 -0.791 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.23 -24.79 27.68 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 120.271 -1.518 . . . . 0.0 110.357 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -79.85 -53.66 6.57 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.83 -34.88 69.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 119.073 0.851 . . . . 0.0 110.98 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -74.65 108.88 7.69 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 119.569 -1.957 . . . . 0.0 110.455 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.66 -33.12 2.8 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.57 144.53 83.65 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.309 -170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.64 138.7 21.85 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 C-N-CA 122.799 2.333 . . . . 0.0 109.833 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.45 -0.07 89.31 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.16 146.8 54.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.054 0.942 . . . . 0.0 111.543 -171.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.55 -42.45 3.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.78 131.11 34.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 pt -149.45 173.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.3 m 66.64 132.94 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.526 1.931 . . . . 0.0 114.163 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.32 -46.82 38.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 115.77 -2.062 . . . . 0.0 112.309 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.5 -11.65 30.2 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 CA-C-N 126.056 3.199 . . . . 0.0 112.293 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.15 -47.63 7.95 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.59 75.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 126.166 1.786 . . . . 0.0 112.37 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.73 -28.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 121.359 0.599 . . . . 0.0 111.115 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -22.29 32.19 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.235 -0.916 . . . . 0.0 109.69 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -78.14 -33.84 50.2 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.76 61.26 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.123 -0.985 . . . . 0.0 110.862 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -138.84 -76.1 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -67.71 -14.88 63.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 112.031 -169.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -64.88 -36.56 84.76 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 126.331 1.852 . . . . 0.0 108.582 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.23 60.28 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.207 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -88.99 13.41 12.96 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 p 56.79 51.1 11.35 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.514 1.526 . . . . 0.0 113.065 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 ' SD ' ' B' ' 75' ' ' MET . 21.3 t -116.19 -104.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.22 71.46 0.73 Allowed Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -66.75 -18.98 65.65 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.587 -0.949 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.51 22.23 6.18 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -56.21 17.12 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.995 0.898 . . . . 0.0 110.131 174.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -147.47 161.68 40.58 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.97 146.94 18.44 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.9 176.53 9.9 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 124.481 3.454 . . . . 0.0 110.341 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 t -112.5 -102.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 120.053 1.297 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -139.53 -41.53 0.45 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -88.07 -19.19 27.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.577 0.751 . . . . 0.0 111.146 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -63.02 -34.56 77.83 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 108.036 170.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.57 79.52 1.44 Allowed Glycine 0 CA--C 1.471 -2.659 1 N-CA-C 100.297 -5.121 . . . . 0.0 100.297 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.447 HH22 ' CG ' ' D' ' 59' ' ' ASP . 49.5 ttm-85 -39.07 -28.15 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 128.806 2.842 . . . . 0.0 114.512 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -53.27 -15.74 1.05 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.53 -46.82 92.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 125.216 1.407 . . . . 0.0 109.399 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.163 0.985 . . . . 0.0 108.899 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.37 -43.24 33.48 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.595 1.558 . . . . 0.0 111.667 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -62.58 -38.17 89.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.13 0.572 . . . . 0.0 111.437 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.71 -38.63 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -176.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -59.95 -44.62 94.27 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.046 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -63.17 -34.3 77.32 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.493 -0.754 . . . . 0.0 110.961 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.92 85.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.753 0.706 . . . . 0.0 111.291 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.29 50.97 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.04 -38.89 62.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 124.562 1.145 . . . . 0.0 108.897 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -70.35 -49.28 50.93 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.815 -1.178 . . . . 0.0 111.177 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.89 -45.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 O-C-N 121.33 -0.856 . . . . 0.0 110.199 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -73.48 -29.69 62.68 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 121.447 -0.783 . . . . 0.0 110.2 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.0 62.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 120.665 -1.272 . . . . 0.0 110.314 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.93 -35.4 80.56 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.935 -1.103 . . . . 0.0 110.769 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.92 -9.07 2.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.161 1.385 . . . . 0.0 111.26 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 m -59.34 -23.01 62.15 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 118.986 -2.321 . . . . 0.0 111.931 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.33 61.26 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.551 -1.343 . . . . 0.0 112.36 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.37 -41.94 9.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.512 1.525 . . . . 0.0 109.577 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -41.76 63.2 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.637 -1.289 . . . . 0.0 111.582 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.19 -5.43 41.85 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 121.037 -1.039 . . . . 0.0 111.12 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -97.54 -5.42 35.8 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.701 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.26 18.2 m-20 -80.13 -16.86 54.04 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 121.094 1.77 . . . . 0.0 111.268 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.49 -29.55 37.37 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.837 -1.164 . . . . 0.0 109.602 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.41 -30.87 50.45 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 124.429 1.092 . . . . 0.0 109.248 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -53.5 -26.44 20.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.001 1.32 . . . . 0.0 112.916 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -62.59 -34.75 77.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.524 1.13 . . . . 0.0 110.689 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.02 -3.18 58.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 121.919 -0.488 . . . . 0.0 110.132 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.61 -174.91 2.61 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 66.52 -64.13 0.23 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.064 2.146 . . . . 0.0 112.432 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -50.83 -51.57 49.76 Favored 'General case' 0 N--CA 1.432 -1.361 1 C-N-CA 131.908 4.083 . . . . 0.0 110.457 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -92.22 -0.06 57.43 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.473 0.709 . . . . 0.0 110.543 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.59 28.51 72.18 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 121.819 -0.551 . . . . 0.0 111.765 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.9 t60 . . . . . 0 CA--C 1.505 -0.754 0 O-C-N 121.619 -0.93 . . . . 0.0 109.419 -174.833 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p . . . . . 0 N--CA 1.432 -1.375 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.69 169.02 10.63 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -47.45 -65.7 0.52 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 127.443 2.297 . . . . 0.0 111.598 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -62.81 -23.63 67.35 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.588 1.955 . . . . 0.0 112.709 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -81.83 -41.58 20.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -70.08 -35.18 74.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.379 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.8 -39.66 85.75 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.494 0.718 . . . . 0.0 110.304 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.61 91.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.408 0.683 . . . . 0.0 111.495 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -68.31 -38.55 81.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 O-C-N 121.594 -0.691 . . . . 0.0 110.219 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.85 -36.27 80.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.46 0.648 . . . . 0.0 110.892 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.14 83.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.839 0.856 . . . . 0.0 111.193 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.27 -32.39 73.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.508 -0.745 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.23 -35.83 71.62 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.165 -0.959 . . . . 0.0 109.597 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.81 -30.21 69.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 120.641 -1.287 . . . . 0.0 110.325 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -61.16 -43.68 98.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 122.978 0.511 . . . . 0.0 111.186 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.33 -35.15 79.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.344 0.658 . . . . 0.0 110.892 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -67.61 -39.11 84.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.274 0.63 . . . . 0.0 110.668 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.76 -39.87 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.797 0.839 . . . . 0.0 109.302 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.22 -43.45 87.73 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.179 0.899 . . . . 0.0 111.969 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.35 -37.39 80.44 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.59 1.156 . . . . 0.0 110.501 -177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.22 -46.06 52.57 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.681 1.229 . . . . 0.0 108.788 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.31 64.57 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 125.043 1.337 . . . . 0.0 112.236 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.8 p -73.32 -31.57 64.08 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.341 -0.849 . . . . 0.0 110.006 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -40.96 71.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.028 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.5 75.22 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.796 1.239 . . . . 0.0 112.742 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.04 -29.96 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 O-C-N 120.912 -1.117 . . . . 0.0 111.381 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.96 -20.57 28.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.153 0.501 . . . . 0.0 110.52 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.34 94.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.412 1.885 . . . . 0.0 109.462 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -69.39 -106.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.571 0.7 . . . . 0.0 111.58 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 58.17 9.66 1.04 Allowed 'General case' 0 C--N 1.346 0.442 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.48 34.63 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.72 149.14 38.64 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -77.14 113.09 3.53 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.486 2.124 . . . . 0.0 110.693 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -65.37 0.28 Allowed Glycine 0 CA--C 1.484 -1.901 0 N-CA-C 103.109 -3.996 . . . . 0.0 103.109 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 75.23 162.47 0.25 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 127.65 2.38 . . . . 0.0 108.424 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.98 -72.61 0.08 Allowed 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.595 -0.691 . . . . 0.0 110.265 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.34 80.5 1.59 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 tt -122.99 93.99 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.5 m -156.07 -150.73 0.3 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -167.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.05 -58.36 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 116.445 -1.741 . . . . 0.0 106.447 169.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.51 -29.03 20.89 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.803 3.108 . . . . 0.0 112.434 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.52 9.12 39.8 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 123.809 0.843 . . . . 0.0 110.148 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.05 -41.22 82.35 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.679 -1.263 . . . . 0.0 109.675 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -73.45 -24.86 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 O-C-N 121.559 -0.713 . . . . 0.0 110.034 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -58.27 -55.66 32.18 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 125.687 1.595 . . . . 0.0 110.195 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -71.09 -34.82 71.51 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -55.84 -43.41 77.0 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.526 1.13 . . . . 0.0 110.954 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.7 t -55.19 -51.15 58.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 124.414 1.086 . . . . 0.0 111.061 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.42 -22.16 55.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.31 -0.869 . . . . 0.0 111.693 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -65.07 -40.96 95.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.183 0.993 . . . . 0.0 109.093 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.17 65.5 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 121.235 -0.916 . . . . 0.0 112.175 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -89.04 5.49 44.14 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.872 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 56.09 28.97 13.75 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.665 1.186 . . . . 0.0 111.463 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.17 -56.66 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.55 62.39 5.84 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.4 -27.5 66.27 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 123.14 1.448 . . . . 0.0 108.115 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.47 43.96 1.4 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 107.446 -2.261 . . . . 0.0 107.446 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.55 -50.97 9.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -133.87 172.57 12.61 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -146.25 149.88 39.54 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.77 166.75 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.524 2.816 . . . . 0.0 109.36 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.24 -144.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 7.3 p -107.12 -59.75 1.77 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.213 1.405 . . . . 0.0 107.781 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.84 -16.28 48.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 130.185 3.394 . . . . 0.0 111.99 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -67.63 -22.71 65.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 124.137 1.923 . . . . 0.0 108.482 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.82 67.92 1.41 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 101.557 -4.617 . . . . 0.0 101.557 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -37.76 -20.71 0.01 OUTLIER 'General case' 0 C--N 1.362 1.124 0 C-N-CA 131.62 3.968 . . . . 0.0 115.461 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -54.69 -14.62 1.42 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.75 1.62 . . . . 0.0 114.499 162.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.98 -44.11 92.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.134 0 CA-C-N 121.709 2.05 . . . . 0.0 107.305 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.54 86.37 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.575 -0.703 . . . . 0.0 110.193 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.42 -45.31 80.77 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 123.762 0.825 . . . . 0.0 110.872 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -55.19 -46.76 75.87 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.627 1.971 . . . . 0.0 111.56 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.5 t -72.35 -44.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 C-N-CA 123.256 0.623 . . . . 0.0 109.494 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 55' ' ' VAL . 72.9 mtm -58.89 -49.18 78.74 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.895 0.878 . . . . 0.0 110.293 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.77 -40.2 94.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.071 0.548 . . . . 0.0 110.783 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.98 76.27 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.116 0.566 . . . . 0.0 111.418 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -44.02 91.78 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 124.259 0.933 . . . . 0.0 111.172 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.96 -42.07 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.796 -0.826 . . . . 0.0 108.954 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.36 -50.85 71.65 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.174 -0.954 . . . . 0.0 111.995 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.3 -41.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 O-C-N 121.829 -0.544 . . . . 0.0 110.577 -173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -75.75 -27.97 58.31 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.588 -0.695 . . . . 0.0 110.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.6 -34.5 69.94 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.008 -1.057 . . . . 0.0 109.584 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.37 -34.0 76.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.296 1.038 . . . . 0.0 110.86 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.44 -21.9 19.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 124.847 1.259 . . . . 0.0 110.691 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 2.5 m -62.23 -16.33 52.7 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.574 -1.329 . . . . 0.0 111.531 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.41 -35.31 80.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.3 -2.125 . . . . 0.0 111.17 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.34 -33.75 61.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -79.83 -25.03 40.94 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.141 0.577 . . . . 0.0 111.569 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.35 -27.96 64.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 120.036 -1.665 . . . . 0.0 109.268 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -9.01 55.28 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.025 -1.047 . . . . 0.0 112.314 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -72.45 -23.09 61.01 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.397 -1.44 . . . . 0.0 110.728 -172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' C' ' 91' ' ' THR . 19.0 p90 -75.23 -28.27 59.83 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.41 -0.806 . . . . 0.0 110.404 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.96 -40.15 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 124.131 0.972 . . . . 0.0 108.64 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -60.5 -23.56 64.63 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.352 -0.842 . . . . 0.0 112.663 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -52.67 -46.51 67.26 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.852 1.261 . . . . 0.0 109.983 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -77.98 -27.2 49.07 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.807 -0.558 . . . . 0.0 110.466 -173.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.25 -36.15 76.86 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.227 0.611 . . . . 0.0 110.305 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.09 -45.35 67.14 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -53.47 -42.09 66.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 112.839 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -122.96 106.52 10.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 -48.91 0.93 Allowed Glycine 0 CA--C 1.486 -1.726 0 N-CA-C 105.907 -2.877 . . . . 0.0 105.907 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 CA--C 1.502 -0.896 0 C-N-CA 126.191 1.796 . . . . 0.0 112.318 -172.187 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.433 -1.297 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.1 27.58 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.61 -46.93 77.28 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 123.003 1.382 . . . . 0.0 109.52 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.491 ' CG ' ' HA ' ' C' ' 88' ' ' ALA . 0.1 OUTLIER -59.09 -29.35 67.29 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.038 1.335 . . . . 0.0 113.733 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -80.64 -43.71 20.03 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -171.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -65.83 -41.55 91.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 123.832 0.853 . . . . 0.0 110.796 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -65.48 -35.67 81.57 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.259 0.624 . . . . 0.0 110.718 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.79 94.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.75 -31.72 66.97 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 121.952 -0.467 . . . . 0.0 111.676 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.0 -36.37 84.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.94 0.896 . . . . 0.0 110.001 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.59 72.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.29 -40.36 85.9 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 111.069 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.65 -25.43 59.19 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.167 1.387 . . . . 0.0 110.533 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.74 -36.74 67.8 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.305 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 tp -63.72 -44.78 92.59 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -65.44 -24.49 67.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.458 -0.776 . . . . 0.0 112.488 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -60.31 -43.81 95.99 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.532 1.133 . . . . 0.0 109.911 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.14 -40.74 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.263 1.025 . . . . 0.0 109.057 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -40.16 95.24 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.721 0.809 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.56 -21.86 38.19 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.0 111.969 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.41 -47.57 17.3 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.33 60.17 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 124.149 0.979 . . . . 0.0 112.592 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.3 p -67.76 -40.36 84.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.034 1.288 . . . . 0.0 109.089 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -68.52 -44.61 74.26 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.45 -42.72 88.01 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.237 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.58 65.0 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.905 1.282 . . . . 0.0 111.48 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 m -72.3 -27.9 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 O-C-N 121.171 -0.956 . . . . 0.0 111.694 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.89 -37.67 67.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.44 -50.34 16.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 126.277 1.831 . . . . 0.0 109.614 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.58 -34.82 78.74 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.967 0.907 . . . . 0.0 111.266 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -66.49 122.83 18.44 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 119.48 -2.013 . . . . 0.0 109.379 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.26 7.04 59.69 Favored Glycine 0 CA--C 1.496 -1.12 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.83 147.43 34.74 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -77.49 131.74 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.976 2.45 . . . . 0.0 110.792 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 0.1 82.16 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.55 26.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.39 1.476 . . . . 0.0 109.825 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.88 -28.25 8.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 14.1 tp -98.74 83.25 2.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.612 -1.305 . . . . 0.0 108.271 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.2 pt -127.3 64.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -154.03 125.17 7.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -60.43 -47.49 96.22 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-O 115.944 -1.979 . . . . 0.0 113.754 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -71.7 -26.54 19.32 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 CA-C-N 126.04 3.193 . . . . 0.0 110.908 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -85.65 -8.81 58.0 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.97 79.68 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.105 -0.997 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.82 -33.32 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.95 -26.96 49.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 120.56 -1.337 . . . . 0.0 111.174 -175.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -70.87 -46.43 62.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -66.25 -20.79 66.21 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.313 -0.867 . . . . 0.0 112.941 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.54 -51.47 72.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 124.457 1.103 . . . . 0.0 110.337 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.26 -27.45 61.58 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 118.803 0.728 . . . . 0.0 110.333 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -69.88 -37.9 76.19 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.94 -29.27 68.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.187 -0.945 . . . . 0.0 111.587 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -88.62 4.67 46.21 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.145 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.384 12.7 p 79.34 -63.62 0.26 Allowed 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 127.762 2.425 . . . . 0.0 107.889 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -1.19 -77.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.023 1 C-N-CA 131.964 4.106 . . . . 0.0 113.064 -177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.57 68.96 1.48 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -63.59 -29.35 70.61 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 121.584 -0.95 . . . . 0.0 111.941 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 42.7 0.88 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -65.24 -46.29 81.2 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -138.95 -152.51 0.42 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -165.99 146.29 5.46 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 100.598 -3.852 . . . . 0.0 100.598 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.83 -174.65 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 124.72 3.613 . . . . 0.0 108.791 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.646 HG22 ' H ' ' C' ' 64' ' ' THR . 13.8 p -135.35 -171.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.646 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.6 m -75.31 -41.86 55.98 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 126.394 1.877 . . . . 0.0 110.389 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.23 -24.42 59.32 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.833 0.853 . . . . 0.0 109.619 -167.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -59.49 -45.91 90.33 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.45 78.03 0.73 Allowed Glycine 0 CA--C 1.465 -3.089 1 N-CA-C 97.44 -6.264 . . . . 0.0 97.44 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -47.51 -17.71 0.1 Allowed 'General case' 0 C--N 1.37 1.499 0 C-N-CA 127.984 2.513 . . . . 0.0 114.629 -166.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -51.18 -16.03 0.44 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 127.637 2.375 . . . . 0.0 113.689 165.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . 0.267 30.0 t -72.04 -39.67 66.36 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 CA-C-N 123.504 2.865 . . . . 0.0 109.2 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.89 95.97 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 110.757 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.34 -43.82 97.93 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.066 0.946 . . . . 0.0 111.066 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -59.58 -51.05 71.51 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 125.077 1.351 . . . . 0.0 111.17 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.08 -43.19 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 26.8 ttp -60.1 -50.32 74.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.266 1.026 . . . . 0.0 110.561 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -65.57 -39.55 91.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.691 -0.631 . . . . 0.0 110.181 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.65 91.73 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.067 0.547 . . . . 0.0 111.059 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.04 -48.22 82.12 Favored Glycine 0 CA--C 1.494 -1.237 0 C-N-CA 123.74 0.686 . . . . 0.0 112.013 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.22 -45.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 124.03 0.932 . . . . 0.0 109.365 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.2 -42.79 95.84 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.27 1.028 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.88 -50.1 78.98 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 110.914 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.27 -35.01 78.63 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 121.363 -0.836 . . . . 0.0 111.167 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.66 -36.95 79.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.128 0.571 . . . . 0.0 110.405 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.01 -25.18 68.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.186 1.394 . . . . 0.0 111.968 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.44 -16.9 8.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 125.155 1.382 . . . . 0.0 110.745 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.8 t -66.16 -11.73 51.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 119.707 -1.87 . . . . 0.0 111.936 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.39 -19.91 63.9 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 110.902 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' C' ' 4' ' ' HIS . . . -89.78 -61.27 1.73 Allowed 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 125.329 1.452 . . . . 0.0 107.722 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.3 mt -68.48 -28.39 66.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -165.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.31 -12.0 60.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 120.626 -1.296 . . . . 0.0 110.632 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -81.58 -15.07 55.89 Favored 'General case' 0 CA--C 1.492 -1.257 0 O-C-N 120.365 -1.46 . . . . 0.0 107.905 175.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.307 63.7 m-20 -93.38 10.57 31.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.222 -155.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -100.12 -19.1 16.63 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 121.515 -0.741 . . . . 0.0 109.793 159.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.9 -25.85 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.487 -1.383 . . . . 0.0 107.339 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -72.22 -3.21 22.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.868 -1.145 . . . . 0.0 112.365 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -61.65 -25.53 67.44 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 120.435 -1.416 . . . . 0.0 109.9 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.25 -32.75 61.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 124.419 1.088 . . . . 0.0 109.311 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -76.09 -35.38 59.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.357 1.863 . . . . 0.0 108.28 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -77.1 -41.69 41.08 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.235 -0.915 . . . . 0.0 112.114 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -89.54 -12.93 38.49 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.074 -1.016 . . . . 0.0 110.91 -172.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -126.53 112.06 15.11 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.81 -10.69 34.86 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 . . . . . 0 CA--C 1.495 -1.135 0 O-C-N 121.085 -1.244 . . . . 0.0 107.731 -177.686 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.432 -1.357 0 N-CA-C 102.602 -3.11 . . . . 0.0 102.602 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.47 -61.02 1.77 Allowed 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -168.3 -89.77 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 -162.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.508 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 5.3 p80 -59.26 -22.65 61.47 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.557 2.743 . . . . 0.0 114.371 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.466 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 44.1 mp0 -67.68 -27.76 67.11 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -69.84 -37.92 76.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -79.36 -34.18 42.26 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.72 95.7 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.424 -0.798 . . . . 0.0 111.355 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.23 67.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.873 -0.517 . . . . 0.0 110.184 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.45 -35.2 79.65 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 124.213 1.005 . . . . 0.0 110.627 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.29 69.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 111.463 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -62.18 -41.07 97.99 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.157 -0.964 . . . . 0.0 110.983 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 -27.46 68.92 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 111.756 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -73.69 -35.32 65.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.0 -41.73 95.12 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.802 -1.187 . . . . 0.0 110.458 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -59.92 -31.35 69.75 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.788 1.235 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -66.67 -47.63 71.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.911 1.284 . . . . 0.0 108.941 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.68 -30.44 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.26 -47.58 83.12 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -65.06 -48.64 73.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 124.657 1.183 . . . . 0.0 109.246 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -66.03 -34.98 79.33 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.506 1.122 . . . . 0.0 110.575 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.27 43.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.534 -1.354 . . . . 0.0 111.295 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -64.31 -43.77 93.66 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.534 -0.729 . . . . 0.0 109.969 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -69.76 -30.18 67.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -66.49 -50.95 61.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -45.54 78.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.895 1.278 . . . . 0.0 112.248 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.88 -28.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.065 -1.022 . . . . 0.0 111.151 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.29 -33.3 22.16 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.545 -1.347 . . . . 0.0 108.674 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.26 74.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.834 2.054 . . . . 0.0 109.408 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -36.51 84.12 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.52 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp85 -78.38 89.07 4.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.239 1.019 . . . . 0.0 111.653 -165.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.42 -12.74 4.32 Favored Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.69 53.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 124.776 1.23 . . . . 0.0 108.493 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.22 141.99 13.19 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 123.108 2.146 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.19 77.33 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 170.87 9.46 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.3 92.32 1.86 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.05 58.46 0.07 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.013 0.911 . . . . 0.0 109.057 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 28.0 pt -95.23 -179.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 O-C-N 119.908 -1.745 . . . . 0.0 108.801 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.8 134.74 0.02 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.411 2.685 . . . . 0.0 114.044 172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -65.97 -46.11 64.1 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 119.715 -1.865 . . . . 0.0 110.484 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -73.45 -11.75 24.67 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 124.185 2.53 . . . . 0.0 113.971 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . 0.251 1.5 m-20 -90.64 -44.6 9.42 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -31.51 72.78 Favored 'General case' 0 CA--C 1.494 -1.205 0 O-C-N 121.178 -0.951 . . . . 0.0 112.238 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.17 -31.98 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 121.892 -0.505 . . . . 0.0 110.698 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -36.51 76.06 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 120.528 -1.357 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' D' ' 60' ' ' ARG . 65.7 t90 -70.55 -35.11 72.94 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.377 -0.827 . . . . 0.0 110.024 174.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -61.69 -42.06 98.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.178 0.991 . . . . 0.0 109.413 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.37 -53.54 42.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 125.159 1.384 . . . . 0.0 110.196 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.79 -45.89 70.86 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.435 1.494 . . . . 0.0 111.782 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 94.9 m -66.9 -38.13 85.67 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.071 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.35 73.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.461 -0.775 . . . . 0.0 111.36 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -86.22 5.07 35.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 118.98 -0.534 . . . . 0.0 112.273 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 62.7 p 55.98 46.04 22.66 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.658 1.183 . . . . 0.0 112.982 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.527 HG23 ' H ' ' D' ' 56' ' ' GLY . 0.3 OUTLIER -112.03 -93.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.527 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 101.89 64.68 0.75 Allowed Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -28.57 68.01 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -172.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 129.01 2.27 5.63 Favored Glycine 0 CA--C 1.488 -1.654 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.447 ' CG ' HH22 ' A' ' 68' ' ' ARG . 1.7 m-20 -64.79 -41.79 95.54 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.446 ' HB2' ' CD1' ' D' ' 47' ' ' TRP . 50.5 mmt-85 -134.56 143.72 47.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 102.634 -3.099 . . . . 0.0 102.634 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -128.41 130.61 23.53 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.61 170.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 108.841 172.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -128.96 -167.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -76.8 -36.21 57.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 120.606 -1.309 . . . . 0.0 109.125 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -72.4 -24.06 61.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.059 1.344 . . . . 0.0 112.369 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.11 -24.44 51.74 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 123.108 1.432 . . . . 0.0 107.249 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 60.72 1.17 Allowed Glycine 0 CA--C 1.463 -3.209 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -31.88 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 1 C-N-CA 131.963 4.105 . . . . 0.0 116.927 -171.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.06 1.34 2.81 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 120.375 -1.453 . . . . 0.0 113.309 167.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -51.55 57.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.36 67.88 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.605 1.162 . . . . 0.0 110.965 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -52.44 -40.13 61.86 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.033 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -67.64 -33.75 75.59 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.61 -38.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 120.788 -1.195 . . . . 0.0 109.463 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -60.52 -39.61 88.45 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.761 -0.587 . . . . 0.0 110.902 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -57.52 -47.37 82.14 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 123.738 0.815 . . . . 0.0 110.76 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.06 97.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.875 0.47 . . . . 0.0 110.993 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.09 -50.57 50.95 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.15 -48.29 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.35 1.06 . . . . 0.0 109.385 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.29 -36.86 84.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.88 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.99 -51.83 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 119.388 0.995 . . . . 0.0 109.658 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.87 -21.84 63.3 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.448 -0.783 . . . . 0.0 111.114 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.02 -33.63 20.99 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.89 -39.19 88.31 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 124.529 1.132 . . . . 0.0 110.233 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.94 -7.99 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 121.519 -0.738 . . . . 0.0 112.321 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -60.86 -18.06 53.84 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-N 119.205 0.911 . . . . 0.0 110.229 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 119.704 -1.873 . . . . 0.0 112.372 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.79 71.69 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.06 -25.83 58.93 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.878 0.371 . . . . 0.0 110.9 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.19 -49.71 33.31 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 120.578 -1.326 . . . . 0.0 109.816 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -71.26 1.8 5.6 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.987 -1.07 . . . . 0.0 111.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.34 -24.09 63.86 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.957 -1.09 . . . . 0.0 108.56 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -67.3 -16.52 64.32 Favored 'General case' 0 C--N 1.362 1.119 0 O-C-N 119.913 -1.742 . . . . 0.0 112.5 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 5.1 m -73.61 -21.64 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 O-C-N 119.652 -1.905 . . . . 0.0 110.561 -173.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -74.6 3.76 7.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.746 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -80.12 -35.77 36.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -92.29 -48.84 6.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -86.25 174.04 9.36 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 68.82 -66.48 0.24 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.682 1.993 . . . . 0.0 110.285 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -54.74 -53.76 50.86 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 129.395 3.078 . . . . 0.0 109.228 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -115.09 134.87 54.8 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.69 -31.29 6.6 Favored Glycine 0 CA--C 1.494 -1.273 0 O-C-N 121.54 -0.725 . . . . 0.0 111.349 172.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 35.2 p80 . . . . . 0 CA--C 1.502 -0.872 0 C-N-CA 125.072 1.349 . . . . 0.0 112.719 -172.037 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.17 23.12 1.08 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.745 2.418 . . . . 0.0 113.544 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 62.96 12.04 5.56 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.938 2.095 . . . . 0.0 112.113 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -154.68 -36.35 0.09 Allowed 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 120.84 -1.163 . . . . 0.0 111.0 -164.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.6 -45.76 71.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -62.26 -37.76 86.67 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.386 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.47 -37.62 56.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.99 0.916 . . . . 0.0 109.289 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.57 89.45 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.948 0.899 . . . . 0.0 111.434 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -75.79 -16.75 60.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.315 -0.866 . . . . 0.0 111.583 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -76.6 -36.89 57.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.2 80.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.655 1.182 . . . . 0.0 111.19 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -55.83 -42.45 75.74 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 123.719 0.807 . . . . 0.0 111.7 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.9 -28.82 67.03 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.27 1.028 . . . . 0.0 110.601 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -41.59 87.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 81' ' ' VAL . 24.9 tp -64.83 -39.43 93.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 122.632 0.373 . . . . 0.0 111.36 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -54.52 -46.09 73.48 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.206 0.602 . . . . 0.0 111.847 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -74.44 -32.26 62.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.88 -1.137 . . . . 0.0 111.855 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.65 -42.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.781 -1.2 . . . . 0.0 109.706 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.47 -30.42 69.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.923 -1.11 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -65.04 -41.64 95.01 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.607 -1.308 . . . . 0.0 111.033 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -62.29 -47.05 86.02 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.16 0.981 . . . . 0.0 109.268 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -27.89 69.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.76 0.824 . . . . 0.0 112.39 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.7 m -63.18 -33.33 75.24 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.366 1.067 . . . . 0.0 111.379 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -72.56 -36.37 68.21 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.22 -47.55 67.56 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -47.17 79.08 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.992 1.717 . . . . 0.0 112.672 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.6 -30.33 46.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 O-C-N 120.748 -1.22 . . . . 0.0 110.789 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.06 -41.74 41.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.677 -1.264 . . . . 0.0 108.515 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.51 38.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 128.005 2.522 . . . . 0.0 108.634 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -63.82 -50.71 67.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.509 1.124 . . . . 0.0 111.134 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.0 ttp85 -81.55 101.58 10.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 119.681 -1.887 . . . . 0.0 111.266 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -27.18 2.16 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 104.593 -3.403 . . . . 0.0 104.593 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.09 151.13 62.79 Favored Pre-proline 0 N--CA 1.439 -1.025 0 C-N-CA 124.016 0.927 . . . . 0.0 111.932 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -77.62 105.5 2.04 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.878 2.386 . . . . 0.0 112.12 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.67 11.62 11.28 Favored Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.91 132.3 5.34 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 127.442 2.297 . . . . 0.0 115.276 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.06 -61.69 1.65 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.279 1.032 . . . . 0.0 111.166 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.79 106.85 18.35 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-O 122.257 1.027 . . . . 0.0 112.798 -171.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -111.41 169.58 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 O-C-N 120.266 -1.521 . . . . 0.0 108.586 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 m 71.81 146.01 0.07 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.771 2.428 . . . . 0.0 113.141 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -72.69 -51.58 6.8 Favored Pre-proline 0 C--N 1.349 0.583 0 CA-C-O 115.925 -1.988 . . . . 0.0 111.886 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.14 -11.02 26.71 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 125.338 2.942 . . . . 0.0 111.992 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.2 -34.7 11.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.1 96.04 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.037 -1.04 . . . . 0.0 110.771 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.88 -33.4 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 122.753 0.421 . . . . 0.0 111.562 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -28.79 65.45 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.152 -1.592 . . . . 0.0 110.763 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -76.93 -40.55 46.77 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 107.962 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.4 m -63.87 -30.81 71.86 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 121.026 -1.046 . . . . 0.0 112.61 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.23 -36.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-N 118.723 0.692 . . . . 0.0 110.155 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -63.19 -61.1 2.6 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -50.33 -36.99 34.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.176 1.79 . . . . 0.0 113.25 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.38 97.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.707 1.203 . . . . 0.0 111.71 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -91.51 4.68 51.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.283 30.1 p 66.86 -136.54 0.14 Allowed 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 127.304 2.242 . . . . 0.0 108.244 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 t 69.19 -79.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.64 87.45 0.47 Allowed Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -72.01 -33.31 67.97 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.399 -1.059 . . . . 0.0 108.263 -170.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.57 16.55 1.65 Allowed Glycine 0 CA--C 1.489 -1.575 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -58.93 -56.36 23.25 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 117.838 0.819 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 166.34 24.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 174.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.8 142.7 19.21 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 102.314 -3.217 . . . . 0.0 102.314 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -84.06 162.53 13.6 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.02 2.48 . . . . 0.0 110.132 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 64' ' ' THR . 1.7 p -104.77 176.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 122.288 1.042 . . . . 0.0 108.965 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.551 ' HA ' ' CE2' ' D' ' 46' ' ' TRP . 0.2 OUTLIER -61.67 -47.8 83.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 127.59 2.356 . . . . 0.0 114.219 -166.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -81.48 1.09 34.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 118.967 -2.333 . . . . 0.0 110.246 -170.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -32.43 72.23 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-O 123.372 1.558 . . . . 0.0 107.797 175.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.0 85.78 0.96 Allowed Glycine 0 CA--C 1.471 -2.714 1 N-CA-C 100.995 -4.842 . . . . 0.0 100.995 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.59 ' HB2' ' CE2' ' D' ' 46' ' ' TRP . 1.7 ttp85 -58.62 -9.0 1.44 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 118.24 1.02 . . . . 0.0 113.202 -169.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -45.96 -35.9 5.07 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.207 1.403 . . . . 0.0 112.659 160.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.36 -59.5 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.12 77.21 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.503 0.721 . . . . 0.0 112.436 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.16 -39.08 71.78 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.595 2.358 . . . . 0.0 111.57 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -70.13 -31.03 68.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 t -71.65 -41.76 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 O-C-N 121.512 -0.742 . . . . 0.0 109.073 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 59.9 mtt -56.28 -49.52 74.01 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.604 1.162 . . . . 0.0 110.433 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -66.76 -37.24 84.23 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.15 -0.969 . . . . 0.0 110.647 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.56 87.34 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.152 -0.968 . . . . 0.0 111.015 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -71.08 -38.94 63.51 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -70.88 -35.77 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 O-C-N 121.289 -1.124 . . . . 0.0 109.348 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.87 -38.15 89.7 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 120.429 -1.419 . . . . 0.0 112.285 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 15' ' ' LEU . 30.7 m -68.51 -39.11 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -78.17 -30.43 49.11 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.477 0.58 . . . . 0.0 109.922 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.89 89.08 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 123.575 0.75 . . . . 0.0 110.494 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.91 -30.31 71.3 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.849 1.26 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.48 -11.99 7.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 C-N-CA 125.327 1.451 . . . . 0.0 110.614 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.681 HG21 ' HB3' ' D' ' 89' ' ' LEU . 6.8 t -53.55 -25.74 18.33 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 119.728 -1.857 . . . . 0.0 112.621 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -18.98 63.82 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 121.094 -1.004 . . . . 0.0 109.716 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.85 -50.8 7.23 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.47 -48.42 69.94 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.428 1.091 . . . . 0.0 113.423 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.18 -12.6 60.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -84.7 -27.25 27.15 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -32.97 74.6 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.557 -1.339 . . . . 0.0 110.991 -159.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -62.38 -30.64 71.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.32 -0.862 . . . . 0.0 112.837 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.78 -24.37 35.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 125.237 1.415 . . . . 0.0 108.819 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -59.35 -24.14 63.12 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.31 -0.869 . . . . 0.0 112.471 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -64.87 -28.55 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.972 -1.08 . . . . 0.0 110.395 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.51 -24.34 58.98 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 119.253 0.933 . . . . 0.0 109.805 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.4 -42.3 54.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.195 -0.941 . . . . 0.0 108.922 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -72.05 -30.51 65.22 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.663 -0.648 . . . . 0.0 110.726 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -66.98 -31.37 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.865 -1.147 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -72.59 -41.34 65.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.143 -0.973 . . . . 0.0 108.686 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.94 27.01 27.46 Favored Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.963 . . . . 0.0 111.266 -179.477 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' B' ' 5' ' ' GLU . . . -81.51 175.44 10.52 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.367 0.603 . . . . 0.0 109.773 -174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.92 -52.63 31.68 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 127.696 2.398 . . . . 0.0 111.709 -172.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -73.33 -19.53 61.0 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.264 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' B' ' 2' ' ' ALA . 3.1 mm-40 -82.33 -32.53 29.33 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.49 -25.44 61.41 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.623 -0.673 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.27 -49.85 72.46 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.568 1.147 . . . . 0.0 108.879 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.56 87.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.03 1.332 . . . . 0.0 110.838 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.23 -37.95 87.36 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.924 0.89 . . . . 0.0 110.75 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -69.46 -25.94 64.34 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 120.42 -1.425 . . . . 0.0 110.702 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.91 71.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 120.701 -1.249 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.0 -37.61 77.26 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.742 1.217 . . . . 0.0 111.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.29 -30.78 71.27 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.587 1.555 . . . . 0.0 110.11 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -70.64 -42.67 70.53 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.536 1.134 . . . . 0.0 108.57 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.21 -38.61 91.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 123.865 0.866 . . . . 0.0 111.364 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -63.77 -29.72 70.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.446 -0.784 . . . . 0.0 111.789 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -75.58 -30.28 59.59 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.858 -1.151 . . . . 0.0 110.637 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.11 -38.9 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.87 -44.95 78.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 124.069 0.948 . . . . 0.0 111.784 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.85 -48.88 67.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.337 0.655 . . . . 0.0 110.31 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.14 -24.2 60.56 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.936 -1.102 . . . . 0.0 110.898 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 -26.03 62.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 120.981 -1.075 . . . . 0.0 111.532 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -63.75 -46.8 83.66 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.64 -45.31 87.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.667 1.187 . . . . 0.0 109.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -60.55 -59.11 5.92 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.446 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.02 89.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 111.804 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.79 -35.71 61.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.72 -1.238 . . . . 0.0 110.317 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.16 -39.17 55.53 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.047 -1.033 . . . . 0.0 109.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.59 70.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 127.072 2.149 . . . . 0.0 109.461 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.58 61.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.816 -0.552 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -72.83 95.94 2.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.693 -1.879 . . . . 0.0 111.379 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.18 -11.95 3.3 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.63 152.65 47.32 Favored Pre-proline 0 N--CA 1.442 -0.845 0 O-C-N 121.254 -1.144 . . . . 0.0 109.496 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.64 152.75 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.022 2.481 . . . . 0.0 109.576 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -78.14 1.8 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.509 -3.437 . . . . 0.0 104.509 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.13 138.71 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 129.226 3.01 . . . . 0.0 111.247 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.73 -39.85 1.95 Allowed 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 120.278 -1.514 . . . . 0.0 108.289 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -100.18 137.24 38.88 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.79 0.805 . . . . 0.0 109.575 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.6 pt -147.02 175.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 100.497 -3.89 . . . . 0.0 100.497 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m 72.77 129.88 0.04 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 112.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -67.77 -48.71 41.13 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 116.818 -1.563 . . . . 0.0 110.102 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.66 -13.08 29.66 Favored 'Trans proline' 0 CA--C 1.509 -0.751 0 CA-C-N 124.987 2.817 . . . . 0.0 113.004 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.24 -25.83 17.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.988 1.267 . . . . 0.0 107.649 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.66 81.48 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.359 -0.838 . . . . 0.0 111.162 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.04 -34.12 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 121.444 -0.785 . . . . 0.0 110.301 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -36.35 72.08 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.801 -1.187 . . . . 0.0 110.327 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -64.49 -44.26 91.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.44 1.496 . . . . 0.0 109.368 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -57.74 -39.36 77.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.867 1.667 . . . . 0.0 111.3 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -53.84 -51.98 39.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 124.716 1.206 . . . . 0.0 111.271 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -71.9 -22.08 61.55 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.762 0.71 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.0 m -74.07 -40.71 62.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.017 0.927 . . . . 0.0 108.757 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -28.83 63.49 Favored 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 121.142 -0.974 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.4 p -84.64 3.83 35.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.568 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 53.82 51.58 14.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.822 1.649 . . . . 0.0 111.062 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -117.81 -111.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.105 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.21 76.39 1.22 Allowed Glycine 0 CA--C 1.483 -1.924 0 N-CA-C 104.804 -3.318 . . . . 0.0 104.804 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -74.49 -16.59 60.84 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.868 -1.371 . . . . 0.0 109.745 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.75 52.85 0.53 Allowed Glycine 0 CA--C 1.481 -2.092 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.15 -59.12 2.9 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -144.02 174.93 10.42 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -142.28 129.35 11.19 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.82 165.87 27.89 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 124.116 3.211 . . . . 0.0 110.318 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.526 HG22 ' H ' ' B' ' 64' ' ' THR . 3.8 p -101.61 -167.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 122.752 1.263 . . . . 0.0 109.234 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.526 ' H ' HG22 ' B' ' 63' ' ' VAL . 3.1 p -86.89 -39.68 15.58 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.872 -1.767 . . . . 0.0 109.245 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.62 -9.12 59.8 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.011 1.725 . . . . 0.0 110.884 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.39 -23.79 61.95 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-O 124.297 1.998 . . . . 0.0 107.18 169.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.54 75.72 1.27 Allowed Glycine 0 CA--C 1.468 -2.873 1 N-CA-C 101.978 -4.449 . . . . 0.0 101.978 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -47.61 -12.2 0.03 OUTLIER 'General case' 0 C--N 1.373 1.587 0 C-N-CA 129.96 3.304 . . . . 0.0 113.729 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -50.63 -19.62 0.97 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.458 1.903 . . . . 0.0 113.627 158.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.93 -54.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 CA-C-N 122.089 2.222 . . . . 0.0 107.342 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.54 84.85 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.324 0.583 . . . . 0.0 110.733 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.89 -42.66 80.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.269 1.428 . . . . 0.0 111.996 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.96 -40.96 95.79 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.392 1.077 . . . . 0.0 110.1 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.09 -46.92 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 C-N-CA 123.536 0.734 . . . . 0.0 109.578 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 46.1 mtp -59.23 -48.77 80.37 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.18 0.992 . . . . 0.0 110.285 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -61.99 -41.02 97.58 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.167 0.987 . . . . 0.0 110.771 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.59 91.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 123.01 0.524 . . . . 0.0 111.122 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.64 -49.57 63.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.37 -44.66 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 124.192 0.997 . . . . 0.0 109.316 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.68 -38.35 90.71 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.788 -1.195 . . . . 0.0 111.754 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.48 -53.03 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.207 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.2 -11.63 60.58 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.336 0.655 . . . . 0.0 112.118 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.99 -21.13 15.13 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 123.755 0.822 . . . . 0.0 109.657 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.94 -28.13 64.27 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 119.632 -1.918 . . . . 0.0 108.976 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.16 -14.94 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.943 0.897 . . . . 0.0 111.996 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 66.8 m -58.95 -12.44 4.55 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 125.936 1.694 . . . . 0.0 111.674 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.82 -26.05 68.55 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.538 -1.976 . . . . 0.0 112.388 167.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.01 -30.81 27.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 119.856 -1.778 . . . . 0.0 108.742 175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.26 31.42 0.65 Allowed 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 126.04 1.736 . . . . 0.0 109.29 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.6 -1.98 1.11 Allowed 'General case' 0 N--CA 1.433 -1.316 0 O-C-N 120.59 -1.318 . . . . 0.0 108.26 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -116.85 16.94 15.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -83.2 -48.52 10.41 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.354 2.262 . . . . 0.0 107.188 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -65.2 -20.41 66.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.481 1.113 . . . . 0.0 111.648 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.55 -28.53 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 124.657 1.183 . . . . 0.0 109.375 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -65.65 -21.72 66.58 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 124.51 1.124 . . . . 0.0 111.916 -172.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -19.18 63.33 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.828 -1.17 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -96.26 179.58 4.99 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.311 7.6 mt-10 70.21 -59.26 0.52 Allowed 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.355 1.462 . . . . 0.0 112.058 -172.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -30.71 70.16 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.935 1.294 . . . . 0.0 109.762 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.91 -33.35 61.98 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 126.568 1.947 . . . . 0.0 112.796 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -110.35 -0.8 17.47 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 108.651 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.2 11.46 85.03 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 121.402 -0.811 . . . . 0.0 112.363 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 CA--C 1.504 -0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 110.865 -171.289 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.15 -7.53 0.95 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.304 2.242 . . . . 0.0 113.69 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . 0.28 38.1 m-20 19.17 68.35 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.911 1 C-N-CA 132.657 4.383 . . . . 0.0 113.328 -173.68 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -161.68 -45.61 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.48 -47.69 83.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.879 2.072 . . . . 0.0 110.263 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -80.73 -6.63 58.72 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.645 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.84 -47.36 11.95 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.65 93.85 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.044 0.938 . . . . 0.0 110.632 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -57.11 -38.28 73.18 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 124.815 1.246 . . . . 0.0 111.751 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -72.92 -28.11 62.26 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.167 -0.958 . . . . 0.0 110.446 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.27 -40.29 77.9 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.056 0.542 . . . . 0.0 109.695 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.11 -40.33 93.36 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.515 0.726 . . . . 0.0 110.947 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.36 -38.8 81.33 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.74 0.816 . . . . 0.0 111.442 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.29 -40.09 93.39 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.116 1.366 . . . . 0.0 109.519 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.49 -38.65 91.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.555 -0.716 . . . . 0.0 111.055 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.44 -31.8 72.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.382 -0.824 . . . . 0.0 112.149 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -67.73 -39.65 84.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.05 0.94 . . . . 0.0 109.368 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.54 -32.61 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 124.286 1.034 . . . . 0.0 109.035 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.3 -44.95 88.78 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.016 0.825 . . . . 0.0 111.176 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.54 -38.27 80.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.398 0.679 . . . . 0.0 110.242 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.56 -44.42 86.79 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 121.186 -0.946 . . . . 0.0 109.077 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.18 72.91 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.807 1.643 . . . . 0.0 111.41 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -59.42 -47.6 84.84 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.006 0.922 . . . . 0.0 111.553 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -45.69 69.76 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 125.149 1.38 . . . . 0.0 108.221 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.64 -36.07 78.12 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.893 0.477 . . . . 0.0 111.01 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.73 -44.42 61.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 123.825 0.85 . . . . 0.0 110.73 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.57 -32.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 121.471 -0.768 . . . . 0.0 110.018 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -84.66 -12.85 53.09 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.108 -0.995 . . . . 0.0 111.382 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.4 78.73 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.494 ' OE1' HG12 ' C' ' 63' ' ' VAL . 80.6 mm-40 -81.33 -10.12 59.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.764 0.792 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -78.97 81.96 5.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 119.921 -1.737 . . . . 0.0 108.3 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.09 0.51 4.22 Favored Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.21 42.89 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.37 112.51 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.533 2.155 . . . . 0.0 113.388 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.26 -46.27 0.67 Allowed Glycine 0 CA--C 1.482 -1.999 1 N-CA-C 101.949 -4.461 . . . . 0.0 101.949 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 73.16 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.626 1.97 . . . . 0.0 108.419 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.6 -71.39 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 112.573 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 tt -100.68 120.35 39.94 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.48 13.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 28.3 t -109.67 130.49 55.51 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.72 -56.36 9.74 Favored Pre-proline 0 C--N 1.349 0.572 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.026 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.02 -12.07 25.73 Favored 'Trans proline' 0 CA--C 1.511 -0.669 0 CA-C-N 124.988 2.817 . . . . 0.0 111.386 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.83 -20.34 21.58 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 119.366 0.985 . . . . 0.0 108.7 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.49 -36.25 83.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.338 -0.851 . . . . 0.0 109.95 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -72.35 -25.92 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.876 1.27 . . . . 0.0 110.557 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 -42.27 37.02 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.525 -1.359 . . . . 0.0 107.812 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -70.07 -32.47 70.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.657 0.783 . . . . 0.0 110.684 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 54.6 p -68.67 -27.52 66.06 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 120.249 -1.532 . . . . 0.0 111.311 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.03 -53.57 47.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 CA-C-N 119.14 0.882 . . . . 0.0 109.601 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.96 -10.94 59.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.812 -0.555 . . . . 0.0 112.005 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -81.12 -33.32 33.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.172 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -35.55 75.35 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.775 -1.203 . . . . 0.0 111.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.46 0.73 48.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 122.039 -0.413 . . . . 0.0 110.596 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.9 p 65.42 20.18 11.72 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 126.085 1.754 . . . . 0.0 111.493 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.79 -55.89 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.39 44.31 97.81 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 121.629 -0.669 . . . . 0.0 112.125 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 1.5 t80 -55.84 -40.65 73.13 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.616 1.567 . . . . 0.0 110.518 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.59 -122.79 1.12 Allowed Glycine 0 CA--C 1.48 -2.14 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.322 4.4 t0 62.62 -85.29 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 127.072 2.149 . . . . 0.0 108.947 -168.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -119.67 169.07 10.42 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.34 148.72 21.48 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.92 176.58 7.49 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.033 2.488 . . . . 0.0 108.695 171.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.755 HG13 ' H ' ' C' ' 64' ' ' THR 0.285 9.9 p -101.2 -121.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 170.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.755 ' H ' HG13 ' C' ' 63' ' ' VAL . 12.6 m -107.34 -82.67 0.55 Allowed 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 120.283 -1.511 . . . . 0.0 107.174 -171.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.05 122.41 12.98 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.101 1.36 . . . . 0.0 109.406 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . 0.28 6.6 tt0 76.33 -68.63 0.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.301 -1.333 . . . . 0.0 112.637 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -37.15 -49.07 1.54 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 128.216 2.817 . . . . 0.0 114.646 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -75.31 -38.46 60.26 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.798 1.239 . . . . 0.0 112.094 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -76.48 -29.74 56.99 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.84 -44.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 O-C-N 119.766 -1.834 . . . . 0.0 109.08 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.14 99.37 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 111.205 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -48.82 -44.85 39.69 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.692 1.997 . . . . 0.0 112.194 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -63.94 -40.1 95.66 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.69 -39.23 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 124.342 1.057 . . . . 0.0 109.263 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.42 -45.86 87.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.28 -39.34 94.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.696 0.799 . . . . 0.0 110.931 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.48 71.61 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.914 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.65 -49.87 7.63 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.13 -46.29 84.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 110.167 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.62 -31.83 73.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.421 -0.799 . . . . 0.0 112.572 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.59 -51.59 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -66.17 -33.98 77.01 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 122.878 0.471 . . . . 0.0 110.975 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.56 83.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.53 1.132 . . . . 0.0 110.517 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.72 -22.16 66.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.772 1.229 . . . . 0.0 112.935 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -59.59 -19.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 124.892 1.277 . . . . 0.0 110.401 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -57.77 -20.42 34.95 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 112.631 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.0 51.15 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.311 -1.493 . . . . 0.0 112.422 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.09 -31.57 11.7 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.792 1.237 . . . . 0.0 110.644 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 35.1 mt -82.62 -41.43 19.47 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.428 -0.795 . . . . 0.0 109.956 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.84 72.75 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.5 1.12 . . . . 0.0 109.62 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -16.79 64.13 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.522 -1.361 . . . . 0.0 112.098 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 26.4 t70 -74.36 -24.42 59.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.497 1.044 . . . . 0.0 110.518 -168.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -37.97 61.3 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 120.705 -1.247 . . . . 0.0 109.705 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.25 -27.85 42.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 125.32 1.448 . . . . 0.0 110.191 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -59.72 -22.52 62.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.342 1.057 . . . . 0.0 113.027 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . 0.3 18.3 ptt85 -69.46 -28.59 66.23 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 121.254 1.843 . . . . 0.0 111.506 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.8 -13.45 59.8 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 119.621 -1.924 . . . . 0.0 110.345 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.437 ' OE1' ' HE1' ' C' ' 103' ' ' HIS . 87.4 mt-10 -87.76 -36.72 17.16 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.269 -0.895 . . . . 0.0 108.924 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -51.97 -42.73 63.13 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 128.008 2.523 . . . . 0.0 109.545 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -45.66 -37.66 5.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.368 2.667 . . . . 0.0 114.289 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -90.62 -12.91 35.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.329 -0.857 . . . . 0.0 110.459 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.08 82.38 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 123.85 0.738 . . . . 0.0 111.74 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.437 ' HE1' ' OE1' ' C' ' 98' ' ' GLU . 83.9 m-70 . . . . . 0 CA--C 1.504 -0.795 0 C-N-CA 124.527 1.131 . . . . 0.0 111.202 -172.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 144.98 33.96 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -55.85 -46.28 78.23 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.087 2.155 . . . . 0.0 110.466 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CD2' ' HB1' ' D' ' 87' ' ' ALA 0.252 1.4 m80 -81.15 -16.34 53.25 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -169.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.06 -30.82 31.17 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.418 1.008 . . . . 0.0 109.166 169.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -63.42 -46.1 87.94 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.54 -31.17 66.74 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.97 -0.457 . . . . 0.0 110.4 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.21 70.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 121.353 -0.842 . . . . 0.0 110.744 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -69.84 -29.95 67.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.835 -0.54 . . . . 0.0 111.574 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.27 -40.62 91.0 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.713 0.805 . . . . 0.0 110.232 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.46 84.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.591 0.756 . . . . 0.0 111.445 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.19 -37.88 81.56 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 121.459 -0.775 . . . . 0.0 110.912 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -70.96 -26.53 63.2 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.981 -1.075 . . . . 0.0 111.337 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -76.15 -34.19 59.38 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.23 -39.53 93.12 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.33 0.652 . . . . 0.0 111.164 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.02 -35.19 74.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.615 0.766 . . . . 0.0 111.916 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -67.11 -39.25 86.64 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.691 -0.631 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.65 -39.85 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.075 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.738 HD22 ' H ' ' D' ' 49' ' ' VAL . 87.3 mt -64.84 -37.5 87.84 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.136 0.974 . . . . 0.0 112.478 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -67.84 -32.69 73.38 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.61 0.719 . . . . 0.0 111.577 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.79 -36.4 28.48 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 121.417 -0.802 . . . . 0.0 108.949 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.35 84.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 125.455 1.502 . . . . 0.0 111.992 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -66.77 -40.95 88.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.597 0.713 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -69.09 -39.47 78.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 109.175 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -73.59 -40.33 63.96 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.855 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.21 80.89 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.092 1.357 . . . . 0.0 112.642 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.96 -38.05 81.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 O-C-N 120.832 -1.168 . . . . 0.0 111.647 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.91 -23.17 36.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.964 -1.085 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.24 -52.81 20.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.641 1.976 . . . . 0.0 107.774 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.02 -33.44 70.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.582 1.182 . . . . 0.0 111.946 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -68.93 104.77 2.17 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.63 -1.919 . . . . 0.0 112.14 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.06 -33.92 1.98 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 104.824 -3.311 . . . . 0.0 104.824 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.41 150.64 73.95 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 123.771 0.828 . . . . 0.0 110.412 -173.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.46 145.63 23.81 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.064 1.842 . . . . 0.0 109.301 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.11 17.57 74.07 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 118.563 0.619 . . . . 0.0 112.125 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.49 128.41 22.79 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.891 1.676 . . . . 0.0 113.573 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.44 -39.46 1.02 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.993 1.317 . . . . 0.0 109.709 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.39 15.3 1.28 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.84 1.656 . . . . 0.0 111.609 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tp -98.63 121.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 119.6 -1.937 . . . . 0.0 108.257 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.8 p -172.82 -105.06 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.81 -65.21 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.006 0 C-N-CA 128.111 2.565 . . . . 0.0 106.827 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 -18.98 28.24 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 CA-C-N 124.837 2.763 . . . . 0.0 110.804 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.62 -22.56 26.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.87 -33.64 62.11 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 120.941 -1.099 . . . . 0.0 111.468 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.67 -20.79 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.607 1.194 . . . . 0.0 108.747 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.59 ' CE2' ' HB2' ' A' ' 68' ' ' ARG . 24.9 t90 -77.55 -40.43 42.51 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.336 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -60.14 -44.14 95.19 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.19 1.396 . . . . 0.0 109.925 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 82.3 p -74.97 -169.76 0.97 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.999 0.904 . . . . 0.0 108.982 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.738 ' H ' HD22 ' D' ' 19' ' ' LEU 0.352 2.1 t 71.58 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.955 2.102 . . . . 0.0 110.683 -170.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -28.63 70.13 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.618 1.099 . . . . 0.0 110.415 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -29.87 69.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.037 0.935 . . . . 0.0 111.126 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -77.94 -27.75 49.42 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.809 -1.182 . . . . 0.0 109.844 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -83.74 3.63 32.43 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.442 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 71.2 p 54.61 59.59 4.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.252 2.221 . . . . 0.0 111.871 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -109.06 -89.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 89.45 60.45 1.45 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -9.95 59.24 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 121.674 -0.898 . . . . 0.0 111.498 -170.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.37 35.35 3.63 Favored Glycine 0 CA--C 1.486 -1.763 0 O-C-N 120.467 -1.395 . . . . 0.0 110.81 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.02 -65.23 0.8 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -138.01 153.76 49.37 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 102.957 -2.979 . . . . 0.0 102.957 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.69 144.22 48.05 Favored Pre-proline 0 N--CA 1.44 -0.937 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.01 165.9 25.62 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.249 2.632 . . . . 0.0 109.546 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.546 HG12 ' H ' ' D' ' 64' ' ' THR . 2.8 t -103.69 -153.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.546 ' H ' HG12 ' D' ' 63' ' ' VAL . 0.2 OUTLIER -93.14 -54.29 3.78 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 119.619 -1.926 . . . . 0.0 109.279 -161.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.03 3.65 33.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 109.245 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -25.91 62.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.85 55.54 1.4 Allowed Glycine 0 CA--C 1.466 -3.012 0 N-CA-C 104.575 -3.41 . . . . 0.0 104.575 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -21.42 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.376 1.733 1 C-N-CA 133.878 4.871 . . . . 0.0 116.825 -174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -52.47 -16.21 0.84 Allowed 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 125.601 1.56 . . . . 0.0 113.256 162.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.05 -47.39 88.09 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 122.246 2.294 . . . . 0.0 108.449 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.94 -47.84 73.35 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.099 0.56 . . . . 0.0 110.63 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.03 -38.95 80.5 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 111.704 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -67.79 -29.33 68.49 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.561 -1.337 . . . . 0.0 111.44 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.71 -42.13 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 121.307 -0.87 . . . . 0.0 108.672 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.54 -49.71 76.44 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.717 1.207 . . . . 0.0 109.829 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -65.32 -37.77 88.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.015 -0.428 . . . . 0.0 111.298 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.94 92.38 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -50.39 61.49 Favored Glycine 0 CA--C 1.49 -1.478 0 C-N-CA 124.129 0.871 . . . . 0.0 111.067 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -57.83 -48.29 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.387 1.075 . . . . 0.0 109.598 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.05 -32.05 73.57 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 t -65.62 -55.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-N 119.371 0.987 . . . . 0.0 109.388 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.63 -38.6 84.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.324 0.583 . . . . 0.0 110.375 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.53 63.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.346 -0.847 . . . . 0.0 111.047 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.06 -30.9 71.5 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.182 -1.574 . . . . 0.0 110.118 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 -12.47 7.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.804 1.242 . . . . 0.0 110.68 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -52.79 -22.82 5.78 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.448 -1.408 . . . . 0.0 111.621 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' D' ' 4' ' ' HIS . . . -73.54 -19.26 60.95 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 119.466 -2.021 . . . . 0.0 114.423 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.32 -41.8 15.19 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.681 ' HB3' HG21 ' A' ' 86' ' ' THR . 39.8 mt -59.91 -40.98 90.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 112.525 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.83 64.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.201 -0.937 . . . . 0.0 111.871 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -92.14 -1.0 57.42 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 120.777 -1.202 . . . . 0.0 108.462 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -74.58 -30.22 61.63 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 119.253 0.933 . . . . 0.0 109.753 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -80.83 -31.8 35.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 120.597 -1.314 . . . . 0.0 111.524 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -23.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 125.163 1.385 . . . . 0.0 109.294 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -50.16 -35.35 25.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 125.606 1.563 . . . . 0.0 113.256 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ptt85 -71.24 -16.57 62.5 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.315 -0.866 . . . . 0.0 110.87 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -77.45 -43.88 30.91 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.38 -45.29 76.69 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.517 -0.74 . . . . 0.0 111.454 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.4 -9.91 59.19 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.281 -0.887 . . . . 0.0 111.5 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 18.8 ttp-105 -70.25 -31.09 68.32 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -78.92 -23.6 44.59 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.163 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.07 17.15 59.78 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 . . . . . 0 C--N 1.357 0.905 0 C-N-CA 125.916 1.686 . . . . 0.0 112.409 -178.182 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -72.08 0.23 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 123.225 0.61 . . . . 0.0 109.407 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -151.85 -82.49 0.09 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -0.28 31.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 121.068 -1.02 . . . . 0.0 113.324 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -30.06 68.26 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.334 1.454 . . . . 0.0 108.248 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -66.88 -37.9 85.29 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.606 0.763 . . . . 0.0 109.05 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.7 -28.55 36.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.38 76.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.421 0.629 . . . . 0.0 111.16 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -75.32 -23.49 57.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.568 -0.707 . . . . 0.0 111.043 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.84 -36.03 77.68 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.588 -0.695 . . . . 0.0 109.51 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.84 71.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.976 -1.078 . . . . 0.0 111.471 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.83 -23.22 65.14 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.417 -0.802 . . . . 0.0 111.97 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.47 -43.09 67.24 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 120.658 -1.276 . . . . 0.0 109.242 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.48 -39.14 92.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.653 1.181 . . . . 0.0 108.645 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.24 -43.29 92.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.003 0.521 . . . . 0.0 111.562 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.17 -30.9 71.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.812 0.845 . . . . 0.0 111.905 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -69.43 -39.8 77.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.49 -0.756 . . . . 0.0 109.646 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.8 -38.79 82.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 O-C-N 121.29 -0.881 . . . . 0.0 109.202 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -58.77 -42.68 89.53 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.788 0.835 . . . . 0.0 111.618 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.82 -28.53 62.61 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 124.33 1.052 . . . . 0.0 111.737 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -73.73 -46.12 47.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.745 -1.222 . . . . 0.0 107.798 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -27.95 68.73 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.761 1.225 . . . . 0.0 112.221 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 p -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.654 1.116 . . . . 0.0 110.791 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -68.32 -43.62 77.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.58 -44.72 95.61 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.02 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 126.212 1.805 . . . . 0.0 112.42 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 41' ' ' TYR . 26.2 m -64.66 -34.94 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 119.955 1.252 . . . . 0.0 112.131 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -78.18 -35.48 48.64 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 125.256 1.423 . . . . 0.0 108.38 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -77.67 -51.2 10.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 124.662 1.185 . . . . 0.0 108.505 -175.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.03 -40.66 87.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.085 0.945 . . . . 0.0 110.267 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -77.23 104.82 7.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 119.802 -1.811 . . . . 0.0 111.349 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -21.89 2.36 Favored Glycine 0 CA--C 1.49 -1.489 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.23 89.0 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 123.4 0.68 . . . . 0.0 110.702 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.68 126.05 11.69 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.971 2.448 . . . . 0.0 110.105 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -67.81 3.26 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 106.069 -2.812 . . . . 0.0 106.069 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.7 -172.98 0.18 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 126.516 1.926 . . . . 0.0 108.55 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.81 -40.41 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 120.752 -1.217 . . . . 0.0 110.969 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.33 -68.47 0.64 Allowed 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt 32.02 37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 128.326 2.65 . . . . 0.0 114.934 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -148.72 133.6 18.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' HG11 ' A' ' 27' ' ' VAL . 73.8 t80 -79.67 -52.14 1.12 Allowed Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-O 116.01 -1.947 . . . . 0.0 110.8 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.71 -13.42 29.66 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 CA-C-N 126.145 3.23 . . . . 0.0 111.73 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.57 -27.79 29.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.487 1.515 . . . . 0.0 108.559 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.46 -33.72 76.6 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.778 0.831 . . . . 0.0 111.785 -167.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -73.56 -24.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 123.836 0.855 . . . . 0.0 110.376 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.85 -32.45 21.71 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 120.744 -1.222 . . . . 0.0 108.766 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -70.23 -35.57 73.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.554 1.169 . . . . 0.0 108.974 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -81.27 62.47 5.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 120.674 -1.266 . . . . 0.0 108.907 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.87 -68.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -46.88 -32.99 4.15 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 130.107 3.363 . . . . 0.0 114.231 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -69.21 -37.61 78.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.879 1.672 . . . . 0.0 109.851 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.43 58.17 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 120.177 -1.577 . . . . 0.0 109.724 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -79.59 -11.09 59.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.416 1.487 . . . . 0.0 109.319 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 54.11 62.88 2.38 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.848 2.059 . . . . 0.0 112.144 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.49 -84.17 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.58 -84.66 0.36 Allowed Glycine 0 CA--C 1.482 -2.0 1 N-CA-C 101.902 -4.479 . . . . 0.0 101.902 -173.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CZ ' ' HA2' ' B' ' 56' ' ' GLY . 0.1 OUTLIER 65.13 -69.87 0.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 127.046 2.138 . . . . 0.0 111.448 179.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.32 53.15 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.722 0 O-C-N 120.529 -1.357 . . . . 0.0 115.507 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.12 -64.87 0.89 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.241 2.02 . . . . 0.0 108.113 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.82 179.05 6.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -157.72 152.82 21.51 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.47 172.22 13.8 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.782 2.988 . . . . 0.0 109.409 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 t -115.92 -100.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 119.463 1.029 . . . . 0.0 108.535 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -140.77 -44.0 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.12 -16.21 41.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.406 -0.809 . . . . 0.0 111.793 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -61.06 -35.95 78.31 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.928 1.291 . . . . 0.0 108.11 171.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 97.81 2.02 Favored Glycine 0 N--CA 1.418 -2.53 1 N-CA-C 97.548 -6.221 . . . . 0.0 97.548 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -62.08 -16.62 53.53 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 119.239 1.519 . . . . 0.0 110.112 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.46 -10.14 4.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 125.196 1.398 . . . . 0.0 112.97 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.55 -46.35 75.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 120.748 -1.22 . . . . 0.0 108.165 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.11 74.28 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -49.22 -45.15 44.04 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.529 1.532 . . . . 0.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -58.69 -47.71 83.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.759 1.224 . . . . 0.0 111.232 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.5 -42.31 72.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 O-C-N 121.749 -0.594 . . . . 0.0 109.574 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.444 ' SD ' HG11 ' D' ' 55' ' ' VAL . 48.9 mtm -61.59 -48.18 82.1 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.111 0.964 . . . . 0.0 110.105 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.52 -36.22 78.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 121.295 -0.878 . . . . 0.0 110.862 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.85 98.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.709 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.91 92.75 Favored Glycine 0 CA--C 1.491 -1.427 0 C-N-CA 124.244 0.926 . . . . 0.0 111.135 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.83 -45.39 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.127 0.971 . . . . 0.0 109.562 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -64.78 -33.7 76.6 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.587 -1.32 . . . . 0.0 111.6 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.8 -53.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 124.098 0.959 . . . . 0.0 109.692 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -71.36 -20.91 62.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.832 0.825 . . . . 0.0 111.395 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 -33.54 31.0 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.084 -1.635 . . . . 0.0 110.082 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.16 -39.8 91.49 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 124.501 1.12 . . . . 0.0 110.622 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.3 m -66.88 -6.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 O-C-N 121.65 -0.656 . . . . 0.0 112.522 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.4 m -53.69 -25.69 19.4 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 125.66 1.584 . . . . 0.0 110.427 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.14 -43.27 74.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.56 -1.337 . . . . 0.0 112.764 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -42.33 58.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.39 1.076 . . . . 0.0 109.257 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.29 -34.3 77.1 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.156 0.503 . . . . 0.0 110.68 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.41 75.88 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.824 -1.173 . . . . 0.0 111.751 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -13.1 60.0 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.757 -1.214 . . . . 0.0 111.954 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.86 -35.93 81.16 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.615 1.197 . . . . 0.0 109.106 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -73.89 -35.53 64.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 119.794 -1.816 . . . . 0.0 112.068 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.92 -25.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 C-N-CA 125.929 1.692 . . . . 0.0 109.229 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -56.47 -24.91 49.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.775 1.63 . . . . 0.0 112.71 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.71 -16.95 59.37 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.015 -1.053 . . . . 0.0 111.132 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -72.2 -30.55 65.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.02 -41.32 91.1 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 123.31 0.644 . . . . 0.0 110.296 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.01 -30.82 71.87 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 111.339 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -65.89 -38.68 89.39 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.76 0.824 . . . . 0.0 110.363 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -96.02 -7.07 37.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.126 0.571 . . . . 0.0 110.596 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.18 24.99 60.32 Favored Glycine 0 C--N 1.347 1.142 0 C-N-CA 124.707 1.146 . . . . 0.0 111.744 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t60 . . . . . 0 C--N 1.351 0.648 0 C-N-CA 126.508 1.923 . . . . 0.0 111.416 -168.868 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.98 175.57 10.88 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.72 -63.94 0.8 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 129.811 3.245 . . . . 0.0 111.589 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -59.97 -31.95 70.36 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.849 1.26 . . . . 0.0 113.382 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -71.56 -34.03 69.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.038 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -70.69 -35.7 72.92 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 120.968 -1.082 . . . . 0.0 110.397 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.56 -35.32 67.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 -46.48 81.15 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.015 0.926 . . . . 0.0 111.334 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -66.53 -34.28 77.55 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.541 -0.725 . . . . 0.0 110.467 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.91 -41.3 99.4 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 109.996 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.87 80.72 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.652 0.781 . . . . 0.0 111.228 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.55 -31.88 73.29 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.478 -0.764 . . . . 0.0 111.957 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -70.75 -32.87 70.18 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.038 -1.038 . . . . 0.0 109.425 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.82 -34.25 77.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.88 -1.138 . . . . 0.0 109.395 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.23 -38.14 87.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.447 0.699 . . . . 0.0 110.24 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -58.42 -36.48 73.66 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 124.221 1.008 . . . . 0.0 111.766 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.23 -44.77 87.17 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.867 0.867 . . . . 0.0 110.057 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 -20.05 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 121.438 -0.789 . . . . 0.0 110.698 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.76 -48.76 79.23 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 119.564 1.074 . . . . 0.0 109.874 172.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.29 -40.5 90.07 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.06 -1.025 . . . . 0.0 110.347 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -63.55 -40.05 95.98 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.735 0.814 . . . . 0.0 111.277 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.63 98.58 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 125.204 1.401 . . . . 0.0 109.575 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -57.38 -35.28 69.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.187 1.395 . . . . 0.0 112.318 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.71 -51.84 9.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.563 -0.711 . . . . 0.0 109.925 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -63.89 -28.61 69.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 120.58 -1.325 . . . . 0.0 110.796 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.75 94.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.408 1.083 . . . . 0.0 112.244 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.59 -14.69 13.77 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-O 122.35 1.071 . . . . 0.0 110.395 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -87.17 -38.61 16.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.726 -2.484 . . . . 0.0 107.862 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.22 65.79 6.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.014 1.726 . . . . 0.0 108.692 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -31.54 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.13 30.47 0.0 OUTLIER 'General case' 0 C--N 1.355 0.821 0 C-N-CA 130.527 3.531 . . . . 0.0 117.549 -168.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.84 36.66 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.12 156.69 35.74 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 119.062 1.431 . . . . 0.0 108.947 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -85.14 117.41 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.711 2.274 . . . . 0.0 112.517 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 31.35 26.34 Favored Glycine 0 CA--C 1.494 -1.269 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.84 137.87 47.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.034 0.933 . . . . 0.0 109.272 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.04 -37.99 8.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 123.529 0.732 . . . . 0.0 109.924 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.04 140.56 29.53 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 pt -156.35 37.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 CA-C-N 118.971 0.805 . . . . 0.0 109.164 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -137.59 -117.87 0.15 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 118.255 -2.778 . . . . 0.0 112.101 -158.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.68 -68.95 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.755 0 C-N-CA 128.487 2.715 . . . . 0.0 103.951 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.61 -20.05 27.32 Favored 'Trans proline' 0 CA--C 1.513 -0.55 0 CA-C-N 125.654 3.055 . . . . 0.0 111.419 -173.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.88 -25.31 61.88 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.649 1.18 . . . . 0.0 109.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.23 -36.51 79.62 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 123.542 0.737 . . . . 0.0 110.284 -167.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.89 -29.15 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.899 -0.501 . . . . 0.0 110.686 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -42.18 76.48 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.881 -1.137 . . . . 0.0 108.735 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -59.16 -48.01 83.21 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 110.09 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.5 m -57.89 -36.41 72.38 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.422 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.2 -53.69 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 123.762 0.825 . . . . 0.0 109.253 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.48 -20.88 63.73 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.279 1.038 . . . . 0.0 111.757 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -74.64 -39.77 61.89 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 120.664 -1.272 . . . . 0.0 109.253 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.29 66.91 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 120.712 -1.242 . . . . 0.0 111.933 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -1.18 56.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.646 0.778 . . . . 0.0 110.124 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 42.9 p 65.64 16.14 10.36 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.44 1.896 . . . . 0.0 111.92 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.98 -58.45 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . 62.2 56.36 22.57 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 174.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' HA2' ' C' ' 56' ' ' GLY . 6.2 t80 -57.43 -41.85 81.25 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.736 1.214 . . . . 0.0 110.422 -168.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.69 8.63 0.58 Allowed Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.13 -55.57 5.93 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 118.959 1.38 . . . . 0.0 111.734 -170.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.97 155.86 49.2 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -160.3 137.59 6.88 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.428 ' HA ' ' OE1' ' B' ' 66' ' ' GLU . 34.8 Cg_endo -82.21 159.22 17.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 122.687 1.995 . . . . 0.0 112.119 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . 0.263 34.9 m -106.33 -154.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 122.663 1.22 . . . . 0.0 111.32 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -73.41 -54.82 7.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.257 1.823 . . . . 0.0 111.434 -165.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -69.39 -16.84 63.6 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.154 1.782 . . . . 0.0 109.376 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' B' ' 62' ' ' PRO . 94.8 mt-10 -81.97 -18.5 43.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.53 93.34 0.65 Allowed Glycine 0 CA--C 1.483 -1.917 1 N-CA-C 102.129 -4.388 . . . . 0.0 102.129 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -53.72 -28.66 35.33 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 119.162 1.481 . . . . 0.0 110.709 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -58.16 -11.95 3.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.18 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 120.988 1.722 . . . . 0.0 109.756 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.57 -57.94 3.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -53.39 -38.89 63.82 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.089 1.356 . . . . 0.0 112.93 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -76.76 -24.56 52.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.953 -1.092 . . . . 0.0 111.104 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.16 -43.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.03 -49.95 75.96 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.236 1.014 . . . . 0.0 110.647 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -72.8 -15.72 61.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.877 -1.139 . . . . 0.0 112.162 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.18 65.5 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 120.051 -1.656 . . . . 0.0 108.626 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.05 -46.97 89.87 Favored Glycine 0 CA--C 1.492 -1.347 0 C-N-CA 124.676 1.131 . . . . 0.0 111.217 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.15 -48.5 65.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 C-N-CA 124.869 1.268 . . . . 0.0 110.421 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.35 -22.55 63.73 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 120.914 -1.116 . . . . 0.0 112.523 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.84 -53.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -62.83 -41.19 99.22 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.896 0.878 . . . . 0.0 110.439 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -30.53 71.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.766 0.826 . . . . 0.0 111.381 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.85 -30.36 67.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.965 -1.085 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.5 -14.87 11.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 120.843 -1.16 . . . . 0.0 110.324 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -61.28 -20.91 63.43 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.341 -2.099 . . . . 0.0 112.241 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.35 -17.39 62.54 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 120.47 -1.394 . . . . 0.0 111.593 172.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.5 -46.87 6.8 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 124.87 1.268 . . . . 0.0 108.605 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 55.0 mt -61.2 -38.49 86.75 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 121.294 -0.879 . . . . 0.0 112.414 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.87 0.13 19.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.038 -1.039 . . . . 0.0 111.212 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.1 p -97.94 -14.27 20.72 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 120.835 -1.166 . . . . 0.0 109.716 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.33 -18.86 60.64 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 119.557 1.071 . . . . 0.0 111.054 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -91.24 -16.76 27.11 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 120.658 -1.276 . . . . 0.0 112.295 170.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.43 -27.09 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -53.69 -22.35 8.85 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 126.028 1.731 . . . . 0.0 114.572 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -66.66 -28.0 68.12 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.585 -0.697 . . . . 0.0 110.063 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.14 172.19 9.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.275 46.6 mt-10 69.88 -50.2 0.63 Allowed 'General case' 0 C--N 1.35 0.589 0 C-N-CA 126.444 1.898 . . . . 0.0 112.426 -173.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -71.53 -45.2 63.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 120.154 -1.592 . . . . 0.0 108.534 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -77.04 -31.08 55.96 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.82 -0.55 . . . . 0.0 111.986 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 36.9 ttp-105 -117.12 108.71 16.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.54 -52.59 0.76 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 105.272 -3.131 . . . . 0.0 105.272 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 CA--C 1.501 -0.934 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -170.173 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 122.772 1.272 . . . . 0.0 107.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.58 142.27 18.83 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -89.14 -53.41 4.59 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.433 ' HE1' ' OE2' ' C' ' 5' ' ' GLU . 18.6 p80 -48.87 -35.83 15.64 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.497 1.919 . . . . 0.0 114.691 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.433 ' OE2' ' HE1' ' C' ' 4' ' ' HIS . 14.0 mt-10 -80.15 -33.57 38.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.316 -1.49 . . . . 0.0 110.567 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -73.31 -31.12 63.82 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.676 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.87 -49.81 69.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.148 2.179 . . . . 0.0 108.798 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.9 87.82 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.807 1.243 . . . . 0.0 112.067 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -60.17 -36.71 78.19 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.189 0.996 . . . . 0.0 111.174 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -74.66 -19.98 60.06 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.116 -0.99 . . . . 0.0 111.705 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.99 90.56 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.573 -0.704 . . . . 0.0 109.185 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -63.24 -39.0 93.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.682 1.193 . . . . 0.0 111.344 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.24 -39.83 71.43 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.762 0.825 . . . . 0.0 109.827 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.37 -31.21 71.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.405 1.082 . . . . 0.0 110.148 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.01 -47.96 73.98 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 125.505 1.522 . . . . 0.0 110.414 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.03 -35.56 80.89 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.519 0.727 . . . . 0.0 110.374 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -67.3 -49.33 64.68 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 111.308 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.9 -40.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 121.806 -0.558 . . . . 0.0 110.322 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.73 -35.06 72.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 O-C-N 122.02 -0.425 . . . . 0.0 109.99 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.82 -38.2 76.48 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 119.264 0.938 . . . . 0.0 111.465 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.65 -20.62 46.25 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.103 -0.998 . . . . 0.0 108.399 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.04 46.75 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.958 -1.089 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m -52.48 -46.41 66.56 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 125.384 1.474 . . . . 0.0 111.528 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.72 -43.31 98.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 126.383 1.873 . . . . 0.0 108.859 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -71.48 -41.78 68.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 117.344 -1.312 . . . . 0.0 109.231 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.42 -51.8 67.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.874 1.215 . . . . 0.0 110.998 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.61 -37.23 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 O-C-N 121.617 -0.677 . . . . 0.0 110.538 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -75.39 -28.04 59.3 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.248 -1.533 . . . . 0.0 110.166 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.11 68.41 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.245 1.418 . . . . 0.0 109.335 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -2.15 58.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.5 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -67.34 95.66 0.45 Allowed 'General case' 0 C--N 1.357 0.897 0 O-C-N 120.981 -1.074 . . . . 0.0 109.653 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.76 6.05 30.84 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.96 152.6 68.9 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 118.586 1.193 . . . . 0.0 108.841 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.52 137.51 14.7 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.115 1.877 . . . . 0.0 110.217 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.21 28.15 70.58 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.54 155.21 19.08 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.455 1.902 . . . . 0.0 111.236 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.76 -22.59 0.87 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.675 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.29 37.34 2.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.655 1.982 . . . . 0.0 108.511 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.03 -15.77 20.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 50.8 m -89.68 124.89 35.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 121.163 -0.96 . . . . 0.0 112.47 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -67.21 -61.05 5.1 Favored Pre-proline 0 C--N 1.348 0.522 0 C-N-CA 127.059 2.143 . . . . 0.0 113.221 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -14.03 24.66 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 CA-C-N 125.679 3.064 . . . . 0.0 110.874 -172.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.36 -16.4 49.29 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 124.357 1.063 . . . . 0.0 108.73 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.03 74.22 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 123.469 0.708 . . . . 0.0 111.224 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.63 -31.99 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 123.753 0.821 . . . . 0.0 110.542 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.74 -34.39 69.49 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 119.758 -1.839 . . . . 0.0 109.282 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -72.33 -43.64 63.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -68.91 -28.0 66.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.779 -1.201 . . . . 0.0 112.051 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.8 t -56.52 -54.63 26.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 124.064 0.946 . . . . 0.0 109.967 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.68 -21.63 51.79 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.703 -0.623 . . . . 0.0 111.431 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -67.8 -39.22 84.04 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.126 0.97 . . . . 0.0 110.038 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.78 -22.93 62.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.889 -1.132 . . . . 0.0 111.631 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -91.92 4.02 53.89 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.607 -0.683 . . . . 0.0 110.199 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 56.9 p 49.38 41.77 21.14 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.859 2.064 . . . . 0.0 111.453 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.3 -66.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' B' ' 57' ' ' TYR . . . 74.14 52.02 8.23 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 174.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.409 ' CZ ' ' HA2' ' D' ' 56' ' ' GLY . 0.1 OUTLIER -73.86 -14.44 61.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.652 -0.911 . . . . 0.0 110.907 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.99 29.89 3.88 Favored Glycine 0 CA--C 1.49 -1.478 0 O-C-N 121.019 -1.051 . . . . 0.0 110.917 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -70.95 -59.77 2.6 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -138.87 173.36 11.65 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -143.96 144.81 27.89 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.74 164.36 14.0 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.543 2.829 . . . . 0.0 110.03 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.8 -162.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -91.17 -47.77 7.33 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.775 1.63 . . . . 0.0 107.548 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.13 2.19 18.8 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.556 1.542 . . . . 0.0 111.864 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.81 -27.31 63.78 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.296 1.998 . . . . 0.0 106.354 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.95 82.89 0.97 Allowed Glycine 0 CA--C 1.471 -2.673 1 N-CA-C 100.451 -5.06 . . . . 0.0 100.451 -170.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -57.79 -7.69 0.77 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.513 1.525 . . . . 0.0 112.768 -170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.74 -13.17 53.87 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 119.918 -1.739 . . . . 0.0 113.193 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.7 -58.39 5.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 120.821 1.646 . . . . 0.0 106.689 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.43 68.53 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.201 1.0 . . . . 0.0 112.627 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -62.44 -34.22 76.36 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.423 1.089 . . . . 0.0 111.654 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.56 -33.89 76.98 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.132 -1.605 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.25 -43.29 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 O-C-N 121.731 -0.605 . . . . 0.0 109.47 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.12 -49.79 76.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.458 1.103 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -66.29 -35.59 80.78 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.474 -0.766 . . . . 0.0 111.293 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.91 79.09 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.502 -0.749 . . . . 0.0 110.668 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.38 -45.66 77.25 Favored Glycine 0 CA--C 1.495 -1.178 0 C-N-CA 124.144 0.878 . . . . 0.0 111.584 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -44.94 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.312 1.045 . . . . 0.0 109.449 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -65.84 -24.82 66.97 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.118 -0.989 . . . . 0.0 112.288 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.37 -53.38 32.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 120.439 1.472 . . . . 0.0 109.418 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -71.81 -21.9 61.64 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.474 0.654 . . . . 0.0 111.211 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.79 -35.31 26.6 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.361 -0.837 . . . . 0.0 110.949 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.61 -35.28 77.11 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 119.939 -1.726 . . . . 0.0 110.78 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.33 -9.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 121.145 -0.972 . . . . 0.0 112.258 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 20.0 m -65.42 -9.69 27.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.647 1.179 . . . . 0.0 111.804 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.99 -58.21 9.17 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.441 -1.412 . . . . 0.0 110.532 166.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.1 86.84 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 120.978 -1.076 . . . . 0.0 110.692 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -67.25 -40.64 86.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.043 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -12.46 60.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 121.092 -1.005 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 7.3 m -82.21 -23.69 35.3 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.77 -35.39 79.99 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 120.903 -1.123 . . . . 0.0 110.504 -159.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -66.34 -26.52 67.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.795 -0.566 . . . . 0.0 112.196 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.32 -27.33 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 124.455 1.102 . . . . 0.0 108.228 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -59.73 -14.41 14.22 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.164 -0.96 . . . . 0.0 112.423 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.986 -1.071 . . . . 0.0 111.018 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -74.04 138.42 44.03 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.258 29.7 mt-10 71.28 -55.91 0.64 Allowed 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.049 1.34 . . . . 0.0 112.565 -173.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.6 -32.74 74.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.013 1.279 . . . . 0.0 112.827 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -81.38 -16.44 52.22 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 119.326 0.967 . . . . 0.0 110.962 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -82.47 -39.0 23.13 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.109 -1.619 . . . . 0.0 107.325 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.81 25.13 11.97 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.5 t60 . . . . . 0 C--N 1.352 0.714 0 C-N-CA 124.925 1.29 . . . . 0.0 111.56 -173.158 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 102.783 -3.043 . . . . 0.0 102.783 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.31 -66.57 0.91 Allowed 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -162.96 -92.31 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -168.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 1.9 p80 -63.97 -18.07 63.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.493 1.517 . . . . 0.0 113.343 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 35.3 mp0 -69.92 -34.16 73.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 120.652 -1.28 . . . . 0.0 109.582 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -73.47 -38.76 65.33 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.036 -1.04 . . . . 0.0 108.633 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.95 -42.51 99.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.64 87.59 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.6 1.16 . . . . 0.0 112.119 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.15 -42.36 94.74 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.261 0.625 . . . . 0.0 111.181 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.79 -38.2 90.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.177 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.81 89.62 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.41 -0.806 . . . . 0.0 111.014 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.83 -36.94 84.86 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.453 -0.78 . . . . 0.0 111.027 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.61 -29.99 70.65 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.548 1.139 . . . . 0.0 110.748 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -74.97 -38.44 61.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.561 1.144 . . . . 0.0 108.259 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.95 -45.73 93.54 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.571 0.748 . . . . 0.0 110.666 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -58.2 -31.42 67.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 112.67 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -69.78 -41.1 75.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.424 0.69 . . . . 0.0 109.677 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.39 -35.45 74.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 124.061 0.944 . . . . 0.0 109.175 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.38 -37.8 84.73 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 121.238 -0.914 . . . . 0.0 111.708 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -82.79 -16.89 46.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.514 0.726 . . . . 0.0 111.278 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -77.64 -46.34 22.36 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 168.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -35.37 74.38 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 126.327 1.851 . . . . 0.0 111.374 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -62.52 -44.35 96.57 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.388 0.675 . . . . 0.0 110.772 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -67.99 -50.09 57.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -61.47 -42.46 98.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.793 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.06 99.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.217 1.407 . . . . 0.0 111.673 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.8 -45.16 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 O-C-N 121.025 -1.047 . . . . 0.0 109.448 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -70.23 -27.82 64.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.317 -0.864 . . . . 0.0 110.703 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -57.03 4.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.421 1.889 . . . . 0.0 108.782 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.53 -32.44 74.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.095 0.958 . . . . 0.0 111.776 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -66.84 104.32 1.32 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.135 -1.603 . . . . 0.0 110.559 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.98 -28.29 3.7 Favored Glycine 0 CA--C 1.489 -1.556 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.52 145.01 70.89 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 123.351 0.661 . . . . 0.0 110.75 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -78.78 138.37 14.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.192 1.928 . . . . 0.0 110.231 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.06 80.91 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.439 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.84 147.95 36.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.813 1.245 . . . . 0.0 111.698 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.53 -37.7 2.48 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 tp -106.93 93.98 4.86 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.124 -0.985 . . . . 0.0 108.883 -173.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -135.58 57.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 120.229 -1.545 . . . . 0.0 109.047 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 30.9 t -150.31 135.03 17.5 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -68.82 -43.09 26.65 Favored Pre-proline 0 C--N 1.351 0.632 0 CA-C-O 115.625 -2.131 . . . . 0.0 111.256 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -68.53 -28.18 32.19 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-N 126.106 3.216 . . . . 0.0 111.966 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.83 -17.65 31.06 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 118.957 0.799 . . . . 0.0 108.949 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.68 86.82 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 124.677 1.191 . . . . 0.0 112.039 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.54 -14.87 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 123.579 0.751 . . . . 0.0 110.305 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 -33.19 18.35 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 120.881 -1.137 . . . . 0.0 107.944 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -73.3 -40.02 64.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 15.0 p -76.18 59.05 1.31 Allowed 'General case' 0 C--N 1.358 0.943 0 O-C-N 121.234 -0.916 . . . . 0.0 111.419 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 72.0 t -133.48 -65.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 -21.41 65.26 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.505 0.722 . . . . 0.0 111.784 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -69.69 -28.91 66.25 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 121.507 -0.745 . . . . 0.0 110.394 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.17 -26.47 42.69 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.161 -0.962 . . . . 0.0 109.655 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 15.3 p -91.89 3.35 55.39 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.578 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 12.7 p 54.04 25.88 5.93 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.427 1.891 . . . . 0.0 113.095 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.444 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.8 p -86.22 -53.0 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -171.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.409 ' HA2' ' CZ ' ' C' ' 57' ' ' TYR . . . 70.85 73.07 0.82 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -23.77 53.56 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.621 -1.517 . . . . 0.0 109.852 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.57 35.71 1.85 Allowed Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.12 -64.42 0.87 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -155.2 176.37 12.65 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -149.2 145.92 20.29 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -80.3 165.78 20.84 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 CA-C-N 121.944 1.73 . . . . 0.0 110.527 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.29 -146.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.538 0 CA-C-N 119.218 0.917 . . . . 0.0 109.959 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -91.59 -54.09 4.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.273 -1.517 . . . . 0.0 109.849 -163.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -89.34 16.73 6.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.439 0.696 . . . . 0.0 109.608 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -30.29 62.6 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 163.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.34 83.48 1.18 Allowed Glycine 0 CA--C 1.476 -2.385 1 N-CA-C 99.583 -5.407 . . . . 0.0 99.583 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.58 HH11 ' HG3' ' D' ' 68' ' ' ARG . 20.1 ttm-85 -52.44 -18.57 1.71 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.056 1.742 . . . . 0.0 112.003 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -53.97 -28.22 36.2 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.504 2.322 . . . . 0.0 113.26 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.57 -53.2 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.391 0.677 . . . . 0.0 111.88 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.3 -46.65 55.53 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 126.233 1.813 . . . . 0.0 110.721 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.84 -38.06 89.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.493 0.717 . . . . 0.0 110.8 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.77 -39.05 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 123.446 0.698 . . . . 0.0 109.125 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 49.0 mtt -57.81 -52.91 63.53 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.984 1.314 . . . . 0.0 110.253 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.8 -38.0 89.47 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.033 0.533 . . . . 0.0 110.659 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.16 79.03 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.661 0.784 . . . . 0.0 111.58 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.81 -45.77 80.78 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.57 -48.97 85.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 C-N-CA 124.268 1.027 . . . . 0.0 108.932 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -57.03 -42.29 80.17 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.208 1.403 . . . . 0.0 112.503 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -65.56 -55.48 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 124.744 1.218 . . . . 0.0 109.248 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -67.26 -34.84 78.27 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.748 -0.595 . . . . 0.0 110.617 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.38 78.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.463 1.105 . . . . 0.0 111.135 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.65 -38.2 90.2 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 124.536 1.135 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.1 -14.5 7.75 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 125.128 1.371 . . . . 0.0 111.279 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 6.3 m -61.81 -20.59 63.79 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 119.376 -2.078 . . . . 0.0 111.696 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.66 66.73 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.684 -1.26 . . . . 0.0 111.336 171.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.91 -49.75 11.45 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.33 -32.25 73.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.736 0.814 . . . . 0.0 112.741 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.99 63.64 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.26 -1.525 . . . . 0.0 111.121 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -82.45 -11.02 58.8 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.701 -1.249 . . . . 0.0 111.225 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -32.55 74.17 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 119.454 1.024 . . . . 0.0 111.206 -171.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -77.17 -32.99 56.55 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 120.969 -1.082 . . . . 0.0 111.173 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.71 -26.64 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 125.884 1.674 . . . . 0.0 108.973 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -66.55 -5.73 12.47 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 112.331 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -69.16 -18.41 63.93 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 119.81 1.187 . . . . 0.0 110.997 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.73 159.76 23.1 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 61.73 -78.48 0.03 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.729 2.012 . . . . 0.0 111.881 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -55.14 -37.59 67.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.032 2.533 . . . . 0.0 110.15 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -61.29 -27.91 68.81 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.485 -0.759 . . . . 0.0 112.255 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -82.05 -22.74 36.22 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.328 -0.857 . . . . 0.0 109.291 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.34 3.97 89.9 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 121.463 -0.773 . . . . 0.0 112.072 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 8.1 t60 . . . . . 0 N--CA 1.442 -0.834 0 C-N-CA 125.989 1.715 . . . . 0.0 111.301 -169.805 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.95 169.76 9.41 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -41.68 -57.87 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 128.786 2.835 . . . . 0.0 112.446 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.572 ' HB3' HH12 ' D' ' 96' ' ' ARG . 22.9 p80 -77.97 -19.21 54.94 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 125.082 1.353 . . . . 0.0 112.674 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.93 -38.47 57.61 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -60.96 -35.31 76.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 123.816 0.846 . . . . 0.0 111.622 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -59.96 -41.93 92.98 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.737 2.015 . . . . 0.0 110.175 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -41.75 74.4 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 123.593 0.757 . . . . 0.0 110.263 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.39 -32.56 72.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.799 0.84 . . . . 0.0 111.408 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -71.94 -32.67 67.55 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.363 1.065 . . . . 0.0 110.527 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.123 0.569 . . . . 0.0 110.213 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -55.64 -42.84 75.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.709 1.204 . . . . 0.0 111.795 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -76.7 -29.89 56.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 121.777 -0.577 . . . . 0.0 109.578 -174.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.22 -31.21 69.63 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.477 -0.764 . . . . 0.0 109.975 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.18 -43.1 92.15 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 121.725 -0.609 . . . . 0.0 111.326 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -62.46 -29.43 70.51 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.187 -0.946 . . . . 0.0 112.209 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.37 -31.62 67.53 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.654 -0.654 . . . . 0.0 110.267 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.65 -41.55 90.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.187 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.92 -42.81 85.57 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.914 0.886 . . . . 0.0 110.305 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.31 -42.7 99.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.378 -0.826 . . . . 0.0 111.699 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.16 -38.63 69.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.65 79.46 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 124.914 1.286 . . . . 0.0 111.639 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -66.56 -32.96 74.63 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 124.146 0.978 . . . . 0.0 111.124 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -70.75 -47.1 61.44 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 121.568 -0.708 . . . . 0.0 109.747 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -60.14 -50.39 73.88 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.129 0.972 . . . . 0.0 109.35 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.81 88.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.646 1.579 . . . . 0.0 112.554 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.88 -48.14 89.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.191 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.33 -29.02 61.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.41 -0.806 . . . . 0.0 111.216 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.16 91.53 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.079 1.352 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.43 -20.0 60.2 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.544 -0.722 . . . . 0.0 112.021 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -75.09 87.13 2.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 120.194 -1.566 . . . . 0.0 110.577 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.88 3.11 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.61 140.58 59.57 Favored Pre-proline 0 N--CA 1.442 -0.825 0 O-C-N 121.703 -0.881 . . . . 0.0 110.046 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.15 135.43 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.495 2.13 . . . . 0.0 110.245 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.86 24.75 68.71 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.67 144.59 56.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.085 0.954 . . . . 0.0 110.103 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.08 -34.47 2.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.79 131.66 36.99 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 pt -151.23 169.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 100.649 -3.834 . . . . 0.0 100.649 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t 76.89 134.07 0.06 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.963 1.705 . . . . 0.0 111.082 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -66.01 -49.48 56.9 Favored Pre-proline 0 C--N 1.352 0.701 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.072 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -70.21 -14.46 34.68 Favored 'Trans proline' 0 CA--C 1.514 -0.513 0 CA-C-N 125.308 2.932 . . . . 0.0 112.584 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.23 -43.14 12.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.97 77.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.235 1.014 . . . . 0.0 112.215 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.14 -16.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-O 121.714 0.769 . . . . 0.0 111.397 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -31.76 17.31 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 120.757 -1.214 . . . . 0.0 108.162 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.33 -40.02 94.97 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 120.795 -1.19 . . . . 0.0 110.244 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -67.05 -17.3 64.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.948 -1.095 . . . . 0.0 111.669 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.5 -51.09 67.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.682 1.193 . . . . 0.0 109.315 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.61 -7.41 50.08 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 124.07 0.948 . . . . 0.0 111.167 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.6 m -94.13 -45.11 7.69 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 120.36 -1.462 . . . . 0.0 107.058 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.01 70.15 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.308 -0.87 . . . . 0.0 112.325 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -91.77 3.83 54.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.272 67.8 p 59.53 -142.46 0.6 Allowed 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.447 1.899 . . . . 0.0 107.334 -167.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t 75.63 -90.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.94 94.28 0.25 Allowed Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -80.07 -20.8 44.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.305 -1.703 . . . . 0.0 109.711 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.73 25.29 4.31 Favored Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.58 -48.19 34.74 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.277 1.539 . . . . 0.0 110.055 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.36 152.88 51.12 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.457 ' CD1' ' HD2' ' A' ' 62' ' ' PRO . 17.6 t80 -145.17 137.71 13.55 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 46.5 Cg_endo -80.97 168.17 17.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.908 2.405 . . . . 0.0 110.951 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -88.91 -111.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -134.83 -39.42 0.78 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-O 122.224 1.011 . . . . 0.0 109.225 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -79.28 -22.58 44.46 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.601 -1.312 . . . . 0.0 109.627 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -62.08 -32.03 72.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.075 1.75 . . . . 0.0 108.386 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.42 65.18 0.93 Allowed Glycine 0 CA--C 1.465 -3.081 1 N-CA-C 102.483 -4.247 . . . . 0.0 102.483 168.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -26.33 -26.39 0.0 OUTLIER 'General case' 0 C--N 1.363 1.185 1 C-N-CA 132.65 4.38 . . . . 0.0 116.851 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -49.34 -20.47 0.67 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.06 -42.92 94.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 124.954 1.301 . . . . 0.0 109.693 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -48.51 31.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.12 -50.82 19.46 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 126.463 1.905 . . . . 0.0 111.303 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.27 -35.53 81.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.427 0.632 . . . . 0.0 110.692 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.1 t -73.22 -37.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.41 -0.806 . . . . 0.0 109.14 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.5 mtt -61.83 -46.36 89.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 123.632 0.773 . . . . 0.0 109.656 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.48 -33.27 75.31 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.078 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.18 97.04 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 121.746 -0.596 . . . . 0.0 110.656 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.06 -46.93 77.5 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.35 -45.49 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 109.602 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.87 -36.38 83.72 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.855 -1.153 . . . . 0.0 110.681 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.03 -52.07 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 119.959 1.254 . . . . 0.0 110.563 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -70.47 -22.76 62.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.809 -0.557 . . . . 0.0 111.126 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.54 -32.94 23.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.382 -0.824 . . . . 0.0 110.546 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.43 -24.25 67.14 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.496 -1.377 . . . . 0.0 111.207 -172.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.17 -11.26 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.484 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.402 HG23 ' HB2' ' A' ' 90' ' ' ALA . 56.0 m -45.24 -29.68 1.04 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 127.826 2.45 . . . . 0.0 112.058 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.72 -39.77 52.64 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.406 1.482 . . . . 0.0 113.889 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 -36.12 6.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.94 1.296 . . . . 0.0 109.307 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.31 -41.57 66.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.736 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -78.21 -32.19 49.81 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 119.813 -1.805 . . . . 0.0 111.229 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -73.86 -0.36 15.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.529 -1.357 . . . . 0.0 110.003 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.24 -26.56 64.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 121.245 -0.909 . . . . 0.0 109.414 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -72.83 -33.4 66.15 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.454 -1.404 . . . . 0.0 110.634 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.17 -21.91 27.11 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.223 1.409 . . . . 0.0 109.171 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.39 -29.47 48.83 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 125.399 1.48 . . . . 0.0 112.247 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -65.57 -36.56 84.14 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-O 121.541 0.686 . . . . 0.0 110.479 -174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.18 154.01 18.95 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -170.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.292 40.1 mm-40 71.03 -51.59 0.69 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.446 1.898 . . . . 0.0 112.036 -168.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.05 -46.59 71.97 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.645 1.978 . . . . 0.0 109.871 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.53 -24.54 67.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.322 -0.861 . . . . 0.0 112.936 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -80.91 -20.17 42.7 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.45 -0.781 . . . . 0.0 110.094 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.96 34.66 61.83 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.9 m170 . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.65 170.68 15.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.03 -34.77 78.29 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 124.588 1.155 . . . . 0.0 112.242 -167.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 3.5 p-80 -83.77 -23.64 31.44 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.58 -0.7 . . . . 0.0 110.601 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.16 -38.06 21.13 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -63.19 -47.61 81.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 125.225 1.41 . . . . 0.0 110.954 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -26.44 65.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.371 -0.83 . . . . 0.0 111.256 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.91 -35.44 74.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.319 -0.863 . . . . 0.0 110.657 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -64.74 -45.87 84.64 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.999 0.92 . . . . 0.0 109.231 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -64.34 -31.94 73.35 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.112 0.565 . . . . 0.0 111.534 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.93 81.62 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.755 0.822 . . . . 0.0 110.685 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -39.5 81.5 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.074 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.53 -43.04 84.04 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 125.748 1.619 . . . . 0.0 110.484 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.37 -38.92 91.42 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.138 1.375 . . . . 0.0 110.079 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.441 ' HB2' HG21 ' B' ' 81' ' ' VAL . 21.3 tp -59.3 -41.56 89.29 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 123.908 0.883 . . . . 0.0 111.391 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -63.91 -29.58 70.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.866 1.266 . . . . 0.0 110.73 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -76.08 -30.33 58.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.246 1.019 . . . . 0.0 110.217 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -70.35 -35.67 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 31.2 mt -61.76 -42.32 98.83 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.809 -0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -60.75 -45.54 93.9 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.086 0.857 . . . . 0.0 110.519 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -68.93 -40.18 79.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.874 0.845 . . . . 0.0 110.486 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -31.11 71.29 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.264 1.426 . . . . 0.0 111.256 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -66.0 -44.25 85.34 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.085 0.954 . . . . 0.0 110.199 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -61.03 -49.68 76.4 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.025 1.33 . . . . 0.0 107.785 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.83 -41.96 99.54 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.388 0.675 . . . . 0.0 111.232 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.21 91.38 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 124.892 1.277 . . . . 0.0 111.965 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.45 -40.97 73.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.17 -10.67 59.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.291 -1.506 . . . . 0.0 111.704 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.485 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -70.58 -21.25 62.7 Favored 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.907 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.97 -1.99 41.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.27 79.36 2.8 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.2 -41.6 0.71 Allowed Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.81 154.93 70.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 O-C-N 122.185 -0.597 . . . . 0.0 111.457 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.1 151.27 23.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.014 2.476 . . . . 0.0 110.41 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.61 41.23 65.54 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 173.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 136.64 57.92 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.376 1.071 . . . . 0.0 112.205 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.11 -57.28 2.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.62 97.95 10.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.094 0.95 . . . . 0.0 108.455 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.49 12.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -105.08 129.99 53.37 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -78.93 -57.81 0.75 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 127.257 2.223 . . . . 0.0 108.692 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.45 -13.89 25.13 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.344 2.944 . . . . 0.0 111.69 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -93.35 -10.34 35.65 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.397 0.998 . . . . 0.0 108.417 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.64 83.73 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.61 -1.306 . . . . 0.0 110.512 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.92 -9.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 C-N-CA 124.454 1.102 . . . . 0.0 110.562 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.85 -41.08 16.37 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 120.14 -1.6 . . . . 0.0 107.28 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -68.87 -32.83 72.76 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.538 -0.727 . . . . 0.0 110.815 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 7.0 p -66.41 -17.41 64.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.978 -1.076 . . . . 0.0 111.586 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.76 -17.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.924 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -97.72 10.82 39.07 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.488 -1.383 . . . . 0.0 109.177 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -123.26 -173.75 2.79 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.45 -3.537 . . . . 0.0 101.45 173.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 77.24 -42.27 0.4 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 126.1 1.76 . . . . 0.0 111.095 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.0 p -81.19 2.75 26.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 126.22 1.808 . . . . 0.0 111.692 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p 52.07 59.3 4.63 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 126.826 2.051 . . . . 0.0 111.595 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.41 -77.01 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.08 66.49 1.96 Allowed Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -72.45 -46.04 56.81 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.64 -105.48 0.24 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.327 5.2 t70 56.92 -72.63 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 128.271 2.628 . . . . 0.0 112.232 -163.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -163.59 1.35 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -173.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -153.24 153.49 29.52 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.6 168.41 9.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.331 3.354 . . . . 0.0 112.847 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 m -83.14 177.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.55 1.14 . . . . 0.0 112.442 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -83.21 -69.44 0.63 Allowed 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 125.475 1.51 . . . . 0.0 111.337 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.99 -37.5 64.07 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 124.611 1.165 . . . . 0.0 112.907 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -121.16 -107.62 0.36 Allowed 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 167.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.485 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 40.13 -73.55 0.0 OUTLIER Glycine 0 C--N 1.358 1.785 0 C-N-CA 129.748 3.547 . . . . 0.0 116.165 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.39 -37.86 87.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.363 2.665 . . . . 0.0 111.488 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.838 0.827 . . . . 0.0 109.275 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.05 -46.42 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.58 84.49 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.408 1.483 . . . . 0.0 111.603 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.67 -47.22 29.55 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.049 1.739 . . . . 0.0 110.938 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.72 -36.59 84.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.119 1.368 . . . . 0.0 110.283 -176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.33 -42.01 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.679 -0.638 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -60.59 -46.74 89.09 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 121.553 -0.717 . . . . 0.0 109.782 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -63.13 -38.3 90.62 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 122.121 -0.362 . . . . 0.0 111.158 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.02 80.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 123.159 0.584 . . . . 0.0 111.301 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.13 91.65 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 124.483 1.039 . . . . 0.0 111.214 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.08 -42.52 90.17 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 123.853 0.861 . . . . 0.0 108.707 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.81 -51.19 65.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 120.94 -1.1 . . . . 0.0 112.275 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' B' ' 15' ' ' LEU . 27.7 m -72.88 -41.32 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 112.144 -171.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -74.15 -38.51 63.7 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.25 -32.18 71.22 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.69 -31.88 62.8 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.759 1.223 . . . . 0.0 111.406 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.9 -12.05 8.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.666 1.186 . . . . 0.0 111.099 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 16.2 m -64.4 -24.82 67.77 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 118.897 -2.377 . . . . 0.0 110.761 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.58 -20.35 65.99 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.154 -1.591 . . . . 0.0 111.318 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -90.27 -40.71 11.99 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.38 1.072 . . . . 0.0 108.913 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.96 -31.75 51.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 122.785 0.434 . . . . 0.0 111.545 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.29 -23.02 66.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.122 -0.986 . . . . 0.0 111.374 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . 0.343 0.6 OUTLIER -83.36 -10.72 58.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.916 -1.115 . . . . 0.0 109.47 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.275 46.1 m-20 -82.46 -2.68 54.02 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.458 -1.401 . . . . 0.0 111.801 -172.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.19 -35.88 15.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.27 -1.519 . . . . 0.0 108.538 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 t -66.84 -25.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 125.074 1.349 . . . . 0.0 110.224 -169.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -63.58 -8.92 11.02 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.422 -0.799 . . . . 0.0 112.844 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -66.34 -32.85 74.49 Favored 'General case' 0 C--N 1.359 1.004 0 O-C-N 120.851 -1.156 . . . . 0.0 110.068 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -87.88 159.09 18.52 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -172.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 74.59 -59.98 0.53 Allowed 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.326 1.85 . . . . 0.0 110.514 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -59.59 -29.22 67.82 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.11 2.164 . . . . 0.0 109.857 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -62.6 -38.87 91.85 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.576 -0.703 . . . . 0.0 111.465 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -78.6 -27.18 45.55 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.712 -1.243 . . . . 0.0 108.553 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.21 33.94 27.65 Favored Glycine 0 CA--C 1.491 -1.466 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--N 1.357 0.929 0 C-N-CA 123.712 0.805 . . . . 0.0 111.955 176.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 102.118 -3.29 . . . . 0.0 102.118 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.13 158.32 15.51 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.28 -46.86 85.29 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.428 1.091 . . . . 0.0 110.671 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CE1' HG21 ' C' ' 91' ' ' THR . 4.5 p80 -67.07 -27.83 67.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.56 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.61 -42.88 57.83 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -65.75 -37.71 87.12 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.827 -1.171 . . . . 0.0 110.826 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.87 -31.44 72.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.379 1.072 . . . . 0.0 110.987 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.84 -47.68 71.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.729 0.812 . . . . 0.0 110.203 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.357 -0.839 . . . . 0.0 111.615 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -65.44 -39.63 92.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.873 1.269 . . . . 0.0 109.311 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.4 82.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.896 0.878 . . . . 0.0 110.681 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -55.53 -42.76 75.03 Favored 'General case' 0 C--N 1.36 1.03 0 CA-C-O 121.667 0.746 . . . . 0.0 110.829 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -60.93 -39.38 89.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.139 1.376 . . . . 0.0 110.363 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.98 -34.2 76.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.149 0.979 . . . . 0.0 109.505 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.47 -40.33 89.29 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.819 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.31 -28.02 68.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.546 -0.721 . . . . 0.0 111.558 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -66.04 -39.77 90.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.977 0.911 . . . . 0.0 110.181 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.7 -35.15 74.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 124.247 1.019 . . . . 0.0 109.198 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.57 -35.67 80.22 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 121.29 -0.881 . . . . 0.0 111.898 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.8 -32.62 59.94 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.137 0.575 . . . . 0.0 110.337 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 -42.06 59.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.12 -0.987 . . . . 0.0 108.767 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -36.01 78.24 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.758 1.623 . . . . 0.0 111.895 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -69.4 -36.63 76.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.909 -0.494 . . . . 0.0 110.299 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -67.58 -38.03 83.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -66.19 -55.24 17.24 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.0 68.69 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.739 1.215 . . . . 0.0 111.984 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.68 -43.92 96.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 O-C-N 119.962 -1.712 . . . . 0.0 111.985 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.79 -34.99 20.99 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 121.211 -0.931 . . . . 0.0 109.274 -171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.37 -50.77 58.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.552 1.941 . . . . 0.0 109.546 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.04 -24.1 62.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.236 -0.915 . . . . 0.0 111.637 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.95 95.19 6.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.455 -1.403 . . . . 0.0 111.918 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.46 -7.57 4.98 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.71 148.02 37.53 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 123.577 0.751 . . . . 0.0 109.788 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -77.69 103.46 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.895 2.397 . . . . 0.0 113.051 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 -52.44 0.72 Allowed Glycine 0 CA--C 1.477 -2.324 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.719 2.008 . . . . 0.0 110.901 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.34 -91.62 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.92 127.14 31.62 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.27 131.18 1.84 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 169.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.86 -49.03 60.83 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.038 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.0 -5.52 17.13 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 CA-C-N 124.777 2.742 . . . . 0.0 111.955 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -99.88 -29.27 12.68 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.67 76.32 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 111.939 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.71 -36.89 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 123.418 0.687 . . . . 0.0 110.222 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -30.22 60.59 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.474 -1.391 . . . . 0.0 109.92 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -72.85 -32.05 65.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.984 0.897 . . . . 0.0 109.124 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -67.04 -42.24 85.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 121.279 -0.888 . . . . 0.0 110.358 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -67.66 -23.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 C-N-CA 124.155 0.982 . . . . 0.0 112.87 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.4 -13.72 51.4 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 120.07 -1.644 . . . . 0.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -104.61 -175.02 2.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . 79.47 -33.63 0.14 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 126.952 2.101 . . . . 0.0 110.672 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 4.1 p -89.73 3.78 51.69 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 125.956 1.703 . . . . 0.0 111.949 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.278 41.5 p 52.43 63.87 2.07 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.503 1.921 . . . . 0.0 111.917 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.21 -107.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 1 N-CA-C 98.546 -4.613 . . . . 0.0 98.546 173.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.3 87.48 1.09 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 106.651 -2.58 . . . . 0.0 106.651 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -69.2 -45.63 69.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.357 1.075 . . . . 0.0 109.118 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.44 48.48 0.28 Allowed Glycine 0 CA--C 1.485 -1.797 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.414 ' CG ' HH22 ' D' ' 68' ' ' ARG . 34.8 t70 -73.48 -45.35 54.59 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -132.96 -154.2 0.6 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.83 142.86 2.04 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 100.829 -3.767 . . . . 0.0 100.829 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.07 179.8 3.53 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 123.664 2.344 . . . . 0.0 107.49 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.487 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.7 t -100.6 -121.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.405 1.482 . . . . 0.0 110.118 -168.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 73.4 m -136.48 -38.8 0.66 Allowed 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.692 -1.255 . . . . 0.0 108.584 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -86.17 -6.11 59.06 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.979 -1.076 . . . . 0.0 109.834 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -63.98 -36.83 85.24 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 123.216 1.484 . . . . 0.0 107.373 175.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.94 62.41 0.85 Allowed Glycine 0 CA--C 1.464 -3.111 1 N-CA-C 100.643 -4.983 . . . . 0.0 100.643 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -26.86 -25.2 0.0 OUTLIER 'General case' 0 C--N 1.36 1.04 1 C-N-CA 132.989 4.516 . . . . 0.0 117.778 -175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -52.87 -15.44 0.75 Allowed 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 161.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.23 -44.39 87.84 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 O-C-N 120.153 -1.592 . . . . 0.0 109.294 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.59 66.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 123.142 0.577 . . . . 0.0 109.681 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . 0.258 1.1 pp20? -65.38 -33.72 76.63 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 121.799 -0.563 . . . . 0.0 111.836 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.31 -36.99 79.18 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 121.55 0.691 . . . . 0.0 110.624 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.3 t -72.77 -37.82 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.507 -0.745 . . . . 0.0 109.477 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 50.8 mtt -64.42 -47.91 77.34 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 123.856 0.863 . . . . 0.0 109.55 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -61.83 -40.58 95.79 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.425 0.69 . . . . 0.0 110.747 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.05 94.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.546 0.738 . . . . 0.0 110.872 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.64 78.09 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.28 -49.54 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 124.195 0.998 . . . . 0.0 108.943 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.83 -39.19 87.56 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 118.531 0.605 . . . . 0.0 111.474 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.32 -54.85 28.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 119.331 0.969 . . . . 0.0 110.4 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.58 -14.02 60.03 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 111.737 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.94 -37.62 22.07 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.623 -1.298 . . . . 0.0 108.035 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.97 -33.63 72.2 Favored 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 124.996 1.318 . . . . 0.0 111.738 -175.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -64.56 -5.31 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 O-C-N 121.335 -0.853 . . . . 0.0 112.663 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 26.3 m -59.2 -18.52 37.32 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.742 1.217 . . . . 0.0 111.167 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.62 68.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.847 -1.783 . . . . 0.0 113.104 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.58 -43.46 13.47 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.0 -38.86 92.6 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.079 0.942 . . . . 0.0 111.318 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.29 -20.32 62.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.982 -1.073 . . . . 0.0 111.833 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.515 HG21 ' CE1' ' C' ' 4' ' ' HIS . 9.7 t -99.52 7.71 45.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.4 -45.34 60.14 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.833 1.197 . . . . 0.0 107.978 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -63.09 -34.62 77.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.48 -0.762 . . . . 0.0 111.556 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.03 -23.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.007 1.723 . . . . 0.0 110.033 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -65.48 -16.16 63.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.1 -1.0 . . . . 0.0 111.435 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -64.19 -25.2 67.97 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.32 -0.862 . . . . 0.0 111.833 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.89 -33.16 62.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -76.1 -43.2 44.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 121.314 -0.867 . . . . 0.0 109.289 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -63.76 -26.28 68.57 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.262 1.425 . . . . 0.0 110.356 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.78 -44.79 74.03 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 125.424 1.49 . . . . 0.0 110.845 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -97.18 -26.14 15.05 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.58 35.23 33.07 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 42.6 t60 . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 -179.071 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' D' ' 5' ' ' GLU . . . -88.76 152.9 21.5 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.16 -45.63 84.16 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 123.199 1.476 . . . . 0.0 109.657 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.567 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 17.2 p-80 -69.93 -17.48 63.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.079 1.352 . . . . 0.0 111.917 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' D' ' 2' ' ' ALA . 56.0 tt0 -77.11 -40.12 46.99 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -173.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -55.55 -50.59 69.61 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.195 1.398 . . . . 0.0 110.485 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.88 -37.9 87.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.938 0.895 . . . . 0.0 109.667 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.55 95.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.553 0.741 . . . . 0.0 111.643 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -68.33 -36.7 79.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.669 -0.644 . . . . 0.0 110.774 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -68.12 -35.09 77.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.705 -0.622 . . . . 0.0 111.039 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.14 98.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.363 1.065 . . . . 0.0 111.104 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -66.76 -35.44 80.11 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.323 -0.86 . . . . 0.0 111.636 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -72.42 -34.12 67.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.676 -1.265 . . . . 0.0 111.161 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -64.84 -35.19 80.31 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.831 1.252 . . . . 0.0 108.844 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -63.22 -39.15 93.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.454 -0.779 . . . . 0.0 111.11 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.13 -21.58 63.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.615 -1.303 . . . . 0.0 112.035 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.4 -36.11 71.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.626 0.727 . . . . 0.0 110.464 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.35 -26.25 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 O-C-N 119.854 -1.779 . . . . 0.0 110.358 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.28 -46.13 90.16 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 121.957 0.884 . . . . 0.0 110.864 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.1 -39.15 86.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.52 -1.363 . . . . 0.0 110.177 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.87 96.02 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.361 1.065 . . . . 0.0 110.798 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.69 76.43 Favored 'General case' 0 CA--C 1.496 -1.123 0 O-C-N 121.301 -0.874 . . . . 0.0 111.469 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -65.06 -44.1 90.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 110.496 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.86 -53.32 48.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 125.124 1.37 . . . . 0.0 109.547 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -65.69 -37.98 87.95 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.308 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.91 83.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 124.37 1.068 . . . . 0.0 111.747 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.14 -50.05 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-N 118.509 0.595 . . . . 0.0 109.857 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -72.43 -31.59 65.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 121.447 -0.783 . . . . 0.0 110.732 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.49 67.83 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.955 0.902 . . . . 0.0 109.326 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.9 -40.61 96.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 125.482 1.513 . . . . 0.0 110.219 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.76 91.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.928 1.291 . . . . 0.0 112.387 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.65 -5.84 7.5 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.07 59.15 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 118.677 1.238 . . . . 0.0 111.76 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -80.82 137.54 11.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.585 2.19 . . . . 0.0 110.692 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.46 78.15 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 165.2 24.4 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.921 1.289 . . . . 0.0 111.292 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.9 32.51 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 121.808 -0.557 . . . . 0.0 110.472 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 13.7 tp -145.14 74.43 1.4 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 120.792 -1.192 . . . . 0.0 107.912 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.67 165.19 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 O-C-N 120.948 -1.095 . . . . 0.0 108.197 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t 81.39 131.37 0.05 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.64 1.576 . . . . 0.0 112.201 165.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -62.69 -42.51 79.16 Favored Pre-proline 0 C--N 1.349 0.581 0 CA-C-O 116.864 -1.541 . . . . 0.0 113.328 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -69.06 -24.56 32.76 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 CA-C-N 124.158 2.521 . . . . 0.0 112.404 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 -32.94 19.98 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 124.745 1.218 . . . . 0.0 107.96 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.07 73.45 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.44 -32.95 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 121.729 -0.607 . . . . 0.0 110.118 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -36.18 76.87 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -65.44 -37.6 87.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.848 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -64.56 -44.42 90.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.464 -0.772 . . . . 0.0 109.491 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.86 64.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.705 0 CA-C-O 121.767 0.794 . . . . 0.0 110.856 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -162.42 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -68.48 -36.65 79.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.099 -1.001 . . . . 0.0 110.964 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.05 65.31 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.281 -0.887 . . . . 0.0 111.681 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -93.79 15.21 17.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 33.0 p 47.34 54.47 9.5 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 126.066 1.746 . . . . 0.0 113.06 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.554 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.0 OUTLIER -121.12 -82.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 178.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.554 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 77.78 64.61 2.02 Favored Glycine 0 CA--C 1.491 -1.426 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.82 -27.86 64.19 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.231 1.015 . . . . 0.0 109.899 -165.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.66 31.14 0.16 Allowed Glycine 0 CA--C 1.486 -1.779 0 O-C-N 120.728 -1.232 . . . . 0.0 110.776 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -81.71 -76.06 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 118.751 1.275 . . . . 0.0 110.837 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -128.54 159.42 35.56 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.31 149.23 18.29 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . 0.443 ' CB ' ' HG3' ' D' ' 66' ' ' GLU . 20.6 Cg_endo -73.94 149.89 42.83 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.361 2.707 . . . . 0.0 111.534 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.495 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 14.7 t -86.38 -93.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 124.116 0.966 . . . . 0.0 111.03 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -140.04 -52.58 0.51 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.734 -1.229 . . . . 0.0 108.468 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.73 -16.77 46.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.674 1.189 . . . . 0.0 109.587 -168.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 1.4 pm0 -73.74 -7.27 51.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.09 88.49 0.4 Allowed Glycine 0 CA--C 1.477 -2.303 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.414 HH22 ' CG ' ' C' ' 59' ' ' ASP . 24.9 ttm180 -60.78 -19.77 60.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.39 -1.653 . . . . 0.0 111.235 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -54.57 -16.62 2.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.685 1.194 . . . . 0.0 113.403 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.01 -39.23 84.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 119.992 -1.692 . . . . 0.0 109.229 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -39.84 70.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.115 -0.991 . . . . 0.0 109.922 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -38.01 79.36 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-O 121.876 0.846 . . . . 0.0 110.53 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -29.93 66.56 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.62 -0.675 . . . . 0.0 111.601 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.67 -46.4 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 121.053 -1.029 . . . . 0.0 108.718 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.23 -39.82 89.83 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 122.003 -0.436 . . . . 0.0 110.124 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.56 -47.19 87.29 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.083 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.29 72.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 122.951 0.5 . . . . 0.0 111.275 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -44.22 89.31 Favored Glycine 0 CA--C 1.496 -1.143 0 O-C-N 121.506 -0.746 . . . . 0.0 111.638 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.56 -46.5 95.46 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 C-N-CA 124.357 1.063 . . . . 0.0 108.79 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.43 -46.33 69.78 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.075 1.35 . . . . 0.0 111.24 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.21 -57.35 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 C-N-CA 124.929 1.292 . . . . 0.0 110.522 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -66.78 -35.98 81.34 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.42 -0.8 . . . . 0.0 110.467 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.39 95.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.998 0.919 . . . . 0.0 110.863 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.87 -39.9 95.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.71 -15.82 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.422 1.489 . . . . 0.0 111.137 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -59.24 -13.9 9.2 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.623 1.169 . . . . 0.0 111.544 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.27 -48.44 78.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 119.905 -1.747 . . . . 0.0 112.395 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -68.51 -35.72 77.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 O-C-N 121.348 -0.845 . . . . 0.0 110.156 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.06 -32.65 63.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.42 0.688 . . . . 0.0 110.055 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.43 75.8 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.077 -1.639 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -14.48 62.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.782 -1.199 . . . . 0.0 113.128 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.21 -32.68 74.47 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 120.576 1.535 . . . . 0.0 111.032 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -77.69 -28.64 51.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.064 -1.023 . . . . 0.0 111.421 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -68.86 -24.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 125.291 1.436 . . . . 0.0 108.347 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -59.48 -12.05 5.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.501 1.52 . . . . 0.0 113.797 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 4' ' ' HIS . 1.1 ptp180 -72.88 -33.13 65.86 Favored 'General case' 0 CA--C 1.496 -1.107 0 O-C-N 121.169 -0.957 . . . . 0.0 111.569 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -80.8 174.37 11.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.28 7.3 mp0 71.04 -59.64 0.54 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.309 1.843 . . . . 0.0 111.25 -171.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.06 -52.74 64.44 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 126.552 1.941 . . . . 0.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -67.8 -25.73 65.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.028 0.918 . . . . 0.0 111.656 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -76.3 -25.66 55.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.5 39.08 36.32 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 m170 . . . . . 0 CA--C 1.504 -0.8 0 O-C-N 121.528 -0.983 . . . . 0.0 108.76 178.008 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.425 -1.699 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.24 -62.53 1.48 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.735 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.56 -68.17 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -42.65 86.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.047 2.539 . . . . 0.0 112.08 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 2.3 pm0 -71.0 -26.24 63.04 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.661 0.785 . . . . 0.0 110.585 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.5 -37.04 77.02 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -71.32 -35.05 71.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.309 0.576 . . . . 0.0 109.863 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.0 95.95 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 121.411 -0.805 . . . . 0.0 111.362 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -71.77 -28.81 63.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 121.385 -0.822 . . . . 0.0 111.535 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -69.92 -37.52 75.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 120.898 -1.126 . . . . 0.0 109.361 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.73 97.36 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.98 0.912 . . . . 0.0 111.363 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -63.0 -36.68 84.37 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.44 -0.787 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.11 -35.36 69.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 121.028 -1.045 . . . . 0.0 110.792 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.29 -32.82 74.57 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.26 -42.31 98.41 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.924 -1.11 . . . . 0.0 111.61 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -64.31 -28.31 69.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.677 1.191 . . . . 0.0 111.212 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -69.59 -33.76 73.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.899 1.28 . . . . 0.0 110.452 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -71.62 -29.58 35.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.99 -1.068 . . . . 0.0 108.641 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.21 -29.8 66.74 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.01 -1.056 . . . . 0.0 111.223 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -71.31 -33.6 69.83 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.47 1.508 . . . . 0.0 110.329 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -72.44 -45.47 59.45 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 120.388 -1.445 . . . . 0.0 108.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.02 84.87 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 126.233 1.813 . . . . 0.0 111.483 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -67.6 -38.26 83.72 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 122.655 0.382 . . . . 0.0 110.269 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.959 0.904 . . . . 0.0 109.575 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -67.11 -55.0 16.14 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -41.25 73.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 125.688 1.595 . . . . 0.0 113.015 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.16 -37.1 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 O-C-N 120.735 -1.228 . . . . 0.0 112.582 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.67 -34.2 30.87 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.6 -53.72 37.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.543 1.537 . . . . 0.0 109.219 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.38 12.16 5.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.927 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -71.81 94.87 1.45 Allowed 'General case' 0 C--N 1.351 0.664 0 O-C-N 119.672 -1.892 . . . . 0.0 109.626 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.62 61.86 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 150.13 51.7 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -76.33 145.03 26.66 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 122.836 2.358 . . . . 0.0 108.807 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.25 5.22 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 118.956 0.798 . . . . 0.0 112.575 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 151.79 39.5 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 126.361 1.865 . . . . 0.0 110.039 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.75 6.75 0.54 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.075 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.03 -58.13 3.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.9 pt 34.97 29.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 119.228 3.047 . . . . 0.0 119.228 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -162.98 156.61 19.98 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 119.941 -1.724 . . . . 0.0 106.874 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.88 -44.78 0.61 Allowed Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.671 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.26 -17.6 16.76 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 CA-C-N 125.962 3.165 . . . . 0.0 111.413 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.0 -14.77 24.05 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.478 1.111 . . . . 0.0 109.047 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.43 98.53 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.934 0.873 . . . . 0.0 111.766 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.41 -11.68 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-O 121.57 0.7 . . . . 0.0 109.769 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.13 -41.58 15.56 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.08 -27.95 60.13 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.714 -0.617 . . . . 0.0 111.02 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.6 p -66.97 -20.27 65.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.518 -1.364 . . . . 0.0 111.924 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.47 -18.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.291 1.037 . . . . 0.0 109.844 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -73.19 -42.05 63.13 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 120.367 -1.458 . . . . 0.0 108.337 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.3 t -85.32 -167.76 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 78.98 -31.16 0.14 Allowed 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 127.179 2.192 . . . . 0.0 111.115 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 p -66.27 -24.53 66.58 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 129.834 3.254 . . . . 0.0 110.191 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.358 28.7 p 64.29 37.49 8.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 129.696 3.198 . . . . 0.0 109.712 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.85 147.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 167.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.51 130.82 5.82 Favored Glycine 0 CA--C 1.474 -2.529 1 N-CA-C 95.085 -7.206 . . . . 0.0 95.085 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.493 ' CE2' ' HA2' ' B' ' 56' ' ' GLY . 7.2 t80 -87.51 -36.5 17.59 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.38 47.65 0.25 Allowed Glycine 0 CA--C 1.479 -2.186 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 168.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.99 -55.78 6.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.53 1.165 . . . . 0.0 108.448 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -112.81 171.19 7.68 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -140.12 110.88 7.16 Favored Pre-proline 0 N--CA 1.445 -0.715 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.07 175.49 11.09 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.451 2.768 . . . . 0.0 109.835 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 64' ' ' THR . 13.2 p -143.13 176.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -173.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 63' ' ' VAL . 3.3 m -63.48 -36.61 84.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 113.106 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.25 -27.94 61.86 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.77 0.828 . . . . 0.0 110.026 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -66.58 -30.43 70.73 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 123.577 1.656 . . . . 0.0 106.829 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 75.78 1.3 Allowed Glycine 0 CA--C 1.463 -3.174 1 N-CA-C 99.53 -5.428 . . . . 0.0 99.53 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -46.12 -13.77 0.02 OUTLIER 'General case' 0 C--N 1.367 1.342 0 C-N-CA 128.742 2.817 . . . . 0.0 114.22 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 72' ' ' GLU . 13.8 mtpp -54.19 -18.3 3.69 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 126.992 2.117 . . . . 0.0 114.131 162.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.88 -52.9 24.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-N 120.892 1.678 . . . . 0.0 107.442 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.43 80.32 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 118.386 0.539 . . . . 0.0 111.658 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 28.4 tt0 -52.48 -47.15 66.69 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 126.614 1.966 . . . . 0.0 111.449 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -62.68 -41.57 99.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.469 -0.769 . . . . 0.0 109.556 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.2 -36.17 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.09 0.556 . . . . 0.0 110.012 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.3 mtt -58.59 -53.12 61.9 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.296 0.638 . . . . 0.0 109.921 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.94 -40.11 96.64 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 122.931 0.492 . . . . 0.0 110.336 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.54 79.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.684 0.793 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.74 -45.17 59.69 Favored Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 124.75 1.166 . . . . 0.0 111.144 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -57.66 -45.83 86.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.237 1.015 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -57.31 -43.75 83.52 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.599 0.76 . . . . 0.0 110.562 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.92 -52.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 124.429 1.091 . . . . 0.0 109.451 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.15 -39.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 121.903 -0.498 . . . . 0.0 110.632 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.46 94.33 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 110.776 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.05 -33.38 75.3 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 124.771 1.228 . . . . 0.0 111.616 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.5 -18.08 13.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.806 1.242 . . . . 0.0 110.707 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 m -58.75 -22.99 59.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.05 -1.656 . . . . 0.0 112.134 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.17 -24.09 66.98 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.295 -1.503 . . . . 0.0 111.859 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.79 -43.08 11.51 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.008 0.923 . . . . 0.0 108.561 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.9 -39.58 94.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 122.006 0.907 . . . . 0.0 111.552 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -24.74 63.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.607 0.763 . . . . 0.0 112.294 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.9 t -90.72 -2.81 57.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.5 -41.49 72.57 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 120.534 1.516 . . . . 0.0 108.93 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' B' ' 91' ' ' THR . 7.2 p90 -70.45 -22.2 62.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.732 -1.23 . . . . 0.0 112.978 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.66 -24.98 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.301 1.04 . . . . 0.0 108.783 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -59.0 -19.4 43.15 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 125.626 1.57 . . . . 0.0 113.309 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -72.83 -28.17 62.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.862 -1.149 . . . . 0.0 109.234 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -108.07 -60.36 1.73 Allowed 'General case' 0 CA--C 1.502 -0.904 0 O-C-N 120.944 -1.098 . . . . 0.0 108.634 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -77.29 157.61 30.65 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 77.41 -41.55 0.37 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.155 1.382 . . . . 0.0 111.736 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -52.29 -56.05 17.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 110.548 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -86.35 -0.41 55.83 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.491 -0.756 . . . . 0.0 111.049 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.91 -12.67 61.22 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 121.244 -0.91 . . . . 0.0 112.255 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 m80 . . . . . 0 CA--C 1.507 -0.702 0 C-N-CA 125.88 1.672 . . . . 0.0 107.096 -173.315 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.429 -1.513 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.96 -144.77 0.47 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 111.058 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -144.7 -66.51 0.33 Allowed 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.469 ' CG ' ' HA ' ' B' ' 88' ' ' ALA . 10.9 p80 -55.45 -23.18 24.0 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -68.52 -28.38 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.278 -0.889 . . . . 0.0 109.246 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.42 -23.31 40.43 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.17 -0.956 . . . . 0.0 110.966 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -83.05 -41.5 18.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.22 76.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 112.024 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -61.75 -49.12 77.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 124.589 1.155 . . . . 0.0 109.784 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -64.56 -35.86 82.35 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.698 0.799 . . . . 0.0 110.551 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -44.74 94.69 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -63.55 -43.25 97.62 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.256 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 123.33 0.652 . . . . 0.0 110.062 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . 0.295 4.1 tt0 -77.13 -11.89 59.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.213 -0.929 . . . . 0.0 112.127 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 tp -70.22 -35.04 73.6 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -60.35 -35.66 76.18 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.845 0.858 . . . . 0.0 110.736 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.7 -39.88 95.41 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.726 1.21 . . . . 0.0 109.923 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.05 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 O-C-N 121.379 -0.826 . . . . 0.0 109.526 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.56 -40.19 96.04 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.903 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.47 -44.29 78.94 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.117 -0.989 . . . . 0.0 109.532 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.87 -39.15 90.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.758 1.223 . . . . 0.0 110.477 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.27 77.22 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 126.025 1.73 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -66.43 -44.1 83.81 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.3 1.04 . . . . 0.0 110.197 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -65.44 -53.72 38.83 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.49 1.116 . . . . 0.0 108.68 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -57.39 -48.6 78.65 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.699 1.199 . . . . 0.0 110.698 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 -41.86 65.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 125.057 1.343 . . . . 0.0 111.666 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.22 -47.08 82.6 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 120.797 -1.189 . . . . 0.0 107.949 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.34 -1.89 38.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.06 -1.025 . . . . 0.0 110.918 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.505 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -69.91 -47.76 61.23 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 109.594 176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -80.06 -110.93 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 71.18 -33.34 0.27 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.754 2.022 . . . . 0.0 113.515 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.15 41.05 0.38 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.07 153.86 39.03 Favored Pre-proline 0 C--N 1.35 0.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.75 123.21 3.21 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 C-N-CA 123.265 2.643 . . . . 0.0 111.43 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 23.0 53.05 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.94 33.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 126.851 2.061 . . . . 0.0 111.157 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -37.63 0.22 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.873 0.469 . . . . 0.0 110.528 -172.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.98 60.32 4.76 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-O 124.011 1.862 . . . . 0.0 107.865 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.72 -14.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 O-C-N 120.051 -1.656 . . . . 0.0 112.255 -168.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -99.2 132.41 44.53 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.061 -1.649 . . . . 0.0 112.399 -167.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.36 -54.41 11.4 Favored Pre-proline 0 C--N 1.351 0.644 0 CA-C-O 116.619 -1.658 . . . . 0.0 109.606 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.89 -13.07 24.14 Favored 'Trans proline' 0 CA--C 1.508 -0.815 0 CA-C-N 125.552 3.018 . . . . 0.0 111.297 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.51 -10.83 26.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.62 95.07 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.97 -28.72 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 123.989 0.916 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -37.87 62.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.117 0.967 . . . . 0.0 108.793 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -66.69 -43.17 85.11 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.779 0.831 . . . . 0.0 109.475 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 42.0 m -53.53 -30.4 41.47 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.988 1.315 . . . . 0.0 113.572 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.34 -34.87 51.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.435 1.094 . . . . 0.0 110.715 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -77.81 -36.46 50.25 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.842 -1.161 . . . . 0.0 113.174 -171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -77.26 -37.32 53.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -166.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.11 -26.8 64.14 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.522 -0.736 . . . . 0.0 112.071 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -89.23 7.43 35.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p 55.08 64.07 1.91 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 125.62 1.568 . . . . 0.0 111.778 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.71 -106.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 57' ' ' TYR . . . 98.4 76.55 1.28 Allowed Glycine 0 CA--C 1.484 -1.866 0 N-CA-C 104.634 -3.387 . . . . 0.0 104.634 -174.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -35.78 58.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.65 -0.912 . . . . 0.0 108.911 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 39.45 0.73 Allowed Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.42 ' HB2' HH12 ' C' ' 68' ' ' ARG . 6.5 t70 -77.72 -51.23 10.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 118.554 1.177 . . . . 0.0 108.69 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.32 160.16 38.78 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -130.79 114.45 16.62 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.62 173.08 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.582 2.854 . . . . 0.0 109.349 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.25 -112.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.021 0.929 . . . . 0.0 110.735 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.0 m -136.33 -41.16 0.64 Allowed 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.658 -1.276 . . . . 0.0 108.627 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -81.72 -2.67 51.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.202 -0.936 . . . . 0.0 109.277 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -79.08 -29.52 43.42 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.01 69.66 1.26 Allowed Glycine 0 CA--C 1.47 -2.77 0 N-CA-C 103.795 -3.722 . . . . 0.0 103.795 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -36.03 -18.49 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.444 3.498 . . . . 0.0 116.869 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -53.12 -17.57 1.66 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 119.988 -1.695 . . . . 0.0 113.132 158.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.13 -46.29 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 119.56 -1.962 . . . . 0.0 108.756 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.61 -48.73 63.37 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.59 -47.05 77.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.38 1.072 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -69.85 -37.82 76.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.307 -0.871 . . . . 0.0 112.356 -173.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.35 -43.73 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ttp -62.14 -51.03 69.5 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.298 1.039 . . . . 0.0 110.537 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.31 -30.96 70.95 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.631 0.772 . . . . 0.0 110.044 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.5 73.88 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.331 -0.856 . . . . 0.0 111.12 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.19 85.95 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 mt -60.61 -45.29 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 C-N-CA 124.307 1.043 . . . . 0.0 109.562 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -29.27 70.35 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.111 -0.993 . . . . 0.0 112.078 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.08 -54.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -62.52 -42.19 99.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.728 0.811 . . . . 0.0 110.69 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.11 79.25 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.079 1.352 . . . . 0.0 111.158 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tt -66.77 -34.18 77.27 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.109 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.07 -10.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 124.451 1.101 . . . . 0.0 110.236 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 8.4 m -60.7 -22.98 64.51 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 119.303 -2.123 . . . . 0.0 111.49 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.65 69.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.327 -1.483 . . . . 0.0 111.811 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.469 ' HA ' ' CG ' ' B' ' 4' ' ' HIS . . . -80.27 -45.63 17.6 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.12 -37.8 88.65 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 124.5 1.12 . . . . 0.0 111.795 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.61 65.75 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.598 -0.688 . . . . 0.0 112.202 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -91.5 -6.58 52.35 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.603 -1.311 . . . . 0.0 109.291 176.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.299 0.2 OUTLIER -79.12 -12.38 60.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 120.402 1.455 . . . . 0.0 110.616 -167.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.44 -31.75 54.08 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 168.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.53 -22.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.895 1.278 . . . . 0.0 108.672 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -55.62 -24.79 35.4 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.951 1.7 . . . . 0.0 112.18 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -64.19 -22.02 66.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 120.828 -1.17 . . . . 0.0 110.894 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.05 -37.01 72.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -62.47 -54.7 36.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.07 -31.94 61.55 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -62.34 -40.11 95.3 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -94.97 -20.74 19.12 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.1 0.952 . . . . 0.0 109.461 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.18 17.71 57.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 . . . . . 0 CA--C 1.495 -1.162 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 174.617 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.34 119.23 4.55 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 93.103 -6.629 . . . . 0.0 93.103 165.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.22 93.65 0.07 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 119.837 1.198 . . . . 0.0 109.906 -169.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.553 ' HE1' ' OD1' ' C' ' 92' ' ' ASP . 0.6 OUTLIER -176.09 -37.97 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.89 2.076 . . . . 0.0 105.486 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.17 -35.82 74.24 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.131 0.967 . . . . 0.0 110.325 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -58.27 -36.04 72.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.473 1.909 . . . . 0.0 111.389 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.94 -42.42 39.35 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.196 1.398 . . . . 0.0 108.513 -176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.44 85.62 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.302 1.041 . . . . 0.0 110.889 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.27 -37.53 87.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.391 1.476 . . . . 0.0 110.697 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -67.57 -36.03 80.14 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.009 0.924 . . . . 0.0 109.154 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.92 97.39 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.998 0.919 . . . . 0.0 111.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.66 -27.84 68.66 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 121.235 -0.915 . . . . 0.0 112.435 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.31 -35.73 81.89 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.671 -1.268 . . . . 0.0 109.542 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.74 -44.51 93.76 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.48 -44.05 92.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.034 0.534 . . . . 0.0 110.88 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.35 -40.13 74.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.769 0.827 . . . . 0.0 112.339 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -73.69 -28.53 61.79 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 120.872 -1.142 . . . . 0.0 111.044 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.05 -37.26 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.01 -49.09 69.65 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.085 0.954 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.71 -45.96 91.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.852 0.751 . . . . 0.0 111.672 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -42.71 82.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.715 -0.615 . . . . 0.0 109.99 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.43 84.3 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.963 1.305 . . . . 0.0 111.651 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -62.86 -50.27 71.6 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.977 1.311 . . . . 0.0 109.593 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -67.2 -40.37 86.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -62.0 -48.88 78.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.384 1.074 . . . . 0.0 110.724 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.34 72.66 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 111.824 -173.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.79 -42.39 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 O-C-N 122.204 -0.31 . . . . 0.0 110.396 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.17 -23.63 60.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 120.365 -1.459 . . . . 0.0 112.148 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.55 69.7 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.361 1.464 . . . . 0.0 107.983 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.92 -28.21 63.33 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.739 0.78 . . . . 0.0 111.001 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.34 95.87 1.07 Allowed 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.618 -1.301 . . . . 0.0 110.378 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.0 -11.56 6.54 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.76 142.83 26.12 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 118.272 1.036 . . . . 0.0 109.061 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.54 129.72 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.407 2.071 . . . . 0.0 112.064 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.88 45.01 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 141.69 31.25 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.494 2.318 . . . . 0.0 112.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.89 -45.21 2.59 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.78 65.88 5.92 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 123.018 1.39 . . . . 0.0 109.449 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 31.7 pt -96.79 -10.87 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 O-C-N 119.851 -1.781 . . . . 0.0 111.447 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.3 m -98.71 127.23 44.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.514 -0.741 . . . . 0.0 109.668 -169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.84 -52.19 65.87 Favored Pre-proline 0 N--CA 1.445 -0.712 0 C-N-CA 126.148 1.779 . . . . 0.0 112.187 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.75 -8.41 20.31 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 CA-C-N 125.086 2.852 . . . . 0.0 111.624 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.79 -25.97 20.82 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.55 76.16 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.624 0.77 . . . . 0.0 111.348 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.2 -25.23 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 124.609 1.163 . . . . 0.0 110.411 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -79.57 -44.68 20.62 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 119.737 -1.852 . . . . 0.0 107.164 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.03 -37.5 87.43 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.176 0.991 . . . . 0.0 110.547 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -67.59 -35.34 78.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 120.025 -1.672 . . . . 0.0 111.519 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.26 -51.99 66.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.293 1.037 . . . . 0.0 109.554 -178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.75 -30.81 65.99 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.487 -0.758 . . . . 0.0 110.727 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 80.5 m -62.82 -36.35 82.89 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 120.955 -1.09 . . . . 0.0 110.783 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -16.05 63.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 120.632 -1.292 . . . . 0.0 113.036 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -89.34 -3.99 58.26 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.458 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.314 11.3 p 68.41 2.09 3.19 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 127.343 2.257 . . . . 0.0 112.66 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.81 -53.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.38 1.472 . . . . 0.0 107.418 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.34 -62.02 4.68 Favored Glycine 0 CA--C 1.492 -1.395 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 74.4 -44.95 0.57 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.798 2.839 . . . . 0.0 109.914 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.57 40.0 0.55 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 107.157 -2.377 . . . . 0.0 107.157 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.55 -55.73 9.33 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.503 1.151 . . . . 0.0 108.275 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -149.25 168.34 23.56 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -134.88 126.71 17.98 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -165.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.52 172.19 13.78 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 123.368 2.712 . . . . 0.0 109.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -93.37 -106.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 124.306 1.042 . . . . 0.0 113.641 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 18.7 m -155.86 -38.44 0.08 Allowed 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 119.013 -2.304 . . . . 0.0 106.411 -171.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -91.52 10.26 28.59 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 120.851 -1.156 . . . . 0.0 109.084 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -42.16 67.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.56 91.38 1.91 Allowed Glycine 0 N--CA 1.418 -2.537 1 N-CA-C 96.662 -6.575 . . . . 0.0 96.662 -170.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.42 HH12 ' HB2' ' B' ' 59' ' ' ASP . 24.9 ttm180 -65.87 -11.52 47.4 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.04 1.92 . . . . 0.0 110.388 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -46.14 -23.87 0.38 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 126.456 1.902 . . . . 0.0 113.971 159.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.84 -41.61 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 119.99 -1.694 . . . . 0.0 109.385 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.98 61.76 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -49.8 -49.19 49.6 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 126.236 1.814 . . . . 0.0 111.55 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -44.51 90.05 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.188 0.995 . . . . 0.0 111.813 -173.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.28 -37.92 60.17 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.415 -0.803 . . . . 0.0 109.252 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 73.7 mtm -66.36 -44.77 82.25 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 123.359 0.664 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -59.01 -43.1 91.49 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 123.846 0.858 . . . . 0.0 110.631 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.13 96.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.022 0.529 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.85 91.89 Favored Glycine 0 CA--C 1.493 -1.333 0 C-N-CA 123.905 0.764 . . . . 0.0 111.546 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.25 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 109.017 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.25 -37.97 86.76 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.634 -0.666 . . . . 0.0 111.674 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.57 -53.56 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 119.298 0.953 . . . . 0.0 110.054 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.07 -34.23 76.04 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 122.857 0.463 . . . . 0.0 110.71 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.12 65.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.915 -1.115 . . . . 0.0 110.489 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.03 -32.1 73.38 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 120.647 -1.283 . . . . 0.0 111.481 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.93 -1.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 120.99 -1.069 . . . . 0.0 112.271 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -58.65 -18.06 27.51 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 111.181 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.0 68.44 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.563 -1.336 . . . . 0.0 112.123 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.87 -44.62 16.61 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 121.317 -0.864 . . . . 0.0 108.857 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.4 -40.62 95.07 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.331 1.053 . . . . 0.0 111.633 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.25 99.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.471 0.708 . . . . 0.0 111.312 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -17.78 64.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 120.924 -1.11 . . . . 0.0 113.303 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.553 ' OD1' ' HE1' ' C' ' 4' ' ' HIS . 1.3 m-20 -74.7 -20.07 60.0 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 119.907 1.231 . . . . 0.0 111.028 -167.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -82.41 -31.83 29.39 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.035 -1.04 . . . . 0.0 110.519 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.04 -19.96 26.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.371 1.468 . . . . 0.0 109.382 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -65.17 -15.51 62.51 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 120.319 -1.488 . . . . 0.0 111.543 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -72.36 -14.01 61.62 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.129 -1.607 . . . . 0.0 111.48 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -63.65 -41.25 98.25 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' C' ' 98' ' ' GLU . 4.1 pt-20 -73.59 -34.64 65.18 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 123.98 0.912 . . . . 0.0 110.118 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -74.43 -11.31 60.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.036 0.934 . . . . 0.0 112.79 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -68.86 -31.02 69.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.928 -1.107 . . . . 0.0 110.234 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -112.72 -4.26 14.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.245 -0.91 . . . . 0.0 109.426 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.04 32.75 83.42 Favored Glycine 0 CA--C 1.498 -1.03 0 O-C-N 121.25 -0.907 . . . . 0.0 111.338 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.41 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.433 -1.322 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.23 -46.73 0.57 Allowed 'General case' 0 C--N 1.355 0.809 0 C-N-CA 127.207 2.203 . . . . 0.0 114.32 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . 0.308 3.3 m-20 67.9 -35.08 0.26 Allowed 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 131.358 3.863 . . . . 0.0 111.807 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -68.57 -22.54 64.47 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.856 -1.153 . . . . 0.0 112.528 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.89 -45.77 92.3 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 122.191 0.996 . . . . 0.0 108.845 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -67.1 -38.53 85.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 124.409 1.084 . . . . 0.0 110.142 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.14 -35.39 69.07 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.956 -0.465 . . . . 0.0 109.893 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.68 86.69 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 121.693 -0.63 . . . . 0.0 110.104 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -60.97 -39.71 90.61 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.625 1.57 . . . . 0.0 111.473 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.09 -30.31 62.29 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.358 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.76 79.2 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.822 -1.174 . . . . 0.0 110.982 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.02 -35.92 82.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.596 -0.69 . . . . 0.0 111.966 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.76 -42.82 81.16 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.766 1.226 . . . . 0.0 108.334 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -55.83 -45.13 78.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 125.576 1.55 . . . . 0.0 109.839 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.78 -36.83 79.96 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.542 -0.724 . . . . 0.0 112.348 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -65.01 -34.91 79.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.65 0.78 . . . . 0.0 109.988 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -75.59 -29.3 59.23 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 120.839 -1.163 . . . . 0.0 110.513 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.05 -47.82 52.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.27 -31.84 73.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.512 -0.742 . . . . 0.0 110.445 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -67.39 -43.51 81.15 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.797 -1.189 . . . . 0.0 111.064 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.48 -39.93 95.75 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.82 -1.175 . . . . 0.0 110.456 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.26 -25.6 68.13 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.31 -0.868 . . . . 0.0 112.343 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -66.09 -42.59 89.14 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 124.389 1.076 . . . . 0.0 111.021 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -66.54 -34.83 78.78 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.471 1.109 . . . . 0.0 108.461 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -74.41 -50.49 18.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 118.273 -0.87 . . . . 0.0 108.722 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.11 -41.8 75.81 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 126.83 2.052 . . . . 0.0 113.166 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.82 -31.12 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 O-C-N 120.722 -1.236 . . . . 0.0 110.896 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 -34.11 22.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.69 47.2 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 0.0 109.373 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.37 -36.5 71.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 120.997 0.427 . . . . 0.0 111.191 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.02 106.53 1.63 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 120.024 -1.673 . . . . 0.0 111.568 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.41 -25.13 4.32 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.94 153.81 75.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 123.657 0.783 . . . . 0.0 110.979 -170.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -80.43 135.78 10.78 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.312 2.008 . . . . 0.0 109.988 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.64 14.07 74.14 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.0 135.0 56.28 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.01 1.724 . . . . 0.0 111.725 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.82 -31.08 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.984 1.314 . . . . 0.0 109.047 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' D' ' 60' ' ' ARG . 4.6 tt -86.72 121.97 29.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.246 1.418 . . . . 0.0 109.103 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 pt -148.88 175.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 73.3 m 67.13 122.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.212 2.205 . . . . 0.0 113.662 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -58.9 -50.5 87.65 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 116.815 -1.564 . . . . 0.0 113.189 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.61 -11.93 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 124.459 2.628 . . . . 0.0 111.525 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.56 -37.85 14.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.6 83.59 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.939 1.696 . . . . 0.0 112.207 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -64.8 -31.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.47 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.69 -18.25 41.58 Favored 'General case' 0 N--CA 1.437 -1.108 0 O-C-N 120.674 -1.266 . . . . 0.0 110.878 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -72.01 -43.47 65.0 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -66.03 -26.11 67.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 121.33 -0.856 . . . . 0.0 113.202 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.4 -36.18 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 C-N-CA 124.403 1.081 . . . . 0.0 111.351 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.61 -5.9 57.87 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.649 -1.282 . . . . 0.0 110.133 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.43 HG22 ' H ' ' D' ' 52' ' ' ALA . 23.7 m -96.95 177.72 5.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 174.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.43 ' H ' HG22 ' D' ' 51' ' ' THR . . . 80.96 -41.12 0.16 Allowed 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.328 1.451 . . . . 0.0 110.208 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.6 p -85.33 3.54 39.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.982 1.713 . . . . 0.0 111.939 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p 59.24 53.68 5.23 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 126.095 1.758 . . . . 0.0 112.314 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.28 -99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.13 106.22 0.5 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 106.78 -2.528 . . . . 0.0 106.78 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -86.88 -15.64 38.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.747 -1.443 . . . . 0.0 109.233 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.84 28.6 5.27 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -65.57 -56.21 13.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' D' ' 38' ' ' LEU . 88.5 mtt-85 -137.2 156.97 47.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -128.49 149.92 73.04 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 101.206 -3.628 . . . . 0.0 101.206 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.26 152.06 3.72 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 123.313 2.676 . . . . 0.0 110.057 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.486 HG22 ' H ' ' D' ' 64' ' ' THR . 3.1 p -109.32 -179.59 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 122.328 1.061 . . . . 0.0 109.09 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.486 ' H ' HG22 ' D' ' 63' ' ' VAL . 4.9 m -62.63 -49.13 76.39 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.18 2.192 . . . . 0.0 113.913 -167.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -83.64 -0.0 48.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.744 1.218 . . . . 0.0 110.019 -167.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -28.19 67.41 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 123.745 1.736 . . . . 0.0 106.674 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 75.17 1.27 Allowed Glycine 0 CA--C 1.466 -3.03 1 N-CA-C 99.973 -5.251 . . . . 0.0 99.973 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.26 8.4 mtm180 -55.18 -2.35 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 126.104 1.762 . . . . 0.0 114.92 -169.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HG3' ' D' ' 72' ' ' GLU . 94.1 mttt -67.82 -0.77 4.5 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.828 1.251 . . . . 0.0 112.984 160.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.23 -59.82 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.81 -56.24 17.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 114.647 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' D' ' 69' ' ' LYS 0.302 1.5 pp20? -68.38 -26.63 65.67 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.313 -0.867 . . . . 0.0 111.551 -172.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -67.54 -31.08 70.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.613 -0.679 . . . . 0.0 110.777 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.15 -45.27 86.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 3.1 mtp -64.99 -46.54 81.0 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.662 0.785 . . . . 0.0 110.056 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -63.76 -37.89 89.06 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.222 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.57 91.62 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.396 0.617 . . . . 0.0 110.939 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.59 -41.52 89.69 Favored Glycine 0 CA--C 1.489 -1.588 0 O-C-N 121.615 -0.678 . . . . 0.0 112.469 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.47 -47.35 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.919 0.888 . . . . 0.0 109.709 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.27 -26.14 61.87 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.101 -0.999 . . . . 0.0 111.934 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 t -64.64 -50.91 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.82 -2.87 32.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.527 -0.733 . . . . 0.0 111.397 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -30.94 13.01 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.067 0.947 . . . . 0.0 109.491 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.84 -33.97 75.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.617 -1.302 . . . . 0.0 109.83 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -62.69 -12.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.183 0.993 . . . . 0.0 111.899 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 21.3 m -68.26 -14.87 63.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 120.337 -1.477 . . . . 0.0 111.73 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -16.39 64.19 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 120.007 -1.683 . . . . 0.0 111.31 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.82 -49.33 7.18 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 62.9 mt -60.39 -35.54 75.98 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.652 1.181 . . . . 0.0 112.085 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 120.924 -1.11 . . . . 0.0 112.435 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -4.45 55.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 120.777 -1.202 . . . . 0.0 108.415 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.9 -32.17 67.14 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 119.382 0.992 . . . . 0.0 109.454 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -75.84 -28.59 58.29 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.379 -1.45 . . . . 0.0 111.079 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 t -70.55 -17.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 108.74 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -59.1 -22.21 60.47 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 125.656 1.582 . . . . 0.0 111.606 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -60.66 -33.0 72.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 123.013 1.387 . . . . 0.0 110.242 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -96.54 154.54 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 103.25 -2.871 . . . . 0.0 103.25 -161.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.29 32.1 mt-10 76.23 -47.97 0.56 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.423 1.489 . . . . 0.0 110.546 -171.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -63.29 -35.95 82.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.277 1.431 . . . . 0.0 112.149 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -71.07 -23.35 62.11 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.888 -0.507 . . . . 0.0 111.94 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -85.26 -23.94 27.98 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.177 -0.952 . . . . 0.0 108.52 172.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.22 32.72 25.02 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.701 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.64 -79.08 0.06 Allowed 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.822 0.82 . . . . 0.0 109.103 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -157.03 -74.17 0.09 Allowed 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 23.4 p-80 -58.4 -35.59 72.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 129.456 3.102 . . . . 0.0 112.313 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.477 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 7.7 mt-10 -68.21 -32.66 73.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.113 0.965 . . . . 0.0 111.498 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -65.61 -40.0 92.15 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.72 -31.89 68.9 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.74 0.816 . . . . 0.0 109.636 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.58 -43.05 70.21 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.544 0.738 . . . . 0.0 109.981 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -68.27 -35.98 78.7 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 121.914 -0.491 . . . . 0.0 110.305 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.71 -40.12 78.8 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.689 1.196 . . . . 0.0 110.889 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.45 94.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.729 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -64.67 -28.0 69.31 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.427 -0.796 . . . . 0.0 111.608 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.72 -35.94 72.97 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.789 -1.194 . . . . 0.0 110.246 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -68.15 -38.48 82.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.28 -38.71 84.43 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.309 -0.869 . . . . 0.0 111.747 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -71.18 -27.05 63.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 121.403 -0.811 . . . . 0.0 111.458 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -72.17 -39.14 68.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.443 -0.786 . . . . 0.0 109.488 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.2 -34.57 64.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.568 1.147 . . . . 0.0 109.792 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.95 -48.04 82.93 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.926 -1.109 . . . . 0.0 111.342 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.49 -42.51 87.33 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.808 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.28 -49.18 78.64 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 110.072 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.69 88.24 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 125.732 1.613 . . . . 0.0 111.243 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -43.47 98.81 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.588 0.755 . . . . 0.0 111.103 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -66.08 -40.73 91.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 124.398 1.079 . . . . 0.0 108.916 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -76.27 -44.66 36.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.699 -0.626 . . . . 0.0 111.18 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.6 95.54 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.665 1.586 . . . . 0.0 111.09 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.82 -38.05 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 122.189 -0.319 . . . . 0.0 110.212 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.283 89.0 mt-10 -67.98 -40.03 83.19 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.022 -1.049 . . . . 0.0 109.352 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.02 -47.3 85.38 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.76 1.624 . . . . 0.0 109.613 -171.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.15 -8.62 59.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 121.666 -0.646 . . . . 0.0 111.929 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HD2' HG23 ' A' ' 39' ' ' ILE . 34.9 tpt85 -76.17 80.95 2.98 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.081 -1.637 . . . . 0.0 110.141 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.65 -13.74 5.84 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.89 150.08 97.71 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 118.124 0.962 . . . . 0.0 109.903 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' O ' HG11 ' A' ' 63' ' ' VAL . 37.3 Cg_endo -75.55 147.76 32.35 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 121.984 1.79 . . . . 0.0 108.525 -177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 4.21 64.86 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 120.192 1.36 . . . . 0.0 113.957 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 159.44 27.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.755 0.822 . . . . 0.0 111.736 -171.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.96 -32.32 0.8 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.137 0.975 . . . . 0.0 109.78 -171.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.12 40.73 0.72 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 123.828 1.775 . . . . 0.0 109.392 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG23 ' HD2' ' A' ' 31' ' ' ARG . 7.9 mt -86.66 72.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 O-C-N 119.158 -2.214 . . . . 0.0 105.388 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -158.06 -120.37 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 116.553 -1.689 . . . . 0.0 107.041 -168.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.6 t80 178.23 -64.28 0.0 OUTLIER Pre-proline 0 C--N 1.359 1.0 0 CA-C-N 121.052 1.751 . . . . 0.0 110.355 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -75.14 -8.46 19.92 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 CA-C-N 125.515 3.005 . . . . 0.0 111.887 -167.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -10.18 28.33 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 129.662 3.185 . . . . 0.0 107.136 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -48.7 51.31 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.13 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.3 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -17.51 60.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.498 -1.376 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -86.29 -39.21 16.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.23 -38.3 76.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.745 -1.222 . . . . 0.0 111.726 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.57 -25.85 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.695 1.198 . . . . 0.0 110.824 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.99 -23.03 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.976 -1.078 . . . . 0.0 110.809 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -107.47 -22.85 12.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 -165.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.2 64.17 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.372 -1.455 . . . . 0.0 111.999 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.95 2.35 51.86 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.919 1.288 . . . . 0.0 110.578 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.252 9.6 p 56.67 63.09 2.05 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.34 1.856 . . . . 0.0 111.261 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 56' ' ' GLY . 2.6 t -145.79 -164.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -177.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 55' ' ' VAL . . . 156.67 101.72 0.19 Allowed Glycine 0 CA--C 1.475 -2.459 1 N-CA-C 100.191 -5.164 . . . . 0.0 100.191 -177.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.89 -26.87 29.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.3 33.57 1.6 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' CG ' HH22 ' B' ' 68' ' ' ARG . 30.8 t70 -83.67 -26.46 29.84 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.434 -1.039 . . . . 0.0 109.418 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -179.58 4.69 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -158.7 114.99 1.67 Allowed Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.71 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.697 2.932 . . . . 0.0 109.417 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 34' ' ' PRO . 3.5 t -106.36 -120.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.909 0.883 . . . . 0.0 110.372 -173.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -141.67 -36.28 0.43 Allowed 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -89.41 9.97 24.31 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 120.881 -1.137 . . . . 0.0 108.187 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -43.92 63.21 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.44 90.92 2.03 Favored Glycine 0 N--CA 1.417 -2.594 1 N-CA-C 96.397 -6.681 . . . . 0.0 96.397 -172.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.407 HH12 ' HB2' ' D' ' 59' ' ' ASP . 22.6 ttm180 -64.36 -12.03 38.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 119.364 1.582 . . . . 0.0 111.081 -172.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -46.95 -28.97 1.8 Allowed 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.002 0.921 . . . . 0.0 113.215 162.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.8 t -66.92 -39.4 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 0.0 110.133 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.48 -50.46 18.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 120.951 -1.093 . . . . 0.0 108.42 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -50.81 -44.5 59.05 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.612 1.565 . . . . 0.0 111.998 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -65.64 -36.02 82.48 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.416 0.686 . . . . 0.0 110.148 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.38 -42.59 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.9 mtt -59.79 -50.89 72.03 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.243 1.017 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -64.55 -38.27 90.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.149 0.98 . . . . 0.0 110.83 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.08 96.55 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.188 0.595 . . . . 0.0 110.518 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.69 -48.72 79.21 Favored Glycine 0 CA--C 1.49 -1.522 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.36 -47.48 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.387 1.075 . . . . 0.0 109.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.72 -39.92 95.48 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 120.929 -1.107 . . . . 0.0 111.397 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 t -64.22 -52.89 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.738 0.815 . . . . 0.0 109.851 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.26 -41.22 94.45 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 110.499 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.13 -30.9 71.48 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 123.565 0.746 . . . . 0.0 111.019 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.57 -30.38 69.99 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 121.059 -1.026 . . . . 0.0 110.852 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.3 t -59.87 -18.44 15.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 124.375 1.07 . . . . 0.0 110.582 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 m -56.42 -27.71 57.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.248 1.419 . . . . 0.0 112.739 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.04 -28.28 64.36 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.485 1.114 . . . . 0.0 111.376 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 4' ' ' HIS . . . -89.05 -45.92 9.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.088 0.955 . . . . 0.0 109.495 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.7 mt -49.62 -46.71 49.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.476 1.91 . . . . 0.0 113.434 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.82 42.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.756 -1.215 . . . . 0.0 111.222 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.8 p -64.11 -6.14 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.381 1.072 . . . . 0.0 113.259 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.36 -74.79 0.14 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.31 0.93 57.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.439 -1.413 . . . . 0.0 112.347 -168.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.68 -29.52 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 O-C-N 119.761 -1.837 . . . . 0.0 108.761 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -59.5 -18.08 37.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.001 1.32 . . . . 0.0 113.2 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -52.22 -35.46 49.47 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.28 1.432 . . . . 0.0 111.593 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 100' ' ' ARG . 7.5 tp10 -75.0 -49.76 18.78 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.57 -26.18 63.42 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.575 -0.703 . . . . 0.0 110.919 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -73.77 -27.41 61.14 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 119.816 -1.802 . . . . 0.0 111.412 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' A' ' 97' ' ' GLU . 50.5 ttp180 -74.81 -46.01 39.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -131.03 87.79 2.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -172.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.37 -53.7 0.51 Allowed Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 106.445 -2.662 . . . . 0.0 106.445 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . 0.316 14.1 p80 . . . . . 0 CA--C 1.502 -0.872 0 C-N-CA 128.389 2.675 . . . . 0.0 114.274 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.68 169.11 8.76 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.48 -39.55 88.05 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 123.15 1.453 . . . . 0.0 110.405 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 37.3 p-80 -72.02 -28.92 63.69 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.159 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.62 -43.05 23.61 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.32 -37.47 87.4 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.962 -0.461 . . . . 0.0 110.32 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.35 -34.83 65.83 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.979 0.418 . . . . 0.0 110.036 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.28 78.59 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 123.674 0.79 . . . . 0.0 110.287 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -77.97 -11.98 59.95 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 121.633 -0.667 . . . . 0.0 111.452 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -77.77 -29.34 50.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 121.394 -0.816 . . . . 0.0 109.349 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.62 87.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.41 -23.48 63.71 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.693 0.797 . . . . 0.0 111.905 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -72.28 -44.66 62.44 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.931 -1.106 . . . . 0.0 108.161 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.81 -33.75 76.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.693 1.197 . . . . 0.0 109.818 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.02 -45.58 82.99 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 111.913 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.13 -38.89 90.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.286 1.034 . . . . 0.0 109.916 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -63.48 -41.21 98.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.011 0.924 . . . . 0.0 111.382 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.52 -48.41 47.2 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 124.175 0.99 . . . . 0.0 110.372 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.71 -35.22 80.36 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -65.51 -39.03 91.36 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.795 -1.191 . . . . 0.0 110.929 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.79 -37.62 86.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.437 -1.415 . . . . 0.0 109.217 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.62 66.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 123.387 0.675 . . . . 0.0 111.841 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.5 p -66.93 -39.01 87.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 118.767 0.712 . . . . 0.0 110.694 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.34 -46.03 81.88 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.45 -43.14 99.53 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.621 1.169 . . . . 0.0 108.936 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.99 84.64 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.147 1.379 . . . . 0.0 113.279 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.88 -47.78 91.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-O 121.88 0.847 . . . . 0.0 109.502 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -79.96 -20.79 44.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 O-C-N 121.663 -0.648 . . . . 0.0 110.673 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -51.43 22.74 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 125.9 1.68 . . . . 0.0 109.664 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 -18.37 55.35 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 121.834 -0.542 . . . . 0.0 111.869 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.51 87.67 1.2 Allowed 'General case' 0 C--N 1.353 0.754 0 O-C-N 119.973 -1.704 . . . . 0.0 110.107 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.31 -11.46 3.27 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' B' ' 36' ' ' ALA . . . -88.4 143.77 32.92 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 118.398 1.099 . . . . 0.0 111.69 -170.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.18 125.19 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.359 2.706 . . . . 0.0 111.636 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 23.28 68.0 Favored Glycine 0 CA--C 1.495 -1.206 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' B' ' 33' ' ' ALA . . . -78.19 167.11 21.91 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.157 1.383 . . . . 0.0 109.524 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.58 -39.51 1.28 Allowed 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.222 0.609 . . . . 0.0 109.615 -166.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -94.78 130.57 41.28 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.6 pt -140.56 6.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 O-C-N 120.81 -1.182 . . . . 0.0 111.124 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.9 138.51 26.99 Favored 'General case' 0 CA--C 1.499 -0.99 0 O-C-N 119.944 -1.723 . . . . 0.0 109.502 -161.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -52.98 65.83 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 126.234 1.813 . . . . 0.0 113.347 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.19 -15.28 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 123.732 2.369 . . . . 0.0 111.827 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.86 -40.39 14.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.16 86.19 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 124.891 1.277 . . . . 0.0 111.886 -170.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.42 -38.73 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 122.749 0.419 . . . . 0.0 110.338 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -38.5 72.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.658 -0.651 . . . . 0.0 110.172 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.49 -43.0 99.88 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-O 122.157 0.979 . . . . 0.0 109.796 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 55.9 m -63.58 -30.61 71.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 120.517 -1.364 . . . . 0.0 113.006 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.36 -53.8 43.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 123.687 0.795 . . . . 0.0 109.622 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.91 -18.18 60.45 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 121.35 -0.844 . . . . 0.0 111.89 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -69.49 -36.81 76.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.454 0.702 . . . . 0.0 109.19 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.49 71.3 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.147 0.979 . . . . 0.0 111.664 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -82.97 3.4 30.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.358 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p 55.49 53.17 10.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.889 1.676 . . . . 0.0 112.574 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.71 -69.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.91 80.19 0.25 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -62.61 -43.29 99.19 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.463 1.125 . . . . 0.0 108.499 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.48 -120.67 0.99 Allowed Glycine 0 CA--C 1.48 -2.127 1 N-CA-C 102.043 -4.423 . . . . 0.0 102.043 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . 0.341 0.2 OUTLIER 66.08 -64.05 0.22 Allowed 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 127.241 2.216 . . . . 0.0 114.594 -177.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -132.88 166.71 21.69 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -160.19 135.97 6.05 Favored Pre-proline 0 N--CA 1.436 -1.145 0 CA-C-O 117.391 -1.29 . . . . 0.0 107.536 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.45 151.04 15.23 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.967 2.445 . . . . 0.0 110.801 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' B' ' 66' ' ' GLU . 2.8 t -92.77 -119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 124.524 1.13 . . . . 0.0 109.145 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 13.4 p -113.93 -43.93 3.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.285 -1.51 . . . . 0.0 111.813 -166.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -83.03 -23.63 33.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.745 1.618 . . . . 0.0 108.041 -163.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' B' ' 63' ' ' VAL . 1.2 pm0 -68.23 -14.62 63.12 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.592 1.957 . . . . 0.0 110.169 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.65 87.85 0.39 Allowed Glycine 0 CA--C 1.481 -2.087 1 N-CA-C 103.055 -4.018 . . . . 0.0 103.055 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.502 HH22 ' CG ' ' A' ' 59' ' ' ASP . 36.9 ttm180 -58.27 -21.21 47.73 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.59 -1.535 . . . . 0.0 111.872 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -55.86 -15.75 3.71 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.43 -43.73 97.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 O-C-N 120.722 -1.236 . . . . 0.0 108.729 172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.04 -43.68 67.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.403 0.681 . . . . 0.0 109.601 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.13 -39.85 69.89 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.819 1.648 . . . . 0.0 111.391 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' B' ' 73' ' ' GLN . 0.6 OUTLIER -64.52 -40.52 95.78 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.035 1.334 . . . . 0.0 110.703 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.93 -43.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.8 mtt -57.84 -49.92 75.05 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.096 0.958 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.17 90.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.668 -0.645 . . . . 0.0 111.157 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.5 98.78 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.877 1.227 . . . . 0.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.59 -43.38 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 121.641 -0.917 . . . . 0.0 108.927 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.24 -31.95 70.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.914 -1.116 . . . . 0.0 113.262 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.96 -41.06 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 120.058 1.299 . . . . 0.0 110.607 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.14 -38.58 75.53 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.617 0.644 . . . . 0.0 109.428 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.83 69.86 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.103 -0.998 . . . . 0.0 111.363 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.01 -15.46 63.48 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.546 -1.347 . . . . 0.0 111.207 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -5.34 2.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.5 -1.375 . . . . 0.0 110.157 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 14.8 t -49.58 -26.01 3.21 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 119.602 -1.936 . . . . 0.0 113.048 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.63 -36.49 71.9 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.975 1.31 . . . . 0.0 110.893 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.59 -41.45 23.97 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.305 1.042 . . . . 0.0 108.46 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.44 -42.15 96.16 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 120.788 -1.195 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.84 -1.61 23.04 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.897 -1.127 . . . . 0.0 111.731 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 44.4 p -85.72 -42.1 14.54 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.92 -25.23 52.68 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.789 0.804 . . . . 0.0 110.666 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.96 -50.04 37.54 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 126.736 2.015 . . . . 0.0 111.693 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.61 -30.4 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.749 1.22 . . . . 0.0 109.418 -171.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -58.67 -12.28 4.02 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.371 1.068 . . . . 0.0 112.964 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -54.98 -33.92 62.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.394 -0.816 . . . . 0.0 111.126 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.51 176.24 6.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . 0.264 20.0 mt-10 69.8 -44.46 0.56 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 126.367 1.867 . . . . 0.0 111.786 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -76.1 -50.96 13.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 112.453 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 -78.3 5.96 9.3 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 119.965 1.257 . . . . 0.0 113.507 -172.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -87.88 -28.11 21.77 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 164.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.35 40.65 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 56.1 t60 . . . . . 0 CA--C 1.509 -0.604 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 -176.081 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.81 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.736 2.015 . . . . 0.0 114.399 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -33.21 73.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 119.946 -1.721 . . . . 0.0 109.377 -174.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -79.85 -19.96 47.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.1 0.96 . . . . 0.0 112.165 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -30.76 62.85 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -61.63 -39.8 92.59 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.078 0.951 . . . . 0.0 110.827 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -32.17 73.49 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.346 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' C' ' 85' ' ' VAL . . . -71.69 -35.1 70.15 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 123.482 0.713 . . . . 0.0 110.975 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.15 -33.34 73.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -63.35 -34.3 77.41 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.031 1.733 . . . . 0.0 110.28 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.94 -37.35 81.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.7 -15.56 62.21 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.975 -1.078 . . . . 0.0 111.873 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -69.95 -42.81 72.72 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.48 -1.388 . . . . 0.0 109.034 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.0 -35.78 81.82 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.32 0.648 . . . . 0.0 110.803 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -42.91 88.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.54 -35.14 78.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.331 -0.856 . . . . 0.0 111.706 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -60.16 -46.5 89.47 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.089 1.356 . . . . 0.0 110.058 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.7 -39.07 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.195 0.998 . . . . 0.0 109.819 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.81 -45.32 82.34 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 119.299 0.954 . . . . 0.0 111.925 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.77 -38.08 79.79 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 122.971 0.508 . . . . 0.0 110.851 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -74.33 -39.89 62.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.78 -1.2 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.17 74.58 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 124.883 1.273 . . . . 0.0 112.339 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -70.74 -36.99 73.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.217 0.917 . . . . 0.0 110.473 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -66.73 -41.28 88.16 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -65.5 -46.9 77.88 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.31 -49.02 65.03 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.87 1.668 . . . . 0.0 112.576 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 27.1 m -67.42 -34.27 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 O-C-N 121.795 -0.566 . . . . 0.0 112.17 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -87.91 -24.15 23.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.539 0.685 . . . . 0.0 109.394 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 66' ' ' GLU . . . -73.6 -47.84 37.22 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.54 -8.68 53.24 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 122.058 0.932 . . . . 0.0 112.316 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.52 107.57 13.44 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 119.647 -1.908 . . . . 0.0 108.125 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.03 15.8 40.71 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.18 21.72 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.79 107.64 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.432 2.088 . . . . 0.0 113.179 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.23 27.36 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.14 145.09 22.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.337 1.855 . . . . 0.0 112.911 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.0 -16.08 5.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.344 1.058 . . . . 0.0 110.785 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.59 -79.84 0.3 Allowed 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 121.221 -0.924 . . . . 0.0 108.595 -168.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . 0.359 12.7 pt 38.94 -128.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 126.779 2.032 . . . . 0.0 111.048 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.4 -135.58 0.82 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.913 1.688 . . . . 0.0 109.752 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -173.03 -68.12 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-O 116.653 -1.642 . . . . 0.0 106.758 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.73 -17.84 22.67 Favored 'Trans proline' 0 CA--C 1.51 -0.685 0 CA-C-N 125.321 2.936 . . . . 0.0 111.197 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.44 -23.75 65.56 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.269 1.427 . . . . 0.0 109.947 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -63.2 -42.42 99.31 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 112.259 -167.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -69.3 -33.71 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.18 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 121.543 -0.723 . . . . 0.0 110.19 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -63.16 -45.4 92.01 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.84 0.456 . . . . 0.0 110.508 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 62.0 m -58.94 -36.09 74.21 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.678 -0.639 . . . . 0.0 112.062 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.32 -45.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 C-N-CA 123.89 0.876 . . . . 0.0 110.191 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -73.84 3.24 6.91 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 122.1 0.952 . . . . 0.0 112.785 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -104.71 -36.3 7.49 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.702 -1.249 . . . . 0.0 108.856 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.68 61.39 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.426 -1.421 . . . . 0.0 111.768 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.8 p -87.69 -3.01 58.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.728 1.211 . . . . 0.0 109.983 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.254 6.9 p 55.62 36.35 27.02 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.522 1.929 . . . . 0.0 112.77 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -91.19 -19.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 O-C-N 121.61 -0.681 . . . . 0.0 111.474 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.48 -60.14 1.55 Allowed Glycine 0 CA--C 1.493 -1.334 0 O-C-N 120.59 -1.319 . . . . 0.0 112.412 168.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -75.71 73.09 2.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.875 1.321 . . . . 0.0 113.62 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.09 10.15 75.77 Favored Glycine 0 CA--C 1.492 -1.399 0 O-C-N 118.512 -2.618 . . . . 0.0 114.552 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t0 71.7 -4.73 1.83 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 126.095 1.758 . . . . 0.0 111.562 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -136.53 163.25 30.96 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -136.0 148.32 64.38 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.13 171.19 15.47 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.812 3.008 . . . . 0.0 108.488 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 t -115.21 -95.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 120.655 1.57 . . . . 0.0 110.282 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -140.48 -49.97 0.45 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -85.13 -16.35 40.77 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 123.646 0.778 . . . . 0.0 110.085 -165.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HB1' ' C' ' 29' ' ' ALA . 0.9 OUTLIER -62.16 -33.21 74.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 108.33 171.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.35 95.32 1.81 Allowed Glycine 0 CA--C 1.475 -2.423 1 N-CA-C 98.229 -5.948 . . . . 0.0 98.229 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -61.92 -16.22 49.2 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 118.836 1.318 . . . . 0.0 110.62 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -59.81 -11.21 4.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.22 -39.88 86.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.084 -1.635 . . . . 0.0 108.99 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -45.18 69.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.82 -44.57 66.79 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.789 1.636 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -63.85 -36.0 82.48 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 112.34 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -71.84 -43.85 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 121.062 -1.024 . . . . 0.0 108.801 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.78 -42.51 97.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.606 0.762 . . . . 0.0 110.486 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.69 -47.15 83.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.621 1.168 . . . . 0.0 110.294 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.9 98.14 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.233 0.613 . . . . 0.0 110.509 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.13 77.92 Favored Glycine 0 CA--C 1.496 -1.119 0 C-N-CA 123.75 0.69 . . . . 0.0 111.832 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.75 -49.33 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 125.066 1.346 . . . . 0.0 108.675 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.42 -45.12 94.54 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 111.044 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.2 -52.87 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 C-N-CA 124.258 1.023 . . . . 0.0 110.367 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -72.27 -21.92 61.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.222 -0.924 . . . . 0.0 111.18 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.43 -37.88 36.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.115 -0.991 . . . . 0.0 110.111 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.23 -41.72 84.72 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.421 1.488 . . . . 0.0 110.609 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' C' ' 8' ' ' ALA . 17.1 m -69.04 -2.93 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -62.49 -12.57 22.98 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.361 1.065 . . . . 0.0 110.394 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.21 -57.3 12.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.122 -1.611 . . . . 0.0 111.841 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.4 77.6 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 126.07 1.748 . . . . 0.0 109.807 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.43 -33.37 75.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.35 40.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.007 -1.058 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.437 ' O ' HG22 ' C' ' 94' ' ' VAL 0.334 0.1 OUTLIER -70.36 -2.39 13.49 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.517 -1.23 . . . . 0.0 110.617 -176.93 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.281 0.6 OUTLIER -76.25 1.65 15.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 122.148 2.249 . . . . 0.0 111.531 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.24 -24.03 61.32 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 119.673 -1.892 . . . . 0.0 111.05 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.437 HG22 ' O ' ' C' ' 91' ' ' THR . 4.2 m -75.78 -12.95 14.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 O-C-N 120.112 -1.617 . . . . 0.0 110.275 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -79.64 -3.97 49.58 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.893 1.277 . . . . 0.0 109.388 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -77.77 -27.37 50.27 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.009 -1.682 . . . . 0.0 108.489 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -103.16 159.73 15.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -169.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.312 10.3 mt-10 73.9 -46.25 0.62 Allowed 'General case' 0 C--N 1.35 0.62 0 C-N-CA 126.171 1.789 . . . . 0.0 111.098 -168.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -68.22 -32.55 72.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 125.739 1.616 . . . . 0.0 114.971 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -64.8 -19.02 65.6 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.974 -1.079 . . . . 0.0 113.867 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -90.12 -21.92 22.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.095 -1.003 . . . . 0.0 109.499 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.17 32.32 56.2 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 124.016 0.817 . . . . 0.0 111.42 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 . . . . . 0 CA--C 1.487 -1.469 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.522 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.03 80.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.378 0.671 . . . . 0.0 111.314 -169.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -170.14 -104.38 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 -166.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -53.11 -22.54 6.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.989 3.316 . . . . 0.0 114.366 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.64 -28.56 67.82 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 125.385 1.474 . . . . 0.0 110.447 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -68.28 -43.3 78.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.923 0.889 . . . . 0.0 109.742 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.07 -31.34 62.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.503 -0.748 . . . . 0.0 109.588 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.95 91.44 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.871 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -66.12 -38.4 88.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.56 -42.99 99.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 109.904 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.32 84.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.74 0.816 . . . . 0.0 111.566 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.74 -38.16 77.8 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.564 0.745 . . . . 0.0 110.807 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.6 -30.14 65.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.303 -0.873 . . . . 0.0 110.406 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.76 -32.97 73.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.5 -43.2 97.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.357 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -56.05 -33.55 65.08 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.394 1.078 . . . . 0.0 111.745 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -71.19 -23.63 62.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.143 1.377 . . . . 0.0 111.174 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.68 -42.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.48 -40.23 74.57 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 124.939 1.296 . . . . 0.0 111.261 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -54.3 -51.68 63.85 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.273 1.029 . . . . 0.0 111.728 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.58 -38.37 67.92 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.65 0.78 . . . . 0.0 109.254 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.33 77.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.727 1.611 . . . . 0.0 111.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -64.46 -40.06 94.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.629 1.172 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -68.7 -46.62 68.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.49 -49.07 75.03 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.326 -0.859 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.08 -46.57 87.95 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 126.086 1.755 . . . . 0.0 111.836 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.34 -37.32 78.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 118.42 0.554 . . . . 0.0 110.139 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.34 -33.62 61.13 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.944 -1.098 . . . . 0.0 109.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.8 -55.51 14.55 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.249 1.82 . . . . 0.0 109.195 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.09 -32.9 74.38 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.019 0.928 . . . . 0.0 111.135 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -74.18 101.6 4.01 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 120.339 -1.476 . . . . 0.0 110.892 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.05 -22.49 4.79 Favored Glycine 0 CA--C 1.489 -1.541 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.8 142.96 66.1 Favored Pre-proline 0 N--CA 1.443 -0.801 0 O-C-N 121.547 -0.972 . . . . 0.0 109.653 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.94 140.38 12.64 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 122.781 2.321 . . . . 0.0 109.703 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.04 -8.84 71.67 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 119.132 0.878 . . . . 0.0 110.956 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.89 150.65 27.96 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 126.71 2.004 . . . . 0.0 111.287 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.93 -28.89 1.52 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.035 0.534 . . . . 0.0 110.572 -170.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.7 91.4 8.63 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 120.278 -1.514 . . . . 0.0 107.067 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 tt -122.49 53.13 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 O-C-N 120.848 -1.158 . . . . 0.0 108.117 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 26.4 t -153.97 142.0 20.28 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 119.489 -2.007 . . . . 0.0 106.948 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -80.64 -49.7 1.11 Allowed Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 115.807 -2.044 . . . . 0.0 109.929 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -69.18 -15.24 39.1 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 CA-C-N 126.036 3.192 . . . . 0.0 111.723 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.06 -13.53 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.22 80.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.03 -1.044 . . . . 0.0 109.044 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -67.9 -29.33 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 123.132 0.573 . . . . 0.0 110.909 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -47.48 63.85 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -67.23 -32.99 74.4 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.301 -0.875 . . . . 0.0 111.015 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -57.71 -24.85 58.93 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.618 -1.301 . . . . 0.0 112.523 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -40.65 15.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.709 -1.245 . . . . 0.0 110.228 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.38 -27.38 62.26 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 127.502 2.321 . . . . 0.0 110.835 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -99.31 -37.25 9.33 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 120.06 -1.65 . . . . 0.0 109.865 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.82 -14.12 61.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.394 -1.441 . . . . 0.0 112.262 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.4 p -99.0 2.07 46.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.257 63.5 p 56.31 28.96 14.18 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.343 2.257 . . . . 0.0 111.856 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.89 -52.88 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.88 63.43 4.79 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.816 -0.436 . . . . 0.0 113.626 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.39 -16.74 63.58 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 118.879 1.34 . . . . 0.0 110.092 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.24 36.8 4.28 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.407 ' HB2' HH12 ' A' ' 68' ' ' ARG . 11.6 t70 -70.25 -54.43 12.73 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.65 169.01 14.96 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.06 130.17 10.0 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 100.366 -3.939 . . . . 0.0 100.366 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.35 177.57 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.253 2.635 . . . . 0.0 107.841 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.38 -119.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.745 0 C-N-CA 123.696 0.798 . . . . 0.0 110.949 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -132.63 -38.68 1.01 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -82.88 -14.62 53.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.791 1.636 . . . . 0.0 108.81 -168.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -33.51 68.84 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.18 63.44 0.81 Allowed Glycine 0 CA--C 1.464 -3.127 1 N-CA-C 102.69 -4.164 . . . . 0.0 102.69 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -30.95 -18.76 0.0 OUTLIER 'General case' 0 C--N 1.361 1.077 1 C-N-CA 132.647 4.379 . . . . 0.0 117.466 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.33 -19.08 7.74 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 119.931 -1.73 . . . . 0.0 113.436 160.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.38 -44.18 98.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 124.451 1.1 . . . . 0.0 108.946 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.72 -55.08 7.3 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -40.08 -58.19 1.5 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.833 2.053 . . . . 0.0 112.326 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.14 -34.23 72.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.421 -169.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -74.23 -42.18 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 52.4 mtm -61.66 -49.72 75.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.524 0.73 . . . . 0.0 110.418 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.92 -27.47 66.66 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 121.514 -0.741 . . . . 0.0 111.185 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.35 81.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.677 -0.639 . . . . 0.0 110.811 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.69 89.57 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.91 -47.12 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.24 1.016 . . . . 0.0 109.907 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -69.26 -30.6 68.76 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.113 -0.992 . . . . 0.0 112.112 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.27 -52.1 60.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 C-N-CA 123.709 0.804 . . . . 0.0 109.265 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -69.1 -32.12 71.31 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.744 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.28 77.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.376 -0.827 . . . . 0.0 111.243 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -65.68 -36.14 82.8 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.651 1.18 . . . . 0.0 110.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.92 -19.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.405 1.482 . . . . 0.0 110.497 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -59.88 -20.48 57.47 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.791 -1.193 . . . . 0.0 112.714 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.93 74.8 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.228 -2.17 . . . . 0.0 111.539 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.96 53.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.005 0.922 . . . . 0.0 110.178 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.5 -27.93 18.88 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.864 1.316 . . . . 0.0 108.717 175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.77 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 119.836 -1.79 . . . . 0.0 110.757 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -68.28 -12.23 60.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.992 -1.068 . . . . 0.0 109.487 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.09 -20.78 59.32 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.024 -1.047 . . . . 0.0 111.37 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.02 -31.64 72.9 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.153 0.981 . . . . 0.0 108.976 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 t -90.63 -38.3 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 108.37 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -55.96 -35.76 67.05 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.724 1.61 . . . . 0.0 112.238 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -64.51 -20.36 66.16 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.029 -1.045 . . . . 0.0 112.407 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.17 -33.16 50.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 119.957 -1.714 . . . . 0.0 110.278 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -66.93 -34.22 77.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 119.017 0.826 . . . . 0.0 109.701 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.37 -41.28 75.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.799 1.639 . . . . 0.0 110.911 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -63.22 -41.16 99.08 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.547 0.739 . . . . 0.0 111.368 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -70.6 -31.34 68.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.751 0.821 . . . . 0.0 108.819 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.71 13.82 56.19 Favored Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 25.3 t60 . . . . . 0 C--N 1.353 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 112.328 -178.71 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.432 -1.345 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -73.47 174.49 8.13 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -52.34 62.6 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.404 1.881 . . . . 0.0 109.908 -167.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.605 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 42.7 p-80 -76.53 -15.13 59.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.774 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 8.8 mm-40 -80.66 -32.8 35.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -63.86 -44.66 92.45 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.12 0.968 . . . . 0.0 110.0 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.59 -33.76 76.65 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.87 -0.519 . . . . 0.0 111.579 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.98 80.97 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 121.374 -0.829 . . . . 0.0 110.754 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -67.57 -39.22 84.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.757 -0.589 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.95 -35.88 82.14 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.5 0.72 . . . . 0.0 110.854 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.84 92.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.163 0.985 . . . . 0.0 110.554 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.36 -47.42 81.69 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.839 0.828 . . . . 0.0 110.782 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -70.71 -32.23 69.37 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.725 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -35.79 76.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.749 1.219 . . . . 0.0 109.032 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 tp -67.84 -41.71 82.54 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 121.618 -0.676 . . . . 0.0 111.191 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -66.33 -27.47 67.92 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.564 -0.71 . . . . 0.0 111.731 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -67.71 -39.69 84.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.73 1.212 . . . . 0.0 110.137 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.14 -37.83 77.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.997 0.919 . . . . 0.0 109.101 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.0 mt -56.92 -41.81 78.85 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.124 0.97 . . . . 0.0 112.182 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.54 -46.14 84.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.142 -0.974 . . . . 0.0 110.059 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -67.07 -33.44 75.5 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.918 -1.114 . . . . 0.0 111.54 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.16 -36.37 79.63 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.004 1.321 . . . . 0.0 110.617 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -63.83 -45.11 91.04 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 123.739 0.815 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -67.76 -49.29 63.28 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.565 0.698 . . . . 0.0 110.668 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -67.29 -34.41 77.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.64 0.776 . . . . 0.0 110.842 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.8 -49.09 61.45 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.297 1.039 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.29 -45.86 89.11 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-O 122.417 1.103 . . . . 0.0 110.189 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -86.87 2.07 50.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.525 -0.734 . . . . 0.0 111.302 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.87 27.6 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.23 -42.49 75.61 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 125.048 1.339 . . . . 0.0 108.911 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -69.58 85.93 0.45 Allowed 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.339 -0.851 . . . . 0.0 111.572 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.14 2.26 Favored Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.02 151.07 37.39 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 117.817 0.808 . . . . 0.0 109.24 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.01 131.84 8.13 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.17 1.914 . . . . 0.0 110.79 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.73 16.74 23.27 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.81 134.81 48.05 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 125.898 1.679 . . . . 0.0 114.177 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.03 -58.93 1.36 Allowed 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.466 1.107 . . . . 0.0 110.543 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.26 93.82 9.63 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 122.553 1.168 . . . . 0.0 112.067 -166.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.61 62.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 O-C-N 119.515 -1.991 . . . . 0.0 111.279 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -152.06 118.34 5.59 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 119.904 -1.747 . . . . 0.0 108.52 169.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.9 -48.93 96.55 Favored Pre-proline 0 C--N 1.359 0.993 0 CA-C-O 116.373 -1.775 . . . . 0.0 112.433 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.36 -8.96 23.58 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 CA-C-N 125.551 3.018 . . . . 0.0 112.947 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -101.78 -24.03 14.11 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.05 98.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 124.035 0.934 . . . . 0.0 110.058 -171.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.75 -32.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 124.567 1.147 . . . . 0.0 111.73 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -42.04 61.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 O-C-N 121.388 -0.82 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -67.33 -35.02 78.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -55.98 -34.46 65.75 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.819 -1.176 . . . . 0.0 112.013 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.31 -49.22 84.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -60.15 -38.03 81.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.819 1.648 . . . . 0.0 111.324 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -65.15 -45.56 84.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.554 1.942 . . . . 0.0 109.435 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.46 64.95 Favored 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 121.143 -0.973 . . . . 0.0 111.266 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 p -84.26 1.85 42.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.734 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.365 18.3 p 75.85 -41.04 0.42 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 128.339 2.655 . . . . 0.0 111.289 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.8 t -39.58 -54.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 128.183 2.593 . . . . 0.0 114.277 -169.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.89 65.93 3.03 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -67.16 -9.42 39.84 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.784 1.234 . . . . 0.0 113.464 -167.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 28.06 6.89 Favored Glycine 0 CA--C 1.488 -1.651 0 O-C-N 120.973 -1.079 . . . . 0.0 110.436 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.61 -47.64 31.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.367 -1.078 . . . . 0.0 109.05 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -123.7 160.45 27.2 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -136.57 147.25 58.98 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.98 167.1 12.79 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.617 2.211 . . . . 0.0 110.577 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 64' ' ' THR . 9.8 p -76.79 178.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 125.874 1.67 . . . . 0.0 108.823 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.588 ' H ' HG22 ' A' ' 63' ' ' VAL . 11.4 m -74.56 -83.89 0.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.779 1.632 . . . . 0.0 109.85 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -57.81 -55.08 39.54 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 120.084 1.311 . . . . 0.0 113.958 -161.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -89.87 -56.95 3.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.705 -0.622 . . . . 0.0 111.721 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' H ' ' CG1' ' A' ' 63' ' ' VAL . . . -53.23 -35.17 49.2 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 125.438 1.494 . . . . 0.0 113.81 -169.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -68.39 -38.32 81.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 118.072 0.936 . . . . 0.0 110.775 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -69.75 -39.7 76.56 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 123.654 0.782 . . . . 0.0 109.888 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.71 -46.64 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.29 86.42 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 124.673 1.189 . . . . 0.0 110.41 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -48.53 -51.93 25.13 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 126.675 1.99 . . . . 0.0 110.375 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -71.1 -42.52 69.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.296 -0.877 . . . . 0.0 111.958 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.74 -42.98 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 124.022 0.929 . . . . 0.0 109.748 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.23 -47.87 82.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 124.758 1.223 . . . . 0.0 109.71 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -60.48 -35.59 76.27 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.504 0.722 . . . . 0.0 110.44 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.21 72.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.705 -0.622 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.53 -41.29 90.43 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.65 -46.79 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 124.33 1.052 . . . . 0.0 108.726 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -62.63 -32.72 73.81 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.8 -0.563 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.15 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 123.914 0.886 . . . . 0.0 110.567 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -62.56 -37.42 86.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.736 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.13 63.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.784 -0.572 . . . . 0.0 111.954 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -73.61 -26.21 60.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.099 -1.625 . . . . 0.0 110.309 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.82 -15.46 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 125.093 1.357 . . . . 0.0 110.348 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 m -54.08 -24.31 16.96 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 126.207 1.803 . . . . 0.0 112.849 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.49 64.03 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 120.179 -1.576 . . . . 0.0 112.264 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -92.62 -48.35 6.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.555 1.142 . . . . 0.0 108.746 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.47 -39.91 92.53 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.289 1.042 . . . . 0.0 112.598 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.81 61.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -97.28 11.14 37.52 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 120.805 -1.184 . . . . 0.0 108.824 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -79.36 -29.67 42.28 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.396 -1.44 . . . . 0.0 109.048 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -78.7 -24.71 44.85 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.723 -1.236 . . . . 0.0 110.691 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.76 -32.57 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 123.586 0.754 . . . . 0.0 109.698 -171.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -63.35 -16.58 60.85 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.759 1.224 . . . . 0.0 111.884 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 96' ' ' ARG . 21.6 ttp85 -71.34 -31.76 67.76 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.289 1.036 . . . . 0.0 110.562 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -93.68 157.97 15.91 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 73.08 -47.47 0.67 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.189 1.796 . . . . 0.0 110.851 -173.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.61 -42.96 99.61 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.738 -1.226 . . . . 0.0 110.934 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 mtp-105 -81.51 -10.47 59.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.883 -1.136 . . . . 0.0 111.156 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -133.6 73.3 1.5 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.905 0.882 . . . . 0.0 109.103 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.55 -27.53 2.6 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 176.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 -161.58 0.26 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.272 1.429 . . . . 0.0 110.671 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -139.41 -59.81 0.57 Allowed 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' HG3' ' B' ' 5' ' ' GLU . 12.5 p80 -50.46 -35.34 28.49 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 125.501 1.521 . . . . 0.0 114.743 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' B' ' 4' ' ' HIS . 4.9 mt-10 -67.59 -33.25 74.63 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.36 1.064 . . . . 0.0 110.78 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -81.03 -20.31 41.97 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.613 -0.679 . . . . 0.0 109.764 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -27.06 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -46.06 84.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.833 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.97 -28.59 62.49 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.446 -0.784 . . . . 0.0 111.007 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.9 -40.08 95.66 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.985 0.914 . . . . 0.0 109.8 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.62 76.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.049 0.939 . . . . 0.0 111.401 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -65.28 -39.5 92.65 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.9 -47.35 80.93 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.502 -0.748 . . . . 0.0 110.255 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' B' ' 14' ' ' GLU . 0.8 OUTLIER -70.66 -25.15 62.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.539 -0.726 . . . . 0.0 111.278 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -63.55 -39.73 95.16 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 120.831 -1.168 . . . . 0.0 111.334 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -62.05 -38.93 90.6 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.446 -0.784 . . . . 0.0 110.06 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.58 84.75 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.093 0.957 . . . . 0.0 110.27 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.44 -47.94 89.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.551 -0.718 . . . . 0.0 110.31 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.43 -36.29 80.94 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 121.673 -0.642 . . . . 0.0 110.486 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -62.75 -42.04 99.49 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.116 -1.615 . . . . 0.0 110.104 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -66.49 -36.79 83.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.848 0.832 . . . . 0.0 109.698 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.98 73.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.752 0.821 . . . . 0.0 111.552 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -60.93 -38.02 84.32 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.506 1.123 . . . . 0.0 111.98 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -69.03 -41.64 77.44 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.311 -0.868 . . . . 0.0 109.094 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -70.13 -26.37 63.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 121.822 -0.549 . . . . 0.0 110.933 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.07 95.72 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.303 1.041 . . . . 0.0 111.217 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.31 42.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 124.255 1.979 . . . . 0.0 108.474 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -147.19 -42.24 0.18 Allowed 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 100.875 -3.75 . . . . 0.0 100.875 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 56.52 0.46 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.689 1.996 . . . . 0.0 110.216 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 1.8 pp20? 179.68 -27.49 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 125.921 1.688 . . . . 0.0 108.289 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.43 71.73 6.02 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.495 -0.753 . . . . 0.0 109.985 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.22 -34.47 0.84 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 159.24 57.8 Favored Pre-proline 0 CA--C 1.51 -0.586 0 O-C-N 120.681 -1.482 . . . . 0.0 112.817 -173.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.17 152.26 24.01 Favored 'Trans proline' 0 CA--C 1.501 -1.163 0 C-N-CA 122.062 1.842 . . . . 0.0 109.848 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.13 42.34 84.42 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -66.63 -60.18 2.94 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.859 0.864 . . . . 0.0 109.716 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 65.43 -9.32 0.24 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.557 1.543 . . . . 0.0 113.597 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -123.52 31.64 5.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.732 1.613 . . . . 0.0 107.804 -165.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 45.0 pt -70.45 38.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.425 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -161.72 142.68 10.92 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 119.571 -1.956 . . . . 0.0 109.583 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.81 -57.29 1.55 Allowed Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 126.899 2.079 . . . . 0.0 110.978 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.66 -11.84 26.34 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 CA-C-N 126.076 3.206 . . . . 0.0 111.228 -169.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.71 -7.13 44.53 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 125.67 1.588 . . . . 0.0 107.954 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.09 66.86 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 123.983 0.913 . . . . 0.0 109.06 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 tt -82.21 14.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.348 1.071 . . . . 0.0 109.86 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -94.0 -58.53 2.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 167.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -54.49 -41.62 69.79 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.705 1.602 . . . . 0.0 111.804 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' HG22 ' B' ' 51' ' ' THR . 16.9 m -65.24 -21.81 66.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 120.794 -1.191 . . . . 0.0 113.723 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.25 -53.82 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -47.33 -50.63 21.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 126.682 1.993 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.407 HG22 ' HA ' ' B' ' 48' ' ' SER . 15.2 t -71.99 -30.16 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.772 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.23 60.65 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.223 -0.923 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -83.57 -1.18 53.22 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 122.963 0.505 . . . . 0.0 111.092 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.278 3.4 p 53.89 56.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.323 1.849 . . . . 0.0 112.505 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.0 t -120.54 -72.71 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.05 60.91 1.89 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -19.11 10.38 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.98 27.48 16.28 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.303 -1.498 . . . . 0.0 109.703 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -70.28 -63.67 1.04 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.031 2.133 . . . . 0.0 107.553 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -138.85 170.32 16.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -173.05 138.41 0.82 Allowed Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-O 115.696 -2.097 . . . . 0.0 105.356 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.92 179.38 6.04 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.069 2.513 . . . . 0.0 111.595 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.472 HG22 ' H ' ' B' ' 64' ' ' THR . 12.7 p -123.19 175.34 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.472 ' H ' HG22 ' B' ' 63' ' ' VAL . 19.5 m -48.81 -50.39 34.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 129.25 3.02 . . . . 0.0 113.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.6 -11.88 61.21 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.905 1.282 . . . . 0.0 109.593 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -104.33 5.37 34.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 O-C-N 121.894 -0.504 . . . . 0.0 111.368 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.35 84.07 0.38 Allowed Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 104.543 -3.423 . . . . 0.0 104.543 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.76 -20.37 56.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.535 -1.568 . . . . 0.0 111.125 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -54.84 -13.48 1.08 Allowed 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.828 1.651 . . . . 0.0 113.082 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.98 -40.99 84.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 120.651 -1.281 . . . . 0.0 110.087 169.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.18 -50.17 29.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -48.79 -44.15 38.73 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.989 1.715 . . . . 0.0 111.038 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -48.1 79.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.142 1.377 . . . . 0.0 111.269 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.25 -43.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.53 -46.14 89.72 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.645 1.178 . . . . 0.0 110.413 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.54 -43.03 99.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.29 97.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 122.599 0.36 . . . . 0.0 110.963 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.58 -47.0 93.13 Favored Glycine 0 CA--C 1.495 -1.179 0 C-N-CA 124.358 0.98 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.38 -50.53 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 124.301 1.04 . . . . 0.0 109.054 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -63.28 -33.53 75.71 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 121.802 -0.561 . . . . 0.0 111.782 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.52 -59.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 C-N-CA 124.125 0.97 . . . . 0.0 110.48 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -64.79 -35.62 81.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 121.384 -0.823 . . . . 0.0 110.151 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.62 88.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 111.266 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.45 -35.62 81.52 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 124.4 1.08 . . . . 0.0 110.533 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.72 -16.11 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.796 1.238 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -59.79 -18.65 45.17 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 120.494 -1.379 . . . . 0.0 111.608 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.53 75.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 119.565 -1.96 . . . . 0.0 112.456 171.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.35 -38.73 55.44 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 121.182 -0.949 . . . . 0.0 109.29 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -32.69 69.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.73 67.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 120.389 -1.444 . . . . 0.0 111.685 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -90.63 3.3 54.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 120.706 -1.246 . . . . 0.0 109.014 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -75.34 -33.75 61.13 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 122.118 0.961 . . . . 0.0 108.72 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -68.55 -32.06 71.73 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.403 -1.435 . . . . 0.0 111.944 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 -22.75 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.912 1.285 . . . . 0.0 109.116 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -59.61 -26.32 65.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.329 1.052 . . . . 0.0 112.07 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -67.97 -24.27 65.14 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 120.242 1.383 . . . . 0.0 111.836 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -71.72 -39.54 70.07 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.046 -1.033 . . . . 0.0 108.776 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.63 -43.48 69.15 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.272 0.629 . . . . 0.0 109.793 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -58.24 -43.34 87.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 126.97 2.108 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -59.49 -44.17 93.15 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 111.333 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -92.12 -14.77 28.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.355 -0.841 . . . . 0.0 111.251 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.96 21.89 70.07 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.508 -0.644 0 C-N-CA 124.626 1.17 . . . . 0.0 111.898 -179.759 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.428 -1.562 0 N-CA-C 100.559 -3.867 . . . . 0.0 100.559 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' C' ' 5' ' ' GLU . . . -85.78 179.24 7.09 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.95 -68.82 0.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 129.623 3.169 . . . . 0.0 111.234 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.644 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 48.8 p-80 -72.56 -18.01 61.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.958 1.303 . . . . 0.0 112.88 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' C' ' 2' ' ' ALA . 34.5 mm-40 -75.99 -41.04 52.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -72.51 -31.97 65.78 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.949 -1.094 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -75.1 -27.21 59.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.369 -0.832 . . . . 0.0 110.032 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 -45.82 78.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.161 0.984 . . . . 0.0 110.579 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -62.25 -40.69 97.02 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.475 1.11 . . . . 0.0 110.763 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -60.12 -36.08 76.69 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 124.541 1.136 . . . . 0.0 110.839 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.87 76.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.56 0.744 . . . . 0.0 111.384 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.13 -34.65 78.9 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.184 -0.948 . . . . 0.0 111.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -72.69 -31.9 65.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 110.117 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.85 -33.56 74.02 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.4 1.48 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.93 -42.61 94.54 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.649 0.779 . . . . 0.0 110.663 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -61.9 -36.63 81.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.428 -0.795 . . . . 0.0 111.55 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.65 -43.49 97.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 123.85 0.86 . . . . 0.0 111.277 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.96 -23.89 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 121.119 -0.988 . . . . 0.0 110.692 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.8 mt -68.86 -38.92 80.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 123.789 0.836 . . . . 0.0 110.509 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -65.47 -38.5 89.97 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.568 1.147 . . . . 0.0 110.452 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.02 -38.03 61.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.683 -1.261 . . . . 0.0 109.155 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -37.97 76.34 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 125.107 1.363 . . . . 0.0 111.493 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -43.21 81.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 118.906 0.775 . . . . 0.0 110.358 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.69 -50.6 62.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -59.58 -45.91 90.47 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 124.021 0.928 . . . . 0.0 109.524 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -42.69 99.89 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.968 0.907 . . . . 0.0 111.897 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' C' ' 44' ' ' ALA . 91.5 t -71.52 -33.16 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 O-C-N 120.973 -1.079 . . . . 0.0 110.326 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.64 -33.34 64.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.464 -0.772 . . . . 0.0 109.338 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.55 79.38 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 126.789 2.036 . . . . 0.0 109.725 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -74.44 -12.65 60.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.47 0.652 . . . . 0.0 112.12 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -79.63 77.19 6.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 120.487 -1.383 . . . . 0.0 110.327 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.82 -11.12 1.66 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.67 147.41 46.25 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 117.847 0.824 . . . . 0.0 110.773 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.32 121.73 3.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.843 2.362 . . . . 0.0 112.246 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.87 29.91 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.95 124.34 20.51 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.075 1.75 . . . . 0.0 112.74 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.94 -21.47 6.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.033 0.533 . . . . 0.0 110.638 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -36.64 80.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.648 1.179 . . . . 0.0 110.524 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tp -47.56 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 128.994 2.918 . . . . 0.0 112.067 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -168.3 103.8 0.45 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -60.77 -36.64 37.14 Favored Pre-proline 0 C--N 1.35 0.612 0 CA-C-O 115.315 -2.279 . . . . 0.0 113.101 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.93 -48.79 0.62 Allowed 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 126.757 3.449 . . . . 0.0 110.473 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -6.51 47.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.986 1.314 . . . . 0.0 111.246 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' C' ' 27' ' ' VAL . . . -58.78 -48.62 80.63 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 125.636 1.574 . . . . 0.0 110.876 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.96 -24.84 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.55 -44.66 77.72 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 120.895 -1.128 . . . . 0.0 108.61 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.7 -41.26 99.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.636 -0.665 . . . . 0.0 110.833 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -57.93 -46.12 85.5 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.092 -1.005 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -80.25 74.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 122.206 1.003 . . . . 0.0 108.851 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -165.14 -40.62 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -31.55 71.08 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.968 0.907 . . . . 0.0 110.485 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -68.31 -24.12 64.81 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.441 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.46 6.61 48.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 123.279 0.632 . . . . 0.0 109.55 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 55.92 52.28 10.88 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 126.125 1.77 . . . . 0.0 112.418 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.3 -156.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.37 103.95 0.33 Allowed Glycine 0 CA--C 1.475 -2.467 1 N-CA-C 99.133 -5.587 . . . . 0.0 99.133 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.96 -28.28 62.32 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 118.101 0.951 . . . . 0.0 110.214 -172.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.0 46.04 0.84 Allowed Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -75.44 -51.75 12.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -137.69 172.48 12.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.35 125.17 5.92 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 101.843 -3.391 . . . . 0.0 101.843 -168.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.85 168.68 21.87 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 123.83 3.02 . . . . 0.0 110.757 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.29 -90.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.011 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 12.7 m -165.01 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.624 -1.922 . . . . 0.0 106.732 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -73.74 -18.8 60.94 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.815 1.246 . . . . 0.0 108.979 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -62.07 -36.48 81.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 125.043 1.337 . . . . 0.0 109.576 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.22 -15.62 1.49 Allowed Glycine 0 CA--C 1.481 -2.087 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 172.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' C' ' 66' ' ' GLU 0.352 3.5 ptp85 63.18 -48.63 0.22 Allowed 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 131.481 3.912 . . . . 0.0 111.734 -170.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.25 12.71 2.2 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.51 -49.42 59.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -49.12 65.59 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 122.897 0.479 . . . . 0.0 110.008 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.92 -42.92 69.3 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.067 0.947 . . . . 0.0 111.433 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -67.37 -32.27 73.07 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 111.224 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.74 -42.29 61.91 Favored 'Isoleucine or valine' 0 C--N 1.351 0.652 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.36 -47.39 85.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 110.502 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.22 -40.67 94.86 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.271 1.029 . . . . 0.0 110.914 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.73 85.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.466 0.707 . . . . 0.0 111.18 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.68 -44.27 92.79 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 124.036 0.827 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.7 -43.23 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.689 0.795 . . . . 0.0 109.116 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.09 -52.99 63.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 123.504 0.722 . . . . 0.0 111.608 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.82 -41.57 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 121.952 -0.468 . . . . 0.0 111.028 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -75.38 -25.23 57.49 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.559 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.77 -33.68 34.76 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.67 -1.269 . . . . 0.0 109.773 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.2 -41.59 75.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.789 1.636 . . . . 0.0 110.873 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.42 -8.03 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.489 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 13.0 m -62.98 -17.43 62.1 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.998 -1.064 . . . . 0.0 109.842 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.05 75.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.185 -1.572 . . . . 0.0 112.337 169.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.644 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.72 -52.64 10.02 Favored 'General case' 0 CA--C 1.492 -1.283 0 O-C-N 120.694 -1.254 . . . . 0.0 107.887 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.76 -29.05 70.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.03 0.443 . . . . 0.0 111.938 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.57 -20.72 64.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.587 -1.321 . . . . 0.0 111.074 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -80.95 -10.96 59.65 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.638 -1.289 . . . . 0.0 110.506 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.26 1.8 m-20 -79.39 -12.97 59.9 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 119.869 1.213 . . . . 0.0 110.817 -167.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.49 -19.97 41.15 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.329 -1.482 . . . . 0.0 109.928 167.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.13 -38.4 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 124.718 1.207 . . . . 0.0 108.077 -172.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -50.79 -31.3 16.51 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 125.816 1.646 . . . . 0.0 113.239 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -60.33 -32.18 71.0 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -87.22 147.5 25.54 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.278 23.9 mm-40 73.68 -41.56 0.49 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.845 2.058 . . . . 0.0 112.514 -171.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -70.89 -40.92 71.93 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 119.673 -1.892 . . . . 0.0 109.309 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -63.09 -36.64 84.27 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.481 -0.762 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -139.09 109.1 6.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.62 38.32 4.49 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 . . . . . 0 C--N 1.354 0.778 0 O-C-N 121.49 -1.006 . . . . 0.0 109.901 179.002 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.428 -1.549 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.38 141.58 35.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.59 -29.83 69.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.073 -1.017 . . . . 0.0 111.076 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -68.38 -22.53 64.64 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.051 -1.031 . . . . 0.0 111.908 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.82 -36.02 23.8 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -62.35 -40.81 97.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.125 0.97 . . . . 0.0 110.488 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.62 -38.44 90.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.483 1.113 . . . . 0.0 110.437 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.74 75.35 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.109 0.964 . . . . 0.0 111.207 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -65.15 -41.49 94.69 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.754 -0.591 . . . . 0.0 110.449 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -64.93 -31.75 73.14 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 122.81 0.444 . . . . 0.0 111.76 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.12 81.52 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.897 -0.502 . . . . 0.0 110.35 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.51 -50.65 72.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.97 0.508 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.56 -34.34 75.42 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.805 0.842 . . . . 0.0 111.462 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -73.97 -32.02 63.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.032 -1.042 . . . . 0.0 110.503 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.43 -38.18 90.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.722 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -75.41 -9.03 58.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.961 -1.087 . . . . 0.0 112.525 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -82.9 -38.97 22.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.07 -38.16 81.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 121.227 -0.921 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.8 mt -51.94 -42.95 63.23 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.798 1.239 . . . . 0.0 112.518 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -68.32 -42.93 78.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.785 0.834 . . . . 0.0 110.48 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.21 -38.51 68.98 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.22 73.23 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 125.154 1.381 . . . . 0.0 111.955 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -57.55 -47.96 80.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.069 1.414 . . . . 0.0 110.697 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -73.39 -43.15 61.16 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.723 1.209 . . . . 0.0 108.514 -171.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -73.39 -29.66 62.75 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.723 0.809 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.79 79.15 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.035 0.934 . . . . 0.0 111.492 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.95 -43.59 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-O 122.424 1.106 . . . . 0.0 109.846 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -62.55 -32.97 74.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.48 1.512 . . . . 0.0 109.594 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' D' ' 67' ' ' GLY . . . -62.14 -50.43 71.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 126.099 1.76 . . . . 0.0 110.643 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 111.3 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -80.73 68.24 6.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.414 -1.429 . . . . 0.0 110.987 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.14 -30.43 0.48 Allowed Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.73 150.08 81.35 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.345 1.058 . . . . 0.0 111.778 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -84.27 145.22 10.77 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 122.808 2.339 . . . . 0.0 109.861 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 33.41 55.59 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 147.25 47.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.315 1.046 . . . . 0.0 110.95 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.53 -52.93 1.59 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.98 97.74 10.92 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -137.84 114.05 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -179.6 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -174.86 -65.41 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 116.218 -1.848 . . . . 0.0 106.112 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.84 -16.81 29.44 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 CA-C-N 125.386 2.959 . . . . 0.0 112.637 -166.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -95.03 -8.43 36.79 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 124.948 1.299 . . . . 0.0 109.639 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.26 62.92 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.757 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.99 -33.58 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.029 0.931 . . . . 0.0 109.626 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -27.38 59.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 119.577 -1.952 . . . . 0.0 110.335 -174.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -69.03 -42.36 76.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.0 p -69.28 -32.26 71.31 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.193 -1.567 . . . . 0.0 110.866 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.81 -46.59 83.45 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 125.334 1.453 . . . . 0.0 110.936 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -80.61 -2.14 45.21 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 118.757 0.708 . . . . 0.0 112.013 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -101.22 -40.65 7.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 -22.92 66.31 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.765 -1.21 . . . . 0.0 111.685 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -91.83 2.8 56.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 125.026 1.33 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 25.6 p 52.03 70.42 0.56 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.343 1.857 . . . . 0.0 112.785 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.566 HG13 ' H ' ' D' ' 56' ' ' GLY . 1.2 p -129.24 -80.01 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 104.184 -2.525 . . . . 0.0 104.184 169.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.566 ' H ' HG13 ' D' ' 55' ' ' VAL . . . 80.63 80.36 0.85 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -171.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -74.55 -16.15 60.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.028 -1.278 . . . . 0.0 110.983 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.23 5.76 Favored Glycine 0 CA--C 1.492 -1.378 0 O-C-N 121.393 -0.817 . . . . 0.0 111.103 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -70.12 -59.07 3.12 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -137.97 162.64 33.56 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -158.24 154.68 24.39 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.12 177.77 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.483 2.789 . . . . 0.0 109.878 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.427 HG13 ' H ' ' D' ' 64' ' ' THR 0.264 5.6 p -115.01 -118.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 174.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.427 ' H ' HG13 ' D' ' 63' ' ' VAL . 12.2 m -104.93 -85.62 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.189 -1.569 . . . . 0.0 108.988 -170.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.88 128.77 37.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.576 1.15 . . . . 0.0 109.086 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . 0.3 51.7 mt-10 62.2 -111.26 0.4 Allowed 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 115.441 -2.219 . . . . 0.0 106.972 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' D' ' 29' ' ' ALA . . . 35.51 -80.88 0.0 OUTLIER Glycine 0 C--N 1.353 1.49 0 C-N-CA 129.772 3.558 . . . . 0.0 113.786 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -58.92 -41.97 88.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 127.381 2.272 . . . . 0.0 113.196 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.35 -18.1 62.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.473 1.109 . . . . 0.0 109.464 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' D' ' 29' ' ' ALA . 40.8 t -84.63 -45.11 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 172.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.22 -50.91 69.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.666 1.187 . . . . 0.0 113.104 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.86 -35.46 70.99 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.875 0.87 . . . . 0.0 111.62 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -67.96 -45.51 74.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.248 1.019 . . . . 0.0 109.034 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.53 -43.62 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.932 0.893 . . . . 0.0 109.522 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.9 -43.64 98.26 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 123.387 0.675 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.08 -37.8 83.99 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.234 0.614 . . . . 0.0 111.097 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.11 85.9 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.147 0.579 . . . . 0.0 111.237 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.44 -46.52 55.62 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.81 -47.49 85.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 109.628 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -66.97 -26.69 66.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.13 -0.981 . . . . 0.0 112.372 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.28 -45.18 71.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.748 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.59 -35.2 80.24 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.078 0.942 . . . . 0.0 110.062 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -32.62 67.06 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.391 -0.818 . . . . 0.0 111.332 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.04 -43.92 94.09 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 124.628 1.171 . . . . 0.0 109.727 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -69.96 -4.83 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.375 -0.828 . . . . 0.0 112.061 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -57.49 -24.85 58.22 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.186 1.394 . . . . 0.0 110.344 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.84 78.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 119.847 -1.783 . . . . 0.0 112.163 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.84 -42.87 69.6 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -28.34 63.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.768 0.827 . . . . 0.0 110.858 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.32 76.48 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 119.982 -1.699 . . . . 0.0 109.442 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -11.53 52.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.87 -1.144 . . . . 0.0 112.593 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.37 -26.53 61.94 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.831 1.65 . . . . 0.0 111.595 -170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -79.06 -24.14 43.75 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 119.212 0.915 . . . . 0.0 110.062 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.97 -36.53 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.414 1.085 . . . . 0.0 108.701 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.4 HH12 ' CD ' ' D' ' 99' ' ' GLU . 14.5 ttt-85 -55.5 -32.94 63.29 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 126.421 1.888 . . . . 0.0 110.83 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -61.7 -23.58 66.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.296 1.038 . . . . 0.0 111.74 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.45 -21.05 64.66 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.797 -0.565 . . . . 0.0 109.934 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.93 -39.77 15.43 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' D' ' 95' ' ' ARG . 3.9 tp10 -68.52 -33.75 74.67 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.643 -0.661 . . . . 0.0 111.008 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 55.6 ptt85 -70.24 -19.83 63.11 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.297 -0.877 . . . . 0.0 111.975 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -78.31 -28.31 47.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.323 -0.861 . . . . 0.0 109.469 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.17 13.98 75.68 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 121.618 -0.676 . . . . 0.0 111.671 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.228 0 N-CA-C 102.178 -3.267 . . . . 0.0 102.178 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.17 168.53 27.01 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.59 -43.23 97.6 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.033 1.733 . . . . 0.0 110.604 -171.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -47.09 72.07 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.634 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -38.29 89.06 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 122.578 0.351 . . . . 0.0 110.101 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -64.23 -46.27 84.57 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.682 -0.637 . . . . 0.0 110.871 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 121.796 -0.565 . . . . 0.0 111.04 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.47 85.61 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 110.805 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.8 -36.1 77.84 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.11 -38.07 85.03 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.904 1.282 . . . . 0.0 109.974 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.44 -37.22 86.76 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 111.711 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.38 -29.17 70.24 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.86 -1.15 . . . . 0.0 111.607 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -68.08 -31.94 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -71.9 -29.29 64.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.0 -37.22 83.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.985 -1.072 . . . . 0.0 110.204 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.19 -26.78 66.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.889 -1.132 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -63.85 -50.12 70.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 123.884 0.873 . . . . 0.0 109.605 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.42 -23.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 121.627 -0.671 . . . . 0.0 110.334 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.6 -50.18 74.56 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.364 0.984 . . . . 0.0 109.711 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -64.09 -42.79 96.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.807 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.05 -44.31 76.7 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.938 -0.476 . . . . 0.0 109.921 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.07 -37.45 85.04 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.144 -0.972 . . . . 0.0 112.026 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 -43.89 86.79 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 123.941 0.896 . . . . 0.0 110.738 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.21 -43.54 91.22 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.684 1.194 . . . . 0.0 107.973 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -64.52 -49.02 72.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 124.35 1.06 . . . . 0.0 110.839 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.09 92.97 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.526 1.53 . . . . 0.0 111.216 -173.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.7 -37.78 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 121.465 -0.772 . . . . 0.0 110.344 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -69.72 -38.48 76.91 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.747 -1.221 . . . . 0.0 110.466 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.15 -47.87 66.87 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 126.144 1.777 . . . . 0.0 109.501 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.15 -38.97 79.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.385 1.074 . . . . 0.0 110.977 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -69.74 99.14 1.3 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 119.99 -1.694 . . . . 0.0 113.073 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.81 -3.27 19.54 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.29 148.87 37.42 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 118.193 0.997 . . . . 0.0 108.446 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -80.26 145.59 17.15 Favored 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.418 2.079 . . . . 0.0 109.967 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.31 -8.83 69.35 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 119.239 0.927 . . . . 0.0 111.374 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.01 53.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.92 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.06 -29.25 4.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.31 58.17 4.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.994 1.378 . . . . 0.0 107.959 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -87.5 42.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 O-C-N 119.852 -1.78 . . . . 0.0 111.276 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -135.29 -117.0 0.18 Allowed 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.745 -1.222 . . . . 0.0 109.672 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 t80 171.7 -66.65 0.0 OUTLIER Pre-proline 0 C--N 1.357 0.904 0 CA-C-O 116.315 -1.802 . . . . 0.0 108.766 -172.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -4.64 15.7 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 CA-C-N 125.175 2.884 . . . . 0.0 111.796 -164.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -103.99 -10.15 18.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 127.157 2.183 . . . . 0.0 109.1 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.85 63.89 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.231 -0.918 . . . . 0.0 110.31 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.79 -38.17 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.91 0.862 . . . . 0.0 110.479 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.32 -31.45 26.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -55.77 -40.87 73.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.297 1.039 . . . . 0.0 110.854 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -62.37 -29.36 70.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.698 0.799 . . . . 0.0 112.596 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.78 -36.07 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 120.846 -1.159 . . . . 0.0 108.52 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -65.69 -17.39 64.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.448 1.099 . . . . 0.0 112.166 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 t -109.31 -31.35 7.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.59 -1.319 . . . . 0.0 108.554 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.05 65.57 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.31 -1.494 . . . . 0.0 112.569 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 p -97.9 3.41 49.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.268 12.2 p 55.53 26.71 9.36 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 128.739 2.816 . . . . 0.0 112.569 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG21 ' SD ' ' B' ' 75' ' ' MET . 16.3 m -80.02 -54.48 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 55.87 11.42 Favored Glycine 0 CA--C 1.485 -1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.85 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.89 -17.25 61.36 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.805 0.812 . . . . 0.0 111.96 -173.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.6 40.36 6.82 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.98 -46.61 70.84 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.59 -168.15 1.69 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.04 108.43 5.0 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.11 175.41 10.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.417 2.745 . . . . 0.0 109.281 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 64' ' ' THR . 15.0 p -140.14 -176.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.564 ' H ' HG22 ' A' ' 63' ' ' VAL . 65.7 m -66.7 -45.25 79.36 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.714 -1.866 . . . . 0.0 112.158 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -80.0 -6.77 58.18 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 119.206 0.912 . . . . 0.0 111.156 -170.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.56 -32.68 74.18 Favored 'General case' 0 C--N 1.359 0.986 0 CA-C-O 123.888 1.804 . . . . 0.0 106.259 168.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.26 65.82 1.02 Allowed Glycine 0 CA--C 1.463 -3.168 1 N-CA-C 102.22 -4.352 . . . . 0.0 102.22 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -27.09 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.374 1.665 1 C-N-CA 131.95 4.1 . . . . 0.0 115.472 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -50.72 -12.23 0.1 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 164.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.73 -49.64 49.85 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 123.023 2.647 . . . . 0.0 106.942 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.03 -43.39 98.96 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.871 0.868 . . . . 0.0 110.426 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -65.23 -43.69 90.62 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 122.705 0.402 . . . . 0.0 111.386 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.68 -41.0 96.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 121.184 -0.948 . . . . 0.0 110.767 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.47 -34.44 35.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.889 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 55.9 ttm -62.72 -52.21 64.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.15 -32.49 70.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.426 -0.796 . . . . 0.0 110.481 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.3 -35.08 77.92 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.835 -0.541 . . . . 0.0 110.907 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.78 96.62 Favored Glycine 0 CA--C 1.492 -1.377 0 C-N-CA 123.646 0.641 . . . . 0.0 111.743 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.14 -47.04 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 124.264 1.026 . . . . 0.0 109.016 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.79 -30.21 68.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.139 -0.976 . . . . 0.0 111.572 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.65 -55.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.618 0.767 . . . . 0.0 109.461 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.37 -33.6 74.56 Favored 'General case' 0 CA--C 1.503 -0.834 0 O-C-N 121.464 -0.772 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.72 72.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.153 -0.967 . . . . 0.0 110.529 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.74 -29.06 70.03 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 120.6 -1.312 . . . . 0.0 111.108 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.68 -11.7 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.489 1.515 . . . . 0.0 111.121 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.3 m -51.42 -29.39 15.74 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 119.428 -2.045 . . . . 0.0 112.581 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.14 62.88 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.407 -1.433 . . . . 0.0 112.065 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.2 -56.4 3.29 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 125.695 1.598 . . . . 0.0 108.686 172.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.09 -39.64 75.42 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.994 0.918 . . . . 0.0 112.816 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.9 -14.99 60.27 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.048 -1.033 . . . . 0.0 111.372 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.36 -9.52 47.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 120.683 -1.26 . . . . 0.0 107.702 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -37.52 73.81 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.415 -0.803 . . . . 0.0 109.618 -172.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -71.38 -24.9 62.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.987 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.5 t -70.52 -24.48 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 108.4 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -65.23 -15.7 62.75 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.081 -1.012 . . . . 0.0 111.735 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -55.91 -40.74 73.51 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 124.027 0.931 . . . . 0.0 110.438 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . 0.297 11.3 pt-20 -76.2 -19.28 58.54 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.32 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.58 -45.69 64.89 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -42.58 98.94 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.427 1.091 . . . . 0.0 109.937 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -52.65 -43.46 65.48 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 127.345 2.258 . . . . 0.0 112.818 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -106.41 2.7 26.64 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.603 -0.686 . . . . 0.0 111.469 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.62 19.24 68.9 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 120.888 -1.133 . . . . 0.0 112.759 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.564 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.49 163.18 20.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 120.91 -1.119 . . . . 0.0 108.165 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -69.88 -45.2 68.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 120.262 -1.524 . . . . 0.0 109.736 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -61.36 -20.17 62.69 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.82 -34.37 62.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.048 -1.033 . . . . 0.0 108.537 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -69.1 -25.61 64.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.69 -0.631 . . . . 0.0 111.008 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -69.78 -44.16 70.7 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.87 87.95 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.261 1.424 . . . . 0.0 111.677 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -56.31 -38.7 71.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.771 1.629 . . . . 0.0 111.161 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -79.34 -13.77 59.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.391 -0.818 . . . . 0.0 111.396 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.55 -36.33 63.12 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -62.99 -43.18 99.5 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.78 0.8 . . . . 0.0 110.395 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.86 -43.43 98.81 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.26 1.424 . . . . 0.0 109.932 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.39 -39.93 77.13 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.931 1.692 . . . . 0.0 110.369 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.71 -41.11 98.14 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 123.381 0.672 . . . . 0.0 111.026 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -59.48 -35.63 74.47 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.426 1.091 . . . . 0.0 110.801 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.33 -34.94 79.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.638 1.175 . . . . 0.0 110.595 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.6 -39.67 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.93 -34.49 78.09 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -72.01 -30.71 65.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 111.864 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -81.89 -37.09 27.41 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.599 -1.313 . . . . 0.0 108.892 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.46 92.87 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.494 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 21.5 p -60.62 -38.7 85.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.492 0.717 . . . . 0.0 111.878 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -75.42 -53.84 8.03 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -62.4 -26.52 68.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.874 0.87 . . . . 0.0 111.186 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -43.85 72.14 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.837 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.16 -12.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.603 1.192 . . . . 0.0 109.153 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.52 21.5 17.35 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 119.842 -1.786 . . . . 0.0 107.119 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -92.34 -51.7 5.02 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' B' ' 31' ' ' ARG 0.286 0.6 OUTLIER -76.98 -80.42 0.1 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.129 -170.54 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 9.8 mmm180 59.72 -27.73 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 129.611 3.164 . . . . 0.0 116.584 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.45 37.66 0.23 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.19 156.35 79.15 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.968 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.83 123.14 8.74 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.249 2.633 . . . . 0.0 109.899 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.95 -58.41 3.25 Favored Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.3 174.1 0.16 Allowed 'General case' 0 C--N 1.35 0.598 0 C-N-CA 127.539 2.335 . . . . 0.0 109.515 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 61' ' ' TYR . . . -174.92 -53.2 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.76 -1.212 . . . . 0.0 108.93 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.22 138.34 31.57 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 pt -163.18 177.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t 71.97 102.85 0.07 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.751 2.02 . . . . 0.0 110.662 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -49.67 -53.43 41.59 Favored Pre-proline 0 C--N 1.35 0.627 0 CA-C-O 116.782 -1.58 . . . . 0.0 113.264 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.86 -11.68 25.85 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 124.709 2.718 . . . . 0.0 111.921 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -95.52 -27.96 15.12 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.77 72.13 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.442 1.497 . . . . 0.0 111.491 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.08 -30.37 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 121.506 -0.746 . . . . 0.0 111.206 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.03 -20.9 40.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.659 -1.275 . . . . 0.0 109.912 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -65.32 -47.2 77.36 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -57.85 -30.91 66.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.88 -27.95 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.73 0.812 . . . . 0.0 111.296 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -88.36 -3.55 58.82 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.269 -1.519 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -113.18 -175.75 2.74 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . 81.11 -50.21 0.28 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.351 1.86 . . . . 0.0 109.391 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -88.12 32.27 0.76 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.204 1.401 . . . . 0.0 111.532 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 42.07 61.7 1.87 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.318 2.247 . . . . 0.0 114.313 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.643 HG13 ' H ' ' B' ' 56' ' ' GLY . 1.0 OUTLIER -134.62 -93.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 176.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.643 ' H ' HG13 ' B' ' 55' ' ' VAL . . . 84.97 87.74 0.9 Allowed Glycine 0 CA--C 1.495 -1.2 0 N-CA-C 104.976 -3.25 . . . . 0.0 104.976 -171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -77.73 -18.8 56.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 120.813 -1.404 . . . . 0.0 108.712 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.53 45.53 1.8 Allowed Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.95 -59.55 2.73 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.82 162.04 36.5 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' B' ' 37' ' ' ALA . 34.3 p90 -144.9 148.89 40.68 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.448 ' HB2' ' HG3' ' B' ' 66' ' ' GLU . 32.7 Cg_endo -81.52 160.64 19.53 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 123.381 2.721 . . . . 0.0 108.622 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.23 -99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-N 121.02 1.736 . . . . 0.0 110.424 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -141.57 -48.31 0.39 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 120.13 1.332 . . . . 0.0 111.299 -167.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -27.57 64.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 125.522 1.529 . . . . 0.0 108.196 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' B' ' 62' ' ' PRO . 1.4 pm0 -53.47 -25.44 16.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.067 2.147 . . . . 0.0 111.963 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.32 93.86 1.31 Allowed Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 98.736 -5.746 . . . . 0.0 98.736 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -63.49 -11.6 25.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.69 -1.477 . . . . 0.0 111.9 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -61.58 -17.3 54.47 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.999 0.92 . . . . 0.0 112.328 168.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.78 -33.44 59.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 O-C-N 120.811 -1.181 . . . . 0.0 109.379 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.99 7.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 120.467 -1.395 . . . . 0.0 108.007 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -48.09 -52.43 20.37 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 125.916 1.687 . . . . 0.0 110.29 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -69.36 -29.57 67.39 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.983 -0.448 . . . . 0.0 111.234 -170.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.8 t -75.41 -44.01 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 O-C-N 120.824 -1.172 . . . . 0.0 108.673 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 36.0 mtm -64.75 -45.68 85.4 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 110.516 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -75.39 -21.7 58.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.378 -0.826 . . . . 0.0 111.15 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.24 -31.11 70.38 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 120.889 -1.132 . . . . 0.0 110.486 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.26 -39.23 95.9 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 30.6 mt -61.84 -38.44 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.09 0.956 . . . . 0.0 108.946 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.97 -54.79 24.93 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.623 -1.298 . . . . 0.0 112.065 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 m -66.74 -45.38 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 123.119 0.568 . . . . 0.0 110.513 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.97 -33.29 63.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.04 -28.88 67.77 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.958 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.3 tt -65.55 -36.79 84.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 120.925 -1.11 . . . . 0.0 109.984 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.1 -17.97 20.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 125.135 1.374 . . . . 0.0 110.766 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 7.9 m -54.49 -24.41 20.32 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.701 1.2 . . . . 0.0 111.895 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.66 86.93 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.233 -1.542 . . . . 0.0 112.472 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.1 -45.17 70.91 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.66 1.184 . . . . 0.0 108.683 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.86 -37.36 85.97 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.621 0.724 . . . . 0.0 110.353 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.21 76.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.901 -1.124 . . . . 0.0 111.387 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.7 t -78.51 -0.38 29.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 120.607 -1.308 . . . . 0.0 110.27 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -33.89 65.43 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 119.25 0.932 . . . . 0.0 109.758 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -71.11 -31.07 67.3 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.767 -1.208 . . . . 0.0 110.508 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.07 -24.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.89 1.276 . . . . 0.0 109.455 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -58.52 -21.74 53.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.213 1.005 . . . . 0.0 112.38 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -64.88 -23.01 67.1 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.63 -1.294 . . . . 0.0 111.049 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.25 -21.49 62.1 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.074 -1.016 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -66.53 -49.5 66.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -16.14 54.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.748 -0.595 . . . . 0.0 112.224 -175.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -66.13 -44.58 83.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.867 0.867 . . . . 0.0 109.391 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -87.57 -20.98 25.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.91 -0.494 . . . . 0.0 110.774 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.17 39.91 25.85 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 62.3 t60 . . . . . 0 N--CA 1.438 -1.06 0 C-N-CA 125.004 1.321 . . . . 0.0 108.373 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.05 86.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 172.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.18 -65.89 0.04 OUTLIER 'General case' 0 C--N 1.346 0.42 0 C-N-CA 130.043 3.337 . . . . 0.0 114.126 163.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.596 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 36.6 p-80 -58.35 -25.43 61.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.512 2.325 . . . . 0.0 115.413 -174.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -75.31 -27.15 59.18 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.338 -1.476 . . . . 0.0 110.435 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.47 -36.4 71.17 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.2 -0.937 . . . . 0.0 109.603 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.28 -38.44 65.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.93 0.892 . . . . 0.0 109.29 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.31 93.57 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.235 1.014 . . . . 0.0 111.858 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -27.75 60.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.397 -0.815 . . . . 0.0 110.578 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.69 -33.0 66.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.9 84.72 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -58.8 -35.13 72.34 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.552 0.741 . . . . 0.0 112.128 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.33 -24.08 61.25 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.345 -0.847 . . . . 0.0 111.384 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -73.77 -35.96 65.04 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.82 -42.46 99.05 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.303 -0.873 . . . . 0.0 110.928 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -57.83 -38.07 74.97 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.346 1.058 . . . . 0.0 111.97 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.81 81.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.567 1.147 . . . . 0.0 109.892 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.67 -37.7 79.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 O-C-N 121.15 -0.969 . . . . 0.0 108.748 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.33 -36.48 73.46 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.742 0.817 . . . . 0.0 112.226 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -63.42 -51.91 63.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.703 1.201 . . . . 0.0 109.169 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -63.77 -40.43 96.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.494 0.664 . . . . 0.0 110.216 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -32.27 73.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.386 1.474 . . . . 0.0 112.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -68.94 -34.87 76.06 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.387 -0.821 . . . . 0.0 110.378 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -70.89 -37.59 73.01 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.22 -51.54 63.2 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 -17.55 63.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -82.66 -36.07 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 O-C-N 120.327 -1.483 . . . . 0.0 108.402 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -78.33 -41.8 32.53 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.81 90.23 7.83 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 143.99 2.09 0.0 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.987 3.715 . . . . 0.0 110.085 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -91.05 41.36 1.06 Allowed 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.594 -1.941 . . . . 0.0 112.408 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.31 44.67 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.389 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' C' ' 36' ' ' ALA . . . -103.75 157.42 33.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.21 98.64 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.658 2.239 . . . . 0.0 112.647 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 9.36 36.79 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -52.68 143.6 15.83 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.604 1.562 . . . . 0.0 112.591 -177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.88 -32.4 3.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 124.639 1.176 . . . . 0.0 108.807 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 tt -89.49 50.6 1.94 Allowed 'General case' 0 C--N 1.35 0.603 0 CA-C-O 122.898 1.332 . . . . 0.0 108.144 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.53 53.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 O-C-N 119.915 -1.741 . . . . 0.0 110.083 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -125.87 -151.17 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.89 -1.131 . . . . 0.0 108.401 -167.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -171.32 -64.12 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -69.6 -32.11 19.89 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 CA-C-N 125.214 2.898 . . . . 0.0 112.386 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.469 ' CG ' HH22 ' C' ' 60' ' ' ARG . 8.3 p-10 -95.32 15.71 18.66 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.504 1.047 . . . . 0.0 109.88 -178.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -32.9 73.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.636 -1.29 . . . . 0.0 110.009 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -73.2 -22.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 O-C-N 121.562 -0.711 . . . . 0.0 109.84 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.24 -43.1 58.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.84 -37.24 86.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.75 1.22 . . . . 0.0 109.651 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -58.74 -35.22 72.37 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.73 1.212 . . . . 0.0 111.262 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.54 -52.72 56.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.007 0.923 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.36 -24.98 60.4 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 121.834 -0.541 . . . . 0.0 110.922 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -63.87 -42.77 97.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.002 1.321 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.38 73.9 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.34 -0.85 . . . . 0.0 112.05 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -3.02 45.54 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.158 -0.964 . . . . 0.0 111.405 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.255 3.1 p 59.8 21.71 10.57 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 127.479 2.312 . . . . 0.0 111.578 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.66 -48.05 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.53 74.53 0.35 Allowed Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -69.13 -24.96 64.16 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.217 -1.167 . . . . 0.0 110.867 -170.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.31 10.27 9.75 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.7 -61.4 2.38 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 126.737 2.015 . . . . 0.0 109.509 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.469 HH22 ' CG ' ' C' ' 43' ' ' ASP . 0.0 OUTLIER -145.6 174.14 11.44 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 171.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -167.53 154.37 7.86 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.14 170.63 8.22 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 123.005 2.47 . . . . 0.0 110.73 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.87 -146.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -76.83 -60.52 2.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 126.172 1.789 . . . . 0.0 109.914 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.91 -16.74 61.09 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.897 0.856 . . . . 0.0 110.264 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.412 ' CD ' ' HB2' ' C' ' 33' ' ' ALA . 13.6 mm-40 -75.35 -16.42 60.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.608 -0.682 . . . . 0.0 109.352 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.77 88.76 0.64 Allowed Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 101.252 -4.739 . . . . 0.0 101.252 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -64.47 -13.03 49.77 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.426 -1.632 . . . . 0.0 110.846 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -60.77 -14.07 19.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.165 0.986 . . . . 0.0 113.172 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.09 -37.4 79.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 O-C-N 120.833 -1.167 . . . . 0.0 109.584 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.83 57.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.085 -1.009 . . . . 0.0 108.953 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.69 -48.77 49.45 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.045 1.738 . . . . 0.0 112.235 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -67.69 -32.06 72.44 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 120.47 -1.394 . . . . 0.0 112.056 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.77 -37.62 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.057 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 55' ' ' VAL . 69.5 mtm -63.07 -45.89 90.0 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.538 0.735 . . . . 0.0 110.807 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -62.9 -35.61 80.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.718 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.3 77.93 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 118.271 0.487 . . . . 0.0 111.815 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.18 -53.32 22.69 Favored Glycine 0 CA--C 1.49 -1.482 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.76 -44.59 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.195 0.998 . . . . 0.0 109.382 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -65.39 -40.0 92.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.441 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.58 -50.1 69.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -66.9 -37.39 84.29 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.655 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.82 -32.89 74.67 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.104 0.962 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.19 -35.72 77.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 124.874 1.27 . . . . 0.0 110.963 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.69 -13.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 125.408 1.483 . . . . 0.0 111.118 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.8 m -62.04 -18.1 59.52 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.654 -1.904 . . . . 0.0 111.986 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.71 -17.33 62.87 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.571 -1.331 . . . . 0.0 111.594 170.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -83.45 -54.46 4.95 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.74 -28.44 66.82 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -165.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.76 -14.18 60.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.61 -1.931 . . . . 0.0 111.029 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -73.78 -17.14 61.13 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 119.94 -1.725 . . . . 0.0 109.828 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -30.13 70.43 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.245 0.618 . . . . 0.0 111.064 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -75.42 -23.89 57.04 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.027 -1.046 . . . . 0.0 110.911 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.67 -27.24 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 123.914 0.885 . . . . 0.0 108.675 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -67.49 -10.83 55.3 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 121.698 -0.626 . . . . 0.0 112.538 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -67.24 -36.65 82.09 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 120.782 -1.199 . . . . 0.0 109.074 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.35 166.41 12.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 71.38 -58.53 0.57 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.132 1.773 . . . . 0.0 111.313 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.95 -39.24 93.19 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.418 -1.427 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -76.98 -30.88 56.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.973 -0.455 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -127.48 92.18 3.45 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.35 -28.27 2.8 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 CA--C 1.496 -1.127 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -172.859 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 N--CA 1.427 -1.609 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' D' ' 4' ' ' HIS . . . -85.37 170.86 12.32 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.394 0.616 . . . . 0.0 109.347 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.25 -64.86 0.46 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 129.017 2.927 . . . . 0.0 112.688 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' D' ' 2' ' ' ALA . 39.3 p-80 -62.91 -25.6 68.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 112.996 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -79.61 -39.67 31.08 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -64.07 -44.65 91.75 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.592 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.54 -37.21 86.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 110.563 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.84 72.6 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.092 -1.005 . . . . 0.0 110.215 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.32 -28.31 67.04 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.424 0.69 . . . . 0.0 110.646 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.97 -41.81 75.33 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 125.697 1.599 . . . . 0.0 110.964 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.15 86.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.286 0.634 . . . . 0.0 111.5 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.91 -26.03 65.79 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.069 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -71.43 -33.2 69.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.9 -1.125 . . . . 0.0 109.969 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -65.42 -40.04 92.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 123.905 0.882 . . . . 0.0 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.88 -42.61 89.91 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 123.09 0.556 . . . . 0.0 111.527 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.3 -36.98 79.14 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 112.28 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -68.87 -39.79 79.64 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 110.003 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.06 -40.41 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.15 -53.1 60.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.951 0.796 . . . . 0.0 110.554 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -59.72 -50.02 75.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.869 0.868 . . . . 0.0 111.166 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -73.67 -29.05 62.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.857 -1.152 . . . . 0.0 111.513 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.88 63.94 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -58.51 -45.08 89.54 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.377 1.071 . . . . 0.0 110.565 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -60.9 -49.91 75.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -64.16 -31.82 73.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 123.923 0.889 . . . . 0.0 111.599 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.79 -50.33 68.77 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.346 0.975 . . . . 0.0 110.693 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -88.01 -32.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 O-C-N 121.393 -0.817 . . . . 0.0 111.793 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -75.29 -23.87 57.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 120.227 -1.545 . . . . 0.0 111.413 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.0 37.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.72 -86.54 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 mtm-85 -17.32 90.45 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 129.121 2.968 . . . . 0.0 115.361 -151.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.12 -30.79 2.0 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 107.021 -2.432 . . . . 0.0 107.021 -171.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.62 141.24 25.57 Favored Pre-proline 0 C--N 1.353 0.727 0 C-N-CA 125.728 1.611 . . . . 0.0 114.396 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.07 92.83 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.698 2.266 . . . . 0.0 113.345 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.68 -43.55 1.48 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 103.667 -3.773 . . . . 0.0 103.667 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 64.68 -179.17 0.17 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.551 1.94 . . . . 0.0 109.894 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.7 -41.79 0.05 Allowed 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.75 -14.75 13.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.05 1.34 . . . . 0.0 112.39 -167.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 pt -43.2 105.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -165.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -174.91 -143.53 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.6 -58.8 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.09 0 C-N-CA 126.641 1.977 . . . . 0.0 107.553 173.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.6 -20.71 26.53 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 126.064 3.201 . . . . 0.0 112.334 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.68 6.11 42.87 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 118.632 0.651 . . . . 0.0 110.241 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.0 -50.69 67.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.394 -0.817 . . . . 0.0 109.758 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.6 -7.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.013 0.911 . . . . 0.0 110.625 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 -28.24 15.92 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -83.74 -28.51 28.18 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.4 1.0 . . . . 0.0 108.947 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.8 t -78.17 62.69 2.94 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.484 -1.385 . . . . 0.0 108.717 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 84.4 t -137.87 -77.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.99 -5.61 54.29 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.003 -1.061 . . . . 0.0 111.606 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -82.04 -17.16 47.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 121.076 -1.015 . . . . 0.0 108.493 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.09 -32.77 56.88 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.898 -1.126 . . . . 0.0 109.158 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -91.36 16.86 9.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.193 0.597 . . . . 0.0 110.336 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p 55.1 52.45 11.7 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.143 1.777 . . . . 0.0 114.373 170.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -127.11 -61.87 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 87.65 -51.32 4.11 Favored Glycine 0 CA--C 1.496 -1.13 0 O-C-N 119.997 -1.689 . . . . 0.0 109.785 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 74.89 -24.76 0.21 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 128.151 2.58 . . . . 0.0 110.615 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 111.25 23.87 5.61 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.02 -65.91 0.64 Allowed 'General case' 0 C--N 1.36 1.063 0 CA-C-N 118.905 1.352 . . . . 0.0 110.056 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -126.81 161.72 27.55 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.57 89.06 7.61 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 117.858 -1.067 . . . . 0.0 109.168 -170.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.17 158.85 56.14 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.823 2.349 . . . . 0.0 111.875 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.539 HG22 ' H ' ' D' ' 64' ' ' THR . 3.6 p -111.8 -162.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 120.161 1.346 . . . . 0.0 110.788 -174.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.539 ' H ' HG22 ' D' ' 63' ' ' VAL . 1.3 p -70.09 -49.73 47.97 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 128.968 2.907 . . . . 0.0 111.258 -174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -69.65 -30.63 68.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.003 0.921 . . . . 0.0 110.942 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 8.4 pt-20 -79.49 -1.27 36.77 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.83 82.44 0.21 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 104.131 -3.588 . . . . 0.0 104.131 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -50.87 -22.09 2.03 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 120.642 2.221 . . . . 0.0 111.75 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -43.8 -23.08 0.07 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.412 1.885 . . . . 0.0 115.42 161.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.37 -43.91 97.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 CA-C-N 120.588 1.54 . . . . 0.0 108.778 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.54 87.29 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.026 0.53 . . . . 0.0 110.22 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -57.56 -41.91 81.96 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.722 1.209 . . . . 0.0 110.466 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -62.23 -40.36 95.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.347 1.059 . . . . 0.0 111.429 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.06 -42.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -60.98 -46.43 90.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.526 0.73 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -66.84 -36.12 81.61 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 121.438 -0.789 . . . . 0.0 111.523 -175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -44.75 93.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 121.764 -0.585 . . . . 0.0 110.047 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.04 -47.81 89.21 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 124.465 1.031 . . . . 0.0 112.537 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.17 -49.39 81.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 C-N-CA 124.63 1.172 . . . . 0.0 109.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.36 -31.46 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.477 -0.764 . . . . 0.0 111.429 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.4 -53.0 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 118.862 0.756 . . . . 0.0 110.136 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.53 -32.29 72.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.811 -0.555 . . . . 0.0 110.957 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.54 -39.86 92.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.694 1.198 . . . . 0.0 110.802 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.77 -22.42 12.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 124.766 1.226 . . . . 0.0 110.982 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -60.87 -12.21 10.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.0 95.16 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 118.784 -2.447 . . . . 0.0 112.27 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.88 72.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 36.9 mt -80.36 -28.51 38.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.722 0.772 . . . . 0.0 110.876 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.94 -26.32 59.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 120.326 -1.484 . . . . 0.0 110.025 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -78.65 -2.78 40.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.773 -1.204 . . . . 0.0 109.949 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.251 11.8 m-20 -78.68 -16.83 56.83 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 120.68 1.582 . . . . 0.0 111.663 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -80.68 -11.89 59.56 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.227 -1.546 . . . . 0.0 109.846 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.75 -32.85 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -61.7 -19.29 62.2 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.804 1.642 . . . . 0.0 111.872 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -65.18 -22.16 66.86 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.445 1.098 . . . . 0.0 111.439 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.33 132.15 40.77 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 126.359 1.864 . . . . 0.0 106.16 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.284 4.3 mt-10 71.88 -32.3 0.24 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.307 1.843 . . . . 0.0 112.61 -170.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.4 -46.69 17.07 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.833 1.253 . . . . 0.0 111.741 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . 0.25 37.7 ptt85 -74.6 0.12 16.01 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 120.507 -1.371 . . . . 0.0 112.742 -172.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -69.8 -36.7 75.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.252 -0.905 . . . . 0.0 108.784 167.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.92 27.86 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 CA--C 1.501 -0.914 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.427 -1.618 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 4' ' ' HIS . . . -77.93 -43.66 29.25 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 73.13 -58.27 0.61 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.958 2.103 . . . . 0.0 111.11 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 2' ' ' ALA . 28.9 p80 -61.99 -30.51 70.99 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.962 1.705 . . . . 0.0 111.098 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -67.06 -45.13 78.33 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.67 1.188 . . . . 0.0 108.46 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.04 -44.53 96.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.98 0.912 . . . . 0.0 109.687 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -66.23 -32.97 74.71 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.443 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.38 88.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 121.569 -0.707 . . . . 0.0 110.454 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -69.91 -31.13 68.76 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.614 0.721 . . . . 0.0 110.967 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -66.7 -38.52 86.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.907 0.883 . . . . 0.0 110.088 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.04 77.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.772 0.829 . . . . 0.0 111.075 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.45 -37.11 84.63 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.79 0.836 . . . . 0.0 111.559 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -65.87 -43.42 88.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.78 -32.73 73.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 110.224 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.7 -39.95 91.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.375 0.67 . . . . 0.0 111.525 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -64.64 -32.93 74.81 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.592 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -64.82 -39.76 94.1 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.71 0.804 . . . . 0.0 109.915 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.03 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 O-C-N 120.704 -1.248 . . . . 0.0 109.479 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.2 mt -60.99 -37.41 82.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.292 -0.88 . . . . 0.0 111.573 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.99 -45.48 73.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.933 0.893 . . . . 0.0 109.16 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -63.0 -43.64 98.22 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.969 -0.457 . . . . 0.0 109.814 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.31 74.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.873 1.669 . . . . 0.0 111.554 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -65.96 -37.38 85.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 122.153 -0.342 . . . . 0.0 110.964 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -73.09 -45.59 56.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -61.47 -46.28 90.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.07 53.16 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.027 1.331 . . . . 0.0 111.271 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.99 -39.39 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.767 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -81.96 -15.03 55.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.267 -1.521 . . . . 0.0 111.383 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.02 -51.65 7.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.84 -33.15 74.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.251 1.021 . . . . 0.0 111.465 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -72.31 108.48 5.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 119.541 -1.974 . . . . 0.0 110.356 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.07 -18.83 7.4 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.43 143.82 42.24 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 117.519 0.66 . . . . 0.0 111.0 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.63 116.12 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.575 2.183 . . . . 0.0 111.983 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.3 45.18 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.95 -67.37 0.27 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 127.616 2.366 . . . . 0.0 109.845 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 90.22 -31.1 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 126.754 2.022 . . . . 0.0 108.733 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -89.46 124.92 34.93 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.3 pt -137.63 -3.97 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.986 -1.071 . . . . 0.0 112.483 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -117.99 152.86 34.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 120.097 1.317 . . . . 0.0 109.942 -164.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -83.03 -55.69 0.5 Allowed Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.02 -17.92 28.03 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 CA-C-N 125.404 2.966 . . . . 0.0 111.706 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.64 -21.05 25.52 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.39 70.53 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 120.997 -1.064 . . . . 0.0 110.541 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.68 -28.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.541 -0.725 . . . . 0.0 109.553 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.37 68.71 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 119.752 -1.843 . . . . 0.0 109.927 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -62.79 -47.63 82.63 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.165 0.986 . . . . 0.0 109.815 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -68.73 -28.44 66.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.291 -1.505 . . . . 0.0 111.698 -172.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 51.4 t -56.83 -54.31 31.11 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 124.153 0.981 . . . . 0.0 109.974 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -20.26 61.29 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.787 -0.57 . . . . 0.0 111.116 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.6 m -75.14 -40.36 59.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.37 1.068 . . . . 0.0 109.218 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -26.55 63.07 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 120.86 -1.15 . . . . 0.0 111.359 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 p -83.37 -1.18 52.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.916 -0.49 . . . . 0.0 110.12 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 p 55.3 39.76 31.38 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 126.386 1.874 . . . . 0.0 111.538 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -104.23 -75.12 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.42 91.77 0.12 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CZ ' ' HA3' ' B' ' 56' ' ' GLY . 0.3 OUTLIER -75.95 -28.24 57.86 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.834 -1.392 . . . . 0.0 109.734 -172.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.33 3.64 5.63 Favored Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.6 -50.94 70.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.5 1.52 . . . . 0.0 113.29 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -142.06 158.62 43.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.33 148.06 20.51 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 102.934 -2.987 . . . . 0.0 102.934 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -90.79 171.09 3.41 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.901 2.4 . . . . 0.0 110.707 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.01 -154.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.686 0 CA-C-O 122.61 1.195 . . . . 0.0 110.291 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -83.51 -52.89 6.11 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.029 -1.669 . . . . 0.0 110.89 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -63.65 -32.2 73.6 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.798 2.439 . . . . 0.0 111.657 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -28.04 69.57 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 123.309 1.528 . . . . 0.0 108.1 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.17 65.74 1.22 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 103.097 -4.001 . . . . 0.0 103.097 174.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -27.78 -26.79 0.0 OUTLIER 'General case' 0 C--N 1.376 1.742 1 C-N-CA 131.715 4.006 . . . . 0.0 116.043 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -55.02 -12.77 0.92 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.366 2.666 . . . . 0.0 113.201 167.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 -52.13 34.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.11 99.68 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.555 -0.716 . . . . 0.0 111.347 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -50.6 -47.46 58.14 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.364 1.466 . . . . 0.0 111.379 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.66 -40.91 96.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.58 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.84 -43.77 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.205 1.002 . . . . 0.0 109.375 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.04 -49.1 78.98 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 124.391 1.076 . . . . 0.0 110.111 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -64.38 -35.04 79.6 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.631 -0.668 . . . . 0.0 110.897 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.38 80.6 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.147 0.579 . . . . 0.0 111.262 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.05 -43.65 80.71 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.54 -43.66 97.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 124.279 1.032 . . . . 0.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -60.41 -39.96 89.25 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.393 -0.817 . . . . 0.0 111.271 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.06 -54.28 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.103 0.961 . . . . 0.0 109.537 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -61.67 -40.08 93.67 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.421 0.689 . . . . 0.0 111.302 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.36 80.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.914 0.885 . . . . 0.0 110.981 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.58 -35.24 79.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.529 1.132 . . . . 0.0 110.804 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.12 -16.79 7.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 125.301 1.44 . . . . 0.0 111.206 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.0 m -56.6 -24.35 47.16 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.12 -1.612 . . . . 0.0 112.48 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.18 -23.78 62.52 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 120.842 -1.161 . . . . 0.0 112.439 172.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.59 -3.88 21.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.623 1.169 . . . . 0.0 111.587 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.5 mt -96.67 -42.98 7.76 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.45 64.64 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.343 -0.848 . . . . 0.0 111.067 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -71.32 -20.48 62.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 120.632 -1.292 . . . . 0.0 111.161 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.265 25.5 m-20 -86.8 -8.95 56.88 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.249 -162.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -81.96 -32.36 30.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.442 165.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.67 -32.67 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.789 1.236 . . . . 0.0 109.075 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -53.22 -24.67 11.65 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.583 1.553 . . . . 0.0 112.543 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -54.26 -39.33 66.76 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.596 1.559 . . . . 0.0 110.774 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -69.83 -27.46 64.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.591 -0.693 . . . . 0.0 111.643 -175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -86.14 -34.36 20.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -68.63 -25.2 64.71 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.636 -1.29 . . . . 0.0 111.865 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -67.29 -26.51 66.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 121.262 -0.899 . . . . 0.0 111.26 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -83.32 -31.29 26.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 121.552 -0.717 . . . . 0.0 109.457 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.62 69.97 Favored Glycine 0 CA--C 1.496 -1.112 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.1 m80 . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -170.079 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.44 ' H ' ' HB2' ' B' ' 5' ' ' GLU . . . -126.74 44.35 2.91 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 118.443 0.565 . . . . 0.0 111.521 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.84 -67.38 0.23 Allowed 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 128.794 2.838 . . . . 0.0 110.678 173.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.714 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 35.1 p-80 -63.9 -21.48 66.48 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.501 1.52 . . . . 0.0 111.769 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' B' ' 2' ' ' ALA . 0.8 OUTLIER -68.73 -35.09 76.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.666 1.187 . . . . 0.0 109.044 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -68.69 -31.68 70.94 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 121.407 -0.808 . . . . 0.0 110.894 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.07 -27.9 63.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.297 0.57 . . . . 0.0 110.075 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.35 -35.62 78.01 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.305 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.73 -28.72 61.85 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.436 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.69 -38.34 90.66 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.393 -0.817 . . . . 0.0 109.817 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.45 89.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.956 0.903 . . . . 0.0 110.99 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.45 -37.91 89.18 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 121.302 -0.874 . . . . 0.0 111.335 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -65.62 -41.25 92.9 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.386 -0.821 . . . . 0.0 109.713 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.39 -37.23 74.88 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.765 1.226 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 tp -63.67 -42.67 98.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.26 -29.07 68.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.543 -0.723 . . . . 0.0 111.423 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -66.47 -46.89 74.85 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.804 1.242 . . . . 0.0 109.851 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -76.01 -19.33 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 121.534 -0.729 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.75 -43.3 99.16 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 119.533 1.06 . . . . 0.0 110.323 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.54 -39.18 77.63 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -68.87 -31.93 71.23 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.199 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.32 -32.36 73.93 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.752 1.221 . . . . 0.0 110.636 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.0 t -62.2 -48.23 80.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.429 1.092 . . . . 0.0 109.269 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -60.98 -53.39 57.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 108.793 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -65.15 -38.44 90.58 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.33 -54.05 43.06 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.676 1.126 . . . . 0.0 110.984 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.24 -36.59 75.74 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.814 -0.554 . . . . 0.0 110.082 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.51 -31.88 57.94 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.18 -0.95 . . . . 0.0 110.33 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.5 -41.87 37.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 O-C-N 121.911 -0.493 . . . . 0.0 110.011 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.31 -28.23 69.17 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 121.87 0.843 . . . . 0.0 111.954 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -72.28 107.53 4.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 119.73 -1.856 . . . . 0.0 110.621 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.02 -24.13 4.56 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 106.594 -2.602 . . . . 0.0 106.594 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 147.22 84.37 Favored Pre-proline 0 N--CA 1.444 -0.759 0 O-C-N 121.94 -0.741 . . . . 0.0 111.444 -171.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.92 145.62 22.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.441 2.094 . . . . 0.0 109.689 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.95 -67.55 3.69 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.04 157.45 0.11 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.936 2.894 . . . . 0.0 109.946 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.27 -43.82 0.37 Allowed 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 120.922 -1.111 . . . . 0.0 108.907 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' B' ' 60' ' ' ARG . 12.7 tp -121.64 111.43 17.19 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.8 80.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 O-C-N 120.336 -1.478 . . . . 0.0 108.649 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -159.11 158.86 33.74 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.81 -61.58 0.24 Allowed Pre-proline 0 C--N 1.347 0.5 0 CA-C-O 116.971 -1.49 . . . . 0.0 109.204 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.5 -9.53 24.22 Favored 'Trans proline' 0 CA--C 1.511 -0.646 0 CA-C-N 124.835 2.763 . . . . 0.0 112.121 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.08 -22.22 16.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -40.33 82.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 121.452 -0.78 . . . . 0.0 109.25 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -66.16 -27.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 122.737 0.415 . . . . 0.0 110.937 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -73.14 -43.17 61.97 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.465 -0.772 . . . . 0.0 109.09 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.47 -31.93 73.24 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 125.071 1.349 . . . . 0.0 110.036 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 m -63.06 -36.47 83.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 119.08 -2.262 . . . . 0.0 112.45 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 t -64.87 -45.51 94.66 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 121.534 -0.729 . . . . 0.0 110.54 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -65.42 -33.83 76.86 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 122.008 0.909 . . . . 0.0 110.302 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 87.4 m -67.56 -41.3 84.45 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.285 -0.884 . . . . 0.0 109.85 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.75 61.78 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.173 -0.954 . . . . 0.0 112.189 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -97.29 0.86 48.79 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . 0.263 18.7 p 62.21 31.37 17.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.863 1.665 . . . . 0.0 113.775 173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 78.87 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 57' ' ' TYR . . . -90.93 120.08 5.83 Favored Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 103.584 -3.806 . . . . 0.0 103.584 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -86.08 -84.95 0.16 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -168.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.95 37.6 0.31 Allowed Glycine 0 CA--C 1.479 -2.205 0 N-CA-C 106.292 -2.723 . . . . 0.0 106.292 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.1 -62.1 1.56 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' B' ' 38' ' ' LEU . 62.4 mtt-85 -143.22 170.61 15.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -156.76 153.58 24.75 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.96 173.83 8.84 Favored 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 124.25 3.3 . . . . 0.0 109.692 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.34 -99.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 119.695 1.134 . . . . 0.0 112.505 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 81.7 m -150.46 -40.07 0.13 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.029 1.732 . . . . 0.0 109.106 -172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -88.45 -20.5 25.11 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.283 -0.886 . . . . 0.0 110.645 -169.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -35.08 73.51 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 126.303 1.841 . . . . 0.0 108.315 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.38 90.02 1.88 Allowed Glycine 0 CA--C 1.467 -2.927 1 N-CA-C 97.802 -6.119 . . . . 0.0 97.802 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -56.42 -18.99 12.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.261 1.825 . . . . 0.0 111.382 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -54.72 -22.65 14.63 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 127.104 2.162 . . . . 0.0 113.135 168.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.26 -43.62 98.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.806 -1.184 . . . . 0.0 108.841 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.76 67.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.742 -0.599 . . . . 0.0 109.485 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -52.87 -45.04 67.26 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.482 1.513 . . . . 0.0 110.818 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.57 -39.82 85.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.001 0.92 . . . . 0.0 111.364 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.96 -41.22 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 109.086 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 54.5 mtt -60.43 -47.54 85.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 123.81 0.844 . . . . 0.0 110.049 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.927 -0.483 . . . . 0.0 111.134 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.37 90.76 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.766 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.23 -46.17 88.38 Favored Glycine 0 CA--C 1.495 -1.198 0 C-N-CA 124.061 0.839 . . . . 0.0 111.153 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.89 -46.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 C-N-CA 124.443 1.097 . . . . 0.0 109.182 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -62.76 -51.48 66.96 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.315 -0.866 . . . . 0.0 112.327 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.24 -40.84 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 O-C-N 121.76 -0.587 . . . . 0.0 111.081 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -74.22 -38.57 63.52 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.96 74.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.54 -0.725 . . . . 0.0 111.016 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.28 -30.57 71.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.756 1.222 . . . . 0.0 111.068 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.537 HG12 HD23 ' B' ' 89' ' ' LEU . 92.1 t -63.93 -14.91 15.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.879 1.272 . . . . 0.0 110.397 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 20.6 m -55.86 -23.46 30.96 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.6 -1.313 . . . . 0.0 110.894 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.45 74.92 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 119.251 -2.156 . . . . 0.0 112.446 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.714 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -80.61 -45.15 17.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 120.903 -1.123 . . . . 0.0 108.047 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.537 HD23 HG12 ' B' ' 85' ' ' VAL . 2.2 mm? -70.9 -27.7 63.99 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.877 0.871 . . . . 0.0 111.336 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.06 -17.07 62.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 120.689 -1.257 . . . . 0.0 111.192 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -76.72 -13.92 59.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 120.559 -1.338 . . . . 0.0 111.128 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . 0.259 7.4 t70 -75.71 -18.23 59.67 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 120.231 1.378 . . . . 0.0 111.218 -167.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.43 -36.13 60.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 119.895 -1.753 . . . . 0.0 110.234 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.35 -28.82 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 126.029 1.731 . . . . 0.0 109.437 -171.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -44.21 -36.75 2.83 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 126.835 2.054 . . . . 0.0 112.013 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -58.33 -33.12 69.15 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 123.917 0.887 . . . . 0.0 111.753 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -70.23 -36.25 74.39 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 107.971 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.32 -24.51 46.55 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.666 1.587 . . . . 0.0 110.84 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -81.54 -33.8 31.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 121.603 -0.686 . . . . 0.0 110.258 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -77.81 -48.12 17.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 86.4 mtt85 -92.65 112.21 24.08 Favored 'General case' 0 CA--C 1.498 -1.031 0 O-C-N 121.105 -0.997 . . . . 0.0 109.187 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.96 -2.61 55.49 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 -175.373 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -26.9 113.94 0.06 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.475 3.11 . . . . 0.0 116.625 -163.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.42 -34.03 77.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 125.677 1.591 . . . . 0.0 110.281 -165.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -61.29 -28.34 69.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.93 -37.57 64.55 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 120.137 1.335 . . . . 0.0 107.837 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -73.84 -38.31 64.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -68.43 -35.19 77.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.969 -0.457 . . . . 0.0 110.345 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.56 90.07 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.8 0.84 . . . . 0.0 110.796 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.64 -38.22 83.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.832 -0.542 . . . . 0.0 110.556 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.89 -40.42 92.98 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.72 0.808 . . . . 0.0 110.328 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.15 75.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.588 0.755 . . . . 0.0 111.588 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -38.49 86.41 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.791 -0.568 . . . . 0.0 111.403 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.71 -30.67 69.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 122.219 1.009 . . . . 0.0 109.846 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.29 -33.56 71.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.803 0.841 . . . . 0.0 109.213 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.35 -43.87 93.22 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.42 0.688 . . . . 0.0 110.649 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -52.36 -41.04 62.73 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.906 1.282 . . . . 0.0 111.771 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -24.17 61.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.845 0.858 . . . . 0.0 111.199 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -78.42 -36.55 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.73 -41.85 91.82 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.815 1.246 . . . . 0.0 111.14 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -74.36 -14.95 60.95 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.58 -36.15 19.05 Favored 'General case' 0 CA--C 1.493 -1.232 0 O-C-N 120.672 -1.268 . . . . 0.0 108.023 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.49 72.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.033 0.933 . . . . 0.0 111.152 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -68.95 -36.84 78.39 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.992 0.815 . . . . 0.0 110.432 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -71.15 -43.8 66.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.93 -49.88 76.15 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.591 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.8 86.65 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.432 1.093 . . . . 0.0 112.017 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -37.07 74.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.283 -1.511 . . . . 0.0 110.187 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -73.85 -31.92 63.41 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 120.751 -1.218 . . . . 0.0 109.279 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.24 15.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 126.06 1.744 . . . . 0.0 109.053 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.64 -25.96 64.18 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.143 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.61 104.91 2.5 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 119.481 -2.012 . . . . 0.0 110.59 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.47 -5.76 21.09 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 144.31 28.87 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.68 139.6 11.27 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.367 2.045 . . . . 0.0 110.277 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.65 81.46 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.58 116.01 4.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 125.74 1.616 . . . . 0.0 106.906 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.74 -33.55 15.7 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' C' ' 44' ' ' ALA . 24.5 tp -90.72 127.84 36.45 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 pt -144.88 168.8 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 101.222 -3.622 . . . . 0.0 101.222 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m 74.8 131.2 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.407 1.883 . . . . 0.0 113.402 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -58.64 -49.09 95.35 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 116.194 -1.86 . . . . 0.0 112.527 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.53 -27.94 38.78 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 CA-C-N 125.297 2.928 . . . . 0.0 113.491 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . 0.339 4.8 p-10 -98.7 -1.64 40.15 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 120.739 1.609 . . . . 0.0 111.035 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 38' ' ' LEU . . . -69.08 -34.17 74.69 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 120.713 -1.242 . . . . 0.0 110.878 173.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.66 -16.71 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 O-C-N 121.091 -1.006 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.08 -41.48 28.63 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 120.887 -1.133 . . . . 0.0 108.304 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.7 -33.29 75.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.858 0.837 . . . . 0.0 109.977 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -77.29 53.85 1.05 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 120.935 -1.103 . . . . 0.0 111.144 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -141.69 -54.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -34.25 71.13 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.741 1.216 . . . . 0.0 112.422 -172.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -72.68 -33.29 66.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 125.313 1.445 . . . . 0.0 109.898 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.1 -31.09 58.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 120.411 -1.431 . . . . 0.0 110.309 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -85.01 -1.74 57.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.171 0.588 . . . . 0.0 110.727 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p 51.13 68.01 0.86 Allowed 'General case' 0 C--N 1.352 0.709 0 C-N-CA 127.695 2.398 . . . . 0.0 112.099 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.12 -75.87 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.65 -78.94 0.63 Allowed Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -173.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 83.28 -49.62 0.15 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 127.746 2.419 . . . . 0.0 106.434 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.24 42.49 0.25 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -70.24 -54.12 14.12 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -139.4 -169.57 2.71 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.09 137.71 11.49 Favored Pre-proline 0 N--CA 1.438 -1.067 1 N-CA-C 100.153 -4.017 . . . . 0.0 100.153 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.07 163.0 0.26 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 CA-C-N 123.695 2.355 . . . . 0.0 109.389 166.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.596 HG22 ' H ' ' C' ' 64' ' ' THR . 9.8 p -107.19 -177.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-O 123.24 1.495 . . . . 0.0 111.558 -169.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.596 ' H ' HG22 ' C' ' 63' ' ' VAL . 2.9 m -68.64 -34.82 76.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 119.085 -2.259 . . . . 0.0 111.211 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -78.68 -23.64 45.53 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.444 0.698 . . . . 0.0 110.308 -170.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -67.07 -34.76 78.37 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.34 67.32 0.81 Allowed Glycine 0 CA--C 1.461 -3.327 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 171.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.44 ' HA ' ' OE2' ' C' ' 66' ' ' GLU 0.272 6.4 ttm180 -54.24 1.54 0.02 OUTLIER 'General case' 0 C--N 1.373 1.617 0 C-N-CA 127.582 2.353 . . . . 0.0 116.539 -166.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -54.54 -24.17 19.67 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 127.1 2.16 . . . . 0.0 111.48 155.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.24 -50.25 69.76 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 CA-C-N 120.639 1.563 . . . . 0.0 108.439 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.8 75.42 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.901 0.88 . . . . 0.0 110.869 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -51.87 -44.17 63.59 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.782 1.633 . . . . 0.0 112.081 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -62.4 -35.4 79.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.071 1.348 . . . . 0.0 110.899 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.43 -40.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 O-C-N 121.61 -0.681 . . . . 0.0 109.358 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -59.65 -46.79 87.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.853 1.261 . . . . 0.0 110.115 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.67 -41.08 98.89 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 121.966 -0.459 . . . . 0.0 110.707 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.98 89.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.883 0.473 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.78 87.87 Favored Glycine 0 CA--C 1.494 -1.232 0 C-N-CA 123.744 0.687 . . . . 0.0 111.534 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.66 -44.27 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 123.983 0.913 . . . . 0.0 109.648 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.91 -33.63 76.48 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.397 -0.815 . . . . 0.0 111.911 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.78 -53.68 28.91 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 123.642 0.777 . . . . 0.0 109.581 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -67.11 -36.13 81.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.53 87.58 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.342 0.657 . . . . 0.0 110.644 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.67 -35.39 74.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.213 1.405 . . . . 0.0 111.775 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.63 -16.46 10.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 C-N-CA 125.255 1.422 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -62.72 -13.26 30.46 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 119.602 -1.936 . . . . 0.0 112.166 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.85 67.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.923 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.2 -55.69 4.57 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.8 mt -61.01 -38.63 86.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.403 1.481 . . . . 0.0 113.304 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.68 61.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.558 -1.339 . . . . 0.0 110.852 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 68.7 p -88.78 -12.37 42.26 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 120.82 -1.175 . . . . 0.0 110.616 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.37 -28.45 67.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.229 0.922 . . . . 0.0 110.537 -167.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -77.08 -33.44 57.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.93 -33.06 56.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 125.366 1.466 . . . . 0.0 108.685 -172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -52.51 -24.17 7.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.636 1.974 . . . . 0.0 113.956 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -58.01 -32.98 68.45 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 119.756 1.162 . . . . 0.0 112.111 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.99 -13.79 43.51 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.144 -0.973 . . . . 0.0 111.04 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -89.5 -19.33 25.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.298 0.499 . . . . 0.0 109.849 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -77.04 -54.66 6.26 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.593 -0.692 . . . . 0.0 111.573 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -58.83 -27.75 65.38 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -83.73 -18.62 37.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.817 -0.552 . . . . 0.0 111.299 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.6 44.85 Favored Glycine 0 CA--C 1.495 -1.174 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.501 -0.912 0 O-C-N 121.39 -1.065 . . . . 0.0 108.288 177.63 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.9 165.49 17.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.74 -35.65 81.76 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 121.722 -0.612 . . . . 0.0 111.326 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.446 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 7.3 p80 -73.32 -23.93 60.31 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 121.013 -1.055 . . . . 0.0 111.42 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.446 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 0.1 OUTLIER -83.16 -27.95 29.71 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -63.78 -42.32 97.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.361 1.065 . . . . 0.0 110.361 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.7 -38.74 84.07 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.839 0.828 . . . . 0.0 109.148 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.26 89.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.39 1.076 . . . . 0.0 111.413 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -69.84 -28.76 65.96 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.529 -0.732 . . . . 0.0 110.766 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.75 69.67 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.337 0.655 . . . . 0.0 111.738 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.97 -36.13 82.49 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.44 -0.787 . . . . 0.0 111.365 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.07 -27.11 60.75 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.927 -1.108 . . . . 0.0 110.647 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.72 -27.5 65.03 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.475 -0.765 . . . . 0.0 110.463 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 tp -71.79 -39.19 70.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.342 -0.848 . . . . 0.0 109.996 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -62.42 -31.92 72.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 123.424 0.69 . . . . 0.0 111.519 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.03 -45.5 92.6 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.504 1.122 . . . . 0.0 110.224 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -67.8 -35.67 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 123.917 0.887 . . . . 0.0 109.244 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.27 -53.69 54.71 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.288 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -68.68 -40.89 79.87 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 121.451 -0.78 . . . . 0.0 110.777 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.93 -47.33 83.72 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 109.837 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.56 60.93 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 121.009 -1.057 . . . . 0.0 111.771 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -66.04 -40.33 90.89 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.278 0.945 . . . . 0.0 109.742 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -71.23 -25.57 62.55 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.34 1.456 . . . . 0.0 110.084 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -79.22 -55.5 5.05 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.4 -43.87 79.72 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 126.228 1.811 . . . . 0.0 112.531 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -31.8 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -83.96 -34.45 24.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.12 -50.45 54.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 127.009 2.124 . . . . 0.0 109.92 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -62.88 -41.84 99.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.999 1.32 . . . . 0.0 110.231 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -62.2 121.77 13.95 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 119.722 -1.861 . . . . 0.0 110.233 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.19 -12.44 48.48 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.22 56.66 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 118.144 0.972 . . . . 0.0 110.504 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.85 141.81 19.49 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.894 1.73 . . . . 0.0 109.775 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.81 75.51 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.57 139.28 58.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 111.666 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.91 -29.39 2.33 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 124.5 1.12 . . . . 0.0 110.185 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 30.0 tp -81.4 -106.77 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' D' ' 40' ' ' SER 0.285 35.5 mt 71.97 173.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 -172.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.469 ' H ' HG22 ' D' ' 39' ' ' ILE . 39.0 t 73.17 124.36 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.225 1.488 . . . . 0.0 110.511 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -66.66 -50.11 47.13 Favored Pre-proline 0 C--N 1.348 0.503 0 O-C-N 119.802 -1.811 . . . . 0.0 110.778 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -71.67 -11.71 28.23 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 125.074 2.848 . . . . 0.0 112.227 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.92 -45.3 12.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.61 72.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.048 0.939 . . . . 0.0 112.394 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -82.81 1.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.723 0.773 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -43.27 7.22 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 119.693 -1.879 . . . . 0.0 106.202 171.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -57.79 -32.57 67.67 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.346 1.858 . . . . 0.0 111.967 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 p -68.9 -34.6 75.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.026 -2.296 . . . . 0.0 110.321 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 t -87.93 63.43 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 0.0 108.795 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -175.87 -31.43 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 50.2 m -62.51 -39.28 93.03 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.346 1.458 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.62 65.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.135 -0.978 . . . . 0.0 112.176 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.97 4.38 45.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 122.68 0.392 . . . . 0.0 110.177 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.26 1.0 OUTLIER 64.67 10.63 6.11 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.04 1.736 . . . . 0.0 112.927 174.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.65 -65.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 -63.82 4.22 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.55 -60.57 0.53 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.301 2.24 . . . . 0.0 109.692 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.47 -95.07 0.1 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . 0.286 10.7 t70 43.62 -101.73 0.04 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.178 2.191 . . . . 0.0 113.79 -173.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 170.05 15.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -124.94 150.62 66.84 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.82 165.72 19.72 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.142 2.561 . . . . 0.0 109.427 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.44 -162.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 122.913 1.34 . . . . 0.0 107.837 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -86.58 -52.18 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 125.639 1.576 . . . . 0.0 109.059 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.54 -23.41 64.52 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 128.83 2.852 . . . . 0.0 110.345 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.99 -26.42 66.02 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 123.888 1.804 . . . . 0.0 108.398 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.8 67.6 1.31 Allowed Glycine 0 CA--C 1.462 -3.239 1 N-CA-C 99.483 -5.447 . . . . 0.0 99.483 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -34.22 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.36 1.028 1 C-N-CA 132.134 4.174 . . . . 0.0 114.765 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -55.75 -15.27 2.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 127.387 2.275 . . . . 0.0 113.273 165.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -72.29 -54.9 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.28 85.48 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.014 0.926 . . . . 0.0 112.14 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.13 -45.29 32.93 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.808 2.043 . . . . 0.0 112.108 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.59 -29.65 64.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 121.832 -0.542 . . . . 0.0 110.94 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -72.68 -47.22 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -70.88 -41.39 71.42 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.092 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -64.02 -41.83 97.32 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 121.272 -0.892 . . . . 0.0 110.736 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.07 79.23 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.604 -0.685 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.7 -45.54 96.06 Favored Glycine 0 CA--C 1.494 -1.278 0 C-N-CA 123.827 0.727 . . . . 0.0 111.654 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 86.7 mt -58.67 -47.06 90.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 124.273 1.029 . . . . 0.0 109.409 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -63.72 -34.78 78.63 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.383 -0.823 . . . . 0.0 112.125 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.93 -50.07 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.604 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.72 -21.25 64.41 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.599 -0.688 . . . . 0.0 111.142 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.11 -37.7 25.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.35 -37.2 84.74 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.975 1.31 . . . . 0.0 110.652 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.32 -2.73 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.335 -0.853 . . . . 0.0 112.39 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 24.9 m -63.09 -16.84 61.29 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.818 -1.176 . . . . 0.0 110.856 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.91 -38.05 81.19 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.863 -1.773 . . . . 0.0 111.908 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.24 63.37 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 120.555 -1.341 . . . . 0.0 108.423 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.57 -37.8 87.58 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.807 1.243 . . . . 0.0 111.532 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.63 -21.37 63.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.419 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -85.23 -16.19 41.04 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.48 -38.48 84.44 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.765 -1.209 . . . . 0.0 110.112 -170.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -70.59 -29.51 65.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.291 -1.505 . . . . 0.0 111.043 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.26 -20.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 109.502 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -50.74 -37.45 41.89 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.888 1.675 . . . . 0.0 110.233 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -56.77 -36.22 69.56 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.987 1.315 . . . . 0.0 111.197 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.77 -36.32 43.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -171.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.24 -39.77 78.28 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.905 -0.497 . . . . 0.0 110.49 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -65.9 -43.45 88.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.406 1.082 . . . . 0.0 109.741 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.46 -40.76 96.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.246 1.018 . . . . 0.0 111.14 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -73.96 -39.89 63.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 121.403 -0.811 . . . . 0.0 110.001 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.85 25.48 22.44 Favored Glycine 0 CA--C 1.496 -1.149 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 66.2 m80 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 125.965 1.706 . . . . 0.0 112.831 -179.168 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.01 163.78 0.27 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 126.73 2.012 . . . . 0.0 111.707 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -57.1 2.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -57.04 -24.16 51.77 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 128.079 2.552 . . . . 0.0 114.941 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.88 -28.58 61.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.509 -1.369 . . . . 0.0 110.07 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.87 -32.44 65.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.003 -1.06 . . . . 0.0 110.187 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -71.57 -38.23 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.212 1.005 . . . . 0.0 109.183 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.33 86.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.821 0.848 . . . . 0.0 111.158 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -73.32 -22.28 60.36 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.085 -1.009 . . . . 0.0 111.788 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -73.05 -23.84 60.63 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.129 -0.982 . . . . 0.0 109.879 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.43 77.85 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.9 -1.125 . . . . 0.0 109.98 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.8 -30.26 71.37 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.574 -0.704 . . . . 0.0 111.315 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 120.891 -1.13 . . . . 0.0 111.176 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -68.79 -31.2 70.04 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.618 0.767 . . . . 0.0 109.074 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.07 -40.48 94.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.649 0.737 . . . . 0.0 110.635 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -70.06 -25.27 63.46 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.16 -0.962 . . . . 0.0 111.419 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -71.2 -46.68 60.73 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -70.94 -25.2 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 121.604 -0.685 . . . . 0.0 110.132 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.55 -55.17 38.52 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 118.963 0.802 . . . . 0.0 110.471 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.38 -31.47 67.34 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.624 -0.673 . . . . 0.0 110.986 -174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.23 -48.31 70.99 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.916 -1.115 . . . . 0.0 109.627 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.14 63.39 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 123.989 0.915 . . . . 0.0 112.144 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.4 m -65.65 -39.74 91.74 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.639 -0.663 . . . . 0.0 110.156 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -69.36 -43.45 73.58 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.44 -53.12 61.85 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.499 0.72 . . . . 0.0 110.61 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.47 98.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.08 1.352 . . . . 0.0 112.648 -172.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -71.2 -35.25 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.945 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -77.0 -25.2 52.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 120.934 -1.104 . . . . 0.0 109.576 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.68 96.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.984 1.713 . . . . 0.0 109.495 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.4 -17.62 64.26 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.706 1.202 . . . . 0.0 113.133 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -78.23 80.43 4.64 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.24 -1.537 . . . . 0.0 110.369 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.09 2.76 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.33 143.8 37.23 Favored Pre-proline 0 N--CA 1.444 -0.757 0 O-C-N 120.926 -1.338 . . . . 0.0 110.525 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.71 128.42 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.985 2.456 . . . . 0.0 112.333 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 34.04 45.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.36 147.69 47.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.579 1.151 . . . . 0.0 110.624 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -44.43 0.93 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.217 0.607 . . . . 0.0 109.784 -170.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -87.08 46.48 1.38 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-O 123.13 1.443 . . . . 0.0 108.803 -171.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.04 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 119.4 -2.063 . . . . 0.0 108.94 -171.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.3 m -141.66 -122.01 0.1 Allowed 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -173.13 -71.51 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -20.89 25.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 125.512 3.004 . . . . 0.0 111.341 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.59 -33.17 64.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.443 1.497 . . . . 0.0 109.92 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.776 0.83 . . . . 0.0 109.703 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.96 -34.9 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 122.065 -0.397 . . . . 0.0 110.082 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 109.674 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -64.46 -35.12 79.88 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.512 1.148 . . . . 0.0 110.276 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -65.04 -42.35 94.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.722 -1.236 . . . . 0.0 109.684 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -56.62 -54.37 29.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.212 1.405 . . . . 0.0 110.031 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -69.46 -26.45 64.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.614 0.366 . . . . 0.0 111.455 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.6 m -69.34 -39.43 78.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.431 1.092 . . . . 0.0 109.707 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.37 -30.01 70.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.549 -1.344 . . . . 0.0 111.658 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -87.67 3.49 47.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 121.716 -0.615 . . . . 0.0 110.651 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p 59.85 36.93 21.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.012 1.725 . . . . 0.0 112.324 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 -85.63 0.55 Allowed Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 105.951 -2.859 . . . . 0.0 105.951 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 69.86 -65.18 0.32 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.872 2.469 . . . . 0.0 110.674 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.65 54.68 0.59 Allowed Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' CG ' HH22 ' B' ' 68' ' ' ARG . 36.1 t70 -83.09 -44.23 15.38 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -138.04 168.54 19.51 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.59 128.18 17.92 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 71.6 Cg_endo -80.29 172.78 13.27 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.265 3.31 . . . . 0.0 109.543 169.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.91 -137.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 p -124.04 -27.69 3.85 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.025 1.33 . . . . 0.0 110.723 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.12 6.05 50.13 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -74.25 -36.12 63.84 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.46 -11.44 0.55 Allowed Glycine 0 CA--C 1.477 -2.321 0 CA-C-O 117.096 -1.947 . . . . 0.0 108.968 171.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HA ' ' HE1' ' D' ' 46' ' ' TRP . 43.1 ttm180 67.14 -56.45 0.44 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 130.232 3.413 . . . . 0.0 109.33 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -84.81 20.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.029 1.331 . . . . 0.0 111.061 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.0 -49.39 44.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.7 74.92 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.179 0.592 . . . . 0.0 109.41 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.44 -41.78 69.81 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.226 1.41 . . . . 0.0 111.696 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.87 -49.28 76.85 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.846 -0.533 . . . . 0.0 110.775 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.96 -38.41 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 O-C-N 121.744 -0.597 . . . . 0.0 109.44 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.0 tpp -55.73 -53.74 52.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.572 1.549 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -66.22 -40.8 90.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.112 0.965 . . . . 0.0 109.935 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.11 82.84 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.827 0.851 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -46.37 91.66 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.98 -30.76 47.85 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 O-C-N 121.658 -0.907 . . . . 0.0 109.582 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.98 -46.44 81.44 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 119.661 -1.9 . . . . 0.0 109.866 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 t -63.44 -52.81 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 124.477 1.111 . . . . 0.0 109.782 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -74.41 -8.11 55.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.647 -0.658 . . . . 0.0 112.049 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.89 -32.65 15.94 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.817 -1.177 . . . . 0.0 110.103 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.33 -36.85 85.31 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.781 -1.199 . . . . 0.0 110.096 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -63.44 -12.53 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.0 m -65.16 -15.93 62.96 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.853 1.261 . . . . 0.0 111.173 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.11 71.6 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 111.213 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 -31.86 38.39 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 120.507 -1.371 . . . . 0.0 109.427 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.29 -39.46 39.83 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.411 0.624 . . . . 0.0 111.231 -173.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.97 64.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.198 -0.938 . . . . 0.0 111.734 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -96.6 -0.18 49.03 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.606 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -77.92 -22.84 49.03 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.556 1.525 . . . . 0.0 109.751 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -73.59 -33.02 64.42 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 119.511 -1.993 . . . . 0.0 110.467 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.41 -24.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 124.945 1.298 . . . . 0.0 109.102 -170.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -62.11 -19.06 62.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.428 1.891 . . . . 0.0 110.706 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -65.33 -31.35 72.44 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 120.99 -1.069 . . . . 0.0 110.674 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -72.18 -27.33 62.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 -172.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.43 -49.86 65.31 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.64 -44.26 96.73 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.498 1.519 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.4 -45.16 84.83 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 127.707 2.403 . . . . 0.0 110.533 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -84.96 -27.57 26.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.678 -0.639 . . . . 0.0 109.843 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.39 38.25 33.98 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 t60 . . . . . 0 N--CA 1.445 -0.7 0 C-N-CA 126.074 1.75 . . . . 0.0 114.587 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.416 -2.137 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.98 4.74 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.67 -94.55 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 120.957 -1.089 . . . . 0.0 110.4 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -67.27 -19.53 65.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -75.23 -46.68 32.3 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 124.853 1.261 . . . . 0.0 108.487 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.399 1.08 . . . . 0.0 109.657 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.2 90.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.856 0.862 . . . . 0.0 111.568 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -69.15 -34.15 74.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.69 0.757 . . . . 0.0 111.028 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.084 -1.01 . . . . 0.0 111.224 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.45 -46.38 73.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.895 0.878 . . . . 0.0 109.199 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.91 -38.41 88.28 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.647 1.213 . . . . 0.0 111.625 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.1 -24.07 60.59 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 124.953 1.301 . . . . 0.0 110.322 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.1 -41.48 61.6 Favored 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 120.259 -1.525 . . . . 0.0 107.847 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' B' ' 81' ' ' VAL . 22.4 tp -55.79 -46.76 77.9 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 124.658 1.183 . . . . 0.0 111.552 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -54.87 -37.73 66.62 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.091 0.957 . . . . 0.0 112.236 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -73.86 -32.44 63.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.86 -0.525 . . . . 0.0 110.512 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.3 -35.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.298 -0.876 . . . . 0.0 108.766 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.53 -37.41 87.22 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.065 -1.022 . . . . 0.0 111.279 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.11 -38.83 69.22 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.813 0.845 . . . . 0.0 110.745 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -73.62 -43.65 59.06 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.112 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.43 62.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 121.141 -0.974 . . . . 0.0 111.963 -175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' B' ' 45' ' ' ILE . 3.0 p -71.96 -37.46 69.94 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.204 0.911 . . . . 0.0 110.345 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -43.33 99.07 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 125.323 1.449 . . . . 0.0 108.433 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -66.13 -45.96 79.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.629 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.07 77.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.047 1.339 . . . . 0.0 112.746 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.2 -44.45 97.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 121.817 -0.552 . . . . 0.0 109.832 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.69 -28.29 62.6 Favored 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 120.872 -1.143 . . . . 0.0 111.629 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.32 80.31 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.644 1.578 . . . . 0.0 109.24 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -20.11 51.92 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.286 0.565 . . . . 0.0 110.842 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -70.95 72.63 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 125.055 1.342 . . . . 0.0 113.086 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.28 -18.3 1.04 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.82 147.07 61.31 Favored Pre-proline 0 N--CA 1.444 -0.735 0 O-C-N 121.7 -0.882 . . . . 0.0 110.375 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.413 ' O ' HG11 ' B' ' 63' ' ' VAL . 68.1 Cg_endo -82.66 129.66 5.71 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.54 2.16 . . . . 0.0 111.405 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 27.43 42.46 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.64 139.17 32.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.268 2.227 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.25 -32.36 2.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.398 0.679 . . . . 0.0 109.226 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -99.44 118.82 36.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.41 -154.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 19.6 t 75.1 -149.53 0.03 OUTLIER 'General case' 0 C--N 1.358 0.961 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.466 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 76.7 m-85 -145.64 -56.18 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 116.309 -1.805 . . . . 0.0 106.295 175.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 17.7 Cg_endo -67.33 -29.26 38.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 125.028 2.831 . . . . 0.0 110.734 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.17 -42.93 93.2 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.068 0.947 . . . . 0.0 110.183 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.28 95.2 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 111.121 -172.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' B' ' 23' ' ' SER . 21.6 tt -76.2 -27.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 121.027 0.441 . . . . 0.0 110.843 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -33.62 61.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.385 -1.447 . . . . 0.0 109.696 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -67.76 -34.19 76.31 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.864 0.866 . . . . 0.0 111.413 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.7 p -69.05 -20.76 64.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 119.727 -1.858 . . . . 0.0 111.35 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 -47.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.011 0.924 . . . . 0.0 109.5 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.58 -27.22 65.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.672 1.225 . . . . 0.0 110.933 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -73.98 -32.19 63.33 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.845 -1.16 . . . . 0.0 109.721 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.44 70.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.356 -0.84 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.9 p -93.58 10.89 30.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.446 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p 52.79 26.71 4.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.701 2.001 . . . . 0.0 112.721 174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.11 -41.92 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -61.51 4.62 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 62.94 -85.54 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 128.446 2.698 . . . . 0.0 108.481 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.19 40.97 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.14 -62.57 1.35 Allowed 'General case' 0 C--N 1.358 0.943 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -141.1 170.81 15.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -131.38 146.13 60.64 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -94.06 158.58 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.043 2.495 . . . . 0.0 108.217 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' O ' ' B' ' 34' ' ' PRO . 13.3 t -79.21 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 42.0 m -156.2 -36.67 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 O-C-N 119.047 -2.283 . . . . 0.0 106.927 -170.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -95.61 11.24 33.92 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.367 -0.833 . . . . 0.0 108.918 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.04 -33.41 61.74 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 168.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 88.73 1.24 Allowed Glycine 0 N--CA 1.418 -2.566 1 N-CA-C 98.403 -5.879 . . . . 0.0 98.403 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.401 HH22 ' CG ' ' A' ' 59' ' ' ASP . 34.7 ttm180 -63.53 -11.77 26.94 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 119.439 1.619 . . . . 0.0 110.935 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -46.55 -26.24 0.85 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.494 2.318 . . . . 0.0 113.821 159.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -68.56 -40.99 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.698 1.199 . . . . 0.0 108.734 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.49 -45.49 68.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -51.92 -41.66 62.18 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 126.441 1.897 . . . . 0.0 111.758 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.47 -42.56 92.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.914 1.286 . . . . 0.0 111.064 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.13 -38.38 70.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 O-C-N 121.687 -0.633 . . . . 0.0 109.422 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 42.4 mtt -62.79 -47.85 81.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.862 0.865 . . . . 0.0 110.177 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -61.26 -40.28 93.47 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.609 -0.682 . . . . 0.0 110.772 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.6 -34.8 77.75 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 122.758 0.423 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.97 -52.07 9.61 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.09 -47.01 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 124.39 1.076 . . . . 0.0 109.947 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.9 -38.27 90.4 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.051 -1.03 . . . . 0.0 111.565 -176.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' B' ' 15' ' ' LEU . 33.2 m -73.97 -38.4 49.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 O-C-N 120.642 -1.286 . . . . 0.0 110.906 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.52 -19.85 62.12 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.787 -0.571 . . . . 0.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.84 -38.19 13.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.655 0.782 . . . . 0.0 110.396 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.85 -35.91 71.58 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.008 1.723 . . . . 0.0 111.408 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.67 -6.98 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.751 0.82 . . . . 0.0 112.606 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -55.04 -24.34 24.34 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.364 1.466 . . . . 0.0 110.414 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.26 74.06 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.357 -1.464 . . . . 0.0 113.155 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.68 -33.16 23.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.868 -1.145 . . . . 0.0 108.33 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 72.4 mt -78.91 -28.4 43.94 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.928 0.891 . . . . 0.0 112.066 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -10.64 59.53 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.058 -1.651 . . . . 0.0 111.337 172.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.44 -36.59 74.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.097 1.317 . . . . 0.0 110.664 -169.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -75.21 -20.71 59.12 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.417 -1.427 . . . . 0.0 112.148 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.55 -33.09 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.234 -1.541 . . . . 0.0 107.596 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -60.88 -19.88 60.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.604 1.561 . . . . 0.0 112.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -55.81 -25.25 40.63 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.557 1.143 . . . . 0.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.95 -27.34 54.78 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.59 -1.319 . . . . 0.0 111.162 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.46 -39.67 45.79 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -57.24 -46.4 83.02 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 127.483 2.313 . . . . 0.0 109.552 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -65.43 -28.82 69.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.228 0.611 . . . . 0.0 112.622 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -87.37 -21.88 25.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.16 -0.962 . . . . 0.0 108.822 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.72 41.25 64.42 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.765 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.7 -84.46 0.11 Allowed 'General case' 0 C--N 1.355 0.846 0 CA-C-N 118.458 0.572 . . . . 0.0 109.503 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -136.43 -72.61 0.45 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -16.46 53.91 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 120.243 -1.535 . . . . 0.0 109.651 -167.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -65.8 -36.5 83.68 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.204 1.802 . . . . 0.0 111.161 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -81.87 -33.67 30.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -35.42 74.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.461 0.304 . . . . 0.0 110.544 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.85 96.7 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.824 0.85 . . . . 0.0 111.384 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -71.59 -34.61 70.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.075 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -66.04 -36.6 83.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.535 1.134 . . . . 0.0 109.574 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.41 91.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 124.517 1.127 . . . . 0.0 111.445 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -59.63 -38.6 81.79 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.802 0.811 . . . . 0.0 111.287 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -74.04 -27.56 60.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.583 0.753 . . . . 0.0 110.183 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -66.77 -38.21 86.13 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.147 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.86 -38.1 89.51 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 121.289 -0.882 . . . . 0.0 111.402 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -55.22 -38.68 68.75 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 111.876 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -70.82 -38.91 73.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.171 1.388 . . . . 0.0 109.352 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.9 -28.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 123.872 0.869 . . . . 0.0 108.998 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.09 -39.7 95.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 120.905 -1.122 . . . . 0.0 111.435 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.24 -46.41 87.03 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 121.284 -0.885 . . . . 0.0 109.927 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.33 -52.08 67.11 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-O 121.22 0.533 . . . . 0.0 109.615 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.44 -34.74 74.42 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 126.014 1.726 . . . . 0.0 111.454 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.9 m -63.36 -46.59 85.84 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.812 0.845 . . . . 0.0 110.799 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.45 -40.75 73.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.88 -39.81 95.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.821 0.848 . . . . 0.0 110.913 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -47.38 80.91 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.17 1.388 . . . . 0.0 111.466 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.01 -15.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.4 1.095 . . . . 0.0 110.102 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -101.23 -5.1 25.99 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 119.979 -1.701 . . . . 0.0 108.599 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.42 -18.85 18.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 124.808 1.243 . . . . 0.0 110.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.81 -30.89 69.54 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 121.028 -1.045 . . . . 0.0 108.553 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.44 113.96 4.0 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.32 1.848 . . . . 0.0 108.587 -169.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.02 -5.62 72.3 Favored Glycine 0 CA--C 1.498 -0.999 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.09 148.44 34.4 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.57 125.14 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.353 2.035 . . . . 0.0 111.1 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 45.48 3.08 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.83 24.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.897 -0.766 . . . . 0.0 112.195 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.01 -36.6 1.17 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.663 0.744 . . . . 0.0 110.063 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -85.85 37.42 0.71 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 108.675 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' C' ' 39' ' ' ILE . 16.2 tt -75.08 -22.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.224 2.21 . . . . 0.0 109.519 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -79.93 121.09 25.01 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.738 0.78 . . . . 0.0 109.252 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.84 -55.93 15.64 Favored Pre-proline 0 C--N 1.351 0.631 0 C-N-CA 126.885 2.074 . . . . 0.0 111.369 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.13 -11.96 23.34 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 CA-C-N 125.769 3.096 . . . . 0.0 111.339 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.33 -26.28 28.6 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 124.827 1.251 . . . . 0.0 108.747 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.47 91.32 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.091 0.956 . . . . 0.0 110.706 -167.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.4 -33.43 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.045 0.938 . . . . 0.0 111.267 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -32.51 48.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.909 -1.119 . . . . 0.0 109.964 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.458 ' CD2' HD11 ' C' ' 38' ' ' LEU . 50.0 t90 -67.04 -37.53 84.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.404 -0.81 . . . . 0.0 110.259 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -60.25 -25.11 65.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.239 -0.913 . . . . 0.0 112.735 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.14 -51.41 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 123.694 0.798 . . . . 0.0 109.437 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.76 40.52 0.9 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.62 1.168 . . . . 0.0 111.181 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 17.6 m -141.68 -56.92 0.47 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.75 73.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.353 -0.842 . . . . 0.0 112.923 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 16.5 p -95.01 23.69 5.42 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p 51.24 78.49 0.11 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.619 1.968 . . . . 0.0 111.871 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 t -122.23 -92.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.6 45.67 9.37 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 111.064 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -43.14 92.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.53 1.157 . . . . 0.0 110.375 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.52 -139.92 7.47 Favored Glycine 0 CA--C 1.483 -1.945 1 N-CA-C 101.645 -4.582 . . . . 0.0 101.645 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.3 34.5 t0 65.2 -71.83 0.08 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 127.27 2.228 . . . . 0.0 111.327 -173.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -124.54 158.9 31.84 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.66 154.13 55.58 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 166.8 27.09 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.203 2.602 . . . . 0.0 110.504 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.2 164.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -62.71 -69.19 0.27 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.337 1.455 . . . . 0.0 114.367 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.75 -72.88 0.06 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.651 1.18 . . . . 0.0 111.484 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -94.58 -39.79 10.18 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.155 -0.965 . . . . 0.0 113.317 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.92 -39.46 25.5 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 120.41 1.459 . . . . 0.0 113.938 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.14 -36.87 64.17 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 117.629 0.714 . . . . 0.0 112.26 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -74.29 -30.07 61.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 121.379 -0.826 . . . . 0.0 110.127 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.0 -40.84 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 O-C-N 121.168 -0.957 . . . . 0.0 109.662 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.36 92.9 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -58.13 -36.01 72.34 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 125.729 1.612 . . . . 0.0 111.395 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -66.04 -52.15 51.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.204 1.001 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 p -73.19 -27.27 23.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 121.576 -0.703 . . . . 0.0 109.636 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 19.5 tpp -58.54 -48.24 81.55 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 110.335 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -66.21 -36.75 83.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.993 -0.442 . . . . 0.0 110.518 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.26 78.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.366 0.666 . . . . 0.0 111.425 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.45 -40.94 78.85 Favored Glycine 0 CA--C 1.494 -1.266 0 O-C-N 121.664 -0.647 . . . . 0.0 111.546 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 81.2 mt -63.16 -46.57 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -57.26 -47.68 80.8 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.197 0.999 . . . . 0.0 110.774 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.99 -55.04 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 124.459 1.104 . . . . 0.0 111.086 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -71.61 -33.45 69.0 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 118.551 0.614 . . . . 0.0 110.695 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.33 -30.24 65.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.781 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.75 -12.79 60.82 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 121.138 -0.976 . . . . 0.0 111.589 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.19 -10.99 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 119.988 -1.695 . . . . 0.0 110.51 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -49.39 -27.24 3.87 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.383 1.873 . . . . 0.0 112.717 170.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.7 -27.16 48.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.499 1.12 . . . . 0.0 112.824 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.67 -51.66 2.79 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 112.063 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.15 -2.25 54.99 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.461 -1.399 . . . . 0.0 109.433 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.25 -11.85 45.39 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -33.8 76.49 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.7 -1.25 . . . . 0.0 109.91 -166.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.51 -12.68 60.54 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 121.055 -1.028 . . . . 0.0 112.608 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.48 -32.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -69.14 -8.24 43.6 Favored 'General case' 0 C--N 1.359 1.021 0 O-C-N 121.026 -1.046 . . . . 0.0 111.483 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 48.3 ttp85 -64.73 -29.97 70.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -96.04 156.36 16.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.289 37.3 mt-10 69.91 -60.38 0.48 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.283 1.833 . . . . 0.0 112.6 -167.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.03 -17.46 62.25 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 119.123 0.874 . . . . 0.0 110.771 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -53.2 -38.48 62.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 126.391 1.877 . . . . 0.0 112.91 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -82.69 -47.56 11.88 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.09 57.0 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 CA--C 1.501 -0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 110.107 -177.734 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.48 154.73 24.96 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.45 -36.38 78.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 122.388 1.089 . . . . 0.0 110.763 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -71.02 -17.61 62.62 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.09 -1.006 . . . . 0.0 112.061 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -86.92 -38.95 16.22 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -66.82 -37.59 84.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.077 0.951 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -68.23 -36.88 80.19 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.618 -0.676 . . . . 0.0 110.34 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.62 75.4 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.035 0.934 . . . . 0.0 110.188 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -65.06 -35.99 82.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.204 1.402 . . . . 0.0 111.205 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -69.01 -30.42 68.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.849 -1.157 . . . . 0.0 110.742 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.33 75.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.063 -1.023 . . . . 0.0 110.649 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.94 -38.41 90.93 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.737 0.815 . . . . 0.0 110.516 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.58 1.152 . . . . 0.0 110.219 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.65 -41.68 98.19 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.878 0.871 . . . . 0.0 109.086 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 tp -62.97 -37.52 87.43 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.436 0.694 . . . . 0.0 111.503 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.57 -31.48 72.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.223 -0.923 . . . . 0.0 112.285 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -71.39 -35.46 71.05 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.35 -38.89 83.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 109.307 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.8 -42.39 84.14 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.24 1.019 . . . . 0.0 111.323 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.27 -44.11 65.89 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.957 0.903 . . . . 0.0 109.282 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -66.21 -39.05 89.34 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.04 72.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.191 1.396 . . . . 0.0 112.165 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.49 -43.34 73.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.493 0.717 . . . . 0.0 109.807 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -43.86 75.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.778 1.231 . . . . 0.0 108.677 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -63.91 -48.4 76.74 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.699 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.44 70.06 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 119.769 1.168 . . . . 0.0 110.818 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.74 -39.74 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.67 -30.03 59.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.779 -1.826 . . . . 0.0 110.758 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.98 -45.34 35.27 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.067 0.947 . . . . 0.0 109.752 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -22.56 60.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.507 -0.746 . . . . 0.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -68.9 98.6 0.95 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.028 0.918 . . . . 0.0 111.619 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.24 -4.41 12.42 Favored Glycine 0 CA--C 1.494 -1.251 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.75 146.36 46.25 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 121.629 -0.924 . . . . 0.0 109.088 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -80.5 131.7 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.952 1.768 . . . . 0.0 111.42 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.44 2.91 69.81 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.52 136.65 57.59 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.006 1.722 . . . . 0.0 112.42 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.63 4.31 1.93 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.35 -38.16 20.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.3 tt -5.93 88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 1 C-N-CA 133.248 4.619 . . . . 0.0 114.387 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 33.1 p -162.96 -131.3 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.79 -65.5 0.0 OUTLIER Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 127.925 2.49 . . . . 0.0 106.051 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.93 -14.03 26.47 Favored 'Trans proline' 0 CA--C 1.513 -0.574 0 CA-C-N 125.649 3.053 . . . . 0.0 111.687 -171.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -100.74 -11.36 19.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.66 64.93 Favored 'General case' 0 CA--C 1.504 -0.826 0 O-C-N 120.776 -1.203 . . . . 0.0 109.854 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.25 -7.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 125.178 1.391 . . . . 0.0 109.675 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 68' ' ' ARG . 1.2 t90 -81.84 -49.56 10.22 Favored 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 119.423 -2.048 . . . . 0.0 106.081 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -53.24 -41.68 65.66 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.791 1.636 . . . . 0.0 111.115 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.4 p -69.51 -28.84 66.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.696 -1.877 . . . . 0.0 111.683 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.46 -45.66 81.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.712 0 C-N-CA 123.699 0.799 . . . . 0.0 109.284 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.9 -9.35 57.57 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.445 -0.784 . . . . 0.0 112.006 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 72.4 m -86.14 -48.45 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 120.697 -1.252 . . . . 0.0 111.082 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.18 62.51 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.662 -1.274 . . . . 0.0 112.007 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -87.8 0.86 55.21 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.879 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.7 p 55.18 67.97 0.94 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.875 2.07 . . . . 0.0 110.904 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.83 -98.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.58 102.24 0.46 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 106.58 -2.608 . . . . 0.0 106.58 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -75.73 -33.68 60.3 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.65 39.7 2.32 Favored Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.96 -50.27 30.39 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -130.87 160.95 32.94 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.53 151.78 36.88 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 167.71 26.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.059 2.506 . . . . 0.0 111.275 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.74 -148.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -107.07 -60.35 1.69 Allowed 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.039 1.736 . . . . 0.0 107.573 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -80.13 0.61 31.42 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.352 1.461 . . . . 0.0 111.179 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -64.84 -30.13 71.12 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.845 1.307 . . . . 0.0 108.773 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.26 83.57 1.37 Allowed Glycine 0 CA--C 1.473 -2.557 1 N-CA-C 99.277 -5.529 . . . . 0.0 99.277 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttt85 -60.95 -11.24 7.39 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 122.876 1.322 . . . . 0.0 111.44 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -61.51 -12.92 17.16 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.452 1.101 . . . . 0.0 113.302 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.43 -52.59 58.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.33 97.58 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 123.168 0.587 . . . . 0.0 110.535 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.11 -50.11 38.77 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.946 1.699 . . . . 0.0 111.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.65 -40.08 95.94 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.646 0.779 . . . . 0.0 110.879 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.66 -43.39 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 123.704 0.801 . . . . 0.0 109.579 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.7 mtm -66.91 -42.83 84.77 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 121.806 -0.559 . . . . 0.0 110.621 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -65.58 -35.0 79.55 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.844 -0.535 . . . . 0.0 110.517 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.25 99.13 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.524 0.729 . . . . 0.0 110.494 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.03 81.33 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.1 -46.72 88.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 109.804 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.12 -42.01 94.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.299 -0.876 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.98 -46.94 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.24 -0.913 . . . . 0.0 110.4 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -71.12 -9.0 57.32 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 121.392 -0.817 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.32 -39.76 8.25 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.199 1.0 . . . . 0.0 109.84 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -52.1 -34.93 46.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 127.133 2.173 . . . . 0.0 110.697 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.45 -8.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 124.372 1.069 . . . . 0.0 113.833 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -68.85 -14.28 62.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 120.113 -1.617 . . . . 0.0 111.832 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.16 -27.56 65.77 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 120.748 -1.22 . . . . 0.0 111.494 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.88 -37.04 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 124.458 1.103 . . . . 0.0 109.554 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.32 -37.72 66.06 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.564 -0.71 . . . . 0.0 112.231 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.73 -21.19 63.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.57 -1.331 . . . . 0.0 111.008 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 10.9 t -96.32 11.19 35.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.842 -1.162 . . . . 0.0 108.765 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.3 -33.65 25.91 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -71.67 -32.68 68.14 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.191 -1.568 . . . . 0.0 112.865 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.8 -11.34 14.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 121.461 -0.774 . . . . 0.0 111.275 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -60.99 -19.73 61.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.033 1.333 . . . . 0.0 112.132 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -6.67 58.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.457 1.026 . . . . 0.0 110.81 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -85.02 153.22 22.88 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 72.32 -50.07 0.7 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.114 1.765 . . . . 0.0 111.436 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -61.49 -32.86 72.89 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.72 2.008 . . . . 0.0 110.708 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -58.13 -23.9 56.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.284 1.434 . . . . 0.0 113.356 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -92.92 -10.12 37.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.163 -0.96 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.09 74.17 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.364 0.983 . . . . 0.0 113.426 172.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 31.7 m80 . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.36 -94.63 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -132.89 -78.1 0.49 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.403 ' CE1' ' OE2' ' A' ' 5' ' ' GLU . 1.8 p80 -71.52 -15.83 62.31 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 123.572 0.749 . . . . 0.0 111.69 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' OE2' ' CE1' ' A' ' 4' ' ' HIS . 52.5 mp0 -63.88 -36.9 85.45 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.977 1.711 . . . . 0.0 110.137 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -77.15 -24.11 51.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.455 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -74.27 -41.65 60.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.673 1.189 . . . . 0.0 108.185 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.32 96.87 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.17 -34.07 77.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.732 1.213 . . . . 0.0 111.387 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -71.4 -39.14 71.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.371 -0.831 . . . . 0.0 108.904 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.85 78.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.532 0.733 . . . . 0.0 111.648 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -65.3 -28.35 69.26 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.05 -1.031 . . . . 0.0 111.808 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -73.81 -31.96 63.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.794 0.837 . . . . 0.0 110.06 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.04 -38.94 92.52 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 121.469 -0.769 . . . . 0.0 110.743 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.26 -41.67 84.77 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.532 0.733 . . . . 0.0 111.992 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.735 1.214 . . . . 0.0 109.633 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.31 -40.53 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.053 0.941 . . . . 0.0 109.486 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 52' ' ' ALA . 76.2 mt -58.74 -40.76 84.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 124.083 0.953 . . . . 0.0 111.906 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.25 -41.6 73.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.63 1.572 . . . . 0.0 110.066 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -67.32 -52.32 41.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.521 1.529 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.56 -29.88 63.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.484 1.114 . . . . 0.0 111.977 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -63.05 -41.69 99.55 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 119.129 0.877 . . . . 0.0 110.178 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.82 -43.55 71.8 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.872 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -67.34 -18.96 65.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 120.709 -1.244 . . . . 0.0 111.033 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.86 70.57 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.45 0.7 . . . . 0.0 110.289 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.15 -33.15 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.775 0.798 . . . . 0.0 111.768 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -28.92 61.66 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.87 68.1 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.349 1.059 . . . . 0.0 111.263 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.24 -5.95 53.46 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.462 1.105 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -105.64 71.87 0.94 Allowed 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.647 -1.908 . . . . 0.0 108.508 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.45 -42.32 0.33 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.495 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -92.74 157.94 38.86 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 123.206 0.603 . . . . 0.0 109.665 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -80.9 153.07 19.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.221 1.948 . . . . 0.0 111.121 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.33 15.93 31.18 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.207 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 131.46 50.6 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -166.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.65 -46.99 0.24 Allowed 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.554 0.741 . . . . 0.0 110.009 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.82 62.08 6.73 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 123.01 1.386 . . . . 0.0 107.902 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.9 pt -91.46 -1.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.805 -1.81 . . . . 0.0 109.5 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -89.43 127.85 35.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.469 -0.77 . . . . 0.0 110.997 -174.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -79.44 -54.64 0.95 Allowed Pre-proline 0 C--N 1.347 0.457 0 CA-C-O 116.196 -1.859 . . . . 0.0 112.73 -172.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -73.54 -12.02 24.59 Favored 'Trans proline' 0 CA--C 1.511 -0.658 0 CA-C-N 126.718 3.435 . . . . 0.0 111.813 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.12 -13.17 48.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.38 89.86 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.298 1.039 . . . . 0.0 111.59 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.92 -33.66 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.643 0.735 . . . . 0.0 109.535 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -24.76 57.74 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 119.92 -1.737 . . . . 0.0 109.572 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -69.52 -46.55 66.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.418 1.087 . . . . 0.0 108.396 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.4 p -67.35 -29.81 69.45 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.822 -1.173 . . . . 0.0 111.819 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -51.94 -50.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 124.447 1.099 . . . . 0.0 110.633 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.01 -0.3 43.64 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.488 -0.757 . . . . 0.0 111.792 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.3 m -91.62 -39.92 11.61 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 121.546 -0.721 . . . . 0.0 109.296 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -70.72 -23.83 62.52 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 120.503 -1.373 . . . . 0.0 111.357 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 p -89.35 9.29 26.67 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.473 0.709 . . . . 0.0 110.152 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 51.17 50.03 19.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.422 1.889 . . . . 0.0 112.973 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 56' ' ' GLY . 7.6 p -122.68 -77.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.484 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 73.82 95.12 0.11 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.07 -69.91 0.58 Allowed 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.666 -1.49 . . . . 0.0 109.958 -170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.8 41.57 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.75 -52.74 7.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -134.44 -175.06 3.75 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -143.06 135.78 13.63 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 101.994 -3.336 . . . . 0.0 101.994 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.8 166.2 10.14 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.026 2.484 . . . . 0.0 110.236 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 67' ' ' GLY . 17.5 m -69.41 166.07 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.603 1.192 . . . . 0.0 110.94 173.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 m -78.53 -67.77 0.71 Allowed 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.345 -0.847 . . . . 0.0 109.173 -174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -50.36 -63.5 1.1 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.586 1.555 . . . . 0.0 112.115 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.69 -67.05 0.87 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.324 -0.86 . . . . 0.0 111.412 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.612 ' H ' HG23 ' A' ' 63' ' ' VAL . . . -30.76 -46.22 0.13 Allowed Glycine 0 C--N 1.349 1.293 0 C-N-CA 129.212 3.291 . . . . 0.0 116.114 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -68.19 -51.9 40.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.105 0.952 . . . . 0.0 112.483 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.7 -25.64 68.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 119.419 1.009 . . . . 0.0 110.803 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.88 -50.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.18 85.47 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.062 1.345 . . . . 0.0 112.129 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -51.63 -39.19 57.61 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.893 1.677 . . . . 0.0 110.846 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -29.58 64.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.08 -43.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.8 mtt -58.62 -52.32 66.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.414 1.485 . . . . 0.0 109.917 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -66.04 -36.95 84.63 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.614 -0.679 . . . . 0.0 110.652 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.41 87.77 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.168 -0.958 . . . . 0.0 111.313 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.86 -48.11 75.44 Favored Glycine 0 CA--C 1.492 -1.349 0 C-N-CA 124.646 1.117 . . . . 0.0 110.903 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -43.76 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 C-N-CA 124.113 0.965 . . . . 0.0 109.257 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -61.43 -39.18 89.86 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 120.438 -1.414 . . . . 0.0 111.97 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.16 -54.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 124.41 1.084 . . . . 0.0 108.928 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.47 -40.87 93.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.82 -0.55 . . . . 0.0 110.913 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -27.15 65.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.394 -0.816 . . . . 0.0 111.522 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.82 -35.67 81.86 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.887 -1.133 . . . . 0.0 110.031 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.8 t -59.65 -14.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 125.524 1.53 . . . . 0.0 111.262 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -55.82 -23.31 29.67 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 120.066 -1.646 . . . . 0.0 111.989 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.9 -31.45 69.82 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 120.82 -1.175 . . . . 0.0 112.33 172.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 -45.44 14.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.688 -1.257 . . . . 0.0 107.789 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -62.77 -40.29 96.82 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.182 0.993 . . . . 0.0 113.297 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.36 -11.3 60.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.129 -0.982 . . . . 0.0 111.519 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 m -82.6 -22.66 34.73 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 121.022 -1.049 . . . . 0.0 108.384 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -71.08 -24.5 62.33 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 120.698 -1.252 . . . . 0.0 112.86 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -81.03 -25.33 37.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 120.85 -1.156 . . . . 0.0 111.879 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.78 -28.03 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -70.14 -5.42 26.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 112.05 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -66.57 -31.04 71.49 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.913 -1.117 . . . . 0.0 109.319 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -96.1 173.98 7.14 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -170.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.252 33.1 mt-10 74.08 -65.0 0.37 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 126.301 1.84 . . . . 0.0 109.44 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.02 -8.31 48.11 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.627 1.171 . . . . 0.0 111.872 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -71.82 -35.53 69.95 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.315 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -93.91 -26.68 16.77 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.22 -6.46 68.77 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 175.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.88 161.32 39.61 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.133 0.968 . . . . 0.0 108.752 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.25 -29.85 68.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 126.693 1.997 . . . . 0.0 111.439 -170.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -72.8 -32.26 65.42 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.92 -33.95 66.3 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 123.734 0.814 . . . . 0.0 109.026 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -58.29 -45.28 88.25 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.324 1.05 . . . . 0.0 110.582 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.22 -45.84 79.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.82 1.248 . . . . 0.0 109.051 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.5 92.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 111.567 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.84 -37.1 76.06 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.643 0.777 . . . . 0.0 109.617 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.02 -33.38 75.6 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.784 -1.198 . . . . 0.0 110.251 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.74 75.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.329 -0.857 . . . . 0.0 111.373 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.43 -31.99 73.43 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.844 0.858 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -67.99 -41.22 82.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 121.562 -0.711 . . . . 0.0 109.781 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -66.21 -28.46 68.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.593 -0.692 . . . . 0.0 111.277 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 118.42 0.554 . . . . 0.0 110.738 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -62.32 -36.11 81.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 110.683 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.37 -37.79 86.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.754 0.821 . . . . 0.0 110.741 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.43 -40.19 88.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 121.071 -1.018 . . . . 0.0 109.036 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.93 -42.96 85.92 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 123.634 0.774 . . . . 0.0 111.359 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.77 -46.17 83.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.015 1.326 . . . . 0.0 109.949 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -68.48 -41.95 79.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 122.046 -0.409 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -29.64 69.79 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.726 1.21 . . . . 0.0 111.601 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -61.58 -43.23 99.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.145 0.978 . . . . 0.0 109.491 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -38.57 81.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 124.486 1.114 . . . . 0.0 108.822 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.22 -54.01 40.28 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.108 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.03 75.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.005 1.322 . . . . 0.0 112.915 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.15 -28.18 39.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 120.683 -1.26 . . . . 0.0 113.041 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.63 -34.76 18.37 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -49.46 67.7 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.697 1.599 . . . . 0.0 110.268 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.36 -26.85 66.68 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 112.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 119.614 -1.929 . . . . 0.0 110.801 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.05 -15.14 6.53 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.63 145.33 41.58 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 118.071 0.935 . . . . 0.0 109.801 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.78 135.53 11.46 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 110.136 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 14.41 76.91 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.38 145.49 55.97 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.12 0.968 . . . . 0.0 110.605 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.89 -37.98 0.9 Allowed 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 108.943 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 44' ' ' ALA . 42.1 tp -88.84 129.98 35.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -150.26 -179.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 t 76.23 127.21 0.04 OUTLIER 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.226 1.41 . . . . 0.0 109.502 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -65.13 -46.53 73.1 Favored Pre-proline 0 C--N 1.35 0.623 0 CA-C-O 116.921 -1.514 . . . . 0.0 111.611 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 -10.54 25.15 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 124.953 2.805 . . . . 0.0 112.608 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.02 -39.13 15.93 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.45 ' HA ' HD11 ' B' ' 38' ' ' LEU . . . -64.08 -36.47 84.11 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 123.416 0.686 . . . . 0.0 112.581 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -68.79 -29.19 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 O-C-N 122.03 -0.419 . . . . 0.0 110.08 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -38.22 70.41 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.755 -1.216 . . . . 0.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 57.9 t90 -68.09 -38.29 82.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.679 0.752 . . . . 0.0 109.368 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -59.27 -47.77 84.11 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.013 1.325 . . . . 0.0 110.191 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -54.51 -52.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 125.486 1.514 . . . . 0.0 111.099 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.96 -24.46 63.34 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 121.349 -0.844 . . . . 0.0 111.836 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -76.03 -33.59 59.64 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 123.897 0.879 . . . . 0.0 109.393 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.23 -24.61 65.84 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 120.964 -1.085 . . . . 0.0 111.693 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -92.92 10.41 31.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.542 0.737 . . . . 0.0 111.499 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 p 51.23 53.86 12.18 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 125.675 1.59 . . . . 0.0 112.838 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.56 -87.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.92 74.61 1.2 Allowed Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.53 -21.64 60.33 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 120.781 -1.423 . . . . 0.0 109.756 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.62 40.84 1.82 Allowed Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.26 -29.51 26.39 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 120.884 -1.362 . . . . 0.0 111.25 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.428 ' HG3' HD13 ' B' ' 38' ' ' LEU . 85.7 mmt-85 -144.41 166.89 23.84 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -143.03 115.14 5.94 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.67 161.16 16.6 Favored 'Trans proline' 0 CA--C 1.512 -0.617 0 C-N-CA 122.527 2.151 . . . . 0.0 110.15 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.05 -159.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.742 1.258 . . . . 0.0 110.769 -173.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -86.7 -36.22 18.83 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 119.734 -1.853 . . . . 0.0 110.612 -165.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.63 -15.87 41.07 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.486 1.114 . . . . 0.0 109.499 -167.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -28.77 69.91 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 123.478 1.609 . . . . 0.0 107.417 172.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.17 82.39 1.25 Allowed Glycine 0 CA--C 1.464 -3.152 1 N-CA-C 99.974 -5.25 . . . . 0.0 99.974 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm105 -66.97 3.93 0.98 Allowed 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.643 1.222 . . . . 0.0 112.999 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.14 -12.9 56.02 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 120.987 -1.071 . . . . 0.0 111.895 160.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -50.18 79.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.63 92.79 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.01 0.924 . . . . 0.0 111.701 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -53.95 -42.04 68.43 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.157 1.383 . . . . 0.0 110.623 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -63.76 -40.45 96.74 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.755 -0.591 . . . . 0.0 110.851 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.42 -49.02 80.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.018 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -69.92 -40.86 75.3 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 121.949 -0.469 . . . . 0.0 110.516 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -64.65 -41.59 96.02 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.324 -0.86 . . . . 0.0 109.725 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.94 85.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 122.028 -0.42 . . . . 0.0 111.388 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.34 -47.65 77.4 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.76 -45.18 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.778 1.231 . . . . 0.0 109.006 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.61 -44.21 80.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.112 -0.993 . . . . 0.0 111.357 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.86 -52.49 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.071 0.949 . . . . 0.0 109.599 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -72.19 -18.19 61.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.924 0.489 . . . . 0.0 111.492 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.78 -31.54 16.48 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.08 -31.85 73.19 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 120.38 -1.45 . . . . 0.0 110.018 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.48 -11.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 123.378 0.671 . . . . 0.0 112.098 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 22.8 m -60.35 -15.79 29.06 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.95 1.3 . . . . 0.0 111.426 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.53 -50.55 69.69 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.215 166.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.37 92.63 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 124.609 1.164 . . . . 0.0 110.272 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.03 -39.97 95.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 120.873 -1.142 . . . . 0.0 111.071 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 -15.74 60.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.677 -0.639 . . . . 0.0 110.701 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.4 m -83.25 -32.94 26.17 Favored 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 121.0 -1.062 . . . . 0.0 108.167 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.08 -11.45 59.99 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 111.801 -156.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -72.77 -31.93 65.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 121.387 -0.821 . . . . 0.0 110.299 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 t -74.08 -24.32 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.475 1.51 . . . . 0.0 109.047 -170.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -51.36 -31.91 23.85 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 124.851 1.26 . . . . 0.0 110.184 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -53.93 -31.8 51.5 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.98 1.312 . . . . 0.0 112.56 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -78.24 -19.56 53.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 120.806 -1.184 . . . . 0.0 111.283 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.92 -55.15 3.74 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 165.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -68.43 -34.32 75.78 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.226 2.21 . . . . 0.0 114.853 -163.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 27.4 ttm105 -57.31 -38.65 74.34 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 120.369 1.44 . . . . 0.0 110.969 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -103.85 3.48 33.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.966 0.907 . . . . 0.0 108.813 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.6 12.68 64.54 Favored Glycine 0 C--N 1.347 1.175 0 C-N-CA 124.981 1.277 . . . . 0.0 112.524 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 CA--C 1.496 -1.132 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.112 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.428 -1.548 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.6 128.0 46.12 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.974 0.892 . . . . 0.0 110.438 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -75.15 -26.9 59.47 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.189 0.995 . . . . 0.0 109.242 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.525 ' CD2' ' HA ' ' C' ' 88' ' ' ALA . 5.1 p-80 -67.3 -29.57 69.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.477 -0.764 . . . . 0.0 110.928 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.05 -37.6 46.42 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -57.32 -43.81 83.65 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.693 0.797 . . . . 0.0 111.941 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.57 -24.42 53.53 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.624 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.1 93.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.917 -1.114 . . . . 0.0 110.209 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -65.05 -37.11 86.5 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.659 -0.651 . . . . 0.0 111.225 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -62.44 -35.65 79.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.791 1.236 . . . . 0.0 110.261 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.96 82.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.783 0.833 . . . . 0.0 111.482 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -60.97 -37.79 83.65 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -63.38 -39.48 94.63 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.913 0.885 . . . . 0.0 110.018 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -67.69 -35.9 79.67 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.005 0.922 . . . . 0.0 109.469 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 19.7 tp -65.4 -37.76 87.95 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.229 1.014 . . . . 0.0 110.624 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.74 -21.67 61.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 120.879 -1.138 . . . . 0.0 111.635 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -69.81 -47.2 63.71 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.554 0.742 . . . . 0.0 109.624 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.45 -25.63 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.381 -0.824 . . . . 0.0 110.43 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' C' ' 52' ' ' ALA . 50.8 mt -62.84 -40.66 98.14 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 123.405 0.682 . . . . 0.0 111.059 172.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.91 -47.11 86.41 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.392 0.997 . . . . 0.0 110.229 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -58.86 -55.11 39.38 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.33 83.24 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 125.964 1.706 . . . . 0.0 112.014 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 60.7 m -54.57 -51.2 65.99 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 124.367 1.067 . . . . 0.0 110.066 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -82.63 -35.66 26.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 121.905 -0.497 . . . . 0.0 110.566 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -63.57 -35.12 79.44 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.815 -1.178 . . . . 0.0 109.986 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.53 72.62 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.404 1.081 . . . . 0.0 111.887 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -34.92 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.688 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.42 -18.98 25.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.181 -0.949 . . . . 0.0 108.638 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -28.24 60.99 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.46 -0.775 . . . . 0.0 111.04 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -33.97 57.22 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -70.65 89.73 0.74 Allowed 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 125.972 1.709 . . . . 0.0 110.591 -167.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.24 2.03 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.61 155.11 56.54 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 153.94 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.119 1.879 . . . . 0.0 109.383 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.91 30.63 57.32 Favored Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -36.0 141.44 0.1 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 129.057 2.943 . . . . 0.0 113.493 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -115.51 0.17 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -164.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.403 ' H ' HD13 ' C' ' 38' ' ' LEU . 0.0 OUTLIER -75.79 153.49 36.9 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 19.0 pt -136.23 -158.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -62.21 -169.8 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.508 2.723 . . . . 0.0 111.482 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.417 ' HB3' ' HD2' ' C' ' 42' ' ' PRO . 4.0 m-85 81.38 -178.23 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' C' ' 41' ' ' TYR . 12.7 Cg_endo -74.54 9.24 1.94 Allowed 'Trans proline' 0 CA--C 1.517 -0.35 0 CA-C-N 125.645 3.052 . . . . 0.0 112.262 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.68 -35.81 60.26 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.169 0.988 . . . . 0.0 109.061 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.33 -47.56 72.36 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 125.503 1.521 . . . . 0.0 112.727 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.425 HG22 ' H ' ' C' ' 45' ' ' ILE . 9.3 tt -74.92 -26.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.142 -174.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -39.57 82.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.056 -1.028 . . . . 0.0 110.093 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -71.57 -35.45 70.58 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 118.661 0.664 . . . . 0.0 110.191 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -59.59 -39.21 83.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.823 -1.173 . . . . 0.0 110.048 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.04 68.43 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.019 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.501 ' HB3' HH12 ' D' ' 68' ' ' ARG . 21.4 pt-20 -164.05 -39.48 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -66.28 -41.03 90.41 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.104 0.962 . . . . 0.0 110.653 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -69.51 -24.0 63.69 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 120.929 -1.107 . . . . 0.0 112.358 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.96 -1.2 57.39 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 121.448 -0.783 . . . . 0.0 109.483 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.8 p 52.25 49.43 20.56 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.302 1.841 . . . . 0.0 112.307 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.42 82.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.54 98.33 1.99 Allowed Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -79.28 -21.36 46.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.309 1.052 . . . . 0.0 108.307 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.91 39.76 1.14 Allowed Glycine 0 CA--C 1.483 -1.951 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.488 ' HB2' HH21 ' D' ' 68' ' ' ARG . 40.7 t0 -84.74 -50.34 7.69 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -131.92 -155.82 0.71 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 107.509 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.99 153.37 15.44 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 101.692 -3.447 . . . . 0.0 101.692 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -89.71 -177.36 1.41 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 123.392 2.728 . . . . 0.0 108.73 169.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.39 -167.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 119.81 1.186 . . . . 0.0 108.813 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.46 -56.46 2.18 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.158 0.983 . . . . 0.0 109.806 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.65 -41.33 77.02 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.258 -0.902 . . . . 0.0 112.313 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.52 -138.45 0.19 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 100.686 -3.82 . . . . 0.0 100.686 162.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.21 -73.35 1.09 Allowed Glycine 0 CA--C 1.492 -1.381 0 CA-C-N 120.454 1.479 . . . . 0.0 109.447 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -32.42 68.09 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 125.343 1.457 . . . . 0.0 110.295 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -69.97 -33.45 72.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.8 t -73.42 -47.49 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.89 76.6 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.453 1.501 . . . . 0.0 112.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -48.07 -47.05 34.18 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 126.979 2.112 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.7 -33.13 75.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.012 1.325 . . . . 0.0 110.735 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.65 -42.25 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.347 1.059 . . . . 0.0 109.416 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -60.18 -45.12 94.22 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.691 -0.63 . . . . 0.0 109.943 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -55.01 -50.09 69.89 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.316 1.446 . . . . 0.0 110.98 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -32.17 72.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.473 1.109 . . . . 0.0 110.835 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.72 -47.96 18.78 Favored Glycine 0 CA--C 1.491 -1.435 0 O-C-N 121.779 -0.576 . . . . 0.0 111.784 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.7 -41.14 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 122.068 -0.666 . . . . 0.0 110.084 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.68 -29.81 68.35 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 120.505 -1.372 . . . . 0.0 112.089 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 t -69.36 -49.17 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -73.49 -12.71 60.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 121.52 -0.737 . . . . 0.0 111.201 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.85 -53.94 7.24 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -50.88 -42.14 58.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.452 2.301 . . . . 0.0 112.939 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 m -60.51 -19.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 112.248 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 4.9 m -69.29 -13.39 62.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.919 -1.113 . . . . 0.0 110.647 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.92 68.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.805 -1.81 . . . . 0.0 111.075 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.525 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -74.76 -47.16 32.6 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 120.725 -1.234 . . . . 0.0 108.661 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.44 -31.18 66.91 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.13 0.972 . . . . 0.0 110.777 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.13 64.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.799 -1.188 . . . . 0.0 111.562 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 10.3 t -94.31 1.39 55.93 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.838 -1.163 . . . . 0.0 108.865 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -26.8 58.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 120.341 1.428 . . . . 0.0 110.055 -176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -69.9 -38.9 76.46 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.716 -1.24 . . . . 0.0 109.521 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.09 -25.0 37.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 125.533 1.533 . . . . 0.0 110.643 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -57.08 -24.6 55.12 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.114 1.366 . . . . 0.0 112.678 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -58.31 -31.82 67.88 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 121.138 -0.976 . . . . 0.0 111.628 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -77.33 -15.28 59.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 121.756 -0.59 . . . . 0.0 109.821 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -85.86 -42.88 13.73 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.76 -37.32 86.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -74.98 -14.96 60.68 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.73 -1.231 . . . . 0.0 112.428 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -89.39 -25.15 21.7 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.021 -1.049 . . . . 0.0 108.956 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.24 32.23 48.91 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 73.4 m80 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -178.524 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.35 68.92 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 122.607 0.363 . . . . 0.0 111.911 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -173.71 -120.8 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.056 1 N-CA-C 99.641 -4.207 . . . . 0.0 99.641 -157.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 28.4 p-80 -53.17 -21.58 5.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 129.052 2.941 . . . . 0.0 114.521 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.8 -31.72 71.09 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.857 0.863 . . . . 0.0 111.007 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -68.67 -43.22 76.62 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.946 -1.096 . . . . 0.0 109.951 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.5 -32.05 69.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.86 -46.56 90.09 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.562 0.745 . . . . 0.0 111.457 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.62 -31.98 73.02 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 121.645 -0.659 . . . . 0.0 111.778 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -69.78 -35.65 75.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.479 -0.763 . . . . 0.0 109.438 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.91 82.27 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.941 -1.099 . . . . 0.0 111.353 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.8 -20.79 62.54 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.784 -1.198 . . . . 0.0 112.064 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -74.16 -39.28 63.36 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.031 1.332 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -64.38 -34.83 79.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.254 1.822 . . . . 0.0 110.257 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.94 -41.29 91.51 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 121.895 -0.503 . . . . 0.0 110.311 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.44 -32.75 74.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.308 0.643 . . . . 0.0 110.924 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -64.65 -42.68 95.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.237 1.415 . . . . 0.0 110.904 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.0 -25.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 O-C-N 121.079 -1.013 . . . . 0.0 110.568 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -60.57 -47.98 83.79 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-N 119.361 0.982 . . . . 0.0 109.771 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -61.61 -46.52 89.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.556 0.742 . . . . 0.0 111.137 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -74.39 -34.74 63.4 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.442 -0.786 . . . . 0.0 109.402 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.84 73.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 120.314 -1.491 . . . . 0.0 111.923 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -61.9 -41.75 98.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.413 1.085 . . . . 0.0 110.926 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -69.14 -38.16 78.67 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.56 -53.89 44.63 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.733 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -47.74 74.27 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.181 1.392 . . . . 0.0 112.549 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.495 HG22 HH21 ' D' ' 31' ' ' ARG . 11.2 p -71.13 -26.29 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 120.527 -1.358 . . . . 0.0 111.523 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -89.96 -28.09 19.37 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 109.02 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.92 -55.68 7.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.17 2.588 . . . . 0.0 108.797 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.41 -26.1 68.3 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.95 1.3 . . . . 0.0 111.527 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . 0.495 HH21 HG22 ' D' ' 27' ' ' VAL . 6.8 tpp180 -69.01 104.85 2.22 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 120.035 -1.666 . . . . 0.0 109.876 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.04 -7.8 29.2 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.0 140.26 29.08 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.26 134.46 5.89 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.308 2.005 . . . . 0.0 110.634 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.86 0.46 66.33 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.16 115.48 6.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 125.976 1.71 . . . . 0.0 108.518 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.49 -26.89 13.96 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.23 104.18 16.14 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -148.14 70.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 120.218 -1.551 . . . . 0.0 109.333 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -167.61 157.61 10.59 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -77.18 -50.99 2.11 Favored Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 115.774 -2.06 . . . . 0.0 110.84 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.01 -15.96 36.35 Favored 'Trans proline' 0 CA--C 1.512 -0.575 0 CA-C-N 126.063 3.201 . . . . 0.0 111.396 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -82.26 -36.61 26.94 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.43 90.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.034 0.933 . . . . 0.0 111.999 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tp -72.85 -21.45 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.503 1.144 . . . . 0.0 109.906 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -40.1 25.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 120.266 -1.521 . . . . 0.0 109.311 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -65.0 -35.99 82.98 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.931 1.292 . . . . 0.0 110.64 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -86.27 62.14 7.25 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 120.29 -1.506 . . . . 0.0 109.51 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.84 -61.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -30.17 69.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-N 119.236 0.925 . . . . 0.0 110.62 -167.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -57.12 -35.31 69.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 125.617 1.567 . . . . 0.0 111.077 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.15 -25.26 55.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 119.869 -1.769 . . . . 0.0 110.697 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.67 -0.75 39.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.443 1.497 . . . . 0.0 108.404 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . 0.265 4.1 p 60.72 47.95 7.59 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.007 2.123 . . . . 0.0 111.437 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.2 152.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 99.035 -4.432 . . . . 0.0 99.035 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.6 110.08 0.51 Allowed Glycine 0 CA--C 1.472 -2.645 1 N-CA-C 99.61 -5.396 . . . . 0.0 99.61 176.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -37.78 64.1 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 45.83 0.21 Allowed Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 168.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.9 -48.95 50.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 117.3 0.55 . . . . 0.0 110.463 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -137.7 177.45 7.86 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -149.05 140.65 14.45 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.95 -175.36 2.63 Favored 'Trans proline' 0 CA--C 1.516 -0.382 0 C-N-CA 124.627 3.552 . . . . 0.0 110.311 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.444 HG12 ' H ' ' D' ' 64' ' ' THR . 0.6 OUTLIER -134.78 -157.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.444 ' H ' HG12 ' D' ' 63' ' ' VAL . 1.8 p -77.46 -49.93 13.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 127.618 2.367 . . . . 0.0 109.368 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -85.67 -13.95 46.98 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.846 1.258 . . . . 0.0 111.193 -162.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -22.15 62.75 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.443 1.592 . . . . 0.0 107.484 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.27 54.03 2.51 Favored Glycine 0 CA--C 1.464 -3.104 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.501 HH12 ' HB3' ' C' ' 50' ' ' GLU . 62.0 ttt-85 -20.53 -28.13 0.0 OUTLIER 'General case' 0 C--N 1.368 1.386 1 C-N-CA 134.509 5.124 . . . . 0.0 117.392 -175.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -61.98 2.04 0.25 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.584 1.954 . . . . 0.0 113.263 166.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -70.96 -47.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 168.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.687 0.795 . . . . 0.0 110.516 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.57 -44.52 69.4 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 124.658 1.183 . . . . 0.0 111.036 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -61.52 -44.5 96.95 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.61 -44.91 82.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 121.76 -0.588 . . . . 0.0 109.774 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 70.6 mtm -61.92 -47.69 83.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.84 -31.63 68.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.076 -1.015 . . . . 0.0 111.355 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.28 81.32 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.154 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.63 96.62 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 123.551 0.596 . . . . 0.0 111.748 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.7 mt -57.9 -49.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.789 0 C-N-CA 124.22 1.008 . . . . 0.0 109.599 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.94 -45.34 71.21 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.019 1.328 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.77 -57.0 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 124.695 1.198 . . . . 0.0 109.384 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -68.17 -34.74 76.87 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 121.64 -0.663 . . . . 0.0 110.669 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.73 78.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 110.637 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.94 -36.09 82.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.866 -1.146 . . . . 0.0 110.474 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.58 -10.86 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.042 1.337 . . . . 0.0 110.947 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -58.65 -21.12 53.19 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.665 -1.897 . . . . 0.0 111.015 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.33 68.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 120.314 -1.491 . . . . 0.0 112.525 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.641 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.11 -47.86 22.86 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.22 -32.62 74.15 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.883 0.849 . . . . 0.0 112.022 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.93 -11.84 60.97 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.323 -1.486 . . . . 0.0 111.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.427 HG21 ' CE1' ' D' ' 4' ' ' HIS . 62.6 p -82.93 -19.06 37.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 120.391 -1.443 . . . . 0.0 109.748 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.05 -34.19 77.16 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.987 0.812 . . . . 0.0 111.14 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -77.88 -18.1 56.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.626 -1.296 . . . . 0.0 111.479 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -81.45 -30.08 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -57.13 -23.53 47.82 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 124.909 1.284 . . . . 0.0 111.213 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -59.86 -25.95 65.46 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.242 1.017 . . . . 0.0 112.178 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.418 ' CG ' ' HE ' ' D' ' 100' ' ' ARG . 8.5 tt0 -75.14 -22.06 58.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 120.83 -1.169 . . . . 0.0 110.509 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -88.65 -26.24 21.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.373 -0.829 . . . . 0.0 109.793 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.25 -43.9 96.72 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.452 -0.78 . . . . 0.0 110.1 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.418 ' HE ' ' CG ' ' D' ' 97' ' ' GLU . 44.3 ptt85 -70.16 -19.14 63.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.872 -0.518 . . . . 0.0 112.356 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -73.38 -47.56 41.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.44 41.78 5.04 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 106.749 -2.541 . . . . 0.0 106.749 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 t60 . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 159.87 25.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 120.82 -1.175 . . . . 0.0 108.896 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 4' ' ' HIS . 6.9 p-10 -66.24 -43.35 86.83 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.961 1.704 . . . . 0.0 108.815 -175.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' CD2' ' OD2' ' A' ' 3' ' ' ASP . 57.0 m170 -69.7 -31.07 68.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.355 -0.841 . . . . 0.0 111.75 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.39 -43.58 60.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -66.09 -44.59 83.97 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.081 0.952 . . . . 0.0 110.243 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -66.57 -36.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.901 0.858 . . . . 0.0 110.771 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.84 -43.49 79.41 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 121.162 -0.961 . . . . 0.0 110.367 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -69.83 -31.22 68.97 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.1 0.56 . . . . 0.0 110.348 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -59.45 -40.84 88.14 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.743 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.73 -33.84 75.67 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.715 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.47 -34.24 77.32 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.571 -0.706 . . . . 0.0 111.504 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -60.78 -45.99 92.22 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.133 0.973 . . . . 0.0 109.854 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.53 -34.33 77.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.265 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.78 -35.23 77.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.385 -0.822 . . . . 0.0 111.1 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.13 -36.03 66.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 121.508 -0.745 . . . . 0.0 110.537 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.74 -45.56 93.8 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.498 1.119 . . . . 0.0 110.987 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.04 -20.19 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 O-C-N 121.254 -0.904 . . . . 0.0 111.238 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.29 -41.66 96.77 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 119.435 1.016 . . . . 0.0 110.194 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.68 -26.52 59.9 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.378 1.071 . . . . 0.0 110.328 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -79.52 -41.41 27.4 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 120.483 -1.386 . . . . 0.0 108.51 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.55 69.93 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.102 1.361 . . . . 0.0 111.903 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 45' ' ' ILE . 12.1 p -66.24 -50.54 63.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 119.224 0.92 . . . . 0.0 109.563 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -63.31 -47.15 83.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.363 1.865 . . . . 0.0 109.044 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.5 -32.61 71.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.313 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.21 50.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 119.942 1.247 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.19 -38.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 121.759 0.79 . . . . 0.0 109.58 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.24 -33.74 70.13 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.966 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.19 94.59 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.504 1.122 . . . . 0.0 111.169 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.93 -14.0 54.97 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.933 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -74.11 73.84 1.74 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.055 0.931 . . . . 0.0 111.049 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.73 23.92 0.69 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.274 -1.931 . . . . 0.0 108.274 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.49 142.58 43.45 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -77.86 121.63 5.52 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.936 2.424 . . . . 0.0 110.662 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.23 22.9 6.28 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.58 149.77 20.66 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 126.119 1.768 . . . . 0.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.77 -65.81 0.51 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.244 0.618 . . . . 0.0 111.706 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.56 55.91 3.38 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.591 1.186 . . . . 0.0 108.703 -171.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 tt -72.96 -13.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 125.979 1.712 . . . . 0.0 111.016 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.3 m -90.9 126.92 36.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.061 -1.024 . . . . 0.0 109.448 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.95 -51.21 80.98 Favored Pre-proline 0 C--N 1.349 0.558 0 CA-C-O 116.219 -1.848 . . . . 0.0 113.939 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.64 -8.83 23.13 Favored 'Trans proline' 0 CA--C 1.514 -0.482 0 CA-C-N 126.003 3.18 . . . . 0.0 111.932 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.68 -35.38 14.22 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.579 1.152 . . . . 0.0 108.136 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.29 88.14 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.618 1.567 . . . . 0.0 110.651 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 19.8 tt -66.33 -29.78 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.784 -0.573 . . . . 0.0 111.941 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -27.39 56.91 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.937 -1.102 . . . . 0.0 109.75 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -72.18 -38.85 69.01 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -55.41 -35.38 65.3 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.67 -0.644 . . . . 0.0 111.964 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.42 -39.09 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 110.261 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -80.28 -15.96 55.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.378 -0.826 . . . . 0.0 112.268 -168.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -97.2 -31.06 12.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 110.267 -173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -23.04 62.39 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.04 -1.038 . . . . 0.0 111.701 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 p -84.35 -2.75 57.59 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.424 1.09 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 53.27 65.37 1.54 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 126.067 1.747 . . . . 0.0 112.18 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.47 -84.41 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.75 76.85 1.27 Allowed Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.95 -49.14 16.19 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.1 -122.56 1.18 Allowed Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 104.053 -3.619 . . . . 0.0 104.053 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.547 ' HB3' HH12 ' B' ' 68' ' ' ARG 0.287 8.8 t0 62.95 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.428 1.891 . . . . 0.0 111.211 -169.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.79 -176.95 3.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -156.13 147.12 16.46 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.24 177.55 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.268 2.646 . . . . 0.0 110.199 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.81 170.57 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.27 1.428 . . . . 0.0 107.92 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -62.31 1.69 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.122 2.169 . . . . 0.0 112.47 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.7 -40.9 80.56 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.093 0.957 . . . . 0.0 112.451 -165.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.96 -108.75 0.34 Allowed 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.53 -83.01 0.0 OUTLIER Glycine 0 C--N 1.358 1.79 0 C-N-CA 128.239 2.828 . . . . 0.0 114.53 171.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 68' ' ' ARG . 57.5 ttm-85 -54.79 -44.16 73.49 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.046 2.538 . . . . 0.0 112.439 174.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.98 -30.05 63.51 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.214 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.82 -45.1 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.49 78.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.837 2.055 . . . . 0.0 112.041 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -51.7 -44.44 63.17 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 109.736 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -72.33 -30.27 64.59 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.15 -47.89 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.62 -37.28 82.27 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.97 -38.11 87.3 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.505 -0.747 . . . . 0.0 111.08 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.45 -28.21 69.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.655 0.782 . . . . 0.0 111.385 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.52 -42.59 11.38 Favored Glycine 0 CA--C 1.49 -1.484 0 C-N-CA 124.709 1.147 . . . . 0.0 110.722 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.7 -47.84 81.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 124.678 1.191 . . . . 0.0 109.198 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -69.16 -25.71 64.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.317 -0.865 . . . . 0.0 111.916 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.47 -51.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.178 -0.951 . . . . 0.0 108.526 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.25 -26.03 66.37 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.48 -0.762 . . . . 0.0 111.231 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.57 48.59 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.023 0.929 . . . . 0.0 110.506 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.75 -39.12 87.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 124.803 1.241 . . . . 0.0 111.246 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.72 -6.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 121.366 -0.834 . . . . 0.0 112.679 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -60.31 -20.29 58.63 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.815 1.246 . . . . 0.0 110.682 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.11 78.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.345 -1.472 . . . . 0.0 112.688 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.18 -45.38 60.61 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.39 -37.63 88.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.562 0.745 . . . . 0.0 110.99 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.41 97.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.867 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -15.99 41.03 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.68 -1.263 . . . . 0.0 113.191 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.96 -17.1 60.6 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 111.853 -172.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -77.94 -24.71 48.12 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.239 -1.538 . . . . 0.0 110.734 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.72 -39.57 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -61.86 -20.89 64.18 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 125.18 1.392 . . . . 0.0 112.414 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttp85 -58.81 -22.35 58.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 125.005 1.322 . . . . 0.0 111.896 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -67.14 -29.0 68.6 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.07 -1.644 . . . . 0.0 111.5 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -73.3 -36.37 66.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.303 -0.873 . . . . 0.0 109.621 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -68.56 -29.17 67.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.124 1.37 . . . . 0.0 110.095 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -73.54 -33.69 64.84 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.028 1.331 . . . . 0.0 110.434 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -75.96 -36.22 59.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.532 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.67 38.05 8.35 Favored Glycine 0 CA--C 1.493 -1.307 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.582 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.44 135.16 34.95 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -30.38 71.47 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.184 0.992 . . . . 0.0 111.175 -174.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.468 ' CE1' ' OE1' ' B' ' 5' ' ' GLU . 7.7 p80 -59.91 -28.6 67.73 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.451 1.1 . . . . 0.0 112.413 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.468 ' OE1' ' CE1' ' B' ' 4' ' ' HIS . 9.3 tp10 -80.5 -34.61 35.59 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -167.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -71.34 -37.2 71.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.169 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -60.7 -43.07 98.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.931 1.692 . . . . 0.0 110.076 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.8 -45.42 82.42 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.351 1.06 . . . . 0.0 110.994 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.04 -37.43 87.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.436 1.094 . . . . 0.0 110.996 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.51 -33.48 75.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.382 1.473 . . . . 0.0 110.917 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.72 -37.93 79.84 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.663 -1.273 . . . . 0.0 110.072 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.17 -30.45 71.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.65 -38.39 90.12 Favored 'General case' 0 C--N 1.357 0.906 0 O-C-N 121.223 -0.923 . . . . 0.0 110.865 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -67.74 -36.25 80.22 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 121.627 -0.67 . . . . 0.0 109.795 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -61.61 -40.55 95.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.628 -0.67 . . . . 0.0 110.669 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.21 -27.24 67.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.361 -0.837 . . . . 0.0 111.989 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.63 -39.64 73.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.79 -38.9 83.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 124.426 1.09 . . . . 0.0 109.421 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -42.11 76.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.236 1.014 . . . . 0.0 112.301 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.86 -43.88 67.54 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.46 -33.17 73.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.101 -1.0 . . . . 0.0 111.394 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.73 -32.69 72.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.049 1.339 . . . . 0.0 110.993 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.0 p -66.83 -41.98 86.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -64.63 -45.37 87.13 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.98 1.312 . . . . 0.0 108.646 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -60.82 -58.16 9.63 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 109.807 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.72 79.9 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.824 1.249 . . . . 0.0 112.858 -172.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.57 -49.57 81.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 CA-C-N 118.814 0.734 . . . . 0.0 109.495 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -76.27 -25.11 54.61 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.504 0.669 . . . . 0.0 109.644 -170.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 125.544 1.538 . . . . 0.0 110.159 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.18 -12.66 60.13 Favored 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.025 -1.047 . . . . 0.0 113.128 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.83 77.68 1.6 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.557 -1.339 . . . . 0.0 110.986 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.04 -19.62 1.58 Allowed Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.41 140.95 45.2 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 121.248 -1.148 . . . . 0.0 109.911 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.62 151.25 25.15 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 122.11 1.873 . . . . 0.0 109.131 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.59 16.37 79.07 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 119.179 0.899 . . . . 0.0 112.19 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.53 142.93 57.72 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.355 1.862 . . . . 0.0 110.61 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.72 -25.12 0.32 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.324 0.583 . . . . 0.0 110.702 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.25 -38.14 66.09 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.535 1.534 . . . . 0.0 108.512 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -37.85 115.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 130.169 3.388 . . . . 0.0 111.854 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 47.1 t -177.88 -152.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 99.975 -4.083 . . . . 0.0 99.975 -168.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.26 -56.62 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -69.73 -31.3 20.93 Favored 'Trans proline' 0 CA--C 1.503 -1.034 0 CA-C-N 124.416 2.613 . . . . 0.0 111.404 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -107.77 14.51 25.44 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 119.757 1.162 . . . . 0.0 110.148 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.22 -35.37 73.84 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.404 -0.81 . . . . 0.0 109.336 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -28.2 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 123.814 0.845 . . . . 0.0 109.764 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -34.03 76.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 120.255 -1.528 . . . . 0.0 110.896 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -68.5 -42.76 78.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.685 0.794 . . . . 0.0 109.581 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.6 p -68.38 -28.37 67.05 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.395 -1.441 . . . . 0.0 111.376 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.08 -53.94 24.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 124.568 1.147 . . . . 0.0 110.737 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -73.82 -21.05 60.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.358 -0.838 . . . . 0.0 111.98 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.0 m -72.22 -39.56 68.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.46 67.48 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.371 -0.831 . . . . 0.0 111.727 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 4.37 44.82 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.943 -0.473 . . . . 0.0 110.918 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 24.2 p 55.67 56.58 6.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.273 1.429 . . . . 0.0 112.547 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 55.1 t -121.27 -93.29 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 101.972 -3.344 . . . . 0.0 101.972 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.03 82.98 1.1 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -174.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -73.9 -24.7 59.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.425 -1.044 . . . . 0.0 111.562 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.42 38.58 0.91 Allowed Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -82.32 -60.89 2.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.47 153.99 43.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.7 146.85 36.89 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 161.87 17.28 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.868 2.378 . . . . 0.0 108.797 164.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.18 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 119.465 1.029 . . . . 0.0 108.539 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -114.74 -36.63 4.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.68 1.229 . . . . 0.0 109.054 -172.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.95 -3.63 57.14 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 121.361 -0.837 . . . . 0.0 109.385 -166.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -26.26 60.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 77.11 1.32 Allowed Glycine 0 CA--C 1.471 -2.705 1 N-CA-C 101.445 -4.662 . . . . 0.0 101.445 173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.547 HH12 ' HB3' ' A' ' 59' ' ' ASP . 21.0 ttm180 -53.52 -7.9 0.12 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 128.401 2.68 . . . . 0.0 114.263 -170.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -53.14 -19.98 3.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 120.716 -1.24 . . . . 0.0 113.276 157.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.17 -52.04 63.75 Favored 'Isoleucine or valine' 0 C--N 1.363 1.16 0 CA-C-N 120.464 1.484 . . . . 0.0 107.644 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.78 77.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 O-C-N 121.681 -0.637 . . . . 0.0 109.642 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.06 -46.98 75.42 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.232 1.013 . . . . 0.0 110.553 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.96 -44.04 91.41 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 124.899 1.28 . . . . 0.0 111.094 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.1 -44.16 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.367 0.667 . . . . 0.0 109.969 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.0 mtm -63.16 -46.54 86.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.346 0.593 . . . . 0.0 109.823 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -61.31 -41.51 97.12 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.063 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.13 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.765 0.826 . . . . 0.0 111.033 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.46 -48.17 76.44 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.87 -43.35 91.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 C-N-CA 124.47 1.108 . . . . 0.0 110.206 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.25 -40.9 94.63 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.118 -0.989 . . . . 0.0 111.684 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.9 -47.63 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.26 -11.15 60.76 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 121.562 -0.711 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.76 -42.3 12.7 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.835 -1.166 . . . . 0.0 109.144 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.53 -36.69 74.25 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 126.112 1.765 . . . . 0.0 111.04 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.64 -7.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 112.498 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.6 m -63.65 -16.86 62.1 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.314 -1.492 . . . . 0.0 110.985 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.45 -19.34 63.4 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.52 -1.987 . . . . 0.0 111.751 169.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.08 -54.48 4.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.124 1.37 . . . . 0.0 108.705 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.69 -36.34 70.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.468 -0.77 . . . . 0.0 112.533 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.14 -17.2 61.41 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 119.834 -1.791 . . . . 0.0 110.2 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -87.41 -2.27 58.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.729 -1.232 . . . . 0.0 109.36 175.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.02 -31.45 67.94 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 120.674 1.579 . . . . 0.0 111.302 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -72.94 -25.71 61.13 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.84 -1.163 . . . . 0.0 111.22 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.64 -32.5 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -63.37 -26.1 68.6 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.294 1.038 . . . . 0.0 111.552 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -50.57 -39.77 50.42 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.283 1.433 . . . . 0.0 111.438 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.38 -34.37 77.14 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 120.926 -1.109 . . . . 0.0 112.128 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.64 -35.81 57.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.82 -31.71 73.07 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.607 1.163 . . . . 0.0 111.199 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -63.67 -34.08 77.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.2 1.4 . . . . 0.0 111.579 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.2 -14.41 33.52 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.638 -0.664 . . . . 0.0 109.384 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.0 14.64 66.64 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 CA--C 1.508 -0.67 0 C-N-CA 124.644 1.178 . . . . 0.0 113.002 -179.292 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.7 106.63 17.11 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 171.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 24.13 -78.8 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 130.528 3.531 . . . . 0.0 116.046 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -52.39 -29.8 25.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.365 1.466 . . . . 0.0 113.769 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.82 -25.96 56.8 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.943 -1.098 . . . . 0.0 111.326 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.94 -38.72 69.77 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.186 -0.946 . . . . 0.0 108.524 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.62 -27.95 66.48 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.28 0.562 . . . . 0.0 109.852 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.79 75.97 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 121.253 -0.905 . . . . 0.0 111.193 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -74.53 -29.5 61.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 120.872 -1.143 . . . . 0.0 111.08 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -64.17 -28.79 70.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 111.286 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.36 65.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.893 -1.13 . . . . 0.0 110.438 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.43 -32.35 73.67 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 120.898 -1.126 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.6 -29.31 66.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.793 -1.192 . . . . 0.0 110.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.67 -37.49 79.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.324 1.449 . . . . 0.0 109.181 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 27.4 tp -56.86 -48.89 77.05 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 126.073 1.749 . . . . 0.0 110.026 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.03 -39.79 79.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.673 1.589 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -74.12 -46.7 40.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.338 1.455 . . . . 0.0 110.742 -172.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.98 -36.23 72.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.101 -0.999 . . . . 0.0 111.111 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.19 -28.04 57.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -49.59 74.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -63.19 -43.41 98.28 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.44 1.114 . . . . 0.0 109.197 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.16 63.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.637 -0.665 . . . . 0.0 112.518 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 m -69.13 -47.73 64.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 124.075 0.95 . . . . 0.0 109.702 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -66.24 -43.79 85.58 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.43 -20.61 64.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.461 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -45.09 73.69 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 119.975 1.261 . . . . 0.0 110.451 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.04 -44.29 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.91 -45.02 94.47 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.801 1.64 . . . . 0.0 110.258 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.18 86.45 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 124.869 1.267 . . . . 0.0 111.174 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -32.45 58.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 121.959 -0.463 . . . . 0.0 109.9 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.6 90.49 1.03 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.443 1.097 . . . . 0.0 109.637 -174.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.75 -27.41 2.82 Favored Glycine 0 CA--C 1.491 -1.463 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -93.57 156.07 40.06 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -76.77 154.08 34.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.23 1.953 . . . . 0.0 110.734 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.09 21.41 49.73 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.16 136.41 15.12 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.636 1.974 . . . . 0.0 113.536 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.7 -30.42 0.19 Allowed 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.185 0.994 . . . . 0.0 111.007 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -102.88 148.08 26.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -168.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -156.47 179.43 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m 65.32 109.36 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.572 1.549 . . . . 0.0 114.258 161.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -57.59 -37.89 61.53 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 116.227 -1.844 . . . . 0.0 114.757 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.6 -21.77 14.44 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 CA-C-N 125.628 3.046 . . . . 0.0 112.666 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -82.84 -25.45 32.62 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.72 71.86 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 125.96 1.704 . . . . 0.0 112.507 -172.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 tt -67.13 -25.16 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 123.338 0.655 . . . . 0.0 111.114 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -21.01 56.25 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 120.822 -1.174 . . . . 0.0 110.867 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -80.62 -40.16 26.14 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.372 1.082 . . . . 0.0 108.126 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.3 m -70.61 -31.42 68.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 O-C-N 120.328 -1.483 . . . . 0.0 112.634 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -62.62 -51.05 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.68 -15.76 61.69 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.08 1.352 . . . . 0.0 112.291 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 50.3 m -82.3 -36.73 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.066 -1.021 . . . . 0.0 108.525 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -27.74 61.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.37 -0.831 . . . . 0.0 110.451 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.8 p -93.0 6.91 46.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.452 0.701 . . . . 0.0 110.211 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.259 7.9 p 54.2 55.02 8.71 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 126.855 2.062 . . . . 0.0 114.317 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.87 -75.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.96 -64.06 3.09 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 t80 78.68 -47.6 0.43 Allowed 'General case' 0 C--N 1.351 0.668 0 C-N-CA 127.369 2.267 . . . . 0.0 109.437 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.05 13.72 0.42 Allowed Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -57.57 4.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.658 -0.907 . . . . 0.0 111.144 -173.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 26.0 mtm-85 -138.13 154.95 49.17 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -134.27 150.41 73.97 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.23 166.82 20.21 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 109.556 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' C' ' 33' ' ' ALA . 32.8 m -87.1 -179.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p -82.54 -79.85 0.18 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -32.47 -61.68 0.26 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.596 2.758 . . . . 0.0 110.912 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.77 -59.41 1.8 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -41.02 -41.45 2.67 Favored Glycine 0 CA--C 1.488 -1.639 0 C-N-CA 127.47 2.462 . . . . 0.0 114.819 -169.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -76.36 -30.68 57.68 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.292 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -35.35 71.59 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 121.528 1.967 . . . . 0.0 108.888 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.93 -51.38 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.79 98.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 125.094 1.358 . . . . 0.0 112.551 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.98 -46.89 52.95 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 127.328 2.251 . . . . 0.0 109.457 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -66.59 -36.39 82.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.75 -44.46 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.6 mtt -59.5 -46.26 89.32 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.679 0.791 . . . . 0.0 110.664 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -61.94 -43.61 98.48 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.48 84.12 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.226 0.61 . . . . 0.0 110.931 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.19 86.64 Favored Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 123.821 0.724 . . . . 0.0 111.833 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.99 -43.11 97.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.938 0.895 . . . . 0.0 109.527 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.77 -33.36 73.94 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.342 -0.848 . . . . 0.0 111.94 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.21 -53.59 35.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 123.689 0.796 . . . . 0.0 109.558 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -66.09 -38.79 89.14 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.85 -30.47 71.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.423 0.689 . . . . 0.0 111.842 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.68 -36.86 81.48 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 121.026 -1.046 . . . . 0.0 110.443 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.64 -20.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.932 1.293 . . . . 0.0 110.416 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 2.9 m -55.76 -22.79 25.94 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.927 1.291 . . . . 0.0 112.185 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.66 70.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.662 -1.899 . . . . 0.0 112.826 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.0 -16.68 35.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 123.961 0.904 . . . . 0.0 110.381 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.4 -35.6 17.03 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.33 62.07 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.611 -1.306 . . . . 0.0 111.179 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -73.26 -19.22 61.11 Favored 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 120.44 -1.412 . . . . 0.0 110.787 171.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.7 -11.37 57.28 Favored 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 120.935 -1.103 . . . . 0.0 111.136 -157.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -84.58 -21.3 30.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.109 -0.994 . . . . 0.0 110.336 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.84 -35.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -55.35 -19.46 8.92 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.036 1.334 . . . . 0.0 113.217 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -57.46 -28.87 63.73 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.296 -0.877 . . . . 0.0 110.947 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -75.65 -23.41 56.3 Favored 'General case' 0 N--CA 1.436 -1.17 0 O-C-N 121.319 -0.863 . . . . 0.0 110.805 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -83.78 -31.81 25.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -68.13 -41.9 81.0 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.067 -1.646 . . . . 0.0 110.233 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -67.94 -38.73 83.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.679 1.192 . . . . 0.0 110.967 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -131.7 108.62 9.61 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.1 41.41 4.32 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 . . . . . 0 CA--C 1.502 -0.874 0 O-C-N 121.223 -1.163 . . . . 0.0 109.358 178.505 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.76 57.67 4.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 74.48 -67.69 0.24 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.866 2.066 . . . . 0.0 110.645 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' D' ' 5' ' ' GLU . 5.7 p80 -70.83 -28.93 64.98 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 126.662 1.985 . . . . 0.0 111.857 -175.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' D' ' 4' ' ' HIS . 2.2 mp0 -69.32 -23.46 63.79 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 120.967 -1.083 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.07 -42.78 88.94 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.453 -0.779 . . . . 0.0 109.908 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.76 -39.64 80.17 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.63 93.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.536 0.735 . . . . 0.0 111.17 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.34 -39.52 85.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.469 0.708 . . . . 0.0 110.389 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -64.06 -35.61 81.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.005 0.922 . . . . 0.0 110.808 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 -35.03 79.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.388 1.075 . . . . 0.0 111.122 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -65.26 -34.69 78.96 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 120.901 -1.125 . . . . 0.0 111.17 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.96 -33.67 74.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 121.595 -0.69 . . . . 0.0 110.867 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -61.68 -41.94 98.24 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 125.194 1.398 . . . . 0.0 109.297 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.61 -38.84 91.76 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.051 -1.031 . . . . 0.0 111.417 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -69.12 -22.65 63.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.157 -0.964 . . . . 0.0 112.405 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.48 -39.96 36.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.25 -38.33 80.8 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 124.379 1.071 . . . . 0.0 109.544 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.79 -45.9 63.99 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.556 1.142 . . . . 0.0 112.056 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -71.41 -41.14 69.94 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 122.776 0.431 . . . . 0.0 110.585 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -62.68 -43.37 98.99 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.38 68.69 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.875 1.67 . . . . 0.0 112.17 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -67.08 -37.95 84.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 110.163 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -35.21 63.85 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -64.66 -50.06 68.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.57 0.748 . . . . 0.0 109.185 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.39 69.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.678 1.191 . . . . 0.0 113.507 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.23 -28.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 O-C-N 120.187 -1.57 . . . . 0.0 109.888 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -75.75 -49.17 18.97 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.797 -1.19 . . . . 0.0 108.304 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.27 78.62 6.49 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.82 -55.05 0.06 Allowed 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.889 1.368 . . . . 0.0 108.051 163.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -79.42 103.54 9.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 119.406 -2.058 . . . . 0.0 110.303 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.38 -49.59 0.26 Allowed Glycine 0 CA--C 1.484 -1.847 0 N-CA-C 105.181 -3.168 . . . . 0.0 105.181 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' D' ' 66' ' ' GLU . . . -78.0 161.69 70.05 Favored Pre-proline 0 CA--C 1.504 -0.807 0 C-N-CA 123.446 0.698 . . . . 0.0 112.759 -171.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -78.65 113.78 3.36 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.589 2.193 . . . . 0.0 110.766 172.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.33 2.25 13.55 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.129 -0.817 . . . . 0.0 111.202 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.03 145.09 21.42 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.858 1.263 . . . . 0.0 113.172 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.16 -48.56 1.33 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.626 1.171 . . . . 0.0 111.128 -167.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.78 133.81 34.51 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 pt -148.11 17.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.11 138.65 33.66 Favored 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 120.484 -1.385 . . . . 0.0 108.228 -170.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.58 -49.39 8.57 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.982 -1.961 . . . . 0.0 111.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.27 -8.04 21.35 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 CA-C-N 125.865 3.13 . . . . 0.0 111.101 -173.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -98.82 -25.63 14.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.09 80.5 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.532 1.133 . . . . 0.0 111.086 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.37 -35.53 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 121.977 -0.452 . . . . 0.0 110.445 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -28.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 120.487 -1.383 . . . . 0.0 110.429 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -63.79 -42.93 97.63 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.417 1.103 . . . . 0.0 108.457 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -58.33 -37.47 75.21 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.307 1.443 . . . . 0.0 111.388 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.53 -49.77 71.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 124.328 1.051 . . . . 0.0 110.591 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -75.36 -23.85 57.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.849 0.833 . . . . 0.0 110.863 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 64.3 m -70.31 -39.33 74.87 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.72 67.12 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.098 -1.001 . . . . 0.0 111.942 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -88.65 5.82 41.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 119.149 -0.453 . . . . 0.0 110.077 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 54.3 p 51.48 29.7 5.6 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 127.614 2.366 . . . . 0.0 112.437 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.07 -47.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.31 51.48 58.54 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -71.11 -33.23 69.94 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.978 0.894 . . . . 0.0 109.361 -166.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 155.68 -123.47 1.34 Allowed Glycine 0 CA--C 1.476 -2.36 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 75.13 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.345 1.458 . . . . 0.0 108.016 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -145.37 171.58 14.41 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.478 ' HB2' HH12 ' D' ' 68' ' ' ARG . 11.7 p90 -164.36 148.21 7.97 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -91.67 155.06 3.5 Favored 'Trans proline' 0 CA--C 1.511 -0.635 0 C-N-CA 122.468 2.112 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -155.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.937 0.875 . . . . 0.0 110.424 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -53.84 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 120.382 -1.449 . . . . 0.0 112.26 -164.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -79.86 -7.78 58.91 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.784 1.233 . . . . 0.0 109.621 -165.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' D' ' 33' ' ' ALA . 40.2 mm-40 -95.98 41.26 1.11 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 15.16 81.56 0.01 OUTLIER Glycine 0 CA--C 1.462 -3.253 1 C-N-CA 133.139 5.162 . . . . 0.0 110.434 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.478 HH12 ' HB2' ' D' ' 61' ' ' TYR . 20.7 ttt85 -53.37 -13.8 0.63 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.599 1.96 . . . . 0.0 113.457 -164.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.05 -6.01 0.32 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 160.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.12 -49.15 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 O-C-N 120.274 -1.517 . . . . 0.0 107.713 167.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.23 82.06 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -48.67 -46.28 40.06 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.604 1.161 . . . . 0.0 113.324 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.27 -37.43 83.44 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.107 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.34 -44.97 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 58.2 mtm -63.05 -48.34 79.13 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.21 1.004 . . . . 0.0 110.62 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.39 -38.27 88.98 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.531 -0.731 . . . . 0.0 110.505 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.698 -0.626 . . . . 0.0 111.911 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.17 -46.98 66.97 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.74 -44.89 94.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 C-N-CA 124.559 1.144 . . . . 0.0 109.663 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.78 -47.56 84.3 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 111.388 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.16 -49.99 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 124.284 1.034 . . . . 0.0 109.768 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -71.75 -16.23 62.2 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.903 -0.498 . . . . 0.0 111.482 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.27 -35.55 16.08 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.256 -0.903 . . . . 0.0 109.859 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.52 -31.48 72.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.584 1.554 . . . . 0.0 110.927 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.08 -3.02 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.696 0 O-C-N 121.326 -0.858 . . . . 0.0 112.609 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 88.0 m -58.35 -22.85 54.91 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.476 1.51 . . . . 0.0 111.571 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.88 66.33 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.198 -1.564 . . . . 0.0 111.935 172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.69 -49.06 6.68 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.09 -39.9 91.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.726 -1.234 . . . . 0.0 113.657 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.85 61.81 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.945 -1.097 . . . . 0.0 110.892 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 80.8 p -85.31 -14.47 46.43 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.568 -1.333 . . . . 0.0 110.566 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.39 -16.2 61.34 Favored 'General case' 0 CA--C 1.507 -0.677 0 O-C-N 120.14 -1.6 . . . . 0.0 111.067 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -80.31 -31.36 38.15 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.651 -1.281 . . . . 0.0 111.874 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.19 -11.74 14.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 CA-C-O 121.562 0.696 . . . . 0.0 110.168 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -61.41 -17.26 53.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.788 0.835 . . . . 0.0 110.848 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.58 -22.21 63.46 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.586 1.085 . . . . 0.0 112.021 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.66 -47.84 51.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.682 0.793 . . . . 0.0 109.474 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.14 -35.98 30.84 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.465 -0.772 . . . . 0.0 109.54 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.1 -4.72 37.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 121.282 -0.886 . . . . 0.0 112.057 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -67.82 -40.71 83.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.269 -0.894 . . . . 0.0 109.523 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -91.94 -14.7 29.11 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.514 -0.741 . . . . 0.0 109.19 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.24 62.56 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 m170 . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 179.032 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.76 -161.57 0.23 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.51 2.324 . . . . 0.0 110.558 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 14.8 t0 -136.42 129.47 31.24 Favored 'General case' 0 CA--C 1.477 -1.857 1 N-CA-C 96.573 -5.343 . . . . 0.0 96.573 153.116 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.52 ' CE1' ' OE1' ' A' ' 5' ' ' GLU 0.299 22.4 p80 144.07 -60.88 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 128.5 2.72 . . . . 0.0 107.251 -177.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' OE1' ' CE1' ' A' ' 4' ' ' HIS . 2.8 pt-20 -76.34 -28.15 56.75 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 120.745 -1.222 . . . . 0.0 110.803 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -64.02 -37.54 87.79 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.06 -1.025 . . . . 0.0 111.167 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -73.48 -34.21 65.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.085 1.354 . . . . 0.0 108.27 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.96 90.34 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.953 1.301 . . . . 0.0 110.587 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -61.8 -42.16 98.66 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 110.082 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -64.03 -34.3 77.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.911 0.862 . . . . 0.0 110.947 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.48 70.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.003 -1.061 . . . . 0.0 110.987 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.02 -32.8 74.7 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.191 -0.943 . . . . 0.0 111.038 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.89 -34.81 74.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.744 -1.223 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.54 -36.54 82.93 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.46 -48.77 76.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.594 1.158 . . . . 0.0 110.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -71.49 -27.07 62.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.733 -1.229 . . . . 0.0 112.283 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -67.09 -44.34 80.26 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.211 1.404 . . . . 0.0 109.805 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 77' ' ' ALA . 21.9 m -72.48 -29.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.946 -1.096 . . . . 0.0 110.249 -177.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.0 mt -61.75 -38.87 89.57 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 123.799 0.839 . . . . 0.0 111.168 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.93 -31.55 63.11 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.197 0.999 . . . . 0.0 110.826 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -77.88 -39.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.03 78.79 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.274 1.029 . . . . 0.0 111.715 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -65.83 -32.69 74.36 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.862 -0.524 . . . . 0.0 110.587 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -62.55 -47.43 83.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.395 0.678 . . . . 0.0 109.576 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -64.96 -38.04 89.66 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 110.115 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.23 75.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.149 0.98 . . . . 0.0 112.555 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.8 t -72.71 -43.19 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 121.089 -1.007 . . . . 0.0 109.175 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.0 -37.87 81.98 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.65 -1.282 . . . . 0.0 110.104 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 64.74 6.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.919 1.688 . . . . 0.0 108.219 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -164.74 -53.86 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.91 89.53 0.01 OUTLIER 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.119 1.768 . . . . 0.0 112.269 -170.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.58 10.12 25.74 Favored Glycine 0 CA--C 1.498 -0.995 0 O-C-N 121.035 -1.041 . . . . 0.0 111.792 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.71 133.46 25.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.722 1.261 . . . . 0.0 107.945 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.39 130.0 8.83 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.696 2.264 . . . . 0.0 110.645 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.76 74.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 160.38 16.39 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.9 9.17 Favored 'General case' 0 N--CA 1.427 -1.595 1 N-CA-C 99.04 -4.43 . . . . 0.0 99.04 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' CE3' ' A' ' 47' ' ' TRP . 1.9 tt 82.63 87.99 0.04 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 tt -138.57 142.83 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 -163.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.71 138.73 0.06 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.324 1.849 . . . . 0.0 112.73 169.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -51.65 -53.48 50.01 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 126.033 1.733 . . . . 0.0 114.37 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.77 -6.94 18.83 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 CA-C-N 124.366 2.595 . . . . 0.0 112.316 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.48 -48.08 4.9 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.6 77.77 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 125.382 1.473 . . . . 0.0 112.441 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -66.42 -31.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.509 -0.744 . . . . 0.0 110.452 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -23.16 36.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.394 -0.816 . . . . 0.0 109.916 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CE3' HD11 ' A' ' 38' ' ' LEU . 72.5 t90 -72.37 -38.56 68.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -75.92 65.84 2.06 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.551 1.54 . . . . 0.0 108.318 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -146.69 -71.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.616 ' CD ' HH22 ' B' ' 68' ' ' ARG . 20.0 pt-20 -69.37 -24.4 63.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.869 0.842 . . . . 0.0 111.946 -165.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 51' ' ' THR . 2.5 t -66.93 -35.37 79.84 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 124.837 1.255 . . . . 0.0 107.988 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -76.84 -23.64 52.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 120.358 -1.464 . . . . 0.0 110.695 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -87.31 9.93 18.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.282 5.4 t 48.08 48.29 18.41 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 127.723 2.409 . . . . 0.0 112.569 172.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -110.99 -99.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 171.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' VAL . . . 109.88 67.01 0.57 Allowed Glycine 0 CA--C 1.484 -1.885 0 N-CA-C 103.142 -3.983 . . . . 0.0 103.142 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -68.12 -30.55 69.73 Favored 'General case' 0 C--N 1.356 0.867 0 CA-C-O 122.134 0.969 . . . . 0.0 108.466 -174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.62 49.07 0.53 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.492 ' CG ' HH21 ' B' ' 68' ' ' ARG 0.479 4.6 p-10 -80.48 -28.96 37.41 Favored 'General case' 0 C--N 1.362 1.11 0 CA-C-N 119.063 1.431 . . . . 0.0 110.372 170.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -147.03 -179.84 7.1 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -146.05 137.54 12.97 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -84.49 -177.12 2.8 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 C-N-CA 124.422 3.415 . . . . 0.0 108.863 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' GLU 0.308 7.8 p -112.1 -128.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.657 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 -37.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.443 1.897 . . . . 0.0 107.183 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -84.22 -2.19 56.47 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.77 0.828 . . . . 0.0 109.78 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -73.86 -35.51 64.75 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.81 60.29 0.66 Allowed Glycine 0 CA--C 1.466 -3.017 1 N-CA-C 102.772 -4.131 . . . . 0.0 102.772 168.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -13.84 -30.75 0.0 OUTLIER 'General case' 0 C--N 1.364 1.214 1 C-N-CA 135.489 5.515 . . . . 0.0 117.738 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -53.36 -22.31 7.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 126.737 2.015 . . . . 0.0 112.626 163.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.3 -51.35 65.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.52 -1.363 . . . . 0.0 108.439 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.79 -45.09 68.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.376 0.67 . . . . 0.0 110.341 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.81 -37.09 75.6 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 110.841 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -58.18 -39.65 79.46 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 121.4 -0.812 . . . . 0.0 110.601 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.51 -36.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mmt -57.9 -57.49 12.58 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.397 1.079 . . . . 0.0 109.741 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.95 -28.06 67.98 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 121.345 -0.847 . . . . 0.0 111.057 -175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 18' ' ' VAL . . . -66.92 -22.74 65.94 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.588 -0.695 . . . . 0.0 110.883 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.93 -36.78 10.85 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.25 -42.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 125.359 1.464 . . . . 0.0 110.426 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.76 -37.27 84.29 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.438 -0.789 . . . . 0.0 110.91 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.36 -57.99 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 124.535 1.134 . . . . 0.0 109.979 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.01 -13.7 62.6 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.709 -0.619 . . . . 0.0 110.691 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.62 -46.97 16.23 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 121.112 -0.992 . . . . 0.0 110.091 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.47 -36.9 79.39 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.065 1.346 . . . . 0.0 111.64 -172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.0 m -62.71 -9.99 4.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.408 -0.807 . . . . 0.0 112.602 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -62.91 -18.58 63.22 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.121 1.369 . . . . 0.0 110.941 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.82 -24.28 66.78 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.682 -1.261 . . . . 0.0 111.636 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.47 -46.52 10.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 108.197 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.43 -41.55 98.79 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.17 0.988 . . . . 0.0 112.902 -171.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.04 -9.96 59.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 121.13 -0.981 . . . . 0.0 111.466 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.6 p -83.78 -16.18 45.64 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 120.768 -1.208 . . . . 0.0 110.323 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.73 -24.77 58.77 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.628 -163.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -74.65 -32.02 62.12 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.644 -1.285 . . . . 0.0 110.995 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 t -69.43 -32.87 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 125.399 1.48 . . . . 0.0 108.423 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -61.84 -11.63 13.64 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.398 1.479 . . . . 0.0 112.442 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -68.34 -22.34 64.69 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 120.001 -1.687 . . . . 0.0 110.595 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.33 -44.6 74.96 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -61.4 -52.36 64.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.913 1.685 . . . . 0.0 109.605 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.53 -41.66 92.85 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.851 -0.53 . . . . 0.0 110.068 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -66.26 -33.74 76.43 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.951 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -77.32 -27.67 52.94 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.4 28.4 52.66 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.4 m80 . . . . . 0 CA--C 1.492 -1.287 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 -175.514 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.434 -1.254 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.34 173.24 11.73 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.313 -0.867 . . . . 0.0 108.923 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -53.66 -53.08 57.06 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 123.537 1.637 . . . . 0.0 109.678 -171.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.25 -21.05 63.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.191 -177.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -85.66 -39.11 17.63 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -70.84 -31.25 67.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.478 -0.764 . . . . 0.0 110.864 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.11 -47.64 79.24 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.0 70.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.294 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.14 -35.91 80.72 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.218 1.007 . . . . 0.0 110.208 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.25 -28.12 64.99 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -39.35 93.37 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.09 -47.79 76.0 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.404 -0.81 . . . . 0.0 110.548 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -52.88 -51.97 59.16 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.312 1.845 . . . . 0.0 110.222 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -76.03 -12.59 60.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.443 -0.786 . . . . 0.0 112.045 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.733 -1.229 . . . . 0.0 108.12 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.77 -14.05 60.66 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.54 -1.35 . . . . 0.0 111.193 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.93 -51.65 21.03 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.15 -23.75 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.859 -0.526 . . . . 0.0 111.393 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.14 -39.71 83.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.369 -0.832 . . . . 0.0 112.076 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.74 -24.34 38.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.293 0.568 . . . . 0.0 110.583 -174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.33 -42.15 46.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.82 82.15 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 126.309 1.844 . . . . 0.0 111.584 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -65.99 -44.97 83.29 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 122.111 -0.368 . . . . 0.0 110.324 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.11 -48.16 77.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.248 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -68.31 -25.55 65.19 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.098 -175.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -43.9 58.65 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 109.673 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 73.7 t -60.43 -45.72 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 121.241 -0.912 . . . . 0.0 110.127 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.59 17.96 15.2 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 121.638 -0.664 . . . . 0.0 111.099 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.507 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -75.69 -48.52 21.66 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 170.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' B' ' 36' ' ' ALA . 0.5 OUTLIER -56.66 -27.53 58.78 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 126.396 1.878 . . . . 0.0 115.082 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -73.77 75.88 1.58 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.61 0.764 . . . . 0.0 109.393 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.59 -43.23 0.77 Allowed Glycine 0 CA--C 1.488 -1.618 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.41 152.12 60.35 Favored Pre-proline 0 N--CA 1.445 -0.713 0 O-C-N 121.486 -1.008 . . . . 0.0 111.263 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.05 153.5 11.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.136 1.891 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.17 41.61 10.13 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' B' ' 30' ' ' GLU . . . -62.71 132.44 52.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 -42.06 0.17 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.358 0.263 . . . . 0.0 110.683 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -6.61 54.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.896 1.678 . . . . 0.0 110.739 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.14 84.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 O-C-N 120.634 -1.291 . . . . 0.0 111.929 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.1 112.05 0.74 Allowed 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -53.37 -47.7 95.26 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.404 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -71.47 -20.14 27.7 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-N 124.962 2.808 . . . . 0.0 113.011 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.73 0.63 17.47 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 119.941 1.246 . . . . 0.0 109.922 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.44 -34.72 76.46 Favored 'General case' 0 CA--C 1.499 -0.992 0 O-C-N 121.189 -0.944 . . . . 0.0 110.771 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.422 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.6 tt -70.99 -35.75 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.287 1.035 . . . . 0.0 109.614 175.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.63 -38.83 67.6 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 120.466 -1.396 . . . . 0.0 108.815 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -65.18 -44.86 87.11 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 123.356 0.662 . . . . 0.0 110.152 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -66.96 -29.43 69.28 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 120.953 -1.092 . . . . 0.0 110.851 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 23.3 t -58.35 -43.25 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.453 1.101 . . . . 0.0 111.117 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -82.45 -15.0 54.16 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 119.794 1.179 . . . . 0.0 112.298 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.48 -36.14 29.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.756 -1.215 . . . . 0.0 107.804 -174.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.37 -23.39 61.12 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.882 -1.136 . . . . 0.0 112.066 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.96 -6.28 59.0 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.188 0.995 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 14.6 p 55.7 54.48 8.22 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.863 1.665 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.89 -91.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 1 N-CA-C 100.031 -4.062 . . . . 0.0 100.031 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.52 76.72 1.34 Allowed Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.65 -18.23 51.93 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.49 -1.006 . . . . 0.0 108.605 -171.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.3 48.93 0.68 Allowed Glycine 0 CA--C 1.484 -1.877 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 168.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.61 -54.34 9.37 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -131.33 -136.62 0.2 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.191 0.596 . . . . 0.0 109.594 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -171.91 121.57 0.47 Allowed Pre-proline 0 N--CA 1.444 -0.726 1 N-CA-C 100.029 -4.063 . . . . 0.0 100.029 -168.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.85 158.15 13.82 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 124.59 2.675 . . . . 0.0 109.791 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.407 HG22 ' H ' ' B' ' 63' ' ' VAL . 2.9 m -76.11 169.92 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.635 1.207 . . . . 0.0 111.819 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -59.63 2.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.38 1.072 . . . . 0.0 110.793 -169.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.31 -17.26 64.7 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 -168.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -130.56 -108.05 0.27 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.507 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 25.94 -70.87 0.0 OUTLIER Glycine 0 CA--C 1.486 -1.758 1 C-N-CA 132.442 4.83 . . . . 0.0 116.204 170.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.616 HH22 ' CD ' ' A' ' 50' ' ' GLU . 52.7 ttm-85 -61.78 -42.92 99.61 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 126.083 1.753 . . . . 0.0 112.575 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -67.79 -34.5 76.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 120.251 1.387 . . . . 0.0 109.589 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.99 -47.75 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.2 90.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.876 1.671 . . . . 0.0 110.9 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -50.91 -46.1 60.55 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 127.648 2.379 . . . . 0.0 110.482 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -66.73 -37.46 84.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -74.51 -45.76 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.223 1.009 . . . . 0.0 109.372 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 71.7 mtm -61.06 -45.01 96.48 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.629 1.172 . . . . 0.0 109.759 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -64.8 -32.49 74.2 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.909 -0.495 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.512 -0.743 . . . . 0.0 110.329 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -40.59 97.02 Favored Glycine 0 CA--C 1.495 -1.175 0 C-N-CA 124.186 0.898 . . . . 0.0 111.732 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.63 -51.0 77.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 C-N-CA 124.086 0.954 . . . . 0.0 108.456 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -65.41 -27.4 68.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 121.541 -0.724 . . . . 0.0 111.724 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.87 -58.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 124.391 1.076 . . . . 0.0 110.333 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -65.28 -25.41 67.63 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 121.539 0.685 . . . . 0.0 110.148 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.21 -41.97 32.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 121.367 -0.833 . . . . 0.0 111.268 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.16 -36.93 85.26 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.522 -1.361 . . . . 0.0 110.682 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.79 -3.45 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 O-C-N 121.563 -0.711 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 56.5 m -56.6 -22.77 36.17 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.992 1.317 . . . . 0.0 109.985 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.05 72.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.329 -1.482 . . . . 0.0 112.503 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.01 -35.42 61.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 120.954 -1.091 . . . . 0.0 109.191 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.5 -32.49 62.54 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 122.967 0.507 . . . . 0.0 110.67 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 120.844 -1.16 . . . . 0.0 111.115 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -11.21 60.62 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.066 -1.021 . . . . 0.0 113.22 174.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.7 -47.61 80.46 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-N 120.208 1.367 . . . . 0.0 109.839 -171.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -71.54 -27.16 62.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.941 -1.099 . . . . 0.0 111.736 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.01 -17.75 22.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.982 1.313 . . . . 0.0 109.455 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -70.37 -17.73 63.05 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.082 -1.636 . . . . 0.0 111.707 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -66.41 -13.48 60.77 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 120.496 -1.377 . . . . 0.0 110.478 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -58.1 -47.29 83.69 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 126.195 1.798 . . . . 0.0 109.876 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -60.75 -49.82 75.95 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.63 1.172 . . . . 0.0 109.565 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -0.64 57.69 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.816 -171.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 26.9 ttp-105 -79.98 -40.9 27.0 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.41 -34.37 58.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.712 0.767 . . . . 0.0 109.117 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.28 13.82 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.0 p80 . . . . . 0 CA--C 1.508 -0.642 0 C-N-CA 127.544 2.338 . . . . 0.0 115.572 -174.426 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.53 172.55 18.34 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -48.75 80.25 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 124.765 1.226 . . . . 0.0 109.826 -172.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.407 ' CD2' ' HG3' ' C' ' 5' ' ' GLU . 40.5 p-80 -65.82 -30.33 70.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.803 -0.561 . . . . 0.0 112.004 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.407 ' HG3' ' CD2' ' C' ' 4' ' ' HIS . 7.2 mt-10 -77.36 -40.72 42.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.04 -44.46 96.66 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.521 -0.737 . . . . 0.0 109.986 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -33.98 75.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.025 0.441 . . . . 0.0 110.685 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.73 90.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.669 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -68.64 -34.39 75.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 121.674 -0.641 . . . . 0.0 110.62 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -66.56 -35.39 80.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.219 1.408 . . . . 0.0 110.73 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.42 87.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.351 -0.843 . . . . 0.0 111.069 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -63.76 -33.89 76.67 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.978 0.894 . . . . 0.0 111.5 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -68.33 -30.84 69.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.103 1.361 . . . . 0.0 110.518 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -69.22 -37.01 77.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.777 -1.202 . . . . 0.0 108.987 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.5 -44.43 97.09 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.222 1.009 . . . . 0.0 110.838 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.61 -39.6 70.99 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.254 1.021 . . . . 0.0 112.376 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.2 71.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.274 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.61 -40.66 88.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.73 -42.68 84.36 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.319 1.048 . . . . 0.0 111.095 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.7 -39.96 94.54 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -88.31 -12.54 43.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.949 -1.094 . . . . 0.0 109.983 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.51 -37.51 42.91 Favored 'General case' 0 CA--C 1.497 -1.091 0 O-C-N 120.783 -1.198 . . . . 0.0 109.286 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -37.65 84.97 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.232 0.613 . . . . 0.0 110.311 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -44.26 81.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.285 1.434 . . . . 0.0 109.218 172.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -69.14 -48.77 61.48 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.652 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.98 80.91 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.302 1.041 . . . . 0.0 112.924 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.27 -23.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 O-C-N 121.294 -0.879 . . . . 0.0 110.839 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.85 -4.26 47.36 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 119.854 -1.779 . . . . 0.0 109.016 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.63 -48.62 12.39 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -173.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.85 -110.67 0.13 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . 0.305 11.5 mtm-85 43.23 71.57 0.23 Allowed 'General case' 0 C--N 1.358 0.945 0 C-N-CA 126.32 1.848 . . . . 0.0 112.942 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.14 36.97 2.05 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.83 153.7 42.22 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.19 121.34 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.996 2.464 . . . . 0.0 110.041 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.19 25.78 39.03 Favored Glycine 0 CA--C 1.496 -1.107 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.69 151.65 46.4 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.116 1.366 . . . . 0.0 109.575 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.25 -34.9 0.52 Allowed 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.255 0.622 . . . . 0.0 109.759 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.4 tp -94.75 55.06 1.84 Allowed 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.87 19.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 124.646 1.178 . . . . 0.0 110.28 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.5 t -129.42 125.61 36.91 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.14 -53.05 20.47 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-O 115.85 -2.024 . . . . 0.0 112.109 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.54 -16.2 34.27 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 CA-C-N 126.252 3.269 . . . . 0.0 111.109 -173.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.01 -20.62 44.96 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.8 79.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.159 -0.963 . . . . 0.0 111.63 -167.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.06 -21.86 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.628 0.728 . . . . 0.0 110.632 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -25.34 21.91 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.875 0.87 . . . . 0.0 109.147 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -67.48 -46.67 72.28 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 170.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -77.37 64.25 2.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.734 -0.604 . . . . 0.0 110.037 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 66.2 t -136.1 -71.07 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.38 -15.1 62.36 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-O 121.95 0.881 . . . . 0.0 112.598 -164.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.409 ' H ' HG22 ' C' ' 51' ' ' THR . 2.7 t -73.03 -32.37 65.06 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 124.719 1.207 . . . . 0.0 109.102 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.39 58.71 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 121.08 -1.012 . . . . 0.0 110.55 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -92.23 7.46 42.56 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.05 0.54 . . . . 0.0 110.128 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 51.2 p 49.68 42.33 23.21 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.482 1.913 . . . . 0.0 113.772 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.64 -56.24 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.77 3.06 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' D' ' 56' ' ' GLY . 1.8 t80 -71.23 -45.85 62.38 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -172.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.68 52.25 0.23 Allowed Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.66 -36.42 73.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.863 -0.786 . . . . 0.0 111.493 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -126.79 -163.71 1.27 Allowed 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -148.43 112.2 3.73 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 168.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.57 -173.61 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.769 2.979 . . . . 0.0 108.779 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . 0.268 7.4 p -128.39 -128.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -121.35 -37.16 2.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.279 1.432 . . . . 0.0 108.035 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.71 -12.2 58.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.869 1.268 . . . . 0.0 110.371 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -32.94 68.23 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.09 64.83 0.84 Allowed Glycine 0 CA--C 1.467 -2.943 1 N-CA-C 102.348 -4.301 . . . . 0.0 102.348 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -14.21 -38.6 0.0 OUTLIER 'General case' 0 C--N 1.366 1.284 1 C-N-CA 132.491 4.316 . . . . 0.0 116.434 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.49 -26.88 0.24 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.637 1.575 . . . . 0.0 113.791 165.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.46 -42.78 92.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.409 -1.432 . . . . 0.0 110.833 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.2 31.82 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -60.27 -31.19 69.99 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 123.681 0.792 . . . . 0.0 113.026 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -69.23 -32.45 71.7 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.407 -1.433 . . . . 0.0 110.545 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.92 62.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -57.2 -52.29 65.9 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.706 1.202 . . . . 0.0 110.381 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.83 -42.84 99.52 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 122.015 -0.428 . . . . 0.0 110.88 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.01 -33.92 75.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.688 0.395 . . . . 0.0 111.549 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -45.49 86.41 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 123.837 0.732 . . . . 0.0 111.329 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.34 -45.82 93.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 C-N-CA 124.35 1.06 . . . . 0.0 109.352 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.94 -38.46 85.93 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.519 -0.738 . . . . 0.0 112.31 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.15 -53.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 109.198 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -66.73 -38.91 87.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.919 -0.488 . . . . 0.0 111.041 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.36 73.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 110.997 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.04 -30.93 71.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.314 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.88 -18.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 124.911 1.284 . . . . 0.0 110.775 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -56.53 -20.64 21.53 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 112.424 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.04 72.06 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.136 -1.602 . . . . 0.0 111.898 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -80.08 -50.66 10.03 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.732 -1.23 . . . . 0.0 108.233 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 44.1 mt -59.63 -39.28 83.8 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.802 1.241 . . . . 0.0 112.27 -173.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.13 60.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.039 -1.038 . . . . 0.0 111.396 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 27.0 m -85.65 -18.01 34.45 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.7 -25.03 61.09 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.126 -1.609 . . . . 0.0 111.643 -164.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -77.55 -20.65 53.79 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.669 -1.27 . . . . 0.0 111.176 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.27 -24.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -172.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -53.03 -36.56 60.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.03 1.332 . . . . 0.0 111.846 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -54.84 -40.22 69.4 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 125.057 1.343 . . . . 0.0 110.955 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.83 -33.07 74.81 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.793 0.837 . . . . 0.0 110.206 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -79.79 -37.73 34.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.65 -20.98 60.42 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 121.147 -0.971 . . . . 0.0 112.451 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -67.5 -38.77 84.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.463 1.505 . . . . 0.0 110.131 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -80.91 -26.27 36.9 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.733 -0.604 . . . . 0.0 110.261 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.63 70.38 Favored Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 79.6 m80 . . . . . 0 CA--C 1.494 -1.2 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -175.073 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.17 175.21 8.17 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.74 -66.63 0.31 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 130.042 3.337 . . . . 0.0 112.017 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.492 ' CD2' ' HA ' ' D' ' 88' ' ' ALA . 46.8 p-80 -65.05 -27.62 68.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.333 1.853 . . . . 0.0 112.763 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.76 -31.41 61.77 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.237 -0.914 . . . . 0.0 108.928 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.93 -41.15 91.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.995 0.918 . . . . 0.0 109.282 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.79 -41.87 95.48 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.81 1.244 . . . . 0.0 109.159 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.68 98.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.059 0.944 . . . . 0.0 111.48 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -70.54 -29.81 66.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.556 -0.715 . . . . 0.0 111.832 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -63.95 -34.24 77.52 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.129 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.41 94.05 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.634 0.774 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -63.67 -36.25 83.22 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -71.12 -24.86 62.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.053 -1.03 . . . . 0.0 111.325 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.2 -35.02 73.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.982 0.913 . . . . 0.0 109.185 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 tp -64.66 -40.51 95.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.365 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -60.21 -28.36 67.93 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.023 0.929 . . . . 0.0 112.334 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -70.25 -42.98 71.49 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.35 -29.81 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 123.992 0.917 . . . . 0.0 109.745 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.44 -44.04 97.37 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.283 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -77.54 -31.58 53.41 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.111 1.364 . . . . 0.0 110.988 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -65.14 -53.68 41.38 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.915 1.34 . . . . 0.0 108.962 171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.49 -24.5 60.19 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 124.642 1.177 . . . . 0.0 111.524 -167.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 12.0 p -64.43 -46.33 83.66 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.254 1.026 . . . . 0.0 109.247 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.77 -46.36 88.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.343 1.857 . . . . 0.0 108.586 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -64.32 -47.9 77.66 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.326 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.63 84.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.411 1.084 . . . . 0.0 110.763 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.978 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.77 -34.35 34.3 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.5 91.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.75 1.62 . . . . 0.0 109.364 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 2.2 tp10 -68.22 -26.54 65.76 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.358 1.063 . . . . 0.0 111.889 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -74.12 112.62 10.44 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.64 -1.913 . . . . 0.0 107.836 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.5 -22.97 8.63 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.98 64.73 Favored Pre-proline 0 N--CA 1.443 -0.806 0 O-C-N 121.735 -0.862 . . . . 0.0 110.927 -176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -84.09 128.02 4.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.104 2.536 . . . . 0.0 111.864 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.78 46.88 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' D' ' 30' ' ' GLU . . . -55.43 135.0 50.75 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 127.668 2.387 . . . . 0.0 112.388 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.22 -31.17 1.13 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 123.795 0.838 . . . . 0.0 109.846 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.08 49.83 1.87 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 107.737 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.87 -164.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER 80.88 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 116.51 -1.71 . . . . 0.0 106.966 178.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -157.54 -62.8 0.02 OUTLIER Pre-proline 0 C--N 1.35 0.624 0 CA-C-O 116.135 -1.888 . . . . 0.0 109.037 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.48 -14.37 25.04 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 CA-C-N 125.709 3.075 . . . . 0.0 111.084 -169.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -34.18 29.53 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 128.284 2.634 . . . . 0.0 107.867 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.85 69.49 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.129 0.972 . . . . 0.0 111.62 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 tt -70.6 -33.01 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.341 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -19.29 59.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.316 -1.49 . . . . 0.0 109.984 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -70.03 -53.71 16.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 p -65.1 -19.11 65.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.08 -44.53 99.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 124.097 0.959 . . . . 0.0 111.159 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.2 -32.35 49.94 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.602 1.092 . . . . 0.0 108.494 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -81.36 63.36 5.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.903 0.881 . . . . 0.0 111.055 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.71 -52.14 0.07 Allowed 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 20.8 p -95.53 46.18 1.1 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.954 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 11.9 p 42.86 65.94 0.86 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.919 1.688 . . . . 0.0 113.641 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -116.01 -108.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' C' ' 57' ' ' TYR . . . 98.15 48.36 1.9 Allowed Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 105.813 -2.915 . . . . 0.0 105.813 -174.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -11.98 59.88 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.913 -0.757 . . . . 0.0 111.327 -166.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.16 40.55 3.98 Favored Glycine 0 CA--C 1.495 -1.207 0 O-C-N 120.288 -1.507 . . . . 0.0 110.001 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.0 -56.73 6.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.856 1.263 . . . . 0.0 108.773 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -144.34 167.76 21.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.32 122.91 18.37 Favored Pre-proline 0 CA--C 1.499 -0.985 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.05 169.96 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.374 2.049 . . . . 0.0 108.716 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.99 -106.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-N 119.07 0.85 . . . . 0.0 112.864 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -155.79 -39.46 0.08 Allowed 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -170.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -77.54 -11.7 59.88 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.622 1.969 . . . . 0.0 109.894 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.17 60.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.26 90.5 1.81 Allowed Glycine 0 N--CA 1.418 -2.524 1 N-CA-C 98.029 -6.028 . . . . 0.0 98.029 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -56.49 -18.86 12.87 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 119.664 1.732 . . . . 0.0 110.694 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -49.95 -21.82 1.33 Allowed 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.574 1.55 . . . . 0.0 114.384 165.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.06 -46.22 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 O-C-N 120.562 -1.336 . . . . 0.0 108.809 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -43.06 93.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 123.249 0.62 . . . . 0.0 109.476 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.51 -44.33 69.01 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.444 1.498 . . . . 0.0 111.102 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -57.85 -47.73 81.83 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.352 1.061 . . . . 0.0 111.362 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -45.14 85.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-O 121.535 0.683 . . . . 0.0 109.531 -172.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.46 -43.49 85.38 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.129 0.572 . . . . 0.0 110.807 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.64 -34.67 78.38 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 121.504 -0.748 . . . . 0.0 110.28 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.65 88.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.797 -0.564 . . . . 0.0 110.684 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.33 96.16 Favored Glycine 0 CA--C 1.495 -1.17 0 C-N-CA 124.058 0.837 . . . . 0.0 112.053 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.48 -46.91 92.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 124.413 1.085 . . . . 0.0 109.69 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.22 -36.96 85.79 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.204 -0.935 . . . . 0.0 112.23 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.47 -51.15 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.908 0.883 . . . . 0.0 109.822 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.48 -4.8 50.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.515 -0.741 . . . . 0.0 111.444 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.17 -40.55 12.15 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.353 -0.842 . . . . 0.0 108.991 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tt -57.05 -39.93 75.83 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 126.495 1.918 . . . . 0.0 111.082 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.9 m -62.95 -6.82 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.28 1.032 . . . . 0.0 112.92 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 25.2 m -62.17 -17.72 58.84 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.617 -1.302 . . . . 0.0 110.641 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.9 69.62 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.305 -1.497 . . . . 0.0 111.846 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' D' ' 4' ' ' HIS . . . -82.16 -45.82 14.63 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.046 -1.034 . . . . 0.0 108.519 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -62.79 -34.05 76.46 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.804 0.812 . . . . 0.0 111.915 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.44 66.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.977 -1.077 . . . . 0.0 111.941 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 9.5 t -92.45 0.48 57.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.062 -1.024 . . . . 0.0 108.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.69 -34.52 62.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.69 0.757 . . . . 0.0 109.157 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -73.65 -34.87 65.15 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.786 -1.197 . . . . 0.0 110.764 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.66 -25.85 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 125.582 1.553 . . . . 0.0 109.376 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -47.73 -38.58 15.63 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 125.876 1.67 . . . . 0.0 111.357 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -61.18 -14.05 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -58.35 -37.05 74.4 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.398 -0.814 . . . . 0.0 109.885 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -67.98 -53.0 29.38 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.922 1.289 . . . . 0.0 108.966 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -64.89 -33.01 74.99 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 123.954 0.902 . . . . 0.0 112.355 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -69.08 -41.44 77.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.76 -1.213 . . . . 0.0 110.123 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -73.65 -37.84 65.19 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.49 -0.757 . . . . 0.0 109.589 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.6 12.65 50.15 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 CA--C 1.491 -1.296 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 177.182 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 -56.67 3.62 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.135 -175.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 4' ' ' HIS 0.279 33.9 t70 -176.74 -116.79 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -137.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.582 ' CD2' HG21 ' A' ' 91' ' ' THR . 30.9 p80 -44.38 -35.36 2.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 130.611 3.564 . . . . 0.0 114.919 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.81 -31.35 72.5 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.679 0.792 . . . . 0.0 111.624 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -71.44 -32.06 67.9 Favored 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -78.46 -34.86 47.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.7 79.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.012 0.925 . . . . 0.0 110.487 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -66.0 -35.73 81.37 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 123.992 0.917 . . . . 0.0 111.378 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -62.83 -41.34 99.28 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.313 -0.867 . . . . 0.0 109.818 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.12 71.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.458 0.703 . . . . 0.0 111.579 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -62.94 -30.54 71.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.524 -0.735 . . . . 0.0 111.319 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.43 -33.69 67.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.62 -42.86 97.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 110.254 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.68 -42.15 95.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 123.094 0.558 . . . . 0.0 111.03 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.85 -37.63 79.8 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -67.04 -33.87 76.47 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 121.558 -0.714 . . . . 0.0 111.322 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.35 -30.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.265 -0.897 . . . . 0.0 109.048 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.52 -37.52 81.42 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.948 -1.095 . . . . 0.0 111.72 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.02 -44.56 72.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.643 1.177 . . . . 0.0 110.327 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.43 -39.4 92.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 121.322 -0.861 . . . . 0.0 109.567 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.58 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 124.792 1.237 . . . . 0.0 111.337 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 p -66.65 -43.12 85.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.689 0.677 . . . . 0.0 109.818 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.39 -54.9 37.67 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.062 0.945 . . . . 0.0 110.548 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -71.62 -31.34 66.77 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.865 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.99 71.84 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 119.142 0.883 . . . . 0.0 110.194 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 41' ' ' TYR . 74.2 t -64.68 -38.72 83.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-O 121.856 0.836 . . . . 0.0 110.035 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.03 -33.97 72.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.474 -0.766 . . . . 0.0 110.286 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.9 84.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.433 1.111 . . . . 0.0 111.794 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -36.7 85.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 126.809 2.043 . . . . 0.0 111.207 176.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.72 77.87 9.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.508 1.147 . . . . 0.0 109.493 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.28 -35.55 0.71 Allowed Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 106.239 -2.744 . . . . 0.0 106.239 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.36 156.67 62.62 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 122.305 -0.527 . . . . 0.0 110.221 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.15 152.19 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.053 1.835 . . . . 0.0 110.033 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.32 56.59 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.24 26.38 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.046 1.338 . . . . 0.0 114.145 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.26 -58.27 0.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.599 1.159 . . . . 0.0 111.944 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.8 tp -82.2 76.1 9.1 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.892 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.02 75.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 O-C-N 120.484 -1.385 . . . . 0.0 108.439 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -158.03 120.41 3.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 t80 -59.07 -54.01 60.66 Favored Pre-proline 0 C--N 1.352 0.716 0 CA-C-O 116.355 -1.784 . . . . 0.0 112.518 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.47 -3.91 14.6 Favored 'Trans proline' 0 CA--C 1.514 -0.501 0 CA-C-N 125.277 2.92 . . . . 0.0 112.044 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -105.4 -33.12 8.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.47 -24.41 61.99 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 120.459 -1.401 . . . . 0.0 112.081 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.68 -23.7 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.771 0.796 . . . . 0.0 110.005 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -39.91 51.34 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.542 -1.349 . . . . 0.0 108.173 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 38.2 t90 -64.94 -46.83 79.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 123.81 0.844 . . . . 0.0 108.851 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -64.32 -27.1 68.8 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.71 -54.12 37.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 C-N-CA 123.794 0.838 . . . . 0.0 109.011 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.59 -27.24 62.05 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 121.675 -0.641 . . . . 0.0 111.177 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.3 m -62.22 -40.42 96.06 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.962 0.905 . . . . 0.0 110.769 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.52 74.05 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 121.427 -0.796 . . . . 0.0 111.815 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.53 1.05 39.74 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.937 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p 56.54 21.44 5.69 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.335 1.854 . . . . 0.0 112.474 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.35 -58.72 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.7 72.51 0.63 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.74 -22.19 62.44 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.136 0.97 . . . . 0.0 109.962 -166.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.23 26.06 3.88 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' B' ' 68' ' ' ARG . 19.0 t70 -65.5 -53.74 38.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.966 1.306 . . . . 0.0 110.335 177.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.43 164.73 28.6 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.82 137.19 30.24 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.53 169.17 12.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.621 2.214 . . . . 0.0 110.41 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -71.13 176.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.759 1.266 . . . . 0.0 111.743 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 m -96.96 -51.24 4.32 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.711 1.205 . . . . 0.0 109.959 -172.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.57 -42.9 89.02 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 111.237 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -130.85 -137.1 0.21 Allowed 'General case' 0 CA--C 1.492 -1.27 1 N-CA-C 100.184 -4.006 . . . . 0.0 100.184 165.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.46 -77.98 1.18 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -63.08 -40.81 98.75 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.585 1.954 . . . . 0.0 110.492 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -75.17 -19.26 59.93 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.734 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.01 -50.12 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.6 74.0 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.745 1.618 . . . . 0.0 111.588 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -42.13 -51.96 4.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 127.654 2.382 . . . . 0.0 112.32 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.62 -35.28 75.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.299 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.04 -46.35 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.454 1.102 . . . . 0.0 109.126 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.69 -45.38 94.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.001 1.321 . . . . 0.0 109.717 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -59.73 -37.69 79.65 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.545 0.738 . . . . 0.0 111.947 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.67 89.38 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.587 -0.696 . . . . 0.0 110.543 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.3 -46.85 85.15 Favored Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.8 -47.45 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 109.188 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -62.9 -42.75 99.89 Favored 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.127 -0.983 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.9 t -63.6 -52.13 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.264 0.938 . . . . 0.0 110.142 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.92 -28.94 67.92 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.063 0.545 . . . . 0.0 111.077 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.13 -34.32 32.58 Favored 'General case' 0 CA--C 1.505 -0.75 0 O-C-N 120.932 -1.105 . . . . 0.0 110.606 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.45 -32.68 74.19 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.39 -1.444 . . . . 0.0 110.865 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -65.6 -5.15 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 121.56 -0.713 . . . . 0.0 112.41 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -55.35 -20.88 13.0 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.596 1.559 . . . . 0.0 111.566 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.56 -21.07 65.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 120.422 -1.424 . . . . 0.0 113.046 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.27 -39.16 14.63 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 124.821 1.248 . . . . 0.0 108.727 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.58 -45.53 91.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.883 1.273 . . . . 0.0 110.013 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.33 60.21 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 4' ' ' HIS . 0.5 OUTLIER -79.91 -15.98 56.23 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 119.781 -1.825 . . . . 0.0 107.653 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.413 55.1 m-20 -98.55 14.67 27.53 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.606 -160.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -89.62 -30.86 17.85 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 153.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.65 -24.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.402 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -56.19 -23.79 37.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.597 1.159 . . . . 0.0 111.99 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -64.52 -19.7 65.76 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.182 -1.574 . . . . 0.0 112.061 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -71.43 -25.14 62.2 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.226 -0.921 . . . . 0.0 110.322 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.41 -42.87 34.6 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -61.01 -31.03 70.65 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.17 0.988 . . . . 0.0 111.355 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -66.74 -25.92 66.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.587 -0.696 . . . . 0.0 111.42 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -82.2 -36.82 26.9 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.29 19.24 46.58 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 . . . . . 0 CA--C 1.501 -0.94 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.682 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.32 -177.45 4.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.714 -1.241 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.411 ' OD1' ' HD2' ' B' ' 4' ' ' HIS . 0.4 OUTLIER -60.09 -62.5 1.82 Allowed 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.713 2.005 . . . . 0.0 108.363 176.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.411 ' HD2' ' OD1' ' B' ' 3' ' ' ASP . 18.6 p80 -60.2 -31.75 70.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.819 2.048 . . . . 0.0 113.735 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.402 ' OE2' ' CE1' ' B' ' 4' ' ' HIS . 6.6 mt-10 -74.66 -35.64 62.82 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.047 -1.033 . . . . 0.0 110.959 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -73.95 -36.52 64.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.794 -0.566 . . . . 0.0 110.491 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.82 -37.8 82.42 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.96 90.35 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.908 0.883 . . . . 0.0 111.112 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.13 -35.2 78.02 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.099 0.96 . . . . 0.0 110.913 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -65.13 -38.22 89.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.283 1.033 . . . . 0.0 110.545 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.18 80.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.429 1.092 . . . . 0.0 110.782 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.51 -36.26 83.63 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 121.474 -0.766 . . . . 0.0 111.042 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -75.61 -25.13 56.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.023 -1.048 . . . . 0.0 111.354 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.58 -38.33 83.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.57 -46.18 89.66 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.423 0.689 . . . . 0.0 110.886 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -57.23 -41.02 78.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.339 1.456 . . . . 0.0 111.367 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -66.38 -37.37 85.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.356 1.063 . . . . 0.0 110.761 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.25 -38.34 81.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 O-C-N 120.938 -1.101 . . . . 0.0 108.643 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.47 -44.09 89.16 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 123.736 0.815 . . . . 0.0 110.526 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.68 -48.7 74.63 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 110.592 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -75.57 -36.79 60.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.783 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.16 -29.05 69.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.357 1.063 . . . . 0.0 111.87 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -62.24 -42.3 99.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.758 1.223 . . . . 0.0 110.443 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -67.77 -48.11 67.28 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 125.363 1.465 . . . . 0.0 107.37 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -58.07 -47.48 83.04 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 124.626 1.17 . . . . 0.0 111.299 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.87 78.81 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.979 0.912 . . . . 0.0 111.366 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.95 -44.17 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 -29.26 65.05 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 119.817 1.189 . . . . 0.0 110.947 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.8 -42.67 60.63 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 125.092 1.357 . . . . 0.0 109.611 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -74.98 -21.0 59.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.618 0.723 . . . . 0.0 111.022 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -74.67 89.47 2.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 120.276 -1.515 . . . . 0.0 110.636 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.78 -4.01 11.78 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.92 150.95 56.83 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 118.065 0.933 . . . . 0.0 109.082 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -82.26 132.58 7.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.937 2.425 . . . . 0.0 110.723 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 5.19 88.07 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.47 146.02 55.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 123.671 0.789 . . . . 0.0 111.497 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.43 -47.48 4.09 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 124.906 1.282 . . . . 0.0 108.078 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -90.47 66.07 6.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 122.807 1.289 . . . . 0.0 108.836 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -101.03 26.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 O-C-N 120.344 -1.472 . . . . 0.0 108.485 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 11.6 p -91.05 -114.86 0.08 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 t80 162.2 -70.99 0.0 OUTLIER Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 126.757 2.023 . . . . 0.0 106.296 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.92 -12.03 19.8 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-N 125.112 2.862 . . . . 0.0 111.868 -163.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.0 6.31 36.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.296 1.038 . . . . 0.0 109.059 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.96 74.68 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.368 -0.832 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.63 -30.35 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.075 0.95 . . . . 0.0 111.574 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -85.61 -18.47 33.18 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.343 -0.848 . . . . 0.0 109.962 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -80.72 -41.05 24.24 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -74.88 60.53 0.96 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 111.452 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.43 -64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.86 -19.06 64.99 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -167.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -72.62 -30.76 64.6 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.123 0.969 . . . . 0.0 108.947 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.59 62.17 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.502 -1.374 . . . . 0.0 110.381 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -93.52 14.84 17.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.685 0.794 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 67.5 p 55.4 51.72 12.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.751 1.62 . . . . 0.0 113.728 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.87 -145.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.047 1 N-CA-C 99.473 -4.269 . . . . 0.0 99.473 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.9 90.31 0.13 Allowed Glycine 0 CA--C 1.481 -2.047 1 N-CA-C 99.058 -5.617 . . . . 0.0 99.058 -171.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -81.58 -17.57 47.85 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 121.447 -1.031 . . . . 0.0 108.673 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.41 44.22 1.49 Allowed Glycine 0 CA--C 1.486 -1.764 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -72.28 -63.72 1.09 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -102.06 -169.24 1.65 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -155.35 100.9 2.25 Favored Pre-proline 0 N--CA 1.443 -0.805 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.81 153.34 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.698 2.265 . . . . 0.0 110.255 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.51 -124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -135.2 -11.14 2.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.036 -1.04 . . . . 0.0 109.046 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -112.54 2.67 16.37 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 125.64 1.576 . . . . 0.0 107.433 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.27 43.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.06 91.26 1.54 Allowed Glycine 0 N--CA 1.418 -2.564 1 N-CA-C 98.14 -5.984 . . . . 0.0 98.14 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.457 HH12 ' CG ' ' A' ' 59' ' ' ASP . 37.6 ttm180 -68.74 -3.98 14.21 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.073 1.937 . . . . 0.0 110.648 -174.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.168 1.787 . . . . 0.0 111.638 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -47.89 84.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 124.994 1.317 . . . . 0.0 109.4 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.41 77.44 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -55.18 -41.56 72.07 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.711 1.605 . . . . 0.0 111.114 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -65.38 -35.39 80.83 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.428 -0.795 . . . . 0.0 111.578 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.17 -41.78 44.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 9.2 tpp -53.59 -54.94 30.29 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 126.249 1.819 . . . . 0.0 109.96 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -68.81 -36.11 77.82 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.162 0.985 . . . . 0.0 110.499 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.67 87.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 121.594 -0.691 . . . . 0.0 110.939 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.95 96.96 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 124.455 1.026 . . . . 0.0 111.322 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 72.3 mt -60.36 -42.95 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 109.114 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -73.09 -31.31 64.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.061 -1.025 . . . . 0.0 113.262 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.43 -43.44 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.256 -0.902 . . . . 0.0 109.702 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.81 -36.56 78.39 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 118.686 0.675 . . . . 0.0 110.073 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.46 92.39 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.896 0.878 . . . . 0.0 110.944 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.28 -31.97 73.38 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.579 -1.326 . . . . 0.0 111.651 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.77 -25.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 124.194 0.998 . . . . 0.0 109.762 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -68.33 -3.11 9.93 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 121.142 -0.974 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.52 82.65 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.679 -2.513 . . . . 0.0 110.84 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.53 59.72 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 39.4 mt -110.02 27.22 9.82 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.25 -9.33 8.62 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -100.36 3.36 43.21 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -71.71 -45.41 61.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.517 1.127 . . . . 0.0 109.197 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.59 -26.36 68.65 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.8 -1.187 . . . . 0.0 112.386 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.2 -29.16 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 123.984 0.914 . . . . 0.0 109.993 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -26.06 64.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 120.423 -1.423 . . . . 0.0 109.53 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -70.62 -19.45 62.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.796 -0.565 . . . . 0.0 111.696 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -70.77 -45.28 65.02 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.03 -1.669 . . . . 0.0 109.565 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -92.17 4.41 53.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.259 0.623 . . . . 0.0 110.553 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -80.41 -55.85 4.6 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 167.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -62.53 -51.3 67.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.997 0.903 . . . . 0.0 112.004 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -94.0 116.46 28.9 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.65 -28.04 6.34 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.904 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.63 20.27 0.49 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.086 2.555 . . . . 0.0 115.344 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 63.81 -73.3 0.05 OUTLIER 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.415 2.686 . . . . 0.0 110.061 -175.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -60.38 -36.07 77.2 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 130.312 3.445 . . . . 0.0 110.424 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -75.38 -36.41 60.9 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -33.87 76.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.701 0.801 . . . . 0.0 111.202 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -45.9 64.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.779 0.832 . . . . 0.0 108.877 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.65 98.89 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.163 0.985 . . . . 0.0 111.552 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -71.33 -26.23 62.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.105 1.362 . . . . 0.0 110.702 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.39 -37.93 63.26 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.99 95.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.233 -0.917 . . . . 0.0 111.235 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.98 -34.58 78.77 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.413 -0.805 . . . . 0.0 111.094 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -62.98 -33.48 75.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.606 1.162 . . . . 0.0 110.457 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.98 -42.56 84.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 109.146 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 23.6 tp -62.04 -37.11 83.72 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.16 0.984 . . . . 0.0 110.968 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.64 -27.67 69.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -34.91 63.31 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.518 -1.364 . . . . 0.0 109.289 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.75 -36.51 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.03 -41.04 77.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 123.877 0.871 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -72.07 -35.51 69.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.851 0.86 . . . . 0.0 111.2 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.92 -46.74 56.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.731 1.253 . . . . 0.0 107.992 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.79 64.35 Favored 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 125.787 1.635 . . . . 0.0 111.432 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.497 ' HB3' ' HA ' ' C' ' 45' ' ' ILE . 1.4 p -74.21 -36.6 63.97 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.296 -0.877 . . . . 0.0 110.014 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -64.94 -47.66 76.87 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -64.3 -35.61 81.42 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.338 0.655 . . . . 0.0 111.004 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.04 60.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 124.35 1.06 . . . . 0.0 110.943 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.16 -36.07 73.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 CA-C-O 122.08 0.943 . . . . 0.0 110.069 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.13 -36.16 77.18 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.056 -1.028 . . . . 0.0 110.298 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.8 67.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 125.635 1.574 . . . . 0.0 111.706 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -75.63 -17.6 59.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 121.451 -0.781 . . . . 0.0 110.72 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -85.58 75.48 10.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 120.363 -1.46 . . . . 0.0 110.152 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.37 -42.3 0.44 Allowed Glycine 0 CA--C 1.478 -2.237 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' C' ' 63' ' ' VAL . . . -82.14 151.11 66.02 Favored Pre-proline 0 N--CA 1.437 -1.093 0 O-C-N 122.36 -0.494 . . . . 0.0 110.806 -173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.72 147.73 24.99 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.868 1.712 . . . . 0.0 110.214 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 28.87 35.25 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.509 -0.606 . . . . 0.0 112.17 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.08 132.66 54.16 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 112.703 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.8 -37.21 0.6 Allowed 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.175 0.99 . . . . 0.0 109.539 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.71 35.67 0.78 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.749 1.22 . . . . 0.0 107.906 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 tt -77.41 4.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 123.673 1.702 . . . . 0.0 108.651 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -71.68 125.8 28.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.03 2.132 . . . . 0.0 110.373 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -87.71 -55.85 0.33 Allowed Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.908 -1.52 . . . . 0.0 111.225 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.42 -24.52 16.32 Favored 'Trans proline' 0 CA--C 1.501 -1.172 0 CA-C-N 125.075 2.848 . . . . 0.0 111.228 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.0 -7.2 58.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.89 79.45 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.043 -1.035 . . . . 0.0 111.126 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' C' ' 23' ' ' SER . 20.3 tt -69.17 -29.34 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.485 -0.759 . . . . 0.0 110.186 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -36.71 74.57 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 121.017 -1.052 . . . . 0.0 111.318 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -71.4 -33.32 69.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.632 0.729 . . . . 0.0 109.639 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -59.93 -41.56 92.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.95 -55.03 18.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.174 1.39 . . . . 0.0 110.753 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.89 -13.22 60.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.593 -0.692 . . . . 0.0 112.196 -173.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -79.47 -39.47 32.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.964 0.906 . . . . 0.0 109.252 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -24.02 64.88 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 120.88 -1.137 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p -92.81 2.43 56.76 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.477 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p 50.03 36.98 13.07 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.119 1.768 . . . . 0.0 111.269 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.6 -59.13 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 61.17 6.85 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -43.49 60.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -170.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.93 -114.26 0.59 Allowed Glycine 0 CA--C 1.482 -1.983 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . 0.305 27.2 t70 62.17 -71.38 0.05 OUTLIER 'General case' 0 C--N 1.351 0.672 0 C-N-CA 127.199 2.2 . . . . 0.0 111.185 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -117.19 -163.98 0.96 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -155.53 148.08 17.8 Favored Pre-proline 0 N--CA 1.433 -1.301 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -90.24 159.55 4.67 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.197 1.932 . . . . 0.0 109.684 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 33' ' ' ALA . 16.1 m -82.94 -175.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.91 1.684 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 -79.64 0.2 Allowed 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.461 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -39.7 -43.8 1.43 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.174 2.189 . . . . 0.0 113.31 -165.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -113.92 -91.18 0.51 Allowed 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 8.04 -69.04 0.0 OUTLIER Glycine 0 C--N 1.36 1.863 1 C-N-CA 131.584 4.421 . . . . 0.0 117.267 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -66.61 -41.23 88.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.475 1.51 . . . . 0.0 113.033 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -80.42 -20.2 44.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.098 -1.001 . . . . 0.0 109.031 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.93 -46.41 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 172.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.78 76.67 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 126.116 1.766 . . . . 0.0 111.576 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.51 -53.54 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.495 2.318 . . . . 0.0 111.074 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.24 -39.91 89.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.188 1.395 . . . . 0.0 110.551 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.98 -45.42 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.55 1.14 . . . . 0.0 109.315 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.0 mtm -59.67 -46.81 87.94 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 109.888 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -60.09 -38.68 83.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 111.302 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.58 82.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.609 0.764 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.99 -46.54 58.96 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.99 -45.62 92.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.556 0 C-N-CA 124.388 1.075 . . . . 0.0 109.536 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -61.7 -42.43 98.94 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.445 -0.784 . . . . 0.0 111.692 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.68 -49.88 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 123.956 0.902 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -67.96 -35.02 77.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.925 -0.484 . . . . 0.0 110.648 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.06 -28.46 61.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.055 -1.028 . . . . 0.0 110.715 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.08 -18.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 120.503 -1.373 . . . . 0.0 111.384 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.66 1.5 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 O-C-N 120.144 -1.598 . . . . 0.0 111.22 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 31.4 m -62.9 -20.53 65.26 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 120.104 -1.623 . . . . 0.0 111.31 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.89 44.82 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 124.785 1.234 . . . . 0.0 112.159 169.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.23 -40.21 13.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.529 1.532 . . . . 0.0 110.269 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.65 -46.08 48.79 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.141 0.577 . . . . 0.0 111.297 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.3 -28.16 66.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.603 -0.685 . . . . 0.0 110.815 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 12.3 t -85.59 -14.49 45.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.067 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.363 16.5 t70 -74.29 -30.08 61.93 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-N 121.776 2.08 . . . . 0.0 110.767 -168.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -70.49 -26.13 63.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 119.693 -1.879 . . . . 0.0 112.413 174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.84 -22.47 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 124.521 1.129 . . . . 0.0 108.559 -174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -63.26 -17.42 62.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.331 1.053 . . . . 0.0 111.463 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -71.36 -22.35 61.91 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 120.818 -1.176 . . . . 0.0 112.321 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -92.08 -15.79 27.29 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.48 -0.762 . . . . 0.0 109.565 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -102.76 -172.64 2.16 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.16 -64.45 0.33 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.243 1.817 . . . . 0.0 111.695 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 30.6 ttp85 -59.91 -33.45 71.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 129.796 3.238 . . . . 0.0 110.994 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -42.33 92.01 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.278 1.031 . . . . 0.0 111.023 174.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.59 56.89 5.27 Favored Glycine 0 CA--C 1.493 -1.319 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -172.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 177.397 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.97 66.35 1.07 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.388 1.475 . . . . 0.0 113.207 172.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -52.08 -29.93 23.69 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.515 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 3.5 p-80 -59.56 -33.63 71.67 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.515 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 9.3 mt-10 -79.27 -42.09 26.63 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 23.7 ttp85 -60.87 -38.77 86.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 110.279 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.7 -32.07 71.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.302 -0.873 . . . . 0.0 111.668 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.31 84.06 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.435 0.636 . . . . 0.0 109.597 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -66.83 -37.6 84.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.38 -0.825 . . . . 0.0 110.382 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -69.24 -23.68 63.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.288 -0.882 . . . . 0.0 111.346 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.74 86.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.608 -1.308 . . . . 0.0 111.079 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.12 -31.0 72.04 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.78 -1.2 . . . . 0.0 111.877 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.98 -34.87 79.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.049 1.34 . . . . 0.0 109.3 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -67.91 -41.05 83.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 124.792 1.237 . . . . 0.0 108.785 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.01 -45.33 95.24 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.689 0.796 . . . . 0.0 110.29 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.946 0.794 . . . . 0.0 112.164 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -74.1 -13.49 60.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.096 -1.003 . . . . 0.0 113.405 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.27 -46.51 12.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -53.06 -49.25 66.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 128.126 2.57 . . . . 0.0 110.459 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -78.11 -17.04 57.42 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.533 -1.354 . . . . 0.0 111.0 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -76.98 -31.9 56.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.44 82.81 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 124.767 1.227 . . . . 0.0 111.544 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -59.4 -42.7 92.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.75 1.22 . . . . 0.0 112.168 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -69.59 -37.99 77.15 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.827 0.851 . . . . 0.0 109.005 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -70.51 -51.01 31.86 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.433 0.693 . . . . 0.0 110.09 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.47 92.2 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 126.18 1.792 . . . . 0.0 112.304 -171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.46 -35.7 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -75.45 -36.13 60.78 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -62.4 -42.05 99.13 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.902 2.081 . . . . 0.0 110.201 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -88.48 -21.88 23.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -70.0 84.95 0.51 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 120.444 -1.41 . . . . 0.0 109.787 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.49 -2.2 4.14 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.23 157.55 82.86 Favored Pre-proline 0 N--CA 1.446 -0.644 0 O-C-N 121.138 -1.213 . . . . 0.0 112.55 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.63 131.29 11.29 Favored 'Trans proline' 0 CA--C 1.508 -0.798 0 C-N-CA 123.585 2.856 . . . . 0.0 110.643 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.76 -59.39 4.57 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.37 166.9 0.11 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.729 2.812 . . . . 0.0 110.327 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.05 -53.93 0.13 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.293 -1.744 . . . . 0.0 106.293 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 34.0 tp -99.68 134.83 42.0 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 pt -149.88 167.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m 73.61 131.8 0.04 OUTLIER 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.278 1.831 . . . . 0.0 112.918 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -58.08 -51.65 80.25 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 116.448 -1.739 . . . . 0.0 113.183 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.53 -13.16 24.99 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 CA-C-N 124.306 2.574 . . . . 0.0 111.967 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 -46.84 9.08 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.16 73.78 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.333 1.453 . . . . 0.0 111.716 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -65.98 -31.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 121.686 -0.634 . . . . 0.0 111.178 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -31.97 47.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 O-C-N 120.727 -1.233 . . . . 0.0 109.854 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -61.92 -40.44 95.5 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.388 1.089 . . . . 0.0 109.443 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -64.5 -35.84 82.26 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 119.898 -1.751 . . . . 0.0 112.169 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.98 -53.35 49.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.007 0.923 . . . . 0.0 109.468 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.03 -24.71 64.23 Favored 'General case' 0 C--N 1.351 0.63 0 C-N-CA 123.275 0.63 . . . . 0.0 111.662 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -76.05 -38.54 57.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.337 -0.852 . . . . 0.0 108.74 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.53 -28.19 65.81 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.981 -1.074 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 10.4 p -93.81 9.63 36.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 123.162 0.585 . . . . 0.0 110.335 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 18.3 p 58.68 43.47 18.75 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.901 1.68 . . . . 0.0 114.702 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.68 -69.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.59 -55.66 4.69 Favored Glycine 0 N--CA 1.435 -1.385 0 O-C-N 120.564 -1.335 . . . . 0.0 111.908 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.1 -30.92 0.21 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.5 1.92 . . . . 0.0 113.296 173.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.83 26.26 5.36 Favored Glycine 0 CA--C 1.491 -1.433 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.8 -67.99 0.43 Allowed 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.683 0.793 . . . . 0.0 109.023 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 157.64 46.05 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 102.666 -3.086 . . . . 0.0 102.666 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.9 122.26 4.98 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.78 178.06 6.87 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 C-N-CA 123.022 2.481 . . . . 0.0 110.67 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.626 HG22 ' H ' ' D' ' 64' ' ' THR . 9.8 p -113.27 -177.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 122.895 1.331 . . . . 0.0 111.27 -170.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.626 ' H ' HG22 ' D' ' 63' ' ' VAL . 7.1 m -52.41 -40.65 62.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.733 2.813 . . . . 0.0 113.048 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.63 -11.72 59.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.424 1.09 . . . . 0.0 110.696 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' D' ' 29' ' ' ALA . 0.4 OUTLIER -68.64 -33.27 73.71 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 170.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' D' ' 69' ' ' LYS . . . 131.93 -26.57 3.78 Favored Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . 0.348 9.4 ttt85 57.19 -35.92 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.031 1 C-N-CA 132.458 4.303 . . . . 0.0 113.702 -168.339 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' D' ' 67' ' ' GLY . 9.7 tptm -69.81 -9.28 54.1 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 126.243 1.817 . . . . 0.0 109.957 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 t -72.74 -37.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -53.86 37.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -46.94 -55.17 8.54 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 125.862 1.665 . . . . 0.0 112.947 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -70.02 -25.49 63.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.889 -0.507 . . . . 0.0 111.732 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.39 -45.9 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 8.5 mtp -56.5 -45.89 80.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.064 1.346 . . . . 0.0 110.252 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -59.41 -38.03 79.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.635 1.174 . . . . 0.0 112.101 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -36.99 84.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.998 -0.439 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.55 -43.77 85.05 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 123.731 0.681 . . . . 0.0 111.444 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.78 -47.97 89.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 C-N-CA 124.308 1.043 . . . . 0.0 109.419 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -63.75 -43.43 96.46 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 123.848 0.859 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -61.93 -49.8 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 O-C-N 120.86 -1.15 . . . . 0.0 110.592 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -79.11 0.56 27.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.84 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.25 -40.34 10.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.37 -39.14 72.43 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 126.681 1.992 . . . . 0.0 111.276 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 m -59.1 -15.54 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.106 1.362 . . . . 0.0 112.988 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -70.4 -5.23 26.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.918 1.287 . . . . 0.0 110.12 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.01 70.78 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 119.985 -1.697 . . . . 0.0 109.797 166.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' D' ' 4' ' ' HIS . . . -66.13 -41.62 90.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.827 -1.17 . . . . 0.0 110.476 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.44 -37.96 80.73 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.086 0.554 . . . . 0.0 111.165 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.03 -17.46 60.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.005 -1.06 . . . . 0.0 110.409 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -73.07 -27.84 61.97 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.56 70.47 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.279 -0.888 . . . . 0.0 111.284 -159.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -68.49 -30.12 68.89 Favored 'General case' 0 C--N 1.354 0.772 0 O-C-N 120.676 -1.265 . . . . 0.0 111.563 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 12.4 t -74.82 -25.72 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 123.857 0.863 . . . . 0.0 109.063 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 7.8 mtp-105 -63.55 -25.92 68.46 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 120.992 -1.068 . . . . 0.0 110.931 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.4 -20.88 64.91 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.751 -0.593 . . . . 0.0 111.081 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.5 -14.16 61.59 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -110.53 -36.72 5.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -62.87 -32.0 73.16 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.042 -1.036 . . . . 0.0 112.602 -174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -83.51 -6.68 59.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.519 -0.738 . . . . 0.0 112.123 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -102.34 -40.8 6.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.76 0.58 32.24 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 72.6 t60 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 177.612 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.11 -70.74 0.25 Allowed 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.3 51.9 m-20 74.21 -41.7 0.49 Allowed 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.799 2.039 . . . . 0.0 111.009 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -43.98 83.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.483 1.113 . . . . 0.0 112.643 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.259 1.8 pm0 -72.71 -15.25 61.69 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.333 -2.105 . . . . 0.0 112.959 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -74.43 -42.86 58.44 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 120.432 -1.417 . . . . 0.0 108.521 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.63 -39.29 83.82 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.828 2.051 . . . . 0.0 109.212 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.11 92.4 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.856 1.263 . . . . 0.0 112.279 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.63 -26.22 60.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.394 -0.816 . . . . 0.0 111.169 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -65.7 -40.41 92.27 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.936 -1.103 . . . . 0.0 108.861 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.22 77.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.81 0.844 . . . . 0.0 112.09 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -34.83 76.04 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.495 -0.753 . . . . 0.0 111.735 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -68.87 -27.06 65.47 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 120.617 -1.302 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -64.8 -35.17 80.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.025 1.33 . . . . 0.0 109.375 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.96 -43.94 81.84 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.843 0.857 . . . . 0.0 110.141 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.61 -34.16 72.4 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 124.301 1.04 . . . . 0.0 111.912 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -66.91 -41.98 86.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.621 1.169 . . . . 0.0 110.185 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.13 -42.13 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.5 mt -55.32 -42.92 74.38 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.406 1.082 . . . . 0.0 112.397 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -69.71 -38.63 77.02 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.797 1.239 . . . . 0.0 110.873 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.39 -42.51 65.13 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 120.52 -1.362 . . . . 0.0 108.589 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.66 72.51 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.735 1.614 . . . . 0.0 112.351 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.1 p -69.66 -35.03 74.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -35.15 68.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.415 1.086 . . . . 0.0 109.277 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -69.24 -55.38 10.71 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 124.534 1.134 . . . . 0.0 108.595 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.02 84.1 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.483 1.513 . . . . 0.0 111.658 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.5 -37.09 78.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.214 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.11 -35.09 64.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.148 -1.595 . . . . 0.0 110.013 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.2 -49.75 63.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.095 1.758 . . . . 0.0 108.342 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 3.7 tp10 -68.64 -38.12 80.25 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.655 1.182 . . . . 0.0 111.409 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -71.34 109.27 5.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 119.289 -2.132 . . . . 0.0 110.971 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -9.6 16.83 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.79 152.11 48.41 Favored Pre-proline 0 C--N 1.352 0.683 0 CA-C-N 118.391 1.095 . . . . 0.0 109.713 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.82 144.21 24.27 Favored 'Trans proline' 0 CA--C 1.502 -1.09 0 C-N-CA 122.751 2.301 . . . . 0.0 109.481 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.66 78.99 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -55.73 115.85 2.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 125.966 1.707 . . . . 0.0 109.975 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.98 -43.56 8.48 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.8 tp -90.51 65.31 6.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.928 1.347 . . . . 0.0 110.04 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.93 -0.76 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 O-C-N 119.851 -1.78 . . . . 0.0 112.304 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.5 m -109.44 123.35 49.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 121.147 -0.971 . . . . 0.0 111.247 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.13 -58.65 11.88 Favored Pre-proline 0 C--N 1.351 0.641 0 C-N-CA 125.83 1.652 . . . . 0.0 111.234 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.12 -6.45 17.99 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 CA-C-N 125.078 2.849 . . . . 0.0 111.13 -171.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -100.59 -3.06 31.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.36 -32.9 69.05 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 119.737 -1.852 . . . . 0.0 109.15 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 tt -68.59 -30.0 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.826 0.851 . . . . 0.0 109.684 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.95 -47.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 125.919 1.687 . . . . 0.0 110.054 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.69 -41.93 87.29 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.954 1.702 . . . . 0.0 108.554 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -56.21 -45.74 79.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 111.679 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' ILE . 1.9 t -64.22 -46.22 94.04 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 121.269 -0.894 . . . . 0.0 111.444 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.03 -13.92 59.7 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 118.894 -1.122 . . . . 0.0 112.537 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -69.69 -36.4 75.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.136 -0.978 . . . . 0.0 108.555 171.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.0 63.2 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.297 -1.502 . . . . 0.0 112.186 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 p -95.42 15.09 20.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.443 0.565 . . . . 0.0 109.686 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p 53.35 29.2 8.33 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 126.932 2.093 . . . . 0.0 113.499 166.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.3 p -101.31 -74.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -172.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 81.06 80.65 0.86 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -10.5 59.48 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.992 -1.299 . . . . 0.0 111.4 -170.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.23 18.4 13.53 Favored Glycine 0 CA--C 1.491 -1.443 0 O-C-N 121.061 -1.024 . . . . 0.0 111.79 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -73.16 -46.3 51.62 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 118.533 1.167 . . . . 0.0 109.312 177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.01 164.26 27.72 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.28 146.69 28.66 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 102.019 -3.326 . . . . 0.0 102.019 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.96 -165.36 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.29 3.327 . . . . 0.0 109.858 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 64' ' ' THR . 13.8 p -139.0 -147.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 63' ' ' VAL . 89.6 m -102.49 -48.19 4.23 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.017 1.327 . . . . 0.0 108.282 -170.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -78.97 -17.08 56.05 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.435 0.694 . . . . 0.0 110.47 -169.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.32 -34.3 75.02 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 123.354 1.55 . . . . 0.0 107.477 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.38 79.2 1.43 Allowed Glycine 0 CA--C 1.462 -3.229 1 N-CA-C 98.594 -5.802 . . . . 0.0 98.594 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' D' ' 59' ' ' ASP . 19.8 ttt85 -50.61 -18.16 0.64 Allowed 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.358 1.863 . . . . 0.0 113.731 -171.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -38.78 -31.31 0.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 127.318 2.247 . . . . 0.0 114.697 159.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.06 -43.56 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 119.01 0.823 . . . . 0.0 108.877 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.46 64.38 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.594 -0.691 . . . . 0.0 109.646 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.76 -47.11 51.11 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.402 1.481 . . . . 0.0 112.177 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -68.27 -37.22 80.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.466 0.707 . . . . 0.0 111.033 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.45 -43.47 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.68 -44.27 97.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.2 1.0 . . . . 0.0 110.441 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -66.38 -33.69 76.29 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.204 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.5 74.08 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.347 -0.845 . . . . 0.0 110.928 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.2 86.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.05 -41.47 83.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.855 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -65.92 -43.79 87.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.391 -1.443 . . . . 0.0 113.73 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.2 -45.82 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 118.274 0.488 . . . . 0.0 109.811 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.91 -39.14 72.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.93 81.97 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 121.535 -0.728 . . . . 0.0 111.198 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.43 -31.98 73.37 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 111.736 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.29 -19.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.957 1.303 . . . . 0.0 110.051 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -62.41 -18.1 60.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 120.914 -1.116 . . . . 0.0 112.394 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.1 -55.49 34.31 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.48 -1.388 . . . . 0.0 110.244 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.46 87.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.93 -42.48 90.04 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 121.386 -0.821 . . . . 0.0 110.879 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.38 -14.04 60.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.959 -1.088 . . . . 0.0 110.643 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 m -77.06 -21.98 53.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.837 -1.164 . . . . 0.0 108.786 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.16 -42.95 82.04 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 122.012 0.91 . . . . 0.0 111.311 -165.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -70.76 -18.26 62.77 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.727 -1.233 . . . . 0.0 113.364 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.9 t -75.12 -20.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -75.67 -11.87 60.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 120.982 -1.074 . . . . 0.0 110.244 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -77.55 -17.42 57.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.865 -1.147 . . . . 0.0 110.926 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -96.35 159.89 14.71 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 73.12 -39.35 0.44 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.261 1.824 . . . . 0.0 110.934 -164.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.11 -44.32 91.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 127.119 2.168 . . . . 0.0 112.021 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -63.9 -31.26 72.38 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.848 0.833 . . . . 0.0 112.152 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -88.1 -19.46 27.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.151 0.98 . . . . 0.0 108.999 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.59 73.61 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -177.705 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.426 -1.646 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.94 -134.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -98.5 -62.37 1.25 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -58.02 -30.51 66.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.93 -28.97 58.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.812 0.845 . . . . 0.0 110.499 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -72.0 -39.72 69.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -32.72 74.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.62 0.724 . . . . 0.0 110.481 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.98 -46.45 81.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.773 0.829 . . . . 0.0 111.127 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -72.6 -34.63 67.52 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.654 0.74 . . . . 0.0 110.729 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.03 -35.09 79.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.492 1.917 . . . . 0.0 110.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.76 75.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 111.585 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -32.19 73.59 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.165 0.986 . . . . 0.0 110.998 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.04 -36.32 72.31 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 120.649 -1.282 . . . . 0.0 108.913 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -66.28 -35.73 81.16 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.028 0.931 . . . . 0.0 109.295 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -60.4 -42.26 95.55 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.484 -0.76 . . . . 0.0 111.287 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -59.28 -35.52 73.89 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 123.933 0.893 . . . . 0.0 111.584 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -70.55 -34.98 72.84 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 110.209 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.22 -41.31 86.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 C-N-CA 124.516 1.126 . . . . 0.0 108.335 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 48.0 mt -56.42 -44.63 80.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.447 1.099 . . . . 0.0 111.547 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.61 -31.61 71.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.183 0.993 . . . . 0.0 111.488 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.99 -33.33 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.317 -1.489 . . . . 0.0 108.744 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.56 -31.29 71.91 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.917 1.287 . . . . 0.0 111.509 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 59.1 p -66.22 -39.9 89.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 119.026 0.83 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.34 93.39 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.084 1.754 . . . . 0.0 108.64 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.22 -57.96 5.19 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 117.671 -1.157 . . . . 0.0 108.25 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.52 -48.32 57.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 126.171 1.788 . . . . 0.0 112.855 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.12 -39.63 84.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.77 -1.206 . . . . 0.0 111.357 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.1 -25.67 31.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.117 -0.989 . . . . 0.0 109.464 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 126.465 1.906 . . . . 0.0 108.516 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.06 -34.18 77.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.14 0.976 . . . . 0.0 111.73 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -68.15 109.13 3.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.34 -2.1 . . . . 0.0 111.433 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.57 -10.89 16.31 Favored Glycine 0 CA--C 1.496 -1.104 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.72 147.08 40.52 Favored Pre-proline 0 N--CA 1.442 -0.84 0 O-C-N 121.802 -0.822 . . . . 0.0 109.439 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.51 137.81 11.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.49 2.127 . . . . 0.0 110.067 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.28 81.85 Favored Glycine 0 CA--C 1.492 -1.406 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.1 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.23 104.01 0.22 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.19 1.396 . . . . 0.0 109.56 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.72 -28.63 21.65 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.79 132.71 37.91 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 pt -148.36 170.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 81.47 124.77 0.04 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.741 1.616 . . . . 0.0 109.003 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -66.04 -52.45 39.82 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.602 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.97 -3.48 13.84 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 125.226 2.902 . . . . 0.0 112.314 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -110.61 -10.78 14.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.45 75.88 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.25 -0.906 . . . . 0.0 108.846 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -60.24 -26.15 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 125.765 1.626 . . . . 0.0 111.205 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.731 -1.23 . . . . 0.0 109.569 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -79.26 -35.76 40.96 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.8 p -77.31 57.82 1.54 Allowed 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 122.113 -0.367 . . . . 0.0 110.579 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.35 -53.39 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.77 -26.88 68.55 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 119.328 0.967 . . . . 0.0 111.977 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -67.06 -34.39 77.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.55 1.14 . . . . 0.0 109.439 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.5 62.67 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 120.449 -1.407 . . . . 0.0 111.013 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -93.39 11.92 26.66 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.688 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.7 p 48.89 55.5 9.13 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.267 1.427 . . . . 0.0 113.17 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' B' ' 56' ' ' GLY . 0.2 OUTLIER -121.95 -87.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.45 ' H ' HG23 ' B' ' 55' ' ' VAL . . . 87.15 73.66 1.28 Allowed Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 -19.42 62.12 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 121.344 -1.092 . . . . 0.0 110.429 -173.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.1 37.99 1.3 Allowed Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -93.2 -30.89 14.98 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 118.125 0.963 . . . . 0.0 110.066 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -140.3 176.55 8.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -155.02 149.66 20.01 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 102.295 -3.224 . . . . 0.0 102.295 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -85.04 -178.21 3.09 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 124.74 3.626 . . . . 0.0 109.949 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 0.8 OUTLIER -133.76 -153.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.036 0.922 . . . . 0.0 108.799 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 -46.78 7.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 120.03 -1.669 . . . . 0.0 110.676 -169.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -30.67 67.24 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 109.796 -170.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' B' ' 68' ' ' ARG . 0.8 OUTLIER -64.2 -26.37 68.48 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 123.128 1.442 . . . . 0.0 108.592 -178.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.91 67.67 1.3 Allowed Glycine 0 CA--C 1.461 -3.329 1 N-CA-C 102.534 -4.226 . . . . 0.0 102.534 174.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' OE2' ' B' ' 66' ' ' GLU . 22.0 ttp85 -40.11 -15.32 0.01 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.578 3.551 . . . . 0.0 116.097 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -55.27 -17.84 5.24 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 120.507 -1.371 . . . . 0.0 113.622 160.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.97 -53.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 CA-C-N 121.07 1.759 . . . . 0.0 107.718 173.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.79 91.08 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.272 0.629 . . . . 0.0 111.061 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.1 -38.44 70.73 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.621 1.168 . . . . 0.0 111.66 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.84 -37.47 84.55 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 124.071 0.948 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.53 -42.53 72.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.2 mtm -61.16 -48.92 79.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.094 0.958 . . . . 0.0 110.319 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -66.16 -38.43 88.06 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.81 92.57 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.056 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.28 -46.07 91.76 Favored Glycine 0 CA--C 1.494 -1.257 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -46.64 87.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.666 1.186 . . . . 0.0 109.338 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.15 -45.82 86.73 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 121.173 -0.954 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.68 -51.13 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 124.167 0.987 . . . . 0.0 109.963 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -72.83 -19.46 61.31 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.631 -0.668 . . . . 0.0 111.257 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.5 -27.62 19.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.885 0.874 . . . . 0.0 110.283 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.08 -39.18 85.17 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 126.207 1.803 . . . . 0.0 109.47 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.2 -13.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.823 0.849 . . . . 0.0 111.912 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 5.8 m -61.68 -16.38 48.32 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.624 1.169 . . . . 0.0 110.852 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.58 -51.0 64.4 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.509 1.123 . . . . 0.0 110.629 165.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.16 75.72 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.71 1.604 . . . . 0.0 110.451 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.02 -42.61 97.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.73 -18.96 61.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.872 -0.518 . . . . 0.0 110.687 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.6 m -80.51 -36.61 33.03 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 121.276 -0.89 . . . . 0.0 108.998 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.34 -8.46 58.45 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 120.904 -1.123 . . . . 0.0 111.791 -157.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -75.4 -36.77 60.79 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 165.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 t -71.12 -22.28 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 109.978 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -47.92 -31.57 5.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.694 1.998 . . . . 0.0 111.666 171.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -62.11 -30.7 71.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.686 1.194 . . . . 0.0 112.129 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.31 -27.41 63.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 120.785 -1.197 . . . . 0.0 109.541 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.38 -37.21 80.19 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.999 -1.063 . . . . 0.0 110.241 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -70.52 -23.35 62.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -66.55 -35.65 80.75 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.015 -1.053 . . . . 0.0 109.944 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -89.88 -7.72 53.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 121.594 -0.692 . . . . 0.0 109.519 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.37 90.17 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 121.477 -0.764 . . . . 0.0 111.494 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.769 178.888 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.98 166.04 32.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -65.45 -55.85 15.68 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 129.378 3.071 . . . . 0.0 108.26 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -66.97 -21.99 65.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 125.791 1.636 . . . . 0.0 111.97 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -77.34 -32.65 55.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -72.87 -32.27 65.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.668 0.747 . . . . 0.0 109.95 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.3 -41.56 93.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.642 1.177 . . . . 0.0 109.512 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.08 78.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.357 1.063 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -57.01 -38.25 72.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.282 1.833 . . . . 0.0 111.243 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -64.73 -33.26 75.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.495 1.118 . . . . 0.0 110.815 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.61 68.2 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.037 -1.039 . . . . 0.0 110.287 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.453 -0.78 . . . . 0.0 112.017 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -27.89 63.76 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.889 -1.132 . . . . 0.0 110.473 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.74 -33.29 73.67 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.994 0.918 . . . . 0.0 109.128 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.41 -36.95 84.12 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.941 -1.099 . . . . 0.0 110.687 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.08 -27.65 67.54 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.264 -0.898 . . . . 0.0 111.083 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.61 -45.67 64.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.684 1.194 . . . . 0.0 110.068 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.31 -24.14 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 O-C-N 121.534 -0.729 . . . . 0.0 110.819 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.13 -37.66 80.73 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.417 -0.802 . . . . 0.0 111.408 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -74.34 -24.29 59.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.617 0.767 . . . . 0.0 111.241 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -87.89 -30.87 19.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 120.812 -1.18 . . . . 0.0 107.848 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.98 88.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.655 1.182 . . . . 0.0 111.362 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.0 p -65.2 -38.94 92.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.29 0.636 . . . . 0.0 111.173 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -71.08 -48.88 49.98 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.576 -0.703 . . . . 0.0 110.064 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -72.21 -23.16 61.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 121.262 -0.899 . . . . 0.0 110.931 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.92 -48.45 76.54 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.819 0.736 . . . . 0.0 110.885 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.72 -19.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.03 -176.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -80.2 -25.82 39.48 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.157 -1.59 . . . . 0.0 109.531 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.05 73.49 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.67 1.188 . . . . 0.0 108.874 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' C' ' 38' ' ' LEU . 16.8 mt-10 -85.63 -141.09 0.09 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 122.884 1.326 . . . . 0.0 111.115 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 59.86 52.23 5.51 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 126.763 2.025 . . . . 0.0 111.316 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.37 34.35 0.2 Allowed Glycine 0 CA--C 1.487 -1.696 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.45 155.42 78.67 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.78 152.39 11.44 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.324 2.016 . . . . 0.0 109.498 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 -41.03 2.77 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.974 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -3.02 123.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.808 1 C-N-CA 132.486 4.314 . . . . 0.0 117.292 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.48 -38.38 3.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.566 1.146 . . . . 0.0 110.048 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.437 ' H ' ' CD ' ' C' ' 30' ' ' GLU . 5.2 tt -100.98 66.23 1.14 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.033 2.533 . . . . 0.0 109.436 -169.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.45 33.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 119.463 -2.023 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.2 m -134.0 143.62 48.23 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -80.99 -53.14 0.81 Allowed Pre-proline 0 C--N 1.351 0.631 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.471 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -20.32 24.2 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 CA-C-N 126.404 3.323 . . . . 0.0 110.643 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.9 -13.04 49.07 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 -35.79 81.65 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.186 -0.946 . . . . 0.0 110.928 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.61 -29.08 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.441 0.639 . . . . 0.0 110.278 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -28.75 61.29 Favored 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 119.83 -1.794 . . . . 0.0 110.22 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.434 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 31.8 t90 -69.66 -40.99 76.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.841 -0.537 . . . . 0.0 109.68 172.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -69.58 -14.71 62.98 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.83 -49.9 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 120.884 -1.135 . . . . 0.0 110.504 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -76.04 0.45 18.6 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.036 -1.04 . . . . 0.0 112.247 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.27 -38.69 6.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.122 -0.987 . . . . 0.0 109.096 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.73 61.05 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 120.771 -1.206 . . . . 0.0 111.535 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 5.3 p -90.61 1.31 56.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 110.647 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . 0.297 15.5 p 62.65 30.72 16.95 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.46 2.304 . . . . 0.0 112.751 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.18 -59.33 2.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.92 63.26 3.74 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.858 -1.151 . . . . 0.0 112.493 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -23.14 66.86 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.642 0.777 . . . . 0.0 113.006 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 23.51 10.1 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -50.33 18.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 16.1 mtm-85 -142.52 163.86 31.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -163.12 142.05 6.58 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.98 161.95 20.79 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.044 2.496 . . . . 0.0 110.86 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 1.1 t -107.02 -162.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 123.118 1.437 . . . . 0.0 109.157 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 2.1 m -66.29 -55.5 15.76 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 127.601 2.361 . . . . 0.0 111.553 -167.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -74.12 -16.43 61.01 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.533 1.159 . . . . 0.0 109.27 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -78.08 -23.35 48.02 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 125.514 1.526 . . . . 0.0 107.803 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.89 86.12 0.94 Allowed Glycine 0 CA--C 1.478 -2.276 1 N-CA-C 102.04 -4.424 . . . . 0.0 102.04 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -43.14 -34.81 1.17 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 126.446 1.898 . . . . 0.0 111.482 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -43.44 -26.87 0.23 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.037 2.135 . . . . 0.0 113.721 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.92 -37.72 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.986 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.09 9.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.33 -47.04 69.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.481 2.312 . . . . 0.0 112.136 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 -37.22 71.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.552 -0.718 . . . . 0.0 110.492 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.33 -42.64 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 58.9 ttm -59.1 -45.19 91.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.602 1.161 . . . . 0.0 110.615 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -64.65 -31.75 73.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 122.861 0.464 . . . . 0.0 111.477 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.94 70.17 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.734 -0.604 . . . . 0.0 111.055 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.47 -39.93 86.83 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.28 -46.69 94.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 124.354 1.062 . . . . 0.0 108.947 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -61.24 -39.51 90.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.547 0.739 . . . . 0.0 112.173 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 t -64.06 -52.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.333 1.053 . . . . 0.0 109.575 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.32 -18.67 61.76 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.7 -0.625 . . . . 0.0 111.297 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.51 8.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 121.227 -0.92 . . . . 0.0 109.197 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tt -51.95 -42.01 62.53 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 126.793 2.037 . . . . 0.0 112.832 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 26.5 m -64.56 -11.38 10.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.481 -0.762 . . . . 0.0 112.515 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 16.7 m -67.95 -15.36 63.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.701 -1.25 . . . . 0.0 110.831 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.49 65.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.437 -1.414 . . . . 0.0 111.448 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.87 -46.37 13.09 Favored 'General case' 0 CA--C 1.5 -0.979 0 O-C-N 120.78 -1.2 . . . . 0.0 107.963 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -65.05 -32.47 74.21 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.222 1.009 . . . . 0.0 112.34 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.32 -11.68 60.58 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 120.839 -1.163 . . . . 0.0 111.874 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 51.3 p -82.01 -19.48 40.37 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 120.074 -1.641 . . . . 0.0 109.171 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.27 -16.16 59.86 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.675 -0.641 . . . . 0.0 112.026 -165.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -91.16 -23.69 20.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.874 0.845 . . . . 0.0 110.743 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.02 -29.21 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 O-C-N 120.135 -1.603 . . . . 0.0 108.297 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -62.44 -7.56 4.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.495 1.118 . . . . 0.0 112.961 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -75.51 -26.71 58.34 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.284 -1.51 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 160.4 14.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . 0.499 8.9 pt-20 61.68 -37.14 0.11 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.788 2.435 . . . . 0.0 115.31 -167.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -63.02 -49.48 74.46 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 121.122 1.783 . . . . 0.0 110.368 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 13.0 ttp85 -77.38 -12.94 60.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.333 0.587 . . . . 0.0 111.411 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.61 -29.12 16.3 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.393 -0.817 . . . . 0.0 109.659 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.94 50.47 Favored Glycine 0 C--N 1.343 0.952 0 C-N-CA 124.276 0.941 . . . . 0.0 111.153 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 28.1 t60 . . . . . 0 C--N 1.35 0.615 0 C-N-CA 124.936 1.294 . . . . 0.0 111.507 -174.548 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.57 150.63 21.66 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.03 -43.59 98.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -18.58 63.74 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.201 -0.937 . . . . 0.0 112.385 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -76.58 -44.07 36.11 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -68.06 -36.42 79.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.427 0.632 . . . . 0.0 109.564 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.07 -51.04 67.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.158 2.583 . . . . 0.0 110.016 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.37 81.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.655 1.182 . . . . 0.0 111.901 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -40.67 84.67 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.208 -0.933 . . . . 0.0 110.186 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -68.69 -27.16 65.71 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 121.192 -0.943 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.22 70.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.473 -1.392 . . . . 0.0 111.87 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -67.02 -25.35 66.24 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.568 -0.707 . . . . 0.0 112.032 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.94 -35.76 64.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 109.08 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.61 -17.17 56.46 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.647 -0.658 . . . . 0.0 109.489 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.459 HD13 ' HA2' ' D' ' 78' ' ' GLY . 13.2 tp -68.78 -44.64 73.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.225 -0.922 . . . . 0.0 109.187 171.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.88 -41.05 67.14 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 111.169 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -53.45 -47.79 69.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.324 1.85 . . . . 0.0 112.123 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -87.83 -33.02 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 O-C-N 121.005 -1.06 . . . . 0.0 111.123 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.55 -49.95 74.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 127.863 2.465 . . . . 0.0 109.859 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.12 -42.87 72.06 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.27 -31.24 72.33 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.653 -0.654 . . . . 0.0 112.012 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.72 71.73 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.469 0.708 . . . . 0.0 111.278 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 92.3 p -67.15 -41.0 86.76 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.99 -27.68 61.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 109.723 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -79.61 -51.34 9.4 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.21 97.46 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 111.731 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.49 -29.42 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 119.413 -2.054 . . . . 0.0 112.106 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -89.05 -27.34 20.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 66' ' ' GLU . . . -68.54 -57.09 6.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.935 1.694 . . . . 0.0 108.358 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.43 -7.9 46.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.359 0.663 . . . . 0.0 112.53 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.12 99.55 1.5 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 120.075 -1.641 . . . . 0.0 109.263 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 4.19 35.1 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.5 138.53 26.78 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 118.649 1.224 . . . . 0.0 108.689 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.52 139.49 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.491 2.128 . . . . 0.0 110.178 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.1 16.5 80.65 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.14 147.21 53.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.343 0.657 . . . . 0.0 110.74 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 -35.99 5.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -89.07 136.58 32.94 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 pt -165.89 172.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.6 m 67.65 129.07 0.02 OUTLIER 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.973 2.509 . . . . 0.0 114.285 167.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -61.78 -57.72 22.59 Favored Pre-proline 0 C--N 1.351 0.659 0 CA-C-O 116.976 -1.487 . . . . 0.0 113.397 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.48 -12.13 22.62 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 124.482 2.637 . . . . 0.0 110.653 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.79 -38.83 20.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -36.71 81.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.733 1.213 . . . . 0.0 112.016 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.29 -30.39 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.656 -0.653 . . . . 0.0 110.55 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 -19.5 56.93 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.08 -1.013 . . . . 0.0 110.764 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -91.25 -30.33 16.68 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.94 -37.56 87.86 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.501 -1.375 . . . . 0.0 110.489 -173.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.21 -25.96 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 123.357 0.663 . . . . 0.0 112.091 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.52 -45.81 21.05 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.242 1.017 . . . . 0.0 110.485 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -77.19 -24.52 51.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 120.784 -1.198 . . . . 0.0 109.581 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.38 -29.69 62.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.196 0.598 . . . . 0.0 110.051 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 25.6 p -92.15 -2.46 56.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 118.283 0.492 . . . . 0.0 110.72 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 55.3 p 54.39 59.41 4.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.095 2.158 . . . . 0.0 112.976 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.575 HG23 ' H ' ' D' ' 56' ' ' GLY . 27.4 m -102.98 -75.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.575 ' H ' HG23 ' D' ' 55' ' ' VAL . . . 91.04 54.3 2.05 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -19.53 63.94 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 122.093 0.949 . . . . 0.0 111.87 -170.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.2 11.1 22.82 Favored Glycine 0 CA--C 1.49 -1.481 0 O-C-N 120.325 -1.484 . . . . 0.0 111.421 168.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -68.84 -52.14 33.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.926 -0.749 . . . . 0.0 110.924 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -139.57 163.25 33.07 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.42 151.26 26.9 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -171.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.05 -179.98 5.95 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 124.346 3.364 . . . . 0.0 109.469 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.44 HG13 ' H ' ' D' ' 64' ' ' THR 0.324 3.7 p -123.13 -89.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 CA-C-N 120.705 1.593 . . . . 0.0 111.869 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.44 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.5 m -152.32 -50.31 0.11 Allowed 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 119.376 -2.077 . . . . 0.0 107.019 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.44 -5.66 59.22 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.731 1.212 . . . . 0.0 110.878 -168.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' D' ' 29' ' ' ALA . 2.8 pm0 -66.1 -34.39 77.96 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 120.64 -1.287 . . . . 0.0 107.588 165.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.25 88.52 1.32 Allowed Glycine 0 N--CA 1.419 -2.488 1 N-CA-C 98.784 -5.726 . . . . 0.0 98.784 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . . . . . . . . . 26.5 ttm-85 -55.6 -19.81 11.5 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 125.768 1.627 . . . . 0.0 111.076 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -58.27 -17.1 16.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.1 -47.88 76.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 120.064 1.302 . . . . 0.0 108.424 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.1 78.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -53.37 -44.13 68.33 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.536 1.534 . . . . 0.0 112.328 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -60.38 -47.58 85.44 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.039 0.936 . . . . 0.0 110.51 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.01 -34.28 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 43.3 mtt -56.74 -50.89 70.9 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.838 0.828 . . . . 0.0 110.437 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -68.81 -29.83 68.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 121.876 -0.515 . . . . 0.0 110.42 -171.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.32 71.7 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.953 -0.467 . . . . 0.0 110.303 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -62.05 -46.32 94.28 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 123.927 0.775 . . . . 0.0 111.733 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 98.6 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.9 0.88 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.56 -30.8 71.18 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.957 -1.089 . . . . 0.0 112.521 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 21.0 t -65.87 -53.77 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 109.121 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.5 -35.2 77.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 121.704 -0.623 . . . . 0.0 110.429 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.0 74.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 121.392 -0.818 . . . . 0.0 111.256 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.46 -28.56 69.31 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.608 -1.307 . . . . 0.0 110.929 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.5 -7.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.045 1.338 . . . . 0.0 110.944 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 57.8 m -58.84 -21.23 56.33 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 118.937 -2.352 . . . . 0.0 112.315 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.09 -29.15 67.14 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 120.762 -1.211 . . . . 0.0 110.881 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 -46.54 14.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.988 -1.695 . . . . 0.0 109.163 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.6 -47.58 72.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -167.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.42 -9.84 58.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.112 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -77.72 -38.33 47.43 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 120.447 -1.408 . . . . 0.0 108.148 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . 0.27 55.2 m-20 -83.07 8.64 12.33 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.376 -1.452 . . . . 0.0 112.591 -155.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -96.93 -38.06 9.96 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 117.573 -1.203 . . . . 0.0 111.514 161.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.18 -20.46 27.57 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-N 120.789 1.631 . . . . 0.0 111.113 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -54.08 -22.93 12.06 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.642 1.177 . . . . 0.0 112.308 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.08 -21.73 9.21 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.715 1.606 . . . . 0.0 113.008 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -76.89 -49.18 16.27 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -98.47 -160.36 0.8 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.65 -60.57 0.27 Allowed 'General case' 0 C--N 1.355 0.817 0 C-N-CA 127.506 2.323 . . . . 0.0 110.975 -169.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -59.47 -36.32 75.77 Favored 'General case' 0 N--CA 1.433 -1.317 1 C-N-CA 132.563 4.345 . . . . 0.0 111.181 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -79.15 -21.5 46.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.311 -0.868 . . . . 0.0 110.705 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.83 15.55 61.18 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 121.715 -0.616 . . . . 0.0 112.057 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 CA--C 1.501 -0.919 0 O-C-N 120.568 -1.548 . . . . 0.0 108.544 178.734 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.03 165.16 18.81 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.704 -0.623 . . . . 0.0 109.49 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.0 -62.55 0.71 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 128.037 2.535 . . . . 0.0 112.631 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -64.61 -23.41 67.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 113.974 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -82.78 -44.41 15.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.7 -40.84 98.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.335 1.054 . . . . 0.0 110.401 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.41 -29.72 67.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.357 0.598 . . . . 0.0 110.658 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.44 86.65 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.271 -0.893 . . . . 0.0 110.479 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -63.17 -43.62 97.74 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.577 -0.702 . . . . 0.0 110.5 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.7 -42.36 75.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.084 1.754 . . . . 0.0 110.419 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.32 93.01 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.441 1.096 . . . . 0.0 110.702 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -63.95 -36.52 84.22 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -74.61 -25.91 59.55 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.798 -1.189 . . . . 0.0 111.875 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.52 -35.95 63.18 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.77 -42.51 79.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.417 1.087 . . . . 0.0 111.874 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.0 -34.19 69.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.129 1.372 . . . . 0.0 112.203 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -74.85 -35.17 62.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.621 -0.674 . . . . 0.0 109.392 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.98 -33.76 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.47 -42.69 92.6 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.459 -0.775 . . . . 0.0 112.0 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.65 -42.61 74.01 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 122.098 -0.376 . . . . 0.0 110.493 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.89 -40.65 87.82 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.703 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.19 79.39 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 125.043 1.337 . . . . 0.0 111.479 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -52.56 -47.02 67.05 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 126.016 1.726 . . . . 0.0 109.938 175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -65.39 -46.2 80.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.265 1.026 . . . . 0.0 109.985 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.99 -43.18 88.53 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 123.885 0.874 . . . . 0.0 110.563 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.67 71.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.694 1.198 . . . . 0.0 111.527 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.28 -51.79 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 O-C-N 120.765 -1.209 . . . . 0.0 109.912 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.46 -28.86 63.19 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.722 -0.612 . . . . 0.0 111.092 -166.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.0 81.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.608 0.763 . . . . 0.0 110.311 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.73 -88.93 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 122.545 0.338 . . . . 0.0 111.51 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 20.09 67.59 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 128.302 2.641 . . . . 0.0 116.69 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.29 -23.45 4.31 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 133.63 90.76 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -174.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.62 125.39 4.94 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.35 2.033 . . . . 0.0 111.71 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.7 54.06 Favored Glycine 0 CA--C 1.485 -1.805 0 CA-C-O 117.906 -1.497 . . . . 0.0 109.828 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -32.1 -65.21 0.15 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 114.345 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 73.39 -15.54 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.769 1.627 . . . . 0.0 111.297 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.2 118.23 36.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 pt -143.72 0.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.843 -0.536 . . . . 0.0 111.235 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.9 m -128.24 130.62 48.21 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 120.372 -1.455 . . . . 0.0 109.449 -165.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -57.22 -50.31 88.89 Favored Pre-proline 0 C--N 1.351 0.64 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.783 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.38 -11.98 24.93 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 125.301 2.929 . . . . 0.0 111.881 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.79 -25.09 16.19 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.19 -35.11 78.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 123.656 0.783 . . . . 0.0 111.432 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -69.91 -33.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -31.84 61.04 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 121.333 -0.854 . . . . 0.0 109.739 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -65.33 -45.18 85.27 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.523 1.129 . . . . 0.0 108.919 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -34.33 68.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.243 1.417 . . . . 0.0 111.419 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.89 -52.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 124.254 1.022 . . . . 0.0 110.719 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.21 -22.84 60.36 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 121.537 -0.727 . . . . 0.0 110.961 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.7 m -73.34 -39.49 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.22 64.95 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 121.264 -0.898 . . . . 0.0 111.546 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 p -88.23 12.12 14.69 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.371 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 p 48.96 61.33 3.17 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.949 1.7 . . . . 0.0 112.717 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 56' ' ' GLY . 2.4 p -128.48 -77.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 55' ' ' VAL . . . 82.88 75.04 1.18 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -69.17 -34.19 74.56 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.985 -1.303 . . . . 0.0 110.787 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.13 38.61 0.25 Allowed Glycine 0 CA--C 1.487 -1.714 0 N-CA-C 107.926 -2.069 . . . . 0.0 107.926 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.85 -48.2 22.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -135.3 178.89 6.68 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -149.16 93.89 4.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.131 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.18 166.23 30.54 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.572 2.181 . . . . 0.0 110.842 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 64' ' ' THR . 11.8 p -141.89 177.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 123.002 1.382 . . . . 0.0 107.908 -170.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 63' ' ' VAL . 16.9 m -65.19 -25.01 67.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.853 2.461 . . . . 0.0 112.585 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -75.51 -36.23 60.59 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.304 1.042 . . . . 0.0 109.056 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -53.21 58.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.91 66.67 0.37 Allowed Glycine 0 CA--C 1.461 -3.334 1 N-CA-C 100.797 -4.921 . . . . 0.0 100.797 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.5 ttm-85 -23.18 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.382 2.017 1 C-N-CA 132.258 4.223 . . . . 0.0 115.921 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -54.79 -6.82 0.13 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 116.622 -1.656 . . . . 0.0 115.389 167.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.265 54.8 t -76.01 -46.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.365 1.26 0 CA-C-N 123.771 2.987 . . . . 0.0 107.809 167.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.7 67.75 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.435 1.016 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.64 -34.61 73.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.474 1.11 . . . . 0.0 112.258 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.74 -40.36 84.16 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 120.728 -1.232 . . . . 0.0 110.365 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.38 -43.14 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.3 mtt -59.23 -45.83 90.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 110.147 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.85 -40.44 92.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.929 0.892 . . . . 0.0 111.683 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 81.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.788 0.835 . . . . 0.0 111.071 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.88 -46.22 90.13 Favored Glycine 0 C--N 1.35 1.326 0 C-N-CA 124.678 1.132 . . . . 0.0 110.446 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.04 -41.17 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.894 0.877 . . . . 0.0 109.376 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -59.7 -52.03 67.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.202 -0.936 . . . . 0.0 111.625 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.55 -41.69 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 121.959 -0.463 . . . . 0.0 110.527 -172.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.8 -39.46 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 123.025 0.53 . . . . 0.0 109.688 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 121.42 -0.8 . . . . 0.0 110.919 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.16 -24.85 64.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 121.021 -1.05 . . . . 0.0 111.538 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.92 -15.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 O-C-N 121.012 -1.055 . . . . 0.0 110.697 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.9 m -53.57 -25.38 16.97 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.023 -1.673 . . . . 0.0 113.067 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.0 66.68 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 120.509 -1.369 . . . . 0.0 111.294 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.96 -52.75 5.52 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 108.738 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.1 mt -59.34 -40.25 85.74 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.303 1.041 . . . . 0.0 112.958 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.5 -19.37 62.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 121.073 -1.017 . . . . 0.0 111.228 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.2 p -72.26 -22.32 61.24 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.221 -1.549 . . . . 0.0 110.283 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.86 -5.67 55.92 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.924 -1.11 . . . . 0.0 112.128 -167.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -92.78 -22.72 19.17 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.867 -1.77 . . . . 0.0 109.347 168.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -76.84 -37.72 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 107.983 -170.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -57.9 -18.44 22.98 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.413 1.485 . . . . 0.0 112.479 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -64.97 -32.72 74.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.758 -1.214 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.43 -32.2 66.13 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.038 -1.039 . . . . 0.0 108.917 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.13 -48.3 68.5 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.42 -37.1 84.51 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.518 1.127 . . . . 0.0 110.585 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -61.19 -33.76 73.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.893 1.277 . . . . 0.0 112.115 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -80.61 -24.31 39.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.424 -1.423 . . . . 0.0 110.141 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.53 63.81 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 61.6 t60 . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.146 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . 0.392 . . 21.78 -122.94 0.01 OUTLIER 'General case' 0 C--N 1.353 0.737 0 C-N-CA 129.135 2.974 . . . . 0.0 115.688 -169.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.88 -55.94 0.42 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -165.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -4.27 58.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.881 -1.137 . . . . 0.0 112.159 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -29.75 56.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.787 1.235 . . . . 0.0 108.37 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -70.85 -33.78 70.98 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.931 -1.106 . . . . 0.0 110.432 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.87 -38.81 92.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 122.174 0.988 . . . . 0.0 109.236 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' B' ' 85' ' ' VAL . . . -66.06 -38.51 88.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.541 0.737 . . . . 0.0 111.711 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.13 -41.04 86.82 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.698 -0.626 . . . . 0.0 110.362 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -62.56 -30.96 71.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.625 1.17 . . . . 0.0 111.139 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.414 -0.804 . . . . 0.0 111.354 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -67.58 -33.78 75.71 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.459 -0.776 . . . . 0.0 109.639 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.38 -35.56 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.517 1.127 . . . . 0.0 111.04 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.32 -40.44 95.92 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.78 0.832 . . . . 0.0 109.156 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.728 -0.607 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -58.4 -38.95 78.4 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.094 0.958 . . . . 0.0 112.006 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -62.78 -44.65 95.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.228 1.011 . . . . 0.0 109.452 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.5 -33.39 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.046 0.938 . . . . 0.0 110.062 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.49 HD13 HG22 ' B' ' 49' ' ' VAL . 20.9 mt -66.92 -36.37 82.09 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.52 -1.362 . . . . 0.0 111.205 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -72.01 -35.17 69.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.514 -0.741 . . . . 0.0 110.435 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.723 -1.236 . . . . 0.0 109.189 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.7 74.32 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 126.251 1.82 . . . . 0.0 111.69 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.44 -36.11 63.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -43.16 85.64 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 123.814 0.846 . . . . 0.0 109.18 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.96 -51.73 44.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.816 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.37 96.98 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 124.066 0.946 . . . . 0.0 111.482 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -67.57 -44.78 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 121.112 -0.992 . . . . 0.0 109.501 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -50.59 31.74 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 110.289 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.64 -29.06 67.47 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 121.451 -0.78 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -67.06 100.47 0.76 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.352 -1.468 . . . . 0.0 111.413 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.31 -30.18 3.35 Favored Glycine 0 CA--C 1.488 -1.655 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.08 60.21 Favored Pre-proline 0 N--CA 1.443 -0.781 0 C-N-CA 123.588 0.755 . . . . 0.0 110.478 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.72 148.31 12.42 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 C-N-CA 122.553 2.169 . . . . 0.0 109.449 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.58 -17.18 45.93 Favored Glycine 0 CA--C 1.489 -1.538 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.19 114.36 2.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.002 2.521 . . . . 0.0 107.835 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.78 -18.46 14.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -84.29 -8.67 58.95 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.725 0.81 . . . . 0.0 108.901 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 tt -54.02 69.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 128.809 2.844 . . . . 0.0 114.981 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -140.66 -122.01 0.11 Allowed 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 119.476 -2.015 . . . . 0.0 107.373 -165.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -179.21 -67.45 0.0 OUTLIER Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.9 -29.09 18.95 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 125.201 2.893 . . . . 0.0 111.491 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -91.17 0.85 57.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.407 1.083 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.58 64.32 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.246 -0.909 . . . . 0.0 108.712 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -72.52 -20.46 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 123.084 0.554 . . . . 0.0 110.478 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -66.32 -47.55 73.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -67.06 -44.04 81.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.879 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.3 m -56.02 -33.55 65.01 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.49 HG22 HD13 ' B' ' 19' ' ' LEU . 58.3 t -74.0 -41.52 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.93 -40.73 94.33 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -57.1 -37.51 72.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.653 1.181 . . . . 0.0 111.608 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.18 -22.42 63.91 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 123.089 0.556 . . . . 0.0 112.119 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 62.0 p -84.67 -14.57 48.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.422 HG22 ' HB2' ' B' ' 75' ' ' MET 0.291 19.9 p 76.19 0.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.569 2.348 . . . . 0.0 111.18 -178.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.65 -50.1 77.29 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 C-N-CA 123.465 0.706 . . . . 0.0 109.424 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.93 47.1 92.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.273 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -45.63 -32.31 2.3 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.72 12.46 5.0 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.95 -54.98 16.61 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.628 -0.925 . . . . 0.0 111.108 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -121.78 156.12 33.85 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.83 139.52 34.83 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 102.08 -3.304 . . . . 0.0 102.08 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.11 -173.26 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.145 3.23 . . . . 0.0 108.873 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.664 HG22 ' H ' ' B' ' 64' ' ' THR . 12.9 p -137.23 -158.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.664 ' H ' HG22 ' B' ' 63' ' ' VAL . 53.2 m -92.92 -39.18 11.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 109.672 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.35 -23.59 59.05 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.386 -0.821 . . . . 0.0 110.612 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -29.33 70.59 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 123.732 1.73 . . . . 0.0 108.254 173.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.86 67.21 1.18 Allowed Glycine 0 CA--C 1.461 -3.321 1 N-CA-C 102.335 -4.306 . . . . 0.0 102.335 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -29.61 -24.43 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 133.034 4.534 . . . . 0.0 115.342 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -62.82 0.68 0.49 Allowed 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 125.961 1.704 . . . . 0.0 114.03 165.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.24 -56.11 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.125 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 165.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.21 -43.6 78.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.228 1.411 . . . . 0.0 111.487 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.04 -46.4 61.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.484 1.914 . . . . 0.0 110.805 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.18 -40.13 86.52 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.353 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.23 -49.0 79.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 119.19 0.905 . . . . 0.0 110.055 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.422 ' HB2' HG22 ' B' ' 54' ' ' THR . 21.3 ptp -68.08 -41.45 81.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.936 -0.478 . . . . 0.0 110.338 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -69.37 -32.85 72.15 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.08 89.77 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 123.292 0.637 . . . . 0.0 110.457 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.41 -49.69 63.94 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.42 -51.25 66.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 109.841 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.77 -7.11 56.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.519 -1.363 . . . . 0.0 112.954 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -83.86 -54.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -60.66 -29.79 69.5 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.73 0.812 . . . . 0.0 110.155 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.09 -19.74 36.21 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.418 0.687 . . . . 0.0 112.58 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.74 -37.32 59.45 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 119.153 -2.217 . . . . 0.0 107.747 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' B' ' 8' ' ' ALA . 10.4 m -73.07 -5.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 121.383 -0.823 . . . . 0.0 111.544 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 40.1 m -55.96 -20.54 16.67 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 110.593 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.94 95.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 119.859 -1.776 . . . . 0.0 113.032 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.25 70.55 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 124.516 1.127 . . . . 0.0 108.042 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.54 -27.61 61.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.53 75.48 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.775 -1.828 . . . . 0.0 110.594 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -12.32 28.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.006 -1.059 . . . . 0.0 112.577 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.38 -15.66 61.85 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 119.789 1.177 . . . . 0.0 111.12 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' C' ' 91' ' ' THR . 5.4 p90 -76.14 -26.64 56.51 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.336 -1.477 . . . . 0.0 111.067 171.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.93 -34.0 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.135 0.974 . . . . 0.0 108.504 -171.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -61.59 -20.01 62.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.501 1.12 . . . . 0.0 112.348 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -64.66 -32.93 74.82 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 123.77 0.828 . . . . 0.0 110.813 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -71.94 -32.45 67.34 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 120.479 -1.388 . . . . 0.0 109.938 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.62 -42.55 86.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.11 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' HE1' ' B' ' 103' ' ' HIS . 61.6 mm-40 -76.11 -9.63 58.78 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -69.83 -27.6 65.0 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 120.987 -1.071 . . . . 0.0 109.82 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -79.03 -31.92 44.78 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.57 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.57 -11.49 64.86 Favored Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.412 ' HE1' ' OE2' ' B' ' 99' ' ' GLU . 80.9 m80 . . . . . 0 CA--C 1.508 -0.645 0 C-N-CA 125.321 1.448 . . . . 0.0 108.739 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.23 -100.47 0.06 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 127.841 2.456 . . . . 0.0 111.585 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -171.49 -62.92 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.428 ' CD2' ' HB1' ' C' ' 88' ' ' ALA . 1.4 p-80 -58.86 -28.96 66.59 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 127.082 2.153 . . . . 0.0 113.492 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.86 -32.86 72.84 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.848 1.259 . . . . 0.0 109.92 -168.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -65.35 -43.67 90.11 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.533 1.133 . . . . 0.0 109.992 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -72.11 -37.06 69.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.986 0.914 . . . . 0.0 108.915 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.16 95.89 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -71.3 -35.36 71.26 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.899 0.88 . . . . 0.0 110.317 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.3 88.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.085 0.954 . . . . 0.0 111.833 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.8 -33.83 76.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 121.42 -0.8 . . . . 0.0 111.623 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.01 -35.2 74.19 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.658 0.742 . . . . 0.0 109.601 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -69.62 -29.71 67.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.534 0.734 . . . . 0.0 110.24 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.94 -40.84 95.64 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.77 -34.96 75.27 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.55 -0.719 . . . . 0.0 110.775 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -64.48 -40.72 96.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.505 1.122 . . . . 0.0 111.23 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.4 -31.36 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.618 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.49 -50.23 74.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 126.223 1.809 . . . . 0.0 109.543 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -72.69 -23.93 60.94 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.88 -1.137 . . . . 0.0 110.601 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -72.36 -37.15 68.88 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 -31.58 72.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 124.156 0.982 . . . . 0.0 112.178 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -58.21 -45.23 88.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.894 1.331 . . . . 0.0 111.578 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -70.63 -47.16 61.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.181 1.792 . . . . 0.0 107.506 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -65.28 -31.0 71.92 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 124.452 1.101 . . . . 0.0 112.674 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.69 68.61 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.93 1.292 . . . . 0.0 110.391 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.43 -36.86 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.399 0.68 . . . . 0.0 110.348 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.72 -38.95 89.81 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.466 -0.772 . . . . 0.0 109.701 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.41 71.54 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.175 1.79 . . . . 0.0 111.562 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -67.32 -24.33 65.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 125.178 1.391 . . . . 0.0 112.307 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -91.91 115.95 28.5 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.79 -48.26 0.98 Allowed Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.88 150.52 38.72 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.322 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.81 162.89 18.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.821 1.681 . . . . 0.0 110.263 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 30.76 12.8 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.11 137.14 56.11 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 117.995 0.898 . . . . 0.0 111.94 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.62 -41.96 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 123.828 0.851 . . . . 0.0 110.024 -170.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.85 -27.04 57.67 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.866 1.266 . . . . 0.0 108.412 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 tp -37.22 106.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 127.911 2.484 . . . . 0.0 113.343 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t -172.03 -131.39 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.3 -70.42 0.0 OUTLIER Pre-proline 0 C--N 1.353 0.731 0 CA-C-O 116.914 -1.517 . . . . 0.0 107.038 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.21 -11.55 19.32 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 CA-C-N 125.004 2.823 . . . . 0.0 111.925 -163.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.57 1.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.341 2.657 . . . . 0.0 107.725 -175.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.28 -34.38 70.61 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.065 0.936 . . . . 0.0 110.214 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.01 -19.5 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 125.334 1.454 . . . . 0.0 109.994 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -50.85 28.77 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.599 -1.938 . . . . 0.0 107.511 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -63.32 -34.25 77.29 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 121.957 0.884 . . . . 0.0 111.399 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -73.06 -31.16 64.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 119.587 -1.945 . . . . 0.0 110.907 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.95 -53.39 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 123.922 0.889 . . . . 0.0 108.677 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' C' ' 56' ' ' GLY . 20.3 pt-20 -64.37 -30.91 71.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.014 0.526 . . . . 0.0 111.773 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 79.5 m -70.83 -48.37 54.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.814 0.846 . . . . 0.0 110.754 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -27.52 64.38 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.792 -1.193 . . . . 0.0 111.232 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -85.37 -4.26 59.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.927 -0.483 . . . . 0.0 111.124 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p 55.23 64.2 1.86 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 125.495 1.518 . . . . 0.0 112.059 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.86 -87.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 101.592 -3.485 . . . . 0.0 101.592 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' C' ' 50' ' ' GLU . . . 87.21 80.73 1.21 Allowed Glycine 0 CA--C 1.494 -1.254 0 N-CA-C 104.722 -3.351 . . . . 0.0 104.722 -172.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.447 ' CD2' ' HA3' ' D' ' 56' ' ' GLY . 17.8 t80 -76.34 -30.37 57.61 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.97 35.22 3.77 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.99 -38.44 57.39 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -135.07 157.34 47.19 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -129.41 138.11 32.42 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.37 168.04 22.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.515 2.143 . . . . 0.0 109.307 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' C' ' 63' ' ' VAL . 1.1 m -63.74 175.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 122.242 1.02 . . . . 0.0 111.688 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -83.36 -88.06 0.1 Allowed 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 120.958 -1.089 . . . . 0.0 108.323 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -34.17 -58.03 0.47 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.954 2.502 . . . . 0.0 116.589 -169.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -82.67 -98.93 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.68 -86.52 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.378 0 C-N-CA 126.395 1.95 . . . . 0.0 113.496 160.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -58.11 -42.43 85.72 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.301 1.44 . . . . 0.0 112.157 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -58.87 -27.08 64.84 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 118.902 -2.374 . . . . 0.0 112.283 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.18 -55.25 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.5 77.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 126.001 1.721 . . . . 0.0 112.713 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.0 -43.06 73.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 128.428 2.691 . . . . 0.0 108.555 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -68.2 -43.71 77.46 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 123.894 0.878 . . . . 0.0 110.188 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.51 -48.88 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 124.32 1.048 . . . . 0.0 110.16 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 23.2 ptp -66.56 -34.47 77.98 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.557 -0.715 . . . . 0.0 110.333 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -68.7 -30.53 69.2 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.308 -0.87 . . . . 0.0 110.744 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.11 86.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.909 -0.494 . . . . 0.0 110.206 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.42 92.0 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 123.823 0.725 . . . . 0.0 111.338 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -54.7 -47.46 73.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 125.378 1.471 . . . . 0.0 110.527 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -70.25 -28.41 65.21 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.769 -0.582 . . . . 0.0 112.027 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.58 -48.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 121.008 -1.057 . . . . 0.0 109.509 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -67.14 -25.85 66.38 Favored 'General case' 0 CA--C 1.509 -0.609 0 O-C-N 121.495 -0.753 . . . . 0.0 110.927 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.39 -36.89 57.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.79 -41.83 97.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 124.676 1.19 . . . . 0.0 110.516 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.04 -9.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 O-C-N 121.113 -0.992 . . . . 0.0 111.673 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -19.46 64.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 110.078 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.86 -32.94 74.88 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.434 1.093 . . . . 0.0 111.771 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -73.88 -31.4 63.12 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.446 1.098 . . . . 0.0 109.914 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 -32.68 26.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.56 63.64 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.003 -1.061 . . . . 0.0 111.161 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.438 HG23 ' HB2' ' B' ' 93' ' ' PHE . 8.7 p -75.66 -10.82 59.77 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 120.035 -1.665 . . . . 0.0 110.823 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . 0.337 46.5 m-20 -90.9 -0.77 57.82 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.582 -1.647 . . . . 0.0 109.511 -158.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -89.01 -10.37 47.85 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.906 161.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 t -96.13 -51.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.49 -17.87 24.5 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.396 2.279 . . . . 0.0 111.983 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -68.01 -12.57 61.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.655 -1.278 . . . . 0.0 112.255 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -63.41 145.95 54.55 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 119.956 -1.715 . . . . 0.0 108.097 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 69.01 -63.93 0.35 Allowed 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.204 1.402 . . . . 0.0 111.915 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -63.04 -19.07 64.02 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.05 1.74 . . . . 0.0 111.563 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.8 -33.04 74.37 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.87 -1.144 . . . . 0.0 111.5 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -66.94 -40.28 87.51 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.467 -0.771 . . . . 0.0 109.512 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.83 44.66 19.11 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 CA--C 1.492 -1.26 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 177.049 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.15 80.88 0.06 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.789 2.435 . . . . 0.0 114.006 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -28.91 70.38 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.117 -0.989 . . . . 0.0 112.703 -169.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.447 ' HE1' ' OE2' ' D' ' 5' ' ' GLU . 21.2 p80 -63.02 -33.19 74.89 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.202 -0.936 . . . . 0.0 112.44 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.447 ' OE2' ' HE1' ' D' ' 4' ' ' HIS . 10.8 mt-10 -80.44 -31.99 37.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.876 -1.14 . . . . 0.0 108.812 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.16 -35.96 74.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.902 -1.124 . . . . 0.0 110.725 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.25 -38.99 93.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.947 1.699 . . . . 0.0 110.154 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.21 92.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.153 0.981 . . . . 0.0 111.896 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -65.34 -32.94 74.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.522 1.129 . . . . 0.0 111.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -68.79 -36.16 77.93 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.742 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.63 94.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.485 0.714 . . . . 0.0 110.752 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.19 -44.14 87.91 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.416 1.086 . . . . 0.0 111.525 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -68.34 -44.1 76.06 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.266 1.026 . . . . 0.0 109.148 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -68.41 -31.57 71.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.584 -0.698 . . . . 0.0 110.409 -174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.43 -44.03 92.99 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.509 0.723 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.0 -30.83 71.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -65.91 -41.04 91.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.732 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.67 -38.28 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 C-N-CA 123.965 0.906 . . . . 0.0 108.897 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 37.3 mt -60.37 -48.44 81.73 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.204 1.002 . . . . 0.0 110.279 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -67.45 -36.49 81.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.565 -0.709 . . . . 0.0 111.736 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.63 -47.48 78.4 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.66 -41.52 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 125.367 1.467 . . . . 0.0 110.997 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 58.4 m -52.21 -49.45 63.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 126.064 1.746 . . . . 0.0 112.134 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -61.94 -50.89 70.34 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -62.66 -42.9 99.87 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 117.676 -1.154 . . . . 0.0 110.12 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.34 -47.69 62.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.822 2.049 . . . . 0.0 111.519 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.9 -41.62 76.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.776 -1.202 . . . . 0.0 111.372 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.53 -16.12 37.92 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.128 0.971 . . . . 0.0 109.982 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.12 -56.74 3.89 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.798 1.639 . . . . 0.0 106.73 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.94 -33.65 76.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.999 -0.438 . . . . 0.0 110.418 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -71.3 111.9 7.0 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 120.942 -1.098 . . . . 0.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.88 -32.18 4.69 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.31 73.5 Favored Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 123.521 0.728 . . . . 0.0 110.025 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.73 110.18 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.073 1.848 . . . . 0.0 113.255 -171.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.39 42.88 2.87 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.719 -2.952 . . . . 0.0 105.719 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.01 163.71 24.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.686 1.194 . . . . 0.0 109.301 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.67 -59.59 0.76 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' D' ' 60' ' ' ARG . 8.3 tt -84.67 130.76 34.67 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 pt -150.29 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -142.1 125.74 16.88 Favored 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 119.784 -1.822 . . . . 0.0 109.362 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.04 -48.9 95.79 Favored Pre-proline 0 C--N 1.353 0.735 0 CA-C-O 116.473 -1.727 . . . . 0.0 112.282 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.36 -8.17 22.2 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 CA-C-N 125.33 2.939 . . . . 0.0 112.345 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -101.27 -19.59 15.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.27 75.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 121.043 -1.036 . . . . 0.0 111.519 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -65.92 -28.88 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.612 1.165 . . . . 0.0 110.092 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -86.19 -26.18 25.25 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.483 -0.761 . . . . 0.0 109.788 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -79.17 -34.42 43.15 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.8 m -79.06 51.07 1.1 Allowed 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.721 -0.612 . . . . 0.0 110.669 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.21 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.33 -22.92 55.04 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.416 1.486 . . . . 0.0 113.713 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.411 HG22 ' H ' ' D' ' 51' ' ' THR . 5.1 t -72.15 -35.82 69.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.666 -1.271 . . . . 0.0 109.795 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.29 42.39 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 121.035 -1.041 . . . . 0.0 109.613 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.22 -2.03 54.56 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.861 0.865 . . . . 0.0 109.615 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p 58.93 40.8 22.09 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 127.062 2.145 . . . . 0.0 112.733 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.41 65.69 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' C' ' 57' ' ' TYR . . . -70.25 99.78 0.74 Allowed Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -35.05 40.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.08 39.99 0.17 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.0 -51.38 16.12 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 118.827 1.314 . . . . 0.0 109.249 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.424 ' HD3' HD12 ' D' ' 38' ' ' LEU . 0.1 OUTLIER -141.49 173.27 11.65 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -137.16 127.93 16.16 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.08 -179.44 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.185 3.257 . . . . 0.0 109.481 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.507 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 6.8 t -112.26 -97.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 124.087 0.955 . . . . 0.0 110.076 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -165.67 -46.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -71.96 -10.22 59.47 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.507 ' CG ' ' H ' ' D' ' 63' ' ' VAL . 0.9 OUTLIER -60.84 -33.11 72.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.502 1.121 . . . . 0.0 109.996 172.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.25 -33.02 1.13 Allowed Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.391 -3.483 . . . . 0.0 104.391 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.435 ' H ' ' CD ' ' D' ' 66' ' ' GLU . 37.6 ttm180 74.09 -50.74 0.69 Allowed 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 130.071 3.348 . . . . 0.0 107.578 -171.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -71.76 12.11 0.42 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.672 2.789 . . . . 0.0 110.884 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.89 -61.03 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -49.18 69.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 123.168 0.587 . . . . 0.0 111.031 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.02 -40.24 66.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.935 0.894 . . . . 0.0 111.418 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.8 -37.03 73.26 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 121.708 -0.62 . . . . 0.0 111.348 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.36 -41.95 57.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.146 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 10.3 mtp -56.37 -51.66 67.49 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 124.826 1.251 . . . . 0.0 110.587 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.75 -40.66 97.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.388 0.675 . . . . 0.0 110.768 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.04 87.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.763 0.825 . . . . 0.0 110.985 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.63 -49.44 64.35 Favored Glycine 0 CA--C 1.496 -1.119 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.62 -49.44 80.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 124.186 0.995 . . . . 0.0 110.339 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . 0.273 11.9 pt-20 -77.95 -9.61 59.18 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 120.202 -1.561 . . . . 0.0 112.664 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.69 -47.17 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -67.47 -20.78 65.52 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 121.462 -0.774 . . . . 0.0 111.137 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.6 -14.78 29.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.659 0.742 . . . . 0.0 111.717 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.18 -38.56 56.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 119.876 -1.765 . . . . 0.0 107.651 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 6.6 m -66.96 -6.39 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.646 0.778 . . . . 0.0 111.458 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 9.1 m -63.11 -17.77 62.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.375 1.47 . . . . 0.0 111.487 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.56 62.41 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 120.053 -1.655 . . . . 0.0 111.759 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.32 6.32 17.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 125.166 1.386 . . . . 0.0 111.087 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 92.5 mt -113.47 -39.29 4.13 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.28 -13.16 61.44 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.779 -1.2 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -70.7 -19.17 62.79 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 120.956 -1.09 . . . . 0.0 110.879 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.19 7.47 46.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 119.699 1.136 . . . . 0.0 110.6 -160.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -91.99 -20.5 21.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 158.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.9 -40.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -57.75 -38.24 75.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 126.711 2.005 . . . . 0.0 111.163 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.13 -8.64 55.78 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.386 0.674 . . . . 0.0 112.732 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -105.07 148.67 26.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . 0.268 48.9 mt-10 71.58 -55.96 0.65 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 126.705 2.002 . . . . 0.0 111.813 -174.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.65 -22.18 66.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.354 1.062 . . . . 0.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -68.75 -17.69 64.09 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.641 -1.287 . . . . 0.0 113.202 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -92.49 -10.29 38.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.63 66.64 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 . . . . . 0 CA--C 1.493 -1.243 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 -175.042 . . . . . . . . 0 0 . 1 stop_ save_